PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Komuro, M; Nagane, M; Fukuyama, T; Luo, XL; Hiraki, S; Miyanabe, M; Ishikawa, M; Niwa, C; Murakami, H; Okamoto, M; Yamashita, T				Komuro, Mariko; Nagane, Masaki; Fukuyama, Tomoki; Luo, Xiaolin; Hiraki, Shinobu; Miyanabe, Masakatsu; Ishikawa, Miyuki; Niwa, Chiaki; Murakami, Hironobu; Okamoto, Mariko; Yamashita, Tadashi			Sphingomyelin maintains the cutaneous barrier via regulation of the STAT3 pathway	FASEB JOURNAL			English	Article						cutaneous barrier; sphingomyelin; STAT3	ATOPIC-DERMATITIS; SKIN BARRIER; SIGNAL TRANSDUCER; TRANSCRIPTION 3; LIPID RAFTS; STRATUM-CORNEUM; FILAGGRIN; EXPRESSION; CELLS; ACTIVATOR	Epidermal tissues play vital roles in maintaining homeostasis and preventing the dysregulation of the cutaneous barrier. Sphingomyelin (SM), a sphingolipid synthesized by sphingomyelin synthase (SMS) 1 and 2, is involved in signal transduction via modulation of lipid-raft functions. Though the implications of SMS on inflammatory diseases have been reported, its role in dermatitis has not been clarified. In this study, we investigated the role of SM in the cutaneous barrier using a dermatitis model established by employing Sgms1 and 2 deficient mice. SM deficiency impaired the cutaneous inflammation and upregulated signal transducer and activator of transcription 3 (STAT3) phosphorylation in epithelial tissues. Furthermore, using mouse embryonic fibroblast cells, the sensitivity of STAT3 to Interleukin-6 stimulation was increased in Sgms-deficient cells. Using tofacitinib, a clinical JAK inhibitor, the study showed that SM deficiency might participate in STAT3 phosphorylation via JAK activation. Overall, these results demonstrate that SM is essential for maintaining the cutaneous barrier via the STAT3 pathway, suggesting SM could be a potential therapeutic target for dermatitis treatment.	[Komuro, Mariko; Nagane, Masaki; Ishikawa, Miyuki; Niwa, Chiaki; Yamashita, Tadashi] Azabu Univ, Sch Vet Med, Lab Biochem, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2522472, Japan; [Nagane, Masaki] Azabu Univ, Ctr Human & Anim Symbiosis Sci, Sagamihara, Kanagawa, Japan; [Fukuyama, Tomoki] Azabu Univ, Sch Vet Med, Lab Pharmacol, Sagamihara, Kanagawa, Japan; [Luo, Xiaolin; Hiraki, Shinobu; Miyanabe, Masakatsu] Genuine R&D Co Ltd, Fukuoka, Japan; [Murakami, Hironobu] Azabu Univ, Sch Vet Med, Lab Anim Hlth 2, Sagamihara, Kanagawa, Japan; [Okamoto, Mariko] Azabu Univ, Sch Vet Med, Lab Vet Immunol, Sagamihara, Kanagawa, Japan	Azabu University; Azabu University; Azabu University; Azabu University; Azabu University	Yamashita, T (corresponding author), Azabu Univ, Sch Vet Med, Lab Biochem, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2522472, Japan.	yamashita@azabu-u.ac.jp	Murakami, Hironobu/O-3452-2017	Murakami, Hironobu/0000-0002-7560-4445	Japan Society for the Promotion of Science [17K08140, 19K20452]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	GENUINE R&D Co., Ltd.; Japan Society for the Promotion of Science, Grant/Award Number: 17K08140 and 19K20452	Amano W, 2015, J ALLERGY CLIN IMMUN, V136, P667, DOI 10.1016/j.jaci.2015.03.051; Ando J, 2015, P NATL ACAD SCI USA, V112, P4558, DOI 10.1073/pnas.1418088112; Asano S, 2012, MOL CELL BIOL, V32, P3242, DOI 10.1128/MCB.00121-12; Barcelo-Coblijn G, 2011, P NATL ACAD SCI USA, V108, P19569, DOI 10.1073/pnas.1115484108; Belmonte F, 2015, AM J PHYSIOL-HEART C, V309, pH271, DOI 10.1152/ajpheart.00517.2014; Berdyshev E, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98006; Bhattacharya S, 2018, J INVEST DERMATOL, V138, P1052, DOI 10.1016/j.jid.2017.11.033; Bieberich E, 2018, CHEM PHYS LIPIDS, V216, P114, DOI 10.1016/j.chemphyslip.2018.08.003; Bissonnette R, 2016, BRIT J DERMATOL, V175, P902, DOI 10.1111/bjd.14871; Cao YY, 2019, ARTIF CELL NANOMED B, V47, P3774, DOI 10.1080/21691401.2019.1667817; Chalfant CE, 2000, METHOD ENZYMOL, V312, P420; de Jong PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035070; Ding T, 2008, J LIPID RES, V49, P376, DOI 10.1194/jlr.M700401-JLR200; Elias PM, 2014, J ALLERGY CLIN IMMUN, V134, P781, DOI 10.1016/j.jaci.2014.05.048; Flanagan SE, 2014, NAT GENET, V46, P812, DOI 10.1038/ng.3040; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Fukuyama T, 2015, J PHARMACOL EXP THER, V354, P394, DOI 10.1124/jpet.115.223784; Gowda S, 2011, AM J PHYSIOL-LUNG C, V300, pL430, DOI 10.1152/ajplung.00208.2010; Graefe C, 2019, MOL BIOL REP, V46, P4631, DOI 10.1007/s11033-019-04851-2; Gupta VR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000073; Han NR, 2016, BIOMED PHARMACOTHER, V79, P71, DOI 10.1016/j.biopha.2016.01.046; Higurashi S, 2015, J DAIRY SCI, V98, P6706, DOI 10.3168/jds.2015-9529; Hillmer EJ, 2016, CYTOKINE GROWTH F R, V31, P1, DOI 10.1016/j.cytogfr.2016.05.001; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; IMOKAWA G, 1991, J INVEST DERMATOL, V96, P523, DOI 10.1111/1523-1747.ep12470233; Katsuyama Y, 2017, INT J COSMETIC SCI, V39, P49, DOI 10.1111/ics.12347; Kim JH, 2015, J ALLERGY CLIN IMMUN, V136, P205, DOI 10.1016/j.jaci.2015.04.026; Lee DY, 2017, BIOMOL THER, V25, P535, DOI 10.4062/biomolther.2017.006; Lee SY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02881; Li WJ, 2016, BBA-MOL CELL RES, V1863, P1579, DOI 10.1016/j.bbamcr.2016.04.006; Li Y, 2013, ARTERIOSCL THROM VAS, V33, P1513, DOI 10.1161/ATVBAHA.113.301498; Lyu YN, 2014, CHINESE MED J-PEKING, V127, P2389, DOI 10.3760/cma.j.issn.0366-6999.20140558; Mansouri Y, 2015, J CLIN MED, V4, P858, DOI 10.3390/jcm4050858; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Miyoshi K, 2011, J INVEST DERMATOL, V131, P108, DOI 10.1038/jid.2010.255; Nagane M, 2018, RADIAT RES, V189, P519, DOI 10.1667/RR14781.1; Nagane M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195151; Nagane M, 2013, BIOCHEM BIOPH RES CO, V437, P420, DOI 10.1016/j.bbrc.2013.06.093; Nojiri H, 2018, ARCH DERMATOL RES, V310, P495, DOI 10.1007/s00403-018-1833-9; Nomoto K, 2018, EXP DERMATOL, V27, P827, DOI 10.1111/exd.13497; Nomura T, 2008, J INVEST DERMATOL, V128, P1436, DOI 10.1038/sj.jid.5701205; Ogawa Y, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/5404093; Ohnishi T, 2017, FASEB J, V31, P3816, DOI 10.1096/fj.201601225RR; Otsuka A, 2014, J ALLERGY CLIN IMMUN, V133, P139, DOI 10.1016/j.jaci.2013.07.027; PINNAGODA J, 1990, CONTACT DERMATITIS, V22, P164, DOI 10.1111/j.1600-0536.1990.tb01553.x; Ramana CV, 2005, BIOCHEM BIOPH RES CO, V327, P727, DOI 10.1016/j.bbrc.2004.12.074; Roskoski R, 2016, PHARMACOL RES, V111, P784, DOI 10.1016/j.phrs.2016.07.038; Ryu WI, 2018, J DERMATOL SCI, V90, P313, DOI 10.1016/j.jdermsci.2018.02.017; Sahle FF, 2015, SKIN PHARMACOL PHYS, V28, P42, DOI 10.1159/000360009; Saito F, 2008, AM J RESP CELL MOL, V38, P566, DOI 10.1165/rcmb.2007-0299OC; Samavati L, 2009, MOL IMMUNOL, V46, P1867, DOI 10.1016/j.molimm.2009.02.018; Seltmann J, 2015, J ALLERGY CLIN IMMUN, V135, P1659, DOI 10.1016/j.jaci.2015.01.048; Shen CP, 2018, DERMATITIS, V29, P219, DOI 10.1097/DER.0000000000000392; Siedlikowski S., 2019, EMJ DERAMTOL, V7, P89; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Spessott W, 2010, J BIOL CHEM, V285, P41472, DOI 10.1074/jbc.M110.150011; Tan Q, 2017, MOL MED REP, V16, P8863, DOI 10.3892/mmr.2017.7689; Thyssen JP, 2014, J ALLERGY CLIN IMMUN, V134, P792, DOI 10.1016/j.jaci.2014.06.014; Toshima K, 2019, INT IMMUNOL, V31, P211, DOI 10.1093/intimm/dxy082; Tsoi LC, 2019, J INVEST DERMATOL, V139, P1480, DOI 10.1016/j.jid.2018.12.018; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vannella KM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1938; Yamamoto Mina, 2007, Allergol Int, V56, P139, DOI 10.2332/allergolint.O-06-458; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; Yi L, 2017, MUCOSAL IMMUNOL, V10, P1491, DOI 10.1038/mi.2017.10	66	1	1	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22111	10.1096/fj.202100721RR	http://dx.doi.org/10.1096/fj.202100721RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35230716	hybrid			2022-12-28	WOS:000772957100010
J	Agrafioti, P; Morin-Baxter, J; Tanagala, KKK; Dubey, S; Sims, P; Lalla, E; Momen-Heravi, F				Agrafioti, Panagiota; Morin-Baxter, Joshua; Tanagala, Kranthi K. K.; Dubey, Sunil; Sims, Peter; Lalla, Evanthia; Momen-Heravi, Fatemeh			Decoding the role of macrophages in periodontitis and type 2 diabetes using single-cell RNA-sequencing	FASEB JOURNAL			English	Article						macrophages; periodontitis; single-cell RNA-sequencing; type 2 diabetes	FACTOR-KAPPA-B; TRANSCRIPTION FACTOR; COMPLICATIONS; EXPRESSION; GENE; MECHANISMS; GENOTYPES; RECEPTOR; DISEASE; TARGET	Macrophages are resident myeloid cells in the gingival tissue which control homeostasis and play a pivotal role in orchestrating the immune response in periodontitis. Cell heterogeneity and functional phenotypes of macrophage subpopulations in periodontitis remain elusive. Here, we isolated gingival tissue from periodontitis-affected and healthy sites of patients with and without type 2 diabetes mellitus (T2DM). We then used single-cell RNA-sequencing (scRNA-seq) to define the heterogeneity of tissue-resident macrophages in gingival tissue in health vs. periodontitis. scRNA-seq demonstrated an unforeseen gene expression heterogeneity among macrophages in periodontitis and showed transcriptional and signaling heterogeneity of identified subsets in an independent cohort of patients with periodontitis and T2DM. Our bioinformatic inferences indicated divergent expression profiles in macrophages driven by transcriptional regulators CIITA, RELA, RFX5, and RUNX2. Macrophages in periodontitis expressed both pro-inflammatory and anti-inflammatory markers and their polarization was not mutually exclusive. The majority of macrophages in periodontitis expressed the monocyte lineage marker CD14, indicating their bone marrow lineage. We also found high expression and activation of RELA, a subunit of the NF-kappa B transcription factor complex, in gingival macrophages of periodontitis patients with T2DM. Our data suggested that heterogeneity and hyperinflammatory activation of macrophages may be relevant to the pathogenesis and outcomes of periodontitis, and may be further augmented in patients with T2DM.	[Agrafioti, Panagiota; Tanagala, Kranthi K. K.; Dubey, Sunil; Lalla, Evanthia; Momen-Heravi, Fatemeh] Columbia Univ, Coll Dent Med, Div Periodont, Sect Oral Diagnost & Rehabil Sci, 630 W 168th St,PH7-200, New York, NY 10032 USA; [Agrafioti, Panagiota; Morin-Baxter, Joshua; Tanagala, Kranthi K. K.; Dubey, Sunil; Momen-Heravi, Fatemeh] Columbia Univ, Canc Biol & Immunol Lab, Irving Med Ctr, New York, NY 10032 USA; [Morin-Baxter, Joshua] Columbia Univ, Fu Fdn Sch Engn & Appl Sci, New York, NY 10032 USA; [Sims, Peter] Columbia Univ, Dept Syst Biol, Irving Med Ctr, New York, NY 10032 USA; [Sims, Peter] Columbia Univ, Dept Biochem & Mol Biophys, Irving Med Ctr, New York, NY 10032 USA; [Momen-Heravi, Fatemeh] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Irving Med Ctr, New York, NY 10032 USA	Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital	Momen-Heravi, F (corresponding author), Columbia Univ, Coll Dent Med, Div Periodont, Sect Oral Diagnost & Rehabil Sci, 630 W 168th St,PH7-200, New York, NY 10032 USA.	fm2540@cumc.columbia.edu		DUBEY, SUNIL KUMAR/0000-0001-7107-9148; Morin-Baxter, Joshua/0000-0001-9785-8844; Momen-Heravi, Fatemeh/0000-0003-4534-1450	HHS \ NIH \ National Institute of Dental and Craniofacial Research (NIDCR) [DE029546-01, KL2TR001874]	HHS \ NIH \ National Institute of Dental and Craniofacial Research (NIDCR)	HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR), Grant/Award Number: DE029546-01; HHS | NIH | National Center for Advancing Translational Sciences (NCATS), Grant/Award Number: KL2TR001874	Almubarak A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00330; Ambili R, 2005, J PERIODONTOL, V76, P1148, DOI 10.1902/jop.2005.76.7.1148; Arabaci Taner, 2010, Eur J Dent, V4, P454; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bagnati M, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125736; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Caetano AJ, 2021, ELIFE, V10, DOI 10.7554/eLife.62810; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; Chinniah R, 2021, IMMUNOGENETICS, V73, P291, DOI 10.1007/s00251-021-01212-x; Dambach DM, 2002, HEPATOLOGY, V35, P1093, DOI 10.1053/jhep.2002.33162; Daryabor G, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01582; Eke PI, 2020, PERIODONTOL 2000, V82, P257, DOI 10.1111/prd.12323; Franzen O, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz046; Garcia-Alonso L, 2019, GENOME RES, V29, P1363, DOI 10.1101/gr.240663.118; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gyllenberg A, 2012, GENES IMMUN, V13, P632, DOI 10.1038/gene.2012.44; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jing CZ, 2020, P NATL ACAD SCI USA, V117, P15160, DOI 10.1073/pnas.2000943117; Jotwani R, 2010, ANN NY ACAD SCI, V1192, P278, DOI 10.1111/j.1749-6632.2009.05247.x; Kelley JB, 2019, METHODS, V157, P106, DOI 10.1016/j.ymeth.2018.11.002; Kim JH, 2004, HEPATOLOGY, V39, P129, DOI 10.1002/hep.20017; Lalla E, 2000, J CLIN INVEST, V105, P1117, DOI 10.1172/JCI8942; Lalla E, 2000, PERIODONTOL 2000, V23, P50, DOI 10.1034/j.1600-0757.2000.2230104.x; Lalla E, 1998, J PERIODONTAL RES, V33, P387; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Laria A, 2016, J INFLAMM RES, V9, P1, DOI 10.2147/JIR.S82320; Lebbink RJ, 2008, J IMMUNOL, V180, P1662, DOI 10.4049/jimmunol.180.3.1662; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Martinez A, 2007, ANN RHEUM DIS, V66, P325, DOI 10.1136/ard.2006.059428; Momen-Heravi F, 2021, J DENT RES, V100, P549, DOI 10.1177/0022034520979614; Navegantes KC, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1141-8; Noursadeghi M, 2008, J IMMUNOL METHODS, V329, P194, DOI 10.1016/j.jim.2007.10.015; Ohyama H, 1996, J PERIODONTOL, V67, P888, DOI 10.1902/jop.1996.67.9.888; Papapanou PN, 2018, J CLIN PERIODONTOL, V45, pS162, DOI 10.1111/jcpe.12946; Patel J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7614; Sha H, 2017, MOL MED REP, V16, P3641, DOI 10.3892/mmr.2017.6992; Stein J, 2003, J PERIODONTAL RES, V38, P508, DOI 10.1034/j.1600-0765.2003.00683.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suryavanshi SV, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00798; Szabo PA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12464-3; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tesch GH, 2007, CLIN EXP PHARMACOL P, V34, P1016, DOI 10.1111/j.1440-1681.2007.04729.x; Trizzino M, 2021, SCI ADV, V7, DOI 10.1126/sciadv.aaz8836; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Yang JM, 2018, ARCH ORAL BIOL, V96, P234, DOI 10.1016/j.archoralbio.2017.03.006	46	5	6	9	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22136	10.1096/fj.202101198R	http://dx.doi.org/10.1096/fj.202101198R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35032412				2022-12-28	WOS:000747987800045
J	Jiang, WR; Kakizaki, T; Fujihara, K; Miyata, S; Zhang, Y; Suto, T; Kato, D; Saito, S; Shibasaki, K; Ishizaki, Y; Isoda, K; Yokoo, H; Obinata, H; Hirano, T; Miyasaka, Y; Mashimo, T; Yanagawa, Y				Jiang, Weiru; Kakizaki, Toshikazu; Fujihara, Kazuyuki; Miyata, Shigeo; Zhang, Yue; Suto, Takashi; Kato, Daiki; Saito, Shigeru; Shibasaki, Koji; Ishizaki, Yasuki; Isoda, Koji; Yokoo, Hideaki; Obinata, Hideru; Hirano, Touko; Miyasaka, Yoshiki; Mashimo, Tomoji; Yanagawa, Yuchio			Impact of GAD65 and/or GAD67 deficiency on perinatal development in rats	FASEB JOURNAL			English	Article						GABA; GAD65; GAD67; knockout rats; phenotypes	GAMMA-AMINOBUTYRIC-ACID; MICE LACKING; MESSENGER-RNA; CLEFT-PALATE; GABA; EXPRESSION; ISOFORMS; RETINA; MOUSE; FETAL	GABA is a major neurotransmitter in the mammalian central nervous system. Glutamate decarboxylase (GAD) synthesizes GABA from glutamate, and two isoforms of GAD, GAD65, and GAD67, are separately encoded by the Gad2 and Gad1 genes, respectively. The phenotypes differ in severity between GAD single isoform-deficient mice and rats. For example, GAD67 deficiency causes cleft palate and/or omphalocele in mice but not in rats. In this study, to further investigate the functional roles of GAD65 and/or GAD67 and to determine the contribution of these isoforms to GABA synthesis during development, we generated various kinds of GAD isoform(s)-deficient rats and characterized their phenotypes. The age of death was different among Gad mutant rat genotypes. In particular, all Gad1(-/-); Gad2(-/-) rats died at postnatal day 0 and showed little alveolar space in their lungs, suggesting that the cause of their death was respiratory failure. All Gad1(-/-); Gad2(-/-) rats and 18% of Gad1(-/-); Gad2(+/-) rats showed cleft palate. In contrast, none of the Gad mutant rats including Gad1(-/-); Gad2(-/-) rats, showed omphalocele. These results suggest that both rat GAD65 and GAD67 are involved in palate formation, while neither isoform is critical for abdominal wall formation. The GABA content in Gad1(-/-); Gad2(-/-) rat forebrains and retinas at embryonic day 20 was extremely low, indicating that almost all GABA was synthesized from glutamate by GADs in the perinatal period. The present study shows that Gad mutant rats are a good model for further defining the role of GABA during development.	[Jiang, Weiru; Kakizaki, Toshikazu; Fujihara, Kazuyuki; Miyata, Shigeo; Zhang, Yue; Yanagawa, Yuchio] Gunma Univ, Dept Genet & Behav Neurosci, Grad Sch Med, Maebashi, Gumma 3718511, Japan; [Zhang, Yue] Dalian Med Univ, Dept Physiol, Liaoning Prov Key Lab Cerebral Dis, Dalian, Peoples R China; [Suto, Takashi; Kato, Daiki; Saito, Shigeru] Gunma Univ, Dept Anesthesiol, Grad Sch Med, Maebashi, Gumma, Japan; [Shibasaki, Koji; Ishizaki, Yasuki] Gunma Univ, Dept Mol & Cellular Neurobiol, Grad Sch Med, Maebashi, Gumma, Japan; [Isoda, Koji; Yokoo, Hideaki] Gunma Univ, Dept Human Pathol, Grad Sch Med, Maebashi, Gumma, Japan; [Obinata, Hideru; Hirano, Touko] Gunma Univ, Educ & Res Support Ctr, Lab Analyt Instruments, Grad Sch Med, Maebashi, Gumma, Japan; [Miyasaka, Yoshiki] Osaka Univ, Grad Sch Med, Inst Expt Anim Sci, Suita, Osaka, Japan; [Mashimo, Tomoji] Univ Tokyo, Lab Anim Res Ctr, Inst Med Sci, Tokyo, Japan; [Shibasaki, Koji] Univ Nagasaki, Grad Sch Human Hlth Sci, Lab Neurochem, Nagasaki, Japan	Gunma University; Dalian Medical University; Gunma University; Gunma University; Gunma University; Gunma University; Osaka University; University of Tokyo; Nagasaki University	Yanagawa, Y (corresponding author), Gunma Univ, Dept Genet & Behav Neurosci, Grad Sch Med, Maebashi, Gumma 3718511, Japan.	yuchio@gunma-u.ac.jp		Miyasaka, Yoshiki/0000-0003-4020-9290	Japan Society for the Promotion of Science (KAKENHI) [16H06276, 19K06881]; Ministry of Education Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Collaborative Research Project of the Brain Research Institute, Niigata University	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Collaborative Research Project of the Brain Research Institute, Niigata University	Japan Society for the Promotion of Science (KAKENHI), Grant/Award Number: 16H06276 and 19K06881; Ministry of Education Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Collaborative Research Project of the Brain Research Institute, Niigata University	Addington AM, 2005, MOL PSYCHIATR, V10, P581, DOI 10.1038/sj.mp.4001599; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; Chatron N, 2020, BRAIN, V143, P1447, DOI 10.1093/brain/awaa085; Chintagari NR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014171; Colic L, 2018, J NEUROSCI, V38, P5067, DOI 10.1523/JNEUROSCI.1985-17.2018; Dracheva S, 2004, J NEUROSCI RES, V76, P581, DOI 10.1002/jnr.20122; Eliasson MJL, 1997, NEUROSCIENCE, V79, P863, DOI 10.1016/S0306-4522(97)00032-8; Ellenbroek B, 2016, DIS MODEL MECH, V9, P1079, DOI 10.1242/dmm.026120; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Fujihara K, 2021, FEBS OPEN BIO, V11, P340, DOI 10.1002/2211-5463.13065; Fujihara K, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-01108-6; Fujii M, 2007, NEUROSCIENCE, V146, P1044, DOI 10.1016/j.neuroscience.2007.02.050; Glausier JR, 2015, BIOL PSYCHIAT, V77, P167, DOI 10.1016/j.biopsych.2014.05.010; Hanamura K, 2010, NEUROSCIENCE, V169, P1489, DOI 10.1016/j.neuroscience.2010.06.043; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; HOKOC JN, 1990, BRAIN RES, V532, P197, DOI 10.1016/0006-8993(90)91760-E; Ji FY, 1999, NEUROSCI RES, V33, P187, DOI 10.1016/S0168-0102(99)00011-5; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Jin N, 2008, GENE EXPR PATTERNS, V8, P397, DOI 10.1016/j.gep.2008.04.008; Kakizaki T, 2015, NEUROSCIENCE, V288, P86, DOI 10.1016/j.neuroscience.2014.12.030; Kakizaki T, 2021, FASEB J, V35, DOI 10.1096/fj.202001935R; Le TN, 2017, J NEUROSCI, V37, P8816, DOI 10.1523/JNEUROSCI.2125-16.2017; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; MARTIN DL, 1993, J NEUROCHEM, V60, P395, DOI 10.1111/j.1471-4159.1993.tb03165.x; Muller I, 2015, GENES BRAIN BEHAV, V14, P37, DOI 10.1111/gbb.12188; Neuray Caroline, 2020, Brain, V143, P2388, DOI 10.1093/brain/awaa178; Oda M, 2020, LAB INVEST, V100, P297, DOI 10.1038/s41374-019-0347-1; ROBERTS EUGENE, 1968, BRAIN RES, V8, P1, DOI 10.1016/0006-8993(68)90170-4; Rosenthal N, 2007, NAT CELL BIOL, V9, P993, DOI 10.1038/ncb437; Saito K, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-40; SEILER N, 1974, BIOCHEM J, V144, P29, DOI 10.1042/bj1440029; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; Stork O, 2000, BRAIN RES, V865, P45, DOI 10.1016/S0006-8993(00)02206-X; Suto T, 2019, J PAIN, V20, P600, DOI 10.1016/j.jpain.2018.11.008; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635; Wang SJ, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0160-z; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Wyszynski DF, 1996, CLEFT PALATE-CRAN J, V33, P406, DOI 10.1597/1545-1569(1996)033<0406:GONOCR>2.3.CO;2; Yamasaki EN, 1999, INT J DEV NEUROSCI, V17, P201, DOI 10.1016/S0736-5748(99)00002-7	40	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22123	10.1096/fj.202101389R	http://dx.doi.org/10.1096/fj.202101389R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34972242				2022-12-28	WOS:000747987800033
J	Takahara, M; Takaki, A; Hiraoka, S; Takei, K; Yasutomi, E; Igawa, S; Yamamoto, S; Oka, S; Ohmori, M; Yamasaki, Y; Inokuchi, T; Kinugasa, H; Harada, K; Udono, H; Okada, H				Takahara, Masahiro; Takaki, Akinobu; Hiraoka, Sakiko; Takei, Kensuke; Yasutomi, Eriko; Igawa, Shoko; Yamamoto, Shumpei; Oka, Shohei; Ohmori, Masayasu; Yamasaki, Yasushi; Inokuchi, Toshihiro; Kinugasa, Hideaki; Harada, Keita; Udono, Heiichiro; Okada, Hiroyuki			Metformin ameliorates chronic colitis in a mouse model by regulating interferon-gamma-producing lamina propria CD4(+) T cells through AMPK activation	FASEB JOURNAL			English	Article						AMP-activated protein kinase; chronic colitis; metformin; oxidative phosphorylation	INFLAMMATORY-BOWEL-DISEASE; GUT MICROBIOTA; SCID MICE; MECHANISMS; IL-17; RISK; DRUG	Metformin, a commonly prescribed drug for type 2 diabetes mellitus, has been shown to activate AMP-activated protein kinase (AMPK). Notably, AMPK activation has recently been observed to be associated with anti-inflammatory responses. Metformin is also reported to elicit anti-inflammatory responses in CD4(+) T cells, resulting in improvement in experimental chronic inflammatory diseases, such as systemic lupus erythematosus. To investigate the effect of metformin on inflammatory bowel disease (IBD), we developed a T cell-transfer model of chronic colitis in which SCID mice were injected with CD4(+)CD45RB(high) T cells to induce colitis. We examined the effects of metformin via in vitro and in vivo experiments on lamina propria (LP) CD4(+) T cells. We observed that metformin suppresses the frequency of interferon (IFN) -gamma-producing LP CD4(+) T cells in vitro, which were regulated by AMPK activation, a process possibly induced by the inhibition of oxidative phosphorylation. Furthermore, we examined the effects of metformin on an in vivo IBD model. Metformin-treated mice showed AMPK activation in LP CD4(+) T cells and ameliorated colitis. Our study demonstrates that metformin-induced AMPK activation in mucosal CD4(+) T cells contributes to the improvement of IBD by suppressing IFN-gamma production. Moreover, our results indicate that AMPK may be a target molecule for the regulation of mucosal immunity and inflammation. Thus, AMPK-activating drugs such as metformin may be potential therapeutic agents for the treatment of IBD.	[Takahara, Masahiro; Takaki, Akinobu; Hiraoka, Sakiko; Takei, Kensuke; Yasutomi, Eriko; Igawa, Shoko; Yamamoto, Shumpei; Oka, Shohei; Ohmori, Masayasu; Yamasaki, Yasushi; Inokuchi, Toshihiro; Kinugasa, Hideaki; Harada, Keita; Okada, Hiroyuki] Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Udono, Heiichiro] Okayama Univ, Dept Immunol Dent & Pharmaceut Sci, Grad Sch Med, Okayama, Japan	Okayama University; Okayama University	Takahara, M (corresponding author), Okayama Univ, Dept Gastroenterol & Lepatol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	mtakahara@cc.okayama-u.ac.jp	Yamasaki, Yasushi/H-8863-2019	Yamasaki, Yasushi/0000-0002-2992-9863; Takahara, Masahiro/0000-0002-4601-6644	MEXT | Japan Society for the Promotion of Science (JSPS) [JP20K16957]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP20K16957	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Aljofan M, 2019, FUTUR SCI OA, V5, DOI 10.2144/fsoa-2019-0053; Bian XY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02259; Bregenholt S, 1998, CLIN EXP IMMUNOL, V111, P166; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen L, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00761; Costello SP, 2019, JAMA-J AM MED ASSOC, V321, P156, DOI 10.1001/jama.2018.20046; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; Dulai PS, 2014, GASTROENTEROL CLIN N, V43, P525, DOI 10.1016/j.gtc.2014.05.010; Eikawa S, 2015, P NATL ACAD SCI USA, V112, P1809, DOI 10.1073/pnas.1417636112; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Guo GL, 2018, NAT MED, V24, P1789, DOI 10.1038/s41591-018-0273-6; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hosono K, 2010, CANCER PREV RES, V3, P1077, DOI 10.1158/1940-6207.CAPR-10-0186; Kang KY, 2013, INT IMMUNOPHARMACOL, V16, P85, DOI 10.1016/j.intimp.2013.03.020; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kim JW, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1904-0; Koh SJ, 2014, J GASTROEN HEPATOL, V29, P502, DOI 10.1111/jgh.12435; Kopylov U, 2015, INFLAMM BOWEL DIS, V21, P1847, DOI 10.1097/MIB.0000000000000457; Lee SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135858; Li J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0222-x; Lotfi N, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01265; Ma EH, 2017, CURR OPIN IMMUNOL, V46, P45, DOI 10.1016/j.coi.2017.04.004; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nemoto Y, 2013, GUT, V62, P1142, DOI 10.1136/gutjnl-2012-302029; Newton R, 2016, NAT IMMUNOL, V17, P618, DOI 10.1038/ni.3466; Ni J, 2017, NAT REV GASTRO HEPAT, V14, P573, DOI 10.1038/nrgastro.2017.88; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; O'Malley JT, 2008, J IMMUNOL, V181, P5062, DOI 10.4049/jimmunol.181.7.5062; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Pollak M, 2017, DIABETOLOGIA, V60, P1662, DOI 10.1007/s00125-017-4352-x; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Rangarajan S, 2018, NAT MED, V24, P1121, DOI 10.1038/s41591-018-0087-6; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sanchez B, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600240; Shamoon M, 2019, PHARMACOL RES, V148, DOI 10.1016/j.phrs.2019.104344; Shiomi A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/568543; Soto-Heredero G, 2020, FEBS J, V287, P3350, DOI 10.1111/febs.15327; Takahara M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48331-w; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; Titov AA, 2019, J IMMUNOL, V203, P338, DOI 10.4049/jimmunol.1801651; Totsuka T, 2008, EUR J IMMUNOL, V38, P1275, DOI 10.1002/eji.200737914; Vial G, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00294; Vila AV, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14177-z; Wang SX, 2011, HYPERTENSION, V57, P1010, DOI 10.1161/HYPERTENSIONAHA.110.168906; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yin YM, 2016, J IMMUNOL, V196, P80, DOI 10.4049/jimmunol.1501537; Zhai R, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00239; Zhang Z, 2006, INFLAMM BOWEL DIS, V12, P382, DOI 10.1097/01.MIB.0000218764.06959.91; Zhang Z, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070677	51	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22139	10.1096/fj.202100831RR	http://dx.doi.org/10.1096/fj.202100831RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35064693				2022-12-28	WOS:000747987800042
J	Hotez, P				Hotez, Peter			Science tikkun: Science for humanity in an age of aggression	FASEB JOURNAL			English	Editorial Material									[Hotez, Peter] Baylor Coll Med, Natl Sch Trop Med, Dept Pediat, Texas Childrens Ctr Vaccine Dev, 1 Baylor Plaza, Houston, TX 77030 USA; [Hotez, Peter] Baylor Coll Med, Natl Sch Trop Med, Dept Mol Virol & Microbiol, Texas Childrens Ctr Vaccine Dev, Houston, TX USA; [Hotez, Peter] Baylor Coll Med, Natl Sch Trop Med, Ctr Med Ethics & Hlth Policy, Houston, TX USA; [Hotez, Peter] Rice Univ, James A Baker III Inst Publ Policy, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Rice University	Hotez, P (corresponding author), Baylor Coll Med, Natl Sch Trop Med, Dept Pediat, Texas Childrens Ctr Vaccine Dev, 1 Baylor Plaza, Houston, TX 77030 USA.	hotez@bcm.edu						Aczel A., 2014, WHY SCI DOES NOT DIS; Golshani M., 2021, SCI HUMANITY ISLAMIC; Hotez PJ, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI149072; Hotez PJ, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001369; Hotez PJ, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001068; Hotez PJ, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000683; Hotez PJ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007117; Hotez PJ, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2004186; Hotez PJ., 2017, SCI TIKKUN REPAIRING; Krementsov N, 2006, SOC RES, V73, P1173; Lander E., 2021, REPAIRING WORLD BOOK; Majeed A, 2005, BRIT MED J, V331, P1486, DOI 10.1136/bmj.331.7531.1486; Peritz IJ., 1928, CHRIST ED, V12, P119; Rosenthal GS, 2005, J RELIG, V85, P214, DOI 10.1086/427314; Simmons-Duffin S., 2021, TEXAS ABORTION BAN H; Watkins D., VATICAN NEWS	16	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22047	10.1096/fj.202101604	http://dx.doi.org/10.1096/fj.202101604			4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34806227				2022-12-28	WOS:000722321300047
J	Li, Y; Wang, C; Xi, HM; Li, WT; Liu, YJ; Feng, S; Chu, YJ; Wang, YH				Li, Yan; Wang, Chen; Xi, Hong-min; Li, Wen-ting; Liu, Ya-jun; Feng, Shan; Chu, Yi-jing; Wang, Yi-hao			Chorionic villus-derived mesenchymal stem cells induce E3 ligase TRIM72 expression and regulate cell behaviors through ubiquitination of p53 in trophoblasts	FASEB JOURNAL			English	Article						CVMSC; p53; TRIM72; trophoblasts	PROTEIN UBIQUITINATION; PREECLAMPSIA; EXOSOMES	Preeclampsia is a significant contributor for maternal or fetal morbidity and mortality, which is characterized by reduced invasion capacity of trophoblasts and is regulated by extracellular matrix (ECM). It is still under investigation whether chorionic villus-derived mesenchymal stem cells (CVMSC) could affect the functionality of trophoblasts. In this study, CVMSC-derived exosomes were isolated; their effect on trophoblasts was investigated based on the CCK8 assay, migration assay, and apoptosis detection. And the underlying mechanism of this effect was investigated using mRNA sequencing, western blot, co-immunoprecipitation, luciferase report assay, and ubiquitination assay. The results show that CVMSC-derived exosomes promote migration and proliferation of trophoblasts, and also reduce cell apoptosis. mRNA sequencing confirmed that after treatment of CVMSC-derived exosomes, Tripartite Motif Containing 72 (TRIM72) expression was upregulated and Tumor Protein P53 (P53) expression was downregulated, both significantly in trophoblasts. Subsequent study confirms that TRM72 can directly interact with P53 and promote P53 ubiquitination and proteasomal degradation, reducing apoptosis rate and elevating proliferation and migration in trophoblasts. Our study confirms that CVMSC-derived exosomes promote trophoblast migration and proliferation by upregulating TRIM72 expression, and subsequently advance P53 ubiquitination and proteasomal degradation.	[Li, Yan; Li, Wen-ting; Liu, Ya-jun; Feng, Shan; Chu, Yi-jing] Qingdao Univ, Dept Obstet, Affiliated Hosp, 16 Jiangsu Rd, Qingdao 266003, Shandong, Peoples R China; [Wang, Chen] Qingdao Municipal Hosp, Dept Operating Room, Qingdao, Peoples R China; [Xi, Hong-min] Qingdao Univ, Dept Neonatol, Affiliated Hosp, Qingdao, Peoples R China; [Wang, Yi-hao] Qingdao Municipal Hosp, Dept Pain Management, 5 Donghaizhong Rd, Qingdao 266003, Shandong, Peoples R China	Qingdao University; Qingdao Municipal Hospital; Qingdao University; Qingdao Municipal Hospital	Chu, YJ (corresponding author), Qingdao Univ, Dept Obstet, Affiliated Hosp, 16 Jiangsu Rd, Qingdao 266003, Shandong, Peoples R China.; Wang, YH (corresponding author), Qingdao Municipal Hosp, Dept Pain Management, 5 Donghaizhong Rd, Qingdao 266003, Shandong, Peoples R China.	chuyijing@163.com; wangyihaoqd@163.com						Abumaree MH, 2017, PLACENTA, V59, P74, DOI 10.1016/j.placenta.2017.05.001; Apps R, 2009, IMMUNOLOGY, V127, P26, DOI 10.1111/j.1365-2567.2008.03019.x; Bokslag A, 2016, EARLY HUM DEV, V102, P47, DOI 10.1016/j.earlhumdev.2016.09.007; Chen LY, 2019, STEM CELL RES, V40, DOI 10.1016/j.scr.2019.101537; Chu YJ, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.545852; Colao IL, 2018, TRENDS MOL MED, V24, P242, DOI 10.1016/j.molmed.2018.01.006; Dildy GA, 2007, SEMIN PERINATOL, V31, P135, DOI 10.1053/j.semperi.2007.03.005; Foot N, 2017, PHYSIOL REV, V97, P253, DOI 10.1152/physrev.00012.2016; Gonzalez PL, 2015, STEM CELL TRANSL MED, V4, P1109, DOI 10.5966/sctm.2015-0022; Gupta I, 2020, BIOCHEM BIOPHYS REP, V21, DOI 10.1016/j.bbrep.2020.100729; Ishiwata-Endo H, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97898; Knofler M, 2010, INT J DEV BIOL, V54, P269, DOI 10.1387/ijdb.082769mk; Kobayashi H, 2016, HYPERTENS PREGNANCY, V35, P15, DOI 10.3109/10641955.2015.1116555; Kohr MJ, 2014, J MOL CELL CARDIOL, V69, P67, DOI 10.1016/j.yjmcc.2014.01.010; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Koritzinsky EH, 2017, J CELL PHYSIOL, V232, P1587, DOI 10.1002/jcp.25387; Lee CS, 2010, CELL DEATH DIFFER, V17, P1254, DOI 10.1038/cdd.2010.1; Lee CL, 2019, AM J PATHOL, V189, P467, DOI 10.1016/j.ajpath.2018.10.015; Lu W, 2020, MOL MED REP, V21, P1208, DOI 10.3892/mmr.2019.10901; Ma XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179852; McCarthy FP, 2018, PREGNANCY HYPERTENS, V14, P72, DOI 10.1016/j.preghy.2018.03.010; Meldolesi J, 2018, CURR BIOL, V28, pR435, DOI 10.1016/j.cub.2018.01.059; Moindjie H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.382; Morton A, 2016, PREGNANCY HYPERTENS, V6, P1, DOI 10.1016/j.preghy.2016.02.001; Nagre N, 2018, AM J RESP CELL MOL, V59, P635, DOI 10.1165/rcmb.2017-0364OC; Nagre N, 2018, AM J RESP CELL MOL, V58, P756, DOI 10.1165/rcmb.2017-0236OC; Ottis P, 2017, ACS CHEM BIOL, V12, P2570, DOI 10.1021/acschembio.7b00485; Pennington KA, 2012, DIS MODEL MECH, V5, P9, DOI 10.1242/dmm.008516; Rana S, 2019, CIRC RES, V124, P1094, DOI 10.1161/CIRCRESAHA.118.313276; Steinberg G, 2009, THROMB RES, V123, pS93, DOI 10.1016/S0049-3848(09)70020-9; Tomimatsu T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174246; Uder C, 2018, CYTOM PART A, V93A, P32, DOI 10.1002/cyto.a.23239; Wang Y, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00353; Xu GQ, 2013, BIOTECHNOL GENET ENG, V29, P73, DOI 10.1080/02648725.2013.801232; Xu YY, 2017, J CELL PHYSIOL, V232, P2581, DOI 10.1002/jcp.25661	35	3	3	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22005	10.1096/fj.202100801R	http://dx.doi.org/10.1096/fj.202100801R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34788479				2022-12-28	WOS:000722321300040
J	Simoes, RF; Pino, R; Moreira-Soares, M; Kovarova, J; Neuzil, J; Travasso, R; Oliveira, PJ; Cunha-Oliveira, T; Pereira, FB				Simoes, Rui F.; Pino, Rute; Moreira-Soares, Mauricio; Kovarova, Jaromira; Neuzil, Jiri; Travasso, Rui; Oliveira, Paulo J.; Cunha-Oliveira, Teresa; Pereira, Francisco B.			Quantitative analysis of neuronal mitochondrial movement reveals patterns resulting from neurotoxicity of rotenone and 6-hydroxydopamine	FASEB JOURNAL			English	Article						exploratory data analysis; live cell imaging; mitochondria movement; neurotoxicants; principal component analysis; trajectory descriptors	AXONAL-TRANSPORT; PARKINSONS-DISEASE; OXIDATIVE DAMAGE; ANIMAL-MODELS; TRAFFICKING; MICROTUBULES; TRANSMISSION; MICROSCOPY; DENDRITES; TOXICITY	Alterations in mitochondrial dynamics, including their intracellular trafficking, are common early manifestations of neuronal degeneration. However, current methodologies used to study mitochondrial trafficking events rely on parameters that are primarily altered in later stages of neurodegeneration. Our objective was to establish a reliable applied statistical analysis to detect early alterations in neuronal mitochondrial trafficking. We propose a novel quantitative analysis of mitochondria trajectories based on innovative movement descriptors, including straightness, efficiency, anisotropy, and kurtosis. We evaluated time- and dose-dependent alterations in trajectory descriptors using biological data from differentiated SH-SY5Y cells treated with the mitochondrial toxicants 6-hydroxydopamine and rotenone. MitoTracker Red CMXRos-labelled mitochondria movement was analyzed by total internal reflection fluorescence microscopy followed by computational modelling to describe the process. Based on the aforementioned trajectory descriptors, this innovative analysis of mitochondria trajectories provides insights into mitochondrial movement characteristics and can be a consistent and sensitive method to detect alterations in mitochondrial trafficking occurring in the earliest time points of neurodegeneration.	[Simoes, Rui F.; Oliveira, Paulo J.; Cunha-Oliveira, Teresa] UC Biotech, Ctr Neurosci & Cell Biol, CNC, Cantanhede, Portugal; [Pino, Rute; Pereira, Francisco B.] Univ Coimbra, Dept Informat Engn, CISUC, Coimbra, Portugal; [Moreira-Soares, Mauricio] Univ Oslo, OCBE, Fac Med, Oslo, Norway; [Moreira-Soares, Mauricio] Univ Oslo, Fac Math & Nat Sci, Ctr Bioinformat, Oslo, Norway; [Kovarova, Jaromira; Neuzil, Jiri] Czech Acad Sci, Inst Biotechnol, Prague, Czech Republic; [Neuzil, Jiri] Griffith Univ, Sch Med Sci, Southport, Qld, Australia; [Travasso, Rui] Univ Coimbra, Dept Phys, CFisUC, Coimbra, Portugal; [Pereira, Francisco B.] Coimbra Polytech ISEC, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; University of Oslo; University of Oslo; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Griffith University; Universidade de Coimbra	Cunha-Oliveira, T (corresponding author), Ctr Neuroscience & Cell Biol, CNC, MitoXT Mitochondrial Toxicol & Expt Therapeut Lab, UC Biotech Bldg Lote 8A,Biocant Pk, P-3060197 Cantanhede, Portugal.	teresa.oliveira@uc-biotech.pt	Travasso, Rui/B-8342-2018; Simoes, Rui/AFT-8875-2022; Cunha-Oliveira, Teresa/A-3054-2009; Oliveira, Paulo/H-1980-2011	Travasso, Rui/0000-0001-6078-0721; Simoes, Rui/0000-0003-2718-9950; Cunha-Oliveira, Teresa/0000-0002-7382-0339; Moreira-Soares, Mauricio/0000-0001-9928-7256; Pereira, Francisco B./0000-0002-1937-6548; Oliveira, Paulo/0000-0002-5201-9948	Czech Science Foundation [20-05942S, 21-04607X]; EC \ H2020 \ H2020 Priority Excellent Science \ H2020 Marie Sklodowska-Curie Actions (MSCA) [801133]; MEC \ Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/BTM-SAL/29297/2017, POCI-01-0145-FEDER-029297, PD/ BD/128254/2016, DL57/2016/CP1448/CT0016, UIDB/04539/2020, PTDC/MED-FAR/29391/2017, POCI-01-0145-FEDER-029391, UIDB/04564/2020, UIDP/04564/2020]	Czech Science Foundation(Grant Agency of the Czech Republic); EC \ H2020 \ H2020 Priority Excellent Science \ H2020 Marie Sklodowska-Curie Actions (MSCA); MEC \ Fundacao para a Ciencia e a Tecnologia (FCT)	Czech Science Foundation, Grant/ Award Number: 20--05942S and 21--04607X; EC | H2020 | H2020 Priority Excellent Science | H2020 Marie Sklodowska--Curie Actions (MSCA), Grant/Award Number: 801133; MEC | Fundacao para a Ciencia e a Tecnologia (FCT), Grant/Award Number: PTDC/BTM--SAL/29297/2017, POCI--01--0145--FEDER--029297, PD/ BD/128254/2016, DL57/2016/CP1448/ CT0016, UIDB/04539/2020, PTDC/ MED--FAR/29391/2017, POCI--01--0145--FEDER--029391, UIDB/04564/2020 and UIDP/04564/2020	[Anonymous], 2020, TRAJPY V 1 3 1; Arkin H, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4788616; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Axelrod D, 2008, METHOD CELL BIOL, V89, P169, DOI 10.1016/S0091-679X(08)00607-9; Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; Billups B, 2002, J NEUROSCI, V22, P5840; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Borland MK, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-21; Brickley K, 2011, J BIOL CHEM, V286, P18079, DOI 10.1074/jbc.M111.236018; Bros H, 2015, TRAFFIC, V16, P906, DOI 10.1111/tra.12291; Bros H, 2014, EXP NEUROL, V261, P127, DOI 10.1016/j.expneurol.2014.06.018; Chang DTW, 2006, NEUROBIOL DIS, V22, P388, DOI 10.1016/j.nbd.2005.12.007; Chen MM, 2016, PROTEIN CELL, V7, P804, DOI 10.1007/s13238-016-0268-3; Coutu DL, 2013, J CELL SCI, V126, P3805, DOI 10.1242/jcs.118349; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Fang C, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-29; Friendly M, 2013, STAT SCI, V28, P1, DOI 10.1214/12-STS402; Gerencser AA, 2008, BIOPHYS J, V95, P3079, DOI 10.1529/biophysj.108.135657; GLINKA YY, 1995, EUR J PHARM-ENVIRON, V292, P329, DOI 10.1016/0926-6917(95)90040-3; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Helmuth JA, 2007, J STRUCT BIOL, V159, P347, DOI 10.1016/j.jsb.2007.04.003; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Jiang Q, 2006, J BIOL CHEM, V281, P29391, DOI 10.1074/jbc.M602740200; Kandel J, 2015, BIOTECHNOL BIOENG, V112, P1395, DOI 10.1002/bit.25563; Kapitein LC, 2015, NEURON, V87, P492, DOI 10.1016/j.neuron.2015.05.046; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Lee BJ, 2017, MOL BIOL CELL, V28, P3573, DOI 10.1091/mbc.E17-08-0508; Ligon LA, 2000, J COMP NEUROL, V427, P340, DOI 10.1002/1096-9861(20001120)427:3<340::AID-CNE2>3.0.CO;2-Y; Lu X, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-17; Lummen P, 1998, BBA-BIOENERGETICS, V1364, P287, DOI 10.1016/S0005-2728(98)00034-6; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; MacAskill AF, 2009, MOL CELL NEUROSCI, V40, P301, DOI 10.1016/j.mcn.2008.10.016; Mattheyses AL, 2010, J CELL SCI, V123, P3621, DOI 10.1242/jcs.056218; Medler K, 2002, J NEUROPHYSIOL, V87, P1426, DOI 10.1152/jn.00627.2001; Misgeld T, 2007, NAT METHODS, V4, P559, DOI 10.1038/NMETH1055; Moreira-Soares M, 2020, J PHYS-CONDENS MAT, V32, DOI 10.1088/1361-648X/ab7c17; MORRIS RL, 1993, J CELL SCI, V104, P917; Nguyen MM, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-38; Patel VP, 2012, BBA-MOL BASIS DIS, V1822, P1773, DOI 10.1016/j.bbadis.2012.08.002; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Poulter NS, 2015, METHODS MOL BIOL, V1251, P1, DOI 10.1007/978-1-4939-2080-8_1; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Ren Y, 2005, J BIOL CHEM, V280, P34105, DOI 10.1074/jbc.M503483200; Sanders LH, 2013, FREE RADICAL BIO MED, V62, P111, DOI 10.1016/j.freeradbiomed.2013.01.003; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Schuler F, 2001, BBA-BIOENERGETICS, V1506, P79, DOI 10.1016/S0005-2728(01)00183-9; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Simoes RF, 2021, FOOD CHEM TOXICOL, V149, DOI 10.1016/j.fct.2021.111967; Srivastava AS, 2007, BIOCHEM BIOPH RES CO, V361, P953, DOI 10.1016/j.bbrc.2007.07.139; Stepkowski TM, 2017, CELL MOL NEUROBIOL, V37, P1055, DOI 10.1007/s10571-016-0438-0; Sumantran VN, 2011, METHODS MOL BIOL, V731, P219, DOI 10.1007/978-1-61779-080-5_19; Sun T, 2013, CELL REP, V4, P413, DOI 10.1016/j.celrep.2013.06.040; THEODOROU DN, 1985, MACROMOLECULES, V18, P1206, DOI 10.1021/ma00148a028; Uversky VN, 2004, CELL TISSUE RES, V318, P225, DOI 10.1007/s00441-004-0937-z; Wagner T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170165; Yau KW, 2016, J NEUROSCI, V36, P1071, DOI 10.1523/JNEUROSCI.2430-15.2016	60	1	1	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22024	10.1096/fj.202100899R	http://dx.doi.org/10.1096/fj.202100899R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34751984	Green Submitted, Green Published			2022-12-28	WOS:000722321300021
J	Li, JM; Chen, FF; Li, GH; Zhu, JL; Zhou, Y; Wei, XY; Zheng, F; Wang, LL; Zhang, W; Zhong, M; Zhang, MM; Ding, WY				Li, Jia-Min; Chen, Fang-Fang; Li, Guo-Hua; Zhu, Jia-Liang; Zhou, Yu; Wei, Xin-Yi; Zheng, Fei; Wang, Li-Li; Zhang, Wei; Zhong, Ming; Zhang, Ming-Ming; Ding, Wen-Yuan			Soluble Klotho-integrin beta 1/ERK1/2 pathway ameliorates myocardial fibrosis in diabetic cardiomyopathy	FASEB JOURNAL			English	Article						diabetic cardiomyopathy; diastolic dysfunction; KL-cDNA overexpression; myocardial fibrosis; soluble Klotho	ANTIAGING GENE KLOTHO; INSULIN-RESISTANCE; CARDIAC DYSFUNCTION; HYPERTROPHY; ASSOCIATION; PROTECTS; CELLS; MODEL	Soluble Klotho (sKL) is closely related to insulin resistance, which is a major factor in the progression of diabetic cardiomyopathy (DCM). The purpose of this study was to investigate the role of sKL in the regulation of DCM and the mechanism involved. A mouse model of type 2 diabetes was induced by high-fat diet and streptozotocin injection. An insulin-resistant cardiac fibroblast model was established by high glucose and high insulin. KL gene overexpression was achieved in vivo and vitro through transfection with an adenovirus-harboring KL-cDNA. Gene overexpression was used to evaluate the role of sKL in the pathophysiologic characteristics of DCM. Insulin-resistant cardiac fibroblasts reduced sKL expression and collagen deposition. Diabetic mice constructed by streptozotocin exhibited severe insulin resistance, inflammation, fibrosis, left ventricular dysfunction, and sKL downregulation. The overexpression of sKL mitigated insulin resistance and metabolic disturbance; inflammation, fibrosis, and upregulated collagen I/III content ratio in diabetic state were significantly reduced. Our findings were accompanied by notable moderation of cardiac function. Further, blunted phosphorylation of Akt was restored with sKL gene overexpression, and activated phosphorylation of extracellular signal-regulated kinase 1/2 in DCM was reduced. Our results suggest that sKL protein overexpression exerts a defensive measure by ameliorating selective insulin resistance in mouse DCM, thus revealing its underlying mechanism for potential human DCM treatment.	[Li, Jia-Min; Chen, Fang-Fang; Li, Guo-Hua; Zheng, Fei; Zhang, Ming-Ming; Ding, Wen-Yuan] Shandong First Med Univ, Dept Cardiol 2, Affiliated Hosp 1, Shandong Prov Qianfoshan Hosp, 16766 Jingshi Rd, Jinan 250014, Peoples R China; [Zhu, Jia-Liang] Jinan Univ, Guangzhou, Peoples R China; [Zhou, Yu] Shandong Univ Finance & Econ, Jinan, Peoples R China; [Wei, Xin-Yi] Third Hosp Jinan, Jinan, Peoples R China; [Wang, Li-Li] Shandong Univ Tradit Chinese Med, Dept Cardiol 2, Affiliated Hosp, Jinan, Peoples R China; [Zhang, Wei; Zhong, Ming] Shandong Qilu Hosp, Dept Cardiol, Jinan, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Jinan University; Shandong University of Finance & Economics; Shandong University of Traditional Chinese Medicine; Shandong University	Ding, WY (corresponding author), Shandong First Med Univ, Dept Cardiol 2, Affiliated Hosp 1, Shandong Prov Qianfoshan Hosp, 16766 Jingshi Rd, Jinan 250014, Peoples R China.	dwylucky@163.com	wang, lili/HDL-7210-2022		Natural Science Foundation of Shandong Province [ZR2017BH114]; National Natural Science Foundation of China [81700334]; Jinan Science and Technology Plan Project [201805058]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jinan Science and Technology Plan Project	This work was supported by research grants from the Natural Science Foundation of Shandong Province [grant number ZR2017BH114], the National Natural Science Foundation of China [grant number 81700334], and Jinan Science and Technology Plan Project [grant number 201805058].	Bertrand L, 2008, CARDIOVASC RES, V79, P238, DOI 10.1093/cvr/cvn093; Deng MH, 2015, MOL MED REP, V12, P45, DOI 10.3892/mmr.2015.3367; Ding WY, 2014, J MOL MED, V92, P629, DOI 10.1007/s00109-013-1119-9; Golembiewska E, 2016, CURR PROTEIN PEPT SC, V17, P821, DOI 10.2174/1389203717666160526123646; Guo Y, 2018, BBA-MOL BASIS DIS, V1864, P238, DOI 10.1016/j.bbadis.2017.09.029; Hsieh CC, 2010, AGING-US, V2, P582, DOI 10.18632/aging.100194; Huang JS, 2014, MOL CELL ENDOCRINOL, V390, P45, DOI 10.1016/j.mce.2014.04.001; King GL, 2016, DIABETES, V65, P1462, DOI 10.2337/db16-0152; Kishi S, 2017, JACC-CARDIOVASC IMAG, V10, P105, DOI 10.1016/j.jcmg.2016.02.033; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lai DW, 2017, J MOL MED, V95, P155, DOI 10.1007/s00109-016-1469-1; Lin Y, 2015, DIABETES, V64, P4298, DOI 10.2337/db15-0066; Lin Y, 2015, DIABETES, V64, P1444, DOI 10.2337/db14-0632; Liu JJ, 2014, ATHEROSCLEROSIS, V233, P415, DOI 10.1016/j.atherosclerosis.2014.01.024; Liu MF, 2016, HEART FAIL REV, V21, P723, DOI 10.1007/s10741-016-9565-4; Lorenzi O, 2010, PFLUG ARCH EUR J PHY, V459, P465, DOI 10.1007/s00424-009-0735-2; Malaty AN, 2011, J AM SOC ECHOCARDIOG, V24, P333, DOI 10.1016/j.echo.2010.12.017; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Matyas C, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0309-x; Parim B, 2019, HEART FAIL REV, V24, P279, DOI 10.1007/s10741-018-9749-1; Rodriguez-Rodero S, 2011, AGING DIS, V2, P186; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Ti Y, 2011, DIABETES, V60, P2963, DOI 10.2337/db11-0549; Vogeser M, 2007, CLIN BIOCHEM, V40, P964, DOI 10.1016/j.clinbiochem.2007.05.009; Xie J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2240	25	2	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21960	10.1096/fj.202100952R	http://dx.doi.org/10.1096/fj.202100952R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34694637	hybrid			2022-12-28	WOS:000712009200055
J	Akizawa, H; Saito, S; Kohri, N; Furukawa, E; Hayashi, Y; Bai, H; Nagano, M; Yanagawa, Y; Tsukahara, H; Takahashi, M; Kagawa, S; Kawahara-Miki, R; Kobayashi, H; Kono, T; Kawahara, M				Akizawa, Hiroki; Saito, Shun; Kohri, Nanami; Furukawa, Eri; Hayashi, Yoshihiro; Bai, Hanako; Nagano, Masashi; Yanagawa, Yojiro; Tsukahara, Hayato; Takahashi, Masashi; Kagawa, Shinjiro; Kawahara-Miki, Ryouka; Kobayashi, Hisato; Kono, Tomohiro; Kawahara, Manabu			Deciphering two rounds of cell lineage segregations during bovine preimplantation development	FASEB JOURNAL			English	Article						bovine; differentiation; inner cell mass; on-gel culture; trophectoderm	PRIMITIVE ENDODERM; GENE-EXPRESSION; EARLY EMBRYO; MOUSE; TROPHECTODERM; BLASTOCYST; EPIBLAST; PATTERN; MASS; MORPHOGENESIS	Blastocyst formation gives rise to the inner cell mass (ICM) and trophectoderm (TE) and is followed by the differentiation of the epiblast (Epi) and primitive endoderm (PrE) within the ICM. Although these two-round cell lineage differentiations underpin proper embryogenesis in every mammal, their spatiotemporal dynamics are quite diverse among species. Here, molecular details of the blastocyst stage in cattle were dissected using an optimized in vitro culture method. Blastocyst embryos were placed on agarose gel filled with nutrient-rich media to expose embryos to both gaseous and liquid phases. Embryos derived from this "on-gel" culture were transferred to surrogate mothers on day (D) 10 after fertilization and successfully implanted. Immunofluorescent studies using on-gel-cultured embryos revealed that the proportion of TE cells expressing the pluripotent ICM marker, OCT4, which was beyond 80% on D8, was rapidly reduced after D9 and reached 0% on D9.5. This first lineage segregation process was temporally parallel with the second one, identified by the spatial separation of Epi cells expressing SOX2 and PrE cells expressing SOX17. RNA-seq comparison of TE cells from D8 in vitro fertilized embryos and D14 in vivo embryos revealed that besides drastic reduction of pluripotency-related genes, TE cells highly expressed Wnt, FGF, and VEGF signaling pathways-related genes to facilitate the functional maturation required for feto-maternal interaction. Quantitative PCR analysis of TE cells derived from on-gel culture further confirmed time-dependent increments in the expression of key TE markers. Altogether, the present study provides platforms to understand species-specific strategies for mammalian preimplantation development.	[Akizawa, Hiroki; Saito, Shun; Kohri, Nanami; Hayashi, Yoshihiro; Bai, Hanako; Tsukahara, Hayato; Kawahara, Manabu] Lokkaido Univ, Res Fac Agr, Lab Anim Genet & Reprod, Sapporo, Hokkaido 0608589, Japan; [Furukawa, Eri; Yanagawa, Yojiro] Hokkaido Univ, Fac Vet Med, Lab Theriogenol, Sapporo, Hokkaido, Japan; [Nagano, Masashi] Kitasato Univ, Sch Vet Med, Dept Anim Sci, Lab Anim Reprod, Towada, Aomori, Japan; [Takahashi, Masashi] Global Inst Collaborat Res & Educ GI CoRE, Global Stn Food Land & Water Resources, Sapporo, Hokkaido, Japan; [Kagawa, Shinjiro] Aomori Prefectural Ind Technol Res Ctr, Livestock Res Inst, Aomori, Japan; [Kawahara-Miki, Ryouka] Tokyo Univ Agr, NODAI Genome Res Ctr, Tokyo, Japan; [Kobayashi, Hisato] Nara Med Univ, Dept Embryol, Kashihara, Nara, Japan; [Kono, Tomohiro] Tokyo Univ Agr, Dept Biosci, Tokyo, Japan	Hokkaido University; Kitasato University; Tokyo University of Agriculture; Nara Medical University; Tokyo University of Agriculture	Kawahara, M (corresponding author), Lokkaido Univ, Res Fac Agr, Lab Anim Genet & Reprod, Sapporo, Hokkaido 0608589, Japan.	k-hara@anim.agr.hokudai.ac.jp	Bai, Hanako/K-4769-2019	Bai, Hanako/0000-0001-9940-1880; Akizawa, Hiroki/0000-0003-1091-5629; Kobayashi, Hisato/0000-0003-3800-4691; Hayashi, Yoshihiro/0000-0001-6210-5279	Japan Society for the Promotion of Science (JSPS) [18H02321, 21H02336]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 18H02321 and 21H02336	Akizawa H, 2018, REPRODUCTION, V155, P563, DOI 10.1530/REP-18-0043; Akizawa H, 2016, MOL REPROD DEV, V83, P516, DOI 10.1002/mrd.22646; Artus J, 2011, DEV BIOL, V350, P393, DOI 10.1016/j.ydbio.2010.12.007; Bedzhov I, 2014, CELL, V156, P1032, DOI 10.1016/j.cell.2014.01.023; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; BJORKMAN NH, 1968, J ULTRA MOL STRUCT R, V24, P249, DOI 10.1016/S0022-5320(68)90062-2; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Deglincerti A, 2016, NATURE, V533, P251, DOI 10.1038/nature17948; Denicol AC, 2014, FASEB J, V28, P3975, DOI 10.1096/fj.14-253112; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Ezashi T, 2008, BIOL REPROD, V79, P115, DOI 10.1095/biolreprod.107.066647; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Frankenberg S, 2011, DEV CELL, V21, P1005, DOI 10.1016/j.devcel.2011.10.019; GARDNER RL, 1985, PHILOS T R SOC B, V312, P163, DOI 10.1098/rstb.1985.0186; GARDNER RL, 1972, J EMBRYOL EXP MORPH, V28, P279; GREENSTEIN JS, 1958, ANAT REC, V132, P321, DOI 10.1002/ar.1091320308; Hannan NJ, 2011, ENDOCRINOLOGY, V152, P4948, DOI 10.1210/en.2011-1248; Jen Y, 1997, DEV DYNAM, V208, P92, DOI 10.1002/(SICI)1097-0177(199701)208:1<92::AID-AJA9>3.0.CO;2-X; Kirchhof N, 2000, BIOL REPROD, V63, P1698, DOI 10.1095/biolreprod63.6.1698; Kohri N, 2020, BIOCHEM BIOPH RES CO, V528, P713, DOI 10.1016/j.bbrc.2020.05.210; Kohri N, 2019, J BIOL CHEM, V294, P19209, DOI 10.1074/jbc.RA119.010746; Kuckenberg P, 2010, MOL CELL BIOL, V30, P3310, DOI 10.1128/MCB.01215-09; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Laeno AMA, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109470; Laurent A, 2015, DEVELOPMENT, V142, P3675, DOI 10.1242/dev.125708; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maddox-Hyttel P, 2003, REPRODUCTION, V125, P607, DOI 10.1530/rep.0.1250607; Mann GE, 2001, REPRODUCTION, V121, P175, DOI 10.1530/rep.0.1210175; Mohamed OA, 2004, BIOL REPROD, V71, P417, DOI 10.1095/biolreprod.103.025692; Mohamed OA, 2005, P NATL ACAD SCI USA, V102, P8579, DOI 10.1073/pnas.0500612102; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moraes JGN, 2018, P NATL ACAD SCI USA, V115, pE1749, DOI 10.1073/pnas.1721191115; Morris SA, 2010, P NATL ACAD SCI USA, V107, P6364, DOI 10.1073/pnas.0915063107; Nagatomo H, 2015, JPN J VET RES, V63, P159; Nagatomo H, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108993; Negron-Perez VM, 2018, MOL REPROD DEV, V85, P374, DOI 10.1002/mrd.22976; Negron-Perez VM, 2017, REPRODUCTION, V154, P627, DOI 10.1530/REP-17-0345; Niakan KK, 2013, DEV BIOL, V375, P54, DOI 10.1016/j.ydbio.2012.12.008; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Pfarrer CD, 2006, PLACENTA, V27, P79, DOI 10.1016/j.placenta.2004.11.011; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; Puscheck EE, 2015, ADV EXP MED BIOL, V843, P77, DOI 10.1007/978-1-4939-2480-6_4; ROBERTS RM, 1992, ENDOCR REV, V13, P432, DOI 10.1210/er.13.3.432; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Tribulo P, 2017, REPRODUCTION, V153, P405, DOI 10.1530/REP-16-0610; van Eijk MJT, 1999, BIOL REPROD, V60, P1093, DOI 10.1095/biolreprod60.5.1093; WOODING FBP, 1992, PLACENTA, V13, P101, DOI 10.1016/0143-4004(92)90025-O; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315	50	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21904	10.1096/fj.202002762RR	http://dx.doi.org/10.1096/fj.202002762RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34569650				2022-12-28	WOS:000702238200046
J	Blazquez-Bernal, A; Fernandez-Costa, JM; Bargiela, A; Artero, R				Blazquez-Bernal, Agueda; Fernandez-Costa, Juan M.; Bargiela, Ariadna; Artero, Ruben			Inhibition of autophagy rescues muscle atrophy in a LGMDD2 Drosophila model	FASEB JOURNAL			English	Article						autophagy; chloroquine; Drosophila melanogaster; limb-girdle muscular dystrophy D2; muscle atrophy; transportin 3	GIRDLE MUSCULAR-DYSTROPHY; NUCLEAR IMPORT; SPLICING FACTORS; GENE-EXPRESSION; PROTEINS; DEGENERATION; DEGRADATION; ASSAYS; HEART; 1F	Limb-girdle muscular dystrophy D2 (LGMDD2) is an ultrarare autosomal dominant myopathy caused by mutation of the normal stop codon of the TNPO3 nuclear importin. The mutant protein carries a 15 amino acid C-terminal extension associated with pathogenicity. Here we report the first animal model of the disease by expressing the human mutant TNPO3 gene in Drosophila musculature or motor neurons and concomitantly silencing the endogenous expression of the fly protein ortholog. A similar genotype expressing wildtype TNPO3 served as a control. Phenotypes characterization revealed that mutant TNPO3 expression targeted at muscles or motor neurons caused LGMDD2-like phenotypes such as muscle degeneration and atrophy, and reduced locomotor ability. Notably, LGMDD2 mutation increase TNPO3 at the transcript and protein level in the Drosophila model Upregulated muscle autophagy observed in LGMDD2 patients was also confirmed in the fly model, in which the anti-autophagic drug chloroquine was able to rescue histologic and functional phenotypes. Overall, we provide a proof of concept of autophagy as a target to treat disease phenotypes and propose a neurogenic component to explain mutant TNPO3 pathogenicity in diseased muscles.	[Blazquez-Bernal, Agueda; Fernandez-Costa, Juan M.; Bargiela, Ariadna; Artero, Ruben] Univ Valencia, Univ Inst Biotechnol & Biomed BIOTECMED, Translat Genom Grp, Valencia, Spain; [Blazquez-Bernal, Agueda; Fernandez-Costa, Juan M.; Bargiela, Ariadna; Artero, Ruben] Incl Hlth Res Inst, Area Metab & Organ Failure, Valencia, Spain; [Blazquez-Bernal, Agueda; Fernandez-Costa, Juan M.; Bargiela, Ariadna; Artero, Ruben] Incliva CIPF Joint Unit, Valencia, Spain	University of Valencia	Bargiela, A (corresponding author), Univ Valencia, Univ Inst Biotechnol & Biomed BIOTECMED, Translat Genom Grp, Valencia, Spain.	ariadna.bargiela@uv.es	Artero, Ruben/K-6815-2014; Fernandez-Costa, Juan M/Q-1670-2015; Bargiela, Ariadna/ABF-9125-2020	Artero, Ruben/0000-0003-1596-047X; Fernandez-Costa, Juan M/0000-0002-1854-6082; Blazquez-Bernal, Agueda/0000-0001-7556-452X	Regional Government of Valencia | Conselleria d'Educacio, Investigacio, Cultura i Esport (Ministry of Education, Research, Culture and Sports)	Regional Government of Valencia | Conselleria d'Educacio, Investigacio, Cultura i Esport (Ministry of Education, Research, Culture and Sports)	Asociacion Conquistando Escalones; Regional Government of Valencia | Conselleria d'Educacio, Investigacio, Cultura i Esport (Ministry of Education, Research, Culture and Sports)	Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776; Allemand E, 2002, MOL BIOL CELL, V13, P2436, DOI 10.1091/mbc.E02-02-0102; Allikian MJ, 2007, HUM MOL GENET, V16, P2933, DOI 10.1093/hmg/ddm254; Angelini C, 2019, THER ADV NEUROL DISO, V12, DOI 10.1177/1756286419850433; Babcock DT, 2014, JOVE-J VIS EXP, DOI 10.3791/51223; Bargiela A, 2019, P NATL ACAD SCI USA, V116, P25203, DOI 10.1073/pnas.1820297116; Bargiela A, 2015, DIS MODEL MECH, V8, P679, DOI 10.1242/dmm.018127; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bushby Kate, 2009, Pract Neurol, V9, P314, DOI 10.1136/jnnp.2009.193938; Cenacchi G, 2013, NEUROPATHOLOGY, V33, P276, DOI 10.1111/neup.12003; Cerro-Herreros E, 2020, MOL THER-NUCL ACIDS, V21, P837, DOI 10.1016/j.omtn.2020.07.021; Chakraborty M, 2015, DIS MODEL MECH, V8, P1569, DOI 10.1242/dmm.021428; Costa R, 2021, MOL CELL BIOCHEM, V476, P1797, DOI 10.1007/s11010-020-04023-y; Costa R, 2020, NEUROMUSCULAR DISORD, V30, P685, DOI 10.1016/j.nmd.2020.05.006; De Iaco A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-98; Dobi KC, 2015, WIRES DEV BIOL, V4, P357, DOI 10.1002/wdev.182; Fanin M, 2015, MUSCLE NERVE, V52, P305, DOI 10.1002/mus.24539; Fernandez-Costa JM, 2013, HUM MOL GENET, V22, P704, DOI 10.1093/hmg/dds478; Gamez J, 2001, NEUROLOGY, V56, P450, DOI 10.1212/WNL.56.4.450; Garcia-Lopez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001595; GELLERT M, 1965, J MOL BIOL, V11, P445, DOI 10.1016/S0022-2836(65)80001-8; Gibertini S, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0648-4; Hunt LC, 2013, NAT PROTOC, V8, P2496, DOI 10.1038/nprot.2013.156; Klionsky DJ, 2021, AUTOPHAGY, V17, P1, DOI 10.1080/15548627.2020.1797280; Knuijt S, 2014, DISABIL REHABIL, V36, P1285, DOI 10.3109/09638288.2013.845255; Konieczny P, 2020, FASEB J, V34, P3021, DOI 10.1096/fj.201802554RRR; Kreipke RE, 2017, CURR TOP DEV BIOL, V121, P83, DOI 10.1016/bs.ctdb.2016.07.003; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Li SQ, 2016, HUM MOL GENET, V25, P936, DOI 10.1093/hmg/ddv627; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llamusi B, 2013, DIS MODEL MECH, V6, P184, DOI 10.1242/dmm.009563; Lloyd TE, 2010, ANN NY ACAD SCI, V1184, pE1, DOI 10.1111/j.1749-6632.2010.05432.x; Maertens GN, 2014, P NATL ACAD SCI USA, V111, P2728, DOI 10.1073/pnas.1320755111; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mao YH, 2014, NUCLEIC ACIDS RES, V42, P4813, DOI 10.1093/nar/gku159; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Mauvezin C, 2014, METHODS, V68, P134, DOI 10.1016/j.ymeth.2014.03.014; Melia MJ, 2013, BRAIN, V136, P1508, DOI 10.1093/brain/awt074; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Nagy P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003664; Nigro Vincenzo, 2014, Acta Myol, V33, P1; Pal E, 2019, EUR J MED GENET, V62, DOI 10.1016/j.ejmg.2019.05.001; Palenzuela L, 2003, NEUROLOGY, V61, P404, DOI 10.1212/01.WNL.0000073984.46546.4F; Perkins LA, 2015, GENETICS, V201, P843, DOI 10.1534/genetics.115.180208; Peterle E, 2013, J NEUROL, V260, P2033, DOI 10.1007/s00415-013-6931-1; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Rai M, 2014, CURR TOP DEV BIOL, V108, P247, DOI 10.1016/B978-0-12-391498-9.00007-3; Rodriguez-Mora S, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007958; Sapra AK, 2009, MOL CELL, V34, P179, DOI 10.1016/j.molcel.2009.02.031; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Selma-Soriano E, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.041509; Spring AM, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00113; Straub V, 2018, NEUROMUSCULAR DISORD, V28, P702, DOI 10.1016/j.nmd.2018.05.007; Takats S, 2013, J CELL BIOL, V201, P531, DOI 10.1083/jcb.201211160; Tavakol S, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9100530; Torella A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063536; Vihola A., 2019, NEUROL-GENET, V5, P1; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	59	3	3	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21914	10.1096/fj.202100539RR	http://dx.doi.org/10.1096/fj.202100539RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34547132				2022-12-28	WOS:000702238200039
J	Gu, J; Geng, MY; Qi, MX; Wang, LZ; Zhang, Y; Gao, JL				Gu, Jing; Geng, Mengya; Qi, Mengxiang; Wang, Lizhuo; Zhang, Yao; Gao, Jialin			The role of lysosomal membrane proteins in glucose and lipid metabolism	FASEB JOURNAL			English	Review						glucose metabolism; lipid metabolism; lysosomal membrane protein	TRIGLYCERIDE-RICH LIPOPROTEINS; ACID-METABOLISM; LATE ENDOSOMES; ER STRESS; INSULIN; CHOLESTEROL; TRANSPORTER; DISEASE; SIDT2; TRANSLOCATION	Lysosomes have long been regarded as the "garbage dump" of the cell. More recently, however, researchers have revealed novel roles for lysosomal membranes in autophagy, ion transport, nutrition sensing, and membrane fusion and repair. With active research into lysosomal membrane proteins (LMP), increasing evidence has become available showing that LMPs are inextricably linked to glucose and lipid metabolism, and this relationship represents mutual influence and regulation. In this review, we summarize the roles of LMPs in relation to glucose and lipid metabolism, and describe their roles in glucose transport, glycolysis, cholesterol transport, and lipophagy. The role of transport proteins can be traced back to the original discoveries of GLUT8, NPC1, and NPC2, which were all found to have significant roles in the pathways involved in glucose and lipid metabolism. CLC-5 and SIDT2-knockout animals show serious phenotypic disorders of metabolism, and V-ATPase and LAMP-2 have been found to interact with proteins related to glucose and lipid metabolism. These findings all emphasize the critical role of LMPs in glycolipid metabolism and help to strengthen our understanding of the independent and close relationship between LMPs and glycolipid metabolism.	[Gu, Jing; Geng, Mengya; Gao, Jialin] Yijishan Hosp, Wannan Med Coll, Affiliated Hosp 1, Dept Endocrinol & Genet Metab, Wuhu, Peoples R China; [Gu, Jing; Geng, Mengya; Gao, Jialin] Yijishan Hosp, Wannan Med Coll, Affiliated Hosp 1, Inst Endocrine & Metab Dis,Dept Endocrinol & Gene, Wuhu, Peoples R China; [Gu, Jing; Geng, Mengya; Qi, Mengxiang; Wang, Lizhuo; Zhang, Yao; Gao, Jialin] Wannan Med Coll, Anhui Prov Key Lab Biol Macro Mol Res, Wuhu, Peoples R China; [Geng, Mengya; Qi, Mengxiang] Wannan Med Coll, Sch Clin Med, Wuhu, Peoples R China; [Wang, Lizhuo; Zhang, Yao] Wannan Med Coll, Dept Biochem & Mol Biol, Wuhu, Peoples R China	Wannan Medical College; Wannan Medical College; Wannan Medical College; Wannan Medical College; Wannan Medical College	Gao, JL (corresponding author), Yijishan Hosp, Wannan Med Coll, Affiliated Hosp 1, Wuhu 241002, Peoples R China.	gaojialin@wnmc.edu.cn	GAO, JIALIN/GWN-1905-2022		Natural Science Foundation of Anhui Province (Anhui Provincial Natural Science Foundation) [1708085MH188]; National Natural Science Foundation of China (NSFC) [81200632, 81471002, 81800766]; Climbing Peak"Training Program for Innovative Technology team of Yijishan Hospital [PF2019013]; Peak" Training Program for Scientific Research of Yijishan Hospital [GF2019J07]	Natural Science Foundation of Anhui Province (Anhui Provincial Natural Science Foundation); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Climbing Peak"Training Program for Innovative Technology team of Yijishan Hospital; Peak" Training Program for Scientific Research of Yijishan Hospital	Natural Science Foundation of Anhui Province (Anhui Provincial Natural Science Foundation), Grant/Award Number: 1708085MH188; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81200632, 81471002 and 81800766; Climbing Peak"Training Program for Innovative Technology team of Yijishan Hospital, Grant/Award Number: PF2019013; Peak" Training Program for Scientific Research of Yijishan Hospital, Grant/Award Number: GF2019J07	Aizawa S, 2017, AUTOPHAGY, V13, P218, DOI 10.1080/15548627.2016.1248019; Aizawa S, 2016, AUTOPHAGY, V12, P565, DOI 10.1080/15548627.2016.1145325; Alpy F, 2013, J CELL SCI, V126, P5500, DOI 10.1242/jcs.139295; Aoyagi K, 2016, DIABETES, V65, P1648, DOI 10.2337/db15-1207; APPELMANS F, 1955, BIOCHEM J, V59, P438, DOI 10.1042/bj0590438; Arimon M, 2015, NEUROBIOL DIS, V84, P109, DOI 10.1016/j.nbd.2015.06.013; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Balboa E, 2017, REDOX BIOL, V12, P274, DOI 10.1016/j.redox.2017.02.024; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Berkovic SE, 2008, AM J HUM GENET, V82, P673, DOI 10.1016/j.ajhg.2007.12.019; Carayannopoulos MO, 2000, P NATL ACAD SCI USA, V97, P7313, DOI 10.1073/pnas.97.13.7313; Carraro-Lacroix LR, 2010, CELL PHYSIOL BIOCHEM, V26, P563, DOI 10.1159/000322324; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chan CY, 2014, J BIOL CHEM, V289, P19448, DOI 10.1074/jbc.M114.569855; Chang GY, 2016, J MOL ENDOCRINOL, V56, P249, DOI 10.1530/JME-15-0227; Charman M, 2010, J LIPID RES, V51, P1023, DOI 10.1194/jlr.M002345; Chatterjee P, 2016, J ALZHEIMERS DIS, V50, P887, DOI 10.3233/JAD-150948; Chen XR, 2018, J LIPID RES, V59, P404, DOI 10.1194/jlr.M073817; Cheruku SR, 2006, J BIOL CHEM, V281, P31594, DOI 10.1074/jbc.M602765200; Cliffe ST, 2009, HUM MOL GENET, V18, P2257, DOI 10.1093/hmg/ddp161; Conrad KS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02044-8; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Cui WQ, 2021, AUTOPHAGY, V17, P690, DOI 10.1080/15548627.2020.1728097; CZECH MP, 1993, J BIOL CHEM, V268, P9187; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; DeBosch BJ, 2013, MOL ENDOCRINOL, V27, P1887, DOI 10.1210/me.2013-1137; Doege H, 2000, J BIOL CHEM, V275, P16275, DOI 10.1074/jbc.275.21.16275; Dykes SS, 2016, ONCOTARGET, V7, P31037, DOI 10.18632/oncotarget.8832; Enogieru OJ, 2019, HUM MUTAT, V40, P983, DOI 10.1002/humu.23758; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Fecchi K, 2006, FASEB J, V20, P705, DOI 10.1096/fj.05-4661fje; Figueira MF, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13335; Gao JL, 2016, BIOCHEM BIOPH RES CO, V476, P326, DOI 10.1016/j.bbrc.2016.05.122; Gao JL, 2015, INT J CLIN EXP PATHO, V8, P15622; Gao JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066139; Goginashvili A, 2015, SCIENCE, V347, P878, DOI 10.1126/science.aaa2628; Gombojav B, 2016, J LIPID RES, V57, P318, DOI 10.1194/jlr.P063461; Gorbea C, 2010, J BIOL CHEM, V285, P31616, DOI 10.1074/jbc.M110.154120; Gordts PLSM, 2016, J CLIN INVEST, V126, P2855, DOI 10.1172/JCI86610; Hansen JB, 2012, CELL METAB, V16, P449, DOI 10.1016/j.cmet.2012.09.001; Hansen JS, 2015, DIABETOLOGIA, V58, P1845, DOI 10.1007/s00125-015-3584-x; Haraguchi T, 2006, BIOSCI BIOTECH BIOCH, V70, P1798, DOI 10.1271/bbb.60168; Harder MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120890; Hemming ML, 2008, PLOS BIOL, V6, P2314, DOI 10.1371/journal.pbio.0060257; Hofmann I, 2006, J CELL SCI, V119, P1494, DOI 10.1242/jcs.02958; Huang Q, 2018, FASEB J, V32, P243, DOI 10.1096/fj.201700447RR; Iaea DB, 2015, ESSAYS BIOCHEM, V57, P43, DOI [10.1042/BSE0570043, 10.1042/bse0570043]; Israels SJ, 2010, THROMB RES, V125, P152, DOI 10.1016/j.thromres.2009.07.005; Kato Y, 2020, BIOORG MED CHEM LETT, V30, DOI 10.1016/j.bmcl.2019.126891; Kern L, 2016, CELL TISSUE RES, V366, P651, DOI 10.1007/s00441-016-2477-8; Kettner C, 2003, BIOPHYS J, V85, P3730, DOI 10.1016/S0006-3495(03)74789-4; Kim K, 2018, CELL METAB, V27, P816, DOI 10.1016/j.cmet.2018.02.010; Klec Christiane, 2019, Cell Physiol Biochem, V53, P573, DOI 10.33594/000000158; Klein A, 2006, HEPATOLOGY, V43, P126, DOI 10.1002/hep.20985; Kong XY, 2016, ARCH PHYSIOL BIOCHEM, V122, P36, DOI 10.3109/13813455.2015.1120752; Kong XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129402; Kroner C, 2017, THORAX, V72, P213, DOI 10.1136/thoraxjnl-2016-208649; Li J, 2016, ELIFE, V5, DOI 10.7554/eLife.21635; Li Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep19522; Li YZ, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m997; Liu HY, 2017, AUTOPHAGY, V13, P1952, DOI 10.1080/15548627.2017.1368596; Liu J, 2017, ANALYST, V142, P4522, DOI 10.1039/c7an01280b; Lloyd-Lewis B, 2018, J BIOL CHEM, V293, P4244, DOI 10.1074/jbc.RA118.001777; Lopez DM, 2019, ELIFE, V8, DOI 10.7554/eLife.50025; Mackenzie B, 2007, BIOCHEM J, V403, P59, DOI 10.1042/BJ20061290; Maria Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146033; Medina MW, 2014, ARTERIOSCL THROM VAS, V34, P1917, DOI 10.1161/ATVBAHA.113.302806; Mendez-Acevedo KM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07077-z; Meng Y, 2018, EXP THER MED, V16, P246, DOI 10.3892/etm.2018.6187; Moon S, 2018, HUM GENOMICS, V12, DOI 10.1186/s40246-018-0180-4; Nair S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10925-3; Nakagawa Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051396; Pasquier A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11170-4; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; Piroli GG, 2002, J COMP NEUROL, V452, P103, DOI 10.1002/cne.10368; Prendiville J, 2007, PEDIATR DERMATOL, V24, P101, DOI 10.1111/j.1525-1470.2007.00352.x; Rose AJ, 2009, AM J PHYSIOL-REG I, V297, pR1228, DOI 10.1152/ajpregu.00258.2009; Schmiege P, 2017, NATURE, V550, P366, DOI 10.1038/nature24036; Schultz ML, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06115-2; Schwenk RW, 2010, DIABETOLOGIA, V53, P2209, DOI 10.1007/s00125-010-1832-7; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Smith AJ, 2009, AM J PHYSIOL-RENAL, V296, pF390, DOI 10.1152/ajprenal.90526.2008; Souza-Menezes J, 2007, CELL PHYSIOL BIOCHEM, V20, P455, DOI 10.1159/000107529; Steffensen KR, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-106; Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014; Tan HY, 2019, CHEM COMMUN, V55, P2688, DOI 10.1039/c9cc00113a; Teimouri M, 2017, HORM METAB RES, V49, P109, DOI 10.1055/s-0042-119649; Toledo M, 2018, CELL METAB, V28, P268, DOI 10.1016/j.cmet.2018.05.023; Ungewickell A, 2005, P NATL ACAD SCI USA, V102, P18854, DOI 10.1073/pnas.0509740102; van der Kant R, 2013, J LIPID RES, V54, P2153, DOI 10.1194/jlr.M037325; Ward DM, 2000, MOL BIOL CELL, V11, P2327, DOI 10.1091/mbc.11.7.2327; Winchester B G, 2001, Eur J Paediatr Neurol, V5 Suppl A, P11, DOI 10.1053/ejpn.2000.0428; Wolters JC, 2005, J BIOL CHEM, V280, P23631, DOI 10.1074/jbc.M503231200; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yasuda-Yamahara M, 2015, BIOCHEM BIOPH RES CO, V465, P249, DOI 10.1016/j.bbrc.2015.08.010; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014; Zidova Z, 2014, CELL PHYSIOL BIOCHEM, V34, P2221, DOI 10.1159/000369665	97	3	3	3	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21848	10.1096/fj.202002602R	http://dx.doi.org/10.1096/fj.202002602R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34582051	Bronze			2022-12-28	WOS:000702238200021
J	Jiang, HH; Guo, AN; Chiu, A; Li, HH; Lai, CSW; Lau, CG				Jiang, He-Hai; Guo, Anni; Chiu, Arthur; Li, Huanhuan; Lai, Cora Sau Wan; Lau, Chunyue Geoffrey			Target-specific control of piriform cortical output via distinct inhibitory circuits	FASEB JOURNAL			English	Article						GABAergic interneurons; inhibitory connectivity; inhibitory plasticity; sensory experience	LONG-TERM POTENTIATION; CORTEX; PLASTICITY; NEURONS; PERIOD; CELLS	Information represented by principal neurons in anterior piriform cortex (APC) is regulated by local, recurrent excitation and inhibition, but the circuit mechanisms remain elusive. Two types of layer 2 (L2) principal neurons, semilunar (SL), and superficial pyramidal (SP) cells, are parallel output channels, and the control of their activity gates the output of APC. Here, we examined the hypothesis that recurrent inhibition differentially regulates SL and SP cells. Patterned optogenetic stimulation revealed that the strength of recurrent inhibition is target- and layer-specific: L1 > L3 for SL cells, but L3 > L1 for SP cells. This target- and layer-specific inhibition was largely attributable to the parvalbumin (PV), but not somatostatin, interneurons. Intriguingly, olfactory experience selectively modulated the PV to SP microcircuit while maintaining the overall target and laminar specificity of inhibition. Together, these results indicate the importance of target-specific inhibitory wiring for odor processing, implicating these mechanisms in gating the output of piriform cortex.	[Jiang, He-Hai; Guo, Anni; Chiu, Arthur; Li, Huanhuan; Lau, Chunyue Geoffrey] City Univ Hong Kong, Dept Neurosci, Hong Kong, Peoples R China; [Jiang, He-Hai; Guo, Anni; Chiu, Arthur; Li, Huanhuan; Lau, Chunyue Geoffrey] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Peoples R China; [Jiang, He-Hai; Guo, Anni; Chiu, Arthur; Li, Huanhuan; Lau, Chunyue Geoffrey] City Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Lai, Cora Sau Wan] Univ Hong Kong, LKS Fac Med, Sch Biomed Sci, Pokfulam, Hong Kong, Peoples R China; [Lai, Cora Sau Wan] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Pokfulam, Hong Kong, Peoples R China; [Jiang, He-Hai] Guangzhou Regenerat Med & Hlth Guangdong Lab, Bioland Lab, Guangzhou, Guangdong, Peoples R China	City University of Hong Kong; City University of Hong Kong; City University of Hong Kong; University of Hong Kong; University of Hong Kong; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory)	Lau, CG (corresponding author), City Univ Hong Kong, Dept Neurosci, Kowloon Tong, Kowloon, 1B-203,2-F,Block 1,To Yuen Bldg,31 To Yuen St, Hong Kong, Peoples R China.	geoff.lau@cityu.edu.hk	jiang, he-hai/HGF-2306-2022; Lau, C. Geoffrey/G-4036-2014	/0000-0002-5721-4259; GUO, Anni/0000-0002-1527-3007; Lau, C. Geoffrey/0000-0001-9750-2514; Li, Huanhuan/0000-0001-5260-6993; jiang, hehai/0000-0002-5472-6312	National Natural Science Foundation of China (NSFC) [31571031]; Shenzhen Science and Technology Innovation Commission [JCYJ20190808182203591]; FHB | Health and Medical Research Fund (HMRF) [03143096]; Research Grants Council, University Grants Committee (RGC, UGC) [27103715, 17128816, 21103818, 11104320, 11104521]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Innovation Commission; FHB | Health and Medical Research Fund (HMRF); Research Grants Council, University Grants Committee (RGC, UGC)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31571031; Shenzhen Science and Technology Innovation Commission, Grant/Award Number: JCYJ20190808182203591; FHB | Health and Medical Research Fund (HMRF), Grant/Award Number: 03143096; Research Grants Council, University Grants Committee (RGC, UGC), Grant/Award Number: 27103715, 17128816, 21103818, 11104320 and 11104521	Best AR, 2003, BRAIN RES, V961, P81, DOI 10.1016/S0006-8993(02)03847-7; Bolding KA, 2018, SCIENCE, V361, P1088, DOI 10.1126/science.aat6904; Boyd AM, 2012, NEURON, V76, P1161, DOI 10.1016/j.neuron.2012.10.020; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; Choy JMC, 2017, CEREB CORTEX, V27, P589, DOI 10.1093/cercor/bhv258; Cohen Y, 2015, CEREB CORTEX, V25, P180, DOI 10.1093/cercor/bht215; Diodato A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12238; Franks KM, 2011, NEURON, V72, P49, DOI 10.1016/j.neuron.2011.08.020; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Froemke RC, 2015, ANNU REV NEUROSCI, V38, P195, DOI 10.1146/annurev-neuro-071714-034002; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; JONAS P, 1992, J PHYSIOL-LONDON, V455, P143, DOI 10.1113/jphysiol.1992.sp019294; JUNG MW, 1990, SYNAPSE, V6, P279, DOI 10.1002/syn.890060307; KANTER ED, 1990, BRAIN RES, V525, P175, DOI 10.1016/0006-8993(90)91337-G; Large AM, 2018, P NATL ACAD SCI USA, V115, pE8067, DOI 10.1073/pnas.1802428115; Large AM, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00062; Large AM, 2016, P NATL ACAD SCI USA, V113, P2276, DOI 10.1073/pnas.1519295113; Lee SH, 2014, NEURON, V82, P1129, DOI 10.1016/j.neuron.2014.03.034; Luna VM, 2010, NAT NEUROSCI, V13, P533, DOI 10.1038/nn.2524; Mazo C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08331-0; Meissner-Bernard C, 2019, CURR BIOL, V29, P367, DOI 10.1016/j.cub.2018.12.003; Otazu GH, 2015, NEURON, V86, P1461, DOI 10.1016/j.neuron.2015.05.023; Padmanabhan K, 2016, J NEUROSCI, V36, P7535, DOI 10.1523/JNEUROSCI.3358-15.2016; Penker S, 2020, FRONT SYST NEUROSCI, V14, DOI 10.3389/fnsys.2020.604718; Poo C, 2007, J NEUROSCI, V27, P7553, DOI 10.1523/JNEUROSCI.1786-07.2007; Reuveni I, 2018, NEUROSCIENCE, V381, P105, DOI 10.1016/j.neuroscience.2018.04.023; Roland B, 2017, ELIFE, V6, DOI 10.7554/eLife.26337; Stokes CCA, 2010, NEURON, V67, P452, DOI 10.1016/j.neuron.2010.06.029; Sugai T, 2005, NEUROSCIENCE, V130, P769, DOI 10.1016/j.neuroscience.2004.09.059; Suzuki N, 2011, J NEUROSCI, V31, P2156, DOI 10.1523/JNEUROSCI.5430-10.2011; Suzuki N, 2010, CEREB CORTEX, V20, P2971, DOI 10.1093/cercor/bhq046; Suzuki N, 2010, J COMP NEUROL, V518, P1670, DOI 10.1002/cne.22295; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Tantirigama MLS, 2017, P NATL ACAD SCI USA, V114, P2407, DOI 10.1073/pnas.1620939114; Wiegand HF, 2011, J NEUROSCI, V31, P12149, DOI 10.1523/JNEUROSCI.0285-11.2011; Wilson DA, 2011, NEURON, V72, P506, DOI 10.1016/j.neuron.2011.10.027; Yang JL, 2017, BMC NEUROSCI, V18, P1, DOI 10.1186/s12868-017-0342-7	40	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21944	10.1096/fj.202100757R	http://dx.doi.org/10.1096/fj.202100757R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34569087				2022-12-28	WOS:000702238200061
J	Wang, P; Li, RQ; Yuan, YY; Zhu, ML; Liu, Y; Jin, Y; Yin, YX				Wang, Pan; Li, Ruiqi; Yuan, Yuyao; Zhu, Minglu; Liu, Yang; Jin, Yan; Yin, Yuxin			PTEN alpha is responsible for protection of brain against oxidative stress during aging	FASEB JOURNAL			English	Article						aging; COX4; oxidative stress; PTEN alpha	MITOCHONDRIAL-DNA MUTATIONS; MECHANISMS; PHOSPHORYLATION; INHIBITION; HALLMARKS; SYSTEM; DEFECT	Neural cells are continuously subjected to oxidative stress arising from electrochemical activity, and cellular protection systems can turn on the oxidative stress response to detect and alleviate adverse conditions. However, the function and mechanism of the protective systems are complicated and remain largely elusive. We report that PTEN alpha, an isoform of the PTEN family, mediates defense signaling in response to oxidative stress during brain aging. We show that genetic ablation of Pten alpha in mice increases oxidative stress and results in neuronal cell death, culminating in accelerated decline of cognition and motor coordination as age increases. PTEN alpha maintains COX activity and promotes energy metabolism through abrogating NEDD4L-mediated degradation of COX4 in response to oxidative stress. In the presence of Parkinson's disease-associated mutation, PTEN alpha loses the capability to protect COX4 and ameliorate defects caused by Pten alpha deletion. Our study reveals an important role of PTEN alpha in response to oxidative stress. We propose that dysregulation of PTEN alpha signaling may accelerate the rate of brain aging and promote the development of neurodegenerative disorders.	[Wang, Pan; Yuan, Yuyao; Zhu, Minglu; Liu, Yang; Jin, Yan; Yin, Yuxin] Peking Univ, Dept Pathol, Sch Basic Med Sci, Inst Syst Biomed,Hlth Sci Ctr, Beijing 100191, Peoples R China; [Wang, Pan] Tsinghua Univ, Tsinghua Univ Peking Univ Joint Ctr Life Sci, Beijing, Peoples R China; [Li, Ruiqi; Yin, Yuxin] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Peking University; Tsinghua University; Peking University	Yin, YX (corresponding author), Peking Univ, Dept Pathol, Sch Basic Med Sci, Inst Syst Biomed,Hlth Sci Ctr, Beijing 100191, Peoples R China.	yinyuxin@hsc.pku.edu.cn			National Natural Science Foundation of China [81430056, 31420103905, 81621063, 31800849]; National Key Research and Development Program of China [2016YFA0500302]; Beijing Natural Science Foundation Key Grant [7161007]; China Postdoctoral Science Foundation [2017M620006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Beijing Natural Science Foundation Key Grant; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	National Natural Science Foundation of China, Grant/Award Number: 81430056, 31420103905, 81621063 and 31800849; National Key Research and Development Program of China, Grant/Award Number: 2016YFA0500302; Beijing Natural Science Foundation Key Grant, Grant/Award Number: 7161007; China Postdoctoral Science Foundation, Grant/Award Number: 2017M620006	Abu-Libdeh B, 2017, EUR J HUM GENET, V25, P1142, DOI 10.1038/ejhg.2017.112; Acin-Perez R, 2011, CELL METAB, V13, P712, DOI 10.1016/j.cmet.2011.03.024; Alexander GE, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00021; Barrientos A, 2009, BBA-MOL CELL RES, V1793, P97, DOI 10.1016/j.bbamcr.2008.05.003; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Clipperton-Allen AE, 2014, HUM MOL GENET, V23, P3490, DOI 10.1093/hmg/ddu057; Coenen MJH, 2001, CURR OPIN NEUROL, V14, P777, DOI 10.1097/00019052-200112000-00016; Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6; Dykiert D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045759; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Foti SC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42902-7; Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207; Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003; Hopkins BD, 2013, SCIENCE, V341, P399, DOI 10.1126/science.1234907; Huttemann M, 2001, GENE, V267, P111, DOI 10.1016/S0378-1119(01)00385-7; Kadenbach B, 2015, MITOCHONDRION, V24, P64, DOI 10.1016/j.mito.2015.07.002; Kadenbach B, 2009, TRENDS MOL MED, V15, P139, DOI 10.1016/j.molmed.2009.02.004; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Liang H, 2014, CELL METAB, V19, P836, DOI 10.1016/j.cmet.2014.03.023; Liu ZW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2525967; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mattson MP, 2018, CELL METAB, V27, P1176, DOI 10.1016/j.cmet.2018.05.011; Papagno C, 2018, NEUROL SCI, V39, P215, DOI 10.1007/s10072-017-3154-8; Renaud J, 2019, AGING-US, V11, P853, DOI 10.18632/aging.101806; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001; Shefa U, 2019, NEURAL REGEN RES, V14, P749, DOI 10.4103/1673-5374.249218; Shi Y, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002089; Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200; Sipos I, 2003, J NEUROCHEM, V84, P112, DOI 10.1046/j.1471-4159.2003.01513.x; Stranahan AM, 2012, NAT REV NEUROSCI, V13, P209, DOI 10.1038/nrn3151; Suzuki T, 2017, J BIOL CHEM, V292, P16817, DOI 10.1074/jbc.R117.800169; Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang P, 2017, CELL REP, V19, P2627, DOI 10.1016/j.celrep.2017.05.088; Yuan YY, 2019, FASEB J, V33, P11148, DOI 10.1096/fj.201900588RR	42	1	1	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21943	10.1096/fj.202100753R	http://dx.doi.org/10.1096/fj.202100753R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34582065				2022-12-28	WOS:000702238200052
J	Cao, XL; Tian, Y; Nguyen, V; Zhang, YP; Gao, C; Yin, R; Carver, W; Fan, DP; Albrecht, H; Cui, TX; Tan, WB				Cao, Xiaoling; Tian, Yan; Nguyen, Vi; Zhang, Yuping; Gao, Chao; Yin, Rong; Carver, Wayne; Fan, Daping; Albrecht, Helmut; Cui, Taixing; Tan, Wenbin			Spike protein of SARS-CoV-2 activates macrophages and contributes to induction of acute lung inflammation in male mice	FASEB JOURNAL			English	Article						COVID-19; inflammation; lung; SARS-CoV-2; spike	CHOLESTEROL; COVID-19	The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) plays a crucial role in mediating viral entry into host cells. However, whether it contributes to pulmonary hyperinflammation in patients with coronavirus disease 2019 is not well known. In this study, we developed a spike protein-pseudotyped (Spp) lentivirus with the proper tropism of the SARS-CoV-2 spike protein on the surface and determined the distribution of the Spp lentivirus in wild-type C57BL/6J male mice that received an intravenous injection of the virus. Lentiviruses with vesicular stomatitis virus glycoprotein (VSV-G) or with a deletion of the receptor-binding domain (RBD) in the spike protein [Spp ( increment RBD)] were used as controls. Two hours postinfection (hpi), there were 27-75 times more viral burden from Spp lentivirus in the lungs than in other organs; there were also about 3-5 times more viral burden from Spp lentivirus than from VSV-G lentivirus in the lungs, liver, kidney, and spleen. Deletion of RBD diminished viral loads in the lungs but not in the heart. Acute pneumonia was observed in animals 24 hpi. Spp lentivirus was mainly found in SPC+ and LDLR+ pneumocytes and macrophages in the lungs. IL6, IL10, CD80, and PPAR-gamma were quickly upregulated in response to infection in the lungs as well as in macrophage-like RAW264.7 cells. Furthermore, forced expression of the spike protein in RAW264.7 cells significantly increased the mRNA levels of the same panel of inflammatory factors. Our results demonstrated that the spike protein of SARS-CoV-2 confers the main point of viral entry into the lungs and can induce cellular pathology. Our data also indicate that an alternative ACE2-independent viral entry pathway may be recruited in the heart and aorta.	[Cao, Xiaoling; Tian, Yan; Nguyen, Vi; Zhang, Yuping; Gao, Chao; Yin, Rong; Carver, Wayne; Fan, Daping; Cui, Taixing; Tan, Wenbin] Univ South Carolina, Sch Med, Dept Cell Biol & Anat, 6311 Garners Ferry Rd, Columbia, SC 29209 USA; [Tian, Yan] Cent South Univ, Xiangya Hosp, Dept Obstet & Gynecol, Changsha, Peoples R China; [Zhang, Yuping] Cent South Univ, Dept Gen Surg, Xiangya Hosp 3, Changsha, Peoples R China; [Albrecht, Helmut] Prisma Hlth Med Grp, Dept Internal Med, Columbia, SC USA; [Albrecht, Helmut] Univ South Carolina, Sch Med, Dept Internal Med, Columbia, SC 29209 USA; [Carver, Wayne; Fan, Daping; Cui, Taixing; Tan, Wenbin] Univ South Carolina, Biomed Engn Program, Coll Engn & Comp, Columbia, SC 29209 USA	University of South Carolina System; University of South Carolina Columbia; Central South University; Central South University; University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia	Tan, WB (corresponding author), Univ South Carolina, Sch Med, Dept Cell Biol & Anat, 6311 Garners Ferry Rd, Columbia, SC 29209 USA.	wenbin.tan@uscmed.sc.edu	Cao, Xiaoling/AAE-7555-2022	Cao, Xiaoling/0000-0003-4993-8385	National Institutes of Health (NIH) [AR073172]; NIH Centers of Biomedical Research Excellence (COBRE) [P20GM109091]; Department of Defense Congressionally Directed Medical Research Programs (CDMRP) [W81XWH1810096]; NIH [HL131667]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Centers of Biomedical Research Excellence (COBRE); Department of Defense Congressionally Directed Medical Research Programs (CDMRP)(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH) Grant No AR073172 to WT, the NIH Centers of Biomedical Research Excellence (COBRE) Grant No P20GM109091 pilot award to WT, NIH Grant No. HL131667 to T. C., and the Department of Defense Congressionally Directed Medical Research Programs (CDMRP) Grant No. W81XWH1810096 to WT.	Bestle D, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000786; Bojkova D, 2020, NATURE, V583, P469, DOI 10.1038/s41586-020-2332-7; Buetti N, 2021, CLIN INFECT DIS, V72, pE690, DOI 10.1093/cid/ciaa1315; Cantuti-Castelvetri L, 2020, SCIENCE, V370, P856, DOI 10.1126/science.abd2985; Cao XL, 2020, AM J PHYSIOL-ENDOC M, V319, pE197, DOI 10.1152/ajpendo.00255.2020; Chen WL, 2020, EMERG MICROBES INFEC, V9, P469, DOI 10.1080/22221751.2020.1732837; Corman VM, 2020, TRANSFUSION, V60, P1119, DOI 10.1111/trf.15841; CoronavirusResourceCenter, 2020, COVID 19 DASHB CTR S; Daly JL, 2020, SCIENCE, V370, P861, DOI 10.1126/science.abd3072; Fan JL, 2020, METABOLISM, V107, DOI 10.1016/j.metabol.2020.154243; Fang ZX, 2020, J INFECTION, V81, P172, DOI 10.1016/j.jinf.2020.03.013; Fox SE, 2020, LANCET RESP MED, V8, P681, DOI 10.1016/S2213-2600(20)30243-5; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Gowdy KM, 2013, PULM PHARMACOL THER, V26, P430, DOI 10.1016/j.pupt.2012.06.002; Hoffmann M, 2020, MOL CELL, V78, P779, DOI 10.1016/j.molcel.2020.04.022; Hu XZ, 2020, CLIN CHIM ACTA, V510, P105, DOI 10.1016/j.cca.2020.07.015; Keidar S, 2005, CIRC RES, V97, P946, DOI 10.1161/01.RES.0000187500.24964.7A; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1101/2020.01.22.915660, 10.1038/s41564-020-0688-y]; Li WH, 2004, J VIROL, V78, P11429, DOI 10.1128/JVI.78.20.11429-11433.2004; Moutal Aubin, 2020, bioRxiv, DOI 10.1101/2020.07.17.209288; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Shoemark DK, 2021, ANGEW CHEM INT EDIT, V60, P7098, DOI 10.1002/anie.202015639; Sorokin AV, 2020, FASEB J, V34, P9843, DOI 10.1096/fj.202001451; Tanaka S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239573; Toelzer C, 2020, SCIENCE, V370, P725, DOI 10.1126/science.abd3255; Veyer D, 2021, CLIN INFECT DIS, V73, pE2890, DOI 10.1093/cid/ciaa1196; VOYNOYASENETSKAYA TA, 1993, P NATL ACAD SCI USA, V90, P4256, DOI 10.1073/pnas.90.9.4256; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang GY, 2020, LIPIDS HEALTH DIS, V19, DOI 10.1186/s12944-020-01382-9; Wei XQ, 2020, J CLIN LIPIDOL, V14, P297, DOI 10.1016/j.jacl.2020.04.008; Wei X, 2020, J MED VIROL, V92, P2036, DOI 10.1002/jmv.25957; Wiener RS, 2007, J CELL BIOCHEM, V101, P1278, DOI 10.1002/jcb.21248; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035	35	12	12	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21801	10.1096/fj.202002742RR	http://dx.doi.org/10.1096/fj.202002742RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34365657	Green Published			2022-12-28	WOS:000691122900006
J	Liang, ZT; Guo, CF; Li, J; Zhang, HQ				Liang, Zhuo-Tao; Guo, Chao-Feng; Li, Jiong; Zhang, Hong-Qi			The role of endocrine hormones in the pathogenesis of adolescent idiopathic scoliosis	FASEB JOURNAL			English	Review						adolescent idiopathic scoliosis; estrogen; ghrelin; growth hormone; leptin; melatonin	ESTROGEN-RECEPTOR-ALPHA; MELATONIN SIGNALING DYSFUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; PLATELET CALMODULIN LEVELS; BONE-MINERAL DENSITY; CURVE PROGRESSION; GROWTH-HORMONE; MUSCLE MASS; VITAMIN-D; PARAVERTEBRAL MUSCLES	Adolescent idiopathic scoliosis (AIS) is a common spinal deformity characterized by changes in the three-dimensional structure of the spine. It usually initiates during puberty, the peak period of human growth when the secretion of numerous hormones is changing, and it is more common in females than in males. Accumulating evidence shows that the abnormal levels of many hormones including estrogen, melatonin, growth hormone, leptin, adiponectin and ghrelin, may be related to the occurrence and development of AIS. The purpose of this review is to provide a summary and critique of the research published on each hormone over the past 20 years, and to highlight areas for future study. It is hoped that the presentation will help provide a better understanding of the role of endocrine hormones in the pathogenesis of AIS.	[Liang, Zhuo-Tao; Guo, Chao-Feng; Li, Jiong; Zhang, Hong-Qi] Cent South Univ, Xiangya Hosp, Dept Spine Surg & Orthopaed, Xiangya Rd, Changsha 410008, Hunan, Peoples R China; [Liang, Zhuo-Tao; Guo, Chao-Feng; Li, Jiong; Zhang, Hong-Qi] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China	Central South University; Central South University	Li, J; Zhang, HQ (corresponding author), Cent South Univ, Xiangya Hosp, Dept Spine Surg & Orthopaed, Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	466284467@qq.com; zhq9996@163.com		Zhang, Hongqi/0000-0001-5750-4910	natural science foundation of Hunan province [2019JJ80014]	natural science foundation of Hunan province(Natural Science Foundation of Hunan Province)	natural science foundation of Hunan province, Grant/Award Number: 2019JJ80014	Abou-Samra M, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0051-9; Abu EO, 1997, J CLIN ENDOCR METAB, V82, P3493, DOI 10.1210/jc.82.10.3493; Acaroglu E, 2012, EUR SPINE J, V21, P1033, DOI 10.1007/s00586-012-2245-8; Acaroglu E, 2009, SPINE, V34, pE659, DOI 10.1097/BRS.0b013e3181a3c7a2; AHL T, 1988, SPINE, V13, P139, DOI 10.1097/00007632-198802000-00001; Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Almeida M, 2017, PHYSIOL REV, V97, P135, DOI 10.1152/physrev.00033.2015; Amstrup AK, 2013, OSTEOPOROSIS INT, V24, P2919, DOI 10.1007/s00198-013-2404-8; Azeddine B, 2007, CLIN ORTHOP RELAT R, P45, DOI 10.1097/BLO.0b013e318811f39fa; Bae SH, 2020, J CLIN NEUROSCI, V71, P124, DOI 10.1016/j.jocn.2019.08.106; Bagnall KM, 1996, SPINE, V21, P1974, DOI 10.1097/00007632-199609010-00006; Bartell SM, 2011, J BONE MINER RES, V26, P1710, DOI 10.1002/jbmr.406; Blecher R, 2017, DEV CELL, V42, P388, DOI 10.1016/j.devcel.2017.07.022; Borjesson AE, 2011, P NATL ACAD SCI USA, V108, P6288, DOI 10.1073/pnas.1100454108; Callewaert F, 2010, J BONE MINER RES, V25, P617, DOI 10.1359/jbmr.090828; Catan L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062167; Chagin AS, 2007, J CLIN ENDOCR METAB, V92, P4873, DOI 10.1210/jc.2007-0814; Chen C, 2016, MOL MED REP, V14, P1201, DOI 10.3892/mmr.2016.5384; Chen S, 2014, EUR SPINE J, V23, P2586, DOI 10.1007/s00586-014-3481-x; Cheng JC, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.30; China SP, 2018, CYTOKINE, V112, P116, DOI 10.1016/j.cyto.2018.06.012; Christoforidis Athanasios, 2005, Pediatr Endocrinol Rev, V3, P5; Clark EM, 2014, J BONE MINER RES, V29, P1729, DOI 10.1002/jbmr.2207; Clark PA, 1996, ENDOCRIN METAB CLIN, V25, P665, DOI 10.1016/S0889-8529(05)70346-7; Dalleau G, 2011, EUR SPINE J, V20, P123, DOI 10.1007/s00586-010-1554-z; De Gauzy JS, 2015, SCOLIOSIS SPINAL DIS, V10, DOI 10.1186/s13013-015-0054-7; Delporte C, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/518909; Dewailly D, 2016, HUM REPROD UPDATE, V22, P709, DOI 10.1093/humupd/dmw027; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Esposito T, 2009, J STEROID BIOCHEM, V116, P56, DOI 10.1016/j.jsbmb.2009.04.010; Fan HW, 2016, SPINE, V41, P259, DOI 10.1097/BRS.0000000000001197; Farooqi IS, 2014, J ENDOCRINOL, V223, pT63, DOI 10.1530/JOE-14-0480; GALLAGHER JC, 1980, J CLIN ENDOCR METAB, V51, P1359, DOI 10.1210/jcem-51-6-1359; Gomez R, 2009, ARTHRITIS RHEUM-US, V60, P1704, DOI 10.1002/art.24522; Goultidis TT, 2014, J PEDIATR ORTHOPED, V34, P768, DOI 10.1097/BPO.0000000000000207; Gozdzialska A, 2016, SPINE, V41, P693, DOI 10.1097/BRS.0000000000001286; Grivas TB, 2006, SCOLIOSIS SPINAL DIS, V1, DOI 10.1186/1748-7161-1-9; HAGGLUND G, 1992, SPINE, V17, P108; Haller G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06705-0; Han Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06304-x; Haumont T, 2011, SPINE, V36, pE847, DOI 10.1097/BRS.0b013e3181ff5837; Histing T, 2012, J SURG RES, V173, P83, DOI 10.1016/j.jss.2010.08.036; HO KKY, 1992, J BONE MINER RES, V7, P821; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jiang H, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0049-y; Karasek M, 2006, J PHYSIOL PHARMACOL, V57, P19; Khosla S, 2012, TRENDS ENDOCRIN MET, V23, P576, DOI 10.1016/j.tem.2012.03.008; KINDSFATER K, 1994, J BONE JOINT SURG AM, V76A, P1186, DOI 10.2106/00004623-199408000-00009; Kishida Y, 2005, BONE, V37, P607, DOI 10.1016/j.bone.2005.05.009; Kotwicki T, 2014, SPINE, V39, pE1599, DOI 10.1097/BRS.0000000000000643; Koyama H, 2002, J BONE MINER RES, V17, P1219, DOI 10.1359/jbmr.2002.17.7.1219; Kulis A, 2015, INT ORTHOP, V39, P1227, DOI 10.1007/s00264-015-2742-6; Kulis Aleksandra, 2006, Ortop Traumatol Rehabil, V8, P455; Leboeuf D, 2009, TRENDS ENDOCRIN MET, V20, P147, DOI 10.1016/j.tem.2008.12.004; Letellier K, 2008, J PINEAL RES, V45, P383, DOI 10.1111/j.1600-079X.2008.00603.x; Li J, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1949-7; Li J, 2019, INT J BIOL SCI, V15, P2584, DOI 10.7150/ijbs.33340; Li Y, 2016, OSTEOPOROSIS INT, V27, P1485, DOI 10.1007/s00198-015-3391-8; Liang GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036648; Liang ZT, 2019, BIOCHEM BIOPH RES CO, V518, P259, DOI 10.1016/j.bbrc.2019.08.044; Lindberg MK, 2001, J ENDOCRINOL, V171, P229, DOI 10.1677/joe.0.1710229; Liu H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42467-5; Liu LY, 2018, MOL MED REP, V17, P1609, DOI 10.3892/mmr.2017.8042; Liu Z, 2015, SPINE, V40, P1593, DOI 10.1097/BRS.0000000000001095; Longworth B, 2014, ARCH PHYS MED REHAB, V95, P1725, DOI 10.1016/j.apmr.2014.02.027; Lowe T, 2002, SPINE, V27, P768, DOI 10.1097/00007632-200204010-00016; Lowe TG, 2004, EUR SPINE J, V13, P257, DOI 10.1007/s00586-003-0655-3; Machida M, 1996, SPINE, V21, P1147, DOI 10.1097/00007632-199605150-00005; MACHIDA M, 1995, J BONE JOINT SURG BR, V77B, P134, DOI 10.1302/0301-620X.77B1.7822371; Machida M, 2005, EUR SPINE J, V14, P843, DOI 10.1007/s00586-004-0806-1; Machida M, 2009, J PINEAL RES, V46, P344, DOI 10.1111/j.1600-079X.2009.00669.x; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; Man GCW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53757-3; Man GCW, 2011, J PINEAL RES, V50, P395, DOI 10.1111/j.1600-079X.2011.00857.x; Man GCW, 2010, J PINEAL RES, V49, P69, DOI 10.1111/j.1600-079X.2010.00768.x; Martinez-Llorens J, 2010, EUR RESPIR J, V36, P393, DOI 10.1183/09031936.00025509; Masana MI, 2005, NEUROENDOCRINOLOGY, V81, P87, DOI 10.1159/000084897; Matsunuma A, 2004, ENDOCRINOLOGY, V145, P1367, DOI 10.1210/en.2003-1010; Matusik E, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092657; Morcuende JA, 2003, SPINE, V28, P2025, DOI 10.1097/01.BRS.0000083235.74593.49; Moreau A, 2004, SPINE, V29, P1772, DOI 10.1097/01.BRS.0000134567.52303.1A; Moverare S, 2003, P NATL ACAD SCI USA, V100, P13573, DOI 10.1073/pnas.2233084100; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nilsson O, 2003, J ENDOCRINOL, V177, P319, DOI 10.1677/joe.0.1770319; Nogueiras R, 2008, ANN NY ACAD SCI, V1126, P14, DOI 10.1196/annals.1433.054; Normand E, 2020, SPINE J, V20, P785, DOI 10.1016/j.spinee.2019.11.012; Oishi A, 2018, INT REV CEL MOL BIO, V338, P59, DOI 10.1016/bs.ircmb.2018.02.002; Papaioannou S, 1999, BBA-MOL CELL RES, V1449, P284, DOI 10.1016/S0167-4889(99)00025-7; Park SJ, 2021, J PEDIATR ENDOCR MET, V34, P243, DOI 10.1515/jpem-2020-0393; Porter RW, 2001, EUR SPINE J, V10, P473, DOI 10.1007/s005860100311; Pradhan G, 2013, CURR OPIN CLIN NUTR, V16, P619, DOI 10.1097/MCO.0b013e328365b9be; Qiu XS, 2007, SPINE, V32, P1748, DOI 10.1097/BRS.0b013e3180b9f0ff; Qiu Y, 2007, SPINE, V32, P2703, DOI 10.1097/BRS.0b013e31815a59e5; Qiu Y, 2007, SPINE, V32, P667, DOI 10.1097/01.brs.0000257536.34431.96; Qu RZ, 2018, FASEB J, V32, P1044, DOI 10.1096/fj.201700265R; Raczkowski JW, 2007, NEUROENDOCRINOL LETT, V28, P302; Ram PT, 2000, J PINEAL RES, V28, P210, DOI 10.1034/j.1600-079X.2000.280403.x; Reid IR, 2018, ENDOCR REV, V39, P938, DOI 10.1210/er.2017-00226; Rosen CJ, 2009, NAT REV RHEUMATOL, V5, P657, DOI 10.1038/nrrheum.2009.231; Rusin B, 2012, STUD HEALTH TECHNOL, V176, P59, DOI 10.3233/978-1-61499-067-3-59; Sainz N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006808; Sanders JO, 2007, J BONE JOINT SURG AM, V89A, P64, DOI 10.2106/JBJS.F.00067; Shen V, 2000, J BONE MINER RES, V15, P740, DOI 10.1359/jbmr.2000.15.4.740; Sinha MK, 1996, BIOCHEM BIOPH RES CO, V228, P733, DOI 10.1006/bbrc.1996.1724; Soares JM, 2003, J PHARMACOL EXP THER, V306, P694, DOI 10.1124/jpet.103.049916; Suh KT, 2010, EUR SPINE J, V19, P1545, DOI 10.1007/s00586-010-1385-y; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tam EMS, 2016, SPINE, V41, P940, DOI 10.1097/BRS.0000000000001376; Tam EMS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087939; Tang NLS, 2006, SPINE, V31, P2463, DOI 10.1097/01.brs.0000239179.81596.2b; THILLARD MJ, 1959, CR HEBD ACAD SCI, V248, P1238; Toussirot E, 2017, CLIN RHEUMATOL, V36, P2531, DOI 10.1007/s10067-017-3789-0; Turner RT, 2013, J BONE MINER RES, V28, P22, DOI 10.1002/jbmr.1734; Ueberberg B, 2008, HORM METAB RES, V40, P181, DOI 10.1055/s-2007-1004574; Ueberberg B, 2009, HORM METAB RES, V41, P814, DOI 10.1055/s-0029-1233462; van der Velde M, 2012, ENDOCRINOLOGY, V153, P3593, DOI 10.1210/en.2012-1277; Vidal O, 2000, P NATL ACAD SCI USA, V97, P5474, DOI 10.1073/pnas.97.10.5474; Wang L, 2011, BONE, V48, P1022, DOI 10.1016/j.bone.2011.02.012; Wang Q, 2021, PROTEOM CLIN APPL, V15, DOI 10.1002/prca.202100002; Wang Q, 2020, J ORTHOP SURG RES, V15, DOI 10.1186/s13018-020-01988-w; Wang SJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072028; Wang WWJ, 2014, INT J MOL SCI, V15, P17100, DOI 10.3390/ijms150917100; Wang YJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071160; WARREN MP, 1986, NEW ENGL J MED, V314, P1348, DOI 10.1056/NEJM198605223142104; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3; WILLNER S, 1976, ACTA PAEDIATR SCAND, V65, P547, DOI 10.1111/j.1651-2227.1976.tb04930.x; Wu J, 2006, SPINE, V31, P1131, DOI 10.1097/01.brs.0000216603.91330.6f; Xiao LG, 2020, BONE, V134, DOI 10.1016/j.bone.2020.115291; Yang P, 2015, PAIN PHYSICIAN, V18, P419; Yim APY, 2013, INT J MOL SCI, V14, P6345, DOI 10.3390/ijms14036345; Yu AP, 2014, ACTA PHYSIOL, V211, P201, DOI 10.1111/apha.12263; Yu HG, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9784083; Zamecnik J, 2016, MOL MED REP, V14, P5719, DOI 10.3892/mmr.2016.5927; Zhang HQ, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1805-7; Zhang HQ, 2009, SPINE, V34, P760, DOI 10.1097/BRS.0b013e31818ad5ac; Zhang Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/168106; Zhao Dong, 2009, Orthop Surg, V1, P222, DOI 10.1111/j.1757-7861.2009.00038.x; Zhao Dong, 2009, Orthop Surg, V1, P58, DOI 10.1111/j.1757-7861.2008.00011.x; Zhao LL, 2017, SPINE, V42, P871, DOI 10.1097/BRS.0000000000001932; Zheng SH, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0161-7; Zhou H, 2001, J BONE MINER RES, V16, P1300, DOI 10.1359/jbmr.2001.16.7.1300; Zhu F, 2006, PEDIATR INT, V48, P591, DOI 10.1111/j.1442-200X.2006.02277.x	144	0	0	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21839	10.1096/fj.202100759R	http://dx.doi.org/10.1096/fj.202100759R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34387890	hybrid			2022-12-28	WOS:000691122900048
J	Xu, XF; Gu, HH; Li, HW; Gao, SZ; Shi, XH; Shen, J; Li, B; Wang, H; Zheng, KL; Shao, Z; Cheng, P; Cha, ZS; Peng, SY; Nie, YZ; Li, ZS; Guo, SW; Qian, BH; Jin, G				Xu, Xiongfei; Gu, Haihui; Li, Hongwei; Gao, Suizhi; Shi, Xiaohan; Shen, Jing; Li, Bo; Wang, Huan; Zheng, Kailian; Shao, Zhuo; Cheng, Peng; Cha, Zhanshan; Peng, Siying; Nie, Yongzhan; Li, Zhaoshen; Guo, Shiwei; Qian, Baohua; Jin, Gang			Large-cohort humanized NPI mice reconstituted with CD34(+) hematopoietic stem cells are feasible for evaluating preclinical cancer immunotherapy	FASEB JOURNAL			English	Article						bispecific antibody; cancer immunotherapy; checkpoint blockade; chimeric antigen receptor T cell; humanized mouse; T cell	HUMAN IMMUNE-SYSTEM; MOUSE MODEL; BLOOD; THERAPY	Cancer immunotherapy has achieved impressive therapeutic effects in many cancers, while only a small subset of patients benefit from it and some patients even have experienced severe toxicity. It is urgent to develop a feasible large-cohort humanized mouse model to evaluate the pre-clinical efficacy and safety of cancer immunotherapy. Furthermore, developing potentially effective combination therapy between cancer immunotherapy and other therapies also needs humanized mouse model to adequately mimic clinical actual setting. Herein, we established a humanized mouse model engrafted with less human CD34(+) HSCs than ever before and then evaluated reconstitution efficiency and the profiles of human immune cells in this humanized mouse model. Also, this humanized mouse model was used to evaluate the preclinical efficacy and safety of cancer immunotherapy. For each batch of CD34(+) HSCs humanized mouse model, a relatively-large cohort with over 25% human CD45(+) cells in peripheral blood was established. This humanized mouse model could efficiently reconstitute human innate and adaptive immune cells. This humanized mouse model supported patient-derived xenograft tumor growth and tumor infiltration of PD-1(+) human T cells. Furthermore, therapeutic efficacy, re-activation of tumor-infiltrated T cells, and side effects of checkpoint blockade therapy could be monitored in this humanized mouse model. Human T cells from this humanized mouse model were successfully engineered with CD19-CAR. CD19 CAR-T cells could effectively deplete B cells and suppress tumor growth of acute lymphoblastic leukemia in vivo in this humanized mouse model. This humanized mouse model also could be used to demonstrate the efficacy of bispecific antibodies, such as anti-CD19/CD3. Overall, our work provides a feasible large-cohort humanized mouse model for evaluating a variety of cancer immunotherapy approaches including checkpoint inhibitors, adoptive cell therapy, and bispecific antibody therapy, and demonstrates that human T cells from this humanized mouse model possess anti-tumor activities in vitro and in vivo.	[Xu, Xiongfei; Gao, Suizhi; Shi, Xiaohan; Shen, Jing; Li, Bo; Wang, Huan; Zheng, Kailian; Shao, Zhuo; Cheng, Peng; Guo, Shiwei; Jin, Gang] Naval Med Univ, Changhai Hosp, Dept Hepatobiliary Pancreat Surg, Shanghai 200433, Peoples R China; [Xu, Xiongfei; Li, Zhaoshen; Guo, Shiwei; Jin, Gang] Naval Med Univ, Changhai Hosp, Shanghai Inst Pancreat Dis, Shanghai, Peoples R China; [Gu, Haihui; Cha, Zhanshan; Qian, Baohua] Naval Med Univ, Changhai Hosp, Dept Transfus Med, Shanghai 200433, Peoples R China; [Li, Hongwei; Nie, Yongzhan] Air Force Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian, Peoples R China; [Li, Hongwei; Nie, Yongzhan] Air Force Mil Med Univ, Xijing Hosp Digest Dis, Natl Clin Res Ctr Digest Dis, Xian, Peoples R China; [Peng, Siying] BEIJING IDMO Co Ltd, Beijing, Peoples R China; [Li, Zhaoshen] Naval Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Jin, Gang] Shanghai Univ, Shanghai Inst Adv Commun & Data Sci, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Air Force Military Medical University; Naval Medical University; Shanghai University	Jin, G (corresponding author), Naval Med Univ, Changhai Hosp, Dept Hepatobiliary Pancreat Surg, Shanghai 200433, Peoples R China.; Qian, BH (corresponding author), Naval Med Univ, Changhai Hosp, Dept Transfus Med, Shanghai 200433, Peoples R China.	qianbh1963@163.com; jingang@smmu.edu.cn		Xu, Xiongfei/0000-0001-9532-4582	National Natural Science Foundation of China [81972913, 82172712, 81672830, 81570185, 81970165]; Shanghai Municipal Education Commission [2017-01-07-00-07-E00012]; Beijing Municipal Science & Technology Commission [Z181100001918043]; Shanghai Science and Technology Committee [19140902301, 16140903800]; Clinical Research and Cultivation Project of Shanghai Municipal Hospital [SHDC12019X13]; Shanghai Zhangjiang National Innovation Demonstration Zone Special Development Fund [ZJ2017-ZD-014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Clinical Research and Cultivation Project of Shanghai Municipal Hospital; Shanghai Zhangjiang National Innovation Demonstration Zone Special Development Fund	National Natural Science Foundation of China, Grant/Award Number: 81972913, 82172712, 81672830, 81570185 and 81970165; Shanghai Municipal Education Commission, Grant/Award Number: 2017-01-07-00-07-E00012; Beijing Municipal Science & Technology Commission, Grant/Award Number: Z181100001918043; Shanghai Science and Technology Committee, Grant/Award Number: 19140902301 and 16140903800; Clinical Research and Cultivation Project of Shanghai Municipal Hospital, Grant/Award Number: SHDC12019X13; Shanghai Zhangjiang National Innovation Demonstration Zone Special Development Fund, Grant/Award Number: ZJ2017-ZD-014	Andre MC, 2010, J IMMUNOL, V185, P2710, DOI 10.4049/jimmunol.1000583; Brehm MA, 2010, DIABETES, V59, P2265, DOI 10.2337/db10-0323; Buder-Bakhaya K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01474; Carstens JL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15095; Christofi T, 2019, CANCERS, V11, DOI 10.3390/cancers11101472; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; De La Rochere P, 2018, TRENDS IMMUNOL, V39, P748, DOI 10.1016/j.it.2018.07.001; Dobosz P, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02965; Giavridis T, 2018, NAT MED, V24, P731, DOI 10.1038/s41591-018-0041-7; Guo SW, 2019, FASEB J, V33, P873, DOI 10.1096/fj.201800617R; Hargadon KM, 2018, INT IMMUNOPHARMACOL, V62, P29, DOI 10.1016/j.intimp.2018.06.001; Hegde PS, 2020, IMMUNITY, V52, P17, DOI 10.1016/j.immuni.2019.12.011; Ishiguro T, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4291; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Kang YK, 2016, BLOOD RES, V51, P31, DOI 10.5045/br.2016.51.1.31; Kennedy LB, 2020, CA-CANCER J CLIN, V70, P86, DOI 10.3322/caac.21596; Khalil DN, 2016, NAT REV CLIN ONCOL, V13, P394, DOI 10.1038/nrclinonc.2016.65; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Li JZ, 2019, SUSTAINABILITY-BASEL, V11, DOI [10.1126/scitranslmed.aax8861, 10.3390/su11185015]; Liu LQ, 2017, CLIN CANCER RES, V23, P1506, DOI 10.1158/1078-0432.CCR-16-0666; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; Meraz IM, 2019, CANCER IMMUNOL RES, V7, P1267, DOI 10.1158/2326-6066.CIR-18-0874; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Neelapu SS, 2018, NAT REV CLIN ONCOL, V15, P47, DOI 10.1038/nrclinonc.2017.148; Norelli M, 2018, NAT MED, V24, P739, DOI 10.1038/s41591-018-0036-4; Przepiorka D, 2015, CLIN CANCER RES, V21, P4035, DOI 10.1158/1078-0432.CCR-15-0612; Rader C, 2020, CURR OPIN BIOTECH, V65, P9, DOI 10.1016/j.copbio.2019.11.020; Stadler CR, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1091555; Sun LPL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4802; Vargas FA, 2018, CANCER CELL, V33, P649, DOI 10.1016/j.ccell.2018.02.010; Wang MA, 2018, FASEB J, V32, P1537, DOI 10.1096/fj.201700740R; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050; Zhang J, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1258504; Zhao Y, 2018, GUT, V67, P1845, DOI 10.1136/gutjnl-2017-315201	36	2	2	6	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22244	10.1096/fj.202101548RR	http://dx.doi.org/10.1096/fj.202101548RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CJ	35262964				2022-12-28	WOS:000772944700001
J	Lopez, AIM; Fregoso, DR; Gallegos, A; Yoon, DJ; Fuentes, JJ; Crawford, R; Kaba, H; Yang, HY; Isseroff, RR				Lopez, Andrea I. Medina; Fregoso, Daniel R.; Gallegos, Anthony; Yoon, Daniel J.; Fuentes, Jaime J.; Crawford, Robert; Kaba, Hawa; Yang, Hsin-ya; Isseroff, R. Rivkah			Beta adrenergic receptor antagonist can modify Pseudomonas aeruginosa biofilm formation in vitro: Implications for chronic wounds	FASEB JOURNAL			English	Article						antagonist for adrenergic receptors; biofilm; chronic wounds; infection	DIABETIC FOOT ULCER; TOPICAL TIMOLOL; NEUTROPHIL APOPTOSIS; HOST COMMUNICATION; PYOCYANIN; IDENTIFICATION; VIRULENCE; BACTERIA; CULTURE; STAPHYLOCOCCI	Non-healing wounds are a major medical challenge, affecting over 6.5 million people in the US alone, with associated healthcare costs of about $16 billion annually. They can result in prolonged hospitalizations, work loss, disability, poor quality of life, and in diabetic patients with foot ulcers, amputation of the affected limb in 25% of patients. Though chronic ulcers may arise from different underlying diseases, the unifying feature is chronic infection, driving persistent inflammation that prolongs the healing process. One of the most frequently cultured or genetically identified pathogens in skin wounds is Pseudomonas aeruginosa. This species avidly forms biofilms in the wound that impede bacterial eradication by the host's immune mechanisms and limit efficacy of systemic antibiotics. Thus, non-antibiotic approaches to limit the growth and biofilm formation of this wound pathogen would be an advance in the treatment of chronic wounds. Prior work has demonstrated that the growth of other microbial species can be modulated by catecholamine agonists and antagonists of the adrenergic receptors (ARs). Here, we demonstrate that not only can the growth of this common wound pathogen be modulated by catecholamines, but also that the beta-AR antagonists can significantly decrease their growth, and importantly, limit their ability to form biofilms. These findings suggest that beta adrenergic antagonists may have a therapeutic role in the treatment of chronic skin wounds.	[Lopez, Andrea I. Medina; Fregoso, Daniel R.; Gallegos, Anthony; Yoon, Daniel J.; Kaba, Hawa; Yang, Hsin-ya] Univ Calif Davis, Dept Dermatol, Davis, CA 95816 USA; [Fuentes, Jaime J.; Crawford, Robert] Calif State Univ Sacramento, Dept Biol Sci, Sacramento, CA 95819 USA; [Isseroff, R. Rivkah] VA Northern Calif Hlth Care Syst, Dermatol Sect, Mather, CA USA	University of California System; University of California Davis; California State University System; California State University Sacramento	Isseroff, RR (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, 3301 C St,Suite 1400, Sacramento, CA 95816 USA.	rrisseroff@ucdavis.edu	Isseroff, Roslyn Rivkah/AAD-8478-2021	Isseroff, Roslyn Rivkah/0000-0001-7813-0858; Yang, Hsin-ya/0000-0002-5325-494X	California Institute for Regenerative Medicine (CIRM) [PC1-08118]	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine)	California Institute for Regenerative Medicine (CIRM), Grant/Award Number: PC1-08118	Askarian F, 2014, J INNATE IMMUN, V6, P485, DOI 10.1159/000357618; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Beroukhim K, 2014, DERMATOL SURG, V40, P924, DOI 10.1111/DSU.0000000000000054; Birkenhauer E, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-191; Braun LR, 2013, JAMA DERMATOL, V149, P1400, DOI 10.1001/jamadermatol.2013.7135; BRITIGAN BE, 1992, J CLIN INVEST, V90, P2187, DOI 10.1172/JCI116104; Byrd MS, 2011, INFECT IMMUN, V79, P3087, DOI 10.1128/IAI.00057-11; Cambronel M, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01501; Cambronel M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56666-7; Castaneda-Tamez P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01348; CDC, 2020, NAT DIAB STAT REP 20; Chiaverini C, 2016, J AM ACAD DERMATOL, V75, pE223, DOI 10.1016/j.jaad.2016.08.005; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; ClinicalTrials.gov, 2018, NCT03282981 BETA ADR; Dasu MR, 2014, STEM CELL TRANSL MED, V3, P745, DOI 10.5966/sctm.2013-0200; de la Fuente-Nunez C, 2013, CURR OPIN MICROBIOL, V16, P580, DOI 10.1016/j.mib.2013.06.013; DeLeon S, 2014, INFECT IMMUN, V82, P4718, DOI 10.1128/IAI.02198-14; Dickson RP, 2015, AM J RESP CRIT CARE, V192, P257, DOI 10.1164/rccm.201502-0326LE; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Fazli M, 2009, J CLIN MICROBIOL, V47, P4084, DOI 10.1128/JCM.01395-09; Feraco D, 2016, MICROB PATHOGENESIS, V99, P253, DOI 10.1016/j.micpath.2016.08.015; Freestone PP, 2012, CHEST, V142, P1200, DOI 10.1378/chest.11-2614; Freestone PPE, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-8; Georgescu M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1396-3; Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x; Golovkine G, 2018, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00532; Hegde M, 2009, APPL MICROBIOL BIOT, V84, P763, DOI 10.1007/s00253-009-2045-1; Hoegy F, 2014, METHODS MOL BIOL, V1149, P293, DOI 10.1007/978-1-4939-0473-0_24; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Irie Y, 2012, P NATL ACAD SCI USA, V109, P20632, DOI 10.1073/pnas.1217993109; Jarbrink K, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0329-y; Kang D, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02048; Karavolos MH, 2014, ADV EXP MED BIOL, V817, P241, DOI 10.1007/978-1-4939-0897-4_11; Karavolos MH, 2013, MOL MICROBIOL, V87, P455, DOI 10.1111/mmi.12110; Karavolos MH, 2011, EMBO REP, V12, P252, DOI 10.1038/embor.2011.4; Karin M, 2016, NATURE, V529, P307, DOI 10.1038/nature17039; Kim MH, 2014, J INVEST DERMATOL, V134, P809, DOI 10.1038/jid.2013.415; Kragh KN, 2019, BIOFILM, V1, DOI 10.1016/j.bioflm.2019.100006; Lamont IL, 2002, P NATL ACAD SCI USA, V99, P7072, DOI 10.1073/pnas.092016999; Larsen L, 2018, J TISSUE ENG REGEN M, V12, P186, DOI 10.1002/term.2390; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Lev-Tov H, 2013, J AM ACAD DERMATOL, V69, pE204, DOI 10.1016/j.jaad.2013.06.003; Loesche M, 2017, J INVEST DERMATOL, V137, P237, DOI 10.1016/j.jid.2016.08.009; Luqman A, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-1000-7; Luqman A, 2018, CELL REP, V22, P535, DOI 10.1016/j.celrep.2017.12.058; LYTE M, 1992, LIFE SCI, V50, P203, DOI 10.1016/0024-3205(92)90273-R; Lyte M, 2003, LANCET, V361, P130, DOI 10.1016/S0140-6736(03)12231-3; Malic S, 2009, MICROBIOL-SGM, V155, P2603, DOI 10.1099/mic.0.028712-0; Martin P, 2015, BRIT J DERMATOL, V173, P370, DOI 10.1111/bjd.13954; Martins-Mendes D, 2014, J DIABETES COMPLICAT, V28, P632, DOI 10.1016/j.jdiacomp.2014.04.011; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Meyer JM, 1996, INFECT IMMUN, V64, P518, DOI 10.1128/IAI.64.2.518-523.1996; Mihai MM, 2014, ROM J MORPHOL EMBRYO, V55, P1401; Murakami K, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02587-16; Ndosi M, 2018, DIABETIC MED, V35, P78, DOI 10.1111/dme.13537; Nussbaum SR, 2018, VALUE HEALTH, V21, P27, DOI 10.1016/j.jval.2017.07.007; O'Malley YQ, 2004, AM J PHYSIOL-LUNG C, V287, pL94, DOI 10.1152/ajplung.00025.2004; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Pastar I, 2014, ADV WOUND CARE, V3, P445, DOI 10.1089/wound.2013.0473; Pastar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056846; Pasupuleti S, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00564-17; Perraud Q, 2022, ENVIRON MICROBIOL, V24, P878, DOI 10.1111/1462-2920.15372; Powers JG, 2016, J AM ACAD DERMATOL, V74, P607, DOI 10.1016/j.jaad.2015.08.070; Prince LR, 2008, J IMMUNOL, V180, P3502, DOI 10.4049/jimmunol.180.5.3502; Pullar CE, 2008, PHARMACOL RES, V58, P158, DOI 10.1016/j.phrs.2008.07.012; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; Roberts AEL, 2015, J MOL BIOL, V427, P3646, DOI 10.1016/j.jmb.2015.09.002; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Seleem NM, 2020, EUR J CLIN MICROBIOL, V39, P1687, DOI 10.1007/s10096-020-03882-z; Shishov VA, 2009, APPL BIOCHEM MICRO+, V45, P494, DOI 10.1134/S0003683809050068; Sivamani RK, 2014, J INVEST DERMATOL, V134, P2258, DOI 10.1038/jid.2014.137; Sivamani RK, 2009, PLOS MED, V6, P105, DOI 10.1371/journal.pmed.1000012; Snyder D., 2020, SKIN SUBSTITUTES TRE; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Tang JC, 2012, DERMATOL SURG, V38, P135, DOI 10.1111/j.1524-4725.2011.02200.x; Thomsen TR, 2010, WOUND REPAIR REGEN, V18, P38, DOI 10.1111/j.1524-475X.2009.00561.x; Trivedi U, 2014, J PATHOG, V2014, DOI 10.1155/2014/173053; Tsavkelova EA, 2006, APPL BIOCHEM MICRO+, V42, P229, DOI 10.1134/S000368380603001X; Tsavkelova E A, 2000, Dokl Biochem, V372, P115; Usher LR, 2002, J IMMUNOL, V168, P1861, DOI 10.4049/jimmunol.168.4.1861; Wilson Christina, 2017, Res Rev J Eng Technol, V6; World Health Organization, 2017, GLOBAL PRIORITY LIST, DOI DOI 10.1016/S1473-3099(09)70222-1; Yoon DJ, 2021, J INVEST DERMATOL, V141, P1608, DOI 10.1016/j.jid.2020.11.016; Zhao G, 2013, ADV WOUND CARE, V2, P389, DOI 10.1089/wound.2012.0381; Zhao G, 2012, WOUND REPAIR REGEN, V20, P342, DOI 10.1111/j.1524-475X.2012.00793.x; Zhao RL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122085	91	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22057	10.1096/fj.202100717RR	http://dx.doi.org/10.1096/fj.202100717RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35133020				2022-12-28	WOS:000761250800043
J	Wagner, BM; Robinson, JW; Healy, CL; Gauthier, M; Dickey, DM; Yee, SP; Osborn, JW; O'Connell, TD; Potter, LR				Wagner, Brandon M.; Robinson, Jerid W.; Healy, Chastity L.; Gauthier, Madeline; Dickey, Deborah M.; Yee, Siu-Pok; Osborn, John W.; O'Connell, Timothy D.; Potter, Lincoln R.			Guanylyl cyclase-A phosphorylation decreases cardiac hypertrophy and improves systolic function in male, but not female, mice	FASEB JOURNAL			English	Article						cardiac hypertrophy; extracellular-regulated kinase; guanylyl cyclase; hypertension; natriuretic peptide	NATRIURETIC-PEPTIDE RECEPTOR; ACTIVATED PROTEIN-KINASE; CARDIOMYOCYTE HYPERTROPHY; HOMOLOGY DOMAIN; OOCYTE MEIOSIS; BLOOD-PRESSURE; CGMP; DEPHOSPHORYLATION; LACKING; HYPERTENSION	Atrial natriuretic peptide (NP) and BNP increase cGMP, which reduces blood pressure and cardiac hypertrophy by activating guanylyl cyclase (GC)-A, also known as NPR-A or Npr1. Although GC-A is highly phosphorylated, and dephosphorylation inactivates the enzyme, the significance of GC-A phosphorylation to heart structure and function remains unknown. To identify in vivo processes that are regulated by GC-A phosphorylation, we substituted glutamates for known phosphorylation sites to make GC-A(8E/8E) mice that express an enzyme that cannot be inactivated by dephosphorylation. GC-A activity, but not protein, was increased in heart and kidney membranes from GC-A(8E/8E) mice. Activities were threefold higher in female compared to male cardiac ventricles. Plasma cGMP and testosterone were elevated in male and female GC-A(8E/8E) mice, but aldosterone was only increased in mutant male mice. Plasma and urinary creatinine concentrations were decreased and increased, respectively, but blood pressure and heart rate were unchanged in male GC-A(8E/8E) mice. Heart weight to body weight ratios for GC-A(8E/8E) male, but not female, mice were 12% lower with a 14% reduction in cardiomyocyte cross-sectional area. Subcutaneous injection of fsANP, a long-lived ANP analog, increased plasma cGMP and decreased aldosterone in male GC-A(WT/WT) and GC-A(8E/8E) mice at 15 min, but only GC-A(8E/8E) mice had elevated levels of plasma cGMP and aldosterone at 60 min. fsANP reduced ventricular ERK1/2 phosphorylation to a greater extent and for a longer time in the male mutant compared to WT mice. Finally, ejection fractions were increased in male but not female hearts from GC-A(8E/8E) mice. We conclude that increased phosphorylation-dependent GC-A activity decreases cardiac ERK activity, which results in smaller male hearts with improved systolic function.	[Wagner, Brandon M.; Healy, Chastity L.; Gauthier, Madeline; O'Connell, Timothy D.; Potter, Lincoln R.] Univ Minnesota, Med Sch, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA; [Robinson, Jerid W.; Dickey, Deborah M.; Potter, Lincoln R.] Univ Minnesota, Med Sch, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Yee, Siu-Pok] Univ Connecticut, Dept Cell Biol, Hlth Ctr, Farmington, CT USA; [Osborn, John W.] Univ Minnesota, Med Sch, Dept Surg, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Connecticut; University of Minnesota System; University of Minnesota Twin Cities	O'Connell, TD; Potter, LR (corresponding author), Univ Minnesota, Med Sch, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA.; Potter, LR (corresponding author), Univ Minnesota, Med Sch, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	tdoconne@umn.edu; potter@umn.edu		Wagner, Brandon/0000-0001-9162-3032	National Institutes of Health [R01GM098309]; University of Minnesota Foundation Bridge Grant; University of Minnesota-Mayo Clinic Partnership Grant; University of Minnesota Academic Health Center Faculty Research and Development Grant; Fund for Science and the Hormone Receptor Lund; NIH [R01tIL130099, R0111L152215];  [NIHT32DK007203]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Foundation Bridge Grant; University of Minnesota-Mayo Clinic Partnership Grant; University of Minnesota Academic Health Center Faculty Research and Development Grant; Fund for Science and the Hormone Receptor Lund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	This work was supported by the National Institutes of Health Grant R01GM098309, a University of Minnesota Foundation Bridge Grant, a University of Minnesota-Mayo Clinic Partnership Grant, a University of Minnesota Academic Health Center Faculty Research and Development Grant, and Grants from the Fund for Science and the Hormone Receptor Lund to LRP. NIHT32DK007203 Grant supported JWR. NIH R01tIL130099 and NIH R0111L152215 to TDO also funded portions of this work	Abbey SE, 2002, J BIOL CHEM, V277, P42423, DOI 10.1074/jbc.M206686200; Asirvatham-Jeyaraj N, 2021, HYPERTENSION, V77, P519, DOI 10.1161/HYPERTENSIONAHA.119.14069; Babiker FA, 2004, CIRCULATION, V109, P269, DOI 10.1161/01.CIR.0000105682.85732.BD; Bereta G, 2010, J BIOL CHEM, V285, P1899, DOI 10.1074/jbc.M109.061713; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Chen Y, 2020, AM J PHYSIOL-REG I, V318, pR669, DOI 10.1152/ajpregu.00354.2019; Chen Y, 2020, CARDIOVASC DRUG THER, V34, P3, DOI 10.1007/s10557-020-06936-8; Coue M, 2015, DIABETES, V64, P4033, DOI 10.2337/db15-0305; Dickey DM, 2009, J BIOL CHEM, V284, P19196, DOI 10.1074/jbc.M109.010777; DOMINO SE, 1991, METHOD ENZYMOL, V195, P345; Edmund AB, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau5378; Egbert JR, 2014, DEVELOPMENT, V141, P3594, DOI 10.1242/dev.112219; HANEDA M, 1991, KIDNEY INT, V40, P188, DOI 10.1038/ki.1991.199; Hayashi D, 2004, BIOCHEM BIOPH RES CO, V322, P310, DOI 10.1016/j.bbrc.2004.07.119; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; Hofmann F, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-018-0690-1; Holtwick R, 2003, J CLIN INVEST, V111, P1399, DOI 10.1172/JCI200317061; HORI R, 1985, BIOCHEM BIOPH RES CO, V129, P773, DOI 10.1016/0006-291X(85)91959-X; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Jaffe LA, 2017, ANNU REV PHYSIOL, V79, P237, DOI 10.1146/annurev-physiol-022516-034102; John SWM, 1996, AM J PHYSIOL-REG I, V271, pR109, DOI 10.1152/ajpregu.1996.271.1.R109; Joubert S, 2001, BIOCHEMISTRY-US, V40, P11096, DOI 10.1021/bi010580s; Kehat I, 2010, ANN NY ACAD SCI, V1188, P96, DOI 10.1111/j.1749-6632.2009.05088.x; Keppler A, 2007, KIDNEY INT, V71, P74, DOI 10.1038/sj.ki.5001988; Kishimoto I, 2001, P NATL ACAD SCI USA, V98, P2703, DOI 10.1073/pnas.051625598; Kishimoto I, 1996, P NATL ACAD SCI USA, V93, P6215, DOI 10.1073/pnas.93.12.6215; Knowles JW, 2001, J CLIN INVEST, V107, P975, DOI 10.1172/JCI11273; KOLLER KJ, 1993, J BIOL CHEM, V268, P5997; Kuhn M, 2016, PHYSIOL REV, V96, P751, DOI 10.1152/physrev.00022.2015; Lee DI, 2015, NATURE, V519, P472, DOI 10.1038/nature14332; Li YH, 2004, ENDOCRINOLOGY, V145, P951, DOI 10.1210/en.2003-0816; Li YH, 2002, CIRCULATION, V106, P1722, DOI 10.1161/01.CIR.0000029923.57048.61; Lips DJ, 2004, CIRCULATION, V109, P1938, DOI 10.1161/01.CIR.0000127126.73759.23; Lopez MJ, 1997, J BIOL CHEM, V272, P23064, DOI 10.1074/jbc.272.37.23064; LOPEZ MJ, 1995, NATURE, V378, P65, DOI 10.1038/378065a0; Lukowski R, 2010, P NATL ACAD SCI USA, V107, P5646, DOI 10.1073/pnas.1001360107; MARINGREZ M, 1986, NATURE, V324, P473, DOI 10.1038/324473a0; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; Miyashita K, 2009, DIABETES, V58, P2880, DOI 10.2337/db09-0393; Nakamura M, 2018, NAT REV CARDIOL, V15, P387, DOI 10.1038/s41569-018-0007-y; NUSHIRO N, 1987, TOHOKU J EXP MED, V152, P301, DOI 10.1620/tjem.152.301; O'Connell TD, 2006, J CLIN INVEST, V116, P1005, DOI 10.1172/JCI22811; O'Connell TD, 2003, J CLIN INVEST, V111, P1783, DOI 10.1172/JCI200316100; Oliver PM, 1998, P NATL ACAD SCI USA, V95, P2547, DOI 10.1073/pnas.95.5.2547; Oliver PM, 1997, P NATL ACAD SCI USA, V94, P14730, DOI 10.1073/pnas.94.26.14730; Otani K, 2020, CIRCULATION, V141, P571, DOI 10.1161/CIRCULATIONAHA.119.039761; Otto NM, 2017, MOL PHARMACOL, V92, P67, DOI 10.1124/mol.116.107995; Pandey KN, 1999, ENDOCRINOLOGY, V140, P5112, DOI 10.1210/en.140.11.5112; Pandey KN, 2000, BIOCHEM BIOPH RES CO, V271, P374, DOI 10.1006/bbrc.2000.2627; Patrucco E, 2014, P NATL ACAD SCI USA, V111, P12925, DOI 10.1073/pnas.1414364111; Pichlo M, 2014, J CELL BIOL, V206, P541, DOI 10.1083/jcb.201402027; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Potter LR, 1998, J BIOL CHEM, V273, P15533, DOI 10.1074/jbc.273.25.15533; POTTER LR, 1992, J BIOL CHEM, V267, P14531; Potter LR, 1998, BIOCHEMISTRY-US, V37, P2422, DOI 10.1021/bi972303k; POTTER LR, 1994, J BIOL CHEM, V269, P14636; Potter LR, 1999, MOL BIOL CELL, V10, P1811, DOI 10.1091/mbc.10.6.1811; Potter LR, 1998, MOL CELL BIOL, V18, P2164, DOI 10.1128/MCB.18.4.2164; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; Robinson JW, 2020, BONE, V135, DOI 10.1016/j.bone.2020.115320; Robinson JW, 2017, CELL SIGNAL, V40, P222, DOI 10.1016/j.cellsig.2017.09.021; Robinson JW, 2012, DEV BIOL, V366, P308, DOI 10.1016/j.ydbio.2012.04.019; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Schewe J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13033-4; Schroter J, 2010, FEBS J, V277, P2440, DOI 10.1111/j.1742-4658.2010.07658.x; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; Scott NJA, 2009, BBA-MOL BASIS DIS, V1792, P1175, DOI 10.1016/j.bbadis.2009.09.009; Shuhaibar LC, 2017, ELIFE, V6, DOI 10.7554/eLife.31343; Shuhaibar LC, 2016, DEV BIOL, V409, P194, DOI 10.1016/j.ydbio.2015.10.025; Shuhaibar LC, 2015, P NATL ACAD SCI USA, V112, P5527, DOI 10.1073/pnas.1423598112; Silberbach M, 1999, J BIOL CHEM, V274, P24858, DOI 10.1074/jbc.274.35.24858; SMITH JB, 1987, AM J PHYSIOL, V253, pC147, DOI 10.1152/ajpcell.1987.253.1.C147; Suda M, 1998, P NATL ACAD SCI USA, V95, P2337, DOI 10.1073/pnas.95.5.2337; SUGIMOTO T, 1993, BIOCHEM BIOPH RES CO, V195, P72, DOI 10.1006/bbrc.1993.2011; Suhasini M, 1998, MOL CELL BIOL, V18, P6983, DOI 10.1128/MCB.18.12.6983; Tamura N, 2000, P NATL ACAD SCI USA, V97, P4239, DOI 10.1073/pnas.070371497; Tsai EJ, 2009, PHARMACOL THERAPEUT, V122, P216, DOI 10.1016/j.pharmthera.2009.02.009; Ueyama T, 2000, J MOL CELL CARDIOL, V32, P947, DOI 10.1006/jmcc.2000.1135; van Eickels M, 2001, CIRCULATION, V104, P1419, DOI 10.1161/hc3601.095577; Vellaichamy E, 2014, ENDOCRINOLOGY, V155, P1045, DOI 10.1210/en.2013-1416; Wagner BM, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.147832; Yan ZP, 2021, CARDIOL J, V28, P473, DOI 10.5603/CJ.a2020.0061; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; Yoder AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036747; Yoder AR, 2010, BIOCHEMISTRY-US, V49, P10137, DOI 10.1021/bi101700e	85	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22069	10.1096/fj.202100600RRR	http://dx.doi.org/10.1096/fj.202100600RRR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34859913				2022-12-28	WOS:000734992000049
J	Zhang, XQ; Li, LX; Yu, C; Nath, KA; Zhuang, SG; Li, XG				Zhang, Xiaoqin; Li, Linda Xiaoyan; Yu, Chen; Nath, Karl A.; Zhuang, Shougang; Li, Xiaogang			Targeting lysine-specific demethylase 1A inhibits renal epithelial-mesenchymal transition and attenuates renal fibrosis	FASEB JOURNAL			English	Article						EMT; epigenetic regulation; LSD1; renal fibrosis	TRANSCRIPTION FACTOR SNAIL; CELL-CYCLE ARREST; FIBROBLAST ACTIVATION; ANDROGEN RECEPTOR; MECHANISMS; EXPRESSION; GROWTH	Lysine-specific histone demethylase 1 (LSD1) as the first identified histone/lysine demethylase regulates gene expression and protein functions in diverse diseases. In this study, we show that the expression of LSD1 is increased in mouse kidneys with unilateral ureteral obstruction (UUO) and in cultured NRK-52E cells undergoing TGF-beta 1-induced epithelial-mesenchymal transition (EMT). Inhibition of LSD1 with its specific inhibitor ORY1001 attenuated renal EMT and fibrosis, which was associated with decreased the deposition of extracellular matrix proteins and the expression of fibrotic markers, including alpha-smooth muscle actin (alpha-SMA) and fibronectin, and the recovery of E-cadherin expression and decrease of N-cadherin expression in UUO kidneys and in NRK-52E cells induced with TGF-beta 1. Targeting LSD1 also decreased the expression of Snail family transcriptional repressor 1 (Snail-1) and its interaction with LSD1 in UUO kidneys and in NRK-52E cells treated with TGF-beta 1. In addition, we identified a novel LSD1-14-3-3 zeta-PKC alpha axis in the regulation of the activation of AKT and Stat3 and then the activation of fibroblasts. This study suggests that LSD1 plays a critical role in regulation of renal EMT and fibrosis through activation of diverse signaling pathways and places an emphasis that LSD1 has potential as a therapeutic target for the treatment of renal fibrosis.	[Zhang, Xiaoqin; Li, Linda Xiaoyan; Nath, Karl A.; Li, Xiaogang] Mayo Clin, Dept Internal Med, 200 1st St SW, Rochester, MN 55905 USA; [Zhang, Xiaoqin; Yu, Chen] Tongji Univ, Tongji Hosp, Sch Med, Dept Nephrol, Shanghai, Peoples R China; [Li, Linda Xiaoyan; Li, Xiaogang] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Zhuang, Shougang] Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Dept Med, Providence, RI 02903 USA	Mayo Clinic; Tongji University; Mayo Clinic; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Li, XG (corresponding author), Mayo Clin, Dept Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	li.xiaogang@mayo.edu			Foundation for the National Institutes of Health (FNIH) [R01 DK129241, R01 DK126662, R01 DK119167]; PKD Foundation research [231G18a]	Foundation for the National Institutes of Health (FNIH); PKD Foundation research	Foundation for the National Institutes of Health (FNIH), Grant/Award Number: ROl DK129241; Foundation for the National Institutes of Health (FNIH), Grant/Award Number: RO1 DK126662; Foundation for the National Institutes of Health (FNI11), Grant/Award Number: RO1 DK119167; PKD Foundation research, Grant/Award Number: 231G18a	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Bilyk O, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00145; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Cai CM, 2014, CELL REP, V9, P1618, DOI 10.1016/j.celrep.2014.11.008; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Carmichael CL, 2020, BLOOD, V136, P957, DOI 10.1182/blood.2019002548; Efstratiadis G, 2009, HIPPOKRATIA, V13, P224; Fang Y, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0811-9; Garg Minal, 2013, World J Stem Cells, V5, P188, DOI 10.4252/wjsc.v5.i4.188; Hino S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1755; Huo JL, 2021, CIRC RES, V129, P400, DOI 10.1161/CIRCRESAHA.120.318149; Kang Moon-Il, 2012, Genes Cancer, V3, P37, DOI 10.1177/1947601912448820; Kim DH, 2018, J CLIN MED, V7, DOI 10.3390/jcm7010001; Kittirat Y, 2018, ONCOL LETT, V15, P347, DOI 10.3892/ol.2017.7326; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lan AP, 2015, NEPHROL DIAL TRANSPL, V30, P385, DOI 10.1093/ndt/gfu196; Lee JJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.501; Li Y, 2012, ONCOGENE, V31, P5007, DOI 10.1038/onc.2012.8; Liu LR, 2021, FASEB J, V35, DOI 10.1096/fj.202000554RRR; Lovisa S, 2016, TRENDS ENDOCRIN MET, V27, P681, DOI 10.1016/j.tem.2016.06.004; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Lv SA, 2010, EUR J CELL BIOL, V89, P557, DOI 10.1016/j.ejcb.2010.01.004; Maes T, 2018, CANCER CELL, V33, P495, DOI 10.1016/j.ccell.2018.02.002; Majello B, 2019, CANCERS, V11, DOI 10.3390/cancers11030324; MattoYelin M, 1997, MOL BIOL CELL, V8, P1889, DOI 10.1091/mbc.8.10.1889; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010; Pennington KL, 2018, ONCOGENE, V37, P5587, DOI 10.1038/s41388-018-0348-3; Rivero S, 2015, ONCOGENE, V34, P5264, DOI 10.1038/onc.2014.446; Salamero O, 2020, J CLIN ONCOL, V38, P4260, DOI 10.1200/JCO.19.03250; Sheng LL, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.569322; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sun GD, 2010, J AM SOC NEPHROL, V21, P2069, DOI 10.1681/ASN.2010060633; Sureshbabu A, 2016, AM J PHYSIOL-RENAL, V310, pF596, DOI 10.1152/ajprenal.00365.2015; Takayama K, 2013, INT J UROL, V20, P756, DOI 10.1111/iju.12146; Tampe B, 2014, NEPHROL DIAL TRANSPL, V29, pI1, DOI 10.1093/ndt/gft361; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang YD, 2017, AM J PHYSIOL-RENAL, V313, pF1, DOI 10.1152/ajprenal.00588.2016; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; Wu CF, 2013, AM J PATHOL, V182, P118, DOI 10.1016/j.ajpath.2012.09.009; Yang GJ, 2018, MOLECULES, V23, DOI 10.3390/molecules23123194; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yang SJ, 2017, EMBO J, V36, P1011, DOI 10.15252/embj.201694408; Zhou XX, 2018, FASEB J, V32, P5976, DOI 10.1096/fj.201800237R; Zhu LS, 2019, ACTA PHARM SIN B, V9, P324, DOI 10.1016/j.apsb.2018.10.006	49	2	2	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22122	10.1096/fj.202101566R	http://dx.doi.org/10.1096/fj.202101566R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34958158	Green Accepted			2022-12-28	WOS:000734992000020
J	Cardozo, LLY; Romero, DG				Cardozo, Licy L. Yanes; Romero, Damian G.			Management of cardiometabolic complications in polycystic ovary syndrome: Unmet needs	FASEB JOURNAL			English	Article						androgen receptor; androgens; cardiovascular diseases; cardiovascular risk factors; polycystic ovary syndrome	COMBINED ORAL-CONTRACEPTIVES; OBESE WOMEN; INSULIN-RESISTANCE; ANDROGEN EXCESS; DOUBLE-BLIND; FLUTAMIDE; METFORMIN; RECEPTOR; HYPERANDROGENISM; ROSIGLITAZONE	Polycystic ovary syndrome (PCOS) is the most common endocrine disorder and the most common cause of androgen excess in reproductive-age women. The heterogeneity of the clinical presentation in PCOS patients suggests the involvement of multiples abnormal physiological pathways. In addition, women with PCOS have a high prevalence of cardiometabolic risk factors. Unfortunately, limited effective evidence-based therapeutic agents are available to treat the cardiometabolic complications in PCOS patients. Insights from recent studies highlight the multiple opportunities to deliver timely effective medical care for women with PCOS. This perspective manuscript aims to highlight the unmet need for effective and safe management of the cardiometabolic complications in PCOS patients.	[Cardozo, Licy L. Yanes; Romero, Damian G.] Univ Mississippi, Med Ctr, Dept Cell & Mol Biol, 2500 N State St, Jackson, MS 39216 USA; [Cardozo, Licy L. Yanes] Univ Mississippi, Dept Med, Med Ctr, Jackson, MS 39216 USA; [Cardozo, Licy L. Yanes; Romero, Damian G.] Univ Mississippi, Mississippi Ctr Excellence Perinatal Res, Med Ctr, Jackson, MS 39216 USA; [Cardozo, Licy L. Yanes; Romero, Damian G.] Univ Mississippi, Womens Hlth Res Ctr, Med Ctr, Jackson, MS 39216 USA; [Cardozo, Licy L. Yanes; Romero, Damian G.] Univ Mississippi, Cardio Renal Res Ctr, Med Ctr, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Cardozo, LLY (corresponding author), Univ Mississippi, Med Ctr, Dept Cell & Mol Biol, 2500 N State St, Jackson, MS 39216 USA.	lyanes@umc.edu		Yanes Cardozo, Licy/0000-0002-7295-1871	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [P20GM121334]; HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R21DK113500]	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: P20GM121334; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: R21DK113500	Amer Soc Reprod Med, 2017, FERTIL STERIL, V107, P43, DOI 10.1016/j.fertnstert.2016.09.027; Amiri M, 2018, EUR J CONTRACEP REPR, V23, P64, DOI 10.1080/13625187.2018.1435779; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P453, DOI 10.1210/jc.2003-031122; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Barbieri RL., 2020, UPTODATE; Berni TR., 2021, J CLIN ENDOCR METAB, V106, P3369; Bicalutamide, 2012, LIVERTOX CLIN RES IN; Bozdag G, 2016, HUM REPROD, V31, P2841, DOI 10.1093/humrep/dew218; Brettenthaler N, 2004, J CLIN ENDOCR METAB, V89, P3835, DOI 10.1210/jc.2003-031737; Cardozo LLY, 2017, PHYSIOLOGY, V32, P357, DOI 10.1152/physiol.00030.2016; Cassar S, 2016, HUM REPROD, V31, P2619, DOI 10.1093/humrep/dew243; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chen MJ, 2007, HYPERTENSION, V49, P1442, DOI 10.1161/HYPERTENSIONAHA.106.083972; Cooney LG, 2018, FERTIL STERIL, V110, P161, DOI 10.1016/j.fertnstert.2018.03.028; Cooney LG, 2017, HUM REPROD, V32, P1075, DOI 10.1093/humrep/dex044; Day F, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007813; de Medeiros SF, 2018, INT J INFLAMM, V2018, DOI 10.1155/2018/9591509; Diamanti-Kandarakis E, 1998, J CLIN ENDOCR METAB, V83, P2699, DOI 10.1210/jc.83.8.2699; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; Drucker DJ, 2017, J CLIN INVEST, V127, P4217, DOI 10.1172/JCI97233; Escobar-Morreale HF, 2005, J CLIN ENDOCR METAB, V90, P6364, DOI 10.1210/jc.2005-1490; Fernandez EDT, 2019, ENDOCRINOLOGY, V160, P2787, DOI 10.1210/en.2019-00450; Fernandez EDT, 2018, J ENDOCR SOC, V2, P949, DOI 10.1210/js.2018-00131; Fothergill E, 2016, OBESITY, V24, P1612, DOI 10.1002/oby.21538; Gambineri A, 2004, CLIN ENDOCRINOL, V60, P241, DOI 10.1111/j.1365-2265.2004.01973.x; Gambineri A, 2006, J CLIN ENDOCR METAB, V91, P3970, DOI 10.1210/jc.2005-2250; Gibson-Helm M, 2017, J CLIN ENDOCR METAB, V102, P604, DOI 10.1210/jc.2016-2963; Gil M, 2011, BRIT J CLIN PHARMACO, V72, P965, DOI 10.1111/j.1365-2125.2011.04031.x; Giorgetti R, 2017, EUR REV MED PHARMACO, V21, P69; Glueck CJ, 2005, EUR J OBSTET GYN R B, V122, P206, DOI 10.1016/j.ejogrb.2005.03.010; Guan YY, 2020, INT J ENDOCRINOL, V2020, DOI 10.1155/2020/5150684; Guo ZY, 2002, J BIOL CHEM, V277, P29600, DOI 10.1074/jbc.M202997200; Helsen C, 2014, ENDOCR-RELAT CANCER, V21, pT105, DOI 10.1530/ERC-13-0545; KIDDY DS, 1992, CLIN ENDOCRINOL, V36, P105, DOI 10.1111/j.1365-2265.1992.tb02909.x; Kite C, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-019-0962-3; Legro RS, 2012, SEMIN REPROD MED, V30, P496, DOI 10.1055/s-0032-1328878; Lim SS, 2013, OBES REV, V14, P95, DOI 10.1111/j.1467-789X.2012.01053.x; Lim SS, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007506.pub4; Lucas-Herald AK, 2017, CLIN SCI, V131, P1405, DOI 10.1042/CS20170090; Mehta A, 2017, OBES SCI PRACT, V3, P3, DOI 10.1002/osp4.84; Moghetti P, 2000, J CLIN ENDOCR METAB, V85, P89, DOI 10.1210/jc.85.1.89; Morales AJ, 1996, J CLIN ENDOCR METAB, V81, P2854, DOI 10.1210/jc.81.8.2854; Moretti C, 2018, J CLIN ENDOCR METAB, V103, P824, DOI 10.1210/jc.2017-01186; National Institutes of Health, 2012, EV BAS METH WORKSH P; Nestler JE, 1998, J CLIN ENDOCR METAB, V83, P2001, DOI 10.1210/jc.83.6.2001; Neyman A, 2019, J ADOLESCENT HEALTH, V64, P544, DOI 10.1016/j.jadohealth.2018.10.296; Orio F, 2004, J CLIN ENDOCR METAB, V89, P4588, DOI 10.1210/jc.2003-031867; Ortega-Gonzalez C, 2005, J CLIN ENDOCR METAB, V90, P1360, DOI 10.1210/jc.2004-1965; Randeva HS, 2012, ENDOCR REV, V33, P812, DOI 10.1210/er.2012-1003; Rautio K, 2006, HUM REPROD, V21, P1400, DOI 10.1093/humrep/dei505; Reiter EO, 2010, J PEDIATR ENDOCR MET, V23, P999, DOI 10.1515/jpem.2010.161; Salamun V, 2018, EUR J ENDOCRINOL, V179, P1, DOI 10.1530/EJE-18-0175; Sanchez-Garrido MA, 2020, MOL METAB, V35, DOI 10.1016/j.molmet.2020.01.001; Sepilian V, 2005, J CLIN ENDOCR METAB, V90, P60, DOI 10.1210/jc.2004-1376; Shi YY, 2012, NAT GENET, V44, P1020, DOI 10.1038/ng.2384; Stener-Victorin E, 2020, ENDOCR REV, V41, DOI 10.1210/endrev/bnaa010; Tay CT, 2018, CLIN ENDOCRINOL, V89, P535, DOI 10.1111/cen.13753; Teede HJ, 2018, CLIN ENDOCRINOL, V89, P251, DOI 10.1111/cen.13795; Tehrani FR, 2020, GYNECOL ENDOCRINOL, V36, P12, DOI 10.1080/09513590.2019.1650337; Vejrazkova D, 2017, PHYSIOL RES, V66, P283, DOI 10.33549/physiolres.933366; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Vrbikova J, 2005, HUM REPROD UPDATE, V11, P277, DOI 10.1093/humupd/dmi005; Yanes LL, 2011, GENDER MED, V8, P103, DOI 10.1016/j.genm.2010.11.013; Yanes LL, 2009, MOL CELL ENDOCRINOL, V303, P50, DOI 10.1016/j.mce.2008.12.020; Zawadski JK., 1992, CURRENT ISSUES ENDOC, P377; Zhang BJ, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6869705; Zimmerman Y, 2014, HUM REPROD UPDATE, V20, P76, DOI 10.1093/humupd/dmt038	67	2	2	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21945	10.1096/fj.202002526RR	http://dx.doi.org/10.1096/fj.202002526RR			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34606638				2022-12-28	WOS:000712009200026
J	Hansson, ML; Chatterjee, U; Francis, J; Arndt, T; Broman, C; Johansson, J; Skold, MK; Rising, A				Hansson, Magnus L.; Chatterjee, Urmimala; Francis, Juanita; Arndt, Tina; Broman, Christian; Johansson, Jan; Skold, Mattias K.; Rising, Anna			Artificial spider silk supports and guides neurite extension in vitro	FASEB JOURNAL			English	Article						biomaterial; nerve guidance conduit; peripheral nerve; recombinant spider silk	TERM SELF-RENEWAL; PERIPHERAL-NERVE; STEM-CELLS; DIFFERENTIATION; VITRONECTIN; MATRICES; PEPTIDE; GROWTH; REPAIR; REGENERATION	Surgical intervention with the use of autografts is considered the gold standard to treat peripheral nerve injuries. However, a biomaterial that supports and guides nerve growth would be an attractive alternative to overcome problems with limited availability, morbidity at the site of harvest, and nerve mismatches related to autografts. Native spider silk is a promising material for construction of nerve guidance conduit (NGC), as it enables regeneration of cm-long nerve injuries in sheep, but regulatory requirements for medical devices demand synthetic materials. Here, we use a recombinant spider silk protein (NT2RepCT) and a functionalized variant carrying a peptide derived from vitronectin (VN-NT2RepCT) as substrates for nerve growth support and neurite extension, using a dorsal root ganglion cell line, ND7/23. Two-dimensional coatings were benchmarked against poly-d-lysine and recombinant laminins. Both spider silk coatings performed as the control substrates with regards to proliferation, survival, and neurite growth. Furthermore, NT2RepCT and VN-NT2RepCT spun into continuous fibers in a biomimetic spinning set-up support cell survival, neurite growth, and guidance to an even larger extent than native spider silk. Thus, artificial spider silk is a promising biomaterial for development of NGCs.	[Hansson, Magnus L.; Chatterjee, Urmimala; Francis, Juanita; Arndt, Tina; Johansson, Jan; Rising, Anna] Karolinska Inst, Dept Biosci & Nutr, S-14186 Huddinge, Sweden; [Hansson, Magnus L.; Broman, Christian; Skold, Mattias K.] Karolinska Inst, Dept Neurosci, Expt Traumatol Unit, Biomed B8, S-17177 Stockholm, Sweden; [Skold, Mattias K.] Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden; [Rising, Anna] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Uppsala University; Swedish University of Agricultural Sciences	Rising, A (corresponding author), Karolinska Inst, Dept Biosci & Nutr, S-14186 Huddinge, Sweden.; Skold, MK (corresponding author), Karolinska Inst, Dept Neurosci, Expt Traumatol Unit, Biomed B8, S-17177 Stockholm, Sweden.	mattias.skold@ki.se; anna.rising@ki.se		Arndt, Tina/0000-0002-5190-0039; CHATTERJEE, URMIMALA/0000-0002-6681-1696; Skold, Mattias K./0000-0001-6228-0691; Rising, Anna/0000-0002-1872-1207	EC | European Research Council (ERC) [815357]; Center for Innovative Medicine at Karolinska Institutet; Karolinska Institutet SFO Regen [FOR 4-1364/2019]; Swedish Research Council [2019-01257]; Stockholm City Council	EC | European Research Council (ERC); Center for Innovative Medicine at Karolinska Institutet; Karolinska Institutet SFO Regen; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm City Council	EC | European Research Council (ERC), Grant/Award Number: 815357; The Center for Innovative Medicine at Karolinska Institutet and Stockholm City Council, Karolinska Institutet SFO Regen, Grant/Award Number: FOR 4-1364/2019; Swedish Research Council, Grant/Award Number: 2019-01257	Aggarwal N, 2021, COMMUN CHEM, V4, DOI 10.1038/s42004-021-00494-2; Aigner TB, 2020, MATER TODAY BIO, V5, DOI 10.1016/j.mtbio.2020.100042; Andersson M, 2017, NAT CHEM BIOL, V13, P262, DOI [10.1038/NCHEMBIO.2269, 10.1038/nchembio.2269]; Arndt T, 2021, ACS BIOMATER SCI ENG, V7, P462, DOI 10.1021/acsbiomaterials.0c01308; Augsten K, 2000, SCANNING, V22, P12; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Bergen K, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8080151; Binder C, 2013, J BIOMED MATER RES B, V101, P1200, DOI 10.1002/jbm.b.32931; Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877; Carvalho CR, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00337; Curcio M, 2018, ANNU REV CELL DEV BI, V34, P495, DOI 10.1146/annurev-cellbio-100617-062508; de Luca AC, 2014, NEURAL REGEN RES, V9, P1943, DOI 10.4103/1673-5374.145366; Domogatskaya A, 2012, ANNU REV CELL DEV BI, V28, P523, DOI 10.1146/annurev-cellbio-101011-155750; Elsner MB, 2015, BIOMATER SCI-UK, V3, P543, DOI 10.1039/c4bm00401a; Foelix RF., 2011, BIOL SPIDERS, P136; Greco G, 2020, MOLECULES, V25, DOI 10.3390/molecules25143248; Grinsell D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/698256; Haberberger RV, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00184; Habermann BF, 1993, CURR OPIN CELL BIOL, V5, P864, DOI 10.1016/0955-0674(93)90036-P; Hafner K, 2017, MAT SCI ENG C-MATER, V81, P104, DOI 10.1016/j.msec.2017.07.019; Houschyar K S, 2016, Plast Surg Int, V2016, P4175293, DOI 10.1155/2016/4175293; Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044; Jeon KI, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234950; Kanno H, 2015, REV NEUROSCIENCE, V26, P121, DOI 10.1515/revneuro-2014-0068; Kornfeld T, 2021, BIOMATERIALS, V271, DOI 10.1016/j.biomaterials.2021.120692; Kornfeld T, 2016, J FUNCT BIOMATER, V7, DOI 10.3390/jfb7040030; Landreh M, 2017, CHEM COMMUN, V53, P3319, DOI 10.1039/c7cc00307b; Li GF, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00190; Li H, 2016, CELL REP, V16, P545, DOI 10.1016/j.celrep.2016.06.013; Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073; Mahar M, 2018, NAT REV NEUROSCI, V19, P323, DOI 10.1038/s41583-018-0001-8; Manoukian OS, 2019, J CONTROL RELEASE, V296, P54, DOI 10.1016/j.jconrel.2019.01.013; Meena P, 2021, CELL TISSUE RES, V383, P617, DOI 10.1007/s00441-020-03301-x; Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629; Millesi F, 2021, FASEB J, V35, DOI 10.1096/fj.202001447R; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; Otikovs M, 2017, ANGEW CHEM INT EDIT, V56, P12571, DOI 10.1002/anie.201706649; Otomo A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63537-z; Pabari A, 2011, J CONTROL RELEASE, V156, P2, DOI 10.1016/j.jconrel.2011.07.001; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Petrou G, 2018, BIOMACROMOLECULES, V19, P3268, DOI 10.1021/acs.biomac.8b00578; Plantman S, 2008, MOL CELL NEUROSCI, V39, P50, DOI 10.1016/j.mcn.2008.05.015; Radtke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016990; Rao F, 2020, THERANOSTICS, V10, P1590, DOI 10.7150/thno.36272; Regas I, 2020, HAND SURG REHABIL, V39, P343, DOI 10.1016/j.hansur.2020.05.007; Salehi S, 2020, MOLECULES, V25, DOI 10.3390/molecules25030737; Scheib J, 2013, NAT REV NEUROL, V9, P668, DOI 10.1038/nrneurol.2013.227; Song JL, 2017, INT J NANOMED, V12, P4195, DOI 10.2147/IJN.S132190; Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y; Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034; Varun D, 2017, ACTA BIOMATER, V48, P120, DOI 10.1016/j.actbio.2016.10.037; Wallquist W, 2002, J COMP NEUROL, V454, P284, DOI 10.1002/cne.10434; White JD, 2015, ACTA BIOMATER, V14, P1, DOI 10.1016/j.actbio.2014.11.045; Widhe M, 2013, BIOMATERIALS, V34, P8223, DOI 10.1016/j.biomaterials.2013.07.058; Widhe M, 2010, BIOMATERIALS, V31, P9575, DOI 10.1016/j.biomaterials.2010.08.061; Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Wu D, 2008, J BIOL CHEM, V283, P416, DOI 10.1074/jbc.M703177200; Wu SQ, 2016, CELL MOL LIFE SCI, V73, P1479, DOI 10.1007/s00018-015-2053-5; Wu SQ, 2014, BIOMATERIALS, V35, P8496, DOI 10.1016/j.biomaterials.2014.06.039; Yang SH, 2020, THERANOSTICS, V10, P8227, DOI 10.7150/thno.44276; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhang N, 2019, ADV SCI, V6, DOI 10.1002/advs.201800808	63	2	2	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21896	10.1096/fj.202100916R	http://dx.doi.org/10.1096/fj.202100916R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34634154	Green Published			2022-12-28	WOS:000712009200019
J	Luan, XH; Yang, WX; Bai, XY; Li, HQ; Li, HZ; Fan, WH; Zhang, H; Liu, WJ; Sun, L				Luan, Xiaohan; Yang, Wenxian; Bai, Xiaoyuan; Li, Heqiao; Li, Huizi; Fan, Wenhui; Zhang, He; Liu, Wenjun; Sun, Lei			Cyclophilin A is a key positive and negative feedback regulator within interleukin-6 trans-signaling pathway	FASEB JOURNAL			English	Article						cyclophilin A; gp130; interleukin-6; SOCS1; ubiquitination	JANUS TYROSINE KINASE; IL-6; RECEPTOR; EXPRESSION; GP130; ACTIVATION; SUPPRESSOR; CONTRIBUTE; MECHANISM; BINDING	Cyclophilin A (CypA), a member of the cyclophilin family, plays a vital role in microorganismal infections, inflammatory diseases, and cancers. Interleukin-6 (IL-6) is a pleiotropic cytokine, exerting variety of effects on inflammation, immune response, hematopoiesis, and tumor proliferation. Binding of IL-6 to soluble IL-6 receptor (sIL-6R) induces pro-inflammatory trans-signaling, which has been described to be stronger than anti-inflammatory classic signaling triggered by the binding of IL-6 to membrane-bound IL-6 receptor. Here we found that upon the treatment of IL-6 and sIL-6R, CypA inhibited the ubiquitination-mediated degradation of IL-6 membrane receptor gp130 and enhanced its dimerization, thereby positively regulated the IL-6 trans-signaling and increased the expression of downstream iNOS, IL-6, and CypA. Furthermore, CypA expression could be negatively regulated by suppressor of cytokine signaling 1 (SOCS1). The SH2 and Box domains of SOCS1 interacted with CypA and promoted its K48-linked ubiquitination-mediated degradation, which inhibited the IL-6 trans-signaling pathway. Collectively, our findings reveal an important role of CypA in the positive and negative feedback regulation of the IL-6 trans-signaling pathway.	[Luan, Xiaohan; Yang, Wenxian; Bai, Xiaoyuan; Li, Heqiao; Li, Huizi; Fan, Wenhui; Liu, Wenjun; Sun, Lei] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Luan, Xiaohan; Yang, Wenxian; Bai, Xiaoyuan; Li, Heqiao; Li, Huizi; Liu, Wenjun; Sun, Lei] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China; [Zhang, He; Liu, Wenjun] Shenzhen Bay Lab, Inst Infect Dis, Shenzhen, Guangdong, Peoples R China; [Liu, Wenjun] Chinese Acad Sci, Ctr Biosafety Megasci, Inst Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shenzhen Bay Laboratory; Chinese Academy of Sciences	Sun, L (corresponding author), Chinese Acad Sci, Inst Microbiol, 1 Beichen West Rd, Beijing 100101, Peoples R China.	sunlei362@im.ac.cn	SUN, LEI/B-3288-2018	SUN, LEI/0000-0003-0141-2093	National Natural Science Foundation of China (NSFC) [31972657, 81621091]; Strategic Priority Research Program of Chinese Academy of Sciences [XDB29010000]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31972657; 81621091; Strategic Priority Research Program of Chinese Academy of Sciences, Grant/Award Number: XDB29010000	Arora K, 2005, J IMMUNOL, V175, P517, DOI 10.4049/jimmunol.175.1.517; Aziz M, 2020, J MED VIROL, V92, P2283, DOI 10.1002/jmv.25948; Babon JJ, 2012, GROWTH FACTORS, V30, P207, DOI 10.3109/08977194.2012.687375; Bai XY, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109159; Bauer K, 2009, ONCOGENE, V28, P2784, DOI 10.1038/onc.2009.142; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; DAEIPOUR M, 1993, J IMMUNOL, V150, P4743; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; Hakim S, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101581; HIRATA Y, 1989, J IMMUNOL, V143, P2900; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kang SJ, 2020, P NATL ACAD SCI USA, V117, P22351, DOI 10.1073/pnas.2010229117; Kershaw NJ, 2014, GROWTH FACTORS, V32, P1, DOI 10.3109/08977194.2013.877005; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Liau NPD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04013-1; Liu H, 2021, EMBO REP, V22, DOI 10.15252/embr.202052063; Liu W, 2017, ELIFE, V6, DOI 10.7554/eLife.24425; Liu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031063; Mahesutihan M, 2018, VIROL SIN, V33, P440, DOI 10.1007/s12250-018-0058-6; Matsumoto S, 2010, J IMMUNOL, V184, P1543, DOI 10.4049/jimmunol.0801217; Nigro P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.410; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; SAITO M, 1992, J IMMUNOL, V148, P4066; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; Sobota RM, 2008, BIOCHEM J, V412, P65, DOI 10.1042/BJ20071572; Strebovsky J, 2011, FASEB J, V25, P863, DOI 10.1096/fj.10-170597; Sun S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096211; TAGA T, 1992, RES IMMUNOL, V143, P737, DOI 10.1016/0923-2494(92)80013-B; Tanaka Y, 2008, MOL CELL BIOL, V28, P4805, DOI 10.1128/MCB.01784-07; Volker SE, 2018, CANCER RES, V78, P3877, DOI 10.1158/0008-5472.CAN-17-2892; Wang L, 2010, J CLIN IMMUNOL, V30, P24, DOI 10.1007/s10875-009-9329-1; Xie YF, 2020, CELL SIGNAL, V65, DOI 10.1016/j.cellsig.2019.109413; Yadav A, 2009, VIROLOGY, V385, P126, DOI 10.1016/j.virol.2008.11.039; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Zhai DS, 2017, INFLAMMATION, V40, P1761, DOI 10.1007/s10753-017-0619-0; Zhang TT, 2013, EXP CLIN CARDIOL, V18, pE118; Zheng WN, 2021, SCI CHINA LIFE SCI, V64, P633, DOI 10.1007/s11427-020-1727-y	40	4	4	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21958	10.1096/fj.202101044RRR	http://dx.doi.org/10.1096/fj.202101044RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34606626	hybrid			2022-12-28	WOS:000712009200037
J	Le, N; Hufford, TM; Park, JS; Brewster, RM				Nguyet Le; Hufford, Timothy M.; Park, Jong S.; Brewster, Rachel M.			Differential expression and hypoxia-mediated regulation of the N-myc downstream regulated gene family	FASEB JOURNAL			English	Article						gene expression; hypometabolism; hypoxia; NDRG; zebrafish	NDRG FAMILY; METASTASIS SUPPRESSOR; ISCHEMIA/REPERFUSION INJURY; SUSPENDED ANIMATION; REPERFUSION INJURY; INDUCIBLE FACTORS; HEREDITARY MOTOR; PECTORAL FINS; HEARING-LOSS; BRAIN	Many organisms rely on oxygen to generate cellular energy (adenosine triphosphate or ATP). During severe hypoxia, the production of ATP decreases, leading to cell damage or death. Conversely, excessive oxygen causes oxidative stress that is equally damaging to cells. To mitigate pathological outcomes, organisms have evolved mechanisms to adapt to fluctuations in oxygen levels. Zebrafish embryos are remarkably hypoxia-tolerant, surviving anoxia (zero oxygen) for hours in a hypometabolic, energy-conserving state. To begin to unravel underlying mechanisms, we analyze here the distribution of the N-myc Downstream Regulated Gene (ndrg) family, ndrg1-4, and their transcriptional response to hypoxia. These genes have been primarily studied in cancer cells and hence little is understood about their normal function and regulation. We show here using in situ hybridization that ndrgs are expressed in metabolically demanding organs of the zebrafish embryo, such as the brain, kidney, and heart. To investigate whether ndrgs are hypoxia-responsive, we exposed embryos to different durations and severity of hypoxia and analyzed transcript levels. We observed that ndrgs are differentially regulated by hypoxia and that ndrg1a has the most robust response, with a ninefold increase following prolonged anoxia. We further show that this treatment resulted in de novo expression of ndrg1a in tissues where the transcript is not observed under normoxic conditions and changes in Ndrg1a protein expression post-reoxygenation. These findings provide an entry point into understanding the role of this conserved gene family in the adaptation of normal cells to hypoxia and reoxygenation.	[Nguyet Le; Hufford, Timothy M.; Park, Jong S.; Brewster, Rachel M.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA	University System of Maryland; University of Maryland Baltimore County	Brewster, RM (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA.	brewster@umbc.edu		le, Nguyet/0000-0002-1412-0500	HHS \ NIH \ National Institute of Child Health and Human Development (NICHD) [R21HD089476]; HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [R25GM055036, T32 GM066706, T34 HHS 00001]; DOD | Center for Neuroscience and Regenerative Medicine (CNRM) [RT150086]	HHS \ NIH \ National Institute of Child Health and Human Development (NICHD); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); DOD | Center for Neuroscience and Regenerative Medicine (CNRM)	HHS vertical bar NIH vertical bar National Institute of Child Health and Human Development (NICHD), Grant/Award Number: R21HD089476; HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: R25GM055036, T32 GM066706 and T34 HHS 00001; DOD | Center for Neuroscience and Regenerative Medicine (CNRM), Grant/Award Number: RT150086	Askautrud HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087268; Banasiak KJ, 2000, PROG NEUROBIOL, V62, P215, DOI 10.1016/S0301-0082(00)00011-3; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Berger P, 2004, NEUROBIOL DIS, V17, P290, DOI 10.1016/j.nbd.2004.07.014; Bogdanova A, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00314; Burchfield JG, 2004, J BIOL CHEM, V279, P18623, DOI 10.1074/jbc.M401504200; Burns MJ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-31; Cadenas S, 2018, FREE RADICAL BIO MED, V117, P76, DOI 10.1016/j.freeradbiomed.2018.01.024; Cangul H, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-27; Cangul H, 2002, ENVIRON HEALTH PERSP, V110, P783, DOI 10.1289/ehp.02110s5783; Cavadas MAS, 2017, EXP CELL RES, V356, P173, DOI 10.1016/j.yexcr.2017.02.024; Cavadas MAS, 2016, SCI REP-UK, V6, DOI 10.1038/srep31355; Chen B, 2006, J BIOL CHEM, V281, P2764, DOI 10.1074/jbc.M507330200; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Chilov D, 2001, FASEB J, V15, P2613, DOI 10.1096/fj.01-0092com; Claustrat B, 2015, NEUROCHIRURGIE, V61, P77, DOI 10.1016/j.neuchi.2015.03.002; Cummings KW, 2015, CLIN CHEST MED, V36, P235, DOI 10.1016/j.ccm.2015.02.007; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Dengler VL, 2014, CRIT REV BIOCHEM MOL, V49, P1, DOI 10.3109/10409238.2013.838205; Ebert EC, 2006, MAYO CLIN PROC, V81, P1232, DOI 10.4065/81.9.1232; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Ferdinand Phillip, 2016, Exp Transl Stroke Med, V8, P9; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Granger DN, 2015, REDOX BIOL, V6, P524, DOI 10.1016/j.redox.2015.08.020; Greenald D, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2169-x; Guo MF, 2011, FOLIA NEUROPATHOL, V49, P79; Hale ME, 2014, INTEGR COMP BIOL, V54, P238, DOI 10.1093/icb/icu014; Helenius Iiro T, 2010, Proc Am Thorac Soc, V7, P65, DOI 10.1513/pats.200907-082JS; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1294, DOI 10.1097/00004647-200009000-00003; Hu XL, 2006, CELL TISSUE RES, V325, P67, DOI 10.1007/s00441-005-0137-5; Hwang J, 2011, J BIOL CHEM, V286, P12450, DOI 10.1074/jbc.M110.170803; Inoue D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019713; Jin PP, 2019, ANN ANAT, V221, P148, DOI 10.1016/j.aanat.2018.09.010; Jin RS, 2014, J CELL SCI, V127, P3116, DOI 10.1242/jcs.147835; Johnson AB, 2008, MUTAT RES-FUND MOL M, V640, P174, DOI 10.1016/j.mrfmmm.2008.01.001; Julian CG, 2017, J APPL PHYSIOL, V123, P1362, DOI 10.1152/japplphysiol.00351.2017; Kachhap SK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000844; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kim KR, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010090; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koritzinsky M, 2005, RADIOTHER ONCOL, V76, P177, DOI 10.1016/j.radonc.2005.06.036; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Kyuno J, 2003, BIOCHEM BIOPH RES CO, V309, P52, DOI 10.1016/S0006-291X(03)01522-5; Larson J, 2014, J EXP BIOL, V217, P1024, DOI 10.1242/jeb.085381; Lee DC, 2015, CELL, V161, P595, DOI 10.1016/j.cell.2015.03.011; Lee GY, 2016, ONCOTARGET, V7, P57442, DOI 10.18632/oncotarget.10684; LEES GJ, 1991, BRAIN RES REV, V16, P283, DOI 10.1016/0165-0173(91)90011-V; Li RA, 2016, BLOOD, V128, P3052, DOI 10.1182/blood-2016-09-742502; Lin Hsin-Chen, 2018, Oncotarget, V9, P10470, DOI 10.18632/oncotarget.23732; Maeda A, 2004, GENE, V324, P149, DOI 10.1016/j.gene.2003.09.029; Malek M, 2015, J RENAL INJ PREV, V4, P20, DOI 10.12861/jrip.2015.06; Mazurek B, 2006, MED HYPOTHESES, V67, P892, DOI 10.1016/j.mehy.2006.03.040; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Mendelsohn BA, 2008, DEV DYNAM, V237, P1780, DOI 10.1002/dvdy.21581; Merlot AM, 2019, BBA-MOL BASIS DIS, V1865, P2094, DOI 10.1016/j.bbadis.2019.04.007; Mi L, 2017, ONCOGENE, V36, P4323, DOI 10.1038/onc.2017.74; Mitchelmore C, 2004, NEUROBIOL DIS, V16, P48, DOI 10.1016/j.nbd.2004.01.003; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Mustonen V, 2021, FEBS J, V288, P3507, DOI 10.1111/febs.15660; Nakada N, 2002, DEV BRAIN RES, V135, P45, DOI 10.1016/S0165-3806(02)00303-6; Nakajima W, 2000, J NEUROSCI, V20, P7994; Nakayama K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133278; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; Olivetto E, 2015, HEARING RES, V327, P58, DOI 10.1016/j.heares.2015.05.004; Orellana-Urzua S, 2020, CURR PHARM DESIGN, V26, P4246, DOI 10.2174/1381612826666200708133912; Ortmann B, 2014, CELL MOL LIFE SCI, V71, P3569, DOI 10.1007/s00018-014-1645-9; Padilla PA, 2001, P NATL ACAD SCI USA, V98, P7331, DOI 10.1073/pnas.131213198; Peers C, 2009, ANN NY ACAD SCI, V1177, P169, DOI 10.1111/j.1749-6632.2009.05026.x; Pelster B, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.163709; Pietiainen V, 2013, J CELL SCI, V126, P3961, DOI 10.1242/jcs.128132; Qu XH, 2008, DEV BIOL, V317, P486, DOI 10.1016/j.ydbio.2008.02.044; Reiter RJ, 2016, J PINEAL RES, V61, P253, DOI 10.1111/jpi.12360; Robertson CE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0637; Said HM, 2017, ONCOL REP, V37, P3625, DOI 10.3892/or.2017.5620; Sanchez-Garcia MA, 2019, BIOL BULL-US, V237, P48, DOI 10.1086/704337; Schodel J, 2013, BIOL CHEM, V394, P507, DOI 10.1515/hsz-2012-0351; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Schonkeren SL, 2019, NEUROGENETICS, V20, P173, DOI 10.1007/s10048-019-00587-0; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Shaw E, 2002, PROTEINS, V47, P163, DOI 10.1002/prot.10083; Singhal R, 2020, J BIOL CHEM, V295, P10493, DOI 10.1074/jbc.REV120.011188; Small CD, 2020, J DEV BIOL, V8, DOI 10.3390/jdb8010003; Storey KB, 2007, J EXP BIOL, V210, P1700, DOI 10.1242/jeb.02716; Storey KB, 2007, COMP BIOCHEM PHYS A, V147, P263, DOI 10.1016/j.cbpa.2006.03.019; Sugiki T, 2004, BIOL PHARM BULL, V27, P624, DOI 10.1248/bpb.27.624; Sun J, 2013, CARCINOGENESIS, V34, P1943, DOI 10.1093/carcin/bgt163; Takeda N, 2004, CIRC RES, V95, P146, DOI 10.1161/01.RES.0000134920.10128.b4; Taketomi Y, 2007, J IMMUNOL, V178, P7042, DOI 10.4049/jimmunol.178.11.7042; Takita S, 2016, SCI REP-UK, V6, DOI 10.1038/srep36590; Tanaka S, 2014, AM J PHYSIOL-RENAL, V307, pF1187, DOI 10.1152/ajprenal.00425.2014; Teodoro RO, 2003, EMBO J, V22, P580, DOI 10.1093/emboj/cdg070; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Toffoli S, 2009, ANGIOGENESIS, V12, P339, DOI 10.1007/s10456-009-9156-2; Ton C, 2003, PHYSIOL GENOMICS, V13, P97, DOI 10.1152/physiolgenomics.00128.2002; Tu LC, 2007, MOL CELL PROTEOMICS, V6, P575, DOI 10.1074/mcp.M600249-MCP200; van den Beucken T, 2011, RADIOTHER ONCOL, V99, P379, DOI 10.1016/j.radonc.2011.05.058; Vohwinkel CU, 2015, J APPL PHYSIOL, V119, P1157, DOI 10.1152/japplphysiol.00226.2015; Wang B, 2014, ONCOL REP, V31, P2279, DOI 10.3892/or.2014.3072; Wang LF, 2008, CELL PHYSIOL BIOCHEM, V21, P239, DOI 10.1159/000113765; Wang Q, 2013, MOL BIOL REP, V40, P3723, DOI 10.1007/s11033-012-2448-4; Wen L, 2019, GENES DIS, V6, P448, DOI 10.1016/j.gendis.2019.01.001; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; White RJ, 2017, ELIFE, V6, DOI [10.7554/eLife.30860.001, 10.7554/eLife.30860]; Woods IG, 2015, GENOM DATA, V6, P83, DOI 10.1016/j.gdata.2015.07.025; Wouters BG, 2005, SEMIN CELL DEV BIOL, V16, P487, DOI 10.1016/j.semcdb.2005.03.009; Xia XB, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r113; Xie H, 2017, J BIOL CHEM, V292, P16825, DOI 10.1074/jbc.R117.799973; Xing Y, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-015-0519-0; Xu H, 2016, J FISH BIOL, V88, P2095, DOI 10.1111/jfb.12915; Yeh CC, 2018, RNA BIOL, V15, P1487, DOI 10.1080/15476286.2018.1553480; Yilmaz NDS, 2019, TURK J MED SCI, V49, P1450, DOI 10.3906/sag-1902-210; Zhang TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065058; Zheng L, 2015, AM J PHYSIOL-CELL PH, V309, pC350, DOI 10.1152/ajpcell.00191.2015; Zhong C, 2015, INT J DEV BIOL, V59, P511, DOI 10.1387/ijdb.150178xh; Zhou RH, 2001, GENOMICS, V73, P86, DOI 10.1006/geno.2000.6496; Zimmer AM, 2020, AM J PHYSIOL-REG I, V318, pR89, DOI 10.1152/ajpregu.00265.2019	124	2	3	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21961	10.1096/fj.202100443R	http://dx.doi.org/10.1096/fj.202100443R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34665878	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000712009200066
J	Shinomiya, H; Kato, H; Kuramoto, Y; Watanabe, N; Tsuruda, T; Arimura, T; Miyashita, Y; Miyasaka, Y; Mashimo, T; Takuwa, A; Motooka, D; Okuzaki, D; Matsuoka, K; Tsukamoto, O; Hakui, H; Yamada, N; Lee, JK; Kioka, H; Kitakaze, M; Takashima, S; Sakata, Y; Asano, Y				Shinomiya, Haruki; Kato, Hisakazu; Kuramoto, Yuki; Watanabe, Nozomi; Tsuruda, Toshihiro; Arimura, Tadaaki; Miyashita, Yohei; Miyasaka, Yoshiki; Mashimo, Tomoji; Takuwa, Ayako; Motooka, Daisuke; Okuzaki, Daisuke; Matsuoka, Ken; Tsukamoto, Osamu; Hakui, Hideyuki; Yamada, Noriaki; Lee, Jong-Kook; Kioka, Hidetaka; Kitakaze, Masafumi; Takashima, Seiji; Sakata, Yasushi; Asano, Yoshihiro			Aberrant accumulation of TMEM43 accompanied by perturbed transmural gene expression in arrhythmogenic cardiomyopathy	FASEB JOURNAL			English	Article						arrhythmogenic right ventricular dysplasia; glycosylation; TMEM43 protein	RIGHT-VENTRICULAR CARDIOMYOPATHY; MUSCULAR-DYSTROPHY; MOUSE; MUTATION; INTEGRATION; INCREASES; INTERACTS; DISEASE; STRESS; EMERIN	Arrhythmogenic cardiomyopathy (ACM) caused by TMEM43 p.S358L is a fully penetrant heart disease that results in impaired cardiac function or fatal arrhythmia. However, the molecular mechanism of ACM caused by the TMEM43 variant has not yet been fully elucidated. In this study, we generated knock-in (KI) rats harboring a Tmem43 p.S358L mutation and established induced pluripotent stem cells (iPSCs) from patients based on the identification of TMEM43 p.S358L variant from a family with ACM. The Tmem43-S358L KI rats exhibited ventricular arrhythmia and fibrotic myocardial replacement in the subepicardium, which recapitulated the human ACM phenotype. The four-transmembrane protein TMEM43 with the p.S358L variant (TMEM43(S358L)) was found to be modified by N-linked glycosylation in both KI rat cardiomyocytes and patient-specific iPSC-derived cardiomyocytes. TMEM43(S358L) glycosylation increased under the conditions of enhanced endoplasmic reticulum (ER) stress caused by pharmacological stimulation or age-dependent decline of the ER function. Intriguingly, the specific glycosylation of TMEM43(S358L) resulted from the altered membrane topology of TMEM43. Moreover, unlike TMEM43(WT), which is mainly localized to the ER, TMEM43(S358L) accumulated at the nuclear envelope of cardiomyocytes with the increase in glycosylation. Finally, our comprehensive transcriptomic analysis demonstrated that the regional differences in gene expression patterns between the inner and outer layers observed in the wild type myocardium were partially diminished in the KI myocardium prior to exhibiting histological changes indicative of ACM. Altogether, these findings suggest that the aberrant accumulation of TMEM43(S358L) underlies the pathogenesis of ACM caused by TMEM43 p.S358L variant by affecting the transmural gene expression within the myocardium.	[Shinomiya, Haruki; Kuramoto, Yuki; Hakui, Hideyuki; Yamada, Noriaki; Kioka, Hidetaka; Sakata, Yasushi; Asano, Yoshihiro] Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Kato, Hisakazu; Takuwa, Ayako; Matsuoka, Ken; Tsukamoto, Osamu; Takashima, Seiji] Osaka Univ, Dept Med Biochem, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5630871, Japan; [Watanabe, Nozomi] Univ Miyazaki, Fac Med, Div Cardiovasc Physiol, Miyazaki, Japan; [Tsuruda, Toshihiro] Univ Miyazaki, Fac Med, Dept Internal Med, Circulatory & Body Fluid Regulat, Miyazaki, Japan; [Arimura, Tadaaki] Fukuoka Univ, Dept Cardiol, Sch Med, Fukuoka, Japan; [Miyashita, Yohei] Osaka Univ, Dept Legal Med, Grad Sch Med, Suita, Osaka, Japan; [Miyasaka, Yoshiki; Mashimo, Tomoji] Osaka Univ, Inst Expt Anim Sci, Grad Sch Med, Suita, Osaka, Japan; [Motooka, Daisuke; Okuzaki, Daisuke] Osaka Univ, Genome Informat Res Ctr, Res Inst Microbial Dis, Osaka, Japan; [Lee, Jong-Kook] Osaka Univ, Dept Cardiovasc Regenerat Med, Grad Sch Med, Suita, Osaka, Japan; [Kitakaze, Masafumi] Hanwa Daini Senboku Hosp, Sakai, Osaka, Japan	Osaka University; Osaka University; University of Miyazaki; University of Miyazaki; Fukuoka University; Osaka University; Osaka University; Osaka University; Osaka University	Asano, Y (corresponding author), Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.; Kato, H (corresponding author), Osaka Univ, Dept Med Biochem, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5630871, Japan.	katohisa@medbio.med.osaka-u.ac.jp; asano@cardiology.med.osaka-u.ac.jp		Shinomiya, Haruki/0000-0001-9499-0997; Miyashita, Yohei/0000-0002-1739-4734; Sakata, Yasushi/0000-0002-5618-4721; Tsukamoto, Osamu/0000-0002-9504-8001; Kato, Hisakazu/0000-0003-4619-3680; Miyasaka, Yoshiki/0000-0003-4020-9290	Ministry of Health, Labor, and Welfare-Japan [201442084A]; Japan Agency for Medical Research and Development (AMED) [19ek0109402h0002, 19ek0109412h0001, 19ek0109348s0402, 19bm0804008h0003, 19ek0109349h0002, 21ek0109489h0002]; Ministry of Education, Culture, Sports, Science, and Technology-Japan [19H03652]; Japan Society for the Promotion of Science [17K09577, 18K19547, 19K08581, 19K23984]; Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency; Japan Heart Foundation; Japan Cardiovascular Research Foundation; Japan Intractable Diseases Research Foundation; Takeda Science Foundation; Inoue Foundation for Science; Osaka Medical Research Foundation for Intractable Diseases	Ministry of Health, Labor, and Welfare-Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Culture, Sports, Science, and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Japan Heart Foundation; Japan Cardiovascular Research Foundation; Japan Intractable Diseases Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Inoue Foundation for Science(Inoue Foundation for Science); Osaka Medical Research Foundation for Intractable Diseases	This work was funded by grants-in-aid from the Ministry of Health, Labor, and Welfare-Japan (201442084A), by grants-in-aid from the Japan Agency for Medical Research and Development (AMED; 19ek0109402h0002, 19ek0109412h0001, 19ek0109348s0402, 19bm0804008h0003, 19ek0109349h0002, 21ek0109489h0002), by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology-Japan (19H03652), by grants-in-aid from the Japan Society for the Promotion of Science (17K09577, 18K19547, 19K08581, 19K23984), and by Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency. This research was also supported by grants from Japan Heart Foundation, Japan Cardiovascular Research Foundation, Japan Intractable Diseases Research Foundation, Takeda Science Foundation, Inoue Foundation for Science, and Osaka Medical Research Foundation for Intractable Diseases	Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; Austin KM, 2019, NAT REV CARDIOL, V16, P519, DOI 10.1038/s41569-019-0200-7; Baskin B, 2013, HUM GENET, V132, P1245, DOI 10.1007/s00439-013-1323-2; Bengtsson L, 2008, J CELL SCI, V121, P536, DOI 10.1242/jcs.019281; Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263; Bruegmann T, 2016, J CLIN INVEST, V126, P3894, DOI 10.1172/JCI88950; Buchwalter A, 2019, NAT REV GENET, V20, P39, DOI 10.1038/s41576-018-0063-5; Chelko SP, 2019, CIRCULATION, V140, P1491, DOI 10.1161/CIRCULATIONAHA.119.040676; Cheung JC, 2007, METHODS, V41, P451, DOI 10.1016/j.ymeth.2006.10.002; Choi MY, 2005, J BIOL CHEM, V280, P4968, DOI 10.1074/jbc.M410069200; Choy L, 2016, IJC HEART VASC, V12, P1, DOI 10.1016/j.ijcha.2016.05.005; Christensen AH, 2011, CLIN GENET, V80, P256, DOI 10.1111/j.1399-0004.2011.01623.x; Coelho JPL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08632-0; Corrado D, 2017, CIRC RES, V121, P784, DOI 10.1161/CIRCRESAHA.117.309345; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Dalloz F, 2001, J MOL CELL CARDIOL, V33, P9, DOI 10.1006/jmcc.2000.1289; ELDER JH, 1982, P NATL ACAD SCI-BIOL, V79, P4540, DOI 10.1073/pnas.79.15.4540; Eykyn TR, 2015, J MOL CELL CARDIOL, V86, P95, DOI 10.1016/j.yjmcc.2015.07.009; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Ge SX, 2020, BIOINFORMATICS, V36, P2628, DOI 10.1093/bioinformatics/btz931; Ge SX, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2486-6; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; James CA, 2020, EUR HEART J, V41, P1393, DOI 10.1093/eurheartj/ehaa141; James CA, 2013, J AM COLL CARDIOL, V62, P1290, DOI 10.1016/j.jacc.2013.06.033; Kirchhof P, 2006, CIRCULATION, V114, P1799, DOI 10.1161/CIRCULATIONAHA.106.624502; Kuramoto Y, 2018, J MOL CELL CARDIOL, V121, P256, DOI 10.1016/j.yjmcc.2018.07.246; Litvinukova M, 2020, NATURE, V588, P466, DOI 10.1038/s41586-020-2797-4; Marian AJ, 2014, CIRC RES, V114, pE18, DOI 10.1161/CIRCRESAHA.114.302904; Marshall R D, 1974, Biochem Soc Symp, P17; McCormick ME, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003170; Merner ND, 2008, AM J HUM GENET, V82, P809, DOI 10.1016/j.ajhg.2008.01.010; Milting H, 2015, EUR HEART J, V36, P872, DOI 10.1093/eurheartj/ehu077; Miyasaka Y, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4713-y; Mounkes LC, 2005, HUM MOL GENET, V14, P2167, DOI 10.1093/hmg/ddi221; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Padron-Barthe L, 2019, CIRCULATION, V140, P1188, DOI 10.1161/CIRCULATIONAHA.119.040366; Rosati B, 2006, J MOL CELL CARDIOL, V40, P295, DOI 10.1016/j.yjmcc.2005.11.002; Schlebach JP, 2015, J AM CHEM SOC, V137, P8758, DOI 10.1021/jacs.5b03743; Schlebach JP, 2015, J MEMBRANE BIOL, V248, P371, DOI 10.1007/s00232-014-9726-0; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sharma S, 2003, CARDIOLOGY, V100, P73, DOI 10.1159/000073042; Shin JY, 2013, DEV CELL, V26, P591, DOI 10.1016/j.devcel.2013.08.012; Shintani Y, 2014, EMBO REP, V15, P438, DOI 10.1002/embr.201337945; Siragam V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109128; Stroud MJ, 2018, CARDIOVASC RES, V114, P378, DOI 10.1093/cvr/cvx205; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; van der Voorn SM, 2020, CARDIOVASC RES, V116, P1571, DOI 10.1093/cvr/cvaa084; Zheng GX, 2019, PROTEIN CELL, V10, P104, DOI 10.1007/s13238-018-0563-2	49	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21994	10.1096/fj.202100800R	http://dx.doi.org/10.1096/fj.202100800R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34674311	hybrid			2022-12-28	WOS:000712009200053
J	Yan, TT; Luo, YH; Xia, YL; Hamada, K; Wang, Q; Yan, NN; Krausz, KW; Ward, JM; Hao, HP; Wang, P; Gonzalez, FJ				Yan, Tingting; Luo, Yuhong; Xia, Yangliu; Hamada, Keisuke; Wang, Qiong; Yan, Nana; Krausz, Kristopher W.; Ward, Jerrold M.; Hao, Haiping; Wang, Ping; Gonzalez, Frank J.			St. John's Wort alleviates dextran sodium sulfate-induced colitis through pregnane X receptor-dependent NF kappa B antagonism	FASEB JOURNAL			English	Article						DSS; IBD; natural products; NF kappa B; PXR; small intestine	INFLAMMATORY-BOWEL-DISEASE; TUMOR-NECROSIS-FACTOR; TNF-ALPHA; MOUSE MODELS; HUMAN PXR; METABOLISM; ACTIVATION; PHARMACOLOGY; INDUCTION; RIFAXIMIN	St. John's wort (SJW), from traditional herbs, activates the pregnane X receptor (PXR), a potential drug target for treating inflammatory bowel disease (IBD). However, how SJW alleviates dextran sodium sulfate (DSS)-induced experimental IBD by activating PXR is unknown. To test this, PXR-humanized, wild-type (WT) and Pxr-null mice, primary intestinal organoids cultures, and the luciferase reporter gene assays were employed. In vivo, a diet supplemented with SJW was found to activate intestinal PXR both in WT and PXR-humanized mice, but not in Pxr-null mice. SJW prevented DSS-induced IBD in PXR-humanized and WT mice, but not in Pxr-null mice. In vitro, hyperforin, a major component of SJW, activated PXR and suppressed tumor necrosis factor (TNF)alpha-induced nuclear factor (NF) kappa B translocation in primary intestinal organoids from PXR-humanized mice, but not Pxr-null mice. Luciferase reporter gene assays showed that hyperforin dose-dependently alleviated TNF alpha-induced NF kappa B transactivation by activating human PXR in Caco2 cells. Furthermore, SJW therapeutically attenuated DSS-induced IBD in PXR-humanized mice. These data indicate the therapeutic potential of SJW in alleviating DSS-induced IBD in vivo, and TNF alpha-induced NF kappa B activation in vitro, dependent on PXR activation, which may have clinical implications for using SJW as a herbal drug anti-IBD treatment.	[Yan, Tingting; Luo, Yuhong; Xia, Yangliu; Hamada, Keisuke; Wang, Qiong; Yan, Nana; Krausz, Kristopher W.; Ward, Jerrold M.; Wang, Ping; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Yan, Nana; Hao, Haiping] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, State Key Lab Nat Med, Nanjing, Peoples R China; [Wang, Ping] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Med Res, Shanghai, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); China Pharmaceutical University; Shanghai University of Traditional Chinese Medicine	Wang, P; Gonzalez, FJ (corresponding author), NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	pwang@shutcm.edu.cn; gonzalef@mail.nih.gov	LUO, YUHONG/GPW-8361-2022; yan, na/HDM-3747-2022	Hamada, Keisuke/0000-0002-7774-0790	HHS | NIH | National Cancer Institute (NCI); Office of Dietary Supplements (ODS); Chinese Scholarship Council [201806065070]; National Science Foundation of Shanghai [18ZR1436500]	HHS | NIH | National Cancer Institute (NCI); Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Scholarship Council(China Scholarship Council); National Science Foundation of Shanghai	HHS | NIH | National Cancer Institute (NCI); Office of Dietary Supplements (ODS); Chinese Scholarship Council, Grant/Award Number: 201806065070; National Science Foundation of Shanghai, Grant/Award Number: 18ZR1436500	Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34; Barberio B, 2021, LANCET GASTROENTEROL, V6, P359, DOI 10.1016/S2468-1253(21)00014-5; Barnes J, 2001, J PHARM PHARMACOL, V53, P583, DOI 10.1211/0022357011775910; Beelen EMJ, 2020, GUT, V69, P1708, DOI 10.1136/gutjnl-2019-319321; Chang TKH, 2009, AAPS J, V11, P590, DOI 10.1208/s12248-009-9135-y; Cheng J, 2012, TRENDS PHARMACOL SCI, V33, P323, DOI 10.1016/j.tips.2012.03.003; Cheng J, 2010, J PHARMACOL EXP THER, V335, P32, DOI 10.1124/jpet.110.170225; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Cohen LJ, 2019, GASTROENTEROLOGY, V156, P2174, DOI 10.1053/j.gastro.2019.03.017; Deuring JJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221924; Dost T, 2009, DIGEST DIS SCI, V54, P1214, DOI 10.1007/s10620-008-0477-6; Dou W, 2014, INT IMMUNOPHARMACOL, V23, P170, DOI 10.1016/j.intimp.2014.08.025; Dou W, 2014, J NUTR BIOCHEM, V25, P923, DOI 10.1016/j.jnutbio.2014.04.006; Dou W, 2013, J PHARMACOL EXP THER, V345, P473, DOI 10.1124/jpet.112.201863; DuPont HL, 2011, EXPERT OPIN PHARMACO, V12, P293, DOI 10.1517/14656566.2011.546347; El Mourabet M, 2010, CURR DRUG TARGETS, V11, P234; Erickson SL, 2020, FASEB J, V34, P2198, DOI 10.1096/fj.201902083RR; Ferrari D, 2016, TOXICOL LETT, V264, P51, DOI 10.1016/j.toxlet.2016.10.014; Geier MS, 2009, DIGEST DIS SCI, V54, P1222, DOI 10.1007/s10620-008-0495-4; Goyal N, 2014, INFLAMMOPHARMACOLOGY, V22, P219, DOI 10.1007/s10787-014-0207-y; Ikpa PT, 2020, CELL MOL GASTROENTER, V9, P47, DOI 10.1016/j.jcmgh.2019.08.006; Ikpa PT, 2020, GENOMICS, V112, P1139, DOI 10.1016/j.ygeno.2019.06.028; Kim AH, 2018, J CROHNS COLITIS, V12, P408, DOI 10.1093/ecco-jcc/jjx161; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lang A, 2004, CLIN NUTR, V23, P1199, DOI 10.1016/j.clnu.2004.03.011; LeCluyse EL, 2001, CHEM-BIOL INTERACT, V134, P283, DOI 10.1016/S0009-2797(01)00163-6; Li F, 2013, NAT MED, V19, P418, DOI 10.1038/nm.3104; Liu YM, 2017, EXP CELL RES, V358, P335, DOI 10.1016/j.yexcr.2017.07.008; Liu YF, 2017, P NATL ACAD SCI USA, V114, pE3796, DOI 10.1073/pnas.1700909114; Ma X, 2007, DRUG METAB DISPOS, V35, P194, DOI 10.1124/dmd.106.012831; Manna SK, 2015, CANCER PREV RES, V8, P786, DOI 10.1158/1940-6207.CAPR-14-0113; Moore LB, 2000, P NATL ACAD SCI USA, V97, P7500, DOI 10.1073/pnas.130155097; Moreels TG, 2001, EUR J PHARMACOL, V423, P211, DOI 10.1016/S0014-2999(01)01088-3; Mueller C, 2002, IMMUNOLOGY, V105, P1, DOI 10.1046/j.1365-2567.2002.01329.x; Nunes NS, 2019, EBIOMEDICINE, V45, P495, DOI 10.1016/j.ebiom.2019.06.033; Oh SY, 2014, INT J MOL MED, V33, P333, DOI 10.3892/ijmm.2013.1569; Ohtsuka Y, 2003, PEDIATR RES, V53, P143, DOI 10.1203/01.PDR.0000041519.16507.06; Ojetti V, 2009, EXPERT OPIN DRUG MET, V5, P675, DOI 10.1517/17425250902973695; Pacyniak EK, 2007, TOXICOL SCI, V97, P94, DOI 10.1093/toxsci/kfm025; Pizarro TT, 2003, TRENDS MOL MED, V9, P218, DOI 10.1016/S1471-4914(03)00052-2; Randhawa PK, 2014, KOREAN J PHYSIOL PHA, V18, P279, DOI 10.4196/kjpp.2014.18.4.279; Ren YJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53305-z; Rhodes JM, 2002, TRENDS MOL MED, V8, P10, DOI 10.1016/S1471-4914(01)02194-3; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Sehirli AO, 2015, J PHYSIOL PHARMACOL, V66, P203; Shah YM, 2007, AM J PHYSIOL-GASTR L, V292, pG1114, DOI 10.1152/ajpgi.00528.2006; Shehu AI, 2019, J CLIN INVEST, V129, P2898, DOI 10.1172/JCI128274; Su LP, 2013, GASTROENTEROLOGY, V145, P407, DOI 10.1053/j.gastro.2013.04.011; Sun AN, 2016, J FUNCT FOODS, V21, P418, DOI 10.1016/j.jff.2015.12.029; Sun H, 2008, EXPERT OPIN DRUG MET, V4, P395, DOI 10.1517/17425255.4.4.395 ; Sun RB, 2017, MOL PHARMACOL, V91, P110, DOI 10.1124/mol.116.106617; Trigo-Salado C, 2018, REV ESP ENFERM DIG, V110, P836, DOI 10.17235/reed.2018.5725/2018; Watkins RE, 2003, BIOCHEMISTRY-US, V42, P1430, DOI 10.1021/bi0268753; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307; Xiao YT, 2016, CYTOKINE, V83, P189, DOI 10.1016/j.cyto.2016.04.012; Yan TT, 2020, ACTA PHARM SIN B, V10, P3, DOI 10.1016/j.apsb.2019.11.017; Zhang GH, 2020, J ETHNOPHARMACOL, V248, DOI 10.1016/j.jep.2019.112302; Zhang JJ, 2015, J PHARMACOL EXP THER, V352, P315, DOI 10.1124/jpet.114.218750; Zhang YB, 2020, FREE RADICAL BIO MED, V148, P33, DOI 10.1016/j.freeradbiomed.2019.12.012; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283	60	3	3	9	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21968	10.1096/fj.202001098R	http://dx.doi.org/10.1096/fj.202001098R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34644426				2022-12-28	WOS:000712009200059
J	Zhu, MX; Yang, H; Lu, Y; Yang, HM; Tang, YH; Li, LX; Zhu, YX; Yuan, J				Zhu, Mingxin; Yang, Han; Lu, Yang; Yang, Hongmin; Tang, Yaohan; Li, Lixia; Zhu, Yaoxi; Yuan, Jing			Cardiac ectopic lymphoid follicle formation in viral myocarditis involving the regulation of podoplanin in Th17 cell differentiation	FASEB JOURNAL			English	Article						ectopic lymphoid follicles; podoplanin; Th17 cells; viral myocarditis	ACTIVATION; ANTIBODY; CENTERS; TISSUE	Autoimmunity contributes to the pathogenesis of viral myocarditis (VMC), which is characterized by the production of anti-heart autoantibodies (AHA) from lymphoid follicles. Recently, the formation of ectopic lymphoid follicles (ELFs) was reported in heart grafts. However, the existence and role of ELFs in myocardial tissues of VMC remain unclear. This study aimed to explore whether and how cardiac ELFs with germinal centers (GCs) could be generated during the development of VMC. We identified the existence of ELFs and explored the underlying mechanism. In a BALB/c mouse model of VMC, the dynamic myocardial infiltrations of lymphocytic aggregates and expressions of associated lymphorganogenic factors were investigated, accompanied by the detection of the production and location of myocardial AHA. The data indicated ELFs formation in myocardial tissues of VMC, and the number of ELFs was in accordance with the severity of VMC. Moreover, the functional ELFs with GCs were capable of facilitating the production of local AHA. Blocking IL-17 or podoplanin (PDPN) could inhibit cardiac ELFs generation, perhaps due to the negative regulation of PDPN neutralization in Th17 cell proliferation and differentiation. The presence of cardiac ELFs and AHA might offer new opportunities for stratification and early identification of VMC patients.	[Zhu, Mingxin; Yang, Han; Lu, Yang; Yang, Hongmin; Tang, Yaohan; Li, Lixia; Zhu, Yaoxi; Yuan, Jing] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiol, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology	Yuan, J (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiol, Wuhan 430022, Peoples R China.	yhelen13@163.com			National Natural Science Foundation of China [81770378, 81500294]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China, Grant/Award Number: 81770378 and 81500294	Astarita JL, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00283; Basavalingappa RH, 2020, MOL IMMUNOL, V124, P218, DOI 10.1016/j.molimm.2020.06.017; Blanco P, 2016, EUR J IMMUNOL, V46, P281, DOI 10.1002/eji.201545760; Caforio ALP, 2008, AUTOIMMUNITY, V41, P35, DOI 10.1080/08916930701619235; Canete JD, 2007, ANN RHEUM DIS, V66, P720, DOI 10.1136/ard.2006.062042; Christiansen D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24762-9; Dieu-Nosjean MC, 2014, TRENDS IMMUNOL, V35, P571, DOI 10.1016/j.it.2014.09.006; Ding YN, 2013, J IMMUNOL, V191, P1614, DOI 10.4049/jimmunol.1300479; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Fung G, 2016, CIRC RES, V118, P496, DOI 10.1161/CIRCRESAHA.115.306573; Gunasekaran M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00638; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hur J, 2014, MOL THER, V22, P1518, DOI 10.1038/mt.2014.61; Jones GW, 2016, IMMUNOLOGY, V147, P141, DOI 10.1111/imm.12554; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Liao YH, 2005, J CLIN IMMUNOL, V25, P376, DOI 10.1007/s10875-005-4187-y; Liu K, 2010, J HUAZHONG U SCI-MED, V30, P582, DOI 10.1007/s11596-010-0546-x; Manzo A, 2005, EUR J IMMUNOL, V35, P1347, DOI 10.1002/eji.200425830; Motallebzadeh R, 2012, FASEB J, V26, P51, DOI 10.1096/fj.11-186973; Noack M, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1046-6; Nussinovitch U, 2013, CLIN REV ALLERG IMMU, V44, P98, DOI 10.1007/s12016-010-8229-8; Nylander AN, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92321; Peters A, 2015, J CLIN INVEST, V125, P129, DOI 10.1172/JCI74685; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Pipi E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01952; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Quintanilla M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030707; Rao DA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01924; Rose NR, 2016, CURR OPIN RHEUMATOL, V28, P383, DOI 10.1097/BOR.0000000000000303; Sagar S, 2012, LANCET, V379, P738, DOI 10.1016/S0140-6736(11)60648-X; Subbarayal B, 2016, J IMMUNOL, V197, P3464, DOI 10.4049/jimmunol.1502641; Suzuki-Inoue K, 2017, J THROMB HAEMOST, V15, P219, DOI 10.1111/jth.13590; Toellner KM, 1998, J EXP MED, V187, P1193, DOI 10.1084/jem.187.8.1193; Van Raemdonck K, 2020, CELL MOL LIFE SCI, V77, P1387, DOI 10.1007/s00018-019-03235-w; Villegas JA, 2019, J AUTOIMMUN, V98, P59, DOI 10.1016/j.jaut.2018.11.005; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Weyand CM, 2001, AM J PATHOL, V159, P787, DOI 10.1016/S0002-9440(10)61751-8; Xuan WJ, 2015, J LEUKOCYTE BIOL, V97, P61, DOI 10.1189/jlb.1A0314-170R; Yan LH, 2016, J MOL MED, V94, P1063, DOI 10.1007/s00109-016-1414-3; Yuan J, 2010, J CLIN IMMUNOL, V30, P226, DOI 10.1007/s10875-009-9355-z; Zhou Zi-hua, 2005, Zhonghua Yi Xue Za Zhi, V85, P625; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	42	3	3	5	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21975	10.1096/fj.202101050RR	http://dx.doi.org/10.1096/fj.202101050RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34618980				2022-12-28	WOS:000712009200017
J	Glanville, JRW; Jalali, P; Flint, JD; Patel, AA; Maini, AA; Wallace, JL; Hosin, AA; Gilroy, DW				Glanville, James R. W.; Jalali, Parinaaz; Flint, Julia D.; Patel, Amit A.; Maini, Alexander A.; Wallace, John L.; Hosin, Ali A.; Gilroy, Derek W.			Potent anti-inflammatory effects of an H2S-releasing naproxen (ATB-346) in a human model of inflammation	FASEB JOURNAL			English	Article							HYDROGEN-SULFIDE; GASEOUS MEDIATORS; MECHANISMS; RESOLUTION; DYSREGULATION; NEUTROPHILS; INFECTION; CLEARANCE; TOLERANCE; THERAPY	ATB-346 is a hydrogen sulfide-releasing non-steroidal anti-inflammatory drug (H2S-NSAID) derived from naproxen, which in preclinical studies has been shown to have markedly reduced gastrointestinal adverse effects. However, its anti-inflammatory properties in humans compared to naproxen are yet to be confirmed. To test this, we used a dermal model of acute inflammation in healthy, human volunteers, triggered by ultraviolet-killed Escherichia coll. This robust model allows quantification of the cardinal signs of inflammation along with cellular and humoral factors accumulating within the inflamed skin. ATB-346 was non-inferior to naproxen in terms of its inhibition of cyclooxygenase activity as well as pain and tenderness. ATB-346 significantly inhibited neutrophil infiltration at the site of inflammation at 4 h, compared to untreated controls. Subjects treated with ATB-346 also experienced significantly reduced pain and tenderness compared to healthy controls. Furthermore, both classical and intermediate monocyte subsets infiltrating the site of inflammation at 48 h expressed significantly lower levels of CD14 compared to untreated controls, demonstrating a shift toward an anti-inflammatory phenotype. Collectively, we have shown for the first time in humans that ATB-346 is potently anti-inflammatory and propose that ATB-346 represents the next generation of H2S-NSAIDs, as a viable alternative to conventional NSAIDs, with reduced adverse effects profile.	[Glanville, James R. W.; Jalali, Parinaaz; Flint, Julia D.; Patel, Amit A.; Maini, Alexander A.; Hosin, Ali A.; Gilroy, Derek W.] UCL, Ctr Clin Pharmacol & Therapeut, Div Med, 5 Univ St, London WC1E 6JF, England; [Wallace, John L.] Antibe Therapeut Inc, Toronto, ON, Canada	University of London; University College London	Gilroy, DW (corresponding author), UCL, Ctr Clin Pharmacol & Therapeut, Div Med, 5 Univ St, London WC1E 6JF, England.	d.gilroy@ucl.ac.uk		Glanville, James/0000-0002-5653-3960	Wellcome Trust (Wellcome) [101719/Z/13/Z]	Wellcome Trust (Wellcome)	Wellcome Trust (Wellcome), Grant/Award Number: 101719/Z/13/Z	ABRAMSON SB, 1989, ARTHRITIS RHEUM, V32, P1, DOI 10.1002/anr.1780320102; Bailey CP, 2005, CURR OPIN PHARMACOL, V5, P60, DOI 10.1016/j.coph.2004.08.012; Bannenberg GL, 2009, EXPERT OPIN THER PAT, V19, P663, DOI 10.1517/13543770902858824; Beauvillain C, 2011, BLOOD, V117, P1196, DOI 10.1182/blood-2009-11-254490; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Chan FKL, 2006, NAT CLIN PRACT GASTR, V3, P563, DOI 10.1038/ncpgasthep0610; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Christie MJ, 2008, BRIT J PHARMACOL, V154, P384, DOI 10.1038/bjp.2008.100; De Almeida DE, 2010, J IMMUNOL, V185, P1927, DOI 10.4049/jimmunol.0904002; Dhalla IA, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5142; Dixon WG, 2006, ARTHRITIS RHEUM-US, V54, P2368, DOI 10.1002/art.21978; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Drvota V., 1991, ADV PROSTAG THROMB L, V21, p153; Graham DJ, 2006, JAMA-J AM MED ASSOC, V296, P1653, DOI 10.1001/jama.296.13.jed60058; Hegde Akhil, 2011, Inflammation & Allergy Drug Targets, V10, P118; KASS E H, 1958, Adv Intern Med, V9, P45; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Marsland BJ, 2011, EUR RESPIR J, V38, P500, DOI 10.1183/09031936.00103211; Motwani MP, 2016, J PATHOL CLIN RES, V2, P154, DOI 10.1002/cjp2.43; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Ng SC, 2010, CURR OPIN GASTROEN, V26, P611, DOI 10.1097/MOG.0b013e32833e91eb; Rostom A., 2002, COCHRANE DB SYST REV, P1; SAVILL J, 1995, SEMIN CELL BIOL, V6, P385, DOI 10.1016/S1043-4682(05)80009-1; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Stables MJ, 2010, BLOOD, V116, P2950, DOI 10.1182/blood-2010-05-284844; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Wallace JL, 2007, TRENDS PHARMACOL SCI, V28, P501, DOI 10.1016/j.tips.2007.09.003; Wallace JL, 2020, BRIT J PHARMACOL, V177, P769, DOI 10.1111/bph.14641; Wallace JL, 2018, ANTIOXID REDOX SIGN, V28, P1533, DOI 10.1089/ars.2017.7068; Wallace JL, 2015, SEMIN IMMUNOL, V27, P227, DOI 10.1016/j.smim.2015.05.004; Wallace JL, 2010, BRIT J PHARMACOL, V159, P1236, DOI 10.1111/j.1476-5381.2009.00611.x; WEISSMANN G, 1985, European Journal of Rheumatology and Inflammation, V8, P6; White William B, 2007, Curr Pain Headache Rep, V11, P428, DOI 10.1007/s11926-007-0020-3; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Zink A, 2009, ANN RHEUM DIS, V68, P1240, DOI 10.1136/ard.2008.091926	37	1	1	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21913	10.1096/fj.201902918RR	http://dx.doi.org/10.1096/fj.201902918RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34555204	Green Submitted			2022-12-28	WOS:000702238200038
J	Liu, C; Wang, YL; Yang, YY; Zhang, NP; Niu, C; Shen, XZ; Wu, J				Liu, Chang; Wang, Yu-Li; Yang, Yong-Yu; Zhang, Ning-Ping; Niu, Chen; Shen, Xi-Zhong; Wu, Jian			Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases	FASEB JOURNAL			English	Review						bacteriophage; chronic liver disease; fecal microbial transplantation; gut microbiota	PRIMARY SCLEROSING CHOLANGITIS; PROTEIN-COUPLED RECEPTOR; CHAIN FATTY-ACIDS; DOUBLE-BLIND; NONALCOHOLIC STEATOHEPATITIS; INTESTINAL PERMEABILITY; RANDOMIZED-TRIAL; OBESE CHILDREN; PROBIOTICS; ACTIVATION	Recent investigations of gut microbiota have contributed to understanding of the critical role of microbial community in pathophysiology. Dysbiosis not only causes disturbance directly to the gastrointestinal tract but also affects the liver through gut-liver axis. Various types of dysbiosis have been documented in alcoholic liver disease (ALD), nonalcoholic fatty liver disease, autoimmune hepatitis (AIH), primary sclerosing cholangitis, and may be crucial for the initiation, progression, or deterioration to end-stage liver disease. A few microbial species have been identified as the causal factors leading to these chronic illnesses that either do not have clear etiologies or lack effective treatment. Notably, cytolysin-producing Enterococcus faecalis, Klebsiella pneumoniae and Enterococcus gallinarum were defined for ALD, NASH, and AIH, respectively. These groundbreaking discoveries drive a rapid development in innovative therapeutics, such as fecal microbial transplantation and implementation of specific bacteriophages in addition to prebiotics, probiotics, or synbiotics for intervention of dysbiosis. Although most emerging interventions are in preclinical development or early clinical trials, a better delineation of specific dysbiosis in these disorders at metabolic, immunogenic, or molecular levels in establishing particular causal effects aids in modulating or correcting the microbial community which is the part of daily life for human being.	[Liu, Chang; Wang, Yu-Li; Yang, Yong-Yu; Niu, Chen; Wu, Jian] Fudan Univ, Sch Basic Med Sci, Dept Med Microbiol & Parasitol, MOE NHC CAMS Key Lab Med Mol Virol,Shanghai Med C, 138 Yixue Yuan Rd,POB 228, Shanghai 200032, Peoples R China; [Zhang, Ning-Ping; Shen, Xi-Zhong; Wu, Jian] Fudan Univ, Dept Gastroenterol & Hepatol, Zhongshan Hosp, 180 Fengling Rd, Shanghai 200032, Peoples R China; [Zhang, Ning-Ping; Shen, Xi-Zhong; Wu, Jian] Fudan Univ, Shanghai Inst Liver Dis, Shanghai Med Coll, Shanghai, Peoples R China; [Niu, Chen] Fosunlead Shanghai Pharmaceut Technol Co Ltd, Room F118,Bldg 1,1111,Zhongshan North 1st Rd, Shanghai 200437, Peoples R China	Fudan University; Fudan University; Fudan University	Wu, J (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Med Microbiol & Parasitol, MOE NHC CAMS Key Lab Med Mol Virol,Shanghai Med C, 138 Yixue Yuan Rd,POB 228, Shanghai 200032, Peoples R China.; Shen, XZ; Wu, J (corresponding author), Fudan Univ, Dept Gastroenterol & Hepatol, Zhongshan Hosp, 180 Fengling Rd, Shanghai 200032, Peoples R China.	shen.xizhong@zs-hospital.sh.cn; jian.wu@fudan.edu.cn	Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364	National Key R&D Program of China [2016YFE0107400]; National Natural Science Foundation of China [81572356, 81871997, 82170624]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Dr Jian Wu is supported by the National Key R&D Program of China (#2016YFE0107400); the National Natural Science Foundation of China (NSFC#81572356, 81871997 and 82170624)	Alisi A, 2014, ALIMENT PHARM THER, V39, P1276, DOI 10.1111/apt.12758; Allegretti JR, 2019, AM J GASTROENTEROL, V114, P1071, DOI 10.14309/ajg.0000000000000115; Aller R, 2011, EUR REV MED PHARMACO, V15, P1090; Alves-Bezerra M, 2018, COMPR PHYSIOL, V8, P1, DOI 10.1002/cphy.c170012; Asgharian A, 2016, INT J PREVENTIVE MED, V7, DOI 10.4103/2008-7802.178533; Bajaj JS, 2020, J HEPATOL, V72, P1003, DOI 10.1016/j.jhep.2020.01.017; Beraza N, 2019, CURR OPIN PHARMACOL, V49, P76, DOI 10.1016/j.coph.2019.09.012; Bomhof MR, 2019, EUR J NUTR, V58, P1735, DOI 10.1007/s00394-018-1721-2; Borody Thomas J, 2013, Curr Gastroenterol Rep, V15, P337, DOI 10.1007/s11894-013-0337-1; Bouhnik Y, 2004, AM J CLIN NUTR, V80, P1658, DOI 10.1093/ajcn/80.6.1658; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chapman R, 2010, HEPATOLOGY, V51, P660, DOI 10.1002/hep.23294; Chen YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19076; Choi AY, 2018, J CLIN TRANSL HEPATO, V6, P114, DOI 10.14218/JCTH.2017.00029; Chu HK, 2019, GUT, V68, P359, DOI 10.1136/gutjnl-2018-316307; Craven L, 2020, AM J GASTROENTEROL, V115, P1055, DOI 10.14309/ajg.0000000000000661; Dalmasso M, 2014, TRENDS MICROBIOL, V22, P399, DOI 10.1016/j.tim.2014.02.010; Daubioul CA, 2005, EUR J CLIN NUTR, V59, P723, DOI 10.1038/sj.ejcn.1602127; Davies YK, 2008, J PEDIATR GASTR NUTR, V47, P61, DOI 10.1097/MPG.0b013e31816fee95; de Vrese M, 2008, ADV BIOCHEM ENG BIOT, V111, P1, DOI 10.1007/10_2008_097; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Diehl AM, 2017, NEW ENGL J MED, V377, P2063, DOI 10.1056/NEJMra1503519; Duan Y, 2019, NATURE, V575, P505, DOI 10.1038/s41586-019-1742-x; Duryee MJ, 2007, WORLD J GASTROENTERO, V13, P4938, DOI 10.3748/wjg.v13.i37.4938; Eslamparast T, 2014, AM J CLIN NUTR, V99, P535, DOI 10.3945/ajcn.113.068890; Famouri F, 2017, J PEDIATR GASTR NUTR, V64, P413, DOI 10.1097/MPG.0000000000001422; Farrell GC, 2010, J GASTROEN HEPATOL, V25, P657, DOI 10.1111/j.1440-1746.2009.06167.x; Ferolla SM, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070397; Ferstl PG, 2017, WORLD J GASTROENTERO, V23, P2086, DOI 10.3748/wjg.v23.i11.2086; Gao X, 2014, J BIOSCI BIOENG, V118, P476, DOI 10.1016/j.jbiosc.2014.03.001; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Giorgio V, 2014, DIGEST LIVER DIS, V46, P556, DOI 10.1016/j.dld.2014.02.010; Gomes MT, 2016, J LEUKOCYTE BIOL, V99, P771, DOI 10.1189/jlb.4A0815-346R; Gorski A, 2017, FUTURE MICROBIOL, V12, P905, DOI 10.2217/fmb-2017-0049; Han SH, 2015, EUR J GASTROEN HEPAT, V27, P1300, DOI 10.1097/MEG.0000000000000458; Haque TR, 2016, BEST PRACT RES CL GA, V30, P133, DOI 10.1016/j.bpg.2016.02.004; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Hu HM, 2020, J GASTROENTEROL, V55, P142, DOI 10.1007/s00535-019-01649-8; Jandhyala SM, 2015, WORLD J GASTROENTERO, V21, P8787, DOI 10.3748/wjg.v21.i29.8787; Ji Y, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081712; Karlsen TH, 2017, J HEPATOL, V67, P1298, DOI 10.1016/j.jhep.2017.07.022; Kirpich IA, 2008, ALCOHOL, V42, P675, DOI 10.1016/j.alcohol.2008.08.006; Kobyliak N, 2018, J GASTROINTEST LIVER, V27, P41, DOI 10.15403/jgld.2014.1121.271.kby; Kulaksiz H, 2006, J HEPATOL, V45, P711, DOI 10.1016/j.jhep.2006.07.022; Kummen M, 2017, GUT, V66, P611, DOI 10.1136/gutjnl-2015-310500; Lang S, 2020, LIVER INT, V40, P860, DOI 10.1111/liv.14377; Lechner S, 2020, DIGEST DIS SCI, V65, P897, DOI 10.1007/s10620-020-06100-0; Lindor KD, 2019, HEPATOLOGY, V69, P394, DOI 10.1002/hep.30145; Liu XJ, 2020, LIVER INT, V40, P830, DOI 10.1111/liv.14370; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mack CL, 2020, HEPATOLOGY, V72, P671, DOI 10.1002/hep.31065; Malaguarnera M, 2012, DIGEST DIS SCI, V57, P545, DOI 10.1007/s10620-011-1887-4; Manzhalii E, 2017, J DIGEST DIS, V18, P698, DOI 10.1111/1751-2980.12561; Markowiak-Kopec P, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041107; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Mikolasevic I, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13947; Milosevic I, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020395; Mullish BH, 2018, GUT, V67, P1920, DOI [10.1136/gutjnl-2018-316818, 10.1016/j.jhin.2018.07.037]; Nakamoto N, 2019, NAT MICROBIOL, V4, P492, DOI 10.1038/s41564-018-0333-1; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; Overmann J, 2017, ANNU REV MICROBIOL, V71, P711, DOI 10.1146/annurev-micro-090816-093449; Poeta M, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4080066; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rau M, 2018, UNITED EUR GASTROENT, V6, P1496, DOI 10.1177/2050640618804444; Richardson N, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01586; Rinninella E, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010014; Rodriguez EA, 2017, EXPERT REV GASTROENT, V11, P451, DOI 10.1080/17474124.2017.1293524; Ruhlemann MC, 2017, GUT, V66, P753, DOI 10.1136/gutjnl-2016-312180; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Sarker SA, 2016, EBIOMEDICINE, V4, P124, DOI 10.1016/j.ebiom.2015.12.023; Scorletti E, 2020, GASTROENTEROLOGY, V158, P1597, DOI 10.1053/j.gastro.2020.01.031; Scott NA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao4755; Sepideh A, 2016, J AM COLL NUTR, V35, P500, DOI 10.1080/07315724.2015.1031355; Singal AK, 2018, AM J GASTROENTEROL, V113, P175, DOI 10.1038/ajg.2017.469; Suk KT, 2019, EXPERT REV GASTROENT, V13, P193, DOI 10.1080/17474124.2019.1569513; Sung H, 2016, WORLD J GASTROENTERO, V22, P6673, DOI 10.3748/wjg.v22.i29.6673; Svegliati-Baroni G, 2011, LIVER INT, V31, P1285, DOI 10.1111/j.1478-3231.2011.02462.x; Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Tilg H, 2016, GUT, V65, P2035, DOI 10.1136/gutjnl-2016-312729; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Torres J, 2016, ALIMENT PHARM THER, V43, P790, DOI 10.1111/apt.13552; Trivedi PJ, 2018, GUT, V67, P1135, DOI 10.1136/gutjnl-2016-312354; Vieira SM, 2018, SCIENCE, V359, P1156, DOI 10.1126/science.aar7201; Vleggaar FR, 2008, EUR J GASTROEN HEPAT, V20, P688, DOI 10.1097/MEG.0b013e3282f5197e; Vuppalanchi R, 2021, NAT REV GASTRO HEPAT, V18, P373, DOI 10.1038/s41575-020-00408-y; Wang BH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32002; Wei YR, 2020, GUT, V69, P569, DOI 10.1136/gutjnl-2018-317836; Wong VWS, 2013, ANN HEPATOL, V12, P256, DOI 10.1016/S1665-2681(19)31364-X; Yuan J, 2019, CELL METAB, V30, P675, DOI 10.1016/j.cmet.2019.08.018; Zhao MM, 2020, GASTROENTEROLOGY, V158, P2266, DOI 10.1053/j.gastro.2020.02.033; Zhou D, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0183-1; Zhou D, 2017, WORLD J GASTROENTERO, V23, P60, DOI 10.3748/wjg.v23.i1.60	93	7	7	4	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21871	10.1096/fj.202100939R	http://dx.doi.org/10.1096/fj.202100939R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34473374				2022-12-28	WOS:000702238200032
J	Grunwald, H; Hunker, KL; Birt, I; Aviram, R; Zaffryar-Eilot, S; Ganesh, SK; Hasson, P				Grunwald, Hagar; Hunker, Kristina L.; Birt, Isabelle; Aviram, Rohtem; Zaffryar-Eilot, Shelly; Ganesh, Santhi K.; Hasson, Peleg			Lysyl oxidase interactions with transforming growth factor-beta during angiogenesis are mediated by endothelin 1	FASEB JOURNAL			English	Article						angiogenesis; endothelin; lysyl oxidase; TGF-beta; vascular maturation	MOLECULAR REGULATION; COLLAGEN; STRETCH	Crosstalk between multiple components underlies the formation of mature vessels. Although the players involved in angiogenesis have been identified, mechanisms underlying the crosstalk between them are still unclear. Using the ex vivo aortic ring assay, we set out to dissect the interactions between two key angiogenic signaling pathways, vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF beta), with members of the lysyl oxidase (LOX) family of matrix modifying enzymes. We find an interplay between VEGF, TGF beta, and the LOXs is essential for the formation of mature vascular smooth muscle cells (vSMC)-coated vessels. RNA sequencing analysis further identified an interaction with the endothelin-1 pathway. Our work implicates endothelin-1 downstream of TGF beta in vascular maturation and demonstrate the complexity of processes involved in generating vSMC-coated vessels.	[Grunwald, Hagar; Aviram, Rohtem; Zaffryar-Eilot, Shelly; Hasson, Peleg] Technion Israel Inst Technol, Dept Genet & Dev Biol, Rappaport Fac Med, IL-31096 Haifa, Israel; [Grunwald, Hagar; Aviram, Rohtem; Zaffryar-Eilot, Shelly; Hasson, Peleg] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel; [Hunker, Kristina L.; Birt, Isabelle; Ganesh, Santhi K.] Univ Michigan, Sch Med, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI USA; [Ganesh, Santhi K.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hasson, P (corresponding author), Technion Israel Inst Technol, Dept Genet & Dev Biol, Rappaport Fac Med, IL-31096 Haifa, Israel.; Hasson, P (corresponding author), Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel.	phasson@technion.ac.il		Hasson, Peleg/0000-0002-3594-1594	Israel Science Foundation (ISF) [1072/13]; Rappaport Family Foundation; University of Michigan-Israel partnership; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [R01HL122684, R01HL139672]	Israel Science Foundation (ISF)(Israel Science Foundation); Rappaport Family Foundation; University of Michigan-Israel partnership; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)	Israel Science Foundation (ISF), Grant/Award Number: 1072/13; Rappaport Family Foundation; University of Michigan-Israel partnership; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R01HL122684; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R01HL139672	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Apte RS, 2019, CELL, V176, P1248, DOI 10.1016/j.cell.2019.01.021; Atsawasuwan P, 2008, J BIOL CHEM, V283, P34229, DOI 10.1074/jbc.M803142200; Baker AM, 2013, CANCER RES, V73, P583, DOI 10.1158/0008-5472.CAN-12-2447; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Guo DC, 2016, CIRC RES, V118, P928, DOI 10.1161/CIRCRESAHA.115.307130; Hong HH, 2004, J CELL PHYSIOL, V200, P53, DOI 10.1002/jcp.10476; Hornstra IK, 2003, J BIOL CHEM, V278, P14387, DOI 10.1074/jbc.M210144200; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kraft-Sheleg O, 2016, DEV CELL, V36, P550, DOI 10.1016/j.devcel.2016.02.009; Kutchuk L, 2015, DEVELOPMENT, V142, P983, DOI 10.1242/dev.113449; Lagares D, 2010, ARTHRITIS RHEUM-US, V62, P878, DOI 10.1002/art.27307; Lee VS, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127748; Lee VS, 2016, P NATL ACAD SCI USA, V113, P8759, DOI 10.1073/pnas.1601442113; Lei Y, 2017, J MECH BEHAV BIOMED, V75, P351, DOI 10.1016/j.jmbbm.2017.07.041; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lucero HA, 2008, J BIOL CHEM, V283, P24103, DOI 10.1074/jbc.M709897200; Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Maki JM, 2009, HISTOL HISTOPATHOL, V24, P651, DOI 10.14670/HH-24.651; MCKAY GF, 1954, ARCH BIOCHEM BIOPHYS, V52, P313, DOI 10.1016/0003-9861(54)90129-0; NARAYANAN AS, 1972, BIOCHEM BIOPH RES CO, V46, P745; PINNELL SR, 1968, P NATL ACAD SCI USA, V61, P708, DOI 10.1073/pnas.61.2.708; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Wermuth PJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161988; Yehezkely RG, 2020, DEV CELL, V53, P406, DOI 10.1016/j.devcel.2020.04.002	26	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21824	10.1096/fj.202001860RR	http://dx.doi.org/10.1096/fj.202001860RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34370353	Green Published			2022-12-28	WOS:000691122900033
J	Zhong, DJ; Zhang, Y; Zhang, SY; Ge, YY; Tong, MY; Feng, YJ; You, F; Zhao, XY; Wang, K; Zhang, LP; Liu, XL; Chen, JF				Zhong, Ding-Juan; Zhang, Yu; Zhang, Shuya; Ge, Yuan-Yuan; Tong, Mengyun; Feng, Yijia; You, Feng; Zhao, Xinyue; Wang, Ke; Zhang, Liping; Liu, Xiaoling; Chen, Jiang-Fan			Adenosine A(2A) receptor antagonism protects against hyperoxia-induced retinal vascular loss via cellular proliferation	FASEB JOURNAL			English	Article						activin receptor-like kinase 1; adenosine A(2A) receptor; cell proliferation; DNA-binding protein inhibitor 1; oxygen-induced retinopathy	OXYGEN-INDUCED RETINOPATHY; ISCHEMIC RETINOPATHY; VESSEL LOSS; PREMATURITY; MOUSE; ANGIOGENESIS; APOPTOSIS; NEOVASCULARIZATION; INJURY; CELLS	Retinopathy of prematurity (ROP) remains one of the major causes of blindness in children worldwide. While current ROP treatments are mostly disruptive to reduce proliferative neovascularization by targeting the hypoxic phase, protection against early hyperoxia-induced retinal vascular loss represents an effective therapeutic window, but no such therapeutic strategy is available. Built upon our recent demonstration that the protection against oxygen-induced retinopathy by adenosine A(2A) receptor (A(2A)R) antagonists is most effective when administered at the hyperoxia (not hypoxic) phase, we here uncovered the cellular mechanism underlying the A(2A)R-mediated protection against early hyperoxia-induced retinal vascular loss by reversing the inhibition of cellular proliferation via possibly multiple signaling pathways. Specifically, we revealed two distinct stages of the hyperoxia phase with greater cellular proliferation and apoptosis activities and upregulation of adenosine signaling at postnatal 9 day (P9) but reduced cellular activities and adenosine-A(2A)R signaling at P12. Importantly, the A(2A)R-mediated protection at P9 was associated with the reversal of hyperoxia-induced inhibition of progenitor cells at the peripheral retina at P9 and of retinal endothelial proliferation at P9 and P12. The critical role of cellular proliferation in the hyperoxia-induced retinal vascular loss was validated by the increased avascular areas by siRNA knockdown of the multiple signaling molecules involved in modulation of cellular proliferation, including activin receptor-like kinase 1, DNA-binding protein inhibitor 1, and vascular endothelial growth factor-A.	[Zhong, Ding-Juan; Zhang, Yu; Zhang, Shuya; Ge, Yuan-Yuan; Tong, Mengyun; Feng, Yijia; You, Feng; Zhao, Xinyue; Wang, Ke; Zhang, Liping; Liu, Xiaoling; Chen, Jiang-Fan] Wenzhou Med Univ, Affiliated Eye Hosp, State Key Lab Optometry Ophthalmol & Vis Sci, Wenzhou, Peoples R China; [Zhong, Ding-Juan] Hunan Normal Univ, Hunan Prov Peoples Hosp, Affiliated Hosp 1, Changsha, Peoples R China	Wenzhou Medical University; Hunan Normal University	Liu, XL; Chen, JF (corresponding author), Wenzhou Med Univ, Affiliated Eye Hosp, State Key Lab Optometry Ophthalmol & Vis Sci, Wenzhou, Peoples R China.; Liu, XL (corresponding author), Wenzhou Med Univ, Sch Optometry & Ophthalmol, 270 Xueyuan Rd, Wenzhou, Zhejiang, Peoples R China.; Liu, XL (corresponding author), Wenzhou Med Univ, Eye Hosp, 270 Xueyuan Rd, Wenzhou, Zhejiang, Peoples R China.; Chen, JF (corresponding author), Wenzhou Med Univ, Sch Optometry & Ophthalmol, State Key Lab Optometry, 270 Xueyuan Rd, Wenzhou, Zhejiang, Peoples R China.	drliuxiaolin@163.com; chenjf555@gmail.com	Liu, Xiaoling/HGD-3566-2022	Chen, Jiang-Fan/0000-0002-0446-3956	National Natural Science Foundation of China [81630040, 31771178, 81600753, 81800819]; State Department of Science and Technology of China [2016YFC1306602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Department of Science and Technology of China	The National Natural Science Foundation of China, Grant/Award Number: 81630040 and 31771178; The Program Project grant from the State Department of Science and Technology of China, Grant/Award Number: #2016YFC1306602; The National Natural Science Foundation of China, Grant/Award Number: 81600753 and 81800819	Baranov PY, 2014, TISSUE ENG PT A, V20, P1465, DOI [10.1089/ten.tea.2013.0361, 10.1089/ten.TEA.2013.0361]; Bassett EA, 2012, TRENDS NEUROSCI, V35, P565, DOI 10.1016/j.tins.2012.05.004; Broxterman Emily C, 2016, Mo Med, V113, P187; Calzi SL, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129224; Chan SJ, 2020, STROKE, V51, P2844, DOI 10.1161/STROKEAHA.119.025304; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chen JF, 2017, MOL ASPECTS MED, V55, P118, DOI 10.1016/j.mam.2017.01.001; Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955; Chen Y, 2006, BRIT J OPHTHALMOL, V90, P268, DOI 10.1136/bjo.2005.078063; Clark D, 2008, EARLY HUM DEV, V84, P95, DOI 10.1016/j.earlhumdev.2007.11.007; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Day YJ, 2005, AM J PHYSIOL-RENAL, V288, pF722, DOI 10.1152/ajprenal.00378.2004; Di Fiore JM, 2012, PEDIATR RES, V72, P606, DOI 10.1038/pr.2012.132; Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022; Edgar KS, 2017, INVEST OPHTH VIS SCI, V58, P230, DOI 10.1167/iovs.16-20523; Feungpean Belen, 2002, Journal of the Medical Association of Thailand, V85, pS1219; Fierson WM, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3061; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Geisen P, 2008, MOL VIS, V14, P345; Gilbert C, 2008, EARLY HUM DEV, V84, P77, DOI 10.1016/j.earlhumdev.2007.11.009; Gu XL, 2003, AM J PHYSIOL-CELL PH, V285, pC546, DOI 10.1152/ajpcell.00424.2002; Hartnett ME, 2010, DOC OPHTHALMOL, V120, P25, DOI 10.1007/s10633-009-9181-x; Hartnett ME, 2017, SURV OPHTHALMOL, V62, P257, DOI 10.1016/j.survophthal.2016.12.004; Hashimoto T, 2006, DEVELOPMENT, V133, P2201, DOI 10.1242/dev.02385; Hellstrom A, 2013, LANCET, V382, P1445, DOI 10.1016/S0140-6736(13)60178-6; Hoppe G, 2014, AM J PATHOL, V184, P1890, DOI 10.1016/j.ajpath.2014.02.017; Huang H, 2011, INVEST OPHTH VIS SCI, V52, P7565, DOI 10.1167/iovs.11-8002; Huang QY, 2006, J NEUROSCI, V26, P11371, DOI 10.1523/JNEUROSCI.1907-06.2006; Huang XY, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0294-1; Joyal JS, 2011, BLOOD, V117, P6024, DOI 10.1182/blood-2010-10-311589; Kim KS, 2016, CELL TRANSPLANT, V25, P1145, DOI 10.3727/096368915X688263; Kwinta P, 2008, GRAEF ARCH CLIN EXP, V246, P1467, DOI 10.1007/s00417-008-0865-9; Lange C, 2009, GRAEF ARCH CLIN EXP, V247, P1205, DOI 10.1007/s00417-009-1116-4; Ley D, 2019, J PEDIATR-US, V206, P56, DOI 10.1016/j.jpeds.2018.10.033; Liu CM, 2015, MOL IMMUNOL, V63, P559, DOI 10.1016/j.molimm.2014.10.012; Liu XL, 2010, INVEST OPHTH VIS SCI, V51, P6625, DOI 10.1167/iovs.09-4900; Liu ZP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00551-2; Lu LPL, 2017, HONG KONG MED J, V23, P41, DOI 10.12809/hkmj154811; May CA, 2012, EXP EYE RES, V100, P86, DOI 10.1016/j.exer.2012.04.017; Mora JS, 2018, BRIT J OPHTHALMOL, V102, P9, DOI 10.1136/bjophthalmol-2017-310709; Ohlmann A, 2010, J NEUROSCI, V30, P183, DOI 10.1523/JNEUROSCI.3210-09.2010; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Patel C, 2016, BBA-MOL BASIS DIS, V1862, P1628, DOI 10.1016/j.bbadis.2016.05.020; Phelps DL, 2018, JAMA-J AM MED ASSOC, V320, P1649, DOI 10.1001/jama.2018.14996; Rivera JC, 2013, ARTERIOSCL THROM VAS, V33, P1881, DOI 10.1161/ATVBAHA.113.301331; Romagnoli C, 2009, EARLY HUM DEV, V85, pS79, DOI 10.1016/j.earlhumdev.2009.08.026; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Saito Y, 2007, MOL VIS, V13, P840; Sanghvi KP, 2017, ARCH DIS CHILD-FETAL, V102, pF389, DOI 10.1136/archdischild-2016-311548; Sankar MJ, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009734.pub2; Sapieha P, 2010, J CLIN INVEST, V120, P3022, DOI 10.1172/JCI42142; Shih SC, 2003, J CLIN INVEST, V112, P50, DOI 10.1172/JCI200317808; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smith LH, 2004, INVEST OPHTH VIS SCI, V45, pU162; Stahl A., 2016, LANCET, P21; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Tokunaga CC, 2014, INVEST OPHTH VIS SCI, V55, P1884, DOI 10.1167/iovs.13-13397; Uno K, 2010, EXP EYE RES, V90, P493, DOI 10.1016/j.exer.2009.12.012; Van Geest RJ, 2010, INVEST OPHTH VIS SCI, V51, P1857, DOI 10.1167/iovs.09-4181; Vanhaesebrouck S, 2009, PEDIATR RES, V65, P307, DOI 10.1203/PDR.0b013e3181973dc8; Vartanian RJ, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1978; Vecino E, 2004, INT J DEV BIOL, V48, P965, DOI 10.1387/ijdb.041891ev; Wang XM, 2013, NATURE, V499, P306, DOI 10.1038/nature12345; Wu J, 2016, ACTA ANAESTH SCAND, V60, P492, DOI 10.1111/aas.12646; Xu Y, 2013, INVEST OPHTH VIS SCI, V54, P8229, DOI 10.1167/iovs.13-12297; Zhang HB, 2018, INT J OPHTHALMOL-CHI, V11, P858, DOI 10.18240/ijo.2018.05.24; Zhang SY, 2017, FASEB J, V31, P3334, DOI [10.1096/fj.201601285R, 10.1096/fj.201601285r]; Zhang SY, 2015, INVEST OPHTH VIS SCI, V56, P8108, DOI 10.1167/iovs.15-17202; Zhang WB, 2011, INVEST OPHTH VIS SCI, V52, P6384, DOI 10.1167/iovs.11-7666; Zhou R, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0038-1	71	2	2	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21842	10.1096/fj.202100414RR	http://dx.doi.org/10.1096/fj.202100414RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34418159				2022-12-28	WOS:000691122900012
J	Tuplin, EWN; Alukic, E; Lowry, DE; Chleilat, F; Wang, WL; Cho, NA; Sampsell, K; Sales, KM; Mayengbam, S; McCoy, KD; Reimer, RA				Tuplin, Erin W. Noye; Alukic, Erna; Lowry, Dana E.; Chleilat, Faye; Wang, Weilan; Cho, Nicole A.; Sampsell, Kara; Sales, Kate M.; Mayengbam, Shyamchand; McCoy, Kathy D.; Reimer, Raylene A.			Dietary fiber combinations to mitigate the metabolic, microbial, and cognitive imbalances resulting from diet-induced obesity in rats	FASEB JOURNAL			English	Article						dietary fiber; fecal microbiota transplantation; gastrointestinal microbiota; hippocampus; obesity	HIGH-FAT-DIET; GUT MICROBIOTA; SATIETY HORMONES; WEIGHT-LOSS; OLIGOFRUCTOSE; PREBIOTICS; HEALTH; MICE; IMPROVEMENT; PHYSIOLOGY	Dietary fiber promotes a healthy gut microbiome and shows promise in attenuating the unfavorable microbial changes resulting from a high-fat/sucrose (HFS) diet. High-fiber diets consisting of oligofructose alone (HFS/O) or in combination with beta-glucan (HFS/OB), resistant starch (HFS/OR), or beta-glucan and resistant starch (HFS/OBR) were fed to diet-induced obese rats for 8 weeks to determine if these fibers could attenuate the obese phenotype. Only the HFS/O group displayed a decrease in body weight and body fat, but all fiber interventions improved insulin sensitivity and cognitive function. The HFS/O diet was the least effective at improving cognitive function and only the HFS/OB group showed improvements in glucose tolerance, thus highlighting the differential effects of fiber types. Hippocampal cytokines (IL-6, IL-10) were more pronounced in the HFS/OB group which coincided with the most time spend in the open arms of the elevated plus maze. All fiber groups showed an increase in beneficial Bifidobacterium and Lactobacillus abundance while the HFS group showed higher abundance of Clostridium. Fecal microbiota transplant from fiber-treated rats into germ-free mice did not alter body composition in the mice but did result in a higher abundance of Bacteroides in the HFS/O and HFS/OB groups compared to HFS. The HFS/OB recipient mice also had higher insulin sensitivity compared to the other groups. This study highlights the influence of dietary fiber type on metabolic and cognitive outcomes suggesting that the type of supplementation (single or combined fibers) could be tailored to specific targeted outcomes.	[Tuplin, Erin W. Noye; Alukic, Erna; Lowry, Dana E.; Chleilat, Faye; Wang, Weilan; Cho, Nicole A.; Sampsell, Kara; Sales, Kate M.; Reimer, Raylene A.] Univ Calgary, Fac Kinesiol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Mayengbam, Shyamchand] Mem Univ Newfoundland, Dept Biochem, St John, NL, Canada; [McCoy, Kathy D.] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Reimer, Raylene A.] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada	University of Calgary; Memorial University Newfoundland; University of Calgary; University of Calgary	Reimer, RA (corresponding author), Univ Calgary, Fac Kinesiol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	reimer@ucalgary.ca	Cho, Nicole/GZL-2564-2022; Wang, Weilan/ABH-1501-2020	Cho, Nicole/0000-0002-0553-1754; Wang, Weilan/0000-0002-8469-8797; Reimer, Raylene/0000-0001-5088-7947	Snyder Institute for Chronic Diseases; Alberta Innovates | Alberta Innovates --Health Solutions (AIHS); U of C | Alberta Children's Hospital Research Institute (ACHRI); Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC); Faculty of Kinesiology Dean's Doctoral Scholarship; University of Calgary Eyes High Postdoctoral Fellowship	Snyder Institute for Chronic Diseases; Alberta Innovates | Alberta Innovates --Health Solutions (AIHS); U of C | Alberta Children's Hospital Research Institute (ACHRI); Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC); Faculty of Kinesiology Dean's Doctoral Scholarship; University of Calgary Eyes High Postdoctoral Fellowship	Snyder Institute for Chronic Diseases; Alberta Innovates | Alberta Innovates --Health Solutions (AIHS); U of C | Alberta Children's Hospital Research Institute (ACHRI); Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC); Faculty of Kinesiology Dean's Doctoral Scholarship; University of Calgary Eyes High Postdoctoral Fellowship	Araujo JR, 2017, BIOCHIMIE, V141, P97, DOI 10.1016/j.biochi.2017.05.019; Aslani S, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.178; Bannerman DM, 2014, NAT REV NEUROSCI, V15, P181, DOI 10.1038/nrn3677; Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019; Bomhof MR, 2016, FASEB J, V30, P2720, DOI 10.1096/fj.201600151R; Bomhof MR, 2014, OBESITY, V22, P763, DOI 10.1002/oby.20632; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Bruce-Keller AJ, 2015, BIOL PSYCHIAT, V77, P607, DOI 10.1016/j.biopsych.2014.07.012; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Carlson JL, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121361; Chen KT, 2020, INT J FOOD SCI NUTR, V71, P965, DOI 10.1080/09637486.2020.1754351; Clapp M, 2017, CLINICS PRACT, V7, P131, DOI 10.4081/cp.2017.987; Cluny NL, 2015, OBESITY, V23, P769, DOI 10.1002/oby.21017; Cohen SJ, 2015, BEHAV BRAIN RES, V285, P105, DOI 10.1016/j.bbr.2014.08.002; Cominski TP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00273; Cordner ZA, 2015, PHYSIOL BEHAV, V152, P363, DOI 10.1016/j.physbeh.2015.06.008; de Cossio LF, 2017, BRAIN BEHAV IMMUN, V64, P33, DOI 10.1016/j.bbi.2016.12.022; de la Cuesta-Zuluaga J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010051; Dinel AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024325; Dotson S, 2008, DIABETES CARE, V31, P1222, DOI 10.2337/dc07-2243; Duan YH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02649; Ellacott KLJ, 2010, CELL METAB, V12, P10, DOI 10.1016/j.cmet.2010.06.001; Engin A, 2017, ADV EXP MED BIOL, V960, P111, DOI 10.1007/978-3-319-48382-5_5; Fuller S, 2016, PLANT FOOD HUM NUTR, V71, P1, DOI 10.1007/s11130-016-0529-6; Gibson GR, 2017, NAT REV GASTRO HEPAT, V14, P491, DOI 10.1038/nrgastro.2017.75; Gomes AC, 2018, GUT MICROBES, V9, P308, DOI 10.1080/19490976.2018.1465157; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Holscher HD, 2017, GUT MICROBES, V8, P172, DOI 10.1080/19490976.2017.1290756; Jakobsdottir G, 2013, BRIT J NUTR, V110, P1565, DOI 10.1017/S0007114513000809; Janssen I, 2013, CAN J DIABETES, V37, P90, DOI 10.1016/j.jcjd.2013.02.059; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Klingbeil EA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112710; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Lai ZL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33893-y; Lang UE, 2015, CELL PHYSIOL BIOCHEM, V37, P1029, DOI 10.1159/000430229; Li JM, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0713-7; Maciejewska D, 2018, J PHYSIOL PHARMACOL, V69, DOI 10.26402/jpp.2018.2.05; Maurer AD, 2009, J PHYSIOL-LONDON, V587, P679, DOI 10.1113/jphysiol.2008.161844; Mayengbam S, 2019, J NUTR BIOCHEM, V64, P228, DOI 10.1016/j.jnutbio.2018.11.003; Mulders RJ, 2018, OBES REV, V19, P435, DOI 10.1111/obr.12661; Nicolucci AC, 2017, GASTROENTEROLOGY, V153, P711, DOI 10.1053/j.gastro.2017.05.055; Ong ZY, 2012, J DEV ORIG HLTH DIS, V3, P299, DOI 10.1017/S204017441200030X; Ong ZY, 2011, FASEB J, V25, P2167, DOI 10.1096/fj.10-178392; Parker A, 2020, GUT MICROBES, V11, P135, DOI 10.1080/19490976.2019.1638722; Parnell JA, 2008, OBESITY, V16, P736, DOI 10.1038/oby.2007.128; Parnell JA, 2017, OBESITY, V25, P510, DOI 10.1002/oby.21763; Parnell JA, 2012, BRIT J NUTR, V107, P601, DOI 10.1017/S0007114511003163; Parnell JA, 2009, AM J CLIN NUTR, V89, P1751, DOI 10.3945/ajcn.2009.27465; Paul HA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20683; Proctor C, 2017, METAB BRAIN DIS, V32, P1, DOI 10.1007/s11011-016-9917-8; Rodenburg W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-144; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Shi HL, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00920-y; So D, 2018, AM J CLIN NUTR, V107, P965, DOI 10.1093/ajcn/nqy041; Tang T, 2021, INT J BIOL MACROMOL, V174, P289, DOI 10.1016/j.ijbiomac.2021.01.164; Tran DMD, 2018, J EXP PSYCHOL-ANIM L, V44, P217, DOI 10.1037/xan0000170; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Villanueva-Millan MJ, 2015, J PHYSIOL BIOCHEM, V71, P509, DOI 10.1007/s13105-015-0390-3; Vitaglione P, 2009, APPETITE, V53, P338, DOI 10.1016/j.appet.2009.07.013; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang SM, 2020, J FUNCT FOODS, V66, DOI 10.1016/j.jff.2020.103838; Wang YA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00129; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323; Zhang ZX, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102291; Zheng J, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.22754; Zoll J, 2020, AM J PHYSIOL-ENDOC M, V319, pE203, DOI 10.1152/ajpendo.00037.2020	70	1	1	9	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22269	10.1096/fj.202101750R	http://dx.doi.org/10.1096/fj.202101750R			25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ9SH	35344215				2022-12-28	WOS:000773602700001
J	Kamstra, K; Rizwan, MZ; Grattan, DR; Horsfield, JA; Tups, A				Kamstra, Kaj; Rizwan, Mohammed Z.; Grattan, David R.; Horsfield, Julia A.; Tups, Alexander			Leptin regulates glucose homeostasis via the canonical Wnt pathway in the zebrafish	FASEB JOURNAL			English	Article						CRISPR Cas9; glucose tolerance test; leptin receptor; leptin-a; leptin-b; lithium chloride	SYNTHASE KINASE 3-BETA; BODY-WEIGHT; INSULIN-RESISTANCE; GENETICALLY-OBESE; CATENIN PATHWAY; DANIO-RERIO; FOOD-INTAKE; INHIBITION; THERAPY; MICE	Leptin is best known for its role in adipostasis, but it also regulates blood glucose levels. The molecular mechanism by which leptin controls glucose homeostasis remains largely unknown. Here, we use a zebrafish model to show that Wnt signaling mediates the glucoregulatory effects of leptin. Under normal feeding conditions, leptin regulates glucose homeostasis but not adipostasis in zebrafish. In times of nutrient excess, however, we found that leptin also regulates body weight and size. Using a Wnt signaling reporter fish, we show that leptin activates the canonical Wnt pathway in vivo. Utilizing two paradigms for hyperglycemia, it is revealed that leptin regulates glucose homeostasis via the Wnt pathway, as pharmacological inhibition of this pathway impairs the glucoregulatory actions of leptin. Our results may shed new light on the evolution of the physiological function of leptin.	[Kamstra, Kaj; Rizwan, Mohammed Z.; Grattan, David R.; Tups, Alexander] Univ Otago, Ctr Neuroendocrinol, Dunedin, New Zealand; [Kamstra, Kaj; Rizwan, Mohammed Z.; Grattan, David R.; Tups, Alexander] Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand; [Kamstra, Kaj; Tups, Alexander] Univ Otago, Dunedin Sch Med, Dept Physiol, Dunedin, New Zealand; [Rizwan, Mohammed Z.; Grattan, David R.] Univ Otago, Dunedin Sch Med, Dept Anat, Dunedin, New Zealand; [Horsfield, Julia A.] Univ Otago, Dept Pathol, Dunedin, New Zealand; [Horsfield, Julia A.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand	University of Otago; University of Otago; University of Otago; University of Otago; University of Otago; University of Auckland	Tups, A (corresponding author), Univ Otago, Ctr Neumendocrinol, Otago Sch Biomed Sci, POB 913, Dunedin 9054, New Zealand.	alexander.tups@otago.ac.nz	Horsfield, Julia/B-5091-2012	Horsfield, Julia/0000-0002-9536-7790; Grattan, Dave/0000-0001-5606-2559	Department of Physiology, University of Otago; Maurice Wilkins Centre, University of Otago	Department of Physiology, University of Otago; Maurice Wilkins Centre, University of Otago	K.K. was supported by a PhD scholarship from the Department of Physiology and by the Maurice Wilkins Centre, University of Otago	Aguilar AJ, 2010, PEPTIDES, V31, P1044, DOI 10.1016/j.peptides.2010.02.026; Anagnostou SH, 2008, BIOCHEM J, V416, P211, DOI 10.1042/BJ20081426; Audira G, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124038; Benzler J, 2013, ENDOCRINOLOGY, V154, P4737, DOI 10.1210/en.2013-1746; Benzler J, 2012, BIOCHEM J, V447, P175, DOI 10.1042/BJ20120834; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; Boucsein A, 2016, ENDOCRINOLOGY, V157, P799, DOI 10.1210/en.2015-1708; Capiotti KM, 2014, COMP BIOCHEM PHYS B, V171, P58, DOI 10.1016/j.cbpb.2014.03.005; Chisada S, 2014, GEN COMP ENDOCR, V195, P9, DOI 10.1016/j.ygcen.2013.10.008; de Pedro N, 2006, J ENDOCRINOL, V188, P513, DOI 10.1677/joe.1.06349; Denver RJ, 2011, NEUROENDOCRINOLOGY, V94, P21, DOI 10.1159/000328435; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Facchinello N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09867-x; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; GENUTH SM, 1971, ENDOCRINOLOGY, V88, P1230, DOI 10.1210/endo-88-5-1230; Gleeson M, 2007, ACTA DIABETOL, V44, P157, DOI 10.1007/s00592-007-0257-3; Gorissen M, 2009, J ENDOCRINOL, V201, P329, DOI 10.1677/JOE-09-0034; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Hedbacker K, 2010, CELL METAB, V11, P11, DOI 10.1016/j.cmet.2009.11.007; Helfer G, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12368; Hubschle T, 2001, J NEUROSCI, V21, P2413, DOI 10.1523/JNEUROSCI.21-07-02413.2001; Jansson JO, 2018, P NATL ACAD SCI USA, V115, P427, DOI 10.1073/pnas.1715687114; Kang JS, 2016, NATURE, V532, P201, DOI 10.1038/nature17644; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Koch C, 2010, J NEUROSCI, V30, P16180, DOI 10.1523/JNEUROSCI.3202-10.2010; Krutzfeldt J, 2010, DIABETOLOGIA, V53, P123, DOI 10.1007/s00125-009-1578-2; Leibold S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120776; Liu Q, 2010, GEN COMP ENDOCR, V166, P346, DOI 10.1016/j.ygcen.2009.11.015; Lohr H, 2018, CELL REP, V23, P1728, DOI 10.1016/j.celrep.2018.04.018; Londraville RL, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00058; Michel M, 2016, P NATL ACAD SCI USA, V113, P3084, DOI 10.1073/pnas.1513212113; Moro E, 2012, DEV BIOL, V366, P327, DOI 10.1016/j.ydbio.2012.03.023; Muzzin P, 1996, P NATL ACAD SCI USA, V93, P14804, DOI 10.1073/pnas.93.25.14804; Nikoulina SE, 2002, DIABETES, V51, P2190, DOI 10.2337/diabetes.51.7.2190; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Ohlsson C, 2018, ENDOCRINOLOGY, V159, P2676, DOI 10.1210/en.2018-00307; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Prokop JW, 2012, PEPTIDES, V38, P326, DOI 10.1016/j.peptides.2012.10.002; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Trosset JY, 2006, PROTEINS, V64, P60, DOI 10.1002/prot.20955; Varshney GK, 2016, NAT PROTOC, V11, P2357, DOI 10.1038/nprot.2016.141; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; Yu X, 2008, P NATL ACAD SCI USA, V105, P14070, DOI 10.1073/pnas.0806993105	50	1	1	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22207	10.1096/fj.202101764R	http://dx.doi.org/10.1096/fj.202101764R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35188286				2022-12-28	WOS:000761250800048
J	Sofer, S; Lamkiewicz, K; Eilat, SA; Partouche, S; Marz, M; Moskovits, N; Stemmer, SM; Shlomai, A; Sklan, EH				Sofer, Summer; Lamkiewicz, Kevin; Eilat, Shir Armoza; Partouche, Shirly; Marz, Manja; Moskovits, Neta; Stemmer, Salomon M.; Shlomai, Amir; Sklan, Ella H.			A genome-wide CRISPR activation screen reveals Hexokinase 1 as a critical factor in promoting resistance to multi-kinase inhibitors in hepatocellular carcinoma cells	FASEB JOURNAL			English	Article						CRISPR activation; hepatocellular carcinoma; tyrosine-kinase inhibitors	TRANSCRIPTIONAL ACTIVATION; VIRAL-HEPATITIS; SORAFENIB; METABOLISM; GENE	Hepatocellular carcinoma (HCC) is often diagnosed at an advanced stage and is, therefore, treated with systemic drugs, such as tyrosine-kinase inhibitors (TKIs). These drugs, however, offer only modest survival benefits due to the rapid development of drug resistance. To identify genes implicated in TKI resistance, a cluster of regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 activation screen was performed in hepatoma cells treated with regorafenib, a TKI used as second-line therapy for advanced HCC. The screen results show that Hexokinase 1 (HK1), catalyzing the first step in glucose metabolism, is a top candidate for conferring TKI resistance. Compatible with this, HK1 was upregulated in regorafenib-resistant cells. Using several experimental approaches, both in vitro and in vivo, we show that TKI resistance correlates with HK1 expression. Furthermore, an HK inhibitor resensitized resistant cells to TKI treatment. Together, our data indicate that HK1 may function as a critical factor modulating TKI resistance in hepatoma cells and, therefore, may serve as a biomarker for treatment success.	[Sofer, Summer; Eilat, Shir Armoza; Sklan, Ella H.] Tel Aviv Univ, Sadder Sch Med, Dept Clin Microbiol & Immunol, IL-6997801 Tel Aviv, Israel; [Lamkiewicz, Kevin; Marz, Manja] Friedrich Schiller Univ, RNA Bioinformat & High Throughput Anal, Jena, Germany; [Lamkiewicz, Kevin; Marz, Manja] European Virus Bioinformat Ctr, Jena, Germany; [Partouche, Shirly; Shlomai, Amir] Beilinson Med Ctr, Felsenstein Med Res Ctr, Rabin Med Ctr, Petah Tiqwa, Israel; [Marz, Manja] Leibniz Inst Age Res Fritz Lipmann Inst, Jena, Germany; [Moskovits, Neta; Stemmer, Salomon M.] Tel Aviv Univ, PDX Lab, Felsenstein Med Res Ctr, Tel Aviv, Israel; [Moskovits, Neta; Stemmer, Salomon M.; Shlomai, Amir] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Stemmer, Salomon M.] Davidoff Ctr, Rabin Med Ctr, Inst Oncol, Petah Tiqwa, Israel; [Shlomai, Amir] Beilinson Med Ctr, Rabin Med Ctr, Dept Med, Petah Tiqwa, Israel	Tel Aviv University; Friedrich Schiller University of Jena; Rabin Medical Center; Tel Aviv University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Rabin Medical Center	Sklan, EH (corresponding author), Tel Aviv Univ, Sadder Sch Med, Dept Clin Microbiol & Immunol, IL-6997801 Tel Aviv, Israel.	sklan@taucx.tau.ac.il		Sofer, Summer/0000-0001-6741-2526				[Anonymous], 2013, STIV EPAR PROD INF A; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Caruso S, 2019, GASTROENTEROLOGY, V157, P760, DOI 10.1053/j.gastro.2019.05.001; DeWaal D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02733-4; DOI I, 1975, GANN, V66, P385; Dukhovny A, 2019, J VIROL, V93, DOI 10.1128/JVI.00211-19; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Escudier B, 2019, EXPERT REV ANTICANC, V19, P177, DOI 10.1080/14737140.2019.1559058; Feng J, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-1528-x; FLORIDI A, 1981, CANCER RES, V41, P4661; FUJISE K, 1990, HEPATO-GASTROENTEROL, V37, P457; Gao RZ, 2021, ONCOGENESIS, V10, DOI 10.1038/s41389-021-00338-7; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irwin DM, 2008, COMP BIOCHEM PHYS D, V3, P96, DOI 10.1016/j.cbd.2007.11.002; Jackson KD, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082367; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Kelley RK, 2017, ANN ONCOL, V28, P528, DOI 10.1093/annonc/mdw651; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kudo M, 2018, LANCET, V391, P1163, DOI 10.1016/S0140-6736(18)30207-1; Laizure SC, 2013, PHARMACOTHERAPY, V33, P210, DOI 10.1002/phar.1194; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liu JP, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.165; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Nwosu ZC, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0872-6; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Pusec CM, 2019, ENDOCRINOLOGY, V160, P313, DOI 10.1210/en.2018-00887; Schindler A, 2013, CELL SIGNAL, V25, P2685, DOI 10.1016/j.cellsig.2013.08.035; Shlomai A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207132; Shlomai A, 2014, SEMIN CANCER BIOL, V26, P78, DOI 10.1016/j.semcancer.2014.01.004; Tesori V, 2015, SCI REP-UK, V5, DOI 10.1038/srep09149; Tong M, 2018, J HEPATOL, V69, P826, DOI 10.1016/j.jhep.2018.05.034; Tovoli F, 2020, CURR PHARM DESIGN, V26, P3909, DOI 10.2174/1381612826666200429093648; Wang SJ, 2016, AM J CANCER RES, V6, P1108; Wilhelm SM., REGORAFENIB BAY 73 4; Xu SL, 2019, CANCER RES, V79, P5907, DOI 10.1158/0008-5472.CAN-19-1789; Xu SL, 2018, CANCER METAB, V6, DOI 10.1186/s40170-018-0181-8; Xu SL, 2019, J NUCL MED, V60, P212, DOI 10.2967/jnumed.118.212365; Yoo JJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061292; Zhu YJ, 2017, ACTA PHARMACOL SIN, V38, P614, DOI 10.1038/aps.2017.5	43	1	1	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22191	10.1096/fj.202101507RR	http://dx.doi.org/10.1096/fj.202101507RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35147243				2022-12-28	WOS:000761250800006
J	Xu, C; Liu, SJ; Yang, F; Zhang, KY; Li, Y; Zhao, XL; Zhang, JY; Lu, T; Lu, SQ; Jiang, Y; Qin, WJ; Shi, CH; Zhang, R; Yang, AG; Zhao, AZ; Han, DH; Wen, WH				Xu, Chao; Liu, Shaojie; Yang, Fa; Zhang, Keying; Li, Yu; Zhao, Xiaolong; Zhang, Jiayu; Lu, Tong; Lu, Shiqi; Jiang, Yao; Qin, Weijun; Shi, Changhong; Zhang, Rui; Yang, An-Gang; Zhao, Aizhi; Han, Donghui; Wen, Weihong			Antibody-drug conjugates targeting CD248(+) myofibroblasts effectively alleviate renal fibrosis in mice	FASEB JOURNAL			English	Article						antibody-drug conjugate (ADC); CD248; myofibroblasts; renal fibrosis; specific killing	INTERSTITIAL MYOFIBROBLASTS; ENDOSIALIN; CELL; FIBROBLASTS; MECHANISMS; MARKER; APOPTOSIS; DELIVERY; PROTEINS; PROTECTS	Myofibroblasts, or activated fibroblasts, play a critical role in the process of renal fibrosis. Targeting myofibroblasts to inhibit their activation or induce specific cell death has been considered to be an effective strategy to attenuate renal fibrosis. However, specific biomarkers for myofibroblasts are needed to ensure the efficacy of these strategies. Here, we verified that CD248 was mainly expressed in myofibroblasts in patients with chronic kidney disease, which was inversely correlated with renal function. The same result was also confirmed in renal fibrotic mice induced by unilateral ureteral obstruction and aristolochic acid nephropathy. By using an antibody-drug conjugate (ADC) named IgG78-DM1, in which maytansinoid (DM1) was linked to a fully human antibody IgG78 through an uncleavable SMCC linker, we demonstrated that it could effectively bind with and kill CD248(+) fibroblasts in vitro and alleviate renal fibrosis in mice models. Besides, we confirmed that IgG78-DM1 had qualified biosafety in vivo. Our results confirmed that CD248 can be used as a specific marker for myofibroblasts, and specific killing of CD248(+) myofibroblasts by IgG78-DM1 has excellent anti-fibrotic effect in renal fibrotic mice. Our study expanded the application of ADC and provided a novel strategy for the treatment of renal fibrosis.	[Xu, Chao; Liu, Shaojie; Yang, Fa; Zhang, Keying; Li, Yu; Zhao, Xiaolong; Zhang, Jiayu; Lu, Tong; Jiang, Yao; Qin, Weijun; Han, Donghui] Air Force Mil Med Univ, Xijing Hosp, Dept Urol, 127 Changle West Rd, Xian 710032, Shaanxi, Peoples R China; [Lu, Shiqi; Wen, Weihong] Northwestern Polytech Univ, Inst Med Res, 127 West Youyi Rd, Xian 710072, Shaanxi, Peoples R China; [Shi, Changhong] Air Force Mil Med Univ, Lab Anim Ctr, Xian, Peoples R China; [Zhang, Rui; Yang, An-Gang] Air Force Mil Med Univ, Dept Immunol, State Key Lab Canc Biol, Xian, Peoples R China; [Zhao, Aizhi] OriMAbs Ltd, Newark, DE USA	Air Force Military Medical University; Northwestern Polytechnical University; Air Force Military Medical University	Han, DH (corresponding author), Air Force Mil Med Univ, Xijing Hosp, Dept Urol, 127 Changle West Rd, Xian 710032, Shaanxi, Peoples R China.; Wen, WH (corresponding author), Northwestern Polytech Univ, Inst Med Res, 127 West Youyi Rd, Xian 710072, Shaanxi, Peoples R China.	906812205@qq.com; weihongwen@nwpu.edu.cn	温, 家琦/GYV-3177-2022	Xu, Chao/0000-0001-8462-8337	National Natural Science Foundation of China [81772734]; Innovation Capability Support Program of Shaanxi [2020PT-021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Capability Support Program of Shaanxi	This work was partly supported by grants from the National Natural Science Foundation of China (No. 81772734), and the Innovation Capability Support Program of Shaanxi (Program No. 2020PT-021)	Aghajanian H, 2019, NATURE, V573, P430, DOI 10.1038/s41586-019-1546-z; Ashley SL, 2016, AM J RESP CELL MOL, V54, P482, DOI 10.1165/rcmb.2015-0148OC; Bagley RG, 2008, MICROVASC RES, V76, P180, DOI 10.1016/j.mvr.2008.07.008; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Castello-Cros Remedios, 2009, V522, P275, DOI 10.1007/978-1-59745-413-1_19; Chau CH, 2019, LANCET, V394, P793, DOI 10.1016/S0140-6736(19)31774-X; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Christian S, 2001, J BIOL CHEM, V276, P7408, DOI 10.1074/jbc.M009604200; Darby IA, 2016, CELL MOL LIFE SCI, V73, P1145, DOI 10.1007/s00018-015-2110-0; Hinz B, 2020, NAT REV RHEUMATOL, V16, P11, DOI 10.1038/s41584-019-0324-5; Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227; Kuppe C, 2021, NATURE, V589, P281, DOI 10.1038/s41586-020-2941-1; Lax S, 2007, FEBS LETT, V581, P3550, DOI 10.1016/j.febslet.2007.06.063; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Levey AS, 2015, JAMA-J AM MED ASSOC, V313, P837, DOI 10.1001/jama.2015.0602; Li QH, 2019, J CELL MOL MED, V23, P1951, DOI 10.1111/jcmm.14097; Li R, 2020, J CONTROL RELEASE, V320, P32, DOI 10.1016/j.jconrel.2020.01.017; Li R, 2020, APOPTOSIS, V25, P105, DOI 10.1007/s10495-019-01583-3; Luo JW, 2019, ACS NANO, V13, P3910, DOI 10.1021/acsnano.8b06924; Luyckx VA, 2021, NAT REV NEPHROL, V17, P15, DOI 10.1038/s41581-020-00363-6; MacFadyen JR, 2005, FEBS LETT, V579, P2569, DOI 10.1016/j.febslet.2005.03.071; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Modi S, 2020, NEW ENGL J MED, V382, P610, DOI 10.1056/NEJMoa1914510; Morton RL, 2021, NAT REV NEPHROL, V17, P5, DOI 10.1038/s41581-020-00376-1; Munoz-Felix JM, 2015, PHARMACOL THERAPEUT, V156, P44, DOI 10.1016/j.pharmthera.2015.10.003; O'Shannessy Daniel J., 2016, Sarcoma, V2016, P5213628, DOI 10.1155/2016/5213628; Pai CH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73194-x; Poosti F, 2016, ONCOTARGET, V7, P54240, DOI 10.18632/oncotarget.11095; Poosti F, 2015, FASEB J, V29, P1029, DOI 10.1096/fj.14-258459; Rouleau C, 2008, CLIN CANCER RES, V14, P7223, DOI 10.1158/1078-0432.CCR-08-0499; Safiri S, 2019, ANN RHEUM DIS, V78, P1463, DOI 10.1136/annrheumdis-2019-215920; Shitara K, 2020, NEW ENGL J MED, V382, P2419, DOI 10.1056/NEJMoa2004413; Smith SW, 2011, KIDNEY INT, V80, P200, DOI 10.1038/ki.2011.103; Smith SW, 2015, NEPHRON, V131, P265, DOI 10.1159/000438754; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Teicher Beverly A, 2019, Oncotarget, V10, P993, DOI 10.18632/oncotarget.26590; Thomas A, 2016, LANCET ONCOL, V17, pE254, DOI 10.1016/S1470-2045(16)30030-4; von Minckwitz G, 2019, NEW ENGL J MED, V380, P617, DOI 10.1056/NEJMoa1814017; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yang F, 2020, CANCER RES, V80, P3892, DOI 10.1158/0008-5472.CAN-19-2691; Zhao H, 2020, FASEB J, V34, P12599, DOI 10.1096/fj.202000949R; Zhou J, 2021, MOL PHARMACEUT, V18, P1373, DOI 10.1021/acs.molpharmaceut.0c01182	43	1	1	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22102	10.1096/fj.202101441R	http://dx.doi.org/10.1096/fj.202101441R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34972243				2022-12-28	WOS:000747987800004
J	Yamauchi, I; Sakane, Y; Yamashita, T; Hakata, T; Sugawa, T; Fujita, H; Okamoto, K; Taura, D; Hirota, K; Ueda, Y; Fujii, T; Yasoda, A; Inagaki, N				Yamauchi, Ichiro; Sakane, Yoriko; Yamashita, Takafumi; Hakata, Takuro; Sugawa, Taku; Fujita, Haruka; Okamoto, Kentaro; Taura, Daisuke; Hirota, Keisho; Ueda, Yohei; Fujii, Toshihito; Yasoda, Akihiro; Inagaki, Nobuya			Thyroid hormone economy in mice overexpressing iodothyronine deiodinases	FASEB JOURNAL			English	Article						hydrodynamic gene delivery; hypothyroidism; iodothyronine deiodinase; thyroid hormone action; thyroid hormone economy	IN-VITRO EXPRESSION; CONSUMPTIVE HYPOTHYROIDISM; TARGETED DISRUPTION; TYPE-3 DEIODINASE; THYROXINE; RESISTANCE; SELENOCYSTEINE; INACTIVATION; ASSOCIATION; CONVERSION	In peripheral tissues, triiodothyronine (T3) production and consequent thyroid hormone actions are mainly regulated by iodothyronine deiodinases (DIOs) classified into 3 types: D1, D2, and D3. We aimed to investigate the effects of peripheral DIOs on thyroid hormone economy independent of the hypothalamus-pituitary-thyroid axis. We cloned coding sequences of human DIOs with FLAG-tag and HiBiT-tag sequences into a pcDNA3.1 vector. To obtain full-length proteins, we modified these vectors by cloning the selenocysteine insertion sequence of each DIO (SECIS vectors). Western blot analyses and HiBiT lytic assay using HEK293T cells revealed that SECIS vectors expressed full-length proteins with substantial activity. Subsequently, in vivo transfections of pLIVE-based SECIS vectors into male C57BL/6J mice were performed by hydrodynamic gene delivery to generate mice overexpressing DIOs predominantly in the liver (D1, D2, and D3 mice). After 7 days from transfections, mice were analyzed to clarify phenotypes. To summarize, serum thyroid hormone levels did not change in D1 mice but D2 mice had higher serum free T3 levels. D3 mice developed hypothyroidism with higher serum reverse T3 (rT3) levels. Transfections with levothyroxine administration suggested that thyroid hormone action was upregulated in D2 mice. Our DIO-overexpressing mice provided insights on the physiological properties of upregulated DIOs: D2 augments local thyroid hormone action and recruits T3 into the circulation: D3 decreases circulating T3 and T4 levels with elevated rT3, leading to consumptive hypothyroidism. As D3 mice are expected to be a novel hypothyroidism model, they can contribute to progress in the field of thyroid hormone economy and action.	[Yamauchi, Ichiro; Sakane, Yoriko; Yamashita, Takafumi; Hakata, Takuro; Sugawa, Taku; Fujita, Haruka; Okamoto, Kentaro; Taura, Daisuke; Ueda, Yohei; Fujii, Toshihito; Inagaki, Nobuya] Kyoto Univ, Dept Diabet Endocrinol & Nutr, Grad Sch Med, Kyoto, Japan; [Sakane, Yoriko] Sugawa Clin, Kyoto, Japan; [Yamashita, Takafumi] Kishiwada City Hosp, Metab & Endocrinol Div Internal Med, Osaka, Japan; [Hirota, Keisho] Kyoto Univ, Dept Pathol & Biol Dis, Grad Sch Med, Kyoto, Japan; [Yasoda, Akihiro] Natl Hosp Org, Clin Res Inst, Kyoto Med Ctr, Kyoto, Japan	Kyoto University; Kyoto University	Yamauchi, I (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Sakyo Ku, 54 Kawaharacho, Kyoto 6068507, Japan.	ichiroy@kuhp.kyoto-u.ac.jp		Yamauchi, Ichiro/0000-0002-4236-502X	MEXT | Japan Society for the Promotion of Science (JSPS) [19K18006]; Japan Foundation for Applied Enzymology	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Foundation for Applied Enzymology	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 19K18006; Japan Foundation for Applied Enzymology	Abdulrahman RM, 2010, J CLIN ENDOCR METAB, V95, P3758, DOI 10.1210/jc.2009-2507; BERRY MJ, 1992, ENDOCRINOLOGY, V131, P1848, DOI 10.1210/en.131.4.1848; BERRY MJ, 1991, NATURE, V349, P438, DOI 10.1038/349438a0; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bianco AC, 2014, THYROID, V24, P88, DOI 10.1089/thy.2013.0109; Castagna MG, 2017, J CLIN ENDOCR METAB, V102, P1623, DOI 10.1210/jc.2016-2587; Christoffolete MA, 2006, ENDOCRINOLOGY, V147, P1735, DOI 10.1210/en.2005-1300; CLARK OH, 1976, ENDOCRINOLOGY, V99, P988, DOI 10.1210/endo-99-4-988; Endo T, 2013, AM J PHYSIOL-ENDOC M, V305, pE660, DOI 10.1152/ajpendo.00067.2013; Endo T, 2012, AM J PHYSIOL-ENDOC M, V302, pE1569, DOI 10.1152/ajpendo.00572.2011; Franca MM, 2021, THYROID, V31, P202, DOI 10.1089/thy.2020.0253; Galton VA, 2014, ENDOCRINOLOGY, V155, P4081, DOI 10.1210/en.2014-1184; Galton VA, 2009, ENDOCRINOLOGY, V150, P2957, DOI 10.1210/en.2008-1572; GOLDBERG RC, 1950, ENDOCRINOLOGY, V46, P72, DOI 10.1210/endo-46-1-72; Hernandez A, 2006, J CLIN INVEST, V116, P476, DOI 10.1172/JCI26240; Howard D, 2011, J CLIN ENDOCR METAB, V96, P1966, DOI 10.1210/jc.2010-2104; Huang SA, 2000, NEW ENGL J MED, V343, P185, DOI 10.1056/NEJM200007203430305; Huang SA, 2002, J CLIN ENDOCR METAB, V87, P4457, DOI 10.1210/jc.2002-020627; ISHII H, 1981, J CLIN ENDOCR METAB, V52, P1211, DOI 10.1210/jcem-52-6-1211; Jaeschke H, 2018, THYROID, V28, P1372, DOI 10.1089/thy.2018.0041; Kappers MHW, 2011, J CLIN ENDOCR METAB, V96, P3087, DOI 10.1210/jc.2011-1172; Kim BW, 2003, J CLIN ENDOCR METAB, V88, P594, DOI 10.1210/jc.2002-020921; Kwon MM, 2015, CELL REP, V13, P1521, DOI 10.1016/j.celrep.2015.10.021; Latreche L, 2009, NUCLEIC ACIDS RES, V37, P5868, DOI 10.1093/nar/gkp635; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Maia AL, 2005, J CLIN INVEST, V115, P2524, DOI 10.1172/JCI25083; MAIA AL, 1995, ENDOCRINOLOGY, V136, P4842, DOI 10.1210/en.136.11.4842; MANDEL SJ, 1992, J CLIN ENDOCR METAB, V75, P1133, DOI 10.1210/jc.75.4.1133; Markossian S, 2018, THYROID, V28, P139, DOI 10.1089/thy.2017.0389; Maynard MA, 2014, NEW ENGL J MED, V370, P1327, DOI 10.1056/NEJMoa1308893; Mentuccia D, 2002, DIABETES, V51, P880, DOI 10.2337/diabetes.51.3.880; Miyamura N, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms16017; Ohba K, 2016, ENDOCRINOLOGY, V157, P1660, DOI 10.1210/en.2015-1848; Peeters RP, 2003, J CLIN ENDOCR METAB, V88, P3202, DOI 10.1210/jc.2002-022013; Razavi SA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49247-1; Ruppe MD, 2005, THYROID, V15, P1369, DOI 10.1089/thy.2005.15.1369; SALVATORE D, 1995, J CLIN INVEST, V96, P2421, DOI 10.1172/JCI118299; Salvatore D, 1996, ENDOCRINOLOGY, V137, P3308, DOI 10.1210/en.137.8.3308; Salvatore D, 1996, J CLIN INVEST, V98, P962, DOI 10.1172/JCI118880; Schneider MJ, 2001, MOL ENDOCRINOL, V15, P2137, DOI 10.1210/me.15.12.2137; Schneider MJ, 2006, ENDOCRINOLOGY, V147, P580, DOI 10.1210/en.2005-0739; VISSER TJ, 1982, P NATL ACAD SCI-BIOL, V79, P5080, DOI 10.1073/pnas.79.16.5080; Yamashita T, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa008; Yamauchi I, 2022, CLIN ENDOCRINOL, V96, P236, DOI 10.1111/cen.14591; Yamauchi I, 2018, ENDOCRINE, V59, P353, DOI 10.1007/s12020-017-1495-y	45	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22141	10.1096/fj.202101288RR	http://dx.doi.org/10.1096/fj.202101288RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34981562				2022-12-28	WOS:000747987800012
J	Chellappa, SL; Engen, PA; Naqib, A; Qian, JY; Vujovic, N; Rahman, N; Green, SJ; Garaulet, M; Keshavarzian, A; Scheer, FAJL				Chellappa, Sarah L.; Engen, Phillip A.; Naqib, Ankur; Qian, Jingyi; Vujovic, Nina; Rahman, Nishath; Green, Stefan J.; Garaulet, Marta; Keshavarzian, Ali; Scheer, Frank A. J. L.			Proof-of-principle demonstration of endogenous circadian system and circadian misalignment effects on human oral microbiota	FASEB JOURNAL			English	Article						circadian misalignment; circadian rhythms; functional pathways; microbiota; shift work	NIGHT-SHIFT WORK; IMPACT; RISK; CELL; OSCILLATIONS; METABOLISM; DIVERSITY; BACTERIAL; DISEASE; HEALTH	Circadian misalignment-the misalignment between the central circadian "clock" and behavioral and environmental cycles (including sleep/wake, fasting/eating, dark/light)-results in adverse cardiovascular and metabolic effects. Potential underlying mechanisms for these adverse effects include alterations in the orogastrointestinal microbiota. However, it remains unknown whether human oral microbiota has endogenous circadian rhythms (i.e., independent of sleep/wake, fasting/eating, and dark/light cycles) and whether circadian misalignment influences oral microbiota community composition. Healthy young individuals [27.3 +/- 2.3 years (18-35 years), 4 men and 2 women, body-mass index range: 18-28 kg/m(2)] were enrolled in a stringently controlled 14-day circadian laboratory protocol. This included a 32-h constant routine (CR) protocol (endogenous circadian baseline assessment), a forced desynchrony protocol with four 28-h "days" under similar to 3 lx to induce circadian misalignment, and a post-misalignment 40-h CR protocol. Microbiota assessments were performed on saliva samples collected every 4 h throughout both CR protocols. Total DNA was extracted and processed using high-throughput 16S ribosomal RNA gene amplicon sequencing. The relative abundance of specific oral microbiota populations, i.e., one of the five dominant phyla, and three of the fourteen dominant genera, exhibited significant endogenous circadian rhythms. Importantly, circadian misalignment dramatically altered the oral microbiota landscape, such that four of the five dominant phyla and eight of the fourteen dominant genera exhibited significant circadian misalignment effects. Moreover, circadian misalignment significantly affected the metagenome functional content of oral microbiota (inferred gene content analysis), as indicated by changes in specific functional pathways associated with metabolic control and immunity. Collectively, our proof-of-concept study provides evidence for endogenous circadian rhythms in human oral microbiota and show that even relatively short-term experimental circadian misalignment can dramatically affect microbiota community composition and functional pathways involved in metabolism and immune function. These proof-of-principle findings have translational relevance to individuals typically exposed to circadian misalignment, including night shift workers and frequent flyers.	[Chellappa, Sarah L.; Qian, Jingyi; Vujovic, Nina; Rahman, Nishath; Scheer, Frank A. J. L.] Brigham & Womens Hosp, Dept Med, Div Sleep & Circadian Disorders, Med Chronobiol Program, 75 Francis St, Boston, MA 02115 USA; [Chellappa, Sarah L.; Qian, Jingyi; Vujovic, Nina; Rahman, Nishath; Scheer, Frank A. J. L.] Brigham & Womens Hosp, Dept Neurol, Div Sleep & Circadian Disorders, Med Chronobiol Program, 75 Francis St, Boston, MA 02115 USA; [Chellappa, Sarah L.; Qian, Jingyi; Vujovic, Nina; Scheer, Frank A. J. L.] Harvard Med Sch, Div Sleep Med, Boston, MA 02115 USA; [Chellappa, Sarah L.] Univ Cologne, Fac Med, Dept Nucl Med, Cologne, Germany; [Chellappa, Sarah L.] Univ Cologne, Univ Hosp Cologne, Cologne, Germany; [Engen, Phillip A.; Naqib, Ankur; Keshavarzian, Ali] Rush Univ, Rush Med Coll, Rush Ctr Integrated Microbiome & Chronobiol Res, Med Ctr, Chicago, IL 60612 USA; [Green, Stefan J.] Rush Univ, Genom & Microbiome Core Facil, Med Ctr, Chicago, IL 60612 USA; [Garaulet, Marta] Univ Murcia, Dept Physiol, Reg Campus Int Excellence, Murcia, Spain; [Garaulet, Marta] Univ Clin Hosp, Biomed Res Inst Murcia, IMIB Arrixaca UMU, Murcia, Spain; [Keshavarzian, Ali] Rush Univ, Dept Physiol, Med Ctr, Chicago, IL 60612 USA; [Keshavarzian, Ali] Rush Univ, Dept Med, Med Ctr, Chicago, IL 60612 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Cologne; University of Cologne; Rush University; Rush University; University of Murcia; Rush University; Rush University	Chellappa, SL; Scheer, FAJL (corresponding author), Brigham & Womens Hosp, Dept Med, Div Sleep & Circadian Disorders, Med Chronobiol Program, 75 Francis St, Boston, MA 02115 USA.; Chellappa, SL; Scheer, FAJL (corresponding author), Brigham & Womens Hosp, Dept Neurol, Div Sleep & Circadian Disorders, Med Chronobiol Program, 75 Francis St, Boston, MA 02115 USA.	sarah.chellappa@outlook.com; fscheer@bwh.harvard.edu	Scheer, Frank A.J.L./C-2795-2012	Scheer, Frank A.J.L./0000-0002-2014-7582; Naqib, Ankur/0000-0003-0832-5646; Garaulet, Marta/0000-0002-4066-3509; Green, Stefan/0000-0003-2781-359X; Chellappa, Sarah L./0000-0002-6190-464X	NIH [R01H1.118601, 1UL1TR001102, K 991-11, 148500, R0 1 DK 099512, R01DK102696, R01H1.140574, R01DK105072]; American Diabetes Association [111-17-PDF-103]; Spanish Government of Investigation,Development and Innovation [SAE2017-84135-R]; Seneca Foundation [20795/FI/18]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Spanish Government of Investigation,Development and Innovation; Seneca Foundation(Fundacion Seneca)	NIH, Grant/Award Number: RO1H1.118601, 1UL1TR001102, K 991-11,148500, RO 1 DK 099512, R01DK102696, RO1H1.140574 and RO1DK105072; American Diabetes Association, Grant/Award Number 111-17-PDF-103; The Spanish Government of Investigation,Development and Innovation, Grant/ Award Number: SAE2017-84135-R; Seneca Foundation, Grant/Award Number: 20795/FI/18	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Abranches J, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.GPP3-0042-2018; [Anonymous], [No title captured], DOI [DOI 10.1126/SCIENCE.284.5423.2177, 10.1126/science.284.5423.2177]; Atarashi K, 2017, SCIENCE, V358, P359, DOI 10.1126/science.aan4526; Bishehsari F, 2021, TRANSL RES, V231, P113, DOI 10.1016/j.trsl.2020.11.007; Butler TD, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01783; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caricilli Andrea Moro, 2014, World J Gastrointest Pathophysiol, V5, P18, DOI 10.4291/wjgp.v5.i1.18; Collado MC, 2018, FASEB J, V32, P2060, DOI 10.1096/fj.201700697RR; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Curtis MA, 2011, CELL HOST MICROBE, V10, P302, DOI 10.1016/j.chom.2011.09.008; Deaver JA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00737; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; Duffy JF, 2011, P NATL ACAD SCI USA, V108, P15602, DOI 10.1073/pnas.1010666108; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Flores R, 2012, EUR J CLIN INVEST, V42, P848, DOI 10.1111/j.1365-2362.2012.02660.x; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; GREENHOUSE JB, 1987, STAT MED, V6, P167, DOI 10.1002/sim.4780060209; Grimaldi D, 2016, HYPERTENSION, V68, P243, DOI 10.1161/HYPERTENSIONAHA.115.06847; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Jorge C., 2019, 6 EUR WORK COND SURV; Jurgenson CT, 2009, ANNU REV BIOCHEM, V78, P569, DOI 10.1146/annurev.biochem.78.072407.102340; Karpinski TM, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010020; Kreth J, 2009, DNA CELL BIOL, V28, P397, DOI 10.1089/dna.2009.0868; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Leone V, 2015, CELL HOST MICROBE, V17, P681, DOI 10.1016/j.chom.2015.03.006; Leproult R, 2014, DIABETES, V63, P1860, DOI 10.2337/db13-1546; Liang X, 2015, P NATL ACAD SCI USA, V112, P10479, DOI 10.1073/pnas.1501305112; Liu QY, 2018, INT J EPIDEMIOL, V47, P1956, DOI 10.1093/ije/dyy079; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; Morris CJ, 2016, P NATL ACAD SCI USA, V113, pE1402, DOI 10.1073/pnas.1516953113; Morris CJ, 2015, P NATL ACAD SCI USA, V112, pE2225, DOI 10.1073/pnas.1418955112; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Naqib A, 2018, METHODS MOL BIOL, V1783, P149, DOI 10.1007/978-1-4939-7834-2_7; NHIS. 2010 National Health Interview Survey, PUBL US DAT FIL DOC; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Qian JY, 2016, TRENDS ENDOCRIN MET, V27, P282, DOI 10.1016/j.tem.2016.03.005; Rizzatti G, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9351507; ROZA AM, 1984, AM J CLIN NUTR, V40, P168, DOI 10.1093/ajcn/40.1.168; Sarkar A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81420-3; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Shigi N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00067; Skapenko A, 2005, ARTHRITIS RES THER, V7, pS4, DOI 10.1186/ar1703; Skarke C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17362-6; Spalding MD, 2010, MICROBIOL MOL BIOL R, V74, P200, DOI 10.1128/MMBR.00008-10; Takayasu L, 2017, DNA RES, V24, P261, DOI 10.1093/dnares/dsx001; Terlecky Stanley R, 2012, World J Biol Chem, V3, P93, DOI 10.4331/wjbc.v3.i5.93; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Tonetti MS, 2013, J CLIN PERIODONTOL, V40, pS24, DOI 10.1111/jcpe.12089; Tsay, 1993, HIERARCHICAL MODEL S; Vetter C, 2018, DIABETES CARE, V41, P762, DOI 10.2337/dc17-1933; Vetter C, 2016, JAMA-J AM MED ASSOC, V315, P1726, DOI 10.1001/jama.2016.4454; Voigt RM, 2016, INT REV NEUROBIOL, V131, P193, DOI 10.1016/bs.irn.2016.07.002; Voigt RM, 2016, ALCOHOL CLIN EXP RES, V40, P335, DOI 10.1111/acer.12943; Voigt RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097500; Walters W, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00009-15; Waterhouse J, 2007, LANCET, V369, P1117, DOI 10.1016/S0140-6736(07)60529-7; Wefers J, 2018, P NATL ACAD SCI USA, V115, P7789, DOI 10.1073/pnas.1722295115; Wright KP, 2015, BRAIN BEHAV IMMUN, V47, P24, DOI 10.1016/j.bbi.2015.01.004; Wu G, 2016, BIOINFORMATICS, V32, P3351, DOI 10.1093/bioinformatics/btw405; Yang R, 2010, BIOINFORMATICS, V26, pi168, DOI 10.1093/bioinformatics/btq189; Zarrinpar A, 2014, CELL METAB, V20, P1006, DOI 10.1016/j.cmet.2014.11.008; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhao HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11779-9; Zhao JF, 2018, DIGEST LIVER DIS, V50, P1195, DOI 10.1016/j.dld.2018.04.016	70	4	4	7	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22043	10.1096/fj.202101153R	http://dx.doi.org/10.1096/fj.202101153R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34861073	Green Accepted			2022-12-28	WOS:000734992000027
J	Thomson, K; Game, J; Karouta, C; Morgan, IG; Ashby, R				Thomson, Kate; Game, Jeremy; Karouta, Cindy; Morgan, Ian G.; Ashby, Regan			Correlation between small-scale methylation changes and gene expression during the development of myopia	FASEB JOURNAL			English	Article						EGR1; FOS; methylation; myopia; NAB2; ocular development	MESSENGER-RNA EXPRESSION; DNA METHYLATION; TRANSCRIPTION FACTORS; CYTOSINE METHYLATION; MICROARRAY ANALYSIS; IMAGE DEFOCUS; CPG ISLAND; BINDING; PROTEIN; EGR-1	Visually induced changes in the expression of early growth response-1 (EGR1), FBJ osteosarcoma oncogene (FOS), and NGFI-A binding protein-2 (NAB2) appear to form a part of a retinal network fundamental to ocular growth regulation, and thus, the development of myopia (short-sightedness). However, it is unclear how environmental (visual) cues are translated into these molecular changes. One possibility is through epigenetic modifications such as DNA methylation, a known regulator of such processes. By sequencing bisulfite-converted DNA amplicons, this study examined whether changes in DNA methylation occur within specific regulatory and promoter regions of EGR1, FOS, and NAB2 during the periods of increased and decreased ocular growth in chicks. Visually induced changes in ocular growth rates were associated with single-point, but not large-scale, shifts in methylation levels within the investigated regions. Analysis of methylation pattern variability (entropy) demonstrated that the observed methylation changes are occurring within small subpopulations of retinal cells. This concurs with previous observations that EGR1 and FOS are differentially regulated at the peptide level within specific retinal cell types. Together, the findings of this study support a potential role for DNA methylation in the translation of external visual cues into molecular changes critical for ocular growth regulation and myopia development.	[Thomson, Kate; Game, Jeremy; Karouta, Cindy; Ashby, Regan] Univ Canberra, Fac Sci & Technol, Ctr Res Therapeut Solut, Canberra, ACT, Australia; [Morgan, Ian G.; Ashby, Regan] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	University of Canberra; Australian National University	Thomson, K (corresponding author), Univ Canberra, Fac Sci & Technol, Univ Dr, Canberra, ACT, Australia.	kate.thomson@canberra.edu.au	Morgan, Ian G/D-1190-2009	Morgan, Ian G/0000-0002-4548-3574; Ashby, Regan/0000-0002-8027-6490; Thomson, Kate/0000-0002-2272-2800; Karouta, Cindy/0000-0003-1157-2840	ANU Connect Ventures through a Discovery Translation Fund [DTF311]	ANU Connect Ventures through a Discovery Translation Fund	This work was partially funded by ANU Connect Ventures through a Discovery Translation Fund (Project number DTF311) awarded to RA. http://www.anuconnectventures.com.au/inves tment/discovery-translation-fund2-0/. The hinders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript	Alhendi AMN, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-2114; Ashby R, 2007, EXP EYE RES, V85, P15, DOI 10.1016/j.exer.2007.02.019; Ashby R, 2010, MOL VIS, V16, P639; Ashby RS, 2014, INVEST OPHTH VIS SCI, V55, P5911, DOI 10.1167/iovs.13-11708; Ashby RS, 2010, EXP EYE RES, V90, P238, DOI 10.1016/j.exer.2009.10.011; Ashby RS, 2010, INVEST OPHTH VIS SCI, V51, P3726, DOI 10.1167/iovs.09-4615; Becker C, 2012, CURR OPIN PLANT BIOL, V15, P562, DOI 10.1016/j.pbi.2012.08.004; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bitzer M, 2002, INVEST OPHTH VIS SCI, V43, P246; Brand C, 2005, MOL VIS, V11, P309; Brand C, 2007, MOL VIS, V13, P920; CAO XM, 1990, MOL CELL BIOL, V10, P1931, DOI 10.1128/MCB.10.5.1931; CAO XM, 1993, J BIOL CHEM, V268, P16949; Carvin CD, 2003, NUCLEIC ACIDS RES, V31, P6493, DOI 10.1093/nar/gkg853; Carvin CD, 2003, P NATL ACAD SCI USA, V100, P7743, DOI 10.1073/pnas.1332672100; Ceccarelli V, 2011, J BIOL CHEM, V286, P27092, DOI 10.1074/jbc.M111.253609; Chen SJ, 1998, GENE, V215, P101, DOI 10.1016/S0378-1119(98)00268-6; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Ding X, 2020, OPHTHAL PHYSL OPT, V40, P491, DOI 10.1111/opo.12696; Dong SM, 2005, MODERN PATHOL, V18, P170, DOI 10.1038/modpathol.3800261; Duclot F, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00035; Fischer AJ, 1999, NAT NEUROSCI, V2, P706, DOI 10.1038/11167; Gray S., 2015, EPIGENETIC CANC THER; Hashimoto H, 2014, GENE DEV, V28, P2304, DOI 10.1101/gad.250746.114; Havis E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051664; He JL, 2013, BIOINFORMATICS, V29, P2044, DOI 10.1093/bioinformatics/btt332; He L, 2018, EXP EYE RES, V168, P77, DOI 10.1016/j.exer.2018.01.005; He Y, 2010, NAT NEUROSCI, V13, P1472, DOI 10.1038/nn.2686; HERMANN R, 1991, FEBS LETT, V281, P191, DOI 10.1016/0014-5793(91)80391-F; Holden BA, 2016, OPHTHALMOLOGY, V123, P1036, DOI 10.1016/j.ophtha.2016.01.006; Illum LRH, 2018, J MOL ENDOCRINOL, V60, pR39, DOI 10.1530/JME-17-0189; Jackstadt R, 2013, J EXP MED, V210, P1331, DOI 10.1084/jem.20120812; Jennings LJ, 2017, J MOL DIAGN, V19, P341, DOI 10.1016/j.jmoldx.2017.01.011; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; Karouta C, 2021, FASEB J, V35, DOI 10.1096/fj.202100350RR; Karouta C, 2015, INVEST OPHTH VIS SCI, V56, P299, DOI 10.1167/iovs.14-15499; Khan Reas S, 2010, Int J Pept, V2010, DOI 10.1155/2010/537639; Kint S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199091; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kucharski R, 2020, EPIGENOMES, V4, DOI 10.3390/epigenomes4020010; Kuwahara K, 2003, EMBO J, V22, P6310, DOI 10.1093/emboj/cdg601; KUWAYAMA Y, 1982, INVEST OPHTH VIS SCI, V22, P681; Lee C, 2014, BIOINFORMATICS, V30, P1923, DOI 10.1093/bioinformatics/btu115; Lee I, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.148; Li QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019428; Liu Shuang-Zhen, 2007, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V32, P132; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Luo CY, 2018, SCIENCE, V361, P1336, DOI 10.1126/science.aat6806; Mamrut S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056869; McNamara AR, 2002, NUCLEIC ACIDS RES, V30, P3818, DOI 10.1093/nar/gkf501; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Mesquita P, 2003, CANCER LETT, V189, P129, DOI 10.1016/S0304-3835(02)00549-9; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Morgan IG, 2018, PROG RETIN EYE RES, V62, P134, DOI 10.1016/j.preteyeres.2017.09.004; Mulholland CB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19603-1; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nilsson Eric E, 2018, Environ Epigenet, V4, pdvy016, DOI 10.1093/eep/dvy016; Norton, 2003, J VISUAL-JAPAN, V3; Ohno-Matsui K, 2021, INVEST OPHTH VIS SCI, V62, DOI 10.1167/iovs.62.5.5; Orgeur M, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.161208; Pogribny IP, 2000, CANCER RES, V60, P588; Riddell N, 2018, BMC DEV BIOL, V18, DOI 10.1186/s12861-018-0177-1; Riddell N, 2017, MOL VIS, V23, P872; Saunderson EA, 2016, P NATL ACAD SCI USA, V113, P4830, DOI 10.1073/pnas.1524857113; Schippert R, 2007, INVEST OPHTH VIS SCI, V48, P11, DOI 10.1167/iovs.06-0851; Schippert R, 2009, MOL VIS, V15, P2720; Seow WJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214791; Shao XJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-978; Stone RA, 2011, INVEST OPHTH VIS SCI, V52, P5765, DOI 10.1167/iovs.10-6727; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Szyf M, 2015, TRENDS MOL MED, V21, P134, DOI 10.1016/j.molmed.2014.12.004; Tedja MS, 2019, INVEST OPHTH VIS SCI, V60, pM89, DOI 10.1167/iovs.18-25965; Thomson K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70271-z; Thomson K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54789-5; TORNQVIST K, 1981, EXP EYE RES, V33, P55, DOI 10.1016/S0014-4835(81)80081-4; Trerotola M, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0041-3; Troilo D, 2019, INVEST OPHTH VIS SCI, V60, pM31, DOI 10.1167/iovs.18-25967; Vishweswaraiah S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40299-x; Vohra M, 2020, LAB INVEST, V100, P1090, DOI 10.1038/s41374-020-0422-7; WALLMAN J, 1978, SCIENCE, V201, P1249, DOI 10.1126/science.694514; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; Wong DJ, 1999, MOL CELL BIOL, V19, P5642; Xie HH, 2011, NUCLEIC ACIDS RES, V39, P4099, DOI 10.1093/nar/gkr017; Yearim A, 2015, CELL REP, V10, P1122, DOI 10.1016/j.celrep.2015.01.038; Yu SY, 2016, J BIOL CHEM, V291, P11148, DOI 10.1074/jbc.M116.717801; Zandarashvili L, 2015, FEBS LETT, V589, P1748, DOI 10.1016/j.febslet.2015.05.022; Zhao Y, 2016, P NATL ACAD SCI USA, V113, P2146, DOI 10.1073/pnas.1522658112; Zhong XW, 2004, INVEST OPHTH VIS SCI, V45, P2065, DOI 10.1167/iovs.03-1046; Zhou XT, 2012, MOL VIS, V18, P1312	92	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22129	10.1096/fj.202101487R	http://dx.doi.org/10.1096/fj.202101487R			25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34958689	hybrid			2022-12-28	WOS:000734992000021
J	Wu, YH; Chen, WC; Tseng, CK; Chen, YH; Lin, CK; Lee, JC				Wu, Yu-Hsuan; Chen, Wei-Chun; Tseng, Chin-Kai; Chen, Yen-Hsu; Lin, Chun-Kuang; Lee, Jin-Ching			Heme oxygenase-1 inhibits DENV-induced endothelial hyperpermeability and serves as a potential target against dengue hemorrhagic fever	FASEB JOURNAL			English	Article						andrographolide; celastrol; dengue virus; heme oxygenase-1; vascular leakage; VE-cadherin	ADHERENS JUNCTIONS; CELASTROL; PATHOGENESIS; REPLICATION; MOLECULES; INFECTION; CELLS	Dengue virus (DENV) is a cause of vascular endothelial dysfunction and vascular leakage, which are characterized as hallmarks of dengue hemorrhagic fever or dengue shock syndrome, which become a severe global health emergency with substantial morbidity and mortality. Currently, there are still no promising therapeutics to alleviate the dengue-associated vascular hemorrhage in a clinical setting. In the present study, we first observed that heme oxygenase-1 (HO-1) expression level was highly suppressed in severe DENV-infected patients. In contrast, the overexpression of HO-1 could attenuate DENV-induced pathogenesis, including plasma leakage and thrombocytopenia, in an AG129 mouse model. Our data indicate that overexpression of HO-1 or its metabolite biliverdin can maintain endothelial integrity upon DENV infection in vitro and in vivo. We further characterized the positive regulatory effect of HO-1 on the endothelial adhesion factor vascular endothelial-cadherin to decrease DENV-induced endothelial hyperpermeability. Subsequently, we confirmed that two medicinal plant-derived compounds, andrographolide, and celastrol, widely used as a nutritional or medicinal supplement are useful to attenuate DENV-induced plasma leakage through induction of the HO-1 expression in DENV-infected AG129 mice. In conclusion, our findings reveal that induction of the HO-1 signal pathway is a promising option for the treatment of DENV-induced vascular pathologies.	[Wu, Yu-Hsuan; Chen, Wei-Chun; Lee, Jin-Ching] Kaohsiung Med Univ, Coll Life Sci, Dept Biotechnol, Kaohsiung, Taiwan; [Wu, Yu-Hsuan; Tseng, Chin-Kai] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ, Sch Med, Grad Inst Med, Sepsis Res Ctr,Ctr Dengue Fever Control & Res, Kaohsiung, Taiwan; [Chen, Yen-Hsu] Natl Chiao Tung Univ, Coll Biol Sci & Technol, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Lin, Chun-Kuang; Lee, Jin-Ching] Natl Sun Yat Sen Univ, Coll Marine Sci, Dept Marine Biotechnol & Resources, Doctoral Degree Program Marine Biotechnol, Kaohsiung, Taiwan; [Lee, Jin-Ching] Kaohsiung Med Univ, Grad Inst Med, Drug Dev & Value Creat Res Ctr, Coll Med, Kaohsiung, Taiwan; [Lee, Jin-Ching] Kaohsiung Med Univ, Grad Inst Nat Prod, Drug Dev & Value Creat Res Ctr, Coll Pharm, Kaohsiung, Taiwan; [Lee, Jin-Ching] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan	Kaohsiung Medical University; National Cheng Kung University; Kaohsiung Medical University; National Yang Ming Chiao Tung University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Lee, JC (corresponding author), Natl Sun Yat Sen Univ, Coll Marine Sci, Dept Marine Biotechnol & Resources, Doctoral Degree Program Marine Biotechnol, Kaohsiung, Taiwan.; Lee, JC (corresponding author), Natl Sun Yat Sen Univ, Coll Marine Sci, Dept Marine Biotechnol & Resources, 70 Lien Hai Rd, Kaohsiung 80424, Taiwan.	jclee@mail.nsysu.edu.tw		Chen, Yen-hsu/0000-0002-8667-4844	Ministry of Science and Technology, Taiwan (MOST) [MOST107-2311-B-037-005MY3, MOST110-2314-B-037-117MY2]; Kaohsiung Medical University (KMU) [KMU-DK109002]; NSYSU-KMU Joint Research Project [NSYSUKM11110-1004]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University (KMU); NSYSU-KMU Joint Research Project	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST107-2311-B-037-005MY3 and MOST110-2314-B-037-117MY2; Kaohsiung Medical University (KMU), Grant/Award Number: KMU-DK109002; NSYSU-KMU Joint Research Project, Grant/Award Number NSYSUKM11110-1004	Azizan A, 2006, J VIROL METHODS, V138, P211, DOI 10.1016/j.jviromet.2006.08.010; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787; Chanthick C, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020069; Chanthick C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31855; Chen WC, 2018, VIRULENCE, V9, P588, DOI 10.1080/21505594.2017.1421893; Chung SW, 2009, CELL MICROBIOL, V11, P199, DOI 10.1111/j.1462-5822.2008.01261.x; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; Fredenburgh LE, 2015, EUR HEART J, V36, P1512, DOI 10.1093/eurheartj/ehv114; Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015; Gupta S, 2017, ARCH VIROL, V162, P611, DOI 10.1007/s00705-016-3166-3; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Huang SA, 2012, BIOCHEM BIOPH RES CO, V423, P467, DOI 10.1016/j.bbrc.2012.05.143; Jansen T, 2010, J MOL CELL CARDIOL, V49, P186, DOI 10.1016/j.yjmcc.2010.04.011; Kelley JF, 2012, VIROLOGY, V422, P326, DOI 10.1016/j.virol.2011.10.030; Kloska D, 2019, ARCH BIOCHEM BIOPHYS, V678, DOI 10.1016/j.abb.2019.108182; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Muller DA, 2017, J INFECT DIS, V215, pS89, DOI 10.1093/infdis/jiw649; Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031; Ng SW, 2019, BIOMED PHARMACOTHER, V109, P1785, DOI 10.1016/j.biopha.2018.11.051; Olagnier D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004566; Pang XJ, 2017, VIROL SIN, V32, P16, DOI 10.1007/s12250-016-3855-9; Paracha UZ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-251; Peng YL, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0926-9; Pereira MLM, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/4158698; Sarathy VV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22618-w; Seet RCS, 2009, FREE RADICAL BIO MED, V47, P375, DOI 10.1016/j.freeradbiomed.2009.04.035; Shrivastava G, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00489; Simoes LR, 2011, LETT APPL MICROBIOL, V53, P602, DOI 10.1111/j.1472-765X.2011.03146.x; Singh S, 2018, J GEN VIROL, V99, P1658, DOI 10.1099/jgv.0.001163; Soundravally R, 2008, PLATELETS, V19, P447, DOI 10.1080/09537100802155284; Strengert M, 2014, ANTIOXID REDOX SIGN, V20, P2695, DOI 10.1089/ars.2013.5353; Suttitheptumrong A, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800215; Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672; Tseng CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32176; Vijayan V, 2018, BIOCHEM PHARMACOL, V153, P159, DOI 10.1016/j.bcp.2018.02.010; Wan SW, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0482-9; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055407; Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1; Wu YH, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006848; Wu YJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45743-6; Yadav P, 2018, PHARM PAT ANAL, V7, P155, DOI 10.4155/ppa-2017-0035; Yu JS, 2017, SCI REP-UK, V7, DOI 10.1038/srep45171; Yu JS, 2017, ANTIVIR RES, V137, P49, DOI 10.1016/j.antiviral.2016.11.010; Zevini A, 2020, CURR OPIN VIROL, V43, P35, DOI 10.1016/j.coviro.2020.07.015	47	2	2	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22110	10.1096/fj.202100688RRR	http://dx.doi.org/10.1096/fj.202100688RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34918393				2022-12-28	WOS:000734992000046
J	Kim, W; Chung, C				Kim, Woonhee; Chung, ChiHye			Brain-wide cellular mapping of acute stress-induced activation in male and female mice	FASEB JOURNAL			English	Article						c-Fos; depression; female; immobilization stress; sex specificity	MEDIAL PREFRONTAL CORTEX; GENDER-DIFFERENCES; SEX-DIFFERENCES; SYNAPTIC POTENTIATION; DEPRESSION; PREVALENCE; ADOLESCENT; REUNIENS; HABENULA; MODEL	Mood disorders are more prevalent and often reported to be more severe in women; however, little is known about the underlying mechanisms of this sexual prevalence. To gain insight into the functional differences in female brains in response to stress, we systemically compared brain activation in male and female C57BL/6N mice after acute stress exposure. We measured c-Fos expression levels in 18 brain areas related to stress responses after a 3-h long restraint stress and found that activation was sexually dimorphic in several brain areas, including the nucleus accumbens, ventral tegmental area, nucleus reuniens, and medial part of the lateral habenula. Moreover, stress-activated a substantial number of cells in the medial prefrontal cortex, amygdala, and lateral part of the lateral habenula; however, the levels of activation were comparable in males and females, suggesting that the core stress responding machineries are largely shared. Pearson correlation analysis revealed several interesting connections between the analyzed areas that are implicated in stress responses and depression. Overall, stress strengthened intra-circuitries in the hippocampus, amygdala, and prefrontal cortex in female mice, whereas more longer-range connections were highlighted in stressed male mice. Our study provides a highly valuable neuroanatomical framework for investigating the circuit mechanism underlying the higher vulnerability to depression in women.	[Kim, Woonhee; Chung, ChiHye] Konkuk Univ, Dept Biol Sci, 120 Neungdong Ro, Seoul 05029, South Korea	Konkuk University	Chung, C (corresponding author), Konkuk Univ, Dept Biol Sci, 120 Neungdong Ro, Seoul 05029, South Korea.	cchung@konkuk.ac.kr		Chung, ChiHye/0000-0002-3104-2399	National Research Foundation of Korea [NRF--2019M3C7A1031742, NRF-2020R1A2C2005868]	National Research Foundation of Korea(National Research Foundation of Korea)	National Research Foundation of Korea, Grant/Award Number: NRF--2019M3C7A1031742 and NRF-2020R1A2C2005868	Autry AE, 2009, BIOL PSYCHIAT, V66, P84, DOI 10.1016/j.biopsych.2009.02.007; Bambico FR, 2019, PSYCHOPHARMACOLOGY, V236, P1917, DOI 10.1007/s00213-019-5177-8; Bebbington PE, 1998, PSYCHOL MED, V28, P9, DOI 10.1017/S0033291797006077; Blume SR, 2017, J NEUROSCI, V37, P10567, DOI 10.1523/JNEUROSCI.0758-17.2017; Boku S, 2018, PSYCHIAT CLIN NEUROS, V72, P3, DOI 10.1111/pcn.12604; Brancato A, 2017, NEUROSCIENCE, V350, P180, DOI 10.1016/j.neuroscience.2017.03.014; Cassel JC, 2013, PROG NEUROBIOL, V111, P34, DOI 10.1016/j.pneurobio.2013.08.006; Caviedes A, 2017, CURR PHARM DESIGN, V23, P3154, DOI 10.2174/1381612823666170111141915; Christoffel DJ, 2011, REV NEUROSCIENCE, V22, P535, DOI 10.1515/RNS.2011.044; Di S, 2016, J NEUROSCI, V36, P8461, DOI 10.1523/JNEUROSCI.2279-15.2016; Distler U, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020313; Goodwill HL, 2019, NEUROPSYCHOPHARMACOL, V44, P711, DOI 10.1038/s41386-018-0195-5; Harro Jaanus, 2013, Curr Top Behav Neurosci, V14, P29, DOI 10.1007/7854_2012_221; Hetzel A, 2014, NEUROPSYCHOPHARMACOL, V39, P2114, DOI 10.1038/npp.2014.60; Hodes GE, 2015, J NEUROSCI, V35, P16362, DOI 10.1523/JNEUROSCI.1392-15.2015; Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Maciejewski PK, 2001, PSYCHOL MED, V31, P593, DOI 10.1017/S0033291701003877; Markham JA, 2005, HIPPOCAMPUS, V15, P97, DOI 10.1002/hipo.20034; Monteggia LM, 2007, BIOL PSYCHIAT, V61, P187, DOI 10.1016/j.biopsych.2006.03.021; Nasca C, 2015, P NATL ACAD SCI USA, V112, P14960, DOI 10.1073/pnas.1516016112; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Park H, 2017, CELL REP, V20, P289, DOI 10.1016/j.celrep.2017.06.049; Park H, 2017, J NEUROSCI, V37, P6021, DOI 10.1523/JNEUROSCI.2281-16.2017; Patten SB, 2016, SOC PSYCH PSYCH EPID, V51, P203, DOI 10.1007/s00127-015-1166-3; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Salk RH, 2017, PSYCHOL BULL, V143, P783, DOI 10.1037/bul0000102; Seo JS, 2018, MOL PSYCHIATR, V23, P1113, DOI 10.1038/mp.2017.96; Sood A, 2018, STRESS, V21, P136, DOI 10.1080/10253890.2017.1422488; Staiti AM, 2011, NEUROPHARMACOLOGY, V61, P544, DOI 10.1016/j.neuropharm.2011.04.005; Thompson SM, 2015, TRENDS NEUROSCI, V38, P279, DOI 10.1016/j.tins.2015.03.003; Viena TD, 2018, HIPPOCAMPUS, V28, P297, DOI 10.1002/hipo.22831; Wade TJ, 2002, J AM ACAD CHILD PSY, V41, P190, DOI 10.1097/00004583-200202000-00013; Wellman CL, 2020, INT REV NEUROBIOL, V150, P129, DOI 10.1016/bs.irn.2019.11.007; Wissman AM, 2012, BRAIN STRUCT FUNCT, V217, P181, DOI 10.1007/s00429-011-0353-6; Zhong J, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0066-x; Zimmerman EC, 2016, J NEUROSCI, V36, P8977, DOI 10.1523/JNEUROSCI.1402-16.2016	37	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22041	10.1096/fj.202101287R	http://dx.doi.org/10.1096/fj.202101287R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34780680				2022-12-28	WOS:000722321300049
J	Yi, YY; Zhu, H; Klausen, C; Leung, PCK				Yi, Yuyin; Zhu, Hua; Klausen, Christian; Leung, Peter C. K.			Transcription factor SOX4 facilitates BMP2-regulated gene expression during invasive trophoblast differentiation	FASEB JOURNAL			English	Article						BMP2; SOX4; transcription factor; trophoblast invasion	EPITHELIAL-MESENCHYMAL TRANSITION; NEURITE-PROMOTING FACTOR; EXTRAVILLOUS TROPHOBLAST; MICE LACKING; TGF-BETA; CELLS; TUMORIGENESIS; INHIBITOR; DEFECTS; TARGETS	The interplay between growth factors, signaling pathways and transcription factors during placental development is key to controlling trophoblast differentiation. Bone morphogenetic protein 2 (BMP2) has been implicated in trophoblast invasion and spiral artery remodeling during early placental development. However, the molecular mechanisms by which these are accomplished have not been fully elucidated, particularly for transcriptional regulation of key transcription factors. Here, we identified SOX4 as a direct target gene induced by BMP2 in first-trimester placental trophoblasts. Analysis of single-cell RNA-seq data from first-trimester placentas and decidua tissues revealed that SOX4 expression is mainly localized in extravillous trophoblast and decidual stromal cells. Moreover, gain- and loss-of-function approaches demonstrated that SOX4 exerts a pro-invasive role in human trophoblasts, and this effect contributes to BMP2-enhanced trophoblast invasion. Importantly, we found that SOX4 was required for BMP2-induced regulation of a subset of genes associated with cell migration and extracellular matrix organization. We also show that SOX4-dependent regulation of the BMP2 target SERPINE2 occurs via binding of SOX4 to regulatory elements such as enhancers, thereby promoting BMP2-induced trophoblast invasion. In conclusion, these findings uncover a novel mechanism involving SOX4 that shapes the BMP2-regulated transcriptional network during invasive trophoblast development.	[Yi, Yuyin; Zhu, Hua; Klausen, Christian; Leung, Peter C. K.] Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada	University of British Columbia	Leung, PCK (corresponding author), Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.	peter.leung@ubc.ca		Leung, Peter/0000-0003-3152-3800	Canadian Institutes of Health Research Foundation Grant [143317]; BC Children's Hospital Research Institute studentship	Canadian Institutes of Health Research Foundation Grant(Canadian Institutes of Health Research (CIHR)); BC Children's Hospital Research Institute studentship	This study was supported by a Canadian Institutes of Health Research Foundation Grant to P.C.K.L. (#143317). Y.Y. was supported by a BC Children's Hospital Research Institute studentship	Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Bilir B, 2016, CANCER RES, V76, P1112, DOI 10.1158/0008-5472.CAN-15-1868; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; CARMELIET P, 1993, J CLIN INVEST, V92, P2746, DOI 10.1172/JCI116892; Castillo SD, 2012, CANCER RES, V72, P176, DOI 10.1158/0008-5472.CAN-11-3506; Chern SR, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-106; DaSilva-Arnold S, 2015, PLACENTA, V36, P1412, DOI 10.1016/j.placenta.2015.10.013; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; Davies JE, 2016, CELL ADHES MIGR, V10, P310, DOI 10.1080/19336918.2016.1170258; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; GLOOR S, 1986, CELL, V47, P687; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Hanieh H, 2020, SEMIN CANCER BIOL, V67, P91, DOI 10.1016/j.semcancer.2019.06.022; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; IRVING JA, 1995, PLACENTA, V16, P413, DOI 10.1016/0143-4004(95)90100-0; Jafarnejad SM, 2013, CELL MOL LIFE SCI, V70, P2677, DOI 10.1007/s00018-012-1187-y; Jiao CJ, 2016, ONCOL REP, V36, P2960, DOI 10.3892/or.2016.5121; Kuwahara M, 2012, NAT IMMUNOL, V13, P778, DOI 10.1038/ni.2362; Lai YH, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-50; Latos PA, 2016, DEVELOPMENT, V143, P3650, DOI 10.1242/dev.133462; Liu C, 2019, MOL CELL ENDOCRINOL, V493, DOI 10.1016/j.mce.2019.110485; Lourenco AR, 2017, TRENDS CANCER, V3, P571, DOI 10.1016/j.trecan.2017.06.002; Moreno CS, 2020, SEMIN CANCER BIOL, V67, P57, DOI 10.1016/j.semcancer.2019.08.027; Murer V, 2001, P NATL ACAD SCI USA, V98, P3029, DOI 10.1073/pnas.051630698; Nissen-Meyer LSH, 2007, J CELL SCI, V120, P2785, DOI 10.1242/jcs.003855; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Scharer CD, 2009, CANCER RES, V69, P709, DOI 10.1158/0008-5472.CAN-08-3415; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; STONE SR, 1987, ARCH BIOCHEM BIOPHYS, V252, P237, DOI 10.1016/0003-9861(87)90028-2; Tiwari N, 2013, CANCER CELL, V23, P768, DOI 10.1016/j.ccr.2013.04.020; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Vervoort SJ, 2013, ONCOGENE, V32, P3397, DOI 10.1038/onc.2012.506; Vervoort SJ, 2018, ELIFE, V7, DOI 10.7554/eLife.27706; Vervoort SJ, 2018, NUCLEIC ACIDS RES, V46, P9578, DOI 10.1093/nar/gky755; Vicovac L, 1996, ACTA ANAT, V156, P202; WHITE EA, 1993, THROMB HAEMOSTASIS, V69, P119; Wilson ME, 2005, DIABETES, V54, P3402, DOI 10.2337/diabetes.54.12.3402; Yang F, 2018, CELL DEATH DIFFER, V25, P2209, DOI 10.1038/s41418-018-0123-6; You JL, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.607332; Zhao HJ, 2020, CELL SIGNAL, V67, DOI 10.1016/j.cellsig.2019.109489; Zhao HJ, 2020, FASEB J, V34, P3151, DOI 10.1096/fj.201902168RR; Zhao HJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0230-1	44	2	2	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22028	10.1096/fj.202100925RR	http://dx.doi.org/10.1096/fj.202100925RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34739154				2022-12-28	WOS:000722321300015
J	Kim, SP; Da, H; Wang, L; Taketo, MM; Wan, M; Riddle, RC				Kim, Soohyun P.; Da, Hao; Wang, Lei; Taketo, Makoto M.; Wan, Mei; Riddle, Ryan C.			Bone-derived sclerostin and Wnt/beta-catenin signaling regulate PDGFR alpha(+) adipoprogenitor cell differentiation	FASEB JOURNAL			English	Article						adipoprogenitor; adipose; bone; PDGFR alpha; sclerostin; Wnt; beta-caten	TRANSCRIPTIONAL CONTROL; NEGATIVE REGULATOR; EXPRESSION; ACTIVATION; WHITE; ADIPOGENESIS; MASS; IDENTIFICATION; PREADIPOCYTES; ASSOCIATION	The Wnt signaling antagonist, sclerostin, is a potent suppressor of bone acquisition that also mediates endocrine communication between bone and adipose. As a result, Sost(-/-) mice exhibit dramatic increases in bone formation but marked decreases in visceral and subcutaneous adipose that are secondary to alterations in lipid synthesis and utilization. While interrogating the mechanism by which sclerostin influences adipocyte metabolism, we observed paradoxical increases in the adipogenic potential and numbers of CD45(-) :Sca1(+) :PDGFR alpha(+) adipoprogenitors in the stromal vascular compartment of fat pads isolated from male Sost(-/-) mice. Lineage tracing studies indicated that sclerostin deficiency blocks the differentiation of PDGFR alpha(+) adipoprogenitors to mature adipocytes in association with increased Wnt/beta-catenin signaling. Importantly, osteoblast/osteocyte-specific Sost gene deletion mirrors the accumulation of PDGFR alpha(+) adipoprogenitors, reduction in fat mass, and improved glucose metabolism evident in Sost(-/-) mice. These data indicate that bone-derived sclerostin regulates multiple facets of adipocyte physiology ranging from progenitor cell commitment to anabolic metabolism.	[Kim, Soohyun P.; Da, Hao; Wang, Lei; Wan, Mei; Riddle, Ryan C.] Johns Hopkins Univ, Dept Orthopaed Surg, Sch Med, 1721 E Madison St, Baltimore, MD 21205 USA; [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Div Expt Therapeut, Kyoto, Japan; [Riddle, Ryan C.] Baltimore Vet Adm Med Ctr, Res & Dev Serv, Baltimore, MD USA	Johns Hopkins University; Kyoto University	Riddle, RC (corresponding author), Johns Hopkins Univ, Dept Orthopaed Surg, Sch Med, 1721 E Madison St, Baltimore, MD 21205 USA.	rriddle1@jhmi.edu			U.S. Department of Veterans Affairs (VA) [BX003724]; HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK099134]	U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs); HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	U.S. Department of Veterans Affairs (VA), Grant/Award Number: BX003724; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK099134	Balani DH, 2021, J BONE MINER RES, V36, P757, DOI 10.1002/jbmr.4238; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Boyce Rogely Waite, 2018, Bone Rep, V8, P90, DOI 10.1016/j.bonr.2018.03.001; Chang MK, 2014, P NATL ACAD SCI USA, V111, pE5187, DOI 10.1073/pnas.1413828111; Economides AN, 2013, P NATL ACAD SCI USA, V110, pE3179, DOI 10.1073/pnas.1217812110; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Fairfield H, 2018, J CELL PHYSIOL, V233, P1156, DOI 10.1002/jcp.25976; Gao ZG, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00320-4; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hammarstedt A, 2013, P NATL ACAD SCI USA, V110, P2563, DOI 10.1073/pnas.1211255110; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Jeffery E, 2016, CELL METAB, V24, P142, DOI 10.1016/j.cmet.2016.05.012; Jeffery E, 2015, NAT CELL BIOL, V17, P376, DOI 10.1038/ncb3122; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kim SP, 2019, J BIOL CHEM, V294, P6899, DOI 10.1074/jbc.RA118.006769; Kim SP, 2017, P NATL ACAD SCI USA, V114, pE11238, DOI 10.1073/pnas.1707876115; Lapid K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6196; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Liu JJ, 2004, J BIOL CHEM, V279, P45020, DOI 10.1074/jbc.M407050200; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Negrel R, 2001, Methods Mol Biol, V155, P225; Nguyen NT, 2008, J AM COLL SURGEONS, V207, P928, DOI 10.1016/j.jamcollsurg.2008.08.022; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Pinho S, 2019, NAT REV MOL CELL BIO, V20, P303, DOI 10.1038/s41580-019-0103-9; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Ukita M, 2016, J CELL BIOCHEM, V117, P1419, DOI 10.1002/jcb.25432; Urano T, 2012, J CLIN ENDOCR METAB, V97, pE1473, DOI 10.1210/jc.2012-1218; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; van Bezooijen RL, 2007, DEV DYNAM, V236, P606, DOI 10.1002/dvdy.21054; Vishvanath L, 2016, CELL METAB, V23, P350, DOI 10.1016/j.cmet.2015.10.018; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Weivoda MM, 2017, BONE, V96, P45, DOI 10.1016/j.bone.2016.11.024; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Xiong L, 2015, P NATL ACAD SCI USA, V112, P3487, DOI 10.1073/pnas.1419714112; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Ye RS, 2015, MOL METAB, V4, P771, DOI 10.1016/j.molmet.2015.08.004; Yee CS, 2018, J BONE MINER RES, V33, P1748, DOI 10.1002/jbmr.3467; Zeve D, 2012, CELL METAB, V15, P492, DOI 10.1016/j.cmet.2012.03.010; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	52	6	6	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21957	10.1096/fj.202100691R	http://dx.doi.org/10.1096/fj.202100691R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34606641	Green Published			2022-12-28	WOS:000712009200043
J	Song, AN; Yin, XJ; Gao, P; Tang, H; Meng, XF; Zhang, C				Song, An-Ni; Yin, Xing-Jie; Gao, Pan; Tang, Hui; Meng, Xian-Fang; Zhang, Chun			Inhibition of MAD2B alleviates venous neointimal formation by suppressing VSMCs proliferation and migration	FASEB JOURNAL			English	Article						arteriovenous fistula malfunction; MAD2B; SnoN; vascular smooth muscle cells; venous neointimal formation	VASCULAR ACCESS; ARTERIOVENOUS-FISTULAS; SNON; HEMODIALYSIS; ACTIVATION; PROTEIN; SKI; SENSITIVITY; APC/C-CDH1; SIROLIMUS	The proliferation and migration of vascular smooth muscle cells (VSMCs) are essential events in venous neointimal hyperplasia (VNH), a culprit of arteriovenous fistula (AVF) malfunction. Mitotic arrest-deficient protein 2B (MAD2B) is a critical regulator of cell proliferation and differentiation in many scenarios. To address the role of MAD2B in VSMCs proliferation and migration during VNH, AVFs from patients with end-stage renal disease (ESRD) and chronic kidney disease (CKD) mice were used to evaluate MAD2B expression. In cultured VSMCs treated with platelet-derived growth factor-BB (PDGF-BB), the effect of MAD2B on VSMCs proliferation and migration was detected by cell counting kit-8 (CCK8) assay, immunofluorescence, wound-healing scratch and transwell assays. Besides, we exploited different small interfering RNAs (siRNAs) to explore the potential mechanisms in the issue. Furthermore, rapamycin was applied to reveal whether MAD2B-associated pathways were involved in its inhibitory effect on VSMCs proliferation and migration. Accordingly, we found that MAD2B expression was enhanced in AVFs from patients with ESRD, CKD mice and VSMCs stimulated by PDGF-BB. Meanwhile, inhibition of MAD2B alleviated VSMCs proliferation and migration while the number of ski-related novel gene (SnoN)-positive VSMCs was also increased in vivo and in vitro. Moreover, gene deletion of MAD2B decreased the level of SnoN protein in PDGF-BB-stimulated VSMCs. Furthermore, rapamycin suppressed the increased expressions of MAD2B and SnoN induced by PDGF-BB. Thus, our study demonstrates that inhibition of MAD2B suppresses the proliferation and migration of VSMCs during VNH via reducing SnoN expression. Moreover, rapamycin exerts an inhibitory effect on intimal hyperplasia, possibly via the MAD2B-SnoN axis.	[Song, An-Ni; Yin, Xing-Jie; Gao, Pan; Tang, Hui; Zhang, Chun] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Nephrol, Wuhan 430022, Peoples R China; [Meng, Xian-Fang] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Neurobiol, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, C (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Nephrol, Wuhan 430022, Peoples R China.	drzhangchun@hust.edu.cn			National Natural Science Foundation of China [81974096, 81961138007, 81770711, 81522010, 81671066, 81974162, 81700603, 82100794]; National Key R&D Program of China [2018YFC1314000]; Postdoctoral Science Foundation of China [2021M691158]; Program for HUST Academic Frontier Youth Team [2017QYTD20]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Program for HUST Academic Frontier Youth Team	This study was supported by the National Natural Science Foundation of China (Nos. 81974096, 81961138007, 81770711, 81522010, 81671066, 81974162, 81700603, and 82100794), National Key R&D Program of China (2018YFC1314000), Postdoctoral Science Foundation of China (2021M691158), the Program for HUST Academic Frontier Youth Team (2017QYTD20)	Almasri J, 2016, J VASC SURG, V64, P236, DOI 10.1016/j.jvs.2016.01.053; Arndt S, 2005, LAB INVEST, V85, P1330, DOI 10.1038/labinvest.3700344; Arndt S, 2007, MOL CELL NEUROSCI, V34, P603, DOI 10.1016/j.mcn.2007.01.002; Barrio R, 2007, DEV BIOL, V306, P66, DOI 10.1016/j.ydbio.2007.02.039; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bezhaeva T, 2018, FASEB J, V32, P6293, DOI 10.1096/fj.201800437R; Bond M, 2011, FRONT BIOSCI-LANDMRK, V16, P1517, DOI 10.2741/3802; Brahmbhatt A, 2016, KIDNEY INT, V89, P303, DOI 10.1016/j.kint.2015.12.019; Cahill DP, 1999, GENOMICS, V58, P181, DOI 10.1006/geno.1999.5831; Chen J, 2001, GENE DEV, V15, P1765, DOI 10.1101/gad.898701; Cheung HW, 2006, CANCER RES, V66, P4357, DOI 10.1158/0008-5472.CAN-05-3602; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Dember LM, 2008, JAMA-J AM MED ASSOC, V299, P2164, DOI 10.1001/jama.299.18.2164; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Hu D, 2011, SEMIN CELL DEV BIOL, V22, P579, DOI 10.1016/j.semcdb.2011.03.012; Iglesias JF, 2019, LANCET, V394, P1243, DOI 10.1016/S0140-6736(19)31877-X; Ke R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060844; Lee T, 2016, CLIN J AM SOC NEPHRO, V11, P1504, DOI 10.2215/CJN.02030216; Liang M, 2015, KIDNEY INT, V88, P490, DOI 10.1038/ki.2015.73; Liang M, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0431-z; Listovsky T, 2013, J CELL BIOL, V203, P87, DOI 10.1083/jcb.201302060; Liu J, 2011, MOL CELL BIOCHEM, V355, P127, DOI 10.1007/s11010-011-0846-x; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Lucchesi PA, 2004, AM J PHYSIOL-CELL PH, V286, pC480, DOI 10.1152/ajpcell.00526.2003; Luo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056774; Maeng M, 2014, LANCET, V383, P2047, DOI 10.1016/S0140-6736(14)60405-0; Mizuhara E, 2005, J BIOL CHEM, V280, P26499, DOI 10.1074/jbc.M500375200; Niimi K, 2014, CANCER SCI, V105, P545, DOI 10.1111/cas.12390; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Poon M, 2002, LANCET, V359, P619, DOI 10.1016/S0140-6736(02)07751-6; Raines EW, 2004, CYTOKINE GROWTH F R, V15, P237, DOI 10.1016/j.cytogfr.2004.03.004; Ramel MC, 2007, MECH DEVELOP, V124, P304, DOI 10.1016/j.mod.2006.12.006; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Su H, 2015, AM J PHYSIOL-RENAL, V308, pF728, DOI 10.1152/ajprenal.00409.2014; Sun J, 2001, CIRCULATION, V103, P2967, DOI 10.1161/01.CIR.103.24.2967; Tang H, 2016, J MOL MED, V94, P1297, DOI 10.1007/s00109-016-1448-6; Tang H, 2016, AM J PHYSIOL-RENAL, V311, pF207, DOI 10.1152/ajprenal.00600.2015; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wu JH, 2017, CARDIOVASC RES, V113, P1763, DOI 10.1093/cvr/cvx190; Zhang H, 2019, ONCOL RES, V27, P859, DOI 10.3727/096504017X15049209129277; Zhao JJ, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004891; Zhao J, 2011, J CLIN NEUROSCI, V18, P827, DOI 10.1016/j.jocn.2010.11.009; Zhu QW, 2012, FEBS LETT, V586, P1971, DOI 10.1016/j.febslet.2012.03.005	44	0	0	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21959	10.1096/fj.202100584RR	http://dx.doi.org/10.1096/fj.202100584RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34605572				2022-12-28	WOS:000712009200036
J	Andrisse, S; Feng, MX; Wang, ZQ; Awe, O; Yu, LX; Zhang, HY; Bi, S; Wang, HB; Li, LH; Joseph, S; Heller, N; Mauvais-Jarvis, F; Wong, GW; Segars, J; Wolfe, A; Divall, S; Ahima, R; Wu, S				Andrisse, Stanley; Feng, Mingxiao; Wang, Zhiqiang; Awe, Olubusayo; Yu, Lexiang; Zhang, Haiying; Bi, Sheng; Wang, Hongbing; Li, Linhao; Joseph, Serene; Heller, Nicola; Mauvais-Jarvis, Franck; Wong, Guang William; Segars, James; Wolfe, Andrew; Divall, Sara; Ahima, Rexford; Wu, Sheng			Androgen-induced insulin resistance is ameliorated by deletion of hepatic androgen receptor in females	FASEB JOURNAL			English	Article						androgen; androgen receptor; glucose; insulin signaling; liver; PCOS	POLYCYSTIC-OVARY-SYNDROME; LOW-DOSE DIHYDROTESTOSTERONE; METABOLIC DYSFUNCTION; LIVER; MODEL; MICE; ENDOCRINE; KNOCKOUT; EXCESS; DAMS	Androgen excess is one of the most common endocrine disorders of reproductive-aged women, affecting up to 20% of this population. Women with elevated androgens often exhibit hyperinsulinemia and insulin resistance. The mechanisms of how elevated androgens affect metabolic function are not clear. Hyperandrogenemia in a dihydrotestosterone (DHT)-treated female mouse model induces whole body insulin resistance possibly through activation of the hepatic androgen receptor (AR). We investigated the role of hepatocyte AR in hyperandrogenemia-induced metabolic dysfunction by using several approaches to delete hepatic AR via animal-, cell-, and clinical-based methodologies. We conditionally disrupted hepatocyte AR in female mice developmentally (LivARKO) or acutely by tail vein injection of an adeno-associated virus with a liver-specific promoter for Cre expression in AR(fl/fl) mice (adLivARKO). We observed normal metabolic function in littermate female Control (AR(fl/fl)) and LivARKO (AR(fl/fl); Cre(+/-)) mice. Following chronic DHT treatment, female Control mice treated with DHT (Con-DHT) developed impaired glucose tolerance, pyruvate tolerance, and insulin tolerance, not observed in LivARKO mice treated with DHT (LivARKO-DHT). Furthermore, during an euglycemic hyperinsulinemic clamp, the glucose infusion rate was improved in LivARKO-DHT mice compared to Con-DHT mice. Liver from LivARKO, and primary hepatocytes derived from LivARKO, and adLivARKO mice were protected from DHT-induced insulin resistance and increased gluconeogenesis. These data support a paradigm in which elevated androgens in females disrupt metabolic function via hepatic AR and insulin sensitivity was restored by deletion of hepatic AR.	[Andrisse, Stanley; Feng, Mingxiao; Wang, Zhiqiang; Awe, Olubusayo; Yu, Lexiang; Wolfe, Andrew; Wu, Sheng] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Andrisse, Stanley] Howard Univ, Dept Physiol & Biophys, Washington, DC 20059 USA; [Awe, Olubusayo; Wong, Guang William; Wu, Sheng] Johns Hopkins Univ, Sch Med, Dept Cellular & Mol Physiol, Baltimore, MD USA; [Zhang, Haiying; Bi, Sheng] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Wang, Hongbing; Li, Linhao] Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Joseph, Serene; Wu, Sheng] Temple Univ, Dept Cardiovasc Sci, Ctr Metab Dis Res, Sch Med, Philadelphia, PA 19140 USA; [Heller, Nicola] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Mauvais-Jarvis, Franck] Tulane Univ, Dept Med, Hlth Sci Ctr, New Orleans, LA 70118 USA; [Mauvais-Jarvis, Franck] Tulane Ctr Excellence Sex Based Biol & Med, New Orleans, LA USA; [Mauvais-Jarvis, Franck] VA Med Ctr, New Orleans, LA USA; [Segars, James; Wu, Sheng] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA; [Divall, Sara] Univ Washington, Dept Pediat, Seattles Childrens Hosp, Seattle, WA 98195 USA; [Ahima, Rexford] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Howard University; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Johns Hopkins University; Tulane University; Johns Hopkins University; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Johns Hopkins University	Wu, S (corresponding author), Temple Univ, Dept Physiol, Ctr Metab Dis Res, Sch Med, 3500 North Broad St MERB 456, Philadelphia, PA 19140 USA.	sheng.wu@temple.edu			HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [HD09551201A1]	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: HD09551201A1	Abbott DH, 2010, AM J PHYSIOL-ENDOC M, V299, pE741, DOI 10.1152/ajpendo.00058.2010; Allard C, 2019, DIABETES, V68, P490, DOI 10.2337/db18-0293; Ambroziak U, 2016, CLIN ENDOCRINOL, V84, P23, DOI 10.1111/cen.12935; Andrisse S, 2018, AM J PHYSIOL-ENDOC M, V314, pE353, DOI 10.1152/ajpendo.00195.2017; Andrisse S, 2017, ENDOCRINOLOGY, V158, P531, DOI 10.1210/en.2016-1553; Andrisse S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066027; Arkun Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149684; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Azziz R, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.57; Barber Thomas M, 2015, Clin Med (Lond), V15 Suppl 6, ps72, DOI [10.7861/clinmedicine.16-3-262, 10.7861/clinmedicine.15-6-s72]; Batista TM, 2020, P NATL ACAD SCI USA, V117, P6733, DOI 10.1073/pnas.1922370117; Caldwell ASL, 2014, ENDOCRINOLOGY, V155, P3146, DOI 10.1210/en.2014-1196; Cardoso RC, 2015, NEUROENDOCRINOLOGY, V102, P226, DOI 10.1159/000381830; Chang Chawnshang, 2013, Nucl Recept Signal, V11, pe001, DOI 10.1621/nrs.11001; Cox MJ, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa061; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; DUNAIF A, 1992, DIABETES, V41, P1257, DOI 10.2337/diabetes.41.10.1257; Ehrmann DA, 2012, STEROIDS, V77, P290, DOI 10.1016/j.steroids.2011.12.001; Escobar-Morreale HF, 2014, HUM REPROD, V29, P2083, DOI 10.1093/humrep/deu198; Geraghty RJ, 2014, BRIT J CANCER, V111, P1021, DOI 10.1038/bjc.2014.166; Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659; Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001; Kobayashi A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186683; Lai H, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.120063; Lazic SE, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005282; LeCluyse Edward L, 2005, Methods Mol Biol, V290, P207; LeCluyse EL, 2010, METHODS MOL BIOL, V640, P57, DOI 10.1007/978-1-60761-688-7_3; Lee B, 2014, AM J PHYSIOL-ENDOC M, V306, pE1144, DOI 10.1152/ajpendo.00002.2014; Leonie E, 2012, ENDOCRINOLOGY, V153, P2861, DOI 10.1210/en.2011-1754; Levin ER, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2016.122; Li L, 2016, ENDOCRINOLOGY, V157, P4842, DOI 10.1210/en.2016-1662; Lin HY, 2008, HEPATOLOGY, V47, P1924, DOI 10.1002/hep.22252; Ma YP, 2017, ENDOCRINOLOGY, V158, P98, DOI 10.1210/en.2016-1608; Manneras L, 2007, ENDOCRINOLOGY, V148, P3781, DOI 10.1210/en.2007-0168; Marino JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048643; Naegle K, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1125; Navarro G, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98607; Navarro G, 2015, OBESITY, V23, P713, DOI 10.1002/oby.21033; Padmanabhan V, 2013, MOL CELL ENDOCRINOL, V373, P8, DOI 10.1016/j.mce.2012.10.005; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Qiu SQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01937-4; Roland AV, 2010, J ENDOCRINOL, V207, P213, DOI 10.1677/JOE-10-0217; Sanchez-Garrido MA, 2020, MOL METAB, V35, DOI 10.1016/j.molmet.2020.01.001; Santoleri D, 2019, CELL MOL GASTROENTER, V7, P447, DOI 10.1016/j.jcmgh.2018.10.016; Silfen ME, 2003, J CLIN ENDOCR METAB, V88, P4682, DOI 10.1210/jc.2003-030617; Stener-Victorin E, 2020, ENDOCR REV, V41, DOI 10.1210/endrev/bnaa010; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; van Houten ELAF, 2014, REPROD BIOL, V14, P32, DOI 10.1016/j.repbio.2013.09.007; Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513; Vassilatou E, 2014, WORLD J GASTROENTERO, V20, P8351, DOI 10.3748/wjg.v20.i26.8351; Walters KA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097808; Wang ZQ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127817; Wang ZQ, 2018, ENDOCRINOLOGY, V159, P1242, DOI 10.1210/en.2017-03078; Xu WE, 2019, J ENDOCRINOL, V240, pR97, DOI 10.1530/JOE-18-0573; Xue P, 2018, JOVE-J VIS EXP, DOI 10.3791/58379; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399	57	8	8	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21921	10.1096/fj.202100961R	http://dx.doi.org/10.1096/fj.202100961R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34547140	Green Accepted			2022-12-28	WOS:000702238200013
J	Jin, LL; Li, QY; Li, J; Pan, Y; Zou, J; Wu, XY; Wang, Z				Jin, Liangli; Li, Quanyi; Li, Jing; Pan, Yang; Zou, Jue; Wu, Xiaoyuan; Wang, Zhi			Apela inhibits systemic and renal inflammatory reactions in mice with type I cardiorenal syndrome	FASEB JOURNAL			English	Article						apela; apelin peptide jejunum receptor; inflammation; nuclear factor kappa B; type I cardiorenal syndrome	FACTOR-KAPPA-B; AXIS PROTECTS; IMPROVES; ELABELA; EXPRESSION; HORMONE; CELLS	This study investigated the effect of apela on renal function and anti-inflammatory effect on whole body and kidney tissue in mice with type I cardiorenal syndrome (CRS). The murine type I CRS model was established and apela was subcutaneously infused for two weeks. Cardiac and renal functions were evaluated by echocardiography and blood biochemistry, respectively. The systemic and renal inflammatory responses were examined with molecular biological and histological methods. Human renal glomerular endothelial cells (RGECs) were used to evaluate the adhesion effect of monocytes in vitro. Compared to mice from the control group (CRS + vehicle), the plasma levels of N-terminal pro-brain natriuretic peptide, blood urea nitrogen and creatinine were significantly decreased, while the mean left ventricular ejection fraction was increased in apela-treated CRS mice at the 4th week. The expression of monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor-alpha (TNF-alpha) in the circulation and kidney was decreased in apela-treated mice compared with control mice, and apela improved cardio-renal pathology in mice with type I CRS. Additionally, Apela significantly suppressed the expression of MCP-1, TNF-alpha, intercellular adhesion molecule-1 and vascular intercellular adhesion molecule-1 in RGECs induced by angiotensin II (Ang II), and inhibited the promoting effect of Ang II on the adhesion of THP-1 cells to RGECs. Western blot results showed that the expression of phosphorylated nuclear factor kappa B (phospho-NF kappa B) in CRS mice was increased, but the expression of phospho-NF kappa B was down-regulated after apela treatment. Furthermore, apela significantly inhibited the Ang II-mediated increase in phospho-NF kappa B expression in RGECs in vitro, but the administration of an apelin peptide jejunum receptor (APJ) inhibitor blocked the inhibitory effect of apela. This study revealed that apela improves cardiorenal function and reduces systemic and renal inflammatory response in type I CRS mice and the apela/APJ system may alleviate renal inflammatory responses by inhibiting the NF kappa B signalling pathway.	[Jin, Liangli; Li, Quanyi; Li, Jing; Pan, Yang; Wang, Zhi] Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Cardiovasc Med, 264 Guangzhou Rd, Nanjing 210029, Peoples R China; [Zou, Jue] Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Pathol, Nanjing, Peoples R China; [Wu, Xiaoyuan] Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Cent Lab, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wang, Z (corresponding author), Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Cardiovasc Med, 264 Guangzhou Rd, Nanjing 210029, Peoples R China.	wangzhi1977nj@126.com	Wang, Zhi/AAW-9056-2021		National Natural Science Foundation of China (NSFC) [81570365]; Nanjing Medical and Health Science and Technology Project [201803022]; Nanjing Science and Technology Development Project [ZKX17046]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Nanjing Medical and Health Science and Technology Project; Nanjing Science and Technology Development Project	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81570365; Nanjing Medical and Health Science and Technology Project, Grant/Award Number: 201803022; Nanjing Science and Technology Development Project, Grant/Award Number: ZKX17046	Avila VF, 2019, HYPERTENS RES, V42, P779, DOI 10.1038/s41440-019-0226-6; Bircan B, 2016, RENAL FAILURE, V38, P1122, DOI 10.1080/0886022X.2016.1184957; Cabandugama PK, 2017, MED CLIN N AM, V101, P129, DOI 10.1016/j.mcna.2016.08.009; Chen H, 2017, J AM SOC NEPHROL, V28, P2695, DOI 10.1681/ASN.2016111210; Chen H, 2015, BBA-MOL BASIS DIS, V1852, P1278, DOI 10.1016/j.bbadis.2015.02.013; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Clementi A, 2019, CARDIORENAL MED, V9, P265, DOI 10.1159/000500715; Coquerel D, 2017, CRIT CARE MED, V45, pE1139, DOI 10.1097/CCM.0000000000002639; Costa JCSR, 2006, AM J NEPHROL, V26, P281, DOI 10.1159/000093960; Costanzo MR, 2020, HEART FAIL CLIN, V16, P81, DOI 10.1016/j.hfc.2019.08.010; Dong Y, 2019, CURR PHARM DESIGN, V25, P4235, DOI 10.2174/1381612825666191119094354; Feghali Carol A., 1997, Frontiers in Bioscience (online), V2, pD12; Guijarro C, 2001, KIDNEY INT, V59, P415, DOI 10.1046/j.1523-1755.2001.059002415.x; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Kuba K, 2019, PEPTIDES, V111, P62, DOI 10.1016/j.peptides.2018.04.011; Kumar U, 2019, CARDIOL CLIN, V37, P251, DOI 10.1016/j.ccl.2019.04.001; Kurmani Sameer, 2017, Curr Heart Fail Rep, V14, P385, DOI 10.1007/s11897-017-0351-y; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li LF, 2012, AM J PHYSIOL-HEART C, V303, pH605, DOI 10.1152/ajpheart.00366.2012; Li XC, 2008, CURR OPIN NEPHROL HY, V17, P37, DOI 10.1097/MNH.0b013e3282f2903c; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meng Y, 2014, AM J RESP CELL MOL, V50, P723, DOI 10.1165/rcmb.2012-0451OC; Monu SR, 2013, HYPERTENSION, V62, P310, DOI 10.1161/HYPERTENSIONAHA.111.00495; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ong SB, 2018, PHARMACOL THERAPEUT, V186, P73, DOI 10.1016/j.pharmthera.2018.01.001; Palazzuoli A, 2018, ADV CHRONIC KIDNEY D, V25, P408, DOI 10.1053/j.ackd.2018.08.013; Pan Y, 2020, J CELL MOL MED, V24, P10382, DOI 10.1111/jcmm.15651; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Pesce P, 2015, J ULTRASOUND, V18, P229, DOI 10.1007/s40477-014-0129-y; Rangaswami J, 2019, CIRCULATION, V139, pE840, DOI 10.1161/CIR.0000000000000664; Rischpler C, 2016, Q J NUCL MED MOL IM, V60, P236; Sanz-Rosa D, 2005, AM J PHYSIOL-HEART C, V288, pH111, DOI 10.1152/ajpheart.01061.2003; Sato T, 2017, CARDIOVASC RES, V113, P760, DOI 10.1093/cvr/cvx061; Sharma N, 2019, BIOMED PHARMACOTHER, V110, P764, DOI 10.1016/j.biopha.2018.12.018; Sunjaya Anthony P, 2019, Glob Cardiol Sci Pract, V2019, pe201915, DOI 10.21542/gcsp.2019.15; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Thind GS, 2018, CLEV CLIN J MED, V85, P231, DOI 10.3949/ccjm.85a.17019; Vinod P, 2017, CARDIOL RES, V8, P87, DOI 10.14740/cr553w; Vlahakos DV, 2019, J HYPERTENS, V37, P2145, DOI 10.1097/HJH.0000000000002111; Westman PC, 2016, J AM COLL CARDIOL, V67, P2050, DOI 10.1016/j.jacc.2016.01.073; Xu CM, 2020, AM J PHYSIOL-RENAL, V318, pF1122, DOI 10.1152/ajprenal.00606.2019; Yang F, 2015, PEPTIDES, V69, P133, DOI 10.1016/j.peptides.2015.04.025; Yogasundaram H, 2019, CAN J CARDIOL, V35, P1208, DOI 10.1016/j.cjca.2019.04.002; Zhang HL, 2018, CELL PHYSIOL BIOCHEM, V49, P1918, DOI 10.1159/000493653	44	1	1	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21907	10.1096/fj.202101030R	http://dx.doi.org/10.1096/fj.202101030R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34516679				2022-12-28	WOS:000702238200045
J	Chleilat, F; Schick, A; Deleemans, JM; Ma, K; Alukic, E; Wong, J; Tuplin, EWN; Nettleton, JE; Reimer, RA				Chleilat, Faye; Schick, Alana; Deleemans, Julie M.; Ma, Kyle; Alukic, Erna; Wong, Jolene; Tuplin, Erin W. Noye; Nettleton, Jodi E.; Reimer, Raylene A.			Paternal high protein diet modulates body composition, insulin sensitivity, epigenetics, and gut microbiota intergenerationally in rats	FASEB JOURNAL			English	Article						16S rRNA sequencing; body composition; DNA methyltransferase; epigenetics; gut microbiota; high protein diet; insulin sensitivity; paternal nutrition	HIGH-FAT DIET; DNA METHYLATION; AMINO-ACIDS; SMALL RNAS; GLUCOSE; OBESITY; INHERITANCE; METABOLISM; MICRORNAS; HUMANS	Mounting evidence demonstrates that paternal diet programs offspring metabolism. However, the contribution of a pre-conception paternal high protein (HP) diet to offspring metabolism, gut microbiota, and epigenetic changes remains unclear. Here we show that paternal HP intake in Sprague Dawley rats programs protective metabolic outcomes in offspring. Compared to paternal high fat/sucrose (HF/S), HP diet improved body composition and insulin sensitivity and improved circulating satiety hormones and cecal short-chain fatty acids compared to HF/S and control diet (P < .05). Further, using 16S rRNA gene sequencing to assess gut microbial composition, we observed increased alpha diversity, distinct bacterial clustering, and increased abundance of Bifidobacterium, Akkermansia, Bacteroides, and Marvinbryantia in HP fathers and/or male and female adult offspring. At the epigenetic level, DNMT1and 3b expression was altered intergenerationally. Our study identifies paternal HP diet as a modulator of gut microbial composition, epigenetic markers, and metabolic function intergenerationally.	[Chleilat, Faye; Ma, Kyle; Alukic, Erna; Wong, Jolene; Tuplin, Erin W. Noye; Nettleton, Jodi E.; Reimer, Raylene A.] Univ Calgary, Fac Kinesiol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Schick, Alana] Univ Calgary, Int Microbiome Ctr, Cumming Sch Med, Calgary, AB, Canada; [Deleemans, Julie M.] Univ Calgary, Cumming Sch Med, Div Med Sci & Psychosocial Oncol, Calgary, AB, Canada; [Reimer, Raylene A.] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Reimer, RA (corresponding author), Univ Calgary, Fac Kinesiol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	reimer@ucalgary.ca		Reimer, Raylene/0000-0001-5088-7947	Natural Sciences and Engineering Research Council [NSERC RGPIN/03773--2016]; Faculty of Kinesiology Dean's Doctoral Scholarship; Alberta Children's Hospital Research Institute scholarship; Natural Sciences and Engineering Research Council (NSERC) Summer Studentship; NSERC Undergraduate Student Research Program Studentship; Alberta Children's Hospital Research Institute scholarships	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Faculty of Kinesiology Dean's Doctoral Scholarship; Alberta Children's Hospital Research Institute scholarship; Natural Sciences and Engineering Research Council (NSERC) Summer Studentship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Undergraduate Student Research Program Studentship; Alberta Children's Hospital Research Institute scholarships	This work was supported by a research grant from the Natural Sciences and Engineering Research Council (NSERC RGPIN/03773--2016) and funding from Dr DA Hart. F Chleilat was supported by a Faculty of Kinesiology Dean's Doctoral Scholarship and Alberta Children's Hospital Research Institute scholarship. K Ma was supported by a Natural Sciences and Engineering Research Council (NSERC) Summer Studentship. E Alukic was supported by an NSERC Undergraduate Student Research Program Studentship. JE Nettleton was supported by Alberta Children's Hospital Research Institute scholarships. We thank Kristine Lee, Faculty of Kinesiology, and Dawn Martin, University of Calgary, for their technical assistance. Shelly Wegener and Dr Richard Pon, Centre for Health Genomics and Informatics facility at the University of Calgary for their technical assistance and support with the 16S rRNA sequencing and analysis.	Anderson LM, 2006, NUTRITION, V22, P327, DOI 10.1016/j.nut.2005.09.006; Antunes LC, 2016, ARCH ENDOCRIN METAB, V60, P138, DOI 10.1590/2359-3997000000169; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Benito-Vicente A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228675; Binder NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052304; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Carlin G, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010096; Chen Q, 2016, SCIENCE, V351, P397, DOI 10.1126/science.aad7977; Chleilat F, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22020689; Cho NA, 2018, OBESITY, V26, P1692, DOI 10.1002/oby.22325; Clarke SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065790; Fromentin G, 2012, NUTR RES REV, V25, P29, DOI 10.1017/S0954422411000175; Gaudichon C, 2002, GASTROENTEROLOGY, V123, P50, DOI 10.1053/gast.2002.34233; Gujar H, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020172; Gurung M, 2020, EBIOMEDICINE, V51, DOI 10.1016/j.ebiom.2019.11.051; Hall E, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0522-z; Hallam MC, 2013, BRIT J NUTR, V110, P1732, DOI 10.1017/S0007114513000998; Iacomino G, 2017, GENES NUTR, V12, DOI 10.1186/s12263-017-0577-z; Isokpehi RD, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040345; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Johnstone AM, 2012, P NUTR SOC, V71, P339, DOI 10.1017/S0029665112000122; Kashani A, 2019, ANIM MICROBIOME, V1, DOI 10.1186/s42523-019-0007-1; Kieffer TJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE1, DOI 10.1152/ajpendo.2000.278.1.E1; Kim SH, 2014, J APPL MICROBIOL, V117, P834, DOI 10.1111/jam.12573; Klenk J, 2009, EUR J EPIDEMIOL, V24, P83, DOI 10.1007/s10654-009-9312-4; Lambrot R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3889; Lavery CA, 2016, OBESITY, V24, P1741, DOI 10.1002/oby.21561; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leppert S, 2014, CURR PHARM DESIGN, V20, P1812, DOI 10.2174/13816128113199990534; Ling C, 2019, CELL METAB, V29, P1028, DOI 10.1016/j.cmet.2019.03.009; Liu XX, 2014, AM J PHYSIOL-GASTR L, V307, pG459, DOI 10.1152/ajpgi.00400.2013; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma X, 2019, DIABETES, V68, P871, DOI 10.2337/dbi18-0057; Mandar R, 2015, RES MICROBIOL, V166, P440, DOI 10.1016/j.resmic.2015.03.009; Martin AM, 2019, P NATL ACAD SCI USA, V116, P19802, DOI 10.1073/pnas.1909311116; Mashoodh R, 2012, P NATL ACAD SCI USA, V109, P17232, DOI 10.1073/pnas.1121083109; Maurer AD, 2011, BRIT J NUTR, V105, P329, DOI 10.1017/S0007114510003533; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Miao J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7498; Miner-Williams W, 2012, AM J CLIN NUTR, V96, P508, DOI 10.3945/ajcn.111.033472; Miro-Blanch J, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00638; Mulligan CM, 2017, J ENDOCRINOL, V235, pR1, DOI [10.1530/JOE-17-0303, 10.1530/joe-17-0303]; Nettleton JE, 2020, GUT, V69, P1807, DOI 10.1136/gutjnl-2018-317505; Nettleton JE, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061248; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Nicolucci AC, 2017, GASTROENTEROLOGY, V153, P711, DOI 10.1053/j.gastro.2017.05.055; Paul HA, 2019, FASEB J, V33, P5153, DOI 10.1096/fj.201801551R; Paul HA, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700820; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pesta DH, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-53; Rando OJ, 2015, CELL, V161, P93, DOI 10.1016/j.cell.2015.02.021; Rando OJ, 2012, CELL, V151, P702, DOI 10.1016/j.cell.2012.10.020; Rietman A, 2014, EUR J CLIN NUTR, V68, P973, DOI 10.1038/ejcn.2014.123; Romano KA, 2018, LAB ANIMAL, V47, P240, DOI 10.1038/s41684-018-0129-1; Samblas M, 2019, EPIGENETICS-US, V14, P421, DOI 10.1080/15592294.2019.1595297; Schwarz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047303; Sears B, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0123-1; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sharma U, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00215; Tang MQ, 2009, CURR GENOMICS, V10, P336, DOI 10.2174/138920209788920994; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Veenendaal MVE, 2013, BJOG-INT J OBSTET GY, V120, P548, DOI 10.1111/1471-0528.12136; Velazquez MA, 2019, J ENDOCRINOL, V242, pT33, DOI 10.1530/JOE-18-0676; Watkins AJ, 2014, AM J PHYSIOL-HEART C, V306, DOI 10.1152/ajpheart.00981.2013; Wei YC, 2014, P NATL ACAD SCI USA, V111, P1873, DOI 10.1073/pnas.1321195111; Yan H, 2019, DIABETES, V68, P291, DOI 10.2337/db18-0638; Yoo SR, 2013, OBESITY, V21, P2571, DOI 10.1002/oby.20428; Yu AM, 2012, ACTA PHARM SIN B, V2, P93, DOI 10.1016/j.apsb.2012.02.011	70	4	4	5	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21847	10.1096/fj.202100198RR	http://dx.doi.org/10.1096/fj.202100198RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34405464				2022-12-28	WOS:000691122900010
J	Yu, JH; Zhang, J; Shi, ML; Ding, H; Ma, LY; Zhang, HL; Liu, J				Yu, Jianghong; Zhang, Jun; Shi, Menglin; Ding, Hao; Ma, Liyun; Zhang, Huilu; Liu, Jie			Maintenance of glutamine synthetase expression alleviates endotoxin-induced sepsis via alpha-ketoglutarate-mediated demethylation	FASEB JOURNAL			English	Article						alpha-ketoglutarate; demethylation; glutamine synthetase; macrophages; sepsis	INHIBITION; TLR4	Glutamine synthetase (Glul) is the enzyme that synthesizes endogenous glutamine, which is responsible for critical metabolic pathways and the immune system. However, the role of Glul in regulating endotoxin (lipopolysaccharide, LPS)-induced sepsis remains unclear. Here, we found that Glul expression in macrophages was significantly inhibited in endotoxemia, and that Glul deletion induced macrophages to differentiate into the pro-inflammatory type and aggravated sepsis in mice. Mechanistically, TLR4/NF-kappa B-induced alpha-ketoglutarate (alpha-KG) depletion inhibits Glul expression through H3K27me3-mediated methylation in septic mice. Both Glul overexpression with adeno-associated virus (AAV) and restoration by replenishing alpha-KG can alleviate the severity of sepsis. In conclusion, the study demonstrated that Glul can regulate LPS-induced sepsis and provides a novel strategy for the treatment of this disease.	[Zhang, Huilu; Liu, Jie] Fudan Univ, Huashan Hosp, Dept Digest Dis, 130 Dongan Rd, Shanghai, Peoples R China; [Zhang, Huilu; Liu, Jie] Fudan Univ, Inst Biomed Sci, 130 Dongan Rd, Shanghai, Peoples R China	Fudan University; Fudan University	Zhang, HL; Liu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Digest Dis, 130 Dongan Rd, Shanghai, Peoples R China.; Zhang, HL; Liu, J (corresponding author), Fudan Univ, Inst Biomed Sci, 130 Dongan Rd, Shanghai, Peoples R China.	zhanghuilu003@163.com; jieliu@fudan.edu.cn		Ding, Hao/0000-0003-0774-4670; Yu, Jianghong/0000-0002-1441-1500	National Natural Science Foundation of China [81630016, 81802964]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81630016 and 81802964	Angurana SK, 2018, CRIT CARE MED, V46, P1656, DOI 10.1097/CCM.0000000000003279; Balic JJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17669-5; Bott AJ, 2015, CELL METAB, V22, P1068, DOI 10.1016/j.cmet.2015.09.025; Chung C, 2020, CANCER CELL, V38, P334, DOI 10.1016/j.ccell.2020.07.008; Cruzat V, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111564; Eid T, 2008, BRAIN, V131, P2061, DOI 10.1093/brain/awn133; Freemerman AJ, 2019, J IMMUNOL, V202, P1265, DOI 10.4049/jimmunol.1800002; Gotts JE, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1585; Hakvoort TBM, 2017, HEPATOLOGY, V65, P281, DOI 10.1002/hep.28852; Haniuda K, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108333; Hou YC, 2019, BRIT J NUTR, V122, P657, DOI 10.1017/S0007114519000990; Hu YM, 2014, SHOCK, V41, P115, DOI 10.1097/SHK.0000000000000086; Kim SM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15545-w; Kuzmich NN, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5040034; Lancaster GI, 2018, CELL METAB, V27, P1096, DOI 10.1016/j.cmet.2018.03.014; Lee JB, 2018, METHODS MOL BIOL, V1767, P257, DOI 10.1007/978-1-4939-7774-1_14; Li CW, 2021, J CELL MOL MED, V25, P2013, DOI 10.1111/jcmm.16082; Liu MY, 2020, SHOCK, V53, P103, DOI 10.1097/SHK.0000000000001333; Liu MX, 2018, ONCOGENE, V37, P1637, DOI 10.1038/s41388-017-0070-6; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; Luan HH, 2019, CELL, V178, P1231, DOI 10.1016/j.cell.2019.07.033; Lugin ML, 2020, ACS NANO, V14, P14262, DOI 10.1021/acsnano.0c03850; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Muhling J, 2010, AMINO ACIDS, V38, P167, DOI 10.1007/s00726-008-0224-5; Oliveira GP, 2009, CRIT CARE, V13, DOI 10.1186/cc7888; Pai MH, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041086; Ren WK, 2019, ADV NUTR, V10, P321, DOI 10.1093/advances/nmy084; Sacramento LA, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008435; Shahmirzadi AA, 2020, CELL METAB, V32, P447, DOI 10.1016/j.cmet.2020.08.004; Shakespear MR, 2018, TRENDS IMMUNOL, V39, P473, DOI 10.1016/j.it.2018.02.009; Skirecki T, 2019, FEMS MICROBIOL REV, V43, P239, DOI 10.1093/femsre/fuz004; Slotwinski R, 2011, ARCH IMMUNOL THER EX, V59, P139, DOI 10.1007/s00005-011-0117-2; van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36; Williams NC, 2020, TRENDS IMMUNOL, V41, P93, DOI 10.1016/j.it.2019.12.009; Wu TY, 2019, EUR REV MED PHARMACO, V23, P184, DOI 10.26355/eurrev_201908_18646; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x; Zhu KY, 2021, EXP NEUROL, V345, DOI 10.1016/j.expneurol.2021.113828	37	1	1	6	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22281	10.1096/fj.202200059R	http://dx.doi.org/10.1096/fj.202200059R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0J9NC	35344214				2022-12-28	WOS:000780424000001
J	Xu, CM; Liu, CJ; Xiong, JH; Yu, J				Xu, Chuanming; Liu, Chunju; Xiong, Jianhua; Yu, Jun			Cardiovascular aspects of the (pro)renin receptor: Function and significance	FASEB JOURNAL			English	Review						cardiovascular disease; heart; hypertension; (pro)renin receptor; renin-angiotensin system; vascular	RENIN-ANGIOTENSIN SYSTEM; SMOOTH-MUSCLE-CELLS; VACUOLAR H+-ATPASE; HYPOXIA/REOXYGENATION-INDUCED APOPTOSIS; BLOOD-PRESSURE REGULATION; PRORENIN RECEPTOR; COLLECTING DUCT; HANDLE-REGION; NONPROTEOLYTIC ACTIVATION; ENDOTHELIAL DYSFUNCTION	Cardiovascular diseases (CVDs), including all types of disorders related to the heart or blood vessels, are the major public health problems and the leading causes of mortality globally. (Pro)renin receptor (PRR), a single transmembrane protein, is present in cardiomyocytes, vascular smooth muscle cells, and endothelial cells. PRR plays an essential role in cardiovascular homeostasis by regulating the renin-angiotensin system and several intracellular signals such as mitogen-activated protein kinase signaling and wnt/beta-catenin signaling in various cardiovascular cells. This review discusses the current evidence for the pathophysiological roles of the cardiac and vascular PRR. Activation of PRR in cardiomyocytes may contribute to myocardial ischemia/reperfusion injury, cardiac hypertrophy, diabetic or alcoholic cardiomyopathy, salt-induced heart damage, and heart failure. Activation of PRR promotes vascular smooth muscle cell proliferation, endothelial cell dysfunction, neovascularization, and the progress of vascular diseases. In addition, phenotypes of animals transgenic for PRR and the hypertensive actions of PRR in the brain and kidney and the soluble PRR are also discussed. Targeting PRR in local tissues may offer benefits for patients with CVDs, including heart injury, atherosclerosis, and hypertension.	[Xu, Chuanming] Jiangxi Univ Chinese Med, Translat Med Ctr, Nanchang 330002, Jiangxi, Peoples R China; [Liu, Chunju] Jiangxi Univ Chinese Med, Dept Clin Lab, Affiliated Hosp, Nanchang, Jiangxi, Peoples R China; [Xiong, Jianhua] Jiangxi Univ Chinese Med, Dept Cardiol, Affiliated Hosp, Nanchang, Jiangxi, Peoples R China; [Yu, Jun] Temple Univ, Ctr Metab Dis Res, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Yu, Jun] Temple Univ, Dept Physiol, Philadelphia, PA 19122 USA	Jiangxi University of Traditional Chinese Medicine; Jiangxi University of Traditional Chinese Medicine; Jiangxi University of Traditional Chinese Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Xu, CM (corresponding author), Jiangxi Univ Chinese Med, Translat Med Ctr, Nanchang 330002, Jiangxi, Peoples R China.	xuchuanming2008@163.com			NSFC | National Natural Science Foundation of China [82160051, 32100908]; Jiangxi "Double Thousand Plan" [jxsq2020101074]; Jiangxi Provincial Natural Science Foundation [20212BAB216005]; PhD Start-up Research Fund in Jiangxi University of Chinese Medicine [2020BSZR009]; Jiangxi Key Laboratory grant in Science and Technology Department of Jiangxi Province [20202BCD42014]; Science and Technology Research Project in Education Department of Jiangxi Province [GJJ201262]	NSFC | National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangxi "Double Thousand Plan"; Jiangxi Provincial Natural Science Foundation; PhD Start-up Research Fund in Jiangxi University of Chinese Medicine; Jiangxi Key Laboratory grant in Science and Technology Department of Jiangxi Province; Science and Technology Research Project in Education Department of Jiangxi Province	NSFC | National Natural Science Foundation of China, Grant/Award Number: 82160051 and 32100908; Jiangxi "Double Thousand Plan", Grant/Award Number: jxsq2020101074; Jiangxi Provincial Natural Science Foundation, Grant/Award Number: 20212BAB216005; the PhD Start--up Research Fund in Jiangxi University of Chinese Medicine, Grant/Award Number: 2020BSZR009; Jiangxi Key Laboratory grant in Science and Technology Department of Jiangxi Province, Grant/Award Number: 20202BCD42014; the Science and Technology Research Project in Education Department of Jiangxi Province, Grant/Award Number: GJJ201262	Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; Amari Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233312; Amari Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158068; Batenburg WW, 2007, J HYPERTENS, V25, P2441, DOI 10.1097/HJH.0b013e3282f05bae; Batenburg WW, 2011, HYPERTENSION, V58, P1111, DOI 10.1161/HYPERTENSIONAHA.111.180737; Biswas KB, 2011, HYPERTENS RES, V34, P735, DOI 10.1038/hr.2011.26; Blomqvist SR, 2004, J CLIN INVEST, V113, P1560, DOI 10.1172/JCI200420665; Brooks VL, 2015, AUTON NEUROSCI-BASIC, V187, P18, DOI 10.1016/j.autneu.2014.11.006; Brown MJ, 2008, CIRCULATION, V118, P773, DOI 10.1161/CIRCULATIONAHA.108.787630; Burckle CA, 2006, HYPERTENSION, V47, P552, DOI 10.1161/01.HYP.0000199912.47657.04; Cao XR, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4546975; Chen LH, 2005, AM J PHYSIOL-RENAL, V288, pF939, DOI 10.1152/ajprenal.00369.2004; Chen LH, 2018, AM J PHYSIOL-RENAL, V314, pF572, DOI 10.1152/ajprenal.00436.2017; Chen YT, 2020, FASEB J, V34, P14136, DOI 10.1096/fj.202001711R; Cheng Jun, 2011, Zhonghua Yan Ke Za Zhi, V47, P202; Connelly KA, 2011, J HYPERTENS, V29, P1175, DOI 10.1097/HJH.0b013e3283462674; Cousin C, 2009, HYPERTENSION, V53, P1077, DOI 10.1161/HYPERTENSIONAHA.108.127258; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Danser AHJ, 1999, CARDIOVASC RES, V44, P252, DOI 10.1016/S0008-6363(99)00202-3; Danser AHJ, 2002, J MOL CELL CARDIOL, V34, P1463, DOI 10.1006/jmcc.2002.2078; Daryadel A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147831; Deng HF, 2017, LIFE SCI, V191, P115, DOI 10.1016/j.lfs.2017.10.018; Dong XF, 2019, J BIOL CHEM, V294, P8218, DOI 10.1074/jbc.RA119.007648; DOSTAL DE, 1992, AM J PHYSIOL, V263, pC838, DOI 10.1152/ajpcell.1992.263.4.C838; Ellmers LJ, 2016, J CARD FAIL, V22, P64, DOI 10.1016/j.cardfail.2015.08.341; Eraranta A, 2008, J HYPERTENS, V26, P1661, DOI 10.1097/HJH.0b013e328303205d; Esther CR, 1996, LAB INVEST, V74, P953; Fang H, 2017, AM J PHYSIOL-CELL PH, V313, pC632, DOI 10.1152/ajpcell.00006.2017; Feldman DL, 2008, HYPERTENSION, V52, P130, DOI 10.1161/HYPERTENSIONAHA.107.108845; Feldt S, 2008, J AM SOC NEPHROL, V19, P743, DOI 10.1681/ASN.2007091030; Feldt S, 2008, HYPERTENSION, V51, P682, DOI 10.1161/HYPERTENSIONAHA.107.101444; Feng Y, 2021, HYPERTENSION, V77, P405, DOI 10.1161/HYPERTENSIONAHA.120.15100; Ferri N, 2011, J RENIN-ANGIO-ALDO S, V12, P469, DOI 10.1177/1470320311408751; Figueiredo M, 2021, PFLUG ARCH EUR J PHY, V473, P1229, DOI 10.1007/s00424-021-02598-z; Fu ZW, 2021, CLIN SCI, V135, P793, DOI 10.1042/CS20201047; Fukushima A, 2013, INT J CARDIOL, V168, P4313, DOI 10.1016/j.ijcard.2013.04.176; Gao X, 2020, PHYSIOL RES, V69, P427, DOI 10.33549/physiolres.934210; Gatineau E, 2019, HYPERTENSION, V74, P1014, DOI 10.1161/HYPERTENSIONAHA.119.12906; Gatineau E, 2019, AM J PHYSIOL-HEART C, V316, pH506, DOI 10.1152/ajpheart.00473.2018; Giese MJ, 2014, PHARMACOL THERAPEUT, V142, P11, DOI 10.1016/j.pharmthera.2013.11.002; Gong LH, 2019, PEPTIDES, V111, P152, DOI 10.1016/j.peptides.2018.04.010; Gong X, 2019, EXP THER MED, V18, P1752, DOI 10.3892/etm.2019.7769; Gonzalez AA, 2011, HYPERTENSION, V57, P859, DOI 10.1161/HYPERTENSIONAHA.110.167957; Greco CM, 2012, CARDIOVASC RES, V95, P366, DOI 10.1093/cvr/cvs204; Gupta HV, 2015, PARKINSONISM RELAT D, V21, P1473, DOI 10.1016/j.parkreldis.2015.10.001; Haque R, 2017, J RECEPT SIG TRANSD, V37, P560, DOI 10.1080/10799893.2017.1369120; Haque R, 2017, MOL VIS, V23, P251; Haque R, 2015, MOL VIS, V21, P224; Hase K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189696; Hayakawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120453; Hirose T, 2009, PEPTIDES, V30, P2316, DOI 10.1016/j.peptides.2009.09.015; Huber MJ, 2015, AM J PHYSIOL-HEART C, V309, pH880, DOI 10.1152/ajpheart.00095.2015; Ichihara A, 2004, J CLIN INVEST, V114, P1128, DOI 10.1172/JCI200421398; Jouret F, 2005, J AM SOC NEPHROL, V16, P3235, DOI 10.1681/ASN.2004110935; Kanda A, 2012, DIABETOLOGIA, V55, P3104, DOI 10.1007/s00125-012-2702-2; Kang JJ, 2008, HYPERTENSION, V51, P1597, DOI 10.1161/HYPERTENSIONAHA.107.107268; Katwa LC, 1996, INT J BIOCHEM CELL B, V28, P807, DOI 10.1016/1357-2725(96)00012-X; KIM HS, 1995, P NATL ACAD SCI USA, V92, P2735, DOI 10.1073/pnas.92.7.2735; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Komaki H, 2018, HYPERTENS RES, V41, P886, DOI 10.1038/s41440-018-0099-0; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Kurauchi-Mito A, 2014, HYPERTENS RES, V37, P830, DOI 10.1038/hr.2014.92; Li M, 2014, ATHEROSCLEROSIS, V232, P265, DOI 10.1016/j.atherosclerosis.2013.11.051; Li WC, 2015, HYPERTENSION, V65, P352, DOI 10.1161/HYPERTENSIONAHA.114.04458; Li WC, 2014, HYPERTENSION, V63, P316, DOI 10.1161/HYPERTENSIONAHA.113.02041; Li WC, 2012, HYPERTENSION, V59, P1188, DOI 10.1161/HYPERTENSIONAHA.111.190108; Li YR, 2020, AM J PATHOL, V190, P1971, DOI 10.1016/j.ajpath.2020.06.004; Li Z, 2017, J AM SOC NEPHROL, V28, P2393, DOI 10.1681/ASN.2016070811; Lian H, 2015, INT J CARDIOL, V184, P28, DOI 10.1016/j.ijcard.2015.01.088; Liu B, 2019, MOL MED REP, V20, P2796, DOI 10.3892/mmr.2019.10519; Liu FY, 2014, J RENIN-ANGIO-ALDO S, V15, P99, DOI 10.1177/1470320314525215; Liu G, 2011, J HYPERTENS, V29, P696, DOI 10.1097/HJH.0b013e328343c62b; Liu Y, 2015, MOL CELL BIOCHEM, V403, P267, DOI 10.1007/s11010-015-2356-8; Liu Y, 2019, MOL THER-NUCL ACIDS, V17, P113, DOI 10.1016/j.omtn.2019.05.012; Lu H, 2008, J CLIN INVEST, V118, P984, DOI 10.1172/JCI32970; Lu XH, 2016, P NATL ACAD SCI USA, V113, pE1898, DOI 10.1073/pnas.1602397113; Ma H, 2020, HUM GENE THER, V31, P639, DOI 10.1089/hum.2019.124; Mahmud H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089929; Mahmud H, 2012, J CELL MOL MED, V16, P722, DOI 10.1111/j.1582-4934.2011.01377.x; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Mehta JL, 1998, BIOCHEM BIOPH RES CO, V248, P511, DOI 10.1006/bbrc.1998.9004; Michaud A, 2014, HUM MOL GENET, V23, P1479, DOI 10.1093/hmg/ddt535; Mohsin M, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.606811; Moilanen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041404; Morimoto S, 2021, INT J ENDOCRINOL, V2021, DOI 10.1155/2021/8828610; Morimoto S, 2014, HYPERTENS RES, V37, P642, DOI 10.1038/hr.2014.46; Nabi AHMN, 2009, INT J MOL MED, V24, P83, DOI 10.3892/ijmm_00000210; Nakagawa T, 2017, J BIOCHEM, V161, P369, DOI 10.1093/jb/mvw080; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nguyen G, 2014, HYPERTENSION, V63, P297, DOI 10.1161/HYPERTENSIONAHA.113.02217; Nurun NAHM, 2007, FRONT BIOSCI-LANDMRK, V12, P4810, DOI 10.2741/2429; Obradovic D, 2020, FRONT BIOSCI-LANDMRK, V25, P1839, DOI 10.2741/4880; Okamoto C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189099; Okubo S, 1998, KIDNEY INT, V53, P617, DOI 10.1046/j.1523-1755.1998.00788.x; Oliverio MI, 1998, P NATL ACAD SCI USA, V95, P15496, DOI 10.1073/pnas.95.26.15496; Parreira KS, 2009, PFLUG ARCH EUR J PHY, V458, P745, DOI 10.1007/s00424-009-0667-x; Passier Robert C. J. J., 1996, American Journal of Physiology, V271, pH1040; Patterson LT, 2003, CURR OPIN NEPHROL HY, V12, P19, DOI 10.1097/00041552-200301000-00004; Peng H, 2018, AM J PHYSIOL-HEART C, V314, pH580, DOI 10.1152/ajpheart.00310.2017; Peng H, 2013, J HUAZHONG U SCI-MED, V33, P640, DOI 10.1007/s11596-013-1173-0; Peng KX, 2017, AM J PHYSIOL-RENAL, V312, pF245, DOI 10.1152/ajprenal.00178.2016; Pohl M, 2010, J BIOL CHEM, V285, P41935, DOI 10.1074/jbc.M110.150284; Prieto MC, 2017, AM J PHYSIOL-RENAL, V313, pF1243, DOI 10.1152/ajprenal.00152.2017; Pringle KG, 2011, PLACENTA, V32, P956, DOI 10.1016/j.placenta.2011.09.020; Qin MM, 2021, J PHARMACOL EXP THER, V378, P251, DOI 10.1124/jpet.121.000576; Quadri SS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202419; Rademaker MT, 2012, CIRC-HEART FAIL, V5, P645, DOI 10.1161/CIRCHEARTFAILURE.112.967059; Ramkumar N, 2021, CIRC RES, V129, P50, DOI 10.1161/CIRCRESAHA.120.317532; Ramkumar N, 2018, AM J PHYSIOL-RENAL, V315, pF607, DOI 10.1152/ajprenal.00122.2018; Ramkumar N, 2016, AM J PHYSIOL-RENAL, V311, pF186, DOI 10.1152/ajprenal.00088.2016; Ramkumar N, 2014, AM J PHYSIOL-RENAL, V307, pF931, DOI 10.1152/ajprenal.00367.2014; Ribeiro AA, 2018, INT J BIOL MACROMOL, V108, P817, DOI 10.1016/j.ijbiomac.2017.10.179; Richer J, 2015, AM J MED GENET A, V167, P1654, DOI 10.1002/ajmg.a.37067; Riediger F, 2011, J AM SOC NEPHROL, V22, P2193, DOI 10.1681/ASN.2011020200; Rohrwasser A, 1999, HYPERTENSION, V34, P1265, DOI 10.1161/01.HYP.34.6.1265; Rohrwasser A, 2003, KIDNEY INT, V64, P2155, DOI 10.1046/j.1523-1755.2003.00302.x; Rosendahl A, 2014, LAB INVEST, V94, P863, DOI 10.1038/labinvest.2014.83; Rujano MA, 2017, J EXP MED, V214, P3707, DOI 10.1084/jem.20170453; Saigo S, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23010302; Sakoda M, 2007, HYPERTENS RES, V30, P1139, DOI 10.1291/hypres.30.1139; Saris JJ, 2006, HYPERTENSION, V48, P564, DOI 10.1161/01.HYP.0000240064.19301.1b; Saris JJ, 2001, AM J PHYSIOL-HEART C, V280, pH1706, DOI 10.1152/ajpheart.2001.280.4.H1706; Satofuka S, 2007, INVEST OPHTH VIS SCI, V48, P422, DOI 10.1167/iovs.06-0534; Satofuka S, 2008, AM J PATHOL, V173, P1911, DOI 10.2353/ajpath.2008.080457; Seki Yasufumi, 2010, Front Biosci (Elite Ed), V2, P972; Seto SW, 2014, CLIN SCI, V127, P123, DOI 10.1042/CS20130382; Song RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063835; Souza LAC, 2019, AM J PHYSIOL-HEART C, V316, pH1389, DOI 10.1152/ajpheart.00780.2018; Sun Y, 2020, HYPERTENSION, V75, P1242, DOI 10.1161/HYPERTENSIONAHA.120.14845; Suzuki F, 2003, J BIOL CHEM, V278, P22217, DOI 10.1074/jbc.M302579200; Takahashi N, 2005, J AM SOC NEPHROL, V16, P125, DOI 10.1681/ASN.2004060490; Tamarat R, 2002, LAB INVEST, V82, P747, DOI 10.1097/01.LAB.0000017372.76297.EB; Thakkar S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16740; Trepiccione F, 2016, AM J PHYSIOL-RENAL, V311, pF901, DOI 10.1152/ajprenal.00286.2016; Trepiccione F, 2016, J AM SOC NEPHROL, V27, P3320, DOI 10.1681/ASN.2015080915; Tsuchida S, 1998, J CLIN INVEST, V101, P755, DOI 10.1172/JCI1899; Uraoka M, 2009, BIOCHEM BIOPH RES CO, V390, P1202, DOI 10.1016/j.bbrc.2009.10.121; van Schaijik B, 2019, PEDIATR RES, V86, P202, DOI 10.1038/s41390-019-0430-8; vanKats JP, 1997, HYPERTENSION, V30, P42, DOI 10.1161/01.HYP.30.1.42; Veniant M, 1996, J CLIN INVEST, V98, P1966, DOI 10.1172/JCI119000; Vikram A, 2014, ARTERIOSCL THROM VAS, V34, P2301, DOI 10.1161/ATVBAHA.114.304338; Wang F, 2021, HYPERTENSION, V78, P115, DOI 10.1161/HYPERTENSIONAHA.121.16770; Wang F, 2020, AM J PHYSIOL-RENAL, V319, pF647, DOI 10.1152/ajprenal.00112.2020; Wang F, 2020, AM J PHYSIOL-RENAL, V318, pF817, DOI 10.1152/ajprenal.00436.2019; Wang F, 2016, J AM SOC NEPHROL, V27, P3022, DOI 10.1681/ASN.2015050592; Wang F, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0514-1; Wendling O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08845-7; Wilkinson-Berka JL, 2010, HYPERTENSION, V55, P1454, DOI 10.1161/HYPERTENSIONAHA.109.148221; Worker CJ, 2020, AM J PHYSIOL-ENDOC M, V318, pE765, DOI 10.1152/ajpendo.00406.2019; Wu CH, 2016, HYPERTENSION, V68, P213, DOI 10.1161/HYPERTENSIONAHA.115.06954; Wu HY, 2013, J AM SOC NEPHROL, V24, P243, DOI 10.1681/ASN.2012080866; Wu JY, 2019, MOL MED REP, V19, P573, DOI 10.3892/mmr.2018.9653; Xiao LX, 2019, BBA-MOL BASIS DIS, V1865, P1313, DOI 10.1016/j.bbadis.2019.01.027; Xiong J, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.657378; Xiong J, 2019, ALCOHOL CLIN EXP RES, V43, P2344, DOI 10.1111/acer.14188; Xu CM, 2021, HYPERTENSION, V78, P1027, DOI 10.1161/HYPERTENSIONAHA.121.16981; Xu CM, 2017, HYPERTENSION, V69, P339, DOI 10.1161/HYPERTENSIONAHA.116.08240; Yamashita S, 2018, BIOMED REP, V9, P247, DOI 10.3892/br.2018.1124; Yang TX, 2017, J AM SOC NEPHROL, V28, P1040, DOI 10.1681/ASN.2016070734; Yang XL, 2019, BIOMED PHARMACOTHER, V109, P1163, DOI 10.1016/j.biopha.2018.10.129; Ye D., 2019, THESIS SHENZHEN U MA; Yisireyili M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109268; Yokota Harumasa, 2008, Hokkaido Igaku Zasshi, V83, P159; Yoshikawa A, 2011, HYPERTENS RES, V34, P599, DOI 10.1038/hr.2010.284; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d; Yu SR, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82776-2; Yu SR, 2019, HUM GENE THER, V30, P727, DOI 10.1089/hum.2018.155; Zhang JD, 2008, AM J PHYSIOL-ENDOC M, V295, pE810, DOI 10.1152/ajpendo.90264.2008; Zhang Xun, 1995, American Journal of Physiology, V269, pH1791; Zhou LL, 2015, J AM SOC NEPHROL, V26, P107, DOI 10.1681/ASN.2014010085; Zhuge YZ, 2020, INT J BIOL SCI, V16, P2741, DOI 10.7150/ijbs.49871	171	3	3	6	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22237	10.1096/fj.202101649RRR	http://dx.doi.org/10.1096/fj.202101649RRR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CH	35226776				2022-12-28	WOS:000772944500001
J	Liu, KQ; Lu, LN; Chen, SS; Gu, BL; Cai, H; Wang, Y; Cai, W				Liu, Keqiang; Lu, Lina; Chen, Shanshan; Gu, Beilin; Cai, Hui; Wang, Ying; Cai, Wei			Loss-of-function variants within LMOD1 actin-binding site 2 cause pediatric intestinal pseudo-obstruction by impairing protein stability and actin nucleation	FASEB JOURNAL			English	Article						actin nucleation; gene mutation; leiomodin1 (LMOD1); pediatric intestinal pseudo-obstruction; second actin-binding site	UROLOGICAL MANIFESTATIONS; VISCERAL MYOPATHY; SEQUENCE VARIANTS; MICROCOLON; MEGACYSTIS; MUTATIONS	The leiomodin1 (LMOD1) gene, encoding a potent actin nucleator, was recently reported as a potential pathogenic gene of megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS, OMIM 619362). However, only a single patient has been reported to have LMOD1 mutations, and the underlying pathogenic mechanism remains unknown. Here, we described a male infant with LMOD1 mutations presenting typical symptoms of pediatric intestinal pseudo-obstruction (PIPO) but without megacystis and microcolon. Two compound heterozygous missense variants (c.1106C>T, p.T369M; c.1262G>A, p.R421H) were identified, both affecting highly conserved amino acid residues within the second actin-binding site (ABS2) domain of LMOD1. Expression analysis showed that both variants resulted in significantly reduced protein amounts, especially for p.T369M, which was almost undetectable. The reduction was only partially rescued by the proteasome inhibitor MG-132, indicating that there might be proteasome-independent pathways involved in the degradation of the mutant proteins. Molecular modeling showed that variant p.T369M impaired the local protein conformation of the ABS2 domain, while variant p.R421H directly impaired the intermolecular interaction between ABS2 and actin. Accordingly, both variants significantly damaged LMOD1-mediated actin nucleation. These findings provide further human genetic evidence supporting LMOD1 as a pathogenic gene underlying visceral myopathy including PIPO and MMIHS, strengthen the critical role of ABS2 domain in LMOD1-mediated actin nucleation, and moreover, reveal an unrecognized role of ABS2 in protein stability.	[Liu, Keqiang; Lu, Lina; Chen, Shanshan; Cai, Hui; Wang, Ying; Cai, Wei] Shanghai Jiao Tong Univ, Xinhua Hosp, Div Pediat Gastroenterol & Nutr, Sch Med, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China; [Liu, Keqiang; Gu, Beilin; Cai, Wei] Shanghai Inst Pediat Res, Shanghai, Peoples R China; [Liu, Keqiang; Wang, Ying; Cai, Wei] Shanghai Key Lab Pediat Gastroenterol & Nutr, Shanghai, Peoples R China; [Cai, Wei] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Pediat Surg, Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, Y; Cai, W (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Div Pediat Gastroenterol & Nutr, Sch Med, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.	wangying02@xinhuamed.com; caiw204@sjtu.edu.cn			National Natural Science Foundation of China (NSFC) [81974066, 81630039]; Foundation of Shanghai Municipal Health Commission [shslczdzk05702]; Science and Technology Committee of Shanghai Municipality [19495810500, 21YF1437700]; Shanghai Hospital Development Center (SHDC) [SHDC2020CR2010A]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Foundation of Shanghai Municipal Health Commission; Science and Technology Committee of Shanghai Municipality(Shanghai Science & Technology Committee); Shanghai Hospital Development Center (SHDC)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81974066 and 81630039; Foundation of Shanghai Municipal Health Commission, Grant/Award Number: shslczdzk05702; Science and Technology Committee of Shanghai Municipality, Grant/Award Number: 19495810500 and 21YF1437700; Shanghai Hospital Development Center (SHDC), Grant/Award Number: SHDC2020CR2010A	Ahrens-Nicklas RC, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax2066; Batzir NA, 2020, HUM MUTAT, V41, P641, DOI 10.1002/humu.23960; Billon C, 2020, CLIN GENET, V98, P261, DOI 10.1111/cge.13801; Boczkowska M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9314; Bonora E, 2015, GASTROENTEROLOGY, V148, P771, DOI 10.1053/j.gastro.2014.12.034; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; den Dunnen JT, 2016, HUM MUTAT, V37, P564, DOI 10.1002/humu.22981; Dong WL, 2019, CLIN GENET, V96, P473, DOI 10.1111/cge.13617; Faure C, 1999, DIGEST DIS SCI, V44, P953, DOI 10.1023/A:1026656513463; Fowler VM, 2017, BIOPHYS J, V112, P1742, DOI 10.1016/j.bpj.2017.03.034; Gauthier J, 2015, EUR J HUM GENET, V23, P1266, DOI 10.1038/ejhg.2014.256; Ghavamian R, 1997, J UROLOGY, V158, P1286, DOI 10.1016/S0022-5347(01)64456-2; Gilbert MA, 2020, HUM MUTAT, V41, P973, DOI 10.1002/humu.23986; Halim D, 2017, AM J HUM GENET, V101, P123, DOI 10.1016/j.ajhg.2017.05.011; Halim D, 2017, P NATL ACAD SCI USA, V114, pE2739, DOI 10.1073/pnas.1620507114; Hashmi SK, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140604; Lapointe SP, 2002, J UROLOGY, V168, P1768, DOI 10.1016/S0022-5347(05)64410-2; Lehtonen HJ, 2012, GASTROENTEROLOGY, V143, P1482, DOI 10.1053/j.gastro.2012.08.045; Li Hui, 2009, Zhonghua Er Ke Za Zhi, V47, P487; Li JC, 2018, NUCLEIC ACIDS RES, V46, pD1039, DOI 10.1093/nar/gkx1039; Milunsky A, 2017, J PEDIATR GASTR NUTR, V65, P384, DOI 10.1097/MPG.0000000000001608; Moreno CA, 2018, EUR J HUM GENET, V26, P669, DOI 10.1038/s41431-017-0055-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sipponen T, 2009, J CLIN GASTROENTEROL, V43, P437, DOI 10.1097/MCG.0b013e31817d3f84; Thapar N, 2018, J PEDIATR GASTR NUTR, V66, P991, DOI 10.1097/MPG.0000000000001982; Thorson W, 2014, HUM GENET, V133, P737, DOI 10.1007/s00439-013-1406-0; Wangler MF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004258; Wei ZL, 2021, J PEDIATR GASTR NUTR, V72, P36, DOI 10.1097/MPG.0000000000002897; Yuen M, 2014, J CLIN INVEST, V124, P4693, DOI 10.1172/JCI75199	30	0	0	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22194	10.1096/fj.202101395R	http://dx.doi.org/10.1096/fj.202101395R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35170814				2022-12-28	WOS:000761250800002
J	Sanchez-Navarro, A; Murillo-de-Ozores, AR; Perez-Villalva, R; Linares, N; Carbajal-Contreras, H; Flores, ME; Gamba, G; Castaneda-Bueno, M; Bobadilla, NA				Sanchez-Navarro, Andrea; Rafael Murillo-de-Ozores, Adrian; Perez-Villalva, Rosalba; Linares, Nadyeli; Carbajal-Contreras, Hector; Flores, Maria Elena; Gamba, Gerardo; Castaneda-Bueno, Maria; Bobadilla, Norma A.			Transient response of serpinA3 during cellular stress	FASEB JOURNAL			English	Article						acute kidney injury; cellular stress; oxidative stress; starvation	SERINE-PROTEASE INHIBITOR; ALPHA-1-PROTEINASE INHIBITOR; ALPHA-1-ANTICHYMOTRYPSIN; ALPHA(1)-ANTICHYMOTRYPSIN; GLYCOSYLATION; DISEASE; DISRUPTION; STABILITY; BIOMARKER; PROTECTS	We demonstrated that serpinA3c/k relocates from the cytoplasm to the apical tubular membrane (ATM) in chronic kidney disease (CKD), suggesting its secretion in luminal space in pathophysiological contexts. Here, we studied serpinA3c/k expression and secretion under different stressful conditions in vitro and in vivo. HEK-293 cells were transfected with a FLAG-tagged serpinA3c/k clone and exposed to H2O2 or starvation. Both stressors induced serpinA3c/k secretion but with a higher molecular weight. Glycanase treatment established that serpinA3c/k is glycosylated. Site-directed mutagenesis for each of the four glycosylation sites was performed. During cellular stress, serpinA3c/k secretion increased with each mutant except in the quadruple mutant. In rats and patients suffering acute kidney injury (AKI), an atypical urinary serpinA3c/k excretion (uSerpinA3c/k) was observed. In rats with AKI, the greater the induced kidney damage, the greater the uSerpinA3 c/k, together with relocation toward ATM. Our findings show that: (1) serpinA3c/k is glycosylated and secreted, (2) serpinA3c/k secretion increases during cellular stress, (3) its appearance in urine reveals a pathophysiological state, and (4) urinary serpinA3 excretion could become a potential biomarker for AKI.	[Sanchez-Navarro, Andrea; Rafael Murillo-de-Ozores, Adrian; Perez-Villalva, Rosalba; Gamba, Gerardo; Bobadilla, Norma A.] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mol Physiol Unit, Mexico City, DF, Mexico; [Sanchez-Navarro, Andrea; Rafael Murillo-de-Ozores, Adrian; Perez-Villalva, Rosalba; Linares, Nadyeli; Carbajal-Contreras, Hector; Gamba, Gerardo; Castaneda-Bueno, Maria; Bobadilla, Norma A.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Nephrol & Mineral Metab, Mexico City, DF, Mexico; [Carbajal-Contreras, Hector] Univ Nacl Autonoma Mexico, Combined Studies Program Med MD PhD PECEM, Fac Med, Mexico City, DF, Mexico; [Flores, Maria Elena] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Mol Biol & Biotechnol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Bobadilla, NA (corresponding author), Unidad Fisiol Mol, Vasco Quiruga 15, Mexico City 14000, DF, Mexico.	nab@biomedicas.unam.mx	CASTANEDA-BUENO, MARIA/GYR-1202-2022	Sanchez-Navarro, Andrea/0000-0002-5625-323X; Bobadilla, Norma A/0000-0002-3153-9151	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [235855, 235964, 272390]; Universidad Nacional Autonoma de Mexico (UNAM) [IN201619, IN201022]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico)	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Grant/Award Number: 235855, 235964 and 272390; Universidad Nacional Autonoma de Mexico (UNAM), Grant/Award Number: IN201619 and IN201022	Ortega-Trejo JA, 2015, BIOMARKERS, V20, P453, DOI 10.3109/1354750X.2015.1096305; Baker C, 2007, FRONT BIOSCI, V12, P2821, DOI 10.2741/2275; Barrera-Chimal J, 2011, EMBO MOL MED, V3, P5, DOI 10.1002/emmm.201000105; Benchabane M, 2009, PLANT BIOTECHNOL J, V7, P146, DOI 10.1111/j.1467-7652.2008.00382.x; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Caval T, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.608466; Charlton JR, 2014, NEPHROL DIAL TRANSPL, V29, P1301, DOI 10.1093/ndt/gft510; CONZ P, 1990, NEPHRON, V56, P387, DOI 10.1159/000186180; DeCoux A, 2015, CRIT CARE MED, V43, P2049, DOI 10.1097/CCM.0000000000001134; DeKosky ST, 2003, ANN NEUROL, V53, P81, DOI 10.1002/ana.10414; Morales-Buenrostro LE, 2019, AM J PHYSIOL-RENAL, V317, pF519, DOI 10.1152/ajprenal.00606.2018; Garcia-Ortuno LE, 2019, AM J PHYSIOL-RENAL, V317, pF1637, DOI 10.1152/ajprenal.00356.2019; Garcia-Ortuno LE, 2018, REV INVEST CLIN, V70, P261, DOI 10.24875/RIC.18002546; Flintegaard TV, 2010, ENDOCRINOLOGY, V151, P5326, DOI 10.1210/en.2010-0574; Funk JA, 2012, AM J PHYSIOL-RENAL, V302, pF853, DOI 10.1152/ajprenal.00035.2011; GROSS V, 1990, BIOL CHEM H-S, V371, P231, DOI 10.1515/bchm3.1990.371.1.231; Hu JY, 2013, INVEST OPHTH VIS SCI, V54, P5400, DOI 10.1167/iovs.12-10145; JEPPSSON JO, 1975, NEW ENGL J MED, V293, P576, DOI 10.1056/NEJM197509182931203; Jing Y, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01215; Kamboh MI, 2006, NEUROBIOL AGING, V27, P1435, DOI 10.1016/j.neurobiolaging.2005.07.015; Kidney Dis Improving Global, 2017, KIDNEY INT SUPPL, V7, P1, DOI 10.1016/j.kisu.2017.04.001; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; LECAM A, 1987, EMBO J, V6, P1225, DOI 10.1002/j.1460-2075.1987.tb02358.x; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Limbutara K, 2020, J AM SOC NEPHROL, V31, P1255, DOI 10.1681/ASN.2020010071; Liu XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016712; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; Luo DY, 2017, ONCOTARGETS THER, V10, P2173, DOI 10.2147/OTT.S133022; Mahadeva R, 2001, THORAX, V56, P53, DOI 10.1136/thorax.56.1.53; McCarthy C, 2014, J PROTEOME RES, V13, P596, DOI 10.1021/pr400752t; Morales-Buenrostro LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109407; MUROHARA T, 1995, J PHARMACOL EXP THER, V274, P1246; Pere-Brissaud A, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150071; Perez-Villalva R, 2017, BIOMARKERS, V22, P548, DOI 10.1080/1354750X.2017.1315616; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Reily C, 2019, NAT REV NEPHROL, V15, P346, DOI 10.1038/s41581-019-0129-4; RUDD PM, 1994, BIOCHEMISTRY-US, V33, P17, DOI 10.1021/bi00167a003; Sanchez-Navarro A, 2020, AM J PHYSIOL-CELL PH, V320, pC106, DOI 10.1152/ajpcell.00366.2020; Sanchez-Navarro A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46601-1; Sandford AJ, 1998, DIS MARKERS, V13, P257, DOI 10.1155/1998/867620; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Sun HO, 2008, LUPUS, V17, P56, DOI 10.1177/0961203307083443; TAKADA S, 1988, BIOCHEM INT, V16, P949; Zhang B, 2010, DIABETES, V59, P1809, DOI 10.2337/db09-1056; Zhang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004077; Zhang B, 2009, INVEST OPHTH VIS SCI, V50, P3943, DOI 10.1167/iovs.08-2954; Zheng XL, 2017, INVEST OPHTH VIS SCI, V58, P2874, DOI 10.1167/iovs.17-21544; Zhou T, 2014, INVEST OPHTH VIS SCI, V55, P4863, DOI 10.1167/iovs.14-14023; Zhou T, 2012, INVEST OPHTH VIS SCI, V53, P5033, DOI 10.1167/iovs.12-9729; Zhu HZ, 2017, CELL PHYSIOL BIOCHEM, V41, P2289, DOI 10.1159/000475648	50	3	3	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22190	10.1096/fj.202101912R	http://dx.doi.org/10.1096/fj.202101912R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35147994				2022-12-28	WOS:000761250800005
J	Tian, WQ; Chen, SY; Chuan, FN; Zhao, WR; Zhou, B				Tian, Wen-qing; Chen, Si-yu; Chuan, Feng-ning; Zhao, Wen-rui; Zhou, Bo			Down-regulated TINAGL1 in fibroblasts impairs wound healing in diabetes	FASEB JOURNAL			English	Article						diabetes; fibroblasts; high glucose; TINAGL1; wound healing	MATRICELLULAR PROTEIN CCN1; SKIN; EXPRESSION; PERIOSTIN	Matricellular proteins, a group of extracellular matrix (ECM) proteins, are key regulators of skin repair and their dysregulation impairs wound healing in diabetes. Tubulointerstitial nephritis antigen like 1 (TINAGL1) is a new member of matricellular protein family, and the understanding of its functional role is still relatively limited. In the current study, we detected the expression of TINAGL1 in diabetic skin wound tissues through RT-PCR, ELISA and Western blot analysis, investigated the contribution of TINAGL1 to wound healing through cutaneous administration of recombinant TINAGL1 protein, and characterized its regulation by hyperglycemia through RNA-seq and signal pathway inhibition assay. We showed that TINAGL1 expression has dynamic change and reaching a peak on day-9 after wound during the wound healing process in wild-type (WT) mice. Interestingly, decreased TINAGL1 expression is detected in skin tissues of diabetic patients and mice after wound. Then, we found that high glucose (HG), an important factor that impairs wound healing, reduces the expression of TINAGL1 in fibroblasts through JNK pathway. Notably, the histology analysis, Masson trichrome assay and IHC assay showed that exogenous TINAGL1 promotes wound healing in diabetic mice by accelerating the formation of granulation tissues. Our study provides evidence that TINAGL1 has an essential role in diabetic wound healing, and meanwhile, indicates that manipulation of TINAGL1 might be a possible therapeutic approach.	[Tian, Wen-qing; Chen, Si-yu; Chuan, Feng-ning; Zhao, Wen-rui; Zhou, Bo] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing 400016, Peoples R China	Chongqing Medical University	Zhou, B (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing 400016, Peoples R China.	zhoubo915@126.com	CHEN, SI/GZL-4800-2022					Armstrong DG, 2017, NEW ENGL J MED, V376, P2367, DOI 10.1056/NEJMra1615439; Bergmeier V, 2018, MATRIX BIOL, V65, P59, DOI 10.1016/j.matbio.2017.07.005; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Brown LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013905; Chen H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.544; Elliott CG, 2019, TISSUE ENG PT A, V25, P1326, DOI [10.1089/ten.TEA.2018.0268, 10.1089/ten.tea.2018.0268]; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Foulsham W, 2019, OCUL SURF, V17, P374, DOI 10.1016/j.jtos.2019.06.001; He RG, 2017, MOL IMMUNOL, V90, P42, DOI 10.1016/j.molimm.2017.06.249; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kim KH, 2018, J CELL COMMUN SIGNAL, V12, P273, DOI 10.1007/s12079-018-0450-x; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kunkemoeller B, 2019, DIABETES, V68, P2016, DOI 10.2337/db18-1001; Leask Andrew, 2009, Front Biosci (Elite Ed), V1, P115; Li D, 2007, FEBS J, V274, P2506, DOI 10.1111/j.1742-4658.2007.05786.x; Lim JZM, 2017, J ROY SOC MED, V110, P104, DOI 10.1177/0141076816688346; Mukai K, 2003, J BIOL CHEM, V278, P17084, DOI 10.1074/jbc.M301477200; Murphy-Ullrich JE, 2014, MATRIX BIOL, V37, P1, DOI 10.1016/j.matbio.2014.07.005; Musetti SN, 2021, MOL PHARMACEUT, V18, P2032, DOI 10.1021/acs.molpharmaceut.1c00008; Okamoto H, 2012, CARDIOVASC THER, V30, pe198, DOI 10.1111/j.1755-5922.2011.00276.x; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Rousselle P, 2019, MATRIX BIOL, V75-76, P12, DOI 10.1016/j.matbio.2018.01.002; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Shan ZG, 2021, J GASTROEN HEPATOL, V36, P196, DOI 10.1111/jgh.15150; Shen M, 2019, CANCER CELL, V35, P64, DOI 10.1016/j.ccell.2018.11.016; Sun L, 2019, CANCER MANAG RES, V11, P767, DOI 10.2147/CMAR.S190390; Umeyama H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S9-S2; Yin SL, 2020, CHINESE MED J-PEKING, V133, P2236, DOI 10.1097/CM9.0000000000000949; Zheng XW, 2019, P NATL ACAD SCI USA, V116, P6985, DOI 10.1073/pnas.1900351116	29	0	0	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22235	10.1096/fj.202101438RR	http://dx.doi.org/10.1096/fj.202101438RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35199864				2022-12-28	WOS:000761250800009
J	Kang, SP; Wu, QL; Yang, BY; Wu, CY				Kang, Shuangpeng; Wu, Qiongli; Yang, Binyan; Wu, Changyou			Estrogen enhanced the expression of IL-17 by tissue-resident memory gamma delta T cells from uterus via interferon regulatory factor 4	FASEB JOURNAL			English	Article						CXCR3-CXCL10 chemokine axis; estrogen; IL-17; IRF-4; gamma delta T cells	RECEPTOR; DIFFERENTIATION; TRANSCRIPTION; INDUCTION; ESTRADIOL; ARTHRITIS; ANTIBODY; TARGETS; SIGNAL; MOUSE	Tissue-resident memory gamma delta T cells at mucosal and epithelial sites play an important role for pathogen clearance, immunosurveillance, and participating in physiological processes. Different from other barrier sites, the immune cells in uterus face the protection against infections and tolerate an allogeneic fetus during a successful pregnancy. In the previous study. we found that tissue-resident memory gamma delta T cells were enriched both in human and murine uterus and highly expressed IL-17 that promoted the invasion of trophocytes in vitro. In the current study, we found that gamma delta T cells in uterus but not in blood or spleens expressed higher levels of estrogen receptors. The injection of estrogen into mice increased the proportion of gamma delta T cells in uterus but not in spleens in vivo via CXCR3-CXCL10 chemokine axis. In addition, we found that estrogen enhanced the production of IL-17 but not IFN-gamma in vivo and in vitro via interferon regulatory factor 4 but not ROR gamma t and pSTAT3 at mRNA and protein levels. The analysis of cell transcriptome sequence further identified multiple differentially expressed genes between estrogen and control gamma delta T cells. Our study demonstrated that estrogen directly act on gamma delta T cells in uterus to enhance the production of IL-17 that might promote the invasion of trophocytes. Furthermore, our study might provide a new idea that estrogen increased the prevalence of autoimmune diseases in women by enhancing gamma delta T cell-derived IL-17 production in uterus and uncover the critical pathological roles for estrogen in the development of autoimmune diseases.	[Kang, Shuangpeng] Changsha Med Univ, Academician Workstn, Hunan Key Lab Res & Dev Novel Pharmaceut Preparat, 1501 Leifeng Rd, Changsha 410219, Peoples R China; [Wu, Qiongli; Yang, Binyan; Wu, Changyou] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Immunol, 74 Zhongshan 2nd Rd, Guangzhou 510080, Peoples R China	Changsha Medical University; Sun Yat Sen University	Kang, SP (corresponding author), Changsha Med Univ, Academician Workstn, Hunan Key Lab Res & Dev Novel Pharmaceut Preparat, 1501 Leifeng Rd, Changsha 410219, Peoples R China.; Wu, CY (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Inst Immunol, 74 Zhongshan 2nd Rd, Guangzhou 510080, Peoples R China.	kangshp@163.com; changyou_wu@yahoo.com			National Natural Science Foundation of China (NSFC) [81971556]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81971556	Andersson A, 2015, CLIN IMMUNOL, V161, P324, DOI 10.1016/j.clim.2015.09.014; Andersson A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0548-y; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Carreras E, 2010, BLOOD, V115, P238, DOI 10.1182/blood-2009-08-236935; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Huber M, 2008, P NATL ACAD SCI USA, V105, P20846, DOI 10.1073/pnas.0809077106; Ito Y, 2009, ARTHRITIS RHEUM-US, V60, P2294, DOI 10.1002/art.24687; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kalaitzidis D, 2005, TRENDS ENDOCRIN MET, V16, P46, DOI 10.1016/j.tem.2005.01.004; Kang SP, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.588227; Kassi E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/317452; Khairallah C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02636; Khan D, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00635; Kohlgruber AC, 2018, NAT IMMUNOL, V19, P464, DOI 10.1038/s41590-018-0094-2; Lelu K, 2011, J IMMUNOL, V187, P2386, DOI 10.4049/jimmunol.1101578; Markle JGM, 2013, J IMMUNOL, V190, P5392, DOI 10.4049/jimmunol.1203502; McGeachy MJ, 2019, IMMUNITY, V50, P892, DOI 10.1016/j.immuni.2019.03.021; McInnes IB, 2014, ANN RHEUM DIS, V73, P349, DOI 10.1136/annrheumdis-2012-202646; Michel ML, 2012, P NATL ACAD SCI USA, V109, P17549, DOI 10.1073/pnas.1204327109; Munoz-Ruiz M, 2017, TRENDS IMMUNOL, V38, P336, DOI 10.1016/j.it.2017.01.007; Munoz-Ruiz M, 2016, NAT IMMUNOL, V17, P721, DOI 10.1038/ni.3424; Ning CC, 2016, CANCER RES, V76, P1354, DOI 10.1158/0008-5472.CAN-15-1260; O'Lone R, 2004, MOL ENDOCRINOL, V18, P1859, DOI 10.1210/me.2003-0044; Papotto PH, 2018, J AUTOIMMUN, V87, P26, DOI 10.1016/j.jaut.2017.11.006; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Paul S, 2015, J LEUKOCYTE BIOL, V97, P259, DOI 10.1189/jlb.3RU0914-443R; Pinget GV, 2016, IMMUNOL CELL BIOL, V94, P623, DOI 10.1038/icb.2016.48; Ramirez-Valle F, 2015, P NATL ACAD SCI USA, V112, P8046, DOI 10.1073/pnas.1508990112; Samavat H, 2015, CANCER LETT, V356, P231, DOI 10.1016/j.canlet.2014.04.018; Schirmer L, 2013, JAMA NEUROL, V70, P345, DOI 10.1001/2013.jamaneurol.409; Sentman CL, 2004, J IMMUNOL, V173, P6760, DOI 10.4049/jimmunol.173.11.6760; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; van Mens LJJ, 2018, ARTHRITIS RHEUMATOL, V70, P1994, DOI 10.1002/art.40581; Wang SH, 2012, GASTROENTEROLOGY, V142, P989, DOI 10.1053/j.gastro.2011.12.045; Wu P, 2014, IMMUNITY, V40, P785, DOI 10.1016/j.immuni.2014.03.013; Xu ZX, 2018, J CELL BIOCHEM, V119, P8659, DOI 10.1002/jcb.27111	40	1	1	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22166	10.1096/fj.202101443RR	http://dx.doi.org/10.1096/fj.202101443RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35064703	hybrid			2022-12-28	WOS:000747987800035
J	Cai, JR; Jiang, SL; Quan, YP; Lin, JY; Zhu, SW; Wang, J; Jiang, WQ; Liao, YJ; Lu, F				Cai, Junrong; Jiang, Shenglu; Quan, Yuping; Lin, Jiayan; Zhu, Shaowei; Wang, Jing; Jiang, Wenqing; Liao, Yunjun; Lu, Feng			Skeletal muscle provides a pro-browning microenvironment for transplanted brown adipose tissue to maintain its effect to ameliorate obesity in ob/ob mice	FASEB JOURNAL			English	Article						adipose tissue browning; fat transplantation; obesity; skeletal muscle	ENDOTHELIAL GROWTH-FACTOR; WHITE; FAT; CELLS; INFLAMMATION; ADIPOCYTES; ACTIVATION; EXPRESSION; REVERSAL; THERAPY	Brown adipose tissue (BAT) transplantation is a promising means of increasing whole-body energy metabolism to ameliorate obesity. However, the changes in BAT following transplantation and the effects of the microenvironment of the recipient site on graft function have yet to be fully characterized. Therefore, we aimed to determine the effects of transplanting BAT from C57BL/6 mice into the dorsal subcutaneous region or deep to the quadriceps femoris muscle of leptin-deficient ob/ob mice. Subcutaneously transplanted BAT lost features of BAT and demonstrated greater inflammatory cell infiltration and more oil cysts 16 weeks following transplantation. By contrast, the sub-muscularly transplanted BAT maintained features of BAT and was more highly vascularized. Interestingly, sub-muscular BAT transplantation led to a significant increase in oxygen consumption and less inflammation in subcutaneous fat, which was associated with long-term reductions in insulin resistance and body mass gain, whereas the subcutaneous transplants failed after 16 weeks. These results demonstrate that the beneficial effects of BAT transplantation depend upon the microenvironment of the recipient site. Skeletal muscle may provide a microenvironment that maintains the inherent features of BAT grafts over a long period of time, which facilitates a reduction in obesity and improvements in glucose homeostasis.	[Cai, Junrong; Jiang, Shenglu; Quan, Yuping; Lin, Jiayan; Zhu, Shaowei; Wang, Jing; Jiang, Wenqing; Liao, Yunjun; Lu, Feng] Southern Med Univ, Nanfang Hosp, Dept Plast Surg, Guangzhou, Peoples R China; [Jiang, Shenglu] Taizhou Univ, Taizhou Cent Hosp, Dept Plast Surg, Taizhou, Peoples R China	Southern Medical University - China; Taizhou University	Liao, YJ; Lu, F (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Plast & Cosmet Surg, 1838 Guangzhou North Rd, Guangzhou 510515, Guangdong, Peoples R China.	Yunjun1000@sina.com; doctorlufeng@hotmail.com			National Nature Science Foundation of China [81971852,81801932,81901976]; Natural Science Foundation of Guangdong Province of China [2019A1515010641, 2021A1515011721]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Nature Science Foundation of China (81971852,81801932,81901976), the Natural Science Foundation of Guangdong Province of China (2019A1515010641, 2021A1515011721)	Arroyo-Johnson C, 2016, GASTROENTEROL CLIN N, V45, P571, DOI 10.1016/j.gtc.2016.07.012; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brendle C, 2018, ACAD RADIOL, V25, P102, DOI 10.1016/j.acra.2017.09.007; Cardel MI, 2020, JAMA PEDIATR, V174, P609, DOI 10.1001/jamapediatrics.2020.0085; Soler-Vazquez MC, 2018, BIOCHEM PHARMACOL, V155, P346, DOI 10.1016/j.bcp.2018.07.022; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Crandall JP, 2018, J NUCL MED, V59, P1243, DOI 10.2967/jnumed.117.204339; Cui XW, 2019, FEBS J, V286, P2753, DOI 10.1111/febs.14838; Edwards CM, 2016, ENDOCRIN METAB CLIN, V45, P751, DOI 10.1016/j.ecl.2016.06.007; Fredriksson JM, 2000, J BIOL CHEM, V275, P13802, DOI 10.1074/jbc.275.18.13802; Gozal D, 2017, AM J RESP CELL MOL, V56, P477, DOI 10.1165/rcmb.2016-0243OC; Gunawardana SC, 2015, AM J PHYSIOL-ENDOC M, V308, pE1043, DOI 10.1152/ajpendo.00570.2014; Gunawardana SC, 2012, DIABETES, V61, P674, DOI 10.2337/db11-0510; HAYASHI M, 1983, AM J PHYSIOL, V245, pE582, DOI 10.1152/ajpendo.1983.245.6.E582; Kahan S, 2019, JAMA-J AM MED ASSOC, V321, P1349, DOI 10.1001/jama.2019.2352; Li R, 2019, J TISSUE ENG REGEN M, V13, P1609, DOI 10.1002/term.2913; Liu XM, 2015, ENDOCRINOLOGY, V156, P2461, DOI 10.1210/en.2014-1598; Liu Y, 2019, FASEB J, V33, P8822, DOI 10.1096/fj.201802162RR; Lu KY, 2020, CYTOTHERAPY, V22, P521, DOI 10.1016/j.jcyt.2020.06.004; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Patterson CC, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107842; Payab M, 2021, INT J OBESITY, V45, P109, DOI 10.1038/s41366-020-0616-5; Sakamoto T, 2013, AM J PHYSIOL-CELL PH, V304, pC729, DOI 10.1152/ajpcell.00312.2012; Sanchez-Rangel E, 2020, INT J OBESITY, V44, P964, DOI 10.1038/s41366-019-0471-4; Schosserer M, 2018, GERONTOLOGY, V64, P229, DOI 10.1159/000485183; Shankar K, 2019, EUR J PHARMACOL, V854, P354, DOI 10.1016/j.ejphar.2019.02.044; Shimizu I, 2014, J CLIN INVEST, V124, P2099, DOI 10.1172/JCI71643; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Sun SY, 2012, DIABETES, V61, P1471, DOI 10.2337/db11-1389; Tajima K, 2019, NAT METAB, V1, P886, DOI 10.1038/s42255-019-0106-z; Tonello C, 1999, FEBS LETT, V442, P167, DOI 10.1016/S0014-5793(98)01627-5; Villarroya J, 2019, J ENDOCRINOL, V243, pR19, DOI 10.1530/JOE-19-0295; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Wang S, 2015, BIOCHEM BIOPH RES CO, V466, P247, DOI 10.1016/j.bbrc.2015.09.018; Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120; White JD, 2019, MOL ASPECTS MED, V68, P74, DOI 10.1016/j.mam.2019.06.004	37	2	2	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22056	10.1096/fj.202101144R	http://dx.doi.org/10.1096/fj.202101144R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34939223				2022-12-28	WOS:000734992000004
J	Kaplan, N; Liu, M; Wang, JY; Yang, WD; Fiolek, E; Peng, H; Lavker, RM				Kaplan, Nihal; Liu, Min; Wang, Junyi; Yang, Wending; Fiolek, Elaina; Peng, Han; Lavker, Robert M.			Eph signaling is regulated by miRNA-210: Implications for corneal epithelial repair	FASEB JOURNAL			English	Article						corneal epithelium; Eph; ephrin signaling; F-actin; microRNAs; migration; wound repair	STEM-CELLS; EPIDERMAL DIFFERENTIATION; GENE-EXPRESSION; RECEPTOR; MACROPINOCYTOSIS; MICRORNAS; MIGRATION; AUTOPHAGY; MIR-210; TARGETS	A distinct boundary exists between the progenitor cells in the basal limbal epithelium and the more differentiated corneal epithelial basal cells. We have shown that reciprocal expression patterns of EphA2 and Ephrin-A1 are likely to contribute to normal limbal-corneal epithelial compartmentalization as well as play a role in response to injury. How this signaling axis is regulated remains unclear. We have demonstrated that microRNAs (miRNAs) play critical roles in corneal epithelial wound healing and several miRNAs (e.g. miR-210) have been predicted to target ephrins. Previous expression profiling experiments demonstrated that miR-210 is prominently expressed in corneal epithelial cells. RNA-seq data acquired from miR-210-depleted HCECs showed up-regulation of genes involved in cellular migration. In addition, miR-210 is decreased after corneal injury while EphA2 is increased. Moreover, antago-210-treated HCECs markedly enhanced wound closure in a scratch wound assay. Antago-210 treatment resulted in increased EphA2 protein levels as well as pS897-EphA2, the pro-migratory form of EphA2. As expected, Ephrin-A1 levels were reduced, while levels of a well-known target of miR-210, Ephrin-A3, were increased by antago-210 treatment. The increase in migration with antago-210 could be inhibited by Ephrin-A1 overexpression, Ephrin-A1-Fc treatment or siRNA depletion of EphA2. However, depletion of Ephrin-A3 did not have effects on the antago-210-induced increase in migration. In addition, Ephrin-A1 overexpression and siEphA2 dampened EGFR signaling, which is increased by antago-210. Our data clearly demonstrate a link between miR-210 and EphA2/Ephrin-A1 signaling that regulates, in part, corneal epithelial migration. This interaction might potentially control the limbal-corneal epithelial boundary.	[Kaplan, Nihal; Liu, Min; Wang, Junyi; Yang, Wending; Fiolek, Elaina; Peng, Han; Lavker, Robert M.] Northwestern Univ, Dept Dermatol, 303 East Chicago Ave,Ward 9-124, Chicago, IL 60611 USA; [Wang, Junyi] Chinese Peoples Liberat Army Gen Hosp, Dept Ophthalmol, Ophthalmol & Visual Sci Key Lab PLA, Beijing, Peoples R China	Northwestern University; Chinese People's Liberation Army General Hospital	Lavker, RM (corresponding author), Northwestern Univ, Dept Dermatol, 303 East Chicago Ave,Ward 9-124, Chicago, IL 60611 USA.; Peng, H (corresponding author), Northwestern Univ, Dept Dermatol, 303 East Chicago Ave,Ward 9-120, Chicago, IL 60611 USA.	han-peng@northwestern.edu; r-lavker@northwestern.edu	wang, junyi/GYA-3213-2022	Peng, Han/0000-0002-1105-8254	National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR075049]; NCI [CCSG P30 CA060553]; NIH [1S100 D021704 -01]; National Institutes of Health [EY028560, EY019463, EY032922]; Dermatology Foundation; Eversight research grant	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation; Eversight research grant	The NU-SODRC Skin Tissue Engineering and Morphology Core facility assisted in morphologic analysis. The NUSBDRC Is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR075049. Imaging work was performed at the Northwestern University Center for Advanced Microscopy generously supported by NCI CCSG P30 CA060553 awarded to the Robert I I Lurie Comprehensive Cancer Center. high content imaging was performed on the Nikon Biostation CT system purchased with the support of NIH 1S100 D021704 -01. This research is supported by National Institutes of lealth Grants EY028560 and EY019463 (to R.M.I,.), and EY032922 (to Ht.); a Dermatology Foundation research grant and Career Development Award (to H.P.); and an Eversight research grant (to H.P.).	Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bhattacharya S, 2019, STEM CELLS, V37, P417, DOI 10.1002/stem.2959; Biswas S, 2010, P NATL ACAD SCI USA, V107, P6976, DOI 10.1073/pnas.1001653107; Cakmak H, 2018, CUTAN OCUL TOXICOL, V37, P191, DOI 10.1080/15569527.2017.1375943; Dallas A, 2019, TISSUE ENG PT A, V25, P44, DOI [10.1089/ten.TEA.2017.0484, 10.1089/ten.tea.2017.0484]; Denning MF, 2002, CELL DEATH DIFFER, V9, P40, DOI 10.1038/sj.cdd.4400929; Devlin C, 2011, IUBMB LIFE, V63, P94, DOI [10.1002/iub.00427, 10.1002/iub.427]; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Funari VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084425; Genander M, 2012, CELL ADHES MIGR, V6, P126, DOI 10.4161/cam.18932; Genander M, 2010, CURR OPIN CELL BIOL, V22, P611, DOI 10.1016/j.ceb.2010.08.005; Getsios S, 2009, J CELL BIOL, V185, P1243, DOI 10.1083/jcb.200809044; Huang X, 2010, TRENDS MOL MED, V16, P230, DOI 10.1016/j.molmed.2010.03.004; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Kaplan N, 2020, FASEB J, V34, P525, DOI 10.1096/fj.201901512R; Kaplan N, 2018, INVEST OPHTH VIS SCI, V59, P393, DOI 10.1167/iovs.17-22941; Kaplan N, 2012, INVEST OPHTH VIS SCI, V53, P936, DOI 10.1167/iovs.11-8685; Kojima T, 2007, CORNEA, V26, P569, DOI 10.1097/ICO.0b013e3180335526; Kulkarni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03449-7; Lavker RM, 2004, EXP EYE RES, V78, P433, DOI 10.1016/j.exer.2003.09.008; Lavker Robert M., 2009, Human Genomics, V3, P332; Lee SKW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021249; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin S, 2012, SEMIN CELL DEV BIOL, V23, P92, DOI 10.1016/j.semcdb.2011.10.017; Lin S, 2010, MOL BIOL CELL, V21, P3902, DOI 10.1091/mbc.E10-03-0242; Liu YM, 2019, INVEST OPHTH VIS SCI, V60, P2925, DOI 10.1167/iovs.19-26663; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Mohamed AM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002513; Narayanan S, 2005, EXP EYE RES, V80, P175, DOI 10.1016/j.exer.2004.08.027; Pajoohesh-Ganji A, 2005, BIOL CELL, V97, P265, DOI 10.1042/BC20040114; Park JK, 2017, FASEB J, V31, P257, DOI 10.1096/fj.201600746R; Park JK, 2016, J CELL BIOL, V215, P667, DOI 10.1083/jcb.201604032; Park JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134853; Peng H, 2017, AUTOPHAGY, V13, P975, DOI 10.1080/15548627.2017.1287658; Peng H, 2017, INVEST OPHTH VIS SCI, V58, P416, DOI 10.1167/iovs.16-21111; Peng H, 2015, STEM CELLS, V33, P1642, DOI 10.1002/stem.1962; Peng H, 2013, INVEST OPHTH VIS SCI, V54, P2781, DOI 10.1167/iovs.12-11512; Peng H, 2012, P NATL ACAD SCI USA, V109, P14030, DOI 10.1073/pnas.1111292109; Peng H, 2012, FASEB J, V26, P3140, DOI 10.1096/fj.11-198515; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Ryan D, 2006, MOL VIS, V12, P1175; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Stepp MA, 2005, OCUL SURF, V3, P15, DOI 10.1016/S1542-0124(12)70119-2; Swamynathan SK, 2008, INVEST OPHTH VIS SCI, V49, P3360, DOI 10.1167/iovs.08-1811; Teng YF, 2015, FUNCT INTEGR GENOMIC, V15, P277, DOI 10.1007/s10142-014-0417-9; Tseng SCG, 2016, OCUL SURF, V14, P100, DOI 10.1016/j.jtos.2015.12.002; Ventrella R, 2018, J INVEST DERMATOL, V138, P2133, DOI 10.1016/j.jid.2018.04.011; Ventrella R, 2017, EXP CELL RES, V358, P58, DOI 10.1016/j.yexcr.2017.03.024; Wang JY, 2020, ADV THER-GERMANY, V3, DOI 10.1002/adtp.202000138; Weigelt CM, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800149; White BEP, 2014, CELL ADHES MIGR, V8, P327, DOI 10.4161/19336918.2014.970012; Winkler MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114692; Wykosky J, 2007, MOL CANCER THER, V6, P3208, DOI 10.1158/1535-7163.MCT-07-0200; Yang NY, 2011, CELL SIGNAL, V23, P201, DOI 10.1016/j.cellsig.2010.09.004; Yu J, 2010, FASEB J, V24, P3950, DOI 10.1096/fj.10-157404; Zaccagnini G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09763-4	58	1	1	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22076	10.1096/fj.202101423R	http://dx.doi.org/10.1096/fj.202101423R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34856019				2022-12-28	WOS:000734992000044
J	Li, BW; Liu, Y; Zhang, L; Guo, XQ; Wen, C; Zhang, F; Luo, XY; Xia, YP				Li, Bo-Wei; Liu, Yu; Zhang, Lei; Guo, Xiao-Qing; Wen, Cheng; Zhang, Feng; Luo, Xue-Ying; Xia, Yuan-Peng			Cytotoxin-associated gene A (CagA) promotes aortic endothelial inflammation and accelerates atherosclerosis through the NLRP3/caspase-1/IL-1 beta axis	FASEB JOURNAL			English	Article						atherosclerosis; CagA; endothelial cells; Helicobacter pylori; NLRP3	HELICOBACTER-PYLORI INFECTION; CORONARY-HEART-DISEASE; NLRP3 INFLAMMASOME; IL-1-BETA PRODUCTION; CELLS; IDENTIFICATION; ACTIVATION; STRAINS; PATHWAY; EVENTS	Atherosclerosis is a chronic inflammatory disease. Pathophysiological similarities between chronic infections and atherosclerosis triggered interests between these conditions. The seroepidemiological study showed that Helicobacter pylori strains that express cytotoxin-associated gene A (CagA), an oncoprotein and a major virulence factor, was positively correlated with atherosclerosis and related clinical events. Nevertheless, the underlying mechanism is poorly understood. In this study, the seroprevalence of infection by H. pylori and by strains express CagA assessed by enzyme-linked immunosorbent assay (ELISA) showed that the prevalence of CagA strains rather than H. pylori in patients was positively correlated with atherogenesis. Correspondingly, we found that CagA augmented the growth of plaque of ApoE(-/-) mice in the early stage of atherosclerosis and promoted the expression of adhesion molecules and inflammatory cytokines in mouse aortic endothelial cells (MAECs). Mechanistically, both si-NLRP3 and si-IL-1 beta mitigated the promoting effect of CagA on the inflammatory activation of HAECs. In vivo, the inhibition of NLRP3 by MCC950 significantly attenuated the promoting effect of CagA on plaque growth of ApoE(-/-) mice. We also propose NLRP3 as a potential therapeutic target for CagA-positive H. pylori infection-related atherosclerosis and emphasize the importance of inflammation in atherosclerosis pathology.	[Li, Bo-Wei; Liu, Yu; Zhang, Lei; Guo, Xiao-Qing; Wen, Cheng; Zhang, Feng; Xia, Yuan-Peng] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430022, Peoples R China; [Luo, Xue-Ying] Huazhong Univ Sci & Technol, Tongji Med Coll, Affiliated Wuhan Mental Hlth Ctr, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Xia, YP (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430022, Peoples R China.; Luo, XY (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Affiliated Wuhan Mental Hlth Ctr, Wuhan 430022, Peoples R China.	luoxueying@hust.edu.cn; xiayuanpeng@hust.edu.cn		Li, Bo wei/0000-0002-5624-9361	National Key R&D Program of China [2018YFC1312200]; National Natural Science Foundation of China [81820108010, 81571119, 81771249, 81571139, 8197052225]; National Research Foundation for the Doctoral Program of Higher Education of China [20120142110068]; New Century Excellent Talents in University [NCET-10-0406]; Chinese & Western Medicine [SATCM-20180339]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Chinese & Western Medicine	National Key R&D Program of China, Grant/Award Number: 2018YFC1312200; National Natural Science Foundation of China, Grant/Award Number: 81820108010, 81571119, 81771249, 81571139 and 8197052225; National Research Foundation for the Doctoral Program of Higher Education of China, Grant/Award Number: 20120142110068; New Century Excellent Talents in University, Grant/Award Number: NCET-10-0406; Chinese & Western Medicine, Grant/Award Number: SATCM-20180339	Azarkar Z, 2011, CASP J INTERN MED, V2, P222; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Bloemenkamp DGM, 2002, EUR J CLIN INVEST, V32, P549, DOI 10.1046/j.1365-2362.2002.01022.x; Bobryshev YV, 2000, ATHEROSCLEROSIS, V152, P529, DOI 10.1016/S0021-9150(00)00547-5; Cai JM, 2002, CIRCULATION, V106, P1368, DOI 10.1161/01.CIR.0000028591.44554.F9; Chen DX, 2015, CIRCULATION, V131, P1350, DOI 10.1161/CIRCULATIONAHA.114.013423; Cho Youngjin, 2011, J Am Coll Cardiol, V57, P99, DOI 10.1016/j.jacc.2010.07.035; Chukkapalli SS, 2014, INFECT IMMUN, V82, P1959, DOI 10.1128/IAI.01511-14; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Doring Y, 2019, CIRCULATION, V139, P1338, DOI 10.1161/CIRCULATIONAHA.118.037953; Doyle B, 2007, J AM COLL CARDIOL, V49, P2073, DOI 10.1016/j.jacc.2007.01.089; Fan J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07895-3; Feletou M, 2011, BRIT J PHARMACOL, V164, P894, DOI 10.1111/j.1476-5381.2011.01276.x; Franceschi F, 2009, ATHEROSCLEROSIS, V202, P535, DOI 10.1016/j.atherosclerosis.2008.04.051; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; GIMBRONE MA, 1982, ANN NY ACAD SCI, V401, P171, DOI 10.1111/j.1749-6632.1982.tb25716.x; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Gistera A, 2017, NAT REV NEPHROL, V13, DOI 10.1038/nrneph.2017.51; Grebe A, 2018, CIRC RES, V122, P1722, DOI 10.1161/CIRCRESAHA.118.311362; Hamczyk MR, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809736; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Horvath R, 2000, J CLIN VIROL, V16, P17, DOI 10.1016/S1386-6532(99)00064-5; Hsu YC, 2015, GUT, V64, P495, DOI 10.1136/gutjnl-2014-308163; Jonsson AL, 2017, NAT REV CARDIOL, V14, P79, DOI 10.1038/nrcardio.2016.183; Kakkos SK, 2013, J VASC SURG, V57, P609, DOI 10.1016/j.jvs.2012.09.045; Kim DJ, 2013, EUR J IMMUNOL, V43, P2650, DOI 10.1002/eji.201243281; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Liao J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9977; Lima DS, 2013, NAT MED, V19, P909, DOI 10.1038/nm.3221; Liu YY, 2019, CIRC RES, V124, P575, DOI 10.1161/CIRCRESAHA.118.314010; Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132715; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; MENDALL MA, 1994, BRIT HEART J, V71, P437; Mistriotis P, 2017, AGEING RES REV, V37, P94, DOI 10.1016/j.arr.2017.05.006; Nakamura Y, 2012, IMMUNITY, V37, P85, DOI 10.1016/j.immuni.2012.04.013; Pachathundikandi SK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/192420; PATEL P, 1994, LANCET, V344, P511, DOI 10.1016/S0140-6736(94)91899-6; Pietroiusti A, 2002, CIRCULATION, V106, P580, DOI 10.1161/01.CIR.0000023894.10871.2F; Pothineni NVK, 2017, EUR HEART J, V38, P3195, DOI 10.1093/eurheartj/ehx362; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; Shao BZ, 2019, INFLAMMATION, V42, P1147, DOI 10.1007/s10753-019-01008-y; Shi HX, 2016, NAT IMMUNOL, V17, P250, DOI 10.1038/ni.3333; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; Souilhol C, 2020, NAT REV CARDIOL, V17, P52, DOI 10.1038/s41569-019-0239-5; Tabas I, 2017, IMMUNITY, V47, P621, DOI 10.1016/j.immuni.2017.09.008; Tumurkhuu G, 2018, CELL METAB, V28, P432, DOI 10.1016/j.cmet.2018.05.027; van der Heijden T, 2017, ARTERIOSCL THROM VAS, V37, P1457, DOI 10.1161/ATVBAHA.117.309575; Volgman AS, 2018, CIRCULATION, V138, pE1, DOI 10.1161/CIR.0000000000000580; Wang WZ, 2017, CIRCULATION, V135, P759, DOI 10.1161/CIRCULATIONAHA.116.025250; Waskito LA, 2018, HELICOBACTER, V23, DOI 10.1111/hel.12516; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918; Xie ZL, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007442; YAMASHIROYA HM, 1988, AM J PATHOL, V130, P71; Yang S, 2019, J MOL CELL CARDIOL, V135, P40, DOI 10.1016/j.yjmcc.2019.07.011; Zhang S, 2008, CHINESE MED J-PEKING, V121, P946, DOI 10.1097/00029330-200805020-00015; Zhong SS, 2019, J CLIN INVEST, V129, P252, DOI 10.1172/JCI122064	56	5	5	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21942	10.1096/fj.202100695RR	http://dx.doi.org/10.1096/fj.202100695RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34670018				2022-12-28	WOS:000712009200030
J	Pardasani, M; Marathe, SD; Purnapatre, MM; Dalvi, U; Abraham, NM				Pardasani, Meenakshi; Marathe, Shruti D.; Purnapatre, Maitreyee Mandar; Dalvi, Urvashi; Abraham, Nixon M.			Multimodal learning of pheromone locations	FASEB JOURNAL			English	Article						non-pheromonal volatiles discrimination; olfactory bulb; pheromone location preference; somatosensory cortex	MALE HOUSE MICE; ODOR DISCRIMINATION; MESSENGER-RNA; MUS-MUSCULUS; FEMALE MICE; SCENT; MOUSE; WHISKING; BEHAVIOR; MARKING	Memorizing pheromonal locations is critical for many mammalian species as it involves finding mates and avoiding competitors. In rodents, pheromonal information is perceived by the main and accessory olfactory systems. However, the role of somatosensation in context-dependent learning and memorizing of pheromone locations remains unexplored. We addressed this problem by training female mice on a multimodal task to locate pheromones by sampling volatiles emanating from male urine through the orifices of varying dimensions or shapes that are sensed by their vibrissae. In this novel pheromone location assay, female mice' preference toward male urine scent decayed over time when they were permitted to explore pheromones vs neutral stimuli, water. On training them for the associations involving olfactory and whisker systems, it was established that they were able to memorize the location of opposite sex pheromones, when tested 15 days later. This memory was not formed either when the somatosensory inputs through whisker pad were blocked or when the pheromonal cues were replaced with that of same sex. The association between olfactory and somatosensory systems was further confirmed by the enhanced expression of the activity-regulated cytoskeleton protein. Furthermore, the activation of main olfactory bulb circuitry by pheromone volatiles did not cause any modulation in learning and memorizing non-pheromonal volatiles. Our study thus provides the evidence for associations formed between different sensory modalities facilitating the long-term memory formation relevant to social and reproductive behaviors.	[Pardasani, Meenakshi; Marathe, Shruti D.; Purnapatre, Maitreyee Mandar; Dalvi, Urvashi; Abraham, Nixon M.] Indian Inst Sci Educ & Res IISER, Dept Biol, Lab Neural Circuits & Behav LNCB, Pune, Maharashtra, India; [Purnapatre, Maitreyee Mandar; Dalvi, Urvashi] Savitribai Phule Pune Univ, Inst Bioinformat & Biotechnol, Pune, Maharashtra, India	Indian Institute of Science Education & Research (IISER) Pune; Savitribai Phule Pune University	Abraham, NM (corresponding author), Indian Inst Sci Educ & Res IISER, Dept Biol, Pune 411008, Maharashtra, India.	nabraham@iiserpune.ac.in			Indian Institute of Science Education and Research Pune (IISER Pune); Council of Scientific and Industrial Research (CSIR); DBT India Alliance (India Alliance); Department of Science and Technology, Ministry of Science and Technology (DST)	Indian Institute of Science Education and Research Pune (IISER Pune); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); DBT India Alliance (India Alliance); Department of Science and Technology, Ministry of Science and Technology (DST)(Department of Science & Technology (DOST), Philippines)	Indian Institute of Science Education and Research Pune (IISER Pune); Council of Scientific and Industrial Research (CSIR); DBT India Alliance (India Alliance); Department of Science and Technology, Ministry of Science and Technology (DST)	Abraham NM, 2014, ELIFE, V3, DOI 10.7554/eLife.02109; Abraham NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051789; Abraham NM, 2010, NEURON, V65, P399, DOI 10.1016/j.neuron.2010.01.009; Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Arakawa H, 2008, NEUROSCI BIOBEHAV R, V32, P1236, DOI 10.1016/j.neubiorev.2008.05.012; Bellistri E, 2013, J PHYSIOL-LONDON, V591, P2667, DOI 10.1113/jphysiol.2013.251892; Bhattacharjee AS, 2019, CELL REP, V28, P2966, DOI 10.1016/j.celrep.2019.08.015; Boehm U, 2005, CELL, V123, P683, DOI 10.1016/j.cell.2005.09.027; Bouton ME, 2001, Q J EXP PSYCHOL-B, V54, P109, DOI 10.1080/02724990042000083; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; BRONSON FH, 1975, BIOL REPROD, V13, P94, DOI 10.1095/biolreprod13.1.94; Crandall SR, 2017, CELL REP, V21, P3065, DOI 10.1016/j.celrep.2017.11.049; Crowcroft P., 1966, MICE ALL OVER; Demir E, 2020, NATURE, V578, P137, DOI 10.1038/s41586-020-1967-8; Doty RL, 2001, ANNU REV PSYCHOL, V52, P423, DOI 10.1146/annurev.psych.52.1.423; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; EICHENBAUM H, 1992, BEHAV NEURAL BIOL, V57, P2, DOI 10.1016/0163-1047(92)90724-I; Gao M, 2010, J NEUROSCI, V30, P7168, DOI 10.1523/JNEUROSCI.1067-10.2010; Garcia J, 1966, PSYCHON SCI, V4, P123, DOI [10.3758/BF03342209, DOI 10.3758/BF03342209]; Gener T, 2009, J NEUROSCI METH, V176, P63, DOI 10.1016/j.jneumeth.2008.08.012; Greer PL, 2016, CELL, V165, P1734, DOI 10.1016/j.cell.2016.05.001; Grinevich V, 2009, J NEUROSCI METH, V184, P25, DOI 10.1016/j.jneumeth.2009.07.015; Guthrie K, 2000, NEUROREPORT, V11, P1809, DOI 10.1097/00001756-200006260-00003; Haidarliu S, 2012, ANAT REC, V295, P1181, DOI 10.1002/ar.22501; Hainmueller T, 2020, NAT REV NEUROSCI, V21, P153, DOI 10.1038/s41583-019-0260-z; Halem HA, 1999, J NEUROBIOL, V39, P249, DOI 10.1002/(SICI)1097-4695(199905)39:2<249::AID-NEU9>3.3.CO;2-I; Holy TE, 2018, ANNU REV NEUROSCI, V41, P501, DOI 10.1146/annurev-neuro-080317-061916; Humphries RE, 1999, ANIM BEHAV, V58, P1177, DOI 10.1006/anbe.1999.1252; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; HURST JL, 1993, ANIM BEHAV, V45, P55, DOI 10.1006/anbe.1993.1007; HURST JL, 1987, ANIM BEHAV, V35, P1433, DOI 10.1016/S0003-3472(87)80016-7; Ichikawa M, 2003, ZOOL SCI, V20, P687, DOI 10.2108/zsj.20.687; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; JEMIOLO B, 1986, P NATL ACAD SCI USA, V83, P4576, DOI 10.1073/pnas.83.12.4576; JONES RB, 1973, PHYSIOL BEHAV, V10, P221, DOI 10.1016/0031-9384(73)90301-6; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Kendrick KM, 2014, CURR BIOL, V24, pR228, DOI 10.1016/j.cub.2014.02.019; Khodadad A, 2015, BEHAV BRAIN RES, V284, P249, DOI 10.1016/j.bbr.2015.01.032; Kim J, 2020, NEURON, V108, DOI 10.1016/j.neuron.2020.09.012; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Kumikova A, 2017, CURR BIOL, V27, P688, DOI 10.1016/j.cub.2017.01.013; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2014, ANNU REV PHYSIOL, V76, P151, DOI 10.1146/annurev-physiol-021113-170334; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; MARUNIAK JA, 1974, PHYSIOL BEHAV, V12, P1035, DOI 10.1016/0031-9384(74)90151-6; Montag-Sallaz M, 2003, LEARN MEMORY, V10, P99, DOI 10.1101/lm.53403; Moore JD, 2013, NATURE, V497, P205, DOI 10.1038/nature12076; Pereira A, 2007, P NATL ACAD SCI USA, V104, P18286, DOI 10.1073/pnas.0708611104; Ranade S, 2013, J NEUROSCI, V33, P8250, DOI 10.1523/JNEUROSCI.3874-12.2013; Roberts SA, 2014, ANIM BEHAV, V97, P313, DOI 10.1016/j.anbehav.2014.08.010; Roberts SA, 2012, SCIENCE, V338, P1462, DOI 10.1126/science.1225638; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Rokni D, 2014, NAT NEUROSCI, V17, P1225, DOI 10.1038/nn.3775; SCHWENDE FJ, 1986, J CHEM ECOL, V12, P277, DOI 10.1007/BF01045611; Serguera C, 2008, NAT NEUROSCI, V11, P949, DOI 10.1038/nn.2154; Sheppard JP, 2013, J VISION, V13, DOI 10.1167/13.6.4; Sigl-Glockner J, 2019, CURR BIOL, V29, P3588, DOI 10.1016/j.cub.2019.08.062; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Stowers L, 2010, CURR OPIN NEUROBIOL, V20, P274, DOI 10.1016/j.conb.2010.02.013; Wang DG, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00320; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; WHITTEN WK, 1956, J ENDOCRINOL, V13, P399, DOI 10.1677/joe.0.0130399; Wolfe J, 2008, PLOS BIOL, V6, P1661, DOI 10.1371/journal.pbio.0060215; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zuo YF, 2011, PHILOS T R SOC B, V366, P3058, DOI 10.1098/rstb.2011.0161	67	0	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21836	10.1096/fj.202100167R	http://dx.doi.org/10.1096/fj.202100167R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34407246	Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000691122900051
J	Willis, CRG; Gallagher, IJ; Wilkinson, DJ; Brook, MS; Bass, JJ; Phillips, BE; Smith, K; Etheridge, T; Stokes, T; McGlory, C; Gorissen, SHM; Szewczyk, NJ; Phillips, SM; Atherton, PJ				Willis, Craig R. G.; Gallagher, Iain J.; Wilkinson, Daniel J.; Brook, Matthew S.; Bass, Joseph J.; Phillips, Bethan E.; Smith, Kenneth; Etheridge, Timothy; Stokes, Tanner; McGlory, Chris; Gorissen, Stefan H. M.; Szewczyk, Nathaniel J.; Phillips, Stuart M.; Atherton, Philip J.			Transcriptomic links to muscle mass loss and declines in cumulative muscle protein synthesis during short-term disuse in healthy younger humans	FASEB JOURNAL			English	Article						atrophy; disuse; gene network analysis; muscle protein synthesis; skeletal muscle	HUMAN SKELETAL-MUSCLE; NEUROMUSCULAR ELECTRICAL-STIMULATION; GENE-EXPRESSION PATTERNS; INSULIN-RESISTANCE; EXTRACELLULAR-MATRIX; ANABOLIC RESISTANCE; ATROPHY; EXERCISE; PACKAGE; IMMOBILIZATION	Muscle disuse leads to a rapid decline in muscle mass, with reduced muscle protein synthesis (MPS) considered the primary physiological mechanism. Here, we employed a systems biology approach to uncover molecular networks and key molecular candidates that quantitatively link to the degree of muscle atrophy and/or extent of decline in MPS during short-term disuse in humans. After consuming a bolus dose of deuterium oxide (D2O; 3 mL.kg(-1)), eight healthy males (22 +/- 2 years) underwent 4 days of unilateral lower-limb immobilization. Bilateral muscle biopsies were obtained post-intervention for RNA sequencing and D2O-derived measurement of MPS, with thigh lean mass quantified using dual-energy X-ray absorptiometry. Application of weighted gene co-expression network analysis identified 15 distinct gene clusters ("modules") with an expression profile regulated by disuse and/or quantitatively connected to disuse-induced muscle mass or MPS changes. Module scans for candidate targets established an experimentally tractable set of candidate regulatory molecules (242 hub genes, 31 transcriptional regulators) associated with disuse-induced maladaptation, many themselves potently tied to disuse-induced reductions in muscle mass and/or MPS and, therefore, strong physiologically relevant candidates. Notably, we implicate a putative role for muscle protein breakdown-related molecular networks in impairing MPS during short-term disuse, and further establish DEPTOR (a potent mTOR inhibitor) as a critical mechanistic candidate of disuse driven MPS suppression in humans. Overall, these findings offer a strong benchmark for accelerating mechanistic understanding of short-term muscle disuse atrophy that may help expedite development of therapeutic interventions.	[Willis, Craig R. G.; Etheridge, Timothy] Univ Exeter, Coll Life & Environm Sci, Dept Sport & Hlth Sci, Exeter, Devon, England; [Gallagher, Iain J.] Univ Stirling, Fac Hlth Sci & Sport, Stirling, Scotland; [Wilkinson, Daniel J.; Brook, Matthew S.; Bass, Joseph J.; Phillips, Bethan E.; Smith, Kenneth; Szewczyk, Nathaniel J.; Atherton, Philip J.] Univ Nottingham, Royal Derby Hosp Ctr, Nottingham Biomed Res Ctr,Sch Med, MRC Versus Arthrit Ctr Musculoskeletal Ageing Res, Derby DE22 3DT, England; [Wilkinson, Daniel J.; Brook, Matthew S.; Bass, Joseph J.; Phillips, Bethan E.; Smith, Kenneth; Szewczyk, Nathaniel J.; Atherton, Philip J.] Univ Nottingham, Royal Derby Hosp Ctr, Nottingham Biomed Res Ctr, Natl Inst Hlth Res,Sch Med, Derby DE22 3DT, England; [Stokes, Tanner; McGlory, Chris; Gorissen, Stefan H. M.; Phillips, Stuart M.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Szewczyk, Nathaniel J.] Ohio Univ, Ohio Musculoskeletal & Neurol Inst OMNI, Athens, OH 45701 USA; [Szewczyk, Nathaniel J.] Ohio Univ, Dept Biomed Sci, Athens, OH 45701 USA	University of Exeter; University of Stirling; University of Nottingham; University of Nottingham; McMaster University; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Atherton, PJ (corresponding author), Univ Nottingham, Royal Derby Hosp Ctr, Nottingham Biomed Res Ctr,Sch Med, MRC Versus Arthrit Ctr Musculoskeletal Ageing Res, Derby DE22 3DT, England.; Atherton, PJ (corresponding author), Univ Nottingham, Royal Derby Hosp Ctr, Nottingham Biomed Res Ctr, Natl Inst Hlth Res,Sch Med, Derby DE22 3DT, England.	philip.atherton@nottingham.ac.uk	Phillips, Stuart/B-2343-2009; Gorissen, Stefan/ABA-1008-2021	Phillips, Stuart/0000-0002-1956-4098; Gorissen, Stefan/0000-0003-3737-9053; Szewczyk, Nathaniel/0000-0003-4425-9746; Bass, Joseph/0000-0002-8236-681X; Phillips, Bethan/0000-0002-1430-1870	RCUK \ Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J014400/1, BB/M009122/1, BB/N015894/1]; Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC); RCUK \ Medical Research Council (MRC) [MR/P021220/1, MR/R502364/1]	RCUK \ Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC); RCUK \ Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RCUK vertical bar Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BB/J014400/1, BB/M009122/1 and BB/N015894/1; Gouvernement du Canada vertical bar Natural Sciences and Engineering Research Council of Canada (NSERC); RCUK vertical bar Medical Research Council (MRC), Grant/Award Number: MR/P021220/1 and MR/R502364/1	Abadi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006518; Alibegovic AC, 2010, AM J PHYSIOL-ENDOC M, V299, pE752, DOI 10.1152/ajpendo.00590.2009; Allen JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029348; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Atherton PJ, 2016, AM J PHYSIOL-ENDOC M, V311, pE594, DOI 10.1152/ajpendo.00257.2016; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Brook MS, 2016, ACTA PHYSIOL, V216, P15, DOI 10.1111/apha.12532; Brook MS, 2016, J PHYSIOL-LONDON, V594, P7399, DOI 10.1113/JP272857; Brook MS, 2015, FASEB J, V29, P4485, DOI 10.1096/fj.15-273755; Catena V, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-016-0484-y; Chen YW, 2007, PHYSIOL GENOMICS, V31, P510, DOI 10.1152/physiolgenomics.00115.2006; Clark BC, 2004, ARCH PHYS MED REHAB, V85, P1555, DOI 10.1016/j.apmr.2003.09.011; de Boer MD, 2007, J PHYSIOL-LONDON, V585, P241, DOI 10.1113/jphysiol.2007.142828; Dirks ML, 2016, ACTA PHYSIOL, V218, P10, DOI 10.1111/apha.12699; Dirks ML, 2014, ACTA PHYSIOL, V210, P628, DOI 10.1111/apha.12200; Dirks ML, 2020, J CLIN ENDOCR METAB, V105, P276, DOI 10.1210/clinem/dgz049; Dirks ML, 2018, J APPL PHYSIOL, V125, P850, DOI 10.1152/japplphysiol.00985.2016; Dirks ML, 2016, DIABETES, V65, P2862, DOI 10.2337/db15-1661; Edwards SJ, 2020, AM J CLIN NUTR, V112, P1368, DOI 10.1093/ajcn/nqaa229; Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A; Ferrando AA, 1996, AM J PHYSIOL-ENDOC M, V270, pE627, DOI 10.1152/ajpendo.1996.270.4.E627; Fisher SR, 2010, ARCH INTERN MED, V170, P1942, DOI 10.1001/archinternmed.2010.422; Fitts RH, 2010, J PHYSIOL-LONDON, V588, P3567, DOI 10.1113/jphysiol.2010.188508; Franchi MV, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12593; Gustafsson T, 2010, J APPL PHYSIOL, V109, P721, DOI 10.1152/japplphysiol.00110.2009; Hector AJ., 2015, CELL MOL EXERC PHYSL, V4, P1, DOI [10.7457/cmep.v4i1.e8, DOI 10.7457/CMEP.V4I1.E8]; Holloway TM, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00105; Homma T, 2009, ACTA PHYSIOL, V197, P313, DOI 10.1111/j.1748-1716.2009.02003.x; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Institute for Government, 2019, HOSPITALS; Jones SW, 2004, FASEB J, V18, P1025, DOI 10.1096/fj.03-1228fje; Kazi AA, 2011, MOL MED, V17, P925, DOI 10.2119/molmed.2011.00070; Kilroe SP, 2020, AM J PHYSIOL-ENDOC M, V318, pE117, DOI 10.1152/ajpendo.00360.2019; Kilroe SP, 2020, MED SCI SPORT EXER, V52, P944, DOI 10.1249/MSS.0000000000002200; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Urso M, 2006, J APPL PHYSIOL, V101, P1136, DOI 10.1152/japplphysiol.00180.2006; Langfelder P., 2017, WGCNA PACKAGE FREQUE; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee CG, 2011, J AM GERIATR SOC, V59, P1217, DOI 10.1111/j.1532-5415.2011.03472.x; Li JQ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18705-z; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Londhe P, 2015, BONE, V80, P131, DOI 10.1016/j.bone.2015.03.015; Lun ATL, 2016, METHODS MOL BIOL, V1418, P391, DOI 10.1007/978-1-4939-3578-9_19; Mahmassani ZS, 2019, J APPL PHYSIOL, V126, P894, DOI 10.1152/japplphysiol.00811.2018; Mason MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-327; Mouisel E, 2006, NEUROSCI RES, V55, P389, DOI 10.1016/j.neures.2006.05.002; NHS Digital, 2019, HOSP ADM PAT CAR AD; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Oldham MC, 2014, OMICS APPL NEUROSCIE, P85; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Phillips BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003389; Phillips SM, 2014, J PHYSIOL-LONDON, V592, P5341, DOI 10.1113/jphysiol.2014.273615; Rakobowchuk M, 2011, EUR J APPL PHYSIOL, V111, P203, DOI 10.1007/s00421-010-1636-y; Reich KA, 2010, J APPL PHYSIOL, V109, P1404, DOI 10.1152/japplphysiol.00444.2010; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rudrappa SS, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00361; Shad BJ, 2019, MED SCI SPORT EXER, V51, P2125, DOI 10.1249/MSS.0000000000002034; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimkus KL., 2013, INT J EXERC SCI C P, V2, P7; Smith DA, 2014, ANAT REC, V297, P1637, DOI 10.1002/ar.22980; Spangenburg EE, 2009, APPL PHYSIOL NUTR ME, V34, P328, DOI 10.1139/H09-010; Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Stokes T, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107980; Suetta C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051238; Symons TB, 2009, J APPL PHYSIOL, V107, P34, DOI 10.1152/japplphysiol.91137.2008; Tesch PA, 2008, J APPL PHYSIOL, V105, P902, DOI 10.1152/japplphysiol.90558.2008; Thalacker-Mercer A, 2013, PHYSIOL GENOMICS, V45, P499, DOI 10.1152/physiolgenomics.00167.2012; Tidball JG, 2005, J APPL PHYSIOL, V98, P1900, DOI 10.1152/japplphysiol.01178.2004; Tully MA, 2012, BRIT J SPORT MED, V46, P877, DOI 10.1136/bjsports-2011-090692; Ulbricht Anna, 2013, Commun Integr Biol, V6, pe24925, DOI 10.4161/cib.24925; van Dam S, 2018, BRIEF BIOINFORM, V19, P575, DOI 10.1093/bib/bbw139; Varusai TM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18400-z; Wall BT, 2014, ACTA PHYSIOL, V210, P600, DOI 10.1111/apha.12190; Wall BT, 2016, AM J PHYSIOL-ENDOC M, V310, pE137, DOI 10.1152/ajpendo.00227.2015; Wall BT, 2013, J CLIN ENDOCR METAB, V98, P4872, DOI 10.1210/jc.2013-2098; Wall BT, 2013, AGEING RES REV, V12, P898, DOI 10.1016/j.arr.2013.07.003; Weigl LG, 2012, CURR OPIN PHARMACOL, V12, P377, DOI 10.1016/j.coph.2012.02.017; Wilkinson DJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12433; Wilkinson DJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE571, DOI 10.1152/ajpendo.00650.2013; Willis CRG, 2020, AGING-US, V12, P740, DOI 10.18632/aging.102653; World Health Organization, 2019, AV LENGTH STAY ALL H; World Health Organization, 2018, AG HLTH; Yasuda N, 2005, J APPL PHYSIOL, V99, P1085, DOI 10.1152/japplphysiol.00247.2005; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	92	3	3	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21830	10.1096/fj.202100276RR	http://dx.doi.org/10.1096/fj.202100276RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34342902	Green Published			2022-12-28	WOS:000691122900054
J	Khan, A; Ni, WM; Baltazar, T; Lopez-Giraldez, F; Pober, JS; Pierce, RW				Khan, Alamzeb; Ni, Weiming; Baltazar, Tania; Lopez-Giraldez, Francesc; Pober, Jordan S.; Pierce, Richard W.			ArhGEF12 activates Rap1A and not RhoA in human dermal microvascular endothelial cells to reduce tumor necrosis factor-induced leak	FASEB JOURNAL			English	Article						capillary leak; electrical cell substrate impedance sensing; GTPase signaling; inflammation; permeability; rho guanine nucleotide-exchange factor; trans-endothelial electrical resistance; vascular dysfunction	NUCLEOTIDE-EXCHANGE FACTOR; TIGHT JUNCTIONS; BARRIER; GTPASES; CDC42; RAC; FAMILY; GEFS; IDENTIFICATION; CAMP	Overwhelming inflammation in the setting of acute critical illness induces capillary leak resulting in hypovolemia, edema, tissue dysoxia, organ failure and even death. The tight junction (TJ)-dependent capillary barrier is regulated by small GTPases, but the specific regulatory molecules most active in this vascular segment under such circumstances are not well described. We set out to identify GTPase regulatory molecules specific to endothelial cells (EC) that form TJs. Transcriptional profiling of confluent monolayers of TJ-forming human dermal microvascular ECs (HDMECs) and adherens junction only forming-human umbilical vein EC (HUVECs) demonstrate ARHGEF12 is basally expressed at higher levels and is only downregulated in HDMECs by junction-disrupting tumor necrosis factor (TNF). HDMECs depleted of ArhGEF12 by siRNA demonstrate a significantly exacerbated TNF-induced decrease in trans-endothelial electrical resistance and disruption of TJ continuous staining. ArhGEF12 is established as a RhoA-GEF in HUVECs and its knock down would be expected to reduce RhoA activity and barrier disruption. Pulldown of active GEFs from HDMECs depleted of ArhGEF12 and treated with TNF show decreased GTP-bound Rap1A after four hours but increased GTP-bound RhoA after 12 h. In cell-free assays, ArhGEF12 immunoprecipitated from HDMECs is able to activate both Rap1A and RhoA, but not act on Rap2A-C, RhoB-C, or even Rap1B which shares 95% sequence identity with Rap1A. We conclude that in TJ-forming HDMECs, ArhGEF12 selectively activates Rap1A to limit capillary barrier disruption in a mechanism independent of cAMP-mediated Epac1 activation.	[Khan, Alamzeb; Ni, Weiming; Pierce, Richard W.] Yale Univ, Yale Sch Med, Dept Pediat, 333 Cedar St,POB 208064, New Haven, CT 06520 USA; [Baltazar, Tania; Pober, Jordan S.] Yale Univ, Yale Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Lopez-Giraldez, Francesc] Yale Univ, Yale Sch Med, Dept Genet, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Pierce, RW (corresponding author), Yale Univ, Yale Sch Med, Dept Pediat, 333 Cedar St,POB 208064, New Haven, CT 06520 USA.	Richard.pierce@yale.edu		Pierce, Richard/0000-0001-5941-8805	Charles H. Hood Foundation; NIH/NHLBI [5 T32 HL 7974-19, 1K08HL136898-01A1]; NIH [NIH 1S10OD018521-01]; NIH/NICHD [K12HD047349]	Charles H. Hood Foundation; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work has been supported by grants from the Charles H. Hood Foundation, NIH/NHLBI 1K08HL136898-01A1, NIH/NICHD K12HD047349, NIH/NHLBI 5 T32 HL 7974-19, NIH 1S10OD018521-01	Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Abiko H, 2015, J CELL SCI, V128, P1683, DOI 10.1242/jcs.157503; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Bagci H, 2020, NAT CELL BIOL, V22, P120, DOI 10.1038/s41556-019-0438-7; Baumer Y, 2009, J CELL PHYSIOL, V220, P716, DOI 10.1002/jcp.21819; Beese M, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-68; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Birukova AA, 2011, J CELL PHYSIOL, V226, P2052, DOI 10.1002/jcp.22543; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Burns AR, 2000, J CELL SCI, V113, P45; Burns AR, 1997, J IMMUNOL, V159, P2893; Castillo-Kauil A, 2020, J BIOL CHEM, V295, P16920, DOI 10.1074/jbc.AC120.015204; Cerutti C, 2017, EXP CELL RES, V358, P31, DOI 10.1016/j.yexcr.2017.06.003; Chen HJ, 2013, J MED CHEM, V56, P952, DOI 10.1021/jm3014162; Cherfils J, 2014, GEFS GAPS MECH STRUC, P51, DOI [10.1007/978-3-7091-1806-1_3, DOI 10.1007/978-3-7091-1806-1_3]; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Chrzanowska-Wodnicka M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145689; Clark PR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120075; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; de Rooij J, 1999, J BIOL CHEM, V274, P38125, DOI 10.1074/jbc.274.53.38125; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Duong CN, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00519; Groger M, 2007, J INVEST DERMATOL, V127, P2893, DOI 10.1038/sj.jid.5701031; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Karagkouni D, 2018, NUCLEIC ACIDS RES, V46, pD239, DOI 10.1093/nar/gkx1141; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Khan A, 2021, FASEB J, V35, DOI 10.1096/fj.202002783RR; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kluger MS, 2013, ARTERIOSCL THROM VAS, V33, P489, DOI 10.1161/ATVBAHA.112.300893; Kluger MS, 2002, J IMMUNOL, V168, P2091, DOI 10.4049/jimmunol.168.5.2091; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kuiperij HB, 2003, BBA-MOL CELL RES, V1593, P141, DOI 10.1016/S0167-4889(02)00365-8; Lakshmikanthan S, 2018, J CELL SCI, V131, DOI 10.1242/jcs.207605; Lessey-Morillon EC, 2014, J IMMUNOL, V192, P3390, DOI 10.4049/jimmunol.1302525; Li Y, 2007, J IMMUNOL, V179, P8322, DOI 10.4049/jimmunol.179.12.8322; Liu M, 2008, AM J PATHOL, V172, P1088, DOI 10.2353/ajpath.2008.070603; Lo CM, 1995, BIOPHYS J, V69, P2800, DOI 10.1016/S0006-3495(95)80153-0; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo DH, 2006, AM J PATHOL, V169, P1886, DOI 10.2353/ajpath.2006.060603; Marcos-Ramiro B, 2016, J CELL BIOL, V213, P385, DOI 10.1083/jcb.201504038; Marei Hadir, 2017, Small GTPases, V8, P90, DOI 10.1080/21541248.2016.1202635; Martin K, 2016, SCI REP-UK, V6, DOI 10.1038/srep21901; McRae M, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2017.1405774; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Mosaddeghzadeh N, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071831; Muller PM, 2020, NAT CELL BIOL, V22, DOI 10.1038/s41556-020-0488-x; Naserian S, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00564-3; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Pannekoek Willem-Jan, 2020, Small GTPases, V11, P346, DOI 10.1080/21541248.2018.1431512; Pannekoek WJ, 2014, CELL ADHES MIGR, V8, P100, DOI 10.4161/cam.27352; Pannekoek WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057903; Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pierce RW, 2017, J EXP MED, V214, P3497, DOI 10.1084/jem.20162143; Pierce RW, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0355; Pober JS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016345; Ramos CJ, 2018, J BIOL CHEM, V293, P717, DOI 10.1074/jbc.M117.815381; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; REDL H, 1991, AM J PATHOL, V139, P461; Reuther GW, 2001, J BIOL CHEM, V276, P27145, DOI 10.1074/jbc.M103565200; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; ROUSSEAUMERCK MF, 1990, CYTOGENET CELL GENET, V53, P2, DOI 10.1159/000132883; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sehrawat S, 2008, MOL BIOL CELL, V19, P1261, DOI 10.1091/mbc.E06-10-0972; Siddharthan V, 2007, BRAIN RES, V1147, P39, DOI 10.1016/j.brainres.2007.02.029; Sim X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065804; Solski PA, 2002, CELL GROWTH DIFFER, V13, P363; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Takefuji M, 2013, J EXP MED, V210, P665, DOI 10.1084/jem.20122126; Thompson WR, 2018, BONE, V107, P172, DOI 10.1016/j.bone.2017.12.001; Uechi Y, 2009, BIOCHEM BIOPH RES CO, V378, P732, DOI 10.1016/j.bbrc.2008.11.107; van Dam Teunis J P, 2011, Small GTPases, V2, P4; Wiggins-Dohlvik K, 2014, AM J SURG, V208, P954, DOI 10.1016/j.amjsurg.2014.08.014; Wittchen Erika S, 2011, Small GTPases, V2, P65; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Wojciak-Stothard B, 1998, J CELL PHYSIOL, V176, P150, DOI 10.1002/(SICI)1097-4652(199807)176:1<150::AID-JCP17>3.0.CO;2-B; Xing XQ, 2019, MED SCI MONITOR, V25, P5738, DOI 10.12659/MSM.915709; Zancanaro A, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000591	83	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22254	10.1096/fj.202101873RR	http://dx.doi.org/10.1096/fj.202101873RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0DK	35294066				2022-12-28	WOS:000772947400001
J	Liu, H; Wang, LL; Xu, QH; Wang, J; Zhang, YJ; Luo, J; Liao, AH				Liu, Hong; Wang, Li-Ling; Xu, Qian-Han; Wang, Jing; Zhang, Yu-Jing; Luo, Jing; Liao, Ai-Hua			UHRF1 shapes both the trophoblast invasion and decidual macrophage differentiation in early pregnancy	FASEB JOURNAL			English	Article						CXCL2; early pregnancy; IL-1 beta; trophoblast; Uhrf1	DNA METHYLATION; CELL-LINE; RECURRENT; GENE; ACTIVATION; EXPRESSION; POLYMORPHISMS; PROLIFERATION; ENDOMETRIUM; MATURATION	Trophoblasts play critical roles in establishment and maintenance of a normal pregnancy. Their dysfunction in early pregnancy is closely related to pregnancy-related diseases. including recurrent pregnancy loss (RPL). Epigenetic modifications dynamically change during pregnancy; however, the role of the epigenetic modifier UHRF1 in trophoblast regulation remains unknown. This is the first study to show that UHRF1 expression was localized in the cytoplasm of cytotrophoblasts, syncytiotrophoblasts, and villi columns, and decreased in the villi of patients with RPL. The invasion and cell viability in a UHRF1 knockdown trophoblast cell line were significantly decreased. In addition, the mRNA expression profiles of Swan7l cells were partially altered by UHRF1 knockdown. The altered immune-related genes were screened out and the pro-inflammatory TH1-type chemokine/cytokines CXCL2 and IL-43 were identified as the most promising targets of IA in the trophoblasts, which were significantly increased in the UHRI'l knockdown Swan7l cells, villi, and serum from patients with RPL. The macrophages treated with the supernatants of UHRF1 knockdown Swan71 cells were polarized to the M1 phenotype and secreted high levels of pro-inflammatory cytokines, which might he driven by the activated MyD88/NF-kappa B signaling pathway and mediated by the increased expression of CXCR2 and IL-1R1 (CXCL2 and IL-1 beta receptors. respectively). In addition. the supernatants of UHRF1 knockdown Swan71 cells showed stronger chemotaxis to macrophages than those from the controls. Our findings highlight the previously unknown roles of UHRF1 as one of the key regulators on the trophoblasts and their cross-talk with local immune cells, and demonstrate a potential approach for RPL intervention.	[Liu, Hong; Wang, Li-Ling; Xu, Qian-Han; Wang, Jing; Zhang, Yu-Jing; Luo, Jing; Liao, Ai-Hua] Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Reprod Med, Inst Reprod Hlth, 13 Hangkong Rd, Wuhan 430030, Peoples R China	Huazhong University of Science & Technology	Liao, AH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Reprod Med, Inst Reprod Hlth, 13 Hangkong Rd, Wuhan 430030, Peoples R China.	aihua_liao@hust.edu.cn	Wang, Jin/GYA-2019-2022; wang, jing/GVT-8700-2022; Wu, Jing/GZK-5063-2022	Liao, Aihua/0000-0001-8533-8315	National Key Research & Developmental Program of China [2018YFC1003900, 2018YFC1003904]	National Key Research & Developmental Program of China	National Key Research & Developmental Program of China, Grant/Award Number: 2018YFC1003900 and 2018YFC1003904	Abbas Y, 2020, HUM REPROD UPDATE, V26, P501, DOI 10.1093/humupd/dmaa017; Adan A, 2016, CURR PHARM BIOTECHNO, V17, P1213, DOI 10.2174/1389201017666160808160513; Agrawal S, 2012, REPROD BIOMED ONLINE, V24, P342, DOI 10.1016/j.rbmo.2011.11.021; Bombell S, 2008, AUST NZ J OBSTET GYN, V48, P147, DOI 10.1111/j.1479-828X.2008.00843.x; Boro M, 2017, J IMMUNOL, V199, P1660, DOI 10.4049/jimmunol.1700129; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Boukhari A, 2015, ANTICANCER RES, V35, P149; Branco MR, 2016, DEV CELL, V36, P152, DOI 10.1016/j.devcel.2015.12.027; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; Cao YM, 2019, FASEB J, V33, P8294, DOI 10.1096/fj.201801696RRRR; Chen C, 2018, J EXP MED, V215, P1437, DOI 10.1084/jem.20171815; D'Ippolito S, 2016, FERTIL STERIL, V105, P111, DOI 10.1016/j.fertnstert.2015.09.027; Dong J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12455-4; Fischer Alexandra, 2012, BMC Res Notes, V5, P540, DOI 10.1186/1756-0500-5-540; Fraccaroli L, 2009, HUM REPROD, V24, P166, DOI 10.1093/humrep/den344; Gamage TKJB, 2018, EPIGENETICS-US, V13, P1154, DOI 10.1080/15592294.2018.1549462; Geisert R, 2012, CELL TISSUE RES, V349, P825, DOI 10.1007/s00441-012-1356-1; Gong J, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2710-6; Guleria I, 2000, NAT MED, V6, P589, DOI 10.1038/75074; Guo LY, 2020, CLIN EXP HYPERTENS, V42, P428, DOI 10.1080/10641963.2019.1693585; HASKILL S, 1990, P NATL ACAD SCI USA, V87, P7732, DOI 10.1073/pnas.87.19.7732; Hu QS, 2019, CANCER LETT, V452, P226, DOI 10.1016/j.canlet.2019.03.024; Hu XH, 2020, HUM REPROD, V35, P2454, DOI 10.1093/humrep/deaa223; Huppertz B, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010289; Jiao D, 2019, ONCOGENE, V38, P5686, DOI 10.1038/s41388-019-0822-6; Jones PA, 2019, NAT REV CANCER, V19, P151, DOI 10.1038/s41568-019-0109-9; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim JH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02935-2; Kim JO, 2014, FERTIL STERIL, V102, P206, DOI 10.1016/j.fertnstert.2014.03.037; Krieg S, 2015, SEMIN REPROD MED, V33, P305, DOI 10.1055/s-0035-1554917; Li QY, 2021, CANCER INVEST, V39, P84, DOI 10.1080/07357907.2020.1837152; Li XY, 2019, INT J ONCOL, V54, P271, DOI 10.3892/ijo.2018.4630; Li ZH, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03142; Lin YL, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00266; Lin YL, 2019, ACTA BIOCH BIOPH SIN, V51, P598, DOI 10.1093/abbs/gmz042; Liu H, 2020, PLACENTA, V100, P122, DOI 10.1016/j.placenta.2020.08.013; Liu Y, 2020, PATHOL ONCOL RES, V26, P1079, DOI 10.1007/s12253-019-00656-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maenohara S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007042; Mao LM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02566; Marjoram L, 2015, P NATL ACAD SCI USA, V112, P2770, DOI 10.1073/pnas.1424089112; Mor G, 2017, NAT REV IMMUNOL, V17, P469, DOI 10.1038/nri.2017.64; Moser G, 2015, HUM REPROD, V30, P2747, DOI 10.1093/humrep/dev266; Moser G, 2017, HISTOCHEM CELL BIOL, V147, P353, DOI 10.1007/s00418-016-1509-5; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Ngalamika O, 2015, IMMUNOL INVEST, V44, P126, DOI 10.3109/08820139.2014.938165; Obata Y, 2014, NAT IMMUNOL, V15, P571, DOI 10.1038/ni.2886; Okae H, 2018, CELL STEM CELL, V22, P50, DOI 10.1016/j.stem.2017.11.004; Pan HJ, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2333-3; Piao HL, 2012, CELL MOL IMMUNOL, V9, P423, DOI 10.1038/cmi.2012.23; Porta C, 2015, SEMIN IMMUNOL, V27, P237, DOI 10.1016/j.smim.2015.10.003; Qi SS, 2019, J IMMUNOL, V203, P3045, DOI 10.4049/jimmunol.1900467; Rahmani SA, 2018, HORM MOL BIOL CLIN I, V33, DOI 10.1515/hmbci-2017-0044; Ramhorst R, 2016, CELL ADHES MIGR, V10, P197, DOI 10.1080/19336918.2015.1135285; Reis AS, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax6346; Russo RC, 2014, EXPERT REV CLIN IMMU, V10, P593, DOI 10.1586/1744666X.2014.894886; Pereira VCS, 2019, ARQ NEURO-PSIQUIAT, V77, P166, DOI [10.1590/0004-282X20190026, 10.1590/0004-282x20190026]; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shi XJ, 2020, BIOCHEM BIOPH RES CO, V529, P1018, DOI 10.1016/j.bbrc.2020.06.032; Sidhu H, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317692205; Subat S, 2019, J CANCER RES CLIN, V145, P675, DOI 10.1007/s00432-018-2824-0; Sun X, 2019, J EXP MED, V216, P2819, DOI 10.1084/jem.20190550; Turco MY, 2018, NATURE, V564, P263, DOI 10.1038/s41586-018-0753-3; Unoki M, 2010, BRIT J CANCER, V103, P217, DOI 10.1038/sj.bjc.6605717; Windsperger K, 2017, HUM REPROD, V32, P1208, DOI 10.1093/humrep/dex058; Yao J, 2016, J CLIN INVEST, V126, P732, DOI 10.1172/JCI81937; Yao YL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00792; Zhang HX, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20181065; Zhao R, 2019, NEUROSCIENCE, V422, P99, DOI 10.1016/j.neuroscience.2019.10.048; Zhen Y, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00276; Zhu WQ, 2019, J ASSIST REPROD GEN, V36, P2563, DOI 10.1007/s10815-019-01614-7	71	0	0	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22247	10.1096/fj.202101647RR	http://dx.doi.org/10.1096/fj.202101647RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35262949				2022-12-28	WOS:000772957100005
J	Wang, HQ; Zhang, JB; Zheng, Y; Zhang, WD; Guo, HX; Cong, S; Ding, Y; Yuan, B				Wang, Hao-Qi; Zhang, Jia-Bao; Zheng, Yi; Zhang, Wei-Di; Guo, Hai-Xiang; Cong, Shuai; Ding, Yu; Yuan, Bao			Comprehensive analysis of differences in N6-methyladenosine RNA methylomes in the rat adenohypophysis after GnRH treatment	FASEB JOURNAL			English	Article						animal reproduction; follicle-stimulating hormone; m(6)A modification; m(6)A-seq; Pituitary	MESSENGER-RNA; GENE-EXPRESSION; SUBUNIT; TRANSCRIPTION; TRANSLATION; TURNOVER; ACTIVIN; NUCLEAR	N6-methyladenosine is considered to be the most common and abundant internal chemical modification among the more than 150 identified chemical RNA modifications. It is involved in most biological processes and actively participates in the regulation of animal reproduction. However, the potential function of m(6)A in the pituitaries of mammals is not yet clear. It is also unknown whether m(6)A is involved in the secretion and regulation of FSH by GnRH, which in turn affects mammalian reproduction. In this study, rats were treated with gonadorelin to simulate physiological GnRH-mediated regulation of FSH synthesis and secretion, and m(6)A-seq was used to analyze the differential m(6)A modification of the rat pituitary after gonadorelin treatment. A whole-transcriptome map of m(6)A in the rat pituitary gland before and after gonadorelin treatment was successfully created. A total of 6413 differential peaks were identified, of which 3764 m(6)A peaks were upregulated and 2649 m(6)A peaks were downregulated. Among the 709 differentially expressed genes, 250 genes were discovered with differential methylation modifications. Intriguingly, the altered m(6)A peaks within mRNAs were enriched in steroid biosynthetic processes and responses to cAMP. The results of the study will lay a foundation for further exploration of the potential role of m(6)A modification in the regulation of reproductive hormone secretion and provide a theoretical basis for the application of GnRH analogs in mammalian artificial reproduction.	[Wang, Hao-Qi; Zhang, Jia-Bao; Zheng, Yi; Zhang, Wei-Di; Guo, Hai-Xiang; Cong, Shuai; Ding, Yu; Yuan, Bao] Jilin Univ, Coll Anim Sci, Dept Lab Anim, Changchun 130062, Jilin, Peoples R China	Jilin University	Ding, Y; Yuan, B (corresponding author), Jilin Univ, Coll Anim Sci, Dept Lab Anim, Changchun 130062, Jilin, Peoples R China.	ding_yu@jlu.edu.cn; yuan_bao@jlu.edu.cn			National Natural Science Foundation of China (NSFC) [32172729]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 32172729	Bi XH, 2021, CANCER GENE THER, V28, P335, DOI 10.1038/s41417-020-00222-3; BOURNE GA, 1987, AM J PHYSIOL, V253, pE296, DOI 10.1152/ajpendo.1987.253.3.E296; Bujnicki JM, 2002, J MOL EVOL, V55, P431, DOI 10.1007/s00239-002-2339-8; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Chen De-Quan, 2015, Sheng Li Ke Xue Jin Zhan, V46, P408; Chen YJ, 2007, J ENDOCRINOL, V192, P405, DOI 10.1677/JOE-06-0076; Coss D, 2004, J BIOL CHEM, V279, P152, DOI 10.1074/jbc.M304697200; Cui XC, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12768; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; DUBIN DT, 1975, NUCLEIC ACIDS RES, V2, P1653, DOI 10.1093/nar/2.10.1653; Gan Haili, 2019, Sheng Wu Gong Cheng Xue Bao, V35, P775, DOI 10.13345/j.cjb.180416; Hong GK, 2016, OTOLARYNG CLIN N AM, V49, P21, DOI 10.1016/j.otc.2015.09.002; Hsu PJ, 2017, CELL RES, V27, P1115, DOI 10.1038/cr.2017.99; Jacobs SBR, 2003, MOL ENDOCRINOL, V17, P1470, DOI 10.1210/me.2002-0286; Kaprara A, 2018, METABOLISM, V86, P3, DOI 10.1016/j.metabol.2017.11.018; Kwon J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44714-1; Lamba P, 2010, ENDOCRINOLOGY, V151, P5456, DOI 10.1210/en.2010-0605; LAVI S, 1975, P NATL ACAD SCI USA, V72, P2012, DOI 10.1073/pnas.72.6.2012; Lee H, 2019, NAT CELL BIOL, V21, P700, DOI 10.1038/s41556-019-0318-1; Lesbirel S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32310-8; Li D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051660; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Lin Z, 2017, CELL RES, V27, P1216, DOI 10.1038/cr.2017.117; Liu SP, 2020, AM J CANCER RES, V10, P1631; Livneh I, 2020, NAT REV NEUROSCI, V21, P36, DOI 10.1038/s41583-019-0244-z; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Minegishi T, 1999, MOL CELL ENDOCRINOL, V149, P71, DOI 10.1016/S0303-7207(98)00259-7; PERRY RP, 1973, J MOL BIOL, V79, P681, DOI 10.1016/0022-2836(73)90071-5; PERRY RP, 1974, J MOL BIOL, V82, P315, DOI 10.1016/0022-2836(74)90593-2; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Schang G, 2019, J MOL ENDOCRINOL, V62, P67, DOI 10.1530/JME-18-0145; Scholler E, 2018, RNA, V24, P499, DOI 10.1261/rna.064063.117; Stamatiades GA, 2018, MOL CELL ENDOCRINOL, V463, P131, DOI 10.1016/j.mce.2017.10.015; Thompson IR, 2016, MOL ENDOCRINOL, V30, P348, DOI 10.1210/me.2015-1222; Thompson IR, 2013, MOL ENDOCRINOL, V27, P606, DOI 10.1210/me.2012-1281; Wang CX, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004880; Wang HQ, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11113262; Wang HQ, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11041134; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang YR, 2020, FRONT GENET, V10, DOI 10.3389/fgene.2019.01318; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Wu ZM, 2020, NUCLEIC ACIDS RES, V48, P11083, DOI 10.1093/nar/gkaa816; Xie HM, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0304-z; Xie HM, 2015, MOL ENDOCRINOL, V29, P842, DOI 10.1210/me.2014-1279; Yang Ying, 2018, Yichuan, V40, P964, DOI 10.16288/j.yczz.18-175; Yao YX, 2019, FASEB J, V33, P7529, DOI 10.1096/fj.201802644R; Yuan B, 2015, INT J CLIN EXP MED, V8, P13289; Zhang ZY, 2018, CELL RES, V28, P1050, DOI 10.1038/s41422-018-0092-9; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	51	2	2	6	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22204	10.1096/fj.202101608R	http://dx.doi.org/10.1096/fj.202101608R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35147984				2022-12-28	WOS:000761250800054
J	Chen, M; Yao, LJ; Zhou, LJ; Yang, P; Zou, WH; Xu, LQ; Li, SM; Peng, HJ				Chen, Min; Yao, Lijie; Zhou, Lijuan; Yang, Pei; Zou, Weihao; Xu, Liqing; Li, Shengmin; Peng, Hongjuan			Toxoplasma gondii ROP18(I) inhibits host innate immunity through cGAS-STING signaling	FASEB JOURNAL			English	Article						IFN-beta; p62; TgROP18(I); Toxoplasma gondii; TRAF6	INTERFERON-GAMMA; IFN-GAMMA; EFFECTOR MECHANISMS; HUMAN-FIBROBLASTS; VIRULENCE; RESISTANCE; PHOSPHORYLATION; RECEPTORS; PATHOGEN; DEFENSE	Toxoplasma gondii is an opportunistic protozoan, which widely infects humans and other warm-blooded animals. The type I interferon (IFN) such as IFN-alpha/beta is involved in cGAS-STING signaling to resist T. gondii infection. We found in RAW264.7 cells, that T. gondii virulence factor TgROP18(I), inhibited IFN-beta production through interacting with interferon regulatory factor 3 (IRF3). Besides, TgROP18(I) interacted with p62 and Tumor Necrotic Factor Receptor Associated Factor 6 (TRAF6), which resulted in the inhibition of TRAF6-p62 interaction, and phosphorylation of p62. Furthermore, TgROP18 1 restricted the recruitment of ubiquitin. p62 and microtubule-associated protein light chain 3 (LC3) to the parasitophorous vacuole membrane (PVM) in IFN-gamma-stimulated murine cell line L929 cells. In IFN-gamma-stimulated human cells, TgROP18(I) restricted the decoration of PVM with ubiquitin, p62, and LC3, and bound with TRAF2, TRAF6, and p62, respectively. As a result, TgROP18(I) led to a successful parasitic replication in murine and human cells. Collectively, our study revealed the function of TgROP18(I) in suppressing host type I interferon responses in T. gondii infection for parasitic immune escape.	[Chen, Min; Yao, Lijie; Zhou, Lijuan; Yang, Pei; Zou, Weihao; Xu, Liqing; Li, Shengmin; Peng, Hongjuan] Southern Med Univ, Dept Pathogen Biol, Guangdong Prov Key Lab Trop Dis Res, Sch Publ Hlth, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China	Peng, HJ (corresponding author), Southern Med Univ, Dept Pathogen Biol, Guangdong Prov Key Lab Trop Dis Res, Sch Publ Hlth, Guangzhou 510515, Guangdong, Peoples R China.	floriapeng@hotmail.com	Peng, Hongjuan/GYV-5462-2022		National Key R&D Program of China [2017YFD0500400]; National Natural Science Foundation of China (NSFC) [81971954, 81772217, 201828006]; Science and Technology Planning Project of Guangdong Province [2018A050506038]; Key project of Guangzhou science research [201904020011]	National Key R&D Program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; Key project of Guangzhou science research	National Key R&D Program of China, Grant/Award Number: 2017YFD0500400; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81971954, 81772217 and 201828006; Science and Technology Planning Project of Guangdong Province, Grant/Award Number: 2018A050506038; Key project of Guangzhou science research, Grant/Award Number: 201904020011	Barber GN, 2014, TRENDS IMMUNOL, V35, P88, DOI 10.1016/j.it.2013.10.010; Behnke MS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002992; Bhushan J, 2020, MBIO, V11, DOI 10.1128/mBio.00852-20; Cho CS, 2018, HEPATOLOGY, V68, P1331, DOI 10.1002/hep.29742; Choi J, 2014, IMMUNITY, V40, P924, DOI 10.1016/j.immuni.2014.05.006; Clough B, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006027; Du J, 2014, J BIOL CHEM, V289, P12578, DOI 10.1074/jbc.M113.544718; El Hajj H, 2007, PLOS PATHOG, V3, P200, DOI 10.1371/journal.ppat.0030014; Fentress SJ, 2012, CELL MICROBIOL, V14, P1921, DOI 10.1111/cmi.12022; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Foltz C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05487-7; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; Haldar AK, 2016, MBIO, V7, DOI 10.1128/mBio.01417-16; Haldar AK, 2015, P NATL ACAD SCI USA, V112, pE5628, DOI 10.1073/pnas.1515966112; He C, 2017, INT J BIOL SCI, V13, P1126, DOI 10.7150/ijbs.21247; Howard JC, 2011, CURR OPIN MICROBIOL, V14, P414, DOI 10.1016/j.mib.2011.07.002; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jeffers V, 2018, CELL MOL LIFE SCI, V75, P2355, DOI 10.1007/s00018-018-2808-x; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kong L, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-04251-7; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Lamark T, 2017, ESSAYS BIOCHEM, V61, P609, DOI 10.1042/EBC20170035; Li WW, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay9013; Li XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097775; Li ZR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035834, 10.1371/journal.pone.0051597]; Lieberman LA, 2004, J IMMUNOL, V172, P457, DOI 10.4049/jimmunol.172.1.457; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Matsumoto G, 2015, HUM MOL GENET, V24, P4429, DOI 10.1093/hmg/ddv179; Matta SK, 2019, P NATL ACAD SCI USA, V116, P17480, DOI 10.1073/pnas.1904637116; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Melo MB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003779; Muller UB, 2016, CURR OPIN MICROBIOL, V32, P19, DOI 10.1016/j.mib.2016.04.009; Mukhopadhyay D, 2020, EMBO J, V39, DOI 10.15252/embj.2019103758; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Niedelman W, 2013, INFECT IMMUN, V81, P4341, DOI 10.1128/IAI.00416-13; Paludan SR, 2015, MICROBIOL MOL BIOL R, V79, P225, DOI 10.1128/MMBR.00061-14; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Sanchez-Martin P, 2019, FEBS J, V286, P8, DOI 10.1111/febs.14712; Sanchez-Martin P, 2018, J CELL SCI, V131, DOI 10.1242/jcs.222836; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Sibley LD, 2011, IMMUNOL REV, V240, P72, DOI 10.1111/j.1600-065X.2010.00990.x; Steinfeldt T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000576; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; SUZUKI Y, 1989, J IMMUNOL, V143, P2045; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tao JL, 2016, IUBMB LIFE, V68, P858, DOI 10.1002/iub.1566; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Van Grol J, 2013, INFECT IMMUN, V81, P2002, DOI 10.1128/IAI.01145-12; Virreira Winter S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024434; Wang PY, 2019, J BIOL CHEM, V294, P16494, DOI 10.1074/jbc.RA119.009172; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Wu L, 2016, PARASITOL RES, V115, P2415, DOI 10.1007/s00436-016-4993-6; Xia J, 2020, PARASITOLOGY, V147, P1433, DOI 10.1017/S0031182020001249; Xia J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00061; Xia J, 2017, ACTA MICROBIOL IMM H, V64, P229, DOI 10.1556/030.64.2017.016; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009; Yamamoto M, 2011, J EXP MED, V208, P1533, DOI 10.1084/jem.20101660; Yao LJ, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.685913; Yap G, 2000, J IMMUNOL, V165, P628, DOI 10.4049/jimmunol.165.2.628; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200; Zhou LJ, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3529-1	68	3	3	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22171	10.1096/fj.202101347R	http://dx.doi.org/10.1096/fj.202101347R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35084749	hybrid			2022-12-28	WOS:000747987800052
J	Xing, J; He, YC; Wang, KY; Wan, PZ; Zhai, XY				Xing, Jia; He, Yu-Chen; Wang, Kai-Yue; Wan, Peng-Zhi; Zhai, Xiao-Yue			Involvement of YTHDF1 in renal fibrosis progression via up-regulating YAP	FASEB JOURNAL			English	Article						m6A modification; renal fibrosis; YAP; YTHDF1	MESENCHYMAL TRANSITION; METHYLATION; M(6)A; DIFFERENTIATION; TRANSLATION	Renal fibrosis is a progressive, fatal renal disease characterized by the aberrant accumulation of myofibroblasts that produce excess extracellular matrix (ECM) in the renal interstitium and glomeruli. Yes-associated protein (YAP) has been regarded as a crucial modulator in myofibroblast transformation, but its upstream regulator remains a mystery. In the present study investigating the participation of m6A methylation during renal fibrosis through bioinformatics analysis, we identified YTHDF1, a modulator of m6A methylation, as a key contributor for renal fibrosis because it was highly expressed in human fibrotic kidneys and had a significant correction with YAP. Their co-localization in human fibrotic kidneys was additionally shown by immunofluorescence. We then found that YTHDF1 was also up-regulated in fibrotic mouse kidneys induced by unilateral ureteral obstruction (UUO), high-dose folic acid administration, or the unilateral ischemia-reperfusion injury, further supporting a causal role of YTHDF1 during renal fibrosis. Consistent with this notion, YTHDF1 knockdown alleviated the progression of renal fibrosis both in cultured cells induced by transforming growth factor-beta administration and in the UUO mouse model. Meanwhile, YAP was accordingly down-regulated when YTHDF1 was inhibited. Furthermore, the specific binding of YTHDF1 to YAP mRNA was detected using RNA Binding Protein Immunoprecipitation, and the up-regulation of fibrotic related molecules in cultured cells induced by YTHDF1 over-expression plasmid was attenuated by YAP siRNA. Taken together, our data highlight the potential utility of YTHDF1 as an indicator for renal fibrosis and suggest that YTHDF1 inhibition might be a promising therapeutic strategy to alleviate renal fibrosis via downregulating YAP.	[Xing, Jia; Wang, Kai-Yue; Zhai, Xiao-Yue] China Med Univ, Dept Histol & Embryol, Shenyang, Peoples R China; [He, Yu-Chen] China Med Univ, Hosp 1, Dept Vasc Surg, Shenyang, Peoples R China; [Wan, Peng-Zhi] China Med Univ, Hosp 1, Dept Nephrol, Shenyang, Peoples R China; [Zhai, Xiao-Yue] China Med Univ, Inst Nephropathol, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Zhai, XY (corresponding author), China Med Univ, Dept Histol & Embryol, Shenyang, Peoples R China.	xyzhai@cmu.edu.cn		Xing, Jia/0000-0001-7521-9806	National Natural Scientific Foundation of China [31971115]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Scientific Foundation of China (NSFC. 31971115)	Anorga S, 2018, FASEB J, V32, P2644, DOI 10.1096/fj.201700722R; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Blanco S, 2014, EMBO J, V33, P2020, DOI 10.15252/embj.201489282; Brennan EP, 2017, MOL ASPECTS MED, V58, P102, DOI 10.1016/j.mam.2017.05.001; Bruggenwirth IMA, 2020, AM J TRANSPLANT, V20, P931, DOI 10.1111/ajt.15689; Chang YT, 2016, J CLIN INVEST, V126, P721, DOI 10.1172/JCI82819; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Chen B, 2019, MOL BIOL REP, V46, P2567, DOI 10.1007/s11033-019-04655-4; Chen XW, 2014, J CLIN INVEST, V124, P3295, DOI 10.1172/JCI71668; Feng ZH, 2018, J CELL MOL MED, V22, P2558, DOI 10.1111/jcmm.13491; Flores JV, 2017, STEM CELL REP, V8, P112, DOI 10.1016/j.stemcr.2016.11.014; Han B, 2020, EMBO REP, V21, DOI 10.15252/embr.201949229; He YC, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.12.65; Jin D, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0830-6; Kramann R, 2015, J CLIN INVEST, V125, P2935, DOI 10.1172/JCI74929; Leaf IA, 2017, NEPHROL DIAL TRANSPL, V32, P89, DOI 10.1093/ndt/gfw388; Leaf IA, 2017, J CLIN INVEST, V127, P321, DOI 10.1172/JCI87532; Li HB, 2017, NATURE, V548, P338, DOI 10.1038/nature23450; Li LJ, 2018, MOL IMMUNOL, V93, P55, DOI 10.1016/j.molimm.2017.11.009; Li X, 2020, OXID MED CELL LONGEV, V2020, P1; Liang M, 2017, J AM SOC NEPHROL, V28, P3277, DOI 10.1681/ASN.2015121354; Liu JH, 2018, KIDNEY BLOOD PRESS R, V43, P1677, DOI 10.1159/000494745; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Lovisa S, 2016, TRENDS ENDOCRIN MET, V27, P681, DOI 10.1016/j.tem.2016.06.004; Lv WS, 2018, EUR J PHARMACOL, V820, P65, DOI 10.1016/j.ejphar.2017.12.016; Martinez-Klimova E, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9040141; METZKURSCHEL U, 1990, RENAL FAILURE, V12, P93, DOI 10.3109/08860229009087124; Patil DP, 2018, TRENDS CELL BIOL, V28, P113, DOI 10.1016/j.tcb.2017.10.001; Piersma B, 2015, AM J PATHOL, V185, P3326, DOI 10.1016/j.ajpath.2015.08.011; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Shi Y, 2020, FASEB J, V34, P10286, DOI 10.1096/fj.201902544RR; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Tong JY, 2018, FRONT MED-PRC, V12, P481, DOI 10.1007/s11684-018-0654-8; Wang JH, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/3120391; Wanna-udom S, 2020, BIOCHEM BIOPH RES CO, V524, P150, DOI 10.1016/j.bbrc.2020.01.042; Weng HY, 2018, CELL STEM CELL, V22, P191, DOI 10.1016/j.stem.2017.11.016; Winkler R, 2019, NAT IMMUNOL, V20, P173, DOI 10.1038/s41590-018-0275-z; Xu LY, 2019, J AM SOC NEPHROL, V30, P1825, DOI 10.1681/ASN.2019010068; Zhang JX, 2021, MOL THER, V29, P3436, DOI 10.1016/j.ymthe.2021.06.008	39	3	3	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22144	10.1096/fj.202100172RR	http://dx.doi.org/10.1096/fj.202100172RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34990050				2022-12-28	WOS:000747987800008
J	Bodden, C; Pang, TY; Feng, YS; Mridha, F; Kong, G; Li, SS; Watt, MJ; Reichelt, AC; Hannan, AJ				Bodden, Carina; Pang, Terence Y.; Feng, Yingshi; Mridha, Faria; Kong, Geraldine; Li, Shanshan; Watt, Matthew J.; Reichelt, Amy C.; Hannan, Anthony J.			Intergenerational effects of a paternal Western diet during adolescence on offspring gut microbiota, stress reactivity, and social behavior	FASEB JOURNAL			English	Article						behavioral phenotyping; epigenetic inheritance; gut microbiome; high-fat; high-sugar diet; intergenerational inheritance; paternal effects	HIGH-FAT DIET; MATERNAL DIET; SEX-RATIO; MICE; OBESITY; INHERITANCE; METABOLISM; CONTRIBUTE; EPIGENOME; IMPACT	The global consumption of highly processed, calorie-dense foods has contributed to an epidemic of overweight and obesity, along with negative consequences for metabolic dysfunction and disease susceptibility. As it becomes apparent that overweight and obesity have ripple effects through generations, understanding of the processes involved is required, in both maternal and paternal epigenetic inheritance. We focused on the patrilineal effects of a Western-style high-fat (21%) and high-sugar (34%) diet (WD) compared to control diet (CD) during adolescence and investigated F0 and F1 mice for physiological and behavioral changes. F0 males (fathers) showed increased body weight, impaired glycemic control, and decreased attractiveness to females. Paternal WD caused significant phenotypic changes in F1 offspring, including higher body weights of pups, increased Actinobacteria abundance in the gut microbiota (ascertained using 16S microbiome profiling), a food preference for WD pellets, increased male dominance and attractiveness to females, as well as decreased behavioral despair. These results collectively demonstrate the long-term intergenerational effects of a Western-style diet during paternal adolescence. The behavioral and physiological alterations in F1 offspring provide evidence of adaptive paternal programming via epigenetic inheritance. These findings have important implications for understanding paternally mediated intergenerational inheritance, and its relevance to offspring health and disease susceptibility.	[Bodden, Carina; Pang, Terence Y.; Feng, Yingshi; Mridha, Faria; Kong, Geraldine; Li, Shanshan; Reichelt, Amy C.; Hannan, Anthony J.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Watt, Matthew J.; Hannan, Anthony J.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Anat & Physiol, Melbourne, Vic, Australia; [Reichelt, Amy C.] Univ Adelaide, Adelaide Med Sch, Dept Med Sci, Adelaide, SA, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Adelaide	Bodden, C; Hannan, AJ (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia.	carina.bodden@florey.edu.au; anthony.hannan@florey.edu.au	Pang, Terence Y/D-2826-2012; Pang, Terence Y/L-6444-2019	Pang, Terence Y/0000-0002-7000-5304; Feng, Yingshi/0000-0001-9065-4945; Hannan, Anthony/0000-0001-7532-8922; Reichelt, Amy/0000-0002-0637-0411; Bodden, Carina/0000-0002-8749-8846	Australian Research Council (ARC) [DP180101974]; NEIMRC; DHB Foundation	Australian Research Council (ARC)(Australian Research Council); NEIMRC; DHB Foundation	This work was supported by an Australian Research Council (ARC) Discovery Project grant (DP180101974 to ACR and AJH). AJH is a National Health and Medical Research Council (NI IMRC) Principal Research Fellow and is also supported by NEIMRC Project Grants and the DHB Foundation, Equity 'frustees.	Allen AP, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.191; An T, 2017, ONCOTARGET, V8, P47876, DOI 10.18632/oncotarget.18138; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Barandouzi ZA, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00541; Barbosa TD, 2016, MOL METAB, V5, P184, DOI 10.1016/j.molmet.2015.12.002; Barnes TD, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00243; Bayer TA, 1999, J PSYCHIATR RES, V33, P543, DOI 10.1016/S0022-3956(99)00039-4; Bellisari A, 2008, OBES REV, V9, P165, DOI 10.1111/j.1467-789X.2007.00392.x; Bergmann S, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01156; Beynon RJ, 2002, J CHEM ECOL, V28, P1429, DOI 10.1023/A:1016252703836; Blumberg MS, 2001, PSYCHOL REV, V108, P83, DOI 10.1037//0033-295X.108.1.83; Bodden C, 2020, TRENDS ENDOCRIN MET, V31, P131, DOI 10.1016/j.tem.2019.10.005; Boesveldt S, 2017, PERCEPTION, V46, P307, DOI 10.1177/0301006616685576; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bromfield JJ, 2014, P NATL ACAD SCI USA, V111, P2200, DOI 10.1073/pnas.1305609111; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Chen Q, 2016, SCIENCE, V351, P397, DOI 10.1126/science.aad7977; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Consitt LA, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13583; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; D'Amato FR, 2005, BEHAV GENET, V35, P103, DOI 10.1007/s10519-004-0860-9; Edwards AM, 2014, TRENDS ECOL EVOL, V29, P158, DOI 10.1016/j.tree.2013.12.003; Fan Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120775; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fennell KA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72560-z; Ferramosca A, 2016, ANDROLOGY-US, V4, P520, DOI 10.1111/andr.12182; Fontelles CC, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0729-x; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Garratt M, 2011, J EVOLUTION BIOL, V24, P2398, DOI 10.1111/j.1420-9101.2011.02367.x; Giller K, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0101; Gonzalez A, 2018, NAT METHODS, V15, P796, DOI 10.1038/s41592-018-0141-9; Hasegawa Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71592-9; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hassan AM, 2019, NUTR NEUROSCI, V22, P877, DOI 10.1080/1028415X.2018.1465713; Huypens P, 2016, NAT GENET, V48, P497, DOI 10.1038/ng.3527; Ibanez CA, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00807; Kim SJ, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1557-9; Kleinert M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28540-5; Korgan AC, 2018, PSYCHONEUROENDOCRINO, V91, P20, DOI 10.1016/j.psyneuen.2018.02.010; Kumar V, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.117903; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Lee W, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1570; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Lohse T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148563; Lowe CJ, 2020, LANCET CHILD ADOLESC, V4, P388, DOI 10.1016/S2352-4642(19)30404-3; Macpherson AJ, 2017, NAT REV IMMUNOL, V17, P508, DOI 10.1038/nri.2017.58; Malo AF, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1159; McPherson NO, 2014, FERTIL STERIL, V101, P865, DOI 10.1016/j.fertnstert.2013.12.007; Mitchell M, 2011, FERTIL STERIL, V95, P1349, DOI 10.1016/j.fertnstert.2010.09.038; Mitra R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036092; Natt D, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000559; NCHS, 1999, NATL HLTH NUTR EXAMI; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Ost A, 2014, CELL, V159, P1352, DOI 10.1016/j.cell.2014.11.005; Pecina S, 2003, J NEUROSCI, V23, P9395; Rabasa C, 2016, HORM BEHAV, V85, P56, DOI 10.1016/j.yhbeh.2016.07.008; Ribeiro CT, 2018, ASIAN J ANDROL, V20, P385, DOI 10.4103/aja.aja_68_17; Rinninella E, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010014; Rodriguez-Correa E, 2020, NUTR DIABETES, V10, DOI 10.1038/s41387-020-0127-4; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Rosenfeld CS, 2003, P NATL ACAD SCI USA, V100, P4628, DOI 10.1073/pnas.0330808100; Schacht R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45316-7; Screven LA, 2018, BEHAV PROCESS, V157, P171, DOI 10.1016/j.beproc.2018.09.011; Sharma S, 2013, INT J OBESITY, V37, P382, DOI 10.1038/ijo.2012.48; Short AK, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.109; Sjodin KS, 2019, ALLERGY, V74, P176, DOI 10.1111/all.13485; Speakman JR, 2019, INT J OBESITY, V43, P1491, DOI 10.1038/s41366-019-0363-7; Thompson LR, 2017, NATURE, V551, P457, DOI 10.1038/nature24621; Walker AK, 2009, PSYCHONEUROENDOCRINO, V34, P1515, DOI 10.1016/j.psyneuen.2009.05.010; Wang W, 2014, J CLIN MICROBIOL, V52, P398, DOI 10.1128/JCM.01500-13; WASSERTHEIL S, 1970, BIOMETRICS, V26, P588, DOI 10.2307/2529115; Watkins AJ, 2018, P NATL ACAD SCI USA, V115, P10064, DOI 10.1073/pnas.1806333115; WHO, 2003, WHO TECH REP SER, V916, P1; Wiklund P, 2016, J SPORT HEALTH SCI, V5, P151, DOI 10.1016/j.jshs.2016.04.001; Winther G, 2018, NEUROSCIENCE, V388, P87, DOI 10.1016/j.neuroscience.2018.07.014; World Health Organization, 2020, OB OV FACTSH; Zheng P, 2016, MOL PSYCHIATR, V21, P786, DOI 10.1038/mp.2016.44	78	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e21981	10.1096/fj.202100920RR	http://dx.doi.org/10.1096/fj.202100920RR			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34907601	Green Published, Green Submitted			2022-12-28	WOS:000734992000036
J	Cheng, KC; Hwang, YL; Chiang, HC				Kuan-Chung Cheng; Yu-Luen Hwang; Hsueh-Cheng Chiang			The double-edged sword effect of HDAC6 in A beta toxicities	FASEB JOURNAL			English	Article						A beta; HDAC6; learning and memory; tau	INDUCED MICROTUBULE DEFECTS; AMYLOID-BETA; COGNITIVE DEFICITS; ALZHEIMERS-DISEASE; MOUSE MODEL; TAU; ACETYLATION; DROSOPHILA; PROTEIN; NEURODEGENERATION	Alzheimer's disease (AD) is marked by cognitive impairment, massive cell death, and reduced life expectancy. Pathologically, accumulated beta-amyloid (A beta) aggregates and hyperphosphorylated tau protein is the hallmark of the disease. Although changes in cellular function and protein accumulates have been demonstrated in many different AD animal models, the molecular mechanism involved in different cellular functions and the correlation and causative relation between different protein accumulations remain elusive. Our in vivo genetic studies revealed that the molecular mechanisms involved in memory loss and lifespan shortening are different and that tau plays an essential role in mediating A beta-induced early death. We found that when the first deacetylase (DAC) domain of histone deacetylase 6 (HDAC6) activity was increased, it regulated cortactin deacetylation to reverse A beta-induced learning and memory deficit, but with no effect on the lifespan of the A beta flies. On the other hand, an increased amount of the second DAC domain of HDAC6 promoted tau phosphorylation to facilitate A beta-induced lifespan shortening without affecting learning performance in the A beta flies. Our data also confirmed decreased acetylation in two major HDAC6 downstream proteins, suggesting increased HDAC6 activity in A beta flies. Our data established the double-edged sword effect of HDAC6 activity in A beta-induced pathologies. Not only did we segregate memory loss and lifespan shortening in A beta flies, but we also provided evidence to link the A beta with tau signaling.	[Kuan-Chung Cheng; Yu-Luen Hwang; Hsueh-Cheng Chiang] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Kuan-Chung Cheng; Hsueh-Cheng Chiang] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University	Chiang, HC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan.	chianghc@mail.ncku.edu.tw			Ministry of Science and Technology, Taiwan (MOST) [107-2320-B-006-049-MY3, 108-2321B-006-025-MY2]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: 107-2320-B-006-049-MY3 and 108-2321B-006-025-MY2	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Buhl E, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104507; Busche MA, 2020, NAT NEUROSCI, V23, P1183, DOI 10.1038/s41593-020-0687-6; Carlonnagno Y, 2017, J BIOL CHEM, V292, P15277, DOI 10.1074/jbc.M117.794602; Cheng KC, 2018, MOL NEUROBIOL, V55, P7523, DOI 10.1007/s12035-018-0942-y; Chiang HC, 2010, P NATL ACAD SCI USA, V107, P7060, DOI 10.1073/pnas.0909314107; Cuadrado-Tejedor M, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00149; d'Errico P, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00265; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Ding HP, 2008, J NEUROCHEM, V106, P2119, DOI 10.1111/j.1471-4159.2008.05564.x; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Esteves AR, 2019, BBA-MOL BASIS DIS, V1865, P2008, DOI 10.1016/j.bbadis.2018.11.014; Fan SJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0688-5; Francis YI, 2009, J ALZHEIMERS DIS, V18, P131, DOI 10.3233/JAD-2009-1134; Frost B, 2014, NAT NEUROSCI, V17, P357, DOI 10.1038/nn.3639; Govindarajan N, 2013, EMBO MOL MED, V5, P52, DOI 10.1002/emmm.201201923; He F, 2020, BIOORG CHEM, V103, DOI 10.1016/j.bioorg.2020.104109; Huang JK, 2013, NEUROBIOL DIS, V51, P161, DOI 10.1016/j.nbd.2012.11.006; Huang YP, 2015, J ALZHEIMERS DIS, V45, P235, DOI 10.3233/JAD-141608; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Kommaddi RP, 2018, J NEUROSCI, V38, P1085, DOI 10.1523/JNEUROSCI.2127-17.2017; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Mao CX, 2017, DIS MODEL MECH, V10, P1245, DOI 10.1242/dmm.028316; McGuire SE, 2004, TRENDS GENET, V20, P384, DOI 10.1016/j.tig.2004.06.012; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Odagiri S, 2013, BIOCHEM BIOPH RES CO, V430, P394, DOI 10.1016/j.bbrc.2012.11.034; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Perez M, 2009, J NEUROCHEM, V109, P1756, DOI 10.1111/j.1471-4159.2009.06102.x; Perry S, 2017, CELL REP, V18, P1337, DOI 10.1016/j.celrep.2017.01.028; Pickett EK, 2019, CELL REP, V29, P3592, DOI 10.1016/j.celrep.2019.11.044; Puzzo D, 2020, J CLIN INVEST, V130, P4831, DOI 10.1172/JCI137040; Rabal O, 2019, ACS CHEM NEUROSCI, V10, P4076, DOI 10.1021/acschemneuro.9b00303; Richter-Landsberg C, 2013, ACTA NEUROPATHOL, V126, P793, DOI 10.1007/s00401-013-1158-x; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Rush T, 2018, J NEUROSCI, V38, P10349, DOI 10.1523/JNEUROSCI.1409-18.2018; Salvadores N, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.581767; Schnoor M, 2018, TRENDS CELL BIOL, V28, P79, DOI 10.1016/j.tcb.2017.10.009; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Shipton OA, 2011, J NEUROSCI, V31, P1688, DOI 10.1523/JNEUROSCI.2610-10.2011; Su M, 2011, J NEUROCHEM, V117, P112, DOI 10.1111/j.1471-4159.2011.07180.x; Trzeciakiewicz H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19317-4; Tsushima H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8781; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Xiong Y, 2013, P NATL ACAD SCI USA, V110, P4604, DOI 10.1073/pnas.1207586110; Yan C, 2018, CELL REP, V25, P1051, DOI 10.1016/j.celrep.2018.09.075; Yoshikawa M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00124	51	1	1	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22072	10.1096/fj.202101061R	http://dx.doi.org/10.1096/fj.202101061R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34907598				2022-12-28	WOS:000734992000041
J	Agren, R; Sahlholm, K				Agren, Richard; Sahlholm, Kristoffer			G protein-coupled receptor kinase-2 confers isoform-specific calcium sensitivity to dopamine D-2 receptor desensitization	FASEB JOURNAL			English	Article						beta-arrestin; dopamine receptor isoforms; kinase inhibitors; voltage clamp; Xenopus oocytes	G-BETA-GAMMA; PHOSPHORYLATION; EXPRESSION; GRK2; INHIBITION; RESPONSES; CHANNELS; REVEALS; AGONIST	The dopamine D-2 receptor (D2R) functions as an autoreceptor on dopaminergic cell bodies and terminals and as a postsynaptic receptor on a variety of neurons in the central nervous system. As a result of alternative splicing, the D2R is expressed as two isoforms: long (D2LR) and short (D2SR) differing by a stretch of 29 residues in the third intracellular loop, with D2SR being the predominant presynaptic isoform. Recent reports described a Ca2+ sensitivity of the desensitization time course of potassium currents elicited via D2SR, but not via D2LR, when either isoform was selectively expressed in dopaminergic neurons. Here, we aimed to study the mechanism behind this subtype-specific Ca2+ sensitivity. Thus, we measured the desensitization of potassium channel responses evoked by D2LR and D2SR using two-electrode voltage clamp in Xenopus oocytes in the absence and presence of different amounts of beta-arrestin2 and G protein-coupled receptor kinase-2 (GRK2), both of which are known to play important roles in D2R desensitization in native cells. We found that co-expression of both GRK2 and beta-arrestin2 was necessary for reconstitution of the Ca2+ sensitivity of D2SR desensitization, while D2LR did not display Ca2+ sensitivity under these conditions. The effect of Ca2+ chelation by BAPTA-AM to slow the rate of D2SR desensitization was mimicked by the GRK2 inhibitor, Cmpd101, and by the kinase-inactivating GRK2 mutation, K220R, but not by the PKC inhibitor, Go6976, nor by the calmodulin antagonist, KN-93. Thus, Ca2+-sensitive desensitization of D2SR appears to be mediated via a GRK2 phosphorylation-dependent mechanism.	[Agren, Richard; Sahlholm, Kristoffer] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Sahlholm, Kristoffer] Umea Univ, Wallenberg Ctr Mol Med, Dept Integrat Med Biol, Johan Bures Vag 12, S-90187 Umea, Sweden	Karolinska Institutet; Umea University	Agren, R (corresponding author), Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.; Sahlholm, K (corresponding author), Umea Univ, Wallenberg Ctr Mol Med, Dept Integrat Med Biol, Johan Bures Vag 12, S-90187 Umea, Sweden.	richard.agren@ki.se; kristoffer.sahlholm@ki.se	Sahlholm, Kristoffer/V-1016-2017	Sahlholm, Kristoffer/0000-0001-6536-1972	Stiftelsen Lars Hiertas Minne (Lars Hierta Memorial Foundation) [FO2016-0434, FO2020-0289]; Ahlen-stiftelsen (Ahlen Foundation) [mB3 h18]; Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation) [2018-02980]; Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation); Stockholms Lans Landsting (Stockholm County Council)	Stiftelsen Lars Hiertas Minne (Lars Hierta Memorial Foundation); Ahlen-stiftelsen (Ahlen Foundation); Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation); Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation); Stockholms Lans Landsting (Stockholm County Council)(Stockholm County Council)	Stiftelsen Lars Hiertas Minne (Lars Hierta Memorial Foundation), Grant/Award Number: FO2016-0434; Ahlen-stiftelsen (Ahlen Foundation), Grant/Award Number: mB3 h18; Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation), Grant/Award Number: 2018-02980; Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation); Stockholms Lans Landsting (Stockholm County Council); Stiftelsen Lars Hiertas Minne (Lars Hierta Memorial Foundation), Grant/Award Number: FO2020-0289; Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation), Grant/Award Number: 2018-02980	Abraham AD, 2018, J NEUROSCI, V38, P8031, DOI 10.1523/JNEUROSCI.0653-18.2018; Agren R, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.581151; Agren R, 2018, INT J NEUROPSYCHOPH, V21, P1102, DOI 10.1093/ijnp/pyy059; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Beaulieu JM, 2015, BRIT J PHARMACOL, V172, P1, DOI 10.1111/bph.12906; Cassier E, 2017, ELIFE, V6, DOI 10.7554/eLife.23777; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Celver J, 2013, J NEUROCHEM, V127, P57, DOI 10.1111/jnc.12359; Daigle TL, 2014, NEUROPSYCHOPHARMACOL, V39, P2450, DOI 10.1038/npp.2014.97; Delom Frederic, 2011, Int J Cell Biol, V2011, P246954, DOI 10.1155/2011/246954; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Dragicevic E, 2014, BRAIN, V137, P2287, DOI 10.1093/brain/awu131; Gantz SC, 2015, ELIFE, V4, DOI 10.7554/eLife.09358.001; Hawes BE, 2000, ENDOCRINOLOGY, V141, P4524, DOI 10.1210/en.141.12.4524; He D, 2020, MOL PHARMACOL, V97, P123, DOI 10.1124/mol.119.117473; Heusler P, 2007, NEUROPHARMACOLOGY, V52, P1106, DOI 10.1016/j.neuropharm.2006.11.008; Hoekstra EJ, 2013, EUR J NEUROSCI, V37, P23, DOI 10.1111/ejn.12022; Jomphe C, 2006, NEUROPHARMACOLOGY, V50, P595, DOI 10.1016/j.neuropharm.2005.11.010; Khan ZU, 1998, P NATL ACAD SCI USA, V95, P7731, DOI 10.1073/pnas.95.13.7731; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KONG GH, 1994, J BIOL CHEM, V269, P13084; Krasel C, 2001, J BIOL CHEM, V276, P1911, DOI 10.1074/jbc.M008773200; Mann A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87417-2; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Morris SJ, 2007, EUR J PHARMACOL, V577, P44, DOI 10.1016/j.ejphar.2007.08.027; Namkung Y, 2004, J BIOL CHEM, V279, P49533, DOI 10.1074/jbc.M408319200; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; Neve KA, 2013, NEUROSCIENCE, V248, P479, DOI 10.1016/j.neuroscience.2013.06.035; Pack TF, 2018, J BIOL CHEM, V293, P6161, DOI 10.1074/jbc.RA117.001300; Radl D, 2018, P NATL ACAD SCI USA, V115, P198, DOI 10.1073/pnas.1717194115; Raveh A, 2010, CELL, V143, P750, DOI 10.1016/j.cell.2010.10.018; Rengo G, 2011, J MOL CELL CARDIOL, V50, P785, DOI 10.1016/j.yjmcc.2010.08.014; Robinson BG, 2017, ELIFE, V6, DOI 10.7554/eLife.31924; Sahlholm K, 2011, NEUROPHARMACOLOGY, V61, P937, DOI 10.1016/j.neuropharm.2011.06.022; Sanchez-Soto M, 2020, FASEB J, V34, DOI 10.1096/fasebj.2020.34.s1.03478; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Stepniewski TM, 2021, CHEM SCI, V12, P10990, DOI 10.1039/d1sc00749a; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; TYMIANSKI M, 1994, J NEUROPHYSIOL, V72, P1973, DOI 10.1152/jn.1994.72.4.1973; Urs NM, 2016, P NATL ACAD SCI USA, V113, pE8178, DOI 10.1073/pnas.1614347113; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Weiss S, 2012, CHANNELS, V6, P426, DOI 10.4161/chan.22016; Wong MH, 2019, J MOL BIOL, V431, P1440, DOI 10.1016/j.jmb.2019.02.001; Xu R, 2002, MOL PSYCHIATR, V7, P1075, DOI 10.1038/sj.mp.4001145; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034	45	1	1	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e22013	10.1096/fj.202100704RR	http://dx.doi.org/10.1096/fj.202100704RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34699610	hybrid, Green Published			2022-12-28	WOS:000712009200057
J	Pomar, CA; Serra, F; Palou, A; Sanchez, J				Pomar, Catalina A.; Serra, Francisca; Palou, Andreu; Sanchez, Juana			Lower miR-26a levels in breastmilk affect gene expression in adipose tissue of offspring	FASEB JOURNAL			English	Article						breastfeeding; breastmilk; milk's epigenetic regulators; miR-26a	NECROSIS-FACTOR-ALPHA; INDUCED INSULIN-RESISTANCE; ADIPOCYTE DIFFERENTIATION; RETINOBLASTOMA PROTEIN; CONVERTING-ENZYME; CAFETERIA DIET; MESSENGER-RNA; MICRORNAS; ADIPOGENESIS; OBESITY	Breastmilk miRNAs may act as epigenetic regulators of metabolism and energy homeostasis in offspring. Here, we aimed to investigate the regulatory effects of miR-26a on adipose tissue development. First, the 3T3-L1 cell model was used to identify putative target genes for miR-26a. Then, target genes were analysed in adipose tissue of offspring from dams that supplied lower levels of breastmilk miR-26a to determine whether miR-26a milk concentration might have a long-lasting impact on adipose tissue in the progeny. In the in vitro model, both over- and under-expression of miR-26a were induced by transfecting into 3T3-L1 with miR-26a mimic and inhibitor. Array analysis was performed after induction of miR-26a to ascertain the impact on mRNA target genes and influence of differentiation status. Focusing on genes related to adipose tissue development, transfection with miR-26a mimic reduced the expression of Pten, Hmga1, Stk11, Rb1, and Adam17 in both pre- and mature adipocytes. Data mostly confirmed the results found in the animal model. After weaning, descendants of cafeteria-fed dams breastfed with lower levels of miR-26a displayed greater expression of Hmag1, Rb1, and Adam17 in retroperitoneal white adipose tissue in comparison with controls. Hence, alterations in the amount of miR-26a supplied through milk during lactation is able to alter the expression of target genes in the descendants and may affect adipose tissue development. Thus, milk miR-26a may act as an epigenetic regulator influencing early metabolic program in the progeny, which emerges as a relevant component of an optimal milk composition for correct development.	[Pomar, Catalina A.; Serra, Francisca; Palou, Andreu; Sanchez, Juana] Univ Balearic Isl, Lab Mol Biol Nutr & Biotechnol Nutrigen Biomarker, Edifici Mateu Orfila,Carretera Valldemossa Km 7-5, Palma De Mallorca 07122, Spain; [Pomar, Catalina A.; Serra, Francisca; Palou, Andreu; Sanchez, Juana] IdISBa, Inst Invest Sanitaria Illes Balears, Palma De Mallorca, Spain; [Pomar, Catalina A.; Serra, Francisca; Palou, Andreu; Sanchez, Juana] Inst Salud Carlos III ISCIII, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain	Universitat de les Illes Balears; Institut Investigacio Sanitaria Illes Balears (IdISBa); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Serra, F (corresponding author), Univ Balearic Isl, Lab Mol Biol Nutr & Biotechnol Nutrigen Biomarker, Edifici Mateu Orfila,Carretera Valldemossa Km 7-5, Palma De Mallorca 07122, Spain.	francisca.serra@uih.es	Pomar, Catalina Amadora/AAF-1411-2021; Sanchez, Juana/K-9675-2014; Serra, Francisca/B-8641-2008; Palou, Andreu/K-9881-2014	Pomar, Catalina Amadora/0000-0002-8113-761X; Sanchez, Juana/0000-0002-9176-8060; Serra, Francisca/0000-0002-8307-9732; Palou, Andreu/0000-0002-0295-4452	MINECO | Instituto de Salud Carlos III (ISCIII) [PI17/01614]	MINECO | Instituto de Salud Carlos III (ISCIII)	MINECO | Instituto de Salud Carlos III (ISCIII), Grant/Award Number: PI17/01614	Acharya A, 2019, GENE DEV, V33, P1367, DOI 10.1101/gad.328955.119; Alsaweed M, 2015, INT J ENV RES PUB HE, V12, P13981, DOI 10.3390/ijerph121113981; Arce-Cerezo A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14487; Armstrong J, 2002, LANCET, V359, P2003, DOI 10.1016/S0140-6736(02)08837-2; Baier SR, 2014, J NUTR, V144, P1495, DOI 10.3945/jn.114.196436; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Chen CY, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00338; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; Chiefari E, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00357; Chiefari E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00251; D'Angelo D, 2015, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00039; Dali-Youcef N, 2007, P NATL ACAD SCI USA, V104, P10703, DOI 10.1073/pnas.0611568104; Dey BK, 2012, GENE DEV, V26, P2180, DOI 10.1101/gad.198085.112; Dill H, 2012, GENE DEV, V26, P25, DOI 10.1101/gad.177774.111; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Fiorentino L, 2010, HEPATOLOGY, V51, P103, DOI 10.1002/hep.23250; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Fu XH, 2015, J CLIN INVEST, V125, P2497, DOI 10.1172/JCI75438; Gao J, 2011, ONCOL LETT, V2, P1019, DOI 10.3892/ol.2011.413; Gormand A, 2014, J MOL ENDOCRINOL, V53, P117, DOI 10.1530/JME-13-0296; Hidalgo MR, 2017, ONCOTARGET, V8, P5160, DOI 10.18632/oncotarget.14107; Hilton C, 2013, INT J OBESITY, V37, P325, DOI 10.1038/ijo.2012.59; Hochberg Z, 2011, ENDOCR REV, V32, P159, DOI 10.1210/er.2009-0039; Horta BL, 2015, ACTA PAEDIATR, V104, P30, DOI 10.1111/apa.13133; Izumi H, 2012, J DAIRY SCI, V95, P4831, DOI 10.3168/jds.2012-5489; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kaneko H, 2011, CIRC J, V75, P2482, DOI 10.1253/circj.CJ-11-0182; Karbiener M, 2014, STEM CELLS, V32, P1578, DOI 10.1002/stem.1603; Li GL, 2017, DNA CELL BIOL, V36, P672, DOI 10.1089/dna.2017.3712; Moreno-Navarrete JM, 2013, DIABETES, V62, P1923, DOI 10.2337/db12-0977; McNeill EM, 2020, ANNU REV NUTR, V40, P77, DOI 10.1146/annurev-nutr-122319-035633; Melnik BC, 2017, BEST PRACT RES CL EN, V31, P427, DOI 10.1016/j.beem.2017.10.003; Melnik BC, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-43; Menghini R, 2013, ATHEROSCLEROSIS, V228, P12, DOI 10.1016/j.atherosclerosis.2013.01.024; Mercader J, 2009, AM J PHYSIOL-ENDOC M, V297, pE184, DOI 10.1152/ajpendo.00163.2009; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Munch EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050564; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Petrov PD, 2015, AM J PHYSIOL-ENDOC M, V308, pE172, DOI 10.1152/ajpendo.00308.2014; Pomar CA, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.158556; Pomar CA, 2017, INT J OBESITY, V41, P1279, DOI 10.1038/ijo.2017.42; Pomar CA, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201800928; Pomar CA, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082470; Puigserver P., 1994, International Journal of Obesity, V18, P113; Puigserver P, 1998, EUR J CELL BIOL, V77, P117, DOI 10.1016/S0171-9335(98)80079-4; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Serino M, 2007, DIABETES, V56, P2541, DOI 10.2337/db07-0360; Son YH, 2014, ENDOCRINOL METAB, V29, P122, DOI 10.3803/EnM.2014.29.2.122; Song GX, 2014, GENE, V533, P481, DOI 10.1016/j.gene.2013.10.011; Trompeter HI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-111; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Xi PJ, 2019, GENE, V682, P33, DOI 10.1016/j.gene.2018.10.012; Xi Y, 2016, EUR J CLIN NUTR, V70, P445, DOI 10.1038/ejcn.2015.168; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Xu G, 2015, INT J OBESITY, V39, P1523, DOI 10.1038/ijo.2015.95; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200; Yan J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1267; Yun SJ, 2008, BIOCHEM BIOPH RES CO, V371, P138, DOI 10.1016/j.bbrc.2008.04.029; Zamanillo R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112589; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]	63	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21924	10.1096/fj.202100623R	http://dx.doi.org/10.1096/fj.202100623R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34582059	hybrid			2022-12-28	WOS:000702238200019
J	An, LY; Liu, YH; Li, MY; Liu, ZH; Wang, ZS; Dai, YJ; Presicce, GA; Du, FL				An, Liyou; Liu, Yanhong; Li, Mingyang; Liu, Zhihui; Wang, Zhisong; Dai, Yujian; Presicce, Giorgio Antonio; Du, Fuliang			Site specificity of blastocyst hatching significantly influences pregnancy outcomes in mice	FASEB JOURNAL			English	Article						assisted hatching; blastocyst; hatching site; implantation; pregnancy outcomes	PLACENTA-SPECIFIC PROTEIN-1; EMBRYO IMPLANTATION; ZONA-PELLUCIDA; EXPRESSION; ATTACHMENT; BOVINE	Blastocysts hatch from the zona pellucida (ZP) to enable implantation into the uterine endometrial epithelium, but little is known regarding the effect of hatching sites on pregnancy outcomes. Murine hatching embryos were categorized into five groups based on initial trophectoderm projection (TEP)/ZP position corresponding to the inner cell mass center. In blastocysts (3.5 dpc) post-12 hours in vitro culture, TEP rates of A-site (44.4%) and B-site (38.6%) embryos were higher than those of C-site (12.5%) and D-site (3.1%) embryos, while the O-site (1.4%) was the lowest (P < .05). Post-ET A-site (55.6%) and B-site (65.6%) birth rates were higher than those of C-site embryos (21.3%) and controls (P < .05). Furthermore, live birth rate of B-site embryos remained higher than C-site embryos (68.8% vs 31.3%; P < .05) when both were transferred into the same recipients. Different TEP site blastocysts exhibited different implantation competences: the implantation rate of C-site embryos was lower than that of both A- and B-site groups (67.7% vs 84.3% and 83.2%, respectively; P < .05) at 2 days post-ET. C-site embryos also had a distinctly higher ratio of developmental defects (47.5%) than A- and B-site embryos (22.5% and 14.6%, respectively), with implantation failure mainly associated with poor birth rate, a finding corroborated by differential gene expression analysis such as LIF, LIFR, and S100a9. Surprisingly, acidified Tyrode's solution (AAH)-treated B-site blastocysts had a significantly increased birth rate (77.1%) than C-site (55.3%) and controls (43.4%). Site specificity and differential gene expression during embryo hatching can be applied in ART screening. More importantly, assisted hatching by AAH is effective and feasible for improving pregnancy and term development, particularly at the B-site, for humans and in animal husbandry.	[An, Liyou; Liu, Yanhong; Li, Mingyang; Liu, Zhihui; Wang, Zhisong; Dai, Yujian; Du, Fuliang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, 1 Wenyuan Rd, Nanjing 210046, Peoples R China; [An, Liyou] Xinjiang Univ, Coll Life Sci & Technol, Xinjiang Key Lab Biol Resources & Genet Engn, Urumqi, Peoples R China; [Presicce, Giorgio Antonio] ARSIAL, Rome, Italy	Nanjing Normal University; Xinjiang University	Du, FL (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, 1 Wenyuan Rd, Nanjing 210046, Peoples R China.	fuliangd@njnu.edu.cn	liu, yan/HCI-5542-2022; liu, yan/HGV-1365-2022; Presicce, Giorgio/ABH-0533-2022		Natural Science Foundation of China (NSFC) [31872353, 32072732, 31340041, 31471388]; NSFC [31701285]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC))	Supported in part by Natural Science Foundation of China (NSFC) (Grant No. 31872353, 32072732, 31340041, and 31471388) to FD; NSFC Grant No. 31701285 to LA	Alteri A, 2018, J ASSIST REPROD GEN, V35, P367, DOI 10.1007/s10815-018-1118-4; Baker JR, 2011, DEV DYNAM, V240, P2194, DOI 10.1002/dvdy.22709; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chang WL, 2014, REPRODUCTION, V148, P343, DOI 10.1530/REP-14-0052; Cheon YP, 1999, ZYGOTE, V7, P123, DOI 10.1017/S0967199499000477; Chimote Natachandra M, 2013, J Hum Reprod Sci, V6, P183, DOI 10.4103/0974-1208.121420; Clementi C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003863; Das SK, 2009, REPRODUCTION, V137, P889, DOI 10.1530/REP-08-0539; Ebner T, 2007, J TURK-GER GYNECOL A, V8, P184; Ebner T, 2010, FERTIL STERIL, V94, pE65, DOI 10.1016/j.fertnstert.2010.06.026; Funeshima N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227885; Gonzales DS, 1996, HUM REPROD, V11, P2739; Griffith OW, 2017, P NATL ACAD SCI USA, V114, pE6566, DOI 10.1073/pnas.1701129114; Hammadeh ME, 2011, J ASSIST REPROD GEN, V28, P119, DOI 10.1007/s10815-010-9495-3; Hardy K, 2002, J ENDOCRINOL, V172, P221, DOI 10.1677/joe.0.1720221; He B, 2019, P NATL ACAD SCI USA, V116, P16621, DOI 10.1073/pnas.1900401116; Kelleher AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04848-8; Khorram O, 2000, FERTIL STERIL, V74, P163, DOI 10.1016/S0015-0282(00)00567-7; Kissin DM, 2014, FERTIL STERIL, V102, P795, DOI 10.1016/j.fertnstert.2014.06.013; Kriudtson JF, 2017, FERTIL STERIL, V108, P628, DOI 10.1016/j.fertnstert.2017.07.011; Koot YEM, 2012, BBA-MOL BASIS DIS, V1822, P1943, DOI 10.1016/j.bbadis.2012.05.017; Leonavicius K, 2018, P NATL ACAD SCI USA, V115, P10375, DOI 10.1073/pnas.1719930115; Li D, 2016, SCI REP-UK, V6, DOI 10.1038/srep31228; Liu JL, 2018, P NATL ACAD SCI USA, V115, pE1, DOI 10.1073/pnas.1716675115; Liu SJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59424-2; Lu XM, 2019, LASER MED SCI, V34, P1137, DOI 10.1007/s10103-018-02702-3; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Miyata H, 2010, FERTIL STERIL, V94, P2444, DOI 10.1016/j.fertnstert.2010.01.056; Monsivais D, 2016, P NATL ACAD SCI USA, V113, pE387, DOI 10.1073/pnas.1523758113; Moriwaki K, 2007, DEV BIOL, V312, P509, DOI 10.1016/j.ydbio.2007.09.049; Negron-Perez VM, 2017, J ASSIST REPROD GEN, V34, P725, DOI 10.1007/s10815-017-0933-3; O'Sullivan CM, 2001, REPRODUCTION, V122, P61, DOI 10.1530/rep.0.1220061; Ren XL, 2013, J ASSIST REPROD GEN, V30, P691, DOI 10.1007/s10815-013-9984-2; Salamonsen LA, 2016, AM J REPROD IMMUNOL, V75, P218, DOI 10.1111/aji.12450; Sathananthan Henry, 2003, Reprod Biomed Online, V7, P228; Schimmel T, 2014, HUM REPROD, V29, P2670, DOI 10.1093/humrep/deu245; Sharma S, 2016, AM J REPROD IMMUNOL, V75, P341, DOI 10.1111/aji.12466; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Tannus S, 2019, REPROD SCI, V26, P806, DOI 10.1177/1933719118799192; Veeck LL., 2003, ENCY VISUAL MED SERI, V7; Wan CY, 2014, REPROD BIOMED ONLINE, V28, P582, DOI 10.1016/j.rbmo.2014.01.006; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang YJ, 2022, LASER MED SCI, V37, P1, DOI 10.1007/s10103-020-03230-9; WASSARMAN PM, 1990, DEVELOPMENT, V108, P1; Yilmaz N, 2015, FERTIL STERIL, V104, pE113, DOI 10.1016/j.fertnstert.2015.07.350; Zeng MF, 2018, LASER MED SCI, V33, P655, DOI 10.1007/s10103-017-2372-x	46	0	0	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21812	10.1096/fj.202100653R	http://dx.doi.org/10.1096/fj.202100653R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34411354				2022-12-28	WOS:000691122900018
J	Maitland, MER; Kuljanin, M; Wang, X; Lajoie, GA; Schild-Poulter, C				Maitland, Matthew E. R.; Kuljanin, Miljan; Wang, Xu; Lajoie, Gilles A.; Schild-Poulter, Caroline			Proteomic analysis of ubiquitination substrates reveals a CTLH E3 ligase complex-dependent regulation of glycolysis	FASEB JOURNAL			English	Article						CTLH complex; glycolysis; LDHA; PKM; ubiquitination	PYRUVATE-KINASE; PROTEIN; RANBPM; IDENTIFICATION; ENRICHMENT; TARGETS	Ubiquitination is an essential post-translational modification that regulates protein stability or function. Its substrate specificity is dictated by various E3 ligases. The human C-terminal to LisH (CTLH) complex is a newly discovered multi-subunit really interesting new gene (RING) E3 ligase with only a few known ubiquitination targets. Here, we used mass spectrometry-based proteomic techniques to gain insight into CTLH complex function and ubiquitination substrates in HeLa cells. First, global proteomics determined proteins that were significantly increased, and thus may be substrates targeted for degradation, in cells depleted of CTLH complex member RanBPM. RanBPM-dependent ubiquitination determined using diGLY-enriched proteomics and the endogenous RanBPM interactome further revealed candidate ubiquitination targets. Three glycolysis enzymes alpha-enolase, L-lactate dehydrogenase A chain (LDHA), and pyruvate kinase M1/2 (PKM) had decreased ubiquitin sites in shRanBPM cells and were found associated with RanBPM in the interactome. Reduced polyubiquitination was validated for PKM2 and LDHA in cells depleted of RanBPM and CTLH complex RING domain subunit RMND5A. PKM2 and LDHA protein levels were unchanged, yet their activity was increased in extracts of cells with downregulated RanBPM. Finally, RanBPM deficient cells displayed enhanced glycolysis and deregulated central carbon metabolism. Overall, this study identifies potential CTLH complex ubiquitination substrates and uncovers that the CTLH complex inhibits glycolysis via non-degradative ubiquitination of PKM2 and LDHA.	[Maitland, Matthew E. R.; Wang, Xu; Schild-Poulter, Caroline] Western Univ, Schulich Sch Med & Dent, Robarts Res Inst, 1151 Richmond St North, London, ON N6A 5B7, Canada; [Maitland, Matthew E. R.; Kuljanin, Miljan; Lajoie, Gilles A.; Schild-Poulter, Caroline] Western Univ, Schulich Sch Med & Dent, Dept Biochem, London, ON, Canada; [Maitland, Matthew E. R.; Kuljanin, Miljan; Lajoie, Gilles A.] Western Univ, Schulich Sch Med & Dent, Don Rix Prot Identificat Facil, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Schild-Poulter, C (corresponding author), Western Univ, Schulich Sch Med & Dent, Robarts Res Inst, 1151 Richmond St North, London, ON N6A 5B7, Canada.	cschild-poulter@robarts.ca	Schild-Poulter, Caroline/K-4476-2013		Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) [MOP-142414]; Canada Foundation for Innovation (CFI); Government of Ontario; Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC)	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Government of Ontario; Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC)	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: MOP-142414; Canada Foundation for Innovation (CFI); Government of Ontario, Grant/Award Number: Ontario graduate Scholarship; Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC), Grant/Award Number: Postgraduate Scholarship-Doctoral (PGS D)	Atabakhsh E, 2012, AM J CANCER RES, V2, P549; Atabakhsh E, 2009, MOL CANCER RES, V7, P1962, DOI 10.1158/1541-7786.MCR-09-0098; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Budhidarmo R, 2012, TRENDS BIOCHEM SCI, V37, P58, DOI 10.1016/j.tibs.2011.11.001; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cao WX, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107783; Chaugule VK, 2016, BIOCHEM SOC T, V44, P212, DOI 10.1042/BST20150209; Chen SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aal3655; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Dong C, 2020, P NATL ACAD SCI USA, V117, P14158, DOI 10.1073/pnas.2007085117; Dong C, 2018, NAT CHEM BIOL, V14, P466, DOI 10.1038/s41589-018-0036-1; Fan J, 2011, MOL CELL BIOL, V31, P4938, DOI 10.1128/MCB.06120-11; Foerster S, 2013, PROTEOMICS, V13, P3131, DOI 10.1002/pmic.201300154; Francis O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075217; Goto T, 2016, FEBS LETT, V590, P1291, DOI 10.1002/1873-3468.12180; Heisler FF, 2018, NEURON, V99, P1155, DOI 10.1016/j.neuron.2018.08.010; Hosono K, 2010, GENOMICS, V96, P102, DOI 10.1016/j.ygeno.2010.05.003; Huang H, 2018, MOL CELL, V70, P663, DOI 10.1016/j.molcel.2018.04.011; Huffman N, 2019, J ONCOL, V2019, DOI 10.1155/2019/4216750; Israelsen WJ, 2015, SEMIN CELL DEV BIOL, V43, P43, DOI 10.1016/j.semcdb.2015.08.004; Kaboord B, 2015, METHODS MOL BIOL, V1295, P135, DOI 10.1007/978-1-4939-2550-6_12; Kobayashi N, 2007, GENE, V396, P236, DOI 10.1016/j.gene.2007.02.032; Kucera Mike, 2016, F1000Res, V5, P1717; Kuljanin M, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600337; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Lampert F, 2018, ELIFE, V7, DOI 10.7554/eLife.35528; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Liu HZ, 2020, AUTOPHAGY, V16, P1618, DOI 10.1080/15548627.2019.1695399; Liu HZ, 2019, BIOL CHEM, V400, P1429, DOI 10.1515/hsz-2019-0139; Liu K, 2016, J BIOL CHEM, V291, P10307, DOI 10.1074/jbc.M115.703066; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Maitland MER, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46279-5; McTavish CJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040934; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Puverel S, 2011, DEVELOPMENT, V138, P2511, DOI 10.1242/dev.062505; Qiao S, 2020, MOL CELL, V77, P150, DOI 10.1016/j.molcel.2019.10.009; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Rennie ML, 2020, CURR OPIN STRUC BIOL, V62, P189, DOI 10.1016/j.sbi.2020.02.003; Salemi LM, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170081; Salemi LM, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3430-2; Santt O, 2008, MOL BIOL CELL, V19, P3323, DOI 10.1091/mbc.E08-03-0328; Senft D, 2018, NAT REV CANCER, V18, P69, DOI 10.1038/nrc.2017.105; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soliman SHA., 2020, SCI REP-UK, V10, P1; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; Ventura M, 2010, INT J BIOCHEM CELL B, V42, P1672, DOI 10.1016/j.biocel.2010.06.014; Wei QZ, 2019, BLOOD, V133, P1222, DOI 10.1182/blood-2018-11-888180; Woo JA, 2017, HUM MOL GENET, V26, P3973, DOI 10.1093/hmg/ddx284; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; Zavortink M, 2020, ELIFE, V9, DOI 10.7554/eLife.53889; Zhen R, 2020, BLOOD, V135, P208, DOI 10.1182/blood.2019002165	55	8	8	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21825	10.1096/fj.202100664R	http://dx.doi.org/10.1096/fj.202100664R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34383978	Green Published, hybrid			2022-12-28	WOS:000691122900035
J	Chowdhury, SR; Das, SK; Banerjee, B; Chowdhuri, SP; Majumder, HK; Das, BB				Chowdhury, Somenath Roy; Das, Subhendu K.; Banerjee, Bijoylaxmi; Chowdhuri, Srijita Paul; Majumder, Hemanta K.; Das, Benu Brata			TDP1 knockout Leishmania donovani accumulate topoisomerase 1-linked DNA damage and are hypersensitive to clinically used antileishmanial drugs	FASEB JOURNAL			English	Article						camptothecin; DNA repair; Leishmania donovani; oxidative stress; phosphodiesterase; TDP1; topoisomerase 1	PROGRAMMED CELL-DEATH; PHOSPHODIESTERASE TDP1; ANTIMONY-RESISTANT; BREAK REPAIR; I TOP1; CAMPTOTHECIN; ANTICANCER; APOPTOSIS; PARASITE; NUCLEAR	Leishmania donovani, a unicellular protozoan parasite, causes a wide range of human diseases including fatal visceral leishmaniasis. Tyrosyl DNA-phosphodiesterase 1 (TDP1) hydrolyzes the phosphodiester bond between DNA 3 '-end and a tyrosyl moiety of trapped topoisomerase I-DNA covalent complexes (Top1cc). We have previously shown Leishmania harbors a TDP1 gene (LdTDP1), however, the biological role of TDP1 remains largely unknown. In the present study, we have generated TDP1 knockout L. donovani (LdTDP1(-/-)) promastigotes and have shown that LdTDP1(-/-) parasites are deficient in 3 '-phosphodiesterase activities and were hypersensitive to Top1-poison like camptothecin (CPT), DNA alkylation agent like methyl methanesulfonate, and oxidative DNA lesions generated by hydrogen peroxide but were not sensitive to etoposide. We also detected elevated levels of CPT-induced reactive oxygen species triggering cell cycle arrest and cell death in LdTDP1(-/-) promastigotes. LdTDP1(-/-) promastigotes accumulate a significant change in the membrane morphology with the accumulation of membrane pores, which is associated with oxidative stress and lipid peroxidation. To our surprise, we detected that LdTDP1(-/-) parasites were hypersensitive to antileishmanial drugs like amphotericin B and miltefosine, which could be rescued by complementation of wild-type TDP1 gene in the LdTDP1(-/-) parasites. Notably, multidrug-resistant L. donovani clinical isolates showed a marked reduction in TDP1 expression and were sensitive to Top1 poisons. Taken together, our study provides a new role of LdTDP1 in protecting L. donovani parasites from oxidative stress-induced DNA damage and resistance to amphotericin B and miltefosine.	[Chowdhury, Somenath Roy; Banerjee, Bijoylaxmi; Majumder, Hemanta K.] CSIR Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata, India; [Das, Subhendu K.; Chowdhuri, Srijita Paul; Das, Benu Brata] Indian Assoc Cultivat Sci, Sch Biol Sci, Lab Mol Biol, 2A&B,Raja SC Mullick Rd, Kolkata 700032, India; [Chowdhury, Somenath Roy] Westfalische Wilhelms Univ Munster, Inst Phys Chem, D-48149 Munster, Germany; [Das, Subhendu K.] NCI, Lab Pathol, NIH, Bethesda, MD 20892 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur; University of Munster; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Das, BB (corresponding author), Indian Assoc Cultivat Sci, Sch Biol Sci, Lab Mol Biol, 2A&B,Raja SC Mullick Rd, Kolkata 700032, India.	pcbbd@iacs.res.in			DBT-S Ramachandran National Bioscience Award for Career Development (NBACD)-2019 grant [102/IFD/SAN/3574/2019-20]; DST-SERB core research grant [EMR/2017/001652]; Wellcome Trust/DBT India alliance intermediate fellowship grant [IA/I/13/1/500888]; CSIR [31/002(1128)/2019-EMR-I]; IACS senior Research Fellowship, India	DBT-S Ramachandran National Bioscience Award for Career Development (NBACD)-2019 grant; DST-SERB core research grant; Wellcome Trust/DBT India alliance intermediate fellowship grant(Wellcome Trust DBT India Alliance); CSIR(Council of Scientific & Industrial Research (CSIR) - India); IACS senior Research Fellowship, India	BBD team is supported by DBT-S Ramachandran National Bioscience Award for Career Development (NBACD)-2019 grant (102/IFD/SAN/3574/2019-20); DST-SERB core research grant (EMR/2017/001652), and Wellcome Trust/DBT India alliance intermediate fellowship grant (Award#IA/I/13/1/500888). SRC was supported by the CSIR-Research Associateship (31/002(1128)/2019-EMR-I). SKD and SPC are the recipients of the IACS senior Research Fellowship, India	Ashour ME, 2015, NAT REV CANCER, V15, P137, DOI 10.1038/nrc3892; Banerjee B, 2010, MOL MICROBIOL, V78, P119, DOI 10.1111/j.1365-2958.2010.07318.x; Barthelmes HU, 2004, J BIOL CHEM, V279, P55618, DOI 10.1074/jbc.M405042200; Basu JM, 2006, ANTIMICROB AGENTS CH, V50, P1788, DOI [10.1128/AAC.50.5.1788-1797.2006, 10.1128/AAC.50.5.1768-1797.2006]; Bhattacharjee S., 2022, POST TRANSLATIONAL R, V111; Boonnoy P, 2015, J PHYS CHEM LETT, V6, P4884, DOI 10.1021/acs.jpclett.5b02405; Capranico G, 2017, J MED CHEM, V60, P2169, DOI 10.1021/acs.jmedchem.6b00966; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chiang SC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602506; Chowdhuri Srijita Paul, 2021, NAR Cancer, V3, pzcab003, DOI 10.1093/narcan/zcab003; Chowdhury S, 2012, EMBO MOL MED, V4, P1126, DOI 10.1002/emmm.201201316; Chowdhury SR, 2019, TRENDS BIOCHEM SCI, V44, P415, DOI 10.1016/j.tibs.2018.12.001; Chowdhury SR, 2017, BIOCHEM PHARMACOL, V138, P19, DOI 10.1016/j.bcp.2017.05.002; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; D'Annessa I, 2015, MINI-REV MED CHEM, V15, P203, DOI 10.2174/138955751503150312120912; Das BB, 2006, NUCLEIC ACIDS RES, V34, P1121, DOI 10.1093/nar/gkj502; Das BB, 2004, FEBS LETT, V565, P81, DOI 10.1016/j.febslet.2004.03.078; Das BB, 2021, MITOCHONDRION, V60, P234, DOI 10.1016/j.mito.2021.08.017; Das BB, 2014, NUCLEIC ACIDS RES, V42, P4435, DOI 10.1093/nar/gku088; Das BB, 2010, P NATL ACAD SCI USA, V107, P19790, DOI 10.1073/pnas.1009814107; Das BB, 2009, EMBO J, V28, P3667, DOI 10.1038/emboj.2009.302; Das SK, 2018, J MED CHEM, V61, P804, DOI 10.1021/acs.jmedchem.7b01297; Das SK, 2016, NUCLEIC ACIDS RES, V44, P8363, DOI 10.1093/nar/gkw665; Ghosh A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax9778; Huang SYN, 2013, NUCLEIC ACIDS RES, V41, P7793, DOI 10.1093/nar/gkt483; Interthal H, 2005, J BIOL CHEM, V280, P36518, DOI 10.1074/jbc.M508898200; Katyal S, 2007, EMBO J, V26, P4720, DOI 10.1038/sj.emboj.7601869; Kawale AS, 2018, NUCLEIC ACIDS RES, V46, P520, DOI 10.1093/nar/gkx1219; Laffitte MCN, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006117; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Mandal SM, 2015, MOL BIOSYST, V11, P2551, DOI 10.1039/c5mb00366k; Mukherjee B, 2013, P NATL ACAD SCI USA, V110, pE575, DOI [10.1073/pnas.1213839110, 10.]; Mukhopadhyay R, 2011, INT J PARASITOL, V41, P1311, DOI 10.1016/j.ijpara.2011.07.013; Murai J, 2012, J BIOL CHEM, V287, P12848, DOI 10.1074/jbc.M111.333963; Nitiss KC, 2006, P NATL ACAD SCI USA, V103, P8953, DOI 10.1073/pnas.0603455103; Pal DS, 2015, ANTIMICROB AGENTS CH, V59, P2144, DOI 10.1128/AAC.05146-14; Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111; Pommier Y, 2014, DNA REPAIR, V19, P114, DOI 10.1016/j.dnarep.2014.03.020; Rehman I, 2018, NUCLEIC ACIDS RES, V46, P5601, DOI 10.1093/nar/gky291; Sen N, 2004, J BIOL CHEM, V279, P52366, DOI 10.1074/jbc.M406705200; Sen N, 2004, CELL DEATH DIFFER, V11, P924, DOI 10.1038/sj.cdd.4401435; Sen N, 2007, EXP PARASITOL, V115, P215, DOI 10.1016/j.exppara.2006.08.005; Sundar S, 2015, EXPERT OPIN PHARMACO, V16, P237, DOI 10.1517/14656566.2015.973850; Vermeersch M, 2009, ANTIMICROB AGENTS CH, V53, P3855, DOI 10.1128/AAC.00548-09; Villa H, 2003, J BIOL CHEM, V278, P3521, DOI 10.1074/jbc.M203991200; Zagnoli-Vieira G, 2020, DNA REPAIR, V94, DOI 10.1016/j.dnarep.2020.102900	49	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22265	10.1096/fj.202101668RR	http://dx.doi.org/10.1096/fj.202101668RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35319800				2022-12-28	WOS:000772957100004
J	Huang, J; Chai, XJ; Wu, YJ; Hou, Y; Li, CX; Xue, YH; Pan, JR; Zhao, YK; Su, AM; Zhu, XY; Zhao, ST				Huang, Jian; Chai, Xuejun; Wu, Yongji; Hou, Yan; Li, Cixia; Xue, Yuhuan; Pan, Jiarong; Zhao, Yongkang; Su, Aimin; Zhu, Xiaoyan; Zhao, Shanting			beta-Hydroxybutyric acid attenuates heat stress-induced neuroinflammation via inhibiting TLR4/p38 MAPK and NF-kappa B pathways in the hippocampus	FASEB JOURNAL			English	Article						cognitive dysfunctions; heat stress; MAPKs; neuroinflammation; beta-hydroxybutyric acid	ANXIETY-LIKE BEHAVIOR; OXIDATIVE STRESS; DOPAMINERGIC-NEURONS; CELLS; HSP70; PERFORMANCE; EXPRESSION; MICROGLIA; CONTRIBUTES; ALZHEIMERS	Heat stress causes many pathophysiological responses in the brain, including neuroinflammation and cognitive deficits. p-Hydroxybutyric acid (BHBA) has been shown to have neuroprotective effects against inflammation induced by lipopolysaccharide. The aim of the present study was to evaluate the effects of BHBA on neuroinflammation induced by heat stress, as well as the underlying mechanisms. Mice were pretreated with vehicle. BHBA or minocycline (positive control group) and followed by heat exposure (43 degrees C) for 15 min for 14 days. In mice subjected to heat stress, we found that treatment with BHBA or minocycline significantly decreased the level of serum cortisol, the expressions of heat shock protein 70 (HSP70), and the density of c-Fos(+) cells in the hippocampus. Surprisingly, the ethological tests revealed that heat stress led to cognitive dysfunctions and could be alleviated by BHBA and minocycline administration. Further investigation showed that BHBA and minocycline significantly attenuated the activation of microglia and astrocyte induced by heat stress. Pro-inflammatory cytokines were attenuated in the hippocampus by BHBA and minocycline treatment. Importantly, compared with the heat stress group, mice in the BHBA treatment group and positive control group experienced a decrease in the expressions of toll-like receptor 4 (TLR4), phospho-p38 (p-p38), and nuclear factor kappa B (NF-kappa B). Our results elucidated that BHBA inhibits neuroinflammation induced by heat stress by suppressing the activation of microglia and astrocyte, and modulating TLR4/p38 MAPK and NF-kappa B pathways. This study provides new evidence that BHBA is a potential strategy for protecting animals from heat stress.	[Huang, Jian; Wu, Yongji; Hou, Yan; Li, Cixia; Xue, Yuhuan; Pan, Jiarong; Zhao, Yongkang; Zhu, Xiaoyan; Zhao, Shanting] Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China; [Chai, Xuejun] Xian Med Univ, Dept Basic Med, Xian, Peoples R China; [Su, Aimin] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Xi'an Medical University; Northwest A&F University - China	Zhu, XY; Zhao, ST (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China.	xyzhu0922@163.com; zhaoshanting@nwsuaf.edu.cn			National Natural Science Foundation of China (NSFC) [31802154]; Shaanxi Provincial Regional Inovation Capability Guiding Plan Project [2020QFY10--04]; National Key Research and Develpoment Program of China [2018YFE0127000]; Key Research and Development Projects of Shaanxi Province [2021NY--021]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shaanxi Provincial Regional Inovation Capability Guiding Plan Project; National Key Research and Develpoment Program of China; Key Research and Development Projects of Shaanxi Province	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31802154; Shaanxi Provincial Regional Inovation Capability Guiding Plan Project, Grant/Award Number: 2020QFY10--04; National Key Research and Develpoment Program of China, Grant/Award Number: 2018YFE0127000; Key Research and Development Projects of Shaanxi Province, Grant/Award Number: 2021NY--021	Ari C, 2016, FRONT MOL NEUROSCI, V9, DOI [10.3389/fnmal.2016.00137, 10.3389/fnmol.2016.00137]; Bianchi A, 2014, FREE RADICAL BIO MED, V76, P114, DOI 10.1016/j.freeradbiomed.2014.07.028; Binley KE, 2014, J NEUROSCI METH, V225, P65, DOI 10.1016/j.jneumeth.2014.01.017; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Briggs GD, 2013, NEUROCHEM INT, V63, P726, DOI 10.1016/j.neuint.2013.09.016; Brusa D, 2009, PROSTATE, V69, P1343, DOI 10.1002/pros.20981; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cai M, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1665-3; Camargos QM, 2020, BRAIN RES BULL, V155, P1, DOI 10.1016/j.brainresbull.2019.11.009; Cheng BH, 2007, AUTON NEUROSCI-BASIC, V134, P38, DOI 10.1016/j.autneu.2007.02.002; Cheng BH, 2013, NEUROCHEM INT, V62, P620, DOI 10.1016/j.neuint.2012.09.011; Cheng BH, 2010, NEUROCHEM RES, V35, P444, DOI 10.1007/s11064-009-0078-6; Cheng K, 2019, J THERM BIOL, V82, P70, DOI 10.1016/j.jtherbio.2019.03.012; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Conti P, 2020, EUR J PHARMACOL, V875, DOI 10.1016/j.ejphar.2020.173035; Cunnane SC, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00053; Cwynar P, 2014, BERL MUNCH TIERARZTL, V127, P177, DOI 10.2376/0005-9366-127-177; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Davis BM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01747-8; DAVIS EJ, 1994, BRAIN RES BULL, V34, P73, DOI 10.1016/0361-9230(94)90189-9; DRAGUNOW M, 1987, NATURE, V329, P441, DOI 10.1038/329441a0; Dunkley PR, 2019, J NEUROCHEM, V149, P706, DOI 10.1111/jnc.14675; Erfani M, 2019, EXP PHYSIOL, V104, P1544, DOI 10.1113/EP087535; Fernandez-Arjona MD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00235; Ferreira TA, 2014, NAT METHODS, V11, P982, DOI 10.1038/nmeth.3125; Fu SP, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0230-3; Fu SP, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/983401; Garaschuk O, 2019, METHODS MOL BIOL, V2034, P27, DOI 10.1007/978-1-4939-9658-2_3; Grace AA, 2016, NAT REV NEUROSCI, V17, P524, DOI 10.1038/nrn.2016.57; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Hancock PA, 2007, HUM FACTORS, V49, P851, DOI 10.1518/001872007X230226; Hancock PA, 2003, INT J HYPERTHER, V19, P355, DOI 10.1080/0265673021000054630; HANCOCK PA, 1986, PSYCHOL BULL, V99, P263, DOI 10.1037/0033-2909.99.2.263; Harikai N, 2003, BIOL PHARM BULL, V26, P701, DOI 10.1248/bpb.26.701; Hei MF, 2019, BEHAV BRAIN RES, V365, P26, DOI 10.1016/j.bbr.2019.02.044; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim HG, 2013, BIOL PHARM BULL, V36, P1556, DOI 10.1248/bpb.b13-00268; Kim YH, 2005, LIFE SCI, V77, P2783, DOI 10.1016/j.lfs.2005.04.024; King AM, 2015, ANNU REV ENTOMOL, V60, P59, DOI 10.1146/annurev-ento-011613-162107; Klein MO, 2019, CELL MOL NEUROBIOL, V39, P31, DOI 10.1007/s10571-018-0632-3; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kuniishi H, 2017, NEUROSCI RES, V123, P27, DOI 10.1016/j.neures.2017.04.012; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee W, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0324-6; Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010; Li HB, 2018, ONCOL LETT, V15, P775, DOI 10.3892/ol.2017.7360; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahmoudi J, 2021, NEUROCHEM RES, V46, P2307, DOI 10.1007/s11064-021-03370-6; Marongiu L, 2019, J LEUKOCYTE BIOL, V106, P147, DOI 10.1002/JLB.3MIR1218-483RR; Moon M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101057; Nakagawa H, 2020, J THERM BIOL, V87, DOI 10.1016/j.jtherbio.2019.102458; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Orr AG, 2009, NAT NEUROSCI, V12, P872, DOI 10.1038/nn.2341; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Qu J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0997-0; RAMSEY JD, 1995, ERGONOMICS, V38, P154, DOI 10.1080/00140139508925092; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Ren BQ, 2018, ONCOL REP, V40, P895, DOI 10.3892/or.2018.6485; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Soncin F, 2003, BIOCHEM BIOPH RES CO, V303, P700, DOI 10.1016/S0006-291X(03)00398-X; Taylor L, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00372; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; VanItallie TB, 2005, NEUROLOGY, V64, P728, DOI 10.1212/01.WNL.0000152046.11390.45; Wang L, 2015, BIOMED REP, V3, P425, DOI 10.3892/br.2015.445; Wang YL, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1054-3; White MG, 2003, J NEUROCHEM, V87, P958, DOI 10.1046/j.1471-4159.2003.02077.x; Wu YC, 2020, FASEB J, V34, P1412, DOI 10.1096/fj.201901984R; Xu L, 2016, MOL NEUROBIOL, V53, P6709, DOI 10.1007/s12035-015-9593-4; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Yoshima T, 1998, J BIOL CHEM, V273, P25466, DOI 10.1074/jbc.273.39.25466; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Young K, 2018, JOVE-J VIS EXP, DOI 10.3791/57648; Zheng ZH, 2021, BRAIN BEHAV IMMUN, V91, P505, DOI 10.1016/j.bbi.2020.11.007; Zhou B, 2019, CNS NEUROSCI THER, V25, P665, DOI 10.1111/cns.13123	80	0	0	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22264	10.1096/fj.202101469RR	http://dx.doi.org/10.1096/fj.202101469RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CZ	35333405				2022-12-28	WOS:000772946300001
J	Otsuka, K; Sawai-Ogawa, M; Kihara, A				Otsuka, Kento; Sawai-Ogawa, Megumi; Kihara, Akio			Formation of fatty alcohols-components of meibum lipids-by the fatty acyl-CoA reductase FAR2 is essential for dry eye prevention	FASEB JOURNAL			English	Article						dry eye; fatty acyl-CoA reductase; fatty alcohol; lipid; meibum lipid	GLAND DYSFUNCTION REPORT; MEIBOMIAN GLAND; INTERNATIONAL WORKSHOP; PATHOPHYSIOLOGY; SUBCOMMITTEE; PHYSIOLOGY; BARRIER; ELOVL1; ACIDS	Various lipids (mainly meibum lipids secreted by the meibomian glands) are present in the tear film lipid layer and play important roles in tear stability and the health of the cornea and conjunctiva. Many meibum lipids contain fatty alcohols (FAls) with chain lengths >= C24, but the fatty acyl-CoA reductases (FARs) that produce them remain unclear. Here, using cell-based assays, we found that the two FAR isozymes (FAR1 and FAR2) show different substrate specificities: FAR1 and FAR2 are involved in the production of C16-C18 and >= C20 FAls, respectively. Next, we generated Far2 knockout (KO) mice and examined their dry eye phenotype and meibum lipid composition. These mice showed a severe dry eye phenotype, characterized by plugged meibomian gland orifices, corneal damage, and tear film instability. The plugging was attributed to an increase in the melting point of the meibum lipids. Liquid chromatography coupled with tandem mass spectrometry revealed that FAl-containing meibum lipids (wax monoesters and types 1 omega, 2 alpha, and 2 omega wax diesters) with a hydroxyl group at position 1 were almost completely absent in Far2 KO mice. The levels of di-unsaturated (O-acyl)-omega-hydroxy fatty acids were higher in Far2 KO mice than in wild type mice, but those of tri-unsaturated ones were comparable, suggesting the presence of two synthesis pathways for type 1 omega wax diesters. These results indicate the importance of FAl-containing meibum lipids in the formation of a functional tear film lipid layer. In addition, our study provides clues to the molecular mechanism of the biosynthesis of meibum lipids.	[Otsuka, Kento; Sawai-Ogawa, Megumi; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biochem, Sapporo, Hokkaido, Japan	Hokkaido University	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Biochem, Kita Ku, Kita 12 Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	kihara@pharm.hokudai.ac.jp	KIHARA, AKIO/A-3802-2012	KIHARA, AKIO/0000-0001-5889-0788	Japan Agency for Medical Research and Development (AMED) [JP20gm0910002h0006]; MEXT \ Japan Society for the Promotion of Science (JSPS) [19J22148, 18H03976]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP20gm0910002h0006; MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 18H03976; MHEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 19J22148	Bron AJ, 2004, EXP EYE RES, V78, P347, DOI 10.1016/j.exer.2003.09.019; Bron AJ, 2017, OCUL SURF, V15, P438, DOI 10.1016/j.jtos.2017.05.011; Butovich IA, 2017, EXP EYE RES, V163, P2, DOI 10.1016/j.exer.2017.06.020; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Craig JP, 2017, OCUL SURF, V15, P802, DOI 10.1016/j.jtos.2017.08.003; Cwiklik L, 2016, BBA-BIOMEMBRANES, V1858, P2421, DOI 10.1016/j.bbamem.2016.02.020; Dunphy JC, 2001, ENVIRON SCI TECHNOL, V35, P1223, DOI 10.1021/es001491q; Georgiev GA, 2014, SOFT MATTER, V10, P5579, DOI 10.1039/c4sm00758a; Goto H, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100605; Green-Church KB, 2011, INVEST OPHTH VIS SCI, V52, P1979, DOI 10.1167/iovs.10-6997d; Hama H, 2010, BBA-MOL CELL BIOL L, V1801, P405, DOI 10.1016/j.bbalip.2009.12.004; Horwath-Winter J, 2003, ARCH OPHTHALMOL-CHIC, V121, P1364, DOI 10.1001/archopht.121.10.1364; IYENGAR BTR, 1969, LIPIDS, V4, P28, DOI 10.1007/BF02531790; Kihara A, 2006, J BIOL CHEM, V281, P4532, DOI 10.1074/jbc.M510308200; Kihara A, 2016, PROG LIPID RES, V63, P50, DOI 10.1016/j.plipres.2016.04.001; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kitamura T, 2015, BIOCHEM J, V465, P79, DOI 10.1042/BJ20140624; Knop E, 2011, INVEST OPHTH VIS SCI, V52, P1938, DOI 10.1167/iovs.10-6997c; Lemp MA, 2012, CORNEA, V31, P472, DOI 10.1097/ICO.0b013e318225415a; MAHADEVAN V, 1962, J LIPID RES, V3, P106; Miyamoto M, 2020, ELIFE, V9, DOI 10.7554/eLife.53582; Naganuma T, 2016, J BIOL CHEM, V291, P11676, DOI 10.1074/jbc.M116.714030; NICOLAIDES N, 1981, INVEST OPHTH VIS SCI, V20, P522; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Ohno Y, 2009, GENES CELLS, V14, P911, DOI 10.1111/j.1365-2443.2009.01319.x; Potter KA, 2011, GLIA, V59, P1009, DOI 10.1002/glia.21172; Sassa T, 2018, FASEB J, V32, P2966, DOI 10.1096/fj.201700947R; Sassa T, 2013, MOL CELL BIOL, V33, P2787, DOI 10.1128/MCB.00192-13; Sawai M, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102478; SHIMAZAKI J, 1995, ARCH OPHTHALMOL-CHIC, V113, P1266, DOI 10.1001/archopht.1995.01100100054027; Sundberg JP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205775; Tanno H, 2021, BBA-MOL CELL BIOL L, V1866, DOI 10.1016/j.bbalip.2020.158842; Tomlinson A, 2011, INVEST OPHTH VIS SCI, V52, P2006, DOI 10.1167/iovs.10-6997f; Wallace M, 2018, NAT CHEM BIOL, V14, P1021, DOI 10.1038/s41589-018-0132-2; Widjaja-Adhi MAK, 2020, FASEB J, V34, P13792, DOI 10.1096/fj.202001191R; Wolffsohn JS, 2017, OCUL SURF, V15, P539, DOI 10.1016/j.jtos.2017.05.001	36	3	3	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22216	10.1096/fj.202101733R	http://dx.doi.org/10.1096/fj.202101733R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CO	35238077				2022-12-28	WOS:000772945200001
J	Boscaro, C; Baggio, C; Carotti, M; Sandona, D; Trevisi, L; Cignarella, A; Bolego, C				Boscaro, Carlotta; Baggio, Chiara; Carotti, Marcello; Sandona, Dorianna; Trevisi, Lucia; Cignarella, Andrea; Bolego, Chiara			Targeting of PFKFB3 with miR-206 but not mir-26b inhibits ovarian cancer cell proliferation and migration involving FAK downregulation	FASEB JOURNAL			English	Article						FAK; miR-206; miR-26b; ovarian cancer cells; PFKFB3	FOCAL ADHESION KINASE; MESSENGER-RNA; ER-ALPHA; EXPRESSION; INVASION; GLYCOLYSIS; OVEREXPRESSION; METABOLISM; ACTIVATION; CARCINOMA	Few studies explored the role of microRNAs (miRNAs) in the post-transcriptional regulation of glycolytic proteins and downstream effectors in ovarian cancer cells. We recently showed that the functional activation of the cytoskeletal regulator FAK in endothelial cells is fostered by the glycolytic enhancer 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3). We tested the hypothesis that miR-206 and mir-26b, emerging onco-suppressors targeting PFKFB3 in estrogen-dependent tumors, would regulate proliferation and migration of serous epithelial ovarian cancer (EOC) cells via common glycolytic proteins, i.e., GLUT1 and PFKFB3, and downstream FAK. PFKFB3 was overexpressed in SKOV3, and its pharmacological inhibition with 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3PO) significantly reduced cell proliferation and motility. Both miR-206 and miR-26b directly targeted PFKFB3 as evaluated by a luciferase reporter assay. However, endogenous levels of miR-26b were higher than those of miR-206, which was barely detectable in SKOV3 as well as OVCAR5 and CAOV3 cells. Accordingly, only the anti-miR-26b inhibitor concentration-dependently increased PFKFB3 levels. While miR-206 overexpression impaired proliferation and migration by downregulating PFKFB3 levels, the decreased PFKFB3 protein levels related to miR-26 overexpression had no functional consequences in all EOC cell lines. Finally, consistent with the migration outcome, exogenous miR-206 and miR-26b induced opposite effects on the levels of total FAK and of its phosphorylated form at Tyr576/577. 3PO did not prevent miR-26b-induced SKOV3 migration. Overall, these results support the inverse relation between endogenous miRNA levels and their tumor-suppressive effects and suggest that restoring miR-206 expression represents a potential dual anti-PFKFB3/FAK strategy to control ovarian cancer progression.	[Boscaro, Carlotta; Baggio, Chiara; Trevisi, Lucia; Bolego, Chiara] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Largo Meneghetti 2, I-35131 Padua, Italy; [Carotti, Marcello; Sandona, Dorianna] Univ Padua, Dept Biomed Sci, Padua, Italy; [Cignarella, Andrea] Univ Padua, Dept Med, Padua, Italy	University of Padua; University of Padua; University of Padua	Bolego, C (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Largo Meneghetti 2, I-35131 Padua, Italy.	chiara.bolego@unipd.it			Universita degli Studi di Padova (University of Padova) [PRID 2018]; Muscular Dystrophy Association (MDA) [577888]	Universita degli Studi di Padova (University of Padova); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association)	Universita degli Studi di Padova (University of Padova), Grant/Award Number: PRID 2018; Muscular Dystrophy Association (MDA), Grant/Award Number: 577888	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Adorno-Cruz V, 2021, GENES DIS, V8, P493, DOI 10.1016/j.gendis.2020.01.015; Atsumi T, 2002, CANCER RES, V62, P5881; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Bolego C, 2006, BIOCHEM BIOPH RES CO, V339, P188, DOI 10.1016/j.bbrc.2005.11.017; Boscaro C, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.587221; Boscaro C, 2020, FASEB J, V34, P12768, DOI 10.1096/fj.202001130R; Cantuaria G, 2001, CANCER-AM CANCER SOC, V92, P1144, DOI 10.1002/1097-0142(20010901)92:5<1144::AID-CNCR1432>3.0.CO;2-T; Chen XY, 2012, CANCER LETT, V314, P41, DOI 10.1016/j.canlet.2011.09.014; Cho H, 2013, CANCER INVEST, V31, P607, DOI 10.3109/07357907.2013.849722; Dai CX, 2018, BIOMED PHARMACOTHER, V104, P763, DOI 10.1016/j.biopha.2018.05.077; Diaz Osterman CJ, 2019, ELIFE, V8, DOI 10.7554/eLife.47327; Du JY, 2015, ONCOL REP, V33, P1890, DOI 10.3892/or.2015.3797; Eelen G, 2015, CIRC RES, V116, P1231, DOI 10.1161/CIRCRESAHA.116.302855; Fan JY, 2016, TUMOR BIOL, V37, P6855, DOI 10.1007/s13277-015-4558-9; Fan YB, 2016, ONCOL LETT, V12, P1113, DOI 10.3892/ol.2016.4730; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gajek A, 2021, CANCERS, V13, DOI 10.3390/cancers13112690; Ge X, 2015, BIOCHEM BIOPH RES CO, V463, P1115, DOI 10.1016/j.bbrc.2015.06.068; Ghafouri-Fard S, 2020, EXP MOL PATHOL, V113, DOI 10.1016/j.yexmp.2020.104381; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Gu YF, 2013, ONCOL LETT, V5, P452, DOI 10.3892/ol.2012.1057; He YJ, 2019, EPIGENOMICS-UK, V11, P1021, DOI 10.2217/epi-2019-0072; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Kotowski K, 2021, CANCERS, V13, DOI 10.3390/cancers13040909; Levy A, 2019, CURR CANCER DRUG TAR, V19, P179, DOI 10.2174/1568009618666180706165222; Lin JX, 2015, ONCOTARGET, V6, P23793, DOI 10.18632/oncotarget.4363; Mondal S, 2019, INT J CANCER, V144, P178, DOI 10.1002/ijc.31868; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Murphy JM, 2020, EXP MOL MED, V52, P877, DOI 10.1038/s12276-020-0447-4; Naser R, 2018, CANCERS, V10, DOI 10.3390/cancers10060196; Nguyen N, 2014, J BIOL CHEM, V289, P3209, DOI 10.1074/jbc.M113.525154; Nowak N, 2018, OPEN LIFE SCI, V13, P569, DOI 10.1515/biol-2018-0068; O'Brien J, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00402; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Qi C, 1999, BIOCHEM BIOPH RES CO, V263, P265, DOI 10.1006/bbrc.1999.1328; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Sheng N, 2018, CELL PHYSIOL BIOCHEM, V50, P810, DOI 10.1159/000494467; Shi LL, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.44; Singh Pankaj K, 2011, Mol Cell Pharmacol, V3, P125; Sood AK, 2004, AM J PATHOL, V165, P1087, DOI 10.1016/S0002-9440(10)63370-6; Subramaniam S, 2019, CLIN CHEM, V65, P1090, DOI 10.1373/clinchem.2018.299651; Tan S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3644; Taylor C, 2017, ONCOTARGET, V8, P17960, DOI 10.18632/oncotarget.14910; Trenti A, 2017, J PHARMACOL EXP THER, V361, P398, DOI 10.1124/jpet.116.238212; Tyagi K, 2021, BBA-REV CANCER, V1876, DOI 10.1016/j.bbcan.2021.188563; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; Wu Q, 2019, TOXICOL APPL PHARM, V367, P12, DOI 10.1016/j.taap.2019.01.016; Xintaropoulou C, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4521-4; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Zhao HY, 2019, J CANCER, V10, P4989, DOI 10.7150/jca.30772; Zhu AS, 2016, J CELL BIOCHEM, V117, P1370, DOI 10.1002/jcb.25428; Zhu W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163768	55	1	1	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22140	10.1096/fj.202101222R	http://dx.doi.org/10.1096/fj.202101222R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35107852				2022-12-28	WOS:000761250800019
J	Chou, MY; Appan, D; Chang, KW; Chou, CH; Lin, CY; Gau, SSF; Huang, HS				Chou, Ming-Yi; Appan, Dhivya; Chang, Kai-Wei; Chou, Chih-Hsuan; Lin, Chia-Yi; Gau, Susan Shur-Fen; Huang, Hsien-Sung			Mouse hybrid genome mediates diverse brain phenotypes with the specificity of reciprocal crosses	FASEB JOURNAL			English	Article						brain phenotypes; mouse hybrid genome; reciprocal crosses	LOCUS-CERULEUS; BEHAVIOR; GENE; ANXIETY; STRESS; MICE; ARCHITECTURE; TRANSPORTER; EXPRESSION	Hybrid species have more genetic diversity than their parents. However, the impact of the hybrid genome of reciprocal crosses on brain function remains largely unknown. We performed behavioral, molecular, and neuronal analyses on C57BL/6J mice (B6), CAST/EiJ mice (CAST), and hybrid mice resulting from reciprocal crosses of the two strains, B6/CAST F1i and B6/CAST F1r, respectively. Hybrid mice displayed greater motor strength and coordination, food grinding, social dominance, and less sociability compared to their parental strains. Parental origin influenced body weight, locomotor speed, and heat nociception of hybrid mice. Parental origin, cell type, and the interaction of both affected expression patterns of hybrid genomes including imprinted genes. There was a correlation between affected genes and corresponding behavioral phenotypes. Hybrid genomes mediated neuronal activity in the locus coeruleus, a brain region implicated in arousal, adaptive behaviors, and sleep-wake cycle due to its norepinephrine projections throughout the central nervous system. The comprehensive brain phenotypes in these hybrid mice reveal important functional readouts associated with interactions of hybrid genomes and impacts of parental genomes.	[Chou, Ming-Yi; Appan, Dhivya; Chang, Kai-Wei; Chou, Chih-Hsuan; Lin, Chia-Yi; Gau, Susan Shur-Fen; Huang, Hsien-Sung] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Rm 1547,15th Floor,1,Sec 1,Renai Rd, Taipei 10051, Taiwan; [Gau, Susan Shur-Fen] Natl Taiwan Univ Hosp & Coll Med, Dept Psychiat, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital	Huang, HS (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Rm 1547,15th Floor,1,Sec 1,Renai Rd, Taipei 10051, Taiwan.	huang.hsiensung@gmail.com	GAU, SUSAN SHUR-FEN/P-4726-2017	GAU, SUSAN SHUR-FEN/0000-0002-2718-8221; Huang, Hsien-Sung/0000-0003-2657-3635	National Health Research Institutes (NHRI) [NHRI-EX103-10316NC, NHRI-EX108-10802NI]; National Taiwan University College of Medicine [104C101-B1, 105C101-B1]; National Taiwan University Hospital [104C101-B1, 105C101-B1]; Foundation for the Advancement of Outstanding Scholarship	National Health Research Institutes (NHRI)(National Health Research Institutes - Taiwan); National Taiwan University College of Medicine(National Taiwan University); National Taiwan University Hospital(National Taiwan University); Foundation for the Advancement of Outstanding Scholarship	National Health Research Institutes (NHRI), Grant/Award Number: NHRI-EX103-10316NC and NHRI-EX108-10802NI; National Taiwan University College of Medicine and National Taiwan University Hospital, Grant/Award Number: 104C101-B1 and 105C101-B1; Foundation for the Advancement of Outstanding Scholarship	Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Anchan D, 2014, BRAIN BEHAV, V4, P51, DOI 10.1002/brb3.197; Benarroch EE, 2018, CELL TISSUE RES, V373, P221, DOI 10.1007/s00441-017-2649-1; Benarroch EE, 2009, NEUROLOGY, V73, P1699, DOI 10.1212/WNL.0b013e3181c2937c; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borza R, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2021.101526; Bowden MA, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-22; Calatayud F, 2004, PHYSIOL BEHAV, V80, P465, DOI 10.1016/j.physbeh.2003.10.001; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Champagne FA, 2007, PHYSIOL BEHAV, V91, P325, DOI 10.1016/j.physbeh.2007.03.014; Crews D, 2007, P NATL ACAD SCI USA, V104, P5942, DOI 10.1073/pnas.0610410104; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Dietz DM, 2011, BIOL PSYCHIAT, V70, P408, DOI 10.1016/j.biopsych.2011.05.005; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ehlen JC, 2015, J NEUROSCI, V35, P13587, DOI 10.1523/JNEUROSCI.2194-15.2015; Ferreira CER, 2018, ANDROLOGIA, V50, DOI 10.1111/and.12923; Fisher SP, 2012, J BIOL RHYTHM, V27, P48, DOI 10.1177/0748730411431550; Flint J, 2003, J NEUROBIOL, V54, P46, DOI 10.1002/neu.10161; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; FUNDELE RH, 1994, DEV GENET, V15, P515, DOI 10.1002/dvg.1020150610; Gai YC, 2016, NEURON, V90, P581, DOI 10.1016/j.neuron.2016.03.017; Gao YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36008; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Gonzalez PN, 2016, J EVOLUTION BIOL, V29, P1737, DOI 10.1111/jeb.12906; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Gregorova S, 2008, GENOME RES, V18, P509, DOI 10.1101/gr.7160508; Grijalva I, 2006, SPINAL CORD, V44, P280, DOI 10.1038/sj.sc.3101842; Han ZJ, 2020, GENOME RES, V30, P1097, DOI 10.1101/gr.257568.119; Hsu CL, 2018, HUM MOL GENET, V27, P1039, DOI 10.1093/hmg/ddy023; Jakupovic J, 2008, PHYSIOL BEHAV, V93, P467, DOI 10.1016/j.physbeh.2007.10.005; Kang Du-Seock, 2020, Advances in Biological Regulation, V75, P100654, DOI 10.1016/j.jbior.2019.100654; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kishi Yusuke, 2021, STAR Protoc, V2, P100540, DOI 10.1016/j.xpro.2021.100540; Landry CR, 2007, HEREDITY, V99, P483, DOI 10.1038/sj.hdy.6801045; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Li XM, 2014, ANESTHESIOLOGY, V121, P79, DOI 10.1097/ALN.0000000000000191; Lin CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163663; Lin CY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22753-4; Lin YS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192355; Lin YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164164; Logan RW, 2013, GENES BRAIN BEHAV, V12, P424, DOI 10.1111/gbb.12029; Loos M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108563; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Martin D, 2017, ACS CHEM NEUROSCI, V8, P356, DOI 10.1021/acschemneuro.6b00374; MASUKO S, 1986, J NEUROSCI, V6, P3229; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Moloney RD, 2015, GENES BRAIN BEHAV, V14, P319, DOI 10.1111/gbb.12216; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Nuevo-Tapioles C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17384-1; Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001; Priebe K, 2005, DEV PSYCHOBIOL, V47, P398, DOI 10.1002/dev.20098; Rytelewska E, 2020, MOL REPROD DEV, V87, P739, DOI 10.1002/mrd.23391; Salari AA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29595-0; Shen SQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109382; Shi YC, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.722580; Shorter JR, 2019, G3-GENES GENOM GENET, V9, P1613, DOI 10.1534/g3.118.200847; Srivastava A, 2017, GENETICS, V206, P537, DOI 10.1534/genetics.116.198838; Stelkens RB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-283; Szabadi E, 2013, J PSYCHOPHARMACOL, V27, P659, DOI 10.1177/0269881113490326; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; Thompson EM, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22020776; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tyner C, 2017, NUCLEIC ACIDS RES, V45, pD626, DOI 10.1093/nar/gkw1134; Wahlsten D, 2003, GENES BRAIN BEHAV, V2, P71, DOI 10.1034/j.1601-183X.2003.00012.x; Wang HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17383; Wersinger SR, 2007, GENES BRAIN BEHAV, V6, P540, DOI 10.1111/j.1601-183X.2006.00281.x; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021	70	2	2	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22232	10.1096/fj.202101624R	http://dx.doi.org/10.1096/fj.202101624R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35199866				2022-12-28	WOS:000761250800012
J	Nonnecke, EB; Castillo, PA; Johansson, MEV; Hollox, EJ; Shen, B; Lonnerdal, B; Bevins, CL				Nonnecke, Eric B.; Castillo, Patricia A.; Johansson, Malin E., V; Hollox, Edward J.; Shen, Bo; Lonnerdal, Bo; Bevins, Charles L.			Human intelectin-2 (ITLN2) is selectively expressed by secretory Paneth cells	FASEB JOURNAL			English	Article						alpha-defensin; Crohn's disease; innate immunity; intelectin; lectin; metaplasia; omentin; Paneth cell; small intestine; ulcerative colitis	GENOME-WIDE ASSOCIATION; ANTIMICROBIAL PEPTIDES; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; MICROBIAL GLYCANS; HUMAN DEFENSIN-5; LECTIN; LACTOFERRIN; INTERNALIZATION; IDENTIFICATION	Intelectins (intestinal lectins) are highly conserved across chordate evolution and have been implicated in various human diseases, including Crohn's disease (CD). The human genome encodes two intelectin genes, intelectin-1 (ITLN1) and intelectin-2 (ITLN2). Other than its high sequence similarity with ITLN1, little is known about ITLN2. To address this void in knowledge, we report that ITLN2 exhibits discrete, yet notable differences from ITLN1 in primary structure, including a unique amino terminus, as well as changes in amino acid residues associated with the glycan-binding activity of ITLN1. We identified that ITLN2 is a highly abundant Paneth cell-specific product, which localizes to secretory granules, and is expressed as a multimeric protein in the small intestine. In surgical specimens of ileal CD, ITLN2 mRNA levels were reduced approximately five-fold compared to control specimens. The ileal expression of ITLN2 was unaffected by previously reported disease-associated variants in ITLN2 and CD-associated variants in neighboring ITLN1 as well as NOD2 and ATG16L1. ITLN2 mRNA expression was undetectable in control colon tissue; however, in both ulcerative colitis (UC) and colonic CD, metaplastic Paneth cells were found to express ITLN2. Together, the data reported establish the groundwork for understanding ITLN2 function(s) in the intestine, including its possible role in CD.	[Nonnecke, Eric B.; Castillo, Patricia A.; Bevins, Charles L.] Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA; [Johansson, Malin E., V] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Hollox, Edward J.] Univ Leicester, Dept Genet & Genome Biol, Leicester, Leics, England; [Shen, Bo] Cleveland Clin, Dept Gastroenterol Hepatol & Nutr, Digest Dis & Surg Inst, Cleveland, OH 44106 USA; [Lonnerdal, Bo] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	University of California System; University of California Davis; University of Gothenburg; University of Leicester; Cleveland Clinic Foundation; University of California System; University of California Davis	Nonnecke, EB; Bevins, CL (corresponding author), Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA.	ebnonnecke@ucdavis.edu; clbevins@ucdavis.edu	Johansson, Malin E. V./HCH-7451-2022	Nonnecke, Eric/0000-0001-5345-2009	National Institutes of Health [U01AI125926, R37AI32738]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: U01AI125926 and R37AI32738	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Allot A, 2018, NUCLEIC ACIDS RES, V46, pW530, DOI 10.1093/nar/gky355; Almalki F, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-94679-3; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Artis D, 2006, INT J PARASITOL, V36, P723, DOI 10.1016/j.ijpara.2006.02.011; Au-Yeung CL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17383-2; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Castillo PA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49471-9; Chairatana P, 2016, CHEM SCI, V7, P1738, DOI [10.1039/C5SC04194E, 10.1039/c5sc04194e]; Chen L, 2020, SCAND J IMMUNOL, V92, DOI 10.1111/sji.12882; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Cunliffe RN, 2001, GUT, V48, P176, DOI 10.1136/gut.48.2.176; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Jablonski KA, 2010, DIABETES, V59, P2672, DOI 10.2337/db10-0543; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kerr SC, 2014, AM J RESP CRIT CARE, V189, P1005, DOI 10.1164/rccm.201312-2220LE; Khaloian S, 2020, GUT, V69, P1939, DOI 10.1136/gutjnl-2019-319514; Komiya T, 1998, BIOCHEM BIOPH RES CO, V251, P759, DOI 10.1006/bbrc.1998.9513; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Lee JK, 2001, GLYCOBIOLOGY, V11, P65, DOI 10.1093/glycob/11.1.65; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Liu TC, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86907; Lopez V, 2008, BIOCHEM J, V411, P271, DOI 10.1042/BJ20070393; Lu ZH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-110; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Nonnecke EB, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92198-9; Pemberton AD, 2004, J IMMUNOL, V173, P1894, DOI 10.4049/jimmunol.173.3.1894; Porter EM, 1997, INFECT IMMUN, V65, P2389, DOI 10.1128/IAI.65.6.2389-2395.1997; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Schaffler A, 2005, BBA-GENE STRUCT EXPR, V1732, P96, DOI 10.1016/j.bbaexp.2005.11.005; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Senapati S, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0211-8; Shen B, 2005, J CLIN PATHOL, V58, P687, DOI 10.1136/jcp.2004.022426; Sherry ST, 1999, GENOME RES, V9, P677; Stappenbeck TS, 2017, GASTROENTEROLOGY, V152, P322, DOI 10.1053/j.gastro.2016.10.003; Suzuki YA, 2001, BIOCHEMISTRY-US, V40, P15771, DOI 10.1021/bi0155899; Suzuki YA, 2008, BIOCHEMISTRY-US, V47, P10915, DOI 10.1021/bi8012164; Tanaka M, 2001, J GASTROEN HEPATOL, V16, P1353, DOI 10.1046/j.1440-1746.2001.02629.x; Tsuji S, 2010, BRIT J CANCER, V103, P517, DOI 10.1038/sj.bjc.6605786; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; Tsuji S, 2007, GLYCOBIOLOGY, V17, P1045, DOI 10.1093/glycob/cwm075; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Wang YL, 2020, J EXP MED, V217, DOI 10.1084/jem.20191130; Wangkanont K, 2016, J BIOL CHEM, V291, P5596, DOI 10.1074/jbc.M115.709212; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wehkamp J, 2007, J IMMUNOL, V179, P3109, DOI 10.4049/jimmunol.179.5.3109; Wehkamp J, 2006, FEBS LETT, V580, P5344, DOI 10.1016/j.febslet.2006.08.083; Wehkamp J, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00646; Wesener DA, 2017, CURR OPIN STRUC BIOL, V44, P168, DOI 10.1016/j.sbi.2017.04.002; Wesener DA, 2015, NAT STRUCT MOL BIOL, V22, P603, DOI 10.1038/nsmb.3053; Wrackmeyer U, 2006, BIOCHEMISTRY-US, V45, P9188, DOI 10.1021/bi060570x; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004; Yates AD, 2020, NUCLEIC ACIDS RES, V48, pD682, DOI 10.1093/nar/gkz966	67	2	2	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22200	10.1096/fj.202101870R	http://dx.doi.org/10.1096/fj.202101870R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35182405	hybrid, Green Published			2022-12-28	WOS:000761250800056
J	Sivinski, J; Ngo, D; Zerio, CJ; Ambrose, AJ; Watson, ER; Kaneko, LK; Kostelic, MM; Stevens, M; Ray, AM; Park, Y; Wu, CX; Marty, MT; Hoang, QQ; Zhang, DD; Lander, GC; Johnson, SM; Chapman, E				Sivinski, Jared; Ngo, Duc; Zerio, Christopher J.; Ambrose, Andrew J.; Watson, Edmond R.; Kaneko, Lynn K.; Kostelic, Marius M.; Stevens, Mckayla; Ray, Anne-Marie; Park, Yangshin; Wu, Chunxiang; Marty, Michael T.; Hoang, Quyen Q.; Zhang, Donna D.; Lander, Gabriel C.; Johnson, Steven M.; Chapman, Eli			Allosteric differences dictate GroEL complementation of E. coli	FASEB JOURNAL			English	Article						allostery; chaperone; chaperonin; ESKAPE; GroEL; GroES	ESCHERICHIA-COLI; CHAPERONIN GROEL; CRYSTAL-STRUCTURE; RHIZOBIUM-LEGUMINOSARUM; POLYPEPTIDE BINDING; REACTION CYCLE; HEAT-SHOCK; MECHANISM; RING; ATP	GroES/GroEL is the only bacterial chaperone essential under all conditions, making it a potential antibiotic target. Rationally targeting ESKAPE GroES/GroEL as an antibiotic strategy necessitates studying their structure and function. Herein, we outline the structural similarities between Escherichia coli and ESKAPE GroES/GroEL and identify significant differences in intra- and inter-ring cooperativity, required in the refolding cycle of client polypeptides. Previously, we observed that one-half of ESKAPE GroES/GroEL family members could not support cell viability when each was individually expressed in GroES/GroEL-deficient E. coli cells. Cell viability was found to be dependent on the allosteric compatibility between ESKAPE and E. coli subunits within mixed (E. coli and ESKAPE) tetradecameric GroEL complexes. Interestingly, differences in allostery did not necessarily result in differences in refolding rate for a given homotetradecameric chaperonin. Characterization of ESKAPE GroEL allostery, ATPase, and refolding rates in this study will serve to inform future studies focused on inhibitor design and mechanism of action studies.	[Sivinski, Jared; Ngo, Duc; Zerio, Christopher J.; Ambrose, Andrew J.; Kaneko, Lynn K.; Zhang, Donna D.; Chapman, Eli] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, 1703 E Mabel St,POB 210207, Tucson, AZ 85721 USA; [Watson, Edmond R.; Lander, Gabriel C.] Scripps Res, Dept Integrat Struct & Computat Biol, La Jolla, CA USA; [Kostelic, Marius M.; Marty, Michael T.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA; [Stevens, Mckayla; Ray, Anne-Marie; Park, Yangshin; Hoang, Quyen Q.; Johnson, Steven M.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Park, Yangshin; Hoang, Quyen Q.] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN USA; [Park, Yangshin; Hoang, Quyen Q.] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN USA; [Wu, Chunxiang] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA	University of Arizona; Scripps Research Institute; University of Arizona; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Yale University	Chapman, E (corresponding author), Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, 1703 E Mabel St,POB 210207, Tucson, AZ 85721 USA.	chapman@pharmacy.arizona.edu		Ray, Anne-Marie/0000-0003-2812-7938; Sivinski, Jared/0000-0003-2696-6279	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) [R01GM120350]; NIH [5R01GM111639, 5R01GM115844, R35GM128624, T32 GM008804]	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) under Award no. R01GM120350. S.M.J., Q.Q.H., and E.C. Q.Q.H. additionally acknowledge support by NIH grants 5R01GM111639 and 5R01GM115844. M.T.M. and M.M.K. were supported by NIH R35GM128624. J.S., C.J.Z., and M.M.K. are supported by NIH T32 GM008804. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH	Abdeen S, 2018, J MED CHEM, V61, P7345, DOI 10.1021/acs.jmedchem.8b00989; Abdeen S, 2016, BIOORG MED CHEM LETT, V26, P3127, DOI 10.1016/j.bmcl.2016.04.089; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chapman E, 2006, P NATL ACAD SCI USA, V103, P15800, DOI 10.1073/pnas.0607534103; Chapman E, 2008, P NATL ACAD SCI USA, V105, P19205, DOI 10.1073/pnas.0810657105; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Chilukoti N, 2016, J BACTERIOL, V198, P486, DOI 10.1128/JB.00844-15; Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Coyle JE, 1997, FOLD DES, V2, pR93, DOI 10.1016/S1359-0278(97)00046-1; Danziger O, 2003, P NATL ACAD SCI USA, V100, P13797, DOI 10.1073/pnas.2333925100; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Feltham JL, 2000, CELL, V100, P193, DOI 10.1016/S0092-8674(00)81557-3; Figueiredo L, 2004, J BIOL CHEM, V279, P1090, DOI 10.1074/jbc.M310914200; Fridmann Y, 2000, J BIOL CHEM, V275, P37951, DOI 10.1074/jbc.M007594200; Fridmann Y, 2002, BIOCHEMISTRY-US, V41, P5938, DOI 10.1021/bi020117v; Gallagher LA, 2015, J BACTERIOL, V197, P2027, DOI 10.1128/JB.00131-15; Georgescauld F, 2014, CELL, V157, P922, DOI 10.1016/j.cell.2014.03.038; GEORGOPOULOS CP, 1973, J MOL BIOL, V76, P45, DOI 10.1016/0022-2836(73)90080-6; Gould PS, 2007, CELL STRESS CHAPERON, V12, P123, DOI 10.1379/CSC-227R.1; Grallert H, 2001, J STRUCT BIOL, V135, P95, DOI 10.1006/jsbi.2001.4387; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; HOROVITZ A, 1995, P ROY SOC B-BIOL SCI, V259, P85, DOI 10.1098/rspb.1995.0013; Horovitz A, 2005, CURR OPIN STRUC BIOL, V15, P646, DOI 10.1016/j.sbi.2005.10.001; HORWICH AL, 1993, PHILOS T R SOC B, V339, P313, DOI 10.1098/rstb.1993.0030; Illingworth M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10499-4; Illingworth M, 2011, J BIOL CHEM, V286, P30401, DOI 10.1074/jbc.M111.255935; Ivic A, 1997, GENE, V194, P1, DOI 10.1016/S0378-1119(97)00087-5; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Koike-Takeshita A, 2008, J BIOL CHEM, V283, P23774, DOI 10.1074/jbc.M802542200; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kostelic MM, 2021, ANAL CHEM, V93, P14722, DOI 10.1021/acs.analchem.1c03181; Kostelic MM, 2019, J AM SOC MASS SPECTR, V30, P1416, DOI 10.1007/s13361-019-02174-x; Kumar CMS, 2009, J BACTERIOL, V191, P6525, DOI 10.1128/JB.00652-09; Kunkle T, 2018, J MED CHEM, V61, P10651, DOI 10.1021/acs.jmedchem.8b01293; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lewin GR, 2019, P NATL ACAD SCI USA, V116, P19685, DOI 10.1073/pnas.1907619116; Liu H, 2009, FEBS LETT, V583, P2365, DOI 10.1016/j.febslet.2009.06.027; Llorca O, 1998, J BIOL CHEM, V273, P32587, DOI 10.1074/jbc.273.49.32587; LORIMER GH, 1994, STRUCTURE, V2, P1125, DOI 10.1016/S0969-2126(94)00114-6; Lu HM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000526; Ma JP, 1998, P NATL ACAD SCI USA, V95, P8502, DOI 10.1073/pnas.95.15.8502; Marty MT, 2019, J AM SOC MASS SPECTR, V30, P2174, DOI 10.1007/s13361-019-02286-4; Marty MT, 2015, ANAL CHEM, V87, P4370, DOI 10.1021/acs.analchem.5b00140; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Motojima F, 2004, P NATL ACAD SCI USA, V101, P15005, DOI 10.1073/pnas.0406132101; Mulani MS, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00539; Persyn E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41201-5; Priya S, 2013, P NATL ACAD SCI USA, V110, P7199, DOI 10.1073/pnas.1219867110; Ramage B, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00352-17; Richardson A, 1999, GENETICS, V152, P1449; Richardson A, 1999, J BIOL CHEM, V274, P52, DOI 10.1074/jbc.274.1.52; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Santajit S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2475067; Scarff CA, 2018, JOVE-J VIS EXP, DOI 10.3791/57199; Shah R, 2016, J BACTERIOL, V198, P2692, DOI 10.1128/JB.00317-16; Shiseki K, 2001, J BIOL CHEM, V276, P11335, DOI 10.1074/jbc.M010348200; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Sivinski J, 2021, MBIO, V12, DOI 10.1128/mBio.02167-20; Taguchi H, 2015, J MOL BIOL, V427, P2912, DOI 10.1016/j.jmb.2015.04.007; VANDERVIES SM, 1994, NATURE, V368, P654, DOI 10.1038/368654a0; VANDYK TK, 1989, NATURE, V342, P451, DOI 10.1038/342451a0; Varadi M., 2021, NUCLEIC ACIDS RES, V50, P439; Weaver J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15934; Weiss C, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00080; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YIFRACH O, 1994, J MOL BIOL, V243, P397, DOI 10.1006/jmbi.1994.1667; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; Zahn R, 1996, P NATL ACAD SCI USA, V93, P15024, DOI 10.1073/pnas.93.26.15024	75	0	0	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22198	10.1096/fj.202101708RR	http://dx.doi.org/10.1096/fj.202101708RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35199390				2022-12-28	WOS:000761250800011
J	Cen, HH; Hussein, B; Botezelli, JD; Wang, S; Zhang, JA; Noursadeghi, N; Jessen, N; Rodrigues, B; Timmons, JA; Johnson, JD				Cen, Haoning Howard; Hussein, Bahira; Botezelli, Jose Diego; Wang, Su; Zhang, Jiashuo Aaron; Noursadeghi, Nilou; Jessen, Niels; Rodrigues, Brian; Timmons, James A.; Johnson, James D.			Human and mouse muscle transcriptomic analyses identify insulin receptor mRNA downregulation in hyperinsulinemia-associated insulin resistance	FASEB JOURNAL			English	Article						hyperinsulinemia; insulin receptor; insulin resistance; insulin signaling; SIN3A	GENE-EXPRESSION; DIABETES-MELLITUS; GLUCOSE-TRANSPORT; SECRETION; PROTEIN; BETA; SENSITIVITY; INTERNALIZATION; GLUCAGON; PACKAGE	Hyperinsulinemia is commonly viewed as a compensatory response to insulin resistance, yet studies have demonstrated that chronically elevated insulin may also drive insulin resistance. The molecular mechanisms underpinning this potentially cyclic process remain poorly defined, especially on a transcriptome-wide level. Transcriptomic meta-analysis in >450 human samples demonstrated that fasting insulin reliably and negatively correlated with INSR mRNA in skeletal muscle. To establish causality and study the direct effects of prolonged exposure to excess insulin in muscle cells, we incubated C2C12 myotubes with elevated insulin for 16 h, followed by 6 h of serum starvation, and established that acute AKT and ERK signaling were attenuated in this model of in vitro hyperinsulinemia. Global RNA-sequencing of cells both before and after nutrient withdrawal highlighted genes in the insulin receptor (INSR) signaling, FOXO signaling, and glucose metabolism pathways indicative of 'hyperinsulinemia' and 'starvation' programs. Consistently, we observed that hyperinsulinemia led to a substantial reduction in Insr gene expression, and subsequently a reduced surface INSR and total INSR protein, both in vitro and in vivo. Bioinformatic modeling combined with RNAi identified SIN3A as a negative regulator of Insr mRNA (and JUND, MAX, and MXI as positive regulators of Irs2 mRNA). Together, our analysis identifies mechanisms which may explain the cyclic processes underlying hyperinsulinemia-induced insulin resistance in muscle, a process directly relevant to the etiology and disease progression of type 2 diabetes.	[Cen, Haoning Howard; Botezelli, Jose Diego; Wang, Su; Zhang, Jiashuo Aaron; Noursadeghi, Nilou; Johnson, James D.] Univ British Columbia, Life Sci Inst, Dept Cellular & Physiol Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada; [Hussein, Bahira; Rodrigues, Brian] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Jessen, Niels] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Jessen, Niels] Aarhus Univ Hosp, Steno Diabet Ctr Aarhus, Aarhus, Denmark; [Timmons, James A.] Augur Precis Med LTD, Stirling Univ Innovat Pk, Stirling, Scotland; [Timmons, James A.] Queen Mary Univ London, William Harvey Res Inst, London, England	University of British Columbia; University of British Columbia; Aarhus University; Aarhus University; University of London; Queen Mary University London	Johnson, JD (corresponding author), Univ British Columbia, Life Sci Inst, Dept Cellular & Physiol Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	James.D.Johnson@ubc.ca	Timmons, James A/J-4698-2014; Jessen, Niels/E-1731-2011; Timmons, James A/M-6350-2019; Cen, Haoning Howard/GSN-3597-2022	Timmons, James A/0000-0002-2255-1220; Timmons, James A/0000-0002-2255-1220; Cen, Haoning Howard/0000-0001-8045-1335; Johnson, James/0000-0002-7523-9433; Wang, Su/0000-0003-2439-0974; Noursadeghi, Nilou/0000-0003-3203-2317; Hussein, Bahira/0000-0003-0807-0057; Jessen, Niels/0000-0001-5613-7274; Zhang, Jiashuo/0000-0001-6915-0654	NHGRI intramural projects [ZIAHG000024, Z1BHG000196]; NIDDK [DK062370, DK072193, DK099240]; NHGRI [HG003079]; American Diabetes Association Pathway to Stop Diabetes Grant [1-14-INI-07]; Academy of Finland; British Heart Foundation	NHGRI intramural projects; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); American Diabetes Association Pathway to Stop Diabetes Grant; Academy of Finland(Academy of Finland); British Heart Foundation(British Heart Foundation)	We acknowledge Dr. Stephane Flibotte in LSI Bioinformatics Core for advice. We thank our colleagues Xiaoke Hu and Leanne Beet for performing the insulin radioimmunoassays. Support for the FUSION Tissue Biopsy Study dataset was contributed by the NHGRI intramural projects ZIAHG000024 and Z1BHG000196, NIDDK grants DK062370, DK072193, and DK099240, NHGRI grant HG003079, American Diabetes Association Pathway to Stop Diabetes Grant 1-14-INI-07, and grants from the Academy of Finland. JAT is supported by the British Heart Foundation. We thank those who provided helpful comments on previous drafts of this manuscript posted on Biorxiv.	Azen R, 2003, PSYCHOL METHODS, V8, P129, DOI 10.1037/1082-989X.8.2.129; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Batista TM, 2019, CELL REP, V26, P3429, DOI 10.1016/j.celrep.2019.02.081; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; BRIATA P, 1990, BIOCHEM BIOPH RES CO, V169, P397, DOI 10.1016/0006-291X(90)90345-N; Ciaraldi TP, 1995, J CLIN INVEST, V96, P2820, DOI 10.1172/JCI118352; Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483; Dankner R, 2012, DIABETES-METAB RES, V28, P618, DOI 10.1002/dmrr.2322; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; DELPRATO S, 1994, DIABETOLOGIA, V37, P1025, DOI 10.1007/BF00400466; Di Camillo B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032391; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; El Akoum S, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-34; Foti D, 2005, NAT MED, V11, P765, DOI 10.1038/nm1254; Foti D, 2003, MOL CELL BIOL, V23, P2720, DOI 10.1128/MCB.23.8.2720-2732.2003; Frojdo S, 2009, BBA-MOL BASIS DIS, V1792, P83, DOI 10.1016/j.bbadis.2008.10.019; GARVEY WT, 1985, J CLIN INVEST, V76, P22, DOI 10.1172/JCI111950; Gregory JM, 2019, DIABETES, V68, P1565, DOI 10.2337/db19-0324; Hamley S, 2019, DIABETOLOGIA, V62, P2310, DOI 10.1007/s00125-019-04990-y; Hamza SM, 2017, BBA-GEN SUBJECTS, V1861, P313, DOI 10.1016/j.bbagen.2016.11.029; Harith HH, 2016, J DIABETES, V8, P568, DOI 10.1111/1753-0407.12339; Harrison XA, 2018, PEERJ, V6, DOI 10.7717/peerj.4794; Hengist A, 2020, BRIT J NUTR, V124, P407, DOI 10.1017/S0007114520001270; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; JOCHEN AL, 1986, J CLIN ENDOCR METAB, V62, P268, DOI 10.1210/jcem-62-2-268; Kadamb R, 2013, EUR J CELL BIOL, V92, P237, DOI 10.1016/j.ejcb.2013.09.001; KAHN CR, 1978, METABOLISM, V27, P1893; Kampmann U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027854; Kim B, 2011, ENDOCRINOLOGY, V152, P3638, DOI 10.1210/en.2011-0029; Langlet F, 2017, CELL, V171, P824, DOI 10.1016/j.cell.2017.09.045; LEMARCHANDBRUSTEL Y, 1978, AM J PHYSIOL, V234, pE348, DOI 10.1152/ajpendo.1978.234.4.E348; LESTUNFF C, 1994, DIABETES, V43, P696, DOI 10.2337/diabetes.43.5.696; Lim GE, 2009, ENDOCRINOLOGY, V150, P580, DOI 10.1210/en.2008-0726; Liu HY, 2009, J BIOL CHEM, V284, P27090, DOI 10.1074/jbc.M109.016675; Liu HY, 2009, AM J PHYSIOL-ENDOC M, V297, pE898, DOI 10.1152/ajpendo.00374.2009; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MARANGOU AG, 1986, DIABETES, V35, P1383, DOI 10.2337/diabetes.35.12.1383; Martinez SC, 2006, DIABETES, V55, P1581, DOI 10.2337/db05-0678; Mattson MP, 2017, AGEING RES REV, V39, P46, DOI 10.1016/j.arr.2016.10.005; Mayer CM, 2010, ENDOCRINOLOGY, V151, P75, DOI 10.1210/en.2009-0838; McAuley KA, 2001, DIABETES CARE, V24, P460, DOI 10.2337/diacare.24.3.460; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Melmed S., 2017, WILLIAMS TXB ENDOCRI; Moller AB, 2017, SCI REP-UK, V7, DOI 10.1038/srep43775; Morikawa Y, 2004, J NEUROENDOCRINOL, V16, P105, DOI 10.1111/j.0953-8194.2004.01135.x; Nagarajan A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12639; Nakae J, 2001, BIOCHEMISTRY-US, V40, P11768, DOI 10.1021/bi015532m; Nascimento EM, 2011, NAT CELL BIOL, V13, P1395, DOI 10.1038/ncb2385; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; Nuttall FQ, 2015, METABOLISM, V64, P253, DOI 10.1016/j.metabol.2014.10.004; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; OKABAYASHI Y, 1989, DIABETES, V38, P182, DOI 10.2337/diabetes.38.2.182; Orengo DJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188357; Page MM, 2018, TRENDS ENDOCRIN MET, V29, P389, DOI 10.1016/j.tem.2018.03.018; Page MM, 2018, FASEB J, V32, P1196, DOI [10.1096/fj.201700518R, 10.1096/fj.201700518r]; Palsgaard J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006575; Patterson RE, 2017, ANNU REV NUTR, V37, P371, DOI 10.1146/annurev-nutr-071816-064634; POLONSKY KS, 1988, NEW ENGL J MED, V318, P1231, DOI 10.1056/NEJM198805123181903; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Qiu BY, 2014, CELL REP, V7, P1876, DOI 10.1016/j.celrep.2014.05.030; Rachdaoui N, 2019, J ENDOCR SOC, V3, P69, DOI 10.1210/js.2018-00140; Rome S, 2003, J BIOL CHEM, V278, P18063, DOI 10.1074/jbc.M300293200; Rowzee AM, 2009, ENDOCRINOLOGY, V150, P3611, DOI 10.1210/en.2008-1473; Sbraccia P, 1996, DIABETOLOGIA, V39, P220, DOI 10.1007/BF00403966; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Sood S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw263; Spadaro L, 2011, NUTR METAB CARDIOVAS, V21, P206, DOI 10.1016/j.numecd.2009.09.003; Stokes T, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107980; Sutton EF, 2018, CELL METAB, V27, P1212, DOI 10.1016/j.cmet.2018.04.010; Taylor DL, 2019, P NATL ACAD SCI USA, V116, P10883, DOI 10.1073/pnas.1814263116; Templeman NM, 2017, CELL REP, V20, P451, DOI 10.1016/j.celrep.2017.06.048; Templeman NM, 2017, J ENDOCRINOL, V232, pR173, DOI [10.1530/JOE-16-0449, 10.1530/joe-16-0449]; Timmons JA, 2018, NUCLEIC ACIDS RES, V46, P7772, DOI 10.1093/nar/gky570; Trico D, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124912; TRISCHITTA V, 1986, J CLIN ENDOCR METAB, V62, P522, DOI 10.1210/jcem-62-3-522; Tseng LTL, 2013, J BIOL CHEM, V288, P32424, DOI 10.1074/jbc.M113.479527; Wang GX, 2020, DIABETES, V69, P2294, DOI 10.2337/db20-0439; Welsh EA, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-153; Wiebe N, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.1263; Williams KV, 1998, DIABETES CARE, V21, P2, DOI 10.2337/diacare.21.1.2; Yang XF, 2014, J ENDOCRINOL, V221, P469, DOI 10.1530/JOE-14-0117; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A; Zhang JD, 2001, P NATL ACAD SCI USA, V98, P3756, DOI 10.1073/pnas.071054598; Zhang J, 2014, INT J MOL MED, V33, P1209, DOI 10.3892/ijmm.2014.1695; Zhang ZG, 2011, CELL PHYSIOL BIOCHEM, V27, P637, DOI 10.1159/000330072; Zhou GY, 2019, NUCLEIC ACIDS RES, V47, pW234, DOI 10.1093/nar/gkz240; ZIMMET PZ, 1992, DIABETOLOGIA, V35, P534, DOI 10.1007/BF00400481	91	4	4	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22088	10.1096/fj.202100497RR	http://dx.doi.org/10.1096/fj.202100497RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34921686	Green Published, hybrid			2022-12-28	WOS:000734992000031
J	Huang, QL; Qin, DJ; Pei, DQ; Vermeulen, M; Zhang, XF				Huang, Qiuling; Qin, Dajiang; Pei, Duanqing; Vermeulen, Michiel; Zhang, Xiaofei			UBE2O and USP7 co-regulate RECQL4 ubiquitinylation and homologous recombination-mediated DNA repair	FASEB JOURNAL			English	Article						DNA damage repair; multi-monoubiquitinylation; RECQL4; UBE2O; USP7	GENOMIC INSTABILITY; HELICASE RECQL4; UBIQUITINATION; CANCER; MONOUBIQUITINATION; ASSOCIATION; ACTIVATION; MUTATIONS; ENZYMES; DOMAIN	The human RecQ DNA helicase, RECQL4, plays a pivotal role in maintaining genomic stability by regulating the DNA double-strand breaks (DSBs) repair pathway, and is, thus, involved in the regulation of aging and cancer onset. However, the regulatory mechanisms of RECQL4, especially its post-translational modifications, have not been fully illustrated. Here, we report that the E2/E3 hybrid ubiquitin-conjugating enzyme, UBE2O, physically interacts with RECQL4, and mediates the multi-monoubiquitinylation of RECQL4, subsequently leading to its proteasomal degradation. Functionally, we showed that UBE2O inhibits homologous recombination (HR)-mediated DSBs repair, and this inhibition depends on its E2 catalytic activity and RECQL4 expression. Mechanistically, we showed that UBE2O attenuates the interaction of RECQL4 and DNA damage repair proteins, the MRE11-RAD50-NBS1 complex and CtIP. Furthermore, we show that deubiquitinylase USP7 interacts with both UBE2O and RECQL4, and in that it antagonizes UBE2O-mediated regulation of RECQL4 stability and function. Collectively, we found a novel regulatory mechanism of ubiquitin-mediated regulation of RECQL4 in HR-mediated DSBs repair process.	[Huang, Qiuling; Qin, Dajiang; Pei, Duanqing; Zhang, Xiaofei] Chinese Acad Sci, CAS Key Lab Regenerat Biol, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou Inst Biomed & Hlth,GIBH HKU Guangdong H, Guangzhou 510530, Peoples R China; [Huang, Qiuling; Zhang, Xiaofei] Guangzhou Regenerat Med & Hlth Guangdong Lab, Ctr Cell Lineage & Atlas, BioLand Lab, Guangzhou, Peoples R China; [Pei, Duanqing] Westlake Univ, Sch Life Sci, Lab Cell Fate Control, Hangzhou, Peoples R China; [Vermeulen, Michiel] Radboud Univ Nijmegen, Oncode Inst, Radboud Inst Mol Life Sci, Dept Mol Biol,Fac Sci, Nijmegen, Netherlands	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); Westlake University; Radboud University Nijmegen	Zhang, XF (corresponding author), Chinese Acad Sci, CAS Key Lab Regenerat Biol, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou Inst Biomed & Hlth,GIBH HKU Guangdong H, Guangzhou 510530, Peoples R China.	zhang_xiaofei@gibh.ac.cn	Vermeulen, Michiel/C-8883-2013	Vermeulen, Michiel/0000-0003-0836-6894; Zhang, Xiaofei/0000-0002-2564-9258	Science and Technology Planning Project of Guangdong Province [2018B030306047, 202081212060052]; National Natural Science Foundation [31770889, 31801180]; Guangzhou Science and Technology Project [201904010469]; Guangzhou Regenerative Medicine and Health Guangdong Laboratory project [2018GZR110104003]	Science and Technology Planning Project of Guangdong Province; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guangzhou Science and Technology Project; Guangzhou Regenerative Medicine and Health Guangdong Laboratory project	Science and Technology Planning Project of Guangdong Province, Grant/Award Number: 2018B030306047 and 202081212060052: National Natural Science Foundation, Grant/Award Number: 31770889 and 31801180; Guangzhou Science and Technology Project, Grant/Award Number: 201904010469; Guangzhou Regenerative Medicine and Health Guangdong Laboratory project, Grant/Award Number: 2018GZR110104003	Akutsu M, 2016, J CELL SCI, V129, P875, DOI 10.1242/jcs.183954; Chen SP, 2018, J BIOL CHEM, V293, P11296, DOI 10.1074/jbc.RA117.001432; Croteau DL, 2012, TRENDS GENET, V28, P624, DOI 10.1016/j.tig.2012.08.003; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dietschy T, 2009, J CELL SCI, V122, P1258, DOI 10.1242/jcs.037747; Dimova NV, 2012, NAT CELL BIOL, V14, P168, DOI 10.1038/ncb2425; Duan SL, 2020, NUCLEIC ACIDS RES, V48, P6530, DOI 10.1093/nar/gkaa392; Grice GL, 2016, CELL MOL LIFE SCI, V73, P3497, DOI 10.1007/s00018-016-2255-5; Huang QL, 2020, PROTEOMICS, V20, DOI 10.1002/pmic.201900100; Huang YM, 2021, CELL DEATH DIFFER, V28, P671, DOI 10.1038/s41418-020-00616-8; Kim RQ, 2017, J MOL BIOL, V429, P3395, DOI 10.1016/j.jmb.2017.05.028; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kohzaki M, 2020, INT J CANCER, V146, P3098, DOI 10.1002/ijc.32670; Li YH, 2014, J BIOL CHEM, V289, P5097, DOI 10.1074/jbc.M113.533109; Liang KW, 2017, CELL, V168, P59, DOI 10.1016/j.cell.2016.12.011; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lu HM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02146-3; Lu HM, 2016, CELL REP, V16, P161, DOI 10.1016/j.celrep.2016.05.079; Mann MB, 2005, HUM MOL GENET, V14, P813, DOI 10.1093/hmg/ddi075; Mashtalir N, 2014, MOL CELL, V54, P392, DOI 10.1016/j.molcel.2014.03.002; Mevissen TET, 2017, ANNU REV BIOCHEM, V86, P159, DOI 10.1146/annurev-biochem-061516-044916; Mo DL, 2018, CANCER LETT, V413, P1, DOI 10.1016/j.canlet.2017.10.021; Mo DL, 2016, CANCER RES, V76, P3057, DOI 10.1158/0008-5472.CAN-15-2361; Narayanaswamy PB, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.291; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nguyen AT, 2017, SCIENCE, V357, DOI 10.1126/science.aan0218; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Shamanna RA, 2014, CARCINOGENESIS, V35, P2415, DOI 10.1093/carcin/bgu137; Shi RN, 2021, CELL BIOSCI, V11, DOI 10.1186/s13578-021-00659-5; Siitonen HA, 2003, HUM MOL GENET, V12, P2837, DOI 10.1093/hmg/ddg306; Singh DK, 2010, AGING CELL, V9, P358, DOI 10.1111/j.1474-9726.2010.00562.x; Smeets MF, 2014, J CLIN INVEST, V124, P3551, DOI 10.1172/JCI75334; Su DX, 2018, J CLIN INVEST, V128, P4280, DOI 10.1172/JCI120518; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Ullah K, 2019, FEBS J, V286, P2018, DOI 10.1111/febs.14708; van Brabant AJ, 2000, ANNU REV GENOM HUM G, V1, P409, DOI 10.1146/annurev.genom.1.1.409; Van Maldergem L, 2006, J MED GENET, V43, P148, DOI 10.1136/jmg.2005.031781; Vila IK, 2017, CANCER CELL, V31, P208, DOI 10.1016/j.ccell.2017.01.003; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Xu YJ, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0499-7; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhang XF, 2018, NAT PROTOC, V13, P530, DOI 10.1038/nprot.2017.147; Zhang XF, 2017, MOL CELL, V65, P941, DOI 10.1016/j.molcel.2017.01.004; Zhang XF, 2013, EMBO J, V32, P996, DOI 10.1038/emboj.2013.38; Zhang XF, 2013, CELL RES, V23, P366, DOI 10.1038/cr.2013.21; Zhou FF, 2012, J BIOL CHEM, V287, P11002, DOI 10.1074/jbc.M111.328187; Zhou J, 2018, MED CHEM, V14, P3, DOI 10.2174/1573406413666171020115539	51	4	4	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22112	10.1096/fj.202100974RRR	http://dx.doi.org/10.1096/fj.202100974RRR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34921745	Green Published			2022-12-28	WOS:000734992000038
J	Montgomery, MK; Taddese, AZ; Bayliss, J; Nie, S; Williamson, NA; Watt, MJ				Montgomery, Magdalene K.; Taddese, Amanuiel Z.; Bayliss, Jacqueline; Nie, Shuai; Williamson, Nicholas A.; Watt, Matthew J.			Hexosaminidase A (HEXA) regulates hepatic sphingolipid and lipoprotein metabolism in mice	FASEB JOURNAL			English	Article						ganglioside; HEXA; lipid metabolism; lipid raft; lipoprotein; sphingolipid metabolism; sphingomyelin	O-GLCNACYLATION; NONALCOHOLIC STEATOHEPATITIS; PLASMA-LIPOPROTEINS; LIPID-METABOLISM; KUPFFER CELLS; PROTEIN; LIVER; EXERCISE; VLDL; BIOSYNTHESIS	Hexosaminidase A (HexA), a heterodimer consisting of HEXA and HEXB, converts the ganglioside sphingolipid GM2 to GM3 by removing a terminal N-acetyl-d-galactosamine. HexA enzyme deficiency in humans leads to GM2 accumulation in cells, particularly in neurons, and is associated with neurodegeneration. While HexA and sphingolipid metabolism have been extensively investigated in the context of neuronal lipid metabolism, little is known about the metabolic impact of HexA and ganglioside degradation in other tissues. Here, we focussed on the role of HexA in the liver, which is a major regulator of systemic lipid metabolism. We find that hepatic Hexa expression is induced by lipid availability and increased in the presence of hepatic steatosis, which is associated with increased hepatic GM3 content. To assess the impact of HEXA on hepatic lipid metabolism, we used an adeno-associated virus to overexpress HEXA in the livers of high-fat diet fed mice. HEXA overexpression was associated with increased hepatic GM3 content and increased expression of enzymes involved in the degradation of glycated sphingolipids, ultimately driving sphingomyelin accumulation in the liver. In addition, HEXA overexpression led to substantial proteome remodeling in cell surface lipid rafts, which was associated with increased VLDL processing and secretion, hypertriglyceridemia and ectopic lipid accumulation in peripheral tissues. This study established an important role of HEXA in modulating hepatic sphingolipid and lipoprotein metabolism.	[Montgomery, Magdalene K.; Taddese, Amanuiel Z.; Bayliss, Jacqueline; Watt, Matthew J.] Univ Melbourne, Dept Anat & Physiol, Melbourne, Vic, Australia; [Nie, Shuai; Williamson, Nicholas A.] Univ Melbourne, Mol Sci Biotechnol Inst Bio21, Melbourne Mass Spectrometry & Prote Facil, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne	Montgomery, MK (corresponding author), Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Anat & Physiol, Sch Biomed Sci, Melbourne, Vic 3010, Australia.	magdalene.montgomery@unimelb.edu.au	Nie, Shuai/AAE-7778-2019; Williamson, Nicholas/O-9812-2016	Nie, Shuai/0000-0002-6425-972X; Williamson, Nicholas/0000-0002-2173-3452	National Health and Medical Research Council [APP1162511, APP1156508, APP1143224]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	National Health and Medical Research Council, Grant/Award Number: APP1162511, APP1156508 and APP1143224	Albeituni S, 2019, ADV EXP MED BIOL, V1161, P169, DOI 10.1007/978-3-030-21735-8_15; Alfalah M, 1999, CURR BIOL, V9, P593, DOI 10.1016/S0960-9822(99)80263-2; Andrade CMB, 2003, J CELL BIOCHEM, V88, P533, DOI 10.1002/jcb.10373; Bergmeyer HU, 1980, CLIN CHIM ACTA, V105, P147, DOI DOI 10.1016/0009-8981(80)90105-9; Bijvoet S, 1996, J LIPID RES, V37, P640; Broussard A, 2020, J BIOL CHEM, V295, P1225, DOI 10.1074/jbc.RA119.009271; Cantalupo A, 2015, NAT MED, V21, P1028, DOI 10.1038/nm.3934; Choi H, 2017, J CELL BIOCHEM, V118, P2168, DOI 10.1002/jcb.25860; Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007; Chow JDY, 2014, MOL METAB, V3, P419, DOI 10.1016/j.molmet.2014.02.004; Cohen DE, 2013, SEMIN LIVER DIS, V33, P380, DOI 10.1055/s-0033-1358519; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Doering T, 1999, J BIOL CHEM, V274, P11038, DOI 10.1074/jbc.274.16.11038; Dopico AM, 2007, METHODS MEMBRANE LIP; Ehehalt R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-45; Feingold KR, 2020, ENDOTEXT INTERNET; Ferreira CR, 2017, METABOLIC DISEASES: FOUNDATIONS OF CLINICAL MANAGEMENT, GENETICS, AND PATHOLOGY, 2ND EDITION, P367, DOI 10.3233/978-1-61499-718-4-367; GABELLEC MM, 1983, BIOCHEM BIOPH RES CO, V113, P845, DOI 10.1016/0006-291X(83)91076-8; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; Haimovitz-Friedman A, 1997, BRIT MED BULL, V53, P539; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Heeren J, 2021, MOL METAB, V50, DOI 10.1016/j.molmet.2021.101238; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; Huynh K, 2019, CELL CHEM BIOL, V26, P71, DOI 10.1016/j.chembiol.2018.10.008; Ilan Y, 2016, AM J PHYSIOL-GASTR L, V310, pG1102, DOI 10.1152/ajpgi.00095.2016; Iqbal J, 2017, TRENDS ENDOCRIN MET, V28, P506, DOI 10.1016/j.tem.2017.03.005; IWAMORI M, 1984, J BIOCHEM-TOKYO, V95, P761, DOI 10.1093/oxfordjournals.jbchem.a134667; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Jiang XC, 2009, CLIN LIPIDOL, V4, P595, DOI 10.2217/CLP.09.49; Kamagate A, 2008, CELL CYCLE, V7, P3162, DOI 10.4161/cc.7.20.6882; Lalazar G, 2017, J MED FOOD, V20, P458, DOI 10.1089/jmf.2016.3753; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Lawson CA, 2016, APPL CLIN GENET, V9, DOI 10.2147/TACG.S85354; Li Y, 2013, ARTERIOSCL THROM VAS, V33, P1513, DOI 10.1161/ATVBAHA.113.301498; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Ma JF, 2015, J BIOL CHEM, V290, P29141, DOI 10.1074/jbc.M115.691741; Masuda D, 2009, J LIPID RES, V50, P999, DOI 10.1194/jlr.P700032-JLR200; Mato JM, 2019, WORLD J GASTROENTERO, V25, P3009, DOI 10.3748/wjg.v25.i24.3009; Merrill AH, 2008, N COMP BIOC, P363, DOI 10.1016/B978-044453219-0.50015-5; Michel V, 2007, BIOL CELL, V99, P129, DOI 10.1042/BC20060051; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Mlinac K, 2012, MOL CELL BIOCHEM, V369, P127, DOI 10.1007/s11010-012-1375-y; Mohamed A, 2019, NUCLEIC ACIDS RES, V47, pD459, DOI 10.1093/nar/gky948; Mohktar RAM, 2016, AM J PHYSIOL-ENDOC M, V311, pE128, DOI 10.1152/ajpendo.00084.2016; Montgomery MK, 2015, SCI REP-UK, V5, DOI 10.1038/srep18474; Montgomery MK, 2019, FASEB J, V33, P13267, DOI 10.1096/fj.201900909RR; Niwa H, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030321; Ooi GJ, 2021, J HEPATOL, V75, P524, DOI 10.1016/j.jhep.2021.04.013; Park TS, 2006, ATHEROSCLEROSIS, V189, P264, DOI 10.1016/j.atherosclerosis.2005.12.029; Rodriguez-Calvo R, 2020, CLIN INVEST ARTERIOS, V32, P8, DOI 10.1016/j.arteri.2019.05.001; Sapuri-Butti AR., 2020, BIOCH BIOPHYS ACTA B, V1863; SENN HJ, 1990, ARCH BIOCHEM BIOPHYS, V278, P161, DOI 10.1016/0003-9861(90)90244-S; SENN HJ, 1989, EUR J BIOCHEM, V181, P657, DOI 10.1111/j.1432-1033.1989.tb14773.x; Shao BJ, 2015, P NATL ACAD SCI USA, V112, P8661, DOI 10.1073/pnas.1507712112; Simon J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010040; Slentz CA, 2007, J APPL PHYSIOL, V103, P432, DOI 10.1152/japplphysiol.01314.2006; Solovyeva VV, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01663; Storey SM, 2007, BIOCHEMISTRY-US, V46, P13891, DOI 10.1021/bi700690s; Stutz AE, 2016, ADV CARBOHYD CHEM BI, V73, P225, DOI 10.1016/bs.accb.2016.08.002; Tada Hayato, 2015, Pract Lab Med, V1, P22, DOI 10.1016/j.plabm.2015.03.001; Tiwari S, 2013, J BIOL CHEM, V288, P5157, DOI 10.1074/jbc.M112.434258; Trefts E, 2017, CURR BIOL, V27, pR1147, DOI 10.1016/j.cub.2017.09.019; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Villar VM, 2016, METHOD CELL BIOL, V132, P3, DOI 10.1016/bs.mcb.2015.11.008; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; Wang GQ, 2015, J LIPID RES, V56, P2238, DOI 10.1194/jlr.R056705; Wang YJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214144; Wasserstein M, 2019, MOL GENET METAB, V126, P98, DOI 10.1016/j.ymgme.2018.11.014; Watt MJ, 2019, ENDOCR REV, V40, P1367, DOI 10.1210/er.2019-00034; Watt MJ, 2002, J PHYSIOL-LONDON, V541, P969, DOI 10.1113/jphysiol.2002.018820; Wright CS, 2000, J MOL BIOL, V304, P411, DOI 10.1006/jmbi.2000.4225; Xu YH, 2010, J LIPID RES, V51, P1643, DOI 10.1194/jlr.R003996; YAMANAKA S, 1994, GENOMICS, V21, P588, DOI 10.1006/geno.1994.1318; Yan NL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-46; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Yu RK, 2011, J OLEO SCI, V60, P537, DOI 10.5650/jos.60.537; Zhang KS, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00221; Zhao L, 2016, FREE RADICAL RES, V50, P1080, DOI 10.1080/10715762.2016.1239017; Zigmond H, 2014, J INFLAMM RES, V7, P151, DOI 10.2147/JIR.S50508; Zigmond E, 2009, AM J PHYSIOL-ENDOC M, V296, pE72, DOI 10.1152/ajpendo.90634.2008	80	1	1	6	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22046	10.1096/fj.202101186R	http://dx.doi.org/10.1096/fj.202101186R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34800307				2022-12-28	WOS:000722321300044
J	Thomas, KN; Zimmel, KN; Roach, AN; Basel, A; Mehta, NA; Bedi, YS; Golding, MC				Thomas, Kara N.; Zimmel, Katherine N.; Roach, Alexis N.; Basel, Alison; Mehta, Nicole A.; Bedi, Yudhishtar S.; Golding, Michael C.			Maternal background alters the penetrance of growth phenotypes and sex-specific placental adaptation of offspring sired by alcohol-exposed males	FASEB JOURNAL			English	Article						developmental programming; fetal alcohol spectrum disorder (FASDs); genetic background; mitochondrial disfunction; oxidative phosphorylation; paternal epigenetic inheritance; placental adaptation; placental dysfunction; preconception exposure; RRID; IMSR_CRL; 22; RRID; IMSR_JAX; 000664; RRID; SCR_002798	FETAL-GROWTH; ETHANOL TERATOGENESIS; IMPRINTED GENES; LATE-GESTATION; MOUSE MODEL; MALE-MICE; RESTRICTION; MITOEPIGENETICS; CONSUMPTION; OVERGROWTH	Epigenetic mechanisms of paternal inheritance are an emerging area of interest in our efforts to understand fetal alcohol spectrum disorders. In rodent models examining maternal alcohol exposures, different maternal genetic backgrounds protect or sensitize offspring to alcohol-induced teratogenesis. However, whether maternal background can mitigate sperm-inherited alterations in developmental programming and modify the penetrance of growth defects induced by preconception paternal alcohol exposures remains unaddressed. In our previous studies examining pure C57Bl/6J crosses, the offspring of alcohol-exposed sires exhibited fetal growth restriction, enlarged placentas, and decreased placental efficiency. Here, we find that in contrast to our previous studies, the F1 offspring of alcohol-exposed C57Bl/6J sires and CD-1 dams do not exhibit fetal growth restriction, with male fetuses developing smaller placentas and increased placental efficiencies. However, in these hybrid offspring, preconception paternal alcohol exposure induces sex-specific changes in placental morphology. Specifically, the female offspring of alcohol-exposed sires displayed structural changes in the junctional and labyrinth zones, along with increased placental glycogen content. These changes in placental organization are accompanied by female-specific alterations in the expression of imprinted genes Cdkn1c and H19. Although male placentae do not display overt changes in placental histology, using RNA-sequencing, we identified programmed alterations in genes regulating oxidative phosphorylation, mitochondrial function, and Sirtuin signaling. Collectively, our data reveal that preconception paternal alcohol exposure transmits a stressor to developing offspring, that males and females exhibit distinct patterns of placental adaptation, and that maternal genetic background can modulate the effects of paternal alcohol exposure.	[Thomas, Kara N.; Zimmel, Katherine N.; Roach, Alexis N.; Basel, Alison; Mehta, Nicole A.; Bedi, Yudhishtar S.; Golding, Michael C.] Texas A&M Univ, Dept Vet Physiol & Pharmacol, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Golding, MC (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA.	mgolding@cvm.tamu.edu		Zimmel, Katherine/0000-0002-8243-6953; GOLDING, MICHAEL/0000-0003-1631-2175; Bedi, Yudhishtar/0000-0002-1213-4116	HHS \ NIH \ National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R01AA028219]; W. M. Keck Foundation	HHS \ NIH \ National Institute on Alcohol Abuse and Alcoholism (NIAAA); W. M. Keck Foundation(W.M. Keck Foundation)	HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA), Grant/Award Number: R01AA028219; W. M. Keck Foundation (W.M. Keck Foundation)	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Albers RE, 2018, THERIOGENOLOGY, V107, P115, DOI 10.1016/j.theriogenology.2017.10.049; Bailoo JD, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00232; Bedi Y, 2019, REPROD TOXICOL, V87, P11, DOI 10.1016/j.reprotox.2019.04.006; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carnahan MN, 2013, ALCOHOL, V47, P109, DOI 10.1016/j.alcohol.2012.12.003; Champroux A, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00050; Chan JC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15305-w; Chang RC, 2021, EPIGENET CHROMATIN, V14, DOI 10.1186/s13072-021-00403-w; Chang RC, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0254-0; Chang RC, 2017, EPIGENETICS-US, V12, P841, DOI 10.1080/15592294.2017.1363952; Coan PM, 2010, J PHYSIOL-LONDON, V588, P527, DOI 10.1113/jphysiol.2009.181214; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Dackor J, 2009, GENETICS, V183, P207, DOI 10.1534/genetics.109.104372; Dackor J, 2009, MAMM GENOME, V20, P339, DOI 10.1007/s00335-009-9189-2; De Clercq K, 2019, P NATL ACAD SCI USA, V116, P13927, DOI 10.1073/pnas.1902688116; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donald KA, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00294; Dong Z, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00004; Downing C, 2009, ALCOHOL CLIN EXP RES, V33, P1238, DOI 10.1111/j.1530-0277.2009.00949.x; Eberhart JK, 2016, ALCOHOL CLIN EXP RES, V40, P1154, DOI 10.1111/acer.13066; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Fleming TP, 2018, LANCET, V391, P1842, DOI [10.1016/S0140-6736(18)30312-X, 10.1016/s0140-6736(18)30312-x]; Gardebjer EM, 2014, PLACENTA, V35, P50, DOI 10.1016/j.placenta.2013.10.008; GILLIAM DM, 1990, ALCOHOL CLIN EXP RES, V14, P539, DOI 10.1111/j.1530-0277.1990.tb01196.x; Gilliam DM, 1997, ALCOHOL CLIN EXP RES, V21, P28; Hayward CE, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00028; Heyne GW, 2015, J AM ASSOC LAB ANIM, V54, P368; Hsu CW, 2016, DEV BIOL, V419, P229, DOI 10.1016/j.ydbio.2016.09.011; Immler S, 2018, HEREDITY, V121, P239, DOI 10.1038/s41437-018-0111-0; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; Kalisch-Smith JI, 2017, PLACENTA, V54, P10, DOI 10.1016/j.placenta.2016.12.008; Kalisch-Smith JI, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.172205; Kraut N, 1998, EMBO J, V17, P6276, DOI 10.1093/emboj/17.21.6276; Larriba E, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5020-3; Le Blevec E, 2020, MOL CELL ENDOCRINOL, V518, DOI 10.1016/j.mce.2020.110964; Lesciotto KM, 2020, DEV DYNAM, V249, P573, DOI 10.1002/dvdy.136; Li YH, 1998, NAT GENET, V20, P309, DOI 10.1038/3129; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Piedrahita JA, 2011, BIRTH DEFECTS RES A, V91, P682, DOI 10.1002/bdra.20795; Pruis MGM, 2015, ACTA PHYSIOL, V215, P127, DOI 10.1111/apha.12562; Rennie MY, 2012, AM J PHYSIOL-HEART C, V302, pH1261, DOI 10.1152/ajpheart.00776.2011; Rhodes JS, 2007, GENES BRAIN BEHAV, V6, P1, DOI 10.1111/j.1601-183X.2006.00210.x; Rompala GR, 2019, ALCOHOL CLIN EXP RES, V43, P1032, DOI 10.1111/acer.14029; Rompala GR, 2017, ALCOHOL, V60, P169, DOI 10.1016/j.alcohol.2016.11.001; Rosenfeld CS, 2015, ENDOCRINOLOGY, V156, P3422, DOI 10.1210/en.2015-1227; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sadakierska-Chudy A, 2014, PHARMACOL THERAPEUT, V144, P226, DOI 10.1016/j.pharmthera.2014.06.002; Schaefer G Bradley, 2011, J Ark Med Soc, V108, P38; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sittig LJ, 2011, FASEB J, V25, P2313, DOI 10.1096/fj.10-179234; Sofronescu AG, 2010, CARDIOVASC RES, V87, P102, DOI 10.1093/cvr/cvq025; Thiele Todd E, 2014, Curr Protoc Neurosci, V68, DOI 10.1002/0471142301.ns0949s68; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Tunster SJ, 2016, DEV BIOL, V418, P55, DOI 10.1016/j.ydbio.2016.08.014; Tunster SJ, 2016, DEV BIOL, V409, P251, DOI 10.1016/j.ydbio.2015.10.015; Tunster SJ, 2012, PLACENTA, V33, P124, DOI 10.1016/j.placenta.2011.11.011; Tunster SJ, 2014, DIS MODEL MECH, V7, P1185, DOI 10.1242/dmm.017079; Tunster SJ, 2011, DIS MODEL MECH, V4, P814, DOI 10.1242/dmm.007328; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Watkins AJ, 2017, BBA-MOL BASIS DIS, V1863, P1371, DOI 10.1016/j.bbadis.2017.02.009; WHITTEN WK, 1968, SCIENCE, V161, P584, DOI 10.1126/science.161.3841.584	63	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22035	10.1096/fj.202101131R	http://dx.doi.org/10.1096/fj.202101131R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34748230	Green Published			2022-12-28	WOS:000722321300006
J	Camacho-Munoz, D; Kiezel-Tsugunova, M; Kiss, O; Uddin, M; Sunden, M; Ryaboshapkina, M; Lind, L; Oscarsson, J; Nicolaou, A				Camacho-Munoz, Dolores; Kiezel-Tsugunova, Magdalena; Kiss, Orsolya; Uddin, Mohib; Sunden, Mattias; Ryaboshapkina, Maria; Lind, Lars; Oscarsson, Jan; Nicolaou, Anna			Omega-3 carboxylic acids and fenofibrate differentially alter plasma lipid mediators in patients with non-alcoholic fatty liver disease	FASEB JOURNAL			English	Article						ceramides; eicosanoids; lipidomics; N-acylethanolamines; polyunsaturated fatty acids	STATIN-TREATED PATIENTS; EPOXIDE HYDROLASE AXIS; CARDIOVASCULAR RISK; FISH-OIL; CERAMIDE; HYPERTRIGLYCERIDEMIA; INFLAMMATION; METABOLISM; PROSTAGLANDIN-E2; ACCUMULATION	Fibrates and omega-3 polyunsaturated acids are used for the treatment of hypertriglyceridemia but have not demonstrated consistent effects on cardiovascular (CV) risk. In this study, we investigate how these two pharmacological agents influence plasma levels of bioactive lipid mediators, aiming to explore their efficacy beyond that of lipid-lowering agents. Plasma from overweight patients with non-alcoholic fatty liver disease (NAFLD) and hypertriglyceridemia, participating in a randomized placebo-controlled study investigating the effects of 12 weeks treatment with fenofibrate or omega-3 free carboxylic acids (OM-3CA) (200 mg or 4 g per day, respectively), were analyzed for eicosanoids and related PUFA species, N-acylethanolamines (NAE) and ceramides. OM-3CA reduced plasma concentrations of proinflammatory PGE(2), as well as PGE(1), PGD(1) and thromboxane B2 but increased prostacyclin, and eicosapentaenoic acid- and docosahexaenoic acid-derived lipids of lipoxygenase and cytochrome P450 monooxygenase (CYP) (e.g., 17-HDHA, 18-HEPE, 19,20-DiHDPA). Fenofibrate reduced plasma concentrations of vasoactive CYP-derived eicosanoids (DHETs). Although OM-3CA increased plasma levels of the NAE docosahexaenoyl ethanolamine and docosapentaenoyl ethanolamine, and fenofibrate increased palmitoleoyl ethanolamine, the effect of both treatments may have been masked by the placebo (olive oil). Fenofibrate was more efficacious than OM-3CA in significantly reducing plasma ceramides, pro-inflammatory lipids associated with CV disease risk. Neither treatment affected putative lipid species associated with NAFLD. Our results show that OM-3CA and fenofibrate differentially modulate the plasma mediator lipidome, with OM-3CA promoting the formation of lipid mediators with potential effects on chronic inflammation, while fenofibrate mainly reducing ceramides. These findings suggest that both treatments could ameliorate chronic inflammation with possible impact on disease outcomes, independent of triglyceride reduction.	[Camacho-Munoz, Dolores; Kiezel-Tsugunova, Magdalena; Kiss, Orsolya; Nicolaou, Anna] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Sch Hlth Sci,Lab Lipid & Lipid Biol,Div Pharm & O, Manchester, Lancs, England; [Uddin, Mohib; Ryaboshapkina, Maria; Oscarsson, Jan] AstraZeneca Gothenburg, Biopharmaceut R&D, Molndal, Sweden; [Sunden, Mattias] Univ Gothenburg, Dept Econ, Gothenburg, Sweden; [Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Nicolaou, Anna] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Lydia Becker Inst Immunol & Inflammat, Manchester, Lancs, England	University of Manchester; AstraZeneca; University of Gothenburg; Uppsala University; University of Manchester	Nicolaou, A (corresponding author), Univ Manchester, Div Pharm & Optometry, Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	anna.nicolaou@manchester.ac.uk	Nicolaou, Anna/D-4025-2018	Nicolaou, Anna/0000-0002-1314-413X	AstraZeneca	AstraZeneca(AstraZeneca)	This work was funded by AstraZeneca through a research grant to the University of Manchester. We thank Neil O'Hara, University of Manchester, for excellent technical support.	Alharthi N, 2018, BBA-MOL CELL BIOL L, V1863, P1433, DOI 10.1016/j.bbalip.2018.08.003; Annunziata C, 2020, FASEB J, V34, P350, DOI 10.1096/fj.201901510RR; Barden AE, 2015, AM J CLIN NUTR, V102, P1357, DOI 10.3945/ajcn.115.116384; Belfort R, 2010, J CLIN ENDOCR METAB, V95, P829, DOI 10.1210/jc.2009-1487; Bhatt DL, 2019, NEW ENGL J MED, V380, P11, DOI 10.1056/NEJMoa1812792; Calder PC, 2013, BRIT J CLIN PHARMACO, V75, P645, DOI 10.1111/j.1365-2125.2012.04374.x; Catapano AL, 2016, ATHEROSCLEROSIS, V253, P281, DOI 10.1016/j.atherosclerosis.2016.08.018; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F; Croyal M, 2018, DIABETES METAB, V44, P143, DOI 10.1016/j.diabet.2017.04.003; Cucchi D, 2020, CARDIOVASC RES, V116, P1006, DOI 10.1093/cvr/cvz208; Dawczynski C, 2013, CLIN NUTR, V32, P686, DOI 10.1016/j.clnu.2012.12.010; Dong YQ, 2017, ACTA PHARMACOL SIN, V38, P1601, DOI 10.1038/aps.2017.127; Okada LSDR, 2018, CLIN NUTR, V37, P1474, DOI 10.1016/j.clnu.2017.08.031; Elam MB, 2017, JAMA CARDIOL, V2, P370, DOI 10.1001/jamacardio.2016.4828; Enomoto N, 2000, AM J PHYSIOL-GASTR L, V279, pG100, DOI 10.1152/ajpgi.2000.279.1.G100; Fischer R, 2014, J LIPID RES, V55, P1150, DOI 10.1194/jlr.M047357; Fleming I, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00739; Fleming I, 2014, PHARMACOL REV, V66, P1106, DOI 10.1124/pr.113.007781; Frances DE, 2015, DIABETES, V64, P1522, DOI 10.2337/db14-0979; Gomez-Munoz A, 2016, PROG LIPID RES, V61, P51, DOI 10.1016/j.plipres.2015.09.002; Gorden DL, 2015, J LIPID RES, V56, P722, DOI 10.1194/jlr.P056002; Henkel J, 2012, LAB INVEST, V92, P1597, DOI 10.1038/labinvest.2012.128; Iqbal J, 2017, TRENDS ENDOCRIN MET, V28, P506, DOI 10.1016/j.tem.2017.03.005; Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3; Kastelein JJP, 2014, J CLIN LIPIDOL, V8, P94, DOI 10.1016/j.jacl.2013.10.003; Kasumov T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126910; Katerina C, 2018, TOXICOL APPL PHARM, V355, P156, DOI 10.1016/j.taap.2018.06.025; Keating GM, 2011, AM J CARDIOVASC DRUG, V11, P227, DOI 10.2165/11207690-000000000-00000; Kendall AC, 2019, FASEB J, V33, P13014, DOI 10.1096/fj.201901501R; Kendall AC, 2017, BBA-BIOMEMBRANES, V1859, P1679, DOI 10.1016/j.bbamem.2017.03.016; Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002; Kiezel-Tsugunova M, 2018, BIOCHEM SOC T, V46, P119, DOI 10.1042/BST20160469; Laaksonen R, 2016, EUR HEART J, V37, P1967, DOI 10.1093/eurheartj/ehw148; Loomba R, 2015, J LIPID RES, V56, P185, DOI 10.1194/jlr.P055640; Lucanic M, 2011, NATURE, V473, P226, DOI 10.1038/nature10007; Mach F, 2020, EUR HEART J, V41, P111, DOI [10.1093/eurheartj/ehz455, 10.15829/1560-4071-2020-3826]; Maki KC, 2013, CLIN THER, V35, P1400, DOI 10.1016/j.clinthera.2013.07.420; Mantovani A, 2020, J CLIN LIPIDOL, V14, P176, DOI 10.1016/j.jacl.2020.01.005; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; Massey KA, 2013, FREE RADICAL BIO MED, V59, P45, DOI 10.1016/j.freeradbiomed.2012.08.565; Masukawa Y, 2008, J LIPID RES, V49, P1466, DOI 10.1194/jlr.M800014-JLR200; Mater MK, 1999, J LIPID RES, V40, P1045; McGurk KA, 2021, HUM MOL GENET, V30, P500, DOI 10.1093/hmg/ddab002; Mourikis P, 2020, PHARMACOL THERAPEUT, V213, DOI 10.1016/j.pharmthera.2020.107592; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Ng VY, 2007, DRUG METAB DISPOS, V35, P1126, DOI 10.1124/dmd.106.013839; Nicholls SJ, 2020, JAMA-J AM MED ASSOC, V324, P2268, DOI 10.1001/jama.2020.22258; Nicolaou A, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00075; O'Brien AJ, 2014, NAT MED, V20, P522, DOI 10.1038/nm.3516; Olivier J, 2008, ANN ALLERG ASTHMA IM, V100, P333, DOI 10.1016/S1081-1206(10)60595-9; Oscarsson J, 2018, J CLIN LIPIDOL, V12, P1390, DOI 10.1016/j.jacl.2018.08.003; Oscarsson J, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0541-3; Parker HM, 2012, J HEPATOL, V56, P944, DOI 10.1016/j.jhep.2011.08.018; Paton KF, 2020, EUR J PAIN, V24, P1990, DOI 10.1002/ejp.1641; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Poolman TM, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1825-y; RIMOLA A, 1986, J HEPATOL, V3, P111, DOI 10.1016/S0168-8278(86)80154-4; Sanyal AJ, 2014, GASTROENTEROLOGY, V147, P377, DOI 10.1053/j.gastro.2014.04.046; Schlegel M, 2016, HEPATOLOGY, V63, P1689, DOI 10.1002/hep.28347; Scorletti E, 2014, HEPATOLOGY, V60, P1211, DOI 10.1002/hep.27289; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Takahashi M, 2002, AM J PHYSIOL-GASTR L, V282, pG338, DOI 10.1152/ajpgi.00376.2001; Taltavull N, 2016, FOOD FUNCT, V7, P3981, DOI [10.1039/c6fo00589f, 10.1039/C6FO00589F]; Tam J, 2011, HEPATOLOGY, V53, P346, DOI 10.1002/hep.24077; Targher G, 2016, J HEPATOL, V65, P589, DOI 10.1016/j.jhep.2016.05.013; Tauber Z, 2020, MED MOL MORPHOL, V53, P141, DOI 10.1007/s00795-019-00240-7; Tosi F, 2014, ADV EXP MED BIOL, V824, P61, DOI 10.1007/978-3-319-07320-0_7; Tutunchi H, 2019, OBES REV, V20, P1057, DOI 10.1111/obr.12853; Watt MJ, 2012, DIABETOLOGIA, V55, P2741, DOI 10.1007/s00125-012-2649-3; Wolska A, 2020, CURR OPIN LIPIDOL, V31, P331, DOI 10.1097/MOL.0000000000000710; Younossi ZM, 2019, J HEPATOL, V70, P531, DOI 10.1016/j.jhep.2018.10.033; ZIPSER RD, 1983, GASTROENTEROLOGY, V84, P697	77	4	4	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21976	10.1096/fj.202100380RRR	http://dx.doi.org/10.1096/fj.202100380RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34618982				2022-12-28	WOS:000712009200014
J	Sarver, DC; Xu, C; Cheng, Y; Terrillion, CE; Wong, GW				Sarver, Dylan C.; Xu, Cheng; Cheng, Yi; Terrillion, Chantelle E.; Wong, G. William			CTRP4 ablation impairs associative learning and memory	FASEB JOURNAL			English	Article						C1QTNF4; cortex; hippocampus; learning and memory; mouse behavior; secreted hormone	PROTEIN 4 CTRP4; SYNAPTIC PLASTICITY; ADIPOSE-TISSUE; FOOD-INTAKE; C1Q-DOMAIN-CONTAINING PROTEINS; PHOSPHODIESTERASE 4D; HEPATIC STEATOSIS; SECRETED PROTEIN; C1Q; EXPRESSION	C1q/TNF-related protein (CTRP) family comprises fifteen highly conserved secretory proteins with diverse central and peripheral functions. In zebrafish, mouse, and human, CTRP4 is most highly expressed in the brain. We previously showed that CTRP4 is a metabolically responsive regulator of food intake and energy balance, and mice lacking CTRP4 exhibit sexually dimorphic changes in ingestive behaviors and systemic metabolism. Recent single-cell RNA sequencing also revealed Ctrp4/C1qtnf4 expression in diverse neuronal cell types across distinct anatomical brain regions, hinting at additional roles in the central nervous system not previously characterized. To uncover additional central functions of CTRP4, we subjected Ctrp4 knockout (KO) mice to a battery of behavioral tests. Relative to wild-type (WT) littermates, loss of CTRP4 does not alter exploratory, anxiety-, or depressive-like behaviors, motor function and balance, sensorimotor gating, novel object recognition, and spatial memory. While pain-sensing mechanisms in response to thermal stress and mild shock are intact, both male and female Ctrp4 KO mice have increased sensitivity to pain induced by higher-level shock, suggesting altered nociceptive function. Importantly, CTRP4 deficiency impairs hippocampal-dependent associative learning and memory as assessed by trace fear conditioning paradigm. This deficit is sex-dependent, affects only female mice, and is associated with altered expression of learning and memory genes (Arc, c-fos, and Pde4d) in the hippocampus and cortex. Altogether, our behavioral and gene expression analyses have uncovered novel aspects of the CTRP4 function and provided a physiological context to further investigate its mechanism of action in the central and peripheral nervous system.	[Sarver, Dylan C.; Xu, Cheng; Cheng, Yi; Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Terrillion, Chantelle E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	gwwong@jhmi.edu		Cheng, Henry Yi/0000-0003-4412-4235	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK084171]	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	HHS vertical bar NIH vertical bar National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK084171	Ballinger MD, 2015, NEUROBIOL DIS, V82, P176, DOI 10.1016/j.nbd.2015.06.006; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Beeman CL, 2013, LEARN MEMORY, V20, P336, DOI 10.1101/lm.031161.113; Bilkei-Gorzo A, 2002, J NEUROSCI, V22, P10046; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; Byerly MS, 2014, J BIOL CHEM, V289, P4055, DOI 10.1074/jbc.M113.506956; Cao LL, 2021, EUR J IMMUNOL, V51, P380, DOI 10.1002/eji.202048617; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Colombatti A, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00093; Esclassan F, 2009, J NEUROSCI, V29, P8087, DOI 10.1523/JNEUROSCI.0543-09.2009; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Gallo FT, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00079; Ghai R, 2007, IMMUNOBIOLOGY, V212, P253, DOI 10.1016/j.imbio.2006.11.001; Gilmartin MR, 2010, LEARN MEMORY, V17, P289, DOI 10.1101/lm.1597410; Hamoud N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06897-5; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Isiegas C, 2008, J NEUROSCI, V28, P6220, DOI 10.1523/JNEUROSCI.2935-07.2008; Kakegawa W, 2015, NEURON, V85, P316, DOI 10.1016/j.neuron.2014.12.020; Khoutorsky A, 2013, NEURON, V78, P298, DOI 10.1016/j.neuron.2013.02.025; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kochli DE, 2015, LEARN MEMORY, V22, P92, DOI 10.1101/lm.034918.114; Kovacsics CE, 2010, PHARMACOL BIOCHEM BE, V94, P380, DOI 10.1016/j.pbb.2009.09.020; Krishnan V, 2017, NATURE, V543, P507, DOI 10.1038/nature21678; Lau WB, 2017, CIRC J, V81, P920, DOI 10.1253/circj.CJ-17-0458; Lee YS, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-43; Lei X, 2016, AM J PHYSIOL-ENDOC M, V310, pE1036, DOI 10.1152/ajpendo.00010.2016; Li YJ, 2020, NEUROSCIENCE, V429, P1, DOI 10.1016/j.neuroscience.2019.12.039; Li YF, 2011, J NEUROSCI, V31, P172, DOI 10.1523/JNEUROSCI.5236-10.2011; Little HC, 2019, FASEB J, V33, P8666, DOI 10.1096/fj.201900520R; Luo Y, 2016, CELL MOL IMMUNOL, V13, P688, DOI 10.1038/cmi.2016.16; Martinelli DC, 2016, NEURON, V91, P1034, DOI 10.1016/j.neuron.2016.07.002; Matsuda K, 2010, SCIENCE, V328, P363, DOI 10.1126/science.1185152; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Mei J, 2008, J GENET GENOMICS, V35, P17, DOI 10.1016/S1673-8527(08)60003-X; Mizuno K, 2010, TRENDS NEUROSCI, V33, P285, DOI 10.1016/j.tins.2010.03.001; Pakzad B, 2020, INT J RHEUM DIS, V23, P1594, DOI 10.1111/1756-185X.13981; Petersen PS, 2017, AM J PHYSIOL-ENDOC M, V312, pE309, DOI 10.1152/ajpendo.00344.2016; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Powell SB, 2009, BEHAV BRAIN RES, V204, P282, DOI 10.1016/j.bbr.2009.04.021; Pullabhatla V, 2018, HUM MOL GENET, V27, P421, DOI 10.1093/hmg/ddx407; REID KBM, 1976, BIOCHEM J, V155, P19, DOI 10.1042/bj1550019; Ricciarelli R, 2015, BRIT J PHARMACOL, V172, P4785, DOI 10.1111/bph.13257; Rodriguez S, 2016, AM J PHYSIOL-ENDOC M, V311, pE678, DOI 10.1152/ajpendo.00087.2016; Romeo RD, 2004, NEURON GLIA BIOL, V1, P219, DOI 10.1017/S1740925X05000086; Sarver DC, 2020, AM J PHYSIOL-ENDOC M, V319, pE1084, DOI 10.1152/ajpendo.00448.2020; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seigneur E, 2018, J NEUROSCI, V38, P4774, DOI 10.1523/JNEUROSCI.0360-18.2018; Seldin MM, 2014, REV ENDOCR METAB DIS, V15, P111, DOI 10.1007/s11154-013-9255-7; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Sigoillot SM, 2015, CELL REP, V10, P820, DOI 10.1016/j.celrep.2015.01.034; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tan SY, 2020, AM J PHYSIOL-ENDOC M, V319, pE146, DOI 10.1152/ajpendo.00533.2019; Tang YT, 2005, GENOMICS, V86, P100, DOI 10.1016/j.ygeno.2005.03.001; Terrillion CE, 2017, NEUROPSYCHOPHARMACOL, V42, P2242, DOI 10.1038/npp.2017.129; Thielens NM, 2017, MOL IMMUNOL, V89, P73, DOI 10.1016/j.molimm.2017.05.025; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Vester SK, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100513; Wang WS, 2018, J NEUROSCI, V38, P7935, DOI 10.1523/JNEUROSCI.0801-18.2018; Wei ZK, 2014, AM J PHYSIOL-ENDOC M, V306, pE779, DOI 10.1152/ajpendo.00593.2013; Wei ZK, 2013, J BIOL CHEM, V288, P10214, DOI 10.1074/jbc.M113.458711; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Wolf RM, 2016, AM J PHYSIOL-ENDOC M, V310, pE332, DOI 10.1152/ajpendo.00248.2015; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Xu WS, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.05.01; Yuzaki M, 2017, CURR OPIN NEUROBIOL, V45, P9, DOI 10.1016/j.conb.2017.02.002; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zhao WN, 2018, ACS CHEM NEUROSCI, V9, P2262, DOI 10.1021/acschemneuro.8b00116	78	1	1	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21910	10.1096/fj.202100733RR	http://dx.doi.org/10.1096/fj.202100733RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34610176	Green Accepted			2022-12-28	WOS:000712009200048
J	Chrobok, L; Jeczmien-Lazur, JS; Bubka, M; Pradel, K; Klekocinska, A; Klich, JD; Rahim, AR; Myung, J; Kepczynski, M; Lewandowski, MH				Chrobok, Lukasz; Jeczmien-Lazur, Jagoda Stanislawa; Bubka, Monika; Pradel, Kamil; Klekocinska, Aleksandra; Klich, Jasmin Daniela; Rahim, Amalia Ridla; Myung, Jihwan; Kepczynski, Mariusz; Lewandowski, Marian Henryk			Daily coordination of orexinergic gating in the rat superior colliculus-Implications for intrinsic clock activities in the visual system	FASEB JOURNAL			English	Article						circadian clock; multi-electrode array; orexin; superior colliculus; visual system	PROTEIN-COUPLED RECEPTORS; INTERGENICULATE LEAFLET; CIRCADIAN OSCILLATORS; HYPOCRETIN-OREXIN; NUCLEUS; NEURONS; IMMUNOREACTIVITY; BRAIN; TIME; HALLUCINATIONS	The orexinergic system delivers excitation for multiple brain centers to facilitate behavioral arousal, with its malfunction resulting in narcolepsy, somnolence, and notably, visual hallucinations. Since the circadian clock underlies the daily arousal, a timed coordination is expected between the orexin system and its target subcortical visual system, including the superior colliculus (SC). Here, we use a combination of electrophysiological, immunohistochemical, and molecular approaches across 24 h, together with the neuronal tract-tracing methods to investigate the daily coordination between the orexin system and the rodent SC. Higher orexinergic input was found to occur nocturnally in the superficial layers of the SC, in time for nocturnal silencing of spontaneous firing in this visual brain area. We identify autonomous daily and circadian expression of clock genes in the SC, which may underlie these day-night changes. Additionally, we establish the lateral hypothalamic origin of the orexin innervation to the SC and that the SC neurons robustly respond to orexin A via OX2 receptor in both excitatory and GABA(A) receptor-dependent inhibitory manners. Together, our evidence elucidates the combination of intrinsic and extrinsic clock mechanisms that shape the daily function of the visual layers of the SC.	[Chrobok, Lukasz; Jeczmien-Lazur, Jagoda Stanislawa; Pradel, Kamil; Klekocinska, Aleksandra; Klich, Jasmin Daniela; Lewandowski, Marian Henryk] Jagiellonian Univ Krakow, Inst Zool & Biomed Res, Dept Neurophysiol & Chronobiol, Gronostajowa St 9, PL-30387 Krakow, Poland; [Bubka, Monika] Jagiellonian Univ Krakow, Inst Zool & Biomed Res, Dept Glycoconjugate Biochem, Krakow, Poland; [Rahim, Amalia Ridla; Myung, Jihwan] Taipei Med Univ, Grad Inst Mind Brain & Consciousness, Taipei, Taiwan; [Myung, Jihwan] Taipei Med Univ, Brain & Consciousness Res Ctr, Shuang Ho Hosp, Minist Hlth & Welf, New Taipei, Taiwan; [Kepczynski, Mariusz] Jagiellonian Univ Krakow, Fac Chem, Dept Phys Chem & Electrochem, Krakow, Poland	Jagiellonian University; Jagiellonian University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Jagiellonian University	Chrobok, L; Lewandowski, MH (corresponding author), Jagiellonian Univ Krakow, Inst Zool & Biomed Res, Dept Neurophysiol & Chronobiol, Gronostajowa St 9, PL-30387 Krakow, Poland.	lukasz.chrobok@uj.edu.pl; marian.lewandowski@uj.edu.pl	Myung, Jihwan/D-2048-2013	Myung, Jihwan/0000-0002-2529-8013; Jeczmien-Lazur, Jagoda/0000-0002-3103-2887; Klich, Jasmin/0000-0003-2951-3582; Kepczynski, Mariusz/0000-0002-7304-6881	Polish National Science Centre [2018/28/C/NZ4/00099, 2017/27/N/NZ4/00785]; "Etiuda 8" doctoral scholarship [2020/36/T/NZ4/00341]; European Regional Development Fund [POIG.02.01.00-12-023/08]; Taiwan Ministry of Science and Technology [109-2320-B-038-020, 109-2314-B-038-071, 109-2314-B-038-106-MY3, 108-2321-B-006-023-MY2, 107-2410-H-038-004-MY2]; Taiwan Ministry of Education [DP2-109-21121-01-N-01, DP2-110-21121-01-N-01]; Taipei Medical University [TMU-107-AE1-B15, 107-3805-003-110, 107TMU-SHH-03]; Priority Research Area BioS under the program "Excellence Initiative-Research University" at the Jagiellonian University in Krakow	Polish National Science Centre; "Etiuda 8" doctoral scholarship; European Regional Development Fund(European Commission); Taiwan Ministry of Science and Technology; Taiwan Ministry of Education(Ministry of Education, Taiwan); Taipei Medical University; Priority Research Area BioS under the program "Excellence Initiative-Research University" at the Jagiellonian University in Krakow	This work was financially supported by a project "Sonatina 2" 2018/28/C/NZ4/00099 given to LC and "Preludium 14" 2017/27/N/NZ4/00785 to KP from the Polish National Science Centre. KP was additionally supported by "Etiuda 8" doctoral scholarship 2020/36/T/NZ4/00341. The research was carried out using equipment purchased through financial support from the European Regional Development Fund in the framework of the Polish Innovation Economy Operational Program (contract No. POIG.02.01.00-12-023/08). JM was supported by the Taiwan Ministry of Science and Technology (109-2320-B-038-020, 109-2314-B-038-071, 109-2314-B-038-106-MY3, 108-2321-B-006-023-MY2, 107-2410-H-038-004-MY2), the Higher Education Sprout Project by the Taiwan Ministry of Education (DP2-109-21121-01-N-01, DP2-110-21121-01-N-01), and Taipei Medical University (TMU-107-AE1-B15, 107-3805-003-110, 107TMU-SHH-03). The open-access publication of this article was funded by the Priority Research Area BioS under the program "Excellence Initiative-Research University" at the Jagiellonian University in Krakow.	Azeez IA, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01061; Bano-Otalora B, 2017, PHARMACOL BIOCHEM BE, V162, P46, DOI 10.1016/j.pbb.2017.06.007; Bayer L, 2004, J NEUROSCI, V24, P6760, DOI 10.1523/JNEUROSCI.1783-04.2004; Bayer L, 2002, J NEUROSCI, V22, P7835; Begemann K, 2020, ACTA PHYSIOL, V229, DOI 10.1111/apha.13446; Belle MDC, 2021, METHODS MOL BIOL, V2130, P263, DOI 10.1007/978-1-0716-0381-9_20; Belle MDC, 2018, EUR J NEUROSCI, V48, P2696, DOI 10.1111/ejn.13856; Belle MDC, 2017, EUR J NEUROSCI, V45, P723, DOI 10.1111/ejn.13506; Belle MDC, 2014, J NEUROSCI, V34, P3607, DOI 10.1523/JNEUROSCI.3388-13.2014; Cang JH, 2018, ANNU REV VIS SCI, V4, P239, DOI 10.1146/annurev-vision-091517-034142; Ch'ng SS, 2015, J CHEM NEUROANAT, V66-67, P1, DOI 10.1016/j.jchemneu.2015.03.002; Challet E, 2015, DIABETES OBES METAB, V17, P76, DOI 10.1111/dom.12516; Challet E, 2019, NAT REV ENDOCRINOL, V15, P393, DOI 10.1038/s41574-019-0210-x; Chrobok L, 2021, BRAIN RES, V1768, DOI 10.1016/j.brainres.2021.147603; Chrobok L, 2021, J PHYSIOL-LONDON, V599, P231, DOI 10.1113/JP280275; Chrobok L, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0960-y; Chrobok L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08202-8; Chrobok L, 2016, NEUROPHARMACOLOGY, V103, P236, DOI 10.1016/j.neuropharm.2015.12.008; Cluderay JE, 2002, REGUL PEPTIDES, V104, P131, DOI 10.1016/S0167-0115(01)00357-3; Cutler DJ, 1999, PEPTIDES, V20, P1455, DOI 10.1016/S0196-9781(99)00157-6; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Deboer T, 2004, NEUROSCIENCE, V129, P727, DOI 10.1016/j.neuroscience.2004.07.049; Erskine D, 2017, AM J GERIAT PSYCHIAT, V25, P595, DOI 10.1016/j.jagp.2017.01.005; Gandhi NJ, 2011, ANNU REV NEUROSCI, V34, P205, DOI 10.1146/annurev-neuro-061010-113728; Guilding C, 2010, NEUROSCIENCE, V169, P1630, DOI 10.1016/j.neuroscience.2010.06.015; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Guilding C, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-28; Han Y, 2020, NEUROSCI BULL, V36, P432, DOI 10.1007/s12264-019-00447-9; Ito S, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00010; Iyer R, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00164; Klisch C, 2009, EUR J NEUROSCI, V30, P65, DOI 10.1111/j.1460-9568.2009.06794.x; Krauzlis RJ, 2013, ANNU REV NEUROSCI, V36, P165, DOI 10.1146/annurev-neuro-062012-170249; Kukkonen JP, 2017, CURR TOP BEHAV NEURO, V33, P17, DOI 10.1007/7854_2016_49; Li SB, 2020, NEUROPHARMACOLOGY, V167, DOI 10.1016/j.neuropharm.2020.107993; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Marston OJ, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-19; Masullo L, 2019, CURR BIOL, V29, P2892, DOI 10.1016/j.cub.2019.07.083; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; McGranaghan PA, 2001, BRAIN RES, V904, P234, DOI 10.1016/S0006-8993(01)02463-5; Mei L, 2018, P NATL ACAD SCI USA, V115, P4276, DOI 10.1073/pnas.1717735115; Meredith MA, 1998, J NEUROPHYSIOL, V79, P1597, DOI 10.1152/jn.1998.79.3.1597; Muehlan C, 2020, EXPERT OPIN DRUG MET, V16, P1063, DOI 10.1080/17425255.2020.1817380; Myung J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03507-2; Myung J, 2012, J NEUROSCI, V32, P8900, DOI 10.1523/JNEUROSCI.5586-11.2012; Northeast RC, 2020, FASEB J, V34, P974, DOI 10.1096/fj.201901111R; Orlowska-Feuer P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53012-9; Pachitariu M., 2016, BIORXIV, DOI [10.1101/061481, DOI 10.1101/061481]; Palus K, 2015, NEUROSCIENCE, V300, P370, DOI 10.1016/j.neuroscience.2015.05.039; Palus-Chramiec K, 2019, EUR J NEUROSCI, V50, P2683, DOI 10.1111/ejn.14394; Paul JR, 2020, EUR J NEUROSCI, V51, P109, DOI 10.1111/ejn.14343; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pekala D, 2011, EUR J NEUROSCI, V34, P1406, DOI 10.1111/j.1460-9568.2011.07868.x; Peyron C, 1998, J NEUROSCI, V18, P9996; Qiao SN, 2017, INVEST OPHTH VIS SCI, V58, P4712, DOI 10.1167/iovs.17-21835; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Shine JM, 2014, PROG NEUROBIOL, V116, P58, DOI 10.1016/j.pneurobio.2014.01.004; Taheri S, 1999, FEBS LETT, V457, P157, DOI 10.1016/S0014-5793(99)01030-3; Taheri S, 2000, NEUROSCI LETT, V279, P109, DOI 10.1016/S0304-3940(99)00955-6; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Thompson MD, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00057; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; Webb IC, 2008, EUR J NEUROSCI, V27, P828, DOI 10.1111/j.1460-9568.2008.06074.x; Webb IC, 2014, BEHAV NEUROSCI, V128, P304, DOI 10.1037/a0035885; Whyland KL, 2020, J COMP NEUROL, V528, P308, DOI 10.1002/cne.24754; Xu YL, 2004, EUR J PHARMACOL, V500, P243, DOI 10.1016/j.ejphar.2004.07.029; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zeitzer JM, 2003, J NEUROSCI, V23, P3555; Zhang G, 2018, NEUROPHARMACOLOGY, V133, P38, DOI 10.1016/j.neuropharm.2018.01.007; Zhang SW, 2004, SLEEP, V27, P619, DOI 10.1093/sleep/27.4.619	69	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21930	10.1096/fj.202100779RR	http://dx.doi.org/10.1096/fj.202100779RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34533886	Green Published			2022-12-28	WOS:000702238200078
J	Goto, T; Sapio, MR; Maric, D; Robinson, JM; Domenichiello, AF; Saligan, LN; Mannes, AJ; Iadarola, MJ				Goto, Taichi; Sapio, Matthew R.; Maric, Dragan; Robinson, Jeffrey M.; Domenichiello, Anthony F.; Saligan, Leorey N.; Mannes, Andrew J.; Iadarola, Michael J.			Longitudinal peripheral tissue RNA-Seq transcriptomic profiling, hyperalgesia, and wound healing in the rat plantar surgical incision model	FASEB JOURNAL			English	Article						cytokines; macrophage; neutrophil; postoperative pain; wound healing	RESOLVING LIPID MEDIATORS; DORSAL-ROOT GANGLION; NATRIURETIC PEPTIDE; POSTOPERATIVE PAIN; INFLAMMATORY PAIN; SPINAL-CORD; MAST-CELL; SKIN; MMP-2; METALLOPROTEINASES	Postoperative pain and delayed healing in surgical wounds, which require complex management strategies have understudied complicated mechanisms. Here we investigated temporal changes in behavior, tissue structure, and transcriptomic profiles in a rat model of a surgical incision, using hyperalgesic behavioral tests, histological analyses, and next-generation RNA sequencing, respectively. The most rapidly (1 hour) expressed genes were the chemokines, Cxcl1 and Cxcl2. Consequently, infiltrating leukocytes were abundantly observed starting at 6 and peaking at 24 hours after incising which was supported by histological analysis and appearance of the neutrophil markers, S100a8 and S100a9. At this time, hyperalgesia was at a peak and overall transcriptional activity was most highly activated. At the 1-day timepoint, Nppb, coding for natriuretic peptide precursor B, was the most strongly upregulated gene and was localized by in situ hybridization to the epidermal keratinocytes at the margins of the incision. Nppb was basically unaffected in a peripheral inflammation model transcriptomic dataset. At the late phase of wound healing, five secreted, incision-specific peptidases, Mmp2, Aebp1, Mmp23, Adamts7, and Adamtsl1, showed increased expression, supporting the idea of a sustained tissue remodeling process. Transcripts that are specifically upregulated at each timepoint in the incision model may be potential candidates for either biomarkers or therapeutic targets for wound pain and wound healing. This study incorporates the examination of longitudinal temporal molecular responses, corresponding anatomical localization, and hyperalgesic behavioral alterations in the surgical incision model that together provide important and novel foundational knowledge to understand mechanisms of wound pain and wound healing.	[Goto, Taichi; Saligan, Leorey N.] NINR, Symptoms Biol Unit, NIH, Bethesda, MD 20892 USA; [Sapio, Matthew R.; Mannes, Andrew J.; Iadarola, Michael J.] NIH, Dept Perioperat Med, Clin Ctr, Bldg 10,Room 3D56,10 Ctr Dr,MSC 1510, Bethesda, MD 20892 USA; [Maric, Dragan] NINDS, Flow & Imaging Cytometry Core Facil, NIH, Bethesda, MD USA; [Robinson, Jeffrey M.] Univ Maryland, Translat Life Sci Technol Program, Baltimore, MD 21201 USA; [Domenichiello, Anthony F.] NIA, Lipid Peroxidat Unit, Lab Clin Invest, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Nursing Research (NINR); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Iadarola, MJ (corresponding author), NIH, Dept Perioperat Med, Clin Ctr, Bldg 10,Room 3D56,10 Ctr Dr,MSC 1510, Bethesda, MD 20892 USA.	michael.iadarola@nih.gov	Goto, Taichi/AAU-4349-2020; Saligan, Leorey/M-7101-2015; Iadarola, Michael/J-7145-2013; Sapio, Matthew R./J-5096-2016	Goto, Taichi/0000-0001-7140-8175; Saligan, Leorey/0000-0001-9481-7836; Iadarola, Michael/0000-0001-7188-9810; Sapio, Matthew R./0000-0002-8855-5419; Robinson, Jeffrey/0000-0002-1456-2851; Mannes, Andrew/0000-0001-5834-5667	HHS \ NIH \ National Institute of Nursing Research (NINR); National Institutes of Health Clinical Center; HHS \ NIH \ National Institute of Neurological Disorders and Stroke (NINDS)	HHS \ NIH \ National Institute of Nursing Research (NINR); National Institutes of Health Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHS \ NIH \ National Institute of Neurological Disorders and Stroke (NINDS)	HHS vertical bar NIH vertical bar National Institute of Nursing Research (NINR); National Institutes of Health Clinical Center; HHS vertical bar NIH vertical bar National Institute of Neurological Disorders and Stroke (NINDS)	Alexandre C, 2017, NAT MED, V23, P768, DOI 10.1038/nm.4329; Barr TP, 2014, PAIN, V155, P1091, DOI 10.1016/j.pain.2014.02.014; Basu A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24425-9; Binder JX, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau012; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; Bupp MRG, 2015, CELL IMMUNOL, V294, P102, DOI 10.1016/j.cellimm.2015.02.002; Carreira EU, 2013, EUR J PAIN, V17, P654, DOI 10.1002/j.1532-2149.2012.00240.x; Chiba T, 2016, J BIOL CHEM, V291, P14540, DOI 10.1074/jbc.M115.711267; Cho H, 2016, WOUND REPAIR REGEN, V24, P829, DOI 10.1111/wrr.12453; Cook H, 2000, J INVEST DERMATOL, V115, P225, DOI 10.1046/j.1523-1747.2000.00044.x; Dalli J, 2016, P NATL ACAD SCI USA, V113, P12232, DOI 10.1073/pnas.1607003113; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Dessing MC, 2015, KIDNEY INT, V87, P85, DOI 10.1038/ki.2014.216; Domenichiello AF, 2021, J PAIN, V22, P275, DOI 10.1016/j.jpain.2020.09.001; Ebrecht M, 2004, PSYCHONEUROENDOCRINO, V29, P798, DOI 10.1016/S0306-4530(03)00144-6; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Fivenson David P., 1997, Wound Repair and Regeneration, V5, P310, DOI 10.1046/j.1524-475X.1997.50405.x; Gan TJ, 2014, CURR MED RES OPIN, V30, P149, DOI 10.1185/03007995.2013.860019; Goswami SC, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-44; Goto T, 2021, J PAIN, V22, P322, DOI 10.1016/j.jpain.2020.11.001; Goto T, 2019, J WOUND CARE, V28, P762, DOI 10.12968/jowc.2019.28.11.762; Goto T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167478; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; IADAROLA MJ, 1985, BRAIN RES, V330, P127, DOI 10.1016/0006-8993(85)90013-7; Ishida Y, 2015, INT J LEGAL MED, V129, P1043, DOI 10.1007/s00414-015-1167-5; Joshi GP, 2012, BRIT J SURG, V99, P168, DOI 10.1002/bjs.7660; Kanno E, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225657; Kerkhoff C, 1999, J BIOL CHEM, V274, P32672, DOI 10.1074/jbc.274.46.32672; Khodorova A, 2002, J NEUROSCI, V22, P7788; Kiguchi N, 2016, J PHARMACOL EXP THER, V356, P596, DOI 10.1124/jpet.115.229997; Kroin JS, 2003, CAN J ANAESTH, V50, P904, DOI 10.1007/BF03018737; Kuhn M, 2012, BRIT J PHARMACOL, V166, P522, DOI 10.1111/j.1476-5381.2012.01827.x; LaPaglia DM, 2018, CEPHALALGIA, V38, P912, DOI 10.1177/0333102417720216; Layne MD, 2001, MOL CELL BIOL, V21, P5256, DOI 10.1128/MCB.21.15.5256-5261.2001; Lewis GP, 1986, MEDIAT INFLAMM; Li N, 2020, ELIFE, V9, DOI 10.7554/eLife.61050; Li ZW, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0685-y; Llorian-Salvador M, 2016, BASIC CLIN PHARMACOL, V119, P32, DOI 10.1111/bcpt.12543; Luo P, 2018, ACTA BIOCH BIOPH SIN, V50, P1219, DOI 10.1093/abbs/gmy123; MAJANE EA, 1983, BRAIN RES, V264, P336, DOI 10.1016/0006-8993(83)90837-5; McGuire L, 2006, ANN BEHAV MED, V31, P165, DOI 10.1207/s15324796abm3102_8; Meng JH, 2020, BRIT J PHARMACOL, V177, P1025, DOI 10.1111/bph.14952; Meng JH, 2018, J ALLERGY CLIN IMMUN, V141, P1677, DOI 10.1016/j.jaci.2017.12.1002; Moehring F, 2018, NEURON, V100, P349, DOI 10.1016/j.neuron.2018.10.019; Moehring F, 2018, ELIFE, V7, DOI [10.7554/elife.31684, 10.7554/eLife.31684]; Munoz LD, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239286; Munoz-Garcia A, 2014, BBA-MOL CELL BIOL L, V1841, P401, DOI 10.1016/j.bbalip.2013.08.020; Newbern J, 2010, SEMIN CELL DEV BIOL, V21, P922, DOI 10.1016/j.semcdb.2010.08.008; Nirmal AJ, 2018, CANCER IMMUNOL RES, V6, P1388, DOI 10.1158/2326-6066.CIR-18-0342; NODA M, 1982, NATURE, V295, P202, DOI 10.1038/295202a0; Nussbaum SR, 2018, VALUE HEALTH, V21, P27, DOI 10.1016/j.jval.2017.07.007; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Raithel SJ, 2018, ANESTHESIOLOGY, V128, P620, DOI 10.1097/ALN.0000000000002006; Rastogi S, 2011, NUCLEIC ACIDS RES, V39, pD230, DOI 10.1093/nar/gkq927; Raziyeva K, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11050700; Renaux A, 2018, NUCLEIC ACIDS RES, V46, P2699, DOI 10.1093/nar/gky092; Roberts M, 2012, PAIN MED, V13, P711, DOI 10.1111/j.1526-4637.2012.01359.x; Rose-John S, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028415; Rosen S, 2017, J NEUROSCI RES, V95, P500, DOI 10.1002/jnr.23831; Sahbaie P, 2012, ANESTHESIOLOGY, V117, P602, DOI 10.1097/ALN.0b013e3182655f9f; Samuelsson B, 2012, J BIOL CHEM, V287, P10070, DOI 10.1074/jbc.X112.351437; Sapio MR, 2020, J PAIN, V21, P988, DOI 10.1016/j.jpain.2020.01.001; Schug SA, 2021, J CLIN MED, V10, DOI 10.3390/jcm10112359; Seomun Y, 2008, J CELL BIOCHEM, V104, P934, DOI 10.1002/jcb.21675; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serhan CN, 2018, MOL ASPECTS MED, V64, P1, DOI 10.1016/j.mam.2017.08.002; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; Shime H, 2020, P NATL ACAD SCI USA, V117, P20696, DOI 10.1073/pnas.2000372117; Shipley JM, 1996, P NATL ACAD SCI USA, V93, P3942, DOI 10.1073/pnas.93.9.3942; Slominski AT, 2011, J INVEST DERMATOL, V131, P613, DOI 10.1038/jid.2010.376; Smith JR, 2020, NUCLEIC ACIDS RES, V48, pD731, DOI 10.1093/nar/gkz1041; Solinski HJ, 2019, CELL REP, V26, P3561, DOI 10.1016/j.celrep.2019.02.089; Spofford CM, 2012, ANESTHESIOLOGY, V117, P161, DOI 10.1097/ALN.0b013e31825a2a2b; Taira BR, 2008, ACAD EMERG MED, V15, P945, DOI 10.1111/j.1553-2712.2008.00243.x; Takeichi T, 2020, J CLIN INVEST, V130, P890, DOI 10.1172/JCI130675; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tran PV, 2020, MOL PAIN, V16, DOI 10.1177/1744806920956480; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vane JR, 2003, THROMB RES, V110, P255, DOI 10.1016/S0049-3848(03)00379-7; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; Wang SW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01298; Watanabe M, 2015, NEUROREPORT, V26, P173, DOI 10.1097/WNR.0000000000000322; Werz O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02538-5; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544; Wunsch H, 2016, JAMA-J AM MED ASSOC, V315, P1654, DOI 10.1001/jama.2016.0130; WYSOCKI AB, 1993, J INVEST DERMATOL, V101, P64, DOI 10.1111/1523-1747.ep12359590; Yamane T, 2020, AMINO ACIDS, V52, P505, DOI 10.1007/s00726-020-02831-6; Zhang FX, 2010, J NEUROSCI, V30, P10927, DOI 10.1523/JNEUROSCI.0657-10.2010; Zhang WW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0581-9; Zhang XJ, 2018, NAT MED, V24, P73, DOI 10.1038/nm.4451; Zheng YX, 2011, J BIOL CHEM, V286, P24046, DOI 10.1074/jbc.M111.251496; Zhong AM, 2016, AM J PATHOL, V186, P109, DOI 10.1016/j.ajpath.2015.09.005	98	1	1	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21852	10.1096/fj.202100347R	http://dx.doi.org/10.1096/fj.202100347R			35	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34499774	Green Published, hybrid			2022-12-28	WOS:000702238200076
J	Jana, S; Aujla, P; Hu, M; Kilic, T; Zhabyeyev, P; McCulloch, CA; Oudit, GY; Kassiri, Z				Jana, Sayantan; Aujla, Preetinder; Hu, Mei; Kilic, Tolga; Zhabyeyev, Pavel; McCulloch, Christopher A.; Oudit, Gavin Y.; Kassiri, Zamaneh			Gelsolin is an important mediator of Angiotensin II-induced activation of cardiac fibroblasts and fibrosis	FASEB JOURNAL			English	Article						AMPK; fibroblast; fibrosis; gelsolin	MYOCARDIAL-INFARCTION; AMPK; TARGET; INJURY; PHOSPHORYLATION; HYPERTROPHY; EXPRESSION; PATHOLOGY; FAILURE; TIMP3	Myocardial fibrosis is a characteristic of various cardiomyopathies, and myocardial fibroblasts play a central role in this process. Gelsolin (GSN) is an actin severing and capping protein that regulates actin assembly and may be involved in fibroblast activation. While the role of GSN in mechanical stress-mediated cardiac fibrosis has been explored, its role in myocardial fibrosis in the absence of mechanical stress is not defined. In this study, we investigated the role of GSN in myocardial fibrosis induced by Angiotensin II (Ang II), a profibrotic hormone that is elevated in cardiovascular disease. We utilized mice lacking GSN (Gsn(-/-)) and cultured primary adult cardiac fibroblasts (cFB). In vivo, Ang II infusion in mice resulted in significantly less severe myocardial fibrosis in Gsn(-/-) compared with Gsn(+/+) mice, along with diminished activation of the TGF beta 1-Smad2/3 pathway, and reduced expression of cardiac extracellular matrix proteins (collagen, fibronectin, periostin). Moreover, Gsn-deficient hearts exhibited suppressed activity of the AMPK pathway and its downstream effectors, mTOR and P70S6Kinase, which could contribute to the suppressed TGF beta 1 activity. In vitro, the Ang II-induced activation of cFBs was reduced in Gsn-deficient fibroblasts evident from decreased expression of alpha SMA and periostin, diminished actin filament turnover; which also exhibited reduced activity of the AMPK-mTOR pathway, and P70S6K phosphorylation. AMPK inhibition compensated for the loss of GSN, restored the levels of G-actin in Gsn(-/-) cFBs and promoted activation to myofibroblasts by increasing alpha SMA and periostin levels. This study reveals a novel role for GSN in mediating myocardial fibrosis by regulating the AMPK-mTOR-P70S6K pathway in cFB activation independent from mechanical stress-induced factors.	[Jana, Sayantan; Aujla, Preetinder; Hu, Mei; Kilic, Tolga; Zhabyeyev, Pavel; Oudit, Gavin Y.; Kassiri, Zamaneh] Univ Alberta, Cardiovasc Res Ctr, Dept Physiol, Edmonton, AB T6G 2S2, Canada; [Zhabyeyev, Pavel; Oudit, Gavin Y.] Univ Alberta, Cardiovasc Res Ctr, Mazankowski Alberta Heart Inst, Dept Med,Div Cardiol, Edmonton, AB, Canada; [McCulloch, Christopher A.] Univ Toronto, Fac Med & Dent, Toronto, ON, Canada	University of Alberta; University of Alberta; University of Toronto	Kassiri, Z (corresponding author), Univ Alberta, Cardiovasc Res Ctr, Dept Physiol, Edmonton, AB T6G 2S2, Canada.	z.kassiri@ualberta.ca		JANA, SAYANTAN/0000-0003-2855-1560	Canadian Institute for Health Research [CIHR-PJ-153328, CIHR-PJ-156266]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	Canadian Institute for Health Research, Grant/Award Number: CIHR-PJ-153328 and CIHR-PJ-156266	Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08; Angliker Nico, 2013, Bioarchitecture, V3, P113, DOI 10.4161/bioa.26497; Arora PD, 1996, J BIOL CHEM, V271, P20516, DOI 10.1074/jbc.271.34.20516; Beauloye C, 2011, CARDIOVASC RES, V90, P224, DOI 10.1093/cvr/cvr034; Becker PM, 2003, AM J RESP CELL MOL, V28, P478, DOI 10.1165/rcmb.2002-0024OC; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Burtnick L D, 2001, Results Probl Cell Differ, V32, P201; Chan MWC, 2009, J CELL SCI, V122, P2769, DOI 10.1242/jcs.044008; Chen CC, 2017, ONCOTARGET, V8, P77152, DOI 10.18632/oncotarget.20414; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; CUNNINGHAM CC, 1991, SCIENCE, V251, P1233, DOI 10.1126/science.1848726; Daskalopoulos EP, 2016, J MOL CELL CARDIOL, V91, P188, DOI 10.1016/j.yjmcc.2016.01.001; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; Fan D, 2014, CARDIOVASC RES, V103, P268, DOI 10.1093/cvr/cvu072; Gelinas R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02795-4; Han CS, 2013, EXP BIOL MED, V238, P1318, DOI 10.1177/1535370213503256; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Jana S, 2020, ARTERIOSCL THROM VAS, V40, P1918, DOI 10.1161/ATVBAHA.120.314600; Jana S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010427; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; Kandalam V, 2010, CIRC RES, V106, P796, DOI 10.1161/CIRCRESAHA.109.209189; Kim SW, 2019, INVEST OPHTH VIS SCI, V60, P82, DOI 10.1167/iovs.18-25376; Kiuru-Enari S, 2013, HAND CLINIC, V115, P659, DOI 10.1016/B978-0-444-52902-2.00039-4; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kusano H, 2000, ONCOGENE, V19, P4807, DOI 10.1038/sj.onc.1203868; Lader AS, 1999, AM J PHYSIOL-CELL PH, V277, pC1277, DOI 10.1152/ajpcell.1999.277.6.C1277; Leifeld L, 2006, AM J PATHOL, V168, P778, DOI 10.2353/ajpath.2006.050323; Li GH, 2009, CIRC RES, V104, P896, DOI 10.1161/CIRCRESAHA.108.172882; Li JZ, 2015, KIDNEY INT, V88, P515, DOI 10.1038/ki.2015.119; Li X, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181767; Li Y, 2014, ARCH BIOCHEM BIOPHYS, V558, P79, DOI 10.1016/j.abb.2014.06.023; Moon S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04376; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Oikonomou N, 2009, THORAX, V64, P467, DOI 10.1136/thx.2008.107946; Opie LH, 2001, CIRC RES, V88, P654, DOI 10.1161/hh0701.089175; Patel VB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07812-8; Rettinger CL, 2018, J OCUL PHARMACOL TH, V34, P521, DOI 10.1089/jop.2018.0021; Schrickel JW, 2009, J INTERV CARD ELECTR, V26, P3, DOI 10.1007/s10840-009-9425-4; Shen MC, 2015, ARTERIOSCL THROM VAS, V35, P888, DOI 10.1161/ATVBAHA.114.305115; Solomon JP, 2012, CRIT REV BIOCHEM MOL, V47, P282, DOI 10.3109/10409238.2012.661401; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Takawale A, 2017, AM J PHYSIOL-HEART C, V313, pH224, DOI 10.1152/ajpheart.00108.2017; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Wang DJ, 2004, J BIOL CHEM, V279, P43725, DOI 10.1074/jbc.M407368200; Whyte M, 2009, THORAX, V64, P461, DOI 10.1136/thx.2008.110577; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Zhang L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020390	47	3	3	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21932	10.1096/fj.202100038RR	http://dx.doi.org/10.1096/fj.202100038RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34549830				2022-12-28	WOS:000702238200075
J	Kern, P; Balzer, NR; Blank, N; Cygon, C; Wunderling, K; Bender, F; Frolov, A; Sowa, JP; Bonaguro, L; Ulas, T; Homrich, M; Kiermaier, E; Thiele, C; Schultze, JL; Canbay, A; Bauer, R; Mass, E				Kern, Paul; Balzer, Nora R.; Blank, Nelli; Cygon, Cornelia; Wunderling, Klaus; Bender, Franziska; Frolov, Alex; Sowa, Jan-Peter; Bonaguro, Lorenzo; Ulas, Thomas; Homrich, Mirka; Kiermaier, Eva; Thiele, Christoph; Schultze, Joachim L.; Canbay, Ali; Bauer, Reinhard; Mass, Elvira			Creld2 function during unfolded protein response is essential for liver metabolism homeostasis	FASEB JOURNAL			English	Article						Creld2; ER stress; liver steatosis; NASH; UPR	ENDOPLASMIC-RETICULUM STRESS; HIGH-FAT DIET; ER STRESS; HEPATIC STEATOSIS; LIPID-METABOLISM; INSULIN-RESISTANCE; GLUCOSE; ACTIVATION; DISEASE; MICE	The unfolded protein response (UPR) is associated with hepatic metabolic function, yet it is not well understood how endoplasmic reticulum (ER) disturbance might influence metabolic homeostasis. Here, we describe the physiological function of Cysteine-rich with EGF-like domains 2 (Creld2), previously characterized as a downstream target of the ER-stress signal transducer Atf6. To this end, we generated Creld2-deficient mice and induced UPR by injection of tunicamycin. Creld2 augments protein folding and creates an interlink between the UPR axes through its interaction with proteins involved in the cellular stress response. Thereby, Creld2 promotes tolerance to ER stress and recovery from acute stress. Creld2-deficiency leads to a dysregulated UPR and causes the development of hepatic steatosis during ER stress conditions. Moreover, Creld2-dependent enhancement of the UPR assists in the regulation of energy expenditure. Furthermore, we observed a sex dimorphism in human and mouse livers with only male patients showing an accumulation of CRELD2 protein during the progression from non-alcoholic fatty liver disease to non-alcoholic steatohepatitis and only male Creld2-deficient mice developing hepatic steatosis upon aging. These results reveal a Creld2 function at the intersection between UPR and metabolic homeostasis and suggest a mechanism in which chronic ER stress underlies fatty liver disease in males.	[Kern, Paul; Balzer, Nora R.; Blank, Nelli; Cygon, Cornelia; Frolov, Alex; Mass, Elvira] Univ Bonn, Life & Med Sci LIMES Inst, Dev Biol Immune Syst, D-53115 Bonn, Germany; [Kern, Paul; Bender, Franziska; Bauer, Reinhard] Univ Bonn, Life & Med Sci LIMES Inst, Dev Genet & Mol Physiol, Bonn, Germany; [Wunderling, Klaus; Thiele, Christoph] Univ Bonn, Life & Med Sci LIMES Inst, Biochem & Cell Biol Lipids, Bonn, Germany; [Sowa, Jan-Peter; Canbay, Ali] Univ Hosp Magdeburg, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany; [Sowa, Jan-Peter; Canbay, Ali] Ruhr Univ Bochum, Univ Hosp Knappschaftskrankenhaus Bochum, Dept Med, Bochum, Germany; [Bonaguro, Lorenzo; Ulas, Thomas; Schultze, Joachim L.] Univ Bonn, Life & Med Sci LIMES Inst, Genom & Immunoregulat, Bonn, Germany; [Bonaguro, Lorenzo; Ulas, Thomas; Schultze, Joachim L.] Univ Bonn, Deutsch Zentrum Neurodegenerat Erkrankungen DZNE, Platform Single Cell Genom & Epigen, Bonn, Germany; [Homrich, Mirka; Kiermaier, Eva] Univ Bonn, Life & Med Sci LIMES Inst, Immune & Tumor Biol, Bonn, Germany; [Schultze, Joachim L.] Deutsch Zentrum Neurodegenerat Erkrankungen DZNE, Syst Med, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University Hospital Magdeburg; Ruhr University Bochum; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Mass, E (corresponding author), Univ Bonn, Life & Med Sci LIMES Inst, Dev Biol Immune Syst, D-53115 Bonn, Germany.	emass@uni-bonn.de	Schultze, Joachim L./ABA-8176-2020; Mass, Elvira/AAH-3805-2019	Schultze, Joachim L./0000-0003-2812-9853; Mass, Elvira/0000-0003-2318-2356; Kiermaier, Eva/0000-0001-6165-5738	Fritz Thyssen Stiftung (Fritz Thyssen Foundation) [Az.10.18.2.029MN]; Deutsche Forschungsgemeinschaft (DFG) [EXC2151-390873048, CA267/14-1]; Bundesministerium fur Bildung und Forschung (BMBF) [01EA1809A]; Daimler und Benz Stiftung (Daimler and Benz Foundation) [32-058/18]	Fritz Thyssen Stiftung (Fritz Thyssen Foundation); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Daimler und Benz Stiftung (Daimler and Benz Foundation)	Fritz Thyssen Stiftung (Fritz Thyssen Foundation), Grant/Award Number: Az.10.18.2.029MN; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: EXC2151-390873048 and CA267/14-1; Bundesministerium fur Bildung und Forschung (BMBF), Grant/Award Number: DietBB (01EA1809A); Daimler und Benz Stiftung (Daimler and Benz Foundation), Grant/Award Number: 32-058/18	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Alberti A, 2009, AM J PHYSIOL-ENDOC M, V297, pE812, DOI 10.1152/ajpendo.00053.2009; Ballestri S, 2017, ADV THER, V34, P1291, DOI 10.1007/s12325-017-0556-1; Beckert V, 2021, J MOL CELL CARDIOL, V156, P45, DOI 10.1016/j.yjmcc.2021.03.008; Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Board PG, 2013, BBA-GEN SUBJECTS, V1830, P3267, DOI 10.1016/j.bbagen.2012.11.019; Bonaguro L, 2020, NAT IMMUNOL, V21, P1517, DOI 10.1038/s41590-020-00811-2; Boyle ST, 2020, NAT CELL BIOL, V22, P882, DOI 10.1038/s41556-020-0523-y; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Chen DL, 2012, BIOCHEM BIOPH RES CO, V426, P324, DOI 10.1016/j.bbrc.2012.08.072; Chen MF, 2019, BONE JOINT RES, V8, P179, DOI 10.1302/2046-3758.84.BJR-2018-0291.R1; D'Alessandro M, 2018, ELIFE, V7, DOI 10.7554/eLife.39649; Dennis EP, 2020, J BONE MINER RES, V35, P1452, DOI 10.1002/jbmr.4010; DeZwaan-McCabe D, 2017, CELL REP, V19, P1794, DOI 10.1016/j.celrep.2017.05.020; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gloeckner Christian Johannes, 2009, Methods Mol Biol, V564, P359, DOI 10.1007/978-1-60761-157-8_21; Gonen N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38705-5; Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595; Hartley CL, 2013, HUM MOL GENET, V22, P5262, DOI 10.1093/hmg/ddt383; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hodeify R, 2013, AM J PHYSIOL-RENAL, V304, pF875, DOI 10.1152/ajprenal.00590.2012; Horna-Terron E, 2014, INT J MOL SCI, V15, P23501, DOI 10.3390/ijms151223501; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kim Y, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92896; Kurek K, 2014, LIVER INT, V34, P1074, DOI 10.1111/liv.12331; Leek JT, 2019, SVA SURROGATE VARIAB; Lefere S, 2019, JHEP REP, V1, P30, DOI 10.1016/j.jhepr.2019.02.004; Liu GM, 2019, PATHOL RES PRACT, V215, DOI 10.1016/j.prp.2019.152510; Lonardo A, 2019, HEPATOBIL SURG NUTR, V8, P164, DOI 10.21037/hbsn.2018.12.04; Longato L, 2012, HEPATOL RES, V42, P412, DOI 10.1111/j.1872-034X.2011.00934.x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Mass E, 2014, DEV CELL, V28, P711, DOI 10.1016/j.devcel.2014.02.012; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Medrikova D, 2012, INT J OBESITY, V36, P262, DOI 10.1038/ijo.2011.87; Musso G, 2018, GASTROENTEROLOGY, V155, P282, DOI 10.1053/j.gastro.2018.06.031; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oh-hashi K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30362-4; Oh-hashi K, 2011, FEBS LETT, V585, P2481, DOI 10.1016/j.febslet.2011.06.029; Oh-Hashi K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-664; Oh-hashi K, 2009, BIOCHEM BIOPH RES CO, V387, P504, DOI 10.1016/j.bbrc.2009.07.047; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Palmisano BT, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00044; Pibiri M, 2018, AGING-US, V10, P1801, DOI 10.18632/aging/101524; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rupp PA, 2002, GENE, V293, P47, DOI 10.1016/S0378-1119(02)00696-0; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Savic S, 2014, J AUTOIMMUN, V50, P59, DOI 10.1016/j.jaut.2013.11.002; Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128; Song MJ, 2019, PHARMACOL THERAPEUT, V203, DOI 10.1016/j.pharmthera.2019.107401; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; Usui M, 2012, METABOLISM, V61, P1118, DOI 10.1016/j.metabol.2012.01.004; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang CX, 2010, CELL RES, V20, P174, DOI 10.1038/cr.2010.4; Wang SD, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01539; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52; Zhang Z, 2019, REDOX BIOL, V25, DOI 10.1016/j.redox.2018.11.005	66	3	3	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21939	10.1096/fj.202002713RR	http://dx.doi.org/10.1096/fj.202002713RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34549824	Green Submitted			2022-12-28	WOS:000702238200063
J	Nakamura, T; Tachibana, Y; Murata, T				Nakamura, Tatsuro; Tachibana, Yuri; Murata, Takahisa			8-iso-prostaglandin E-2 induces nasal obstruction via thromboxane receptor in murine model of allergic rhinitis	FASEB JOURNAL			English	Article						8-iso-PGE(2); allergic rhinitis; isoprostane; nasal obstruction; thromboxane receptor	OXIDATIVE STRESS; MAST-CELLS; RHO KINASE; A(2); ISOPROSTANES; INFLAMMATION; GENERATION; BLOCKAGE; IGE	Thromboxane receptor (TP) mediates nasal obstruction, a typical symptom of allergic rhinitis. Since it has been reported that several types of eicosanoids, such as non-enzymatic oxidation product of arachidonic acid isoprostane, act as a TP ligand, there is a possibility that some other eicosanoids contribute to the TP-mediated nasal obstruction. The aim of this study is to investigate the mechanisms of TP-mediated nasal obstruction. Intranasal challenges of ovalbumin (OVA) induced nasal obstruction in mice. Pharmacological blockade of TP receptor but not thromboxane A(2) synthase inhibited OVA-induced nasal obstruction. Simultaneous analysis of eicosanoids in nasal lavage fluid and the responses in trans-endothelial resistance suggested that 8-iso-prostaglandin E-2 (PGE(2)) can be a candidate for TP ligand. Intranasal challenge of 8-iso-PGE(2) induced vascular hyperpermeability and nasal obstruction in TP receptor-dependent manner. Wholemount immunostaining of nasal septum mucosa revealed that 8-iso-PGE(2) increased plasma leakage accompanied by distention of venous sinusoids. This study shows that 8-iso-PGE(2) is a contributor in TP-mediated nasal obstruction in mice.	[Nakamura, Tatsuro; Tachibana, Yuri; Murata, Takahisa] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Tokyo, Japan	University of Tokyo	Murata, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan.	amurata@mail.ecc.u-tokyo.ac.jp		Murata, Takahisa/0000-0002-3328-0796	MEXT \ Japan Society for the Promotion of Science (JSPS) [20H05678, 17H06252, 18K14603]; Kobayashi Foundation; Shimadzu Science Foundation; Takeda Science Foundation	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kobayashi Foundation; Shimadzu Science Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 20H05678, 17H06252 and 18K14603; Kobayashi Foundation; Shimadzu Science Foundation; Takeda Science Foundation	Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Ashina K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132367; Audoly LP, 2000, CIRCULATION, V101, P2833, DOI 10.1161/01.CIR.101.24.2833; Bowler RP, 2002, J ALLERGY CLIN IMMUN, V110, P349, DOI 10.1067/mai.2002.126780; Brash JT, 2018, JOVE-J VIS EXP, DOI 10.3791/57524; BROWN MS, 1987, ARCH OTOLARYNGOL, V113, P179; CAUNA N, 1975, ANAT REC, V181, P1, DOI 10.1002/ar.1091810102; Ciebiada M, 2014, ARCH MED SCI, V10, P1123, DOI [10.5114/aoms.2014.47655, 10.5114/aoms.2015.47655]; Demoly P, 2020, NPJ PRIM CARE RESP M, V30, DOI 10.1038/s41533-020-00195-8; Ellinsworth DC, 2014, CARDIOVASC RES, V102, P9, DOI 10.1093/cvr/cvu015; Foegh ML, 1986, FRONTIERS PERITONEAL, P610; Gratziou C, 2008, INT J IMMUNOPATH PH, V21, P949, DOI 10.1177/039463200802100419; Hanazawa T, 2000, AM J RESP CRIT CARE, V162, P1273, DOI 10.1164/ajrccm.162.4.9912064; Huang JS, 2004, CELL SIGNAL, V16, P521, DOI 10.1016/j.cellsig.2003.10.008; Huber J, 2003, ANTIOXID REDOX SIGN, V5, P163, DOI 10.1089/152308603764816523; HULSMANN AR, 1994, AM J RESP CRIT CARE, V149, P519, DOI 10.1164/ajrccm.149.2.8306055; Ichimura K., 2010, Clinical and Experimental Allergy Reviews, V10, P20; Janssen LJ, 2001, BRIT J PHARMACOL, V132, P127, DOI 10.1038/sj.bjp.0703784; JOHNSTON SL, 1995, EUR RESPIR J, V8, P411, DOI 10.1183/09031936.95.08030411; Kobayashi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep32109; LEWIS RA, 1981, NATURE, V293, P103, DOI 10.1038/293103a0; Liu T, 1999, J BIOMED SCI, V6, P226, DOI 10.1159/000025391; MAIS DE, 1990, EICOSANOIDS, V3, P121; MCCORMICK ML, 1994, J BIOL CHEM, V269, P27914; Mita H, 1999, PROSTAG LEUKOTR ESS, V60, P175, DOI 10.1054/plef.1999.0022; Miyahara S, 2005, J ALLERGY CLIN IMMUN, V116, P1020, DOI 10.1016/j.jaci.2005.08.020; Mizutani N, 2001, JPN J PHARMACOL, V86, P170, DOI 10.1254/jjp.86.170; Shedden Arthur, 2005, Treat Respir Med, V4, P439, DOI 10.2165/00151829-200504060-00007; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Takahashi G, 2012, INT ARCH ALLERGY IMM, V158, P359, DOI 10.1159/000334555; Tanaka Y, 2006, PROSTAG OTH LIPID M, V80, P144, DOI 10.1016/j.prostaglandins.2006.06.003; Terada N, 1998, ACTA OTO-LARYNGOL, P32; Wright DT, 1996, AM J PHYSIOL-LUNG C, V271, pL854, DOI 10.1152/ajplung.1996.271.5.L854; Yamasaki M, 1997, J PHARMACOL EXP THER, V280, P1471; Yamazaki A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234634	35	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21941	10.1096/fj.202100827R	http://dx.doi.org/10.1096/fj.202100827R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34559928				2022-12-28	WOS:000702238200054
J	Mensali, N; Dillard, P; Fayzullin, A; Koksal, H; Gaudernack, G; Kvalheim, G; Inderberg, EM; Walchli, S				Mensali, Nadia; Dillard, Pierre; Fayzullin, Artem; Koksal, Hakan; Gaudernack, Gustav; Kvalheim, Gunnar; Inderberg, Else Marit; Walchli, Sebastien			"Built-in" PD-1 blocker to rescue NK-92 activity from PD-L1-mediated tumor escape mechanisms	FASEB JOURNAL			English	Article						adoptive cell transfer; antitumor immunity; NK-92; programmed cell death protein 1; programmed death-ligand 1; tumor microenvironment	NATURAL-KILLER-CELL; CAR T-CELLS; CHECKPOINT BLOCKADE; IMMUNE CHECKPOINTS; ANTI-PD-1 ANTIBODY; CANCER; THERAPY; IMMUNOTHERAPY; EXPRESSION; SAFETY	Success of adoptive cell therapy mainly depends on the ability of immune cells to persist and function optimally in the immunosuppressive tumor microenvironment. Although present at the cancer site, immune cells become exhausted and/or inhibited, due to the presence of inhibitory receptors such as PD-L1 on malignant cells. Novel genetic strategies to manipulate the PD1/PD-L1 axis comprise (i) PD-1 reversion where the receptor intracellular domain is replaced with an activating unit, (ii) the use of anti-PD-L1 CAR or (iii) the disruption of the PD-1 gene. We here present an alternative strategy to equip therapeutic cells with a truncated PD-1 (tPD-1) to abrogate PD-1/PD-L1 inhibition. We show that engagement of tPD-1 with PD-L1-positive tumor unleashes NK-92 activity in vitro. Furthermore, this binding was sufficiently strong to induce killing of targets otherwise not recognized by NK-92, thus increasing the range of targets. In vivo treatment with NK-92 tPD-1 cells led to reduced tumor growth and improved survival. Importantly, tPD-1 did not interfere with tumor recognition in PD-L1 negative conditions. Thus, tPD-1 represents a straightforward method for improving antitumor immunity and revealing new targets through PD-L1 positivity.	[Mensali, Nadia; Dillard, Pierre; Fayzullin, Artem; Koksal, Hakan; Kvalheim, Gunnar; Inderberg, Else Marit; Walchli, Sebastien] Oslo Univ Hosp, Dept Cellular Therapy, Norwegian Radium Hosp, Oslo, Norway; [Gaudernack, Gustav] Oslo Univ Hosp, Dept Canc Immunol, Norwegian Radium Hosp, Oslo, Norway	University of Oslo; University of Oslo	Inderberg, EM; Walchli, S (corresponding author), Oslo Univ Hosp, Dept Cellular Therapy, Norwegian Radium Hosp, Oslo, Norway.	elsmar@rr-research.no; sebastw@rr-research.no		Walchli, Sebastien/0000-0001-5869-1746	Norwegian Cancer Society [6829007]; Research Council of Norway [254817]; South-Eastern Norway Regional Health Authority [2016006]	Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority	The Norwegian Cancer Society, Grant/Award Number: 6829007; The Research Council of Norway, Grant/Award Number: 254817; Innovation grant from South-Eastern Norway Regional Health Authority, Grant/Award Number: 14170; South-Eastern Norway Regional Health Authority, Grant/Award Number: 2016006	Alsaab HO, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00561; Ankri C, 2013, J IMMUNOL, V191, P4121, DOI 10.4049/jimmunol.1203085; Arai S, 2008, CYTOTHERAPY, V10, P625, DOI 10.1080/14653240802301872; Beane JD., 2014, J IMMUNOTHER CANCER, V2, pP2, DOI [10.1186/2051-1426-2-S3-P2, DOI 10.1186/2051-1426-2-S3-P2]; Benson DM, 2010, BLOOD, V116, P2286, DOI 10.1182/blood-2010-02-271874; Bossi G, 1999, NAT MED, V5, P90, DOI 10.1038/4779; Boutros C, 2016, NAT REV CLIN ONCOL, V13, P473, DOI 10.1038/nrclinonc.2016.58; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Burshtyn DN, 2010, METHODS MOL BIOL, V612, P89, DOI 10.1007/978-1-60761-362-6_7; Cherkassky L, 2016, J CLIN INVEST, V126, P3130, DOI 10.1172/JCI83092; Chong EA, 2017, BLOOD, V129, P1039, DOI 10.1182/blood-2016-09-738245; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Dyck L, 2017, EUR J IMMUNOL, V47, P765, DOI 10.1002/eji.201646875; Fabian KP, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000450; Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469; Gong J, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0316-z; Hsu J, 2018, J CLIN INVEST, V128, P4654, DOI 10.1172/JCI99317; Hu WH, 2019, CANCER IMMUNOL IMMUN, V68, P365, DOI 10.1007/s00262-018-2281-2; Hu WL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01205; Huemer F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082856; Inderberg EM, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1302631; Ishida M, 2002, IMMUNOL LETT, V84, P57, DOI 10.1016/S0165-2478(02)00142-6; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; John LB, 2013, CLIN CANCER RES, V19, P5636, DOI 10.1158/1078-0432.CCR-13-0458; Klingemann H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00091; Koksal H, 2019, BLOOD ADV, V3, P1230, DOI 10.1182/bloodadvances.2018029678; Kotanides H, 2020, CANCER IMMUNOL RES, V8, P1300, DOI 10.1158/2326-6066.CIR-20-0304; Li S, 2017, CLIN CANCER RES, V23, P6982, DOI 10.1158/1078-0432.CCR-17-0867; Lin DYW, 2008, P NATL ACAD SCI USA, V105, P3011, DOI 10.1073/pnas.0712278105; Liu XJ, 2017, CELL RES, V27, P154, DOI 10.1038/cr.2016.142; Liu XJ, 2016, CANCER RES, V76, P1578, DOI 10.1158/0008-5472.CAN-15-2524; Lu Y, 2020, NAT MED, V26, P732, DOI 10.1038/s41591-020-0840-5; Mariotti FR, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2018.1557030; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; Maude SL, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.103; McGowan E, 2020, BIOMED PHARMACOTHER, V121, DOI 10.1016/j.biopha.2019.109625; Mensali N, 2019, EBIOMEDICINE, V40, P106, DOI 10.1016/j.ebiom.2019.01.031; Myers JA, 2021, NAT REV CLIN ONCOL, V18, P85, DOI 10.1038/s41571-020-0426-7; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; Oelsner S, 2017, CYTOTHERAPY, V19, P235, DOI 10.1016/j.jcyt.2016.10.009; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Pardoll DM, 2012, NAT IMMUNOL, V13, P1129, DOI 10.1038/ni.2392; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Park JH, 2018, NEW ENGL J MED, V378, P449, DOI 10.1056/NEJMoa1709919; Park JE, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-000873; Pentcheva-Hoang T, 2007, P NATL ACAD SCI USA, V104, P17765, DOI 10.1073/pnas.0708767104; Pesce S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01242; Pesce S, 2017, J ALLERGY CLIN IMMUN, V139, P335, DOI 10.1016/j.jaci.2016.04.025; Prosser ME, 2012, MOL IMMUNOL, V51, P263, DOI 10.1016/j.molimm.2012.03.023; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Rataj F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01955; Robbins Y, 2020, ELIFE, V9, DOI 10.7554/eLife.54854; Rupp LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00462-8; Schuster SJ, 2017, NEW ENGL J MED, V377, P2545, DOI 10.1056/NEJMoa1708566; Stadtmauer EA, 2020, SCIENCE, V367, P1001, DOI 10.1126/science.aba7365; Su S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20070; Suarez ER, 2016, ONCOTARGET, V7, P34341, DOI 10.18632/oncotarget.9114; Suck G, 2016, TRANSFUS MED HEMOTH, V43, P89, DOI 10.1159/000445325; Suck G, 2016, CANCER IMMUNOL IMMUN, V65, P485, DOI 10.1007/s00262-015-1761-x; Themeli M, 2015, CELL STEM CELL, V16, P357, DOI 10.1016/j.stem.2015.03.011; Themeli M, 2013, NAT BIOTECHNOL, V31, P928, DOI 10.1038/nbt.2678; Tonn T, 2001, J HEMATOTH STEM CELL, V10, P535, DOI 10.1089/15258160152509145; Tonn T, 2013, CYTOTHERAPY, V15, P1563, DOI 10.1016/j.jcyt.2013.06.017; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Waiseng E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11126-y; Walchli B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027930; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Yagita M, 2000, LEUKEMIA, V14, P922, DOI 10.1038/sj.leu.2401769; Yoon DH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020340; Zakrzewski JL, 2008, NAT BIOTECHNOL, V26, P453, DOI 10.1038/nbt1395; Zakrzewski JL, 2006, NAT MED, V12, P1039, DOI 10.1038/nm1463	73	3	3	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21750	10.1096/fj.202100025R	http://dx.doi.org/10.1096/fj.202100025R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34424568				2022-12-28	WOS:000691122900064
J	Hu, WH; Cai, CH; Li, YH; Kang, F; Chu, TW; Dong, SW				Hu, Wenhui; Cai, Chenhui; Li, Yuheng; Kang, Fei; Chu, Tongwei; Dong, Shiwu			Farnesoid X receptor agonist attenuates subchondral bone osteoclast fusion and osteochondral pathologies of osteoarthritis via suppressing JNK1/2/NFATc1 pathway	FASEB JOURNAL			English	Article						farnesoid X receptor; JNK1; 2; NFATc1 pathway; osteoarthritis; osteoclastogenesis; subchondral bone	CRUCIATE LIGAMENT TRANSECTION; MESENCHYMAL STEM-CELLS; CARTILAGE DEGRADATION; ARTICULAR-CARTILAGE; BILE-ACID; INHIBITION; KNEE; MODELS; INJURY; PAIN	Osteoarthritis (OA) is a prevalent degenerative disease of the joint, featured by articular cartilage destruction and subchondral bone marrow lesions. Articular cartilage and subchondral bone constitute an osteochondral unit that guarantees joint homeostasis. During OA initiation, activated osteoclasts in subchondral bone ultimately result in impaired capacities of the subchondral bone in response to mechanical stress, followed by the degradation of overlying articular cartilage. Thus, targeting osteoclasts could be a potential therapeutic option for treating OA. Here, we observed that farnesoid X receptor (FXR) expression and osteoclast fusion and activity in subchondral bone were concomitantly changed during early-stage OA in the OA mouse model established by anterior cruciate ligament transection (ACLT). Then, we explored the therapeutic effects of FXR agonist GW4064 on the osteochondral pathologies in ACLT mice. We showed that GW4064 obviously ameliorated subchondral bone deterioration, associated with reduction in tartrate-resistant acid phosphatase (TRAP) positive multinuclear osteoclast number, as well as articular cartilage degradation, which were blocked by the treatment with FXR antagonist Guggulsterone. Mechanistically, GW4064 impeded osteoclastogenesis through inhibiting subchondral bone osteoclast fusion via suppressing c-Jun N-terminal kinase (JNK) 1/2/nuclear factor of activated T-cells 1 (NFATc1) pathway. Taken together, our results present evidence for the protective effects of GW4064 against OA by blunting osteoclast-mediated aberrant subchondral bone loss and subsequent cartilage deterioration. Therefore, GW4064 demonstrates the potential as an alternative therapeutic option against OA for further drug development.	[Hu, Wenhui; Li, Yuheng; Kang, Fei; Dong, Shiwu] Third Mil Med Univ, Army Med Univ, Coll Biomed Engn, Dept Biomed Mat Sci, Chongqing, Peoples R China; [Cai, Chenhui; Chu, Tongwei] Third Mil Med Univ, Army Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China; [Dong, Shiwu] Third Mil Med Univ, Army Med Univ, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Dong, SW (corresponding author), Third Mil Med Univ, Dept Biomed Mat Sci, Chongqing 400038, Peoples R China.; Chu, TW (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing 400037, Peoples R China.	chtw@sina.com; dongshiwu@163.com		Hu, Wenhui/0000-0002-8886-7260	Key Program of Natural Science Foundation of China [81930067]; Project of Nature Science Foundation of China [31870962]; Medical Innovation of Graduate Students in Chongqing [CYS20372]; General Program of Natural Science Foundation of Chongqing [cstc2019jcyj--msxmX0176]	Key Program of Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Innovation of Graduate Students in Chongqing; General Program of Natural Science Foundation of Chongqing	This work was supported by grants from the Key Program of Natural Science Foundation of China (81930067), the Project of Nature Science Foundation of China (31870962), the Medical Innovation of Graduate Students in Chongqing (CYS20372), and the General Program of Natural Science Foundation of Chongqing (cstc2019jcyj--msxmX0176).	Andriacchi TP, 2020, OSTEOARTHRITIS CARTI, V2; Bingham CO, 2006, ARTHRITIS RHEUM-US, V54, P3494, DOI 10.1002/art.22160; Burr DB, 2012, NAT REV RHEUMATOL, V8, P665, DOI 10.1038/nrrheum.2012.130; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Chang EJ, 2008, J CELL SCI, V121, P2555, DOI 10.1242/jcs.028217; Chang Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082904; Chatziravdeli V, 2019, CURR GENOMICS, V20, P184, DOI 10.2174/1389202920666190422142053; Chen D, 2017, BONE RES, V5, DOI 10.1038/boneres.2016.44; Cho SW, 2013, J BONE MINER RES, V28, P2109, DOI 10.1002/jbmr.1961; Conaghan PG, 2019, NAT REV RHEUMATOL, V15, P355, DOI 10.1038/s41584-019-0221-y; Contartese D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103696; Cosenza S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15376-8; Coughlin TR, 2016, ANN NY ACAD SCI, V1383, P58, DOI 10.1111/nyas.13261; Cui Z, 2016, ANN RHEUM DIS, V75, P1714, DOI 10.1136/annrheumdis-2015-207923; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deng JZ, 2021, FASEB J, V35, DOI 10.1096/fj.202100135R; Dong YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060943; Edd SN, 2018, OSTEOARTHR CARTILAGE, V26, P1425, DOI 10.1016/j.joca.2018.06.017; Fang C, 2022, ACTA PHARMACOL SIN, V43, P1299, DOI 10.1038/s41401-021-00747-9; Fang H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21184-5; Gao XL, 2018, CARDIOVASC RES, V114, P737, DOI 10.1093/cvr/cvy011; Gianotti SM, 2009, J SCI MED SPORT, V12, P622, DOI 10.1016/j.jsams.2008.07.005; Goldring SR, 2016, NAT REV RHEUMATOL, V12, P632, DOI 10.1038/nrrheum.2016.148; Goldring SR, 2012, THER ADV MUSCULOSKEL, V4, P249, DOI 10.1177/1759720X12437353; Han CY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072069; Hayami T, 2006, BONE, V38, P234, DOI 10.1016/j.bone.2005.08.007; Hayami T, 2012, BONE, V50, P1250, DOI 10.1016/j.bone.2012.03.025; Hu WH, 2021, ANN RHEUM DIS, V80, P413, DOI 10.1136/annrheumdis-2020-218089; Hu Y, 2021, BONE RES, V9, DOI 10.1038/s41413-021-00147-z; Huang XJ, 2018, BIOMED PHARMACOTHER, V107, P433, DOI 10.1016/j.biopha.2018.07.161; Hunter DJ, 2019, LANCET, V393, P1745, DOI 10.1016/S0140-6736(19)30417-9; Kitagawa F, 2013, TISSUE ENG PART C-ME, V19, P438, DOI [10.1089/ten.tec.2012.0166, 10.1089/ten.TEC.2012.0166]; Krenn V, 2006, HISTOPATHOLOGY, V49, P358, DOI 10.1111/j.1365-2559.2006.02508.x; Li GY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4405; Lu ZY, 2017, CHEM-BIOL INTERACT, V277, P62, DOI 10.1016/j.cbi.2017.08.011; Ma HL, 2007, OSTEOARTHR CARTILAGE, V15, P695, DOI 10.1016/j.joca.2006.11.005; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Ma L, 2021, INT J MOL MED, V47, DOI 10.3892/ijmm.2021.4855; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Meyer EG, 2008, AM J SPORT MED, V36, P1966, DOI 10.1177/0363546508318046; Park DR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18208-y; Pastoureau PC, 2010, OSTEOARTHR CARTILAGE, V18, pS106, DOI 10.1016/j.joca.2010.05.024; Prodromos CC, 2007, ARTHROSCOPY, V23, P1320, DOI 10.1016/j.arthro.2007.07.003; Qin HJ, 2019, BONE, V125, P140, DOI 10.1016/j.bone.2019.05.010; Sekiguchi Y, 2017, MOL MED REP, V16, P1328, DOI 10.3892/mmr.2017.6752; Shaktivesh, 2019, J MECH BEHAV BIOMED, V90, P388, DOI 10.1016/j.jmbbm.2018.10.023; Sharma AR, 2013, INT J MOL SCI, V14, P19805, DOI 10.3390/ijms141019805; Siebelt M, 2014, BONE, V66, P163, DOI 10.1016/j.bone.2014.06.009; Tavares SJS, 2021, FITOTERAPIA, V150, DOI 10.1016/j.fitote.2021.104842; Srikanth VK, 2005, OSTEOARTHR CARTILAGE, V13, P769, DOI 10.1016/j.joca.2005.04.014; Strassle BW, 2010, OSTEOARTHR CARTILAGE, V18, P1319, DOI 10.1016/j.joca.2010.06.007; Tamimi I, 2020, BONE, V140, DOI 10.1016/j.bone.2020.115558; Tateiwa D, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080818; Temp J, 2020, OSTEOARTHR CARTILAGE, V28, P475, DOI 10.1016/j.joca.2019.11.003; Urizar NL, 2000, J BIOL CHEM, V275, P39313, DOI 10.1074/jbc.M007998200; van Meer BL, 2015, BRIT J SPORT MED, V49, P975, DOI 10.1136/bjsports-2013-093258; Vincent TL, 2019, SEMIN ARTHRITIS RHEU, V49, pS36, DOI 10.1016/j.semarthrit.2019.09.018; Wang TT, 2018, CYTOKINE GROWTH F R, V44, P38, DOI 10.1016/j.cytogfr.2018.10.002; Yahara Y, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.622035; Zeng C, 2015, OSTEOARTHR CARTILAGE, V23, P189, DOI 10.1016/j.joca.2014.11.014; Zeng QY, 2020, CHEM-BIOL INTERACT, V327, DOI 10.1016/j.cbi.2020.109179; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143; Zheng Ting, 2017, J Bone Metab, V24, P207, DOI 10.11005/jbm.2017.24.4.207; Zheng T, 2017, ONCOTARGET, V8, P76558, DOI 10.18632/oncotarget.20576; Zhou F, 2019, ACTA PHARM SIN B, V9, P973, DOI 10.1016/j.apsb.2019.01.015; Zhu M, 2013, FASEB J, V27, P3344, DOI 10.1096/fj.12-220228; Zhu SA, 2019, J CLIN INVEST, V129, P1076, DOI 10.1172/JCI121561; Zhu XB, 2021, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.607764	68	0	0	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22243	10.1096/fj.202101717R	http://dx.doi.org/10.1096/fj.202101717R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CU	35224782				2022-12-28	WOS:000772945800001
J	Sun, YW; Zhang, Y; Zhang, D; Wang, GQ; Song, L; Liu, ZY				Sun, Yuwei; Zhang, Yu; Zhang, Di; Wang, Guangqin; Song, Lei; Liu, Zhiyong			In vivo CRISPR-Cas9-mediated DNA chop identifies a cochlear outer hair cell-specific enhancer	FASEB JOURNAL			English	Article						cochlea; CRISPR/Cas9; inner ear; outer hair cells; Prestin	MOTOR PROTEIN; THYROID-HORMONE; INNER-EAR; VOLTAGE-SENSOR; PRESTIN; EXPRESSION; MEMBRANE; GENE; MICE; ELECTROMOTILITY	Cochlear outer hair cells (OHCs) are essential for hearing. A short, OHC-specific enhancer is necessary but not yet available for gene therapeutic applications in OHC damage. Such damage is a major cause of deafness. Prestin is a motor protein exclusively expressed in OHCs. We hypothesized that the cis-regulatory DNA fragment deletion of Slc26a5 would affect its expression. We tested this hypothesis by conducting CRISPR/Cas9-mediated large DNA fragment deletion of mouse Slc26a5 intron regions. First, starting from a similar to 13 kbp fragment, step-by-step, we narrowed down the sequence to a 1.4 kbp segment. By deleting either a 13 kbp or 1.4 kbp fragment, we observed delayed Prestin expression. Second, we showed that 1.4 kbp was an OHC-specific enhancer because enhanced green fluorescent protein (EGFP) was highly and specifically expressed in OHCs in a transgenic mouse where Rill' was driven by the 1.4 kbp segment. More importantly, specific RIR' was also driven by its homologous 398 by fragment in human Slc26a5. This suggests that the enhancer is likely to be evolutionarily conserved across different species.	[Sun, Yuwei; Zhang, Di; Wang, Guangqin; Liu, Zhiyong] Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Inst Neurosci, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Sun, Yuwei; Zhang, Di; Wang, Guangqin; Liu, Zhiyong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Yu; Song, Lei] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China; [Zhang, Yu; Song, Lei] Shanghai Jiao Tong Univ, Sch Med, Ear Inst, Shanghai, Peoples R China; [Liu, Zhiyong] Shanghai Ctr Brain Sci & Brain Inspired Intellige, Shanghai, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, ZY (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Inst Neurosci, State Key Lab Neurosci, Shanghai 200031, Peoples R China.; Song, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ear Inst, Shanghai, Peoples R China.	lei.song@yale.edu; Zhiyongliu@ion.ac.cn	SUN, YUWEI/GXF-6274-2022	Sun, Yuwei/0000-0001-6375-3358; WANG, GUANGQIN/0000-0002-8613-7619; LIU, ZHIYONG/0000-0002-9675-1233	National Natural Science Foundation of China [81770995, 2018YFC1003003, 81771012]; National Key R&D Program of China [2017YFA0103901]; Strategic Priority Research Program of Chinese Academy of Science [XDB32060100]; Shanghai Municipal Science and Technology Major Project [2018SHZDZX05]; Innovative Research Team of High--Level Local Universities in Shanghai; Shanghai Key Laboratory of Translational Medicine on Ear and Nose diseases [14DZ2260300]; Chinese Thousand Young Talents Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Strategic Priority Research Program of Chinese Academy of Science; Shanghai Municipal Science and Technology Major Project; Innovative Research Team of High--Level Local Universities in Shanghai; Shanghai Key Laboratory of Translational Medicine on Ear and Nose diseases; Chinese Thousand Young Talents Program	National Natural Science Foundation of China (81771012), National Key R&D Program of China (2017YFA0103901), Strategic Priority Research Program of Chinese Academy of Science (XDB32060100), Chinese Thousand Young Talents Program, Shanghai Municipal Science and Technology Major Project (2018SHZDZX05), Innovative Research Team of High--Level Local Universities in Shanghai (Z.L). National Natural Science Foundation of China (81770995) & (2018YFC1003003) to L.S. and Shanghai Key Laboratory of Translational Medicine on Ear and Nose diseases (14DZ2260300)	Abe T, 2007, J MEMBRANE BIOL, V215, P49, DOI 10.1007/s00232-007-9004-5; Adler HJ, 2003, HEARING RES, V184, P27, DOI 10.1016/S0378-5955(03)00192-8; Ashmore J F, 1990, Neurosci Res Suppl, V12, pS39, DOI 10.1016/0921-8696(90)90007-P; Bai JP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52965-1; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Brown RP, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-110; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Cai TT, 2013, J NEUROSCI, V33, P10110, DOI 10.1523/JNEUROSCI.5606-12.2013; Chan CSK., 2020, DEVELOPMENT, V147; Cheatham MA, 2005, J PHYSIOL-LONDON, V569, P229, DOI 10.1113/jphysiol.2005.093518; Chen P, 2002, DEVELOPMENT, V129, P2495; Chessum L, 2018, NATURE, V563, P696, DOI 10.1038/s41586-018-0728-4; Driver EC, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.162263; Fang J, 2012, GENESIS, V50, P124, DOI 10.1002/dvg.20810; Groves AK, 2013, ANNU REV NEUROSCI, V36, P361, DOI 10.1146/annurev-neuro-062012-170309; Homma K., 2021, HEARING RES; Jeng JY, 2020, J PHYSIOL-LONDON, V598, P3891, DOI 10.1113/JP279795; Knipper M, 2001, J BIOL CHEM, V276, P39046, DOI 10.1074/jbc.M103385200; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Legendre K, 2008, J CELL SCI, V121, P3347, DOI 10.1242/jcs.028134; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Li C, 2020, ELIFE, V9, DOI 10.7554/eLife.50491; Li C, 2020, DEV DYNAM, V249, P173, DOI 10.1002/dvdy.111; Li C, 2018, HEARING RES, V364, P12, DOI 10.1016/j.heares.2018.04.006; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Liu ZY, 2012, J NEUROSCI, V32, P6600, DOI 10.1523/JNEUROSCI.0818-12.2012; Lorenzen SM, 2015, MECH DEVELOP, V138, P233, DOI 10.1016/j.mod.2015.11.001; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Petitpre C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06033-3; Ruel J, 2008, AM J HUM GENET, V83, P278, DOI 10.1016/j.ajhg.2008.07.008; Rybalchenko V, 2003, J PHYSIOL-LONDON, V547, P873, DOI 10.1113/jphysiol.2002.036434; Santos-Sacchi J, 2006, J NEUROSCI, V26, P3992, DOI 10.1523/JNEUROSCI.4548-05.2006; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 2002, PFLUG ARCH EUR J PHY, V444, P99, DOI 10.1007/s00424-002-0804-2; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Shrestha BR, 2018, CELL, V174, P1229, DOI 10.1016/j.cell.2018.07.007; Song L, 2005, BIOPHYS J, V88, P2350, DOI 10.1529/biophysj.104.053579; Song L, 2008, JARO-J ASSOC RES OTO, V9, P464, DOI 10.1007/s10162-008-0140-0; Song L, 2013, P NATL ACAD SCI USA, V110, P3883, DOI 10.1073/pnas.1218341110; Sun SH, 2018, CELL, V174, P1247, DOI 10.1016/j.cell.2018.07.008; Sun SH, 2021, ELIFE, V10, DOI 10.7554/eLife.66547; Tateya T, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.177881; Teitz T, 2018, J EXP MED, V215, P1187, DOI 10.1084/jem.20172246; Wang GQ, 2021, DEVELOPMENT, V148, DOI 10.1242/dev.196899; Weber T, 2002, P NATL ACAD SCI USA, V99, P2901, DOI 10.1073/pnas.052609899; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wiwatpanit T, 2018, NATURE, V563, P691, DOI 10.1038/s41586-018-0570-8; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Yamashita T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005500; Yamashita T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045453; Zhang H, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.168906; Zhang XD, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109097; Zhang Y., 2021, HEARING RES; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2003, MAMM GENOME, V14, P87, DOI 10.1007/s00335-002-2227-y; Zuo EW, 2017, CELL RES, V27, P933, DOI 10.1038/cr.2017.81	60	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22233	10.1096/fj.202100421RR	http://dx.doi.org/10.1096/fj.202100421RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CY	35225354				2022-12-28	WOS:000772946200001
J	Li, H; Su, YS; He, W; Zhang, JB; Zhang, Q; Jing, XH; Zhan, LB				Li, Han; Su, Yang-Shuai; He, Wei; Zhang, Jian-Bin; Zhang, Qi; Jing, Xiang-Hong; Zhan, Li-Bin			The nonneuronal cholinergic system in the colon: A comprehensive review	FASEB JOURNAL			English	Review						ACh synthesis; bidirectional regulation; colonic functions; nonneuronal cholinergic systems	ORGANIC CATION TRANSPORTERS; MESENCHYMAL TRANSITION EMT; STEM-CELLS; ACETYLCHOLINE-RECEPTORS; ACTIVATION; RELEASE; STIMULATION; INCREASES; INTEGRITY; MIGRATION	Acetylcholine (ACh) is found not only in cholinergic nerve termini but also in the nonneuronal cholinergic system (NNCS). ACh is released from cholinergic nerves by vesicular ACh transporter (VAChT), but ACh release from the NNCS is mediated by organic cation transporter (OCT). Recent studies have suggested that components of the NNCS are located in intestinal epithelial cells (IECs), crypt-villus organoids, immune cells, intestinal stem cells (ISCs), and vascular endothelial cells (VECs). When ACh enters the interstitial space, its self-modulation or effects on adjacent tissues are part of the range of its biological functions. This review focuses on the current understanding of the mechanisms of ACh synthesis and release in the NNCS. Furthermore, studies on ACh functions in colonic disorders suggest that ACh from the NNCS contributes to immune regulation, IEC and VEC repair, ISC differentiation, colonic movement, and colonic tumor development. As indicated by the features of some colonic disorders, ACh and the NNCS have positive and negative effects on these disorders. Furthermore, the NNCS is located in multiple colonic organs, and the specific effects and cross-talk involving ACh from the NNCS in different colonic tissues are explored.	[Li, Han; Zhang, Qi] Nanjing Univ Chines, Changzhou TCM Hosp, Changzhou, Peoples R China; [Li, Han; Zhan, Li-Bin] Nanjing Univ Chinese Med, Nanjing, Peoples R China; [Su, Yang-Shuai; He, Wei; Jing, Xiang-Hong] China Acad Chinese Med Sci, Res Ctr Meridians, Inst Acupuncture & Moxibust, Beijing, Peoples R China; [Zhang, Jian-Bin] Nanjing Univ Chinese Med, Affiliated Hosp 2, Nanjing, Peoples R China; [Zhan, Li-Bin] Liaoning Univ Tradit Chinese Med, 79 Congshan East Rd, Shenyang 110847, Liaoning, Peoples R China	Nanjing University of Chinese Medicine; China Academy of Chinese Medical Sciences; Institute of Acupuncture & Moxibustion, CACMS; Nanjing University of Chinese Medicine; Liaoning University of Traditional Chinese Medicine	Zhan, LB (corresponding author), Liaoning Univ Tradit Chinese Med, 79 Congshan East Rd, Shenyang 110847, Liaoning, Peoples R China.; Jing, XH (corresponding author), China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, 16 Nanxiao St, Beijing 100700, Peoples R China.	jxhtjb@263.net; zlbln@lnutcm.edu.cn	Jing, Xianghong/HHS-4003-2022	Li, Han/0000-0002-6745-1987	National Key R&D Program of China [2019YFC1709002]; National Natural Science Foundation of China [81973947, 81730111, 82004453]; Natural Science Foundation of Nanjing University of Chinese Medicine [XZR2020043]; Jiangsu Province Chinese Medicine Science and Technology Development Program [YB201951]; Changzhou SciTech Program [CJ 20190070]; Changzhou Municipal Health Commission Science and Technology Program; Changzhou Municipal Health Qing Miao talent training Program [CZQM2020083]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Nanjing University of Chinese Medicine; Jiangsu Province Chinese Medicine Science and Technology Development Program; Changzhou SciTech Program; Changzhou Municipal Health Commission Science and Technology Program; Changzhou Municipal Health Qing Miao talent training Program	All authors thank the funds supporting from National Key R&D Program of China (2019YFC1709002), National Natural Science Foundation of China (No. 81973947, 81730111 and 82004453), Natural Science Foundation of Nanjing University of Chinese Medicine (No. XZR2020043), Jiangsu Province Chinese Medicine Science and Technology Development Program (No. YB201951), Changzhou Sci&Tech Program (No. CJ 20190070), Changzhou Municipal Health Commission Science and Technology Program (No. QN 201939), and Changzhou Municipal Health Qing Miao talent training Program (No. CZQM2020083).	Akhtar MH, 2017, BIOSENS BIOELECTRON, V98, P364, DOI 10.1016/j.bios.2017.07.003; Bader S, 2019, PFLUG ARCH EUR J PHY, V471, P605, DOI 10.1007/s00424-018-2236-7; Bader S, 2014, EUR J PHARMACOL, V733, P23, DOI 10.1016/j.ejphar.2014.03.036; Becker C, 2015, ILAR J, V56, P192, DOI 10.1093/ilar/ilv030; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Cheng KR, 2008, AM J PHYSIOL-GASTR L, V295, pG591, DOI 10.1152/ajpgi.00055.2008; Cox MA, 2020, J INTERN MED, V287, P120, DOI 10.1111/joim.13006; Curtis BJ, 2012, J INVEST DERMATOL, V132, P28, DOI 10.1038/jid.2011.264; Deng XM, 2011, CURR PHARM DESIGN, V17, P1643, DOI 10.2174/138161211796197007; Dhawan S, 2015, ACTA PHYSIOL, V213, P846, DOI 10.1111/apha.12469; Dhawan S, 2012, LIFE SCI, V91, P1038, DOI 10.1016/j.lfs.2012.04.042; Fujii T, 2012, LIFE SCI, V91, P981, DOI 10.1016/j.lfs.2012.04.031; Gaydukov AE, 2016, NEUROSCI LETT, V628, P17, DOI 10.1016/j.neulet.2016.06.014; Gersemann M, 2011, WORLD J GASTROENTERO, V17, P3198, DOI 10.3748/wjg.v17.i27.3198; Ghia JE, 2007, AM J PHYSIOL-GASTR L, V293, pG560, DOI 10.1152/ajpgi.00098.2007; Gomes JP, 2018, PHARMACOL RES, V128, P101, DOI 10.1016/j.phrs.2017.10.005; Gori S, 2017, ALLERGY, V72, P221, DOI 10.1111/all.12926; Grandi A, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00809; Himmerkus N, 2010, PFLUG ARCH EUR J PHY, V460, P177, DOI 10.1007/s00424-009-0780-x; Hirota CL, 2006, CAN J PHYSIOL PHARM, V84, P1153, DOI 10.1139/Y06-068; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Jiang W, 2017, P NATL ACAD SCI USA, V114, pE6202, DOI 10.1073/pnas.1705491114; Jiang XH, 2009, BIOCHEM BIOPH RES CO, V387, P521, DOI 10.1016/j.bbrc.2009.07.060; Jonsson M, 2007, INFLAMM BOWEL DIS, V13, P1347, DOI 10.1002/ibd.20224; Jragh DM, 2011, MED PRIN PRACT, V20, P530, DOI 10.1159/000328419; Kakinuma Y, 2005, FEBS LETT, V579, P2111, DOI 10.1016/j.febslet.2005.02.065; Kawashima K, 2008, J PHARMACOL SCI, V106, P167, DOI 10.1254/jphs.FM0070073; Khan MRI, 2015, FEBS LETT, V589, P3640, DOI 10.1016/j.febslet.2015.10.029; Khan MRI, 2013, J GASTROENTEROL, V48, P885, DOI 10.1007/s00535-012-0718-5; Kurabayashi A, 2018, DIABETES RES CLIN PR, V139, P288, DOI 10.1016/j.diabres.2018.03.009; Lee WK, 2009, AM J PHYSIOL-RENAL, V296, pF1504, DOI 10.1152/ajprenal.90754.2008; Lesko S, 2013, CELLS TISSUES ORGANS, V197, P411, DOI 10.1159/000345437; Lewartowski B, 2015, J PHYSIOL PHARMACOL, V66, P773; Lund ML, 2018, MOL METAB, V11, P70, DOI 10.1016/j.molmet.2018.03.004; Metcalfe C, 2014, CELL STEM CELL, V14, P149, DOI 10.1016/j.stem.2013.11.008; Montalbano AM, 2014, EUR J PHARMACOL, V736, P35, DOI 10.1016/j.ejphar.2014.04.022; Muramatsu I, 2017, J NEUROCHEM, V143, P76, DOI 10.1111/jnc.14127; Nassenstein C, 2015, INT IMMUNOPHARMACOL, V29, P173, DOI 10.1016/j.intimp.2015.08.007; Nittala R, 2020, CLIN GASTROENTEROL H, V18, P3057, DOI 10.1016/j.cgh.2020.02.038; Oikawa S, 2014, CELL PHYSIOL BIOCHEM, V34, P781, DOI 10.1159/000363042; Principi Mariabeatrice, 2013, J Crohns Colitis, V7, pe427, DOI 10.1016/j.crohns.2013.02.001; Qin HY, 2019, LIFE SCI, V239, DOI 10.1016/j.lfs.2019.116886; Qin HY, 2019, J MED FOOD, V22, P663, DOI 10.1089/jmf.2018.4264; Ramirez VT, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007719; Raufman JP, 2011, BIOCHEM BIOPH RES CO, V415, P319, DOI 10.1016/j.bbrc.2011.10.052; Reardon C, 2013, P NATL ACAD SCI USA, V110, P1410, DOI 10.1073/pnas.1221655110; Reichrath S, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.63; Rodrigues HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078342; Rogler G, 2014, CANCER LETT, V345, P235, DOI 10.1016/j.canlet.2013.07.032; Rooks MG, 2014, ISME J, V8, P1403, DOI 10.1038/ismej.2014.3; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Russo P, 2014, CURR MOL MED, V14, P1126, DOI 10.2174/1566524014666141015152601; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; SASTRY BVR, 1978, PHARMACOL REV, V30, P65; Saw EL, 2018, J MOL CELL CARDIOL, V125, P129, DOI 10.1016/j.yjmcc.2018.10.013; Spindel Eliot R, 2012, Handb Exp Pharmacol, P451, DOI 10.1007/978-3-642-23274-9_19; Sun P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069424; Takahashi T, 2019, METHODS MOL BIOL, V1576, P145, DOI 10.1007/7651_2016_1; Takahashi T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030738; Takahashi T, 2014, FEBS J, V281, P4672, DOI 10.1111/febs.12974; Takemura Y, 2013, AM J PHYSIOL-LUNG C, V304, pL428, DOI 10.1152/ajplung.00129.2012; Toledo-Ibarra GA, 2016, VET IMMUNOL IMMUNOP, V176, P58, DOI 10.1016/j.vetimm.2016.05.010; Vivinus-Nebot M, 2014, GUT, V63, P744, DOI 10.1136/gutjnl-2012-304066; Wang RC, 2020, NATURE, V580, P386, DOI 10.1038/s41586-020-2127-x; Wei PL, 2011, ANN SURG ONCOL, V18, P1782, DOI 10.1245/s10434-010-1504-3; Wei PL, 2009, ANN SURG, V249, P978, DOI 10.1097/SLA.0b013e3181a6ce7e; Wessler I, 2015, INT IMMUNOPHARMACOL, V29, P27, DOI 10.1016/j.intimp.2015.04.039; Wolf-Johnston AS, 2012, LIFE SCI, V91, P1065, DOI 10.1016/j.lfs.2012.04.028; Yajima M, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12759; Zhang C, 2016, J CHROMATOGR B, V1022, P265, DOI 10.1016/j.jchromb.2016.04.024; Zhang YY, 2014, ACTA PHARMACOL SIN, V35, P1137, DOI 10.1038/aps.2014.38; Zhao QN, 2015, ONCOTARGET, V6, P29335, DOI 10.18632/oncotarget.5004; Zhao QN, 2015, CANCER BIOL THER, V16, P634, DOI 10.1080/15384047.2015.1029835	74	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22165	10.1096/fj.202101529R	http://dx.doi.org/10.1096/fj.202101529R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35174565				2022-12-28	WOS:000761250800055
J	Lin, YF; Shen, XM; Ke, YZ; Lan, C; Chen, XY; Liang, B; Zhang, YZ; Yan, SJ				Lin, Youfen; Shen, Ximei; Ke, Yuzhen; Lan, Chao; Chen, Xiaoyuan; Liang, Bo; Zhang, Yongze; Yan, Sunjie			Activation of osteoblast ferroptosis via the METTL3/ASK1-p38 signaling pathway in high glucose and high fat (HGHF)-induced diabetic bone loss	FASEB JOURNAL			English	Article						diabetes mellitus; ferroptosis; glycolipid toxicity; m(6)A modifications; osteoporosis	IRON; MICROSTRUCTURE; OSTEOPOROSIS; APOPTOSIS; MELLITUS; RECEPTOR; OBESITY; STRESS; METTL3; MODEL	Diabetes mellitus (DM) and osteoporosis are two common diseases that may develop as a cause-and-effect relationship since the incidence of osteoporotic fractures is significantly increased in DM patients. However, the pathophysiology of diabetic osteoporosis is yet to be clearly understood. Iron overload has been reported to lead to bone loss and closely related to osteoporosis. In this study, we hypothesized that high glucose and high fat (HGHF) may induce osteoblastic ferroptosis for the pathogenesis of diabetic osteoporosis and explored the possible molecular mechanisms behind. Using the diabetic rat model established by HGHF feeding with a subsequent intraperitoneal injection of a single low dose of streptozocin, we found that the serum ferritin level (a biomarker for body iron store) was significantly elevated in HGHF-fed rats and the expression of SLC7A11 and GPX4 (inhibitory marker proteins for ferroptosis) was markedly attenuated in the bone tissue of the rats with diabetic bone loss as compared to the normal rats. In an osteoblast cell model, treatment of pre-osteoblastic MC3T3-E1 cells with high glucose and palmitic acid (HGPA) not only suppressed osteoblast differentiation and mineralization but also triggered ferroptosis-related osteoblastic cell death. m(6)A-seq revealed that m(6)A methylation on ASK1 was 80.9-fold higher in HGPA-treated cells. The expression of p-ASK1 and p-p38 was also significantly elevated in the HGPA-treated cells. Knockout of METTL3 (methyltransferase-like 3), one of the major m(6)A methyltransferases, in MC3T3-E1 cells not only abrogated HGPA-induced activation of ASK1-p38 signaling pathway but also attenuated the level of ferroptosis. Therefore, HGHF-induced ferroptosis in osteoblasts may be the main cause of osteoporosis in DM via activation of METTL3/ASK1-p38 signaling pathway, and inhibition of ferroptosis in osteoblasts may provide a potential therapeutic strategy for diabetic osteoporosis.	[Lin, Youfen; Shen, Ximei; Ke, Yuzhen; Lan, Chao; Chen, Xiaoyuan; Liang, Bo; Zhang, Yongze; Yan, Sunjie] Fujian Med Univ, Dept Endocrinol, Affiliated Hosp 1, 20 Cha Zhong Rd, Fuzhou 350005, Fujian, Peoples R China; [Shen, Ximei; Yan, Sunjie] Fujian Med Univ, Clin Res Ctr Metab Dis Fujian Prov, Affiliated Hosp 1, Fuzhou, Peoples R China; [Shen, Ximei; Yan, Sunjie] Fujian Med Univ, Diabet Res Inst Fujian Prov, Affiliated Hosp 1, Fuzhou, Peoples R China; [Shen, Ximei; Yan, Sunjie] Fujian Med Univ, Metab Dis Res Inst, Affiliated Hosp 1, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University; Fujian Medical University; Fujian Medical University	Yan, SJ (corresponding author), Fujian Med Univ, Dept Endocrinol, Affiliated Hosp 1, 20 Cha Zhong Rd, Fuzhou 350005, Fujian, Peoples R China.	fjyansunjie@163.com	Chen, Xiao/GQA-8928-2022	Chen, Xiao/0000-0002-9797-8384	Fujian Province Finance Project [2019B033]; Nature Science Foundation of Fujian Province [2020J02052]; Joint Funds for the Innovation of Science and Technology, Fujian Province [2019Y9110]; Startup Fund for Scientific Research of Fujian Medical University [2019QH2036]	Fujian Province Finance Project; Nature Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Joint Funds for the Innovation of Science and Technology, Fujian Province; Startup Fund for Scientific Research of Fujian Medical University	Fujian Province Finance Project, Grant/Award Number: 2019B033; Nature Science Foundation of Fujian Province, Grant/Award Number: 2020J02052; Joint Funds for the Innovation of Science and Technology, Fujian Province, Grant/Award Number: 2019Y9110; Startup Fund for Scientific Research of Fujian Medical University, Grant/Award Number: 2019QH2036	Al Saedi A, 2020, J GERONTOL A-BIOL, V75, P58, DOI 10.1093/gerona/glz149; Allen CS, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001347.pub2; Altamura S, 2017, J MOL MED, V95, P1387, DOI 10.1007/s00109-017-1596-3; Asadipooya K, 2019, J ENDOCR SOC, V3, P1799, DOI 10.1210/js.2019-00160; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Canecki-Varzic S, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0094-x; Che JM, 2020, BIOL TRACE ELEM RES, V195, P353, DOI 10.1007/s12011-019-01867-4; Chen HL, 2018, MEDICINE, V97, DOI [10.1097/MD.0000000000010432, 10.1097/md.0000000000010432]; Chen XJ, 2020, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00911; Czekanska EM, 2012, EUR CELLS MATER, V24, P1; Darjani Abbas, 2017, Acta Med Iran, V55, P375; DeGregorio-Rocasolano N, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00085; Hamann C, 2012, NAT REV ENDOCRINOL, V8, P297, DOI 10.1038/nrendo.2011.233; Hattori K, 2018, CELL CYCLE, V17, P5, DOI 10.1080/15384101.2017.1397330; Hattori K, 2017, EMBO REP, V18, P2067, DOI 10.15252/embr.201744228; Hu YB, 2021, EXP THER MED, V22, DOI 10.3892/etm.2021.10358; Huang LL, 2019, J CELL MOL MED, V23, P4153, DOI 10.1111/jcmm.14302; Kechin A, 2017, J COMPUT BIOL, V24, P1138, DOI 10.1089/cmb.2017.0096; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kleinert M, 2018, NAT REV ENDOCRINOL, V14, P140, DOI 10.1038/nrendo.2017.161; Kolluru GK, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/918267; Lei PX, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00139; Leslie WD, 2012, J BONE MINER RES, V27, P2231, DOI 10.1002/jbmr.1759; Li GF, 2012, BIOCHEM BIOPH RES CO, V423, P684, DOI 10.1016/j.bbrc.2012.06.015; Li YQ, 2018, BIOMETALS, V31, P749, DOI 10.1007/s10534-018-0133-3; Liang B, 2021, INT IMMUNOPHARMACOL, V97, DOI 10.1016/j.intimp.2021.107792; Liang C, 2019, ADV MATER, V31, DOI 10.1002/adma.201904197; Liang YW, 2020, J CHIN MED ASSOC, V83, P221, DOI 10.1097/JCMA.0000000000000251; Liu F, 2017, INT J MED SCI, V14, P275, DOI 10.7150/ijms.17860; Lotfy M, 2017, CURR DIABETES REV, V13, P3, DOI 10.2174/1573399812666151016101622; Mohsin S, 2019, EXPERT OPIN BIOL TH, V19, P937, DOI 10.1080/14712598.2019.1618266; Mou YH, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0720-y; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Saito M, 2006, OSTEOPOROSIS INT, V17, P986, DOI 10.1007/s00198-006-0087-0; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sealand R, 2013, CURR DIABETES REP, V13, P411, DOI 10.1007/s11892-013-0376-x; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065598; Simcox JA, 2013, CELL METAB, V17, P329, DOI 10.1016/j.cmet.2013.02.007; Skovso S, 2014, J DIABETES INVEST, V5, P349, DOI 10.1111/jdi.12235; Slater AFG, 1995, TOXICOL LETT, V82-3, P149, DOI 10.1016/0378-4274(95)03474-9; Tamura Y, 2013, DIABETES, V62, P3170, DOI 10.2337/db12-1552; Tsay J, 2010, BLOOD, V116, P2582, DOI 10.1182/blood-2009-12-260083; Wang P, 2016, MOL CELL, V63, P306, DOI 10.1016/j.molcel.2016.05.041; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang XD, 2022, BIOL TRACE ELEM RES, V200, P298, DOI 10.1007/s12011-021-02627-z; Wu YS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06898-4; Yao WF, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2686-7; Yu JJ, 2020, MOL CELL BIOCHEM, V463, P203, DOI 10.1007/s11010-019-03641-5; Zhang HY, 2021, J HAZARD MATER, V411, DOI 10.1016/j.jhazmat.2021.125179; Zhang WL, 2015, INT J MED SCI, V12, P441, DOI 10.7150/ijms.11986; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zhou RP, 2020, THERANOSTICS, V10, P11976, DOI 10.7150/thno.50663	56	14	14	19	39	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22147	10.1096/fj.202101610R	http://dx.doi.org/10.1096/fj.202101610R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35104016				2022-12-28	WOS:000761250800023
J	Zhang, XR; Li, YN; Chen, XP; Jin, BH; Shu, CY; Ni, WM; Jiang, YS; Zhang, J; Ma, LJ; Shu, J				Zhang, Xirong; Li, Yini; Chen, Xiaopan; Jin, Bihui; Shu, Chongyi; Ni, Wanmao; Jiang, Yinshen; Zhang, Jing; Ma, Lijia; Shu, Jing			Single-cell transcriptome analysis uncovers the molecular and cellular characteristics of thin endometrium	FASEB JOURNAL			English	Article						infertility; single-cell RNA sequencing; thin endometrium; transcriptome	IN-VITRO FERTILIZATION; EMBRYO-TRANSFER; IMPLANTATION; THICKNESS; DECIDUALIZATION; PROGESTERONE; PREGNANCY; ADHESION; ANGIOGENESIS; RECEPTIVITY	Infertility is a social and medical problem around the world and the incidence continues to rise. Thin endometrium (TE) is a great challenge of infertility treatment, even by in vitro fertilization and embryo transfer. It is widely believed that TE impairs endometrium receptivity. However, only a few studies have explained the molecular mechanism. Herein, in order to reveal the possible mechanism, we sampled endometrium from a TE patient and a control volunteer and got a transcriptomic atlas of 18 775 individual cells which was constructed using single-cell RNA sequencing, and seven cell types have been identified. The cells were acquired during proliferative and secretory phases, respectively. The proportion of epithelial cells and stromal cells showed a significant difference between the TE group and the control group. In addition, differential expressed genes (DEGs) in diverse cell types were revealed, the enriched pathways of DEGs were found closely related to the protein synthesis in TE of both proliferative and secretory phases. Some DEGs can influence cell-type ratio and impaired endometrial receptivity in TE. Furthermore, divergent expression of estrogen receptors 1 and progesterone receptors in stromal and epithelial cells were compared in the TE sample from the control. The cellular and molecular heterogeneity found in this study provided valuable information for disclosing the mechanisms of impaired receptivity in TE.	[Zhang, Xirong; Shu, Jing] Qingdao Univ, Qingdao Med Coll, Dept Obstet & Gynecol, Qingdao, Peoples R China; [Zhang, Xirong; Chen, Xiaopan; Jin, Bihui; Shu, Chongyi; Jiang, Yinshen; Zhang, Jing; Shu, Jing] Hangzhou Med Coll, Affiliated Peoples Hosp, Zhejiang Prov Peoples Hosp, Ctr Reprod Med,Dept Reprod Endo, Hangzhou, Peoples R China; [Li, Yini; Ma, Lijia] Westlake Univ, Sch Life Sci, Hangzhou 310014, Peoples R China; [Ni, Wanmao] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Canc Ctr,Key Lab Tumor Mol Diag & Individualized, Hangzhou, Peoples R China; [Chen, Xiaopan] Hangzhou Med Coll, Affiliated Peoples Hosp, Zhejiang Prov Peoples Hosp, Dept Genet & Genom Med, Hangzhou, Peoples R China; [Zhang, Jing] Hangzhou Med Coll, Affiliated Peoples Hosp, Zhejiang Prov Peoples Hosp, Dept Obstet, Hangzhou, Peoples R China	Qingdao University; Hangzhou Medical College; Zhejiang Provincial People's Hospital; Westlake University; Hangzhou Medical College; Zhejiang Provincial People's Hospital; Hangzhou Medical College; Zhejiang Provincial People's Hospital; Hangzhou Medical College; Zhejiang Provincial People's Hospital	Ma, LJ (corresponding author), Westlake Univ, Sch Life Sci, Hangzhou 310014, Peoples R China.; Shu, J (corresponding author), Qingdao Univ, Qingdao Med Coll, Qingdao 266073, Shangdong, Peoples R China.	malijia@westlake.edu.cn; shujing@hmc.edu.cn	Shu, Jing/G-1204-2013	Shu, Jing/0000-0003-0398-2188; Zhang, Xirong/0000-0002-9461-9191	Research Program of Medicine and Health of Zhejiang Province [2020KY414, 2020KY448]; Zhejiang Provincial Key Laboratory for Precision Diagnoais & Treatment of Major Gynecological Diseases,Hangzhou, Zhejiang Province, P.R. China, Woman's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, P.R. China [ZDFY2021-MGD/RH-0001]; Bethune Foundation for Women's Health Research Project [X-J-2019-024]; Zhejiang Provincal People's Hospital [ZRY2019B002]	Research Program of Medicine and Health of Zhejiang Province; Zhejiang Provincial Key Laboratory for Precision Diagnoais & Treatment of Major Gynecological Diseases,Hangzhou, Zhejiang Province, P.R. China, Woman's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, P.R. China; Bethune Foundation for Women's Health Research Project; Zhejiang Provincal People's Hospital	Research Program of Medicine and Health of Zhejiang Province, Grant/ Award Number: 2020KY414 to J.S. and 2020KY448 to X.C.; Zhejiang Provincial Key Laboratory for Precision Diagnoais & Treatment of Major Gynecological Diseases,Hangzhou, Zhejiang Province, P.R. China, Woman's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, P.R. China, Grant/ Award Number: ZDFY2021--MGD/RH-0001; Bethune Foundation for Women's Health Research Project, Grant/ Award Number: X-J-2019-024; The initial funding of scientific research for excellent young people of Zhejiang Provincal People's Hospital, Grant/ Award Number: ZRY2019B002	Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Alfer J, 2017, GEBURTSH FRAUENHEILK, V77, P756, DOI 10.1055/s-0043-111899; Aplin JD., 2008, FEMALE SEX STEROID H; Beier HM, 1998, HUM REPROD UPDATE, V4, P448, DOI 10.1093/humupd/4.5.448; Bolnick AD, 2016, HUM REPROD, V31, P2042, DOI 10.1093/humrep/dew143; Bourgain C, 2003, HUM REPROD UPDATE, V9, P515, DOI 10.1093/humupd/dmg045; Cui N, 2019, J ENDOCRINOL INVEST, V42, P27, DOI 10.1007/s40618-018-0877-1; Davie K, 2018, CELL, V174, P982, DOI 10.1016/j.cell.2018.05.057; De Geyter C, 2000, FERTIL STERIL, V73, P106, DOI 10.1016/S0015-0282(99)00484-7; Dehbashi S, 2003, INT J GYNECOL OBSTET, V80, P49, DOI 10.1016/S0020-7292(02)00341-7; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Di Palma T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.262; Dietterich C, 2002, FERTIL STERIL, V77, P781, DOI 10.1016/S0015-0282(01)03276-9; Eftekhar M, 2018, TAIWAN J OBSTET GYNE, V57, P810, DOI 10.1016/j.tjog.2018.10.007; Elgueta R, 2016, J IMMUNOL, V197, P3970, DOI 10.4049/jimmunol.1501859; Franco HL, 2011, FASEB J, V25, P1176, DOI 10.1096/fj.10-175349; Gao MX, 2019, GYNECOL ENDOCRINOL, V35, P544, DOI 10.1080/09513590.2018.1554035; Garcia-Alonso L, 2021, NAT GENET, V53, P1698, DOI 10.1038/s41588-021-00972-2; Halari CD, 2020, MOL HUM REPROD, V26, P784, DOI 10.1093/molehr/gaaa058; Harraz M, 2001, STEM CELLS, V19, P304, DOI 10.1634/stemcells.19-4-304; Heger A, 2012, GEBURTSH FRAUENHEILK, V72, P710, DOI 10.1055/s-0032-1315059; Hu X, 2021, J ENDOCRINOL INVEST, V44, P1609, DOI 10.1007/s40618-020-01455-7; Inhorn MC, 2015, HUM REPROD UPDATE, V21, P411, DOI 10.1093/humupd/dmv016; Jin XY, 2017, HUM REPROD, V32, P2394, DOI 10.1093/humrep/dex312; Kemp SB, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202000935; Kovacs P, 2003, HUM REPROD, V18, P2337, DOI 10.1093/humrep/deg461; Kumar V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01764-7; Ledee-Bataille N, 2002, HUM REPROD, V17, P213, DOI 10.1093/humrep/17.1.213; Li MY, 2020, EXP CELL RES, V394, DOI 10.1016/j.yexcr.2020.112153; Lim HJ, 1999, MOL ENDOCRINOL, V13, P1005, DOI 10.1210/me.13.6.1005; Lip GYH, 1997, CARDIOVASC RES, V34, P255, DOI 10.1016/S0008-6363(97)00039-4; Maekawa R, 2017, REPROD MED BIOL, V16, P206, DOI 10.1002/rmb2.12030; Meng FY, 2018, FERTIL STERIL, V109, P165, DOI 10.1016/j.fertnstert.2017.10.005; Miwa I, 2009, FERTIL STERIL, V91, P998, DOI 10.1016/j.fertnstert.2008.01.029; MOINGEON P, 1989, NATURE, V339, P312, DOI 10.1038/339312a0; Niederberger C, 2018, FERTIL STERIL, V110, P185, DOI 10.1016/j.fertnstert.2018.06.005; Okada H, 2014, J OBSTET GYNAECOL RE, V40, P1180, DOI 10.1111/jog.12392; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Sharma S, 2014, FERTIL STERIL, V102, pE130, DOI 10.1016/j.fertnstert.2014.07.447; Sharma Sunita, 2018, J Hum Reprod Sci, V11, P34, DOI [10.4103/jhrs.JHRS_9_17, 10.4103/jhrs.jhrs_9_17]; Shimomura Y, 2006, MOL HUM REPROD, V12, P491, DOI 10.1093/molehr/gal019; Simon C, 1998, J REPROD IMMUNOL, V39, P117, DOI 10.1016/S0165-0378(98)00017-5; Stoeckelhuber M, 2006, HISTOCHEM CELL BIOL, V126, P103, DOI 10.1007/s00418-005-0137-2; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Taylor HS, 1998, J CLIN INVEST, V101, P1379, DOI 10.1172/JCI1057; Tong W, 1999, MOL CELL BIOL, V19, P2251; Vaegter KK, 2017, FERTIL STERIL, V107, P641, DOI 10.1016/j.fertnstert.2016.12.005; Wang J, 2002, CELLS TISSUES ORGANS, V172, P190, DOI 10.1159/000066970; Wang W, 2018, FERTIL STERIL, V110, pE2, DOI 10.1016/j.fertnstert.2018.07.027; Wang WX, 2020, NAT MED, V26, P1644, DOI 10.1038/s41591-020-1040-z; Wetendorf M, 2012, MOL CELL ENDOCRINOL, V357, P108, DOI 10.1016/j.mce.2011.10.028; Wu FR, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0379-1; Ye Ming-Xia, 2017, Nan Fang Yi Ke Da Xue Xue Bao, V37, P575; Yi KW, 2019, BIOL REPROD, V100, P61, DOI 10.1093/biolre/ioy175; Yuan X, 2016, REPROD BIOMED ONLINE, V33, P197, DOI 10.1016/j.rbmo.2016.05.002; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zhou Y, 2020, CANCER CELL, V38, P818, DOI 10.1016/j.ccell.2020.09.015; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	59	2	2	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22193	10.1096/fj.202101579R	http://dx.doi.org/10.1096/fj.202101579R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35201635	hybrid			2022-12-28	WOS:000761250800001
J	Costiniti, V; Bomfim, GHS; Neginskaya, M; Son, GY; Mitaishvili, E; Giacomello, M; Pavlov, E; Lacruz, RS				Costiniti, Veronica; Bomfim, Guilherme H. S.; Neginskaya, Maria; Son, Ga-Yeon; Mitaishvili, Erna; Giacomello, Marta; Pavlov, Evgeny; Lacruz, Rodrigo S.			Mitochondria modulate ameloblast Ca2+ signaling	FASEB JOURNAL			English	Article						enamel; maturation; MCU; mitochondria; secretory	DENTAL ENAMEL; ESSENTIAL COMPONENT; INTRACELLULAR CA2+; CALCIUM-TRANSPORT; MATRIX; ION; MINERALIZATION; EXPRESSION; MEMBRANE; PROTEIN	The role of mitochondria in enamel, the most mineralized tissue in the body, is poorly defined. Enamel is formed by ameloblast cells in two main sequential stages known as secretory and maturation. Defining the physiological features of each stage is essential to understand mineralization. Here, we analyzed functional features of mitochondria in rat primary secretory and maturation-stage ameloblasts focusing on their role in Ca2+ signaling. Quantification of the Ca2+ stored in the mitochondria by trifluoromethoxy carbonylcyanide phenylhydrazone stimulation was comparable in both stages. The release of endoplasmic reticulum Ca2+ pools by adenosine triphosphate in rhod2AM-loaded cells showed similar mitochondrial Ca2+ (Ca-m(2+)) uptake. However, Ca-m(2+) extrusion via Na+-Li+-Ca2+ exchanger was more prominent in maturation. To address if Ca-m(2+) uptake via the mitochondrial Ca2+ uniporter (MCU) played a role in cytosolic Ca2+ (Ca-c(2+)) buffering, we stimulated Ca2+ influx via the store-operated Ca2+ entry (SOCE) and blocked MCU with the inhibitor Ru265. This inhibitor was first tested using the enamel cell line LS8 cells. Ru265 prevented Ca-c(2+) clearance in permeabilized LS8 cells like ruthenium red, and it did not affect Delta psi m in intact cells. In primary ameloblasts, SOCE stimulation elicited a significantly higher Ca-m(2+) uptake in maturation ameloblasts. The uptake of Ca2+ into the mitochondria was dramatically decreased in the presence of Ru265. Combined, these results suggest an increased mitochondrial Ca2+ handling in maturation but only upon stimulation of Ca2+ influx via SOCE. These functional studies provide insights not only on the role of mitochondria in ameloblast Ca2+ physiology, but also advance the concept that SOCE and Ca-m(2+) uptake are complementary processes in biological mineralization.	[Costiniti, Veronica; Bomfim, Guilherme H. S.; Neginskaya, Maria; Son, Ga-Yeon; Mitaishvili, Erna; Pavlov, Evgeny; Lacruz, Rodrigo S.] NYU, Coll Dent, Dept Mol Pathobiol, 345 East 24th St, New York, NY 10010 USA; [Giacomello, Marta] Univ Padua, Dept Biol, Padua, Italy; [Giacomello, Marta] Univ Padua, Dept Biomed Sci, Padua, Italy	New York University; University of Padua; University of Padua	Lacruz, RS (corresponding author), NYU, Coll Dent, Dept Mol Pathobiol, 345 East 24th St, New York, NY 10010 USA.	rsl10@nyu.edu	GIACOMELLO, MARTA/HGB-1486-2022; Lacruz, Rodrigo/AGY-8090-2022	Souza Bomfim, Guilherme Henrique/0000-0001-9454-7266; Costiniti, Veronica/0000-0002-8472-7797	HHS \ NIH \ National Institute of Dental and Craniofacial Research (NIDCR) [DE025639, DE027679, DE027981]; MIUR PRIN [2017FS5SHL "RADIUS"]; NIGMS [GM15570]	HHS \ NIH \ National Institute of Dental and Craniofacial Research (NIDCR); MIUR PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR), Grant/Award Number: DE025639; HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR), Grant/Award Number: DE027679; HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR), Grant/Award Number: DE027981; MIUR PRIN 2017FS5SHL "RADIUS"; NIGMS, Grant/Award Number: GM15570	Ambudkar IS, 2017, CELL CALCIUM, V63, P33, DOI 10.1016/j.ceca.2016.12.009; Aulestia FJ, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aay0086; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BAWDEN JW, 1989, ANAT REC, V224, P226, DOI 10.1002/ar.1092240212; BENZ R, 1983, BIOPHYS J, V41, P381, DOI 10.1016/S0006-3495(83)84449-X; Bomfim GHS, 2020, CELL CALCIUM, V87, DOI 10.1016/j.ceca.2020.102187; Carvalho EJ, 2020, CURR OPIN PHYSIOL, V17, P197, DOI 10.1016/j.cophys.2020.08.010; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; CHEN LS, 1992, ARCH ORAL BIOL, V37, P771, DOI 10.1016/0003-9969(92)90110-T; Costiniti V, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00538; COX DA, 1993, J CARDIOVASC PHARM, V21, P595, DOI 10.1097/00005344-199304000-00013; De Marchi U, 2014, J BIOL CHEM, V289, P20377, DOI 10.1074/jbc.M113.540898; De Stefani D, 2016, ANNU REV BIOCHEM, V85, P161, DOI 10.1146/annurev-biochem-060614-034216; De Stefani D, 2015, BBA-MOL CELL RES, V1853, P2006, DOI 10.1016/j.bbamcr.2015.04.008; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Demaurex N, 2017, ADV EXP MED BIOL, V993, P277, DOI 10.1007/978-3-319-57732-6_15; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Dimmer KS, 2006, PHYSIOLOGY, V21, P233, DOI 10.1152/physiol.00010.2006; Dobson PF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68566-2; Doonan PJ, 2014, FASEB J, V28, P4936, DOI 10.1096/fj.14-256453; Drago I, 2012, P NATL ACAD SCI USA, V109, P12986, DOI 10.1073/pnas.1210718109; Eckstein M, 2018, CELL CALCIUM, V75, P14, DOI 10.1016/j.ceca.2018.07.012; Eckstein M, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav4663; Eckstein M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91166; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Foskett JK, 2015, J MOL CELL CARDIOL, V78, P3, DOI 10.1016/j.yjmcc.2014.11.015; Franklin IK, 2001, BIOCHEM J, V358, P217, DOI 10.1042/0264-6021:3580217; Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147; Granatiero V, 2017, ADV EXP MED BIOL, V982, P25, DOI 10.1007/978-3-319-55330-6_2; HALSTEAD LB, 1969, CALC TISS RES, V3, P103, DOI 10.1007/BF02058652; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Hubbard MJ, 1996, FEBS LETT, V391, P323, DOI 10.1016/0014-5793(96)00767-3; Hubbard MJ, 2000, CRIT REV ORAL BIOL M, V11, P437, DOI 10.1177/10454411000110040401; Imhof T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77954-7; JOSEPHSEN K, 1977, J ANAT, V124, P45; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Lacruz RS, 2017, CELL CALCIUM, V65, P1, DOI 10.1016/j.ceca.2017.03.006; Lacruz RS, 2017, PHYSIOL REV, V97, P939, DOI 10.1152/physrev.00030.2016; Lacruz RS, 2012, J CELL PHYSIOL, V227, P2264, DOI 10.1002/jcp.22965; Lacruz RS, 2012, J CELL PHYSIOL, V227, P1776, DOI 10.1002/jcp.22911; LEHNINGER AL, 1967, ADV ENZYMOL RAMB, V29, P259; Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200; Mallilankaraman K, 2015, NAT CELL BIOL, V17, P953, DOI 10.1038/ncb3202; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Murgia M, 2015, CELL CALCIUM, V58, P11, DOI 10.1016/j.ceca.2014.11.001; Nurbaeva MK, 2015, J DENT RES, V94, P1471, DOI 10.1177/0022034515598144; Nurbaeva MK, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00801; Nurbaeva MK, 2017, J PHYSIOL-LONDON, V595, P3015, DOI 10.1113/JP272775; Nurbaeva MK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15803; Paine ML., 2020, ION TRANSPORT EPITHE, P363; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; PLACHOT JJ, 1986, BONE MINER, V1, P157; Pozzan T, 2000, CELL CALCIUM, V28, P279, DOI 10.1054/ceca.2000.0166; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Putney JW, 2011, NEUROCHEM RES, V36, P1157, DOI 10.1007/s11064-010-0383-0; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Roy SS, 2008, METHODS, V46, P213, DOI 10.1016/j.ymeth.2008.09.024; SALTER MW, 1994, J NEUROSCI, V14, P1563, DOI 10.1523/JNEUROSCI.14-03-01563.1994; SALTER MW, 1995, J NEUROSCI, V15, P2961; Sarkar J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00277; Shanmughapriya S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005673; SHAPIRO IM, 1969, CALC TISS RES, V3, P100, DOI 10.1007/BF02058651; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Solesio ME, 2020, CELL CALCIUM, V86, DOI 10.1016/j.ceca.2019.102127; Stephanopoulos G, 2005, J DENT RES, V84, P1117, DOI 10.1177/154405910508401206; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; TAKANO Y, 1990, ANAT REC, V228, P123, DOI 10.1002/ar.1092280203; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Vais H, 2016, CELL REP, V14, P403, DOI 10.1016/j.celrep.2015.12.054; Woods JJ, 2021, CHEM COMMUN, V57, P6161, DOI 10.1039/d1cc01623g; Woods JJ, 2019, ACS CENTRAL SCI, V5, P153, DOI 10.1021/acscentsci.8b00773	76	2	2	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22169	10.1096/fj.202100602R	http://dx.doi.org/10.1096/fj.202100602R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35084775				2022-12-28	WOS:000747987800030
J	Mahmud, F; Roy, R; Mohamed, MF; Aboonabi, A; Moric, M; Ghoreishi, K; Bayat, M; Kuzel, TM; Reiser, J; Shafikhani, SH				Mahmud, Foyez; Roy, Ruchi; Mohamed, Mohamed F.; Aboonabi, Anahita; Moric, Mario; Ghoreishi, Kamran; Bayat, Mohammad; Kuzel, Timothy M.; Reiser, Jochen; Shafikhani, Sasha H.			Therapeutic evaluation of immunomodulators in reducing surgical wound infection	FASEB JOURNAL			English	Article						CCL3 (MIP-1 alpha); fMLP (fMLF); immunomodulators; innate immune system; leukocytes; lipopolysaccharides (LPS); neutrophils; Pseudomonas aeruginosa; surgical site infection (SSI); wound healing; wound infection	CARE-ASSOCIATED INFECTIONS; PSEUDOMONAS-AERUGINOSA; SITE INFECTION; PATTERN-RECOGNITION; FUNCTIONAL-CHARACTERIZATION; ANTIMICROBIAL PROPHYLAXIS; ANTIBIOTIC-PROPHYLAXIS; RISK-FACTORS; GM-CSF; TOBRAMYCIN	Despite many advances in infection control practices, including prophylactic antibiotics, surgical site infections (SSIs) remain a significant cause of morbidity, prolonged hospitalization, and death worldwide. Our innate immune system possesses a multitude of powerful antimicrobial strategies which make it highly effective in combating bacterial, fungal, and viral infections. However, pathogens use various stealth mechanisms to avoid the innate immune system, which in turn buy them time to colonize wounds and damage tissues at surgical sites. We hypothesized that immunomodulators that can jumpstart and activate innate immune responses at surgical sites, would likely reduce infection at surgical sites. We used three immunomodulators; fMLP (formyl-Methionine-Lysine-Proline), CCL3 (MIP-1 alpha), and LPS (Lipopolysaccharide), based on their documented ability to elicit strong inflammatory responses; in a surgical wound infection model with Pseudomonas aeruginosa to evaluate our hypothesis. Our data indicate that one-time topical treatment with these immunomodulators at low doses significantly increased proinflammatory responses in infected and uninfected surgical wounds and were as effective, (or even better), than a potent prophylactic antibiotic (Tobramycin) in reducing P. aeruginosa infection in wounds. Our data further show that immunomodulators did not have adverse effects on tissue repair and wound healing processes. Rather, they enhanced healing in both infected and uninfected wounds. Collectively, our data demonstrate that harnessing the power of the innate immune system by immunomodulators can significantly boost infection control and potentially stimulate healing. We propose that topical treatment with these immunomodulators at the time of surgery may have therapeutic potential in combating SSI, alone or in combination with prophylactic antibiotics.	[Mahmud, Foyez; Roy, Ruchi; Mohamed, Mohamed F.; Aboonabi, Anahita; Kuzel, Timothy M.; Reiser, Jochen; Shafikhani, Sasha H.] Rush Univ, Dept Med, Med Ctr, Chicago, IL 60612 USA; [Mahmud, Foyez; Roy, Ruchi; Mohamed, Mohamed F.; Aboonabi, Anahita; Kuzel, Timothy M.; Shafikhani, Sasha H.] Rush Univ, Div Hematol Oncol Cell Therapy, Med Ctr, Chicago, IL 60612 USA; [Moric, Mario] Rush Univ, Dept Anesthesiol, Med Ctr, Chicago, IL 60612 USA; [Ghoreishi, Kamran] Qom Univ, Dept Stat, Qom, Iran; [Bayat, Mohammad] Shahid Beheshti Univ Med Sci, Sch Med, Dept Biol & Anat Sci, Tehran, Iran; [Bayat, Mohammad] Univ Louisville, Price Inst Surg Res, Louisville, KY USA; [Bayat, Mohammad] Noveratech LLC Louisville, Louisville, KY USA; [Shafikhani, Sasha H.] Rush Univ, Canc Ctr, Med Ctr, Chicago, IL 60612 USA	Rush University; Rush University; Rush University; Shahid Beheshti University Medical Sciences; University of Louisville; Rush University	Shafikhani, SH (corresponding author), Rush Univ, Dept Med, Med Ctr, Chicago, IL 60612 USA.	Sasha_Shafikhani@rush.edu	ROY, RUCHI/AEV-9556-2022	ROY, RUCHI/0000-0001-8298-1321; Mahmud, K A Foyez/0000-0001-7485-4699; Shafikhani, Sasha/0000-0003-1755-9997	National Institutes of Health (NIH) [R01AI150668, RO1DK107713]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank the rest of Shafikhani lab members for their valued opinions on these studies. This work was supported by the National Institutes of Health (NIH) grants R01AI150668 and RO1DK107713, both to (S.H.S.).	Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Albrecht C, 2012, P NATL ACAD SCI USA, V109, P303, DOI 10.1073/pnas.1109921108; Allegranzi Benedetta, 2016, Lancet Infect Dis, V16, pe288, DOI 10.1016/S1473-3099(16)30402-9; Anderson DJ, 2014, INFECT CONT HOSP EP, V35, P605, DOI [10.1086/676022, 10.1017/S0899823X00193869]; Anderson DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008305; Anesi JA, 2018, TRANSPLANTATION, V102, P21, DOI 10.1097/TP.0000000000001848; Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091, DOI 10.1177/039139880502801106; Avent ML, 2011, INTERN MED J, V41, P441, DOI 10.1111/j.1445-5994.2011.02452.x; Balazovich KJ, 1996, BLOOD, V88, P690, DOI 10.1182/blood.V88.2.690.bloodjournal882690; Ban KA, 2017, J AM COLL SURGEONS, V224, P59, DOI 10.1016/j.jamcollsurg.2016.10.029; Becattini S, 2016, TRENDS MOL MED, V22, P458, DOI 10.1016/j.molmed.2016.04.003; Berrios SI, 2017, JAMA SURG, V152, P784, DOI 10.1001/jamasurg.2017.0904; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; Bhavsar I, 2015, GEN METHODS BIOMARKE, P223, DOI DOI 10.1007/978-94-007-7696-8_27; Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Bothra M, 2012, EXPERT OPIN PHARMACO, V13, P565, DOI 10.1517/14656566.2012.656090; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Bratzler DW, 2013, SURG INFECT, V14, P73, DOI 10.1089/sur.2013.9999; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BROUQUI P, 1995, ANTIMICROB AGENTS CH, V39, P2423, DOI 10.1128/AAC.39.11.2423; Brubaker AL, 2013, J IMMUNOL, V190, P1746, DOI 10.4049/jimmunol.1201213; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; BUSSOLINO F, 1989, NATURE, V337, P471, DOI 10.1038/337471a0; Campbell J, 2014, AM J SPORT MED, V42, P973, DOI 10.1177/0363546513519950; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; CHRISTOU NV, 1987, ARCH SURG-CHICAGO, V122, P239; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; de Oliveira S, 2016, NAT REV IMMUNOL, V16, P378, DOI 10.1038/nri.2016.49; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; DERIAN CK, 1995, J IMMUNOL, V154, P308; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Dovi JV, 2004, THROMB HAEMOSTASIS, V92, P275, DOI 10.1160/TH03-11-0720; Drummond RA, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00039; Edmiston CE, 2013, AM J INFECT CONTROL, V41, pS49, DOI 10.1016/j.ajic.2012.10.030; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Faure E, 2014, AM J RESP CRIT CARE, V189, P799, DOI 10.1164/rccm.201307-1358OC; Fenteany G, 2000, CURR BIOL, V10, P831, DOI 10.1016/S0960-9822(00)00579-0; Gaynes RP, 2001, CLIN INFECT DIS, V33, pS69, DOI 10.1086/321860; Gillespie BM, 2017, BRIT J SURG, V104, pE55, DOI 10.1002/bjs.10428; Glotzbecker MP, 2013, J PEDIATR ORTHOPED, V33, P479, DOI 10.1097/BPO.0b013e318285c507; Goldufsky J, 2015, WOUND REPAIR REGEN, V23, P557, DOI 10.1111/wrr.12310; Greif R, 2000, NEW ENGL J MED, V342, P161, DOI 10.1056/NEJM200001203420303; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Gupta KH, 2017, DEV CELL, V41, P674, DOI 10.1016/j.devcel.2017.05.014; Hamilton JL, 2021, EUR CELLS MATER, V42, P122, DOI 10.22203/eCM.v042a09; He HQ, 2013, MOL PHARMACOL, V83, P389, DOI 10.1124/mol.112.081315; Hodson ME, 2002, EUR RESPIR J, V20, P658, DOI 10.1183/09031936.02.00248102; HOFF G E, 1974, Scandinavian Journal of Infectious Diseases, V6, P333, DOI 10.3109/inf.1974.6.issue-4.07; Hsu CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134852; Hughes WT, 2002, CLIN INFECT DIS, V34, P730, DOI 10.1086/339215; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jones Stuart G, 2004, Int J Low Extrem Wounds, V3, P201, DOI 10.1177/1534734604271810; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kienle K, 2016, IMMUNOL REV, V273, P76, DOI 10.1111/imr.12458; Kim MH, 2008, J INVEST DERMATOL, V128, P1812, DOI 10.1038/sj.jid.5701223; Kim YK, 2016, YONSEI MED J, V57, P5, DOI 10.3349/ymj.2016.57.1.5; Kirkland KB, 1999, INFECT CONT HOSP EP, V20, P725, DOI 10.1086/501572; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Korpela K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10410; Kroin JS, 2018, REGION ANESTH PAIN M, V43, P795, DOI 10.1097/AAP.0000000000000820; Kroin JS, 2016, J MED MICROBIOL, V65, P738, DOI 10.1099/jmm.0.000295; Kroin JS, 2015, ANESTH ANALG, V120, P1289, DOI 10.1213/ANE.0000000000000650; Langdon A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0294-z; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; Lu ZY, 2018, FASEB J, V32, P3614, DOI 10.1096/fj.201701164R; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Madianos PN, 2005, J CLIN PERIODONTOL, V32, P57, DOI 10.1111/j.1600-051X.2005.00821.x; Magill SS, 2012, INFECT CONT HOSP EP, V33, P283, DOI 10.1086/664048; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132715; Mehta HM, 2015, J IMMUNOL, V195, P1341, DOI 10.4049/jimmunol.1500861; Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005; Metruccio MME, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14243-w; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Namba RS, 2013, J BONE JOINT SURG AM, V95A, P775, DOI 10.2106/JBJS.L.00211; Panahi P, 2012, CLIN ORTHOP RELAT R, V470, P2690, DOI 10.1007/s11999-012-2252-4; Panaro MA, 1999, IMMUNOPHARM IMMUNOT, V21, P397, DOI 10.3109/08923979909007117; Redel H, 2013, J INFECT DIS, V207, P1105, DOI 10.1093/infdis/jit005; Rivas-Santiago B, 2009, INFECT IMMUN, V77, P4690, DOI 10.1128/IAI.01515-08; Roy R, 2022, J INVEST DERMATOL, V142, P692, DOI 10.1016/j.jid.2021.08.428; Sabroe I, 2003, J IMMUNOL, V170, P5268, DOI 10.4049/jimmunol.170.10.5268; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Saunders KT, 2018, OBSTET GYNECOL, V131, p83S, DOI 10.1097/01.AOG.0000533379.96988.6a; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Shafikhani SH, 2006, P NATL ACAD SCI USA, V103, P15605, DOI 10.1073/pnas.0605949103; Sharma P, 2018, PATHOG DIS, V76, DOI 10.1093/femspd/fty001; Shawar RM, 1999, ANTIMICROB AGENTS CH, V43, P2877, DOI 10.1128/AAC.43.12.2877; Sidhwa F, 2015, SURG INFECT, V16, P14, DOI 10.1089/sur.2015.010; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Smyth STM, 2000, J HOSP INFECT, V45, P173, DOI 10.1053/jhin.2000.0736; Stannard JP, 2012, J ORTHOP TRAUMA, V26, P37, DOI 10.1097/BOT.0b013e318216b1e5; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Taxman DJ, 2010, CELL HOST MICROBE, V8, P7, DOI 10.1016/j.chom.2010.06.005; Teneback CC, 2013, ANTIMICROB AGENTS CH, V57, P5559, DOI 10.1128/AAC.00500-13; Tosh PK, 2011, INFECT CONT HOSP EP, V32, P1179, DOI 10.1086/662712; Trda L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00219; van de Vosse E, 2009, LANCET INFECT DIS, V9, P688, DOI 10.1016/S1473-3099(09)70255-5; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Wagner C, 2006, CLIN EXP IMMUNOL, V143, P70, DOI 10.1111/j.1365-2249.2005.02963.x; WAKEFIELD PE, 1990, J AM ACAD DERMATOL, V23, P903, DOI 10.1016/0190-9622(90)70313-7; Wang NZ, 2010, FASEB J, V24, P2178, DOI 10.1096/fj.09-136895; WOOD CA, 1988, J INFECT DIS, V158, P13, DOI 10.1093/infdis/158.1.13; Wood S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004934; Wood S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091574; Wood SJ, 2015, J BIOL CHEM, V290, P29063, DOI 10.1074/jbc.M115.689950; Yassour M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0917; Zibert A, 2004, HUM GENE THER, V15, P21, DOI 10.1089/10430340460732436; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	120	1	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22090	10.1096/fj.202101019R	http://dx.doi.org/10.1096/fj.202101019R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34907595				2022-12-28	WOS:000734992000001
J	Marchiano, S; Biagioli, M; Roselli, R; Zampella, A; Di Giorgio, C; Bordoni, M; Bellini, R; Morretta, E; Monti, MC; Distrutti, E; Fiorucci, S				Marchiano, Silvia; Biagioli, Michele; Roselli, Rosalinda; Zampella, Angela; Di Giorgio, Cristina; Bordoni, Martina; Bellini, Rachele; Morretta, Elva; Monti, Maria Chiara; Distrutti, Eleonora; Fiorucci, Stefano			Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling	FASEB JOURNAL			English	Article						bile acids; cardiovascular diseases; FXR; GPBAR1; intestinal microbiota; liver metabolism; statins	FARNESOID-X-RECEPTOR; BILE-ACID METABOLISM; OBETICHOLIC ACID; INSULIN-RESISTANCE; GUT MICROBES; CHOLESTEROL; TGR5; MICE; DISEASE; ACTIVATION	Farnesoid-x-receptor (FXR) agonists, currently trialed in patients with non-alcoholic steatosis (NAFLD), worsen the pro-atherogenic lipid profile and might require a comedication with statin. Here we report that mice feed a high fat/high cholesterol diet (HFD) are protected from developing a pro-atherogenic lipid profile because their ability to dispose cholesterol through bile acids. This protective mechanism is mediated by suppression of FXR signaling in the liver by muricholic acids (MCAs) generated in mice from chenodeoxycholic acid (CDCA). In contrast to CDCA, MCAs are FXR antagonists and promote a CYP7A1-dependent increase of bile acids synthesis. In mice feed a HFD, the treatment with obeticholic acid, a clinical stage FXR agonist, failed to improve the liver histopathology while reduced Cyp7a1 and Cyp8b1 genes expression and bile acids synthesis and excretion. In contrast, treating mice with atorvastatin mitigated liver and vascular injury caused by the HFD while increased the bile acids synthesis and excretion. Atorvastatin increased the percentage of 7 alpha-dehydroxylase expressing bacteria in the intestine promoting the formation of deoxycholic acid and litocholic acid, two GPBAR1 agonists, along with the expression of GPBAR1-regulated genes in the white adipose tissue and colon. In conclusion, present results highlight the central role of bile acids in regulating lipid and cholesterol metabolism in response to atorvastatin and provide explanations for limited efficacy of FXR agonists in the treatment of NAFLD.	[Marchiano, Silvia; Biagioli, Michele; Di Giorgio, Cristina; Bordoni, Martina; Bellini, Rachele; Fiorucci, Stefano] Univ Perugia, Dept Med & Surg, Perugia, Italy; [Roselli, Rosalinda; Zampella, Angela] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Morretta, Elva; Monti, Maria Chiara] Univ Salerno, Dept Pharm, Salerno, Italy; [Distrutti, Eleonora] Azienda Osped Perugia, Perugia, Italy	University of Perugia; University of Naples Federico II; University of Salerno; University of Perugia; Azienda Ospedaliera di Perugia	Fiorucci, S (corresponding author), Univ Perugia, Dept Med & Surg, Perugia, Italy.	stefano.fiorucci@unipg.it						Alexander M, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5367; Bervoets L, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-10; Biagioli M, 2019, CELL MOL GASTROENTER, V8, P447, DOI 10.1016/j.jcmgh.2019.06.003; Biagioli M, 2017, J IMMUNOL, V199, P718, DOI 10.4049/jimmunol.1700183; Carino A, 2021, FASEB J, V35, DOI 10.1096/fj.202001386R; Carino A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051132; Carino A, 2019, FASEB J, V33, P2809, DOI 10.1096/fj.201801373RR; Carino A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13102-y; Carino A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42801; Chen JY, 2002, J BIOL CHEM, V277, P42588, DOI 10.1074/jbc.M205117200; Chiang John Y L, 2017, Liver Res, V1, P3, DOI 10.1016/j.livres.2017.05.001; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Chiang John Yl, 2017, F1000Res, V6, P2029, DOI 10.12688/f1000research.12449.1; Cipriani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025637; Cipriani S, 2010, J LIPID RES, V51, P771, DOI 10.1194/jlr.M001602; de Boer JF, 2020, J LIPID RES, V61, P291, DOI 10.1194/jlr.RA119000243; de Boer JF, 2017, GASTROENTEROLOGY, V152, P1126, DOI 10.1053/j.gastro.2016.12.037; Donepudi AC, 2017, HEPATOLOGY, V65, P813, DOI 10.1002/hep.28707; EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y; Eng JM, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071805; Estes C, 2018, J HEPATOL, V69, P896, DOI 10.1016/j.jhep.2018.05.036; Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466; Fang N, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001920; Festa C, 2014, J MED CHEM, V57, P8477, DOI 10.1021/jm501273r; Fiorucci S, 2005, J PHARMACOL EXP THER, V313, P604, DOI 10.1124/jpet.104.079665; Fiorucci S, 2004, GASTROENTEROLOGY, V127, P1497, DOI 10.1053/j.gastro.2004.08.001; Fiorucci S, 2021, EXPERT OPIN DRUG DIS, V16, P1193, DOI 10.1080/17460441.2021.1916465; Fiorucci S, 2021, PROG LIPID RES, V82, DOI 10.1016/j.plipres.2021.101094; Fiorucci S, 2020, EXPERT OPIN INV DRUG, V29, P623, DOI 10.1080/13543784.2020.1763302; Fiorucci S, 2019, HANDB EXP PHARMACOL, V256, P3, DOI 10.1007/164_2019_238; Fiorucci S, 2019, HANDB EXP PHARMACOL, V256, P283, DOI 10.1007/164_2019_227; Fiorucci S, 2018, PHARMACOL RES, V134, P289, DOI 10.1016/j.phrs.2018.07.014; Fiorucci S, 2017, AM J PHYSIOL-HEART C, V312, pH21, DOI 10.1152/ajpheart.00577.2016; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Gaillard D, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22137163; Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Guo GCL, 2020, J LIPID RES, V61, P269, DOI 10.1194/jlr.C120000621; Hirschfield GM, 2015, GASTROENTEROLOGY, V148, P751, DOI 10.1053/j.gastro.2014.12.005; Huang YB, 2013, J ATHEROSCLER THROMB, V20, P108, DOI 10.5551/jat.14001; Ichikawa R, 2012, IMMUNOLOGY, V136, P153, DOI 10.1111/j.1365-2567.2012.03554.x; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jiang CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10166; Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2008, WORLD J GASTROENTERO, V14, P5620, DOI 10.3748/wjg.14.5620; Keitel V, 2008, BIOCHEM BIOPH RES CO, V372, P78, DOI 10.1016/j.bbrc.2008.04.171; Keitel V, 2007, HEPATOLOGY, V45, P695, DOI 10.1002/hep.21458; Keitel V, 2015, CLIN REV ALLERG IMMU, V48, P218, DOI 10.1007/s12016-014-8443-x; Keitel V, 2009, HEPATOLOGY, V50, P861, DOI 10.1002/hep.23032; Kida T, 2014, J PHARMACOL EXP THER, V348, P125, DOI 10.1124/jpet.113.209288; Kida T, 2013, ARTERIOSCL THROM VAS, V33, P1663, DOI 10.1161/ATVBAHA.113.301565; Levy C, 2019, J HEPATOL, V70, pE400, DOI 10.1016/S0618-8278(19)30787-X; Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Li TG, 2013, HEPATOLOGY, V58, P1111, DOI 10.1002/hep.26427; Lonardo A, 2018, J HEPATOL, V68, P335, DOI 10.1016/j.jhep.2017.09.021; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Maruyama T, 2006, J ENDOCRINOL, V191, P197, DOI 10.1677/joe.1.06546; Mencarelli A, 2013, DIABETES, V62, P3384, DOI 10.2337/db13-0299; Mencarelli A, 2009, AM J PHYSIOL-HEART C, V296, pH272, DOI 10.1152/ajpheart.01075.2008; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Nevens F, 2016, NEW ENGL J MED, V375, P631, DOI 10.1056/NEJMoa1509840; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Pellicciari R, 2002, J MED CHEM, V45, P3569, DOI 10.1021/jm025529g; Pockros PJ, 2019, LIVER INT, V39, P2082, DOI 10.1111/liv.14209; Pols TWH, 2011, CELL METAB, V14, P747, DOI 10.1016/j.cmet.2011.11.006; Renga B, 2015, AM J PHYSIOL-HEART C, V309, pH114, DOI 10.1152/ajpheart.00087.2015; Renga B, 2011, BBA-GENE REGUL MECH, V1809, P157, DOI 10.1016/j.bbagrm.2011.01.008; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Sepe V, 2016, STEROIDS, V105, P59, DOI 10.1016/j.steroids.2015.11.003; Sepe V, 2016, SCI REP-UK, V6, DOI 10.1038/srep19008; Sepe V, 2014, J MED CHEM, V57, P7687, DOI 10.1021/jm500889f; Shapiro H, 2018, J EXP MED, V215, P383, DOI 10.1084/jem.20171965; Sinn DH, 2020, J GASTROEN HEPATOL, V35, P833, DOI 10.1111/jgh.14856; Smith GI, 2020, J CLIN INVEST, V130, P1453, DOI 10.1172/JCI134165; Soehnlein O, 2021, NAT REV DRUG DISCOV, V20, P589, DOI 10.1038/s41573-021-00198-1; Song C, 2007, INT J CANCER, V121, P1055, DOI 10.1002/ijc.22808; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; Song ZW, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0628-3; Straniero S, 2020, J LIPID RES, V61, P480, DOI 10.1194/jlr.RA119000307; Takahashi S, 2016, J LIPID RES, V57, P2130, DOI 10.1194/jlr.M071183; Tanigawa H, 2007, CIRCULATION, V116, P1267, DOI 10.1161/CIRCULATIONAHA.107.704254; Targher G, 2016, J HEPATOL, V65, P589, DOI 10.1016/j.jhep.2016.05.013; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vassileva G, 2010, J ENDOCRINOL, V205, P225, DOI 10.1677/JOE-10-0009; Veseli BE, 2017, EUR J PHARMACOL, V816, P3, DOI 10.1016/j.ejphar.2017.05.010; Vital M, 2019, COMPUT STRUCT BIOTEC, V17, P1016, DOI 10.1016/j.csbj.2019.07.012; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Xu GR, 2004, AM J PHYSIOL-GASTR L, V286, pG730, DOI 10.1152/ajpgi.00397.2003; Xu PR, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-283; Younossi ZM, 2019, LANCET, V394, P2184, DOI 10.1016/S0140-6736(19)33041-7; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	97	5	5	3	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22060	10.1096/fj.202101397R	http://dx.doi.org/10.1096/fj.202101397R			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34862975				2022-12-28	WOS:000734992000060
J	Ruiz-Serrano, A; Rodriguez, JMM; Gunter, J; Sherman, SPM; Jucht, AE; Fluechter, P; Volkova, YL; Pfundstein, S; Pellegrini, G; Wagner, CA; Schneider, C; Wenger, RH; Scholz, CC				Ruiz-Serrano, Amalia; Monne Rodriguez, Josep M.; Gunter, Julia; Sherman, Samantha P. M.; Jucht, Agnieszka E.; Fluechter, Pascal; Volkova, Yulia L.; Pfundstein, Svende; Pellegrini, Giovanni; Wagner, Carsten A.; Schneider, Christoph; Wenger, Roland H.; Scholz, Carsten C.			OTUB1 regulates lung development, adult lung tissue homeostasis, and respiratory control	FASEB JOURNAL			English	Article						deubiquitinating enzyme; FIH; HIF1AN; hypoxia; respiratory distress syndrome; respiratory failure	NF-KAPPA-B; GENE-EXPRESSION; ENZYME; INHIBITION; CANCER; SPECIFICITY; METABOLISM; STABILITY; PATHWAY; BINDING	OTUB1 is one of the most highly expressed deubiquitinases, counter-regulating the two most abundant ubiquitin chain types. OTUB1 expression is linked to the development and progression of lung cancer and idiopathic pulmonary fibrosis in humans. However, the physiological function of OTUB1 is unknown. Here, we show that constitutive whole-body Otub1 deletion in mice leads to perinatal lethality by asphyxiation. Analysis of (single-cell) RNA sequencing and proteome data demonstrated that OTUB1 is expressed in all lung cell types with a particularly high expression during late-stage lung development (E16.5, E18.5). At E18.5, the lungs of animals with Otub1 deletion presented with increased cell proliferation that decreased saccular air space and prevented inhalation. Flow cytometry-based analysis of E18.5 lung tissue revealed that Otub1 deletion increased proliferation of major lung parenchymal and mesenchymal/other non-hematopoietic cell types. Adult mice with conditional whole-body Otub1 deletion (wbOtub1(del/del)) also displayed increased lung cell proliferation in addition to hyperventilation and failure to adapt the respiratory pattern to hypoxia. On the molecular level, Otub1 deletion enhanced mTOR signaling in embryonic and adult lung tissues. Based on these results, we propose that OTUB1 is a negative regulator of mTOR signaling with essential functions for lung cell proliferation, lung development, adult lung tissue homeostasis, and respiratory regulation.	[Ruiz-Serrano, Amalia; Gunter, Julia; Sherman, Samantha P. M.; Jucht, Agnieszka E.; Fluechter, Pascal; Volkova, Yulia L.; Pfundstein, Svende; Wagner, Carsten A.; Schneider, Christoph; Wenger, Roland H.; Scholz, Carsten C.] Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Monne Rodriguez, Josep M.; Pellegrini, Giovanni] Univ Zurich, Inst Vet Pathol, Lab Anim Model Pathol LAMP, Zurich, Switzerland; [Gunter, Julia; Wagner, Carsten A.; Wenger, Roland H.; Scholz, Carsten C.] Natl Ctr Competence Res Kidney CH, Zurich, Switzerland	University of Zurich; University of Zurich	Wenger, RH; Scholz, CC (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.; Wenger, RH; Scholz, CC (corresponding author), Natl Ctr Competence Res Kidney CH, Zurich, Switzerland.	roland.wenger@access.uzh.ch; carsten.scholz@uzh.ch		Volkova, Yulia/0000-0001-5772-2889; pellegrini, giovanni/0000-0001-9593-5578; Wagner, Carsten/0000-0002-9874-8898; Jucht, Agnieszka/0000-0002-4553-4319; Scholz, Carsten/0000-0001-6579-8015	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF) [31003A_165679]; National Centre of Competence in Research Kidney.CH; Hartmann Mueller-Stiftung; Peter Hans Hofschneider Professorship for Molecular Medicine	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF); National Centre of Competence in Research Kidney.CH; Hartmann Mueller-Stiftung; Peter Hans Hofschneider Professorship for Molecular Medicine	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF), Grant/Award Number: 31003A_165679; National Centre of Competence in Research Kidney.CH, Grant/Award Number: Junior Grant; Hartmann Mueller-Stiftung; Peter Hans Hofschneider Professorship for Molecular Medicine	Baietti MF, 2016, EMBO MOL MED, V8, P288, DOI 10.15252/emmm.201505972; Bisserier M, 2020, MOL THER, V28, P394, DOI 10.1016/j.ymthe.2019.11.027; Caron A, 2018, PHYSIOL REV, V98, P1765, DOI 10.1152/physrev.00064.2017; Clague MJ, 2019, NAT REV MOL CELL BIO, V20, P338, DOI 10.1038/s41580-019-0099-1; Clague MJ, 2015, TRENDS CELL BIOL, V25, P417, DOI 10.1016/j.tcb.2015.03.002; Clapcote SJ, 2005, BIOTECHNIQUES, V38, P702, DOI 10.2144/05385BM05; Cole-Jeffrey CT, 2012, ANAT REC, V295, P764, DOI 10.1002/ar.22432; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Du Y., 2020, LUNG GLANCE INTEGRAT; Du YN, 2017, THORAX, V72, P481, DOI 10.1136/thoraxjnl-2016-209598; Du YN, 2015, THORAX, V70, P1092, DOI 10.1136/thoraxjnl-2015-207035; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Goncharov T, 2013, EMBO J, V32, P1103, DOI 10.1038/emboj.2013.62; Gschwend J, 2021, J EXP MED, V218, DOI 10.1084/jem.20210745; Gunter J, 2017, EXP CELL RES, V356, P152, DOI 10.1016/j.yexcr.2017.03.027; Gutsche K, 2016, FREE RADICAL BIO MED, V101, P129, DOI 10.1016/j.freeradbiomed.2016.10.002; Herhaus L, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa0441; Horimasu Y, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0449-9; Huang KZ, 2014, SEMIN CELL DEV BIOL, V36, P79, DOI 10.1016/j.semcdb.2014.09.011; Ikeda H, 2011, MOL CELL BIOL, V31, P1054, DOI 10.1128/MCB.00732-10; Imeri F, 2019, KIDNEY INT, V95, P375, DOI 10.1016/j.kint.2018.08.043; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Koschel J, 2021, CELL DEATH DIFFER, V28, P2257, DOI 10.1038/s41418-021-00752-9; Land SC, 2014, SEMIN CELL DEV BIOL, V36, P68, DOI 10.1016/j.semcdb.2014.09.023; Li YC, 2019, CELL RES, V29, P474, DOI 10.1038/s41422-019-0174-3; Li YH, 2014, J BIOL CHEM, V289, P5097, DOI 10.1074/jbc.M113.533109; Lin JT, 2009, J IMMUNOL, V182, P5919, DOI 10.4049/jimmunol.0803986; Lopez-Barneo J, 2016, PFLUG ARCH EUR J PHY, V468, P59, DOI 10.1007/s00424-015-1734-0; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Mulas F, 2021, CELL MOL IMMUNOL, V18, P1512, DOI 10.1038/s41423-020-0362-6; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Orlando IMC, 2020, HAEMATOLOGICA, V105, P2774, DOI 10.3324/haematol.2019.236406; Pickel C, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101265; Prabhakar NR, 2016, PFLUG ARCH EUR J PHY, V468, P71, DOI 10.1007/s00424-015-1719-z; Randi EB, 2020, ANTIOXID REDOX SIGN, V32, P1155, DOI 10.1089/ars.2019.7868; Saldana M, 2019, ENDOCR-RELAT CANCER, V26, pR1, DOI 10.1530/ERC-18-0264; Sato Y, 2012, J BIOL CHEM, V287, P25860, DOI 10.1074/jbc.M112.364752; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schittny JC, 2017, CELL TISSUE RES, V367, P427, DOI 10.1007/s00441-016-2545-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scholz CC, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002347; Scholz CC, 2013, P NATL ACAD SCI USA, V110, P18490, DOI 10.1073/pnas.1309718110; Sulser P, 2020, FASEB J, V34, P2344, DOI 10.1096/fj.201902240R; Sun XX, 2012, EMBO J, V31, P576, DOI 10.1038/emboj.2011.434; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Wang X, 2019, EMBO J, V38, DOI 10.15252/embj.2018100947; Wiener R, 2013, NAT STRUCT MOL BIOL, V20, P1033, DOI 10.1038/nsmb.2655; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Xie JJ, 2019, J CELL PHYSIOL, V234, P22845, DOI 10.1002/jcp.28848; Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001; Zhao LL, 2018, J BIOL CHEM, V293, P4883, DOI 10.1074/jbc.M117.809533; Zhou K, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00408-0; Zhou XF, 2019, NAT IMMUNOL, V20, P879, DOI 10.1038/s41590-019-0405-2; Zhu Q, 2021, AGEING RES REV, V67, DOI 10.1016/j.arr.2021.101303	58	4	4	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22039	10.1096/fj.202100346R	http://dx.doi.org/10.1096/fj.202100346R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34793600	Green Published			2022-12-28	WOS:000722321300003
J	Gao, Y; Luo, CL; Rui, TY; Fan, YY; Yao, Y; Shen, HJ; Gao, C; Wang, T; Wang, HC; Chen, XS; Zhang, JX; Li, DY; Xia, CJ; Li, LL; Wang, ZF; Zhang, MY; Chen, XP; Tao, LY				Gao, Yuan; Luo, Chengliang; Rui, Tongyu; Fan, Yanyan; Yao, Yi; Shen, Hengji; Gao, Cheng; Wang, Tao; Wang, Haochen; Chen, Xueshi; Zhang, Jiaxin; Li, Dongya; Xia, Chongjian; Li, Li-Li; Wang, Zufeng; Zhang, Mingyang; Chen, Xiping; Tao, Luyang			Autophagy inhibition facilitates wound closure partially dependent on the YAP/IL-33 signaling in a mouse model of skin wound healing	FASEB JOURNAL			English	Article						autophagy; hippo signaling pathway; interleukin-33; skin wound healing; ST2; YAP	STEM-CELLS; YAP; TAZ	Autophagy is a self-phagocytic and highly evolutionarily conserved intracellular lysosomal catabolic system, which plays a vital role in a variety of trauma models, including skin wound healing (SWH). However, the roles and potential mechanisms of autophagy in SWH are still controversial. We firstly investigated the role of autophagy in SWH-induced wound closure rate, inflammatory response, and histopathology, utilizing an inhibitor of autophagy 3-methyladenine (3-MA) and its agonist rapamycin (RAP). As expected, we found 3-MA treatment remarkably increased the wound closure rate, combated inflammation response, and mitigated histopathological changes, while RAP delivery aggravated SWH-induced pathological damage. To further exploit the underlying mechanism of autophagy regulating inflammation, the specific inhibitors of yes-associated protein (YAP), Verteporfin, and Anti-IL-33 were applied. Herein, treating with 3-MA markedly suppressed the expression of tumor necrosis factor-alpha (TNF-alpha), IL-1 beta, and IL-6, promoted that of IL-10, IL-33, and ST2, while RAP administration reverted SWH-induced the up-regulation of these inflammatory cytokines mentioned above. Importantly, Verteporfin administration not only down-regulated the expression levels of YAP, TNF-alpha, and IL-6 but also up-regulated that of IL-33 and IL-10. Unexpectedly, 3-MA or RAP retreatment did not have any impact on the changes in IL-33 among these inflammatory indicators. Furthermore, elevated expression of IL-33 promoted wound closure and alleviated the pathological damage, whereas, its antagonist Anti-IL-33 treatment overtly reversed the above-mentioned effects of IL-33. Moreover, 3-MA in combination with anti-IL-33 treatment reversed the role of 3-MA alone in mitigated pathological changes, but they failed to revert the effect of anti-IL-33 alone on worsening pathological damage. In sum, emerging data support the novel contribution of the YAP/IL-33 pathway in autophagy inhibition against SWH-induced pathological damage, and highlight that the autophagy/YAP/IL-33 signal axis is expected to become a new therapeutic target for SWH.	[Gao, Yuan; Luo, Chengliang; Rui, Tongyu; Gao, Cheng; Wang, Tao; Wang, Haochen; Chen, Xueshi; Zhang, Jiaxin; Wang, Zufeng; Zhang, Mingyang; Chen, Xiping; Tao, Luyang] Soochow Univ, Dept Forens Sci, Med Sch, 178 Ganjiang East Rd, Suzhou 215123, Peoples R China; [Gao, Yuan; Fan, Yanyan; Yao, Yi; Shen, Hengji; Xia, Chongjian] Wenzhou Med Univ, Dept Forens Sci, Wenzhou, Peoples R China; [Gao, Yuan] Acad Forens Sci, Dept Shanghai Key Lab Forens Med, Shanghai Forens Serv Platform, Shanghai, Peoples R China; [Li, Dongya] Soochow Univ, Affiliated Hosp 1, Orthoped Inst, Dept Orthoped, Suzhou, Peoples R China; [Li, Li-Li] Soochow Univ, Dept Child & Adolescent Healthcare, Childrens Hosp, Suzhou, Peoples R China	Soochow University - China; Wenzhou Medical University; Soochow University - China; Soochow University - China	Chen, XP; Tao, LY (corresponding author), Soochow Univ, Dept Forens Sci, Med Sch, 178 Ganjiang East Rd, Suzhou 215123, Peoples R China.	xiping.chen@163.com; taoluyang@suda.edu.cn	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237	National Natural Science Foundation	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation	Allan D, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0344-1; Bharath LP, 2020, CELL METAB, V32, P44, DOI 10.1016/j.cmet.2020.04.015; Cheng JB, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00281; Chiu HW, 2016, J MOL MED, V94, P809, DOI 10.1007/s00109-016-1389-0; Davis FM, 2019, J IMMUNOL, V202, P1777, DOI 10.4049/jimmunol.1801258; Elbediwy A, 2016, DEVELOPMENT, V143, P1674, DOI 10.1242/dev.133728; Fallah M, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1106-8; Ferhat M, 2018, J AM SOC NEPHROL, V29, P1272, DOI 10.1681/ASN.2017060650; Gao Y, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.83; Gao Y, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00898; Gorbunov NV, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081693; Griffin DR, 2021, NAT MATER, V20, P560, DOI 10.1038/s41563-020-00844-w; Guo YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36416; Hao D, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1261-y; He RG, 2017, MOL IMMUNOL, V90, P42, DOI 10.1016/j.molimm.2017.06.249; He ZH, 2017, AUTOPHAGY, V13, P1884, DOI 10.1080/15548627.2017.1359449; Holgado A, 2019, J ALLERGY CLIN IMMUN, V144, P204, DOI 10.1016/j.jaci.2019.02.028; Huang LP, 2020, EXP NEUROL, V333, DOI 10.1016/j.expneurol.2020.113431; Jin GX, 2018, NAT IMMUNOL, V19, P29, DOI 10.1038/s41590-017-0002-1; Kessing BF, 2014, AM J GASTROENTEROL, V109, P1196, DOI 10.1038/ajg.2014.165; Kim W, 2018, GUT, V67, P1692, DOI 10.1136/gutjnl-2017-314061; Kim YH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08773-2; Koo Jeung-Hyun, 2019, Exp Mol Med, V51, P1, DOI 10.1038/s12276-019-0248-9; Lee MJ, 2014, J INVEST DERMATOL, V134, P518, DOI 10.1038/jid.2013.339; Lei M, 2019, INFLAMM RES, V68, P665, DOI 10.1007/s00011-019-01250-y; Leyva-Castillo JM, 2019, IMMUNITY, V50, P1262, DOI 10.1016/j.immuni.2019.03.023; Li W, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0612-3; Liu B, 2016, CELL, V164, P406, DOI 10.1016/j.cell.2015.12.029; Liu J, 2017, AM J PATHOL, V187, P1313, DOI 10.1016/j.ajpath.2017.02.010; Lv Y, 2018, CIRC RES, V123, P43, DOI 10.1161/CIRCRESAHA.118.313143; Maday S, 2016, J NEUROSCI, V36, P5933, DOI 10.1523/JNEUROSCI.4401-15.2016; Manfredi AA, 2017, PHARMACOL RES, V123, P146, DOI 10.1016/j.phrs.2016.08.008; Meng CL, 2020, CELL DEATH DIFFER, V27, P2797, DOI 10.1038/s41418-020-0544-x; Mills RE, 2008, J IMMUNOL, V181, P3974, DOI 10.4049/jimmunol.181.6.3974; Mooring M, 2020, HEPATOLOGY, V71, P1813, DOI 10.1002/hep.30928; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Nussbaum SR, 2018, VALUE HEALTH, V21, P27, DOI 10.1016/j.jval.2017.07.007; Rak GD, 2016, J INVEST DERMATOL, V136, P487, DOI 10.1038/JID.2015.406; Romeo-Guitart D, 2020, THERANOSTICS, V10, P5154, DOI 10.7150/thno.43765; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Sangiovanni E, 2019, PHYTOTHER RES, V33, P2083, DOI 10.1002/ptr.6400; SARDA AK, 1990, ANN ROY COLL SURG, V72, P18; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Song XZ, 2017, REDOX BIOL, V11, P219, DOI 10.1016/j.redox.2016.12.015; Sun X, 2020, NUCLEIC ACIDS RES, V48, P7182, DOI 10.1093/nar/gkaa482; Taniguchi S, 2020, SCIENCE, V369, P269, DOI 10.1126/science.aay1813; Totaro A, 2019, P NATL ACAD SCI USA, V116, P17848, DOI 10.1073/pnas.1908228116; Tuncel J, 2019, J EXP MED, V216, P1328, DOI 10.1084/jem.20182002; Wicher G, 2017, J NEUROTRAUM, V34, P3173, DOI 10.1089/neu.2016.4900; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Wu YL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13393; Xue R, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2798070; Yang Y, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158779; Yang YY, 2017, J NEUROSCI, V37, P4692, DOI 10.1523/JNEUROSCI.3233-16.2017; Yuan P, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2343-1	55	1	1	4	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21920	10.1096/fj.202002623RRR	http://dx.doi.org/10.1096/fj.202002623RRR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34547141				2022-12-28	WOS:000702238200010
J	Garbioglu, DB; Demir, N; Ozel, C; Avci, H; Dincer, M				Garbioglu, Duygu Bayir; Demir, Nazan; Ozel, Ceren; Avci, Huseyin; Dincer, Murat			Determination of therapeutic agents efficiencies of microsatellite instability high colon cancer cells in post-metastatic liver biochip modeling	FASEB JOURNAL			English	Article						colon cancer; drug screen platforms; microsatellite instability high type; organ-on-a-chip	COLORECTAL-CANCER; ADJUVANT CHEMOTHERAPY; CHIP; FLUOROURACIL; EFFICACY; CULTURE; PREDICT	Two distinct genetic mutational pathways characterized by either chromosomal instability or high-frequency microsatellite instability (MSI-H) are recognized in the pathogenesis of colorectal cancer (CRC). Recently, it has been shown that patients with primary CRC that displays MSI-H have a significant, stage-independent, multivariate survival advantage. Biological properties of CMS1 (MSI-H type) can affect therapeutic efficiencies of agents used in the treatment of CRC, and therefore become a new predictive factor of the treatment. But, the predictive impact of MSI-H status for adjuvant chemotherapy remains controversial. This study will assess whether there is any unnecessary or inappropriate use of treatment agents recommended for adjuvant therapy of stage 2 and 3 of disease and for palliative or curative treatment of liver metastatic disease in microsatellite instability high group, a molecular subtype of colon cancer. Within this scope, the efficiencies of fluorouracil- and oxaliplatin-based chemotherapeutic agents will be shown on stage 3 microsatellite instability high colon tumor cell lines first, and then a microfluidic model will be created, imitating the metastasis of colon cancer to the liver. In the microfluidic chip model, we will create in liver tissue, where the metastasis of microsatellite instability high colon cancer will be simulated; the effectiveness of chemotherapeutic agents, immunotherapy agents, and targeted agents on tumor cells as well as drug response will be assessed according to cell viability through released biomarkers from the cells. The proposed hypothesis study includes the modeling and treatment of patient-derived post-metastatic liver cancer in microfluidics which has priority at the global and our region and consequently develop personal medication.	[Garbioglu, Duygu Bayir; Demir, Nazan; Dincer, Murat] Eskisehir Osmangazi Univ, Fac Med, Dept Med Oncol, TR-26040 Eskisehir, Turkey; [Ozel, Ceren; Avci, Huseyin] Eskisehir Osmangazi Univ, Cellular Therapy & Stem Cell Prod Applicat & Res, ESTEM, Eskisehir, Turkey; [Ozel, Ceren; Avci, Huseyin] Eskisehir Osmangazi Univ, Inst Hlth Sci, Dept Stem Cell, Eskisehir, Turkey; [Avci, Huseyin] Eskisehir Osmangazi Univ, Met & Mat Engn, Eskisehir, Turkey	Eskisehir Osmangazi University; Eskisehir Osmangazi University; Eskisehir Osmangazi University; Eskisehir Osmangazi University	Garbioglu, DB (corresponding author), Eskisehir Osmangazi Univ, Fac Med, Dept Med Oncol, TR-26040 Eskisehir, Turkey.; Ozel, C (corresponding author), Eskisehir Osmangazi Univ, Stem Cell Dept, Cellular Therapy & Stem Cell Prod Applicat & Res, ESTEM,Inst Hlth Sci, TR-26040 Eskisehir, Turkey.	duygubayir@hotmail.com; ceren.zel@gmail.com		Avci, Huseyin/0000-0002-2475-1963				Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Aleman J, 2019, BIOTECHNOL BIOENG, V116, P936, DOI 10.1002/bit.26871; Alwers E, 2020, MOL ONCOL, V14, P363, DOI 10.1002/1878-0261.12611; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Avci H, 2018, TURK J CHEM, V42, P587, DOI 10.3906/kim-1611-35; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Bregenzer ME, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216564; Cohen R, 2021, J CLIN ONCOL, V39, P642, DOI 10.1200/JCO.20.01600; Coluccio ML, 2019, MICROELECTRON ENG, V208, P14, DOI 10.1016/j.mee.2019.01.004; Cui P, 2019, J PHARM ANAL, V9, P238, DOI 10.1016/j.jpha.2018.12.001; Deng J, 2019, MICROMACHINES-BASEL, V10, DOI 10.3390/mi10100676; Des Guetz G, 2009, EUR J CANCER, V45, P1890, DOI 10.1016/j.ejca.2009.04.018; Des Guetz G, 2009, ANTICANCER RES, V29, P1615; Di Modugno F, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1086-2; Diaz LA, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.4_suppl.TPS877; Esch MB, 2015, LAB CHIP, V15, P2269, DOI 10.1039/c5lc00237k; Fujiyoshi K, 2017, ANTICANCER RES, V37, P239, DOI 10.21873/anticanres.11313; Ghaemmaghami AM, 2012, DRUG DISCOV TODAY, V17, P173, DOI 10.1016/j.drudis.2011.10.029; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Haddad R, 2004, ANN SURG ONCOL, V11, P977, DOI 10.1245/ASO.2004.03.585; Jang KJ, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax5516; Kashaninejad N, 2016, MICROMACHINES-BASEL, V7, DOI 10.3390/mi7080130; Le DT, 2016, J CLIN ONCOL, V34, DOI 10.1200/jco.2016.34.4_suppl.tps787; Lei H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02667; Li K, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-019-1091-8; Low LA, 2021, NAT REV DRUG DISCOV, V20, P345, DOI 10.1038/s41573-020-0079-3; Low LA, 2017, EXP BIOL MED, V242, P1573, DOI 10.1177/1535370217700523; Lu SM, 2018, LAB CHIP, V18, DOI 10.1039/c8lc00852c; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; Menter David G, 2019, Curr Gastroenterol Rep, V21, P5, DOI 10.1007/s11894-019-0674-9; Ogura T, 2014, ONCOL REP, V32, P50, DOI 10.3892/or.2014.3165; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Ramadan Q, 2020, BIOMICROFLUIDICS, V14, DOI 10.1063/5.0011583; Rennert K, 2015, BIOMATERIALS, V71, P119, DOI 10.1016/j.biomaterials.2015.08.043; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654; Skardal A, 2016, BIOTECHNOL BIOENG, V113, P2020, DOI 10.1002/bit.25950; Sontheimer-Phelps A, 2019, NAT REV CANCER, V19, P65, DOI 10.1038/s41568-018-0104-6; Soreide K, 2006, BRIT J SURG, V93, P395, DOI 10.1002/bjs.5328; Sreepadmanabh M, 2018, BIOTECHNOL ADV, V36, P1094, DOI 10.1016/j.biotechadv.2018.03.009; Tanaka HY, 2018, CANCER SCI, V109, P2085, DOI 10.1111/cas.13630; Tougeron D, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv438; van Duinen V, 2015, CURR OPIN BIOTECH, V35, P118, DOI 10.1016/j.copbio.2015.05.002; Warusavitarne J, 2007, INT J COLORECTAL DIS, V22, P739, DOI 10.1007/s00384-006-0228-0; Webber EM, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1093-4; Williamson T, 2019, CLIN TRANSL MED, V8, DOI 10.1186/s40169-019-0237-6; Yu XZ, 2020, ONCOTARGETS THER, V13, P11645, DOI 10.2147/OTT.S271955; Zhang QC, 2012, BIONANOSCIENCE, V2, P277, DOI 10.1007/s12668-012-0051-8	49	1	1	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21834	10.1096/fj.202100333R	http://dx.doi.org/10.1096/fj.202100333R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34403553				2022-12-28	WOS:000691122900049
J	Kohno, T; Konno, T; Kikuchi, S; Kondoh, M; Kojima, T				Kohno, Takayuki; Konno, Takumi; Kikuchi, Shin; Kondoh, Masuo; Kojima, Takashi			Translocation of LSR from tricellular corners causes macropinocytosis at cell-cell interface as a trigger for breaking out of contact inhibition	FASEB JOURNAL			English	Article						contact inhibition; endometrial cancer; macropinocytosis; multilayered cell growth; planar cell migration	STIMULATED LIPOPROTEIN RECEPTOR; TIGHT JUNCTION PROTEINS; CIRCULAR DORSAL RUFFLES; PARACELLULAR PERMEABILITY; SIGNALING-PATHWAY; BARRIER FUNCTION; DOWN-REGULATION; EXCHANGER NHE1; INTERNALIZATION; MIGRATION	Withdrawal from contact inhibition is necessary for epithelial cancer precursor cells to initiate cell growth and motility. Nevertheless, little is understood about the mechanism for the sudden initiation of cell growth under static conditions. We focused on cellular junctions as one region where breaking out of contact inhibition occurs. In well-differentiated endometrial cancer cells, Sawano, the ligand administration for tricellular tight junction protein LSR, which transiently decreased the robust junction property, caused an abrupt increase in cell motility and consequent excessive multilayered cell growth despite being under contact inhibition conditions. We observed that macropinocytosis essentially and temporarily occurred as an antecedent event for the above process at intercellular junctions without disruption of the junction apparatus but not at the apical plasma membrane. Collectively, we concluded that the formation of macropinocytosis, which is derived from tight junction-mediated signaling, was triggered for the initiation of cell growth in static precancerous epithelium.	[Kohno, Takayuki; Konno, Takumi; Kojima, Takashi] Sapporo Med Univ, Res Inst Frontier Med, Dept Cell Sci, Sapporo, Hokkaido, Japan; [Kikuchi, Shin] Sapporo Med Univ, Dept Anat, Sapporo, Hokkaido, Japan; [Kondoh, Masuo] Osaka Univ, Drug Innovat Ctr, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan	Sapporo Medical University; Sapporo Medical University; Osaka University	Kohno, T (corresponding author), Sapporo Med Univ, Res Inst Frontier Med, Dept Cell Sci, Chuo Ku, Minami 1,Nishi 17, Sapporo, Hokkaido 0608556, Japan.	kohno@sapmed.ac.jp		Kohno, Takayuki/0000-0002-1782-3578	MEXT | Japan Society for the Promotion of Science (JSPS) [JP19K05736]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP19K05736	Amith SR, 2015, ONCOTARGET, V6, P1262, DOI 10.18632/oncotarget.2860; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Bhat AA, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01942; Bohdanowicz M, 2013, PHYSIOL REV, V93, P69, DOI 10.1152/physrev.00002.2012; Bretou M, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aak9573; Bruewer M, 2005, FASEB J, V19, P923, DOI 10.1096/fj.04-3260com; Buckley CM, 2017, FEBS J, V284, P3778, DOI 10.1111/febs.14115; Chen YH, 2000, MOL BIOL CELL, V11, P849, DOI 10.1091/mbc.11.3.849; Chiasson-MacKenzie C, 2018, GENE DEV, V32, P1201, DOI 10.1101/gad.317354.118; Citi Sandra, 2019, Biophys Rev, V11, P783, DOI 10.1007/s12551-019-00582-7; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Condon KJ, 2019, J CELL SCI, V132, DOI 10.1242/jcs.222570; Davidson SM, 2017, NAT MED, V23, P235, DOI 10.1038/nm.4256; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Donowitz M, 2013, MOL ASPECTS MED, V34, P236, DOI 10.1016/j.mam.2012.05.001; Eisenhoffer GT, 2013, TRENDS CELL BIOL, V23, P185, DOI 10.1016/j.tcb.2012.11.006; Ferreira APA, 2018, TRENDS CELL BIOL, V28, P188, DOI 10.1016/j.tcb.2017.11.004; Fliegel L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102378; Garcia MA, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029181; Gu ZZ, 2011, J CELL BIOL, V193, P61, DOI 10.1083/jcb.201007003; Guan XD, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0923-z; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Gumbiner BM, 2014, J CELL SCI, V127, P709, DOI 10.1242/jcs.140103; Hendus-Altenburger R, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0252-7; Higashi T, 2013, J CELL SCI, V126, P966, DOI 10.1242/jcs.116442; Hopkins AM, 2003, J CELL SCI, V116, P725, DOI 10.1242/jcs.00300; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoue S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13708-y; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Kaminota T, 2017, BIOCHEM BIOPH RES CO, V486, P101, DOI 10.1016/j.bbrc.2017.03.007; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; King JS, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0158; Kodera Y, 2020, BIOCHEM BIOPH RES CO, V527, P553, DOI 10.1016/j.bbrc.2020.04.113; Kohno T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143555; Kohno T, 2017, ANN NY ACAD SCI, V1397, P185, DOI 10.1111/nyas.13362; Kohno T, 2015, MOL PHARMACOL, V87, P815, DOI 10.1124/mol.114.096982; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Konno T, 2020, TISSUE BARRIERS, V8, DOI 10.1080/21688370.2019.1695475; Krug SM, 2017, J CONTROL RELEASE, V260, P1, DOI 10.1016/j.jconrel.2017.05.024; Kyuno T, 2020, HISTOCHEM CELL BIOL, V153, P5, DOI 10.1007/s00418-019-01821-4; Liu ZZ, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00001; Magi S., 2012, SCI REP-UK, V2, P1; Maltese WA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00038; Matsuda M, 2004, J CELL SCI, V117, P1247, DOI 10.1242/jcs.00972; Mayor R, 2010, TRENDS CELL BIOL, V20, P319, DOI 10.1016/j.tcb.2010.03.005; McClatchey AI, 2012, CURR OPIN CELL BIOL, V24, P685, DOI 10.1016/j.ceb.2012.06.009; Mettlen M, 2006, TRAFFIC, V7, P589, DOI 10.1111/j.1600-0854.2006.00412.x; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Nagahama M, 2018, TOXINS, V10, DOI 10.3390/toxins10100405; Ohsawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054503; Okada T, 2007, TRENDS CELL BIOL, V17, P222, DOI 10.1016/j.tcb.2007.03.006; Papatheodorou P, 2011, P NATL ACAD SCI USA, V108, P16422, DOI 10.1073/pnas.1109772108; Pernet-Gallay K, 2017, J CEREBR BLOOD F MET, V37, P1264, DOI 10.1177/0271678X16654157; Recouvreux MV, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00261; Selwan EM, 2016, FEBS LETT, V590, P885, DOI 10.1002/1873-3468.12121; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Shimada H, 2017, ONCOL LETT, V14, P6776, DOI 10.3892/ol.2017.7038; Shimada H, 2017, SCI REP-UK, V7, DOI 10.1038/srep37049; Shimada H, 2016, ONCOTARGET, V7, P27735, DOI 10.18632/oncotarget.8408; Sohet F, 2015, J CELL BIOL, V208, P703, DOI 10.1083/jcb.201410131; Srivastava RK, 2019, P NATL ACAD SCI USA, V116, P24583, DOI 10.1073/pnas.1911393116; Stamatovic SM, 2017, ANN NY ACAD SCI, V1397, P54, DOI 10.1111/nyas.13346; Stramer B, 2017, NAT REV MOL CELL BIO, V18, P43, DOI 10.1038/nrm.2016.118; Takano K, 2016, ANTICANCER RES, V36, P5895, DOI 10.21873/anticanres.11176; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; Valdivia A, 2017, MOL BIOL CELL, V28, P1768, DOI 10.1091/mbc.E16-06-0412; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wu N., 2020, ENCY GASTROENTEROL, V42, P300; Yamada T, 2020, NAT STRUCT MOL BIOL, V27, P288, DOI 10.1038/s41594-020-0388-6; Yamaki T, 2013, BIOL PHARM BULL, V36, P432, DOI 10.1248/bpb.b12-00878; Yoshida S, 2018, J CELL SCI, V131, DOI 10.1242/jcs.220517; Yoshida S, 2018, CELL MOL LIFE SCI, V75, P1227, DOI 10.1007/s00018-017-2710-y; Zeniya S, 2018, J CONTROL RELEASE, V283, P126, DOI 10.1016/j.jconrel.2018.05.010; Zhang YJ, 2019, TRENDS CANCER, V5, P332, DOI 10.1016/j.trecan.2019.04.002; Zihni C, 2014, J CELL SCI, V127, P3401, DOI 10.1242/jcs.145029	76	1	1	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21742	10.1096/fj.202100299R	http://dx.doi.org/10.1096/fj.202100299R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34403506				2022-12-28	WOS:000691122900037
J	Yang, L; Li, DX; Cao, BQ; Liu, SJ; Xu, DH; Zhu, XY; Liu, YJ				Yang, Lu; Li, Dong-Xia; Cao, Bu-Qing; Liu, Shu-Juan; Xu, Dan-Hong; Zhu, Xiao-Yan; Liu, Yu-Jian			Exercise training ameliorates early diabetic kidney injury by regulating the H2S/SIRT1/p53 pathway	FASEB JOURNAL			English	Article						apoptosis; diabetic nephropathy; exercise training; H2S; p53; SIRT1	HYDROGEN-SULFIDE; OXIDATIVE STRESS; NEPHROPATHY; APOPTOSIS; CONTRIBUTES; PROGRESSION; EXPRESSION; PROTECTS; FIBROSIS; MELLITUS	Exercise training exerts protective effects against diabetic nephropathy. This study aimed to investigate whether exercise training could attenuate diabetic renal injury via regulating endogenous hydrogen sulfide (H2S) production. First, C57BL/6 mice were allocated into the control, diabetes, exercise, and diabetes + exercise groups. Diabetes was induced by intraperitoneal injection of streptozotocin (STZ). Treadmill exercise continued for four weeks. Second, mice was allocated into the control, diabetes, H2S and diabetes + H2S groups. H2S donor sodium hydrosulfide (NaHS) was intraperitoneally injected once daily for four weeks. STZ-induced diabetic mice exhibited glomerular hypertrophy, tissue fibrosis and increased urine albumin levels, urine protein- and albumin-to-creatinine ratios, which were relieved by exercise training. Diabetic renal injury was associated with apoptotic cell death, as evidenced by the enhanced caspase-3 activity, the increased TdT-mediated dUTP nick-end labeling -positive cells and the reduced expression of anti-apoptotic proteins, all of which were attenuated by exercise training. Exercise training enhanced renal sirtuin 1 (SIRT1) expression in diabetic mice, accompanied by an inhibition of the p53-#ediated pro-apoptotic pathway. Furthermore, exercise training restored the STZ-mediated downregulation of cystathionine-beta-synthase (CBS) and cystathionine-gamma-lyase (CSE) and the reduced renal H2S production. NaHS treatment restored SIRT1 expression, inhibited the p53-mediated pro-apoptotic pathway and attenuated diabetes-associated apoptosis and renal injury. In high glucose-treated MPC5 podocytes, NaHS treatment inhibited the p53-mediated pro-apoptotic pathway and podocyte apoptosis in a SIRT1-dependent manner. Collectively, exercise training upregulated CBS/CSE expression and enhanced the endogenous H2S production in renal tissues, thereby contributing to the modulation of the SIRT1/p53 apoptosis pathway and improvement of diabetic nephropathy.	[Yang, Lu; Li, Dong-Xia; Xu, Dan-Hong; Liu, Yu-Jian] Shanghai Univ Sport, Sch Kinesiol, Key Lab Exercise & Hlth Sci, Minist Educ, 200 Hengren Rd, Shanghai 200438, Peoples R China; [Cao, Bu-Qing; Zhu, Xiao-Yan] Navy Med Univ, Dept Physiol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China; [Cao, Bu-Qing] Guangxi Univ Chinese Med, Ruikang Hosp, Dept Lab Med, Nanning, Peoples R China; [Liu, Shu-Juan] China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China	Shanghai University of Sport; Naval Medical University; Guangxi University of Chinese Medicine	Liu, YJ (corresponding author), Shanghai Univ Sport, Sch Kinesiol, Key Lab Exercise & Hlth Sci, Minist Educ, 200 Hengren Rd, Shanghai 200438, Peoples R China.; Zhu, XY (corresponding author), Navy Med Univ, Dept Physiol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.	liuyujian@sus.edu.cn	Li, Dongxia/AAD-2297-2022	Liu, Yu-Jian/0000-0002-1920-6653	National Natural Science Foundation of China (NSFC) [81672266, 31671213, 31871156, 31971101]; Foundation of Health Commission of Guangxi Zhuang Automomous Region [Z20170056]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Foundation of Health Commission of Guangxi Zhuang Automomous Region	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81672266, 31671213, 31871156 and 31971101; Foundation of Health Commission of Guangxi Zhuang Automomous Region, Grant/Award Number: Z20170056	Abdelbasset WK, 2020, CLIN RHEUMATOL, V39, P3091, DOI 10.1007/s10067-020-05086-4; Ahmed HH, 2019, MOL CELL BIOCHEM, V457, P1, DOI 10.1007/s11010-019-03506-x; Barlovic DP, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1157-y; Behera J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33149-9; Cao X, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00385; Chen Y., 2018, OXID MED CELL LONGEV, V2018, P1, DOI [10.1155/2018/6717212, DOI 10.1155/2018/6141035]; Du SF, 2019, ACTA PHYSIOL, V225, DOI 10.1111/apha.13177; Elbassuoni EA, 2020, J CELL PHYSIOL, V235, P5223, DOI 10.1002/jcp.29403; Feliers D, 2016, ANTIOXID REDOX SIGN, V25, P720, DOI 10.1089/ars.2015.6596; Gadalla MM, 2010, J NEUROCHEM, V113, P14, DOI 10.1111/j.1471-4159.2010.06580.x; Guo L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147018; Haku S, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2817045; Heiwe S, 2014, AM J KIDNEY DIS, V64, P383, DOI 10.1053/j.ajkd.2014.03.020; Howden EJ, 2015, CURR OPIN NEPHROL HY, V24, P480, DOI 10.1097/MNH.0000000000000165; Huang CC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020613; Ishikawa Y, 2012, EXP DIABETES RES, DOI 10.1155/2012/702948; Jiang YP, 2021, FASEB J, V35, DOI 10.1096/fj.202001138RR; John ASP, 2019, AM J PHYSIOL-ENDOC M, V317, pE269, DOI 10.1152/ajpendo.00251.2018; Jung KJ, 2013, BBA-MOL BASIS DIS, V1832, P1989, DOI 10.1016/j.bbadis.2013.06.015; Kang B, 2017, CELL PHYSIOL BIOCHEM, V41, P10, DOI 10.1159/000455816; Kar S, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8120638; Karimi Asiyeh, 2017, J Nephropathol, V6, P150, DOI 10.15171/jnp.2017.26; Kaur M, 2015, J DIABETES METAB DIS, V14, DOI 10.1186/s40200-015-0185-7; Kundu S, 2015, NITRIC OXIDE-BIOL CH, V46, P172, DOI 10.1016/j.niox.2015.02.003; Kundu S, 2013, AM J PHYSIOL-ENDOC M, V304, pE1365, DOI 10.1152/ajpendo.00604.2012; Lee HJ, 2012, J BIOL CHEM, V287, P4451, DOI 10.1074/jbc.M111.278325; Li L, 2017, MOL MED REP, V16, P1715, DOI 10.3892/mmr.2017.6813; Liu F, 2016, SCI REP-UK, V6, DOI 10.1038/srep33676; Liu HY, 2020, CLIN EXP PHARMACOL P, V47, P302, DOI 10.1111/1440-1681.13201; Liu HW, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0349-4; Liu LL, 2019, LIFE SCI, V238, DOI 10.1016/j.lfs.2019.116957; Liu WT, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.335; Liu Y, 2015, INT J CLIN EXP PATHO, V8, P6814; Lotfy M, 2017, CURR DIABETES REV, V13, P3, DOI 10.2174/1573399812666151016101622; Ma YQ, 2016, DIABETES RES CLIN PR, V113, P171, DOI 10.1016/j.diabres.2015.12.013; Mao ZM, 2019, FREE RADICAL BIO MED, V134, P190, DOI 10.1016/j.freeradbiomed.2019.01.009; Mohan T, 2017, J AGR FOOD CHEM, V65, P8028, DOI 10.1021/acs.jafc.7b03301; Mrakovcic M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102415; Nagata M, 2016, KIDNEY INT, V89, P1221, DOI 10.1016/j.kint.2016.01.012; Oghbaei H, 2015, ADV PHARM BULL, V5, P127, DOI 10.5681/apb.2015.018; Oliverio AL, 2020, ADV CHRONIC KIDNEY D, V27, P477, DOI 10.1053/j.ackd.2020.06.001; Palamarchuk I, 2020, Georgian Med News, P147; Pushpakumar S, 2021, GEROSCIENCE, V43, P1349, DOI 10.1007/s11357-020-00299-6; Pushpakumar S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38467-6; Rodrigues AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097452; Safar MM, 2015, PHARMACOL REP, V67, P17, DOI 10.1016/j.pharep.2014.08.001; Seo DY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246284; Sha JB, 2017, MOL MED REP, V16, P7715, DOI 10.3892/mmr.2017.7522; Shi XJ, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00274; Somineni HK, 2014, J ENDOCRINOL, V221, P235, DOI 10.1530/JOE-13-0532; Song K, 2014, KIDNEY INT, V85, P1318, DOI 10.1038/ki.2013.449; Sun HJ, 2019, MOLECULES, V24, DOI 10.3390/molecules24152857; Tang LX, 2018, MED SCI MONITOR, V24, P9081, DOI 10.12659/MSM.912877; Tang ZP, 2016, INT HEART J, V57, P96, DOI 10.1536/ihj.15-099; Tesch GH, 2010, SEMIN NEPHROL, V30, P290, DOI 10.1016/j.semnephrol.2010.03.007; Torban E, 2019, KIDNEY INT, V96, P850, DOI 10.1016/j.kint.2019.05.015; Turkmen K, 2017, INT UROL NEPHROL, V49, P837, DOI 10.1007/s11255-016-1488-4; Umanath K, 2018, AM J KIDNEY DIS, V71, P884, DOI 10.1053/j.ajkd.2017.10.026; Wang LM, 2015, EXP LUNG RES, V41, P146, DOI 10.3109/01902148.2014.983280; Wang XL, 2016, BIOMED PHARMACOTHER, V83, P41, DOI 10.1016/j.biopha.2016.06.009; Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887; Xu BH, 2020, METABOLISM, V103, DOI 10.1016/j.metabol.2019.154013; Xu CF, 2019, CRIT CARE MED, V47, pE587, DOI 10.1097/CCM.0000000000003767; Yao Q, 2020, J ETHNOPHARMACOL, V261, DOI 10.1016/j.jep.2020.113165; Youssef MK, 2016, INT J THER REHABIL, V23, P472, DOI 10.12968/ijtr.2016.23.10.472; Zhong YF, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00624; Zhou X, 2014, J BIOL CHEM, V289, P28827, DOI 10.1074/jbc.M114.596593; Zhou YY, 2020, EXP CELL RES, V387, DOI 10.1016/j.yexcr.2019.111779	68	9	9	5	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21823	10.1096/fj.202100219R	http://dx.doi.org/10.1096/fj.202100219R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34396581				2022-12-28	WOS:000691122900031
J	Tomiga, Y; Sakai, K; Ra, SG; Kusano, M; Ito, A; Uehara, Y; Takahashi, H; Kawanaka, K; Soejima, H; Higaki, Y				Tomiga, Yuki; Sakai, Kazuya; Ra, Song-Gyu; Kusano, Masaki; Ito, Ai; Uehara, Yoshinari; Takahashi, Hirokazu; Kawanaka, Kentaro; Soejima, Hidenobu; Higaki, Yasuki			Short-term running exercise alters DNA methylation patterns in neuronal nitric oxide synthase and brain-derived neurotrophic factor genes in the mouse hippocampus and reduces anxiety-like behaviors	FASEB JOURNAL			English	Article						anxiety; BDNF; DNA methylation; exercise; hippocampus; nNOS	PHYSICAL-EXERCISE; ENVIRONMENTAL ENRICHMENT; CELL-PROLIFERATION; 5-HT1A RECEPTOR; UP-REGULATION; BDNF; EXPRESSION; MEMORY; NEUROGENESIS; NNOS	Running exercise has beneficial effects on brain health. However, the effects of relatively short-term running exercise (STEx) on behavior, and its underlying signaling pathways, are poorly understood. In this study, we evaluated the possibility that the regulation by STEx of brain-derived neurotrophic factor (BDNF) and neuronal nitric oxide synthase (nNOS, encoded by NOS1), which are important molecules for anxiety regulation, might involve mechanisms of epigenetic modification, such as DNA methylation. C57BL/6J male mice were divided into sedentary (SED, n = 12) and STEx (EX, n = 15) groups; STEx was conducted with the mice for a duration of 11 days. STEx reduced anxiety-like behaviors, and STEx reduced Nos1 alpha and increased Bdnf exon I and IV mRNA levels in the hippocampus. Interestingly, behavioral parameters were associated with Bdnf exon I and IV and Nos1 alpha mRNA levels in the ventral, but not dorsal, hippocampal region. However, STEx had no effect on peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (Pgc-1 alpha) or fibronectin type III domain-containing 5 (Fndc5) mRNA levels, which are relatively long-term exercise-induced upstream regulators of BDNF. In parallel with gene expression changes, we found, for the first time, that STEx downregulated Bdnf promoter IV and upregulated Nos1 DNA methylation levels in the hippocampus, and these patterns were partially different between the dorsal and ventral regions. These findings suggest that the beneficial effects of running exercise on mood regulation may be controlled by alterations in epigenetic mechanisms, especially in the ventral hippocampus. These effects occur even after a relatively short-term period of exercise.	[Tomiga, Yuki; Ra, Song-Gyu; Ito, Ai; Uehara, Yoshinari; Kawanaka, Kentaro; Higaki, Yasuki] Fukuoka Univ, Inst Phys Act, Fukuoka, Japan; [Tomiga, Yuki; Takahashi, Hirokazu] Saga Univ, Fac Med, Divis Metab & Endocrinol, Saga, Japan; [Tomiga, Yuki] Japan Soc Promot Sci, Tokyo, Japan; [Sakai, Kazuya; Kusano, Masaki] Fukuoka Univ, Grad Sch Sports & Hlth Sci, Fukuoka, Japan; [Ra, Song-Gyu] Tokushima Univ, Inst Liberal Arts & Sci, Tokushima, Japan; [Ra, Song-Gyu; Uehara, Yoshinari; Kawanaka, Kentaro; Higaki, Yasuki] Fukuoka Univ, Fac Sports & Hlth Sci, Fukuoka, Japan; [Takahashi, Hirokazu] Saga Univ Hosp, Liver Ctr, Saga, Japan; [Soejima, Hidenobu] Saga Univ, Fac Med, Dept Biomol Sci, Div Mol Genet & Epigenet, Saga, Japan	Fukuoka University; Saga University; Japan Society for the Promotion of Science; Fukuoka University; Tokushima University; Fukuoka University; Saga University; Saga University	Tomiga, Y (corresponding author), Fukuoka Univ, Inst Phys Act, Jonan Ku, 8-19-1 Nanakuma, Fukuoka 8140180, Japan.	tomiga0507@gmail.com	Ra, Song-Gyu/AFM-3003-2022	Ra, Song-Gyu/0000-0002-8685-4554; Soejima, Hidenobu/0000-0001-5076-6563	Japan Society for the Promotion of Science (JSPS) KAKENHI [19H04012, 19K21505, 20K19502]; Fukuoka University [177011, 197110]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Fukuoka University	Japan Society for the Promotion of Science (JSPS) KAKENHI, Grant/Award Number: 19H04012, 19K21505 and 20K19502; Fukuoka University, Grant/Award Number: 177011 and 197110	Abbasian S, 2020, BRAIN RES, V1729, DOI 10.1016/j.brainres.2019.146618; Alomari MA, 2013, BEHAV BRAIN RES, V247, P34, DOI 10.1016/j.bbr.2013.03.007; Azimi M, 2018, PEPTIDES, V102, P78, DOI 10.1016/j.peptides.2017.12.027; Baj G, 2012, NEUROPSYCHOPHARMACOL, V37, P1600, DOI 10.1038/npp.2012.5; Baldelli S, 2014, J CELL SCI, V127, P4813, DOI 10.1242/jcs.154229; Balke JE, 2019, NITRIC OXIDE-BIOL CH, V82, P35, DOI 10.1016/j.niox.2018.11.004; Bannerman DM, 2014, NAT REV NEUROSCI, V15, P181, DOI 10.1038/nrn3677; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Bartling B, 2017, EXP GERONTOL, V87, P139, DOI 10.1016/j.exger.2016.04.011; Belviranli M, 2018, NEUROMOL MED, V20, P386, DOI 10.1007/s12017-018-8500-3; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; CHAOULOFF F, 1994, NEUROSCI LETT, V176, P226, DOI 10.1016/0304-3940(94)90088-4; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; de Mello MT, 2013, J AFFECT DISORDERS, V149, P241, DOI 10.1016/j.jad.2013.01.035; El Hayek L, 2019, J NEUROSCI, V39, P2369, DOI 10.1523/JNEUROSCI.1661-18.2019; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Ferreira AFB, 2011, BRAIN RES, V1425, P111, DOI 10.1016/j.brainres.2011.10.004; Garza AA, 2004, PHARMACOL BIOCHEM BE, V77, P209, DOI 10.1016/j.pbb.2003.10.020; Gasparoni G, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0211-3; Gomez-Pinilla F, 2011, EUR J NEUROSCI, V33, P383, DOI 10.1111/j.1460-9568.2010.07508.x; Heldt SA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.101; Ihara H, 2006, NITRIC OXIDE-BIOL CH, V15, P13, DOI 10.1016/j.niox.2005.11.011; JOHNSTON AL, 1991, PHYSIOL BEHAV, V49, P245, DOI 10.1016/0031-9384(91)90039-Q; Kashimoto RK, 2016, BEHAV BRAIN RES, V296, P286, DOI 10.1016/j.bbr.2015.08.038; King-Himmelreich TS, 2016, BIOCHEM BIOPH RES CO, V474, P284, DOI 10.1016/j.bbrc.2016.04.078; Klein C, 2016, NEUROBIOL LEARN MEM, V131, P26, DOI 10.1016/j.nlm.2016.03.002; Klempin F, 2013, J NEUROSCI, V33, P8270, DOI 10.1523/JNEUROSCI.5855-12.2013; Koehl M, 2008, FASEB J, V22, P2253, DOI 10.1096/fj.07-099101; Kondo M, 2015, MOL PSYCHIATR, V20, P1428, DOI 10.1038/mp.2014.153; Kundakovic M, 2015, P NATL ACAD SCI USA, V112, P6807, DOI 10.1073/pnas.1408355111; Liu SG, 2017, NEUROCHEM INT, V108, P230, DOI 10.1016/j.neuint.2017.04.005; Liu YF, 2008, NEUROBIOL LEARN MEM, V90, P81, DOI 10.1016/j.nlm.2008.02.005; Llorens-Martin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012188; LLorens-Martin M, 2010, MOL CELL NEUROSCI, V44, P109, DOI 10.1016/j.mcn.2010.02.006; Moon HY, 2016, CELL METAB, V24, P332, DOI 10.1016/j.cmet.2016.05.025; Morgan JA, 2018, BEHAV BRAIN RES, V337, P193, DOI 10.1016/j.bbr.2017.09.022; O'Callaghan RM, 2007, BEHAV BRAIN RES, V176, P362, DOI 10.1016/j.bbr.2006.10.018; Otsuka T, 2016, BEHAV BRAIN RES, V298, P44, DOI 10.1016/j.bbr.2015.10.055; Petrus DS, 2009, EUR J NEUROSCI, V29, P244, DOI 10.1111/j.1460-9568.2008.06579.x; Pinar Cristina, 2018, Brain Plast, V4, P185, DOI 10.3233/BPL-170052; Putzke J, 2000, MOL BRAIN RES, V85, P13, DOI 10.1016/S0169-328X(00)00220-5; Schoenfeld TJ, 2013, J NEUROSCI, V33, P7770, DOI 10.1523/JNEUROSCI.5352-12.2013; Sleiman SF, 2016, ELIFE, V5, DOI 10.7554/eLife.15092; Soya H, 2007, BIOCHEM BIOPH RES CO, V358, P961, DOI 10.1016/j.bbrc.2007.04.173; Stanquini LA, 2018, ACTA NEUROPSYCHIATR, V30, P127, DOI 10.1017/neu.2017.28; Stranahan AM, 2007, HIPPOCAMPUS, V17, P1017, DOI 10.1002/hipo.20348; Takahashi H, 2019, NAT METAB, V1, P291, DOI 10.1038/s42255-018-0030-7; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tillmann S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182698; Tomiga Y, 2019, J PHYSIOL-LONDON, V597, P5145, DOI 10.1113/JP277019; Tomiga Y, 2019, J PHYSIOL SCI, V69, P711, DOI 10.1007/s12576-019-00686-5; Tomiga Y, 2017, NITRIC OXIDE-BIOL CH, V66, P71, DOI 10.1016/j.niox.2017.03.002; Tomiga Y, 2016, BIOCHEM BIOPH RES CO, V476, P635, DOI 10.1016/j.bbrc.2016.06.010; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Volke V, 2003, BEHAV BRAIN RES, V140, P141, DOI 10.1016/S0166-4328(02)00312-1; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Zhang J, 2010, J NEUROSCI, V30, P2433, DOI 10.1523/JNEUROSCI.5880-09.2010; Zheng J, 2017, J NEUROSCI, V37, P4145, DOI 10.1523/JNEUROSCI.3333-16.2017	61	6	6	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21767	10.1096/fj.202100630R	http://dx.doi.org/10.1096/fj.202100630R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34325488				2022-12-28	WOS:000678975300047
J	McCoy, MG; Perez-Cremades, D; Belkin, N; Peng, WH; Zhang, BF; Chen, JS; Sachan, M; Wara, AKMK; Zhuang, RL; Cheng, HS; Feinberg, MW				McCoy, Michael G.; Perez-Cremades, Daniel; Belkin, Nathan; Peng, Wenhui; Zhang, Bofang; Chen, Jingshu; Sachan, Madhur; Wara, A. K. M. Khyrul; Zhuang, Rulin; Cheng, Henry S.; Feinberg, Mark W.			A miRNA cassette reprograms smooth muscle cells into endothelial cells	FASEB JOURNAL			English	Article						angiogenesis; endothelial miRNA; miRNA; miRNA reprogramming; transdifferentiation	MESENCHYMAL TRANSITION; VASCULAR INFLAMMATION; HUMAN FIBROBLASTS; STEM-CELLS; MICRORNAS; DIFFERENTIATION; ACTIVATION; ATHEROSCLEROSIS; EXPRESSION; MIR-145	Cellular reprogramming through targeting microRNAs (miRNAs) holds promise for regenerative therapy due to their profound regulatory effects in proliferation, differentiation, and function. We hypothesized that transdifferentiation of vascular smooth muscle cells (SMCs) into endothelial cells (ECs) using a miRNA cassette may provide a novel approach for use in vascular disease states associated with endothelial injury or dysfunction. miRNA profiling of SMCs and ECs and iterative combinatorial miRNA transfections of human coronary SMCs revealed a 4-miRNA cassette consisting of miR-143-3p and miR-145-5p inhibitors and miR-146a-5p and miR-181b-5p mimics that efficiently produced induced endothelial cells (iECs). Transcriptome profiling, protein expression, and functional studies demonstrated that iECs exhibit high similarity to ECs. Injected iECs restored blood flow recovery even faster than conventional ECs in a murine hindlimb ischemia model. This study demonstrates that a 4-miRNA cassette is sufficient to reprogram SMCs into ECs and shows promise as a novel regenerative strategy for endothelial repair.	[McCoy, Michael G.; Perez-Cremades, Daniel; Belkin, Nathan; Peng, Wenhui; Zhang, Bofang; Chen, Jingshu; Sachan, Madhur; Wara, A. K. M. Khyrul; Zhuang, Rulin; Cheng, Henry S.; Feinberg, Mark W.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Cardiovasc Div, Boston, MA 02115 USA; [Perez-Cremades, Daniel] Univ Valencia, INCLIVA Biomed Res Inst, Dept Physiol, Valencia, Spain; [Belkin, Nathan] Hosp Univ Penn, Dept Surg, 3400 Spruce St, Philadelphia, PA 19104 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Valencia; University of Pennsylvania; Pennsylvania Medicine	Feinberg, MW (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Cardiovasc Div, Boston, MA 02115 USA.	mfeinberg@bwh.harvard.edu	Zhuang, Rulin/GXG-5835-2022	Zhang, Bofang/0000-0002-6823-7755; McCoy, Michael/0000-0002-1981-6398; Perez-Cremades, Daniel/0000-0002-0969-8762; Feinberg, Mark/0000-0001-9523-3859	National Institutes of Health [HL115141, HL134849, HL148207, HL148355, HL153356]; American Heart Association [18SFRN33900144, 20SFRN35200163]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by the National Institutes of Health (HL115141, HL134849, HL148207, HL148355, HL153356 to M.W.F.), and the American Heart Association (18SFRN33900144 and 20SFRN35200163 to M.W.F.)	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Cheng HS, 2013, EMBO MOL MED, V5, P1017, DOI 10.1002/emmm.201202318; Cipollone F, 2011, STROKE, V42, P2556, DOI 10.1161/STROKEAHA.110.597575; Climent M, 2015, CIRC RES, V116, P1753, DOI 10.1161/CIRCRESAHA.116.305178; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Deng L, 2015, CIRC RES, V117, P870, DOI 10.1161/CIRCRESAHA.115.306806; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Feinberg MW, 2016, CIRC RES, V118, P703, DOI 10.1161/CIRCRESAHA.115.306300; Feng B, 2016, DIABETES, V65, P768, DOI 10.2337/db15-1033; Fernandez-Hernando C, 2018, CURR OPIN HEMATOL, V25, P227, DOI 10.1097/MOH.0000000000000424; Fontaine M, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23010331; Giacomelli E, 2020, CELL STEM CELL, V26, P862, DOI 10.1016/j.stem.2020.05.004; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Ginsberg M, 2012, CELL, V151, P559, DOI 10.1016/j.cell.2012.09.032; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Guo LL, 2016, TUMOR BIOL, V37, P115, DOI 10.1007/s13277-015-4374-2; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Hong XC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05665-7; Hori D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174108; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Judson RL, 2013, NAT STRUCT MOL BIOL, V20, P1227, DOI 10.1038/nsmb.2665; Kane NM, 2012, STEM CELLS, V30, P643, DOI 10.1002/stem.1026; Kim J, 2018, BMB REP, V51, P65, DOI 10.5483/BMBRep.2018.51.2.011; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3798; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lin JB, 2016, FASEB J, V30, P3216, DOI 10.1096/fj.201500163R; Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Luo ZL, 2013, STEM CELLS, V31, P1749, DOI 10.1002/stem.1448; Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333; Nagai N, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007826; Nam YJ, 2013, P NATL ACAD SCI USA, V110, P5588, DOI 10.1073/pnas.1301019110; Ni HE, 2021, ARTERIOSCL THROM VAS, V41, P2399, DOI 10.1161/ATVBAHA.120.315911; Rangrez AY, 2011, CIRC-CARDIOVASC GENE, V4, P197, DOI 10.1161/CIRCGENETICS.110.958702; Rippo MR, 2014, EXP GERONTOL, V56, P154, DOI 10.1016/j.exger.2014.03.002; Robbins N, 2014, JOVE-J VIS EXP, DOI 10.3791/52172; Sayed N, 2015, CIRCULATION, V131, P300, DOI 10.1161/CIRCULATIONAHA.113.007394; Song ZF, 2010, J CARDIOVASC TRANSL, V3, P246, DOI 10.1007/s12265-010-9163-0; Su YX, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1599-9; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Sun XH, 2016, CIRC RES, V118, P810, DOI 10.1161/CIRCRESAHA.115.308166; Sun XH, 2014, TRENDS CARDIOVAS MED, V24, P105, DOI 10.1016/j.tcm.2013.09.002; Sun XH, 2014, CIRC RES, V114, P32, DOI 10.1161/CIRCRESAHA.113.302089; Sun XH, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0372-2; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Thyberg J, 2002, ARTERIOSCL THROM VAS, V22, P1509, DOI 10.1161/01.ATV.0000036415.04486.01; Treguer K, 2012, J VASC RES, V49, P447, DOI 10.1159/000339429; Wang DD, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020324; Wang XH, 2013, CARDIOVASC RES, V97, P432, DOI 10.1093/cvr/cvs356; Wang Y, 2020, MOL THER-NUCL ACIDS, V20, P421, DOI 10.1016/j.omtn.2020.03.002; Watabe T, 2003, J CELL BIOL, V163, P1303, DOI 10.1083/jcb.200305147; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yamamoto T, 2013, ARTERIOSCL THROM VAS, V33, P2218, DOI 10.1161/ATVBAHA.113.301313; Yang SZ, 2013, FASEB J, V27, P2382, DOI 10.1096/fj.12-219493	56	0	0	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22239	10.1096/fj.202101872R	http://dx.doi.org/10.1096/fj.202101872R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35235229				2022-12-28	WOS:000772957100007
J	Salinas, EY; Donahue, RP; Herrera, JM; Hu, JC; Athanasiou, KA				Salinas, Evelia Y.; Donahue, Ryan P.; Herrera, Jessica M.; Hu, Jerry C.; Athanasiou, Kyriacos A.			The functionality and translatability of neocartilage constructs are improved with the combination of fluid-induced shear stress and bioactive factors	FASEB JOURNAL			English	Article						articular cartilage; fluid-induced shear stress; mechanical stimulation; neocartilage; tissue engineering	TENSILE MECHANICAL-PROPERTIES; TEMPOROMANDIBULAR-JOINT DISC; ARTICULAR-CARTILAGE; BIOMECHANICAL PROPERTIES; CHONDROITINASE-ABC; TREATMENT REGIMEN; GROWTH-FACTORS; MINIPIG MODEL; PRIMARY CILIA; TISSUE	Neocartilage tissue engineering aims to address the shortcomings of current clinical treatments for articular cartilage indications. However, advancement is required toward neocartilage functionality (mechanical and biochemical properties) and translatability (construct size, gross morphology, passage number, cell source, and cell type). Using fluid-induced shear (FIS) stress, a potent mechanical stimulus, over four phases, this work investigates FIS stress' efficacy toward creating large neocartilage derived from highly passaged minipig costal chondrocytes, a species relevant to the preclinical regulatory process. In Phase I, FIS stress application timing was investigated in bovine articular chondrocytes and found to improve the aggregate modulus of neocartilage by 151% over unstimulated controls when stimulated during the maturation stage. In Phase II, FIS stress stimulation was translated from bovine articular chondrocytes to expanded minipig costal chondrocytes, yielding a 46% improvement in aggregate modulus over nonstimulated controls. In Phase III, bioactive factors were combined with FIS stress to improve the shear modulus by 115% over bioactive factor-only controls. The translatability of neocartilage was improved in Phase IV by utilizing highly passaged cells to form constructs more than 9-times larger in the area (11 x 17 mm), yielding an improved aggregate modulus by 134% and a flat morphology compared to free-floating, bioactive factor-only controls. Overall, this study represents a significant step toward generating mechanically robust, large constructs necessary for animal studies, and eventually, human clinical studies.	[Salinas, Evelia Y.; Donahue, Ryan P.; Hu, Jerry C.; Athanasiou, Kyriacos A.] Univ Calif Irvine, Dept Biomed Engn, 3120 Nat Sci 2, Irvine, CA 92697 USA; [Herrera, Jessica M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California Irvine; University of California System; University of California San Francisco	Athanasiou, KA (corresponding author), Univ Calif Irvine, Dept Biomed Engn, 3120 Nat Sci 2, Irvine, CA 92697 USA.	athens@uci.edu		Donahue, Ryan/0000-0003-0542-1034; Salinas, Evelia/0000-0002-0343-9444	HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR) [R01 DE015038]; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01 AR078389, R01 AR067821]; California Alliance for Minority Participation	HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR); HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); California Alliance for Minority Participation	HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR), Grant/Award Number: R01 DE015038; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: R01 AR078389 and R01 AR067821; California Alliance for Minority Participation	Allen KD, 2006, J BIOMECH, V39, P312, DOI 10.1016/j.jbiomech.2004.11.012; [Anonymous], 2018, OSTEOARTHRITIS; ATHANASIOU KA, 1995, CLIN ORTHOP RELAT R, P254; Athanasiou KA, 1998, CLIN ORTHOP RELAT R, P269; Athanasiou KA., 2017, ARTICULAR CARTILAGE; Athanasiou KA, 2013, ANNU REV BIOMED ENG, V15, P115, DOI [10.1146/annurev-bioeng-071812-15242, 10.1146/annurev-bioeng-071812-152423]; Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010; Bastow ER, 2005, J BIOL CHEM, V280, P11749, DOI 10.1074/jbc.M414495200; Berson RE, 2008, ADV EXP MED BIOL, V614, P189, DOI 10.1007/978-0-387-74911-2_22; Blunk T, 2002, TISSUE ENG, V8, P73, DOI 10.1089/107632702753503072; Brama PAJ, 2000, ANN RHEUM DIS, V59, P155, DOI 10.1136/ard.59.2.155; Brown WE, 2016, TISSUE ENG PART C-ME, V22, P895, DOI [10.1089/ten.tec.2016.0184, 10.1089/ten.TEC.2016.0184]; Centers for Disease Control and Prevention, 2018, ARTHR REL STAT; Chakraborty A, 2016, ANN BIOMED ENG, V44, P3032, DOI 10.1007/s10439-016-1626-2; Christensen Bjorn Borsoe, 2015, J Exp Orthop, V2, P13, DOI 10.1186/s40634-015-0031-3; Cissell DD, 2017, TISSUE ENG PART C-ME, V23, P243, DOI 10.1089/ten.tec.2017.0018; Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008; Dowthwaite GP, 2003, MATRIX BIOL, V22, P311, DOI 10.1016/S0945-053X(03)00037-4; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Elder BD, 2009, OSTEOARTHR CARTILAGE, V17, P114, DOI 10.1016/j.joca.2008.05.006; Elder BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002341; Elisseeff J, 2001, J ORTHOP RES, V19, P1098, DOI 10.1016/S0736-0266(01)00054-7; Fisher MB, 2015, TISSUE ENG PT A, V21, P850, DOI [10.1089/ten.tea.2014.0384, 10.1089/ten.TEA.2014.0384]; Gemmiti CV, 2009, BIOTECHNOL BIOENG, V104, P809, DOI 10.1002/bit.22440; Gemmiti CV, 2006, TISSUE ENG, V12, P469, DOI 10.1089/ten.2006.12.469; Gonzalez-Leon EA, 2020, ACTA BIOMATER, V109, P73, DOI 10.1016/j.actbio.2020.04.019; Gotterbarm T, 2008, LAB ANIM-UK, V42, P71, DOI 10.1258/la.2007.06029e; Gutierrez K, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00293; Huang BJ, 2018, TISSUE ENG PT A, V24, P1652, DOI [10.1089/ten.TEA.2017.0495, 10.1089/ten.tea.2017.0495]; Huang BJ, 2017, J TISSUE ENG REGEN M, V11, P2323, DOI 10.1002/term.2132; Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454; Huwe LW, 2018, J TISSUE ENG REGEN M, V12, P1163, DOI 10.1002/term.2630; Huwe LW, 2018, TISSUE ENG PT A, V24, P516, DOI [10.1089/ten.tea.2017.0136, 10.1089/ten.TEA.2017.0136]; Kim IG, 2016, BIOMATERIALS, V85, P18, DOI 10.1016/j.biomaterials.2016.01.048; Kwon H, 2021, BIOFABRICATION, V13, DOI 10.1088/1758-5090/abd9d9; Kwon H, 2019, J TISSUE ENG REGEN M, V13, P283, DOI 10.1002/term.2791; Lee JK, 2017, NAT MATER, V16, P864, DOI [10.1038/NMAT4917, 10.1038/nmat4917]; Lee J, 2017, CELL TRANSPLANT, V26, P1673, DOI 10.1177/0963689717724794; Link JM, 2021, CARTILAGE, V13, p672S, DOI 10.1177/1947603520918653; MacBarb RF, 2013, ACTA BIOMATER, V9, P4626, DOI 10.1016/j.actbio.2012.09.037; Madry H, 2014, TISSUE ENG PART B-RE, V20, P106, DOI [10.1089/ten.teb.2013.0271, 10.1089/ten.TEB.2013.0271]; Makris EA, 2014, BIOMATERIALS, V35, P6787, DOI 10.1016/j.biomaterials.2014.04.083; Makris EA, 2013, FASEB J, V27, P2421, DOI 10.1096/fj.12-224030; Mao Y, 2018, CARTILAGE, V9, P202, DOI 10.1177/1947603517746724; McCormick F, 2014, ARTHROSCOPY, V30, P222, DOI 10.1016/j.arthro.2013.11.001; Moore ER, 2018, J ORTHOP RES, V36, P533, DOI 10.1002/jor.23732; Murphy MK, 2015, STEM CELLS, V33, P762, DOI 10.1002/stem.1890; Murphy MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056983; Ofek G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002795; Otsuki S, 2019, AM J SPORT MED, V47, P1804, DOI 10.1177/0363546519850578; PANEPINTO LM, 1986, LAB ANIM SCI, V36, P344; Pfeifer CG, 2017, TISSUE ENG PART C-ME, V23, P745, DOI [10.1089/ten.TEC.2017.0109, 10.1089/ten.tec.2017.0109]; Ruhlen R, 2014, OSTEOARTHR CARTILAGE, V22, P1071, DOI 10.1016/j.joca.2014.05.011; Salinas EY, 2020, BIOFABRICATION, V12, DOI 10.1088/1758-5090/aba412; Salinas EY, 2018, TISSUE ENG PART B-RE, V24, P345, DOI [10.1089/ten.teb.2018.0006, 10.1089/ten.TEB.2018.0006]; Thomas JMD, 2017, AICHE J, V63, P4233, DOI 10.1002/aic.15762; Thomas JMD, 2011, BIOTECHNOL PROGR, V27, P460, DOI 10.1002/btpr.507; Thompson CL, 2017, EUR CELLS MATER, V34, P128, DOI 10.22203/eCM.v034a09; van der Kraan PM, 2002, OSTEOARTHR CARTILAGE, V10, P631, DOI 10.1053/joca.2002.0806; Vapniarsky N, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq1802; Vapniarsky N, 2017, TISSUE ENG PART C-ME, V23, P700, DOI [10.1089/ten.tec.2017.0149, 10.1089/ten.TEC.2017.0149]; Waller KA, 2017, AM J SPORT MED, V45, P1512, DOI 10.1177/0363546516686965; Wann AKT, 2012, FASEB J, V26, P1663, DOI 10.1096/fj.11-193649; Yoon KH, 2020, AM J SPORT MED, V48, P1236, DOI 10.1177/0363546520905565; Zimmerman BK, 2015, J DENT RES, V94, P85, DOI 10.1177/0022034514553626	65	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22225	10.1096/fj.202101699R	http://dx.doi.org/10.1096/fj.202101699R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CR	35224777				2022-12-28	WOS:000772945500001
J	Grau-Bove, C; Grau-Bove, X; Terra, X; Garcia-Vallve, S; Rodriguez-Gallego, E; Beltran-Debon, R; Blay, MT; Ardevol, A; Pinent, M				Grau-Bove, Carme; Grau-Bove, Xavier; Terra, Ximena; Garcia-Vallve, Santi; Rodriguez-Gallego, Esther; Beltran-Debon, Raul; Teresa Blay, M.; Ardevol, Anna; Pinent, Montserrat			Functional and genomic comparative study of the bitter taste receptor family TAS2R: Insight into the role of human TAS2R5	FASEB JOURNAL			English	Review						agonist assays; bitter taste receptor	REVEALS; CHEMORECEPTORS; SELECTIVITY; RANGES	Bitterness is perceived in humans by 25 subtypes of bitter taste receptors (hTAS2R) that range from broadly tuned to more narrowly tuned receptors. hTAS2R5 is one of the most narrowly tuned bitter taste receptors in humans. In this study, we review the literature on this receptor and show there is no consensus about its role. We then compare the possible role of hTAS2R5 with that of the proteins of the TAS2R family in rat, mouse, and pig. A phylogenetic tree of all mammalian TAS2R domain-containing proteins showed that human hTAS2R5 has no ortholog in pig, mouse, or rat genomes. By comparing the agonists that are common to hTAS2R5 and other members of the family, we observed that hTAS2R39 is the receptor that shares most agonists with hTAS2R5. In mouse, some of these agonists activate mTas2r105 and mTas2r144, which are distant paralogs of hTAS2R5. mTas2r144 seems to be the receptor that is most similar to hTAS2R5 because they are both activated by the same agonists and have affinities in the same range of values. Then, we can conclude that hTAS2R5 has a unique functional specificity in humans as it is activated by selective agonists and that its closest functional homolog in mouse is the phylogenetically distant mTas2r144.	[Grau-Bove, Carme; Terra, Ximena; Rodriguez-Gallego, Esther; Beltran-Debon, Raul; Teresa Blay, M.; Ardevol, Anna; Pinent, Montserrat] Univ Rovira & Virgili, Dept Biochem & Biotechnol, MoBioFood Res Grp, C Marcelli Domingo 1, Tarragona 43007, Spain; [Grau-Bove, Xavier] Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat CRG, Barcelona, Spain; [Garcia-Vallve, Santi] Univ Rovira & Virgili, Dept Biochem & Biotechnol, Res Grp Cheminformat & Nutr, Tarragona, Spain	Universitat Rovira i Virgili; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Universitat Rovira i Virgili	Ardevol, A (corresponding author), Univ Rovira & Virgili, Dept Biochem & Biotechnol, MoBioFood Res Grp, C Marcelli Domingo 1, Tarragona 43007, Spain.	anna.ardevol@urv.cat	Grau-Bové, Xavier/E-8223-2017; Pinent, Montserrat/C-7109-2011; Garcia-Vallve, Santi/A-4226-2008; Rodríguez-Gallego, Esther/B-6581-2016; Beltran-Debon, Raul/A-9287-2014; Terra, Ximena/K-3918-2014	Grau-Bové, Xavier/0000-0003-1978-5824; Pinent, Montserrat/0000-0003-3550-5378; Garcia-Vallve, Santi/0000-0002-0348-7497; Rodríguez-Gallego, Esther/0000-0002-6363-2510; Beltran-Debon, Raul/0000-0001-9691-1906; Terra, Ximena/0000-0003-1043-5844	Ministerio de Ciencia e Innovacion (MICINN) [AGL2017-83477-R]	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Ministerio de Ciencia e Innovacion (MICINN), Grant/Award Number: AGL2017-83477-R	Bachmanov AA, 2007, ANNU REV NUTR, V27, P389, DOI 10.1146/annurev.nutr.26.061505.111329; Brockhoff A, 2011, J NEUROSCI, V31, P14775, DOI 10.1523/JNEUROSCI.2923-11.2011; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Choi JH, 2017, APPETITE, V113, P178, DOI 10.1016/j.appet.2017.02.022; Conte C, 2002, CYTOGENET GENOME RES, V98, P45, DOI 10.1159/000068546; Cygankiewicz AI, 2014, CRIT REV FOOD SCI, V54, P771, DOI 10.1080/10408398.2011.606929; Di Pizio A, 2015, BIOORGAN MED CHEM, V23, P4082, DOI 10.1016/j.bmc.2015.04.025; Dotson CD, 2012, CHEM SENSES, V37, P737, DOI 10.1093/chemse/bjs063; Duarte AC, 2020, BIOCHEM PHARMACOL, V177, DOI 10.1016/j.bcp.2020.113954; Duffy VB, 2010, CHEMOSENS PERCEPT, V3, P137, DOI 10.1007/s12078-010-9079-8; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Garcia-Esparcia P, 2013, J NEUROPATH EXP NEUR, V72, P524, DOI 10.1097/NEN.0b013e318294fd76; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; GODFREY S, 1975, J PEDIATR-US, V87, P465, DOI 10.1016/S0022-3476(75)80663-9; Grassin-Delyle S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01267; Grau-Bove X, 2021, MOL BIOL EVOL, V38, P5204, DOI 10.1093/molbev/msab234; Hayes JE, 2011, CHEM SENSES, V36, P311, DOI 10.1093/chemse/bjq132; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keast RS, 2015, FLAVOUR, V4, P5, DOI [10.1186/2044-7248-4-5, DOI 10.1186/2044-7248-4-5]; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lee SJ, 2019, NAT REV DRUG DISCOV, V18, P116, DOI 10.1038/s41573-018-0002-3; Lee YC, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00280; Lin HF, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S7; Lossow K, 2016, J BIOL CHEM, V291, P15358, DOI 10.1074/jbc.M116.718544; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mikolajczyk-Stecyna J, 2020, ACTA SCI POLON-TECHN, V19, P109, DOI [10.17306/J.AFS.2020.0729, 10.17306/J.AFS.0729]; Nissim I, 2017, IUBMB LIFE, V69, P938, DOI 10.1002/iub.1694; Palmer RK, 2019, PHARMACOL REV, V71, P20, DOI 10.1124/pr.118.015974; Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633; Park J, 2015, BIOCHEM BIOPH RES CO, V468, P306, DOI 10.1016/j.bbrc.2015.10.107; Prandi S, 2018, CELL MOL LIFE SCI, V75, P49, DOI 10.1007/s00018-017-2621-y; Punta M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI 10.1093/nar/gkr1065; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Risso D, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0198-8; Roura E, 2019, ANIMAL, V13, P2714, DOI 10.1017/S1751731119001794; Roura E, 2017, ANIM FEED SCI TECH, V233, P3, DOI 10.1016/j.anifeedsci.2017.08.002; Roy S, 2008, CHEMMEDCHEM, V3, P1427, DOI 10.1002/cmdc.200800097; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Shaw L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205322; Soares S, 2018, J AGR FOOD CHEM, V66, P8814, DOI 10.1021/acs.jafc.8b03569; Soares S, 2013, J AGR FOOD CHEM, V61, P1525, DOI 10.1021/jf304198k; Steensels S, 2018, ANNU REV PHYSIOL, V80, P117, DOI 10.1146/annurev-physiol-021317-121332; Tomas J, 2016, NEUROSCIENCE, V320, P160, DOI 10.1016/j.neuroscience.2016.01.057; Tomas J, 2019, MOL CELL ENDOCRINOL, V495, DOI 10.1016/j.mce.2019.110521; Turner A., 2021, NUTRIENTS, V13, P1; Wang QL, 2019, FASEB J, V33, P4907, DOI 10.1096/fj.201801661RR; Zheng KZ, 2017, FASEB J, V31, P4037, DOI 10.1096/fj.201601323RR	50	0	0	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22175	10.1096/fj.202101128RR	http://dx.doi.org/10.1096/fj.202101128RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35107858	Green Published			2022-12-28	WOS:000761250800038
J	Locatelli, L; Inglebert, M; Scrimieri, R; Sinha, PK; Zuccotti, GV; Milani, P; Bureau, L; Misbah, C; Maier, JAM				Locatelli, Laura; Inglebert, Mehdi; Scrimieri, Roberta; Sinha, Priti Kumari; Zuccotti, Gian Vincenzo; Milani, Paolo; Bureau, Lionel; Misbah, Chaouqi; Maier, Jeanette A. M.			Human endothelial cells in high glucose: New clues from culture in 3D microfluidic chips	FASEB JOURNAL			English	Article						cytoskeleton; diabetes; endothelium; glucose; microfluidics; microvasculature on a chip	VASCULAR ENDOTHELIUM; DYSFUNCTION; COMPLICATIONS; GLYCOCALYX; MECHANISMS; APOPTOSIS; STRESS	Several studies have demonstrated the role of high glucose in promoting endothelial dysfunction utilizing traditional two-dimensional (2D) culture systems, which, however, do not replicate the complex organization of the endothelium within a vessel constantly exposed to flow. Here we describe the response to high glucose of micro- and macro-vascular human endothelial cells (EC) cultured in biomimetic microchannels fabricated through soft lithography and perfused to generate shear stress. In 3D macrovascular EC exposed to a shear stress of 0.4 Pa respond to high glucose with cytoskeletal remodeling and alterations in cell shape. Under the same experimental conditions, these effects are more pronounced in microvascular cells that show massive cytoskeletal disassembly and apoptosis after culture in high glucose. However, when exposed to a shear stress of 4 Pa, which is physiological in the microvasculature, human dermal microvascular endothelial cells (HDMEC) show alterations of the cytoskeleton but no apoptosis. This result emphasizes the sensitivity of HDMEC to different regimens of flow. No significant variations in the thickness of glycocalyx were detected in both human endothelial cells from the umbilical vein and HDMEC exposed to high glucose in 3D, whereas clear differences emerge between cells cultured in static 2D versus microfluidic channels. We conclude that culture in microfluidic microchannels unveils unique insights into endothelial dysfunction by high glucose.	[Locatelli, Laura; Scrimieri, Roberta; Zuccotti, Gian Vincenzo; Maier, Jeanette A. M.] Univ Milan, Dipartimento Sci Biomed & Clin L Sacco, Via GB Grassi 74, I-20157 Milan, Italy; [Inglebert, Mehdi; Sinha, Priti Kumari; Bureau, Lionel; Misbah, Chaouqi] Univ Grenoble Alpes, CNRS, LIPhy, Grenoble, France; [Milani, Paolo; Maier, Jeanette A. M.] Univ Milan, Interdisciplinary Ctr Nanostruct Mat & Interfaces, Milan, Italy; [Milani, Paolo] Univ Milan, Dipartimento Fis A Pontremoli, Milan, Italy	University of Milan; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Milan; University of Milan	Locatelli, L (corresponding author), Univ Milan, Dipartimento Sci Biomed & Clin L Sacco, Via GB Grassi 74, I-20157 Milan, Italy.	laura.locatelli@unimi.it	Zuccotti, Gianvincenzo/H-8572-2017	Zuccotti, Gianvincenzo/0000-0002-2795-9874; SCRIMIERI, ROBERTA/0000-0001-8888-2594; LOCATELLI, LAURA/0000-0002-4568-7825	Living fluids [CFDA-Q1-14]; Call Hub Ricerca e Inno-vazione [170989-PRINTMED-3D]; French-German University; Regione Lombardia	Living fluids; Call Hub Ricerca e Inno-vazione; French-German University; Regione Lombardia(Regione Lombardia)	Living fluids, Grant/Award Number: CFDA--Q1--14; "Call Hub Ricerca e Inno--vazione", Grant/Award Number: 1170989--PRINTMED--3D; French-German University; Regione Lombardia	Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Barakat AI, 2013, CR PHYS, V14, P479, DOI 10.1016/j.crhy.2013.05.003; Beckman JA, 2016, CIRC RES, V118, P1771, DOI 10.1161/CIRCRESAHA.115.306884; Blackman BR, 2002, J BIOMECH ENG-T ASME, V124, P397, DOI 10.1115/1.1486468; Butler MJ, 2020, AM J PATHOL, V190, P742, DOI 10.1016/j.ajpath.2019.11.015; Cahill PA, 2016, ATHEROSCLEROSIS, V248, P97, DOI 10.1016/j.atherosclerosis.2016.03.007; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Danese S, 2007, J IMMUNOL, V178, P6017, DOI 10.4049/jimmunol.178.10.6017; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Dejana E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14361; Domingueti CP, 2016, J DIABETES COMPLICAT, V30, P738, DOI 10.1016/j.jdiacomp.2015.12.018; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Duval K, 2017, PHYSIOLOGY, V32, P266, DOI 10.1152/physiol.00036.2016; El-Asrar MA, 2012, PEDIATR DIABETES, V13, P616, DOI 10.1111/j.1399-5448.2012.00881.x; Flammer AJ, 2012, CIRCULATION, V126, P753, DOI 10.1161/CIRCULATIONAHA.112.093245; Gordon E, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00684; Haymet AB, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.647086; Ido Y, 2002, DIABETES, V51, P159, DOI 10.2337/diabetes.51.1.159; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Inglebert M, 2020, BIOMICROFLUIDICS, V14, DOI 10.1063/1.5143391; Locatelli L, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.733573; Locatelli L, 2020, FASEB J, V34, P1833, DOI 10.1096/fj.201901785RRR; Mandelkow R, 2017, ANTICANCER RES, V37, P2239, DOI 10.21873/anticanres.11560; Papaioannou Theodoros G, 2005, Hellenic J Cardiol, V46, P9; Pi XC, 2018, CIRC RES, V123, P477, DOI 10.1161/CIRCRESAHA.118.313237; Reinitz A, 2015, MICROVASC RES, V99, P8, DOI 10.1016/j.mvr.2015.02.008; Rimann M, 2012, CURR OPIN BIOTECH, V23, P803, DOI 10.1016/j.copbio.2012.01.011; Scrimieri R, 2019, MAGNESIUM RES, V32, P54, DOI 10.1684/mrh.2019.0456; Sena CM, 2013, BBA-MOL BASIS DIS, V1832, P2216, DOI 10.1016/j.bbadis.2013.08.006; Sheu ML, 2005, ARTERIOSCL THROM VAS, V25, P539, DOI 10.1161/01.ATV.0000155462.24263.e4; Shi Y, 2017, J DIABETES, V9, P434, DOI 10.1111/1753-0407.12521; Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108; Stepan JG, 2014, J HAND SURG-AM, V39, P706, DOI 10.1016/j.jhsa.2014.01.014; Targosz-Korecka M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16179-7; Thomas CC, 2015, MED CLIN N AM, V99, P1, DOI 10.1016/j.mcna.2014.08.015; Tsvirkun D, 2017, SCI REP-UK, V7, DOI 10.1038/srep45036; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Yilmaz O, 2019, CLIN KIDNEY J, V12, P611, DOI 10.1093/ckj/sfz042; Zhang J, 2019, EXP THER MED, V18, P621, DOI 10.3892/etm.2019.7609	39	3	3	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22137	10.1096/fj.202100914R	http://dx.doi.org/10.1096/fj.202100914R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35066939	Green Submitted			2022-12-28	WOS:000747987800044
J	Meng, J; Lv, ZY; Guo, MM; Sun, CX; Li, XP; Jiang, ZG; Zhang, WC; Chen, C				Meng, Jiao; Lv, Zhenyu; Guo, Miaomiao; Sun, Chuanxin; Li, Xiaopeng; Jiang, Zhenguo; Zhang, Wanchang; Chen, Chang			A Lycium barbarum extract inhibits beta-amyloid toxicity by activating the antioxidant system and mtUPR in a Caenorhabditis elegans model of Alzheimer's disease	FASEB JOURNAL			English	Article						Alzheimer's disease; antioxidant activity; A beta; Lycium barbarum extract; mtUPR	UNFOLDED PROTEIN RESPONSE; A-BETA; PEPTIDE; PROTEOSTASIS; CAPACITY; STRESS; GENES	Lycium barbarum, a traditional Chinese medicine, has been shown to have antioxidant properties and has a protective effect in many diseases related to oxidative stress, such as neurodegenerative diseases, cardiovascular diseases, and cancer. Although the neuroprotective effects of L. barbarum extract (LBE) have been reported in several studies, the underlying molecular mechanisms are still unclear. In this study, the transgenic Caenorhabditis elegans strain CL2006 was used to investigate the function and molecular mechanism of an LBE in Alzheimer's disease (AD). LBE had high antioxidant potential and effectively delayed A beta-induced paralysis in the CL2006 strain. LBE inhibited the production of excessive reactive oxygen species by inducing the SKN-1-mediated antioxidant system, thereby inhibiting the generation of A beta and inhibiting mitochondrial damage. Importantly, LBE reduced A beta levels by inducing FSHR-1-mediated activation of the mtUPR. Therefore, our study not only reveals a new mechanism of LBE in the treatment of AD but also identifies a novel strategy for the treatment of AD by enhancing the mtUPR.	[Meng, Jiao; Lv, Zhenyu; Guo, Miaomiao; Sun, Chuanxin; Li, Xiaopeng; Chen, Chang] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Lv, Zhenyu; Guo, Miaomiao; Chen, Chang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Jiang, Zhenguo; Zhang, Wanchang] Hosp Tradit Chinese Med Zhongning Cty, Yinchuan, Ningxia, Peoples R China; [Chen, Chang] Capital Med Univ, Beijing Inst Brain Disorders, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Capital Medical University	Chen, C (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	changchen@moon.ibp.ac.cn		Meng, Jiao/0000-0001-9645-758X	National Key R&D Program of China [2017YFA0504000]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB39000000]; Ningxia Key Research and Development Program Grant [2016BZ05]; Regional key projects of science and technology service network plan (STS plan) of Chinese Academy of Sciences [KFJ-STS-QYZD-181]; National Natural Science Foundation of China-Key program project [91849203]	National Key R&D Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Ningxia Key Research and Development Program Grant; Regional key projects of science and technology service network plan (STS plan) of Chinese Academy of Sciences; National Natural Science Foundation of China-Key program project	This research was financially supported by National Key R&D Program of China (Grant No. 2017YFA0504000), Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDB39000000), Ningxia Key Research and Development Program Grant (Grant No. 2016BZ05), Regional key projects of science and technology service network plan (STS plan) of Chinese Academy of Sciences (Grant No. KFJ-STS-QYZD-181), National Natural Science Foundation of China-Key program project (Grant No. 91849203)	Beck JS, 2016, CURR ALZHEIMER RES, V13, P610, DOI 10.2174/1567205013666151221145445; Benzie IFF, 1999, METHOD ENZYMOL, V299, P15; Bull K, 2007, INT J PARASITOL, V37, P627, DOI 10.1016/j.ijpara.2006.10.013; Cai ZY, 2011, NEUROMOL MED, V13, P223, DOI 10.1007/s12017-011-8155-9; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088076; Cheng J, 2015, DRUG DES DEV THER, V9, P33, DOI [10.2147/DDDT.S72892, 10.2147/DDDT.572892]; Ewald CY, 2010, BRAIN STRUCT FUNCT, V214, P263, DOI 10.1007/s00429-009-0235-3; Gao K, 2015, MOLECULES, V20, P293, DOI 10.3390/molecules20010293; GRAY EG, 1987, NEUROPATH APPL NEURO, V13, P91, DOI 10.1111/j.1365-2990.1987.tb00174.x; Haque R, 2018, ADV BIOTECHNOL MICRO, V11; Hu XY, 2018, MOL MED REP, V17, P3599, DOI 10.3892/mmr.2017.8310; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim HY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9997; Kim S, 2020, GENETICS, V214, P409, DOI 10.1534/genetics.119.302947; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Meng J, 2021, ANTIOXID REDOX SIGN, V34, P1069, DOI 10.1089/ars.2020.8212; Meng J, 2020, FASEB J, V34, P11460, DOI 10.1096/fj.202000136R; [孟姣 Meng Jiao], 2018, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V29, P2489; Meng J, 2017, REDOX BIOL, V11, P365, DOI 10.1016/j.redox.2016.12.026; Price DL, 1998, NAT GENET, V19, P314, DOI 10.1038/1196; Rebolledo DL, 2011, J NEUROSCI, V31, P10149, DOI 10.1523/JNEUROSCI.0336-11.2011; Scheper W, 2011, AUTOPHAGY, V7, P910, DOI 10.4161/auto.7.8.15761; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shen Y, 2020, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00568; Singh SK, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7361613; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Sorrentino V, 2017, NATURE, V552, P187, DOI 10.1038/nature25143; van Marum RJ, 2008, FUND CLIN PHARMACOL, V22, P265, DOI 10.1111/j.1472-8206.2008.00578.x; Wang HB, 2013, EUR REV MED PHARMACO, V17, P2760; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Yu MS, 2007, INT J MOL MED, V20, P261; Yu MS, 2005, EXP GERONTOL, V40, P716, DOI 10.1016/j.exger.2005.06.010; Zhang QL, 2013, EXP THER MED, V5, P1528, DOI 10.3892/etm.2013.1006; Zhou XL, 2014, NUCLEIC ACIDS RES, V42, P13873, DOI 10.1093/nar/gku1218; Zhou Y, 2020, INT J BIOL MACROMOL, V144, P1004, DOI 10.1016/j.ijbiomac.2019.09.177	38	5	5	7	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22156	10.1096/fj.202101116RR	http://dx.doi.org/10.1096/fj.202101116RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35044707				2022-12-28	WOS:000747987800020
J	du Preez, HN; Aldous, C; Hayden, MR; Kruger, HG; Lin, J				du Preez, Heidi N.; Aldous, Colleen; Hayden, Melvin R.; Kruger, Hendrik G.; Lin, Johnson			Pathogenesis of COVID-19 described through the lens of an undersulfated and degraded epithelial and endothelial glycocalyx	FASEB JOURNAL			English	Review						COVID-19; glycocalyx; heparan sulfate; inorganic sulfate; SARS-CoV-2	HERPES-SIMPLEX-VIRUS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CORONAVIRUS DISEASE 2019; HEPARAN-SULFATE; N-ACETYLCYSTEINE; DOWN-REGULATION; CYSTEINE DIOXYGENASE; INORGANIC SULFATE; INTERFERON-GAMMA; DERMATAN SULFATE	The glycocalyx surrounds every eukaryotic cell and is a complex mesh of proteins and carbohydrates. It consists of proteoglycans with glycosaminoglycan side chains, which are highly sulfated under normal physiological conditions. The degree of sulfation and the position of the sulfate groups mainly determine biological function. The intact highly sulfated glycocalyx of the epithelium may repel severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) through electrostatic forces. However, if the glycocalyx is undersulfated and 3-O-sulfotransferase 3B (3OST-3B) is overexpressed, as is the case during chronic inflammatory conditions, SARS-CoV-2 entry may be facilitated by the glycocalyx. The degree of sulfation and position of the sulfate groups will also affect functions such as immune modulation, the inflammatory response, vascular permeability and tone, coagulation, mediation of sheer stress, and protection against oxidative stress. The rate-limiting factor to sulfation is the availability of inorganic sulfate. Various genetic and epigenetic factors will affect sulfur metabolism and inorganic sulfate availability, such as various dietary factors, and exposure to drugs, environmental toxins, and biotoxins, which will deplete inorganic sulfate. The role that undersulfation plays in the various comorbid conditions that predispose to coronavirus disease 2019 (COVID-19), is also considered. The undersulfated glycocalyx may not only increase susceptibility to SARS-CoV-2 infection, but would also result in a hyperinflammatory response, vascular permeability, and shedding of the glycocalyx components, giving rise to a procoagulant and antifibrinolytic state and eventual multiple organ failure. These symptoms relate to a diagnosis of systemic septic shock seen in almost all COVID-19 deaths. The focus of prevention and treatment protocols proposed is the preservation of epithelial and endothelial glycocalyx integrity.	[du Preez, Heidi N.; Kruger, Hendrik G.] Univ KwaZulu Natal, Catalysis & Peptide Res Unit, Westville Campus, Durban, South Africa; [Aldous, Colleen] Univ KwaZulu Natal, Coll Hlth Sci, Durban, South Africa; [Hayden, Melvin R.] Univ Missouri, Dept Internal Med, Div Endocrinol Diabet & Metab, Columbia Sch Med, Columbia, MO USA; [Hayden, Melvin R.] Univ Missouri, Diabet & Cardiovasc Dis Ctr, Columbia Sch Med, Columbia, MO USA; [Lin, Johnson] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa	University of Kwazulu Natal; University of Kwazulu Natal; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Kwazulu Natal	du Preez, HN; Kruger, HG (corresponding author), Univ KwaZulu Natal, Catalysis & Peptide Res Unit, Westville Campus, Durban, South Africa.	hdp@heididupreez.com; KRUGER@ukzn.ac.za	Kruger, Gert/B-1687-2009; Aldous, Colleen/N-5389-2013	Kruger, Gert/0000-0003-0606-2053; du Preez, Heidi N/0000-0002-1717-9452; Lin, Johnson/0000-0002-9621-9343; Hayden, Melvin/0000-0001-5178-4245; Aldous, Colleen/0000-0002-7199-9160				Abu-Fanne R, 2019, BLOOD, V133, P481, DOI 10.1182/blood-2018-07-861237; Aldecoa C, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00697-1; Amadi B, 2009, AM J CLIN NUTR, V89, P592, DOI 10.3945/ajcn.2008.27092; Amirshahrokhi K, 2013, INFLAMMATION, V36, P1111, DOI 10.1007/s10753-013-9645-8; Ando Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35976-2; Andreou A, 2020, IN VIVO, V34, P1567, DOI 10.21873/invivo.11946; Antalis TM, 1998, CLIN CANCER RES, V4, P1857; Aquino RS, 2016, FRONT BIOSCI-LANDMRK, V21, P1260, DOI 10.2741/4455; Arokiasamy S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02316; Atefi N, 2020, J RES MED SCI, V25, DOI 10.4103/jrms.JRMS_777_20; Awadasseid A, 2020, INT J BIOL SCI, V16, P1846, DOI 10.7150/ijbs.45018; AWWAD HK, 1970, J BIOL CHEM, V245, P469; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Ayerst BI, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10020054; Baig MS, 2020, DRUGS R&D, V20, P161, DOI 10.1007/s40268-020-00312-5; Ban GY, 2016, IMMUNE NETW, V16, P256, DOI 10.4110/in.2016.16.4.256; Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082; Beane J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r201; Becker BF, 2010, CARDIOVASC RES, V87, P300, DOI 10.1093/cvr/cvq137; Becker RC, 2020, J THROMB THROMBOLYS, V50, P499, DOI 10.1007/s11239-020-02230-4; Benatti MN, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00488-7; Biagi, 2016, MESOSCALE INVESTIGAT; Bittker S, 2016, J AUTISM, V3, P3, DOI [DOI 10.7243/2054-992X-3-3, 10.7243/2054-992x-3-3]; Bolt MJG, 2004, AM J PHYSIOL-ENDOC M, V287, pE744, DOI 10.1152/ajpendo.00151.2004; Boshuizen JA, 2005, VIROLOGY, V337, P210, DOI 10.1016/j.virol.2005.03.039; Bourgonje AR, 2021, ANTIOXID REDOX SIGN, V35, P1207, DOI 10.1089/ars.2020.8247; Breljak D, 2015, CROAT MED J, V56, P447, DOI 10.3325/cmj.2015.56.447; Brzica H, 2009, PFLUG ARCH EUR J PHY, V457, P1381, DOI 10.1007/s00424-008-0611-5; Buijsers B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.575047; Buijsers B, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102969; Buret AG, 2022, ANTIOXID REDOX SIGN, V36, P211, DOI 10.1089/ars.2021.0004; Busher JT, 1990, SERUM ALBUMIN GLOBUL, V3rd; Butler-Laporte G, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003605; Cagno V, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070596; Cao W, 2020, CELL RES, V30, P367, DOI 10.1038/s41422-020-0327-4; Carpentier A, 1998, DIABETES CARE, V21, P1571, DOI 10.2337/diacare.21.9.1571; Chaufan G, 2014, INT J TOXICOL, V33, P29, DOI 10.1177/1091581813517906; CHEN MF, 1995, NUTR CANCER, V23, P77, DOI 10.1080/01635589509514363; Chen XY, 2020, THER ADV RESPIR DIS, V14, DOI 10.1177/1753466620926800; Chen YF, 2020, J MED VIROL, V92, P833, DOI 10.1002/jmv.25825; CHENG PW, 1989, J CLIN INVEST, V84, P68, DOI 10.1172/JCI114171; Cheung ST, 2017, ACS CHEM BIOL, V12, P3126, DOI 10.1021/acschembio.7b00885; Clausen TM, 2020, CELL, V183, P1043, DOI [10.1016/j.cell.2020.09.033, 10.1101/2020.07.14.201616]; Cohen IV, 2018, EBIOMEDICINE, V28, P316, DOI 10.1016/j.ebiom.2018.01.033; Collins LE, 2019, J LEUKOCYTE BIOL, V105, P81, DOI 10.1002/JLB.3RU0618-246R; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Corfield AP, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6030078; COUGHTRIE MWH, 1994, CHEM-BIOL INTERACT, V92, P247, DOI 10.1016/0009-2797(94)90067-1; Cuervo NZ, 2020, ELIFE, V9, DOI 10.7554/eLife.61390; Cumpstey AF, 2021, ANTIOXID REDOX SIGN, V35, P1226, DOI 10.1089/ars.2021.0017; da Costa DS, 2017, ANNU REV BIOMED ENG, V19, P1, DOI [10.1146/annurev-bioeng-071516044610, 10.1146/annurev-bioeng-071516-044610]; Dal Pizzol TD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214329; Dane MJC, 2015, AM J PHYSIOL-RENAL, V308, pF956, DOI 10.1152/ajprenal.00532.2014; DARLING IM, 1994, DRUG METAB DISPOS, V22, P318; Dawson PA, 2010, J CLIN INVEST, V120, P706, DOI 10.1172/JCI31474; De Flora S, 2020, FASEB J, V34, P13185, DOI 10.1096/fj.202001807; Delos M, 2017, FEBS OPEN BIO, V7, P133, DOI 10.1002/2211-5463.12145; Demir M, 2021, J MED VIROL, V93, P2992, DOI 10.1002/jmv.26832; Denys A, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00507; DEVRIES BJ, 1985, ARTHRITIS RHEUM, V28, P922, DOI 10.1002/art.1780280812; Dhahri M, 2020, ACS OMEGA, V5, P14786, DOI 10.1021/acsomega.0c01724; Dhar D, 2020, VIRUS RES, V285, DOI 10.1016/j.virusres.2020.198018; Dhochak N, 2020, INDIAN J PEDIATR, V87, P537, DOI 10.1007/s12098-020-03322-y; Dhounchak S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252607; Dissayabutra T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213180; Dogne S, 2018, ARTERIOSCL THROM VAS, V38, P1427, DOI 10.1161/ATVBAHA.118.310839; Dull RO, 2003, AM J PHYSIOL-LUNG C, V285, pL986, DOI 10.1152/ajplung.00022.2003; DUNNE JW, 1984, BRIT J CLIN PHARMACO, V17, P356, DOI 10.1111/j.1365-2125.1984.tb02354.x; El Masri R, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00570; El-Missiry MA, 2020, EUR J PHARMACOL, V882, DOI 10.1016/j.ejphar.2020.173329; Ellul MA, 2020, LANCET NEUROL, V19, P767, DOI 10.1016/S1474-4422(20)30221-0; Everett HE, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13010113; Evgen'ev MB, 2020, CELL STRESS CHAPERON, V25, P713, DOI 10.1007/s12192-020-01120-1; Farach-Carson MC, 2014, MATRIX BIOL, V34, P64, DOI 10.1016/j.matbio.2013.08.004; Fernandes I, 2001, KIDNEY INT, V59, P210, DOI 10.1046/j.1523-1755.2001.00481.x; Ferrara F, 2021, CARDIOVASC TOXICOL, V21, P498, DOI 10.1007/s12012-021-09649-y; Fontana F, 2020, KIDNEY INT REP, V5, P1815, DOI 10.1016/j.ekir.2020.07.008; Foster PA, 2018, J MOL ENDOCRINOL, V61, pT271, DOI 10.1530/JME-18-0086; Fotuhi M, 2020, J ALZHEIMERS DIS, V76, P3, DOI 10.3233/JAD-200581; Fruitwala S, 2019, SEMIN CELL DEV BIOL, V88, P163, DOI 10.1016/j.semcdb.2018.02.023; Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109; FULLER MF, 1994, ANNU REV NUTR, V14, P217, DOI 10.1146/annurev.nu.14.070194.001245; Galvis-Ramirez MF, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01470; Gepdiremen A, 2020, BEZMIALEM SCI, V8, P79, DOI 10.14235/bas.galenos.2020.4756; Gianni T, 2006, J VIROL, V80, P8190, DOI 10.1128/JVI.00504-06; Girard JP, 1998, FASEB J, V12, P603, DOI 10.1096/fasebj.12.7.603; Gordts PLSM, 2015, CYTOKINE, V72, P118, DOI 10.1016/j.cyto.2014.12.013; Gordts PLSM, 2014, CELL METAB, V20, P813, DOI 10.1016/j.cmet.2014.09.016; Gout I, 2018, BIOCHEM SOC T, V46, P721, DOI 10.1042/BST20170506; Gouverneur M, 2008, FASEB J, V22, DOI 10.1096/fasebj.22.2_supplement.83; Greaves P, 2012, HISTOPATHOLOGY OF PRECLINICAL TOXICITY STUDIES: INTERPRETATION AND RELEVANCE IN DRUG SAFETY EVALUATION, 4TH EDITION, P325, DOI 10.1016/B978-0-444-53856-7.00008-7; GREGUS Z, 1994, CHEM-BIOL INTERACT, V92, P169, DOI 10.1016/0009-2797(94)90062-0; GREGUS Z, 1994, DRUG METAB DISPOS, V22, P725; Gu HG, 2020, VIRUS EVOL, V6, DOI 10.1093/ve/veaa032; HABEGGER L, 2020, AM J RESP CRIT CARE, V201, P2; Haeger SM, 2018, AM J RESP CELL MOL, V59, P363, DOI 10.1165/rcmb.2017-0428OC; Haeger SM, 2016, AM J RESP CELL MOL, V55, P5, DOI 10.1165/rcmb.2016-0043TR; Hagiwara A, 2014, AMINO ACIDS, V46, P1275, DOI 10.1007/s00726-014-1693-3; HajMohammadi S, 2003, J CLIN INVEST, V111, P989, DOI 10.1172/JCI200315809; Hallak LK, 2000, J VIROL, V74, P10508, DOI 10.1128/JVI.74.22.10508-10513.2000; Harrison JS, 2013, STRUCTURE, V21, P1085, DOI 10.1016/j.str.2013.05.009; Hasan MJ, 2020, SAGE OPEN MED CASE R, V8, DOI 10.1177/2050313X20934708; Hayden MR, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115427; Hayden MR, 2020, J INT MED RES, V48, DOI 10.1177/0300060520939746; Hayden MR, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9100262; He H, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006992; Hellec C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194676; Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597; Hermans C, 1999, AM J RESP CRIT CARE, V159, P646, DOI 10.1164/ajrccm.159.2.9806064; Herrero R, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2017.12.18; Hicks BM, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4209; Hippensteel JA, 2019, J CLIN INVEST, V129, P1779, DOI 10.1172/JCI124485; Hirano K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043440; Hornich BF, 2021, J VIROL, V95, DOI 10.1128/JVI.00002-21; Hoffer LJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030257; Huang ML, 2018, STEM CELLS, V36, P45, DOI 10.1002/stem.2714; Huang Y, 2020, UROL INT, V104, P167, DOI 10.1159/000504417; Iba T, 2019, J THROMB HAEMOST, V17, P283, DOI 10.1111/jth.14371; Ibrahim H, 2020, CLIN IMMUNOL, V219, DOI 10.1016/j.clim.2020.108544; Irie F, 2012, P NATL ACAD SCI USA, V109, P5052, DOI 10.1073/pnas.1117881109; Izvolsky KI, 2003, DEV BIOL, V258, P185, DOI 10.1016/S0012-1606(03)00114-3; Jancova P, 2012, TOPICS ON DRUG METABOLISM, P35; Jiang L, 2020, LANCET INFECT DIS, V20, pE276, DOI 10.1016/S1473-3099(20)30651-4; Johnson AS, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00153; JOHNSON L R, 1970, Gastroenterology, V58, P208; Jones ST, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax9318; Joonaki E, 2020, CHEM-US, V6, P2135, DOI 10.1016/j.chempr.2020.08.001; Jung SH, 2016, CELL DEATH DIFFER, V23, P417, DOI 10.1038/cdd.2015.107; Kato R, 2017, BRAIN DEV-JPN, V39, P418, DOI 10.1016/j.braindev.2016.12.008; Kaufman HW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239252; KAZATCHKINE MD, 1981, J CLIN INVEST, V67, P223, DOI 10.1172/JCI110017; Kern JK, 2013, INT J ENV RES PUB HE, V10, P3771, DOI 10.3390/ijerph10083771; Kim SY, 2020, ANTIVIR RES, V181, DOI 10.1016/j.antiviral.2020.104873; Kim Youn-Hyun, 2017, Curr Heart Fail Rep, V14, P117, DOI 10.1007/s11897-017-0320-5; Kirk MA., CYANIDE HYDROGEN SUL; Kitazawa K, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-020-01618-5; Kolarova H, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/694312; Kolipinski M, 2020, J ENVIRON PUBLIC HEA, V2020, DOI 10.1155/2020/8184614; Ku SK, 2014, ARCH PHARM RES, V37, P1454, DOI 10.1007/s12272-014-0403-8; Kurogi K, 2017, FEBS LETT, V591, P2417, DOI 10.1002/1873-3468.12767; Kwiatkowska D., 2019, BIOMEDICAL J SCI TEC, V12, P9434, DOI [DOI 10.26717/BJSTR.2019.12.002293, 10.26717/bjstr.2019.12.002293]; Kwon PS, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-00192-8; Lam DCL, 2015, SCI REP-UK, V5, DOI 10.1038/srep12945; LaRiviere WB, 2020, AM J PHYSIOL-LUNG C, V318, pL1198, DOI 10.1152/ajplung.00063.2020; Larsen K, 2012, ENVIRON TOXICOL PHAR, V34, P811, DOI 10.1016/j.etap.2012.09.005; Lee, 2020, QEIOS, P1, DOI [10.32388/of0l6s.5, DOI 10.32388/OF0L6S.5]; Lemkes BA, 2012, DIABETES TECHNOL THE, V14, pS3, DOI 10.1089/dia.2012.0011; Leu CH, 2015, ANTIMICROB AGENTS CH, V59, P5619, DOI 10.1128/AAC.00065-15; Li J, 2021, BIOMED PHARMACOTHER, V133, DOI 10.1016/j.biopha.2020.111026; Li XW, 2020, J PHARM ANAL, V10, P102, DOI 10.1016/j.jpha.2020.03.001; Liang QT, 2015, GLYCOBIOLOGY, V25, P714, DOI 10.1093/glycob/cwv011; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Liotta EM, 2020, ANN CLIN TRANSL NEUR, V7, P2221, DOI 10.1002/acn3.51210; Lipowsky HH, 2013, MICROVASC RES, V90, P80, DOI 10.1016/j.mvr.2013.07.004; Liu J, 2020, RES PRACT THROMB HAE, V4, P518, DOI 10.1002/rth2.12353; Liu L, 2021, ACS CENTRAL SCI, V7, P1009, DOI [10.1101/2020.05.10.087288, 10.1021/acscentsci.1c00010]; Liu XQ, 2020, AM J RESP CRIT CARE, V201, P1297, DOI 10.1164/rccm.202002-0373LE; LORTAT-JACOB H, 1992, BIOCHIM BIOPHYS ACTA, V1117, P126, DOI 10.1016/0304-4165(92)90069-7; Luther T, 2021, ACTA ANAESTH SCAND, V65, P364, DOI 10.1111/aas.13746; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Machin DR, 2018, AM J PHYSIOL-HEART C, V315, pH531, DOI 10.1152/ajpheart.00104.2018; Mahapatra SJ., 2020, EFFICACY FAMOTIDINE; Majerczak J, 2017, EXP PHYSIOL, V102, P70, DOI 10.1113/EP085887; Mandal, 2020, CONFORMATIONAL PERTU; Marki A, 2015, J LEUKOCYTE BIOL, V98, P503, DOI 10.1189/jlb.3MR0115-011R; Markovich D, 2011, AM J PHYSIOL-RENAL, V300, pF1267, DOI 10.1152/ajprenal.00061.2011; Martin L, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3758278; Mason RJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00607-2020; Mason SA, 2020, REDOX BIOL, V35, DOI 10.1016/j.redox.2020.101471; Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0; McGill MR, 2013, PHARM RES-DORDR, V30, P2174, DOI 10.1007/s11095-013-1007-6; Meli I., 2019, ASSESSING ROLE ALBUM; Melnick JG, 2010, J AM CHEM SOC, V132, P647, DOI 10.1021/ja907523x; Meneghetti MCZ, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0589; Mercante G, 2020, JAMA OTOLARYNGOL, V146, P723, DOI 10.1001/jamaoto.2020.1155; Meyer M, 2015, AM J PHYSIOL-LUNG C, V308, pL1189, DOI 10.1152/ajplung.00028.2015; Meyerowitz EA, 2021, LANCET INFECT DIS, V21, pE163, DOI 10.1016/S1473-3099(20)30837-9; Milani GP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77125-8; Minich DM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092073; Mycroft-West C., 2020, BIORXIV, DOI [10.1101/2020.02.29.971093, 10]; Nadanaka S, 2014, GLYCOBIOLOGY, V24, P1206; Nagarajan A, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00483; Naicker, 2020, AMPATHCHAT; Naidoo V, 2019, J PSYCHIATR RES, V112, P7, DOI 10.1016/j.jpsychires.2019.02.003; Nikitina LE, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00116; Nimni ME, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-24; Odhaib S.A, 2020, RES SQUARE, V11, P1, DOI [10.21203/rs.3.rs-63469/v1, DOI 10.21203/RS.3.RS-63469/V1]; OECD, 2019, Addressing problematic opioid use in OECD countries, DOI 10.1787/a18286f0-en; Oh MJ, 2010, BIOCHEM BIOPH RES CO, V391, P176, DOI 10.1016/j.bbrc.2009.11.027; Oshima K, 2017, PULM CIRC, V8, DOI 10.1177/2045893217745786; Oxley TJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009787; Pace BT, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/5186904; Palkovicova L, 2008, J EXPO SCI ENV EPID, V18, P326, DOI 10.1038/sj.jes.7500606; Paterson RW, 2020, BRAIN, V143, P3104, DOI 10.1093/brain/awaa240; Pecora F, 2006, BIOCHEM J, V398, P509, DOI 10.1042/BJ20060566; Peerboom N, 2017, BIOPHYS J, V113, P1223, DOI 10.1016/j.bpj.2017.06.028; Pessentheiner AR, 2020, FASEB J, V34, DOI 10.1096/fasebj.2020.34.s1.03687; Pessentheiner AR, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00769; Pickles Raymond J, 2004, Proc Am Thorac Soc, V1, P302, DOI 10.1513/pats.200403-024MS; Pineiro-Carrero VM, 2004, PEDIATRICS, V113, P1097; Pizzorno Lara, 2015, Integr Med (Encinitas), V14, P35; Poe FL, 2020, MED HYPOTHESES, V143, DOI 10.1016/j.mehy.2020.109862; Polonikov A, 2020, ACS INFECT DIS, V6, P1558, DOI 10.1021/acsinfecdis.0c00288; Pons S, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03062-7; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Putz ND, 2020, FASEB J, V34, DOI 10.1096/fasebj.2020.34.s1.06603; Rangel-Mendez JA, 2020, FUTURE MICROBIOL, V15, P959, DOI 10.2217/fmb-2020-0074; Rapista A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-45; Rees MD, 2005, BIOCHEM J, V391, P125, DOI 10.1042/BJ20050630; Reine TM, 2013, J HISTOCHEM CYTOCHEM, V61, P606, DOI 10.1369/0022155413494392; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Remond D, 2015, ONCOTARGET, V6, P13858, DOI 10.18632/oncotarget.4030; Renes IB., 2002, INTESTINAL EPITHELIU; Rodriguez EA, 2016, ENVIRON SCI TECHNOL, V50, P5320, DOI 10.1021/acs.est.6b00484; Rodriguez LAG, 2001, ARTHRITIS RES, V3, P98, DOI 10.1186/ar146; Rubio ML, 2000, EUR RESPIR J, V15, P505, DOI 10.1034/j.1399-3003.2000.15.13.x; Salgado-Benvindo C, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.00900-20; Samsel Anthony, 2013, Interdiscip Toxicol, V6, P159, DOI 10.2478/intox-2013-0026; Sansone C, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9050392; Santos JS, 2020, PESQUI BRAS ODONTOPE, V20, DOI 10.1590/pboci.2020.045; Sarrazin S, 2006, BBA-REV CANCER, V1765, P25, DOI 10.1016/j.bbcan.2005.08.004; Schmidtchen A, 2001, MOL MICROBIOL, V39, P708, DOI 10.1046/j.1365-2958.2001.02251.x; Schneider, 2018, BRUSSELS TIMES 0410; Sen CK, 1999, MOL CELL BIOCHEM, V196, P31, DOI 10.1023/A:1006910011048; Seneff Stephanie, 2017, Journal of Biological Physics and Chemistry, V17, P53, DOI 10.4024/04SE17A.jbpc.17.02; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Sharthiya H, 2017, J NEUROVIROL, V23, P483, DOI 10.1007/s13365-017-0521-4; Shi ZC, 2020, THER CLIN RISK MANAG, V16, P1047, DOI 10.2147/TCRM.S273700; Shobo A, 2018, NANOMEDICINE-UK, V13, P997, DOI 10.2217/nnm-2017-0365; Simeonovic CJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191360; Sinha S, 2003, ANTIMICROB AGENTS CH, V47, P494, DOI 10.1128/AAC.47.2.494-500.2003; Smadja DM, 2020, ANGIOGENESIS, V23, P611, DOI 10.1007/s10456-020-09730-0; Smits NC, 2010, ANAT REC, V293, P955, DOI 10.1002/ar.20895; Song S, 2020, FOOD FUNCT, V11, P7415, DOI 10.1039/d0fo02017f; Sousa-Lima I, 2016, METABOLISM, V65, P1508, DOI 10.1016/j.metabol.2016.07.007; Spencer JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031712; Stieger B, 2011, J HEPATOL, V54, P406, DOI 10.1016/j.jhep.2010.09.011; Stonebraker JR, 2004, J VIROL, V78, P13755, DOI 10.1128/JVI.78.24.13755-13768.2004; Stopschinski BE, 2018, J BIOL CHEM, V293, P10826, DOI 10.1074/jbc.RA117.000378; Suzuki K, 2019, AM J PATHOL, V189, P1526, DOI 10.1016/j.ajpath.2019.05.002; Szabo C, 2014, BRIT J PHARMACOL, V171, P2099, DOI 10.1111/bph.12369; Takahashi I, 2009, BIOCHEM BIOPH RES CO, V383, P113, DOI 10.1016/j.bbrc.2009.03.140; Tandon R, 2021, J VIROL, V95, DOI [10.1128/JVI.01987-20, 10.1101/2020.06.08.140236]; Thacker BE, 2014, MATRIX BIOL, V35, P60, DOI 10.1016/j.matbio.2013.12.001; Thelin MA, 2013, FEBS J, V280, P2431, DOI 10.1111/febs.12214; Tiwari Vaibhav, 2020, bioRxiv, DOI 10.1101/2020.10.08.331751; Tiwari V, 2009, BIOCHEM BIOPH RES CO, V390, P382, DOI 10.1016/j.bbrc.2009.08.174; Tobacman JK., 2020, BIORXIV PREPRINT, DOI [10.1101/2020.06.25.171975, DOI 10.1101/2020.06.25.171975]; Tran-Lundmark K, 2008, CIRC RES, V103, P43, DOI 10.1161/CIRCRESAHA.108.172833; Troeberg L, 2014, CHEM BIOL, V21, P1300, DOI 10.1016/j.chembiol.2014.07.014; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; Uchimido R, 2019, CRIT CARE, V23, DOI 10.1186/s13054-018-2292-6; ul Qamar MT, 2020, J PHARM ANAL, V10, P313, DOI 10.1016/j.jpha.2020.03.009; van Gemst JJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201560; vanDet NF, 1996, KIDNEY INT, V49, P1079, DOI 10.1038/ki.1996.157; Vanpouille C, 2007, J BIOL CHEM, V282, P24416, DOI 10.1074/jbc.M701835200; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Velez A, 2002, J AM ACAD DERMATOL, V46, P469, DOI 10.1067/mjd.2002.118557; Velusamy RK, 2018, J PHARM PHARMACOL, V70, P1188, DOI 10.1111/jphp.12946; Veraldi N, 2020, MOLECULES, V25, DOI 10.3390/molecules25020390; Verma S, 2006, J VIROL, V80, P4344, DOI 10.1128/JVI.80.9.4344-4355.2006; Vietri M, 2000, EUR J CLIN PHARMACOL, V56, P81, DOI 10.1007/s002280050725; Villalba N, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.711003; Voyvodic PL, 2014, J BIOL CHEM, V289, P9547, DOI 10.1074/jbc.M113.541573; Wadowski PP, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.607306; Walter FR, 2021, TISSUE BARRIERS, V9, DOI 10.1080/21688370.2021.1904773; Waring RH, 2013, CURR DRUG METAB, V14, P361, DOI 10.2174/1389200211314030011; Weidenfeld S, 2018, AM J RESP CELL MOL, V59, P283, DOI 10.1165/rcmb.2018-0108ED; Weir EK, 2020, CLIN MED, V20, pE107, DOI 10.7861/clinmed.2020-0301; Westling, 2003, N UNSUBSTITUTED GLUC; Wielgat P, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9091963; Wilkinson LJ, 2002, TOXICOL IN VITRO, V16, P481, DOI 10.1016/S0887-2333(02)00031-0; Wu T, 2021, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.582338; Wu X, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd4049; Xia JG, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05360-5; Xu CA, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13071246; Xu D, 2015, INFECT IMMUN, V83, P3648, DOI 10.1128/IAI.00545-15; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Yamaoka-Tojo M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249712; Yamashita Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25635-x; Yarandi SS, 2011, CURR OPIN CLIN NUTR, V14, P75, DOI 10.1097/MCO.0b013e328341235a; Yard BA, 1998, TRANSPLANTATION, V66, P1244, DOI 10.1097/00007890-199811150-00021; Yasin B, 2004, J VIROL, V78, P5147, DOI 10.1128/JVI.78.10.5147-5156.2004; Yasuda S, 2007, TOXICOL APPL PHARM, V221, P13, DOI 10.1016/j.taap.2007.02.013; Yates PA, 2020, THER ADV RESPIR DIS, V14, DOI 10.1177/1753466620951053; Yeoh YK, 2021, GUT, V70, P698, DOI 10.1136/gutjnl-2020-323020; Yildirim C, 2021, NEPHROLOGY, V26, P513, DOI 10.1111/nep.13856; Yin WC, 2021, NAT STRUCT MOL BIOL, V28, DOI 10.1038/s41594-021-00570-0; Yuki K, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108427; Zhan M, 2020, AM J KIDNEY DIS, V76, P184, DOI 10.1053/j.ajkd.2019.12.010; Zhao J, 2020, ANGEW CHEM INT EDIT, V59, P1818, DOI 10.1002/anie.201913029; Zhu ZJ, 2021, COMPR REV FOOD SCI F, V20, P2882, DOI 10.1111/1541-4337.12754; Zuo YY, 2020, ACS NANO, V14, P16502, DOI 10.1021/acsnano.0c08484	294	11	11	12	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22052	10.1096/fj.202101100RR	http://dx.doi.org/10.1096/fj.202101100RR			41	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34862979				2022-12-28	WOS:000734992000012
J	Ida, Y; Umetsu, A; Furuhashi, M; Watanabe, M; Hikage, F; Ohguro, H				Ida, Yosuke; Umetsu, Araya; Furuhashi, Masato; Watanabe, Megumi; Hikage, Fumihito; Ohguro, Hiroshi			The EP2 agonist, omidenepag, alters the physical stiffness of 3D spheroids prepared from human corneal stroma fibroblasts differently depending on the osmotic pressure	FASEB JOURNAL			English	Article						3D spheroid culture; EP2 agonist; human corneal stroma fibroblasts (HCSFs); omidenepag (OMD); osmotic pressures	AQUAPORINS; ISOPROPYL	The objective of the current study was to examine the drug-induced effects of the EP2 agonist, omidenapag (OMD), on human corneal stroma, two- and three-dimensional (2D and 3D) cultures of human corneal stroma fibroblasts (HCSFs). The drug-induced effects on 2D monolayers and 3D spheroids were characterized by examining the ultrastructures by scanning electron microscope (SEM), transendothelial electrical resistance (TEER) measurements, and fluorescein isothiocyanate (FITC)-dextran permeability. The physical properties of 3D spheroids with respect to size and stiffness were also examined. In addition, the gene expressions of extracellular matrix (ECM) molecules, including collagen (COL) 1, 4, and 6, and fibronectin (FN), a tissue inhibitor of metalloproteinase (TIMP) 1-4, matrix metalloproteinase (MMP) 2, 9, and 14, aquaporin1 (AQP1), and several endoplasmic reticulum (ER) stress-related factors were evaluated. In the 2D HCSFs, OMD induced (1) a significant increase in ECM deposits, as evidenced by SEM, the mRNA expression of COL4 and FN, and (2) a decrease in TEER values and a concentration-dependent increase in FITC-dextran permeability. In the case of 3D spheroids, OMD had no effect on size but a substantial increase in stiffness was observed. Furthermore, such OMD-induced effects on stiffness were dramatically modulated by the osmotic pressure of the system. In contrast to the above 2D cultures, among the ECM molecules and the modulators of 3D spheroids, namely, TIMPS and MMPs, the down-regulation of COL1, TIMP1 and 2 and the up-regulation of MMP9 were observed. Interestingly, such diversity in terms of OMD-induced gene expressions between 2D and 3D cultures was also recognized in AQP1 (2D; no significant change, 3D; significant up-regulation) and ER stress-related genes. The findings presented herein suggest that the EP2 agonist, OMD, alters the physical stiffness of 3D spheroids obtained from human corneal stroma fibroblasts and this alteration is dependent on the osmotic pressures. 2D and 3D cell cultures may be useful for evaluating the drug induced effects of OMD toward human corneal stroma.	[Ida, Yosuke; Umetsu, Araya; Watanabe, Megumi; Hikage, Fumihito; Ohguro, Hiroshi] Sapporo Med Univ, Dept Ophthalmol, Sch Med, Sapporo, Hokkaido, Japan; [Furuhashi, Masato] Sapporo Med Univ, Dept Cardiovasc Renal & Metab Med, Sch Med, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University	Ohguro, H (corresponding author), Sapporo Med Univ, Dept Ophthalmol, Sch Med, Sapporo, Hokkaido, Japan.	ooguro@sapmed.ac.jp		Hikage, Fumihito/0000-0002-0124-5494				Aihara M, 2020, AM J OPHTHALMOL, V220, P53, DOI 10.1016/j.ajo.2020.06.003; Aihara M, 2019, J OCUL PHARMACOL TH, V35, P542, DOI 10.1089/jop.2019.0044; Alhaque S, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0216; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; CINTRON C, 1983, INVEST OPHTH VIS SCI, V24, P543; DelMonte DW, 2011, J CATARACT REFR SURG, V37, P588, DOI 10.1016/j.jcrs.2010.12.037; Dimasi DP, 2010, MOL VIS, V16, P562; DONOHUE DJ, 1995, J OPT SOC AM A, V12, P1425, DOI 10.1364/JOSAA.12.001425; Fuwa M, 2018, INVEST OPHTH VIS SCI, V59, DOI 10.1089/jop.2017.0146; Garcia-Posadas L, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12121215; GIPSON IK, 1988, DEV BIOL, V126, P253, DOI 10.1016/0012-1606(88)90136-4; Greenwood M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124956; Hachez C, 2010, ADV EXP MED BIOL, V679, P1; Hamann S, 1998, AM J PHYSIOL-CELL PH, V274, pC1332, DOI 10.1152/ajpcell.1998.274.5.C1332; Hikage F, 2019, ENDOCRINOLOGY, V160, P20, DOI 10.1210/en.2018-00272; Holloway EM, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.166173; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Ichioka H, 2021, EXP EYE RES, V205, DOI 10.1016/j.exer.2021.108489; Ida Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64674-1; Ishibashi K, 2011, AM J PHYSIOL-REG I, V300, pR566, DOI 10.1007/978-94-024-1057-0_2; Itoh K, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.6.13; Kaneko Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep19640; Kirihara T, 2018, INVEST OPHTH VIS SCI, V59, P145, DOI 10.1167/iovs.17-22745; Lagali N, 2020, CURR EYE RES, V45, P278, DOI 10.1080/02713683.2019.1663874; Miyagi H, 2018, EXP EYE RES, V176, P235, DOI 10.1016/j.exer.2018.09.001; NEGISHI M, 1993, PROG LIPID RES, V32, P417, DOI 10.1016/0163-7827(93)90017-Q; Ota C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77302-9; Park Y, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052491; Prasanna G, 2011, EXP EYE RES, V93, P256, DOI 10.1016/j.exer.2011.02.015; Ruberti JW, 2011, ANNU REV BIOMED ENG, V13, P269, DOI 10.1146/annurev-bioeng-070909-105243; Schachar RA, 2013, CORNEA, V32, P306, DOI 10.1097/ICO.0b013e3182523f40; Schachar RA, 2011, CURR EYE RES, V36, P809, DOI 10.3109/02713683.2011.593725; Schey KL, 2014, BBA-GEN SUBJECTS, V1840, P1513, DOI 10.1016/j.bbagen.2013.10.037; Soo JYC, 2018, NAT REV NEPHROL, V14, P378, DOI 10.1038/s41581-018-0003-9; Suzawa T, 2000, ENDOCRINOLOGY, V141, P1554, DOI 10.1210/en.141.4.1554; Thiagarajah JR, 2002, J BIOL CHEM, V277, P19139, DOI 10.1074/jbc.M202071200; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Ungrin MD, 2001, MOL PHARMACOL, V59, P1446, DOI 10.1124/mol.59.6.1446; Verkman AS, 2008, PROG RETIN EYE RES, V27, P420, DOI 10.1016/j.preteyeres.2008.04.001; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Winkler M, 2011, INVEST OPHTH VIS SCI, V52, P8818, DOI 10.1167/iovs.11-8070; Yamamoto Y, 2020, J OCUL PHARMACOL TH, V36, P162, DOI 10.1089/jop.2019.0079; Zeidel Mark L, 2012, Trans Am Clin Climatol Assoc, V123, P93	43	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22067	10.1096/fj.202101263R	http://dx.doi.org/10.1096/fj.202101263R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34914140				2022-12-28	WOS:000734992000052
J	Iqbal, AJ; Krautter, F; Blacksell, IA; Wright, RD; Austin-Williams, SN; Voisin, MB; Hussain, MT; Law, HL; Niki, T; Hirashima, M; Bombardieri, M; Pitzalis, C; Tiwari, A; Nash, GB; Norling, LV; Cooper, D				Iqbal, Asif J.; Krautter, Franziska; Blacksell, Isobel A.; Wright, Rachael D.; Austin-Williams, Shani N.; Voisin, Mathieu-Benoit; Hussain, Mohammed T.; Law, Hannah L.; Niki, Toshiro; Hirashima, Mitsuomi; Bombardieri, Michele; Pitzalis, Costantino; Tiwari, Alok; Nash, Gerard B.; Norling, Lucy, V; Cooper, Dianne			Galectin-9 mediates neutrophil capture and adhesion in a CD44 and beta 2 integrin-dependent manner	FASEB JOURNAL			English	Article						adhesion; innate immunity; leukocyte trafficking	ENDOTHELIAL-CELLS; TRANSENDOTHELIAL MIGRATION; RHEUMATOID-ARTHRITIS; LINKER PEPTIDE; IN-VITRO; EXPRESSION; HYALURONAN; SELECTIN; LIGAND; CHEMOATTRACTANT	Neutrophil trafficking is a key component of the inflammatory response. Here, we have investigated the role of the immunomodulatory lectin Galectin-9 (Gal-9) on neutrophil recruitment. Our data indicate that Gal-9 is upregulated in the inflamed vasculature of RA synovial biopsies and report the release of Gal-9 into the extracellular environment following endothelial cell activation. siRNA knockdown of endothelial Gal-9 resulted in reduced neutrophil adhesion and neutrophil recruitment was significantly reduced in Gal-9 knockout mice in a model of zymosan-induced peritonitis. We also provide evidence for Gal-9 binding sites on human neutrophils; Gal-9 binding induced neutrophil activation (increased expression of beta 2 integrins and reduced expression of CD62L). Intra-vital microscopy confirmed a pro-recruitment role for Gal-9, with increased numbers of transmigrated neutrophils following Gal-9 administration. We studied the role of both soluble and immobilized Gal-9 on human neutrophil recruitment. Soluble Gal-9 significantly strengthened the interaction between neutrophils and the endothelium and inhibited neutrophil crawling on ICAM-1. When immobilized, Gal-9 functioned as an adhesion molecule and captured neutrophils from the flow. Neutrophils adherent to Gal-9 exhibited a spread/activated phenotype that was inhibited by CD18 and CD44 neutralizing antibodies, suggesting a role for these molecules in the pro-adhesive effects of Gal-9. Our data indicate that Gal-9 is expressed and released by the activated endothelium and functions both in soluble form and when immobilized as a neutrophil adhesion molecule. This study paves the way for further investigation of the role of Gal-9 in leukocyte recruitment in different inflammatory settings.	[Iqbal, Asif J.; Krautter, Franziska; Hussain, Mohammed T.; Nash, Gerard B.] Univ Birmingham, Coll Med & Dent Sci, Inst Cardiovasc Sci ICVS, Birmingham B15 2TT, W Midlands, England; [Blacksell, Isobel A.; Wright, Rachael D.; Austin-Williams, Shani N.; Voisin, Mathieu-Benoit; Law, Hannah L.; Bombardieri, Michele; Pitzalis, Costantino; Norling, Lucy, V; Cooper, Dianne] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London, England; [Niki, Toshiro] GalPharma Co Ltd, Res Div, Takamatsu, Kagawa, Japan; [Hirashima, Mitsuomi] Kagawa Univ, Fac Med, Dept Immunol & Immunopathol, Takamatsu, Kagawa, Japan; [Tiwari, Alok] Univ Hosp Birmingham, Dept Vasc Surg, Birmingham, W Midlands, England	University of Birmingham; University of London; Queen Mary University London; Kagawa University; University of Birmingham	Iqbal, AJ (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Cardiovasc Sci ICVS, Birmingham B15 2TT, W Midlands, England.; Cooper, D (corresponding author), Queen Mary Univ London, Ctr Biochem Pharmacol, Barts & London Sch Med, William Harvey Res Inst, London EC1M 6BQ, England.	a.j.iqbal@bham.ac.uk; d.cooper@qmul.ac.uk	Law, Hannah/GPS-7197-2022; Nash, Gerard B/E-4182-2010	Nash, Gerard B/0000-0002-5935-2831; Iqbal, Asif/0000-0002-3224-3651; Pitzalis, Costantino/0000-0003-1326-5051	Versus Arthritis [20387]; ARTS Springboard [W003 1156]	Versus Arthritis(Versus Arthritis); ARTS Springboard	Versus Arthritis, Grant/Award Number: 20387; ARTS Springboard, Grant/Award Number: W003 1156	ABBASSI O, 1993, J CLIN INVEST, V92, P2719, DOI 10.1172/JCI116889; Alam S, 2011, J BIOL CHEM, V286, P44211, DOI 10.1074/jbc.M111.242289; Alstergren P, 2004, CELL IMMUNOL, V231, P146, DOI 10.1016/j.cellimm.2005.01.007; Begandt D, 2017, J LEUKOCYTE BIOL, V102, P699, DOI 10.1189/jlb.3MR0117-026RR; Bi SG, 2011, P NATL ACAD SCI USA, V108, P10650, DOI 10.1073/pnas.1017954108; Butler LM, 2009, EXP CELL RES, V315, P3433, DOI 10.1016/j.yexcr.2009.08.012; Chakraborty A, 2021, J AUTOIMMUN, V117, DOI 10.1016/j.jaut.2020.102575; Chavakis T, 2004, J BIOL CHEM, V279, P55602, DOI 10.1074/jbc.M404676200; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Cooper D, 2008, J LEUKOCYTE BIOL, V83, P1459, DOI 10.1189/jlb.1207831; Cooper D, 2012, ANN NY ACAD SCI, V1253, P181, DOI 10.1111/j.1749-6632.2011.06291.x; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; David BA, 2019, IMMUNOL REV, V289, P9, DOI 10.1111/imr.12757; Eckardt V, 2020, EMBO REP, V21, DOI 10.15252/embr.201947852; Fujisaki T, 1999, CANCER RES, V59, P4427; Fujita K, 2018, J GASTROEN HEPATOL, V33, P492, DOI 10.1111/jgh.13851; Fujita Y, 2020, ARTHRITIS RES THER, V22, DOI 10.1186/s13075-020-02158-3; Gillespie J, 2012, ARTHRITIS RHEUM-US, V64, P418, DOI 10.1002/art.33382; Giovannone N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05770-9; Gittens BR, 2017, J IMMUNOL, V198, P4458, DOI 10.4049/jimmunol.1600709; Goswami D, 2017, BLOOD, V129, P1811, DOI 10.1182/blood-2016-08-733394; HALL CL, 1994, J CELL BIOL, V126, P575, DOI 10.1083/jcb.126.2.575; He J, 2006, LAB INVEST, V86, P578, DOI 10.1038/labinvest.3700420; Horio Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180742; HUMBRIA A, 1994, ARTHRITIS RHEUM, V37, P342, DOI 10.1002/art.1780370307; Imaizumi T, 2002, J LEUKOCYTE BIOL, V72, P486; Ishikawa A, 2004, IMMUNOL CELL BIOL, V82, P410, DOI 10.1111/j.0818-9641.2004.01248.x; Kageshita T, 2002, INT J CANCER, V99, P809, DOI 10.1002/ijc.10436; Katayama Y, 2005, J EXP MED, V201, P1183, DOI 10.1084/jem.20042014; Katoh S, 2007, AM J RESP CRIT CARE, V176, P27, DOI 10.1164/rccm.200608-1243OC; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; KUIJPERS TW, 1992, J CELL BIOL, V117, P565, DOI 10.1083/jcb.117.3.565; Kurose Y, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-23; Ley K, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat4579; Li N, 2018, MOL BIOL CELL, V29, P408, DOI 10.1091/mbc.E16-12-0827; Liu XW, 2012, NAT IMMUNOL, V13, P457, DOI 10.1038/ni.2258; Lokuta MA, 2005, J LEUKOCYTE BIOL, V78, P210, DOI 10.1189/jlb.0205067; Malik RKJ, 2009, GLYCOBIOLOGY, V19, P1402, DOI 10.1093/glycob/cwp077; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Matsuoka N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227069; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; Nishi N, 2005, FEBS LETT, V579, P2058, DOI 10.1016/j.febslet.2005.02.054; Nishi N, 2006, GLYCOBIOLOGY, V16, p15C, DOI 10.1093/glycob/cwl028; Nishi N, 2008, GLYCOBIOLOGY, V18, P1065, DOI 10.1093/glycob/cwn089; Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Rainger GE, 1998, BLOOD, V92, P4819, DOI 10.1182/blood.V92.12.4819.424k16_4819_4827; Reinhardt PH, 1997, BLOOD, V89, P3837, DOI 10.1182/blood.V89.10.3837.3837_3837_3846; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Sato M, 2002, GLYCOBIOLOGY, V12, P191, DOI 10.1093/glycob/12.3.191; Schaefer K, 2017, GLYCOBIOLOGY, V27, P878, DOI 10.1093/glycob/cwx065; Seveau S, 2001, MOL BIOL CELL, V12, P3550, DOI 10.1091/mbc.12.11.3550; Tureci O, 1997, J BIOL CHEM, V272, P6416, DOI 10.1074/jbc.272.10.6416; van den Hoogen LL, 2018, ANN RHEUM DIS, V77, P1810, DOI 10.1136/annrheumdis-2018-213497; Vega-Carrascal I, 2014, J IMMUNOL, V192, P2418, DOI 10.4049/jimmunol.1300711; Vilar KD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223191; Wiersma VR, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20164046; Wilson ZS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58882-y; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; YURUKER B, 1992, J CELL SCI, V101, P403; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	63	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22065	10.1096/fj.202100832R	http://dx.doi.org/10.1096/fj.202100832R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34847625				2022-12-28	WOS:000734992000061
J	Qian, ZY; Yang, CC; Xu, LH; Mickael, HK; Chen, SF; Zhang, YK; Xia, YP; Li, TY; Yu, WH; Huang, F				Qian, Zhongyao; Yang, Chenchen; Xu, Liangheng; Mickael, Houfack K.; Chen, Shuangfeng; Zhang, Yike; Xia, Yueping; Li, Tengyuan; Yu, Wenhai; Huang, Fen			Hepatitis E virus-encoded microRNA promotes viral replication by inhibiting type I interferon	FASEB JOURNAL			English	Article						hepatitis E virus; IFN-beta; microRNA; SIRP-alpha; viral replication	PATHOGEN RECOGNITION; SMALL RNA; PROTEIN; EXPRESSION; RELEASE; CELLS	MicroRNAs (miRNAs), the non-coding RNAs of similar to 22 nucleotides (nt) in length, play a vital role in regulating viral replication. Hepatitis E virus (HEV), a single-stranded RNA virus, is a predominant pathogen of acute hepatitis worldwide. Virus-encoded miRNAs regulate the viral life cycle and escape from the host innate immune system. However, it is rarely known about HEV-encoded miRNA (HEV-miR-A6). In the present study, HEV-miR-A6 was screened by microarray, and further identified in vivo and in vitro. HEV-miR-A6 originated from the methylase (MeT) of HEV open reading frame 1 (ORF1) and was highly conserved in eight HEV genotypes. HEV-miR-A6 expression was growing during HEV replication, and significantly increased in acute hepatitis E patients than convalescence patients. Furthermore, HEV-miR-A6 was specifically detected in liver, spleen, kidney and colon by in situ hybridization. To identify the specificity of HEV-miR-A6, its mutants (HEV-miR-A6M1 and HEV-miR-A6M2) were constructed to change the stem-loop structure. Interestingly, over-expression of HEV-miR-A6 or HEV-miR-A6M1 significantly facilitated viral replication, while HEV-miR-A6M2, another mutant completely changed the stem-loop structure was invalid. SIRP-alpha, a candidate target gene of HEV-miR-A6, was activated when HEV-miR-A6 over-expressed to inhibit the phosphorylation of IRF3, and subsequently suppressed the expression of type I interferon beta (IFN-beta). The promotion of viral replication by HEV-miR-A6 further identified in vivo. Significant suppression of IFN-beta production in the serum of HEV-infected mice pre-treated with HEV-miR-A6 was observed. In summary, HEV-miR-A6 activates SIRP-alpha to promote viral replication by inhibition of IFN-beta expression.	[Qian, Zhongyao; Yang, Chenchen; Xu, Liangheng; Mickael, Houfack K.; Chen, Shuangfeng; Zhang, Yike; Xia, Yueping; Li, Tengyuan; Huang, Fen] Kunming Univ Sci & Technol, Med Sch, Kunming, Yunnan, Peoples R China; [Yu, Wenhai] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Kunming, Yunnan, Peoples R China	Kunming University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Peking Union Medical College	Huang, F (corresponding author), Kunming Univ Sci & Technol, Med Sch, Kunming, Yunnan, Peoples R China.	huangfen6789@163.com		huang, fen/0000-0001-9147-2537; Zhongyao, Qian/0000-0002-1078-9055	National Natural Science Foundation of China (NSFC) [81660338]; Natural Science Foundation of Yunnan Province (Yunnan Provincial Natural Science Foundation) [2017E1036, 20200 lAV070005, 2018E19, 132]; Yunnan Provincial Key Laboratory of Clinical Virology [202005AG070062-011]; Chinese Academy of Medical Sciences Innovation Fund for Medical Science [2019-I2M-1-004]; PUNIC Youth Fund [3332019008]; Program for Cultivating Reserve Talents in Medical Disciplines from the Health Committee of Yunnan Province [H-2019043]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province (Yunnan Provincial Natural Science Foundation); Yunnan Provincial Key Laboratory of Clinical Virology; Chinese Academy of Medical Sciences Innovation Fund for Medical Science; PUNIC Youth Fund; Program for Cultivating Reserve Talents in Medical Disciplines from the Health Committee of Yunnan Province	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81660338; Natural Science Foundation of Yunnan Province (Yunnan Provincial Natural Science Foundation), Grant/Award Number: 2017E1036, 20200 lAV070005 and 2018E19,132; Yunnan Provincial Key Laboratory of Clinical Virology, Grant/Award Number: 202005AG070062-011; Chinese Academy of Medical Sciences Innovation Fund for Medical Science, Grant/Award Number: 2019-I2M-1-004; PUNIC Youth Fund, Grant/Award Number: 3332019008; Program for Cultivating Reserve Talents in Medical Disciplines from the Health Committee of Yunnan Province, Grant/Award Number: H-2019043	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bandiera S, 2015, J HEPATOL, V62, P448, DOI 10.1016/j.jhep.2014.10.004; Boss IW, 2010, CURR OPIN MICROBIOL, V13, P540, DOI 10.1016/j.mib.2010.05.017; Chipman LB, 2019, TRENDS GENET, V35, P215, DOI 10.1016/j.tig.2018.12.005; Devhare PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063793; Dong LW, 2008, MOL IMMUNOL, V45, P3025, DOI 10.1016/j.molimm.2008.03.012; Emerson SU, 2010, J VIROL, V84, P9059, DOI 10.1128/JVI.00593-10; Gupta A, 2011, METHODS MOL BIOL, V676, P73, DOI 10.1007/978-1-60761-863-8_6; Haldipur B, 2018, J VIROL, V92, DOI 10.1128/JVI.01999-17; Huang F, 2016, HEPATOLOGY, V64, P350, DOI 10.1002/hep.28668; Huang F, 2016, IMMUNOL RES, V64, P115, DOI 10.1007/s12026-015-8729-y; Huang F, 2010, VET MICROBIOL, V142, P261, DOI 10.1016/j.vetmic.2009.10.023; Huang FF, 2002, J CLIN MICROBIOL, V40, P1326, DOI 10.1128/JCM.40.4.1326-1332.2002; Hussain M, 2014, P NATL ACAD SCI USA, V111, P2746, DOI 10.1073/pnas.1320123111; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Kalia M, 2009, J VIROL, V83, P12714, DOI 10.1128/JVI.00717-09; Kamar N, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080222; Kamar N, 2013, J CLIN EXP HEPATOL, V3, P134, DOI 10.1016/j.jceh.2013.05.003; Kang S, 2018, J MICROBIOL BIOTECHN, V28, P1554, DOI 10.4014/jmb.1808.08058; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Labrique AB, 2012, EMERG INFECT DIS, V18, P1401, DOI 10.3201/eid1809.120241; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Matsumoto M, 2001, Uirusu, V51, P209; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Nimgaonkar I, 2018, NAT REV GASTRO HEPAT, V15, P96, DOI 10.1038/nrgastro.2017.150; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Primadharsini PP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11050456; Rein DB, 2012, HEPATOLOGY, V55, P988, DOI 10.1002/hep.25505; Reyes G R, 1993, Arch Virol Suppl, V7, P15; Shi JD, 2016, VIRUS GENES, V52, P317, DOI 10.1007/s11262-016-1306-1; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Yamada K, 2009, J GEN VIROL, V90, P1880, DOI 10.1099/vir.0.010561-0; Yamamichi N, 2009, CLIN CANCER RES, V15, P4009, DOI 10.1158/1078-0432.CCR-08-3257; Yang X, 2017, J VIROL, V91, DOI [10.1128/JVI.01919-16, 10.1128/jvi.01919-16]; Zhan Shoubin, 2020, ExRNA, V2, P15, DOI 10.1186/s41544-020-00056-z; Zhou Y, 2018, BBA-MOL BASIS DIS, V1864, P60, DOI 10.1016/j.bbadis.2017.09.028; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	39	1	1	4	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22104	10.1096/fj.202101042R	http://dx.doi.org/10.1096/fj.202101042R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34918388				2022-12-28	WOS:000734992000057
J	Tsai, SF; Hung, HC; Shih, MMC; Chang, FC; Chung, BC; Wang, CY; Lin, YL; Kuo, YM				Tsai, Sheng-Feng; Hung, Hao-Chang; Shih, Monica Meng-Chun; Chang, Fu-Chuan; Chung, Bon-chu; Wang, Chia-Yih; Lin, Yu-Ling; Kuo, Yu-Min			High-fat diet-induced increases in glucocorticoids contribute to the development of non-alcoholic fatty liver disease in mice	FASEB JOURNAL			English	Article						CD36; corticosterone; hepatic steatosis; lipid metabolism; triglycerides	11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; INHIBITORY POLYPEPTIDE GIP; INDUCED HEPATIC STEATOSIS; ADIPOSE-TISSUE; CORTISOL METABOLISM; VISCERAL OBESITY; ACID TRANSPORT; RECEPTOR-BETA; RISK-FACTORS; EXPRESSION	This study aimed to investigate the causal relationship between chronic ingestion of a high-fat diet (HFD)-induced secretion of glucocorticoids (GCs) and the development of non-alcoholic fatty liver disease (NAFLD). We have produced a strain of transgenic mice (termed L/L mice) that have normal levels of circulating corticosterone (CORT), the major type of GCs in rodents, but unlike wild-type (WT) mice, their circulating CORT was not affected by HFD. Compared to WT mice, 12-week HFD-induced fatty liver was less pronounced with higher plasma levels of triglycerides in L/L mice. These changes were reversed by CORT supplement to L/L mice. By analyzing a sort of lipid metabolism-related proteins, we found that expressions of the hepatic cluster of differentiation 36 (CD36) were upregulated by HFD-induced CORT and involved in CORT-mediated fatty liver. Dexamethasone, an agonist of the glucocorticoid receptor (GR), upregulated expressions of CD36 in HepG2 hepatocytes and facilitated lipid accumulation in the cells. In conclusion, the fat ingestion-induced release of CORT contributes to NAFLD. This study highlights the pathogenic role of CORT-mediated upregulation of hepatic CD 36 in diet-induced NAFLD.	[Tsai, Sheng-Feng; Wang, Chia-Yih; Kuo, Yu-Min] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan; [Tsai, Sheng-Feng; Chang, Fu-Chuan; Wang, Chia-Yih; Kuo, Yu-Min] Natl Cheng Kung Univ, Coll Med, Dept Cell Biol & Anat, 1 Ta Hsueh Rd, Tainan 70101, Taiwan; [Hung, Hao-Chang] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med,Div Endocrinol & Metab, Tainan, Taiwan; [Hung, Hao-Chang] Kaohsiung Vet Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Kaohsiung, Taiwan; [Shih, Monica Meng-Chun] Natl Lab Anim Ctr, Taipei, Taiwan; [Chung, Bon-chu] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Lin, Yu-Ling] Ditmanson Med Fdn Chia Yi Christian Hosp, Dept Internal Med, Div Gastroenterol, Chiayi, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Veterans General Hospital; Academia Sinica - Taiwan	Kuo, YM (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Cell Biol & Anat, 1 Ta Hsueh Rd, Tainan 70101, Taiwan.; Lin, YL (corresponding author), Ditmanson Med Fdn Chia Yi Christian Hosp, Dept Digest Syst, 539 Zhongxiao Rd, Chiayi 60002, Taiwan.	02557@cych.org.tw; kuoym@mail.ncku.edu.tw	Kuo, Yu-Min/A-9050-2013	Kuo, Yu-Min/0000-0003-4867-2482; Wang, Chia-Yih/0000-0002-9196-0802	Diabetes Association of the Republic of China, Taiwan [DAROC2017YPI-0001]; Ministry of Science and Technology, Taiwan (MOST) [MOST 109-2320-B-006-043-MY3, MOST 109-2811-B-006-520, MOST 107-2320B-006-054 MY3, MOST 107-2321B-001-034]	Diabetes Association of the Republic of China, Taiwan; Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan)	'The Diabetes Association of the Republic of China, Taiwan, Grant/Award Number DAROC2017YPI-0001; Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST 109-2320-B-006-043-MY3, MOST 109-2811-B-006-520, MOST 107-2320B-006-054 MY3 and MOST 107-2321B-001-034	Ballestri S, 2017, ADV THER, V34, P1291, DOI 10.1007/s12325-017-0556-1; Bates HE, 2012, DIABETES, V61, P40, DOI 10.2337/db11-1060; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; Bonen A, 2004, P NUTR SOC, V63, P245, DOI 10.1079/PNS2004331; Bruno S, 2005, BMJ-BRIT MED J, V330, P932, DOI 10.1136/bmj.38391.663287.E0; BUCHAN AMJ, 1978, HISTOCHEMISTRY, V56, P37, DOI 10.1007/BF00492251; Bursac B, 2018, MOL CELL ENDOCRINOL, V476, P110, DOI 10.1016/j.mce.2018.04.015; Cassano AE, 2012, COMPARATIVE MED, V62, P348; D'souza AM, 2012, AM J PHYSIOL-GASTR L, V302, pG850, DOI 10.1152/ajpgi.00378.2011; Damholt AB, 1999, CELL TISSUE RES, V298, P287, DOI 10.1007/s004419900093; de Souza DN, 2021, LIFE SCI, V265, DOI 10.1016/j.lfs.2020.118765; Diakogiannaki E, 2012, PHYSIOL BEHAV, V106, P387, DOI 10.1016/j.physbeh.2011.12.001; DIAMANT S, 1975, EUR J BIOCHEM, V53, P541, DOI 10.1111/j.1432-1033.1975.tb04097.x; Dolinsky VW, 2004, BIOCHEM J, V378, P967, DOI 10.1042/BJ20031320; Duma D, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001077; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRAYN KN, 1995, ADV ENZYME REGUL, V35, P163, DOI 10.1016/0065-2571(94)00011-Q; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Guan HG, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.594437; Harris RBS, 2002, AM J PHYSIOL-REG I, V282, pR77, DOI 10.1152/ajpregu.2002.282.1.R77; Hinds TD, 2010, MOL ENDOCRINOL, V24, P1715, DOI 10.1210/me.2009-0411; Hunkeler M, 2018, NATURE, V558, P470, DOI 10.1038/s41586-018-0201-4; Jamieson PM, 2000, J ENDOCRINOL, V165, P685, DOI 10.1677/joe.0.1650685; John K, 2016, AM J PHYSIOL-ENDOC M, V310, pE249, DOI 10.1152/ajpendo.00478.2015; Kazantzis M, 2012, BBA-MOL CELL BIOL L, V1821, P852, DOI 10.1016/j.bbalip.2011.09.010; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Koorneef LL, 2018, ENDOCRINOLOGY, V159, P3925, DOI 10.1210/en.2018-00671; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Krupkova M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-38; Lemke U, 2008, CELL METAB, V8, P212, DOI 10.1016/j.cmet.2008.08.001; Li HS, 2021, DRUG DES DEV THER, V15, P2309, DOI 10.2147/DDDT.S285828; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; Marino JS, 2016, J BIOL CHEM, V291, P25776, DOI 10.1074/jbc.M116.752311; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Nakamura A, 2013, INT J MOL SCI, V14, P21240, DOI 10.3390/ijms141121240; Olsson B, 2005, ENDOCRINOLOGY, V146, P920, DOI 10.1210/en.2004-1232; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Patel R, 2011, J CLIN INVEST, V121, P431, DOI 10.1172/JCI41681; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Paulmyer-Lacroix O, 2002, J CLIN ENDOCR METAB, V87, P2701, DOI 10.1210/jc.87.6.2701; Rahimi L, 2020, DIABET METAB SYND OB, V13, P1133, DOI 10.2147/DMSO.S247379; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Rask E, 2002, J CLIN ENDOCR METAB, V87, P3330, DOI 10.1210/jc.87.7.3330; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Shih MC, 2008, MOL ENDOCRINOL, V22, P915, DOI 10.1210/me.2007-0222; SKANSE B, 1959, ACTA ENDOCRINOL-COP, V31, P442; Stahlberg N, 2004, ENDOCRINOLOGY, V145, P1972, DOI 10.1210/en.2003-0874; Stulnig TM, 2004, DIABETOLOGIA, V47, P1, DOI 10.1007/s00125-003-1284-4; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Suzuki K, 2013, J BIOL CHEM, V288, P1929, DOI 10.1074/jbc.M112.423137; Swierczynska MM, 2015, INT J OBESITY, V39, P321, DOI 10.1038/ijo.2014.102; Tanaka Y, 2008, J PHARMACOL EXP THER, V325, P655, DOI 10.1124/jpet.107.135822; Tsai SF, 2018, BRAIN RES, V1700, P66, DOI 10.1016/j.brainres.2018.07.017; Tsai SF, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00027; Wang YX, 2004, J NUTR, V134, P1032; Warrier M, 2010, ENDOCRINOLOGY, V151, P3225, DOI 10.1210/en.2009-1158; Weickert MO, 2006, DIABETOLOGIA, V49, P1732, DOI 10.1007/s00125-006-0295-3; Wilson CG, 2016, ENDOCRINOLOGY, V157, P570, DOI 10.1210/en.2015-1866; Witchel SF, 2006, NAT CLIN PRACT ENDOC, V2, P621, DOI 10.1038/ncpendmet0323; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Yu CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015188	67	3	3	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22130	10.1096/fj.202101570R	http://dx.doi.org/10.1096/fj.202101570R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34959259				2022-12-28	WOS:000734992000015
J	Ishihama, S; Yoshida, S; Yoshida, T; Mori, Y; Ouchi, N; Eguchi, S; Sakaguchi, T; Tsuda, T; Kato, K; Shimizu, Y; Ohashi, K; Okumura, T; Bando, YK; Yagyu, H; Wettschureck, N; Kubota, N; Offermanns, S; Kadowaki, T; Murohara, T; Takefuji, M				Ishihama, Sohta; Yoshida, Satoya; Yoshida, Tatsuya; Mori, Yu; Ouchi, Noriyuki; Eguchi, Shunsuke; Sakaguchi, Teruhiro; Tsuda, Takuma; Kato, Katsuhiro; Shimizu, Yuuki; Ohashi, Koji; Okumura, Takahiro; Bando, Yasuko K.; Yagyu, Hiroaki; Wettschureck, Nina; Kubota, Naoto; Offermanns, Stefan; Kadowaki, Takashi; Murohara, Toyoaki; Takefuji, Mikito			LPL/AQP7/GPD2 promotes glycerol metabolism under hypoxia and prevents cardiac dysfunction during ischemia	FASEB JOURNAL			English	Article						aquaporins; glycerol; myocardial infarction	FATTY-ACID-METABOLISM; LIPOPROTEIN-LIPASE; HEART-FAILURE; TRIGLYCERIDE-METABOLISM; GENE; SUBSTRATE; SURVIVAL; MYOCYTES	In the heart, fatty acid is a major energy substrate to fuel contraction under aerobic conditions. Ischemia downregulates fatty acid metabolism to adapt to the limited oxygen supply, making glucose the preferred substrate. However, the mechanism underlying the myocardial metabolic shift during ischemia remains unknown. Here, we show that lipoprotein lipase (LPL) expression in cardiomyocytes, a principal enzyme that converts triglycerides to free fatty acids and glycerol, increases during myocardial infarction (MI). Cardiomyocyte-specific LPL deficiency enhanced cardiac dysfunction and apoptosis following MI. Deficiency of aquaporin 7 (AQP7), a glycerol channel in cardiomyocytes, increased the myocardial infarct size and apoptosis in response to ischemia. Ischemic conditions activated glycerol-3-phosphate dehydrogenase 2 (GPD2), which converts glycerol-3-phosphate into dihydroxyacetone phosphate to facilitate adenosine triphosphate (ATP) synthesis from glycerol. Conversely, GPD2 deficiency exacerbated cardiac dysfunction after acute MI. Moreover, cardiomyocyte-specific LPL deficiency suppressed the effectiveness of peroxisome proliferator-activated receptor alpha (PPAR alpha) agonist treatment for MI-induced cardiac dysfunction. These results suggest that LPL/AQP7/GPD2-mediated glycerol metabolism plays an important role in preventing myocardial ischemia-related damage.	[Ishihama, Sohta; Yoshida, Satoya; Yoshida, Tatsuya; Mori, Yu; Eguchi, Shunsuke; Sakaguchi, Teruhiro; Tsuda, Takuma; Kato, Katsuhiro; Shimizu, Yuuki; Okumura, Takahiro; Bando, Yasuko K.; Murohara, Toyoaki; Takefuji, Mikito] Nagoya Univ, Dept Cardiol, Sch Med, Nagoya, Aichi, Japan; [Ouchi, Noriyuki; Ohashi, Koji] Nagoya Univ, Dept Mol Med & Cardiol, Sch Med, Nagoya, Aichi, Japan; [Yagyu, Hiroaki] Jichi Med Univ, Div Endocrinol & Metab, Dept Internal Med, Shimotsuke, Tochigi, Japan; [Wettschureck, Nina; Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, Bad Nauheim, Germany; [Kubota, Naoto; Kadowaki, Takashi] Univ Tokyo, Dept Diabet & Metab Dis, Grad Sch Med, Tokyo, Japan	Nagoya University; Nagoya University; Jichi Medical University; Max Planck Society; University of Tokyo	Takefuji, M (corresponding author), Nagoya Univ, Dept Cardiol, Sch Med, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	takefuji@med.nagoya-u.ac.jp	Takefuji, Mikito/GXG-5982-2022; Kato, Katsuhiro/AAV-8356-2020		Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Abdurrachim D, 2015, CARDIOVASC RES, V106, P194, DOI 10.1093/cvr/cvv105; Ackers-Johnson M, 2016, CIRC RES, V119, P909, DOI 10.1161/CIRCRESAHA.116.309202; Augustus A, 2004, J BIOL CHEM, V279, P25050, DOI 10.1074/jbc.M401028200; BELEZNAI Z, 1988, EUR J BIOCHEM, V170, P631, DOI 10.1111/j.1432-1033.1988.tb13744.x; Brisson D, 2001, BIOESSAYS, V23, P534, DOI 10.1002/bies.1073; Chiu APL, 2016, BBA-MOL CELL BIOL L, V1861, P1434, DOI 10.1016/j.bbalip.2016.03.016; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Eguchi S, 2019, J BIOL CHEM, V294, P11665, DOI 10.1074/jbc.RA119.007537; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; Fillmore N, 2014, BRIT J PHARMACOL, V171, P2080, DOI 10.1111/bph.12475; Gambert S, 2005, BBA-MOL CELL BIOL L, V1736, P152, DOI 10.1016/j.bbalip.2005.08.004; Gambert S, 2007, AM J PHYSIOL-HEART C, V292, pH1600, DOI 10.1152/ajpheart.00563.2006; GERDES AM, 1995, J MOL CELL CARDIOL, V27, P849, DOI 10.1016/0022-2828(95)90000-4; Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006; Gupta A, 2017, HEART FAIL REV, V22, P825, DOI 10.1007/s10741-017-9623-6; Heather LC, 2013, CIRC-HEART FAIL, V6, P1058, DOI 10.1161/CIRCHEARTFAILURE.112.000342; Hibuse T, 2009, CARDIOVASC RES, V83, P34, DOI 10.1093/cvr/cvp095; Kersten S, 2014, BBA-MOL CELL BIOL L, V1841, P919, DOI 10.1016/j.bbalip.2014.03.013; Khera AV, 2017, JAMA-J AM MED ASSOC, V317, P937, DOI 10.1001/jama.2017.0972; Kolwicz SC, 2013, CIRC RES, V113, P603, DOI 10.1161/CIRCRESAHA.113.302095; Langston PK, 2019, NAT IMMUNOL, V20, P1186, DOI 10.1038/s41590-019-0453-7; LIN ECC, 1977, ANNU REV BIOCHEM, V46, P765, DOI 10.1146/annurev.bi.46.070177.004001; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Maeda N, 2004, P NATL ACAD SCI USA, V101, P17801, DOI 10.1073/pnas.0406230101; Miles JM, 2004, DIABETES, V53, P521, DOI 10.2337/diabetes.53.3.521; Mracek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014; Qi D, 2015, TRENDS ENDOCRIN MET, V26, P422, DOI 10.1016/j.tem.2015.05.010; Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452; Schoonjans K, 1996, J LIPID RES, V37, P907; Skowronski MT, 2007, AM J PHYSIOL-RENAL, V292, pP956, DOI 10.1152/ajprenal.00314.2006; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Takefuji M, 2012, CIRCULATION, V126, P1972, DOI 10.1161/CIRCULATIONAHA.112.109256; Verkerk AO, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20082039; Yagyu H, 2003, J CLIN INVEST, V111, P419, DOI [10.1172/JCI200316751, 10.1172/JCI16751]; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Young SG, 2019, CELL METAB, V30, P51, DOI 10.1016/j.cmet.2019.05.023	36	5	5	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22048	10.1096/fj.202100882R	http://dx.doi.org/10.1096/fj.202100882R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34807469	Green Submitted			2022-12-28	WOS:000722321300039
J	Swanson, BA; Carson, MD; Hathaway-Schrader, JD; Warner, AJ; Kirkpatrick, JE; Corker, A; Alekseyenko, AV; Westwater, C; Aguirre, JI; Novince, CM				Swanson, Brooks A.; Carson, Matthew D.; Hathaway-Schrader, Jessica D.; Warner, Amy J.; Kirkpatrick, Joy E.; Corker, Alexa; Alekseyenko, Alexander, V; Westwater, Caroline; Aguirre, J. Ignacio; Novince, Chad M.			Antimicrobial-induced oral dysbiosis exacerbates naturally occurring alveolar bone loss	FASEB JOURNAL			English	Article						alveolar bone loss; antibiotics; antiseptics; host microbial interactions; microbiota	EXPERIMENTAL PERIODONTAL-DISEASE; HISTOLOGICAL-CHANGES; CRITICAL WINDOWS; GENE-EXPRESSION; ANTIBIOTICS; IMMUNE; CELLS; NEUTROPHILS; MICROBIOTA; THERAPY	Periodontitis-mediated alveolar bone loss is caused by dysbiotic shifts in the commensal oral microbiota that upregulate proinflammatory osteoimmune responses. The study purpose was to determine whether antimicrobial-induced disruption of the commensal microbiota has deleterious effects on alveolar bone. We administered an antibiotic cocktail, minocycline, or vehicle-control to sex-matched C57BL/6T mice from age 6- to 12 weeks. Antibiotic cocktail and minocycline had catabolic effects on alveolar bone in specific-pathogen-free (SPF) mice. We then administered minocycline or vehicle-control to male mice reared under SPF and germ-free conditions, and we subjected minocycline-treated SPF mice to chlorhexidine oral antiseptic rinses. Alveolar bone loss was greater in vehicle-treated SPF versus germ-free mice, demonstrating that the commensal microbiota drives naturally occurring alveolar bone loss. Minocycline- versus vehicle-treated germ-free mice had similar alveolar bone loss outcomes, implying that antimicrobial-driven alveolar bone loss is microbiota dependent. Minocycline induced phylum-level shifts in the oral bacteriome and exacerbated naturally occurring alveolar bone loss in SPF mice. Chlorhexidine further disrupted the oral bacteriome and worsened alveolar bone loss in minocycline-treated SPF mice, validating that antimicrobial-induced oral dysbiosis has deleterious effects on alveolar bone. Minocycline enhanced osteoclast size and interface with alveolar bone in SPF mice. Neutrophils and plasmacytoid dendritic cells were upregulated in cervical lymph nodes of minocycline-treated SPF mice. Paralleling the upregulated proinflammatory innate immune cells, minocycline therapy increased T(H)1 and T(H)17 cells that have known pro-osteoclastic actions in the alveolar bone. This report reveals that antimicrobial perturbation of the commensal microbiota induces a proinflammatory oral dysbiotic state that exacerbates naturally occurring alveolar bone loss.	[Swanson, Brooks A.; Carson, Matthew D.; Hathaway-Schrader, Jessica D.; Warner, Amy J.; Kirkpatrick, Joy E.; Corker, Alexa; Alekseyenko, Alexander, V; Westwater, Caroline; Novince, Chad M.] Med Univ South Carolina, Coll Dent Med, Dept Oral Hlth Sci, Charleston, SC 29425 USA; [Swanson, Brooks A.; Carson, Matthew D.; Hathaway-Schrader, Jessica D.; Warner, Amy J.; Kirkpatrick, Joy E.; Corker, Alexa; Novince, Chad M.] Med Univ South Carolina, Coll Dent Med, Dept Stomatol, Div Periodont, Charleston, SC 29425 USA; [Swanson, Brooks A.; Carson, Matthew D.; Hathaway-Schrader, Jessica D.; Warner, Amy J.; Kirkpatrick, Joy E.; Corker, Alexa; Novince, Chad M.] Med Univ South Carolina, Coll Med, Dept Pediat, Div Endocrinol, Charleston, SC 29425 USA; [Kirkpatrick, Joy E.] Med Univ South Carolina, Coll Pharm, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Alekseyenko, Alexander, V] Med Univ South Carolina, Program Human Microbiome Res, Biomed Informat Ctr, Dept Publ Hlth Sci,Coll Med, Charleston, SC 29425 USA; [Alekseyenko, Alexander, V] Med Univ South Carolina, Coll Hlth Profess, Dept Healthcare Leadership & Management, Charleston, SC 29425 USA; [Westwater, Caroline] Med Univ South Carolina, Hollings Canc Ctr, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Aguirre, J. Ignacio] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; State University System of Florida; University of Florida	Novince, CM (corresponding author), Med Univ South Carolina, Dept Oral Hlth Sci, 173 Ashley Ave,MSC 507, Charleston, SC 29425 USA.	novincec@musc.edu		Alekseyenko, Alexander/0000-0002-5748-2085; Corker, Alexa/0000-0002-1288-3475	American Society for Bone and Mineral Research (ASBMR); HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR) [K08DE025337, R01DE029637, T32DE017551, R01DE023783]; General Medical Sciences (NIGMS) [P20GM130457, P20GM121342, T32GM132055]; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [P30DK123704]; HHS | NIH | U.S. National Library of Medicine (NLM) [R01LM012517]	American Society for Bone and Mineral Research (ASBMR); HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR); General Medical Sciences (NIGMS); HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); HHS | NIH | U.S. National Library of Medicine (NLM)	American Society for Bone and Mineral Research (ASBMR); HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR), Grant/Award Number: K08DE025337, R01DE029637, T32DE017551 and R01DE023783; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: P20GM130457, P20GM121342 and T32GM132055; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: P30DK123704; HHS | NIH | National Center for Advancing Translational Sciences (NCATS), Grant/ Award Number: R21TR002513; HHS | NIH | U.S. National Library of Medicine (NLM), Grant/Award Number: R01LM012517	Abdallah DSA, 2011, INT IMMUNOL, V23, P317, DOI 10.1093/intimm/dxr007; Abusleme L, 2020, J DENT RES, V99, P721, DOI 10.1177/0022034520915485; Almeida L, 2021, IMMUNITY, V54, P68, DOI 10.1016/j.immuni.2020.11.001; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Bain S, 1997, BONE, V21, P147, DOI 10.1016/S8756-3282(97)00104-X; Barbieri JS, 2019, JAMA DERMATOL, V155, P290, DOI 10.1001/jamadermatol.2018.4944; BARON R, 1978, J PERIODONTAL RES, V13, P309, DOI 10.1111/j.1600-0765.1978.tb00185.x; Belibasakis GN, 2012, J CLIN PERIODONTOL, V39, P239, DOI 10.1111/j.1600-051X.2011.01810.x; Bescos R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61912-4; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brown L R, 1969, J Periodontol, V40, P725; Chatzigiannidou I, 2020, NPJ BIOFILMS MICROME, V6, DOI 10.1038/s41522-020-0124-3; Chesnut C H 3rd, 2001, Ann Periodontol, V6, P193; Cho MI, 2000, PERIODONTOL 2000, V24, P9, DOI 10.1034/j.1600-0757.2000.2240102.x; Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233; Dar Hamid Y, 2018, Bone Rep, V8, P46, DOI 10.1016/j.bonr.2018.02.001; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dietert RR, 2000, ENVIRON HEALTH PERSP, V108, P483, DOI 10.2307/3454540; Dutzan N, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0797; Dutzan N, 2017, IMMUNITY, V46, P133, DOI 10.1016/j.immuni.2016.12.010; Gaboriau-Routhiau V, 2011, CURR OPIN GASTROEN, V27, P502, DOI 10.1097/MOG.0b013e32834bb82b; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Garrido-Mesa N, 2013, PHARMACOL RES, V67, P18, DOI 10.1016/j.phrs.2012.10.006; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; Hajishengallis E, 2014, J DENT RES, V93, P231, DOI 10.1177/0022034513507956; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hampton HR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8139; Han H, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020277; Hathaway-Schrader JD, 2021, PERIODONTOL 2000, V86, P157, DOI 10.1111/prd.12368; Hathaway-Schrader JD, 2020, JBMR PLUS, V4, DOI 10.1002/jbm4.10338; Hernandez-Arriaga A, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7090283; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Ioannidou E, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00189; Irie K, 2014, J DENT RES, V93, P801, DOI 10.1177/0022034514540173; IRVING JT, 1974, J PERIODONTAL RES, V9, P73, DOI 10.1111/j.1600-0765.1974.tb00656.x; IRVING JT, 1975, ARCH ORAL BIOL, V20, P219, DOI 10.1016/0003-9969(75)90013-8; Josefsdottir KS, 2017, BLOOD, V129, P729, DOI 10.1182/blood-2016-03-708594; Joseph S, 2021, MSYSTEMS, V6, DOI 10.1128/mSystems.01222-20; Kawai T, 2000, J IMMUNOL, V164, P2102, DOI 10.4049/jimmunol.164.4.2102; Khattri S, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD012568.pub2, 10.1002/14551858.CD012553.pub2]; Kinane DF, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.38; Kulkarni Meghana M, 2011, Curr Protoc Mol Biol, VChapter 25, DOI 10.1002/0471142727.mb25b10s94; Lamont RJ, 2018, NAT REV MICROBIOL, V16, P745, DOI 10.1038/s41579-018-0089-x; Landreth KS, 2002, HUM EXP TOXICOL, V21, P493, DOI 10.1191/0960327102ht287oa; Lazarevic V, 2013, CLIN MICROBIOL INFEC, V19, pE335, DOI 10.1111/1469-0691.12213; Lee YH, 2014, J AM ACAD DERMATOL, V71, P70, DOI 10.1016/j.jaad.2014.02.031; Levy RM, 2003, ARCH DERMATOL, V139, P467, DOI 10.1001/archderm.139.4.467; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAKRIS GP, 1985, J PERIODONTAL RES, V20, P411, DOI 10.1111/j.1600-0765.1985.tb00453.x; MARKKANEN H, 1981, J PERIODONTOL, V52, P99, DOI 10.1902/jop.1981.52.2.99; Marsh P D, 1994, Adv Dent Res, V8, P263; Monasterio G, 2019, J PERIODONTOL, V90, P522, DOI 10.1002/JPER.18-0079; Nagler AR, 2016, J AM ACAD DERMATOL, V74, P273, DOI 10.1016/j.jaad.2015.09.046; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nibali L, 2019, J CLIN PERIODONTOL, V46, P999, DOI 10.1111/jcpe.13164; Novince CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06126-x; Ortiz S, 2019, J ORAL MICROBIOL, V11, DOI 10.1080/20002297.2019.1653124; Packey CD, 2013, GUT MICROBES, V4, P361, DOI 10.4161/gmic.25824; Page RC., 1982, PERIODONTITIS MAN OT; Pan WY, 2019, INT J ORAL SCI, V11, DOI 10.1038/s41368-019-0064-z; ROHNER F, 1983, J CLIN PERIODONTOL, V10, P643, DOI 10.1111/j.1600-051X.1983.tb01302.x; Sapra L, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80536-2; Sasaki H, 2008, J IMMUNOL, V180, P6193, DOI 10.4049/jimmunol.180.9.6193; Scapini P, 2014, BLOOD, V124, P710, DOI 10.1182/blood-2014-03-453217; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SELIKOWITZ HS, 1981, J CLIN PERIODONTOL, V8, P431, DOI 10.1111/j.1600-051X.1981.tb00892.x; Shaw LP, 2019, ISME J, V13, P1845, DOI 10.1038/s41396-019-0392-1; Sima C, 2019, J LEUKOCYTE BIOL, V105, P473, DOI 10.1002/JLB.1RU0818-310R; SIMMONS DJ, 1983, CLIN ORTHOP RELAT R, P253; Song L, 2018, MOL ORAL MICROBIOL, V33, P13, DOI 10.1111/omi.12195; Stashenko P, 2007, AM J PATHOL, V170, P203, DOI 10.2353/ajpath.2007.060597; TAL H, 1984, J PERIODONTOL, V55, P604, DOI 10.1902/jop.1984.55.10.604; Treuting P. M., 2018, COMP ANATOMY HISTOLO, P115; Tsukasaki M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03147-6; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Tuzlak S, 2021, NAT IMMUNOL, V22, P1210, DOI 10.1038/s41590-021-01009-w; Vono M, 2017, BLOOD, V129, P1991, DOI 10.1182/blood-2016-10-744441; Walsh MC, 2018, NAT REV RHEUMATOL, V14, P146, DOI 10.1038/nrrheum.2017.213; Weinmann JP., 1941, J PERIODONTOL, V12, P71, DOI 10.1902/jop.1941.12.2.71; Williams S, 1996, BONE, V19, P637, DOI 10.1016/S8756-3282(96)00302-X; Wu YY, 2018, MOL ORAL MICROBIOL, V33, P38, DOI 10.1111/omi.12194; Zaenglein AL, 2016, J AM ACAD DERMATOL, V74, P945, DOI 10.1016/j.jaad.2015.12.037; Zaura E, 2015, MBIO, V6, DOI 10.1128/mBio.01693-15; Zhu L, 2020, IMMUN AGEING, V17, DOI 10.1186/s12979-020-00202-z	88	0	0	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e22015	10.1096/fj.202101169R	http://dx.doi.org/10.1096/fj.202101169R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34699641	Green Accepted			2022-12-28	WOS:000712009200056
J	Rumpret, M; von Richthofen, HJ; van der Linden, M; Westerlaken, GHA; Ormeno, CT; van Strijp, JAG; Landau, M; Ovaa, H; van Sorge, NM; Meyaard, L				Rumpret, Matevz; von Richthofen, Helen J.; van der Linden, Maarten; Westerlaken, Geertje H. A.; Ormeno, Cami Talavera; van Strijp, Jos A. G.; Landau, Meytal; Ovaa, Huib; van Sorge, Nina M.; Meyaard, Linde			Signal inhibitory receptor on leukocytes-1 recognizes bacterial and endogenous amphipathic alpha-helical peptides	FASEB JOURNAL			English	Article						cathelicidin LL-37; phenol-soluble modulin; SIRL-1; Staphylococcus	PHENOL-SOLUBLE MODULINS; STAPHYLOCOCCUS-AUREUS BIOFILMS; HUMAN CATHELICIDIN LL-37; ANTIMICROBIAL PEPTIDES; ANTIBACTERIAL PEPTIDE; HUMAN SKIN; EXPRESSION; KERATINOCYTES; DETERMINANTS; INFLAMMATION	Signal inhibitory receptor on leukocytes-1 (SIRL-1) is a negative regulator of myeloid cell function and dampens antimicrobial responses. We here show that different species of the genus Staphylococcus secrete SIRL-1-engaging factors. By screening a library of single-gene transposon mutants in Staphylococcus aureus, we identified these factors as phenol-soluble modulins (PSMs). PSMs are amphipathic alpha-helical peptides involved in multiple aspects of staphylococcal virulence and physiology. They are cytotoxic and activate the chemotactic formyl peptide receptor 2 (FPR2) on immune cells. Human cathelicidin LL-37 is also an amphipathic alpha-helical peptide with antimicrobial and chemotactic activities, structurally and functionally similar to alpha-type PSMs. We demonstrate that alpha-type PSMs from multiple staphylococcal species as well as human cathelicidin LL-37 activate SIRL-1, suggesting that SIRL-1 recognizes alpha-helical peptides with an amphipathic arrangement of hydrophobicity, although we were not able to show direct binding to SIRL-1. Upon rational peptide design, we identified artificial peptides in which the capacity to ligate SIRL-1 is segregated from cytotoxic and FPR2-activating properties, allowing specific engagement of SIRL-1. In conclusion, we propose staphylococcal PSMs and human LL-37 as a potential new class of natural ligands for SIRL-1.	[Rumpret, Matevz; von Richthofen, Helen J.; van der Linden, Maarten; Westerlaken, Geertje H. A.; Meyaard, Linde] Univ Utrecht, Univ Med Ctr Utrecht, Ctr Translat Immunol, Lundlaan 6, NL-3584 EA Utrecht, Netherlands; [Rumpret, Matevz; von Richthofen, Helen J.; Westerlaken, Geertje H. A.; Ormeno, Cami Talavera; Ovaa, Huib; Meyaard, Linde] Oncode Inst, Utrecht, Netherlands; [Ormeno, Cami Talavera; Ovaa, Huib] Leiden Univ, Dept Cell & Chem Biol, Med Ctr, Leiden, Netherlands; [van Strijp, Jos A. G.; van Sorge, Nina M.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Landau, Meytal] Technion Israel Inst Technol, Dept Biol, Haifa, Israel; [van Sorge, Nina M.] Univ Amsterdam, Locat Amsterdam Med Ctr, Amsterdam Inst Infect & Immun,Amsterdam UMC, Dept Med Microbiol & Infect Prevent,Netherlands R, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Technion Israel Institute of Technology; University of Amsterdam	Meyaard, L (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Ctr Translat Immunol, Lundlaan 6, NL-3584 EA Utrecht, Netherlands.	l.meyaard@umcutrecht.nl	Rumpret, Matevž/GQY-5895-2022; van Sorge, Nina/E-3290-2017; Landau, Meytal/J-3075-2012; Van Strijp, Jos A. G./J-9549-2014	Rumpret, Matevž/0000-0002-8631-8049; van Sorge, Nina/0000-0002-2695-5863; Talavera Ormeno, Cami Margaretha Paula/0000-0001-5502-2985; Landau, Meytal/0000-0002-1743-3430; Meyaard, Linde/0000-0003-0707-4793; Van Strijp, Jos A. G./0000-0001-6253-0830	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) [91815608]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO))	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), Grant/Award Number: 91815608	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Armbruster NS, 2016, INT J MED MICROBIOL, V306, P666, DOI 10.1016/j.ijmm.2016.09.002; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Becker K, 2014, CLIN MICROBIOL REV, V27, P870, DOI 10.1128/CMR.00109-13; Besteman SB, 2020, CLIN IMMUNOL, V211, DOI 10.1016/j.clim.2019.108324; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown MM, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1009026; Byrd AL, 2018, NAT REV MICROBIOL, V16, P143, DOI 10.1038/nrmicro.2017.157; CHEUNG AL, 1994, J BACTERIOL, V176, P4168, DOI 10.1128/JB.176.13.4168-4172.1994; Cheung GYC, 2015, SCI REP-UK, V5, DOI 10.1038/srep18023; Cheung GYC, 2014, FEMS MICROBIOL REV, V38, P698, DOI 10.1111/1574-6976.12057; Christensen GJM, 2014, BENEF MICROBES, V5, P201, DOI 10.3920/BM2012.0062; Coffelt SB, 2009, MOL CANCER RES, V7, P907, DOI 10.1158/1541-7786.MCR-08-0326; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Da F, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00206; Dastgheyb SS, 2015, INFECT IMMUN, V83, P2966, DOI 10.1128/IAI.00394-15; De Jong NWM, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.GPP3-0061-2019; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Edwards AM, 2011, TRENDS MICROBIOL, V19, P184, DOI 10.1016/j.tim.2010.12.005; Engelberg Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17736-x; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Geoghegan JA, 2018, TRENDS MICROBIOL, V26, P484, DOI 10.1016/j.tim.2017.11.008; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Hase K, 2002, INFECT IMMUN, V70, P953, DOI 10.1128/IAI.70.2.953-963.2002; Into T, 2010, CELL IMMUNOL, V264, P104, DOI 10.1016/j.cellimm.2010.05.005; Joo HS, 2011, J BIOL CHEM, V286, P8933, DOI 10.1074/jbc.M111.221382; Kanda N, 2012, ALLERGY, V67, P804, DOI 10.1111/j.1398-9995.2012.02824.x; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Krismer B, 2017, NAT REV MICROBIOL, V15, P675, DOI 10.1038/nrmicro.2017.104; Kumar D, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0404-6; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; LARRICK JW, 1995, INFECT IMMUN, V63, P1291, DOI 10.1128/IAI.63.4.1291-1297.1995; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lyon GJ, 2000, P NATL ACAD SCI USA, V97, P13330, DOI 10.1073/pnas.97.24.13330; Mallbris L, 2010, EXP DERMATOL, V19, P442, DOI 10.1111/j.1600-0625.2009.00918.x; Malm J, 2000, INFECT IMMUN, V68, P4297, DOI 10.1128/IAI.68.7.4297-4302.2000; Morizane S, 2012, J INVEST DERMATOL, V132, P135, DOI 10.1038/jid.2011.259; Morizane S, 2010, J INVEST DERMATOL, V130, P1297, DOI 10.1038/jid.2009.435; Nakamura Y, 2013, NATURE, V503, P397, DOI 10.1038/nature12655; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Otto M, 2004, J INFECT DIS, V190, P748, DOI 10.1086/422157; Otto M, 2014, INT J MED MICROBIOL, V304, P164, DOI 10.1016/j.ijmm.2013.11.019; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Pistolic J, 2009, J INNATE IMMUN, V1, P254, DOI 10.1159/000171533; Qin L, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01293; Rautenberg M, 2011, FASEB J, V25, P1254, DOI 10.1096/fj.10-175208; Richardson JR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02603; Rumpret M, 2021, EUR J IMMUNOL, V51, P2210, DOI 10.1002/eji.202149278; Rumpret M, 2020, NAT REV IMMUNOL, V20, P771, DOI 10.1038/s41577-020-0352-z; Schittek B, 2012, J INNATE IMMUN, V4, P349, DOI 10.1159/000336844; Schroder JM, 1999, INT J BIOCHEM CELL B, V31, P645, DOI 10.1016/S1357-2725(99)00013-8; Schwartz K, 2014, INFECT IMMUN, V82, P3837, DOI 10.1128/IAI.02111-14; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Steevels TAM, 2013, EUR J IMMUNOL, V43, P1297, DOI 10.1002/eji.201242916; Steevels TAM, 2010, J IMMUNOL, V184, P4741, DOI 10.4049/jimmunol.0902039; Tayeb-Fligelman E, 2017, SCIENCE, V355, P831, DOI 10.1126/science.aaf4901; Thennarasu S, 2010, BIOPHYS J, V98, P248, DOI 10.1016/j.bpj.2009.09.060; Tomasinsig L, 2008, J BIOL CHEM, V283, P30471, DOI 10.1074/jbc.M802185200; Tsompanidou E, 2013, APPL ENVIRON MICROB, V79, P886, DOI 10.1128/AEM.03157-12; Van Avondt K, 2016, J IMMUNOL, V196, P3686, DOI 10.4049/jimmunol.1501650; Van Avondt K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004644; Van Avondt K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078459; van der Vlist M, 2016, NAT REV RHEUMATOL, V12, P593, DOI 10.1038/nrrheum.2016.131; Vandamme D, 2012, CELL IMMUNOL, V280, P22, DOI 10.1016/j.cellimm.2012.11.009; von Richthofen HJ, 2020, CELL IMMUNOL, V357, DOI 10.1016/j.cellimm.2020.104199; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520; Williams MR, 2017, CELL HOST MICROBE, V22, P579, DOI 10.1016/j.chom.2017.10.015; Xhindoli D, 2016, BBA-BIOMEMBRANES, V1858, P546, DOI 10.1016/j.bbamem.2015.11.003; Yamasaki K, 2007, NAT MED, V13, P975, DOI 10.1038/nm1616; Yang D, 2017, IMMUNOL REV, V280, P41, DOI 10.1111/imr.12577	85	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21875	10.1096/fj.202100812R	http://dx.doi.org/10.1096/fj.202100812R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34533845				2022-12-28	WOS:000702238200037
J	Sibley, LA; Broda, N; Gross, WR; Menezes, AF; Embry, RB; Swaroop, VT; Chambers, HG; Schipma, MJ; Lieber, RL; Domenighetti, AA				Sibley, Lydia A.; Broda, Nicole; Gross, Wendy R.; Menezes, Austin F.; Embry, Ryan B.; Swaroop, Vineeta T.; Chambers, Henry G.; Schipma, Matthew J.; Lieber, Richard L.; Domenighetti, Andrea A.			Differential DNA methylation and transcriptional signatures characterize impairment of muscle stem cells in pediatric human muscle contractures after brain injury	FASEB JOURNAL			English	Article						5-azacytidine; cerebral palsy; DNA methylation; myoblast; satellite cell	SATELLITE CELLS; CEREBRAL-PALSY; EXTRACELLULAR-MATRIX; LONGITUDINAL GROWTH; IN-SITU; CHILDREN; EXPRESSION; DEMETHYLATION; ESTABLISHMENT; ACTIVATION	Limb contractures are a debilitating and progressive consequence of a wide range of upper motor neuron injuries that affect skeletal muscle function. One type of perinatal brain injury causes cerebral palsy (CP), which affects a child's ability to move and is often painful. While several rehabilitation therapies are used to treat contractures, their long-term effectiveness is marginal since such therapies do not change muscle biological properties. Therefore, new therapies based on a biological understanding of contracture development are needed. Here, we show that myoblast progenitors from contractured muscle in children with CP are hyperproliferative. This phenotype is associated with DNA hypermethylation and specific gene expression patterns that favor cell proliferation over quiescence. Treatment of CP myoblasts with 5-azacytidine, a DNA hypomethylating agent, reduced this epigenetic imprint to TD levels, promoting exit from mitosis and molecular mechanisms of cellular quiescence. Together with previous studies demonstrating reduction in myoblast differentiation, this suggests a mechanism of contracture formation that is due to epigenetic modifications that alter the myogenic program of muscle-generating stem cells. We suggest that normalization of DNA methylation levels could rescue myogenesis and promote regulated muscle growth in muscle contracture and thus may represent a new nonsurgical approach to treating this devastating neuromuscular condition.	[Sibley, Lydia A.; Broda, Nicole; Gross, Wendy R.; Menezes, Austin F.; Swaroop, Vineeta T.; Lieber, Richard L.; Domenighetti, Andrea A.] Shirley Ryan AbilityLab, Chicago, IL 60611 USA; [Embry, Ryan B.] Northwestern Univ, NUseq Core, Chicago, IL 60611 USA; [Swaroop, Vineeta T.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Chambers, Henry G.; Schipma, Matthew J.] Rady Childrens Hosp & Hlth Ctr, San Diego, CA USA; [Lieber, Richard L.; Domenighetti, Andrea A.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Lieber, Richard L.] Hines VA Med Ctr, Maywood, IL USA; [Sibley, Lydia A.] Univ Virginia, Dept Neurosci, Charlottesville, VA USA	Shirley Ryan AbilityLab; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Rady Childrens Hospital San Diego; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; University of Virginia	Domenighetti, AA (corresponding author), Shirley Ryan AbilityLab, Biol Lab, 26th Floor,355 E Erie, Chicago, IL 60611 USA.	adomenighe@sralab.org		Lieber, Richard/0000-0002-7203-4520; Domenighetti, Andrea/0000-0002-0644-6199	Shirley Ryan AbilityLab; Department of Physical Therapy & Human Movement Sciences, Northwestern University; Cures Within Reach and the Searle Funds at The Chicago Community Trust; Pedal-with-Pete Foundation; American Academy of Cerebral Palsy and Developmental Medicine (AACPDM); United States (U.S.) Department of Veterans Affairs Rehabilitation R&D (Rehab RD) Service [IK6 RX003351]	Shirley Ryan AbilityLab; Department of Physical Therapy & Human Movement Sciences, Northwestern University; Cures Within Reach and the Searle Funds at The Chicago Community Trust; Pedal-with-Pete Foundation; American Academy of Cerebral Palsy and Developmental Medicine (AACPDM); United States (U.S.) Department of Veterans Affairs Rehabilitation R&D (Rehab RD) Service	Shirley Ryan AbilityLab; Department of Physical Therapy & Human Movement Sciences, Northwestern University; Cures Within Reach and the Searle Funds at The Chicago Community Trust; Pedal-with-Pete Foundation; American Academy of Cerebral Palsy and Developmental Medicine (AACPDM); United States (U.S.) Department of Veterans Affairs Rehabilitation R&D (Rehab RD) Service, Grant/Award Number: IK6 RX003351	Abou-Khalil R, 2010, CELL CYCLE, V9, P2575, DOI 10.4161/cc.9.13.12149; Allouh MZ, 2008, J HISTOCHEM CYTOCHEM, V56, P77, DOI 10.1369/jhc.7A7301.2007; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arnold AS, 2006, J BIOMECH, V39, P1498, DOI 10.1016/j.jbiomech.2005.03.026; Bachman JF, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.167197; Bahado-Singh RO, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092075; Banerjee S, 2019, COMPUT STRUCT BIOTEC, V17, P507, DOI 10.1016/j.csbj.2019.04.003; Barber L, 2011, DEV MED CHILD NEUROL, V53, P543, DOI 10.1111/j.1469-8749.2011.03913.x; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; CARDASIS CA, 1975, J EXP ZOOL, V191, P347, DOI 10.1002/jez.1401910305; Garcia CC, 2016, J EXERC REHABIL, V12, P124, DOI 10.12965/jer.1632552.276; Carrio E, 2015, STEM CELLS, V33, P2025, DOI 10.1002/stem.1998; Chakkalakal JV, 2014, DEVELOPMENT, V141, P1649, DOI 10.1242/dev.100842; Chang EI, 2020, J ENDOCRINOL, V244, P339, DOI 10.1530/JOE-19-0273; Chang YQ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1549; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Crowgey EL, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2224-0; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dayanidhi S, 2020, CLIN ORTHOP RELAT R, V478, P886, DOI 10.1097/CORR.0000000000001134; Dayanidhi S, 2015, J ORTHOP RES, V33, P1039, DOI 10.1002/jor.22860; Delhaas T, 2013, ANAT REC, V296, P192, DOI 10.1002/ar.22631; Derissen EJB, 2013, ONCOLOGIST, V18, P619, DOI 10.1634/theoncologist.2012-0465; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Domenighetti AA, 2018, AM J PHYSIOL-CELL PH, V315, pC247, DOI 10.1152/ajpcell.00351.2017; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Duddy W, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0041-y; Dumon NA, 2015, DEVELOPMENT, V142, P1572, DOI 10.1242/dev.114223; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkz1031, 10.1093/nar/gkx1132]; Farmer SE, 2001, DISABIL REHABIL, V23, P549; Fitzgerald E, 2018, CURR GENOMICS, V19, P507, DOI 10.2174/1389202919666171229144807; Gattazzo F, 2020, STEM CELL REP, V15, P597, DOI 10.1016/j.stemcr.2020.07.011; Graham HK., 2016, NAT REV DIS PRIMERS, V2, P15082, DOI DOI 10.1038/nrdp.2015.82; GRIFFIN GE, 1971, NATURE-NEW BIOL, V232, P28, DOI 10.1038/newbio232028a0; Gujar H, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020172; Hartley I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077859; Hoare BJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003469.pub4; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hupkes M, 2011, FASEB J, V25, P3861, DOI 10.1096/fj.11-186122; Ikeda K, 2017, SCI REP-UK, V7, DOI 10.1038/srep44570; Jiao Z, 2017, MOL MED REP, V16, P9423, DOI 10.3892/mmr.2017.7800; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kalkman BM, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00131; Kim JH, 2016, NAT CELL BIOL, V18, P930, DOI 10.1038/ncb3401; Lassar AB, 2017, SEMIN CELL DEV BIOL, V72, P3, DOI 10.1016/j.semcdb.2017.10.021; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lieber RL, 2011, PHILOS T R SOC B, V366, P1466, DOI 10.1098/rstb.2010.0316; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Machado L, 2017, CELL REP, V21, P1982, DOI 10.1016/j.celrep.2017.10.080; Makki D, 2014, J CHILD ORTHOP, V8, P215, DOI 10.1007/s11832-014-0593-0; Maksimovic Jovana, 2016, F1000Res, V5, P1281, DOI 10.12688/f1000research.8839.3; Marnef A, 2019, GENE DEV, V33, P1175, DOI 10.1101/gad.324012.119; Mohan KN, 2013, INT REV CEL MOL BIO, V306, P1, DOI 10.1016/B978-0-12-407694-5.00001-8; Mohandas N, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0457-4; Moncaut N, 2013, FEBS J, V280, P3980, DOI 10.1111/febs.12379; Montesano A, 2013, INT J BIOL SCI, V9, P391, DOI 10.7150/ijbs.4729; Murach KA, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0132-z; Noble JJ, 2014, BRAIN DEV-JPN, V36, P294, DOI 10.1016/j.braindev.2013.05.008; Nuckolls GH, 2020, MUSCLE NERVE, V61, P740, DOI 10.1002/mus.26845; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ostojic K, 2020, ARCH PHYS MED REHAB, V101, P213, DOI 10.1016/j.apmr.2019.08.475; Palisano RJ, 2008, DEV MED CHILD NEUROL, V50, P744, DOI 10.1111/j.1469-8749.2008.03089.x; Peterson MD, 2012, AM J PHYSIOL-ENDOC M, V303, pE1085, DOI 10.1152/ajpendo.00338.2012; Prabhu RKR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009331.pub2; Ren WD, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120620; Robson LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027116; Rose J, 2005, DEV MED CHILD NEUROL, V47, P329, DOI 10.1017/S0012162205000629; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sato T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5597; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith KJ, 2019, JAMA NEUROL, V76, P294, DOI 10.1001/jamaneurol.2018.4147; Smith LR, 2013, DEV MED CHILD NEUROL, V55, P264, DOI 10.1111/dmcn.12027; Smith LR, 2011, J PHYSIOL-LONDON, V589, P2625, DOI 10.1113/jphysiol.2010.203364; So AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019503; Stewart R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024714; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Tierney MT, 2016, CELL REP, V14, P1940, DOI 10.1016/j.celrep.2016.01.072; Tsumagari K, 2013, EPIGENETICS-US, V8, P317, DOI 10.4161/epi.23989; Von Walden F, 2018, MUSCLE NERVE, V58, P277, DOI 10.1002/mus.26130; Wei F, 2015, ONCOGENE, V34, P3063, DOI 10.1038/onc.2014.235; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; WILLIAMS PE, 1971, J CELL SCI, V9, P751; Yang QL, 2016, MOL NEUROBIOL, V53, P436, DOI 10.1007/s12035-014-9027-8; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; ZHANG M, 1995, DEV DYNAM, V204, P168, DOI 10.1002/aja.1002040207; Zollner AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045661	88	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21928	10.1096/fj.202100649R	http://dx.doi.org/10.1096/fj.202100649R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34559924				2022-12-28	WOS:000702238200001
J	Wilson, CS; Dohare, P; Orbeta, S; Nalwalk, JW; Huang, YF; Ferland, RJ; Sah, R; Scimemi, A; Mongin, AA				Wilson, Corinne S.; Dohare, Preeti; Orbeta, Shaina; Nalwalk, Julia W.; Huang, Yunfei; Ferland, Russell J.; Sah, Rajan; Scimemi, Annalisa; Mongin, Alexander A.			Late adolescence mortality in mice with brain-specific deletion of the volume-regulated anion channel subunit LRRC8A	FASEB JOURNAL			English	Article						GABA signaling; glutamate-glutamine cycle; LRRC8A; VRAC	PROBABILITY FLUCTUATION ANALYSIS; GLUTAMATE-GLUTAMINE CYCLE; EXCITATORY AMINO-ACIDS; MEGALENCEPHALIC LEUKOENCEPHALOPATHY; EXTRACELLULAR-SPACE; RECURRENT SEIZURES; ESSENTIAL COMPONENT; ENERGY-METABOLISM; SUBCORTICAL CYSTS; MEMBRANE-PROTEIN	The leucine-rich repeat-containing family 8 member A (LRRC8A) is an essential subunit of the volume-regulated anion channel (VRAC). VRAC is critical for cell volume control, but its broader physiological functions remain under investigation. Recent studies in the field indicate that Lrrc8a disruption in the brain astrocytes reduces neuronal excitability, impairs synaptic plasticity and memory, and protects against cerebral ischemia. In the present work, we generated brain-wide conditional LRRC8A knockout mice (LRRC8A bKO) using Nestin(Cre)-driven Lrrc8a(flox/flox) excision in neurons, astrocytes, and oligodendroglia. LRRC8A bKO animals were born close to the expected Mendelian ratio and developed without overt histological abnormalities, but, surprisingly, all died between 5 and 9 weeks of age with a seizure phenotype, which was confirmed by video and EEG recordings. Brain slice electrophysiology detected changes in the excitability of pyramidal cells and modified GABAergic inputs in the hippocampal CA1 region of LRRC8A bKO. LRRC8A-null hippocampi showed increased immunoreactivity of the astrocytic marker GFAP, indicating reactive astrogliosis. We also found decreased whole-brain protein levels of the GABA transporter GAT-1, the glutamate transporter GLT-1, and the astrocytic enzyme glutamine synthetase. Complementary HPLC assays identified reduction in the tissue levels of the glutamate and GABA precursor glutamine. Together, these findings suggest that VRAC provides vital control of brain excitability in mouse adolescence. VRAC deletion leads to a lethal phenotype involving progressive astrogliosis and dysregulation of astrocytic uptake and supply of amino acid neurotransmitters and their precursors.	[Wilson, Corinne S.; Dohare, Preeti; Orbeta, Shaina; Nalwalk, Julia W.; Huang, Yunfei; Mongin, Alexander A.] Albany Med Coll, Dept Neurosci & Expt Therapeut, 47 New Scotland Ave,MC-136, Albany, NY 12208 USA; [Ferland, Russell J.] Univ New England, Dept Biomed Sci, Coll Osteopath Med, Biddeford, ME USA; [Sah, Rajan] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Scimemi, Annalisa] SUNY Albany, Dept Biol, Albany, NY 12222 USA	Albany Medical College; University of New England - Maine; Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Albany	Mongin, AA (corresponding author), Albany Med Coll, Dept Neurosci & Expt Therapeut, 47 New Scotland Ave,MC-136, Albany, NY 12208 USA.	mongina@amc.edu	huang, yunfei/HCH-7746-2022; Mongin, Alexander A./A-5526-2008; Scimemi, Annalisa/O-5396-2014	Mongin, Alexander A./0000-0002-2501-3778; Ferland, Russell/0000-0002-8044-2479; Sah, Rajan/0000-0003-1092-1244; Huang, Yunfei/0000-0002-7129-1250; Scimemi, Annalisa/0000-0003-4975-093X	HHS \ National Institutes of Health (NIH) [R01 NS111943, F31 NS111889, R01 NS092062, R01 NS093045]; National Science Foundation (NSF) [IOS2011998, IOS1655365]	HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF))	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: R01 NS111943, F31 NS111889, R01 NS092062 and R01 NS093045; National Science Foundation (NSF), Grant/ Award Number: IOS2011998 and IOS1655365	Abascal F, 2012, BIOESSAYS, V34, P551, DOI 10.1002/bies.201100173; Abdullaev IF, 2006, J PHYSIOL-LONDON, V572, P677, DOI 10.1113/jphysiol.2005.103820; Aiba I, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4050; Akbar MT, 1998, NEUROSCIENCE, V85, P1235, DOI 10.1016/S0306-4522(97)00684-2; Albrecht J, 2005, NEUROCHEM RES, V30, P1615, DOI 10.1007/s11064-005-8986-6; Alghanem AF, 2021, ELIFE, V10, DOI 10.7554/eLife.61313; Alvestad S, 2008, NEUROCHEM RES, V33, P257, DOI 10.1007/s11064-007-9435-5; Andre V, 2001, HIPPOCAMPUS, V11, P452, DOI 10.1002/hipo.1060.abs; ANDREW RD, 1991, J NEUROL SCI, V101, P7, DOI 10.1016/0022-510X(91)90013-W; ANDREW RD, 1994, NEUROSCIENCE, V62, P371, DOI 10.1016/0306-4522(94)90372-7; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Bao JQ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99767; Binder DK, 2004, NEUROREPORT, V15, P259, DOI 10.1097/00001756-200402090-00009; Carvill GL, 2015, AM J HUM GENET, V96, P808, DOI 10.1016/j.ajhg.2015.02.016; Chen LY, 2019, J BIOL CHEM, V294, P14279, DOI 10.1074/jbc.RA119.008840; Chowdhury GMI, 2007, J CEREBR BLOOD F MET, V27, P1895, DOI 10.1038/sj.jcbfm.9600490; Clements JD, 2000, TRENDS NEUROSCI, V23, P105, DOI 10.1016/S0166-2236(99)01520-9; Conti F, 1998, J COMP NEUROL, V396, P51, DOI 10.1002/(SICI)1096-9861(19980622)396:1<51::AID-CNE5>3.0.CO;2-H; Coulter DA, 2012, GLIA, V60, P1215, DOI 10.1002/glia.22341; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; Deneka D, 2018, NATURE, V558, P254, DOI 10.1038/s41586-018-0134-y; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Dohare P, 2014, FREE RADICAL BIO MED, V77, P168, DOI 10.1016/j.freeradbiomed.2014.08.029; Dubey M, 2018, ANN NEUROL, V83, P636, DOI 10.1002/ana.25190; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; Eid T, 2004, LANCET, V363, P28, DOI 10.1016/S0140-6736(03)15166-5; Eid T, 2008, BRAIN, V131, P2061, DOI 10.1093/brain/awn133; El Idrissi A, 2004, NEUROCHEM RES, V29, P189, DOI 10.1023/B:NERE.0000010448.17740.6e; Vidal XE, 2018, NEUROBIOL DIS, V119, P88, DOI 10.1016/j.nbd.2018.07.031; Formaggio F, 2019, FASEB J, V33, P101, DOI 10.1096/fj.201701397RR; Fricke MN, 2007, J NEUROCHEM, V102, P1895, DOI 10.1111/j.1471-4159.2007.04649.x; Gaitan-Penas H, 2016, BIOPHYS J, V111, P1429, DOI 10.1016/j.bpj.2016.08.030; Goodspeed K, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa170; Haj-Yasein NN, 2012, GLIA, V60, P867, DOI 10.1002/glia.22319; Hertz Leif, 2013, Front Endocrinol (Lausanne), V4, P59, DOI 10.3389/fendo.2013.00059; Hines RM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05481-1; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Holthoff K, 1996, J NEUROSCI, V16, P2740, DOI 10.1523/jneurosci.16-08-02740.1996; Hyzinski-Garcia MC, 2014, J PHYSIOL-LONDON, V592, P4855, DOI 10.1113/jphysiol.2014.278887; Jensen K, 2003, J NEUROPHYSIOL, V90, P2690, DOI 10.1152/jn.00240.2003; Jentsch TJ, 2016, NAT REV MOL CELL BIO, V17, P293, DOI 10.1038/nrm.2016.29; Kadiyala SB, 2016, J NEUROSCI, V36, P7485, DOI 10.1523/JNEUROSCI.3232-14.2016; Kang C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02664-0; Kasuya G, 2018, NAT STRUCT MOL BIOL, V25, P797, DOI 10.1038/s41594-018-0109-6; Kern DM, 2019, ELIFE, V8, DOI 10.7554/eLife.42636; Kimelberg HK, 1998, CONTRIB NEPHROL, V123, P240, DOI 10.1159/000059916; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; Kumar A, 2020, ELIFE, V9, DOI 10.7554/eLife.58941; Kumar L, 2014, J EXP MED, V211, P929, DOI 10.1084/jem.20131379; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Leegwater PAJ, 2001, AM J HUM GENET, V68, P831, DOI 10.1086/319519; Liang SL, 2006, J NEUROSCI, V26, P8537, DOI 10.1523/JNEUROSCI.0329-06.2006; Lopez-Hernandez T, 2011, AM J HUM GENET, V88, P422, DOI 10.1016/j.ajhg.2011.02.009; Luck JC, 2018, J BIOL CHEM, V293, P11796, DOI 10.1074/jbc.RA118.003853; Magloczky Z, 2005, TRENDS NEUROSCI, V28, P334, DOI 10.1016/j.tins.2005.04.002; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; Mongin Alexander A, 2007, Pathophysiology, V14, P183, DOI 10.1016/j.pathophys.2007.09.009; Mongin AA, 2016, PFLUG ARCH EUR J PHY, V468, P421, DOI 10.1007/s00424-015-1765-6; Murphy TR, 2017, NEUROBIOL DIS, V104, P24, DOI 10.1016/j.nbd.2017.04.016; National Research Council (US) Committee, 2011, GUIDE CARE USE LAB A, V8th; Nilius B, 1997, PROG BIOPHYS MOL BIO, V68, P69, DOI 10.1016/S0079-6107(97)00021-7; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Patel AB, 2005, P NATL ACAD SCI USA, V102, P5588, DOI 10.1073/pnas.0501703102; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pedersen SF, 2016, PFLUG ARCH EUR J PHY, V468, P371, DOI 10.1007/s00424-015-1781-6; Perez EL, 2012, NEUROBIOL DIS, V47, P331, DOI 10.1016/j.nbd.2012.05.010; Petr GT, 2015, J NEUROSCI, V35, P5187, DOI 10.1523/JNEUROSCI.4255-14.2015; Planells-Cases R, 2015, EMBO J, V34, P2993, DOI 10.15252/embj.201592409; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ribak CE, 1996, J COMP NEUROL, V367, P595, DOI 10.1002/(SICI)1096-9861(19960415)367:4<595::AID-CNE9>3.0.CO;2-#; Ridder MC, 2011, BRAIN, V134, P3342, DOI 10.1093/brain/awr255; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider M, 2013, CELL TISSUE RES, V354, P99, DOI 10.1007/s00441-013-1581-2; Schober AL, 2017, J PHYSIOL-LONDON, V595, P6939, DOI 10.1113/JP275053; Schousboe A, 2003, NEUROCHEM INT, V43, P311, DOI 10.1016/S0197-0186(03)00017-2; Silver RA, 2003, J NEUROSCI METH, V130, P127, DOI 10.1016/j.jneumeth.2003.09.030; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; Staley K, 2015, NAT NEUROSCI, V18, P367, DOI 10.1038/nn.3947; Strange K, 1996, AM J PHYSIOL-CELL PH, V270, pC711, DOI 10.1152/ajpcell.1996.270.3.C711; Strange K, 2019, J GEN PHYSIOL, V151, P100, DOI 10.1085/jgp.201812138; SVOBODA J, 1991, BRAIN RES, V560, P216, DOI 10.1016/0006-8993(91)91235-S; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TRAYNELIS SF, 1989, J NEUROPHYSIOL, V61, P927, DOI 10.1152/jn.1989.61.5.927; Treiman DM, 2001, EPILEPSIA, V42, P8, DOI 10.1046/j.1528-1157.2001.042suppl.3008.x; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Ullrich F, 2016, J BIOL CHEM, V291, P17040, DOI 10.1074/jbc.M116.739342; van der Knaap MS, 2012, LANCET NEUROL, V11, P973, DOI 10.1016/S1474-4422(12)70192-8; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wang Y, 2009, EXP NEUROL, V220, P293, DOI 10.1016/j.expneurol.2009.08.034; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x; Wilson CS, 2018, CURR TOP MEMBR, V81, P385, DOI 10.1016/bs.ctm.2018.07.006; Yalcinkaya C, 2003, SEIZURE-EUR J EPILEP, V12, P388, DOI 10.1016/S1059-1311(02)00350-3; Yamada T, 2018, J GEN PHYSIOL, V150, P1003, DOI 10.1085/jgp.201812016; Yang JH, 2019, NEURON, V102, P813, DOI 10.1016/j.neuron.2019.03.029; Zhang YH, 2017, NAT CELL BIOL, V19, P504, DOI 10.1038/ncb3514; Zhou C, 2020, IMMUNITY, V52, P767, DOI 10.1016/j.immuni.2020.03.016; Zhou JJ, 2020, EXP NEUROL, V332, DOI 10.1016/j.expneurol.2020.113391	103	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21869	10.1096/fj.202002745R	http://dx.doi.org/10.1096/fj.202002745R			25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34469026	Green Submitted, Green Accepted			2022-12-28	WOS:000702238200057
J	Zhu, P; Dyka, F; Ma, XJ; Yin, L; Yu, H; Baehr, W; Hauswirth, WW; Deng, WT				Zhu, Ping; Dyka, Frank; Ma, Xiaojie; Yin, Ling; Yu, Heather; Baehr, Wolfgang; Hauswirth, William W.; Deng, Wen-Tao			Disease mechanisms of X-linked cone dystrophy caused by missense mutations in the red and green cone opsins	FASEB JOURNAL			English	Article						blue cone monochromacy; cone dystrophy; cone opsin; disease mechanism; photoreceptors	RHODOPSIN RETINITIS-PIGMENTOSA; COLOR-VISION; MOLECULAR-GENETICS; RETINAL STRUCTURE; MOUSE MODEL; EXON 3; BLUE; GENES; DISRUPTION; PHENOTYPE	Cone photoreceptors are responsible for the visual acuity and color vision of the human eye. Red/green cone opsin missense mutations N94K, W177R, P307L, R330Q, and G338E have been identified in subjects with congenital blue cone monochromacy or color-vision deficiency. Studies on disease mechanisms due to these cone opsin mutations have been previously carried out exclusively in vitro, and the reported impairments were not always consistent. Here we expressed these mutants via AAV specifically in vivo in M-opsin knockout mouse cones to investigate their subcellular localization, the pathogenic effects on cone structure, function, and cone viability. We show that these mutations alter the M-opsin structure, function, and localization. N94K and W177R mutants appeared to be misfolded since they localized exclusively in cone inner segments and endoplasmic reticulum. In contrast, P307L, R330Q, and G338E mutants were detected predominately in cone outer segments. Expression of R330Q and G338E, but not P307L opsins, also partially restored expression and correct localization of cone PDE6 alpha' and cone transducin gamma and resulted in partial rescue of M-cone-mediated light responses. Expression of W177R and P307L mutants significantly reduced cone viability, whereas N94K, R330Q, and G338E were only modestly toxic. We propose that although the underlying biochemical and cellular defects caused by these mutants are distinct, they all seem to exhibit a dominant phenotype, resembling autosomal dominant retinitis pigmentosa associated with the majority of rhodopsin missense mutations. The understanding of the molecular mechanisms associated with these cone opsin mutants is fundamental to developing targeted therapies for cone dystrophy/dysfunction.	[Zhu, Ping; Dyka, Frank; Ma, Xiaojie; Yin, Ling; Yu, Heather; Hauswirth, William W.; Deng, Wen-Tao] Univ Florida, Dept Ophthalmol, Gainesville, FL USA; [Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, John A Moran Eye Ctr, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Deng, Wen-Tao] West Virginia Univ, Dept Ophthalmol & Visual Sci, Morgantown, WV 26501 USA; [Deng, Wen-Tao] West Virginia Univ, Dept Biochem, Morgantown, WV 26501 USA	State University System of Florida; University of Florida; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; West Virginia University; West Virginia University	Deng, WT (corresponding author), West Virginia Univ, Dept Ophthalmol & Visual Sci, 1 Med Ctr Dr,Box 9193, Morgantown, WV 26506 USA.	wen.deng@hsc.wvu.edu			National Institutes of Health [R01 EY030056, EY021721, R01 EY08123, 1S10OD028476]; National Eye Institute [EY014800-039003]; Research to Prevent Blindness	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB))	National Institutes of Health, Grant/Award Number: R01 EY030056, EY021721, R01 EY08123 and 1S10OD028476; National Eye Institute, Grant/Award Number: EY014800-039003; Research to Prevent Blindness; National Institutes of Health, Grant/Award Number: R01 EY030056, EY021721, R01 EY08123 and 1S10OD028476	Athanasiou D, 2018, PROG RETIN EYE RES, V62, P1, DOI 10.1016/j.preteyeres.2017.10.002; Ayyagari R, 1999, MOL VIS, V5; Bakondi B, 2016, MOL THER, V24, P556, DOI 10.1038/mt.2015.220; Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; BLANKS JC, 1983, J COMP NEUROL, V221, P31, DOI 10.1002/cne.902210103; Buena-Atienza E, 2016, SCI REP-UK, V6, DOI 10.1038/srep28253; Carroll J, 2004, P NATL ACAD SCI USA, V101, P8461, DOI 10.1073/pnas.0401440101; Carroll J, 2012, INVEST OPHTH VIS SCI, V53, P8006, DOI 10.1167/iovs.12-11087; Carroll J, 2010, VISION RES, V50, P1989, DOI 10.1016/j.visres.2010.07.009; Carroll J, 2009, P NATL ACAD SCI USA, V106, P20948, DOI 10.1073/pnas.0910128106; Cideciyan AV, 2018, P NATL ACAD SCI USA, V115, pE8547, DOI 10.1073/pnas.1805055115; Cideciyan AV, 2013, HUM GENE THER, V24, P993, DOI 10.1089/hum.2013.153; Crognale MA, 2004, VISUAL NEUROSCI, V21, P197, DOI 10.1017/S0952523804213384; CURCIO CA, 1991, J COMP NEUROL, V312, P610, DOI 10.1002/cne.903120411; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; DEEB SS, 1992, AM J HUM GENET, V51, P687; Deming JD, 2015, INVEST OPHTH VIS SCI, V56, P7618, DOI 10.1167/iovs.15-17832; Deng WT, 2018, MOL VIS, V24, P17; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Gardner JC, 2014, HUM MUTAT, V35, P1354, DOI 10.1002/humu.22679; Gardner JC, 2010, AM J HUM GENET, V87, P26, DOI 10.1016/j.ajhg.2010.05.019; Gardner JC, 2009, MOL VIS, V15, P876; Giannelli SG, 2018, HUM MOL GENET, V27, P761, DOI 10.1093/hmg/ddx438; Greenwald SH, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.3.2; Griciuc A, 2011, TRENDS MOL MED, V17, P442, DOI 10.1016/j.molmed.2011.04.002; Hofmann L, 2017, BIOCHEMISTRY-US, V56, P2338, DOI 10.1021/acs.biochem.7b00165; Hwa J, 1999, P NATL ACAD SCI USA, V96, P1932, DOI 10.1073/pnas.96.5.1932; Jagla WM, 2002, HUM MOL GENET, V11, P23, DOI 10.1093/hmg/11.1.23; Jones BW, 2011, J COMP NEUROL, V519, P2713, DOI 10.1002/cne.22703; Kazmi MA, 1997, INVEST OPHTH VIS SCI, V38, P1074; Kellner U, 2004, GRAEF ARCH CLIN EXP, V242, P729, DOI 10.1007/s00417-004-0921-z; Kirchberg K, 2011, P NATL ACAD SCI USA, V108, P18690, DOI 10.1073/pnas.1015461108; Li PJ, 2018, CRISPR J, V1, P55, DOI 10.1089/crispr.2017.0009; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; Mao HY, 2012, HUM GENE THER, V23, P356, DOI 10.1089/hum.2011.213; Mao HY, 2011, HUM GENE THER, V22, P567, DOI 10.1089/hum.2010.140; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Michaelides M, 2005, OPHTHALMOLOGY, V112, P1448, DOI 10.1016/j.ophtha.2005.02.021; Michaelides M, 2005, EYE, V19, P2, DOI 10.1038/sj.eye.6701391; Mizrahi-Meissonnier L, 2010, INVEST OPHTH VIS SCI, V51, P3884, DOI 10.1167/iovs.09-4592; Mustafi D, 2009, PROG RETIN EYE RES, V28, P289, DOI 10.1016/j.preteyeres.2009.05.003; NATHANS J, 1993, AM J HUM GENET, V53, P987; NATHANS J, 1989, SCIENCE, V245, P831, DOI 10.1126/science.2788922; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Neitz J, 2011, VISION RES, V51, P633, DOI 10.1016/j.visres.2010.12.002; Neitz M, 2004, VISUAL NEUROSCI, V21, P205, DOI 10.1017/S0952523804213293; Nemet I, 2015, PROG MOL BIOL TRANSL, V132, P39, DOI 10.1016/bs.pmbts.2015.02.007; Orosz O, 2017, INVEST OPHTH VIS SCI, V58, P1834, DOI 10.1167/iovs.16-21405; Ostrer H, 1997, Mol Vis, V3, P16; Ostrer H, 1998, Mol Vis, V4, P28; Pang JJ, 2008, INVEST OPHTH VIS SCI, V49, P4278, DOI 10.1167/iovs.07-1622; Pang JJ, 2006, MOL THER, V13, P565, DOI 10.1016/j.ymthe.2005.09.001; Park Paul Shin-Hyun, 2014, Adv Pharmacol, V70, P1, DOI 10.1016/B978-0-12-417197-8.00001-8; REYNIERS E, 1995, GENOMICS, V29, P323, DOI 10.1006/geno.1995.9998; Riedmayr LM, 2020, HUM MOL GENET, V29, P295, DOI 10.1093/hmg/ddz291; Rivera-De la Parra D, 2013, GENE, V519, P173, DOI 10.1016/j.gene.2013.01.048; Sohocki MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K; Srinivasan S, 2017, BBA-MOL BASIS DIS, V1863, P1840, DOI 10.1016/j.bbadis.2017.05.006; Stenkamp RE, 2002, BBA-BIOMEMBRANES, V1565, P168, DOI 10.1016/S0005-2736(02)00567-9; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P3052, DOI 10.1167/iovs.05-1443; Sumaroka A, 2018, INVEST OPHTH VIS SCI, V59, P5762, DOI 10.1167/iovs.18-25280; Tanner G, 2009, HUM MUTAT, V30, P255, DOI 10.1002/humu.20861; Ueyama H, 2002, BIOCHEM BIOPH RES CO, V294, P205, DOI 10.1016/S0006-291X(02)00458-8; Ueyama H, 2012, BIOCHEM BIOPH RES CO, V424, P152, DOI 10.1016/j.bbrc.2012.06.094; Vissers PMAM, 1996, FEBS LETT, V396, P26, DOI 10.1016/0014-5793(96)01064-2; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; WINDERICKX J, 1992, NAT GENET, V1, P251, DOI 10.1038/ng0792-251; YOSHIZAWA T, 1992, PHOTOCHEM PHOTOBIOL, V56, P859, DOI 10.1111/j.1751-1097.1992.tb09707.x; Zhang F, 1998, Yan Ke Xue Bao, V14, P210; Zhang YX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06982-7; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	72	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21927	10.1096/fj.202101066R	http://dx.doi.org/10.1096/fj.202101066R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34547123	hybrid, Green Published			2022-12-28	WOS:000702238200005
J	Kappert, L; Ruzicka, P; Kutikhin, A; De la Torre, C; Fischer, A; Hecker, M; Arnold, C; Korff, T				Kappert, Lena; Ruzicka, Philipp; Kutikhin, Anton; De la Torre, Carolina; Fischer, Andreas; Hecker, Markus; Arnold, Caroline; Korff, Thomas			Loss of Nfat5 promotes lipid accumulation in vascular smooth muscle cells	FASEB JOURNAL			English	Article						cholesterol; foam cells; lipids; NFAT5; vascular smooth muscle cells	SUPEROXIDE-DISMUTASE; METABOLIC DISEASES; CHOLESTEROL EFFLUX; HIGH NACL; EXPRESSION; ATHEROSCLEROSIS; TRANSCRIPTION; ACID; HYPERTENSION; ACTIVATION	The nuclear factor of activated T-cells 5 (NFAT5) is a transcriptional regulator of macrophage activation and T-cell development, which controls stabilizing responses of cells to hypertonic and biomechanical stress. In this study, we detected NFAT5 in the media layer of arteries adjacent to human arteriosclerotic plaques and analyzed its role in vascular smooth muscle cells (VSMCs) known to contribute to arteriosclerosis through the uptake of lipids and transformation into foam cells. Exposure of both human and mouse VSMCs to cholesterol stimulated the nuclear translocation of NFAT5 and increased the expression of the ATP-binding cassette transporter Abca1, required to regulate cholesterol efflux from cells. Loss of Nfat5 promoted cholesterol accumulation in these cells and inhibited the expression of genes involved in the management of oxidative stress or lipid handling, such as Sod1, Plin2, Fabp3, and Ppard. The functional relevance of these observations was subsequently investigated in mice fed a high-fat diet upon induction of a smooth muscle cell-specific genetic ablation of Nfat5 (Nfat5((SMC)-/-)). Under these conditions, Nfat5((SMC)-/-) but not Nfat5(fl/fl) mice developed small, focal lipid-rich lesions in the aorta after 14 and 25 weeks, which were formed by intracellular lipid droplets deposited in the sub-intimal VSMCs layer. While known for being activated by external stimuli, NFAT5 was found to mediate the expression of VSMC genes associated with the handling of lipids in response to a cholesterol-rich environment. Failure of this protective function may promote the formation of lipid-laden arterial VSMCs and pro-atherogenic vascular responses.	[Kappert, Lena; Ruzicka, Philipp; Hecker, Markus; Arnold, Caroline; Korff, Thomas] Heidelberg Univ, Inst Physiol & Pathophysiol, Dept Cardiovasc Physiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany; [Kutikhin, Anton] Res Inst Complex Issues Cardiovasc Dis, Div Expt Med, Kemerovo, Russia; [De la Torre, Carolina] Heidelberg Univ, Med Fac Mannheim, Ctr Med Res, Heidelberg, Germany; [Fischer, Andreas] German Canc Res Ctr, Div Vasc Signaling & Canc, Heidelberg, Germany; [Fischer, Andreas] Heidelberg Univ, Dept Internal Med 1, Heidelberg, Germany; [Fischer, Andreas; Korff, Thomas] Heidelberg Univ, Med Fac Mannheim, European Ctr Angiosci ECAS, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Russian Academy of Medical Sciences; Research Institute for Complex Issues of Cardiovascular Diseases; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Korff, T (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, Dept Cardiovasc Physiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany.	korff@physiologie.uni-heidelberg.de	Kutikhin, Anton/B-9397-2012	Kutikhin, Anton/0000-0001-8679-4857	Deutsche Forschungsgemeinschaft (DFG) [394046768-SFB, 1366-B5, 1366-C4, 1366-Z4]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: 394046768-SFB, 1366-B5, 1366-C4 and 1366-Z4	Allahverdian S, 2014, CIRCULATION, V129, P1551, DOI 10.1161/CIRCULATIONAHA.113.005015; Arnold C, 2019, FASEB J, V33, P3364, DOI 10.1096/fj.201801594R; Cen LS, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/6927429; Chattopadhyay A, 2021, ARTERIOSCL THROM VAS, V41, P302, DOI 10.1161/ATVBAHA.120.315164; Chellan B, 2016, ARTERIOSCL THROM VAS, V36, P1101, DOI 10.1161/ATVBAHA.116.307306; Choi SY, 2020, NAT REV NEPHROL, V16, P352, DOI 10.1038/s41581-020-0261-1; Conte M, 2016, TRENDS ENDOCRIN MET, V27, P893, DOI 10.1016/j.tem.2016.09.001; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Dove DE, 2005, ARTERIOSCL THROM VAS, V25, P128, DOI 10.1161/01.ATV.0000148323.94021.e5; Dubland JA, 2016, CURR OPIN LIPIDOL, V27, P155, DOI 10.1097/MOL.0000000000000279; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gallazzini M, 2010, FASEB J, V24, P4325, DOI 10.1096/fj.10-157362; Halterman JA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00313; Halterman JA, 2011, ARTERIOSCL THROM VAS, V31, P2287, DOI 10.1161/ATVBAHA.111.232165; HAUDENSCHILD CC, 1985, HYPERTENSION, V7, pI101, DOI 10.1161/01.HYP.7.3_Pt_2.I101; Hodebeck M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00467; HOLNESS CL, 1993, BLOOD, V81, P1607; Irarrazabal CE, 2010, P NATL ACAD SCI USA, V107, P906, DOI 10.1073/pnas.0913415107; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Izumi Y, 2012, AM J PHYSIOL-CELL PH, V303, pC1061, DOI 10.1152/ajpcell.00265.2012; Korff T, 2007, CIRCULATION, V116, P2288, DOI 10.1161/CIRCULATIONAHA.107.730309; Kuper C, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00507; Kurahashi T, 2015, BIOCHEM BIOPH RES CO, V467, P866, DOI 10.1016/j.bbrc.2015.10.052; Kurushima H, 2000, J LEUKOCYTE BIOL, V67, P104, DOI 10.1002/jlb.67.1.104; Maouyo D, 2002, AM J PHYSIOL-RENAL, V282, pF802, DOI 10.1152/ajprenal.00123.2001; Meng Y, 2020, TRENDS CELL BIOL, V30, P452, DOI 10.1016/j.tcb.2020.02.007; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Murphy C, 2005, BBA-MOL CELL BIOL L, V1735, P167, DOI 10.1016/j.bbalip.2005.06.001; Nakashima Y, 2007, ARTERIOSCL THROM VAS, V27, P1159, DOI 10.1161/ATVBAHA.106.134080; OLIVETTI G, 1982, CIRC RES, V51, P19, DOI 10.1161/01.RES.51.1.19; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Rong JX, 2003, P NATL ACAD SCI USA, V100, P13531, DOI 10.1073/pnas.1735526100; Scherer C, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000626; Sun YY, 2011, FUND CLIN PHARMACOL, V25, P572, DOI 10.1111/j.1472-8206.2010.00885.x; Verreth W, 2007, BRIT J PHARMACOL, V151, P347, DOI 10.1038/sj.bjp.0707231; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Wang Y, 2019, ARTERIOSCL THROM VAS, V39, P876, DOI 10.1161/ATVBAHA.119.312434; Yang H, 2004, CIRC RES, V95, P1075, DOI 10.1161/01.RES.0000149564.49410.0d; Yang H, 2009, ATHEROSCLEROSIS, V207, P51, DOI 10.1016/j.atherosclerosis.2009.03.052; Zappe M, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01190	41	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21831	10.1096/fj.202100682R	http://dx.doi.org/10.1096/fj.202100682R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34383982	hybrid			2022-12-28	WOS:000691122900055
J	Rodriguez-Cuenca, S; Lelliot, CJ; Campbell, M; Peddinti, G; Martinez-Una, M; Ingvorsen, C; Dias, AR; Relat, J; Mora, S; Hyotylainen, T; Zorzano, A; Oresic, M; Bjursell, M; Bohlooly-Y, M; Linden, D; Vidal-Puig, A				Rodriguez-Cuenca, Sergio; Lelliot, Christopher J.; Campbell, Mark; Peddinti, Gopal; Martinez-Una, Maite; Ingvorsen, Camilla; Dias, Ana Rita; Relat, Joana; Mora, Silvia; Hyotylainen, Tuulia; Zorzano, Antonio; Oresic, Matej; Bjursell, Mikael; Bohlooly-Y, Mohammad; Linden, Daniel; Vidal-Puig, Antonio			Allostatic hypermetabolic response in PGC1 alpha/beta heterozygote mouse despite mitochondrial defects	FASEB JOURNAL			English	Article						adipose tissue; hepatic lipidome; lipotoxicity; mitochondrial dysfunction; PGC-1alpha	PROLIFERATOR-ACTIVATED RECEPTOR; GAMMA COACTIVATOR 1-ALPHA; SKELETAL-MUSCLE; GENE-EXPRESSION; ADIPOSE-TISSUE; PGC-1-ALPHA; METABOLISM; CHAIN; BIOGENESIS; RESISTANCE	Aging, obesity, and insulin resistance are associated with low levels of PGC1 alpha and PGC1 beta coactivators and defective mitochondrial function. We studied mice deficient for PGC1 alpha and PGC1 beta [double heterozygous (DH)] to investigate their combined pathogenic contribution. Contrary to our hypothesis, DH mice were leaner, had increased energy dissipation, a pro-thermogenic profile in BAT and WAT, and improved carbohydrate metabolism compared to wild types. WAT showed upregulation of mitochondriogenesis/oxphos machinery upon allelic compensation of PGC1 alpha 4 from the remaining allele. However, DH mice had decreased mitochondrial OXPHOS and biogenesis transcriptomes in mitochondria-rich organs. Despite being metabolically healthy, mitochondrial defects in DH mice impaired muscle fiber remodeling and caused qualitative changes in the hepatic lipidome. Our data evidence first the existence of organ-specific compensatory allostatic mechanisms are robust enough to drive an unexpected phenotype. Second, optimization of adipose tissue bioenergetics is sufficient to maintain a healthy metabolic phenotype despite a broad severe mitochondrial dysfunction in other relevant metabolic organs. Third, the decrease in PGC1s in adipose tissue of obese and diabetic patients is in contrast with the robustness of the compensatory upregulation in the adipose of the DH mice.	[Rodriguez-Cuenca, Sergio; Campbell, Mark; Ingvorsen, Camilla; Dias, Ana Rita; Vidal-Puig, Antonio] Univ Cambridge, Wellcome MRC Inst Metab Sci, Cambridge, England; [Lelliot, Christopher J.; Bjursell, Mikael; Bohlooly-Y, Mohammad] AstraZeneca, BioPharmaceut R&D, Discovery Sci, Gothenburg, Sweden; [Peddinti, Gopal] Tech Res Ctr Finland, VTT, Espoo, Finland; [Martinez-Una, Maite] Univ Basque Country, Dept Physiol, UPV EHU, Bilbao, Spain; [Relat, Joana] Univ Barcelona UB, Sch Pharm & Food Sci, Dept Nutr Food Sci & Gastron, Food & Nutr Torribera Campus, Santa Coloma De Gramenet, Spain; [Relat, Joana] Univ Barcelona, Nutr & Food Safety Res Inst, INSA UB, Barcelona, Spain; [Mora, Silvia] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool, Merseyside, England; [Hyotylainen, Tuulia; Oresic, Matej] Orebro Univ, Sch Sci & Technol, Orebro, Sweden; [Zorzano, Antonio] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Zorzano, Antonio] Univ Barcelona, Dept Biochem & Mol Biomed, Barcelona, Spain; [Zorzano, Antonio] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Oresic, Matej] Univ Turku, Turku Biosci Ctr, Turku, Finland; [Oresic, Matej] Abo Akad Univ, Turku, Finland; [Linden, Daniel] AstraZeneca, BioPharmaceut R&D, Res & Early Dev Cardiovasc Renal & Metab, Gothenburg, Sweden; [Linden, Daniel] Univ Gothenburg, Sahlgrenska Acad, Dept Neurosci & Physiol, Div Endocrinol, Gothenburg, Sweden; [Vidal-Puig, Antonio] Wellcome Trust Res Labs, Sanger Inst, Genome Campus, Hinxton, England	University of Cambridge; AstraZeneca; VTT Technical Research Center Finland; University of Basque Country; University of Barcelona; University of Liverpool; Orebro University; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; University of Turku; Abo Akademi University; AstraZeneca; University of Gothenburg; Wellcome Trust Sanger Institute	Rodriguez-Cuenca, S (corresponding author), Univ Cambridge, Wellcome MRC Inst Metab Sci, Cambridge, England.; Linden, D (corresponding author), AstraZeneca, BioPharmaceut R&D, Res & Early Dev Cardiovasc Renal & Metab, Gothenburg, Sweden.	sr441@medschl.cam.ac.uk; daniel.linden@astrazeneca.com	; Relat, Joana/I-5473-2015	Mora, Silvia/0000-0002-8473-1497; Oresic, Matej/0000-0002-2856-9165; Relat, Joana/0000-0001-8974-1785	EC | FP7 | FP7 Health (HEALTH) [HEALTH-F4-2008-223450]; RCUK | Medical Research Council (MRC) [MC_UU_12012/2, MC_UU_00014/5]; European Commission (EC) [MEIF-CT-2005-023061]; Wellcome Trust [208363/Z/17/Z]	EC | FP7 | FP7 Health (HEALTH); RCUK | Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission)	EC | FP7 | FP7 Health (HEALTH), Grant/Award Number: [HEALTH-F4-2008-223450; RCUK | Medical Research Council (MRC), Grant/Award Number: MC_UU_12012/2 and MC_UU_00014/5; European Commission (EC), Grant/ Award Number: MEIF-CT-2005-023061; Wellcome Trust (Wellcome), Grant/Award Number: 208363/Z/17/Z	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arendt BM, 2013, APPL PHYSIOL NUTR ME, V38, P334, DOI 10.1139/apnm-2012-0261; Baker CD, 2016, MOL BIOL CELL, V27, P2161, DOI 10.1091/mbc.E15-12-0865; Barbato DL, 2015, AGING-US, V7, P869, DOI 10.18632/aging.100832; Besse-Patin A, 2017, GASTROENTEROLOGY, V152, P243, DOI 10.1053/j.gastro.2016.09.017; Bombassaro B, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0740-6; Breit SN, 2021, ANNU REV PHYSIOL, V83, P127, DOI 10.1146/annurev-physiol-022020-045449; D'Errico I, 2011, P NATL ACAD SCI USA, V108, P6603, DOI 10.1073/pnas.1016354108; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Fan WW, 2018, CELL REP, V22, P2521, DOI 10.1016/j.celrep.2018.02.047; Heinonen S, 2017, DIABETOLOGIA, V60, P169, DOI 10.1007/s00125-016-4121-2; Heinonen S, 2015, DIABETES, V64, P3135, DOI 10.2337/db14-1937; Hernandez-Alvarez MI, 2010, DIABETES CARE, V33, P645, DOI 10.2337/dc09-1305; Kelstrup L, 2016, DIABETES, V65, P2900, DOI 10.2337/db16-0227; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lelliott CJ, 2007, ARTERIOSCL THROM VAS, V27, P2707, DOI 10.1161/ATVBAHA.107.155739; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889; Liu J, 2009, ARTERIOSCL THROM VAS, V29, P850, DOI 10.1161/ATVBAHA.109.185223; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Martinez-Redondo V, 2016, J BIOL CHEM, V291, P15169, DOI 10.1074/jbc.M115.705822; Martinez-Redondo V, 2015, DIABETOLOGIA, V58, P1969, DOI 10.1007/s00125-015-3671-z; Masand R, 2018, CELL METAB, V27, P616, DOI 10.1016/j.cmet.2018.01.018; Medina-Gomez G, 2009, DIS MODEL MECH, V2, P582, DOI 10.1242/dmm.003251; Mensink M, 2007, INT J OBESITY, V31, P1302, DOI 10.1038/sj.ijo.0803567; Molenaar MR, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz061; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moreno-Santos I, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0999-1; Nakatsuka A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21721; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pellegrinelli V, 2015, DIABETES, V64, P3121, DOI 10.2337/db14-0796; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Rodriguez-Cuenca S, 2018, DIABETES OBES METAB, V20, P2339, DOI 10.1111/dom.13370; Rowe GC, 2013, CELL REP, V3, P1449, DOI 10.1016/j.celrep.2013.04.023; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Sczelecki S, 2014, AM J PHYSIOL-ENDOC M, V306, pE157, DOI 10.1152/ajpendo.00578.2013; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; van der Veen JN, 2014, DIABETES, V63, P2620, DOI 10.2337/db13-0993; Vandenbeek R, 2018, ENDOCRINOLOGY, V159, P853, DOI 10.1210/en.2017-00872; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; Villegas R, 2014, ANN HUM GENET, V78, P23, DOI 10.1111/ahg.12044; Virtue S, 2012, DIABETES, V61, P3139, DOI 10.2337/db12-0015; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029; Xia WN, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/2970401; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; Zhai N, 2015, ENDOCR J, V62, P633, DOI 10.1507/endocrj.EJ14-0383	51	2	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21752	10.1096/fj.202100262RR	http://dx.doi.org/10.1096/fj.202100262RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34369602	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000691122900067
J	Zafar, A; Ng, HP; Diamond-Zaluski, R; Kim, GD; Chan, ER; Dunwoodie, SL; Smith, JD; Mahabeleshwar, GH				Zafar, Atif; Ng, Hang Pong; Diamond-Zaluski, Rachel; Kim, Gun-Dong; Chan, Ernest Ricky; Dunwoodie, Sally L.; Smith, Jonathan D.; Mahabeleshwar, Ganapati H.			CITED2 inhibits STAT1-IRF1 signaling and atherogenesis	FASEB JOURNAL			English	Article						atherosclerosis; gene regulation; inflammation; macrophage; signal transduction	BINDING-PROTEIN; ATHEROSCLEROSIS; MACROPHAGES; RECEPTORS; GENE; TRANSACTIVATION; ACTIVATION; EXPRESSION; DEFICIENT; CBP/P300	Macrophages are the principal component of the innate immune system. They play very crucial and multifaceted roles in the pathogenesis of inflammatory vascular diseases. There is an increasing recognition that transcriptionally dynamic macrophages are the key players in the pathogenesis of inflammatory vascular diseases. In this context, the accumulation and aberrant activation of macrophages in the subendothelial layers govern atherosclerotic plaque development. Macrophage-mediated inflammation is an explicitly robust biological response that involves broad alterations in inflammatory gene expression. Thus, cell-intrinsic negative regulatory mechanisms must exist which can restrain inflammatory response in a spatiotemporal manner. In this study, we identified CBP/p300-interacting transactivator with glutamic acid/aspartic acid-rich carboxyl-terminal domain 2 (CITED2) as one such cell-intrinsic negative regulator of inflammation. Our in vivo studies show that myeloid-CITED2-deficient mice on the Apoe(-/-) background have larger atherosclerotic lesions on both control and high-fat/high-cholesterol diets. Our integrated transcriptomics and gene set enrichment analyses studies show that CITED2 deficiency elevates STAT1 and interferon regulatory factor 1 (IRF1) regulated pro-inflammatory gene expression in macrophages. At the molecular level, our studies identify that CITED2 deficiency elevates IFN gamma-induced STAT1 transcriptional activity and STAT1 enrichment on IRF1 promoter in macrophages. More importantly, siRNA-mediated knockdown of IRF1 completely reversed elevated pro-inflammatory target gene expression in CITED2-deficient macrophages. Collectively, our study findings demonstrate that CITED2 restrains the STAT1-IRF1 signaling axis in macrophages and limits the development of atherosclerotic plaques.	[Zafar, Atif; Ng, Hang Pong; Diamond-Zaluski, Rachel; Kim, Gun-Dong; Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Sch Med, Dept Pathol, 2103 Cornell Rd,Room WRB5527, Cleveland, OH 44106 USA; [Chan, Ernest Ricky] Case Western Reserve Univ, Sch Med, Cleveland Inst Computat Biol, Cleveland, OH 44106 USA; [Dunwoodie, Sally L.] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; [Dunwoodie, Sally L.] UNSW Sydney, Fac Med & Sci, Sydney, NSW, Australia; [Smith, Jonathan D.] Cleveland Clin, Dept Cardiovasc & Metab Sci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; Cleveland Clinic Foundation	Mahabeleshwar, GH (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, 2103 Cornell Rd,Room WRB5527, Cleveland, OH 44106 USA.	ghm4@case.edu			HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [HL126626, HL141423]; Crohn's and Colitis Foundation (Crohn's & Colitis Foundation) [421904]; Department of Health \ National Health and Medical Research Council (NHMRC) [ID1135886]	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); Crohn's and Colitis Foundation (Crohn's & Colitis Foundation); Department of Health \ National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL126626 and HL141423; Crohn's and Colitis Foundation (Crohn's & Colitis Foundation), Grant/Award Number: 421904; Department of Health vertical bar National Health and Medical Research Council (NHMRC), Grant/Award Number: ID1135886	Agrawal S, 2007, CIRCULATION, V115, P2939, DOI 10.1161/CIRCULATIONAHA.107.696922; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boshuizen MCS, 2015, ARTERIOSCL THROM VAS, V35, P1579, DOI 10.1161/ATVBAHA.115.305464; Chmielewski S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113318; Chou YT, 2012, CELL DEATH DIFFER, V19, P2015, DOI 10.1038/cdd.2012.91; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; Du JW, 2012, BLOOD, V119, P2789, DOI 10.1182/blood-2011-10-387902; Du M, 2019, THERANOSTICS, V9, P4688, DOI 10.7150/thno.36862; Dunwoodie SL, 1998, MECH DEVELOP, V72, P27, DOI 10.1016/S0925-4773(98)00011-2; Fitzgerald KA, 2020, CELL, V180, P1044, DOI 10.1016/j.cell.2020.02.041; Ng HP, 2020, FASEB J, V34, P12100, DOI 10.1096/fj.202000864R; Hopkins PN, 2013, PHYSIOL REV, V93, P1317, DOI 10.1152/physrev.00004.2012; Kim GD, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00452-17; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Langlais D, 2016, J EXP MED, V213, P585, DOI 10.1084/jem.20151764; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Lau WM, 2013, BIOCHEM BIOPH RES CO, V437, P261, DOI 10.1016/j.bbrc.2013.06.063; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Molawi K, 2013, ADV IMMUNOL, V120, P269, DOI 10.1016/B978-0-12-417028-5.00010-7; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Pedraza-Alva G, 2015, IMMUNOL REV, V265, P231, DOI 10.1111/imr.12294; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; Qu X, 2007, EMBO J, V26, P4445, DOI 10.1038/sj.emboj.7601883; Semper C, 2014, MOL CELL BIOL, V34, P2235, DOI 10.1128/MCB.00295-14; Sikorski Krzysztof, 2012, JAKSTAT, V1, P241, DOI 10.4161/jkst.22469; Sperling S, 2005, HUM MUTAT, V26, P575, DOI 10.1002/humu.20262; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun HB, 1998, P NATL ACAD SCI USA, V95, P13555, DOI 10.1073/pnas.95.23.13555; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Weninger WJ, 2005, DEVELOPMENT, V132, P1337, DOI 10.1242/dev.01696; Whitman SC, 2000, AM J PATHOL, V157, P1819, DOI 10.1016/S0002-9440(10)64820-1; Whitman SC, 2002, J INTERF CYTOK RES, V22, P661, DOI 10.1089/10799900260100141; Withington SL, 2006, DEV BIOL, V294, P67, DOI 10.1016/j.ydbio.2006.02.025; Wojciak JM, 2009, EMBO J, V28, P948, DOI 10.1038/emboj.2009.30; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092	39	0	0	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21833	10.1096/fj.202100792R	http://dx.doi.org/10.1096/fj.202100792R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34365659	Green Accepted			2022-12-28	WOS:000691122900061
J	Zhang, XL; Hasan, AA; Wu, HW; Gaballa, MMS; Zeng, SM; Liu, LP; Xie, L; Jung, T; Grune, T; Kramer, BK; Kleuser, B; Li, J; Hocher, B				Zhang, Xiaoli; Hasan, Ahmed A.; Wu, Hongwei; Gaballa, Mohamed M. S.; Zeng, Suimin; Liu, Liping; Xie, Li; Jung, Tobias; Grune, Tilman; Kramer, Bernhard K.; Kleuser, Burkhard; Li, Jian; Hocher, Berthold			High-fat, sucrose and salt-rich diet during rat spermatogenesis lead to the development of chronic kidney disease in the female offspring of the F2 generation	FASEB JOURNAL			English	Article						epigenetics; high-fat-sucrose-salt diet; kidney function; paternal programming	METABOLISM; IMMUNORECEPTOR; RESTRICTION; EXPOSURE; IMPROVE; OBESITY; HEALTH; INJURY; CD300F	Effects of feeding male rats during spermatogenesis a high-fat, high-sucrose and high-salt diet (HFSSD) over two generations (F0 and F1) on renal outcomes are unknown. Male F0 and F1 rats were fed either control diet (F0CD+F1CD) or HFSSD (F0HD+F1HD). The outcomes were glomerular filtration rate and urinary albumin excretion in F1 and F2 offspring. If both outcomes were altered a morphological and molecular assessment was done. F2 offspring of both sexes had a decreased GFR. However, increased urinary albumin excretion was only observed in female F2 F0HD+F1HD offspring compared with controls. F0HD+F1HD female F2 offspring developed glomerulosclerosis (+31%; p < .01) and increased renal interstitial fibrosis (+52%; p < .05). RNA sequencing followed by qRT-PCR validation showed that four genes (Enpp6, Tmem144, Cd300lf, and Actr3b) were differentially regulated in the kidneys of female F2 offspring. lncRNA XR-146683.1 expression decreased in female F0HD+F1HD F2 offspring and its expression was (r = 0.44, p = .027) correlated with the expression of Tmem144. Methylation of CpG islands in the promoter region of the Cd300lf gene was increased (p = .001) in female F2 F0HD+F1HD offspring compared to controls. Promoter CpG island methylation rate of Cd300lf was inversely correlated with Cd300lf mRNA expression in F2 female offspring (r = -0.483, p = .012). Cd300lf mRNA expression was inversely correlated with the urinary albumin-to-creatinine ratio in female F2 offspring (r = -0.588, p = .005). Paternal pre-conceptional unhealthy diet given for two generations predispose female F2 offspring to chronic kidney disease due to epigenetic alterations of renal gene expression. Particularly, Cd300lf gene promotor methylation was inversely associated with Cd300lf mRNA expression and Cd300lf mRNA expression itself was inversely associated with urinary albumin excretion in F2 female offspring whose fathers and grandfathers got a pre-conceptional unhealthy diet.	[Zhang, Xiaoli; Liu, Liping; Xie, Li; Li, Jian; Hocher, Berthold] Hunan Normal Univ, Sch Med, Key Lab Study & Discovery Small Targeted Mol Huna, Changsha 410013, Peoples R China; [Zhang, Xiaoli; Hasan, Ahmed A.; Kleuser, Burkhard] Free Univ Berlin, Inst Pharm, Berlin, Germany; [Zhang, Xiaoli; Hasan, Ahmed A.; Wu, Hongwei; Gaballa, Mohamed M. S.; Kramer, Bernhard K.; Hocher, Berthold] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Med Nephrol Endocrinol Rheumatol 5, Heidelberg, Germany; [Wu, Hongwei] Jinan Univ, Dept Nephrol, Affiliated Hosp 1, Guangzhou, Peoples R China; [Gaballa, Mohamed M. S.] Benha Univ, Fac Vet Med, Toukh, Egypt; [Zeng, Suimin] First Hosp Tradit Chinese Med, Yiyang, Peoples R China; [Jung, Tobias; Grune, Tilman] German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Mol Toxicol, Nuthetal, Germany; [Grune, Tilman] Univ Vienna, Fac Chem, Dept Physiol Chem, Vienna, Austria; [Hocher, Berthold] Reprod & Genet Hosp Cit Xiangya, Changsha, Peoples R China; [Hocher, Berthold] IMD Berlin, Inst Med Diagnost, Berlin, Germany	Hunan Normal University; Free University of Berlin; Ruprecht Karls University Heidelberg; Jinan University; Egyptian Knowledge Bank (EKB); Benha University; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Vienna	Li, J; Hocher, B (corresponding author), Hunan Normal Univ, Sch Med, Key Lab Study & Discovery Small Targeted Mol Huna, Changsha 410013, Peoples R China.	angela13656355@qq.com; berthold.hocher@medma.uni-heidelberg.de	Hasan, Ahmed A./AAR-5857-2020	Hasan, Ahmed A./0000-0002-0382-4916; Gaballa, Mohamed/0000-0003-2949-430X	National Natural Science Foundation of China [81873861]; Hunan Province Natural Science Foundation [2018JJ3366]; Huxiang Young Talents project [2021RC3094]; Hunan Province Science and Technology Plan [2014SK3003]; Deutsche Akademische Ausstasch Dienst (DAAD); Deutsche Forschungsgemeinschaft; China Scholarship Council (CSC); BMBF	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Province Natural Science Foundation(Natural Science Foundation of Hunan Province); Huxiang Young Talents project; Hunan Province Science and Technology Plan; Deutsche Akademische Ausstasch Dienst (DAAD); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); China Scholarship Council (CSC)(China Scholarship Council); BMBF(Federal Ministry of Education & Research (BMBF))	National Natural Science Foundation of China, Grant/Award Number: 81873861; Hunan Province Natural Science Foundation, Grant/Award Number: 2018JJ3366; Huxiang Young Talents project, Grant/Award Number: 2021RC3094; Hunan Province Science and Technology Plan, Grant/Award Number: 2014SK3003; Deutsche Akademische Ausstasch Dienst (DAAD); Deutsche Forschungsgemeinschaft; China Scholarship Council (CSC) grant to the first author Xiaoli Zhang; BMBF	Alvarez-Errico D, 2004, EUR J IMMUNOL, V34, P3690, DOI 10.1002/eji.200425433; Barbosa TD, 2019, FASEB J, V33, P6269, DOI 10.1096/fj.201801879RR; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chen Q, 2016, SCIENCE, V351, P397, DOI 10.1126/science.aad7977; Chen YX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046512, 10.1371/journal.pone.0036329, 10.1371/journal.pone.0030437]; Chowdhury SS, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090521; Dwivedi RS, 2011, KIDNEY INT, V79, P23, DOI 10.1038/ki.2010.335; Fullston T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166076; Graziano VR, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008242; Hur SSJ, 2017, J MOL ENDOCRINOL, V58, pR159, DOI 10.1530/JME-16-0236; Jackson CM, 2012, AM J PHYSIOL-RENAL, V302, pF774, DOI 10.1152/ajprenal.00491.2011; Kataoka S, 2018, J NUTR BIOCHEM, V56, P99, DOI 10.1016/j.jnutbio.2018.01.012; Keswani T, 2020, GENES IMMUN, V21, P45, DOI 10.1038/s41435-019-0085-9; Krause BJ, 2021, J CELL PHYSIOL, V236, P7984, DOI 10.1002/jcp.30470; Lago N, 2020, P NATL ACAD SCI USA, V117, P6651, DOI 10.1073/pnas.1911816117; Lane RH, 2014, CLIN PERINATOL, V41, P815, DOI 10.1016/j.clp.2014.08.006; Lecomte V, 2013, BIOESSAYS, V35, P787, DOI 10.1002/bies.201300051; Lee YQ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020241; Li J, 2016, J HYPERTENS, V34, P2111, DOI 10.1097/HJH.0000000000001051; Masuyama H, 2016, AM J PHYSIOL-ENDOC M, V311, pE236, DOI 10.1152/ajpendo.00095.2016; McGee M, 2018, NUTR REV, V76, P469, DOI 10.1093/nutrit/nuy006; McPherson NO, 2014, ANN NUTR METAB, V64, P231, DOI 10.1159/000365026; Morgan HL, 2020, J PHYSIOL-LONDON, V598, P699, DOI 10.1113/JP278270; Moritz KM, 2003, BIOESSAYS, V25, P212, DOI 10.1002/bies.10240; Nembhard WN, 2018, AM J MED GENET A, V176, P609, DOI 10.1002/ajmg.a.38611; Ng SF, 2014, FASEB J, V28, P1830, DOI 10.1096/fj.13-244046; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Ornellas F, 2017, J PEDIAT-BRAZIL, V93, P551, DOI 10.1016/j.jped.2017.02.004; Oshio LT, 2020, J DEV ORIG HLTH DIS, V11, P653, DOI 10.1017/S2040174419000904; Peluffo H, 2012, BRAIN PATHOL, V22, P318, DOI 10.1111/j.1750-3639.2011.00537.x; Petropoulos S, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115899; Putra SED, 2017, J HYPERTENS, V35, P2276, DOI 10.1097/HJH.0000000000001450; Reichetzeder C, 2016, CELL PHYSIOL BIOCHEM, V39, P919, DOI 10.1159/000447801; Sharkey D, 2009, AM J PHYSIOL-RENAL, V297, pF1199, DOI 10.1152/ajprenal.00303.2009; Soubry A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-29; Tian M, 2019, J HYPERTENS, V37, P2123, DOI 10.1097/HJH.0000000000002156; Tozour J, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10101359; Wood-Bradley RJ, 2015, NUTRIENTS, V7, P1881, DOI 10.3390/nu7031881; Wu L, 2016, CELL METAB, V23, P735, DOI 10.1016/j.cmet.2016.01.014; Zhang XL, 2019, KIDNEY BLOOD PRESS R, V44, P133, DOI 10.1159/000497487	41	2	2	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22259	10.1096/fj.202101789RR	http://dx.doi.org/10.1096/fj.202101789RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CL	35294083	hybrid, Green Published			2022-12-28	WOS:000772944900001
J	Zhou, L; Li, HR; Sun, SW; Zhang, TQ; Yu, YM; Xu, L; Wang, MH				Zhou, Lei; Li, Haoran; Sun, Shiwei; Zhang, Tieqi; Yu, Yueming; Xu, Liang; Wang, Minghai			Thrap3 promotes osteogenesis by inhibiting the degradation of Runx2	FASEB JOURNAL			English	Article						osteogenesis; Runx2; Sox9; Thrap3	CHONDROCYTE DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; NUCLEAR RECEPTORS; CBFA1; INTERACTS; COMPONENT; COMPLEX; TRAP; SOX9	The dysfunction of osteogenesis is a key character in the pathogenesis of osteoporosis, but the network of signaling mechanisms in controlling the differentiation of osteoblast remain unclear. Thrap3 has been proved participating in various biological process, especially in the differentiation of stem cells. Here, we demonstrate that Thrap3 could promote osteogenesis through the inhibition of the degradation of Runx2, which is a key molecular structure in early osteoblast differentiation. Furthermore, we found that the osteogenesis enhancing capacity of Thrap3 was caused by physically binding with Sox9, inhibiting the transcriptional activity of Sox9, and then decreasing the decomposition-promoted effect of Sox9 on Runx2. Our data shows that Thrap3 promotes osteoblast differentiation through the Thrap3-Sox9-Runx2 axis. What we found may help for further clarifying the molecular mechanism of osteogenic differentiation and give a new potential therapeutic target for osteoporosis.	[Zhou, Lei; Li, Haoran; Sun, Shiwei; Zhang, Tieqi; Yu, Yueming; Xu, Liang; Wang, Minghai] Fudan Univ, Shanghai Peoples Hosp 5, Dept Orthoped, 801 Heqing Rd, Shanghai, Peoples R China; [Zhou, Lei] Fudan Univ, Zhongshan Hosp, Dept Orthoped Surg, Shanghai, Peoples R China	Fudan University; Fudan University	Zhang, TQ; Wang, MH (corresponding author), Fudan Univ, Shanghai Peoples Hosp 5, Dept Orthoped, 801 Heqing Rd, Shanghai, Peoples R China.	13681914915@163.com; wangminghai@5thhospital.com			Key Department of Minhang District [2020MWTZB03]; Key Deparment of the Fifth People's Hospital of Shanghai [2020WYZDZK03]; Fifth People's Hosptal of Shanghai, Fudan University [2018WYZT01, N123E5]; Natural Science Foundation of Minhang District of Shanghai [2019MHZ013]; Minhang District Leading Talent Development Funds	Key Department of Minhang District; Key Deparment of the Fifth People's Hospital of Shanghai; Fifth People's Hosptal of Shanghai, Fudan University; Natural Science Foundation of Minhang District of Shanghai; Minhang District Leading Talent Development Funds	The Key Department of Minhang District, Grant/Award Number: 2020MWTZB03; The Key Deparment of the Fifth People's Hospital of Shanghai, Grant/Award Number: 2020WYZDZK03; The Fifth People's Hosptal of Shanghai, Fudan University, Grant/Award Number: 2018WYZT01 and N123E5; The Natural Science Foundation of Minhang District of Shanghai, Grant/Award Number: 2019MHZ013; The Minhang District Leading Talent Development Funds	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Cairns DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039642; Cheng AX, 2010, J BONE MINER RES, V25, P2404, DOI 10.1002/jbmr.174; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Delitala AP, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041034; ERIKSEN EF, 1985, BONE, V6, P421, DOI 10.1016/8756-3282(85)90218-2; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Guerit D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062582; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Ino Y, 2016, PROTEOMICS, V16, P1069, DOI 10.1002/pmic.201500365; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Ito M, 2002, EMBO J, V21, P3464, DOI 10.1093/emboj/cdf348; Katano-Toki A, 2013, MOL ENDOCRINOL, V27, P769, DOI 10.1210/me.2012-1332; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lee WC, 2017, ENDOCR REV, V38, P255, DOI 10.1210/er.2017-00064; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Sanghani-Kerai A, 2018, CURR STEM CELL RES T, V13, P369, DOI 10.2174/1574888X13666180410160511; Sono T, 2018, J BONE MINER METAB, V36, P410, DOI 10.1007/s00774-017-0855-2; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zaidi Mone, 2009, Curr Osteoporos Rep, V7, P47	24	1	1	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22231	10.1096/fj.202101706R	http://dx.doi.org/10.1096/fj.202101706R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35230719				2022-12-28	WOS:000772957100009
J	Shimizu, T; Saito, T; Aoki-Saito, H; Okada, S; Ikeda, H; Nakakura, T; Fukuda, H; Arai, S; Fujiwara, K; Nakajima, Y; Horiguchi, K; Yamada, S; Ishida, E; Hisada, T; Shuto, S; Yamada, M				Shimizu, Tomohiko; Saito, Tsugumichi; Aoki-Saito, Haruka; Okada, Shuichi; Ikeda, Hiroyuki; Nakakura, Takashi; Fukuda, Hayato; Arai, Syota; Fujiwara, Kouichi; Nakajima, Yasuyo; Horiguchi, Kazuhiro; Yamada, Sayaka; Ishida, Emi; Hisada, Takeshi; Shuto, Satoshi; Yamada, Masanobu			Resolvin E3 ameliorates high-fat diet-induced insulin resistance via the phosphatidylinositol-3-kinase/Akt signaling pathway in adipocytes	FASEB JOURNAL			English	Article						eicosapentaenoic acid; insulin resistance; omega-3 fatty acids; PI3K; Akt pathway; Resolvin E3	DIABETES-MELLITUS; LIPID MEDIATOR; INFLAMMATION; E1; OMEGA-3-FATTY-ACIDS; EXPRESSION; OBESITY; IDENTIFICATION; ABSORPTION; RESOLUTION	Obesity-associated type 2 diabetes mellitus is associated with the development of insulin resistance. Among several metabolites, resolvins that are metabolites of eicosapentaenoic acid have been shown to exert insulin-sensitizing effects; however, the role of resolvin E3 (RvE3) in glucose metabolism has not been studied. In this study, the effect of RvE3 on glucose metabolism in mice with high-fat diet-induced obesity and 3T3L1 adipocytes was studied. C57BL/6 mice fed a high-fat diet were administered RvE3, for which insulin tolerance, oral glucose tolerance tests, and the homeostasis model assessment of insulin resistance, were performed. RvE3 treatment significantly improved insulin sensitivity and glucose tolerance and regulated protein kinase B (Akt) phosphorylation in the adipose tissue. Moreover, RvE3 treatment enhanced the insulin-stimulated glucose transporter 4 (Glut4) translocation, glucose uptake, phosphatidylinositol-3-kinase (PI3K) activity, and Akt phosphorylation in 3T3L1 adipocytes, whereas a PI3K inhibitor inhibited the enhanced insulin-stimulated glucose uptake induced by RvE3. These findings indicate that RvE3 likely improves insulin sensitivity, resulting in the upregulation of glucose uptake in adipocytes by activating the PI3K/Akt signaling pathways. Collectively, the findings of this study show that RvE3 may play a role in glucose homeostasis and could be used as a potential therapeutic target for developing treatments for obesity-associated diabetes.	[Shimizu, Tomohiko; Saito, Tsugumichi; Okada, Shuichi; Nakajima, Yasuyo; Horiguchi, Kazuhiro; Yamada, Sayaka; Ishida, Emi; Yamada, Masanobu] Gunma Univ, Dept Internal Med, Div Endocrinol & Metab, Grad Sch Med, Maebashi, Gumma 3718511, Japan; [Saito, Tsugumichi] Gunma Univ, Ctr Med Educ, Grad Sch Med, Maebashi, Gumma, Japan; [Aoki-Saito, Haruka] Gunma Univ, Grad Sch Med, Dept Resp Med, Maebashi, Gumma, Japan; [Aoki-Saito, Haruka] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gumma, Japan; [Ikeda, Hiroyuki; Arai, Syota; Fujiwara, Kouichi; Shuto, Satoshi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan; [Nakakura, Takashi] Teikyo Univ, Dept Anat, Tokyo, Japan; [Fukuda, Hayato] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan; [Hisada, Takeshi] Gunma Univ, Grad Sch Hlth Sci, Maebashi, Gumma, Japan	Gunma University; Gunma University; Gunma University; Gunma University; Hokkaido University; Teikyo University; Nagasaki University; Gunma University	Saito, T (corresponding author), Gunma Univ, Dept Internal Med, Div Endocrinol & Metab, Grad Sch Med, Maebashi, Gumma 3718511, Japan.	saitotsu@gunma-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25860087, 16K01812, 19K08993, 18K08404, 17K08360, 15H02495, 19H0101409]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 25860087, 16K01812, 19K08993, 18K08404, 17K08360, 15H02495 and 19H0101409	Altaf QA, 2015, DIABETES OBES METAB, V17, P319, DOI 10.1111/dom.12400; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Chen L, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/508409; Ezaki O, 1997, BIOCHEM BIOPH RES CO, V241, P1, DOI 10.1006/bbrc.1997.7587; Freire MO, 2017, J IMMUNOL, V198, P718, DOI 10.4049/jimmunol.1601543; Fukuda H, 2020, J ORG CHEM, V85, P14190, DOI 10.1021/acs.joc.0c01701; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Hameed I, 2015, WORLD J DIABETES, V6, P598, DOI 10.4239/wjd.v6.i4.598; Hellmann J, 2011, FASEB J, V25, P2399, DOI 10.1096/fj.10-178657; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Ishimura K, 2021, ACS MED CHEM LETT, V12, P256, DOI 10.1021/acsmedchemlett.0c00639; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Kalupahana NS, 2011, ADV NUTR, V2, P304, DOI 10.3945/an.111.000505; Lombardo YB, 2006, J NUTR BIOCHEM, V17, P1, DOI 10.1016/j.jnutbio.2005.08.002; Lontchi-Yimagou E, 2013, CURR DIABETES REP, V13, P435, DOI 10.1007/s11892-013-0375-y; Martinez-Fernandez L, 2015, PROSTAG OTH LIPID M, V121, P24, DOI 10.1016/j.prostaglandins.2015.07.003; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Nagy C, 2018, JOVE-J VIS EXP, DOI 10.3791/56672; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pal A, 2020, FASEB J, V34, P10640, DOI 10.1096/fj.202000830R; Perez-Matute P, 2005, AM J PHYSIOL-REG I, V288, pR1682, DOI 10.1152/ajpregu.00727.2004; Remesar X, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207729; Sato M, 2019, FASEB J, V33, P12750, DOI 10.1096/fj.201900283R; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Sima C, 2018, CRIT REV IMMUNOL, V38, P343, DOI 10.1615/CritRevImmunol.2018026750; Sima C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13185-7; Simons PJ, 2007, J ENDOCRINOL, V192, P289, DOI 10.1677/JOE-06-0047; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; SUN XJ, 1992, J BIOL CHEM, V267, P22662; THOMSON ABR, 1989, CAN J PHYSIOL PHARM, V67, P179, DOI 10.1139/y89-031; THOMSON ABR, 1989, LIPIDS, V24, P494, DOI 10.1007/BF02535128; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; WHITE MF, 1994, J BIOL CHEM, V269, P1; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	39	6	5	4	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22188	10.1096/fj.202100053R	http://dx.doi.org/10.1096/fj.202100053R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35129868				2022-12-28	WOS:000761250800026
J	Xu, LB; Lin, XY; Li, XL; Hu, ZY; Hou, QL; Wang, Y; Wang, ZH				Xu, Lianbin; Lin, Xueyan; Li, Xiuli; Hu, Zhiyong; Hou, Qiuling; Wang, Yun; Wang, Zhonghua			Integration of transcriptomics and metabolomics provides metabolic and functional insights into reduced insulin secretion in MIN6 beta-cells exposed to deficient and excessive arginine	FASEB JOURNAL			English	Article						arginine availability; functional integrity; glucose-stimulated insulin secretion; insulin release; metabolomics; MIN6 beta-cell; transcriptomics	NITRIC-OXIDE PATHWAY; CATIONIC AMINO-ACID; NUTRIENT REGULATION; FATTY-ACIDS; GLUCOSE; PROLIFERATION; ALANINE	Previous work demonstrated that arginine is one of the strongest insulin secretagogues. However, knowledge of the mechanisms linking chronic arginine metabolism with beta-cell function and insulin secretion is relatively limited. After preliminary selection of concentration according to the cell proliferation, the MIN6 pancreatic beta-cells were randomly assigned to culture in 0.04 mM (low-arginine, LA), 0.4 mM (standard-arginine, SA), or 8 mM arginine (high-arginine, HA) for 24 h. Following the treatment, a combination of transcriptomics and metabolomics, together with a series of molecular biological tests were performed to investigate the responses of beta-cells to varied arginine availability. Our results showed that HA treatment reduced the chronic insulin releases, and LA and HA treatments decreased the glucose-stimulated insulin secretions (GSIS) of beta-cells relative to the SA group (p < .05). Transcriptomics analysis indicated that LA administration significantly inhibited oxidative phosphorylation and ATP metabolic process but promoted DNA repair and mRNA processing in beta-cells, while HA administration affected ammonium ion metabolic process and mRNA export (p < .05). Both LA and HA regulated the expressions of genes involved in DNA replication, cell-cycle phase transition, and response to oxidative stress (p < .05). Protein-protein interaction and transcription factor analyses suggested that Trp53 and Nr4a2 genes may play key roles during arginine stimulation. On the contrary, metabolomics analysis demonstrated that the differentially expressed metabolites (DEM) of MIN6 beta-cells induced by LA were mainly enriched in glycerophospholipid metabolism, linoleic acid metabolism, and purine metabolism, while most DEMs between LA vs. SA comparison belonged to amino acid metabolism. When combined the three groups, co-expression analysis suggested that insulin secretions had strong associations with L-pyroglutamic acid, L-glutamate, and creatine concentrations, while intracellular insulin contents were mainly correlated to L-arginine, argininosuccinic acid, and phosphorylcholine. At last, integrated analysis of transcriptomics and metabolomics showed that glycerophospholipid metabolism, biosynthesis of unsaturated fatty acids, and amino acid metabolism were the most relevant pathways in beta-cells exposed to abnormal arginine supply. This descriptive bioinformatics analysis suggested that the disturbed carbohydrate, lipid, and amino acid metabolisms, as well as the increased apoptosis and elevated oxidative stress, contributed to the reduced insulin secretion and lower GSIS in beta-cells induced by LA or HA treatments, while some underlying mechanisms need to be further explored.	[Xu, Lianbin; Lin, Xueyan; Hu, Zhiyong; Hou, Qiuling; Wang, Yun; Wang, Zhonghua] Shandong Agr Univ, Coll Anim Sci & Technol, Tai An 271018, Shandong, Peoples R China; [Li, Xiuli] Jiangsu Acad Agr Sci, Inst Anim Immune Engn, Nanjing, Peoples R China	Shandong Agricultural University; Jiangsu Academy of Agricultural Sciences	Wang, ZH (corresponding author), Shandong Agr Univ, Coll Anim Sci & Technol, Tai An 271018, Shandong, Peoples R China.	zhwang@sdau.edu.cn		Xu, Lianbin/0000-0003-1286-3527	Natural Science Foundation of China [31772623]; Modern Agro-industry Technology Research System of China [CARS-36]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern Agro-industry Technology Research System of China	Natural Science Foundation of China, Grant/Award Number: 31772623; Modern Agro-industry Technology Research System of China, Grant/Award Number: CARS-36	Bode-Boger SM, 1999, J INVEST MED, V47, P43; Brennan L, 2002, DIABETES, V51, P1714, DOI 10.2337/diabetes.51.6.1714; Caballano-Infantes E, 2017, WORLD J STEM CELLS, V9, P26, DOI 10.4252/wjsc.v9.i2.26; Calbet JAL, 2002, J NUTR, V132, P2174, DOI 10.1093/jn/132.8.2174; Cho J, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01226-3; Cnop M, 2008, BIOCHEM SOC T, V36, P348, DOI 10.1042/BST0360348; Crow J P, 1995, Curr Top Microbiol Immunol, V196, P57; Diaz-Vivancos P, 2015, FREE RADICAL BIO MED, V89, P1154, DOI 10.1016/j.freeradbiomed.2015.09.023; Dobbins RL, 1998, DIABETES, V47, P1613, DOI 10.2337/diabetes.47.10.1613; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fujiwara T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092168; Gammelsaeter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022960; Greene JM, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-15; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; Hubbi ME, 2015, AM J PHYSIOL-CELL PH, V309, pC775, DOI 10.1152/ajpcell.00279.2015; Jobgen WS, 2006, J NUTR BIOCHEM, V17, P571, DOI 10.1016/j.jnutbio.2005.12.001; Kiely A, 2007, J ENDOCRINOL, V195, P113, DOI 10.1677/JOE-07-0306; Krause MS, 2011, J ENDOCRINOL, V211, P87, DOI 10.1530/JOE-11-0236; Li J, 2004, AM J PHYSIOL-ENDOC M, V287, pE834, DOI 10.1152/ajpendo.00234.2004; Mandl J, 2009, TRENDS ENDOCRIN MET, V20, P194, DOI 10.1016/j.tem.2009.01.003; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Mullooly N, 2014, EXP PHYSIOL, V99, P538, DOI 10.1113/expphysiol.2013.077495; Murakami S, 2015, FREE RADICAL BIO MED, V88, P168, DOI 10.1016/j.freeradbiomed.2015.06.030; Newsholme P, 2007, BIOCHEM SOC T, V35, P1180, DOI 10.1042/BST0351180; Newsholme P, 2014, J ENDOCRINOL, V221, pR105, DOI 10.1530/JOE-13-0616; Newsholme P, 2010, ADV EXP MED BIOL, V654, P91, DOI 10.1007/978-90-481-3271-3_6; Nolan CJ, 2008, TRENDS ENDOCRIN MET, V19, P285, DOI 10.1016/j.tem.2008.07.006; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Ramirez-Zamora S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066823; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Salvucci M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052611; Sener A, 2000, ENDOCRINE, V13, P329, DOI 10.1385/ENDO:13:3:329; Spinas GA, 1999, NEWS PHYSIOL SCI, V14, P49, DOI 10.1152/physiologyonline.1999.14.2.49; Stanley CA, 2009, AM J CLIN NUTR, V90, p862S, DOI 10.3945/ajcn.2009.27462AA; Stefano GB, 2015, ANN TRANSPL, V20, DOI 10.12659/AOT.894289; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vassiliou EK, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-25; Werner A, 2016, EUR J IMMUNOL, V46, P92, DOI 10.1002/eji.201546047	39	1	1	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22206	10.1096/fj.202101723R	http://dx.doi.org/10.1096/fj.202101723R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35199385				2022-12-28	WOS:000761250800047
J	Hou, ZJ; Gangjee, A; Matherly, LH				Hou, Zhanjun; Gangjee, Aleem; Matherly, Larry H.			The evolving biology of the proton-coupled folate transporter: New insights into regulation, structure, and mechanism	FASEB JOURNAL			English	Review						antifolate; major facilitator superfamily; membrane transporter; proton-coupled folate transporter	SUBSTITUTED-CYSTEINE ACCESSIBILITY; OF-FUNCTION MUTATION; CELL LUNG-CANCER; TRANSMEMBRANE DOMAIN; FUNCTIONAL-CHARACTERIZATION; THIENOYL ANTIFOLATE; CRYSTAL-STRUCTURE; HIGH-AFFINITY; GXXXG MOTIF; 6-SUBSTITUTED PYRROLO	The human proton-coupled folate transporter (PCFT; SLC46A1) or hPCFT was identified in 2006 as the principal folate transporter involved in the intestinal absorption of dietary folates. A rare autosomal recessive hereditary folate malabsorption syndrome is attributable to human SLC46A1 variants. The recognition that hPCFT was highly expressed in many tumors stimulated substantial interest in its potential for cytotoxic drug targeting, taking advantage of its high-level transport activity under acidic pH conditions that characterize many tumors and its modest expression in most normal tissues. To better understand the basis for variations in hPCFT levels between tissues including human tumors, studies have examined the transcriptional regulation of hPCFT including the roles of CpG hypermethylation and critical transcription factors and cis elements. Additional focus involved identifying key structural and functional determinants of hPCFT transport that, combined with homology models based on structural homologies to the bacterial transporters GlpT and LacY, have enabled new structural and mechanistic insights. Recently, cryo-electron microscopy structures of chicken PCFT in a substrate-free state and in complex with the antifolate pemetrexed were reported, providing further structural insights into determinants of (anti)folate recognition and the mechanism of pH-regulated (anti)folate transport by PCFT. Like many major facilitator proteins, hPCFT exists as a homo-oligomer, and evidence suggests that homo-oligomerization of hPCFT monomeric proteins may be important for its intracellular trafficking and/or transport function. Better understanding of the structure, function and regulation of hPCFT should facilitate the rational development of new therapeutic strategies for conditions associated with folate deficiency, as well as cancer.	[Hou, Zhanjun; Matherly, Larry H.] Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, 421 East Canfield St, Detroit, MI 48201 USA; [Hou, Zhanjun; Matherly, Larry H.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Gangjee, Aleem] Duquesne Univ, Grad Sch Pharmaceut Sci, Div Med Chem, Pittsburgh, PA 15219 USA; [Matherly, Larry H.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Duquesne University; Wayne State University	Hou, ZJ; Matherly, LH (corresponding author), Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, 421 East Canfield St, Detroit, MI 48201 USA.	houz@karmanos.org; matherly@karmanos.org			NIH/NCI [R01 CA053535, R01 CA250469]; Milton Ring Endowed Chair for Cancer Research; Duquesne University Adrian Van Kaam Chair in Scholarly Excellence	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Milton Ring Endowed Chair for Cancer Research; Duquesne University Adrian Van Kaam Chair in Scholarly Excellence	This work was supported by NIH/NCI grant R01 CA053535 (Z. Hou, L.H. Matherly), R01 CA250469 (L.H. Matherly, A. Gangjee), the Eunice and the Milton Ring Endowed Chair for Cancer Research (L.H. Matherly), and the Duquesne University Adrian Van Kaam Chair in Scholarly Excellence (A. Gangjee)	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Abramson J, 2004, CURR OPIN STRUC BIOL, V14, P413, DOI 10.1016/j.sbi.2004.07.005; Aduri NG, 2018, BIOCHEM BIOPH RES CO, V495, P1738, DOI 10.1016/j.bbrc.2017.12.008; Alam C, 2020, TRENDS PHARMACOL SCI, V41, P349, DOI 10.1016/j.tips.2020.02.004; Aluri S, 2019, J BIOL CHEM, V294, P7245, DOI 10.1074/jbc.RA118.005533; Aluri S, 2018, AM J PHYSIOL-CELL PH, V314, pC289, DOI 10.1152/ajpcell.00215.2017; Aluri S, 2018, BLOOD ADV, V2, P61, DOI 10.1182/bloodadvances.2017012690; Aluri S, 2017, BBA-BIOMEMBRANES, V1859, P2193, DOI 10.1016/j.bbamem.2017.08.006; Arselin G, 2003, EUR J BIOCHEM, V270, P1875, DOI 10.1046/j.1432-1033.2003.03557.x; Atabay B, 2010, PEDIATR HEMAT ONCOL, V27, P614, DOI 10.3109/08880018.2010.481705; Babu M, 2012, NATURE, V489, P585, DOI 10.1038/nature11354; Bailey L. B., 2010, FOLATE HLTH DIS; Borzutzky A, 2009, CLIN IMMUNOL, V133, P287, DOI 10.1016/j.clim.2009.08.006; Braun P, 2012, PROTEOMICS, V12, P1478, DOI 10.1002/pmic.201100563; Caviedes L, 2016, PLACENTA, V38, P24, DOI 10.1016/j.placenta.2015.12.007; Chattopadhyay S, 2007, MOL CANCER THER, V6, P404, DOI 10.1158/1535-7163.MCT-06-0343; Cohen MH, 2010, ONCOLOGIST, V15, P1352, DOI 10.1634/theoncologist.2010-0224; Cohen MH, 2009, ONCOLOGIST, V14, P930, DOI 10.1634/theoncologist.2009-0092; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Counillon L, 2000, J BIOL CHEM, V275, P1, DOI 10.1074/jbc.275.1.1; Dahl NK, 2003, J BIOL CHEM, V278, P44949, DOI 10.1074/jbc.M308660200; Date SS, 2016, FEBS OPEN BIO, V6, P216, DOI 10.1002/2211-5463.12041; Dekhne AS, 2020, MOL PHARMACOL, V97, P9, DOI 10.1124/mol.119.117937; Deng D, 2015, NATURE, V526, P391, DOI 10.1038/nature14655; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Deng YJ, 2009, J MED CHEM, V52, P2940, DOI 10.1021/jm8011323; Desmoulin SK, 2012, CANCER BIOL THER, V13, P1355, DOI 10.4161/cbt.22020; Desmoulin SK, 2012, MOL PHARMACOL, V82, P591, DOI 10.1124/mol.112.079004; Desmoulin SK, 2011, MOL PHARMACOL, V80, P1096, DOI 10.1124/mol.111.073833; Diop-Bove N, 2013, GENE, V527, P673, DOI 10.1016/j.gene.2013.06.039; Diop-Bove NK, 2009, MOL CANCER THER, V8, P2424, DOI 10.1158/1535-7163.MCT-08-0938; Drew D, 2021, CHEM REV, V121, P5289, DOI 10.1021/acs.chemrev.0c00983; Duan Peng, 2011, Int J Biochem Mol Biol, V2, P1; Duddempudi PK, 2013, FEBS J, V280, P2900, DOI 10.1111/febs.12293; Duddempudi PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078301; Eloranta JJ, 2009, MOL PHARMACOL, V76, P1062, DOI 10.1124/mol.109.055392; Erlacher M, 2015, PEDIATR BLOOD CANCER, V62, P1091, DOI 10.1002/pbc.25364; Furumiya M, 2013, BIOCHEM BIOPH RES CO, V431, P158, DOI 10.1016/j.bbrc.2013.01.004; Gerber D, 2001, J BIOL CHEM, V276, P31229, DOI 10.1074/jbc.M101889200; Giovannetti E, 2017, ANN ONCOL, V28, P2725, DOI 10.1093/annonc/mdx499; Gonen N, 2008, BIOCHEM BIOPH RES CO, V376, P787, DOI 10.1016/j.bbrc.2008.09.074; Gonen N, 2010, J BIOL CHEM, V285, P33602, DOI 10.1074/jbc.M110.135640; Gonzalez MW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002819; Gupta K, 2017, NATURE, V541, P421, DOI 10.1038/nature20820; HEBERT DN, 1991, BIOCHEMISTRY-US, V30, P4654, DOI 10.1021/bi00233a003; HICKMAN RK, 1988, J BACTERIOL, V170, P1715, DOI 10.1128/jb.170.4.1715-1720.1988; Hou ZJ, 2019, BIOCHEM J, V476, P1247, DOI 10.1042/BCJ20180394; Hou ZJ, 2017, MOL CANCER THER, V16, P819, DOI 10.1158/1535-7163.MCT-16-0444; Hou ZJ, 2012, J BIOL CHEM, V287, P4982, DOI 10.1074/jbc.M111.306860; Hou ZJ, 2009, J BIOL CHEM, V284, P3285, DOI 10.1074/jbc.M807206200; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Inoue K, 2008, AM J PHYSIOL-GASTR L, V294, pG660, DOI 10.1152/ajpgi.00309.2007; Jiang DH, 2013, P NATL ACAD SCI USA, V110, P14664, DOI 10.1073/pnas.1308127110; Kishimoto K, 2014, CLIN IMMUNOL, V153, P17, DOI 10.1016/j.clim.2014.03.014; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Lasry I, 2009, BIOCHEM BIOPH RES CO, V386, P426, DOI 10.1016/j.bbrc.2009.06.007; Mahadeo K, 2010, AM J PHYSIOL-CELL PH, V299, pC1153, DOI 10.1152/ajpcell.00113.2010; Mahadeo KM, 2011, J PEDIATR-US, V159, P623, DOI 10.1016/j.jpeds.2011.03.005; Manea E, 2018, JIMD REP, V39, P7, DOI 10.1007/8904_2017_39; Matherly LH, 2007, CANCER METAST REV, V26, P111, DOI 10.1007/s10555-007-9046-2; Matherly LH, 2018, CANCER CHEMOTH PHARM, V81, P1, DOI 10.1007/s00280-017-3473-8; Matherly LH, 2014, DRUG METAB DISPOS, V42, P632, DOI 10.1124/dmd.113.055723; Mcclain MS, 2003, J BIOL CHEM, V278, P12101, DOI 10.1074/jbc.M212595200; MCEWAN GTA, 1990, J MED ENG TECHNOL, V14, P16, DOI 10.3109/03091909009028758; Melnyk RA, 2002, J MOL BIOL, V315, P63, DOI 10.1006/jmbi.2001.5214; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Menter A, 2012, J PHARMACOL EXP THER, V342, P696, DOI 10.1124/jpet.112.195479; Meyer E, 2010, MOL GENET METAB, V99, P325, DOI 10.1016/j.ymgme.2009.11.004; Min SH, 2008, J PEDIATR-US, V153, P435, DOI 10.1016/j.jpeds.2008.04.009; Mueller BK, 2014, P NATL ACAD SCI USA, V111, pE888, DOI 10.1073/pnas.1319944111; Najmi M, 2016, AM J PHYSIOL-CELL PH, V311, pC150, DOI 10.1152/ajpcell.00084.2016; Nakai Y, 2007, J PHARMACOL EXP THER, V322, P469, DOI 10.1124/jpet.107.122606; Nomura N, 2015, NATURE, V526, P397, DOI 10.1038/nature14909; O'Connor C, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85818-x; Overton MC, 2003, J BIOL CHEM, V278, P49369, DOI 10.1074/jbc.M308654200; Parker JL, 2021, NATURE, V595, P130, DOI 10.1038/s41586-021-03579-z; Pedersen BP, 2013, NATURE, V496, P533, DOI 10.1038/nature12042; Polgar O, 2004, BIOCHEMISTRY-US, V43, P9448, DOI 10.1021/bi0497953; Qiu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1669, DOI 10.1152/ajpcell.00202.2007; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Reddy VS, 2012, FEBS J, V279, P2036, DOI 10.1111/j.1742-4658.2012.08590.x; Roux Kyle J, 2013, Curr Protoc Protein Sci, V74, DOI 10.1002/0471140864.ps1923s74; Roux KJ, 2013, CELL MOL LIFE SCI, V70, P3657, DOI 10.1007/s00018-013-1287-3; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; SAID HM, 1987, PEDIATR RES, V22, P497, DOI 10.1203/00006450-198711000-00002; Saier MH, 1999, INT REV CYTOL, V190, P61, DOI 10.1016/S0074-7696(08)62146-4; Shi YG, 2013, ANNU REV BIOPHYS, V42, P51, DOI 10.1146/annurev-biophys-083012-130429; Shin DS, 2013, AM J PHYSIOL-CELL PH, V304, pC1159, DOI 10.1152/ajpcell.00353.2012; Shin DS, 2010, BLOOD, V116, P5162, DOI 10.1182/blood-2010-06-291237; Stark M, 2009, BIOCHEM BIOPH RES CO, V388, P79, DOI 10.1016/j.bbrc.2009.07.116; Subramanian VS, 2008, AM J PHYSIOL-CELL PH, V294, pC233, DOI 10.1152/ajpcell.00468.2007; Tan JM, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008712; Taylor AM, 2001, BIOCHEM J, V359, P661, DOI 10.1042/0264-6021:3590661; Tozawa Y, 2019, CLIN IMMUNOL, V208, DOI 10.1016/j.clim.2019.108256; Umapathy NS, 2007, INVEST OPHTH VIS SCI, V48, P5299, DOI 10.1167/iovs.07-0288; Unal ES, 2009, AM J PHYSIOL-CELL PH, V297, pC66, DOI 10.1152/ajpcell.00096.2009; Unal ES, 2009, J BIOL CHEM, V284, P17846, DOI 10.1074/jbc.M109.008060; Unal ES, 2008, BBA-BIOMEMBRANES, V1778, P1407, DOI 10.1016/j.bbamem.2008.03.009; Veenhoff LM, 2001, EMBO J, V20, P3056, DOI 10.1093/emboj/20.12.3056; Visentin M, 2015, AM J PHYSIOL-CELL PH, V308, pC631, DOI 10.1152/ajpcell.00238.2014; Wang L, 2011, J MED CHEM, V54, P7150, DOI 10.1021/jm200739e; Wang L, 2010, J MED CHEM, V53, P1306, DOI 10.1021/jm9015729; Wang Q, 2015, BRAIN DEV-JPN, V37, P163, DOI 10.1016/j.braindev.2014.01.010; Wang YH, 2004, CLIN CANCER RES, V10, P6256, DOI 10.1158/1078-0432.CCR-04-0645; Whittington DA, 2001, P NATL ACAD SCI USA, V98, P9545, DOI 10.1073/pnas.161301298; Wilson MR, 2016, BIOCHEM J, V473, P3545, DOI 10.1042/BCJ20160399; Wilson MR, 2016, MOL PHARMACOL, V89, P425, DOI 10.1124/mol.115.102798; Wilson MR, 2015, BIOCHEM J, V469, P33, DOI 10.1042/BJ20150169; Wilson MR, 2014, J BIOL CHEM, V289, P25287, DOI 10.1074/jbc.M114.578252; Wright NJ, 2019, NAT STRUCT MOL BIOL, V26, P599, DOI 10.1038/s41594-019-0245-7; Yamamoto J, 2004, J BIOL CHEM, V279, P16954, DOI 10.1074/jbc.M312079200; Yamashiro T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54367-9; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; Yin CC, 2000, MOL MICROBIOL, V38, P482, DOI 10.1046/j.1365-2958.2000.02149.x; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zhan HQ, 2020, J BIOL CHEM, V295, P15650, DOI 10.1074/jbc.RA120.014757; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Zhao RB, 2007, CANCER METAST REV, V26, P129, DOI 10.1007/s10555-007-9047-1; Zhao RB, 2017, AM J PHYSIOL-CELL PH, V312, pC517, DOI 10.1152/ajpcell.00350.2016; Zhao RB, 2017, MOL ASPECTS MED, V53, P57, DOI 10.1016/j.mam.2016.09.002; Zhao RB, 2016, J BIOL CHEM, V291, P8162, DOI 10.1074/jbc.M115.693929; Zhao RB, 2013, MOL PHARMACOL, V84, P95, DOI 10.1124/mol.113.085605; Zhao RB, 2012, AM J PHYSIOL-CELL PH, V303, pC673, DOI 10.1152/ajpcell.00123.2012; Zhao RB, 2011, J BIOL CHEM, V286, P24150, DOI 10.1074/jbc.M111.236539; Zhao RB, 2010, BIOCHEMISTRY-US, V49, P2925, DOI 10.1021/bi9021439; Zhao RB, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000969; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	127	4	4	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22164	10.1096/fj.202101704R	http://dx.doi.org/10.1096/fj.202101704R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35061292	Green Published			2022-12-28	WOS:000747987800036
J	Liu, JQ; Yao, S; Jia, JS; Chen, ZF; Yuan, Y; He, Y; Wasti, B; Duan, WT; Li, DH; Wang, GY; Jia, AJ; Sun, WJ; Qiu, SF; Ma, LB; Li, JM; Liu, Y; Zheng, JF; Xiang, XD; Zhang, XF; Liu, SK; He, ZB; Peng, ZY; Zhang, HL; Zhang, DS; Xiao, B				Liu, Jiqiang; Yao, Shuo; Jia, Jingsi; Chen, Zhifeng; Yuan, Yu; He, Yi; Wasti, Binaya; Duan, Wentao; Li, Danhong; Wang, Guyi; Jia, Aijun; Sun, Wenjin; Qiu, Shuangfa; Ma, Libing; Li, Jianmin; Liu, Yi; Zheng, Jianfei; Xiang, Xudong; Zhang, Xiufeng; Liu, Shaokun; He, Zhibiao; Peng, Zhenyu; Zhang, Hongliang; Zhang, Dongshan; Xiao, Bing			Loss of MBD2 ameliorates LPS-induced alveolar epithelial cell apoptosis and ALI in mice via modulating intracellular zinc homeostasis	FASEB JOURNAL			English	Article						acute lung injury; alveolar epithelial cell; apoptosis; MBD2; MTF1; zinc homeostasis	ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; DNA-METHYLATION; LABILE ZINC; ACTIVATION; STRESS; GROWTH	Apoptosis of alveolar epithelial cells is a critical initial link in the pathogenesis of acute lung injury (ALI), recent studies have revealed that Methyl-CpG binding domain protein 2 (MBD2) was involved in the execution of apoptosis, yet its role in ALI remained unclear. In the present study, we aim to explore the role and mechanism of MBD2 in the pathogenesis of ALI. We have found that MBD2 expression, in parallel to apoptosis, increased in alveolar epithelial cells of mice treated with LPS, knockout of MBD2 reduced apoptosis and protected mice from LPS-induced ALI. In MLE-12 cells, a cell line of murine alveolar epithelial cells, LPS induced MBD2 expression and apoptosis in a dose- and time-dependent manner. Knockdown of MBD2 with shRNA alleviated, while overexpression of MBD2 increased LPS-induced apoptosis. Mechanistically, intracellular zinc level decreased when MLE-12 cells were treated with LPS. MBD2 knockdown restored intracellular zinc level after LPS treatment, and MBD2 overexpression further aggravated LPS-induced intracellular zinc loss. Metal transcription factor 1 (MTF1) is a critical transcription factor in charge of intracellular zinc efflux. LPS treatment induced MTF1 expression both in vivo and in vitro. Inhibition of MTF1 reduced LPS-induced apoptosis in MLE-12 cells. MBD2 could bind to the promoter region of MTF1 and promote MTF1 expression. Collectively, these data indicated that loss of MBD2-ameliorated LPS-induced alveolar epithelial cell apoptosis and ALI in mice via modulating intracellular zinc homeostasis by upregulating MTF1.	[Liu, Jiqiang; Yao, Shuo; Jia, Jingsi; Qiu, Shuangfa; Zheng, Jianfei; Xiang, Xudong; He, Zhibiao; Peng, Zhenyu; Zhang, Hongliang; Zhang, Dongshan; Xiao, Bing] Cent South Univ, Emergency & Difficult Dis Inst, Xiangya Hosp 2, Dept Emergency Med, 139 Middle Renmin Rd, Changsha 410011, Hunan, Peoples R China; [Chen, Zhifeng; Yuan, Yu; He, Yi; Wasti, Binaya; Duan, Wentao; Li, Danhong; Liu, Shaokun] Cent South Univ, Xiangya Hosp 2, Res Unit Resp Dis, Dept Resp Med,Hunan Ctr Evidence Based Med, Changsha, Peoples R China; [Wang, Guyi] Cent South Univ, Xiangya Hosp 2, Dept Intens Care Med, Changsha, Peoples R China; [Jia, Aijun] Hunan Prov Peoples Hosp, Dept Third Emergency Yuelushan Hosp Dist, Changsha, Peoples R China; [Sun, Wenjin] Sichuan Univ, West China Hosp, Dept Gen Med, Chengdu, Peoples R China; [Ma, Libing] Guilin Med Univ, Affiliated Hosp, Dept Resp & Crit Care Med, Guilin, Guangxi, Peoples R China; [Li, Jianmin] Hunan Prov Peoples Hosp, Dept Resp & Crit Care Med, Changsha, Peoples R China; [Liu, Yi] Zhuzhou City Cent Hosp, Dept Resp Med, Zhuzhou, Peoples R China; [Zhang, Xiufeng] Hainan Med Univ, Affiliated Hosp 2, Dept Resp Med, Haikou, Hainan, Peoples R China	Central South University; Central South University; Central South University; Sichuan University; Guilin Medical University; Hainan Medical University	Xiao, B (corresponding author), Cent South Univ, Emergency & Difficult Dis Inst, Xiangya Hosp 2, Dept Emergency Med, 139 Middle Renmin Rd, Changsha 410011, Hunan, Peoples R China.	xiaobing@csu.edu.cn	Li, Jing/GYU-5036-2022; li, jian/GSE-0245-2022; LI, JIAN/GRY-2197-2022		National Natural Science Foundation of China [81760009, 82000032]; Natural Science Foundation of Hunan Province [2019JJ40451, 2021JJ40879]; Science and Technology Base, and Talent Special Project of Guangxi Province [AD19110160]; Beijing Medical and Health Foundation [YWJKJJHKYJJ-B17418-Z03]; General Project of Department of Education of Hunan Province [20C1117]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Science and Technology Base, and Talent Special Project of Guangxi Province; Beijing Medical and Health Foundation; General Project of Department of Education of Hunan Province	This study was supported by the National Natural Science Foundation of China (No. 81760009, 82000032), Natural Science Foundation of Hunan Province (No. 2019JJ40451, 2021JJ40879), Science and Technology Base, and Talent Special Project of Guangxi Province (No. AD19110160), Beijing Medical and Health Foundation (YWJKJJHKYJJ-B17418-Z03), and General Project of Department of Education of Hunan Province (No.20C1117).	Albertine KH, 2002, AM J PATHOL, V161, P1783, DOI 10.1016/S0002-9440(10)64455-0; Alker W, 2018, NUTRIENTS, V10, DOI 10.3390/nu10080976; Banupriya N, 2021, INDIAN J PEDIATR, V88, P696, DOI 10.1007/s12098-021-03748-y; Bao SY, 2006, AM J PHYSIOL-LUNG C, V291, pL1132, DOI 10.1152/ajplung.00207.2006; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Boudreault F, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.86507; Chai F, 2000, J INFECT DIS, V182, pS85, DOI 10.1086/315914; Chasapis CT, 2020, ARCH TOXICOL, V94, P1443, DOI 10.1007/s00204-020-02702-9; Chen QJ, 2021, SCIENCE, V372, P1349, DOI 10.1126/science.abc0269; Choi SY, 2014, METALLOMICS, V6, P1198, DOI 10.1039/c4mt00064a; Cui HC, 2019, AM J RESP CELL MOL, V60, P167, DOI 10.1165/rcmb.2018-0152OC; Daniel AG, 2014, ANGEW CHEM INT EDIT, V53, P4098, DOI 10.1002/anie.201311114; Doboszewska U, 2020, BRIT J PHARMACOL, V177, P4887, DOI 10.1111/bph.15199; Du Q, 2015, EPIGENOMICS-UK, V7, P1051, DOI 10.2217/epi.15.39; Fujishiro H, 2009, TOXICOL APPL PHARM, V241, P195, DOI 10.1016/j.taap.2009.08.015; Gao H, 2017, P NATL ACAD SCI USA, V114, P12940, DOI 10.1073/pnas.1708018114; Ge YN, 2020, MOL THER-NUCL ACIDS, V19, P1250, DOI 10.1016/j.omtn.2020.01.011; Goncalves TJM, 2021, NUTR CLIN PRACT, V36, P186, DOI 10.1002/ncp.10612; Haase H, 2006, ANAL BIOCHEM, V352, P222, DOI 10.1016/j.ab.2006.02.009; He BC, 2021, AM J RESP CELL MOL, V64, P196, DOI 10.1165/rcmb.2020-0112OC; Herrero R, 2019, THORAX, V74, P69, DOI 10.1136/thoraxjnl-2018-211535; Hou L, 2021, FREE RADICAL BIO MED, V165, P219, DOI 10.1016/j.freeradbiomed.2021.01.045; Jia AJ, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/6249685; Jothimani D, 2020, INT J INFECT DIS, V100, P343, DOI 10.1016/j.ijid.2020.09.014; Kessels JE, 2016, J TRACE ELEM MED BIO, V37, P125, DOI 10.1016/j.jtemb.2016.02.003; Kiefmann M, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.403; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Kitamura Y, 2001, AM J RESP CRIT CARE, V163, P762, DOI 10.1164/ajrccm.163.3.2003065; Le X, 2020, THERANOSTICS, V10, P9495, DOI 10.7150/thno.45631; Liang X, 2010, MOL CANCER RES, V8, P1619, DOI 10.1158/1541-7786.MCR-10-0341; Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Menafra R, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00428; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morris G, 2020, LIFE SCI, V258, DOI 10.1016/j.lfs.2020.118166; Nagamine Y, 2016, AM J RESP CELL MOL, V55, P878, DOI 10.1165/rcmb.2015-0266OC; Nagata S, 2018, ANNU REV IMMUNOL, V36, P489, DOI 10.1146/annurev-immunol-042617-053010; Pei YF, 2019, AM J PATHOL, V189, P1065, DOI 10.1016/j.ajpath.2019.01.010; Perera M, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040580; Potey PMD, 2019, J PATHOL, V247, P672, DOI 10.1002/path.5221; Rao XQ, 2011, CIRCULATION, V123, P2964, DOI 10.1161/CIRCULATIONAHA.110.966408; Roberson EC, 2012, AM J RESP CELL MOL, V46, P573, DOI 10.1165/rcmb.2010-0460OC; Rushton MD, 2015, ANN RHEUM DIS, V74, P1778, DOI 10.1136/annrheumdis-2014-206752; Sheng MW, 2018, ANESTH ANALG, V127, P267, DOI 10.1213/ANE.0000000000003414; Sun TS, 2021, J CELL MOL MED, V25, P4562, DOI 10.1111/jcmm.16207; Sun WJ, 2018, EXP CELL RES, V371, P196, DOI 10.1016/j.yexcr.2018.08.010; Tang ZL, 2002, MOL CELL BIOCHEM, V234, P211, DOI 10.1023/A:1015930927407; Thambiayya Kalidasan, 2012, Pulm Circ, V2, P443, DOI 10.4103/2045-8932.105032; Thambiayya K, 2012, AM J PHYSIOL-LUNG C, V302, pL1287, DOI 10.1152/ajplung.00385.2011; Thambiayya K, 2011, AM J PHYSIOL-LUNG C, V300, pL624, DOI 10.1152/ajplung.00376.2010; Tojo K, 2018, FASEB J, V32, P2258, DOI 10.1096/fj.201700888R; Wang C, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan3682; Wang J, 2021, BBA-REV CANCER, V1875, DOI 10.1016/j.bbcan.2020.188454; Wang J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.509; Wessels I, 2020, THORAX, V75, P253, DOI 10.1136/thoraxjnl-2019-213357; Xie YX, 2021, MOL THER-NUCL ACIDS, V23, P76, DOI 10.1016/j.omtn.2020.09.028; Xu L, 2018, J INFLAMM-LOND, V15, DOI 10.1186/s12950-018-0191-x; Younes N, 2020, THORAX, V75, P556, DOI 10.1136/thoraxjnl-2019-213561	60	3	3	5	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22162	10.1096/fj.202100924RR	http://dx.doi.org/10.1096/fj.202100924RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35061304				2022-12-28	WOS:000747987800039
J	Scolnick, EM; Saphire, EO				Scolnick, Edward M.; Saphire, Erica Ollmann			A Manhattan Project against COVID	FASEB JOURNAL			English	Editorial Material									[Scolnick, Edward M.] MIT, Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Saphire, Erica Ollmann] La Jolla Inst Immunol, La Jolla, CA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; La Jolla Institute for Immunology	Scolnick, EM (corresponding author), MIT, Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	scolnick@broad.mit.edu						Havlir DV, 1998, NEW ENGL J MED, V339, P1261, DOI 10.1056/NEJM199810293391801	1	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22117	10.1096/fj.202101891	http://dx.doi.org/10.1096/fj.202101891			2	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35060642				2022-12-28	WOS:000747987800013
J	Zhang, JQ; Liu, WB; Li, GY; Xu, CP; Nie, XQ; Qin, DD; Wang, QZ; Lu, XK; Liu, JQ; Li, L				Zhang, Jiaqi; Liu, Wenbo; Li, Guangyue; Xu, Chengpeng; Nie, Xiaoqing; Qin, Dandan; Wang, Qizhi; Lu, Xukun; Liu, Jianqiao; Li, Lei			BCAS2 is involved in alternative splicing and mouse oocyte development	FASEB JOURNAL			English	Article						alternative splicing; BCAS2; follicle; oogenesis; PRP19 complex	POLY(A)-BINDING PROTEIN EPAB; PRP19P-ASSOCIATED COMPLEX; MOLECULAR CONTROL; GENE-EXPRESSION; SPLICEOSOME; ACTIVATION; PRP19; IDENTIFICATION; COMPONENTS; CHROMATIN	Alternative splicing (AS) is an important mechanism to regulate organogenesis and fertility. Breast carcinoma amplified sequence 2 (BCAS2) is one of the core components of the PRP19 complex, a multiple function complex including splicing, and it is involved in the initiation of meiosis through regulating AS in male mice. However, the role of BCAS2 in mouse oogenesis remains largely unknown. In this study, we found that BCAS2 was highly expressed in the oocytes of primordial follicles. Vasa-Cre-mediated deletion of Bcas2 caused poor oocyte quality, abnormal oogenesis and follicular development. The deletion of Bcas2 in mouse oocytes caused alteration in 991 AS events that corresponded to 706 genes, including Pabpc1l, Nobox, Zfp207, Mybl2, Prc1, and Spc25, which were associated with oogenesis and spindle assembly. Moreover, the disruption of BCAS2 led to degradation of PRP19 core proteins in mouse oocytes. These results suggested that BCAS2 was involved in the AS of functional genes through PRP19 complex during mouse oocyte development.	[Zhang, Jiaqi; Liu, Wenbo; Xu, Chengpeng; Nie, Xiaoqing; Qin, Dandan; Wang, Qizhi; Lu, Xukun; Li, Lei] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Zhang, Jiaqi; Xu, Chengpeng; Nie, Xiaoqing; Wang, Qizhi] Chinese Acad Sci, Univ Chinese Acad Sci, Beijing, Peoples R China; [Liu, Wenbo; Liu, Jianqiao] Guangzhou Med Univ, Ctr Reprod Med, Dept Obstet & Gynecol, Key Lab Major Obstet Dis Guangdong Prov,Affiliate, Guangzhou, Peoples R China; [Liu, Wenbo; Liu, Jianqiao] Guangzhou Med Univ, Key Lab Reprod Med Guangdong Prov, Affiliated Hosp 3, Guangzhou, Peoples R China; [Li, Guangyue] Northeast Forestry Univ, Coll Life Sci, Key Lab Saline Alkali Vegetat Ecol Restorat, Minist Educ, Harbin, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangzhou Medical University; Guangzhou Medical University; Northeast Forestry University - China	Li, L (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.	lil@ioz.ac.cn		Li, Lei/0000-0001-5478-5681	National Key R&D Program of China [2018YFC1004500, 2021YFC2700300]; National Natural Science Foundation of China [31801241, 31930033, 31771633, 81971452]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Key R&D Program of China (2018YFC1004500 and 2021YFC2700300) and the National Natural Science Foundation of China (31801241, 31930033, 31771633, and 81971452)	Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Bennabi I, 2016, J CELL BIOL, V215, P611, DOI 10.1083/jcb.201607062; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chanarat S, 2013, BBA-MOL CELL RES, V1833, P2126, DOI 10.1016/j.bbamcr.2013.05.023; Chen HR, 1999, P NATL ACAD SCI USA, V96, P5406, DOI 10.1073/pnas.96.10.5406; Chen PH, 2013, RNA, V19, P208, DOI 10.1261/rna.034835.112; Chou MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130706; Do DV, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0032-3; de Moura TR, 2018, MOL CELL, V69, P979, DOI 10.1016/j.molcel.2018.02.022; Fan XY, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3001017; Gagliardi M, 2016, METHODS MOL BIOL, V1480, P73, DOI 10.1007/978-1-4939-6380-5_7; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Girard C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1998; Guzeloglu-Kayisli O, 2012, BIOCHEM J, V446, P47, DOI 10.1042/BJ20120467; Hamid FM, 2014, BIOCHEM SOC T, V42, P1168, DOI 10.1042/BST20140066; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43, DOI 10.1016/s0074-7696(08)61524-7; Hofmann JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074851; Huang CW., 2016, SCI REP-UK, V6; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kuo PC, 2009, CANCER RES, V69, P8877, DOI 10.1158/0008-5472.CAN-09-2023; Lee S, 2002, CANCER LETT, V188, P121, DOI 10.1016/S0304-3835(02)00055-1; Lei L, 2013, DEVELOPMENT, V140, P2075, DOI 10.1242/dev.093864; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Liu L, 2013, REPROD FERT DEVELOP, V25, P463, DOI 10.1071/RD12310; Liu WB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14182; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marechal A, 2014, MOL CELL, V53, P235, DOI 10.1016/j.molcel.2013.11.002; MATTSON BA, 1990, MOL REPROD DEV, V25, P374, DOI 10.1002/mrd.1080250411; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Nagasaki K, 1999, CANCER LETT, V140, P219, DOI 10.1016/S0304-3835(99)00091-9; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Oktem O, 2010, HUM REPROD, V25, P2944, DOI 10.1093/humrep/deq275; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Salmeron-Hernandez A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040966; Sanchez F, 2012, BBA-MOL BASIS DIS, V1822, P1896, DOI 10.1016/j.bbadis.2012.05.013; Seli E, 2005, P NATL ACAD SCI USA, V102, P367, DOI 10.1073/pnas.0408378102; Shi YG, 2017, NAT REV MOL CELL BIO, V18, P655, DOI 10.1038/nrm.2017.86; Sibley CR, 2014, BIOCHEM SOC T, V42, P1196, DOI 10.1042/BST20140102; Supek F, 2021, TRENDS GENET, V37, P657, DOI 10.1016/j.tig.2020.11.002; Tan JH, 2009, MOL HUM REPROD, V15, P1, DOI 10.1093/molehr/gan069; TARN WY, 1994, EMBO J, V13, P2421, DOI 10.1002/j.1460-2075.1994.tb06527.x; Trincado JL, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1417-1; Wan L, 2014, J BIOL CHEM, V289, P6619, DOI 10.1074/jbc.M113.543439; Wan RX, 2020, ANNU REV BIOCHEM, V89, P333, DOI 10.1146/annurev-biochem-013118-111024; Wan RX, 2019, CURR OPIN STRUC BIOL, V59, P124, DOI 10.1016/j.sbi.2019.07.010; Wang LP, 2020, BRIT J CANCER, V123, P1796, DOI 10.1038/s41416-020-01086-y; Xu QH, 2015, DEVELOPMENT, V142, P3943, DOI 10.1242/dev.129841; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yu LP, 2021, DEVELOPMENT, V148, DOI 10.1242/dev.196931; Yu SS, 2019, BLOOD, V133, P805, DOI 10.1182/blood-2018-09-876599	56	1	1	4	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22128	10.1096/fj.202101279R	http://dx.doi.org/10.1096/fj.202101279R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34972250				2022-12-28	WOS:000747987800026
J	Ji, LY; Waduge, P; Hao, LL; Kaur, A; Wan, WC; Wu, Y; Tian, H; Zhang, JS; Webster, KA; Li, W				Ji, Liyang; Waduge, Prabuddha; Hao, Lili; Kaur, Avinash; Wan, Wencui; Wu, Yan; Tian, Hong; Zhang, Jinsong; Webster, Keith A.; Li, Wei			Selectively targeting disease-restricted secretogranin III to alleviate choroidal neovascularization	FASEB JOURNAL			English	Article						age-related macular degeneration; angiogenic factor; anti-angiogenic therapy; choroidal neovascularization; secretogranin III	ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; DIABETIC-RETINOPATHY; ANGIOGENIC FACTOR; RANIBIZUMAB; VEGF; INFLAMMATION; THERAPY; BINDING; CELLS	Choroidal neovascularization (CNV), a leading cause of blindness in the elderly, is routinely treated with vascular endothelial growth factor (VEGF) inhibitors that have limited efficacy and potentially adverse side effects. An unmet clinical need is to develop novel therapies against other angiogenic factors for alternative or combination treatment to improve efficacy and safety. We recently described secretogranin III (Scg3) as a disease-selective angiogenic factor, causally linked to diabetic retinopathy and acting independently of the VEGF pathway. An important question is whether such a disease-selective Scg3 pathway contributes to other states of pathological angiogenesis beyond diabetic retinopathy. By applying a novel in vivo endothelial ligand binding assay, we found that the binding of Scg3 to CNV vessels in live mice was markedly increased over background binding to healthy choriocapillaris and blocked by an Scg3-neutralizing antibody, whereas VEGF showed no such differential binding. Intravitreal injection of anti-Scg3 humanized antibody Fab (hFab) inhibited Matrigel-induced CNV with similar efficacy to the anti-VEGF drug aflibercept. Importantly, a combination of anti-Scg3 hFab and aflibercept synergistically alleviated CNV. Homozygous deletion of the Scg3 gene markedly reduced CNV severity and abolished the therapeutic activity of anti-Scg3 hFab, but not aflibercept, suggesting a role for Scg3 in VEGF-independent CNV pathogenesis and therapy. Our work demonstrates the stringent disease selectivity of Scg3 binding and positions anti-Scg3 hFab as a next-generation disease-targeted anti-angiogenic therapy for CNV.	[Ji, Liyang; Waduge, Prabuddha; Kaur, Avinash; Webster, Keith A.; Li, Wei] Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, One Baylor Plaza,NC205, Houston, TX 77030 USA; [Ji, Liyang; Waduge, Prabuddha; Hao, Lili; Kaur, Avinash; Wan, Wencui; Wu, Yan; Webster, Keith A.; Li, Wei] Univ Miami, Sch Med, Bascom Palmer Eye Inst, Miami, FL USA; [Ji, Liyang; Zhang, Jinsong] China Med Univ, Affiliated Hosp 4, Dept Ophthalmol, Shenyang, Peoples R China; [Hao, Lili] Jinan Univ, Affiliated Hosp 1, Dept Ophthalmol, Guangzhou, Peoples R China; [Wan, Wencui] Zhengzhou Univ, Affiliated Hosp 1, Dept Ophthalmol, Zhengzhou, Peoples R China; [Tian, Hong; Webster, Keith A.] Everglades Biopharma LLC, Houston, TX USA	Baylor College of Medicine; Bascom Palmer Eye Institute; University of Miami; China Medical University; Jinan University; Zhengzhou University	Li, W (corresponding author), Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, One Baylor Plaza,NC205, Houston, TX 77030 USA.	wei.li4@bcm.edu		Webster, Keith A/0000-0002-6431-3642; Li, Wei/0000-0001-9566-8764; Kaur, Avinash/0000-0003-2667-8146	NIII [Y027749, R24EY028764, R24EY02876401A1S1, R43FY031238, R43FY031643, R43EY032827, R41 EY027665]; American Diabetes Association [1 -18 -IBS -172]; NIH [P30EY002520, P30EY014801]; Knights Templar Eye Foundation Endowment in Ophthalmology; Research to Prevent Blindness (RPB)	NIII; American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knights Templar Eye Foundation Endowment in Ophthalmology; Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB))	We thank Drs. Yingbin Fu, Philp Rosenfeld and Rong Wen for scientific discussion and Dr. Yuqin Wang for technical support. This work was supported by NIII RO1 [Y027749 (WI,), R24EY028764 (WI. and KAW), R24EY02876401A1S1 (WI, and KAW), R43FY031238 (IIT, KAW and WI.), R43FY031643 (HT), R43EY032827 (HT and WI,), R41 EY027665 (WI. and HT), American Diabetes Association 1 -18 -IBS -172 (WL), NIH P30EY002520, P30EY014801, Knights Templar Eye Foundation Endowment in Ophthalmology (WL) and unrestricted institutional grants from Research to Prevent Blindness (RPB) to the Department of Ophthalmology, University of Miami and Department of Ophthalmology, Baylor College of Medicine.	Abhinandan KR, 2007, J MOL BIOL, V369, P852, DOI 10.1016/j.jmb.2007.02.100; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Baumal CR, 2020, AM J MANAG CARE, V26, pS103, DOI 10.37765/ajmc.2020.43435; Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018; Bucher F, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.10.20; Byeon SH, 2010, INVEST OPHTH VIS SCI, V51, P1190, DOI 10.1167/iovs.09-4144; Caberoy NB, 2010, EMBO J, V29, P3898, DOI 10.1038/emboj.2010.265; Caberoy NB, 2010, J MOL RECOGNIT, V23, P74, DOI 10.1002/jmr.983; Calvo PM, 2018, NEURAL REGEN RES, V13, P1181, DOI 10.4103/1673-5374.235024; Cao JT, 2010, INVEST OPHTH VIS SCI, V51, P6009, DOI 10.1167/iovs.09-4956; Cooper ME, 1999, DIABETES, V48, P2229, DOI 10.2337/diabetes.48.11.2229; Dedania VS, 2015, CLIN OPHTHALMOL, V9, P533, DOI 10.2147/OPTH.S80049; Egawa G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01932; Estep P, 2013, MABS-AUSTIN, V5, P270, DOI 10.4161/mabs.23049; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; GitayGoren H, 1996, J BIOL CHEM, V271, P5519, DOI 10.1074/jbc.271.10.5519; Gonzalez-Buendia L, 2021, AM J PATHOL, V191, P418, DOI 10.1016/j.ajpath.2020.12.005; Grunwald JE, 2017, OPHTHALMOLOGY, V124, P97, DOI 10.1016/j.ophtha.2016.09.012; Hara C, 2013, INVEST OPHTH VIS SCI, V54, P4321, DOI 10.1167/iovs.13-11611; Ho AC, 2014, OPHTHALMOLOGY, V121, P2181, DOI 10.1016/j.ophtha.2014.05.009; Hosaka M, 2010, ENDOCR J, V57, P275, DOI 10.1507/endocrj.K10E-038; Humbles AA, 2002, P NATL ACAD SCI USA, V99, P1479, DOI 10.1073/pnas.261462598; Ji LY, 2021, CELL MOL LIFE SCI, V78, P5977, DOI 10.1007/s00018-021-03893-9; KINGSLEY DM, 1990, EMBO J, V9, P395, DOI 10.1002/j.1460-2075.1990.tb08123.x; LeBlanc ME, 2019, EXP EYE RES, V181, P120, DOI 10.1016/j.exer.2019.01.009; LeBlanc ME, 2017, J EXP MED, V214, P1029, DOI 10.1084/jem.20161802; LeBlanc ME, 2016, MOL VIS, V22, P374; LeBlanc ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127904; Li W, 2018, DRUG DISCOV TODAY, V23, P636, DOI 10.1016/j.drudis.2018.01.013; Li W, 2018, CELL MOL LIFE SCI, V75, P635, DOI 10.1007/s00018-017-2635-5; Li YW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017106; Maguire MG, 2016, OPHTHALMOLOGY, V123, P1751, DOI 10.1016/j.ophtha.2016.03.045; Matsunaga N, 2008, OPHTHALMOLOGY, V115, P1916, DOI 10.1016/j.ophtha.2008.06.025; Mettu PS, 2021, PROG RETIN EYE RES, V82, DOI 10.1016/j.preteyeres.2020.100906; Morin J, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3218; OTTIGER HP, 1990, J NEUROSCI, V10, P3135; Pinheiro-Costa J, 2015, OPHTHALMOLOGICA, V233, P155, DOI 10.1159/000381221; Rong X, 2019, EXP EYE RES, V182, P57, DOI 10.1016/j.exer.2019.03.009; Samanta A, 2020, ASIA-PAC J OPHTHALMO, V9, P250, DOI 10.1097/APO.0000000000000291; Sepah YJ, 2016, OPHTHALMOLOGY, V123, P2581, DOI 10.1016/j.ophtha.2016.08.040; Shao J, 2016, DEV OPHTHALMOL, V55, P125, DOI 10.1159/000438969; Sultana J, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00315; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Tang F, 2019, ANGIOGENESIS, V22, P369, DOI 10.1007/s10456-019-09662-4; Tang F, 2018, BIOCHEM BIOPH RES CO, V495, P781, DOI 10.1016/j.bbrc.2017.11.080; Tokuda K, 2018, JPN J OPHTHALMOL, V62, P481, DOI 10.1007/s10384-018-0592-7; Wang WW, 2017, ANGIOGENESIS, V20, P479, DOI 10.1007/s10456-017-9557-6; Watanabe D, 2005, NEW ENGL J MED, V353, P782, DOI 10.1056/NEJMoa041773; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1	49	4	4	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22106	10.1096/fj.202101085RR	http://dx.doi.org/10.1096/fj.202101085RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34918375				2022-12-28	WOS:000734992000055
J	Kleene, R; Loers, G; Castillo, G; Schachner, M				Kleene, Ralf; Loers, Gabriele; Castillo, Gaston; Schachner, Melitta			Cell adhesion molecule L1 interacts with the chromo shadow domain of heterochromatin protein 1 isoforms alpha, beta, and gamma via its intracellular domain	FASEB JOURNAL			English	Article						cell adhesion molecule L1; chromo shadow domain; heterochromatin protein 1; neuritogenesis; neuronal migration; PxVxL motif	RECOGNITION MOLECULES; PRESENILIN/GAMMA-SECRETASE; IMMUNOGLOBULIN SUPERFAMILY; NUCLEAR TRANSLOCATION; CLINICAL SPECTRUM; HP1 SUGGESTS; MIGRATION; L1CAM; ASSOCIATION; CLEAVAGE	Cell adhesion molecule L1 regulates multiple cell functions and L1 deficiency is linked to several neural diseases. Proteolytic processing generates functionally decisive L1 fragments, which are imported into the nucleus. By computational analysis, we found at L1's C-terminal end the chromo shadow domain-binding motif PxVxL, which directs the binding of nuclear proteins to the heterochromatin protein 1 (HP1) isoforms alpha, beta, and gamma. By enzyme-linked immunosorbent assay, we show that the intracellular L1 domain binds to all HP1 isoforms. These interactions involve the HP1 chromo shadow domain and are mediated via the sequence 1158KDET1161 in the intracellular domain of murine L1, but not by L1's C-terminal PxVxL motif. Immunoprecipitation using nuclear extracts from the brain and from cultured cerebellar and cortical neurons indicates that HP1 isoforms interact with a yet unknown nuclear L1 fragment of approximately 55 kDa (L1-55), which carries ubiquitin residues. Proximity ligation indicates a close association between L1-55 and the HP1 isoforms in neuronal nuclei. This association is reduced after the treatment of neurons with inhibitors of metalloproteases, beta-site of amyloid precursor protein cleaving enzyme (BACE1), or gamma-secretase, suggesting that cleavage of full-length L1 by these proteases generates L1-55. Reduction of HP1 alpha, -beta, or -gamma expression by siRNA decreases L1-dependent neurite outgrowth from cultured cortical neurons and decreases the L1-dependent migration of L1-transfected HEK293 cells in a scratch assay. These findings indicate that the interaction of the novel fragment L1-55 with HP1 isoforms in nuclei affects L1-dependent functions, such as neurite outgrowth and neuronal migration.	[Kleene, Ralf; Loers, Gabriele; Castillo, Gaston] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Res Grp Biosynth Neural Struct, Hamburg, Germany; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Rutgers State University New Brunswick	Schachner, M (corresponding author), Rutgers State Univ, Keck Ctr Collaborat Neurosci, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA.	schachner@dls.rutgers.edu						Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Ainsztein AM, 1998, J CELL BIOL, V143, P1763, DOI 10.1083/jcb.143.7.1763; APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; Aucott R, 2008, J CELL BIOL, V183, P597, DOI 10.1083/jcb.200804041; Bosch-Presegue L, 2017, CELL REP, V21, P2048, DOI 10.1016/j.celrep.2017.10.092; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Brown JP, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-9; Canudas S, 2011, GENE DEV, V25, P1807, DOI 10.1101/gad.17325211; Canzio D, 2014, TRENDS CELL BIOL, V24, P377, DOI 10.1016/j.tcb.2014.01.002; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Charo NL, 2018, BBA-MOL CELL RES, V1865, P432, DOI 10.1016/j.bbamcr.2017.11.015; Chen Y, 2021, J ENDOCRINOL INVEST, V44, P1739, DOI 10.1007/s40618-020-01485-1; Cheng L, 2011, EMBO J, V30, P800, DOI 10.1038/emboj.2011.10; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; Dinant C, 2009, MOL CELL BIOL, V29, P6335, DOI 10.1128/MCB.01048-09; Fankhauser CD, 2016, J CLIN PATHOL, V69, P460, DOI 10.1136/jclinpath-2016-203603; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Fransen E, 1996, AM J MED GENET, V64, P73, DOI 10.1002/(SICI)1096-8628(19960712)64:1<73::AID-AJMG11>3.0.CO;2-P; Guseva D, 2009, BRAIN, V132, P2180, DOI 10.1093/brain/awp160; Gutwein P, 2005, CLIN CANCER RES, V11, P2492, DOI 10.1158/1078-0432.CCR-04-1688; Gutwein P, 2000, J BIOL CHEM, V275, P15490, DOI 10.1074/jbc.275.20.15490; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Hayakawa T, 2003, J CELL SCI, V116, P3327, DOI 10.1242/jcs.00635; Hortsch M, 2000, MOL CELL NEUROSCI, V15, P1, DOI 10.1006/mcne.1999.0809; Hortsch Michael, 2014, Adv Neurobiol, V8, P195; Kakad PP, 2018, J BIOL CHEM, V293, P17442, DOI 10.1074/jbc.RA118.004240; Kalus I, 2003, J BIOL CHEM, V278, P10381, DOI 10.1074/jbc.M208351200; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kleene R, 2021, J NEUROCHEM, V157, P1102, DOI 10.1111/jnc.15201; Kraus K, 2018, MOL NEUROBIOL, V55, P7164, DOI 10.1007/s12035-018-0901-7; Kurumaji A, 2001, AM J MED GENET, V105, P99; Kwon SH, 2008, MOL CELLS, V26, P217; Kwon SH, 2011, BIOESSAYS, V33, P280, DOI 10.1002/bies.201000138; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Linneberg C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39884-x; Loers G, 2007, J NEUROCHEM, V101, P865, DOI 10.1111/j.1471-4159.2006.04409.x; Lutz D, 2016, MOL NEUROBIOL, V53, P3360, DOI 10.1007/s12035-015-9277-0; Lutz D, 2014, J BIOL CHEM, V289, P13503, DOI 10.1074/jbc.M113.530238; Lutz D, 2014, J NEUROCHEM, V128, P713, DOI 10.1111/jnc.12473; Lutz D, 2012, J BIOL CHEM, V287, P17161, DOI 10.1074/jbc.M112.346759; Maeng YS, 2015, STEM CELLS, V33, P1512, DOI 10.1002/stem.1954; Makhina T, 2009, MOL CELL NEUROSCI, V41, P206, DOI 10.1016/j.mcn.2009.02.010; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Matsumoto-Miyai K, 2003, J NEUROSCI, V23, P7727; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Mrazkova B, 2018, AGING-US, V10, P434, DOI 10.18632/aging.101404; Nayeem N, 1999, J CELL SCI, V112, P4739; Nock ML, 2006, EXP NEUROL, V202, P262, DOI 10.1016/j.expneurol.2006.05.029; Oshiro H, 2015, GENES CELLS, V20, P108, DOI 10.1111/gtc.12205; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; POLTORAK M, 1995, EXP NEUROL, V131, P266, DOI 10.1016/0014-4886(95)90048-9; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; SADOUL K, 1988, J NEUROCHEM, V50, P510, DOI 10.1111/j.1471-4159.1988.tb02941.x; Saftig P, 2015, PROG NEUROBIOL, V135, P1, DOI 10.1016/j.pneurobio.2015.10.003; Saint-Andre V, 2011, NAT STRUCT MOL BIOL, V18, P337, DOI 10.1038/nsmb.1995; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Sewduth RN, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093036; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Smallwood A, 2012, GENOME RES, V22, P1426, DOI 10.1101/gr.124818.111; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Smothers JF, 2001, MOL CELL BIOL, V21, P2555, DOI 10.1128/MCB.21.7.2555-2569.2001; Soria G, 2013, CELL CYCLE, V12, P422, DOI 10.4161/cc.23215; Stephens GE, 2005, BIOCHEMISTRY-US, V44, P13394, DOI 10.1021/bi051006+; Strekalova H, 2006, NEUROBIOL AGING, V27, P1, DOI 10.1016/j.neurobiolaging.2004.11.013; Sytnyk V, 2017, TRENDS NEUROSCI, V40, P295, DOI 10.1016/j.tins.2017.03.003; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Wakabayashi Y, 2008, PROG NEURO-PSYCHOPH, V32, P1199, DOI 10.1016/j.pnpbp.2008.03.005; Xiao MF, 2009, J NEUROSCI, V29, P14752, DOI 10.1523/JNEUROSCI.4860-09.2009; Zhang C, 2018, CARDIOVASC RES, V114, P443, DOI 10.1093/cvr/cvx236; Zhou LJ, 2012, J BIOL CHEM, V287, P25927, DOI 10.1074/jbc.M112.377465	73	4	4	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22074	10.1096/fj.202100816R	http://dx.doi.org/10.1096/fj.202100816R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34859928				2022-12-28	WOS:000734992000047
J	Liu, L; Cao, Q; Gao, WW; Li, BY; Zeng, C; Xia, ZY; Zhao, B				Liu, Lian; Cao, Quan; Gao, Wenwei; Li, Bing-yu; Zeng, Cheng; Xia, Zhongyuan; Zhao, Bo			Melatonin ameliorates cerebral ischemia-reperfusion injury in diabetic mice by enhancing autophagy via the SIRT1-BMAL1 pathway	FASEB JOURNAL			English	Article						autophagy; cerebral ischemia-reperfusion; diabetes; melatonin	PANCREATIC BETA-CELLS; STRESS HYPERGLYCEMIA; CIRCADIAN CLOCK; EXPERIMENTAL-MODELS; SIGNALING PATHWAY; OXIDATIVE STRESS; STROKE; APOPTOSIS; PROTECTS; BRAIN	Diabetic brains are more vulnerable to ischemia-reperfusion injury. Previous studies have proved that melatonin could protect against cerebral ischemia-reperfusion (CIR) injury in non-diabetic stroke models; however, its roles and the underlying mechanisms against CIR injury in diabetic mice remain unknown. Streptozotocin-induced diabetic mice and high-glucose-cultured HT22 cells were exposed to melatonin, with or without administration of the autophagy inhibitor 3-methyladenine (3-MA) and the specifically silent information regulator 1 (SIRT1) inhibitor EX527, and then subjected to CIR or oxygen-glucose deprivation/reperfusion operation. We found that diabetic mice showed aggravated brain damage, increased apoptosis and oxidative stress, and deficient autophagy following CIR compared with non-diabetic counterparts. Melatonin treatment exhibited improved histological damage, neurological outcomes, and cerebral infarct size. Intriguingly, melatonin markedly increased cell survival, anti-oxidative and anti-apoptosis effects, and significantly enhanced autophagy. However, these effects were largely attenuated by 3-MA or EX527. Additionally, our cellular experiments demonstrated that melatonin increased the SIRT1-BMAL1 pathway-related proteins' expression in a dose-dependent manner. In conclusion, these results indicate that melatonin treatment can protect against CIR-induced brain damage in diabetic mice, which may be achieved by the autophagy enhancement mediated by the SIRT1-BMAL1 pathway.	[Liu, Lian; Li, Bing-yu; Zeng, Cheng; Xia, Zhongyuan; Zhao, Bo] Wuhan Univ, Dept Anesthesiol, Renmin Hosp, Wuhan 430060, Hubei, Peoples R China; [Cao, Quan] Wuhan Univ, Dept Ultrasound Imaging, Renmin Hosp, Wuhan, Peoples R China; [Gao, Wenwei] Wuhan Univ, Crit Care Med, Renmin Hosp, Wuhan, Peoples R China; [Cao, Quan] Wuhan Univ, Dept Nephrol, Zhongnan Hosp, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University	Zhao, B (corresponding author), Wuhan Univ, Dept Anesthesiol, Renmin Hosp, Wuhan 430060, Hubei, Peoples R China.	zb14526@163.com			National Natural Science Foundation of China [81471844, 81901994]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81471844 and 81901994	Al-Khaldi A, 2019, BMC ENDOCR DISORD, V19, DOI 10.1186/s12902-019-0350-y; Al-Rubeaan K, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/4132589; Amaral FG, 2014, J PINEAL RES, V57, P67, DOI 10.1111/jpi.12144; [Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; Bejot Y, 2010, DIABETES METAB, V36, pS84, DOI 10.1016/S1262-3636(10)70472-9; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Carloni S, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12434; Caron AZ, 2014, FASEB J, V28, P1306, DOI 10.1096/fj.13-243568; Chen BH, 2018, BIOMED PHARMACOTHER, V108, P687, DOI 10.1016/j.biopha.2018.09.077; Chen RF, 2015, NEURAL REGEN RES, V10, P1433, DOI 10.4103/1673-5374.165511; Codogno P, 2010, CELL METAB, V11, P449, DOI 10.1016/j.cmet.2010.05.006; Deng HY, 2016, NEUROCHEM RES, V41, P2367, DOI 10.1007/s11064-016-1950-9; Desposito D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09721-0; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Elgebaly MM, 2019, J STROKE CEREBROVASC, V28, P1413, DOI 10.1016/j.jstrokecerebrovasdis.2019.02.005; Feidantsis K, 2018, NUTR METAB CARDIOVAS, V28, P952, DOI 10.1016/j.numecd.2018.06.005; Forte M, 2020, AUTOPHAGY, V16, P1468, DOI 10.1080/15548627.2019.1687215; Guo XY, 2019, LIFE SCI, V239, DOI 10.1016/j.lfs.2019.117020; Haley MJ, 2019, J CEREBR BLOOD F MET, V39, P1026, DOI 10.1177/0271678X17744718; Hou JL, 2011, CURR NEUROVASC RES, V8, P220, DOI 10.2174/156720211796558069; Hu YY, 2017, NEUROSCI LETT, V653, P105, DOI 10.1016/j.neulet.2016.11.050; Hwang JW, 2014, FASEB J, V28, P176, DOI 10.1096/fj.13-232629; Ishii T, 2013, FASEB J, V27, P1362, DOI 10.1096/fj.12-221325; Ji YQ, 2017, NEUROSCIENCE, V362, P13, DOI 10.1016/j.neuroscience.2017.08.032; Kampmann U, 2021, J PINEAL RES, V70, DOI 10.1111/jpi.12706; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Karamitri A, 2019, NAT REV ENDOCRINOL, V15, P105, DOI 10.1038/s41574-018-0130-1; Khapre RV, 2014, AGING-US, V6, P48, DOI 10.18632/aging.100633; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Kryl'skii ED, 2019, NEUROSCIENCE, V406, P653, DOI 10.1016/j.neuroscience.2019.01.046; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li W, 2020, BIOMED PHARMACOTHER, V121, DOI 10.1016/j.biopha.2019.109563; Linnemann AK, 2017, FASEB J, V31, P4140, DOI 10.1096/fj.201700061RR; Liu LL, 2019, LIFE SCI, V239, DOI 10.1016/j.lfs.2019.117036; Luitse MJA, 2012, LANCET NEUROL, V11, P261, DOI 10.1016/S1474-4422(12)70005-4; Ma D, 2012, AUTOPHAGY, V8, P124, DOI 10.4161/auto.8.1.18081; Manev H, 1996, FASEB J, V10, P1546, DOI 10.1096/fasebj.10.13.8940301; Marik PE, 2013, CRIT CARE MED, V41, pE93, DOI 10.1097/CCM.0b013e318283d124; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mazzoccoli G, 2015, JIMD REP, V18, P93, DOI 10.1007/8904_2014_354; de Assis LVM, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00185; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Mukherjee D, 2009, BEST PRACT RES CL EN, V23, P335, DOI 10.1016/j.beem.2008.10.015; Nopparat C, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12407; Ozkan N, 2018, ULUS TRAVMA ACIL CER, V24, P1, DOI 10.5505/tjtes.2017.23539; Petrosillo G, 2006, FASEB J, V20, P269, DOI 10.1096/fj.05-4692com; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; Qiao L, 2017, ONCOTARGET, V8, P80612, DOI 10.18632/oncotarget.20811; Riehle C, 2014, CIRC J, V78, P2569, DOI 10.1253/circj.CJ-14-1080; Salehi B, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070681; Shi S, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181614; Sun JD, 2019, NEUROPSYCH DIS TREAT, V15, P2991, DOI 10.2147/NDT.S220224; Sweetnam D, 2012, J NEUROSCI, V32, P5132, DOI 10.1523/JNEUROSCI.5075-11.2012; Tamaru T, 2003, GENES CELLS, V8, P973, DOI 10.1046/j.1365-2443.2003.00686.x; Tong X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130047; Tosches MA, 2014, CELL, V159, P46, DOI 10.1016/j.cell.2014.07.042; Tziomalos K, 2017, METABOLISM, V67, P99, DOI 10.1016/j.metabol.2016.11.011; Venkat P, 2018, STEM CELL TRANSL MED, V7, P451, DOI 10.1002/sctm.18-0014; Vinatier C, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00706; Wang B, 2016, FREE RADICAL BIO MED, V96, P89, DOI 10.1016/j.freeradbiomed.2016.03.038; Wang P, 2018, PROG NEUROBIOL, V163, P98, DOI 10.1016/j.pneurobio.2018.01.001; Wang YL, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4854732; Ward R, 2019, PHARMACOL RES, V142, P237, DOI 10.1016/j.phrs.2019.01.035; Wei N, 2019, BIOMED PHARMACOTHER, V110, P203, DOI 10.1016/j.biopha.2018.11.060; Xian WJ, 2019, BRAIN RES, V1711, P83, DOI 10.1016/j.brainres.2019.01.013; Xiong XW, 2012, J BIOL CHEM, V287, P39107, DOI 10.1074/jbc.M112.412569; Xu XM, 2013, J BIOL CHEM, V288, P18077, DOI 10.1074/jbc.M113.474650; Yang D, 2013, BRAIN RES, V1517, P104, DOI 10.1016/j.brainres.2013.04.015; Yang HP, 2016, PHARM BIOL, V54, P2288, DOI 10.3109/13880209.2016.1155625; Yang JH, 2020, FASEB J, V34, P12324, DOI 10.1096/fj.202001252R; Yang Y, 2015, J PINEAL RES, V58, P61, DOI 10.1111/jpi.12193; Yao HW, 2015, AM J RESP CELL MOL, V53, P782, DOI 10.1165/rcmb.2014-0474OC; Ye YZ, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00553; Yu LM, 2021, J PINEAL RES, V70, DOI 10.1111/jpi.12698; Zanuto R, 2013, J PINEAL RES, V55, P156, DOI 10.1111/jpi.12056; Zhang J, 2018, CELL PHYSIOL BIOCHEM, V51, P1448, DOI 10.1159/000495593; Zhang L, 2016, STROKE, V47, P2112, DOI 10.1161/STROKEAHA.115.012578; Zhang WX, 2019, LIFE SCI, V217, P8, DOI 10.1016/j.lfs.2018.11.055; Zhao B, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/8520856; Zhou B, 2017, MOL MED REP, V16, P3648, DOI 10.3892/mmr.2017.7033; Zhou H, 2014, J NEUROSCI, V34, P2967, DOI 10.1523/JNEUROSCI.1948-13.2014	82	9	9	6	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22040	10.1096/fj.202002718RR	http://dx.doi.org/10.1096/fj.202002718RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34800293				2022-12-28	WOS:000722321300048
J	Wang, QJ; Guo, Y; Yao, CY; Zhang, KH; Li, Q; Shan, CH; Liu, P; Wang, MZ; Zhu, F; An, L; Tian, JH; Wu, ZH				Wang, Qiang-Jun; Guo, Yao; Yao, Chun-Yan; Zhang, Ke-Hao; Li, Qin; Shan, Chun-Hua; Liu, Peng; Wang, Mei-Zhi; Zhu, Feng; An, Lei; Tian, Jian-Hui; Wu, Zhong-Hong			Loss of diurnal behavioral rhythms and impaired lipid metabolism in growing pigs with mistimed feeding	FASEB JOURNAL			English	Article						behavioral rhythms; circadian rhythm; feeding time; growing pig; metabolic syndrome	GUT MICROBIOTA; OXIDATIVE STRESS; CIRCADIAN CLOCK; HEALTH; DIET; LIPOPOLYSACCHARIDE; ADIPOSITY; RECEPTOR; PATTERN; ANXIETY	The misalignment of eating time and the endogenous circadian rhythm impairs the body's ability to maintain homeostasis. Although it is well established that children and growing animals differ from adults in their energy metabolism and behavioral patterns, little is known about how mistimed feeding disturbs the diurnal rhythms of behavior and metabolism in children and growing diurnal animals. In this study, growing pigs (diurnal animal) were randomly assigned to the daytime-restricted feeding (DRF) and nighttime-restricted feeding (NRF) groups for 5 weeks. Compared with observations in the DRF group, NRF disrupted the diurnal rhythm of behavior and clock genes and lowered the serum ghrelin, dopamine, and serotonin levels during the daytime and nighttime. Microbiome analysis results suggested that NRF altered the diurnal rhythm and composition of the gut microbiota, and increased log-ratios of Catenibacterium:Butyrivibrio and Streptococcus:Butyrivibrio. Based on the serum proteome, the results further revealed that rhythmic and upregulated proteins in NRF were mainly involved in oxidative stress, lipid metabolism, immunity, and cancer biological pathways. Serum physiological indicators further confirmed that NRF decreased the concentration of melatonin and fibroblast growth factor 21 during the daytime and nighttime, increased the diurnal amplitude and concentrations of very-low-density lipoprotein cholesterol, triglyceride, and total cholesterol, and increased the apolipoprotein B/ApoA1 ratio, which is a marker of metabolic syndrome. Taken together, this study is the first to reveal that mistimed feeding disrupts the behavioral rhythms of growing pigs, reprograms gut microbiota composition, reduces the serum levels of hormones associated with fighting depression and anxiety, and increases the risk of lipid metabolic dysregulation.	[Wang, Qiang-Jun; Guo, Yao; Yao, Chun-Yan; Zhang, Ke-Hao; Li, Qin; Shan, Chun-Hua; Liu, Peng; Wang, Mei-Zhi; Zhu, Feng; Wu, Zhong-Hong] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China; [An, Lei; Tian, Jian-Hui] China Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod, Minist Agr & Rural Affairs,Natl Engn Lab Anim Bre, Beijing, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Wu, ZH (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	wuzhh@cau.edu.cn	An, Lei/GQB-0039-2022	Guo, Yao/0000-0002-4691-5623	National Key Research and Development Program of China [2016YFD0500506]; Beijing Innovation Consortium of Agriculture Research System [BAIC02-2021]; China Agriculture Research System [CARS-43-D-1]	National Key Research and Development Program of China; Beijing Innovation Consortium of Agriculture Research System; China Agriculture Research System	National Key Research and Development Program of China, Grant/Award Number: 2016YFD0500506; Beijing Innovation Consortium of Agriculture Research System, Grant/Award Number: BAIC02-2021; China Agriculture Research System, Grant/Award Number: CARS-43-D-1	Adeoye AM, 2015, J CLIN HYPERTENS, V17, P880, DOI 10.1111/jch.12595; Aiello I, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz4530; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Benedict C, 2016, MOL METAB, V5, P1175, DOI 10.1016/j.molmet.2016.10.003; Bian SB, 2021, ANN NY ACAD SCI, V1484, P74, DOI 10.1111/nyas.14466; Blasiole DA, 2008, J BIOL CHEM, V283, P11374, DOI 10.1074/jbc.M710457200; Bo TB, 2020, ISME J, V14, P2625, DOI 10.1038/s41396-020-0711-6; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Borges MC, 2013, NUTRITION, V29, P443, DOI 10.1016/j.nut.2012.06.008; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Challet E, 2019, NAT REV ENDOCRINOL, V15, P393, DOI 10.1038/s41574-019-0210-x; Chavan R, 2017, BIOL OPEN, V6, P1, DOI 10.1242/bio.021519; Chen S, 2013, INFLAMMATION, V36, P968, DOI 10.1007/s10753-013-9628-9; Choudhury R, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01886; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Daut RA, 2019, FRONT NEUROENDOCRIN, V54, DOI 10.1016/j.yfrne.2019.04.003; Depner CM, 2018, P NATL ACAD SCI USA, V115, pE5390, DOI 10.1073/pnas.1714813115; Dortland AKBV, 2013, PSYCHOSOM MED, V75, P83, DOI 10.1097/PSY.0b013e318274d30f; Dube N, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0547-2; Eisenhofer G, 1997, J CLIN ENDOCR METAB, V82, P3864, DOI 10.1210/jc.82.11.3864; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Gallardo-Becerra L, 2020, MICROB CELL FACT, V19, DOI 10.1186/s12934-020-01319-y; Gao ZG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00020; Guo Y., 2021, FASEB J, V35; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Han H, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01093-y; Heinritz SN, 2013, NUTR RES REV, V26, P191, DOI 10.1017/S0954422413000152; Hornedo-Ortega R, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700383; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Hyun Y, 1997, J ANIM SCI, V75, P1443; Jha PK, 2015, MOL CELL ENDOCRINOL, V418, P74, DOI 10.1016/j.mce.2015.01.024; Kaufman A, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100057; Kecklund G, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5210; Kleiman SC, 2015, PSYCHOSOM MED, V77, P969, DOI 10.1097/PSY.0000000000000247; Kogevinas M, 2018, INT J CANCER, V143, P2380, DOI 10.1002/ijc.31649; Koritala BSC, 2021, J PINEAL RES, V70, DOI 10.1111/jpi.12726; Krell-Roesch J, 2021, J NEUROPSYCH CLIN N, V33, P64, DOI 10.1176/appi.neuropsych.20050103; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Lee YH, 2011, CLIN ENDOCRINOL, V74, P579, DOI 10.1111/j.1365-2265.2010.03953.x; Linnaranta O, 2020, ANN BEHAV MED, V54, P680, DOI 10.1093/abm/kaaa012; Ma B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199237; Medic G, 2017, NAT SCI SLEEP, V9, P151, DOI 10.2147/NSS.S134864; Mirzaei R, 2021, BIOMED PHARMACOTHER, V139, DOI 10.1016/j.biopha.2021.111619; Mishra SP, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8060154; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Morton JT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10656-5; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Niiranen J, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-040848; NIIYAMA M, 1985, JPN J VET RES, V33, P1; Norscia I, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.630164; Petersen C, 2019, SCIENCE, V365, P340, DOI 10.1126/science.aat9351; Robles MS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004047; Rogers GB, 2016, MOL PSYCHIATR, V21, P738, DOI 10.1038/mp.2016.50; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Sandhu KV, 2017, TRANSL RES, V179, P223, DOI 10.1016/j.trsl.2016.10.002; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Segers A, 2021, NAT REV GASTRO HEPAT, V18, P239, DOI 10.1038/s41575-020-00401-5; Sen P, 2021, TRENDS MOL MED, V27, P935, DOI 10.1016/j.molmed.2021.07.004; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Tachibana M, 2019, J CLIN INVEST, V129, P1272, DOI 10.1172/JCI124853; Tahara Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19836-7; Teixeira TFS, 2013, BRIT J NUTR, V109, P914, DOI 10.1017/S0007114512002723; Torres-Fuentes C, 2019, FASEB J, V33, P13546, DOI 10.1096/fj.201901433R; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van de Wouw M, 2017, J NUTR, V147, P727, DOI 10.3945/jn.116.240481; van Erp RJJ., 2019, BRIT J NUTR, V123, P1; Wang QJ, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9060346; Watson NF, 2017, SLEEP, V40, DOI 10.1093/sleep/zsw019; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Yang G, 2014, ANTIOXID REDOX SIGN, V21, P17, DOI 10.1089/ars.2013.5539; Yang QM, 2018, COMPUT ELECTRON AGR, V155, P453, DOI 10.1016/j.compag.2018.11.002; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Yoshida J, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6262-3; Zaibi MS, 2010, FEBS LETT, V584, P2381, DOI 10.1016/j.febslet.2010.04.027; Zarrinpar A, 2014, CELL METAB, V20, P1006, DOI 10.1016/j.cmet.2014.11.008; Zhang X, 2015, CLIN CANCER RES, V21, P1225, DOI 10.1158/1078-0432.CCR-14-1761; Zhong HZ, 2019, MICROBIOME, V7, DOI 10.1186/s40168-018-0608-z; Zhong L, 2010, INFLAMMATION, V33, P353, DOI 10.1007/s10753-010-9193-4	80	1	1	8	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21972	10.1096/fj.202100768R	http://dx.doi.org/10.1096/fj.202100768R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34613642				2022-12-28	WOS:000712009200020
J	Yanda, MK; Cebotaru, L				Yanda, Murali K.; Cebotaru, Liudmila			VX-809 mitigates disease in a mouse model of autosomal dominant polycystic kidney disease bearing the R3277C human mutation	FASEB JOURNAL			English	Article						absorption; CFTR; cysts; polycystic kidney disease; secretion; VX-809	CFTR INHIBITORS; CL-CONDUCTANCE; CYST FORMATION; IN-VITRO; VASOPRESSIN; DELTA-F508-CFTR; PROLIFERATION; EXPRESSION; CORRECTORS; TOLVAPTAN	Autosomal dominant. polycystic kidney disease (ADPKD) is associated with the formation of renal cysts. We have devised a therapeutic approach, based on reversing the cyst phenotype from secretion to absorption by using VX-809, a modulator of the cystic fibrosis transmembrane regulator trafficking and processing. Our goal is to test VX-809 in RC/RC mice bearing the R3277C human mutation to demonstrate its therapeutic potential. We found that by 5 months of age, RC/RC mice had large cysts and impaired renal function, but when treated with VX-809 between the ages of 3 and 5 months, or 6 and 8 months, the cyst area was reduced in both groups, suggesting that VX-809 had shrunk previously existing cysts. After 2 months of treatment, the cyst size was lower than that of untreated animals of the same age. Our co-localization studies confirmed that cystic fibrosis transmembrane conductance regulator (cFrit) is found predominately at the apical membrane in the untreated animals of each age group, consistent with its role in Cl- secretion; after VX-809 treatment, the basolateral membrane co-localization of CFTR increased similar to 4-fold. accompanied by a decrease of similar to 2-3-fold in its apical co-localization, indicating that VX-809 alters the phenotype to favor fluid absorption. Sodium/hydrogen exchanger and epithelial sodium channel, found in normal kidneys at the apical membrane, were almost absent from the cysts. VX-809 restored both levels toward normal. HSP27 is highly expressed in RC/RC mice and lowered toward normal by VX-809. Our demonstration of cyst reduction. improved renal function, and generation of an absorptive phenotype all strongly support the therapeutic potential of VX-809 as a treatment for ADPKD. We show here in an animal model of slowly progressing cyst formation typical of human ADPKD that VX-809 reduces the growth of already established cysts. The magnitude of the effect in the RC/RC mouse model when compared to previous experiments using the same mouse model to evaluate tolvaptan indicates that CFTR modulators warrant further development as a treatment for ADPKD.	[Yanda, Murali K.; Cebotaru, Liudmila] Johns Hopkins Univ, Dept Med, Sch Med, Div Gastroenterol & Hepatol, Hunterian Bldg,Room 414-725 N Wolfe St, Baltimore, MD 21205 USA	Johns Hopkins University	Cebotaru, L (corresponding author), Johns Hopkins Univ, Dept Med, Sch Med, Div Gastroenterol & Hepatol, Hunterian Bldg,Room 414-725 N Wolfe St, Baltimore, MD 21205 USA.	lcebotaru@jhmi.edu		Cebotaru, Liudmila/0000-0002-4362-8995	NIH [DK125272]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was funded by NIH Grant #DK125272 to LC	Arroyo J, 2021, KIDNEY INT, V99, P1392, DOI 10.1016/j.kint.2021.01.028; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bidaud-Meynard A., 2018, J BIORXIV; Calvet JP, 2001, SEMIN NEPHROL, V21, P107, DOI 10.1053/snep.2001.20929; Chou CL, 2000, J BIOL CHEM, V275, P36839, DOI 10.1074/jbc.M005552200; Cohen-Cymberknoh M, 2011, AM J RESP CRIT CARE, V183, P1463, DOI 10.1164/rccm.201009-1478CI; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Devuyst O, 2013, CURR OPIN NEPHROL HY, V22, P459, DOI 10.1097/MNH.0b013e3283621510; Drumm M, 1999, J CLIN INVEST, V103, P1369, DOI 10.1172/JCI7119; FRIEDLANDER G, 1986, FEBS LETT, V198, P38, DOI 10.1016/0014-5793(86)81180-2; GRANTHAM JJ, 1989, T ASSOC AM PHYSICIAN, V102, P158; Hanaoka K, 1996, AM J PHYSIOL-CELL PH, V270, pC389, DOI 10.1152/ajpcell.1996.270.1.C389; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179, DOI 10.1681/ASN.V1171179; Higashihara E, 2011, CLIN J AM SOC NEPHRO, V6, P2499, DOI 10.2215/CJN.03530411; Hopp K, 2015, J AM SOC NEPHROL, V26, P39, DOI 10.1681/ASN.2013121312; Hopp K, 2012, J CLIN INVEST, V122, P4257, DOI 10.1172/JCI64313; Ikeda M, 2006, CELL PHYSIOL BIOCHEM, V18, P9, DOI 10.1159/000095133; Jiang ST, 2006, AM J PATHOL, V168, P205, DOI 10.2353/ajpath.2006.050342; Koeppen B.M., 2012, RENAL PHYSL E BOOK M; Li HY, 2009, BIODRUGS, V23, P203, DOI 10.2165/11313570-000000000-00000; Lopes-Pacheco M, 2015, J BIOL CHEM, V290, P25636, DOI 10.1074/jbc.M115.671925; MAEDA Y, 1993, AM J PHYSIOL, V265, pF15, DOI 10.1152/ajprenal.1993.265.1.F15; Morales MM, 2001, PFLUG ARCH EUR J PHY, V443, P202, DOI 10.1007/s004240100671; Ong ACM, 2015, KIDNEY INT, V88, P699, DOI 10.1038/ki.2015.207; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; QUINTON PM, 1989, ANN NY ACAD SCI, V574, P438; QUINTON PM, 1991, ADV EXP MED BIOL, V290, P159; REDDY MM, 1989, AM J PHYSIOL, V257, pC727, DOI 10.1152/ajpcell.1989.257.4.C727; Schmid HA, 2008, MOL CELL ENDOCRINOL, V286, P69, DOI 10.1016/j.mce.2007.09.006; Skach William R, 2007, Biochem J, V406, pe1; Skach WR, 2006, CELL, V127, P673, DOI 10.1016/j.cell.2006.11.002; STAR RA, 1988, J CLIN INVEST, V81, P1879, DOI 10.1172/JCI113534; Staufer K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228586; Sullivan LP, 1998, PHYSIOL REV, V78, P1165, DOI 10.1152/physrev.1998.78.4.1165; Tarran R, 2001, J GEN PHYSIOL, V118, P223, DOI 10.1085/jgp.118.2.223; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Tradtrantip L, 2009, J MED CHEM, V52, P6447, DOI 10.1021/jm9009873; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Verkman AS, 2006, CURR PHARM DESIGN, V12, P2235, DOI 10.2174/138161206777585148; Yamaguchi T, 2000, KIDNEY INT, V57, P1460, DOI 10.1046/j.1523-1755.2000.00991.x; Yanda MK, 2019, J BIOL CHEM, V294, P17090, DOI 10.1074/jbc.RA119.010320; Yanda MK, 2018, J BIOL CHEM, V293, P11513, DOI 10.1074/jbc.RA118.001846; Yang BX, 2008, J AM SOC NEPHROL, V19, P1300, DOI 10.1681/ASN.2007070828	44	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21987	10.1096/fj.202101315R	http://dx.doi.org/10.1096/fj.202101315R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34662459	Green Accepted			2022-12-28	WOS:000712009200029
J	Ferrara, PJ; Verkerke, ARP; Maschek, JA; Shahtout, JL; Siripoksup, P; Eshima, H; Johnson, JM; Petrocelli, JJ; Mahmassani, ZS; Green, TD; McClung, JM; Cox, JE; Drummond, MJ; Funai, K				Ferrara, Patrick J.; Verkerke, Anthony R. P.; Maschek, J. Alan; Shahtout, Justin L.; Siripoksup, Piyarat; Eshima, Hiroaki; Johnson, Jordan M.; Petrocelli, Jonathan J.; Mahmassani, Ziad S.; Green, Thomas D.; McClung, Joseph M.; Cox, James E.; Drummond, Micah J.; Funai, Katsuhiko			Low lysophosphatidylcholine induces skeletal muscle myopathy that is aggravated by high-fat diet feeding	FASEB JOURNAL			English	Article						diabetes; lysophospholipid; myopathy; skeletal muscle	INSULIN SENSITIVITY; RAT; METABOLISM; STRENGTH; QUALITY; TRIGLYCERIDE; SPACEFLIGHT; VELOCITY; FIBERS; HEALTH	Obesity alters skeletal muscle lipidome and promotes myopathy, but it is unknown whether aberrant muscle lipidome contributes to the reduction in skeletal muscle contractile force-generating capacity. Comprehensive lipidomic analyses of mouse skeletal muscle revealed a very strong positive correlation between the abundance of lysophosphatidylcholine (lyso-PC), a class of lipids that is known to be downregulated with obesity, with maximal tetanic force production. The level of lyso-PC is regulated primarily by lyso-PC acyltransferase 3 (LPCAT3), which acylates lyso-PC to form phosphatidylcholine. Tamoxifen-inducible skeletal muscle-specific overexpression of LPCAT3 (LPCAT3-MKI) was sufficient to reduce muscle lyso-PC content in both standard chow diet- and high-fat diet (HFD)-fed conditions. Strikingly, the assessment of skeletal muscle force-generating capacity ex vivo revealed that muscles from LPCAT3-MKI mice were weaker regardless of diet. Defects in force production were more apparent in HFD-fed condition, where tetanic force production was 40% lower in muscles from LPCAT3-MKI compared to that of control mice. These observations were partly explained by reductions in the cross-sectional area in type IIa and IIx fibers, and signs of muscle edema in the absence of fibrosis. Future studies will pursue the mechanism by which LPCAT3 may alter protein turnover to promote myopathy.	[Ferrara, Patrick J.; Verkerke, Anthony R. P.; Maschek, J. Alan; Shahtout, Justin L.; Siripoksup, Piyarat; Eshima, Hiroaki; Johnson, Jordan M.; Petrocelli, Jonathan J.; Mahmassani, Ziad S.; Cox, James E.; Drummond, Micah J.; Funai, Katsuhiko] Univ Utah, Diabet & Metab Res Ctr, 15N,2030E, Salt Lake City, UT 84112 USA; [Ferrara, Patrick J.; Verkerke, Anthony R. P.; Johnson, Jordan M.; Funai, Katsuhiko] Univ Utah, Dept Nutr & Integrat Physiol, Salt Lake City, UT 84112 USA; [Ferrara, Patrick J.; Verkerke, Anthony R. P.; Johnson, Jordan M.; Green, Thomas D.; McClung, Joseph M.; Funai, Katsuhiko] East Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC 27858 USA; [Ferrara, Patrick J.; Drummond, Micah J.; Funai, Katsuhiko] Univ Utah, Mol Med Program, Salt Lake City, UT 84112 USA; [Maschek, J. Alan; Cox, James E.] Univ Utah, Metabol Mass Spectrometry & Prote Core, Salt Lake City, UT 84112 USA; [Shahtout, Justin L.; Siripoksup, Piyarat; Petrocelli, Jonathan J.; Mahmassani, Ziad S.; Drummond, Micah J.; Funai, Katsuhiko] Univ Utah, Dept Phys Therapy & Athlet Training, Salt Lake City, UT 84112 USA; [Eshima, Hiroaki] Nagasaki Int Univ, Dept Int Tourism, Sasebo, Japan; [Cox, James E.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of North Carolina; East Carolina University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Nagasaki International University; Utah System of Higher Education; University of Utah	Funai, K (corresponding author), Univ Utah, Diabet & Metab Res Ctr, 15N,2030E, Salt Lake City, UT 84112 USA.	kfunai@utah.edu		Johnson, Jordan/0000-0002-2971-2322; SHAHTOUT, JUSTIN/0000-0003-4111-4293	NIH [DK107397, DK109888, AG063077, AG050781, HL125695]; American Heart Association [18PRE33960491, 19PRE34380991]; University of Utah Center on Aging; University of Utah [S10 OD016232, S10 OD021505, U54DK110858]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Utah Center on Aging; University of Utah	NIH, Grant/Award Number: DK107397, DK109888, AG063077, AG050781 and HL125695; American Heart Association, Grant/Award Number: 18PRE33960491 and 19PRE34380991; University of Utah Center on Aging; Larry H. and Gail Miller Family Foundation; University of Utah, Grant/Award Number: S10 OD016232, S10 OD021505 and U54DK110858	Almurdhi MM, 2016, DIABETES CARE, V39, P441, DOI 10.2337/dc15-0995; Aversa Z, 2019, BONE, V127, P26, DOI 10.1016/j.bone.2019.05.021; BOTTINELLI R, 1991, J PHYSIOL-LONDON, V437, P655, DOI 10.1113/jphysiol.1991.sp018617; D'Souza DM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00379; Eid S, 2019, DIABETOLOGIA, V62, P1539, DOI 10.1007/s00125-019-4959-1; Eshima H, 2020, J APPL PHYSIOL, V129, P124, DOI 10.1152/japplphysiol.00456.2019; Eshima H, 2020, J APPL PHYSIOL, V128, P1153, DOI 10.1152/japplphysiol.00530.2019; Eto M, 2012, INT J MOL SCI, V13, P16267, DOI 10.3390/ijms131216267; Ferrara PJ, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI135963; Ferrara PJ, 2018, MED SCI SPORT EXER, V50, P2015, DOI 10.1249/MSS.0000000000001673; Funai K, 2016, DIABETES, V65, P358, DOI 10.2337/db15-0659; Funai K, 2013, J CLIN INVEST, V123, P1229, DOI 10.1172/JCI65726; Funai K, 2011, AM J PHYSIOL-ENDOC M, V301, pE245, DOI 10.1152/ajpendo.00152.2011; Heden TD, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax8352; Hinkley JM, 2020, AGING CELL, V19, DOI 10.1111/acel.13135; Johnson JM, 2018, J MOL CELL CARDIOL, V121, P94, DOI 10.1016/j.yjmcc.2018.07.001; Kell RT, 2001, SPORTS MED, V31, P863, DOI 10.2165/00007256-200131120-00003; Kelley DE, 2001, DIABETES CARE, V24, P933, DOI 10.2337/diacare.24.5.933; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Martignoni Marcus E, 2003, Mol Cancer, V2, P36, DOI 10.1186/1476-4598-2-36; Martin SA, 2014, J LIPID RES, V55, P782, DOI 10.1194/jlr.D044636; MARTIN TP, 1988, J APPL PHYSIOL, V65, P2318, DOI 10.1152/jappl.1988.65.5.2318; McMahon CJ, 2010, AM J ROENTGENOL, V194, pW284, DOI 10.2214/AJR.10.4247; MIU B, 1990, FASEB J, V4, P64, DOI 10.1096/fasebj.4.1.2136839; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Paran CW, 2015, BBA-MOL CELL BIOL L, V1851, P1530, DOI 10.1016/j.bbalip.2015.09.001; Park SW, 2006, DIABETES, V55, P1813, DOI 10.2337/db05-1183; Pellegrino MA, 2003, J PHYSIOL-LONDON, V546, P677, DOI 10.1113/jphysiol.2002.027375; Powers SK, 2005, AM J PHYSIOL-REG I, V288, pR337, DOI 10.1152/ajpregu.00469.2004; Rashid T, 2019, EMBO J, V38, DOI 10.15252/embj.201899576; Rizzoli R, 2013, CALCIFIED TISSUE INT, V93, P101, DOI 10.1007/s00223-013-9758-y; Saini-Chohan HK, 2012, J LIPID RES, V53, P4, DOI 10.1194/jlr.R012120; Schweitzer GG, 2019, FASEB J, V33, P652, DOI 10.1096/fj.201800361R; Senoo N, 2020, MUSCLE NERVE, V62, P413, DOI 10.1002/mus.26993; Shindou H, 2013, J BIOCHEM, V154, P21, DOI 10.1093/jb/mvt048; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Toniolo L, 2008, AM J PHYSIOL-CELL PH, V295, pC1535, DOI 10.1152/ajpcell.00093.2008; Vance DE, 2008, N COMP BIOC, pV, DOI 10.1016/B978-044453219-0.50001-5; Verkerke ARP, 2019, NAT METAB, V1, P876, DOI 10.1038/s42255-019-0111-2; Vincent AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30610	40	5	6	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21867	10.1096/fj.202101104R	http://dx.doi.org/10.1096/fj.202101104R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34499764	Green Accepted			2022-12-28	WOS:000702238200059
J	Talbi, K; Cabrita, I; Kraus, A; Hofmann, S; Skoczynski, K; Kunzelmann, K; Buchholz, B; Schreiber, R				Talbi, Khaoula; Cabrita, Ines; Kraus, Andre; Hofmann, Sascha; Skoczynski, Kathrin; Kunzelmann, Karl; Buchholz, Bjoern; Schreiber, Rainer			The chloride channel CFTR is not required for cyst growth in an ADPKD mouse model	FASEB JOURNAL			English	Article						ADPKD; CFTR; cyst growth; proliferation; TMEM16A	FLUID SECRETION; FIBROSIS; EXPRESSION; GENE; EPITHELIUM; TRANSPORT	Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the development of bilateral renal cysts which enlarge continuously, leading to compression of adjacent intact nephrons. The growing cysts lead to a progressive decline in renal function. Cyst growth is driven by enhanced cell proliferation and chloride secretion into the cyst lumen. Chloride secretion is believed to occur mainly by the cAMP-activated cystic fibrosis transmembrane conductance regulator (CFTR), with some contribution by the calcium-activated chloride channel TMEM16A. However, our previous work suggested TMEM16A as a major factor for renal cyst formation. The contribution of CFTR to cyst formation has never been demonstrated in an adult ADPKD mouse model. We used mice with an inducible tubule-specific Pkd1 knockout, which consistently develop polycystic kidneys upon deletion of Pkd1. Cellular properties, ion currents, and cyst development in these mice were compared with that of mice carrying a co-deletion of Pkd1 and Cftr. Knockout of Cftr did not reveal any significant impact on cyst formation in the ADPKD mouse model. Furthermore, knockout of Cftr did not attenuate the largely augmented cell proliferation observed in Pkd1 knockout kidneys. Patch clamp analysis on primary renal epithelial cells lacking expression of Pkd1 indicated an only marginal contribution of CFTR to whole cell Cl- currents, which were clearly dominated by calcium-activated TMEM16A currents. In conclusion, CFTR does not essentially contribute to renal cyst formation in mice caused by deletion of Pkd1. Enhanced cell proliferation and chloride secretion is caused primarily by upregulation of the calcium-activated chloride channel TMEM16A.	[Talbi, Khaoula; Cabrita, Ines; Hofmann, Sascha; Kunzelmann, Karl; Schreiber, Rainer] Univ Regensburg, Dept Physiol, Univ Str 31, D-93053 Regensburg, Germany; [Kraus, Andre; Skoczynski, Kathrin; Buchholz, Bjoern] Friedrich Alexander Univ Erlangen Nuremberg, Dept Nephrol & Hypertens, Erlangen, Germany	University of Regensburg; University of Erlangen Nuremberg	Schreiber, R (corresponding author), Univ Regensburg, Dept Physiol, Univ Str 31, D-93053 Regensburg, Germany.	rainer.schreiber@ur.de		Buchholz, Bjoern/0000-0003-3730-5425	Deutsche Forschungsgemeinschaft [387509280, SFB 1350]; Interdisciplinary Center for Clinical Research Erlangen [J71]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research Erlangen	Deutsche Forschungsgemeinschaft, Grant/Award Number: 387509280 and SFB 1350; Interdisciplinary Center for Clinical Research Erlangen, Grant/Award Number: project J71	Benedetto R, 2019, J MOL MED, V97, P711, DOI 10.1007/s00109-019-01770-4; Benedetto R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10910-0; Berg P, 2020, J AM SOC NEPHROL, V31, P1711, DOI 10.1681/ASN.2020010053; Brill SR, 1996, P NATL ACAD SCI USA, V93, P10206, DOI 10.1073/pnas.93.19.10206; Buchholz B, 2014, KIDNEY INT, V85, P1058, DOI 10.1038/ki.2013.418; Buchholz B, 2014, J AM SOC NEPHROL, V25, P465, DOI 10.1681/ASN.2013030209; Buchholz B, 2011, J MOL MED-JMM, V89, P251, DOI 10.1007/s00109-010-0715-1; Cabrita I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18104-5; Cabrita I, 2020, J MOL MED, V98, P659, DOI 10.1007/s00109-020-01894-y; Chenevert J, 2012, MODERN PATHOL, V25, P919, DOI 10.1038/modpathol.2012.57; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; Davidow CJ, 1996, KIDNEY INT, V50, P208, DOI 10.1038/ki.1996.304; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Grantham JJ, 2011, NAT REV NEPHROL, V7, P556, DOI 10.1038/nrneph.2011.109; GRANTHAM JJ, 1995, J CLIN INVEST, V95, P195, DOI 10.1172/JCI117638; Guilbault C, 2007, AM J RESP CELL MOL, V36, P1, DOI 10.1165/rcmb.2006-0184TR; Hanaoka K, 1996, AM J PHYSIOL-CELL PH, V270, pC389, DOI 10.1152/ajpcell.1996.270.1.C389; Kraus A, 2018, KIDNEY INT, V94, P887, DOI 10.1016/j.kint.2018.06.008; Kraus A, 2016, PURINERG SIGNAL, V12, P687, DOI 10.1007/s11302-016-9532-5; Lerias J, 2018, CELL SIGNAL, V44, P10, DOI 10.1016/j.cellsig.2018.01.008; Magayr TA, 2020, KIDNEY INT, V98, P420, DOI 10.1016/j.kint.2020.02.008; Magenheimer BS, 2006, J AM SOC NEPHROL, V17, P3424, DOI 10.1681/ASN.2006030295; MANGOOKARIM R, 1995, AM J PHYSIOL-RENAL, V269, pF381, DOI 10.1152/ajprenal.1995.269.3.F381; O'Sullivan DA, 1998, AM J KIDNEY DIS, V32, P976, DOI 10.1016/S0272-6386(98)70072-1; Persu A, 2000, J AM SOC NEPHROL, V11, P2285, DOI 10.1681/ASN.V11122285; Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Ruiz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043265; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Schwiebert EM, 2002, AM J PHYSIOL-RENAL, V282, pF763, DOI 10.1152/ajprenal.0337.2000; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Terryn S, 2011, BBA-MOL BASIS DIS, V1812, P1314, DOI 10.1016/j.bbadis.2011.01.011; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Viau A, 2020, BIOCHEM BIOPH RES CO, V521, P290, DOI 10.1016/j.bbrc.2019.10.074; Wallace DP, 1996, KIDNEY INT, V50, P1327, DOI 10.1038/ki.1996.445; Wilson PD, 1999, J AM SOC NEPHROL, V10, P218; Xu N, 2006, J NEPHROL, V19, P529; Yanda MK, 2019, J BIOL CHEM, V294, P17090, DOI 10.1074/jbc.RA119.010320; Yang BX, 2008, J AM SOC NEPHROL, V19, P1300, DOI 10.1681/ASN.2007070828; YE M, 1993, NEW ENGL J MED, V329, P310, DOI 10.1056/NEJM199307293290503; Zhang C, 2021, J AM SOC NEPHROL, V32, P41, DOI 10.1681/ASN.2020040511	42	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21897	10.1096/fj.202100843R	http://dx.doi.org/10.1096/fj.202100843R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34473378	hybrid, Green Published			2022-12-28	WOS:000702238200077
J	Xie, KY; Chien, SJ; Tan, BCM; Chen, YW				Xie, Ke-Yun; Chien, Shao-Ju; Tan, Bertrand Chin-Ming; Chen, Yun-Wen			RNA editing of 5-HT2CR impairs insulin secretion of pancreatic beta cells via altered store-operated calcium entry	FASEB JOURNAL			English	Article						5-hydroxytryptamine 2C receptor; calcium homeostasis; RNA editing; type II diabetes mellitus	PLASMA-GLUCOSE; FATTY-ACIDS; RECEPTOR; RESISTANCE; NEURONS; DESENSITIZATION; HOMEOSTASIS; EXPRESSION; OBESITY; ENERGY	Recent studies emphasize the importance of 5-HT2C receptor (5-HT2CR) signaling in the regulation of energy homeostasis. The 5-HT2CR is the only G-protein-coupled receptor known to undergo post-transcriptional adenosine to inosine (A-to-I) editing by adenosine deaminase acting on RNA (ADAR). 5-HT2CR has emerged as an important role in the modulation of pancreatic beta cell functions. This study investigated mechanisms behind the effects of palmitic acid (PA) on insulin secretion in different overexpressed 5-HT2CR edited isoforms in pancreatic MIN6 beta cells. Results showed that the expressions of 5HT(2C)R and ADAR2 were upregulated in the pancreatic islets of mice fed with high-fat diet (HFD) compared to control mice. PA treatment significantly induced the expressions of 5-HT2CR and ADAR2 in pancreatic MIN6 beta cells. PA treatment significantly induced the editing of 5-HT2CR in pancreatic MIN6 beta cells. There was no significant difference in cell viability between naive cells and three overexpressed 5-HT2CR edited isoforms in pancreatic MIN6 beta cells. Overexpressed 5-HT2CR edited isoforms showed reduced glucose-stimulated insulin secretion (GSIS) compared with green fluorescent protein (GFP) expressed cells. Moreover, 5-HT2CR edited isoforms displayed reduced endoplasmic reticulum (ER) calcium release and store-operated calcium entry (SOCE) activation, probably through inhibition of stromal interaction molecule 1 trafficking under PA treatment. Altogether, our results show that PA-mediated editing of 5-HT2CR modulates GSIS through alteration of ER calcium release and SOCE activation in pancreatic MIN6 beta cells.	[Xie, Ke-Yun; Chien, Shao-Ju; Chen, Yun-Wen] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 701, Taiwan; [Tan, Bertrand Chin-Ming] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Tan, Bertrand Chin-Ming] Chang Gung Univ, Coll Med, Dept Biomed Sci, Taoyuan, Taiwan; [Tan, Bertrand Chin-Ming] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurosurg, Linkou, Taiwan; [Tan, Bertrand Chin-Ming] Chang Gung Univ, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan	National Cheng Kung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chen, YW (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 701, Taiwan.	yunwen_chen@mail.ncku.edu.tw			Ministry of Science and Technology, Taiwan (MOST) [MOST 106-2320-B-006-058-MY3]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST 106-2320-B-006-058-MY3	Asadzadeh Azizeh, 2019, Avicenna Journal of Medical Biotechnology, V11, P239; Berg KA, 2001, J PHARMACOL EXP THER, V299, P593; Berglund ED, 2013, J CLIN INVEST, V123, P5061, DOI 10.1172/JCI70338; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; Chagraoui A, 2016, PROG NEURO-PSYCHOPH, V66, P120, DOI 10.1016/j.pnpbp.2015.12.006; Chang HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03747-0; Chaudhari S, 2016, EXP BIOL MED, V241, P343, DOI 10.1177/1535370215609693; Chaudhari S, 2014, AM J PHYSIOL-RENAL, V306, pF1069, DOI 10.1152/ajprenal.00463.2013; Chen YF, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-23; Chen YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep22142; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; HASHIMOTO Y, 1985, BIOCHIM BIOPHYS ACTA, V841, P283, DOI 10.1016/0304-4165(85)90070-4; Heisler LK, 2007, GENES BRAIN BEHAV, V6, P491, DOI 10.1111/j.1601-183X.2007.00316.x; Kawahara Y, 2008, J NEUROSCI, V28, P12834, DOI 10.1523/JNEUROSCI.3896-08.2008; Kono T, 2018, DIABETES, V67, P2293, DOI 10.2337/db17-1351; Lanfranco MF, 2009, J NEUROSCI METH, V179, P247, DOI 10.1016/j.jneumeth.2009.01.027; Lazarte J, 2020, CAN J DIABETES, V44, P53, DOI 10.1016/j.jcjd.2019.07.003; Maas Stefan, 2006, RNA Biol, V3, P1; Marion S, 2004, J BIOL CHEM, V279, P2945, DOI 10.1074/jbc.M308742200; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Morabito MV, 2010, NEUROBIOL DIS, V39, P169, DOI 10.1016/j.nbd.2010.04.004; Nelson HA, 2018, EXP BIOL MED, V243, P451, DOI 10.1177/1535370218754524; Niswender CM, 1998, ANN NY ACAD SCI, V861, P38, DOI 10.1111/j.1749-6632.1998.tb10171.x; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1213, DOI 10.1007/BF00422371; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; Pooley EC, 2004, AM J MED GENET B, V126B, P124, DOI 10.1002/ajmg.b.20143; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Sabourin J, 2015, J BIOL CHEM, V290, P30530, DOI 10.1074/jbc.M115.682583; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Slotkin W, 2013, GENOME MED, V5, DOI 10.1186/gm508; Srinivasan K, 2007, INDIAN J MED RES, V125, P451; Tamarina NA, 2008, CELL CALCIUM, V44, P533, DOI 10.1016/j.ceca.2008.03.007; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Werry TD, 2008, PHARMACOL THERAPEUT, V119, P7, DOI 10.1016/j.pharmthera.2008.03.012; Wu HT, 2016, DIABETOLOGIA, V59, P1732, DOI 10.1007/s00125-016-3991-7; Xu Y, 2010, NAT NEUROSCI, V13, P1457, DOI 10.1038/nn.2664; Yang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048611; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054250, 10.1371/journal.pone.0059667]; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042; Zuurbier CJ, 2008, ANESTH ANALG, V106, P135, DOI 10.1213/01.ane.0000297299.91527.74	47	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21929	10.1096/fj.202100265RR	http://dx.doi.org/10.1096/fj.202100265RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34553421				2022-12-28	WOS:000702238200002
J	Cai, J; Huang, L; Tang, HR; Xu, HL; Wang, LJ; Zheng, MH; Yu, HS; Liu, H				Cai, Juan; Huang, Lin; Tang, Hongri; Xu, Hongling; Wang, Lingjun; Zheng, Minghui; Yu, Hongsong; Liu, Hui			Macrophage migration inhibitory factor of Thelazia callipaeda induces M2-like macrophage polarization through TLR4-mediated activation of the PI3K-Akt pathway	FASEB JOURNAL			English	Article						immune escape; macrophage migration inhibitory factor; macrophage polarization; Thelazia callipaeda	NEOSPORA-CANINUM; FUNCTIONAL-CHARACTERIZATION; PLASMODIUM-FALCIPARUM; FACTOR HOMOLOG; HOST; INFECTION; TLR4; MIF	Macrophage migration inhibitory factor (MIF), an immunoregulatory cytokine plays an important role in inflammation and the immune response, and has been described as having a potential role in immune evasion by parasites. Thelazia callipaeda, a vector-borne zoonotic eye worm with a broad host range, has been documented as an agent of ocular infection of thelaziosis. The ability of T. callipaeda to persist in an immunologically competent host has led to the suggestion that it has evolved specific measures to counter immune defenses. To date, whether the immune evasion of T. callipaeda is related to MIF and the possible related signaling pathway and molecular mechanism have remained unclear. In the present study, we examined the effect of T. callipaeda MIF (T. cp-MIF) on macrophages. We analyzed the antigenic epitopes of the candidate T. cp-MIF and found that it exhibited an ideal antigenic index. Morphology, Flow cytometry, and cytokine analysis showed that T. cp-MIF induced the dynamic polarization of THP-1 macrophages from the M1-like phenotype to the M2-like phenotype. The chemotaxis assay revealed an inhibitory effect of T. cp-MIF on THP-1 macrophages. Western blotting suggested that, compared to the control, THP-1 macrophages exposed to T. cp-MIF had higher TLR4 protein expression and the phosphatidylinositol 3 '-kinase (PI3K) -Akt pathway activation. In conclusion, T. cp-MIF induces M2-like macrophage polarization through TLR4-mediated activation of the PI3K-Akt pathway, which might provide a basis for future research on how it affects the immune system of the host.	[Cai, Juan; Tang, Hongri; Xu, Hongling; Wang, Lingjun; Zheng, Minghui; Liu, Hui] Zunyi Med Univ, Dept Parasitol, 6 Xuefu West Rd, Zunyi 563000, Guizhou, Peoples R China; [Huang, Lin] Qiannan Med Coll Nationalities, Duyun, Peoples R China; [Yu, Hongsong] Zunyi Med Univ, Dept Immunol, Special Key Lab Ocular Dis Guizhou Prov, 6 Xuefu West Rd, Zunyi 563000, Guizhou, Peoples R China	Zunyi Medical University; Zunyi Medical University	Liu, H (corresponding author), Zunyi Med Univ, Dept Parasitol, 6 Xuefu West Rd, Zunyi 563000, Guizhou, Peoples R China.; Yu, HS (corresponding author), Zunyi Med Univ, Dept Immunol, Special Key Lab Ocular Dis Guizhou Prov, 6 Xuefu West Rd, Zunyi 563000, Guizhou, Peoples R China.	yuhongsong@163.com; liuhi191112@sina.com	Yu, Hongsong/J-9106-2014	Yu, Hongsong/0000-0002-1209-2104	National Natural Science Foundation of China [82060374, 81760373]; Key Project of Guizhou Provincial Science and Technology Department [QKH-JC-2019-1464]; Excellent Talent Support Program of Guizhou Provincial Education Department [QJH-KY-2017-077]; Program for Excellent Young Talents of Zunyi Medical University [18-ZY-001]; Qiannan Ethnic Medical College Foundation [QNYZ201928]; Joint Fund of Schools in Zunyi City, Guizhou Province [Kehezi (2017) 08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Guizhou Provincial Science and Technology Department; Excellent Talent Support Program of Guizhou Provincial Education Department; Program for Excellent Young Talents of Zunyi Medical University; Qiannan Ethnic Medical College Foundation; Joint Fund of Schools in Zunyi City, Guizhou Province	This study was supported by grants from the National Natural Science Foundation of China (Nos. 82060374, 81760373), the Key Project of Guizhou Provincial Science and Technology Department (No. QKH-JC-2019-1464), the Excellent Talent Support Program of Guizhou Provincial Education Department (No. QJH-KY-2017-077), the Program for Excellent Young Talents of Zunyi Medical University (No. 18-ZY-001), Qiannan Ethnic Medical College Foundation (No. QNYZ201928), and Joint Fund of Schools in Zunyi City, Guizhou Province [No. Kehezi (2017) 08].	Ajonina-Ekoti I, 2013, PARASITOL RES, V112, P3335, DOI 10.1007/s00436-013-3513-1; Augustijn KD, 2007, INFECT IMMUN, V75, P1116, DOI 10.1128/IAI.00902-06; Bussiere FI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116509; Caescu CI, 2015, BLOOD, V125, pE1, DOI 10.1182/blood-2014-10-608000; Chan MM, 2012, PPAR RES, V2012, DOI 10.1155/2012/796235; Cote NM, 2013, EXP PARASITOL, V135, P175, DOI 10.1016/j.exppara.2013.06.012; Dubey JP, 2009, VET PARASITOL, V161, P330, DOI 10.1016/j.vetpar.2009.01.002; Garcia AB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001115; He XX, 2017, EXP PARASITOL, V178, P37, DOI 10.1016/j.exppara.2017.05.002; Ives A, 2021, FASEB J, V35, DOI 10.1096/fj.202001605R; Kamir D, 2008, J IMMUNOL, V180, P8250, DOI 10.4049/jimmunol.180.12.8250; Kim EM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005614; Kim S, 2010, DEV COMP IMMUNOL, V34, P1021, DOI 10.1016/j.dci.2010.05.005; [廖一露 Liao Yilu], 2017, [中华地方病学杂志, Chinese Journal of Endemiology], V36, P557; Lin Huang, 2019, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V31, P446, DOI 10.16250/j.32.1374.2018229; Miska KB, 2013, PARASITOL RES, V112, P1935, DOI 10.1007/s00436-013-3345-z; Nan Jiang, 2018, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V31, P224, DOI 10.16250/j.32.1374.2018109; Pastrana DV, 1998, INFECT IMMUN, V66, P5955, DOI 10.1128/IAI.66.12.5955-5963.1998; Peng JL, 2016, PARASITOL RES, V115, P4681, DOI 10.1007/s00436-016-5226-8; Prieto-Lafuente L, 2009, J LEUKOCYTE BIOL, V85, P844, DOI 10.1189/jlb.0808459; Qu GG, 2013, EXP PARASITOL, V135, P246, DOI 10.1016/j.exppara.2013.07.001; Salazar-Castanon VH, 2018, PARASITOL RES, V117, P2767, DOI 10.1007/s00436-018-5965-9; Shao DD, 2008, ACTA TROP, V106, P9, DOI 10.1016/j.actatropica.2007.12.008; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Twu O, 2014, P NATL ACAD SCI USA, V111, P8179, DOI 10.1073/pnas.1321884111; Vergadi E, 2017, J IMMUNOL, V198, P1006, DOI 10.4049/jimmunol.1601515; Wang JJ, 2016, WORLD LATEST MED INF, V43, P101; Wang YC, 2016, CLIN REV ALLERG IMMU, V51, P353, DOI 10.1007/s12016-016-8531-1; Wang YJ, 2017, ONCOTARGET, V8, P40052, DOI 10.18632/oncotarget.16675; Williams JL, 2014, J EXP MED, V211, P791, DOI 10.1084/jem.20131224; Xi ZD, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0895-0; Younis AE, 2012, MICROBES INFECT, V14, P279, DOI 10.1016/j.micinf.2011.09.006; Zhang Lu-fei, 2018, Zhongguo Xuexichongbing Fangzhi Zazhi, V30, P312, DOI 10.16250/j.32.1374.2017184; Zhang YJ, 2016, EXP PARASITOL, V170, P73, DOI 10.1016/j.exppara.2016.09.003; Zheng MingHui, 2018, Chinese Journal of Zoonoses, V34, P12	36	5	5	4	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21866	10.1096/fj.202100676R	http://dx.doi.org/10.1096/fj.202100676R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34416031				2022-12-28	WOS:000691122900042
J	Oh, JY; Bae, CY; Kasztan, M; Pollock, DM; Russell, RT; Lebensburger, J; Patel, RP				Oh, Joo-Yeun; Bae, Chae Yun; Kasztan, Malgorzata; Pollock, David M.; Russell, Robert T.; Lebensburger, Jeffrey; Patel, Rakesh P.			Peroxiredoxin-2 recycling is slower in denser and pediatric sickle cell red cells	FASEB JOURNAL			English	Article						antioxidant; hemoglobin; hydrogen peroxide; Red blood cells; sickle cell disease	HYDROGEN-PEROXIDE; NITRIC-OXIDE; BLOOD-CELLS; OXIDATIVE STRESS; HEMOGLOBIN; PATHOPHYSIOLOGY; ERYTHROCYTES; MODEL; H2O2	Peroxiredoxin-2 (Prx-2) is a critical antioxidant protein in red blood cells (RBC). Prx-2 is oxidized to a disulfide covalently-bound dimer by H2O2, and then reduced back by the NADPH-dependent thioredoxin-thioredoxin reductase system. The reduction of oxidized Prx-2 is relatively slow in RBCs. Since Prx-2 is highly abundant, Prx-2s' peroxidase catalytic cycle is not considered to be limiting under normal conditions. However, whether Prx-2 recycling becomes limiting when RBCs are exposed to stress is not known. Using three different model systems characterized by increased oxidative damage to RBCs spanning the physiologic (endogenous RBCs of different ages), therapeutic (cold-stored RBCs in blood banks) and pathologic (RBCs from sickle cell disease (SCD) patients and humanized SCD mice) spectrum, basal levels of Prx-2 oxidation and Prx-2 recycling kinetics after addition of H2O2 were determined. The reduction of oxidized Prx-2 was significantly slower in older versuin older versus younger RBCs, in RBCs stored for 4-5 weeks compared to 1 week, and in RBC from pediatric SCD patients compared to RBCs from control non-SCD patients. Similarly, the rate of Prx-2 recycling was slower in humanized SCD mice compared to WT mice. Treatment of RBC with carbon monoxide (CO) to limit heme-peroxidase activity had no effect on Prx-2 recycling kinetics. Treatment with glucose attenuated slowed Prx-2 recycling in older RBCs and SCD RBCs, but not stored RBCs. In conclusion, the reduction of oxidized Prx-2 can be further slowed in RBCs, which may limit the protection afforded by this antioxidant protein in settings associated with erythrocyte stress.	[Oh, Joo-Yeun; Bae, Chae Yun; Patel, Rakesh P.] Univ Alabama Birmingham, Dept Pathol, 901 19th St South,BMRII 532, Birmingham, AL 35294 USA; [Oh, Joo-Yeun; Bae, Chae Yun; Patel, Rakesh P.] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Kasztan, Malgorzata; Lebensburger, Jeffrey] Univ Alabama Birmingham, Pediat Hematol Oncol, Birmingham, AL 35294 USA; [Pollock, David M.] Univ Alabama Birmingham, Dept Med, Div Nephrol, Sect Cardiorenal Physiol & Med, Birmingham, AL 35294 USA; [Russell, Robert T.] Univ Alabama Birmingham, Dept Surg, Div Pediat Surg, Childrens Alabama, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Patel, RP (corresponding author), Univ Alabama Birmingham, Dept Pathol, 901 19th St South,BMRII 532, Birmingham, AL 35294 USA.	rakeshpatel@uabmc.edu		Patel, Rakesh/0000-0002-1526-4303	HHS | National Institutes of Health (NIH) [NIH R03HL244485, R00 KL144871]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS | National Institutes of Health (NIH), Grant/Award Number: NIH R03HL244485 and R00 KL144871	ABRAHAM EC, 1978, BIOCHEM J, V174, P819, DOI 10.1042/bj1740819; Alayash AI, 2018, BLOOD CELL MOL DIS, V70, P78, DOI 10.1016/j.bcmd.2017.05.009; Aslan M, 2001, P NATL ACAD SCI USA, V98, P15215, DOI 10.1073/pnas.221292098; Baek JH, 2012, J CLIN INVEST, V122, P1444, DOI 10.1172/JCI59770; Bayer SB, 2013, FASEB J, V27, P3315, DOI 10.1096/fj.13-227298; Benfeitas R, 2014, FREE RADICAL BIO MED, V74, P35, DOI 10.1016/j.freeradbiomed.2014.06.007; Chen WY, 2018, FREE RADICAL BIO MED, V115, P156, DOI 10.1016/j.freeradbiomed.2017.11.020; Cho CS, 2010, ANTIOXID REDOX SIGN, V12, P1235, DOI 10.1089/ars.2009.2701; DeSantis SM, 2019, TRANSFUSION, V59, P2699, DOI 10.1111/trf.15334; Detterich JA, 2019, FREE RADICAL BIO MED, V141, P408, DOI 10.1016/j.freeradbiomed.2019.07.004; Donadee C, 2011, CIRCULATION, V124, P465, DOI 10.1161/CIRCULATIONAHA.110.008698; Feliciano A, 2017, BBA-MOL BASIS DIS, V1863, P621, DOI 10.1016/j.bbadis.2016.11.019; George A, 2013, BLOOD, V121, P2099, DOI 10.1182/blood-2012-07-441188; Gifford SC, 2006, BRIT J HAEMATOL, V135, P395, DOI 10.1111/j.1365-2141.2006.06279.x; Harper VM, 2015, ANTIOXID REDOX SIGN, V22, P294, DOI 10.1089/ars.2014.5950; Johnson RM, 2010, FREE RADICAL BIO MED, V48, P519, DOI 10.1016/j.freeradbiomed.2009.11.021; Kato GJ, 2017, J CLIN INVEST, V127, P750, DOI 10.1172/JCI89741; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Low FM, 2007, BLOOD, V109, P2611, DOI 10.1182/blood-2006-09-048728; Mohanty JG, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00084; Nagababu E, 2013, FREE RADICAL RES, V47, P164, DOI 10.3109/10715762.2012.756138; Oh JY, 2015, TRANSFUSION, V55, P2967, DOI 10.1111/trf.13248; Orrico F, 2018, FREE RADICAL BIO MED, V121, P231, DOI 10.1016/j.freeradbiomed.2018.05.006; Owusu BY, 2013, ANTIOXID REDOX SIGN, V19, P1198, DOI 10.1089/ars.2012.4884; Pastor-Flores D, 2020, P NATL ACAD SCI USA, V117, P16313, DOI 10.1073/pnas.1915275117; Randall L, 2016, ARCH BIOCHEM BIOPHYS, V590, P101, DOI 10.1016/j.abb.2015.11.032; Randall LM, 2019, FREE RADICAL BIO MED, V141, P492, DOI 10.1016/j.freeradbiomed.2019.07.016; Reisz JA, 2016, BLOOD, V128, pE32, DOI 10.1182/blood-2016-05-714816; Rinalducci S, 2011, BIOCHIMIE, V93, P845, DOI 10.1016/j.biochi.2011.02.005; Rinalducci S, 2011, TRANSFUSION, V51, P1439, DOI 10.1111/j.1537-2995.2010.03032.x; Ryan TM, 1997, SCIENCE, V278, P873, DOI 10.1126/science.278.5339.873; Wagener BM, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002522; WAGNER TC, 1994, ANAL BIOCHEM, V222, P417, DOI 10.1006/abio.1994.1511; Wang YM, 2014, INTEGR BIOL-UK, V6, P65, DOI 10.1039/c3ib40187a; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405	35	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22267	10.1096/fj.202200052R	http://dx.doi.org/10.1096/fj.202200052R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CD	35306694				2022-12-28	WOS:000772944100001
J	Lee, H; Kwon, YJ; Jin, H; Liu, HF; Kang, W; Chun, YJ; Bae, J; Choi, HK				Lee, Hwanhui; Kwon, Yeo-Jung; Jin, Hanyong; Liu, Heifeng; Kang, Wonku; Chun, Young-Jin; Bae, Jeehyeon; Choi, Hyung-Kyoon			Anticancer activity and metabolic profile alterations by ortho-topolin riboside in in vitro and in vivo models of non-small cell lung cancer	FASEB JOURNAL			English	Article						GC-MS; metabolic alteration; nanoESI-MS; non-small cell lung cancer; ortho-topolin riboside	MOUSE MODEL; FATTY-ACID; PHOSPHATIDYLCHOLINE; APOPTOSIS; PHOSPHATIDYLSERINE; PROLIFERATION; INHIBITION; CYTOKININS; MECHANISM; STRESS	Lung cancer has the highest incidence and mortality rates among all types of cancer worldwide, and 80%-85% of patients with lung cancer are diagnosed with non-small cell lung cancer (NSCLC), which has 5-year survival rate of only 5% at advanced stages. Development of new therapeutic agents and strategies is required to enhance the treatment efficiency in patients with NSCLC. Metabolic alterations and anticancer effects of plant hormones and their derivatives have not been investigated in NSCLC in vitro and in vivo. The present study investigated the cytotoxic effects of 11 plant hormones and their derivatives against NSCLC cell lines; ortho-topolin riboside (oTR) showed the highest cytotoxicity among all tested compounds against NSCLC cells. Alteration of metabolites and lipids was investigated using gas chromatography-mass spectrometry and nano electrospray ionization-mass spectrometry in oTR-treated NSCLC cells and a xenograft mouse model. oTR reduced amino acid and pyrimidine synthesis in NSCLC cells and xenograft tumors. Moreover, oTR reduced glycolytic function and decreased mitochondrial respiration function by inhibiting glutamine and fatty acid oxidation. Increased levels of phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine species suggested that oTR might act as a fatty acid oxidation inhibitor. In addition, the increased level of phosphatidylserine species implied that phosphatidylserine-mediated apoptosis occurred in oTR-treated NSCLC cells and xenograft tumor. The antiproliferative and apoptotic effects of oTR were mediated by the reduced p-ERK and p-AKT levels and increased cleaved Caspase-3 levels, respectively. This is the first study to investigate the metabolic alterations and anticancer activity of oTR in in vitro and in vivo models of NSCLC. Our results provide basis for the development of oTR-based therapeutic agent for patients with NSCLC.	[Lee, Hwanhui; Kwon, Yeo-Jung; Liu, Heifeng; Kang, Wonku; Chun, Young-Jin; Bae, Jeehyeon; Choi, Hyung-Kyoon] Chung Ang Univ, Coll Pharm, Seoul 06974, South Korea; [Jin, Hanyong] Yanbian Univ, Coll Pharm, Key Lab Nat Med Changbai Mt, Minist Educ, Yanji, Peoples R China	Chung Ang University; Yanbian University	Bae, J; Choi, HK (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 06974, South Korea.	jeehyeon@cau.ac.kr; hykychoi@cau.ac.kr		Jin, Hanyong/0000-0002-5850-0791; Choi, Hyung-Kyoon/0000-0002-4523-0534	National Research Foundation of Korea (NRF) [NRF-2015R1A5A1008958, 2019R1F1A1062127]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2015R1A5A1008958 and 2019R1F1A1062127	Alkan HF, 2018, CELL METAB, V28, P706, DOI 10.1016/j.cmet.2018.07.021; Anthony ML, 1999, J BIOL CHEM, V274, P19686, DOI 10.1074/jbc.274.28.19686; Armitage EG, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1093-7; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Caetano Aline C., 2013, BMC Physiology, V13, P3, DOI 10.1186/1472-6793-13-3; Cheng XF, 2018, BIOCHEM BIOPH RES CO, V496, P31, DOI 10.1016/j.bbrc.2017.12.160; Cho JH, 2017, IMMUNE NETW, V17, P378, DOI 10.4110/in.2017.17.6.378; Moraes DFC, 2017, BIOTECHNOLOGY AND PRODUCTION OF ANTI-CANCER COMPOUNDS, P121, DOI 10.1007/978-3-319-53880-8_5; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Croze ML, 2013, BIOCHIMIE, V95, P1811, DOI 10.1016/j.biochi.2013.05.011; Cui Z, 2002, BBA-MOL CELL BIOL L, V1585, P87, DOI 10.1016/S1388-1981(02)00328-1; Eriksson L, 2006, MULTI MEGAVARIATE DA, P39; Fingrut O, 2002, LEUKEMIA, V16, P608, DOI 10.1038/sj.leu.2402419; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gintant GA, 2018, EXPERT OPIN DRUG DIS, V13, P753, DOI 10.1080/17460441.2018.1480608; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Greco O, 2001, MOL CANCER THER, V1, P151; Griffaut B, 2004, INT J BIOL MACROMOL, V34, P271, DOI 10.1016/j.ijbiomac.2004.06.004; Hassanein M, 2015, INT J CANCER, V137, P1587, DOI 10.1002/ijc.29535; HEWETT EW, 1973, PLANTA, V114, P119, DOI 10.1007/BF00387470; Howlader N., 2021, SEER CANC STAT REV, P1975; Icard P, 2012, BBA-REV CANCER, V1825, P111, DOI 10.1016/j.bbcan.2011.10.007; Iguchi K, 2001, APOPTOSIS, V6, P263, DOI 10.1023/A:1011331424311; Jiang SH, 2020, FASEB J, V34, P3943, DOI 10.1096/fj.201901237R; Jin H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15748-1; Kallenberg K, 2009, RADIOLOGY, V253, P805, DOI 10.1148/radiol.2533071654; Kalyanaraman B, 2017, REDOX BIOL, V12, P833, DOI 10.1016/j.redox.2017.04.018; Kefeli V., 2013, NATURAL GROWTH INHIB; Kim HY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39990-w; Kim HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08433-9; Kim SW, 2020, BIOCHEM PHARMACOL, V175, DOI 10.1016/j.bcp.2020.113866; Klupczynska A, 2017, J CANCER RES CLIN, V143, P649, DOI 10.1007/s00432-017-2347-0; Knight SB, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170070; Koundouros N, 2020, BRIT J CANCER, V122, P4, DOI 10.1038/s41416-019-0650-z; Li C, 2020, FASEB J, V34, P13333, DOI 10.1096/fj.202000555R; Li L, 2012, PHARMACOGENET GENOM, V22, P105, DOI 10.1097/FPC.0b013e32834dd7e2; Li MY, 2010, J MOL MED, V88, P1265, DOI 10.1007/s00109-010-0676-4; Li W, 2016, EXP CELL RES, V349, P320, DOI 10.1016/j.yexcr.2016.11.002; Li Z, 2017, ONCOL REP, V38, P611, DOI 10.3892/or.2017.5718; Lieu EL, 2020, EXP MOL MED, V52, P15, DOI 10.1038/s12276-020-0375-3; Maeda J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-690; Nguyen TL, 2018, CANCER DRUG RESIST, V1, P126, DOI 10.20517/cdr.2018.08; Paramee S, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2241-6; Patel S, 2015, J PHARMACEUT BIOMED, V107, P63, DOI 10.1016/j.jpba.2014.12.020; Plewa S, 2019, LIFE SCI, V222, P235, DOI 10.1016/j.lfs.2019.03.004; Pradelli LA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.371; Ridgway ND, 2013, CRIT REV BIOCHEM MOL, V48, P20, DOI 10.3109/10409238.2012.735643; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sellers K, 2015, J CLIN INVEST, V125, P687, DOI 10.1172/JCI72873; Sharma B, 2018, SEMIN CANCER BIOL, V52, P17, DOI 10.1016/j.semcancer.2017.08.012; Shin E, 2020, EMBO J, V39, DOI [10.15252/embj.2020104719|, 10.15252/embj.2020104719]; Snaebjornsson MT, 2020, CELL METAB, V31, P62, DOI 10.1016/j.cmet.2019.11.010; Sturla L, 2009, J BIOL CHEM, V284, P28045, DOI 10.1074/jbc.M109.035329; Sun H, 2018, J CHROMATOGR B, V1102, P143, DOI 10.1016/j.jchromb.2018.10.017; Sun Y, 2020, ANTICANCER RES, V40, P6083, DOI 10.21873/anticanres.14629; Swanson MG, 2003, MAGN RESON MED, V50, P944, DOI 10.1002/mrm.10614; Van der Sanden MHM, 2003, BIOCHEM J, V369, P643, DOI 10.1042/BJ20020285; Voller J, 2019, PHYTOCHEM REV, V18, P1101, DOI 10.1007/s11101-019-09620-4; Voller J, 2010, PHYTOCHEMISTRY, V71, P1350, DOI 10.1016/j.phytochem.2010.04.018; Wang JP, 2017, ONCOL LETT, V14, P3503, DOI 10.3892/ol.2017.6586; Wang L, 2019, TURK J HEMATOL, V36, P162, DOI 10.4274/tjh.galenos.2019.2019.0020; Wang L, 2012, FOOD CHEM TOXICOL, V50, P1962, DOI 10.1016/j.fct.2012.03.053; Xu FY, 2003, J LIPID RES, V44, P415, DOI 10.1194/jlr.M200335-JLR200; Yang HT, 2020, ANTICANCER RES, V40, P4969, DOI 10.21873/anticanres.14500; Yi HW, 2020, J BIOMED RES, V34, P260, DOI 10.7555/JBR.34.20190037; Yu A, 2000, BBA-MOL CELL BIOL L, V1487, P296, DOI 10.1016/S1388-1981(00)00100-1	66	0	0	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22127	10.1096/fj.202101333R	http://dx.doi.org/10.1096/fj.202101333R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35066937				2022-12-28	WOS:000747987800028
J	Soundararajan, R; Varanasi, SM; Patil, SS; Srinivas, S; Hernandez-Cuervo, H; Czachor, A; Bulkhi, A; Fukumoto, J; Galam, L; Lockey, RF; Kolliputi, N				Soundararajan, Ramani; Varanasi, Sai Manasa; Patil, Sahebgowda Sidramagowda; Srinivas, Sriraja; Hernandez-Cuervo, Helena; Czachor, Alexander; Bulkhi, Adeeb; Fukumoto, Jutaro; Galam, Lakshmi; Lockey, Richard F.; Kolliputi, Narasaiah			Lung fibrosis is induced in ADAR2 overexpressing mice via HuR-induced CTGF signaling	FASEB JOURNAL			English	Article						ADAR2; CTGF; HuR; lung fibrosis; Delta ECS mice	TISSUE GROWTH FACTOR/CCN2; MESSENGER-RNA; ADENOSINE-DEAMINASE; PULMONARY-FIBROSIS; BINDING PROTEIN; GLUR-B; GENE; INJURY; EXPRESSION; STABILITY	Adenosine deaminase acting on RNA 2 (ADAR2), an RNA editing enzyme is involved in a site-selective modification of adenosine (A) to inosine (I) in double-stranded RNA (dsRNA). Its role in the lungs is unknown. The phenotypic characterization of Adarb1 mice that lacked ADAR2 auto-regulation due to the deletion of editing complementary sequence (ABCS mice) determined the functional role of ADAR2 in the lungs. ADAR2 protein expression increased in the Delta ECS mice. These mice display immune cell infiltration and alveolar disorganization. The lung wet by dry ratio indicates there is no lung edema in Delta ECS mice. Bronchoalveolar lavage (BAL) analysis of ABCS mice reveals a significant increase in neutrophils. Interestingly, Delta ECS mice spontaneously develop lung fibrosis as indicated by Sirius red staining of collagen fibers in the lung sections and a significant increase in hydroxyproline level in their lungs. ADAR2 expression increased significantly in a bleomycin mouse model, implicating a role of ADAR2 in lung fibrosis. Furthermore, there is a likely possibility that the genetically modified ARCS mice does not model the physiological or pathophysiological process of lung fibrosis. Nevertheless, this model is useful in interrogating the role of ADAR2 in the lungs. The CtemRNA and connective tissue growth factor (CTGF) protein significantly increased in ABCS lungs and occurs in bronchial epithelial cells. There is a significant increase in Human antigen R (ELAVL1; HuR) protein levels in ABCS lungs and suggests a role in stabilizing Ctgf m RNA. Lung mechanics such as total respiratory resistance, Newtonian resistance and tissue damping were increased, whereas inspiratory capacity was decreased in the Delta ECS mice. Taken together, these data indicate that overexpression of ADAR2 causes spontaneous lung fibrosis via HuR-mediated CTGF signaling and implicate a role for ADAR2 auto-regulation in lung homeostasis. The identification of ADAR2 target genes in Delta ECS mice would facilitate a mechanistic understanding of the role of ADAR2 in the lungs and provide a therapeutic strategy for lung fibrosis.	[Soundararajan, Ramani; Varanasi, Sai Manasa; Patil, Sahebgowda Sidramagowda; Srinivas, Sriraja; Hernandez-Cuervo, Helena; Czachor, Alexander; Bulkhi, Adeeb; Fukumoto, Jutaro; Galam, Lakshmi; Lockey, Richard F.; Kolliputi, Narasaiah] Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA; [Srinivas, Sriraja] Auburn Univ, Dept Drug Discovery & Dev, Auburn, AL 36849 USA; [Hernandez-Cuervo, Helena] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Czachor, Alexander] Jagiellonian Univ Med Coll, Dept Med, Krakow, Poland; [Bulkhi, Adeeb] Umm Al Qura Univ, Coll Med, Dept Internal Med, Mecca, Saudi Arabia	State University System of Florida; University of South Florida; Auburn University System; Auburn University; State University System of Florida; University of South Florida; Jagiellonian University; Collegium Medicum Jagiellonian University; Umm Al Qura University	Kolliputi, N (corresponding author), Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	nkollipu@usf.edu	Bulkhi, Adeeb A/AAD-8924-2019	Bulkhi, Adeeb A/0000-0001-5857-7097	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [R01 HL105932]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R01 HL105932	Anantharaman A, 2017, FEBS LETT, V591, P2890, DOI 10.1002/1873-3468.12795; Anantharaman A, 2017, NUCLEIC ACIDS RES, V45, P4189, DOI 10.1093/nar/gkw1304; Ask K, 2008, INT J BIOCHEM CELL B, V40, P484, DOI 10.1016/j.biocel.2007.08.016; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Ben-Shoshan SO, 2017, RNA BIOL, V14, P587, DOI 10.1080/15476286.2016.1203501; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Cicha I, 2009, BIOFACTORS, V35, P200, DOI 10.1002/biof.30; Cortes A, 2015, MED RES REV, V35, P85, DOI 10.1002/med.21324; Cox R, 2015, AM J RESP CELL MOL, V53, P422, DOI 10.1165/rcmb.2014-0339OC; Cronstein Bruce N, 2011, F1000 Biol Rep, V3, P21, DOI 10.3410/B3-21; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9; Feng Y, 2006, MOL CELL BIOL, V26, P480, DOI 10.1128/MCB.26.2.480-488.2006; Fukumoto J, 2019, AM J PHYSIOL-CELL PH, V316, pC492, DOI 10.1152/ajpcell.00330.2018; Fukumoto J, 2013, AM J PHYSIOL-CELL PH, V305, pC182, DOI 10.1152/ajpcell.00086.2013; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Galam L, 2016, AM J PHYSIOL-LUNG C, V310, pL572, DOI 10.1152/ajplung.00417.2015; Galam L, 2015, FREE RADICAL BIO MED, V84, P196, DOI 10.1016/j.freeradbiomed.2015.03.036; Gerber A, 1997, RNA, V3, P453; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Hasko G, 2005, TRENDS PHARMACOL SCI, V26, P511, DOI 10.1016/j.tips.2005.08.004; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00085; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Herrera J, 2018, J CLIN INVEST, V128, P45, DOI 10.1172/JCI93557; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Horowitz JC, 2006, SEMIN RESP CRIT CARE, V27, P600, DOI 10.1055/s-2006-957332; Kaljas Y, 2017, CELL MOL LIFE SCI, V74, P555, DOI 10.1007/s00018-016-2357-0; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kitamura Y, 2001, AM J RESP CRIT CARE, V163, P762, DOI 10.1164/ajrccm.163.3.2003065; Kondo S, 2006, ONCOGENE, V25, P1099, DOI 10.1038/sj.onc.1209129; Kutryb-Zajac B, 2019, J MOL CELL CARDIOL, V128, P62, DOI 10.1016/j.yjmcc.2019.01.004; Lagishetty V, 2014, AM J PHYSIOL-CELL PH, V306, pC999, DOI 10.1152/ajpcell.00064.2013; Lawson WE, 2005, AM J PATHOL, V167, P1267, DOI 10.1016/S0002-9440(10)61214-X; LeRoy E C, 1990, Eur Cytokine Netw, V1, P215; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; Moreno E, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00106; Mukherjee N, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r12; Narala VR, 2018, AM J PHYSIOL-LUNG C, V314, pL860, DOI 10.1152/ajplung.00365.2017; Neumark N, 2020, AM J PHYSIOL-LUNG C, V319, pL887, DOI 10.1152/ajplung.00451.2020; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; OConnell MA, 1997, J BIOL CHEM, V272, P473; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Ponticos M, 2009, ARTHRITIS RHEUM-US, V60, P2142, DOI 10.1002/art.24620; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Stellos K, 2016, NAT MED, V22, P1140, DOI 10.1038/nm.4172; Tan MH, 2017, NATURE, V550, P249, DOI 10.1038/nature24041; Tashiro J, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00118; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; WAGNER RW, 1990, MOL CELL BIOL, V10, P5586, DOI 10.1128/MCB.10.10.5586; Wang GL, 2015, AM J PATHOL, V185, P3224, DOI 10.1016/j.ajpath.2015.08.002; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Woodhoo A, 2012, HEPATOLOGY, V56, P1870, DOI 10.1002/hep.25828	67	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22143	10.1096/fj.202101511R	http://dx.doi.org/10.1096/fj.202101511R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34985777				2022-12-28	WOS:000747987800009
J	Bruno, NE; Nwachukwu, JC; Hughes, DC; Srinivasan, S; Hawkins, R; Sturgill, D; Hager, GL; Hurst, S; Sheu, SS; Bodine, SC; Conkright, MD; Nettles, KW				Bruno, Nelson E.; Nwachukwu, Jerome C.; Hughes, David C.; Srinivasan, Sathish; Hawkins, Richard; Sturgill, David; Hager, Gordon L.; Hurst, Stephen; Sheu, Shey-Shing; Bodine, Sue C.; Conkright, Michael D.; Nettles, Kendall W.			Activation of Crtc2/Creb1 in skeletal muscle enhances weight loss during intermittent fasting	FASEB JOURNAL			English	Article						Creb1; Crtc2; intermittent fasting; skeletal muscle	CREB COACTIVATOR TORC2; WORK EFFICIENCY; MITOCHONDRIAL BIOGENESIS; INDUCE PGC-1-ALPHA; PHYSICAL-ACTIVITY; REGULAR EXERCISE; MESSENGER-RNA; BODY-WEIGHT; TRANSCRIPTION; KINASE	The Creb-Regulated Transcriptional Coactivator (Crtc) family of transcriptional coregulators drive Creb1-mediated transcription effects on metabolism in many tissues, but the in vivo effects of Crtc2/Creb1 transcription on skeletal muscle metabolism are not known. Skeletal muscle-specific overexpression of Crtc2 (Crtc2 mice) induced greater mitochondrial activity, metabolic flux capacity for both carbohydrates and fats, improved glucose tolerance and insulin sensitivity, and increased oxidative capacity, supported by upregulation of key metabolic genes. Crtc2 overexpression led to greater weight loss during alternate day fasting (ADF), selective loss of fat rather than lean mass, maintenance of higher energy expenditure during the fast and reduced binge-eating during the feeding period. ADF downregulated most of the mitochondrial electron transport genes, and other regulators of mitochondrial function, that were substantially reversed by Crtc2-driven transcription. Glucocorticoids acted with AMPK to drive atrophy and mitophagy, which was reversed by Crtc2/Creb1 signaling. Crtc2/Creb1-mediated signaling coordinates metabolic adaptations in skeletal muscle that explain how Crtc2/Creb1 regulates metabolism and weight loss.	[Bruno, Nelson E.; Nwachukwu, Jerome C.; Srinivasan, Sathish; Nettles, Kendall W.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, 130 Scripps Way, Jupiter, FL 33458 USA; [Hughes, David C.; Bodine, Sue C.] Univ Iowa, Dept Internal Med, Sect Endocrinol & Metab, Iowa City, IA 52242 USA; [Hawkins, Richard; Conkright, Michael D.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Sturgill, David; Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA; [Hurst, Stephen; Sheu, Shey-Shing] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA	Scripps Research Institute; University of Iowa; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Jefferson University	Bruno, NE; Nettles, KW (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, 130 Scripps Way, Jupiter, FL 33458 USA.	nbruno@scripps.edu; knettles@scripps.edu		Hawkins, Richard/0000-0002-7481-5419; Hughes, David/0000-0002-5433-8782	Frenchman's Creek Women for Cancer Research	Frenchman's Creek Women for Cancer Research	JCN was supported by the Frenchman's Creek Women for Cancer Research. The authors thank Ana Lira (University of Iowa) for technical assistance on this project.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; ARONNE LJ, 1995, AM J PHYSIOL-REG I, V269, pR222, DOI 10.1152/ajpregu.1995.269.1.R222; Baxter PS, 2011, J NEUROCHEM, V118, P365, DOI 10.1111/j.1471-4159.2011.07330.x; BLANCO CE, 1988, HISTOCHEM J, V20, P230, DOI 10.1007/BF01747468; Bordeaux R, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00535; Brandt N, 2018, AM J PHYSIOL-ENDOC M, V314, pE1, DOI 10.1152/ajpendo.00082.2017; Bruno NE, 2014, EMBO J, V33, P1027, DOI 10.1002/embj.201386145; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Ch'ng TH, 2012, CELL, V150, P207, DOI 10.1016/j.cell.2012.05.027; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Drake JC, 2016, FASEB J, V30, P13, DOI 10.1096/fj.15-276337; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; Foright RM, 2018, PHYSIOL BEHAV, V188, P86, DOI 10.1016/j.physbeh.2018.01.025; Gilliat-Wimberly M, 2001, J AM DIET ASSOC, V101, P1181, DOI 10.1016/S0002-8223(01)00289-9; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Goldsmith R, 2010, AM J PHYSIOL-REG I, V298, pR79, DOI 10.1152/ajpregu.00053.2009; Goldstein I, 2017, GENOME RES, V27, P427, DOI 10.1101/gr.212175.116; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Grannell A, 2019, EXPERT REV ENDOCRINO, V14, P267, DOI 10.1080/17446651.2019.1618185; Grill MA, 2003, TRANSGENIC RES, V12, P33, DOI 10.1023/A:1022119005836; Heikkinen S., 2007, CURR PROTOC MOL BIOL; Higgins JA, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-49; Hughes DC, 2021, AM J PHYSIOL-CELL PH, V320, pC45, DOI 10.1152/ajpcell.00432.2020; Kim SH, 2013, AM J PHYSIOL-ENDOC M, V304, pE844, DOI 10.1152/ajpendo.00581.2012; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kuo TY, 2012, P NATL ACAD SCI USA, V109, P11160, DOI 10.1073/pnas.1111334109; Levin BE, 2004, AM J PHYSIOL-REG I, V286, pR771, DOI 10.1152/ajpregu.00650.2003; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu J, 2016, MOL PHARMACEUT, V13, P73, DOI 10.1021/acs.molpharmaceut.5b00516; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MacLean PS, 2009, AM J PHYSIOL-REG I, V297, pR793, DOI 10.1152/ajpregu.00192.2009; Margolis RN, 2005, MOL ENDOCRINOL, V19, P2433, DOI 10.1210/me.2004-0461; Maxwell MA, 2005, J BIOL CHEM, V280, P12573, DOI 10.1074/jbc.M409580200; Medvedeva YA, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav067; Meinken John, 2015, Database (Oxford), V2015, DOI 10.1093/database/bav077; Melby CL, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050468; Miura S, 2007, ENDOCRINOLOGY, V148, P3441, DOI 10.1210/en.2006-1646; Mourier A, 1997, DIABETES CARE, V20, P385, DOI 10.2337/diacare.20.3.385; Nasta V, 2020, FEBS J, V287, P2312, DOI 10.1111/febs.15140; Ostendorf DM, 2019, OBESITY, V27, P496, DOI 10.1002/oby.22373; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Perry RJ, 2019, P NATL ACAD SCI USA, V116, P13670, DOI 10.1073/pnas.1901795116; Popov DV, 2019, AM J PHYSIOL-ENDOC M, V316, pE605, DOI 10.1152/ajpendo.00449.2018; Popov DV, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13868; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Ratman D, 2016, NUCLEIC ACIDS RES, V44, P10539, DOI 10.1093/nar/gkw742; Rosenbaum M, 2003, AM J PHYSIOL-REG I, V285, pR183, DOI 10.1152/ajpregu.00474.2002; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; Rosenbaum M, 2018, OBESITY, V26, P1576, DOI 10.1002/oby.22274; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shook RP, 2014, MAYO CLIN PROC, V89, P763, DOI 10.1016/j.mayocp.2013.12.017; Sonntag T, 2019, ISCIENCE, V11, P134, DOI 10.1016/j.isci.2018.12.012; Springer ML, 1997, SOMAT CELL MOLEC GEN, V23, P203, DOI 10.1007/BF02721371; Steig AJ, 2011, AM J PHYSIOL-REG I, V301, pR656, DOI 10.1152/ajpregu.00212.2011; Stengel A, 2010, PHYSIOL BEHAV, V101, P614, DOI 10.1016/j.physbeh.2010.09.009; Tadaishi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028290; Taub M, 2015, CELL SIGNAL, V27, P2568, DOI 10.1016/j.cellsig.2015.09.015; Than TA, 2011, J BIOL CHEM, V286, P22047, DOI 10.1074/jbc.M111.240481; Turk Y, 2017, OBES SCI PRACT, V3, P258, DOI 10.1002/osp4.109; Verheggen RJHM, 2016, OBES REV, V17, P664, DOI 10.1111/obr.12406; Voltarelli VA, 2014, J CELL MOL MED, V18, P1087, DOI 10.1111/jcmm.12253; WALSH DA, 1968, J BIOL CHEM, V243, P3763; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103	68	1	1	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e21999	10.1096/fj.202100171R	http://dx.doi.org/10.1096/fj.202100171R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34748223	Green Published			2022-12-28	WOS:000722321300037
J	Piedrafita, A; Balayssac, S; Casemayou, A; Saulnier-Blache, JS; Lucas, A; Iacovoni, JS; Breuil, B; Chauveau, D; Decramer, S; Malet-Martino, M; Schanstra, JP; Faguer, S				Piedrafita, Alexis; Balayssac, Stephane; Casemayou, Audrey; Saulnier-Blache, Jean-Sebastien; Lucas, Alexandre; Iacovoni, Jason S.; Breuil, Benjamin; Chauveau, Dominique; Decramer, Stephane; Malet-Martino, Myriam; Schanstra, Joost P.; Faguer, Stanislas			Hepatocyte nuclear factor-1 beta shapes the energetic homeostasis of kidney tubule cells	FASEB JOURNAL			English	Article						HNF-1 beta; hypoxia; kidney tubule; metabolism	TRANSCRIPTION FACTOR HNF1-BETA; HNF1B MUTATIONS; FIBROBLAST ACTIVATION; INTRACELLULAR ATP; EPITHELIAL-CELLS; EXPRESSION; CARCINOMA; APOPTOSIS; INJURY; SWITCH	Energetic metabolism controls key steps of kidney development, homeostasis, and epithelial repair following acute kidney injury (AKI). Hepatocyte nuclear factor-1 beta (HNF-1 beta) is a master transcription factor that controls mitochondrial function in proximal tubule (PT) cells. Patients with HNF1B pathogenic variant display a wide range of kidney developmental abnormalities and progressive kidney fibrosis. Characterizing the metabolic changes in PT cells with HNF-1 beta deficiency may help to identify new targetable molecular hubs involved in HNF1B-related kidney phenotypes and AKI. Here, we combined H-1-NMR-based metabolomic analysis in a murine PT( )cell line with CrispR/Cas9-induced Hnf1b invalidation (Hnf1b(-/-)), clustering analysis, targeted metabolic assays, and data-mining of published RNA-seq and ChIP-seq dataset to identify the role of HNF-1 beta in metabolism. Hnf1b(-/-) cells grown in normoxic conditions display intracellular ATP depletion, increased cytosolic lactate concentration, increased lipid droplet content, failure to use pyruvate for energetic purposes, increased levels of tricar-boxylic acid (TCA) cycle intermediates and oxidized glutathione, and a reduction of TCA cycle byproducts, all features consistent with mitochondrial dysfunction and an irreversible switch toward glycolysis. Unsupervised clustering analysis showed that Hnf1b(-/-) cells mimic a hypoxic signature and that they cannot furthermore increase glycolysis-dependent energetic supply during hypoxic challenge. Metabolome analysis also showed alteration of phospholipid biosynthesis in Hnf1b(-/-) cells leading to the identification of Chka, the gene coding for choline kinase alpha, as a new putative target of HNF-1 beta. HNF-1 beta shapes the energetic metabolism of PT cells and HNF1B deficiency in patients could lead to a hypoxia-like metabolic state precluding further adaptation to ATP depletion following AKI.	[Piedrafita, Alexis; Casemayou, Audrey; Saulnier-Blache, Jean-Sebastien; Lucas, Alexandre; Iacovoni, Jason S.; Breuil, Benjamin; Chauveau, Dominique; Decramer, Stephane; Schanstra, Joost P.; Faguer, Stanislas] Hop Rangueil, Inst Natl Sante & Rech Med, UMR 1297, Inst Malad Metab & Cardiovasc, Toulouse, France; [Piedrafita, Alexis; Casemayou, Audrey; Saulnier-Blache, Jean-Sebastien; Chauveau, Dominique; Decramer, Stephane; Schanstra, Joost P.; Faguer, Stanislas] Univ Paul Sabatier Toulouse 3, Toulouse, France; [Piedrafita, Alexis; Casemayou, Audrey; Chauveau, Dominique; Faguer, Stanislas] CHU Toulouse, Ctr Reference Malad Renales Rares, Dept Nephrol & Transplantat Organes, Toulouse, France; [Balayssac, Stephane; Malet-Martino, Myriam] Univ Paul Sabatier, UMR CNRS 5068, Lab SPCMIB, Grp RMN Biomed,CNRS, Toulouse, France; [Balayssac, Stephane] Lab Interact Mol & Reactivite Chim & Photochim IM, UMR 5623, Toulouse, France; [Decramer, Stephane] CHU Toulouse, Hop Enfants, Ctr Reference Malad Renales Rares, Serv Nephrol Med Interne & Hypertens Arterielle, Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Faguer, S (corresponding author), Univ Hosp Toulouse, Dept Nephrol & Organ Transplantat, 1 Ave Pr Jean Poulhes, F-31059 Toulouse, France.	stanislas.faguer@inserm.fr	Lucas, Ana/GZA-9861-2022; Schanstra, Joost P/X-7724-2018	Schanstra, Joost P/0000-0002-7471-372X	European grant from the ERA PerMed initiative (KIDNEY ATTACK) [ANR-18-PERM-0003]; Fondation pour la Recherche Medicale [DEQ20170336759]; Toulouse University	European grant from the ERA PerMed initiative (KIDNEY ATTACK); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Toulouse University	This work was partly funded by a European grant from the ERA PerMed initiative (KIDNEY ATTACK ANR-18-PERM-0003) and the "Fondation pour la Recherche Medicale" (grant number DEQ20170336759). AP was supported by a research grant from the Toulouse University.	Aboudehen K, 2017, J AM SOC NEPHROL, V28, P2887, DOI 10.1681/ASN.2016101095; Aboudehen K, 2016, J AM SOC NEPHROL, V27, P2408, DOI 10.1681/ASN.2015060607; Adalat S, 2019, KIDNEY INT REP, V4, P1304, DOI 10.1016/j.ekir.2019.05.019; Adalat S, 2009, J AM SOC NEPHROL, V20, P1123, DOI 10.1681/ASN.2008060633; Almeida L, 2016, SEMIN IMMUNOL, V28, P514, DOI 10.1016/j.smim.2016.10.009; Amano Y, 2015, ONCOTARGET, V6, P26002, DOI 10.18632/oncotarget.4692; Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bhargava P, 2017, NAT REV NEPHROL, V13, P629, DOI 10.1038/nrneph.2017.107; Bockenhauer D, 2016, PEDIATR NEPHROL, V31, P707, DOI 10.1007/s00467-015-3142-2; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Bueno M, 2020, REDOX BIOL, V33, DOI 10.1016/j.redox.2020.101509; Casemayou A, 2017, J AM SOC NEPHROL, V28, P3204, DOI 10.1681/ASN.2016050508; Chan SC, 2018, J AM SOC NEPHROL, V29, P2493, DOI 10.1681/ASN.2018040437; Chandra S, 2021, CANCER MED-US, V10, P1791, DOI 10.1002/cam4.3676; Choi YH, 2013, AM J PHYSIOL-RENAL, V305, pF100, DOI 10.1152/ajprenal.00582.2012; Clissold RL, 2015, NAT REV NEPHROL, V11, P102, DOI 10.1038/nrneph.2014.232; Coffinier C, 1999, DEVELOPMENT, V126, P4785; Coffinier C, 1999, MECH DEVELOP, V89, P211, DOI 10.1016/S0925-4773(99)00221-X; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Desgrange A, 2017, DEVELOPMENT, V144, P4704, DOI 10.1242/dev.154336; Ding H, 2017, AM J PHYSIOL-RENAL, V313, pF561, DOI 10.1152/ajprenal.00036.2017; Dubois-Laforgue D, 2017, DIABETES CARE, V40, P1436, DOI 10.2337/dc16-2462; Dudziak K, 2008, KIDNEY INT, V74, P210, DOI 10.1038/ki.2008.149; Eguchi Y, 1997, CANCER RES, V57, P1835; Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214; Faguer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063585; Faguer S, 2011, KIDNEY INT, V80, P768, DOI 10.1038/ki.2011.225; Ferre S, 2019, PEDIATR NEPHROL, V34, P1325, DOI 10.1007/s00467-018-3990-7; Ferre S, 2011, BIOCHEM BIOPH RES CO, V404, P284, DOI 10.1016/j.bbrc.2010.11.108; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; HAVERTY TP, 1988, J CELL BIOL, V107, P1359, DOI 10.1083/jcb.107.4.1359; He LY, 2017, KIDNEY INT, V92, P1071, DOI 10.1016/j.kint.2017.06.030; He ZM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00410; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heidet L, 2010, CLIN J AM SOC NEPHRO, V5, P1079, DOI 10.2215/CJN.06810909; Heliot C, 2013, DEVELOPMENT, V140, P873, DOI 10.1242/dev.086538; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; KENT C, 1990, PROG LIPID RES, V29, P87, DOI 10.1016/0163-7827(90)90010-I; Khundmiri SJ, 2021, J AM SOC NEPHROL, V32, P86, DOI 10.1681/ASN.2020010009; Kim S, 2016, EXP TOXICOL PATHOL, V68, P553, DOI 10.1016/j.etp.2016.08.005; Kompatscher A, 2018, AM J PHYSIOL-RENAL, V315, pF27, DOI 10.1152/ajprenal.00601.2017; Kompatscher A, 2017, KIDNEY INT, V92, P1145, DOI 10.1016/j.kint.2017.03.034; Lan RP, 2016, J AM SOC NEPHROL, V27, P3356, DOI 10.1681/ASN.2015020177; Lankadeva YR, 2019, SEMIN NEPHROL, V39, P543, DOI 10.1016/j.semnephrol.2019.10.004; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Li SY, 2018, SEMIN NEPHROL, V38, P121, DOI 10.1016/j.semnephrol.2018.01.003; Li XY, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00316-9; Liu J, 2017, J AM SOC NEPHROL, V28, P3323, DOI 10.1681/ASN.2016111246; Lokmane L, 2010, DEVELOPMENT, V137, P347, DOI 10.1242/dev.042226; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu W, 2020, J CELL MOL MED, V24, P14539, DOI 10.1111/jcmm.16081; Ma ZD, 2007, P NATL ACAD SCI USA, V104, P20386, DOI 10.1073/pnas.0705957104; Mandai M, 2015, ONCOTARGET, V6, P30704, DOI 10.18632/oncotarget.5228; Massa F, 2013, DEVELOPMENT, V140, P886, DOI 10.1242/dev.086546; Miguel V, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI140695; Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Nagarajan SR, 2019, AM J PHYSIOL-ENDOC M, V316, pE578, DOI 10.1152/ajpendo.00365.2018; Naylor RW, 2013, J AM SOC NEPHROL, V24, P77, DOI 10.1681/ASN.2012070756; Nicotera P, 1998, TOXICOL LETT, V103, P139; Okamoto T, 2015, MOL CARCINOGEN, V54, P35, DOI 10.1002/mc.22072; Rao S, 2016, AM J PHYSIOL-RENAL, V310, pF1136, DOI 10.1152/ajprenal.00100.2016; Samuvel DJ, 2009, J IMMUNOL, V182, P2476, DOI 10.4049/jimmunol.0802059; Scantlebery AML, 2021, J PATHOL, V253, P404, DOI 10.1002/path.5605; Shen Y, 2020, AM J PHYSIOL-RENAL, V318, pF689, DOI 10.1152/ajprenal.00229.2019; Shu SQ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030207; Simon N, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00052; Solati Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195172; Thevenot EA, 2015, J PROTEOME RES, V14, P3322, DOI 10.1021/acs.jproteome.5b00354; TOBACK FG, 1977, AM J PHYSIOL, V232, pE216; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Verdeguer F, 2010, NAT MED, V16, P106, DOI 10.1038/nm.2068; Wei QQ, 2019, AM J PHYSIOL-RENAL, V316, pF1162, DOI 10.1152/ajprenal.00422.2018; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yamaguchi K, 2010, ONCOGENE, V29, P1741, DOI 10.1038/onc.2009.470; Yin XN, 2018, EUR REV MED PHARMACO, V22, P4243, DOI 10.26355/eurrev_201807_15419; Zhang J, 2012, CELL STEM CELL, V11, P589, DOI 10.1016/j.stem.2012.10.005; Zheng X, 2016, ELIFE, V5, DOI [10.7554/eLife.18638, 10.7554/eLife.13374]; Zhu JJ, 2019, NAT REV MOL CELL BIO, V20, P436, DOI 10.1038/s41580-019-0123-5	82	2	2	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21931	10.1096/fj.202100782RR	http://dx.doi.org/10.1096/fj.202100782RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34653285				2022-12-28	WOS:000712009200015
J	Yasuda, H; Fukusumi, Y; Ivanov, V; Zhang, Y; Kawachi, H				Yasuda, Hidenori; Fukusumi, Yoshiyasu; Ivanov, Veniamin; Zhang, Ying; Kawachi, Hiroshi			Tacrolimus ameliorates podocyte injury by restoring FK506 binding protein 12 (FKBP12) at actin cytoskeleton	FASEB JOURNAL			English	Article						actin cytoskeleton; calcineurin inhibitor; glomerular epithelial cell; immunofilin; nephropathy; proteinuria	CYCLOSPORINE-A; SLIT DIAPHRAGM; PUROMYCIN AMINONUCLEOSIDE; EXPRESSION; SYNAPTOPODIN; CYCLOPHILIN; GLOMERULONEPHRITIS; IDENTIFICATION; DYSFUNCTION; ACTIVATION	FKBP12 was identified as a binding protein of tacrolimus (Tac). Tac binds to FKBP12 and exhibits immunosuppressive effects in T cells. Although it is reported that Tac treatment directly ameliorates the dysfunction of the podocyte in nephrotic syndrome, the precise pharmacological mechanism of Tac is not well understood yet. It is also known that FKBP12 functions independently of Tac. However, the localization and the physiological function of FKBP12 are not well elucidated. In this study, we observed that FKBP12 is highly expressed in glomeruli, and the FKBP12 in glomeruli is restricted in podocytes. FKBP12 in cultured podocytes was expressed along the actin cytoskeleton and associated with filamentous actin (F-actin). FKBP12 interacted with the actin-associated proteins 14-3-3 and synaptopodin. RNA silencing for FKBP12 reduced 14-3-3 expression, F-actin staining, and process formation in cultured podocytes. FKBP12 expression was decreased in the nephrotic model caused by adriamycin (ADR) and the cultured podocyte treated with ADR. The process formation was deteriorated in the podocytes treated with ADR. Tac treatment ameliorated these decreases. Tac treatment to the normal cells increased the expression of FKBP12 at F-actin in processes and enhanced process formation. Tac enhanced the interaction of FKBP12 with synaptopodin. These observations suggested that FKBP12 at actin cytoskeleton participates in the maintenance of processes, and Tac treatment ameliorates podocyte injury by restoring FKBP12 at actin cytoskeleton.	[Yasuda, Hidenori; Fukusumi, Yoshiyasu; Ivanov, Veniamin; Zhang, Ying; Kawachi, Hiroshi] Niigata Univ, Kidney Res Ctr, Dept Cell Biol, Grad Sch Med & Dent Sci, 1-757 Asahimachi Dori, Niigata 9518510, Japan	Niigata University	Kawachi, H (corresponding author), Niigata Univ, Kidney Res Ctr, Dept Cell Biol, Grad Sch Med & Dent Sci, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	kawachi@med.niigata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [19H03673, 20K08587, 19K08720, 18K15996]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Ministry of Education, Culture, Sports, Science and Technology of Japan, Grant/Award Number: 19H03673, 20K08587, 19K08720 and 18K15996	Aghdasi B, 2001, P NATL ACAD SCI USA, V98, P2425, DOI 10.1073/pnas.041614198; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Azzi JR, 2013, J IMMUNOL, V191, P5785, DOI 10.4049/jimmunol.1390055; Banhara PB, 2015, CLIN NEPHROL, V83, P331, DOI 10.5414/CN108541; BRAM RJ, 1993, MOL CELL BIOL, V13, P4760, DOI 10.1128/MCB.13.8.4760; Chiasson VL, 2011, J PHARMACOL EXP THER, V337, P718, DOI 10.1124/jpet.110.178095; Choudhry S, 2009, AM J KIDNEY DIS, V53, P760, DOI 10.1053/j.ajkd.2008.11.033; Colucci S, 2017, BLOOD, V130, P2111, DOI 10.1182/blood-2017-04-780692; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Fukusumi Y, 2018, J AM SOC NEPHROL, V29, P1462, DOI 10.1681/ASN.2017090993; Fukusumi Y, 2015, LAB INVEST, V95, P534, DOI 10.1038/labinvest.2015.39; Guasch A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134569; Hashimoto T, 2007, KIDNEY INT, V72, P954, DOI 10.1038/sj.ki.5002454; Henriksson ML, 2002, EUR J BIOCHEM, V269, P4921, DOI 10.1046/j.1432-1033.2002.03191.x; HIROMURA K, 1994, KIDNEY INT, V45, P1572, DOI 10.1038/ki.1994.207; Holthofer H, 2007, NEPHROL DIAL TRANSPL, V22, P2124, DOI 10.1093/ndt/gfm344; Ikezumi Y, 2002, KIDNEY INT, V61, P1339, DOI 10.1046/j.1523-1755.2002.00259.x; Ito Y, 2002, KIDNEY INT, V61, P2044, DOI 10.1046/j.1523-1755.2002.00369.x; Jin ZG, 2000, CIRC RES, V87, P789, DOI 10.1161/01.RES.87.9.789; KAWACHI H, 1992, CLIN EXP IMMUNOL, V88, P399; Kawachi H, 2003, J AM SOC NEPHROL, V14, P46, DOI 10.1097/01.ASN.0000037401.02391.76; Kawachi H, 2000, KIDNEY INT, V57, P1949, DOI 10.1046/j.1523-1755.2000.00044.x; Kawachi H, 2020, CLIN EXP NEPHROL, V24, P193, DOI 10.1007/s10157-020-01854-3; Kidokoro K, 2012, KIDNEY BLOOD PRESS R, V35, P549, DOI 10.1159/000339494; Kobayashi M, 1998, NEPHROL DIAL TRANSPL, V13, P2501, DOI 10.1093/ndt/13.10.2501; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; Leong KG, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103667; Lloberas N, 2008, NEPHROL DIAL TRANSPL, V23, P3111, DOI 10.1093/ndt/gfn223; Maeda K, 2018, J CLIN INVEST, V128, P3445, DOI 10.1172/JCI99507; Martins L, 2004, TRANSPL P, V36, P877, DOI 10.1016/j.transproceed.2004.03.083; Mihatsch MJ, 1998, CLIN NEPHROL, V49, P356; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Nakahama H, 1999, NEPHRON, V81, P421, DOI 10.1159/000045326; Nakatsue T, 2005, KIDNEY INT, V67, P2239, DOI 10.1111/j.1523-1755.2005.00328.x; Nijenhuis T, 2011, AM J PATHOL, V179, P1719, DOI 10.1016/j.ajpath.2011.06.033; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Penninga L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008817.pub2; Radziejewski K, 2016, ACTA VET HUNG, V64, P313, DOI 10.1556/004.2016.030; Saito A, 2011, AM J PHYSIOL-REG I, V300, pR340, DOI 10.1152/ajpregu.00640.2009; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sharma R, 1996, TRANSPLANTATION, V62, P1916, DOI 10.1097/00007890-199612270-00041; Shen XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32087; SHERRY B, 1992, P NATL ACAD SCI USA, V89, P3511, DOI 10.1073/pnas.89.8.3511; Spurney RF, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00181; Suzuki J, 2006, CIRC RES, V98, P811, DOI 10.1161/01.RES.0000216405.85080.a6; Suzuki K, 2015, CELL TISSUE RES, V362, P201, DOI 10.1007/s00441-015-2178-8; Takamura S, 2020, AM J PATHOL, V190, P333, DOI 10.1016/j.ajpath.2019.10.015; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Wakamatsu A, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12679; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Wang YQ, 2010, J AM SOC NEPHROL, V21, P1657, DOI 10.1681/ASN.2009121253; XU Q, 1992, J BIOL CHEM, V267, P11968; Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067471	57	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21983	10.1096/fj.202101052R	http://dx.doi.org/10.1096/fj.202101052R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34662453	hybrid			2022-12-28	WOS:000712009200034
J	Kitchen, GB; Hopwood, T; Ramamoorthy, TG; Downton, P; Begley, N; Hussell, T; Dockrell, DH; Gibbs, JE; Ray, DW; Loudon, ASI				Kitchen, Gareth B.; Hopwood, Thomas; Ramamoorthy, Thanuja Gali; Downton, Polly; Begley, Nicola; Hussell, Tracy; Dockrell, David H.; Gibbs, Julie E.; Ray, David W.; Loudon, Andrew S., I			The histone methyltransferase Ezh2 restrains macrophage inflammatory responses	FASEB JOURNAL			English	Article						EZHZ; inflammation; lung; macrophage; neutrophil		Robust inflammatory responses are critical to survival following respiratory infection, with current attention focused on the clinical consequences of the Coronavirus pandemic. Epigenetic factors are increasingly recognized as important determinants of immune responses, and EZH2 is a prominent target due to the availability of highly specific and efficacious antagonists. However, very little is known about the role of EZH2 in the myeloid lineage. Here, we show EZH2 acts in macrophages to limit inflammatory responses to activation, and in neutrophils for chemotaxis. Selective genetic deletion in macrophages results in a remarkable gain in protection from infection with the prevalent lung pathogen, pneumococcus. In contrast, neutrophils lacking EZH2 showed impaired mobility in response to chemotactic signals, and resulted in increased susceptibility to pneumococcus. In summary, EZH2 shows complex, and divergent roles in different myeloid lineages, likely contributing to the earlier conflicting reports. Compounds targeting EZH2 are likely to impair mucosal immunity; however, they may prove useful for conditions driven by pulmonary neutrophil influx, such as adult respiratory distress syndrome.	[Kitchen, Gareth B.; Hopwood, Thomas; Ramamoorthy, Thanuja Gali; Downton, Polly; Begley, Nicola; Hussell, Tracy; Gibbs, Julie E.; Loudon, Andrew S., I] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Lealth, Manchester M13 9PT, Lancs, England; [Kitchen, Gareth B.] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Dockrell, David H.] Univ Edinburgh, Dept Infect Med, Edinburgh, Midlothian, Scotland; [Dockrell, David H.] Univ Edinburgh, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Ray, David W.] John Radcliffe Hosp, NIHR Oxford Biomed Res Ctr, Oxford, England; [Ray, David W.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England	University of Manchester; University of Manchester; University of Edinburgh; University of Edinburgh; University of Oxford; University of Oxford	Loudon, ASI (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Lealth, Manchester M13 9PT, Lancs, England.; Ray, DW (corresponding author), John Radcliffe Hosp, NIHR Oxford Biomed Res Ctr, Oxford, England.	david.ray@ocdem.ox.ac.uk; andrew.loudon@manchester.ac.uk	Downton, Polly/HCI-9878-2022; Gali Ramamoorthy, Thanuja/AFV-8484-2022	Gali Ramamoorthy, Thanuja/0000-0003-3314-0352; Downton, Polly/0000-0002-1617-6153; Loudon, Andrew/0000-0003-3648-445X; Gibbs, Julie/0000-0002-4248-2947; Ray, David/0000-0002-4739-6773; Kitchen, Gareth/0000-0001-5070-3183	Medical Research Council Canada (MRC) [MR/N002024/1]; RCUK \ Medical Research Council (MRC) [MRNO2995X/1]; Wellcome Trust (Wellcome) [107849/Z/15/Z, 107851/Z/15/Z]; RCUK \ Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L000954/1, BB/K003097/1]	Medical Research Council Canada (MRC); RCUK \ Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust (Wellcome); RCUK \ Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Medical Research Council Canada (MRC), Grant/Award Number: MR/N002024/1; RCUK | Medical Research Council (MRC), Grant/Award Number: MRNO2995X/1; Wellcome Trust (Wellcome), Grant/Award Number: 107849/Z/15/Z and 107851/Z/15/Z; RCUK | Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BB/L000954/1 and BB/K003097/1	Bamidele AO, 2019, CELL MOL GASTROENTER, V7, P55, DOI 10.1016/j.jcmgh.2018.08.009; Dagvadorj J, 2015, IMMUNITY, V42, P640, DOI 10.1016/j.immuni.2015.03.007; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; DuPage M, 2015, IMMUNITY, V42, P227, DOI 10.1016/j.immuni.2015.01.007; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Gunawan M, 2015, NAT IMMUNOL, V16, P505, DOI 10.1038/ni.3125; He J, 2019, J CLIN INVEST, V129, P3877, DOI 10.1172/JCI123374; Kitchen GB, 2020, P NATL ACAD SCI USA, V117, P1543, DOI 10.1073/pnas.1915932117; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133j, 10.1021/cb400133J]; Lim TJF, 2018, J IMMUNOL, V201, P3651, DOI 10.4049/jimmunol.1800567; Liu YF, 2017, P NATL ACAD SCI USA, V114, pE3796, DOI 10.1073/pnas.1700909114; Nicod LP, 2005, EUR RESPIR REV, V14, P45, DOI 10.1183/09059180.05.00009501; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pariollaud M, 2018, J CLIN INVEST, V128, P2281, DOI 10.1172/JCI93910; Preston JA, 2019, AM J RESP CRIT CARE, V200, P84, DOI 10.1164/rccm.201804-0646OC; Reiner SL, 2005, HUM MOL GENET, V14, pR41, DOI 10.1093/hmg/ddi115; Richart L, 2020, CURR OPIN CHEM BIOL, V56, P51, DOI 10.1016/j.cbpa.2019.11.009; Serresi M, 2016, CANCER CELL, V29, P17, DOI 10.1016/j.ccell.2015.12.006; Tano JYK, 2012, CHANNELS, V6, P141, DOI 10.4161/chan.20292; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu BW, 2015, EXP HEMATOL, V43, P698, DOI 10.1016/j.exphem.2015.05.001; Yang XP, 2015, SCI REP-UK, V5, DOI 10.1038/srep10643; Zhang XL, 2018, J EXP MED, V215, P1365, DOI 10.1084/jem.20171417	24	4	4	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21843	10.1096/fj.202100044RRR	http://dx.doi.org/10.1096/fj.202100044RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34464475	Green Published, hybrid			2022-12-28	WOS:000702238200011
J	Samvelyan, HJ; Mathers, JC; Skerry, TM				Samvelyan, Hasmik Jasmine; Mathers, John Cummings; Skerry, Timothy Michael			Feeding intervention potentiates the effect of mechanical loading to induce new bone formation in mice	FASEB JOURNAL			English	Article						aging; analysis of bone; exercise; nutrition; osteoporosis	SERUM GROWTH-HORMONE; PARATHYROID-HORMONE; ADAPTIVE RESPONSE; SOMATIC GROWTH; ADULT HAMSTERS; CORTICAL BONE; LEPTIN; AGE; OSTEOBLASTS; RECEPTOR	The benefits of increased human lifespan depend upon duration of healthy, independent living; the healthspan. Bone-wasting disorders contribute significantly to loss of independence, frailty, and morbidity in older people. Therefore, there is an unmet need globally for lifestyle interventions to reduce the likelihood of bone fractures with age. Although many mechanisms are involved in disorders of bone loss, there is no single regulatory pathway and, therefore, there is no single treatment available to prevent their occurrence. Our aim in these studies was to determine whether fasting/feeding interventions alter the effect of mechanical loading on bone anabolic activities and increase bone mass. In young 17-week-old mice, 16-hour fasting period followed by reintroduction of food for 2 hours increased markedly the potency of mechanical loading, that mimics the effect of exercise, to induce new cortical bone formation. Consistent with this finding, fasting and re-feeding increased the response of bone to a loading stimulus that, alone, does not stimulate new bone formation in ad-lib fed mice. Older mice (20 months) experienced no potentiation of loading-induced bone formation with the same timing of feeding interventions. Interestingly, the pre-, prandial, and postprandial endocrine responses in older mice were different from those in young animals. The hormones that change in response to timing of feeding have osteogenic effects that interact with loading-mediated effects. Our findings indicate associations between timing of food ingestion and bone adaptation to loading. If translated to humans, such non-pharmacological lifestyle interventions may benefit skeletal health of humans throughout life-course and in older age.	[Samvelyan, Hasmik Jasmine; Mathers, John Cummings; Skerry, Timothy Michael] Univ Sheffield, MRC Versus Arthrit Ctr Integrated Res Musculoskel, CIMA, Sheffield, S Yorkshire, England; [Samvelyan, Hasmik Jasmine; Skerry, Timothy Michael] Univ Sheffield, Mellanby Ctr Bone Res, Med Sch, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Mathers, John Cummings] Newcastle Univ, Human Nutr Res Ctr, Ctr Healthier Lives, Populat Hlth Sci Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Samvelyan, Hasmik Jasmine] Anglia Ruskin Univ, Fac Hlth Educ Med & Social Care, Sch Med, Chelmsford, Essex, England	University of Sheffield; University of Sheffield; Newcastle University - UK; Anglia Ruskin University	Skerry, TM (corresponding author), Univ Sheffield, Med Sch, Dept Oncol & Metab, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	t.skerry@sheffield.ac.uk		Mathers, John/0000-0003-3406-3002; Skerry, Timothy/0000-0003-1319-5575; Samvelyan, Jasmine/0000-0001-9576-8001	CIMA [MR/K006312/1]	CIMA(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	CIMA, Grant/Award Number: MR/ K006312/1	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Ahren B, 1997, AM J PHYSIOL-REG I, V273, pR113, DOI 10.1152/ajpregu.1997.273.1.R113; Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Bollag RJ, 2000, ENDOCRINOLOGY, V141, P1228, DOI 10.1210/en.141.3.1228; Bonnet N., 2010, IBMS BONEKEY, V7, P235, DOI [10.1138/20100453, DOI 10.1138/20100453]; Borer KT, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071494; BORER KT, 1979, NEUROENDOCRINOLOGY, V29, P22, DOI 10.1159/000122901; BORER KT, 1978, AM J PHYSIOL, V234, pE611, DOI 10.1152/ajpendo.1978.234.6.E611; BORER KT, 1977, GROWTH, V41, P1; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Cornish J, 1996, CALCIFIED TISSUE INT, V59, P492, DOI 10.1007/BF00369216; D'Amour P, 2012, CLIN BIOCHEM, V45, P964, DOI 10.1016/j.clinbiochem.2012.04.029; de Paula FJA, 2013, BONE RES, V1, DOI 10.4248/BR201301005; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Elefteriou F, 2005, CELL MOL LIFE SCI, V62, P2339, DOI 10.1007/s00018-005-5175-3; Fritton SP., 2001, BONE MECH HDB, V8, P8, DOI 10.1201/b14263-11; Frost H. M., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P136; Fukushima N, 2005, J BONE MINER RES, V20, P790, DOI 10.1359/JBMR.041237; Fulzele K, 2007, J BIOL CHEM, V282, P25649, DOI 10.1074/jbc.M700651200; Govoni Kristen E, 2012, Curr Mol Pharmacol, V5, P143; Hamrick MW, 2008, OSTEOPOROSIS INT, V19, P905, DOI 10.1007/s00198-007-0487-9; He W, 2016, P95161 US CENS BUR; HILLAM RA, 1995, J BONE MINER RES, V10, P683; Kim CH, 2003, J BONE MINER RES, V18, P2116, DOI 10.1359/jbmr.2003.18.12.2116; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Konda NN, 2019, NPJ MICROGRAVITY, V5, DOI 10.1038/s41526-019-0073-4; LANYON LE, 1986, CALCIFIED TISSUE INT, V38, P209, DOI 10.1007/BF02556712; Li J, 2003, ENDOCRINOLOGY, V144, P1226, DOI 10.1210/en.2002-220821; Ma YF, 1999, J BONE MINER RES, V14, P439, DOI 10.1359/jbmr.1999.14.3.439; Meakin LB, 2014, J BONE MINER RES, V29, P1859, DOI 10.1002/jbmr.2222; Perrini S, 2010, J ENDOCRINOL, V205, P201, DOI 10.1677/JOE-09-0431; PUN KK, 1989, J BONE MINER RES, V4, P853; Sadler AM, 2013, LAB ANIM-UK, V47, P316, DOI 10.1177/0023677213494366; Sanz C, 2010, AM J PHYSIOL-ENDOC M, V298, pE634, DOI 10.1152/ajpendo.00460.2009; Schemitsch EH, 2019, J ORTHOP TRAUMA, V33, P292, DOI 10.1097/BOT.0000000000001444; Shibamoto A, 2018, INT J ORAL SCI, V10, DOI 10.1038/s41368-018-0009-y; Sugiyama T, 2008, BONE, V43, P238, DOI 10.1016/j.bone.2008.04.012; Sugiyama T, 2012, J BONE MINER RES, V27, P1784, DOI 10.1002/jbmr.1599; Thomas DM, 1998, BONE, V23, P181, DOI 10.1016/S8756-3282(98)00095-7; Thomas T, 1999, ENDOCRINOLOGY, V140, P1630, DOI 10.1210/en.140.4.1630; Trayhurn P, 1998, ARCH ANIM NUTR, V51, P177, DOI 10.1080/17450399809381917; Upadhyay J, 2015, METABOLISM, V64, P105, DOI 10.1016/j.metabol.2014.10.021; van der Velde M, 2012, ENDOCRINOLOGY, V153, P3593, DOI 10.1210/en.2012-1277; Wolff J, 1870, VIRCHOWS ARCH PATHOL, V50, P389, DOI [10.1007/BF01944490, DOI 10.1007/BF01944490]; Xie D, 2007, BONE, V40, P1352, DOI 10.1016/j.bone.2007.01.007; Yamada C, 2008, ENDOCRINOLOGY, V149, P574, DOI 10.1210/en.2007-1292; Zhong Q, 2007, AM J PHYSIOL-ENDOC M, V292, pE543, DOI 10.1152/ajpendo.00364.2006	48	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21792	10.1096/fj.202100334RR	http://dx.doi.org/10.1096/fj.202100334RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34516688	Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000702238200030
J	Luquero, A; Vilahur, G; Casani, L; Badimon, L; Borrell-Pages, M				Luquero, Aureli; Vilahur, Gemma; Casani, Laura; Badimon, Lina; Borrell-Pages, Maria			Differential cholesterol uptake in liver cells: A role for PCSK9	FASEB JOURNAL			English	Article						cholesterol uptake; hepatic stellate cells; liver; LRP5; PCSK9	DENSITY-LIPOPROTEIN RECEPTOR; AGGREGATED LDL UPTAKE; SMOOTH-MUSCLE-CELLS; KNOCKOUT MICE; ATHEROSCLEROTIC LESIONS; SCAVENGER RECEPTOR; PLASMA-CHOLESTEROL; LIPID-COMPOSITION; GENE-TRANSFER; WNT PATHWAY	The clearance of low-density lipoprotein (LDL) particles from the circulation is regulated by the LDL receptor (LDLR) and proprotein convertase subtilisin/kexin 9 (PCSK9) interaction. Its disruption reduces blood cholesterol levels and delays atherosclerosis progression. Whether other members of the LDLR superfamily are in vivo targets of PCSK9 has been poorly explored. The aim of this work was to study the interaction between PCSK9 and members of the LDLR superfamily in the regulation of liver cholesterol homeostasis in an in vivo low-density lipoprotein receptor related protein 5 (LRP5) deficient mice model challenged with high-fat diet. Our results show that Wt and Lrp5(-/-) mice fed a hypercholesterolemic diet (HC) have increased cholesterol ester accumulation and decreased liver LDLR and LRP5 gene and protein expression. Very low-density lipoprotein receptor (VLDLR), LRP6, LRP2, and LRP1 expression levels were analyzed in liver samples and show that they do not participate in Lrp5(-/-) liver cholesterol uptake. Immunoprecipitation experiments show that LRP5 forms a complex with PCSK9 in liver-specific fat-storing stellate cells but not in structural HepG2 cells. Hepatic stellate cells silenced for LRP5 and/or PCSK9 expression and challenged with lipids show reduced cholesterol ester accumulation, indicating that both proteins are involved in lipid processing in the liver. Our results indicate that cholesterol esters accumulate in livers of Wt mice in a LDLR-family-members dependent manner as VLDLR, LRP2, and LRP6 show increased expression in HC mice. However, this increase is lost in livers of Lrp5(-/-) mice, where scavenger receptors are involved in cholesterol uptake. PCSK9 expression is strongly downregulated in mice livers after HC feeding. However PCSK9 and LRP5 bind in the cytoplasm of fat storing liver cells, indicating that this PCSK9-LRP5 interaction is cell-type specific and that both proteins contribute to lipid uptake.	[Luquero, Aureli; Vilahur, Gemma; Casani, Laura; Badimon, Lina; Borrell-Pages, Maria] IIB St Pau, Cardiovasc Program ICCC, Hosp Santa Creu & St Pau, Res Inst, Barcelona, Spain; [Vilahur, Gemma; Badimon, Lina; Borrell-Pages, Maria] Inst Salud Carlos III, CIBER CV, Madrid, Spain; [Badimon, Lina] UAB, Cardiovasc Res Chair, Barcelona, Spain	Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Instituto de Salud Carlos III; Autonomous University of Barcelona	Borrell-Pages, M (corresponding author), Cardiovasc Program ICCC, IR Hosp Santa Creu & St Pau, C St Antoni Maria Claret 167, Barcelona 08025, Spain.	mborrellpa@santpau.cat	Borrell-Pages, Maria/Q-6307-2019	Borrell-Pages, Maria/0000-0002-1759-9756; Luquero, Aureli/0000-0002-1104-5963	Ministerio de Ciencia e Innovacion (MICINN) [PID2019--107160RB--I00, PGC 2018--094025--B--I00]; MINECO | Instituto de Salud Carlos III (ISCIII) [IBERCV CB16/11/00411, TERCEL RD16/0011/018, FIS2020--01282]; Generalitat de Catalunya (Government of Catalonia) [2017SGR1480]; Sociedad Espanola de Cardiologia (Spanish Society of Cardiology) [FEC2019, FEC2020]; Government of Catalonia | Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [2016PROD00043]	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MINECO | Instituto de Salud Carlos III (ISCIII)(Spanish Government); Generalitat de Catalunya (Government of Catalonia); Sociedad Espanola de Cardiologia (Spanish Society of Cardiology); Government of Catalonia | Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)	Ministerio de Ciencia e Innovacion (MICINN), Grant/Award Number: PID2019--107160RB--I00 and PGC 2018--094025--B--I00; MINECO | Instituto de Salud Carlos III (ISCIII), Grant/Award Number: CIBERCV CB16/11/00411, TERCEL RD16/0011/018 and FIS2020--01282; Generalitat de Catalunya (Government of Catalonia), Grant/Award Number: 2017SGR1480; Sociedad Espanola de Cardiologia (Spanish Society of Cardiology), Grant/Award Number: FEC2019 and FEC2020; Government of Catalonia | Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Grant/Award Number: 2016PROD00043	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Accad M, 1998, CURR BIOL, V8, pR601, DOI 10.1016/S0960-9822(98)70386-0; ASMIS R, 1995, EUR J BIOCHEM, V233, P171, DOI 10.1111/j.1432-1033.1995.171_1.x; Awan Z, 2011, ATHEROSCLEROSIS, V219, P455, DOI 10.1016/j.atherosclerosis.2011.08.035; Badimon L, 2021, CARDIOVASC RES, V117, P2054, DOI 10.1093/cvr/cvaa254; Badimon L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218098; Barker N, 2000, ADV CANCER RES, V77, P1; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Borrell-Pages M, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0585-y; Borrell-Pages M, 2014, ATHEROSCLEROSIS, V235, P363, DOI 10.1016/j.atherosclerosis.2014.05.922; Borrell-Pages M, 2015, IMMUNOL CELL BIOL, V93, P653, DOI 10.1038/icb.2015.41; Borrell-Pages M, 2015, J CELL MOL MED, V19, P770, DOI 10.1111/jcmm.12396; Borrell-Pages M, 2014, J CELL MOL MED, V18, P314, DOI 10.1111/jcmm.12190; Borrell-Pages M, 2011, EUR HEART J, V32, P2841, DOI 10.1093/eurheartj/ehr062; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brundert M, 2011, J LIPID RES, V52, P745, DOI 10.1194/jlr.M011981; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Go Gwang-woong, 2012, Yale Journal of Biology and Medicine, V85, P19; Hiltunen TP, 1998, CIRCULATION, V97, P1079, DOI 10.1161/01.CIR.97.11.1079; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; Keramati AR, 2011, P NATL ACAD SCI USA, V108, P1914, DOI 10.1073/pnas.1019443108; Kobayashi K, 1996, J BIOL CHEM, V271, P6852, DOI 10.1074/jbc.271.12.6852; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; KRUTH HS, 1984, AM J PATHOL, V114, P201; Kysenius K, 2012, CELL MOL LIFE SCI, V69, P1903, DOI 10.1007/s00018-012-0977-6; Lambert G, 2009, ATHEROSCLEROSIS, V203, P1, DOI 10.1016/j.atherosclerosis.2008.06.010; LAURELL S, 1971, ACTA MED SCAND, V189, P65; Libby P, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0116-x, 10.1038/s41572-019-0106-z]; Liu ML, 2010, J LIPID RES, V51, P2611, DOI 10.1194/jlr.M006635; Llorente-Cortes V, 1998, ARTERIOSCL THROM VAS, V18, P738, DOI 10.1161/01.ATV.18.5.738; Llorente-Cortes V, 2006, ARTERIOSCL THROM VAS, V26, P117, DOI 10.1161/01.ATV.0000193618.32611.8b; Llorente-Cortes V, 2005, ARTERIOSCL THROM VAS, V25, P497, DOI 10.1161/01.ATV.0000154280.62072.fd; Llorente-Cortes V, 2002, CIRCULATION, V106, P3104, DOI 10.1161/01.CIR.0000041434.28573.0B; Llorente-Cortes V, 2000, ARTERIOSCL THROM VAS, V20, P1572, DOI 10.1161/01.ATV.20.6.1572; Llorente-Cortes V, 2007, CARDIOVASC RES, V74, P526, DOI 10.1016/j.cardiores.2007.02.020; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; MORIWAKI H, 1988, J LIPID RES, V29, P1523; Nicholls SJ, 2016, JAMA-J AM MED ASSOC, V316, P2373, DOI 10.1001/jama.2016.16951; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Schmidt RJ, 2008, BIOCHEM BIOPH RES CO, V370, P634, DOI 10.1016/j.bbrc.2008.04.004; Schwartz GG, 2018, NEW ENGL J MED, V379, P2097, DOI 10.1056/NEJMoa1801174; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Walley KR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008782; WILLNOW TE, 1994, SCIENCE, V264, P1471, DOI 10.1126/science.7515194; Ye ZJ, 2012, J BIOL CHEM, V287, P1335, DOI 10.1074/jbc.M111.295287	58	1	1	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22291	10.1096/fj.202101660RR	http://dx.doi.org/10.1096/fj.202101660RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ9SI	35344222				2022-12-28	WOS:000773602800001
J	Ayabe, T; Takahashi, C; Ohya, R; Ano, Y				Ayabe, Tatsuhiro; Takahashi, Chika; Ohya, Rena; Ano, Yasuhisa			beta-Lactolin improves mitochondrial function in A beta-treated mouse hippocampal neuronal cell line and a human iPSC-derived neuronal cell model of Alzheimer's disease	FASEB JOURNAL			English	Article						Alzheimer's disease; amyloid beta; mitochondria; neuronal cell	OXIDATIVE STRESS; DYSFUNCTION; DYNAMICS; FUSION; FRAGMENTATION; PRESENILIN-1; PATHOGENESIS; INFLAMMATION; MITOFUSINS; FISSION	Mitochondrial dysfunctions are a key hallmark of Alzheimer's disease (AD). beta-Lactolin, a whey-derived glycine-threonine-tryptophan-tyrosine tetrapeptide, has been previously reported to prevent AD-like pathologies in an AD mouse model via regulation of microglial functions. However, the direct effect of beta-lactolin on neuronal cells and neuronal mitochondrial functions remains unknown. Here, we investigated the effects of beta-lactolin on mitochondrial functions in amyloid beta (A beta)-treated mouse hippocampal neuronal HT22 cells and human induced-pluripotent cell (hiPSC)-derived AD model neurons. Adding beta-lactolin to A beta-treated HT22 cells increased both the oxygen consumption rate and cellular ATP concentrations, suggesting that beta-lactolin improves mitochondrial respiration and energy production. Using high content image analysis, we found that beta-lactolin improved mitochondrial fragmentation, membrane potential, and oxidative stress in A beta-treated cells, eventually preventing neuronal cell death. From a mechanistic perspective, we found that beta-lactolin increased gene expression of mitofusin-2, which contributes to mitochondrial fusion events. Finally, we showed that beta-lactolin improves both mitochondrial morphologies and membrane potentials in hiPSC-derived AD model neurons. Taken together, beta-lactolin improved mitochondrial functions AD-related neuronal cell models and prevented neuronal cell death. The dual function of beta-lactolin on both neuron and microglia marks an advantage in maintaining neuronal health.	[Ayabe, Tatsuhiro; Takahashi, Chika; Ohya, Rena; Ano, Yasuhisa] Kirin Holdings Co Ltd, Kirin Cent Res Inst, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan	Kirin Holdings Co Ltd	Ayabe, T (corresponding author), Kirin Holdings Co Ltd, Kirin Cent Res Inst, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan.	Tatsuhiro_Ayabe@kirin.co.jp			Kirin Holdings Company Limited	Kirin Holdings Company Limited	This study was supported by Kirin Holdings Company Limited.	Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Ano Y., 2021, CURR DEV NUTR, V5, P889; Ano Y, 2021, J CLIN MED, V10, DOI 10.3390/jcm10030480; Ano Y, 2020, AGING-US, V12, P18660, DOI 10.18632/aging.103951; Ano Y, 2020, J ALZHEIMERS DIS, V73, P1331, DOI 10.3233/JAD-190997; Ano Y, 2019, J NUTR SCI VITAMINOL, V65, P430, DOI 10.3177/jnsv.65.430; Ano Y, 2018, NEUROBIOL AGING, V72, P23, DOI 10.1016/j.neurobiolaging.2018.07.016; Ano Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118512; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Ayabe T, 2020, BIOSCI BIOTECH BIOCH, V84, P1039, DOI 10.1080/09168451.2020.1714424; Ayabe T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102469; Bertholet AM, 2016, NEUROBIOL DIS, V90, P3, DOI 10.1016/j.nbd.2015.10.011; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Cadonic C, 2016, MOL NEUROBIOL, V53, P6078, DOI 10.1007/s12035-015-9515-5; Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381; Camfield DA, 2011, BRIT J NUTR, V106, P159, DOI 10.1017/S0007114511000158; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Cerejeira J, 2012, Front Neurol, V3, P73, DOI 10.3389/fneur.2012.00073; Cha MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034929; Chandrasekaran K, 1996, EXP NEUROL, V142, P80, DOI 10.1006/exnr.1996.0180; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Connolly NMC, 2018, CELL DEATH DIFFER, V25, P542, DOI 10.1038/s41418-017-0020-4; Connolly NMC, 2014, J NEUROSCI, V34, P10192, DOI 10.1523/JNEUROSCI.3127-13.2014; de la Torre JC, 2020, NEUROPHARMACOLOGY, V171, DOI 10.1016/j.neuropharm.2019.107841; Dixit S, 2017, FREE RADICAL BIO MED, V112, P515, DOI 10.1016/j.freeradbiomed.2017.08.021; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Fabiani M, 2014, NEUROIMAGE, V85, P592, DOI 10.1016/j.neuroimage.2013.04.113; Fu YJ, 2009, CELL MOL NEUROBIOL, V29, P649, DOI 10.1007/s10571-009-9359-5; FUKUYAMA H, 1994, J NUCL MED, V35, P1; Fung A, 2012, BRAIN RES, V1446, P144, DOI 10.1016/j.brainres.2012.01.061; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005; Honda M, 2016, BIOCHEM BIOPH RES CO, V469, P587, DOI 10.1016/j.bbrc.2015.12.025; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Kang S, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-017-0023-4; Kita M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00399; Kita M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070899; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Manji H, 2012, NAT REV NEUROSCI, V13, P293, DOI 10.1038/nrn3229; Mansur A, 2021, J CEREBR BLOOD F MET, V41, P771, DOI 10.1177/0271678X20928149; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Mishra A, 2020, BEHAV BRAIN RES, V378, DOI 10.1016/j.bbr.2019.112304; Mishra A, 2019, NEUROCHEM INT, V129, DOI 10.1016/j.neuint.2019.104463; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Ortiz JMP, 2019, BRIT J PHARMACOL, V176, P3489, DOI 10.1111/bph.14585; Ozawa M, 2013, AM J CLIN NUTR, V97, P1076, DOI 10.3945/ajcn.112.045575; Park J, 2015, J NEUROCHEM, V132, P687, DOI 10.1111/jnc.12984; Park YH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21113879; Pauwels K, 2012, J BIOL CHEM, V287, P5650, DOI 10.1074/jbc.M111.264473; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ramsay RR, 2016, PROG NEURO-PSYCHOPH, V69, P81, DOI 10.1016/j.pnpbp.2016.02.005; Reddy PH, 2018, HUM MOL GENET, V27, P2502, DOI 10.1093/hmg/ddy154; Reddy PH, 2017, J ALZHEIMERS DIS, V58, P147, DOI 10.3233/JAD-170051; Reddy PH, 2016, J INVEST MED, V64, P1220, DOI 10.1136/jim-2016-000240; Shin SJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20123030; Tarantini S, 2018, AGING CELL, V17, DOI 10.1111/acel.12731; Tarantini S, 2017, EXP GERONTOL, V94, P52, DOI 10.1016/j.exger.2016.11.004; Terada T, 2020, NEUROLOGY, V94, pE1592, DOI 10.1212/WNL.0000000000009249; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x; Wisniewski T, 1998, NEUROREPORT, V9, P217, DOI 10.1097/00001756-199801260-00008; Wu ZF, 2014, MOL NEUROBIOL, V50, P986, DOI 10.1007/s12035-014-8675-z	63	0	0	4	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22277	10.1096/fj.202101366RR	http://dx.doi.org/10.1096/fj.202101366RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35319792				2022-12-28	WOS:000772957100011
J	Jin, XD; Kuang, YB; Li, LY; Li, HB; Zhao, T; He, YF; Di, CX; Kang, J; Yuan, LY; Yu, BY; Li, Q				Jin, Xiaodong; Kuang, Yanbei; Li, Linying; Li, Hongbin; Zhao, Ting; He, Yufang; Di, Cuixia; Kang, Jian; Yuan, Lingyan; Yu, Boyi; Li, Qiang			A positive feedback circuit comprising p21 and HIF-1 alpha aggravates hypoxia-induced radioresistance of glioblastoma by promoting Glut1/LDHA-mediated glycolysis	FASEB JOURNAL			English	Article						glioblastoma; glycolysis; HIF-1 alpha; hypoxia; p21; radioresistance	FUNCTIONAL INTERACTION; RECIPROCAL REGULATION; INDUCIBLE FACTOR; DNA-DAMAGE; CELL-DEATH; CANCER; GLIOMA; RESISTANCE; INHIBITOR; RADIOSENSITIZATION	The radioresistance induced by hypoxia is the major obstacle in the successful treatment of cancer radiotherapy. p21 was initially identified as a widespread inhibitor of cyclin-dependent kinases, through which mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. In this study, we discovered a novel function of p21, which participated in the regulation of metabolic pathways under hypoxia. We found that p21 was upregulated in glioblastoma (GBM) cells under hypoxic conditions, which enhanced the radioresistance of GBM cells. In principle, HIF-1 alpha is bound directly to the hypoxia response elements (HREs) of the p21 promoter to enhance its transcription activity, in turn, p21 also promoted the transcription of HIF-1 alpha at the mRNA level and maintained HIF-1 alpha function under oxygen deficiency. The positive correlation between p21 and HIF-1 alpha augmented Glut1/LDHA-mediated glycolysis and aggravated the radioresistance of GBM cells. Thus, our results constructed a positive feedback circuit comprising p21/HIF-1 alpha that might play a key role in enhancing the radioresistance of GBM under hypoxia.	[Jin, Xiaodong; Kuang, Yanbei; Li, Linying; Zhao, Ting; Di, Cuixia; Yuan, Lingyan; Yu, Boyi; Li, Qiang] Chinese Acad Sci, Inst Modern Phys, 509 Nanchang Rd, Lanzhou 730000, Gansu, Peoples R China; [Jin, Xiaodong; Kuang, Yanbei; Li, Linying; Zhao, Ting; Di, Cuixia; Yu, Boyi; Li, Qiang] Chinese Acad Sci, Key Lab Heavy Ion Radiat Biol & Med, Lanzhou, Peoples R China; [Jin, Xiaodong; Kuang, Yanbei; Li, Linying; Zhao, Ting; Di, Cuixia; Yu, Boyi; Li, Qiang] Key Lab Basic Res Heavy Ion Radiat Applicat Med, Lanzhou, Gansu, Peoples R China; [Jin, Xiaodong; Kuang, Yanbei; Li, Linying; Zhao, Ting; Di, Cuixia; Yu, Boyi; Li, Qiang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Jin, Xiaodong; Di, Cuixia; Li, Qiang] Lanhai Nucl Med Res Ctr, Putian, Peoples R China; [Li, Hongbin] Lanzhou Univ Technol, Sch Life Sci & Engn, Lanzhou, Peoples R China; [He, Yufang] Third Hosp Gansu Prov, Lanzhou, Peoples R China; [Kang, Jian] Lanzhou Univ Technol, Coll Energy & Power Engn, Lanzhou, Peoples R China	Chinese Academy of Sciences; Institute of Modern Physics, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Lanzhou University of Technology; Lanzhou University of Technology	Li, Q (corresponding author), Chinese Acad Sci, Inst Modern Phys, 509 Nanchang Rd, Lanzhou 730000, Gansu, Peoples R China.	liqiang@impcas.ac.cn			National Natural Science Foundation of China [11875299, U1532264]; National Key Research Program of China [2018YFC0115700, 2018YFC0115702]; Key Deployment Project of Chinese Academy of Sciences [KFZD-SW-222]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research Program of China; Key Deployment Project of Chinese Academy of Sciences	National Natural Science Foundation of China, Grant/Award Number: 11875299 and U1532264; National Key Research Program of China, Grant/Award Number: 2018YFC0115700 and 2018YFC0115702; Key Deployment Project of Chinese Academy of Sciences, Grant/Award Number: KFZD-SW-222	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Bao YY, 2015, ONCOL REP, V34, P1805, DOI 10.3892/or.2015.4158; Bartrons R, 2007, J BIOENERG BIOMEMBR, V39, P223, DOI 10.1007/S10863-007-9080-3; Bhatt AN, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1368-9; Cohen AL, 2015, CANCER TREAT RES, V163, P15, DOI 10.1007/978-3-319-12048-5_2; Coqueret O, 2000, J BIOL CHEM, V275, P18794, DOI 10.1074/jbc.M001601200; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Faramarz-Allandini, 2010, WORLD NEUROSURG, V73, P128, DOI 10.1016/j.wneu.2009.06.001; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; GRAY LH, 1953, BRIT J RADIOL, V26, P638, DOI 10.1259/0007-1285-26-312-638; Grossman SA, 2004, SEMIN ONCOL, V31, P635, DOI 10.1053/j.seminoncol.2004.07.005; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jakob B, 2002, INT J RADIAT BIOL, V78, P75, DOI 10.1080/09553000110090007; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; Kitaura H, 2000, J BIOL CHEM, V275, P10477, DOI 10.1074/jbc.275.14.10477; Koike M, 2011, BIOCHEM BIOPH RES CO, V412, P39, DOI 10.1016/j.bbrc.2011.07.032; Kokunai T, 1999, JPN J CANCER RES, V90, P638, DOI 10.1111/j.1349-7006.1999.tb00795.x; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Koukourakis MI, 2014, BRIT J CANCER, V110, P2217, DOI 10.1038/bjc.2014.158; Koukourakis M, 2017, BIOCHEM BIOPH RES CO, V491, P932, DOI 10.1016/j.bbrc.2017.07.138; Li HB, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6017-2; Li XG, 2016, MOL MED REP, V13, P3661, DOI 10.3892/mmr.2016.4974; Luczak MW, 2017, TOXICOL APPL PHARM, V331, P94, DOI 10.1016/j.taap.2017.05.029; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Muz B, 2015, HYPOXIA, V3, P83, DOI 10.2147/HP.S93413; Ostrom QT, 2018, NEURO-ONCOLOGY, V20, P1, DOI 10.1093/neuonc/noy131; Pena-Rico MA, 2011, RADIOTHER ONCOL, V101, P132, DOI 10.1016/j.radonc.2011.07.002; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shimura T, 2014, RADIOTHER ONCOL, V112, P302, DOI 10.1016/j.radonc.2014.07.015; Snowden AW, 2000, MOL CELL BIOL, V20, P2676, DOI 10.1128/MCB.20.8.2676-2686.2000; Stubbs M, 2010, ADV ENZYME REGUL, V50, P44, DOI 10.1016/j.advenzreg.2009.10.027; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sunada S, 2016, CANCER SCI, V107, P1250, DOI 10.1111/cas.12998; Thompson CB, 2009, NEW ENGL J MED, V360, P813, DOI 10.1056/NEJMe0810213; Vogelbaum Michael A, 2012, Clin Neurosurg, V59, P79; Wanka C, 2012, J BIOL CHEM, V287, P33436, DOI 10.1074/jbc.M112.384578; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yan SX, 2013, INT J MED SCI, V10, P1375, DOI 10.7150/ijms.6855; Yang F, 2014, MOL CELL, V53, P88, DOI 10.1016/j.molcel.2013.11.004; Zhao F, 2016, CANCER CHEMOTH PHARM, V77, P963, DOI 10.1007/s00280-016-3007-9; Zhong JT, 2019, ONCOTARGETS THER, V12, P9129, DOI 10.2147/OTT.S221423; Zhu P, 2017, ONCOTARGET, V8, P44015, DOI 10.18632/oncotarget.17054	45	4	4	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22229	10.1096/fj.202101736R	http://dx.doi.org/10.1096/fj.202101736R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35199870				2022-12-28	WOS:000761250800015
J	Elangovan, M; Ka, J; Pak, B; Choi, W; Oh, SR; Jin, SW; Yoo, YJ				Elangovan, Muthukumar; Ka, Jun; Pak, Boryeong; Choi, Woosoung; Oh, Se-Ra; Jin, Suk-Won; Yoo, Yung Joon			Ubiquitin-conjugating enzyme V variant 1 enables cellular responses toward fibroblast growth factor signaling in endothelium	FASEB JOURNAL			English	Article						angiogenesis; FGF; MEKK1; ubiquitin-conjugating enzyme	MIDBLASTULA TRANSITION; MATERNAL CONTROL; E2 ENZYMES; ACTIVATION; ZEBRAFISH; MEKK1; PHOSPHORYLATION; ANGIOGENESIS; PROTEASOME; LIGASE	Ubiquitination has been shown to provide an essential regulatory role in modulating the duration and amplitude of the signaling activity in angiogenesis. While successive enzymatic reactions mediated by three distinct types of enzymes commonly known as E1, E2, and E3 are required for ubiquitination, the role of E3s which govern the final step of ubiquitination has been extensively analyzed in angiogenesis. In contrast, the role of E2s, which determine the context and functional consequences of ubiquitination, remains largely unknown with respect to angiogenesis. To better elucidate the role of E2s in modulating endothelial behaviors during angiogenesis, we first systematically analyze the expression pattern of E2s in endothelial cells (ECs) using previously published scRNA-seq data and identify ubiquitin-conjugating enzyme variant 1 (UBE2V1), an unconventional E2 without innate catalytic activity, as one of the most abundantly expressed E2s in ECs. While ubiquitously expressed in diverse cell types, abrogation of UBE2V1 significantly impairs proliferation and viability of human umbilical vein endothelial cells (HUVECs) without affecting other cell types, suggesting that UBE2V1 is likely to possess nonredundant functions in ECs. Consistent with this idea, UBE2V1 appears to be critical for morphogenesis and migration of ECs during angiogenesis. Interestingly, we find that UBE2V1 is essential for fibroblast growth factor 2 (FGF2)-induced angiogenesis, but appears to have minor effects on vascular endothelial growth factor-A-induced angiogenesis in vitro as well as in vivo. Therefore, it seems that UBE2V1 could enable ECs to distinguish two related yet distinct angiogenic cues. Mechanistically, we show that UBE2V1 promotes ubiquitination of MEK kinase 1, a key mediator of FGF2 signaling, to enhance phosphorylation of extracellular signal-regulated kinase 1/2 in HUVECs. Taken together, our results illustrate the unique role of UBE2V1 as a key modulator for angiogenic behaviors in ECs.	[Elangovan, Muthukumar; Ka, Jun; Pak, Boryeong; Choi, Woosoung; Oh, Se-Ra; Jin, Suk-Won] Gwangju Inst Sci & Technol GIST, Cell Logist Res Ctr, Gwangju, South Korea; [Elangovan, Muthukumar; Ka, Jun; Pak, Boryeong; Choi, Woosoung; Oh, Se-Ra; Jin, Suk-Won; Yoo, Yung Joon] Gwangju Inst Sci & Technol GIST, Sch Life Sci, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Jin, SW (corresponding author), Gwangju Inst Sci & Technol GIST, Cell Logist Res Ctr, Gwangju, South Korea.; Yoo, YJ (corresponding author), Gwangju Inst Sci & Technol GIST, Sch Life Sci, Gwangju, South Korea.	sukwonjin@gist.ac.kr; yjyoo@gist.ac.kr	Choi, Woosoung/ABF-2933-2020	Choi, Woosoung/0000-0002-8017-3838	National Research Foundation of Korea (NRF) [2016R1A5A1007318, 2019R1A2C2088125]; GIST Research Institute	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); GIST Research Institute	National Research Foundation of Korea (NRF), Grant/Award Number: 2016R1A5A1007318 and 2019R1A2C2088125; GIST Research Institute	Akutsu M, 2016, J CELL SCI, V129, P875, DOI 10.1242/jcs.183954; Beedie SL, 2020, FASEB J, V34, P11395, DOI 10.1096/fj.201903060RR; Cao RH, 2004, CIRC RES, V94, P664, DOI 10.1161/01.RES.0000118600.91698.BB; Ceci C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041388; Charlaftis N, 2014, EMBO J, V33, P2581, DOI 10.15252/embj.201488351; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Choi W, 2021, FASEB J, V35, DOI 10.1096/fj.202002071R; Clague MJ, 2015, TRENDS CELL BIOL, V25, P417, DOI 10.1016/j.tcb.2015.03.002; Critchley WR, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7030022; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dosch R, 2004, DEV CELL, V6, P771, DOI 10.1016/j.devcel.2004.05.002; Elangovan M, 2017, J CELL COMMUN SIGNAL, V11, P265, DOI 10.1007/s12079-017-0386-6; Farnsworth DR, 2020, DEV BIOL, V459, P100, DOI 10.1016/j.ydbio.2019.11.008; Gallagher E, 2007, NAT IMMUNOL, V8, P57, DOI 10.1038/ni1421; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jeltsch M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009183; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Li W, 2008, CELL MOL LIFE SCI, V65, P2397, DOI 10.1007/s00018-008-8090-6; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Molina GA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-62; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Nicoli S, 2009, J CELL MOL MED, V13, P2061, DOI 10.1111/j.1582-4934.2008.00432.x; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Rahimi N, 2012, MOL CANCER THER, V11, P538, DOI 10.1158/1535-7163.MCT-11-0555; Rahimi N, 2009, BIOCHEM SOC T, V37, P1189, DOI 10.1042/BST0371189; Rivkin E, 2013, NATURE, V498, P318, DOI 10.1038/nature12296; Sancho E, 1998, MOL CELL BIOL, V18, P576, DOI 10.1128/MCB.18.1.576; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; Singh AJ, 2007, P NATL ACAD SCI USA, V104, P5413, DOI 10.1073/pnas.0700809104; Stewart MD, 2016, CELL RES, V26, P423, DOI 10.1038/cr.2016.35; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tan MJ, 2011, DEV CELL, V21, P1062, DOI 10.1016/j.devcel.2011.09.014; Wagner DS, 2004, DEV CELL, V6, P781, DOI 10.1016/j.devcel.2004.04.001; Witowsky JA, 2003, J BIOL CHEM, V278, P1403, DOI 10.1074/jbc.C200616200; Wong A, 2002, P NATL ACAD SCI USA, V99, P6684, DOI 10.1073/pnas.052138899; Xie YL, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00222-7; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yu PC, 2017, NATURE, V545, P224, DOI 10.1038/nature22322; Zhang WW, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.366; Zhao YJ, 2015, ONCOLOGIST, V20, P660, DOI 10.1634/theoncologist.2014-0465	48	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22103	10.1096/fj.202100808RRR	http://dx.doi.org/10.1096/fj.202100808RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34921695				2022-12-28	WOS:000734992000050
J	Xing, YJ; Zhao, JL; Zhou, MJ; Jing, SL; Zhao, X; Mao, P; Qian, JN; Huang, C; Tian, Z; Wang, Q; Zeng, XF; Li, MT; Yang, J				Xing, Yanjiang; Zhao, Jiuliang; Zhou, Meijun; Jing, Shuliang; Zhao, Xin; Mao, Pei; Qian, Junyan; Huang, Can; Tian, Zhuang; Wang, Qian; Zeng, Xiaofeng; Li, Mengtao; Yang, Jun			The LPS induced pyroptosis exacerbates BMPR2 signaling deficiency to potentiate SLE-PAH	FASEB JOURNAL			English	Article						BMPR2; SLE-PAH; systemic lupus erythematosus	BONE MORPHOGENETIC PROTEIN; PULMONARY ARTERIAL-HYPERTENSION; INFLAMMATORY CASPASES; RECEPTOR; MUTATIONS; DISEASE	Pulmonary arterial hypertension (PAH) is a common and fatal complication of systemic lupus erythematosus (SLE). Whether the BMP receptor deficiency found in the genetic form of PAH is also involved in SLE-PAH patients remains to be identified. In this study, we employed patient-derived samples from SLE-associated PAH (SLE-PAH) and established comparable mouse models to clarify the role of BMP signaling in the pathobiology of SLE-PAH. Firstly, serum levels of LPS and autoantibodies (auto-Abs) directed at BMP receptors were significantly increased in patients with SLE-PAH compared with control subjects, measured by ELISA. Mass cytometry was applied to compare peripheral blood leukocyte phenotype in patients prior to and after treatment with steroids, which demonstrated inflammatory cells alteration in SLE-PAH. Furthermore, BMPR2 signaling and pyroptotic factors were examined in human pulmonary arterial endothelial cells (PAECs) in response to LPS stimulation. Interleukin-8 (IL-8) and E-selectin (SELE) expressions were up-regulated in autologous BMPR2(+/R899X) endothelial cells and siBMPR2-interfered PAECs. A SLE-PH model was established in mice induced with pristane and hypoxia. Moreover, the combination of endothelial specific BMPR2 knockout in SLE mice exacerbated pulmonary hypertension. Pyroptotic factors including gasdermin D (GSDMD) were elevated in the lungs of SLE-PH mice, and the pyroptotic effects of serum samples isolated from SLE-PAH patients on PAECs were analyzed. BMPR2 signaling upregulator (BUR1) showed anti-pyroptotic effects in SLE-PH mice and PAECs. Our results implied that deficiencies of BMPR2 signaling and proinflammatory factors together contribute to the development of PAH in SLE.	[Xing, Yanjiang; Zhou, Meijun; Zhao, Xin; Yang, Jun] Chinese Acad Med Sci, Inst Basic Med Sci, Sch Basic Med, Peking Union Med Coll, Beijing, Peoples R China; [Xing, Yanjiang; Zhou, Meijun; Jing, Shuliang; Zhao, Xin; Mao, Pei; Yang, Jun] Zhejiang Univ, Dept Physiol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Zhao, Jiuliang; Qian, Junyan; Huang, Can; Wang, Qian; Zeng, Xiaofeng; Li, Mengtao] Peking Union Med Coll & Chinese Acad Med Sci, Dept Rheumatol, Peking Union Med Coll Hosp, Beijing, Peoples R China; [Zhao, Jiuliang; Qian, Junyan; Huang, Can; Wang, Qian; Zeng, Xiaofeng; Li, Mengtao] Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing, Peoples R China; [Zhou, Meijun; Jing, Shuliang; Zhao, Xin; Mao, Pei; Yang, Jun] Zhejiang Univ, Dept Cardiol, Affiliated Hosp 2, Sch Med, Hangzhou, Peoples R China; [Tian, Zhuang] Peking Union Med Coll & Chinese Acad Med Sci, Dept Cardiol, Peking Union Med Coll Hosp, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Zhejiang University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Zhejiang University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Yang, J (corresponding author), Zhejiang Univ, Dept Physiol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.	yang_jun@zju.edu.cn	Yang, Jun/AAA-6895-2022; Jiuliang, Zhao/AAW-5669-2020; Zeng, Xiao/ABG-5938-2021	Yang, Jun/0000-0001-9715-8100; Jiuliang, Zhao/0000-0001-9308-2858; 	National Natural Science Foundation of China (NSFC) [81670054, 81870051, 81901588]; National Key Research and Development Program of China-stem cell and translational research [2016YFA0102300]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-4-003]; Youth Program of National Nature Science Foundation of China [81900054]; Postdoctoral Science Foundation Program of Chinese Academy of Medical Sciences & Peking Union Medical College	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China-stem cell and translational research; CAMS Innovation Fund for Medical Sciences (CIFMS); Youth Program of National Nature Science Foundation of China; Postdoctoral Science Foundation Program of Chinese Academy of Medical Sciences & Peking Union Medical College	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81670054, 81870051 to Jun Yang and 81901588 to Yanjiang Xing; National Key Research and Development Program of China-stem cell and translational research, Grant/ Award Number: 2016YFA0102300 to Jun Yang; The CAMS Innovation Fund for Medical Sciences (CIFMS), Grant/ Award Number: 2016-I2M-4-003 to Jun Yang; Youth Program of National Nature Science Foundation of China, Grant/Award Number: 81900054 to Junyan Qian; The Postdoctoral Science Foundation Program of Chinese Academy of Medical Sciences & Peking Union Medical College, Grant/Award Number: to Yanjiang Xing	Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Chaouat A, 2004, THORAX, V59, P446, DOI 10.1136/thx.2003.11890; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Faliti CE, 2019, J EXP MED, V216, P317, DOI 10.1084/jem.20171976; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Hao YJ, 2014, EUR RESPIR J, V44, P963, DOI 10.1183/09031936.00182813; Harrison RE, 2003, J MED GENET, V40, P865, DOI 10.1136/jmg.40.12.865; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Long L, 2015, NAT MED, V21, P777, DOI 10.1038/nm.3877; Long L, 2009, CIRCULATION, V119, P566, DOI 10.1161/CIRCULATIONAHA.108.821504; Loyd James E, 2011, Proc Am Thorac Soc, V8, P154, DOI 10.1513/pats.201007-047MS; Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285; Maston LD, 2017, AM J PHYSIOL-LUNG C, V312, P1609, DOI 10.1152/ajplung.00531.2016; Mori H, 2020, CIRC J, V84, P1163, DOI 10.1253/circj.CJ-19-1102; Morty RE, 2007, ARTERIOSCL THROM VAS, V27, P1072, DOI 10.1161/ATVBAHA.107.141200; Nasim MT, 2011, HUM MUTAT, V32, P1385, DOI 10.1002/humu.21605; Nicod LP, 2007, SWISS MED WKLY, V137, P437; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Ranchoux B, 2017, AM J RESP CELL MOL, V56, P402, DOI 10.1165/rcmb.2015-0404LE; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Soon E, 2015, AM J RESP CRIT CARE, V192, P859, DOI 10.1164/rccm.201408-1509OC; Teichert-Kuliszewska K, 2006, CIRC RES, V98, P209, DOI 10.1161/01.RES.0000200180.01710.e6; Tielemans B, 2019, PULM CIRC, V9, DOI 10.1177/2045894019883607; Toral M, 2019, FASEB J, V33, P10005, DOI 10.1096/fj.201900545RR; Wang JJ, 2018, EXP CELL RES, V365, P97, DOI 10.1016/j.yexcr.2018.02.026; Xing YJ, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02229-2017	30	4	4	5	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22044	10.1096/fj.202100851RR	http://dx.doi.org/10.1096/fj.202100851RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34818449				2022-12-28	WOS:000722321300041
J	Yin, M; O'Neill, LAJ				Yin, Maureen; O'Neill, Luke A. J.			The role of the electron transport chain in immunity	FASEB JOURNAL			English	Review						electron transport chain (ETC); immunometabolism; macrophage; mitochondria; oxidative phosphorylation; T-lymphocytes	MITOCHONDRIAL COMPLEX-III; T-CELL-ACTIVATION; HYDROGEN-PEROXIDE PRODUCTION; RESPIRATORY-CHAIN; SUCCINATE-DEHYDROGENASE; NLRP3 INFLAMMASOME; SUPEROXIDE-PRODUCTION; ENERGY-METABOLISM; ROS PRODUCTION; ATP SYNTHASE	The electron transport chain (ETC) couples oxidative phosphorylation (OXPHOS) with ATP synthase to drive the generation of ATP. In immune cells, research surrounding the ETC has drifted away from bioenergetics since the discovery of cytochrome c (Cyt c) release as a signal for programmed cell death. Complex I has been shown to generate reactive oxygen species (ROS), with key roles identified in inflammatory macrophages and T helper 17 cells (T(H)17) cells. Complex II is the site of reverse electron transport (RET) in inflammatory macrophages and is also responsible for regulating fumarate levels linking to epigenetic changes. Complex III also produces ROS which activate hypoxia-inducible factor 1-alpha (HIF-1 alpha) and can participate in regulatory T cell (T-reg) function. Complex IV is required for T cell activation and differentiation and the proper development of T-reg subsets. Complex V is required for T(H)17 differentiation and can be expressed on the surface of tumor cells where it is recognized by anti-tumor T and NK cells. In this review, we summarize these findings and speculate on the therapeutic potential of targeting the ETC as an anti-inflammatory strategy.	[Yin, Maureen; O'Neill, Luke A. J.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland.	laoneill@tcd.ie		Yin, Maureen/0000-0003-1451-9906	Wellcome Trust (Wellcome) [205455]; EC \ European Research Council (ERC) [834370]; Science Foundation Ireland (SFI) [12/IA/1531]	Wellcome Trust (Wellcome); EC \ European Research Council (ERC); Science Foundation Ireland (SFI)(Science Foundation Ireland)	Wellcome Trust (Wellcome), Grant/Award Number: 205455; EC | European Research Council (ERC), Grant/Award Number: 834370; Science Foundation Ireland (SFI), Grant/Award Number: 12/IA/1531; This article is part of the Special Review Series on Mitochondria: The Inescapabl e Portals of Modern Biomedicine.	Ahmed D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55295-4; Angelin A, 2017, CELL METAB, V25, P1282, DOI 10.1016/j.cmet.2016.12.018; Angireddy R, 2019, FASEB J, V33, P9167, DOI 10.1096/fj.201900010RR; Anso E, 2017, NAT CELL BIOL, V19, P614, DOI 10.1038/ncb3529; Enriquez JA, 2016, ANNU REV PHYSIOL, V78, P533, DOI 10.1146/annurev-physiol-021115-105031; Arakaki R, 2014, CRIT REV IMMUNOL, V34, P301, DOI 10.1615/CritRevImmunol.2014009988; Arts RJW, 2016, CELL METAB, V24, P807, DOI 10.1016/j.cmet.2016.10.008; Bailis W, 2019, NATURE, V571, P403, DOI 10.1038/s41586-019-1311-3; Bambouskova M, 2018, NATURE, V556, P501, DOI 10.1038/s41586-018-0052-z; Batandier C, 2006, J BIOENERG BIOMEMBR, V38, P33, DOI 10.1007/s10863-006-9003-8; Beach TE, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101640; Beier UH, 2015, FASEB J, V29, P2315, DOI 10.1096/fj.14-268409; BENDTZEN K, 1986, SCIENCE, V232, P1545, DOI 10.1126/science.3086977; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Champagne DP, 2016, IMMUNITY, V44, P1299, DOI 10.1016/j.immuni.2016.02.018; Champagne E, 2006, CURR OPIN LIPIDOL, V17, P279, DOI 10.1097/01.mol.0000226120.27931.76; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cobley JN, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100933; Corcoran SE, 2016, J CLIN INVEST, V126, P3699, DOI 10.1172/JCI84431; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; CROFFORD OB, 1995, NEW ENGL J MED, V333, P588, DOI 10.1056/NEJM199508313330910; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; DAS B, 1994, J EXP MED, V180, P273, DOI 10.1084/jem.180.1.273; Day EA, 2019, NAT METAB, V1, P1202, DOI 10.1038/s42255-019-0146-4; Del Prete A, 2008, FREE RADICAL BIO MED, V44, P1443, DOI 10.1016/j.freeradbiomed.2007.12.037; DERVARTANIAN DV, 1964, BIOCHIM BIOPHYS ACTA, V92, P233, DOI 10.1016/0926-6569(64)90182-8; Diaz F, 2012, HUM MOL GENET, V21, P5066, DOI 10.1093/hmg/dds350; Diaz F, 2010, BBA-MOL BASIS DIS, V1802, P100, DOI 10.1016/j.bbadis.2009.07.013; Dominguez-Andres J, 2019, CELL METAB, V29, P211, DOI 10.1016/j.cmet.2018.09.003; Duan W, 2019, AM J TRANSL RES, V11, P2393; Franchi L, 2017, J IMMUNOL, V198, P2735, DOI 10.4049/jimmunol.1600810; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Giannarelli R., 2003, Diabetes & Metabolism, V29, p6S28; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Han D, 2003, MOL PHARMACOL, V64, P1136, DOI 10.1124/mol.64.5.1136; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Hatle KM, 2013, MOL CELL BIOL, V33, P2302, DOI 10.1128/MCB.00189-13; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hooftman A, 2020, CELL METAB, V32, P468, DOI 10.1016/j.cmet.2020.07.016; Hu LY, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22083838; Izquierdo E, 2015, J IMMUNOL, V195, P2442, DOI 10.4049/jimmunol.1403045; Jantsch J, 2008, J IMMUNOL, V180, P4697, DOI 10.4049/jimmunol.180.7.4697; Jett KA, 2018, J BIOL CHEM, V293, P4644, DOI 10.1074/jbc.R117.816132; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Jin ZX, 2014, CELL METAB, V20, P483, DOI 10.1016/j.cmet.2014.07.011; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; Kaminski M, 2007, MOL CELL BIOL, V27, P3625, DOI 10.1128/MCB.02295-06; Kelly B, 2015, J BIOL CHEM, V290, P20348, DOI 10.1074/jbc.M115.662114; Kim EK, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5813030; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Lee G, 2016, SCI REP-UK, V6, DOI 10.1038/srep18928; Lee SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135858; Lenaz G, 2006, BBA-BIOENERGETICS, V1757, P1406, DOI 10.1016/j.bbabio.2006.05.007; Letts JA, 2017, NAT STRUCT MOL BIOL, V24, P800, DOI 10.1038/nsmb.3460; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Loftus RM, 2016, J BIOL CHEM, V291, P1, DOI 10.1074/jbc.R115.693903; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Mah-Som AY, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109209; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Mansilla N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030662; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McNamee EN, 2013, IMMUNOL RES, V55, P58, DOI 10.1007/s12026-012-8349-8; Mehta MM, 2017, NAT REV IMMUNOL, V17, P608, DOI 10.1038/nri.2017.66; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Miwa S, 2005, BBA-BIOENERGETICS, V1709, P214, DOI 10.1016/j.bbabio.2005.08.003; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Mookerjee-Basu J, 2010, J IMMUNOL, V184, P6920, DOI 10.4049/jimmunol.0904024; Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; OROURKE AM, 1989, BIOCHIM BIOPHYS ACTA, V1010, P342, DOI 10.1016/0167-4889(89)90059-1; Orr DL, 2015, NAT CHEM BIOL, V11, P834, DOI [10.1038/nchembio.1910, 10.1038/NCHEMBIO.1910]; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Ozay EI, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01284; Palsson-McDermott EM, 2020, CELL RES, V30, P300, DOI 10.1038/s41422-020-0291-z; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; Samon JB, 2008, BLOOD, V112, P1813, DOI 10.1182/blood-2008-03-144980; Saravia J, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaw6443; Scharping NE, 2021, NAT IMMUNOL, V22, P205, DOI 10.1038/s41590-020-00834-9; Schull S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.62; Scialo F, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00428; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shin BY, 2020, CELL REP, V30, P1898, DOI 10.1016/j.celrep.2020.01.022; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Son HJ, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/973986; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tarasenko TN, 2017, CELL METAB, V25, P1254, DOI 10.1016/j.cmet.2017.05.007; Tsuji G, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-0245-8; Vantourout P, 2009, J IMMUNOL, V183, P3848, DOI 10.4049/jimmunol.0901085; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829; Walls J, 2016, SEMIN IMMUNOL, V28, P396, DOI 10.1016/j.smim.2016.09.001; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wang FL, 2018, CELL METAB, V28, P463, DOI 10.1016/j.cmet.2018.08.012; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Weinberg SE, 2019, NATURE, V565, P495, DOI 10.1038/s41586-018-0846-z; Weng XF, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021385118; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Xian HX, 2021, IMMUNITY, V54, P1463, DOI 10.1016/j.immuni.2021.05.004; Xu JF, 2018, NEUROSCIENCE, V393, P24, DOI 10.1016/j.neuroscience.2018.09.041; Yang YQ, 2019, INNATE IMMUN-LONDON, V25, P522, DOI 10.1177/1753425919873042; Yi JS, 2006, J IMMUNOL, V177, P852, DOI 10.4049/jimmunol.177.2.852; Yin YM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0835	118	13	13	9	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e21974	10.1096/fj.202101161R	http://dx.doi.org/10.1096/fj.202101161R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34793601				2022-12-28	WOS:000722321300017
J	Bernhardt, A; Haberer, S; Xu, JJ; Damerau, H; Steffen, J; Reichardt, C; Wolters, K; Steffen, H; Isermann, B; Borucki, K; Artelt, N; Endlich, N; Kozyraki, R; Brandt, S; Lindquist, JA; Mertens, PR				Bernhardt, Anja; Haeberer, Saskia; Xu, JingJing; Damerau, Hannah; Steffen, Johannes; Reichardt, Charlotte; Wolters, Katharina; Steffen, Hannes; Isermann, Berend; Borucki, Katrin; Artelt, Nadine; Endlich, Nicole; Kozyraki, Renata; Brandt, Sabine; Lindquist, Jonathan A.; Mertens, Peter R.			High salt diet-induced proximal tubular phenotypic changes and sodium-glucose cotransporter-2 expression are coordinated by cold shock Y-box binding protein-1	FASEB JOURNAL			English	Article						cold shock protein; high salt diet; sodium glucose transporter; tubular damage	ALBUMIN REABSORPTION; EPITHELIAL POLARITY; RENIN SYNTHESIS; BLOOD-PRESSURE; YB-1; AQUAPORIN-2; ACTIVATION; PREVENTION; EXCRETION; TRANSPORT	High salt diet (HSD) is a hallmark of blood pressure elevations, weight gain and diabetes onset in the metabolic syndrome. In kidney, compensatory mechanisms are activated to balance salt turnover and maintain homeostasis. Data on the long-term effects of HSD with respect to tubular cell functions and kidney architecture that exclude confounding indirect blood pressure effects are scarce. Additionally we focus on cold shock Y-box binding protein-1 as a tubular cell protective factor. A HSD model (4% NaCl in chow; 1% NaCl in water) was compared to normal salt diet (NSD, standard chow) over 16 months using wild type mice and an inducible conditional whole body knockout for cold shock Y-box binding protein-1 (BL6J/N, Ybx1). HSD induced no difference in blood pressure over 16 months, comparing NSD/HSD and Ybx1 wild type/knockout. Nevertheless, marked phenotypic changes were detected. Glucosuria and subnephrotic albuminuria ensued in wild type animals under HSD, which subsided in Ybx1-deficient animals. At the same time megalin receptors were upregulated. The sodium-glucose cotransporter-2 (SGLT2) was completely downregulated in wild type HSD animals that developed glucosuria. In Ybx1 knockouts, expression of AQP1 and SGLT2 was maintained under HSD; proximal tubular widening and glomerular tubularization developed. Concurrently, amino aciduria of neutral and hydrophobic amino acids was seen. In vitro translation confirmed that YB-1 translationally represses Sglt2 transcripts. Our data reveal profound effects of HSD primarily within glomeruli and proximal tubular segments. YB-1 is regulated by HSD and orchestrates HSD-dependent changes; notably, sets reabsorption thresholds for amino acids, proteins and glucose.	[Bernhardt, Anja; Haeberer, Saskia; Xu, JingJing; Damerau, Hannah; Steffen, Johannes; Reichardt, Charlotte; Wolters, Katharina; Steffen, Hannes; Brandt, Sabine; Lindquist, Jonathan A.; Mertens, Peter R.] Otto von Guericke Univ, Diabet & Endocrinol, Clin Nephrol & Hypertens, Leipziger Str 44, D-39120 Magdeburg, Germany; [Isermann, Berend; Borucki, Katrin] Otto von Guericke Univ, Inst Clin Chem & Pathobiochem, Magdeburg, Germany; [Artelt, Nadine; Endlich, Nicole] Univ Med Greifswald, Inst Anat & Cell Biol, Greifswald, Germany; [Artelt, Nadine; Endlich, Nicole] NIPOKA GmbH, Greifswald, Germany; [Kozyraki, Renata] Univ Paris, Ctr Rech Cordeliers, INSERM, UMRS 1138, Paris, France	Otto von Guericke University; Otto von Guericke University; Greifswald Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Mertens, PR (corresponding author), Otto von Guericke Univ, Diabet & Endocrinol, Clin Nephrol & Hypertens, Leipziger Str 44, D-39120 Magdeburg, Germany.	peter.mertens@med.ovgu.de		Steffen, Johannes/0000-0002-0647-4157	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [97850925-SFB 854, GRK 2408, ME-1365/7-2, ME-1365/9-2, LI-1031/4-1]; federal state Saxony-Anhalt; European Structural and Investment Funds (ESF) [ZS/2016/08/80645]; BMBF (Bundesministerium fur Bildung und Forschung) STOP-FSGS [01GM1518B]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); federal state Saxony-Anhalt; European Structural and Investment Funds (ESF); BMBF (Bundesministerium fur Bildung und Forschung) STOP-FSGS	This work was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-Project-ID 97850925-SFB 854: PRM (Project A01), BI (Project B26N) GRK 2408, project 7 to BI, project 8 to PRM, grants ME-1365/7-2 and ME-1365/9-2 to PRM and LI-1031/4-1 to JAL, also by the federal state Saxony-Anhalt and the European Structural and Investment Funds (ESF, 2014-2020), project number ZS/2016/08/80645 to PRM as well as by the BMBF (Bundesministerium fur Bildung und Forschung) STOP-FSGS 01GM1518B to NE	Amsellem S, 2010, J AM SOC NEPHROL, V21, P1859, DOI 10.1681/ASN.2010050492; Ansermet C, 2020, ACTA PHYSIOL, V229, DOI 10.1111/apha.13457; Artelt N, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00292; Bobulescu IA, 2009, PFLUG ARCH EUR J PHY, V458, P5, DOI 10.1007/s00424-008-0595-1; Boero R, 2002, J NEPHROL, V15, P225; Ding J, 2011, AGE, V33, P291, DOI 10.1007/s11357-010-9179-z; Dong W, 2015, J AM SOC NEPHROL, V26, P2789, DOI 10.1681/ASN.2014080846; du Cailar G, 2002, AM J HYPERTENS, V15, P222, DOI 10.1016/S0895-7061(01)02287-7; Duranton F, 2014, CLIN J AM SOC NEPHRO, V9, P37, DOI 10.2215/CJN.06000613; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Farquhar WB, 2015, J AM COLL CARDIOL, V65, P1042, DOI 10.1016/j.jacc.2014.12.039; Feng MJ, 2008, AM J HYPERTENS, V21, P1288, DOI 10.1038/ajh.2008.301; Figueira MF, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13335; Graffe CC, 2012, AM J PHYSIOL-RENAL, V302, pF264, DOI 10.1152/ajprenal.00442.2010; Greger R, 2000, AM J MED SCI, V319, P51, DOI 10.1097/00000441-200001000-00005; Hohlfeld Raphael, 2018, Oncotarget, V9, P19039, DOI 10.18632/oncotarget.24886; Hosohata K, 2016, HYPERTENS RES, V39, P19, DOI 10.1038/hr.2015.103; Hucke S, 2016, J AUTOIMMUN, V67, P90, DOI 10.1016/j.jaut.2015.11.001; Humphreys BD, 2018, SCIENCE, V360, P709, DOI 10.1126/science.aat7271; Isaac J, 2007, NEPHRON EXP NEPHROL, V105, pE33, DOI 10.1159/000097017; Jantsch J, 2015, CELL METAB, V21, P493, DOI 10.1016/j.cmet.2015.02.003; Jobin K, 2021, TRENDS IMMUNOL, V42, P469, DOI 10.1016/j.it.2021.04.002; Kluger AY, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0903-4; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Korte S, 2014, FASEB J, V28, P4015, DOI 10.1096/fj.14-250282; Kotchen TA, 2013, NEW ENGL J MED, V368, P1229, DOI 10.1056/NEJMra1212606; Kurtz A, 2012, AM J HYPERTENS, V25, P839, DOI 10.1038/ajh.2011.246; Kwon E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04092-0; Lambers Heerspink HJ, 2012, J AM SOC NEPHROL, V23, P1136, DOI 10.1681/ASN.2012010099; Lantelme P, 2002, HYPERTENSION, V39, P1007, DOI 10.1161/01.HYP.0000016177.20565.A0; Ledoussal C, 2001, AM J PHYSIOL-RENAL, V281, pF718, DOI 10.1152/ajprenal.2001.281.4.F718; Li CN, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0143-8; Lindquist JA, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0274-6; Loffing J, 2000, AM J PHYSIOL-RENAL, V278, pF530, DOI 10.1152/ajprenal.2000.278.4.F530; Lu ZH, 2005, MOL CELL BIOL, V25, P4625, DOI 10.1128/MCB.25.11.4625-4637.2005; Lu ZH, 2006, MOL CELL BIOL, V26, P8410, DOI 10.1128/MCB.01196-06; Lyabin DN, 2020, RNA BIOL, V17, P487, DOI 10.1080/15476286.2019.1710050; Mehta S, 2020, CANCERS, V12, DOI 10.3390/cancers12020315; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; MOLITORIS BA, 1989, J CLIN INVEST, V84, P1334, DOI 10.1172/JCI114302; MOLITORIS BA, 1989, J MEMBRANE BIOL, V107, P119, DOI 10.1007/BF01871717; Molitoris BA, 1996, KIDNEY INT, V49, P1592, DOI 10.1038/ki.1996.231; Mukherjee M, 2019, J AM SOC NEPHROL, V30, P110, DOI 10.1681/ASN.2018040440; Ohta Y, 2013, HYPERTENS RES, V36, P172, DOI 10.1038/hr.2012.155; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; Rakova N, 2013, CELL METAB, V17, P125, DOI 10.1016/j.cmet.2012.11.013; SAHALI D, 1993, AM J PATHOL, V142, P1654; Schock-Kusch D, 2009, NEPHROL DIAL TRANSPL, V24, P2997, DOI 10.1093/ndt/gfp225; Siegerist F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11553-x; Skalweit A, 2003, CIRC RES, V92, P419, DOI 10.1161/01.RES.0000059300.67152.4E; Staruschenko A, 2012, COMPR PHYSIOL, V2, P1541, DOI 10.1002/cphy.c110052; Stockand JD, 2002, AM J PHYSIOL-RENAL, V282, pF559, DOI 10.1152/ajprenal.00320.2001; Tabatabai NM, 2014, J MEMBRANE BIOL, V247, P675, DOI 10.1007/s00232-014-9686-4; Takesue H, 2018, MOL PHARMACOL, V94, P953, DOI 10.1124/mol.118.111807; Theilig F, 2015, AM J PHYSIOL-RENAL, V308, pF1047, DOI 10.1152/ajprenal.00164.2014; Tikellis C, 2012, HYPERTENSION, V60, P98, DOI 10.1161/HYPERTENSIONAHA.112.191767; Titze J, 2015, CURR OPIN NEPHROL HY, V24, P14, DOI 10.1097/MNH.0000000000000085; Tojo A, 2001, HISTOCHEM CELL BIOL, V116, P269, DOI 10.1007/s004180100317; Turck D, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5778; Udwan K, 2017, J PHYSIOL-LONDON, V595, P6905, DOI 10.1113/JP274927; Verhave JC, 2004, J INTERN MED, V256, P324, DOI 10.1111/j.1365-2796.2004.01390.x; Vlotides G, 2015, NEPHROL DIAL TRANSPL, V30, P1272, DOI 10.1093/ndt/gfu299; Wenzel UO, 2019, BRIT J PHARMACOL, V176, P1853, DOI 10.1111/bph.14359; Weyer K, 2011, NEPHROL DIAL TRANSPL, V26, P3446, DOI 10.1093/ndt/gfr525; Wheeler DC, 2020, NEPHROL DIAL TRANSPL, V35, P1700, DOI 10.1093/ndt/gfaa234; WHO, 2012, GUID SOD INT AD CHIL; Xiao YZ, 2020, CELL METAB, V31, P534, DOI 10.1016/j.cmet.2020.01.002; Yu Qianli, 2004, Cardiovasc Toxicol, V4, P37; Zaika O, 2013, CURR HYPERTENS REP, V15, P17, DOI 10.1007/s11906-012-0316-1; Zhang J, 2012, J ZHEJIANG UNIV-SC B, V13, P511, DOI 10.1631/jzus.B1200042; Zhao Y, 2016, CELL METAB, V23, P699, DOI 10.1016/j.cmet.2016.02.019; Zhu C, 2016, J AM SOC NEPHROL, V27, P3678, DOI 10.1681/ASN.2015121367	72	0	0	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21912	10.1096/fj.202100667RR	http://dx.doi.org/10.1096/fj.202100667RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34533842	hybrid, Green Published			2022-12-28	WOS:000702238200043
J	Cho, S; Lee, H; Jung, M; Hong, K; Woo, SH; Lee, YS; Kim, BJ; Jeon, MY; Seo, J; Mun, JY				Cho, Sukhee; Lee, Hyein; Jung, Minkyo; Hong, Kirim; Woo, Seung-Hwa; Lee, Young-Sam; Kim, Byoung Joon; Jeon, Mi Young; Seo, Jinsoo; Mun, Ji Young			Neuromyelitis optica (NMO)-IgG-driven organelle reorganization in human iPSC-derived astrocytes	FASEB JOURNAL			English	Article						astrocytes; autophagy; endoplasmic reticulum; human iPSC; lysosome; metabolic flux; mitochondria; neuromyelitis optica (NMO)	AQUAPORIN-4; DIFFERENTIATION; CYTOTOXICITY; PATHOGENESIS; LESIONS; BRAIN; AQP4	Neuromyelitis optica (NMO) is an autoimmune disease that primarily targets astrocytes. Autoantibodies (NMO-IgG) against the water channel protein, aquaporin 4 (AQP4), are a serologic marker in NMO patients, and they are known to be responsible for the pathophysiology of the disease. In the brain, AQP4 is mainly expressed in astrocytes, especially at the end-feet, where they form the blood-brain barrier. Following the interaction between NMO-IgG and AQP4 in astrocytes, rapid AQP4 endocytosis initiates pathogenesis. However, the cellular and molecular mechanisms of astrocyte destruction by autoantibodies remain largely elusive. We established an in vitro human astrocyte model system using induced pluripotent stem cells (iPSCs) technology in combination with NMO patient-derived serum and IgG to elucidate the cellular and functional changes caused by NMO-IgG. Herein, we observed that NMO-IgG induces structural alterations in mitochondria and their association with the endoplasmic reticulum (ER) and lysosomes at the ultrastructural level, which potentially leads to impaired mitochondrial functions and dynamics. Indeed, human astrocytes display impaired mitochondrial bioenergetics and autophagy activity in the presence of NMO-IgG. We further demonstrated NMO-IgG-driven ER membrane deformation into a multilamellar structure in human astrocytes. Together, we show that NMO-IgG rearranges cellular organelles and alter their functions and that our in vitro system using human iPSCs offers previously unavailable experimental opportunities to study the pathophysiological mechanisms of NMO in human astrocytes or conduct large-scale screening for potential therapeutic compounds targeting astrocytic abnormalities in patients with NMO.	[Cho, Sukhee; Jung, Minkyo; Mun, Ji Young] Korea Brain Res Inst, Neural Circuit Res Grp, 61 Cheomdan Ro, Daegu 41062, South Korea; [Cho, Sukhee; Lee, Hyein; Hong, Kirim; Seo, Jinsoo] DGIST, Dept Brain & Cognit Sci, 333 Technojungang Daero, Daegu 42988, South Korea; [Woo, Seung-Hwa; Lee, Young-Sam] DGIST, Dept New Biol, Daegu, South Korea; [Kim, Byoung Joon; Jeon, Mi Young] Sungkyunkwan Univ, Dept Neurol, Samsung Med Ctr, Sch Med, Seoul, South Korea	Korea Brain Research Institute (KBRI); Daegu Gyeongbuk Institute of Science & Technology (DGIST); Daegu Gyeongbuk Institute of Science & Technology (DGIST); Sungkyunkwan University (SKKU); Samsung Medical Center	Mun, JY (corresponding author), Korea Brain Res Inst, Neural Circuit Res Grp, 61 Cheomdan Ro, Daegu 41062, South Korea.; Seo, J (corresponding author), DGIST, Dept Brain & Cognit Sci, 333 Technojungang Daero, Daegu 42988, South Korea.	jsseo@dgist.ac.kr; jymun@kbri.re.kr		Lee, Hyein/0000-0002-1525-2599; Seo, Jinsoo/0000-0001-6432-6964	Ministry of Education [2020R1A6A3A01099337]; Ministry of Science and ICT of Korea [20-CoE-BT-01]; NRF [2019R1A2C1010634]; KBRI basic research program [21-BR-01-11]	Ministry of Education; Ministry of Science and ICT of Korea; NRF; KBRI basic research program	Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by Ministry of Education, Grant/Award Number: 2020R1A6A3A01099337; R&D Programs of DGIST funded by the Ministry of Science and ICT of Korea, Grant/Award Number: 20-CoE-BT-01; NRF, Grant/Award Number: 2019R1A2C1010634; KBRI basic research program, Grant/Award Number: 21-BR-01-11	Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735; Asavapanumas N, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-16; Bantle CM, 2021, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.608026; Betz C, 2013, P NATL ACAD SCI USA, V110, P12526, DOI 10.1073/pnas.1302455110; Chen TJ, 2020, J CLIN INVEST, V130, P4025, DOI 10.1172/JCI134816; Cho S, 2018, P NATL ACAD SCI USA, V115, P11316, DOI 10.1073/pnas.1800830115; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; Du L, 2020, LIFE SCI, V258, DOI 10.1016/j.lfs.2020.118217; Fujihara K, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000841; Gobel J, 2020, CELL METAB, V31, P791, DOI 10.1016/j.cmet.2020.03.005; Haruki H, 2013, J NEUROL SCI, V331, P136, DOI 10.1016/j.jns.2013.05.035; Hinson SR, 2008, J EXP MED, V205, P2473, DOI 10.1084/jem.20081241; Hinson SR, 2017, P NATL ACAD SCI USA, V114, P5491, DOI 10.1073/pnas.1701960114; Hinson SR, 2012, P NATL ACAD SCI USA, V109, P1245, DOI 10.1073/pnas.1109980108; Howe CL, 2014, GLIA, V62, P692, DOI 10.1002/glia.22635; Jarius S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-8; Jones JR, 2018, CELL REP, V25, P947, DOI 10.1016/j.celrep.2018.09.083; Julia TCW, 2017, STEM CELL REP, V9, P600, DOI 10.1016/j.stemcr.2017.06.018; Khakh BS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020404; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Lin YT, 2018, NEURON, V98, P1141, DOI 10.1016/j.neuron.2018.05.008; Ma ZG, 2016, NATURE, V539, P428, DOI 10.1038/nature20145; Meyer K, 2019, CELL REP, V26, P1112, DOI 10.1016/j.celrep.2019.01.023; Motori E, 2013, CELL METAB, V18, P844, DOI 10.1016/j.cmet.2013.11.005; Naon D, 2016, P NATL ACAD SCI USA, V113, P11249, DOI 10.1073/pnas.1606786113; Nishiyama S, 2016, Biochem Biophys Rep, V7, P45, DOI 10.1016/j.bbrep.2016.05.012; Papadopoulos MC, 2012, LANCET NEUROL, V11, P535, DOI 10.1016/S1474-4422(12)70133-3; Phuan PW, 2012, J BIOL CHEM, V287, P13829, DOI 10.1074/jbc.M112.344325; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P964, DOI 10.1001/archneur.63.7.964; Ratelade J, 2012, INT J BIOCHEM CELL B, V44, P1519, DOI 10.1016/j.biocel.2012.06.013; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Sabater L, 2009, J NEUROIMMUNOL, V215, P31, DOI 10.1016/j.jneuroim.2009.07.014; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Thoudam T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/1851420; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	40	0	0	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21894	10.1096/fj.202100637R	http://dx.doi.org/10.1096/fj.202100637R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34460995	hybrid			2022-12-28	WOS:000702238200069
J	Fischer, TT; Nguyen, LD; Ehrlich, BE				Fischer, Tom T.; Nguyen, Lien D.; Ehrlich, Barbara E.			Neuronal calcium sensor 1 (NCS1) dependent modulation of neuronal morphology and development	FASEB JOURNAL			English	Article						calcium signaling; gene expression; nervous system disease; neurogenesis; RNA sequencing	PREFRONTAL CORTEX; SYNAPTIC FUNCTION; BIPOLAR DISORDER; BINDING PROTEIN; CA2+; EXPRESSION; MEMORY; MODEL; SCHIZOPHRENIA; ADF/COFILIN	Calcium (Ca2+) signaling is critical for neuronal functioning and requires the concerted interplay of numerous Ca2+-binding proteins, including neuronal calcium sensor 1 (NCS1). Although an important role of NCS1 in neuronal processes and in neurodevelopmental and neurodegenerative diseases has been established, the underlying mechanisms remain enigmatic. Here, we systematically investigated the functions of NCS1 in the brain. Using Golgi-Cox staining, we observed a reduction in dendritic complexity and spine density in the prefrontal cortex and the dorsal hippocampus of Ncs1(-/-) mice, which may underlie concomitantly observed deficits in memory acquisition. Subsequent RNA sequencing of Ncs1(-/-) and Ncs1(+/+) mouse brain tissues revealed that NCS1 modulates gene expression related to neuronal morphology and development. Investigation of developmental databases further supported a molecular role of NCS1 during brain development by identifying temporal gene expression patterns. Collectively, this study provides insights into NCS1-dependent signaling and lays the foundation for a better understanding of NCS1-associated diseases.	[Fischer, Tom T.; Nguyen, Lien D.; Ehrlich, Barbara E.] Yale Univ, Dept Pharmacol, New Haven, CT 06510 USA; [Fischer, Tom T.] Heidelberg Univ, Inst Pharmacol, Heidelberg, Germany; [Nguyen, Lien D.; Ehrlich, Barbara E.] Yale Univ, Interdept Neurosci Program, New Haven, CT USA; [Ehrlich, Barbara E.] Yale Univ, Dept Celluar & Mol Physiol, New Haven, CT USA; [Nguyen, Lien D.] Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [Nguyen, Lien D.] Harvard Med Sch, Boston, MA 02115 USA	Yale University; Ruprecht Karls University Heidelberg; Yale University; Yale University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ehrlich, BE (corresponding author), Yale Univ, Dept Pharmacol, New Haven, CT 06510 USA.	barbara.ehrlich@yale.edu		Fischer, Tom Tobias/0000-0002-2138-9102; Nguyen, Lien/0000-0001-8096-1570	NIH [5P01DK057751]; German Academic Scholarship Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Academic Scholarship Foundation	NIH grant 5P01DK057751 and a gift from a generous donor (BEE) supported this work. TTF was supported by a scholarship from the German Academic Scholarship Foundation	Angebault C, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aaq1380; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Apasu JE, 2019, FASEB J, V33, P4802, DOI 10.1096/fj.201802004R; Bandura J, 2019, MOL NEUROBIOL, V56, P6080, DOI 10.1007/s12035-019-1497-2; Benkert J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12834-x; Berridge M, 2014, CELL TISSUE RES, V357, P477, DOI 10.1007/s00441-014-1806-z; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Bong AHL, 2020, MOL ONCOL, V14, P87, DOI 10.1002/1878-0261.12589; Brini M, 2014, CELL MOL LIFE SCI, V71, P2787, DOI 10.1007/s00018-013-1550-7; Canal-Martin A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10627-w; Cardoso-Moreira M, 2019, NATURE, V571, P505, DOI 10.1038/s41586-019-1338-5; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Dason JS, 2012, MOL NEUROBIOL, V45, P388, DOI 10.1007/s12035-012-8250-4; de Rezende VB, 2014, PHYSIOL BEHAV, V130, P91, DOI 10.1016/j.physbeh.2014.03.005; DeVito LM, 2010, BEHAV BRAIN RES, V215, P318, DOI 10.1016/j.bbr.2009.09.014; Dragicevic E, 2014, BRAIN, V137, P2287, DOI 10.1093/brain/awu131; Fischer TT, 2020, CURR OPIN PHYSIOL, V17, P115, DOI 10.1016/j.cophys.2020.07.009; Flynn KC, 2012, NEURON, V76, P1091, DOI 10.1016/j.neuron.2012.09.038; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Grosshans HK, 2020, MOL ONCOL, V14, P1134, DOI 10.1002/1878-0261.12678; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Handley MTW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010534; Hermainski JG., 2012, UNTERSUCHUNGEN FUNKT; Hui K, 2007, DEVELOPMENT, V134, P4479, DOI 10.1242/dev.008979; Iketani M, 2009, NEUROSCIENCE, V161, P743, DOI 10.1016/j.neuroscience.2009.04.019; Kawasaki T, 2003, J COMP NEUROL, V460, P465, DOI 10.1002/cne.10649; Kobayashi M, 2005, NEUROSCIENCE, V133, P471, DOI 10.1016/j.neuroscience.2005.02.034; Koh PO, 2003, P NATL ACAD SCI USA, V100, P313, DOI 10.1073/pnas.232693499; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Mansilla A, 2017, P NATL ACAD SCI USA, V114, pE999, DOI 10.1073/pnas.1611089114; Mikhaylova M, 2011, J NEUROCHEM, V118, P695, DOI 10.1111/j.1471-4159.2011.07372.x; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Moore LM, 2017, MOL CANCER RES, V15, P942, DOI 10.1158/1541-7786.MCR-16-0408; Nakamura TY, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00056; Nakamura TY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170829; Nakamura TY, 2011, CIRC RES, V109, P512, DOI 10.1161/CIRCRESAHA.111.248864; Nakamura TY, 2006, J CELL BIOL, V172, P1081, DOI 10.1083/jcb.200508156; Nakao S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125050; Ng E, 2020, BEHAV BRAIN RES, V381, DOI 10.1016/j.bbr.2019.112420; Ng E, 2016, BEHAV BRAIN RES, V301, P213, DOI 10.1016/j.bbr.2015.12.037; Nguyen LD, 2021, MOL NEURODEGENER, V16, DOI 10.1186/s13024-021-00463-2; Nguyen LD, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81650-5; Nguyen LD, 2020, P NATL ACAD SCI USA, V117, P17389, DOI 10.1073/pnas.2007136117; Nguyen LD, 2019, J BIOL CHEM, V294, P18923, DOI 10.1074/jbc.RA119.009736; Nguyen RL, 2018, BBA-MOL CELL RES, V1865, P1718, DOI 10.1016/j.bbamcr.2018.08.003; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Reynolds AJ, 2001, NEUROREPORT, V12, P725, DOI 10.1097/00001756-200103260-00022; Rust MB, 2015, CELL MOL LIFE SCI, V72, P3521, DOI 10.1007/s00018-015-1941-z; Saab BJ, 2009, NEURON, V63, P643, DOI 10.1016/j.neuron.2009.08.014; Saneyoshi T, 2012, CYTOSKELETON, V69, P545, DOI 10.1002/cm.21037; Schaad NC, 1996, P NATL ACAD SCI USA, V93, P9253, DOI 10.1073/pnas.93.17.9253; Schlecker C, 2006, J CLIN INVEST, V116, P1668, DOI 10.1172/JCI22466; Schuette D, 2018, CANCER EPIDEM BIOMAR, V27, P1091, DOI 10.1158/1055-9965.EPI-18-0167; Simons C, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00252; Takemura M, 2009, J BIOL CHEM, V284, P28554, DOI 10.1074/jbc.M109.006296; Torres KCL, 2009, PROG NEURO-PSYCHOPH, V33, P229, DOI 10.1016/j.pnpbp.2008.11.011; Toth AB, 2016, CELL CALCIUM, V59, P124, DOI 10.1016/j.ceca.2016.02.011; Treloar HB, 2005, J COMP NEUROL, V482, P201, DOI 10.1002/cne.20431; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Valverde F, 1998, GOLGI ATLAS OF THE POSTNATAL MOUSE BRAIN, P1; Vogel-Ciernia Annie, 2014, Curr Protoc Neurosci, V69, DOI 10.1002/0471142301.ns0831s69; Weiss JL, 2010, CELL MOL NEUROBIOL, V30, P1283, DOI 10.1007/s10571-010-9588-7; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Yip PK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000399	68	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21873	10.1096/fj.202100731R	http://dx.doi.org/10.1096/fj.202100731R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34499766	Green Accepted			2022-12-28	WOS:000702238200031
J	Tan, JY; Che, YP; Liu, YY; Hu, JQ; Wang, WJ; Hu, LB; Zhou, QH; Wang, H; Li, JS				Tan, Junyang; Che, Yaping; Liu, Yanyan; Hu, Jiaqiao; Wang, Wenjun; Hu, Liubing; Zhou, Qinghua; Wang, Hao; Li, Jianshuang			CELSR2 deficiency suppresses lipid accumulation in hepatocyte by impairing the UPR and elevating ROS level	FASEB JOURNAL			English	Article						cell survival; CELSR2; lipid metabolism; unfolded protein response	7-PASS TRANSMEMBRANE CADHERIN; CORONARY-ARTERY-DISEASE; PLANAR CELL POLARITY; ATP CITRATE LYASE; ENDOPLASMIC-RETICULUM; JOUBERT SYNDROME; GENE-EXPRESSION; FLAMINGO; METABOLISM; PROTEIN	Cadherin EGF LAG seven-pass G-type receptor 2 (CELSR2), a mammalian orthologue of drosophila flamingo, belongs to the cadherin subfamily. CELSR2 mainly function in neural development and cilium polarity. Recent studies showed that the CELSR2 gene is related to many human diseases, including coronary artery disease, idiopathic scoliosis, and cancer. Genome-Wide Association Studies data showed that SNP in the CELSR2-PSRC1-SORT1 gene loci has a strong association with circulating lipid levels and coronary artery disease. However, the function and underlying mechanism of CELSR2 in hepatic lipid metabolism remain unknown. Here, we found that CELSR2 expression is decreased in the liver of NAFLD/NASH patients and db/db mice. Depletion of CELSR2 significantly decreased the lipid accumulation in hepatocytes by suppressing the expression of lipid synthesis enzymes. Moreover, CELSR2 deficiency impaired the physiological unfolded protein response (UPR), which damages the ER homeostasis, and elevates the reactive oxygen species (ROS) level by decreasing the antioxidant expression. Scavenging of ROS by N-acetylcysteine treatment could restore the decreased lipid accumulation of CELSR2 knockdown cells. Furthermore, CELSR2 loss impaired cell survival by suppressing cell proliferation and promoting apoptosis. Our results uncovered a new role of CELSR2 in regulating lipid homeostasis and UPR, suggesting CELSR2 may be a new therapeutic target for non-alcoholic fatty liver disease.	[Tan, Junyang; Wang, Wenjun; Zhou, Qinghua; Li, Jianshuang] Jinan Univ, Zhuhai Peoples Hosp, Zhuhai Inst Translat Med, Zhuhai 519000, Guangdong, Peoples R China; [Tan, Junyang; Che, Yaping; Liu, Yanyan; Hu, Jiaqiao; Wang, Wenjun; Hu, Liubing; Zhou, Qinghua; Li, Jianshuang] Jinan Univ, Fac Med Sci, Biomed Translat Res Inst, Guangzhou, Peoples R China; [Wang, Wenjun; Zhou, Qinghua; Wang, Hao] Jinan Univ, Affiliated Hosp 1, Guangzhou 510632, Guangdong, Peoples R China	Jinan University; Jinan University; Jinan University	Li, JS (corresponding author), Jinan Univ, Zhuhai Peoples Hosp, Zhuhai Inst Translat Med, Zhuhai 519000, Guangdong, Peoples R China.; Wang, H (corresponding author), Jinan Univ, Affiliated Hosp 1, Guangzhou 510632, Guangdong, Peoples R China.	haowang@jnu.edu.cn; lijianshtian1314@jnu.edu.cn	liu, yan/HGV-1365-2022	Tan, Junyang/0000-0001-5238-1480	National Natural Science Foundation of China [81802189, 82071340, 81800833]; 111 Project [B16021]; National Key R&D Program of China [2018YFC2002000]; China Postdoctoral Science Foundation [2018M631054]; Natural Science Foundation of Guangdong Province [2018A0303131002, 2019A1515011847, 2019A1515010591, 2021A15115011227]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); National Key R&D Program of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	National Natural Science Foundation of China, Grant/Award Number: 81802189, 82071340 and 81800833; 111 Project, Grant/Award Number: B16021; National Key R&D Program of China, Grant/Award Number: 2018YFC2002000; China Postdoctoral Science Foundation, Grant/Award Number: 2018M631054; Natural Science Foundation of Guangdong Province, Grant/Award Number: 2018A0303131002, 2019A1515011847, 2019A1515010591 and 2021A15115011227	Amengual J, 2018, CIRC RES, V122, P568, DOI 10.1161/CIRCRESAHA.117.311240; Arvind P, 2014, J CARDIOL, V64, P339, DOI 10.1016/j.jjcc.2014.02.012; Berger-Muller S, 2011, MOL NEUROBIOL, V44, P313, DOI 10.1007/s12035-011-8201-5; Bravo R, 2013, INT REV CEL MOL BIO, V301, P215, DOI 10.1016/B978-0-12-407704-1.00005-1; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Conlon DM, 2019, CURR OPIN LIPIDOL, V30, P198, DOI 10.1097/MOL.0000000000000598; Einarsdottir E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189591; Eletto D, 2014, J CELL SCI, V127, P3649, DOI 10.1242/jcs.153643; Goffinet AM, 2017, SEMIN CELL DEV BIOL, V69, P102, DOI 10.1016/j.semcdb.2017.07.014; Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595; Hayes CN, 2019, HEPATOCELLULAR CARCI; Huang DIQ, 2021, NAT REV GASTRO HEPAT, V18, P223, DOI 10.1038/s41575-020-00381-6; Icard P, 2020, CANCER LETT, V471, P125, DOI 10.1016/j.canlet.2019.12.010; Icard P, 2012, BBA-REV CANCER, V1825, P111, DOI 10.1016/j.bbcan.2011.10.007; Ipsen DH, 2018, CELL MOL LIFE SCI, V75, P3313, DOI 10.1007/s00018-018-2860-6; Kakehashi A, 2012, TOXICOL SCI, V126, P39, DOI 10.1093/toxsci/kfs016; Kasper P, 2021, CLIN RES CARDIOL, V110, P921, DOI 10.1007/s00392-020-01709-7; Kimura H, 2006, J CELL SCI, V119, P1118, DOI 10.1242/jcs.02832; Kjolby M, 2010, CELL METAB, V12, P213, DOI 10.1016/j.cmet.2010.08.006; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Li JS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02413-3; Lindholm D, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00048; Meroni M, 2021, CANCERS, V13, DOI 10.3390/cancers13081783; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Samani NJ, 2008, J MOL MED, V86, P1233, DOI 10.1007/s00109-008-0387-2; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schwarz DS, 2016, CELL MOL LIFE SCI, V73, P79, DOI 10.1007/s00018-015-2052-6; Shima Y, 2007, NAT NEUROSCI, V10, P963, DOI 10.1038/nn1933; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suppli MP, 2019, AM J PHYSIOL-GASTR L, V316, pG462, DOI 10.1152/ajpgi.00358.2018; Tissir F, 2002, MECH DEVELOP, V112, P157, DOI 10.1016/S0925-4773(01)00623-2; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; van Schadewijk A, 2012, CELL STRESS CHAPERON, V17, P275, DOI 10.1007/s12192-011-0306-2; Vilboux T, 2017, GENET MED, V19, P875, DOI 10.1038/gim.2016.204; Vilboux T, 2017, AM J MED GENET A, V173, P661, DOI 10.1002/ajmg.a.38005; Wei MQ, 2020, MOL CELL BIOCHEM, V465, P125, DOI 10.1007/s11010-019-03673-x; Xu MX, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-06813-5; Yoon SB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219978; Zhou HP, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00112; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	43	1	1	3	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21908	10.1096/fj.202100786RR	http://dx.doi.org/10.1096/fj.202100786RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34478580				2022-12-28	WOS:000702238200049
J	Taneja, A; Ravi, V; Hong, JY; Lin, HN; Sundaresan, NR				Taneja, Arushi; Ravi, Venkatraman; Hong, Jun Young; Lin, Hening; Sundaresan, Nagalingam Ravi			Emerging roles of Sirtuin 2 in cardiovascular diseases	FASEB JOURNAL			English	Review						cardiac hypertrophy; cardiovascular diseases; oxidative stress; SIRT2; Sirtuins	ACTIVATED PROTEIN-KINASE; DOXORUBICIN-INDUCED CARDIOTOXICITY; OXIDATIVE STRESS; CARDIAC-HYPERTROPHY; HEART-DISEASE; ACETYLATION; DEACETYLASE; HOMEOSTASIS; TUBULIN; BINDING	Sirtuins are a family of NAD(+)-dependent deacetylases implicated in a wide variety of age-associated pathologies, including cardiovascular disorders. Among the seven mammalian sirtuins, SIRT2 modulates various cellular processes through the deacetylation or deacylation of their target proteins. Notably, the levels of SIRT2 in the heart decline with age and other pathological conditions, leading to cardiovascular dysfunction. In the present review, we discuss the emerging roles of SIRT2 in cardiovascular dysfunction and heart failure associated with factors like age, hypertension, oxidative stress, and diabetes. We also discuss the potential of using inhibitors to study the unexplored role of SIRT2 in the heart. While SIRT2 undoubtedly plays a crucial role in the cardiovascular system, its functions are only beginning to be understood, making it an attractive candidate for further research in the field.	[Taneja, Arushi; Ravi, Venkatraman; Sundaresan, Nagalingam Ravi] Indian Inst Sci, Dept Microbiol & Cell Biol, Cardiovasc & Muscle Res Lab, Bengaluru, India; [Hong, Jun Young; Lin, Hening] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Lin, Hening] Cornell Univ, Howard Hughes Med Inst, Ithaca, NY USA	Indian Institute of Science (IISC) - Bangalore; Cornell University; Cornell University; Howard Hughes Medical Institute	Sundaresan, NR (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Div Biol Sci, Cardiovasc & Muscle Res Lab, SB-02, Bengaluru 560012, Karnataka, India.	rsundaresan@iisc.ac.in		TANEJA, ARUSHI/0000-0002-2719-8067	Ramalingaswami Re-entry Fellowship; Innovative Young Biotechnologist Award (IYBA) from the Department of Biotechnology, Government of India; Department of Science and Technology [EMR/2014/000065]; Department of Biotechnology [BRB/10/1294/2014, MED/30/1454/2014]; Council for Scientific and Industrial Research [37(1646)/15/EMR-II]; Department of Biotechnology-Indian Institute of Science partnership program for advanced research	Ramalingaswami Re-entry Fellowship; Innovative Young Biotechnologist Award (IYBA) from the Department of Biotechnology, Government of India; Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology; Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology-Indian Institute of Science partnership program for advanced research	NRS is the recipient of Ramalingaswami Re-entry Fellowship and the Innovative Young Biotechnologist Award (IYBA) from the Department of Biotechnology, Government of India. NRS laboratory is supported by research funding from the Department of Science and Technology (EMR/2014/000065), The Department of Biotechnology (BRB/10/1294/2014 and MED/30/1454/2014), The Council for Scientific and Industrial Research (37(1646)/15/EMR--II) and the Department of Biotechnology-Indian Institute of Science partnership program for advanced research	Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Bagul PK, 2015, BIOCHEM BIOPH RES CO, V468, P221, DOI 10.1016/j.bbrc.2015.10.126; Bao XC, 2014, ELIFE, V3, DOI 10.7554/eLife.02999; Bartlett B, 2019, AM J PHYSIOL-HEART C, V317, pH375, DOI 10.1152/ajpheart.00206.2019; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Beirowski B, 2011, P NATL ACAD SCI USA, V108, pE952, DOI 10.1073/pnas.1104969108; Black JC, 2008, MOL CELL, V32, P449, DOI 10.1016/j.molcel.2008.09.018; Bodiga VL, 2014, HEART FAIL REV, V19, P49, DOI 10.1007/s10741-013-9374-y; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Budayeva HG, 2016, MOL CELL PROTEOMICS, V15, P3107, DOI 10.1074/mcp.M116.061333; Cen Y, 2011, CURR MED CHEM, V18, P1919, DOI 10.2174/092986711795590084; Cha Y, 2017, NAT CELL BIOL, V19, P445, DOI 10.1038/ncb3517; Chan AYM, 2008, J BIOL CHEM, V283, P24194, DOI 10.1074/jbc.M802869200; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Choi YH, 2014, BIOCHEM BIOPH RES CO, V450, P1120, DOI 10.1016/j.bbrc.2014.06.117; Chowdhury S, 2020, MOLECULES, V25, DOI 10.3390/molecules25030455; D'Onofrio N, 2018, ANTIOXID REDOX SIGN, V28, P711, DOI 10.1089/ars.2017.7178; D'Oria R, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/5732956; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Donato AJ, 2015, J MOL CELL CARDIOL, V89, P122, DOI 10.1016/j.yjmcc.2015.01.021; Dutta D, 2012, CIRC RES, V110, P1125, DOI 10.1161/CIRCRESAHA.111.246108; Eskandarian HA, 2013, SCIENCE, V341, P525, DOI 10.1126/science.1238858; Fang EF, 2017, TRENDS MOL MED, V23, P899, DOI 10.1016/j.molmed.2017.08.001; Farooqi AS, 2019, J MED CHEM, V62, P4131, DOI 10.1021/acs.jmedchem.9b00191; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gelinas R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02795-4; Gu W, 2021, CARDIOVASC TOXICOL, V21, P451, DOI 10.1007/s12012-021-09639-0; Gundewar S, 2009, CIRC RES, V104, P403, DOI 10.1161/CIRCRESAHA.108.190918; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hashimoto-Komatsu A, 2011, HYPERTENS RES, V34, P949, DOI 10.1038/hr.2011.64; Huang H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05567-w; Imai S, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.17; Inoue T, 2007, ONCOGENE, V26, P945, DOI 10.1038/sj.onc.1209857; Jia GH, 2018, CIRC RES, V122, P624, DOI 10.1161/CIRCRESAHA.117.311586; Jia GH, 2016, NAT REV ENDOCRINOL, V12, P144, DOI 10.1038/nrendo.2015.216; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Jin J, 2016, J AM CHEM SOC, V138, P12304, DOI 10.1021/jacs.6b04977; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Jing H, 2017, ELIFE, V6, DOI 10.7554/eLife.32436; Jing H, 2016, CANCER CELL, V29, P297, DOI 10.1016/j.ccell.2016.02.007; Kane AE, 2018, CIRC RES, V123, P868, DOI 10.1161/CIRCRESAHA.118.312498; Katsuumi G, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00018; Khan D, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109190; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kosciuczuk EM, 2019, J BIOL CHEM, V294, P827, DOI 10.1074/jbc.RA118.005956; Kosciuk T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14893-x; Kozako T, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4710-1; Kudo N, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0070; Kupis W, 2016, J PHYSIOL BIOCHEM, V72, P371, DOI 10.1007/s13105-016-0492-6; Li J, 2019, AGING CELL, V18, DOI 10.1111/acel.13026; Liu GX, 2017, ANTIOXID REDOX SIGN, V26, P849, DOI 10.1089/ars.2016.6662; Liu QQ, 2019, INT J MOL MED, V43, P839, DOI 10.3892/ijmm.2018.3996; Luo YX, 2017, EUR HEART J, V38, P1389, DOI 10.1093/eurheartj/ehw138; Ma L, 2010, P NATL ACAD SCI USA, V107, P19314, DOI 10.1073/pnas.1010253107; Matsushima S, 2015, AM J PHYSIOL-HEART C, V309, pH1375, DOI 10.1152/ajpheart.00053.2015; Mei SB, 2019, TOXICOL LETT, V307, P41, DOI 10.1016/j.toxlet.2019.02.013; Mei ZL, 2020, EXP CELL RES, V396, DOI 10.1016/j.yexcr.2020.112245; Mellini P, 2017, CHEM SCI, V8, P6400, DOI 10.1039/c7sc02738a; Mericskay M, 2016, ARCH CARDIOVASC DIS, V109, P207, DOI 10.1016/j.acvd.2015.10.004; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; North BJ, 2014, EMBO J, V33, P1438, DOI 10.15252/embj.201386907; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Peng LY, 2020, NUCLEIC ACIDS RES, V48, P4992, DOI 10.1093/nar/gkaa214; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Rack JGM, 2014, J MOL BIOL, V426, P1677, DOI 10.1016/j.jmb.2013.10.027; Ravi V, 2019, NUCLEIC ACIDS RES, V47, P9115, DOI 10.1093/nar/gkz648; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Roos CM, 2013, AM J PHYSIOL-HEART C, V305, pH1428, DOI 10.1152/ajpheart.00735.2012; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Rumpf T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7263; Sack MN, 2012, J MOL CELL CARDIOL, V52, P520, DOI 10.1016/j.yjmcc.2011.11.004; Sarikhani M, 2018, CELL DEATH DIFFER, V25, P1638, DOI 10.1038/s41418-018-0069-8; Sarikhani M, 2018, ELIFE, V7, DOI 10.7554/eLife.32952; Sarikhani M, 2018, J BIOL CHEM, V293, P5281, DOI 10.1074/jbc.RA117.000915; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Saxena M, 2015, ONCOGENE, V34, P188, DOI 10.1038/onc.2013.549; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Seo KS, 2015, ONCOGENE, V34, P1354, DOI 10.1038/onc.2014.76; Shi LY, 2021, ANN PALLIAT MED, V10, P2596, DOI 10.21037/apm-20-603; Shiels H, 2007, MOL CELL BIOCHEM, V294, P173, DOI 10.1007/s11010-006-9257-9; Spiegelman NA, 2019, ACS CHEM BIOL, V14, P2014, DOI 10.1021/acschembio.9b00492; Spiegelman NA, 2019, CHEMMEDCHEM, V14, P744, DOI 10.1002/cmdc.201800715; Spiegelman NA, 2018, CHEMMEDCHEM, V13, P1890, DOI 10.1002/cmdc.201800391; Sundaresan NR, 2016, MOL CELL BIOL, V36, P678, DOI 10.1128/MCB.00586-15; Sundaresan NR, 2021, SIRTUIN BIOL MED, P261, DOI [10.1016/B978-0-12-814118-2.00021-5, DOI 10.1016/B978-0-12-814118-2.00021-5]; Tang XQ, 2017, CIRCULATION, V136, P2051, DOI 10.1161/CIRCULATIONAHA.117.028728; Teng YB, 2015, SCI REP-UK, V5, DOI 10.1038/srep08529; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Wagner JUG, 2020, J MOL CELL CARDIOL, V138, P136, DOI 10.1016/j.yjmcc.2019.11.152; Wang F, 2012, ONCOGENE, V31, P1546, DOI 10.1038/onc.2011.347; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wang L, 2018, CARDIOVASC RES, V114, P805, DOI 10.1093/cvr/cvy033; Wang XF, 2011, CLIN EXP PHARMACOL P, V38, P94, DOI 10.1111/j.1440-1681.2010.05470.x; Wang Y, 2019, AGEING RES REV, V55, DOI 10.1016/j.arr.2019.100961; Wang YP, 2014, EMBO J, V33, P1304, DOI 10.1002/embj.201387224; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Xu DJ, 2019, LIFE SCI, V232, DOI 10.1016/j.lfs.2019.116639; Xu DJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061365; Xu WY, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00901; Yazdanyar A, 2009, CLIN GERIATR MED, V25, P563, DOI 10.1016/j.cger.2009.07.007; Yuan Q, 2015, EUR J PHARMACOL, V764, P554, DOI 10.1016/j.ejphar.2015.07.045; Zhang BC, 2018, BIOMED PHARMACOTHER, V97, P1238, DOI 10.1016/j.biopha.2017.11.061; Zhang CX, 2011, CLIN EXP PHARMACOL P, V38, P55, DOI 10.1111/j.1440-1681.2010.05461.x; Zhang H, 2016, CELL REP, V14, P1435, DOI 10.1016/j.celrep.2016.01.018; Zhang H, 2013, P NATL ACAD SCI USA, V110, P13546, DOI 10.1073/pnas.1301463110; Zhang Jie, 2016, Int J Physiol Pathophysiol Pharmacol, V8, P120; Zhang L, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01721; Zhang WG, 2018, BIOTECHNOL LETT, V40, P271, DOI 10.1007/s10529-017-2487-y; Zhao D, 2013, CANCER CELL, V23, P464, DOI 10.1016/j.ccr.2013.02.005; Zhao LS, 2018, REDOX BIOL, V16, P189, DOI 10.1016/j.redox.2018.02.026; Zhao LS, 2018, REDOX BIOL, V15, P284, DOI 10.1016/j.redox.2017.12.013; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zhou WH, 2016, CELL REP, V17, P1302, DOI 10.1016/j.celrep.2016.10.006	122	2	2	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21841	10.1096/fj.202100490R	http://dx.doi.org/10.1096/fj.202100490R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34582046				2022-12-28	WOS:000702238200016
J	Wan, SJ; Datta, A; Flandrin, O; Metruccio, MME; Ma, S; Nieto, V; Kroken, AR; Hill, RZ; Bautista, DM; Evans, DJ; Fleiszig, SMJ				Wan, Stephanie J.; Datta, Ananya; Flandrin, Orneika; Metruccio, Matteo M. E.; Ma, Sophia; Nieto, Vincent; Kroken, Abby R.; Hill, Rose Z.; Bautista, Diana M.; Evans, David J.; Fleiszig, Suzanne M. J.			Nerve-associated transient receptor potential ion channels can contribute to intrinsic resistance to bacterial adhesion in vivo	FASEB JOURNAL			English	Article						bacterial adhesion; cornea; epithelial defense; sensory nerves; TRP ion channels	PSEUDOMONAS-AERUGINOSA INVASION; CORNEAL EPITHELIAL-CELLS; OCULAR SURFACE; SENSORY NEURONS; INNATE DEFENSE; SUBSTANCE-P; TRPA1; INFLAMMATION; HOST; SUSCEPTIBILITY	The cornea of the eye differs from other mucosal surfaces in that it lacks a viable bacterial microbiome and by its unusually high density of sensory nerve endings. Here, we explored the role of corneal nerves in preventing bacterial adhesion. Pharmacological and genetic methods were used to inhibit the function of corneal sensory nerves or their associated transient receptor potential cation channels TRPA1 and TRPV1. Impacts on bacterial adhesion, resident immune cells, and epithelial integrity were examined using fluorescent labeling and quantitative confocal imaging. TRPA1/TRPV1 double gene-knockout mice were more susceptible to adhesion of environmental bacteria and to that of deliberately-inoculated Pseudomonas aeruginosa. Supporting the involvement of TRPA1/TRPV1-expressing corneal nerves, P. aeruginosa adhesion was also promoted by treatment with bupivacaine, or ablation of TRPA1/TRPV1-expressing nerves using RTX. Moreover, TRPA1/TRPV1-dependent defense was abolished by enucleation which severs corneal nerves. High-resolution imaging showed normal corneal ultrastructure and surface-labeling by wheat-germ agglutinin for TRPA1/TRPV1 knockout murine corneas, and intact barrier function by absence of fluorescein staining. P. aeruginosa adhering to corneas after perturbation of nerve or TRPA1/TRPV1 function failed to penetrate the surface. Single gene-knockout mice showed roles for both TRPA1 and TRPV1, with TRPA1(-/-) more susceptible to P. aeruginosa adhesion while TRPV1(-/-) corneas instead accumulated environmental bacteria. Corneal CD45+/CD11c+ cell responses to P. aeruginosa challenge, previously shown to counter bacterial adhesion, also depended on TRPA1/TRPV1 and sensory nerves. Together, these results demonstrate roles for corneal nerves and TRPA1/TRPV1 in corneal resistance to bacterial adhesion in vivo and suggest that the mechanisms involve resident immune cell populations.	[Wan, Stephanie J.; Flandrin, Orneika; Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA; [Datta, Ananya; Metruccio, Matteo M. E.; Ma, Sophia; Nieto, Vincent; Kroken, Abby R.; Evans, David J.; Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Hill, Rose Z.; Bautista, Diana M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Hill, Rose Z.; Bautista, Diana M.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Evans, David J.] Touro Univ Calif, Coll Pharm, Vallejo, CA USA; [Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Grad Grp Microbiol & Infect Dis & Immun, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Touro University California; University of California System; University of California Berkeley	Fleiszig, SMJ (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	fleiszig@berkeley.edu	Datta, Ananya/AAG-9052-2021	metruccio, matteo/0000-0002-2456-2652; Evans, David/0000-0002-6885-2053	National Eye Institute [EY011221, EY030350]	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by the National Eye Institute: EY011221 & EY030350 (SMJF)	Al-Aqaba MA, 2019, PROG RETIN EYE RES, V73, DOI 10.1016/j.preteyeres.2019.05.003; Alarcon I, 2011, INVEST OPHTH VIS SCI, V52, P1368, DOI 10.1167/iovs.10-6125; Alarcon I, 2009, INFECT IMMUN, V77, P3264, DOI 10.1128/IAI.00111-09; Augustin DK, 2011, INFECT IMMUN, V79, P595, DOI 10.1128/IAI.00854-10; Baral P, 2018, NAT MED, V24, P417, DOI 10.1038/nm.4501; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Belmonte C, 2017, OCUL SURF, V15, P404, DOI 10.1016/j.jtos.2017.05.002; Blalock TD, 2007, INVEST OPHTH VIS SCI, V48, P4509, DOI 10.1167/iovs.07-0430; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caudle RM, 2003, NEUROTOXICOLOGY, V24, P895, DOI 10.1016/S0161-813X(03)00146-3; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Engel MA, 2011, GASTROENTEROLOGY, V141, P1346, DOI 10.1053/j.gastro.2011.07.002; Flanagan JL, 2009, BIOCHIMIE, V91, P35, DOI 10.1016/j.biochi.2008.07.007; FLEISZIG SMJ, 1994, INFECT IMMUN, V62, P1799, DOI 10.1128/IAI.62.5.1799-1804.1994; Fleiszig SMJ, 2003, INFECT IMMUN, V71, P3866, DOI 10.1128/IAI.71.7.3866-3874.2003; Fleiszig SMJ, 1998, INFECT IMMUN, V66, P3443, DOI 10.1128/IAI.66.7.3443-3446.1998; Fleiszig SMJ, 1997, INFECT IMMUN, V65, P2861, DOI 10.1128/IAI.65.7.2861-2867.1997; FLEISZIG SMJ, 1992, J CLIN MICROBIOL, V30, P1156, DOI 10.1128/JCM.30.5.1156-1161.1992; FLEISZIG SMJ, 1995, INFECT IMMUN, V63, P4072, DOI 10.1128/IAI.63.10.4072-4077.1995; Fleiszig SMJ, 1997, INFECT IMMUN, V65, P579, DOI 10.1128/IAI.65.2.579-586.1997; Gao N, 2016, SCI REP-UK, V6, DOI 10.1038/srep36414; Gipson IK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100393; HABIB NE, 1993, EYE, V7, P757, DOI 10.1038/eye.1993.176; Haynes RJ, 1998, LANCET, V352, P451, DOI 10.1016/S0140-6736(05)79185-6; HOSOI J, 1993, NATURE, V363, P159, DOI 10.1038/363159a0; Huang LC, 2007, INVEST OPHTH VIS SCI, V48, P4498, DOI 10.1167/iovs.07-0274; Jinks MR, 2018, VET OPHTHALMOL, V21, P498, DOI 10.1111/vop.12537; Jolly AL, 2017, FASEB J, V31, P2393, DOI 10.1096/fj.201601198R; Kroken AR, 2018, MBIO, V9, DOI 10.1128/mBio.00668-18; Kwong MSF, 2007, INFECT IMMUN, V75, P2325, DOI 10.1128/IAI.01404-06; Lai NY, 2017, J INTERN MED, V282, P5, DOI 10.1111/joim.12591; Lai NY, 2020, CELL, V180, P33, DOI 10.1016/j.cell.2019.11.014; Li JF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49543-w; Li JF, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006392; Lin T, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009557; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Liu BY, 2013, FASEB J, V27, P3549, DOI 10.1096/fj.13-229948; Maltseva IA, 2007, EXP EYE RES, V85, P142, DOI 10.1016/j.exer.2007.04.001; Mantelli F, 2008, CURR OPIN ALLERGY CL, V8, P477, DOI 10.1097/ACI.0b013e32830e6b04; Mantelli F, 2010, CURR OPIN ALLERGY CL, V10, P498, DOI 10.1097/ACI.0b013e32833e16cc; McDermott AM, 2013, EXP EYE RES, V117, P53, DOI 10.1016/j.exer.2013.07.014; McDermott AM, 2003, INVEST OPHTH VIS SCI, V44, P1859, DOI 10.1167/iovs.02-0787; McNamara NA, 1999, EXP EYE RES, V69, P483, DOI 10.1006/exer.1999.0722; Mergler S, 2011, J CELL PHYSIOL, V226, P1828, DOI 10.1002/jcp.22514; Meseguer V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4125; Metruccio MME, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14243-w; Mochizuki H, 2010, CLIN OPHTHALMOL, V4, P925, DOI 10.2147/OPTH.S12648; Mohammed I, 2017, PROG RETIN EYE RES, V61, P1, DOI 10.1016/j.preteyeres.2017.03.004; MOSIMANN BL, 1993, J ALLERGY CLIN IMMUN, V92, P95, DOI 10.1016/0091-6749(93)90043-F; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Mun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057850; Mun JJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00008; Mun JJ, 2009, INFECT IMMUN, V77, P2392, DOI 10.1128/IAI.00173-09; Okada Y, 2015, CORNEA, V34, pS136, DOI 10.1097/ICO.0000000000000602; Ozkan J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10494-9; Pecze L, 2009, CAN J NEUROL SCI, V36, P234, DOI 10.1017/S0317167100006600; Pinho-Ribeiro FA, 2018, CELL, V173, P1083, DOI 10.1016/j.cell.2018.04.006; Pinho-Ribeiro FA, 2017, TRENDS IMMUNOL, V38, P5, DOI 10.1016/j.it.2016.10.001; Redfern RL, 2011, EXP EYE RES, V92, P209, DOI 10.1016/j.exer.2010.12.005; Reilly CA, 2005, J BIOCHEM MOL TOXIC, V19, P266, DOI 10.1002/jbt.20084; Reinach PS, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0135-7; Reins RY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182153; Seyed-Razavi Y, 2014, INVEST OPHTH VIS SCI, V55, P1313, DOI 10.1167/iovs.13-12995; Singer JT, 2010, APPL ENVIRON MICROB, V76, P3467, DOI 10.1128/AEM.01679-09; Startek JB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30534-2; Sullivan AB, 2015, INFECT IMMUN, V83, P1629, DOI 10.1128/IAI.02329-14; Tam C, 2012, J CLIN INVEST, V122, P3665, DOI 10.1172/JCI64416; Tam C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024008; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Wan SJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234013; Wan SJ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01117; Welch JLM, 2016, P NATL ACAD SCI USA, V113, pE791, DOI 10.1073/pnas.1522149113; Willcox MDP, 2013, EXP EYE RES, V117, P99, DOI 10.1016/j.exer.2013.06.003; Zolfaghar I, 2003, INFECT IMMUN, V71, P5389, DOI 10.1128/IAI.71.9.5389-5393.2003	77	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21899	10.1096/fj.202100874R	http://dx.doi.org/10.1096/fj.202100874R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34569661	Green Accepted			2022-12-28	WOS:000702238200074
J	Bush, MA; Florence, SM; Yeo, TW; Kalingonji, AR; Chen, YW; Granger, DL; Rubach, MP; Anstey, NM; Mwaikambo, ED; Weinberg, JB				Bush, Margaret A.; Florence, Salvatore M.; Yeo, Tsin W.; Kalingonji, Ayam R.; Chen, Youwei; Granger, Donald L.; Rubach, Matthew P.; Anstey, Nicholas M.; Mwaikambo, Esther D.; Weinberg, Joe Brice			Degradation of endothelial glycocalyx in Tanzanian children with falciparum malaria	FASEB JOURNAL			English	Article						endothelium; glycocalyx; glycosaminoglycans; malaria; vascular dysfunction	NITRIC-OXIDE; DYSFUNCTION	A layer of glycocalyx covers the vascular endothelium serving important protective and homeostatic functions. The objective of this study was to determine if breakdown of the endothelial glycocalyx (eGC) occurs during malaria infection in children. Measures of eGC integrity, endothelial activation, and microvascular reactivity were prospectively evaluated in 146 children: 44 with moderately severe malaria (MSM), 42 with severe malaria (SM), and 60 healthy controls (HC). Biochemical measures of eGC integrity included plasma syndecan-1 and total urinary glycosaminoglycans (GAG). Side-stream dark field imaging was used to quantitatively assess integrity of eGC. Plasma angiopoietin-2 (Ang-2) was measured as a marker of endothelial activation and also as a possible mediator of eGC breakdown. Our results show that urinary GAG, syndecan-1, and Ang-2 were elevated in patients with MSM and SM compared with HC. Syndecan-1 and GAG levels correlated significantly with each other and with plasma Ang-2. The eGC breakdown products also inversely correlated significantly with hemoglobin and platelet count. In the MSM group, imaging results provided further evidence for eGC degradation. Although not correlated with markers of eGC degradation, vascular function (assessed by non-invasive near infrared spectroscopy [NIRS]) demonstrated reduced microvascular reactivity, particularly affecting the SM group. Our findings provide further evidence for breakdown of eGC in falciparum malaria that may contribute to endothelial activation and adhesion of parasitized red blood cells, with reduced nitric oxide formation, and vascular dysfunction.	[Bush, Margaret A.; Chen, Youwei; Rubach, Matthew P.; Weinberg, Joe Brice] Duke Univ, Sch Med, Durham, NC 27705 USA; [Bush, Margaret A.; Chen, Youwei; Rubach, Matthew P.; Weinberg, Joe Brice] Durham VA Med Ctr, Durham, NC USA; [Florence, Salvatore M.; Kalingonji, Ayam R.; Mwaikambo, Esther D.] Hubert Kairuki Mem Univ, Dar Es Salaam, Tanzania; [Yeo, Tsin W.; Anstey, Nicholas M.] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia; [Yeo, Tsin W.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Yeo, Tsin W.] Tan Tock Seng Hosp, Natl Ctr Infect Dis, Singapore, Singapore; [Granger, Donald L.] Univ Utah, Salt Lake City, UT USA; [Granger, Donald L.] VA Med Ctr, Salt Lake City, UT USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Charles Darwin University; Menzies School of Health Research; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Centre for Infectious Diseases Singapore; Tan Tock Seng Hospital; Utah System of Higher Education; University of Utah	Weinberg, JB (corresponding author), Duke Univ, Lematol Oncol Div, 508 Fulton St, Durham, NC 27705 USA.; Weinberg, JB (corresponding author), VA Med Ctr, 508 Fulton St, Durham, NC 27705 USA.	brice@duke.edu		kalingonji, ayam/0000-0003-3787-1021; Bush, Margaret/0000-0003-1937-2640; Weinberg, J. Brice/0000-0003-4052-5576	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [HL130763]; U.S. Department of Veterans Affairs (VA) [2772]; Department of Health \ National Health and Medical Research Council (NHMRC) [1135820]; HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID) [AI116869]	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs); Department of Health \ National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID)	HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL130763; U.S. Department of Veterans Affairs (VA), Grant/Award Number: 2772; Department of Health vertical bar National Health and Medical Research Council (NHMRC), Grant/Award Number: 1135820; HHS vertical bar NIH vertical bar National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: AI116869	Akwii RG, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050471; [Anonymous], 2015, GUID TREATM MAL; Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; Beurskens DMH, 2020, ANAESTH INTENS CARE, V48, P221, DOI 10.1177/0310057X20916471; Chappell D, 2014, EUR J ANAESTH, V31, P474, DOI 10.1097/EJA.0000000000000085; Conroy AL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-295; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Graham SM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1106-z; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hempel C, 2019, FASEB J, V33, P2058, DOI 10.1096/fj.201800657R; Hempel C, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1844-6; Hempel C, 2016, TRENDS MOL MED, V22, P453, DOI 10.1016/j.molmed.2016.04.004; Hempel C, 2014, J CEREBR BLOOD F MET, V34, P1107, DOI 10.1038/jcbfm.2014.79; Henry CBS, 1999, AM J PHYSIOL-HEART C, V277, pH508, DOI 10.1152/ajpheart.1999.277.2.H508; Hippensteel JA, 2019, J CLIN INVEST, V129, P1779, DOI 10.1172/JCI124485; HUSDAN H, 1968, CLIN CHEM, V14, P222; Komosinska-Vassev K, 2014, CLIN BIOCHEM, V47, P1341, DOI 10.1016/j.clinbiochem.2014.06.012; Lee DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096477; Leitgeb AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188754; Liew H, 2021, BMC NEPHROL, V22, DOI 10.1186/s12882-020-02219-4; Lukasz A, 2017, CARDIOVASC RES, V113, P671, DOI 10.1093/cvr/cvx023; Lyimo E, 2020, INFECT IMMUN, V88, DOI 10.1128/IAI.00679-19; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Mulivor AW, 2002, AM J PHYSIOL-HEART C, V283, pH1282, DOI 10.1152/ajpheart.00117.2002; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Rubach MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035985; Saiwaew S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172718; Schmidt EP, 2016, AM J RESP CRIT CARE, V194, P439, DOI 10.1164/rccm.201511-2281OC; Stahl K, 2020, AM J RESP CRIT CARE, V202, P1178, DOI 10.1164/rccm.202007-2676LE; Sun XJ, 2015, ANAL CHEM, V87, P6220, DOI 10.1021/acs.analchem.5b00913; Tang THC, 2017, SCI REP-UK, V7, DOI 10.1038/srep46191; Tarbell JM, 2016, J INTERN MED, V280, P97, DOI 10.1111/joim.12465; Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x; Tarbell JM, 2014, ANNU REV BIOMED ENG, V16, P505, DOI 10.1146/annurev-bioeng-071813-104908; van Elteren HA, 2015, J CLIN MONIT COMPUT, V29, P543, DOI 10.1007/s10877-015-9708-5; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Woodford J, 2020, INFECT IMMUN, V88, DOI 10.1128/IAI.00895-19; Yen WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117133; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819; Yeo TW, 2019, FASEB J, V33, P14185, DOI 10.1096/fj.201901048RR; Yeo TW, 2019, CLIN INFECT DIS, V69, P1712, DOI 10.1093/cid/ciz038; Yeo TW, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx079; Yeo TW, 2014, J INFECT DIS, V210, P1627, DOI 10.1093/infdis/jiu308; Yeo TW, 2013, J INFECT DIS, V207, P528, DOI 10.1093/infdis/jis692	47	3	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21805	10.1096/fj.202100277RR	http://dx.doi.org/10.1096/fj.202100277RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34403544	Green Accepted			2022-12-28	WOS:000691122900001
J	Karouta, C; Kucharski, R; Hardy, K; Thomson, K; Maleszka, R; Morgan, I; Ashby, R				Karouta, Cindy; Kucharski, Robert; Hardy, Kristine; Thomson, Kate; Maleszka, Ryszard; Morgan, Ian; Ashby, Regan			Transcriptome-based insights into gene networks controlling myopia prevention	FASEB JOURNAL			English	Article						gene expression; myopia; retina; RNA sequencing; transcriptome	FORM-DEPRIVATION MYOPIA; RETINAL-PIGMENT EPITHELIUM; FIBROBLAST-GROWTH-FACTOR; MESSENGER-RNA; REFRACTIVE DEVELOPMENT; DOPAMINERGIC AGENTS; OCULAR GROWTH; IMAGE DEFOCUS; BRIEF PERIODS; AXIAL MYOPIA	Myopia (short-sightedness), usually caused by excessive elongation of the eye during development, has reached epidemic proportions worldwide. In animal systems including the chicken model, several treatments have been shown to inhibit ocular elongation and experimental myopia. Although diverse in their apparent mechanism of action, each one leads to a reduction in the rate of ocular growth. We hypothesize that a defined set of retinal molecular changes may underlie growth inhibition, irrespective of the treatment agent used. Accordingly, across five well-established but diverse methods of inhibiting myopia, significant overlap is seen in the retinal transcriptome profile (transcript levels and alternative splicing events) in chicks when analyzed by RNA-seq. Within the two major pathway networks enriched during growth inhibition, that of cell signaling and circadian entrainment, transcription factors form the largest functional grouping. Importantly, a large percentage of those genes forming the defined retinal response are downstream targets of the transcription factor EGR1 which itself shows a universal response to all five growth-inhibitory treatments. This supports EGR1's previously implicated role in ocular growth regulation. Finally, by contrasting our data with human linkage and GWAS studies on refractive error, we confirm the applicability of our study to the human condition. Together, these findings suggest that a universal set of transcriptome changes, which sit within a well-defined retinal network that cannot be bypassed, is fundamental to growth regulation, thus paving a way for designing novel targets for myopia therapies.	[Karouta, Cindy; Kucharski, Robert; Hardy, Kristine; Thomson, Kate; Ashby, Regan] Univ Canberra, Fac Sci & Technol, Ctr Res Therapeut Solut, Biomed Sci, Bldg 3,Level D,Room 61, Canberra, ACT, Australia; [Kucharski, Robert; Maleszka, Ryszard; Morgan, Ian; Ashby, Regan] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	University of Canberra; Australian National University	Karouta, C (corresponding author), Univ Canberra, Fac Sci & Technol, Ctr Res Therapeut Solut, Biomed Sci, Bldg 3,Level D,Room 61, Canberra, ACT, Australia.	cindy.karouta@canberra.edu.au	Morgan, Ian G/D-1190-2009; Maleszka, Ryszard/A-6078-2008	Morgan, Ian G/0000-0002-4548-3574; Maleszka, Ryszard/0000-0003-1855-555X; Hardy, Kristine/0000-0003-1660-4477; Karouta, Cindy/0000-0003-1157-2840; Ashby, Regan/0000-0002-8027-6490; Thomson, Kate/0000-0002-2272-2800; Kucharski, Robert/0000-0002-1708-1877	ANU Connect Ventures through a Discovery Translation Fund [DTF311]	ANU Connect Ventures through a Discovery Translation Fund	This work was partially funded by ANU Connect Ventures through a Discovery Translation Fund (Project number DTF311) and was awarded to RA. http://www.anuconnectventures.com.au/investment/discovery-translation-fund-2-0/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Al Dhaibani MA, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0482-8; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Ashby R, 2007, EXP EYE RES, V85, P15, DOI 10.1016/j.exer.2007.02.019; Ashby R, 2016, OPTOMETRY VISION SCI, V93, P1052, DOI 10.1097/OPX.0000000000000978; Ashby R, 2016, SCI REP-UK, V6, DOI 10.1038/srep18794; Ashby R, 2010, MOL VIS, V16, P639; Ashby RS, 2014, INVEST OPHTH VIS SCI, V55, P5911, DOI 10.1167/iovs.13-11708; Ashby RS, 2010, EXP EYE RES, V90, P238, DOI 10.1016/j.exer.2009.10.011; Ashby RS, 2010, INVEST OPHTH VIS SCI, V51, P3726, DOI 10.1167/iovs.09-4615; Bitzer M, 2002, INVEST OPHTH VIS SCI, V43, P246; Boelen MK, 1998, VISUAL NEUROSCI, V15, P97, DOI 10.1017/S0952523898151040; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Brand C, 2005, MOL VIS, V11, P309; Brand C, 2007, MOL VIS, V13, P920; Caputto BL, 2000, NEUROCHEM RES, V25, P153, DOI 10.1023/A:1007508020173; Chen MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096952; Collins S, 2006, J IMMUNOL, V177, P8301, DOI 10.4049/jimmunol.177.12.8301; Contestabile A, 2008, PROG NEUROBIOL, V84, P317, DOI 10.1016/j.pneurobio.2008.01.002; Crewther SG, 2003, NEUROREPORT, V14, P1233, DOI 10.1097/00001756-200307010-00009; Duclot F, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00035; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Feldkaemper MP, 2009, INVEST OPHTH VIS SCI, V50, P13, DOI 10.1167/iovs.08-1702; Fischer AJ, 1999, NAT NEUROSCI, V2, P706, DOI 10.1038/11167; Flitcroft DI, 2012, PROG RETIN EYE RES, V31, P622, DOI 10.1016/j.preteyeres.2012.06.004; Francisco BM, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/750637; Giovannone AJ, 2018, J BIOL CHEM, V293, P5478, DOI 10.1074/jbc.RA117.000874; Goldstein LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156132; Guo H, 2014, J MED GENET, V51, P518, DOI 10.1136/jmedgenet-2014-102351; He L, 2018, EXP EYE RES, V168, P77, DOI 10.1016/j.exer.2018.01.005; He L, 2014, VISION RES, V102, P52, DOI 10.1016/j.visres.2014.07.005; ITOH S, 1988, PEPTIDES, V9, P315, DOI 10.1016/0196-9781(88)90266-5; Karouta C, 2015, INVEST OPHTH VIS SCI, V56, P299, DOI 10.1167/iovs.14-15499; LARSEN FG, 1994, J INVEST DERMATOL, V102, P730, DOI 10.1111/1523-1747.ep12375840; LEECH EM, 1995, OPHTHAL PHYSL OPT, V15, P351, DOI 10.1016/0275-5408(95)00074-N; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Li Q, 2019, NEUROSCI LETT, V708, DOI 10.1016/j.neulet.2019.134337; Liu Shuang-Zhen, 2007, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V32, P132; Makman M H, 1975, Adv Cyclic Nucleotide Res, V5, P661; Marballi KK, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00023; Mathis U, 2020, GRAEF ARCH CLIN EXP, V258, P319, DOI 10.1007/s00417-019-04573-y; Mathis U, 2014, EXP EYE RES, V127, P161, DOI 10.1016/j.exer.2014.07.022; McCarthy CS, 2007, EXP EYE RES, V84, P100, DOI 10.1016/j.exer.2006.09.018; McGlinn AM, 2007, INVEST OPHTH VIS SCI, V48, P3430, DOI 10.1167/iovs.06-1538; Mei F, 2017, OPHTHALMIC RES, V57, P186, DOI 10.1159/000452421; Meng WH, 2012, INVEST OPHTH VIS SCI, V53, P7983, DOI 10.1167/iovs.12-10409; Metlapally R, 2016, INVEST OPHTH VIS SCI, V57, P6089, DOI 10.1167/iovs.16-19563; Middlebrooks C, 2018, INVEST OPHTH VIS SCI, V59; Nakazawa T, 2003, CURR EYE RES, V26, P55, DOI 10.1076/ceyr.26.1.55.14254; Nickla DL, 2013, OPTOMETRY VISION SCI, V90, P1167, DOI 10.1097/OPX.0000000000000041; Nickla DL, 2013, EXP EYE RES, V114, P25, DOI 10.1016/j.exer.2012.12.013; Norton TT, 2016, OPTOMETRY VISION SCI, V93, P1049, DOI 10.1097/OPX.0000000000000917; Norton TT, 2013, EXP EYE RES, V114, P48, DOI 10.1016/j.exer.2013.05.004; Ohno-Matsui K, 2017, RETINA-J RET VIT DIS, V37, P1043, DOI 10.1097/IAE.0000000000001348; Orgeur M, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.161208; Pardue MT, 2008, INVEST OPHTH VIS SCI, V49, P706, DOI 10.1167/iovs.07-0643; Pendrak K, 1997, CURR EYE RES, V16, P152, DOI 10.1076/ceyr.16.2.152.5090; Penha AM, 2012, MOL VIS, V18, P2608; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qian YS, 2009, CURR EYE RES, V34, P623, DOI 10.1080/02713680903003492; Qin D, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/920280; Riddell N, 2018, BMC DEV BIOL, V18, DOI 10.1186/s12861-018-0177-1; Riddell N, 2017, MOL VIS, V23, P872; Riddell N, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00390; ROHRER B, 1994, EXP EYE RES, V58, P553, DOI 10.1006/exer.1994.1049; Rohrer B, 1997, NEUROSCIENCE, V79, P775, DOI 10.1016/S0306-4522(97)00042-0; Rucker FJ, 2013, OPHTHAL PHYSL OPT, V33, P196, DOI 10.1111/opo.12050; Russell C, 2003, VISION RES, V43, P899, DOI 10.1016/S0042-6989(02)00416-9; Schippert R, 2007, INVEST OPHTH VIS SCI, V48, P11, DOI 10.1167/iovs.06-0851; Schmid KL, 2013, EXP EYE RES, V110, P88, DOI 10.1016/j.exer.2013.02.017; Schwahn HN, 2000, VISUAL NEUROSCI, V17, P165, DOI 10.1017/S0952523800171184; Seko Y, 1999, INVEST OPHTH VIS SCI, V40, P3287; SEKO Y, 1995, OPHTHALMIC RES, V27, P144, DOI 10.1159/000267651; SEKO Y, 1995, INVEST OPHTH VIS SCI, V36, P1183; Sevetson BR, 2000, J BIOL CHEM, V275, P9749, DOI 10.1074/jbc.275.13.9749; SMITH EL, 1991, VISION RES, V31, P833, DOI 10.1016/0042-6989(91)90150-4; Snow WM, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00118; Stell WK., 2003, J VISUAL-JAPAN, V3; STONE RA, 1989, P NATL ACAD SCI USA, V86, P704, DOI 10.1073/pnas.86.2.704; Stone RA, 2016, INVEST OPHTH VIS SCI, V57, P4779, DOI 10.1167/iovs.16-19310; Stone RA, 2011, INVEST OPHTH VIS SCI, V52, P5765, DOI 10.1167/iovs.10-6727; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Tang RH, 2012, CLIN EXP OPHTHALMOL, V40, P503, DOI 10.1111/j.1442-9071.2011.02683.x; Thomson K, 2021, BRIT J PHARMACOL, V178, P4501, DOI 10.1111/bph.15629; Thomson K, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.12.4; Thomson K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70271-z; Thomson K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54789-5; Thomson K, 2018, INVEST OPHTH VIS SCI, V59; Tkatchenko TV, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006021; Troilo D, 2019, INVEST OPHTH VIS SCI, V60, pM31, DOI 10.1167/iovs.18-25967; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Vishweswaraiah S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40299-x; Wei TW, 2015, TWIN RES HUM GENET, V18, P393, DOI 10.1017/thg.2015.34; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Xi LYY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08765-6; Yin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052177; Yip SP, 2011, MOL VIS, V17, P810; You JJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18480-x; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482; Zhang PF, 2017, CELL SIGNAL, V37, P115, DOI 10.1016/j.cellsig.2017.06.006; Zhang Y, 2012, INVEST OPHTH VIS SCI, V53, P6072, DOI 10.1167/iovs.12-9917; Zhong XW, 2004, INVEST OPHTH VIS SCI, V45, P2065, DOI 10.1167/iovs.03-1046; Zhou L, 2018, MOL VIS, V24, P560; Zhu XY, 2009, INVEST OPHTH VIS SCI, V50, P24, DOI 10.1167/iovs.08-1708	104	4	4	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21846	10.1096/fj.202100350RR	http://dx.doi.org/10.1096/fj.202100350RR			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34405458	hybrid			2022-12-28	WOS:000691122900007
J	Caputo, R; Poirel, VJ; Challet, E; Meijer, JH; Raison, S				Caputo, Rosanna; Poirel, Vincent-Joseph; Challet, Etienne; Meijer, Johanna H.; Raison, Sylvie			Bimodal serotonin synthesis in the diurnal rodent, Arvicanthis ansorgei	FASEB JOURNAL			English	Article						5HT; Arvicanthis; circadian; raphe nuclei; rhythm; rodent; SCN; tryptophan hydroxylase 2	DORSAL RAPHE NUCLEUS; SUPRACHIASMATIC NUCLEUS; CIRCADIAN-RHYTHMS; CORTICOSTERONE RHYTHM; TRYPTOPHAN HYDROXYLASE-2; PLASMA-CORTICOSTERONE; RETINAL PROJECTION; AFFECTIVE-DISORDER; LOCOMOTOR-ACTIVITY; SLEEP-DEPRIVATION	In mammals, behavioral activity is regulated both by the circadian system, orchestrated by the suprachiasmatic nucleus (SCN), and by arousal structures, including the serotonergic system. While the SCN is active at the same astronomical time in diurnal and nocturnal species, little data are available concerning the serotonergic (5HT) system in diurnal mammals. In this study, we investigated the functioning of the 5HT system, which is involved both in regulating the sleep/wake cycle and in synchronizing the SCN, in a diurnal rodent, Arvicanthis ansorgei. Using in situ hybridization, we characterized the anatomical extension of the raphe nuclei and we investigated 24 h mRNA levels of the serotonin rate-limiting enzyme, tryptophan hydroxylase 2 (tph2). Under both 12 h:12 h light/dark (LD) and constant darkness (DD) conditions, tph2 mRNA expression varies significantly over 24 h, displaying a bimodal profile with higher values around the (projected) light transitions. Furthermore, we considered several SCN outputs, namely melatonin, corticosterone, and locomotor activity. In both LD and DD, melatonin profiles display peak levels during the biological night. Corticosterone plasma levels show a bimodal rhythmic profile in both conditions, with higher levels preceding the two peaks of Arvicanthis locomotor activity, occurring at dawn and dusk. These data demonstrate that serotonin synthesis in Arvicanthis is rhythmic and reflects its bimodal behavioral phenotype, but differs from what has been previously described in nocturnal species.	[Caputo, Rosanna; Poirel, Vincent-Joseph; Challet, Etienne; Raison, Sylvie] Inst Cellular & Integrat Neurosci, CNRS, INCI 8,Allee Gen Rouvillois, F-67000 Strasbourg, France; [Caputo, Rosanna; Poirel, Vincent-Joseph; Challet, Etienne; Raison, Sylvie] Univ Strasbourg, INCI 8,Allee Gen Rouvillois, F-67000 Strasbourg, France; [Caputo, Rosanna; Meijer, Johanna H.] Leiden Univ, Dept Mol Cell Biol, Div Neurophysiol, Med Ctr, Leiden, Netherlands	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Raison, S (corresponding author), Inst Cellular & Integrat Neurosci, CNRS, INCI 8,Allee Gen Rouvillois, F-67000 Strasbourg, France.; Raison, S (corresponding author), Univ Strasbourg, INCI 8,Allee Gen Rouvillois, F-67000 Strasbourg, France.	raison@unistra.fr		RAISON, sylvie/0000-0003-0977-5315; Caputo, Rosanna/0000-0002-7655-6676; Challet, Etienne/0000-0001-9416-9496	IDEX-Unistra [ANR-10-IDEX-0002-02]	IDEX-Unistra	IDEX-Unistra, Grant/Award Number: ANR-10-IDEX-0002-02	ABE K, 1979, NEUROENDOCRINOLOGY, V29, P119, DOI 10.1159/000122913; Adidharma W, 2012, NEUROSCIENCE, V220, P201, DOI 10.1016/j.neuroscience.2012.06.020; Adidharma W, 2019, HORM BEHAV, V116, DOI 10.1016/j.yhbeh.2019.104584; ALBERS HE, 1985, AM J PHYSIOL, V248, pR434, DOI 10.1152/ajpregu.1985.248.4.R434; ALLENROWLANDS CF, 1980, J ENDOCRINOL INVEST, V3, P371, DOI 10.1007/BF03349373; Barassin S, 2002, EUR J NEUROSCI, V15, P833, DOI 10.1046/j.1460-9568.2002.01928.x; Bedrosian TA, 2013, MOL PSYCHIATR, V18, P930, DOI 10.1038/mp.2012.96; Bobrzynska KJ, 1996, PHYSIOL BEHAV, V59, P221, DOI 10.1016/0031-9384(95)02130-2; Brown MJ, 2011, PUBLIC HEALTH REP, V126, P131, DOI 10.1177/00333549111260S117; Buijs Ruud M., 1993, American Journal of Physiology, V264, pR1186; CAGAMPANG FRA, 1994, BRAIN RES, V639, P175, DOI 10.1016/0006-8993(94)91780-9; Caldelas I, 2003, NEUROSCIENCE, V116, P583, DOI 10.1016/S0306-4522(02)00654-1; CARD JP, 1989, J COMP NEUROL, V284, P135, DOI 10.1002/cne.902840110; Challet E, 2001, BRAIN RES, V909, P81, DOI 10.1016/S0006-8993(01)02625-7; Challet E, 2007, ENDOCRINOLOGY, V148, P5648, DOI 10.1210/en.2007-0804; Clark MS, 2006, J COMP NEUROL, V498, P611, DOI 10.1002/cne.21073; Cuesta M, 2008, EXP NEUROL, V210, P501, DOI 10.1016/j.expneurol.2007.11.026; Cuesta M, 2009, HORM BEHAV, V55, P338, DOI 10.1016/j.yhbeh.2008.10.015; Cutrera RA, 1996, NEUROSCI LETT, V210, P1, DOI 10.1016/0304-3940(96)12655-0; Dalm S, 2005, NEUROENDOCRINOLOGY, V81, P372, DOI 10.1159/000089555; Dardente H, 2004, MOL BRAIN RES, V124, P143, DOI 10.1016/j.molbrainres.2004.01.010; Daut RA, 2019, FRONT NEUROENDOCRIN, V54, DOI 10.1016/j.yfrne.2019.04.003; Deats SP, 2014, NEUROSCIENCE, V272, P252, DOI 10.1016/j.neuroscience.2014.04.069; Dudley TE, 1998, J NEUROSCI, V18, P5045; Fisher Simon P, 2013, Handb Exp Pharmacol, P157, DOI 10.1007/978-3-642-25950-0_7; Fite KV, 2001, BRAIN RES, V895, P139, DOI 10.1016/S0006-8993(01)02061-3; Flaive A, 2020, FRONT NEURAL CIRCUIT, V14, DOI 10.3389/fncir.2020.590299; Fu WY, 2010, J COMP NEUROL, V518, P3464, DOI 10.1002/cne.22407; Gandhi AV, 2015, NEURON, V85, P1193, DOI 10.1016/j.neuron.2015.02.016; Garabette ML, 2000, BRIT J PHARMACOL, V131, P1569, DOI 10.1038/sj.bjp.0703753; Garidou ML, 2002, EUR J NEUROSCI, V15, P1632, DOI 10.1046/j.1460-9568.2002.02034.x; Germain A, 2008, HUM PSYCHOPHARM CLIN, V23, P571, DOI 10.1002/hup.964; Gunduz B, 2002, COMP BIOCHEM PHYS A, V132, P393, DOI 10.1016/S1095-6433(02)00041-7; HENSLER JG, 1994, SYNAPSE, V17, P1, DOI 10.1002/syn.890170102; Huang KW, 2019, ELIFE, V8, DOI 10.7554/eLife.46464; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; JACOBS BL, 1990, NEUROPSYCHOPHARMACOL, V3, P473; Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019; Kalsbeek A, 1996, J NEUROENDOCRINOL, V8, P299, DOI 10.1046/j.1365-2826.1996.04597.x; Kawano H, 1996, NEUROSCI LETT, V212, P143, DOI 10.1016/0304-3940(96)12795-6; KAZAKOV VN, 1993, NEUROSCIENCE, V56, P157, DOI 10.1016/0306-4522(93)90570-6; Kennaway DJ, 2002, AM J PHYSIOL-REG I, V282, pR358, DOI 10.1152/ajpregu.00360.2001; Knoch ME, 2004, EUR J NEUROSCI, V19, P2779, DOI 10.1111/j.0953-816X.2004.03371.x; Leach G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057115; LeGates TA, 2014, NAT REV NEUROSCI, V15, P443, DOI 10.1038/nrn3743; LEWY AJ, 1980, J CLIN ENDOCR METAB, V50, P204, DOI 10.1210/jcem-50-1-204; Lowry CA, 2008, ANN NY ACAD SCI, V1148, P86, DOI 10.1196/annals.1410.004; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; Malek ZS, 2007, ENDOCRINOLOGY, V148, P5165, DOI 10.1210/en.2007-0526; Malek ZS, 2005, EUR J NEUROSCI, V22, P895, DOI 10.1111/j.1460-9568.2005.04264.x; Malek ZS, 2004, NEUROSCIENCE, V125, P749, DOI 10.1016/j.neuroscience.2004.01.031; Manoogian ENC, 2017, AGEING RES REV, V39, P59, DOI 10.1016/j.arr.2016.12.006; MEIJER JH, 1989, PHYSIOL REV, V69, P671, DOI 10.1152/physrev.1989.69.3.671; Mendoza J, 2010, J NEUROCHEM, V112, P1489, DOI 10.1111/j.1471-4159.2010.06570.x; MeyerBernstein EL, 1996, J NEUROSCI, V16, P2097; Moga MM, 1997, J COMP NEUROL, V389, P508, DOI 10.1002/(SICI)1096-9861(19971222)389:3<508::AID-CNE11>3.0.CO;2-H; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Mulinari S, 2012, J HIST NEUROSCI, V21, P366, DOI 10.1080/0964704X.2011.623917; Nexon L, 2011, EUR J NEUROSCI, V33, P1308, DOI 10.1111/j.1460-9568.2010.07586.x; Nexon L, 2009, EUR J NEUROSCI, V30, P1790, DOI 10.1111/j.1460-9568.2009.06986.x; NIKLOWITZ P, 1994, BIOL REPROD, V51, P714, DOI 10.1095/biolreprod51.4.714; PANKE ES, 1979, ENDOCRINOLOGY, V104, P194, DOI 10.1210/endo-104-1-194; Parker NG, 2000, ANN PHARMACOTHER, V34, P761; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Perez-Caballero L, 2014, EXPERT OPIN DRUG DIS, V9, P567, DOI 10.1517/17460441.2014.907790; Pevet Paul, 2002, Dialogues Clin Neurosci, V4, P57; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Rastad Cecilia, 2017, Psychiatry J, V2017, P6867957, DOI 10.1155/2017/6867957; Refinetti R, 2008, BIOL RHYTHM RES, V39, P173, DOI 10.1080/09291010701682690; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; Sage D, 2004, J BIOL RHYTHM, V19, P144, DOI 10.1177/0748730403261894; Sakowski SA, 2006, BRAIN RES, V1085, P11, DOI 10.1016/j.brainres.2006.02.047; SATO T, 1984, Neuroscience Research, V1, P45, DOI 10.1016/0168-0102(84)90029-4; Schmidt BJ, 2000, BRAIN RES BULL, V53, P689, DOI 10.1016/S0361-9230(00)00402-0; SHEN H, 1994, BRAIN RES, V635, P159, DOI 10.1016/0006-8993(94)91435-4; TOMINAGA K, 1992, EUR J PHARMACOL, V214, P79, DOI 10.1016/0014-2999(92)90099-P; Verhagen LAW, 2004, BRAIN RES, V995, P197, DOI 10.1016/j.brainres.2003.10.003; Weber ET, 1998, J BIOL RHYTHM, V13, P209, DOI 10.1177/074873098129000057; WEITZMAN ED, 1971, J CLIN ENDOCR METAB, V33, P14, DOI 10.1210/jcem-33-1-14; WONG DT, 1995, LIFE SCI, V57, P411, DOI 10.1016/0024-3205(95)00209-O; Yannielli P, 2004, PROG NEUROBIOL, V74, P59, DOI 10.1016/j.pneurobio.2004.06.001; Young SN, 2002, PHARMACOL BIOCHEM BE, V71, P857, DOI 10.1016/S0091-3057(01)00670-0; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Zeitzer JM, 2007, SLEEP, V30, P1437, DOI 10.1093/sleep/30.11.1437; Zhdanova IV, 1998, J GERONTOL A-BIOL, V53, pB293, DOI 10.1093/gerona/53A.4.B293; Zhdanova IV, 2005, SLEEP MED REV, V9, P51, DOI 10.1016/j.smrv.2004.04.003	87	0	0	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22255	10.1096/fj.202101726R	http://dx.doi.org/10.1096/fj.202101726R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CG	35294080	Green Submitted, hybrid			2022-12-28	WOS:000772944400001
J	Peck, BD; Murach, KA; Walton, RG; Simmons, AJ; Long, DE; Kosmac, K; Dungan, CM; Kern, PA; Bamman, MM; Peterson, CA				Peck, Bailey D.; Murach, Kevin A.; Walton, R. Grace; Simmons, Alexander J.; Long, Douglas E.; Kosmac, Kate; Dungan, Cory M.; Kern, Philip A.; Bamman, Marcas M.; Peterson, Charlotte A.			A muscle cell-macrophage axis involving matrix metalloproteinase 14 facilitates extracellular matrix remodeling with mechanical loading	FASEB JOURNAL			English	Article						extracellular matrix remodeling; macrophage; muscle hypertrophy; scRNA-seq	LEUKEMIA INHIBITORY FACTOR; REGENERATION; INFLAMMATION; MMP-14	The extracellular matrix (ECM) in skeletal muscle plays an integral role in tissue development, structural support, and force transmission. For successful adaptation to mechanical loading, remodeling processes must occur. In a large cohort of older adults, transcriptomics revealed that genes involved in ECM remodeling, including matrix metalloproteinase 14 (MMP14), were the most upregulated following 14 weeks of progressive resistance exercise training (PRT). Using single-cell RNA-seq, we identified macrophages as a source of Mmp14 in muscle following a hypertrophic exercise stimulus in mice. In vitro contractile activity in myotubes revealed that the gene encoding cytokine leukemia inhibitory factor (LIF) is robustly upregulated and can stimulate Mmp14 expression in macrophages. Functional experiments confirmed that modulation of this muscle cell-macrophage axis facilitated Type I collagen turnover. Finally, changes in LIF expression were significantly correlated with MMP14 expression in humans following 14 weeks of PRT. Our experiments reveal a mechanism whereby muscle fibers influence macrophage behavior to promote ECM remodeling in response to mechanical loading.	[Peck, Bailey D.; Murach, Kevin A.; Walton, R. Grace; Simmons, Alexander J.; Long, Douglas E.; Kosmac, Kate; Dungan, Cory M.; Peterson, Charlotte A.] Univ Kentucky, Ctr Muscle Biol, 900 S Limestone,CTW 439, Lexington, KY 40536 USA; [Peck, Bailey D.; Murach, Kevin A.; Walton, R. Grace; Simmons, Alexander J.; Long, Douglas E.; Kosmac, Kate; Dungan, Cory M.; Peterson, Charlotte A.] Univ Kentucky, Coll Hlth Sci, Dept Phys Therapy, Lexington, KY USA; [Kern, Philip A.] Univ Kentucky, Dept Med, Div Endocrinol, Lexington, KY 40506 USA; [Bamman, Marcas M.] Univ Alabama Birmingham, UAB Ctr Exercise Med, Birmingham, AL USA; [Bamman, Marcas M.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Peterson, CA (corresponding author), Univ Kentucky, Ctr Muscle Biol, 900 S Limestone,CTW 439, Lexington, KY 40536 USA.	cpete4@uky.edu			National Institutes of Arthritis and Musculoskeletal and Skin Diseases [AR060701, AR071753]; National Institute on Aging [AG046920, AG049086, AG063994]; National Institute of Diabetes and Digestive and Kidney Diseases [DK119619]; University of Kentucky [UL1TR001998]; Paul Glenn Investigator Award	National Institutes of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Kentucky; Paul Glenn Investigator Award	National Institutes of Arthritis and Musculoskeletal and Skin Diseases, Grant/Award Number: AR060701 and AR071753; National Institute on Aging, Grant/Award Number: AG046920, AG049086 and AG063994; National Institute of Diabetes and Digestive and Kidney Diseases, Grant/Award Number: DK119619; Paul Glenn Investigator Award; University of Kentucky, Grant/Award Number: UL1TR001998	Abbott CB, 2021, FUNCTION, V2, DOI 10.1093/function/zqab028; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Broholm C, 2008, J PHYSIOL-LONDON, V586, P2195, DOI 10.1113/jphysiol.2007.149781; Broholm C, 2010, EXERC IMMUNOL REV, V16, P77; Cathcart JM, 2016, ONCOTARGET, V7, P61107, DOI 10.18632/oncotarget.11243; Chazaud B, 2020, TRENDS IMMUNOL, V41, P481, DOI 10.1016/j.it.2020.04.006; De Micheli AJ, 2020, CELL REP, V30, P3583, DOI 10.1016/j.celrep.2020.02.067; DiPasquale DM, 2007, AM J PHYSIOL-CELL PH, V293, pC1278, DOI 10.1152/ajpcell.00201.2007; Giannakis N, 2019, NAT IMMUNOL, V20, P626, DOI 10.1038/s41590-019-0356-7; Gramolelli S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27739-w; Jensen SM, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00811; Juban G, 2018, CELL REP, V25, P2163, DOI 10.1016/j.celrep.2018.10.077; Juhas M, 2018, NAT BIOMED ENG, V2, P942, DOI 10.1038/s41551-018-0290-2; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kosmac K, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2883; Kulkarni AS, 2020, AGING-US, V12, P19852, DOI 10.18632/aging.104096; Liu L, 2015, NAT PROTOC, V10, P1612, DOI 10.1038/nprot.2015.110; Lohi J, 2000, GENE, V242, P75, DOI 10.1016/S0378-1119(99)00549-1; Long DE, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1932-5; McKee TJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46896-0; Murach KA, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102372; Snyman C, 2015, J MUSCLE RES CELL M, V36, P215, DOI 10.1007/s10974-015-9414-4; Spangenburg EE, 2006, CYTOKINE, V34, P125, DOI 10.1016/j.cyto.2006.05.001; Tonkin J, 2015, MOL THER, V23, P1189, DOI 10.1038/mt.2015.66; Varga T, 2016, J IMMUNOL, V196, P4771, DOI 10.4049/jimmunol.1502490; Walton RG, 2019, AGING CELL, V18, DOI 10.1111/acel.13039; Walton RG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37187-1; Welc SS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10614-1; Wen Y, 2018, J APPL PHYSIOL, V124, P40, DOI 10.1152/japplphysiol.00762.2017; Yu HY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6218; Zhang Qia, 2014, Muscles Ligaments Tendons J, V4, P446	31	9	9	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22155	10.1096/fj.202100182RR	http://dx.doi.org/10.1096/fj.202100182RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35044708	hybrid, Green Published			2022-12-28	WOS:000747987800021
J	Garcia, AB; Siu, E; Du, X; Leng, L; Franke-Fayard, B; Janse, CJ; Howland, SW; Renia, L; Lolis, E; Bucala, R				Baeza Garcia, Alvaro; Siu, Edwin; Du, Xin; Leng, Lin; Franke-Fayard, Blandine; Janse, Chris J.; Howland, Shanshan W.; Renia, Laurent; Lolis, Elias; Bucala, Richard			Suppression of Plasmodium MIF-CD74 signaling protects against severe malaria	FASEB JOURNAL			English	Article						apoptosis; CD74; cerebral malaria; PMIF	MIGRATION INHIBITORY FACTOR; CD8(+) T-CELLS; LIVER-STAGE; CROSS-PRESENTATION; CEREBRAL MALARIA; FALCIPARUM; MIF; INFECTION; IMMUNITY; DATABASE	The deadliest complication of infection by Plasmodium parasites, cerebral malaria, accounts for the majority of malarial fatalities. Although our understanding of the cellular and molecular mechanisms underlying the pathology remains incomplete, recent studies support the contribution of systemic and neuroinflammation as the cause of cerebral edema and blood-brain barrier (BBB) dysfunction. All Plasmodium species encode an orthologue of the innate cytokine, Macrophage Migration Inhibitory Factor (MIF), which functions in mammalian biology to regulate innate responses. Plasmodium MIF (PMIF) similarly signals through the host MIF receptor CD74, leading to an enhanced inflammatory response. We investigated the PMIF-CD74 interaction in the onset of experimental cerebral malaria (ECM) and liver stage Plasmodium development by using a combination of CD74 deficient (Cd74(-/-)) hosts and PMIF deficient parasites. Cd74(-/-) mice were found to be protected from ECM and the protection was associated with the inability of brain microvessels to present parasite antigen to sequestered and pathogenic Plasmodium-specific CD8(+) T cells. Infection of WT hosts with PMIF-deficient sporozoites or infection of Cd74(-/-) hosts with WT sporozoites impacted the survival of infected hepatocytes and subsequently reduced blood-stage associated inflammation, contributing to protection from ECM. We recapitulated these finding with a novel pharmacologic PMIF-selective antagonist that reduced PMIF/CD74 signaling and fully protected mice from ECM. These findings reveal a conserved mechanism for Plasmodium usurpation of host CD74 signaling and suggest a tractable approach for new pharmacologic intervention.	[Baeza Garcia, Alvaro; Siu, Edwin; Du, Xin; Leng, Lin; Bucala, Richard] Yale Sch Publ Hlth, Dept Internal Med, New Haven, CT 06520 USA; [Franke-Fayard, Blandine; Janse, Chris J.] Leiden Univ Med Ctr, Dept Parasitol, Leiden, Netherlands; [Howland, Shanshan W.; Renia, Laurent] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Lolis, Elias] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Bucala, Richard] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA	Yale University; Leiden University; Leiden University Medical Center (LUMC); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Yale University; Yale University	Garcia, AB; Bucala, R (corresponding author), Yale Sch Publ Hlth, Dept Internal Med, New Haven, CT 06520 USA.	alvaro.baeza-garcia@inserm.fr; richard.bucala@yale.edu	Howland, Shanshan W/I-2245-2014; Renia, Laurent/HCH-4853-2022	Howland, Shanshan W/0000-0003-4794-1564; Renia, Laurent/0000-0003-0349-1557; Baeza Garcia, Alvaro/0000-0001-6032-7847; Lolis, Elias/0000-0002-7902-7868; Bucala, Richard/0000-0001-5783-5736; Leng, Lin/0000-0002-0605-358X; Siu, Edwin/0000-0003-1046-2279	HHS | National Institutes of Health (NIH) [AI 5R01-51306--05, AI 2R01--042310--12]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS | National Institutes of Health (NIH), Grant/Award Number: AI 5R01-51306--05 and AI 2R01--042310--12	Ataide MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003885; Augustijn KD, 2007, INFECT IMMUN, V75, P1116, DOI 10.1128/IAI.00902-06; Aurrecoechea C, 2017, NUCLEIC ACIDS RES, V45, pD581, DOI 10.1093/nar/gkw1105; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Basha G, 2012, NAT IMMUNOL, V13, P237, DOI 10.1038/ni.2225; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Cho Y, 2010, P NATL ACAD SCI USA, V107, P11313, DOI 10.1073/pnas.1002716107; Cournia Z, 2009, J MED CHEM, V52, P416, DOI 10.1021/jm801100v; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; da Silva ML, 2012, TRAFFIC, V13, P1351, DOI 10.1111/j.1600-0854.2012.01398.x; Dahlgren MK, 2012, J MED CHEM, V55, P10148, DOI 10.1021/jm301269s; Fernandez-Ruiz D, 2017, J IMMUNOL, V199, P4165, DOI 10.4049/jimmunol.1700186; Fox RJ, 2016, CONTEMP CLIN TRIALS, V50, P166, DOI 10.1016/j.cct.2016.08.009; Garcia AB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05041-7; Han C, 2010, CLIN VACCINE IMMUNOL, V17, P1524, DOI 10.1128/CVI.00149-10; Howland SW, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004963; Howland SW, 2013, EMBO MOL MED, V5, P984, DOI 10.1002/emmm.201202273; Howland SW, 2015, SEMIN IMMUNOPATHOL, V37, P221, DOI 10.1007/s00281-015-0476-6; Kalantari P, 2014, CELL REP, V6, P196, DOI 10.1016/j.celrep.2013.12.014; Kamir D, 2008, J IMMUNOL, V180, P8250, DOI 10.4049/jimmunol.180.12.8250; Kaushansky A, 2015, INFECT IMMUN, V83, P39, DOI 10.1128/IAI.02230-14; Kaushansky A, 2013, CELL REP, V3, P630, DOI 10.1016/j.celrep.2013.02.010; Lang T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04581-2; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lee K, 2009, GLOB INST, P1; Leiriao P, 2005, CELL MICROBIOL, V7, P603, DOI 10.1111/j.1462-5822.2004.00490.x; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; McDevitt MA, 2015, J EXP MED, V212, P825, DOI 10.1084/jem.2005239804172015c; Miller JL, 2012, INFECT IMMUN, V80, P1399, DOI 10.1128/IAI.05861-11; Milner DA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00104; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Pantouris G, 2014, J MED CHEM, V57, P8652, DOI 10.1021/jm501168q; Prudencio M, 2011, TRENDS PARASITOL, V27, P565, DOI 10.1016/j.pt.2011.09.004; Riggle BA, 2020, J CLIN INVEST, V130, P1128, DOI 10.1172/JCI133474; Sato Y, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02554; SHACHAR I, 1995, IMMUNITY, V3, P373, DOI 10.1016/1074-7613(95)90121-3; Shaw TN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005210; Shin MS, 2019, ARTHRITIS RHEUMATOL, V71, P109, DOI 10.1002/art.40672; Strangward P, 2018, P NATL ACAD SCI USA, V115, P7404, DOI 10.1073/pnas.1801737115; Sun T, 2012, P NATL ACAD SCI USA, V109, pE2117, DOI 10.1073/pnas.1206573109; Tanese K, 2015, J INVEST DERMATOL, V135, P2775, DOI 10.1038/jid.2015.204; Thuma PE, 2011, J INFECT DIS, V203, P211, DOI 10.1093/infdis/jiq041; Topilski I, 2002, J IMMUNOL, V168, P1610, DOI 10.4049/jimmunol.168.4.1610; van de Sand C, 2005, MOL MICROBIOL, V58, P731, DOI 10.1111/j.1365-2958.2005.04888.x; Villegas-Mendez A, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.01035-16	46	3	3	5	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e21997	10.1096/fj.202101072R	http://dx.doi.org/10.1096/fj.202101072R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34719814	Green Accepted, Green Submitted			2022-12-28	WOS:000722321300036
J	Zhang, FZ; Yu, SS; Chai, QY; Wang, J; Wu, TY; Liu, RM; Liu, Y; Liu, CH; Pang, Y				Zhang, Fuzhen; Yu, Shanshan; Chai, Qiyao; Wang, Jing; Wu, Tuoya; Liu, Rongmei; Liu, Yi; Liu, Cui Hua; Pang, Yu			HDAC6 contributes to human resistance against Mycobacterium tuberculosis infection via mediating innate immune responses	FASEB JOURNAL			English	Article						histone deacetylase 6; innate immunity; mycobacterium tuberculosis; resister; tuberculosis	IN-VITRO; CELLS; DEACETYLASES; INHIBITOR	Tuberculosis (TB), which is caused by Mycobacterium tuberculosis (Mtb), remains a major cause of morbidity and mortality worldwide. Increasing lines of evidence indicate that certain individuals, which are termed resisters, are naturally resistant to TB infection. The resister phenotype has been linked to host efficient innate immune responses, but the underlying mechanisms and the key immune factors remain unclear. Here, we find that upon Mtb infection, monocyte-derived macrophages (MDMs) from TB resisters exhibited distinctly higher production of TNF-alpha, IL-1 beta and IL-6, higher ratio of bacteria in acidic vacuoles, and lower intracellular bacterial loads, as compared to that from the healthy controls, individuals with latent TB infection, and TB patients. Such enhanced anti-Mtb immune capacity of macrophages from resisters largely depends on histone deacetylase 6 (HDAC6), whose expression is specifically maintained in MDMs from TB resisters during Mtb infection. Furthermore, we demonstrate that HDAC6 is required for acidification of Mtb-containing phagosomes in macrophages, thus controlling the intracellular survival of Mtb. Taken together, these findings unravel an indispensable role of HDAC6 in human innate resistance against Mtb infection, suggesting that HDAC6 may serve as a marker for individual TB risk as well as a novel host-directed anti-TB therapeutic target.	[Zhang, Fuzhen; Yu, Shanshan; Wu, Tuoya; Liu, Rongmei; Liu, Yi; Pang, Yu] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing 101149, Peoples R China; [Chai, Qiyao; Wang, Jing; Liu, Cui Hua] Chinese Acad Sci, Ctr Biosafety Megasci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Liu, Cui Hua] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China	Capital Medical University; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Pang, Y (corresponding author), Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing 101149, Peoples R China.; Liu, CH (corresponding author), Chinese Acad Sci, Ctr Biosafety Megasci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.	liucuihua@im.ac.cn; pangyupound@163.com		liu, cui hua/0000-0002-8035-7792; Wu, Tuoya/0000-0002-2473-5189	National Key Research and Development Program of China [2017YFA0505900]; National Natural Science Foundation of China [81825014, 31830003, 82022041, 82072243, 82171744]; Beijing Hospitals Authority' Ascent Plan [DFL20191601]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Hospitals Authority' Ascent Plan	National Key Research and Development Program of China, Grant/Award Number: 2017YFA0505900; National Natural Science Foundation of China, Grant/Award Number: 81825014, 31830003, 82022041, 82072243 and 82171744; Beijing Hospitals Authority' Ascent Plan, Grant/Award Number: DFL20191601;	Al-Fifi ZIA, 1998, INSECT BIOCHEM MOLEC, V28, P201, DOI 10.1016/S0965-1748(98)00025-3; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Cadena AM, 2017, NAT REV IMMUNOL, V17, P691, DOI 10.1038/nri.2017.69; Chai QY, 2020, CELL MOL IMMUNOL, V17, P901, DOI 10.1038/s41423-020-0502-z; Chai QY, 2020, CELL MOL LIFE SCI, V77, P1859, DOI 10.1007/s00018-019-03353-5; Chai QY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09955-8; Chai QY, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00158; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot5571; Chee CBE, 2009, EUR J CLIN MICROBIOL, V28, P667, DOI 10.1007/s10096-008-0670-8; Chen H, 2019, J VIROL, V93, DOI 10.1128/JVI.01896-18; Chen YC, 2017, AM J TRANSL RES, V9, P1943; Cowley SC, 2003, J IMMUNOL, V171, P4689, DOI 10.4049/jimmunol.171.9.4689; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fuss Ivan J, 2009, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0701s85; Harris J, 2009, VET IMMUNOL IMMUNOP, V128, P37, DOI 10.1016/j.vetimm.2008.10.293; Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068; Hu YQ, 2017, ADV EXP MED BIOL, V1024, P91, DOI 10.1007/978-981-10-5987-2_4; Into T, 2010, J BIOL CHEM, V285, P35759, DOI 10.1074/jbc.M110.126904; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Lewis AJ, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010020; Liu CH, 2017, CELL MOL IMMUNOL, V14, P963, DOI 10.1038/cmi.2017.88; Ma NN, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-352; Malvaez M, 2013, P NATL ACAD SCI USA, V110, P2647, DOI 10.1073/pnas.1213364110; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Moores RC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00602; Moreno-Gonzalo O, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006799; New M, 2016, CANCER RES, V76, P6975, DOI 10.1158/0008-5472.CAN-16-0504; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Pauwels AM, 2017, TRENDS IMMUNOL, V38, P407, DOI 10.1016/j.it.2017.03.006; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Seshadri C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175844; Simmons JD, 2018, NAT REV IMMUNOL, V18, P575, DOI 10.1038/s41577-018-0025-3; Stein CM, 2018, AM J EPIDEMIOL, V187, P1477, DOI 10.1093/aje/kwx380; Verma D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12110-2; Wagstaff AJ, 2006, MOL DIAGN THER, V10, P57, DOI 10.1007/BF03256443; Wang J, 2015, NAT IMMUNOL, V16, P237, DOI 10.1038/ni.3096; World Health Organization (WHO), 2019, TUBERCULOSIS; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yao XY, 2017, TUBERCULOSIS, V107, P88, DOI 10.1016/j.tube.2017.07.013; Youn GS, 2015, GLIA, V63, P1953, DOI 10.1002/glia.22865; Zhang Q, 2019, NAT REV IMMUNOL, V19, P417, DOI 10.1038/s41577-019-0151-6; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	46	2	2	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e22009	10.1096/fj.202100614R	http://dx.doi.org/10.1096/fj.202100614R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34694026				2022-12-28	WOS:000712009200047
J	Zhang, Q; Xiao, XH; Zheng, J; Li, M; Yu, M; Ping, F; Wang, T; Wang, XJ				Zhang, Qian; Xiao, Xinhua; Zheng, Jia; Li, Ming; Yu, Miao; Ping, Fan; Wang, Tong; Wang, Xiaojing			Improvement in glucose metabolism in adult male offspring of maternal mice fed diets supplemented with inulin via regulation of the hepatic long noncoding RNA profile	FASEB JOURNAL			English	Article						ceRNA; diabetes; fetal programming; inulin; lncRNA	INSULIN-RESISTANCE; OVERWEIGHT; OBESITY	Maternal overnutrition during pregnancy and lactation is an important risk factor for the later development of metabolic disease, especially diabetes, among mothers and their offspring. As a fructan-type plant polysaccharide, inulin has prebiotic functions and is widely used as a natural antidiabetic supplement. However, to date, the mechanism of maternal inulin treatment in the livers of offspring has not been addressed, especially with respect to long noncoding RNAs (lncRNAs). In this study, female C57BL6/J mice were fed either a high-fat diet (HFD) with or without inulin supplementation or a standard rodent diet (SD) during gestation and lactation. After the offspring were weaned, they were fed a SD for 5 weeks. At 8 weeks of age, the glucose metabolism indexes of the offspring were assessed, and their livers were collected to assay lncRNA and mRNA profiles to investigate the effects of early maternal inulin intervention on offspring. Our results indicate that male offspring from HFD-fed dams displayed glucose intolerance and an insulin resistance phenotype at 8 weeks of age. Early maternal inulin intervention improved glucose metabolism in male offspring of mothers fed a HFD during gestation and lactation. The lncRNA and mRNA profile data revealed that compared with the offspring from HFD dams, offspring from the early inulin intervention dams had 99 differentially expressed hepatic lncRNAs and 529 differentially expressed mRNAs. The differentially expressed lncRNA-mRNA coexpression analysis demonstrated that early maternal inulin intervention may change hepatic lncRNA expression in offspring; there lncRNAs are involved in metabolic pathways and the AMP-activated protein kinase signaling pathway. Importantly, the early maternal inulin intervention alleviated glucose metabolism by inhibiting the lncRNA Serpina4-ps1/let-7b-5p/Ppargc1a as a competing endogenous RNA in male offspring.	[Zhang, Qian; Xiao, Xinhua; Zheng, Jia; Li, Ming; Yu, Miao; Ping, Fan; Wang, Tong; Wang, Xiaojing] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Key Lab Endocrinol,Minist Hlth,Dept Endocrinol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Xiao, XH (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Key Lab Endocrinol,Minist Hlth,Dept Endocrinol, Beijing 100730, Peoples R China.	xiaoxh2014@vip.163.com			National Natural Science Foundation of China [81870579, 81870545, 81570715, 81170736]; Beijing Natural Science Foundation [7202163]; Beijing Municipal Science & Technology Commission [Z201100005520011]; National Key R&D Program of China [2017YFC1309603]; National Key Research and Development Program of China [2016YFA0101002, 2018YFC2001100]; Scientific Activities Foundation for Selected Returned Overseas Professionals of Human Resources and Social Security Ministry, Beijing Dongcheng District Outstanding Talent Funding Project [2019DCT-M-05]; Medical Epigenetics Research Center, Chinese Academy of Medical Sciences [2017PT31036, 2018PT31021]; Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences [2017PT32020, 2018PT32001]; Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences [CIFMS2017-I2M-1-008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); National Key R&D Program of China; National Key Research and Development Program of China; Scientific Activities Foundation for Selected Returned Overseas Professionals of Human Resources and Social Security Ministry, Beijing Dongcheng District Outstanding Talent Funding Project; Medical Epigenetics Research Center, Chinese Academy of Medical Sciences; Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences; Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences	This work was supported by the grants from National Natural Science Foundation of China (Nos. 81870579, 81870545, 81570715, 81170736), Beijing Natural Science Foundation (7202163), Beijing Municipal Science & Technology Commission (Z201100005520011), National Key R&D Program of China (2017YFC1309603), National Key Research and Development Program of China (2016YFA0101002, 2018YFC2001100), Scientific Activities Foundation for Selected Returned Overseas Professionals of Human Resources and Social Security Ministry, Beijing Dongcheng District Outstanding Talent Funding Project (2019DCT-M-05), Medical Epigenetics Research Center, Chinese Academy of Medical Sciences (2017PT31036, 2018PT31021), the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (Nos. 2017PT32020, 2018PT32001), Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (CIFMS2017-I2M-1-008)	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anand A, 2021, LIFE-BASEL, V11, DOI 10.3390/life11010049; Anastasovska J, 2012, OBESITY, V20, P1016, DOI 10.1038/oby.2012.6; Boeijen LL, 2019, J VIROL, V93, DOI 10.1128/JVI.00575-18; Chen DL, 2019, EUR REV MED PHARMACO, V23, P5456, DOI 10.26355/eurrev_201906_18215; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067; Cribbs SK, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0147-4; Cui XW, 2018, J BIOL CHEM, V293, P4097, DOI 10.1074/jbc.M117.812818; Dendup T, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010078; Gao N, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.598817; Goyal N, 2019, J MOL MED, V97, P115, DOI 10.1007/s00109-018-1718-6; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hume MP, 2017, AM J CLIN NUTR, V105, P790, DOI 10.3945/ajcn.116.140947; Jiang LQ, 2013, AM J PHYSIOL-ENDOC M, V305, pE1359, DOI 10.1152/ajpendo.00236.2013; Kadayifci FZ, 2019, CURR GENOMICS, V20, P453, DOI 10.2174/1389202920666191009110724; Karagkouni D, 2020, NUCLEIC ACIDS RES, V48, pD101, DOI 10.1093/nar/gkz1036; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Laker RC, 2021, J APPL PHYSIOL, V130, P605, DOI 10.1152/japplphysiol.00641.2020; Levin BE, 2006, PHILOS T R SOC B, V361, P1107, DOI 10.1098/rstb.2006.1851; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li M, 2018, EUR REV MED PHARMACO, V22, P7883, DOI 10.26355/eurrev_201811_16414; Liu YZ, 2021, J EXP CLIN CANC RES, V40, DOI 10.1186/s13046-020-01798-2; Liyanarachchi S, 2016, J CLIN ENDOCR METAB, V101, P4005, DOI 10.1210/jc.2016-1991; Logan S, 2018, CELL PHYSIOL BIOCHEM, V49, P2496, DOI 10.1159/000493875; Long JY, 2016, J CLIN INVEST, V126, P4205, DOI 10.1172/JCI87927; Lucas A, 2000, AM J CLIN NUTR, V71, P602; Morris EM, 2012, AM J PHYSIOL-GASTR L, V303, pG979, DOI 10.1152/ajpgi.00169.2012; Nilsson E, 2015, J CLIN ENDOCR METAB, V100, pE1491, DOI 10.1210/jc.2015-3204; Nishimura Mie, 2015, J Tradit Complement Med, V5, P161, DOI 10.1016/j.jtcme.2014.11.016; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; Pool-Zobel BL, 2005, BRIT J NUTR, V93, pS73, DOI 10.1079/BJN20041349; Pradas-Juni M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14323-y; Santoro M, 2016, J MOL NEUROSCI, V59, P18, DOI 10.1007/s12031-016-0741-8; Sebastian-delaCruz M, 2021, NON-CODING RNA, V7, DOI 10.3390/ncrna7010003; Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359; Sun X, 2016, J CELL MOL MED, V20, P1779, DOI 10.1111/jcmm.12861; Vaiserman AM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030236; Yan CF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0321-7; Yang HY, 2012, BRIT J NUTR, V107, P749, DOI 10.1017/S0007114511005095; Yin LJ, 2021, CLIN CHIM ACTA, V515, P80, DOI 10.1016/j.cca.2021.01.001; Yun H, 2009, J MED FOOD, V12, P1023, DOI 10.1089/jmf.2009.0128; Zhang N, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120304; Zhang Q, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00871; Zhang Q, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101767; Zhou LY, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00292; Zhu X, 2019, INT J MOL MED, V43, P345, DOI 10.3892/ijmm.2018.3975; Zhu X, 2019, J CELL BIOCHEM, V120, P4192, DOI 10.1002/jcb.27706; Zhu X, 2016, BIOCHEM BIOPH RES CO, V469, P319, DOI 10.1016/j.bbrc.2015.11.048	49	0	0	5	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e22003	10.1096/fj.202100355RRR	http://dx.doi.org/10.1096/fj.202100355RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34706105				2022-12-28	WOS:000712009200039
J	Santos-Miranda, A; Costa, AD; Joviano-Santos, JV; Rhana, P; Bruno, AS; Rocha, P; Cau, SB; Vieira, LQ; Cruz, JS; Roman-Campos, D				Santos-Miranda, Artur; Costa, Alexandre D.; Joviano-Santos, Julliane, V; Rhana, Paula; Bruno, Alexandre Santos; Rocha, Peter; Cau, Stefany Bruno; Vieira, Leda Q.; Cruz, Jader S.; Roman-Campos, Danilo			Inhibition of calcium/calmodulin (Ca2+/CaM)-Calcium/calmodulin-dependent protein kinase II (CaMKII) axis reduces in vitro and ex vivo arrhythmias in experimental Chagas disease	FASEB JOURNAL			English	Article						arrhythmias; CAMKII; Chagas disease; chagasic cardiomyopathy; electrophysiology	ONSET ATRIAL-FIBRILLATION; QT SYNDROME TYPE-3; DIASTOLIC CA2+; HEART-FAILURE; CALCIUM; CARDIOMYOPATHY; DYSFUNCTION; MECHANISMS; MORBIDITY; MORTALITY	Chagasic cardiomyopathy (CCC) is one of the main causes of heart failure and sudden death in Latin America. To date, there is no available medication to prevent or reverse the onset of cardiac symptoms. CCC occurs in a scenario of disrupted calcium dynamics and enhanced oxidative stress, which combined, may favor the hyper activation of calcium/calmodulin (Ca2+/CaM)-calcium/calmodulin-dependent protein kinase II (CaMKII) (Ca2+/CaM-CaMKII) pathway, which is fundamental for heart physiology and it is implicated in other cardiac diseases. Here, we evaluated the association between Ca2+/CaM-CaMKII in the electro-mechanical (dys)function of the heart in the early stage of chronic experimental Trypanosoma cruzi infection. We observed that in vitro and ex vivo inhibition of Ca2+/CaM-CaMKII reversed the arrhythmic profile of isolated hearts and isolated left-ventricles cardiomyocytes. The benefits of the limited Ca2+/CaM-CaMKII activation to cardiomyocytes' electrical properties are partially related to the restoration of Ca2+ dynamics in a damaged cellular environment created after T. cruzi infection. Moreover, Ca2+/CaM-CaMKII inhibition prevented the onset of arrhythmic contractions on isolated heart preparations of chagasic mice and restored the responsiveness to the increase in the left-ventricle pre-load. Taken together, our data provide the first experimental evidence for the potential of targeting Ca2+/CaM-CaMKII pathway as a novel therapeutic target to treat CCC.	[Santos-Miranda, Artur; Joviano-Santos, Julliane, V; Roman-Campos, Danilo] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Costa, Alexandre D.] Univ Fed Minas Gerais, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil; [Rhana, Paula; Rocha, Peter; Vieira, Leda Q.; Cruz, Jader S.] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [Bruno, Alexandre Santos; Cau, Stefany Bruno] Univ Fed Minas Gerais, Dept Pharmacol, Belo Horizonte, MG, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Roman-Campos, D (corresponding author), Univ Fed Sao Paulo, Lab CardioBiol, Edificio Ciencias BiornediLms, Rua Botucatu 862, BR-04023062 Sao Paulo, SP, Brazil.; Cruz, JS (corresponding author), Univ Fed Minas Gerais, Dept Biochem & Immunol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.	jcruz@ufmg.br; drcampos@unifesp.br	Joviano-Santos, Julliane Vasconcelos/S-4749-2018; Cau, Stefany/AAL-3224-2021; Miranda, Artur S/S-5848-2018	Joviano-Santos, Julliane Vasconcelos/0000-0002-5788-6223; Cau, Stefany/0000-0002-0442-739X; Miranda, Artur S/0000-0001-6458-4592; Roman-Campos, Danilo/0000-0002-2690-912X	State Funding of Sao Paulo [FAPESP] [2019/21304-4]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG - PRONEX); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [312474/2017-2, 437969/2018-5, 304257/2020-6]; FAPESP [2018/20777-3, 2018/22830-9]	State Funding of Sao Paulo [FAPESP]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG - PRONEX)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the State Funding of Sao Paulo [FAPESP #2019/21304-4 to DRC], Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG - PRONEX to LQV and JSC) and CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico to JSC (Grants #312474/2017-2 and #437969/2018-5) and to DRC (#304257/2020-6). ASM holds a Fellowship from FAPESP [grant #2018/22830-9]; JVJS holds a Fellowship from FAPESP [grant #2018/20777-3]	ANDRADE S G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P29, DOI 10.1590/S0074-02761986000100004; Barros M V L, 2004, Eur J Echocardiogr, V5, P182, DOI 10.1016/S1525-2167(03)00078-7; Beckendorf J, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-018-0688-8; Benchimol-Barbosa PR, 2008, INT J CARDIOL, V127, pE113, DOI 10.1016/j.ijcard.2007.04.103; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Chao C, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165689; Chelu MG, 2009, J CLIN INVEST, V119, P1940, DOI 10.1172/JCI37059; Chu PY, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00117; Cuello F, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0582-1; DIAS J C P, 1968, Revista do Instituto de Medicina Tropical de Sao Paulo, V10, P158; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Eisner DA, 2006, HEART RHYTHM, V3, P743, DOI 10.1016/j.hrthm.2005.12.020; Enriquez A, 2014, AM J CARDIOL, V113, P1740, DOI 10.1016/j.amjcard.2014.02.036; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Erickson JR, 2011, PHYSIOL REV, V91, P889, DOI 10.1152/physrev.00018.2010; Fredj S, 2006, CIRC RES, V99, P1225, DOI 10.1161/01.RES.0000251305.25604.b0; Howe CJ, 2004, J BIOL CHEM, V279, P44573, DOI 10.1074/jbc.M404175200; Johnson CN, 2019, CELL CALCIUM, V82, DOI 10.1016/j.ceca.2019.102063; LAI Y, 1987, P NATL ACAD SCI USA, V84, P5710, DOI 10.1073/pnas.84.16.5710; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Laurita KR, 2008, PROG BIOPHYS MOL BIO, V97, P332, DOI 10.1016/j.pbiomolbio.2008.02.014; Lindegger N, 2009, J MOL CELL CARDIOL, V47, P326, DOI 10.1016/j.yjmcc.2009.04.003; Ljubojevic S, 2011, BIOPHYS J, V100, P2356, DOI 10.1016/j.bpj.2011.03.060; Lopez JR, 2011, REV ESP CARDIOL, V64, P456, DOI [10.1016/j.recesp.2011.01.008, 10.1016/j.rec.2011.01.008]; Machado FS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000539; MAGUIRE JH, 1987, CIRCULATION, V75, P1140, DOI 10.1161/01.CIR.75.6.1140; Manne-Goehler J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005033; Marcolino MS, 2015, GLOB HEART, V10, P167, DOI 10.1016/j.gheart.2015.07.001; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Meissner G, 2010, CURR TOP MEMBR, V66, P91, DOI 10.1016/S1063-5823(10)66005-X; Michailowsky V, 2001, AM J PATHOL, V159, P1723, DOI 10.1016/S0002-9440(10)63019-2; Mijares A, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008162; Mills RM, 2020, AM J MED, V133, P1262, DOI 10.1016/j.amjmed.2020.05.022; Nascimento CAS, 2013, J AM SOC ECHOCARDIOG, V26, P1424, DOI 10.1016/j.echo.2013.08.018; Neef S, 2010, CIRC RES, V106, P1134, DOI 10.1161/CIRCRESAHA.109.203836; NOLASCO JB, 1968, J APPL PHYSIOL, V25, P191, DOI 10.1152/jappl.1968.25.2.191; Nunes MCP, 2018, CIRCULATION, V138, pE169, DOI 10.1161/CIR.0000000000000599; Nunes MCP, 2013, J AM COLL CARDIOL, V62, P767, DOI 10.1016/j.jacc.2013.05.046; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; Pogwizd SM, 1999, CIRC RES, V85, P1009; Rassi A, 2009, MEM I OSWALDO CRUZ, V104, P152, DOI 10.1590/S0074-02762009000900021; Ribeiro AL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002078; Ribeiro AL, 2012, NAT REV CARDIOL, V9, P576, DOI 10.1038/nrcardio.2012.109; Ribeiro ALP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000632; Rincon LG, 2006, REV SOC BRAS MED TRO, V39, P245, DOI 10.1590/S0037-86822006000300003; Roman-Campos D, 2013, INT J CARDIOL, V167, P3011, DOI 10.1016/j.ijcard.2012.09.020; Roman-Campos D, 2013, MEM I OSWALDO CRUZ, V108, P243, DOI 10.1590/0074-0276108022013019; Roman-Campos D, 2009, BASIC RES CARDIOL, V104, P238, DOI 10.1007/s00395-009-0776-x; Santos-Miranda A, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008379; Shioya T, 2007, J PHYSIOL SCI, V57, P327, DOI 10.2170/physiolsci.RP010107; Swaminathan PD, 2012, CIRC RES, V110, P1661, DOI 10.1161/CIRCRESAHA.111.243956; Vilar-Pereira G, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005947; Weiss JN, 2011, CIRC RES, V108, P98, DOI 10.1161/CIRCRESAHA.110.223586; Wen JJ, 2004, FREE RADICAL BIO MED, V37, P2072, DOI 10.1016/j.freeradbiomed.2004.09.011; Wen JJ, 2004, FREE RADICAL BIO MED, V37, P1821, DOI 10.1016/j.freeradbiomed.2004.08.018; WIT AL, 1992, CIRCULATION, V85, P32; Wit AL, 2017, ELECTROPHYSIOLOGICAL; Wong MH, 2019, J MOL BIOL, V431, P1440, DOI 10.1016/j.jmb.2019.02.001; World Health Organization (WHO), 2018, FACT SHEET CHAG DIS; Zhang T, 2004, CARDIOVASC RES, V63, P476, DOI 10.1016/j.cardiores.2004.04.026	60	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21901	10.1096/fj.202101060R	http://dx.doi.org/10.1096/fj.202101060R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34569665				2022-12-28	WOS:000702238200062
J	Langer, HT; Mossakowski, AA; Avey, AM; Wohlgemuth, RP; Smith, LR; Zbinden-Foncea, H; Baar, K				Langer, Henning T.; Mossakowski, Agata A.; Avey, Alec M.; Wohlgemuth, Ross P.; Smith, Lucas R.; Zbinden-Foncea, Herman; Baar, Keith			A mutation in desmin makes skeletal muscle less vulnerable to acute muscle damage after eccentric loading in rats	FASEB JOURNAL			English	Article						exercise; filament; injury; intermediate; muscle; signaling	INTERMEDIATE-FILAMENTS; SARCOMERE-LENGTH; EXERCISE; RESISTANCE; TITIN; REGENERATION; CYTOSKELETON; CONTRACTILE; METABOLISM; EXPRESSION	Desminopathy is the most common intermediate filament disease in humans. The most frequent mutation causing desminopathy in patients is a R350P DES missense mutation. We have developed a rat model with an analogous mutation in R349P Des. To investigate the role of R349P Des in mechanical loading, we stimulated the sciatic nerve of wild-type littermates (WT) (n = 6) and animals carrying the mutation (MUT) (n = 6) causing a lengthening contraction of the dorsi flexor muscles. MUT animals showed signs of ongoing regeneration at baseline as indicated by a higher number of central nuclei (genotype: P < .0001). While stimulation did not impact central nuclei, we found an increased number of IgG positive fibers (membrane damage indicator) after eccentric contractions with both genotypes (stimulation: P < .01). Interestingly, WT animals displayed a more pronounced increase in IgG positive fibers with stimulation compared to MUT (interaction: P < .05). In addition to altered histology, molecular signaling on the protein level differed between WT and MUT. The membrane repair protein dysferlin decreased with eccentric loading in WT but increased in MUT (interaction: P < .05). The autophagic substrate p62 was increased in both genotypes with loading (stimulation: P < .05) but tended to be more elevated in WT (interaction: P = .05). Caspase 3 levels, a central regulator of apoptotic cell death, was increased with stimulation in both genotypes (stimulation: P < .01) but more so in WT animals (interaction: P < .0001). Overall, our data indicate that R349P Des rats have a lower susceptibility to structural muscle damage of the cytoskeleton and sarcolemma with acute eccentric loading.	[Langer, Henning T.; Baar, Keith] Univ Calif Davis, Dept Physiol & Membrane Biol, Funct Mol Biol Lab, Davis, CA 95616 USA; [Mossakowski, Agata A.; Avey, Alec M.; Wohlgemuth, Ross P.; Smith, Lucas R.; Baar, Keith] Univ Calif Davis, Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Mossakowski, Agata A.] Charite Univ Med Berlin, Berlin, Germany; [Mossakowski, Agata A.] Free Univ Berlin, Berlin, Germany; [Mossakowski, Agata A.] Humboldt Univ, Berlin, Germany; [Mossakowski, Agata A.] Berlin Inst Hlth, Berlin, Germany; [Baar, Keith] VA Northern Calif Hlth Care Syst, Mather, CA USA; [Zbinden-Foncea, Herman] Univ Finis Terrae, Sch Kinesiol, Exercise Physiol Lab, Santiago, Chile	University of California System; University of California Davis; University of California System; University of California Davis; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Universidad Finis Terrae	Langer, HT (corresponding author), Univ Calif Davis, Dept Physiol & Membrane Biol, Funct Mol Biol Lab, Davis, CA 95616 USA.	htlanger@ucdavis.edu	; Smith, Lucas/S-2157-2018	Mossakowski, Agata/0000-0001-5792-4501; Smith, Lucas/0000-0002-7610-4231	National Institute of Aging [R01AG056999, R01AG45375]; Deutsche Forschungsgemeinschaft	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The current study was funded by a generous gift from the Bertin-Barbe Family to HZF, and KB. The work was further supported by the National Institute of Aging through project grants (R01AG056999 and R01AG45375). AAM was supported by a postdoctoral fellowship from Deutsche Forschungsgemeinschaft	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Bar H, 2005, HUM MOL GENET, V14, P1251, DOI 10.1093/hmg/ddi136; Barash IA, 2002, AM J PHYSIOL-REG I, V283, pR958, DOI 10.1152/ajpregu.00185.2002; BENOIT PW, 1970, J ANAT, V107, P547; Bhosle RC, 2006, BIOCHEM BIOPH RES CO, V346, P768, DOI 10.1016/j.bbrc.2006.05.192; Bonnemann CG, 2014, NEUROMUSCULAR DISORD, V24, P289, DOI 10.1016/j.nmd.2013.12.011; Bonakdar N, 2012, BIOCHEM BIOPH RES CO, V419, P703, DOI 10.1016/j.bbrc.2012.02.083; Bostock EL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121947; Brashear SE, 2021, J PHYSIOL-LONDON, V599, P943, DOI 10.1113/JP280656; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Brynnel A, 2018, ELIFE, V7, DOI 10.7554/eLife.40532; Burkholder TJ, 2001, J EXP BIOL, V204, P1529; Capetanaki Y, 1997, CELL STRUCT FUNCT, V22, P103, DOI 10.1247/csf.22.103; Capetanaki Y, 2002, TRENDS CARDIOVAS MED, V12, P339, DOI 10.1016/S1050-1738(02)00184-6; Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033; Clemen CS, 2015, ACTA NEUROPATHOL, V129, P297, DOI 10.1007/s00401-014-1363-2; Clemen CS, 2013, ACTA NEUROPATHOL, V125, P47, DOI 10.1007/s00401-012-1057-6; COLLIS WJ, 1968, NEUROLOGY, V18, P915, DOI 10.1212/WNL.18.9.915; Creemers LB, 1997, BIOTECHNIQUES, V22, P656, DOI 10.2144/97224bm19; Damas F, 2016, J PHYSIOL-LONDON, V594, P5209, DOI 10.1113/JP272472; Diermeier S, 2017, NEUROBIOL AGING, V58, P77, DOI 10.1016/j.neurobiolaging.2017.06.001; Galler S, 1998, ACTA PHYSIOL SCAND, V162, P119; Gilda JE, 2013, ANAL BIOCHEM, V440, P186, DOI 10.1016/j.ab.2013.05.027; GOEBEL HH, 1993, VIRCHOWS ARCH B, V64, P127, DOI 10.1007/BF02915105; GOLDMAN YE, 1984, J PHYSIOL-LONDON, V350, P497, DOI 10.1113/jphysiol.1984.sp015215; Gottlieb RA, 2015, CIRC RES, V116, P504, DOI 10.1161/CIRCRESAHA.116.303787; Henderson M, 2013, ACTA NEUROPATHOL, V125, P917, DOI 10.1007/s00401-013-1113-x; Hoffmann C, 2014, MOL CELL BIOL, V34, P3053, DOI 10.1128/MCB.00651-14; Hughes DC, 2018, J PHYSIOL-LONDON, V596, P2883, DOI 10.1113/JP275833; KarisAllen JJ, 2020, J BIOMECH, V104, DOI 10.1016/j.jbiomech.2020.109720; Keller S., 2014, GC MS AND LC MS BASE; KIRWAN JP, 1992, J APPL PHYSIOL, V72, P2197, DOI 10.1152/jappl.1992.72.6.2197; Knoll R, 2010, CIRC RES, V106, P695, DOI 10.1161/CIRCRESAHA.109.206243; Lahmers S, 2004, CIRC RES, V94, P505, DOI 10.1161/01.RES.0000115522.52554.86; Langer HT, 2020, J CACHEXIA SARCOPENI, V11, P1364, DOI 10.1002/jcsm.12619; Langer HT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58213-1; LIEBER RL, 1994, J APPL PHYSIOL, V77, P1926, DOI 10.1152/jappl.1994.77.4.1926; Linke WA, 2018, ANNU REV PHYSIOL, V80, P389, DOI 10.1146/annurev-physiol-021317-121234; Lorenzon A, 2013, AM J CARDIOL, V111, P400, DOI 10.1016/j.amjcard.2012.10.017; Lovering RM, 2004, AM J PHYSIOL-CELL PH, V286, pC230, DOI 10.1152/ajpcell.00199.2003; Meyer GA, 2012, AM J PHYSIOL-CELL PH, V302, pC1609, DOI 10.1152/ajpcell.00441.2011; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Mutlak YE, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14895-9; Ottenheijm CAC, 2009, BIOPHYS J, V97, P2277, DOI 10.1016/j.bpj.2009.07.041; Pigna E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26991; Roche SM, 2015, JOVE-J VIS EXP, DOI 10.3791/52695; Sam M, 2000, AM J PHYSIOL-CELL PH, V279, pC1116, DOI 10.1152/ajpcell.2000.279.4.C1116; SCHMALBRUCH H, 1976, TISSUE CELL, V8, P673, DOI 10.1016/0040-8166(76)90039-2; Schneider SM, 2018, MOL IMAGING BIOL, V20, P780, DOI 10.1007/s11307-018-1174-2; Shah SB, 2003, J HISTOCHEM CYTOCHEM, V51, P19, DOI 10.1177/002215540305100104; Shinde A, 2008, NEUROMUSCULAR DISORD, V18, P215, DOI 10.1016/j.nmd.2007.12.006; Smith LR, 2014, AM J PHYSIOL-CELL PH, V306, pC889, DOI 10.1152/ajpcell.00383.2013; SOLARO RJ, 1971, BIOCHIM BIOPHYS ACTA, V245, P259, DOI 10.1016/0005-2728(71)90033-8; Tomalka A, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2497; Vafiadaki E, 2015, GENE, V566, P1, DOI 10.1016/j.gene.2015.04.077; Walter MC, 2007, BRAIN, V130, P1485, DOI 10.1093/brain/awm039; Weber-Carstens S, 2013, AM J RESP CRIT CARE, V187, P387, DOI 10.1164/rccm.201209-1649OC; West DWD, 2016, J PHYSIOL-LONDON, V594, P453, DOI 10.1113/JP271365; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; WONG TS, 1990, J APPL PHYSIOL, V69, P1718, DOI 10.1152/jappl.1990.69.5.1718; Xiao YZ, 2019, RHEUMATOLOGY, V58, P1474, DOI 10.1093/rheumatology/kez085	61	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21860	10.1096/fj.202100711RR	http://dx.doi.org/10.1096/fj.202100711RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34411340	Green Published, hybrid			2022-12-28	WOS:000691122900044
J	Lee, HJ; Seo, M; Choi, HJ; Rengaraj, D; Jung, KM; Park, JS; Lee, KY; Kim, YM; Park, KJ; Han, ST; Lee, KH; Yao, HHC; Han, JY				Lee, Hong Jo; Seo, Minseok; Choi, Hee Jung; Rengaraj, Deivendran; Jung, Kyung Min; Park, Jin Se; Lee, Kyung Youn; Kim, Young Min; Park, Kyung Je; Han, Soo Taek; Lee, Kyu Hyuk; Yao, Humphrey Hung-Chang; Han, Jae Yong			DMRT1 gene disruption alone induces incomplete gonad feminization in chicken	FASEB JOURNAL			English	Article						chicken; DMRT1; genome editing; sex determination	EXPRESSION PATTERN; SEX DETERMINATION; NONCODING RNA; MALE PATHWAY; DNA-BINDING; GERM-CELLS; CHROMOSOME; PROTEIN; SUGGESTS; REGION	Compared with the well-described XY sex determination system in mammals, the avian ZW sex determination system is poorly understood. Knockdown and overexpression studies identified doublesex and mab-3-related transcription factor 1 (DMRT1) as the testis-determining gene in chicken. However, the detailed effects of DMRT1 gene disruption from embryonic to adult development are not clear. Herein, we have generated DMRT1-disrupted chickens using the clustered regularly interspaced short palindromic repeats-associated protein 9 system, followed by an analysis of physiological, hormonal, and molecular changes in the genome-modified chickens. In the early stages of male chicken development, disruption of DMRT1 induced gonad feminization with extensive physiological and molecular changes; however, functional feminine reproductivity could not be implemented with disturbed hormone synthesis. Subsequent RNA-sequencing analysis of the DMRT1-disrupted chicken gonads revealed gene networks, including several novel genes linearly and non-linearly associated with DMRT1, which are involved in gonad feminization. By comparing the gonads of wild type with the genome-modified chickens, a set of genes were identified that is involved in the ZW sex determination system independent of DMRT1. Our results extend beyond the Z-dosage hypothesis to provide further information about the avian ZW sex determination system and epigenetic effects of gonad feminization.	[Lee, Hong Jo; Choi, Hee Jung; Rengaraj, Deivendran; Jung, Kyung Min; Park, Jin Se; Lee, Kyung Youn; Kim, Young Min; Park, Kyung Je; Han, Soo Taek; Lee, Kyu Hyuk; Han, Jae Yong] Seoul Natl Univ, Dept Agr Biotechnol, 1 Gwanak Ro, Seoul 08826, South Korea; [Lee, Hong Jo; Choi, Hee Jung; Rengaraj, Deivendran; Jung, Kyung Min; Park, Jin Se; Lee, Kyung Youn; Kim, Young Min; Park, Kyung Je; Han, Soo Taek; Lee, Kyu Hyuk; Han, Jae Yong] Seoul Natl Univ, Res Inst Agr & Life Sci, 1 Gwanak Ro, Seoul 08826, South Korea; [Seo, Minseok] Korea Univ, Dept Comp Convergence Software, Sejong Metropolitan City, South Korea; [Yao, Humphrey Hung-Chang] NIEHS, Reprod Dev Biol Grp, Durham, NC USA	Seoul National University (SNU); Seoul National University (SNU); Korea University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Han, JY (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, 1 Gwanak Ro, Seoul 08826, South Korea.; Han, JY (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, 1 Gwanak Ro, Seoul 08826, South Korea.	jaehan@snu.ac.kr	Rengaraj, Deivendran/C-5593-2015	Rengaraj, Deivendran/0000-0001-9274-9921; Jung, Kyung Min/0000-0002-5791-2655	National Research Foundation of Korea (NRF) [2015R1A3A2033826]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 2015R1A3A2033826	Aoyama S, 2003, CYTOGENET GENOME RES, V101, P295, DOI 10.1159/000074352; Ayers KL, 2015, DEV BIOL, V400, P224, DOI 10.1016/j.ydbio.2015.02.001; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNETT CP, 1993, J MED GENET, V30, P518, DOI 10.1136/jmg.30.6.518; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; CLIFTON VL, 1995, EUR J ENDOCRINOL, V133, P591, DOI 10.1530/eje.0.1330591; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; De Grandi A, 2000, MECH DEVELOP, V90, P323, DOI 10.1016/S0925-4773(99)00282-8; de Santa Barbara P, 2000, DEV DYNAM, V217, P293, DOI 10.1002/(SICI)1097-0177(200003)217:3<293::AID-DVDY7>3.0.CO;2-P; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; ELBRECHT A, 1992, SCIENCE, V255, P467, DOI 10.1126/science.1734525; Elzaiat M, 2017, CLIN GENET, V91, P173, DOI 10.1111/cge.12862; Estermann MA, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.055; Farboud B, 2013, GENE DEV, V27, P1159, DOI 10.1101/gad.217026.113; Fischer AJ, 2011, NEUROSCIENCE, V178, P250, DOI 10.1016/j.neuroscience.2011.01.022; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Ge CT, 2017, DEVELOPMENT, V144, P2222, DOI 10.1242/dev.152033; Gil N, 2020, NAT REV GENET, V21, P102, DOI 10.1038/s41576-019-0184-5; Guioli S, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.181693; HAQQ CM, 1994, SCIENCE, V266, P1494, DOI 10.1126/science.7985018; Ioannidis J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2020909118; Jorgensen A, 2012, MOL HUM REPROD, V18, P523, DOI 10.1093/molehr/gas030; Kang SH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17418-8; Kettlewell JR, 2000, GENESIS, V26, P174, DOI 10.1002/(SICI)1526-968X(200003)26:3<174::AID-GENE2>3.0.CO;2-J; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim M, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007842; Kim S, 2007, DEV BIOL, V307, P314, DOI 10.1016/j.ydbio.2007.04.046; Kim YM, 2017, J ANIM SCI, V95, P3479, DOI [10.2527/jas.2017.1418, 10.2527/jas2017.1418]; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Krentz AD, 2011, DEV BIOL, V356, P63, DOI 10.1016/j.ydbio.2011.05.658; Lambeth LS, 2014, DEV BIOL, V389, P160, DOI 10.1016/j.ydbio.2014.02.012; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee HJ, 2019, FASEB J, V33, P8519, DOI 10.1096/fj.201802671R; Lee HJ, 2016, FASEB J, V30, P555, DOI 10.1096/fj.15-274712; Lee HC, 2016, STEM CELLS DEV, V25, P68, DOI 10.1089/scd.2015.0208; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin QH, 2017, GENETICS, V207, P1007, DOI 10.1534/genetics.117.300274; Lin X, 2018, AGING-US, V10, P819, DOI 10.18632/aging.101436; Loda A, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008333; Marchand O, 2000, BBA-GENE STRUCT EXPR, V1493, P180, DOI 10.1016/S0167-4781(00)00186-X; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Moniot B, 2000, MECH DEVELOP, V91, P323, DOI 10.1016/S0925-4773(99)00267-1; Morris KR, 2018, ENDOCRINOLOGY, V159, P3492, DOI 10.1210/en.2018-00553; Murphy MW, 2015, NAT STRUCT MOL BIOL, V22, P442, DOI 10.1038/nsmb.3032; Murphy MW, 2010, P NATL ACAD SCI USA, V107, P13360, DOI 10.1073/pnas.1006243107; Ogawa A, 1997, CHROMOSOME RES, V5, P93, DOI 10.1023/A:1018461906913; Prestel M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-216; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Raymond CS, 1999, DEV BIOL, V215, P208, DOI 10.1006/dbio.1999.9461; Rengaraj D, 2015, J PROTEOME RES, V14, P3503, DOI 10.1021/acs.jproteome.5b00491; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roeszler KN, 2012, DEV BIOL, V366, P317, DOI 10.1016/j.ydbio.2012.03.025; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Smith CA, 1999, NATURE, V402, P601, DOI 10.1038/45130; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Stern CD, 1998, CURR TOP DEV BIOL, V36, P223; Takashima S, 2013, GENE DEV, V27, P1949, DOI 10.1101/gad.220194.113; Teranishi M, 2001, CHROMOSOME RES, V9, P147, DOI 10.1023/A:1009235120741; Veitia R, 1997, GENOMICS, V41, P271, DOI 10.1006/geno.1997.4648; Webster KA, 2017, DEV BIOL, V422, P33, DOI 10.1016/j.ydbio.2016.12.008; Yoshimoto S, 2010, DEVELOPMENT, V137, P2519, DOI 10.1242/dev.048751; Zarkower D, 2013, CURR TOP DEV BIOL, V102, P327, DOI 10.1016/B978-0-12-416024-8.00012-X; Zhao D, 2010, NATURE, V464, P237, DOI 10.1038/nature08852; Zuo EW, 2020, NAT PROTOC, V15, P3009, DOI 10.1038/s41596-020-0361-1	72	4	4	8	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21876	10.1096/fj.202100902R	http://dx.doi.org/10.1096/fj.202100902R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34449112				2022-12-28	WOS:000691122900060
J	Li, CL; Guan, X; Jing, HG; Xiao, X; Jin, H; Xiong, JS; Ai, SQ; Wang, YJ; Su, TQ; Sun, GY; Fu, TJ; Wang, YJ; Guo, SL; Liang, P				Li, Chenlong; Guan, Xue; Jing, Hanguang; Xiao, Xu; Jin, Hua; Xiong, Jinsheng; Ai, Siqi; Wang, Yingjie; Su, Tianqi; Sun, Guiyin; Fu, Tianjiao; Wang, Yujie; Guo, Shouli; Liang, Peng			Circular RNA circBFAR promotes glioblastoma progression by regulating a miR-548b/FoxM1 axis	FASEB JOURNAL			English	Article						circBFAR; FoxM1; glioma; miR-548b; proliferation	CELL-PROLIFERATION; GASTRIC-CANCER; IN-VITRO; EXPRESSION; DIAGNOSIS; MIRNA; GLYCOLYSIS; DISCOVERY; APOPTOSIS; BIOMARKER	Glioblastoma multiforme (GBM) is the most common and aggressive type of tumor of the primary nervous system. Treatment options for GBM include surgery, chemotherapy, and radiation therapy; however, the clinical outcomes are poor, with a high rate of recurrence. An increasing number of studies have shown that circular RNAs (circRNAs) serve important roles in several types of cancer. Gene Expression Omnibus (GEO) database was utilized to identify the differentially expressed circRNAs and their biological functions. Then, we detected the circular RNA bifunctional apoptosis regulator (circBFAR) was significantly increased in three GEO datasets. However, the role of circBFAR has not been reported in GBM. In this study, the expression of circBFAR was significantly increased both in GBM tissues or cell lines and was negatively correlated with overall survival in patients with GBM. Knockdown of circBFAR inhibited proliferation and invasion both in vitro and in vivo. Increased expression of circBFAR resulted in a reduction of miR-548b expression in glioma cells. A luciferase reporter and RIP assay indicated that miR-548b was a direct target of circBFAR, and miR-548b may negatively regulate the expression of FoxM1. Rescue experiments showed that overexpression of FoxM1 could counter the effect of circBFAR silencing on the proliferation and invasion of glioma cell lines. Moreover, we identified that circBFAR regulates FoxM1 by interacting with miR-548b in glioma cells. In conclusion, the present study demonstrated that a circBFAR/miR-548b/FoxM1 axis regulates the development of GBM and highlights potentially novel therapeutic targets for the treatment of GBM.	[Li, Chenlong; Xiao, Xu; Jin, Hua; Xiong, Jinsheng; Ai, Siqi; Wang, Yingjie; Su, Tianqi; Sun, Guiyin; Fu, Tianjiao; Wang, Yujie; Liang, Peng] Harbin Med Univ, Dept Neurosurg, Canc Hosp, 150 Haping Rd, Harbin 150086, Heilongjiang, Peoples R China; [Guan, Xue] Harbin Med Univ, Anim Lab Ctr, Affiliated Hosp 2, Harbin, Peoples R China; [Jing, Hanguang] Guangdong Prov Hosp Tradit Chinese Med, Lin Yi Famous Doctor Studio, Breast Surg, Guangzhou, Peoples R China; [Guo, Shouli] Harbin Med Univ, Anim Expt Ctr, Affiliated Hosp 2, 256 Xuefu Rd, Harbin 150086, Lleilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Guangzhou University of Chinese Medicine; Harbin Medical University	Liang, P (corresponding author), Harbin Med Univ, Dept Neurosurg, Canc Hosp, 150 Haping Rd, Harbin 150086, Heilongjiang, Peoples R China.; Guo, SL (corresponding author), Harbin Med Univ, Anim Expt Ctr, Affiliated Hosp 2, 256 Xuefu Rd, Harbin 150086, Lleilongjiang, Peoples R China.	gsljkjy@126.com; liangpengd@yahoo.com		li, chenlong/0000-0002-1822-928X	Haiyan Fund Project of Harbin Medical University Cancer Hospital [JJMS2021-08]; Heilongjiang Provincial Postdoctoral Science Foundation (Heilongjiang Postdoctoral Science Foundation) [LBH-Z20073]; Postdoctoral Research Foundation of China (China Postdoctoral Research Foundation) [2021M693819]; Top Young Talents Program of Harbin Medical University Cancer Hospital [BJQN2021-05]; Natural Science Foundation of Heilongjiang Province [JJ2021LH1458]	Haiyan Fund Project of Harbin Medical University Cancer Hospital; Heilongjiang Provincial Postdoctoral Science Foundation (Heilongjiang Postdoctoral Science Foundation); Postdoctoral Research Foundation of China (China Postdoctoral Research Foundation); Top Young Talents Program of Harbin Medical University Cancer Hospital; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	Haiyan Fund Project of Harbin Medical University Cancer Hospital, Grant/Award Number: JJMS2021-08; Heilongjiang Provincial Postdoctoral Science Foundation (Heilongjiang Postdoctoral Science Foundation), Grant/Award Number: LBH-Z20073; Postdoctoral Research Foundation of China (China Postdoctoral Research Foundation), Grant/Award Number: 2021M693819; The Top Young Talents Program of Harbin Medical University Cancer Hospital, Grant/Award Number: BJQN2021-05; Natural Science Foundation of Heilongjiang Province, Grant/Award Number: JJ2021LH1458	Barbagallo I, 2015, ACTA HISTOCHEM, V117, P705, DOI 10.1016/j.acthis.2015.09.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianchini M, 2006, INT J ONCOL, V29, P83; Burri SH, 2018, AM J CLIN ONCOL-CANC, V41, P191, DOI 10.1097/COC.0000000000000395; Castaneda CA, 2011, EXPERT REV ANTICANC, V11, P1265, DOI [10.1586/era.11.40, 10.1586/ERA.11.40]; Chen HW, 2019, ONCOL LETT, V17, P5343, DOI 10.3892/ol.2019.10235; Chen X, 2018, CLIN CANCER RES, V24, P6319, DOI 10.1158/1078-0432.CCR-18-1270; Deng Z, 2019, J NEURORESTORATOLOGY, V7, P143, DOI 10.26599/JNR.2019.9040015; Di Fruscia P, 2015, CHEMMEDCHEM, V10, P69, DOI 10.1002/cmdc.201402431; Dong SQ, 2019, FEBS OPEN BIO, V9, P519, DOI 10.1002/2211-5463.12592; Fanale D, 2018, ADV EXP MED BIOL, V1087, P109, DOI 10.1007/978-981-13-1426-1_9; Guo XF, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01196-4; Han W, 2020, ONCOTARGETS THER, V13, P6937, DOI 10.2147/OTT.S260376; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hawkins SFC, 2017, METHODS MOL BIOL, V1546, P125, DOI 10.1007/978-1-4939-6730-8_8; Hou NY, 2018, CLIN EXP PHARMACOL P, V45, P729, DOI 10.1111/1440-1681.12931; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Jia Y, 2020, PATHOL ONCOL RES, V26, P753, DOI 10.1007/s12253-019-00622-3; Kaminski A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32491-2; Kim H, 2020, NEUROPATH APPL NEURO, V46, P125, DOI 10.1111/nan.12571; Kwok CTD, 2016, STEM CELL RES, V16, P651, DOI 10.1016/j.scr.2016.03.007; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Lee B, 2007, CANCER LETT, V247, P110, DOI 10.1016/j.canlet.2006.03.033; Li F, 2015, ONCOTARGET, V6, P6001, DOI 10.18632/oncotarget.3469; Li J, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0822-3; Li Y, 2015, CELL RES, V25, P981, DOI 10.1038/cr.2015.82; Liang YJ, 2020, J GENE MED, V22, DOI 10.1002/jgm.3237; Lim YP, 2004, CLIN CANCER RES, V10, P3980, DOI 10.1158/1078-0432.CCR-03-0663; Liu LY, 2018, AGING-US, V10, P4120, DOI 10.18632/aging.101706; Lu S, 2018, LUNG CANCER, V123, P44, DOI 10.1016/j.lungcan.2018.06.027; Meganck RM, 2018, MOL THER-NUCL ACIDS, V13, P89, DOI 10.1016/j.omtn.2018.08.008; Min LY, 2019, FRONT BIOSCI-LANDMRK, V24, P819, DOI 10.2741/4753; Nishikawa M, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/5387041; Panda AC, 2018, ADV EXP MED BIOL, V1087, P67, DOI 10.1007/978-981-13-1426-1_6; Park JK, 2010, J CLIN ONCOL, V28, P3838, DOI 10.1200/JCO.2010.30.0582; Peng P, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.118039; Qiao YW, 2019, BIOENGINEERED, V10, P593, DOI 10.1080/21655979.2019.1679698; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Tachon G, 2019, MODERN PATHOL, V32, P774, DOI 10.1038/s41379-018-0192-6; Tan YL, 2019, INT J ONCOL, V54, P87, DOI 10.3892/ijo.2018.4598; Wang L, 2016, FRONT MED-PRC, V10, P41, DOI 10.1007/s11684-016-0429-z; Wang LJ, 2018, ADV EXP MED BIOL, V1087, P191, DOI 10.1007/978-981-13-1426-1_15; Wang L, 2012, SCI WORLD J, DOI 10.1100/2012/428979; Wang RL, 2017, NEUROPSYCH DIS TREAT, V13, P1805, DOI 10.2147/NDT.S137171; Wang YH, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01217; Wang YN, 2021, BIOCHEM BIOPH RES CO, V560, P80, DOI 10.1016/j.bbrc.2021.04.131; Waseem A, 2010, ORAL ONCOL, V46, P536, DOI 10.1016/j.oraloncology.2010.03.022; Weng WH, 2017, CLIN CANCER RES, V23, P3918, DOI 10.1158/1078-0432.CCR-16-2541; Wesselhoeft RA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05096-6; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Xiao BX, 2017, INT J CLIN EXP PATHO, V10, P7661; Xiu GH, 2018, EUR J PHARMACOL, V833, P79, DOI 10.1016/j.ejphar.2018.04.021; Yang HJ, 2010, CANCER INVEST, V28, P127, DOI 10.3109/07357900903147184; Yao S, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0641-1; Yu CY, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0523-z; Yu X, 2016, J CELL MOL MED, V20, P10, DOI 10.1111/jcmm.12650; Zealy RW, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1414; Zhang CL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0482-4; Zhang L, 2019, INT J BIOL SCI, V15, P1091, DOI 10.7150/ijbs.31533	60	2	2	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22183	10.1096/fj.202101307R	http://dx.doi.org/10.1096/fj.202101307R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35202487	hybrid			2022-12-28	WOS:000761250800017
J	Raun, SH; Knudsen, JR; Han, XQ; Jensen, TE; Sylow, L				Raun, Steffen H.; Knudsen, Jonas Roland; Han, Xiuqing; Jensen, Thomas E.; Sylow, Lykke			Cancer causes dysfunctional insulin signaling and glucose transport in a muscle-type-specific manner	FASEB JOURNAL			English	Article						Akt; AMPK; cachexia; cancer; glucose metabolism; insulin resistance; Lewis lung carcinoma; muscle; mTORC1	GLYCOGEN-SYNTHASE KINASE-3; ACTIVATED PROTEIN-KINASE; BODY-WEIGHT LOSS; SKELETAL-MUSCLE; 14-3-3 BINDING; MASS INDEX; PHOSPHORYLATION; RESISTANCE; AMPK; CONTRACTION	Metabolic dysfunction and insulin resistance are emerging as hallmarks of cancer and cachexia, and impair cancer prognosis. Yet, the molecular mechanisms underlying impaired metabolic regulation are not fully understood. To elucidate the mechanisms behind cancer-induced insulin resistance in muscle, we isolated extensor digitorum longus (EDL) and soleus muscles from Lewis Lung Carcinoma tumor-bearing mice. Three weeks after tumor inoculation, muscles were isolated and stimulated with or without a submaximal dose of insulin (1.5 nM). Glucose transport was measured using 2-[H-3]Deoxy-Glucose and intramyocellular signaling was investigated using immunoblotting. In soleus muscles from tumor-bearing mice, insulin-stimulated glucose transport was abrogated concomitantly with abolished insulin-induced TBC1D4 and GSK3 phosphorylation. In EDL, glucose transport and TBC1D4 phosphorylation were not impaired in muscles from tumor-bearing mice, while AMPK signaling was elevated. Anabolic insulin signaling via phosphorylation of the mTORC1 targets, p70S6K thr389, and ribosomal-S6 ser235, were decreased by cancer in soleus muscle while increased or unaffected in EDL. In contrast, the mTOR substrate, pULK1 ser757, was reduced in both soleus and EDL by cancer. Hence, cancer causes considerable changes in skeletal muscle insulin signaling that is dependent on muscle-type, which could contribute to metabolic dysregulation in cancer. Thus, the skeletal muscle could be a target for managing metabolic dysfunction in cancer.	[Raun, Steffen H.; Knudsen, Jonas Roland; Han, Xiuqing; Jensen, Thomas E.; Sylow, Lykke] Univ Copenhagen, Dept Nutr Exercise & Sports, Sect Mol Physiol, Panum Bldg,Blegdamsvej 3, DK-2200 Copenhagen, Denmark; [Sylow, Lykke] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Sylow, L (corresponding author), Univ Copenhagen, Dept Nutr Exercise & Sports, Sect Mol Physiol, Panum Bldg,Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	Lykkesylow@sund.ku.dk	Jensen, Thomas/E-1215-2015; Sylow, Lykke/C-8997-2015	Jensen, Thomas/0000-0001-6139-8268; Sylow, Lykke/0000-0003-0905-5932	Novo Nordisk Foundation [NNF16OC0023418, NNF20OC0063577, NNF18OC0032082]; Independent Research Fund Denmark [9039-00170B]; Independent Research Fund Denmark	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Independent Research Fund Denmark; Independent Research Fund Denmark	Steffen H. Raun is supported via a grant to Lykke Sylow from the Novo Nordisk Foundation (NNF18OC0032082). Lykke Sylow is further supported by grants from Novo Nordisk Foundation (NNF16OC0023418 and NNF20OC0063577) and Independent Research Fund Denmark (9039--00170B). Jonas Roland Knudsen is supported by an international Postdoc grant from the Independent Research Fund Denmark	Albers PH, 2015, DIABETES, V64, P485, DOI 10.2337/db14-0590; Alves CRR, 2021, FASEB J, V35, DOI 10.1096/fj.202100263R; Alves CRR, 2020, MOL METAB, V39, DOI 10.1016/j.molmet.2020.101012; Asp ML, 2010, INT J CANCER, V126, P756, DOI 10.1002/ijc.24784; Ballaro R, 2016, CURR OPIN SUPPORT PA, V10, P281, DOI 10.1097/SPC.0000000000000233; Baracos VE, 2010, AM J CLIN NUTR, V91, p1133S, DOI 10.3945/ajcn.2010.28608C; Barreto R, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00472; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Bohnert KR, 2016, FASEB J, V30, P3053, DOI 10.1096/fj.201600250RR; Brown JL, 2017, J CACHEXIA SARCOPENI, V8, P926, DOI 10.1002/jcsm.12232; Calip GS, 2014, BREAST CANCER RES TR, V148, P363, DOI 10.1007/s10549-014-3157-6; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Campbell PT, 2012, DIABETES CARE, V35, P1835, DOI 10.2337/dc12-0002; Chadt A, 2020, PFLUG ARCH EUR J PHY, V472, P1273, DOI 10.1007/s00424-020-02417-x; Chen SA, 2011, CELL METAB, V13, P68, DOI 10.1016/j.cmet.2010.12.005; Ciaraldi TP, 2005, J CLIN ENDOCR METAB, V90, P352, DOI 10.1210/jc.2004-0516; Cohen P, 1999, PHILOS T R SOC B, V354, P485, DOI 10.1098/rstb.1999.0399; COPELAND GP, 1987, BRIT J SURG, V74, P1031, DOI 10.1002/bjs.1800741124; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; den Kamp CMO, 2013, AM J CLIN NUTR, V98, P738, DOI 10.3945/ajcn.113.058388; Dev R, 2018, ANN ONCOL, V29, P18, DOI 10.1093/annonc/mdx815; Ebhardt HA, 2017, J CACHEXIA SARCOPENI, V8, P567, DOI 10.1002/jcsm.12188; ELDER GCB, 1982, J APPL PHYSIOL, V53, P1473, DOI 10.1152/jappl.1982.53.6.1473; Fazakerley DJ, 2019, J LIPID RES, V60, P1720, DOI 10.1194/jlr.R087510; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Gallot YS, 2014, CANCER RES, V74, P7344, DOI 10.1158/0008-5472.CAN-14-0057; Gaster M, 2001, DIABETES, V50, P1324, DOI 10.2337/diabetes.50.6.1324; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; Han XQ, 2020, METABOLISM, V105, DOI 10.1016/j.metabol.2020.154169; Hanson ED, 2017, J CLIN ENDOCR METAB, V102, P1076, DOI 10.1210/jc.2016-3383; Hardee JP, 2018, J CACHEXIA SARCOPENI, V9, P369, DOI 10.1002/jcsm.12271; Hardee JP, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8018197; Harding JL, 2020, DIABETOLOGIA, V63, P75, DOI 10.1007/s00125-019-04991-x; Huot JR, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.136687; Kampmann U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027854; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kjobsted R, 2019, DIABETES, V68, P1427, DOI 10.2337/db19-0050; Kjobsted R, 2019, DIABETES, V68, P1756, DOI 10.2337/db18-0769; Kjobsted R, 2018, FASEB J, V32, P1741, DOI 10.1096/fj.201700442R; Kjobsted R, 2017, DIABETES, V66, P598, DOI 10.2337/db16-0530; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Kramer HF, 2006, J BIOL CHEM, V281, P31478, DOI 10.1074/jbc.M605461200; Larsen MR, 2020, J PHYSIOL-LONDON, V598, P5687, DOI 10.1113/JP280475; Martin A, 2021, J CACHEXIA SARCOPENI, V12, P252, DOI 10.1002/jcsm.12678; Moltke I, 2014, NATURE, V512, P190, DOI 10.1038/nature13425; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; PARKER PJ, 1983, EUR J BIOCHEM, V130, P227; Pehmoller C, 2009, AM J PHYSIOL-ENDOC M, V297, pE665, DOI 10.1152/ajpendo.00115.2009; Penna F, 2016, SEMIN CELL DEV BIOL, V54, P20, DOI 10.1016/j.semcdb.2015.09.002; Penna F, 2010, INT J CANCER, V127, P1706, DOI 10.1002/ijc.25146; PERMERT J, 1993, AM J SURG, V165, P61, DOI 10.1016/S0002-9610(05)80405-2; PISTERS PWT, 1992, SURGERY, V111, P301; Porporato PE, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.3; Puppa MJ, 2014, J APPL PHYSIOL, V116, P1078, DOI 10.1152/japplphysiol.01270.2013; Raun SH, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073469; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Reynolds TH, 2002, J BIOL CHEM, V277, P17657, DOI 10.1074/jbc.M201142200; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Shum Angie M Y, 2018, Oncotarget, V9, P22001, DOI 10.18632/oncotarget.25146; SMITH KL, 1993, BRIT J CANCER, V67, P680, DOI 10.1038/bjc.1993.126; Sylow L, 2017, DIABETES, V66, P1548, DOI 10.2337/db16-1138; Tan SX, 2015, J BIOL CHEM, V290, P11337, DOI 10.1074/jbc.M114.623686; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vind BF, 2011, DIABETOLOGIA, V54, P157, DOI 10.1007/s00125-010-1924-4; Wallengren O, 2015, SUPPORT CARE CANCER, V23, P79, DOI 10.1007/s00520-014-2332-y; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; White JP, 2013, AM J PHYSIOL-ENDOC M, V304, pE1042, DOI 10.1152/ajpendo.00410.2012; Williams JP, 2012, AM J CLIN NUTR, V96, P1064, DOI 10.3945/ajcn.112.045708; Winter A, 2012, CLIN NUTR, V31, P765, DOI 10.1016/j.clnu.2012.05.003; Xie BX, 2016, DIABETES, V65, P3327, DOI 10.2337/db16-0416; Yamada T, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00445; YOSHIKAWA T, 1994, SURGERY, V116, P62; Yoskikawa T, 2001, NUTRITION, V17, P590, DOI 10.1016/S0899-9007(01)00561-5	81	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22211	10.1096/fj.202101759R	http://dx.doi.org/10.1096/fj.202101759R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35195922	hybrid, Green Submitted			2022-12-28	WOS:000761250800042
J	Teng, XY; Hu, P; Chen, YY; Zang, YY; Ye, XL; Ou, JM; Chen, GQ; Shi, YS				Teng, Xiao-Yu; Hu, Ping; Chen, Yangyang; Zang, Yanyu; Ye, Xiaolian; Ou, Jingmin; Chen, Guiquan; Shi, Yun Stone			A novel Lgi1 mutation causes white matter abnormalities and impairs motor coordination in mice	FASEB JOURNAL			English	Article						LGI1; myelination; oligodendrocyte differentiation; Sox10; white matter	DOMINANT PARTIAL EPILEPSY; AUTOSOMAL-DOMINANT; MAMMALIAN TARGET; OLIGODENDROCYTE DIFFERENTIATION; MOUSE MODEL; GENE; DISRUPTION; INTEGRITY; AKT; TRANSCRIPTION	Leucine-rich glioma-inactivated protein 1 (LGI1) is known to play a key role in autosomal dominant lateral temporal lobe epilepsy (ADLTE). The ADLTE is an inherited disease characterized by focal seizures with distinctive auditory or aphasic symptoms. A large number of mutations on the Lgi1 gene have been reported and are believed to be the genetic cause for ADLTE. We identified a novel missense mutation, c.152A>G (p.Asp51Gly), on Lgi1 from a Chinese ADLTE patient who manifests locomotor imbalance and white matter reduction. However, it remains unknown how mutant LGI1 causes white matter abnormalities at molecular and cellular levels. Here, we generated a knock-in mouse bearing this Lgi1 mutation. We found that Lgi1(D51G)(/)(D51G) mice exhibited impaired defective white matter and motor coordination. We observed that Lgi1(D51G)(/)(D51G) mice displayed a reduced number of mature oligodendrocytes (OLs) and deficient OL differentiation in the white matter. However, the population of oligodendrocyte precursor cells was not affected in Lgi1(D51G)(/)(D51G) mice. Mechanistically, we showed that the Lgi1(D51G) mutation resulted in altered mTOR signaling and led to decreased levels of Sox10. Given that Sox10 is a key transcriptional factor to control OL differentiation, our results strongly suggest that the Lgi1(D51G) mutation may cause white matter abnormalities via inhibiting Sox10-dependent OL differentiation and myelination in the central nervous system.	[Teng, Xiao-Yu; Chen, Yangyang; Zang, Yanyu; Ye, Xiaolian; Chen, Guiquan; Shi, Yun Stone] Nanjing Univ, Med Sch, Model Anim Res Ctr, Minister Educ,Key Lab Model Anim Dis Study, Nanjing, Peoples R China; [Hu, Ping] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Womens Hosp, State Key Lab Reprod Med,Dept Prenatal Diag, Nanjing, Peoples R China; [Ou, Jingmin] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg, Shanghai, Peoples R China; [Shi, Yun Stone] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Dept Neurol, Affiliated Drum Tower Hosp,Med Sch, Nanjing, Peoples R China; [Shi, Yun Stone] Nanjing Univ, Inst Brain Sci, Nanjing, Peoples R China; [Shi, Yun Stone] Nanjing Univ, Chem & Biomed Innovat Ctr, Nanjing, Peoples R China	Nanjing University; Nanjing Medical University; Shanghai Jiao Tong University; Nanjing University; Nanjing University; Nanjing University	Chen, GQ; Shi, YS (corresponding author), Nanjing Univ, Model Anim Res Ctr, Minister Educ, Key Lab Model Anim Dis Study, 12 Xuefu Ave, Nanjing 210023, Peoples R China.	chenguiquan@nju.edu.cn; yunshi@nju.edu.cn	Shi, Yun S/T-8845-2018; Teng, Xiao-Yu/GQH-5261-2022; Shi, Yun/B-5623-2009	Teng, Xiao-Yu/0000-0003-4631-6716; Shi, Yun/0000-0002-8842-9818	National Natural Science Foundation of China [91849112, 31571060]; Natural Science Foundation of Jiangsu Province [BE2019707, BK20201255]; Fundamental Research Funds for the Central Universities [0903-14380029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	National Natural Science Foundation of China, Grant/Award Number: 91849112 and 31571060; Natural Science Foundation of Jiangsu Province, Grant/Award Number: BE2019707 and BK20201255; Fundamental Research Funds for the Central Universities, Grant/Award Number: 0903-14380029	Assareh A, 2011, CNS NEUROSCI THER, V17, P525, DOI 10.1111/j.1755-5949.2010.00181.x; Bercury KK, 2014, J NEUROSCI, V34, P4466, DOI 10.1523/JNEUROSCI.4314-13.2014; Bujalka H, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001625; Cheng SS, 2014, INT J BIOCHEM CELL B, V57, P186, DOI 10.1016/j.biocel.2014.10.029; Chernova OB, 1998, ONCOGENE, V17, P2873, DOI 10.1038/sj.onc.1202481; Cordon-Barris L, 2016, MOL CELL BIOL, V36, P2967, DOI 10.1128/MCB.00230-16; Elbaz B, 2019, TRENDS NEUROSCI, V42, P263, DOI 10.1016/j.tins.2019.01.002; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Figlia G, 2017, ELIFE, V6, DOI 10.7554/eLife.29241; Fleischman DA, 2015, NEUROLOGY, V84, P1294, DOI 10.1212/WNL.0000000000001417; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; Fukata Y, 2006, SCIENCE, V313, P1792, DOI 10.1126/science.1129947; Guardiola-Diaz HM, 2012, GLIA, V60, P476, DOI 10.1002/glia.22281; He DY, 2016, NAT NEUROSCI, V19, P678, DOI 10.1038/nn.4258; He ZH, 2018, NAT MED, V24, P29, DOI 10.1038/nm.4443; Holland PR, 2015, J CEREBR BLOOD F MET, V35, P1005, DOI 10.1038/jcbfm.2015.12; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hornig J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003907; Horsburgh K, 2011, BIOCHEM SOC T, V39, P881, DOI 10.1042/BST0390881; Hoshi Y, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abj8080; Hou JX, 2021, J NEUROSCI, V41, P4976, DOI 10.1523/JNEUROSCI.2455-19.2021; Jiang MQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12185; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Lebrun-Julien F, 2014, J NEUROSCI, V34, P8432, DOI 10.1523/JNEUROSCI.1105-14.2014; Lee MK, 2014, SEIZURE-EUR J EPILEP, V23, P69, DOI 10.1016/j.seizure.2013.10.001; Li HL, 2007, J NEUROSCI, V27, P14375, DOI 10.1523/JNEUROSCI.4456-07.2007; Liu F, 2019, BRAIN RES, V1721, DOI 10.1016/j.brainres.2019.146332; Narayanan SP, 2009, J NEUROSCI, V29, P6860, DOI 10.1523/JNEUROSCI.0232-09.2009; Nobile C, 2009, HUM MUTAT, V30, P530, DOI 10.1002/humu.20925; Ohkawa T, 2013, J NEUROSCI, V33, P18161, DOI 10.1523/JNEUROSCI.3506-13.2013; Ottman R, 2004, NEUROLOGY, V62, P1120, DOI 10.1212/01.WNL.0000120098.39231.6E; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; Reimer MM, 2011, J NEUROSCI, V31, P18185, DOI 10.1523/JNEUROSCI.4936-11.2011; Riddle A, 2011, ANN NEUROL, V70, P493, DOI 10.1002/ana.22501; Rosanoff MJ, 2008, NEUROLOGY, V71, P567, DOI 10.1212/01.wnl.0000323926.77565.ee; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Senechal KR, 2005, HUM MOL GENET, V14, P1613, DOI 10.1093/hmg/ddi169; Shi Y, 2021, NEURON, V109, P2413, DOI 10.1016/j.neuron.2021.05.034; Silva J, 2015, BRAIN PATHOL, V25, P587, DOI 10.1111/bpa.12225; Silva J, 2010, J NEUROSCI RES, V88, P3328, DOI 10.1002/jnr.22496; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Striano P, 2011, NEUROLOGY, V76, P1173, DOI 10.1212/WNL.0b013e318212ab2e; Su LD, 2015, CEREBELLUM, V14, P12, DOI 10.1007/s12311-014-0628-6; Tabuchi K, 2009, J NEUROSCI, V29, P7290, DOI 10.1523/JNEUROSCI.1320-09.2009; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Thomas R, 2010, J NEUROSCI, V30, P6607, DOI 10.1523/JNEUROSCI.5147-09.2010; Tyler WA, 2009, J NEUROSCI, V29, P6367, DOI 10.1523/JNEUROSCI.0234-09.2009; Wahl SE, 2014, J NEUROSCI, V34, P4453, DOI 10.1523/JNEUROSCI.4311-13.2014; Walther S, 2012, NEUROBIOL DIS, V47, P13, DOI 10.1016/j.nbd.2012.03.019; Wang F, 2018, NEURON, V99, P689, DOI 10.1016/j.neuron.2018.07.017; Wang H, 2021, J NEUROSCI, V41, P8163, DOI 10.1523/JNEUROSCI.2432-20.2021; Wang H, 2021, NEUROBIOL DIS, V148, DOI 10.1016/j.nbd.2020.105212; Wang H, 2017, CNS NEUROSCI THER, V23, P99, DOI 10.1111/cns.12647; Xie YJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00231; Xie YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07827; Xu CY, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00330; Yamagata A, 2020, CELL MOL LIFE SCI, V77, P267, DOI 10.1007/s00018-019-03269-0; Yamagata A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03947-w; Yokoi N, 2015, NAT MED, V21, P19, DOI 10.1038/nm.3759; Zhu XQ, 2012, DEVELOPMENT, V139, P2299, DOI 10.1242/dev.078873	61	4	4	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22212	10.1096/fj.202101652R	http://dx.doi.org/10.1096/fj.202101652R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35167164				2022-12-28	WOS:000761250800036
J	Liu, JL; Yu, LD; Castro, L; Yan, YT; Clayton, NP; Bushel, P; Flagler, ND; Scappini, E; Dixon, D				Liu, Jingli; Yu, Linda; Castro, Lysandra; Yan, Yitang; Clayton, Natasha P.; Bushel, Pierre; Flagler, Norris D.; Scappini, Erica; Dixon, Darlene			Short-term tetrabromobisphenol A exposure promotes fibrosis of human uterine fibroid cells in a 3D culture system through TGF-beta signaling	FASEB JOURNAL			English	Article						extracellular matrix; fibrosis; tetrabromobisphenol A; TGFB; uterine fibroid	BROMINATED FLAME-RETARDANTS; BISPHENOL-A; TOXICOKINETICS; INDUCTION; LEIOMYOMA; RATS	Tetrabromobisphenol A (TBBPA), a derivative of BPA, is a ubiquitous environmental contaminant with weak estrogenic properties. In women, uterine fibroids are highly prevalent estrogen-responsive tumors often with excessive accumulation of extracellular matrix (ECM) and may be the target of environmental estrogens. We have found that BPA has profibrotic effects in vitro, in addition to previous reports of the in vivo fibrotic effects of BPA in mouse uterus. However, the role of TBBPA in fibrosis is unclear. To investigate the effects of TBBPA on uterine fibrosis, we developed a 3D human uterine leiomyoma (ht-UtLM) spheroid culture model. Cell proliferation was evaluated in 3D ht-UtLM spheroids following TBBPA (10(-6)-200 mu M) administration at 48 h. Fibrosis was assessed using a Masson's Trichrome stain and light microscopy at 7 days of TBBPA (10(-3) mu M) treatment. Differential expression of ECM and fibrosis genes were determined using RT2 Profiler (TM) PCR arrays. Network and pathway analyses were conducted using Ingenuity Pathway Analysis. The activation of pathway proteins was analyzed by a transforming growth factor-beta (TGFB) protein array. We found that TBBPA increased cell proliferation and promoted fibrosis in 3D ht-UtLM spheroids with increased deposition of collagens. TBBPA upregulated the expression of profibrotic genes and corresponding proteins associated with the TGFB pathway. TBBPA activated TGFB signaling through phosphorylation of TGFBR1 and downstream effectors-small mothers against decapentaplegic -2 and -3 proteins (SMAD2 and SMAD3). The 3D ht-UtLM spheroid model is an effective system for studying environmental agents on human uterine fibrosis. TBBPA can promote fibrosis in uterine fibroid through TGFB/SMAD signaling.	[Liu, Jingli; Yu, Linda; Castro, Lysandra; Yan, Yitang; Dixon, Darlene] NIEHS, Div Natl Toxicol Program DNTP, Mechanist Toxicol Branch MTB, NIH, Res Triangle Pk, NC 27709 USA; [Clayton, Natasha P.; Flagler, Norris D.] NIEHS, Cellular & Mol Pathogenesis Branch, DNTP, NIH, Res Triangle Pk, NC 27709 USA; [Bushel, Pierre] NIEHS, Biostat & Computat Biol Branch, Div Intramural Res DIR, NIH, Res Triangle Pk, NC 27709 USA; [Scappini, Erica] NIEHS, Signal Transduct Lab, DIR, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Dixon, D (corresponding author), NIEHS, Mol Pathogenesis Grp, MTB, NIH, 111 TW Alexander Dr,Bldg 101,South Campus, Res Triangle Pk, NC 27709 USA.	dixon@niehs.nih.gov	Liu, Jingli/ABU-8123-2022; Liu, Jingli/GQH-2490-2022		HHS | National Institutes of Health (NIH) [ES021196--27]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS | National Institutes of Health (NIH), Grant/Award Number: ES021196--27	Abdallah MA, 2016, ENVIRON INT, V94, P235, DOI 10.1016/j.envint.2016.05.026; Akiyama E, 2015, ENVIRON RES, V140, P157, DOI 10.1016/j.envres.2015.03.035; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Bastos PM, 2008, CHEMOSPHERE, V70, P1196, DOI 10.1016/j.chemosphere.2007.08.019; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Carney SA, 2002, LAB INVEST, V82, P719, DOI 10.1097/01.LAB.0000017499.51216.3E; Ciebiera M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112435; Clayton NP, 2018, TOXICOL PATHOL, V46, P653, DOI 10.1177/0192623318789069; Debenest T, 2010, COMP BIOCHEM PHYS C, V152, P407, DOI 10.1016/j.cbpc.2010.06.009; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dunnick JK, 2015, TOXICOL PATHOL, V43, P464, DOI 10.1177/0192623314557335; Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573; Elswefy SES, 2016, INT J EXP PATHOL, V97, P369, DOI 10.1111/iep.12207; Evans P, 2007, AM FAM PHYSICIAN, V75, P1503; Farini A, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00403; Fini JB, 2012, TOXICOL SCI, V125, P359, DOI 10.1093/toxsci/kfr312; Flake GP, 2018, CURR OBSTET GYNECOL, V7, P97, DOI 10.1007/s13669-018-0241-7; Flake GP, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/285103; Frangogiannis NG, 2020, J EXP MED, V217, DOI 10.1084/jem.20190103; Gyorfi AH, 2018, MATRIX BIOL, V68-69, P8, DOI 10.1016/j.matbio.2017.12.016; Hakk H, 2003, ENVIRON INT, V29, P801, DOI 10.1016/S0160-4120(03)00109-0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Howard PH, 2013, ENVIRON SCI TECHNOL, V47, P5259, DOI 10.1021/es4004075; Hu YY, 2016, TOXICOL LETT, V250, P1, DOI 10.1016/j.toxlet.2016.03.008; Kendziorski JA, 2015, REPROD TOXICOL, V58, P119, DOI 10.1016/j.reprotox.2015.08.001; Kicinski M, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-86; Kim UJ, 2014, ENVIRON POLLUT, V184, P193, DOI 10.1016/j.envpol.2013.08.034; Kitamura S, 2005, TOXICOL SCI, V84, P249, DOI 10.1093/toxsci/kfi074; Knudsen GA, 2014, TOXICOL REP, V1, P214, DOI 10.1016/j.toxrep.2014.03.005; Li J, 2010, TOXICOL IN VITRO, V24, P201, DOI 10.1016/j.tiv.2009.09.008; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Lyche JL, 2015, ENVIRON INT, V74, P170, DOI 10.1016/j.envint.2014.09.006; McCormick JM, 2010, AQUAT TOXICOL, V100, P255, DOI 10.1016/j.aquatox.2010.07.019; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Newbold RR, 2007, REPROD TOXICOL, V24, P253, DOI 10.1016/j.reprotox.2007.07.006; NTP, TECHN REP TOX STUD T; Sabry M, 2012, REPROD SCI, V19, P339, DOI 10.1177/1933719111432867; Samuelsen M, 2001, CELL BIOL TOXICOL, V17, P139, DOI 10.1023/A:1011974012602; Schauer UMD, 2006, TOXICOL SCI, V91, P49, DOI 10.1093/toxsci/kfj132; Song KH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.10.33; Stewart EA, 2015, NEW ENGL J MED, V372, P1646, DOI [10.1056/NEJMcp1411029, 10.1038/nrdp.2016.43]; Xie J, 2018, LAB INVEST, V98, P1575, DOI 10.1038/s41374-018-0117-5; Yoshida K, 2018, CANCERS, V10, DOI 10.3390/cancers10060183; Yu YJ, 2019, ENVIRON POLLUT, V253, P909, DOI 10.1016/j.envpol.2019.07.067; Yu YJ, 2016, CHEMOSPHERE, V146, P189, DOI 10.1016/j.chemosphere.2015.12.027	45	0	0	8	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22101	10.1096/fj.202101262R	http://dx.doi.org/10.1096/fj.202101262R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35032343	Green Published			2022-12-28	WOS:000747987800007
J	Ren, LY; Zeng, FC; Deng, JZ; Bai, Y; Chen, K; Chen, L; Sun, L				Ren, Lingyan; Zeng, Fanchun; Deng, Jiezhong; Bai, Yun; Chen, Kun; Chen, Long; Sun, Li			Inflammatory osteoclasts-derived exosomes promote bone formation by selectively transferring lncRNA LIOCE into osteoblasts to interact with and stabilize Osterix	FASEB JOURNAL			English	Article						exosomes; inflammatory osteoclasts; lncRNA; osteoblasts	BIOLOGY; CELLS	Bone loss is a hallmark of inflammatory bone diseases caused by aberrantly activated osteoclasts (OCLs). Studies have shown that OCLs exhibit various phenotypes and functions due to variations in the source(s) of precursor cells, cytokine expressions, and microenvironment-dependent factors. During these conditions, inflammatory osteoclasts (iOCLs) lose their immune-suppressive effect relative to OCLs under physiological conditions. This induces TNF alpha-producing CD4(+) T cells in an antigen-dependent manner and finally leads to cascade amplification of iOCLs. OCL-derived exosomes have been reported to regulate OCL formation and inhibit the osteoblast activity. However, the specific function and mechanism of iOCL-derived exosomes on osteoblast have not been studied yet. In the present study, we compare the osteoblast promoting activities of iOCL-derived exosomes and OCL-derived exosomes. We found that iOCLs exosomes specifically target osteoblasts through ephrinA2/EphA2. Mechanistically, the lncRNA LIOCE is enriched in iOCL exosomes and promotes the osteoblast activity after being incorporated into osteoblasts. Furthermore, our results revealed that exosomal lncRNA LIOCE stabilizes osteogenic transcription factor Osterix by interacting and reducing the ubiquitination level of Osterix. This study demonstrated that the bone loss is alleviated in the inflammatory osteolysis mice model after injection of iOCL exosomes encapsulating lncRNA LIOCE. The role of exosomes encapsulating lncRNA LIOCE in promoting bone formation was well established in the rat bone repair model. Our results indicate that iOCL-derived exosomal lncRNA LIOCE promotes bone formation by upregulating Osx expression, and thus, the exosomes encapsulating lncRNA LIOCE may be an effective strategy to increase bone formation in osteoporosis and other bone metabolic disorders.	[Ren, Lingyan; Sun, Li] Guizhou Univ, Med Coll, Guiyang 550025, Peoples R China; [Ren, Lingyan; Chen, Long; Sun, Li] Guizhou Prov Peoples Hosp, Dept Orthoped, Guiyang, Peoples R China; [Ren, Lingyan] Guizhou Prov Peoples Hosp, Antenatal Diag Ctr, Guiyang, Peoples R China; [Zeng, Fanchun] Chongqing Univ, Bioengn Coll, Chongqing, Peoples R China; [Deng, Jiezhong; Bai, Yun] Army Med Univ, Southwest Hosp, Dept Orthoped Surg, Mil Med Univ 3, Chongqing, Peoples R China; [Chen, Kun] Guizhou Prov Peoples Hosp, Ctr Lab, Guiyang, Peoples R China	Guizhou University; Chongqing University; Army Medical University	Sun, L (corresponding author), Guizhou Univ, Med Coll, Guiyang 550025, Peoples R China.	lisun@gzu.edu.cn			Nature Science Foundation of China [81960401]; Basic Research Plan of Guizhou Province [[2019]1429, [2021]394]; NHC Key Laboratory of Pulmonary Immunological Diseases; Nonprofit Central Research Institute Fund of the Chinese Academy of Medical Sciences [2019PT320003]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Plan of Guizhou Province; NHC Key Laboratory of Pulmonary Immunological Diseases; Nonprofit Central Research Institute Fund of the Chinese Academy of Medical Sciences	This work was funded by grants from the Nature Science Foundation of China (81960401), Basic Research Plan of Guizhou Province ([2019]1429) ([2021]394), and NHC Key Laboratory of Pulmonary Immunological Diseases. This work was also supported by the Nonprofit Central Research Institute Fund of the Chinese Academy of Medical Sciences (2019PT320003)	Alves CH, 2016, CLIN REV ALLERG IMMU, V51, P27, DOI 10.1007/s12016-015-8522-7; Baassiri A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041398; Buchwald ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038199; Chen Z, 2019, NAT REV RHEUMATOL, V15, P9, DOI 10.1038/s41584-018-0109-2; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Cully M, 2021, NAT REV DRUG DISCOV, V20, P6, DOI 10.1038/d41573-020-00220-y; Dai JJ, 2020, AM J PHYSIOL-CELL PH, V319, pC21, DOI 10.1152/ajpcell.00039.2020; Dou C, 2016, SCI REP-UK, V6, DOI 10.1038/srep21499; Drissi H, 2016, J CELL BIOCHEM, V117, P1753, DOI 10.1002/jcb.25560; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; He CJ, 2018, THERANOSTICS, V8, P237, DOI 10.7150/thno.21945; Ibanez L, 2016, J BONE MINER RES, V31, P1899, DOI 10.1002/jbmr.2868; Irie N, 2009, J BIOL CHEM, V284, P14637, DOI 10.1074/jbc.M807598200; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kiesel JR, 2009, J IMMUNOL, V182, P5477, DOI 10.4049/jimmunol.0803897; Li DF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10872; Li Y, 2019, SIGNAL TRANSDUCT TAR, V4, DOI 10.1038/s41392-019-0080-7; Liang LY, 2019, ONCOGENE, V38, P6567, DOI 10.1038/s41388-019-0931-2; Liu WJ, 2020, J CELL MOL MED, V24, P9786, DOI 10.1111/jcmm.15560; Ma LN, 2013, RNA BIOL, V10, P925, DOI 10.4161/rna.24604; Ma QY, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12068; Madel MB, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01408; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Oryan A, 2015, BIOMED ENVIRON SCI, V28, P57, DOI 10.3967/bes2015.006; Park SY, 2020, BLOOD, V135, P2071, DOI 10.1182/blood.2019002227; Patil S, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.584118; Pegtel DM, 2019, ANNU REV BIOCHEM, V88, P487, DOI 10.1146/annurev-biochem-013118-111902; Speziani C, 2007, EUR J IMMUNOL, V37, P747, DOI 10.1002/eji.200636534; Sun WJ, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.15; Sun Y, 2019, NAT METAB, V1, P485, DOI 10.1038/s42255-019-0053-8; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Wakkach A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00640; Xiao YL, 2015, STEM CELL REP, V4, P984, DOI 10.1016/j.stemcr.2015.04.012; Yang JX, 2020, CELL SIGNAL, V70, DOI 10.1016/j.cellsig.2019.109504; Yousefi H, 2020, ONCOGENE, V39, P953, DOI 10.1038/s41388-019-1040-y; Yu LJ, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12056; Yuan FL, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00628	39	3	3	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22115	10.1096/fj.202101106RR	http://dx.doi.org/10.1096/fj.202101106RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35032415	hybrid			2022-12-28	WOS:000747987800014
J	Vaughan-Shaw, PG; Blackmur, JP; Grimes, G; Ooi, LY; Ochocka-Fox, AM; Dunbar, K; von Kriegsheim, A; Rajasekaran, V; Timofeeva, M; Walker, M; Svinti, V; Din, FVN; Farrington, SM; Dunlop, MG				Vaughan-Shaw, Peter G.; Blackmur, James P.; Grimes, Graeme; Ooi, Li-Yin; Ochocka-Fox, Anna M.; Dunbar, Karen; von Kriegsheim, Alex; Rajasekaran, Vidya; Timofeeva, Maria; Walker, Marion; Svinti, Victoria; Din, Farhat V. N.; Farrington, Susan M.; Dunlop, Malcolm G.			Vitamin D treatment induces in vitro and ex vivo transcriptomic changes indicating anti-tumor effects	FASEB JOURNAL			English	Article						colorectal cancer; gene expression; vitamin D	NORMAL COLON MUCOSA; GENE-EXPRESSION; D-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; D SUPPLEMENTATION; TARGET GENES; CANCER CELLS; RNA-SEQ; CALCIUM; DIFFERENTIATION	Vitamin D deficiency is associated with risk of several common cancers, including colorectal cancer (CRC). Here we have utilized patient derived epithelial organoids (ex vivo) and CRC cell lines (in vitro) to show that calcitriol (1,25OHD) increased the expression of the CRC tumor suppressor gene, CDH1, at both the transcript and protein level. Whole genome expression analysis demonstrated significant differential expression of a further six genes after 1,25OHD treatment, including genes with established links to carcinogenesis GADD45, EFTUD1 and KIAA1199. Furthermore, gene ontologies relevant to carcinogenesis were enriched by 1,25OHD treatment (e.g., 'regulation of Wnt signaling pathway', 'regulation of cell death'), with common enriched processes across in vitro and ex vivo cultures including 'negative regulation of cell proliferation', 'regulation of cell migration' and 'regulation of cell differentiation'. Our results identify genes and pathways that are modifiable by calcitriol that have links to CRC tumorigenesis. Hence the findings provide potential mechanism to the epidemiological and clinical trial data indicating a causal association between vitamin D and CRC. We suggest there is strong rationale for further well-designed trials of vitamin D supplementation as a novel CRC chemopreventive and chemotherapeutic agent.	[Vaughan-Shaw, Peter G.; Blackmur, James P.; Grimes, Graeme; Ochocka-Fox, Anna M.; Dunbar, Karen; Rajasekaran, Vidya; Walker, Marion; Farrington, Susan M.; Dunlop, Malcolm G.] Univ Edinburgh, Inst Genet & Canc, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Vaughan-Shaw, Peter G.; Blackmur, James P.; Grimes, Graeme; Ooi, Li-Yin; Ochocka-Fox, Anna M.; Dunbar, Karen; von Kriegsheim, Alex; Rajasekaran, Vidya; Timofeeva, Maria; Walker, Marion; Svinti, Victoria; Din, Farhat V. N.; Farrington, Susan M.; Dunlop, Malcolm G.] Univ Edinburgh, Canc Res UK Edinburgh Ctr, Inst Genet & Canc, Edinburgh EH4 2XU, Midlothian, Scotland; [Ooi, Li-Yin] Natl Univ Hlth Syst, Natl Univ Hosp, Dept Pathol, Singapore, Singapore; [Timofeeva, Maria] Univ Southern Denmark, Danish Inst Adv Study, Dept Publ Hlth, Odense, Denmark	University of Edinburgh; University of Edinburgh; National University of Singapore; University of Southern Denmark	Farrington, SM; Dunlop, MG (corresponding author), Univ Edinburgh, Canc Res UK Edinburgh Ctr, Inst Genet & Canc, Edinburgh EH4 2XU, Midlothian, Scotland.	susan.farrington@ed.ac.uk; malcolm.dunlop@ed.ac.uk	Blackmur, James/ABM-7695-2022; Farrington, Susan M/Q-2710-2019	Farrington, Susan M/0000-0001-5955-7389; Timofeeva, Maria/0000-0002-2503-4253	Edinburgh CRUK Cancer Research Centre; CRUK programme grant [C34871118927]; MRC Clinical Research Training Fellowship [MR/M004007/1]; Harold Bridges bequest; Melville Trust for the Care and Cure of Cancer; Cancer Research UK Research Training Fellowship [C10195/A12996]; Edinburgh Clinical Academic Track (ECAT); COST Action [Bh41206]	Edinburgh CRUK Cancer Research Centre; CRUK programme grant; MRC Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Harold Bridges bequest; Melville Trust for the Care and Cure of Cancer; Cancer Research UK Research Training Fellowship; Edinburgh Clinical Academic Track (ECAT); COST Action(European Cooperation in Science and Technology (COST))	This work was supported by funding for the infrastructure and staffing of the Edinburgh CRUK Cancer Research Centre; CRUK programme grant C34871118927 (MGDiSMF). PVS was supported by MRC Clinical Research Training Fellowship (MR/M004007/1), a Research Fellowship from the Harold Bridges bequest and by the Melville Trust for the Care and Cure of Cancer. The work received support from COST Action Bh41206. I,V0 is supported by a Cancer Research UK Research Training Fellowship (C10195/A12996). JB is supported by an Edinburgh Clinical Academic Track (ECAT) linked Cancer Research UK	Ahearn TU, 2012, CANCER PREV RES, V5, P1247, DOI 10.1158/1940-6207.CAPR-12-0292; Akutsu N, 2001, MOL ENDOCRINOL, V15, P1127, DOI 10.1210/me.15.7.1127; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Barry EL, 2017, JAMA ONCOL, V3, P628, DOI 10.1001/jamaoncol.2016.5917; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg KCG, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0691-y; Bertucci F, 2004, ONCOGENE, V23, P1377, DOI 10.1038/sj.onc.1207262; Birkenkamp-Demtroder K, 2002, CANCER RES, V62, P4352; Chan SK, 2008, CANCER EPIDEM BIOMAR, V17, P543, DOI 10.1158/1055-9965.EPI-07-2615; Chen L, 2017, GENE, V628, P200, DOI 10.1016/j.gene.2017.07.056; Costales-Carrera A, 2020, CANCERS, V12, DOI 10.3390/cancers12082302; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Din FVN, 2012, GASTROENTEROLOGY, V142, P1504, DOI 10.1053/j.gastro.2012.02.050; Dou RX, 2016, BRIT J NUTR, V115, P1643, DOI 10.1017/S0007114516000696; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fedirko V, 2010, CANCER EPIDEM BIOMAR, V19, P280, DOI 10.1158/1055-9965.EPI-09-0448; Fedirko V, 2009, CANCER EPIDEM BIOMAR, V18, P2933, DOI 10.1158/1055-9965.EPI-09-0239; Fedirko V, 2009, CANCER PREV RES, V2, P213, DOI 10.1158/1940-6207.CAPR-08-0157; Fernandez-Barral A, 2020, FEBS J, V287, P53, DOI 10.1111/febs.14998; Fleet JC, 2012, BIOCHEM J, V441, P61, DOI 10.1042/BJ20110744; Flores O, 2010, ENDOCRINOLOGY, V151, P4654, DOI 10.1210/en.2010-0434; Haw R, 2011, PROTEOMICS, V11, P3598, DOI 10.1002/pmic.201100066; He YZ, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1119-2; Hermann J, 2015, PRZ GASTROENTEROL, V10, P83, DOI 10.5114/pg.2015.49684; Hopkins MH, 2011, CANCER PREV RES, V4, P1645, DOI 10.1158/1940-6207.CAPR-11-0105; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jersie-Christensen RR, 2016, METHODS MOL BIOL, V1355, P251, DOI 10.1007/978-1-4939-3049-4_17; Jiang F, 2003, J BIOL CHEM, V278, P48030, DOI 10.1074/jbc.M308430200; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Keum N, 2019, ANN ONCOL, V30, P733, DOI 10.1093/annonc/mdz059; Kogenaru S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-629; Krishnan AV, 2003, J CELL BIOCHEM, V88, P363, DOI 10.1002/jcb.10334; Liu JM, 2021, BIOMED PHARMACOTHER, V138, DOI 10.1016/j.biopha.2021.111507; Manson JE, 2019, NEW ENGL J MED, V380, P33, DOI [10.1056/NEJMoa1809944, 10.1056/nejmoa1809944]; Masters JRW, 2000, BRIT J CANCER, V82, P1495; McCray T, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2020.101974; Meng XR, 2019, INT J EPIDEMIOL, V48, P1425, DOI 10.1093/ije/dyz182; Palmer HG, 2003, CANCER RES, V63, P7799; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pike JW, 2010, ENDOCRIN METAB CLIN, V39, P255, DOI 10.1016/j.ecl.2010.02.007; Protiva P, 2016, AM J CLIN NUTR, V103, P1224, DOI 10.3945/ajcn.114.105304; R Core Team, 2022, R LANG ENV STAT COMP; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rondini EA, 2014, DRUG METAB DISPOS, V42, P361, DOI 10.1124/dmd.113.055673; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Scragg R, 2018, JAMA ONCOL, V4, DOI 10.1001/jamaoncol.2018.2178; Sheng L, 2016, J STEROID BIOCHEM, V164, P90, DOI 10.1016/j.jsbmb.2015.10.012; Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swami S, 2003, BREAST CANCER RES TR, V80, P49, DOI 10.1023/A:1024487118457; Tamura RE, 2012, CURR MOL MED, V12, P634; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; Turriziani Benedetta, 2014, Biology (Basel), V3, P320, DOI 10.3390/biology3020320; Vaughan-Shaw PG, 2021, BMC MED, V19, DOI 10.1186/s12916-021-02044-y; Vaughan-Shaw PG, 2020, GUT, V69, P103, DOI 10.1136/gutjnl-2018-317922; Vaughan-Shaw PG, 2017, BRIT J CANCER, V116, P1092, DOI 10.1038/bjc.2017.44; Vaughan-Shaw PG, 2021, INT J CANCER, V149, P1100, DOI 10.1002/ijc.33616; Vaughan-Shaw PG, 2020, BRIT J CANCER, V123, P1705, DOI 10.1038/s41416-020-01060-8; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wood RJ, 2004, PHYSIOL GENOMICS, V17, P122, DOI 10.1152/physiolgenomics.00002.2003; Ye YX, 2021, GENET EPIDEMIOL, V45, P24, DOI 10.1002/gepi.22357; Yu XY, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.684855	68	2	2	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22082	10.1096/fj.202101430RR	http://dx.doi.org/10.1096/fj.202101430RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34918389	Green Published			2022-12-28	WOS:000734992000026
J	Wan, Y; Li, XD; Slevin, E; Harrison, K; Li, T; Zhang, YD; Klaunig, JE; Wu, CD; Shetty, AK; Dong, XC; Meng, FY				Wan, Ying; Li, Xuedong; Slevin, Elise; Harrison, Kelly; Li, Tian; Zhang, Yudian; Klaunig, James E.; Wu, Chaodong; Shetty, Ashok K.; Dong, X. Charlie; Meng, Fanyin			Endothelial dysfunction in pathological processes of chronic liver disease during aging	FASEB JOURNAL			English	Review						aging; chronic liver injury; endothelial dysfunction; inflammation; liver fibrosis	AGE-RELATED PSEUDOCAPILLARIZATION; SINUSOIDAL ENDOTHELIUM; NITRIC-OXIDE; EXTRACELLULAR-MATRIX; HEPATIC-FIBROSIS; CELL PHENOTYPE; T-CELLS; OLD-AGE; EXPRESSION; INDUCTION	Aging is associated with gradual changes in liver structure and physiological/pathological functions in hepatic cells including hepatocytes, cholangiocytes, Kupffer cells, hepatic stellate cells (HSCs), and liver sinusoidal endothelial cells (LSECs). LSECs are specialized hepatic endothelial cells that regulate liver homeostasis. These cells actively impact the hepatic microenvironment as they have fenestrations and a thin morphology to allow substance exchange between circulating blood and the liver tissue. As aging occurs, LSECs have a reduction in both the number and size of fenestrations, which is referred to as pseudocapillarization. This along with the aging of the liver leads to increased oxidative stress, decreased availability of nitric oxide, decreased hepatic blood flow, and increased inflammatory cytokines in LSECs. Vascular aging can also lead to hepatic hypoxia, HSC activation, and liver fibrosis. In this review, we described the basic structure of LSECs, and the effect of LSECs on hepatic inflammation and fibrosis during aging process. We briefly summarized the changes of hepatic microcirculation during liver inflammation, the effect of aging on the clearance function of LSECs, the interactions between LSECs and immunity, hepatocytes or other hepatic nonparenchymal cells, and the therapeutic intervention of liver diseases by targeting LSECs and vascular system. Since LSECs play an important role in the development of liver fibrosis and the changes of LSEC phenotype occur in the early stage of liver fibrosis, the study of LSECs in the fibrotic liver is valuable for the detection of early liver fibrosis and the early intervention of fibrotic response.	[Wan, Ying; Li, Xuedong; Li, Tian; Zhang, Yudian] Southwest Med Univ, Sch Basic Med Sci, Dept Pathophysiol, Luzhou, Peoples R China; [Slevin, Elise; Meng, Fanyin] Indiana Univ Sch Med, Indiana Ctr Liver Res, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA; [Harrison, Kelly] Baylor Scott & White Mem Hosp, Dept Transplant Surg, Temple, TX USA; [Klaunig, James E.] Indiana Univ, Indiana Sch Publ Hlth, Dept Environm & Occupat Hlth, Lab Invest Toxicol & Pathol, Bloomington, IN USA; [Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA; [Shetty, Ashok K.] Texas A&M Coll Med, Inst Regenerat Med, Dept Mol & Cellular Med, College Stn, TX USA; [Dong, X. Charlie] Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr,MS-1 Brandeis Univ 021D, Indianapolis, IN 46202 USA; [Meng, Fanyin] Richard L Roudebush VA Med Ctr, Indianapolis, IN USA	Southwest Medical University; Indiana University System; Indiana University Bloomington; Baylor Health Care System; Indiana University System; Indiana University Bloomington; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Dong, XC (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr,MS-1 Brandeis Univ 021D, Indianapolis, IN 46202 USA.; Meng, FY (corresponding author), Indiana Univ Sch Med, Indiana Ctr Liver Res, Richard L Roudebush VA Med Ctr, Div Gastroenterol & Hepatol,Dept Med, 702 Rotary Circle,Room 013E, Indianapolis, IN 46202 USA.	xcdong@iu.edu; mengf@iu.edu	Shetty, Ashok/AAT-7273-2020	Shetty, Ashok/0000-0001-5049-6671; Klaunig, James/0000-0002-4736-2223	VA Merit Review Award from the United States Department of Veteran's Affairs Biomedical Laboratory Research and Development Service, U.S. National Institutes of Health [1101BX001724, N11-1]; National Institute of Diabetes and Digestive and Kidney Diseases [DK054811, DK076898, DK107310, DK120689, DK121925]; NIH National Institute on Alcohol Abuse and Alcoholism [AA025997, AA025157]; Nature Science Foundation of China [81873563]; Indiana University Health Indiana University School of Medicine Strategic Research Initiative; PSC Partners Seeking a Cure	VA Merit Review Award from the United States Department of Veteran's Affairs Biomedical Laboratory Research and Development Service, U.S. National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Indiana University Health Indiana University School of Medicine Strategic Research Initiative; PSC Partners Seeking a Cure	The work was supported by the VA Merit Review Award to Dr. Meng (1101BX001724) from the United States Department of Veteran's Affairs Biomedical Laboratory Research and Development Service, U.S. National Institutes of Health (N11-1) National Institute of Diabetes and Digestive and Kidney Diseases Grants DK054811, DK076898 and DK107310 to Dr. Meng, NIH National Institute on Alcohol Abuse and Alcoholism Grants AA025997 and AA025157 to Dr. Meng, and a grant from Nature Science Foundation of China (No. 81873563) to YW; The project described was supported by the Indiana University Health Indiana University School of Medicine Strategic Research Initiative. Dr. Meng acknowledges the support from PSC Partners Seeking a Cure. This material is the result of work supported by resources at Richard L. Roudebush VA Medical Center, Indianapolis, IN. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs. This work was also partly supported by the National Institute of Diabetes and Digestive and Kidney Diseases awards DK120689 and DK121925 to Dr. Dong	Abdelmegeed MA, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/149627; Ahsan F, 2020, CUREUS, V12, DOI 10.7759/cureus.10446; Al-Serri A, 2012, J HEPATOL, V56, P448, DOI 10.1016/j.jhep.2011.05.029; Alidori S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12343; BABBS C, 1990, HEPATOLOGY, V11, P723, DOI 10.1002/hep.1840110503; Berg M, 2006, EUR J IMMUNOL, V36, P2960, DOI 10.1002/eji.200636033; Breiner KM, 2001, HEPATOLOGY, V34, P803, DOI 10.1053/jhep.2001.27810; Carambia A, 2015, J HEPATOL, V62, P1349, DOI 10.1016/j.jhep.2015.01.006; Carambia A, 2014, J HEPATOL, V61, P594, DOI 10.1016/j.jhep.2014.04.027; Carnovale CE, 2012, ANN HEPATOL, V11, P636, DOI 10.1016/S1665-2681(19)31436-X; Cheluvappa R, 2007, EXP GERONTOL, V42, P1012, DOI 10.1016/j.exger.2007.06.001; Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002; Connolly MK, 2010, J IMMUNOL, V185, P2200, DOI 10.4049/jimmunol.1000332; Crispe IN, 2011, J HEPATOL, V54, P357, DOI 10.1016/j.jhep.2010.10.005; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; DeLeve LD, 2008, HEPATOLOGY, V48, P920, DOI 10.1002/hep.22351; DeLeve LD, 2015, HEPATOLOGY, V61, P1740, DOI 10.1002/hep.27376; DeLeve LD, 2013, J CLIN INVEST, V123, P1861, DOI 10.1172/JCI66025; DeLeve LD, 2004, AM J PHYSIOL-GASTR L, V287, pG757, DOI 10.1152/ajpgi.00017.2004; Dill MT, 2012, GASTROENTEROLOGY, V142, P967, DOI 10.1053/j.gastro.2011.12.052; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Dixon LJ, 2013, COMPR PHYSIOL, V3, P785, DOI 10.1002/cphy.c120026; Duan JL, 2018, HEPATOLOGY, V68, P677, DOI 10.1002/hep.29834; Ford AJ, 2015, ACTA BIOMATER, V24, P220, DOI 10.1016/j.actbio.2015.06.028; FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Ganesan LP, 2012, J IMMUNOL, V189, P4981, DOI 10.4049/jimmunol.1202017; Glinska-Suchocka K, 2015, POL J VET SCI, V18, P873, DOI 10.1515/pjvs-2015-0113; Guidotti LG, 1999, J EXP MED, V189, P1555, DOI 10.1084/jem.189.10.1555; Harris, 2014, INT SCHOLARLY RES NO, V2014; Hu JH, 2014, SCIENCE, V343, P416, DOI 10.1126/science.1244880; Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021; Hunt NJ, 2020, J GERONTOL A-BIOL, V75, P278, DOI 10.1093/gerona/glz153; Hunt NJ, 2018, ADV DRUG DELIVER REV, V135, P39, DOI 10.1016/j.addr.2018.09.006; Ito Y, 2007, EXP GERONTOL, V42, P789, DOI 10.1016/j.exger.2007.04.008; Iwakiri Y, 2015, TRENDS PHARMACOL SCI, V36, P524, DOI 10.1016/j.tips.2015.05.001; Jamieson HA, 2007, EXP GERONTOL, V42, P374, DOI 10.1016/j.exger.2006.11.004; Jansen PLM, 2002, BEST PRACT RES CL GA, V16, P149, DOI 10.1053/bega.2002.0271; JARNAGIN WR, 1994, J CELL BIOL, V127, P2037, DOI 10.1083/jcb.127.6.2037; Kamada Y, 2015, MOL MED REP, V11, P3573, DOI 10.3892/mmr.2015.3168; Kang JH, 2016, CRIT REV BIOTECHNOL, V36, P132, DOI 10.3109/07388551.2014.930017; Kitano M, 2016, J CLIN MED, V5, DOI 10.3390/jcm5030038; Kmiec Z, 2001, ADV ANAT EMBRYOL CEL, V161, P1; Knolle PA, 1999, GASTROENTEROLOGY, V116, P1428, DOI 10.1016/S0016-5085(99)70508-1; Knolle PA, 2016, CELL MOL IMMUNOL, V13, P347, DOI 10.1038/cmi.2016.5; Kocabayoglu Peri, 2013, Front Biosci (Schol Ed), V5, P217; La Mura V, 2014, J HEPATOL, V61, P1321, DOI 10.1016/j.jhep.2014.07.014; Lafoz E, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040929; Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661; Le Couteur DG, 2007, ANN NY ACAD SCI, V1114, P79, DOI 10.1196/annals.1396.003; Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0; Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754; Leifeld L, 2002, J HEPATOL, V37, P613, DOI 10.1016/S0168-8278(02)00271-4; Li H, 2016, BMJ OPEN GASTROENTER, V3, DOI 10.1136/bmjgast-2016-000079; Licastro Federico, 2005, Immun Ageing, V2, P8; Limmer A, 1998, EUR J IMMUNOL, V28, P2395, DOI 10.1002/(SICI)1521-4141(199808)28:08<2395::AID-IMMU2395>3.0.CO;2-D; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; Liu LP, 2012, HEPATOLOGY, V55, P1529, DOI 10.1002/hep.24815; Maeso-Diaz R, 2018, AGING CELL, V17, DOI 10.1111/acel.12829; MAHER JJ, 1990, J CLIN INVEST, V86, P1641, DOI 10.1172/JCI114886; Marrone G, 2016, J HEPATOL, V65, P608, DOI 10.1016/j.jhep.2016.04.018; Maslak E, 2015, PHARMACOL REP, V67, P689, DOI 10.1016/j.pharep.2015.04.010; May D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021478; MCGARY CT, 1989, BIOCHEM J, V257, P875, DOI 10.1042/bj2570875; MCGUIRE RF, 1992, HEPATOLOGY, V15, P989, DOI 10.1002/hep.1840150603; McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4; McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328; McMahan RH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159217; Miyachi Y, 2017, CELL REP, V18, P2766, DOI 10.1016/j.celrep.2017.02.039; Miyao M, 2015, LAB INVEST, V95, P1130, DOI 10.1038/labinvest.2015.95; Natarajan V, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4097205; Neubauer K, 1999, J HEPATOL, V31, P692, DOI 10.1016/S0168-8278(99)80350-X; Neumann K, 2015, EUR J IMMUNOL, V45, P2008, DOI 10.1002/eji.201445346; Ni Y, 2017, WORLD J GASTROENTERO, V23, P7666, DOI 10.3748/wjg.v23.i43.7666; Pandey E, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00873; Pasarin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032785; Poisson J, 2017, J HEPATOL, V66, P212, DOI 10.1016/j.jhep.2016.07.009; POPPER H, 1986, PROG LIVER DIS, V8, P659; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Rafii S, 2016, NATURE, V529, P316, DOI 10.1038/nature17040; Rautou PE, 2012, GASTROENTEROLOGY, V143, P166, DOI 10.1053/j.gastro.2012.03.040; Ray Katrina, 2014, Nat Rev Gastroenterol Hepatol, V11, P74, DOI 10.1038/nrgastro.2013.244; RIEDER H, 1987, HEPATOLOGY, V7, P856, DOI 10.1002/hep.1840070511; Rocha AS, 2015, CELL REP, V13, P1757, DOI 10.1016/j.celrep.2015.10.049; Ruart M, 2019, J HEPATOL, V70, P458, DOI 10.1016/j.jhep.2018.10.015; Sakata K, 2014, BIOCHEM BIOPH RES CO, V443, P950, DOI 10.1016/j.bbrc.2013.12.074; Sato Y, 2016, MOL THER, V24, P788, DOI 10.1038/mt.2015.222; Scholzel K, 2014, J HEPATOL, V61, P600, DOI 10.1016/j.jhep.2014.04.028; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Schurich A, 2010, J IMMUNOL, V184, P4107, DOI 10.4049/jimmunol.0902580; Sellaro TL, 2007, TISSUE ENG, V13, P2301, DOI 10.1089/ten.2006.0437; Shan Z, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00322; Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128; Shetty S, 2018, NAT REV GASTRO HEPAT, V15, P555, DOI 10.1038/s41575-018-0020-y; Smedsrod B, 1997, BIOCHEM J, V322, P567, DOI 10.1042/bj3220567; Sorensen KK, 2015, COMPR PHYSIOL, V5, P1751, DOI 10.1002/cphy.c140078; STEINHOFF G, 1993, AM J PATHOL, V142, P481; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; Wang RS, 2015, J BIOL CHEM, V290, P30684, DOI 10.1074/jbc.M115.671735; Warren A, 2007, J HEPATOL, V46, P239, DOI 10.1016/j.jhep.2006.08.022; Weiskirchen R, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010016; Xie GH, 2012, GASTROENTEROLOGY, V142, P918, DOI 10.1053/j.gastro.2011.12.017; Yang L, 2014, GASTROENTEROLOGY, V146, P1339, DOI 10.1053/j.gastro.2014.01.061	105	3	3	7	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22125	10.1096/fj.202101426R	http://dx.doi.org/10.1096/fj.202101426R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34958687	Green Published, hybrid			2022-12-28	WOS:000734992000018
J	Nagata, N; Hamasaki, Y; Inagaki, S; Nakamura, T; Horikami, D; Yamamoto-Hanada, K; Inuzuka, Y; Shimosawa, T; Kobayashi, K; Narita, M; Ohya, Y; Murata, T				Nagata, Nanae; Hamasaki, Yuta; Inagaki, Shinichiro; Nakamura, Tatsuro; Horikami, Daiki; Yamamoto-Hanada, Kiwako; Inuzuka, Yusuke; Shimosawa, Tatsuo; Kobayashi, Koji; Narita, Masami; Ohya, Yukihiro; Murata, Takahisa			Urinary lipid profile of atopic dermatitis in murine model and human patients	FASEB JOURNAL			English	Article						atopic dermatitis; human patient; lipid; murine model; urine	LANGERHANS CELLS; MEDIATORS; CHILDREN; SKIN; IGE	Atopic dermatitis (AD) is the most common inflammatory skin disease in children. The serum level of thymus and activation-regulated chemokine (TARC) is a useful AD index to reflect disease severity; however, it requires blood collection from young children. In comparison, urine samples are easier to collect in a pediatric clinical setting. Here, we analyzed the lipids excreted in urine to identify a diagnostic biomarker for AD. We generated a murine dermatitis model by repeated topical application of 2,4-dinitrofluorobenzene (DNFB) or tape-stripping the dorsal skin. Lipid metabolites excreted in the urine were comprehensively analyzed using liquid chromatography-tandem mass spectrometry. To corroborate our findings, we also analyzed urine samples from patients with AD. DNFB application induced AD-like skin lesions, including epidermal thickening, infiltration of eosinophils and T cells, and an increase in Th2 cytokine levels. Assessment of lipids excreted in urine showed a dominance of prostaglandins (PGs), namely, a PGF(2 alpha) metabolite (13,14-dihydro-15-keto-tetranor-PGF(1 alpha)), a PGE(2) metabolite (13,14-dihydro-15-keto-tetranor-PGE(2)), and a PGD(2) metabolite (13,14-dihydro-15-keto PGJ(2)). mRNA and protein expression of PGF(2 alpha), PGE(2), and PGD(2) synthase was upregulated in DNFB-treated skin. The tape-stripping model also caused dermatitis but without Th2 inflammation; urine PGF(2 alpha) and PGD(2) metabolite levels remained unaffected. Finally, we confirmed that the urinary levels of the aforementioned PG metabolites, as well as PGI(2) metabolite, 6,15-diketo-13,14-dihydro-PGF(1 alpha) and arachidonic acid metabolite, 17-hydroxyeicosatetraenoic acid (17-HETE) increased in patients with AD. Our data highlights the unique urinary lipid profile in patients with AD, which may provide insight into novel urinary biomarkers for AD diagnosis.	[Nagata, Nanae; Hamasaki, Yuta; Nakamura, Tatsuro; Horikami, Daiki; Kobayashi, Koji; Murata, Takahisa] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Tokyo, Japan; [Inagaki, Shinichiro; Yamamoto-Hanada, Kiwako; Inuzuka, Yusuke; Narita, Masami; Ohya, Yukihiro] Natl Ctr Child Hlth & Dev, Allergy Ctr, Tokyo, Japan; [Shimosawa, Tatsuo] Int Univ Hlth & Welf, Sch Med, Dept Clin Lab, Chiba, Japan	University of Tokyo; National Center for Child Health & Development - Japan; International University of Health & Welfare	Murata, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.; Ohya, Y (corresponding author), Natl Ctr Child Hlth & Dev, Allergy Ctr, Setagaya Ku, 2-10-1 Ohkura, Tokyo 1578535, Japan.	ohya-y@ncchd.go.jp; amurata@mail.ecc.u-tokyo.ac.jp	Yamamoto-Hanada, Kiwako/AAR-3094-2020; Yamamoto-Hanada, Kiwako/GQH-6445-2022	Yamamoto-Hanada, Kiwako/0000-0003-1288-9620; Yamamoto-Hanada, Kiwako/0000-0003-1288-9620; Murata, Takahisa/0000-0002-3328-0796	Japan Society for the Promotion of Science [20H05678, 17H06252, 18K14603, 19K16603, 19H03569, 19K15975]; Kobayashi Foundation; Shimadzu Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kobayashi Foundation; Shimadzu Science Foundation	Japan Society for the Promotion of Science, Grant/Award Number: 20H05678, 17H06252, 18K14603, 19K16603, 19H03569 and 19K15975; Kobayashi Foundation; Shimadzu Science Foundation	Akdis CA, 2006, J ALLERGY CLIN IMMUN, V118, P152, DOI 10.1016/j.jaci.2006.03.045; Black AT, 2008, TOXICOL APPL PHARM, V232, P14, DOI 10.1016/j.taap.2008.05.017; Bylund J, 2001, ARCH BIOCHEM BIOPHYS, V389, P123, DOI 10.1006/abbi.2001.2322; Carroll MA, 1996, AM J PHYSIOL-REG I, V271, pR863, DOI 10.1152/ajpregu.1996.271.4.R863; Carroll MA, 1997, KIDNEY INT, V51, P1696, DOI 10.1038/ki.1997.234; Dainichi T, 2018, NAT IMMUNOL, V19, P1286, DOI 10.1038/s41590-018-0256-2; FOGH K, 1989, J ALLERGY CLIN IMMUN, V83, P450, DOI 10.1016/0091-6749(89)90132-2; Furue M, 2015, J DERMATOL SCI, V80, P83, DOI 10.1016/j.jdermsci.2015.07.011; Inagaki S, 2018, J ALLERGY CLIN IMMUN, V142, P1634, DOI 10.1016/j.jaci.2018.06.032; Kabututu Z, 2009, J BIOCHEM, V145, P161, DOI 10.1093/jb/mvn152; Katoh N, 2020, ALLERGOL INT, V69, P356, DOI 10.1016/j.alit.2020.02.006; Komoto J, 2004, BIOCHEMISTRY-US, V43, P2188, DOI 10.1021/bi036046x; Kostenis E, 2006, TRENDS MOL MED, V12, P148, DOI 10.1016/j.molmed.2006.02.005; Maeda S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17798-w; Mantel A, 2012, J INVEST DERMATOL, V132, P1103, DOI 10.1038/jid.2011.412; Martinez-Silvestre A, 2005, RES VET SCI, V78, P127, DOI 10.1016/j.rvsc.2004.07.009; Masuoka M, 2012, J CLIN INVEST, V122, P2590, DOI 10.1172/JCI58978; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Nagao M, 2018, J ALLERGY CLIN IMMUN, V141, P1934, DOI 10.1016/j.jaci.2018.01.021; Nakajima S, 2012, J ALLERGY CLIN IMMUN, V129, P1048, DOI 10.1016/j.jaci.2012.01.063; Ohkusu-Tsukada K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21049-x; Otsuka A, 2017, IMMUNOL REV, V278, P246, DOI 10.1111/imr.12545; Oymar K, 2004, ACTA DERM-VENEREOL, V84, P359, DOI 10.1080/00015550410035515; PENTLAND AP, 1986, J CLIN INVEST, V77, P246, DOI 10.1172/JCI112283; Schiering C, 2017, NATURE, V542, P242, DOI 10.1038/nature21080; Shimanaka Y, 2017, NAT MED, V23, P1287, DOI 10.1038/nm.4417; Shoieb SM, 2019, CHEM-BIOL INTERACT, V299, P140, DOI 10.1016/j.cbi.2018.12.004; STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298; Sugimoto M, 2006, EXP DERMATOL, V15, P875, DOI 10.1111/j.1600-0625.2006.00480.x; Takeuchi S, 2015, ACTA DERM-VENEREOL, V95, P480, DOI 10.2340/00015555-1989; Tenor H, 1996, BRIT J PHARMACOL, V118, P1727, DOI 10.1111/j.1476-5381.1996.tb15598.x; Thijs J, 2015, CURR OPIN ALLERGY CL, V15, P453, DOI 10.1097/ACI.0000000000000198; Werz O, 2006, PHARMACOL THERAPEUT, V112, P701, DOI 10.1016/j.pharmthera.2006.05.009; WILLIAMS DE, 1984, J BIOL CHEM, V259, P4600; Xiao T, 2003, CYTOKINE, V23, P126, DOI 10.1016/S1043-4666(03)00221-7	35	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21949	10.1096/fj.202100828R	http://dx.doi.org/10.1096/fj.202100828R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34591339				2022-12-28	WOS:000712009200022
J	Hughes, S; Edwards, JK; Wilcox, AG; Pothecary, CA; Barnard, AR; Joynson, R; Joynson, G; Hankins, MW; Peirson, SN; Banks, G; Nolan, PM				Hughes, Steven; Edwards, Jessica K.; Wilcox, Ashleigh G.; Pothecary, Carina A.; Barnard, Alun R.; Joynson, Russell; Joynson, Greg; Hankins, Mark W.; Peirson, Stuart N.; Banks, Gareth; Nolan, Patrick M.			Zfhx3 modulates retinal sensitivity and circadian responses to light	FASEB JOURNAL			English	Article						amacrine cell; light sensitivity; mutation; pleiotropy; pupillary reflex	GANGLION-CELLS	Mutations in transcription factors often exhibit pleiotropic effects related to their complex expression patterns and multiple regulatory targets. One such mutation in the zinc finger homeobox 3 (ZFHX3) transcription factor, short circuit (Sci, Zfhx3(Sci/+)), is associated with significant circadian deficits in mice. However, given evidence of its retinal expression, we set out to establish the effects of the mutation on retinal function using molecular, cellular, behavioral and electrophysiological measures. Immunohistochemistry confirms the expression of ZFHX3 in multiple retinal cell types, including GABAergic amacrine cells and retinal ganglion cells including intrinsically photosensitive retinal ganglion cells (ipRGCs). Zfhx3(Sci/+)mutants display reduced light responsiveness in locomotor activity and circadian entrainment, relatively normal electroretinogram and optomotor responses but exhibit an unexpected pupillary reflex phenotype with markedly increased sensitivity. Furthermore, multiple electrode array recordings of Zfhx3(Sci/+)retina show an increased sensitivity of ipRGC light responses.	[Hughes, Steven; Pothecary, Carina A.; Hankins, Mark W.; Peirson, Stuart N.] Univ Oxford, Sir William Dunn Sch Pathol, Sleep & Circadian Neurosci Inst, Nuffield Dept Clin Neurosci, Oxford, England; [Edwards, Jessica K.; Wilcox, Ashleigh G.; Joynson, Russell; Joynson, Greg; Banks, Gareth; Nolan, Patrick M.] MRC Harwell Inst, Didcot, Oxon, England; [Barnard, Alun R.] Univ Oxford, Dept Clin Neurosci, Nuffield Lab Ophthalmol, Oxford, England	University of Oxford; MRC Harwell; University of Oxford	Nolan, PM (corresponding author), MRC Harwell, Neurobehav Genet, Harwell Sci & Innovat Campus, Didcot OX11 0RD, Oxon, England.	p.nolan@har.mrc.ac.uk			MRC [MC_U142684173]; BBSRC [BB/I021086/1]; Wellcome Trust [098461/Z/12/Z]	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	MRC, Grant/Award Number: MC_U142684173; BBSRC, Grant/Award Number: BB/I021086/1; Wellcome Trust, Grant/Award Number: 098461/Z/12/Z	Bacon Y, 2004, GENES BRAIN BEHAV, V3, P196, DOI 10.1111/j.1601-183X.2004.00070.x; Banks G, 2015, NEUROBIOL AGING, V36, P380, DOI 10.1016/j.neurobiolaging.2014.07.040; Banks Gareth T, 2011, Curr Protoc Mouse Biol, V1, P369, DOI 10.1002/9780470942390.mo110123; Barnard AR, 2011, EXP EYE RES, V93, P771, DOI 10.1016/j.exer.2011.07.004; Bedont JL, 2014, CELL REP, V7, P609, DOI 10.1016/j.celrep.2014.03.060; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Ehlen JC, 2009, AM J PHYSIOL-REG I, V296, pR1606, DOI 10.1152/ajpregu.90878.2008; Felder-Schmittbuhl MP, 2018, INVEST OPHTH VIS SCI, V59, P4856, DOI 10.1167/iovs.18-24957; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hughes S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28086; Hughes S, 2013, CURR BIOL, V23, P1696, DOI 10.1016/j.cub.2013.07.010; Hughes S, 2012, EUR J NEUROSCI, V35, P34, DOI 10.1111/j.1460-9568.2011.07944.x; Ishii Y, 2003, J COMP NEUROL, V465, P57, DOI 10.1002/cne.10807; Laranjeiro R, 2014, DEVELOPMENT, V141, P2644, DOI 10.1242/dev.104380; Lucas RJ, 2014, TRENDS NEUROSCI, V37, P1, DOI 10.1016/j.tins.2013.10.004; Mayer C, 2018, NATURE, V555, P457, DOI 10.1038/nature25999; McMahon DG, 2014, PROG RETIN EYE RES, V39, P58, DOI 10.1016/j.preteyeres.2013.12.001; Parsons MJ, 2015, CELL, V162, P607, DOI 10.1016/j.cell.2015.06.060; Rodgers J, 2018, HUM MOL GENET, V27, P2589, DOI 10.1093/hmg/ddy150; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Villard J, 2004, SWISS MED WKLY, V134, P571; Wilcox AG, 2017, J BIOL RHYTHM, V32, P433, DOI 10.1177/0748730417722631; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Zhang ZZ, 2019, EXP NEUROL, V322, DOI 10.1016/j.expneurol.2019.113055	25	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21802	10.1096/fj.202100563R	http://dx.doi.org/10.1096/fj.202100563R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34383984	hybrid, Green Published			2022-12-28	WOS:000691122900008
J	Zhang, Q; Fang, YL; Lv, CJ; Zhu, YR; Xia, YF; Wei, ZF; Dai, Y				Zhang, Qin; Fang, Yulai; Lv, Changjun; Zhu, Yanrong; Xia, Yufeng; Wei, Zhifeng; Dai, Yue			Norisoboldine induces the development of Treg cells by promoting fatty acid oxidation-mediated H3K27 acetylation of Foxp3	FASEB JOURNAL			English	Article						collagen-induced arthritis; fatty acid oxidation; norisoboldine; regulatory T cells	REGULATORY T-CELLS; MACROPHAGE METABOLISM	Norisoboldine (NOR), an alkaloid isolated from Radix Lindera, was previously reported to promote the differentiation of regulatory T cells (Treg cells), an important subtype of lymphocytes capable of controlling autoimmune diseases. The present study was performed to explore the mechanism of NOR in the view of cellular metabolism. A global metabolomic analysis indicated that NOR preferentially altered the fatty acid oxidation (FAO) pathway and elevated the content of related metabolites during Treg cell differentiation. The detection of oxygen consumption rate (OCR) and mRNA expression of FAO-related enzymes demonstrated that NOR promoted FAO in the early stage of Treg cell differentiation. Consistently, pharmacological or genetic inhibition of FAO markedly diminished the induction of NOR on Treg cell differentiation. Furthermore, NOR was shown to elevate the level of acetyl-CoA derived from FAO and acetylation of lysine 27 on histone 3 (H3K27) at the Foxp3 promoter and CNS2 regions. A knockdown of CPT1, the rate-limiting enzyme of FAO, weakened the promotion of NOR on the development, acetyl-CoA level, and acetylation of H3K27 of Treg cells in vitro and in the mice with collagen-induced arthritis, and attenuated the anti-arthritic effect of NOR. These findings demonstrate that NOR induces the development of Treg cells through promoting FAO, therefore, facilitating gene transcription of Foxp3 via acetyl-CoA-mediated H3K27 acetylation modification, and FAO might serve as a novel target to induce Treg cell development.	[Zhang, Qin; Fang, Yulai; Lv, Changjun; Zhu, Yanrong; Xia, Yufeng; Wei, Zhifeng; Dai, Yue] China Pharmaceut Univ, Sch Tradit Chinese Pharm, Dept Pharmacol Chinese Mat Med, Nanjing 210009, Peoples R China	China Pharmaceutical University	Wei, ZF; Dai, Y (corresponding author), China Pharmaceut Univ, Sch Tradit Chinese Pharm, Dept Pharmacol Chinese Mat Med, Nanjing 210009, Peoples R China.	1020132346@cpu.edu.cn; yuedaicpu@cpu.edu.cn			National Natural Science Foundation of China (NSFC) [81872881]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81872881	Almeida L, 2016, SEMIN IMMUNOL, V28, P514, DOI 10.1016/j.smim.2016.10.009; Baeten P, 2022, CLIN REV ALLERG IMMU, V62, P363, DOI 10.1007/s12016-021-08866-1; Bailis W, 2019, NATURE, V571, P403, DOI 10.1038/s41586-019-1311-3; Bluestone JA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad4134; Bradshaw PC, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10040572; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Chang L, 2021, BIOORG MED CHEM LETT, V37, DOI 10.1016/j.bmcl.2021.127844; Chen XL, 2021, CELL IMMUNOL, V365, DOI 10.1016/j.cellimm.2021.104378; Chwojnicki K, 2021, BIODRUGS, V35, P47, DOI 10.1007/s40259-020-00462-7; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Eleftheriadis T, 2016, INT J MOL MED, V38, P1605, DOI 10.3892/ijmm.2016.2750; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Georgiev P, 2019, J CLIN IMMUNOL, V39, P623, DOI 10.1007/s10875-019-00684-7; Guo Q, 2021, J BONE MINER RES, V36, P2065, DOI 10.1002/jbmr.4399; Hague M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00209; Hawse WF, 2019, J IMMUNOL, V203, P2771, DOI 10.4049/jimmunol.1900749; Iizuka-Koga M, 2017, J AUTOIMMUN, V83, P113, DOI 10.1016/j.jaut.2017.07.002; Lauterbach MA, 2019, IMMUNITY, V51, P997, DOI 10.1016/j.immuni.2019.11.009; Li XH, 2021, NEURON, V109, DOI 10.1016/j.neuron.2021.01.005; Liu RT, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1095-7; Lv Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0297-3; Metzler B, 2016, J IMMUNOL, V196, P3618, DOI 10.4049/jimmunol.1501756; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Miyara M, 2014, NAT REV RHEUMATOL, V10, P543, DOI 10.1038/nrrheum.2014.105; Ohkura N, 2020, CELL RES, V30, P465, DOI 10.1038/s41422-020-0324-7; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Pompura SL, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI138519; Saigusa R, 2020, NAT REV CARDIOL, V17, P387, DOI 10.1038/s41569-020-0352-5; Schroeder S, 2014, AUTOPHAGY, V10, P1335, DOI 10.4161/auto.28919; Song DY, 2020, FRONT MED-PRC, V14, P564, DOI 10.1007/s11684-019-0724-6; Spinner CA, 2021, IMMUNOL REV, V300, P65, DOI 10.1111/imr.12935; Takahashi D, 2020, EBIOMEDICINE, V58, DOI 10.1016/j.ebiom.2020.102913; Timblin GA, 2021, NAT METAB, V3, P618, DOI 10.1038/s42255-021-00392-w; Tong B, 2016, INT J BIOCHEM CELL B, V75, P63, DOI 10.1016/j.biocel.2016.03.014; von Knethen A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072356; Wang Y, 2020, EXP MOL MED, V52, P1959, DOI 10.1038/s12276-020-00534-2; Zhang Sheng-Xiao, 2021, Ther Adv Musculoskelet Dis, V13, p1759720X211011370, DOI 10.1177/1759720X211011370; Zhou L, 2021, CELL MOL IMMUNOL, V18, P698, DOI 10.1038/s41423-020-00623-2	39	0	0	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22230	10.1096/fj.202101643R	http://dx.doi.org/10.1096/fj.202101643R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CP	35233835				2022-12-28	WOS:000772945300001
J	Kraft, JD; Blomgran, R; Bergstrom, I; Sotak, M; Clark, M; Rani, A; Rajan, MR; Dalli, J; Nystrom, S; Quiding-Jarbrink, M; Bromberg, J; Skoog, P; Borgeson, E				Kraft, Jamie D.; Blomgran, Robert; Bergstrom, Ida; Sotak, Matus; Clark, Madison; Rani, Alankrita; Rajan, Meenu Rohini; Dalli, Jesmond; Nystrom, Sofia; Quiding-Jarbrink, Marianne; Bromberg, Jonathan; Skoog, Per; Borgeson, Emma			Lipoxins modulate neutrophil oxidative burst, integrin expression and lymphatic transmigration differentially in human health and atherosclerosis	FASEB JOURNAL			English	Article						atherosclerosis; cardiovascular disease; CD11b; CD18 integrin; lipoxins; lymphatics transmigration; neutrophils; reactive oxygen species; resolution of inflammation; specialized pro-resolving mediators	RESOLVING LIPID MEDIATORS; FPR2/ALX RECEPTOR; INFLAMMATION; A(4); RESOLUTION; CELLS; ATORVASTATIN; PROGRESSION; GENERATION; MECHANISM	Dysregulated chronic inflammation plays a crucial role in the pathophysiology of atherosclerosis and may be a result of impaired resolution. Thus, restoring levels of specialized pro-resolving mediators (SPMs) to promote the resolution of inflammation has been proposed as a therapeutic strategy for patients with atherosclerosis, in addition to standard clinical care. Herein, we evaluated the effects of the SPM lipids, lipoxin A(4) (LXA(4)) and lipoxin B-4 (LXB4), on neutrophils isolated from patients with atherosclerosis compared with healthy controls. Patients displayed altered endogenous SPM production, and we demonstrated that lipoxin treatment in whole blood from atherosclerosis patients attenuates neutrophil oxidative burst, a key contributor to atherosclerotic development. We found the opposite effect in neutrophils from healthy controls, indicating a potential mechanism whereby lipoxins aid the endogenous neutrophil function in health but reduce its excessive activation in disease. We also demonstrated that lipoxins attenuated upregulation of the high-affinity conformation of the CD11b/CD18 integrin, which plays a central role in clot activation and atherosclerosis. Finally, LXB4 enhanced lymphatic transmigration of human neutrophils isolated from patients with atherosclerosis. This finding is noteworthy, as impaired lymphatic function is now recognized as an important contributor to atherosclerosis. Although both lipoxins modulated neutrophil function, LXB4 displayed more potent effects than LXA(4) in humans. This study highlights the therapeutic potential of lipoxins in atherosclerotic disease and demonstrates that the effect of these SPMs may be specifically tailored to the need of the individual.	[Kraft, Jamie D.; Sotak, Matus; Clark, Madison; Rani, Alankrita; Rajan, Meenu Rohini; Borgeson, Emma] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med,Wallenberg Lab, S-40530 Gothenburg, Sweden; [Kraft, Jamie D.; Sotak, Matus; Clark, Madison; Rani, Alankrita; Rajan, Meenu Rohini; Borgeson, Emma] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden; [Blomgran, Robert] Linkoping Univ, Fac Med & Hlth Sci, Dept Biomed & Clin Sci, Div Inflammat & Infect, Linkoping, Sweden; [Bergstrom, Ida; Nystrom, Sofia] Linkoping Univ, Dept Clin Immunol & Transfus Med, Linkoping, Sweden; [Bergstrom, Ida; Nystrom, Sofia] Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden; [Sotak, Matus; Rani, Alankrita; Rajan, Meenu Rohini; Borgeson, Emma] Sahlgrens Univ Hosp, Dept Clin Physiol, Reg Vaestra Goetaland, Gothenburg, Sweden; [Dalli, Jesmond] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Dalli, Jesmond] Queen Mary Univ London, Ctr Inflammat & Therapeut Innovat, London, England; [Quiding-Jarbrink, Marianne] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Bromberg, Jonathan] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Bromberg, Jonathan] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Bromberg, Jonathan] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Bromberg, Jonathan] Univ Maryland, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA; [Skoog, Per] Sahlgrenska Univ Hosp & Acad, Dept Vasc Surg, Gothenburg, Sweden; [Skoog, Per] Sahlgrenska Univ Hosp & Acad, Inst Med, Gothenburg, Sweden; [Skoog, Per] Sahlgrenska Univ Hosp & Acad, Dept Mol & Clin Med, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; Linkoping University; Linkoping University; Linkoping University; Sahlgrenska University Hospital; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Gothenburg; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg	Borgeson, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med,Wallenberg Lab, S-40530 Gothenburg, Sweden.	emma.borgeson@wlab.gu.se	NystrÃm, Sofia/GYQ-5893-2022; Skoog, Per/HDO-6164-2022; Sotak, Matus/C-3407-2013	Sotak, Matus/0000-0002-9984-9340; Blomgran, Robert/0000-0002-2767-8175; Rani, Alankrita/0000-0003-3412-0994; Skoog, Per/0000-0003-0934-0063; Dalli, Jesmond/0000-0001-6328-3640	Vetenskapsradet (VR) [2016/82]; Svenska Sallskapet for Medicinsk Forskning (SSMF) [S150086]; EC \ H2020 \ H2020 Priority Excellent Science \ H2020 European Research Council (ERC) [804418]; Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation)	Vetenskapsradet (VR)(Swedish Research Council); Svenska Sallskapet for Medicinsk Forskning (SSMF); EC \ H2020 \ H2020 Priority Excellent Science \ H2020 European Research Council (ERC); Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation)	Vetenskapsradet (VR), Grant/Award Number: 2016/82; Svenska Sallskapet for Medicinsk Forskning (SSMF), Grant/Award Number: S150086; EC | H2020 | H2020 Priority Excellent Science | H2020 European Research Council (ERC), Grant/Award Number: 804418; Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation)	Back M, 2019, NAT REV CARDIOL, V16, P389, DOI 10.1038/s41569-019-0169-2; Basil MC, 2016, NAT REV IMMUNOL, V16, P51, DOI 10.1038/nri.2015.4; Birnbaum Y, 2006, CIRCULATION, V114, P929, DOI 10.1161/CIRCULATIONAHA.106.629907; Borgeson E, 2015, CELL METAB, V22, P125, DOI 10.1016/j.cmet.2015.05.003; Borgeson E, 2012, FASEB J, V26, P4287, DOI 10.1096/fj.12-208249; Borgeson E, 2011, FASEB J, V25, P2967, DOI 10.1096/fj.11-185017; Borgeson E, 2011, INFECT IMMUN, V79, P1489, DOI 10.1128/IAI.00777-10; Brennan EP, 2018, DIABETES, V67, P2657, DOI 10.2337/db17-1317; Chandrasekharan JA, 2015, J INFLAMM RES, V8, P181, DOI 10.2147/JIR.S90380; Chistiakov DA, 2015, EXP MOL PATHOL, V99, P663, DOI 10.1016/j.yexmp.2015.11.011; Cochain C, 2018, CARDIOVASC RES, V114, P1573, DOI 10.1093/cvr/cvy168; Conte MS, 2018, J CLIN INVEST, V128, P3727, DOI 10.1172/JCI97947; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; Dalli J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149319; Doring Y, 2015, ARTERIOSCL THROM VAS, V35, P288, DOI 10.1161/ATVBAHA.114.303564; Drechsler M, 2015, CIRC RES, V116, P827, DOI 10.1161/CIRCRESAHA.116.305825; Drechsler M, 2011, THROMB HAEMOSTASIS, V106, P839, DOI 10.1160/TH11-07-0501; Elajami TK, 2016, FASEB J, V30, P2792, DOI 10.1096/fj.201500155R; Fava C, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00055; Fredman G, 2017, AM J PATHOL, V187, P1211, DOI 10.1016/j.ajpath.2017.01.018; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Fredman G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1065; Fulop T, 2019, GERONTOLOGY, V65, P495, DOI 10.1159/000497375; Gavins FNE, 2010, TRENDS PHARMACOL SCI, V31, P266, DOI 10.1016/j.tips.2010.04.001; Geovanini GR, 2018, CLIN SCI, V132, P1243, DOI 10.1042/CS20180306; Gilroy DW, 2005, PROSTAG LEUKOTR ESS, V73, P203, DOI 10.1016/j.plefa.2005.05.007; Gomez EA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19176-z; Hasturk H, 2015, ARTERIOSCL THROM VAS, V35, P1123, DOI 10.1161/ATVBAHA.115.305324; Headland SE, 2015, SEMIN IMMUNOL, V27, P149, DOI 10.1016/j.smim.2015.03.014; Husten L., 2017, EXPERTS CAUTION CANT; Ionita MG, 2010, ARTERIOSCL THROM VAS, V30, P1842, DOI 10.1161/ATVBAHA.110.209296; Kasikara C, 2018, J CLIN INVEST, V128, P2713, DOI 10.1172/JCI97950; Kauffman D., 2020, CARDIOVASCULAR DIS B; Koenis DS, 2021, CIRC RES, V129, pE54, DOI 10.1161/CIRCRESAHA.121.319142; Kraft JD, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052750; Levy BD, 2006, CIRCULATION, V114, P873, DOI 10.1161/CIRCULATIONAHA.106.647925; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liu GZ, 2018, FASEB J, V32, P5413, DOI 10.1096/fj.201800173R; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; Maderna P, 2010, FASEB J, V24, P4240, DOI 10.1096/fj.10-159913; Milasan A, 2019, ATHEROSCLEROSIS, V283, P106, DOI 10.1016/j.atherosclerosis.2019.01.031; Nascimento-Silva V, 2007, THROMB HAEMOSTASIS, V97, P88, DOI 10.1160/TH06-06-0315; Nguyen GT, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00373; Perretti M, 2020, BRIT J PHARMACOL, V177, P4595, DOI 10.1111/bph.15212; Petri MH, 2018, JACC-BASIC TRANSL SC, V3, P719, DOI 10.1016/j.jacbts.2018.08.005; Petri MH, 2017, BRIT J PHARMACOL, V174, P4043, DOI 10.1111/bph.13707; Petri MH, 2015, CARDIOVASC RES, V105, P65, DOI 10.1093/cvr/cvu224; Petri MH, 2015, INT J CARDIOL, V179, P370, DOI 10.1016/j.ijcard.2014.11.010; Pirault J, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01273; Rademakers T, 2017, SCI REP-UK, V7, DOI 10.1038/srep45263; Rajan MR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51673-0; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ruparelia N, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2016.185; Salic K, 2016, ATHEROSCLEROSIS, V250, P158, DOI 10.1016/j.atherosclerosis.2016.05.001; Sarndahl E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001056; Serhan CN, 2017, MOL ASPECTS MED, V58, P1, DOI 10.1016/j.mam.2017.03.001; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2005, PROSTAG LEUKOTR ESS, V73, P141, DOI 10.1016/j.plefa.2005.05.002; Silvestre-Roig C, 2020, NAT REV CARDIOL, V17, P327, DOI 10.1038/s41569-019-0326-7; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Thul S, 2017, EUR J PREV CARDIOL, V24, P903, DOI 10.1177/2047487317694464; Titos E, 2013, PROSTAG OTH LIPID M, V107, P77, DOI 10.1016/j.prostaglandins.2013.05.003; Vasconcelos DP, 2015, BIOMATERIALS, V37, P116, DOI 10.1016/j.biomaterials.2014.10.035; Viola JR, 2016, CIRC RES, V119, P1030, DOI 10.1161/CIRCRESAHA.116.309492; Wenceslau CF, 2014, J VASC RES, V51, P407, DOI 10.1159/000371490; Wu Y, 2012, NEUROCHEM RES, V37, P1690, DOI 10.1007/s11064-012-0776-3; Xiong YB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01575-w; Yeo KP, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10061344; Zhou GY, 2010, CARDIOLOGY, V115, P221, DOI 10.1159/000296017; Zhou Y, 2020, EXP THER MED, V20, P1682, DOI 10.3892/etm.2020.8812; Zong L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6815727	74	3	3	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22173	10.1096/fj.202101219RR	http://dx.doi.org/10.1096/fj.202101219RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35104001	Green Published			2022-12-28	WOS:000761250800032
J	Niehues, RV; Wozniak, J; Wiersch, F; Lilienthal, E; Tacken, N; Schumertl, T; Garbers, C; Ludwig, A; Dusterhoft, S				Niehues, Rabea Victoria; Wozniak, Justyna; Wiersch, Florian; Lilienthal, Eva; Tacken, Nikola; Schumertl, Tim; Garbers, Christoph; Ludwig, Andreas; Duesterhoeft, Stefan			The collectrin-like part of the SARS-CoV-1 and-2 receptor ACE2 is shed by the metalloproteinases ADAM10 and ADAM17	FASEB JOURNAL			English	Article						ADAM10; ADAM17; ectodomain shedding; SARS-CoV receptor; soluble ACE2	CONVERTING ENZYME 2; FACTOR-ALPHA; SUBSTRATE SELECTIVITY; SPIKE PROTEIN; SARS-COV; IRHOM2; DISINTEGRIN; ACTIVATION; CELLS; CLEAVAGE	The transmembrane protease angiotensin converting enzyme 2 (ACE2) is a protective regulator within the renin angiotensin system and additionally represents the cellular receptor for SARS-CoV. The release of soluble ACE2 (sACE2) from the cell surface is hence believed to be a crucial part of its (patho)physiological functions, as both, ACE2 protease activity and SARS-CoV binding ability, are transferred from the cell membrane to body fluids. Yet, the molecular sources of sACE2 are still not completely investigated. In this study, we show different sources and prerequisites for the release of sACE2 from the cell membrane. By using inhibitors as well as CRISPR/Cas9-derived cells, we demonstrated that, in addition to the metalloprotease ADAM17, also ADAM10 is an important novel shedding protease of ACE2. Moreover, we observed that ACE2 can also be released in extracellular vesicles. The degree of either ADAM10- or ADAM17-mediated ACE2 shedding is dependent on stimulatory conditions and on the expression level of the pro-inflammatory ADAM17 regulator iRhom2. Finally, by using structural analysis and in vitro verification, we determined for the first time that the susceptibility to ADAM10- and ADAM17-mediated shedding is mediated by the collectrin-like part of ACE2. Overall, our findings give novel insights into sACE2 release by several independent molecular mechanisms.	[Niehues, Rabea Victoria; Wozniak, Justyna; Wiersch, Florian; Lilienthal, Eva; Tacken, Nikola; Ludwig, Andreas; Duesterhoeft, Stefan] Rhein Westfal TH Aachen, Med Fac, Inst Mol Pharmacol, Aachen, Germany; [Schumertl, Tim; Garbers, Christoph] Otto von Guericke Univ, Med Fac, Dept Pathol, Magdeburg, Germany	RWTH Aachen University; Otto von Guericke University	Ludwig, A; Dusterhoft, S (corresponding author), Rhein Westfal TH Aachen, Inst Mol Pharmacol, Wendlingweg 2, D-52074 Aachen, Germany.	aludwig@ukaachen.de; sduesterhoeft@ukaachen.de	Garbers, Christoph/D-9932-2015	Garbers, Christoph/0000-0003-4939-6950; Dusterhoft, Stefan/0000-0002-6926-136X	Deutsche Forschungsgemeinschaft (DFG) [DU 1582/1-1, LU 869/9-1]; RWTH Aachen \ Medizinische Fakultat, RWTH Aachen University (Medical Faculty, RWTH Aachen University) [691903-06/19]; Bundesministerium fur Bildung und Forschung (BMBF) [01KI20207]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); RWTH Aachen \ Medizinische Fakultat, RWTH Aachen University (Medical Faculty, RWTH Aachen University); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: DU 1582/1-1 and LU 869/9-1; RWTH Aachen | Medizinische Fakultat, RWTH Aachen University (Medical Faculty, RWTH Aachen University), Grant/Award Number: START #691903-06/19; Bundesministerium fur Bildung und Forschung (BMBF), Grant/Award Number: 01KI20207	Abd El-Aziz TM, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00374-6; Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Adrain C, 2011, EMBO REP, V12, P421, DOI 10.1038/embor.2011.50; Andring JT., 2020, AMINO ACID TRANSPORT, DOI [10.1101/2020.1110.1130.361873, DOI 10.1101/2020.1110.1130.361873]; Anguiano L, 2017, CURR MED CHEM, V24, P3231, DOI 10.2174/0929867324666170414162841; Arndt PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019938; Babendreyer A, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.610344; Bleibaum F, 2019, J MOL CELL BIOL, V11, P979, DOI 10.1093/jmcb/mjz008; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Camargo SMR, 2009, GASTROENTEROLOGY, V136, P872, DOI 10.1053/j.gastro.2008.10.055; Caolo V, 2020, ELIFE, V9, DOI 10.7554/eLife.50684; Chan KK, 2020, SCIENCE, V369, P1261, DOI 10.1126/science.abc0870; Christova Y, 2013, EMBO REP, V14, P884, DOI 10.1038/embor.2013.128; Clarke NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034747; Cocozza F, 2020, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12050; Danser AHJ, 2020, HYPERTENSION, V75, P1382, DOI 10.1161/HYPERTENSIONAHA.120.15082; Dempsey PJ, 2017, BBA-MOL CELL RES, V1864, P2228, DOI 10.1016/j.bbamcr.2017.07.011; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Dreymueller D, 2014, J IMMUNOL, V192, P722, DOI 10.4049/jimmunol.1302496; Dreymueller D, 2012, EMBO MOL MED, V4, P412, DOI 10.1002/emmm.201200217; Dreymueller D, 2012, EUR J CELL BIOL, V91, P472, DOI 10.1016/j.ejcb.2011.09.003; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dusterhoft S, 2019, BBA-MOL CELL RES, V1866, P1567, DOI 10.1016/j.bbamcr.2019.06.017; Dusterhoft S, 2021, CELL MOL LIFE SCI, V78, P5015, DOI 10.1007/s00018-021-03845-3; Endres K, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00056; Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015; Glowacka I, 2010, J VIROL, V84, P1198, DOI 10.1128/JVI.01248-09; Groth E, 2016, BBA-MOL CELL RES, V1863, P2795, DOI 10.1016/j.bbamcr.2016.09.002; Haga S, 2010, ANTIVIR RES, V85, P551, DOI 10.1016/j.antiviral.2009.12.001; Harper MT, 2011, J THROMB HAEMOST, V9, P1599, DOI 10.1111/j.1538-7836.2011.04393.x; Heurich A, 2014, J VIROL, V88, P1293, DOI 10.1128/JVI.02202-13; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Hundhausen C, 2007, J IMMUNOL, V178, P8064, DOI 10.4049/jimmunol.178.12.8064; Inada M, 2016, INT J MOL MED, V37, P1521, DOI 10.3892/ijmm.2016.2568; Issuree PDA, 2013, J CLIN INVEST, V123, P928, DOI 10.1172/JCI66168; Iwata M., 2011, CURR ENZYME INHIBIT, V7, P42, DOI DOI 10.2174/157340811795713756; Iwata M, 2009, AM J PHYSIOL-CELL PH, V297, pC1318, DOI 10.1152/ajpcell.00036.2009; Jaimes JA, 2020, J MOL BIOL, V432, P3309, DOI 10.1016/j.jmb.2020.04.009; Jia HP, 2009, AM J PHYSIOL-LUNG C, V297, pL84, DOI 10.1152/ajplung.00071.2009; Jia HP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18880-0; Johnson N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07556-3; Kato T, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00153; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; Koch L, 2021, FASEB J, V35, DOI 10.1096/fj.202002087R; Kowalczuk S, 2008, FASEB J, V22, P2880, DOI 10.1096/fj.08-107300; Kuba K, 2013, CIRC J, V77, P301, DOI 10.1253/circj.CJ-12-1544; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Lambrecht BN, 2018, NAT REV IMMUNOL, V18, P745, DOI 10.1038/s41577-018-0068-5; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lorenzen I, 2016, SCI REP-UK, V6, DOI 10.1038/srep35067; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Maretzky T, 2013, P NATL ACAD SCI USA, V110, P11433, DOI 10.1073/pnas.1302553110; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Palau V, 2020, NEPHROL DIAL TRANSPL, V35, P1071, DOI 10.1093/ndt/gfaa093; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Rahman MM, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2213; Riera M, 2016, AM J PHYSIOL-RENAL, V310, pF534, DOI 10.1152/ajprenal.00082.2015; Riethmueller S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25550; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Seifert A, 2021, CELL MOL LIFE SCI, V78, P715, DOI 10.1007/s00018-020-03507-w; SHIVNAN E, 1995, J IMMUNOL, V154, P1146; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siggs OM, 2012, BLOOD, V119, P5769, DOI 10.1182/blood-2012-03-417949; Simossis VA, 2003, COMPUT BIOL CHEM, V27, P511, DOI 10.1016/j.compbiolchem.2003.09.002; Sommer A, 2016, CELL CYCLE, V15, P2995, DOI 10.1080/15384101.2016.1211449; Sommer A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11523; Stepanova G, 2021, BIOL FUTURA, V72, P291, DOI 10.1007/s42977-021-00092-2; Stevens BR., 2020, TMPRSS2 ADAM17 INTER, DOI [10.1101/2020.1110.1131.363473, DOI 10.1101/2020.1110.1131.363473]; Stevens BR, 2021, FUNCTION, V2, DOI 10.1093/function/zqab027; Vogel AB, 2021, NATURE, V592, P283, DOI 10.1038/s41586-021-03275-y; Wang JJ, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4213541; Wang YL, 2020, INT J MED SCI, V17, P1522, DOI 10.7150/ijms.46695; Wozniak J, 2021, NAT REV NEPHROL, V17, P513, DOI 10.1038/s41581-021-00415-5; Wysocki J, 2021, J AM SOC NEPHROL, V32, P795, DOI 10.1681/ASN.2020101537; Xiao FX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085958; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yeung ML, 2021, CELL, V184, P2212, DOI 10.1016/j.cell.2021.02.053; Yoda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054412; Zoufaly A, 2020, LANCET RESP MED, V8, P1154, DOI 10.1016/S2213-2600(20)30418-5; Zunke F, 2017, BBA-MOL CELL RES, V1864, P2059, DOI 10.1016/j.bbamcr.2017.07.001	92	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22234	10.1096/fj.202101521R	http://dx.doi.org/10.1096/fj.202101521R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35199397	hybrid, Green Published			2022-12-28	WOS:000761250800008
J	Wu, YZ; Chen, YH; Cheng, CT; Ann, DK; Kuo, CY				Wu, Yi-Zhen; Chen, Yi-Hsuan; Cheng, Chun-Ting; Ann, David K.; Kuo, Ching-Ying			Amino acid restriction induces a long non-coding RNA UBA6-AS1 to regulate GCN2-mediated integrated stress response in breast cancer	FASEB JOURNAL			English	Article						amino acid restriction; integrated stress response; long non-coding RNA; PARP1; UBA6-AS1; UBA6-DT	METABOLIC STRESS; DNA-DAMAGE; CELLS; PARP-1; INHIBITION; EXPRESSION; AUTOPHAGY; INDUCTION; APOPTOSIS; LNCRNAS	Oncogene activation, massive proliferation, and increased nutrient demands often result in nutrient and oxygen deprivation in solid tumors including breast cancer (BC), leading to the induction of oxidative stress and endoplasmic reticulum (ER) stress, and subsequently triggering integrated stress response (ISR). To elucidate the role of long non-coding RNAs (lncRNAs) in the ISR of BC, we performed transcriptome analyses and identified a lncRNA, UBA6-AS1, which was upregulated upon amino acid deprivation and ER stress. UBA6-AS1 was preferentially induced in triple-negative BC (TNBC) cells deprived of arginine or glutamine, two critical amino acids required for cancer cell growth, or treated with ER stress inducers. Mechanistically, UBA6-AS1 was regulated through the GCN2/eIF2 alpha/ATF4 pathway, one of the major routes mediating ISR in amino acid sensing. In addition, both in vitro and in vivo assays indicated that UBA6-AS1 promoted TNBC cell survival when cells encountered metabolic stress, implicating a regulatory role of UBA6-AS1 in response to intratumoral metabolic stress during tumor progression. Moreover, PARP1 expression and activity were positively regulated by the GCN2/UBA6-AS1 axis upon amino acid deprivation. In conclusion, our data suggest that UBA6-AS1 is a novel lncRNA regulating ISR upon metabolic stress induction to promote TNBC cell survival. Furthermore, the GCN2-ATF4 axis is important for UBA6-AS1 induction to enhance PARP1 activity and could serve as a marker for the susceptibility of PARP inhibitors in TNBC.	[Wu, Yi-Zhen; Chen, Yi-Hsuan; Kuo, Ching-Ying] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei, Taiwan; [Chen, Yi-Hsuan; Ann, David K.] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Duarte, CA USA; [Cheng, Chun-Ting; Ann, David K.] City Hope Natl Med Ctr, Diabet & Metab Res Inst, Duarte, CA USA; [Kuo, Ching-Ying] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan University; City of Hope; City of Hope; National Taiwan University; National Taiwan University Hospital	Kuo, CY (corresponding author), Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei, Taiwan.	cykuo27@ntu.edu.tw		KUO, CHING-YING/0000-0003-1555-3057	Ministry of Science and Technology [MOST107-2320-B-002-037-MY2, MOST109-2320-B-002-022, MOST110-2320-B-002-061]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	Ministry of Science and Technology, Grant/Award Number: MOST107-2320-B-002-037-MY2, MOST109-2320-B-002-022 and MOST110-2320-B-002-061	Agliarulo I, 2015, BBA-MOL CELL RES, V1853, P2570, DOI 10.1016/j.bbamcr.2015.05.034; Ahmadiankia N, 2020, CELL BIOL INT, V44, P1588, DOI 10.1002/cbin.11368; Anda S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182143; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Balasubramanian MN, 2013, AM J PHYSIOL-ENDOC M, V304, pE789, DOI 10.1152/ajpendo.00015.2013; Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634; Bi FF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/946268; Caino MC, 2013, J CLIN INVEST, V123, P2907, DOI 10.1172/JCI67841; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chang H, 2022, CANCER BIOTHER RADIO, V37, P824, DOI 10.1089/cbr.2020.4394; Chen JX, 2021, AM J CANCER RES, V11, P624; Connerty P, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00285; Darini C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10138-8; Deng SJ, 2019, CANCER RES, V79, P1398, DOI 10.1158/0008-5472.CAN-18-0419; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Domagala P, 2011, BREAST CANCER RES TR, V127, P861, DOI 10.1007/s10549-011-1441-2; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Dutta P, 2020, CANCERS, V12, DOI 10.3390/cancers12051317; Endo H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28074-w; Ewelina W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10307-z; Feng YX, 2014, CANCER DISCOV, V4, P702, DOI 10.1158/2159-8290.CD-13-0945; Fernandes JCR, 2019, NON-CODING RNA, V5, DOI 10.3390/ncrna5010017; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Gagnon KT, 2014, NAT PROTOC, V9, P2045, DOI 10.1038/nprot.2014.135; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; Gallaher JA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39636-x; Gandhi M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17007-9; Garcia-Jimenez C, 2019, CELL METAB, V29, P254, DOI 10.1016/j.cmet.2018.11.018; Gibbons HR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02512; Gwangwa MV, 2019, BIOL RES, V52, DOI 10.1186/s40659-019-0224-9; Han J, 2021, ONCOGENE, V40, P833, DOI 10.1038/s41388-020-01574-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hocsak E, 2017, FREE RADICAL BIO MED, V108, P770, DOI 10.1016/j.freeradbiomed.2017.04.018; Hou WH, 2019, MUTAT RES-REV MUTAT, V780, P82, DOI 10.1016/j.mrrev.2017.09.004; Hu F, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/3405695; Iurlaro R, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00479-16; Jeon H, 2016, ONCOTARGET, V7, P67223, DOI 10.18632/oncotarget.11615; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kan ZY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04129-4; Karlsson Oskar, 2016, Curr Environ Health Rep, V3, P178, DOI 10.1007/s40572-016-0092-1; Khan MR, 2021, TRENDS GENET, V37, P695, DOI 10.1016/j.tig.2021.03.010; Kim KH, 2010, NUCLEIC ACIDS RES, V38, P48, DOI 10.1093/nar/gkp865; Lai JZ, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5798-7; Lieu EL, 2020, EXP MOL MED, V52, P15, DOI 10.1038/s12276-020-0375-3; Liu DX, 2010, CANCER LETT, V296, P194, DOI 10.1016/j.canlet.2010.04.017; Liu Y, 2017, CANCER GENE THER, V24, P208, DOI 10.1038/cgt.2017.6; Long Y, 2017, CANCER LETT, V388, P54, DOI 10.1016/j.canlet.2016.11.028; Luhr M, 2019, J BIOL CHEM, V294, P8197, DOI 10.1074/jbc.RA118.002829; Luo S, 2016, CELL STEM CELL, V18, P637, DOI 10.1016/j.stem.2016.01.024; Mahmood T, 2012, N AM J MED SCI, V4, P429, DOI 10.4103/1947-2714.100998; Rodriguez-Vargas JM, 2012, CELL RES, V22, P1181, DOI 10.1038/cr.2012.70; Martinet W, 2005, BIOTECHNOL LETT, V27, P1157, DOI 10.1007/s10529-005-0007-y; Martinez-Romero R, 2008, J CELL BIOCHEM, V104, P2248, DOI 10.1002/jcb.21781; McCann Kelly E, 2018, Drugs Context, V7, P212540, DOI 10.7573/dic.212540; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nyunt T, 2019, FREE RADICAL BIO MED, V143, P25, DOI 10.1016/j.freeradbiomed.2019.07.024; Okazaki A, 2017, J CLIN INVEST, V127, P1631, DOI 10.1172/JCI87800; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Pan M, 2016, NAT CELL BIOL, V18, P1090, DOI 10.1038/ncb3410; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Peeters JGC, 2019, AUTOPHAGY, V15, P98, DOI 10.1080/15548627.2018.1509608; Rabanal-Ruiz Y, 2017, ESSAYS BIOCHEM, V61, P565, DOI 10.1042/EBC20170027; Rodriguez-Vargas JM, 2016, CELL DEATH DIFFER, V23, P2007, DOI 10.1038/cdd.2016.80; Rojo F, 2012, ANN ONCOL, V23, P1156, DOI 10.1093/annonc/mdr361; Sang LJ, 2021, NAT METAB, V3, P90, DOI 10.1038/s42255-020-00325-z; Sant Shilpa, 2017, Drug Discov Today Technol, V23, P27, DOI 10.1016/j.ddtec.2017.03.002; Schewe DM, 2009, CANCER RES, V69, P1545, DOI 10.1158/0008-5472.CAN-08-3858; Schiewer MJ, 2012, CANCER DISCOV, V2, P1134, DOI 10.1158/2159-8290.CD-12-0120; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Stuart JR, 2005, ONCOGENE, V24, P8085, DOI 10.1038/sj.onc.1208953; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tajan M, 2018, CELL METAB, V28, P721, DOI 10.1016/j.cmet.2018.07.005; Teng Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.24; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Wagle N, 2016, J CLIN ONCOL, V34; Wei HT, 2016, GENOM PROTEOM BIOINF, V14, P131, DOI 10.1016/j.gpb.2016.05.001; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wek RC, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032870; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Wortel IMN, 2017, TRENDS ENDOCRIN MET, V28, P794, DOI 10.1016/j.tem.2017.07.003; Wu T, 2014, FREE RADICAL BIO MED, V67, P69, DOI 10.1016/j.freeradbiomed.2013.10.806; Zhu CG, 2021, CELL CYCLE, V20, P575, DOI 10.1080/15384101.2021.1885236	84	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22201	10.1096/fj.202101466R	http://dx.doi.org/10.1096/fj.202101466R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35137449				2022-12-28	WOS:000761250800051
J	Shiraishi, M; Yamaguchi, A; Suzuki, K				Shiraishi, Manabu; Yamaguchi, Atsushi; Suzuki, Ken			Nrg1/ErbB signaling-mediated regulation of fibrosis after myocardial infarction	FASEB JOURNAL			English	Article						apoptosis; cardiac fibroblast; fibrosis; macrophage; myocardial infarction; senescence	CELLULAR SENESCENCE; EPITHELIAL-CELLS; HEART-FAILURE; PROLIFERATION; MACROPHAGES; APOPTOSIS; REPAIR; INFLAMMATION; FIBROBLASTS; METABOLISM	Appropriate fibrotic tissue formation after myocardial infarction (MI) is crucial to the maintenance of the heart's structure. M2-like macrophages play a vital role in post-MI fibrosis by activating cardiac fibroblasts. Because the mechanism by which post-MI cardiac fibrosis is regulated is not fully understood, we investigated, in vitro and in vivo, the cellular and molecular mechanisms of post-MI fibrotic tissue formation, especially those related to the regulation of cellular senescence and apoptosis. CD206(+)F4/80(+)CD11b(+) M2-like macrophages collected from mouse hearts on post-MI day 7 showed increased expression of neuregulin 1 (Nrg1). Nrg1 receptor epidermal growth factor receptors ErbB2 and ErbB4 were expressed on cardiac fibroblasts in the infarct area. M2-like macrophage-derived Nrg1 suppressed both hydrogen peroxide-induced senescence and apoptosis of fibroblasts, whereas blockade of ErbB function significantly accelerated both processes. M2-like macrophage-derived Nrg1/ErbB/PI3K/Akt signaling, shown to be related to anti-senescence, was activated in damaged cardiac fibroblasts. Interestingly, systemic blockade of ErbB function in MI model mice enhanced senescence and apoptosis of cardiac fibroblasts and exacerbated inflammation. Further, increased accumulation of M2-like macrophages resulted in excessive post-MI progression of fibrosis in mice hearts. The molecular mechanism underlying the regulation of fibrotic tissue formation in the infarcted myocardium was shown in part to be attenuation of apoptosis and senescence of cardiac fibroblasts by the activation of Nrg1/ErbB/PI3K/Akt signaling. M2-like macrophage-mediated regulation of Nrg1/ErbB signaling has a substantial effect on fibrotic tissue formation in the infarcted adult mouse heart and is critical for suppressing the progression of senescence and apoptosis of cardiac fibroblasts.	[Shiraishi, Manabu; Yamaguchi, Atsushi] Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Surg, Saitama 3300834, Japan; [Shiraishi, Manabu; Suzuki, Ken] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England	Jichi Medical University; University of London; Queen Mary University London	Shiraishi, M (corresponding author), Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Surg, Saitama 3300834, Japan.	manabu@omiya.jichi.ac.jp		SHIRAISHI, MANABU/0000-0002-4491-7473	Uehara Memorial Foundation; SENSHIN Medical Research Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation; Public Trust Surgery Research Fund	Uehara Memorial Foundation(Uehara Memorial Foundation); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation(Takeda Science Foundation (TSF)); Public Trust Surgery Research Fund	Uehara Memorial Foundation; SENSHIN Medical Research Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation; Public Trust Surgery Research Fund	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Aden N, 2010, J INVEST DERMATOL, V130, P2191, DOI 10.1038/jid.2010.120; Alam P, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012089; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Ashcroft GS, 2000, NAT MED, V6, P1147, DOI 10.1038/80489; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; Baliga RR, 1999, AM J PHYSIOL-HEART C, V277, pH2026, DOI 10.1152/ajpheart.1999.277.5.H2026; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bladier C, 1997, CELL GROWTH DIFFER, V8, P589; Brown CW, 2000, NAT GENET, V25, P453, DOI 10.1038/78140; Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000; Choi JS, 2015, MUCOSAL IMMUNOL, V8, P1285, DOI 10.1038/mi.2015.19; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; ElZarrad MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079543; Farr L, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01273; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gemberling M, 2015, ELIFE, V4, DOI 10.7554/eLife.05871; Gould KE, 2002, AM J PHYSIOL-HEART C, V282, pH615, DOI 10.1152/ajpheart.00206.2001; Hayakawa K, 2003, CIRCULATION, V108, P104, DOI 10.1161/01.CIR.0000074225.62168.68; Hedhli N, 2011, CIRCULATION, V123, P2254, DOI 10.1161/CIRCULATIONAHA.110.991125; Ikeda N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat0207; Kallergi G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2149; Kirabo A, 2017, J MOL CELL CARDIOL, V105, P59, DOI 10.1016/j.yjmcc.2017.03.001; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kuramochi Y, 2004, J BIOL CHEM, V279, P51141, DOI 10.1074/jbc.M408662200; Leicht M, 2000, CARDIOVASC RES, V48, P274, DOI 10.1016/S0008-6363(00)00170-X; Lemmens K, 2007, CIRCULATION, V116, P954, DOI 10.1161/CIRCULATIONAHA.107.690487; Meyer D, 1997, DEVELOPMENT, V124, P3575; Moritz KE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09715-y; Morse C, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.02441-2018; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Orecchioni M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01084; Park S, 2010, CANCER CELL, V18, P160, DOI 10.1016/j.ccr.2010.06.014; Pascual-Gil S, 2019, J DRUG TARGET, V27, P573, DOI 10.1080/1061186X.2018.1531417; Polizzotti BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5171; Saalbach A, 2019, FASEB J, V33, P6689, DOI 10.1096/fj.201802224R; Sasaki M, 2010, J HEPATOL, V53, P318, DOI 10.1016/j.jhep.2010.03.008; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Shih H, 2011, J AM COLL CARDIOL, V57, P9, DOI 10.1016/j.jacc.2010.08.623; Shiiba M, 2015, INT J ONCOL, V46, P1978, DOI 10.3892/ijo.2015.2917; Shinde AV, 2014, J MOL CELL CARDIOL, V70, P74, DOI 10.1016/j.yjmcc.2013.11.015; Shintani Y, 2013, P NATL ACAD SCI USA, V110, P5109, DOI 10.1073/pnas.1219243110; Shiraishi M, 2016, J CLIN INVEST, V126, P2151, DOI 10.1172/JCI85782; Sohn JH, 2003, NAT MED, V9, P206, DOI 10.1038/nm814; STEIN GH, 1991, P NATL ACAD SCI USA, V88, P11012, DOI 10.1073/pnas.88.24.11012; Suzuki T, 2014, NATURE, V514, P450, DOI 10.1038/nature13807; Takemura G, 1998, CIRC RES, V82, P1130, DOI 10.1161/01.RES.82.11.1130; Tanol N, 2014, MOL THER, V22, P1864, DOI 10.1038/mt.2014.110; Uckelmann H, 2016, J EXP MED, V213, P1961, DOI 10.1084/jem.20151713; Uray IP, 2002, J HEART LUNG TRANSPL, V21, P771, DOI 10.1016/S1053-2498(02)00390-X; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Vanheule V, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00530; Vermeulen Z, 2017, AM J PHYSIOL-HEART C, V313, pH934, DOI 10.1152/ajpheart.00206.2017; Wang YA, 1997, P NATL ACAD SCI USA, V94, P14590, DOI 10.1073/pnas.94.26.14590; Watanabe Y, 2003, J CELL BIOCHEM, V89, P244, DOI 10.1002/jcb.10501; Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386; Yu JSL, 2016, DEVELOPMENT, V143, P3050, DOI 10.1242/dev.137075; Zhu FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074535	65	2	2	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22150	10.1096/fj.202101428RR	http://dx.doi.org/10.1096/fj.202101428RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34997943	Green Submitted			2022-12-28	WOS:000747987800025
J	Kurane, T; Matsunaga, T; Ida, T; Sawada, K; Nishimura, A; Fukui, M; Umemura, M; Nakayama, M; Ohara, N; Matsumoto, S; Akaike, T; Matsuzaki, G; Takaesu, G				Kurane, Tomomi; Matsunaga, Tetsuro; Ida, Tomoaki; Sawada, Kazuko; Nishimura, Akira; Fukui, Masayuki; Umemura, Masayuki; Nakayama, Masaaki; Ohara, Naoya; Matsumoto, Sohkichi; Akaike, Takaaki; Matsuzaki, Goro; Takaesu, Giichi			GRIM-19 is a target of mycobacterial Zn2+ metalloprotease 1 and indispensable for NLRP3 inflammasome activation	FASEB JOURNAL			English	Article						inflammasome; interleukin-1 beta; macrophages; mitochondria; Mycobacterium tuberculosis	MITOCHONDRIAL COMPLEX-I; REGULATORY GENE-PRODUCT; CELL-DEATH; RESPIRATORY-CHAIN; INTERFERON-BETA; TUBERCULOSIS; PROTEIN; MACROPHAGES; VECTOR; ESX-1	Tuberculosis is a communicable disease caused by Mycobacterium tuberculosis which primarily infects macrophages and establishes intracellular parasitism. A mycobacterial virulence factor Zn2+ metalloprotease 1 (Zmp1) is known to suppress interleukin (IL)-1 beta production by inhibiting caspase-1 resulting in phagosome maturation arrest. However, the molecular mechanism of caspase-1 inhibition by Zmp1 is still elusive. Here, we identified GRIM-19 (also known as NDUFA13), an essential subunit of mitochondrial respiratory chain complex I, as a novel Zmp1-binding protein. Using the CRISPR/Cas9 system, we generated GRIM-19 knockout murine macrophage cell line J774.1 and found that GRIM-19 is essential for IL-1 beta production during mycobacterial infection as well as in response to NLRP3 inflammasome-activating stimuli such as extracellular ATP or nigericin. We also found that GRIM-19 is required for the generation of mitochondrial reactive oxygen species and NLRP3-dependent activation of caspase-1. Loss of GRIM-19 or forced expression of Zmp1 resulted in a decrease in mitochondrial membrane potential. Our study revealed a previously unrecognized role of GRIM-19 as an essential regulator of NLRP3 inflammasome and a molecular mechanism underlying Zmp1-mediated suppression of IL-1 beta production during mycobacterial infection.	[Kurane, Tomomi; Umemura, Masayuki; Matsuzaki, Goro; Takaesu, Giichi] Univ Ryukyus, Grad Sch Med, Dept Host Def, Nishihara, Okinawa, Japan; [Matsunaga, Tetsuro; Ida, Tomoaki; Nishimura, Akira; Akaike, Takaaki] Tohoku Univ, Dept Environm Med & Mol Toxicol, Grad Sch Med, Sendai, Miyagi, Japan; [Sawada, Kazuko; Fukui, Masayuki; Umemura, Masayuki; Matsuzaki, Goro; Takaesu, Giichi] Univ Ryukyus, Trop Biosphere Res Ctr, Mol Microbiol Grp, 1 Senbaru, Nishihara, Okinawa 9030213, Japan; [Umemura, Masayuki; Matsuzaki, Goro; Takaesu, Giichi] Univ Ryukyus, Fac Med, Adv Med Res Ctr, Nishihara, Okinawa, Japan; [Nakayama, Masaaki; Ohara, Naoya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Microbiol, Okayama, Japan; [Matsumoto, Sohkichi] Niigata Univ, Dept Bacteriol, Sch Med, Niigata, Japan; [Nishimura, Akira] Nara Inst Sci & Technol, Grad Sch Sci & Technol, Nara, Japan; [Fukui, Masayuki] Aomori Univ, Dept Pharmacol, Aomori, Japan	University of the Ryukyus; Tohoku University; University of the Ryukyus; University of the Ryukyus; Okayama University; Niigata University; Nara Institute of Science & Technology	Matsuzaki, G; Takaesu, G (corresponding author), Univ Ryukyus, Trop Biosphere Res Ctr, Mol Microbiol Grp, 1 Senbaru, Nishihara, Okinawa 9030213, Japan.	matsuzak@comb.u-ryukyu.ac.jp; takaesug@comb.u-ryukyu.ac.jp	Takaesu, Giichi/AFT-9970-2022; OHARA, Naoya/B-2481-2011	Takaesu, Giichi/0000-0002-1581-1055; Matsunaga, Tetsuro/0000-0003-2944-3326	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP18K07179, JP20H03487]; Takeda Science	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science	Japan Society for the Promotion of Science (JSPS) KAK.ENHI, Grant/Award Number: JP18K07179 and JP20H03487; Takeda Science	Akaike T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01311-y; Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Barnich N, 2005, J BIOL CHEM, V280, P19021, DOI 10.1074/jbc.M413776200; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Chung IC, 2020, MOL CELL PROTEOMICS, V19, P142, DOI 10.1074/mcp.RA119.001808; Dorhoi A, 2012, EUR J IMMUNOL, V42, P374, DOI 10.1002/eji.201141548; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; GOREN MB, 1976, P NATL ACAD SCI USA, V73, P2510, DOI 10.1073/pnas.73.7.2510; GOTO Y, 1991, FEMS MICROBIOL LETT, V83, P277; Groschel MI, 2017, CELL REP, V18, P2752, DOI 10.1016/j.celrep.2017.02.057; Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002; Hu HX, 2017, P NATL ACAD SCI USA, V114, P11908, DOI 10.1073/pnas.1704723114; Huang G, 2007, CELL DEATH DIFFER, V14, P327, DOI 10.1038/sj.cdd.4402004; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Jayaraman P, 2013, J IMMUNOL, V190, P4196, DOI 10.4049/jimmunol.1202688; Jayaraman P, 2010, J EXP MED, V207, P2343, DOI 10.1084/jem.20100687; Jin ZX, 2014, CELL METAB, V20, P483, DOI 10.1016/j.cmet.2014.07.011; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Kurenuma T, 2009, INFECT IMMUN, V77, P3992, DOI 10.1128/IAI.00015-09; Lu H, 2008, MOL BIOL CELL, V19, P1893, DOI 10.1091/mbc.E07-07-0683; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Mantovani A, 2019, IMMUNITY, V50, P778, DOI 10.1016/j.immuni.2019.03.012; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Nallar SC, 2017, CYTOKINE GROWTH F R, V33, P1, DOI 10.1016/j.cytogfr.2016.09.001; Romagnoli A, 2012, AUTOPHAGY, V8, P1357, DOI 10.4161/auto.20881; Saiga H, 2012, INT IMMUNOL, V24, P637, DOI 10.1093/intimm/dxs062; Scialo F, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00428; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Wada T, 2015, SCI REP-UK, V5, DOI 10.1038/srep17827; Wong KW, 2011, CELL MICROBIOL, V13, P1371, DOI 10.1111/j.1462-5822.2011.01625.x; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	40	0	0	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22096	10.1096/fj.202101074RR	http://dx.doi.org/10.1096/fj.202101074RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34907600	hybrid			2022-12-28	WOS:000734992000013
J	Lindsay, A; Trewin, AJ; Sadler, KJ; Laird, C; Della Gatta, PA; Russell, AP				Lindsay, Angus; Trewin, Adam J.; Sadler, Kate J.; Laird, Claire; Della Gatta, Paul A.; Russell, Aaron P.			Sensitivity to behavioral stress impacts disease pathogenesis in dystrophin-deficient mice	FASEB JOURNAL			English	Article						blood pressure; dystrophin; estrogen; hypothalamic pituitary adrenal axis; skeletal muscle	DUCHENNE MUSCULAR-DYSTROPHY; MOUSE MODEL; SOCIAL STRESS; MDX MODEL; DYSFUNCTION; EXPRESSION; UTROPHIN; RESTRAINT; PATHOLOGY; BRAIN	Mutation to the gene encoding dystrophin can cause Duchenne muscular dystrophy (DMD) and increase the sensitivity to stress in vertebrate species, including the mdx mouse model of DMD. Behavioral stressors can exacerbate some dystrophinopathy phenotypes of mdx skeletal muscle and cause hypotension-induced death. However, we have discovered that a subpopulation of mdx mice present with a wildtype-like response to mild (forced downhill treadmill exercise) and moderate (scruff restraint) behavioral stressors. These "stress-resistant" mdx mice are more physically active, capable of super-activating the hypothalamic-pituitary-adrenal and renin-angiotensin-aldosterone pathways following behavioral stress and they express greater levels of mineralocorticoid and glucocorticoid receptors in striated muscle relative to "stress-sensitive" mdx mice. Stress-resistant mdx mice also presented with a less severe striated muscle histopathology and greater exercise and skeletal muscle oxidative capacity at rest. Most interestingly, female mdx mice were more physically active following behavioral stressors compared to male mdx mice; a response abolished after ovariectomy and rescued with estradiol. We demonstrate that the response to behavioral stress greatly impacts disease severity in mdx mice suggesting the management of stress in patients with DMD be considered as a therapeutic approach to ameliorate disease progression.	[Lindsay, Angus; Trewin, Adam J.; Sadler, Kate J.; Della Gatta, Paul A.; Russell, Aaron P.] Deakin Univ, Inst Phys Act & Nutr, Sch Exercise & Nutr Sci, Geelong, Vic, Australia; [Laird, Claire] Deakin Univ, Researcher Dev, Deakin Res, Geelong, Vic, Australia	Deakin University; Deakin University	Lindsay, A (corresponding author), Deakin Univ, Inst Phys Act & Nutr, Sch Exercise & Nutr Sci, Geelong, Vic, Australia.	a.lindsay@deakin.edu.au		Lindsay, Angus/0000-0002-5195-1901	Deakin University; Alfred Deakin Postdoctoral Research Fellowship; Neurological Foundation	Deakin University; Alfred Deakin Postdoctoral Research Fellowship; Neurological Foundation	Deakin University, Grant/Award Number: HAtCH Grant, Seed Funding, (Institute for Physical Activity and Nutrition) and Alfred Deakin Postdoctoral Research Fellowship; Neurological Foundation, Grant/Award Number: Philip Wrightson Fellowship	Acin-Perez R, 2020, EMBO J, V39, DOI 10.15252/embj.2019104073; Atlas SA, 2007, J MANAGE CARE PHARM, V13, pS9, DOI 10.18553/jmcp.2007.13.s8-b.9; Belanto JJ, 2016, HUM MOL GENET, V25, P4951, DOI 10.1093/hmg/ddw318; Belanto JJ, 2014, P NATL ACAD SCI USA, V111, P5723, DOI 10.1073/pnas.1323842111; Bostick B, 2012, J MOL CELL CARDIOL, V53, P217, DOI 10.1016/j.yjmcc.2012.05.002; Bostick B, 2010, MUSCLE NERVE, V42, P600, DOI 10.1002/mus.21763; Bowden SA, 2019, J NEUROMUSCULAR DIS, V6, P31, DOI 10.3233/JND-180346; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Chaussenot R, 2015, NEUROBIOL LEARN MEM, V124, P111, DOI 10.1016/j.nlm.2015.07.006; Della Gatta PA, 2014, EUR J APPL PHYSIOL, V114, P2157, DOI 10.1007/s00421-014-2936-4; Demirci H, 2020, MUSCLE NERVE, V62, P710, DOI 10.1002/mus.27057; Dorchies OM, 2013, AM J PATHOL, V182, P485, DOI 10.1016/j.ajpath.2012.10.018; Fragapane P, 2020, EXP CELL RES, V386, DOI 10.1016/j.yexcr.2019.111715; Fresard L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-551; Gramolini AO, 2001, AM J PHYSIOL-CELL PH, V281, pC1300, DOI 10.1152/ajpcell.2001.281.4.C1300; Guiraud S, 2018, EXPERT OPIN ORPHAN D, V6, P179, DOI 10.1080/21678707.2018.1438261; Hagg U, 2005, AM J PHYSIOL-HEART C, V289, pH1627, DOI 10.1152/ajpheart.00135.2005; Han TK, 2015, METAB BRAIN DIS, V30, P711, DOI 10.1007/s11011-014-9624-2; Hauck JS, 2019, HUM MOL GENET, V28, P2030, DOI 10.1093/hmg/ddz039; Hinton VJ, 2001, J INT NEUROPSYCH SOC, V7, P45, DOI 10.1017/S1355617701711058; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Huynh T, 2013, J PATHOL, V231, P223, DOI 10.1002/path.4231; Johansen IB, 2017, J EXP BIOL, V220, P2545, DOI 10.1242/jeb.135046; Johansen IB, 2011, J EXP BIOL, V214, P1313, DOI 10.1242/jeb.053058; Kinnett K, 2017, PLOS CURR-TREE LIFE, P9, DOI [10.1371/currents.md.d18deef7dac96ed135e0dc8739917b6e, DOI 10.1371/CURRENTS.MD.D18DEEF7DAC96ED135E0DC8739917B6E]; Klingler Werner, 2012, Acta Myol, V31, P184; Kobayashi YM, 2008, NATURE, V456, P511, DOI 10.1038/nature07414; Kodippili K, 2021, J PATHOL, V254, P589, DOI 10.1002/path.5704; Lagunas N, 2010, HORM BEHAV, V58, P786, DOI 10.1016/j.yhbeh.2010.07.014; Leasure JL, 2008, NEUROSCIENCE, V156, P456, DOI 10.1016/j.neuroscience.2008.07.041; Lindsay A, 2021, FASEB J, V35, DOI 10.1096/fj.202002500R; Lindsay A, 2019, FEBS J, V286, P2562, DOI 10.1111/febs.14831; Lindsay A, 2019, J APPL PHYSIOL, V126, P363, DOI 10.1152/japplphysiol.00948.2018; Lindsay A, 2019, HUM MOL GENET, V28, P942, DOI 10.1093/hmg/ddy404; Mah JK, 2014, NEUROMUSCULAR DISORD, V24, P482, DOI 10.1016/j.nmd.2014.03.008; Masukagami Y, 2019, VET MICROBIOL, V234, P8, DOI 10.1016/j.vetmic.2019.05.008; Matsuzaka Y, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01805-5; McDonald CM, 2018, LANCET, V391, P451, DOI 10.1016/S0140-6736(17)32160-8; Meadows E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016184; Meyers TA, 2019, J MOL CELL CARDIOL, V128, P51, DOI 10.1016/j.yjmcc.2019.01.013; Moran AL, 2007, J APPL PHYSIOL, V102, P1387, DOI 10.1152/japplphysiol.01305.2006; Naarding KJ, 2020, NEUROLOGY, V94, pE1386, DOI 10.1212/WNL.0000000000008939; Naidoo M, 2020, MOL NEUROBIOL, V57, P1748, DOI 10.1007/s12035-019-01845-w; Nelson DM, 2018, HUM MOL GENET, V27, P2090, DOI 10.1093/hmg/ddy113; OGASAWARA A, 1989, AM J MENT RETARD, V93, P544; Percival JM, 2013, HUM MOL GENET, V22, P153, DOI 10.1093/hmg/dds415; Polavarapu K, 2016, NEUROMUSCULAR DISORD, V26, P768, DOI 10.1016/j.nmd.2016.09.002; PRATT NC, 1989, J REPROD FERTIL, V87, P763, DOI 10.1530/jrf.0.0870763; Quattrocelli M, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.132402; Quattrocelli M, 2017, J CLIN INVEST, V127, P2418, DOI 10.1172/JCI91445; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Razzoli M, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102700; ROMANUL FCA, 1965, ARCH NEUROL-CHICAGO, V12, P497, DOI 10.1001/archneur.1965.00460290053007; Rybalka E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115763; Sekiguchi M, 2009, BRAIN, V132, P124, DOI 10.1093/brain/awn253; Selye H, 1950, PHYSL PATHOLOGY EXPO; Shimizu-Motohashi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120325; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Trewin AJ, 2018, AM J PHYSIOL-REG I, V315, pR1003, DOI 10.1152/ajpregu.00096.2018; Trewin AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188421; Vaillend C, 2017, HUM MOL GENET, V26, P1041, DOI 10.1093/hmg/ddx013; Vang P, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249472; Weir AP, 2002, J BIOL CHEM, V277, P45285, DOI 10.1074/jbc.M205177200; Wicksell RK, 2004, DEV MED CHILD NEUROL, V46, P154, DOI 10.1017/S0012162204000283; Yamamoto K, 2010, NEUROMUSCULAR DISORD, V20, P505, DOI 10.1016/j.nmd.2010.05.006	65	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22034	10.1096/fj.202101163RR	http://dx.doi.org/10.1096/fj.202101163RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34780665				2022-12-28	WOS:000722321300005
J	Carasso, S; Fishman, B; Lask, LS; Shochat, T; Geva-Zatorsky, N; Tauber, E				Carasso, Shaqed; Fishman, Bettina; Lask, Liel Stelmach; Shochat, Tamar; Geva-Zatorsky, Naama; Tauber, Eran			Metagenomic analysis reveals the signature of gut microbiota associated with human chronotypes	FASEB JOURNAL			English	Article						chronotype; circadian clock; gut microbiome; metagenomics; sleep	DIET; RHYTHMICITY; PATHWAYS	Patterns of diurnal activity differ substantially between individuals, with early risers and late sleepers being examples of opposite chronotypes. Growing evidence suggests that the late chronotype significantly impacts the risk of developing mood disorders, obesity, diabetes, and other chronic diseases. Despite the vast potential of utilizing chronotype information for precision medicine, those factors that shape chronotypes remain poorly understood. Here, we assessed whether the various chronotypes are associated with different gut microbiome compositions. Using metagenomic sequencing analysis, we established a distinct signature associated with chronotype based on two bacterial genera, Alistipes (elevated in "larks") and Lachnospira (elevated in "owls"). We identified three metabolic pathways associated with the early chronotype, and linked distinct dietary patterns with different chronotypes. Our work demonstrates an association between the gut microbiome and chronotype and may represent the first step towards developing dietary interventions aimed at ameliorating the deleterious health correlates of the late chronotype.	[Carasso, Shaqed; Geva-Zatorsky, Naama] Rappaport Technion Integrated Canc Ctr TICC, Rappaport Fac Med, Dept Cell Biol & Canc Sci, IL-3525422 Haifa, Israel; [Fishman, Bettina; Tauber, Eran] Univ Haifa, Dept Evolutionary & Environm Biol, IL-3498838 Haifa, Israel; [Fishman, Bettina; Tauber, Eran] Univ Haifa, Inst Evolut, IL-3498838 Haifa, Israel; [Lask, Liel Stelmach; Shochat, Tamar] Univ Haifa, Fac Social Welf & Hlth Sci, Cheryl Spencer Dept Nursing, Haifa, Israel; [Geva-Zatorsky, Naama] Canadian Inst Adv Res CIFAR, MaRS Ctr, Toronto, ON, Canada	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Haifa; University of Haifa; University of Haifa; Canadian Institute for Advanced Research (CIFAR); University of Toronto	Geva-Zatorsky, N (corresponding author), Rappaport Technion Integrated Canc Ctr TICC, Rappaport Fac Med, Dept Cell Biol & Canc Sci, IL-3525422 Haifa, Israel.; Tauber, E (corresponding author), Univ Haifa, Dept Evolutionary & Environm Biol, IL-3498838 Haifa, Israel.; Tauber, E (corresponding author), Univ Haifa, Inst Evolut, IL-3498838 Haifa, Israel.	naama_gz@technion.ac.il; etauber@univ.haifa.ac.il	Tauber, Eran/AAA-1562-2022; Tauber, Eran/F-9826-2011	Tauber, Eran/0000-0003-4018-6535; Tauber, Eran/0000-0003-4018-6535; Carasso, Shaqed/0000-0001-5770-9801	Israel Science Foundation (ISF) [1737/17]; Milgrom Foundation [45862]; Human Frontier Science Program (HFSP) [CDA00025/2019-C]	Israel Science Foundation (ISF)(Israel Science Foundation); Milgrom Foundation; Human Frontier Science Program (HFSP)(Human Frontier Science Program)	Israel Science Foundation (ISF), Grant/Award Number: 1737/17; Milgrom Foundation, Grant/Award Number: 45862; Human Frontier Science Program (HFSP), Grant/Award Number: CDA00025/2019-C	Collado MC, 2018, FASEB J, V32, P2060, DOI 10.1096/fj.201700697RR; Caspi R, 2018, NUCLEIC ACIDS RES, V46, pD633, DOI 10.1093/nar/gkx935; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Deaver JA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00737; Dhariwal A, 2017, NUCLEIC ACIDS RES, V45, pW180, DOI 10.1093/nar/gkx295; Fischer D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178782; Heath ALM, 2020, EUR J CLIN NUTR, V74, P1362, DOI 10.1038/s41430-019-0556-0; Jiang ZL, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01842-0; Jones SE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08259-7; Kaczmarek JL, 2017, AM J CLIN NUTR, V106, P1220, DOI 10.3945/ajcn.117.156380; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Langille MG, 2014, MICROBIOME, V2, DOI 10.1186/s40168-014-0050-9; Leone V, 2015, CELL HOST MICROBE, V17, P681, DOI 10.1016/j.chom.2015.03.006; Liang X, 2015, P NATL ACAD SCI USA, V112, P10479, DOI 10.1073/pnas.1501305112; Magzal F, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83389-5; Maukonen M, 2016, CHRONOBIOL INT, V33, P972, DOI 10.1080/07420528.2016.1183022; Mazri FH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010068; McIver LJ, 2018, BIOINFORMATICS, V34, P1235, DOI 10.1093/bioinformatics/btx754; McMurdie PJ, 2015, BIOINFORMATICS, V31, P282, DOI 10.1093/bioinformatics/btu616; Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082; Mu CL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00345; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Patterson F, 2016, ANN BEHAV MED, V50, P715, DOI 10.1007/s12160-016-9797-5; Reitmeier S, 2020, CELL HOST MICROBE, V28, P258, DOI 10.1016/j.chom.2020.06.004; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Sato-Mito N, 2011, SLEEP MED, V12, P289, DOI 10.1016/j.sleep.2010.09.012; Szentirmai E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43502-1; Thaiss CA, 2016, CELL, V167, P1495, DOI 10.1016/j.cell.2016.11.003; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Voigt RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097500; Xiao Q, 2019, INT J OBESITY, V43, P1701, DOI 10.1038/s41366-018-0284-x; Zarrinpar A, 2014, CELL METAB, V20, P1006, DOI 10.1016/j.cmet.2014.11.008	34	3	3	5	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e22011	10.1096/fj.202100857RR	http://dx.doi.org/10.1096/fj.202100857RR			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34695305	Green Submitted			2022-12-28	WOS:000712009200058
J	Kusamoto, A; Harada, M; Azhary, JMK; Kunitomi, C; Nose, E; Koike, H; Xu, ZX; Urata, Y; Kaku, T; Takahashi, N; Wada-Hiraike, O; Hirota, Y; Koga, K; Fujii, T; Osuga, Y				Kusamoto, Akari; Harada, Miyuki; Azhary, Jerilee M. K.; Kunitomi, Chisato; Nose, Emi; Koike, Hiroshi; Xu, Zixin; Urata, Yoko; Kaku, Tetsuaki; Takahashi, Nozomi; Wada-Hiraike, Osamu; Hirota, Yasushi; Koga, Kaori; Fujii, Tomoyuki; Osuga, Yutaka			Temporal relationship between alterations in the gut microbiome and the development of polycystic ovary syndrome-like phenotypes in prenatally androgenized female mice	FASEB JOURNAL			English	Article						androgens; delayed effects of prenatal exposure; gastrointestinal microbiome; polycystic ovary syndrome	LABORATORY RAT; EXPOSURE; CRITERIA; PUBERTY; MODEL; AGE	It has been recently recognized that prenatal androgen exposure is involved in the development of polycystic ovary syndrome (PCOS) in adulthood. In addition, the gut microbiome in adult patients and rodents with PCOS differs from that of healthy individuals. Moreover, recent studies have suggested that the gut microbiome may play a causative role in the pathogenesis of PCOS. We wondered whether prenatal androgen exposure induces gut microbial dysbiosis early in life and is associated with the development of PCOS in later life. To test this hypothesis, we studied the development of PCOS-like phenotypes in prenatally androgenized (PNA) female mice and compared the gut microbiome of PNA and control offspring from 4 to 16 weeks of age. PNA offspring showed a reproductive phenotype from 6 weeks and a metabolic phenotype from 12 weeks of age. The alpha-diversity of the gut microbiome of the PNA group was higher at 8 weeks and lower at 12 and 16 weeks of age, and the beta-diversity differed from control at 8 weeks. However, a significant difference in the composition of gut microbiome between the PNA and control groups was already apparent at 4 weeks. Allobaculum and Roseburia were less abundant in PNA offspring, and may therefore be targets for future interventional studies. In conclusion, abnormalities in the gut microbiome appear as early as or even before PCOS-like phenotypes develop in PNA mice. Thus, the gut microbiome in early life is a potential target for the prevention of PCOS in later life.	[Kusamoto, Akari; Harada, Miyuki; Azhary, Jerilee M. K.; Kunitomi, Chisato; Nose, Emi; Koike, Hiroshi; Xu, Zixin; Urata, Yoko; Kaku, Tetsuaki; Takahashi, Nozomi; Wada-Hiraike, Osamu; Hirota, Yasushi; Koga, Kaori; Fujii, Tomoyuki; Osuga, Yutaka] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo, Japan; [Azhary, Jerilee M. K.] Univ Malaya, Fac Med, Dept Obstet & Gynaecol, Kuala Lumpur, Malaysia	University of Tokyo; Universiti Malaya	Harada, M (corresponding author), Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	haradam-tky@umin.ac.jp	Koga, Kaori/ABA-5601-2020; Azhary, Jerilee MK/GQB-4545-2022; Azhary, Jerilee Mariam Khong/AAG-5549-2021	Koga, Kaori/0000-0002-5057-4120; Azhary, Jerilee Mariam Khong/0000-0002-9849-9799; Takahashi, Nozomi/0000-0002-3685-3502	Takeda Science Foundation; Tokyo Society of Medical Science; Japan Society for the Promotion of Science [19k09749, 19k24045, 21k16808, 19k24021]; Yakult Bio-Science Foundation	Takeda Science Foundation(Takeda Science Foundation (TSF)); Tokyo Society of Medical Science; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yakult Bio-Science Foundation	Takeda Science Foundation; Yakult Bio--Science Foundation; The Tokyo Society of Medical Science; Japan Society for the Promotion of Science, Grant/Award Number: 19k09749, 19k24045, 21k16808 and 19k24021	Ajayi Ayodeji Folorunsho, 2020, Fertil Res Pract, V6, P5, DOI 10.1186/s40738-020-00074-3; Arroyo P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223274; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Benrick A, 2017, P NATL ACAD SCI USA, V114, pE7187, DOI 10.1073/pnas.1708854114; Caldwell ASL, 2014, ENDOCRINOLOGY, V155, P3146, DOI 10.1210/en.2014-1196; Clavel T, 2016, INT J MED MICROBIOL, V306, P316, DOI 10.1016/j.ijmm.2016.03.002; Cora MC, 2015, TOXICOL PATHOL, V43, P776, DOI 10.1177/0192623315570339; Dumesic DA, 2020, REPRODUCTION, V159, pR1, DOI 10.1530/REP-19-0197; Dumesic DA, 2015, ENDOCR REV, V36, P487, DOI 10.1210/er.2015-1018; Escobar-Morreale HF, 2018, NAT REV ENDOCRINOL, V14, P270, DOI 10.1038/nrendo.2018.24; Filippou P, 2017, HUM REPROD UPDATE, V23, P421, DOI 10.1093/humupd/dmx013; Flak MB, 2013, SCIENCE, V339, P1044, DOI 10.1126/science.1236226; Guo YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153196; Haikal C, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0175-7; Insenser M, 2018, J CLIN ENDOCR METAB, V103, P2552, DOI 10.1210/jc.2017-02799; Jobira B, 2020, J CLIN ENDOCR METAB, V105, pE2134, DOI 10.1210/clinem/dgz263; Kelley ST, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146509; Kunitomi C, 2021, MOL HUM REPROD, V27, DOI 10.1093/molehr/gaab003; Liang YJ, 2020, CAN J PHYSIOL PHARM, V98, P803, DOI 10.1139/cjpp-2019-0413; Lindheim L, 2018, J ENDOCR SOC, V2, P1363, DOI 10.1210/js.2018-00266; Lindheim L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168390; Liu R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00324; Maliqueo M, 2013, EUR J OBSTET GYN R B, V166, P151, DOI 10.1016/j.ejogrb.2012.10.015; Menni C, 2020, GUT MICROBES, V11, P1632, DOI 10.1080/19490976.2020.1778261; Moore AM, 2013, ENDOCRINOLOGY, V154, P796, DOI 10.1210/en.2012-1954; Mosca A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00455; OSMAN P, 1985, J REPROD FERTIL, V73, P261, DOI 10.1530/jrf.0.0730261; Osuka S, 2019, REPROD MED BIOL, V18, P151, DOI 10.1002/rmb2.12262; Osuka S, 2017, ENDOCRINOLOGY, V158, P367, DOI 10.1210/en.2016-1333; Pujo J, 2021, GUT, V70, P1088, DOI 10.1136/gutjnl-2020-321173; Risal S, 2019, NAT MED, V25, P1894, DOI 10.1038/s41591-019-0666-1; Rizk MG, 2021, J ENDOCR SOC, V5, DOI 10.1210/jendso/bvaa177; Roland AV, 2010, J ENDOCRINOL, V207, P213, DOI 10.1677/JOE-10-0217; Sanders ME, 2019, NAT REV GASTRO HEPAT, V16, P605, DOI 10.1038/s41575-019-0173-3; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Sherman SB, 2018, GUT MICROBES, V9, P400, DOI 10.1080/19490976.2018.1441664; Skarra DV, 2017, ENDOCRINOLOGY, V158, P2988, DOI 10.1210/en.2016-1898; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Sudun, 2019, FOOD FUNCT, V10, P6098, DOI [10.1039/c9fo00444k, 10.1039/C9FO00444K]; Sullivan SD, 2004, P NATL ACAD SCI USA, V101, P7129, DOI 10.1073/pnas.0308058101; Takagi T, 2020, NUTRIENTS, V12, DOI 10.3390/nu12102996; Tamanai-Shacoori Z, 2017, FUTURE MICROBIOL, V12, P157, DOI 10.2217/fmb-2016-0130; Thackray VG, 2019, TRENDS ENDOCRIN MET, V30, P54, DOI 10.1016/j.tem.2018.11.001; Torres PJ, 2019, ENDOCRINOLOGY, V160, P1193, DOI 10.1210/en.2019-00050; Torres PJ, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1425-7; Torres PJ, 2018, J CLIN ENDOCR METAB, V103, P1502, DOI 10.1210/jc.2017-02153; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Wang T, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00284; Wang ZQ, 2018, ENDOCRINOLOGY, V159, P1242, DOI 10.1210/en.2017-03078; Witham EA, 2012, ENDOCRINOLOGY, V153, P4522, DOI 10.1210/en.2012-1283; Wu XY, 2010, ENDOCR J, V57, P201, DOI 10.1507/endocrj.K09E-205; Wu YL, 2021, FASEB J, V35, DOI 10.1096/fj.202002212R; Yan XN, 2013, J ENDOCRINOL, V217, P119, DOI 10.1530/JOE-12-0577; Yang C, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0031-4; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang JC, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00017-19; Zhang X, 2015, SCI REP-UK, V5, DOI 10.1038/srep14405; Zheng YH, 2021, BIOPROC BIOSYST ENG, V44, P953, DOI 10.1007/s00449-020-02320-w	58	3	3	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21971	10.1096/fj.202101051R	http://dx.doi.org/10.1096/fj.202101051R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34653284				2022-12-28	WOS:000712009200002
J	Smolka, C; Schlosser, D; Koentges, C; Tarkhnishvili, A; Gorka, O; Pfeifer, D; Bemtgen, X; Asmussen, A; Gross, O; Diehl, P; Moser, M; Bode, C; Bugger, H; Grundmann, S; Pankratz, F				Smolka, Christian; Schloesser, Delia; Koentges, Christoph; Tarkhnishvili, Aleksandre; Gorka, Oliver; Pfeifer, Dietmar; Bemtgen, Xavier; Asmussen, Alexander; Gross, Olaf; Diehl, Philipp; Moser, Martin; Bode, Christoph; Bugger, Heiko; Grundmann, Sebastian; Pankratz, Franziska			Cardiomyocyte-specific miR-100 overexpression preserves heart function under pressure overload in mice and diminishes fatty acid uptake as well as ROS production by direct suppression of Nox4 and CD36	FASEB JOURNAL			English	Article						cardiac metabolism; CD36; fatty acid; miRNA-100; pressure-overload-induced heart failure	HYPERTROPHY; EXPRESSION; MICRORNAS; FAILURE; METABOLISM; DEFICIENCY; APOPTOSIS; ABLATION; TARGET	MicroRNAs are key regulators of the cardiac response to injury. MiR-100 has recently been suggested to be involved in different forms of heart failure, but functional studies are lacking. In the present study, we examined the impact of transgenic miR-100 overexpression on cardiac structure and function during physiological aging and pathological pressure-overload-induced heart failure in mice after transverse aortic constriction surgery. MiR-100 was moderately upregulated after induction of pressure overload in mice. While in our transgenic model the cardiomyocyte-specific overexpression of miR-100 did not result in an obvious cardiac phenotype in unchallenged mice, the transgenic mouse strain exhibited less left ventricular dilatation and a higher ejection fraction than wildtype animals, demonstrating an attenuation of maladaptive cardiac remodeling by miR-100. Cardiac transcriptome analysis identified a repression of several regulatory genes related to cardiac metabolism, lipid peroxidation, and production of reactive oxygen species (ROS) by miR-100 overexpression, possibly mediating the observed functional effects. While the modulation of ROS-production seemed to be indirectly affected by miR-100 via Alox5-and Nox4-downregulation, we demonstrated that miR-100 induced a direct repression of the scavenger protein CD36 in murine hearts resulting in a decreased uptake of long-chain fatty acids and an alteration of mitochondrial respiratory function with an enhanced glycolytic state. In summary, we identified miR-100 as a modulator of cardiac metabolism and ROS production without an apparent cardiac phenotype at baseline but a protective effect under conditions of pressure-overload-induced cardiac stress, providing new insight into the mechanisms of heart failure.	[Smolka, Christian; Schloesser, Delia; Koentges, Christoph; Tarkhnishvili, Aleksandre; Bemtgen, Xavier; Asmussen, Alexander; Diehl, Philipp; Moser, Martin; Bode, Christoph; Grundmann, Sebastian; Pankratz, Franziska] Univ Freiburg, Heart Ctr, Fac Med, Dept Cardiol & Angiol 1, Breisacher Str 33, D-79106 Freiburg, Germany; [Gorka, Oliver; Gross, Olaf] Univ Freiburg, Fac Med, Inst Neuropathol, Freiburg, Germany; [Pfeifer, Dietmar] Univ Freiburg, Fac Med, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany; [Gross, Olaf] Univ Freiburg, Signalling Res Ctr BIOSS, Freiburg, Germany; [Gross, Olaf] Univ Freiburg, Signalling Res Ctr CIBSS, Freiburg, Germany; [Gross, Olaf] Univ Freiburg, Fac Med, Ctr Basics NeuroModulat NeuroModulBasics, Freiburg, Germany; [Bugger, Heiko] Med Univ Graz, Div Cardiol, Graz, Austria	Universitats Herzzentrum Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Medical University of Graz	Pankratz, F (corresponding author), Univ Freiburg, Heart Ctr, Fac Med, Dept Cardiol & Angiol 1, Breisacher Str 33, D-79106 Freiburg, Germany.	franziska.pankratz@uniklinik-freiburg.de	Gross, Olaf/E-4570-2010	Gross, Olaf/0000-0001-8660-3619; Gorka, Oliver/0000-0002-8245-3008; Bugger, Heiko/0000-0002-3524-0405	Else Kroner-Fresenius-Stiftung (EKFS) [2016_A106]; Deutsche Forschungsgemeinschaft (DFG) [PA 2779/2-1, GR 3459/4-2]	Else Kroner-Fresenius-Stiftung (EKFS); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Else Kroner-Fresenius-Stiftung (EKFS), Grant/Award Number: Nr 2016_A106; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: PA 2779/2-1 and GR 3459/4-2	Abumrad NA, 2016, BBA-MOL CELL BIOL L, V1861, P1442, DOI 10.1016/j.bbalip.2016.03.015; Ago T, 2010, CIRC RES, V106, P1253, DOI 10.1161/CIRCRESAHA.109.213116; Aguirre A, 2014, CELL STEM CELL, V15, P589, DOI 10.1016/j.stem.2014.10.003; Breitzig M, 2016, AM J PHYSIOL-CELL PH, V311, pC537, DOI 10.1152/ajpcell.00101.2016; Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203; Chen A, 2015, INT J CLIN EXP PATHO, V8, P5491; Cheng JL, 2017, ADV EXP MED BIOL, V982, P359, DOI 10.1007/978-3-319-55330-6_20; Cho KJ, 2011, MOL CELLS, V32, P1, DOI 10.1007/s10059-011-1021-7; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Duygu B, 2016, TRENDS CARDIOVAS MED, V26, P99, DOI 10.1016/j.tcm.2015.05.008; Fillmore N, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0005-x; Fillmore N, 2013, BBA-MOL CELL RES, V1833, P857, DOI 10.1016/j.bbamcr.2012.08.014; Gianazza E, 2019, REDOX BIOL, V23, DOI 10.1016/j.redox.2019.101119; Griesser M, 2009, J LIPID RES, V50, P2455, DOI 10.1194/jlr.M900181-JLR200; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Kato T, 2010, CIRC-HEART FAIL, V3, P420, DOI 10.1161/CIRCHEARTFAILURE.109.888479; Kawahara Y, 2005, J PHARMACOL SCI, V99, P95, DOI 10.1254/jphs.FP0050343; Kemp CD, 2012, CARDIOVASC PATHOL, V21, P365, DOI 10.1016/j.carpath.2011.11.007; Kim TT, 2016, BBA-MOL CELL BIOL L, V1861, P1450, DOI 10.1016/j.bbalip.2016.03.018; Koentges C, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-017-0666-6; Koentges C, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0493-6; Koonen DPY, 2007, CIRCULATION, V116, P2139, DOI 10.1161/CIRCULATIONAHA.107.712901; Kriegel AJ, 2015, HYPERTENSION, V66, P793, DOI 10.1161/HYPERTENSIONAHA.115.05645; Kuang M, 2004, CIRCULATION, V109, P1550, DOI 10.1161/01.CIR.0000121730.41801.12; Kuroda J, 2010, P NATL ACAD SCI USA, V107, P15565, DOI 10.1073/pnas.1002178107; Kuroda J, 2010, J CARDIOVASC TRANSL, V3, P314, DOI 10.1007/s12265-010-9184-8; Lisovyy OO, 2009, ACTA BIOCHIM POL, V56, P687; Liu XM, 2022, CTS-CLIN TRANSL SCI, V15, P567, DOI 10.1111/cts.12798; Nabeebaccus AA, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96184; Nagendran J, 2013, J MOL CELL CARDIOL, V63, P180, DOI 10.1016/j.yjmcc.2013.07.020; Onrat ST, 2018, GENET TEST MOL BIOMA, V22, P644, DOI 10.1089/gtmb.2018.0188; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Peoples JN, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0355-7; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Ponikowski P, 2014, ESC HEART FAIL, V1, P4, DOI 10.1002/ehf2.12005; Ramasamy S, 2018, EXP CELL RES, V365, P46, DOI 10.1016/j.yexcr.2018.02.016; Ramasamy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121401; Rossary A, 2007, BIOCHEM J, V406, P77, DOI 10.1042/BJ20061009; Savarese Gianluigi, 2017, Card Fail Rev, V3, P7, DOI 10.15420/cfr.2016:25:2; Schirone L, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3920195; Shiose A, 2000, J BIOL CHEM, V275, P13793, DOI 10.1074/jbc.275.18.13793; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; Sun QY, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2749173; Sung MM, 2017, AM J PHYSIOL-HEART C, V312, pH552, DOI 10.1152/ajpheart.00626.2016; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Tullio F, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0392-7; Umbarawan Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30616-1; Varga ZV, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00935; Vegter EL, 2016, EUR J HEART FAIL, V18, P457, DOI 10.1002/ejhf.495; Wambolt RB, 1999, J MOL CELL CARDIOL, V31, P493, DOI 10.1006/jmcc.1998.0804; Wang YG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01913-y; Wong LL, 2015, J MOL CELL CARDIOL, V82, P13, DOI 10.1016/j.yjmcc.2015.02.019; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6; Zeng JY, 2021, HUM CELL, V34, P1388, DOI 10.1007/s13577-021-00566-4; Zhang M, 2018, CARDIOVASC RES, V114, P401, DOI 10.1093/cvr/cvx204; Zhao QD, 2015, CIRCULATION, V131, P643, DOI 10.1161/CIRCULATIONAHA.114.011079	59	1	1	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21956	10.1096/fj.202100829RR	http://dx.doi.org/10.1096/fj.202100829RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34605573				2022-12-28	WOS:000712009200044
J	Du, M; Yang, L; Liu, B; Yang, LY; Mao, XX; Liang, ML; Huang, K				Du, Meng; Yang, Liu; Liu, Bing; Yang, Liuye; Mao, Xiaoxiang; Liang, Minglu; Huang, Kai			Inhibition of NFAT suppresses foam cell formation and the development of diet-induced atherosclerosis	FASEB JOURNAL			English	Article						atherosclerosis; cholesterol efflux; foam cell formation; NFAT	ACTIVATED T-CELLS; NUCLEAR FACTOR; MACROPHAGE DIFFERENTIATION; PPAR-GAMMA; CYCLOSPORINE; PROTEIN; TRANSPLANTATION; TRANSCRIPTION	Deciphering the molecular and cellular processes involved in foam cell formation is critical for us to understand the pathogenesis of atherosclerosis. Nuclear factor of activated T cells (NFAT) is a transcription factor originally identified as a key player in the differentiation of T cells and maturation of immune system. Nowadays it has been brought into attention that NFAT also regulates multiple pathophysiological processes and targeted intervention in NFAT may be effective in the treatment of some cardiovascular diseases. However, whether NFAT is involved in foam cell formation remains elusive. NFAT in human monocyte-derived macrophage was activated by ox-LDL and translocated from the cytoplasm to the nucleus. NFAT then directly bound to peroxisome proliferator-activated receptor gamma (PPAR gamma) in the nucleus and negatively regulated its transcriptional activity. NFATc2 knockdown or NFAT inhibitor 11R-VIVIT increased cholesterol efflux (by activating PPAR gamma-LXR alpha-ABCA1 cascade) and reduced the uptake of modified lipoprotein (in a PPAR gamma-independent way) in macrophage, thus prevented foam cell formation. Besides, 11R-VIVIT also exerted a protective role in the development of atherosclerosis in western diet-fed ApoE(-/-) mice. These results suggest NFAT inhibition as a potential therapeutic strategy in atherosclerosis.	[Du, Meng; Yang, Liu; Liu, Bing; Yang, Liuye; Mao, Xiaoxiang; Huang, Kai] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiol, 1277 Jiefang Ave, Wuhan 430000, Hubei, Peoples R China; [Du, Meng; Yang, Liu; Liu, Bing; Yang, Liuye; Mao, Xiaoxiang; Liang, Minglu; Huang, Kai] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Clin Ctr Human Gene Res, Wuhan, Peoples R China; [Du, Meng; Huang, Kai] Huazhong Univ Sci & Technol, Tongji Med Coll, Liyuan Cardiovasc Ctr, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Du, M; Huang, K (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiol, 1277 Jiefang Ave, Wuhan 430000, Hubei, Peoples R China.	D201378184@alumni.hust.edu.cn; unionhuang@163.com		yang, liuye/0000-0002-5773-8036	National Natural Science Foundation of China (NSFC) [82071794, 81400235, 91949201, 81830014]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 82071794, 81400235, 91949201 and 81830014	Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chinetti G, 2000, CIRCULATION, V101, P2411, DOI 10.1161/01.CIR.101.20.2411; Clark RB, 2000, J IMMUNOL, V164, P1364, DOI 10.4049/jimmunol.164.3.1364; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; Du M, 2019, THERANOSTICS, V9, P4688, DOI 10.7150/thno.36862; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Im SH, 2004, MOL CELLS, V18, P1; Kuriyama M, 2006, CHEM BIOL DRUG DES, V67, P238, DOI 10.1111/j.1747-0285.2006.00360.x; Kzhyshkowska J, 2012, IMMUNOBIOLOGY, V217, P492, DOI 10.1016/j.imbio.2012.02.015; Lahoute C, 2011, NAT REV CARDIOL, V8, P348, DOI 10.1038/nrcardio.2011.62; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Liu QH, 2012, CIRC RES, V110, P1077, DOI 10.1161/CIRCRESAHA.111.260729; Liu ZM, 2005, J BIOL CHEM, V280, P14700, DOI 10.1074/jbc.M500322200; Liu ZM, 2004, J BIOL CHEM, V279, P41218, DOI 10.1074/jbc.M406917200; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Moore KJ, 2001, NAT MED, V7, P41, DOI 10.1038/83328; Natarajan C, 2002, GENES IMMUN, V3, P59, DOI 10.1038/sj.gene.6363832; Nilsson LM, 2007, AM J PHYSIOL-CELL PH, V292, pC1167, DOI 10.1152/ajpcell.00590.2005; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Pascual M, 1998, IMMUNOL TODAY, V19, P514, DOI 10.1016/S0167-5699(98)01324-3; PLATZ KP, 1994, TRANSPLANTATION, V58, P170, DOI 10.1097/00007890-199405820-00007; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Shashkin P, 2005, CURR PHARM DESIGN, V11, P3061, DOI 10.2174/1381612054865064; SIGAL NH, 1991, J EXP MED, V173, P619, DOI 10.1084/jem.173.3.619; Silva AR, 2019, EUR J PHARMACOL, V854, P272, DOI 10.1016/j.ejphar.2019.04.008; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; VANVLIJMEN BJM, 1994, J CLIN INVEST, V93, P1403, DOI 10.1172/JCI117117; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Yu HX, 2007, CARDIOVASC DRUG REV, V25, P175, DOI 10.1111/j.1527-3466.2007.00011.x	38	3	3	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21951	10.1096/fj.202100947R	http://dx.doi.org/10.1096/fj.202100947R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34551141				2022-12-28	WOS:000702238200034
J	Murach, KA; Fry, CS; Dupont-Versteegden, EE; McCarthy, JJ; Peterson, CA				Murach, Kevin A.; Fry, Christopher S.; Dupont-Versteegden, Esther E.; McCarthy, John J.; Peterson, Charlotte A.			Fusion and beyond: Satellite cell contributions to loading-induced skeletal muscle adaptation	FASEB JOURNAL			English	Review						endurance exercise; extracellular vesicles; hypertrophy; muscle stem cells; myonuclei; regeneration; resistance exercise	ISSUES LIMIT INTERPRETATION; STRETCH-INDUCED ACTIVATION; MEMBRANE REPAIR; MYONUCLEAR ADDITION; FIBER HYPERTROPHY; NITRIC-OXIDE; OLDER MEN; PROTEIN-SYNTHESIS; MYOBLAST FUSION; MYOGENIC CELLS	Satellite cells support adult skeletal muscle fiber adaptations to loading in numerous ways. The fusion of satellite cells, driven by cell-autonomous and/or extrinsic factors, contributes new myonuclei to muscle fibers, associates with load-induced hypertrophy, and may support focal membrane damage repair and long-term myonuclear transcriptional output. Recent studies have also revealed that satellite cells communicate within their niche to mediate muscle remodeling in response to resistance exercise, regulating the activity of numerous cell types through various mechanisms such as secretory signaling and cell-cell contact. Muscular adaptation to resistance and endurance activity can be initiated and sustained for a period of time in the absence of satellite cells, but satellite cell participation is ultimately required to achieve full adaptive potential, be it growth, function, or proprioceptive coordination. While significant progress has been made in understanding the roles of satellite cells in adult muscle over the last few decades, many conclusions have been extrapolated from regeneration studies. This review highlights our current understanding of satellite cell behavior and contributions to adaptation outside of regeneration in adult muscle, as well as the roles of satellite cells beyond fusion and myonuclear accretion, which are gaining broader recognition.	[Murach, Kevin A.; Fry, Christopher S.; Dupont-Versteegden, Esther E.; McCarthy, John J.; Peterson, Charlotte A.] Univ Kentucky, Ctr Muscle Biol, 900 S Limestone,CTW 439, Lexington, KY 40536 USA; [Murach, Kevin A.] Univ Arkansas, Exercise Sci Res Ctr, Dept Hlth Human Performance & Recreat, Mol Muscle Mass Regulat Lab, 303 HPER Bldg,155 Stadium Dr, Fayetteville, AR 72701 USA; [Murach, Kevin A.] Univ Arkansas, Cell & Mol Biol Program, Fayetteville, AR 72701 USA; [Fry, Christopher S.] Univ Kentucky, Coll Hlth Sci, Dept Athlet Training & Clin Nutr, Lexington, KY 40536 USA; [Dupont-Versteegden, Esther E.; Peterson, Charlotte A.] Univ Kentucky, Coll Hlth Sci, Dept Phys Therapy, Lexington, KY 40536 USA; [McCarthy, John J.; Peterson, Charlotte A.] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40536 USA	University of Kentucky; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville; University of Kentucky; University of Kentucky; University of Kentucky	Murach, KA; Peterson, CA (corresponding author), Univ Kentucky, Ctr Muscle Biol, 900 S Limestone,CTW 439, Lexington, KY 40536 USA.; Murach, KA (corresponding author), Univ Arkansas, Exercise Sci Res Ctr, Dept Hlth Human Performance & Recreat, Mol Muscle Mass Regulat Lab, 303 HPER Bldg,155 Stadium Dr, Fayetteville, AR 72701 USA.; Peterson, CA (corresponding author), Univ Kentucky, Dept Phys Therapy, 900 S Limestone,CTW 439, Lexington, KY 40536 USA.	kmurach@uark.edu; cpete4@uky.edu			NIH; National Institutes of Arthritis and Musculoskeletal and Skin Diseases [AR060701, AR071753]; National Institute on Aging [AG049086, AG063994]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NIH; National Institutes of Arthritis and Musculoskeletal and Skin Diseases, Grant/Award Number: AR060701 and AR071753; National Institute on Aging, Grant/Award Number: AG049086 and AG063994	Abou Sawan S, 2021, J APPL PHYSIOL, V131, P871, DOI 10.1152/japplphysiol.00424.2021; Abou-Khalil R, 2010, CELL CYCLE, V9, P892, DOI 10.4161/cc.9.5.10851; Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; Abreu P, 2020, J CACHEXIA SARCOPENI, V11, P1661, DOI 10.1002/jcsm.12601; Abreu P, 2017, LIFE SCI, V170, P33, DOI 10.1016/j.lfs.2016.11.016; Allbrook D, 1966, J Bone Joint Surg Br, V48, P153; ALLBROOK D, 1962, J ANAT, V96, P137; Amthor H, 2009, P NATL ACAD SCI USA, V106, P7479, DOI 10.1073/pnas.0811129106; Anderson JE, 2006, J EXP BIOL, V209, P2276, DOI 10.1242/jeb.02088; Bachman JF, 2022, FEBS J, V289, P2710, DOI 10.1111/febs.15856; Bachman JF, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101760; Bachman JF, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.167197; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Barthelemy Florian, 2018, J Neuromuscul Dis, V5, P21, DOI 10.3233/JND-170251; Ben-Yair R, 2005, DEVELOPMENT, V132, P689, DOI 10.1242/dev.01617; Biferali B, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01074; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; BISCHOFF R, 1990, J CELL BIOL, V111, P201, DOI 10.1083/jcb.111.1.201; BISCHOFF R, 1990, DEVELOPMENT, V109, P943; BISCHOFF R, 1986, DEV BIOL, V115, P140, DOI 10.1016/0012-1606(86)90235-6; Blaauw B, 2009, FASEB J, V23, P3896, DOI 10.1096/fj.09-131870; Brett JO, 2020, NAT METAB, V2, P307, DOI 10.1038/s42255-020-0190-0; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Cantini M, 2002, NEUROL SCI, V23, P189, DOI 10.1007/s100720200060; Carmeille R, 2016, BBA-MOL CELL RES, V1863, P2267, DOI 10.1016/j.bbamcr.2016.06.003; Ceafalan LC, 2018, CELL ADHES MIGR, V12, P228, DOI 10.1080/19336918.2017.1346774; Charifi N, 2003, MUSCLE NERVE, V28, P87, DOI 10.1002/mus.10394; Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046; CHEEK DB, 1971, PEDIATR RES, V5, P312, DOI 10.1203/00006450-197107000-00004; Chen Z, 2020, THERANOSTICS, V10, P6448, DOI 10.7150/thno.43577; Chretien F, 2005, AM J PATHOL, V166, P1741, DOI 10.1016/S0002-9440(10)62484-4; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Collins BC, 2019, CELL REP, V28, P368, DOI 10.1016/j.celrep.2019.06.025; Cramer AAW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20058-7; Damas F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191039; Damas F, 2016, J PHYSIOL-LONDON, V594, P5209, DOI 10.1113/JP272472; DARR KC, 1987, J APPL PHYSIOL, V63, P1816, DOI 10.1152/jappl.1987.63.5.1816; Dayanidhi S, 2014, MUSCLE NERVE, V50, P723, DOI 10.1002/mus.24441; de Lima JE, 2016, ELIFE, V5, DOI 10.7554/eLife.15593; Dellavalle A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1508; Demonbreun AR, 2016, J CELL BIOL, V213, P705, DOI 10.1083/jcb.201512022; Du HL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15324; DUNCAN CJ, 1987, J CELL SCI, V87, P581; DUNCAN CJ, 1978, EXPERIENTIA, V34, P1531, DOI 10.1007/BF02034655; Dungan CM, 2019, AM J PHYSIOL-CELL PH, V316, pC649, DOI 10.1152/ajpcell.00050.2019; Egner IM, 2017, DEVELOPMENT, V144, P1365, DOI 10.1242/dev.148163; Egner IM, 2016, DEVELOPMENT, V143, P2898, DOI 10.1242/dev.134411; Egner IM, 2013, J PHYSIOL-LONDON, V591, P6221, DOI 10.1113/jphysiol.2013.264457; Eliazer S, 2019, CELL STEM CELL, V25, P654, DOI 10.1016/j.stem.2019.08.007; Englund DA, 2021, FUNCTION, V2, DOI 10.1093/function/zqaa033; Englund DA, 2020, AM J PHYSIOL-CELL PH, V318, pC1178, DOI 10.1152/ajpcell.00090.2020; Englund DA, 2019, AM J PHYSIOL-CELL PH, V317, pC719, DOI 10.1152/ajpcell.00260.2019; Farup J, 2014, J APPL PHYSIOL, V117, P898, DOI 10.1152/japplphysiol.00261.2014; Filigheddu N, 2007, MOL BIOL CELL, V18, P986, DOI 10.1091/mbc.E06-05-0402; Forterre A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084153; Frese S., 2016, DTSCH SPORTMED, V67, P150; Frese S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132099; FRIDEN J, 1983, INT J SPORTS MED, V4, P170, DOI 10.1055/s-2008-1026030; Fry CS, 2017, CELL STEM CELL, V20, P56, DOI 10.1016/j.stem.2016.09.010; Fry CS, 2015, NAT MED, V21, P76, DOI 10.1038/nm.3710; Fry CS, 2014, J PHYSIOL-LONDON, V592, P2625, DOI 10.1113/jphysiol.2014.271288; Fry CS, 2014, FASEB J, V28, P1654, DOI 10.1096/fj.13-239426; Fukada S-I., 2020, BIOCH BIOPHYS ACTA M, V1867; Fukuda S, 2019, ELIFE, V8, DOI 10.7554/eLife.48284; FURUKAWA K, 1984, MUSCLE NERVE, V7, P610, DOI 10.1002/mus.880070803; Gilson H, 2009, AM J PHYSIOL-ENDOC M, V297, pE157, DOI 10.1152/ajpendo.00193.2009; Goh Q, 2019, ELIFE, V8, DOI 10.7554/eLife.44876; Goh Q, 2017, ELIFE, V6, DOI 10.7554/eLife.20007; GOLDBERG AL, 1967, AM J PHYSIOL, V213, P1193, DOI 10.1152/ajplegacy.1967.213.5.1193; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Guerci A, 2012, CELL METAB, V15, P25, DOI 10.1016/j.cmet.2011.12.001; HAMOSH M, 1967, SCIENCE, V157, P935, DOI 10.1126/science.157.3791.935; Hansson KA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20057-8; Haroon M, 2021, BIOPHYS J, V120, P2665, DOI 10.1016/j.bpj.2021.05.021; Herman-Montemayor JR, 2015, J STRENGTH COND RES, V29, P3105, DOI 10.1519/JSC.0000000000000925; Hindi SM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01866-w; Hirai H, 2010, J CELL BIOL, V191, P347, DOI 10.1083/jcb.201006025; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Hunt ER, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14200; IRINTCHEV A, 1987, CELL TISSUE RES, V249, P509; Iwata M, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0181-y; Jackson JR, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0065-3; JACOBS SCJM, 1995, ANAT REC, V242, P329, DOI 10.1002/ar.1092420306; Jakobsen JR, 2018, SCAND J MED SCI SPOR, V28, P1859, DOI 10.1111/sms.13196; JAMES NT, 1976, J ANAT, V122, P121; JAMES NT, 1981, BRIT J EXP PATHOL, V62, P600; Joanisse S, 2015, AM J PHYSIOL-REG I, V309, pR1101, DOI 10.1152/ajpregu.00249.2015; Joanisse S, 2013, FASEB J, V27, P4596, DOI 10.1096/fj.13-229799; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; JOPLIN RE, 1987, J ANAT, V155, P39; Kadi F, 2005, PFLUG ARCH EUR J PHY, V451, P319, DOI 10.1007/s00424-005-1406-6; Kadi F, 2004, J PHYSIOL-LONDON, V558, P1005, DOI 10.1113/jphysiol.2004.065904; Kadi F, 2000, HISTOCHEM CELL BIOL, V113, P99, DOI 10.1007/s004180050012; Kann AP, 2021, CURR OPIN CELL BIOL, V73, P78, DOI 10.1016/j.ceb.2021.06.003; Kargl CK, 2019, J PHYSIOL-LONDON, V597, P5109, DOI 10.1113/JP278165; Karlsen A, 2020, FASEB J, V34, P6418, DOI 10.1096/fj.202000196R; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; KATZ B, 1961, PHILOS T ROY SOC B, V243, P221, DOI 10.1098/rstb.1961.0001; Keefe AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8087; KELLY AM, 1978, ANAT REC, V190, P891, DOI 10.1002/ar.1091900409; Kim E., 2020, INTRINSIC EXTRINSIC, DOI [10.1101/2020.05.21.108951, DOI 10.1101/2020.05.21.108951]; Kirby TJ, 2016, METHODS MOL BIOL, V1460, P43, DOI 10.1007/978-1-4939-3810-0_4; Kirby TJ, 2016, MOL BIOL CELL, V27, P788, DOI 10.1091/mbc.E15-08-0585; Kobayashi Y, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.564581; Konopka AR, 2014, EXERC SPORT SCI REV, V42, P53, DOI 10.1249/JES.0000000000000007; Kook SH, 2008, MOL CELLS, V25, P479; Kook SH, 2008, MOL CELL BIOCHEM, V309, P133, DOI 10.1007/s11010-007-9651-y; Kosmac K, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.118.015929; Kumar A, 2004, FASEB J, V18, P1524, DOI 10.1096/fj.04-2414com; Kurosaka M, 2009, J SPORT SCI MED, V8, P51; Larouche JA, 2021, ELIFE, V10, DOI 10.7554/eLife.66749; Lee JD, 2016, J GERONTOL A-BIOL, V71, P461, DOI 10.1093/gerona/glv033; Lee SJ, 2012, P NATL ACAD SCI USA, V109, pE2353, DOI 10.1073/pnas.1206410109; Leikina E, 2015, SCI REP-UK, V5, DOI 10.1038/srep18246; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Liu N, 2017, NAT CELL BIOL, V19, P202, DOI 10.1038/ncb3477; Liu WX, 2017, ELIFE, V6, DOI [10.7554/eLife.26464, 10.7554/elife.26464]; Liu WX, 2015, ELIFE, V4, DOI 10.7554/eLife.09221; Lundberg TR, 2020, AM J PHYSIOL-REG I, V319, pR50, DOI 10.1152/ajpregu.00061.2020; Mackey AL, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0142-x; Masschelein E, 2020, SKELET MUSCLE, V10, DOI 10.1186/s13395-020-00237-2; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McCarthy JJ, 2007, J APPL PHYSIOL, V103, P1100, DOI 10.1152/japplphysiol.00101.2007a; McCarthy JJ, 2017, DEVELOPMENT, V144, P1363, DOI 10.1242/dev.145797; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; McKenzie AI, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00550; McLoon Linda K, 2002, Trans Am Ophthalmol Soc, V100, P119; McLoon LK, 2002, MUSCLE NERVE, V25, P348, DOI 10.1002/mus.10056; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Miller BF, 2018, J PHYSIOL-LONDON, V596, P83, DOI 10.1113/JP275089; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Moriya N, 2018, AM J PHYSIOL-REG I, V314, pR741, DOI 10.1152/ajpregu.00336.2017; Moro T, 2020, J APPL PHYSIOL, V128, P795, DOI 10.1152/japplphysiol.00723.2019; MOSS FP, 1970, J CELL BIOL, V44, P459, DOI 10.1083/jcb.44.2.459; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; Murach KA, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102372; Murach KA, 2020, J CACHEXIA SARCOPENI, V11, P1705, DOI 10.1002/jcsm.12617; Murach KA, 2020, FUNCTION, V1, DOI 10.1093/function/zqaa009; Murach KA, 2020, J APPL PHYSIOL, V129, P516, DOI 10.1152/japplphysiol.00319.2020; Murach KA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00635; Murach KA, 2018, PHYSIOLOGY, V33, P26, DOI 10.1152/physiol.00019.2017; Murach KA, 2017, J PHYSIOL-LONDON, V595, P6299, DOI 10.1113/JP274611; Murach KA, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0132-z; Murach KA, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12973; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nederveen JP, 2021, EXERC SPORT SCI REV, V49, P284, DOI 10.1249/JES.0000000000000270; Nederveen JP, 2017, AM J PHYSIOL-REG I, V312, pR85, DOI 10.1152/ajpregu.00221.2016; Nederveen JP, 2016, J CACHEXIA SARCOPENI, V7, P547, DOI 10.1002/jcsm.12105; Noehren B, 2018, OSTEOARTHR CARTILAGE, V26, P1359, DOI 10.1016/j.joca.2018.05.011; Omairi S, 2016, ELIFE, V5, DOI 10.7554/eLife.16940; PAPADIMITRIOU JM, 1990, J STRUCT BIOL, V103, P124, DOI 10.1016/1047-8477(90)90016-6; Patsalos A, 2017, J PHYSIOL-LONDON, V595, P5815, DOI 10.1113/JP274361; PAVLATH GK, 1989, NATURE, V337, P570, DOI 10.1038/337570a0; Pawlikowski B, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0067-1; Petrella JK, 2008, J APPL PHYSIOL, V104, P1736, DOI 10.1152/japplphysiol.01215.2007; Petrella JK, 2006, AM J PHYSIOL-ENDOC M, V291, pE937, DOI 10.1152/ajpendo.00190.2006; Pisconti A, 2006, J CELL BIOL, V172, P233, DOI 10.1083/jcb.200507083; Prasad V, 2021, SEMIN CELL DEV BIOL, V119, P3, DOI 10.1016/j.semcdb.2021.04.015; Psilander N, 2019, J APPL PHYSIOL, V126, P1636, DOI 10.1152/japplphysiol.00917.2018; Raffaello A, 2010, J CELL BIOL, V191, P101, DOI 10.1083/jcb.201001136; RALSTON E, 1989, SCIENCE, V244, P1066, DOI 10.1126/science.2543074; RALSTON E, 1992, J CELL BIOL, V119, P1063, DOI 10.1083/jcb.119.5.1063; Randrianarison-Huetz V, 2018, J CELL BIOL, V217, P685, DOI 10.1083/jcb.201705130; Ratnayake D, 2021, NATURE, V591, P281, DOI 10.1038/s41586-021-03199-7; REGER JF, 1968, ANAT REC, V162, P483, DOI 10.1002/ar.1091620410; Rehfeldt C, 2007, J APPL PHYSIOL, V103, P1104, DOI 10.1152/japplphysiol.00466.2007; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; REZNIK M, 1969, LAB INVEST, V20, P353; REZNIK M, 1969, J CELL BIOL, V40, P568, DOI 10.1083/jcb.40.2.568; ROBERTSON TA, 1993, NEUROPATH APPL NEURO, V19, P350, DOI 10.1111/j.1365-2990.1993.tb00451.x; ROSENBLATT JD, 1992, J APPL PHYSIOL, V73, P2538, DOI 10.1152/jappl.1992.73.6.2538; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; Ross JA, 2018, J CELL PHYSIOL, V233, P7157, DOI 10.1002/jcp.26542; Roth SM, 1999, J APPL PHYSIOL, V86, P1833, DOI 10.1152/jappl.1999.86.6.1833; Roth SM, 2001, J GERONTOL A-BIOL, V56, pB240, DOI 10.1093/gerona/56.6.B240; Roth SM, 2000, J APPL PHYSIOL, V88, P1112, DOI 10.1152/jappl.2000.88.3.1112; Saclier M, 2013, STEM CELLS, V31, P384, DOI 10.1002/stem.1288; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sandona M, 2020, EMBO REP, V21, DOI 10.15252/embr.202050863; SCHIAFFINO S, 1972, VIRCHOWS ARCH B, V11, P268; SCHIAFFINO S, 1976, VIRCHOWS ARCH B, V21, P113; SCHULTZ E, 1985, MUSCLE NERVE, V8, P217, DOI 10.1002/mus.880080307; Schwartz LM, 2009, METHODS MOL BIOL, V559, P313, DOI 10.1007/978-1-60327-017-5_22; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; SHAFIQ SA, 1965, J PATHOL BACTERIOL, V90, P123, DOI 10.1002/path.1700900113; Shamim B, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.625044; Shang M, 2020, NATURE, V587, P626, DOI 10.1038/s41586-020-2857-9; Shefer G, 2013, FEBS J, V280, P4063, DOI 10.1111/febs.12228; Shefer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013307; Shuler KT, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9122544; Sinha-Hikim I, 2004, J CLIN ENDOCR METAB, V89, P5245, DOI 10.1210/jc.2004-0084; Smith HK, 2001, J APPL PHYSIOL, V90, P1407, DOI 10.1152/jappl.2001.90.4.1407; Snijders T, 2021, ACTA PHYSIOL, V231, DOI 10.1111/apha.13599; Snijders T, 2017, J CACHEXIA SARCOPENI, V8, P267, DOI 10.1002/jcsm.12137; Snijders T, 2014, AGE, V36, DOI 10.1007/s11357-014-9699-z; SNOW MH, 1990, ANAT REC, V227, P437, DOI 10.1002/ar.1092270407; Sotiropoulos A, 2006, P NATL ACAD SCI USA, V103, P7315, DOI 10.1073/pnas.0510033103; Stromberg A, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-12; Tatsumi R., 2002, Animal Science Journal, V73, P235, DOI 10.1046/j.1344-3941.2002.00033.x; Tatsumi R, 2002, MOL BIOL CELL, V13, P2909, DOI 10.1091/mbc.E02-01-0062; Tatsumi R, 2001, EXP CELL RES, V267, P107, DOI 10.1006/excr.2001.5252; Tatsumi R, 2010, ANIM SCI J, V81, P11, DOI 10.1111/j.1740-0929.2009.00712.x; Tavi P, 2010, J CELL PHYSIOL, V223, P376, DOI 10.1002/jcp.22044; Taylor-Weiner H, 2020, P NATL ACAD SCI USA, V117, P2978, DOI 10.1073/pnas.1919600117; Tonkin J, 2015, MOL THER, V23, P1189, DOI 10.1038/mt.2015.66; Tsuchiya Y, 2020, STEM CELL REP, V15, P926, DOI 10.1016/j.stemcr.2020.08.002; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; van der Meer SFT, 2011, ANN ANAT, V193, P56, DOI 10.1016/j.aanat.2010.08.004; Varga T, 2016, IMMUNITY, V45, P1038, DOI 10.1016/j.immuni.2016.10.016; Verdijk LB, 2007, AM J PHYSIOL-ENDOC M, V292, pE151, DOI 10.1152/ajpendo.00278.2006; Verdijk LB, 2009, J GERONTOL A-BIOL, V64, P332, DOI 10.1093/gerona/gln050; Verma M, 2018, CELL STEM CELL, V23, P530, DOI 10.1016/j.stem.2018.09.007; Vinel C, 2018, NAT MED, V24, P1360, DOI 10.1038/s41591-018-0131-6; Walker DK, 2012, MUSCLE NERVE, V46, P51, DOI 10.1002/mus.23266; Walton RG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37187-1; Wang Q, 2012, J PHYSIOL-LONDON, V590, P2151, DOI 10.1113/jphysiol.2011.226001; Welle S, 2007, AM J PHYSIOL-ENDOC M, V292, pE985, DOI 10.1152/ajpendo.00531.2006; Wen Y, 2021, FUNCTION, V2, DOI 10.1093/function/zqab038; WERNIG A, 1990, J PHYSIOL-LONDON, V428, P639, DOI 10.1113/jphysiol.1990.sp018232; WINCHESTER PK, 1992, ANAT REC, V232, P369, DOI 10.1002/ar.1092320306; Wosczyna MN, 2021, CELL STEM CELL, V28, P1323, DOI 10.1016/j.stem.2021.04.008; Wozniak AC, 2009, INT J BIOCHEM CELL B, V41, P625, DOI 10.1016/j.biocel.2008.07.005; Wozniak AC, 2003, J HISTOCHEM CYTOCHEM, V51, P1437, DOI 10.1177/002215540305101104; Yamada M, 2008, INT J BIOCHEM CELL B, V40, P2183, DOI 10.1016/j.biocel.2008.02.017; Yaseen W, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24159-9; Zhang CC, 2020, J CACHEXIA SARCOPENI, V11, P1291, DOI 10.1002/jcsm.12584	227	16	17	4	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21893	10.1096/fj.202101096R	http://dx.doi.org/10.1096/fj.202101096R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34480776	Green Published, hybrid			2022-12-28	WOS:000702238200073
J	LLabre, JE; Trujillo, R; Sroga, GE; Figueiro, MG; Vashishth, D				LLabre, Joan E.; Trujillo, Ruben; Sroga, Grazyna E.; Figueiro, Mariana G.; Vashishth, Deepak			Circadian rhythm disruption with high-fat diet impairs glycemic control and bone quality	FASEB JOURNAL			English	Article						biomechanics; bone QCT; micro-CT; collagen; preclinical studies	GLYCATION END-PRODUCTS; NONENZYMATIC GLYCATION; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; COGNITIVE DECLINE; ALZHEIMER-DISEASE; OLDER-ADULTS; SLEEP; OBESITY; FRACTURE	Biological functions, including glycemic control and bone metabolism, are highly influenced by the body's internal clock. Circadian rhythms are biological rhythms that run with a period close to 24 hours and receive input from environmental stimuli, such as the light/dark cycle. We investigated the effects of circadian rhythm disruption (CRD), through alteration of the light/dark schedule, on glycemic control and bone quality of mice. Ten-week-old male mice (C57/BL6, n = 48) were given a low-fat diet (LFD) or a high-fat diet (HFD) and kept on a dayshift or altered schedule (RSS3) for 22 weeks. Mice were divided into four experimental groups (n = 12/group): Dayshift/LFD, Dayshift/HFD, RSS3/LFD, and RSS3/HFD. CRD in growing mice fed a HFD resulted in a diabetic state, with a 36.2% increase in fasting glucose levels compared to the Dayshift/LFD group. Micro-CT scans of femora revealed a reduction in inner and outer surface expansion for mice on a HFD and altered light schedule. Cancellous bone demonstrated deterioration of bone quality as trabecular number and thickness decreased while trabecular separation increased. While HFD increased cortical bone mineral density, its combination with CRD reduced this phenomenon. The growth of mineral crystals, determined by small angle X-ray scattering, showed HFD led to smaller crystals. Considering modifications of the organic matrix, regardless of diet, CRD exacerbated the accumulation of fluorescent advanced glycation end-products (fAGEs) in collagen. Strength testing of tibiae showed that CRD mitigated the higher strength in the HFD group and increased brittleness indicated by lower post-yield deflection and work-to-fracture. Consistent with accumulation of fAGEs, various measures of toughness were lowered with CRD, but combination of CRD with HFD protected against this decrease. Differences between strength and toughness results represent different contributions of structural and material properties of bone to energy dissipation. Collectively, these results demonstrate that combination of CRD with HFD impairs glycemic control and have complex effects on bone quality.	[LLabre, Joan E.; Trujillo, Ruben; Sroga, Grazyna E.; Vashishth, Deepak] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [LLabre, Joan E.; Trujillo, Ruben; Sroga, Grazyna E.; Vashishth, Deepak] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Trujillo, Ruben] Univ New Mexico, Dept Chem & Biol Engn, Albuquerque, NM USA; [Figueiro, Mariana G.] Rensselaer Polytech Inst, Lighting Res Ctr, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of New Mexico; Rensselaer Polytechnic Institute	Vashishth, D (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biomed Engn, 110 8th St, Troy, NY 12180 USA.	vashid@rpi.edu			HHS \ National Institutes of Health (NIH) [T32AG057464 (1-5)]; HHS \ NIH \ National Institute on Aging (NIA) [R56 AG20618]; NSF \ ENG \ Division of Engineering Education and Centers (EEC) [EEC-1559963]; Energimyndigheten (Swedish Energy Agency)	HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHS \ NIH \ National Institute on Aging (NIA); NSF \ ENG \ Division of Engineering Education and Centers (EEC); Energimyndigheten (Swedish Energy Agency)(Swedish Energy Agency)	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: T32AG057464 (1-5); HHS | NIH | National Institute on Aging (NIA), Grant/Award Number: R56 AG20618; NSF | ENG | Division of Engineering Education and Centers (EEC), Grant/Award Number: EEC-1559963; Energimyndigheten (Swedish Energy Agency)	Acevedo C, 2018, J BONE MINER RES, V33, P1066, DOI 10.1002/jbmr.3393; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Bailey SM, 2014, J ENDOCRINOL, V222, pR75, DOI 10.1530/JOE-14-0200; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Busquets O, 2017, MECH AGEING DEV, V162, P38, DOI 10.1016/j.mad.2016.11.002; Carriero A, 2014, J MECH BEHAV BIOMED, V39, P38, DOI 10.1016/j.jmbbm.2014.06.017; Cerda C, 2014, ADV EXP MED BIOL, V824, P5, DOI 10.1007/978-3-319-07320-0_2; Chen NX, 2020, J BONE MINER RES, V35, P608, DOI 10.1002/jbmr.3925; Craft S, 2012, NAT REV NEUROL, V8, P360, DOI 10.1038/nrneurol.2012.112; Creecy A, 2016, CALCIFIED TISSUE INT, V99, P289, DOI 10.1007/s00223-016-0149-z; Dimitri P, 2012, BONE, V50, P457, DOI 10.1016/j.bone.2011.05.011; Duffy CM, 2019, NEUROBIOL LEARN MEM, V157, P41, DOI 10.1016/j.nlm.2018.11.008; Eckel-Mahan K, 2009, NAT STRUCT MOL BIOL, V16, P462, DOI 10.1038/nsmb.1595; Eckhardt BA, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.135236; Eriksen C, 2014, J APPL PHYSIOL, V117, P840, DOI 10.1152/japplphysiol.00584.2014; Fajardo RJ, 2014, J BONE MINER RES, V29, P1025, DOI 10.1002/jbmr.2210; Figueiro MG, 2019, J CLIN SLEEP MED, V15, P1757, DOI 10.5664/jcsm.8078; Figueiro MG, 2017, NEURODEGENER DIS MAN, V7, P119, DOI 10.2217/nmt-2016-0060; Figueiro MG, 2017, SLEEP HEALTH, V3, P204, DOI 10.1016/j.sleh.2017.03.005; Figueiro MG, 2017, SCI REP-UK, V7, DOI 10.1038/srep40661; Figueiro MG, 2016, NAT SCI SLEEP, V8, P91, DOI 10.2147/NSS.S85849; Hofstra WA, 2008, EPILEPSY BEHAV, V13, P438, DOI 10.1016/j.yebeh.2008.06.002; Ionova-Martin SS, 2011, OSTEOPOROSIS INT, V22, P2283, DOI 10.1007/s00198-010-1432-x; Ionova-Martin SS, 2010, BONE, V46, P217, DOI 10.1016/j.bone.2009.10.015; Jepsen KJ, 2015, J BONE MINER RES, V30, P951, DOI 10.1002/jbmr.2539; Kalsbeek A, 2014, MOL METAB, V3, P372, DOI 10.1016/j.molmet.2014.03.002; Karim L, 2016, BONE, V82, P21, DOI 10.1016/j.bone.2015.07.028; Kim SM, 2018, FASEB J, V32, P3085, DOI 10.1096/fj.201700784R; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Koenig AM, 2017, ALZ DIS ASSOC DIS, V31, P107, DOI 10.1097/WAD.0000000000000202; Kothari V, 2017, BBA-MOL BASIS DIS, V1863, P499, DOI 10.1016/j.bbadis.2016.10.006; Melton LJ, 2008, J CLIN ENDOCR METAB, V93, P4804, DOI 10.1210/jc.2008-0639; Morris CJ, 2012, MOL CELL ENDOCRINOL, V349, P91, DOI 10.1016/j.mce.2011.09.003; Musiek ES, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.121; Perelis M, 2016, J BIOL RHYTHM, V31, P323, DOI 10.1177/0748730416656949; Poundarik AA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19253-w; Poundarik AA, 2015, J MECH BEHAV BIOMED, V52, P120, DOI 10.1016/j.jmbbm.2015.08.012; Pugazhenthi S, 2017, BBA-MOL BASIS DIS, V1863, P1037, DOI 10.1016/j.bbadis.2016.04.017; Qian JY, 2015, ENDOCRINOLOGY, V156, P4426, DOI 10.1210/en.2015-1516; Razavi P, 2019, CANCER EPIDEM BIOMAR, V28, P1177, DOI 10.1158/1055-9965.EPI-18-1018; Reutrakul S, 2018, METABOLISM, V84, P56, DOI 10.1016/j.metabol.2018.02.010; Riley LA, 2017, CURR OSTEOPOROS REP, V15, P222, DOI 10.1007/s11914-017-0363-2; Ritchie RO, 2008, BONE, V43, P798, DOI 10.1016/j.bone.2008.04.027; Samsa WE, 2016, BONE, V84, P194, DOI 10.1016/j.bone.2016.01.006; Sanyaolu Adekunle, 2019, Glob Pediatr Health, V6, p2333794X19891305, DOI 10.1177/2333794X19891305; Schilperoort M, 2020, FASEB J, V34, P1052, DOI 10.1096/fj.201901929R; Song C, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9156478; Sroga GE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117240; Stunes AK, 2020, BONE, V132, DOI 10.1016/j.bone.2019.115193; Swanson CM, 2018, METABOLISM, V84, P28, DOI 10.1016/j.metabol.2017.12.002; Tang SY, 2007, BONE, V40, P1144, DOI 10.1016/j.bone.2006.12.056; Thome J, 2011, J Aging Res, V2011, P383091, DOI 10.4061/2011/383091; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Vashishth D, 2001, BONE, V28, P195, DOI 10.1016/S8756-3282(00)00434-8; Vashishth D., 2003, T ORTH RES SOC, V1, P497; Vashishth Deepak, 2009, IBMS Bonekey, V6, P268; Walker JM, 2017, NEUROBIOL DIS, V100, P87, DOI 10.1016/j.nbd.2017.01.004; Wang B., 2020, P 2020 ANN M ORTH RE, P0432; Willett TL, 2019, BONE, V120, P187, DOI 10.1016/j.bone.2018.10.024; Wu QY, 2019, J MOL MED, V97, P19, DOI 10.1007/s00109-018-1723-9; Yang X, 2016, CALCIFIED TISSUE INT, V99, P373, DOI 10.1007/s00223-016-0153-3	61	4	4	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21786	10.1096/fj.202100610RR	http://dx.doi.org/10.1096/fj.202100610RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34411349	Green Accepted			2022-12-28	WOS:000691122900038
J	Wang, HR; Hussain, T; Yao, J; Li, J; Sabir, N; Liao, Y; Liang, ZM; Wang, YZ; Liu, YD; Zhao, DM; Zhou, XM				Wang, Haoran; Hussain, Tariq; Yao, Jiao; Li, Jing; Sabir, Naveed; Liao, Yi; Liang, Zhengmin; Wang, Yuanzhi; Liu, Yiduo; Zhao, Deming; Zhou, Xiangmei			Koumiss promotes Mycobacterium bovis infection by disturbing intestinal flora and inhibiting endoplasmic reticulum stress	FASEB JOURNAL			English	Article						gut microbiota; gut-lung axis; koumiss; M bovis; tuberculosis	SULFATE-REDUCING BACTERIA; TUBERCULOSIS; APOPTOSIS	Mycobacterium bovis is the causative agent of bovine tuberculosis and also responsible for serious threat to public health. Koumiss is a fermented mare's milk product, used as traditional drink. Here, we explored the effect of koumiss on gut microbiota and the host immune response against M bovis infection. Therefore, mice were treated with koumiss and fresh mare milk for 14 days before M bovis infection and continue for 5 weeks after infection. The results showed a clear change in the intestinal flora of mice treated with koumiss, and the lungs of mice treated with koumiss showed severe edema, inflammatory infiltration, and pulmonary nodules in M bovis-infected mice. Notably, we found that the content of short-chain fatty acids was significantly lower in the koumiss-treated group compared with the control group. However, the expression of endoplasmic reticulum stress and apoptosis-related proteins in the lungs of koumiss-treated mice were significantly decreased. Collectively, these findings suggest that koumiss treatment disturb the intestinal flora of, which is associated with disease severity and the possible mechanism that induces lungs pathology. Our current findings can be exploited further to establish the "gut-lung" axis which might be a novel strategy for the control of tuberculosis.	[Wang, Haoran; Yao, Jiao; Liang, Zhengmin; Wang, Yuanzhi; Liu, Yiduo; Zhao, Deming] China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis,Minist Agr, Natl Anim Transmissible Spongiform Encephalopathy, Beijing, Peoples R China; [Wang, Haoran; Yao, Jiao; Li, Jing; Liang, Zhengmin; Wang, Yuanzhi; Liu, Yiduo; Zhao, Deming; Zhou, Xiangmei] China Agr Univ, Coll Vet Med, 2 West Yuanmingyuan Rd, Beijing, Peoples R China; [Hussain, Tariq] Univ Agr Peshawar, Coll Vet Sci, Peshawar, Pakistan; [Sabir, Naveed] Univ Poonch, Fac Vet & Anim Sci, Dept Pathobiol, Rawalakot, Pakistan; [Liao, Yi] Southwest Univ Nationalities, Anim Husb & Vet Coll, Chengdu, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University; Southwest Minzu University	Zhou, XM (corresponding author), China Agr Univ, Coll Vet Med, 2 West Yuanmingyuan Rd, Beijing, Peoples R China.	Zhouxm@cau.edu.cn	Hussain, Muhammad/AAD-2380-2022	Sabir, Naveed/0000-0001-7276-6513	National Natural Science Foundation of China [31873005]; National Key Research and Development Program [2017YFD0500901]; China Agriculture Research System [CARS-36]; MoSTRCUK international cooperation project [2013DFG32500]; High-end Foreign Experts Recruitment Program [GDW20151100036, GDW20161100071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program; China Agriculture Research System; MoSTRCUK international cooperation project; High-end Foreign Experts Recruitment Program	This work was supported by "National Natural Science Foundation of China (Project No. 31873005)"; "National Key Research and Development Program (Project No. 2017YFD0500901)"; "China Agriculture Research System (No. CARS-36)", "the MoSTRCUK international cooperation project (Project No. 2013DFG32500)," and "the High-end Foreign Experts Recruitment Program (Project No. GDW20151100036, GDW20161100071)"	Anand S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02147; Babidge W, 1998, MOL CELL BIOCHEM, V181, P117, DOI 10.1023/A:1006838231432; Bennett RM, 2017, REV SCI TECH OIE, V36, P105, DOI 10.20506/rst.36.1.2614; Bertholet S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001094; Budden KF, 2017, NAT REV MICROBIOL, V15, P55, DOI 10.1038/nrmicro.2016.142; Chen YR, 2019, LETT APPL MICROBIOL, V68, P553, DOI 10.1111/lam.13149; Chen YH, 2020, J NUTR BIOCHEM, V79, DOI 10.1016/j.jnutbio.2020.108362; Chenard T, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-01724-8; D'Arcy MS, 2019, CELL BIOL INT, V43, P582, DOI 10.1002/cbin.11137; Guo L, 2019, J DAIRY SCI, V102, P1972, DOI 10.3168/jds.2018-15155; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hu YF, 2019, J INFECTION, V78, P317, DOI 10.1016/j.jinf.2018.08.006; Khan N, 2019, MUCOSAL IMMUNOL, V12, P772, DOI 10.1038/s41385-019-0147-3; Khan N, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00529; Kim B, 2017, METHODS MOL BIOL, V1606, P133, DOI 10.1007/978-1-4939-6990-6_9; Lam A, 2017, AM J PHYSIOL-LUNG C, V313, pL218, DOI 10.1152/ajplung.00162.2017; Coutinho CMLM, 2017, MICROB PATHOGENESIS, V112, P126, DOI 10.1016/j.micpath.2017.09.054; Law BA, 1997, MICROBIOLOGY BIOCH C, P1; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li HB, 2020, J SCI FOOD AGR, V100, P1822, DOI 10.1002/jsfa.10220; Liao Y, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00268; Lim YJ, 2015, APOPTOSIS, V20, P358, DOI 10.1007/s10495-014-1080-2; Liu MQ, 2015, APOPTOSIS, V20, P883, DOI 10.1007/s10495-015-1115-3; Luo M, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00822; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Naidoo CC, 2019, LANCET RESP MED, V7, P892, DOI 10.1016/S2213-2600(18)30501-0; Namasivayam S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0286-2; Negatu DA, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01571-17; Olea-Popelka F, 2017, LANCET INFECT DIS, V17, pE21, DOI 10.1016/S1473-3099(16)30139-6; Robles-Vera I, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112564; Rowan FE, 2009, BRIT J SURG, V96, P151, DOI 10.1002/bjs.6454; Schwarz DS, 2016, CELL MOL LIFE SCI, V73, P79, DOI 10.1007/s00018-015-2052-6; Sekyere JO, 2020, ANN NY ACAD SCI, V1467, P21, DOI 10.1111/nyas.14300; Sibhat B, 2017, PREV VET MED, V147, P149, DOI 10.1016/j.prevetmed.2017.09.006; So JS, 2018, MOL CELLS, V41, P705, DOI 10.14348/molcells.2018.0241; Uniacke-Lowe T, 2010, INT DAIRY J, V20, P609, DOI 10.1016/j.idairyj.2010.02.007; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wt H, 1989, J ANIM HUSB VET MED, V4, P1; Yang DM, 2020, NEUROBIOL DIS, V135, DOI 10.1016/j.nbd.2019.104704; Ye JZ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01967; Zhang K, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00433; Zhao YL, 2020, SCI TOTAL ENVIRON, V721, DOI 10.1016/j.scitotenv.2020.137639	42	1	1	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21777	10.1096/fj.202002485RR	http://dx.doi.org/10.1096/fj.202002485RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34403519				2022-12-28	WOS:000691122900025
J	Dong, DD; Zhang, Y; He, H; Zhu, Y; Ou, HL				Dong, Doudou; Zhang, Yun; He, Hui; Zhu, Yuan; Ou, Hailong			Alpinetin inhibits macrophage infiltration and atherosclerosis by improving the thiol redox state: Requirement of GSk3 beta/Fyn-dependent Nrf2 activation	FASEB JOURNAL			English	Article						alpinetin; atherosclerosis; macrophage infiltration; Nrf2; redox state	INFLAMMATORY RESPONSE; CELL-PROLIFERATION; OXIDATIVE STRESS; UP-REGULATION; ACCUMULATION; THIOREDOXIN; EXPRESSION; PATHWAY; INJURY	Alpinetin is a plant flavonoid isolated from Alpinia katsumadai Hayata with antioxidant and anti-inflammatory properties. Monocyte infiltration into the intima promotes atherosclerotic development and causes plaque instability at the later stage, which is profoundly influenced by various oxidants. In this study, we investigated whether alpinetin restores the redox state to inhibit monocyte infiltration and ameliorates atherosclerosis. ApoE-deficient (ApoE(-/-)) mice were fed a high-fat diet and treated with alpinetin. We found that alpinetin significantly attenuated atherosclerotic lesions and reduced necrotic core size associated with the reduction in infiltrated macrophages within the plaques. Alpinetin inhibited macrophage adhesion and migration, and the expression of chemokines and adhesion molecules, such as MCP-1, VCAM-1, and ICAM-1. Intraplaque MMP2 and MMP9 were reduced, while collagen contents were increased and elastin fiber was prevented from degradation in the alpinetin-treated mice. Data further showed that alpinetin reduced reactive oxygen species generation and promoted thiol-dependent glutathione and thioredoxin antioxidant systems in macrophages. Alpinetin activated Nfr2, an upstream activator of the thiol-dependent redox signaling by increasing the nuclear translocation. The nuclear accumulation of Nrf2 was enhanced by reducing nuclear export, which was achieved through the regulation of the GSk3 beta/Fyn pathway. Finally, inhibition of Nrf2 in HFD-apoE(-/-) mice blockaded the effect of alpinetin, which increased aortic macrophage recruitment and aggravated atherosclerosis concurrently with elevating the expression of MCP-1, VCAM-1, and ICAM-1. Altogether, these findings indicated that alpinetin improved Nrf2-mediated redox homeostasis, which consequently inhibited macrophage infiltration and atherosclerosis, suggesting a useful compound for treating atherosclerosis.	[Dong, Doudou; Zhang, Yun; He, Hui; Zhu, Yuan; Ou, Hailong] Guizhou Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Guiyang 550025, Guizhou, Peoples R China	Guizhou Medical University	Ou, HL (corresponding author), Guizhou Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Guiyang 550025, Guizhou, Peoples R China.	ouhailong@gmc.edu.cn		Ou, Hailong/0000-0001-7298-1977	National Natural Science Foundation of China (NSFC) [81760088, 32060219, 82060232]; Special grant for central government Supporting local Science and technology development, Science and Technology Department of Guizhou province, China [[2019]4008]; Science and Technology Plan Project of Guizhou Province (Basic Science and Technology Cooperation), China [[2020]1Z060, ZK[2022]038]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Special grant for central government Supporting local Science and technology development, Science and Technology Department of Guizhou province, China; Science and Technology Plan Project of Guizhou Province (Basic Science and Technology Cooperation), China	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81760088, 32060219 and 82060232; Special grant for central government Supporting local Science and technology development, Science and Technology Department of Guizhou province, China, Grant/Award Number: [2019]4008; Science and Technology Plan Project of Guizhou Province (Basic Science and Technology Cooperation), China, Grant/Award Number: [2020]1Z060 and ZK[2022]038	Abdelhamid AM, 2020, LIFE SCI, V256, DOI 10.1016/j.lfs.2020.117908; Ajsuvakova OP, 2020, COORDIN CHEM REV, V417, DOI 10.1016/j.ccr.2020.213343; BABAEV VR, 1993, ATHEROSCLEROSIS, V100, P237, DOI 10.1016/0021-9150(93)90210-L; DREW AF, 1995, ARTERIOSCL THROM VAS, V15, P1563, DOI 10.1161/01.ATV.15.10.1563; Farr SA, 2016, J ALZHEIMERS DIS, V54, P1339, DOI 10.3233/JAD-160416; Gao Y, 2020, INFLAMMATION, V43, P1742, DOI 10.1007/s10753-020-01248-3; He XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep28370; Hu K, 2013, EUR J PHARMACOL, V721, P96, DOI 10.1016/j.ejphar.2013.09.049; Hu ZP, 2020, VASC PHARMACOL, V127, DOI 10.1016/j.vph.2020.106659; Huang Y, 2015, INT IMMUNOPHARMACOL, V28, P1003, DOI 10.1016/j.intimp.2015.08.002; IKEDA U, 1993, ATHEROSCLEROSIS, V104, P61, DOI 10.1016/0021-9150(93)90176-U; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jiang ZM, 2015, BIOTECHNOL APPL BIOC, V62, P840, DOI 10.1002/bab.1328; Kapoor R, 2019, J NUTR BIOCHEM, V70, P215, DOI 10.1016/j.jnutbio.2019.05.003; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kim M, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10050787; Lee MY, 2012, INFLAMMATION, V35, P746, DOI 10.1007/s10753-011-9370-0; Li XM, 2020, FOOD CHEM TOXICOL, V144, DOI 10.1016/j.fct.2020.111644; Li X, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/6286984; Li YJ, 2004, J ASIAN NAT PROD RES, V6, P87, DOI 10.1080/1028602031000135558; Liang YJ, 2018, INT IMMUNOPHARMACOL, V62, P309, DOI 10.1016/j.intimp.2018.07.010; Lin SK, 2008, ARTHRITIS RHEUM, V58, P3145, DOI 10.1002/art.23937; Liu BY, 2018, J NUTR BIOCHEM, V52, P115, DOI 10.1016/j.jnutbio.2017.09.025; Liu P, 2020, FASEB J, V34, P1481, DOI 10.1096/fj.201901629RR; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; McAlpine CS, 2012, ARTERIOSCL THROM VAS, V32, P82, DOI 10.1161/ATVBAHA.111.237941; Nakashima Y, 2007, ARTERIOSCL THROM VAS, V27, P1159, DOI 10.1161/ATVBAHA.106.134080; Newby AC, 1999, CARDIOVASC RES, V41, P345, DOI 10.1016/S0008-6363(98)00286-7; Ouyang YF, 2018, METALLOMICS, V10, P218, DOI 10.1039/c7mt00327g; Pan J, 2021, INT IMMUNOPHARMACOL, V95, DOI 10.1016/j.intimp.2021.107527; Qian B, 2021, DIABETOLOGIA, V64, P2037, DOI 10.1007/s00125-021-05489-1; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Sarkar A, 2015, ENVIRON TOXICOL, V30, P396, DOI 10.1002/tox.21901; Shimura T, 2019, FASEB J, V33, P6867, DOI 10.1096/fj.201802246RR; Tan Y, 2018, AM J MED SCI, V355, P377, DOI 10.1016/j.amjms.2018.01.002; Tavakoli S, 2012, ANTIOXID REDOX SIGN, V17, P1785, DOI 10.1089/ars.2012.4638; Tikellis C, 2008, ATHEROSCLEROSIS, V199, P55, DOI 10.1016/j.atherosclerosis.2007.10.038; Tonelli C, 2018, ANTIOXID REDOX SIGN, V29, P1727, DOI 10.1089/ars.2017.7342; Tong GZ, 2020, BIOCHEM BIOPH RES CO, V527, P15, DOI 10.1016/j.bbrc.2020.04.053; Wang ZT, 2001, J CARDIOVASC PHARM, V37, P596, DOI 10.1097/00005344-200105000-00011; Wu D, 2020, INT IMMUNOPHARMACOL, V89, DOI 10.1016/j.intimp.2020.107073; Xing HY, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01065; Xue JL, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/3690561; Zhang T, 2020, J CELL MOL MED, V24, P8430, DOI 10.1111/jcmm.15371; Zhang X, 2020, CELL DEATH DIFFER, V27, P540, DOI 10.1038/s41418-019-0372-z; Zhou JJ, 2017, INFLAMM RES, V66, P177, DOI 10.1007/s00011-016-1004-4; Zhou Y, 2018, BIOMED PHARMACOTHER, V97, P1397, DOI 10.1016/j.biopha.2017.10.035	48	3	3	10	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22261	10.1096/fj.202101567R	http://dx.doi.org/10.1096/fj.202101567R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZY7CO	35332570				2022-12-28	WOS:000772741400001
J	Alferiev, IS; Guerrero, DT; Guan, P; Nguyen, F; Kolla, V; Soberman, D; Pressly, BB; Fishbein, I; Brodeur, GM; Chorny, M				Alferiev, Ivan S.; Guerrero, David T.; Guan, Peng; Nguyen, Ferro; Kolla, Venkatadri; Soberman, Danielle; Pressly, Benjamin B.; Fishbein, Ilia; Brodeur, Garrett M.; Chorny, Michael			Poloxamer-linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high-risk neuroblastoma with primary and acquired chemoresistance	FASEB JOURNAL			English	Article						ABCG2; drug resistance; neuroblastoma; SN22; topoisomerase I inhibitor	MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; CELL-LINES; POLY(ETHYLENE GLYCOL); CAMPTOTHECIN ANALOGS; P53 MUTATIONS; CANCER	High-risk solid tumors continue to pose a tremendous therapeutic challenge due to multidrug resistance. Biological mechanisms driving chemoresistance in high-risk primary and recurrent disease are distinct: in newly diagnosed patients, non-response to therapy is often associated with a higher level of tumor "stemness" paralleled by overexpression of the ABCG2 drug efflux pump, whereas in tumors relapsing after non-curative therapy, poor drug sensitivity is most commonly linked to the dysfunction of the tumor suppressor protein, p53. In this study, we used preclinical models of aggressive neuroblastoma featuring these characteristic mechanisms of primary and acquired drug resistance to experimentally evaluate a macromolecular prodrug of a structurally enhanced camptothecin analog, SN22, resisting ABCG2-mediated export, and glucuronidation. Together with extended tumor exposure to therapeutically effective drug levels via reversible conjugation to Pluronic F-108 (PF108), these features translated into rapid tumor regression and long-term survival in models of both ABCG2-overexpressing and p53-mutant high-risk neuroblastomas, in contrast to a marginal effect of the clinically used camptothecin derivative, irinotecan. Our results demonstrate that pharmacophore enhancement, increased tumor uptake, and optimally stable carrier-drug association integrated into the design of the hydrolytically activatable PF108-[SN22](2) have the potential to effectively combat multiple mechanisms governing chemoresistance in newly diagnosed (chemo-naive) and recurrent forms of aggressive malignancies. As a macromolecular carrier-based delivery system exhibiting remarkable efficacy against two particularly challenging forms of high-risk neuroblastoma, PF108-[SN22](2) can pave the way to a robust and clinically viable therapeutic strategy urgently needed for patients with multidrug-resistant disease presently lacking effective treatment options.	[Alferiev, Ivan S.; Guerrero, David T.; Guan, Peng; Nguyen, Ferro; Kolla, Venkatadri; Soberman, Danielle; Pressly, Benjamin B.; Fishbein, Ilia; Brodeur, Garrett M.; Chorny, Michael] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Pediat, Abramson Res Bldg,Suite 702,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Chorny, M (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Pediat, Abramson Res Bldg,Suite 702,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	chorny@chop.edu	Guan, Peng/GWM-9170-2022	Chorny, Michael/0000-0002-8243-9089	HHS \ NIH \ National Cancer Institute (NCI) [R01-CA251883]; Solving Kids' Cancer (SKC); Alex's Lemonade Stand Foundation for Childhood Cancer (ALSF); CURE Childhood Cancer (CURE); Peel Therapeutics; Audrey E. Evans Endowed Chair; U.S. Department of Defense (DOD) [W81XWH2110536]	HHS \ NIH \ National Cancer Institute (NCI); Solving Kids' Cancer (SKC); Alex's Lemonade Stand Foundation for Childhood Cancer (ALSF); CURE Childhood Cancer (CURE); Peel Therapeutics; Audrey E. Evans Endowed Chair; U.S. Department of Defense (DOD)(United States Department of Defense)	HHS vertical bar NIH vertical bar National Cancer Institute (NCI), Grant/Award Number: R01-CA251883; Solving Kids' Cancer (SKC); Alex's Lemonade Stand Foundation for Childhood Cancer (ALSF); CURE Childhood Cancer (CURE); Peel Therapeutics; Audrey E. Evans Endowed Chair; U.S. Department of Defense (DOD), Grant/Award Number: W81XWH2110536	Alakhova DY, 2014, MOL PHARMACEUT, V11, P2566, DOI 10.1021/mp500298q; Alvarez-Lorenzo C, 2011, CURR DRUG TARGETS, V12, P1112, DOI 10.2174/138945011795906615; Bates SE, 2004, J PHARMACOL EXP THER, V310, P836, DOI 10.1124/jpet.103.063149; BIEDLER JL, 1976, J NATL CANCER I, V57, P683, DOI 10.1093/jnci/57.3.683; Brangi M, 1999, CANCER RES, V59, P5938; Byrne FL, 2016, METHODS MOL BIOL, V1372, P61, DOI 10.1007/978-1-4939-3148-4_5; Chen L, 2018, INT J ONCOL, V52, P967, DOI 10.3892/ijo.2018.4261; Chesler L, 2011, SEMIN CANCER BIOL, V21, P245, DOI 10.1016/j.semcancer.2011.09.011; Cialfi S, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.9524; Davis SS, 2002, DRUG DISCOV TODAY, V7, P1159, DOI 10.1016/S1359-6446(02)02517-5; Ekladious I, 2019, NAT REV DRUG DISCOV, V18, P273, DOI 10.1038/s41573-018-0005-0; Fox ME, 2009, ACCOUNTS CHEM RES, V42, P1141, DOI 10.1021/ar900035f; Gandhi YA, 2009, AAPS J, V11, P541, DOI 10.1208/s12248-009-9132-1; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Huang M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014415; Ivens IA, 2015, TOXICOL PATHOL, V43, P959, DOI 10.1177/0192623315591171; Keshelava N, 2001, CANCER RES, V61, P6185; Keshelava N, 1998, CANCER RES, V58, P5396; Keshelava N, 2000, CANCER CHEMOTH PHARM, V45, P1, DOI 10.1007/PL00006736; Keshelava N, 2000, MED PEDIATR ONCOL, V35, P563, DOI 10.1002/1096-911X(20001201)35:6<563::AID-MPO15>3.0.CO;2-J; KUNIMOTO T, 1987, CANCER RES, V47, P5944; Kuosmanen T, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1009418; Laetsch TW, 2021, CANCER DISCOV, V11, P545, DOI 10.1158/2159-8290.CD-20-0779; Lele BS, 1998, J APPL POLYM SCI, V70, P883, DOI 10.1002/(SICI)1097-4628(19981031)70:5<883::AID-APP7>3.0.CO;2-P; London WB, 2017, CANCER-AM CANCER SOC, V123, P4914, DOI 10.1002/cncr.30934; Maskarinec SA, 2003, LANGMUIR, V19, P1809, DOI 10.1021/la026175z; Moloughney Joseph G, 2012, Recent Pat Biotechnol, V6, P200; MOORE JS, 1990, MACROMOLECULES, V23, P65, DOI 10.1021/ma00203a013; Nakagawa H, 2006, CANCER LETT, V234, P81, DOI 10.1016/j.canlet.2005.05.052; Nema Sandeep, 2011, PDA J Pharm Sci Technol, V65, P287, DOI 10.5731/pdajpst.2011.00634; Nguyen F, 2020, CANCER RES, V80, P4258, DOI 10.1158/0008-5472.CAN-20-1344; Pastorino F, 2010, CLIN CANCER RES, V16, P4809, DOI 10.1158/1078-0432.CCR-10-1354; Patterson Danielle M, 2011, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1417s52; Pitto-Barry A, 2014, POLYM CHEM-UK, V5, P3291, DOI 10.1039/c4py00039k; Polunin Y, 2021, ACS PHARMACOL TRANSL, V4, P240, DOI 10.1021/acsptsci.0c00182; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rebucci M, 2013, BIOCHEM PHARMACOL, V85, P1219, DOI 10.1016/j.bcp.2013.02.017; Sapra P, 2008, CLIN CANCER RES, V14, P1888, DOI 10.1158/1078-0432.CCR-07-4456; Sawada S., 1995, CURR PHARM DESIGN, V1, P113; Schellens JHM, 2000, ANN NY ACAD SCI, V922, P188; Serrano LA, 2018, CHEM COMMUN, V54, P1485, DOI 10.1039/c7cc07668a; Shah N., 2019, CANC DRUG RESIST, V2, P428; Singh-Joy SD, 2008, INT J TOXICOL, V27, P93, DOI 10.1080/10915810802244595; Singla P, 2022, ADV COLLOID INTERFAC, V299, DOI 10.1016/j.cis.2021.102563; Smith V, 2018, CHILDREN-BASEL, V5, DOI 10.3390/children5090114; Strickley RG, 2004, PHARM RES-DORDR, V21, P201, DOI 10.1023/B:PHAM.0000016235.32639.23; Swift CC, 2018, RADIOGRAPHICS, V38, P566, DOI 10.1148/rg.2018170132; Teitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019133; Thomas A, 2019, CLIN CANCER RES, V25, P6581, DOI 10.1158/1078-0432.CCR-19-1089; Toyoda Y, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00208; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; Tweddle DA, 2001, CANCER RES, V61, P8; Westover D, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0275-x; Wong M, 2020, NAT MED, V26, P1742, DOI 10.1038/s41591-020-1072-4; Wu CP, 2011, MOL PHARMACEUT, V8, P1996, DOI 10.1021/mp200261n; Yamauchi T, 2011, ONCOL REP, V25, P347, DOI 10.3892/or.2010.1100; Yoshikawa M, 2004, INT J CANCER, V110, P921, DOI 10.1002/ijc.20216; Zage PE, 2018, CHILDREN-BASEL, V5, DOI 10.3390/children5110148; Zhao H, 2008, BIOCONJUGATE CHEM, V19, P849, DOI 10.1021/bc700333s	59	0	0	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22213	10.1096/fj.202101830RR	http://dx.doi.org/10.1096/fj.202101830RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35192728	hybrid, Green Published			2022-12-28	WOS:000761250800037
J	Khan, N; Halcrow, PW; Afghah, Z; Baral, A; Geiger, JD; Chen, XS				Khan, Nabab; Halcrow, Peter W.; Afghah, Zahra; Baral, Aparajita; Geiger, Jonathan D.; Chen, Xuesong			HIV-1 Tat endocytosis and retention in endolysosomes affects HIV-1 Tat-induced LTR transactivation in astrocytes	FASEB JOURNAL			English	Article						astrocytes; endolysosomes; HIV-1 latency; HIV-1 LTR transactivation; HIV-1 Tat	IMMUNODEFICIENCY-VIRUS TYPE-1; LYSOSOMAL MEMBRANE PERMEABILIZATION; ARGININE-RICH PEPTIDES; CENTRAL-NERVOUS-SYSTEM; CELLULAR UPTAKE; ANTIRETROVIRAL THERAPY; NEURONAL DYSFUNCTION; LATE ENDOSOMES; PROTEIN; INFECTION	The presence of latent HIV-1 reservoirs in the periphery and brain represents a major obstacle to curing HIV-1 infection. As an essential protein for HIV-1 viral replication, HIV-1 Tat, mostly intracellular, has been implicated in latent HIV-1 infection. From HIV-1 infected cells, HIV-1 Tat is actively secreted and bystander cells uptake the released Tat whereupon it is endocytosed and internalized into endolysosomes. However, to activate the HIV-1 LTR promoter and increase HIV-1 replication, HIV-1 Tat must first escape from the endolysosomes and then enter the nucleus. Here, we tested the hypothesis that HIV-1 Tat can accumulate in endolysosomes and contribute to the activation of latent HIV-1 in astrocytes. Using U87MG astrocytoma cells expressing HIV-1 LTR-driven luciferase and primary human astrocytes we found that exogenous HIV-1 Tat enters endolysosomes, resides in endolysosomes for extended periods of time, and induces endolysosome de-acidification as well as enlargement. The weak base chloroquine promoted the release of HIV-1 Tat from endolysosomes and induced HIV-1 LTR transactivation. Similar results were observed by activating endolysosome Toll-like receptor 3 (TLR3) and TLR7/8. Conversely, pharmacological block of TLRs and knocking down expression levels of TLR3 and TLR7, but not TLR8, prevented endolysosome leakage and attenuated HIV-1 Tat-mediated HIV-1 LTR transactivation. Our findings suggest that HIV-1 Tat accumulation in endolysosomes may play an important role in controlling HIV-1 transactivation.	[Khan, Nabab; Halcrow, Peter W.; Afghah, Zahra; Baral, Aparajita; Geiger, Jonathan D.; Chen, Xuesong] Univ North Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, Grand Forks, ND 58203 USA	University of North Dakota Grand Forks	Geiger, JD; Chen, XS (corresponding author), Univ North Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, Grand Forks, ND 58203 USA.	jonathan.geiger@und.edu; xuesong.chen@und.edu		Chen, Xuesong/0000-0003-0714-1378	HHS \ NIH \ National Institute of Neurological Disorders and Stroke (NINDS) [R01NS065957]; HHS \ NIH \ National Institute on Drug Abuse (NIDA) [R01DA032444]; National Institute of General Medical Sciences [P30GM100329, U54GM115458]; National Institute of Mental Health [R01MH100972, R01MH105329, R01MH119000]	HHS \ NIH \ National Institute of Neurological Disorders and Stroke (NINDS); HHS \ NIH \ National Institute on Drug Abuse (NIDA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	HHS vertical bar NIH vertical bar National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: R01NS065957; HHS vertical bar NIH vertical bar National Institute on Drug Abuse (NIDA), Grant/Award Number: R01DA032444; National Institute of General Medical Sciences, Grant/Award Number: P30GM100329 and U54GM115458; National Institute of Mental Health, Grant/Award Number: R01MH100972, R01MH105329 and R01MH119000	Abu-Remaileh M, 2017, SCIENCE, V358, P807, DOI 10.1126/science.aan6298; Afghah Z, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104670; Agostini S, 2017, EBIOMEDICINE, V21, P170, DOI 10.1016/j.ebiom.2017.06.011; Aits S, 2015, AUTOPHAGY, V11, P1408, DOI 10.1080/15548627.2015.1063871; Aits S, 2015, METHOD CELL BIOL, V126, P261, DOI 10.1016/bs.mcb.2014.10.032; Ajasin D, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00061; Alirezaei M, 2008, AUTOPHAGY, V4, P963, DOI 10.4161/auto.6805; Andres-Alonso M, 2021, CELL MOL LIFE SCI, V78, P2621, DOI 10.1007/s00018-020-03722-5; Badadani M, 2012, ISRN CELL BIOL, V2012, DOI DOI 10.5402/2012/927064; Beckel JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23877-3; Bender Andrew T, 2020, Immunohorizons, V4, P93, DOI 10.4049/immunohorizons.2000002; Boliar S, 2021, MOL THER-NUCL ACIDS, V23, P1272, DOI 10.1016/j.omtn.2021.02.004; Brack-Werner R, 1999, AIDS, V13, P1, DOI 10.1097/00002030-199901140-00003; Brencicova E, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00037; Bright NA, 2005, CURR BIOL, V15, P360, DOI 10.1016/j.cub.2005.01.049; Bright NA, 2016, CURR BIOL, V26, P2233, DOI 10.1016/j.cub.2016.06.046; Browne EP, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8111787; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Chang JR, 2011, J BIOL CHEM, V286, P41125, DOI 10.1074/jbc.M111.268466; Chauhan A, 2015, MICROB PATHOGENESIS, V78, P1, DOI 10.1016/j.micpath.2014.11.003; Chauhan A, 2014, VIROLOGY, V456, P1, DOI 10.1016/j.virol.2014.03.002; Chen WW, 2016, CELL, V166, P1324, DOI 10.1016/j.cell.2016.07.040; Chen XS, 2013, NEUROBIOL AGING, V34, P2370, DOI 10.1016/j.neurobiolaging.2013.04.015; Churchill MJ, 2006, J NEUROVIROL, V12, P146, DOI 10.1080/13550280600748946; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; Clark E, 2017, ONCOTARGET, V8, P27569, DOI 10.18632/oncotarget.15174; de Marcken M, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw1347; Debaisieux S, 2012, TRAFFIC, V13, P355, DOI 10.1111/j.1600-0854.2011.01286.x; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Dominguez-Villar M, 2015, NAT IMMUNOL, V16, P118, DOI 10.1038/ni.3036; Dossou AS, 2019, CANCERS, V11, DOI 10.3390/cancers11101422; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Ellis RJ, 2010, ARCH NEUROL-CHICAGO, V67, P552, DOI 10.1001/archneurol.2010.76; Elsheikh MM, 2019, EBIOMEDICINE, V45, P624, DOI 10.1016/j.ebiom.2019.06.020; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Fields J, 2015, J NEUROSCI, V35, P1921, DOI 10.1523/JNEUROSCI.3207-14.2015; Fitting S, 2010, AM J PATHOL, V177, P1397, DOI 10.2353/ajpath.2010.090945; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Gaskill PJ, 2017, NEUROBIOL DIS, V105, P51, DOI 10.1016/j.nbd.2017.04.015; Ghezzi S, 2000, BIOCHEM BIOPH RES CO, V270, P992, DOI 10.1006/bbrc.2000.2523; Giovedi S, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.602116; Gorry PR, 2003, CURR HIV RES, V1, P463, DOI 10.2174/1570162033485122; Gray LR, 2014, CURR OPIN HIV AIDS, V9, P552, DOI 10.1097/COH.0000000000000108; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Guerra F, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5030034; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Henderson LJ, 2019, AIDS, V33, pS145, DOI 10.1097/QAD.0000000000002268; Herbein G, 2020, EBIOMEDICINE, V58, DOI 10.1016/j.ebiom.2020.102906; Hu XT, 2016, CURR DRUG TARGETS, V17, P4, DOI 10.2174/1389450116666150531162212; Hu ZY, 2018, CELL CHEM BIOL, V25, P1286, DOI 10.1016/j.chembiol.2018.07.004; Hui L, 2012, ASN NEURO, V4, P243, DOI 10.1042/AN20120017; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Johnson TP, 2013, P NATL ACAD SCI USA, V110, P13588, DOI 10.1073/pnas.1308673110; Kamori D, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00080; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Khan N, 2020, J ALLERGY INFECT DIS, V1, P38; Khan N, 2021, J NEUROVIROL, V27, P755, DOI 10.1007/s13365-021-01016-5; Khan N, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.595888; Khan N, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040471; Khan N, 2020, FASEB J, V34, P4147, DOI 10.1096/fj.201902534R; Khan N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48777-y; Khan N, 2019, BRAIN RES, V1722, DOI 10.1016/j.brainres.2019.146389; Khan N, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1129-1; Khanal S, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020475; Khoury G, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0421-6; Larange A, 2009, J LEUKOCYTE BIOL, V85, P673, DOI 10.1189/jlb.0808504; Lebbink RJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41968; Lederman MM, 2015, NAT IMMUNOL, V16, P8, DOI 10.1038/ni.3051; Li C, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0267-8; Li GH, 2020, AIDS, V34, P963, DOI 10.1097/QAD.0000000000002512; Li M, 2013, J BIOL CHEM, V288, P35769, DOI 10.1074/jbc.M113.511212; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Luo XY, 2015, J NEUROVIROL, V21, P66, DOI 10.1007/s13365-014-0304-0; Lutgen V, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008381; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Luzio JP, 2010, BIOCHEM SOC T, V38, P1413, DOI 10.1042/BST0381413; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; Marban C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00397; Marceau F, 2012, TOXICOL APPL PHARM, V259, P1, DOI 10.1016/j.taap.2011.12.004; Marcello A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-7; MCCARTHY GF, 1988, J COMP NEUROL, V271, P589, DOI 10.1002/cne.902710409; Meas HZ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13837-4; Mediouni S, 2019, FASEB J, V33, P8280, DOI 10.1096/fj.201801165R; Mediouni Sonia, 2012, Infectious Disorders - Drug Targets, V12, P81; Minton K, 2019, NAT REV IMMUNOL, V19, P660; Moranguinho I, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12121443; Morissette G, 2004, J PHARMACOL EXP THER, V310, P395, DOI 10.1124/jpet.104.066084; Mousseau G, 2015, MBIO, V6, DOI 10.1128/mBio.00465-15; Mullock BM, 1998, J CELL BIOL, V140, P591, DOI 10.1083/jcb.140.3.591; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Piper RC, 2001, TRAFFIC, V2, P612, DOI 10.1034/j.1600-0854.2001.20904.x; Pomerantz RJ, 2002, CLIN INFECT DIS, V34, P91, DOI 10.1086/338256; Pryor PR, 2009, BBA-MOL CELL RES, V1793, P615, DOI 10.1016/j.bbamcr.2008.12.022; Rahimian P, 2016, J NEUROVIROL, V22, P774, DOI 10.1007/s13365-016-0451-6; Rayne F, 2010, CELL BIOL INT, V34, P409, DOI 10.1042/CBI20090376; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Razooky BS, 2011, METHODS, V53, P68, DOI 10.1016/j.ymeth.2010.12.006; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Romani B, 2010, J GEN VIROL, V91, P1, DOI 10.1099/vir.0.016303-0; Sagnier S, 2015, J VIROL, V89, P615, DOI 10.1128/JVI.02174-14; Saylor D, 2016, NAT REV NEUROL, V12, P234, DOI [10.1038/nrneurol.2016.27, 10.1038/nrneurol.2016.53]; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Spector SA, 2008, AUTOPHAGY, V4, P704, DOI 10.4161/auto.6105; Spudich S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007120; Thangaraj A, 2018, AUTOPHAGY, V14, P1596, DOI 10.1080/15548627.2018.1476810; Thompson KA, 2011, AM J PATHOL, V179, P1623, DOI 10.1016/j.ajpath.2011.06.039; Trillo-Pazos G, 2003, BRAIN PATHOL, V13, P144; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Urbinati C, 2009, BLOOD, V114, P3335, DOI 10.1182/blood-2009-01-198945; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Valdebenito S, 2021, J NEUROCHEM, V158, P429, DOI 10.1111/jnc.15336; Van Grol J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011733; Vasile F, 2017, BRAIN STRUCT FUNCT, V222, P2017, DOI 10.1007/s00429-017-1383-5; Vendeville A, 2004, MOL BIOL CELL, V15, P2347, DOI 10.1091/mbc.E03-12-0921; Vives E, 2003, J MOL RECOGNIT, V16, P265, DOI 10.1002/jmr.636; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wallet C, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00362; Wang G, 2016, MOL THER, V24, P522, DOI 10.1038/mt.2016.24; Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042; Williams ME, 2020, NEUROBIOL DIS, V136, DOI 10.1016/j.nbd.2019.104701; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Zeitler M, 2015, J BIOL CHEM, V290, P21976, DOI 10.1074/jbc.M115.667097; Zhou DJ, 2008, AIDS, V22, P695, DOI 10.1097/QAD.0b013e3282f4a836; Zhou DJ, 2011, J INFECT DIS, V203, P1647, DOI 10.1093/infdis/jir163; Zucchini S, 2013, NEUROBIOL DIS, V55, P110, DOI 10.1016/j.nbd.2013.02.004	130	0	0	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22184	10.1096/fj.202101722R	http://dx.doi.org/10.1096/fj.202101722R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35113458				2022-12-28	WOS:000761250800018
J	Airik, M; McCourt, B; Ozturk, TT; Huynh, AB; Zhang, XY; Tometich, JT; Topaloglu, R; Ozen, H; Orhan, D; Nejak-Bowen, K; Monga, SP; Hand, TW; Ozaltin, F; Airik, R				Airik, Merlin; McCourt, Blake; Ozturk, Tugba Tastemel; Huynh, Amy B.; Zhang, Xiaoyi; Tometich, Justin T.; Topaloglu, Rezan; Ozen, Hasan; Orhan, Diclehan; Nejak-Bowen, Kari; Monga, Satdarshan P.; Hand, Timothy W.; Ozaltin, Fatih; Airik, Rannar			Mitigation of portal fibrosis and cholestatic liver disease in ANKS6-deficient livers by macrophage depletion	FASEB JOURNAL			English	Article						ANKS6; congenital liver fibrosis; inflammation; nephronophthisis	POLYCYSTIC KIDNEY-DISEASE; DUCT EPITHELIAL-CELLS; GROWTH-FACTOR; BILE-DUCTS; BILIARY; INFILTRATION; PATHOGENESIS; COMPARTMENT; HOMEOSTASIS; INHIBITION	Congenital hepatic fibrosis (CHF) is a developmental liver disease that is caused by mutations in genes that encode ciliary proteins and is characterized by bile duct dysplasia and portal fibrosis. Recent work has demonstrated that mutations in ANKS6 can cause CHF due to its role in bile duct development. Here, we report a novel ANKS6 mutation, which was identified in an infant presenting with neonatal jaundice due to underlying biliary abnormalities and liver fibrosis. Molecular analysis revealed that ANKS6 liver pathology is associated with the infiltration of inflammatory macrophages to the periportal fibrotic tissue and ductal epithelium. To further investigate the role of macrophages in CHF pathophysiology, we generated a novel liver-specific Anks6 knockout mouse model. The mutant mice develop biliary abnormalities and rapidly progressing periportal fibrosis reminiscent of human CHF. The development of portal fibrosis in Anks6 KO mice coincided with the accumulation of inflammatory monocytes and macrophages in the mutant liver. Gene expression and flow cytometric analysis demonstrated the preponderance of M1- over M2-like macrophages at the onset of fibrosis. A critical role for macrophages in promoting peribiliary fibrosis was demonstrated by depleting the macrophages with clodronate liposomes which effectively reduced inflammatory gene expression and fibrosis, and ameliorated tissue histology and biliary function in Anks6 KO livers. Together, this study demonstrates that macrophages play an important role in the initiation of liver fibrosis in ANKS6-deficient livers and their therapeutic elimination may provide an avenue to mitigate CHF in patients.	[Airik, Merlin; McCourt, Blake; Huynh, Amy B.; Airik, Rannar] Univ Pittsburgh, Dept Pediat, Div Nephrol, Pittsburgh, PA 15260 USA; [Ozturk, Tugba Tastemel; Topaloglu, Rezan; Ozaltin, Fatih] Hacettepe Univ, Dept Pediat, Div Pediat Nephrol, Ankara, Turkey; [Zhang, Xiaoyi] Univ Pittsburgh, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15260 USA; [Tometich, Justin T.; Hand, Timothy W.] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, RK Mellon Inst Pediat Res, Dept Pediat,Div Infect Dis, Pittsburgh, PA 15260 USA; [Ozen, Hasan] Hacettepe Univ, Dept Pediat, Div Gastroenterol, Ankara, Turkey; [Orhan, Diclehan] Hacettepe Univ, Dept Pediat, Pediat Pathol Unit, Ankara, Turkey; [Nejak-Bowen, Kari; Monga, Satdarshan P.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Nejak-Bowen, Kari; Monga, Satdarshan P.] Univ Pittsburgh, Pittsburgh Liver Res Ctr, Pittsburgh, PA USA; [Nejak-Bowen, Kari; Monga, Satdarshan P.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Ozaltin, Fatih] Hacettepe Univ, Dept Pediat, Div Pediat Nephrol, Nephrogenet Lab, Ankara, Turkey; [Airik, Rannar] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Hacettepe University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Hacettepe University; Hacettepe University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Hacettepe University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Airik, R (corresponding author), UPMC Childrens Hosp Pittsburgh, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	airikr@pitt.edu	Zhang, Xiaoyi/AGI-2976-2022	Zhang, Xiaoyi/0000-0002-4988-819X; Topaloglu, Rezan/0000-0002-6423-0927; McCourt, Blake/0000-0002-1488-2572	National Institutes of Health [DK099434, DK115403, P30DK079307]; Pittsburgh Liver Research Center [P30DK120531]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pittsburgh Liver Research Center	This research was supported by grants from the National Institutes of Health to R.A. (DK099434, DK115403, P30DK079307). The human disease samples were provided in part by the Pittsburgh Liver Research Center funded by P30DK120531 (SPM).	Airik M, 2020, HUM MOL GENET, V29, P3064, DOI 10.1093/hmg/ddaa197; Baeck C, 2014, HEPATOLOGY, V59, P1060, DOI 10.1002/hep.26783; Beljaars L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00430; Bennett HW, 2020, MOL BIOL CELL, V31, P619, DOI 10.1091/mbc.E19-09-0499; Bergmann C, 2008, AM J HUM GENET, V82, P959, DOI 10.1016/j.ajhg.2008.02.017; Best J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162286; Cadamuro M, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00115; CHAPMAN RW, 1988, GUT, V29, P422, DOI 10.1136/gut.29.4.422; Czarnecki PG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7023; Dal-Secco D, 2015, J EXP MED, V212, P447, DOI 10.1084/jem.20141539; De Vito R, 2012, INT J MOL MED, V30, P49, DOI 10.3892/ijmm.2012.965; DESMET VJ, 1992, HEPATOLOGY, V16, P1069, DOI 10.1002/hep.1840160434; Desmet VJ, 1998, MAYO CLIN PROC, V73, P80; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Guay-Woodford LM, 2014, J PEDIATR GENET, V3, P89, DOI 10.3233/PGE-14092; Guicciardi ME, 2018, J HEPATOL, V69, P676, DOI 10.1016/j.jhep.2018.05.018; Guillot A, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI132305; Gunay-Aygun M, 2009, AM J MED GENET C, V151C, P296, DOI 10.1002/ajmg.c.30225; Hasita H, 2010, CANCER SCI, V101, P1913, DOI 10.1111/j.1349-7006.2010.01614.x; Hoff S, 2013, NAT GENET, V45, P951, DOI 10.1038/ng.2681; Jemail L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24825-x; Kaffe E, 2018, HEPATOLOGY, V67, P1903, DOI 10.1002/hep.29652; Katsumi T, 2019, AM J PHYSIOL-CELL PH, V317, pC788, DOI 10.1152/ajpcell.00250.2019; Kulkarni S, 2020, PEDIATR DEVEL PATHOL, V23, P235, DOI 10.1177/1093526619881541; Locatelli L, 2016, HEPATOLOGY, V63, P965, DOI 10.1002/hep.28382; Lu H, 2017, NAT GENET, V49, P1025, DOI 10.1038/ng.3871; Mitchell C, 2009, AM J PATHOL, V174, P1766, DOI 10.2353/ajpath.2009.080632; Moser M, 2005, HEPATOLOGY, V41, P1113, DOI 10.1002/hep.20655; Mousa HS, 2016, AUTOIMMUN REV, V15, P870, DOI 10.1016/j.autrev.2016.07.003; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Nakajima Y, 2018, KIDNEY INT, V93, P1108, DOI 10.1016/j.kint.2017.11.016; Patsenker E, 2008, GASTROENTEROLOGY, V135, P660, DOI 10.1053/j.gastro.2008.04.009; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Popov Y, 2008, J HEPATOL, V48, P453, DOI 10.1016/j.jhep.2007.11.021; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Sanzen T, 2001, AM J PATHOL, V158, P1605, DOI 10.1016/S0002-9440(10)64116-8; Sasaki M, 2014, J CLIN PATHOL, V67, P470, DOI 10.1136/jclinpath-2013-201917; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sedlaczek N, 2001, AM J PATHOL, V158, P1239, DOI 10.1016/S0002-9440(10)64074-6; SPENGLER U, 1988, HEPATOLOGY, V8, P459, DOI 10.1002/hep.1840080304; Tan-Garcia A, 2020, JHEP REP, V2, DOI 10.1016/j.jhepr.2019.11.006; Taskiran EZ, 2014, J AM SOC NEPHROL, V25, P1653, DOI 10.1681/ASN.2013060646; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Wu CT, 2003, HEPATOLOGY, V38, P1018, DOI 10.1053/jhep.2003.50407; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xi SJ, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.627927; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zimmerman KA, 2018, AM J PHYSIOL-GASTR L, V314, pG677, DOI 10.1152/ajpgi.00381.2017	49	0	0	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22157	10.1096/fj.202101387R	http://dx.doi.org/10.1096/fj.202101387R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35032404				2022-12-28	WOS:000747987800018
J	Fan, XW; Wu, XX; De Lima, LTF; Stehbens, S; Punyadeera, C; Webb, R; Hamilton, B; Ayyapann, V; McLauchlan, C; Crawford, R; Zheng, MH; Xiao, Y; Prasadam, I				Fan, Xiwei; Wu, Xiaoxin; De Lima, Lucas Trevisan Franca; Stehbens, Samantha; Punyadeera, Chamindie; Webb, Richard; Hamilton, Brett; Ayyapann, Vijay; McLauchlan, Connor; Crawford, Ross; Zheng, Minghao; Xiao, Yin; Prasadam, Indira			The deterioration of calcified cartilage integrity reflects the severity of osteoarthritis-A structural, molecular, and biochemical analysis	FASEB JOURNAL			English	Article						calcified cartilage zone; microenvironment; osteoarthritis; osteochondral interface; proteomics	ARTICULAR-CARTILAGE; MASS-SPECTROMETRY; SUBCHONDRAL BONE; PATHWAYS; MATRIX; KNEE; CHONDROCYTES; PROGRESSION; INTERFACE; MODELS	The calcified cartilage zone (CCZ) is a thin interlayer between the hyaline articular cartilage and the subchondral bone and plays an important role in maintaining the joint homeostasis by providing biological and mechanical support from unmineralized cartilage to the underlying mineralized subchondral bone. The hallmark of CCZ characteristics in osteoarthritis (OA) is less well known. The aim of our study is to evaluate the structural, molecular, and biochemical composition of CCZ in tissues affected by primary knee OA and its relationship with disease severity. We collected osteochondral tissue samples stratified according to disease severity, from 16 knee OA patients who underwent knee replacement surgery. We also used meniscectomy-induced rat samples to confirm the pathophysiologic changes of human samples. We defined the characteristics of the calcified cartilage layer using a combination of morphological, biochemical, proteomic analyses on laser micro-dissected tissue. Our results demonstrated that the Calcium/Phosphate ratio is unchanged during the OA progression, but the calcium-binding protein and cadherin binding protein, as well as carbohydrate metabolism-related proteins, undergo significant changes. These changes were further accompanied by thinning of the CCZ, loss of collagen and proteoglycan content, the occurrence of the endochondral ossification, neovasculature, loss of the elastic module, loss of the collagen direction, and increase of the tortuosity indicating an altered structural and mechanical properties of the CCZ in OA. In conclusion, our results suggest that the calcified cartilage changes can reflect the disease progression.	[Fan, Xiwei; Wu, Xiaoxin; De Lima, Lucas Trevisan Franca; Punyadeera, Chamindie; Ayyapann, Vijay; McLauchlan, Connor; Crawford, Ross; Xiao, Yin; Prasadam, Indira] Queensland Univ Technol, Ctr Biomed Technol, Brisbane, Qld, Australia; [Wu, Xiaoxin] Cent South Univ, Xiangya Hosp 2, Dept Orthopaed Surg, Changsha, Peoples R China; [Stehbens, Samantha] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Punyadeera, Chamindie] Translat Res Inst, Brisbane, Qld, Australia; [Webb, Richard; Hamilton, Brett] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia; [Crawford, Ross] Prince Charles Hosp, Brisbane, Qld, Australia; [Zheng, Minghao] Univ Western Australia, Med Sch, Perth, WA, Australia; [Xiao, Yin] Queensland Univ Technol, Australia China Ctr Tissue Engn & Regenerat Med, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Central South University; University of Queensland; University of Queensland; Prince Charles Hospital; University of Western Australia; Queensland University of Technology (QUT)	Prasadam, I (corresponding author), Queensland Univ Technol, Fac Engn, Ctr Biomed Technol, Q Block,60 Musk Ave, Brisbane, Qld 4059, Australia.	i.prasadam@qut.edu.au	; Stehbens, Sam/D-3512-2019	Punyadeera, Chamindie/0000-0001-9039-8259; Stehbens, Sam/0000-0002-8145-2708; Trevisan Franca de Lima, Lucas/0000-0002-4993-5945; Prasadam, Indira/0000-0001-5057-2427; Zheng, Minghao/0000-0003-1185-4768; Xiao, Yin/0000-0003-1785-3491	Prince Charles Hospital Research Foundation [RF-01, TM2017-05]; Cancer Australia [APP1145657]; NHMRC [APP1176298, APP2002576]	Prince Charles Hospital Research Foundation; Cancer Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The Prince Charles Hospital Research Foundation, Grant/Award Number: RF-01 and TM2017-05; NHMRC Investigator, Grant/Award Number: APP1176298 and APP2002576; Cancer Australia, Grant/Award Number: APP1145657	Aghajanian P, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0021-z; Akkiraju H, 2015, J DEV BIOL, V3, P177, DOI 10.3390/jdb3040177; Bellis DJ, 2006, J ANAL ATOM SPECTROM, V21, P948, DOI 10.1039/b603435g; BERRY JL, 1986, FOOT ANKLE, V7, P2, DOI 10.1177/107110078600700103; Boyde A, 2011, EUR CELLS MATER, V21, P470, DOI 10.22203/eCM.v021a35; BROWER TD, 1962, J BONE JOINT SURG AM, V44, P456, DOI 10.2106/00004623-196244030-00002; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Callister SJ, 2006, J PROTEOME RES, V5, P277, DOI 10.1021/pr050300l; Chen LZ, 2020, ANN RHEUM DIS, V79, P811, DOI 10.1136/annrheumdis-2020-216942; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Collins D, 1949, PATHOLOGY ARTICULAR; Dai GM, 2020, INT J MOL MED, V46, P167, DOI 10.3892/ijmm.2020.4576; Deng B, 2016, CURR RES TRANSL MED, V64, P149, DOI 10.1016/j.retram.2016.01.009; Eveque-Mourroux MR, 2020, J PROTEOMICS, V215, DOI 10.1016/j.jprot.2020.103637; Fan XW, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.659654; Ferguson VL, 2003, J ANAT, V203, P191, DOI 10.1046/j.1469-7580.2003.00193.x; Firner S, 2017, J HISTOCHEM CYTOCHEM, V65, P593, DOI 10.1369/0022155417729154; Furman BD, 2007, J ORTHOP RES, V25, P578, DOI 10.1002/jor.20331; Ghanbarian B, 2013, SOIL SCI SOC AM J, V77, P1461, DOI 10.2136/sssaj2012.0435; Goldring SR, 2016, NAT REV RHEUMATOL, V12, P632, DOI 10.1038/nrrheum.2016.148; Haseeb A, 2013, CLIN IMMUNOL, V146, P185, DOI 10.1016/j.clim.2012.12.011; HENEGHAN L, 2002, ECOLOGICAL RESTORATI, V20, P108, DOI DOI 10.3368/er.20.2.108; HONNER R, 1971, J BONE JOINT SURG AM, VA 53, P742, DOI 10.2106/00004623-197153040-00013; Hosseininia S, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-18; Hsueh MF, 2014, MATRIX BIOL, V39, P56, DOI 10.1016/j.matbio.2014.08.012; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imhof H, 1999, Top Magn Reson Imaging, V10, P180, DOI 10.1097/00002142-199906000-00002; James SL, 2018, LANCET, V392, P1789, DOI 10.1016/s0140-6736(18)32279-7; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Khanarian NT, 2014, J BONE MINER RES, V29, P2643, DOI 10.1002/jbmr.2284; Kourkoumelis N, 2012, J BIOL PHYS, V38, P279, DOI 10.1007/s10867-011-9247-3; Lord SJ, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202001064; Lotz MK, 2010, ARTHRITIS RHEUM-US, V62, P2206, DOI 10.1002/art.27528; Lyons TJ, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-52; MAROUDAS A, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P166; MATTHEWSON MH, 1978, J BONE JOINT SURG BR, V60, P199, DOI 10.1302/0301-620X.60B2.659464; MEACHIM G, 1978, ARTHRITIS RHEUM, V21, P669, DOI 10.1002/art.1780210610; Mehana ESE, 2019, LIFE SCI, V234, DOI 10.1016/j.lfs.2019.116786; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Milovanovic P, 2012, EXP GERONTOL, V47, P154, DOI 10.1016/j.exger.2011.11.011; Mobasheri A, 2017, NAT REV RHEUMATOL, V13, P302, DOI 10.1038/nrrheum.2017.50; Nair AK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2720; Nanba Y, 1997, ACTA MED OKAYAMA, V51, P239; OGATA K, 1979, CLIN ORTHOP RELAT R, P273; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Orlowsky EW, 2015, J RHEUMATOL, V42, P363, DOI 10.3899/jrheum.140382; Poole AR, 2002, ANN RHEUM DIS, V61, P78, DOI 10.1136/ard.61.suppl_2.ii78; Prasadam I., 2009, CROSS TALK SUBCHONDR; Prasadam I, 2013, J MOL MED, V91, P369, DOI 10.1007/s00109-012-0953-5; Prasadam I, 2012, J RHEUMATOL, V39, P621, DOI 10.3899/jrheum.110777; Ruiz-Romero C, 2010, OSTEOARTHR CARTILAGE, V18, P500, DOI 10.1016/j.joca.2009.11.012; Schultz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120949; Sekar S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020509; Serrano RL, 2018, ARTHRITIS RHEUMATOL, V70, P1030, DOI 10.1002/art.40456; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shepherd C, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1934-7; Steinberg J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09335-6; Suri S, 2012, BONE, V51, P204, DOI 10.1016/j.bone.2011.10.010; Tian J, 2020, PAIN RES MANAG, V2020, DOI 10.1155/2020/3428587; Wang FY, 2009, J STRUCT BIOL, V168, P359, DOI 10.1016/j.jsb.2009.08.010; Wang Fuyou, 2008, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V22, P524; Wen CY, 2012, OSTEOARTHR CARTILAGE, V20, P916, DOI 10.1016/j.joca.2012.04.018; Woodell-May JE, 2020, J ORTHOP RES, V38, P253, DOI 10.1002/jor.24457; Zeng GQ, 2015, GENET MOL RES, V14, P14811, DOI 10.4238/2015.November.18.46; Zhai GJ, 2019, METABOLITES, V9, DOI 10.3390/metabo9010011; Zhang Y, 2012, INT J MED SCI, V9, P353, DOI 10.7150/ijms.4276; Zheng LL, 2021, AGEING RES REV, V66, DOI 10.1016/j.arr.2020.101249; Zhong LL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071126; Zougman A, 2014, PROTEOMICS, V14, P1006, DOI 10.1002/pmic.201300553	69	5	5	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22142	10.1096/fj.202101449R	http://dx.doi.org/10.1096/fj.202101449R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35032407				2022-12-28	WOS:000747987800011
J	Kang, HL; Guo, Q; Dong, YM; Peng, RP; Song, KH; Wang, J; Liu, HY; Zhu, MP; Zhao, HJ; Guan, HF; Li, F				Kang, Honglei; Guo, Qian; Dong, Yimin; Peng, Renpeng; Song, Kehan; Wang, Jia; Liu, Haiyang; Zhu, Meipeng; Zhao, Hongjian; Guan, Hanfeng; Li, Feng			Inhibition of MAT2A suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss	FASEB JOURNAL			English	Article						bone remodeling; MAT2A; osteoclast; osteoporosis; RANKL	NF-KAPPA-B; DIFFERENTIATION; METHIONINE; IMMUNE; MASS	Methionine adenosyltransferase II alpha (MAT2A) is the key enzyme to transform methionine and adenosine-triphosphate (ATP) to S-adenosylmethionine (SAM), a general methyl-group donor in vitro. MAT2A has been reported to participate in the NF-kappa B pathway and maintain the methylated modification, which also affects osteoclastogenesis. In this study, we found the expression of MAT2A was increased upon RANKL stimulation. Pharmacological inhibition of MAT2A by its selective inhibitor AG-270 or genetic silencing by MAT2A-shRNA suppressed osteoclast formation and function in vitro. In vivo treatment with the inhibitor AG-270 also prevented OVX-induced bone loss. Further study revealed that the inhibition of MAT2A affected osteoclast differentiation mainly by suppressing crucial transcription factors and reactive oxygen species induced by RANKL. A quasi-targeted metabolomics assay performed by LC-MS/MS indicated that SAM was reduced by MAT2A knockdown, and the administration of SAM partly rescued the effects of MAT2A inhibition on osteoclastogenesis. These findings revealed that MAT2A is crucial for osteoclastogenesis and might be a potential target for the treatment of osteoporosis attributed to osteoclast dysfunction.	[Kang, Honglei; Guo, Qian; Dong, Yimin; Peng, Renpeng; Song, Kehan; Wang, Jia; Liu, Haiyang; Zhu, Meipeng; Zhao, Hongjian; Guan, Hanfeng; Li, Feng] Huazhong Univ Sci & Technol, Dept Orthoped, Tongji Med Coll, Tongji Hosp, 1095 Jiefang Ave, Wuhan 430030, Peoples R China	Huazhong University of Science & Technology	Guan, HF; Li, F (corresponding author), Huazhong Univ Sci & Technol, Dept Orthoped, Tongji Med Coll, Tongji Hosp, 1095 Jiefang Ave, Wuhan 430030, Peoples R China.	hguan@hust.edu.cn; lifengmd@hust.edu.cn			National Natural Science Foundation of China (NSFC) [82072500, 81874024]; Key Research and Development Program of Hubei Province [2020BCB049]; Wuhan Huanghe Talent Program [HHYC-201601]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Research and Development Program of Hubei Province; Wuhan Huanghe Talent Program	National Natural Science Foundation of China (NSFC), Grant/Award Number: 82072500 and 81874024; Key Research and Development Program of Hubei Province, Grant/Award Number: 2020BCB049; Wuhan Huanghe Talent Program, Grant/Award Number: HHYC-201601	Abato JE, 2022, NUTR NEUROSCI, V25, P558, DOI 10.1080/1028415X.2020.1769412; Agidigbi TS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143576; Anselmino N, 2020, ANTIOXID REDOX SIGN, V32, P1243, DOI 10.1089/ars.2019.7879; Astleford K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197080; Compston JE, 2019, LANCET, V393, P364, DOI 10.1016/S0140-6736(18)32112-3; Da WCL, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.675385; Gao X, 2019, NATURE, V572, P397, DOI 10.1038/s41586-019-1437-3; Goettsch C, 2013, J CLIN INVEST, V123, P4731, DOI 10.1172/JCI67603; Hiruma Y, 2009, BLOOD, V113, P4894, DOI 10.1182/blood-2008-08-173948; Huh YJ, 2006, CELL DEATH DIFFER, V13, P1138, DOI 10.1038/sj.cdd.4401793; Hyeon S, 2013, FREE RADICAL BIO MED, V65, P789, DOI 10.1016/j.freeradbiomed.2013.08.005; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Ivashkiv LB, 2015, NAT MED, V21, P212, DOI 10.1038/nm.3815; Jacome-Galarza CE, 2019, NATURE, V568, P541, DOI 10.1038/s41586-019-1105-7; Kanzaki H, 2016, REDOX BIOL, V8, P186, DOI 10.1016/j.redox.2016.01.006; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Krzeszinski JY, 2015, CLIN EXP METASTAS, V32, P245; Kurotaki D, 2020, BONE, V138, DOI 10.1016/j.bone.2020.115471; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Li D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051660; Luo P, 2015, ANAL CHEM, V87, P5050, DOI 10.1021/acs.analchem.5b00615; McDonald MM, 2021, CELL, V184, P1330, DOI 10.1016/j.cell.2021.02.002; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Munoz J, 2020, NUTRIENTS, V12, DOI 10.3390/nu12102999; Nishikawa K, 2015, NAT MED, V21, P281, DOI 10.1038/nm.3774; Okamoto K, 2017, PHYSIOL REV, V97, P1295, DOI 10.1152/physrev.00036.2016; Park-Min KH, 2019, SEMIN IMMUNOPATHOL, V41, P565, DOI 10.1007/s00281-019-00757-0; Roscher Anne, 2016, Bone Rep, V5, P214, DOI 10.1016/j.bonr.2016.07.002; Song C, 2018, FASEB J, V32, P3215, DOI 10.1096/fj.201600825RRR; Sun XW, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101309; Villanueva JA, 2004, HEPATOLOGY, V39, P1303, DOI 10.1002/hep.20168; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Walsh MC, 2015, IMMUNOL REV, V266, P72, DOI 10.1111/imr.12302; Wang ZX, 2019, NAT MED, V25, P825, DOI 10.1038/s41591-019-0423-5; Yang HB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7973; Yang HP, 2003, J BIOL CHEM, V278, P50887, DOI 10.1074/jbc.M307600200	36	2	2	3	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22167	10.1096/fj.202101205RR	http://dx.doi.org/10.1096/fj.202101205RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35064691	hybrid			2022-12-28	WOS:000747987800034
J	Sun, CF; Wei, JC; Long, ZL; Zhao, WX; Qi, HF; Qi, X; Wang, BH; Wen, JM				Sun, Chengfang; Wei, Jingchao; Long, Zhilin; Zhao, Weixi; Qi Huangfu; Qi Xie; Wang, Bohan; Wen, Jiaming			Spindle pole body component 24 homolog potentiates tumor progression via regulation of SRY-box transcription factor 2 in clear cell renal cell carcinoma	FASEB JOURNAL			English	Article						clear cell renal cell carcinoma; metastasis; spindle pole body component 24 homolog; SRY-box transcription factor 2	CLINICAL-PRACTICE-GUIDELINES; EXTRACELLULAR-MATRIX; CANCER; SPC24; NDC80; DIAGNOSIS	Clear cell renal cell carcinoma (ccRCC) is the most common pathological subtype of human kidney cancer with a high probability of metastasis. To understand the molecular processing essential for ccRCC tumorigenicity, we conducted an integrative in silico analysis of The Cancer Genome Atlas (TCGA) ccRCC dataset and clustered randomly interspersed short palindromic repeats (CRISPR) screening dataset of ccRCC cell lines from Depmap. We identified spindle pole body component 24 homolog (SPC24) as an essential gene for ccRCC cell lines with prognostic significance in the TCGA database. Targeting SPC24 by CRISPR/Cas9-mediated gene knockout attenuated ccRCC proliferation, metastasis, and in vivo tumor growth. Furthermore, we found that SPC24 regulates metastasis genes expression in a SRY-box transcription factor 2 (SOX2)-dependent manner. The anti-proliferative effects of SPC24 knockout were strengthened with SOX2 knockdown. Collectively, our findings suggest SPC24 has a pivotal function in promoting ccRCC progression, providing a new insight for the treatment of ccRCC.	[Sun, Chengfang; Wei, Jingchao; Qi Huangfu; Wang, Bohan; Wen, Jiaming] Zhejiang Univ, Dept Urol, Sch Med, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China; [Long, Zhilin; Zhao, Weixi; Qi Xie] Westlake Univ, Sch Life Sci, Key Lab Growth Regulat & Translat Res Zhejiang Pr, Hangzhou, Peoples R China; [Long, Zhilin; Zhao, Weixi; Qi Xie] Westlake Lab Life Sci & Biomed, Hangzhou, Peoples R China; [Long, Zhilin; Zhao, Weixi; Qi Xie] Westlake Inst Adv Study, Inst Basic Med Sci, Hangzhou, Peoples R China	Zhejiang University; Westlake University; Westlake University	Wang, BH; Wen, JM (corresponding author), Zhejiang Univ, Dept Urol, Sch Med, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China.	wangbohan@zju.edu.cn; wenjiaming@zju.edu.cn			National Natural Science Foundation of China [81871153, 82073268]; Westlake Education Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Westlake Education Foundation	This research was funded by the National Natural Science Foundation of China (No. 81871153 to Jiaming Wen, No. 82073268 to QiXie) and Westlake Education Foundation	Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bhattacharya S, 2019, STEM CELLS, V37, P417, DOI 10.1002/stem.2959; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Bushweller JH, 2019, NAT REV CANCER, V19, P611, DOI 10.1038/s41568-019-0196-7; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chen SX, 2021, EXP THER MED, V22, DOI 10.3892/etm.2021.10355; Chen WF, 2016, NATURE, V539, P112, DOI 10.1038/nature19796; Clark DJ, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.AM2019-2458; de Klerk E, 2015, TRENDS GENET, V31, P128, DOI 10.1016/j.tig.2015.01.001; Dempster J.M.R.J., 2019, BIORXIV, P720243, DOI [10.1101/720243, DOI 10.1101/720243]; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Dudani S, 2019, EUR UROL, V76, P861, DOI 10.1016/j.eururo.2019.07.048; Escudier B, 2019, ANN ONCOL, V30, P706, DOI 10.1093/annonc/mdz056; Escudier B, 2016, ANN ONCOL, V27, pv58, DOI 10.1093/annonc/mdw328; Francois M, 2020, SEMIN CELL DEV BIOL, V99, P12, DOI [10.1016/j.semedb.2018.07.019, 10.1016/j.semcdb.2018.07.019]; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Hsieh JJ, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.9; Huser L, 2018, EXPERT OPIN THER TAR, V22, P983, DOI 10.1080/14728222.2018.1538359; Hutter C, 2018, CELL, V173, P283, DOI 10.1016/j.cell.2018.03.042; Jiramongkol Y, 2020, CANCER METAST REV, V39, P681, DOI 10.1007/s10555-020-09883-w; Kotecha RR, 2019, NAT REV CLIN ONCOL, V16, P621, DOI 10.1038/s41571-019-0209-1; Lambert M, 2018, MOLECULES, V23, DOI 10.3390/molecules23061479; Linehan WM, 2019, NAT REV UROL, V16, P539, DOI 10.1038/s41585-019-0211-5; Ljungberg B, 2019, EUR UROL, V75, P799, DOI 10.1016/j.eururo.2019.02.011; Low JZB, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1974-4; Makhov P, 2018, MOL CANCER THER, V17, P1355, DOI 10.1158/1535-7163.MCT-17-1299; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; Meng QC, 2015, AM J CANCER RES, V5, P1730; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Mittal V, 2018, ANNU REV PATHOL-MECH, V13, P395, DOI 10.1146/annurev-pathol-020117-043854; Papavassiliou KA, 2016, J CELL BIOCHEM, V117, P2693, DOI 10.1002/jcb.25605; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Powles T, 2021, ANN ONCOL, V32, P422, DOI 10.1016/j.annonc.2020.11.016; Qu Y, 2014, J GASTROENTEROL, V49, P408, DOI 10.1007/s00535-013-0809-y; Rini BI, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0813-8; Sheng J, 2017, ONCOTARGET, V8, P105276, DOI 10.18632/oncotarget.22167; Sun ZY, 2020, J CANCER, V11, P2921, DOI 10.7150/jca.41834; Turajlic S, 2018, J EXP MED, V215, P2477, DOI 10.1084/jem.20181617; Wang Y, 2021, BIOCHEM BIOPH RES CO, V561, P80, DOI 10.1016/j.bbrc.2021.05.020; Xue DW, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1072-5; Yin HB, 2017, ONCOTARGET, V8, P21884, DOI 10.18632/oncotarget.15670; Zhang C, 2019, CLIN CANCER RES, V25, P6827, DOI 10.1158/1078-0432.CCR-19-0733; Zhou J, 2018, GENE, V675, P272, DOI 10.1016/j.gene.2018.07.017; Zhou J, 2017, ONCOTARGET, V8, P65469, DOI 10.18632/oncotarget.18971; Zhu PP, 2015, ONCOTARGET, V6, P41383, DOI 10.18632/oncotarget.5510	45	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22086	10.1096/fj.202101310R	http://dx.doi.org/10.1096/fj.202101310R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35028983				2022-12-28	WOS:000747987800038
J	Agborbesong, E; Zhou, JX; Li, LX; Calvet, JP; Li, XG				Agborbesong, Ewud; Zhou, Julie Xia; Li, Linda Xiaoyan; Calvet, James P.; Li, Xiaogang			Antioxidant enzyme peroxiredoxin 5 regulates cyst growth and ciliogenesis via modulating Plk1 stability	FASEB JOURNAL			English	Article						ADPKD; ciliogenesis; cyst growth; peroxiredoxin 5; Plk1	POLYCYSTIC KIDNEY-DISEASE; BETA-CATENIN; OXIDATIVE STRESS; CENTROSOME AMPLIFICATION; PRIMARY CILIUM; AURORA-A; EXPRESSION; GENE; HOMEOSTASIS; IDENTIFICATION	Oxidative stress is emerging as a contributing factor to the homeostasis in cystic diseases. However, the role antioxidant enzymes play in the pathogenesis of autosomal dominant polycystic kidney disease (ADPKD) remains elusive. Peroxiredoxin 5 (Prdx5) is an antioxidant enzyme that catalyzes the reduction of H2O2 and alkyl hydroperoxide and plays an important role in different biological processes. In this study, we show that Prdx5 is downregulated in a PKD mutant mouse model and ADPKD patient kidneys. Knockdown of Prdx5 resulted in the formation of cysts in a three-dimensional mouse inner medullar collecting duct (IMCD) cell Matrigel culture system. The mechanisms of Prdx5 deficiency mediated cyst growth include: (1) induction of oxidative stress as indicated by increased mRNA expression of heme oxygenase-1, an oxidant stress marker; (2) activation of Erk, S6 and mTORC1, which contribute to cystic renal epithelial cell proliferation and cyst growth; (3) abnormal centrosome amplification and multipolar spindle formation which result in genome instability; (4) upregulation of Polo-like kinase 1 (Plk1) and Aurora kinase A, important mitotic kinases involved in cell proliferation and ciliogenesis; (5) impaired formation of primary cilia in mouse IMCD3 and retinal pigment epithelial cells, which could be rescued by inhibiting Plk1 activity; and (6) restraining the effect of Wnt3a and Wnt5a ligands on primary cilia in mouse IMCD3 cells, while regulating the activity of the canonical and non-canonical Wnt signaling in a separate cilia independent mechanism, respectively. Importantly, we found that targeting Plk1 with its inhibitor, volasertib, delayed cyst growth in Pkd1 conditional knockout mouse kidneys. Together, these findings indicate that Prdx5 is an important antioxidant that regulates cyst growth via diverse mechanisms, in particular, the Prdx5-Plk1 axis, and that induction and activation of Prdx5, alone or together with inhibition of Plk1, represent a promising strategy for combatting ADPKD.	[Agborbesong, Ewud; Zhou, Julie Xia; Li, Linda Xiaoyan; Li, Xiaogang] Mayo Clin, Dept Internal Med, Rochester, MN 55905 USA; [Agborbesong, Ewud; Zhou, Julie Xia; Li, Linda Xiaoyan; Li, Xiaogang] Mayo Clin, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA; [Agborbesong, Ewud; Calvet, James P.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA	Mayo Clinic; Mayo Clinic; University of Kansas; University of Kansas Medical Center	Li, XG (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.; Li, XG (corresponding author), Mayo Clin, Med, 200 1st St SW, Rochester, MN 55905 USA.	li.xiaogang@mayo.edu			NIH [RO1 DK126662, DK.129241, P30 DK106912]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH, Grant/Award Number: RO1 DK126662, DK.129241. and NIH P30 DK106912	Argyropoulou V, 2016, FREE RADICAL BIO MED, V100, pS92, DOI 10.1016/j.freeradbiomed.2016.10.229; Battini L, 2008, HUM MOL GENET, V17, P2819, DOI 10.1093/hmg/ddn180; Bernkopf DB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12203-8; Bur H, 2014, HISTOPATHOLOGY, V65, P319, DOI 10.1111/his.12389; Choi HI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149266; Drummen GPC, 2002, FREE RADICAL BIO MED, V33, P473, DOI 10.1016/S0891-5849(02)00848-1; Fernandez-Ranvier GG, 2008, WORLD J SURG, V32, P873, DOI 10.1007/s00268-008-9521-0; Fujita H, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1075643; Gerard AC, 2005, THYROID, V15, P205, DOI 10.1089/thy.2005.15.205; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gjertsen BT, 2015, LEUKEMIA, V29, P11, DOI 10.1038/leu.2014.222; Gleixner KV, 2010, CANCER RES, V70, P1513, DOI 10.1158/0008-5472.CAN-09-2181; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Goepfert TM, 2002, CANCER RES, V62, P4115; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Karihtala P, 2003, CLIN CANCER RES, V9, P3418; Kim JI, 2013, AM J PHYSIOL-RENAL, V304, pF1283, DOI 10.1152/ajprenal.00427.2012; Kim MH, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101315; Knoops B, 2011, ANTIOXID REDOX SIGN, V15, P817, DOI 10.1089/ars.2010.3584; Kropotov A, 2007, FEBS J, V274, P5804, DOI 10.1111/j.1742-4658.2007.06103.x; Kyun ML, 2020, CELL REP, V30, P1447, DOI 10.1016/j.celrep.2020.01.019; Lal M, 2008, HUM MOL GENET, V17, P3105, DOI 10.1093/hmg/ddn208; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Lee EJ, 2020, P NATL ACAD SCI USA, V117, P29001, DOI 10.1073/pnas.2009334117; Lee KH, 2020, FEBS J, V287, P5027, DOI 10.1111/febs.15579; Lee KH, 2012, EMBO J, V31, P3104, DOI 10.1038/emboj.2012.144; Li A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.95874; Li XG, 2005, NAT CELL BIOL, V7, P1202, DOI 10.1038/ncb1326; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lin XR, 2020, AM J CANCER RES, V10, P2705; Ling NXY, 2020, NAT METAB, V2, P41, DOI 10.1038/s42255-019-0157-1; Liu ZX, 2017, TRANSL ONCOL, V10, P22, DOI 10.1016/j.tranon.2016.10.003; Loncarek J, 2010, CURR BIOL, V20, P1277, DOI 10.1016/j.cub.2010.05.050; Lu Y, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aba3613; Ma M, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028209; Ma M, 2013, NAT GENET, V45, P1004, DOI 10.1038/ng.2715; Ma YN, 2014, FREE RADICAL BIO MED, V76, P251, DOI 10.1016/j.freeradbiomed.2014.08.015; Maser RL, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134991; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Menezes LF, 2016, EBIOMEDICINE, V5, P183, DOI 10.1016/j.ebiom.2016.01.027; Miller MM, 2011, KIDNEY INT, V80, P147, DOI 10.1038/ki.2011.56; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Plaisant F, 2003, FREE RADICAL BIO MED, V34, P862, DOI 10.1016/S0891-5849(02)01440-5; Poprac P, 2017, TRENDS PHARMACOL SCI, V38, P592, DOI 10.1016/j.tips.2017.04.005; Rezatabar S, 2019, J CELL PHYSIOL, V234, P14951, DOI 10.1002/jcp.28334; Seeger-Nukpezah T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038838; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037; Su LJ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/5080843; Torres VE, 1997, J AM SOC NEPHROL, V8, P1283; Tyagi S, 2010, BIOCHEM PHARMACOL, V80, P1326, DOI 10.1016/j.bcp.2010.07.025; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wang G, 2013, J CELL SCI, V126, P1355, DOI 10.1242/jcs.114918; Wang MX, 2002, FEBS LETT, V531, P359, DOI 10.1016/S0014-5793(02)03511-1; Wuebken A, 2011, KIDNEY INT, V80, P135, DOI 10.1038/ki.2011.87; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Zhang XQ, 2021, J AM SOC NEPHROL, V32, P2759, DOI 10.1681/ASN.2021040460; Zhou D, 2012, KIDNEY INT, V82, P537, DOI 10.1038/ki.2012.173; Zhou X, 2015, HUM MOL GENET, V24, P3982, DOI 10.1093/hmg/ddv136	65	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22089	10.1096/fj.202101270RR	http://dx.doi.org/10.1096/fj.202101270RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34888938				2022-12-28	WOS:000734992000019
J	Beterams, A; De Paepe, K; Maes, L; Wise, IJ; De Keersmaecker, H; Rajkovic, A; Laukens, D; van de Wiele, T; Arroyo, MC				Beterams, Annelore; De Paepe, Kim; Maes, Laure; Wise, India Jane; De Keersmaecker, Herlinde; Rajkovic, Andreja; Laukens, Debby; van de Wiele, Tom; Calatayud Arroyo, Marta			Versatile human in vitro triple coculture model coincubated with adhered gut microbes reproducibly mimics pro-inflammatory host-microbe interactions in the colon	FASEB JOURNAL			English	Article						coculture techniques; epithelial cells; gastrointestinal microbiome; gene expression profiling; host microbial interactions	LACTOBACILLUS-RHAMNOSUS GG; EPITHELIAL-CELL LINES; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; HUMAN INTESTINE; CACO-2; INTERLEUKIN-8; BARRIER; CACO-2/HT29-MTX; ORGANOIDS	The colonic epithelial barrier is vital to preserve gut and host health by maintaining the immune homeostasis between host and microbes. The mechanisms underlying beneficial or harmful host-microbe interactions are poorly understood and impossible to study in vivo given the limited accessibility and ethical constraints. Moreover, existing in vitro models lack the required cellular complexity for the routine, yet profound, analysis of the intricate interplay between different types of host and microbial cells. We developed and characterized a broadly applicable, easy-to-handle in vitro triple coculture model that combines chemically-induced macrophage-like, goblet and epithelial cells covered by a mucus layer, which can be coincubated with complex human-derived gut microbiota samples for 16 h. Comparison with a standard epithelial monolayer model revealed that triple cocultures produce thicker mucus layers, morphologically organize in a network and upon exposure to human-derived gut microbiota samples, respond via pro-inflammatory cytokine production. Both model systems, however, were not suffering from cytotoxic stress or different microbial loads, indicating that the obtained endpoints were caused by the imposed conditions. Addition of the probiotic Lactobacillus rhamnosus GG to assess its immunomodulating capacity in the triple coculture slightly suppressed pro-inflammatory cytokine responses, based on transcriptomic microarray analyses. TNF conditioning of the models prior to microbial exposure did not cause shifts in cytokines, suggesting a strong epithelial barrier in which TNF did not reach the basolateral side. To conclude, the triple coculture model is tolerable towards manipulations and allows to address mechanistic host-microbe research questions in a stable in vitro environment.	[Beterams, Annelore; De Paepe, Kim; Maes, Laure; Wise, India Jane; van de Wiele, Tom; Calatayud Arroyo, Marta] Univ Ghent, Ctr Microbial Ecol & Technol CMET, Coupure Links 653,Bldg A, B-9000 Ghent, Belgium; [Maes, Laure; Laukens, Debby] Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium; [De Keersmaecker, Herlinde] Univ Ghent, Ctr Adv Light Microscopy, Ghent, Belgium; [Rajkovic, Andreja] Univ Ghent, Lab Food Microbiol & Food Preservat, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University	van de Wiele, T (corresponding author), Univ Ghent, Ctr Microbial Ecol & Technol CMET, Coupure Links 653,Bldg A, B-9000 Ghent, Belgium.	Tom.VandeWiele@UGent.be	Calatayud, Marta/B-6850-2019; Rajkovic, Andreja/H-5357-2013; De Paepe, Kim/B-9000-2018	Calatayud, Marta/0000-0003-3592-3377; Rajkovic, Andreja/0000-0003-1062-0564; De Paepe, Kim/0000-0002-7948-6765	Fonds Wetenschappelijk Onderzoek (FWO) [G062519N, 12R2717N]; EC \ Horizon 2020 (EU Framework Programme for Research and Innovation) [810752]; Bijzonder Onderzoeksfonds (BOF) [GOA032-17]	Fonds Wetenschappelijk Onderzoek (FWO)(FWO); EC \ Horizon 2020 (EU Framework Programme for Research and Innovation); Bijzonder Onderzoeksfonds (BOF)	Fonds Wetenschappelijk Onderzoek (FWO), Grant/Award Number: G062519N and 12R2717N; EC | Horizon 2020 (EU Framework Programme for Research and Innovation), Grant/Award Number: 810752; Bijzonder Onderzoeksfonds (BOF), Grant/Award Number: GOA032--17	Agace WW, 2017, IMMUNITY, V46, P532, DOI 10.1016/j.immuni.2017.04.004; Aguirre M, 2016, RES MICROBIOL, V167, P114, DOI 10.1016/j.resmic.2015.09.006; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Araujo F, 2013, INT J PHARMACEUT, V458, P128, DOI 10.1016/j.ijpharm.2013.10.003; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Beduneau A, 2014, EUR J PHARM BIOPHARM, V87, P290, DOI 10.1016/j.ejpb.2014.03.017; Bein A, 2018, CELL MOL GASTROENTER, V5, P659, DOI 10.1016/j.jcmgh.2017.12.010; Bolstad B. M., 2004, LOW LEVEL ANAL HIGH; Bu XD, 2011, TISSUE CELL, V43, P201, DOI 10.1016/j.tice.2011.03.002; Calatayud M, 2019, FASEB J, V33, P3985, DOI 10.1096/fj.201801414R; Cani PD, 2018, GUT, V67, P1716, DOI 10.1136/gutjnl-2018-316723; Chanput W, 2010, FOOD FUNCT, V1, P254, DOI 10.1039/c0fo00113a; Chen Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187880; CLINTON SK, 1988, CANCER RES, V48, P3035; Devriese S, 2017, HISTOCHEM CELL BIOL, V148, P85, DOI 10.1007/s00418-017-1539-7; ECKMANN L, 1993, GASTROENTEROLOGY, V105, P1689, DOI 10.1016/0016-5085(93)91064-O; ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993; Fatehullah A, 2016, NAT CELL BIOL, V18, P246, DOI 10.1038/ncb3312; Fish SM, 1999, GUT, V45, P191, DOI 10.1136/gut.45.2.191; Fofanova TY., 2019, NOVEL HUMAN ENTEROID, DOI [10.1101/555755v1, DOI 10.1101/555755V1]; Ganguli K, 2015, PEDIATR RES, V77, P528, DOI 10.1038/pr.2015.5; Genin M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1546-9; Gill RK, 2005, AM J PHYSIOL-CELL PH, V289, pC846, DOI 10.1152/ajpcell.00112.2005; Gonzalez I, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-19; Gullberg E, 2000, BIOCHEM BIOPH RES CO, V279, P808, DOI 10.1006/bbrc.2000.4038; Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011, 10.1152/ajpgi.00405.2011.]; Hormel T.T., 2017, BIOTRIBOLOGY, V11, P73, DOI [10.1016/j.biotri.2017.04.004, DOI 10.1016/J.BIOTRI.2017.04.004]; Hughes R, 2008, NUTR CANCER, V60, P259, DOI 10.1080/01635580701649644; Jalili-Firoozinezhad S, 2019, NAT BIOMED ENG, V3, P520, DOI 10.1038/s41551-019-0397-0; Jalili-Firoozinezhad S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0304-8; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Kampfer AAM, 2017, TOXICOL IN VITRO, V45, P31, DOI 10.1016/j.tiv.2017.08.011; Kasendra M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21201-7; Kim HJ, 2016, P NATL ACAD SCI USA, V113, pE7, DOI 10.1073/pnas.1522193112; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Klaus Bernd, 2016, F1000Res, V5, P1384, DOI 10.12688/f1000research.8967.1; Koslowski M, 2008, CANCER RES, V68, P3458, DOI 10.1158/0008-5472.CAN-07-5768; Lebeer S, 2018, CURR OPIN BIOTECH, V49, P217, DOI 10.1016/j.copbio.2017.10.007; Leonard F, 2010, MOL PHARMACEUT, V7, P2103, DOI 10.1021/mp1000795; LESUFFLEUR T, 1990, CANCER RES, V50, P6334; Lippa Katrice A, 2010, BMC Res Notes, V3, P349, DOI 10.1186/1756-0500-3-349; Lozoya-Agullo I, 2017, MOL PHARMACEUT, V14, P1264, DOI 10.1021/acs.molpharmaceut.6b01165; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Marzorati M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-133; Mirabelli P, 2019, CANCERS, V11, DOI 10.3390/cancers11081098; MOLLY K, 1993, APPL MICROBIOL BIOT, V39, P254, DOI 10.1007/BF00228615; Monnappa AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep33485; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Navabi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068761; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Noel G, 2017, SCI REP-UK, V7, DOI 10.1038/srep45270; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Paone P, 2020, GUT, V69, P2232, DOI 10.1136/gutjnl-2020-322260; Pearce SC, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01584; Phipson B, 2016, ANN APPL STAT, V10, P946, DOI 10.1214/16-AOAS920; Puschhof J, 2021, CELL HOST MICROBE, V29, P867, DOI 10.1016/j.chom.2021.04.002; Renz H, 2018, J ALLERGY CLIN IMMUN, V141, P1212, DOI 10.1016/j.jaci.2017.11.019; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roh TT, 2019, BIOMATERIALS, V225, DOI 10.1016/j.biomaterials.2019.119517; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; SCHUERERMALY CC, 1994, IMMUNOLOGY, V81, P85; Shah P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11535; Singh A, 2019, BIOINFORMATICS, V35, P3055, DOI 10.1093/bioinformatics/bty1054; Sontheimer-Phelps A, 2020, CELL MOL GASTROENTER, V9, P507, DOI 10.1016/j.jcmgh.2019.11.008; Tsilia V, 2015, FOLIA MICROBIOL, V60, P435, DOI 10.1007/s12223-015-0376-0; Upton Graham J. G., 2009, Briefings in Functional Genomics & Proteomics, V8, P199, DOI 10.1093/bfgp/elp027; Van de Wiele T, 2016, NAT REV RHEUMATOL, V12, P398, DOI 10.1038/nrrheum.2016.85; Van den Abbeele P, 2018, J FUNCT FOODS, V47, P163, DOI 10.1016/j.jff.2018.05.053; Van Nevel S, 2013, J MICROBIOL METH, V94, P73, DOI 10.1016/j.mimet.2013.05.007; VanDussen KL, 2015, GUT, V64, P911, DOI 10.1136/gutjnl-2013-306651; Vreeburg RAM, 2011, FOOD FUNCT, V2, P124, DOI 10.1039/c0fo00068j; WALTER E, 1995, EUR J PHARM SCI, V3, P215, DOI 10.1016/0928-0987(95)00010-B; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Yan F, 2013, J BIOL CHEM, V288, P30742, DOI 10.1074/jbc.M113.492397; Zhang JB, 2021, MED-CAMBRIDGE, V2, P74, DOI 10.1016/j.medj.2020.07.001; Zhang LY, 2005, J NUTR, V135, P1752, DOI 10.1093/jn/135.7.1752; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	78	3	3	8	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e21992	10.1096/fj.202101135R	http://dx.doi.org/10.1096/fj.202101135R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34719821	Green Published			2022-12-28	WOS:000722321300046
J	Li, YL; Sha, YQ; Wang, HT; He, LP; Li, LJ; Wen, S; Sheng, L; Hu, WG; Zhou, H				Li, Yinling; Sha, Yeqin; Wang, Haitao; He, Lianping; Li, Longjun; Wen, Shuang; Sheng, Liang; Hu, Weiguo; Zhou, Hong			Intracellular C3 prevents hepatic steatosis by promoting autophagy and very-low-density lipoprotein secretion	FASEB JOURNAL			English	Article						C3(-); mice; lipophagy; liver; triglyceride	COMPLEMENT-SYSTEM; TRANSFER PROTEIN; ER STRESS; APO-B; OBESITY; PATHWAY	Complement component C3, mainly synthesized by hepatocytes, acts as the convergence point of three different pathways in activating the complement cascade. Besides its well-established roles in the extracellular milieu, C3 performs various intracellular functions such as immunomodulation and pathogen recognition. Although C3 is present at extremely high concentrations in hepatocytes, little is known about its intrahepatic function. In this study, we found that C3 knockout (C3(-/-)) mice displayed accelerated hepatic triglyceride (TG) accumulation compared with C57BL/6J wild type mice. Mechanistically, C3 deficiency impaired lipophagy in hepatocytes, owing to the disrupted interaction between C3 and autophagy-related 16 like 1, which is essential for autolysosome assembly. Furthermore, lipophagy deficiency affected the function of the endoplasmic reticulum in C3(-/-) mice, subsequently affecting the expression of protein disulfide isomerase and activity of microsomal TG transfer protein, and ultimately impairing the production of hepatic very-low-density lipoproteins (VLDLs). Rapamycin and thapsigargin treatment accelerated VLDL secretion and alleviated hepatic lipid accumulation in C3(-/-) mice. Our study demonstrates that C3 promotes lipophagy to facilitate VLDL secretion in hepatocytes, thus playing an essential role in balancing TG levels in the liver.	[Li, Yinling; Sha, Yeqin; Wang, Haitao; He, Lianping; Li, Longjun; Wen, Shuang; Zhou, Hong] Nanjing Med Univ, Dept Immunol, Nanjing 211166, Jiangsu, Peoples R China; [Sheng, Liang] Nanjing Med Univ, Sch Basic Med Sci, Dept Pharmacol, Nanjing, Peoples R China; [Hu, Weiguo] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Shanghai, Peoples R China; [Hu, Weiguo] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai, Peoples R China; [Zhou, Hong] Anhui Med Univ, Sch Life Sci, Dept Cell Biol, Hefei, Peoples R China	Nanjing Medical University; Nanjing Medical University; Fudan University; Fudan University; Anhui Medical University	Zhou, H (corresponding author), Nanjing Med Univ, Dept Immunol, Nanjing 211166, Jiangsu, Peoples R China.	hongzhou@live.com	Hu, Weiguo/AAP-2239-2021	Hu, Weiguo/0000-0002-7397-6800	National Natural Science Foundation of China [81871241, 82071849]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Nos. 81871241 and 82071849)	Afshar-Kharghan V, 2017, J CLIN INVEST, V127, P780, DOI 10.1172/JCI90962; Baiceanu A, 2016, NAT REV ENDOCRINOL, V12, P710, DOI 10.1038/nrendo.2016.124; Bains M, 2009, J BIOL CHEM, V284, P20398, DOI 10.1074/jbc.M109.011791; Bamba V, 2007, GASTROENTEROLOGY, V132, P2181, DOI 10.1053/j.gastro.2007.03.056; Barbier-Torres L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01970-x; Carroll M, 2006, NATURE, V444, P159, DOI 10.1038/nature05307; Chen J, 2020, AGING-US, V12, P24242, DOI 10.18632/aging.104160; Conlon DM, 2016, J CLIN INVEST, V126, P3852, DOI 10.1172/JCI86028; Cui W, 2007, AM J PHYSIOL-ENDOC M, V293, pE1482, DOI 10.1152/ajpendo.00565.2006; Fas BA, 2021, AUTOPHAGY, V17, P2818, DOI 10.1080/15548627.2020.1847443; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; He SQ, 2009, J CLIN INVEST, V119, P2304, DOI 10.1172/JCI38289; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; King BC, 2019, CELL METAB, V29, P202, DOI 10.1016/j.cmet.2018.09.009; Kloska A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176113; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Lebeaupin C, 2018, J HEPATOL, V69, P927, DOI 10.1016/j.jhep.2018.06.008; Li J, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03264-5; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Madrigal-Matute J, 2016, GASTROENTEROLOGY, V150, P328, DOI 10.1053/j.gastro.2015.09.042; Martinez-Lopez N, 2015, ANNU REV NUTR, V35, P215, DOI 10.1146/annurev-nutr-071813-105336; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; MORRIS KM, 1982, SCIENCE, V215, P399, DOI 10.1126/science.7199205; Park HS, 2021, AUTOPHAGY, V17, P2549, DOI 10.1080/15548627.2020.1834711; Phieler J, 2013, SEMIN IMMUNOL, V25, P47, DOI 10.1016/j.smim.2013.04.003; Qiu W, 2011, HEPATOLOGY, V53, P1515, DOI 10.1002/hep.24269; Reis ES, 2019, NAT REV IMMUNOL, V19, P503, DOI 10.1038/s41577-019-0168-x; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085; Sheng Y, 2018, CELL DEATH DIFFER, V25, P918, DOI 10.1038/s41418-017-0023-1; Shenkman M, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0174-8; Singh BK, 2020, AGING-US, V12, P13958, DOI 10.18632/aging.103740; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sorbara MT, 2018, CELL HOST MICROBE, V23, P644, DOI 10.1016/j.chom.2018.04.008; Ueno T, 2017, NAT REV GASTRO HEPAT, V14, P170, DOI 10.1038/nrgastro.2016.185; Wang SY, 2012, CELL METAB, V16, P473, DOI 10.1016/j.cmet.2012.09.003; Wang YL, 2022, ACTA PHARMACOL SIN, V43, P10, DOI 10.1038/s41401-021-00629-0; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005	43	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22037	10.1096/fj.202100856R	http://dx.doi.org/10.1096/fj.202100856R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34762761				2022-12-28	WOS:000722321300001
J	Winestock, CH				Winestock, Claire H.			Purnell W. Choppin (1929-2021)	FASEB JOURNAL			English	Biographical-Item									[Winestock, Claire H.] Howard Hughes Med Inst, Chevy Chase, MD USA	Howard Hughes Medical Institute	Winestock, CH (corresponding author), 5707 Glenwood Rd, Bethesda, MD 20817 USA.	c.winestock@att.net						CHOPPIN PW, PUBLICATION LIST	1	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22004	10.1096/fj.202101575	http://dx.doi.org/10.1096/fj.202101575			4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34739147	Bronze			2022-12-28	WOS:000722321300038
J	Lovaszi, M; Nemeth, ZH; Gause, WC; Beesley, J; Pacher, P; Hasko, G				Lovaszi, Marianna; Nemeth, Zoltan H.; Gause, William C.; Beesley, Jennet; Pacher, Pal; Hasko, Gyorgy			Inosine monophosphate and inosine differentially regulate endotoxemia and bacterial sepsis	FASEB JOURNAL			English	Article						endotoxemia; inosine; inosine 5 '-monophosphate; sepsis	PURINE NUCLEOSIDE PHOSPHORYLASE; ADENOSINE A(2A) RECEPTOR; IMPROVES SURVIVAL; DEPENDENT INDUCTION; THERAPEUTIC TARGET; AMP-DEAMINASE; TNF-ALPHA; INFLAMMATION; NUCLEOTIDE; MACROPHAGE	Inosine monophosphate (IMP) is the intracellular precursor for both adenosine monophosphate and guanosine monophosphate and thus plays a central role in intracellular purine metabolism. IMP can also serve as an extracellular signaling molecule, and can regulate diverse processes such as taste sensation, neutrophil function, and ischemia-reperfusion injury. How IMP regulates inflammation induced by bacterial products or bacteria is unknown. In this study, we demonstrate that IMP suppressed tumor necrosis factor (TNF)-alpha production and augmented IL-10 production in endotoxemic mice. IMP exerted its effects through metabolism to inosine, as IMP only suppressed TNF-alpha following its CD73-mediated degradation to inosine in lipopolysaccharide-activated macrophages. Studies with gene targeted mice and pharmacological antagonism indicated that A(2A), A(2B), and A(3) adenosine receptors are not required for the inosine suppression of TNF-alpha production. The inosine suppression of TNF-alpha production did not require its metabolism to hypoxanthine through purine nucleoside phosphorylase or its uptake into cells through concentrative nucleoside transporters indicating a role for alternative metabolic/uptake pathways. Inosine augmented IL-beta production by macrophages in which inflammasome was activated by lipopolysaccharide and ATP. In contrast to its effects in endotoxemia, IMP failed to affect the inflammatory response to abdominal sepsis and pneumonia. We conclude that extracellular IMP and inosine differentially regulate the inflammatory response.	[Lovaszi, Marianna; Nemeth, Zoltan H.; Hasko, Gyorgy] Columbia Univ, Dept Anesthesiol, 622 W 168th St,P&S Box 46, New York, NY 10032 USA; [Nemeth, Zoltan H.] Morristown Med Ctr, Dept Surg, Morristown, NJ USA; [Gause, William C.] Rutgers New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ USA; [Gause, William C.] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ USA; [Beesley, Jennet] Daresbury Prot Ltd, Sci Tech Dareshury, Warrington, Cheshire, England; [Pacher, Pal] NIAAA, Lab Cardiovasc Physiol & Tissue Injury, NIH, Bethesda, MD USA	Columbia University; Atlantic Health System; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Hasko, G (corresponding author), Columbia Univ, Dept Anesthesiol, 622 W 168th St,P&S Box 46, New York, NY 10032 USA.	gh2503@cumc.columbia.edu	Pacher, Pal/B-6378-2008	Pacher, Pal/0000-0001-7036-8108	National Institutes of Health [R01GM066189, R01DK113790, R01HL158519]; NIH/NCI Cancer Center Support [P30CA013696]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI Cancer Center Support(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health, Grant/Award Number: R01GM066189, R01DK113790 and R01HL158519; NIH/NCI Cancer Center Support, Grant/Award Number: P30CA013696	Antonioli L, 2015, NAT REV ENDOCRINOL, V11, P228, DOI 10.1038/nrendo.2015.10; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Bretonnet AS, 2005, FEBS LETT, V579, P3363, DOI 10.1016/j.febslet.2005.05.014; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Choudhuri SP, 2016, NEUROSCIENCE, V316, P94, DOI 10.1016/j.neuroscience.2015.12.008; Csoka B, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99431; Csoka B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006409; Csoka B, 2015, FASEB J, V29, P3626, DOI 10.1096/fj.15-272450; Csoka B, 2015, FASEB J, V29, P25, DOI 10.1096/fj.14-253567; Csoka B, 2014, DIABETES, V63, P850, DOI 10.2337/db13-0573; Csoka B, 2010, J IMMUNOL, V185, P542, DOI 10.4049/jimmunol.0901295; Cunha RA, 2001, NEUROCHEM RES, V26, P979, DOI 10.1023/A:1012392719601; Deganutti G, 2017, CHEMMEDCHEM, V12, P1319, DOI 10.1002/cmdc.201700200; Doyle C, 2017, SCI REP-UK, V7, DOI 10.1038/srep44416; Eltzschig HK, 2013, TRENDS MOL MED, V19, P345, DOI 10.1016/j.molmed.2013.02.005; Fonseca MT, 2021, SCI SIGNAL, V14, DOI 10.1126/scisignal.abb0969; Gomez G, 2003, BLOOD, V102, P4472, DOI 10.1182/blood-2002-11-3624; Gupte A, 2009, BIOORG MED CHEM LETT, V19, P917, DOI 10.1016/j.bmcl.2008.11.112; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; Hasko G, 2004, TRENDS PHARMACOL SCI, V25, P152, DOI 10.1016/j.tips.2004.01.006; Hasko G, 1999, BRIT J PHARMACOL, V127, P1295, DOI 10.1038/sj.bjp.0702689; Hasko G, 2000, J IMMUNOL, V164, P1013, DOI 10.4049/jimmunol.164.2.1013; Hasko G, 1996, J IMMUNOL, V157, P4634; Hasko G, 2000, FASEB J, V14, P2065, DOI 10.1096/fj.99-0508com; Hasko G, 2011, J IMMUNOL, V187, P4256, DOI 10.4049/jimmunol.1003379; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; He BK, 2017, J EXP MED, V214, P107, DOI 10.1084/jem.20160961; Idzko M, 2014, BLOOD, V124, P1029, DOI 10.1182/blood-2013-09-402560; Ji M, 2021, B KOREAN CHEM SOC, V42, P611, DOI 10.1002/bkcs.12240; Jin XW, 1997, J CLIN INVEST, V100, P2849, DOI 10.1172/JCI119833; Kicska GA, 2002, J BIOL CHEM, V277, P3219, DOI 10.1074/jbc.M105905200; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Koscso B, 2013, J LEUKOCYTE BIOL, V94, P1309, DOI 10.1189/jlb.0113043; Li JW, 2021, J EXP MED, V218, DOI 10.1084/jem.20210008; Li PL, 2007, CIRC J, V71, P591, DOI 10.1253/circj.71.591; Liaudet L, 2001, AM J RESP CRIT CARE, V164, P1213, DOI 10.1164/ajrccm.164.7.2101013; Lukashev D, 2007, CANCER METAST REV, V26, P273, DOI 10.1007/s10555-007-9054-2; Lukashey D, 2004, DRUG DISCOV TODAY, V9, P403, DOI 10.1016/S1359-6446(04)03044-2; Mabley JG, 2003, AM J PHYSIOL-GASTR L, V284, pG138, DOI 10.1152/ajpgi.00060.2002; Mager LF, 2020, SCIENCE, V369, P1481, DOI 10.1126/science.abc3421; Masaki T, 2005, FASEB J, V19, P1245, DOI 10.1096/fj.04-3195com; Morote-Garcia JC, 2008, BLOOD, V111, P5571, DOI 10.1182/blood-2007-11-126763; MOULTON R, 1957, BRIT J PHARM CHEMOTH, V12, P365, DOI 10.1111/j.1476-5381.1957.tb00150.x; Muller CE, 2011, BBA-BIOMEMBRANES, V1808, P1290, DOI 10.1016/j.bbamem.2010.12.017; Nemeth ZH, 2003, J PHARMACOL EXP THER, V306, P1042, DOI 10.1124/jpet.103.052944; Ouyang XS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3909; Pareek V, 2021, CRIT REV BIOCHEM MOL, V56, P1, DOI 10.1080/10409238.2020.1832438; Pastor-Anglada M, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00627; Pedley AM, 2017, TRENDS BIOCHEM SCI, V42, P141, DOI 10.1016/j.tibs.2016.09.009; Poth JM, 2013, J MOL MED, V91, P183, DOI 10.1007/s00109-012-0988-7; Qiu FH, 2000, P NATL ACAD SCI USA, V97, P4267, DOI 10.1073/pnas.97.8.4267; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Schramm VL, 2002, BBA-MOL BASIS DIS, V1587, P107, DOI 10.1016/S0925-4439(02)00073-X; Scott GS, 2002, P NATL ACAD SCI USA, V99, P16303, DOI 10.1073/pnas.212645999; Simone PD, 2013, MUTAT RES-REV MUTAT, V753, P131, DOI 10.1016/j.mrrev.2013.08.001; Sitkovsky MV, 2009, TRENDS IMMUNOL, V30, P102, DOI 10.1016/j.it.2008.12.002; Soriano FG, 2001, CRIT CARE MED, V29, P703, DOI 10.1097/00003246-200104000-00001; Szabo C, 1998, BRIT J PHARMACOL, V125, P379, DOI 10.1038/sj.bjp.0702040; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Wada K, 2001, J HEMATOTH STEM CELL, V10, P75, DOI 10.1089/152581601750098273; Welihinda AA, 2018, CELL SIGNAL, V42, P227, DOI 10.1016/j.cellsig.2017.11.002; Welihinda AA, 2016, CELL SIGNAL, V28, P552, DOI 10.1016/j.cellsig.2016.02.010; Xiao CY, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000161; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Zabielska MA, 2015, PHARMACOL REP, V67, P682, DOI 10.1016/j.pharep.2015.04.007; Zhan XM, 2020, BLOOD ADV, V4, P3594, DOI 10.1182/bloodadvances.2020001762; Zhang F, 2008, P NATL ACAD SCI USA, V105, P20930, DOI 10.1073/pnas.0810174106	69	5	5	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21935	10.1096/fj.202100862R	http://dx.doi.org/10.1096/fj.202100862R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34591327				2022-12-28	WOS:000712009200007
J	Pang, JM; Wang, SL; Wang, ZY; Wu, YJ; Zhang, XY; Pi, Y; Han, DD; Zhang, S; Wang, JJ				Pang, Jiaman; Wang, Shilan; Wang, Zhenyu; Wu, Yujun; Zhang, Xiangyu; Pi, Yu; Han, Dandan; Zhang, Shuai; Wang, Junjun			Xylo-oligosaccharide alleviates Salmonella induced inflammation by stimulating Bifidobacterium animalis and inhibiting Salmonella colonization	FASEB JOURNAL			English	Article						adhesibility; Bifidobacterium animalis; intestinal inflammation; Salmonella Typhimurium; xylo-oligosaccharide	GUT MICROBIOTA; DIETARY FIBER; MUCOSAL BARRIER; FATTY-ACIDS; SHORT-CHAIN; TYPHIMURIUM; HEALTH; GROWTH; SUPPLEMENTATION; LACTOBACILLI	Xylo-oligosaccharide (XOS), which is considered as a potential prebiotic, exhibits multiple beneficial effects on modulation of gut microbiota, strength of intestinal barrier, and inhibition of intestinal inflammation. The objective of this study is to investigate whether XOS protects against Salmonella infection by modulating gut microbiota, enhancing the intestinal barrier, and resisting colonization. C57BL/6 male mice received water supplementation with 5% XOS for 14 days before Salmonella Typhimurium infection. The results showed that XOS suppressed the Salmonella-induced inflammation, but had limited effects on tight junction molecules and mRNA expression of mucus proteins, except for claudin-1 in the colon. Data of 16S rDNA sequencing indicated that XOS modulated gut microbiota composition by significantly stimulating Bifidobacterium animalis (B. animalis), and reducing Salmonella counts. Therefore, the potential protective effects of B. animalis against Salmonella challenge were investigated as well. Bifidobacterium animalis subsp lactis BB-12 (BB12), which could markedly increase in XOS, was selected to treat mice. Similarly, Salmonella-induced inflammatory reactions were alleviated by BB12 but tight junction molecules and mucin proteins in the colonic tissues were not affected. Administration of BB12 remarkably decreased the copies of Salmonella in cecal digesta post Salmonella infection. Additionally, the decrease concentrations of cecal propionate and total short-chain fatty acids (SCFAs) in Salmonella-infected mice were reversed by BB12 treatment, and propionate performed a strong inhibitory effect on Salmonella growth in vitro. Besides that, BB12 could directly restrict Salmonella proliferation in vitro. Moreover, BB12 reduced the adhesion ability of Salmonella on the Caco-2 cells model. Our results suggest that XOS could be considered as a candidate of functional food to protect against Salmonella infection by stimulating Bifidobacterium, which then resists Salmonella colonization by maintaining the intestinal SCFAs levels and suppressing adhesibility.	[Pang, Jiaman; Wang, Shilan; Wang, Zhenyu; Wu, Yujun; Zhang, Xiangyu; Pi, Yu; Han, Dandan; Zhang, Shuai; Wang, Junjun] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China	China Agricultural University	Wang, JJ (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	wangjj@cau.edu.cn	Pi, Yu/GZM-4565-2022; Wang, Junjun/G-8893-2011	Pang, Jiaman/0000-0001-8276-5637; Pi, Yu/0000-0003-1320-0290; Wang, Junjun/0000-0001-9427-3824	National Natural Science Foundation of China [31972596, 31630074]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 31972596 and 31630074	Baumler AJ, 2016, NATURE, V535, P85, DOI 10.1038/nature18849; Broekaert WF, 2011, CRIT REV FOOD SCI, V51, P178, DOI 10.1080/10408390903044768; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Carlson JL, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121361; Chen H, 2013, BRIT J NUTR, V110, P1837, DOI 10.1017/S0007114513001293; Christensen Ellen Gerd, 2014, BMC Res Notes, V7, P660, DOI 10.1186/1756-0500-7-660; Cohen HJ, 1996, APPL ENVIRON MICROB, V62, P4303, DOI 10.1128/AEM.62.12.4303-4308.1996; Collado MC, 2007, LETT APPL MICROBIOL, V45, P454, DOI 10.1111/j.1472-765X.2007.02212.x; De Keersmaecker SCJ, 2006, FEMS MICROBIOL LETT, V259, P89, DOI 10.1111/j.1574-6968.2006.00250.x; Ducarmon QR, 2019, MICROBIOL MOL BIOL R, V83, DOI 10.1128/MMBR.00007-19; Fei YQ, 2020, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01601; Ferreira RBR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020338; Finegold SM, 2014, FOOD FUNCT, V5, P436, DOI 10.1039/c3fo60348b; Fu AK, 2019, FOOD FUNCT, V10, P7653, DOI 10.1039/c9fo01651a; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gordon MA, 2008, J INFECTION, V56, P413, DOI 10.1016/j.jinf.2008.03.012; Hansen CHF, 2013, J NUTR, V143, P533, DOI 10.3945/jn.112.172361; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; He BB, 2019, SCI CHINA LIFE SCI, V62, P959, DOI 10.1007/s11427-018-9372-6; Hetzel M, 2003, EUR J BIOCHEM, V270, P902, DOI 10.1046/j.1432-1033.2003.03450.x; Hidalgo-Cantabrana C, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.BAD-0010-2016; Holscher HD, 2017, GUT MICROBES, V8, P172, DOI 10.1080/19490976.2017.1290756; Jacobson A, 2018, CELL HOST MICROBE, V24, P296, DOI 10.1016/j.chom.2018.07.002; Jazi V, 2019, POULTRY SCI, V98, P5648, DOI 10.3382/ps/pez338; Jiminez JA, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0076-y; Kariuki S, 2015, VACCINE, V33, pS21, DOI 10.1016/j.vaccine.2015.03.102; Keestra-Gounder AM, 2015, NAT REV MICROBIOL, V13, P206, DOI 10.1038/nrmicro3428; Knudsen KEB, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101499; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Koutsoumanis KP, 2004, J FOOD PROTECT, V67, P53, DOI 10.4315/0362-028X-67.1.53; LaRock DL, 2015, NAT REV MICROBIOL, V13, P191, DOI 10.1038/nrmicro3420; Lecerf JM, 2012, BRIT J NUTR, V108, P1847, DOI 10.1017/S0007114511007252; Li N, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00797; Lidar M, 2009, ISR MED ASSOC J, V11, P558; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Liu C, 2021, GUT MICROBES, V13, P1, DOI 10.1080/19490976.2021.1903826; Liu JS, 2018, FOOD FUNCT, V9, P3673, DOI 10.1039/c8fo00365c; Long JF, 2019, J FUNCT FOODS, V52, P138, DOI 10.1016/j.jff.2018.10.035; Louis P, 2017, ENVIRON MICROBIOL, V19, P29, DOI 10.1111/1462-2920.13589; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Makelainen H, 2010, BENEF MICROBES, V1, P139, DOI 10.3920/BM2009.0029; Makelainen H, 2010, BENEF MICROBES, V1, P81, DOI 10.3920/BM2009.0025; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Nair DVT, 2018, FOODS, V7, DOI 10.3390/foods7100167; Natividad JMM, 2013, PHARMACOL RES, V69, P42, DOI 10.1016/j.phrs.2012.10.007; Okumura R, 2018, INFLAMM REGEN, V38, DOI 10.1186/s41232-018-0063-z; Pan J, 2019, AMB EXPRESS, V9, DOI 10.1186/s13568-019-0858-6; Peng MF, 2017, CRIT REV FOOD SCI, V57, P3987, DOI 10.1080/10408398.2016.1203286; Petersen A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-245; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sheng KL, 2020, FOOD FUNCT, V11, P3964, DOI [10.1039/d0fo00518e, 10.1039/D0FO00518E]; Sokol CL, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016303; Splichalova A, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9020183; Splichalova A, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8122002; Stecher B, 2005, INFECT IMMUN, V73, P3228, DOI 10.1128/IAI.73.6.3228-3241.2005; Verruck S, 2020, FOOD RES INT, V133, DOI 10.1016/j.foodres.2020.109131; Wen SCH, 2017, J PAEDIATR CHILD H, V53, P936, DOI 10.1111/jpc.13585; Zhang ZW, 2018, APPL MICROBIOL BIOT, V102, P8135, DOI 10.1007/s00253-018-9217-9; Zhu CX, 2018, MOL MED REP, V17, P7567, DOI 10.3892/mmr.2018.8833; Zou Y, 2020, FOODS, V9, DOI 10.3390/foods9111710	61	4	4	13	53	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21977	10.1096/fj.202100919RR	http://dx.doi.org/10.1096/fj.202100919RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34613640				2022-12-28	WOS:000712009200011
J	Snyder, MM; Yue, F; Zhang, LJ; Shang, RJ; Qiu, JM; Chen, JJ; Kim, KH; Peng, Y; Oprescu, SN; Donkin, SS; Bi, PP; Kuang, SH				Snyder, Madigan M.; Yue, Feng; Zhang, Lijia; Shang, Renjie; Qiu, Jiamin; Chen, Jingjuan; Kim, Kun Ho; Peng, Ying; Oprescu, Stephanie N.; Donkin, Shawn S.; Bi, Pengpeng; Kuang, Shihuan			LETMD1 is required for mitochondrial structure and thermogenic function of brown adipocytes	FASEB JOURNAL			English	Article						brown adipose tissue; cold intolerance; LETM1 domain containing 1; mitochondria; thermogenesis	ADIPOSE-TISSUE; ADAPTIVE THERMOGENESIS; FAT; MFN2; INNERVATION; ADAPTATION; GENERATION; MORPHOLOGY; TOLERANCE; MUSCLE	Obesity and metabolic disorders caused by energy surplus pose an increasing concern within the global population. Brown adipose tissue (BAT) dissipates energy through mitochondrial non-shivering thermogenesis, thus representing a powerful agent against obesity. Here we explore the novel role of a mitochondrial outer membrane protein, LETM1-domain containing 1 (LETMD1), in BAT. We generated a knockout (Letmd1(KO)) mouse model and analyzed BAT morphology, function and gene expression under various physiological conditions. While the Letmd1(KO) mice are born normally and have normal morphology and body weight, they lose multilocular brown adipocytes completely and have diminished mitochondrial abundance, DNA copy number, cristae structure, and thermogenic gene expression in the intrascapular BAT, associated with elevated reactive oxidative stress. In consequence, the Letmd1(KO) mice fail to maintain body temperature in response to acute cold exposure without food and become hypothermic within 4 h. Although the cold-exposed Letmd1(KO) mice can maintain body temperature in the presence of food, they cannot upregulate expression of uncoupling protein 1 (UCP1) and convert white to beige adipocytes, nor can they respond to adrenergic stimulation. These results demonstrate that LETMD1 is essential for mitochondrial structure and function, and thermogenesis of brown adipocytes.	[Snyder, Madigan M.; Yue, Feng; Zhang, Lijia; Qiu, Jiamin; Chen, Jingjuan; Kim, Kun Ho; Peng, Ying; Oprescu, Stephanie N.; Donkin, Shawn S.; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, 2098 Hobart & Russell Creighton Hall Anim Sci, W Lafayette, IN 47907 USA; [Snyder, Madigan M.; Oprescu, Stephanie N.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Shang, Renjie; Bi, Pengpeng] Univ Georgia, Ctr Mol Med, Athens, GA 30602 USA; [Shang, Renjie; Bi, Pengpeng] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Kuang, Shihuan] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Yue, F; Kuang, SH (corresponding author), Purdue Univ, Dept Anim Sci, 2098 Hobart & Russell Creighton Hall Anim Sci, W Lafayette, IN 47907 USA.	fyue@purdue.edu; skuang@purdue.edu		Kim, Kun Ho/0000-0002-5047-703X; Snyder, Madigan/0000-0002-7168-7829	HHS | NIH | National Cancer Institute (NCI) [R01CA212609]; U.S. Department of Agriculture (USDA) [NC-1184]	HHS | NIH | National Cancer Institute (NCI); U.S. Department of Agriculture (USDA)(United States Department of Agriculture (USDA))	HHS | NIH | National Cancer Institute (NCI), Grant/Award Number: R01CA212609; U.S. Department of Agriculture (USDA), Grant/Award Number: NC-1184	Alvarez-Dominguez JR, 2015, CELL METAB, V21, P764, DOI 10.1016/j.cmet.2015.04.003; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Betz MJ, 2018, NAT REV ENDOCRINOL, V14, P77, DOI 10.1038/nrendo.2017.132; Bi PP, 2014, NAT MED, V20, P911, DOI 10.1038/nm.3615; Bianco AC, 2013, LANCET DIABETES ENDO, V1, P250, DOI 10.1016/S2213-8587(13)70069-X; Boutant M, 2017, EMBO J, V36, P1543, DOI 10.15252/embj.201694914; Boutant M, 2015, MOL METAB, V4, P118, DOI 10.1016/j.molmet.2014.12.008; Burl RB, 2018, CELL METAB, V28, P300, DOI 10.1016/j.cmet.2018.05.025; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cho GW, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-50; Chouchani ET, 2019, NAT METAB, V1, P189, DOI 10.1038/s42255-018-0021-8; Cohen P, 2021, NAT REV MOL CELL BIO, V22, P393, DOI 10.1038/s41580-021-00350-0; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Hu B, 2020, NATURE, V578, P610, DOI 10.1038/s41586-020-2028-z; Huynh FK, 2014, METHOD ENZYMOL, V542, P391, DOI 10.1016/B978-0-12-416618-9.00020-0; Inokuma K, 2005, DIABETES, V54, P1385, DOI 10.2337/diabetes.54.5.1385; Jeong JH, 2015, MOL METAB, V4, P483, DOI 10.1016/j.molmet.2015.03.006; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Jiang SR, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0238-8; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Ko J, 2003, ONCOGENE, V22, P4679, DOI 10.1038/sj.onc.1206624; Krstic J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092622; Li YG, 2018, CELL, V175, P1561, DOI 10.1016/j.cell.2018.10.016; Lim SG, 2020, J IMMUNOL, V204, P1299, DOI 10.4049/jimmunol.1900551; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Mahdaviani K, 2017, EMBO REP, V18, P1123, DOI 10.15252/embr.201643827; Matsushita M, 2014, INT J OBESITY, V38, P812, DOI 10.1038/ijo.2013.206; Mills EL, 2018, NATURE, V560, P102, DOI 10.1038/s41586-018-0353-2; Morrison Shaun F, 2012, Front Endocrinol (Lausanne), V3; Nakamura S, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0832-5; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; NICHOLLS DG, 1979, BIOCHIM BIOPHYS ACTA, V549, P1, DOI 10.1016/0304-4173(79)90016-8; Ohtsuka M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1400-x; Okla M, 2017, ADV NUTR, V8, P473, DOI 10.3945/an.116.014332; Pereira RO, 2021, ELIFE, V10, DOI 10.7554/eLife.66519; Piquereau J, 2012, CARDIOVASC RES, V94, P408, DOI 10.1093/cvr/cvs117; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Schreiber R, 2017, CELL METAB, V26, P753, DOI 10.1016/j.cmet.2017.09.004; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Sebaa R, 2019, MOL METAB, V25, P35, DOI 10.1016/j.molmet.2019.04.008; Shang RJ, 2021, GENOME RES, V31, P121, DOI 10.1101/gr.265439.120; Shi M, 2021, NAT CELL BIOL, V23, DOI 10.1038/s41556-021-00642-9; Song AY, 2020, J CLIN INVEST, V130, P247, DOI 10.1172/JCI129167; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sun K, 2014, MOL METAB, V3, P474, DOI 10.1016/j.molmet.2014.03.010; Sustarsic EG, 2018, CELL METAB, V28, P159, DOI 10.1016/j.cmet.2018.05.003; Townsend KL, 2014, TRENDS ENDOCRIN MET, V25, P168, DOI 10.1016/j.tem.2013.12.004; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang GX, 2015, TRENDS ENDOCRIN MET, V26, P231, DOI 10.1016/j.tem.2015.03.002; Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Ye L, 2013, P NATL ACAD SCI USA, V110, P12480, DOI 10.1073/pnas.1310261110; Yoneshiro T, 2019, NATURE, V572, P614, DOI 10.1038/s41586-019-1503-x; You H, 2020, MOL METAB, V31, P109, DOI 10.1016/j.molmet.2019.11.013; Zeng X, 2019, NATURE, V569, P229, DOI 10.1038/s41586-019-1156-9; Zhou HY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20665-4	58	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21965	10.1096/fj.202100597R	http://dx.doi.org/10.1096/fj.202100597R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34669999				2022-12-28	WOS:000712009200062
J	Su, GH; Wang, LN; Gao, GQ; Wu, SS; Yang, L; Wu, ML; Liu, XF; Yang, MM; Wei, ZY; Bai, CL; Li, GP				Su, Guanghua; Wang, Lina; Gao, Guangqi; Wu, Shanshan; Yang, Lei; Wu, Meiling; Liu, Xuefei; Yang, Miaomiao; Wei, Zhuying; Bai, Chunling; Li, Guangpeng			C23 gene regulates the nucleolin structure and biosynthesis of ribosomes in bovine intraspecific and interspecific somatic cell nuclear transfer embryos	FASEB JOURNAL			English	Article						iSCNT; nucleolin; ribosome; SCNT; transcriptome; ZGA	PREIMPLANTATION EMBRYOS; GENOME ACTIVATION; IN-VITRO; OOCYTES; PORCINE; EXPRESSION; PROTEINS	Somatic cell nuclear transfer (SCNT) can reprogram differentiated somatic cells to produce individual animals, thus having advantages in animal breeding and chromatin reprogramming. Interspecies SCNT (iSCNT) provides extreme cases of reprogramming failure that can be used to understand the basic biological mechanism of genome reprogramming. It is important to understand the possible mechanisms for the failure of zygotic genome activation (ZGA) in iSCNT embryos in order to improve the efficiency of SCNT embryos. In the present study, we compared the development of bovine-bovine (B-B), ovine-ovine (O-O) SCNT, and ovine-bovine (O-B) iSCNT embryos and found that a developmental block existed in the 8-cell stage in O-B iSCNT embryos. RNA sequencing and q-PCR analysis revealed that the large ribosomal subunit genes (RPL) or the small ribosomal subunit genes (RPS) were expressed at lower levels in the O-B iSCNT embryos. The nucleolin (C23) gene that regulates the ribosomal subunit generation was transcribed at a lower level during embryonic development in O-B iSCNT embryos. In addition, the nucleolin exhibited a clear circular-ring structure in B-B 8-cell stage embryos, whereas this was shell-like or dot-like in the O-B embryos. Furthermore, overexpression of C23 could increase the blastocyst rate of both SCNT and iSCNT embryos and partly rectify the ring-like nucleolin structure and the expression of ribosomal subunit related genes were upregulation, while knockdown of C23 increased the shell-like nucleolin-structure in B-B cloned embryos and downregulated the expression of ribosomal subunit related genes. These results implied that abnormal C23 and ribosome subunit gene expression would lead to the developmental block of iSCNT embryos and ZGA failure. Overexpression of the C23 gene could partly improve the blastocyst development and facilitate the nucleolin structure in bovine preimplantation SCNT embryos.	[Su, Guanghua; Wang, Lina; Gao, Guangqi; Wu, Shanshan; Yang, Lei; Wu, Meiling; Liu, Xuefei; Yang, Miaomiao; Wei, Zhuying; Bai, Chunling; Li, Guangpeng] Inner Mongolia Univ, State Key Lab Reprod Regulat & Breeding Grassland, 24 Zhaojun Rd, Hohhot 010070, Peoples R China; [Su, Guanghua; Wang, Lina; Wu, Shanshan; Yang, Lei; Wu, Meiling; Liu, Xuefei; Yang, Miaomiao; Wei, Zhuying; Bai, Chunling; Li, Guangpeng] Inner Mongolia Univ, Coll Life Sci, Hohhot, Peoples R China; [Gao, Guangqi] Inner Mongolia Agr Univ, Key Lab Dairy Biotechnol & Engn, Minist Educ, Hohhot, Peoples R China	Inner Mongolia University; Inner Mongolia University; Inner Mongolia Agricultural University	Li, GP (corresponding author), Inner Mongolia Univ, State Key Lab Reprod Regulat & Breeding Grassland, 24 Zhaojun Rd, Hohhot 010070, Peoples R China.	gpengli@imu.edu.cn		Yang, Lei/0000-0002-9767-9026; su, guanghua/0000-0003-1473-3814	National Natural Science Foundation of China (NSFC) [32060755]; Natural Science Foundation of Inner Mongolia (Inner Mongolia Natural Science Foundation) [2020BS03023]; Genetically Modified Organisms Breeding Major Projects [2016ZX08007-002]; State Key Laboratory of R2BGL [SKL-IT-201813]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Inner Mongolia (Inner Mongolia Natural Science Foundation); Genetically Modified Organisms Breeding Major Projects; State Key Laboratory of R2BGL	National Natural Science Foundation of China (NSFC), Grant/Award Number: 32060755; Natural Science Foundation of Inner Mongolia (Inner Mongolia Natural Science Foundation), Grant/Award Number: 2020BS03023; Genetically Modified Organisms Breeding Major Projects, Grant/Award Number: 2016ZX08007-002; The opening project of State Key Laboratory of R2BGL, Grant/Award Number: SKL-IT-201813	Bjerregaard B, 2004, BIOL REPROD, V70, P867, DOI 10.1095/biolreprod.103.021683; Bjerregaard B, 2007, MOL REPROD DEV, V74, P35, DOI 10.1002/mrd.20594; Burns KH, 2003, SCIENCE, V300, P633, DOI 10.1126/science.1081813; Canovas S., 2014, PRINCIPLES CLONING, V2nd ed, P441; CHOUINARD LA, 1975, J CELL SCI, V17, P589; Dundr M, 2012, CURR OPIN CELL BIOL, V24, P415, DOI 10.1016/j.ceb.2012.03.010; Flechon JE, 1998, ZYGOTE, V6, P183, DOI 10.1017/S0967199498000112; Fulka H, 2004, FERTIL STERIL, V82, P486, DOI 10.1016/j.fertnstert.2003.12.042; Fulka H, 2020, BIOCHEM SOC T, V48, P581, DOI 10.1042/BST20190847; Fulka H, 2019, CHROMOSOME RES, V27, P129, DOI 10.1007/s10577-018-9590-3; Fulka H, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136093; Fulka H, 2010, MOL HUM REPROD, V16, P63, DOI 10.1093/molehr/gap088; Graf A, 2014, ANIM REPROD SCI, V149, P46, DOI 10.1016/j.anireprosci.2014.05.016; Graf A, 2014, P NATL ACAD SCI USA, V111, P4139, DOI 10.1073/pnas.1321569111; Hamilton HM, 2004, MOL REPROD DEV, V69, P117, DOI 10.1002/mrd.20160; Huang X, 2017, CELL REPROGRAM, V19, P344, DOI 10.1089/cell.2017.0021; Hyttel P, 2001, REPRODUCTION, V122, P21, DOI 10.1530/rep.0.1220021; Jian-Jun L., 2010, J CELL PHYSL, V207, P287; KING WA, 1988, J REPROD FERTIL, V82, P87, DOI 10.1530/jrf.0.0820087; Kyogoku H, 2014, DEVELOPMENT, V141, P2255, DOI 10.1242/dev.106948; Lagutina I, 2013, CELL REPROGRAM, V15, P374, DOI 10.1089/cell.2013.0036; Lagutina I, 2011, REPRODUCTION, V141, P453, DOI 10.1530/REP-10-0266; Laurincik J, 2000, BIOL REPROD, V62, P1024, DOI 10.1095/biolreprod62.4.1024; Liao C, 2020, FASEB J, V34, P8283, DOI 10.1096/fj.202000025RR; Loi P, 2011, THERIOGENOLOGY, V76, P217, DOI 10.1016/j.theriogenology.2011.01.016; Matoba S, 2018, CELL STEM CELL, V23, P471, DOI 10.1016/j.stem.2018.06.018; Min B, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00042; Ogushi S, 2008, SCIENCE, V319, P613, DOI 10.1126/science.1151276; Percharde M, 2018, CELL, V174, P391, DOI 10.1016/j.cell.2018.05.043; Popken J, 2014, NUCLEUS-PHILA, V5, P555, DOI 10.4161/19491034.2014.979712; Song BS, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-44; Sun Z, 2022, PROTEIN CELL, V13, P490, DOI 10.1007/s13238-021-00864-5; Vassena R, 2011, DEVELOPMENT, V138, P3699, DOI 10.1242/dev.064741; WACHTLER F, 1993, MICRON, V24, P473, DOI 10.1016/0968-4328(93)90026-W; Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022197; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xie D, 2010, GENOME RES, V20, P804, DOI 10.1101/gr.100594.109; Yang L, 2018, EMBO REP, V19, DOI 10.15252/embr.201846240; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Zuo YC, 2017, ONCOTARGET, V8, P65847, DOI 10.18632/oncotarget.19504; Zuo YC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1113	41	3	3	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21993	10.1096/fj.202100737RR	http://dx.doi.org/10.1096/fj.202100737RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34670005				2022-12-28	WOS:000712009200038
J	Haq, S; Grondin, JA; Khan, WI				Haq, Sabah; Grondin, Jensine A.; Khan, Waliul, I			Tryptophan-derived serotonin-kynurenine balance in immune activation and intestinal inflammation	FASEB JOURNAL			English	Review						immune cells; intestinal inflammation; kynurenine; microbiota; serotonin	IRRITABLE-BOWEL-SYNDROME; ENTEROCHROMAFFIN CELL HYPERPLASIA; ARYL-HYDROCARBON RECEPTOR; SULFONIC-ACID COLITIS; TUMOR-NECROSIS-FACTOR; CHAIN FATTY-ACIDS; INDOLEAMINE 2,3-DIOXYGENASE; T-CELL; INTERFERON-GAMMA; PERIPHERAL SEROTONIN	Endogenous tryptophan metabolism pathways lead to the production of serotonin (5-hydroxytryptamine; 5-HT), kynurenine, and several downstream metabolites which are involved in a multitude of immunological functions in both health and disease states. Ingested tryptophan is largely shunted to the kynurenine pathway (95%) while only minor portions (1%-2%) are sequestered for 5-HT production. Though often associated with the functioning of the central nervous system, significant production of 5-HT, kynurenine and their downstream metabolites takes place within the gut. Accumulating evidence suggests that these metabolites have essential roles in regulating immune cell function, intestinal inflammation, as well as in altering the production and suppression of inflammatory cytokines. In addition, both 5-HT and kynurenine have a considerable influence on gut microbiota suggesting that these metabolites impact host physiology both directly and indirectly via compositional changes. It is also now evident that complex interactions exist between the two pathways to maintain gut homeostasis. Alterations in 5-HT and kynurenine are implicated in the pathogenesis of many gastrointestinal dysfunctions, including inflammatory bowel disease. Thus, these pathways present numerous potential therapeutic targets, manipulation of which may aid those suffering from gastrointestinal disorders. This review aims to update both the role of 5-HT and kynurenine in immune regulation and intestinal inflammation, and analyze the current knowledge of the relationship and interactions between 5-HT and kynurenine pathways.	[Haq, Sabah; Grondin, Jensine A.; Khan, Waliul, I] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada; [Haq, Sabah; Grondin, Jensine A.; Khan, Waliul, I] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Khan, Waliul, I] Hamilton Hlth Sci, Lab Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Khan, WI (corresponding author), McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hlth Sci Ctr, Room 3N7,1280 Main St West, Hamilton, ON, Canada.	khanwal@mcmaster.ca	Haq, Sabah/GLU-4093-2022		Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) [PJT 156262]	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: PJT 156262	Agus A, 2018, CELL HOST MICROBE, V23, P716, DOI 10.1016/j.chom.2018.05.003; Ahern GP, 2011, CURR OPIN PHARMACOL, V11, P29, DOI 10.1016/j.coph.2011.02.004; Alvarado D., 2015, TARGETING BROADLY PA, P157; Amireault P, 2013, ACS CHEM NEUROSCI, V4, P64, DOI 10.1021/cn300154j; Andre C, 2008, J NEUROIMMUNOL, V200, P90, DOI 10.1016/j.jneuroim.2008.06.011; Andresen V, 2008, CLIN GASTROENTEROL H, V6, P545, DOI 10.1016/j.cgh.2007.12.015; AUNE TM, 1994, J IMMUNOL, V153, P489; Baganz NL, 2013, ACS CHEM NEUROSCI, V4, P48, DOI 10.1021/cn300186b; Banskota S, 2019, BIOCHIMIE, V161, P56, DOI 10.1016/j.biochi.2018.06.008; Banskota S, 2017, FREE RADICAL BIO MED, V106, P196, DOI 10.1016/j.freeradbiomed.2017.02.034; Banskota S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148133; Barbaro MR, 2016, AM J PHYSIOL-GASTR L, V310, pG439, DOI 10.1152/ajpgi.00368.2015; Belladonna ML, 2007, TRANSPLANTATION, V84, pS17, DOI 10.1097/01.tp.0000269199.16209.22; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Bertrand PP, 2010, AUTON NEUROSCI-BASIC, V153, P47, DOI 10.1016/j.autneu.2009.08.002; Betten A, 2001, J LEUKOCYTE BIOL, V70, P65; Bischoff SC, 2009, AM J PHYSIOL-GASTR L, V296, pG685, DOI 10.1152/ajpgi.90685.2008; Bishnupuri KS, 2019, CANCER RES, V79, P1138, DOI 10.1158/0008-5472.CAN-18-0668; BISHOP AE, 1987, VIRCHOWS ARCH A, V410, P391, DOI 10.1007/BF00712758; BOADLEBIBER MC, 1993, PROG BIOPHYS MOL BIO, V60, P1, DOI 10.1016/0079-6107(93)90009-9; Bogunovic M, 2007, AM J PHYSIOL-GASTR L, V292, pG1770, DOI 10.1152/ajpgi.00249.2006; Braidy N, 2019, ANTIOXID REDOX SIGN, V30, P251, DOI 10.1089/ars.2017.7269; Brown PM, 2011, GASTROENTEROLOGY, V141, P507, DOI 10.1053/j.gastro.2011.05.005; Bubenik GA, 1997, BIOL SIGNAL, V6, P40; Camilleri M, 2011, NEUROGASTROENT MOTIL, V23, P193, DOI 10.1111/j.1365-2982.2010.01643.x; Campbell BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00012; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Capellino S, 2020, CELL MOL IMMUNOL, V17, P705, DOI 10.1038/s41423-020-0477-9; Carrillo-Vico A, 2005, ENDOCRINE, V27, P189, DOI 10.1385/ENDO:27:2:189; Cervenka I, 2017, SCIENCE, V357, DOI 10.1126/science.aaf9794; Charbonnier LM, 2019, NAT IMMUNOL, V20, P1208, DOI 10.1038/s41590-019-0442-x; Chen CQ, 2011, WORLD J GASTROENTERO, V17, P3888, DOI 10.3748/wjg.v17.i34.3888; Chen Y, 2015, ACTA PHYSIOL, V213, P860, DOI 10.1111/apha.12470; Chen ZJ, 2021, IMMUNITY, V54, P151, DOI 10.1016/j.immuni.2020.10.014; Ciorba MA, 2013, CURR OPIN GASTROEN, V29, P146, DOI 10.1097/MOG.0b013e32835c9cb3; Ciorba MA, 2010, J IMMUNOL, V184, P3907, DOI 10.4049/jimmunol.0900291; Coates MD, 2004, GASTROENTEROLOGY, V126, P1657, DOI 10.1053/j.gastro.2004.03.013; Coleman NS, 2006, CLIN GASTROENTEROL H, V4, P874, DOI 10.1016/j.cgh.2006.04.017; Davydova SM, 2010, B EXP BIOL MED+, V150, P219, DOI 10.1007/s10517-010-1109-7; de las Casas-Engel M, 2013, J IMMUNOL, V190, P2301, DOI 10.4049/jimmunol.1201133; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Dolecka J, 2011, PHARMACOL REP, V63, P548, DOI 10.1016/S1734-1140(11)70522-9; Dudzinska E, 2019, THER ADV GASTROENTER, V12, DOI 10.1177/1756284819881304; Duerschmied D, 2013, BLOOD, V121, P1008, DOI 10.1182/blood-2012-06-437392; El-Merahbi R, 2015, FEBS LETT, V589, P1728, DOI 10.1016/j.febslet.2015.05.054; El-Salhy M, 1997, J INTERN MED, V242, P413, DOI 10.1046/j.1365-2796.1997.00237.x; ERSPAMER V, 1952, NATURE, V169, P800, DOI 10.1038/169800b0; Hernandez ME, 2010, EUR NEUROPSYCHOPHARM, V20, P88, DOI 10.1016/j.euroneuro.2009.11.005; Evans BW, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003960.pub3; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Ferdinande L, 2008, INT J IMMUNOPATH PH, V21, P289, DOI 10.1177/039463200802100205; Ferdinande L, 2012, BRIT J CANCER, V106, P141, DOI 10.1038/bjc.2011.513; Fernandez-Banares F, 2007, AM J GASTROENTEROL, V102, P324, DOI 10.1111/j.1572-0241.2006.00902.x; Forrest CM, 2003, ADV EXP MED BIOL, V527, P395; Freire-Garabal M, 2003, BRIT J PHARMACOL, V139, P457, DOI 10.1038/sj.bjp.0705188; Frolkis AD, 2019, GUT, V68, P1606, DOI 10.1136/gutjnl-2018-317182; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Fukumoto S, 2003, AM J PHYSIOL-REG I, V284, pR1269, DOI 10.1152/ajpregu.00442.2002; Fung TC, 2019, NAT MICROBIOL, V4, P2064, DOI 10.1038/s41564-019-0540-4; Furuzawa-Carballeda J, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/278035; Gale JD, 1995, J PEDIATR GASTR NUTR, V21, pS22, DOI 10.1097/00005176-199501001-00008; Galligan JJ, 2003, NEUROGASTROENT MOTIL, V15, P523, DOI 10.1046/j.1365-2982.2003.00428.x; Gao J, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00013; Gargaro M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01973; Ge XL, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-016-1105-4; Gershon MD, 2004, ALIMENT PHARM THER, V20, P3, DOI 10.1111/j.1365-2036.2004.02180.x; Gershon MD, 1999, ALIMENT PHARM THER, V13, P15; GERSHON MD, 1966, J PHYSIOL-LONDON, V186, P451, DOI 10.1113/jphysiol.1966.sp008046; Gershon Michael D, 2012, Trans Am Clin Climatol Assoc, V123, P268; Ghia JE, 2009, GASTROENTEROLOGY, V137, P1649, DOI 10.1053/j.gastro.2009.08.041; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Gupta NK, 2012, INFLAMM BOWEL DIS, V18, P1214, DOI 10.1002/ibd.21849; Gurtner GJ, 2003, GASTROENTEROLOGY, V125, P1762, DOI 10.1053/j.gastro.2003.08.031; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; Han Q, 2001, BIOCHEM J, V360, P617, DOI 10.1042/0264-6021:3600617; Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020; Hansen JJ, 2009, INFLAMM BOWEL DIS, V15, P890, DOI 10.1002/ibd.20850; Hardeland R, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12525; Hardeland R, 2009, J PINEAL RES, V47, P109, DOI 10.1111/j.1600-079X.2009.00701.x; Harrington L, 2008, INFECT IMMUN, V76, P3045, DOI 10.1128/IAI.00193-08; HELLSTRAND K, 1993, J INTERFERON RES, V13, P33, DOI 10.1089/jir.1993.13.33; HELLSTRAND K, 1993, SCAND J IMMUNOL, V37, P7, DOI 10.1111/j.1365-3083.1993.tb01658.x; Herr N, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00048; Hoffman JM, 2012, GASTROENTEROLOGY, V142, P844, DOI 10.1053/j.gastro.2011.12.041; Holmgaard RB, 2015, CELL REP, V13, P412, DOI 10.1016/j.celrep.2015.08.077; Hoshi M, 2010, J IMMUNOL, V185, P3305, DOI 10.4049/jimmunol.0901150; Huengsberg M, 1998, CLIN CHEM, V44, P858; Idzko M, 2004, J IMMUNOL, V172, P6011, DOI 10.4049/jimmunol.172.10.6011; IKEN K, 1995, CELL IMMUNOL, V163, P1, DOI 10.1006/cimm.1995.1092; Inoue M, 2011, INT IMMUNOPHARMACOL, V11, P67, DOI 10.1016/j.intimp.2010.10.007; Jorandli JW, 2021, AM J PHYSIOL-GASTR L, V319, pG761, DOI 10.1152/ajpgi.00244.2020; Kang BN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054840; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Kassianos AJ, 2012, EUR J IMMUNOL, V42, P1512, DOI 10.1002/eji.201142098; Kaszaki J, 2008, NEUROGASTROENT MOTIL, V20, P53, DOI 10.1111/j.1365-2982.2007.00989.x; Keating DJ, 2019, PHARMACOL RES, V140, P50, DOI 10.1016/j.phrs.2018.06.017; Kennedy PJ, 2017, NEUROPHARMACOLOGY, V112, P399, DOI 10.1016/j.neuropharm.2016.07.002; Keszthelyi D, 2009, NEUROGASTROENT MOTIL, V21, P1239, DOI 10.1111/j.1365-2982.2009.01370.x; Khan NA, 1999, J NEUROIMMUNOL, V99, P53, DOI 10.1016/S0165-5728(99)00101-0; Khan WI, 2006, AM J PHYSIOL-GASTR L, V291, pG803, DOI 10.1152/ajpgi.00069.2006; Khan WI, 2010, CLIN EXP IMMUNOL, V161, P19, DOI 10.1111/j.1365-2249.2010.04150.x; Kidd M, 2009, NEUROGASTROENT MOTIL, V21, P439, DOI 10.1111/j.1365-2982.2008.01210.x; Kim JJ, 2015, AM J PHYSIOL-GASTR L, V309, pG455, DOI 10.1152/ajpgi.00299.2014; Kim JJ, 2013, J IMMUNOL, V190, P4795, DOI 10.4049/jimmunol.1201887; Kong E, 2015, SCI REP-UK, V5, DOI 10.1038/srep09009; Kumar A, 2020, CELL HOST MICROBE, V28, P41, DOI 10.1016/j.chom.2020.05.004; Kushnir-Sukhov NM, 2006, J IMMUNOL, V177, P6422, DOI 10.4049/jimmunol.177.9.6422; Kwon YH, 2019, CELL MOL GASTROENTER, V7, P709, DOI 10.1016/j.jcmgh.2019.01.004; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Latorre E, 2013, CYTOKINE, V61, P778, DOI 10.1016/j.cyto.2013.01.012; Layunta E, 2018, J CELL PHYSIOL, V233, P4183, DOI 10.1002/jcp.26229; Lee GK, 2002, IMMUNOLOGY, V107, P452, DOI 10.1046/j.1365-2567.2002.01526.x; Lee K, 2016, FOOD FUNCT, V7, P3073, DOI 10.1039/c6fo00187d; Leon-Ponte M, 2007, BLOOD, V109, P3139, DOI 10.1182/blood-2006-10-052787; Lesch KP, 2012, PHILOS T R SOC B, V367, P2426, DOI 10.1098/rstb.2012.0039; Li N, 2011, AM J PATHOL, V178, P662, DOI 10.1016/j.ajpath.2010.10.028; Li PP, 2020, EUR J HISTOCHEM, V64, DOI 10.4081/ejh.2020.3132; Li XL, 2021, MOL NUTR FOOD RES, V65, DOI 10.1002/mnfr.202000461; Li Y, 2017, FEBS J, V284, P948, DOI 10.1111/febs.14026; Linden DR, 2003, AM J PHYSIOL-GASTR L, V285, pG207, DOI 10.1152/ajpgi.00488.2002; Liu M, 2005, AM J PHYSIOL-GASTR L, V289, pG1148, DOI 10.1152/ajpgi.00245.2005; Liu XD, 2010, BLOOD, V115, P3520, DOI 10.1182/blood-2009-09-246124; Liu XT, 2018, INT J CANCER, V143, P1516, DOI 10.1002/ijc.31417; Lund ML, 2018, MOL METAB, V11, P70, DOI 10.1016/j.molmet.2018.03.004; Luo P, 2020, J CELL MOL MED, V24, P34, DOI 10.1111/jcmm.14770; Macer BJD, 2017, INFLAMM BOWEL DIS, V23, P534, DOI 10.1097/MIB.0000000000001059; Manocha M, 2013, MUCOSAL IMMUNOL, V6, P146, DOI 10.1038/mi.2012.58; Manocha Marcus, 2012, Clin Transl Gastroenterol, V3, pe13, DOI 10.1038/ctg.2012.8; Manzella C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24213-5; Manzella CR, 2020, INFLAMM BOWEL DIS, V26, P1607, DOI 10.1093/ibd/izaa208; Margolis KG, 2017, J CHEM NEUROANAT, V83, P36, DOI 10.1016/j.jchemneu.2017.02.001; Margolis KG, 2014, GUT, V63, P928, DOI 10.1136/gutjnl-2013-304901; Marsilio I, 2021, NEUROGASTROENT MOTIL, V33, DOI 10.1111/nmo.14036; Masab M, 2017, CANCER CHEMOTH PHARM, V80, P1055, DOI 10.1007/s00280-017-3462-y; Matthes S, 2018, TRENDS PHARMACOL SCI, V39, P560, DOI 10.1016/j.tips.2018.03.004; Mawe GM, 2013, NAT REV GASTRO HEPAT, V10, P473, DOI 10.1038/nrgastro.2013.105; Mellor AL, 1999, IMMUNOL TODAY, V20, P469, DOI 10.1016/S0167-5699(99)01520-0; Metz R, 2012, ONCOIMMUNOLOGY, V1, P1460, DOI 10.4161/onci.21716; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Mikocka-Walus A, 2017, J CROHNS COLITIS, V11, P509, DOI 10.1093/ecco-jcc/jjw165; Miura H, 2008, STRESS, V11, P198, DOI 10.1080/10253890701754068; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Munoz-Bellido JL, 2000, INT J ANTIMICROB AG, V14, P177, DOI 10.1016/S0924-8579(99)00154-5; Myint AM, 2003, MED HYPOTHESES, V61, P519, DOI 10.1016/S0306-9877(03)00207-X; Myint AM, 2007, J AFFECT DISORDERS, V98, P143, DOI 10.1016/j.jad.2006.07.013; Nakamura K, 2008, AM J PATHOL, V172, P333, DOI 10.2353/ajpath.2008.070358; Ng QX, 2018, J INFLAMM RES, V11, P345, DOI 10.2147/JIR.S174982; Nikolaus S, 2017, GASTROENTEROLOGY, V153, P1504, DOI 10.1053/j.gastro.2017.08.028; O'Hara JR, 2006, CELL MICROBIOL, V8, P646, DOI 10.1111/j.1462-5822.2005.00657.x; Oleskin AV, 2017, PROBIOTICS ANTIMICRO, V9, P215, DOI 10.1007/s12602-017-9262-1; Oshima S, 1999, HISTOCHEM CELL BIOL, V112, P257, DOI 10.1007/s004180050445; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; Pflugler S, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0989-y; Pilarczyk-Zurek M, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0540-2; Platten M, 2019, NAT REV DRUG DISCOV, V18, P379, DOI 10.1038/s41573-019-0016-5; Prendergast GC, 2014, CANCER IMMUNOL IMMUN, V63, P721, DOI 10.1007/s00262-014-1549-4; Rahimi R, 2008, CLIN THER, V30, P884, DOI 10.1016/j.clinthera.2008.05.002; Reigstad CS, 2015, FASEB J, V29, P1395, DOI 10.1096/fj.14-259598; Serafeim A, 2003, BLOOD, V101, P3212, DOI 10.1182/blood-2002-07-2044; Serafeim A, 2002, BLOOD, V99, P2545, DOI 10.1182/blood.V99.7.2545; Shajib MS, 2015, ACTA PHYSIOL, V213, P561, DOI 10.1111/apha.12430; Shajib Md Sharif, 2019, J Can Assoc Gastroenterol, V2, P132, DOI 10.1093/jcag/gwy039; Shajib MS, 2017, ACS CHEM NEUROSCI, V8, P920, DOI 10.1021/acschemneuro.6b00414; Shajib MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072774; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Shon WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17305; SILVERMAN DHS, 1985, BIOCHEM BIOPH RES CO, V131, P1160, DOI 10.1016/0006-291X(85)90212-8; Singhal M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38489-8; Sjogren K, 2012, J BONE MINER RES, V27, P1357, DOI 10.1002/jbmr.1588; Sofia MA, 2018, INFLAMM BOWEL DIS, V24, P1471, DOI 10.1093/ibd/izy103; Spiller R, 2007, NEUROGASTROENT MOTIL, V19, P25, DOI 10.1111/j.1365-2982.2007.00965.x; Spohn SN, 2017, NAT REV GASTRO HEPAT, V14, P412, DOI 10.1038/nrgastro.2017.51; Spohn SN, 2016, GASTROENTEROLOGY, V151, P933, DOI 10.1053/j.gastro.2016.07.032; Stefulj J, 2001, NEUROIMMUNOMODULAT, V9, P103, DOI 10.1159/000049013; STERNBERG EM, 1987, J IMMUNOL, V138, P4360; Stone TW, 2013, TRENDS PHARMACOL SCI, V34, P136, DOI 10.1016/j.tips.2012.09.006; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Tack J, 2012, ALIMENT PHARM THER, V35, P745, DOI 10.1111/j.1365-2036.2012.05011.x; Takamatsu M, 2013, J IMMUNOL, V191, P3057, DOI 10.4049/jimmunol.1203306; TAMIR H, 1990, ANN NY ACAD SCI, V600, P53, DOI 10.1111/j.1749-6632.1990.tb16872.x; Tashita C, 2020, WORLD J GASTROENTERO, V26, P918, DOI 10.3748/wjg.v26.i9.918; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Thaker AI, 2013, GASTROENTEROLOGY, V145, P416, DOI 10.1053/j.gastro.2013.05.002; Torres MI, 2007, CLIN EXP IMMUNOL, V148, P419, DOI 10.1111/j.1365-2249.2007.03365.x; TYERS MB, 1992, ONCOLOGY, V49, P263; Walczak K, 2011, SCAND J GASTROENTERO, V46, P903, DOI 10.3109/00365521.2011.579159; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Wan MJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00186; Wang HQ, 2007, GUT, V56, P949, DOI 10.1136/gut.2006.103226; Wang HQ, 2019, J IMMUNOL, V202, P3041, DOI 10.4049/jimmunol.1801034; Wang QX, 2015, FRONT BIOSCI-LANDMRK, V20, P1116, DOI 10.2741/4363; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; Wichers MC, 2005, MOL PSYCHIATR, V10, P538, DOI 10.1038/sj.mp.4001600; Willemssen R, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006453, 10.1371/journal.pone.0004898]; Wirthgen E, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00313; Wolf AM, 2004, CLIN IMMUNOL, V113, P47, DOI 10.1016/j.clim.2004.05.004; Wu H, 2019, PHARMACOL RES, V140, P100, DOI 10.1016/j.phrs.2018.06.015; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xie N, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00311-7; YAMAZAKI F, 1985, BIOCHEM J, V230, P635, DOI 10.1042/bj2300635; Yang GB, 2004, J NEUROIMMUNOL, V146, P46, DOI 10.1016/j.jneuroim.2003.10.044; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Yeung AWS, 2012, J LEUKOCYTE BIOL, V91, P657, DOI 10.1189/jlb.1011532; Yin J, 2006, J NEUROIMMUNOL, V181, P68, DOI 10.1016/j.jneuroim.2006.08.004; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540; Zhu CB, 2006, NEUROPSYCHOPHARMACOL, V31, P2121, DOI 10.1038/sj.npp.1301029; Zimmer P, 2017, INT J SPORTS MED, V38, P857, DOI 10.1055/s-0043-113042	208	11	11	6	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21888	10.1096/fj.202100702R	http://dx.doi.org/10.1096/fj.202100702R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34473368	Green Published, hybrid			2022-12-28	WOS:000702238200014
J	He, SW; Zhang, Y; Chen, L; Luo, WJ; Li, XM; Chen, Y; Huang, SY; He, QM; Yang, XJ; Li, YQ; Liu, N; Zhao, Y; Ma, J				He, Shi-Wei; Zhang, Yuan; Chen, Lei; Luo, Wei-Jie; Li, Xiao-Min; Chen, Yang; Huang, Sheng-Yan; He, Qing-Mei; Yang, Xiao-Jing; Li, Ying-Qin; Liu, Na; Zhao, Yin; Ma, Jun			Gemcitabine synergizes with cisplatin to inhibit nasopharyngeal carcinoma cell proliferation and tumor growth	FASEB JOURNAL			English	Article						cell proliferation; cisplatin; gemcitabine; nasopharyngeal carcinoma; tumor growth	INTENSITY-MODULATED RADIOTHERAPY; DRUG-COMBINATION; CANCER-CELLS; CYCLE; PHOSPHORYLATION; RESISTANCE; MECHANISM; EVOLUTION; APOPTOSIS; ABCB1	In a recently published phase III clinical trial, gemcitabine (GEM) plus cisplatin (DDP) induction chemotherapy significantly improved recurrence-free survival and overall survival and became the standard of care among patients with locoregionally advanced NPC. However, the molecular mechanisms of GEM synergized with DPP in NPC cells remain elucidated. These findings prompt us to explore the effect of the combination between GEM and DDP in NPC cell lines through proliferative phenotype, immunofluorescence, flow cytometry, and western blotting assays. In vitro studies reveal that GEM or DPP treated alone induces cell cycle arrest, promotes cell apoptosis, forces DNA damage response, and GEM synergism with DDP significantly increases the above effects in NPC cells. In vivo studies indicate that GEM or DPP treated alone significantly inhibits the tumor growth and prolongs the survival time of mice injected with SUNE1 cells compared to the control group. Moreover, the mice treated with GEM combined with DDP have smaller tumors and survive longer than those in GEM or DPP treated alone group. In addition, P-gp may be the key molecule that regulates the synergistic effect of gemcitabine and cisplatin. GEM synergizes with DPP to inhibit NPC cell proliferation and tumor growth by inducing cell cycle arrest, cell apoptosis, and DNA damage response, which reveals the mechanisms of combined GEM and DDP induction chemotherapy in improving locoregionally advanced NPC.	[He, Shi-Wei; Zhang, Yuan; Chen, Lei; Luo, Wei-Jie; Li, Xiao-Min; Chen, Yang; Huang, Sheng-Yan; He, Qing-Mei; Yang, Xiao-Jing; Li, Ying-Qin; Liu, Na; Zhao, Yin; Ma, Jun] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangdong Key Lab Nasopharyngeal Carcinoma Diag &, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Zhao, Y; Ma, J (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangdong Key Lab Nasopharyngeal Carcinoma Diag &, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China.	zhaoyin@sysucc.org.cn; majun2@mail.sysu.edu.cn		Ma, Jun/0000-0002-1137-9349	National Natural Science Foundation of China (NSFC) [81930072]; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) [2017A030312003]; Innovation Team Development Plan of the Ministry of Education [IRT_17R110]; Overseas Expertise Introduction Project for Discipline Innovation	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)(National Natural Science Foundation of Guangdong Province); Innovation Team Development Plan of the Ministry of Education; Overseas Expertise Introduction Project for Discipline Innovation	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81930072; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation), Grant/Award Number: 2017A030312003; Innovation Team Development Plan of the Ministry of Education, Grant/Award Number: IRT_17R110; Overseas Expertise Introduction Project for Discipline Innovation, Grant/Award	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Al-Ejeh F, 2010, ONCOGENE, V29, P6085, DOI 10.1038/onc.2010.407; Alexa-Stratulat T, 2019, DRUG RESIST UPDATE, V46, DOI 10.1016/j.drup.2019.100643; Ashton JC, 2015, CANCER RES, V75, P2400, DOI 10.1158/0008-5472.CAN-14-3763; Besancon OG, 2012, CANCER LETT, V319, P23, DOI 10.1016/j.canlet.2011.12.016; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Binenbaum Y, 2015, DRUG RESIST UPDATE, V23, P55, DOI 10.1016/j.drup.2015.10.002; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen QY, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0330-z; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Dart Anna, 2019, Nat Rev Cancer, V19, P610, DOI 10.1038/s41568-019-0215-8; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Engeland K, 2018, CELL DEATH DIFFER, V25, P114, DOI 10.1038/cdd.2017.172; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Gao MZ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00366; Gentilin E, 2019, TRENDS MOL MED, V25, P1123, DOI 10.1016/j.molmed.2019.08.002; Iannelli F, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01670; Indran IR, 2011, BBA-BIOENERGETICS, V1807, P735, DOI 10.1016/j.bbabio.2011.03.010; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Koh SB, 2015, CANCER RES, V75, P3583, DOI 10.1158/0008-5472.CAN-14-3347; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Lee AWM, 2014, RADIOTHER ONCOL, V110, P377, DOI 10.1016/j.radonc.2014.02.003; Li WL, 2021, MOL CANCER THER, V20, P1173, DOI 10.1158/1535-7163.MCT-20-0705; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mao YP, 2009, INT J RADIAT ONCOL, V73, P1326, DOI 10.1016/j.ijrobp.2008.07.062; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; N'Guessan KF, 2020, MOL THER, V28, P1876, DOI 10.1016/j.ymthe.2020.05.013; Okada S, 2003, J BIOL CHEM, V278, P2015, DOI 10.1074/jbc.M208685200; Pauwels B, 2003, INT J RADIAT ONCOL, V57, P1075, DOI 10.1016/S0360-3016(03)01443-3; Sinha BK, 2021, CANCERS, V13, DOI 10.3390/cancers13071680; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Sun M, 2020, BIOMATERIALS, V257, DOI 10.1016/j.biomaterials.2020.120252; Syn NL, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0010-0; Tang X, 2008, MOL CELL BIOL, V28, P2559, DOI 10.1128/MCB.01711-07; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tompkins JD, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-10; Trendowski MR, 2019, CLIN CANCER RES, V25, P1147, DOI 10.1158/1078-0432.CCR-18-2244; van Moorsel CJA, 1999, BRIT J CANCER, V80, P981, DOI 10.1038/sj.bjc.6690452; Venkatasubbarao K, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-104; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Wu CP, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052592; Zacharioudakis E, 2017, ANGEW CHEM INT EDIT, V56, P6483, DOI 10.1002/anie.201701144; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; Zhang L, 2016, LANCET, V388, P1883, DOI 10.1016/S0140-6736(16)31388-5; Zhang Y, 2019, NEW ENGL J MED, V381, P1124, DOI 10.1056/NEJMoa1905287; Zhang Y, 2019, BIOMATERIALS, V189, P48, DOI 10.1016/j.biomaterials.2018.10.022; Zhao FG, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9122643; Zisowsky J, 2007, BIOCHEM PHARMACOL, V73, P298, DOI 10.1016/j.bcp.2006.10.003	52	2	2	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21885	10.1096/fj.202100076RR	http://dx.doi.org/10.1096/fj.202100076RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34478585				2022-12-28	WOS:000702238200015
J	Joshi, A; Upadhyay, KK; Vohra, A; Shirsath, K; Devkar, R				Joshi, Apeksha; Upadhyay, Kapil K.; Vohra, Aliasgar; Shirsath, Kavita; Devkar, Ranjitsinh			Melatonin induces Nrf2-HO-1 reprogramming and corrections in hepatic core clock oscillations in Non-alcoholic fatty liver disease	FASEB JOURNAL			English	Article						clock genes; melatonin; NAFLD; Nrf2-HO-1	CIRCADIAN-CLOCK; OXIDATIVE STRESS; METABOLISM; DIET; PHYSIOLOGY; MECHANISMS; NUTRITION; RHYTHMS; OBESITY; GENES	Melatonin pleiotropically regulates physiological events and has a putative regulatory role in the circadian clock desynchrony-mediated Non-alcoholic fatty liver disease (NAFLD). In this study, we investigated perturbations in the hepatic circadian clock gene, and Nrf2-HO-1 oscillations in conditions of high-fat high fructose (HFHF) diet and/or jet lag (JL)-mediated NAFLD. Melatonin treatment (100 mu M) to HepG2 cells led to an improvement in oscillatory pattern of clock genes (Clock, Bmal1, and Per) in oleic acid (OA)-induced circadian desynchrony, while Cry, Nrf2, and HO-1 remain oblivious of melatonin treatment that was also validated by circwave analysis. C57BL/6J mice subjected to HFHF and/or JL, and treated with melatonin showed an improvement in the profile of lipid regulatory genes (CPT-1, PPARa, and SREBP-1c), liver function (AST and ALT) and histomorphology of fatty liver. A detailed scrutiny revealed that hepatic mRNA and protein profiles of Bmal1 (at ZT6) and Clock (at ZT12) underwent corrective changes in oscillations, but moderate corrections were recorded in other components of clock genes (Per1, Per2, and Cry2). Melatonin induced changes in oscillations of anti-oxidant genes (Nrf2, HO-1, and Keap1) subtly contributed in the overall improvement in NAFLD recorded herein. Taken together, melatonin induced reprograming of hepatic core clock and Nrf2-HO-1 genes leads to an improvement in HFHF/JL-induced NAFLD.	[Joshi, Apeksha; Vohra, Aliasgar; Shirsath, Kavita; Devkar, Ranjitsinh] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Zool, Div Chronobiol & Metab Endocrinol, Vadodara 390002, Gujarat, India; [Upadhyay, Kapil K.] Univ Michigan, Dept Internal Med, Div Gastroenterol & Hepatol, Med Sch, Ann Arbor, MI USA	Maharaja Sayajirao University Baroda; University of Michigan System; University of Michigan	Devkar, R (corresponding author), Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Zool, Div Chronobiol & Metab Endocrinol, Vadodara 390002, Gujarat, India.	rv.devkar-zoo@msubaroda.ac.in	Upadhyay, Kapil/AAU-2192-2020; Vohra, Aliasgar/AAV-7935-2021	Upadhyay, Kapil/0000-0002-0000-5085; Devkar, Ranjitsinh/0000-0002-9863-7418; VOHRA, ALIASGAR/0000-0002-4845-084X	DST-SERB; SERB [EMR/2015/002001]	DST-SERB(Department of Science & Technology (India)Science Engineering Research Board (SERB), India); SERB(Department of Science & Technology (India)Science Engineering Research Board (SERB), India)	DST-SERB, Grant/Award Number: SERB EMR/2015/002001	Adamovich Y, 2014, CELL METAB, V19, P319, DOI 10.1016/j.cmet.2013.12.016; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Baxi DB, 2013, CLIMACTERIC, V16, P274, DOI 10.3109/13697137.2012.682108; Cipolla-Neto J, 2014, J PINEAL RES, V56, P371, DOI 10.1111/jpi.12137; Claustrat B, 2005, SLEEP MED REV, V9, P11, DOI 10.1016/j.smrv.2004.08.001; Cousin SP, 2001, ENDOCRINOLOGY, V142, P229, DOI 10.1210/en.142.1.229; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Das N, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12404; Early JO, 2018, P NATL ACAD SCI USA, V115, pE8460, DOI 10.1073/pnas.1800431115; Froy O, 2007, FRONT NEUROENDOCRIN, V28, P61, DOI 10.1016/j.yfrne.2007.03.001; Gonzalez A, 2011, J PINEAL RES, V50, P250, DOI 10.1111/j.1600-079X.2010.00834.x; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Hong F, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020489; Hsieh MC, 2010, INT J OBESITY, V34, P227, DOI 10.1038/ijo.2009.228; Iwamoto A, 2014, CHRONOBIOL INT, V31, P189, DOI 10.3109/07420528.2013.837478; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kettner NM, 2016, CANCER CELL, V30, P909, DOI 10.1016/j.ccell.2016.10.007; Khan S, 2018, INT J GENOMICS, V2018, DOI 10.1155/2018/8576890; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lee J, 2013, MOL CELL BIOL, V33, P2327, DOI 10.1128/MCB.01421-12; Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115922; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Mazzoccoli G, 2016, CHRONOBIOL INT, V33, P181, DOI 10.3109/07420528.2015.1132722; Mi Y, 2018, CELL BIOCHEM BIOPHYS, V76, P463, DOI 10.1007/s12013-018-0859-0; Mi YS, 2017, BBA-MOL BASIS DIS, V1863, P1575, DOI 10.1016/j.bbadis.2017.04.009; Pan M, 2006, J PINEAL RES, V41, P79, DOI 10.1111/j.1600-079X.2006.00346.x; Panda S, 2016, SCIENCE, V354, P1008, DOI 10.1126/science.aah4967; Parsons MJ, 2015, INT J OBESITY, V39, P842, DOI 10.1038/ijo.2014.201; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Pekovic-Vaughan V, 2014, GENE DEV, V28, P548, DOI 10.1101/gad.237081.113; Qi GY, 2018, BBA-MOL CELL BIOL L, V1863, P549, DOI 10.1016/j.bbalip.2018.02.009; Qi GY, 2017, FOOD CHEM TOXICOL, V110, P189, DOI 10.1016/j.fct.2017.10.031; Rowe C, 2013, HEPATOLOGY, V58, P799, DOI 10.1002/hep.26414; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sato K, 2020, J PINEAL RES, V68, DOI 10.1111/jpi.12639; Sun H, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0370-9; Sun H, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0081-7; Takaki A, 2013, INT J MOL SCI, V14, P20704, DOI 10.3390/ijms141020704; Tong X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130047; Upadhyay KK, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101314; Wang DX, 2015, J PINEAL RES, V59, P497, DOI 10.1111/jpi.12281; Wisniewski JR, 2016, J PROTEOMICS, V136, P234, DOI 10.1016/j.jprot.2016.01.016; Xu KY, 2011, CELL METAB, V13, P639, DOI 10.1016/j.cmet.2011.05.001; Xu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044237; Zhou B, 2014, HEPATOLOGY, V59, P2196, DOI 10.1002/hep.26992	45	10	10	4	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21803	10.1096/fj.202002556RRR	http://dx.doi.org/10.1096/fj.202002556RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34365685	Green Published			2022-12-28	WOS:000691122900009
J	Qu, Y; Xu, YH; Jiang, YC; Yu, DH; Jiang, X; Zhao, L				Qu, Yao; Xu, Yunhe; Jiang, Yuncheng; Yu, Dehai; Jiang, Xi; Zhao, Ling			Macrophage-derived extracellular vesicles regulates USP5-mediated HDAC2/NRF2 axis to ameliorate inflammatory pain	FASEB JOURNAL			English	Article						extracellular vesicles; HDAC2; inflammatory pain; microRNA-23a-3p; NRF2; USP5	MICROGLIA; MECHANISMS; MICRORNAS; PATHWAY; ROLES	Emerging research has highlighted the capacity of microRNA-23a-3p (miR-23a-3p) to alleviate inflammatory pain. However, the molecular mechanism by which miR-23a-3p attenuates inflammatory pain is yet to be fully understood. Hence, the current study aimed to elucidate the mechanism by which miR-23a-3p influences inflammatory pain. Bioinformatics was initially performed to predict the inflammatory pain related downstream targets of miR-23a-3p in macrophage-derived extracellular vesicles (EVs). An animal inflammatory pain model was established using Complete Freund's Adjuvant (CFA). The miR-23a-3p expression was downregulated in the microglia of CFA-induced mice, after which the inflammatory factors were determined by ELISA. FISH and immunofluorescence were performed to analyze the co-localization of miR-23a-3p and microglia. Interestingly, miR-23a-3p was transported to the microglia via M2 macrophage-EVs, which elevated the mechanical allodynia and the thermal hyperalgesia thresholds in mice model. The miR-23a-3p downstream target, USP5, was found to stabilize HDAC2 via deubiquitination to promote its expression while inhibiting the expression of NRF2. Taken together, the key findings of the current study demonstrate that macrophage-derived EVs containing miR-23a-3p regulates the HDAC2/NRF2 axis by decreasing USP5 expression to alleviate inflammatory pain, which may provide novel therapeutic targets for the treatment of inflammatory pain.	[Qu, Yao] First Hosp Jilin Univ, Dept Pain Management, Changchun, Peoples R China; [Xu, Yunhe] First Hosp Jilin Univ, Dept Stomatol, Changchun, Peoples R China; [Jiang, Yuncheng] Dehui Peoples Hosp, Dept Anesthesiol, Dehui, Peoples R China; [Yu, Dehai] First Hosp Jilin Univ, Lab Canc Precis Med, Changchun, Peoples R China; [Jiang, Xi] First Hosp Jilin Univ, Hlth Promot Ctr, 1 Xinmin Rd, Changchun 130021, Jilin, Peoples R China; [Zhao, Ling] First Hosp Jilin Univ, Dept Rheumatol, Changchun, Peoples R China	Jilin University; Jilin University; Jilin University; Jilin University; Jilin University	Jiang, X (corresponding author), First Hosp Jilin Univ, Hlth Promot Ctr, 1 Xinmin Rd, Changchun 130021, Jilin, Peoples R China.	zhaoling17@jlu.edu.cn						Ahmed SMU, 2017, BBA-MOL BASIS DIS, V1863, P585, DOI 10.1016/j.bbadis.2016.11.005; Akkina S, 2011, TRANSL RES, V157, P236, DOI 10.1016/j.trsl.2011.01.011; ALBRECHT ED, 1987, AM J OBSTET GYNECOL, V156, P1275, DOI 10.1016/0002-9378(87)90162-1; Anand KJS, 2007, PEDIATR RES, V62, P283, DOI 10.1203/PDR.0b013e3180986d2f; Barwari T, 2016, J AM COLL CARDIOL, V68, P2577, DOI 10.1016/j.jacc.2016.09.945; Binenbaum Y, 2018, CANCER RES, V78, P5287, DOI 10.1158/0008-5472.CAN-18-0124; Cai C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00723; Cianciulli A, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010137; Das A, 2015, AM J PATHOL, V185, P2596, DOI 10.1016/j.ajpath.2015.06.001; Dayal S, 2009, J BIOL CHEM, V284, P5030, DOI 10.1074/jbc.M805871200; Du YH, 2019, AGING-US, V11, P9778, DOI 10.18632/aging.102425; Essandoh K, 2016, SHOCK, V46, P122, DOI 10.1097/SHK.0000000000000604; Fang T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02583-0; Fang Y, 2020, FISH SHELLFISH IMMUN, V98, P34, DOI 10.1016/j.fsi.2019.12.076; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Gadotti VM, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0011-8; Garcia-Caballero A, 2014, NEURON, V83, P1144, DOI 10.1016/j.neuron.2014.07.036; Guan Zhonghui, 2016, F1000Res, V5; Hutvagner G, 2005, FEBS LETT, V579, P5850, DOI 10.1016/j.febslet.2005.08.071; Igolnikov I, 2018, HAND CLINIC, V158, P423, DOI 10.1016/B978-0-444-63954-7.00039-2; Kany S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236008; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Khalid S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00140; Kidd BL, 2001, BRIT J ANAESTH, V87, P3, DOI 10.1093/bja/87.1.3; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lee YC, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-012-0300-4; Li ZK, 2020, CELL CYCLE, V19, P24, DOI 10.1080/15384101.2019.1691763; Liang M, 2019, BMC ANESTHESIOL, V19, DOI 10.1186/s12871-019-0801-z; Lopez-Gonzalez MJ, 2017, PHARMACOL THERAPEUT, V180, P1, DOI 10.1016/j.pharmthera.2017.06.001; Lu Y, 2013, NEUROSCIENCE, V241, P22, DOI 10.1016/j.neuroscience.2013.03.003; Luo XB, 2020, MEDIAT INFLAMM, V2020, DOI 10.1155/2020/8295149; McDonald MK, 2014, PAIN, V155, P1527, DOI 10.1016/j.pain.2014.04.029; Mills CD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00212; Mosser CA, 2017, PROG NEUROBIOL, V149-150, P1, DOI 10.1016/j.pneurobio.2017.01.002; Nakajima S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084899; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Nguyen MA, 2018, ARTERIOSCL THROM VAS, V38, P49, DOI 10.1161/ATVBAHA.117.309795; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Pan ZQ, 2014, J NEUROSCI, V34, P9476, DOI 10.1523/JNEUROSCI.5346-13.2014; Paolicelli RC, 2019, NEUROSCIENCE, V405, P148, DOI 10.1016/j.neuroscience.2018.04.003; Peng SY, 2015, J NEUROSCI, V35, P1250, DOI 10.1523/JNEUROSCI.2444-14.2015; Redondo A, 2017, J PHARMACOL EXP THER, V363, P293, DOI 10.1124/jpet.117.244376; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Ronchetti S, 2017, BIOMED PHARMACOTHER, V96, P1445, DOI 10.1016/j.biopha.2017.12.001; Sabirzhanov B., 2020, INT J MOL SCI, V21, P3695; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; Samuel P, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600375; Sharma H, 2018, FASEB J, V32, P5174, DOI 10.1096/fj.201701558R; Shen WS, 2017, GENE THER, V24, P353, DOI 10.1038/gt.2017.28; Shi GD, 2013, GLIA, V61, P504, DOI 10.1002/glia.22451; Shi Y, 2020, MUCOSAL IMMUNOL, V13, P303, DOI 10.1038/s41385-019-0216-7; Song HH, 2015, INT J CLIN EXP PATHO, V8, P10707; Stein C, 2009, BRAIN RES REV, V60, P90, DOI 10.1016/j.brainresrev.2008.12.017; Stemkowski P, 2017, MOL PAIN, V13, DOI 10.1177/1744806917724698; Subhramanyam CS, 2019, SEMIN CELL DEV BIOL, V94, P112, DOI 10.1016/j.semcdb.2019.05.004; Sun XJ, 2018, CELL TISSUE RES, V374, P487, DOI 10.1007/s00441-018-2898-7; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Tian J, 2020, J MOL NEUROSCI, V70, P84, DOI 10.1007/s12031-019-01403-y; Xu L, 2016, MOL NEUROBIOL, V53, P6709, DOI 10.1007/s12035-015-9593-4; Xue F, 2016, BEHAV BRAIN RES, V309, P1, DOI 10.1016/j.bbr.2016.04.045; Yang T, 2020, EXP NEUROL, V325, DOI 10.1016/j.expneurol.2019.113142; Zhang SJ, 2018, INT J BIOL MACROMOL, V107, P2094, DOI 10.1016/j.ijbiomac.2017.10.080; Zhou YQ, 2020, ACTA PHARMACOL SIN, V41, P1041, DOI 10.1038/s41401-020-0394-6; Zhu LN, 2015, INT REV IMMUNOL, V34, P82, DOI 10.3109/08830185.2014.969421; Zhu MD, 2014, BRAIN RES BULL, V109, P54, DOI 10.1016/j.brainresbull.2014.10.002	66	4	4	3	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21332	10.1096/fj.202001185RR	http://dx.doi.org/10.1096/fj.202001185RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34423867				2022-12-28	WOS:000691122900028
J	Zhou, TT; Ni, TX; Li, Y; Zhang, Q; Yan, JH; Chen, ZJ				Zhou, Tingting; Ni, Tianxiang; Li, Yan; Zhang, Qian; Yan, Junhao; Chen, Zi-Jiang			circFAM120A participates in repeated implantation failure by regulating decidualization via the miR-29/ABHD5 axis	FASEB JOURNAL			English	Article						ABHD5; circFAM120A; decidualization; miR-29; RIF	CIRCULAR RNAS; IDENTIFICATION; ENDOMETRIUM; INFERTILITY; BIOMARKERS; EXPRESSION; MICRORNAS	Repeated implantation failure (RIF) is a major problem that limits the pregnancy rate associated with assisted reproductive technology. However, the pathogenesis of RIF is still unknown. Recently, the expression levels of circular RNAs (circRNAs) were profiled in the endometrial tissues of patients with RIF. However, the exact role of circRNAs in RIF remains unclear. In our study, we found that circFAM120A levels were significantly down-regulated in the endometrium at the window of implantation in RIF patients compared with non-RIF controls. The suppression of circFAM120A expression inhibited decidualization in human endometrial stromal cells (hESCs). Furthermore, RNA-seq analysis after circFAM120A knockdown revealed ABHD5 as a potential downstream target gene of circFAM120A. As expected, down-regulating ABHD5 in hESCs also inhibited decidualization. Using the starBase and TargetScan databases, we predicted that miR-29 may interact with ABHD5, based on nucleotide sequence matching. Luciferase reporter assay showed that miR-29 bound to the 3 ' UTR of ABHD5 at the predicted complementary sites. Moreover, miR-29 mimics efficiently reduced ABHD5 expression levels and suppressed the decidualization process, whereas a miR-29 inhibitor partly rescued ABHD5 mRNA expression level and decidualization reduced by the knockdown of circFAM120A. Therefore, circFAM120A modulated decidualization in RIF through the miR-29/ABHD5 axis.	[Zhou, Tingting; Ni, Tianxiang; Li, Yan; Zhang, Qian; Yan, Junhao; Chen, Zi-Jiang] Shandong Univ, Cheeloo Coll Med, Ctr Reprod Med, 157 Jingliu Rd, Jinan 250012, Peoples R China; [Zhou, Tingting; Ni, Tianxiang; Li, Yan; Zhang, Qian; Yan, Junhao; Chen, Zi-Jiang] Shandong Univ, Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Peoples R China	Shandong University; Shandong University	Yan, JH (corresponding author), Shandong Univ, Cheeloo Coll Med, Ctr Reprod Med, 157 Jingliu Rd, Jinan 250012, Peoples R China.	yyy306@126.com	Chen, Zi-Jiang/GOE-6119-2022	Li, Yan/0000-0003-1813-8115	National Key Research and Development Program of China [2018YFC1002804]; Taishan Scholars Program for Young Experts of Shandong Province [tsqn201812154]; Youth Program of National Natural Science Foundation of China [81901556]	National Key Research and Development Program of China; Taishan Scholars Program for Young Experts of Shandong Province; Youth Program of National Natural Science Foundation of China	This study was funded by the National Key Research and Development Program of China (2018YFC1002804), the Taishan Scholars Program for Young Experts of Shandong Province (tsqn201812154), and the Youth Program of National Natural Science Foundation of China (81901556)	Altmae S, 2014, HUM REPROD UPDATE, V20, P12, DOI 10.1093/humupd/dmt048; Anastasiadou E, 2018, NAT REV CANCER, V18, P5, DOI 10.1038/nrc.2017.99; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen WQ, 2019, J ENDOCRINOL, V243, P137, DOI 10.1530/JOE-19-0127; Cheng XH, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.08.79; Coughlan C, 2014, REPROD BIOMED ONLINE, V28, P14, DOI 10.1016/j.rbmo.2013.08.011; Dessolle L, 2009, HUM REPROD, V24, P3082, DOI 10.1093/humrep/dep303; Feng C, 2018, INT J BIOL SCI, V14, P1361, DOI 10.7150/ijbs.25081; Ge MX, 2019, CELL REP, V29, P2489, DOI 10.1016/j.celrep.2019.10.062; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Inhorn MC, 2015, HUM REPROD UPDATE, V21, P411, DOI 10.1093/humupd/dmv016; Kohlmeier A, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa070; Koler M, 2009, HUM REPROD, V24, P2541, DOI 10.1093/humrep/dep193; Kristensen LS, 2019, NAT REV GENET, V20, P675, DOI 10.1038/s41576-019-0158-7; Kuokkanen S, 2010, BIOL REPROD, V82, P791, DOI 10.1095/biolreprod.109.081059; Kwon JJ, 2019, MOL THER-ONCOLYTICS, V12, P173, DOI 10.1016/j.omto.2018.12.011; Li MY, 2020, J CELL MOL MED, V24, P10730, DOI 10.1111/jcmm.15696; Liu KS, 2019, AM J TRANSL RES, V11, P1; Liu L, 2017, CELL PHYSIOL BIOCHEM, V44, P303, DOI 10.1159/000484887; Liu SM, 2015, CHINESE MED J-PEKING, V128, P3173, DOI 10.4103/0366-6999.170258; Lu LS, 2017, ONCOTARGET, V8, P44096, DOI 10.18632/oncotarget.17307; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Oberer M, 2011, CURR OPIN LIPIDOL, V22, P149, DOI 10.1097/MOL.0b013e328346230e; Ombelet W, 2008, HUM REPROD UPDATE, V14, P605, DOI 10.1093/humupd/dmn042; Paul ABM, 2019, J ASSIST REPROD GEN, V36, P179, DOI 10.1007/s10815-018-1326-y; Rekker K, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120574; Revel A, 2011, HUM REPROD, V26, P2830, DOI 10.1093/humrep/der255; Ruiz-Alonso M, 2013, FERTIL STERIL, V100, P818, DOI 10.1016/j.fertnstert.2013.05.004; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Sanders MA, 2017, SCI REP-UK, V7, DOI 10.1038/srep42589; Shi C, 2017, CHINESE MED J-PEKING, V130, P566, DOI 10.4103/0366-6999.200550; Simon A, 2012, FERTIL STERIL, V97, P1039, DOI 10.1016/j.fertnstert.2012.03.010; Tamura I, 2020, J BIOL CHEM, V295, P4673, DOI 10.1074/jbc.RA120.012841; Teklenburg G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010258; Wang J, 2019, BIOINFORMATICS, V35, P5235, DOI 10.1093/bioinformatics/btz382; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Xu HH, 2019, GENE, V720, DOI 10.1016/j.gene.2019.144056; Zhang C, 2019, ARCH TOXICOL, V93, P3601, DOI 10.1007/s00204-019-02601-8; Zhang JY, 2019, EXP THER MED, V17, P3108, DOI 10.3892/etm.2019.7323; Zhang S, 2019, J CELL PHYSIOL, V234, P9862, DOI 10.1002/jcp.27675	40	2	2	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21872	10.1096/fj.202002298RR	http://dx.doi.org/10.1096/fj.202002298RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34449947				2022-12-28	WOS:000691122900065
J	Tebbe, L; Sakthivel, H; Makia, MS; Kakakhel, M; Conley, SM; Al-Ubaidi, MR; Naash, MI				Tebbe, Lars; Sakthivel, Haarthi; Makia, Mustafa S.; Kakakhel, Mashal; Conley, Shannon M.; Al-Ubaidi, Muayyad R.; Naash, Muna, I			Prph2 disease mutations lead to structural and functional defects in the RPE	FASEB JOURNAL			English	Article						AB_571111; AB_628459; AB_785511; AB_839504; AB_2285290; AB_2533073; AB_2535792; AB_2535794; AB_2536180; AB_2833006; AB_10003146; macular degeneration; phagocytosis; Prph2; RPE	RETINAL-PIGMENT EPITHELIUM; OUTER SEGMENT MEMBRANES; LIGHT-EVOKED RESPONSES; PERIPHERIN RDS GENE; CONE-ROD DYSTROPHY; MACULAR DYSTROPHY; R172W MUTATION; RETINITIS-PIGMENTOSA; PATTERN DYSTROPHY; POINT MUTATION	Prph2 is a photoreceptor-specific tetraspanin with an essential role in the structure and function of photoreceptor outer segments. PRPH2 mutations cause a multitude of retinal diseases characterized by the degeneration of photoreceptors as well as defects in neighboring tissues such as the RPE. While extensive research has analyzed photoreceptors, less attention has been paid to these secondary defects. Here, we use different Prph2 disease models to evaluate the damage of the RPE arising from photoreceptor defects. In Prph2 disease models, the RPE exhibits structural abnormalities and cell loss. Furthermore, RPE functional defects are observed, including impaired clearance of phagocytosed outer segment material and increased microglia activation. The severity of RPE damage is different between models, suggesting that the different abnormal outer segment structures caused by Prph2 disease mutations lead to varying degrees of RPE stress and thus influence the clinical phenotype observed in patients.	[Tebbe, Lars; Sakthivel, Haarthi; Makia, Mustafa S.; Kakakhel, Mashal; Al-Ubaidi, Muayyad R.; Naash, Muna, I] Univ Houston, Dept Biomed Engn, 3517 Cullen Blvd Room 2027, Houston, TX 77204 USA; [Conley, Shannon M.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA	University of Houston System; University of Houston; University of Oklahoma System; University of Oklahoma Health Sciences Center	Al-Ubaidi, MR; Naash, MI (corresponding author), Univ Houston, Dept Biomed Engn, 3517 Cullen Blvd Room 2027, Houston, TX 77204 USA.	mnaash@central.uh.edu; malubaid@central.uh.edu		kakakhel, mashal/0000-0001-9516-8161; Conley, Shannon/0000-0002-7550-3898	National Institutes of Health [EY10609, EY018656, P20 GM125528, R01--AG070915]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health (EY10609 & EY018656--MIN&MRA, P20 GM125528, R01--AG070915--SMC)	ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; Baeken MW, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102315; Bazzoni G, 2000, J BIOL CHEM, V275, P20520, DOI 10.1074/jbc.M905251199; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Boesze-Battaglia K, 1998, BIOCHEMISTRY-US, V37, P9477, DOI 10.1021/bi980173p; Boon CJF, 2008, PROG RETIN EYE RES, V27, P213, DOI 10.1016/j.preteyeres.2008.01.002; BOSCH E, 1993, J HISTOCHEM CYTOCHEM, V41, P253, DOI 10.1177/41.2.8419462; Bressler SB, 2009, OPHTHALMOLOGY, V116, pS1, DOI 10.1016/j.ophtha.2009.06.045; Chakraborty D, 2008, BIOCHEMISTRY-US, V47, P1144, DOI 10.1021/bi701807c; Chakraborty D, 2020, FASEB J, V34, P1211, DOI 10.1096/fj.201901888R; Chakraborty D, 2016, HUM MOL GENET, V25, P3500, DOI 10.1093/hmg/ddw193; Chakraborty D, 2009, HUM MOL GENET, V18, P797, DOI 10.1093/hmg/ddn406; Cheng T, 1997, J NEUROSCI, V17, P8118, DOI 10.1523/jneurosci.17-21-08118.1997; Cheng XT, 2018, AUTOPHAGY, V14, P1472, DOI 10.1080/15548627.2018.1482147; Conley S, 2007, INVEST OPHTH VIS SCI, V48, P5397, DOI 10.1167/iovs.07-0663; Conley SM, 2008, CURR OPIN MOL THER, V10, P456; Conley SM, 2017, HUM MOL GENET, V26, P509, DOI 10.1093/hmg/ddw408; Conley SM, 2014, HUM MOL GENET, V23, P3102, DOI 10.1093/hmg/ddu014; Cook NR, 2004, TRAFFIC, V5, P685, DOI 10.1111/j.1600-0854.2004.00212.x; Cunha-Vaz J, 2011, EUR J OPHTHALMOL, V21, pS3, DOI 10.5301/EJO.2010.6049; Dhingra A, 2018, ADV EXP MED BIOL, V1074, P609, DOI 10.1007/978-3-319-75402-4_74; Ding XQ, 2004, HUM MOL GENET, V13, P2075, DOI 10.1093/hmg/ddh211; Dornonville de la Cour M, 1993, Acta Ophthalmol Suppl, P1; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Esteve-Rudd J, 2018, P NATL ACAD SCI USA, V115, P5468, DOI 10.1073/pnas.1709211115; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Farjood F, 2017, MOL VIS, V23, P431; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Fossarello M, 1996, ARCH OPHTHALMOL-CHIC, V114, P448, DOI 10.1001/archopht.1996.01100130444016; Francis PJ, 2005, BRIT J OPHTHALMOL, V89, P1115, DOI 10.1136/bjo.2004.062695; Frost LS, 2015, MOL NEUROBIOL, V52, P1135, DOI 10.1007/s12035-014-8920-5; Futter CE, 2006, PIGM CELL RES, V19, P104, DOI 10.1111/j.1600-0749.2006.00303.x; Gocho K, 2016, OSLI RETINA, V47, P1115, DOI 10.3928/23258160-20161130-05; Goldberg AFX, 2001, J BIOL CHEM, V276, P42700, DOI 10.1074/jbc.M107511200; Goldberg AFX, 2000, METHOD ENZYMOL, V316, P671; Gourier HCY, 2015, J CLIN MED, V4, P874, DOI 10.3390/jcm4050874; Grace MS, 1996, BRAIN RES, V735, P93; Green W R, 1999, Mol Vis, V5, P27; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Guziewicz KE, 2017, PROG RETIN EYE RES, V58, P70, DOI 10.1016/j.preteyeres.2017.01.005; Han Z, 2012, INVEST OPHTH VIS SCI, V53, P361, DOI 10.1167/iovs.11-8635; HERMAN KG, 1982, INVEST OPHTH VIS SCI, V23, P291; HERMAN KG, 1982, INVEST OPHTH VIS SCI, V23, P277; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jones BW, 2016, EXP EYE RES, V150, P149, DOI 10.1016/j.exer.2016.03.018; Kauppinen A, 2016, CELL MOL LIFE SCI, V73, P1765, DOI 10.1007/s00018-016-2147-8; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Khani SC, 2003, INVEST OPHTH VIS SCI, V44, P3570, DOI 10.1167/iovs.02-1287; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Kim SY, 2014, INVEST OPHTH VIS SCI, V55, P6031, DOI 10.1167/iovs.14-15091; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Kuny S, 2015, INVEST OPHTH VIS SCI, V56, P7109, DOI 10.1167/iovs.15-17567; Lakkaraju A, 2020, PROG RETIN EYE RES, V78, DOI 10.1016/j.preteyeres.2020.100846; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Loewen CJR, 2000, J BIOL CHEM, V275, P5370, DOI 10.1074/jbc.275.8.5370; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X; Michaelides M, 2005, OPHTHALMOLOGY, V112, P1592, DOI 10.1016/j.ophtha.2005.04.004; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Moritz OL, 1996, INVEST OPHTH VIS SCI, V37, P352; Nakazawa M, 1995, RETINA-J RET VIT DIS, V15, P518, DOI 10.1097/00006982-199515060-00011; Nandrot EF, 2014, ADV EXP MED BIOL, V801, P77, DOI 10.1007/978-1-4614-3209-8_10; Naylor A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010211; NICHOLS BE, 1993, NAT GENET, V3, P202, DOI 10.1038/ng0393-202; OAKLEY B, 1978, J MEMBRANE BIOL, V44, P281, DOI 10.1007/BF01944225; OAKLEY B, 1976, J NEUROPHYSIOL, V39, P1117, DOI 10.1152/jn.1976.39.5.1117; OAKLEY B, 1977, J GEN PHYSIOL, V70, P405, DOI 10.1085/jgp.70.4.405; Piguet B, 1996, OPHTHALMIC GENET, V17, P175, DOI 10.3109/13816819609057891; Piippo N, 2014, BBA-MOL CELL RES, V1843, P3038, DOI 10.1016/j.bbamcr.2014.09.015; Poloschek CM, 2010, INVEST OPHTH VIS SCI, V51, P4253, DOI 10.1167/iovs.09-4655; REIG C, 1995, OPHTHALMIC GENET, V16, P39, DOI 10.3109/13816819509056911; Saadat KASM, 2014, FEBS OPEN BIO, V4, P1007, DOI 10.1016/j.fob.2014.11.003; Samuels IS, 2010, J NEUROPHYSIOL, V104, P391, DOI 10.1152/jn.00088.2010; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Song DL, 2016, EXP EYE RES, V151, P122, DOI 10.1016/j.exer.2016.08.008; Sparrrow JR, 2010, CURR MOL MED, V10, P802; STEINBERG RH, 1985, DOC OPHTHALMOL, V60, P327, DOI 10.1007/BF00158922; STEINBERG RH, 1970, NATURE, V227, P728, DOI 10.1038/227728a0; STEINBERG RH, 1973, EXP EYE RES, V16, P365, DOI 10.1016/0014-4835(73)90130-9; STEINBERG RH, 1983, VISION RES, V23, P1315, DOI 10.1016/0042-6989(83)90107-4; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Stricker HM, 2005, BIOCHEM J, V388, P605, DOI 10.1042/BJ20041960; Stuck MW, 2014, HUM MOL GENET, V23, P6260, DOI 10.1093/hmg/ddu345; Taubit T, 2018, PEERJ, V6, DOI 10.7717/peerj.5215; Telegina DV, 2017, SCI REP-UK, V7, DOI 10.1038/srep41533; TERMAN JS, 1993, BRAIN RES, V605, P256; WALD G, 1956, NATURE, V177, P174, DOI 10.1038/177174a0; Wavre-Shapton ST, 2014, J CELL SCI, V127, P3852, DOI 10.1242/jcs.154757; WELEBER RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1531, DOI 10.1001/archopht.1993.01090110097033; Wickham L, 2009, INVEST OPHTH VIS SCI, V50, P3553, DOI 10.1167/iovs.08-2715; Wimmers S, 2007, PROG RETIN EYE RES, V26, P263, DOI 10.1016/j.preteyeres.2006.12.002; WITKOVSKY P, 1975, J GEN PHYSIOL, V65, P119, DOI 10.1085/jgp.65.2.119; Wrigley JDJ, 2000, J BIOL CHEM, V275, P13191, DOI 10.1074/jbc.C900853199; WROBLEWSKI JJ, 1994, OPHTHALMOLOGY, V101, P12; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; YOUNG RW, 1977, J ULTRA MOL STRUCT R, V61, P172, DOI 10.1016/S0022-5320(77)80084-1; YOUNG RW, 1978, INVEST OPHTH VIS SCI, V17, P105; Zhang K, 2002, ARCH OPHTHALMOL-CHIC, V120, P485; Zhang Q, 2019, MOL VIS, V25, P70; Zhang Y, 2017, MOL VIS, V23, P228	102	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22284	10.1096/fj.202101562RR	http://dx.doi.org/10.1096/fj.202101562RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ9SK	35344225				2022-12-28	WOS:000773603000001
J	Eng, ME; Bloise, E; Matthews, SG				Eng, Margaret Elizabeth; Bloise, Enrrico; Matthews, Stephen G.			Fetal glucocorticoid exposure leads to sex-specific changes in drug-transporter function at the blood-brain barrier in juvenile guinea pigs	FASEB JOURNAL			English	Article						blood-brain barrier; breast cancer resistance protein (BCRP; Abcg2); drug transporters; fetal development; glucocorticoids (betamethasone); P-glycoprotein (P-gp; Abcb1)	ANTENATAL CORTICOSTEROIDS; MULTIDRUG-RESISTANCE; CORTISOL RESISTANCE; MULTIPLE COURSES; EXPRESSION; RECEPTOR; EFFLUX; BIRTH	Antenatal synthetic glucocorticoids (sGCs) are a life-saving treatment in managing pre-term birth. However, off-target effects of sGCs can impact blood-brain barrier (BBB) drug transporters essential for fetal brain protection, including P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (BCRP/Abcg2). We hypothesized that maternal antenatal sGC treatment modifies BBB function in juvenile offspring in a sex-dependent manner. Thus, the objective of this study was to determine the long-term impact of a single or multiple courses of betamethasone on P-gp/Abcb1 and BCRP/Abcg2 expression and function at the BBB. Pregnant guinea pigs (N = 42) received 3 courses (gestation days (GDs) 40, 50, and 60) or a single course (GD50) of betamethasone (1 mg/kg) or vehicle (saline). Cerebral microvessels and brain endothelial cells (BEC) were collected from the post-natal day (PND) 14 offspring to measure protein, gene expression, and function of the drug transporters P-gp/Abcb1 and BCRP/Abcg2. P-gp protein expression was decreased (p < .05) in microvessels from male offspring that had been exposed to multiple courses and a single course of sGC, in utero. Multiple courses of sGC resulted in a significant decrease in P-gp function in BECs from males (p < .05), but not females. There was a very strong trend for increased P-gp function in males compared to females (p = .055). Reduced P-gp expression and function at the BBB of young male offspring following multiple prenatal sGC exposures, is clinically relevant as many drugs administered postnatally are P-gp substrates. These novel sex differences in drug transporter function may underlie potential sexual dimorphism in drug sensitivity and toxicity in the newborn and juvenile brain.	[Eng, Margaret Elizabeth; Matthews, Stephen G.] Univ Toronto, Temerty Fac Med, Dept Physiol, Med Sci Bldg Room 3207,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada; [Bloise, Enrrico] Univ Fed Minas Gerais, Dept Morphol, Belo Horizonte, MG, Brazil; [Matthews, Stephen G.] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Matthews, Stephen G.] Univ Toronto, Temerty Fac Med, Dept Obstet & Gynecol, Toronto, ON, Canada; [Matthews, Stephen G.] Univ Toronto, Temerty Fac Med, Dept Med, Toronto, ON, Canada	University of Toronto; Universidade Federal de Minas Gerais; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	Matthews, SG (corresponding author), Univ Toronto, Temerty Fac Med, Dept Physiol, Med Sci Bldg Room 3207,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	stephen.matthews@utoronto.ca	Bloise, Enrrico/O-6710-2018	Bloise, Enrrico/0000-0003-0275-8686	Canadian Institutes of Health Research (CIHR) [FDN-148368]; Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST); Higher Education Personnel Improvement Coordination (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior [CAPES]) [001]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [10578/2020-5]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST); Higher Education Personnel Improvement Coordination (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior [CAPES]); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by a Foundation grant from Canadian Institutes of Health Research (CIHR; FDN-148368) to S.G.M. M.E.E. was supported in part by a Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST). E.B. is supported by the Higher Education Personnel Improvement Coordination (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior [CAPES]; finance code 001, CAPES-Print fellowship) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; 10578/2020-5)	Baello S, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12853; Baello S, 2016, GROWTH FACTORS, V34, P33, DOI 10.3109/08977194.2016.1162163; Bloise E, 2016, HUM REPROD UPDATE, V22, P164, DOI 10.1093/humupd/dmv049; Bloise E.., 2019, MULTIDRUG RESISTANCE, P228, DOI [10.1016/B978-0-12-813146-6.00020-5, DOI 10.1016/B978-0-12-813146-6.00020-5]; Brocklehurst P, 1999, BRIT J OBSTET GYNAEC, V106, P977, DOI 10.1111/j.1471-0528.1999.tb08440.x; Dagenais C, 2001, PHARMACEUT RES, V18, P957, DOI 10.1023/A:1010984110732; Daood M, 2008, NEUROPEDIATRICS, V39, P211, DOI 10.1055/s-0028-1103272; Dean F, 1999, BRAIN RES, V846, P253, DOI 10.1016/S0006-8993(99)02064-8; Dou L, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12040296; Eustaquio Do Imperio Guinever, 2021, Tissue Barriers, V9, P1860616, DOI 10.1080/21688370.2020.1860616; Fowden AL, 1998, P NUTR SOC, V57, P113, DOI 10.1079/PNS19980017; Fu D, 2012, INT J BIOCHEM CELL B, V44, P461, DOI 10.1016/j.biocel.2011.12.009; Goralski KB, 2006, DRUG METAB DISPOS, V34, P288, DOI 10.1124/dmd.105.007427; Gottschalk S, 2011, NEUROTOXICOLOGY, V32, P50, DOI 10.1016/j.neuro.2010.10.006; Hartz AMS, 2006, MOL PHARMACOL, V69, P462, DOI 10.1124/mol.105.017954; Iqbal M, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12360; Iqbal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043022; Iqbal M, 2012, ENDOCRINOLOGY, V153, P3295, DOI 10.1210/en.2012-1054; Iqbal M, 2011, ENDOCRINOLOGY, V152, P1067, DOI 10.1210/en.2010-1227; Jullienne A, 2014, J CEREBR BLOOD F MET, V34, P1637, DOI 10.1038/jcbfm.2014.124; Kaguelidou F, 2016, BRIT J CLIN PHARMACO, V82, P1058, DOI 10.1111/bcp.13034; Kanado Y, 2019, BIOCHEM BIOPH RES CO, V519, P613, DOI 10.1016/j.bbrc.2019.09.021; KEIGHTLEY MC, 1995, STEROIDS, V60, P87, DOI 10.1016/0039-128X(94)00014-4; Keightley MC, 1998, ENDOCRINOLOGY, V139, P2479, DOI 10.1210/en.139.5.2479; Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038; Lam FC, 2001, J NEUROCHEM, V76, P1121, DOI 10.1046/j.1471-4159.2001.00113.x; Liu WH, 2010, J BIOL CHEM, V285, P6101, DOI 10.1074/jbc.M109.050229; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1007/BF03206645; Mai Y, 2020, INT J PHARMACEUT, V587, DOI 10.1016/j.ijpharm.2020.119678; McGoldrick E, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub4; Mess A, 2007, PLACENTA, V28, P812, DOI 10.1016/j.placenta.2007.02.005; Moisiadis VG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11635-w; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P403, DOI 10.1038/nrendo.2014.74; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P391, DOI 10.1038/nrendo.2014.73; Morrison JL, 2018, J PHYSIOL-LONDON, V596, P5535, DOI 10.1113/JP274948; Murphy KE, 2008, LANCET, V372, P2143, DOI 10.1016/S0140-6736(08)61929-7; Nierwinska K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211818; Obermeier B, 2016, HAND CLINIC, V133, P39, DOI 10.1016/B978-0-444-63432-0.00003-7; Owen D, 2003, ENDOCRINOLOGY, V144, P2775, DOI 10.1210/en.2002-0145; Pappas JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111135; Petropoulos S, 2011, BIOL REPROD, V84, P783, DOI 10.1095/biolreprod.110.088468; Petropoulos S, 2010, BRAIN RES, V1357, P9, DOI 10.1016/j.brainres.2010.08.016; Potschka H, 2002, NEUROSCI LETT, V327, P173, DOI 10.1016/S0304-3940(02)00423-8; RIGAUDIERE N, 1976, J REPROD FERTIL, V48, P291, DOI 10.1530/jrf.0.0480291; Sadowska GB, 2010, AM J PHYSIOL-HEART C, V298, pH179, DOI 10.1152/ajpheart.00828.2009; Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046; Schumacher U, 1997, HISTOCHEM CELL BIOL, V108, P179, DOI 10.1007/s004180050159; Scotto KW, 2003, ONCOGENE, V22, P7496, DOI 10.1038/sj.onc.1206950; Seelbach MJ, 2007, J NEUROCHEM, V102, P1677, DOI 10.1111/j.1471-4159.2007.04644.x; Skoll A, 2018, J OBSTET GYNAECOL CA, V40, P1219, DOI 10.1016/j.jogc.2018.04.018; Slosky LM, 2013, MOL PHARMACOL, V84, P774, DOI 10.1124/mol.113.086298; Soares MJ, 2018, BIOL REPROD, V99, P196, DOI 10.1093/biolre/ioy049; Soldin OP, 2009, CLIN PHARMACOKINET, V48, P143, DOI 10.2165/00003088-200948030-00001; Stonestreet BS, 2000, AM J PHYSIOL-REG I, V279, pR468, DOI 10.1152/ajpregu.2000.279.2.R468; Strazielle N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00021; van Assema DME, 2012, MOL IMAGING BIOL, V14, P771, DOI 10.1007/s11307-012-0556-0; Wang XQ, 2010, MOL PHARMACOL, V78, P376, DOI 10.1124/mol.110.063685; Yang XB, 2017, NEUROSCI LETT, V645, P60, DOI 10.1016/j.neulet.2017.02.044; Zucchi FCR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056967	60	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22245	10.1096/fj.202101552RR	http://dx.doi.org/10.1096/fj.202101552RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CE	35262963	Green Published			2022-12-28	WOS:000772944200001
J	Hoshino, Y; Okuno, T; Saigusa, D; Kano, K; Yamamoto, S; Shindou, H; Aoki, J; Uchida, K; Yokomizo, T; Ito, N				Hoshino, Yoko; Okuno, Toshiaki; Saigusa, Daisuke; Kano, Kuniyuki; Yamamoto, Shota; Shindou, Hideo; Aoki, Junken; Uchida, Kanji; Yokomizo, Takehiko; Ito, Nobuko			Lysophosphatidic acid receptor(1/3) antagonist inhibits the activation of satellite glial cells and reduces acute nociceptive responses	FASEB JOURNAL			English	Article						acute pain; lysophosphatidic acid; neuroglia; nociceptive pain; satellite glial cells	DORSAL-ROOT GANGLIA; TNF-ALPHA; LPA RECEPTORS; FORMALIN TEST; EDG-FAMILY; PAIN; AUTOTAXIN; INJURY; ROLES; EXCITABILITY	Lysophosphatidic acid (LPA) exerts various biological activities through six characterized G protein-coupled receptors (LPA(1-6)). While LPA-LPA(1) signaling contributes toward the demyelination and retraction of C-fiber and induces neuropathic pain, the effects of LPA-LPA(1) signaling on acute nociceptive pain is uncertain. This study investigated the role of LPA-LPA(1) signaling in acute nociceptive pain using the formalin test. The pharmacological inhibition of the LPA-LPA(1) axis significantly attenuated formalin-induced nociceptive behavior. The LPA(1) mRNA was expressed in satellite glial cells (SGCs) in dorsal root ganglion (DRG) and was particularly abundant in SGCs surrounding large DRG neurons, which express neurofilament 200. Treatment with LPA(1/3) receptor (LPA(1/3)) antagonist inhibited the upregulation of glial markers and inflammatory cytokines in DRG following formalin injection. The LPA(1/3) antagonist also attenuated phosphorylation of extracellular signal-regulated kinase, especially in SGCs and cyclic AMP response element-binding protein in the dorsal horn following formalin injection. LPA amounts after formalin injection to the footpad were quantified by liquid chromatography/tandem mass spectrometry, and LPA levels were found to be increased in the innervated DRGs. Our results indicate that LPA produced in the innervated DRGs promotes the activation of SGCs through LPA(1), increases the sensitivity of primary neurons, and modulates pain behavior. These results facilitate our understanding of the pathology of acute nociceptive pain and demonstrate the possibility of the LPA(1) on SGCs as a novel target for acute pain control.	[Hoshino, Yoko; Okuno, Toshiaki; Yokomizo, Takehiko] Juntendo Univ, Grad Sch Med, Dept Biochem, Tokyo, Japan; [Hoshino, Yoko; Uchida, Kanji; Ito, Nobuko] Univ Tokyo, Grad Sch Med, Dept Anesthesiol, Tokyo, Japan; [Saigusa, Daisuke] Teikyo Univ, Fac Pharma Sci, Lab Biomed & Analyt Sci, Tokyo, Japan; [Saigusa, Daisuke] Tohoku Univ, Tohoku Med Megabank Org, Dept Integrat Genom, Sendai, Miyagi, Japan; [Kano, Kuniyuki; Aoki, Junken] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Tokyo, Japan; [Yamamoto, Shota; Shindou, Hideo] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Tokyo, Japan; [Shindou, Hideo] Univ Tokyo, Grad Sch Med, Dept Lipid Med Sci, Tokyo, Japan	Juntendo University; University of Tokyo; Teikyo University; Tohoku University; University of Tokyo; National Center for Global Health & Medicine - Japan; University of Tokyo	Ito, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Anesthesiol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	nobuko.tky@gmail.com	; Yokomizo, Takehiko/P-5673-2016	Kano, Kuniyuki/0000-0002-4539-5750; Uchida, Kanji/0000-0001-9337-1916; Aoki, Junken/0000-0001-9435-1896; Yokomizo, Takehiko/0000-0002-5219-1553	MEXT | Japan Society for the Promotion of Science (JSPS) [20K09190, 19K07357, 18H02627]; Japan Agency for Medical Research and Development (AMED) [J200001087, 20km0105001]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 20K09190, 19K07357, 18H02627, 20K09190, 20K09190 and 20K09190; Japan Agency for Medical Research and Development (AMED), Grant/Award Number: J200001087, 20km0105001, J200001087, J200001087 and J200001087	Aikawa S, 2015, J BIOCHEM, V157, P81, DOI 10.1093/jb/mvu077; Valdes-Rives SA, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9173090; Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Asahara M, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0010-9; Bandoh K, 2000, FEBS LETT, V478, P159, DOI 10.1016/S0014-5793(00)01827-5; Salinas-Abarca AB, 2017, EUR J PHARMACOL, V797, P83, DOI 10.1016/j.ejphar.2017.01.018; Berta T, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-18; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Dubovy P, 2006, CELL MOL NEUROBIOL, V26, P1205, DOI 10.1007/s10571-006-9006-3; de San Roman EG, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00223; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Hanani M, 2020, NAT REV NEUROSCI, V21, P485, DOI 10.1038/s41583-020-0333-z; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; HUNSKAAR S, 1985, J NEUROSCI METH, V14, P69, DOI 10.1016/0165-0270(85)90116-5; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Iizuka Y, 2010, FASEB J, V24, P4678, DOI 10.1096/fj.10-165050; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Jancalek R, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-11; Ji RR, 1997, J NEUROSCI, V17, P1776; Jimenez-Andrade JM, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-10; Kato K, 2016, NAT STRUCT MOL BIOL, V23, P395, DOI 10.1038/nsmb.3200; Knowlden S, 2014, J IMMUNOL, V192, P851, DOI 10.4049/jimmunol.1302831; Koltzenburg M, 1999, TRENDS NEUROSCI, V22, P122, DOI 10.1016/S0166-2236(98)01302-2; Kritikou E, 2016, SCI REP-UK, V6, DOI 10.1038/srep37585; Kuwajima K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207310; Li CL, 2016, CELL RES, V26, P83, DOI 10.1038/cr.2015.149; Ma L, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-29; Ma PC, 2020, PAIN, V161, P1584, DOI 10.1097/j.pain.0000000000001855; Nascimento DSM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108152; Marsh B, 2012, MOL CELL NEUROSCI, V49, P375, DOI 10.1016/j.mcn.2012.01.002; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Miyabe C, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1973-0; Miyagi M, 2006, EUR SPINE J, V15, P953, DOI 10.1007/s00586-005-1031-2; Morita M, 2020, NEUROSCIENCE, V428, P217, DOI 10.1016/j.neuroscience.2019.12.029; Nieto-Posadas A, 2012, NAT CHEM BIOL, V8, P78, DOI 10.1038/nchembio.712; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Ohashi T, 2015, EXP DERMATOL, V24, P698, DOI 10.1111/exd.12752; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Okudaira S, 2010, BIOCHIMIE, V92, P698, DOI 10.1016/j.biochi.2010.04.015; Lemes JBP, 2018, NEUROSCI LETT, V676, P8, DOI 10.1016/j.neulet.2018.04.003; Ray M, 2020, J LIPID RES, V61, P1244, DOI 10.1194/jlr.D120000880; Rimola V, 2020, J NEUROSCI, V40, P9519, DOI 10.1523/JNEUROSCI.1223-20.2020; Robering JW, 2019, GLIA, V67, P999, DOI 10.1002/glia.23585; Sahbaie P, 2012, ANESTHESIOLOGY, V117, P602, DOI 10.1097/ALN.0b013e3182655f9f; Sanchez-Maran L, 2018, NEUROPHARMACOLOGY, V133, P189, DOI 10.1016/j.neuropharm.2018.01.033; Sleigh James N, 2016, BMC Res Notes, V9, P82, DOI 10.1186/s13104-016-1915-8; Szepanowski F, 2018, NEUROSCI LETT, V662, P136, DOI 10.1016/j.neulet.2017.10.023; Tabbai S, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00146; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Takeda M, 2007, PAIN, V129, P155, DOI 10.1016/j.pain.2006.10.007; Teo ST, 2009, IUBMB LIFE, V61, P791, DOI 10.1002/iub.220; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Uchida H, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-71; Uranbileg B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52999-5; Yano R, 2013, CELL MOL NEUROBIOL, V33, P1033, DOI 10.1007/s10571-013-9970-3; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zhou Z, 2011, CELL METAB, V13, P592, DOI 10.1016/j.cmet.2011.02.016	59	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22236	10.1096/fj.202101678R	http://dx.doi.org/10.1096/fj.202101678R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35218596				2022-12-28	WOS:000772957100012
J	Lamuedra, A; Gratal, P; Calatrava, L; Ruiz-Perez, VL; Palencia-Campos, A; Portal-Nunez, S; Mediero, A; Herrero-Beaumont, G; Largo, R				Lamuedra, Ana; Gratal, Paula; Calatrava, Lucia; Ruiz-Perez, Victor Luis; Palencia-Campos, Adrian; Portal-Nunez, Sergio; Mediero, Aranzazu; Herrero-Beaumont, Gabriel; Largo, Raquel			Blocking chondrocyte hypertrophy in conditional Evc knockout mice does not modify cartilage damage in osteoarthritis	FASEB JOURNAL			English	Article						cartilage; chondrocyte hypertrophy; Ellis-van Creveld; Hedgehog; osteoarthritis	INDIAN HEDGEHOG; PRIMARY CILIA; MURINE OSTEOARTHRITIS; PROTEIN MODIFICATION; ARTICULAR-CARTILAGE; EXPRESSION; PATHWAY; JOINT; CYCLOPAMINE; INHIBITION	Chondrocytes in osteoarthritic (OA) cartilage acquire a hypertrophic-like phenotype, where Hedgehog (Hh) signaling is pivotal. Hh overexpression causes OA-like cartilage lesions, whereas its downregulation prevents articular destruction in mouse models. Mutations in EVC and EVC2 genes disrupt Hh signaling, and are responsible for the Ellis-van Creveld syndrome skeletal dysplasia. Since Ellis-van Creveld syndrome protein (Evc) deletion is expected to hamper Hh target gene expression we hypothesized that it would also prevent OA progression avoiding chondrocyte hypertrophy. Our aim was to study Evc as a new therapeutic target in OA, and whether Evc deletion restrains chondrocyte hypertrophy and prevents joint damage in an Evc tamoxifen induced knockout (Evc(cKO)) model of OA. For this purpose, OA was induced by surgical knee destabilization in wild-type (WT) and Evc(cKO) adult mice, and healthy WT mice were used as controls (n = 10 knees/group). Hypertrophic markers and Hh genes were measured by qRT-PCR, and metalloproteinases (MMP) levels assessed by western blot. Human OA chondrocytes and cartilage samples were obtained from patients undergoing knee joint replacement surgery. Cyclopamine (CPA) was used for Hh pharmacological inhibition and IL-1 beta as an inflammatory insult. Our results showed that tamoxifen induced inactivation of Evc inhibited Hh overexpression and partially prevented chondrocyte hypertrophy during OA, although it did not ameliorate cartilage damage in DMM-Evc(cKO) mice. Hh pathway inhibition did not modify the expression of proinflammatory mediators induced by IL-1 beta in human OA chondrocytes in culture. We found that hypertrophic-IHH-and inflammatory-COX-2-markers co-localized in OA cartilage samples. We concluded that tamoxifen induced inactivation of Evc partially prevented chondrocyte hypertrophy in DMM-Evc(cKO) mice, but it did not ameliorate cartilage damage. Overall, our results suggest that chondrocyte hypertrophy per se is not a pathogenic event in the progression of OA.	[Lamuedra, Ana; Gratal, Paula; Mediero, Aranzazu; Herrero-Beaumont, Gabriel; Largo, Raquel] Autonomous Univ Madrid, IIS Fdn Jimenez Diaz, Serv Rheumatol, Bone & Joint Res Unit, Madrid, Spain; [Calatrava, Lucia; Ruiz-Perez, Victor Luis; Palencia-Campos, Adrian] CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Calatrava, Lucia; Ruiz-Perez, Victor Luis] ISCIII, CIBER Enfermedades Raras CIBERER, Madrid, Spain; [Ruiz-Perez, Victor Luis] Hosp Univ La Paz IdiPaz UAM, Inst Genet Med & Mol INGEMM, Madrid, Spain; [Portal-Nunez, Sergio] Univ San Pablo CEU, Appl Mol Med Inst IMMA, Bone Physiopathol Lab, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Hospital Universitario La Paz; San Pablo CEU University	Herrero-Beaumont, G (corresponding author), IIS Fdn Jimenez Diaz UAM, Rheumatol Dept, Bone & Joint Res Unit, Reyes Catolicos 2, Madrid 28040, Spain.	GHerrero@fjd.es	Portal-Núñez, Sergio/L-7391-2014; Ruiz-Perez, Victor Luis/K-6066-2014; Largo, Raquel/B-2949-2009	Portal-Núñez, Sergio/0000-0003-0659-1545; Mediero, Aranzazu/0000-0002-5368-574X; Ruiz-Perez, Victor Luis/0000-0003-0635-3619; Largo, Raquel/0000-0001-6525-2944; Herrero-Beaumont, Gabriel/0000-0002-3241-991X	Instituto de Salud Carlos III [PI20/00349, PI16/00065, PI18/00261]; Fondo Europeo de Desarrollo Regional (FEDER); Spanish Ministry of Science and Innovatin (MICINN) [SAF-2013-43365-R, SAF2016-75434-R]; Fundacion Conchita Rabago	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Spanish Ministry of Science and Innovatin (MICINN); Fundacion Conchita Rabago	This work was financially supported by grants from the Instituto de Salud Carlos III [PI20/00349, PI16/00065, PI18/00261] and Fondo Europeo de Desarrollo Regional (FEDER); and by the Spanish Ministry of Science and Innovatin (MICINN) [SAF-2013-43365-R and SAF2016-75434-R] to VLR-P. AL and PG were funded by Fundacion Conchita Rabago. The authors thank Dr. David Santamaria for providing UBC--CreERT2 mice and Maria Gracia Gonzalez Bueno for helping to organize mouse crosses and technical work.	Abe Y, 2017, J DEV BIOL, V5, DOI 10.3390/jdb5040012; Andres-Bergos J, 2012, J BIOL CHEM, V287, P33615, DOI 10.1074/jbc.M112.354241; Anvarian Z, 2019, NAT REV NEPHROL, V15, P199, DOI 10.1038/s41581-019-0116-9; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Bruce SJ, 2010, J BIOL CHEM, V285, P27967, DOI 10.1074/jbc.M109.091785; Burleigh A, 2012, ARTHRITIS RHEUM-US, V64, P2278, DOI 10.1002/art.34420; Caparros-Martin JA, 2013, HUM MOL GENET, V22, P124, DOI 10.1093/hmg/dds409; Chang CF, 2012, OSTEOARTHR CARTILAGE, V20, P152, DOI 10.1016/j.joca.2011.11.009; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Cortes JE, 2019, CANCER TREAT REV, V76, P41, DOI 10.1016/j.ctrv.2019.04.005; Didiasova M, 2018, MOLECULES, V23, DOI 10.3390/molecules23051003; Dunaeva M, 2017, CELL MOL LIFE SCI, V74, P3481, DOI 10.1007/s00018-017-2534-9; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Giarretta I, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215270; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Gratal P, 2019, OSTEOARTHR CARTILAGE, V27, P1229, DOI 10.1016/j.joca.2019.04.013; Gratal P., 2021, AUTHOREA, DOI [10.22541/au.162949181.11616718/v1, DOI 10.22541/AU.162949181.11616718/V1]; Gutzmer R, 2019, TARGET ONCOL, V14, P253, DOI 10.1007/s11523-019-00648-2; Herrero-Beaumont G, 2019, BIOCHEM PHARMACOL, V165, P24, DOI 10.1016/j.bcp.2019.02.030; Kozhemyakina E, 2015, DEVELOPMENT, V142, P817, DOI 10.1242/dev.105536; Lacouture ME, 2016, ONCOLOGIST, V21, P1218, DOI 10.1634/theoncologist.2016-0186; Lamuedra A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67518-0; Larranaga-Vera A, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1473-z; Lee JJ, 2016, P NATL ACAD SCI USA, V113, pE7545, DOI 10.1073/pnas.1616447113; Li R, 2015, J PHARM PHARMACOL, V67, P963, DOI 10.1111/jphp.12379; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Liu QB, 2019, GENE, V712, DOI 10.1016/j.gene.2019.143959; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Lorenz J, 2014, METHODS MOL BIOL, V1194, P401, DOI 10.1007/978-1-4939-1215-5_23; Martel-Pelletier J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.72; McGlashan SR, 2008, DEV DYNAM, V237, P2013, DOI 10.1002/dvdy.21501; Mediero A, 2016, FASEB J, V30, P3835, DOI 10.1096/fj.201600615R; Muscatello LV, 2015, VET PATHOL, V52, P957, DOI 10.1177/0300985815588610; Pacheco M, 2012, BONE, V50, P28, DOI 10.1016/j.bone.2011.08.025; Peer E, 2019, CANCERS, V11, DOI 10.3390/cancers11040538; Peluso MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090534; Perez-Baos S, 2019, J INFLAMM-LOND, V16, DOI 10.1186/s12950-019-0206-2; Petrova R, 2014, DEVELOPMENT, V141, P3445, DOI 10.1242/dev.083691; Pietrobono S, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00556; POTOCKI L, 1995, AM J MED GENET, V59, P295, DOI 10.1002/ajmg.1320590306; Rimkus TK, 2016, CANCERS, V8, DOI 10.3390/cancers8020022; Ripmeester EGJ, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00018; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Ruhlen R, 2014, OSTEOARTHR CARTILAGE, V22, P1071, DOI 10.1016/j.joca.2014.05.011; Ruiz-Perez VL, 2007, DEVELOPMENT, V134, P2903, DOI 10.1242/dev.007542; Sasai N, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01103; Shen F, 2013, MOL PHARMACOL, V83, P691, DOI 10.1124/mol.112.082511; Singh P, 2019, ANN NY ACAD SCI, V1442, P17, DOI 10.1111/nyas.13930; Takada S, 2020, J ORTHOP RES, V38, P609, DOI 10.1002/jor.24494; Tao FH, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12765; Tardio L, 2014, OSTEOARTHR CARTILAGE, V22, P259, DOI 10.1016/j.joca.2013.12.001; Thompson CL, 2014, OSTEOARTHR CARTILAGE, V22, P490, DOI 10.1016/j.joca.2013.12.016; Thompson CL, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0891-z; Villalvilla A, 2016, MATURITAS, V85, P27, DOI 10.1016/j.maturitas.2015.12.001; Wang CQ, 2019, J DEV BIOL, V7, DOI 10.3390/jdb7030014; Wang Y, 2012, CANCER CELL, V21, P374, DOI 10.1016/j.ccr.2011.12.028; Wei F, 2012, OSTEOARTHR CARTILAGE, V20, P755, DOI 10.1016/j.joca.2012.03.010; Will AJ, 2017, NAT GENET, V49, P1539, DOI 10.1038/ng.3939; Xu T, 2017, J ORAL PATHOL MED, V46, P284, DOI 10.1111/jop.12497; Zarebska JM, 2017, OSTEOARTHR CARTILAGE, V25, P406, DOI 10.1016/j.joca.2016.10.008; Zhang CM, 2014, INT J MOL SCI, V15, P7250, DOI 10.3390/ijms15057250; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3; Zhou JM, 2014, CONNECT TISSUE RES, V55, P257, DOI 10.3109/03008207.2014.925885; Zhou JM, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4437; Zhou XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044121; Zhu LY, 2020, ACR OPEN RHEUMATOL, V2, P605, DOI 10.1002/acr2.11176	68	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22258	10.1096/fj.202101791RR	http://dx.doi.org/10.1096/fj.202101791RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CF	35334131	Green Published			2022-12-28	WOS:000772944300001
J	Wirianto, M; Wang, CY; Kim, E; Koike, N; Gomez-Gutierrez, R; Nohara, K; Escobedo, G; Choi, JM; Han, CR; Yagita, K; Jung, SY; Soto, C; Lee, HK; Morales, R; Yoo, SH; Chen, Z				Wirianto, Marvin; Wang, Chih-Yen; Kim, Eunju; Koike, Nobuya; Gomez-Gutierrez, Ruben; Nohara, Kazunari; Escobedo, Gabriel, Jr.; Choi, Jong Min; Han, Chorong; Yagita, Kazuhiro; Jung, Sung Yun; Soto, Claudio; Lee, Hyun Kyoung; Morales, Rodrigo; Yoo, Seung-Hee; Chen, Zheng			The clock modulator Nobiletin mitigates astrogliosis-associated neuroinflammation and disease hallmarks in an Alzheimer's disease model	FASEB JOURNAL			English	Article						Alzheimer's disease; A beta pathology; circadian clock; neuroinflammation; Nobiletin (NOB); ROR nuclear receptors	COGNITIVE IMPAIRMENT; CIRCADIAN-RHYTHMS; GENE-EXPRESSION; MOUSE MODEL; NLRP3 INFLAMMASOME; AMYLOID-BETA; A-BETA; SLEEP; DEMENTIA; DISTURBANCES	Alzheimer's disease (AD) is a devastating neurodegenerative disorder, and there is a pressing need to identify disease-modifying factors and devise interventional strategies. The circadian clock, our intrinsic biological timer, orchestrates various cellular and physiological processes including gene expression, sleep, and neuroinflammation; conversely, circadian dysfunctions are closely associated with and/or contribute to AD hallmarks. We previously reported that the natural compound Nobiletin (NOB) is a clock-enhancing modulator that promotes physiological health and healthy aging. In the current study, we treated the double transgenic AD model mice, APP/PS1, with NOB-containing diets. NOB significantly alleviated beta-amyloid burden in both the hippocampus and the cortex, and exhibited a trend to improve cognitive function in these mice. While several systemic parameters for circadian wheel-running activity, sleep, and metabolism were unchanged, NOB treatment showed a marked effect on the expression of clock and clock-controlled AD gene expression in the cortex. In accordance, cortical proteomic profiling demonstrated circadian time-dependent restoration of the protein landscape in APP/PS1 mice treated with NOB. More importantly, we found a potent efficacy of NOB to inhibit proinflammatory cytokine gene expression and inflammasome formation in the cortex, and immunostaining further revealed a specific effect to diminish astrogliosis, but not microgliosis, by NOB in APP/PS1 mice. Together, these results underscore beneficial effects of a clock modulator to mitigate pathological and cognitive hallmarks of AD, and suggest a possible mechanism via suppressing astrogliosis-associated neuroinflammation.	[Wirianto, Marvin; Kim, Eunju; Nohara, Kazunari; Han, Chorong; Yoo, Seung-Hee; Chen, Zheng] Univ Texas Hlth Sci Ctr Houston UTHlth, Dept Biochem & Mol Biol, Houston, TX 70030 USA; [Wang, Chih-Yen; Lee, Hyun Kyoung] Texas Childrens Hosp, Baylor Coll Med, Neurol Res Inst, Dept Pediat, Houston, TX USA; [Koike, Nobuya; Yagita, Kazuhiro] Kyoto Prefectural Univ Med, Grad Sch Med, Dept Physiol & Syst Biosci, Kyoto, Japan; [Gomez-Gutierrez, Ruben; Escobedo, Gabriel, Jr.; Soto, Claudio; Morales, Rodrigo] Univ Texas Hlth Sci Ctr UTHlth, Dept Neurol, Houston, TX USA; [Gomez-Gutierrez, Ruben] Univ Malaga, Fac Sci, Dept Cell Biol Genet & Physiol, Malaga, Spain; [Choi, Jong Min; Jung, Sung Yun] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX USA; [Morales, Rodrigo] Univ Bernardo OHiggins, Ctr Integrat Biol & Quim Aplicada CIBQA, Santiago, Chile	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Kyoto Prefectural University of Medicine; University of Texas System; University of Texas Health Science Center Houston; Universidad de Malaga; Baylor College of Medicine; Universidad  Bernardo O'Higgins	Chen, Z (corresponding author), Univ Texas Hlth Sci Ctr Houston UTHlth, Dept Biochem & Mol Biol, UT McGovern Med Sch, 6431 Fannin St,MSB 6-200, Houston, TX 70030 USA.	Zheng.chen.1@uth.tmc.edu	Morales, Rodrigo/K-7173-2015	Yagita, Kazuhiro/0000-0002-1889-7050; Jung, Sung Yun/0000-0003-1521-7977; Gomez-Gutierrez, Ruben/0000-0001-9134-4375	HHS \ NIH \ National Institute on Aging (NIA) [RF1AG061901]	HHS \ NIH \ National Institute on Aging (NIA)	HHS vertical bar NIH vertical bar National Institute on Aging (NIA), Grant/Award Number: RF1AG061901	Aguilar BJ, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0320-4; Ahsan S., 2017, CURR PROTOC BIOINFOR, V57, P11; Bass J, 2016, SCIENCE, V354, P994, DOI 10.1126/science.aah4965; Bedrosian TA, 2013, EXP NEUROL, V243, P67, DOI 10.1016/j.expneurol.2012.05.005; Burish MJ, 2021, CHRONOBIOL INT, V38, P839, DOI 10.1080/07420528.2021.1892127; Cermakian N, 2011, J BIOL RHYTHM, V26, P160, DOI 10.1177/0748730410395732; Cirmi S, 2016, MOLECULES, V21, DOI 10.3390/molecules21101312; Coogan AN, 2013, BIOL PSYCHIAT, V74, P333, DOI 10.1016/j.biopsych.2012.11.021; Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002; Duncan MJ, 2012, EXP NEUROL, V236, P249, DOI 10.1016/j.expneurol.2012.05.011; Duran-Aniotz C, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01155-0; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Escartin C, 2021, NAT NEUROSCI, V24, P312, DOI 10.1038/s41593-020-00783-4; Fonken LK, 2015, BRAIN BEHAV IMMUN, V45, P171, DOI 10.1016/j.bbi.2014.11.009; Fusilier AR, 2021, NEUROBIOL DIS, V158, DOI 10.1016/j.nbd.2021.105454; Griffin P, 2020, ELIFE, V9, DOI 10.7554/eLife.58765; Griffin P, 2019, P NATL ACAD SCI USA, V116, P5102, DOI 10.1073/pnas.1812405116; Han CR, 2021, CLOCKS SLEEP, V3, P351, DOI 10.3390/clockssleep3030022; He BK, 2016, CELL METAB, V23, P610, DOI 10.1016/j.cmet.2016.03.007; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Holth JK, 2019, SCIENCE, V363, P880, DOI 10.1126/science.aav2546; Homolak Jan, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6030052; Hsu ET, 2018, ACTA NEUROPATHOL, V136, P955, DOI 10.1007/s00401-018-1902-3; Huang H, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/2918796; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Jones CR, 2013, EXP NEUROL, V243, P28, DOI 10.1016/j.expneurol.2012.07.012; Jung SY, 2017, MOL CELL PROTEOMICS, V16, P581, DOI 10.1074/mcp.M116.061440; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kashon ML, 2004, J ALZHEIMERS DIS, V6, P595; Kim E, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11071004; Kress GJ, 2018, J EXP MED, V215, P1059, DOI 10.1084/jem.20172347; Lalonde R, 2004, NEUROSCI LETT, V369, P156, DOI 10.1016/j.neulet.2004.07.069; Lananna BV, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax3519; Lananna BV, 2018, CELL REP, V25, P1, DOI 10.1016/j.celrep.2018.09.015; Lee J, 2020, AGING CELL, V19, DOI 10.1111/acel.13078; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lim ASP, 2013, JAMA NEUROL, V70, P1544, DOI 10.1001/jamaneurol.2013.4215; Long JM, 2019, CELL, V179, P312, DOI 10.1016/j.cell.2019.09.001; Lonnemann N, 2020, P NATL ACAD SCI USA, V117, P32145, DOI 10.1073/pnas.2009680117; Lopez-Gonzalez I, 2015, J NEUROPATH EXP NEUR, V74, P319, DOI 10.1097/NEN.0000000000000176; Ma ZX, 2016, SCI REP-UK, V6, DOI 10.1038/srep36035; Manocha GD, 2016, J NEUROSCI, V36, P8471, DOI 10.1523/JNEUROSCI.4654-15.2016; Meda L, 2001, NEUROBIOL AGING, V22, P885, DOI 10.1016/S0197-4580(01)00307-4; Mileykovskaya E, 2020, BIOCHEMISTRY-MOSCOW+, V85, P1554, DOI 10.1134/S000629792012007X; Mogensen FLH, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22147491; Morales R, 2021, MOL PSYCHIATR, V26, P5690, DOI 10.1038/s41380-021-01150-w; Mulvihill EE, 2016, ANNU REV NUTR, V36, P275, DOI 10.1146/annurev-nutr-071715-050718; Mure LS, 2018, SCIENCE, V359, P1232, DOI 10.1126/science.aao0318; Musiek ES, 2016, SCIENCE, V354, P1004, DOI 10.1126/science.aah4968; Musiek ES, 2013, J CLIN INVEST, V123, P5389, DOI 10.1172/JCI70317; Nakajima A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143380; Nakajima A, 2015, BEHAV BRAIN RES, V289, P69, DOI 10.1016/j.bbr.2015.04.028; Ni JJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1562-9; Nohara K, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/5304768; Nohara K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174281; Nohara K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11926-y; Nohara K, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0020-7; Onyango IG, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9050524; Qi GY, 2019, J AGR FOOD CHEM, V67, P5122, DOI 10.1021/acs.jafc.9b00133; Roh JH, 2014, J EXP MED, V211, P2487, DOI 10.1084/jem.20141788; Saltzman AB, 2018, MOL CELL PROTEOMICS, V17, P2270, DOI 10.1074/mcp.TIR118.000850; Sarlus H, 2017, J CLIN INVEST, V127, P3240, DOI 10.1172/JCI90606; Scheiermann C, 2018, NAT REV IMMUNOL, V18, P423, DOI 10.1038/s41577-018-0008-4; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; Sheehan PW, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00703; Socodato R, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107796; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Tranah GJ, 2011, ANN NEUROL, V70, P722, DOI 10.1002/ana.22468; Van Zeller M, 2021, J ALZHEIMERS DIS, V83, P939, DOI 10.3233/JAD-210268; Vanderheyden WM, 2018, J NEUROSCI, V38, P2901, DOI 10.1523/JNEUROSCI.1135-17.2017; Videnovic A, 2014, NAT REV NEUROL, V10, P683, DOI 10.1038/nrneurol.2014.206; Volianskis A, 2010, NEUROBIOL AGING, V31, P1173, DOI 10.1016/j.neurobiolaging.2008.08.005; Walle T, 2007, SEMIN CANCER BIOL, V17, P354, DOI 10.1016/j.semcancer.2007.05.002; Weldemichael Dawit A, 2010, Int J Alzheimers Dis, V2010, DOI 10.4061/2010/716453; Wirianto M, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108140; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zhang R, 2012, J ALZHEIMERS DIS, V31, P801, DOI 10.3233/JAD-2012-120151; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	81	6	6	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22186	10.1096/fj.202101633R	http://dx.doi.org/10.1096/fj.202101633R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35120261	Green Published			2022-12-28	WOS:000761250800024
J	Luo, S; Wang, F; Chen, SY; Chen, AQ; Wang, ZM; Gao, XF; Kong, XQ; Zuo, GF; Zhou, WY; Gu, Y; Ge, Z; Zhang, JJ				Luo, Shuai; Wang, Feng; Chen, Siyu; Chen, Aiqun; Wang, Zhimei; Gao, Xiaofei; Kong, Xiangquan; Zuo, Guangfeng; Zhou, Wenying; Gu, Yue; Ge, Zhen; Zhang, Junjie			NRP2 promotes atherosclerosis by upregulating PARP1 expression and enhancing low shear stress-induced endothelial cell apoptosis	FASEB JOURNAL			English	Article						apoptosis; atherosclerosis; NRP2; PARP1; shear stress	NEUROPILIN-2; LYMPHANGIOGENESIS; MECHANISM; INFLAMMATION; HOMEOSTASIS; METASTASIS; RECEPTOR; GATA2; FLOW	Atherosclerosis-related cardiovascular diseases are leading causes of mortality worldwide, characterized by the development of endothelial cell dysfunction, increased oxidized low-density lipoprotein uptake by macrophages, and the ensuing formation of atherosclerotic plaque. Local blood flow patterns cause uneven atherosclerotic lesion distribution, and endothelial dysfunction caused by disturbed flow is an early step in the development of atherosclerosis. The present research aims to elucidate the mechanism underlying the regulation of Neuropilin 2 (NRP2) under low shear stress (LSS) in the atheroprone phenotype of endothelial cells. We observed that NRP2 expression was significantly upregulated in LSS-stimulated human umbilical vein endothelial cells (HUVECs) and in mouse aortic endothelial cells. Knockdown of NRP2 in HUVECs significantly ameliorated cell apoptosis induced by LSS. Conversely, overexpression of NRP2 had the opposite effect on HUVEC apoptosis. Animal experiments suggest that NRP2 knockdown markedly mitigated the development of atherosclerosis in Apoe(-/-) mice. Mechanistically, NRP2 knockdown and overexpression regulated PARP1 protein expression in the condition of LSS, which in turn affected the expression of apoptosis-related genes. Moreover, the upstream transcription factor GATA2 was found to regulate NRP2 expression in the progression of atherosclerosis. These findings suggest that NRP2 plays an essential proatherosclerotic role through the regulation of cell apoptosis, and the results reveal that NRP2 is a promising therapeutic target for the treatment of atherosclerotic disorders.	[Luo, Shuai; Wang, Feng; Chen, Siyu; Chen, Aiqun; Wang, Zhimei; Gao, Xiaofei; Kong, Xiangquan; Zuo, Guangfeng; Zhou, Wenying; Gu, Yue; Ge, Zhen; Zhang, Junjie] Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, 68 Changle Rd, Nanjing 210000, Peoples R China; [Gao, Xiaofei; Zhang, Junjie] Nanjing Heart Ctr, Dept Cardiol, Nanjing, Peoples R China	Nanjing Medical University	Zhang, JJ (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, 68 Changle Rd, Nanjing 210000, Peoples R China.	jameszli@163.com		Wang, Feng/0000-0003-2771-5543	National Natural Science Foundation of China (NSFC) [81970307]; Six Talent Peaks Project in Jiangsu Province (Six Talent Peaks Project in Jiangsu Province of China) [2019-WSN-156]; Social Development Project of Jiangsu Province [BE2019616]; Jiangsu Commission of Health [H2019077]; Jiangsu Provincial Special Program of Medical Science [BE2019615]; Nanjing Commission of Health [ZKX19027]; Nanjing Health Youth Talent Training project [QRX17017]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Six Talent Peaks Project in Jiangsu Province (Six Talent Peaks Project in Jiangsu Province of China); Social Development Project of Jiangsu Province; Jiangsu Commission of Health; Jiangsu Provincial Special Program of Medical Science; Nanjing Commission of Health; Nanjing Health Youth Talent Training project	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81970307; Six Talent Peaks Project in Jiangsu Province (Six Talent Peaks Project in Jiangsu Province of China), Grant/Award Number: 2019-WSN-156; Social Development Project of Jiangsu Province, Grant/Award Number: BE2019616; Jiangsu Commission of Health, Grant/Award Number: H2019077; Jiangsu Provincial Special Program of Medical Science, Grant/Award Number: BE2019615; Nanjing Commission of Health, Grant/Award Number: ZKX19027; Nanjing Health Youth Talent Training project, Grant/Award Number: QRX17017	Alghamdi AAA, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00395; Ayari H, 2013, J BIOSCIENCES, V38, P311, DOI 10.1007/s12038-013-9310-2; Byers LA, 2012, CANCER DISCOV, V2, P798, DOI 10.1158/2159-8290.CD-12-0112; Caligiuri G, 2019, CARDIOVASC RES, V115, P1425, DOI 10.1093/cvr/cvz132; Campolo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090213; Cao Y, 2013, CANCER RES, V73, P4579, DOI 10.1158/0008-5472.CAN-13-0529; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Coma S, 2013, ANGIOGENESIS, V16, P939, DOI 10.1007/s10456-013-9370-9; DAVIS JB, 1990, AM SURGEON, V56, P47; Favier B, 2006, BLOOD, V108, P1243, DOI 10.1182/blood-2005-11-4447; Grandclement C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020444; Gupte R, 2017, GENE DEV, V31, P101, DOI 10.1101/gad.291518.116; Hebbel RP, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016134; Hossain M, 2015, J IMMUNOL, V195, P2408, DOI 10.4049/jimmunol.1402225; Hu H, 2019, NUCLEIC ACIDS RES, V47, pD33, DOI 10.1093/nar/gky822; Ji T, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0359-4; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Lala PK, 2018, CANCER METAST REV, V37, P369, DOI 10.1007/s10555-018-9734-0; Libby P, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0116-x, 10.1038/s41572-019-0106-z]; Lugus JJ, 2007, DEVELOPMENT, V134, P393, DOI 10.1242/dev.02731; Montero J, 2013, CELL DEATH DIFFER, V20, P1465, DOI 10.1038/cdd.2013.52; Mucka P, 2016, AM J PATHOL, V186, P2803, DOI 10.1016/j.ajpath.2016.07.022; Nakayama H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11789; Neiger JD, 2005, LIFE SCI, V76, P1895, DOI 10.1016/j.lfs.2004.11.004; Ou JJ, 2015, CANCER LETT, V358, P200, DOI 10.1016/j.canlet.2014.12.046; Paone S, 2019, CELL MOL LIFE SCI, V76, P1093, DOI 10.1007/s00018-018-2983-9; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Pellet-Many C, 2015, CARDIOVASC RES, V108, P288, DOI 10.1093/cvr/cvv229; Prud'homme GJ, 2012, ONCOTARGET, V3, P921, DOI 10.18632/oncotarget.626; Rizzolio S, 2018, CANCER RES, V78, P1058, DOI 10.1158/0008-5472.CAN-17-2020; Roy S, 2018, CANCER RES, V78, P5600, DOI 10.1158/0008-5472.CAN-18-0562; Schnittler HJ, 1998, BASIC RES CARDIOL, V93, P30; Schulz A, 2020, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01461; Shimizu A, 2008, J BIOL CHEM, V283, P27230, DOI 10.1074/jbc.M804520200; Sun XL, 2016, P NATL ACAD SCI USA, V113, P769, DOI 10.1073/pnas.1524523113; Umesh A, 2006, J BIOL CHEM, V281, P34312, DOI 10.1074/jbc.M606765200; Venturini G, 2019, AM J PHYSIOL-CELL PH, V317, pC326, DOI 10.1152/ajpcell.00128.2018; Wang F, 2019, LIFE SCI, V224, P212, DOI 10.1016/j.lfs.2019.03.033; Wang JW, 2018, CANCER LETT, V418, P176, DOI 10.1016/j.canlet.2018.01.040; Xu SW, 2021, PHARMACOL REV, V73, P924, DOI 10.1124/pharmrev.120.000096; Xu SW, 2014, MED RES REV, V34, P644, DOI 10.1002/med.21300; Yamashiro Y, 2020, CLIN SCI, V134, P2399, DOI 10.1042/CS20190488; Yuan T, 2019, REDOX BIOL, V20, P247, DOI 10.1016/j.redox.2018.09.025; Zhong TT, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-3426	45	4	4	4	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22079	10.1096/fj.202101250RR	http://dx.doi.org/10.1096/fj.202101250RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35028975				2022-12-28	WOS:000747987800019
J	Ma, GJ; Chen, F; Liu, YX; Zheng, LX; Jiang, XH; Tian, HL; Wang, XX; Song, XY; Yu, Y; Wang, DF				Ma, Guojing; Chen, Feng; Liu, Yixuan; Zheng, Lixia; Jiang, Xuehan; Tian, Huanlian; Wang, Xiaoxun; Song, Xiaoyu; Yu, Yang; Wang, Difei			Nur77 ameliorates age-related renal tubulointerstitial fibrosis by suppressing the TGF-beta/Smads signaling pathway	FASEB JOURNAL			English	Article						aging; Nur77; renal fibrosis; Smad7; TGF-beta/Smads signaling pathway	SMAD7; BETA; EXPRESSION	Nerve growth factor-induced gene B (Nur77) has been shown to ameliorate several biological processes in chronic diseases, including inflammatory response, cellular proliferation, and metabolism. Chronic kidney disease (CKD) is characterized by tubulointerstitial fibrosis for which no targeted therapies are available as yet. In this study, we performed in vivo and in vitro experiments to demonstrate that Nur77 targets fibrosis signals and attenuates renal tubulointerstitial fibrosis during the aging process. We observed that the TGF-beta/Smads signal pathway was significantly suppressed by Nur77, suggesting that Nur77 controlled the activation of key steps in TGF-beta/Smads signaling. We further showed that Nur77 interacted with Smad7, the main repressor of nuclear translocation of Smad 2/3, and stabilized Smad7 protein homeostasis. Nur77 deficiency resulted in Smad7 degradation, aggravating Smad2/3 phosphorylation, and promoting transcription of its downstream target genes, ACTA2 and collagen I. Our findings demonstrate that Nur77 is a potential therapeutic target for age-related kidney diseases including CKD. Maintenance of Nur77 may be an effective strategy for blocking renal tubulointerstitial fibrosis and improving renal function in the elderly.	[Ma, Guojing; Chen, Feng; Liu, Yixuan; Wang, Difei] China Med Univ, Dept Gerontol & Geriatr, Shengjing Hosp, Shenyang 110001, Liaoning, Peoples R China; [Ma, Guojing; Zheng, Lixia; Jiang, Xuehan; Song, Xiaoyu; Yu, Yang] China Med Univ, Inst Translat Med, Key Lab Med Cell Biol, Shenyang, Peoples R China; [Zheng, Lixia; Jiang, Xuehan; Song, Xiaoyu; Yu, Yang] China Med Univ, Inst Hlth Sci, Shenyang 110122, Liaoning, Peoples R China; [Tian, Huanlian] China Med Univ, Sch Publ Hlth, Dept Hlth Stat, Shenyang, Peoples R China; [Wang, Xiaoxun] China Med Univ, Dept Med Oncol, Hosp 1, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University; China Medical University	Wang, DF (corresponding author), China Med Univ, Dept Gerontol & Geriatr, Shengjing Hosp, Shenyang 110001, Liaoning, Peoples R China.; Yu, Y (corresponding author), China Med Univ, Inst Hlth Sci, Shenyang 110122, Liaoning, Peoples R China.	youngf_0322@126.com; dfwang@cmu.edu.cn	Yu, Yang/GZG-4493-2022	Yu, Yang/0000-0002-2480-7306	Talent Project of Revitalizing Liaoning, People's Republic of China [XLYC1902013, XLYC1808036]; National Science Foundation of China [82000827]; Natural Science Foundation of Liaoning Province of China [2020-BS-087]	Talent Project of Revitalizing Liaoning, People's Republic of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province of China(Natural Science Foundation of Liaoning Province)	This work was supported by the Talent Project of Revitalizing Liaoning, People's Republic of China to D.F. Wang (grant number XLYC1902013, XLYC1808036), the National Science Foundation of China to Y. Yu (grant number 82000827), the Natural Science Foundation of Liaoning Province of China to Y. Yu (grant number 2020-BS-087)	Chen JH, 2021, J CELL PHYSIOL, V236, P495, DOI 10.1002/jcp.29877; Chen Y, 2015, DIABETES, V64, P2069, DOI 10.2337/db14-1206; Chen YT, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI143645; Chou YH, 2021, AGING DIS, V12, P515, DOI 10.14336/AD.2020.0703; Chung ACK, 2013, MOL THER, V21, P388, DOI 10.1038/mt.2012.251; Chung ACK, 2009, NEPHROL DIAL TRANSPL, V24, P1443, DOI 10.1093/ndt/gfn699; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Cortez-Toledo O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171268; Crean D, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.589770; DEMIGUEL MH, 1994, J AM SOC NEPHROL, V4, P1861; Dou F, 2020, BIOCHEM PHARMACOL, V180, DOI 10.1016/j.bcp.2020.114079; Elliot SJ, 2006, J AM SOC NEPHROL, V17, P3315, DOI 10.1681/ASN.2006070799; Haub J, 2019, J INVEST DERMATOL, V139, P2144, DOI 10.1016/j.jid.2019.04.006; Hiwatashi N, 2017, LARYNGOSCOPE, V127, pE317, DOI 10.1002/lary.26678; Huang CL, 2013, DIABETES, V62, P2923, DOI 10.2337/db13-0135; Jung YS, 2019, INT J OBESITY, V43, P952, DOI 10.1038/s41366-018-0276-x; Kalantar-Zadeh K, 2021, LANCET, V398, P786, DOI 10.1016/S0140-6736(21)00519-5; Kume S, 2007, J BIOL CHEM, V282, P151, DOI 10.1074/jbc.M605904200; Lan HY, 2008, FRONT BIOSCI-LANDMRK, V13, P4984, DOI 10.2741/3057; Lee SY, 2009, FREE RADICAL BIO MED, V47, P1591, DOI 10.1016/j.freeradbiomed.2009.09.004; Li XC, 2019, J MOL MED, V97, P1359, DOI 10.1007/s00109-019-01819-4; Li XM, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0085-0; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Luo CW, 2018, J AM SOC NEPHROL, V29, P1238, DOI 10.1681/ASN.2017050574; Luo FB, 2021, FEBS J, V288, P1243, DOI 10.1111/febs.15459; Medzikovic L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041600; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Miao JH, 2019, AGING CELL, V18, DOI 10.1111/acel.13004; Miyazawa K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022095; Nakao A, 2002, TRENDS MOL MED, V8, P361, DOI 10.1016/S1471-4914(02)02376-6; PALLER MS, 1984, J CLIN INVEST, V74, P1156, DOI 10.1172/JCI111524; Palumbo-Zerr K, 2015, NAT MED, V21, P150, DOI 10.1038/nm.3777; Quan Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020402; Schroth J, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.564461; ShamsEldeen AM, 2021, CLIN EXP PHARMACOL P, V48, P1402, DOI 10.1111/1440-1681.13546; Venu VKP, 2021, AM J PHYSIOL-GASTR L, V321, pG280, DOI 10.1152/ajpgi.00338.2019; Wang QW, 2021, PHARM BIOL, V59, P106, DOI 10.1080/13880209.2020.1867197; Xie Y, 2018, KIDNEY INT, V94, P567, DOI 10.1016/j.kint.2018.04.011; Yan JQ, 2020, AGING-US, V12, P8107, DOI 10.18632/aging.103128; Yan XH, 2016, J BIOL CHEM, V291, P382, DOI 10.1074/jbc.M115.694281; Yin HM, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.357; Zhang GL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29023-3; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	43	3	3	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22124	10.1096/fj.202101332R	http://dx.doi.org/10.1096/fj.202101332R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34972249				2022-12-28	WOS:000747987800031
J	Tempfer, H; Spitzer, G; Lehner, C; Wagner, A; Gehwolf, R; Fierlbeck, J; Weissenbacher, N; Jessen, M; Heindl, LM; Traweger, A				Tempfer, Herbert; Spitzer, Gabriel; Lehner, Christine; Wagner, Andrea; Gehwolf, Renate; Fierlbeck, Johann; Weissenbacher, Nadja; Jessen, Malik; Heindl, Ludwig M.; Traweger, Andreas			VEGF-D-mediated signaling in tendon cells is involved in degenerative processes	FASEB JOURNAL			English	Article						biomechanics; bioreactor; extracellular matrix degradation; fibrosis; tendon cells; VEGF signaling	ENDOTHELIAL GROWTH-FACTOR; CYCLIC TENSILE STRAIN; EXPRESSION; INTERLEUKIN-1-BETA; CANCER	Vascular endothelial growth factor (VEGF) signaling is crucial for a large variety of cellular processes, not only related to angiogenesis but also in nonvascular cell types. We have previously shown that controlling angiogenesis by reducing VEGF-A signaling positively affects tendon healing. We now hypothesize that VEGF signaling in non-endothelial cells may contribute to tendon pathologies. By immunohistochemistry we show that VEGFR1, VEGFR2, and VEGFR3 are expressed in murine and human tendon cells in vivo. In a rat Achilles tendon defect model we show that VEGFR1, VEGFR3, and VEGF-D expression are increased after injury. On cultured rat tendon cells we show that VEGF-D stimulates cell proliferation in a dose-dependent manner; the specific VEGFR3 inhibitor SAR131675 reduces cell proliferation and cell migration. Furthermore, activation of VEGFR2 and -3 in tendon-derived cells affects the expression of mRNAs encoding extracellular matrix and matrix remodeling proteins. Using explant model systems, we provide evidence, that VEGFR3 inhibition prevents biomechanical deterioration in rat tail tendon fascicles cultured without load and attenuates matrix damage if exposed to dynamic overload in a bioreactor system. Together, these results suggest a strong role of tendon cell VEGF signaling in mediation of degenerative processes. These findings give novel insight into tendon cell biology and may pave the way for novel treatment options for degenerative tendon diseases.	[Tempfer, Herbert; Spitzer, Gabriel; Lehner, Christine; Wagner, Andrea; Gehwolf, Renate; Weissenbacher, Nadja; Jessen, Malik; Traweger, Andreas] Paracelsus Med Univ, Inst Tendon & Bone Regenerat, Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria; [Tempfer, Herbert; Spitzer, Gabriel; Lehner, Christine; Wagner, Andrea; Gehwolf, Renate; Weissenbacher, Nadja; Jessen, Malik; Traweger, Andreas] Austrian Cluster Tissue Regenerat, Vienna, Austria; [Fierlbeck, Johann] PMU Innovat GmbH, Salzburg, Austria; [Heindl, Ludwig M.] Univ Cologne, Univ Hosp Cologne, Fac Med, Dept Ophthalmol, Cologne, Germany	Paracelsus Private Medical University; University of Cologne	Tempfer, H (corresponding author), Paracelsus Med Univ, Inst Tendon & Bone Regenerat, Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria.	Herbert.Tempfer@pmu.ac.at		Traweger, Andreas/0000-0002-0220-4766; Jessen, Malik/0000-0002-7845-2758	Austrian Agency for International Collaboration in Education and Research [3/18];  [SPA06/224]	Austrian Agency for International Collaboration in Education and Research; 	Lorenz Boehler Funds, Grant/Award Number: 3/18; Austrian Agency for International Collaboration in Education and Research, Grant/Award Number: SPA06/224	Adekanmbi I, 2013, MED ENG PHYS, V35, P205, DOI 10.1016/j.medengphy.2012.08.015; Amano H, 2019, BIOMED PHARMACOTHER, V117, DOI 10.1016/j.biopha.2019.109067; Arnoczky SP, 2004, J ORTHOPAED RES, V22, P328, DOI 10.1016/S0736-0266(03)00185-2; Blache U, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85331-1; Chung CC, 2020, LAB INVEST, V100, P285, DOI 10.1038/s41374-019-0341-7; Deng Y, 2015, ARTERIOSCL THROM VAS, V35, P421, DOI 10.1161/ATVBAHA.114.304881; Duffy A.M., 2000, MADAME CURIE BIOSCIE; Enomoto H, 2003, AM J PATHOL, V162, P171, DOI 10.1016/S0002-9440(10)63808-4; Gehwolf R, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050399; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Ji RC, 2012, CELL MOL LIFE SCI, V69, P897, DOI 10.1007/s00018-011-0848-6; Josza L., 1997, HUMAN TENDONS ANATOM; Korntner S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00700-z; Kunkel N, 2017, J TISSUE ENG REGEN M, V11, P2014, DOI 10.1002/term.2097; Lehner C, 2016, EUR CELLS MATER, V31, P296, DOI 10.22203/eCM.v031a19; Mac Gabhann F, 2010, WIRES SYST BIOL MED, V2, P694, DOI 10.1002/wsbm.92; Maeda E, 2007, BIOCHEM BIOPH RES CO, V362, P399, DOI 10.1016/j.bbrc.2007.08.029; Maruyama K, 1999, J MOL CELL CARDIOL, V31, P607, DOI 10.1006/jmcc.1998.0895; Morita W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55387-1; Nagao M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13417-w; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Petersen W, 2003, ARCH ORTHOP TRAUM SU, V123, P475, DOI 10.1007/s00402-003-0490-3; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Screen HRC, 2005, BIOCHEM BIOPH RES CO, V336, P424, DOI 10.1016/j.bbrc.2005.08.102; Shakibaei M, 2003, HISTOCHEM CELL BIOL, V120, P235, DOI 10.1007/s00418-003-0558-8; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Steinmann S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030844; Su JL, 2006, CANCER CELL, V9, P209, DOI 10.1016/j.ccr.2006.02.018; Tempfer H, 2018, CELL PHYSIOL BIOCHEM, V46, P1148, DOI 10.1159/000489057; Tempfer H, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00330; Wu Y, 2009, CURR MED CHEM, V16, P2890, DOI 10.2174/092986709788803169; Zhao TQ, 2016, MOL CELL BIOCHEM, V413, P127, DOI 10.1007/s11010-015-2646-1; Zhao TQ, 2014, AM J PHYSIOL-HEART C, V306, pH789, DOI 10.1152/ajpheart.00559.2013	33	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22126	10.1096/fj.202100773RRR	http://dx.doi.org/10.1096/fj.202100773RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35044682	hybrid			2022-12-28	WOS:000747987800029
J	Chen, FY; Li, Q; Chen, Y; Wei, YH; Liang, JJ; Song, YY; Shi, LN; Wang, J; Mao, LM; Zhang, B; Zhang, ZQ				Chen, Fengyan; Li, Qing; Chen, Ying; Wei, Yuanhuan; Liang, Jingjing; Song, Yanyan; Shi, Linna; Wang, Jue; Mao, Limei; Zhang, Bo; Zhang, Zheqing			Association of the gut microbiota and fecal short-chain fatty acids with skeletal muscle mass and strength in children	FASEB JOURNAL			English	Article						children; cross-sectional study; gut microbiota; handgrip strength; short-chain fatty acids; skeletal muscle mass	INSULIN-RESISTANCE; EXERCISE; HEALTH; GROWTH; FIBER; RISK	We aimed to investigate whether the gut microbiota and fecal short-chain fatty acids (SCFAs) are associated with skeletal muscle mass and strength in healthy Chinese children aged 6-9 years. In this study, 412 children were enrolled. 16S rRNA gene sequencing was used to characterize the gut microbiota compositions. Fecal SCFAs were quantified using high-performance liquid chromatography. Dual X-ray absorptiometry was used to measure the total body lean soft tissue mass (TSM), total body fat mass (TBF), appendicular skeletal muscle mass (ASM), and appendicular fat mass (AFM). TSM/height(2) (TSMI), ASM/height(2) (ASMI), TSM/weight (TSMR), ASM/weight (ASMR), and the ratio of TSM/TBF and ASM/AFM were calculated. Handgrip strength (HGS) was measured using the Jamar (R) Plus+ Hand Dynamometer. A multiple regression analysis after adjustment for covariates and multiple test correction showed some operational taxonomic units in partial least squares models identified by Multivariate methods with Unbiased Variable selection analysis such as genera of Faecalibacterium, Lachnospira, Lachnospiraceae_ND3007_group, and Lachnospiraceae_UCG-004 were positively correlated with at least one measure of TSM, TSMI, ASM, ASMI, and ASMI Z-score (beta: 0.103-0.143, p(FDR): .008-.032) but negatively correlated with at least one measure of TSMR, TSM/TBF, ASMR, ASM/AFM, and ASMR Z-score (beta: -0.185 to 0.124, p(FDR) = .008-.045). Children with higher fecal butyric acid, acetic acid, and total SCFA levels exhibited higher TSM, ASM, TSMI, ASMI, and ASMI Z-score and lower TSM/TBF, ASM/AFM, TSMR, ASMR, and ASMR Z-score. However, after additional adjustment for TBF or body mass index, only the associations for Faecalitalea and Pyramidobacter still existed. Mediation analysis suggested that total body fat significantly mediated 66.3%-95.3% of the estimated association of microbiota and SCFAs with TSM, ASM, and ASMI Z-score. Our results suggest that the associations of gut microbiota and SCFAs with skeletal muscle quality in children may largely depend upon on total body fat content.	[Chen, Fengyan; Chen, Ying; Wei, Yuanhuan; Wang, Jue; Mao, Limei; Zhang, Zheqing] Southern Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Peoples R China; [Li, Qing; Shi, Linna] Southern Med Univ, Nanfang Hosp, Dept Dietet, Guangzhou, Peoples R China; [Wei, Yuanhuan] Huazhong Univ Sci & Technol, Union Shenzhen Hosp, Dept Clin Nutr, Shenzhen, Peoples R China; [Liang, Jingjing; Song, Yanyan] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Dept Child Hlth Care, Guangzhou, Peoples R China; [Zhang, Bo] Southern Med Univ, Food Safety & Hlth Res Ctr, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Huazhong University of Science & Technology; Guangzhou Medical University; Southern Medical University - China	Zhang, ZQ (corresponding author), Southern Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Peoples R China.; Zhang, B (corresponding author), Southern Med Univ, Food Safety & Hlth Res Ctr, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China.	zhangbo2018@smu.edu.cn; zzqaa501@smu.edu.cn			National Natural Science Foundation of China [81973045, 81903347]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81973045 and 81903347	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Aleman FDD, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007727; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biagi E, 2012, AGE, V34, P247, DOI 10.1007/s11357-011-9217-5; Bjorkhaug ST, 2019, GUT MICROBES, V10, P663, DOI 10.1080/19490976.2019.1580097; Buckinx F, 2018, J CACHEXIA SARCOPENI, V9, P269, DOI 10.1002/jcsm.12268; Buigues C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060932; Byrne CS, 2015, INT J OBESITY, V39, P1331, DOI 10.1038/ijo.2015.84; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Cleasby ME, 2016, J ENDOCRINOL, V229, pR67, DOI 10.1530/JOE-15-0533; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Fabbri E, 2017, J CACHEXIA SARCOPENI, V8, P490, DOI 10.1002/jcsm.12183; Fairchild AJ, 2017, AM J CLIN NUTR, V105, P1259, DOI 10.3945/ajcn.117.152546; Fielding RA, 2019, EXP GERONTOL, V127, DOI 10.1016/j.exger.2019.110722; Hernandez MAG, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081943; Huang WC, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01906; Kang L, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84031-0; Kim H, 2016, GERIATR GERONTOL INT, V16, P110, DOI 10.1111/ggi.12723; Kim S, 2015, OBES RES CLIN PRACT, V9, P125, DOI 10.1016/j.orcp.2014.05.002; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Lahiri S, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aan5662; LeBrasseur NK, 2012, J BONE MINER RES, V27, P2159, DOI 10.1002/jbmr.1666; Lee CJ, 2020, ANN NY ACAD SCI, V1461, P37, DOI 10.1111/nyas.14107; Lees MJ, 2019, EUR J APPL PHYSIOL, V119, P1171, DOI 10.1007/s00421-019-04107-8; Li LL, 2021, OBES REV, V22, DOI 10.1111/obr.13341; Liang JJ, 2020, BIOL TRACE ELEM RES, V198, P430, DOI 10.1007/s12011-020-02105-y; Liu JH, 2021, ADV SCI, V8, DOI 10.1002/advs.202004831; Liu JT, 2019, J CACHEXIA SARCOPENI, V10, P155, DOI 10.1002/jcsm.12361; Lloyd-Price J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0307-y; Louis P, 2017, ENVIRON MICROBIOL, V19, P29, DOI 10.1111/1462-2920.13589; Lustgarten MS, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01435; Ma BJ, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00040; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Manickam R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082418; Mueller NT, 2020, AM J CLIN NUTR, V111, P545, DOI 10.1093/ajcn/nqz322; Nay K, 2019, AM J PHYSIOL-ENDOC M, V317, pE158, DOI 10.1152/ajpendo.00521.2018; Nobel YR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8486; Okamoto T, 2019, AM J PHYSIOL-ENDOC M, V316, pE956, DOI 10.1152/ajpendo.00510.2018; Ostler JE, 2014, AM J PHYSIOL-ENDOC M, V306, pE592, DOI 10.1152/ajpendo.00277.2013; Peterson MD, 2016, AM J PREV MED, V50, P593, DOI 10.1016/j.amepre.2015.09.019; Picca A, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/7026198; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Sayer AA, 2008, J NUTR HEALTH AGING, V12, P427, DOI 10.1007/BF02982703; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Ticinesi A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071633; Tingley D, 2014, J STAT SOFTW, V59; Tomlinson DJ, 2016, BIOGERONTOLOGY, V17, P467, DOI 10.1007/s10522-015-9626-4; Torii T, 2010, ANN CLIN BIOCHEM, V47, P447, DOI 10.1258/acb.2010.010047; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Walsh ME, 2015, AGING CELL, V14, P957, DOI 10.1111/acel.12387; Walter J, 2020, CELL, V180, P221, DOI 10.1016/j.cell.2019.12.025; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475; Yang YX., 2009, CHINA FOOD COMPOSITI	54	4	4	4	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22109	10.1096/fj.202002697RRR	http://dx.doi.org/10.1096/fj.202002697RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34941012				2022-12-28	WOS:000734992000034
J	Hao, JZ; Brosse, L; Bonnet, C; Ducrocq, M; Padilla, F; Penalba, V; Desplat, A; Ruel, J; Delmas, P				Hao, Jizhe; Brosse, Lucie; Bonnet, Caroline; Ducrocq, Myriam; Padilla, Francoise; Penalba, Virginie; Desplat, Angelique; Ruel, Jerome; Delmas, Patrick			The widely used antihistamine mepyramine causes topical pain relief through direct blockade of nociceptor sodium channels	FASEB JOURNAL			English	Article							GAIN-OF-FUNCTION; INTERNATIONAL-UNION; FUNCTION MUTATIONS; ION-CHANNEL; HISTAMINE; PYRILAMINE; NA(V)1.7; ELECTROGENESIS; INACTIVATION; EXCITABILITY	Mepyramine, a first-generation antihistamine targeting the histamine H(1) receptor, was extensively prescribed to patients suffering from allergic reactions and urticaria. Serious adverse effects, especially in case of overdose, were frequently reported, including drowsiness. impaired thinking, convulsion, and coma. Many of these side effects were associated with the blockade of histaminergic or cholinergic receptors. Here we show that mepyramine directly inhibits a variety of voltage-gated sodium channels, including the Tetrodotoxin-sensitive isoforms and the main isoforms (Nav1.7, Nav1.8, and Nav1.9) of nociceptors. Estimated IC50 were within the range of drug concentrations detected in poisoned patients. Mepyramine inhibited sodium channels through fast- or slow-inactivated state preference depending on the isoform. Moreover, mepyramine inhibited the firing responses of C- and A beta-type nerve fibers in ex vivo skin-nerve preparations. Locally applied mepyramine had analgesic effects on the scorpion toxin-induced excruciating pain and produced pain relief in acute, inflammatory, and chronic pain models. Collectively, these data provide evidence that mepyramine has the potential to be developed as a topical analgesic agent.	[Hao, Jizhe; Brosse, Lucie; Bonnet, Caroline; Ducrocq, Myriam; Padilla, Francoise; Penalba, Virginie; Desplat, Angelique; Ruel, Jerome; Delmas, Patrick] Aix Marseille Univ, CNRS, Lab Neurosci Cognit, UMR 7291, CS80011,Bd Pierre Dramard, F-13344 Marseille 15, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Delmas, P (corresponding author), Aix Marseille Univ, CNRS, Lab Neurosci Cognit, UMR 7291, CS80011,Bd Pierre Dramard, F-13344 Marseille 15, France.	patrick.delmas@univ-amu.fr	hao, jizhe/AFS-9867-2022	Ruel, Jerome/0000-0003-2871-7321	Fondation pour la Recherche Medicale (FRM) [DEQ20130326482]	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	Fondation pour la Recherche Medicale (FRM), Grant/Award Number: DEQ20130326482	Abbas N, 2013, PAIN, V154, P1204, DOI 10.1016/j.pain.2013.03.037; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Amsalem M, 2018, EMBO J, V37, DOI 10.15252/embj.201797349; BAIN WA, 1948, LANCET, V252, P964, DOI 10.1016/S0140-6736(48)91644-4; Bonnet C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12197-3; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; CHEN NBW, 1983, J FORENSIC SCI, V28, P398; Chevrier P, 2004, BRIT J PHARMACOL, V142, P576, DOI 10.1038/sj.bjp.0705796; Coste B, 2004, MOL CELL NEUROSCI, V26, P123, DOI 10.1016/j.mcn.2004.01.015; Coste B, 2007, J GEN PHYSIOL, V129, P57, DOI 10.1085/jgp.200609665; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0001.1999; De Sutter AIM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004976.pub3; DEWS PB, 1946, BRIT J PHARM CHEMOTH, V1, P278, DOI 10.1111/j.1476-5381.1946.tb00048.x; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; Dib-Hajj SD, 2015, NAT REV NEUROSCI, V16, P511, DOI 10.1038/nrn3977; Emery EC, 2016, EXPERT OPIN THER TAR, V20, P975, DOI 10.1517/14728222.2016.1162295; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Gawali VS, 2015, MOL PHARMACOL, V88, P866, DOI 10.1124/mol.115.099580; GELGOR L, 1986, PAIN, V26, P353, DOI 10.1016/0304-3959(86)90063-1; Gilman AG., 1990, GOODMAN GILMANS PHAR, V8th, P586; Habib AM, 2015, HANDB EXP PHARMACOL, V227, P39, DOI 10.1007/978-3-662-46450-2_3; HALEY TJ, 1983, J PHARM SCI, V72, P3, DOI 10.1002/jps.2600720103; Hao JZ, 2013, NEURON, V77, P899, DOI 10.1016/j.neuron.2012.12.035; Hao JZ, 2010, J NEUROSCI, V30, P13384, DOI 10.1523/JNEUROSCI.2926-10.2010; Hill SJ, 1997, PHARMACOL REV, V49, P253; HOOPER RG, 1979, JACEP-J AM COLL EMER, V8, P98, DOI 10.1016/S0361-1124(79)80150-1; Huang JY, 2014, BRAIN, V137, P1627, DOI 10.1093/brain/awu079; JOHNSON EA, 1956, J PHARMACOL EXP THER, V117, P237; JOHNSON EA, 1957, J PHARMACOL EXP THER, V120, P460; JOHNSON GR, 1981, CLIN TOXICOL, V18, P907, DOI 10.3109/15563658108990317; KUBO N, 1987, JPN J PHARMACOL, V43, P277, DOI 10.1254/jjp.43.277; Leipold E, 2013, NAT GENET, V45, P1399, DOI 10.1038/ng.2767; Lolignier S, 2015, CELL REP, V11, P1067, DOI 10.1016/j.celrep.2015.04.027; Ma RSY, 2019, J PAIN RES, V12, P2709, DOI 10.2147/JPR.S207610; Maingret F, 2008, J GEN PHYSIOL, V131, P211, DOI 10.1085/jgp.200709935; Mojtahedin A, 2008, Pak J Biol Sci, V11, P2573, DOI 10.3923/pjbs.2008.2573.2578; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Osorio N, 2014, J NEUROSCI, V34, P5233, DOI 10.1523/JNEUROSCI.0057-14.2014; Panula P, 2015, PHARMACOL REV, V67, P601, DOI 10.1124/pr.114.010249; Parsons ME, 2006, BRIT J PHARMACOL, V147, pS127, DOI 10.1038/sj.bjp.0706440; Paudel G, 2011, PEDIATR EMERG CARE, V27, P945, DOI 10.1097/PEC.0b013e3182309ae2; Raouf R, 2010, J CLIN INVEST, V120, P3745, DOI 10.1172/JCI43158; Renganathan M, 2002, MOL BRAIN RES, V106, P70, DOI 10.1016/S0169-328X(02)00411-4; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Sangalli BC, 1997, PROG NEUROBIOL, V52, P145, DOI 10.1016/S0301-0082(97)00011-7; Ulbricht W, 2005, PHYSIOL REV, V85, P1271, DOI 10.1152/physrev.00024.2004; Waxman SG, 2014, NAT NEUROSCI, V17, P153, DOI 10.1038/nn.3602; Yokoyama H, 1996, CNS DRUGS, V5, P321, DOI 10.2165/00023210-199605050-00002; Zhang XY, 2013, AM J HUM GENET, V93, P957, DOI 10.1016/j.ajhg.2013.09.016; Zimmermann K, 2009, NAT PROTOC, V4, P174, DOI 10.1038/nprot.2008.223	52	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22025	10.1096/fj.202100976RR	http://dx.doi.org/10.1096/fj.202100976RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34758144				2022-12-28	WOS:000722321300022
J	Wright, A; Hall, A; Daly, T; Fontelonga, T; Potter, S; Schafer, C; Lindsley, A; Hung, C; Bodamer, O; Gussoni, E				Wright, Alec; Hall, Arielle; Daly, Tara; Fontelonga, Tatiana; Potter, Sarah; Schafer, Caitlin; Lindsley, Andrew; Hung, Christina; Bodamer, Olaf; Gussoni, Emanuela			Lysine methyltransferase 2D regulates muscle fiber size and muscle cell differentiation	FASEB JOURNAL			English	Article						Kabuki syndrome; muscle differentiation; muscle regeneration; muscle stem cells; muscular dystrophy; NMJ	FIBRO/ADIPOGENIC PROGENITORS; KABUKI-SYNDROME; UTX; INJURY; MODEL; MICE; SEX	Kabuki syndrome (KS) is a rare genetic disorder caused primarily by mutations in the histone modifier genes KMT2D and KDM6A. The genes have broad temporal and spatial expression in many organs, resulting in complex phenotypes observed in KS patients. Hypotonia is one of the clinical presentations associated with KS, yet detailed examination of skeletal muscle samples from KS patients has not been reported. We studied the consequences of loss of KMT2D function in both mouse and human muscles. In mice, heterozygous loss of Kmt2d resulted in reduced neuromuscular junction (NMJ) perimeter, decreased muscle cell differentiation in vitro and impaired myofiber regeneration in vivo. Muscle samples from KS patients of different ages showed presence of increased fibrotic tissue interspersed between myofiber fascicles, which was not seen in mouse muscles. Importantly, when Kmt2d-deficient muscle stem cells were transplanted in vivo in a physiologic non-Kabuki environment, their differentiation potential is restored to levels undistinguishable from control cells. Thus, the epigenetic changes due to loss of function of KMT2D appear reversible through a change in milieu, opening a potential therapeutic avenue.	[Wright, Alec; Hall, Arielle; Daly, Tara; Fontelonga, Tatiana; Hung, Christina; Bodamer, Olaf; Gussoni, Emanuela] Boston Childrens Hosp, Div Genet & Genom, 3 Blackfan Circle 15021, Boston, MA 02115 USA; [Daly, Tara; Hung, Christina; Bodamer, Olaf; Gussoni, Emanuela] Boston Childrens Hosp, Roya Kabuki Program, Boston, MA 02115 USA; [Potter, Sarah; Schafer, Caitlin; Lindsley, Andrew] Cincinnati Childrens Hosp, Div Allergy & Immunol, Cincinnati, OH USA; [Lindsley, Andrew] Amgen Inc, Thousand Oaks, CA USA; [Bodamer, Olaf] Broad Inst MIT & Harvard Univ, Div Genet & Genom, Cambridge, MA USA; [Gussoni, Emanuela] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Amgen; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital	Gussoni, E (corresponding author), Boston Childrens Hosp, Div Genet & Genom, 3 Blackfan Circle 15021, Boston, MA 02115 USA.	emanuela.gussoni@enders.tch.harvard.edu	Gussoni, Emanuela/AAL-6150-2021	Gussoni, Emanuela/0000-0002-9915-3677; Hall, Arielle/0000-0002-8870-1260	Roya Kabuki Program; NIH/NIAMS [1R01AR069582]	Roya Kabuki Program; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Roya Kabuki Program; NIH/NIAMS, Grant/Award Number: 1R01AR069582 (EG)	Adam MP, 2019, J MED GENET, V56, P89, DOI 10.1136/jmedgenet-2018-105625; Baghdadi MB, 2018, DEV BIOL, V433, P200, DOI 10.1016/j.ydbio.2017.07.026; Bartling B, 2017, EXP GERONTOL, V87, P139, DOI 10.1016/j.exger.2016.04.011; Benjamin JS, 2017, P NATL ACAD SCI USA, V114, P125, DOI 10.1073/pnas.1611431114; Berdeaux R, 2012, AM J PHYSIOL-ENDOC M, V303, pE1, DOI 10.1152/ajpendo.00555.2011; Bjornsson HT, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009278; Carosso GA, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129375; Chal J, 2015, NAT BIOTECHNOL, V33, P962, DOI 10.1038/nbt.3297; Dhar SS, 2016, NUCLEIC ACIDS RES, V44, P3659, DOI 10.1093/nar/gkv1516; Dorighi KM, 2017, MOL CELL, V66, P568, DOI 10.1016/j.molcel.2017.04.018; Fahrner JA, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129380; Faralli H, 2016, J CLIN INVEST, V126, P1555, DOI 10.1172/JCI83239; Froimchuk E, 2017, GENE, V627, P337, DOI 10.1016/j.gene.2017.06.056; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Hall A, 2020, SKELET MUSCLE, V10, DOI 10.1186/s13395-020-00252-3; Jang YH, 2017, J MOL BIOL, V429, P2046, DOI 10.1016/j.jmb.2016.12.016; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; KUROKI Y, 1981, J PEDIATR-US, V99, P570, DOI 10.1016/S0022-3476(81)80256-9; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; LIDOV HGW, 1990, NATURE, V348, P725, DOI 10.1038/348725a0; Liu L, 2020, J CLIN INVEST, V130, P4710, DOI 10.1172/JCI136155; Meng Hui, 2014, J Vis Exp, DOI 10.3791/51586; Miyake N, 2013, AM J MED GENET A, V161, P2234, DOI 10.1002/ajmg.a.36072; Natarajan A, 2010, CELL CYCLE, V9, P2045, DOI 10.4161/cc.9.11.11854; Pakula A, 2019, METHODS MOL BIOL, V1889, P1, DOI 10.1007/978-1-4939-8897-6_1; Pallafacchina G, 2013, NUTR METAB CARDIOVAS, V23, pS12, DOI 10.1016/j.numecd.2012.02.002; Pratt SJP, 2013, J PHYSIOL-LONDON, V591, P559, DOI 10.1113/jphysiol.2012.241679; Rezende EL, 2006, PHYSIOL BIOCHEM ZOOL, V79, P83, DOI 10.1086/498187; Rickels R, 2017, NAT GENET, V49, P1647, DOI 10.1038/ng.3965; Roberts MD, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00834; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Schafer C, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00318; Schrander-Stumpel CTRM, 2005, AM J MED GENET A, V132A, P234, DOI 10.1002/ajmg.a.30331; Seenundun S, 2010, EMBO J, V29, P1401, DOI 10.1038/emboj.2010.37; Shpargel KB, 2017, P NATL ACAD SCI USA, V114, pE9046, DOI 10.1073/pnas.1705011114; Smith LR, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-21; Sobreira N, 2017, EUR J HUM GENET, V25, P1335, DOI 10.1038/s41431-017-0023-0; Spinazzola JM, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2591; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Wosczyna MN, 2018, DEV CELL, V46, P135, DOI 10.1016/j.devcel.2018.06.018; Yamamoto PK, 2019, GENES BRAIN BEHAV, V18, DOI 10.1111/gbb.12568; Zhou CN, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00243	42	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21955	10.1096/fj.202100823R	http://dx.doi.org/10.1096/fj.202100823R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34613626	Green Published			2022-12-28	WOS:000712009200045
J	Estrada-Cortes, E; Ortiz, W; Rabaglino, MB; Block, J; Rae, O; Jannaman, EA; Xiao, Y; Hansen, PJ				Estrada-Cortes, Eliab; Ortiz, William; Rabaglino, Maria B.; Block, Jeremy; Rae, Owen; Jannaman, Elizabeth A.; Xiao, Yao; Hansen, Peter J.			Choline acts during preimplantation development of the bovine embryo to program postnatal growth and alter muscle DNA methylation	FASEB JOURNAL			English	Article							COLONY-STIMULATING FACTOR-2; FETAL-GROWTH; IN-VITRO; METHIONINE; SUPPLEMENTATION; CONSEQUENCES; PROPORTION; CONTRIBUTE; PHENOTYPE; EXPOSURE	The preimplantation period of embryonic development can be a key window for programming of postnatal development because extensive epigenetic remodeling occurs during this time. It was hypothesized that modification of one-carbon metabolism of the bovine embryo by addition of the methyl-donor choline to culture medium would change postnatal phenotype through epigenetic modification. Embryos produced in vitro were cultured with 1.8 mM choline chloride or control medium. Blastocysts were transferred into females and pregnancy outcomes and postnatal phenotype of the resultant calves determined. Exposure of embryos to choline increased gestation length and calf birth weight. Calves derived from choline-treated embryos were also heavier at weaning and had increased ratio of body weight to hip height than control calves. Choline altered muscle DNA methylation of calves 4 months after birth. A total of 670 of the 8149 CpG examined were differentially methylated, with the predominant effect of choline being hypomethylation. Among the genes associated with differentially methylated CpG were ribosomal RNAs and genes in AMPK, mTOR, integrin, and BEX2 canonical pathways and cellular functions involved in growth and proliferation. Results demonstrate that provision of the methyl-donor choline to the preimplantation embryo can alter its developmental program to increase gestation length, birth weight, and weaning weight and cause postnatal changes in muscle DNA methylation including those associated with genes related to anabolic processes and cellular growth. The importance of the nutritional status of the embryo with respect to one-carbon metabolism for ensuring health and well-being after birth is emphasized by these observations.	[Estrada-Cortes, Eliab; Ortiz, William; Jannaman, Elizabeth A.; Xiao, Yao; Hansen, Peter J.] Univ Florida, Dept Anim Sci, POB 110910, Gainesville, FL 32611 USA; [Estrada-Cortes, Eliab; Ortiz, William; Jannaman, Elizabeth A.; Xiao, Yao; Hansen, Peter J.] Univ Florida, DH Barron Reprod & Perinatal Biol Res Program, POB 110910, Gainesville, FL 32611 USA; [Estrada-Cortes, Eliab; Ortiz, William; Jannaman, Elizabeth A.; Xiao, Yao; Hansen, Peter J.] Univ Florida, Genet Inst, POB 110910, Gainesville, FL 32611 USA; [Estrada-Cortes, Eliab] Inst Nacl Invest Forestales Agr & Pecuarias, Campo Expt Ctr Altos Jalisco, Tepatitlan De Morelos, Mexico; [Rabaglino, Maria B.] Tech Univ Denmark, Dept Appl Math & Comp Sci, Quantitat Genet Bioinformat & Computat Biol Grp, Lyngby, Denmark; [Block, Jeremy] Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA; [Rae, Owen] Univ Florida, Coll Vet Med, Dept Large Anim Clin Sci, Gainesville, FL 32611 USA; [Ortiz, William] Dept Nutr Anim Grp Matsuda, Rodovia Raposo Tavares,SP 270,Km 575, Alvares Machado, SP, Brazil; [Rabaglino, Maria B.] Univ Coll Dublin, Sch Agr & Food Sci, Dublin 4, Ireland; [Jannaman, Elizabeth A.] CCRM Colorado, Lone Tree, CO USA; [Xiao, Yao] Shandong Acad Agr Sci, Inst Anim Sci & Vet Med, Jinan 250100, Shandong, Peoples R China	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Technical University of Denmark; University of Wyoming; State University System of Florida; University of Florida; University College Dublin; Shandong Academy of Agricultural Sciences	Hansen, PJ (corresponding author), Univ Florida, Dept Anim Sci, POB 110910, Gainesville, FL 32611 USA.; Hansen, PJ (corresponding author), Univ Florida, DH Barron Reprod & Perinatal Biol Res Program, POB 110910, Gainesville, FL 32611 USA.; Hansen, PJ (corresponding author), Univ Florida, Genet Inst, POB 110910, Gainesville, FL 32611 USA.	pjhansen@ufl.edu		Jannaman, Elizabeth/0000-0003-2461-6793; Rabaglino, Maria/0000-0002-0099-045X; Xiao, Yao/0000-0002-5153-6839; ESTRADA CORTES, ELIAB/0000-0003-0226-9794; Block, Jeremy/0000-0002-6279-8543; Ortiz, William/0000-0002-7335-3961; Hansen, Peter/0000-0003-3061-9333	USDA-NIFA [2020-67015-30821]; CONACyT-Mexico; LE "Red" Larson Endowment; Florida Cattlemen's Association	USDA-NIFA(United States Department of Agriculture (USDA)); CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); LE "Red" Larson Endowment; Florida Cattlemen's Association	Research was supported by USDA-NIFA 2020-67015-30821, LE "Red" Larson Endowment, Florida Cattlemen's Association, an unrestricted gift from Balchem Corporation and funding for E. Estrada-Cortes by CONACyT-Mexico	Acosta DAV, 2016, THERIOGENOLOGY, V85, P1669, DOI 10.1016/j.theriogenology.2016.01.024; Adam MA, 2017, EPIGENOMES, V1, DOI 10.3390/epigenomes1030015; Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R87, 10.1186/gb-2012-13-10-r87]; Ardalan M, 2010, J ANIM PHYSIOL AN N, V94, pE259, DOI 10.1111/j.1439-0396.2009.00966.x; Barker DJP, 2013, PLACENTA, V34, P841, DOI 10.1016/j.placenta.2013.07.063; Bernadzki KM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09590-7; Block J, 2010, J DAIRY SCI, V93, P5234, DOI 10.3168/jds.2010-3443; Bonilla L, 2010, J REPROD DEVELOP, V56, P527, DOI 10.1262/jrd.10-037H; Bromfield JJ, 2014, P NATL ACAD SCI USA, V111, P2200, DOI 10.1073/pnas.1305609111; Burns BM, 2018, J ANIM SCI, V96, P4186, DOI 10.1093/jas/sky290; Caudill MA, 2010, J AM DIET ASSOC, V110, P1198, DOI 10.1016/j.jada.2010.05.009; Chaillou T, 2014, J CELL PHYSIOL, V229, P1584, DOI 10.1002/jcp.24604; Cruickshank MN, 2013, GENOME MED, V5, DOI 10.1186/gm500; Eckersley-Maslin MA, 2018, NAT REV MOL CELL BIO, V19, P436, DOI 10.1038/s41580-018-0008-z; Estrada-Cortes E, 2020, J DAIRY SCI, V103, P10784, DOI 10.3168/jds.2020-18598; Estrada-Cortes E, 2021, J ANIM SCI, V99, DOI 10.1093/jas/skab180; Figueiredo VC, 2021, J CACHEXIA SARCOPENI, V12, P130, DOI 10.1002/jcsm.12636; Freedman R, 2022, SCHIZOPHR RES, V247, P16, DOI 10.1016/j.schres.2021.03.008; Fu Q, 2009, FASEB J, V23, P2438, DOI 10.1096/fj.08-124768; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Gould JM, 2018, P NATL ACAD SCI USA, V115, pE7398, DOI 10.1073/pnas.1721876115; Greenberg MVC, 2019, NAT REV MOL CELL BIO, V20, P590, DOI 10.1038/s41580-019-0159-6; Hansen PJ, 2020, ANNU REV ANIM BIOSCI, V8, P395, DOI 10.1146/annurev-animal-021419-084010; Hansen PJ, 2016, CELL TISSUE RES, V363, P237, DOI 10.1007/s00441-015-2287-4; Hofstee P, 2018, CLIN EXP PHARMACOL P, V45, P871, DOI 10.1111/1440-1681.12954; Hoyo C, 2011, EPIGENETICS-US, V6, P928, DOI 10.4161/epi.6.7.16263; Ishitani H, 2020, J ASSIST REPROD GEN, V37, P1807, DOI 10.1007/s10815-020-01898-0; Jiang XY, 2012, FASEB J, V26, P3563, DOI 10.1096/fj.12-207894; Kannampuzha-Francis J, 2015, MOL REPROD DEV, V82, P892, DOI 10.1002/mrd.22533; Koch JM, 2010, J ANIM SCI, V88, P1619, DOI 10.2527/jas.2009-2392; Kovacheva VP, 2007, J BIOL CHEM, V282, P31777, DOI 10.1074/jbc.M705539200; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kudo M, 2015, J NUTR BIOCHEM, V26, P1664, DOI 10.1016/j.jnutbio.2015.08.009; Lafuente E, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00720; Liu HY, 2020, REPROD SCI, V27, P963, DOI 10.1007/s43032-020-00161-2; Maloney CA, 2013, GENES NUTR, V8, P181, DOI 10.1007/s12263-012-0314-6; McGee M, 2018, NUTR REV, V76, P469, DOI 10.1093/nutrit/nuy006; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Ortiz WG, 2019, J DAIRY SCI, V102, P6587, DOI 10.3168/jds.2019-16251; Oster M, 2016, EUR J NUTR, V55, P1717, DOI 10.1007/s00394-015-0990-2; Pfeffer PL, 2018, BIOLOGY-BASEL, V7, DOI 10.3390/biology7030041; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Tobi EW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6592; Toledo MZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189117; Tribulo P, 2017, J ANIM SCI, V95, P4407, DOI 10.2527/jas2017.1927; Tribulo P, 2019, MOL REPROD DEV, V86, P75, DOI 10.1002/mrd.23082; Vineis P, 2011, EPIGENETICS-US, V6, P195, DOI 10.4161/epi.6.2.13573; von Walden F, 2019, J APPL PHYSIOL, V127, P591, DOI 10.1152/japplphysiol.00963.2018; Wang HQ, 2011, BIOINFORMATICS, V27, P225, DOI 10.1093/bioinformatics/btq650; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Watson ZL, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0758-2; Williams CL, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-49; Williams TC, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0121; Wood CE, 1999, J REPROD FERTIL, P115; Yadav VR, 2018, AM J PHYSIOL-LUNG C, V314, pL724, DOI 10.1152/ajplung.00243.2017; Zhang BH, 2015, FASEB J, V29, P1069, DOI 10.1096/fj.14-261131	57	2	2	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21926	10.1096/fj.202100991R	http://dx.doi.org/10.1096/fj.202100991R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34533870	Green Published			2022-12-28	WOS:000702238200004
J	Hatters, DM; Halfmann, R; Baum, J				Hatters, Danny M.; Halfmann, Randal; Baum, Jean			The 2021 FASEB Virtual Science Research Conference on Protein Aggregation: Function, Dysfunction, and Disease, June 23-25, 2021	FASEB JOURNAL			English	Editorial Material									[Hatters, Danny M.] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Pharmacol, Melbourne, Vic, Australia; [Halfmann, Randal] Stowers Inst Med Res, Kansas City, MO USA; [Baum, Jean] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ USA	University of Melbourne; Stowers Institute for Medical Research; Rutgers State University New Brunswick	Hatters, DM (corresponding author), Univ Melbourne, Dept Biochem & Pharmacol, Melbourne, Vic 3010, Australia.	dhatters@unimelb.edu.au		Hatters, Danny/0000-0002-9965-2847	Genentech (South San Francisco, CA, USA); Company of Biologists (Cambridge, UK); GenNext Technologies (Half Moon Bay, CA, USA); European Molecular Biology Organization (EMBO; Heidelberg, Germany); Journal of Biological Chemistry	Genentech (South San Francisco, CA, USA)(Roche HoldingGenentech); Company of Biologists (Cambridge, UK); GenNext Technologies (Half Moon Bay, CA, USA); European Molecular Biology Organization (EMBO; Heidelberg, Germany); Journal of Biological Chemistry	The meeting was chaired by Danny Hatters (University of Melbourne, Melbourne, VIC, Australia), co--chaired by Marina Ramirez--Alvarado (Mayo Clinic, Rochester, MN, USA). Jean Baum (Rutgers University, Piscataway, NJ, USA) and Randal Halfmann (Stowers Institute, Kansas City, MO, USA) made up the other organizing committee. The meeting was sponsored by Genentech (South San Francisco, CA, USA), Company of Biologists (Cambridge, UK), GenNext Technologies (Half Moon Bay, CA, USA), the European Molecular Biology Organization (EMBO; Heidelberg, Germany), and the Journal of Biological Chemistry. The organizers are grateful for this support.		0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21884	10.1096/fj.202101291	http://dx.doi.org/10.1096/fj.202101291			3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34463393	Bronze			2022-12-28	WOS:000702238200007
J	Yao, Q; Outeda, P; Xu, HX; Walker, R; Basquin, D; Qian, F; Cebotaru, L; Watnick, T; Cebotaru, V				Yao, Qin; Outeda, Patricia; Xu, Hangxue; Walker, Rebecca; Basquin, Denis; Qian, Feng; Cebotaru, Liudmila; Watnick, Terry; Cebotaru, Valeriu			Polycystin-1 dependent regulation of polycystin-2 via GRP94, a member of HSP90 family that resides in the endoplasmic reticulum	FASEB JOURNAL			English	Article						ADPKD; autophagy; chaperone; GRP94; HDAC6; HSP; HSP90; kidney; polycystin-1; polycystin-2; proteasome; UPR	CYST GROWTH; KIDNEY; PROTEIN; PATHWAY; DISEASE; GENE; PKD2; INHIBITION; ACTIVATION; CLEAVAGE	Autosomal dominant polycystic kidney disease is a common inherited renal disorder that results from mutations in either PKD1 or PKD2, encoding polycystin-1 (PC1) and polycystin-2 (PC2), respectively. Downregulation or overexpression of PKD1 or PKD2 in mouse models results in renal cyst formation, suggesting that the quantity of PC1 and PC2 needs to be maintained within a tight functional window to prevent cystogenesis. Here we show that enhanced PC2 expression is a common feature of PKD1 mutant tissues, in part due to an increase in Pkd2 mRNA. However, our data also suggest that more effective protein folding contributes to the augmented levels of PC2. We demonstrate that the unfolded protein response is activated in Pkd1 knockout kidneys and in Pkd1 mutant cells and that this is coupled with increased levels of GRP94, an endoplasmic reticulum protein that is a member of the HSP90 family of chaperones. GRP94 was found to physically interact with PC2 and depletion or chemical inhibition of GRP94 led to a decrease in PC2, suggesting that GRP94 serves as its chaperone. Moreover, GRP94 is acetylated and binds to histone deacetylase 6 (HDAC6), a known deacetylase and activator of HSP90 proteins. Inhibition of HDAC6 decreased PC2 suggesting that HDAC6 and GRP94 work together to regulate PC2 levels. Lastly, we showed that inhibition of GRP94 prevents cAMP-induced cyst formation in vitro. Taken together our data uncovered a novel HDAC6-GRP94-related axis that likely participates in maintaining elevated PC2 levels in Pkd1 mutant cells.	[Yao, Qin; Outeda, Patricia; Xu, Hangxue; Walker, Rebecca; Basquin, Denis; Qian, Feng; Watnick, Terry; Cebotaru, Valeriu] Univ Maryland, Sch Med, Dept Med, Div Nephrol, 22 S Greene St,Room N3W143, Baltimore, MD 21201 USA; [Cebotaru, Liudmila] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA; [Yao, Qin] NIA, Baltimore, MD 21224 USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cebotaru, V (corresponding author), Univ Maryland, Sch Med, Dept Med, Div Nephrol, 22 S Greene St,Room N3W143, Baltimore, MD 21201 USA.	vcebotaru@som.umaryland.edu			National Institutes of Health [K08DK103078, R01DK111611, P30 DK090868]; NIDDK-sponsored Baltimore Polycystic Kidney Disease Research and Clinical Core Center [P30 DK090868]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK-sponsored Baltimore Polycystic Kidney Disease Research and Clinical Core Center	This work was supported by a National Institutes of Health Grant K08DK103078 (to VC), and R01DK111611 (to F. Q.). Pilot and Feasibility Award from P30 DK090868 (to VC). These studies utilized resources provided by the NIDDK-sponsored Baltimore Polycystic Kidney Disease Research and Clinical Core Center, P30 DK090868. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health	Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Brill AL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57286-x; Casuscelli J, 2009, AM J PHYSIOL-RENAL, V297, pF1310, DOI 10.1152/ajprenal.00412.2009; Cebotaru L, 2016, KIDNEY INT, V90, P90, DOI 10.1016/j.kint.2016.01.026; Cebotaru V, 2014, J BIOL CHEM, V289, P6404, DOI 10.1074/jbc.M113.501205; Chapin HC, 2010, MOL BIOL CELL, V21, P4338, DOI 10.1091/mbc.E10-05-0407; Fedeles SV, 2011, NAT GENET, V43, P639, DOI 10.1038/ng.860; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hoter A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092560; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Kahali S, 2012, FASEB J, V26, P2437, DOI 10.1096/fj.11-193706; Kim H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6482; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kraus A, 2018, KIDNEY INT, V94, P887, DOI 10.1016/j.kint.2018.06.008; Kurbegovic A, 2016, AM J PHYSIOL-RENAL, V311, pF740, DOI 10.1152/ajprenal.00167.2016; Li A, 2015, AM J PATHOL, V185, P2843, DOI 10.1016/j.ajpath.2015.06.014; Li Y, 2013, FEBS J, V280, P775, DOI 10.1111/febs.12079; Liang GQ, 2008, HUM MOL GENET, V17, P1109, DOI 10.1093/hmg/ddm383; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Ma M, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028209; Marzec M, 2012, BBA-MOL CELL RES, V1823, P774, DOI 10.1016/j.bbamcr.2011.10.013; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Nikonova AS, 2018, FASEB J, V32, P2735, DOI 10.1096/fj.201700909R; Nims N, 2003, BIOCHEMISTRY-US, V42, P13035, DOI 10.1021/bi035074c; Park EY, 2009, J BIOL CHEM, V284, P7214, DOI 10.1074/jbc.M805890200; Pazour GJ, 2004, J AM SOC NEPHROL, V15, P2528, DOI 10.1097/01.ASN.0000141055.57643.E0; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; Seeger-Nukpezah T, 2013, P NATL ACAD SCI USA, V110, P12786, DOI 10.1073/pnas.1301904110; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Su Q, 2018, SCIENCE, V361, P992, DOI 10.1126/science.aat9819; Thivierge C, 2006, MOL CELL BIOL, V26, P1538, DOI 10.1128/MCB.26.4.1538-1548.2006; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wei F, 2008, KIDNEY INT, V74, P1310, DOI 10.1038/ki.2008.395; Wu GQ, 2000, NAT GENET, V24, P75, DOI 10.1038/71724; Yanda MK, 2018, J BIOL CHEM, V293, P11513, DOI 10.1074/jbc.RA118.001846; Yu SQ, 2007, P NATL ACAD SCI USA, V104, P18688, DOI 10.1073/pnas.0708217104	43	1	1	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21865	10.1096/fj.202100325RR	http://dx.doi.org/10.1096/fj.202100325RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34486178	Green Accepted			2022-12-28	WOS:000702238200051
J	Wang, YN; Liao, GN; Wang, RP; Tang, DD				Wang, Yinna; Liao, Guoning; Wang, Ruping; Tang, Dale D.			Acetylation of Abelson interactor 1 at K416 regulates actin cytoskeleton and smooth muscle contraction	FASEB JOURNAL			English	Article						actin cytoskeleton; adapter protein; contraction; smooth muscle	VIMENTIN PHOSPHORYLATION; P21-ACTIVATED KINASE; CELL-ADHESION; N-WASP; POLYMERIZATION; ABI1; DYNAMICS; SER-56; MECHANISM; CORTACTIN	Actin cytoskeletal reorganization plays an important role in regulating smooth muscle contraction, which is essential for the modulation of various physiological functions including airway tone. The adapter protein Abi1 (Abelson interactor 1) participates in the control of smooth muscle contraction. The mechanisms by which Abi1 coordinates smooth muscle function are not fully understood. Here, we found that contractile stimulation elicited Abi1 acetylation in human airway smooth muscle (HASM) cells. Mutagenesis analysis identified lysine-416 (K416) as a major acetylation site. Replacement of K416 with Q (glutamine) enhanced the interaction of Abi1 with neuronal Wiskott-Aldrich syndrome protein (N-WASP), an important actin-regulatory protein. Moreover, the expression of K416Q Abi1 promoted actin polymerization and smooth muscle contraction without affecting myosin light chain phosphorylation at Ser-19 and vimentin phosphorylation at Ser-56. Furthermore, p300 is a lysine acetyltransferase that catalyzes acetylation of histone and non-histone proteins in various cell types. Here, we discovered that a portion of p300 was localized in the cytoplasm of HASM cells. Knockdown of p300 reduced the agonist-induced Abi1 acetylation in HASM cells and in mouse airway smooth muscle tissues. Smooth muscle conditional knockout of p300 inhibited actin polymerization and the contraction of airway smooth muscle tissues without affecting myosin light chain phosphorylation and vimentin phosphorylation. Together, our results suggest that contractile stimulation induces Abi1 acetylation via p300 in smooth muscle. Acetylation at K416 promotes the coupling of Abi1 with N-WASP, which facilitates actin polymerization and smooth muscle contraction. This is a novel acetylation-dependent regulation of the actin cytoskeleton in smooth muscle.	[Wang, Yinna; Liao, Guoning; Wang, Ruping; Tang, Dale D.] Albany Med Coll, Dept Mol & Cellular Physiol, 47 New Scotland Ave,MC 8, Albany, NY 12208 USA	Albany Medical College	Tang, DD (corresponding author), Albany Med Coll, Dept Mol & Cellular Physiol, 47 New Scotland Ave,MC 8, Albany, NY 12208 USA.	tangd@amc.edu			HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [HL-110951, HL-130304, HL-145392]	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI)	HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL-110951, HL-130304 and HL-145392	Ali I, 2018, CHEM REV, V118, P340, DOI 10.1021/acs.chemrev.7b00181; An SS, 2016, J ALLERGY CLIN IMMUN, V138, P294, DOI 10.1016/j.jaci.2015.12.1315; Anfinogenova Y, 2007, CIRC RES, V101, P420, DOI 10.1161/CIRCRESAHA.107.156463; Burton EA, 2005, MOL CELL BIOL, V25, P8834, DOI 10.1128/MCB.25.20.8834-8843.2005; Cipolla MJ, 2002, FASEB J, V16, P72, DOI 10.1096/cj.01-0104hyp; Dancy BM, 2015, CHEM REV, V115, P2419, DOI 10.1021/cr500452k; Fermento ME, 2010, EXP MOL PATHOL, V88, P256, DOI 10.1016/j.yexmp.2010.01.007; Gao Y, 2020, NAT CELL BIOL, V22, P1064, DOI 10.1038/s41556-020-0562-4; Gerlach BD, 2019, AM J RESP CELL MOL, V61, P219, DOI 10.1165/rcmb.2018-0352OC; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Herrera AM, 2004, AM J PHYSIOL-LUNG C, V286, pL1161, DOI 10.1152/ajplung.00298.2003; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Jia L, 2012, AM J PHYSIOL-CELL PH, V302, pC1026, DOI 10.1152/ajpcell.00373.2011; Jiang SX, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0257-8; Jin LY, 2017, CANCER RES, V77, P5564, DOI 10.1158/0008-5472.CAN-17-0314; Kim HR, 2010, AM J PHYSIOL-CELL PH, V298, pC559, DOI 10.1152/ajpcell.00431.2009; Li J, 2016, J BIOL CHEM, V291, P23693, DOI 10.1074/jbc.M116.749341; Li J, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0415-7; Li J, 2014, AM J PHYSIOL-CELL PH, V307, pC288, DOI 10.1152/ajpcell.00102.2014; Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200; Liao GN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30895-8; Liao GN, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12541; Liu TG, 2014, J CELL PHYSIOL, V229, P1484, DOI 10.1002/jcp.24590; Long JY, 2019, J CELL SCI, V132, DOI 10.1242/jcs.222380; Michael JV, 2019, FASEB J, V33, P4780, DOI 10.1096/fj.201801959R; Nakamura N, 2021, RESPIROLOGY, V26, P19, DOI 10.1111/resp.13910; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Rezey AC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43927-8; Ring C, 2011, P NATL ACAD SCI USA, V108, P149, DOI 10.1073/pnas.1012316108; Ryu JR, 2009, MOL CELL BIOL, V29, P1735, DOI 10.1128/MCB.01483-08; Sin TK, 2021, CANCER RES, V81, P885, DOI 10.1158/0008-5472.CAN-19-3219; Stradal T, 2001, CURR BIOL, V11, P891, DOI 10.1016/S0960-9822(01)00239-1; Tang DD, 2008, AM J PHYSIOL-CELL PH, V294, pC869, DOI 10.1152/ajpcell.00154.2007; Tang Dale D, 2018, Adv Pharmacol, V81, P1, DOI 10.1016/bs.apha.2017.06.001; Tang DD, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0296-1; Tang DD, 2005, BIOCHEM J, V388, P773, DOI 10.1042/BJ20050065; Wang RP, 2007, AM J PHYSIOL-LUNG C, V292, pL240, DOI 10.1152/ajplung.00199.2006; Wang RP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67781-1; Wang RP, 2014, J BIOL CHEM, V289, P14157, DOI 10.1074/jbc.M114.548099; Wang RP, 2013, AM J RESP CELL MOL, V48, P172, DOI 10.1165/rcmb.2012-0315OC; Wang T, 2015, J BIOL CHEM, V290, P8913, DOI 10.1074/jbc.M114.621003; Wang T, 2014, AM J RESP CELL MOL, V51, P652, DOI 10.1165/rcmb.2014-0125OC; Wang T, 2013, J BIOL CHEM, V288, P20713, DOI 10.1074/jbc.M112.439877; Wang YN, 2020, AM J RESP CELL MOL, V62, P645, DOI 10.1165/rcmb.2019-0310OC; Wang YN, 2018, RESP RES, V19, DOI 10.1186/s12931-017-0709-4; Wu YD, 2015, J BIOL CHEM, V290, P11403, DOI 10.1074/jbc.M115.645788; Yu WD, 2008, CARCINOGENESIS, V29, P1717, DOI 10.1093/carcin/bgn098; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	48	5	5	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21811	10.1096/fj.202100415R	http://dx.doi.org/10.1096/fj.202100415R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34369620	Green Published			2022-12-28	WOS:000691122900026
J	Yu, LT; Liu, SX; Zhou, RX; Sun, H; Su, XJ; Liu, Q; Li, SP; Ying, JJ; Zhao, FY; Mu, DZ; Qu, Y				Yu, Luting; Liu, Shixi; Zhou, Ruixi; Sun, Hao; Su, Xiaojuan; Liu, Qian; Li, Shiping; Ying, Junjie; Zhao, Fengyan; Mu, Dezhi; Qu, Yi			Atorvastatin inhibits neuronal apoptosis via activating cAMP/PKA/p-CREB/BDNF pathway in hypoxic-ischemic neonatal rats	FASEB JOURNAL			English	Article						apoptosis; cAMP; PKA; p-CREB; BDNF pathway; hypoxic-ischemic; neuron	CEREBRAL ISCHEMIA/REPERFUSION INJURY; HIPPOCAMPAL-NEURONS; NEUROTROPHIC FACTOR; GENE-EXPRESSION; CAMP RESPONSE; IN-VITRO; BDNF; SIMVASTATIN; NEURODEGENERATION; ENCEPHALOPATHY	Neuronal apoptosis is one of the main pathological processes of hypoxic-ischemic brain damage (HIBD) and is involved in the development of hypoxic-ischemic encephalopathy (HIE) in neonates. Atorvastatin has been found to have neuroprotective effects in some nervous system diseases, but its role in regulating the pathogenesis of neonatal HIBD remains elusive. Thus, this study aimed to explore the effects and related mechanisms of atorvastatin on the regulation of neuronal apoptosis after HIBD in newborn rats. The rat HIBD model and the neuronal oxygen glucose deprivation (OGD) model were established routinely. Atorvastatin, cAMP inhibitor (SQ22536), and BDNF inhibitor (ANA-12) were used to treat HIBD rats and OGD neurons. Cerebral infarction, learning and memory ability, cAMP/PKA/p-CREB/BDNF signaling molecules, and apoptosis-related indicators (TUNEL, cleaved caspase-3, and Bax/Bcl2) were then examined. In vivo, atorvastatin reduced cerebral infarction, improved learning and memory ability, decreased the number of TUNEL-positive neurons, inhibited the expression of cleaved caspase-3 and Bax/Bcl2, and activated the cAMP/PKA/p-CREB/BDNF pathway in the cerebral cortex after HIBD. In vitro, atorvastatin also decreased the apoptosis-related indicators and activated the cAMP/PKA/p-CREB/BDNF pathway in neurons after OGD. Furthermore, inhibition of cAMP or BDNF attenuated the effect of atorvastatin on the reduction of neuronal apoptosis, suggesting that atorvastatin inhibits HIBD-induced neuronal apoptosis and alleviates brain injury in neonatal rats mainly by activating the cAMP/PKA/p-CREB/BDNF pathway. In conclusion, atorvastatin may be developed as a potential drug for the treatment of neonatal HIE.	[Yu, Luting; Liu, Shixi; Zhou, Ruixi; Sun, Hao; Su, Xiaojuan; Liu, Qian; Li, Shiping; Ying, Junjie; Zhao, Fengyan; Mu, Dezhi; Qu, Yi] Sichuan Univ, West China Univ Hosp 2, Dept Paediat, Chengdu 610041, Sichuan, Peoples R China; [Yu, Luting; Liu, Shixi; Zhou, Ruixi; Sun, Hao; Su, Xiaojuan; Liu, Qian; Li, Shiping; Ying, Junjie; Zhao, Fengyan; Mu, Dezhi; Qu, Yi] Sichuan Univ, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, Chengdu, Peoples R China	Sichuan University; Sichuan University	Mu, DZ; Qu, Y (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Paediat, Chengdu 610041, Sichuan, Peoples R China.	mudezhi@scu.edu.cn; quyi712002@163.com			National Natural Science Foundation of China [81630038, 81771634, 81971433, 81971428, 81801629]; Science and Technology Bureau of Sichuan Province [2021YJ0017, 2020YFS0041]; Fundamental Research Funds for the Central University [SCU2020D006]; National Key Project of Neonatal Children [1311200003303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Bureau of Sichuan Province; Fundamental Research Funds for the Central University; National Key Project of Neonatal Children	National Natural Science Foundation of China, Grant/Award Number: 81630038, 81771634, 81971433, 81971428 and 81801629; Science and Technology Bureau of Sichuan Province, Grant/Award Number: 2021YJ0017 and 2020YFS0041; Fundamental Research Funds for the Central University, Grant/Award Number: SCU2020D006; National Key Project of Neonatal Children, Grant/Award Number: 1311200003303	Ahnaou A, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-00875-6; Askalan R, 2015, BRAIN RES, V1629, P94, DOI 10.1016/j.brainres.2015.10.020; Balduini W, 2009, AUTOPHAGY, V5, P221, DOI 10.4161/auto.5.2.7363; Bauman AL, 2002, NAT CELL BIOL, V4, pE203, DOI 10.1038/ncb0802-e203; Beitner-Johnson D, 1998, BIOCHEM BIOPH RES CO, V242, P61, DOI 10.1006/bbrc.1997.7907; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Caracciolo L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04445-9; Cardenas-Aguayo MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053596; Chavez-Valdez R, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/257563; Che HX, 2020, FOOD FUNCT, V11, P1729, DOI [10.1039/C9FO02323B, 10.1039/c9fo02323b]; Cong L, 2007, BIOCHEM J, V403, P519, DOI 10.1042/BJ20061478; Cui JJ, 2012, CELL BIOCHEM BIOPHYS, V62, P87, DOI 10.1007/s12013-011-9264-7; Cui LL, 2010, BRAIN RES, V1325, P164, DOI 10.1016/j.brainres.2010.02.036; Douglas-Escobar M, 2015, JAMA PEDIATR, V169, P397, DOI 10.1001/jamapediatrics.2014.3269; Funck VR, 2011, EPILEPSIA, V52, P2094, DOI 10.1111/j.1528-1167.2011.03261.x; Ginet V, 2014, AUTOPHAGY, V10, P846, DOI 10.4161/auto.28264; Huang J, 2019, FREE RADICAL BIO MED, V141, P322, DOI 10.1016/j.freeradbiomed.2019.07.001; Huang X, 2014, PHARMAZIE, V69, P909, DOI 10.1691/ph.2014.4661; Huang X, 2014, INT J CLIN EXP PATHO, V7, P4577; Hung PL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092573; Johnson-Anuna LN, 2005, J PHARMACOL EXP THER, V312, P786, DOI 10.1124/jpet.104.075028; Kho AR, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094385; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Koppel I, 2018, GLIA, V66, P206, DOI 10.1002/glia.23238; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Landucci E, 2018, NEUROSCI LETT, V668, P103, DOI 10.1016/j.neulet.2018.01.023; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lee DK, 2012, CELL PHYSIOL BIOCHEM, V30, P499, DOI 10.1159/000341433; Lee HL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103161; Li HJ, 2018, J CELL BIOCHEM, V119, P1616, DOI 10.1002/jcb.26321; Lu YY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3852; Rodriguez-Perea AL, 2017, J NEUROIMMUNE PHARM, V12, P152, DOI 10.1007/s11481-016-9706-5; Lutjohann D, 2004, STEROIDS, V69, P431, DOI 10.1016/j.steroids.2004.03.012; Ma CL, 2020, HUM EXP TOXICOL, V39, P1118, DOI 10.1177/0960327120911438; Maeda T, 2009, J BIOCHEM, V145, P771, DOI 10.1093/jb/mvp035; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; Nakajima W, 2000, J NEUROSCI, V20, P7994; Saito T, 2014, LIFE SCI, V94, P106, DOI 10.1016/j.lfs.2013.11.018; Song D, 2017, MOL MED REP, V16, P6428, DOI 10.3892/mmr.2017.7396; Song T, 2014, GENET MOL RES, V13, P10632, DOI 10.4238/2014.December.18.5; Thangamalai R, 2014, SHOCK, V41, P406, DOI 10.1097/SHK.0000000000000138; Tu QY, 2014, NEURAL REGEN RES, V9, P268, DOI 10.4103/1673-5374.128220; Vaughan CJ, 2003, AM J CARDIOL, V91, p23B, DOI 10.1016/S0002-9149(02)03270-8; de la Torre AV, 2013, PHARMACOL RES, V70, P116, DOI 10.1016/j.phrs.2013.01.007; Wang D, 2014, J NEUROL SCI, V336, P237, DOI 10.1016/j.jns.2013.11.005; Wang L, 2015, J CLIN INVEST, V125, P796, DOI 10.1172/JCI79220; Wu BW, 2018, J CELL PHYSIOL, V233, P5281, DOI 10.1002/jcp.26328; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Xue LL, 2021, BRAIN RES BULL, V174, P131, DOI 10.1016/j.brainresbull.2021.05.013; Yamamoto N, 2016, GLIA, V64, P952, DOI 10.1002/glia.22974; Yang JW, 2015, NEURAL REGEN RES, V10, P1239, DOI 10.4103/1673-5374.162755; Yang YP, 2019, ENVIRON TOXICOL, V34, P1052, DOI 10.1002/tox.22776; You MM, 2019, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00428; Zhang JM, 2017, INT J NEUROSCI, V127, P92, DOI 10.3109/00207454.2016.1146882; Zhang Y, 2015, J ETHNOPHARMACOL, V172, P124, DOI 10.1016/j.jep.2015.06.032; Zhao FY, 2014, INT J DEV NEUROSCI, V38, P147, DOI 10.1016/j.ijdevneu.2014.06.014	57	1	1	4	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22263	10.1096/fj.202101654RR	http://dx.doi.org/10.1096/fj.202101654RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35303316				2022-12-28	WOS:000772957100002
J	Zhou, JM; Sun, CB; Yang, L; Wang, JH; Jn-Simon, N; Zhou, C; Bryant, A; Cao, Q; Li, CL; Petersen, B; Pi, LY				Zhou, Junmei; Sun, Chunbao; Yang, Lu; Wang, Jinhui; Jn-Simon, Natacha; Zhou, Chen; Bryant, Andrew; Cao, Qi; Li, Chenglong; Petersen, Bryon; Pi, Liya			Liver regeneration and ethanol detoxification: A new link in YAP regulation of ALDH1A1 during alcohol-related hepatocyte damage	FASEB JOURNAL			English	Article						Aldh1a1; carbon tetrachloride (CCl4); ethanol; liver regeneration; Yes-associated protein	TISSUE GROWTH-FACTOR; HIPPO PATHWAY; ALDEHYDE DEHYDROGENASES; CELLS; GENE; METABOLISM; INHIBITION; EXPRESSION; INDUCTION; MECHANISM	Yes-associated protein (YAP), a central effector in the Hippo pathway, is involved in the regulation of organ size, stem cell self-renewal, and tissue regeneration. In this study, we observed YAP activation in patients with alcoholic steatosis, hepatitis, and cirrhosis. Accumulation of this protein in the nucleus was also observed in murine livers that were damaged after chronic-plus-single binge or moderate ethanol ingestion combined with carbon tetrachloride intoxication (ethanol/CCl4). To understand the role of this transcriptional coactivator in alcohol-related liver injury, we knocked out the Yap1 gene in hepatocytes of floxed homozygotes through adeno-associated virus (AAV8)-mediated deletion utilizing Cre recombinase. Yap1 hepatocyte-specific knockouts (KO) exhibited hemorrhage, massive hepatic necrosis, enhanced oxidative stress, elevated hypoxia, and extensive infiltration of CD11b(+) inflammatory cells into hepatic microenvironments rich for connective tissue growth factor (Ctgf) during ethanol/CCl4-induced liver damage. Analysis of whole-genome transcriptomics indicated upregulation of genes involved in hypoxia and extracellular matrix (ECM) remodeling, whereas genes related to hepatocyte proliferation, progenitor cell activation, and ethanol detoxification were downregulated in the damaged livers of Yap1 KO. Acetaldehyde dehydrogenase (Aldh)1a1, a gene that encodes a detoxification enzyme for aldehyde substrates, was identified as a potential YAP target because this gene could be transcriptionally activated by a hyperactive YAP mutant. The ectopic expression of the human ALDH1A1 gene caused increase in hepatocyte proliferation and decrease in hepatic necrosis, oxidative stress, ECM remodeling, and inflammation during ethanol/CCl4-induced liver damage. Taken together, these observations indicated that YAP was crucial for liver repair during alcohol-associated injury. Its regulation of ALDH1A1 represents a new link in liver regeneration and detoxification.	[Zhou, Junmei] Guilin Med Univ, Guangxi Key Lab Mol Med Liver Injury & Repair, Affiliated Hosp, Guilin, Peoples R China; [Sun, Chunbao; Jn-Simon, Natacha; Pi, Liya] Tulane Univ, Dept Pathol, New Orleans, LA 70118 USA; [Yang, Lu] Beckman Res Inst City Hope, Dept Syst Biol, Duarte, CA USA; [Wang, Jinhui] Beckman Res Inst City Hope, Integrat Genom Core, Duarte, CA USA; [Zhou, Chen; Li, Chenglong] Univ Florida, Dept Med Chem, Gainesville, FL USA; [Bryant, Andrew] Univ Florida, Dept Med, Gainesville, FL USA; [Cao, Qi] Univ Maryland, Dept Diagnost Radiol & Nucl Med, Sch Med, Baltimore, MD USA; [Petersen, Bryon] Univ Florida, Dept Pediat, Gainesville, FL USA	Guilin Medical University; Tulane University; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University System of Maryland; University of Maryland Baltimore; State University System of Florida; University of Florida	Pi, LY (corresponding author), Tulane Univ, Sch Med, Dept Pathol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	lpi@tulane.edu	Wang, Jin/GYA-2019-2022		National Institutes of Health NIAAA [KO1AA024174, RO1AA028035]; Children Miracle Research Foundation; National Natural Science Foundation	National Institutes of Health NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Children Miracle Research Foundation; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study is supported by National Institutes of Health NIAAA KO1AA024174 and RO1AA028035 grants as well as Children Miracle Research Foundation grant awarded to LP. This study is also partially supported by the National Natural Science Foundation	Adams MK, 2014, J BIOL CHEM, V289, P14868, DOI 10.1074/jbc.M114.552257; Bai HB, 2012, HEPATOLOGY, V56, P1097, DOI 10.1002/hep.25769; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Chen Y, 2013, PROG RETIN EYE RES, V33, P28, DOI 10.1016/j.preteyeres.2012.10.001; Chiang DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069114; Del Re DP, 2013, J BIOL CHEM, V288, P3977, DOI 10.1074/jbc.M112.436311; Deshpande KT, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010005; Enzo E, 2015, EMBO J, V34, P1349, DOI 10.15252/embj.201490379; Fan XH, 2003, MOL CELL BIOL, V23, P4637, DOI 10.1128/MCB.23.13.4637-4648.2003; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hoshino M, 2006, J CELL BIOL, V172, P589, DOI 10.1083/jcb.200509132; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Lai YS, 2019, J CELL MOL MED, V23, P1257, DOI 10.1111/jcmm.14027; LIEBER CS, 1968, SCIENCE, V162, P917, DOI 10.1126/science.162.3856.917; Liu HX, 2014, BIOCHEM PHARMACOL, V91, P256, DOI 10.1016/j.bcp.2014.07.003; Liu Y, 2019, J HEPATOL, V71, P719, DOI 10.1016/j.jhep.2019.05.029; Lu L, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.205; Machado MV, 2015, J HEPATOL, V63, P962, DOI 10.1016/j.jhep.2015.05.031; Makia NL, 2011, CHEM-BIOL INTERACT, V191, P278, DOI 10.1016/j.cbi.2011.01.013; Marchitti SA, 2007, PHARMACOL REV, V59, P125, DOI 10.1124/pr.59.2.1; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Miyamura N, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms16017; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Moya IM, 2019, NAT REV MOL CELL BIO, V20, P211, DOI 10.1038/s41580-018-0086-y; Nielsen MC, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051175; Pi LY, 2015, HEPATOLOGY, V61, P678, DOI 10.1002/hep.27425; Polfliet MMJ, 2006, IMMUNOBIOLOGY, V211, P419, DOI 10.1016/j.imbio.2006.05.015; Rebollido-Rios R, 2020, ONCOGENE, V39, P2756, DOI 10.1038/s41388-020-1184-9; Roychowdhury S, 2014, PHARMACOL RES PERSPE, V2, DOI 10.1002/prp2.61; Saleh MB, 2021, J HEPATOL, V75, P912, DOI 10.1016/j.jhep.2021.05.041; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Shabtai Y, 2018, BIOCHEM CELL BIOL, V96, P148, DOI 10.1139/bcb-2017-0132; Shao D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4315; Sica A, 2014, HEPATOLOGY, V59, P2034, DOI 10.1002/hep.26754; Steg AD, 2012, CLIN CANCER RES, V18, P869, DOI 10.1158/1078-0432.CCR-11-2188; Su T, 2015, ELIFE, V4, DOI 10.7554/eLife.02948; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Suzuki E, 2012, HEPATOL RES, V42, P1100, DOI 10.1111/j.1872-034X.2012.01028.x; Svendsen P, 2017, MOL THER-METH CLIN D, V4, P50, DOI 10.1016/j.omtm.2016.11.004; Swiderska-Syn M, 2016, HEPATOLOGY, V64, P232, DOI 10.1002/hep.28542; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Vasiliou V, 2000, PHARMACOLOGY, V61, P192, DOI 10.1159/000028400; Vidal F, 1998, ALCOHOL, V15, P3, DOI 10.1016/S0741-8329(97)00073-6; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Webb C, 2011, BIOCHEMISTRY-US, V50, P3300, DOI 10.1021/bi2001888; Wu HT, 2013, CELL REP, V3, P1663, DOI 10.1016/j.celrep.2013.04.020; Xiao Y, 2018, DEV CELL, V45, P153, DOI 10.1016/j.devcel.2018.03.019; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Yu JH, 2017, ONCOTARGET, V8, P38426, DOI 10.18632/oncotarget.16430; Zhao AY, 2018, ONCOTARGETS THER, V11, P6657, DOI 10.2147/OTT.S170858; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou JM, 2020, FASEB J, V34, P4970, DOI 10.1096/fj.201902382R	54	2	2	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22224	10.1096/fj.202101686R	http://dx.doi.org/10.1096/fj.202101686R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CX	35218575	hybrid, Green Published			2022-12-28	WOS:000772946100001
J	Ma, YH; Cai, FH; Huang, XH; Wang, HJ; Yu, BF; Wang, JN; Nie, WY; Cai, KD; Yang, Y; Chen, JH; Xiao, L; Han, F				Ma, Yanhong; Cai, Fanghao; Huang, Xiaohan; Wang, Huijing; Yu, Binfeng; Wang, Junni; Nie, Wanyun; Cai, Kedan; Yang, Yi; Chen, Jianghua; Xiao, Liang; Han, Fei			Mannose-binding lectin activates the nuclear factor-kappa B and renal inflammation in the progression of diabetic nephropathy	FASEB JOURNAL			English	Article						diabetic nephropathy; macrophage; mannose-binding lectin; nuclear factor-kappa B	RECEPTOR 4; ASSOCIATION	Increased serum mannose-binding lectin (MBL) level has been proven to correlate with the development of diabetic nephropathy (DN). Here, we aim to find the role and mechanism of MBL involved in the progression of DN. Patients with DN were recruited and divided into two groups according to different rs1800450 genotypes of the MBL2 gene, and inflammatory profiles in monocytes/macrophages were compared between the two groups. MBL was given to treat macrophages, HK2, and HMC, and a co-culture transwell system was then employed. Renal inflammation and fibrosis parameters were measured after knocking down or overexpressing MBL genes in mice. Proinflammatory profile, manifesting as enhanced IL-1 beta production and M1 polarization, was found in monocytes/macrophages from DN with a rs1800450 GG genotype of MBL2 gene who had higher MBL level, compared with those with a rs1800450 GA genotype. In mechanism, MBL directly induced inflammatory responses in macrophages, which promoted inflammatory and fibrotic markers in HK2 and HMCs during co-culture. Further experiments showed that MBL can promote macrophages transforming to the M1 subset mainly by activating the nuclear factor-kappa B pathway. After downregulation of MBL, the blood glucose, triglyceride, urine protein, injuries of glomerulus and tubules, and the degree of renal inflammation and fibrosis were ameliorated in db/db mice treated with AAV-MBL1/2-shRNA. Overexpression of MBL promoted macrophage infiltration in the kidney. In conclusion, MBL is a crucial mediator in the progression of DN via activating the nuclear factor-kappa B pathway in macrophages. This will serve as a genetic base for some patients with DN who have poor outcomes and provide a direction for the screening.	[Ma, Yanhong; Cai, Fanghao; Huang, Xiaohan; Wang, Huijing; Yu, Binfeng; Wang, Junni; Nie, Wanyun; Cai, Kedan; Yang, Yi; Chen, Jianghua; Xiao, Liang; Han, Fei] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Kidney Dis Ctr, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China; [Ma, Yanhong; Cai, Fanghao; Huang, Xiaohan; Wang, Huijing; Yu, Binfeng; Wang, Junni; Nie, Wanyun; Cai, Kedan; Yang, Yi; Chen, Jianghua; Xiao, Liang; Han, Fei] Zhejiang Univ, Inst Nephrol, Hangzhou, Peoples R China; [Ma, Yanhong; Cai, Fanghao; Huang, Xiaohan; Wang, Huijing; Yu, Binfeng; Wang, Junni; Nie, Wanyun; Cai, Kedan; Yang, Yi; Chen, Jianghua; Xiao, Liang; Han, Fei] Key Lab Kidney Dis Prevent & Control Technol, Hangzhou, Peoples R China; [Cai, Kedan] Univ Chinese Acad Sci, HwaMei Hosp, Ningbo, Peoples R China	Zhejiang University; Zhejiang University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xiao, L; Han, F (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Kidney Dis Ctr, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	xiaoliang@zju.edu.cn; hanf8876@zju.edu.cn	MA, YAN/HHN-2912-2022; Xiao, Liang/HCI-1002-2022	Xiao, Liang/0000-0003-0312-7149	National key R&D Program of China [2018YFC1314003]; National Natural Science Foundation of China (NSFC) [81770674]; Primary Research and Development Plan of Zhejiang Province [2020C03034]	National key R&D Program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Primary Research and Development Plan of Zhejiang Province	National key R&D Program of China, Grant/Award Number: 2018YFC1314003; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81770674; Primary Research and Development Plan of Zhejiang Province, Grant/Award Number: 2020C03034	Aso Y, 2004, CLIN CHIM ACTA, V348, P139, DOI 10.1016/j.cccn.2004.05.006; Awad AS, 2015, KIDNEY INT, V88, P722, DOI 10.1038/ki.2015.162; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Cai KD, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-1073; Campbell MT, 2011, J SURG RES, V168, pE61, DOI 10.1016/j.jss.2009.09.053; Cha JJ, 2013, ENDOCRINOLOGY, V154, P2144, DOI 10.1210/en.2012-2080; Chen CA, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-020-03362-4; Chung ACK, 2011, J AM SOC NEPHROL, V22, P802, DOI 10.1681/ASN.2010050510; Cooper ME, 1998, LANCET, V352, P213, DOI 10.1016/S0140-6736(98)01346-4; de Zeeuw D, 2015, LANCET DIABETES ENDO, V3, P687, DOI 10.1016/S2213-8587(15)00261-2; Fernandez-Fernandez B, 2014, NAT REV NEPHROL, V10, P325, DOI 10.1038/nrneph.2014.74; Fioretto P, 2016, DIABETES CARE, V39, pS165, DOI 10.2337/dcS15-3006; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Hansen TK, 2004, DIABETES, V53, P1570, DOI 10.2337/diabetes.53.6.1570; Hansen TK, 2006, ARCH INTERN MED, V166, P2007, DOI 10.1001/archinte.166.18.2007; Hovind P, 2005, DIABETES, V54, P1523, DOI 10.2337/diabetes.54.5.1523; Klessens CQF, 2017, NEPHROL DIAL TRANSPL, V32, P1322, DOI 10.1093/ndt/gfw260; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; Leemans JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005704; Li XQ, 2019, DIABETES METAB, V45, P248, DOI 10.1016/j.diabet.2018.04.001; Luan PP, 2018, FASEB J, V32, P1070, DOI 10.1096/fj.201700511RR; Mack M, 2015, KIDNEY INT, V87, P297, DOI 10.1038/ki.2014.287; Mezzano S, 2004, NEPHROL DIAL TRANSPL, V19, P2505, DOI 10.1093/ndt/gfh207; Mogues T, 1996, GLYCOBIOLOGY, V6, P543, DOI 10.1093/glycob/6.5.543; Nguyen D, 2006, NEPHROLOGY, V11, P226, DOI 10.1111/j.1440-1797.2006.00576.x; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Ostergaard J, 2007, DIABETOLOGIA, V50, P1541, DOI 10.1007/s00125-007-0686-0; Ostergaard JA, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1825738; Pan HZ, 2010, ACTA DIABETOL, V47, pS71, DOI 10.1007/s00592-009-0128-1; Rogacev KS, 2010, EUR HEART J, V31, P369, DOI 10.1093/eurheartj/ehp308; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Tang SCW, 2020, NAT REV NEPHROL, V16, P206, DOI 10.1038/s41581-019-0234-4; Tang SCW, 2010, NEPHROL DIAL TRANSPL, V25, P698, DOI 10.1093/ndt/gfp599; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Turner M W, 2000, Rev Immunogenet, V2, P305; van der Pol P, 2012, AM J TRANSPLANT, V12, P877, DOI 10.1111/j.1600-6143.2011.03887.x; Vorup-Jensen T, 2000, J IMMUNOL, V165, P2093, DOI 10.4049/jimmunol.165.4.2093; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; You HN, 2013, AM J PHYSIOL-RENAL, V305, pF1719, DOI 10.1152/ajprenal.00141.2013; Zhang NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083059	40	1	1	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22227	10.1096/fj.202101852R	http://dx.doi.org/10.1096/fj.202101852R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35195918				2022-12-28	WOS:000761250800014
J	de Goede, P; Wust, RCI; Schomakers, BV; Denis, S; Vaz, FM; Pras-Raves, ML; Weeghel, M; Yi, CX; Kalsbeek, A; Houtkooper, RH				de Goede, Paul; Wust, Rob C., I; Schomakers, Bauke, V; Denis, Simone; Vaz, Frederic M.; Pras-Raves, Mia L.; Weeghel, Michel; Yi, Chun-Xia; Kalsbeek, Andries; Houtkooper, Riekelt H.			Time-restricted feeding during the inactive phase abolishes the daily rhythm in mitochondrial respiration in rat skeletal muscle	FASEB JOURNAL			English	Article						lipidomics; metabolomics; mitochondrial respiration; soleus muscle; time-restricted feeding	OXIDATIVE CAPACITY; CIRCADIAN-RHYTHMS; GENE-EXPRESSION; CLOCK-GENES; SHIFT WORK; DYSFUNCTION; METABOLISM; DYNAMICS	Shift-workers show an increased incidence of type 2 diabetes mellitus (T2DM). A possible mechanism is the disruption of the circadian timing of glucose homeostasis. Skeletal muscle mitochondrial function is modulated by the molecular clock. We used time-restricted feeding (TRF) during the inactive phase to investigate how mistimed feeding affects muscle mitochondrial metabolism. Rats on an ad libitum (AL) diet were compared to those that could eat only during the light (inactive) or dark (active) phase. Mitochondrial respiration, metabolic gene expressions, and metabolite concentrations were determined in the soleus muscle. Rats on AL feeding or dark-fed TRF showed a clear daily rhythm in muscle mitochondrial respiration. This rhythm in mitochondrial oxidative phosphorylation capacity was abolished in light-fed TRF animals and overall 24h respiration was lower. The expression of several genes involved in mitochondrial biogenesis and the fission/fusion machinery was altered in light-fed animals. Metabolomics analysis indicated that light-fed animals had lost rhythmic levels of alpha-ketoglutarate and citric acid. Contrastingly, lipidomics showed that light-fed animals abundantly gained rhythmicity in levels of triglycerides. Furthermore, while the RER shifted entirely with the food intake in the light-fed animals, many measured metabolic parameters (e.g., activity and mitochondrial respiration) did not strictly align with the shifted timing of food intake, resulting in a mismatch between expected metabolic supply/demand (as dictated by the circadian timing system and light/dark-cycle) and the actual metabolic supply/demand (as dictated by the timing of food intake). These data suggest that shift-work impairs mitochondrial metabolism and causes metabolic inflexibility, which can predispose to T2DM.	[de Goede, Paul; Yi, Chun-Xia; Kalsbeek, Andries] Univ Amsterdam, Amsterdam Univ Med Ctr, Lab Endocrinol, Amsterdam Gastroenterol Endocrinol & Metab, Amsterdam, Netherlands; [de Goede, Paul; Kalsbeek, Andries] Inst Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci NIN, Hypothalam Integrat Mech Grp, Amsterdam, Netherlands; [Wust, Rob C., I; Schomakers, Bauke, V; Denis, Simone; Vaz, Frederic M.; Pras-Raves, Mia L.; Weeghel, Michel; Houtkooper, Riekelt H.] Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam Cardiovasc Sci,Lab Genet Metab Dis, Amsterdam Gastroenterol Endocrinol & Metab, Amsterdam, Netherlands; [Wust, Rob C., I] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Human Movement Sci, Lab Myol, Amsterdam, Netherlands; [Schomakers, Bauke, V; Vaz, Frederic M.; Pras-Raves, Mia L.; Weeghel, Michel] Univ Amsterdam, Amsterdam Univ Med Ctr, Core Facil Metabol, Amsterdam, Netherlands; [Yi, Chun-Xia; Kalsbeek, Andries] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Endocrinol & Metab, Amsterdam, Netherlands	University of Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; University of Amsterdam	Houtkooper, RH (corresponding author), Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam Cardiovasc Sci,Lab Genet Metab Dis, Amsterdam Gastroenterol Endocrinol & Metab, Amsterdam, Netherlands.	r.h.houtkooper@amsterdamumc.nl		Wust, Rob C.I./0000-0003-3781-5177; de Goede, Paul/0000-0003-4489-7422; Houtkooper, Riekelt/0000-0001-9961-0842; Kalsbeek, Andries/0000-0001-9606-8453	ZonMW TOP grant [91214047]	ZonMW TOP grant	P. de Goede was funded by a ZonMW TOP grant (#91214047).	Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107; Bailey SM, 2014, J ENDOCRINOL, V222, pR75, DOI 10.1530/JOE-14-0200; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Cela O, 2016, BBA-MOL CELL RES, V1863, P596, DOI 10.1016/j.bbamcr.2015.12.018; de Goede P, 2020, OBESITY, V28, pS68, DOI 10.1002/oby.22830; de Goede P, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00554; de Goede P, 2018, J MOL ENDOCRINOL, V60, pR115, DOI 10.1530/JME-17-0196; Deshmukh AS, 2016, HORM MOL BIOL CLIN I, V26, P13, DOI 10.1515/hmbci-2015-0041; Dyar KA, 2014, MOL METAB, V3, P29, DOI 10.1016/j.molmet.2013.10.005; Fujimaki S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102147; Goede Paul de, 2018, Neurobiology of Sleep and Circadian Rhythms, V4, P24, DOI 10.1016/j.nbscr.2017.09.002; Gong CX, 2015, CHRONOBIOL INT, V32, P1254, DOI 10.3109/07420528.2015.1085388; Gordon JW, 2015, BIOCHEM CELL BIOL, V93, P452, DOI 10.1139/bcb-2015-0012; Grabner GF, 2020, J LIPID RES, V61, P995, DOI 10.1194/jlr.RA119000516; Harfmann BD, 2015, J BIOL RHYTHM, V30, P84, DOI 10.1177/0748730414561638; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; Held NM, 2020, MOL METAB, V37, DOI 10.1016/j.molmet.2020.100989; Hesselink MKC, 2016, NAT REV ENDOCRINOL, V12, P633, DOI 10.1038/nrendo.2016.104; Heyde I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56323-z; Hodge BA, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0039-5; Honka MJ, 2018, EUR J ENDOCRINOL, V178, P523, DOI 10.1530/EJE-17-0882; Hoppeler H, 2002, J EXP BIOL, V205, P2143; Jacobi D, 2015, CELL METAB, V22, P709, DOI 10.1016/j.cmet.2015.08.006; Jordan SD, 2017, CELL METAB, V26, P243, DOI 10.1016/j.cmet.2017.06.002; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Knutsson A, 2014, CHRONOBIOL INT, V31, P1146, DOI 10.3109/07420528.2014.957308; Krishnaiah SY, 2017, CELL METAB, V25, P961, DOI 10.1016/j.cmet.2017.03.019; Kwak SH, 2010, J DIABETES INVEST, V1, P161, DOI 10.1111/j.2040-1124.2010.00047.x; Makrecka-Kuka M, 2020, ACTA PHYSIOL, V228, DOI 10.1111/apha.13430; Manella G, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00162; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Mehus AA, 2021, J NUTR BIOCHEM, V88, DOI 10.1016/j.jnutbio.2020.108531; Molenaars M, 2021, DIS MODEL MECH, V14, DOI 10.1242/dmm.047746; Montgomery MK, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0092; Neufeld-Cohen A, 2016, P NATL ACAD SCI USA, V113, pE1673, DOI 10.1073/pnas.1519650113; Oliva-Ramirez J, 2014, IMMUNOLOGY, V143, P490, DOI 10.1111/imm.12329; Oosterman JE, 2020, OBESITY, V28, pS81, DOI 10.1002/oby.22832; Opperhuizen AL, 2016, EUR J NEUROSCI, V44, P2795, DOI 10.1111/ejn.13377; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Perrin L, 2018, ELIFE, V7, DOI 10.7554/eLife.34114; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Phielix E, 2010, DIABETOLOGIA, V53, P1714, DOI 10.1007/s00125-010-1764-2; Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391; Puig LS, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00452; Schrauwen P, 2004, DIABETES, V53, P1412, DOI 10.2337/diabetes.53.6.1412; Scrima R, 2016, BBA-BIOENERGETICS, V1857, P1344, DOI 10.1016/j.bbabio.2016.03.035; Shepherd D., 1969, METHODS ENZYMOL, V13, P11, DOI [10.1016/0076-6879(69)13006-2, DOI 10.1016/0076-6879(69)13006-2]; Simon N, 2003, CHRONOBIOL INT, V20, P451, DOI 10.1081/CBI-120021385; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Smith RL, 2018, ENDOCR REV, V39, P489, DOI 10.1210/er.2017-00211; van den Berg M, 2017, AM J RESP CRIT CARE, V196, P1544, DOI 10.1164/rccm.201703-0501OC; van Moorsel D, 2016, MOL METAB, V5, P635, DOI 10.1016/j.molmet.2016.06.012; Vetter C, 2018, DIABETES CARE, V41, P762, DOI 10.2337/dc17-1933; Wefers J, 2018, P NATL ACAD SCI USA, V115, P7789, DOI 10.1073/pnas.1722295115; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Wust RCI, 2012, AM J PHYSIOL-HEART C, V302, pH402, DOI 10.1152/ajpheart.00653.2011; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	58	4	4	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22133	10.1096/fj.202100707R	http://dx.doi.org/10.1096/fj.202100707R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35032416				2022-12-28	WOS:000747987800048
J	Sotoyama, H; Inaba, H; Iwakura, Y; Namba, H; Takei, N; Sasaoka, T; Nawa, H				Sotoyama, Hidekazu; Inaba, Hiroyoshi; Iwakura, Yuriko; Namba, Hisaaki; Takei, Nobuyuki; Sasaoka, Toshikuni; Nawa, Hiroyuki			The dual role of dopamine in the modulation of information processing in the prefrontal cortex underlying social behavior	FASEB JOURNAL			English	Article						dopamine; prefrontal cortex; schizophrenia; social behavior	NEGATIVE SYMPTOMS; UNTREATED PSYCHOSIS; PYRAMIDAL NEURONS; WORKING-MEMORY; D1 RECEPTORS; SCHIZOPHRENIA; STIMULATION; HYPOFRONTALITY; EXCITABILITY; ACTIVATION	Dopamine in the prefrontal cortex is essential for the regulation of social behavior. However, stress-causing social withdrawal also promotes dopamine release in the prefrontal cortex. Thus, this evidence suggests opposite functions of dopamine in the prefrontal cortex. However, the influence of dopamine on prefrontal functions is yet to be fully understood. Here, we show that dopamine differentially modulated the neuronal activity triggered by social stimuli in the prefrontal cortex, depending on the duration of the dopamine activation (transient or sustained activation). Using chemogenetic techniques, we have found that social behavior was negatively regulated by a sustained increase in dopamine neuronal activity in the ventral tegmental area, while it was positively regulated by an acute increase. The duration of social interactions was positively correlated with the transient dopamine release triggered by social stimuli in the prefrontal cortex and negatively correlated with the sustained increase in prefrontal dopamine levels. Furthermore, the elevation of neural calcium signal, triggered by social stimuli, in the prefrontal cortex was attenuated by the persistent elevation of prefrontal dopamine levels, whereas an acute increase in dopamine levels enhanced it. Additionally, the chronic excess of dopamine suppressed c-Fos induction triggered by social stimuli in prefrontal neurons expressing dopamine D1 receptors, but not D2 receptors. These results suggest that sustained activation of prefrontal dopamine, at the opposite of its transient activation, can reduce prefrontal activity associated with social behavior, even for identical dopamine concentrations. Thus, dopamine plays opposite roles in modulating prefrontal activity depending on the duration of its action.	[Sotoyama, Hidekazu; Inaba, Hiroyoshi; Iwakura, Yuriko; Namba, Hisaaki; Takei, Nobuyuki; Nawa, Hiroyuki] Niigata Univ, Brain Res Inst, Dept Mol Neurobiol, Niigata, Japan; [Iwakura, Yuriko; Takei, Nobuyuki] Niigata Univ, Brain Res Inst, Dept Brain Tumor Biol, Niigata, Japan; [Namba, Hisaaki; Nawa, Hiroyuki] Wakayama Med Univ, Sch Pharmaceut Sci, Dept Physiol Sci, Wakayama, Japan; [Sasaoka, Toshikuni] Niigata Univ, Brain Res Inst, Dept Comparat & Expt Med, Niigata, Japan	Niigata University; Niigata University; Wakayama Medical University; Niigata University	Sotoyama, H (corresponding author), Niigata Univ, Brain Res Inst, Dept Mol Neurobiol, Chuoh Ku, Asahimachi Dori 1-757, Niigata, Niigata 9518585, Japan.	sotoyama69@gmail.com	, 笹岡俊邦/N-9152-2015	, 笹岡俊邦/0000-0002-7797-4394; Sotoyama, Hidekazu/0000-0002-7206-0454	KAKENHI [JP 16K07052, 17H04030];  [18H05428];  [18H05429]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); ; 	Supported by KAKENHI JP 16K07052 and 17H04030; Grant-in-Aid Scientific Research on Innovation Area 18H05428 and 18H05429	Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Andreasen NC, 1997, LANCET, V349, P1730, DOI 10.1016/S0140-6736(96)08258-X; Arnsten AFT, 2017, BIOL PSYCHIAT, V81, P67, DOI 10.1016/j.biopsych.2015.12.028; BARNETT JV, 1987, J PHARMACOL EXP THER, V242, P40; Boonstra N, 2012, SCHIZOPHR RES, V142, P12, DOI 10.1016/j.schres.2012.08.017; BREIER A, 1987, AM J PSYCHIAT, V144, P1549; Breton JM, 2019, J COMP NEUROL, V527, P916, DOI 10.1002/cne.24572; Brumback AC, 2018, MOL PSYCHIATR, V23, P2078, DOI 10.1038/mp.2017.213; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Chang WC, 2013, PSYCHOL MED, V43, P1883, DOI 10.1017/S0033291712002838; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Cui WP, 2020, J NEUROSCI, V40, P7241, DOI 10.1523/JNEUROSCI.0444-20.2020; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; De Leonibus E, 2006, EUR J NEUROSCI, V23, P1332, DOI 10.1111/j.1460-9568.2006.04658.x; Didriksen M, 2017, J PSYCHIATR NEUROSCI, V42, P48, DOI 10.1503/jpn.150381; Fauchey V, 2000, EUR J NEUROSCI, V12, P19, DOI 10.1046/j.1460-9568.2000.00876.x; GRACE AA, 1984, J NEUROSCI, V4, P2877; Gulledge AT, 1998, J NEUROSCI, V18, P9139; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; HATANAKA H, 1984, Neuroscience Research, V1, P253, DOI 10.1016/S0168-0102(84)80004-8; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Henze DA, 2000, J NEUROPHYSIOL, V84, P2799, DOI 10.1152/jn.2000.84.6.2799; Hill K, 2004, ACTA PSYCHIAT SCAND, V110, P243, DOI 10.1111/j.1600-0447.2004.00376.x; HOLLERMAN JR, 1990, BRAIN RES, V533, P203, DOI 10.1016/0006-8993(90)91341-D; Jiang LN, 2015, NEUROBIOL DIS, V76, P137, DOI 10.1016/j.nbd.2015.02.006; Juarez B, 2016, NEUROPSYCHOPHARMACOL, V41, P2424, DOI 10.1038/npp.2016.32; Kelly MP, 2007, NEUROPSYCHOPHARMACOL, V32, P577, DOI 10.1038/sj.npp.1301099; Kumar N, 2020, BRAIN STIMUL, V13, P840, DOI 10.1016/j.brs.2020.02.016; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lavin A, 2001, NEUROSCIENCE, V104, P335, DOI 10.1016/S0306-4522(01)00096-3; Lehrer DS, 2010, SCHIZOPHR RES, V122, P43, DOI 10.1016/j.schres.2010.03.043; Liang B, 2018, NEURON, V100, P700, DOI 10.1016/j.neuron.2018.08.043; Lindstrom LH, 1999, BIOL PSYCHIAT, V46, P681, DOI 10.1016/S0006-3223(99)00109-2; Lohani S, 2019, CELL REP, V27, P99, DOI 10.1016/j.celrep.2019.03.012; Mameli-Engvall M, 2006, NEURON, V50, P911, DOI 10.1016/j.neuron.2006.05.007; Mediero A, 2014, FASEB J, V28, P4901, DOI 10.1096/fj.14-255703; Michaeli A, 2012, NEUROPHARMACOLOGY, V62, P1834, DOI 10.1016/j.neuropharm.2011.12.005; MILLER DD, 1994, NEUROPSYCHOPHARMACOL, V11, P11, DOI 10.1038/npp.1994.31; Mizuta K, 2012, AM J PHYSIOL-LUNG C, V302, pL316, DOI 10.1152/ajplung.00130.2011; Namba H, 2017, J NEUROCHEM, V142, P886, DOI 10.1111/jnc.14097; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Okubo Y, 1997, NATURE, V385, P634, DOI 10.1038/385634a0; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pinto DFC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12392-2; Potkin SG, 2002, AM J PSYCHIAT, V159, P227, DOI 10.1176/appi.ajp.159.2.227; Rao N, 2019, SCHIZOPHRENIA BULL, V45, P670, DOI 10.1093/schbul/sby076; Saito N, 2020, NEUROSCI RES, V156, P58, DOI 10.1016/j.neures.2020.04.006; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Shinohara F, 2017, BIOL PHARM BULL, V40, P1983, DOI 10.1248/bpb.b17-00614; Sotoyama H, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-021-01346-2; Sotoyama H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025831; Stenkrona P, 2019, INT J NEUROPSYCHOPH, V22, P415, DOI 10.1093/ijnp/pyz017; Takahashi K, 2019, NEUROPHARMACOLOGY, V150, P1, DOI 10.1016/j.neuropharm.2019.02.034; Tidey JW, 1996, BRAIN RES, V721, P140, DOI 10.1016/0006-8993(96)00159-X; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wilson CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089104; Winter C, 2009, INT J NEUROPSYCHOPH, V12, P513, DOI 10.1017/S1461145708009206; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; WOLKIN A, 1992, ARCH GEN PSYCHIAT, V49, P959; Woolfrey KM, 2009, NAT NEUROSCI, V12, P1275, DOI 10.1038/nn.2386; Xing B, 2021, BIOL PSYCHIAT, V89, P521, DOI 10.1016/j.biopsych.2020.08.023; Zahrt J, 1997, J NEUROSCI, V17, P8528; Zhong P, 2020, CEREB CORTEX, V30, P4402, DOI 10.1093/cercor/bhaa027	64	1	1	8	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22160	10.1096/fj.202101637R	http://dx.doi.org/10.1096/fj.202101637R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35064699				2022-12-28	WOS:000747987800041
J	Molina-Berenguer, M; Vila-Julia, F; Perez-Ramos, S; Salcedo-Allende, MT; Camara, Y; Torres-Torronteras, J; Marti, R				Molina-Berenguer, Miguel; Vila-Julia, Ferran; Perez-Ramos, Sandra; Teresa Salcedo-Allende, Maria; Camara, Yolanda; Torres-Torronteras, Javier; Marti, Ramon			Dysfunctional mitochondrial translation and combined oxidative phosphorylation deficiency in a mouse model of hepatoencephalopathy due to Gfm1 mutations	FASEB JOURNAL			English	Article						animal model; COXPD1; elongation factor G1; Gfm1; mitochondria; translation	ELONGATION-FACTOR-G; ENCEPHALOPATHY; RIBOSOME	Hepatoencephalopathy due to combined oxidative phosphorylation deficiency type 1 (COXPD1) is a recessive mitochondrial translation disorder caused by mutations in GFM1, a nuclear gene encoding mitochondrial elongation factor G1 (EFG1). Patients with COXPD1 typically present hepatoencephalopathy early after birth with rapid disease progression, and usually die within the first few weeks or years of life. We have generated two different mouse models: a Gfm1 knock-in (KI) harboring the p.R671C missense mutation, found in at least 10 patients who survived more than 1 year, and a Gfm1 knock-out (KO) model. Homozygous KO mice (Gfm1(-/-)) were embryonically lethal, whereas homozygous KI (Gfm1(R671C)(/)(R671C)) mice were viable and showed normal growth. R671C mutation in Gfm1 caused drastic reductions in the mitochondrial EFG1 protein content in different organs. Six- to eight-week-old Gfm1(R671C)(/)(R671C) mice showed partial reductions of in organello mitochondrial translation and respiratory complex IV enzyme activity in the liver. Compound heterozygous Gfm1(R671C)(/-) showed a more pronounced decrease of EFG1 protein in liver and brain mitochondria, as compared with Gfm1(R671C)(/)(R671C) mice. At 8 weeks of age, their mitochondrial translation rates were significantly reduced in both tissues. Additionally, Gfm1(R671C)(/-) mice showed combined oxidative phosphorylation deficiency (reduced complex I and IV enzyme activities in liver and brain), and blue native polyacrylamide gel electrophoresis analysis revealed lower amounts of both affected complexes. We conclude that the compound heterozygous Gfm1(R671C)(/-) mouse presents a clear dysfunctional molecular phenotype, showing impaired mitochondrial translation and combined respiratory chain dysfunction, making it a suitable animal model for the study of COXPD1.	[Molina-Berenguer, Miguel; Vila-Julia, Ferran; Perez-Ramos, Sandra; Camara, Yolanda; Torres-Torronteras, Javier; Marti, Ramon] Univ Autonoma Barcelona, Vall dHebron Res Inst, Res Grp Neuromuscular & Mitochondrial Dis, Barcelona, Catalonia, Spain; [Molina-Berenguer, Miguel; Vila-Julia, Ferran; Perez-Ramos, Sandra; Camara, Yolanda; Torres-Torronteras, Javier; Marti, Ramon] Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid, Spain; [Teresa Salcedo-Allende, Maria] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Vall dHebron Res Inst, Pathol Dept, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Torres-Torronteras, J; Marti, R (corresponding author), Univ Autonoma Barcelona, Vall dHebron Res Inst, Res Grp Neuromuscular & Mitochondrial Dis, Barcelona, Catalonia, Spain.	javier.torres@vhir.org; ramon.marti@vhir.org	Martí, Ramon/Q-3442-2016; Torres-Torronteras, Javier/K-4974-2014	Martí, Ramon/0000-0002-8273-9540; Torres-Torronteras, Javier/0000-0002-6092-9458; Molina Berenguer, Miguel/0000-0001-8087-4709	PERIS program [SLT002/16/00370]; Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) Ft program [2018FI_B_01115]; La Caixa Foundation; Spanish Institut de Salud Carlos III [PMP15/00025]; Fundacion Mutua Madrilefia; Fundacion Mencia [LCF/PR/P1216/51110011]	PERIS program; Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) Ft program; La Caixa Foundation(La Caixa Foundation); Spanish Institut de Salud Carlos III(Instituto de Salud Carlos III); Fundacion Mutua Madrilefia; Fundacion Mencia	PERIS program, Grant/Award Number: SLT002/16/00370; Agenda de GestiO d'Ajuts Universitaris i de Recerca (AGAUR) Ft program, Grant/Award Number: 2018FI_B_01115; La Caixa Foundation and FundaciOn Mencia, Grant/Award Number: LCF/PR/P1216/51110011; Spanish Institut de Salud Carlos III, Grant/Award Number: PMP15/00025; FundaciOn Mutua Madrilefia	Aartsma-Rus Annemieke, 2014, J Vis Exp, DOI 10.3791/51303; Almeida L, 2021, IMMUNITY, V54, P68, DOI 10.1016/j.immuni.2020.11.001; Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106; Balasubramaniam S, 2012, JIMD REP, V5, P113, DOI 10.1007/8904_2011_107; Barcia G, 2020, HUM MUTAT, V41, P397, DOI 10.1002/humu.23937; Bhargava K, 2004, PROTEIN EXPRES PURIF, V37, P368, DOI 10.1016/j.pep.2004.06.030; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo-Alonso I, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111811; Brito S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00102; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Cabrera-Perez R, 2019, HUM GENE THER, V30, P985, DOI 10.1089/hum.2018.217; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Cannon B, 1979, Methods Enzymol, V55, P65; CHUNG HKJ, 1990, J BIOL CHEM, V265, P21000; Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878; Deacon RMJ, 2013, JOVE-J VIS EXP, DOI 10.3791/2610; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004; Fernandez-Silva P, 2007, METHOD CELL BIOL, V80, P571, DOI 10.1016/S0091-679X(06)80028-2; Galmiche L, 2012, MITOCHONDRION, V12, P242, DOI 10.1016/j.mito.2011.09.007; Gonzalez-Vioque E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002035; Katunin VI, 2002, BIOCHEMISTRY-US, V41, P12806, DOI 10.1021/bi0264871; Kawashita E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36862-7; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Koripella RK, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17715-2; Kummer E, 2020, EMBO J, V39, DOI 10.15252/embj.2020104820; Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001; Meehan TF, 2015, NUCLEIC ACIDS RES, V43, pD1171, DOI 10.1093/nar/gku1193; Nechifor R, 2007, J MOL BIOL, V368, P1412, DOI 10.1016/j.jmb.2007.03.009; Nogales-Gadea G, 2012, BRAIN, V135, P2048, DOI 10.1093/brain/aws141; Papaioannou VE, 2012, VET PATHOL, V49, P64, DOI 10.1177/0300985810395725; Ravn K, 2015, MOLEC GENET METAB RE, V3, P5, DOI 10.1016/j.ymgmr.2015.01.004; Richman TR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11884; Rudler DL, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aay2118; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Simon MT, 2017, MITOCHONDRION, V34, P84, DOI 10.1016/j.mito.2017.02.004; Smits P, 2011, EUR J HUM GENET, V19, P275, DOI 10.1038/ejhg.2010.208; Su C, 2020, EXP THER MED, V20, DOI 10.3892/etm.2020.9303; Szczepanowska K, 2016, EMBO J, V35, P2566, DOI 10.15252/embj.201694253; Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; You CP, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1791; Zurita-Diaz F, 2016, STEM CELL RES, V16, P124, DOI 10.1016/j.scr.2015.12.019	44	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22091	10.1096/fj.202100819RRR	http://dx.doi.org/10.1096/fj.202100819RRR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34919756				2022-12-28	WOS:000734992000002
J	Ruhs, S; Griesler, B; Huebschmann, R; Stroedecke, K; Straetz, N; Ihling, C; Sinz, A; Masch, A; Schutkowski, M; Gekle, M; Grossmann, C				Ruhs, Stefanie; Griesler, Bruno; Huebschmann, Ralf; Stroedecke, Katharina; Straetz, Nicole; Ihling, Christian; Sinz, Andrea; Masch, Antonia; Schutkowski, Mike; Gekle, Michael; Grossmann, Claudia			Modulation of transcriptional mineralocorticoid receptor activity by casein kinase 1	FASEB JOURNAL			English	Article						aldosterone; casein kinase 1; mineralocorticoid receptor; phosphorylation; cardiovascular diseases; aging; posttranslational modification	NUCLEAR-LOCALIZATION; BINDING-PROTEIN; REGULATES EXPRESSION; PHOSPHORYLATION; CK1; RNA; MOTIF	The mineralocorticoid receptor (MR) with its ligand aldosterone (aldo) physiologically regulates electrolyte homeostasis and blood pressure but it can also lead to pathophysiological effects in the cardiovascular system. Previous results show that posttranslational modifications (PTM) can influence MR signaling and function. Based on in silico and in vitro data, casein kinase 1 (CK1) was predicted as a candidate for MR phosphorylation. To gain a deeper mechanistic insight into MR activation, we investigated the influence of CK1 on MR function in HEK cells. Co-immunoprecipitation experiments indicated that the MR is located in a protein-protein complex with CK1 alpha and CK1 epsilon. Reporter gene assays with pharmacological inhibitors and MR constructs demonstrated that especially CK1 epsilon acts as a positive modulator of GRE activity via the C-terminal MR domains CDEF. CK1 enhanced the binding affinity of aldosterone to the MR, facilitated nuclear translocation and DNA interaction of the MR, and led to expression changes of pathophysiologically relevant genes like Per-1 and Phlda1. By peptide microarray and site-directed mutagenesis experiments, we identified the highly conserved T800 as a direct CK1 phosphorylation site of the MR, which modulates the nuclear import and genomic activity of the receptor. Direct phosphorylation of the MR was unable to fully account for all of the CK1 effects on MR signaling, suggesting additional phosphorylation of MR co-regulators. By LC/MS/MS, we identified the MR-associated proteins NOLC1 and TCOF1 as candidates for such CK1-regulated co-factors. Overall, we found that CK1 acts as a co-activator of MR GRE activity through direct and indirect phosphorylation, which accelerates cytosolic-nuclear trafficking, facilitates nuclear accumulation and DNA binding of the MR, and increases the expression of pathologically relevant MR-target genes.	[Ruhs, Stefanie; Griesler, Bruno; Huebschmann, Ralf; Stroedecke, Katharina; Straetz, Nicole; Gekle, Michael; Grossmann, Claudia] Martin Luther Univ Halle Wittenberg, Julius Bernstein Inst Physiol, Magdeburger Str 6, D-06112 Halle, Saale, Germany; [Ruhs, Stefanie] Univ Hosp Halle Saale, Dept Anesthesiol & Surg Intens Care, Halle, Saale, Germany; [Ihling, Christian; Sinz, Andrea] Martin Luther Univ Halle Wittenberg, Ctr Struct Mass Spectrometry, Inst Pharm, Dept Pharmaceut Chem & Bioanalyt, Halle, Saale, Germany; [Masch, Antonia; Schutkowski, Mike] Martin Luther Univ Halle Wittenberg, Inst Biochem & Biotechnol, Dept Enzymol, Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Grossmann, C (corresponding author), Martin Luther Univ Halle Wittenberg, Julius Bernstein Inst Physiol, Magdeburger Str 6, D-06112 Halle, Saale, Germany.	claudia.grossmann@medizin.uni-halle.de			Deutsche Forschungsgemeinschaft (DEG) [GR 3415/1-5, RTG 2155 ProMoAge SP11]; European Section of the Aldosterone Council (ESAC); ttaPKoM (Graduate School of Medicine, Halle)	Deutsche Forschungsgemeinschaft (DEG)(German Research Foundation (DFG)); European Section of the Aldosterone Council (ESAC); ttaPKoM (Graduate School of Medicine, Halle)	This study was supported by the Deutsche Forschungsgemeinschaft (DEG): grant GR 3415/1-5 (CG) and RTG 2155 ProMoAge SP11 (CG) as well as the European Section of the Aldosterone Council (ESAC) (SR) and ttaPKoM (Graduate School of Medicine, Halle) (BG)	Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Cheong JK, 2011, INT J BIOCHEM CELL B, V43, P465, DOI 10.1016/j.biocel.2010.12.004; Cozza G, 2016, EXPERT OPIN THER TAR, V20, P319, DOI 10.1517/14728222.2016.1091883; Cruciat CM, 2013, SCIENCE, V339, P1436, DOI 10.1126/science.1231499; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Faresse N, 2014, J STEROID BIOCHEM, V143, P334, DOI 10.1016/j.jsbmb.2014.04.015; Fuller PJ, 2017, J ENDOCRINOL, V234, pT23, DOI 10.1530/JOE-17-0060; Gadaleta RM, 2014, J MOL ENDOCRINOL, V52, pR137, DOI 10.1530/JME-13-0170; Gao XS, 2011, BMB REP, V44, P70, DOI 10.5483/BMBRep.2011.44.1.70; Giamas G, 2009, NUCLEIC ACIDS RES, V37, P3110, DOI 10.1093/nar/gkp136; Grossmann C, 2008, J BIOL CHEM, V283, P7109, DOI 10.1074/jbc.M708751200; Gumz ML, 2009, J CLIN INVEST, V119, P2423, DOI 10.1172/JCI36908; Guo YX, 2020, LIFE SCI, V245, DOI 10.1016/j.lfs.2020.117347; Han CJ, 2020, BRAIN BEHAV IMMUN, V88, P640, DOI 10.1016/j.bbi.2020.04.064; Horiuchi J, 2004, J BIOL CHEM, V279, P12117, DOI 10.1074/jbc.M212839200; Ihling A, 2015, J PROTEOME RES, V14, P3996, DOI 10.1021/acs.jproteome.5b00503; Kino T, 2010, MOL ENDOCRINOL, V24, P941, DOI 10.1210/me.2009-0395; Le Billan F, 2015, FASEB J, V29, P3977, DOI 10.1096/fj.15-274266; Lother A, 2015, ANNU REV PHARMACOL, V55, P289, DOI 10.1146/annurev-pharmtox-010814-124302; MEIER UT, 1992, CELL, V70, P127; MEIER UT, 1990, J CELL BIOL, V111, P2235, DOI 10.1083/jcb.111.6.2235; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P1158, DOI 10.1210/me.2004-0331; Pilipuk GP, 2007, BIOCHEMISTRY-US, V46, P1389, DOI 10.1021/bi0621819; Qiao YT, 2019, EUR J MED CHEM, V181, DOI 10.1016/j.ejmech.2019.111581; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Richards J, 2012, AM J PHYSIOL-RENAL, V303, pF918, DOI 10.1152/ajprenal.00678.2011; Ruhs S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15418-1; Sakai D, 2016, DEV GROWTH DIFFER, V58, P577, DOI 10.1111/dgd.12305; Schittek B, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-231; Shanware NP, 2007, J BIOL CHEM, V282, P6283, DOI 10.1074/jbc.M610674200; Shibata S, 2013, CELL METAB, V18, P660, DOI 10.1016/j.cmet.2013.10.005; Walther RF, 2005, J BIOL CHEM, V280, P17549, DOI 10.1074/jbc.M501548200; Wang CH, 2019, BBA-MOL CELL RES, V1866, P1282, DOI 10.1016/j.bbamcr.2019.03.014; Weigel NL, 1996, BIOCHEM J, V319, P657, DOI 10.1042/bj3190657; Werner A, 2015, NATURE, V525, P523, DOI 10.1038/nature14978; Yang J, 2014, MOL ENDOCRINOL, V28, P1571, DOI 10.1210/me.2014-1101; Yang J, 2009, J MOL ENDOCRINOL, V43, P53, DOI 10.1677/JME-09-0031; Yang PF, 2000, J BIOL CHEM, V275, P18905, DOI 10.1074/jbc.M002134200; Yasojima K, 2000, BRAIN RES, V865, P116, DOI 10.1016/S0006-8993(00)02200-9; Yong TJK, 2000, BBA-GENE STRUCT EXPR, V1492, P425, DOI 10.1016/S0167-4781(00)00146-9; Zhang PY, 2012, CANCER RES, V72, P1751, DOI 10.1158/0008-5472.CAN-11-3027	42	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22059	10.1096/fj.202100977RR	http://dx.doi.org/10.1096/fj.202100977RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34847273				2022-12-28	WOS:000734992000003
J	Gentili, M; Hidalgo-Garcia, L; Vezza, T; Ricci, E; Migliorati, G; Rodriguez-Nogales, A; Riccardi, C; Galvez, J; Ronchetti, S				Gentili, Marco; Hidalgo-Garcia, Laura; Vezza, Teresa; Ricci, Erika; Migliorati, Graziella; Rodriguez-Nogales, Alba; Riccardi, Carlo; Galvez, Julio; Ronchetti, Simona			A recombinant glucocorticoid-induced leucine zipper protein ameliorates symptoms of dextran sulfate sodium-induced colitis by improving intestinal permeability	FASEB JOURNAL			English	Article						colitis; dysbiosis; GILZ; glucocorticoids; microbiota	NF-KAPPA-B; BARRIER FUNCTION; T-LYMPHOCYTES; GILZ; EXPRESSION; INFLAMMATION; RECEPTOR; CELLS; MICE; GENE	Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders characterized by relapsing intestinal inflammation, but many details of pathogenesis remain to be fully unraveled. Glucocorticoid (GC)-induced leucine zipper (GILZ) is a mediator of the anti-inflammatory effects of GCs, the most powerful drugs for IBD treatment, but they cause several unwanted side effects. The fusion protein TAT-GILZ has been successfully used in some pre-clinical models of inflammatory and autoimmune diseases. To test the efficacy of TAT-GILZ for treating dextran sulfate sodium (DSS)-induced colitis and explore its impact on the gut microbiome, colitis was induced by DSS in C57BL/6J mice and treated with TAT-GILZ or dexamethasone. Various hallmarks of colitis were analyzed, including disease activity index, gut permeability, and expression of pro-inflammatory cytokines and tight junction proteins. TAT-GILZ treatment showed a therapeutic effect when administered after the onset of colitis. Its efficacy was associated with improved gut permeability, as evidenced by zonula occludens-1 and CD74 upregulation in inflamed colonic tissue. TAT-GILZ also ameliorated the changes in the gut microbiota induced by the DSS, thus potentially providing an optimal environment for colonization of the mucosa surface by beneficial bacteria. Overall, our results demonstrated for the first time that TAT-GILZ treatment proved effective after disease onset allowing restoration of gut permeability, a key pathogenic feature of colitis. Additionally, TAT-GILZ restored gut dysbiosis, thereby contributing to healing mechanisms. Interestingly, we found unprecedented effects of exogenous GILZ that did not overlap with those of GCs.	[Gentili, Marco; Ricci, Erika; Migliorati, Graziella; Riccardi, Carlo; Ronchetti, Simona] Univ Perugia, Dept Med & Surg, Pharmacol Div, I-06132 Perugia, Italy; [Hidalgo-Garcia, Laura; Vezza, Teresa; Rodriguez-Nogales, Alba; Galvez, Julio] Univ Granada, Ctr Biomed Res CIBM, Ibs GRANADA, CIBER EHD,Dept Pharmacol, Granada, Spain; [Hidalgo-Garcia, Laura; Vezza, Teresa; Rodriguez-Nogales, Alba; Galvez, Julio] Inst Invest Biosanitaria Granada Ibs GRANADA, Granada, Spain	University of Perugia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Instituto de Investigacion Biosanitaria IBS Granada	Ronchetti, S (corresponding author), Univ Perugia, Dept Med & Surg, Pharmacol Div, I-06132 Perugia, Italy.	simona.ronchetti@unipg.it	Gentili, Marco/ABA-7786-2021; Vezza, Teresa/ABB-9263-2021	Gentili, Marco/0000-0002-2305-4488; Vezza, Teresa/0000-0002-9780-0180; ronchetti, simona/0000-0002-5639-4243; Riccardi, Carlo/0000-0001-9257-3997	Italian Ministry of Education, Universities and Research [PRIN 2017B9NCSX]; Vini di Batasiolo S.p.A.; Junta de Andalucia [CTS 164]; Instituto de Salud Carlos III [PI19/1058, CP19/00191]; EMBO	Italian Ministry of Education, Universities and Research(Ministry of Education, Universities and Research (MIUR)); Vini di Batasiolo S.p.A.; Junta de Andalucia(Junta de Andalucia); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); EMBO(European Molecular Biology Organization (EMBO))	Italian Ministry of Education, Universities and Research, Grant/Award Number: PRIN 2017B9NCSX; Vini di Batasiolo S.p.A.; Junta de Andalucia, Grant/Award Number: CTS 164; Instituto de Salud Carlos III, Grant/Award Number: PI19/1058 and CP19/00191; EMBO	Asselin-Labat ML, 2005, MOL ENDOCRINOL, V19, P1752, DOI 10.1210/me.2004-0206; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayyar VS, 2017, J PHARMACOL EXP THER, V363, P45, DOI 10.1124/jpet.117.242990; Baban B, 2018, J PHARMACOL EXP THER, V367, P483, DOI 10.1124/jpet.118.251371; Bereshchenko O, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00308; Bereshchenko O, 2014, CELL REP, V7, P464, DOI 10.1016/j.celrep.2014.03.004; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; Bourchany A, 2020, CURR OPIN PHARMACOL, V54, P51, DOI 10.1016/j.coph.2020.07.012; Brodziak F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072317; Bruscoli S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01720; Cannarile L, 2006, BLOOD, V107, P1039, DOI 10.1182/blood-2005-05-2183; Cannarile L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01823; Cannarile L, 2009, GASTROENTEROLOGY, V136, P530, DOI 10.1053/j.gastro.2008.09.024; Cheng Q, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00169; Cheng Q, 2013, J IMMUNOL, V191, P424, DOI 10.4049/jimmunol.1202662; Crowe AR, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3465; Deriu E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005572; du Sert NP, 2020, BRIT J PHARMACOL, V177, P3617, DOI 10.1111/bph.15193; Erben U, 2014, INT J CLIN EXP PATHO, V7, P4557; Escoll P, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/347965; Espinasse MA, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0210-0; Esposito E, 2012, NEUROTHERAPEUTICS, V9, P210, DOI 10.1007/s13311-011-0084-7; Farr L, 2020, CELL MOL GASTROENTER, V10, P101, DOI 10.1016/j.jcmgh.2020.01.009; Farrell RJ, 2003, J ENDOCRINOL, V178, P339, DOI 10.1677/joe.0.1780339; FILMUS J, 1994, ONCOGENE, V9, P3627; Fischer A, 2014, AM J PHYSIOL-GASTR L, V306, pG218, DOI 10.1152/ajpgi.00095.2013; Fuss IJ, 2008, INFLAMM BOWEL DIS, V14, pS110, DOI 10.1002/ibd.20683; Garrido-Mesa J, 2018, BRIT J PHARMACOL, V175, P4353, DOI 10.1111/bph.14494; Gu RP, 2017, INVEST OPHTH VIS SCI, V58, P631, DOI 10.1167/iovs.16-20933; Gui XY, 2018, J CROHNS COLITIS, V12, P1448, DOI 10.1093/ecco-jcc/jjy116; Huang EY, 2015, INFLAMM BOWEL DIS, V21, P963, DOI 10.1097/MIB.0000000000000332; Joha S, 2012, ONCOGENE, V31, P1419, DOI 10.1038/onc.2011.328; Jones SA, 2015, J AUTOIMMUN, V61, P73, DOI 10.1016/j.jaut.2015.05.010; Kabat AM, 2014, TRENDS IMMUNOL, V35, P507, DOI 10.1016/j.it.2014.07.010; Kominsky DJ, 2014, J IMMUNOL, V192, P1267, DOI 10.4049/jimmunol.1301757; Leblanc JF, 2019, WORLD J GASTROENTERO, V25, P4158, DOI 10.3748/wjg.v25.i30.4158; Meddings JB, 2000, GASTROENTEROLOGY, V119, P1019, DOI 10.1053/gast.2000.18152; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Muzaki ARBM, 2016, MUCOSAL IMMUNOL, V9, P336, DOI 10.1038/mi.2015.64; Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851, DOI 10.1152/ajpgi.2000.279.5.G851; Pinheiro I, 2013, EMBO MOL MED, V5, P456, DOI 10.1002/emmm.201201683; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Pozzesi N, 2007, J CHEMOTHERAPY, V19, P562, DOI 10.1179/joc.2007.19.5.562; Ricci E, 2019, J LEUKOCYTE BIOL, V105, P187, DOI 10.1002/JLB.3AB0718-255R; Ricci E, 2017, FASEB J, V31, P3054, DOI 10.1096/fj.201601315R; Rodriguez-Nogales A, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700144; Ronchetti S, 2020, INFLAMM BOWEL DIS, V26, P1017, DOI [10.1093/ibd/irz331, 10.1093/ibd/izz331]; Ronchetti S, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00170; Roy U, 2017, CELL REP, V21, P994, DOI 10.1016/j.celrep.2017.09.097; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Sidoroff M, 2012, ANN MED, V44, P578, DOI 10.3109/07853890.2011.590521; Solitano V, 2020, EXPERT REV CLIN IMMU, V16, P1019, DOI 10.1080/1744666X.2021.1826311; Srinivasan M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160314; Srinivasan M, 2011, J BIOL CHEM, V286, P44799, DOI 10.1074/jbc.M111.279257; Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334; Thompson CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010335; Torii S, 2006, CANCER SCI, V97, P697, DOI 10.1111/j.1349-7006.2006.00244.x; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vago JP, 2020, PHARMACOL RES, V158, DOI 10.1016/j.phrs.2020.104842; Vago JP, 2015, J IMMUNOL, V194, P4940, DOI 10.4049/jimmunol.1401722; Venugopal S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225655; Wang Q, 2008, SHOCK, V29, P531, DOI 10.1097/SHK.0b013e318150737f; Windsor Joseph W, 2019, Curr Gastroenterol Rep, V21, P40, DOI 10.1007/s11894-019-0705-6; Xu CL, 2020, IMMUNITY, V53, P417, DOI 10.1016/j.immuni.2020.06.025; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200; Zimmer A, 2011, J IMMUNOL, V186, P3966, DOI 10.4049/jimmunol.1003184; Zong Y, 2019, NEUROGASTROENT MOTIL, V31, DOI 10.1111/nmo.13477; Zuo T, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02247	70	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21950	10.1096/fj.202100778RRRR	http://dx.doi.org/10.1096/fj.202100778RRRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34613638	Green Published			2022-12-28	WOS:000712009200054
J	Gohlke, S; Mancini, C; Garcia-Carrizo, F; Schulz, TJ				Gohlke, Sabrina; Mancini, Carola; Garcia-Carrizo, Francisco; Schulz, Tim J.			Loss of the ciliary gene Bbs4 results in defective thermogenesis due to metabolic inefficiency and impaired lipid metabolism	FASEB JOURNAL			English	Article						adipose tissue; Bbs4; BBsome; browning; cilium; lipid metabolism	BROWN ADIPOSE-TISSUE; BARDET-BIEDL-SYNDROME; SYNDROME PROTEINS; DIFFERENTIATION; IDENTIFICATION; ADIPOGENESIS; ADIPOCYTES; REVEALS; OBESITY; CELLS	Adipose tissue is central to the regulation of energy balance. While white adipose tissue (WAT) is responsible for triglyceride storage, brown adipose tissue specializes in energy expenditure. Deterioration of brown adipocyte function contributes to the development of metabolic complications like obesity and diabetes. These disorders are also leading symptoms of the Bardet-Biedl syndrome (BBS), a hereditary disorder in humans which is caused by dysfunctions of the primary cilium and which therefore belongs to the group of ciliopathies. The cilium is a hair-like organelle involved in cellular signal transduction. The BBSome, a supercomplex of several Bbs gene products, localizes to the basal body of cilia and is thought to be involved in protein sorting to and from the ciliary membrane. The effects of a functional BBSome on energy metabolism and lipid mobilization in brown and white adipocytes were tested in whole-body Bbs4 knockout mice that were subjected to metabolic challenges. Chronic cold exposure reveals cold-intolerance of knockout mice but also ameliorates the markers of metabolic pathology detected in knockouts prior to cold. Hepatic triglyceride content is markedly reduced in knockout mice while circulating lipids are elevated, altogether suggesting that defective lipid metabolism in adipose tissue creates increased demand for systemic lipid mobilization to meet energetic demands of reduced body temperatures. These findings taken together suggest that Bbs4 is essential for the regulation of adipose tissue lipid metabolism, representing a potential target to treat metabolic disorders.	[Gohlke, Sabrina; Mancini, Carola; Garcia-Carrizo, Francisco; Schulz, Tim J.] German Inst Human Nutr, Dept Adipocyte Dev & Nutr, Nuthetal, Germany; [Schulz, Tim J.] German Ctr Diabet Res DZD, Munich, Germany; [Schulz, Tim J.] Univ Potsdam, Inst Nutr Sci, Nuthetal, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Potsdam	Gohlke, S (corresponding author), German Inst Human Nutr, 114-116 Arthur Scheunert Allee, D-14558 Potsdam, Germany.	Sahrina.Gohlke@dife.de		Garcia-Carrizo, Francisco/0000-0002-2484-4000; Gohlke, Sabrina/0000-0001-9332-5637	Deutsche Forschungsgemeinschaft (DFG) [2445/5-1, 2445/2-1]; Bundesministerium fur Bildung und Forschung (BMBF); Paul--Ehrlich-Stiftung; Deutsches Zentrum fur Diabetesforschung DZD [82DZD00302, 82DZD0042G, 82DZD03C3G, 82DZD03D03]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Paul--Ehrlich-Stiftung; Deutsches Zentrum fur Diabetesforschung DZD	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: 2445/5-1 and 2445/2-1; Bundesministerium fur Bildung und Forschung (BMBF); Paul--Ehrlich-Stiftung; Deutsches Zentrum fur Diabetesforschung DZD, Grant/Award Number: 82DZD00302, 82DZD0042G, 82DZD03C3G and 82DZD03D03	Aksanov O, 2014, CELL MOL LIFE SCI, V71, P3381, DOI 10.1007/s00018-014-1571-x; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Benzinou M, 2006, DIABETES, V55, P2876, DOI 10.2337/db06-0337; Blondin DP, 2017, CELL METAB, V25, P438, DOI 10.1016/j.cmet.2016.12.005; Cannon B, 2000, METH MOL B, V155, P295; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Eichers ER, 2006, HUM GENET, V120, P211, DOI 10.1007/s00439-006-0197-y; Forti E, 2007, INT J BIOCHEM CELL B, V39, P1055, DOI 10.1016/j.biocel.2007.02.014; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gerdes JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6308; Gerdes JM, 2005, CELL MOL LIFE SCI, V62, P1556, DOI 10.1007/s00018-005-5007-5; Gohlke S, 2019, MOL METAB, V24, P1, DOI 10.1016/j.molmet.2019.03.011; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; HOLM C, 1987, BIOCHEM BIOPH RES CO, V148, P99, DOI 10.1016/0006-291X(87)91081-3; Hu QC, 2011, CYTOSKELETON, V68, P313, DOI 10.1002/cm.20514; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Labbe SM, 2015, FASEB J, V29, P2046, DOI 10.1096/fj.14-266247; Leitch CC, 2014, J CELL SCI, V127, P2407, DOI 10.1242/jcs.130344; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Marion V, 2012, CELL METAB, V16, P363, DOI 10.1016/j.cmet.2012.08.005; Marion V, 2009, P NATL ACAD SCI USA, V106, P1820, DOI 10.1073/pnas.0812518106; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nahum N, 2017, IUBMB LIFE, V69, P489, DOI 10.1002/iub.1626; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Novas R, 2015, FEBS LETT, V589, P3479, DOI 10.1016/j.febslet.2015.07.031; Parlee SD, 2014, METHOD ENZYMOL, V537, P93, DOI 10.1016/B978-0-12-411619-1.00006-9; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Rahmouni K, 2008, J CLIN INVEST, V118, P1458, DOI 10.1172/JCI32357; Richard D, 2011, FRONT BIOSCI-LANDMRK, V16, P1233, DOI 10.2741/3786; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Sen Gupta P, 2009, J ENDOCRINOL, V203, P327, DOI 10.1677/JOE-09-0116; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Steinbring J, 2017, METHODS MOL BIOL, V1566, P25, DOI 10.1007/978-1-4939-6820-6_4; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wingfield JL, 2018, ESSAYS BIOCHEM, V62, P753, DOI 10.1042/EBC20180030; Wu QW, 2006, DIABETES, V55, P3229, DOI 10.2337/db06-0749	41	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21966	10.1096/fj.202100772RR	http://dx.doi.org/10.1096/fj.202100772RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34624148	Green Published			2022-12-28	WOS:000712009200061
J	Lee, JJ; Alzamil, J; Rehman, S; Pan, WL; Dimke, H; Alexander, RT				Lee, Justin J.; Alzamil, Jawad; Rehman, Saba; Pan, Wanling; Dimke, Henrik; Alexander, R. Todd			Activation of the calcium sensing receptor increases claudin-14 expression via a PLC-p38-Sp1 pathway	FASEB JOURNAL			English	Article						calcium homeostasis; claudins; urine calcium excretion	KINASE KINASE KINASE; EXTRACELLULAR CALCIUM; STONE COMPOSITION; KIDNEY-STONES; PROTEIN; CA2+; CELLS; SP1; PHOSPHORYLATION; NEPHROLITHIASIS	Activation of the basolateral calcium sensing receptor (CaSR) in the renal tubular thick ascending limb (TAL) increases claudin-14 expression, which reduces paracellular calcium (Ca2+) permeability, thus increasing urinary Ca2+ excretion. However, the upstream signaling pathway contributing to altered CLDN14 gene expression is unknown. To delineate this pathway, we identified and then cloned the CaSR responsive region including the promoter of mouse Cldn14 into a luciferase reporter vector. This 1500 bp sequence upstream of the 5' UTR of Cldn14 variant 1, conferred increased reporter activity in the presence of high extracellular Ca2+ (5 mM) relative to a lower (0.5 mM) concentration. Assessment of Cldn14 reporter activity in response to increased extracellular Ca2+ in the presence or absence of specific inhibitors confirmed signaling through PLC and p38, but not JNK. Overexpression of SP1 attenuated Cldn14 reporter activity in response to CasR signaling. SP1 is expressed in the TAL and phosphorylation was attenuated by CaSR signaling. Finally, activating mutations in the CaSR increased Cldn14 reporter activity while a dominant negative mutation in the CaSR inhibited it. Together, these studies suggest that basolateral activation of the CASR leads to increased Cldn14 expression via a PLC- stimulated p38 pathway that prevents Sp1 mediated repression.	[Lee, Justin J.; Alzamil, Jawad; Rehman, Saba; Pan, Wanling; Alexander, R. Todd] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Lee, Justin J.; Alexander, R. Todd] Womens & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Dimke, Henrik] Univ Southern Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, Odense, Denmark; [Dimke, Henrik] Odense Univ Hosp, Dept Nephrol, Odense, Denmark; [Alexander, R. Todd] Univ Alberta, Dept Pediat, Edmonton, AB, Canada	University of Alberta; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Alberta	Alexander, RT (corresponding author), Univ Alberta, Dept Pediat, Edmonton Clin Hlth Acad 4 585, 11405 87th Ave, Edmonton, AB T6G 2R7, Canada.	todd2@ualberta.ca	Dimke, Henrik/G-7970-2011	Dimke, Henrik/0000-0002-9170-2168	Canadian Institutes for Health Research [CIHR MOP 136891]; Independent Research Fund Denmark	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Independent Research Fund Denmark	This work was funded by grants from the Canadian Institutes for Health Research to Dr RT Alexander, CIHR MOP 136891. The laboratory of H. Dimke is supported by the Independent Research Fund Denmark	Abdullah HI, 2008, AM J PHYSIOL-RENAL, V294, pF345, DOI 10.1152/ajprenal.00509.2006; Alexander RT, 2015, AM J PHYSIOL-RENAL, V309, pF604, DOI 10.1152/ajprenal.00651.2014; Alexander RT, 2014, BIOCHEM CELL BIOL, V92, P467, DOI 10.1139/bcb-2014-0061; An HJ, 2016, MOL CELL BIOCHEM, V414, P201, DOI 10.1007/s11010-016-2672-7; Blaine J, 2015, CLIN J AM SOC NEPHRO, V10, P1257, DOI 10.2215/CJN.09750913; Bonny O, 2013, AM J PHYSIOL-RENAL, V304, pF585, DOI 10.1152/ajprenal.00493.2012; Brown EM, 2013, BEST PRACT RES CL EN, V27, P333, DOI 10.1016/j.beem.2013.02.006; BROWN EM, 1978, ENDOCRINOLOGY, V103, P2323, DOI 10.1210/endo-103-6-2323; Canadillas S, 2010, AM J PHYSIOL-RENAL, V298, pF1197, DOI 10.1152/ajprenal.00529.2009; Chu SJ, 2012, GENE, V508, P1, DOI 10.1016/j.gene.2012.07.022; Conigrave AD, 2004, J BIOL CHEM, V279, P38151, DOI 10.1074/jbc.M406373200; Conigrave AD, 2013, BEST PRACT RES CL EN, V27, P315, DOI 10.1016/j.beem.2013.05.010; Dimke H, 2013, AM J PHYSIOL-RENAL, V304, pF761, DOI 10.1152/ajprenal.00263.2012; Eng B, 2007, AM J PHYSIOL-RENAL, V293, pF1413, DOI 10.1152/ajprenal.00426.2006; ETTINGER B, 1988, J UROLOGY, V139, P679, DOI 10.1016/S0022-5347(17)42599-7; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Frassetto L, 2011, AM FAM PHYSICIAN, V84, P1234; Gong YF, 2014, J AM SOC NEPHROL, V25, P745, DOI 10.1681/ASN.2013050553; Gong YF, 2012, EMBO J, V31, P1999, DOI 10.1038/emboj.2012.49; Honda H, 2007, CANCER BIOL THER, V6, P1733, DOI 10.4161/cbt.6.11.4832; Honda H, 2006, J BIOL CHEM, V281, P21433, DOI 10.1074/jbc.M603767200; Horinouchi T, 2020, J PHARMACOL SCI, V143, P315, DOI 10.1016/j.jphs.2019.06.009; Kifor O, 2001, AM J PHYSIOL-RENAL, V280, pF291, DOI 10.1152/ajprenal.2001.280.2.F291; LAERUM E, 1984, ACTA MED SCAND, V215, P383; Lee JY, 2018, BEST PRACT RES CL EN, V32, P609, DOI 10.1016/j.beem.2018.05.004; Lee JJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.128013; LEVY FL, 1995, AM J MED, V98, P50, DOI 10.1016/S0002-9343(99)80080-1; Li SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep25754; Lieske JC, 2014, CLIN J AM SOC NEPHRO, V9, P2141, DOI 10.2215/CJN.05660614; Loupy A, 2012, J CLIN INVEST, V122, P3355, DOI 10.1172/JCI57407; Negri AL, 2015, NEFROLOGIA, V35, P347, DOI 10.1016/j.nefro.2015.06.011; Maiti A, 2008, J BIOL CHEM, V283, P175, DOI 10.1074/jbc.M707269200; Moor MB, 2016, AM J PHYSIOL-RENAL, V310, pF1337, DOI 10.1152/ajprenal.00273.2015; Nesbit MA, 2013, NEW ENGL J MED, V368, P2476, DOI 10.1056/NEJMoa1300253; Plain A, 2016, PFLUG ARCH EUR J PHY, V468, P293, DOI 10.1007/s00424-015-1748-7; Riccardi D, 1998, AM J PHYSIOL-RENAL, V274, pF611, DOI 10.1152/ajprenal.1998.274.3.F611; Roszko KL, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00458; Saigal CS, 2005, KIDNEY INT, V68, P1808, DOI 10.1111/j.1523-1755.2005.00599.x; Singh P, 2015, MAYO CLIN PROC, V90, P1356, DOI 10.1016/j.mayocp.2015.07.016; Takeda K, 2007, J BIOL CHEM, V282, P7522, DOI 10.1074/jbc.M607177200; Thorleifsson G, 2009, NAT GENET, V41, P926, DOI 10.1038/ng.404; Toka HR, 2015, PHYSIOLOGY, V30, P317, DOI 10.1152/physiol.00042.2014; Ure ME, 2017, HUM MUTAT, V38, P649, DOI 10.1002/humu.23202; Wang XHSN, 1998, BIOCHEM BIOPH RES CO, V253, P33, DOI 10.1006/bbrc.1998.9749; Wiebe SA, 2019, AM J PHYSIOL-RENAL, V317, pF240, DOI 10.1152/ajprenal.00329.2018; Wu XC, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11121141; Zhen YL, 2016, AM J TRANSL RES, V8, P911	47	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21982	10.1096/fj.202002137RRR	http://dx.doi.org/10.1096/fj.202002137RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34694654	Green Published, hybrid			2022-12-28	WOS:000712009200024
J	Moss, JJ; Wirth, M; Tooze, SA; Lane, JD; Hammond, CL				Moss, Joanna J.; Wirth, Martina; Tooze, Sharon A.; Lane, Jon D.; Hammond, Chrissy L.			Autophagy coordinates chondrocyte development and early joint formation in zebrafish	FASEB JOURNAL			English	Article						Atg13; autophagy; chondrocytes; joints; zebrafish	ULK1 COMPLEX; NONCANONICAL AUTOPHAGY; MAMMALIAN DEVELOPMENT; SIGNALING PATHWAYS; TARGETED DELETION; CELL-DEATH; CARTILAGE; GROWTH; SOX9; PROMOTES	Autophagy is a catabolic process responsible for the removal of waste and damaged cellular components by lysosomal degradation. It plays a key role in fundamental cell processes, including ER stress mitigation, control of cell metabolism, and cell differentiation and proliferation, all of which are essential for cartilage cell (chondrocyte) development and survival, and for the formation of cartilage. Correspondingly, autophagy dysregulation has been implicated in several skeletal disorders such as osteoarthritis and osteoporosis. To test the requirement for autophagy during skeletal development in zebrafish, we generated an atg13 CRISPR knockout zebrafish line. This line showed a complete loss of atg13 expression, and restricted autophagic activity in vivo. In the absence of autophagy, chondrocyte maturation was accelerated, with chondrocytes exhibiting signs of premature hypertrophy. Focussing on the jaw element, autophagy disruption affected joint articulation causing restricted mouth opening. This gross behavioural phenotype corresponded with a failure to thrive, and death in homozygote atg13 nulls within 17 days. Taken together, our results are consistent with autophagy contributing to the timely regulation of chondrocyte maturation and for extracellular matrix formation.	[Moss, Joanna J.; Lane, Jon D.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Moss, Joanna J.; Hammond, Chrissy L.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England; [Wirth, Martina; Tooze, Sharon A.] Francis Crick Inst, Mol Cell Biol Autophagy, London, England; [Wirth, Martina] Leiden Univ, Dept Cell & Chem Biol, Med Ctr, Leiden, Netherlands	University of Bristol; University of Bristol; Francis Crick Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hammond, CL (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England.	chrissy.hammond@bristol.ac.uk	Moss, Joanna/GYU-6732-2022; Hammond, Chrissy/D-6568-2013	Moss, Joanna/0000-0003-1690-6512; Hammond, Chrissy/0000-0002-4935-6724; Lane, Jon/0000-0002-6828-5888; Wirth, Martina/0000-0002-3210-8644	Wellcome Trust Dynamic Molecular Cell Biology PhD Programme at the University of Bristol [083474]; The Francis Crick Institute - Cancer Research UK [FC001187, FC001999]; UK Medical Research Council [FC001187, FC001999]; Wellcome Trust [FC001187, FC001999]; European Union Marie Curie fellowship [IEF-330396]; Versus Arthritis senior fellowship [21937]	Wellcome Trust Dynamic Molecular Cell Biology PhD Programme at the University of Bristol(Wellcome Trust); The Francis Crick Institute - Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Union Marie Curie fellowship(European Commission); Versus Arthritis senior fellowship	Joanna J. Moss was funded by the Wellcome Trust Dynamic Molecular Cell Biology PhD Programme at the University of Bristol (083474). Martina Wirth and Sharon A. Tooze were supported by The Francis Crick Institute which receives its core funding from Cancer Research UK (FC001187, FC001999), the UK Medical Research Council (FC001187, FC001999) and the Wellcome Trust (FC001187, FC001999). Martina Wirth had been supported by a European Union Marie Curie fellowship IEF-330396. Chrissy L. Hammond was funded by Versus Arthritis senior fellowship 21937.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akkiraju H, 2015, J DEV BIOL, V3, P177, DOI 10.3390/jdb3040177; Alers S, 2014, AUTOPHAGY, V10, P944, DOI 10.4161/auto.28987; Alers S, 2011, AUTOPHAGY, V7, P1424, DOI 10.4161/auto.7.12.18027; Alestrom P, 2020, LAB ANIM-UK, V54, P213, DOI 10.1177/0023677219869037; [Anonymous], 2019, MIA VERSION 0 9 30; [Anonymous], 2017, J ARTHRITIS; Askary A, 2016, ELIFE, V5, DOI 10.7554/eLife.16415; Baker-LePain JC, 2010, CURR OPIN RHEUMATOL, V22, P538, DOI 10.1097/BOR.0b013e32833d20ae; Beck M, 2005, J BONE JOINT SURG BR, V87B, P1012, DOI 10.1302/0301-620X.87B7.15203; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bouderlique T, 2016, ANN RHEUM DIS, V75, P627, DOI 10.1136/annrheumdis-2015-207742; Brunt LH, 2017, DEVELOPMENT, V144, P2798, DOI 10.1242/dev.153528; Cadwell K, 2018, J CELL BIOL, V217, P813, DOI 10.1083/jcb.201706157; Carames B, 2010, ARTHRITIS RHEUM-US, V62, P791, DOI 10.1002/art.27305; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chang J, 2013, INT J MOL MED, V32, P1311, DOI 10.3892/ijmm.2013.1520; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Chavez MN, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59106-z; Chiang EFL, 2001, DEV BIOL, V231, P149, DOI 10.1006/dbio.2000.0129; Cinque L, 2015, NATURE, V528, P272, DOI 10.1038/nature16063; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Davidson LA, 2010, J BIOMECH, V43, P63, DOI 10.1016/j.jbiomech.2009.09.010; Deegan S, 2013, CELL MOL LIFE SCI, V70, P2425, DOI 10.1007/s00018-012-1173-4; Di Bartolomeo S, 2010, TRAFFIC, V11, P1280, DOI 10.1111/j.1600-0854.2010.01103.x; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Dodds GS, 1930, ANAT REC, V46, P385, DOI 10.1002/ar.1090460409; Dreier R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3117; Duan R, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.608388; Faber BG, 2017, OSTEOARTHR CARTILAGE, V25, P2031, DOI 10.1016/j.joca.2017.09.006; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Hammond CL, 2009, DEVELOPMENT, V136, P3991, DOI 10.1242/dev.042150; He CC, 2009, AUTOPHAGY, V5, P520, DOI 10.4161/auto.5.4.7768; Hegedus K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/470482; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; Hernandez LP, 2002, INTEGR COMP BIOL, V42, P222, DOI 10.1093/icb/42.2.222; Hieke N, 2015, AUTOPHAGY, V11, P1471, DOI 10.1080/15548627.2015.1068488; Horigome Y, 2020, AUTOPHAGY, V16, P501, DOI 10.1080/15548627.2019.1628541; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Ikegami D, 2011, DEVELOPMENT, V138, P1507, DOI 10.1242/dev.057802; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jao CC, 2013, P NATL ACAD SCI USA, V110, P5486, DOI 10.1073/pnas.1220306110; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jeon H, 2017, CONNECT TISSUE RES, V58, P497, DOI 10.1080/03008207.2016.1240790; Kaizuka T, 2016, MOL CELL BIOL, V36, P585, DOI 10.1128/MCB.01005-15; Kang XM, 2017, J BONE MINER RES, V32, P2128, DOI 10.1002/jbmr.3134; Karanasios E, 2013, J CELL SCI, V126, P5224, DOI 10.1242/jcs.132415; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kraft C, 2012, EMBO J, V31, P3691, DOI 10.1038/emboj.2012.225; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kuma A, 2017, AUTOPHAGY, V13, P1619, DOI 10.1080/15548627.2017.1343770; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048; Li YS, 2016, JOINT BONE SPINE, V83, P143, DOI 10.1016/j.jbspin.2015.06.009; Liang QQ, 2012, AUTOPHAGY, V8, P1426, DOI 10.4161/auto.21163; Litwic A, 2013, BRIT MED BULL, V105, P185, DOI 10.1093/bmb/lds038; Mawed SA., 2021, AQUACULT FISH, DOI [10.1016/j.aaf.2021.01.002, DOI 10.1016/J.AAF.2021.01.002]; Mercer TJ, 2018, J BIOL CHEM, V293, P5386, DOI 10.1074/jbc.R117.810366; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Montero JA, 2021, DEV DYNAM, V250, P1236, DOI 10.1002/dvdy.237; Morishita H, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108477; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Neogi T, 2013, OSTEOARTHR CARTILAGE, V21, P1145, DOI 10.1016/j.joca.2013.03.018; Neufeld TP, 2012, J CELL SCI, V125, P2359, DOI 10.1242/jcs.103333; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Nollet M, 2014, AUTOPHAGY, V10, P1965, DOI 10.4161/auto.36182; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park JM, 2016, AUTOPHAGY, V12, P547, DOI 10.1080/15548627.2016.1140293; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Qi SQ, 2015, STRUCTURE, V23, P1848, DOI 10.1016/j.str.2015.07.011; Rabanal-Ruiz Y, 2017, ESSAYS BIOCHEM, V61, P565, DOI 10.1042/EBC20170027; Samsa WE, 2017, SEMIN CELL DEV BIOL, V62, P3, DOI 10.1016/j.semcdb.2016.07.008; Santos-Ledo A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006918; Sasaki T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004409; Schilling TF, 1997, DEVELOPMENT, V124, P2945; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Srinivas V, 2009, CELLS TISSUES ORGANS, V189, P88, DOI 10.1159/000151428; Tettamanti G, 2019, EUR ZOOL J, V86, P113, DOI 10.1080/24750263.2019.1601271; Tian E, 2009, AUTOPHAGY, V5, P608, DOI 10.4161/auto.5.5.8624; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Vuppalapati KK, 2015, J BONE MINER RES, V30, P2249, DOI 10.1002/jbmr.2575; Waarsing JH, 2010, OSTEOARTHR CARTILAGE, V18, P787, DOI 10.1016/j.joca.2010.02.003; Wilkinson RN, 2013, BIOTECHNIQUES, V55, P314, DOI 10.2144/000114116; Yan YL, 2005, DEVELOPMENT, V132, P1069, DOI 10.1242/dev.01674; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zachari M, 2017, ESSAYS BIOCHEM, V61, P585, DOI 10.1042/EBC20170021; Zhou XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016358	92	2	3	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e22002	10.1096/fj.202101167R	http://dx.doi.org/10.1096/fj.202101167R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34708458	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000712009200040
J	Wang, YM; Zheng, XM; Cheng, R; Han, J; Ma, X; Xu, WJ; Gao, L; Lei, AM; Liu, J; Quan, FS; Zhang, Y; Liu, X				Wang, Yingmei; Zheng, Xiaoman; Cheng, Rui; Han, Jing; Ma, Xing; Xu, Wenjun; Gao, Lu; Lei, Anmin; Liu, Jun; Quan, Fusheng; Zhang, Yong; Liu, Xu			Asymmetric expression of maternal mRNA governs first cell-fate decision	FASEB JOURNAL			English	Article						cell-fate decision; embryonic development; HMGA1; maternal mRNA	GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; HMGA PROTEINS; MOUSE; TROPHECTODERM; PLURIPOTENCY; LINEAGE; SOX2; SPECIFICATION; METHYLATION	The goal of preimplantation development is to establish the fates of the embryonic and extra-embryonic cells. However, when and how cell fates are determined during early mammalian embryonic development remains unclear. We report that the high mobility group (HMG) protein family member HMGA1 was distributed differentially in mouse two-cell blastomeres. Knockdown of Hmga1 expression in one of the two cells reduced the number of cells contributing to the inner cell mass (ICM), suggesting that differential distribution of HMGA1 in the blastomeres in two-cell mouse embryos affected the selection of embryonic cell lineages. Mechanistically, HMGA1 promotes the expression of the ICM-specific gene Sox2. The results of this study show that mouse embryos demonstrate heterogeneity as early as the two-cell stage, and that these differences are related to cell-fate differentiation in early mouse embryos.	[Wang, Yingmei; Zheng, Xiaoman; Cheng, Rui; Han, Jing; Ma, Xing; Xu, Wenjun; Gao, Lu; Liu, Jun; Quan, Fusheng; Zhang, Yong; Liu, Xu] Northwest A&F Univ, Coll Vet Med, Key Lab Anim Biotechnol, Minist Agr, Yangling 712100, Shaanxi, Peoples R China; [Lei, Anmin] Northwest A&F Univ, Coll Vet Med, Shaanxi Stem Cell Engn & Technol Ctr, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China	Zhang, Y; Liu, X (corresponding author), Northwest A&F Univ, Coll Vet Med, Key Lab Anim Biotechnol, Minist Agr, Yangling 712100, Shaanxi, Peoples R China.	zhy1956@yeah.net; liuxu1658@163.com		LEI, An-min/0000-0002-5066-8709	NSFC \ National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund) [31802153]; Northwest A and F University (NWAFU) [Z111021512, Z109021702]; Natural Science Foundation of Shaanxi Province (Shaanxi Province Natural Science Foundation) [2018JQ3035]	NSFC \ National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund); Northwest A and F University (NWAFU); Natural Science Foundation of Shaanxi Province (Shaanxi Province Natural Science Foundation)	NSFC vertical bar National Natural Science Foundation of China--Yunnan Joint Fund (NSFC-Yunnan Joint Fund), Grant/Award Number: 31802153; Northwest A and F University (NWAFU), Grant/Award Number: Z111021512 and Z109021702; Natural Science Foundation of Shaanxi Province (Shaanxi Province Natural Science Foundation), Grant/Award Number: 2018JQ3035	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Blase FH, 2014, GENOME RES, V24, P1787, DOI 10.1101/gr.177725.114; Casser E, 2017, SCI REP-UK, V7, P10, DOI 10.1038/s41598-017-08266-6; Chiappetta G, 1996, ONCOGENE, V13, P2439; CHIAPPETTA G, 1995, ONCOGENE, V10, P1307; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; Dard N, 2004, DEV BIOL, V271, P87, DOI 10.1016/j.ydbio.2004.03.024; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Fedele M, 2006, CELL CYCLE, V5, P2045, DOI 10.4161/cc.5.18.3211; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Goolam M, 2016, CELL, V165, P61, DOI 10.1016/j.cell.2016.01.047; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hillion J, 2012, PANCREATOLOGY, V12, P372, DOI 10.1016/j.pan.2012.05.005; Jedrusik A, 2008, GENE DEV, V22, P2692, DOI 10.1101/gad.486108; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; Kim M, 2014, HUM MOL GENET, V23, P657, DOI 10.1093/hmg/ddt453; Moor AE, 2017, SCIENCE, V357, P1299, DOI 10.1126/science.aan2399; Morris SA, 2012, CELL REP, V2, P756, DOI 10.1016/j.celrep.2012.08.029; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Pierantoni GM, 2005, ENDOCR-RELAT CANCER, V12, P867, DOI 10.1677/erc.1.01049; Piotrowska-Nitsche K, 2005, DEVELOPMENT, V132, P479, DOI 10.1242/dev.01602; Plachta N, 2011, NAT CELL BIOL, V13, P117, DOI 10.1038/ncb2154; Plusa B, 2005, J CELL SCI, V118, P505, DOI 10.1242/jcs.01666; Reeves R, 2003, BIOCHEM CELL BIOL, V81, P185, DOI 10.1139/o03-044; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Sgarra R, 2010, BBA-GENE REGUL MECH, V1799, P37, DOI 10.1016/j.bbagrm.2009.08.009; Shah SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048533; Shi JC, 2015, DEVELOPMENT, V142, P3468, DOI 10.1242/dev.123950; Singer-Kruger B, 2014, RNA BIOL, V11, P1031, DOI 10.4161/rna.29945; Tabansky I, 2013, CURR BIOL, V23, P21, DOI 10.1016/j.cub.2012.10.054; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Wang JQ, 2018, CELL, V175, P1887, DOI 10.1016/j.cell.2018.11.039; White MD, 2016, CELL, V165, P75, DOI 10.1016/j.cell.2016.02.032; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Yao Chunmeng, 2019, Cell Regen, V8, P51, DOI 10.1016/j.cr.2019.10.001; Zernicka-Goetz MZ, 2005, NAT REV MOL CELL BIO, V6, P919, DOI 10.1038/nrm1782; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	41	0	0	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e22006	10.1096/fj.202101196R	http://dx.doi.org/10.1096/fj.202101196R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34694646				2022-12-28	WOS:000712009200052
J	Aushev, VN; Li, Q; Deyssenroth, M; Zhang, W; Finik, J; Hurd, YL; Nomura, Y; Chen, J				Aushev, Vasily N.; Li, Qian; Deyssenroth, Maya; Zhang, Wei; Finik, Jackie; Hurd, Yasmin L.; Nomura, Yoko; Chen, Jia			Placental gene network modules are associated with maternal stress during pregnancy and infant temperament	FASEB JOURNAL			English	Article						infant temperament; maternal stress; placental genes	SYMPTOMS; BEHAVIOR; ORIGINS; HEALTH	Maternal psychosocial stress during pregnancy (MPSP) is a known contributor to maladaptive neurobehavioral development of the offspring; however, the underlying molecular mechanisms linking MPSP with childhood outcome remain largely unknown. Transcriptome-wide gene expression data were generated using RNA-seq from placenta samples collected in a multi-ethnic urban birth cohort in New York City (n = 129). Weighted gene co-expression network analysis (WGCNA) was used to characterize placental co-expression modules, which were then evaluated for their associations with MPSP and infant temperament. WGCNA revealed 16 gene coexpression modules. One module, enriched for regulation of chromosome organization/gene expression, was positively associated with MPSP and negatively associated with Regulatory Capacity (REG), a component of infant temperament. Two other modules, enriched for cotranslational protein targeting and cell cycle regulation, respectively, displayed negative associations with MPSP and positive associations with REG. A module enriched with oxidative phosphorylation/mitochondrial translation was positively associated with REG. These findings support the notion that the placenta provides a functional in utero link between MPSP and infant temperament, possibly through transcriptional regulation of placental gene expression.	[Aushev, Vasily N.; Li, Qian; Nomura, Yoko; Chen, Jia] Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA; [Deyssenroth, Maya] Columbia Univ, Dept Environm Hlth Sci, New York, NY USA; [Zhang, Wei] New Jersey City Univ, Dept Psychol, Jersey City, NJ USA; [Finik, Jackie; Nomura, Yoko] CUNY, Dept Psychol, Queens Coll, Flushing, NY USA; [Finik, Jackie] CUNY, Dept Epidemiol & Biostat, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA; [Hurd, Yasmin L.] Icahn Sch Med Mt Sinai, Addict Inst Mt Sinai, Psychiat & Neurosci, New York, NY 10029 USA; [Chen, Jia] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Chen, Jia] Icahn Sch Med Mt Sinai, Dept Med Hematol & Med Oncol, New York, NY 10029 USA; [Chen, Jia] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Columbia University; City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Nomura, Y; Chen, J (corresponding author), Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA.	yoko.nomura@qc.cuny.edu; jia.chen@mssm.edu			National Institutes of Health [R01 MH102729, R01ES029212, P30ES023515, R01HD067611]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the grant from the National Institutes of Health (R01 MH102729) and in part by grants (R01ES029212; P30ES023515, R01HD067611).	Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Boyd RC, 2006, MATERN CHILD HLTH J, V10, P139, DOI 10.1007/s10995-005-0042-2; Bridgett DJ, 2009, INFANT BEHAV DEV, V32, P103, DOI 10.1016/j.infbeh.2008.10.007; Buckberry S, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3384-9; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cox B, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00354; Deyssenroth MA, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3878-0; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edhborg M, 2001, J REPROD INFANT PSYC, V19, P61, DOI 10.1080/02646830123255; Finik J, 2017, INT J EPIDEMIOL, V46, P1388, DOI 10.1093/ije/dyw264; Fleming TP, 2018, LANCET, V391, P1842, DOI [10.1016/S0140-6736(18)30312-X, 10.1016/s0140-6736(18)30312-x]; Gartstein MA, 2003, INFANT BEHAV DEV, V26, P64, DOI 10.1016/S0163-6383(02)00169-8; Gray J. A., 1991, EXPLORATIONS TEMPERA, P105, DOI [DOI 10.1007/978-1-4899-0643-4_8, 10.1007/978-1-4899-0643-4_8, 10.1007/978-1-4899-0643-4]; Hemberger M, 2020, NAT REV GENET, V21, P27, DOI 10.1038/s41576-019-0169-4; Hsiao EY, 2012, DEV NEUROBIOL, V72, P1317, DOI 10.1002/dneu.22045; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Nomura Y, 2019, INFANT MENT HEALTH J, V40, P204, DOI 10.1002/imhj.21766; O'Connor TG, 2003, J CHILD PSYCHOL PSYC, V44, P1025, DOI 10.1111/1469-7610.00187; O'Donnell KJ, 2017, AM J PSYCHIAT, V174, P319, DOI 10.1176/appi.ajp.2016.16020138; Pauli-Pott U, 2004, DEV PSYCHOPATHOL, V16, P19, DOI 10.1017/S0954579404040398; Pehme PM, 2018, INFANT CHILD DEV, V27, DOI 10.1002/icd.2094; Peterson ER, 2018, EARLY EDUC DEV, V29, P435, DOI 10.1080/10409289.2018.1457391; Putnam SP, 2008, INFANT CHILD DEV, V17, P387, DOI 10.1002/ICD.582; Rahnenfuhrer J, 2021, TOPGO ENRICHMENT ANA; Rodriguez A, 2005, J CHILD PSYCHOL PSYC, V46, P246, DOI 10.1111/j.1469-7610.2004.00359.x; Rothbart M.K., 1998, HDB CHILD PSYCHOL, P105, DOI DOI 10.1002/9780470147658.CHPSY0303; ROTHBART MK, 1994, MERRILL PALMER QUART, V40, P21; St-Pierre J, 2018, PSYCHONEUROENDOCRINO, V94, P38, DOI 10.1016/j.psyneuen.2018.04.027; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tingley D, 2014, J STAT SOFTW, V59; Toffol E, 2019, EUR CHILD ADOLES PSY, V28, P847, DOI 10.1007/s00787-018-1243-8; Wyatt SM, 2005, PLACENTA, V26, P372, DOI 10.1016/j.placenta.2004.07.003; Zhang W, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12581; Zhang W, 2018, J AFFECT DISORDERS, V234, P335, DOI 10.1016/j.jad.2018.02.067; Zhao XM, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.515	38	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21922	10.1096/fj.202100144RRR	http://dx.doi.org/10.1096/fj.202100144RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34533879	Green Accepted			2022-12-28	WOS:000702238200022
J	Butenko, S; Ben Jashar, N; Sheffer, T; Sabo, E; Schif-Zuck, S; Ariel, A				Butenko, Sergei; Ben Jashar, Nofar; Sheffer, Tsofiya; Sabo, Edmond; Schif-Zuck, Sagie; Ariel, Amiram			ACKR2 limits skin fibrosis and hair loss through IFN-beta	FASEB JOURNAL			English	Article						ACKR2; collagen deposition; IFN-beta; resolving inflammation; skin fibrosis	CHEMOKINE RECEPTOR D6; TISSUE-REPAIR; INFLAMMATION; INTERFERON; RESOLUTION; MACROPHAGES; TRANSITION; MEDIATORS	The resolution of inflammation facilitates proper wound healing and limits tissue repair short of exaggerated fibrotic scarring. The atypical chemokine receptor (ACKR)2/D6 scavenges inflammatory chemokines, while IFN-beta is a recently unveiled pro-resolving cytokine. Both effector molecules limit acute inflammatory episodes and promote their resolution in various organs. Here, we found fibrotic skin lesions from ACKR2(-/-) mice presented increased epidermal and dermal thickening, atrophy of the subcutaneous adipose tissue, augmented disorientation of collagen deposition, and enhanced deformation and loss of hair follicles compared to WT counterparts. In addition, affected skin sections from ACKR2(-/-) mice contained reduced levels of the pro-resolving mediators IFN-beta and IL-10, but increased levels of the pro-inflammatory chemokines CCL2 and 3, the pro-fibrotic cytokine TGF-beta, and the immune-stimulating cytokine IL-12. Notably, treatment with exogenous IFN-beta rescued, at least in part, all the pro-fibrotic outcomes and lesion size in ACKR2(-/-) mice and promoted expression of the pro-resolving enzyme 12/15-lipoxygenase (LO) in both ACKR2(-/-) and WT mice. Moreover, Ifnb(-/-) mice displayed enhanced pro-fibrotic indices upon exposure to bleomycin. These findings suggest ACKR2 is an important mediator in limiting inflammatory skin fibrosis and acts via IFN-beta production to promote the resolution of inflammation and minimize tissue scaring.	[Butenko, Sergei; Ben Jashar, Nofar; Sheffer, Tsofiya; Schif-Zuck, Sagie; Ariel, Amiram] Univ Haifa, Dept Biol & Human Biol, Haifa, Israel; [Sabo, Edmond] Carmel Hosp, Inst Pathol, Haifa, Israel	University of Haifa; Clalit Health Services; Carmel Medical Center	Ariel, A (corresponding author), Univ Haifa, Dept & Luman Biol, 199 Aba Khoushy Ave, IL-3498838 Haifa, Israel.	amiram@research.haifa.ac.il	Butenko, Sergei/ABE-6515-2021	Butenko, Sergei/0000-0001-9759-9897	Israel Science Foundation [678/13]; Rosetrees Trust; Wolfson Family Charitable Trust; University of Haifa	Israel Science Foundation(Israel Science Foundation); Rosetrees Trust(Rosetrees Trust); Wolfson Family Charitable Trust; University of Haifa	The study was supported by grants from the Israel Science Foundation (Grant No. 678/13), the Rosetrees Trust, and the Wolfson Family Charitable Trust. S.B. is a recipient of a presidential scholarship from the University of Haifa.	Ariel A, 2005, J BIOL CHEM, V280, P43079, DOI 10.1074/jbc.M509796200; Ariel A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00004; Aswad M, 2017, J IMMUNOL, V199, P1393, DOI 10.4049/jimmunol.1502542; Avouac J, 2014, METHODS MOL BIOL, V1142, P91, DOI 10.1007/978-1-4939-0404-4_11; Azuma A, 2005, AM J RESP CELL MOL, V32, P93, DOI 10.1165/rcmb.2003-0374OC; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bazzan E, 2013, CHEST, V143, P98, DOI 10.1378/chest.11-3220; Bideak A, 2018, KIDNEY INT, V93, P826, DOI 10.1016/j.kint.2017.11.013; Borthwick LA, 2013, BBA-MOL BASIS DIS, V1832, P1049, DOI 10.1016/j.bbadis.2012.09.014; Brennan EP, 2017, MOL ASPECTS MED, V58, P102, DOI 10.1016/j.mam.2017.05.001; Butenko S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00405; Chen Y, 2017, INT J CLIN EXP MED, V10, P14904; Cho JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162758; Dalli J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01400; Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046; de la Torre YM, 2007, P NATL ACAD SCI USA, V104, P2319, DOI 10.1073/pnas.0607514104; de la Torre YM, 2005, EUR J IMMUNOL, V35, P1342, DOI 10.1002/eji.200526114; Delaney TA, 2016, J IMMUNOL, V197, P42, DOI 10.4049/jimmunol.1502190; Distler JHW, 2019, NAT REV RHEUMATOL, V15, P705, DOI 10.1038/s41584-019-0322-7; Elliott MR, 2016, DEV CELL, V38, P147, DOI 10.1016/j.devcel.2016.06.029; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Eshleman EM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00431; Goncalves RSG, 2019, EXP DERMATOL, V28, P1172, DOI 10.1111/exd.13982; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Haub J, 2019, J INVEST DERMATOL, V139, P2144, DOI 10.1016/j.jid.2019.04.006; Ishikawa M, 2021, EXP DERMATOL, V30, P179, DOI 10.1111/exd.14088; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; Jordan PM, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108247; Kania G, 2019, NAT REV RHEUMATOL, V15, P288, DOI 10.1038/s41584-019-0212-z; Kronke G, 2012, ANN RHEUM DIS, V71, P1081, DOI 10.1136/annrheumdis-2011-200745; Landen NX, 2016, CELL MOL LIFE SCI, V73, P3861, DOI 10.1007/s00018-016-2268-0; Lech M, 2013, BBA-MOL BASIS DIS, V1832, P989, DOI 10.1016/j.bbadis.2012.12.001; Lee KM, 2011, BLOOD, V118, P6220, DOI 10.1182/blood-2011-03-344044; Liu LP, 2006, J IMMUNOL, V177, P17, DOI 10.4049/jimmunol.177.1.17; Lux M, 2019, AM J PATHOL, V189, P231, DOI 10.1016/j.ajpath.2018.09.016; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Massara M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03080-8; McKimmie CS, 2008, J IMMUNOL, V181, P3353, DOI 10.4049/jimmunol.181.5.3353; Do NN, 2018, J IMMUNOL, V201, P663, DOI 10.4049/jimmunol.1701791; Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Osman OS, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-260; Pashover-Schallinger E, 2012, FASEB J, V26, P3891, DOI 10.1096/fj.11-194894; Perkins DJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003479; Satyanarayanan SK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10903-9; Savino B, 2012, BLOOD, V119, P5250, DOI 10.1182/blood-2011-10-388082; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Schulz JN, 2018, MATRIX BIOL, V68-69, P522, DOI 10.1016/j.matbio.2018.01.025; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Shams K, 2017, J INVEST DERMATOL, V137, P85, DOI 10.1016/j.jid.2016.07.039; Sharif MN, 2006, J EXP MED, V203, P1891, DOI 10.1084/jem.20051725; Shi JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098228; Castanheira FVES, 2018, SHOCK, V49, P682, DOI 10.1097/SHK.0000000000000969; Stone RC, 2016, CELL TISSUE RES, V365, P495, DOI 10.1007/s00441-016-2464-0; Taylor Samuel E, 2013, Curr Protoc Essent Lab Tech, V95; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xue ML, 2015, ADV WOUND CARE, V4, P119, DOI 10.1089/wound.2013.0485; Yamamoto T, 2003, J INVEST DERMATOL, V121, P510, DOI 10.1046/j.1523-1747.2003.12408.x; Yoo CH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04220; Zheng SR, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5362506; Zhou Z, 2020, AM J PATHOL, V190, P614, DOI 10.1016/j.ajpath.2019.11.012	63	3	3	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21917	10.1096/fj.202002395RR	http://dx.doi.org/10.1096/fj.202002395RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34533865				2022-12-28	WOS:000702238200025
J	Morales, PE; Monsalves-Alvarez, M; Tadinada, SM; Harris, MP; Ramirez-Sagredo, A; Ortiz-Quintero, J; Troncoso, MF; De Gregorio, N; Calle, X; Pereira, RO; Lira, VA; Espinosa, A; Abel, ED; Lavandero, S				Morales, Pablo E.; Monsalves-Alvarez, Matias; Tadinada, Satya Murthy; Harris, Matthew P.; Ramirez-Sagredo, Andrea; Ortiz-Quintero, Jafet; Francisca Troncoso, Mayarling; De Gregorio, Nicole; Calle, Ximena; Pereira, Renata O.; Lira, Vitor A.; Espinosa, Alejandra; Abel, E. Dale; Lavandero, Sergio			Skeletal muscle type-specific mitochondrial adaptation to high-fat diet relies on differential autophagy modulation	FASEB JOURNAL			English	Article						Atg7; fatty acids; obesity; skeletal muscle fiber	INSULIN-RESISTANCE; OXIDATIVE STRESS; TOLERANCE-TESTS; ACID OXIDATION; FIBER TYPES; OBESITY; DYSFUNCTION; MITOPHAGY; PGC-1-ALPHA; BIOGENESIS	In obesity, skeletal muscle mitochondrial activity changes to cope with increased nutrient availability. Autophagy has been proposed as an essential mechanism involved in the regulation of mitochondrial metabolism. Still, the contribution of autophagy to mitochondrial adaptations in skeletal muscle during obesity is unknown. Here, we show that in response to high-fat diet (HFD) feeding, distinct skeletal muscles in mice exhibit differentially regulated autophagy that may modulate mitochondrial activity. We observed that after 4 and 40 weeks of high-fat diet feeding, OXPHOS subunits and mitochondrial DNA content increased in the oxidative soleus muscle. However, in gastrocnemius muscle, which has a mixed fiber-type composition, the mitochondrial mass increased only after 40 weeks of HFD feeding. Interestingly, fatty acid-supported mitochondrial respiration was enhanced in gastrocnemius, but not in soleus muscle after a 4-week HFD feeding. This increased metabolic profile in gastrocnemius was paralleled by preserving autophagy flux, while autophagy flux in soleus was reduced. To determine the role of autophagy in this differential response, we used an autophagy-deficient mouse model with partial deletion of Atg7 specifically in skeletal muscle (SkM-Atg7(+/-) mice). We observed that Atg7 reduction resulted in diminished autophagic flux in skeletal muscle, alongside blunting the HFD-induced increase in fatty acid-supported mitochondrial respiration observed in gastrocnemius. Remarkably, SkM-Atg7(+/-) mice did not present increased mitochondria accumulation. Altogether, our results show that HFD triggers specific mitochondrial adaptations in skeletal muscles with different fiber type compositions, and that Atg7-mediated autophagy modulates mitochondrial respiratory capacity but not its content in response to an obesogenic diet.	[Morales, Pablo E.; Monsalves-Alvarez, Matias; Ramirez-Sagredo, Andrea; Ortiz-Quintero, Jafet; Francisca Troncoso, Mayarling; De Gregorio, Nicole; Calle, Ximena; Lavandero, Sergio] Univ Chile, Fac Ciencias Quim & Farmaceut, Adv Ctr Chron Dis ACCDiS, Olivos 1007, Santiago 8380492, Chile; [Morales, Pablo E.; Monsalves-Alvarez, Matias; Ramirez-Sagredo, Andrea; Ortiz-Quintero, Jafet; Francisca Troncoso, Mayarling; De Gregorio, Nicole; Calle, Ximena; Lavandero, Sergio] Univ Chile, Fac Med, Olivos 1007, Santiago 8380492, Chile; [Monsalves-Alvarez, Matias] Univ OHiggins, Inst Ciencias Salud, Rancagua, Chile; [Tadinada, Satya Murthy; Pereira, Renata O.; Abel, E. Dale] Univ Iowa, Carver Coll Med, Fraternal Order Eagles Diabet Res Ctr, Div Endocrinol & Metab, Iowa City, IA 52242 USA; [Harris, Matthew P.; Lira, Vitor A.] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Dept Hlth & Human Physiol, Iowa City, IA 52242 USA; [Ortiz-Quintero, Jafet] Univ Nacl Autonoma Honduras, Fac Ciencias, Dept Bioanal & Inmunol, Escuela Microbiol, Tegucigalpa, Honduras; [Espinosa, Alejandra] Univ Chile, Fac Med, Dept Tecnol Med, Santiago, Chile; [Lavandero, Sergio] Corp Ctr Estudios Cient Enfermedades Cron CECEC, Santiago, Chile; [Lavandero, Sergio] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Cardiol Div, Dallas, TX USA; [Morales, Pablo E.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX 75390 USA	Universidad de Chile; Universidad de Chile; Universidad de O'Higgins; University of Iowa; University of Iowa; Universidad Nacional Autonoma de Honduras; Universidad de Chile; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lavandero, S (corresponding author), Univ Chile, Fac Ciencias Quim & Farmaceut, Adv Ctr Chron Dis ACCDiS, Olivos 1007, Santiago 8380492, Chile.; Lavandero, S (corresponding author), Univ Chile, Fac Med, Olivos 1007, Santiago 8380492, Chile.; Abel, ED (corresponding author), Univ Iowa, Carver Coll Med, Fraternal Order Eagles Diabet Res Ctr, 169 Newton Rd 4312PBDB, Iowa City, IA 52242 USA.; Abel, ED (corresponding author), Univ Iowa, Carver Coll Med, Div Endocrinol & Metab, 169 Newton Rd 4312PBDB, Iowa City, IA 52242 USA.	DRCAdmin@uiowa.edu; slavander@uchile.cl	Ortiz-Quintero, Jafet/GPF-3377-2022; Monsalves-Alvarez, Matias/A-6303-2017	Ortiz-Quintero, Jafet/0000-0001-7656-6367; Troncoso, Mayarling/0000-0002-3492-8283; Harris, Matthew/0000-0002-8078-3847; Tadinada, Satya Murthy/0000-0003-3620-9167; Monsalves-Alvarez, Matias/0000-0003-3163-3911; Alambert, Renata/0000-0001-5809-4669; Ramirez Sagredo, Andrea/0000-0003-1081-0704; De Gregorio, Nicole/0000-0002-4433-9407	Agencia Nacional de Investigacion y Desarrollo (ANID), Chile [FONDECYT 1161156, FONDECYT 1200490, FONDAP 15130011, FONDECYT 1181774]; National Institutes of Health [DK092065, R01HL108379]	Agencia Nacional de Investigacion y Desarrollo (ANID), Chile; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Agencia Nacional de Investigacion y Desarrollo (ANID), Chile, Grant/Award Number: FONDECYT 1161156, FONDECYT 1200490, FONDAP 15130011 and FONDECYT 1181774; National Institutes of Health, Grant/Award Number: DK092065 and R01HL108379	Albers PH, 2015, DIABETES, V64, P485, DOI 10.2337/db14-0590; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Augusto V, 2004, BRAZ J MORPHOL SCIS, V21, P89; Baldelli S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.458; Barclay CJ, 2017, J MUSCLE RES CELL M, V38, P143, DOI 10.1007/s10974-017-9467-7; Benede-Ubieto R, 2020, DIABETES METAB SYNDR, V13, P439, DOI 10.2147/DMSO.S234665; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; del Campo A, 2018, AGING-US, V10, P34, DOI 10.18632/aging.101358; DeNies MS, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.204; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Fortini P, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.50; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Ghaben AL, 2019, NAT REV MOL CELL BIO, V20, P242, DOI 10.1038/s41580-018-0093-z; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Hirota Y, 2015, AUTOPHAGY, V11, P332, DOI 10.1080/15548627.2015.1023047; HOWALD H, 1985, PFLUG ARCH EUR J PHY, V403, P369, DOI 10.1007/BF00589248; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jain SS, 2014, DIABETES, V63, P1907, DOI 10.2337/db13-0816; Jorgensen MS, 2017, J AM ASSOC LAB ANIM, V56, P95; Ju JS, 2016, J PHYSIOL SCI, V66, P417, DOI 10.1007/s12576-016-0440-9; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kwong JQ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121689; Lark DS, 2016, AM J PHYSIOL-CELL PH, V311, pC239, DOI 10.1152/ajpcell.00124.2016; Li JP, 2018, BBA-GEN SUBJECTS, V1862, P1547, DOI 10.1016/j.bbagen.2018.03.013; Lim YM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5934; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Liu Y, 2015, DIABETES, V64, P36, DOI 10.2337/db14-0267; Ma XC, 2015, MOL CELL BIOL, V35, P956, DOI 10.1128/MCB.01091-14; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Muller MJ, 2012, OBES REV, V13, P6, DOI 10.1111/j.1467-789X.2012.01033.x; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nezich CL, 2015, J CELL BIOL, V210, P435, DOI 10.1083/jcb.201501002; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Oberbach A, 2006, DIABETES CARE, V29, P895, DOI 10.2337/diacare.29.04.06.dc05-1854; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Pereira RO, 2017, EMBO J, V36, P2126, DOI 10.15252/embj.201696179; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004; Pietrangelo L, 2015, ONCOTARGET, V6, P35358, DOI 10.18632/oncotarget.6139; Qi ZT, 2016, J NUTR BIOCHEM, V36, P31, DOI 10.1016/j.jnutbio.2016.07.005; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schrauwen P, 2001, INT J OBESITY, V25, P449, DOI 10.1038/sj.ijo.0801566; Shortreed KE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007293; Sin J, 2016, AUTOPHAGY, V12, P369, DOI 10.1080/15548627.2015.1115172; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Stephenson EJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1541, DOI 10.1152/ajpendo.00590.2011; Stuart CA, 2013, J CLIN ENDOCR METAB, V98, P2027, DOI 10.1210/jc.2012-3876; Terry Rebecca L, 2016, Curr Protoc Mouse Biol, V6, P343, DOI 10.1002/cpmo.19; Tong MM, 2019, CIRC RES, V124, P1360, DOI 10.1161/CIRCRESAHA.118.314607; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Vainshtein A, 2015, AM J PHYSIOL-CELL PH, V308, pC710, DOI 10.1152/ajpcell.00380.2014; Wells GD, 2008, CAN J NEUROL SCI, V35, P31, DOI 10.1017/S0317167100007538; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Yamano K, 2016, EMBO REP, V17, P300, DOI 10.15252/embr.201541486; Yan Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08480-2; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zhou B, 2016, INT J OBESITY, V40, P833, DOI 10.1038/ijo.2016.1	68	0	0	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21933	10.1096/fj.202001593RR	http://dx.doi.org/10.1096/fj.202001593RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34555201				2022-12-28	WOS:000702238200080
J	Rich, TC; Leavesley, SJ; Brandon, AP; Evans, CA; Raju, SV; Wagener, BM				Rich, Thomas C.; Leavesley, Silas J.; Brandon, Angela P.; Evans, Cilina A.; Raju, S. Vamsee; Wagener, Brant M.			Phosphodiesterase 4 mediates interleukin-8-induced heterologous desensitization of the beta(2)-adrenergic receptor	FASEB JOURNAL			English	Article						acute lung injury; FRET; internalization; recycling; trauma	RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; BETA-ARRESTIN; SODIUM-CHANNELS; PULMONARY-EDEMA; CAMP; PROTEIN; CELLS; INHIBITOR; AGONIST	Acute respiratory distress syndrome (ARDS) is a life-threatening illness characterized by decreased alveolar-capillary barrier function, pulmonary edema consisting of proteinaceous fluid, and inhibition of net alveolar fluid transport responsible for resolution of pulmonary edema. There is currently no pharmacotherapy that has proven useful to prevent or treat ARDS, and two trials using beta-agonist therapy to treat ARDS demonstrated no effect. Prior studies indicated that IL-8-induced heterologous desensitization of the beta2-adrenergic receptor (beta(2)-AR) led to decreased beta-agonist-induced mobilization of cyclic adenosine monophosphate (cAMP). Interestingly, phosphodiesterase (PDE) 4 inhibitors have been used in human airway diseases characterized by low intracellular cAMP levels and increases in specific cAMP hydrolyzing activity. Therefore, we hypothesized that PDE4 would mediate IL-8-induced heterologous internalization of the beta(2)-AR and that PDE4 inhibition would restore beta-agonist-induced functions. We determined that CINC-1 (a functional IL-8 analog in rats) induces internalization of beta(2)-AR from the cell surface, and arrestin-2, PDE4, and beta(2)-AR form a complex during this process. Furthermore, we determined that cAMP associated with the plasma membrane was adversely affected by beta(2)-AR heterologous desensitization. Additionally, we determined that rolipram, a PDE4 inhibitor, reversed CINC-1-induced derangements of cAMP and also caused beta(2)-AR to successfully recycle back to the cell surface. Finally, we demonstrated that rolipram could reverse CINC-1-mediated inhibition of beta-agonist-induced alveolar fluid clearance in a murine model of trauma-shock. These results indicate that PDE4 plays a role in CINC-1-induced heterologous internalization of the beta(2)-AR; PDE4 inhibition reverses these effects and may be a useful adjunct in particular ARDS patients.	[Rich, Thomas C.; Leavesley, Silas J.] Univ S Alabama, Dept Pharmacol, Mobile, AL USA; [Rich, Thomas C.; Leavesley, Silas J.] Univ S Alabama, Ctr Lung Biol, Mobile, AL USA; [Leavesley, Silas J.] Univ S Alabama, Dept Chem & Biomol Engn, Mobile, AL USA; [Brandon, Angela P.; Evans, Cilina A.; Wagener, Brant M.] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Div Mol & Translat Biomed, Birmingham, AL 35294 USA; [Raju, S. Vamsee] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Dept Med, Birmingham, AL 35294 USA; [Raju, S. Vamsee] Univ Alabama Birmingham, UAB Lung Hlth Ctr, Birmingham, AL 35294 USA; [Raju, S. Vamsee] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; [Wagener, Brant M.] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Div Crit Care Med, Birmingham, AL 35294 USA; [Wagener, Brant M.] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA	University of South Alabama; University of South Alabama; University of South Alabama; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wagener, BM (corresponding author), Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Div Mol & Translat Biomed, Birmingham, AL 35294 USA.	bwagener@uabmc.edu	Shanmugam, Raju/N-8120-2013	Shanmugam, Raju/0000-0002-8613-9518; Wagener, Brant/0000-0001-7889-1526	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [R01GM127584]; HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [P01HL066299]; HHS \ NIH \ National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R01AA027528]	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); HHS \ NIH \ National Institute on Alcohol Abuse and Alcoholism (NIAAA)	HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: R01GM127584; HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: P01HL066299; HHS vertical bar NIH vertical bar National Institute on Alcohol Abuse and Alcoholism (NIAAA), Grant/Award Number: R01AA027528	Agarwal SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095835; Baillie GS, 2005, CURR OPIN CELL BIOL, V17, P129, DOI 10.1016/j.ceb.2005.01.003; Bang I, 2015, MOL CELLS, V38, P105, DOI 10.14348/molcells.2015.2301; Barnes AP, 2005, J BIOL CHEM, V280, P7997, DOI 10.1074/jbc.M407521200; Bice T, 2019, SEMIN RESP CRIT CARE, V40, P137, DOI 10.1055/s-0039-1685463; Blackman BE, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203604; Bolger GB, 2003, J BIOL CHEM, V278, P49230, DOI 10.1074/jbc.M303772200; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Bos LD, 2017, THORAX, V72, P876, DOI 10.1136/thoraxjnl-2016-209719; Calfee CS, 2015, CHEST, V147, P1539, DOI 10.1378/chest.14-2454; Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9; Carles M, 2010, ANESTHESIOLOGY, V113, P1134, DOI 10.1097/ALN.0b013e3181f4171b; Carr R, 2016, P NATL ACAD SCI USA, V113, pE4107, DOI [10.1073/pnas.1606267113d, 10.1073/pnas.1606267113]; Che P, 2020, FASEB J, V34, P3305, DOI 10.1096/fj.201902915R; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Davis IC, 2007, AM J PHYSIOL-LUNG C, V293, pL281, DOI 10.1152/ajplung.00458.2006; De Arcangelis V, 2009, J BIOL CHEM, V284, P33824, DOI 10.1074/jbc.M109.020388; de Magalhaes SF, 2021, EUR J NEUROSCI, V53, P376, DOI 10.1111/ejn.14985; Derwall M, 2018, EXPERT REV RESP MED, V12, P1021, DOI 10.1080/17476348.2018.1548280; Giembycz MA, 2011, HANDB EXP PHARMACOL, V204, P415, DOI 10.1007/978-3-642-17969-3_18; Greenlee MM, 2013, AM J PHYSIOL-LUNG C, V305, pL878, DOI 10.1152/ajplung.00008.2013; Gupta MK, 2018, INT REV CEL MOL BIO, V339, P63, DOI 10.1016/bs.ircmb.2018.03.002; Gupta MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125803; Gurevich VV, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00125; Hamamoto M, 2004, EUR J CARDIO-THORAC, V25, P833, DOI 10.1016/j.ejcts.2004.01.054; Handa O, 2006, J CLIN BIOCHEM NUTR, V38, P51, DOI 10.3164/jcbn.38.51; Helms MN, 2006, AM J PHYSIOL-LUNG C, V291, pL610, DOI 10.1152/ajplung.00426.2005; Houslay MD, 2003, BIOCHEM SOC T, V31, P1186; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Huppert LA, 2019, SEMIN RESP CRIT CARE, V40, P31, DOI 10.1055/s-0039-1683996; Jiao YC, 2019, J MOL MED, V97, P25, DOI 10.1007/s00109-018-1712-z; Kelly FL, 2019, TOXICOL SCI, V169, P534, DOI 10.1093/toxsci/kfz066; Kolosionek E, 2009, MOL BIOL CELL, V20, P4751, DOI 10.1091/mbc.E09-01-0019; Lefkowitz RJ, 2013, PROG MOL BIOL TRANSL, V118, P3, DOI 10.1016/B978-0-12-394440-5.00001-2; Li X, 2006, BIOCHEM J, V394, P427, DOI 10.1042/BJ20051560; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC; McAuley DF, 2004, CRIT CARE MED, V32, P1470, DOI 10.1097/01.CCM.0000129489.34416.0E; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; Miotla JM, 1998, AM J RESP CELL MOL, V18, P411, DOI 10.1165/ajrcmb.18.3.2913; Mohan ML., 2012, CURR MOL PHARMACOL, V5, P350, DOI DOI 10.2174/1874467211205030004; Niimi K, 2012, AM J PHYSIOL-LUNG C, V302, pL334, DOI 10.1152/ajplung.00163.2011; Nikolaev VO, 2005, J BIOL CHEM, V280, P1716, DOI 10.1074/jbc.C400505200; Nino G, 2009, AM J PHYSIOL-LUNG C, V297, pL746, DOI 10.1152/ajplung.00079.2009; Pavlos NJ, 2017, TRENDS ENDOCRIN MET, V28, P213, DOI 10.1016/j.tem.2016.10.007; Peck Tyler J, 2019, F1000Res, V8, DOI 10.12688/f1000research.20411.1; Perkins GD, 2006, AM J RESP CRIT CARE, V173, P281, DOI 10.1164/rccm.200508-1302OC; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Pittet JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063907; PITTET JF, 1994, J CLIN INVEST, V94, P663, DOI 10.1172/JCI117383; Rabe KF, 2011, BRIT J PHARMACOL, V163, P53, DOI 10.1111/j.1476-5381.2011.01218.x; Rajagopal S, 2017, CELL SIGNAL, V41, P9, DOI 10.1016/j.cellsig.2017.01.024; Reilly JP, 2019, SEMIN RESP CRIT CARE, V40, P19, DOI 10.1055/s-0039-1684049; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Roux J, 2013, FASEB J, V27, P1095, DOI 10.1096/fj.12-219295; Shan WJ, 2012, BIOORG MED CHEM LETT, V22, P1523, DOI 10.1016/j.bmcl.2012.01.013; Shi Q, 2017, CARDIOVASC RES, V113, P656, DOI 10.1093/cvr/cvx036; Singh B, 2014, RESP CARE, V59, P288, DOI 10.4187/respcare.02571; Smith FG, 2012, LANCET, V379, P229, DOI 10.1016/S0140-6736(11)61623-1; Su X, 2006, AM J PHYSIOL-LUNG C, V290, pL769, DOI 10.1152/ajplung.00334.2005; Trian T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020000; Wachten S, 2010, J CELL SCI, V123, P95, DOI 10.1242/jcs.058594; Wagener BM, 2020, AM J RESP CELL MOL, V63, P234, DOI 10.1165/rcmb.2019-0185OC; Wagener BM, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002522; Wagener BM, 2016, FASEB J, V30, P2557, DOI 10.1096/fj.201600102R; Wagener BM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147442; Wagener BM, 2015, ANESTHESIOLOGY, V122, P1084, DOI 10.1097/ALN.0000000000000595; Wagener BM, 2009, TRAFFIC, V10, P1286, DOI 10.1111/j.1600-0854.2009.00957.x; Weis WI, 2018, ANNU REV BIOCHEM, V87, P897, DOI 10.1146/annurev-biochem-060614-033910; Willis Miranda J, 2014, Handb Exp Pharmacol, V219, P293, DOI 10.1007/978-3-642-41199-1_15; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Xin WK, 2008, J GEN PHYSIOL, V131, P349, DOI 10.1085/jgp.200709881; Yadav H, 2017, AM J RESP CRIT CARE, V195, P725, DOI 10.1164/rccm.201609-1767CI	74	0	0	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21946	10.1096/fj.202002712RR	http://dx.doi.org/10.1096/fj.202002712RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34555226	Green Accepted			2022-12-28	WOS:000702238200056
J	Wang, PL; Hua, XM; Sun, Y; Li, HY; Bryner, YH; Hsung, RP; Dai, J				Wang, Peiling; Hua, Xiangmei; Sun, Yang; Li, Hongyu; Bryner, Yuge Han; Hsung, Richard P.; Dai, Jun			Loss of haspin suppresses cancer cell proliferation by interfering with cell cycle progression at multiple stages	FASEB JOURNAL			English	Article						cell cycle; haspin; kinase; mitosis; p21	HISTONE H3; THR-3 PHOSPHORYLATION; CENTROSOME LOSS; KINASE HASPIN; AURORA B; INHIBITOR; COHESION; IDENTIFICATION; REVEAL; ARREST	Our recent studies have shown that haspin, a protein kinase imperative for mitosis, is engaged in the interphase progression of HeLa and U2OS cancer cells. In this investigation, we employed the Fucci reporter system and time-lapse imaging to examine the impact of haspin gene silencing on cell cycle progressions at a single-cell level. We found that the loss of haspin induced multiple cell cycle defects. Specifically, the S/G2 duration was greatly prolonged by haspin gene depletion or inhibition in synchronous HeLa cells. Haspin gene depletion in asynchronous HeLa and U2OS cells led to a similarly protracted S/G2 phase, followed by mitotic cell death or postmitotic G1 arrest. In addition, haspin deficiency resulted in robust induction of the p21(CIP1/WAF1) checkpoint protein, a target of the p53 activation. Also, co-depleting haspin with either p21 or p53 could rescue U2OS cells from postmitotic G1 arrest and partially restore their proliferation. These results substantiate the haspin's capacity to regulate interphase and mitotic progression, offering a broader antiproliferative potential of haspin loss in cancer cells.	[Wang, Peiling] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin, Peoples R China; [Wang, Peiling; Hua, Xiangmei; Sun, Yang; Li, Hongyu; Bryner, Yuge Han; Hsung, Richard P.; Dai, Jun] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, 5121 Rennebohm Hall,777 Highland Ave, Madison, WI 53705 USA	Tianjin University; University of Wisconsin System; University of Wisconsin Madison	Dai, J (corresponding author), Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, 5121 Rennebohm Hall,777 Highland Ave, Madison, WI 53705 USA.	jdai32@wisc.edu			Wisconsin Alumni Research Foundation; School of Pharmacy of the University of Wisconsin-Madison	Wisconsin Alumni Research Foundation; School of Pharmacy of the University of Wisconsin-Madison	The authors thank the Flow Cytometry Laboratory of the University of Wisconsin-Madison Carbone Cancer Center for cell sorting. J. Dai would thank the Wisconsin Alumni Research Foundation and the School of Pharmacy of the University of Wisconsin-Madison for financial support. R. P. Hsung would like to thank the Laura and Edward Kremers Family Foundation for a generously endowed chairship in natural products chemistry and the Vilas Trust and the University of Wisconsin-Madison for a Distinguished Achievement Professorship.	Aspinall CF, 2015, ONCOTARGET, V6, P36472, DOI 10.18632/oncotarget.5507; Balzano D, 2011, CHEM BIOL, V18, P966, DOI 10.1016/j.chembiol.2011.04.013; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Chen JG, 2003, CANCER RES, V63, P7891; Cuny GD, 2012, BIOORG MED CHEM LETT, V22, P2015, DOI 10.1016/j.bmcl.2012.01.028; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Dai J, 2009, J CELL SCI, V122, P4168, DOI 10.1242/jcs.054122; De Antoni A, 2012, J CELL BIOL, V199, P269, DOI 10.1083/jcb.201205119; Eswaran J, 2009, P NATL ACAD SCI USA, V106, P20198, DOI 10.1073/pnas.0901989106; Fong CS, 2016, ELIFE, V5, DOI [10.7554/eLite.16270, 10.7554/eLife.16270]; Fresan U, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008962; Goto Y, 2017, CURR BIOL, V27, P1005, DOI 10.1016/j.cub.2017.02.066; Hadders MA, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201907087; Han LL, 2017, J CANCER, V8, P2933, DOI 10.7150/jca.20319; Higgins JMG, 2010, CHROMOSOMA, V119, P137, DOI 10.1007/s00412-009-0250-4; Hindriksen S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179514; Huang M, 2020, ONCOGENE, V39, P4312, DOI 10.1038/s41388-020-1296-2; Huertas D, 2012, ONCOGENE, V31, P1408, DOI 10.1038/onc.2011.335; Kestav K, 2017, CURR MED CHEM, V24, P2276, DOI 10.2174/0929867324666170414155520; Kurihara D, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-73; Lambrus BG, 2016, J CELL BIOL, V214, P143, DOI 10.1083/jcb.201604054; Liang C, 2018, EMBO REP, V19, P43, DOI 10.15252/embr.201744737; Maiolica A, 2014, MOL CELL PROTEOMICS, V13, P1724, DOI 10.1074/mcp.M113.034819; MASSILLON D, 1994, BIOCHEM J, V299, P123, DOI 10.1042/bj2990123; MAY E, 1991, ONCOGENE, V6, P1363; Meitinger F, 2016, J CELL BIOL, V214, P155, DOI 10.1083/jcb.201604081; Melms JC, 2020, CANCER RES, V80, P798, DOI 10.1158/0008-5472.CAN-19-2330; Nelson L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14551-2; Nguyen AL, 2014, J CELL SCI, V127, P5066, DOI 10.1242/jcs.158840; Nishida-Fukuda H, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249912; Panigada D, 2013, DEV CELL, V26, P483, DOI 10.1016/j.devcel.2013.07.013; Patnaik D, 2008, J BIOMOL SCREEN, V13, P1025, DOI 10.1177/1087057108326081; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Tanaka H, 2020, EUR J CANCER PREV, V29, P481, DOI 10.1097/CEJ.0000000000000562; Uetake Y, 2010, CURR BIOL, V20, P1666, DOI 10.1016/j.cub.2010.08.018; Wang FW, 2012, J CELL BIOL, V199, P251, DOI 10.1083/jcb.201205106; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wang PL, 2020, J CELL PHYSIOL, V235, P4508, DOI 10.1002/jcp.29328; Wang Q, 2016, CELL CYCLE, V15, P213, DOI 10.1080/15384101.2015.1121330; Xie J, 2015, CELL, V163, P920, DOI 10.1016/j.cell.2015.10.002; Yi Q, 2018, EMBO REP, V19, DOI 10.15252/embr.201745484; Zhou LL, 2017, CURR BIOL, V27, P992, DOI 10.1016/j.cub.2017.02.019; Zhu DW, 2020, EXP CELL RES, V390, DOI 10.1016/j.yexcr.2020.111863	44	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21923	10.1096/fj.202100099R	http://dx.doi.org/10.1096/fj.202100099R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34551143				2022-12-28	WOS:000702238200024
J	Isoe, J; Petchampai, N; Joseph, V; Scaraffia, PY				Isoe, Jun; Petchampai, Natthida; Joseph, Vena; Scaraffia, Patricia Y.			Ornithine decarboxylase deficiency critically impairs nitrogen metabolism and survival in Aedes aegypti mosquitoes	FASEB JOURNAL			English	Article						ammonia metabolism; glucose metabolism; oxidative stress; polyamines; survival	AMMONIA METABOLISM; POLYAMINES; SPERMINE; AUTOPHAGY; PROMOTES	Ornithine decarboxylase (ODC; EC 4.1.1.17) catalyzes the conversion of ornithine to putrescine, the rate-limiting first step for de novo polyamine biosynthesis. Previously, we reported that genetic knockdown of xanthine dehydrogenase 1 (XDH1)-a gene encoding the enzyme involved in the last two steps of uric acid synthesis-causes an increase in ODC transcript levels in fat body of blood-fed Aedes aegypti mosquitoes, suggesting a crosstalk at molecular level between XDH1 and ODC during nitrogen disposal. To further investigate the role of ODC in nitrogen metabolism, we conducted several biochemical and genetic analyses in sugar- and blood-fed A. aegypti females. Distinct ODC gene and protein expression patterns were observed in mosquito tissues dissected during the first gonotrophic cycle. Both pharmacological and RNA interference-mediated knockdown of ODC negatively impacted mosquito survival, disrupted nitrogen waste disposal, delayed oviposition onset, and decreased fecundity in vitellogenic blood-fed females. A lag in the expression of two major digestive serine proteases, a reduction of blood meal digestion in the midgut, and a decrease in vitellogenin yolk protein uptake in ovarian follicles were observed by western blots in ODC-deficient females. Moreover, genetic silencing of ODC showed a broad transcriptional modulation of genes encoding proteins involved in multiple metabolic pathways in mosquito fat body, midgut, and Malpighian tubules prior to and after blood feeding. All together, these data demonstrate that ODC plays an essential role in mosquito metabolism, and that ODC crosstalks with multiple genes and proteins to prevent deadly nitrogen perturbations in A. aegypti females.	[Isoe, Jun] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Petchampai, Natthida; Joseph, Vena; Scaraffia, Patricia Y.] Tulane Univ, Vector Borne Infect Dis Res Ctr, Sch Publ Hlth & Trop Med, Dept Trop Med, New Orleans, LA USA	University of Arizona; Tulane University	Scaraffia, PY (corresponding author), Vector Borne Infect Dis Res Ctr, Dept Trop Med, 1430 Tulane Ave,SL-17 J Bennett Johnston Bldg, New Orleans, LA 70112 USA.	pscaraff@tulane.edu		Scaraffia, Patricia/0000-0003-2985-933X	Corine Adams Baines Professorship Award; Carol Lavin Bernick Faculty Grants; National Institutes of Health; National Institute of Allergy and Infectious Diseases [R01AI146199]	Corine Adams Baines Professorship Award; Carol Lavin Bernick Faculty Grants; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Corine Adams Baines Professorship Award; Carol Lavin Bernick Faculty Grants; National Institutes of Health; National Institute of Allergy and Infectious Diseases, Grant/Award Number: R01AI146199	Bachmann AS, 2018, J BIOL CHEM, V293, P18757, DOI 10.1074/jbc.TM118.003336; Bae DH, 2018, BBA-GEN SUBJECTS, V1862, P2053, DOI 10.1016/j.bbagen.2018.06.004; BIRNBAUM MJ, 1990, J COMP PHYSIOL B, V160, P145, DOI 10.1007/BF00300946; Cardoso VV, 2009, BRAZ J BIOL, V69, P149, DOI 10.1590/S1519-69842009000100019; Cayre M, 1996, BEHAV NEUROSCI, V110, P1117; Chang L, 2021, INSECTS, V12, DOI 10.3390/insects12070624; Coni S, 2021, ELIFE, V10, DOI 10.7554/eLife.69269; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Firpo MR, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040628; Gupta VK, 2013, NAT NEUROSCI, V16, P1453, DOI 10.1038/nn.3512; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Horvath TD, 2021, TRENDS PARASITOL, V37, P747, DOI 10.1016/j.pt.2021.03.010; Horvath TD, 2018, FASEB J, V32, P466, DOI 10.1096/fj.201700657R; Huang MY, 2020, INFECT DRUG RESIST, V13, P4335, DOI 10.2147/IDR.S262024; Inoue K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02364; Isoe J, 2017, FASEB J, V31, P2276, DOI 10.1096/fj.201601185R; Isoe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065393; Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P903, DOI 10.1016/j.ibmb.2009.10.008; Kahana C, 2018, J BIOL CHEM, V293, P18730, DOI 10.1074/jbc.TM118.003339; Kogan PH, 2000, J INSECT PHYSIOL, V46, P1079, DOI 10.1016/S0022-1910(99)00084-0; Leon KE, 2020, BIOCHEM BIOPH RES CO, V523, P429, DOI 10.1016/j.bbrc.2019.12.078; Li C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01289-7; Mazzalupo S, 2016, FASEB J, V30, P111, DOI 10.1096/fj.15-277087; Minois N, 2011, AGING-US, V3, P716, DOI 10.18632/aging.100361; Mounce BC, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00029-17; Nanduri B, 2021, PNEUMONIA, V13, DOI 10.1186/s41479-021-00082-x; Nishimura K, 2009, INT J BIOCHEM CELL B, V41, P2251, DOI 10.1016/j.biocel.2009.04.021; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Petchampai N, 2020, INSECT BIOCHEM MOLEC, V121, DOI 10.1016/j.ibmb.2020.103366; Phillips MA, 2018, J BIOL CHEM, V293, P18746, DOI 10.1074/jbc.TM118.003342; Rider JE, 2007, AMINO ACIDS, V33, P231, DOI 10.1007/s00726-007-0513-4; Scaraffia PY, 2008, P NATL ACAD SCI USA, V105, P518, DOI 10.1073/pnas.0708098105; Scaraffia PY, 2006, INSECT BIOCHEM MOLEC, V36, P614, DOI 10.1016/j.ibmb.2006.05.003; Scaraffia PY, 2010, J INSECT PHYSIOL, V56, P1040, DOI 10.1016/j.jinsphys.2010.02.016; Scaraffia PY, 2005, INSECT BIOCHEM MOLEC, V35, P491, DOI 10.1016/j.ibmb.2005.01.012; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stewart TM, 2018, J BIOL CHEM, V293, P18736, DOI 10.1074/jbc.TM118.003337; Tain LS, 2020, AGING CELL, V19, DOI 10.1111/acel.13043; Vannini L, 2014, INSECT BIOCHEM MOLEC, V44, P33, DOI 10.1016/j.ibmb.2013.11.002; von Dungern P, 2001, J INSECT PHYSIOL, V47, P73, DOI 10.1016/S0022-1910(00)00095-0; Zhang ZC, 2008, ENTOMOL EXP APPL, V129, P18, DOI 10.1111/j.1570-7458.2008.00742.x	41	0	0	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22279	10.1096/fj.202200008R	http://dx.doi.org/10.1096/fj.202200008R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ9SA	35344219				2022-12-28	WOS:000773602000001
J	Killoy, KM; Harlan, BA; Pehar, M; Vargas, MR				Killoy, Kelby M.; Harlan, Benjamin A.; Pehar, Mariana; Vargas, Marcelo R.			NR1D1 downregulation in astrocytes induces a phenotype that is detrimental to cocultured motor neurons	FASEB JOURNAL			English	Article						amyotrophic lateral sclerosis; astrocytes; inflammation; motor neurons; NR1D1; Rev-erb alpha	AMYOTROPHIC-LATERAL-SCLEROSIS; REV-ERB-ALPHA; BODY-MASS INDEX; CU,ZN SUPEROXIDE-DISMUTASE; DISEASE ONSET; REACTIVE ASTROGLIOSIS; CIRCADIAN BEHAVIOR; NRF2 ACTIVATION; SPINAL-CORD; ALS	Nuclear receptor subfamily 1 group D member 1 (NR1D1, also known as Reverb alpha) is a nuclear transcription factor that is part of the molecular clock encoding circadian rhythms and may link daily rhythms with metabolism and inflammation. NR1D1. unlike most nuclear receptors, lacks a ligand-dependent activation function domain 2 and is a constitutive transcriptional repressor. Amyotrophic lateral sclerosis (ALS) is the most common adult-onset motor neuron disease, caused by the progressive degeneration of motor neurons in the spinal cord, brain stem, and motor cortex. Approximately 10%-20% of familial ALS is caused by a toxic gain-of-function induced by mutations of the Cu/Zn superoxide dismutase (SODI). Dysregulated clock and clock-controlled gene expression occur in multiple tissues from mutant hSOD1-linked ALS mouse models. Here we explore NR1D1 dysregulation in the spinal cord of ALS mouse models and its consequences on astrocyte-motor neuron interaction. NR1D1 protein and mRNA expression are significantly downregulated in the spinal cord of symptomatic mice expressing mutant hSOD1. while no changes were observed in age-matched animals overexpressing wild-type hSOD1. In addition, NR1D1 downregulation in primary astrocyte cultures induces a pro-inflammatory phenotype and decreases the survival of cocultured motor neurons. NR1D1 orchestrates the cross talk between physiological pathways identified to be disrupted in ALS (e.g., metabolism, inflammation, redox homeostasis, and circadian rhythms) and we observed that downregulation of NR1D1 alters astrocyte-motor neuron interaction. Our results suggest that NR1D1 could be a potential therapeutic target to prevent astrocyte-mediated motor neuron toxicity in ALS.	[Killoy, Kelby M.; Vargas, Marcelo R.] Univ Wisconsin, Dept Neurol, 600 Highland Ave,CSC K6-444, Madison, WI 53792 USA; [Harlan, Benjamin A.] Med Univ South Carolina, Biomed Sci Training Program, Charleston, SC 29425 USA; [Pehar, Mariana] Univ Wisconsin, Dept Med, Div Geriatr & Gerontol, Madison, WI 53792 USA; [Pehar, Mariana] Vet Affairs Med Ctr, Geriatr Res Educ Clin Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Medical University of South Carolina; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Vargas, MR (corresponding author), Univ Wisconsin, Dept Neurol, 600 Highland Ave,CSC K6-444, Madison, WI 53792 USA.	mvargas@wisc.edu			National Institutes of Health (NIH) [R21NS102599, R01NS089640]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: R21NS102599 and R01NS089640	Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Barbeito LH, 2004, BRAIN RES REV, V47, P263, DOI 10.1016/j.brainresrev.2004.05.003; Barca-Mayo O, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14336; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; Brancaccio M, 2017, NEURON, V93, P1420, DOI 10.1016/j.neuron.2017.02.030; Brown RH, 2017, NEW ENGL J MED, V377, P1602, DOI [10.1056/NEJMra1603471, 10.1038/nrdp.2017.71, 10.1016/S0140-6736(10)61156-7, 10.1056/NEJMc1710379, 10.1038/nrdp.2017.85, 10.1016/S0140-6736(17)31287-4]; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Chen H, 2015, J CLIN INVEST, V125, P1033, DOI 10.1172/JCI69097; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; de Boer AS, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009351; Desport JC, 1999, NEUROLOGY, V53, P1059, DOI 10.1212/WNL.53.5.1059; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Ditsworth D, 2017, ACTA NEUROPATHOL, V133, P907, DOI 10.1007/s00401-017-1698-6; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Gallo V, 2013, NEUROLOGY, V80, P829, DOI 10.1212/WNL.0b013e3182840689; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Gray E, 2015, AMYOTROPH LAT SCL FR, V16, P456, DOI 10.3109/21678421.2015.1053490; Griffin P, 2019, P NATL ACAD SCI USA, V116, P5102, DOI 10.1073/pnas.1812405116; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; Harlan BA, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113219; Harlan BA, 2019, FASEB J, V33, P7084, DOI 10.1096/fj.201802752R; Harlan BA, 2016, J BIOL CHEM, V291, P10836, DOI 10.1074/jbc.M115.698779; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Huisman MHB, 2015, JAMA NEUROL, V72, P1155, DOI 10.1001/jamaneurol.2015.1584; Kia A, 2018, GLIA, V66, P1016, DOI 10.1002/glia.23298; Killoy KM, 2021, FASEB J, V35, DOI 10.1096/fj.202000386RR; Killoy KM, 2020, GLIA, V68, P2693, DOI 10.1002/glia.23879; KUSHNER PD, 1991, J NEUROPATH EXP NEUR, V50, P263, DOI 10.1097/00005072-199105000-00008; Lawton KA, 2012, AMYOTROPH LATERAL SC, V13, P110, DOI 10.3109/17482968.2011.619197; Lee J, 2020, AGING CELL, V19, DOI 10.1111/acel.13078; Marin B, 2016, NEURODEGENER DIS, V16, P225, DOI 10.1159/000442444; Maury E, 2014, DIABETES METAB, V40, P338, DOI 10.1016/j.diabet.2013.12.005; McKee CA, 2020, CELL MOL LIFE SCI, V77, P1049, DOI 10.1007/s00018-019-03314-y; Meyer K, 2014, P NATL ACAD SCI USA, V111, P829, DOI 10.1073/pnas.1314085111; Miquel E, 2014, FREE RADICAL BIO MED, V70, P204, DOI 10.1016/j.freeradbiomed.2014.02.019; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; NAGY D, 1994, J NEUROSCI RES, V38, P336, DOI 10.1002/jnr.490380312; O'Reilly EJ, 2013, AMYOTROPH LAT SCL FR, V14, P205, DOI 10.3109/21678421.2012.735240; OREILLY SA, 1995, EXP NEUROL, V131, P203, DOI 10.1016/0014-4886(95)90042-X; Paganoni S, 2011, MUSCLE NERVE, V44, P20, DOI 10.1002/mus.22114; Pehar M, 2017, CURR PHARM DESIGN, V23, P5010, DOI 10.2174/1381612823666170622095802; Pehar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103438; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Pradat PF, 2010, AMYOTROPH LATERAL SC, V11, P166, DOI 10.3109/17482960902822960; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Qian K, 2017, STEM CELL REP, V8, P843, DOI 10.1016/j.stemcr.2017.03.003; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Renaud JP, 2000, MOL ENDOCRINOL, V14, P700, DOI 10.1210/me.14.5.700; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Saneto RP., 1987, NEUROCHEMISTRY PRACT, P27; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Sawada H, 2017, EXPERT OPIN PHARMACO, V18, P735, DOI 10.1080/14656566.2017.1319937; Schibler U, 2015, COLD SH Q B, V80, P223, DOI 10.1101/sqb.2015.80.027490; Schiffer D, 1996, J NEUROL SCI, V139, P27, DOI 10.1016/0022-510X(96)00073-1; Schiffer D, 2004, AMYOTROPH LATERAL SC, V5, P22, DOI 10.1080/14660820310016822; Schnell A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099883; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Song S, 2016, NAT MED, V22, P397, DOI 10.1038/nm.4052; Stubblefield JJ, 2012, TRENDS ENDOCRIN MET, V23, P326, DOI 10.1016/j.tem.2012.03.007; Sun SY, 2015, P NATL ACAD SCI USA, V112, pE6993, DOI 10.1073/pnas.1520639112; Swarup V, 2011, J EXP MED, V208, P2429, DOI 10.1084/jem.20111313; Tso CF, 2017, CURR BIOL, V27, P1055, DOI 10.1016/j.cub.2017.02.037; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Vanderheyden W.M., 2021, CURR RES NEUROBIOL, V2; Vargas MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056625; Vargas MR, 2011, NEUROBIOL DIS, V43, P543, DOI 10.1016/j.nbd.2011.04.025; Vargas MR, 2010, NEUROTHERAPEUTICS, V7, P471, DOI 10.1016/j.nurt.2010.05.012; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Vargas MR, 2006, J NEUROCHEM, V97, P687, DOI 10.1111/j.1471-4159.2006.03742.x; Vargas MR, 2005, J BIOL CHEM, V280, P25571, DOI 10.1074/jbc.M501920200; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang LJ, 2011, HUM MOL GENET, V20, P286, DOI 10.1093/hmg/ddq463; Wang S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06568-5; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	86	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22262	10.1096/fj.202101275R	http://dx.doi.org/10.1096/fj.202101275R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35319791	Green Published			2022-12-28	WOS:000772957100001
J	Chambers, CA; Dadelahi, AS; Moley, CR; Olson, RM; Logue, CM; Skyberg, JA				Chambers, Catherine A.; Dadelahi, Alexis S.; Moley, Charles R.; Olson, Rachel M.; Logue, Catherine M.; Skyberg, Jerod A.			Nucleotide receptors mediate protection against neonatal sepsis and meningitis caused by alpha-hemolysin expressing Escherichia coli K1	FASEB JOURNAL			English	Article						hemolysin; inflammasome; neonatal immunity; neonatal meningitis-associated Escherichia coli (NMEC); NLRP3; nucleotide receptor	BACTERIAL-MENINGITIS; MULTIDRUG-RESISTANT; NLRP3 INFLAMMASOME; ATP RELEASE; MACROPHAGES; ACTIVATION; INHIBITION; PYROPTOSIS; DAMAGE; MODEL	Neonatal meningitis-associated Escherichia coli (NMEC) is among the leading causes of bacterial meningitis and sepsis in newborn infants. Several virulence factors have been identified as common among NMEC, and have been shown to play an important role in the development of bacteremia and/or meningitis. However, there is significant variability in virulence factor expression between NMEC isolates, and relatively little research has been done to assess the impact of variable virulence factor expression on immune cell activation and the outcome of infection. Here, we investigated the role of NMEC strain-dependent P2X receptor (P2XR) signaling on the outcome of infection in neonatal mice. We found that alpha-hemolysin (HlyA)-expressing NMEC (HlyA(+)) induced robust P2XR-dependent macrophage cell death in vitro, while HlyA(-) NMEC did not. P2XR-dependent cell death was inflammasome independent, suggesting an uncoupling of P2XR and inflammasome activation in the context of NMEC infection. In vivo inhibition of P2XRs was associated with increased mortality in neonatal mice infected with HlyA(+) NMEC, but had no effect on the survival of neonatal mice infected with HlyA(-) NMEC. Furthermore, we found that P2XR-dependent protection against HlyA(+) NMEC in vivo required macrophages, but not neutrophils or NLRP3. Taken together, these data suggest that HlyA(+) NMEC activates P2XRs which in turn confers macrophage-dependent protection against infection in neonates. In addition, our findings indicate that strain-dependent virulence factor expression should be taken into account when studying the immune response to NMEC.	[Chambers, Catherine A.; Dadelahi, Alexis S.; Moley, Charles R.; Olson, Rachel M.; Skyberg, Jerod A.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA; [Logue, Catherine M.] Univ Georgia, Coll Vet Med, Dept Populat Heath, Athens, GA USA	University of Missouri System; University of Missouri Columbia; University System of Georgia; University of Georgia	Skyberg, JA (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO 65211 USA.	skybergj@missouri.edu		Olson, Rachel/0000-0002-6973-4331; Logue, Catherine/0000-0002-6098-2662	University of Missouri College of Veterinary Medicine Committee on Research	University of Missouri College of Veterinary Medicine Committee on Research	University of Missouri College of Veterinary Medicine Committee on Research	Benz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112248; BHAKDI S, 1986, INFECT IMMUN, V52, P63, DOI 10.1128/IAI.52.1.63-69.1986; Blake KJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02448-6; Borges JP., 2021, GLYCINE TARGETS NINJ, DOI 10.1101/2021.12.12.471765; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Chambers CA, 2021, IMMUNOL CELL BIOL, V99, P596, DOI 10.1111/imcb.12445; Chang AC, 2016, VIRULENCE, V7, P806, DOI 10.1080/21505594.2016.1192730; Cole BK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219352; Demirel I, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00081; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Deshmukh HS, 2014, NAT MED, V20, P528, DOI 10.1038/nm.3542; Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; DiPeso L, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.70; Fabbri A, 2010, TOXINS, V2, P283, DOI [10.3390/toxins2020283, 10.3390/toxins2020282]; Feldman Elana A, 2017, Hosp Pediatr, DOI 10.1542/hpeds.2016-0162; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Greve AS, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00113; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Iqbal J, 2016, INFECT DIS-NOR, V48, P461, DOI 10.3109/23744235.2016.1144142; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Jo S, 2011, MOL PHARMACOL, V80, P247, DOI 10.1124/mol.110.070276; Johnson JR, 2002, J INFECT DIS, V185, P774, DOI 10.1086/339343; Johnson TJ, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01913-18; Kayagaki N, 2021, NATURE, V591, P131, DOI 10.1038/s41586-021-03218-7; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; KIM KS, 1992, J CLIN INVEST, V90, P897, DOI 10.1172/JCI115965; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Knust Z, 2010, TOXINS, V2, P116, DOI 10.3390/toxins2010116; Kong Qiongman, 2005, Purinergic Signal, V1, P337, DOI 10.1007/s11302-005-7145-5; Ku LC, 2015, CLIN PERINATOL, V42, P29, DOI 10.1016/j.clp.2014.10.004; Lacey CA, 2019, J LEUKOCYTE BIOL, V106, P27, DOI 10.1002/JLB.4MIA1018-409R; Lieberman J, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav1447; Lister Martin F, 2007, J Inflamm (Lond), V4, P5, DOI 10.1186/1476-9255-4-5; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Logue CM, 2012, APPL ENVIRON MICROB, V78, P5824, DOI 10.1128/AEM.07869-11; Lu K, 2013, NEURAL REGEN RES, V8, P599, DOI 10.3969/j.issn.1673-5374.2013.07.003; Maitre B, 2015, J IMMUNOL, V194, P739, DOI 10.4049/jimmunol.1401786; Mittal R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001203; Mittal R, 2010, J EXP MED, V207, P1307, DOI 10.1084/jem.20092265; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Muendlein HI, 2020, CELL REP, V30, P699, DOI 10.1016/j.celrep.2019.12.073; Murthy AMV, 2019, FASEB J, V33, P7437, DOI 10.1096/fj.201802100R; Murthy AMV, 2018, VIRULENCE, V9, P967, DOI 10.1080/21505594.2018.1465786; Nagamatsu K, 2015, P NATL ACAD SCI USA, V112, pE871, DOI 10.1073/pnas.1500374112; Nicholson BA, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01239-16; Pelegrin P, 2021, BIOCHEM PHARMACOL, V187, DOI 10.1016/j.bcp.2020.114385; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Prasadarao NV, 2002, J IMMUNOL, V169, P6352, DOI 10.4049/jimmunol.169.11.6352; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Rathkey JK, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat2738; Ribes S, 2013, INFECT IMMUN, V81, P1810, DOI 10.1128/IAI.01349-12; Rincon JC, 2021, SHOCK, V55, P274, DOI 10.1097/SHK.0000000000001623; RYNING FW, 1978, INFECT IMMUN, V20, P739, DOI 10.1128/IAI.20.3.739-743.1978; Samir P, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00238; Schleicher Ulrike, 2009, V531, P203, DOI 10.1007/978-1-59745-396-7_14; Schneider KS, 2017, CELL REP, V21, P3846, DOI 10.1016/j.celrep.2017.12.018; Sharma AA, 2015, EUR J IMMUNOL, V45, P238, DOI 10.1002/eji.201444707; Skals M, 2014, J BIOL CHEM, V289, P19098, DOI 10.1074/jbc.M114.571414; Skalsa M, 2009, P NATL ACAD SCI USA, V106, P4030, DOI 10.1073/pnas.0807044106; Skyberg JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021978; SPANJAARD L, 1985, J INFECTION, V11, P259, DOI 10.1016/S0163-4453(85)93327-4; Stevens JP, 2003, ARCH DIS CHILD-FETAL, V88, P179; Sukumaran SK, 2003, INFECT IMMUN, V71, P5951, DOI 10.1128/IAI.71.10.5951-5961.2003; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Therkildsen JR, 2019, AM J PATHOL, V189, P1201, DOI 10.1016/j.ajpath.2019.02.013; Tivendale KA, 2010, INFECT IMMUN, V78, P3412, DOI 10.1128/IAI.00347-10; van Rooijen N, 2003, METHOD ENZYMOL, V373, P3; Verma V, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69501-1; Wang CY, 2020, MUCOSAL IMMUNOL, V13, P22, DOI 10.1038/s41385-019-0225-6; Wang JJ, 2013, J GEN PHYSIOL, V141, P649, DOI 10.1085/jgp.201310966; Wang XC, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2197-2; Weissman SJ, 2016, J PEDIAT INF DIS SOC, V5, P269, DOI 10.1093/jpids/piv013; Werner S, 2019, J MED CHEM, V62, P11194, DOI 10.1021/acs.jmedchem.9b01304; Wijetunge DSS, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0547-9; Wijetunge DSS, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00804-15; Woll C, 2018, J PEDIATR-US, V200, P210, DOI 10.1016/j.jpeds.2018.04.033; Yang H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01987; Yusef D, 2018, PEDIATR NEONATOL, V59, P35, DOI 10.1016/j.pedneo.2017.06.001	79	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22197	10.1096/fj.202101485R	http://dx.doi.org/10.1096/fj.202101485R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35147989	hybrid			2022-12-28	WOS:000761250800010
J	Yuan, XH; Wu, Y; Lin, J; Weng, QY; Wu, LQ; Yang, S; Li, X; Tan, M; Lin, ZX; Lian, XL; Chen, YZ				Yuan, Xiaohong; Wu, Yong; Lin, Jia; Weng, Qinyong; Wu, Linqing; Yang, Shu; Li, Xin; Tan, Ming; Lin, Zhenxing; Lian, Xiaolan; Chen, Yuanzhong			Plasma fibronectin can affect the cytokine profile and monocytes/macrophages function in addition to predicting the prognosis of advanced sepsis	FASEB JOURNAL			English	Article						cytokine storm; fibronectin; immunosuppression; macrophage; sepsis	INDUCED LIVER-INJURY; STAPHYLOCOCCUS-AUREUS; PARTIAL-HEPATECTOMY; HEPATIC-FAILURE; ENDOTOXIN; IMMUNOSUPPRESSION; POLARIZATION; PROGRESSION; DEFICIENCY; FIBRINOGEN	The value of plasma fibronectin (pFN) in the diagnosis and prognosis of sepsis has not been fully established. Previous studies finding that pFN is significantly reduced in sepsis, however, whether reduced pFn affects the prognosis of sepsis has not been clarified. Here, we detected and analyzed pFN and other conventional inflammatory markers in advanced sepsis patients and performed correlation analysis with SOFA score. We also used Fn gene conditional knockout mice which were performed by cecum ligation and puncture (CLP) to investigate the effect of FN deficiency on sepsis prognosis. We found, compared with procalcitonin, c-reactive protein, and interleukin-6, pFN was more correlated with SOFA score in advanced sepsis patients (r -.720, p < .001). In animal experiments, Fn gene knockout mice showed significantly greater mortality after CLP compared with the control group because of inhibited phagocytosis and bacterial clearance ability of macrophages, with double cytokine storm. Furthermore, FN can regulate macrophages through the integrin alpha 5 beta 1/Fak/Src signaling pathway. Overall, we found pFN can more accurately reflect the severity and prognosis of advanced sepsis. The absence of FN altered the cytokine storm and phagocytic function of macrophages, suggesting that FN could be a potential therapeutic target in sepsis.	[Yuan, Xiaohong; Wu, Yong; Lin, Jia; Yang, Shu; Li, Xin; Tan, Ming; Lin, Zhenxing; Lian, Xiaolan; Chen, Yuanzhong] Fujian Med Univ Union Hosp, Fujian Inst Hematol, Fujian Prov Key Lab Hematol, 29 Xinquan Rd, Fuzhou, Peoples R China; [Weng, Qinyong] Fujian Med Univ Union Hosp, Dept Crit Care Med, Fuzhou, Peoples R China; [Wu, Linqing] Fujian Med Univ, Dept Immunol, Fuzhou, Peoples R China	Fujian Medical University	Chen, YZ (corresponding author), Fujian Med Univ Union Hosp, Fujian Inst Hematol, Fujian Prov Key Lab Hematol, 29 Xinquan Rd, Fuzhou, Peoples R China.	chenyz@fjmu.edu.cn		Yuan, Xiaohong/0000-0003-3658-3001	Science and Technology Innovation Joint Fund Project of Fujian Province [2018Y9062]; Natural Science Foundation of Fujian Province [2020J011011]; Construction Project of Fujian Medical Center of Hematology [Min 2017-04]; National and Fujian Provincial Key Clinical Specialty Discipline Construction Program of China	Science and Technology Innovation Joint Fund Project of Fujian Province; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Construction Project of Fujian Medical Center of Hematology; National and Fujian Provincial Key Clinical Specialty Discipline Construction Program of China	This work was supported by the Science and Technology Innovation Joint Fund Project of Fujian Province (2018Y9062), Natural Science Foundation of Fujian Province (2020J011011), Construction Project of Fujian Medical Center of Hematology (Min 2017-04), and National and Fujian Provincial Key Clinical Specialty Discipline Construction Program of China	Abshire MY, 2011, J LEUKOCYTE BIOL, V89, P251, DOI 10.1189/jlb.0710395; Almeida JF, 2016, VACCINE, V34, P1312, DOI 10.1016/j.vaccine.2016.01.022; AlRawahi AN, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2669-1; Bauer M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02950-2; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; BRODIN B, 1985, SCAND J CLIN LAB INV, V45, P57; BRODIN B, 1986, ACTA CHIR SCAND, V152, P721; Choi, 2014, INFECT CHEMOTHER, V46, p1; Delano MJ, 2016, IMMUNOL REV, V274, P330, DOI 10.1111/imr.12499; Delano MJ, 2016, J CLIN INVEST, V126, P23, DOI 10.1172/JCI82224; ERIKSEN HO, 1984, HAEMATOLOGIA, V17, P93; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Hart R, 2010, J IMMUNOL, V185, P3728, DOI 10.4049/jimmunol.0902154; Hotchkiss RS, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.45; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hynes RO, 2012, J CELL BIOL, V196, P671, DOI 10.1083/jcb.201109041; Josse J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02433; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Kwon AH, 2004, TRANSPLANT P, V36, P1985, DOI 10.1016/j.transproceed.2004.08.074; Li CL, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01962; Lin FB, 2020, J INVEST DERMATOL, V140, P1480, DOI 10.1016/j.jid.2019.10.021; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879; Lysenko L, 2017, POSTEP HIG MED DOSW, V71, P703; Maa MC, 2008, J BIOL CHEM, V283, P31408, DOI 10.1074/jbc.M801158200; Martin GR, 2004, INT J INFECT DIS, V8, P236, DOI 10.1016/j.ijid.2003.10.005; Maurer LM, 2016, CRIT REV BIOCHEM MOL, V51, P213, DOI 10.1080/10409238.2016.1184224; MOSESSON MW, 1970, J BIOL CHEM, V245, P5728; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Ni HY, 2003, P NATL ACAD SCI USA, V100, P2415, DOI 10.1073/pnas.2628067100; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Park YM, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.38; Qiu ZY, 2006, SHOCK, V25, P80, DOI 10.1097/01.shk.0000185797.04589.5c; Plaza JQ, 2016, INJURY, V47, pS15, DOI 10.1016/S0020-1383(16)30601-5; Rohwedder I, 2012, EMBO MOL MED, V4, P564, DOI 10.1002/emmm.201200237; SABA TM, 1986, AM J MED, V80, P229, DOI 10.1016/0002-9343(86)90014-8; Saito T, 2005, J SURG RES, V124, P79, DOI 10.1016/j.jss.2004.10.018; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Shen C, 2018, J IMMUNOL, V201, P2986, DOI 10.4049/jimmunol.1700954; Sikkema AH, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1238-x; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stemberk V, 2014, J BIOL CHEM, V289, P12842, DOI 10.1074/jbc.M113.543546; STEVENS LE, 1986, SURG GYNECOL OBSTET, V162, P222; Stoller J, 2016, J CRIT CARE, V31, P58, DOI 10.1016/j.jcrc.2015.09.034; Szederjesi J, 2015, J CRIT CARE MED, V1, P147, DOI 10.1515/jccm-2015-0022; Tang NH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-552; Toscano MG, 2011, JOVE-J VIS EXP, DOI 10.3791/2860; van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36; Vardon-Bounes F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143494; Vincent JL, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2478-6; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Wang YM, 2016, CURR OPIN HEMATOL, V23, P280, DOI 10.1097/MOH.0000000000000237; Wang YM, 2015, BLOOD, V125, P3043, DOI 10.1182/blood-2015-03-630855; Wang YM, 2014, J CLIN INVEST, V124, P4281, DOI 10.1172/JCI74630; Wu Y, 2004, ACTA PHARMACOL SIN, V25, P783; YODER MC, 1991, CLIN PERINATOL, V18, P325, DOI 10.1016/S0095-5108(18)30526-8; Yuan XH, 2020, PEERJ, V8, DOI 10.7717/peerj.10224; Zhou JF, 2017, CRIT CARE MED, V45, P1168, DOI 10.1097/CCM.0000000000002414; Zou Qi-lian, 2009, Zhonghua Yi Xue Za Zhi, V89, P3425	60	1	1	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22179	10.1096/fj.202100760RRR	http://dx.doi.org/10.1096/fj.202100760RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35182399	hybrid			2022-12-28	WOS:000761250800035
J	Fernando, S; Salagaras, T; Schwarz, N; Sandeman, L; Tan, JTM; Xie, JL; Zareh, J; Jensen, K; Williamson, A; Dimasi, C; Chhay, P; Toledo-Flores, D; Long, A; Manavis, J; Worthington, M; Fitridge, R; Di Bartolo, BA; Bursill, CA; Nicholls, SJ; Proud, CG; Psaltis, PJ				Fernando, Sanuja; Salagaras, Thalia; Schwarz, Nisha; Sandeman, Lauren; Tan, Joanne T. M.; Xie, Jianling; Zareh, Jonar; Jensen, Kirk; Williamson, Anna; Dimasi, Catherine; Chhay, Pich; Toledo-Flores, Deborah; Long, Aaron; Manavis, Jim; Worthington, Michael; Fitridge, Robert; Di Bartolo, Belinda A.; Bursill, Christina A.; Nicholls, Stephen J.; Proud, Christopher G.; Psaltis, Peter J.			Eukaryotic elongation factor 2 kinase regulates foam cell formation via translation of CD36	FASEB JOURNAL			English	Article						atherosclerosis; CD36; eEF2K; foam cells; macrophages; protein translation	SCAVENGER RECEPTOR CD36; EXPRESSION; EEF2K; PHOSPHORYLATION; PROLIFERATION; HYPERTENSION; APOPTOSIS; MIGRATION; PROTECTS; SURVIVAL	Eukaryotic elongation factor 2 kinase (eEF2K) is an atypical protein kinase that controls protein synthesis in cells under stress. Although well studied in cancer, less is known about its roles in chronic inflammatory diseases. Here, we examined its regulation of macrophage cholesterol handling in the context of atherosclerosis. eEF2K mRNA expression and protein activity were upregulated in murine bone marrow-derived macrophages (BMDMs) exposed to oxidized low-density lipoprotein cholesterol (oxLDL). When incubated with oxLDL, BMDMs from eEF2K knockout (Eef2k(-/-)) mice formed fewer Oil Red O+ foam cells than Eef2k(+/+) BMDMs (12.5% +/- 2.3% vs. 32.3% +/- 2.0%, p < .01). Treatment with a selective eEF2K inhibitor, JAN-384, also decreased foam cell formation for C57BL/6J BMDMs and human monocyte-derived macrophages. Disabling eEF2K selectively decreased protein expression of the CD36 cholesterol uptake receptor, mediated by a reduction in the proportion of translationally active Cd36 mRNA. Eef2k(-/-) mice bred onto the Ldlr(-/-) background developed aortic sinus atherosclerotic plaques that were 30% smaller than Eef2k(+/+)-Ldlr(-/-) mice after 16 weeks of high cholesterol diet (p < .05). Although accompanied by a reduction in plaque CD36(+) staining (p < .05) and lower CD36 expression in circulating monocytes (p < .01), this was not associated with reduced lipid content in plaques as measured by oil red O staining. Finally, EEF2K and CD36 mRNA levels were higher in blood mononuclear cells from patients with coronary artery disease and recent myocardial infarction compared to healthy controls without coronary artery disease. These results reveal a new role for eEF2K in translationally regulating CD36 expression and foam cell formation in macrophages. Further studies are required to explore therapeutic targeting of eEF2K in atherosclerosis.	[Fernando, Sanuja; Salagaras, Thalia; Schwarz, Nisha; Sandeman, Lauren; Tan, Joanne T. M.; Zareh, Jonar; Williamson, Anna; Dimasi, Catherine; Chhay, Pich; Toledo-Flores, Deborah; Long, Aaron; Bursill, Christina A.; Nicholls, Stephen J.; Psaltis, Peter J.] Vasc Res Ctr, South Australian Hlth & Med Res Inst, Lifelong Hlth Theme, Heart & Vasc Program, Level 6,POB 11060, Adelaide, SA 5001, Australia; [Fernando, Sanuja; Sandeman, Lauren; Tan, Joanne T. M.; Williamson, Anna; Manavis, Jim; Fitridge, Robert; Bursill, Christina A.; Psaltis, Peter J.] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia; [Xie, Jianling; Jensen, Kirk; Proud, Christopher G.] South Australian Hlth & Med Res Inst, Lifelong Hlth Theme, Lifelong Hlth Nutr & Metab, Adelaide, SA, Australia; [Worthington, Michael] Royal Adelaide Hosp, Dept Cardiothorac Surg, Cent Adelaide Local Hlth Network, Adelaide, SA, Australia; [Fitridge, Robert] Royal Adelaide Hosp, Dept Vasc Surg, Cent Adelaide Local Hlth Network, Adelaide, SA, Australia; [Di Bartolo, Belinda A.] Univ Sydney, Kolling Inst, Sydney, NSW, Australia; [Nicholls, Stephen J.] Monash Univ, Monash Cardiovasc Res Ctr, Victoria, Australia; [Proud, Christopher G.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Psaltis, Peter J.] Royal Adelaide Hosp, Dept Cardiol, Cent Adelaide Local Hlth Network, Adelaide, SA, Australia	South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI); Royal Adelaide Hospital; Royal Adelaide Hospital; University of Sydney; Kolling Institute of Medical Research; Monash University; University of Adelaide; Royal Adelaide Hospital	Psaltis, PJ (corresponding author), Vasc Res Ctr, South Australian Hlth & Med Res Inst, Lifelong Hlth Theme, Heart & Vasc Program, Level 6,POB 11060, Adelaide, SA 5001, Australia.	peter.psaltis@sahmri.com		Fitridge, Robert/0000-0001-6258-5997; Tan, Joanne/0000-0003-1875-4882; Bursill, Christina/0000-0002-0682-8760; Dimasi, Catherine/0000-0001-9907-2909	National Health and Medical Research Council (NHMRC) [PG 1142794, CDF 1161506]; National Heart Foundation of Australia (Heart Foundation) [FLF 102056]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia (Heart Foundation)	National Health and Medical Research Council (NHMRC), Grant/Award Number: PG 1142794; CDF 1161506; National Heart Foundation of Australia (Heart Foundation), Grant/Award Number: FLF 102056	Ashour AA, 2014, APOPTOSIS, V19, P241, DOI 10.1007/s10495-013-0927-2; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Chen JH, 2009, ARTERIOSCL THROM VAS, V29, P92, DOI 10.1161/ATVBAHA.108.174599; Chistiakov DA, 2016, J CELL MOL MED, V20, P17, DOI 10.1111/jcmm.12689; Chu D, 2014, EMBO J, V33, P21, DOI 10.1002/embj.201385651; Corpeleijn E, 2008, J PHYSIOL PHARMACOL, V59, P77; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Fu LL, 2014, APOPTOSIS, V19, P1527, DOI 10.1007/s10495-014-1019-7; Holcik M, 1999, NAT CELL BIOL, V1, P190, DOI 10.1038/11109; Kameshima S, 2015, AM J PHYSIOL-HEART C, V308, pH1298, DOI 10.1152/ajpheart.00864.2014; Kennedy DJ, 2009, ARTERIOSCL THROM VAS, V29, P1481, DOI 10.1161/ATVBAHA.109.191940; Kenney JW, 2016, J NEUROCHEM, V136, P276, DOI 10.1111/jnc.13407; Kenney Justin W., 2014, Advances in Biological Regulation, V55, P15, DOI 10.1016/j.jbior.2014.04.003; Kuchibhotla S, 2008, CARDIOVASC RES, V78, P185, DOI 10.1093/cvr/cvm093; Manning-Tobin JJ, 2009, ARTERIOSCL THROM VAS, V29, P19, DOI 10.1161/ATVBAHA.108.176644; Martinet W, 2014, ATHEROSCLEROSIS, V233, P601, DOI 10.1016/j.atherosclerosis.2014.01.040; Moore CEJ, 2016, CELL SIGNAL, V28, P284, DOI 10.1016/j.cellsig.2016.01.005; Mozaffarian D, 2016, CIRCULATION, V133, P187, DOI 10.1161/CIRCULATIONAHA.115.018585; Nakata A, 1999, ARTERIOSCL THROM VAS, V19, P1333, DOI 10.1161/01.ATV.19.5.1333; Niculite CM, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00680; Piechota M, 2012, PROTEIN J, V31, P511, DOI 10.1007/s10930-012-9431-8; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Portal VL, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1564-1; Proud CG, 2015, BIOCHEM SOC T, V43, P328, DOI 10.1042/BST20140323; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Ryazanov AG, 2002, FEBS LETT, V514, P26, DOI 10.1016/S0014-5793(02)02299-8; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Samovski D, 2012, J LIPID RES, V53, P709, DOI 10.1194/jlr.M023424; Taha E, 2020, CURR BIOL, V30, P3507, DOI 10.1016/j.cub.2020.06.061; Usui T, 2015, ACTA PHYSIOL, V213, P472, DOI 10.1111/apha.12354; Usui T, 2013, AM J PHYSIOL-HEART C, V305, pH756, DOI 10.1152/ajpheart.00373.2013; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103071; Wang XM, 2017, CANCERS, V9, DOI 10.3390/cancers9120162; Wu Y, 2020, BIOCHEM J, V477, P4367, DOI 10.1042/BCJ20200697; Xie JL, 2019, J BIOL CHEM, V294, P7169, DOI 10.1074/jbc.AC119.008036; Xie JL, 2018, INT J CANCER, V142, P1865, DOI 10.1002/ijc.31210; Xie JL, 2015, MOL CELL BIOL, V35, P1805, DOI 10.1128/MCB.00012-15; Yan PK, 2011, INT J BIOL SCI, V7, P937, DOI 10.7150/ijbs.7.937; Yuasa-Kawase M, 2012, J ATHEROSCLER THROMB, V19, P263, DOI 10.5551/jat.10603; Zhang P, 2014, CAN J CARDIOL, V30, P1684, DOI 10.1016/j.cjca.2014.09.019; Zhu HC, 2017, RADIOTHER ONCOL, V124, P439, DOI 10.1016/j.radonc.2017.04.001	44	0	0	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22154	10.1096/fj.202101034R	http://dx.doi.org/10.1096/fj.202101034R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35032419				2022-12-28	WOS:000747987800022
J	Forsdyke, DR				Forsdyke, Donald R.			When "doping" is OK: The importance not only of basic research, but how it is funded	FASEB JOURNAL			English	Editorial Material									[Forsdyke, Donald R.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Forsdyke, DR (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.	forsdyke@queensu.ca	Forsdyke, Donald/A-1182-2012	Forsdyke, Donald/0000-0002-4844-1417				Anonymous,, 2021, IMMUNITY, V54, P2673; APIRION D, 1979, FED PROC, V38, P2649; Fauci AS, 2021, IMMUNITY, V54, P2676, DOI 10.1016/j.immuni.2021.10.018; FORSDYKE DR, 1993, FASEB J, V7, P619, DOI 10.1096/fasebj.7.8.8500686; FORSDYKE DR, 1991, FASEB J, V5, P2313, DOI 10.1096/fasebj.5.9.1860622; Forsdyke DR, PEER REV WEBPAGES PE; Forsdyke DR., 2000, TOMORROWS CURES TODA; Germain RN, 2015, CELL, V161, P1485, DOI 10.1016/j.cell.2015.05.052; Gibson EK, 2020, SCIENCE, V369, P258, DOI 10.1126/science.abb4913; Pederson T, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.2110706118j1of3, 10.1073/pnas.2110706118]; Shapiro L, 2021, CELL, V184, P5271, DOI 10.1016/j.cell.2021.08.019; Wilkinson E, 2010, LANCET, V375, P185, DOI 10.1016/S0140-6736(10)60075-X	12	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22158	10.1096/fj.202101955	http://dx.doi.org/10.1096/fj.202101955			3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35028966				2022-12-28	WOS:000747987800017
J	Kuwahara, M; Akasaki, Y; Kurakazu, I; Sueishi, T; Toya, M; Uchida, T; Tsutsui, T; Hirose, R; Tsushima, H; Teramura, T; Nakashima, Y				Kuwahara, Masanari; Akasaki, Yukio; Kurakazu, Ichiro; Sueishi, Takuya; Toya, Masakazu; Uchida, Taisuke; Tsutsui, Tomoaki; Hirose, Ryota; Tsushima, Hidetoshi; Teramura, Takeshi; Nakashima, Yasuharu			C10orf10/DEPP activates mitochondrial autophagy and maintains chondrocyte viability in the pathogenesis of osteoarthritis	FASEB JOURNAL			English	Article						autophagy; C10orf10; DEPP; chondrocyte; mitochondria; osteoarthritis	FOXO TRANSCRIPTION FACTORS; OXIDATIVE STRESS; CARTILAGE; HOMEOSTASIS; DEGRADATION; MECHANISMS; EXPRESSION; PROTEIN; GENES; BNIP3	Osteoarthritis (OA), the most prevalent joint disease, is characterized by the progressive loss of articular cartilage. Autophagy, a lysosomal degradation pathway, maintains cellular homeostasis, and autophagic dysfunction in chondrocytes is a hallmark of OA pathogenesis. However, the cause of autophagic dysfunction in OA chondrocytes remains incompletely understood. Recent studies have reported that decidual protein induced by progesterone (C10orf10/DEPP) positively regulates autophagic functions. In this study, we found that DEPP was involved in mitochondrial autophagic functions of chondrocytes, as well as in OA pathogenesis. DEPP expression decreased in human OA chondrocytes in the absence or presence of pro-inflammatory cytokines, and was induced by starvation, hydrogen peroxide (H2O2), and hypoxia (cobalt chloride). For functional studies, DEPP knockdown decreased autophagic flux induced by H2O2, whereas DEPP overexpression increased autophagic flux and maintained cell viability following H2O2 treatment. DEPP was downregulated by knockdown of forkhead box class O (FOXO) transcription factors and modulated the autophagic function regulated by FOXO3. In an OA mouse model by destabilization of the medial meniscus, DEPP-knockout mice exacerbated the progression of cartilage degradation with TUNEL-positive cells, and chondrocytes isolated from knockout mice were decreased autophagic flux and increased cell death following H2O2 treatment. Subcellular fractionation analysis revealed that mitochondria-located DEPP activated mitochondrial autophagy via BCL2 interacting protein 3. Taken together, our data demonstrate that DEPP is a major stress-inducible gene involved in the activation of mitochondrial autophagy in chondrocytes, and maintains chondrocyte viability during OA pathogenesis. DEPP represents a potential therapeutic target for enhancing autophagy in patients with OA.	[Kuwahara, Masanari; Akasaki, Yukio; Kurakazu, Ichiro; Sueishi, Takuya; Toya, Masakazu; Uchida, Taisuke; Tsutsui, Tomoaki; Hirose, Ryota; Tsushima, Hidetoshi; Nakashima, Yasuharu] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka, Japan; [Teramura, Takeshi] Kindai Univ, Inst Adv Clin Med, Div Cell Biol Regenerat Med, Fac Med, Osaka, Japan	Kyushu University; Kindai University (Kinki University)	Akasaki, Y (corresponding author), Kyushu Univ, Dept Orthopaed Surg, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan.	alcasaki.yukio.443@m.kyushu-u.ac.jp	Teramura, Takeshi/ELU-7591-2022	Kuwahara, Masanari/0000-0002-8621-4629; Akasaki, Yukio/0000-0002-3666-3952; Sueishi, Takuya/0000-0001-8799-0315	Japan Orthopaedics and Traumatology Foundation; Japan Society for the Promotion of Science [17H05097]	Japan Orthopaedics and Traumatology Foundation(Japan Orthopaedics and Traumatology Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Orthopaedics and Traumatology Foundation (JOTF); Japan Society for the Promotion of Science, Grant/Award Number: 17H05097	Akasaki Y, 2014, ARTHRITIS RHEUMATOL, V66, P3349, DOI 10.1002/art.38868; Alvarez-Garcia O, 2017, ARTHRITIS RHEUMATOL, V69, P1418, DOI 10.1002/art.40104; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Blanco FJ, 2020, OSTEOARTHR CARTILAGE, V28, P1003, DOI 10.1016/j.joca.2020.03.018; Carames B, 2015, ARTHRITIS RHEUMATOL, V67, P1568, DOI 10.1002/art.39073; Carames B, 2012, ANN RHEUM DIS, V71, P575, DOI 10.1136/annrheumdis-2011-200557; Carames B, 2010, ARTHRITIS RHEUM-US, V62, P791, DOI 10.1002/art.27305; Chen SM, 2011, FEBS LETT, V585, P1796, DOI 10.1016/j.febslet.2011.04.024; Coimbra IB, 2004, OSTEOARTHR CARTILAGE, V12, P336, DOI 10.1016/j.joca.2003.12.005; Dahlman I, 2005, AM J CLIN NUTR, V81, P1275; Duan R, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.608388; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goldring SR, 2004, CLIN ORTHOP RELAT R, pS27, DOI 10.1097/01.blo.0000144854.66565.8f; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Henrotin Y, 2005, OSTEOARTHR CARTILAGE, V13, P643, DOI 10.1016/j.joca.2005.04.002; Kurakazu I, 2019, J BIOL CHEM, V294, P17555, DOI 10.1074/jbc.RA119.009409; Li LL, 2015, CELL MOL NEUROBIOL, V35, P615, DOI 10.1007/s10571-015-0166-x; Li W, 2018, FASEB J, V32, P5459, DOI 10.1096/fj.201800357R; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Loeser RF, 2016, NAT REV RHEUMATOL, V12, P412, DOI 10.1038/nrrheum.2016.65; Lotz M, 2012, BONE, V51, P241, DOI 10.1016/j.bone.2012.03.023; Lotz MK, 2011, NAT REV RHEUMATOL, V7, P579, DOI 10.1038/nrrheum.2011.109; Mao K, 2014, AUTOPHAGY, V10, P652, DOI 10.4161/auto.27852; Matsuzaki T, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan0746; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Milner PJ, 2006, ARTHRITIS RHEUM-US, V54, P3523, DOI 10.1002/art.22209; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2; Salcher S, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0661-4; Salcher S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-224; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Salvat C, 2005, OSTEOARTHR CARTILAGE, V13, P243, DOI 10.1016/j.joca.2004.11.008; Sasaki H, 2012, ARTHRITIS RHEUM-US, V64, P1920, DOI 10.1002/art.34323; Shin DH, 2005, DEV DYNAM, V233, P1589, DOI 10.1002/dvdy.20479; Stepp MW, 2014, BBA-MOL CELL RES, V1843, P1076, DOI 10.1016/j.bbamcr.2014.02.003; Sueishi T, 2020, ARTHRITIS RHEUMATOL, V72, P620, DOI 10.1002/art.41152; Sun K, 2021, AUTOPHAGY, V17, P2082, DOI 10.1080/15548627.2020.1822097; Vasheghani F, 2015, ANN RHEUM DIS, V74, P569, DOI 10.1136/annrheumdis-2014-205743; Vellai T, 2009, CELL DEATH DIFFER, V16, P94, DOI 10.1038/cdd.2008.126; Watanabe H, 2005, MOL HUM REPROD, V11, P471, DOI 10.1093/molehr/gah186; Webb AE, 2014, TRENDS BIOCHEM SCI, V39, P159, DOI 10.1016/j.tibs.2014.02.003; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang Y, 2015, ANN RHEUM DIS, V74, P1432, DOI 10.1136/annrheumdis-2013-204599	47	2	2	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22145	10.1096/fj.202100896R	http://dx.doi.org/10.1096/fj.202100896R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34997944	Green Accepted			2022-12-28	WOS:000747987800006
J	Garcia-Padilla, C; Dominguez, JN; Lodde, V; Munk, R; Abdelmohsen, K; Gorospe, M; Jimenez-Sabado, V; Ginel, A; Hove-Madsen, L; Aranega, AE; Franco, D				Garcia-Padilla, Carlos; Dominguez, Jorge N.; Lodde, Valeria; Munk, Rachel; Abdelmohsen, Kotb; Gorospe, Myriam; Jimenez-Sabado, Veronica; Ginel, Antonino; Hove-Madsen, Leif; Aranega, Amelia E.; Franco, Diego			Identification of atrial-enriched lncRNA Walras linked to cardiomyocyte cytoarchitecture and atrial fibrillation	FASEB JOURNAL			English	Article						atrial fibrillation; lncRNA; post-transcriptional regulation	LONG NONCODING RNAS; MYOSIN HEAVY-CHAIN; EXPRESSION PROFILE; COMMON VARIANTS; ANGIOTENSIN-II; GENE; HEART; PITX2; ASSOCIATION; 4Q25	Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia in humans. Genetic and genomic analyses have recently demonstrated that the homeobox transcription factor Pitx2 plays a fundamental role regulating expression of distinct growth factors, microRNAs and ion channels leading to morphological and molecular alterations that promote the onset of AF. Here we address the plausible contribution of long non-coding (lnc)RNAs within the Pitx2>Wnt>miRNA signaling pathway. In silico analyses of annotated lncRNAs in the vicinity of the Pitx2, Wnt8 and Wnt11 chromosomal loci identified five novel lncRNAs with differential expression during cardiac development. Importantly, three of them, Walaa, Walras, and Wallrd, are evolutionarily conserved in humans and displayed preferential atrial expression during embryogenesis. In addition, Walrad displayed moderate expression during embryogenesis but was more abundant in the right atrium. Walaa, Walras and Wallrd were distinctly regulated by Pitx2, Wnt8, and Wnt11, and Wallrd was severely elevated in conditional atrium-specific Pitx2-deficient mice. Furthermore, pro-arrhythmogenic and pro-hypertrophic substrate administration to primary cardiomyocyte cell cultures consistently modulate expression of these lncRNAs, supporting distinct modulatory roles of the AF cardiovascular risk factors in the regulation of these lncRNAs. Walras affinity pulldown assays revealed its association with distinct cytoplasmic and nuclear proteins previously involved in cardiac pathophysiology, while loss-of-function assays further support a pivotal role of this lncRNA in cytoskeletal organization. We propose that lncRNAs Walaa, Walras and Wallrd, distinctly regulated by Pitx2>Wnt>miRNA signaling and pro-arrhythmogenic and pro-hypertrophic factors, are implicated in atrial arrhythmogenesis, and Walras additionally in cardiomyocyte cytoarchitecture.	[Garcia-Padilla, Carlos; Dominguez, Jorge N.; Aranega, Amelia E.; Franco, Diego] Univ Jaen, Dept Expt Biol, Cardiovasc Dev Grp, Jaen, Spain; [Lodde, Valeria; Munk, Rachel; Abdelmohsen, Kotb; Gorospe, Myriam] NIA, Lab Genet & Genom, IRP, NIH, Baltimore, MD 21224 USA; [Lodde, Valeria] Univ Sassari, Dept Biomed Sci, Sassari, Italy; [Jimenez-Sabado, Veronica; Hove-Madsen, Leif] CIBERCV, Barcelona, Spain; [Ginel, Antonino] Hosp Santa Creu & Sant Pau, Dept Cardiac Surg, Barcelona, Spain; [Ginel, Antonino; Hove-Madsen, Leif] IIB St Pau, Biomed Res Inst, Barcelona, Spain; [Hove-Madsen, Leif] Biomed Res Inst Barcelona IIBB CSIC, Barcelona, Spain	Universidad de Jaen; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Sassari; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Hospital of Santa Creu i Sant Pau; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB)	Franco, D (corresponding author), Univ Jaen, Dept Expt Biol, Cardiovasc Dev Res Grp, B3-362, Jaen 23071, Spain.	dfranco@ujaen.es	Aranega, Amelia/AAA-8908-2019	Aranega, Amelia/0000-0002-0046-9410; Garcia-Padilla, Carlos/0000-0003-2061-3157; Jimenez-Sabado, Veronica/0000-0001-7720-988X	Junta de Andalucia Regional Council [1CTS4461]; Ministry of Science, Innovation and Universities [RFU2015-67131P]; NIA IRE, NIH	Junta de Andalucia Regional Council(Junta de Andalucia); Ministry of Science, Innovation and Universities; NIA IRE, NIH	This work was supported by a grant-in-aid from the Junta de Andalucia Regional Council to DF and AA 1CTS4461 and by a grant from the Ministry of Science, Innovation and Universities for the Spanish Government to AA and DF (RFU2015-67131P). VF, RM, KA, and MG were supported by the NIA IRE, NIH	Aguirre LA, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0138-0; Anumonwo JMB, 2014, CARDIOL CLIN, V32, P485, DOI 10.1016/j.ccl.2014.07.007; Bai JY, 2020, IEEE ENG MED BIO, P2353, DOI 10.1109/EMBC44109.2020.9175466; Bai JY, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007678; Bai JY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33958-y; Bar C, 2016, CIRCULATION, V134, P1484, DOI 10.1161/CIRCULATIONAHA.116.023686; Barreto-Chaves MLM, 2020, ENDOCR CONNECT, V9, pR59, DOI 10.1530/EC-19-0543; Boucher JM, 2011, J BIOL CHEM, V286, P28312, DOI 10.1074/jbc.M111.221945; Cabili MN, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0586-4; Carniel E, 2005, CIRCULATION, V112, P54, DOI 10.1161/CIRCULATIONAHA.104.507699; Chen LL, 2016, TRENDS BIOCHEM SCI, V41, P761, DOI 10.1016/j.tibs.2016.07.003; Chinchilla A, 2011, CIRC-CARDIOVASC GENE, V4, P269, DOI 10.1161/CIRCGENETICS.110.958116; Coassin SR, 2014, METHODS MOL BIOL, V1211, P189, DOI 10.1007/978-1-4939-1459-3_15; Daimi H, 2015, HEART RHYTHM, V12, P1333, DOI 10.1016/j.hrthm.2015.02.018; Das S, 2018, CIRC RES, V123, P1298, DOI 10.1161/CIRCRESAHA.118.313207; de Lange FJ, 2003, GENESIS, V37, P1, DOI 10.1002/gene.10220; Dempsey J, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5235-3; Dorr M, 2005, Minerva Endocrinol, V30, P199; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Engreitz JM, 2016, NAT REV MOL CELL BIO, V17, P756, DOI 10.1038/nrm.2016.126; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Garcia-Padilla C, 2019, BBA-GENE REGUL MECH, V1862, DOI 10.1016/j.bbagrm.2019.194435; Gloss BS, 2016, BBA-GENE REGUL MECH, V1859, P16, DOI 10.1016/j.bbagrm.2015.08.005; Gore-Panter SR, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.003197; Goudis CA, 2015, J CARDIOL, V66, P361, DOI 10.1016/j.jjcc.2015.04.002; Granados-Riveron JT, 2010, HUM MOL GENET, V19, P4007, DOI 10.1093/hmg/ddq315; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Henningsen KMA, 2011, SCAND CARDIOVASC J, V45, P324, DOI 10.3109/14017431.2011.594081; Hershberger RE, 2010, CIRC-CARDIOVASC GENE, V3, P155, DOI 10.1161/CIRCGENETICS.109.912345; Higa Satoshi, 2021, Card Electrophysiol Clin, V13, P63, DOI 10.1016/j.ccep.2020.11.005; Hitachi K, 2019, EMBO REP, V20, DOI 10.15252/embr.201847468; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Hori Y, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5233-5; Jalife J, 2015, TRENDS CARDIOVAS MED, V25, P475, DOI 10.1016/j.tcm.2014.12.015; Jia YZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160755; Jiang JM, 2013, SCIENCE, V342, P111, DOI 10.1126/science.1236921; Kaab S, 2009, EUR HEART J, V30, P813, DOI 10.1093/eurheartj/ehn578; Kiliszek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021790; Kirchhof P, 2011, CIRC-CARDIOVASC GENE, V4, P123, DOI 10.1161/CIRCGENETICS.110.958058; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kumar Kartik R, 2015, Card Electrophysiol Clin, V7, P173, DOI 10.1016/j.ccep.2015.03.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozano-Velasco Estefania, 2019, Cardiovascular & Hematological Disorders - Drug Targets, V19, P183, DOI 10.2174/1871529X19666190206150349; Lozano-Velasco E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188473; Lozano-Velasco E, 2016, CARDIOVASC RES, V109, P55, DOI 10.1093/cvr/cvv207; Lunde IG, 2011, J APPL PHYSIOL, V111, P1278, DOI 10.1152/japplphysiol.01383.2010; Mahlapuu M, 2001, DEVELOPMENT, V128, P155; Manso AM, 2017, P NATL ACAD SCI USA, V114, pE6250, DOI 10.1073/pnas.1701416114; Manso AM, 2013, J BIOL CHEM, V288, P4252, DOI 10.1074/jbc.M112.427484; Marian AJ, 2017, CIRC RES, V121, P749, DOI 10.1161/CIRCRESAHA.117.311059; McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862; Mei B, 2018, EUR REV MED PHARMACO, V22, P6940, DOI 10.26355/eurrev_201810_16165; Mohanty S, 2013, J CARDIOVASC ELECTR, V24, P155, DOI 10.1111/jce.12017; Nielsen JB, 2018, NAT GENET, V50, P1234, DOI 10.1038/s41588-018-0171-3; Nooh MM, 2017, CELL SIGNAL, V29, P192, DOI 10.1016/j.cellsig.2016.10.014; Olesen MS, 2012, CAN J CARDIOL, V28, P191, DOI 10.1016/j.cjca.2011.11.016; Ounzain S, 2015, J MOL CELL CARDIOL, V89, P98, DOI 10.1016/j.yjmcc.2015.09.016; Panda Amaresh C, 2016, Bio Protoc, V6, DOI 10.21769/BioProtoc.2062; Parvez B, 2013, HEART RHYTHM, V10, P849, DOI 10.1016/j.hrthm.2013.02.018; Pereyra AS, 2017, J BIOL CHEM, V292, P18443, DOI 10.1074/jbc.M117.800839; Perez-Hernandez M, 2016, CARDIOVASC RES, V109, P431, DOI 10.1093/cvr/cvv280; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Prisant L Michael, 2006, J Clin Hypertens (Greenwich), V8, P596, DOI 10.1111/j.1524-6175.2006.05180.x; Qian C, 2019, J CELL PHYSIOL, V234, P11620, DOI 10.1002/jcp.27819; Roselli C, 2018, NAT GENET, V50, P1225, DOI 10.1038/s41588-018-0133-9; Ruan ZB, 2015, INT J CLIN EXP PATHO, V8, P8402; Sasagawa S, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00162; Satoh K, 2011, ARTERIOSCL THROM VAS, V31, P1116, DOI 10.1161/ATVBAHA.110.214601; Schnabel RB, 2011, CIRC-CARDIOVASC GENE, V4, P557, DOI 10.1161/CIRCGENETICS.110.959197; Shu Q, 2018, BIOCHEM BIOPH RES CO, V505, P317, DOI 10.1016/j.bbrc.2018.09.100; Su DM, 2014, BIOCHEM CELL BIOL, V92, P183, DOI 10.1139/bcb-2013-0124; Su Y, 2018, GENE, V642, P125, DOI 10.1016/j.gene.2017.11.025; Tang Y, 2014, CARDIOVASC PATHOL, V23, P101, DOI 10.1016/j.carpath.2013.11.002; Tao Y, 2014, CIRC-CARDIOVASC GENE, V7, P23, DOI 10.1161/CIRCGENETICS.113.000259; Terreri S, 2021, CANCERS, V13, DOI 10.3390/cancers13040681; Torrado M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090561; Tribulova N, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082844; Veluchamy A, 2019, ARTERIOSCL THROM VAS, V39, P2542, DOI 10.1161/ATVBAHA.119.312552; Villegas VE, 2015, INT J MOL SCI, V16, P3251, DOI 10.3390/ijms16023251; Wang J, 2010, P NATL ACAD SCI USA, V107, P9753, DOI 10.1073/pnas.0912585107; Wang KCW, 2013, METABOLISM, V62, P1662, DOI 10.1016/j.metabol.2013.06.013; Wang YG, 2003, J PHYSIOL-LONDON, V546, P491, DOI 10.1113/jphysiol.2002.032847; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Welsh IC, 2015, CELL REP, V13, P337, DOI 10.1016/j.celrep.2015.08.075; Wolf CM, 2019, CARDIOVASC DIAGN THE, V9, pS388, DOI 10.21037/cdt.2019.02.01; Yadava M, 2014, CARDIOL CLIN, V32, P627, DOI 10.1016/j.ccl.2014.07.002; Zhang M, 2019, P NATL ACAD SCI USA, V116, P22692, DOI 10.1073/pnas.1907418116; Zhang QT, 2014, CARDIOVASC THER, V32, P233, DOI 10.1111/1755-5922.12089; Zhou B, 2009, CLIN CHIM ACTA, V400, P21, DOI 10.1016/j.cca.2008.09.028	91	3	3	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22051	10.1096/fj.202100844RR	http://dx.doi.org/10.1096/fj.202100844RR			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34861058	Green Published, hybrid			2022-12-28	WOS:000734992000007
J	Zhang, CL; Tang, QL; Xia, HW; Xu, HJ; Bi, F				Zhang, Chenliang; Tang, Qiulin; Xia, Hongwei; Xu, Huanji; Bi, Feng			PKM2 compensates for proteasome dysfunction by mediating the formation of the CHIP-HSP70-BAG3 complex and the aggregation of ubiquitinated proteins	FASEB JOURNAL			English	Article						aggregation; aggresome; BAG3; PKM2; proteasome inhibition	PYRUVATE-KINASE M2; CANCER METABOLISM; INDUCED APOPTOSIS; ISOFORM; AUTOPHAGY; DEGRADATION; AGGRESOMES; PROMOTES; GENE	Protein aggregation and degradation via autophagy (aggrephagy) are major strategies adopted by cells to remove misfolded polypeptides when there is proteasome dysfunction. The functional protein complex consisting of heat shock protein 70 (Hsp70), cochaperone ubiquitin ligase carboxyl-terminal of Hsp70/Hsp90 interacting protein (CHIP), and co-chaperone Bcl-2-associated athanogene 3 (BAG3) has been associated with the activation of protein aggregation. However, data on the mechanisms of action of the complex in the protein degradation remains scant. Here, we report that upon proteasome stress, the M2 isoform of pyruvate kinase (PKM2) promotes the aggregation of ubiquitinated proteins and its knockout or knockdown aggravates the sensitivity of cells to proteasome inhibitors. Besides, following proteasome inhibition, PKM2 promotes the interaction of BAG3 with CHIP and HSP70. Interestingly, re-expression of loss-of-function mutants in PKM2-knockout cells showed that the regulatory function of PKM2 in this progress does not depend on the activity of glycolytic enzymes or protein kinases. Taken together, these findings demonstrate that PKM2 mediates the formation of the CHIP-HSP70-BAG3 protein complex and promotes the aggregation of ubiquitinated misfolded proteins, thus compensating for proteasome stress in cells.	[Zhang, Chenliang; Tang, Qiulin; Xia, Hongwei; Bi, Feng] Sichuan Univ, Lab Mol Targeted Therapy Oncol, West China Hosp, Chengdu 610041, Sichuan, Peoples R China; [Xu, Huanji; Bi, Feng] Sichuan Univ, Canc Ctr, Dept Med Oncol, West China Hosp, Chengdu, Peoples R China	Sichuan University; Sichuan University	Bi, F (corresponding author), Sichuan Univ, Lab Mol Targeted Therapy Oncol, West China Hosp, Chengdu 610041, Sichuan, Peoples R China.	bifeng@scu.edu.cn		Zhang, Chenliang/0000-0003-2274-2657	National Natural Science Foundation of China [32000533, 82073059]; Sichuan Science and Technology Program [2019YJ0056, 2021YFS0215]; 1.1.3.5 Project for Disciplines of excellence, West China Hospital, Sichuan University [ZYGD18005]; West China Hospital, Sichuan University [2020HXBH113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Science and Technology Program; 1.1.3.5 Project for Disciplines of excellence, West China Hospital, Sichuan University; West China Hospital, Sichuan University(Sichuan University)	This work was supported by research grants from the National Natural Science Foundation of China (32000533, 82073059); Sichuan Science and Technology Program (2019YJ0056, 2021YFS0215); 1.1.3.5 Project for Disciplines of excellence, West China Hospital, Sichuan University (ZYGD18005); Post-doctor Research Project, West China Hospital, Sichuan University (2020HXBH113).	Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Choi WH, 2020, P NATL ACAD SCI USA, V117, P19190, DOI 10.1073/pnas.1920327117; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cortes-Cros M, 2013, P NATL ACAD SCI USA, V110, P489, DOI 10.1073/pnas.1212780110; Dayton TL, 2016, EMBO REP, V17, P1721, DOI 10.15252/embr.201643300; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Eigenbrodt E., 1992, Critical Reviews in Oncogenesis, V3, P91; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Gao J, 2016, AUTOPHAGY, V12, P632, DOI 10.1080/15548627.2016.1147667; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Grice GL, 2016, CELL MOL LIFE SCI, V73, P3497, DOI 10.1007/s00018-016-2255-5; Guilbert SM, 2018, FASEB J, V32, P3518, DOI 10.1096/fj.201700558RR; Hartl FU, 2017, ANNU REV BIOCHEM, V86, P21, DOI 10.1146/annurev-biochem-061516-044518; He YH, 2015, LEUKEMIA RES, V39, P1428, DOI 10.1016/j.leukres.2015.09.019; Israelsen WJ, 2015, SEMIN CELL DEV BIOL, V43, P43, DOI 10.1016/j.semcdb.2015.08.004; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Jiang YH, 2014, MOL CELL, V53, P75, DOI 10.1016/j.molcel.2013.11.001; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Klimek C, 2017, J CELL SCI, V130, P2781, DOI 10.1242/jcs.203679; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lamark Trond, 2012, Int J Cell Biol, V2012, P736905, DOI 10.1155/2012/736905; Li ZW, 2014, BBA-REV CANCER, V1846, P285, DOI 10.1016/j.bbcan.2014.07.008; Liang J, 2017, CELL RES, V27, P329, DOI 10.1038/cr.2016.159; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Lv L, 2013, MOL CELL, V52, P340, DOI 10.1016/j.molcel.2013.09.004; Malek MAYA, 2015, ONCOTARGET, V6, P3098; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meriin AB, 2018, P NATL ACAD SCI USA, V115, pE7043, DOI 10.1073/pnas.1803130115; Minoia M, 2014, AUTOPHAGY, V10, P1603, DOI 10.4161/auto.29409; Nawrocki ST, 2006, CANCER RES, V66, P3773, DOI 10.1158/0008-5472.CAN-05-2961; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Sha YB, 2009, MOL CELL BIOL, V29, P116, DOI 10.1128/MCB.00829-08; Sha Z, 2018, J CELL BIOL, V217, P1757, DOI 10.1083/jcb.201708168; Shang Y, 2017, ONCOGENE, V36, P4191, DOI 10.1038/onc.2017.31; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Wang YH, 2014, CELL, V158, P1309, DOI 10.1016/j.cell.2014.07.048; Webster BM, 2020, NAT CELL BIOL, V22, P911, DOI 10.1038/s41556-020-0534-8; Wilde IB, 2011, J PROTEOME RES, V10, P1062, DOI 10.1021/pr1008543; Xu YN, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.230; Yang YC, 2016, ONCOGENE, V35, P3387, DOI 10.1038/onc.2015.397; Zhang CL, 2018, J CELL SCI, V131, DOI 10.1242/jcs.216671; Zhang XQ, 2011, MOL BIOL CELL, V22, P3277, DOI 10.1091/mbc.E11-05-0388	48	1	1	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22121	10.1096/fj.202101342RR	http://dx.doi.org/10.1096/fj.202101342RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34951719				2022-12-28	WOS:000734992000030
J	Bortolotti, D; Simioni, C; Neri, LM; Rizzo, R; Semprini, CM; Occhionorelli, S; Laface, I; Sanz, JM; Schiuma, G; Rizzo, S; Varano, G; Beltrami, S; Gentili, V; Gafa, R; Passaro, A				Bortolotti, Daria; Simioni, Carolina; Neri, Luca Maria; Rizzo, Roberta; Semprini, Chiara Marina; Occhionorelli, Savino; Laface, Ilaria; Sanz, Juana Maria; Schiuma, Giovanna; Rizzo, Sabrina; Varano, Gabriele; Beltrami, Silvia; Gentili, Valentina; Gafa, Roberta; Passaro, Angelina			Relevance of VEGF and CD147 in different SARS-CoV-2 positive digestive tracts characterized by thrombotic damage	FASEB JOURNAL			English	Article						CD147; digestive tract; inflammation; SARS-CoV-2; thrombosis	COVID-19; EXPRESSION; CELLS; MMP-9; HLA; INFECTION; INCREASE; ENTRY	Several evidence suggests that, in addition to the respiratory tract, also the gastrointestinal tract is a main site of severe acute respiratory syndrome CoronaVirus 2 (SARS-CoV-2) infection, as an example of a multi-organ vascular damage, likely associated with poor prognosis. To assess mechanisms SARS-CoV-2 responsible of tissue infection and vascular injury, correlating with thrombotic damage, specimens of the digestive tract positive for SARS-CoV-2 nucleocapsid protein were analyzed deriving from three patients, negative to naso-oro-pharyngeal swab for SARS-CoV-2. These COVID-19-negative patients came to clinical observation due to urgent abdominal surgery that removed different sections of the digestive tract after thrombotic events. Immunohistochemical for the expression of SARS-CoV-2 combined with a panel of SARS-CoV-2 related proteins angiotensin-converting enzyme 2 receptor, cluster of differentiation 147 (CD147), human leukocyte antigen-G (HLA-G), vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 was performed. Tissue samples were also evaluated by electron microscopy for ultrastructural virus localization and cell characterization. The damage of the tissue was assessed by ultrastructural analysis. It has been observed that CD147 expression levels correlate with SARS-CoV-2 infection extent, vascular damage and an increased expression of VEGF and thrombosis. The confirmation of CD147 co-localization with SARS-CoV-2 Spike protein binding on gastrointestinal tissues and the reduction of the infection level in intestinal epithelial cells after CD147 neutralization, suggest CD147 as a possible key factor for viral susceptibility of gastrointestinal tissue. The presence of SARS-CoV-2 infection of gastrointestinal tissue might be consequently implicated in abdominal thrombosis, where VEGF might mediate the vascular damage.	[Bortolotti, Daria; Rizzo, Roberta; Sanz, Juana Maria; Schiuma, Giovanna; Rizzo, Sabrina; Beltrami, Silvia; Gentili, Valentina] Univ Ferrara, Dept Chem & Pharmaceut Sci, Via Luigi Borsari 46, I-44121 Ferrara, Italy; [Simioni, Carolina] Univ Ferrara, Dept Life Sci & Biotechnol, Ferrara, Italy; [Simioni, Carolina; Neri, Luca Maria] Univ Ferrara, Lab Technol Adv Therapies LTTA, Electron Microscopy Ctr, Ferrara, Italy; [Neri, Luca Maria; Semprini, Chiara Marina; Occhionorelli, Savino; Laface, Ilaria; Varano, Gabriele; Gafa, Roberta; Passaro, Angelina] Univ Ferrara, Dept Translat Med, Via Luigi Borsari 46, I-44121 Ferrara, Italy; [Passaro, Angelina] Univ Hosp Ferrara Arcispedale SantAnna, Med Dept, Ferrara, Italy; [Occhionorelli, Savino] Univ Hosp Ferrara Arcispedale SantAnna, Surg Dept, Ferrara, Italy; [Gafa, Roberta] Univ Hosp Ferrara Arcispedale SantAnna, Oncol & Med Dept, Ferrara, Italy	University of Ferrara; University of Ferrara; University of Ferrara; University of Ferrara	Rizzo, R (corresponding author), Univ Ferrara, Dept Chem & Pharmaceut Sci, Via Luigi Borsari 46, I-44121 Ferrara, Italy.; Passaro, A (corresponding author), Univ Ferrara, Dept Translat Med, Via Luigi Borsari 46, I-44121 Ferrara, Italy.	roberta.rizzo@unife.it; angelina.passaro@unife.it	Passaro, Angelina/P-3401-2015; Occhionorelli, Savino/AAB-2552-2022; Gentili, Valentina/AAC-1028-2022	Passaro, Angelina/0000-0001-8462-7000; Gentili, Valentina/0000-0003-4572-5497	University of Ferrara	University of Ferrara	This study was supported by COVID--19 grant from the University of Ferrara (PI: Roberta Rizzo and Angelina Passaro) and by crowdfunding campaign from University of Ferrara (PI Daria Bortolotti).	Abebe EC, 2021, BIOL-TARGETS THER, V15, P143, DOI 10.2147/BTT.S307352; Besutti G, 2020, EMERG INFECT DIS, V26, P1926, DOI 10.3201/eid2608.201161; Bortolotti D, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9091975; Bortolotti D, 2015, INFECT IMMUN, V83, P3918, DOI 10.1128/IAI.00803-15; Burke RM, 2020, MMWR-MORBID MORTAL W, V69, P245, DOI 10.15585/mmwr.mm6909e1; Evans JP, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100847; Fenizia C, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10061434; Fu JW, 2020, MOL BIOL REP, V47, P4383, DOI 10.1007/s11033-020-05478-4; Galan M, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.588692; Hasegawa K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172030; Helal MA, 2022, J BIOMOL STRUCT DYN, V40, P1109, DOI 10.1080/07391102.2020.1822208; Ji KY, 2021, FASEB J, V35, DOI 10.1096/fj.202002325RR; Jin R, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00853; Jouneau S, 2011, RESPIROLOGY, V16, P705, DOI 10.1111/j.1440-1843.2011.01960.x; Keshavarz P, 2021, CLIN IMAG, V73, P86, DOI 10.1016/j.clinimag.2020.11.054; LeMaoult J, 2005, FASEB J, V19, P662, DOI 10.1096/fj.04-1617fje; Liu Chenglong, 2020, Med Drug Discov, V7, P100056, DOI 10.1016/j.medidd.2020.100056; Loconsole D, 2020, INFECTION, V48, P965, DOI 10.1007/s15010-020-01444-1; Meini S, 2020, MOL BIOL REP, V47, P8301, DOI 10.1007/s11033-020-05831-7; Montet X, 2006, LAB INVEST, V86, P517, DOI 10.1038/labinvest.3700404; Nighot P, 2015, AM J PHYSIOL-GASTR L, V309, pG988, DOI 10.1152/ajpgi.00256.2015; Pamukcu B, 2020, ANATOL J CARDIOL, V24, P224, DOI 10.14744/AnatolJCardiol.2020.56727; Rizzo R, 2021, CLIN MICROBIOL INFEC, V27, P936, DOI 10.1016/j.cmi.2021.01.012; Rizzo R, 2018, ACTA MICROBIOL IMM H, V65, P119, DOI 10.1556/030.65.2018.010; Rizzo R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00592; Rizzo R, 2013, MOL CELL BIOCHEM, V381, P243, DOI 10.1007/s11010-013-1708-5; Rizzo S, 2021, TRANSL VIS SCI TECHN, V10, DOI 10.1167/tvst.10.9.7; Saulle I, 2021, HUM IMMUNOL, V82, P551, DOI 10.1016/j.humimm.2021.05.003; Shilts J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80464-1; Song CY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72718-9; Song PP, 2020, CLIN CHIM ACTA, V509, P280, DOI 10.1016/j.cca.2020.06.017; Sun JX, 2001, CANCER RES, V61, P2276; Suzuki S, 2021, ADV CLIN EXP MED, V30, P41, DOI 10.17219/acem/128228; Ueland T, 2020, J INFECTION, V81, pE41, DOI 10.1016/j.jinf.2020.06.061; Wang HL, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/7647181; Wang K, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00426-x; Yan TT, 2020, FASEB J, V34, P6017, DOI 10.1096/fj.202000782; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Yurchenko V, 2010, CLIN EXP IMMUNOL, V160, P305, DOI 10.1111/j.1365-2249.2010.04115.x; Zeng HZ, 2011, NEOPLASMA, V58, P449, DOI 10.4149/neo_2011_05_449; Zong JX, 2016, ARCH BIOCHEM BIOPHYS, V609, P31, DOI 10.1016/j.abb.2016.09.001	41	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e21969	10.1096/fj.202100821RRR	http://dx.doi.org/10.1096/fj.202100821RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34822202				2022-12-28	WOS:000722321300025
J	Colicchio, R; Nigro, E; Colavita, I; Pagliuca, C; Di Maro, S; Tomassi, S; Scaglione, E; Carbone, F; Carriero, MV; Matarese, G; Daniele, A; Cosconati, S; Pessi, A; Salvatore, F; Salvatore, P				Colicchio, Roberta; Nigro, Ersilia; Colavita, Irene; Pagliuca, Chiara; Di Maro, Salvatore; Tomassi, Stefano; Scaglione, Elena; Carbone, Fortunata; Carriero, Maria Vincenza; Matarese, Giuseppe; Daniele, Aurora; Cosconati, Sandro; Pessi, Antonello; Salvatore, Francesco; Salvatore, Paola			A novel smaller beta-defensin-derived peptide is active against multidrug-resistant bacterial strains	FASEB JOURNAL			English	Article						antimicrobial activity; human beta-defensin 3; multidrug-resistant bacteria; peptide synthesis; gamma-core	ANTIBIOTIC-RESISTANCE; UROKINASE RECEPTOR; ANTIBACTERIAL; MOLECULES; MIGRATION; THEMES; POTENT	Antibiotic resistance is becoming a severe obstacle in the fight against acute and chronic infectious diseases that accompany most degenerative illnesses from neoplasia to osteo-arthritis and obesity. Currently, the race is on to identify pharmaceutical molecules or combinations of molecules able to prevent or reduce the insurgence and/or progression of infectivity. Attempts to substitute antibiotics with antimicrobial peptides have, thus far, met with little success against multidrug-resistant (MDR) bacterial strains. During the last decade, we designed and studied the activity and features of human beta-defensin analogs, which are saltresistant, and hence active also under high salt concentrations as, for instance, in cystic fibrosis. Herein, we describe the design, synthesis, and major features of a new 21 as long molecule, peptide gamma 2. The latter derives from the gamma-core of the beta-defensin natural molecules, a small fragment of these molecules still bearing high antibacterial activity. We found that peptide gamma 2, which contains only one disulphide bond, recapitulates most of the biological properties of natural human beta-defensins and can also counteract both Gram-positive and Gram-negative MDR bacterial strains and biofilm formation. Moreover, it has great stability in human serum thereby enhancing its antibacterial presence and activity without cytotoxicity in human cells. In conclusion, peptide gamma 2 is a promising new weapon also in the battle against intractable infectious diseases.	[Colicchio, Roberta; Pagliuca, Chiara; Salvatore, Francesco; Salvatore, Paola] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Via S Pansini 5, I-80131 Naples, Italy; [Nigro, Ersilia; Colavita, Irene; Pessi, Antonello; Salvatore, Francesco; Salvatore, Paola] Biotecnol Avanzate Scarl, CEINGE, Via G Salvatore 486, I-80145 Naples, Italy; [Nigro, Ersilia; Di Maro, Salvatore; Cosconati, Sandro] Univ Campania Luigi Vanvitelli, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy; [Tomassi, Stefano] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Scaglione, Elena] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy; [Carbone, Fortunata; Matarese, Giuseppe] Consiglio Nazl Ric IEOS CNR, Lab Immunol, Ist Endocrinol & Oncol Sperimentale, Naples, Italy; [Carbone, Fortunata] IRCCS Fdn Santa Lucia, Unita Neuroimmunol, Rome, Italy; [Carriero, Maria Vincenza] Ist Nazl Tumori Fdn G Pascale IRCCS, Dept Expt Oncol, Tumor Progress Unit, Naples, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate; Universita della Campania Vanvitelli; University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); IRCCS Santa Lucia; IRCCS Fondazione Pascale	Salvatore, P (corresponding author), Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Via S Pansini 5, I-80131 Naples, Italy.; Salvatore, F (corresponding author), Biotecnol Avanzate Scarl, CEINGE, Via G Salvatore 486, I-80145 Naples, Italy.	salvator@unina.it; psalvato@unina.it	Matarese, Giuseppe/AAO-4077-2021; Carbone, Fortunata/K-3176-2016; Pagliuca, Chiara/P-5351-2016; Cosconati, Sandro/A-8678-2019	Matarese, Giuseppe/0000-0001-9429-0616; Carbone, Fortunata/0000-0003-4299-6515; Pagliuca, Chiara/0000-0003-1704-6606; tomassi, stefano/0000-0003-3152-4467; Cosconati, Sandro/0000-0002-8900-0968	PRIN MIUR 2017 [2017SFBFER]; Italian Ministry of Health [GR-2016-02363725, RF-2010-23183729]; POR Regione Campania [FESR 2014/2020]; Regione Campania; Progetti di Rilevante Interesse Nazionale [PRIN] [2017 K55HLC 001]; Ministero della Salute [RF-2019-12371111]	PRIN MIUR 2017(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy); POR Regione Campania [FESR 2014/2020]; Regione Campania(Regione Campania); Progetti di Rilevante Interesse Nazionale [PRIN](Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ministero della Salute(Ministry of Health, Italy)	The study was supported by: PRIN MIUR 2017 [grant number 2017SFBFER]: "An integrated approach to tackle the interplay among adaptation, stressful conditions and antimicrobial resistance of challenging pathogens" to P.S.; Italian Ministry of Health [RF--2010--23183729 to F.S.]; POR Regione Campania [FESR 2014/2020 to F.S.]; Regione Campania (contribution to F.S. CEINGE 2018 and 2020); Progetti di Rilevante Interesse Nazionale [PRIN; grant 2017 K55HLC 001 to G.M.], Ministero della Salute [grant RF--2019--12371111 to G.M.].; Italian Ministry of Health [GR--2016--02363725 to F.C.].	[Anonymous], 2018, SURVEILLANCE ANTIMIC; Antcheva N, 2009, BIOCHEM J, V421, P435, DOI 10.1042/BJ20082242; Arora A, 2018, J BIOSCIENCES, V43, P707, DOI 10.1007/s12038-018-9790-1; Bifulco K, 2008, FEBS LETT, V582, P1141, DOI 10.1016/j.febslet.2008.03.001; Bifulco K, 2013, MOL CANCER THER, V12, P1981, DOI 10.1158/1535-7163.MCT-13-0077; Bottger R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178943; Boniotto M, 2003, BIOCHEM J, V374, P707, DOI 10.1042/BJ20030528; Browne K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197047; Ciandrini E, 2018, CURR TOP MED CHEM, V18, P2116, DOI [10.1174/1568016618666181011140348, 10.2174/1568026618666181022140348]; Cicatiello AG, 2014, NEW MICROBIOL, V37, P567; Colicchio R, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00688-18; Colicchio R, 2015, ANTIMICROB AGENTS CH, V59, P7637, DOI 10.1128/AAC.01746-15; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; de Opitz CLM, 2020, FUTURE MICROBIOL, V15, P703, DOI 10.2217/fmb-2020-0048; Deslouches B, 2017, ONCOTARGET, V8, P46635, DOI 10.18632/oncotarget.16743; Di Maro S, 2017, J MED CHEM, V60, P9641, DOI 10.1021/acs.jmedchem.7b01062; Evans BC, 2013, JOVE-J VIS EXP, DOI 10.3791/50166; Falanga A, 2017, MOLECULES, V22, DOI 10.3390/molecules22071217; Fanelli U, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00745; Ferrazzano GF, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2152749; Fodor A, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9070522; Geitani R, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1416-8; Ghosh SK, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00341; Guani-Guerra E, 2010, CLIN IMMUNOL, V135, P1, DOI 10.1016/j.clim.2009.12.004; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Imperlini E, 2021, NANOSCALE, V13, DOI 10.1039/d0nr07229j; Isnansetyo A, 2003, ANTIMICROB AGENTS CH, V47, P480, DOI 10.1128/AAC.47.2.480-488.2003; Juba ML, 2015, BBA-BIOMEMBRANES, V1848, P1081, DOI 10.1016/j.bbamem.2015.01.007; Knappe D, 2010, ANTIMICROB AGENTS CH, V54, P4003, DOI 10.1128/AAC.00300-10; Lee Jong-Kook, 2018, Oncotarget, V9, P15616, DOI 10.18632/oncotarget.24582; Lee JH, 2019, J MICROBIOL, V57, P181, DOI 10.1007/s12275-019-0718-8; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mandal SM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00105; Merlino F, 2019, ORG LETT, V21, P6378, DOI 10.1021/acs.orglett.9b02283; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Moerman L, 2002, EUR J BIOCHEM, V269, P4799, DOI 10.1046/j.1432-1033.2002.03177.x; Nekhotiaeva N, 2003, FASEB J, V17, P394, DOI 10.1096/fj.03-0449fje; Nigro E, 2017, J PEPT SCI, V23, P303, DOI 10.1002/psc.2962; Nigro E, 2015, SCI REP-UK, V5, DOI 10.1038/srep18450; Niyonsaba F, 2004, IMMUNOLOGY, V111, P273, DOI 10.1111/j.0019-2805.2004.01816.x; O'Neill J., 2016, Tackling drug-resistant infections globally: final report and recommendations; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI [10.1586/ERI.13.12, 10.1586/eri.13.12]; Provenzani A, 2020, INT J CLIN PHARM-NET, V42, P1016, DOI 10.1007/s11096-020-01089-y; Rohrl J, 2010, J IMMUNOL, V184, P6688, DOI 10.4049/jimmunol.0903984; Ruiz J., 2014, ADV COMPUTATIONAL BI, P253, DOI DOI 10.1007/978-3-319-01568-2_36; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; Scudiero O, 2013, ANTIMICROB AGENTS CH, V57, P1701, DOI 10.1128/AAC.00934-12; Scudiero O, 2010, ANTIMICROB AGENTS CH, V54, P2312, DOI 10.1128/AAC.01550-09; Shwaiki LN, 2021, MOLECULES, V26, DOI 10.3390/molecules26010165; Sogawa K, 2011, ANAL BIOANAL CHEM, V400, P1905, DOI 10.1007/s00216-011-4877-7; Spinosa MR, 2007, INFECT IMMUN, V75, P3594, DOI 10.1128/IAI.01945-06; Steinstraesser L, 2009, INT J MOL SCI, V10, P3951, DOI 10.3390/ijms10093951; Stewardson AJ, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.33.30319; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Yount NY, 2012, ANNU REV PHARMACOL, V52, P337, DOI 10.1146/annurev-pharmtox-010611-134535; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101; Zhang R, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01175; Zhen XM, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0590-7	62	2	2	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22026	10.1096/fj.202002330RR	http://dx.doi.org/10.1096/fj.202002330RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34818435	hybrid			2022-12-28	WOS:000722321300013
J	Li, XY; Kang, JN; Lv, H; Liu, RH; Chen, JA; Zhang, YN; Zhang, Y; Yu, GL; Zhang, XD; Ning, B				Li, Xinyu; Kang, Jianning; Lv, Hong; Liu, Ronghan; Chen, Jianan; Zhang, Yining; Zhang, Ying; Yu, Guilian; Zhang, Xiaodi; Ning, Bin			CircPrkcsh, a circular RNA, contributes to the polarization of microglia towards the M1 phenotype induced by spinal cord injury and acts via the JNK/p38 MAPK pathway	FASEB JOURNAL			English	Article						circPrkcsh; inflammation; JNK; p38; M1 polarization; spinal cord injury	FUNCTIONAL RECOVERY; KAPPA-B; ACTIVATION; KINASE; MECHANISMS; DEFICITS; SYSTEM; TARGET; JNK	Spinal cord injury (SCI) is a complex pathological change that includes primary SCI and gradually evolves into secondary SCI. Accumulating evidence demonstrates that circular RNAs (circRNAs) are involved in the pathology of a variety of neurological diseases and injuries. However, the characteristics and function of circRNAs in SCI have yet to be elucidated. Although previous research demonstrated that circPrkcsh induces astrocytes to produce inflammatory factors and chemokines, the precise function and mechanism of circPrkcsh in microglia after SCI remains unknown. In this study, we constructed a mouse model of SCI by applying a SCI impactor. Quantitative Real-time PCR and Fluorescence in situ hybridization analysis revealed that circPrkcsh was upregulated in the microglia of SCI mice when compared to sham-operated mice. Gain- or loss-of-function experiments and in vivo assays further indicated that circPrkcsh promotes microglia M1 polarization both in vivo and in vitro. Furthermore, bioinformatics analysis, dual-luciferase assays, and RNA immunoprecipitation assays, confirmed that circPrkcsh serves as a competing endogenous RNA (ceRNA) to promote the expression of MEKK1 mRNA by sponging miR-488. Double knockout rescue experiments further showed that circPrkcsh regulates the MEKK1/JNK/p38 MAPK pathway via miR-488. Our research provides a better understanding of the mechanism of circPrkcsh in SCI and demonstrates that the circPrkcsh/miR-488/Mekk1 axis is a promising regulatory method for the treatment of SCI.	[Li, Xinyu; Kang, Jianning; Lv, Hong; Liu, Ronghan; Chen, Jianan; Zhang, Yining; Zhang, Ying; Yu, Guilian; Zhang, Xiaodi; Ning, Bin] Shandong Univ, Jinan Cent Hosp, Cheeloo Coll Med, 105 Jiefang Rd, Jinan 250013, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Ning, B (corresponding author), Shandong Univ, Jinan Cent Hosp, Cheeloo Coll Med, 105 Jiefang Rd, Jinan 250013, Shandong, Peoples R China.	ningbin@sdu.edu.cn	Liu, Ronghan/ABH-1619-2021	Liu, Ronghan/0000-0002-6897-0279; Ning, Bin/0000-0002-7592-9485	National Natural Science Foundation of China (NSFC) [81771346, 82071383]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81771346 and 82071383	Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Briggs JA, 2015, NEURON, V88, P861, DOI 10.1016/j.neuron.2015.09.045; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen JN, 2022, NEURAL REGEN RES, V17, P144, DOI 10.4103/1673-5374.314114; Chen LL, 2020, NAT REV MOL CELL BIO, V21, P475, DOI 10.1038/s41580-020-0243-y; Chen SP, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1140-6; Chen SB, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1193-6; Correa F, 2011, GLIA, V59, P785, DOI 10.1002/glia.21151; Das A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0644-1; Fan H, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1613-2; Francos-Quijorna I, 2016, GLIA, V64, P2079, DOI 10.1002/glia.23041; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; He ZW, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1065-7; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Huang RR, 2017, AUTOPHAGY, V13, P1722, DOI 10.1080/15548627.2017.1356975; Jee MK, 2012, BRAIN, V135, P1237, DOI 10.1093/brain/aws047; Kristensen LS, 2019, NAT REV GENET, V20, P675, DOI 10.1038/s41576-019-0158-7; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Li X, 2018, MOL CELL, V71, P428, DOI 10.1016/j.molcel.2018.06.034; Li XY, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/9494352; Liu JF, 2020, J CELL PHYSIOL, V235, P4766, DOI 10.1002/jcp.29354; Liu W, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1726-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mehta SL, 2020, PROG NEUROBIOL, V186, DOI 10.1016/j.pneurobio.2020.101746; Milich LM, 2019, ACTA NEUROPATHOL, V137, P785, DOI 10.1007/s00401-019-01992-3; Morton PE, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw2418; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Plastira I, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01809-1; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Stirling DP, 2014, BRAIN, V137, P707, DOI 10.1093/brain/awt341; Su YL, 2019, FASEB J, V33, P10859, DOI 10.1096/fj.201900743R; Tramullas M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6299; Tsarouchas TM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07036-w; Wang D, 2018, CLIN SCI, V132, P943, DOI 10.1042/CS20180083; Wang WZ, 2019, AGING-US, V11, P2352, DOI 10.18632/aging.101919; Wang X, 2018, BIOL PSYCHIAT, V83, P395, DOI 10.1016/j.biopsych.2017.07.023; Wang ZC, 2017, BIOMATERIALS, V112, P62, DOI 10.1016/j.biomaterials.2016.10.002; Wu FF, 2019, J NEUROSCI, V39, P7369, DOI 10.1523/JNEUROSCI.0299-19.2019; Xia XH, 2019, PROG NEUROBIOL, V183, DOI 10.1016/j.pneurobio.2019.101694; Xia Y, 1998, GENE DEV, V12, P3369, DOI 10.1101/gad.12.21.3369; Zeng H, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1658-2; Zeng KW, 2014, PHYTOMEDICINE, V21, P298, DOI 10.1016/j.phymed.2013.08.016; Zhang SB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12049-0; Zhong J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.102; Zhou JH, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01805-5; Zhou WD, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1418-6; Zhou ZB, 2018, MOL THER-NUCL ACIDS, V12, P718, DOI 10.1016/j.omtn.2018.07.011	50	7	7	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22014	10.1096/fj.202100993R	http://dx.doi.org/10.1096/fj.202100993R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34751973				2022-12-28	WOS:000722321300031
J	Taesuwan, S; McDougall, MQ; Malysheva, OV; Bender, E; Nevins, JEH; Devapatla, S; Vidavalur, R; Caudill, MA; Klatt, KC				Taesuwan, Siraphat; McDougall, Melissa Q.; Malysheva, Olga V.; Bender, Erica; Nevins, Julie E. H.; Devapatla, Srisatish; Vidavalur, Ramesh; Caudill, Marie A.; Klatt, Kevin C.			Choline metabolome response to prenatal choline supplementation across pregnancy: A randomized controlled trial	FASEB JOURNAL			English	Article						choline metabolome; PEMT pathway; phosphatidylcholine; pregnancy; prenatal choline supplementation	HUMAN-PLACENTA; BETAINE; PLASMA; DIMETHYLGLYCINE; WOMEN; PHOSPHATIDYLCHOLINE; LACTATION; DILUTION	Pregnancy places a unique stress upon choline metabolism, requiring adaptations to support both maternal and fetal requirements. The impact of pregnancy and prenatal choline supplementation on choline and its metabolome in free-living, healthy adults is relatively uncharacterized. This study investigated the effect of prenatal choline supplementation on maternal and fetal biomarkers of choline metabolism among free-living pregnant persons consuming self-selected diets. Participants were randomized to supplemental choline (as choline chloride) intakes of 550 mg/d (500 mg/d d0-choline + 50 mg/d methyl-d9-choline; intervention) or 25 mg/d d9-choline (control) from gestational week (GW) 12-16 until Delivery. Fasting blood and 24-h urine samples were obtained at study Visit 1 (GW 12-16), Visit 2 (GW 20-24), and Visit 3 (GW 28-32). At Delivery, maternal and cord blood and placental tissue samples were collected. Participants randomized to 550 (vs. 25) mg supplemental choline/d achieved higher (p < .05) plasma concentrations of free choline, betaine, dimethylglycine, phosphatidylcholine (PC), and sphingomyelin at one or more study timepoint. Betaine was most responsive to prenatal choline supplementation with increases (p <= .001) in maternal plasma observed at Visit 2-Delivery (relative to Visit 1 and control), as well as in the placenta and cord plasma. Notably, greater plasma enrichments of d3-PC and LDL-C were observed in the intervention (vs. control) group, indicating enhanced PC synthesis through the de novo phosphatidylethanolamine N-methyltransferase pathway and lipid export. Overall, these data show that prenatal choline supplementation profoundly alters the choline metabolome, supporting pregnancy-related metabolic adaptations and revealing biomarkers for use in nutritional assessment and monitoring during pregnancy.	[Taesuwan, Siraphat; McDougall, Melissa Q.; Malysheva, Olga V.; Bender, Erica; Nevins, Julie E. H.; Caudill, Marie A.; Klatt, Kevin C.] Cornell Univ, Div Nutr Sci, Ithaca, NY USA; [Taesuwan, Siraphat] Chiang Mai Univ, Fac Agro Ind, Cluster Agro Bio Circular Green Ind, Chiang Mai, Thailand; [Vidavalur, Ramesh] Cayuga Med Ctr, Ithaca, NY USA; [Klatt, Kevin C.] Baylor Coll Med, Ctr Precis Environm Hlth, Childrens Nutr Res Ctr, Houston, TX 77030 USA	Cornell University; Chiang Mai University; Baylor College of Medicine	Klatt, KC (corresponding author), Baylor Coll Med, Ctr Precis Environm Hlth, Childrens Nutr Res Ctr, Houston, TX 77030 USA.	Klatt@bcm.edu		Vidavalur, Ramesh/0000-0003-1476-7619; Nevins, Julie/0000-0002-9414-320X; Klatt, Kevin/0000-0003-0223-8250; Taesuwan, Siraphat/0000-0002-0140-4942	Balchem Corporation; Cornell Institute of Biotechnology's Center for Advanced Technology (CAT); National Institute of Food and Agriculture U.S. Department of Agriculture (NIFA/USDA) [1013729]; National Institute of Health Training [T32HD087137]; Chiang Mai University [CMU-8392(10)/COE65]	Balchem Corporation; Cornell Institute of Biotechnology's Center for Advanced Technology (CAT); National Institute of Food and Agriculture U.S. Department of Agriculture (NIFA/USDA); National Institute of Health Training; Chiang Mai University	Balchem Corporation; Cornell Institute of Biotechnology's Center for Advanced Technology (CAT); National Institute of Food and Agriculture U.S. Department of Agriculture (NIFA/USDA), Grant/Award Number: 1013729; National Institute of Health Training, Grant/Award Number: T32HD087137; Chiang Mai University, Grant/Award Number: CMU--8392(10)/COE65	Bailey RL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.5967; Baumgartner HK, 2015, PLACENTA, V36, P1362, DOI 10.1016/j.placenta.2015.10.001; Brenna JT, 2011, MATERN CHILD NUTR, V7, P59, DOI 10.1111/j.1740-8709.2011.00301.x; Caudill MA, 2018, FASEB J, V32, P2172, DOI 10.1096/fj.201700692RR; Caudill MA, 2010, J AM DIET ASSOC, V110, P1198, DOI 10.1016/j.jada.2010.05.009; DARMADY JM, 1982, BRIT J OBSTET GYNAEC, V89, P211, DOI 10.1111/j.1471-0528.1982.tb03616.x; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Fernandez-Roig S, 2013, AM J CLIN NUTR, V97, P1252, DOI 10.3945/ajcn.112.054189; Friesen RW, 2007, J NUTR, V137, P2641; Ganz AB, 2016, FASEB J, V30, P3321, DOI 10.1096/fj.201500138RR; GARNER SC, 1995, J NUTR, V125, P2851; GWEE MCE, 1978, CLIN EXP PHARMACOL P, V5, P649, DOI 10.1111/j.1440-1681.1978.tb00721.x; Holm PI, 2003, CLIN CHEM, V49, P286, DOI 10.1373/49.2.286; Ilcol Y. Ozarda, 2002, Archives of Physiology and Biochemistry, V110, P393, DOI 10.1076/apab.110.5.393.11832; Jiang XY, 2014, TRENDS ENDOCRIN MET, V25, P263, DOI 10.1016/j.tem.2014.02.001; Klatt KC, 2019, BRIT J NUTR, V122, P1221, DOI 10.1017/S0007114519002009; KNOPP RH, 1982, AM J OBSTET GYNECOL, V143, P626, DOI 10.1016/0002-9378(82)90107-7; Koc H, 2002, ANAL CHEM, V74, P4734, DOI 10.1021/ac025624x; Koletzko B, 2007, BRIT J NUTR, V98, P873, DOI 10.1017/S0007114507764747; Korsmo HW, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081823; Kwan ST, 2017, PLACENTA, V53, P57, DOI 10.1016/j.placenta.2017.03.019; Lewis ED, 2014, BRIT J NUTR, V112, P112, DOI 10.1017/S0007114514000555; Luxwolda MF, 2012, EUR J NUTR, V51, P665, DOI 10.1007/s00394-011-0245-9; MCMAHON KE, 1985, CLIN CHIM ACTA, V149, P1, DOI 10.1016/0009-8981(85)90267-0; Meck WH, 2003, NEUROSCI BIOBEHAV R, V27, P385, DOI 10.1016/S0149-7634(03)00069-1; Olsson U, 2005, J STAT EDUC, V13, DOI 10.1080/10691898.2005.11910638; SWEIRY JH, 1986, J DEV PHYSIOL, V8, P435; Velzing-Aarts FV, 2005, AM J CLIN NUTR, V81, P1383; Wallace TC, 2016, J AM COLL NUTR, V35, P108, DOI 10.1080/07315724.2015.1080127; WELSCH F, 1976, BIOCHEM PHARMACOL, V25, P1021, DOI 10.1016/0006-2952(76)90490-1; Yan J, 2013, AM J CLIN NUTR, V98, P1459, DOI 10.3945/ajcn.113.066092; Yan J, 2012, AM J CLIN NUTR, V95, P1060, DOI 10.3945/ajcn.111.022772; YAO ZM, 1988, J BIOL CHEM, V263, P2998; ZEISEL SH, 1980, LIFE SCI, V26, P1827, DOI 10.1016/0024-3205(80)90585-8; ZEISEL SH, 1995, J NUTR, V125, P3049	35	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22063	10.1096/fj.202101401RR	http://dx.doi.org/10.1096/fj.202101401RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34820909				2022-12-28	WOS:000722321300023
J	Anderson, R; Agarwal, A; Ghosh, A; Guan, BJ; Casteel, J; Dvorina, N; Baldwin, WM; Mazumder, B; Nazarko, TY; Merrick, WC; Buchner, DA; Hatzoglou, M; Kondratov, RV; Komar, AA				Anderson, Richard; Agarwal, Anchal; Ghosh, Arnab; Guan, Bo-Jhih; Casteel, Jackson; Dvorina, Nina; Baldwin, William M.; Mazumder, Barsanjit; Nazarko, Taras Y.; Merrick, William C.; Buchner, David A.; Hatzoglou, Maria; Kondratov, Roman, V; Komar, Anton A.			eIF2A-knockout mice reveal decreased life span and metabolic syndrome	FASEB JOURNAL			English	Article						ER stress; eukaryotic initiation factor 2A (eIF2A); life span; lipid homeostasis; metabolic syndrome	EUKARYOTIC TRANSLATION INITIATION; DIET-INDUCED OBESITY; PROTEIN-SYNTHESIS; B-CELLS; MECHANISM; HOMEOSTASIS; PATHOPHYSIOLOGY; DIFFERENTIATION; EXPRESSION; PRINCIPLES	Eukaryotic initiation factor 2A (eIF2A) is a 65 kDa protein that functions in minor initiation pathways, which affect the translation of only a subset of messenger ribonucleic acid (mRNAs), such as internal ribosome entry site (IRES)-containing mRNAs and/or mRNAs harboring upstream near cognate/non-AUG start codons. These non-canonical initiation events are important for regulation of protein synthesis during cellular development and/or the integrated stress response. Selective eIF2A knockdown in cellular systems significantly inhibits translation of such mRNAs, which rely on alternative initiation mechanisms for their translation. However, there exists a gap in our understanding of how eIF2A functions in mammalian systems in vivo (on the organismal level) and ex vivo (in cells). Here, using an eIF2A-knockout (KO) mouse model, we present evidence implicating eIF2A in the biology of aging, metabolic syndrome and central tolerance. We discovered that eIF2A-KO mice have reduced life span and that eIF2A plays an important role in maintenance of lipid homeostasis, the control of glucose tolerance, insulin resistance and also reduces the abundance of B lymphocytes and dendritic cells in the thymic medulla of mice. We also show the eIF2A KO affects male and female mice differently, suggesting that eIF2A may affect sex-specific pathways. Interestingly, our experiments involving pharmacological induction of endoplasmic reticulum (ER) stress with tunicamycin did not reveal any substantial difference between the response to ER stress in eIF2A-KO and wild-type mice. The identification of eIF2A function in the development of metabolic syndrome bears promise for the further identification of specific eIF2A targets responsible for these changes.	[Anderson, Richard; Agarwal, Anchal; Ghosh, Arnab; Casteel, Jackson; Mazumder, Barsanjit; Kondratov, Roman, V; Komar, Anton A.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Guan, Bo-Jhih; Buchner, David A.; Hatzoglou, Maria] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH USA; [Dvorina, Nina; Baldwin, William M.] Cleveland Clin, Dept Inflammat & Immun, Lerner Coll Med, Cleveland, OH 44106 USA; [Nazarko, Taras Y.] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Merrick, William C.; Buchner, David A.; Komar, Anton A.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	University System of Ohio; Cleveland State University; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; University System of Georgia; Georgia State University; Case Western Reserve University	Komar, AA (corresponding author), Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA.; Komar, AA (corresponding author), Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA.	a.komar@csuohio.edu	GHOSH, ARNAB/J-2299-2019	GHOSH, ARNAB/0000-0003-1952-1044; Komar, Anton/0000-0003-4188-0633	NIH [GM128981, HL151392, DK119305, GM119571, DK053307, DK060596, HL079164, AG039547]; Center for Gene Regulation in Health and Disease (GRHD); CSU	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Gene Regulation in Health and Disease (GRHD); CSU	This work was supported by NIH grants GM128981 (AAK, WCM, DAB) and in part by HL151392 (AAK), DK119305 (DAB), GM119571 (TYN), DK053307 and DK060596 (MH), HL079164 (BM) and AG039547 (RVK) and internal funds from the Center for Gene Regulation in Health and Disease (GRHD) and CSU to AAK	ADAMS SL, 1975, J BIOL CHEM, V250, P9083; Catalan V, 2009, J MOL MED, V87, P803, DOI 10.1007/s00109-009-0486-8; Chen L, 2019, J CELL MOL MED, V23, P6060, DOI 10.1111/jcmm.14469; Choi SK, 1998, SCIENCE, V280, P1757, DOI 10.1126/science.280.5370.1757; Chu J, 2016, TRENDS CELL BIOL, V26, P918, DOI 10.1016/j.tcb.2016.06.005; COFFMAN RL, 1983, IMMUNOL REV, V69, P5, DOI 10.1111/j.1600-065X.1983.tb00446.x; Conn CS, 2021, NAT METAB, V3, P244, DOI 10.1038/s42255-021-00349-z; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Dmitriev SE, 2010, J BIOL CHEM, V285, P26779, DOI 10.1074/jbc.M110.119693; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ellacott KLJ, 2010, CELL METAB, V12, P10, DOI 10.1016/j.cmet.2010.06.001; Feldman AT, 2014, METHODS MOL BIOL, V1180, P31, DOI 10.1007/978-1-4939-1050-2_3; Feng B, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081710; Ghaben AL, 2019, NAT REV MOL CELL BIO, V20, P242, DOI 10.1038/s41580-018-0093-z; Golovko A, 2016, CELL CYCLE, V15, P3115, DOI 10.1080/15384101.2016.1237324; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HATHCOCK KS, 1992, J IMMUNOL, V149, P2286; Hetz C, 2020, NAT REV MOL CELL BIO, V21, P421, DOI 10.1038/s41580-020-0250-z; Heydemann A, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2902351; Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Holm C, 2000, ANNU REV NUTR, V20, P365, DOI 10.1146/annurev.nutr.20.1.365; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jo S, 2021, DIABETES, V70, P155, DOI 10.2337/db20-0057; Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137; Kearse MG, 2017, GENE DEV, V31, P1717, DOI 10.1101/gad.305250.117; Komar AA, 2005, J BIOL CHEM, V280, P15601, DOI 10.1074/jbc.M413728200; Komar AA, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062054; Kraus NA, 2016, ADIPOCYTE, V5, P351, DOI 10.1080/21623945.2016.1240137; Kuscuoglu D, 2018, J HEPATOL, V69, P512, DOI 10.1016/j.jhep.2018.04.018; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Le Bacquer O, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600128; Le Quesne JPC, 2010, J PATHOL, V220, P140, DOI 10.1002/path.2627; Lo KA, 2013, BIOSCIENCE REP, V33, P711, DOI 10.1042/BSR20130046; Maric C, 2009, AM J PHYSIOL-RENAL, V296, pF680, DOI 10.1152/ajprenal.90505.2008; Marin RD, 2019, METHODSX, V6, P918, DOI 10.1016/j.mex.2019.04.010; McLeland CB, 2011, METHODS MOL BIOL, V697, P199, DOI 10.1007/978-1-60327-198-1_21; MERRICK WC, 1975, J BIOL CHEM, V250, P1197; Nishikawa S, 2007, EXP ANIM TOKYO, V56, P263, DOI 10.1538/expanim.56.263; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Olzmann JA, 2019, NAT REV MOL CELL BIO, V20, P137, DOI 10.1038/s41580-018-0085-z; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pearl D, 2020, J IMMUNOL, V204, P2392, DOI 10.4049/jimmunol.1900538; Pelletier J, 2019, ANNU REV BIOCHEM, V88, P307, DOI 10.1146/annurev-biochem-013118-111042; Pestova TV, 2008, EMBO J, V27, P1060, DOI 10.1038/emboj.2008.49; Piccirillo CA, 2014, NAT IMMUNOL, V15, P503, DOI 10.1038/ni.2891; Poltorak MP, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00199; Rahman MA, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22158144; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Robichaud N, 2017, CURR OPIN CELL BIOL, V45, P102, DOI 10.1016/j.ceb.2017.05.007; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Sendoel A, 2017, NATURE, V541, P494, DOI 10.1038/nature21036; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Skabkin MA, 2010, GENE DEV, V24, P1787, DOI 10.1101/gad.1957510; Sonobe Y, 2018, NEUROBIOL DIS, V116, P155, DOI 10.1016/j.nbd.2018.05.009; Speakman J, 2007, OBES REV, V8, P55, DOI 10.1111/j.1467-789X.2007.00319.x; Starck SR, 2016, SCIENCE, V351, DOI 10.1126/science.aad3867; Starck SR, 2012, SCIENCE, V336, P1719, DOI 10.1126/science.1220270; Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011; Terenin IM, 2008, NAT STRUCT MOL BIOL, V15, P836, DOI 10.1038/nsmb.1445; Thapa P, 2019, THORAC SURG CLIN, V29, P123, DOI 10.1016/j.thorsurg.2018.12.001; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Valentinuzzi VS, 1997, AM J PHYSIOL-REG I, V273, pR1957, DOI 10.1152/ajpregu.1997.273.6.R1957; Voigts-Hoffmann F, 2012, CURR OPIN STRUC BIOL, V22, P768, DOI 10.1016/j.sbi.2012.07.010; Volchuk A, 2010, DIABETES OBES METAB, V12, P48, DOI 10.1111/j.1463-1326.2010.01271.x; Wang CY, 2012, METHODS MOL BIOL, V821, P421, DOI 10.1007/978-1-61779-430-8_27; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Yamano T, 2015, IMMUNITY, V42, P1048, DOI 10.1016/j.immuni.2015.05.013; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Young SG, 2013, GENE DEV, V27, P459, DOI 10.1101/gad.209296.112; Yu H, 2018, METHODS MOL BIOL, V1773, P273, DOI 10.1007/978-1-4939-7799-4_21; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zhang XY, 2018, CURR OPIN LIPIDOL, V29, P203, DOI 10.1097/MOL.0000000000000509; Ziller N, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102236; Zoll WL, 2002, J BIOL CHEM, V277, P37079, DOI 10.1074/jbc.M207109200	78	1	1	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21990	10.1096/fj.202101105R	http://dx.doi.org/10.1096/fj.202101105R			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34665898	Green Published			2022-12-28	WOS:000712009200042
J	Barton, M; Frigo, DE; Madak-Erdogan, Z; Mauvais-Jarvis, F; Prossnitz, ER				Barton, Matthias; Frigo, Daniel E.; Madak-Erdogan, Zeynep; Mauvais-Jarvis, Franck; Prossnitz, Eric R.			Steroid Hormones and Receptors in Health and Disease	FASEB JOURNAL			English	Article						aldosterone; androgens; estradiol; estrogen; glucocorticoids; GR; MR; nuclear receptors; progesterone; thyroid hormone; VDR; vitamin D	RAPID RESPONSES; MEMBRANE; ESTROGEN		[Barton, Matthias] Univ Zurich, Y44 G22,Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Frigo, Daniel E.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Madak-Erdogan, Zeynep] Univ Illinois, Urbana, IL USA; [Mauvais-Jarvis, Franck] Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70118 USA; [Mauvais-Jarvis, Franck] Southeast Louisiana VA Med Ctr, New Orleans, LA USA; [Prossnitz, Eric R.] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA	University of Zurich; University of Texas System; UTMD Anderson Cancer Center; University of Illinois System; University of Illinois Urbana-Champaign; Tulane University; University of New Mexico; University of New Mexico's Health Sciences Center	Barton, M (corresponding author), Univ Zurich, Y44 G22,Winterthurerstr 190, CH-8057 Zurich, Switzerland.	barton@access.uzh.ch		Madak-Erdogan, Zeynep/0000-0003-2607-1643; Mauvais-Jarvis, Franck/0000-0002-0874-0754; Frigo, Daniel/0000-0002-0713-471X; Prossnitz, Eric/0000-0001-9190-8302	US National Institutes of Health (NIH)/National Institute of Diabetes and Digestive Diseases (NIDDK) [R13 DK126171]; US National Institutes of Health (NIH)/National Cancer Institute (NCI) [R13 DK126171]; FASEB; Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, Albany, NY, USA; University of Illinois Urbana-Champaign (Urbana, IL, USA); University of New Mexico (Albuquerque. NM, USA); Tulane University (New Orleans, LA, USA); AbbVie (Lake Bluff, IL, USA); Pfizer (New York, NY, USA); journals Science Signaling (American Association for the Advancement of Science, Washington, DC, USA); Journal of Biological Chemistry (American Society for Biochemistry and Molecular Biology, Rockville, MD, USA); Journal of Neuroendocrinology (John Wiley & Sons, Hoboken, NJ, USA); Endocrine-Related Cancer (Society for Endocrinology, North Bristol, UK); NIH/NIDDK [R13 DK126171]; Swiss National Science Foundation [108 258, 122 504]; NIH [R01CA184208, P50CA140388, DK107444, DK074970, R01 CA163890, R01 CA194496, P30 CA118100, P20 GM121176]; US Department of Agriculture/National Institute of Food and Agriculture [ILLU-698-331, ILLU-698-924]; Dialysis Clinic, Inc (Nashville, TN, USA) [C3937]; US Department of Veterans Affairs [BX003725]; Steroids (Elsevier, Amsterdam, The Netherlands)	US National Institutes of Health (NIH)/National Institute of Diabetes and Digestive Diseases (NIDDK); US National Institutes of Health (NIH)/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FASEB; Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, Albany, NY, USA; University of Illinois Urbana-Champaign (Urbana, IL, USA); University of New Mexico (Albuquerque. NM, USA); Tulane University (New Orleans, LA, USA); AbbVie (Lake Bluff, IL, USA)(AbbVie); Pfizer (New York, NY, USA)(Pfizer); journals Science Signaling (American Association for the Advancement of Science, Washington, DC, USA); Journal of Biological Chemistry (American Society for Biochemistry and Molecular Biology, Rockville, MD, USA); Journal of Neuroendocrinology (John Wiley & Sons, Hoboken, NJ, USA); Endocrine-Related Cancer (Society for Endocrinology, North Bristol, UK); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Agriculture/National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Dialysis Clinic, Inc (Nashville, TN, USA); US Department of Veterans Affairs(US Department of Veterans Affairs); Steroids (Elsevier, Amsterdam, The Netherlands)	The authors extend special thanks to FASEB for their assistance throughout the organization of this conference, especially Andrea Bauerfeind for her support with organizing the online conference. The authors also thank Silvy Song, their FASEB conference manager, for her hard work in ensuring a well-organized and smoothly run meeting, as well as Bahara Saleh, who was instrumental in coordinating the meeting's sponsors and finances. They also thank Paul Mermelstein, who helped plan initial stages of the meeting. Finally, they thank their sponsors for their maintained support throughout the COVID-19 pandemic, as well as the US National Institutes of Health (NIH)/National Institute of Diabetes and Digestive Diseases (NIDDK) and National Cancer Institute (NCI) for providing generous support for the conference (R13 DK126171). This conference was supported by generous contributions from FASEB, Dr Paul J. Davis (Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, Albany, NY, USA), the University of Illinois Urbana-Champaign (Urbana, IL, USA), the University of New Mexico (Albuquerque. NM, USA), Tulane University (New Orleans, LA, USA), AbbVie (Lake Bluff, IL, USA), Pfizer (New York, NY, USA), and the journals Science Signaling (American Association for the Advancement of Science, Washington, DC, USA), the Journal of Biological Chemistry (American Society for Biochemistry and Molecular Biology, Rockville, MD, USA), Steroids (Elsevier, Amsterdam, The Netherlands), the Journal of Neuroendocrinology (John Wiley & Sons, Hoboken, NJ, USA), and Endocrine-Related Cancer (Society for Endocrinology, North Bristol, UK). This conference was supported by grant R13 DK126171 from NIH/NIDDK and NCI. M. Barton is supported by the Swiss National Science Foundation (grants 108 258 and 122 504); D. E. Frigo is funded by NIH (grants R01CA184208 and P50CA140388); Z. Madak-Erdogan is funded by the US Department of Agriculture/National Institute of Food and Agriculture (grants ILLU-698-331 and ILLU-698-924); F. Mauvais-Jarvis is funded by NIH (grants DK107444 and DK074970) and a US Department of Veterans Affairs Merit Award (BX003725); and E. R. Prossnitz is supported by NIH (grants R01 CA163890, R01 CA194496, P30 CA118100, P20 GM121176) and Dialysis Clinic, Inc (Nashville, TN, USA; grant RF#C3937). The views expressed in written conference materials or publications and by organizers, speakers, and moderators do not necessarily reflect the official policies of the NIH, nor does mention by trade names, commercial practices, or organizations imply endorsement by the US Government.	[Anonymous], 2022, 13 INT M RAP RESP ST; Boyan BD, 2019, STEROIDS, V142, P1, DOI 10.1016/j.steroids.2019.01.007; Caldwell JD, 2014, STEROIDS, V81, P1, DOI 10.1016/j.steroids.2013.10.014; Chien EJ., 2016, STEROIDS, V111, P1; Clouse SD, 2015, J PLANT GROWTH REGUL, V34, P828, DOI 10.1007/s00344-015-9540-7; DeFranco DB., 2016, STEROIDS, V114, P1; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Dwyer AR, 2020, J MOL ENDOCRINOL, V65, pT35, DOI 10.1530/JME-19-0274; Falkenstein E, 2000, J CLIN ENDOCR METAB, V85, P2072, DOI 10.1210/jc.85.5.2072; Funder JW, 2019, HYPERTENSION, V74, P458, DOI 10.1161/HYPERTENSIONAHA.119.12935; Hammes ER., 2013, STEROIDS, V78, P529; Hammes SR, 2018, STEROIDS, V133, P1, DOI 10.1016/j.steroids.2018.03.002; Harvey B, 2008, STEROIDS, V73, P851, DOI 10.1016/j.steroids.2008.04.007; Harvey BJ, 2020, STEROIDS, V154, DOI 10.1016/j.steroids.2019.108552; Kampa M, 2012, STEROIDS, V77, P891, DOI 10.1016/j.steroids.2012.05.001; Lange CA., 2009, STEROIDS, V74, P551; Lange CA, 2007, STEROIDS, V72, P105, DOI 10.1016/j.steroids.2006.11.021; Mackenzie J., 1884, AM J MED SCI, V87, P360; Markee JE, 1932, AM J PHYSIOL, V100, P32, DOI 10.1152/ajplegacy.1932.100.1.32; Nadal A, 2010, STEROIDS, V75, P519, DOI 10.1016/j.steroids.2010.02.001; Norman AW, 2004, STEROIDS, V69, P515, DOI 10.1016/j.steroids.2004.07.001; Norman AW, 2002, STEROIDS, V67, P411, DOI 10.1016/S0039-128X(02)00018-1; Norman AW., 2006, STEROIDS, V71, P277; Pietras RJ, 2005, STEROIDS, V70, P345, DOI 10.1016/j.steroids.2005.02.002; Reynolds SRM, 1939, J CLIN INVEST, V18, P649, DOI 10.1172/JCI101080; Stephen R., 2011, STEROIDS, V76, P821; Watson C S, 1999, Sci STKE, V1999, pPE1, DOI 10.1126/stke.1999.12.pe1; Wehling M., 1998, EXP CLIN ENDOCR DIAB, V106, pA39	28	0	0	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21858	10.1096/fj.202101228	http://dx.doi.org/10.1096/fj.202101228			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34634152	Green Accepted			2022-12-28	WOS:000712009200006
J	Kong, Y; Li, HD; Wang, D; Gao, XL; Yang, CS; Li, MS; Chang, T; Liu, Q				Kong, Ying; Li, Han-Dong; Wang, Dan; Gao, Xiaolin; Yang, Chunsheng; Li, Minshu; Chang, Ting; Liu, Qiang			Group 2 innate lymphoid cells suppress the pathology of neuromyelitis optica spectrum disorder	FASEB JOURNAL			English	Article						autoimmunity; CNS inflammation; innate immunity; innate lymphoid cells; neuromyelitis optica	BRAIN-INJURY; AUTOIMMUNITY; AQUAPORIN-4; PROTECTION; MARKER; IL-33	Neuromyelitis optica spectrum disorder (NMOSD) is a severe central nervous system (CNS) autoimmune disease that primarily damages the optic nerves and spinal cord. Group 2 innate lymphoid cells (ILC2) are potent producers of type 2 cytokines that orchestrate immune and inflammatory responses. However, the role of ILC2 in CNS autoimmune diseases remains unknown. In patients with NMOSD, we identified a significant reduction of ILC2 in peripheral blood, which was correlated with disease severity. Using a mouse model of NMOSD induced by intracerebral injection of NMOSD-IgG with complement, we found CNS infiltration of ILC2 mainly expressing interleukin (IL)-5 and IL-13. The depletion of ILC2 led to increased CNS lesion volume, reduced CNS glucose metabolism, and augmented astrocyte injury and demyelination. The exacerbated NMOSD pathology was accompanied by increased accumulation of Iba1(+) cells and complement activity in CNS lesions. In addition, the expansion of ILC2 using IL-33 attenuated NMO pathology. Collectively, these findings suggest a beneficial role of ILC2 in NMOSD, which deserves further investigation for future design of immune therapies to treat patients with NMOSD.	[Kong, Ying; Li, Han-Dong; Wang, Dan; Gao, Xiaolin; Yang, Chunsheng; Li, Minshu; Liu, Qiang] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin, Peoples R China; [Li, Minshu; Liu, Qiang] Tianjin Neurol Inst, Minist Educ, Key Lab Postneurotrauma Neurorepair & Regenerat C, Tianjin, Peoples R China; [Chang, Ting] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurol, Xian, Peoples R China	Tianjin Medical University; Air Force Military Medical University	Liu, Q (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin, Peoples R China.; Chang, T (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Neurol, Xian, Peoples R China.	changting1981@163.com; qliu@tmu.edu.cn	Liu, Qiang/HHZ-3181-2022	Chang, Ting/0000-0002-7546-8017	Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation) [18JCZDJC97600]; National Natural Science Foundation of China (NSFC) [82071327]; Key Research and Development Program of Shaanxi Province-Innovation chain of key industries [2021ZDLSF02-01]	Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Research and Development Program of Shaanxi Province-Innovation chain of key industries	Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation), Grant/Award Number: 18JCZDJC97600; National Natural Science Foundation of China (NSFC), Grant/Award Number: 82071327; The Key Research and Development Program of Shaanxi Province-Innovation chain of key industries, Grant/Award Number: 2021ZDLSF02-01	Agasing AM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16625-7; Dong EL, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0269-1; Duan TJ, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0766-7; Duerr CU, 2016, NAT IMMUNOL, V17, P65, DOI 10.1038/ni.3308; Finlay CM, 2016, J IMMUNOL, V196, P703, DOI 10.4049/jimmunol.1501820; Fujihara K, 2019, CURR OPIN NEUROL, V32, P385, DOI 10.1097/WCO.0000000000000694; Hinson SR, 2012, P NATL ACAD SCI USA, V109, P1245, DOI 10.1073/pnas.1109980108; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Li MS, 2017, J CEREBR BLOOD F MET, V37, P2383, DOI 10.1177/0271678X16666551; Li MS, 2017, P NATL ACAD SCI USA, V114, pE396, DOI 10.1073/pnas.1612930114; Li Q, 2018, IMMUNITY, V48, P258, DOI 10.1016/j.immuni.2017.12.013; Li ZG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00523; Liu B, 2015, J IMMUNOL, V194, P3583, DOI 10.4049/jimmunol.1400951; Monticelli LA, 2015, P NATL ACAD SCI USA, V112, P10762, DOI 10.1073/pnas.1509070112; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Rak GD, 2016, J INVEST DERMATOL, V136, P487, DOI 10.1038/JID.2015.406; Ren HL, 2018, STROKE, V49, P184, DOI 10.1161/STROKEAHA.117.018904; Ren W, 2020, LIFE SCI, V241, DOI 10.1016/j.lfs.2019.117144; Riedel JH, 2017, J AM SOC NEPHROL, V28, P2068, DOI 10.1681/ASN.2016080877; Roediger B, 2015, ADV IMMUNOL, V125, P111, DOI 10.1016/bs.ai.2014.09.004; Russi AE, 2015, J IMMUNOL, V194, P5609, DOI 10.4049/jimmunol.1500068; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Satoh-Takayama N, 2020, IMMUNITY, V52, P635, DOI 10.1016/j.immuni.2020.03.002; Shi KB, 2016, J IMMUNOL, V197, P3471, DOI 10.4049/jimmunol.1600135; Wang Z, 2017, BRAIN BEHAV IMMUN, V65, P173, DOI 10.1016/j.bbi.2017.04.023; Weinshenker BG, 2017, MAYO CLIN PROC, V92, P663, DOI 10.1016/j.mayocp.2016.12.014; Williams J, 2020, LANCET NEUROL, V19, P31, DOI 10.1016/S1474-4422(19)30445-4; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729; Xu H, 2018, IMMUNOL CELL BIOL, V96, P935, DOI 10.1111/imcb.12159	33	0	0	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21856	10.1096/fj.202100673R	http://dx.doi.org/10.1096/fj.202100673R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34606651				2022-12-28	WOS:000712009200012
J	Li, YY; Li, HX; Xing, WJ; Li, JW; Du, RK; Cao, DC; Wang, YB; Yang, XY; Zhong, GH; Zhao, YL; Sun, WJ; Liu, CZ; Gao, XC; Li, YH; Liu, ZZ; Jin, XY; Zhao, DS; Tan, YJ; Wang, YQ; Liu, SJ; Yuan, M; Song, JP; Chang, YZ; Gao, F; Ling, SK; Li, YX				Li, Youyou; Li, Hongxing; Xing, Wenjuan; Li, Jianwei; Du, Ruikai; Cao, Dengchao; Wang, Yinbo; Yang, Xueyi; Zhong, Guohui; Zhao, Yinlong; Sun, Weijia; Liu, Caizhi; Gao, Xingcheng; Li, Yeheng; Liu, Zizhong; Jin, Xiaoyan; Zhao, Dingsheng; Tan, Yingjun; Wang, Yanqing; Liu, Shujuan; Yuan, Min; Song, Jinping; Chang, Yan-Zhong; Gao, Feng; Ling, Shukuan; Li, Yingxian			Vascular smooth muscle cell-specific miRNA-214 knockout inhibits angiotensin II-induced hypertension through upregulation of Smad7	FASEB JOURNAL			English	Article						angiotensin II; hypertension; miR-214; Smad7; vascular remodeling	BLOOD-PRESSURE; ANG-II; FIBROSIS; ACTIVATION; SYSTEM; RATS	Vascular remodeling is a prominent trait during the development of hypertension, attributable to the phenotypic transition of vascular smooth muscle cells (VSMCs). Increasing studies demonstrate that microRNA plays an important role in this process. Here, we surprisingly found that smooth muscle cell-specific miR-214 knockout (miR-214 cKO) significantly alleviates angiotensin II (Ang II)-induced hypertension, which has the same effect as that of miR-214 global knockout mice in response to Ang II stimulation. Under the treatment of Ang II, miR-214 cKO mice exhibit substantially reduced systolic blood pressure. The vascular medial thickness and area in miR-214 cKO blood vessels were obviously reduced, the expression of collagen I and proinflammatory factors were also inhibited. VSMC-specific deletion of miR-214 blunts the response of blood vessels to the stimulation of endothelium-dependent and -independent vasorelaxation and phenylephrine and 5-HT induced vasocontraction. In vitro, Ang II-induced VSMC proliferation, migration, contraction, hypertrophy, and stiffness were all repressed with miR-214 KO in VSMC. To further explore the mechanism of miR-214 in the regulation of the VSMC function, it is very interesting to find that the TGF-beta signaling pathway is mostly enriched in miR-214 KO VSMC. Smad7, the potent negative regulator of the TGF-beta/Smad pathway, is identified to be the target of miR-214 in VSMC. By which, miR-214 KO sharply enhances Smad7 levels and decreases the phosphorylation of Smad3, and accordingly alleviates the downstream gene expression. Further, Ang II-induced hypertension and vascular dysfunction were reversed by antagomir-214. These results indicate that miR-214 in VSMC established a crosstalk between Ang II-induced AT1R signaling and TGF-beta induced T beta RI /Smad signaling, by which it exerts a pivotal role in vascular remodeling and hypertension and imply that miR-214 has the potential as a therapeutic target for the treatment of hypertension.	[Li, Youyou; Li, Hongxing; Xing, Wenjuan; Li, Jianwei; Du, Ruikai; Cao, Dengchao; Wang, Yinbo; Zhong, Guohui; Sun, Weijia; Liu, Caizhi; Gao, Xingcheng; Li, Yeheng; Liu, Zizhong; Jin, Xiaoyan; Zhao, Dingsheng; Tan, Yingjun; Wang, Yanqing; Liu, Shujuan; Yuan, Min; Song, Jinping; Ling, Shukuan; Li, Yingxian] China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, 26 Beiqing Rd, Beijing 100094, Peoples R China; [Li, Youyou; Xing, Wenjuan; Wang, Yinbo; Zhong, Guohui; Li, Yeheng; Gao, Feng] Fourth Mil Med Univ, Sch Aerosp Med, Xian, Peoples R China; [Li, Hongxing; Zhao, Yinlong; Chang, Yan-Zhong] Hebei Normal Univ, Coll Life Sci, Key Lab Mol & Cellular Biol, Minist Educ, Shijiazhuang, Hebei, Peoples R China; [Yang, Xueyi] Tsinghua Univ, Inst Biomech & Med Engn, Beijing, Peoples R China	Air Force Military Medical University; Hebei Normal University; Tsinghua University	Ling, SK; Li, YX (corresponding author), China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, 26 Beiqing Rd, Beijing 100094, Peoples R China.	sh2ling@126.com; yingxianli@aliyun.com	Cao, Dengchao/AIA-7934-2022; Chang, Yan-Zhong/AAB-5676-2020; Song, Jin/HHS-8731-2022	Cao, Dengchao/0000-0001-9808-991X; Chang, Yan-Zhong/0000-0002-6386-9649; 	National Natural Science Foundation of China (NSFC) [81822026, 91740114, 81470429]; State Key Lab of Space Medicine Fundamentals and Application [SMFA16B03, SMFA17B05, SMFA18B08, SMFA19A02]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); State Key Lab of Space Medicine Fundamentals and Application	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81822026, 91740114 and 81470429; State Key Lab of Space Medicine Fundamentals and Application, Grant/Award Number: SMFA16B03, SMFA17B05, SMFA18B08 and SMFA19A02	Afzal TA, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004629; Alesutan I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01882-2; Aubdool AA, 2017, CIRCULATION, V136, P367, DOI 10.1161/CIRCULATIONAHA.117.028388; CATT KJ, 1971, LANCET, V1, P459; Cui ML, 2016, HYPERTENSION, V67, P153, DOI 10.1161/HYPERTENSIONAHA.115.06114; Cui YM, 2019, AM J TRANSL RES, V11, P3167; Eskildsen TV, 2013, INT J MOL SCI, V14, P11190, DOI 10.3390/ijms140611190; Gatineau E, 2019, HYPERTENSION, V74, P1014, DOI 10.1161/HYPERTENSIONAHA.119.12906; Hu ZY, 2018, CIRCULATION, V138, P1431, DOI 10.1161/CIRCULATIONAHA.117.031231; Huo KG, 2019, HYPERTENSION, V73, P1007, DOI 10.1161/HYPERTENSIONAHA.119.12619; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Jia GH, 2018, HYPERTENSION, V72, P537, DOI 10.1161/HYPERTENSIONAHA.118.11065; Kohnken R, 2019, J INVEST DERMATOL, V139, P1966, DOI 10.1016/j.jid.2019.01.033; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Li GH, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2277-7; Li HP, 2016, CIRCULATION, V134, P734, DOI 10.1161/CIRCULATIONAHA.116.023926; Li XX, 2019, HYPERTENSION, V73, pE14, DOI 10.1161/HYPERTENSIONAHA.118.12319; Liu CZ, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12783; Liu JF, 2019, BRIT J PHARMACOL, V176, P4666, DOI 10.1111/bph.14831; Liu Y, 2018, J AM SOC NEPHROL, V29, P2518, DOI 10.1681/ASN.2018020117; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Marques FD, 2011, HYPERTENSION, V57, P477, DOI 10.1161/HYPERTENSIONAHA.110.167346; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Nosalski R, 2020, CIRC RES, V126, P988, DOI 10.1161/CIRCRESAHA.119.315428; Pan XB, 2018, CELL METAB, V27, P1323, DOI 10.1016/j.cmet.2018.04.002; Romero JC, 1999, HYPERTENSION, V34, P943, DOI 10.1161/01.HYP.34.4.943; Ryan MJ, 2004, HYPERTENSION, V43, P1074, DOI 10.1161/01.HYP.0000123074.89717.3d; Sharma N, 2019, ARTERIOSCL THROM VAS, V39, P212, DOI 10.1161/ATVBAHA.118.311969; Sorescu D, 2006, CIRC RES, V98, P988, DOI 10.1161/01.RES.0000221824.87718.c0; Srivastava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076994; Sun HJ, 2016, ANTIOXID REDOX SIGN, V24, P1045, DOI 10.1089/ars.2015.6475; Takemori K, 2007, HYPERTENSION, V49, P365, DOI 10.1161/01.HYP.0000255576.16089.b9; Wang LP, 2016, PFLUG ARCH EUR J PHY, V468, P2041, DOI 10.1007/s00424-016-1875-9; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Wu YT, 2017, ONCOTARGET, V8, P19866, DOI 10.18632/oncotarget.15189; Xiang R, 2020, CIRC RES, V126, P1746, DOI 10.1161/CIRCRESAHA.119.315558; Xu L, 2017, J CELL MOL MED, V21, P1545, DOI 10.1111/jcmm.13085; Xue BJ, 2009, AM J PHYSIOL-HEART C, V297, pH1638, DOI 10.1152/ajpheart.00502.2009; Xue BJ, 2005, AM J PHYSIOL-HEART C, V288, pH2177, DOI 10.1152/ajpheart.00969.2004; Zeng XL, 2019, J MOL CELL CARDIOL, V134, P131, DOI 10.1016/j.yjmcc.2019.07.002; Zhang J, 2014, PROTEIN CELL, V5, P503, DOI 10.1007/s13238-014-0058-8; Zhang Z, 2012, CIRC RES, V111, P1137, DOI 10.1161/CIRCRESAHA.112.273755	44	2	2	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21947	10.1096/fj.202100766RR	http://dx.doi.org/10.1096/fj.202100766RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34637552				2022-12-28	WOS:000712009200023
J	Kim, SE; Zhang, J; Jiang, E; Overholtzer, M				Kim, Sung Eun; Zhang, Justin; Jiang, Enoch; Overholtzer, Michael			Amino acids and mechanistic target of rapamycin regulate the fate of live engulfed cells	FASEB JOURNAL			English	Article						amino acids; cell death; entosis; metabolism; mTOR	DEATH PROCESS; ENTOSIS; PATHWAY	Metabolic stress contributes to the regulation of cell death in normal and diseased tissues. While different forms of cell death are known to be regulated by metabolic stress, how the cell engulfment and killing mechanism entosis is regulated is not well understood. Here we find that the death of entotic cells is regulated by the presence of amino acids and activity of the mechanistic target of rapamycin (mTOR). Amino acid withdrawal or mTOR inhibition induces apoptosis of engulfed cells and blocks entotic cell death that is associated with the lipidation of the autophagy protein microtubule-associated protein light chain 3 (LC3) to entotic vacuoles. Two other live cell engulfment programs, homotypic cell cannibalism (HoCC) and anti-CD47 antibody-mediated phagocytosis, known as phagoptosis, also undergo a similar vacuole maturation sequence involving LC3 lipidation and lysosome fusion, but only HoCC involves mTOR-dependent regulation of vacuole maturation and engulfed cell death similar to entosis. We further find that the regulation of cell death by mTOR is independent of autophagy activation and instead involves the 4E-BP1/2 proteins that are known regulators of mRNA translation. Depletion of 4E-BP1/2 proteins can restore the mTOR-regulated changes of entotic death and apoptosis rates of engulfed cells. These results identify amino acid signaling and the mTOR-4E-BP1/2 pathway as an upstream regulation mechanism for the fate of live engulfed cells formed by entosis and HoCC.	[Kim, Sung Eun; Zhang, Justin; Jiang, Enoch; Overholtzer, Michael] Sloan Kettering Inst Canc Res, Cell Biol Program, New York, NY USA; [Kim, Sung Eun; Overholtzer, Michael] Weill Cornell Med Coll, BCMB Allied Program, New York, NY USA; [Overholtzer, Michael] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, 411 East 67th St,Rm RRL 629, New York, NY 10065 USA; [Kim, Sung Eun] Korea Univ, Coll Hlth Sci, Dept Biosyst & Biomed Sci, Seoul 02841, South Korea; [Kim, Sung Eun] Korea Univ, Coll Hlth Sci, Dept Integrated Biomed & Life Sci, Seoul 02841, South Korea	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Korea University; Korea University	Overholtzer, M (corresponding author), Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, 411 East 67th St,Rm RRL 629, New York, NY 10065 USA.; Kim, SE (corresponding author), Korea Univ, Coll Hlth Sci, Sch Biosyst & Biomed Sci, Hana Sci Bldg B,Rm 165,145 Anam Ro, Seoul 02841, South Korea.	sek19@korea.ac.kr; overhom1@mskcc.org		Kim, Sung Eun/0000-0002-4281-5625	National Research Foundation of Korea (NRF) [NRF-2020R1C1C1013220]; Korea University Grant [K1926621]; National Cancer Institute [RO1CA154649]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea University Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2020R1C1C1013220; Korea University Grant, Grant/Award Number: K1926621; National Cancer Institute, Grant/Award Number: RO1CA154649	Benseler V, 2011, P NATL ACAD SCI USA, V108, P16735, DOI 10.1073/pnas.1112251108; Brown GC, 2012, TRENDS BIOCHEM SCI, V37, P325, DOI 10.1016/j.tibs.2012.05.002; Cano CE, 2012, EMBO MOL MED, V4, P964, DOI 10.1002/emmm.201201255; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Durgan J, 2017, ELIFE, V6, DOI 10.7554/eLife.27134; Florey O, 2012, TRENDS CELL BIOL, V22, P374, DOI 10.1016/j.tcb.2012.04.005; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Hamann JC, 2017, CELL REP, V20, P201, DOI 10.1016/j.celrep.2017.06.037; Lee Y, 2019, CELL REP, V26, P3212, DOI 10.1016/j.celrep.2019.02.073; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Metayer LE, 2017, ONCOTARGET, V8, P60892, DOI 10.18632/oncotarget.18492; Overholtzer M, 2008, NAT REV MOL CELL BIO, V9, P796, DOI 10.1038/nrm2504; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Tait SWG, 2014, J CELL SCI, V127, P2135, DOI 10.1242/jcs.093575; Wang S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.352; Yuan JY, 2010, GENE DEV, V24, P2592, DOI 10.1101/gad.1984410	20	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21909	10.1096/fj.202100870R	http://dx.doi.org/10.1096/fj.202100870R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34547144	hybrid, Green Published			2022-12-28	WOS:000702238200050
J	Liu, X; Shi, BS; Suo, R; Xiong, SL; Wang, XW; Liang, X; Li, XJ; Li, GP				Liu, Xing; Shi, Bingshuo; Suo, Rong; Xiong, Shenglin; Wang, Xuewen; Liang, Xue; Li, Xinjian; Li, Guangping			Itaconate regulates macrophage function through stressful iron-sulfur cluster disrupting and iron metabolism rebalancing	FASEB JOURNAL			English	Article						aconitase; IL-1 beta; IRG1; iron metabolism; iron-sulfur cluster; itaconate	NLRP3 INFLAMMASOME; SUCCINATE-DEHYDROGENASE; K+ EFFLUX; ACTIVATION; INHIBITION; GENE-1; POLARIZATION; ACONITASE; PROTEINS; PROGRAMS	Lipopolysaccharide (LPS)-stimulated macrophages express an aconitate decarboxylase (IRG1, also called ACOD1), leading to accumulation of the endogenous metabolite itaconate. However, the precise mechanisms by which elevated itaconate levels alter macrophage function are not clear. Our hypothesis is itaconate affects macrophage function through some uncertain mechanism. Based on this, we established a transcriptional and proteomic signature of macrophages stimulated by itaconate and identified the pathways of IL-1 beta secretion and altered iron metabolism. Consistently, the effect of IRG1 deficiency on IL-1 beta secretion and iron metabolism was confirmed in IRG1 knockout THP-1 cell lines. Several common inhibitors and other compounds were used to examine the molecular mechanisms involved. Only cysteine and antioxidants (catechin hydrate) could inhibit. caspase-1 activation and IL-1 beta secretion in itaconate-stimulated macrophages. We further found that aconitase activity was decreased by itaconate stimulation. Our results demonstrate the counteracting effects of overexpression of mitochondria] aconitase (ACO2, a tricarboxylic acid cycle enzyme) or cytosolic aconitase (ACO1, an iron regulatory protein) on IL-1 beta secretion and altered iron metabolism. Both enzyme activities were inhibited by itaconate because of iron-sulfur (Fe-S) cluster destruction. Our findings indicate that the immunoregulatory functions of IRG1 and itaconate in macrophages are stressful Fe-S cluster of aconitases disrupting and iron metabolism rebalancing.	[Liu, Xing; Shi, Bingshuo; Wang, Xuewen; Liang, Xue; Li, Xinjian; Li, Guangping] Tianjin Med Univ, Tianjin Inst Cardiol, Dept Cardiol, Hosp 2,Tianjin Key Lab Ion Mol Funct Cardiovasc D, 23 Pingjiang Rd, Tianjin 300211, Peoples R China; [Suo, Rong] Tianjin Hosp, Dept Cardiol, Tianjin, Peoples R China; [Xiong, Shenglin] You Country Peoples Hosp, Dept Cardiol, Zhuzhou, Peoples R China	Tianjin Medical University	Liu, X; Li, GP (corresponding author), Tianjin Med Univ, Tianjin Inst Cardiol, Dept Cardiol, Hosp 2,Tianjin Key Lab Ion Mol Funct Cardiovasc D, 23 Pingjiang Rd, Tianjin 300211, Peoples R China.	liuxing0626@163.com; tjcardiol@126.com			National Natural Science Foundation of China [81900314]; Science & Technology Development Fund of Tianjin Education Commission for Higher Education [2017KJ205]; Scientific Research Fund Project of Key Laboratory of Second Hospital of Tianjin Medical University [2019ZDSYS16, 2019ZDSYS11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Development Fund of Tianjin Education Commission for Higher Education; Scientific Research Fund Project of Key Laboratory of Second Hospital of Tianjin Medical University	National Natural Science Foundation of China, Grant/Award Number: 81900314; Science & Technology Development Fund of Tianjin Education Commission for Higher Education, Grant/Award Number: 2017KJ205; Scientific Research Fund Project of Key Laboratory of Second Hospital of Tianjin Medical University, Grant/Award Number: 2019ZDSYS16 and 2019ZDSYS11	An YA, 2019, FASEB J, V33, P12515, DOI 10.1096/fj.201802805RR; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Basler T, 2006, J LEUKOCYTE BIOL, V79, P628, DOI 10.1189/jlb.0905520; Beloborodova N, 2019, METABOLITES, V9, DOI 10.3390/metabo9100196; Bronner DN, 2015, IMMUNITY, V43, P451, DOI 10.1016/j.immuni.2015.08.008; Chinetti-Gbaguidi G, 2015, NAT REV CARDIOL, V12, P10, DOI 10.1038/nrcardio.2014.173; Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108; Cordes T, 2016, J BIOL CHEM, V291, P14274, DOI 10.1074/jbc.M115.685792; Curi R, 2017, CLIN SCI, V131, P1329, DOI 10.1042/CS20170220; de Couto G, 2017, CIRCULATION, V136, P200, DOI 10.1161/CIRCULATIONAHA.116.024590; de Couto G, 2015, J CLIN INVEST, V125, P3147, DOI 10.1172/JCI81321; Ganta VC, 2017, CIRCULATION, V135, P2403, DOI 10.1161/CIRCULATIONAHA.116.025490; Ghosh MC, 2013, CELL METAB, V17, P271, DOI 10.1016/j.cmet.2012.12.016; Hansen JB, 2012, CELL METAB, V16, P449, DOI 10.1016/j.cmet.2012.09.001; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Karmakar M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10555; Katsnelson MA, 2016, AM J PHYSIOL-CELL PH, V311, pC83, DOI 10.1152/ajpcell.00298.2015; Katsnelson MA, 2015, J IMMUNOL, V194, P3937, DOI 10.4049/jimmunol.1402658; Konert G, 2015, NEW PHYTOL, V205, P1250, DOI 10.1111/nph.13097; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Latonen L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03573-6; Lehmann JS, 2017, JOVE-J VIS EXP, DOI 10.3791/56440; Li JC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52013-y; Li YK, 2013, J BIOL CHEM, V288, P16225, DOI 10.1074/jbc.M113.454538; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lin SJ, 2015, J VIROL, V89, P1083, DOI 10.1128/JVI.02318-14; Liu X, 2017, INT IMMUNOPHARMACOL, V48, P76, DOI 10.1016/j.intimp.2017.04.012; Mariano LL, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5739; Franco JLM, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108547; Matulova M, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-37; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nakamura K, 2016, EXP HEMATOL, V44, P116, DOI 10.1016/j.exphem.2015.11.002; Nnah IC, 2020, J NEUROCHEM, V154, P177, DOI 10.1111/jnc.14906; PHILPOTT CC, 1994, P NATL ACAD SCI USA, V91, P7321, DOI 10.1073/pnas.91.15.7321; Piccolo V, 2017, NAT IMMUNOL, V18, P530, DOI 10.1038/ni.3710; Qin W, 2019, NAT CHEM BIOL, V15, P983, DOI 10.1038/s41589-019-0323-5; Sottile R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00224; Taxman DJ, 2010, CELL HOST MICROBE, V8, P7, DOI 10.1016/j.chom.2010.06.005; Tong WH, 2007, BIOMETALS, V20, P549, DOI 10.1007/s10534-006-9047-6; Tucey TM, 2018, CELL METAB, V27, P988, DOI 10.1016/j.cmet.2018.03.019; Velayudhan J, 2014, INFECT IMMUN, V82, P1390, DOI 10.1128/IAI.01022-13; Wilkinson N, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00176; Williams NC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00141; Wynosky-Dolfi MA, 2014, J EXP MED, V211, P653, DOI 10.1084/jem.20130627; Zou YL, 2020, NAT CHEM BIOL, V16, P302, DOI 10.1038/s41589-020-0472-6	47	2	2	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21936	10.1096/fj.202100726RR	http://dx.doi.org/10.1096/fj.202100726RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34547129				2022-12-28	WOS:000702238200079
J	Xie, C; Habif, JC; Uytingco, CR; Ukhanov, K; Zhang, L; de Celis, C; Sheffield, VC; Martens, JR				Xie, Chao; Habif, Julien C.; Uytingco, Cedric R.; Ukhanov, Kirill; Zhang, Lian; de Celis, Carlos; Sheffield, Val C.; Martens, Jeffrey R.			Gene therapy rescues olfactory perception in a clinically relevant ciliopathy model of Bardet-Biedl syndrome	FASEB JOURNAL			English	Article						Bardet-Biedl syndrome; ciliopathies; gene therapy; olfactory cilia; olfactory perception; whole body plethysmography	SYNDROME PROTEINS; MOUSE MODEL; CILIA; MUTATIONS; OBESITY; IDENTIFICATION; COMPLEX; BBS1; LOCALIZATION; DYSFUNCTION	Bardet-Biedl syndrome (BBS) is a hereditary genetic disorder that results in numerous clinical manifestations including olfactory dysfunction. Of at least 21 BBS-related genes that can carry multiple mutations, a pathogenic mutation, BBS1M390R, is the single most common mutation of clinically diagnosed BBS outcomes. While the deletion of BBS-related genes in mice can cause variable penetrance in different organ systems, the impact of the Bbs1M390R mutation in the olfactory system remains unclear. Using a clinically relevant knock-in mouse model homozygous for Bbs1M390R, we investigated the impact of the mutation on the olfactory system and tested the potential of viral-mediated, wildtype gene replacement therapy to rescue smell loss. The cilia of olfactory sensory neurons (OSNs) in Bbs1(M390R/M390R) mice were significantly shorter and fewer than those of wild-type mice. Also, both peripheral cellular odor detection and synaptic-dependent activity in the olfactory bulb were significantly decreased in the mutant mice. Furthermore, to gain insight into the degree to which perceptual features are impaired in the mutant mice, we used whole-body plethysmography to quantitatively measure odor-evoked sniffing. The Bbs1(M390R/M390R) mice showed significantly higher odor detection thresholds (reduced odor sensitivity) compared to wild-type mice; however, their odor discrimination acuity was still well maintained. Importantly, adenoviral expression of Bbs1 in OSNs restored cilia length and re-established both peripheral odorant detection and odor perception. Together, our findings further expand our understanding for the development of gene therapeutic treatment for congenital ciliopathies in the olfactory system.	[Xie, Chao; Habif, Julien C.; Uytingco, Cedric R.; Ukhanov, Kirill; Zhang, Lian; de Celis, Carlos; Martens, Jeffrey R.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Xie, Chao; Habif, Julien C.; Uytingco, Cedric R.; Ukhanov, Kirill; Zhang, Lian; de Celis, Carlos; Martens, Jeffrey R.] Univ Florida, Ctr Smell & Taste, Coll Med, Gainesville, FL 32610 USA; [Sheffield, Val C.] Univ Iowa, Dept Pediat, Div Med Genet & Genom, Iowa City, IA USA; [Sheffield, Val C.] Univ Iowa, Dept Ophthalmol & Vis Res, Iowa City, IA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Iowa; University of Iowa	Martens, JR (corresponding author), Univ Florida, Dept Pharmacol & Therapeut, 1200 Newell Dr,POB 100267, Gainesville, FL 32610 USA.	martensj@ufl.edu	Xie, Chao/ABA-7345-2021	Xie, Chao/0000-0001-7645-1922; Habif, Julien/0000-0002-4661-3115	National Institute on Deafness and Other Communication Disorders (NIDCD) [R01DC019345, T32DC015994]	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	National Institute on Deafness and Other Communication Disorders (NIDCD), Grant/Award Number: R01DC019345 and T32DC015994	Agassandian K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093484; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Badano JL, 2003, AM J HUM GENET, V72, P650, DOI 10.1086/368204; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Cring Matthew R, 2022, Gene Ther, V29, P227, DOI 10.1038/s41434-021-00241-1; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Daya S, 2008, CLIN MICROBIOL REV, V21, P583, DOI 10.1128/CMR.00008-08; Drack AV, 2012, INVEST OPHTH VIS SCI, V53, P100, DOI 10.1167/iovs.11-8544; Fattahi Z, 2014, J HUM GENET, V59, P368, DOI 10.1038/jhg.2014.28; Forsyth R., 2003, GENEREVIEWS; Green WW, 2018, J NEUROSCI, V38, P7462, DOI 10.1523/JNEUROSCI.0084-18.2018; Hoffman HJ, 1998, ANN NY ACAD SCI, V855, P716, DOI 10.1111/j.1749-6632.1998.tb10650.x; Hsu Y, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007057; Huttenbrink KB, 2013, DTSCH ARZTEBL INT, V110, P1, DOI 10.3238/arztebl.2013.0001; Hummel T, 2005, ACTA OTO-LARYNGOL, V125, P116, DOI 10.1080/00016480410022787; Iannaccone A, 2005, AM J MED GENET A, V132A, P343, DOI 10.1002/ajmg.a.30512; Imhoff O, 2011, CLIN J AM SOC NEPHRO, V6, P22, DOI 10.2215/CJN.03320410; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Johnson ME, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66201-8; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Khan SA, 2016, CLIN GENET, V90, P3, DOI 10.1111/cge.12737; Klink BU, 2020, ELIFE, V9, DOI 10.7554/eLife.53910; Kousi M, 2020, NAT GENET, V52, P1145, DOI 10.1038/s41588-020-0707-1; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Lehmkuhl Andrew M, 2014, J Vis Exp, pe51804, DOI 10.3791/51804; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lindstrand A, 2016, AM J HUM GENET, V99, P318, DOI 10.1016/j.ajhg.2015.04.023; Linster C, 2002, J NEUROSCI, V22, P6842; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Manara E, 2019, ITAL J PEDIATR, V45, DOI 10.1186/s13052-019-0659-1; McClintock TS, 2020, CHEM SENSES, V45, P805, DOI 10.1093/chemse/bjaa070; McEwen DP, 2007, P NATL ACAD SCI USA, V104, P15917, DOI 10.1073/pnas.0704140104; McIntyre JC, 2013, TRENDS BIOTECHNOL, V31, P355, DOI 10.1016/j.tibtech.2013.03.005; Meng XM, 2020, AM J OTOLARYNG, V41, DOI 10.1016/j.amjoto.2020.102581; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; Mirich JM, 2002, J COMP NEUROL, V454, P361, DOI 10.1002/cne.10426; Mokrzan EM, 2007, NEPHRON EXP NEPHROL, V106, P88, DOI 10.1159/000103021; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nagayama S, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00098; Nishimura DY, 2005, AM J HUM GENET, V77, P1021, DOI 10.1086/498323; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Novas R, 2015, FEBS LETT, V589, P3479, DOI 10.1016/j.febslet.2015.07.031; Nozaki S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195005; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; Pak TK, 2021, PLOS GENET, V17, DOI 10.1371/journal.pgen.1009484; Parma V, 2020, CHEM SENSES, V45, P609, DOI 10.1093/chemse/bjaa041; Peng M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29874; Prasai A, 2020, J BIOL CHEM, V295, P14279, DOI 10.1074/jbc.RA120.013905; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Sarafoleanu C, 2009, J Med Life, V2, P196; Seo S, 2013, INVEST OPHTH VIS SCI, V54, P6118, DOI 10.1167/iovs.13-11673; Shah AS, 2008, P NATL ACAD SCI USA, V105, P3380, DOI 10.1073/pnas.0712327105; Slavotinek AM, 2000, AM J MED GENET, V95, P208, DOI 10.1002/1096-8628(20001127)95:3<208::AID-AJMG5>3.3.CO;2-A; Su XF, 2014, HUM MOL GENET, V23, P5441, DOI 10.1093/hmg/ddu267; SUNDBERG H, 1982, BEHAV NEURAL BIOL, V34, P113, DOI 10.1016/S0163-1047(82)91501-1; Tadenev ALD, 2011, P NATL ACAD SCI USA, V108, P10320, DOI 10.1073/pnas.1016531108; Uytingco CR, 2019, J CELL SCI, V132, DOI 10.1242/jcs.222331; Uytingco CR, 2019, CURR MED CHEM, V26, P3103, DOI 10.2174/0929867325666180105102447; Veitia RA, 2007, PLANT CELL, V19, P3843, DOI 10.1105/tpc.107.055053; Wei Q, 2012, NAT CELL BIOL, V14, P950, DOI 10.1038/ncb2560; Wesson DW, 2011, BEHAV BRAIN RES, V223, P99, DOI 10.1016/j.bbr.2011.04.016; Williams CL, 2017, MOL THER, V25, P904, DOI 10.1016/j.ymthe.2017.02.006; Williams CL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6813; Wilson DA, 2008, J NEUROPHYSIOL, V100, P2, DOI 10.1152/jn.90479.2008; Wingfield JL, 2018, ESSAYS BIOCHEM, V62, P753, DOI 10.1042/EBC20180030; Yang Jingpu, 2016, Curr Otorhinolaryngol Rep, V4, P130, DOI 10.1007/s40136-016-0120-6; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107; Zhang QH, 2012, J BIOL CHEM, V287, P20625, DOI 10.1074/jbc.M112.341487; Zimmerman K, 2015, CELL, V161, P692, DOI 10.1016/j.cell.2015.04.015; Zou Junhui, 2015, Curr Protoc Toxicol, V63, DOI 10.1002/0471140856.tx1118s63; Zou JH, 2012, J NEUROSCI, V32, P4118, DOI 10.1523/JNEUROSCI.6260-11.2012	79	2	2	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21766	10.1096/fj.202100627R	http://dx.doi.org/10.1096/fj.202100627R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34383976	Green Accepted			2022-12-28	WOS:000691122900013
J	Ye, ML; Wang, C; Zhu, J; Chen, MK; Wang, SH; Li, MX; Lu, YJ; Xiao, PP; Zhou, MS; Li, XQ; Zhou, R				Ye, Mengling; Wang, Cheng; Zhu, Jie; Chen, Mingkai; Wang, Shuhong; Li, Mingxuan; Lu, Yajing; Xiao, Pingping; Zhou, Mengsi; Li, Xiaoqing; Zhou, Rui			An NF-kappa B-responsive long noncoding RNA, PINT, regulates TNF-alpha gene transcription by scaffolding p65 and EZH2	FASEB JOURNAL			English	Article						EZH2; long noncoding RNA; p65; PINT; TNF-alpha	EXPRESSION; LNCRNA; COOPERATION; MALAT1; BREAST	Long noncoding RNAs (lncRNAs) are central regulators of the inflammatory response and play an important role in inflammatory diseases. PINT has been reported to be involved in embryonic development and tumorigenesis. However, the potential functions of PINT in the innate immune system are largely unknown. Here, we revealed the transcriptional regulation of inflammatory genes by PINT, whose expression is primarily dependent on the NF-kappa B signaling pathway in human and mouse macrophage and intestinal epithelial cell lines. Functionally, PINT selectively regulates the expression of TNF-alpha in basal and LPS-stimulated cells. Mechanistically, PINT acts as a modular scaffold of p65 and EZH2 to coordinate their localization and specify their binding to the target genes. Further, a high expression level of PINT was detected in intestinal mucosal tissues from patients with ulcerative colitis (UC). Together, these findings demonstrate that PINT acts as an activator of inflammatory responses, highlighting the importance of this lncRNA as a potential therapeutic target in infectious diseases and inflammatory diseases.	[Ye, Mengling; Wang, Cheng; Zhu, Jie; Wang, Shuhong; Li, Mingxuan; Xiao, Pingping; Zhou, Mengsi; Zhou, Rui] Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Allergy & Immunol, Wuhan, Peoples R China; [Ye, Mengling] Guangxi Med Univ, Tumor Hosp, Dept Res, Nanning, Peoples R China; [Chen, Mingkai] Wuhan Univ, Dept Gastroenterol, Renmin Hosp, Wuhan, Peoples R China; [Lu, Yajing] Huazhong Univ Sci & Technol, Liyuan Hosp, Tongji Med Coll, Dept Endocrinol,Inst Geriatr Med, Wuhan, Peoples R China; [Li, Xiaoqing] Huazhong Univ Sci & Technol, Union Hosp, Ctr Stem Cell Res & Applicat, Tongji Med Sch, Wuhan, Peoples R China	Wuhan University; Guangxi Medical University; Wuhan University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhou, R (corresponding author), Wuhan Univ, Sch Basic Med Sci, 185 Donghu Rd, Wuhan 430071, Hubei, Peoples R China.	ruizhou@whu.edu.cn		Chen, Mingkai/0000-0003-2652-6863; Chen, Mingkai/0000-0001-6771-0523	National Natural Science Foundation of China [81771702, 81373132, 31300744]; Doctoral Program of Higher Education of China [20130141120011]; Fundamental Research Funds for the Central Universities [2042018kf0249]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	National Natural Science Foundation of China, Grant/Award Number: 81771702, 81373132 and 31300744; Doctoral Program of Higher Education of China, Grant/Award Number: 20130141120011; Fundamental Research Funds for the Central Universities, Grant/Award Number: 2042018kf0249	Ben-Horin S, 2014, AUTOIMMUN REV, V13, P24, DOI 10.1016/j.autrev.2013.06.002; Bernstein CN, 2010, INFLAMM BOWEL DIS, V16, P112, DOI 10.1002/ibd.21048; Bohl JL, 2015, SURG CLIN N AM, V95, P1211, DOI 10.1016/j.suc.2015.07.003; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Brave M, 2015, ONCOTARGET, V6, P19962, DOI 10.18632/oncotarget.4780; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Das S, 2018, ARTERIOSCL THROM VAS, V38, P1806, DOI 10.1161/ATVBAHA.117.310663; Deb G, 2013, EPIGENETICS-US, V8, P464, DOI 10.4161/epi.24532; Fukata M, 2007, BIOCHEM SOC T, V35, P1473, DOI 10.1042/BST0351473; Garitano-Trojaola Andoni, 2018, Oncotarget, V9, P12842, DOI 10.18632/oncotarget.24401; Gaudio E, 1999, DIGEST DIS SCI, V44, P1458, DOI 10.1023/A:1026620322859; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; Hinrichs AS, 2016, BIOINFORMATICS, V32, P1430, DOI 10.1093/bioinformatics/btv766; Johnsson P, 2014, BBA-GEN SUBJECTS, V1840, P1063, DOI 10.1016/j.bbagen.2013.10.035; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Kong HJ, 2011, FISH SHELLFISH IMMUN, V30, P406, DOI 10.1016/j.fsi.2010.11.024; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133j, 10.1021/cb400133J]; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Li L, 2016, ONCOTARGET, V7, P71773, DOI 10.18632/oncotarget.12365; Liu Q, 2016, IMMUNOL CELL BIOL, V94, P538, DOI 10.1038/icb.2016.18; Liu X, 2019, J IMMUNOL, V203, P1548, DOI 10.4049/jimmunol.1900256; Lu YJ, 2017, J IMMUNOL, V199, P3571, DOI 10.4049/jimmunol.1700091; Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263; Marin-Bejar O, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1331-y; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Murphy MB, 2016, J LEUKOCYTE BIOL, V99, P839, DOI 10.1189/jlb.2RU1215-575R; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Pinot F, 1998, LIFE SCI, V64, P125, DOI 10.1016/S0024-3205(98)00542-6; Rajabi H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07850-0; Roux BT, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01038; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Shin HM, 2004, FEBS LETT, V571, P50, DOI 10.1016/j.febslet.2004.06.056; Skoog T, 2006, BIOCHEM BIOPH RES CO, V351, P777, DOI 10.1016/j.bbrc.2006.10.114; Sun M, 2016, CANCER RES, V76, P6299, DOI 10.1158/0008-5472.CAN-16-0356; Tan JZ, 2014, ACTA PHARMACOL SIN, V35, P161, DOI 10.1038/aps.2013.161; Volders PJ, 2019, NUCLEIC ACIDS RES, V47, pD135, DOI 10.1093/nar/gky1031; Xue JP, 2009, PHYSIOL GENOMICS, V38, P42, DOI 10.1152/physiolgenomics.00012.2009; Yang GD, 2014, BBA-GENE REGUL MECH, V1839, P1097, DOI 10.1016/j.bbagrm.2014.08.012; Yang T, 2018, CANCER MED-US, V7, P2048, DOI 10.1002/cam4.1405; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhang HJ, 2017, INT IMMUNOPHARMACOL, V50, P283, DOI 10.1016/j.intimp.2017.06.021; Zhao G, 2016, FEBS LETT, V590, P2884, DOI 10.1002/1873-3468.12315	46	3	3	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21667	10.1096/fj.202002263R	http://dx.doi.org/10.1096/fj.202002263R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34405442				2022-12-28	WOS:000691122900041
J	Bhat, N; Esteghamat, F; Chaube, BK; Gunawardhana, K; Mani, M; Thames, C; Jain, D; Ginsberg, HN; Fernandes-Hernando, C; Mani, A				Bhat, Neha; Esteghamat, Fatemehsadat; Chaube, Bal Krishna; Gunawardhana, Kushan; Mani, Mitra; Thames, Clay; Jain, Dhanpat; Ginsberg, Henry N.; Fernandes-Hernando, Carlos; Mani, Arya			TCF7L2 transcriptionally regulates Fgf15 to maintain bile acid and lipid homeostasis through gut-liver crosstalk	FASEB JOURNAL			English	Article						Fgf19; lipid absorption; NASH; tcf7l2	FIBROBLAST GROWTH FACTOR-19; HEPATIC RESPONSE; METABOLIC-RATE; DISEASE; PROTEIN; GENE; FXR; WNT; CHOLESTEROL; ABSORPTION	FGF19/FGF15 is an endocrine regulator of hepatic bile salt and lipid metabolism, which has shown promising effects in the treatment of NASH in clinical trials. FGF19/15 is transcribed and released from enterocytes of the small intestine into enterohepatic circulation in response to bile-induced FXR activation. Previously, the TSS of FGF19 was identified to bind Wnt-regulated TCF7L2/encoded transcription factor TCF4 in colorectal cancer cells. Impaired Wnt signaling and specifical loss of function of its coreceptor LRP6 have been associated with NASH. We, therefore, examined if TCF7L2/TCF4 upregulates Fgf19 in the small intestine and restrains NASH through gut-liver crosstalk. We examined the mice globally overexpressing, haploinsufficient, and conditional knockout models of TCF7L2 in the intestinal epithelium. The TCF7L2(+/-) mice exhibited increased plasma bile salts and lipids and developed diet-induced fatty liver disease while mice globally overexpressing TCF7L2 were protected against these traits. Comprehensive in vivo analysis revealed that TCF7L2 transcriptionally upregulates FGF15 in the gut, leading to reduced bile synthesis and diminished intestinal lipid uptake. Accordingly, Vilin(Creert2); Tcf7L2(fl/fl) mice showed reduced Fgf19 in the ileum, and increased plasma bile. The global overexpression of TCF7L2 in mice with metabolic syndrome-linked LRP6(R611C) substitution rescued the fatty liver and fibrosis in the latter. Strikingly, the hepatic levels of TCF4 were reduced and CYP7a1 was increased in human NASH, indicating the relevance of TCF4-dependent regulation of bile synthesis to human disease. These studies identify the critical role of TCF4 as an upstream regulator of the FGF15-mediated gut-liver crosstalk that maintains bile and liver triglyceride homeostasis.	[Bhat, Neha; Esteghamat, Fatemehsadat; Gunawardhana, Kushan; Thames, Clay; Mani, Arya] Yale Univ, Cardiovasc Res Ctr, Dept Internal Med, Sch Med, New Haven, CT 06511 USA; [Chaube, Bal Krishna; Fernandes-Hernando, Carlos] Yale Sch Med, Dept Comparat Med, New Haven, CT USA; [Mani, Mitra] New York Med Coll, Valhalla, NY 10595 USA; [Mani, Mitra; Ginsberg, Henry N.] Columbia Univ, Dept Internal Med, Coll Phys & Surg, New York, NY USA; [Jain, Dhanpat] Yale Sch Med, Dept Pathol, New Haven, CT USA; [Mani, Arya] Yale Sch Med, Dept Genet, New Haven, CT USA	Yale University; Yale University; New York Medical College; Columbia University; Yale University; Yale University	Mani, A (corresponding author), Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, Dept Internal Med, 300 George St, New Haven, CT 06511 USA.	arya.mani@yale.edu	Chaube, Balkrishna/F-8879-2012	Chaube, Balkrishna/0000-0003-4378-7416	NHLBI [5R35HL135767, 5R35HL135833]	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NHLBI, Grant/Award Number: 5R35HL135767 and 5R35HL135833	Alvarez-Sola G, 2017, GUT, V66, P1818, DOI 10.1136/gutjnl-2016-312975; Appleby RN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211348; Aryal B, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97918; Azzu V, 2021, MOL METAB, V48, DOI 10.1016/j.molmet.2021.101210; Bhat N, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI153724; Bhat N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166703; Bhatnagar S, 2009, J BIOL CHEM, V284, P10023, DOI 10.1074/jbc.M808818200; Boj SF, 2012, CELL, V151, P1595, DOI 10.1016/j.cell.2012.10.053; Bozadjieva N, 2018, DIABETES, V67, P1720, DOI 10.2337/dbi17-0007; Brighton CA, 2015, ENDOCRINOLOGY, V156, P3961, DOI 10.1210/en.2015-1321; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chen MM, 2018, J ENDOCRINOL, V237, P139, DOI 10.1530/JOE-17-0727; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Geoghegan G, 2019, MOL METAB, V24, P44, DOI 10.1016/j.molmet.2019.03.003; Go GW, 2014, CELL METAB, V19, P209, DOI 10.1016/j.cmet.2013.11.023; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Huertas-Vazquez A, 2008, DIABETOLOGIA, V51, P62, DOI 10.1007/s00125-007-0850-6; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594; Jones S, 2008, MOL PHARMACEUT, V5, P42, DOI 10.1021/mp700105z; Jung D, 2007, J LIPID RES, V48, P2693, DOI 10.1194/jlr.M700351-JLR200; Kim YC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19803-9; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; McCarthy MI, 2013, CELL METAB, V17, P157, DOI 10.1016/j.cmet.2013.01.011; Miyata M, 2012, J STEROID BIOCHEM, V132, P41, DOI 10.1016/j.jsbmb.2012.04.008; MORGAN RGH, 1969, Q J EXP PHYSIOL CMS, V54, P228, DOI 10.1113/expphysiol.1969.sp002021; Nishikawa K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103103; O'Rourke Kevin P, 2016, Bio Protoc, V6; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Savic D, 2011, GENOME RES, V21, P1417, DOI 10.1101/gr.123745.111; Schreuder TCMA, 2010, AM J PHYSIOL-GASTR L, V298, pG440, DOI 10.1152/ajpgi.00322.2009; Shin DJ, 2009, J BIOL CHEM, V284, P11110, DOI 10.1074/jbc.M808747200; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; Srivastava R, 2019, ARTERIOSCL THROM VAS, V39, P250, DOI 10.1161/ATVBAHA.118.311830; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; van Es JH, 2012, MOL CELL BIOL, V32, P1918, DOI 10.1128/MCB.06288-11; Wang JN, 2018, GENE, V674, P57, DOI 10.1016/j.gene.2018.06.053; Wang SX, 2015, FASEB J, V29, P3436, DOI 10.1096/fj.15-271171; Wojcik M, 2012, J PEDIATR ENDOCR MET, V25, P1089, DOI 10.1515/jpem-2012-0253; Woollett LA, 2006, GUT, V55, P197, DOI 10.1136/gut.2005.069906; Wright TJ, 2004, DEV BIOL, V269, P264, DOI 10.1016/j.ydbio.2004.02.003; Xavier GD, 2012, DIABETOLOGIA, V55, P2667, DOI 10.1007/s00125-012-2600-7; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187; Yang ZH, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-32; Ye ZJ, 2012, J BIOL CHEM, V287, P1335, DOI 10.1074/jbc.M111.295287; Zhou M, 2017, HEPATOL COMMUN, V1, P1024, DOI 10.1002/hep4.1108	50	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22185	10.1096/fj.202101607R	http://dx.doi.org/10.1096/fj.202101607R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35133032				2022-12-28	WOS:000761250800020
J	Zhang, WY; Rong, G; Gu, JG; Fan, CL; Guo, TT; Jiang, TT; Deng, WQ; Xie, JY; Su, ZH; Yu, QM; Mai, JY; Zheng, RN; Chen, XL; Tang, X; Zhang, J				Zhang, Wenying; Rong, Guang; Gu, Jinge; Fan, Cuiling; Guo, Tingting; Jiang, Tingting; Deng, Weiqian; Xie, Jiayu; Su, Zhihua; Yu, Qimin; Mai, Jingyi; Zheng, Rinan; Chen, Xingling; Tang, Xun; Zhang, Jun			Nicotinamide N-methyltransferase ameliorates renal fibrosis by its metabolite 1-methylnicotinamide inhibiting the TGF-beta 1/Smad3 pathway	FASEB JOURNAL			English	Article						1-methylnicotinamide (MNAM); chronic kidney disease (CKD); nicotinamide N-methyltransferase (NNMT); TGF-beta 1/Smad3; tubulointerstitial fibrosis (TIF)	MATRIX GENE-EXPRESSION; TGF-BETA; ANTIBODY THERAPY; CELL-DEATH; NEPHROPATHY; MICRORNA; PROTECTS; INJURY; MICE	Chronic kidney disease (CKD), a disease involving damage to the kidney structure and function, is a global public health problem. Tubulointerstitial fibrosis (TIF) is both an inevitable pathological change in individuals with CKD and a driving force in the progression of renal fibrosis. Nicotinamide N-methyltransferase (NNMT) and its metabolite 1-methylnicotinamide (MNAM) have been shown to protect against lipotoxicity-induced kidney tubular injury. However, the biological roles of NNMT and MNAM in regulating TIF remain elusive. This study aimed to investigate the protective effect of NNMT and MNAM on TIF and the mechanisms involved. We explored the functions and mechanisms of NNMT and MNAM in TIF, as well as the interaction between NNMT and MNAM, using unilateral ureteral obstruction (UUO) mice and cultured mouse tubular epithelial cells (mTECs) stimulated with transforming growth factor-beta 1 (TGF-beta 1). Several important findings were obtained as follows: (1) NNMT expression was upregulated in the kidneys of UUO mice and TGF-beta 1-induced mTECs, and this upregulation was proposed to be a protective compensatory response to TIF. (2) MNAM was a potentially effective antifibrotic and anti-inflammatory medication in UUO mice. (3) The antifibrotic effect of NNMT overexpression was exerted by increasing the concentration of MNAM. (4) The renoprotective role of MNAM depended on the selective blockade of the interaction of Smad3 with TGF beta receptor I. Overall, our study shows that NNMT is involved in the development and progression of CKD and that its metabolite MNAM may be a novel inhibitor of the TGF-beta 1/Smad3 pathway with great therapeutic potential for CKD.	[Zhang, Wenying; Gu, Jinge; Fan, Cuiling; Guo, Tingting; Su, Zhihua; Yu, Qimin; Mai, Jingyi; Zheng, Rinan; Chen, Xingling; Tang, Xun; Zhang, Jun] Southern Med Univ, Zhujiang Hosp, Dept Nephrol, Ind Rd 253, Guangzhou 510280, Guangdong, Peoples R China; [Zhang, Wenying] Guangzhou Med Univ, Dept Nephrol, Affiliated Hosp 2, Guangzhou, Peoples R China; [Rong, Guang] SSL Cent Hosp Dongguan City, Dept Nephrol, Dongguan, Peoples R China; [Jiang, Tingting] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Nephrol, Nanning, Peoples R China; [Deng, Weiqian] Southern Med Univ, Affiliated Hosp 5, Dept Nephrol, Guangzhou, Peoples R China; [Xie, Jiayu] Southern Med Univ, Guangdong Prov Key Lab Brain Funct Repair & Regen, Dept Neurosurg,Engn Technol Res Ctr Educ,Minist C, Zhujiang Hosp,Natl Key Clin Specialty,Neurosurg I, Guangzhou, Peoples R China	Southern Medical University - China; Guangzhou Medical University; Southern Medical University - China; Southern Medical University - China	Tang, X; Zhang, J (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Nephrol, Ind Rd 253, Guangzhou 510280, Guangdong, Peoples R China.	1847672118@qq.com; gzh_zj@qq.com	Su, Zhihua/GWN-1858-2022		Guangdong Medical Research Foundation (Guangdong Province Medical Research Foundation) [A2019169]; Natural Science Foundation of Guangdong Province [2018A030313557, 2021A1515012175]	Guangdong Medical Research Foundation (Guangdong Province Medical Research Foundation); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	Guangdong Medical Research Foundation (Guangdong Province Medical Research Foundation), Grant/Award Number: A2019169; Natural Science Foundation of Guangdong Province, Grant/Award Number: 2018A030313557 and 2021A1515012175	Ai J, 2015, J AM SOC NEPHROL, V26, P1827, DOI 10.1681/ASN.2014040363; AKSOY S, 1994, J BIOL CHEM, V269, P14835; Bar A, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00183; Campagna R, 2021, BBA-MOL CELL RES, V1868, DOI 10.1016/j.bbamcr.2021.119082; Chen HY, 2014, MOL THER, V22, P842, DOI 10.1038/mt.2013.235; CHRIST M, 1994, J IMMUNOL, V153, P1936; Chung ACK, 2013, INT J NEPHROL RENOV, V6, P169, DOI 10.2147/IJNRD.S37885; Chung ACK, 2011, J AM SOC NEPHROL, V22, P802, DOI 10.1681/ASN.2010050510; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Cui YY, 2020, MOL CARCINOGEN, V59, P940, DOI 10.1002/mc.23209; Dai CS, 2002, J AM SOC NEPHROL, V13, P411, DOI 10.1681/ASN.V132411; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Denton CP, 2007, ARTHRITIS RHEUM-US, V56, P323, DOI 10.1002/art.22289; Domagala TB, 2012, HYPERTENSION, V59, P825, DOI 10.1161/HYPERTENSIONAHA.111.183210; El Chaar M, 2007, AM J PHYSIOL-RENAL, V292, pF1291, DOI 10.1152/ajprenal.00327.2005; Ferenbach D, 2007, SEMIN NEPHROL, V27, P250, DOI 10.1016/j.semnephrol.2007.02.001; Gisewhite S, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03544-2; Giusti B, 2008, J MED GENET, V45, P721, DOI 10.1136/jmg.2008.057851; Hall MC, 2003, J BIOL CHEM, V278, P10304, DOI 10.1074/jbc.M212334200; Harmankaya I, 2021, J OBSTET GYNAECOL, V41, P248, DOI 10.1080/01443615.2020.1732891; Hong SY, 2015, NAT MED, V21, P887, DOI 10.1038/nm.3882; Kannt A, 2015, DIABETOLOGIA, V58, P799, DOI 10.1007/s00125-014-3490-7; Kim HC, 2010, AM J RESP CRIT CARE, V181, P797, DOI 10.1164/rccm.200906-0936OC; Lan HY, 2003, J AM SOC NEPHROL, V14, P1535, DOI 10.1097/01.ASN.0000067632.04658.B8; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Li JH, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014252.37680.E4; Li R, 2013, KIDNEY INT, V84, P1129, DOI 10.1038/ki.2013.272; Liang XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155534; Liu WT, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.335; Liu WT, 2019, PHARMACOL RES, V150, DOI 10.1016/j.phrs.2019.104506; Mateuszuk L, 2016, J PHARMACOL EXP THER, V356, P514, DOI 10.1124/jpet.115.228643; Mistry RJ, 2020, J BIOCHEM MOL TOXIC, V34, DOI 10.1002/jbt.22439; Miyajima A, 2000, KIDNEY INT, V58, P2301, DOI 10.1046/j.1523-1755.2000.00414.x; Nath KA, 2011, AM J PHYSIOL-RENAL, V301, pF436, DOI 10.1152/ajprenal.00162.2011; Niewczas MA, 2019, NAT MED, V25, P805, DOI 10.1038/s41591-019-0415-5; Pissios P, 2017, TRENDS ENDOCRIN MET, V28, P340, DOI 10.1016/j.tem.2017.02.004; SANO A, 1989, CHEM PHARM BULL, V37, P3330; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Sharma K, 1996, DIABETES, V45, P522, DOI 10.2337/diabetes.45.4.522; Song MM, 2020, CANCER MED-US, V9, P2030, DOI 10.1002/cam4.2890; Tanaka Y, 2015, FREE RADICAL BIO MED, V89, P831, DOI 10.1016/j.freeradbiomed.2015.10.414; Tang SCW, 2010, NEPHROL DIAL TRANSPL, V25, P698, DOI 10.1093/ndt/gfp599; Tonelli M, 2020, J AM SOC NEPHROL, V31, P1931, DOI 10.1681/ASN.2020030277; Voelker J, 2017, J AM SOC NEPHROL, V28, P953, DOI 10.1681/ASN.2015111230; Wang A, 2007, AM J PHYSIOL-RENAL, V293, pF1657, DOI 10.1152/ajprenal.00274.2007; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Xu BH, 2020, METABOLISM, V103, DOI 10.1016/j.metabol.2019.154013; Yang JW, 2002, J AM SOC NEPHROL, V13, P2464, DOI 10.1097/01.ASN.0000031827.16102.C1; Zhang JF, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/1080152; Zhao LJ, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00187; Zhong X, 2013, DIABETOLOGIA, V56, P663, DOI 10.1007/s00125-012-2804-x; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097	52	2	2	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22084	10.1096/fj.202100913RRR	http://dx.doi.org/10.1096/fj.202100913RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35107844				2022-12-28	WOS:000761250800050
J	Wu, XT; Yang, X; Tian, R; Li, YH; Wang, CY; Fan, YB; Sun, LW				Wu, Xin-Tong; Yang, Xiao; Tian, Ran; Li, Ying-Hui; Wang, Chun-Yan; Fan, Yu-Bo; Sun, Lian-Wen			Cells respond to space microgravity through cytoskeleton reorganization	FASEB JOURNAL			English	Review						bone; cell; cytoskeleton; microgravity; muscle; space flight	CARDIOVASCULAR RISKS; PROTEIN-SYNTHESIS; GENE-EXPRESSION; BED REST; SPACEFLIGHT; FLIGHT; DIFFERENTIATION; MICROTUBULES; LYMPHOCYTES; ACTIVATION	Decades of spaceflight studies have provided abundant evidence that individual cells in vitro are capable of sensing space microgravity and responding with cellular changes both structurally and functionally. However, how microgravity is perceived, transmitted, and converted to biochemical signals by single cells remains unrevealed. Here in this review, over 40 cellular biology studies of real space fights were summarized. Studies on cells of the musculoskeletal system, cardiovascular system, and immune system were covered. Among all the reported cellular changes in response to space microgravity, cytoskeleton (CSK) reorganization emerges as a key indicator. Based on the evidence of CSK reorganization from space flight research, a possible mechanism from the standpoint of "cellular mechanical equilibrium" is proposed for the explanation of cellular response to space microgravity. Cytoskeletal equilibrium is broken by the gravitational change from ground to space and is followed by cellular morphological changes, cell mechanical properties changes, extracellular matrix reorganization, as well as signaling pathway activation/inactivation, all of which ultimately lead to the cell functional changes in space microgravity.	[Wu, Xin-Tong; Yang, Xiao; Tian, Ran; Fan, Yu-Bo; Sun, Lian-Wen] Beihang Univ, Sch Biol Sci & Med Engn, Beijing Adv Innovat Ctr Biomed Engn, Key Lab Biomech & Mechanobiol,Minist Educ, 5th Bldg,37th XueYuan Rd, Beijing 100083, Peoples R China; [Li, Ying-Hui; Wang, Chun-Yan] China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China; [Fan, Yu-Bo] Beihang Univ, Sch Engn Med, Beijing, Peoples R China	Beihang University; Beihang University	Fan, YB; Sun, LW (corresponding author), Beihang Univ, Sch Biol Sci & Med Engn, Beijing Adv Innovat Ctr Biomed Engn, Key Lab Biomech & Mechanobiol,Minist Educ, 5th Bldg,37th XueYuan Rd, Beijing 100083, Peoples R China.	yubofan@buaa.edu.cn; sunlw@buaa.edu.cn	wu, xintong/AGQ-3046-2022; XIAO, YANG/GPW-5529-2022	Fan, Yubo/0000-0002-3480-4395; Wu, Xintong/0000-0003-2154-8860	National Natural Science Foundation of China [12002026, 11972068]; China Space Station Engineering Experiment Project [HYZHXM01016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Space Station Engineering Experiment Project	National Natural Science Foundation of China, Grant/Award Number: 12002026 and 11972068; China Space Station Engineering Experiment Project, Grant/Award Number: HYZHXM01016	Atherton PJ, 2012, J PHYSIOL-LONDON, V590, P1049, DOI 10.1113/jphysiol.2011.225003; Bacabac RG., 2007, BIOL SPACE LIFE EART, P157; BACKUP P, 1994, AM J PHYSIOL, V266, pE567, DOI 10.1152/ajpendo.1994.266.4.E567; Baio J, 2018, NPJ MICROGRAVITY, V4, DOI 10.1038/s41526-018-0048-x; Bao H, 2020, ACTA PHYSIOL, V228, DOI 10.1111/apha.13374; BARANSKA W, 1990, Materia Medica Polona, V22, P255; Blaber E, 2014, STEM CELLS DEV, V23, P73, DOI 10.1089/scd.2014.0408; Carmeliet G., 2007, BIOL SPACE LIFE EART, P179; Chang TT, 2012, J LEUKOCYTE BIOL, V92, P1133, DOI 10.1189/jlb.0312157; COGOLI A, 1993, J LEUKOCYTE BIOL, V53, P569, DOI 10.1002/jlb.53.5.569; Cogoli A, 1997, Gravit Space Biol Bull, V10, P5; Colucci S, 2020, FASEB J, V34, P10096, DOI 10.1096/fj.202000216R; Convertino VA, 2005, AVIAT SPACE ENVIR MD, V76, P869; Convertino Victor A, 2002, J Gravit Physiol, V9, P1; Crucian B, 2016, J ALLER CL IMM-PRACT, V4, P759, DOI 10.1016/j.jaip.2015.12.021; Crucian B, 2015, NPJ MICROGRAVITY, V1, DOI 10.1038/npjmgrav.2015.13; da Silveira WA, 2020, CELL, V183, P1185, DOI 10.1016/j.cell.2020.11.002; de la Pena A, 2021, EXP DERMATOL, V30, P74, DOI 10.1111/exd.14166; Ding D, 2020, BIOCHEM BIOPH RES CO, V530, P167, DOI 10.1016/j.bbrc.2020.06.119; Dogterom M, 2019, NAT REV MOL CELL BIO, V20, P38, DOI 10.1038/s41580-018-0067-1; Fitts RH, 2010, J PHYSIOL-LONDON, V588, P3567, DOI 10.1113/jphysiol.2010.188508; Fitts RH, 2000, J APPL PHYSIOL, V89, P823, DOI 10.1152/jappl.2000.89.2.823; Garcia-Ovejero D, 2001, DEV BRAIN RES, V130, P191, DOI 10.1016/S0165-3806(01)00236-X; Garrett-Bakelman FE, 2019, SCIENCE, V364, P144, DOI 10.1126/science.aau8650; Gertz ML, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108429; Gerzer R., 2012, FLIEGERARZTLEHRGANG; GOLDSTEIN MA, 1992, J APPL PHYSIOL, V73, pS94, DOI 10.1152/jappl.1992.73.2.S94; Grimm D, 2011, EXPERT REV PROTEOMIC, V8, P13, DOI 10.1586/EPR.10.105; Guignandon A, 1997, BONE, V20, P109, DOI 10.1016/S8756-3282(96)00337-7; Guignandon A, 2001, FASEB J, V15, P2036, DOI 10.1096/fj.00-0837fje; HANSON J, 1953, NATURE, V172, P530, DOI 10.1038/172530b0; Henderson CA, 2017, COMPR PHYSIOL, V7, P891, DOI 10.1002/cphy.c160033; HENRY WI, 1975, AM J CARDIOL, V35, P143, DOI 10.1016/0002-9149(75)90678-5; Hughes-Fulford M, 2003, ADV SPACE RES-SERIES, V32, P1585, DOI 10.1016/S0273-1177(03)90399-1; Hughes-Fulford Millie, 2002, Adv Space Biol Med, V8, P129; Hughes-Fulford M, 2015, FASEB J, V29, P4893, DOI 10.1096/fj.15-277392; HughesFulford M, 1996, EXP CELL RES, V224, P103, DOI 10.1006/excr.1996.0116; Ingber D, 1999, FASEB J, V13, pS3; INGBER DE, 1993, J CELL SCI, V104, P613; Jaminet S-C., 2018, ENDOTHELIAL CELLS MI; Johnston RS., 1976, BIOSCIENCE, V11, P932; Kapitonova M Y, 2012, Malays J Pathol, V34, P103; Kaur I, 2005, BRAIN BEHAV IMMUN, V19, P547, DOI 10.1016/j.bbi.2004.12.006; Kaur I, 2004, BRAIN BEHAV IMMUN, V18, P443, DOI 10.1016/j.bbi.2003.10.005; Kawata K, 2021, BONE, V150, DOI 10.1016/j.bone.2021.116001; KONSTANT.IV, 1973, KOSM BIOL AVIAK MED+, V7, P35; KULESH DA, 1994, J CELL BIOCHEM, V55, P530, DOI 10.1002/jcb.240550412; Kumei Y, 2006, ANN NY ACAD SCI, V1090, P311, DOI 10.1196/annals.1378.034; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; LEBLANC A, 1995, AVIAT SPACE ENVIR MD, V66, P1151; LeBlanc A., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P157; LeBlanc A. D., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P33; Lei XH, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12466; Lewis ML, 1998, FASEB J, V12, P1007, DOI 10.1096/fasebj.12.11.1007; Li H, 2019, STEM CELLS DEV, V28, P357, DOI 10.1089/scd.2018.0240; Li N, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01025; [刘红菊 Liu Hongju], 2016, [航天医学与医学工程, Space Medicine & Medical Engineering], V29, P391; Marcus R., 2010, FUNDAMENTALS OSTEOPO, P1; Meloni MA, 2011, CYTOSKELETON, V68, P125, DOI 10.1002/cm.20499; Monticone M, 2010, J CELL BIOCHEM, V111, P442, DOI 10.1002/jcb.22765; Nabavi N, 2011, BONE, V49, P965, DOI 10.1016/j.bone.2011.07.036; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; Novak R, 2020, NAT BIOMED ENG, DOI 10.1038/s41551-019-0497-x; Ogneva IV, 2014, J APPL PHYSIOL, V116, P1315, DOI 10.1152/japplphysiol.00134.2014; Perhonen MA, 2001, J APPL PHYSIOL, V91, P645, DOI 10.1152/jappl.2001.91.2.645; Riley DA, 1996, J APPL PHYSIOL, V81, P133, DOI 10.1152/jappl.1996.81.1.133; RILEY DA, 1992, J APPL PHYSIOL, V73, pS33, DOI 10.1152/jappl.1992.73.2.S33; Riley DA, 2000, J APPL PHYSIOL, V88, P567, DOI 10.1152/jappl.2000.88.2.567; Rindom E, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00547; Rittweger J., 2018, NPJ MICROGRAVITY, V4; Rykova MP, 2008, ACTA ASTRONAUT, V63, P697, DOI 10.1016/j.actaastro.2008.03.016; Schatten H, 2001, ACTA ASTRONAUT, V49, P399, DOI 10.1016/S0094-5765(01)00116-3; Sciola L, 1999, ADV SPACE RES, V24, P801, DOI 10.1016/S0273-1177(99)00078-2; Semov A, 2002, FASEB J, V16, P899, DOI 10.1096/fj.01-1002fje; Shi WG, 2020, BONE, V136, DOI 10.1016/j.bone.2020.115346; Sides MB, 2005, AVIAT SPACE ENVIR MD, V76, P877; Stenger M. B., 2017, EVIDENCE REPORT RISK; Stowe RP, 2011, J MED VIROL, V83, P1071, DOI 10.1002/jmv.22079; Tamma R, 2009, FASEB J, V23, P2549, DOI 10.1096/fj.08-127951; Todd P, 1985, Physiologist, V28, pS183; Versari S, 2013, FASEB J, V27, P4466, DOI 10.1096/fj.13-229195; Vico L, 2000, LANCET, V355, P1607, DOI 10.1016/S0140-6736(00)02217-0; Voorhies AA, 2016, FRONT ASTRON SPACE, V3, DOI 10.3389/fspas.2016.00023; Vorselen D, 2014, FASEB J, V28, P536, DOI 10.1096/fj.13-236356; Wang P, 2019, FASEB J, V33, P5903, DOI 10.1096/fj.201802413R; Widrick JJ, 1999, J PHYSIOL-LONDON, V516, P915, DOI 10.1111/j.1469-7793.1999.0915u.x; Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916; Wolff J., 1986, LAW BONE REMODELING; Wu XT, 2017, SCI REP-UK, V7, DOI 10.1038/srep40940; Yang F, 2008, CHINESE SCI BULL, V53, P1185, DOI 10.1007/s11434-008-0167-y; Yang X, 2018, MICROGRAVITY SCI TEC, V30, P469, DOI 10.1007/s12217-018-9613-x; Yeung CK, 2020, CTS-CLIN TRANSL SCI, V13, P8, DOI 10.1111/cts.12689; Zhai Z., 2011, CELL BIOL; Zhang LF, 2001, J APPL PHYSIOL, V91, P2415, DOI 10.1152/jappl.2001.91.6.2415; Zhang Q, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15664	95	2	3	17	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22114	10.1096/fj.202101140R	http://dx.doi.org/10.1096/fj.202101140R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35076958				2022-12-28	WOS:000747987800016
J	Fisher-Wellman, KH; Hagen, JT; Kassai, M; Kao, LP; Nelson, MAM; McLaughlin, KL; Coalson, HS; Fox, TE; Tan, SF; Feith, DJ; Kester, M; Loughran, TP; Claxton, DF; Cabot, MC				Fisher-Wellman, Kelsey H.; Hagen, James T.; Kassai, Miki; Kao, Li-Pin; Nelson, Margaret A. M.; McLaughlin, Kelsey L.; Coalson, Hannah S.; Fox, Todd E.; Tan, Su-Fern; Feith, David J.; Kester, Mark; Loughran, Thomas P. Jr Jr; Claxton, David F.; Cabot, Myles C.			Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia	FASEB JOURNAL			English	Article						acute myeloid leukemia; chemotherapy resistance; HL-60 cells; mitochondrial bioenergetics; sphingolipids; vincristine	GLUCOSYLCERAMIDE SYNTHASE; DRUG-RESISTANCE; CANCER-CELLS; CERAMIDE METABOLISM; P-GLYCOPROTEIN; INHIBITION; APOPTOSIS; ACCUMULATION; CYTOTOXICITY; DIAGNOSTICS	Modifications in sphingolipid (SL) metabolism and mitochondrial bioenergetics are key factors implicated in cancer cell response to chemotherapy, including chemotherapy resistance. In the present work, we utilized acute myeloid leukemia (AML) cell lines, selected to be refractory to various chemotherapeutics, to explore the interplay between SL metabolism and mitochondrial biology supportive of multidrug resistance (MDR). In agreement with previous findings in cytarabine or daunorubicin resistant AML cells, relative to chemosensitive wildtype controls, HL-60 cells refractory to vincristine (HL60/VCR) presented with alterations in SL enzyme expression and lipidome composition. Such changes were typified by upregulated expression of various ceramide detoxifying enzymes, as well as corresponding shifts in ceramide, glucosylceramide, and sphingomyelin (SM) molecular species. With respect to mitochondria, despite consistent increases in both basal respiration and maximal respiratory capacity, direct interrogation of the oxidative phosphorylation (OXPHOS) system revealed intrinsic deficiencies in HL60/VCR, as well as across multiple MDR model systems. Based on the apparent requirement for augmented SL and mitochondrial flux to support the MDR phenotype, we explored a combinatorial therapeutic paradigm designed to target each pathway. Remarkably, despite minimal cytotoxicity in peripheral blood mononuclear cells (PBMC), co-targeting SL metabolism, and respiratory complex I (CI) induced synergistic cytotoxicity consistently across multiple MDR leukemia models. Together, these data underscore the intimate connection between cellular sphingolipids and mitochondrial metabolism and suggest that pharmacological intervention across both pathways may represent a novel treatment strategy against MDR.	[Fisher-Wellman, Kelsey H.; Hagen, James T.; Nelson, Margaret A. M.; McLaughlin, Kelsey L.; Coalson, Hannah S.] East Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27834 USA; [Fisher-Wellman, Kelsey H.; Hagen, James T.; Kassai, Miki; Kao, Li-Pin; Nelson, Margaret A. M.; McLaughlin, Kelsey L.; Coalson, Hannah S.; Cabot, Myles C.] East Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC 27834 USA; [Kassai, Miki; Kao, Li-Pin; Cabot, Myles C.] East Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27834 USA; [Fox, Todd E.] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA; [Tan, Su-Fern; Feith, David J.; Kester, Mark; Loughran, Thomas P. Jr Jr] Univ Virginia, Sch Med, Dept Med Hematol Oncol, Charlottesville, VA 22908 USA; [Feith, David J.; Kester, Mark; Loughran, Thomas P. Jr Jr] Univ Virginia, Canc Ctr, Charlottesville, VA 22908 USA; [Claxton, David F.] Penn State Univ, Coll Med, Dept Med, Div Hematol & Oncol, Hershey, PA USA; [Claxton, David F.] Penn State Canc Inst, Hershey, PA USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of Virginia; University of Virginia; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Fisher-Wellman, KH (corresponding author), East Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27834 USA.; Fisher-Wellman, KH; Cabot, MC (corresponding author), East Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC 27834 USA.; Cabot, MC (corresponding author), East Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27834 USA.	fisherwellmank17@ecu.edu; cabotm@ecu.edu		Mclaughlin, Kelsey/0000-0001-6175-7523	NIH [P01 CA171983]; Brody Brothers Foundation, Kinston, NC;  [DOD-W81XWH-19-1-0213]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brody Brothers Foundation, Kinston, NC; 	The work was supported by DOD-W81XWH-19-1-0213 (K.H.F.-W.) and NIH P01 CA171983 (M.C.C), as well as a grant from the Brody Brothers Foundation, Kinston, NC	Baran Y, 2011, J CANCER RES CLIN, V137, P1535, DOI 10.1007/s00432-011-1016-y; Barth BM, 2019, BLOOD ADV, V3, P2598, DOI 10.1182/bloodadvances.2018021295; Bartholomae S, 2016, PEDIATR BLOOD CANCER, V63, P242, DOI 10.1002/pbc.25785; Bonhoure E, 2006, LEUKEMIA, V20, P95, DOI 10.1038/sj.leu.2404023; Bridges HR, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0287-9; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Chatzakos V, 2012, BIOCHEM PHARMACOL, V84, P712, DOI 10.1016/j.bcp.2012.06.009; Chen JH, 2019, NAT MED, V25, P103, DOI 10.1038/s41591-018-0267-4; Colombini M, 2010, BBA-BIOENERGETICS, V1797, P1239, DOI 10.1016/j.bbabio.2010.01.021; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Farge T, 2017, CANCER DISCOV, V7, P716, DOI 10.1158/2159-8290.CD-16-0441; Fisher-Wellman KH, 2021, CELL SIGNAL, V78, DOI 10.1016/j.cellsig.2020.109838; Fisher-Wellman KH, 2018, CELL REP, V24, P3593, DOI 10.1016/j.celrep.2018.08.091; Fisher-Wellman KH, 2013, FREE RADICAL BIO MED, V65, P1201, DOI 10.1016/j.freeradbiomed.2013.09.008; Giussani P, 2014, INT J MOL SCI, V15, P4356, DOI 10.3390/ijms15034356; Gottesman MM, 2016, ANNU REV PHARMACOL, V56, P85, DOI 10.1146/annurev-pharmtox-010715-103111; Gouaze V, 2004, MOL CANCER THER, V3, P633; Gouaze-Andersson V, 2007, BBA-MOL CELL BIOL L, V1771, P1407, DOI 10.1016/j.bbalip.2007.09.005; Gouaze-Andersson V, 2011, ANTI-CANCER AGENT ME, V11, P891, DOI 10.2174/187152011797655069; Gu WX, 2021, J CONTROL RELEASE, V329, P706, DOI 10.1016/j.jconrel.2020.10.005; Guieze R, 2019, CANCER CELL, V36, P369, DOI 10.1016/j.ccell.2019.08.005; Huang WC, 2011, FASEB J, V25, P3661, DOI 10.1096/fj.10-180190; Jiang WH, 2014, BBA-MOL CELL BIOL L, V1841, P783, DOI 10.1016/j.bbalip.2013.09.005; Kao LP, 2019, J LIPID RES, V60, P1590, DOI 10.1194/jlr.RA119000251; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530; Lee WK, 2017, CELL SIGNAL, V38, P134, DOI 10.1016/j.cellsig.2017.06.017; Lesack Kyle, 2011, J Pathol Inform, V2, P52, DOI 10.4103/2153-3539.91130; Liu YY, 2011, INT J ONCOL, V39, P425, DOI 10.3892/ijo.2011.1052; Liu YY, 2001, FASEB J, V15, P719, DOI 10.1096/fj.00-0223com; Lucci A, 1998, ANTICANCER RES, V18, P475; Maurer BJ, 2000, JNCI-J NATL CANCER I, V92, P1897, DOI 10.1093/jnci/92.23.1897; McLaughlin KL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74718-1; McLaughlin KL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60536-y; McLaughlin KL, 2018, BIOCHEM BIOPH RES CO, V504, P742, DOI 10.1016/j.bbrc.2018.09.022; Messner MC, 2010, ADV EXP MED BIOL, V688, P156; Molina JR, 2018, NAT MED, V24, P1036, DOI 10.1038/s41591-018-0052-4; Morad SAF, 2018, ADV CANCER RES, V140, P235, DOI 10.1016/bs.acr.2018.04.013; Morad SAF, 2016, J LIPID RES, V57, P1231, DOI 10.1194/jlr.M067389; Morad SAF, 2015, BBA-MOL CELL BIOL L, V1851, P919, DOI 10.1016/j.bbalip.2015.03.001; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Nelson MAM, 2021, ELIFE, V10, DOI [10.7554/elife.63104, 10.7554/eLife.63104]; Nelson MAM, 2021, METHODS MOL BIOL, V2277, P371, DOI 10.1007/978-1-0716-1270-5_23; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Ogretmen B, 2000, BIOCHEMISTRY-US, V39, P194, DOI 10.1021/bi991943f; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Okuda S, 2017, NUCLEIC ACIDS RES, V45, pD1107, DOI 10.1093/nar/gkw1080; Olshefski RS, 2001, INT J CANCER, V93, P131, DOI 10.1002/ijc.1301; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Pearson JM, 2020, MOL CANCER RES, V18, P352, DOI 10.1158/1541-7786.MCR-19-0619; Sanchenkov A, 2001, JNCI-J NATL CANCER I, V93, P347, DOI 10.1093/jnci/93.5.347; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shabbits JA, 2002, MOL CANCER THER, V1, P205; Shaffer BC, 2012, DRUG RESIST UPDATE, V15, P62, DOI 10.1016/j.drup.2012.02.001; Snider JM, 2019, J LIPID RES, V60, P819, DOI 10.1194/jlr.M089714; Song MS, 2003, NEUROPHARMACOLOGY, V45, P1130, DOI 10.1016/S0028-3908(03)00284-3; Tan SF, 2019, J LIPID RES, V60, P1078, DOI 10.1194/jlr.M091876; Tan SF, 2016, ONCOTARGET, V7, P83208, DOI 10.18632/oncotarget.13079; Truman JP, 2014, BBA-MOL CELL BIOL L, V1841, P1174, DOI 10.1016/j.bbalip.2013.12.013; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Vasan K, 2020, CELL METAB, V32, P341, DOI 10.1016/j.cmet.2020.06.019; Yamane M, 2011, BIOCHIMIE, V93, P1446, DOI 10.1016/j.biochi.2011.04.016; Yang YL, 2012, CANCER SCI, V103, P1538, DOI 10.1111/j.1349-7006.2012.02335.x	64	3	3	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22094	10.1096/fj.202101194RRR	http://dx.doi.org/10.1096/fj.202101194RRR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34888943	Green Submitted, Green Accepted			2022-12-28	WOS:000734992000005
J	Wang, ZY; Liu, Y; Zhang, JN; Lin, MM; Xiao, CF; Bai, HY; Liu, C				Wang, Ziyan; Liu, Yang; Zhang, Jianing; Lin, Minmin; Xiao, Chufan; Bai, Haoying; Liu, Chao			Mechanical loading alleviated the inhibition of beta 2-adrenergic receptor agonist terbutaline on bone regeneration	FASEB JOURNAL			English	Article						biomechanics; bone regeneration; osteoblast; periostin; terbutaline	MESENCHYMAL STEM-CELLS; ANGIOGENESIS; ACTIVATION; PERIOSTIN; MASS; FRACTURE; EXPRESSION; INDUCTION; PROTEIN; LEPTIN	The long-term use of adrenergic medication in treating various conditions, such as asthma, increases the chances of bone fracture. Dynamic mechanical loading at a specific time is a method for improving bone quality and promoting healing. Therefore, we hypothesized that precisely controlling the mechanical environment can contribute to the alleviation of the negative effects of chronic treatment with the common asthma drug terbutaline, which is a beta 2-adrenergic receptor agonist that facilitates bone homeostasis and defect repair through its anabolic effect on osteogenic cells. Our in vitro results showed that terbutaline can directly inhibit osteogenesis by impairing osteogenic differentiation and mineralization. Chronic treatment in vivo was simulated by administering terbutaline to C57BL/6J mice for 4 weeks before bone defect surgery and mechanical loading. We utilized a stabilized tibial defect model, which allowed the application of anabolic mechanical loading. During homeostasis, chronic terbutaline treatment reduced the bone formation rate, the fracture toughness of long bones, and the concentrations of bone formation markers in the sera. During defect repair, terbutaline decreased the bone volume, type H vessel, and total blood vessel volume. Terbutaline treatment reduced the number of osteogenic cells. Periostin, which was secreted mainly by Prrx1+ osteoprogenitors and F4/80+ macrophages, was inhibited by treating the bone defect with terbutaline. Interestingly, controlled mechanical loading facilitated the recovery of bone volume and periostin expression and the number of osteogenic cells within the defect. In conclusion, mechanical loading can rescue negative effects on new bone accrual and repair induced by chronic terbutaline treatment.	[Wang, Ziyan; Liu, Yang; Zhang, Jianing; Lin, Minmin; Xiao, Chufan; Bai, Haoying; Liu, Chao] Southern Univ Sci & Technol, Dept Biomed Engn, Coll Engn, 1088 Xueyuan Ave,Coll Engn Bldg South 732, Shenzhen 518055, Peoples R China	Southern University of Science & Technology	Liu, C (corresponding author), Southern Univ Sci & Technol, Dept Biomed Engn, Coll Engn, 1088 Xueyuan Ave,Coll Engn Bldg South 732, Shenzhen 518055, Peoples R China.	liuc33@sustech.edu.cn	Wang, Ziyan/HII-8458-2022	Liu, Yang/0000-0002-2226-0941	Shenzhen Science and Technology Innovation Commission [JCYJ20190809114209434]; SUSTech Core Research Core Research Facilities	Shenzhen Science and Technology Innovation Commission; SUSTech Core Research Core Research Facilities	The work was supported by Shenzhen Science and Technology Innovation Commission (Grant No. JCYJ20190809114209434) for financial support. We acknowledge the assistance of Ying Wang for the Micro-CT imaging and Yilin Wang for the confocal imaging from the SUSTech Core Research Core Research Facilities.	Acevedo C, 2018, NAT BIOMED ENG, V2, P62, DOI 10.1038/s41551-017-0183-9; Billington CK, 2013, PULM PHARMACOL THER, V26, P112, DOI 10.1016/j.pupt.2012.05.007; Bluteau G, 2007, BONE, V40, P568, DOI 10.1016/j.bone.2006.09.024; Bonnet N, 2005, BONE, V37, P622, DOI 10.1016/j.bone.2005.07.012; Bonnet N., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P94; Bonnet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078347; Bonnet N, 2009, J BIOL CHEM, V284, P35939, DOI 10.1074/jbc.M109.060335; Bordon Y, 2016, NAT REV IMMUNOL, V16, P129, DOI 10.1038/nri.2016.21; Bouxsein ML, 2009, ENDOCRINOLOGY, V150, P144, DOI 10.1210/en.2008-0843; Buettmann EG, 2019, J BONE MINER RES, V34, P1690, DOI 10.1002/jbmr.3755; Chen J, 2020, STEM CELL REP, V15, P110, DOI 10.1016/j.stemcr.2020.06.007; Chiarella SE, 2014, J CLIN INVEST, V124, P2935, DOI 10.1172/JCI75157; Chu SY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09402-8; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dam TT, 2010, OSTEOPOROSIS INT, V21, P1341, DOI 10.1007/s00198-009-1076-x; de Lageneste OD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03124-z; de Vries F, 2007, PHARMACOEPIDEM DR S, V16, P612, DOI 10.1002/pds.1318; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; Elefteriou F, 2004, PATHOL BIOL, V52, P148, DOI 10.1016/j.patbio.2003.05.006; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215; Fang TD, 2005, J BONE MINER RES, V20, P1114, DOI 10.1359/JBMR.050301; Gao B, 2019, J CLIN INVEST, V129, P2578, DOI 10.1172/JCI98857; Gerbaix M, 2015, BONE, V71, P94, DOI 10.1016/j.bone.2014.10.011; Gohin S, 2020, J APPL PHYSIOL, V128, P838, DOI 10.1152/japplphysiol.00416.2019; Grailer JJ, 2014, J INNATE IMMUN, V6, P607, DOI 10.1159/000358524; Hu K, 2016, J CLIN INVEST, V126, P509, DOI 10.1172/JCI82585; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; James AW, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/684736; Jenei-Lanzl Z, 2014, ARTHRITIS RHEUMATOL, V66, P2472, DOI 10.1002/art.38695; King C, 2020, PHARMACOGENOMICS J, V20, P621, DOI 10.1038/s41397-019-0140-y; Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200; Kondo H, 2013, AM J PHYSIOL-ENDOC M, V304, pE507, DOI 10.1152/ajpendo.00191.2012; Kondo H, 2011, CALCIFIED TISSUE INT, V88, P23, DOI 10.1007/s00223-010-9421-9; Kormann R, 2020, J AM SOC NEPHROL, V31, P85, DOI 10.1681/ASN.2019020113; Langhammer Arnulf, 2009, Int J Chron Obstruct Pulmon Dis, V4, P365; Le Provost GS, 2015, J INVEST DERMATOL, V135, P279, DOI 10.1038/jid.2014.312; Lee J, 2021, NAT BIOMED ENG, V5, P89, DOI 10.1038/s41551-020-00674-w; Lemmens S, 2017, J CELL PHYSIOL, V232, P298, DOI 10.1002/jcp.25483; Li DD, 2019, J MOL HISTOL, V50, P493, DOI 10.1007/s10735-019-09843-x; Li HF, 2010, MOL CELL ENDOCRINOL, V323, P201, DOI 10.1016/j.mce.2010.03.021; Li HF, 2010, ARCH BIOCHEM BIOPHYS, V496, P77, DOI 10.1016/j.abb.2010.01.016; Li W, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0218-2; Liu C, 2019, J BONE MINER RES, V34, P896, DOI 10.1002/jbmr.3668; Liu C, 2018, BONE, V108, P145, DOI 10.1016/j.bone.2017.12.027; Liu S., 2021, GENET MOL BIOL, V3; Makela MJ, 2013, RESP MED, V107, P1481, DOI 10.1016/j.rmed.2013.04.005; Mansur AH, 2014, J ASTHMA, V51, P1076, DOI 10.3109/02770903.2014.939281; Matsumoto H, 2019, ADV EXP MED BIOL, V1132, P145, DOI 10.1007/978-981-13-6657-4_15; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Moore ER, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/3094154; Nagao M, 2011, P NATL ACAD SCI USA, V108, P17767, DOI 10.1073/pnas.1109402108; Noh H, 2017, KIDNEY INT, V92, P101, DOI 10.1016/j.kint.2017.02.013; Osman L, 2007, CIRCULATION, V116, pI282, DOI 10.1161/CIRCULATIONAHA.106.681072; Panchamanon P, 2019, CELL BIOL INT, V43, P506, DOI 10.1002/cbin.11116; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Ruehle MA, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb6351; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Soriano JB, 2020, LANCET RESP MED, V8, P585, DOI 10.1016/S2213-2600(20)30105-3; Sutter SA, 2016, CURR OSTEOPOROS REP, V14, P106, DOI 10.1007/s11914-016-0308-1; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Tang Y, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12369; van Staa TP, 2006, CALCIFIED TISSUE INT, V79, P129, DOI 10.1007/s00223-006-0019-1; Veldhuis-Vlug AG, 2015, BONE, V71, P196, DOI 10.1016/j.bone.2014.10.024; Vestergaard P, 2007, CHEST, V132, P1599, DOI 10.1378/chest.07-1092; Vi L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07666-0; Walsh LJ, 2001, THORAX, V56, P279, DOI 10.1136/thorax.56.4.279; Wang XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072962; Wang XT, 2021, FASEB J, V35, DOI 10.1096/fj.202001080RR; Yamada T, 2015, J CELL BIOCHEM, V116, P1144, DOI 10.1002/jcb.25071; Zhang F, 2017, SCI REP-UK, V7, DOI 10.1038/srep41634; Zhang M, 2017, IN VIVO, V31, P87, DOI 10.21873/invivo.11029	74	1	1	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22033	10.1096/fj.202101045RR	http://dx.doi.org/10.1096/fj.202101045RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34739146				2022-12-28	WOS:000722321300004
J	Chen, XJ; He, WX; Sun, MZ; Yan, YJ; Pang, YC; Chai, G				Chen, Xiaojun; He, Wenxin; Sun, Mengzhe; Yan, Yingjie; Pang, Yichuan; Chai, Gang			STING inhibition accelerates the bone healing process while enhancing type H vessel formation	FASEB JOURNAL			English	Article						angiogenesis; bone healing; stimulator of interferon genes; type H vessels	ANGIOGENESIS; CELLS; OSTEOGENESIS; RESOLUTION; REPAIR	The stimulator of interferon genes (STING), one of the critical factors of innate immunity, is indicated to be closely related to angiogenesis. This study examined STING's role in angiogenesis and the formation of type H vessels, a specific subtype of bone vessels that regulates bone healing. Different concentrations of 2 ',3 '-cGAMP, and H-151 or C-176 were applied to activate or inhibit STING, respectively. Human umbilical vein endothelial cells were used to examine the effect of STING on angiogenesis in vitro; cell viability, cell migration, and quantitative real-time polymerase chain reactions were performed. Also, the metatarsal experiment was applied as ex vivo proof. Bone fracture or defect mice models were used to examine the effect of STING in vivo; the bone healing process was evaluated by radiography weekly and by mu CT on the 14th day after surgery. The formation of type H vessels (CD31(hi)Emcn(hi) endothelial cells) and osteogenesis (OCN-positive cells) was assessed using the cryosection and paraffin section. STING activation inhibited angiogenesis both in vitro and ex vivo and slowed down the bone healing process in vivo. Histological analysis showed an increased callus formation, fewer type H vessels, and almost no callus mineralization in the STING activation group compared to the control group. By contrast, H-151 (a hsSTING inhibitor) promoted angiogenesis at a low dose. Moreover, inhibition of mmSTING by C-176 enhanced type H vessels' formation, implying osteogenesis promotion in bone healing (higher bone volume density and more OCN-positive cells). Our data suggested that STING inhibition accelerates the bone healing process while enhancing type H vessel formation.	[Chen, Xiaojun; Sun, Mengzhe; Yan, Yingjie; Chai, Gang] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, Sch Med, 639 ZhiZaoJu Rd, Shanghai 200011, Peoples R China; [He, Wenxin] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Orthopaed, Sch Med, Shanghai, Peoples R China; [Pang, Yichuan] Tongji Univ, Shanghai Peoples Hosp 10, Dept Nucl Med, Sch Med, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University	Chai, G (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, Sch Med, 639 ZhiZaoJu Rd, Shanghai 200011, Peoples R China.; Pang, YC (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Nucl Med, Sch Med, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China.	pangyichuan@hotmail.com; chaig1081@sh9hospital.org.cn	pang, yichuan/GWQ-7981-2022		National Natural Science Foundation of China (NSFC) [81741012]; Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine [JYLJ031]; Shanghai Municipal Key Clinical Specialty [shslczdzk00901]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine; Shanghai Municipal Key Clinical Specialty	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81741012; Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Grant/Award Number: JYLJ031; Shanghai Municipal Key Clinical Specialty, Grant/Award Number: shslczdzk00901	Almine JF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14392; Clark D, 2020, AGING CELL, V19, DOI 10.1111/acel.13112; Deckers M, 2001, LAB INVEST, V81, P5, DOI 10.1038/labinvest.3780207; Demaria O, 2015, P NATL ACAD SCI USA, V112, P15408, DOI 10.1073/pnas.1512832112; Deng ZH, 2020, AM J TRANSL RES, V12, P2640; Dodd KM, 2015, ONCOGENE, V34, P2239, DOI 10.1038/onc.2014.164; Filipowska J, 2017, ANGIOGENESIS, V20, P291, DOI 10.1007/s10456-017-9541-1; Gajewski TF, 2015, CYTOKINE GROWTH F R, V26, P175, DOI 10.1016/j.cytogfr.2015.01.001; Haag SM, 2018, NATURE, V559, P269, DOI 10.1038/s41586-018-0287-8; Hao ZC, 2021, J BONE MINER RES, V36, P186, DOI 10.1002/jbmr.4175; Hozain S, 2020, BONE, V138, DOI 10.1016/j.bone.2020.115479; Huang R, 2020, FASEB J, V34, P13521, DOI 10.1096/fj.202001145R; Jiang XF, 2019, FISH SHELLFISH IMMUN, V95, P220, DOI 10.1016/j.fsi.2019.09.075; Julien A, 2020, STEM CELL REP, V15, P955, DOI 10.1016/j.stemcr.2020.08.005; Kusumbe AP, 2016, NATURE, V532, P380, DOI 10.1038/nature17638; Kusumbe AP, 2015, NAT PROTOC, V10, P1904, DOI 10.1038/nprot.2015.125; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Kwon Y, 2019, J BONE MINER RES, V34, P1366, DOI 10.1002/jbmr.3701; Langen UH, 2017, NAT CELL BIOL, V19, P189, DOI 10.1038/ncb3476; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Morehouse BR, 2020, NATURE, V586, P429, DOI 10.1038/s41586-020-2719-5; Morgan EF, 2014, METHODS MOL BIOL, V1130, P13, DOI 10.1007/978-1-62703-989-5_2; Paul MA, 2020, J CRANIOFAC SURG, V31, P2123, DOI 10.1097/SCS.0000000000006616; Peng Y, 2020, THERANOSTICS, V10, P426, DOI 10.7150/thno.34126; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Schmidt-Bleek K, 2014, J TISSUE ENG REGEN M, V8, P120, DOI 10.1002/term.1505; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sivaraj KK, 2016, DEVELOPMENT, V143, P2706, DOI 10.1242/dev.136861; Xie H, 2014, NAT MED, V20, P1270, DOI 10.1038/nm.3668; Yang H, 2019, J CLIN INVEST, V129, P4350, DOI 10.1172/JCI125413; Yuan LS, 2017, J BIOL CHEM, V292, P15002, DOI 10.1074/jbc.M117.804005; Zhao J, 2018, ONCOGENE, V37, P4094, DOI 10.1038/s41388-018-0250-z	34	2	3	6	33	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21964	10.1096/fj.202100069RR	http://dx.doi.org/10.1096/fj.202100069RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34694030				2022-12-28	WOS:000712009200063
J	Cronin, T; Croyal, M; Provost, N; Ducloyer, JB; Mendes-Madeira, A; Libeau, L; Morival, C; Toublanc, E; Audrain, C; Isiegas, C; Pichard, V; Adjali, O				Cronin, T.; Croyal, M.; Provost, N.; Ducloyer, J. B.; Mendes-Madeira, A.; Libeau, L.; Morival, C.; Toublanc, E.; Audrain, C.; Isiegas, C.; Pichard, V; Adjali, O.			Effect of retinol dehydrogenase gene transfer in a novel rat model of Stargardt disease	FASEB JOURNAL			English	Article						ABCA4; NADPH; retinoid toxicity; retinol dehydrogenase; Stargardt disease; transgenic rat	DARK-ADAPTATION; ABC TRANSPORTER; PIGMENT; A2E; LIPOFUSCIN; MICE; PHOTORECEPTORS; RDH12; CYCLE; AUTOFLUORESCENCE	Dysfunction of the ATPase-binding Cassette Transporter protein (ABCA4) can lead to early onset macular degeneration, in particular to Stargardt disease. To enable translational research into this form of blindness, we evaluated the effect of Cas9-induced disruptions of the ABCA4 gene to potentially generate new transgenic rat models of the disease. We show that deletion of the short exon preceding the second nucleotide-binding domain is sufficient to drastically knock down protein levels and results in accumulation of retinoid dimers similar to that associated with Stargardt disease. Overexpression of the retinol dehydrogenase enzymes RDH8 and RDH12 can to a limited extent offset the increase in the bisretinoid levels in the Abca4(Ex42-/)- KO rats possibly by restricting the time window in which retinal can dimerize before being reduced to retinol. However, in vivo imaging shows that overexpression of RDH8 can induce retinal degeneration. This may be due to the depletion in the outer segment of the cofactor NADPH, needed for RDH function. The translational potential of RDH therapy as well as other Stargardt disease therapies can be tested using the Abca4 knockdown rat model.	[Cronin, T.; Provost, N.; Mendes-Madeira, A.; Libeau, L.; Morival, C.; Toublanc, E.; Audrain, C.; Isiegas, C.; Pichard, V; Adjali, O.] Univ Nantes, CHU Nantes, INSERM UMR 1089, Translat Gene Therapy Genet Dis, Nantes, France; [Croyal, M.] Inserm UMR1280, Nantes, France; [Ducloyer, J. B.] Univ Hosp Nantes, CHU Nantes, Dept Ophthalmol, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Cronin, T; Adjali, O (corresponding author), Univ Nantes, IRS Nantes Biotech 2, 22 Blvd Benoni Goullin, F-44200 Nantes, France.	therese.cronin@univ-nantes.fr; oumeya.adjali@univ-nantes.fr		Cronin, Therese/0000-0002-2938-2765; Ducloyer, Jean-Baptiste/0000-0002-1306-1908	Connect Talent 2015 (Pays de la loire) [19UU50]	Connect Talent 2015 (Pays de la loire)	Aviesan/Unadev, Grant/Award Number: 19UU50; Connect Talent 2015 (Pays de la loire)	Adler L, 2014, J BIOL CHEM, V289, P1519, DOI 10.1074/jbc.M113.511295; Allikmets R, 1998, GENE, V215, P111, DOI 10.1016/S0378-1119(98)00269-8; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Beharry S, 2004, J BIOL CHEM, V279, P53972, DOI 10.1074/jbc.M405216200; Bennett J., 2018, Methods and compositions for treatment of disorders and diseases involving rdh12, Patent No. [WO2018009814A1, 2018009814]; Biswas-Fiss EE, 2006, BIOCHEMISTRY-US, V45, P3813, DOI 10.1021/bi052059u; Care RA, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107730; Cella W, 2009, EXP EYE RES, V89, P16, DOI 10.1016/j.exer.2009.02.001; Chen CH, 2012, J BIOL CHEM, V287, P24662, DOI 10.1074/jbc.M112.354514; Dyka FM, 2019, HUM GENE THER, V30, P1361, DOI 10.1089/hum.2019.132; ELDRED GE, 1993, NATURE, V361, P724, DOI 10.1038/361724a0; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Fishkin N, 2003, ORG BIOMOL CHEM, V1, P1101, DOI 10.1039/b212213h; Fujinami K, 2019, BRIT J OPHTHALMOL, V103, P390, DOI 10.1136/bjophthalmol-2018-312064; Gutierrez DB, 2010, PHOTOCH PHOTOBIO SCI, V9, P1513, DOI 10.1039/c0pp00230e; Issa PC, 2015, P NATL ACAD SCI USA, V112, P8415, DOI 10.1073/pnas.1506960112; Issa PC, 2012, INVEST OPHTH VIS SCI, V53, P1066, DOI 10.1167/iovs.11-8767; Jin MH, 2007, J BIOL CHEM, V282, P20915, DOI 10.1074/jbc.M701432200; Kaufman Y, 2011, J BIOL CHEM, V286, P7958, DOI 10.1074/jbc.M110.178640; Kurth I, 2007, MOL CELL BIOL, V27, P1370, DOI 10.1128/MCB.01486-06; Lakkaraju A, 2007, P NATL ACAD SCI USA, V104, P11026, DOI 10.1073/pnas.0702504104; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Leinonen H, 2020, ELIFE, V9, DOI 10.7554/eLife.59422; Lenis TL, 2017, P NATL ACAD SCI USA, V114, P3987, DOI 10.1073/pnas.1620299114; Luo WQ, 2004, J NEUROSCI, V24, P2623, DOI 10.1523/JNEUROSCI.5302-03.2004; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200; Maeda A, 2009, INVEST OPHTH VIS SCI, V50, P5435, DOI 10.1167/iovs.09-3944; Makelainen S, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007873; Marc RE, 2003, MOL NEUROBIOL, V28, P139, DOI 10.1385/MN:28:2:139; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; McClements ME, 2019, HUM GENE THER, V30, P590, DOI 10.1089/hum.2018.156; Molday LL, 2018, HUM MOL GENET, V27, P295, DOI 10.1093/hmg/ddx400; Molday LL, 2000, NAT GENET, V25, P257, DOI 10.1038/77004; Najafi M, 2012, P NATL ACAD SCI USA, V109, P203, DOI 10.1073/pnas.1115109109; Parker RO, 2010, EXP EYE RES, V91, P788, DOI 10.1016/j.exer.2010.08.013; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Pawar AS, 2008, INVEST OPHTH VIS SCI, V49, P2743, DOI 10.1167/iovs.07-1499; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quazi F, 2013, J BIOL CHEM, V288, P34414, DOI 10.1074/jbc.M113.508812; Quazi F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1927; Racz B, 2018, J BIOL CHEM, V293, P11574, DOI 10.1074/jbc.RA118.002062; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Remy S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16328-y; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337; Sparrow JR, 2008, ADV EXP MED BIOL, V613, P393, DOI 10.1007/978-0-387-74904-4_46; Sparrow JR, 2003, VISION RES, V43, P2983, DOI 10.1016/S0042-6989(03)00475-9; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Tornabene P, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav4523; Ueda K, 2018, ADV EXP MED BIOL, V1074, P395, DOI 10.1007/978-3-319-75402-4_49; Vives-Bauza C, 2008, J BIOL CHEM, V283, P24770, DOI 10.1074/jbc.M800706200; Washington I, 2016, ADV EXP MED BIOL, V854, P347, DOI 10.1007/978-3-319-17121-0_46; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; WILLNER P, 1984, PSYCHOPHARMACOLOGY, V83, P1, DOI 10.1007/BF00427414; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	57	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21934	10.1096/fj.202002525RRR	http://dx.doi.org/10.1096/fj.202002525RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34599778	Green Published			2022-12-28	WOS:000712009200009
J	Dole, NS; Yoon, J; Monteiro, DA; Yang, J; Mazur, CM; Kaya, S; Belair, CD; Alliston, T				Dole, Neha S.; Yoon, Jihee; Monteiro, David A.; Yang, Jason; Mazur, Courtney M.; Kaya, Serra; Belair, Cassandra D.; Alliston, Tamara			Mechanosensitive miR-100 coordinates TGF beta and Wnt signaling in osteocytes during fluid shear stress	FASEB JOURNAL			English	Article						fluid shear stress; mechanobiology; microRNA; osteocytes; TGF beta; Wnt	MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; MICRORNA-100 SUPPRESSES; CIRCULATING MIRNAS; CANCELLOUS BONE; GENE-EXPRESSION; MLO-Y4 CELLS; PATHWAYS; FORCES	Organism scale mechanical forces elicit cellular scale changes through coordinated regulation of multiple signaling pathways. The mechanisms by which cells integrate signaling to generate a unified biological response remains a major question in mechanobiology. For example, the mechanosensitive response of bone and other tissues requires coordinated signaling by the transforming growth factor beta (TGF beta) and Wnt pathways through mechanisms that are not well-defined. Isere we report a new microRNA-dependent mechanism that mediates mechanosensitive crosstalk between TGFI3 and Wnt signaling in osteocytes exposed to fluid shear stress (FSS). From 60 mechanosensitive microRNA (miRs) identified by small-RNAseq, miR100 expression is suppressed by in vivo hind limb loading in the murine tibia and by cellular scale FSS in OCY454 cells. Though FSS activates both TGF beta and Wnt signaling in osteocytes, only TGIT represses miR100 expression. miR-100, in turn, antagonizes Wnt signaling by targeting and inhibiting expression of Frizzled receptors (FZD5/FZD8). Accordingly, miR-100 inhibition blunts FSS- and TGF beta-inducible Wnt signaling. Therefore, our results identify FSS-responsive mi RNAs in osteocytes, including one that integrates the mechanosensitive function of two essential signaling pathways in the osteoanabolic response of bone to mechanical load.	[Dole, Neha S.; Yoon, Jihee; Monteiro, David A.; Mazur, Courtney M.; Kaya, Serra; Alliston, Tamara] Univ Calif San Francisco, Dept Orthopaed Surg, 513 Parnassus Ave,S1155, San Francisco, CA 94143 USA; [Yang, Jason] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Belair, Cassandra D.; Alliston, Tamara] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Belair, Cassandra D.] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Dole, NS; Alliston, T (corresponding author), Univ Calif San Francisco, Dept Orthopaed Surg, 513 Parnassus Ave,S1155, San Francisco, CA 94143 USA.	NehaShashank.Dole@ucsf.edu; Tamara.Alliston@ucsf.edu	Kaya, Serra/J-8447-2019	Kaya, Serra/0000-0002-4979-3705; Yang, Jason/0000-0002-7156-5872	NIAMS [R21 AR067439, P30 AR066262-01]; NIH-NIDCR [R01 DE019284]; Office of Research on Women's Health [1636331]; Department of Defense [PRORP OR130191]	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH-NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Department of Defense(United States Department of Defense)	NIAMS, Grant/Award Number: R21 AR067439 and P30 AR066262-01; NIH-NIDCR, Grant/Award Number: R01 DE019284; Office of Research on Women's Health, Grant/Award Number: 1636331; Department of Defense, Grant/Award Number: PRORP OR130191	Alfieri Roberta, 2019, Biophys Rev, V11, P729, DOI 10.1007/s12551-019-00596-1; Alford AI, 2003, BONE, V33, P64, DOI 10.1016/S8756-3282(03)00167-4; Arfat Y, 2015, CURR MED CHEM, V22, P748, DOI 10.2174/0929867321999141106121227; Bacabac RG, 2004, BIOCHEM BIOPH RES CO, V315, P823, DOI 10.1016/j.bbrc.2004.01.138; Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Battaglino RA, 2012, CURR OSTEOPOROS REP, V10, P278, DOI 10.1007/s11914-012-0117-0; Belair CD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38458-7; Bonewald LF, 1999, J BONE MINER METAB, V17, P61, DOI 10.1007/s007740050066; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bouhaddioui W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111855; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Catalanotto C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101712; Chen JC, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt318; Chen WC, 2010, CELL BIOL INT, V34, P425, DOI 10.1042/CBI20090061; Chen X, 2015, BIOMATERIALS, V53, P239, DOI 10.1016/j.biomaterials.2015.02.071; Chen ZH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081684; Chen ZH, 2016, ACTA ASTRONAUT, V129, P186, DOI 10.1016/j.actaastro.2016.09.017; Chia CY, 2019, STEM CELL REP, V12, P57, DOI 10.1016/j.stemcr.2018.12.003; Choudhary S, 2003, J BONE MINER RES, V18, P1813, DOI 10.1359/jbmr.2003.18.10.1813; Ciani C, 2005, BONE, V37, P379, DOI 10.1016/j.bone.2005.04.004; Dole NS, 2017, CELL REP, V21, P2585, DOI 10.1016/j.celrep.2017.10.115; Dole NS, 2015, J BONE MINER RES, V30, P723, DOI 10.1002/jbmr.2378; Emmrich S, 2014, GENE DEV, V28, P858, DOI 10.1101/gad.233791.113; Franceschetti T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107262; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Frith JE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02486-0; Fritton SP, 2009, ANNU REV FLUID MECH, V41, P347, DOI 10.1146/annurev.fluid.010908.165136; Fu Y, 2020, REJUV RES, V23, P313, DOI 10.1089/rej.2019.2239; Garcia J, 2021, BONE, V143, DOI 10.1016/j.bone.2020.115791; Gillespie J, 2018, ARTHRITIS RHEUMATOL, V70, P932, DOI 10.1002/art.40437; Govey PM, 2014, J BIOMECH, V47, P1838, DOI 10.1016/j.jbiomech.2014.03.022; HALL BK, 1990, J MORPHOL, V206, P45, DOI 10.1002/jmor.1052060105; Hart NH, 2017, J MUSCULOSKEL NEURON, V17, P114; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Heuslein JL, 2018, MOL THER-NUCL ACIDS, V12, P829, DOI 10.1016/j.omtn.2018.08.001; Hill CS, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022079; Hou QK, 2017, AM J TRANSL RES, V9, P4963; Hu R, 2010, EXPERT OPIN THER TAR, V14, P1109, DOI 10.1517/14728222.2010.512916; Jiang Q, 2016, TUMOR BIOL, V37, P5001, DOI 10.1007/s13277-015-4342-x; Kapinas K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3325; Kelch S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16113-x; Kelly NH, 2016, BONE, V86, P22, DOI 10.1016/j.bone.2016.02.007; Kouzbari K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42302-x; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; KrishnaPriya S., 2020, BIORXIV2020083275065; Kumar S, 2014, ARTERIOSCL THROM VAS, V34, P2206, DOI 10.1161/ATVBAHA.114.303425; Kunnen SJ, 2017, CELL MOL LIFE SCI, V74, P2283, DOI 10.1007/s00018-017-2460-x; Lara-Castillo N, 2015, BONE, V76, P58, DOI 10.1016/j.bone.2015.03.019; Lee DY, 2010, J BIOL CHEM, V285, P30, DOI 10.1074/jbc.M109.010512; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Liu DW, 2008, BONE, V42, P644, DOI 10.1016/j.bone.2007.09.058; Lozano C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00375; Lu TW, 2012, KAOHSIUNG J MED SCI, V28, pS13, DOI 10.1016/j.kjms.2011.08.004; Lu TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042390; Lu YY, 2017, NAT MED, V23, P1331, DOI 10.1038/nm.4424; Lynch ME, 2014, ADV DRUG DELIVER REV, V79-80, P119, DOI 10.1016/j.addr.2014.08.009; Ma JX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13643-2; Mai ZH, 2013, CHINESE MED J-PEKING, V126, P1544, DOI 10.3760/cma.j.issn.0366-6999.20123137; Mao G, 2017, OSTEOARTHR CARTILAGE, V25, P521, DOI 10.1016/j.joca.2016.11.006; Monteiro DA, 2021, FASEB J, V35, DOI 10.1096/fj.202001998R; Neth P, 2013, CARDIOVASC RES, V99, P294, DOI 10.1093/cvr/cvt096; Nguyen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053813; Ni CW, 2011, AM J PHYSIOL-HEART C, V300, pH1762, DOI 10.1152/ajpheart.00829.2010; Nlandu-Khodo S, 2017, J AM SOC NEPHROL, V28, P3490, DOI 10.1681/ASN.2016121351; Pan BL, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180696; Pankratz F, 2018, CIRC RES, V122, P417, DOI 10.1161/CIRCRESAHA.117.311428; Patel V, 2015, FASEB J, V29, P1859, DOI 10.1096/fj.14-257808; Peters AE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24258-6; Qin L, 2020, BONE RES, V8, DOI 10.1038/s41413-020-0099-y; Rangaswami H, 2012, J BIOL CHEM, V287, P21509, DOI 10.1074/jbc.M112.347245; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Robling AG, 2009, CRIT REV EUKAR GENE, V19, P319, DOI 10.1615/CritRevEukarGeneExpr.v19.i4.50; Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028; Rysa J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23042-w; Seeliger C, 2014, J BONE MINER RES, V29, P1718, DOI 10.1002/jbmr.2175; Shah CA, 2011, J BIOL CHEM, V286, P3161, DOI 10.1074/jbc.M110.183251; Sheng X, 2018, INT J MOL MED, V42, P1809, DOI 10.3892/ijmm.2018.3758; Smith SS, 2016, J BIOL CHEM, V291, P21717, DOI 10.1074/jbc.M116.737890; Spatz JM, 2015, J BIOL CHEM, V290, P16744, DOI 10.1074/jbc.M114.628313; Sugiyama T, 2010, BONE, V46, P314, DOI 10.1016/j.bone.2009.08.054; Takahara S, 2018, BONE JOINT RES, V7, P139, DOI 10.1302/2046-3758.72.BJR-2017-0082.R1; Tang Simon Y, 2013, Bonekey Rep, V2, P255, DOI 10.1038/bonekey.2012.255; Tian LJ, 2017, GENE, V627, P32, DOI 10.1016/j.gene.2017.06.002; Uda Y, 2017, CURR OSTEOPOROS REP, V15, P318, DOI 10.1007/s11914-017-0373-0; van Wijnen AJ, 2013, CURR OSTEOPOROS REP, V11, P72, DOI 10.1007/s11914-013-0143-6; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Vining KH, 2017, NAT REV MOL CELL BIO, V18, P728, DOI 10.1038/nrm.2017.108; Wang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep23170; Wei BF, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9015758; Weilner S, 2015, BONE, V79, P43, DOI 10.1016/j.bone.2015.05.027; Wittkowske C, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00087; Wu JY, 2019, BIOMATERIALS, V206, P87, DOI 10.1016/j.biomaterials.2019.03.022; Yavropoulou MP, 2016, J MUSCULOSKEL NEURON, V16, P221; Yu T, 2020, AGING-US, V12, P9500, DOI 10.18632/aging.103223; Zeng Y, 2012, FEBS LETT, V586, P2375, DOI 10.1016/j.febslet.2012.05.049; Zhang BB, 2018, REDOX BIOL, V14, P492, DOI 10.1016/j.redox.2017.10.021; Zhou L, 2019, INT J MOL MED, V43, P727, DOI 10.3892/ijmm.2018.4017; Zhou SH, 2004, J BONE MINER RES, V19, P463, DOI 10.1359/JBMR.0301239; Zimmermann EA, 2016, SCI REP-UK, V6, DOI 10.1038/srep21072	100	0	0	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21883	10.1096/fj.202100930	http://dx.doi.org/10.1096/fj.202100930			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34569659	Green Published, hybrid			2022-12-28	WOS:000702238200006
J	Tyganov, SA; Mochalova, EP; Melnikov, IY; Vikhlyantsev, IM; Ulanova, AD; Sharlo, KA; Mirzoev, TM; Shenkman, BS				Tyganov, Sergey A.; Mochalova, Ekaterina P.; Melnikov, Ivan Y.; Vikhlyantsev, Ivan M.; Ulanova, Anna D.; Sharlo, Kristina A.; Mirzoev, Timur M.; Shenkman, Boris S.			NOS-dependent effects of plantar mechanical stimulation on mechanical characteristics and cytoskeletal proteins in rat soleus muscle during hindlimb suspension	FASEB JOURNAL			English	Article						cytoskeletal proteins; hindlimb suspension; passive stiffness; plantar mechanical stimulation; soleus muscle	THIN FILAMENT DENSITY; SKELETAL-MUSCLE; NITRIC-OXIDE; PASSIVE TENSION; MU-CALPAIN; TRANSVERSAL STIFFNESS; CROSS-BRIDGES; SINGLE FIBERS; MYOSIN HEADS; ATROPHY	The study was aimed at investigating the mechanisms and structures which determine mechanical properties of skeletal muscles under gravitational unloading and plantar mechanical stimulation (PMS). We hypothesized that PMS would increase NO production and prevent an unloading-induced reduction in skeletal muscle passive stiffness. Wistar rats were hindlimb suspended and subjected to a daily PMS and one group of stimulated animals was also treated with nitric oxide synthase (NOS) inhibitor (L-NAME). Animals received mechanical stimulation of the feet for 4 h a day throughout 7-day hindlimb suspension (HS) according to a scheme that mimics the normal walking of the animal. Seven-day HS led to a significant reduction in soleus muscle weight by 25%. However, PMS did not prevent the atrophic effect induced by HS. Gravitational unloading led to a significant decrease in maximum isometric force and passive stiffness by 38% and 31%, respectively. The use of PMS prevented a decrease in the maximum isometric strength of the soleus muscle. At the same time, the passive stiffness of the soleus in the PMS group significantly exceeded the control values by 40%. L-NAME (NOS inhibitor) administration attenuated the effect of PMS on passive stiffness and maximum force of the soleus muscle. The content of the studied cytoskeletal proteins (alpha-actinin-2, alpha-actinin-3, desmin, titin, nebulin) decreased after 7-day HS, but this decrease was successfully prevented by PMS in a NOS-dependent manner. We also observed significant decreases in mRNA expression levels of alpha-actinin-2, desmin, and titin after HS, which was prevented by PMS. The study also revealed a significant NOS-dependent effect of PMS on the content of collagen-1a, but not collagen-3a. Thus, PMS during mechanical unloading is able to maintain soleus muscle passive tension and force as well as mRNA transcription and protein contents of cytoskeletal proteins in a NOS-dependent manner.	[Tyganov, Sergey A.; Mochalova, Ekaterina P.; Melnikov, Ivan Y.; Sharlo, Kristina A.; Mirzoev, Timur M.; Shenkman, Boris S.] Russian Acad Sci, Inst Biomed Problems, Myol Lab, Khoroshevskoe Shosse 76a, Moscow, Russia; [Vikhlyantsev, Ivan M.; Ulanova, Anna D.] Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino, Russia	Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics	Tyganov, SA (corresponding author), Russian Acad Sci, Inst Biomed Problems, Myol Lab, Khoroshevskoe Shosse 76a, Moscow, Russia.	sentackle@yandex.ru	SHARLO, KRISTINA/ABB-6619-2020; Kalashnikova, Ekaterina/ABD-3623-2020; Mirzoev, Timur/N-2803-2016	SHARLO, KRISTINA/0000-0002-5413-6312; Mirzoev, Timur/0000-0002-1986-6221; Tyganov, Sergey/0000-0001-8334-8608	Basic Research Program of the Institute of Biomedical Problems RAS [65.3]	Basic Research Program of the Institute of Biomedical Problems RAS	The study was supported by the Basic Research Program of the Institute of Biomedical Problems RAS (topic 65.3)	Ahtikoski AM, 2001, ACTA PHYSIOL SCAND, V172, P131, DOI 10.1046/j.1365-201X.2001.00848.x; Allen DG, 2010, CAN J PHYSIOL PHARM, V88, P83, DOI 10.1139/Y09-058; ANDERSON DJ, 1986, EXP BRAIN RES, V64, P380; Anderson J, 2002, PFLUG ARCH EUR J PHY, V444, P771, DOI 10.1007/s00424-002-0875-0; Anderson J, 2001, MUSCLE NERVE, V24, P1090, DOI 10.1002/mus.1115; Aweida D, 2018, J CELL BIOL, V217, P3698, DOI 10.1083/jcb.201802018; Bucher RM, 2010, J MOL BIOL, V401, P843, DOI 10.1016/j.jmb.2010.06.011; CANON F, 1995, PFLUG ARCH EUR J PHY, V429, P332, DOI 10.1007/BF00374147; De-Doncker L, 2000, J APPL PHYSIOL, V89, P2344, DOI 10.1152/jappl.2000.89.6.2344; El-Khoury R, 2012, PHYSIOL RES, V61, P195, DOI 10.33549/physiolres.932140; FAUTECK SP, 1995, AM J PHYSIOL-CELL PH, V268, pC419, DOI 10.1152/ajpcell.1995.268.2.C419; Fusi L, 2015, BIOPHYS J, V109, P783, DOI 10.1016/j.bpj.2015.06.038; Garton FC, 2014, HUM MOL GENET, V23, P1879, DOI 10.1093/hmg/ddt580; Golaszewski SM, 2006, NEUROIMAGE, V29, P923, DOI 10.1016/j.neuroimage.2005.08.052; GOLLNICK PD, 1981, J APPL PHYSIOL, V50, P936, DOI 10.1152/jappl.1981.50.5.936; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; GRANZIER HLM, 1993, BIOPHYS J, V65, P2141, DOI 10.1016/S0006-3495(93)81262-1; Grundy D, 2015, J PHYSIOL-LONDON, V593, P2547, DOI 10.1113/JP270818; Han XY, 1999, PFLUG ARCH EUR J PHY, V437, P857, DOI 10.1007/s004240050855; HERNANDEZKORWO R, 1983, KOSM BIOL AVIAK MED+, V17, P37; Hsu YC, 2006, NITRIC OXIDE-BIOL CH, V14, P327, DOI 10.1016/j.niox.2006.01.006; ILYIN EA, 1980, KOSM BIOL AVIAK MED+, V14, P79; Kang Gu Eon, 2019, J Diabetes Sci Technol, V13, P847, DOI 10.1177/1932296819839703; Kawano F, 2002, NEUROSCIENCE, V114, P1133, DOI 10.1016/S0306-4522(02)00304-4; Kensler RW, 2017, P NATL ACAD SCI USA, V114, pE1355, DOI 10.1073/pnas.1614020114; Kobayashi N, 2000, AM J HYPERTENS, V13, P199, DOI 10.1016/S0895-7061(99)00117-X; Koh TJ, 2000, AM J PHYSIOL-CELL PH, V279, pC806, DOI 10.1152/ajpcell.2000.279.3.C806; Kovanen V, 2002, EXERC SPORT SCI REV, V30, P20, DOI 10.1097/00003677-200201000-00005; Kremneva E I, 2012, Fiziol Cheloveka, V38, P61; Kuisk IR, 1996, DEV BIOL, V174, P1, DOI 10.1006/dbio.1996.0046; Kyparos A, 2005, J APPL PHYSIOL, V99, P739, DOI 10.1152/japplphysiol.00771.2004; Layne CS, 1998, ACTA ASTRONAUT, V42, P231, DOI 10.1016/S0094-5765(98)00120-9; Li YP, 2014, J AGR FOOD CHEM, V62, P5972, DOI 10.1021/jf501332d; Litvinova K S, 2004, J Gravit Physiol, V11, pP131; Liu R, 2019, FOOD CHEM, V275, P77, DOI 10.1016/j.foodchem.2018.09.104; Liu R, 2016, FOOD CHEM, V213, P470, DOI 10.1016/j.foodchem.2016.06.104; Lomonosova YN, 2011, BIOCHEMISTRY-MOSCOW+, V76, P571, DOI 10.1134/S0006297911050075; Martins KJB, 2012, J PHYSIOL-LONDON, V590, P1427, DOI 10.1113/jphysiol.2011.223370; Masi AT, 2008, J BODYW MOV THER, V12, P320, DOI 10.1016/j.jbmt.2008.05.007; MCDONALD KS, 1995, J APPL PHYSIOL, V79, P1796, DOI 10.1152/jappl.1995.79.5.1796; MCDONALD KS, 1994, J APPL PHYSIOL, V77, P1609, DOI 10.1152/jappl.1994.77.4.1609; McElhinny AS, 2003, TRENDS CARDIOVAS MED, V13, P195, DOI 10.1016/S1050-1738(03)00076-8; MICHETTI M, 1995, BIOCHEM BIOPH RES CO, V207, P1009, DOI 10.1006/bbrc.1995.1285; Miller TA, 2001, AM J PHYSIOL-REG I, V281, pR1710, DOI 10.1152/ajpregu.2001.281.5.R1710; Mirzoev TM, 2012, DOKL BIOCHEM BIOPHYS, V444, P144, DOI 10.1134/S1607672912030052; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Moukhina Alexandra, 2004, J Gravit Physiol, V11, pP137; Muhle-Goll C, 2001, J MOL BIOL, V313, P431, DOI 10.1006/jmbi.2001.5017; Murphy RM, 2006, J PHYSIOL-LONDON, V576, P595, DOI 10.1113/jphysiol.2006.114090; MURRANT CL, 1994, CAN J PHYSIOL PHARM, V72, P1089, DOI 10.1139/y94-152; Nemirovskaya TL, 2002, EUR J APPL PHYSIOL, V87, P120, DOI 10.1007/s00421-002-0603-7; Ogneva IV, 2011, ACTA ASTRONAUT, V68, P1478, DOI 10.1016/j.actaastro.2010.01.012; Ogneva I V, 2011, Dokl Biol Sci, V436, P20, DOI 10.1134/S0012496611010145; Ogneva IV, 2010, J APPL PHYSIOL, V109, P1702, DOI 10.1152/japplphysiol.00793.2010; Ohira Yoshinobu, 2002, Biol Sci Space, V16, P147; Oishi Y, 1998, ACTA PHYSIOL SCAND, V162, P127; Petrova IO, 2018, DOKL BIOCHEM BIOPHYS, V481, P205, DOI 10.1134/S1607672918040075; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pinotsis N, 2006, J STRUCT BIOL, V155, P239, DOI 10.1016/j.jsb.2006.03.028; Riley DA, 2005, AM J PHYSIOL-CELL PH, V288, pC360, DOI 10.1152/ajpcell.00386.2004; Riley DA, 2002, J APPL PHYSIOL, V92, P817, DOI 10.1152/japplphysiol.00717.2001; Riley DA, 1998, MUSCLE NERVE, V21, P1280; Riley DA, 2000, J APPL PHYSIOL, V88, P567, DOI 10.1152/jappl.2000.88.2.567; Rudnick J, 2004, FASEB J, V18, P1228, DOI 10.1096/fj.03-0792fje; Sebastian S, 2013, GENE DEV, V27, P1247, DOI 10.1101/gad.215400.113; Sharlo K, 2019, J APPL PHYSIOL, V126, P1769, DOI 10.1152/japplphysiol.00029.2019; Sharlo KA, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031372; Shenkman BS, 2021, ACTA NATURAE, V13, P85, DOI 10.32607/actanaturae.10953; Shenkman B. S., 2014, Uspekhi Fiziologicheskikh Nauk, V45, P37; Shenkman BS, 2004, BIOFIZIKA+, V49, P881; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; TATSUMI R, 1995, ANAL BIOCHEM, V224, P28, DOI 10.1006/abio.1995.1004; TAYLOR DC, 1990, AM J SPORT MED, V18, P300, DOI 10.1177/036354659001800314; THOMASON DB, 1990, J APPL PHYSIOL, V68, P1, DOI 10.1152/jappl.1990.68.1.1; Tidball JG, 1998, AM J PHYSIOL-CELL PH, V275, pC260, DOI 10.1152/ajpcell.1998.275.1.C260; Toursel T, 2002, J APPL PHYSIOL, V92, P1465, DOI 10.1152/japplphysiol.00621.2001; Trinick J, 1991, CURR OPIN CELL BIOL, V3, P112, DOI 10.1016/0955-0674(91)90173-V; Tyganov SA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89362-6; Tyganov SA, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01252; Ulanova A, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01221; Ulanova A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/104735; Vikhlyantsev Ivan M, 2017, Biophys Rev, V9, P189, DOI 10.1007/s12551-017-0266-6; Vyas-Read S, 2007, AM J PHYSIOL-LUNG C, V293, pL212, DOI 10.1152/ajplung.00475.2006	83	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21905	10.1096/fj.202100783R	http://dx.doi.org/10.1096/fj.202100783R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34569672				2022-12-28	WOS:000702238200048
J	Wu, SW; Li, LX; Wu, XL; Wong, CKC; Sun, F; Cheng, CY				Wu, Siwen; Li, Linxi; Wu, Xiaolong; Wong, Chris K. C.; Sun, Fei; Cheng, C. Yan			AKAP9 supports spermatogenesis through its effects on microtubule and actin cytoskeletons in the rat testis	FASEB JOURNAL			English	Article						AKAP9; Sertoli cells; blood-testis barrier; cytoskeleton; F-actin; microtubule; spermatogenesis; testis	TRANSEPITHELIAL ELECTRICAL-RESISTANCE; SIGNALING COMPLEXES; BARRIER DISRUPTION; JUNCTION DYNAMICS; CADMIUM CHLORIDE; GOLGI-APPARATUS; PROTEIN-KINASE; SERTOLI-CELLS; CG-NAP; EXPRESSION	In mammalian testes, extensive remodeling of the microtubule (MT) and actin cytoskeletons takes place in Sertoli cells across the seminiferous epithelium to support spermatogenesis. However, the mechanism(s) involving regulatory and signaling proteins remains poorly understood. Herein, A-kinase anchoring protein 9 (AKAP9, a member of the AKAP multivalent scaffold protein family) was shown to be one of these crucial regulatory proteins in the rat testis. Earlier studies have shown that AKAP9 serves as a signaling platform by recruiting multiple signaling and regulatory proteins to create a large protein complex that binds to the Golgi and centrosome to facilitate the assembly of the MT-nucleating gamma-tubulin ring complex to initiate MT polymerization. We further expanded our earlier studies based on a Sertoli cell-specific AKAP9 knockout mouse model to probe the function of AKAP9 by using the techniques of immunofluorescence analysis, RNA interference (RNAi), and biochemical assays on an in vitro primary Sertoli cell culture model, and an adjudin-based animal model. AKAP9 robustly expressed across the seminiferous epithelium in adult rat testes, colocalizing with MT-based tracks, and laid perpendicular across the seminiferous epithelium, and prominently expressed at the Sertoli-spermatid cell-cell anchoring junction (called apical ectoplasmic specialization [ES]) and at the Sertoli cell-cell interface (called basal ES, which together with tight junction [TJ] created the blood-testis barrier [BTB]) stage specifically. AKAP9 knockdown in Sertoli cells by RNAi was found to perturb the TJ-permeability barrier through disruptive changes in the distribution of BTB-associated proteins at the Sertoli cell cortical zone, mediated by a considerable loss of ability to induce both MT polymerization and actin filament bundling. A considerable decline in AKAP9 expression and a disruptive distribution of AKAP9 across the seminiferous tubules was also noted during adjudin-induced germ cell (GC) exfoliation in this animal model, illustrating AKAP9 is essential to maintain the homeostasis of cytoskeletons to maintain Sertoli and GC adhesion in the testis.	[Wu, Siwen; Li, Linxi; Cheng, C. Yan] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Peoples R China; [Wu, Siwen; Li, Linxi; Cheng, C. Yan] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China; [Wu, Siwen; Cheng, C. Yan] Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA; [Wu, Xiaolong; Sun, Fei; Cheng, C. Yan] Nantong Univ, Inst Reprod Med, Sch Med, Nantong 226001, Jiangsu, Peoples R China; [Wong, Chris K. C.] Hong Kong Baptist Univ, Croucher Inst Environm Sci, Dept Biol, Kowloon, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Population Council; Nantong University; Hong Kong Baptist University	Cheng, CY (corresponding author), Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA.	ccheng@mail.rockefeller.edu	wong, chris/GSN-0962-2022; Li, Linxi/AFZ-9275-2022	wu, xiaolong/0000-0003-3050-0324; Cheng, C Yan/0000-0003-3117-3791	National Institutes of Health (NICHD) [R01 HD056034]; National Key Research and Development Program of China [2018YFC1003500]; National Natural Science Foundation of China [NSFC 81971367]; Wenzhou Science and Technology Bureau [Y20190015]; China Shenzhen Science Technology and Innovation Commission (SZSTI) [SZSTI-JCYJ20180508152336419]	National Institutes of Health (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Science and Technology Bureau; China Shenzhen Science Technology and Innovation Commission (SZSTI)	This work was supported in part by grants from the National Institutes of Health (NICHD, R01 HD056034 to CYC), the National Key Research and Development Program of China (2018YFC1003500 to FS), National Natural Science Foundation of China (NSFC 81971367 to LL); The Wenzhou Science and Technology Bureau (Y20190015 to LL), the China Shenzhen Science Technology and Innovation Commission (SZSTI) (SZSTI-JCYJ20180508152336419 to CKCW).	Aravindan GR, 1996, J CELL PHYSIOL, V168, P123; Borovac J, 2012, AM J PHYSIOL-CELL PH, V303, pC1278, DOI 10.1152/ajpcell.00434.2011; Bouguenina H, 2017, P NATL ACAD SCI USA, V114, pE10687, DOI 10.1073/pnas.1705682114; Bucko PJ, 2021, ANNU REV PHARMACOL, V61, P361, DOI 10.1146/annurev-pharmtox-022420-112134; Cheng C.Y., 2014, SPERMATOGENESIS, V4, pe981485, DOI [10.4161/21565562.2014.9814895, DOI 10.4161/21565562.2014.9814895, 10.4161/21565562.2014.981485, DOI 10.4161/21565562.2014.981485]; Cheng CY, 2011, BIOCHEM J, V435, P553, DOI 10.1042/BJ20102121; Cheng CY, 2005, CONTRACEPTION, V72, P251, DOI 10.1016/j.contraception.2005.03.008; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Chung NPY, 2001, ENDOCRINOLOGY, V142, P1878, DOI 10.1210/en.142.5.1878; Chung NPY, 2001, BIOL REPROD, V65, P1340, DOI 10.1095/biolreprod65.5.1340; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; de Kretser D.M., 1988, P837; Diviani D, 2001, J CELL SCI, V114, P1431; Du M, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104851; Dunleavy JEM, 2019, REPRODUCTION, V157, pR53, DOI 10.1530/REP-18-0457; Dunleavy JEM, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007078; Faruque OM, 2009, AM J PHYSIOL-CELL PH, V296, pC306, DOI 10.1152/ajpcell.00216.2008; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; Gao Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep28589; Grima J, 1998, J BIOL CHEM, V273, P21040, DOI 10.1074/jbc.273.33.21040; GRIMA J, 1992, MOL CELL ENDOCRINOL, V89, P127, DOI 10.1016/0303-7207(92)90219-V; Hermo L, 2019, SPERMATOGENESIS BIOL, P1; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P279, DOI 10.1002/jemt.20787; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; HEW KW, 1993, BIOL REPROD, V49, P840, DOI 10.1095/biolreprod49.4.840; HEW KW, 1993, TOXICOL APPL PHARM, V121, P15, DOI 10.1006/taap.1993.1123; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Hurtado L, 2011, J CELL BIOL, V193, P917, DOI 10.1083/jcb.201011014; JANECKI A, 1992, TOXICOL APPL PHARM, V112, P51, DOI 10.1016/0041-008X(92)90278-Z; JANECKI A, 1991, ENDOCRINOLOGY, V129, P1489, DOI 10.1210/endo-129-3-1489; Janke C, 2020, NAT REV MOL CELL BIO, V21, P307, DOI 10.1038/s41580-020-0214-3; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Kaitu'u-Lino TJ, 2007, REPRODUCTION, V133, P1169, DOI 10.1530/REP-06-0385; Kim HS, 2007, GENES CELLS, V12, P421, DOI 10.1111/j.1365-2443.2007.01055.x; Kolobova E, 2017, J BIOL CHEM, V292, P20394, DOI 10.1074/jbc.M117.806018; Langeberg LK, 2005, J CELL SCI, V118, P3217, DOI 10.1242/jcs.02416; Li LX, 2017, ENDOCRINOLOGY, V158, P4300, DOI 10.1210/en.2017-00660; Li MWM, 2009, INT J BIOCHEM CELL B, V41, P2302, DOI 10.1016/j.biocel.2009.05.016; Li N, 2016, ENDOCRINOLOGY, V157, P2894, DOI 10.1210/en.2016-1133; Lie PPY, 2012, P NATL ACAD SCI USA, V109, P12562, DOI 10.1073/pnas.1202316109; Lie PPY, 2010, P NATL ACAD SCI USA, V107, P11411, DOI 10.1073/pnas.1001823107; Lie PPY, 2010, INT J BIOCHEM CELL B, V42, P975, DOI 10.1016/j.biocel.2010.02.010; Lie PPY, 2009, FASEB J, V23, P2555, DOI 10.1096/fj.06-070573; McCahill A, 2005, CELL SIGNAL, V17, P1158, DOI 10.1016/j.cellsig.2005.04.003; Mruk DD, 2008, PHARMACOL REV, V60, P146, DOI 10.1124/pr.107.07105; Mruk Dolores D, 2011, Spermatogenesis, V1, P121; Mruk DD, 2011, METHODS MOL BIOL, V763, P237, DOI 10.1007/978-1-61779-191-8_16; Nicholls PK, 2013, MOL CELL ENDOCRINOL, V377, P33, DOI 10.1016/j.mce.2013.06.034; Nygren PJ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00158; O'Donnell L., 2014, SPERMATOGENESIS, V4, pe979623, DOI [10.4161/21565562.2014.979623, DOI 10.4161/21565562.2014.979623]; O'Donnell L, 2014, SEMIN CELL DEV BIOL, V30, P45, DOI 10.1016/j.semcdb.2014.01.003; Omar MH, 2020, TRENDS PHARMACOL SCI, V41, P933, DOI 10.1016/j.tips.2020.09.007; Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47; Rotkopf S, 2011, DEVELOPMENT, V138, P2729, DOI 10.1242/dev.059865; Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492; Roubin R, 2013, BIOL OPEN, V2, P238, DOI 10.1242/bio.20123392; Schimenti KJ, 2013, GENETICS, V194, P447, DOI 10.1534/genetics.113.150789; Schmidt PH, 1999, J BIOL CHEM, V274, P3055, DOI 10.1074/jbc.274.5.3055; Siu MKY, 2005, J BIOL CHEM, V280, P25029, DOI 10.1074/jbc.M501049200; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; Suryavanshi SV, 2018, J CARDIOVASC DEV DIS, V5, DOI 10.3390/jcdd5010007; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; Tang EI, 2016, SEMIN CELL DEV BIOL, V59, P35, DOI 10.1016/j.semcdb.2016.01.004; Tang EI, 2016, ENDOCRINOLOGY, V157, P1644, DOI 10.1210/en.2015-1962; Tang EI, 2015, ENDOCRINOLOGY, V156, P680, DOI 10.1210/en.2014-1720; TURNER TT, 1984, ENDOCRINOLOGY, V115, P1925, DOI 10.1210/endo-115-5-1925; Upadhyay RD, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-27; Varadarajan R, 2017, J BIOL CHEM, V292, P20410, DOI 10.1074/jbc.H117.806018; Venkatesh D, 2016, AM J PATHOL, V186, P270, DOI 10.1016/j.ajpath.2015.10.007; Vergarajauregui S, 2020, ELIFE, V9, DOI 10.7554/eLife.61669; Vogl AW, 2008, ADV EXP MED BIOL, V636, P186, DOI 10.1007/978-0-387-09597-4_11; Wang L, 2021, ENDOCRINOLOGY, V162, P1, DOI DOI 10.1210/ENDOCR/BQAA1196; Wang LL, 2021, HISTOL HISTOPATHOL, V36, P249, DOI 10.14670/HH-18-279; Wang LL, 2020, TOXICOL SCI, V177, P305, DOI 10.1093/toxsci/kfaa109; Wang LL, 2020, REPROD TOXICOL, V96, P76, DOI 10.1016/j.reprotox.2020.05.017; Wang Z, 2014, J CELL SCI, V127, P4904, DOI 10.1242/jcs.155408; Wen Q, 2019, ENDOCRINOLOGY, V160, P484, DOI 10.1210/en.2018-00855; Wen Q, 2018, AM J PHYSIOL-ENDOC M, V315, pE924, DOI 10.1152/ajpendo.00114.2018; Wen Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0201-6; Wolski KM, 2005, J ANDROL, V26, P354, DOI 10.2164/jandrol.04142; Wong CCS, 2000, J ANDROL, V21, P227; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu SW, 2021, METHODS MOL BIOL, V2367, P207, DOI 10.1007/7651_2021_390; Wu SW, 2021, ENDOCRINOLOGY, V162, DOI 10.1210/endocr/bqab010; Xiao X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004447	85	1	1	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21925	10.1096/fj.202100960R	http://dx.doi.org/10.1096/fj.202100960R			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34569663				2022-12-28	WOS:000702238200020
J	Sun, ZL; Su, ZY; Zhou, ZY; Wang, SJ; Wang, Z; Tong, X; Li, C; Wang, YX; Chen, XY; Lei, Z; Zhang, HT				Sun, Zelong; Su, Zhiyue; Zhou, Zhengyu; Wang, Shengjie; Wang, Zhao; Tong, Xin; Li, Chang; Wang, Yuxin; Chen, Xiaoyan; Lei, Zhe; Zhang, Hong-Tao			RNA demethylase ALKBH5 inhibits TGF-beta-induced EMT by regulating TGF-beta/SMAD signaling in non-small cell lung cancer	FASEB JOURNAL			English	Article						ALKBH5; m(6)A; NSCLC; TGF-beta-induced EMT; YTHDF1/2/3	MESSENGER-RNA; MESENCHYMAL TRANSITION; EXPRESSION; PROLIFERATION; TRANSLATION; STABILITY	AlkB homolog 5 (ALKBH5) has been revealed as a key RNA N-6-methyladenosine (m(6)A) demethylase that is implicated in development and diseases. However, the function of ALKBH5 in TGF-beta-induced epithelial-mesenchymal transition (EMT) and tumor metastasis of non-small-cell lung cancer (NSCLC) remains unknown. Here, we firstly show that ALKBH5 expression is significantly reduced in metastatic NSCLC. ALKBH5 overexpression inhibits TGF-beta-induced EMT and invasion of NSCLC cells, whereas ALKBH5 knockdown promotes the corresponding phenotypes. ALKBH5 overexpression suppresses TGF-beta-stimulated NSCLC cell metastasis in vivo. ALKBH5 overexpression decreases the expression and mRNA stability of TGF beta R2 and SMAD3 but increases those of SMAD6, while ALKBH5 knockdown causes the opposite results. Importantly, ALKBH5 overexpression or knockdown leads respectively to an attenuated or augmented phosphorylation of SMAD3, an indispensable downstream effector that activates TGF-beta/SMAD signaling. Moreover, m(6)A-binding proteins YTHDF1/3 promotes TGF beta R2 and SMAD3 expression, and YTHDF2 inhibits SMAD6 expression. YTHDF1/2/3 facilitates TGF-beta-stimulated EMT and invasion of NSCLC cells. Mechanistically, ALKBH5 affects TGF beta R2, SMAD3 and SMAD6 expression and mRNA stability by erasing m(6)A modification in NSCLC cells. ALKBH5 weakens YTHDF1/3-mediated TGF beta R2 and SMAD3 mRNA stabilization, and abolishes YTHDF2-mediated SMAD6 mRNA degradation, supporting the notion that ALKBH5 inhibits TGF-beta-induced EMT and invasion of NSCLC cells via YTHD1/2/3-mediated mechanism. Taken together, our findings highlight an important role of ALKBH5 in regulating TGF-beta/SMAD signaling, and establish a mechanistic interaction of ALKBH5 with TGF-beta R2/SMAD3/SMAD6 for controlling TGF-beta-induced EMT in NSCLCs.	[Sun, Zelong; Su, Zhiyue; Wang, Shengjie; Wang, Zhao; Tong, Xin; Wang, Yuxin; Chen, Xiaoyan; Lei, Zhe; Zhang, Hong-Tao] Soochow Univ, Suzhou Med Coll, Lab Canc Mol Genet, Suzhou, Peoples R China; [Sun, Zelong; Su, Zhiyue; Wang, Zhao; Tong, Xin; Wang, Yuxin; Chen, Xiaoyan; Lei, Zhe; Zhang, Hong-Tao] Soochow Univ, Suzhou Med Coll, Sch Biol & Basic Med Sci, Dept Genet, Suzhou, Peoples R China; [Zhou, Zhengyu] Soochow Univ, Suzhou Med Coll, Lab Anim Ctr, Suzhou, Peoples R China; [Wang, Shengjie] Nanjing Med Univ, Kangda Coll, Dept Basic Med, Lianyungang, Peoples R China; [Li, Chang] Soochow Univ, Affiliated Hosp 1, Suzhou Med Coll, Dept Thorac Surg, Suzhou, Peoples R China; [Zhang, Hong-Tao] Suzhou Key Lab Mol Canc Genet, Suzhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Nanjing Medical University; Soochow University - China	Zhang, HT (corresponding author), Soochow Univ, Med Coll, Lab Canc Mol Genet, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China.	htzhang@suda.edu.cn	Chen, Xiao/GQA-8928-2022; Lei, Zhe/AGZ-4963-2022; Zhang, Hong-Tao/P-9661-2017	Chen, Xiao/0000-0002-9797-8384; Zhang, Hong-Tao/0000-0003-4182-421X	National Natural Science Foundation of China [82073198, 81872343]; Suzhou Key Laboratory for Molecular Cancer Genetics [SZS201209]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou Key Laboratory for Molecular Cancer Genetics; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	We are grateful for participation and cooperation from the patients with NSCLC. Funding was provided by grants from National Natural Science Foundation of China (82073198, 81872343), and Suzhou Key Laboratory for Molecular Cancer Genetics (SZS201209), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen XY, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1033-z; Chen YH, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01239-w; Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Deng XL, 2018, CELL RES, V28, P507, DOI 10.1038/s41422-018-0034-6; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626; Gao YF, 2019, CELL RES, V29, P767, DOI 10.1038/s41422-019-0210-3; Guo XY, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01158-w; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hirsch FR, 2017, LANCET, V389, P299, DOI 10.1016/S0140-6736(16)30958-8; Hua W, 2020, CELL MOL LIFE SCI, V77, P2103, DOI 10.1007/s00018-019-03398-6; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Jeon HS, 2010, J THORAC ONCOL, V5, P417, DOI 10.1097/JTO.0b013e3181ce3afd; Jin D, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01161-1; Jin D, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0830-6; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li XC, 2019, THERANOSTICS, V9, P3853, DOI 10.7150/thno.31868; Li Y, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03763-z; Liu J, 2019, TRENDS CELL BIOL, V29, P487, DOI 10.1016/j.tcb.2019.02.008; Park OH, 2019, MOL CELL, V74, P494, DOI 10.1016/j.molcel.2019.02.034; Pastushenko I, 2019, TRENDS CELL BIOL, V29, P212, DOI 10.1016/j.tcb.2018.12.001; PERRY RP, 1975, CELL, V4, P387, DOI 10.1016/0092-8674(75)90159-2; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Sheng H, 2020, CARCINOGENESIS, V41, P541, DOI 10.1093/carcin/bgz152; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Tang B, 2020, MOL CANCER, V19, DOI 10.1186/s12943-019-1128-6; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tong X, 2020, ONCOGENE, V39, P2890, DOI 10.1038/s41388-020-1189-4; Wang L, 2016, ONCOGENE, V35, P867, DOI 10.1038/onc.2015.141; Wang MY, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.118082; Wang SJ, 2021, EMBO REP, V22, DOI 10.15252/embr.202052079; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Xu YR, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.629560; Yang HP, 2015, LUNG CANCER, V87, P249, DOI 10.1016/j.lungcan.2014.12.015; Zaccara S, 2020, CELL, V181, P1582, DOI 10.1016/j.cell.2020.05.012; Zaccara S, 2019, NAT REV MOL CELL BIO, V20, P608, DOI 10.1038/s41580-019-0168-5; Zhang CZ, 2016, P NATL ACAD SCI USA, V113, pE2047, DOI 10.1073/pnas.1602883113; Zhang J, 2019, J PHYSIOL BIOCHEM, V75, P379, DOI 10.1007/s13105-019-00690-8; Zhang SC, 2017, CANCER CELL, V31, P591, DOI 10.1016/j.ccell.2017.02.013; Zhao W, 2020, MOL THER-NUCL ACIDS, V20, P1, DOI 10.1016/j.omtn.2020.01.033	46	2	2	9	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22283	10.1096/fj.202200005RR	http://dx.doi.org/10.1096/fj.202200005RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ9SF	35344216				2022-12-28	WOS:000773602500001
J	Nanut, MP; Zurga, S; Konjar, S; Prunk, M; Kos, J; Sabotic, J				Nanut, Milica Perisic; Zurga, Simon; Konjar, Spela; Prunk, Mateja; Kos, Janko; Sabotic, Jerica			The fungal Clitocybe nebularis lectin binds distinct cell surface glycoprotein receptors to induce cell death selectively in Jurkat cells	FASEB JOURNAL			English	Article						CD45; cytotoxicity; homotypic aggregation; lectin; T cell leukemia	GROUP BOX-1 PROTEIN; EDIBLE MUSHROOM; CROSS-LINKING; NEGATIVE REGULATION; ANTITUMOR LECTIN; DENDRITIC CELLS; APOPTOSIS; CD45; GLYCOSYLATION; ANTIGEN	Clitocybe nebularis lectin (CNL) is a GalNAc beta 1-4GlcNAc-binding lectin that exhibits an antiproliferative effect exclusively on the Jurkat leukemic T cell line by provoking homotypic aggregation and dose-dependent cell death. Cell death of Jurkat cells exhibited typical features of early apoptosis, but lacked the activation of initiating and executing caspases. None of the features of CNL-induced cell death were effectively blocked with the pan-caspase inhibitor or different cysteine peptidase inhibitors. Furthermore, CNL binding induced Jurkat cells to release the endogenous damage-associated molecular pattern molecule high-mobility group box 1 (HMGB1). A plant lectin with similar glycan-binding specificity, Wisteria floribunda agglutinin (WFA) showed less selective toxicity and induced cell death in Jurkat, Tall-104, and Hut-87 cell lines. HMGB1 release was also detected when Jurkat cells were treated with WFA. We identified the CD45 and CD43 cell surface glycoproteins on Jurkat cells as the main targets for CNL binding. However, the blockade of CD45 phosphatase activity failed to block either CNL-induced homotypic agglutination or cell death. Overall, our results indicate that CNL triggers atypical cell death selectively on Jurkat cells, suggesting the potential applicability of CNL in novel strategies for treating and/or detecting acute T cell leukemia.	[Nanut, Milica Perisic; Zurga, Simon; Konjar, Spela; Prunk, Mateja; Sabotic, Jerica] Jozef Stefan Inst, Dept Biotechnol, Jamova Testa 39, Ljubljana 1000, Slovenia; [Kos, Janko] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana	Sabotic, J (corresponding author), Jozef Stefan Inst, Dept Biotechnol, Jamova Testa 39, Ljubljana 1000, Slovenia.	jerica.sabotic@ijs.si	Konjar, Špela/AAU-6390-2020	Prunk, Mateja/0000-0002-9117-633X; Konjar, Spela/0000-0002-8969-0233; Perisic Nanut, Milica/0000-0003-2314-2733	Research Agency of the Republic of Slovenia [P4-0127]	Research Agency of the Republic of Slovenia(Slovenian Research Agency - Slovenia)	This research was funded by the Research Agency of the Republic of Slovenia, grant number P4-0127 to J.K.	Altin JG, 1997, IMMUNOL CELL BIOL, V75, P430, DOI 10.1038/icb.1997.68; Andersson U, 2018, SEMIN IMMUNOL, V38, P40, DOI 10.1016/j.smim.2018.02.011; Barrows BD, 2006, METHOD ENZYMOL, V417, P340, DOI 10.1016/S0076-6879(06)17021-4; BAZIL V, 1995, BLOOD, V86, P502, DOI 10.1182/blood.V86.2.502.bloodjournal862502; Bovi M, 2013, GLYCOBIOLOGY, V23, P578, DOI 10.1093/glycob/cws164; Brojatsch J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095032; Brown TJ, 1996, J BIOL CHEM, V271, P27686, DOI 10.1074/jbc.271.44.27686; Cermak L, 2002, J BIOL CHEM, V277, P7955, DOI 10.1074/jbc.M108048200; Che MI, 2014, ONCOTARGET, V5, P3673, DOI 10.18632/oncotarget.1981; Cho JY, 2003, EXP CELL RES, V290, P155, DOI 10.1016/S0014-4827(03)00322-7; Dang AM, 1996, CELL IMMUNOL, V169, P196, DOI 10.1006/cimm.1996.0110; Degryse B, 2001, J CELL BIOL, V152, P1197, DOI 10.1083/jcb.152.6.1197; Dumitriu IE, 2005, TRENDS IMMUNOL, V26, P381, DOI 10.1016/j.it.2005.04.009; Erbacher A, 2009, HUM IMMUNOL, V70, P308, DOI 10.1016/j.humimm.2009.02.005; Esko JD., 1999, ESSENTIALS GLYCOBIOL, P375; Fukushima K, 2010, GLYCOBIOLOGY, V20, P452, DOI 10.1093/glycob/cwp197; Gotoh M, 2004, FEBS LETT, V562, P134, DOI 10.1016/S0014-5793(04)00219-4; Haji-Ghassemi O, 2016, J BIOL CHEM, V291, P24085, DOI 10.1074/jbc.M116.750463; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hassan MAA, 2015, INT J MOL SCI, V16, P7802, DOI 10.3390/ijms16047802; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hirano K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/981627; Huang J, 2007, MOL CANCER RES, V5, P543, DOI 10.1158/1541-7786.MCR-06-0431; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; Irie-Sasaki J, 2003, CURR TOP MED CHEM, V3, P783, DOI 10.2174/1568026033452339; Jacobson LS, 2013, J BIOL CHEM, V288, P7481, DOI 10.1074/jbc.M112.400655; Karmakar S, 2008, GLYCOBIOLOGY, V18, P770, DOI 10.1093/glycob/cwn066; KAWAGISHI H, 1990, BIOCHIM BIOPHYS ACTA, V1034, P247, DOI 10.1016/0304-4165(90)90045-X; Kim HJ, 2006, EXP MOL MED, V38, P357, DOI 10.1038/emm.2006.42; Klaus SJ, 1996, J IMMUNOL, V156, P2743; Koyama Y, 2002, BIOSCI BIOTECH BIOCH, V66, P784, DOI 10.1271/bbb.66.784; Lesage S, 1997, J IMMUNOL, V159, P4762; Li J, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2298-2; LIN JY, 1984, J BIOCHEM, V96, P35, DOI 10.1093/oxfordjournals.jbchem.a134826; Liu J, 2020, CANCER GENE THER, V27, P267, DOI 10.1038/s41417-019-0134-6; Liu YD, 2017, J BIOL CHEM, V292, P3186, DOI 10.1074/jbc.M116.751685; Machado E, 2011, GLYCOBIOLOGY, V21, P376, DOI 10.1093/glycob/cwq170; MANJUNATH N, 1995, NATURE, V377, P535, DOI 10.1038/377535a0; Manzella SM, 1996, J BIOL CHEM, V271, P12117, DOI 10.1074/jbc.271.21.12117; Mitola S, 2006, J IMMUNOL, V176, P12, DOI 10.4049/jimmunol.176.1.12; MODY R, 1995, J PHARMACOL TOX MET, V33, P1, DOI 10.1016/1056-8719(94)00052-6; Muramatsu T, 2002, SCIENCE, V295, P53, DOI 10.1126/science.1068156; Park WS, 2004, TISSUE ANTIGENS, V63, P46, DOI 10.1111/j.1399-0039.2004.00151.x; Peracaula R, 2003, GLYCOBIOLOGY, V13, P227, DOI 10.1093/glycob/cwg019; Pereira MS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02754; Pericolini E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012720; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Perron M, 2018, MOL PHARMACOL, V93, P575, DOI 10.1124/mol.117.110908; Pohleven J, 2012, J BIOL CHEM, V287, P10602, DOI 10.1074/jbc.M111.317263; Pohleven J, 2009, BBA-GEN SUBJECTS, V1790, P173, DOI 10.1016/j.bbagen.2008.11.006; Sabotic J, 2019, MOLECULES, V24, DOI 10.3390/molecules24234204; Sato T, 2017, GLYCOBIOLOGY, V27, P743, DOI 10.1093/glycob/cwx038; Sawai H, 2011, BIOCHEM BIOPH RES CO, V411, P569, DOI 10.1016/j.bbrc.2011.06.186; Schietinger A, 2008, SEMIN IMMUNOL, V20, P276, DOI 10.1016/j.smim.2008.07.001; SPERTINI F, 1994, J IMMUNOL, V153, P1593; Steff AM, 2003, CRIT REV IMMUNOL, V23, P421, DOI 10.1615/CritRevImmunol.v23.i56.40; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Van Dyken SJ, 2007, MOL CELL BIOL, V27, P1096, DOI 10.1128/MCB.01750-06; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Xu YF, 2005, IMMUNOL CELL BIOL, V83, P440, DOI 10.1111/j.1440-1711.2005.01347.x; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Yang N, 2009, J MOL BIOL, V387, P694, DOI 10.1016/j.jmb.2009.02.002; YU LG, 1993, CANCER RES, V53, P4627; Yu LG, 2007, GLYCOCONJUGATE J, V24, P411, DOI 10.1007/s10719-007-9034-3; YUAN M, 1986, CANCER RES, V46, P4841; Zhao CG, 2003, BIOCHEM J, V374, P321, DOI 10.1042/BJ20030300; Zurga S, 2017, ONCOTARGET, V8, P26896, DOI 10.18632/oncotarget.15849	69	2	2	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22215	10.1096/fj.202101056RR	http://dx.doi.org/10.1096/fj.202101056RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0DF	35224765				2022-12-28	WOS:000772946900001
J	Li, JH; Forghani, R; Bure, L; Wojtkiewicz, GR; Wu, Y; Iwamoto, Y; Ali, M; Li, AN; Wang, CH; Motlagh, NJ; Papadakis, AI; Pusztaszeri, MP; Spatz, A; Curtin, H; Cheng, YS; Chen, O				Li, Jing-Hui; Forghani, Reza; Bure, Lionel; Wojtkiewicz, Gregory R.; Wu, Yue; Iwamoto, Yoshiko; Ali, Muhammad; Li, Anning; Wang, Cuihua; Motlagh, Negin Jalali; Papadakis, Andreas, I; Pusztaszeri, Marc P.; Spatz, Alan; Curtin, Hugh; Cheng, Ying-Sheng; Chen, John W.			Molecular immuno-imaging improves tumor detection in head and neck cancer	FASEB JOURNAL			English	Article						head and neck squamous cell carcinoma; inflammation; magnetic resonance imaging; molecular imaging; myeloperoxidase	MYELOPEROXIDASE ACTIVITY; SUPEROXIDE-DISMUTASE; ORAL-CAVITY; CELL; NEUTROPHILS; CARCINOGENESIS; INFILTRATION; PEROXIDASE; EXPRESSION; SURVIVAL	Detection and accurate delineation of tumor is important for the management of head and neck squamous cell carcinoma (HNSCC) but is challenging with current imaging techniques. In this study, we evaluated whether molecular immuno-imaging targeting myeloperoxidase (MPO) activity, an oxidative enzyme secreted by many myeloid innate immune cells, would be superior in detecting tumor extent compared to conventional contrast agent (DTPA-Gd) in a carcinogen-induced immunocompetent HNSCC murine model and corroborated in human surgical specimens. In C57BL/6 mice given 4-nitroquinoline-N-oxide (4-NQO), there was increased MPO activity in the head and neck region as detected by luminol bioluminescence compared to that of the control group. On magnetic resonance imaging, the mean enhancing volume detected by the MPO-targeting agent (MPO-Gd) was higher than that by the conventional agent DTPA-Gd. The tumor volume detected by MPO-Gd strongly correlated with tumor size on histology, and higher MPO-Gd signal corresponded to larger tumor size found by imaging and histology. On the contrary, the tumor volume detected by DTPA-Gd did not correlate as well with tumor size on histology. Importantly, MPO-Gd imaging detected areas not visualized with DTPA-Gd imaging that were confirmed histopathologically to represent early tumor. In human specimens, MPO was similarly associated with tumors, especially at the tumor margins. Thus, molecular immuno-imaging targeting MPO not only detects oxidative immune response in HNSCC, but can better detect and delineate tumor extent than nonselective imaging agents. Thus, our findings revealed that MPO imaging could improve tumor resection as well as be a useful imaging biomarker for tumor progression, and potentially improve clinical management of HNSCC once translated.	[Li, Jing-Hui; Forghani, Reza; Bure, Lionel; Wojtkiewicz, Gregory R.; Wu, Yue; Iwamoto, Yoshiko; Ali, Muhammad; Li, Anning; Wang, Cuihua; Motlagh, Negin Jalali; Chen, John W.] Harvard Med Sch, Dept Radiol, Massachusetts Gen Hosp, Inst Innovat Imaging, 10-114 Bldg 149 CNY, Boston, MA 02129 USA; [Li, Jing-Hui; Forghani, Reza; Bure, Lionel; Wojtkiewicz, Gregory R.; Wu, Yue; Iwamoto, Yoshiko; Ali, Muhammad; Li, Anning; Wang, Cuihua; Motlagh, Negin Jalali; Chen, John W.] Harvard Med Sch, Ctr Syst Biol, Massachusetts Gen Hosp, 10-114 Bldg 149 CNY, Boston, MA 02129 USA; [Li, Jing-Hui] Peking Union Med Coll & Chinese Acad Med Sci, FuWai Hosp, Dept Magnet Resonance Imaging, Beijing, Peoples R China; [Forghani, Reza] McGill Univ, Dept Radiol, Augmented Intelligence & Precis Hlth Lab AIPHL, Res Inst,Hlth Ctr, Montreal, PQ, Canada; [Forghani, Reza] Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ, Canada; [Forghani, Reza] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Papadakis, Andreas, I; Pusztaszeri, Marc P.; Spatz, Alan] Jewish Gen Hosp, Dept Pathol, Montreal, PQ, Canada; [Papadakis, Andreas, I; Pusztaszeri, Marc P.; Spatz, Alan] McGill Univ, Montreal, PQ, Canada; [Curtin, Hugh] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Radiol, Boston, MA 02129 USA; [Cheng, Ying-Sheng] Shanghai Jiao Tong Univ, Dept Radiol, Affiliated Peoples Hosp 6, Shanghai, Peoples R China; [Wu, Yue] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Radiol, Shanghai, Peoples R China; [Li, Anning] Shandong Univ, Qilu Hosp, Dept Radiol, Jinan, Peoples R China	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; McGill University; McGill University; Lady Davis Institute; McGill University; McGill University; McGill University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Shanghai Jiao Tong University; Fudan University; Shandong University	Chen, O (corresponding author), Harvard Med Sch, Dept Radiol, Massachusetts Gen Hosp, Inst Innovat Imaging, 10-114 Bldg 149 CNY, Boston, MA 02129 USA.; Chen, O (corresponding author), Harvard Med Sch, Ctr Syst Biol, Massachusetts Gen Hosp, 10-114 Bldg 149 CNY, Boston, MA 02129 USA.	jwchen@mgh.harvard.edu	; Pusztaszeri, Marc/AFT-1929-2022	Spatz, Alan/0000-0003-3020-1420; Forghani, Reza/0000-0002-8572-1864; Pusztaszeri, Marc/0000-0001-6490-4189	National Institutes of Health [R01-NS103998]; National Natural Science Foundation of China [51873107]; FRQS (Fonds de recherche en sante du Quebec)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); FRQS (Fonds de recherche en sante du Quebec)	This work was funded by the National Institutes of Health (R01-NS103998) and the National Natural Science Foundation of China (51873107). R.F. is a clinical research scholar supported by the FRQS (Fonds de recherche en sante du Quebec)	Breckwoldt MO, 2008, P NATL ACAD SCI USA, V105, P18584, DOI 10.1073/pnas.0803945105; Brouwer CL, 2015, RADIOTHER ONCOL, V117, P83, DOI 10.1016/j.radonc.2015.07.041; Chen JW, 2008, BRAIN, V131, P1123, DOI 10.1093/brain/awn004; Chen JW, 2006, RADIOLOGY, V240, P473, DOI 10.1148/radiol.2402050994; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Dasgupta S, 2012, J CELL PHYSIOL, V227, P467, DOI 10.1002/jcp.22767; Droeser RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064814; Eruslanov EB, 2014, J CLIN INVEST, V124, P5466, DOI 10.1172/JCI77053; Escott EJ, 2013, RADIOL CLIN N AM, V51, P881, DOI 10.1016/j.rcl.2013.05.002; Forghani R, 2015, J CEREBR BLOOD F MET, V35, P485, DOI 10.1038/jcbfm.2014.222; Forghani R, 2012, RADIOLOGY, V263, P451, DOI 10.1148/radiol.12111593; Fu TY, 2011, HEAD NECK-J SCI SPEC, V33, P1606, DOI 10.1002/hed.21653; Golusinski W, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00293; Gomez-Mejiba SE, 2010, J BIOL CHEM, V285, P20062, DOI 10.1074/jbc.M109.086579; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Harrison LB, 2013, HEAD NECK CANC MULTI, V4th; Hornes A, 2010, J AM CHEM SOC, V132, P34, DOI 10.1021/ja9089846; Jaillon S, 2020, NAT REV CANCER, V20, P485, DOI 10.1038/s41568-020-0281-y; Jucaite A, 2015, BRAIN, V138, P2687, DOI 10.1093/brain/awv184; Kim T, 2011, J SURG ONCOL, V103, P179, DOI 10.1002/jso.21784; Kleijn A, 2011, CLIN CANCER RES, V17, P4484, DOI 10.1158/1078-0432.CCR-11-0575; Lai WM, 2013, OR SURG OR MED OR PA, V116, P464, DOI 10.1016/j.oooo.2013.06.018; Lassen P, 2009, J CLIN ONCOL, V27, P1992, DOI 10.1200/JCO.2008.20.2853; LeBlanc BJ, 2015, JAMA OTOLARYNGOL, V141, P169, DOI 10.1001/jamaoto.2014.2998; Li C, 2019, CANCER MANAG RES, V11, P5171, DOI 10.2147/CMAR.S202465; Lu SL, 2006, HEAD NECK-J SCI SPEC, V28, P945, DOI 10.1002/hed.20397; Meng QT, 2018, CANCER RES, V78, P2760, DOI 10.1158/0008-5472.CAN-17-2538; Mirza AH, 2019, HEAD NECK-J SCI SPEC, V41, P2789, DOI 10.1002/hed.25716; Nahrendorf M, 2008, CIRCULATION, V117, P1153, DOI 10.1161/CIRCULATIONAHA.107.756510; Querol M, 2005, ORG LETT, V7, P1719, DOI 10.1021/ol050208v; Roncucci L, 2008, CANCER EPIDEM BIOMAR, V17, P2291, DOI 10.1158/1055-9965.EPI-08-0224; Rymaszewski AL, 2014, CANCERS, V6, P1111, DOI 10.3390/cancers6021111; Salim DK, 2015, MOL CLIN ONCOL, V3, P839, DOI 10.3892/mco.2015.557; Shaul ME, 2019, NAT REV CLIN ONCOL, V16, P601, DOI 10.1038/s41571-019-0222-4; Shenoi MM, 2011, NANOMEDICINE-UK, V6, P545, DOI [10.2217/nnm.10.153, 10.2217/NNM.10.153]; Stambuk HE, 2007, RADIOL CLIN N AM, V45, P1, DOI 10.1016/j.rcl.2006.10.010; Swirski FK, 2010, J CLIN INVEST, V120, P2627, DOI 10.1172/JCI42304; Tan XM, 2015, CANCER CAUSE CONTROL, V26, P111, DOI 10.1007/s10552-014-0490-3; Tang XH, 2004, CLIN CANCER RES, V10, P301, DOI 10.1158/1078-0432.CCR-0999-3; Thakare Eesha, 2013, J Oral Maxillofac Pathol, V17, P374, DOI 10.4103/0973-029X.125202; Wheatley-Price P, 2008, CANCER-AM CANCER SOC, V112, P1037, DOI 10.1002/cncr.23267; Yang B, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00563; Zhang X, 2016, INT J ONCOL, V49, P857, DOI 10.3892/ijo.2016.3616; Zhang YN, 2016, RADIOLOGY, V278, P822, DOI 10.1148/radiol.2015141922	44	0	0	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22092	10.1096/fj.202100864R	http://dx.doi.org/10.1096/fj.202100864R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34919761				2022-12-28	WOS:000734992000008
J	Baraldo, M; Nogara, L; Dumitras, GA; Dondjang, AHT; Geremia, A; Scalabrin, M; Turk, C; Telkamp, F; Zentilin, L; Giacca, M; Kruger, M; Blaauw, B				Baraldo, Martina; Nogara, Leonardo; Dumitras, Georgia Ana; Tchampda Dondjang, Achille Homere; Geremia, Alessia; Scalabrin, Marco; Turk, Clara; Telkamp, Frederik; Zentilin, Lorena; Giacca, Mauro; Kruger, Marcus; Blaauw, Bert			Raptor is critical for increasing the mitochondrial proteome and skeletal muscle force during hypertrophy	FASEB JOURNAL			English	Article						hypertrophy; mitochondria; mTOR; rapamycin; Raptor; skeletal muscle	PATHWAY; GROWTH; REGENERATION; ABLATION; RICTOR; 4E-BP1	Loss of skeletal muscle mass and force is of critical importance in numerous pathologies, like age-related sarcopenia or cancer. It has been shown that the Akt-mTORC1 pathway is critical for stimulating adult muscle mass and function, however, it is unknown if mTORC1 is the only mediator downstream of Akt and which intracellular processes are required for functional muscle growth. Here, we show that loss of Raptor reduces muscle hypertrophy after Akt activation and completely prevents increases in muscle force. Interestingly, the residual hypertrophy after Raptor deletion can be completely prevented by administration of the mTORC1 inhibitor rapamycin. Using a quantitative proteomics approach we find that loss of Raptor affects the increases in mitochondrial proteins, while rapamycin mainly affects ribosomal proteins. Taken together, these results suggest that mTORC1 is the key mediator of Akt-dependent muscle growth and its regulation of the mitochondrial proteome is critical for increasing muscle force.	[Baraldo, Martina; Nogara, Leonardo; Geremia, Alessia; Blaauw, Bert] Venetian Inst Mol Med VIMM, Via Orus 2, I-35129 Padua, Italy; [Baraldo, Martina; Nogara, Leonardo; Dumitras, Georgia Ana; Tchampda Dondjang, Achille Homere; Geremia, Alessia; Scalabrin, Marco; Blaauw, Bert] Univ Padua, Dept Biomed Sci, Padua, Italy; [Turk, Clara; Telkamp, Frederik; Kruger, Marcus] Univ Cologne, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Zentilin, Lorena] Int Ctr Genet Engn & Biotechnol ICGEB, AAV Vector Unit, Trieste, Italy; [Giacca, Mauro] Kings Coll London, Sch Cardiovasc Med & Sci, British Heart Fdn Ctr Res Excellence, London, England; [Kruger, Marcus] Univ Cologne, Ctr Mol Med CMMC, Cologne, Germany	Veneto Institute Molecular Medicine; University of Padua; University of Cologne; International Center for Genetic Engineering & Biotechnology (ICGEB); University of London; King's College London; University of Cologne	Blaauw, B (corresponding author), Venetian Inst Mol Med VIMM, Via Orus 2, I-35129 Padua, Italy.; Blaauw, B (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	bert.blaauw@unipd.it	Tellkamp, Frederik/D-8027-2014	Tellkamp, Frederik/0000-0002-0473-7320; BLAAUW, BERT/0000-0002-4167-5106; BARALDO, MARTINA/0000-0002-3838-0526	Associazione Italiana per la Ricerca sul Cancro (AIRC) [20406]; Association Francaise contre les Myopathies (AFM) [21865]; University of Padova	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); University of Padova	Associazione Italiana per la Ricerca sul Cancro (AIRC), Grant/Award Number: 20406; Association Francaise contre les Myopathies (AFM), Grant/Award Number: 21865; University of Padova	Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Baraldo M, 2020, J CACHEXIA SARCOPENI, V11, P208, DOI 10.1002/jcsm.12496; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Blaauw B, 2010, J APPL PHYSIOL, V108, P105, DOI 10.1152/japplphysiol.00803.2009; Blaauw B, 2009, FASEB J, V23, P3896, DOI 10.1096/fj.09-131870; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Goncalves DA, 2019, J CACHEXIA SARCOPENI, V10, P455, DOI 10.1002/jcsm.12395; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Kallabis S, 2020, SKELET MUSCLE, V10, DOI 10.1186/s13395-020-00226-5; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Lossie J, 2014, BIOCHEM BIOPH RES CO, V450, P464, DOI 10.1016/j.bbrc.2014.05.142; Marabita M, 2016, CELL REP, V17, P501, DOI 10.1016/j.celrep.2016.09.020; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Nolte H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31154-6; Ogasawara R, 2018, FASEB J, V32, P5824, DOI 10.1096/fj.201701422R; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Pansters NAM, 2015, BBA-MOL BASIS DIS, V1852, P490, DOI 10.1016/j.bbadis.2014.12.006; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; Pereira MG, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00963; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Raffaello A, 2010, J CELL BIOL, V191, P101, DOI 10.1083/jcb.201001136; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Wang Y, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00591-0; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; You JS, 2019, FASEB J, V33, P4021, DOI 10.1096/fj.201801653RR; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008	35	6	6	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22031	10.1096/fj.202101054RR	http://dx.doi.org/10.1096/fj.202101054RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34767636				2022-12-28	WOS:000722321300009
J	Gauhar, A; Privezentzev, CV; Demydchuk, M; Gerlza, T; Rieger, J; Kungl, AJ; Walsh, FS; Rutkowski, JL; Stocki, P				Gauhar, Aziz; Privezentzev, Cyril, V; Demydchuk, Mykhaylo; Gerlza, Tanja; Rieger, Julia; Kungl, Andreas J.; Walsh, Frank S.; Rutkowski, J. Lynn; Stocki, Pawel			Single domain shark VNAR antibodies neutralize SARS-CoV-2 infection in vitro	FASEB JOURNAL			English	Article						COVID-19; neutralizing antibody; SARS-CoV-2; single domain antibody; VNAR	RECEPTOR-BINDING DOMAIN; PROTEIN; ACE2	Single domain shark variable domain of new antigen receptor (VNAR) antibodies can offer a viable alternative to conventional Ig-based monoclonal antibodies in treating COVID-19 disease during the current pandemic. Here we report the identification of neutralizing single domain VNAR antibodies selected against the severe acute respiratory syndrome coronavirus 2 spike protein derived from the Wuhan variant using phage display. We identified 56 unique binding clones that exhibited high affinity and specificity to the spike protein. Of those, 10 showed an ability to block both the spike protein receptor binding domain from the Wuhan variant and the N501Y mutant from interacting with recombinant angiotensin-converting enzyme 2 (ACE2) receptor in vitro. In addition, three antibody clones retained in vitro blocking activity when the E484K spike protein mutant was used. The inhibitory property of the VNAR antibodies was further confirmed for all 10 antibody clones using ACE2 expressing cells with spike protein from the Wuhan variant. The viral neutralizing potential of the VNAR clones was also confirmed for the 10 antibodies tested using live Wuhan variant virus in in vitro cell infectivity assays. Single domain VNAR antibodies, due to their low complexity, small size, unique epitope recognition, and formatting flexibility, should be a useful adjunct to existing antibody approaches to treat COVID-19.	[Gauhar, Aziz; Privezentzev, Cyril, V; Demydchuk, Mykhaylo; Walsh, Frank S.; Rutkowski, J. Lynn; Stocki, Pawel] Ossianix Inc, Stevenage Biosci Catalyst, Gunnels Wood Rd, Stevenage SG1 2FX, Herts, England; [Gauhar, Aziz; Privezentzev, Cyril, V; Demydchuk, Mykhaylo; Walsh, Frank S.; Rutkowski, J. Lynn; Stocki, Pawel] Ossianix Inc, Philadelphia, PA USA; [Gerlza, Tanja; Kungl, Andreas J.] Karl Franzens Univ Graz, Inst Pharmaceut Sci, Graz, Austria; [Rieger, Julia] Med Univ Graz, Inst Pathol, Graz, Austria	University of Graz; Medical University of Graz	Stocki, P (corresponding author), Ossianix Inc, Stevenage Biosci Catalyst, Gunnels Wood Rd, Stevenage SG1 2FX, Herts, England.	pawel@ossianix.com	Gerlza, Tanja/ABF-3562-2021	Gerlza, Tanja/0000-0003-4947-9721; Kungl, Andreas/0000-0003-3362-797X	Pennsylvania Department of Community and Economic Development (DCED) [CV19-VTT]; Karl-Franzens-Universitat Graz (Universitat Graz) [COVID-19]	Pennsylvania Department of Community and Economic Development (DCED); Karl-Franzens-Universitat Graz (Universitat Graz)	Pennsylvania Department of Community and Economic Development (DCED), Grant/Award Number: CV19-VTT; Karl-Franzens-Universitat Graz (Universitat Graz), Grant/Award Number: COVID-19	Al Qaraghuli MM, 2017, J MOL RECOGNIT, V30, DOI 10.1002/jmr.2592; Amraei Razie, 2021, ACS Cent Sci, V7, P1156, DOI [10.1101/2020.06.22.165803, 10.1021/acscentsci.0c01537]; Avanzato VA, 2020, CELL, V183, P1901, DOI 10.1016/j.cell.2020.10.049; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Baum A, 2020, SCIENCE, V370, P1110, DOI 10.1126/science.abe2402; Baum A, 2020, SCIENCE, V369, P1014, DOI 10.1126/science.abd0831; Bradley AJ, 1999, BBA-BIOMEMBRANES, V1418, P19, DOI 10.1016/S0005-2736(99)00013-9; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Chi XJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18387-8; Choi B, 2020, NEW ENGL J MED, V383, P2291, DOI 10.1056/NEJMc2031364; Clover Biopharmaceuticals, 2021, COVID 19 VACCINE PLA; Duchene S, 2020, VIRUS EVOL, V6, DOI 10.1093/ve/veaa061; Gao Chao, 2020, bioRxiv, DOI 10.1101/2020.07.29.227462; Greaney AJ, 2021, CELL HOST MICROBE, V29, P44, DOI 10.1016/j.chom.2020.11.007; Gu HJ, 2020, SCIENCE, V369, P1603, DOI 10.1126/science.abc4730; Hanke L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18174-5; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Hasler J., 2017, US patent, Patent No. [10,479,990, 10479990]; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hoffmann M, 2020, MOL CELL, V78, P779, DOI 10.1016/j.molcel.2020.04.022; Jeyanathan M, 2020, NAT REV IMMUNOL, V20, P615, DOI 10.1038/s41577-020-00434-6; Krammer F, 2020, NATURE, V586, P516, DOI 10.1038/s41586-020-2798-3; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1101/2020.01.22.915660, 10.1038/s41564-020-0688-y]; Lilly Eli., 2020, NEWS RELEASE LILLY A; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Liu Zhuoming, 2021, bioRxiv, DOI 10.1101/2020.11.06.372037; M. H. Cheng, 2021, bioRxiv, DOI 10.1101/2021.01.10.426143; Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n296; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Rambaut A., 2020, BEHALF COVID 19 GENO; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Tai WB, 2020, CELL MOL IMMUNOL, V17, P613, DOI 10.1038/s41423-020-0400-4; Tegally H, 2020, MEDRXIV, DOI [10.1101/2020.12.21.20248640, DOI 10.1101/2020.12.21.20248640]; Vaccine Centre L. S. o. H. a. T. M, 2021, COVID 19 VACCINE DEV; Wang YJ, 2020, P NATL ACAD SCI USA, V117, P13967, DOI 10.1073/pnas.2008209117; Wang Zijun, 2021, Nature, V592, P616, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Weisblum Y, 2020, ELIFE, V9, DOI 10.7554/eLife.61312; Wrapp D, 2020, CELL, V181, P1436, DOI 10.1016/j.cell.2020.05.047; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu Kai, 2021, bioRxiv, DOI 10.1101/2021.01.25.427948; Wu YL, 2020, CELL HOST MICROBE, V27, P891, DOI 10.1016/j.chom.2020.04.023; Xie XP, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01270-4, 10.1101/2021.01.27.427998]; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yang Lifei, 2020, Antib Ther, V3, P205, DOI 10.1093/abt/tbaa020; Yi CY, 2020, CELL MOL IMMUNOL, V17, P621, DOI 10.1038/s41423-020-0458-z; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zielonka S, 2015, MABS-AUSTIN, V7, P15, DOI 10.4161/19420862.2015.989032	52	4	5	3	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21970	10.1096/fj.202100986RR	http://dx.doi.org/10.1096/fj.202100986RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34637549	Green Submitted, Green Published			2022-12-28	WOS:000712009200003
J	Takakura, Y; Hori, N; Terada, N; Machida, M; Yamaguchi, N; Takano, H; Yamaguchi, N				Takakura, Yuki; Hori, Naoto; Terada, Natsumi; Machida, Moeka; Yamaguchi, Naoto; Takano, Hiroyuki; Yamaguchi, Noritaka			VGLL3 activates inflammatory responses by inducing interleukin-1 alpha secretion	FASEB JOURNAL			English	Article						IL-1; inflammation; NF-KB; signal transduction; TGF-beta	NF-KAPPA-B; TGF-BETA; GENE-EXPRESSION; VESTIGIAL-LIKE; GASDERMIN D; IKK-ALPHA; CANCER; PATHWAY; TRANSCRIPTION; PROLIFERATION	Vestigial-like family member 3 (VGLL3), a member of the vestigial-like family, is a cofactor of the TEA-domain-containing transcription factor (TEAD). Although elevation in VGLL3 expression is associated with inflammatory diseases, such as inflammatory sarcomas and autoimmune diseases, the molecular mechanisms underlying VGLL3-mediated inflammation remain largely unknown. In this study, we analyzed the relationship between elevated VGLL3 expression and the levels of NF-kappa B, a transcription factor that plays a pivotal role in inflammation. NF-kappa B was found to be activated in a cell line stably expressing VGLL3. Mechanistically, VGLL3 was shown to promote the expression and secretion of the potent NF-kappa B-activating cytokine interleukin (IL)-1 alpha, probably through its association with TEADs. As VGLL3 is a target of transforming growth factor beta (TGF-beta) signaling, we analyzed IL-1 alpha induction upon TGF-beta stimulation. TGF-beta stimulation was observed to induce IL-1 alpha secretion and NF-kappa B activation, and VGLL3 was associated with this phenomenon. The TGF-beta transcription factors Smad3 and Smad4 were shown to be necessary for inducing VGLL3 and IL-1 alpha expression. Lastly, we found that VGLL3-dependent IL-1 alpha secretion is involved in constitutive NF-kappa B activation in highly malignant breast cancer cells. Collectively, the findings suggested that VGLL3 expression and TGF-beta stimulation activate the inflammatory response by inducing IL-1 alpha secretion.	[Takakura, Yuki; Hori, Naoto; Machida, Moeka; Yamaguchi, Naoto; Yamaguchi, Noritaka] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Mol Cell Biol, Chiba, Japan; [Hori, Naoto; Terada, Natsumi; Machida, Moeka; Takano, Hiroyuki; Yamaguchi, Noritaka] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cardiovasc Pharmacol, Chiba, Japan	Chiba University; Chiba University	Yamaguchi, N (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cardiovasc Pharmacol, Chuo Ku, Inohana 1-8-1, Chiba 2608675, Japan.	yamaguchinoritaka@chiba-u.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [19K22482, 21K06543]; Takeda Science Foundation; Foundation for Promotion of Cancer	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Foundation for Promotion of Cancer	Japanese Ministry of Education, Culture, Sports, Science and Technology, Grant/Award Number: 19K22482 and 21K06543; Takeda Science Foundation; Foundation for Promotion of Cancer	Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Agata Y, 2001, J EXP MED, V193, P873, DOI 10.1084/jem.193.7.873; Arbajian E, 2020, GENE CHROMOSOME CANC, V59, P309, DOI 10.1002/gcc.22832; Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Balzer MS, 2020, CELL SIGNAL, V75, DOI 10.1016/j.cellsig.2020.109778; Billi AC, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127291; Brandl M, 2010, J CELL SCI, V123, P4231, DOI 10.1242/jcs.071100; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7; David CJ, 2018, NAT REV MOL CELL BIO, V19, P419, DOI 10.1038/s41580-018-0007-0; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Di Paolo NC, 2016, NAT IMMUNOL, V17, P906, DOI 10.1038/ni.3503; Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Freudlsperger C, 2013, ONCOGENE, V32, P1549, DOI 10.1038/onc.2012.171; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Hogan KA, 2013, CYTOKINE, V64, P652, DOI 10.1016/j.cyto.2013.09.004; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Hori N, 2020, J BIOL CHEM, V295, P8798, DOI 10.1074/jbc.RA120.012781; Ieremia E, 2014, ARCH PATHOL LAB MED, V138, P1406, DOI 10.5858/arpa.2013-0549-RS; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; Liang Y, 2017, NAT IMMUNOL, V18, P152, DOI 10.1038/ni.3643; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lopez-Rovira T, 2000, J BIOL CHEM, V275, P28937, DOI 10.1074/jbc.M909923199; Luo K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022137; Malik A, 2018, IMMUNOL REV, V281, P124, DOI 10.1111/imr.12615; Mao RF, 2011, CELL SIGNAL, V23, P222, DOI 10.1016/j.cellsig.2010.09.006; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Mielcarek M, 2009, GENE EXPR PATTERNS, V9, P129, DOI 10.1016/j.gep.2008.12.002; Miyazawa K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022095; Pagenkopf A, 2020, FEBS LETT, V594, P3371, DOI 10.1002/1873-3468.13911; Perez LG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16363-w; Sanjabi S, 2009, CURR OPIN PHARMACOL, V9, P447, DOI 10.1016/j.coph.2009.04.008; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Simon E, 2016, DEV GENES EVOL, V226, P297, DOI 10.1007/s00427-016-0546-3; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vidakovic AT, 2015, CELL REP, V13, P2480, DOI 10.1016/j.celrep.2015.11.040; Yamaguchi N, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01266; Yamaguchi N, 2017, J BIOL CHEM, V292, P8136, DOI 10.1074/jbc.M116.763276; Yamaguchi N, 2015, BIOCHEM J, V471, P67, DOI 10.1042/BJ20150372; Yamaguchi N, 2009, CANCER SCI, V100, P1668, DOI 10.1111/j.1349-7006.2009.01228.x; Zhang L, 2013, MOL CELL, V51, P559, DOI 10.1016/j.molcel.2013.07.014; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012; Zhang Y, 2014, CLIN EXP PHARMACOL P, V41, P921, DOI 10.1111/1440-1681.12294; Zhou YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010138	50	4	4	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21996	10.1096/fj.202100679RR	http://dx.doi.org/10.1096/fj.202100679RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34679187				2022-12-28	WOS:000712009200051
J	Zhou, SX; Xie, JG; Yu, CP; Feng, ZS; Cheng, K; Ma, JC; Wang, YL; Duan, CJ; Zhang, Y; Jin, BQ; Yin, W; Zhuang, R				Zhou, Shangxun; Xie, Jiangang; Yu, Chaoping; Feng, Zhusheng; Cheng, Kun; Ma, Jingchang; Wang, Yuling; Duan, Chujun; Zhang, Yuan; Jin, Boquan; Yin, Wen; Zhuang, Ran			CD226 deficiency promotes glutaminolysis and alleviates mitochondria damage in vascular endothelial cells under hemorrhagic shock	FASEB JOURNAL			English	Article						CD226; energy metabolism; hemorrhagic shock; HUVEC; hypoxia	ACUTE LUNG INJURY; RESUSCITATION; PLASMA; LACTATE; HIF-1-ALPHA; ACTIVATION; SYNDECAN-1; BALANCE; PATHWAY; MODEL	Hemorrhagic shock (HS) is common in clinical emergencies, leading to millions of deaths each year globally. CD226 is a costimulatory adhesion molecule expressed on both immune cells and endothelial cells (ECs) to regulate their metabolic activity and function. As endothelial dysfunction occurs after HS, the roles CD226 plays in vascular EC metabolism were investigated. CD226(fl/fl) Tek(cre) mice were adopted to achieve vascular EC-specific knockout of CD226, and subjected to HS modelling. Serum levels of crucial intermediate metabolites were evaluated through liquid chromatography-mass spectrometry analysis. Human umbilical vein ECs (HUVECs) were used to study the effects of CD226 under hypoxia in vitro. Seahorse analysis evaluated the cellular glycolysis and mitochondria bioenergetics. Results showed that CD226 deficiency in vascular ECs alleviated HS-induced intestinal damage and inflammatory response in mice. Animal studies indicated an improved energy metabolism when CD226 was knocked out in ECs after HS, as evidenced by enhanced glutamine-glutamate metabolism and decreased lactic acid levels. Glut-1 was upregulated in mouse vascular ECs after HS and HUVECs under hypoxia, combined with decreased CD226. Moreover, HUVECs with CD226 knockdown exhibited relieved mitochondrial damage and early apoptosis under hypoxia, whereas CD226 overexpression showed opposite effects. Seahorse analysis showed that downregulated CD226 significantly increased mitochondrial ATP production and glucose uptake in HUVECs under hypoxia. Additionally, Erk/PHD2 signaling-mediated HIF-1 alpha/Glut-1 and HIF-2 alpha/ASCT2 pathways were involved in CD226 regulation on HUVEC glutaminolysis after hypoxia. Hence, CD226 deficiency promotes bypass energy supply to vascular ECs under ischemic or hypoxic stress, to ameliorate the stress-mediated metabolic disturbance.	[Zhou, Shangxun; Xie, Jiangang; Yu, Chaoping; Cheng, Kun; Ma, Jingchang; Wang, Yuling; Jin, Boquan; Zhuang, Ran] Fourth Mil Med Univ, Dept Immunol, 169 West Changle Rd, Xian 710032, Shaanxi, Peoples R China; [Zhou, Shangxun; Xie, Jiangang; Yu, Chaoping; Feng, Zhusheng; Duan, Chujun; Yin, Wen] Fourth Mil Med Univ, Xijing Hosp, Dept Emergency, 169 West Changle Rd, Xian 710032, Shaanxi, Peoples R China; [Zhang, Yuan; Zhuang, Ran] Northwestern Polytech Univ, Inst Med Res, Xian, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Northwestern Polytechnical University	Zhuang, R (corresponding author), Fourth Mil Med Univ, Dept Immunol, 169 West Changle Rd, Xian 710032, Shaanxi, Peoples R China.; Yin, W (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Emergency, 169 West Changle Rd, Xian 710032, Shaanxi, Peoples R China.	xjyyyw@126.com; fmmuzhr@fmmu.edu.cn	Zhuang, Ran/I-7336-2019	Zhuang, Ran/0000-0002-3614-0422; Feng, Zhusheng/0000-0002-7765-8922; shang xun, zhou/0000-0002-4453-9361	Natural Science Foundation of China [81871258, 81671575, 81871587]; Basic research program of Natural Science in Shaanxi Province [2020JQ-466]; Medical Science and Technique Foundation for Fostering Young Scientist [18QNP026]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic research program of Natural Science in Shaanxi Province; Medical Science and Technique Foundation for Fostering Young Scientist	Natural Science Foundation of China, Grant/Award Number: 81871258, 81671575 and 81871587; Basic research program of Natural Science in Shaanxi Province, Grant/Award Number: 2020JQ-466; Medical Science and Technique Foundation for Fostering Young Scientist, Grant/Award Number: 18QNP026	Ali L, 2018, CURR OPIN LIPIDOL, V29, P475, DOI 10.1097/MOL.0000000000000550; AlKukhun A, 2017, J AM COLL SURGEONS, V224, P1066, DOI 10.1016/j.jamcollsurg.2016.12.016; Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; Bordoli MR, 2011, ONCOGENE, V30, P548, DOI 10.1038/onc.2010.433; Cannon JW, 2018, NEW ENGL J MED, V378, P370, DOI 10.1056/NEJMra1705649; Chen Li-Hua, 2003, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V19, P397; Crouser ED, 2004, MITOCHONDRION, V4, P729, DOI 10.1016/j.mito.2004.07.023; D'Alessandro A, 2016, SHOCK, V46, P173, DOI 10.1097/SHK.0000000000000588; D'Alessandro A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0612-z; Eun JC, 2012, SHOCK, V37, P599, DOI 10.1097/SHK.0b013e31824ee7bc; Fujita M, 2007, ACTA HISTOCHEM CYTOC, V40, P139, DOI 10.1267/ahc.07024; Ge YS, 2019, INT J ONCOL, V54, P585, DOI 10.3892/ijo.2018.4651; Genet GF, 2017, J NEUROTRAUM, V34, P1054, DOI 10.1089/neu.2016.4574; Guo JQ, 2020, ARTIF CELL NANOMED B, V48, P37, DOI 10.1080/21691401.2019.1699806; Hodson EJ, 2016, J PHYSIOL-LONDON, V594, P1179, DOI 10.1113/JP271050; Huda Shehzad A, 2019, Pathophysiology, V26, P169, DOI 10.1016/j.pathophys.2019.03.003; Jian JL, 2006, J BIOL CHEM, V281, P28731, DOI 10.1074/jbc.M601786200; Jin YX, 2012, METHODS MOL BIOL, V843, P147, DOI 10.1007/978-1-61779-523-7_14; Kapitsinou PP, 2016, MOL CELL BIOL, V36, P1584, DOI 10.1128/MCB.01055-15; Kaplan LJ, 2004, CRIT CARE MED, V32, P1120, DOI 10.1097/01.CCM.0000125517.28517.74; Kobayashi H, 2016, J CLIN INVEST, V126, P1926, DOI 10.1172/JCI83551; Krausgruber T, 2020, NATURE, V583, P296, DOI 10.1038/s41586-020-2424-4; Kwon HJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11686; Li J, 2020, MOL MED REP, V21, P1527, DOI 10.3892/mmr.2020.10966; Li PY, 2015, ONCOTARGET, V6, P36998, DOI 10.18632/oncotarget.6076; Li ZQ, 2019, CLIN CANCER RES, V25, P5947, DOI 10.1158/1078-0432.CCR-18-4145; Liu M, 2018, CANCER BIOL MED, V15, P389, DOI 10.20892/j.issn.2095-3941.2018.0122; Lozano E, 2013, J IMMUNOL, V191, P3673, DOI 10.4049/jimmunol.1300945; Maegele M, 2017, EUR J TRAUMA EMERG S, V43, P439, DOI 10.1007/s00068-017-0771-0; Mierzejewska P, 2019, MOL CELL BIOCHEM, V458, P133, DOI 10.1007/s11010-019-03537-4; Mu Y, 2020, J LEUKOCYTE BIOL, V107, P573, DOI 10.1002/JLB.2MA1119-174RR; Muckart DJJ, 2018, ANAESTH INTENSIVE TH, V50, P1, DOI 10.5603/AIT.a2017.0060; Nanayakkara GK, 2019, ARCH BIOCHEM BIOPHYS, V662, P68, DOI 10.1016/j.abb.2018.12.002; Pauken KE, 2014, CANCER CELL, V26, P785, DOI 10.1016/j.ccell.2014.11.016; Peiro C, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0397-2; Peitzman A B, 1995, Curr Probl Surg, V32, P925, DOI 10.1016/S0011-3840(05)80008-5; Peng WX, 2019, DNA CELL BIOL, V38, P597, DOI 10.1089/dna.2018.4552; Peng YP, 2016, ONCOTARGET, V7, P66586, DOI 10.18632/oncotarget.11953; Penn AH, 2021, SHOCK, V55, P832, DOI 10.1097/SHK.0000000000001667; Perez-Escuredo J, 2016, CELL CYCLE, V15, P72, DOI 10.1080/15384101.2015.1120930; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Qiao N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.8; Qie S, 2019, METHODS MOL BIOL, V1928, P427, DOI 10.1007/978-1-4939-9027-6_22; Ravi Parli R, 2017, Disaster Mil Med, V3, P2, DOI 10.1186/s40696-017-0030-2; Reisz JA, 2017, BLOOD ADV, V1, P1296, DOI 10.1182/bloodadvances.2017007187; Rytkonen KT, 2011, MOL BIOL EVOL, V28, P1913, DOI 10.1093/molbev/msr012; Safi SZ, 2015, CLINICS, V70, P569, DOI 10.6061/clinics/2015(08)07; Sawant DA, 2014, J CARDIOVASC TRANSL, V7, P711, DOI 10.1007/s12265-014-9589-x; Scalise M, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00096; Schucht JE, 2020, J TRAUMA ACUTE CARE, V89, P649, DOI 10.1097/TA.0000000000002847; Slaughter AL, 2018, SHOCK, V49, P580, DOI 10.1097/SHK.0000000000000948; Slaughter AL, 2016, J TRAUMA ACUTE CARE, V81, P1012, DOI 10.1097/TA.0000000000001256; Song Y, 2001, AM J PHYSIOL-LUNG C, V281, pL677, DOI 10.1152/ajplung.2001.281.3.L677; Sun Y, 2010, LAB INVEST, V90, P68, DOI 10.1038/labinvest.2009.102; Torres IP, 2016, AM J PHYSIOL-HEART C, V310, pH1468, DOI 10.1152/ajpheart.00006.2016; Wang G, 2017, ONCOL REP, V37, P657, DOI 10.3892/or.2016.5309; Wu F, 2017, SHOCK, V48, P340, DOI 10.1097/SHK.0000000000000832; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025; Yang YD, 2019, J CELL BIOCHEM, V120, P18967, DOI 10.1002/jcb.29220; Zeng H, 2019, J CARDIOVASC PHARM, V74, P315, DOI 10.1097/FJC.0000000000000719; Zhang Y, 2016, ONCOTARGET, V7, P12010, DOI 10.18632/oncotarget.7505; Zhou Shangxun, 2020, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V36, P130	63	4	4	9	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21998	10.1096/fj.202101134R	http://dx.doi.org/10.1096/fj.202101134R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34669985				2022-12-28	WOS:000712009200046
J	Chung, CC; Chan, L; Chen, JH; Bamodu, OA; Chiu, HW; Hong, CT				Chung, Chen-Chih; Chan, Lung; Chen, Jia-Hung; Bamodu, Oluwaseun Adebayo; Chiu, Hung-Wen; Hong, Chien-Tai			Plasma extracellular vesicles tau and beta-amyloid as biomarkers of cognitive dysfunction of Parkinson's disease	FASEB JOURNAL			English	Article						ANN model; cognition; extracellular vesicles; Parkinson's disease; tau; beta-amyloid	ALPHA-SYNUCLEIN; CLINICAL-DIAGNOSIS; DEMENTIA; PERFORMANCE; IMPAIRMENT; LEWY	The contribution of circulatory tau and -amyloid in Parkinson's disease (PD), especially the cognitive function, remains inconclusive. Extracellular vesicles (EVs) cargo these proteins throughout the bloodstream after they are directly secreted from many cells, including neurons. The present study aims to investigate the role of the plasma EV-borne tau and beta-amyloid as biomarkers for cognitive dysfunction in PD by investigating subjects with mild to moderate stage of PD (n = 116) and non-PD controls (n = 46). Plasma EVs were isolated, and immunomagnetic reduction-based immunoassay was used to assess the levels of alpha-synuclein, tau, and beta-amyloid 1-42 (A beta 1-42) within the EVs. Artificial neural network (ANN) models were then applied to predict cognitive dysfunction. We observed no significant difference in plasma EV tau and A beta 1-42 between PD patients and controls. Plasma EV tau was significantly associated with cognitive function. Moreover, plasma EV tau and A beta 1-42 were significantly elevated in PD patients with cognitive impairment when compared to PD patients with optimal cognition. The ANN model used the plasma EV alpha-synuclein, tau, and A beta 1-42, as well as the patient's age and gender, as predicting factors. The model achieved an accuracy of 91.3% in identifying cognitive dysfunction in PD patients, and plasma EV tau and A beta 1-42 are the most valuable factors. In conclusion, plasma EV tau and AO42 are significant markers of cognitive function in PD patients. Combining with the plasma EV alpha-synuclein, age, and sex, plasma EV tau and A beta 1-42 can identify cognitive dysfunction in PD patients. This study corroborates the prognostic roles of plasma EV tau and A beta 1-42 in PD.	[Chung, Chen-Chih; Chan, Lung; Chen, Jia-Hung; Hong, Chien-Tai] Taipei Med Univ, Dept Neurol, Shuang Ho Hosp, 291 Zhongzheng Rd, New Taipei 23561, Taiwan; [Chung, Chen-Chih; Chan, Lung; Hong, Chien-Tai] Taipei Med Univ, Coll Med, Sch Med, Dept Neurol, Taipei, Taiwan; [Chung, Chen-Chih; Chiu, Hung-Wen] Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan; [Bamodu, Oluwaseun Adebayo] Taipei Med Univ, Dept Urol, Shuang Ho Hosp, New Taipei, Taiwan; [Bamodu, Oluwaseun Adebayo] Taipei Med Univ, Dept Med Res & Educ, Shuang Ho Hosp, New Taipei, Taiwan; [Chiu, Hung-Wen] Taipei Med Univ Hosp, Clin Big Data Res Ctr, Taipei, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University Hospital	Hong, CT (corresponding author), Taipei Med Univ, Dept Neurol, Shuang Ho Hosp, 291 Zhongzheng Rd, New Taipei 23561, Taiwan.	ct.hong@tmu.edu.tw	Bamodu, Oluwaseun Adebayo/B-9784-2018	Bamodu, Oluwaseun Adebayo/0000-0001-8229-0408	Ministry of Science and Technology [MOST 107-2314-B-038-043]; Taipei Medical University - Shuang Ho Hospital [108YSR-02]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taipei Medical University - Shuang Ho Hospital	This work was supported by grants from the Ministry of Science and Technology (MOST 107-2314-B-038-043) and Taipei Medical University - Shuang Ho Hospital (108YSR-02)	Alves G, 2014, NEUROLOGY, V82, P1784, DOI 10.1212/WNL.0000000000000425; Alves G, 2010, J NEUROL NEUROSUR PS, V81, P1080, DOI 10.1136/jnnp.2009.199950; Amato F, 2013, J APPL BIOMED, V11, P47, DOI 10.2478/v10136-012-0031-x; Bellin G, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020166; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Chi NF, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00715; Chiaravalloti A, 2014, EUR J NUCL MED MOL I, V41, P2137, DOI 10.1007/s00259-014-2841-4; Choi JU, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197363; Chung CC, 2021, J NEUROL SCI, V425, DOI 10.1016/j.jns.2021.117445; Chung CC, 2020, J NEUROL SCI, V410, DOI 10.1016/j.jns.2020.116667; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Compta Y, 2009, MOVEMENT DISORD, V24, P2203, DOI 10.1002/mds.22594; D'Anca M, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00232; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Duits FH, 2016, ALZHEIMERS DEMENT, V12, P154, DOI 10.1016/j.jalz.2015.08.003; Eggers C, 2011, MOVEMENT DISORD, V26, P416, DOI 10.1002/mds.23468; Fang CC, 2020, PARKINSONS DIS-US, V2020, DOI 10.1155/2020/2076942; Goldman JG, 2013, MOVEMENT DISORD, V28, P1972, DOI 10.1002/mds.25655; Gomperts SN, 2016, JAMA NEUROL, V73, P1334, DOI 10.1001/jamaneurol.2016.3338; Hansson O, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt255; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Irwin David J, 2018, J Alzheimers Dis Parkinsonism, V8, DOI 10.4172/2161-0460.1000444; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Jan AT, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00317; Jellinger KA, 2007, J NEURAL TRANSM-SUPP, P91; Jiang F, 2017, STROKE VASC NEUROL, V2, P230, DOI 10.1136/svn-2017-000101; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Lakshmi S, 2020, NEUROCHEM RES, V45, P2553, DOI 10.1007/s11064-020-03111-1; Lawton M, 2020, MOVEMENT DISORD, V35, P279, DOI 10.1002/mds.27888; Lin CH, 2017, J NEUROL NEUROSUR PS, V88, P818, DOI 10.1136/jnnp-2016-314857; Lue LF, 2017, NEUROL THER, V6, pS25, DOI 10.1007/s40120-017-0074-8; Mullins RJ, 2017, HUM BRAIN MAPP, V38, P1933, DOI 10.1002/hbm.23494; Parnetti L, 2019, LANCET NEUROL, V18, P573, DOI 10.1016/S1474-4422(19)30024-9; Sarkar A, 2019, NEUROTOX RES, V36, P627, DOI 10.1007/s12640-019-00080-4; Shi M, 2014, ACTA NEUROPATHOL, V128, P639, DOI 10.1007/s00401-014-1314-y; Smith C, 2019, J NEUROL NEUROSUR PS, V90, P1234, DOI 10.1136/jnnp-2019-321111; Vacchi E, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000866; Wijeyekoon RS, 2020, MOVEMENT DISORD, V35, P1062, DOI 10.1002/mds.28015; Wills J, 2010, EXP NEUROL, V225, P210, DOI 10.1016/j.expneurol.2010.06.017; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Yang SY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09009-3; Yang SY, 2016, J NANOBIOTECHNOL, V14, DOI 10.1186/s12951-016-0198-5	42	5	5	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21895	10.1096/fj.202100787R	http://dx.doi.org/10.1096/fj.202100787R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34478572				2022-12-28	WOS:000702238200070
J	Xu, X; Xia, J; Zhao, SY; Wang, Q; Ge, GB; Xu, F; Liu, X; Zhang, WD; Yang, YL				Xu, Xin; Xia, Jun; Zhao, Shiyi; Wang, Qun; Ge, Guangbo; Xu, Feng; Liu, Xia; Zhang, Weidong; Yang, Yili			Qing-Fei-Pai-Du decoction and wogonoside exert anti-inflammatory action through down-regulating USP14 to promote the degradation of activating transcription factor 2	FASEB JOURNAL			English	Article						ATF2; KLHL5; QFPDD; ubiquitination; USP14; wogonoside	DISEASE 2019 COVID-19; CONVERTING ENZYME 2; UBIQUITIN; PROGRESSION; PROGNOSIS; PROTEIN; ATF2	COVID-19 is often characterized by dysregulated inflammatory and immune responses. It has been shown that the Traditional Chinese Medicine formulation Qing-Fei-Pai-Du decoction (QFPDD) is effective in the treatment of the disease, especially for patients in the early stage. Our network pharmacology analyses indicated that many inflammation and immune-related molecules were the targets of the active components of QFPDD, which propelled us to examine the effects of the decoction on inflammation. We found in the present study that QFPDD effectively alleviated dextran sulfate sodium-induced intestinal inflammation in mice. It inhibited the production of pro-inflammatory cytokines IL-6 and TNF alpha, and promoted the expression of anti-inflammatory cytokine IL-10 by macrophagic cells. Further investigations found that QFPDD and one of its active components wogonoside markedly reduced LPS-stimulated phosphorylation of transcription factor ATF2, an important regulator of multiple cytokines expression. Our data revealed that both QFPDD and wogonoside decreased the half-life of ATF2 and promoted its proteasomal degradation. Of note, QFPDD and wogonoside down-regulated deubiquitinating enzyme USP14 along with inducing ATF2 degradation. Inhibition of USP14 with the small molecular inhibitor IU1 also led to the decrease of ATF2 in the cells, indicating that QFPDD and wogonoside may act through regulating USP14 to promote ATF2 degradation. To further assess the importance of ubiquitination in regulating ATF2, we generated mice that were intestinal-specific KLHL5 deficiency, a CUL3-interacting protein participating in substrate recognition of E3s. In these mice, QFPDD mitigated inflammatory reaction in the spleen, but not intestinal inflammation, suggesting CUL3-KLHL5 may function as an E3 for ATF2 degradation.	[Xu, Xin; Zhao, Shiyi; Wang, Qun; Yang, Yili] Chinese Acad Med Sci & Peking Union Med Coll, Suzhou Inst Syst Med, Suzhou, Jiangsu, Peoples R China; [Xia, Jun; Xu, Feng] Soochow Univ, Dept Emergency Med, Affiliated Hosp 1, Suzhou, Peoples R China; [Ge, Guangbo; Zhang, Weidong] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Med Res, Shanghai, Peoples R China; [Liu, Xia] Second Mil Med Univ, Sch Pharm, Dept Clin Pharm, Shanghai 200433, Peoples R China; [Yang, Yili] China Reg Res Ctr, Int Ctr Genet Engn & Biotechnol, Taizhou, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Soochow University - China; Shanghai University of Traditional Chinese Medicine; Naval Medical University	Yang, YL (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Suzhou Inst Syst Med, Suzhou, Jiangsu, Peoples R China.; Liu, X (corresponding author), Second Mil Med Univ, Sch Pharm, Dept Clin Pharm, Shanghai 200433, Peoples R China.	lxflying@aliyun.com; yangyl@ism.pumc.edu.cn		Yang, Yili/0000-0002-4152-1801	National Key Research and Development Program of China [2020YFC0845400]; NSFC \ National Natural Science Foundation of China [81973358]	National Key Research and Development Program of China; NSFC \ National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Key Research and Development Program of China, Grant/Award Number: 2020YFC0845400; NSFC vertical bar National Natural Science Foundation of China, Grant/Award Number: 81973358	[Anonymous], 2020, Drug Ther Bull, V58, P133, DOI 10.1136/dtb.2020.000045; Bajema KL, 2021, JAMA INTERN MED, V181, P450, DOI 10.1001/jamainternmed.2020.7976; Cao P, 2020, CARBOHYD POLYM, V240, DOI 10.1016/j.carbpol.2020.116346; Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3; Chen JNS, 2021, J VIROL, V95, DOI 10.1128/JVI.00014-21; Cheng H, 2020, J MED VIROL, V92, P726, DOI 10.1002/jmv.25785; Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1038/s41591-020-1051-9, 10.1101/2020.05.28.20115758]; Ding WP, 2015, MOL MED REP, V11, P968, DOI 10.3892/mmr.2014.2838; Fan E, 2020, LANCET RESP MED, V8, P816, DOI 10.1016/S2213-2600(20)30304-0; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Gendrot M, 2020, INT J INFECT DIS, V99, P437, DOI 10.1016/j.ijid.2020.08.032; Geng L, 2020, BIOCHEM BIOPH RES CO, V524, P16, DOI 10.1016/j.bbrc.2019.12.128; Goh KJ, 2020, ANN ACAD MED SINGAP, V49, P108; Harrison AG, 2020, TRENDS IMMUNOL, V41, P1100, DOI 10.1016/j.it.2020.10.004; Hong KH, 2020, ANN LAB MED, V40, P351, DOI 10.3343/alm.2020.40.5.351; Hu SS, 2020, J MED VIROL, V92, P1425, DOI 10.1002/jmv.25937; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huebner K, 2019, MUTAGENESIS, V34, P375, DOI 10.1093/mutage/gez041; Kihara N, 2003, GUT, V52, P713, DOI 10.1136/gut.52.5.713; Kohli A, 2021, STATPEARLS INTERNET; Luo ED, 2020, CHIN MED-UK, V15, DOI 10.1186/s13020-020-00317-x; Ma J, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0809-0; Mann ER, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6197; Mehra MR, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMoa2007621; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; Powell JA, 2019, BIOCHEM J, V476, P3211, DOI 10.1042/BCJ20190245; Ren JL, 2020, PHARMACOL RES, V155, DOI 10.1016/j.phrs.2020.104743; Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2; Sacchi A, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03125-1; Sanchez-Cerrillo I, 2020, J CLIN INVEST, V130, P6290, DOI 10.1172/JCI140335; Schneekloth JS, 2011, CURR DRUG TARGETS, V12, P1581; Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001; Shi NN, 2020, PHARMACOL RES, V161, DOI 10.1016/j.phrs.2020.105290; Stebbing Justin, 2020, Lancet Infect Dis, V20, P400, DOI 10.1016/S1473-3099(20)30132-8; Wang S, 2001, BIOCHEM GENET, V39, P227, DOI 10.1023/A:1010203114697; Watson G, 2017, PHARMACOL RES, V119, P347, DOI 10.1016/j.phrs.2017.02.004; Wong AYS, 2021, ANN RHEUM DIS, V80, P943, DOI 10.1136/annrheumdis-2020-219517; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Zhao J, 2021, PHYTOMEDICINE, V85, DOI 10.1016/j.phymed.2020.153315; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	41	3	4	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21870	10.1096/fj.202100370RR	http://dx.doi.org/10.1096/fj.202100370RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34436790				2022-12-28	WOS:000691122900063
J	dos Santos, C; Rafacho, A; Ferreira, SM; Vettorazzi, JF; Araujo, TD; Goncalves, LM; Ruhrmann, S; Bacos, K; Ling, CR; Boschero, AC; dos Santos, GJ				dos Santos, Cristiane; Rafacho, Alex; Ferreira, Sandra Mara; Vettorazzi, Jean Franciesco; dos Reis Araujo, Thiago; Mateus Goncalves, Luciana; Ruhrmann, Sabrina; Bacos, Karl; Ling, Charlotte; Boschero, Antonio Carlos; Jorge dos Santos, Gustavo			Excess of glucocorticoids during late gestation impairs the recovery of offspring's beta-cell function after a postnatal injury	FASEB JOURNAL			English	Article						beta-cell regeneration; glucocorticoid; Hnf4-alpha; low birth weight; offspring	STREPTOZOTOCIN; RAT; REGENERATION; GROWTH; EXPOSURE; PROLIFERATION; CONVERSION; GLUCOSE; OBESITY; MICE	Since prenatal glucocorticoids (GC) excess increases the risk of metabolic dysfunctions in the offspring and its effect on beta-cell recovery capacity remains unknown we investigated these aspects in offspring from mice treated with dexamethasone (DEX) in the late pregnancy. Half of the pups were treated with streptozotocin (STZ) on the sixth postnatal day (PN). Functional and molecular analyses were performed in male offspring on PN25 and PN225. Prenatal DEX treatment resulted in low birth weight. At PN25, both the STZ-treated offspring developed hyperglycemia and had lower beta-cell mass, in parallel with higher a-cell mass and glucose intolerance, with no impact of prenatal DEX on such parameters. At PN225, the beta-cell mass was partially recovered in the STZ-treated mice, but they remained glucose-intolerant, irrespective of being insulin sensitive. Prenatal exposition to DEX predisposed adult offspring to sustained hyperglycemia and perturbed islet function (lower insulin and higher glucagon response to glucose) in parallel with exacerbated glucose intolerance. beta-cell-specific knockdown of the Hnf4 alpha in mice from the DS group resulted in exacerbated glucose intolerance. We conclude that high GC exposure during the prenatal period exacerbates the metabolic dysfunctions in adult life of mice exposed to STZ early in life, resulting in a lesser ability to recover the islets' function over time. This study alerts to the importance of proper management of exogenous GCs during pregnancy and a healthy postnatal lifestyle since the combination of adverse factors during the prenatal and postnatal period accentuates the predisposition to metabolic disorders in adult life.	[dos Santos, Cristiane; Ferreira, Sandra Mara; Vettorazzi, Jean Franciesco; dos Reis Araujo, Thiago; Mateus Goncalves, Luciana; Boschero, Antonio Carlos] Campinas State Univ UNICAMP, Dept Struct & Funct Biol, Lab Endocrine Pancreas & Metab LAPEM, Inst Biol, Campinas, Brazil; [Rafacho, Alex; Jorge dos Santos, Gustavo] Fed Univ Santa Catarina UFSC, Ctr Biol Sci, Dept Physiol Sci, Lab Invest Chron Dis LIDoC, BR-88040900 Florianopolis, SC, Brazil; [Ruhrmann, Sabrina; Bacos, Karl; Ling, Charlotte] Scania Univ Hosp, Lund Univ Diabet Ctr, Dept Clin Sci Malmo, Epigenet & Diabet Unit, Malmo, Sweden	Universidade de Sao Paulo; Universidade Estadual de Campinas; Lund University	dos Santos, GJ (corresponding author), Fed Univ Santa Catarina UFSC, Ctr Biol Sci, Dept Physiol Sci, Lab Invest Chron Dis LIDoC, BR-88040900 Florianopolis, SC, Brazil.	gustavo.js@ufsc.br	Santos, Gustavo/L-6419-2013; Rafacho, Alex/O-8609-2016	Santos, Gustavo/0000-0001-9135-7184; Rafacho, Alex/0000-0002-8637-6097; VETTORAZZI, JEAN/0000-0002-6411-2947	Sao Paulo Research Foundation (FAPESP) [2015/12611-0, 2016/23140-0, 2019/10543-8]; Santa Catarina Research Foundation [2017TR1760]; National Counsel of Technological and Scientific Development - CNPq [420602/2018-6, 304388/2020-3]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Santa Catarina Research Foundation; National Counsel of Technological and Scientific Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by grants from the Sao Paulo Research Foundation (FAPESP grants 2015/12611--0, 2016/23140--0, and 2019/10543--8), Santa Catarina Research Foundation (2017TR1760) and, National Counsel of Technological and Scientific Development --CNPq (420602/2018--6 and 304388/2020--3)	Aguayo-Mazzucato C, 2018, CELL METAB, V27, P57, DOI 10.1016/j.cmet.2017.08.007; Bacos K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11089; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; BARKER DJP, 1989, LANCET, V2, P577; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Blondeau B, 2001, AM J PHYSIOL-ENDOC M, V281, pE592, DOI 10.1152/ajpendo.2001.281.3.E592; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; Chen YT, 2020, DIABETES, V69, P1662, DOI 10.2337/db20-0009; Chera S, 2014, NATURE, V514, P503, DOI 10.1038/nature13633; Chung CH, 2010, STEM CELLS, V28, P1630, DOI 10.1002/stem.482; de Vries A, 2007, J CLIN INVEST, V117, P1058, DOI 10.1172/JCI30982; dos Santos C, 2021, J NUTR BIOCHEM, V90, DOI 10.1016/j.jnutbio.2020.108572; Feng AL, 2017, DIABETOLOGIA, V60, P1033, DOI 10.1007/s00125-017-4239-x; Franko KL, 2010, J ENDOCRINOL, V204, P319, DOI 10.1677/JOE-09-0390; Godfrey Keith M, 2016, Nestle Nutr Inst Workshop Ser, V85, P71, DOI 10.1159/000439488; Goyal D, 2019, J ENDOCRINOL, V242, pT105, DOI 10.1530/JOE-19-0009; Guz Y, 2001, ENDOCRINOLOGY, V142, P4956, DOI 10.1210/en.142.11.4956; Karlsson L, 2017, CLIN ENDOCRINOL, V87, P651, DOI 10.1111/cen.13441; Kataoka M, 2013, BIOCHEM BIOPH RES CO, V430, P1103, DOI 10.1016/j.bbrc.2012.12.030; King R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030605; Korchynska S, 2020, EMBO J, V39, DOI 10.15252/embj.2018100882; Li L, 2004, DIABETES, V53, P608, DOI 10.2337/diabetes.53.3.608; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Lundy BL, 1999, INFANT BEHAV DEV, V22, P119, DOI 10.1016/S0163-6383(99)80009-5; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P391, DOI 10.1038/nrendo.2014.73; Movassat J, 1999, DIABETOLOGIA, V42, P1098, DOI 10.1007/s001250051277; Muller TD, 2019, MOL METAB, V30, P72, DOI 10.1016/j.molmet.2019.09.010; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Nyirenda MJ, 1998, J CLIN INVEST, V101, P2174, DOI 10.1172/JCI1567; O'Regan D, 2004, AM J PHYSIOL-ENDOC M, V287, pE863, DOI 10.1152/ajpendo.00137.2004; Ozanne SE, 2004, CLIN SCI, V106, P141, DOI 10.1042/CS20030278; Pantaleao LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10642-1; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; PORTHA B, 1974, DIABETES, V23, P889, DOI 10.2337/diab.23.11.889; Protzek AOP, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/983453; RAKIETEN N, 1963, CANCER CHEMOTH REP, P91; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Riveline JP, 2020, J CLIN ENDOCR METAB, V105, pE191, DOI 10.1210/clinem/dgz145; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Sandovici I, 2011, P NATL ACAD SCI USA, V108, P5449, DOI 10.1073/pnas.1019007108; Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Thyssen S, 2006, ENDOCRINOLOGY, V147, P2346, DOI 10.1210/en.2005-0396; Valtat B, 2011, DIABETOLOGIA, V54, P350, DOI 10.1007/s00125-010-1898-2; WANG RN, 1994, DIABETOLOGIA, V37, P1088; Wang RN, 1996, DIABETOLOGIA, V39, P548, DOI 10.1007/BF00403301; Wang ZY, 1998, DIABETES, V47, P50, DOI 10.2337/diabetes.47.1.50; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015	48	2	2	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21828	10.1096/fj.202100841R	http://dx.doi.org/10.1096/fj.202100841R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34325494				2022-12-28	WOS:000678975300013
J	Andersen-Civil, AIS; Myhill, LJ; Gokgoz, NB; Engstrom, MT; Mejer, H; Zhu, L; Zeller, WE; Salminen, JP; Krych, L; Lauridsen, C; Nielsen, DS; Thamsborg, SM; Williams, AR				Andersen-Civil, Audrey Inge Schytz; Myhill, Laura J.; Gokgoz, Nilay Budeyri; Engstrom, Marica T.; Mejer, Helena; Zhu, Ling; Zeller, Wayne E.; Salminen, Juha-Pekka; Krych, Lukasz; Lauridsen, Charlotte; Nielsen, Dennis S.; Thamsborg, Stig M.; Williams, Andrew R.			Dietary proanthocyanidins promote localized antioxidant responses in porcine pulmonary and gastrointestinal tissues during Ascaris suum-induced type 2 inflammation	FASEB JOURNAL			English	Article						Ascaris suum; gut microbiota; helminth; pig; polyphenols; proanthocyandins	INFECTION; EXPRESSION; PIG; RESISTANCE; MICROBIOTA; PATHWAYS; COCOA; ACID; B2	Proanthocyanidins (PAC) are dietary polyphenols with putative anti-inflammatory and immunomodulatory effects. However, whether dietary PAC can regulate type-2 immune function and inflammation at mucosal surfaces remains unclear. Here, we investigated if diets supplemented with purified PAC modulated pulmonary and intestinal mucosal immune responses during infection with the helminth parasite Ascaris suum in pigs. A. suum infection induced a type-2 biased immune response in lung and intestinal tissues, characterized by pulmonary granulocytosis, increased Th2/Th1 T cell ratios in tracheal-bronchial lymph nodes, intestinal eosinophilia, and modulation of genes involved in mucosal barrier function and immunity. Whilst PAC had only minor effects on pulmonary immune responses, RNA-sequencing of intestinal tissues revealed that dietary PAC significantly enhanced transcriptional responses related to immune function and antioxidant responses in the gut of both naive and A. suum-infected animals. A. suum infection and dietary PAC induced distinct changes in gut microbiota composition, primarily in the jejunum and colon, respectively. Notably, PAC consumption substantially increased the abundance of Limosilactobacillus reuteri. In vitro experiments with porcine macrophages and intestinal epithelial cells supported a role for both PAC polymers and PAC-derived microbial metabolites in regulating oxidative stress responses in host tissues. Thus, dietary PAC may have distinct beneficial effects on intestinal health during infection with mucosal pathogens, while having a limited activity to modulate naturally-induced type-2 pulmonary inflammation. Our results shed further light on the mechanisms underlying the health-promoting properties of PAC-rich foods, and may aid in the design of novel dietary supplements to regulate mucosal inflammatory responses in the gastrointestinal tract.	[Andersen-Civil, Audrey Inge Schytz; Myhill, Laura J.; Mejer, Helena; Zhu, Ling; Thamsborg, Stig M.; Williams, Andrew R.] Univ Copenhagen, Dept Vet & Anim Sci, Dyrlaegevej 100, DK-1870 Frederiksberg C, Denmark; [Gokgoz, Nilay Budeyri; Krych, Lukasz; Nielsen, Dennis S.] Univ Copenhagen, Dept Food Sci, Frederiksberg, Denmark; [Engstrom, Marica T.; Salminen, Juha-Pekka] Univ Turku, Dept Chem, Nat Chem Res Grp, Turku, Finland; [Zeller, Wayne E.] USDA ARS, US Dairy Forage Res Ctr, Madison, WI 53706 USA; [Lauridsen, Charlotte] Aarhus Univ, Dept Anim Sci, Tjele, Denmark	University of Copenhagen; University of Copenhagen; University of Turku; United States Department of Agriculture (USDA); Aarhus University	Williams, AR (corresponding author), Univ Copenhagen, Dept Vet & Anim Sci, Dyrlaegevej 100, DK-1870 Frederiksberg C, Denmark.	arw@sund.ku.dk		Andersen-Civil, Audrey Inge/0000-0003-2175-8972; Engstrom, Marica/0000-0003-4123-6039	Independent Research Fund Denmark [7026-0094B]	Independent Research Fund Denmark	This work was funded by the Independent Research Fund Denmark (Grant #7026-0094B). Data were generated through accessing research infrastructure at the University of Copenhagen, including FOODHAY (Food and Health Open Innovation Laboratory, Danish Roadmap for Research Infrastructure)	Andersen-Civil AIS, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.637603; Andersen-Civil AIS, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02408-3; Dang AT, 2019, MUCOSAL IMMUNOL, V12, P843, DOI 10.1038/s41385-019-0160-6; Appeldoorn MM, 2009, J NUTR, V139, P1469, DOI 10.3945/jn.109.106765; AUGUST DA, 1985, CANCER-AM CANCER SOC, V55, P1490, DOI 10.1002/1097-0142(19850401)55:7<1490::AID-CNCR2820550712>3.0.CO;2-N; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bouron A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081800; Brosschot TP, 2018, MUCOSAL IMMUNOL, V11, P1039, DOI 10.1038/s41385-018-0008-5; Canibe N, 2007, J ANIM SCI, V85, P2959, DOI 10.2527/jas.2006-744; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cabral PC, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00425; Choy YY, 2014, FOOD FUNCT, V5, P2298, DOI [10.1039/c4fo00325j, 10.1039/C4FO00325J]; Chu HQ, 2016, ENVIRON TOXICOL PHAR, V41, P159, DOI 10.1016/j.etap.2015.11.018; Colombo SAP, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01286; CURTIS SE, 1987, CAN J VET RES, V51, P525; Dawson H, 2009, INFECT IMMUN, V77, P2576, DOI 10.1128/IAI.00827-07; De Coster W, 2018, BIOINFORMATICS, V34, P2666, DOI 10.1093/bioinformatics/bty149; Dicksved J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046399; Engstrom MT, 2015, J AGR FOOD CHEM, V63, P4068, DOI 10.1021/acs.jafc.5b00595; Engstrom MT, 2014, J AGR FOOD CHEM, V62, P3390, DOI 10.1021/jf500745y; Fiesel A, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0196-5; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Garnier S, 2021, R PACKAGE VIRIDIS; Gauer JS, 2018, BIOCHEM PHARMACOL, V152, P11, DOI 10.1016/j.bcp.2018.03.011; Gazzinelli-Guimaraes PH, 2013, INT J PARASITOL, V43, P697, DOI 10.1016/j.ijpara.2013.02.009; Glabska D, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030771; Goedhart J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76603-3; Gonzalez-Quilen C, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010130; Jakobsen SR, 2019, VET IMMUNOL IMMUNOP, V211, P6, DOI 10.1016/j.vetimm.2019.03.012; Jang S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101113; Jang S, 2016, J NUTR, V146, P673, DOI 10.3945/jn.115.222968; Kassambara, 2020, PACKAGE GGPUBR; Lee T, 2012, J CLIN IMMUNOL, V32, P1292, DOI 10.1007/s10875-012-9742-8; Li XL, 2011, MOLECULES, V16, P6721, DOI 10.3390/molecules16086721; Liu W, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201601082; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Masure D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002588; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; MINOWADA G, 1995, J CLIN INVEST, V95, P3, DOI 10.1172/JCI117655; Morgan ER, 2019, TRENDS PARASITOL, V35, P52, DOI 10.1016/j.pt.2018.10.006; Murrell KD, 1997, J PARASITOL, V83, P255, DOI 10.2307/3284450; Nogueira DS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004382; Oksanen J., **DATA OBJECT**; Piekarska-Radzik L, 2021, EUR FOOD RES TECHNOL, V247, P9, DOI 10.1007/s00217-020-03603-y; R Core Team, 2015, R LANGUAGE ENV STAT; Reynolds LA, 2014, GUT MICROBES, V5, P522, DOI 10.4161/gmic.32155; Roager HM, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.93, 10.1038/NMICROBIOL.2016.93]; Rodriguez-Daza MC, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.689456; Rodriguez-Ramiro I, 2012, EUR J NUTR, V51, P881, DOI 10.1007/s00394-011-0269-1; Roepstorff A, 1997, PARASITOLOGY, V115, P443, DOI 10.1017/S0031182097001480; Roepstorff A, 2011, VET PARASITOL, V180, P72, DOI 10.1016/j.vetpar.2011.05.029; Schewe T, 2001, BIOL CHEM, V382, P1687, DOI 10.1515/BC.2001.204; Sehm J, 2007, J ANIM PHYSIOL AN N, V91, P289, DOI 10.1111/j.1439-0396.2006.00650.x; Skallerup P, 2012, INT J PARASITOL, V42, P383, DOI 10.1016/j.ijpara.2012.02.010; Slotved HC, 1997, ACTA VET SCAND, V38, P207; Snyder R, 2012, J MOL ENDOCRINOL, V48, P99, DOI 10.1530/JME-11-0095; Spinler JK, 2008, ANAEROBE, V14, P166, DOI 10.1016/j.anaerobe.2008.02.001; Tao WY, 2019, COMPR REV FOOD SCI F, V18, P971, DOI 10.1111/1541-4337.12444; TJORNEHOJ K, 1992, PARASITOL RES, V78, P525, DOI 10.1007/BF00931575; Tsuji T, 2013, INT J MOL MED, V31, P1037, DOI 10.3892/ijmm.2013.1294; Tzounis X, 2011, AM J CLIN NUTR, V93, P62, DOI 10.3945/ajcn.110.000075; Van Tassell ML, 2011, NUTRIENTS, V3, P613, DOI 10.3390/nu3050613; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Weatherhead JE, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.594520; Wickham H, 2007, J STAT SOFTW, V21, P1; Williams AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186546; Williams AR, 2017, VET IMMUNOL IMMUNOP, V189, P43, DOI 10.1016/j.vetimm.2017.06.004; Wu Y, 2019, J NUTR, V149, P1523, DOI 10.1093/jn/nxz102; Yagi K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms221910872; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zhu L, 2022, J NUTR BIOCHEM, V100, P8887, DOI 10.1016/j.jnutbio.2021.108887	73	1	1	6	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22256	10.1096/fj.202101603RR	http://dx.doi.org/10.1096/fj.202101603RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZY9ZR	35333423	Green Submitted			2022-12-28	WOS:000772937700001
J	Buurstede, JC; Paul, SN; De Bosscher, K; Meijer, OC; Kroon, J				Buurstede, Jacobus C.; Paul, Susana N.; De Bosscher, Karolien; Meijer, Onno C.; Kroon, Jan			Hepatic glucocorticoid-induced transcriptional regulation is androgen-dependent after chronic but not acute glucocorticoid exposure	FASEB JOURNAL			English	Article						androgen receptor; androgens; glucocorticoid receptor; glucocorticoids; liver	HEPATOCELLULAR-CARCINOMA; TARGET GENES; FATTY LIVER; RECEPTOR; GR; INHIBITION; RESISTANCE; STEATOSIS; HEALTH; ALPHA	Glucocorticoids exert their pleiotropic effects by activating the glucocorticoid receptor (GR), which is expressed throughout the body. GR-mediated transcription is regulated by a multitude of tissue- and cell type-specific mechanisms, including interactions with other transcription factors such as the androgen receptor (AR). We previously showed that the transcription of canonical glucocorticoid-responsive genes is dependent on active androgen signaling, but the extent of this glucocorticoid-androgen crosstalk warrants further investigation. In this study, we investigated the overall glucocorticoid-androgen crosstalk in the hepatic transcriptome. Male mice were exposed to GR agonist corticosterone and AR antagonist enzalutamide in order to determine the extent of androgen-dependency after acute and chronic exposure. We found that a substantial proportion of the hepatic transcriptome is androgen-dependent after chronic exposure, while after acute exposure the transcriptomic effects of glucocorticoids are largely androgen-independent. We propose that prolonged glucocorticoid exposure triggers a gradual upregulation of AR expression, instating a situation of androgen dependence which is likely not driven by direct AR-GR interactions. This indirect mode of glucocorticoid-androgen interaction is in accordance with the absence of enriched AR DNA-binding near AR-dependent corticosterone-regulated genes after chronic exposure. In conclusion, we demonstrate that glucocorticoid effects and their interaction with androgen signaling are dependent on the duration of exposure and believe that our findings contribute to a better understanding of hepatic glucocorticoid biology in health and disease.	[Buurstede, Jacobus C.; Paul, Susana N.; Meijer, Onno C.; Kroon, Jan] Leiden Univ, Med Ctr, Dept Med, Div Endocrinol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands; [De Bosscher, Karolien] UGent, VIB Ctr Med Biotechnol, Translat Nucl Receptor Res, Dept Biomol Med, Ghent, Belgium	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Flanders Institute for Biotechnology (VIB); Ghent University	Buurstede, JC; Kroon, J (corresponding author), Leiden Univ, Med Ctr, Dept Med, Div Endocrinol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	j.c.buurstede@lumc.nl; j.kroon@lumc.nl	Buurstede, Jacobus/G-6237-2019	Buurstede, Jacobus/0000-0002-3620-9311	Board of Directors of Leiden University Medical Center	Board of Directors of Leiden University Medical Center	JCB was funded with a PhD grant by the Board of Directors of Leiden University Medical Center	Aizarani N, 2019, NATURE, V572, P199, DOI 10.1038/s41586-019-1373-2; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Atkinson HC, 2006, J NEUROENDOCRINOL, V18, P526, DOI 10.1111/j.1365-2826.2006.01444.x; Balakrishnan M, 2021, CLIN GASTROENTEROL H, V19, P61, DOI 10.1016/j.cgh.2020.04.067; Bebermeier JH, 2006, J MOL MED, V84, P919, DOI 10.1007/s00109-006-0081-1; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Bose SK, 2016, ENDOCRINOLOGY, V157, P4943, DOI 10.1210/en.2016-1615; Chen TY, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.141024; Claessens F, 2017, CELL MOL LIFE SCI, V74, P2217, DOI 10.1007/s00018-017-2467-3; Cohen DM, 2017, TRENDS ENDOCRIN MET, V28, P531, DOI 10.1016/j.tem.2017.04.001; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; De Bosscher K, 2020, NAT REV ENDOCRINOL, V16, P363, DOI 10.1038/s41574-020-0349-5; de Quervain D, 2017, NAT REV NEUROSCI, V18, P7, DOI 10.1038/nrn.2016.155; Della Torre S, 2018, J ENDOCRINOL, V238, P165, DOI 10.1530/JOE-18-0003; Della Torre S, 2018, CELL METAB, V28, P256, DOI 10.1016/j.cmet.2018.05.021; Donahue J L, 2000, Am J Ther, V7, P365, DOI 10.1097/00045391-200007060-00005; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; Duma D, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001077; Gasparini SJ, 2019, DIABETOLOGIA, V62, P1463, DOI 10.1007/s00125-019-4887-0; Hartig SM, 2012, CHEM BIOL, V19, P1126, DOI 10.1016/j.chembiol.2012.07.020; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helms TH, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82252-x; Hemmer MC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08196-5; Hunt HJ, 2017, J MED CHEM, V60, P3405, DOI 10.1021/acs.jmedchem.7b00162; Jin HJ, 2013, TRANSL ANDROL UROL, V2, P158, DOI 10.3978/j.issn.2223-4683.2013.09.01; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Kaikaew K, 2019, ENDOCRINOLOGY, V160, P2367, DOI 10.1210/en.2019-00194; Kroon J, 2021, MOL METAB, V47, DOI 10.1016/j.molmet.2021.101179; Kulik M, 2021, NUCLEIC ACIDS RES, V49, P3856, DOI 10.1093/nar/gkab185; Lee I, 2018, NEUROL-NEUROIMMUNOL, V5, DOI 10.1212/NXI.0000000000000507; Lempiainen JK, 2017, MOL CELL PROTEOMICS, V16, P1462, DOI 10.1074/mcp.M117.067488; Li HK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46378-3; Lin HY, 2008, HEPATOLOGY, V47, P1924, DOI 10.1002/hep.22252; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma WL, 2014, ENDOCR-RELAT CANCER, V21, pR165, DOI 10.1530/ERC-13-0283; Ma WL, 2012, HEPATOLOGY, V56, P176, DOI 10.1002/hep.25644; Nixon M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9074; Pihlajamaa P, 2014, EMBO J, V33, P312, DOI 10.1002/embj.201385895; Presman DM, 2016, P NATL ACAD SCI USA, V113, P8236, DOI 10.1073/pnas.1606774113; Quatrini L, 2021, CELL MOL IMMUNOL, V18, P269, DOI 10.1038/s41423-020-00526-2; Quinn MA, 2018, CELL REP, V22, P2690, DOI 10.1016/j.celrep.2018.02.041; Quinn MA, 2016, FASEB J, V30, P971, DOI 10.1096/fj.15-278309; Ratman D, 2013, MOL CELL ENDOCRINOL, V380, P41, DOI 10.1016/j.mce.2012.12.014; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Spaanderman DCE, 2019, J ENDOCRINOL, V240, P51, DOI 10.1530/JOE-18-0503; Spiga F, 2014, COMPR PHYSIOL, V4, P1273, DOI 10.1002/cphy.c140003; Timmermans S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01545; Wang YM, 2015, BIOCHEM PHARMACOL, V96, P357, DOI 10.1016/j.bcp.2015.06.018; Weikum ER, 2017, NAT REV MOL CELL BIO, V18, P159, DOI 10.1038/nrm.2016.152; Whirledge S, 2018, ENDOCRINOLOGY, V159, P46, DOI 10.1210/en.2017-00728; Wilson S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32611; Woods CP, 2015, J STEROID BIOCHEM, V154, P94, DOI 10.1016/j.jsbmb.2015.07.020; Yang F, 2017, MOL CELL, V66, P321, DOI 10.1016/j.molcel.2017.03.019; Zheng DS, 2018, MOL CELL ENDOCRINOL, V471, P33, DOI 10.1016/j.mce.2017.05.025	55	1	1	5	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22251	10.1096/fj.202101313R	http://dx.doi.org/10.1096/fj.202101313R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35262955	Green Published			2022-12-28	WOS:000772957100008
J	Cooper, SL; Wragg, ES; Pannucci, P; Soave, M; Hill, SJ; Woolard, J				Cooper, Samantha L.; Wragg, Edward S.; Pannucci, Patrizia; Soave, Mark; Hill, Stephen J.; Woolard, Jeanette			Regionally selective cardiovascular responses to adenosine A(2A) and A(2B) receptor activation	FASEB JOURNAL			English	Article						A(2) receptor activation; adenosine; Doppler flow; hemodynamics	K-ATP CHANNEL; CUTTING EDGE; MICE LACKING; AGONIST; CELLS; RELAXATION; MECHANISM; BINDING; KIDNEY	Adenosine is a local mediator that regulates changes in the cardiovascular system via activation of four G protein-coupled receptors (A(1), A(2A), A(2B), A(3)). Here, we have investigated the effect of A(2A) and A(2B)-selective agonists on vasodilatation in three distinct vascular beds of the rat cardiovascular system. NanoBRET ligand binding studies were used to confirm receptor selectivity. The regional hemodynamic effects of adenosine A(2A) and A(2B) selective agonists were investigated in conscious rats. Male Sprague-Dawley rats (350-450 g) were chronically implanted with pulsed Doppler flow probes on the renal artery, mesenteric artery, and the descending abdominal aorta. Cardiovascular responses were measured following intravenous infusion (3 min for each dose) of the A(2A)-selective agonist CGS 21680 (0.1, 0.3, 1 mu g kg(-1) min(-1)) or the A(2B)-selective agonist BAY 60-6583 (4,13.3, 40 mu g kg(-1) min(-1)) following predosing with the A(2A)-selective antagonist SCH 58261 (0.1 or 1 mg kg(-1) min(-1)), the A(2B)/A(2A) antagonist PSB 1115 (10 mg kg(-1) min(-1)) or vehicle. The A(2A)-selective agonist CGS 21680 produced a striking increase in heart rate (HR) and hindquarters vascular conductance (VC) that was accompanied by a significant decrease in mean arterial pressure (MAP) in conscious rats. In marked contrast, the A(2B)-selective agonist BAY 60-6583 significantly increased HR and VC in the renal and mesenteric vascular beds, but not in the hindquarters. Taken together, these data indicate that A(2A) and A(2B) receptors are regionally selective in their regulation of vascular tone. These results suggest that the development of A(2B) receptor agonists to induce vasodilatation in the kidney may provide a good therapeutic approach for the treatment of acute kidney injury.	[Cooper, Samantha L.; Wragg, Edward S.; Pannucci, Patrizia; Soave, Mark; Hill, Stephen J.; Woolard, Jeanette] Univ Nottingham, Sch Life Sci, Div Physiol, Nottingham, England; [Cooper, Samantha L.; Wragg, Edward S.; Pannucci, Patrizia; Soave, Mark; Hill, Stephen J.; Woolard, Jeanette] Univ Birmingham, Ctr Membrane Prot & Receptors, Birmingham, W Midlands, England; [Cooper, Samantha L.; Wragg, Edward S.; Pannucci, Patrizia; Soave, Mark; Hill, Stephen J.; Woolard, Jeanette] Univ Nottingham, Midlands, England	University of Nottingham; University of Birmingham; University of Nottingham	Woolard, J (corresponding author), Univ Nottingham, Sch Life Sci, Div Physiol Pharmacol & Neurosci, Nottingham NG7 2UH, England.	jeanette.woolard@nottingham.ac.uk	Hill, Stephen/N-6753-2013	Hill, Stephen/0000-0002-4424-239X; Cooper, Samantha/0000-0002-9062-5893; Soave, Mark/0000-0002-9199-1772; Woolard, Jeanette/0000-0001-5406-6847	British Heart Foundation (BHF) [PG/14/95/31248]; RCUK | Medical Research Council (MRC) [MR/N020081/1]; European Union [858070]	British Heart Foundation (BHF)(British Heart Foundation); RCUK | Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission)	British Heart Foundation (BHF), Grant/Award Number: PG/14/95/31248; RCUK | Medical Research Council (MRC), Grant/Award Number: MR/N020081/1; European Union's Horizon 2020 Research and Innovation Program (H2020--MSCA--ITN Program), Grant/Award Number: 858070	Alberti C, 1997, J CARDIOVASC PHARM, V30, P320, DOI 10.1097/00005344-199709000-00008; AREND LJ, 1985, CIRC RES, V56, P242, DOI 10.1161/01.RES.56.2.242; Borea PA, 2018, PHYSIOL REV, V98, P1591, DOI 10.1152/physrev.00049.2017; Carter JJ, 2017, FASEB J, V31, P1193, DOI 10.1096/fj.201600749R; CHURCHILL PC, 1987, AM J PHYSIOL, V252, pF299, DOI 10.1152/ajprenal.1987.252.2.F299; Cooper SL, 2020, BRIT J PHARMACOL, V177, P346, DOI 10.1111/bph.14870; Cooper SL, 2019, BRIT J PHARMACOL, V176, P864, DOI 10.1111/bph.14575; Corriden R, 2014, FASEB J, V28, P4211, DOI 10.1096/fj.13-247270; Csoka B, 2008, FASEB J, V22, P3491, DOI 10.1096/fj.08-107458; Dionisotti S, 1997, BRIT J PHARMACOL, V121, P353, DOI 10.1038/sj.bjp.0701119; El-Mas MM, 2011, TOXICOL APPL PHARM, V254, P229, DOI 10.1016/j.taap.2011.04.014; EVONIUK G, 1987, J PHARMACOL EXP THER, V240, P428; Fan F, 2008, ACS CHEM BIOL, V3, P346, DOI 10.1021/cb8000414; Feng MG, 2010, AM J PHYSIOL-RENAL, V299, pF310, DOI 10.1152/ajprenal.00149.2010; Franco R, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10112831; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Goulding J, 2018, BIOCHEM PHARMACOL, V147, P55, DOI 10.1016/j.bcp.2017.10.013; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Hart ML, 2009, J IMMUNOL, V182, P3965, DOI 10.4049/jimmunol.0802193; Headrick JP, 2013, PHARMACOL THERAPEUT, V140, P92, DOI 10.1016/j.pharmthera.2013.06.002; Hinz S, 2014, J PHARMACOL EXP THER, V349, P427, DOI 10.1124/jpet.113.210849; HOLZ FG, 1987, RENAL PHYSIOL BIOCH, V10, P272; HUTCHISON AJ, 1989, J PHARMACOL EXP THER, V251, P47; Ichinose TK, 2009, AM J PHYSIOL-HEART C, V296, pH1058, DOI 10.1152/ajpheart.00906.2008; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jamwal S, 2019, CURR PHARM DESIGN, V25, P2892, DOI 10.2174/1381612825666190716112319; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/expphysiol.2010.053793, 10.1113/jphysiol.2010.192278]; Lai EY, 2006, KIDNEY INT, V70, P690, DOI 10.1038/sj.ki.5001650; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Lee TK, 2009, J CARDIOVASC PHARM, V53, P167, DOI 10.1097/FJC.0b013e318198ca6b; Linden J, 1999, MOL PHARMACOL, V56, P705; Linden J, 2012, ARTERIOSCL THROM VAS, V32, P2097, DOI 10.1161/ATVBAHA.111.226837; MATHOT RAA, 1995, BRIT J PHARMACOL, V114, P761, DOI 10.1111/j.1476-5381.1995.tb13270.x; McGrath JC, 2015, BRIT J PHARMACOL, V172, P3189, DOI 10.1111/bph.12955; Muller CE, 2011, BBA-BIOMEMBRANES, V1808, P1290, DOI 10.1016/j.bbamem.2010.12.017; Naganuma M, 2006, J IMMUNOL, V177, P2765, DOI 10.4049/jimmunol.177.5.2765; Ponnoth DS, 2009, AM J PHYSIOL-HEART C, V297, pH1655, DOI 10.1152/ajpheart.00192.2009; Prentice DJ, 2002, N-S ARCH PHARMACOL, V366, P127, DOI 10.1007/s00210-002-0581-7; Rabadi MM, 2015, ACTA PHYSIOL, V213, P222, DOI 10.1111/apha.12402; Sanjani MS, 2011, AM J PHYSIOL-HEART C, V301, pH2322, DOI 10.1152/ajpheart.00052.2011; Sitkovsky MV, 2014, CANCER IMMUNOL RES, V2, P598, DOI 10.1158/2326-6066.CIR-14-0075; Soave M, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.250; SPIELMAN WS, 1991, HYPERTENSION, V17, P117, DOI 10.1161/01.HYP.17.2.117; Stoddart LA, 2015, NAT METHODS, V12, P661, DOI [10.1038/nmeth.3398, 10.1038/NMETH.3398]; Sun BF, 2017, P NATL ACAD SCI USA, V114, P2066, DOI 10.1073/pnas.1621423114; Tang LL, 1999, AM J PHYSIOL-RENAL, V277, pF926, DOI 10.1152/ajprenal.1999.277.6.F926	46	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22214	10.1096/fj.202101945R	http://dx.doi.org/10.1096/fj.202101945R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CW	35230706	hybrid, Green Published			2022-12-28	WOS:000772946000001
J	Du, Y; Cao, ML; Liu, YW; He, YQ; Yang, CX; Zhang, GL; Fan, YB; Gao, F				Du, Yan; Cao, Manlin; Liu, Yiwen; He, Yiqing; Yang, Cuixia; Zhang, Guoliang; Fan, Youben; Gao, Feng			Tumor microenvironment remodeling modulates macrophage phenotype in breast cancer lymphangiogenesis	FASEB JOURNAL			English	Article						bone marrow-derived macrophages; hyaluronan remodeling; LMW-HA; lymphangiogenesis; tumor microenvironment	MOLECULAR-WEIGHT HYALURONAN; ANGIOGENESIS; CELLS; OLIGOSACCHARIDES; INDUCTION; MONOCYTES; NODE	Hyaluronan (HA) is dynamically remodeled in tumor microenvironment (TME) and is reported to be closely related to tumor lymphatic metastasis by inducing lymphangiogenesis. Macrophages are known to be involved in neo-lymphatic vessels formation. However, few studies have investigated the role of HA-mediated TME remodeling on macrophages-dependent lymphangiogenesis. We previously showed that HA could drive macrophages to acquire the M2 phenotype. In this study, we attempt to study the crosstalk between HA in TME and macrophages dependent lymphangiogenesis. First, we found that the abundant assembly of HA in breast cancer tissue was accompanied by increased infiltration of macrophages featured by expressing lymphatic endothelial markers. Then, to further identify the remodeling of HA in regulating macrophage phenotype, we used HA fragments which are usually enriched in TME for this purpose. Our results showed that the reconstructed HA could induce bone marrow-derived macrophages (BMDMs) to express markers of lymphatic endothelium and form tube-like structures, suggesting a novel function of HA from TME on macrophages-dependent lymphangiogenesis. Finally, we found that inhibition of the HA-TLR4 pathway could reduce the ability of BMDMs to exhibit lymphatic endothelial phenotype. Our results provide new insight into tumor microenvironment remodeling and macrophages in breast cancer lymphangiogenesis.	[Du, Yan; Liu, Yiwen; He, Yiqing; Yang, Cuixia; Zhang, Guoliang; Gao, Feng] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Mol Biol, 600 Yishan Rd, Shanghai 200233, Peoples R China; [Du, Yan; Yang, Cuixia; Gao, Feng] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Clin Lab, Shanghai, Peoples R China; [Cao, Manlin] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Rehabil Med, Shanghai, Peoples R China; [Fan, Youben] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Gen Surg, 600 Yishan Rd, Shanghai 200233, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gao, F (corresponding author), Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Mol Biol, 600 Yishan Rd, Shanghai 200233, Peoples R China.; Fan, YB (corresponding author), Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Gen Surg, 600 Yishan Rd, Shanghai 200233, Peoples R China.	ybfan@sjtu.edu.cn; gaofengly@sjtu.edu.cn	liu, yi/GXE-9662-2022		National Natural Science Foundation of China (NSFC) [81872357, 81974446, 81502490, 81974445, 82073199, 81572821, 81672843, 81702852]; Shanghai Pujiang Program [2019PJD037]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support [20171924]; Shanghai Young Talents in Clinical Medical Technology [2017]; Sailing Program of Shanghai Committee of Science and Technology [14YF1412200]; Shanghai Shen-Kang Hospital Development Center [SHDC22014004]; Shanghai 'Rising Stars of Medical Talent' Youth Development Program Clinical Laboratory Practitioners Program [2021, 2020]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support; Shanghai Young Talents in Clinical Medical Technology; Sailing Program of Shanghai Committee of Science and Technology; Shanghai Shen-Kang Hospital Development Center; Shanghai 'Rising Stars of Medical Talent' Youth Development Program Clinical Laboratory Practitioners Program	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81872357, 81974446, 81502490, 81974445, 82073199, 81572821, 81672843 and 81702852; Shanghai Pujiang Program, Grant/Award Number: 2019PJD037; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support, Grant/Award Number: 20171924; Shanghai Young Talents in Clinical Medical Technology, Grant/Award Number: 2017; the Sailing Program of Shanghai Committee of Science and Technology, Grant/Award Number: 14YF1412200; the Shanghai Shen-Kang Hospital Development Center, Grant/Award Number: SHDC22014004; Shanghai 'Rising Stars of Medical Talent' Youth Development Program Clinical Laboratory Practitioners Program, Grant/Award Number: 2020; Shanghai 'Rising Stars of Medical Talent' Youth Development Program Clinical Laboratory Practitioners Program, Grant/Award Number: 2021	Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Arneth B, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56010015; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Bauer J, 2018, J MOL MED, V96, P199, DOI 10.1007/s00109-017-1615-4; Bieniasz-Krzywiec P, 2019, CELL METAB, V30, P917, DOI 10.1016/j.cmet.2019.07.015; Bron S, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1073882; Caon I, 2020, SEMIN CANCER BIOL, V62, P9, DOI 10.1016/j.semcancer.2019.07.007; Changming W, 2011, LYMPHOLOGY, V44, P48; Chanmee T, 2016, CANCER LETT, V375, P20, DOI 10.1016/j.canlet.2016.02.031; Corliss BA, 2016, MICROCIRCULATION, V23, P95, DOI 10.1111/micc.12259; Da W, 2019, INT J IMMUNOPATH PH, V33, DOI 10.1177/2058738419861600; Danussi C, 2008, MOL CELL BIOL, V28, P4026, DOI 10.1128/MCB.02062-07; Dicker KT, 2014, ACTA BIOMATER, V10, P1558, DOI 10.1016/j.actbio.2013.12.019; Du Y, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1232235; Gomes FG, 2013, LIFE SCI, V92, P101, DOI 10.1016/j.lfs.2012.10.008; Guo QJ, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/9720912; Hall KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031794; Hinshaw DC, 2019, CANCER RES, V79, P4557, DOI 10.1158/0008-5472.CAN-18-3962; Horton MR, 1999, J IMMUNOL, V162, P4171; Hu XT, 2018, CANCER SCI, V109, P3005, DOI 10.1111/cas.13738; Huang CY, 2017, SAUDI MED J, V38, P237, DOI 10.15537/smj.2017.3.16245; Hwang I, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02618-z; Itano N, 2008, CANCER SCI, V99, P1720, DOI 10.1111/j.1349-7006.2008.00885.x; Jung YJ, 2015, BIOCHEM BIOPH RES CO, V466, P339, DOI 10.1016/j.bbrc.2015.09.023; Karousou E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/606458; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Lee JY, 2010, CIRCULATION, V122, P1413, DOI 10.1161/CIRCULATIONAHA.110.941468; Li ZY, 2018, J IMMUNOL, V200, P2826, DOI 10.4049/jimmunol.1701471; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Pereira ER, 2018, SCIENCE, V359, P1403, DOI 10.1126/science.aal3622; Poltavets V, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00431; Rayahin JE, 2015, ACS BIOMATER SCI ENG, V1, P481, DOI 10.1021/acsbiomaterials.5b00181; Ren B, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0858-1; Riabov V, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00075; Schmaus A, 2014, BRIT J CANCER, V111, P559, DOI 10.1038/bjc.2014.332; Schmieder A, 2011, INT J CANCER, V129, P122, DOI 10.1002/ijc.25657; Sokolowska M, 2014, J BIOL CHEM, V289, P4470, DOI 10.1074/jbc.M113.515106; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; van't Hull EF, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.29080; Volk-Draper L, 2019, AM J PATHOL, V189, P2269, DOI 10.1016/j.ajpath.2019.07.006; Wu H, 2012, J SURG ONCOL, V106, P462, DOI 10.1002/jso.23110; Wu M, 2015, FASEB J, V29, P1290, DOI 10.1096/fj.14-259978; Yan SS, 2020, CANCER LETT, V488, P18, DOI 10.1016/j.canlet.2020.04.021; Yu MS, 2015, EXP CELL RES, V336, P150, DOI 10.1016/j.yexcr.2015.06.014; Zhang BK, 2019, CANCER IMMUNOL IMMUN, V68, P189, DOI 10.1007/s00262-018-2261-6; Zhang GL, 2019, FEBS J, V286, P3148, DOI 10.1111/febs.14859; Zhang GL, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1172154; Zhang Y, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-020-03385-x	49	1	1	6	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22248	10.1096/fj.202101230R	http://dx.doi.org/10.1096/fj.202101230R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0DC	35239213				2022-12-28	WOS:000772946600001
J	McKie, GL; Medak, KD; Shamshoum, H; Wright, DC				McKie, Greg L.; Medak, Kyle D.; Shamshoum, Hesham; Wright, David C.			Topical application of the pharmacological cold mimetic menthol stimulates brown adipose tissue thermogenesis through a TRPM8, UCP1, and norepinephrine dependent mechanism in mice housed at thermoneutrality	FASEB JOURNAL			English	Article						menthol; thermoneutral; topical; TRPM8; UCP1	DIET-INDUCED OBESITY; ENERGY-EXPENDITURE; RECEPTOR TRPM8; WHITE FAT; ACTIVATION; ADIPOCYTES; AGONIST; TEMPERATURE; SKIN; PGC-1-ALPHA	Increasing whole-body energy expenditure via the pharmacological activation of uncoupling protein 1 (UCP1)-dependent brown adipose tissue (BAT) thermogenesis is a promising weight management strategy, yet most therapeutics studied in rodents to date either induce compensatory increases in energy intake, have thermogenic effects that are confounded by sub-thermoneutral housing temperatures or are not well tolerated in humans. Here, we sought to determine whether the non-invasive topical application of the pharmacological cold mimetic and transient receptor potential (TRP) cation channel subfamily M member 8 (TRPM8) agonist L-menthol (MNTH), could be used to stimulate BAT thermogenesis and attenuate weight gain in mice housed at thermoneutrality. Using three different strains of mice and multiple complimentary approaches to quantify thermogenesis in vivo, coupled with ex vivo models to quantify direct thermogenic effects, we were able to convincingly demonstrate the following: (1) acute topical MNTH application induces BAT thermogenesis in a TRPM8- and UCP1-dependent manner; (2) MNTH-induced BAT thermogenesis is sufficient to attenuate weight gain over time without affecting energy intake in lean and obese mice; (3) the ability of topical MNTH application to stimulate BAT thermogenesis is mediated, in part, by a central mechanism involving the release of norepinephrine. These data collectively suggest that topical application of MNTH may be a promising weight management strategy.	[McKie, Greg L.; Medak, Kyle D.; Shamshoum, Hesham; Wright, David C.] Univ Guelph, Dept Human Hlth & Nutr Sci, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada	University of Guelph	Wright, DC (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	dcwright@uoguelph.ca		Wright, David/0000-0003-3867-8901; McKie, Greg/0000-0002-6469-0747	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC Canada Graduate Scholarship; NSERC Postgraduate Scholarships	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Postgraduate Scholarships(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to DCW, who was a Tier II Canada Research Chair in Lipids, Metabolism, and Health. GLM was supported by an NSERC Canada Graduate Scholarship; KDM and HS were supported by NSERC Postgraduate Scholarships	Aldiss P., 2021, 789289 BIORXIV; Aldiss P, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00097; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Baskin AS, 2018, DIABETES, V67, P2113, DOI 10.2337/db18-0462; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Berbee JFP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7356; Beukema P, 2018, J COMP NEUROL, V526, P1444, DOI 10.1002/cne.24418; Blondin DP, 2020, CELL METAB, V32, P287, DOI 10.1016/j.cmet.2020.07.005; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Buemann B, 2000, INT J OBESITY, V24, P1553, DOI 10.1038/sj.ijo.0801452; Campero M, 2009, J PHYSIOL-LONDON, V587, P5633, DOI 10.1113/jphysiol.2009.176040; Carey AL, 2013, DIABETOLOGIA, V56, P147, DOI 10.1007/s00125-012-2748-1; Clemmensen C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06769-y; Crane JD, 2014, MOL METAB, V3, P490, DOI 10.1016/j.molmet.2014.04.007; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2012, P NATL ACAD SCI USA, V109, P10001, DOI 10.1073/pnas.1207911109; de Jong JMA, 2019, NAT METAB, V1, P830, DOI 10.1038/s42255-019-0101-4; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Facer P, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-11; Fan L, 2016, TOB CONTROL, V25, pii50, DOI 10.1136/tobaccocontrol-2016-053209; Fernandez-Carvajal A, 2020, EXPERT OPIN INV DRUG, V29, P1209, DOI 10.1080/13543784.2020.1825680; Finlin BS, 2020, J CLIN INVEST, V130, P2319, DOI 10.1172/JCI134892; Finlin BS, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121510; Fischer AW, 2018, MOL METAB, V7, P161, DOI 10.1016/j.molmet.2017.10.009; Fonfria E, 2006, J RECEPT SIG TRANSD, V26, P159, DOI 10.1080/10799890600637506; GALBO H, 1986, Diabetes Metabolism Reviews, V1, P385; Ghorbani M, 1997, BIOCHEM PHARMACOL, V54, P121, DOI 10.1016/S0006-2952(97)00162-7; Gkika D, 2010, ONCOGENE, V29, P4611, DOI 10.1038/onc.2010.210; Greaney JL, 2017, J NEUROPHYSIOL, V118, P2181, DOI 10.1152/jn.00283.2017; Grolez GP, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1891-8; Grujic D, 1997, J BIOL CHEM, V272, P17686, DOI 10.1074/jbc.272.28.17686; Hanssen MJW, 2016, DIABETES, V65, P1179, DOI 10.2337/db15-1372; Hanssen MJW, 2015, NAT MED, V21, P863, DOI 10.1038/nm.3891; Hao L, 2019, J PHARMACOL EXP THER, V369, P419, DOI 10.1124/jpet.118.255778; HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Jiang CY, 2017, ONCOTARGET, V8, P75114, DOI 10.18632/oncotarget.20540; Johnson CD, 2009, AM J PHYSIOL-HEART C, V296, pH1868, DOI 10.1152/ajpheart.01112.2008; Kaur J, 2022, INT J OBESITY, V46, P153, DOI 10.1038/s41366-021-00967-3; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Keijer J, 2019, MOL METAB, V25, P168, DOI 10.1016/j.molmet.2019.04.001; Keipert S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14069-2; Khare P, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050383; Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109; Labbe SM, 2018, AM J PHYSIOL-ENDOC M, V315, pE815, DOI 10.1152/ajpendo.00210.2018; Labbe SM, 2016, AM J PHYSIOL-ENDOC M, V311, pE260, DOI 10.1152/ajpendo.00545.2015; Larsen TM, 2002, AM J CLIN NUTR, V76, P780, DOI 10.1093/ajcn/76.4.780; Lehr L, 2006, FEBS LETT, V580, P4661, DOI 10.1016/j.febslet.2006.07.037; Li YG, 2014, EMBO REP, V15, P1069, DOI 10.15252/embr.201438775; Lidell ME, 2014, J INTERN MED, V276, P364, DOI 10.1111/joim.12255; Vizin RCL, 2018, J APPL PHYSIOL, V124, P672, DOI 10.1152/japplphysiol.00770.2017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loh RKC, 2019, DIABETES OBES METAB, V21, P276, DOI 10.1111/dom.13516; LOMAX P, 1966, NATURE, V210, P854, DOI 10.1038/210854a0; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Lynes MD, 2017, NAT MED, V23, P631, DOI 10.1038/nm.4297; Ma ST, 2012, J MOL CELL BIOL, V4, P88, DOI 10.1093/jmcb/mjs001; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; McKie GL, 2022, J PHYSIOL-LONDON, V600, P829, DOI 10.1113/JP281774; McKie GL, 2021, BIOL LETTERS, V17, DOI 10.1098/rsbl.2021.0171; McKie GL, 2019, J PHYSIOL-LONDON, V597, P4581, DOI 10.1113/JP278221; Nakamura K, 2011, AM J PHYSIOL-REG I, V301, pR1207, DOI 10.1152/ajpregu.00109.2011; O'Mara AE, 2020, J CLIN INVEST, V130, P2209, DOI 10.1172/JCI131126; Ohlson KBE, 2003, ANESTHESIOLOGY, V98, P437, DOI 10.1097/00000542-200302000-00025; OHLSON KBE, 1994, ANESTHESIOLOGY, V81, P176, DOI 10.1097/00000542-199407000-00024; Potapova TA, 2011, B EXP BIOL MED+, V151, P223, DOI 10.1007/s10517-011-1294-z; Putri M, 2015, BIOCHEM BIOPH RES CO, V457, P520, DOI 10.1016/j.bbrc.2014.12.124; Ramachandran R, 2013, P NATL ACAD SCI USA, V110, P7476, DOI 10.1073/pnas.1217431110; Redman LM, 2007, J CLIN ENDOCR METAB, V92, P527, DOI 10.1210/jc.2006-1740; Richard JE, 2017, AM J PHYSIOL-ENDOC M, V313, pE344, DOI 10.1152/ajpendo.00418.2016; RICQUIER D, 1976, BIOCHEM BIOPH RES CO, V73, P577, DOI 10.1016/0006-291X(76)90849-4; Roesler A, 2020, BIOCHEM J, V477, P709, DOI 10.1042/BCJ20190463; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Rossato M, 2014, MOL CELL ENDOCRINOL, V383, P137, DOI 10.1016/j.mce.2013.12.005; Tajino K, 2007, AM J PHYSIOL-REG I, V293, pR2128, DOI 10.1152/ajpregu.00377.2007; Trayhurn P, 2017, BIOCHIMIE, V134, P62, DOI 10.1016/j.biochi.2016.09.007; Valente A, 2015, FOOD CHEM TOXICOL, V86, P262, DOI 10.1016/j.fct.2015.09.018; Valgas P, 2021, CLIN EXP PHARMACOL P, V48, P1477; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Vaughan CH, 2014, METHOD ENZYMOL, V537, P199, DOI 10.1016/B978-0-12-411619-1.00011-2; Worthmann A, 2017, NAT MED, V23, P839, DOI 10.1038/nm.4357; Yamamura H, 2008, AM J PHYSIOL-CELL PH, V295, pC296, DOI 10.1152/ajpcell.00499.2007; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; ZARORBEHRENS G, 1983, AM J PHYSIOL, V244, pE361, DOI 10.1152/ajpendo.1983.244.4.E361; Zietak M, 2016, CELL METAB, V23, P1216, DOI 10.1016/j.cmet.2016.05.001	85	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22205	10.1096/fj.202101905RR	http://dx.doi.org/10.1096/fj.202101905RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35157333				2022-12-28	WOS:000761250800046
J	Yue, W; Wang, Y; Meng, TG; Zhang, HY; Zhang, XR; Ouyang, YC; Hou, Y; Schatten, H; Wang, ZB; Sun, QY				Yue, Wei; Wang, Yue; Meng, Tie-Gang; Zhang, Hong-Yong; Zhang, Xin-Ran; Ouyang, Ying-Chun; Hou, Yi; Schatten, Heide; Wang, Zhen-Bo; Sun, Qing-Yuan			Kinetochore scaffold 1 regulates SAC function during mouse oocyte meiotic maturation	FASEB JOURNAL			English	Article						kinetochore-microtubule attachment; KNL1; meiosis; oocyte; spindle assembly checkpoint	SPINDLE-ASSEMBLY CHECKPOINT; MICROTUBULE-BINDING; MEIOSIS-I; OUTER KINETOCHORE; CYCLIN-A; COMPLEX; KNL1; PHOSPHORYLATION; SEGREGATION; APC/C-CDC20	Precise regulation of chromosome separation through spindle assembly checkpoint (SAC) during oocyte meiosis is critical for mammalian reproduction. The kinetochore plays an important role in the regulation of SAC through sensing microtubule tension imbalance or missing microtubule connections. Here, we report that kinetochore scaffold 1 (KNL1, also known as CASC5), an outer kinetochore protein, plays a critical role in the SAC function of mouse oocytes. KNL1 localized at kinetochores from GVBD to the MII stage, and microinjection of KNL1-siRNA caused accelerated metaphase-anaphase transition and premature first meiosis completion, producing aneuploid eggs. The SAC was prematurely silenced in the presence of unstable kinetochore-microtubule attachments and misaligned chromosomes in KNL1-depleted oocytes. Additionally, KNL1 and MPS1 had a synergistic effect on the activation and maintenance of SAC. Taken together, our results suggest that KNL1, as a kinetochore platform protein, stabilizes SAC to ensure timely anaphase entry and accurate chromosome segregation during oocyte meiotic maturation.	[Yue, Wei; Meng, Tie-Gang; Zhang, Xin-Ran; Ouyang, Ying-Chun; Hou, Yi; Wang, Zhen-Bo] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Yue, Wei; Zhang, Xin-Ran; Wang, Zhen-Bo] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Yue] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Peoples R China; [Zhang, Hong-Yong] Peking Univ Shenzhen Hosp, Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Dept Reprod Med, Shenzhen, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA; [Sun, Qing-Yuan] Guangdong Second Prov Gen Hosp, Reprod Med Ctr, Fertil Preservat Lab, Guangdong Hong Kong Metab & Reprod Joint Lab, Guangzhou 510317, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanjing Agricultural University; Hong Kong University of Science & Technology; Peking University; University of Missouri System; University of Missouri Columbia	Wang, ZB (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Sun, QY (corresponding author), Guangdong Second Prov Gen Hosp, Reprod Med Ctr, Fertil Preservat Lab, Guangdong Hong Kong Metab & Reprod Joint Lab, Guangzhou 510317, Peoples R China.	wangzb@ioz.ac.cn; sunqy@gd2h.org.cn		Sun, Qing-Yuan/0000-0002-0148-2414	National Natural Science Foundation of China [32570854]; Natural Science Foundation of Shandong Province [ZR2021ZD33]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	National Natural Science Foundation of China, Grant/Award Number: 32570854; Natural Science Foundation of Shandong Province, Grant/Award Number: ZR2021ZD33	Caldas GV, 2013, J CELL BIOL, V203, P957, DOI 10.1083/jcb.201306054; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Cheeseman IM, 2008, MOL BIOL CELL, V19, P587, DOI 10.1091/mbc.E07-10-1051; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Corbett KD, 2017, PROG MOL SUBCELL BIO, V56, P429, DOI 10.1007/978-3-319-58592-5_18; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Ding Y, 2013, CANCER DISCOV, V3, P198, DOI 10.1158/2159-8290.CD-12-0353; Dumont J, 2010, NAT CELL BIOL, V12, P894, DOI 10.1038/ncb2093; EDWARDS RG, 1965, NATURE, V208, P349, DOI 10.1038/208349a0; Espeut J, 2012, J CELL BIOL, V196, P469, DOI 10.1083/jcb.201111107; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Fukagawa T, 2008, FRONT BIOSCI-LANDMRK, V13, P2705, DOI 10.2741/2877; Gerton JL, 2007, GENE DEV, V21, P238, DOI 10.1101/gad.1523107; Gorbsky GJ, 2015, FEBS J, V282, P2458, DOI 10.1111/febs.13166; Gui LM, 2012, DEVELOPMENT, V139, P1941, DOI 10.1242/dev.078352; Hached K, 2011, DEVELOPMENT, V138, P2261, DOI 10.1242/dev.061317; Herbert M, 2003, NAT CELL BIOL, V5, P1023, DOI 10.1038/ncb1062; Homer HA, 2006, HISTOL HISTOPATHOL, V21, P873, DOI 10.14670/HH-21.873; Hunt PA, 2008, TRENDS GENET, V24, P86, DOI 10.1016/j.tig.2007.11.010; Jia LY, 2013, TRENDS BIOCHEM SCI, V38, P302, DOI 10.1016/j.tibs.2013.03.004; Jones KT, 2013, DEVELOPMENT, V140, P3719, DOI 10.1242/dev.090589; Kabeche L, 2013, NATURE, V502, P110, DOI 10.1038/nature12507; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kerres A, 2004, MOL BIOL CELL, V15, P5255, DOI 10.1091/mbc.E04-06-0443; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kolano A, 2012, P NATL ACAD SCI USA, V109, pE1858, DOI 10.1073/pnas.1204686109; Lane SIR, 2012, DEVELOPMENT, V139, P1947, DOI 10.1242/dev.077040; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Li M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007701; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Ma JY, 2020, J GENET GENOMICS, V47, P659, DOI 10.1016/j.jgg.2020.04.003; Ma RJ, 2014, FASEB J, V28, P4026, DOI 10.1096/fj.14-250886; MacLennan M, 2015, SEMIN CELL DEV BIOL, V45, P68, DOI 10.1016/j.semcdb.2015.10.005; Malmanche N, 2006, FEBS LETT, V580, P2888, DOI 10.1016/j.febslet.2006.03.081; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; McGulnness BE, 2009, CURR BIOL, V19, P369, DOI 10.1016/j.cub.2009.01.064; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Nagaoka SI, 2011, CURR BIOL, V21, P651, DOI 10.1016/j.cub.2011.03.003; Nekrasov VS, 2003, MOL BIOL CELL, V14, P4931, DOI 10.1091/mbc.E03-06-0419; Pagliuca C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007640; Przewloka MR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000478; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Schittenhelm RB, 2009, EMBO J, V28, P2374, DOI 10.1038/emboj.2009.188; Sebestova J, 2012, CELL CYCLE, V11, P3011, DOI 10.4161/cc.21398; Sen Aritro, 2013, Front Biosci (Schol Ed), V5, P451; Seo DW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15431; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tanaka K, 2013, CELL MOL LIFE SCI, V70, P559, DOI 10.1007/s00018-012-1057-7; Touati SA, 2016, CHROMOSOMA, V125, P321, DOI 10.1007/s00412-015-0536-7; Touati SA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7946; van Zon W, 2010, BIOCHEM SOC T, V38, P72, DOI 10.1042/BST0380072; Varma D, 2012, J CELL SCI, V125, P5927, DOI 10.1242/jcs.093724; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yoshida S, 2015, DEV CELL, V33, P589, DOI 10.1016/j.devcel.2015.04.020; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4	58	0	0	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22210	10.1096/fj.202101586RR	http://dx.doi.org/10.1096/fj.202101586RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35167144				2022-12-28	WOS:000761250800040
J	Zivic, Z; Strmsek, Z; Novinec, M; Lah, J; Hadzi, S				Zivic, Zala; Strmsek, Ziga; Novinec, Marko; Lah, Jurij; Hadzi, San			Structural polymorphism of coiled-coils from the stalk domain of SARS-CoV-2 spike protein	FASEB JOURNAL			English	Article						coiled-coil; SARS-CoV-2; spike; thermodynamics; X-ray		Spike trimer plays a key role in SARS-CoV-2 infection and vaccine development. It consists of a globular head and a flexible stalk domain that anchors the protein into the viral membrane. While the head domain has been extensively studied, the properties of the adjoining stalk are poorly understood. Here, we characterize the coiled-coil formation and thermodynamic stability of the stalk domain and its segments. We find that the N-terminal segment of the stalk does not form coiled-coils and remains disordered in solution. The C-terminal stalk segment forms a trimeric coiled-coil in solution, which becomes significantly stabilized in the context of the full-length stalk. Its crystal structure reveals a novel antiparallel tetramer coiled-coil with an unusual combination of a-d and e-a-d hydrophobic core packing. Structural analysis shows that a subset of hydrophobic residues stabilizes different coiled-coil structures: trimer, tetramer, and heterohexamer, underscoring a highly polymorphic nature of the SARS-CoV-2 stalk sequence.	[Zivic, Zala; Novinec, Marko; Lah, Jurij; Hadzi, San] Univ Ljubljana, Fac Chem & Chem Technol, Vecna Pot 113, Ljubljana, Slovenia; [Strmsek, Ziga; Hadzi, San] Natl Inst Chem, Dept Synthet Biol & Immunol, Ljubljana, Slovenia	University of Ljubljana; National Institute of Chemistry - Slovenia	Lah, J; Hadzi, S (corresponding author), Univ Ljubljana, Fac Chem & Chem Technol, Vecna Pot 113, Ljubljana, Slovenia.	jurij.lah@fkkt.uni-lj.si; san.hadzi@fkkt.uni-lj.si		Hadzi, San/0000-0002-5615-7918; Novinec, Marko/0000-0003-1824-1649; Zivic, Zala/0000-0001-9044-3064	Javna Agencija za Raziskovalno Dejavnost RS (ARRS) [J1-1709, P1-0201]	Javna Agencija za Raziskovalno Dejavnost RS (ARRS)(Slovenian Research Agency - Slovenia)	Javna Agencija za Raziskovalno Dejavnost RS (ARRS), Grant/Award Number: J1-1709 and P1-0201	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Cai YF, 2020, SCIENCE, V369, P1586, DOI [10.1126/science.abd4251, 10.1101/2020.05.16.099317]; Casalino L, 2020, ACS CENTRAL SCI, V6, P1722, DOI 10.1021/acscentsci.0c01056; Celigoy J, 2011, PROTEIN SCI, V20, P2125, DOI 10.1002/pro.736; Choi YK, 2021, J CHEM THEORY COMPUT, V17, P2479, DOI 10.1021/acs.jctc.0c01144; Deng YQ, 2006, STRUCTURE, V14, P889, DOI 10.1016/j.str.2006.03.007; Duquerroy S, 2005, VIROLOGY, V335, P276, DOI 10.1016/j.virol.2005.02.022; Durr E, 2000, PROTEIN SCI, V9, P1410; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gradisar H, 2011, J PEPT SCI, V17, P100, DOI 10.1002/psc.1331; Gurnon DG, 2003, J AM CHEM SOC, V125, P7518, DOI 10.1021/ja0357590; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang Y, 2020, ACTA PHARMACOL SIN, V41, P1141, DOI 10.1038/s41401-020-0485-4; Ingallinella P, 2004, P NATL ACAD SCI USA, V101, P8709, DOI 10.1073/pnas.0402753101; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krammer F, 2020, NATURE, V586, P516, DOI 10.1038/s41586-020-2798-3; Liu J, 2006, BIOCHEMISTRY-US, V45, P15224, DOI 10.1021/bi061914m; Loladze VV, 2001, PROTEIN SCI, V10, P1343, DOI 10.1110/ps.370101; Manalastas-Cantos K, 2021, J APPL CRYSTALLOGR, V54, P343, DOI 10.1107/S1600576720013412; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Sammito M, 2013, NAT METHODS, V10, P1099, DOI [10.1038/nmeth.2644, 10.1038/NMETH.2644]; Turonova B, 2020, SCIENCE, V370, P203, DOI 10.1126/science.abd5223; Vincent TL, 2013, BIOINFORMATICS, V29, P69, DOI 10.1093/bioinformatics/bts648; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang MY, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.587269; Wang XH, 2019, J MOL MODEL, V25, DOI 10.1007/s00894-018-3886-2; Watanabe Y, 2020, SCIENCE, V369, P330, DOI 10.1126/science.abb9983; Yao HP, 2020, CELL, V183, P730, DOI 10.1016/j.cell.2020.09.018	28	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22199	10.1096/fj.202101670R	http://dx.doi.org/10.1096/fj.202101670R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35157347	Green Published, hybrid			2022-12-28	WOS:000761250800013
J	Junker, A; Wang, J; Gouspillou, G; Ehinger, JK; Elmer, E; Sjovall, F; Fisher-Wellman, KH; Neufer, PD; Molina, AJA; Ferrucci, L; Picard, M				Junker, Alex; Wang, Jennifer; Gouspillou, Gilles; Ehinger, Johannes K.; Elmer, Eskil; Sjovall, Fredrik; Fisher-Wellman, Kelsey H.; Neufer, P. Darrell; Molina, Anthony J. A.; Ferrucci, Luigi; Picard, Martin			Human studies of mitochondrial biology demonstrate an overall lack of binary sex differences: A multivariate meta-analysis	FASEB JOURNAL			English	Article						mitochondrion; mtDNAcn; respirometry; sex differences; sexual dimorphism	SKELETAL-MUSCLE MITOCHONDRIAL; MARITAL TRANSITIONS; PHYSICAL-ACTIVITY; HEALTH BEHAVIORS; OXIDATIVE STRESS; EFFECT SIZES; BLOOD-CELLS; WEIGHT-LOSS; METABOLISM; EXERCISE	Mitochondria are maternally inherited organelles that play critical tissue-specific roles, including hormone synthesis and energy production, that influence human development, health, and aging. However, whether mitochondria from women and men exhibit consistent biological differences remains unclear, representing a major gap in knowledge. This meta-analysis systematically examined four domains and six subdomains of mitochondrial biology (total 39 measures), including mitochondrial content, respiratory capacity, reactive oxygen species (ROS) production, morphometry, and mitochondrial DNA copy number. Standardized effect sizes (Hedge's g) of sex differences were computed for each measure using data in 2258 participants (51.5% women) from 50 studies. Only two measures demonstrated aggregate binary sex differences: higher mitochondrial content in women's WAT and isolated leukocyte subpopulations (g = 0.20, chi(2) p = .01), and higher ROS production in men's skeletal muscle (g = 0.49, chi(2) p < .0001). Sex differences showed weak to no correlation with age or BMI. Studies with small sample sizes tended to overestimate effect sizes (r = -.17, p < .001), and sex differences varied by tissue examined. Our findings point to a wide variability of findings in the literature concerning possible binary sex differences in mitochondrial biology. Studies specifically designed to capture sex- and gender-related differences in mitochondrial biology are needed, including detailed considerations of physical activity and sex hormones.	[Junker, Alex; Wang, Jennifer; Picard, Martin] Columbia Univ, Irving Med Ctr, Dept Psychiat, Div Behav Med, 630 West 168th St,Box 172, New York, NY 10032 USA; [Gouspillou, Gilles] Univ Quebec Montreal UQAM, Fac Sci, Dept Sci Activite Phys, Montreal, PQ, Canada; [Ehinger, Johannes K.; Elmer, Eskil; Sjovall, Fredrik] Lund Univ, Dept Clin Sci, Mitochondrial Med, Lund, Sweden; [Ehinger, Johannes K.] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Otorhinolaryngol Head & Neck Surg, Lund, Sweden; [Fisher-Wellman, Kelsey H.; Neufer, P. Darrell] East Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC 27858 USA; [Fisher-Wellman, Kelsey H.; Neufer, P. Darrell] East Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27858 USA; [Molina, Anthony J. A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ferrucci, Luigi] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA; [Picard, Martin] Columbia Univ, Irving Med Ctr, H Houston Merritt Ctr, Dept Neurol,Translat Neurosci Initiat, New York, NY 10032 USA; [Picard, Martin] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; NewYork-Presbyterian Hospital; University of Quebec; University of Quebec Montreal; Lund University; Lund University; Skane University Hospital; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Columbia University; NewYork-Presbyterian Hospital; New York State Psychiatry Institute	Picard, M (corresponding author), Columbia Univ, Irving Med Ctr, Dept Psychiat, Div Behav Med, 630 West 168th St,Box 172, New York, NY 10032 USA.	martin.picard@columbia.edu		Junker, Alex/0000-0003-1746-7160; Sjovall, Fredrik/0000-0001-5612-0325	FRQS grant [297877]; Wharton Fund; NIH [R01MH119336, R01AG066828, R01MH122706, R21MH123927]	FRQS grant; Wharton Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This meta-analysis was a group effort from investigators across multiple fields including metabolism/diabetes, exercise physiology, skeletal muscle biology, gerontology, and others. We are grateful to investigators and their team who provided sex-disaggregated data for this cross-disciplinary effort. The work of the authors was supported by FRQS grant 297877 to G.G., the Wharton Fund to A.J. and M.P., and NIH grants R01MH119336, R01AG066828, R01MH122706, and R21MH123927 to M.P.	AlGhatrif M, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006604; Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, pC844, DOI 10.1152/ajpcell.00402.2005; Anderson SF, 2017, PSYCHOL SCI, V28, P1547, DOI 10.1177/0956797617723724; [Anonymous], 2016, Nat Rev Dis Primers, V2, P16058, DOI 10.1038/nrdp.2016.58; Arribat Y, 2019, ACTA PHYSIOL, V225, DOI 10.1111/apha.13179; Banuls C, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0514-7; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Bektas A, 2019, AGING-US, V11, P9234, DOI 10.18632/aging.102438; Bescos R, 2018, ACTA PHYSIOL, V223, DOI 10.1111/apha.13039; Broskey NT, 2014, J CLIN ENDOCR METAB, V99, P1852, DOI 10.1210/jc.2013-3983; Brydges CR, 2019, INNOV AGING, V3, DOI 10.1093/geroni/igz036; Butler ES, 2020, J SLEEP RES, V29, DOI 10.1111/jsr.12928; Cardinale DA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01133; Chomentowski P, 2011, J CLIN ENDOCR METAB, V96, P494, DOI 10.1210/jc.2010-0822; COGGAN AR, 1992, J APPL PHYSIOL, V72, P1780, DOI 10.1152/jappl.1992.72.5.1780; COGGAN AR, 1992, J GERONTOL, V47, pB71, DOI 10.1093/geronj/47.3.B71; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Courtenay WH., 2000, J MENS STUD; Crane JD, 2010, J GERONTOL A-BIOL, V65, P119, DOI 10.1093/gerona/glp179; Cree-Green M, 2017, J CLIN ENDOCR METAB, V102, P1652, DOI 10.1210/jc.2016-3912; Da Silva T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24355-6; de Vries GJ, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0032-z; DeConne TM, 2020, AM J PHYSIOL-HEART C, V319, pH481, DOI 10.1152/ajpheart.00434.2020; Dodds RM, 2018, EXP GERONTOL, V113, P80, DOI 10.1016/j.exger.2018.09.020; Dohlmann TL, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13857; Ehinger JK, 2015, J NEUROL, V262, P1493, DOI 10.1007/s00415-015-7737-0; Faris MAIE, 2020, BRIT J NUTR, V123, P1, DOI 10.1017/S000711451900254X; Fausto-Sterling A, 2005, SIGNS, V30, P1491, DOI 10.1086/424932; Fausto-Sterling A., 2012, SEX GENDER BIOL SOCI; Ferrucci L, 2020, AGING CELL, V19, DOI 10.1111/acel.13080; Fidolini V, 2022, FOOD CULT SOC, V25, P254, DOI 10.1080/15528014.2021.1882795; Fisher AJ, 2018, P NATL ACAD SCI USA, V115, pE6106, DOI 10.1073/pnas.1711978115; Fisher-Wellman KH, 2014, DIABETES, V63, P132, DOI 10.2337/db13-0940; Gaeta L, 2020, J SPEECH LANG HEAR R, V63, P1572, DOI 10.1044/2020_JSLHR-19-00299; Gettler LT, 2011, P NATL ACAD SCI USA, V108, P16194, DOI 10.1073/pnas.1105403108; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Gonzalez-Freire M, 2018, AGING CELL, V17, DOI 10.1111/acel.12725; Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80; Goulet-Pelletier JC, 2018, QUANT METH PSYCHOL, V14, P242, DOI 10.20982/tqmp.14.4.p242; Hafen PS, 2019, J APPL PHYSIOL, V127, P47, DOI 10.1152/japplphysiol.01098.2018; Hafen PS, 2018, J APPL PHYSIOL, V125, P1447, DOI 10.1152/japplphysiol.00383.2018; Harish G, 2013, NEUROPATH APPL NEURO, V39, P298, DOI 10.1111/j.1365-2990.2012.01285.x; Harry-Hernandez S, 2020, TRANSGENDER HEALTH, V5, P59, DOI 10.1089/trgh.2019.0007; Hill BG, 2020, BIOL CHEM, V401, P3, DOI 10.1515/hsz-2019-0268; Innocenti P, 2011, SCIENCE, V332, P845, DOI 10.1126/science.1201157; Jang JY, 2018, J CLIN INVEST, V128, P3662, DOI 10.1172/JCI120842; Joel D, 2021, NEUROSCI BIOBEHAV R, V122, P165, DOI 10.1016/j.neubiorev.2020.11.018; Joel D, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0451; Johnson J., 2012, DESIGNING CONDUCTING, P17, DOI DOI 10.4135/9781452230610.N2; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kutob RM, 2017, J WOMENS HEALTH, V26, P313, DOI 10.1089/jwh.2016.5925; Labbe K, 2014, ANNU REV CELL DEV BI, V30, P357, DOI 10.1146/annurev-cellbio-101011-155756; Lalia AZ, 2017, AGING-US, V9, P1096, DOI 10.18632/aging.101210; Lalia AZ, 2016, J CLIN ENDOCR METAB, V101, P626, DOI 10.1210/jc.2015-2892; Lane N, 2015, VITAL QUESTION ENERG; Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618; Lee S, 2005, INT J EPIDEMIOL, V34, P69, DOI 10.1093/ije/dyh258; Li JZ, 2018, J BIOL CHEM, V293, P12719, DOI 10.1074/jbc.RA118.003075; Marais GAB, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0181-y; Martelli M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph181910074; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; McCully KK, 2011, J APPL PHYSIOL, V111, P143, DOI 10.1152/japplphysiol.00094.2011; McKeough ZJ, 2006, RESP MED, V100, P1817, DOI 10.1016/j.rmed.2006.01.017; McLaughlin KL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74718-1; Memme JM, 2021, J PHYSIOL-LONDON, V599, P803, DOI 10.1113/JP278853; Miller MS, 2017, J APPL PHYSIOL, V122, P775, DOI 10.1152/japplphysiol.00830.2016; Miotto PM, 2018, AM J PHYSIOL-REG I, V314, pR909, DOI 10.1152/ajpregu.00025.2018; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Monaco CMF, 2018, DIABETOLOGIA, V61, P1411, DOI 10.1007/s00125-018-4602-6; Mottis A, 2019, SCIENCE, V366, P827, DOI 10.1126/science.aax3768; Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011; Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5; Panee J, 2018, J NEUROIMMUNE PHARM, V13, P113, DOI 10.1007/s11481-017-9767-0; Patel MR, 2016, ELIFE, V5, DOI 10.7554/eLife.16923; Pearse RV, 2019, BRAIN RES, V1722, DOI 10.1016/j.brainres.2019.146352; Perrotte JK, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10608-z; Picard M, 2021, MITOCHONDRION, V60, P1, DOI 10.1016/j.mito.2021.06.010; Picard M, 2018, FRONT NEUROENDOCRIN, V49, P72, DOI 10.1016/j.yfrne.2018.01.001; Picard M, 2018, BIOL PSYCHIAT, V84, P9, DOI 10.1016/j.biopsych.2018.01.012; Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003; Picard M, 2012, AM J PHYSIOL-CELL PH, V302, pC629, DOI 10.1152/ajpcell.00368.2011; Picard Martin, 2010, Aging Cell, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x; Porat-Shliom N, 2019, ISCIENCE, V11, P440, DOI 10.1016/j.isci.2018.12.036; Rath S, 2021, NUCLEIC ACIDS RES, V49, pD1541, DOI 10.1093/nar/gkaa1011; Rausser S, 2021, ELIFE, V10, DOI [10.7554/eLife.70899, 10.7554/eLife.70899.sa0, 10.7554/eLife.70899.sa1, 10.7554/eLife.70899.sa2]; Richardson S., 2021, PHILOS THEORY PRACTI, V13, DOI [10.3998/ptpbio.16039257.0013.009, DOI 10.3998/PTPBIO.16039257.0013.009]; Richardson Sarah., 2013, SEX ITSELF SEARCH MA; Ritz SA, 2014, FASEB J, V28, P4, DOI 10.1096/fj.13-233395; Rosenwohl-Mack A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240088; Rothgerber H, 2013, PSYCHOL MEN MASCULIN, V14, P363, DOI 10.1037/a0030379; Santanasto AJ, 2015, J GERONTOL A-BIOL, V70, P1379, DOI 10.1093/gerona/glu134; Selvaraj V, 2018, BIOL REPROD, V99, P13, DOI 10.1093/biolre/ioy102; Sharara E, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5472-z; Silaidos C, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0193-7; Sjovall F, 2013, CRIT CARE, V17, DOI 10.1186/cc12831; Sjovall F, 2013, MITOCHONDRION, V13, P7, DOI 10.1016/j.mito.2012.11.001; Sjovall F, 2010, CRIT CARE, V14, DOI 10.1186/cc9337; Smith SA, 2004, J APPL PHYSIOL, V96, P2288, DOI 10.1152/japplphysiol.01021.2003; Spencer RA, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0166-8; Tcymbal A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00157; Tecilazich F, 2013, J VASC SURG, V57, P997, DOI 10.1016/j.jvs.2012.10.011; Tevald MA, 2014, AGE, V36, DOI 10.1007/s11357-014-9713-5; Thompson JR, 2013, J SURG RES, V185, P206, DOI 10.1016/j.jss.2013.05.054; Thubron EB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47783-4; Tian J, 2020, INT J BEHAV NUTR PHY, V17, DOI 10.1186/s12966-020-00989-6; Tian Q, 2021, AGING CELL, V20, DOI 10.1111/acel.13487; Toledo FGS, 2008, DIABETES, V57, P987, DOI 10.2337/db07-1429; Toledo FGS, 2006, J CLIN ENDOCR METAB, V91, P3224, DOI 10.1210/jc.2006-0002; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Tyrrell DJ, 2015, J GERONTOL A-BIOL, V70, P1394, DOI 10.1093/gerona/glu096; van den Beld AW, 2018, LANCET DIABETES ENDO, V6, P647, DOI 10.1016/S2213-8587(18)30026-3; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; VanKim NA, 2019, J ACAD NUTR DIET, V119, P2028, DOI 10.1016/j.jand.2019.05.014; Venn S, 2008, BRIT J SOCIOL, V59, P79, DOI 10.1111/j.1468-4446.2007.00183.x; Ventura-Clapier R, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00557; Ventura-Clapier R, 2017, CLIN SCI, V131, P803, DOI 10.1042/CS20160485; Victor VM, 2014, J SEX MED, V11, P454, DOI 10.1111/jsm.12376; Wachsmuth M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005939; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Waters DL, 2009, MECH AGEING DEV, V130, P315, DOI 10.1016/j.mad.2009.01.006; Willcocks RJ, 2010, NMR BIOMED, V23, P569, DOI 10.1002/nbm.1495; Wu A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49180-3; Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111; Yen HH, 2012, WORLD J GASTROENTERO, V18, P5084, DOI 10.3748/wjg.v18.i36.5084; Yin X, 2014, J CLIN ENDOCR METAB, V99, pE209, DOI 10.1210/jc.2013-3042; Yonova-Doing E, 2021, NAT GENET, V53, P982, DOI 10.1038/s41588-021-00868-1; Zeeman L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186533; Zhang Q, 2020, INT J TRANSGEND HEAL, V21, P125, DOI 10.1080/26895269.2020.1753136; Zhang RY, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4287-0	130	1	1	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22146	10.1096/fj.202101628R	http://dx.doi.org/10.1096/fj.202101628R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35073429	Green Submitted			2022-12-28	WOS:000747987800005
J	Linsambarth, S; Carvajal, FJ; Moraga-Amaro, R; Mendez, L; Tamburini, G; Jimenez, I; Verdugo, DA; Gomez, GI; Jury, N; Martinez, P; van Zundert, B; Varela-Nallar, L; Retamal, MA; Martin, C; Altenberg, GA; Fiori, MC; Cerpa, W; Orellana, JA; Stehberg, J				Linsambarth, Sergio; Carvajal, Francisco J.; Moraga-Amaro, Rodrigo; Mendez, Luis; Tamburini, Giovanni; Jimenez, Ivanka; Antonio Verdugo, Daniel; Gomez, Gonzalo, I; Jury, Nur; Martinez, Pablo; van Zundert, Brigitte; Varela-Nallar, Lorena; Retamal, Mauricio A.; Martin, Claire; Altenberg, Guillermo A.; Fiori, Mariana C.; Cerpa, Waldo; Orellana, Juan A.; Stehberg, Jimmy			Astroglial gliotransmitters released via Cx43 hemichannels regulate NMDAR-dependent transmission and short-term fear memory in the basolateral amygdala	FASEB JOURNAL			English	Article						astrocytes; basolateral amygdala; Connexin 43 hemichannels; Cx43; d-serine; fear conditioning; HCs; memory; NMDA receptor; short-term memory	GAP-JUNCTION HEMICHANNELS; D-SERINE; LONG-TERM; CONNEXIN-43 HEMICHANNELS; CONDITIONAL FEAR; GLIAL-CELLS; ASTROCYTES; GLUTAMATE; CALCIUM; CHANNELS	Astrocytes release gliotransmitters via connexin 43 (Cx43) hemichannels into neighboring synapses, which can modulate synaptic activity and are necessary for fear memory consolidation. However, the gliotransmitters released, and their mechanisms of action remain elusive. Here, we report that fear conditioning training elevated Cx43 hemichannel activity in astrocytes from the basolateral amygdala (BLA). The selective blockade of Cx43 hemichannels by microinfusion of TAT-Cx43L2 peptide into the BLA induced memory deficits 1 and 24 h after training, without affecting learning. The memory impairments were prevented by the co-injection of glutamate and D-serine, but not by the injection of either alone, suggesting a role for NMDA receptors (NMDAR). The incubation with TAT-Cx43L2 decreased NMDAR-mediated currents in BLA slices, effect that was also prevented by the addition of glutamate and D-serine. NMDARs in primary neuronal cultures were unaffected by TAT-Cx43L2, ruling out direct effects of the peptide on NMDARs. Finally, we show that D-serine permeates through purified Cx43 hemichannels reconstituted in liposomes. We propose that the release of glutamate and D-serine from astrocytes through Cx43 hemichannels is necessary for the activation of post-synaptic NMDARs during training, to allow for the formation of short-term and subsequent long-term memory, but not for learning per se.	[Linsambarth, Sergio; Moraga-Amaro, Rodrigo; Mendez, Luis; Tamburini, Giovanni; Jimenez, Ivanka; Antonio Verdugo, Daniel; Stehberg, Jimmy] Univ Andres Bello, Fac Med & Fac Ciencias La Vida, Inst Ciencias Biomed, Lab Neurobiol, Santiago, Chile; [Carvajal, Francisco J.; Cerpa, Waldo] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Lab Func & Patol Neuronal, Santiago, Chile; [Gomez, Gonzalo, I] Univ Autonoma Chile, Fac Ciencias Salud, Inst Ciencias Biomed, Santiago, Chile; [Jury, Nur; Martinez, Pablo; van Zundert, Brigitte; Varela-Nallar, Lorena] Univ Andres Bello, Fac Med, Inst Ciencias Biomed, Santiago, Chile; [Jury, Nur; Martinez, Pablo; van Zundert, Brigitte; Varela-Nallar, Lorena] Univ Andres Bello, Fac Ciencias Vida, Santiago, Chile; [Retamal, Mauricio A.] Clin Alemana Univ Desarrollo, Ctr Fisiol Celular & Integrat, Fac Med, Santiago, Chile; [Martin, Claire] Univ Paris Diderot, CNRS, Unite Biol Fonct & Adaptat, Unite Mixte Rech 8251,Sorbonne Paris Cite, Paris, France; [Altenberg, Guillermo A.; Fiori, Mariana C.] Texas Tech Univ, Ctr Membrane Prot Res, Dept Cell Physiol & Mol Biophys, Hlth Sci Ctr, Lubbock, TX 79409 USA; [Orellana, Juan A.] Pontificia Univ Catolica Chile, Dept Neurol, Escuela Med, Santiago, Chile	Universidad Andres Bello; Pontificia Universidad Catolica de Chile; Universidad Autonoma de Chile; Universidad Andres Bello; Universidad Andres Bello; Universidad del Desarrollo; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Pontificia Universidad Catolica de Chile	Stehberg, J (corresponding author), Univ Andres Bello, Inst Ciencias Biomed, Lab Neurobiol, Santiago, Chile.	jstehberg@unab.cl	Cerpa, Waldo/GSI-5204-2022; Gomez, Gonzalo I/N-6443-2019; Martin, Claire/T-1360-2019	Cerpa, Waldo/0000-0001-7344-0144; Gomez, Gonzalo I/0000-0001-7761-8675; Martin, Claire/0000-0001-5340-8323; Martinez Contreras, Pablo/0000-0003-3496-4652; Verdugo, Daniel Antonio/0000-0003-0256-454X; Retamal, Mauricio A./0000-0003-2562-6686; Orellana, Juan Andres/0000-0003-4076-207X; Jimenez, Ivanka/0000-0002-5118-6349	UNAB [DI-603-14/N, DI-4/17N]; FONDECYT [1160986, 1200452, 1160227, 1190461, 1140301, 1210375]; CORFO INNOVA [14IDL2-30195]; FONDEQUIP EQM [140166]; ECOS-CONICYT [C15B01]; Programa de Investigacion Asociativa (PIA): Grant Anillo de Ciencia y Tecnologia [ACT1411]; BMBF [20150065]; Proyecto interno Universidad del Desarrollo [23.400.521]	UNAB; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CORFO INNOVA; FONDEQUIP EQM; ECOS-CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Programa de Investigacion Asociativa (PIA): Grant Anillo de Ciencia y Tecnologia; BMBF(Federal Ministry of Education & Research (BMBF)); Proyecto interno Universidad del Desarrollo	UNAB, Grant/Award Number: DI-603-14/N and DI-4/17N; FONDECYT, Grant/Award Number: 1160986, 1200452, 1160227, 1190461, 1140301 and 1210375; CORFO INNOVA, Grant/Award Number: 14IDL2-30195; FONDEQUIP EQM, Grant/Award Number: 140166; ECOS-CONICYT, Grant/Award Number: C15B01; Programa de Investigacion Asociativa (PIA): Grant Anillo de Ciencia y Tecnologia, Grant/Award Number: ACT1411; BMBF, Grant/Award Number: 20150065; Proyecto interno Universidad del Desarrollo, Grant/Award Number: 23.400.521	Achour SB, 2010, NEUROCHEM INT, V57, P440, DOI 10.1016/j.neuint.2010.02.013; Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Allen NJ, 2005, CURR OPIN NEUROBIOL, V15, P542, DOI 10.1016/j.conb.2005.08.006; Anderson WW, 2007, J NEUROSCI METH, V162, P346, DOI 10.1016/j.jneumeth.2006.12.018; Arwert LI, 2003, NUTR NEUROSCI, V6, P269, DOI 10.1080/10284150310001612195; Balu DT, 2014, CELL MOL NEUROBIOL, V34, P419, DOI 10.1007/s10571-014-0027-z; Bao XY, 2007, P NATL ACAD SCI USA, V104, P4919, DOI 10.1073/pnas.0603154104; Bao XY, 2004, J BIOL CHEM, V279, P20058, DOI 10.1074/jbc.M311137200; Bonansco C, 2011, EUR J NEUROSCI, V33, P1483, DOI 10.1111/j.1460-9568.2011.07631.x; Bruzzone S, 2001, FASEB J, V15, P10; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Chever O, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0596; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Dzamba D, 2013, CURR NEUROPHARMACOL, V11, P250, DOI 10.2174/1570159X11311030002; Ehmsen JT, 2013, J NEUROSCI, V33, P12464, DOI 10.1523/JNEUROSCI.4914-12.2013; FANSELOW MS, 1994, BEHAV NEUROSCI, V108, P235, DOI 10.1037/0735-7044.108.2.235; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Fiori MC, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140089; Fiori MC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00071; Fiori MC, 2012, J BIOL CHEM, V287, P40826, DOI 10.1074/jbc.M112.383281; Gajardo-Gomez R, 2017, GLIA, V65, P122, DOI 10.1002/glia.23080; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Gold PE, 2006, LEARN MEMORY, V13, P506, DOI 10.1101/lm.277406; GUTNICK MJ, 1981, BRAIN RES, V213, P486, DOI 10.1016/0006-8993(81)90259-6; Hansen KB, 2013, MOL PHARMACOL, V84, P114, DOI 10.1124/mol.113.085803; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hilgenberg Lutz G W, 2007, J Vis Exp, P562, DOI 10.3791/562; HOLOPAINEN I, 1989, J NEUROSCI RES, V24, P374, DOI 10.1002/jnr.490240306; Karpuk N, 2011, J NEUROSCI, V31, P414, DOI 10.1523/JNEUROSCI.5247-10.2011; KIM JJ, 1992, BEHAV NEUROSCI, V106, P591, DOI 10.1037/0735-7044.106.4.591; KIM JJ, 1991, BEHAV NEUROSCI, V105, P126, DOI 10.1037/0735-7044.105.1.126; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; Lee H, 1998, J NEUROSCI, V18, P8444; Liu QS, 2004, P NATL ACAD SCI USA, V101, P3172, DOI 10.1073/pnas.0306731101; Maren S, 1996, BEHAV NEUROSCI, V110, P1365, DOI 10.1037/0735-7044.110.6.1365; Meunier C, 2017, J NEUROSCI, V37, P9064, DOI 10.1523/JNEUROSCI.2204-16.2017; Moraga-Amaro R, 2014, J PHYSIOL-PARIS, V108, P240, DOI 10.1016/j.jphysparis.2014.08.005; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; Orellana JA, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00102; Orellana JA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00193; Orellana JA, 2011, J NEUROCHEM, V118, P826, DOI 10.1111/j.1471-4159.2011.07210.x; Pan HC, 2015, GLIA, V63, P877, DOI 10.1002/glia.22790; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pellerin L, 2005, MOL NEUROBIOL, V32, P59, DOI 10.1385/MN:32:1:059; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Pocivavsek A, 2011, NEUROPSYCHOPHARMACOL, V36, P2357, DOI 10.1038/npp.2011.127; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; Redman S, 1996, CLIN EXP PHARMACOL P, V23, P961, DOI 10.1111/j.1440-1681.1996.tb01149.x; Retamal MA, 2007, J NEUROSCI, V27, P13781, DOI 10.1523/JNEUROSCI.2042-07.2007; Saez JC, 2003, ACTA PHYSIOL SCAND, V179, P9, DOI 10.1046/j.1365-201X.2003.01196.x; Saez JC, 2010, EXP CELL RES, V316, P2377, DOI 10.1016/j.yexcr.2010.05.026; Sebastiao Ana M, 2009, Handb Exp Pharmacol, P471, DOI 10.1007/978-3-540-89615-9_16; Seki A, 2004, CIRC RES, V95, P22, DOI 10.1161/01.RES.0000140737.62245.c5; Shigetomi E, 2013, J NEUROSCI, V33, P10143, DOI 10.1523/JNEUROSCI.5779-12.2013; Sibille J, 2014, J PHYSIOL-LONDON, V592, P87, DOI 10.1113/jphysiol.2013.261735; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Song EK, 2011, J BIOL CHEM, V286, P44480, DOI 10.1074/jbc.M111.307645; Stehberg J, 2012, FASEB J, V26, P3649, DOI 10.1096/fj.11-198416; Stout C, 2003, GLIA, V43, P265, DOI 10.1002/glia.10257; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Wallraff A, 2006, J NEUROSCI, V26, P5438, DOI 10.1523/JNEUROSCI.0037-06.2006; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Zhang Z, 2008, CEREB CORTEX, V18, P2391, DOI 10.1093/cercor/bhn008	70	3	3	6	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22134	10.1096/fj.202100798RR	http://dx.doi.org/10.1096/fj.202100798RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35061296				2022-12-28	WOS:000747987800047
J	Jiang, XP; Wojtkiewicz, M; Patwardhan, C; Greer, S; Kong, YF; Kuss, M; Huang, X; Liao, J; Lu, YF; Dudley, A; Gundry, RL; Fuchs, M; Streubel, P; Duan, B				Jiang, Xiping; Wojtkiewicz, Melinda; Patwardhan, Chinmay; Greer, Sydney; Kong, Yunfan; Kuss, Mitchell; Huang, Xi; Liao, Jun; Lu, Yongfeng; Dudley, Andrew; Gundry, Rebekah L.; Fuchs, Matthias; Streubel, Philipp; Duan, Bin			The effects of maturation and aging on the rotator cuff tendon-to-bone interface	FASEB JOURNAL			English	Article						age; biomechanical properties; enthesis; nanoindentation; proteomics	GLYCATION END-PRODUCTS; RISK-FACTORS; CELLS; AGE; ATTACHMENT; ORGANIZATION; PREVALENCE; STRATEGIES; CARTILAGE; SECTIONS	Rotator cuff tendon injuries often occur at the tendon-to-bone interface (i.e., enthesis) area, with a high prevalence for the elderly population, but the underlying reason for this phenomenon is still unknown. The objective of this study is to identify the histological, molecular, and biomechanical alterations of the rotator cuff enthesis with maturation and aging in a mouse model. Four different age groups of mice (newborn, young, adult, and old) were studied. Striking variations of the entheses were observed between the newborn and other matured groups, with collagen content, proteoglycan deposition, collagen fiber dispersion was significantly higher in the newborn group. The compositional and histological features of young, adult, and old groups did not show significant differences, except having increased proteoglycan deposition and thinner collagen fibers at the insertion sites in the old group. Nanoindentation testing showed that the old group had a smaller compressive modulus at the insertion site when compared with other groups. However, tensile mechanical testing reported that the old group demonstrated a significantly higher failure stress when compared with the young and adult groups. The proteomics analysis detected dramatic differences in protein content between newborn and young groups but minor changes among young, adult, and old groups. These results demonstrated: (1) the significant alterations of the enthesis composition and structure occur from the newborn to the young time period; (2) the increased risk of rotator cuff tendon injuries in the elderly population is not solely because of old age alone in the rodent model.	[Jiang, Xiping; Greer, Sydney; Kong, Yunfan; Kuss, Mitchell; Dudley, Andrew; Duan, Bin] Univ Nebraska Med Ctr, Mary & Dick Holland Regenerat Med Program, Omaha, NE USA; [Jiang, Xiping; Duan, Bin] Univ Nebraska Med Ctr, Div Cardiol, Dept Internal Med, Omaha, NE USA; [Jiang, Xiping; Greer, Sydney; Dudley, Andrew] Univ Nebraska Med Ctr, Mol Genet & Cell Biol Program, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Wojtkiewicz, Melinda; Gundry, Rebekah L.] Univ Nebraska Med Ctr, CardiOm Program, Ctr Heart & Vasc Res, Div Cardiovasc Med, Omaha, NE USA; [Wojtkiewicz, Melinda; Gundry, Rebekah L.] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE USA; [Patwardhan, Chinmay; Liao, Jun] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA; [Huang, Xi; Lu, Yongfeng] Univ Nebraska Lincoln, Dept Elect & Comp Engn, Lincoln, NE USA; [Fuchs, Matthias] Univ Nebraska Lincoln, Dept Phys & Astron, Lincoln, NE USA; [Streubel, Philipp] Univ Nebraska Med Ctr, Dept Orthoped Surg & Rehabil, Omaha, NE USA; [Duan, Bin] Univ Nebraska Med Ctr, Dept Surg, Coll Med, Omaha, NE USA; [Duan, Bin] Univ Nebraska Lincoln, Dept Mech & Mat Engn, Lincoln, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Texas System; University of Texas Arlington; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln	Duan, B (corresponding author), Univ Nebraska Med Ctr, DRC2 6014,601 S Saddle Creek Rd, Omaha, NE 68106 USA.	bin.duan@unmc.edu	Fuchs, Matthias/K-8476-2013	Fuchs, Matthias/0000-0003-1878-8986; Gundry, Rebekah L./0000-0002-9263-833X	National Institute of Health [NIH R01 AR073225]; China Scholarship Council; UNMC	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); UNMC	National Institute of Health, Grant/Award Number: NIH R01 AR073225; China Scholarship Council; UNMC	Abate M, 2017, ORTHOP TRAUMATOL-SUR, V103, P841, DOI 10.1016/j.otsr.2017.03.027; Abate M, 2014, MENOPAUSE, V21, P275, DOI 10.1097/GME.0b013e31829638e3; Abraham AC, 2013, ACTA BIOMATER, V9, P6322, DOI 10.1016/j.actbio.2013.01.031; Aifantis KE, 2011, J MATER SCI-MATER M, V22, P1375, DOI 10.1007/s10856-011-4320-9; Apostolakos John, 2014, Muscles Ligaments Tendons J, V4, P333; Armitage OE, 2017, ACTA BIOMATER, V56, P36, DOI 10.1016/j.actbio.2016.12.036; Bah I, 2020, J MECH BEHAV BIOMED, V112, DOI 10.1016/j.jmbbm.2020.104031; Benjamin M, 2002, COMP BIOCHEM PHYS A, V133, P931, DOI 10.1016/S1095-6433(02)00138-1; Blitz E, 2013, DEVELOPMENT, V140, P2680, DOI 10.1242/dev.093906; Chaudhuri J, 2018, CELL METAB, V28, P337, DOI 10.1016/j.cmet.2018.08.014; Deak F, 1999, MATRIX BIOL, V18, P55, DOI 10.1016/S0945-053X(98)00006-7; Degen RM, 2016, ARTHROSCOPY, V32, P2435, DOI 10.1016/j.arthro.2016.04.019; Diebold G, 2017, J BONE JOINT SURG AM, V99, P1198, DOI 10.2106/JBJS.16.00770; Duan B, 2016, ACTA BIOMATER, V36, P42, DOI 10.1016/j.actbio.2016.03.007; Duan B, 2015, TISSUE ENG PART C-ME, V21, P795, DOI [10.1089/ten.tec.2014.0589, 10.1089/ten.TEC.2014.0589]; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Golub EE., 2007, CURR OPIN ORTHOP, V18, P444, DOI [10.1097/BCO.0b013e3282630851, 10.1084/jem.93.5.415, DOI 10.1084/JEM.93.5.415]; Gulotta LV, 2009, CLIN SPORT MED, V28, P13, DOI 10.1016/j.csm.2008.09.002; Hauch KN, 2009, J MECH BEHAV BIOMED, V2, P339, DOI 10.1016/j.jmbbm.2008.10.005; Jie Shu, 2013, 2013 Seventh International Conference on Image and Graphics (ICIG), P937, DOI 10.1109/ICIG.2013.197; Kawamoto T, 2014, METHODS MOL BIOL, V1130, P149, DOI 10.1007/978-1-62703-989-5_11; Kielty CM, 2002, PHILOS T R SOC B, V357, P207, DOI 10.1098/rstb.2001.1029; Killian ML, 2016, FASEB J, V30, P301, DOI 10.1096/fj.14-258236; Klatt AR, 2011, INT J BIOCHEM CELL B, V43, P320, DOI 10.1016/j.biocel.2010.12.010; Lee YS, 2017, AM J SPORT MED, V45, P1755, DOI 10.1177/0363546517695234; Li DW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15191-2; Li YF, 2013, MATRIX BIOL, V32, P169, DOI 10.1016/j.matbio.2013.01.003; Lu HH, 2013, ANNU REV BIOMED ENG, V15, P201, DOI 10.1146/annurev-bioeng-071910-124656; Lui PPY, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-59; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; MILGROM C, 1995, J BONE JOINT SURG BR, V77B, P296, DOI 10.1302/0301-620X.77B2.7706351; Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; Odetti P, 2005, ANN NY ACAD SCI, V1043, P710, DOI 10.1196/annals.1333.082; Oh LS, 2007, CLIN ORTHOP RELAT R, P52, DOI 10.1097/BLO.0b013e31802fc175; Paracuellos P, 2017, MATRIX BIOL, V63, P106, DOI 10.1016/j.matbio.2017.02.002; Plate JF, 2014, AM J SPORT MED, V42, P859, DOI 10.1177/0363546513518418; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Saveh-Shemshaki N, 2019, ACTA BIOMATER, V94, P64, DOI 10.1016/j.actbio.2019.05.041; Schwartz AG, 2013, BONE, V55, P44, DOI 10.1016/j.bone.2013.03.010; Schwartz AG, 2015, DEVELOPMENT, V142, P196, DOI 10.1242/dev.112714; Smith L, 2012, CONNECT TISSUE RES, V53, P95, DOI 10.3109/03008207.2011.650804; Soboleva A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122557; Sugimoto Y, 2013, DEVELOPMENT, V140, P2280, DOI 10.1242/dev.096354; Sun M, 2020, MATRIX BIOL, V94, P77, DOI 10.1016/j.matbio.2020.09.001; Suzuki A, 2022, METHODS, V203, P179, DOI 10.1016/j.ymeth.2020.09.012; Tanaka E, 2001, ARCH ORAL BIOL, V46, P997, DOI 10.1016/S0003-9969(01)00072-3; Tellado SF, 2015, ADV DRUG DELIVER REV, V94, P126, DOI 10.1016/j.addr.2015.03.004; Teunis T, 2014, J SHOULDER ELB SURG, V23, P1913, DOI 10.1016/j.jse.2014.08.001; Thomopoulos S, 2007, J ORTHOP RES, V25, P1154, DOI 10.1002/jor.20418; Thomopoulos S, 2012, J ORTHOP RES, V30, P1702, DOI 10.1002/jor.22151; Thornalley PJ, 2005, PERITON DIALYSIS INT, V25, P522; TUMA HJ, 1962, J ANIM SCI, V21, P33, DOI 10.2527/jas1962.21133x; van de Vlekkert D, 2020, BIO-PROTOCOL, V10, DOI 10.21769/BioProtoc.3629; VANDERWINDT DAWM, 1995, ANN RHEUM DIS, V54, P959, DOI 10.1136/ard.54.12.959; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Wang INE, 2006, J ORTHOP RES, V24, P1745, DOI 10.1002/jor.20149; Yamaguchi K, 2006, J BONE JOINT SURG AM, V88A, P1699, DOI 10.2106/JBJS.E.00835; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zerbinati N, 2018, CLIN COSMET INV DERM, V11, P29, DOI 10.2147/CCID.S143015; Zhang HX, 2019, NEUROCHEM INT, V127, P2, DOI 10.1016/j.neuint.2018.10.005; Zhou YQ, 2017, J TISSUE ENG REGEN M, V11, P3445, DOI 10.1002/term.2258	64	1	1	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22066	10.1096/fj.202101484R	http://dx.doi.org/10.1096/fj.202101484R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34822203	Green Accepted			2022-12-28	WOS:000722321300019
J	Liu, ZY; Chaillou, T; Alves, ES; Mader, T; Jude, B; Ferreira, DMS; Hynynen, H; Cheng, AJ; Jonsson, WO; Pironti, G; Andersson, DC; Kenne, E; Ruas, JL; Tavi, P; Lanner, JT				Liu, Zhengye; Chaillou, Thomas; Santos Alves, Estela; Mader, Theresa; Jude, Baptiste; Ferreira, Duarte M. S.; Hynynen, Heidi; Cheng, Arthur J.; Jonsson, William O.; Pironti, Gianluigi; Andersson, Daniel C.; Kenne, Ellinor; Ruas, Jorge L.; Tavi, Pasi; Lanner, Johanna T.			Mitochondrial NDUFA4L2 is a novel regulator of skeletal muscle mass and force	FASEB JOURNAL			English	Article						mitochondria; muscle mass; NDUFA4L2; skeletal muscle	PERIPHERAL ARTERIAL-DISEASE; HOMEOSTASIS; AUTOPHAGY; ATROPHY; OXYGEN; METABOLISM; EXPRESSION; INDUCTION; ALTITUDE; PROTEIN	The hypoxia-inducible nuclear-encoded mitochondrial protein NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 (NDUFA4L2) has been demonstrated to decrease oxidative phosphorylation and production of reactive oxygen species in neonatal cardiomyocytes, brain tissue and hypoxic domains of cancer cells. Prolonged local hypoxia can negatively affect skeletal muscle size and tissue oxidative capacity. Although skeletal muscle is a mitochondrial rich, oxygen sensitive tissue, the role of NDUFA4L2 in skeletal muscle has not previously been investigated. Here we ectopically expressed NDUFA4L2 in mouse skeletal muscles using adenovirus-mediated expression and in vivo electroporation. Moreover, femoral artery ligation (FAL) was used as a model of peripheral vascular disease to induce hind limb ischemia and muscle damage. Ectopic NDUFA4L2 expression resulted in reduced mitochondrial respiration and reactive oxygen species followed by lowered AMP, ADP, ATP, and NAD(+) levels without affecting the overall protein content of the mitochondrial electron transport chain. Furthermore, ec-topically expressed NDUFA4L2 caused a similar to 20% reduction in muscle mass that resulted in weaker muscles. The loss of muscle mass was associated with increased gene expression of atrogenes MurF1 and Mul1, and apoptotic genes caspase 3 and Bax. Finally, we showed that NDUFA4L2 was induced by FAL and that the Ndufa4l2 mRNA expression correlated with the reduced capacity of the muscle to generate force after the ischemic insult. These results show, for the first time, that mitochondrial NDUFA4L2 is a novel regulator of skeletal muscle mass and force. Specifically, induced NDUFA4L2 reduces mitochondrial activity leading to lower levels of important intramuscular metabolites, including adenine nucleotides and NAD(+), which are hallmarks of mitochondrial dysfunction and hence shows that dysfunctional mitochondrial activity may drive muscle wasting.	[Liu, Zhengye; Chaillou, Thomas; Santos Alves, Estela; Mader, Theresa; Jude, Baptiste; Cheng, Arthur J.; Jonsson, William O.; Kenne, Ellinor; Lanner, Johanna T.] Karolinska Inst, Dept Physiol & Pharmacol, Mol Muscle Physiol & Pathophysiol, Biomedicum C5,Solnavagen 9, SE-17177 Stockholm, Sweden; [Ferreira, Duarte M. S.; Ruas, Jorge L.] Karolinska Inst, Dept Physiol & Pharmacol, Mol & Cellular Exercise Physiol, Stockholm, Sweden; [Hynynen, Heidi; Tavi, Pasi] Univ Eastern Finland, AI Virtanen Inst, Kuopio, Finland; [Pironti, Gianluigi; Andersson, Daniel C.] Karolinska Inst, Dept Physiol & Pharmacol, Med Cardiac & Skeletal Muscle Res, Stockholm, Sweden; [Andersson, Daniel C.] Karolinska Univ Hosp, Cardiol Unit, Heart Vasc & Neurol Theme, Stockholm, Sweden; [Chaillou, Thomas] Orebro Univ, Sch Hlth Sci, Orebro, Sweden; [Cheng, Arthur J.] York Univ, Fac Hlth, Toronto, ON, Canada	Karolinska Institutet; Karolinska Institutet; University of Eastern Finland; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Orebro University; York University - Canada	Lanner, JT (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Mol Muscle Physiol & Pathophysiol, Biomedicum C5,Solnavagen 9, SE-17177 Stockholm, Sweden.	johanna.lanner@ki.se	Alves, Estela/AAX-1575-2020; Kenne, Ellinor/HCH-1218-2022; Cheng, Arthur J/Q-9379-2019; Andersson, Daniel/AAE-9968-2019; Ruas, Jorge/T-3040-2017	Alves, Estela/0000-0001-8084-0859; Cheng, Arthur J/0000-0003-3862-2967; Andersson, Daniel/0000-0003-4548-702X; Ruas, Jorge/0000-0002-1110-2606; Mader, Theresa/0000-0001-9114-9289	Swedish Research Council; Swedish Diabetes Foundation; Strategic research program in Diabetes at Karolinska Institutet; Sigrid Juselius Foundation; Wenner-Gren Foundation (Wenner-Gren Foundation for Anthropological Research); Chinese Scholarship Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Foundation; Strategic research program in Diabetes at Karolinska Institutet; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Wenner-Gren Foundation (Wenner-Gren Foundation for Anthropological Research); Chinese Scholarship Council(China Scholarship Council)	The Swedish Research Council; The Swedish Diabetes Foundation; Strategic research program in Diabetes at Karolinska Institutet; Sigrid Juselius Foundation; Wenner-Gren Foundation (Wenner-Gren Foundation for Anthropological Research); Chinese Scholarship Council	Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Brocca L, 2017, J PHYSIOL-LONDON, V595, P1143, DOI 10.1113/JP273097; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Canto Carles, 2015, Curr Protoc Mouse Biol, V5, P135, DOI 10.1002/9780470942390.mo140061; Chaillou T, 2016, FASEB J, V30, P3929, DOI 10.1096/fj.201600757R; Cheng AJ, 2016, J PHYSIOL-LONDON, V594, P5149, DOI 10.1113/JP270650; Chini CCS, 2021, CELL METAB, V33, P1076, DOI 10.1016/j.cmet.2021.04.003; Cluff K, 2013, AM J PHYSIOL-REG I, V305, pR291, DOI 10.1152/ajpregu.00525.2012; DiFranco Marino, 2009, J Vis Exp, DOI 10.3791/1520; Djafarzadeh S, 2017, JOVE-J VIS EXP, DOI 10.3791/54985; Frederick DW, 2016, CELL METAB, V24, P269, DOI 10.1016/j.cmet.2016.07.005; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Howald H, 2003, EUR J APPL PHYSIOL, V90, P360, DOI 10.1007/s00421-003-0872-9; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Lai RKH, 2016, CLIN CANCER RES, V22, P3105, DOI 10.1158/1078-0432.CCR-15-1987; Levett DZH, 2015, PROTEOMICS, V15, P160, DOI 10.1002/pmic.201400306; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Llano-Diez M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167090; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; McDermott MM, 2012, J AM COLL CARDIOL, V59, P1159, DOI 10.1016/j.jacc.2011.12.019; McDonald JH, 2013, J MICROSC-OXFORD, V252, P295, DOI 10.1111/jmi.12093; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Melber A, 2018, CELL RES, V28, P281, DOI 10.1038/cr.2018.16; Migliavacca E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13694-1; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Minton DR, 2016, CLIN CANCER RES, V22, P2791, DOI 10.1158/1078-0432.CCR-15-1511; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Murray AJ, 2016, EXP PHYSIOL, V101, P23, DOI 10.1113/EP085317; Niiyama Hiroshi, 2009, J Vis Exp, DOI 10.3791/1035; Palus S, 2014, J CACHEXIA SARCOPENI, V5, P193, DOI 10.1007/s13539-014-0157-7; Porter M. M., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P129; Powers SK, 2011, J PHYSIOL-LONDON, V589, P2129, DOI 10.1113/jphysiol.2010.201327; REGENSTEINER JG, 1993, CIRCULATION, V87, P413, DOI 10.1161/01.CIR.87.2.413; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Siu PM, 2003, J APPL PHYSIOL, V94, P555, DOI 10.1152/japplphysiol.00821.2002; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Tezze C, 2017, CELL METAB, V25, P1374, DOI 10.1016/j.cmet.2017.04.021; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Weiss DJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-230; Wollenman LC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187523; Wu MY, 2018, CELL PHYSIOL BIOCHEM, V46, P1650, DOI 10.1159/000489241; Xu WN, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0331-2	46	3	3	5	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22010	10.1096/fj.202100066R	http://dx.doi.org/10.1096/fj.202100066R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34724256				2022-12-28	WOS:000722321300034
J	Matsushita, K; Nakahara, C; Kimura, S; Sakamoto, N; Ii, S; Miyoshi, H				Matsushita, Kojiro; Nakahara, Chiharu; Kimura, Shun; Sakamoto, Naoya; Ii, Satoshi; Miyoshi, Hiromi			Intranuclear mesoscale viscoelastic changes during osteoblastic differentiation of human mesenchymal stem cells	FASEB JOURNAL			English	Article						cell nucleus; mesenchymal stem cell; osteoblast; single-particle tracking; viscoelastic substance	GENE-EXPRESSION; CHROMATIN; NUCLEUS; MATRIX; MECHANOTRANSDUCTION; ORGANIZATION; MECHANICS; STIFFNESS; RHEOLOGY; GENOME	Cell nuclei behave as viscoelastic materials. Dynamic regulation of the viscoelastic properties of nuclei in living cells is crucial for diverse biological and biophysical processes, specifically for intranuclear mesoscale viscoelasticity, through modulation of the efficiency of force propagation to the nucleoplasm and gene expression patterns. However, how the intranuclear mesoscale viscoelasticity of stem cells changes with differentiation is unclear and so is its biological significance. Here, we quantified the changes in intranuclear mesoscale viscoelasticity during osteoblastic differentiation of human mesenchymal stem cells. This analysis revealed that the intranuclear region is a viscoelastic solid, probably with a higher efficiency of force transmission that results in high sensitivity to mechanical signals in the early stages of osteoblastic differentiation. The intranuclear region was noted to alter to a viscoelastic liquid with a lower efficiency, which is responsible for the robustness of gene expression toward terminal differentiation. Additionally, evaluation of changes in the mesoscale viscoelasticity due to chromatin decondensation and correlation between the mesoscale viscoelasticity and local DNA density suggested that size of gap and flexibility of chromatin meshwork structures, which are modulated depending on chromatin condensation state, determine mesoscale viscoelasticity. with various rates of contribution in different differentiation stages. Given that chromatin within the nucleus condenses into heterochromatin as stem cells adopt a specific lineage by restricting transcription, viscoelasticity is perhaps a key factor in cooperative regulation of the nuclear mechanosensitivity and gene expression pattern for stem cell differentiation.	[Matsushita, Kojiro; Nakahara, Chiharu; Kimura, Shun; Sakamoto, Naoya; Ii, Satoshi; Miyoshi, Hiromi] Tokyo Metropolitan Univ, Grad Sch Syst Design, Dept Mech Syst Engn, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan	Tokyo Metropolitan University	Miyoshi, H (corresponding author), Tokyo Metropolitan Univ, Grad Sch Syst Design, Dept Mech Syst Engn, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	hiromi-miyoshi@tmu.ac.jp		Miyoshi, Hiromi/0000-0003-2314-2119; Sakamoto, Naoya/0000-0002-5472-7200	MEXT \ Japan Society for the Promotion of Science (JSPS) [18H03521]; Japan Agency for Medical Research and Development (AMED) [18gm5810012h9904]; Tokyo Metropolitan Government [R2-2]; Faculty of Systems Design, Tokyo Metropolitan University	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Tokyo Metropolitan Government(Tokyo Metropolitan Government); Faculty of Systems Design, Tokyo Metropolitan University	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: KAKENHI (18H03521); Japan Agency for Medical Research and Development (AMED), Grant/Award Number: PRIME(18gm5810012h9904); Tokyo Metropolitan Government, Grant/Award Number: Advanced Research (R2--2); Faculty of Systems Design, Tokyo Metropolitan University	Ricci MA, 2015, CELL, V160, P1145, DOI 10.1016/j.cell.2015.01.054; Bongiorno T, 2014, J BIOMECH, V47, P2197, DOI 10.1016/j.jbiomech.2013.11.017; Bronshtein I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9044; Chen YQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31547; Corbin EA, 2016, APPL PHYS LETT, V108, DOI 10.1063/1.4942364; Dahl KN, 2005, BIOPHYS J, V89, P2855, DOI 10.1529/biophysj.105.062554; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gerlitz G, 2013, CELL MOL LIFE SCI, V70, P1255, DOI 10.1007/s00018-012-1200-5; Guigas G, 2007, BIOPHYS J, V93, P316, DOI 10.1529/biophysj.106.099267; Guo M, 2017, P NATL ACAD SCI USA, V114, pE8618, DOI 10.1073/pnas.1705179114; Hakelien AM, 2014, STEM CELLS, V32, P2780, DOI 10.1002/stem.1759; Heo SJ, 2016, ELIFE, V5, DOI 10.7554/eLife.18207; Huang CY, 2010, FASEB J, V24, P3625, DOI 10.1096/fj.10-157370; Irianto J, 2014, MED ENG PHYS, V36, P412, DOI 10.1016/j.medengphy.2013.09.006; Laly AC, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd6187; Li QS, 2014, BIOMATERIALS, V35, P961, DOI 10.1016/j.biomaterials.2013.10.037; Mason TG, 2000, RHEOL ACTA, V39, P371, DOI 10.1007/s003970000094; Mathieu S, 2019, CURR OPIN CELL BIOL, V56, P34, DOI 10.1016/j.ceb.2018.08.007; McAndrews KM, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/5/056004; Miroshnikova YA, 2017, J CELL SCI, V130, P2243, DOI 10.1242/jcs.202192; Miyoshi H, 2014, TISSUE ENG PART B-RE, V20, P609, DOI [10.1089/ten.teb.2013.0728, 10.1089/ten.TEB.2013.0728]; Nava MM, 2020, CELL, V181, P800, DOI 10.1016/j.cell.2020.03.052; Newberg J, 2020, J BIOMECH, V111, DOI 10.1016/j.jbiomech.2020.110012; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Politz JC, 1998, P NATL ACAD SCI USA, V95, P6043, DOI 10.1073/pnas.95.11.6043; Politz JC, 2000, J STRUCT BIOL, V129, P252, DOI 10.1006/jsbi.2000.4227; Richter K, 2007, J CELL SCI, V120, P1673, DOI 10.1242/jcs.03440; Shimamoto Y, 2017, MOL BIOL CELL, V28, P1580, DOI 10.1091/mbc.E16-11-0783; Soda N, 2019, J IMMUNOL, V203, P1356, DOI 10.4049/jimmunol.1900354; Stephens AD, 2017, MOL BIOL CELL, V28, P1984, DOI 10.1091/mbc.E16-09-0653; Tajik A, 2016, NAT MATER, V15, P1287, DOI [10.1038/NMAT4729, 10.1038/nmat4729]; Talwar S, 2014, BIOMATERIALS, V35, P2411, DOI 10.1016/j.biomaterials.2013.12.010; Thorpe SD, 2017, NUCLEUS-PHILA, V8, P287, DOI 10.1080/19491034.2017.1285988; Titushkin I, 2007, BIOPHYS J, V93, P3693, DOI 10.1529/biophysj.107.107797; Tseng Y, 2004, J CELL SCI, V117, P2159, DOI 10.1242/jcs.01073; Uhler C, 2017, NAT REV MOL CELL BIO, V18, P717, DOI 10.1038/nrm.2017.101; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wei FX, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18584-5; Yang LL, 2020, BIOMATER SCI-UK, V8, P2638, DOI 10.1039/d0bm00264j	40	0	0	7	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22071	10.1096/fj.202100536RR	http://dx.doi.org/10.1096/fj.202100536RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34820910				2022-12-28	WOS:000722321300011
J	Zhang, H; Xue, YF; Yang, X; Liu, J; Liu, Q				Zhang, Heng; Xue, Yangfei; Yang, Xu; Liu, Jing; Liu, Qun			Toxoplasma gondii UBL-UBA shuttle proteins regulate several important cellular processes	FASEB JOURNAL			English	Article						DNA replication; HIV-1 protease inhibitor; ROP18; Toxoplasma gondii; UBL-UBA shuttle proteins	DNA-REPLICATION; HIV-PROTEASE; UBIQUITIN; INHIBITORS; YEAST; DDI1; SCREEN; RAD23	Toxoplasma gondii is an obligate intracellular apicomplexan parasite causing lethal diseases in immunocompromised patients. UBL-UBA shuttle proteins (DDI1, RAD23, and DSK2) are important components of the ubiquitin-proteasome system. By degrading ubiquitinated proteins, UBL-UBA shuttle proteins regulate many cellular processes. However, the specific processes regulated by UBL-UBA shuttle proteins remain elusive. Here, we revealed that the deletion of shuttle proteins results in a selective accumulation of ubiquitinated proteins in the nucleus and aberrant DNA replication. ROP18 was mistargeted and accumulated in the shuttle protein mutant strain, resulting in the recruitment of immunity-related GTPases to the parasitophorous vacuole membrane (PVM). Furthermore, the mistargeting of ROP18 and the recruitment of Irgb6 to the PVM were also observed in the DDI1 mutant strain. DDI1 is a nonclassical UBL-UBA shuttle protein homologous to the HIV-1 protease. Molecular docking showed that DDI1 was a potential target of HIV-1 protease inhibitors. However, these inhibitors blocked the growth of T gondii in vitro but not in vivo. In conclusion, the Toxoplasma UBL-UBA shuttle protein regulates several important cellular processes and the mistargeting of ROP18 may be a representative of the abnormal homeostasis caused by shuttle protein mutation.	[Zhang, Heng; Xue, Yangfei; Yang, Xu; Liu, Jing; Liu, Qun] China Agr Univ, Coll Vet Med, Natl Anim Protozoa Lab, Beijing, Peoples R China; [Zhang, Heng; Xue, Yangfei; Yang, Xu; Liu, Jing; Liu, Qun] China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol, Minist Agr, Beijing, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Liu, J; Liu, Q (corresponding author), China Agr 18 Univ, Coll Vet Med, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	liujingvip@126.com; qunliu@cau.edu.cn			National Natural Science Foundation of China [81971964, 31730096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81971964 and 31730096).	Biggins S, 1996, J CELL BIOL, V133, P1331, DOI 10.1083/jcb.133.6.1331; Castilho Vanessa V S, 2018, BMC Res Notes, V11, P825, DOI 10.1186/s13104-018-3927-z; Cho WH, 2013, P NATL ACAD SCI USA, V110, P2523, DOI 10.1073/pnas.1222494110; Coffey MJ, 2015, ELIFE, V4, DOI 10.7554/eLife.10809; de Monerri NCS, 2015, CELL HOST MICROBE, V18, P621, DOI 10.1016/j.chom.2015.10.014; Dogga SK, 2017, ELIFE, V6, DOI [10.7554/eLife.27480, 10.7554/elife.27480]; Dunn BM, 2002, CHEM REV, V102, P4431, DOI 10.1021/cr010167q; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Grice GL, 2016, CELL MOL LIFE SCI, V73, P3497, DOI 10.1007/s00018-016-2255-5; Hanzelmann P, 2010, J BIOL CHEM, V285, P20390, DOI 10.1074/jbc.M110.112532; Hoegl L, 1999, PHARMAZIE, V54, P319; HUFF JR, 1991, J MED CHEM, V34, P2305, DOI 10.1021/jm00112a001; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Kang Y, 2006, J MOL BIOL, V356, P1027, DOI 10.1016/j.jmb.2005.12.001; Kaplun L, 2005, MOL CELL BIOL, V25, P5355, DOI 10.1128/MCB.25.13.5355-5362.2005; Kim K, 2018, ANNU REV MICROBIOL, V72, P479, DOI 10.1146/annurev-micro-090817-062741; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lourido S, 2019, TRENDS PARASITOL, V35, P944, DOI 10.1016/j.pt.2019.07.001; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Motyan JA, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041352; Ngo HM, 2000, TRENDS CELL BIOL, V10, P67, DOI 10.1016/S0962-8924(99)01698-0; Ohshima J, 2014, J IMMUNOL, V192, P3328, DOI 10.4049/jimmunol.1302822; Onchieku NM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201556; Paugam A, 2001, PARASITE, V8, P267, DOI 10.1051/parasite/2001084267; Perteguer MJ, 2013, CELL STRESS CHAPERON, V18, P171, DOI 10.1007/s12192-012-0368-9; Pohl C, 2019, SCIENCE, V366, P818, DOI 10.1126/science.aax3769; Pozio E, 2005, TRENDS PARASITOL, V21, P58, DOI 10.1016/j.pt.2004.11.003; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P105; Sacco E, 2012, BIOTECHNOL ADV, V30, P73, DOI 10.1016/j.biotechadv.2011.09.009; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Sirkis R, 2006, J MOL BIOL, V364, P376, DOI 10.1016/j.jmb.2006.08.086; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Wang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111993; White RE, 2011, FASEB J, V25, P1729, DOI 10.1096/fj.10-178947; White RE, 2011, FEBS LETT, V585, P139, DOI 10.1016/j.febslet.2010.11.026; Yip MCJ, 2020, P NATL ACAD SCI USA, V117, P7776, DOI 10.1073/pnas.1902298117; Zhang H, 2020, FASEB J, V34, P13711, DOI 10.1096/fj.202000759RR	39	1	1	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e21898	10.1096/fj.202100662RR	http://dx.doi.org/10.1096/fj.202100662RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34727385				2022-12-28	WOS:000722321300012
J	Li, JA; Xie, RT; Jiang, F; Li, YM; Zhu, YF; Liu, ZH; Liao, MY; Liu, YY; Meng, XD; Chen, S; Yu, JG; Du, M; Wang, XH; Chen, YP; Yan, H				Li, Jianan; Xie, Ruotian; Jiang, Feng; Li, Yiming; Zhu, Yanfang; Liu, Zhiheng; Liao, Mengyu; Liu, Yuanyuan; Meng, Xiangda; Chen, Song; Yu, Jinguo; Du, Mei; Wang, Xiaohong; Chen, Yupeng; Yan, Hua			Tumor necrosis factor ligand-related molecule 1A maintains blood-retinal barrier via modulating SHP-1-Src-VE-cadherin signaling in diabetic retinopathy	FASEB JOURNAL			English	Article						diabetic macular edema; inner blood-retinal barrier; retinal vascular endothelial cell; TL1A; vascular integrity	VASCULAR-PERMEABILITY; ACTIVATION; TL1A; EXPRESSION; APOPTOSIS; CADHERIN; SHP-1; DR3	An impaired blood-retinal barrier (BRB) leads to diabetic macular edema (DME), which is a major complication of Diabetic retinopathy (DR). Mediators such as inflammation cause BRB breakdown. However, the explicit mechanism of its disruption is largely unknown. In this study, we identified tumor necrosis factor ligand-related molecule 1A (TL1A) as a crucial factor which protect retinal endothelial cells integrity in DR. By providing both human and mouse data, we show that TL1A is significantly decreased in the retinas of DME patients and diabetic rodents. We further demonstrate that the loss of TL1A accelerated diabetes-induced retinal barrier breakdown. TL1A supplementation protects the diabetic retina against BRB breakdown. Mechanistically, TL1A stabilize intracellular junctions and protect vascular integrity by blocking SHP1-Src-regulated VE-cadherin phosphorylation. Collectively, our findings reveal that loss of TL1A in the retina leads to increased vascular permeability in DR, and that TL1A treatment is of potential therapeutic interest for the treatment of DME.	[Li, Jianan; Xie, Ruotian; Jiang, Feng; Li, Yiming; Zhu, Yanfang; Liao, Mengyu; Liu, Yuanyuan; Meng, Xiangda; Chen, Song; Yu, Jinguo; Yan, Hua] Tianjin Med Univ, Gen Hosp, Dept Ophthalmol, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Li, Jianan; Li, Yiming; Zhu, Yanfang; Liao, Mengyu; Du, Mei; Wang, Xiaohong; Yan, Hua] Tianjin Med Univ, Lab Mol Ophthalmol, Tianjin, Peoples R China; [Li, Jianan; Du, Mei; Wang, Xiaohong] Tianjin Med Univ, Sch Basic Med Sci, Dept Pharmacol, Tianjin, Peoples R China; [Li, Jianan; Du, Mei; Wang, Xiaohong] Tianjin Med Univ, Sch Basic Med Sci, Tianjin Key Lab Inflammat Biol, Tianjin, Peoples R China; [Li, Jianan] Minist Educ & Tianjin City, Tianjin Neurol Inst, Key Lab Postneuroinjury Neuro Repair & Regenerat, Tianjin, Peoples R China; [Liu, Zhiheng; Chen, Yupeng] Tianjin Med Univ, Key Lab Immune Microenvironm & Dis, Tianjin Inst Urol,Minist Educ,Sch Basic Med Sci, Dept Biochem & Mol Biol,Prov & Minist Cosponsored, Tianjin 300070, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Yan, H (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Ophthalmol, 154 Anshan Rd, Tianjin 300052, Peoples R China.; Chen, YP (corresponding author), Tianjin Med Univ, Key Lab Immune Microenvironm & Dis, Tianjin Inst Urol,Minist Educ,Sch Basic Med Sci, Dept Biochem & Mol Biol,Prov & Minist Cosponsored, Tianjin 300070, Peoples R China.	ychen@tmu.edu.cn; zyyyanhua@tmu.edu.cn	liu, yuanyuan/GWZ-5838-2022; Chen, Yupeng/T-5275-2019	Wang, Xiaohong/0000-0001-8628-243X; LI, YIMING/0000-0002-6107-5618; Chen, Yupeng/0000-0001-8887-9547; Yan, Hua/0000-0002-7651-840X	Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation) [19JCZDJC64300]; National Natural Science Foundation of China [81830026, 31871184, 81900883]	Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation), Grant/Award Number: 19JCZDJC64300; National Natural Science Foundation of China, Grant/Award Number: 81830026, 31871184 and 81900883	Akla N, 2018, ARTERIOSCL THROM VAS, V38, P1821, DOI 10.1161/ATVBAHA.118.310733; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; BAYLESS TM, 1978, SOUTHERN MED J, V71, P825, DOI 10.1097/00007611-197807000-00026; Bayry J, 2010, NAT REV RHEUMATOL, V6, P67, DOI 10.1038/nrrheum.2009.263; Byrne LC, 2015, J CLIN INVEST, V125, P105, DOI 10.1172/JCI65654; Cantelmo AR, 2016, CANCER CELL, V30, P968, DOI 10.1016/j.ccell.2016.10.006; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cerani A, 2013, CELL METAB, V18, P505, DOI 10.1016/j.cmet.2013.09.003; CUNHAVAZ JG, 1978, BRIT J OPHTHALMOL, V62, P351, DOI 10.1136/bjo.62.6.351; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Deng WM, 2012, ANGIOGENESIS, V15, P71, DOI 10.1007/s10456-011-9244-y; Devraj K, 2018, JOVE-J VIS EXP, DOI 10.3791/57038; Dong X, 2021, THERANOSTICS, V11, P5107, DOI 10.7150/thno.54755; Du M, 2015, MOL CELL BIOL, V35, P2771, DOI 10.1128/MCB.00181-15; Duan LJ, 2012, TARGET ONCOL, V7, P87, DOI 10.1007/s11523-012-0206-0; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Elman MJ, 2011, OPHTHALMOLOGY, V118, P609, DOI 10.1016/j.ophtha.2010.12.033; Fraccaroli A, 2015, CIRC RES, V117, P29, DOI 10.1161/CIRCRESAHA.117.305818; Gao BB, 2007, NAT MED, V13, P181, DOI 10.1038/nm1534; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Grundmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070873; Haidari M, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-105; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; HOPKINS DJ, 1974, BRIT J OPHTHALMOL, V58, P732, DOI 10.1136/bjo.58.8.732; Jiang F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050615; KNOX DL, 1984, OPHTHALMOLOGY, V91, P163; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Li HJ, 2017, J CLIN INVEST, V127, P1241, DOI 10.1172/JCI89511; Liang PH, 2011, ANGIOGENESIS, V14, P61, DOI 10.1007/s10456-010-9195-8; Liu B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08300-3; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Meylan F, 2008, IMMUNITY, V29, P79, DOI 10.1016/j.immuni.2008.04.021; Meylan F, 2011, IMMUNOL REV, V244, P188, DOI 10.1111/j.1600-065X.2011.01068.x; Miloudi K, 2016, J CLIN INVEST, V126, P3006, DOI 10.1172/JCI84767; Moss SE, 1998, OPHTHALMOLOGY, V105, P998, DOI 10.1016/S0161-6420(98)96025-0; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Parr Christian, 2006, Angiogenesis, V9, P73, DOI 10.1007/s10456-006-9033-1; Qi JW, 2013, P NATL ACAD SCI USA, V110, P13863, DOI 10.1073/pnas.1304529110; Richard AC, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007458; Romero-Aroca P, 2011, WORLD J DIABETES, V2, P98, DOI 10.4239/wjd.v2.i6.98; SALMON JF, 1991, OPHTHALMOLOGY, V98, P480; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Shi C, 2004, J CLIN INVEST, V114, P408, DOI 10.1172/jci200421100; Sinha RK, 2016, ARTERIOSCL THROM VAS, V36, P518, DOI 10.1161/ATVBAHA.115.306795; Sodhi A, 2019, J CLIN INVEST, V129, P4593, DOI 10.1172/JCI120879; Somani AK, 1997, J BIOL CHEM, V272, P21113, DOI 10.1074/jbc.272.34.21113; Sun YZ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw3593; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Wang PJ, 2012, DIABETES, V61, P2155, DOI 10.2337/db11-1503; Wei J, 2019, J CLIN INVEST, V129, P137, DOI 10.1172/JCI121266; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Wong TY, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.12; Xiao T, 2010, CELL RES, V20, P367, DOI 10.1038/cr.2009.126; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yang CR, 2004, CANCER RES, V64, P1122, DOI 10.1158/0008-5472.CAN-03-0609; Yang GL, 2017, FASEB J, V31, P2001, DOI 10.1096/fj.201600800R; Yu JY, 2016, DIABETOLOGIA, V59, P2026, DOI 10.1007/s00125-016-4012-6; Yu JY, 2001, CIRC RES, V89, P1161, DOI 10.1161/hh2401.101909; Zhang YJ, 2005, KIDNEY INT, V68, P1071, DOI 10.1111/j.1523-1755.2005.00499.x; Zhuang T, 2019, CIRC RES, V125, P590, DOI 10.1161/CIRCRESAHA.118.314402	62	2	2	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e22008	10.1096/fj.202100807RR	http://dx.doi.org/10.1096/fj.202100807RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34679191	hybrid			2022-12-28	WOS:000712009200050
J	Tushaus, J; Muller, SA; Shrouder, J; Arends, M; Simons, M; Plesnila, N; Blobel, CP; Lichtenthaler, SF				Tueshaus, Johanna; Mueller, Stephan A.; Shrouder, Joshua; Arends, Martina; Simons, Mikael; Plesnila, Nikolaus; Blobel, Carl P.; Lichtenthaler, Stefan F.			The pseudoprotease iRhom1 controls ectodomain shedding of membrane proteins in the nervous system	FASEB JOURNAL			English	Article						ADAM17; CSF; hiSPECS; iRhom1; myelination; secretome	NECROSIS-FACTOR-ALPHA; SUBSTRATE SELECTIVITY; HB-EGF; MEGF10; ADAM17; RECEPTOR; CELLS; METALLOPROTEINASE; DISINTEGRIN; MYELINATION	Proteolytic ectodomain shedding of membrane proteins is a fundamental mechanism to control the communication between cells and their environment. A key protease for membrane protein shedding is ADAM17, which requires a non-proteolytic subunit, either inactive Rhomboid 1 (iRhom1) or iRhom2 for its activity. While iRhom1 and iRhom2 are co-expressed in most tissues and appear to have largely redundant functions, the brain is an organ with predominant expression of iRhom1. Yet, little is known about the spatio-temporal expression of iRhom1 in mammalian brain and about its function in controlling membrane protein shedding in the nervous system. Here, we demonstrate that iRhom1 is expressed in mouse brain from the prenatal stage to adulthood with a peak in early postnatal development. In the adult mouse brain iRhom1 was widely expressed, including in cortex, hippocampus, olfactory bulb, and cerebellum. Proteomic analysis of the secretome of primary neurons using the hiSPECS method and of cerebrospinal fluid, obtained from iRhom1-deficient and control mice, identified several membrane proteins that require iRhom1 for their shedding in vitro or in vivo. One of these proteins was 'multiple-EGF-like-domains protein 10' (MEGF10), a phagocytic receptor in the brain that is linked to the removal of amyloid beta and apoptotic neurons. MEGF10 was further validated as an ADAM17 substrate using ADAM17-deficient mouse embryonic fibroblasts. Taken together, this study discovers a role for iRhom1 in controlling membrane protein shedding in the mouse brain, establishes MEGF10 as an iRhom1-dependent ADAM17 substrate and demonstrates that iRhom1 is widely expressed in murine brain.	[Tueshaus, Johanna; Mueller, Stephan A.; Arends, Martina; Simons, Mikael; Lichtenthaler, Stefan F.] German Ctr Neurodegenerat Dis DZNE, Feodor Lynen Str 17, D-81377 Munich, Germany; [Tueshaus, Johanna; Mueller, Stephan A.; Lichtenthaler, Stefan F.] Tech Univ Munich, Sch Med, Klinikum Rechts Isar, Neuroprote, Munich, Germany; [Shrouder, Joshua; Plesnila, Nikolaus] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Inst Stroke & Dementia Res ISD, Munich, Germany; [Arends, Martina; Simons, Mikael] Tech Univ Munich, Inst Neuronal Cell Biol, Munich, Germany; [Simons, Mikael; Plesnila, Nikolaus; Lichtenthaler, Stefan F.] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Blobel, Carl P.] Weill Cornell Med, Dept Physiol Biophys & Syst Biol, New York, NY USA; [Blobel, Carl P.] Weill Cornell Med, Dept Med, New York, NY USA; [Blobel, Carl P.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; University of Munich; Technical University of Munich; University of Munich; Cornell University; Cornell University	Lichtenthaler, SF (corresponding author), German Ctr Neurodegenerat Dis DZNE, Feodor Lynen Str 17, D-81377 Munich, Germany.	stefan.lichtenthaler@dzne.de	Arends, Martina/HIA-0265-2022	Simons, Mikael/0000-0001-5329-192X	Deutsche Forschungsgemeinschaft (DFG) [EXC 2145, ID390857198, FOR2290, 263531414]; Bundesministerium fur Bildung und Forschung (BMBF); HHS | National Institutes of Health (NIH) [R35 GM134907]; Boehringer Ingelheim Fonds (BIF)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds (BIF)(Boehringer Ingelheim)	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: EXC 2145 SyNergy,ID390857198 and FOR2290,263531414; Bundesministerium fur Bildung und Forschung (BMBF), Grant/Award Number: CLINSPECT--M; HHS | National Institutes of Health (NIH), Grant/Award Number: R35 GM134907; Boehringer Ingelheim Fonds (BIF)	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Badenes M, 2020, MOL METAB, V31, P67, DOI 10.1016/j.molmet.2019.10.006; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Browne K, 2012, J NEUROCHEM, V123, P135, DOI 10.1111/j.1471-4159.2012.07885.x; Bruderer R, 2016, PROTEOMICS, V16, P2246, DOI 10.1002/pmic.201500488; Brummer T, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809695; Brummer T, 2018, FASEB J, V32, P3560, DOI 10.1096/fj.201700823RR; Canault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013433; Christova Y, 2013, EMBO REP, V14, P884, DOI 10.1038/embor.2013.128; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Colombo A, 2018, EMBO J, V37, DOI 10.15252/embj.201797390; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Deng M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005548; Dreymueller D, 2015, AM J PHYSIOL-LUNG C, V308, pL325, DOI 10.1152/ajplung.00294.2014; Dulloo I, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190003; Fredrickx E, 2020, GLIA, V68, P1148, DOI 10.1002/glia.23765; Fujita Y, 2020, NEUROSCIENCE, V443, P1, DOI 10.1016/j.neuroscience.2020.07.016; Fujita Y, 2017, NEUROSCI LETT, V653, P25, DOI 10.1016/j.neulet.2017.05.029; Geesala R, 2019, J LEUKOCYTE BIOL, V105, P767, DOI 10.1002/JLB.4A0718-283RR; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Grieve AG, 2017, ELIFE, V6, DOI 10.7554/eLife.23968; Haxaire C, 2018, BLOOD, V132, P1064, DOI 10.1182/blood-2017-12-820571; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hosur V, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02086-0; Hsia HE, 2019, CELL MOL LIFE SCI, V76, P3055, DOI 10.1007/s00018-019-03173-7; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Iram T, 2016, J NEUROSCI, V36, P5185, DOI 10.1523/JNEUROSCI.3850-15.2016; Issuree PDA, 2013, J CLIN INVEST, V123, P928, DOI 10.1172/JCI66168; Ivankov DN, 2013, NUCLEIC ACIDS RES, V41, pW459, DOI 10.1093/nar/gkt436; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Jones JC, 2016, ANNU REV PHYSIOL, V78, P243, DOI 10.1146/annurev-physiol-021014-071720; Kay JN, 2012, NATURE, V483, P465, DOI 10.1038/nature10877; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Kuhn PH, 2016, ELIFE, V5, DOI 10.7554/eLife.12748; Kuhn PH, 2015, MOL CELL PROTEOMICS, V14, P1584, DOI 10.1074/mcp.M115.048298; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Kunzel U, 2018, ELIFE, V7, DOI 10.7554/eLife.35012; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Lee JH, 2021, NATURE, V590, DOI 10.1038/s41586-020-03060-3; Li NY, 2007, EMBO J, V26, P494, DOI 10.1038/sj.emboj.7601520; Li X, 2017, J CELL SCI, V130, P868, DOI 10.1242/jcs.196436; Li X, 2015, P NATL ACAD SCI USA, V112, P6080, DOI 10.1073/pnas.1505649112; Liang LY, 2019, ONCOGENE, V38, P6567, DOI 10.1038/s41388-019-0931-2; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lichtenthaler SF, 2018, EMBO J, V37, DOI 10.15252/embj.201899456; Lichtenthaler SF, 2015, CELL CYCLE, V14, P3003, DOI 10.1080/15384101.2015.1084187; Lim NKH, 2018, JOVE-J VIS EXP, DOI 10.3791/56774; Liu Li, 2008, J Vis Exp, DOI 10.3791/960; Logan CV, 2011, NAT GENET, V43, P1189, DOI 10.1038/ng.995; Lorenzen I, 2016, SCI REP-UK, V6, DOI 10.1038/srep35067; Maretzky T, 2013, P NATL ACAD SCI USA, V110, P11433, DOI 10.1073/pnas.1302553110; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Melander MC, 2015, INT J ONCOL, V47, P1177, DOI 10.3892/ijo.2015.3120; Mine N, 2005, DEVELOPMENT, V132, P4317, DOI 10.1242/dev.02030; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Oikonomidi I, 2018, ELIFE, V7, DOI 10.7554/eLife.35032; Palazuelos J, 2015, J NEUROSCI, V35, P12241, DOI 10.1523/JNEUROSCI.3937-14.2015; Palazuelos J, 2014, J NEUROSCI, V34, P11884, DOI 10.1523/JNEUROSCI.1220-14.2014; Palmieri C, 2013, BRIT J CANCER, V108, P163, DOI 10.1038/bjc.2012.540; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Pigoni M, 2020, EMBO J, V39, DOI 10.15252/embj.2019103457; Pigoni M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0134-z; Qing XP, 2018, J CLIN INVEST, V128, P1397, DOI 10.1172/JCI97650; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Njavro JR, 2020, FASEB J, V34, P2465, DOI 10.1096/fj.201902347R; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin U, 2007, FEBS LETT, V581, P41, DOI 10.1016/j.febslet.2006.11.074; Sanderson MP, 2005, J BIOL CHEM, V280, P1826, DOI 10.1074/jbc.M408804200; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Sharma K, 2015, NAT NEUROSCI, V18, P1819, DOI 10.1038/nn.4160; Singh TD, 2010, FEBS LETT, V584, P3936, DOI 10.1016/j.febslet.2010.08.050; Skurski J, 2020, METABOLISM, V106, DOI 10.1016/j.metabol.2020.154194; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Tang BY, 2020, FASEB J, V34, P4956, DOI 10.1096/fj.201902649R; Tushaus J, 2021, PROTEOMICS, V21, DOI 10.1002/pmic.202000174; Tushaus J, 2020, EMBO J, V39, DOI 10.15252/embj.2020105693; Vinothkumar KR, 2010, EMBO J, V29, P3797, DOI 10.1038/emboj.2010.243; Weskamp G, 2020, J BIOL CHEM, V295, P4350, DOI 10.1074/jbc.RA119.011136; Weskamp G, 2010, CIRC RES, V106, P932, DOI 10.1161/CIRCRESAHA.109.207415; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Zellner A, 2018, ACTA NEUROPATHOL, V136, P111, DOI 10.1007/s00401-018-1853-8; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zunke F, 2017, BBA-MOL CELL RES, V1864, P2059, DOI 10.1016/j.bbamcr.2017.07.001	85	2	2	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21962	10.1096/fj.202100936R	http://dx.doi.org/10.1096/fj.202100936R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34613632	Green Accepted			2022-12-28	WOS:000712009200064
J	Wang, YY; Liu, RC; Liao, J; Jiang, LC; Jeong, GH; Zhou, L; Polite, M; Duong, D; Seyfried, NT; Wang, HD; Kiyokawa, H; Yin, J				Wang, Yiyang; Liu, Ruochuan; Liao, Jia; Jiang, Lucen; Jeong, Geon H.; Zhou, Li; Polite, Monica; Duong, Duc; Seyfried, Nicholas T.; Wang, Huadong; Kiyokawa, Hiroaki; Yin, Jun			Orthogonal ubiquitin transfer reveals human papillomavirus E6 downregulates nuclear transport to disarm interferon-gamma dependent apoptosis of cervical cancer cells	FASEB JOURNAL			English	Article						apoptosis; E6; E6AP; nuclear transport; orthogonal ubiquitin transfer	TYPE-16 E7 ONCOPROTEIN; HPV E6; SIGNALING PATHWAY; IMPORTIN-ALPHA; DEGRADATION; PROTEINS; LIGASE; P53; TRANSCRIPTION; ASSOCIATION	The E6 protein of the human papillomavirus (HPV) underpins important protein interaction networks between the virus and host to promote viral infection. Through its interaction with E6AP, a host E3 ubiquitin (UB) ligase, E6 stirs the protein ubiquitination pathways toward the oncogenic transformation of the infected cells. For a systematic measurement of E6 reprogramming of the substrate pool of E6AP, we performed a proteomic screen based on "orthogonal UB transfer (OUT)" that allowed us to identify the ubiquitination targets of E6AP dependent on the E6 protein of HPV-16, a high-risk viral subtype for the development of cervical cancer. The OUT screen identified more than 200 potential substrates of the E6-E6AP pair based on the transfer of UB from E6AP to the substrate proteins. Among them, we verified that E6 would induce E6AP-catalyzed ubiquitination of importin proteins KPNA1-3, protein phosphatase PGAM5, and arginine methyltransferases CARM1 to trigger their degradation by the proteasome. We further found that E6 could significantly reduce the cellular level of KPNA1 that resulted in the suppression of nuclear transport of phosphorylated STAT1 and the inhibition of interferon-gamma-induced apoptosis in cervical cancer cells. Overall, our work demonstrates OUT as a powerful proteomic platform to probe the interaction of E6 and host cells through protein ubiquitination and reveals a new role of E6 in down-regulating nuclear transport proteins to attenuate tumor-suppressive signaling.	[Wang, Yiyang; Liao, Jia; Wang, Huadong] Jinan Univ, Sch Med, Dept Pathophysiol, Guangzhou, Peoples R China; [Wang, Yiyang; Liu, Ruochuan; Jeong, Geon H.; Zhou, Li; Polite, Monica; Yin, Jun] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Wang, Yiyang; Liu, Ruochuan; Jeong, Geon H.; Zhou, Li; Polite, Monica; Yin, Jun] Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA; [Jiang, Lucen] Southern Med Univ, Dept Pathol, Affiliated Hosp 3, Guangzhou, Peoples R China; [Duong, Duc] Emory Univ, Integrated Prote Core, Atlanta, GA 30322 USA; [Seyfried, Nicholas T.] Emory Univ, Dept Biochem, Sch Med, Atlanta, GA 30322 USA; [Kiyokawa, Hiroaki] Northwestern Univ, Dept Pharmacol, Chicago, IL 60611 USA	Jinan University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Southern Medical University - China; Emory University; Emory University; Northwestern University	Wang, HD (corresponding author), Jinan Univ, Sch Med, Dept Pathophysiol, Guangzhou, Peoples R China.; Yin, J (corresponding author), Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA.; Yin, J (corresponding author), Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA.; Kiyokawa, H (corresponding author), Northwestern Univ, Dept Pharmacol, Chicago, IL 60611 USA.	twhd@jnu.edu.cn; kiyokawa@northwestern.edu; junyin@gsu.edu	Zhou, Li/GQA-6272-2022	Zhou, Li/0000-0002-2815-9430; Liu, Ruochuan/0000-0003-2529-7587; wang, yiyang/0000-0002-0318-6715	National Science Foundation (NSF) [1710460, 2109051]; Fundamental Research Funds for the Central Universities of China [21619329]; HHS \ National Institutes of Health (NIH) [R01GM104498]	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Science Foundation (NSF), Grant/Award Number: 1710460 and 2109051; Fundamental Research Funds for the Central Universities of China, Grant/Award Number: 21619329; HHS | National Institutes of Health (NIH), Grant/Award Number: R01GM104498	Bedard KM, 2008, J VIROL, V82, P3894, DOI 10.1128/JVI.01818-07; Bhuripanyo K, 2018, SCI ADV, V4, DOI 10.1126/sciadv.1701393; Cagatay T, 2018, CURR OPIN CELL BIOL, V52, P30, DOI 10.1016/j.ceb.2018.01.006; Cautain B, 2015, FEBS J, V282, P445, DOI 10.1111/febs.13163; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; CROOK T, 1991, ONCOGENE, V6, P873; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Du YJ, 2014, J VIROL, V88, P4908, DOI 10.1128/JVI.03668-13; Dukic A, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9020133; Ebner FA, 2020, J BIOL CHEM, V295, P15070, DOI 10.1074/jbc.RA120.015603; Fagerlund R, 2002, J BIOL CHEM, V277, P30072, DOI 10.1074/jbc.M202943200; Frieman M, 2007, J VIROL, V81, P9812, DOI 10.1128/JVI.01012-07; Grace M, 2017, VIROLOGY, V500, P71, DOI 10.1016/j.virol.2016.10.010; Gross-Mesilaty S, 1998, P NATL ACAD SCI USA, V95, P8058, DOI 10.1073/pnas.95.14.8058; Handa K, 2007, J VIROL, V81, P1379, DOI 10.1128/JVI.01712-06; Hsu CH, 2012, ONCOGENE, V31, P2335, DOI 10.1038/onc.2011.415; Huh KW, 2005, P NATL ACAD SCI USA, V102, P11492, DOI 10.1073/pnas.0505337102; Huh K, 2007, J VIROL, V81, P9737, DOI 10.1128/JVI.00881-07; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Jha S, 2010, MOL CELL, V38, P700, DOI 10.1016/j.molcel.2010.05.020; Jing M, 2007, J VIROL, V81, P2231, DOI 10.1128/JVI.01979-06; Kang YJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9371; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Lee AJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02061; Li SY, 1999, ONCOGENE, V18, P5727, DOI 10.1038/sj.onc.1202960; Liang PZ, 2013, TRAFFIC, V14, P1132, DOI 10.1111/tra.12097; Marchenko ND, 2010, CELL DEATH DIFFER, V17, P255, DOI 10.1038/cdd.2009.173; Massimi P, 2008, ONCOGENE, V27, P1800, DOI 10.1038/sj.onc.1210810; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; Miyamoto Y, 2016, J BIOCHEM, V160, P69, DOI 10.1093/jb/mvw036; Mortensen F, 2015, P NATL ACAD SCI USA, V112, P9872, DOI 10.1073/pnas.1505923112; MUNGER K, 1989, J VIROL, V63, P4417; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Nardozzi J, 2010, J MOL BIOL, V402, P83, DOI 10.1016/j.jmb.2010.07.013; Neveu G, 2012, METHODS, V58, P349, DOI 10.1016/j.ymeth.2012.07.029; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Poirson J, 2017, FEBS J, V284, P3171, DOI 10.1111/febs.14193; Pumroy RA, 2015, BIOCHEM J, V466, P13, DOI 10.1042/BJ20141186; Ronco LV, 1998, GENE DEV, V12, P2061, DOI 10.1101/gad.12.13.2061; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; Sailer C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06953-0; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHNEIDERGADICKE A, 1986, EMBO J, V5, P2285, DOI 10.1002/j.1460-2075.1986.tb04496.x; SEEDORF K, 1987, EMBO J, V6, P139, DOI 10.1002/j.1460-2075.1987.tb04731.x; Snijders PJF, 2006, J PATHOL, V208, P152, DOI 10.1002/path.1866; Spangle JM, 2012, J VIROL, V86, P7466, DOI 10.1128/JVI.00487-12; Steben M, 2007, GYNECOL ONCOL, V107, pS2, DOI 10.1016/j.ygyno.2007.07.067; Storrs CH, 2007, J VIROL, V81, P4080, DOI 10.1128/JVI.02545-06; Subbaiah VK, 2016, ONCOGENE, V35, P2062, DOI 10.1038/onc.2015.268; Suk K, 2001, J BIOL CHEM, V276, P13153, DOI 10.1074/jbc.M007646200; Tan MJA, 2012, P NATL ACAD SCI USA, V109, pE1473, DOI 10.1073/pnas.1205991109; Tessier TM, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060559; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Thomas M, 1998, ONCOGENE, V17, P2943, DOI 10.1038/sj.onc.1202223; Tomaic V, 2016, CANCERS, V8, DOI 10.3390/cancers8100095; Underbrink MP, 2008, J VIROL, V82, P10408, DOI 10.1128/JVI.00902-08; Vande Pol SB, 2013, VIROLOGY, V445, P115, DOI 10.1016/j.virol.2013.04.026; Vats A, 2019, J GEN VIROL, V100, P1674, DOI 10.1099/jgv.0.001331; Wallace NA, 2015, ANNU REV VIROL, V2, P403, DOI 10.1146/annurev-virology-100114-055021; Wang R, 2013, J VIROL, V87, P5219, DOI 10.1128/JVI.02643-12; Wang YY, 2021, CELL CHEM BIOL, V28, P1283, DOI 10.1016/j.chembiol.2021.02.005; Wang YY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01974-7; Welch K, 1999, MOL CELL BIOL, V19, P8400; White EA, 2013, VIROLOGY, V435, P57, DOI 10.1016/j.virol.2012.09.046; White EA, 2012, J VIROL, V86, P13174, DOI 10.1128/JVI.02172-12; Xu M, 2008, MOL CELL BIOL, V28, P4819, DOI 10.1128/MCB.01969-07; Yang F, 2020, LIFE SCI, V252, DOI 10.1016/j.lfs.2020.117611; YEE C, 1985, AM J PATHOL, V119, P361; Zanier K, 2013, SCIENCE, V339, P694, DOI 10.1126/science.1229934; Zhao B, 2012, CHEM BIOL, V19, P1265, DOI 10.1016/j.chembiol.2012.07.023; zur Hausen H, 1999, P ASSOC AM PHYSICIAN, V111, P581, DOI 10.1046/j.1525-1381.1999.99723.x	73	1	1	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21986	10.1096/fj.202101232RR	http://dx.doi.org/10.1096/fj.202101232RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34662469				2022-12-28	WOS:000712009200031
J	Wu, YM; Shi, Q; Zhu, PF; Ma, HJ; Cui, SC; Li, J; Hou, AJ; Li, JY				Wu, Yong-Mei; Shi, Qing; Zhu, Peng-Fei; Ma, Hai-Jian; Cui, Shi-Chao; Li, Jia; Hou, Ai-Jun; Li, Jing-Ya			Rhodomeroterpene alleviates macrophage infiltration and the inflammatory response in renal tissue to improve acute kidney injury	FASEB JOURNAL			English	Article						acute kidney injury; IKK/NF-kappa B; inflammation; macrophage; PI3K/PDK1/Akt; rhodomeroterpene	RHODODENDRON; AKI; MEROTERPENOIDS; ACTIVATION; CONTRIBUTE; MECHANISM; SEPSIS; SYSTEM; ROLES; CELLS	Inflammation is broadly recognized as an important factor in the pathogenesis of acute kidney injury (AKI), but pharmacological approaches to alleviate inflammation in AKI have not been proved successful in clinical trials. Macrophage infiltration into renal tissue promotes inflammatory responses that contribute to the pathogenesis of AKI. Suppression of renal tissue inflammatory responses is postulated to improve renal injury of patients and animals. Rhodomeroterpene (RMT) is a novel meroterpenoid isolated from the Rhododendron genus that was shown to exert anti-inflammatory action in vivo or in vitro in this study. We investigated the treatment effects of RMT on LPS-induced sepsis and two different AKI models. The results showed that pretreatment with RMT (30 mg kg(-1) d(-1) , ip, for 3 days) significantly inhibited acute inflammatory responses in LPS-induced septic mice. In both renal ischemia-reperfusion injury (I/R) and sepsis-induced AKI models, RMT (30 mg kg(-1) d(-1), ip, for 3 days) ameliorated renal function and injury and alleviated inflammation by reducing the infiltration of immune cells, including macrophages and neutrophils. Furthermore, our study demonstrated that RMT inhibits inflammatory responses in macrophages. The anti-inflammatory effects of RMT may be due to the inactivation of the IKK/NF-kappa B and PI3K/PDK1/Akt inflammatory signaling pathways in macrophages. Collectively, our findings indicate that RMT ameliorates renal injury and alleviates the renal inflammatory state in different AKI models, suggesting that RMT may be a potential agent for the treatment of AKI.	[Wu, Yong-Mei; Zhu, Peng-Fei; Li, Jia; Li, Jing-Ya] Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing, Peoples R China; [Wu, Yong-Mei; Zhu, Peng-Fei; Cui, Shi-Chao; Li, Jia; Li, Jing-Ya] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China; [Shi, Qing; Ma, Hai-Jian; Hou, Ai-Jun] Fudan Univ, Sch Pharm, State Key Lab Med Neurobiol, Shanghai, Peoples R China	Nanjing University of Chinese Medicine; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Fudan University	Li, J; Li, JY (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, 189 Guo Shou Jing Rd, Shanghai, Peoples R China.	jli@simm.ac.cn; jyli@simm.ac.cn	Li, Jia/F-9116-2011	Li, Jingya/0000-0003-3457-8153; Cui, Shicao/0000-0002-8604-1270	Ministry of Science and Technology Key Research Program [2016YFC1305505]; Fudan University-Shanghai Institute of Materia Medica Cooperation Program [FU-SIMM20181011]; Central Asian Drug Discovery and Development of ACS [CAM202001]	Ministry of Science and Technology Key Research Program; Fudan University-Shanghai Institute of Materia Medica Cooperation Program; Central Asian Drug Discovery and Development of ACS	The Ministry of Science and Technology Key Research Program, Grant/Award Number: 2016YFC1305505; The Fudan University-Shanghai Institute of Materia Medica Cooperation Program, Grant/Award Number: FU-SIMM20181011; Central Asian Drug Discovery and Development of ACS, Grant/Award Number: CAM202001	Abdulkhaleq LA, 2018, VET WORLD, V11, P627, DOI 10.14202/vetworld.2018.627-635; Alge JL, 2015, CLIN J AM SOC NEPHRO, V10, P147, DOI 10.2215/CJN.12191213; Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; Bonavia A, 2018, PEDIATR NEPHROL, V33, P1629, DOI 10.1007/s00467-017-3774-5; Chen YT, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-51; Chen YT, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-270; Cheng SC, 2016, NAT IMMUNOL, V17, P406, DOI 10.1038/ni.3398; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Ferenbach DA, 2011, KIDNEY INT, V79, P966, DOI 10.1038/ki.2010.535; Fulop T, 2014, CURR OPIN IMMUNOL, V29, P105, DOI 10.1016/j.coi.2014.05.007; Han HI, 2019, PEDIATR NEPHROL, V34, P561, DOI 10.1007/s00467-017-3883-1; Han SJ, 2019, KIDNEY RES CLIN PRAC, V38, P427, DOI 10.23876/j.krcp.19.062; Hoste EAJ, 2018, NAT REV NEPHROL, V14, P607, DOI 10.1038/s41581-018-0052-0; Huang GH, 2018, J NAT PROD, V81, P1810, DOI 10.1021/acs.jnatprod.8b00273; Inoue T, 2017, KIDNEY INT, V91, P526, DOI 10.1016/j.kint.2016.11.026; Iwata N, 2010, J NAT PROD, V73, P1203, DOI 10.1021/np900543r; Jang HR, 2015, NAT REV NEPHROL, V11, P88, DOI 10.1038/nrneph.2014.180; Jou IM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/316482; Kim EA, 2019, J FUNCT FOODS, V52, P109, DOI 10.1016/j.jff.2018.10.030; Kim JH, 2014, NEPHRON EXP NEPHROL, V128, P21, DOI 10.1159/000365851; Kinsey GR, 2008, NEPHRON EXP NEPHROL, V109, pE102, DOI 10.1159/000142934; Kinsey GR, 2014, J AM SOC NEPHROL, V25, P209, DOI 10.1681/ASN.2013101110; Kishore N, 2019, EUR J MED CHEM, V179, P272, DOI 10.1016/j.ejmech.2019.06.034; Kuang Y, 2021, NAT PROD REP, V38, P83, DOI 10.1039/d0np00023j; Kumar S, 2018, KIDNEY INT, V93, P27, DOI 10.1016/j.kint.2017.07.030; Kurts C, 2013, NAT REV IMMUNOL, V13, P738, DOI 10.1038/nri3523; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Lee ES, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179221; Li YM, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01415; Li Y, 2013, PHYTOCHEM REV, V12, P305, DOI 10.1007/s11101-013-9299-z; Liao HB, 2015, ORG LETT, V17, P5040, DOI 10.1021/acs.orglett.5b02515; Lin FM, 2003, J AM SOC NEPHROL, V14, P1188, DOI 10.1097/01.ASN.0000061595.28546.A0; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Mastora C, 2013, GENETICALLY MODIFIED, P1; Meng XM, 2015, KIDNEY DIS-BASEL, V1, P138, DOI 10.1159/000431214; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Peerapornratana S, 2019, KIDNEY INT, V96, P1083, DOI 10.1016/j.kint.2019.05.026; Popescu R, 2013, J ETHNOPHARMACOL, V147, P42, DOI 10.1016/j.jep.2013.02.022; Rabb H, 2016, J AM SOC NEPHROL, V27, P371, DOI 10.1681/ASN.2015030261; Ronco C, 2019, LANCET, V394, P1949, DOI 10.1016/S0140-6736(19)32563-2; Said IH, 2017, PHYTOCHEM ANALYSIS, V28, P454, DOI 10.1002/pca.2694; Sato Y, 2018, AM J PHYSIOL-RENAL, V315, pF1501, DOI 10.1152/ajprenal.00195.2018; Shi Q, 2020, PHYTOCHEMISTRY, V180, DOI 10.1016/j.phytochem.2020.112524; Susnik N, 2014, KIDNEY INT, V85, P1357, DOI 10.1038/ki.2013.525; Um Y, 2020, J ETHNOPHARMACOL, V263, DOI 10.1016/j.jep.2020.113218; Waikar SS., 2018, CORE CONCEPTS ACUTE, P1; Wang P, 2015, INT J MOL SCI, V16, P20595, DOI 10.3390/ijms160920595; Wang S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.104; Wen Y, 2020, CURR OPIN NEPHROL HY, V29, P286, DOI 10.1097/MNH.0000000000000595; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xie XC, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00473; Yuan A., 2020, AUTHOREA PREPRINTS; Zarjou A, 2011, J AM SOC NEPHROL, V22, P999, DOI 10.1681/ASN.2010050484; Zbakh H, 2020, MAR DRUGS, V18, DOI 10.3390/md18040207; Zegeye MM, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0268-4; Zhao JX, 2018, ORG CHEM FRONT, V5, P2202, DOI 10.1039/c8qo00469b; Zhong DD, 2015, SCI REP-UK, V5, DOI 10.1038/srep16910	58	4	4	5	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21985	10.1096/fj.202100981RR	http://dx.doi.org/10.1096/fj.202100981RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34674317				2022-12-28	WOS:000712009200032
J	Al-Ahmadi, W; Webberley, TS; Joseph, A; Harris, F; Chan, YH; Alotibi, R; Williams, JO; Alahmadi, A; Decker, T; Hughes, TR; Ramji, DP				Al-Ahmadi, Wijdan; Webberley, Thomas S.; Joseph, Alex; Harris, Ffion; Chan, Yee-Hung; Alotibi, Reem; Williams, Jessica O.; Alahmadi, Alaa; Decker, Thomas; Hughes, Timothy R.; Ramji, Dipak P.			Pro-atherogenic actions of signal transducer and activator of transcription 1 serine 727 phosphorylation in LDL receptor deficient mice via modulation of plaque inflammation	FASEB JOURNAL			English	Article						atherosclerosis; extracellular signal-regulated kinase 1; 2; inflammation; LDL receptor deficient mice; signal transducer and activator of transcription-1	GAMMA-MEDIATED INHIBITION; LOW-DENSITY-LIPOPROTEIN; FOAM CELL-FORMATION; ATHEROSCLEROTIC LESIONS; PROTEIN-KINASE; EXPRESSION; MACROPHAGES; DISEASE; CYTOKINES; PATHWAY	Atherosclerosis is a chronic inflammatory disorder of the vasculature regulated by cytokines. We have previously shown that extracellular signal-regulated kinase-1/2 (ERK1/2) plays an important role in serine 727 phosphorylation of signal transducer and activator of transcription-1 (STAT1) transactivation domain, which is required for maximal interferon-gamma signaling, and the regulation of modified LDL uptake by macrophages in vitro. Unfortunately, the roles of ERK1/2 and STAT1 serine 727 phosphorylation in atherosclerosis are poorly understood and were investigated using ERK1 deficient mice (ERK2 knockout mice die in utero) and STAT1 knock-in mice (serine 727 replaced by alanine; STAT1 S727A). Mouse Atherosclerosis RT2 Profiler PCR Array analysis showed that ERK1 deficiency and STAT1 S727A modification produced significant changes in the expression of 18 and 49 genes, respectively, in bone marrow-derived macrophages, with 17 common regulated genes that included those that play key roles in inflammation and cell migration. Indeed, ERK1 deficiency and STAT1 S727A modification attenuated chemokine-driven migration of macrophages with the former also impacting proliferation and the latter phagocytosis. In LDL receptor deficient mice fed a high fat diet, both ERK1 deficiency and STAT1 S727A modification produced significant reduction in plaque lipid content, albeit at different time points. The STAT1 S727A modification additionally caused a significant reduction in plaque content of macrophages and CD3 T cells and diet-induced cardiac hypertrophy index. In addition, there was a significant increase in plasma IL-2 levels and a trend toward increase in plasma IL-5 levels. These studies demonstrate important roles of STAT1 S727 phosphorylation in particular in the regulation of atherosclerosis-associated macrophage processes in vitro together with plaque lipid content and inflammation in vivo, and support further assessment of its therapeutical potential.	[Al-Ahmadi, Wijdan; Webberley, Thomas S.; Joseph, Alex; Harris, Ffion; Chan, Yee-Hung; Alotibi, Reem; Williams, Jessica O.; Alahmadi, Alaa; Ramji, Dipak P.] Cardiff Univ, Cardiff Sch Biosci, Sir Martin Evans Bldg,Museum Ave, Cardiff CF10 3AX, Wales; [Decker, Thomas] Univ Vienna, Dept Microbiol & Immunol, Max F Perutz Labs, Vienna, Austria; [Hughes, Timothy R.] Cardiff Univ, Sch Med, Syst Immun Res Inst, Cardiff, Wales	Cardiff University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Cardiff University	Ramji, DP (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Sir Martin Evans Bldg,Museum Ave, Cardiff CF10 3AX, Wales.	Ramji@Cardiff.ac.uk			British Heart Foundation (BHF) [PG/12/50/29691, PG/16/25/32097, FS/17/75/33257]; Saudi Arabia Cultural Bureau in London (SACB)	British Heart Foundation (BHF)(British Heart Foundation); Saudi Arabia Cultural Bureau in London (SACB)	British Heart Foundation (BHF), Grant/Award Number: PG/12/50/29691, PG/16/25/32097 and FS/17/75/33257; Saudi Arabia Cultural Bureau in London (SACB)	Agrawal S, 2007, CIRCULATION, V115, P2939, DOI 10.1161/CIRCULATIONAHA.107.696922; Al Rifai M, 2015, ATHEROSCLEROSIS, V239, P629, DOI 10.1016/j.atherosclerosis.2015.02.011; Barnholt KE, 2009, J IMMUNOL, V183, P6767, DOI 10.4049/jimmunol.0900331; Barrett TJ, 2020, ARTERIOSCL THROM VAS, V40, P20, DOI 10.1161/ATVBAHA.119.312802; Buckley ML, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47620-8; Buckley ML, 2015, BBA-MOL BASIS DIS, V1852, P1498, DOI 10.1016/j.bbadis.2015.04.011; Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; Chai JT, 2018, ARTERIOSCL THROM VAS, V38, P2718, DOI 10.1161/ATVBAHA.118.311209; Chan YH, 2020, FUTURE MED CHEM, V12, P613, DOI 10.4155/fmc-2019-0301; Chen YL, 2015, ARTERIOSCL THROM VAS, V35, P948, DOI 10.1161/ATVBAHA.114.305116; Fernandez-Laso V, 2017, SCI REP-UK, V7, DOI 10.1038/srep46679; Gallagher H, 2019, BBA-MOL BASIS DIS, V1865, P2538, DOI 10.1016/j.bbadis.2019.06.011; Harris SM, 2008, CELL SIGNAL, V20, P2296, DOI 10.1016/j.cellsig.2008.08.016; Harvey EJ, 2007, ARTERIOSCL THROM VAS, V27, P806, DOI 10.1161/01.ATV.0000258867.79411.96; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; Hughes TR, 2002, J BIOL CHEM, V277, P11097, DOI 10.1074/jbc.M106774200; Jager J, 2011, DIABETOLOGIA, V54, P180, DOI 10.1007/s00125-010-1944-0; Jiao P, 2013, MOL CELL ENDOCRINOL, V375, P157, DOI 10.1016/j.mce.2013.05.021; Kasahara K, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000719; Kim JY, 2009, CELL SIGNAL, V21, P1758, DOI 10.1016/j.cellsig.2009.07.011; Kim JS, 2009, BIOCHEM BIOPH RES CO, V390, P196, DOI 10.1016/j.bbrc.2009.09.009; Kimura A, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008145; Knight Richard A, 2012, JAKSTAT, V1, P111, DOI 10.4161/jkst.20078; Laguna-Fernandez A, 2015, VASC PHARMACOL, V73, P104, DOI 10.1016/j.vph.2015.05.013; Lawan A, 2017, TRENDS ENDOCRIN MET, V28, P868, DOI 10.1016/j.tem.2017.10.007; Lewis RD, 2011, AM J PATHOL, V179, P1601, DOI 10.1016/j.ajpath.2011.06.015; Lewis RD, 2010, MOL IMMUNOL, V47, P1098, DOI 10.1016/j.molimm.2009.10.035; Li N, 2010, J IMMUNOL, V185, P3041, DOI 10.4049/jimmunol.1000993; Lim WS, 2008, CIRCULATION, V117, P940, DOI 10.1161/CIRCULATIONAHA.107.711275; Lindau A, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0535-8; Mathur P, 2015, CARDIOVASC DRUG THER, V29, P319, DOI 10.1007/s10557-015-6596-3; McLaren JE, 2011, PROG LIPID RES, V50, P331, DOI 10.1016/j.plipres.2011.04.002; McLaren JE, 2010, J IMMUNOL, V185, P1222, DOI 10.4049/jimmunol.1000520; McLaren JE, 2009, CYTOKINE GROWTH F R, V20, P125, DOI 10.1016/j.cytogfr.2008.11.003; Mead JR, 2003, J BIOL CHEM, V278, P17741, DOI 10.1074/jbc.M301602200; Michael DR, 2013, CYTOKINE, V64, P357, DOI 10.1016/j.cyto.2013.05.016; Michael DR, 2012, BBA-MOL BASIS DIS, V1822, P1608, DOI 10.1016/j.bbadis.2012.06.002; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Moss JWE, 2016, FUTURE MED CHEM, V8, P1317, DOI 10.4155/fmc-2016-0072; Moss JWE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151057; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Mutlak M, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00149; Ramji DP, 2015, CYTOKINE GROWTH F R, V26, P673, DOI 10.1016/j.cytogfr.2015.04.003; Ray M, 2019, CYTOKINE, V122, DOI 10.1016/j.cyto.2017.09.031; Recio C, 2014, ARTERIOSCL THROM VAS, V34, P1953, DOI 10.1161/ATVBAHA.114.304144; Rezende AB, 2011, J SURG RES, V171, pE231, DOI 10.1016/j.jss.2011.08.010; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Roos KP, 2007, J CARD FAIL, V13, P318, DOI 10.1016/j.cardfail.2007.01.004; Salter RC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34368; Sikorski K, 2014, INT J MOL SCI, V15, P14313, DOI 10.3390/ijms150814313; Sisler JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144444; Takai S, 2009, J ATHEROSCLER THROMB, V16, P480, DOI 10.5551/jat.No430; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; Wang XQ, 2002, ARTERIOSCL THROM VAS, V22, pE5, DOI 10.1161/01.ATV.0000018287.03856.DD; Weber Daniel, 2010, Zhong Xi Yi Jie He Xue Bao, V8, P1006, DOI 10.3736/jcim20101101; Whitman SC, 2002, J LIPID RES, V43, P1201, DOI 10.1194/jlr.M200116-JLR200; Whitman SC, 2002, J INTERF CYTOK RES, V22, P661, DOI 10.1089/10799900260100141; YIN FCP, 1982, AM J PHYSIOL, V243, pH941, DOI 10.1152/ajpheart.1982.243.6.H941; Zhen CL, 2021, FASEB J, V35, DOI 10.1096/fj.202000325RRR; Zhou XY, 2010, J BIOL CHEM, V285, P6316, DOI 10.1074/jbc.M109.073601	61	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21892	10.1096/fj.202100571RR	http://dx.doi.org/10.1096/fj.202100571RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34569651	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000702238200072
J	Chang, YC; Li, JL; Mirhaidari, G; Zbinden, J; Barker, J; Blum, K; Reinhardt, J; Best, C; Kelly, J; Shoji, T; Yi, T; Breuer, C				Chang, Yu-Chun; Li, Junlang; Mirhaidari, Gabriel; Zbinden, Jacob; Barker, Jenny; Blum, Kevin; Reinhardt, James; Best, Cameron; Kelly, John; Shoji, Toshihiro; Yi, Tai; Breuer, Christopher			Zoledronate alters natural progression of tissue-engineered vascular grafts	FASEB JOURNAL			English	Article						bisphosphonates; inflammation; macrophages; neovessel; stenosis	CONGENITAL HEART-DISEASE; BLOOD-VESSELS; IN-VITRO; BISPHOSPHONATES; MACROPHAGES; COLLAGEN; ACID; COMPLICATIONS; ACCUMULATION; CLODRONATE	Macrophages are a critical driver of neovessel formation in tissue-engineered vascular grafts (TEVGs), but also contribute to graft stenosis, a leading clinical trial complication. Macrophage depletion via liposomal delivery of clodronate, a first-generation bisphosphonate, mitigates stenosis, but simultaneously leads to a complete lack of tissue development in TEVGs. This result and the associated difficulty of utilizing liposomal delivery means that clodronate may not be an ideal means of preventing graft stenosis. Newer generation bisphosphonates, such as zoledronate, may have differential effects on graft development with more facile drug delivery. We sought to examine the effect of zoledronate on TEVG neotissue formation and its potential application for mitigating TEVG stenosis. Thus, mice implanted with TEVGs received zoledronate or no treatment and were monitored by serial ultrasound for graft dilation and stenosis. After two weeks, TEVGs were explanted for histological examination. The overall graft area and remaining graft material (polyglycolic-acid) were higher in the zoledronate treatment group. These effects were associated with a corresponding decrease in macrophage infiltration. In addition, zoledronate affected the deposition of collagen in TEVGs, specifically, total and mature collagen. These differences may be, in part, explained by a depletion of leukocytes within the bone marrow that subsequently led to a decrease in the number of tissue-infiltrating macrophages. TEVGs from zoledronate-treated mice demonstrated a significantly greater degree of smooth muscle cell presence. There was no statistical difference in graft patency between treatment and control groups. While zoledronate led to a decrease in the number of macrophages in the TEVGs, the severity of stenosis appears to have increased significantly. Zoledronate treatment demonstrates that the process of smooth muscle cell-mediated neointimal hyperplasia may occur separately from a macrophage-mediated mechanism.	[Chang, Yu-Chun; Li, Junlang; Mirhaidari, Gabriel; Zbinden, Jacob; Barker, Jenny; Blum, Kevin; Reinhardt, James; Best, Cameron; Kelly, John; Shoji, Toshihiro; Yi, Tai; Breuer, Christopher] Nationwide Childrens Hosp, Ctr Regenerat Med, Abigail Wexner Res Inst, Columbus, OH 43205 USA; [Chang, Yu-Chun; Mirhaidari, Gabriel; Best, Cameron] Ohio State Univ, Coll Med, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Zbinden, Jacob; Blum, Kevin] Ohio State Univ, Dept Biomed Engn, Coll Engn, Columbus, OH 43210 USA; [Barker, Jenny] Ohio State Univ, Dept Plast & Reconstruct Surg, Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Chang, YC (corresponding author), Nationwide Childrens Hosp, Ctr Regenerat Med, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	yu-chun.chang@nationwidechildrens.org	Li, Junlang/GSO-0056-2022	Reinhardt, James/0000-0001-8406-8421	HHS \ National Institutes of Health (NIH) [R01HL098228, 5T32AI106704-04, T32HL098039-06A1, F31HL1145962, T32HL098039]; American Heart Association (AHA) [18POST33990231]; Pharmaceutical Research and Manufacturers of America Foundation (PhRMA Foundation)	HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); Pharmaceutical Research and Manufacturers of America Foundation (PhRMA Foundation)	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: R01HL098228, 5T32AI106704-04, T32HL098039-06A1, F31HL1145962 and T32HL098039; American Heart Association (AHA), Grant/Award Number: 18POST33990231; Pharmaceutical Research and Manufacturers of America Foundation (PhRMA Foundation)	Allen MR, 2008, OSTEOPOROSIS INT, V19, P329, DOI 10.1007/s00198-007-0533-7; Benavidez OJ, 2007, ANN THORAC SURG, V84, P147, DOI 10.1016/j.athoracsur.2007.02.048; Best C, 2017, ACS BIOMATER SCI ENG, V3, P1972, DOI 10.1021/acsbiomaterials.6b00123; Best CA, 2019, ACTA BIOMATER, V94, P183, DOI 10.1016/j.actbio.2019.05.063; CAMILLERI JP, 1995, CLIN EXP IMMUNOL, V99, P269; Cheung YF, 2005, INT J CARDIOL, V102, P509, DOI 10.1016/j.ijcard.2004.05.051; Ferretti G, 2005, ONCOLOGY-BASEL, V69, P35, DOI 10.1159/000087286; Fournier P, 2002, CANCER RES, V62, P6538; Fowler DW, 2017, CANCER IMMUNOL IMMUN, V66, P1205, DOI 10.1007/s00262-017-2011-1; Garnero P, 2001, BONE, V28, P461, DOI 10.1016/S8756-3282(01)00431-8; Gilboa SM, 2010, CIRCULATION, V122, P2254, DOI 10.1161/CIRCULATIONAHA.110.947002; Hibino N, 2015, FASEB J, V29, P2431, DOI 10.1096/fj.14-268334; Hibino N, 2011, FASEB J, V25, P4253, DOI 10.1096/fj.11-186585; Iguchi T, 2007, INT J ONCOL, V31, P285; Lawson MA, 2010, J BIOMED MATER RES B, V92B, P149, DOI 10.1002/jbm.b.31500; Lee YU, 2014, JOVE-J VIS EXP, DOI 10.3791/51632; Liu RH, 2018, TISSUE ENG PART B-RE, V24, P133, DOI [10.1089/ten.teb.2017.0350, 10.1089/ten.TEB.2017.0350]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3; Moreau MF, 2007, BIOCHEM PHARMACOL, V73, P718, DOI 10.1016/j.bcp.2006.09.031; Moschetta M, 2010, EUR J CANCER, V46, P420, DOI 10.1016/j.ejca.2009.10.019; Naito Y, 2014, ANAT REC, V297, P83, DOI 10.1002/ar.22838; Opperman KS, 2019, NEOPLASIA, V21, P777, DOI 10.1016/j.neo.2019.05.006; Puljula E, 2015, ACS MED CHEM LETT, V6, P397, DOI 10.1021/ml5004603; Rogers TL, 2013, CELL ONCOL, V36, P505, DOI 10.1007/s13402-013-0156-2; Roh JD, 2008, BIOMATERIALS, V29, P1454, DOI 10.1016/j.biomaterials.2007.11.041; Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107; Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022; Sabatino R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101260; Sercombe L, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00286; Shinoka Toshiharu, 2008, Yale Journal of Biology and Medicine, V81, P161; Sugiura T, 2018, SEMIN THORAC CARDIOV, V30, P175, DOI 10.1053/j.semtcvs.2018.02.002; Thompson RW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000023; Triedman JK, 2016, CIRCULATION, V133, P2716, DOI 10.1161/CIRCULATIONAHA.116.023544; Wehrhan F, 2017, J CRANIO MAXILL SURG, V45, P944, DOI 10.1016/j.jcms.2017.02.023; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278; Wood J, 2002, J PHARMACOL EXP THER, V302, P1055, DOI 10.1124/jpet.102.035295; Wu L, 2011, EUR J VASC ENDOVASC, V41, P288, DOI 10.1016/j.ejvs.2010.07.028; Wu L, 2009, EUR J PHARMACOL, V602, P124, DOI 10.1016/j.ejphar.2008.10.043; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Ylitalo R, 1996, J LAB CLIN MED, V127, P200, DOI 10.1016/S0022-2143(96)90079-7; Ylitalo R, 1998, PHARMACOL TOXICOL, V83, P125, DOI 10.1111/j.1600-0773.1998.tb01455.x	42	1	1	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21849	10.1096/fj.202001606RR	http://dx.doi.org/10.1096/fj.202001606RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34473380	Green Accepted			2022-12-28	WOS:000702238200003
J	Di Mise, A; Wang, XF; Ye, H; Pellegrini, L; Torres, VE; Valenti, G				Di Mise, Annarita; Wang, Xiaofang; Ye, Hong; Pellegrini, Lorenzo; Torres, Vicente E.; Valenti, Giovanna			Pre-clinical evaluation of dual targeting of the GPCRs CaSR and V2R as therapeutic strategy for autosomal dominant polycystic kidney disease	FASEB JOURNAL			English	Article						calcimimetics; calcium-sensing receptor; GPCRs; polycystic kidney disease; vaptans; vasopressin V2 receptor	EPITHELIAL-CELLS; LIVER-INJURY; TOLVAPTAN; MODEL; PROGRESSION; ACTIVATION; EXPRESSION; RAT; INHIBITION; MECHANISMS	Autosomal dominant polycystic kidney disease (ADPKD), caused by mutations of PKD1 or PKD2 genes, is characterized by development and growth of cysts causing progressive kidney enlargement. Reduced resting cytosolic calcium and increased cAMP levels associated with the tonic action of vasopressin are two central biochemical defects in ADPKD. Here we show that co-targeting two GPCRs, the vasopressin V2 receptor (V2R) and the calcium sensing receptor, using the novel V2R antagonist lixivaptan in combination with the calcimimetic R-568, reduced cyst progression in two animal models of human PKD. Lixivaptan is expected to have a safer liver profile compared to tolvaptan, the only drug approved to delay PKD progression, based on computational model results and initial clinical evidence. PCK rat and Pkd1(RC/RC) mouse littermates were fed without or with lixivaptan (0.5%) and R-568 (0.025% for rats and 0.04% for mice), alone or in combination, for 7 (rats) or 13 (mice) weeks. In PCK rats, the combined treatment strongly decreased kidney weight, cyst and fibrosis volumes by 20%, 49%, and 73%, respectively, compared to untreated animals. In Pkd1(RC/RC) mice, the same parameters were reduced by 20%, 56%, and 69%, respectively. In both cases the combined treatment appeared nominally more effective than the individual drugs used alone. These data point to an intriguing new application for two existing drugs in PKD treatment. The potential for synergy between these two compounds suggested in these animal studies, if confirmed in appropriate clinical investigations, would represent a welcome advancement in the treatment of ADPKD.	[Di Mise, Annarita; Valenti, Giovanna] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4, I-70125 Bari, Italy; [Wang, Xiaofang; Ye, Hong; Torres, Vicente E.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Pellegrini, Lorenzo] Palladio Biosci Inc, Horsham, PA USA	Universita degli Studi di Bari Aldo Moro; Mayo Clinic	Di Mise, A; Valenti, G (corresponding author), Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4, I-70125 Bari, Italy.	annarita.dimise@uniba.it; giovanna.valenti@uniba.it		Torres, Vicente/0000-0003-2008-1576	Regional project POR Puglia Innonetwork [H6GG787]; National Institute of Diabetes and Digestive and Kidney Diseases [DK-44863, DK-90728]; Attrazione e Mobilita dei Ricercatori [AIM1893457-3]; Mayo Clinic Robert M. and Billie Kelley Pirnie Translational PKD Research Center	Regional project POR Puglia Innonetwork; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Attrazione e Mobilita dei Ricercatori; Mayo Clinic Robert M. and Billie Kelley Pirnie Translational PKD Research Center	Regional project POR Puglia Innonetwork, Grant/Award Number: H6GG787; National Institute of Diabetes and Digestive and Kidney Diseases, Grant/Award Number: DK-44863 and DK--90728; Mayo Clinic Robert M. and Billie Kelley Pirnie Translational PKD Research Center; Attrazione e Mobilita dei Ricercatori, PON "R&I" 2014-2020, Azione I.2, Grant/Award Number: AIM1893457--3 and linea 1	Aihara M, 2014, J PHARMACOL EXP THER, V349, P258, DOI 10.1124/jpet.114.213256; Bowman BT, 2013, CORE EVID, V8, P47, DOI 10.2147/CE.S36744; Chebib FT, 2018, J AM SOC NEPHROL, V29, P2458, DOI 10.1681/ASN.2018060590; Chebib FT, 2016, AM J KIDNEY DIS, V67, P792, DOI 10.1053/j.ajkd.2015.07.037; Chen NX, 2011, KIDNEY INT, V80, P612, DOI 10.1038/ki.2011.139; Dai XQ, 2017, EXP CELL RES, V350, P50, DOI 10.1016/j.yexcr.2016.11.004; Di Mise A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010183; Di Mise A, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00077; Di Mise A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23732-5; Di Mise A, 2015, AM J PHYSIOL-RENAL, V308, pF1200, DOI 10.1152/ajprenal.00352.2014; Dwivedi N, 2020, J AM SOC NEPHROL, V31, P1697, DOI 10.1681/ASN.2020020190; Gattone VH, 1999, DEV GENET, V24, P309, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<309::AID-DVG14>3.0.CO;2-5; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Gattone VH, 2009, J AM SOC NEPHROL, V20, P1527, DOI 10.1681/ASN.2008090927; Grantham JJ, 2008, NEW ENGL J MED, V359, P1477, DOI 10.1056/NEJMcp0804458; Hopp K, 2015, J AM SOC NEPHROL, V26, P39, DOI 10.1681/ASN.2013121312; Hopp K, 2012, J CLIN INVEST, V122, P4257, DOI 10.1172/JCI64313; Ibrahim S, 2007, THESCIENTIFICWORLDJO, V7, P1757, DOI 10.1100/tsw.2007.274; Katsuyama M, 2000, EXP ANIM TOKYO, V49, P51, DOI 10.1538/expanim.49.51; Lager DJ, 2001, KIDNEY INT, V59, P126, DOI 10.1046/j.1523-1755.2001.00473.x; Omori S, 2006, J AM SOC NEPHROL, V17, P1604, DOI 10.1681/ASN.2004090800; Pathomthongtaweechai N, 2014, EUR J PHARMACOL, V724, P67, DOI 10.1016/j.ejphar.2013.12.013; Ranieri M, 2020, VITAM HORM, V112, P289, DOI 10.1016/bs.vh.2019.08.008; Ranieri Marianna, 2019, F1000Res, V8, DOI 10.12688/f1000research.16654.1; Ranieri M, 2018, FASEB J, V32, P2148, DOI 10.1096/fj.201700412RR; Riccardi D, 2016, NAT REV NEPHROL, V12, P414, DOI 10.1038/nrneph.2016.59; Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092; Spithoven EM, 2014, NEPHROL DIAL TRANSPL, V29, P15, DOI 10.1093/ndt/gfu017; Sussman CR, 2020, CELL SIGNAL, V72, DOI 10.1016/j.cellsig.2020.109649; Takiar V, 2011, P NATL ACAD SCI USA, V108, P2462, DOI 10.1073/pnas.1011498108; Testa F, 2020, J NEPHROL, V33, P223, DOI 10.1007/s40620-019-00679-y; Torres JA, 2019, J CLIN INVEST, V129, P4506, DOI 10.1172/JCI128503; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Torres VE, 2004, NAT MED, V10, P363, DOI 10.1038/nm1004; Torres VE, 2017, NEW ENGL J MED, V377, P1930, DOI 10.1056/NEJMoa1710030; Torres VE, 2018, NEPHROL DIAL TRANSPL, V33, P477, DOI 10.1093/ndt/gfx043; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; van Gastel MDA, 2017, ANN NUTR METAB, V70, P43, DOI 10.1159/000463063; Vezzoli G, 2019, UROLITHIASIS, V47, P23, DOI 10.1007/s00240-018-1096-0; Wang XF, 2005, J AM SOC NEPHROL, V16, P846, DOI 10.1681/ASN.2004121090; Wang XF, 2019, AM J NEPHROL, V49, P487, DOI 10.1159/000500667; Wang XF, 2009, NEPHROL DIAL TRANSPL, V24, P526, DOI 10.1093/ndt/gfn527; Watkins PB, 2015, DRUG SAFETY, V38, P1103, DOI 10.1007/s40264-015-0327-3; Woodhead JL, 2020, PHARM RES-DORDR, V37, DOI 10.1007/s11095-019-2726-0; Woodhead JL, 2017, TOXICOL SCI, V155, P61, DOI 10.1093/toxsci/kfw193; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200; Yamaguchi T, 2006, J AM SOC NEPHROL, V17, P178, DOI 10.1681/ASN.2005060645; ZEIER M, 1992, KIDNEY INT, V42, P1259, DOI 10.1038/ki.1992.413	49	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21874	10.1096/fj.202100774R	http://dx.doi.org/10.1096/fj.202100774R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34486176	hybrid, Green Published			2022-12-28	WOS:000702238200035
J	Jesus, ICG; Araujo, FM; Mesquita, T; Junior, NNS; Silva, MM; Morgan, HJN; Silva, KSC; Silva, CLA; Birbrair, A; Amaral, FA; Navegantes, LC; Salgado, HC; Szawka, RE; Poletini, MO; Guatimosim, S				Jesus, Itamar C. G.; Araujo, Flavia M.; Mesquita, Thassio; Junior, Nilton N. S.; Silva, Mario M.; Morgan, Henrique J. N.; Silva, Kaoma S. C.; Silva, Cleide L. A.; Birbrair, Alexander; Amaral, Flavio A.; Navegantes, Luiz C.; Salgado, Helio C.; Szawka, Raphael E.; Poletini, Maristela O.; Guatimosim, Silvia			Molecular basis of Period 1 regulation by adrenergic signaling in the heart	FASEB JOURNAL			English	Article						beta 2 adrenergic receptor; cardiac; clock genes; ERK1; 2; noradrenaline; PI3K	CIRCADIAN GENE-EXPRESSION; BLOOD-PRESSURE; CONTRACTILE FUNCTION; CLOCK; MUTATION; RHYTHMICITY; ACTIVATION; PATTERNS; SYSTEM; KINASE	The cardiac circadian clock is responsible for the modulation of different myocardial processes, and its dysregulation has been linked to disease development. How this clock machinery is regulated in the heart remains an open question. Because noradrenaline (NE) can act as a zeitgeber in cardiomyocytes, we tested the hypothesis that adrenergic signaling resets cardiac clock gene expression in vivo. In its anti-phase with Clock and Bmal1, cardiac Per1 abundance increased during the dark phase, concurrent with the rise in heart rate and preceded by an increase in NE levels. Sympathetic denervation altered Bmal1 and Clock amplitude, while Per1 was affected in both amplitude and oscillatory pattern. We next treated mice with a beta-adrenergic receptor (beta-AR) blocker. Strikingly, the beta-AR blockade during the day suppressed the nocturnal increase in Per1 mRNA, without altering Clock or Bmal1. In contrast, activating beta-AR with isoproterenol (ISO) promoted an increase in Per1 expression, demonstrating its responsiveness to adrenergic input. Inhibitors of ERK1/2 and CREB attenuated ISO-induced Per1 expression. Upstream of ERK1/2, PI3K gamma mediated ISO induction of Per1 transcription, while activation of beta 2-AR, but not beta 1-AR induced increases in ERK1/2 phosphorylation and Per1 expression. Consistent with the beta 2-induction of Per1 mRNA, ISO failed to activate ERK1/2 and elevate Per1 in the heart of beta 2-AR(-/-) mice, whereas a beta 2-AR antagonist attenuated the nocturnal rise in Per1 expression. Our study established a link between NE/beta 2-AR signaling and Per1 oscillation via the PI3Ky-ERK1/2-CREB pathway, providing a new framework for understanding the physiological mechanism involved in resetting cardiac clock genes.	[Jesus, Itamar C. G.; Araujo, Flavia M.; Silva, Mario M.; Silva, Kaoma S. C.; Szawka, Raphael E.; Poletini, Maristela O.; Guatimosim, Silvia] Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol & Biophys, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil; [Mesquita, Thassio] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA; [Junior, Nilton N. S.; Morgan, Henrique J. N.; Navegantes, Luiz C.; Salgado, Helio C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Physiol, Ribeirao Preto, Brazil; [Silva, Cleide L. A.] Univ Sao Paulo, Blood Ctr Fdn, Ribeirao Preto Med Sch, Anim Facil, Ribeirao Preto, Brazil; [Birbrair, Alexander] Univ Fed Minas Gerais, Inst Biol Sci, Dept Pathol, Belo Horizonte, MG, Brazil; [Amaral, Flavio A.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Cedars Sinai Medical Center; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Poletini, MO; Guatimosim, S (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol & Biophys, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.	marispoletini@icb.ufmg.br; guatimosim@icb.ufmg.br	Szawka, Raphael E/V-7475-2017; Poletini, Maristela O/D-5855-2015; Morgan, Henrique/AAO-7529-2021; Silva, Kaoma/GSD-7858-2022; Amaral, Flavio/D-5489-2014	Szawka, Raphael E/0000-0002-2639-3469; Poletini, Maristela O/0000-0003-4917-889X; Morgan, Henrique/0000-0001-5062-4493; Silva, Mario/0000-0003-2592-2370; Silva, Kaoma/0000-0003-1990-5224; Amaral, Flavio/0000-0002-1695-0612; Mesquita, Thassio/0000-0002-6927-5745	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); PRPq (Pro--reitoria de Pesquisa da UFMG)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PRPq (Pro--reitoria de Pesquisa da UFMG)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); PRPq (Pro--reitoria de Pesquisa da UFMG)	Akashi M, 2008, J NEUROSCI, V28, P4619, DOI 10.1523/JNEUROSCI.3410-07.2008; Beesley S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159618; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; BRISTOW MR, 1986, CIRC RES, V59, P297, DOI 10.1161/01.RES.59.3.297; Bulluck H, 2017, INT J CARDIOL, V230, P149, DOI 10.1016/j.ijcard.2016.12.030; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; Collins HE, 2010, CIRC RES, V106, P1244, DOI 10.1161/CIRCRESAHA.109.213942; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Davidson AJ, 2005, CLIN EXP HYPERTENS, V27, P307, DOI 10.1081/CEH-200048933; DEGAUTE JP, 1991, HYPERTENSION, V18, P199, DOI 10.1161/01.HYP.18.2.199; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Durgan DJ, 2005, AM J PHYSIOL-HEART C, V289, pH1530, DOI 10.1152/ajpheart.00406.2005; Goldsmith CS, 2013, ADV GENET, V84, P1, DOI 10.1016/B978-0-12-407703-4.00001-3; Gomes ERM, 2010, HYPERTENSION, V55, P153, DOI 10.1161/HYPERTENSIONAHA.109.143255; Jesus ICG, 2020, AM J PHYSIOL-CELL PH, V318, pC740, DOI 10.1152/ajpcell.00153.2019; Hida A, 2000, GENOMICS, V65, P224, DOI 10.1006/geno.2000.6166; Husse J, 2014, FASEB J, V28, P4950, DOI 10.1096/fj.14-256594; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Kanazawa H, 2010, J CLIN INVEST, V120, P408, DOI 10.1172/JCI39778; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Ko ML, 2011, J BIOL RHYTHM, V26, P412, DOI 10.1177/0748730411414170; Kreusser MM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00036; Lavie P, 2001, ANNU REV PSYCHOL, V52, P277, DOI 10.1146/annurev.psych.52.1.277; Lefta M, 2012, AM J PHYSIOL-HEART C, V303, pH475, DOI 10.1152/ajpheart.00238.2012; Leibetseder V, 2009, CHRONOBIOL INT, V26, P621, DOI 10.1080/07420520902924939; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Manfredini R, 2013, CHRONOBIOL INT, V30, P6, DOI 10.3109/07420528.2012.715843; Martino T, 2004, J MOL MED, V82, P256, DOI 10.1007/s00109-003-0520-1; McGinnis GR, 2016, NAT SCI SLEEP, V8, P163, DOI 10.2147/NSS.S78946; Menet JS, 2012, ELIFE, V1, DOI 10.7554/eLife.00011; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Patke A, 2020, NAT REV MOL CELL BIO, V21, P67, DOI 10.1038/s41580-019-0179-2; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Pizzio GA, 2003, NEUROREPORT, V14, P1417, DOI 10.1097/00001756-200308060-00002; Portaluppi F, 2007, ADV DRUG DELIVER REV, V59, P940, DOI 10.1016/j.addr.2006.10.011; PRINZ PN, 1979, J CLIN ENDOCR METAB, V49, P300, DOI 10.1210/jcem-49-2-300; Reilly DF, 2008, ARTERIOSCL THROM VAS, V28, P121, DOI 10.1161/ATVBAHA.107.152538; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RICHARDS AM, 1986, CLIN EXP HYPERTENS A, V8, P153, DOI 10.3109/10641968609074769; Rijo-Ferreira F, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0704-0; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; STERN N, 1985, HYPERTENSION, V7, P1023, DOI 10.1161/01.HYP.7.6.1023; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Teixeira VP, 2021, AM J PHYSIOL-CELL PH, V320, pC602, DOI 10.1152/ajpcell.00142.2020; Terazono H, 2003, P NATL ACAD SCI USA, V100, P6795, DOI 10.1073/pnas.0936797100; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Tsuchiya Y, 2013, P JPN ACAD B-PHYS, V89, P59, DOI 10.2183/pjab.89.59; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; URETSKY NJ, 1969, NATURE, V221, P557, DOI 10.1038/221557a0; Vadas O, 2013, P NATL ACAD SCI USA, V110, P18862, DOI 10.1073/pnas.1304801110; Viswambharan H, 2007, CIRCULATION, V115, P2188, DOI 10.1161/CIRCULATIONAHA.106.653303; Vukolic A, 2010, AM J PHYSIOL-REG I, V298, pR627, DOI 10.1152/ajpregu.00404.2009; Wang YW, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82202-7; Wellman PJ, 2000, NUTRITION, V16, P837, DOI 10.1016/S0899-9007(00)00415-9; Young ME, 2014, J BIOL RHYTHM, V29, P257, DOI 10.1177/0748730414543141; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zhang WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026581; Zhou L, 2011, BASIC RES CARDIOL, V106, P37, DOI 10.1007/s00395-010-0110-7	61	4	4	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21886	10.1096/fj.202100441R	http://dx.doi.org/10.1096/fj.202100441R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34473369				2022-12-28	WOS:000702238200018
J	Garcia, R; Itto-Nakama, K; Rodriguez-Pena, JM; Chen, XL; Sanz, AB; de Lorenzo, A; Pavon-Verges, M; Kubo, K; Ohnuki, S; Nombela, C; Popolo, L; Ohya, Y; Arroyo, J				Garcia, Raul; Itto-Nakama, Kaori; Rodriguez-Pena, Jose Manuel; Chen, Xiaolin; Sanz, Ana Belen; de Lorenzo, Alba; Pavon-Verges, Monica; Kubo, Karen; Ohnuki, Shinsuke; Nombela, Cesar; Popolo, Laura; Ohya, Yoshikazu; Arroyo, Javier			Poacic acid, a beta-1,3-glucan-binding antifungal agent, inhibits cell-wall remodeling and activates transcriptional responses regulated by the cell-wall integrity and high-osmolarity glycerol pathways in yeast	FASEB JOURNAL			English	Article						beta-1,3-glucan; antifungal agents; cell wall remodeling; MAPK; poacic acid; Saccharomyces cerevisiae; transcriptomics; transglycosylases	SACCHAROMYCES-CEREVISIAE; CATALYTIC-PROPERTIES; FLUORESCENCE ASSAY; MAPK PATHWAY; CHITIN; STRESS; EXPRESSION; MEMBRANE; DAMAGE; FAMILY	As a result of the relatively few available antifungals and the increasing frequency of resistance to them, the development of novel antifungals is increasingly important. The plant natural product poacic acid (PA) inhibits beta-1,3-glucan synthesis in Saccharomyces cerevisiae and has antifungal activity against a wide range of plant pathogens. However, the mode of action of PA is unclear. Here, we reveal that PA specifically binds to beta-1,3-glucan, its affinity for which is similar to 30-fold that for chitin. Besides its effect on beta-1,3-glucan synthase activity, PA inhibited the yeast glucan-elongating activity of Gas1 and Gas2 and the chitin-glucan transglycosylase activity of Crh1. Regarding the cellular response to PA, transcriptional co-regulation was mediated by parallel activation of the cell-wall integrity (CWI) and high-osmolarity glycerol signaling pathways. Despite targeting beta-1,3-glucan remodeling, the transcriptional profiles and regulatory circuits activated by caspofungin, zymolyase, and PA differed, indicating that their effects on CWI have different mechanisms. The effects of PA on the growth of yeast strains indicated that it has a mode of action distinct from that of echinocandins, suggesting it is a unique antifungal agent.	[Garcia, Raul; Rodriguez-Pena, Jose Manuel; Sanz, Ana Belen; de Lorenzo, Alba; Pavon-Verges, Monica; Nombela, Cesar; Arroyo, Javier] Univ Complutense Madrid, Fac Farm, Dept Microbiol & Parasitol, IRYCIS, Madrid 28040, Spain; [Itto-Nakama, Kaori; Chen, Xiaolin; Kubo, Karen; Ohnuki, Shinsuke; Ohya, Yoshikazu] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Popolo, Laura] Univ Milan, Dept Biosci, Milan, Italy; [Ohya, Yoshikazu] Univ Tokyo, Collaborat Res Inst Innovat Microbiol CRIIM, Tokyo, Japan	Complutense University of Madrid; University of Tokyo; University of Milan; University of Tokyo	Arroyo, J (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol & Parasitol, IRYCIS, Madrid 28040, Spain.; Ohya, Y (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	ohya@edu.k.u-tokyo.ac.jp; jarroyo@ucm.es	Sanchez, Raúl García/E-9303-2016; Sanz, Belén/HDM-8495-2022; Sanz, Ana Belen/H-3775-2017; RODRIGUEZ PENA, JOSE MANUEL/E-9624-2016	Sanchez, Raúl García/0000-0002-7389-4696; Pavon Verges, Monica/0000-0001-9335-9933; Sanz, Ana Belen/0000-0002-5717-0217; RODRIGUEZ PENA, JOSE MANUEL/0000-0002-8792-362X	Ministerio de Ciencia e Innovacion, MICINN, Spain [BIO2016-79289-P, PID2019-105223GB-I00]; Comunidad de Madrid, Spain [S2017/BMD3691-InGEMICS]; Center of excellence for Glycomics - ERDF [ITMS 26240120031]; Ministry of Education Culture, Sports, Science and Technology, Japan [19H03205, 18K14351]	Ministerio de Ciencia e Innovacion, MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid, Spain(Comunidad de Madrid); Center of excellence for Glycomics - ERDF; Ministry of Education Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants BIO2016-79289-P and PID2019-105223GB-I00 (Ministerio de Ciencia e Innovacion, MICINN, Spain) and S2017/BMD3691-InGEMICS (Comunidad de Madrid, Spain) to J.A, "Center of excellence for Glycomics", ITMS 26240120031 (Research & Development Operational Programme funded by the ERDF) to Vladimir Farkas, and 19H03205 and 18K14351 (Grants-in-Aid for Scientific Research from the Ministry of Education Culture, Sports, Science and Technology, Japan) to Y.O and K.I.N, respectively	Aimanianda V, 2017, MBIO, V8, DOI [10.1128/mBio.00619-17, 10.1128/mbio.00619-17]; Arroyo J, 2009, CLIN MICROBIOL INFEC, V15, P44, DOI 10.1111/j.1469-0691.2008.02676.x; Arroyo J, 2016, CELL MICROBIOL, V18, P1239, DOI 10.1111/cmi.12615; Beauvais A, 2001, J BACTERIOL, V183, P2273, DOI 10.1128/JB.183.7.2273-2279.2001; Sanz AB, 2012, MOL BIOL CELL, V23, P2805, DOI 10.1091/mbc.E12-04-0278; Sanz AB, 2018, J FUNGI, V4, DOI 10.3390/jof4010001; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; Bermejo C, 2010, OMICS, V14, P679, DOI 10.1089/omi.2010.0060; Bongomin F, 2017, J FUNGI, V3, DOI 10.3390/jof3040057; BROWN JL, 1993, GENETICS, V133, P837; Cabib E, 2007, MOL MICROBIOL, V63, P921, DOI 10.1111/j.1365-2958.2006.05565.x; Arroyo ECJ, 2013, NAT REV MICROBIOL, V11, P648, DOI 10.1038/nrmicro3090; Cabib E, 2009, EUKARYOT CELL, V8, P1626, DOI 10.1128/EC.00228-09; Chen JX, 2020, SCI REP-UK, V10, DOI [10.1038/s41598-020-62884-1, 10.1038/s41598-020-59451-z]; Cortes JCG, 2019, BIOTECHNOL ADV, V37, DOI 10.1016/j.biotechadv.2019.02.008; Costa-de-Oliveira S, 2013, CYTOM PART A, V83A, P324, DOI 10.1002/cyto.a.22250; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; Denning DW, 2015, SCIENCE, V347, P1414, DOI 10.1126/science.aaa6097; Elhasi T, 2019, MICROB CELL, V6, P335, DOI 10.15698/mic2019.08.686; EVANS NA, 1984, CARBOHYD POLYM, V4, P215, DOI 10.1016/0144-8617(84)90012-2; Fernandes C, 2014, ANTIMICROB AGENTS CH, V58, P2894, DOI 10.1128/AAC.02647-13; Free SJ, 2013, ADV GENET, V81, P33, DOI 10.1016/B978-0-12-407677-8.00002-6; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Garcia R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06001-9; Garcia R, 2016, J CELL SCI, V129, P1649, DOI 10.1242/jcs.180190; Garcia R, 2009, J BIOL CHEM, V284, P10901, DOI 10.1074/jbc.M808693200; Gow NAR, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0035-2016; Heinisch JJ, 2018, FEMS MICROBIOL REV, V42, P22, DOI 10.1093/femsre/fux051; Jendretzki A, 2011, EUR J CELL BIOL, V90, P740, DOI 10.1016/j.ejcb.2011.04.006; Kock C, 2016, CELL MICROBIOL, V18, P1251, DOI 10.1111/cmi.12635; Kock C, 2015, APPL ENVIRON MICROB, V81, P806, DOI 10.1128/AEM.03273-14; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; Latge JP, 2017, MED MYCOL, V55, P4, DOI 10.1093/mmy/myw076; Lee HS, 2020, J MICROBIOL BIOTECHN, V30, P967, DOI 10.4014/jmb.2002.02025; Lee Keunsook K, 2018, Cell Surf, V3, P12, DOI 10.1016/j.tcsw.2018.09.001; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazan M, 2013, BIOCHEM J, V455, P307, DOI 10.1042/BJ20130354; Mazan M, 2011, BIOCHEM J, V438, P275, DOI 10.1042/BJ20110405; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; Mouyna I, 2000, BIOCHEM J, V347, P741, DOI 10.1042/0264-6021:3470741; Nett JE, 2016, INFECT DIS CLIN N AM, V30, P51, DOI 10.1016/j.idc.2015.10.012; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; OHNO N, 1986, CHEM PHARM BULL, V34, P1362; Okada Hiroki, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot085241; Okada H, 2010, GENETICS, V184, P1013, DOI 10.1534/genetics.109.109892; Orlean P, 2012, GENETICS, V192, P775, DOI 10.1534/genetics.112.144485; Perfect JR, 2017, NAT REV DRUG DISCOV, V16, P603, DOI 10.1038/nrd.2017.46; Piotrowski JS, 2015, P NATL ACAD SCI USA, V112, pE1490, DOI 10.1073/pnas.1410400112; Popolo L, 2001, MED MYCOL, V39, P111, DOI 10.1080/744118881; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Reinoso-Martin C, 2003, EUKARYOT CELL, V2, P1200, DOI 10.1128/EC.2.6.1200-1210.2003; Rodriguez-Pena JM, 2000, MOL CELL BIOL, V20, P3245, DOI 10.1128/MCB.20.9.3245-3255.2000; Rodriguez-Pena JM, 2013, FEBS LETT, V587, P3675, DOI 10.1016/j.febslet.2013.09.030; Sanchez-Maldonado AF, 2011, J APPL MICROBIOL, V111, P1176, DOI 10.1111/j.1365-2672.2011.05141.x; Shedletzky E, 1997, ANAL BIOCHEM, V249, P88, DOI 10.1006/abio.1997.2162; Tada R, 2013, CURR PHARM DESIGN, V19, P3738, DOI 10.2174/1381612811319200012; Tatebayashi K, 2007, EMBO J, V26, P3521, DOI 10.1038/sj.emboj.7601796; Udom N, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00551-19; Walker LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000040; Wiederhold NP, 2018, INT J ANTIMICROB AG, V51, P333, DOI 10.1016/j.ijantimicag.2017.09.002; Yvert G, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-54	63	3	3	6	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21778	10.1096/fj.202100278R	http://dx.doi.org/10.1096/fj.202100278R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34383971	Green Accepted, Green Published			2022-12-28	WOS:000691122900027
J	Ungvari, O; Kiraly, L; Bakos, E; Ozvegy-Laczka, C				Ungvari, Orsolya; Kiraly, Laura; Bakos, Eva; Ozvegy-Laczka, Csilla			8-acetoxy-trisulfopyrene as the first activatable fluorogenic probe for add-and-read assessment of Organic anion-transporting polypeptides, OATP1B1, OATP1B3, and OATP2B1	FASEB JOURNAL			English	Article						activatable fluorogenic substrate; competitive counterflow; drug interaction; hepatic OATP	DRUG-INTERACTION; VECTORIAL TRANSPORT; INHIBITION; CONSORTIUM; EXPRESSION; MECHANISM; SUBSTRATE; INDUSTRY	Organic anion-transporting polypeptides, OATP1B1, OATP1B3, and OATP2B1 are multispecific membrane proteins mediating the hepatocellular uptake of structurally diverse endo- and exogenous compounds, including various kinds of drugs. Co-administration of OATP1B/2B1 substrates may lead to altered pharmacokinetics or even toxicity. Therefore, the study of the interaction with these OATPs is essential in drug development and is recommended by international regulatory agencies, the FDA, EMA, and PMDA. In general, radiolabeled indicators are used to measure drug interactions of OATPs, and, lately, fluorescent probes are also gaining wider application in OATP tests. However, all of the currently available methods (either radioactive or fluorescence-based) comprise multiple steps, including the removal of the indicator in the end of the experiment. Hence, they are not ideally suited for high-throughput screening. In the current study, in order to find an indicator allowing real-time assessment of hepatic OATP function, we searched for an activatable fluorogenic OATP substrate. Here, we show that 8-acetoxypyrene-1,3,6-trisulfonate (Ace), a fluorogenic derivative of the hepatic OATP substrate pyranine (8-hydroxypyrene-1,3,6-trisulfonate) enters the cells via OATP1B1/3 or OATP2B1 function. In living cells, Ace is then converted into highly fluorescent pyranine, allowing "no-wash" measurement of OATP function and drug interactions. Furthermore, we demonstrate that Ace can be used in an indirect assay termed as competitive counterflow suitable to distinguish between transported substrates and inhibitors of OATP1B1. The fluorescence-based methods described here are unique and open the way toward high-throughput screening of interactions between new molecular entities and OATPs.	[Ungvari, Orsolya; Kiraly, Laura; Bakos, Eva; Ozvegy-Laczka, Csilla] Eotvos Lorand Res Network, Inst Enzymol, RCNS, Magyar Tudosok Krt 2, H-1117 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Ozvegy-Laczka, C (corresponding author), Eotvos Lorand Res Network, Inst Enzymol, RCNS, Magyar Tudosok Krt 2, H-1117 Budapest, Hungary.	laczka.csilla@ttk.hu			National Research Development and Innovation Office [FK 128751]	National Research Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	National Research Development and Innovation Office, Grant/Award Number: FK 128751	Ansbro MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060334; Bakos E, 2020, BIOCHEM PHARMACOL, V182, DOI 10.1016/j.bcp.2020.114250; Bakos E, 2020, FEBS J, V287, P2468, DOI 10.1111/febs.15156; Bednarczyk D, 2010, ANAL BIOCHEM, V405, P50, DOI 10.1016/j.ab.2010.06.012; Cui YH, 2001, MOL PHARMACOL, V60, P934, DOI 10.1124/mol.60.5.934; De Bruyn T, 2011, J PHARM SCI-US, V100, P5018, DOI 10.1002/jps.22694; Gan BS, 1998, AM J PHYSIOL-CELL PH, V275, pC1158, DOI 10.1152/ajpcell.1998.275.4.C1158; Giacomini KM, 2013, CLIN PHARMACOL THER, V94, P3, DOI 10.1038/clpt.2013.86; Giacomini KM, 2013, CLIN PHARMACOL THER, V94, P23, DOI 10.1038/clpt.2013.12; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gui Chunshan, 2010, Curr Chem Genomics, V4, P1, DOI 10.2174/1875397301004010001; Hagenbuch B, 2013, MOL ASPECTS MED, V34, P396, DOI 10.1016/j.mam.2012.10.009; Harper JN, 2013, AM J PHYSIOL-RENAL, V304, pF56, DOI 10.1152/ajprenal.00486.2012; Hirouchi M, 2009, DRUG METAB DISPOS, V37, P2103, DOI 10.1124/dmd.109.027193; Hollo Z, 1996, FEBS LETT, V383, P99, DOI 10.1016/0014-5793(96)00237-2; HOLLO Z, 1994, BBA-BIOMEMBRANES, V1191, P384, DOI 10.1016/0005-2736(94)90190-2; Huang SM, 2010, CLIN PHARMACOL THER, V87, P32, DOI 10.1038/clpt.2009.236; Izumi S, 2016, MOL PHARMACEUT, V13, P438, DOI 10.1021/acs.molpharmaceut.5b00664; Izumi S, 2013, DRUG METAB DISPOS, V41, P1859, DOI 10.1124/dmd.113.052290; Jones HM, 2015, CLIN PHARMACOL THER, V97, P247, DOI 10.1002/cpt.37; Karlgren M, 2012, J MED CHEM, V55, P4740, DOI 10.1021/jm300212s; Kawasaki T, 2020, PHARM RES-DORDR, V37, DOI 10.1007/s11095-020-02831-x; Konig J, 2000, J BIOL CHEM, V275, P23161, DOI 10.1074/jbc.M001448200; Kullak-Ublick GA, 2001, GASTROENTEROLOGY, V120, P525, DOI 10.1053/gast.2001.21176; Langton MJ, 2017, NAT CHEM, V9, P426, DOI [10.1038/NCHEM.2678, 10.1038/nchem.2678]; Lavis LD, 2011, CHEM SCI, V2, P521, DOI 10.1039/c0sc00466a; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Liu LC, 2006, J PHARMACOL EXP THER, V318, P395, DOI 10.1124/jpet.106.103390; Matsushima S, 2005, J PHARMACOL EXP THER, V314, P1059, DOI 10.1124/jpet.105.085589; Nagai N, 2010, DRUG METAB PHARMACOK, V25, P3, DOI 10.2133/dmpk.25.3; Obaidat A, 2012, ANNU REV PHARMACOL, V52, P135, DOI 10.1146/annurev-pharmtox-010510-100556; Patik I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20815-1; Peterson BG, 2017, PHARMACOL RES, V119, P313, DOI 10.1016/j.phrs.2017.02.024; Pottel J, 2020, SCIENCE, V369, P403, DOI 10.1126/science.aaz9906; ROSENBERG T, 1957, J GEN PHYSIOL, V41, P289, DOI 10.1085/jgp.41.2.289; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; SAEKI T, 1993, J BIOL CHEM, V268, P6077; Santockyte R, 2018, BIOANALYSIS, V10, P1473, DOI 10.4155/bio-2018-0170; Schafer AM, 2020, MOL PHARMACEUT, V17, P1987, DOI 10.1021/acs.molpharmaceut.0c00159; Schafer AM, 2018, MOL PHARMACEUT, V15, P5501, DOI 10.1021/acs.molpharmaceut.8b00631; Shitara Y, 2003, J PHARMACOL EXP THER, V304, P610, DOI 10.1124/jpet.102.041921; Shitara Y, 2013, BIOPHARM DRUG DISPOS, V34, P45, DOI 10.1002/bdd.1823; Shitara Y, 2011, DRUG METAB PHARMACOK, V26, P220, DOI 10.2133/dmpk.DMPK-10-RV-094; Szekely V, 2020, EUR J PHARM SCI, V151, DOI 10.1016/j.ejps.2020.105395; Telbisz A, 2021, PHARMACEUTICS, V13, DOI 10.3390/pharmaceutics13010081; Urquhart BL, 2009, EUR J CLIN PHARMACOL, V65, P1063, DOI 10.1007/s00228-009-0714-8; Yang JJ, 2020, MOL PHARMACEUT, V17, P3966, DOI 10.1021/acs.molpharmaceut.0c00747; Zamek-Gliszczynski MJ, 2018, CLIN PHARMACOL THER, V104, P890, DOI 10.1002/cpt.1112; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	49	3	3	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21863	10.1096/fj.202100648R	http://dx.doi.org/10.1096/fj.202100648R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34411334	hybrid			2022-12-28	WOS:000691122900036
J	Mezzasoma, L; Bellezza, I; Orvietani, P; Manni, G; Gargaro, M; Sagini, K; Llorente, A; Scarpelli, P; Pascucci, L; Cellini, B; Talesa, VN; Fallarino, F; Romani, R				Mezzasoma, Letizia; Bellezza, Ilaria; Orvietani, Pierluigi; Manni, Giorgia; Gargaro, Marco; Sagini, Krizia; Llorente, Alicia; Scarpelli, Paolo; Pascucci, Luisa; Cellini, Barbara; Talesa, Vincenzo Nicola; Fallarino, Francesca; Romani, Rita			Amniotic fluid stem cell-derived extracellular vesicles are independent metabolic units capable of modulating inflammasome activation in THP-1 cells	FASEB JOURNAL			English	Article						ATP production; immunoregulation; inflammasomes; stem cell-derived extracellular vesicles	A(2A) ADENOSINE RECEPTOR; NLRP3 INFLAMMASOME; IMMUNE-RESPONSES; EXOSOMES; PROSTASOMES; REGULATORS; AGONISTS; INJURY; CD39; CD73	An immunoregulatory role of stem cells, often mediated by their secretome, has been claimed by several studies. Stem cell-derived extracellular vesicles (EVs) are crucial components of the secretome. EVs, a heterogeneous group of membranous vesicles released by many cell types into the extracellular space, are now considered as an additional mechanism for intercellular communication. In this study, we aimed at investigating whether human amniotic stem cell-derived extracellular vesicles (HASC-EVs) were able to interfere with inflammasome activation in the THP-1 cell line. Two subsets of HASC-EVs were collected by sequential centrifugation, namely HASC-P10 and HASC-P100. We demonstrated that HASC-EVs were neither internalized into nor undertake a direct interaction with THP-1 cells. We showed that HASC-P10 and P100 were able to intrinsically produce ATP, which was further converted to adenosine by 5'-nucleotidase (CD73) and ectonucleoside triphosphate diphosphohydrolase-1 (CD39). We found that THP-1 cells conditioned with both types of HASC-EVs failed to activate the NLRP3/caspase-1/inflammasome platform in response to LPS and ATP treatment by a mechanism involving A2a adenosine receptor activation. These results support a role for HASC-EVs as independent metabolic units capable of modifying the cellular functions, leading to anti-inflammatory effects in monocytic cells.	[Mezzasoma, Letizia; Bellezza, Ilaria; Orvietani, Pierluigi; Manni, Giorgia; Gargaro, Marco; Scarpelli, Paolo; Cellini, Barbara; Talesa, Vincenzo Nicola; Fallarino, Francesca; Romani, Rita] Univ Perugia, Dept Med & Surg, Polo Unico St Andrea Fratte, Pe Lucio Severi 1, I-06132 Perugia, Italy; [Sagini, Krizia; Llorente, Alicia] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Mol Cell Biol, Oslo, Norway; [Pascucci, Luisa] Dept Vet Med, Perugia, Italy	University of Perugia; University of Oslo	Romani, R (corresponding author), Univ Perugia, Dept Med & Surg, Polo Unico St Andrea Fratte, Pe Lucio Severi 1, I-06132 Perugia, Italy.	rita.romani@unipg.it	SAGINI, Krizia/Z-1629-2019; Cellini, Barbara/AAC-6401-2019; Gargaro, Marco/K-7077-2016; Fallarino, Francesca/O-3358-2013	SAGINI, Krizia/0000-0003-3357-2171; Cellini, Barbara/0000-0002-5221-9288; Gargaro, Marco/0000-0003-0645-9800; Scarpelli, Paolo/0000-0001-6583-3693; Llorente, Alicia/0000-0002-0045-071X; Fallarino, Francesca/0000-0002-8501-2136; BELLEZZA, ILARIA/0000-0002-8106-1600; Pascucci, Luisa/0000-0002-2562-1140	Department of Medicine and Surgery, Perugia University	Department of Medicine and Surgery, Perugia University	Department of Medicine and Surgery, Perugia University	Angioni R, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2020.1757900; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Balbi C, 2017, STEM CELL TRANSL MED, V6, P1340, DOI 10.1002/sctm.16-0297; Bebelman MP, 2018, PHARMACOL THERAPEUT, V188, P1, DOI 10.1016/j.pharmthera.2018.02.013; Biasizzo M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.591803; Bjorge IM, 2017, BIOMATER SCI-UK, V6, P60, DOI 10.1039/c7bm00479f; Campden RI, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2021.101459; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen BY, 2019, CLIN CHIM ACTA, V493, P14, DOI 10.1016/j.cca.2019.02.021; Chiasserini D, 2017, J PROTEOMICS, V152, P329, DOI 10.1016/j.jprot.2016.11.013; Clayton A, 2011, J IMMUNOL, V187, P676, DOI 10.4049/jimmunol.1003884; Faas MM, 2017, MOL ASPECTS MED, V55, P9, DOI 10.1016/j.mam.2017.01.002; Fonseka P, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2020.166747; Garcia NA, 2016, CARDIOVASC RES, V109, P397, DOI 10.1093/cvr/cvv260; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Goran-Ronquist K, 2013, BBA-GEN SUBJECTS, V1830, P4604, DOI 10.1016/j.bbagen.2013.05.019; Harrell CR, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121605; Harrell CR, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050467; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 1998, EUR J PHARMACOL, V358, P261, DOI 10.1016/S0014-2999(98)00619-0; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Iraci N, 2017, NAT CHEM BIOL, V13, P951, DOI [10.1038/nchembio.2422, 10.1038/NCHEMBIO.2422]; Jiang LR, 2019, BIOCHEM BIOPH RES CO, V508, P735, DOI 10.1016/j.bbrc.2018.11.189; Kelley N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133328; Keshtkar S, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0791-7; Lappas CM, 2005, EXPERT OPIN INV DRUG, V14, P797, DOI 10.1517/13543784.14.7.797; Lin LY, 2018, CELL IMMUNOL, V326, P24, DOI 10.1016/j.cellimm.2017.07.010; Liu YN, 2018, EBIOMEDICINE, V36, P140, DOI 10.1016/j.ebiom.2018.08.054; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; McKelvey Kelly J, 2015, J Circ Biomark, V4, P7, DOI 10.5772/61186; Mezzasoma L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010024; Mezzasoma L, 2019, CANCERS, V11, DOI 10.3390/cancers11091276; Mezzasoma L, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/5858315; Mezzasoma L, 2016, IMMUNOL RES, V64, P303, DOI 10.1007/s12026-015-8751-0; Morello S, 2009, J RECEPT LIGAND CH R, V2, P11, DOI 10.2147/JRLCR.S4710; Nojehdehi S, 2018, J CELL BIOCHEM, V119, P9433, DOI 10.1002/jcb.27260; O'Connell JS, 2021, PEDIATR SURG INT, V37, P301, DOI 10.1007/s00383-020-04826-6; Okusa MD, 2000, AM J PHYSIOL-RENAL, V279, pF809, DOI 10.1152/ajprenal.2000.279.5.F809; Palmer TM, 2008, BRIT J PHARMACOL, V153, pS27, DOI 10.1038/sj.bjp.0707524; Phinney DG, 2017, STEM CELLS, V35, P851, DOI 10.1002/stem.2575; Poli G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165758; Rajan TS, 2017, INT J IMMUNOPATH PH, V30, P238, DOI 10.1177/0394632017722332; Ralevic V, 1998, PHARMACOL REV, V50, P413; Ratajczak MZ, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.603942; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Romani R, 2015, J CELL MOL MED, V19, P1593, DOI 10.1111/jcmm.12534; Ronquist KG, 2013, AM J PHYSIOL-ENDOC M, V304, pE576, DOI 10.1152/ajpendo.00511.2012; Ronquist KG, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.29877; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shigemoto-Kuroda T, 2017, STEM CELL REP, V8, P1214, DOI 10.1016/j.stemcr.2017.04.008; Sitkovsky MV, 2003, BIOCHEM PHARMACOL, V65, P493, DOI 10.1016/S0006-2952(02)01548-4; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Song N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02305; Takov K, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0785-3; Taylor DD, 2015, METHODS, V87, P3, DOI 10.1016/j.ymeth.2015.02.019; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Todorova D, 2017, CIRC RES, V120, P1658, DOI 10.1161/CIRCRESAHA.117.309681; Veerman RE, 2019, TRENDS MOL MED, V25, P382, DOI 10.1016/j.molmed.2019.02.003; Zeng Q, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00182; Zhang SP, 2019, BIOMATERIALS, V200, P35, DOI 10.1016/j.biomaterials.2019.02.006; Zhang W, 2019, INVEST OPHTH VIS SCI, V60, P294, DOI 10.1167/iovs.18-25617; Zhang X, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0181-x; Zhu Y, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0510-9	66	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22218	10.1096/fj.202101657R	http://dx.doi.org/10.1096/fj.202101657R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CK	35218567	hybrid			2022-12-28	WOS:000772944800001
J	Oyabu, M; Takigawa, K; Mizutani, S; Hatazawa, Y; Fujita, M; Ohira, Y; Sugimoto, T; Suzuki, O; Tsuchiya, K; Suganami, T; Ogawa, Y; Ishihara, K; Miura, S; Kamei, Y				Oyabu, Mamoru; Takigawa, Kaho; Mizutani, Sako; Hatazawa, Yukino; Fujita, Mariko; Ohira, Yuto; Sugimoto, Takumi; Suzuki, Osamu; Tsuchiya, Kyoichiro; Suganami, Takayoshi; Ogawa, Yoshihiro; Ishihara, Kengo; Miura, Shinji; Kamei, Yasutomi			FOXO1 cooperates with C/EBP delta and ATF4 to regulate skeletal muscle atrophy transcriptional program during fasting	FASEB JOURNAL			English	Article						ATF4; C/EBE delta; fasting; FOXO1; skeletal muscle atrophy	UNFOLDED PROTEIN RESPONSE; GLUCOCORTICOID-RECEPTOR; CANCER CACHEXIA; GENE-EXPRESSION; CATHEPSIN-L; INSULIN; ACTIVATION; STRESS; MICE; IDENTIFICATION	Catabolic conditions, such as starvation, inactivity, and cancer cachexia, induce Forkhead box O (FOXO) transcription factor(s) expression and severe muscle atrophy via the induction of ubiquitin-proteasome system-mediated muscle proteolysis, resulting in frailty and poor quality of life. Although FOXOs are clearly essential for the induction of muscle atrophy, it is unclear whether there are other factors involved in the FOXO-mediated transcriptional regulation. As such, we identified FOXO-CCAAT/enhancer-binding protein delta (C/EBP delta) signaling pathway as a novel proteolytic pathway. By comparing the gene expression profiles of FOXO1-transgenic (gain-of-function model) and FOXO1,3a,4(-/-) (lossof-function model) mice, we identified several novel FOXO1-target genes in skeletal muscle including Reddl, Sestrin1, Castor2, Chad, Depp1, Lat3, as well as C/EBP delta. During starvation, C/EBP delta abundance was increased in a FOXOs-dependent manner. Notably, knockdown of C/EBP delta prevented the induction of the ubiquitin-proteasome system and decrease of myofibers in FOXO1-activated myotubes. Conversely, C/EBP delta overexpression in primary myotubes induced myotube atrophy. Furthermore, we demonstrated that FOXOI enhances the promoter activity of target genes in cooperation with C/EBP delta and ATF4. This research comprehensively identifies novel FOXO1 target genes in skeletal muscle and clarifies the pathophysiological role of FOXO1, a master regulator of skeletal muscle atrophy.	[Oyabu, Mamoru; Takigawa, Kaho; Mizutani, Sako; Hatazawa, Yukino; Fujita, Mariko; Ohira, Yuto; Sugimoto, Takumi; Kamei, Yasutomi] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Lab Mol Nutr, Kyoto 6068522, Japan; [Suzuki, Osamu] Natl Inst Biomed Innovat Hlth & Nutr, Lab Anim Models Human Dis, Osaka, Japan; [Tsuchiya, Kyoichiro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Internal Med 3, Kofu, Yamanashi, Japan; [Suganami, Takayoshi] Nagoya Univ, Res Inst Environm Med, Dept Mol Med & Metab, Nagoya, Aichi, Japan; [Ogawa, Yoshihiro] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka, Japan; [Ishihara, Kengo] Ryukoku Univ, Fac Agr, Dept Food Sci & Human Nutr, Otsu, Shiga, Japan; [Miura, Shinji] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Shizuoka, Japan	Kyoto Prefectural University; University of Yamanashi; Nagoya University; Kyushu University; Ryukoku University; University of Shizuoka	Kamei, Y (corresponding author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Lab Mol Nutr, Kyoto 6068522, Japan.	kamei@kpu.ac.jp	Miura, Shinji/K-6516-2013; Ishihara, Kengo/J-7913-2019	Miura, Shinji/0000-0001-8806-9763; Ishihara, Kengo/0000-0001-9374-5033; Suzuki, Osamu/0000-0002-9003-7282	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [19H04058, 21K19728]; Fuji Foundation for Protein Research; Tojuro Iijima Foundation for Food Science and Technology	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fuji Foundation for Protein Research(Fuji Foundation for Protein Research); Tojuro Iijima Foundation for Food Science and Technology	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant/Award Number: 19H04058 and 21K19728; The Fuji Foundation for Protein Research; The Tojuro Iijima Foundation for Food Science and Technology	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Allen DL, 2010, AM J PHYSIOL-REG I, V299, pR1592, DOI 10.1152/ajpregu.00247.2010; Balamurugan K, 2019, ONCOGENE, V38, P3765, DOI 10.1038/s41388-018-0516-5; Bastie CC, 2005, J BIOL CHEM, V280, P14222, DOI 10.1074/jbc.M413625200; Batista TM, 2019, CELL REP, V26, P3429, DOI 10.1016/j.celrep.2019.02.081; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bohnert KR, 2018, J CELL PHYSIOL, V233, P67, DOI 10.1002/jcp.25852; Brocca L, 2017, J PHYSIOL-LONDON, V595, P1143, DOI 10.1113/JP273097; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Choi RH, 2019, FASEB J, V33, P5654, DOI 10.1096/fj.201802145RR; Daitoku H, 2011, BBA-MOL CELL RES, V1813, P1954, DOI 10.1016/j.bbamcr.2011.03.001; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Deval C, 2001, BIOCHEM J, V360, P143, DOI 10.1042/0264-6021:3600143; Ebert SM, 2020, J BIOL CHEM, V295, P2787, DOI 10.1074/jbc.RA119.012095; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Fukuhara D, 2007, AM J PATHOL, V170, P888, DOI 10.2353/ajpath.2007.060428; Furuyama T, 2003, BIOCHEM J, V375, P365, DOI 10.1042/BJ20030022; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Hirata Y, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124952; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishihara K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193470; Ito Y, 2009, BIOCHEM BIOPH RES CO, V378, P290, DOI 10.1016/j.bbrc.2008.11.043; Iwasaki Y, 2014, DIABETES, V63, P152, DOI 10.2337/db13-0757; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kuo T, 2013, MOL CELL ENDOCRINOL, V380, P79, DOI 10.1016/j.mce.2013.03.003; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Niu MY, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03932-0; O'Neill BT, 2019, DIABETES, V68, P556, DOI 10.2337/db18-0416; O'Neill BT, 2016, J CLIN INVEST, V126, P3433, DOI 10.1172/JCI86522; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Pin F, 2019, FASEB J, V33, P7778, DOI 10.1096/fj.201802799R; Reed SA, 2012, FASEB J, V26, P987, DOI 10.1096/fj.11-189977; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Salcher S, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0661-4; Sanchez AMJ, 2014, CELL MOL LIFE SCI, V71, P1657, DOI 10.1007/s00018-013-1513-z; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Silva KAS, 2015, J BIOL CHEM, V290, P11177, DOI 10.1074/jbc.M115.641514; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Segales J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13832-9; Sekine K, 2007, EMBO J, V26, P3607, DOI 10.1038/sj.emboj.7601784; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tang HB, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004809; Taniguchi H, 2019, J NUTR SCI VITAMINOL, V65, P515, DOI 10.3177/jnsv.65.515; Tsai S, 2015, J CLIN INVEST, V125, P2952, DOI 10.1172/JCI77361; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200; Xu DD, 2019, AM J PHYSIOL-ENDOC M, V316, pE817, DOI 10.1152/ajpendo.00522.2018; Xu J, 2012, KIDNEY INT, V82, P401, DOI 10.1038/ki.2012.84; Yamazaki Y, 2010, BIOCHEM J, V427, P171, DOI 10.1042/BJ20091346; Yang HM, 2005, J CELL PHYSIOL, V204, P219, DOI 10.1002/jcp.20278; Zhang LP, 2013, CELL METAB, V18, P368, DOI 10.1016/j.cmet.2013.07.012; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	71	4	4	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22152	10.1096/fj.202101385RR	http://dx.doi.org/10.1096/fj.202101385RR			29	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35061305				2022-12-28	WOS:000747987800024
J	Kumari, R; Irudayam, MJ; Al Abdallah, Q; Jones, TL; Mims, TS; Puchowicz, MA; Pierre, JF; Brown, CW				Kumari, Roshan; Irudayam, Maria Johnson; Al Abdallah, Qusai; Jones, Tamekia L.; Mims, Tahliyah S.; Puchowicz, Michelle A.; Pierre, Joseph F.; Brown, Chester W.			SMAD2 and SMAD3 differentially regulate adiposity and the growth of subcutaneous white adipose tissue	FASEB JOURNAL			English	Article						activin; adipogenesis; SMAD2; SMAD3; white adipose tissue	FACTOR-BETA SUPERFAMILY; TARGETED DISRUPTION; FUNCTIONAL-ANALYSIS; SECRETORY FUNCTION; OBESITY; FAT; ACTIVINS; REVEALS; ROLES; HOMEOSTASIS	Adipose tissue is the primary site of energy storage, playing important roles in health. While adipose research largely focuses on obesity, fat also has other critical functions, producing adipocytokines and contributing to normal nutrient metabolism, which in turn play important roles in satiety and total energy homeostasis. SMAD2/3 proteins are downstream mediators of activin signaling, which regulate critical preadipocyte and mature adipocyte functions. Smad2 global knockout mice exhibit embryonic lethality, whereas global loss of Smad3 protects mice against diet-induced obesity. The direct contributions of Smad2 and Smad3 in adipose tissues, however, are unknown. Here, we sought to determine the primary effects of adipocyte-selective reduction of Smad2 or Smad3 on diet-induced adiposity using Smad2 or Smad3 "floxed" mice intercrossed with Adiponectin-Cre mice. Additionally, we examined visceral and subcutaneous preadipocyte differentiation efficiency in vitro. Almost all wild type subcutaneous preadipocytes differentiated into mature adipocytes. In contrast, visceral preadipocytes differentiated poorly. Exogenous activin A suppressed differentiation of preadipocytes from both depots. Smad2 conditional knockout (Smad2cKO) mice did not exhibit significant effects on weight gain, irrespective of diet, whereas Smad3 conditional knockout (Smad3cKO) male mice displayed a trend of reduced body weight on high-fat diet. On both diets, Smad3cKO mice displayed an adipose depot-selective phenotype, with a significant reduction in subcutaneous fat mass but not visceral fat mass. Our data suggest that Smad3 is an important contributor to the maintenance of subcutaneous white adipose tissue in a sex-selective fashion. These findings have implications for understanding SMAD-mediated, depot selective regulation of adipocyte growth and differentiation.	[Kumari, Roshan; Irudayam, Maria Johnson; Al Abdallah, Qusai; Jones, Tamekia L.; Mims, Tahliyah S.; Puchowicz, Michelle A.; Pierre, Joseph F.; Brown, Chester W.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, 71 S Manassas St,Rm 431, Memphis, TN 38103 USA; [Kumari, Roshan; Brown, Chester W.] Univ Tennessee, Ctr Hlth Sci, Dept Genet Genom & Informat, Memphis, TN 38163 USA; [Jones, Tamekia L.] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA; [Jones, Tamekia L.] Childrens Fdn Res Inst, Memphis, TN USA; [Brown, Chester W.] Le Bonheur Childrens Hosp, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Brown, CW (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pediat, 71 S Manassas St,Rm 431, Memphis, TN 38103 USA.	cbrow171@uthsc.edu	Pierre, Joseph/HCH-3993-2022		University of Tennessee Health Science Center; Center for Pediatric Experimental Therapeutics fellowship	University of Tennessee Health Science Center; Center for Pediatric Experimental Therapeutics fellowship	This study was supported by Institutional startup funds, University of Tennessee Health Science Center and Center for Pediatric Experimental Therapeutics fellowship	Aragon E, 2019, GENE DEV, V33, P1506, DOI 10.1101/gad.330837.119; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Aykul S., TGF B FAMILY INHIBIT, DOI [10.1101/2020.03.12.988568v1, DOI 10.1101/2020.03.12.988568V1]; Bederman IR, 2018, AM J PHYSIOL-GASTR L, V315, pG685, DOI 10.1152/ajpgi.00344.2017; Bonomi L, 2012, AM J PHYSIOL-ENDOC M, V303, pE587, DOI 10.1152/ajpendo.00177.2012; Brown CW, 2000, NAT GENET, V25, P453, DOI 10.1038/78140; Brown CW, 2003, MOL ENDOCRINOL, V17, P2404, DOI 10.1210/me.2003-0051; Carlsson LMS, 2009, BIOCHEM BIOPH RES CO, V382, P309, DOI 10.1016/j.bbrc.2009.03.014; Choe SS, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00030; Chooi YC, 2019, METABOLISM, V92, P6, DOI 10.1016/j.metabol.2018.09.005; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Dani C, 2013, INT J OBESITY, V37, P163, DOI 10.1038/ijo.2012.28; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Fei T, 2010, CELL RES, V20, P1306, DOI 10.1038/cr.2010.158; Gardan D, 2006, AM J PHYSIOL-ENDOC M, V291, pE372, DOI 10.1152/ajpendo.00482.2005; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Hayes SA, 2001, CANCER RES, V61, P2112; Heyer J, 1999, P NATL ACAD SCI USA, V96, P12595, DOI 10.1073/pnas.96.22.12595; Hirai S, 2005, MOL CELL ENDOCRINOL, V232, P21, DOI 10.1016/j.mce.2005.01.001; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Ju WJ, 2006, MOL CELL BIOL, V26, P654, DOI 10.1128/MCB.26.2.654-667.2006; Kriseman M, 2019, P NATL ACAD SCI USA, V116, P3873, DOI 10.1073/pnas.1806862116; Latres E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15153; Lee JH, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2365-8; Lee MJ, 2018, BBA-MOL BASIS DIS, V1864, P1160, DOI 10.1016/j.bbadis.2018.01.025; Li LN, 2009, ENDOCRINOLOGY, V150, P3521, DOI 10.1210/en.2008-0922; Li QL, 2008, MOL CELL BIOL, V28, P7001, DOI 10.1128/MCB.00732-08; Li QL, 2007, MOL ENDOCRINOL, V21, P2472, DOI 10.1210/me.2007-0147; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Longo M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092358; MATZUK MM, 1995, NATURE, V374, P354, DOI 10.1038/374354a0; MATZUK MM, 1995, TRENDS ENDOCRIN MET, V6, P120, DOI 10.1016/1043-2760(95)00032-D; Merrick D, 2019, SCIENCE, V364, P353, DOI 10.1126/science.aav2501; Namwanje M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021881; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Sarjeant K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008417; SCHREWE H, 1994, MECH DEVELOP, V47, P43, DOI 10.1016/0925-4773(94)90094-9; Shao M, 2017, MOL METAB, V6, P111, DOI 10.1016/j.molmet.2016.11.009; Shen JJ, 2009, MOL ENDOCRINOL, V23, P113, DOI 10.1210/me.2007-0322; Song W, 2017, P NATL ACAD SCI USA, V114, P8596, DOI 10.1073/pnas.1708037114; Tan CK, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.1; Tan CK, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000269; Tan CK, 2011, DIABETES, V60, P464, DOI 10.2337/db10-0801; Traustadottir GA, 2013, ADIPOCYTE, V2, P272, DOI 10.4161/adip.24994; Tsuchida K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-15; Tsurutani Y, 2011, BIOCHEM BIOPH RES CO, V407, P68, DOI 10.1016/j.bbrc.2011.02.106; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; VASSALLI A, 1994, GENE DEV, V8, P414, DOI 10.1101/gad.8.4.414; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Wang P, 2008, J CELL PHYSIOL, V216, P3, DOI 10.1002/jcp.21386; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Xue LX, 2016, BIOCHEM BIOPH RES CO, V480, P355, DOI 10.1016/j.bbrc.2016.10.050; Yadav H, 2017, J BIOL CHEM, V292, P3420, DOI 10.1074/jbc.M116.764910; Yadav Hariom, 2012, Front Endocrinol (Lausanne), V3, P35, DOI 10.3389/fendo.2012.00035; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zamani N, 2011, ENDOCR REV, V32, P387, DOI 10.1210/er.2010-0018; Zaragosi LE, 2010, DIABETES, V59, P2513, DOI 10.2337/db10-0013; Zhu QW, 2018, J BIOL CHEM, V293, P14100, DOI 10.1074/jbc.RA118.003678; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	66	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22018	10.1096/fj.202101244R	http://dx.doi.org/10.1096/fj.202101244R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34731499				2022-12-28	WOS:000722321300028
J	Kuefner, MS; Stephenson, E; Savikj, M; Smallwood, HS; Dong, QM; Payre, C; Lambeau, G; Park, EA				Kuefner, Michael S.; Stephenson, Erin; Savikj, Mladen; Smallwood, Heather S.; Dong, Qingming; Payre, Christine; Lambeau, Gerard; Park, Edwards A.			Group IIA secreted phospholipase A2 (PLA2G2A) augments adipose tissue thermogenesis	FASEB JOURNAL			English	Article						brown adipose tissue; thermogenesis; UCP1	DIET-INDUCED THERMOGENESIS; FATTY-ACID TRANSPORT; SKELETAL-MUSCLE; BROWN FAT; GENE-TRANSCRIPTION; BETA-OXIDATION; WHITE FAT; A(2) GENE; COLD; EXPRESSION	Group IIA secreted phospholipase A2 (PLA2G2A) hydrolyzes glycerophospholipids at the sn-2 position resulting in the release of fatty acids and lysophospholipids. C57BL/6 mice do not express Pla2g2a due to a frameshift mutation (wild-type [WT] mice). We previously reported that transgenic expression of human PLA2G2A in C57BL/6 mice (IIA+ mice) protects against weight gain and insulin resistance, in part by increasing total energy expenditure. Additionally, we found that brown and white adipocytes from IIA+ mice have increased expression of mitochondrial uncoupling markers, such as uncoupling protein 1 (UCP1), peroxisome proliferator-activated receptor-gamma coactivator, and PR domain containing 16, suggesting that the energy expenditure phenotype might be due to an increased thermogenic capacity in adipose tissue. Here, we further characterize the impact of PLA2G2A on thermogenic mechanisms in adipose tissue. Metabolic analysis of WT and IIA+ mice revealed that even when housed within their thermoneutral zone, IIA+ mice have elevated energy expenditure compared to WT littermates. Increased energy expenditure in IIA+ mice is associated with increased citrate synthase activity in brown adipose tissue (BAT) and increased mitochondrial respiration in both brown and white adipocytes. We also observed that direct addition of recombinant PLA2G2A enzyme to in vitro cultured adipocytes results in the marked induction of UCP1 protein expression. Finally, we report that PLA2G2A induces the expression of numerous transcripts related to energy substrate transport and metabolism in BAT, suggestive of an increase in substrate flux to fuel BAT activity. These data demonstrate that PLA2G2A enhances adipose tissue thermogenesis, in part, through elevated substrate delivery and increased mitochondrial content in BAT.	[Kuefner, Michael S.; Savikj, Mladen] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Stephenson, Erin] Midwestern Univ, Coll Grad Studies, Dept Anat, Downers Grove, IL 60515 USA; [Stephenson, Erin] Midwestern Univ, Chicago Coll Osteopath Med, Downers Grove, IL 60515 USA; [Smallwood, Heather S.; Dong, Qingming; Park, Edwards A.] Univ Tennessee, Dept Pharmacol, Hlth Sci Ctr, 71 S Manassas, Memphis, TN 38163 USA; [Dong, Qingming; Park, Edwards A.] Dept Vet Affairs Med Ctr, 71 S Manassas, Memphis, TN 38163 USA; [Payre, Christine; Lambeau, Gerard] Univ Cote dAzur, CNRS, Inst Pharmacol Mol & Cellulaire, Valbonne Sophia Antipoli, France	Karolinska Institutet; Midwestern University; Midwestern University; Midwestern University - Chicago College of Osteopathic Medicine; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Park, EA (corresponding author), Univ Tennessee, Dept Pharmacol, Hlth Sci Ctr, 71 S Manassas, Memphis, TN 38163 USA.; Park, EA (corresponding author), Dept Vet Affairs Med Ctr, 71 S Manassas, Memphis, TN 38163 USA.	epark@uthsc.edu	Lambeau, Gerard/GRJ-5624-2022; Stephenson, Erin J/AHD-5759-2022	Stephenson, Erin J/0000-0001-5812-408X; Savikj, Mladen/0000-0002-9708-0750; Lambeau, Gerard/0000-0002-9239-518X	U.S. Department of Veterans Affairs (VA) [1I01BX002408]; Agence Nationale de la Recherche (ANR) [ANR-17-CE17-0012-01]; Centre National de la Recherche Scientifique; Fondation pour la Recherche Medicale [DEQ20180339193]; Fondation Jean Valade/Fondation de France [FJV_FDF-00112090]; Wenner-Gren foundation; Le Bonheur Children's Hospital; Children's Foundation Research Institute	U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Jean Valade/Fondation de France; Wenner-Gren foundation; Le Bonheur Children's Hospital; Children's Foundation Research Institute	U.S. Department of Veterans Affairs (VA), Grant/Award Number: 1I01BX002408; Agence Nationale de la Recherche (ANR), Grant/Award Number: ANR-17-CE17-0012-01; Centre National de la Recherche Scientifique; Fondation pour la Recherche Medicale, Grant/Award Number: DEQ20180339193; Fondation Jean Valade/Fondation de France, Grant/Award Number: FJV_FDF-00112090; Wenner-Gren foundation; Le Bonheur Children's Hospital and the Children's Foundation Research Institute	AARSMAN AJ, 1989, J BIOL CHEM, V264, P10008; Akinkuolie AO, 2019, ARTERIOSCL THROM VAS, V39, P1182, DOI 10.1161/ATVBAHA.118.311894; Anderson CM, 2013, MOL ASPECTS MED, V34, P516, DOI 10.1016/j.mam.2012.07.010; Antonio V, 2002, BIOCHEM J, V368, P415, DOI 10.1042/BJ20020658; Aune UL, 2013, JOVE-J VIS EXP, DOI 10.3791/50191; Boilard E, 2010, EMBO MOL MED, V2, P172, DOI 10.1002/emmm.201000072; Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543; Calderon-Dominguez M, 2017, ADV SCI, V4, DOI 10.1002/advs.201600274; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; CROWL RM, 1991, J BIOL CHEM, V266, P2647; Cui X, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12799; Cypess AM, 2010, CURR OPIN PEDIATR, V22, P478, DOI 10.1097/MOP.0b013e32833a8d6e; Dacheux M, 2021, BIOCHIMIE, V189, P120, DOI 10.1016/j.biochi.2021.06.009; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; Dutour A, 2010, J CLIN ENDOCR METAB, V95, P963, DOI 10.1210/jc.2009-1222; Eerola LI, 2006, BBA-MOL CELL BIOL L, V1761, P745, DOI 10.1016/j.bbalip.2006.04.002; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Fasshauer M, 2000, J BIOL CHEM, V275, P25494, DOI 10.1074/jbc.M004046200; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Garcia-Alonso V, 2013, J BIOL CHEM, V288, P28230, DOI 10.1074/jbc.M113.468603; Ghomashchi F, 2017, METHOD ENZYMOL, V583, P35, DOI 10.1016/bs.mie.2016.10.034; Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403; Gnad T, 2014, NATURE, V516, P395, DOI 10.1038/nature13816; Gonzalez-Hurtado E, 2018, MOL METAB, V7, P45, DOI 10.1016/j.molmet.2017.11.004; Grass DS, 1996, J CLIN INVEST, V97, P2233, DOI 10.1172/JCI118664; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x; Held NM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27875-3; Hibi M, 2016, INT J OBESITY, V40, P1655, DOI 10.1038/ijo.2016.124; Hui DY, 2009, BRIT J PHARMACOL, V157, P1263, DOI 10.1111/j.1476-5381.2009.00308.x; Hurt-Camejo E, 2013, ARTERIOSCL THROM VAS, V33, P2707, DOI 10.1161/ATVBAHA.113.301410; Janssen I, 2000, J APPL PHYSIOL, V89, P81; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; Kim SH, 2016, DIABETES METAB J, V40, P12, DOI 10.4093/dmj.2016.40.1.12; Krammer J, 2011, INT J MED SCI, V8, P599, DOI 10.7150/ijms.8.599; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Kuefner MS, 2019, FASEB J, V33, P738, DOI 10.1096/fj.201800711R; Kuefner MS, 2017, J LIPID RES, V58, P1822, DOI 10.1194/jlr.M076141; Kugiyama K, 1999, CIRCULATION, V100, P1280, DOI 10.1161/01.CIR.100.12.1280; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lee J, 2015, CELL REP, V10, P266, DOI 10.1016/j.celrep.2014.12.023; Lynes MD, 2017, NAT MED, V23, P631, DOI 10.1038/nm.4297; Mallat Z, 2010, CIRCULATION, V122, P2183, DOI 10.1161/CIRCULATIONAHA.110.936393; Massaad C, 2000, J BIOL CHEM, V275, P22686, DOI 10.1074/jbc.M001250200; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; Murakami M, 2015, J LIPID RES, V56, P1248, DOI 10.1194/jlr.R058123; NAKANO T, 1990, FEBS LETT, V261, P171, DOI 10.1016/0014-5793(90)80663-4; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Pant M, 2016, TRENDS ENDOCRIN MET, V27, P881, DOI 10.1016/j.tem.2016.08.006; Periasamy M, 2017, COMPR PHYSIOL, V7, P879, DOI 10.1002/cphy.c160030; Poher AL, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00004; PRUZANSKI W, 1988, J RHEUMATOL, V15, P1351; REED BC, 1980, P NATL ACAD SCI-BIOL, V77, P285, DOI 10.1073/pnas.77.1.285; Ribeiro MO, 2010, ENDOCRINOLOGY, V151, P432, DOI 10.1210/en.2009-0667; RICQUIER D, 1979, CAN J BIOCHEM CELL B, V57, P1262, DOI 10.1139/o79-167; Ricquier D, 2017, BIOCHIMIE, V134, P3, DOI 10.1016/j.biochi.2016.10.018; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Rouault M, 2003, BIOCHEMISTRY-US, V42, P11494, DOI 10.1021/bi0349930; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Sato H, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107579; Sato H, 2014, CELL METAB, V20, P119, DOI 10.1016/j.cmet.2014.05.002; Sharma P, 2013, J BIOL CHEM, V288, P16321, DOI 10.1074/jbc.M112.445569; Stephenson EJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1541, DOI 10.1152/ajpendo.00590.2011; Sun CQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34929; Ueta CB, 2012, J ENDOCRINOL, V214, P359, DOI 10.1530/JOE-12-0155; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Weir G, 2018, CELL METAB, V27, P1348, DOI 10.1016/j.cmet.2018.04.020; Wu LY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00122; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Yu XX, 2002, FASEB J, V16, P155, DOI 10.1096/fj.01-0568com; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857; ZURLO F, 1994, METABOLISM, V43, P481, DOI 10.1016/0026-0495(94)90081-7	73	4	4	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21881	10.1096/fj.202002481RR	http://dx.doi.org/10.1096/fj.202002481RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34478587				2022-12-28	WOS:000702238200008
J	Li, BW; Cao, Y; Sun, MJ; Feng, H				Li, Bowen; Cao, Yu; Sun, Mingjun; Feng, Hui			Expression, regulation, and function of exosome-derived miRNAs in cancer progression and therapy	FASEB JOURNAL			English	Review						exosome; micro-RNA; nanotechnology; oncomiR; tumor	EPITHELIAL-MESENCHYMAL TRANSITION; HEPATOCELLULAR-CARCINOMA; EXTRACELLULAR VESICLES; PROMOTES ANGIOGENESIS; MICRORNA; CELLS; MIR-21; GROWTH; PROLIFERATION; METASTASIS	Exosomes are a novel class of intercellular signal modulators that contain a wide range of molecules and deliver information between cells and tissues. MicroRNAs (miRNAs), a type of regulatory non-coding RNA, are often incorporated into exosomes as signaling molecules. In this review, we discuss the expression of exosomal miRNAs from diverse origins such as tumor cells, solid tumor tissue, and biological fluids in various cancers (lung, breast, colorectal, liver, stomach, and pancreatic). We address the biological functions of exosome-derived miRNAs in processes such as tumor-cell proliferation, angiogenesis, metastasis, and chemoresistance in the tumor microenvironment. In particular, we discuss three oncogenic miRNAs, miR-21, miR-141, and miR-451, which occur within exosomes, in terms of gene regulation and intercellular communication. We consider therapeutic miRNA-based nanoparticles, which are widely expressed in tumors and show promise in drug therapy. The review assesses the wide-ranging evidence for using exosomal miRNAs as tumor markers in molecular diagnosis. Further, we consider the use of nanoparticle platforms to transport miRNAs, in the targeted treatment of disease and tumors.	[Li, Bowen; Sun, Mingjun] China Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Shenyang 110001, Peoples R China; [Cao, Yu] China Med Univ, Dept Breast Surg, Affiliated Hosp 1, Shenyang, Peoples R China; [Feng, Hui] China Med Univ, Coll Basic Med Sci, Dept Immunol, Shenyang 110122, Peoples R China	China Medical University; China Medical University; China Medical University	Sun, MJ (corresponding author), China Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Shenyang 110001, Peoples R China.; Feng, H (corresponding author), China Med Univ, Coll Basic Med Sci, Dept Immunol, Shenyang 110122, Peoples R China.	cmusunmingjun@163.com; hfeng@cmu.edu.cn			National Natural Science Foundation of China [82002890]; Natural Science Foundation of Liaoning Province [2020-MS--183]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was supported by National Natural Science Foundation of China (82002890) and Natural Science Foundation of Liaoning Province (2020-MS--183)	Abudoureyimu M, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12541; Bao LL, 2018, ONCOGENE, V37, P2873, DOI 10.1038/s41388-018-0183-6; Binenbaum Y, 2018, CANCER RES, V78, P5287, DOI 10.1158/0008-5472.CAN-18-0124; Cai J, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03490-5; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Cao LQ, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1075-2; Chen CM, 2021, ORAL ONCOL, V120, DOI 10.1016/j.oraloncology.2021.105402; Cheng YW, 2018, SURG ONCOL, V27, P76, DOI 10.1016/j.suronc.2017.12.004; Cui ZL, 2018, BIOMED PHARMACOTHER, V104, P223, DOI 10.1016/j.biopha.2018.05.046; Dang EL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0824-2; Ding T, 2018, MOL THER-NUCL ACIDS, V13, P244, DOI 10.1016/j.omtn.2018.09.004; Dong HJ, 2019, ANGIOGENESIS, V22, P251, DOI 10.1007/s10456-018-9654-1; Drury RE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01182; Fang JH, 2018, HEPATOLOGY, V68, P1459, DOI 10.1002/hep.29920; Fang T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02583-0; Ferhan AR, 2018, ADV DRUG DELIVER REV, V125, P48, DOI 10.1016/j.addr.2017.12.004; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gong CA, 2019, J NANOBIOTECHNOL, V17, DOI 10.1186/s12951-019-0526-7; Guo XF, 2018, ONCOGENE, V37, P4239, DOI 10.1038/s41388-018-0261-9; Hannafon BN, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0753-x; He QL, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03803-8; Hsieh CH, 2018, NEOPLASIA, V20, P775, DOI 10.1016/j.neo.2018.06.004; Huang S, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0645-7; Huang XY, 2015, EUR UROL, V67, P33, DOI 10.1016/j.eururo.2014.07.035; Hurley JH, 2015, EMBO J, V34, P2398, DOI 10.15252/embj.201592484; JOHNSTONE RM, 1989, BLOOD, V74, P1844; Kaiser J, 2016, SCIENCE, V352, P164, DOI 10.1126/science.352.6282.164; Kamerkar S, 2017, NATURE, V546, P498, DOI 10.1038/nature22341; Kanlikilicer P, 2018, EBIOMEDICINE, V38, P100, DOI 10.1016/j.ebiom.2018.11.004; Kim M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86785-z; Kitdumrongthum S, 2018, LIFE SCI, V210, P65, DOI 10.1016/j.lfs.2018.08.058; Koutsioumpa M, 2018, MOL CANCER THER, V17, P1430, DOI 10.1158/1535-7163.MCT-17-1049; Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141; Lan JQ, 2019, CANCER RES, V79, P146, DOI 10.1158/0008-5472.CAN-18-0014; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YR, 2019, INT J CANCER, V144, P1444, DOI 10.1002/ijc.31931; Li C, 2018, CANCER LETT, V418, P185, DOI 10.1016/j.canlet.2018.01.036; Li DD, 2020, MOL THER-NUCL ACIDS, V19, P109, DOI 10.1016/j.omtn.2019.11.003; Li G, 2018, J CELL MOL MED, V22, P5565, DOI 10.1111/jcmm.13830; Li JH, 2018, ARCH BIOCHEM BIOPHYS, V657, P23, DOI 10.1016/j.abb.2018.09.008; Li L, 2016, CANCER RES, V76, P1770, DOI 10.1158/0008-5472.CAN-15-1625; Li MH, 2018, BREAST CANCER RES TR, V170, P257, DOI 10.1007/s10549-018-4757-3; Li Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0928-8; Li XH, 2018, CHEM-BIOL INTERACT, V288, P76, DOI 10.1016/j.cbi.2018.04.021; Li X, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00273-18; Li YY, 2018, EBIOMEDICINE, V36, P209, DOI 10.1016/j.ebiom.2018.09.006; Li Zongshan, 2021, Life Sci, P119339, DOI 10.1016/j.lfs.2021.119339; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Lin XJ, 2018, MOL THER-NUCL ACIDS, V11, P243, DOI 10.1016/j.omtn.2018.02.014; Liu B, 2019, ARTIF CELL NANOMED B, V47, P2507, DOI 10.1080/21691401.2019.1626404; Liu C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14270; Liu CZ, 2010, J HEPATOL, V53, P98, DOI 10.1016/j.jhep.2010.02.021; Liu KH, 2019, J CELL BIOCHEM, V120, P12074, DOI 10.1002/jcb.26657; Liu L, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-021-02007-6; Liu T, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0981-7; Liu XM, 2016, ONCOL REP, V36, P1385, DOI 10.3892/or.2016.4971; Liu YK, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0734-2; Lou GH, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0220-7; Malla B, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1592-6; Mantilla-Escalante DC, 2021, EUR J NUTR, V60, P4279, DOI 10.1007/s00394-021-02594-0; Mao GM, 2015, ANGIOGENESIS, V18, P373, DOI 10.1007/s10456-015-9474-5; Matsumura T, 2015, BRIT J CANCER, V113, P275, DOI 10.1038/bjc.2015.201; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Morceau F, 2013, INT J MOL SCI, V14, P14744, DOI 10.3390/ijms140714744; Mousavi S, 2019, J CELL PHYSIOL, V234, P12422, DOI 10.1002/jcp.28080; Ni SJ, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0562-z; Peng ZY, 2019, J CELL BIOCHEM, V120, P1457, DOI 10.1002/jcb.27291; Plebanek MP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01433-3; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Qin X, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-018-1604-0; Reshke R, 2020, NAT BIOMED ENG, V4, P52, DOI 10.1038/s41551-019-0502-4; Salehi M, 2018, J CELL PHYSIOL, V233, P6370, DOI 10.1002/jcp.26481; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Sha M, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0725-3; Shah KB, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041091; Shi L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0243-9; Shin S, 2021, NPJ GENOM MED, V6, DOI 10.1038/s41525-021-00212-w; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skotland T, 2017, PROG LIPID RES, V66, P30, DOI 10.1016/j.plipres.2017.03.001; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tian XP, 2019, THERANOSTICS, V9, P1965, DOI 10.7150/thno.30958; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; TRAMS EG, 1981, BIOCHIM BIOPHYS ACTA, V645, P63, DOI 10.1016/0005-2736(81)90512-5; Uchida A, 2019, CANCERS, V11, DOI 10.3390/cancers11020258; Usmani A, 2015, AM J CANCER RES, V5, P2484; Wang F, 2018, HEPATOLOGY, V67, P940, DOI 10.1002/hep.29586; Wang HJ, 2018, BIOMED PHARMACOTHER, V106, P1607, DOI 10.1016/j.biopha.2018.07.131; Wang WR, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.460; Wang XC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0180-7; Wang XG, 2019, J CELL BIOCHEM, V120, P1492, DOI 10.1002/jcb.27347; Wei SG, 2020, BIOMED PHARMACOTHER, V122, DOI 10.1016/j.biopha.2019.109473; Wei ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep31175; Wischhusen JC, 2020, J CONTROL RELEASE, V321, P272, DOI 10.1016/j.jconrel.2020.01.051; Wu LL, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0260-z; Wu M, 2021, BIOSENS BIOELECTRON, V171, DOI 10.1016/j.bios.2020.112733; Xie Y, 2020, ACS NANO, V14, P255, DOI 10.1021/acsnano.9b03978; Xu K, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1403-x; Yan W, 2018, NAT CELL BIOL, V20, P597, DOI 10.1038/s41556-018-0083-6; Yang H, 2018, MOL CARCINOGEN, V57, P1223, DOI 10.1002/mc.22838; Yang H, 2016, CLIN CHEM LAB MED, V54, P1871, DOI 10.1515/cclm-2016-0029; Yin HR, 2019, MOL THER, V27, P1252, DOI 10.1016/j.ymthe.2019.04.018; Yin HR, 2019, ACS NANO, V13, P706, DOI 10.1021/acsnano.8b07948; Zeng AL, 2018, CANCER LETT, V436, P10, DOI 10.1016/j.canlet.2018.08.004; Zeng BH, 2019, EXP CELL RES, V374, P365, DOI 10.1016/j.yexcr.2018.12.014; Zeng ZC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07810-w; Zennami K, 2019, MOL CANCER RES, V17, P618, DOI 10.1158/1541-7786.MCR-18-0837; Zhang C, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.663147; Zhang Y, 2021, MOL ONCOL, V15, P1566, DOI 10.1002/1878-0261.12934; Zhang ZC, 2017, CANCER LETT, V397, P33, DOI 10.1016/j.canlet.2017.03.004; Zhao QY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1182-9; Zheng PM, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0528-y; Zhou B, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-2375; Zhou L, 2017, CANCER LETT, V407, P84, DOI 10.1016/j.canlet.2017.08.003; Zhu MZ, 2019, ARCH BIOCHEM BIOPHYS, V661, P22, DOI 10.1016/j.abb.2018.10.021; Zhu XL, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1095-1; Zuo BF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15569-2	119	17	17	7	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21916	10.1096/fj.202100294RR	http://dx.doi.org/10.1096/fj.202100294RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34510546	hybrid			2022-12-28	WOS:000702238200029
J	Ashraf, S; Santerre, P; Kandel, R				Ashraf, Sajjad; Santerre, Paul; Kandel, Rita			Induced senescence of healthy nucleus pulposus cells is mediated by paracrine signaling from TNF-alpha-activated cells	FASEB JOURNAL			English	Article						IL-6; intervertebral disc; paracrine effect; senescence; STAT3; TNF-alpha	INTERVERTEBRAL DISC DEGENERATION; CELLULAR SENESCENCE.; PREMATURE SENESCENCE; MECHANISMS; STRESS; DAMAGE; BACK; AXIS	Intervertebral disc degeneration is an irreversible process associated with accumulation of senescent nucleus pulposus (NP) cells. This study investigates the hypothesis that Tumor necrosis factor-alpha (TNF-alpha)-treated senescent NP cells propagate senescence of neighboring healthy cells via a paracrine effect that involves p-Stat3 signaling and the cytokine interleukin-6 (IL-6). NP cells isolated from bovine caudal intervertebral disc (IVD) were treated with TNF-alpha to induce senescence which was confirmed by demonstrating upregulation of senescence-associated beta-galactosidase and p16. This was correlated with downregulation of NP-associated markers, Aggrecan, Col2A1, and Sox9. Direct contact and non-contact co-culture of healthy and senescent cells showed that TNF-alpha-treated cells increased the senescence in healthy cells via a paracrine effect. The senescent cells have a secretory phenotype as indicated by increased gene and protein levels of IL-6. Phosphorylated Signal Transducer and Activator of Transcription 3 (pStat3) levels were also high in treated cells and appeared to upregulate IL-6 as inhibition of Stat3 phosphorylation by StatticV downregulated IL-6 mRNA expression in cells and protein levels in the culture media. All trans retinoic acid, an IL-6 inhibitor, also decreased the secretion of IL-6 and reduced the paracrine effect of senescent cells on healthy cells. Decreased pStat3 levels and inhibition of IL-6 secretion did not fully restore NP gene expression of Col2A1 but importantly, appeared to cause senescent cells to undergo apoptosis and cell death. This study demonstrated the paracrine effect of senescent NP cells which involves Stat3 and IL-6 and may explain why senescent NP cells accumulate in IVD with age. The role of pSTAT3 and IL-6 in mediating NP senescence requires further study as it may be a novel strategy for modulating the senescent-inducing effects of TNF-alpha.	[Ashraf, Sajjad; Kandel, Rita] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Santerre, Paul; Kandel, Rita] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Kandel, Rita] Sinai Hlth Syst, Pathol & Lab Med, Toronto, ON, Canada; [Kandel, Rita] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Ashraf, S (corresponding author), Lunenfeld Tanenbaum Res Inst, 60 Murray St, Toronto, ON M5T 3L9, Canada.; Santerre, P (corresponding author), Inst Biomat & Biomed Engn, Fac Dent, Translat Biol & Engn Program, 661 Univ Ave,14th Floor,Room 1435, Toronto, ON M5G 1M1, Canada.	sashraf@lunenfeld.ca; paul.santerre@utoronto.ca	Ashraf, Sajjad/A-7479-2019		Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR) [MOP-142325]	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Gouvernement du Canada vertical bar Canadian Institutes of Health Research (CIHR), Grant/Award Number: MOP-142325	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Aryappalli P, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00167; Ashraf S, 2020, J ORTHOP RES, V38, P438, DOI 10.1002/jor.24476; Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031; Bernadotte A, 2016, AGING-US, V8, P3, DOI 10.18632/aging.100871; Boquoi A, 2015, AGING CELL, V14, P139, DOI 10.1111/acel.12279; Chang Q, 2013, NEOPLASIA, V15, P848, DOI 10.1593/neo.13706; Feng CC, 2016, CELL CYCLE, V15, P1674, DOI 10.1080/15384101.2016.1152433; Gawri R, 2017, J ORTHOP RES, V35, P41, DOI 10.1002/jor.23288; Gruber HE, 2007, SPINE, V32, P321, DOI 10.1097/01.brs.0000253960.57051.de; Gruber HE, 2009, SPINE J, V9, P210, DOI 10.1016/j.spinee.2008.01.012; Johnson DE, 2018, NAT REV CLIN ONCOL, V15, P234, DOI 10.1038/nrclinonc.2018.8; Kim KW, 2009, SPINE J, V9, P658, DOI 10.1016/j.spinee.2009.04.018; Kirchmeyer M, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2569; Kojima H, 2012, CELL CYCLE, V11, P730, DOI 10.4161/cc.11.4.19172; Kumar S, 2019, AGING-US, V11, P4145, DOI 10.18632/aging.102043; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2198; Li P, 2017, SCI REP-UK, V7, DOI 10.1038/srep42938; Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513; Liu JY, 2019, P NATL ACAD SCI USA, V116, P2603, DOI 10.1073/pnas.1818313116; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Menendez JA, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00049; Nedresky D., 2020, ANATOMY BACK NUCLEUS; Novais EJ, 2019, MATRIX BIOL, V82, P54, DOI 10.1016/j.matbio.2019.02.004; Ortiz-Montero P, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0172-3; Patil P, 2019, AGING CELL, V18, DOI 10.1111/acel.12927; Patil Prashanti, 2018, Curr Mol Biol Rep, V4, P180, DOI 10.1007/s40610-018-0108-8; Pluquet O, 2015, AM J PHYSIOL-CELL PH, V308, pC415, DOI 10.1152/ajpcell.00334.2014; Ravindra VM, 2018, GLOB SPINE J, V8, P784, DOI 10.1177/2192568218770769; Ritschka B, 2017, GENE DEV, V31, P172, DOI 10.1101/gad.290635.116; Roberts S, 2006, EUR SPINE J, V15, pS312, DOI 10.1007/s00586-006-0126-8; Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340; Sadowska A., 2018, CLIN TRANSL NEUROSCI, V2; Sapochnik M, 2017, J MOL ENDOCRINOL, V58, pR241, DOI 10.1530/JME-17-0026; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Singh K, 2009, SPINE, V34, P10, DOI 10.1097/BRS.0b013e31818e5ddd; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Vo N, 2010, J ORTHOP RES, V28, P1600, DOI 10.1002/jor.21153; Vo NV, 2016, J ORTHOP RES, V34, P1289, DOI 10.1002/jor.23195; Wang C, 2017, ACTA BIOCH BIOPH SIN, V49, P1, DOI 10.1093/abbs/gmw112; Wang YJ, 2020, BIOMED PHARMACOTHER, V131, DOI 10.1016/j.biopha.2020.110660; Zhang YJ, 2016, AM J PHYS MED REHAB, V95, P407, DOI 10.1097/PHM.0000000000000399	44	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21795	10.1096/fj.202002201R	http://dx.doi.org/10.1096/fj.202002201R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34403508				2022-12-28	WOS:000691122900066
J	Liu, Y; Wang, YF; Xiao, YS; Li, XM; Ruan, S; Luo, XT; Wan, XL; Wang, FH; Sun, XD				Liu, Yang; Wang, Yafang; Xiao, Yushu; Li, Xiaomeng; Ruan, Shang; Luo, Xueting; Wan, Xiaoling; Wang, Fenghua; Sun, Xiaodong			Retinal degeneration in mice lacking the cyclic nucleotide-gated channel subunit CNGA1	FASEB JOURNAL			English	Article						CNGA1; mouse model; retinal degeneration; retinitis pigmentosa; rod	RD10 MOUSE MODEL; CELL-DEATH; LYSOSOME DYSFUNCTION; ALPHA-SUBUNIT; AUTOPHAGY; PHOTORECEPTOR; EXPRESSION; MICROGLIA; NEUROPROTECTION; ANTIOXIDANTS	Cyclic nucleotide-gated (CNG) channels are important mediators in the transduction pathways of rod and cone photoreceptors. Native CNG channels are heterotetramers composed of homologous A and B subunits. Biallelic mutations in CNGA1 or CNGB1 genes result in autosomal recessive retinitis pigmentosa (RP). To investigate the pathogenic mechanism of CNG channel-associated retinal degeneration, we developed a mouse model of CNGA1 knock-out using CRISPR/Cas9 technology. We observed progressive retinal thinning and a concomitant functional deficit in vivo as typical phenotypes for RP. Immunofluorescence and TUNEL staining showed progressive degeneration in rods and cones. Moreover, microglial activation and oxidative stress damage occurred in parallel. RNA-sequencing analysis of the retinae suggested down-regulated synaptic transmission and phototransduction as early as 9 days postnatal, possibly inducing later photoreceptor degeneration. In addition, the down-regulated PI3K-AKT-mTOR pathway indicated upregulation of autophagic process, and chaperone-mediated autophagy was further shown to coincide with the time course of photoreceptor death. Taken together, our studies add to a growing body of research exploring the mechanisms of photoreceptor death during RP progression and provide a novel CNGA1 knockout mouse model for potential development of therapies.	[Liu, Yang; Wang, Yafang; Xiao, Yushu; Li, Xiaomeng; Ruan, Shang; Luo, Xueting; Wan, Xiaoling; Wang, Fenghua; Sun, Xiaodong] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai Gen Hosp,Sch Med, 100 Haining Rd, Shanghai 200080, Peoples R China; [Luo, Xueting; Wan, Xiaoling; Wang, Fenghua; Sun, Xiaodong] Shanghai Key Lab Ocular Fundus Dis, Shanghai, Peoples R China; [Wang, Fenghua; Sun, Xiaodong] Shanghai Engn Ctr Visual Sci & Photomed, Shanghai, Peoples R China; [Wang, Fenghua; Sun, Xiaodong] Natl Clin Res Ctr Eye Dis, Shanghai, Peoples R China; [Wang, Fenghua; Sun, Xiaodong] Shanghai Engn Ctr Precise Diag & Treatment Eye Di, Shanghai, Peoples R China	Shanghai Jiao Tong University	Wan, XL; Wang, FH (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai Gen Hosp,Sch Med, 100 Haining Rd, Shanghai 200080, Peoples R China.	shaolin.72@163.com; shretina@sjtu.edu.cn		Sun, Xiaodong/0000-0001-5015-0945	National Natural Science Foundation of China [81970845, 82000906]; Shanghai Sailing Program [19YF1439200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Sailing Program	National Natural Science Foundation of China, Grant/Award Number: 81970845 and 82000906; Shanghai Sailing Program, Grant/Award Number: 19YF1439200	Abcouwer SF, 2017, DIABETES, V66, P261, DOI 10.2337/dbi16-0047; Arroba AI, 2011, INVEST OPHTH VIS SCI, V52, P9124, DOI 10.1167/iovs.11-7736; Barhoum R, 2008, NEUROSCIENCE, V155, P698, DOI 10.1016/j.neuroscience.2008.06.042; Biel M, 1999, Rev Physiol Biochem Pharmacol, V135, P151, DOI 10.1007/BFb0033672; Blank T, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01930; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Calakos N, 2004, NEURON, V42, P889, DOI 10.1016/j.neuron.2004.05.014; Chrenek MA, 2012, ADV EXP MED BIOL, V723, P641, DOI 10.1007/978-1-4614-0631-0_81; Claes E, 2004, INVEST OPHTH VIS SCI, V45, P2039, DOI 10.1167/iovs.03-0741; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Connaughton V., WEBVISION ORG RETINA; Datta P, 2015, P NATL ACAD SCI USA, V112, pE4400, DOI 10.1073/pnas.1510111112; Dharmarajan S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0855-0; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; Fahim AT., GENEREVIEWS; Fulda S, 2015, ONCOGENE, V34, P5105, DOI 10.1038/onc.2014.458; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Gao FJ, 2019, OPHTHALMOLOGY, V126, P1549, DOI 10.1016/j.ophtha.2019.04.038; Gasparini SJ, 2019, PROG RETIN EYE RES, V69, P1, DOI 10.1016/j.preteyeres.2018.11.001; Geiger P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.333; GRAEBER MB, 1990, J NEUROIMMUNOL, V27, P121, DOI 10.1016/0165-5728(90)90061-Q; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Hirasawa H, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0186; Hofmann F, 2003, PHARMACOL REV, V55, P587, DOI 10.1124/pr.55.4.10; Hull S, 2017, JAMA OPHTHALMOL, V135, P137, DOI 10.1001/jamaophthalmol.2016.5213; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; Jauregui R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31488-1; Jiang DQ, 2019, J NEURAL TRANSM, V126, P559, DOI 10.1007/s00702-019-02005-z; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kaushik S, 2008, MOL BIOL CELL, V19, P2179, DOI 10.1091/mbc.E07-11-1155; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Kramer RH, 2001, J EXP BIOL, V204, P2921; Leconte L, 2000, INVEST OPHTH VIS SCI, V41, P917; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li Y, 2019, TISSUE CELL, V61, P98, DOI 10.1016/j.tice.2019.09.008; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Low BE, 2016, METHODS MOL BIOL, V1438, P19, DOI 10.1007/978-1-4939-3661-8_2; Lu YJ, 2017, J ALZHEIMERS DIS, V56, P1469, DOI 10.3233/JAD-160869; Massey A, 2004, INT J BIOCHEM CELL B, V36, P2420, DOI 10.1016/j.biocel.2004.04.010; Metrailler S, 2012, EXP EYE RES, V96, P70, DOI 10.1016/j.exer.2011.12.019; Munoz-Pinedo C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.246; Ni JJ, 2019, AGING CELL, V18, DOI 10.1111/acel.12856; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Parodi MB, 2017, BRIT J OPHTHALMOL, V101, P428, DOI 10.1136/bjophthalmol-2016-308925; Petersen-Jones SM, 2018, J CLIN INVEST, V128, P190, DOI 10.1172/JCI95161; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Puthussery T, 2009, EUR J NEUROSCI, V29, P1533, DOI 10.1111/j.1460-9568.2009.06728.x; Ren CR, 2013, NEUROPSYCHOPHARMACOL, V38, P1163, DOI 10.1038/npp.2013.35; Richter K, 2018, NEUROSCIENCE, V371, P29, DOI 10.1016/j.neuroscience.2017.11.034; Roche SL, 2018, GLIA, V66, P295, DOI 10.1002/glia.23243; Rodriguez-Muela N, 2015, CELL DEATH DIFFER, V22, P476, DOI 10.1038/cdd.2014.203; Sanz MM, 2007, NEUROSCIENCE, V145, P1120, DOI 10.1016/j.neuroscience.2006.12.034; Schon C, 2013, MOL GENET GENOMICS, V288, P459, DOI 10.1007/s00438-013-0766-4; Trachsel-Moncho L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0855-8; Walls KC, 2010, J BIOL CHEM, V285, P10497, DOI 10.1074/jbc.M110.103747; Wang MH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-173; Wang T, 2019, J NEUROSCI, V39, P6798, DOI 10.1523/JNEUROSCI.2902-18.2019; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Wu N, 2018, J CANCER, V9, P987, DOI 10.7150/jca.22861; Xiao MC, 2019, FASEB J, V33, P13920, DOI 10.1096/fj.201901283RR; Zhang TZ, 2014, BIOCHEM BIOPH RES CO, V450, P966, DOI 10.1016/j.bbrc.2014.06.082; Zhang T, 2016, SCI REP-UK, V6, DOI 10.1038/srep26060	70	2	2	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21859	10.1096/fj.202101004R	http://dx.doi.org/10.1096/fj.202101004R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34418172				2022-12-28	WOS:000691122900022
J	Pattanaik, B; Hammarlund, M; Mjornstedt, F; Ulleryd, MA; Zhong, W; Uhlen, M; Gummesson, A; Bergstrom, G; Johansson, ME				Pattanaik, Bagmi; Hammarlund, Maria; Mjornstedt, Filip; Ulleryd, Marcus A.; Zhong, Wen; Uhlen, Mathias; Gummesson, Anders; Bergstrom, Goran; Johansson, Maria E.			Polymorphisms in alpha 7 nicotinic acetylcholine receptor gene, CHRNA7, and its partially duplicated gene, CHRFAM7A, associate with increased inflammatory response in human peripheral mononuclear cells	FASEB JOURNAL			English	Article						alpha 7 nicotinic acetylcholine receptor; CHRFAM7A; CHRNA7; immune response; inflammation; polymorphisms; alpha 7nAChR	CHOLINERGIC ANTIINFLAMMATORY PATHWAY; VAGUS NERVE-STIMULATION; CYTOKINE PRODUCTION; EXPRESSION; SUBUNIT; DISEASE; MODULATION; REGULATOR; SEVERITY; VARIANT	The vagus nerve can, via the alpha 7 nicotinic acetylcholine receptor (alpha 7nAChR), regulate inflammation. The gene coding for the alpha 7nAChR, CHRNA7, can be partially duplicated, that is, CHRFAM7A, which is reported to impair the anti-inflammatory effect mediated via the alpha 7nAChR. Several single nucleotide polymorphisms (SNPs) have been described in both CHRNA7 and CHRFAM7A, however, the functional role of these SNPs for immune responses remains to be investigated. In the current study, we set out to investigate whether genetic variants of CHRNA7 and CHRFAM7A can influence immune responses. By investigating data available from the Swedish SciLifeLab SCAPIS Wellness Profiling (S3WP) study, in combination with droplet digital PCR and freshly isolated PBMCs from the S3WP participants, challenged with lipopolysaccharide (LPS), we show that CHRNA7 and CHRFAM7A are expressed in human PBMCs, with approximately four times higher expression of CHRFAM7A compared with CHRNA7. One SNP in CHRFAM7A, rs34007223, is positively associated with hsCRP in healthy individuals. Furthermore, gene ontology (GO)-terms analysis of plasma proteins associated with gene expression of CHRNA7 and CHRFAM7A demonstrated an involvement for these genes in immune responses. This was further supported by in vitro data showing that several SNPs in both CHRNA7 and CHRFAM7A are significantly associated with cytokine response. In conclusion, genetic variants of CHRNA7 and CHRFAM7A alters cytokine responses. Furthermore, given that CHRFAM7A SNP rs34007223 is associated with inflammatory marker hsCRY in healthy individuals suggests that CHRFAM7A may have a more pronounced role in regulating inflammatory processes in humans than previously been recognized.	[Pattanaik, Bagmi; Hammarlund, Maria; Mjornstedt, Filip; Ulleryd, Marcus A.; Johansson, Maria E.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Box 432, S-40530 Gothenburg, Sweden; [Zhong, Wen; Uhlen, Mathias] KTH Royal Inst Technol, Dept Prot Sci, Sci Life Lab, Stockholm, Sweden; [Gummesson, Anders; Bergstrom, Goran] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab Cardiovasc & Metab Res, Gothenburg, Sweden	University of Gothenburg; Royal Institute of Technology; University of Gothenburg	Johansson, ME (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Box 432, S-40530 Gothenburg, Sweden.	maria.e.johansson@neuro.gu.se		Johansson, Maria/0000-0002-2569-2977	Swedish Research Council; Swedish Heart-Lung Foundation; Swedish Stroke Association; Mary von Sydow foundation; Stiftelsen Langmanska kulturfonden; Stiftelsen Gamla tjanarinnor; OE and Edla Johanssons vetenskapliga stiftelse; Stiftelsen Tornspiran; Emil and Wera Cornells foundation; Dr. Felix Neuberghs Foundation; Emelle Foundation; Wilhelm and Martina Lundgren foundation; Swedish government; ALF [ALF GBG-723131]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Stroke Association; Mary von Sydow foundation; Stiftelsen Langmanska kulturfonden; Stiftelsen Gamla tjanarinnor; OE and Edla Johanssons vetenskapliga stiftelse; Stiftelsen Tornspiran; Emil and Wera Cornells foundation; Dr. Felix Neuberghs Foundation; Emelle Foundation; Wilhelm and Martina Lundgren foundation; Swedish government; ALF	The authors thank the data analysis support from the Bioinformatics Core Facility at Sahlgrenska Academy and National bioinformatics infrastructure Sweden (NBIS). This work was supported by the FSwedish Research Council, the Swedish Heart-Lung Foundation, The Swedish Stroke Association, Mary von Sydow foundation, Stiftelsen Langmanska kulturfonden, Stiftelsen Gamla tjanarinnor, OE and Edla Johanssons vetenskapliga stiftelse, Stiftelsen Tornspiran, Emil and Wera Cornells foundation, Dr. Felix Neuberghs Foundation, Emelle Foundation, Wilhelm and Martina Lundgren foundation and grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALF GBG-723131).	Araud T, 2011, BIOCHEM PHARMACOL, V82, P904, DOI 10.1016/j.bcp.2011.06.018; Baird A, 2016, BBA CLIN, V5, P66, DOI 10.1016/j.bbacli.2015.12.003; Bergstrom G, 2015, J INTERN MED, V278, P645, DOI 10.1111/joim.12384; Bonaz B, 2016, NEUROGASTROENT MOTIL, V28, P948, DOI 10.1111/nmo.12792; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Cedillo JL, 2015, J INFECT DIS, V211, P146, DOI 10.1093/infdis/jiu425; Chan T, 2019, NEUROSCI LETT, V690, P126, DOI 10.1016/j.neulet.2018.10.010; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen XY, 2016, BIOINFORMATICS, V32, P1220, DOI 10.1093/bioinformatics/btv710; Corradi J, 2016, MOL PHARMACOL, V90, P288, DOI 10.1124/mol.116.104240; Costantini TW, 2019, P NATL ACAD SCI USA, V116, P7932, DOI 10.1073/pnas.1821853116; Costantini TW, 2015, MOL MED, V21, P323, DOI 10.2119/molmed.2015.00018; Costantini TW, 2015, J LEUKOCYTE BIOL, V97, P247, DOI 10.1189/jlb.4RU0814-381R; Courties A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91417-7; Courties A, 2020, ARTHRITIS RHEUMATOL, V72, P2072, DOI 10.1002/art.41429; Dang XT, 2015, FASEB J, V29, P2292, DOI 10.1096/fj.14-268037; de Lucas-Cerrillo AM, 2011, J BIOL CHEM, V286, P594, DOI 10.1074/jbc.M110.180067; De Rosa MJ, 2005, J NEUROIMMUNOL, V160, P154, DOI 10.1016/j.jneuroim.2004.11.010; Feher A, 2009, DEMENT GERIATR COGN, V28, P56, DOI 10.1159/000230036; Freedman Robert, 2003, Curr Psychiatry Rep, V5, P155, DOI 10.1007/s11920-003-0032-2; Fujii T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01085; Garcia-Moreno A., 2021, GENECODIS 4 EXPANDIN; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hammarlund ME, 2021, BIOSCIENCE REP, V41, DOI 10.1042/BSR20210736; Hong CJ, 2004, NEUROSCI LETT, V355, P69, DOI 10.1016/j.neulet.2003.10.043; Hoover DB, 2017, PHARMACOL THERAPEUT, V179, P1, DOI 10.1016/j.pharmthera.2017.05.002; Hoskin JL, 2019, NICOTINE TOB RES, V21, P370, DOI 10.1093/ntr/nty116; Hua SS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/718769; Huang W, 2019, J NEUROTRAUM, V36, P3026, DOI 10.1089/neu.2018.6200; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Iwata Y, 2007, NEUROSCI RES, V57, P194, DOI 10.1016/j.neures.2006.10.002; Jin Y, 2010, INT J IMMUNOGENET, V37, P361, DOI 10.1111/j.1744-313X.2010.00933.x; Johansson ME, 2014, ARTERIOSCL THROM VAS, V34, P2632, DOI 10.1161/ATVBAHA.114.303892; Kiss A, 2017, ACTA PHYSIOL, V221, P174, DOI 10.1111/apha.12861; Koopman FA, 2016, P NATL ACAD SCI USA, V113, P8284, DOI 10.1073/pnas.1605635113; Kuhlmann K, 2021, BIOL PROCED ONLINE, V23, DOI 10.1186/s12575-021-00144-w; Kunii Y, 2015, AM J PSYCHIAT, V172, P1122, DOI 10.1176/appi.ajp.2015.14080978; Leonard S, 2001, Nicotine Tob Res, V3, P203; Liu Y, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-98; Maldifassi MC, 2018, J BIOL CHEM, V293, P13874, DOI 10.1074/jbc.RA118.003443; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Pena G, 2010, EUR J IMMUNOL, V40, P2580, DOI 10.1002/eji.201040540; Quik M, 2015, BIOCHEM PHARMACOL, V97, P399, DOI 10.1016/j.bcp.2015.06.014; Robert F, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00507; Russo P, 2017, CURR DRUG TARGETS, V18, P1179, DOI 10.2174/1389450116666151001111826; Severance EG, 2008, GENES BRAIN BEHAV, V7, P37, DOI 10.1111/j.1601-183X.2007.00323.x; Shen JX, 2012, J MOL NEUROSCI, V48, P14, DOI 10.1007/s12031-012-9719-3; Sinkus ML, 2015, NEUROPHARMACOLOGY, V96, P274, DOI 10.1016/j.neuropharm.2015.02.006; Sinkus ML, 2009, BRAIN RES, V1291, P1, DOI 10.1016/j.brainres.2009.07.041; Stephens SH, 2009, SCHIZOPHR RES, V109, P102, DOI 10.1016/j.schres.2008.12.017; Stranneheim H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1090; Taylor SC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02217-x; Tebani A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18148-7; The FO, 2007, GASTROENTEROLOGY, V133, P1219, DOI 10.1053/j.gastro.2007.07.022; Ulleryd MA, 2019, ATHEROSCLEROSIS, V287, P122, DOI 10.1016/j.atherosclerosis.2019.06.903; van der Zanden EP, 2012, NEUROIMMUNOMODULAT, V19, P255, DOI 10.1159/000335185; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; Villiger Y, 2002, J NEUROIMMUNOL, V126, P86, DOI 10.1016/S0165-5728(02)00057-7; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Weng PH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27231; Weng PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084059; Yang L, 2015, EUR J HUM GENET, V23, P1019, DOI 10.1038/ejhg.2014.229; Zhong W, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00755-0; Zoheir N, 2012, INFLAMM RES, V61, P915, DOI 10.1007/s00011-012-0513-z	65	2	2	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22271	10.1096/fj.202101898R	http://dx.doi.org/10.1096/fj.202101898R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ9SE	35344211				2022-12-28	WOS:000773602400001
J	Shapira, G; Abu Hamad, R; Weiner, C; Rainy, N; Sorek-Abramovich, R; Benveniste-Levkovitz, P; Rock, R; Avnat, E; Levtzion-Korach, O; Bar Chaim, A; Shomron, N				Shapira, Guy; Abu Hamad, Ramzia; Weiner, Chen; Rainy, Nir; Sorek-Abramovich, Reut; Benveniste-Levkovitz, Patricia; Rock, Rachel; Avnat, Eden; Levtzion-Korach, Osnat; Bar Chaim, Adina; Shomron, Noam			Population differences in antibody response to SARS-CoV-2 infection and BNT162b2 vaccination	FASEB JOURNAL			English	Article						antibodies; COVID-19; SARS-CoV-2; severity; vaccination; vaccine	PROTECTION; AGE	The concentration of SARS-CoV-2-specific serum antibodies, elicited by vaccination or infection, is a primary determinant of anti-viral immunity, which correlates with protection against infection and COVID-19. Serum samples were obtained from 25 897 participants and assayed for anti-SARS-CoV-2 spike protein RBD IgG antibodies. The cohort was composed of newly vaccinated BNT162b2 recipients, in the first month or 6 months after vaccination, COVID-19 patients and a general sample of the Israeli population. Antibody levels of BNT162b2 vaccine recipients were negatively correlated with age, with a prominent decrease in recipients over 55 years old, which was most significant in males. This trend was observable within the first month and 6 months after vaccination, while younger participants were more likely to maintain stable levels of serum antibodies. The antibody concentration of participants previously infected with SARS-CoV-2 was lower than the vaccinated and had a more complex, non-linear relation to age, sex and COVID-19 symptoms. Taken together, our data supports age and sex as primary determining factors for both the magnitude and durability of humoral response to SARS-CoV-2 infection and the COVID-19 vaccine. Our results could inform vaccination policies, prioritizing the most susceptible populations for repeated vaccination.	[Shapira, Guy; Weiner, Chen; Avnat, Eden; Shomron, Noam] Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, Tel Aviv, Israel; [Shapira, Guy; Shomron, Noam] Tel Aviv Univ, Edmond J Safra Ctr Bioinformat, Tel Aviv, Israel; [Abu Hamad, Ramzia; Weiner, Chen; Rainy, Nir; Sorek-Abramovich, Reut; Benveniste-Levkovitz, Patricia; Rock, Rachel; Levtzion-Korach, Osnat; Bar Chaim, Adina] Shamir Med Ctr, Beer Yaagov, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Shamir Medical Center (Assaf Harofeh)	Bar Chaim, A (corresponding author), Shamir Med Ctr, Beer Yaagov, Israel.; Shomron, N (corresponding author), Tel Aviv Univ, Fac Med, Haim Levanon 1, IL-6997801 Tel Aviv, Israel.	adinab@shamir.gov.il; nshomron@tauex.tau.ac.il		Shapira, Guy/0000-0001-9376-4955; Avnat, Eden/0000-0002-5455-0994	Israel Science Foundation (ISF) [1852/16]; Horizon 2020-Research and Innovation Framework Programme, PSY-PGx; Israeli Ministry of Defense, Office of Assistant Minister of Defense for Chemical, Biological, Radiological and Nuclear (CBRN) Defense; Foundation Fighting Blindness; Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Koret-UC Berkeley-Tel Aviv University Initiative in Computational Biology and Bioinformatics; QBI/UCSF-Tel Aviv University joint Initiative in Computational Biology and Drug Discovery; Zimin Institute for Engineering Solutions Advancing Better Lives; Tel Aviv University	Israel Science Foundation (ISF)(Israel Science Foundation); Horizon 2020-Research and Innovation Framework Programme, PSY-PGx; Israeli Ministry of Defense, Office of Assistant Minister of Defense for Chemical, Biological, Radiological and Nuclear (CBRN) Defense; Foundation Fighting Blindness(European Commission); Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Koret-UC Berkeley-Tel Aviv University Initiative in Computational Biology and Bioinformatics; QBI/UCSF-Tel Aviv University joint Initiative in Computational Biology and Drug Discovery; Zimin Institute for Engineering Solutions Advancing Better Lives; Tel Aviv University	The Shomron Laboratory is supported by the Israel Science Foundation (ISF; 1852/16); Horizon 2020-Research and Innovation Framework Programme, PSY-PGx; Israeli Ministry of Defense, Office of Assistant Minister of Defense for Chemical, Biological, Radiological and Nuclear (CBRN) Defense; Foundation Fighting Blindness; The Edmond J. Safra Center for Bioinformatics at Tel Aviv University; The Koret-UC Berkeley-Tel Aviv University Initiative in Computational Biology and Bioinformatics; The QBI/UCSF-Tel Aviv University joint Initiative in Computational Biology and Drug Discovery; Zimin Institute for Engineering Solutions Advancing Better Lives; Tel Aviv University	Akkaya M, 2020, NAT REV IMMUNOL, V20, P229, DOI 10.1038/s41577-019-0244-2; Al-kuraishy HM, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.649128; Apostolidis SA, 2021, NAT MED, V27, P1990, DOI 10.1038/s41591-021-01507-2; Asano T, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4348; Blomberg BB, 2011, J CLIN INVEST, V121, P2981, DOI 10.1172/JCI58406; Cayan S, 2020, AGING MALE, V23, P1493, DOI 10.1080/13685538.2020.1807930; Costeira R, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257051; Cylus J, 2021, ISR J HEALTH POLICY, V10, DOI 10.1186/s13584-021-00453-1; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Fathi A, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.601170; Fujimoto AB, 2021, VACCINE, V39, P5055, DOI 10.1016/j.vaccine.2021.06.067; Furman D, 2015, EXPERT REV VACCINES, V14, P461, DOI 10.1586/14760584.2015.966694; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Garcia-Beltran WF, 2021, CELL, V184, P476, DOI 10.1016/j.cell.2020.12.015; Goel RR, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abi6950; Goldberg Y, 2021, NEW ENGL J MED, V385, pE85, DOI 10.1056/NEJMoa2114228; Hoepel W, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf8654; Hoffmann M, 2022, CELL, V185, P447, DOI 10.1016/j.cell.2021.12.032; Iyer AS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe0367; Jonsdottir HR, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13020284; Kelsey TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109346; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Leung K, 2022, LANCET, V399, P2, DOI 10.1016/S0140-6736(21)02841-5; Levin EG, 2021, NEW ENGL J MED, V385, pE84, DOI 10.1056/NEJMoa2114583; Mishra S, 2021, ECLINICALMEDICINE, V39, DOI 10.1016/j.eclinm.2021.101064; Muller L, 2021, CLIN INFECT DIS, V73, P2065, DOI 10.1093/cid/ciab381; O'Driscoll M, 2020, NATURE, DOI 10.1038/s41586-020-2918-0; Parazzini F, 2007, MATURITAS, V56, P280, DOI 10.1016/j.maturitas.2006.09.003; Pellini R, 2021, ECLINICALMEDICINE, V36, DOI 10.1016/j.eclinm.2021.100928; Penna C, 2020, BRIT J PHARMACOL, V177, P4375, DOI 10.1111/bph.15207; Perkmann T, 2021, MICROBIOL SPECTR, V9, DOI 10.1128/Spectrum.00247-21; Robbiani DF, 2020, NATURE, V584, P437, DOI 10.1038/s41586-020-2456-9; Salonia A, 2021, ANDROLOGY-US, V9, P1043, DOI 10.1111/andr.12993; Scully EP, 2020, NAT REV IMMUNOL, V20, P442, DOI 10.1038/s41577-020-0348-8; Shapiro JR, 2021, NPJ VACCINES, V6, DOI 10.1038/s41541-021-00412-6; Tregoning JS, 2021, NAT REV IMMUNOL, V21, P626, DOI 10.1038/s41577-021-00592-1; Vogl T, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100191; Wang ZJ, 2021, NATURE, V595, P426, DOI 10.1038/s41586-021-03696-9; Weisberg SP, 2021, NAT IMMUNOL, V22, P25, DOI 10.1038/s41590-020-00826-9; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	41	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22223	10.1096/fj.202101492R	http://dx.doi.org/10.1096/fj.202101492R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CA	35239233	Green Published, hybrid			2022-12-28	WOS:000772943800001
J	Delgado-Calle, J; McAndrews, K; Wu, G; Orr, AL; Ferrari, A; Tu, X; Srinivasan, V; Roodman, GD; Ebetino, FH; Boeckman, RK; Bellido, T				Delgado-Calle, Jesus; McAndrews, Kevin; Wu, Gerald; Orr, Ashley L.; Ferrari, Adam; Tu, Xiaolin; Srinivasan, Venkatesan; Roodman, G. David; Ebetino, Frank H.; Boeckman, Robert K.; Bellido, Teresita			The Notch pathway regulates the bone gain induced by PTH anabolic signaling	FASEB JOURNAL			English	Article						bone; Notch; osteoblasts; osteoclasts; osteocytes; PTH; resorption	PARATHYROID-HORMONE; LIGAND JAGGED1; BETA-CATENIN; OSTEOCYTES; RECEPTOR; GENE; OSTEOPOROSIS; OSTEOBLASTS; ACTIVATION; MECHANISMS	Parathyroid hormone (PTH) signaling downstream of the PTH 1 receptor (Pth1r) results in both bone anabolic and catabolic actions by mechanisms not yet fully understood. In this study, we show that Pth1r signaling upregulates the expression of several components of the Notch pathway and that Notch signals contribute to the catabolic actions of PTH in bone. We found that constitutive genetic activation of PTH receptor signaling in osteocytes (caPth1r(Ot)) or treatment with PTH daily increased the expression of several Notch ligands/receptors in bone. In contrast, sustained elevation of endogenous PTH did not change Notch components expression. Deletion of the PTH receptor or sclerostin overexpression in osteocytes abolished Notch increases by PTH. Further, deleting the canonical Notch transcription factor Rbpjk in osteocytes decreased bone mass and increased resorption and Rankl expression in caPth1r(Ot) mice. Moreover, pharmacological bone-targeted Notch inhibition potentiated the bone mass gain induced by intermittent PTH by reducing bone resorption and preserving bone formation. Thus, Notch activation lies downstream of anabolic signaling driven by PTH actions in osteocytes, and Notch pharmacological inhibition maximizes the bone anabolic effects of PTH.	[Delgado-Calle, Jesus; Bellido, Teresita] Univ Arkansas Med Sci, Dept Physiol & Cell Biol, 4301 W Markham St, Little Rock, AR 72205 USA; [Delgado-Calle, Jesus; Bellido, Teresita] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA; [McAndrews, Kevin; Wu, Gerald; Tu, Xiaolin] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA; [Orr, Ashley L.; Ferrari, Adam; Roodman, G. David] Univ Rochester, Dept Med, Div Hematol Oncol, Rochester, NY USA; [Srinivasan, Venkatesan; Ebetino, Frank H.; Boeckman, Robert K.] Univ Rochester, Dept Chem, Rochester, NY USA; [Ebetino, Frank H.] Biovinc LLC, Pasadena, CA USA; [Bellido, Teresita] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Indiana University System; Indiana University Bloomington; University of Rochester; University of Rochester; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Delgado-Calle, J; Bellido, T (corresponding author), Univ Arkansas Med Sci, Dept Physiol & Cell Biol, 4301 W Markham St, Little Rock, AR 72205 USA.	jdelgadocalle@uams.edu; tmbellido@uams.edu	Delgado-Calle, Jesus/AAG-1417-2020	Delgado-Calle, Jesus/0000-0002-2083-2774	HHS \ National Institutes of Health (NIH) [R37-CA251763, R01-AR059357, P20GM125503]; U.S. Department of Veterans Affairs (VA) [I01 BX002104, IK6BX004596]	HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs)	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: R37--CA251763, R01--AR059357 and P20GM125503; U.S. Department of Veterans Affairs (VA), Grant/Award Number: I01 BX002104 and IK6BX004596	Armas LAG, 2012, ENDOCRIN METAB CLIN, V41, P475, DOI 10.1016/j.ecl.2012.04.006; Bagheri L, 2018, J TISSUE ENG REGEN M, V12, P304, DOI 10.1002/term.2455; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Ben-Awadh AN, 2014, ENDOCRINOLOGY, V155, P2797, DOI 10.1210/en.2014-1046; Bivi N, 2012, CALCIFIED TISSUE INT, V91, P215, DOI 10.1007/s00223-012-9628-z; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Canalis E, 2018, OSTEOPOROSIS INT, V29, P2611, DOI 10.1007/s00198-018-4694-3; Canalis E, 2016, J BIOL CHEM, V191, P1538, DOI 10.1074/jbc.M115.685453; Canalis E, 2016, AM J PHYSIOL-ENDOC M, V310, pE171, DOI 10.1152/ajpendo.00395.2015; Chakravorty N, 2014, CLIN ORAL IMPLAN RES, V25, P475, DOI 10.1111/clr.12178; Chen SX, 2015, J BONE MINER RES, V30, P1184, DOI 10.1002/jbmr.2453; Cosman Felicia, 2005, Curr Osteoporos Rep, V3, P143, DOI 10.1007/BF02686941; Cosman F, 2017, J BONE MINER RES, V32, P198, DOI 10.1002/jbmr.3051; Delgado-Calle J, 2022, PHYSIOL REV, V102, DOI 10.1152/physrev.00043.2020; Delgado-Calle J, 2018, FASEB J, V32, P2878, DOI 10.1096/fj.201700919RRR; Delgado-Calle J, 2017, J BONE MINER RES, V32, P522, DOI 10.1002/jbmr.3011; Eriksen EF, 2016, BONE, V86, P139, DOI 10.1016/j.bone.2016.02.009; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kode A, 2014, NATURE, V506, P240, DOI 10.1038/nature12883; Lawal RA, 2017, J BONE MINER RES, V32, P1320, DOI 10.1002/jbmr.3106; Leder BZ, 2016, BONE, V89, P73, DOI 10.1016/j.bone.2016.04.026; Li JY, 2019, J BONE MINER RES, V34, P349, DOI 10.1002/jbmr.3600; Liu P, 2016, P NATL ACAD SCI USA, V113, pE2152, DOI 10.1073/pnas.1603399113; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manolagas SC, 2018, J BONE MINER RES, V33, P371, DOI 10.1002/jbmr.3400; Martin TJ, 2021, ENDOCR REV, V42, P383, DOI 10.1210/endrev/bnab005; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Qiu T, 2015, J BONE MINER RES, V30, P309, DOI 10.1002/jbmr.2327; Reid IR, 2015, NAT REV ENDOCRINOL, V11, P418, DOI 10.1038/nrendo.2015.71; Sabol HM, 2021, CANCER RES, V81, P5102, DOI 10.1158/0008-5472.CAN-21-0524; Saini V, 2013, J BIOL CHEM, V288, P20122, DOI 10.1074/jbc.M112.441360; Tu XL, 2015, P NATL ACAD SCI USA, V112, pE478, DOI 10.1073/pnas.1409857112; Weber JM, 2006, BONE, V39, P485, DOI 10.1016/j.bone.2006.03.002; Xiong JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138189; Yu J, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101376; Yu J, 2020, BONE, V138, DOI 10.1016/j.bone.2020.115474; Zanotti S, 2017, BONE, V103, P159, DOI 10.1016/j.bone.2017.06.027	42	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22196	10.1096/fj.202101807R	http://dx.doi.org/10.1096/fj.202101807R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35137455				2022-12-28	WOS:000761250800004
J	Li, ZF; Kim, KH; Bhatnagar, N; Park, BR; Jeeva, S; Jung, YJ; Raha, J; Kang, SM; Chen, XY				Li, Zhuofan; Kim, Ki-Hye; Bhatnagar, Noopur; Park, Bo Ryoung; Jeeva, Subbiah; Jung, Yu-Jin; Raha, Jannatul; Kang, Sang-Moo; Chen, Xinyuan			Physical radiofrequency adjuvant enhances immune responses to influenza H5N1 vaccination	FASEB JOURNAL			English	Article						MF59; physical adjuvant; radiofrequency; RFA	CROSS-PROTECTION	Pre-pandemic influenza H5N1 vaccine has relatively low immunogenicity and often requires high antigen amounts and two immunizations to induce protective immunity. Incorporation of vaccine adjuvants is promising to stretch vaccine doses during pandemic outbreaks. This study presents a physical radiofrequency (RF) adjuvant (RFA) to conveniently and effectively increase the immunogenicity and efficacy of H5N1 vaccine without modification of vaccine preparation. Physical RFA is based on a brief RF treatment of the skin to induce thermal stress to enhance intradermal vaccine-induced immune responses with minimal local or systemic adverse reactions. We found that physical RFA could significantly increase H5N1 vaccine-induced hemagglutination inhibition antibody titers in murine models. Intradermal H5N1 vaccine in the presence of RFA but not vaccine alone significantly lowered lung viral titers, reduced body weight loss, and improved survival rates after lethal viral challenges. The improved protection in the presence of RFA was correlated with enhanced humoral and cellular immune responses to H5N1 vaccination in both male and female mice, indicating no gender difference of RFA effects in murine models. Our data support further development of the physical RFA to conveniently enhance the efficacy of H5N1 vaccine.	[Li, Zhuofan; Chen, Xinyuan] Univ Rhode Isl, Coll Pharm, Biomed & Pharmaceut Sci, 7 Greenhouse Rd,Pharm Bldg,Room 480, Kingston, RI 02881 USA; [Kim, Ki-Hye; Bhatnagar, Noopur; Park, Bo Ryoung; Jeeva, Subbiah; Jung, Yu-Jin; Raha, Jannatul; Kang, Sang-Moo] Georgia State Univ, Ctr Inflammat Immun & Infect, Inst Biomed Sci, Atlanta, GA 30302 USA	University of Rhode Island; University System of Georgia; Georgia State University	Chen, XY (corresponding author), Univ Rhode Isl, Coll Pharm, Biomed & Pharmaceut Sci, 7 Greenhouse Rd,Pharm Bldg,Room 480, Kingston, RI 02881 USA.; Kang, SM (corresponding author), Georgia State Univ, Ctr Inflammat Immun & Infect, Inst Biomed Sci, Atlanta, GA 30302 USA.	skang24@gsu.edu; xchen14@uri.edu	Bhatnagar, Noopur/HGE-6220-2022	chen, xinyuan/0000-0003-4735-3922	HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID) [AI139473, AI156510, AI093772, AI152800, AI154656]	HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID)	HHS vertical bar NIH vertical bar National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: AI139473, AI156510, AI093772, AI152800 and AI154656	Bartee E, 2008, CURR OPIN MICROBIOL, V11, P378, DOI 10.1016/j.mib.2008.05.015; Baz M, 2013, VIRUS RES, V178, P78, DOI 10.1016/j.virusres.2013.05.006; Cao Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06151-y; Chen XY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013776; Clegg CH, 2013, EXPERT REV VACCINES, V12, P767, DOI 10.1586/14760584.2013.811178; El Sahlyt HM, 2008, EXPERT REV VACCINES, V7, P241, DOI 10.1586/14760584.7.2.241; Fischinger S, 2019, SEMIN IMMUNOPATHOL, V41, P239, DOI 10.1007/s00281-018-0726-5; Gelfand JA, 2019, FASEB J, V33, P3074, DOI 10.1096/fj.201801095R; Godeaux O, 2015, VACCINE, V33, P2189, DOI 10.1016/j.vaccine.2014.07.062; Guan Y, 2009, REV SCI TECH OIE, V28, P39, DOI 10.20506/rst.28.1.1868; Kashiwagi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082899; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Kim KH, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9050516; Kim KH, 2020, VIROLOGY, V550, P51, DOI 10.1016/j.virol.2020.08.003; Kim KH, 2019, VIROLOGY, V535, P179, DOI 10.1016/j.virol.2019.07.008; Ko EJ, 2018, ANTIVIR RES, V156, P107, DOI 10.1016/j.antiviral.2018.06.004; Li YB, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9121382; Li ZF, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.nsight.144627; Li ZF, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020075; Long JS, 2019, NAT REV MICROBIOL, V17, P67, DOI 10.1038/s41579-018-0115-z; MacPherson A, 2021, ANN INTERN MED, V174, P326, DOI 10.7326/M20-5350; Mena I, 2016, ELIFE, V5, DOI 10.7554/eLife.16777; Morse K, 2017, J IMMUNOL, V199, P1319, DOI 10.4049/jimmunol.1601873; Nickol ME, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3750-8; O'Hagan DT, 2013, HUM VACC IMMUNOTHER, V9, P1698, DOI 10.4161/hv.24829; Peteranderl C, 2016, SEMIN RESP CRIT CARE, V37, P487, DOI 10.1055/s-0036-1584801; Petrova VN, 2018, NAT REV MICROBIOL, V16, P60, DOI [10.1038/nrmicro.2017.146, 10.1038/nrmicro.2017.118]; Poovorawan Y, 2013, PATHOG GLOB HEALTH, V107, P217, DOI 10.1179/2047773213Y.0000000103; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saunders-Hastings PR, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5040066; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Song JM, 2011, P NATL ACAD SCI USA, V108, P757, DOI 10.1073/pnas.1012199108; Taubenberger JK, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau5485; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; To J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070654; Tokars JI, 2018, CLIN INFECT DIS, V66, P1511, DOI 10.1093/cid/cix1060; Wang J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5447; Wu JT, 2011, EXP BIOL MED, V236, P955, DOI 10.1258/ebm.2010.010271; Yokomizo S, 2021, NANOPHOTONICS-BERLIN, V10, P3187, DOI 10.1515/nanoph-2021-0133	39	1	1	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22182	10.1096/fj.202101703R	http://dx.doi.org/10.1096/fj.202101703R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35113455				2022-12-28	WOS:000761250800016
J	Kihara, Y; Jonnalagadda, D; Zhu, YJ; Ray, M; Ngo, T; Palmer, C; Rivera, R; Chun, J				Kihara, Yasuyuki; Jonnalagadda, Deepa; Zhu, Yunjiao; Ray, Manisha; Ngo, Tony; Palmer, Carter; Rivera, Richard; Chun, Jerold			Ponesimod inhibits astrocyte-mediated neuroinflammation and protects against cingulum demyelination via S1P(1)-selective modulation	FASEB JOURNAL			English	Article						GPCR; lysophospholipid; multiple sclerosis; neuroinflammation; sphingolipid	CUPRIZONE-INDUCED DEMYELINATION; MULTIPLE-SCLEROSIS; RECEPTOR MODULATOR; FTY720 FINGOLIMOD; ORAL FINGOLIMOD; BRAIN; FATIGUE; THERAPY; EXPRESSION; MECHANISM	Ponesimod is a sphingosine 1-phosphate (S1P) receptor (S1PR) modulator that was recently approved for treating relapsing forms of multiple sclerosis (MS). Three other FDA-approved S1PR modulators for MS-fingolimod, siponimod, and ozanimod-share peripheral immunological effects via common S1P(1) interactions, yet ponesimod may access distinct central nervous system (CNS) mechanisms through its selectivity for the S1P(1) receptor. Here, ponesimod was examined for S1PR internalization and binding, human astrocyte signaling and single-cell RNA-seq (scRNA-seq) gene expression, and in vivo using murine cuprizone-mediated demyelination. Studies confirmed ponesimod's selectivity for S1P(1) without comparable engagement to the other S1PR subtypes (S1P(2,3,4,5)). Ponesimod showed pharmacological properties of acute agonism followed by chronic functional antagonism of S1P(1). A major locus of S1P(1) expression in the CNS is on astrocytes, and scRNA-seq of primary human astrocytes exposed to ponesimod identified a gene ontology relationship of reduced neuroinflammation and reduction in known astrocyte disease-related genes including those of immediate early astrocytes that have been strongly associated with disease progression in MS animal models. Remarkably, ponesimod prevented cuprizone-induced demyelination selectively in the cingulum, but not in the corpus callosum. These data support the CNS activities of ponesimod through S1P(1), including protective, and likely selective, effects against demyelination in a major connection pathway of the brain, the limbic fibers of the cingulum, lesions of which have been associated with several neurologic impairments including MS fatigue.	[Kihara, Yasuyuki; Jonnalagadda, Deepa; Zhu, Yunjiao; Ray, Manisha; Ngo, Tony; Palmer, Carter; Rivera, Richard; Chun, Jerold] Sanford Burnham Prebys Med Discovery Inst, Translat Neurosci Initiat, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Palmer, Carter] Univ Calif San Diego, Biomed Sci Program, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Chun, J (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Translat Neurosci Initiat, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jchun@sbpdiscovery.org			NIH | National Institute of Neurological Disorders and Stroke (NINDS) [R01NS103940]; Janssen Research & Development LLC	NIH | National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Janssen Research & Development LLC	NIH | National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: R01NS103940; Janssen Research & Development LLC	Al-Dalahmah O, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-0880-6; Basu N, 2013, RHEUMATOLOGY, V52, P1429, DOI 10.1093/rheumatology/ket135; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bisecco A, 2016, MULT SCLER J, V22, P1676, DOI 10.1177/1352458516628331; Bolli MH, 2010, J MED CHEM, V53, P4198, DOI 10.1021/jm100181s; Bracht T, 2015, J AFFECT DISORDERS, V187, P45, DOI 10.1016/j.jad.2015.06.041; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Bubb EJ, 2018, NEUROSCI BIOBEHAV R, V92, P104, DOI 10.1016/j.neubiorev.2018.05.008; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Chun J, 2021, DRUGS, V81, P207, DOI 10.1007/s40265-020-01431-8; Chun J, 2019, ANNU REV PHARMACOL, V59, P149, DOI 10.1146/annurev-pharmtox-010818-021358; Chun J, 2011, DISCOV MED, V12, P213; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Clark AL, 2017, BRAIN IMAGING BEHAV, V11, P1548, DOI 10.1007/s11682-016-9594-6; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; D'Ambrosio D, 2016, THER ADV CHRONIC DIS, V7, P18, DOI 10.1177/2040622315617354; Daniels JK, 2013, DEPRESS ANXIETY, V30, P207, DOI 10.1002/da.22044; De Keyser J, 2003, ARCH NEUROL-CHICAGO, V60, P132, DOI 10.1001/archneur.60.1.132; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Fourgeaud L, 2021, CENTRAL EFFECT PONES; Gergely P, 2012, BRIT J PHARMACOL, V167, P1035, DOI 10.1111/j.1476-5381.2012.02061.x; Grandjean J, 2016, NEUROIMAGE, V142, P544, DOI 10.1016/j.neuroimage.2016.08.013; Groves A, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0239-18.2018; Groves A, 2013, J NEUROL SCI, V328, P9, DOI 10.1016/j.jns.2013.02.011; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hiremath MM, 1998, J NEUROIMMUNOL, V92, P38, DOI 10.1016/S0165-5728(98)00168-4; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Kang SY, 2020, J NEURAL TRANSM, V127, P301, DOI 10.1007/s00702-019-02130-9; Kappos L, 2021, JAMA NEUROL, V78, P558, DOI 10.1001/jamaneurol.2021.0405; Kappos L, 2018, LANCET, V391, P1263, DOI 10.1016/S0140-6736(18)30475-6; Kihara Y, 2014, BRIT J PHARMACOL, V171, P3575, DOI 10.1111/bph.12678; Kiray H, 2016, EXP NEUROL, V283, P541, DOI 10.1016/j.expneurol.2016.03.009; Koenig KA, 2015, MULT SCLER J, V21, P1794, DOI 10.1177/1352458515576983; Lee CW, 2010, ARCH PHARM RES, V33, P1567, DOI 10.1007/s12272-010-1008-5; LEE SC, 1990, J NEUROPATH EXP NEUR, V49, P122, DOI 10.1097/00005072-199003000-00005; Lees AJ, 2017, JAMA NEUROL, V74, P197, DOI 10.1001/jamaneurol.2016.4703; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Masiulionyte B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41974-9; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mizuno H, 2019, J LIPID RES, V60, P212, DOI 10.1194/jlr.D089938; Molina-Gonzalez I, 2019, NEUROSCI LETT, V713, DOI 10.1016/j.neulet.2019.134532; Morell P, 1998, MOL CELL NEUROSCI, V12, P220, DOI 10.1006/mcne.1998.0715; Nash B, 2011, J NEUROSCI, V31, P13028, DOI 10.1523/JNEUROSCI.1449-11.2011; Novo AM, 2018, NEUROL-CLIN PRACT, V8, P492, DOI 10.1212/CPJ.0000000000000545; Pardini M, 2015, MULT SCLER J, V21, P442, DOI 10.1177/1352458514546791; Pfeil EM, 2020, MOL CELL, V80, P940, DOI 10.1016/j.molcel.2020.10.027; Piali L, 2011, J PHARMACOL EXP THER, V337, P547, DOI 10.1124/jpet.110.176487; Provenzano D, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10070456; Radua J, 2014, NEUROPSYCHOPHARMACOL, V39, P1547, DOI 10.1038/npp.2014.5; Ray M, 2020, J LIPID RES, V61, P1244, DOI 10.1194/jlr.D120000880; Schmidt T, 2013, J MOL NEUROSCI, V49, P80, DOI 10.1007/s12031-012-9896-0; Sepulcre J, 2009, MULT SCLER J, V15, P337, DOI 10.1177/1352458508098373; Shepherd AM, 2012, NEUROSCI BIOBEHAV R, V36, P1342, DOI 10.1016/j.neubiorev.2011.12.015; Silvestroff L, 2010, J COMP NEUROL, V518, P2261, DOI 10.1002/cne.22330; Soliven B, 2011, NEUROLOGY, V76, pS9, DOI 10.1212/WNL.0b013e31820d9507; Sorensen A, 2008, GLIA, V56, P750, DOI 10.1002/glia.20650; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tansey FA, 1997, MOL CHEM NEUROPATHOL, V31, P161, DOI 10.1007/BF02815240; Tran JQ, 2020, ADV THER, V37, P4381, DOI 10.1007/s12325-020-01473-0; Travers BG, 2012, AUTISM RES, V5, P289, DOI 10.1002/aur.1243; van Ewijk H, 2012, NEUROSCI BIOBEHAV R, V36, P1093, DOI 10.1016/j.neubiorev.2012.01.003; Vidal-Jordana A, 2013, MULT SCLER J, V19, P1175, DOI 10.1177/1352458512473190; Werkman IL, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02045-3	67	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22132	10.1096/fj.202101531R	http://dx.doi.org/10.1096/fj.202101531R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34986275	Green Published			2022-12-28	WOS:000747987800050
J	Sivaraj, D; Padmanabhan, J; Chen, KE; Henn, D; Noishiki, C; Trotsyuk, AA; Kussie, HC; Leeolou, MC; Magbual, NJ; Andrikopoulos, S; Perrault, DP; Barrera, JA; Januszyk, M; Gurtner, GC				Sivaraj, Dharshan; Padmanabhan, Jagannath; Chen, Kellen; Henn, Dominic; Noishiki, Chikage; Trotsyuk, Artem A.; Kussie, Hudson C.; Leeolou, Melissa C.; Magbual, Noah J.; Andrikopoulos, Sophia; Perrault, David P.; Barrera, Janos A.; Januszyk, Michael; Gurtner, Geoffrey C.			IQGAP1-mediated mechanical signaling promotes the foreign body response to biomedical implants	FASEB JOURNAL			English	Article						fibrosis; foreign body response; inflammation; mechanotransduction	PROTEIN; IQGAP1; EXPRESSION; THROMBOSPONDIN-1; INFLAMMATION; CHEMOKINE; ADHESION; INJURY; LUNG	The aim of this study was to further elucidate the molecular mechanisms that mediate pathologic foreign body response (FBR) to biomedical implants. The longevity of biomedical implants is limited by the FBR, which leads to implant failure and patient morbidity. Since the specific molecular mechanisms underlying fibrotic responses to biomedical implants have yet to be fully described, there are currently no targeted approaches to reduce pathologic FBR. We utilized proteomics analysis of human FBR samples to identify potential molecular targets for therapeutic inhibition of FBR. We then employed a murine model of FBR to further evaluate the role of this potential target. We performed histological and immunohistochemical analysis on the murine FBR capsule tissue, as well as single-cell RNA sequencing (scRNA-seq) on cells isolated from the capsules. We identified IQ motif containing GTPase activating protein 1 (IQGAP1) as the most promising of several targets, serving as a central molecular mediator in human and murine FBR compared to control subcutaneous tissue. IQGAP1-deficient mice displayed a significantly reduced FBR compared to wild-type mice as evidenced by lower levels of collagen deposition and maturity. Our scRNA-seq analysis revealed that decreasing IQGAP1 resulted in diminished transcription of mechanotransduction, inflammation, and fibrosis-related genes, which was confirmed on the protein level with immunofluorescent staining. The deficiency of IQGAP1 significantly attenuates FBR by deactivating downstream mechanotransduction signaling, inflammation, and fibrotic pathways. IQGAP1 may be a promising target for rational therapeutic design to mitigate pathologic FBR around biomedical implants.	[Sivaraj, Dharshan; Padmanabhan, Jagannath; Chen, Kellen; Henn, Dominic; Noishiki, Chikage; Trotsyuk, Artem A.; Kussie, Hudson C.; Leeolou, Melissa C.; Magbual, Noah J.; Andrikopoulos, Sophia; Perrault, David P.; Barrera, Janos A.; Januszyk, Michael; Gurtner, Geoffrey C.] Stanford Univ, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA	Stanford University	Gurtner, GC (corresponding author), Stanford Univ, Sch Med, Div Plast & Reconstruct Surg, 257 Campus Dr West,Hagey Bldg GK 201, Stanford, CA 94305 USA.	ggurtner@stanford.edu		Kussie, Hudson/0000-0001-9877-2313; Leeolou, Melissa/0000-0002-9223-2380; Henn, Dominic/0000-0003-4775-0151; Chen, Kellen/0000-0002-7023-7850; Trotsyuk, Artem/0000-0001-8886-5583	Plastic Surgery Foundation (PSF)	Plastic Surgery Foundation (PSF)	Plastic Surgery Foundation (PSF)	Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com; Agha R, 2011, J SURG RES, V171, P700, DOI 10.1016/j.jss.2011.07.007; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Bhattacharya M, 2012, AM J PHYSIOL-LUNG C, V303, pL12, DOI 10.1152/ajplung.00375.2011; Brzoska E, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0041-1; Chen K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25410-z; Chen KL, 2022, ADV WOUND CARE, V11, P466, DOI 10.1089/wound.2021.0036; Chen K, 2018, P NATL ACAD SCI USA, V115, P986, DOI 10.1073/pnas.1715059115; Duscher D, 2014, J BIOMECH, V47, P1997, DOI 10.1016/j.jbiomech.2014.03.031; Dvorak HF, 2015, CANCER IMMUNOL RES, V3, P1, DOI 10.1158/2326-6066.CIR-14-0209; Emes RD, 2003, FEBS LETT, V533, P124, DOI 10.1016/S0014-5793(02)03741-9; Gharaee-Kermani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049278; Gorka-Dynysiewicz J, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/2639248; Goss-Varley M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15623-y; Gould RA, 2016, CURR BIOL, V26, P27, DOI 10.1016/j.cub.2015.11.033; Harvey T, 2019, NAT CELL BIOL, V21, P1490, DOI 10.1038/s41556-019-0417-z; Hu W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44048-y; Huang ZH, 2006, DIABETES, V55, P3394, DOI 10.2337/db06-0354; Hwaiz R, 2013, J SURG RES, V183, P798, DOI 10.1016/j.jss.2013.02.045; Information K, GLOB MARK MED DEV; Li SH, 2000, MOL CELL BIOL, V20, P697, DOI 10.1128/MCB.20.2.697-701.2000; Liu JQ, 2019, J CELL BIOCHEM, V120, P15790, DOI 10.1002/jcb.28849; Liu X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116071; Liu Yuan, 2020, Cell Regen, V9, P14, DOI 10.1186/s13619-020-00053-5; Liu ZJ, 2015, CIRC RES, V117, P129, DOI 10.1161/CIRCRESAHA.117.305262; Major MR, 2015, PLAST RECONSTR SURG, V135, P1489, DOI 10.1097/PRS.0000000000001193; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; Mittal S, 2014, HEART RHYTHM, V11, P595, DOI 10.1016/j.hrthm.2013.12.013; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Owen D, 2008, J BIOL CHEM, V283, P1692, DOI 10.1074/jbc.M707257200; Padmanabhan J., 2018, PRS-GLOB OPEN; Padmanabhan J., 2022, 476395 BIORXIV; Padnnanabhan J, 2019, ADV WOUND CARE, V8, P645, DOI 10.1089/wound.2018.0909; Patsalos A, 2019, J IMMUNOL, V203, P1532, DOI 10.4049/jimmunol.1900553; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Rao KB, 2014, J CLIN DIAGN RES, V8, pZC14, DOI 10.7860/JCDR/2014/7820.4231; Rinkevich Y, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2151; Rockey DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077166; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Sabbir MG, 2016, BIOL OPEN, V5, P452, DOI 10.1242/bio.015859; Sid B, 2004, CRIT REV ONCOL HEMAT, V49, P245, DOI 10.1016/j.critrevonc.2003.09.009; Siegmund SV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150893; Simpson-Haidaris PJ, 2001, ANN NY ACAD SCI, V936, P406; Solis AG, 2019, NATURE, V573, P69, DOI 10.1038/s41586-019-1485-8; Strieter RM, 2007, J CLIN INVEST, V117, P549, DOI 10.1172/JCI30562; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Urao N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013440; Wang JH, 2013, DEV BIOL, V382, P427, DOI 10.1016/j.ydbio.2013.08.012; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997; WENSTRUP RJ, 1988, J BIOL CHEM, V263, P7734; Wong VW, 2012, NAT MED, V18, P148, DOI 10.1038/nm.2574; YOUN BS, 1995, J IMMUNOL, V155, P2661	54	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22007	10.1096/fj.202101354	http://dx.doi.org/10.1096/fj.202101354			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35051300				2022-12-28	WOS:000747987800027
J	Tupta, B; Stuehr, E; Sumi, MP; Sweeny, EA; Smith, B; Stuehr, DJ; Ghosh, A				Tupta, Blair; Stuehr, Eric; Sumi, Mamta P.; Sweeny, Elizabeth A.; Smith, Brandon; Stuehr, Dennis J.; Ghosh, Arnab			GAPDH is involved in the heme-maturation of myoglobin and hemoglobin	FASEB JOURNAL			English	Article						dimerization; GAPDH; globin; heme-maturation	SOLUBLE GUANYLATE-CYCLASE; 3-DIMENSIONAL FOURIER SYNTHESIS; GLOBIN GENE-EXPRESSION; SHOCK-PROTEIN 90; NITRIC-OXIDE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ALPHA-GLOBIN; MECHANISMS; CHAPERONE; HSP90	GAPDH, a heme chaperone, has been previously implicated in the incorporation of heme into iNOS and soluble guanylyl cyclase (sGC). Since sGC is critical for myoglobin (Mb) heme-maturation, we investigated the role of GAPDH in the maturation of this globin, as well as hemoglobins alpha, beta, and gamma. Utilizing cell culture systems, we found that overexpression of wild-type GAPDH increased, whereas GAPDH mutants H53A and K227A decreased, the heme content of Mb and Hb alpha and Hb beta. Overexpression of wild-type GAPDH fully recovered the heme-maturation inhibition observed with the GAPDH mutants. Partial rescue was observed by overexpression of sGC beta 1 but not by overexpression of a sGC Delta beta 1 deletion mutant, which is unable to bind the sGC alpha 1 subunit required to form the active sGC alpha 1 beta 1 complex. Wild type and mutant GAPDH was found to be associated in a complex with each of the globins and Hsp90. GAPDH at endogenous levels was found to be associated with Mb in differentiating C2C12 myoblasts, and with Hb gamma or Hb alpha in differentiating HiDEP-1 erythroid progenitor cells. Knockdown of GAPDH in C2C12 cells suppressed Mb heme-maturation. GAPDH knockdown in K562 erythroleukemia cells suppressed Hb alpha and Hb gamma heme-maturation as well as Hb dimerization. Globin heme incorporation was not only dependent on elevated sGC alpha 1 beta 1 heterodimer formation, but also influenced by iron provision and magnitude of expression of GAPDH, d-aminolevulinic acid, and FLVCR1b. Together, our data support an important role for GAPDH in the maturation of myoglobin and gamma, beta, and alpha hemoglobins.	[Tupta, Blair; Stuehr, Eric; Sumi, Mamta P.; Sweeny, Elizabeth A.; Smith, Brandon; Stuehr, Dennis J.; Ghosh, Arnab] Cleveland Clin, Dept Inflammat & Immun, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Stuehr, E; Ghosh, A (corresponding author), Cleveland Clin, Dept Inflammat & Immun NC22, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org; ghosha3@ccf.org		GHOSH, ARNAB/0000-0002-7498-1994	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [R56HL139564, R01HL150049, K99 HL144921]; HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [R01 GM130624]	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R56HL139564, R01HL150049 and K99 HL144921; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: R01 GM130624	Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Byon JCH, 2013, BLOOD, V122, P2903, DOI 10.1182/blood-2012-10-465104; Chakravarti R, 2010, P NATL ACAD SCI USA, V107, P18004, DOI 10.1073/pnas.1008133107; Chiabrando D, 2014, HAEMATOLOGICA, V99, P973, DOI 10.3324/haematol.2013.091991; Chiabrando D, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00061; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; Chiche J, 2015, LEUKEMIA, V29, P1163, DOI 10.1038/leu.2014.324; Cokic VP, 2003, J CLIN INVEST, V111, P231, DOI 10.1172/JCI200316672; CONGIUCASTELLANO A, 1987, BIOCHEM BIOPH RES CO, V147, P31, DOI 10.1016/S0006-291X(87)80083-9; Dai Y, 2020, J BIOL CHEM, V295, P8145, DOI 10.1074/jbc.RA120.013802; Donegan RK, 2019, FREE RADICAL BIO MED, V133, P88, DOI 10.1016/j.freeradbiomed.2018.08.005; Echeverria PC, 2016, MOL CELL BIOL, V36, P1310, DOI 10.1128/MCB.01099-15; Fleischhacker AS, 2018, J BIOL CHEM, V293, P14569, DOI 10.1074/jbc.H118.005247; Flonta SE, 2009, AM J PATHOL, V175, P201, DOI 10.2353/ajpath.2009.081124; Friebe A, 2022, BRIT J PHARMACOL, V179, P2328, DOI 10.1111/bph.15345; Friebe A, 2020, N-S ARCH PHARMACOL, V393, P287, DOI 10.1007/s00210-019-01779-z; Genest O, 2019, J BIOL CHEM, V294, P2109, DOI 10.1074/jbc.REV118.002806; Ghosh A, 2021, REDOX BIOL, V39, DOI 10.1016/j.redox.2020.101832; Ghosh A, 2019, FASEB J, V33, P9885, DOI 10.1096/fj.201802793RR; Ghosh A, 2018, P NATL ACAD SCI USA, V115, pE1117, DOI 10.1073/pnas.1717993115; Ghosh A, 2016, P NATL ACAD SCI USA, V113, pE2355, DOI 10.1073/pnas.1524398113; Ghosh A, 2014, J BIOL CHEM, V289, P15259, DOI 10.1074/jbc.M114.559393; Ghosh A, 2012, P NATL ACAD SCI USA, V109, P12998, DOI 10.1073/pnas.1205854109; Ghosh A, 2011, FASEB J, V25, P2049, DOI 10.1096/fj.10-180554; Guo CM, 2013, CLIN TRANSL ONCOL, V15, P167, DOI 10.1007/s12094-012-0924-x; Hanna DA, 2016, P NATL ACAD SCI USA, V113, P7539, DOI 10.1073/pnas.1523802113; Hannibal L, 2012, BIOCHEMISTRY-US, V51, P8514, DOI 10.1021/bi300863a; Hara MR, 2006, CELL MOL NEUROBIOL, V26, P527, DOI 10.1007/s10571-006-9011-6; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hardison RC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011627; Huang Y, 2017, ARCH BIOCHEM BIOPHYS, V619, P54, DOI 10.1016/j.abb.2017.03.005; HUBBARD SR, 1990, J MOL BIOL, V213, P215, DOI 10.1016/S0022-2836(05)80181-0; Ikuta T, 2001, P NATL ACAD SCI USA, V98, P1847, DOI 10.1073/pnas.041599798; Kanatous SB, 2010, J EXP BIOL, V213, P2741, DOI 10.1242/jeb.041442; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; Khandros E, 2010, HEMATOL ONCOL CLIN N, V24, P1071, DOI 10.1016/j.hoc.2010.08.013; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; Lackie RE, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00254; Longeville S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09146-9; Mercurio S, 2015, HAEMATOLOGICA, V100, P720, DOI 10.3324/haematol.2014.114488; Moras M, 2017, FRONT PHYSIOL, V8, DOI [10.3389/FPHYS.2017.01076, 10.3389/fphys.2017.01076]; Nakamura T, 2002, BIOCHEM BIOPH RES CO, V290, P858, DOI 10.1006/bbrc.2001.6271; Ordway GA, 2004, J EXP BIOL, V207, P3441, DOI 10.1242/jeb.01172; ORKIN SH, 1995, EUR J BIOCHEM, V231, P271, DOI 10.1111/j.1432-1033.1995.tb20697.x; Paoli M, 2002, DNA CELL BIOL, V21, P271, DOI 10.1089/104454902753759690; PERUTZ M F, 1960, Brookhaven Symp Biol, V13, P165; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; PERUTZ MF, 1968, NATURE, V219, P131, DOI 10.1038/219131a0; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Ponka P, 1997, BLOOD, V89, P1; Reedy CJ, 2008, NUCLEIC ACIDS RES, V36, pD307, DOI 10.1093/nar/gkm814; Sawicki KT, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001138; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; Seo MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4724; Shimizu T, 2019, CHEM SOC REV, V48, P5624, DOI 10.1039/c9cs00268e; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Stuehr DJ, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100336; Sweeny EA, 2018, J BIOL CHEM, V293, P14557, DOI 10.1074/jbc.RA118.004169; Taketani S, 2005, TOHOKU J EXP MED, V205, P297, DOI 10.1620/tjem.205.297; Tittelmeier J, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.581374; Voon HPJ, 2008, HAEMATOL-HEMATOL J, V93, P1868, DOI 10.3324/haematol.13490; Weiss MJ, 2005, ANN NY ACAD SCI, V1054, P103, DOI 10.1196/annals.1345.013; WELLER PA, 1986, MOL CELL BIOL, V6, P4539, DOI 10.1128/MCB.6.12.4539; WITTENBERG BA, 1989, ANNU REV PHYSIOL, V51, P857, DOI 10.1146/annurev.physiol.51.1.857; Yin T, 2015, J IMMUNOL, V194, P429, DOI 10.4049/jimmunol.1400643; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; Zhang JY, 2015, CANCER BIOL MED, V12, P10, DOI 10.7497/j.issn.2095-3941.2014.0019; Zhang J, 2019, GENES-BASEL, V10, DOI 10.3390/genes10010064; Zhang K, 2017, ADV EXP MED BIOL, V977, P367, DOI 10.1007/978-3-319-55231-6_48; Zheng Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14344	72	7	7	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22099	10.1096/fj.202101237RR	http://dx.doi.org/10.1096/fj.202101237RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34972240	Green Accepted			2022-12-28	WOS:000747987800049
J	Bahnfleth, CL; Strupp, BJ; Caudill, MA; Canfield, RL				Bahnfleth, Charlotte L.; Strupp, Barbara J.; Caudill, Marie A.; Canfield, Richard L.			Prenatal choline supplementation improves child sustained attention: A 7-year follow-up of a randomized controlled feeding trial	FASEB JOURNAL			English	Article						attention; child development; choline; cognition; dietary supplements	192 IGG-SAPORIN; TS65DN MOUSE MODEL; ALCOHOL EXPOSURE; ACETYLCHOLINE-RELEASE; 3RD TRIMESTER; DOUBLE-BLIND; PREGNANCY; ALTERS; PERFORMANCE; MEMORY	Numerous rodent studies demonstrate developmental programming of offspring cognition by maternal choline intake, with prenatal choline deprivation causing lasting adverse effects and supplemental choline producing lasting benefits. Few human studies have evaluated the effect of maternal choline supplementation on offspring cognition, with none following children to school age. Here, we report results from a controlled feeding study in which pregnant women were randomized to consume 480 mg choline/d (approximately the Adequate Intake [AI]) or 930 mg choline/d during the 3rd trimester. Sustained attention was assessed in the offspring at age 7 years (n = 20) using a signal detection task that showed benefits of maternal choline supplementation in a murine model. Children in the 930 mg/d group showed superior performance (vs. 480 mg/d group) on the primary endpoint (SAT score, p = .02) and a superior ability to maintain correct signal detections (hits) across the 12-min session (p = .02), indicative of improved sustained attention. This group difference in vigilance decrement varied by signal duration (p = .04). For the briefest (17 ms) signals, the 480 mg/d group showed a 22.9% decline in hits across the session compared to a 1.5% increase in hits for the 930 mg/d group (p = .04). The groups did not differ in vigilance decrement for 29 or 50 ms signals. This pattern suggests an enhanced ability to sustain perceptual amplification of a brief low-contrast visual signal by children in the 930 mg/d group. This inference of improved sustained attention by the 930 mg/d group is strengthened by the absence of group differences for false alarms, omissions, and off-task behaviors. This pattern of results indicates that maternal 3rd trimester consumption of the choline AI for pregnancy (vs. double the AI) produces offspring with a poorer ability to sustain attention-reinforcing concerns that, on average, choline consumption by pregnant women is approximately 70% of the AI.	[Bahnfleth, Charlotte L.; Strupp, Barbara J.; Caudill, Marie A.; Canfield, Richard L.] Cornell Univ, Div Nutr Sci, 102 Savage Hall, Ithaca, NY 14853 USA; [Strupp, Barbara J.] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Strupp, BJ (corresponding author), Cornell Univ, Div Nutr Sci, 102 Savage Hall, Ithaca, NY 14853 USA.; Canfield, RL (corresponding author), Cornell Univ, Div Nutr Sci, 115 Savage Hall, Ithaca, NY 14853 USA.	bjs13@cornell.edu; rlc5@cornell.edu			NIFA/USDA [1007195]; Balchem Corp.; NICHD [1T32HD087137-01]; Egg Nutrition Center Young Investigator Research Award for Early Exploration	NIFA/USDA(United States Department of Agriculture (USDA)); Balchem Corp.; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Egg Nutrition Center Young Investigator Research Award for Early Exploration	The 7-year follow-up was funded by NIFA/USDA (Hatch Accession Number: 1007195) and Balchem Corp. CLB was supported by an NICHD Traineeship (1T32HD087137-01) and the Egg Nutrition Center Young Investigator Research Award for Early Exploration. We thank Bailey Drewes for her contribution to data collection and Faith Park for her contribution to video coding. Additionally, we thank Dr. Martin Sarter for his important insights into attentional control and signal detection task outcome measures, and for feedback on an earlier version of this manuscript. Finally, we thank Dr. Lynn Johnson and the Cornell Statistical Consulting Unit for the assistance with statistical analyses.	Abelson RP, 1997, PSYCHOL METHODS, V2, P315, DOI 10.1037/1082-989X.2.4.315; Abreu-Villaca Y, 2011, BEHAV BRAIN RES, V221, P367, DOI 10.1016/j.bbr.2009.12.049; Ash JA, 2014, NEUROBIOL DIS, V70, P32, DOI 10.1016/j.nbd.2014.06.001; Bahnfleth C., 2019, CURR DEV NUTR, V3, P1260, DOI [10.1093/cdn/nzz048.FS05-01-19, DOI 10.1093/CDN/NZZ048.FS05-01-19]; Bahnfleth CL., 2019, THESIS CORNELL U; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Bell CC., 2016, J FAM MED DIS PREV, V2; Bixler R, 2016, USER MODEL USER-ADAP, V26, P33, DOI 10.1007/s11257-015-9167-1; Blusztajn JK, 1998, SCIENCE, V281, P794, DOI 10.1126/science.281.5378.794; Boeke CE, 2013, AM J EPIDEMIOL, V177, P1338, DOI 10.1093/aje/kws395; BUNSEY MD, 1995, BEHAV NEUROSCI, V109, P903, DOI 10.1037/0735-7044.109.5.903; Burk JA, 2002, NEUROBIOL AGING, V23, P467, DOI 10.1016/S0197-4580(01)00315-3; Burk JA, 2001, NEUROSCIENCE, V105, P899, DOI 10.1016/S0306-4522(01)00233-0; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Caudill MA, 2018, FASEB J, V32, P2172, DOI 10.1096/fj.201700692RR; Cermak JM, 1998, FASEB J, V12, P349, DOI 10.1096/fasebj.12.3.349; Chamberlain SR, 2007, BIOL PSYCHIAT, V62, P977, DOI 10.1016/j.biopsych.2007.03.003; Cheatham CL, 2012, AM J CLIN NUTR, V96, P1465, DOI 10.3945/ajcn.112.037184; Demeter E, 2008, NEUROPSYCHOLOGY, V22, P787, DOI 10.1037/a0013712; Demeter E, 2013, SCHIZOPHR RES, V144, P136, DOI 10.1016/j.schres.2013.01.003; Fischer LM, 2010, AM J CLIN NUTR, V92, P336, DOI 10.3945/ajcn.2010.29459; Food andNutrition Board Institute of Medicine, 1998, DIET REF INT THIAM R, DOI 10.17226/6015; Friard O, 2016, METHODS ECOL EVOL, V7, P1325, DOI 10.1111/2041-210X.12584; Greene CM, 2009, NEUROPSYCHOLOGIA, V47, P591, DOI 10.1016/j.neuropsychologia.2008.10.003; HANADA K, 1991, BIOCHIM BIOPHYS ACTA, V1086, P151, DOI 10.1016/0005-2760(91)90002-Y; Hasselmo ME, 2011, NEUROPSYCHOPHARMACOL, V36, P52, DOI 10.1038/npp.2010.104; Holmes GL, 2002, EPILEPSY RES, V48, P3, DOI 10.1016/S0920-1211(01)00321-7; Jacobson SW, 2018, ALCOHOL CLIN EXP RES, V42, P1327, DOI 10.1111/acer.13769; Jiang XY, 2013, FASEB J, V27, P1245, DOI 10.1096/fj.12-221648; Jiang XY, 2012, FASEB J, V26, P3563, DOI 10.1096/fj.12-207894; Kable JA, 2015, ALCOHOL, V49, P647, DOI 10.1016/j.alcohol.2015.08.005; Kane MJ, 2008, VARIATION WORKING ME, P21; Kang JI, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00172; Kelley CM, 2014, J COMP NEUROL, V522, P1390, DOI 10.1002/cne.23492; KENT C, 1990, PROG LIPID RES, V29, P87, DOI 10.1016/0163-7827(90)90010-I; Langley EA, 2015, BEHAV BRAIN RES, V278, P210, DOI 10.1016/j.bbr.2014.09.043; Lauder JM, 1999, ENVIRON HEALTH PERSP, V107, P65, DOI 10.2307/3434473; Lewis ED, 2014, BRIT J NUTR, V112, P112, DOI 10.1017/S0007114514000555; LOY R, 1991, ADV EXP MED BIOL, V295, P373; McClelland MM, 2007, DEV PSYCHOL, V43, P947, DOI 10.1037/0012-1649.43.4.947; McGaughy J, 1999, BEHAV NEUROSCI, V113, P1216, DOI 10.1037/0735-7044.113.6.1216; McGaughy J, 1996, BEHAV NEUROSCI, V110, P247, DOI 10.1037/0735-7044.110.2.247; McGaughy J, 1998, BEHAV NEUROSCI, V112, P1519, DOI 10.1037/0735-7044.112.6.1519; Meck WH, 2008, FRONT INTEGR NEUROSC, V1, DOI 10.3389/neuro.07.007.2007; MECK WH, 1988, DEV PSYCHOBIOL, V21, P339, DOI 10.1002/dev.420210405; Meck WH, 1997, NEUROREPORT, V8, P3045, DOI 10.1097/00001756-199709290-00009; Meck WH, 2003, NEUROSCI BIOBEHAV R, V27, P385, DOI 10.1016/S0149-7634(03)00069-1; Mehedint MG, 2010, FASEB J, V24, P184, DOI 10.1096/fj.09-140145; Mellott TJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170450; Metallidou P., 2016, J ED HUM DEV, V5, P68, DOI 10.15640/jehd.v5n3a8; Mohler EG., 2001, INT J COMP PSYCHOL, V14, P136; Moon J, 2010, BEHAV NEUROSCI, V124, P346, DOI 10.1037/a0019590; Muris P, 2006, PERCEPT MOTOR SKILL, V102, P78, DOI 10.2466/PMS.102.1.78-80; Nag N, 2008, BRAIN RES, V1237, P101, DOI 10.1016/j.brainres.2008.08.042; Nag N, 2007, NEUROBIOL DIS, V26, P473, DOI 10.1016/j.nbd.2007.02.003; Napoli I, 2008, BRAIN RES, V1237, P124, DOI 10.1016/j.brainres.2008.08.046; Nevins J., 2018, CURR DEV NUTR, V2, P3, DOI [10.1093/cdn/nzy043, DOI 10.1093/CDN/NZY043]; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; NUECHTERLEIN KH, 1983, SCIENCE, V220, P327, DOI 10.1126/science.6836276; Parasuraman R., 1987, REC RES PSY, P11, DOI 10.1007/978-1-4612-4756-2_2; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Powers BE, 2017, NEUROSCIENCE, V340, P501, DOI 10.1016/j.neuroscience.2016.11.001; Ricceri L, 2011, BEHAV BRAIN RES, V221, P623, DOI 10.1016/j.bbr.2011.03.051; Ross RG, 2013, AM J PSYCHIAT, V170, P290, DOI 10.1176/appi.ajp.2012.12070940; Ryan SH, 2008, BRAIN RES, V1237, P91, DOI 10.1016/j.brainres.2008.08.048; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Sarter M, 2015, CURR OPIN BEHAV SCI, V4, P22, DOI 10.1016/j.cobeha.2015.01.004; Schneider RD, 2016, ALCOHOL CLIN EXP RES, V40, P897, DOI 10.1111/acer.13021; Schulz KM, 2014, BEHAV BRAIN RES, V268, P104, DOI 10.1016/j.bbr.2014.03.031; Shalev L, 2011, NEUROPSYCHOLOGIA, V49, P2584, DOI 10.1016/j.neuropsychologia.2011.05.006; Signore C, 2008, AM J CLIN NUTR, V87, P896, DOI 10.1093/ajcn/87.4.896; Smilek D, 2010, NEUROPSYCHOLOGIA, V48, P2564, DOI 10.1016/j.neuropsychologia.2010.05.002; Strupp BJ, 2016, CURR ALZHEIMER RES, V13, P97, DOI 10.2174/1567205012666150921100311; Thomas JD, 2000, NEUROTOXICOL TERATOL, V22, P703, DOI 10.1016/S0892-0362(00)00097-0; Thomas JD, 2007, BEHAV NEUROSCI, V121, P120, DOI 10.1037/0735-7044.121.1.120; Unsworth N, 2017, PSYCHON B REV, V24, P1282, DOI 10.3758/s13423-016-1220-5; VanderWeele TJ, 2019, AM J EPIDEMIOL, V188, P617, DOI 10.1093/aje/kwy250; Velazquez R, 2019, AGING CELL, V18, DOI 10.1111/acel.13037; Velazquez R, 2013, NEUROBIOL DIS, V58, P92, DOI 10.1016/j.nbd.2013.04.016; Villamor E, 2012, PAEDIATR PERINAT EP, V26, P328, DOI 10.1111/j.1365-3016.2012.01264.x; Visentin CE, 2015, J NUTR, V145, P1491, DOI 10.3945/jn.115.211136; Wallace TC, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080839; Williams CL, 1998, BRAIN RES, V794, P225, DOI 10.1016/S0006-8993(98)00229-7; Wong-Goodrich SJE, 2011, HIPPOCAMPUS, V21, P584, DOI 10.1002/hipo.20783; Wozniak JR, 2020, J NEURODEV DISORD, V12, DOI 10.1186/s11689-020-09312-7; Wu BTF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043448; Yan J, 2013, AM J CLIN NUTR, V98, P1459, DOI 10.3945/ajcn.113.066092; Yan J, 2012, AM J CLIN NUTR, V95, P1060, DOI 10.3945/ajcn.111.022772; Yang YL, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0006.2000; ZEISEL SH, 1995, J NUTR, V125, P3049	92	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22054	10.1096/fj.202101217R	http://dx.doi.org/10.1096/fj.202101217R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34962672	Green Published			2022-12-28	WOS:000734992000011
J	Shukla, PK; Meena, AS; Pierre, JF; Rao, R				Shukla, Pradeep K.; Meena, Avtar S.; Pierre, Joseph F.; Rao, RadhaKrishna			Central role of intestinal epithelial glucocorticoid receptor in alcohol- and corticosterone-induced gut permeability and systemic response	FASEB JOURNAL			English	Article						endotoxemia; hepatitis; hypothalamus; inflammation; tight junction	PITUITARY-ADRENAL AXIS; STRESSFUL LIFE EVENTS; TIGHT JUNCTIONS; TNF-ALPHA; LIVER-DISEASE; KUPFFER CELLS; FATTY LIVER; ENDOTOXEMIA; PHOSPHORYLATION; CONSUMPTION	Corticosterone, the stress hormone, exacerbates alcohol-associated tissue injury, but the mechanism involved is unknown. We examined the role of the glucocorticoid receptor (GR) in corticosterone-mediated potentiation of alcohol-induced gut barrier dysfunction and systemic response. Hepatocyte-specific GR-deficient (GR(Delta HC)) and intestinal epithelial-specific GR-deficient (GR(Delta IEC)) mice were fed ethanol, combined with corticosterone treatment. Intestinal epithelial tight junction integrity, mucosal barrier function, microbiota dysbiosis, endotoxemia, systemic inflammation, liver damage, and neuroinflammation were assessed. Corticosterone potentiated ethanol-induced epithelial tight junction disruption, mucosal permeability, and inflammatory response in GR(Delta HC) mouse colon; these effects of ethanol and corticosterone were absent in GR(Delta IEC) mice. Gut microbiota compositions in ethanol-fed GR(Delta HC) and GR(Delta IEC) mice were similar to each other. However, corticosterone treatment in ethanol-fed mice shifted the microbiota composition to distinctly different directions in GR(Delta HC) and GR(Delta IEC) mice. Ethanol and corticosterone synergistically elevated the abundance of Enterobacteriaceae and Escherichia coli and reduced the abundance of Lactobacillus in GR(Delta HC) mice but not in GR(Delta IEC) mice. In GR(Delta HC) mice, corticosterone potentiated ethanol-induced endotoxemia and systemic inflammation, but these effects were absent in GR(Delta IEC) mice. Interestingly, ethanol-induced liver damage and its potentiation by corticosterone were observed in GR(Delta HC) mice but not in GR(Delta IEC) mice. GR(Delta IEC) mice were also resistant to ethanol- and corticosterone-induced inflammatory response in the hypothalamus. These data indicate that the intestinal epithelial GR plays a central role in alcohol- and corticosterone-induced gut barrier dysfunction, microbiota dysbiosis, endotoxemia, systemic inflammation, liver damage, and neuroinflammation. This study identifies a novel target for potential therapeutic for alcohol-associated tissue injury.	[Shukla, Pradeep K.; Meena, Avtar S.; Rao, RadhaKrishna] Univ Tennessee, Coll Med, Dept Physiol, Hlth Sci Ctr, Memphis, TN 38163 USA; [Pierre, Joseph F.] Univ Tennessee, Coll Med, Dept Pediat, Hlth Sci Ctr, Memphis, TN 38163 USA; [Rao, RadhaKrishna] Memphis Vet Affairs Med Ctr, Memphis, TN USA; [Meena, Avtar S.] Ctr Cellular & Mol Biol, Hyderabad, Telangana, India	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Rao, R (corresponding author), Univ Tennessee, Dept Physiol, Hlth Sci Ctr, 3 N Dunlap,Suite S303, Memphis, TN 38163 USA.	rrao2@uthsc.edu	Pierre, Joseph/HCH-3993-2022		U.S. Department of Veterans Affairs (VA) [I01 BX003014]; HHS I National Institutes of Health (NTH) [R01-AA12307, R01-DK55532]	U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs); HHS I National Institutes of Health (NTH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	U.S. Department of Veterans Affairs (VA), Grant/Award Number: I01 BX003014; HHS I National Institutes of Health (NTH), Grant/Award Number: R01-AA12307 and R01-DK55532	ALLAN CA, 1985, J STUD ALCOHOL, V46, P147, DOI 10.15288/jsa.1985.46.147; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Andreasen AS, 2008, CURR MED CHEM, V15, P1697, DOI 10.2174/092986708784872393; Bengtsson-Palme J, 2018, BIOINFORMATICS, V34, P4027, DOI 10.1093/bioinformatics/bty482; Blaine SK, 2016, CAN J PSYCHIAT, V61, P145, DOI 10.1177/0706743716632512; Campbell HK, 2017, EXP CELL RES, V358, P39, DOI 10.1016/j.yexcr.2017.03.061; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chi HM, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-020-02053-3; Ciocan D, 2018, ALIMENT PHARM THER, V48, P961, DOI 10.1111/apt.14949; Ciocan D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23146-3; Coopman P, 2016, CELL MOL LIFE SCI, V73, P3535, DOI 10.1007/s00018-016-2260-8; Covelli V, 2005, CURR MED CHEM, V12, P1801, DOI 10.2174/0929867054367202; de Punder K, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00223; Debell F, 2014, SOC PSYCH PSYCH EPID, V49, P1401, DOI 10.1007/s00127-014-0855-7; Elias BC, 2009, J BIOL CHEM, V284, P1559, DOI 10.1074/jbc.M804783200; Erickson EK, 2019, PHARMACOL BIOCHEM BE, V177, P34, DOI 10.1016/j.pbb.2018.12.007; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Flynn NE, 2009, AMINO ACIDS, V37, P123, DOI 10.1007/s00726-008-0206-7; Gameiro GH, 2006, PHYSIOL BEHAV, V87, P643, DOI 10.1016/j.physbeh.2005.12.007; Gao YH, 2019, GUT, V68, P1311, DOI 10.1136/gutjnl-2018-316221; Grander C, 2018, GUT, V67, P892, DOI 10.1136/gutjnl-2016-313432; Haddad JJ, 2004, BIOCHEM BIOPH RES CO, V323, P361, DOI 10.1016/j.bbrc.2004.08.119; HENRY JP, 1993, INTEGR PHYS BEH SCI, V28, P369, DOI 10.1007/BF02690935; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Im GY, 2019, CLIN LIVER DIS, V23, P81, DOI 10.1016/j.cld.2018.09.005; KATHOL RG, 1988, PSYCHIAT CLIN N AM, V11, P335; Kumar M, 2019, J CLIN EXP HEPATOL, V9, P215, DOI 10.1016/j.jceh.2018.09.002; Kumari S, 2016, STEROIDS, V114, P68, DOI 10.1016/j.steroids.2016.03.016; Litwinowicz K, 2020, AM J DRUG ALCOHOL AB, V46, P4, DOI 10.1080/00952990.2019.1669629; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lv WJ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7902874; Morris NL, 2015, ALCOHOL, V49, P1, DOI 10.1016/j.alcohol.2014.07.018; Mueller, 2020, ALCOHOLIC LIVER DIS; Mueller KM, 2012, MOL CELL ENDOCRINOL, V361, P1, DOI 10.1016/j.mce.2012.03.026; Mutlu E, 2009, ALCOHOL CLIN EXP RES, V33, P1836, DOI 10.1111/j.1530-0277.2009.01022.x; Nagy LE, 2016, GASTROENTEROLOGY, V150, P1756, DOI 10.1053/j.gastro.2016.02.035; Osna NA, 2017, ALCOHOL RES-CURR REV, V38, P147; Pervanidou P, 2018, HORM RES PAEDIAT, V89, P372, DOI 10.1159/000488468; Pierre JF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70461-9; Rao R, 2009, HEPATOLOGY, V50, P638, DOI 10.1002/hep.23009; Rao R, 2009, ANN NY ACAD SCI, V1165, P62, DOI 10.1111/j.1749-6632.2009.04054.x; Rose AK, 2010, ALCOHOL CLIN EXP RES, V34, P2011, DOI 10.1111/j.1530-0277.2010.01298.x; Russell G, 2019, NAT REV ENDOCRINOL, V15, P525, DOI 10.1038/s41574-019-0228-0; Samak G, 2016, SCI REP-UK, V6, DOI 10.1038/srep38899; Samak G, 2015, BIOCHEM J, V465, P503, DOI 10.1042/BJ20140450; Seabra V, 1998, J LEUKOCYTE BIOL, V64, P615, DOI 10.1002/jlb.64.5.615; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sheppard KE, 2002, AM J PHYSIOL-GASTR L, V282, pG742, DOI 10.1152/ajpgi.00531.2001; Shukla PK, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80637-y; Shukla PK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34263-4; Shukla PK, 2018, FASEB J, V32, P6274, DOI 10.1096/fj.201800351R; Sillaber I, 2004, ANN MED, V36, P596, DOI 10.1080/07853890410018862; Smart Laura, 2013, Curr Hepat Rep, V12, P59; Stephens MAC, 2012, ALCOHOL RES-CURR REV, V34, P468; Thomas P, 2006, J ENDOTOXIN RES, V12, P352, DOI 10.1179/096805106X118898; Tsukamoto H, 2009, SEMIN LIVER DIS, V29, P178, DOI 10.1055/s-0029-1214373; Van Itallie CM, 2014, SEMIN CELL DEV BIOL, V36, P157, DOI 10.1016/j.semcdb.2014.08.011; VANTHIEL DH, 1978, J CLIN INVEST, V61, P624, DOI 10.1172/JCI108973; VENKATESAN S, 1989, BIOCHEM SOC T, V17, P1114, DOI 10.1042/bst0171114; WAND GS, 1991, J CLIN ENDOCR METAB, V72, P1290, DOI 10.1210/jcem-72-6-1290; WEINHOLD L, 1991, BIOL CHEM H-S, V372, P829, DOI 10.1515/bchm3.1991.372.2.829; Westfall S, 2017, CELL MOL LIFE SCI, V74, P3769, DOI 10.1007/s00018-017-2550-9; Woods CP, 2015, J STEROID BIOCHEM, V154, P94, DOI 10.1016/j.jsbmb.2015.07.020; Yang XX, 2020, HISTOL HISTOPATHOL, V35, P1379, DOI 10.14670/HH-18-241; Young-Wolff KC, 2012, J STUD ALCOHOL DRUGS, V73, P559, DOI 10.15288/jsad.2012.73.559; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725	67	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22061	10.1096/fj.202101424R	http://dx.doi.org/10.1096/fj.202101424R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34861075	hybrid, Green Published			2022-12-28	WOS:000734992000058
J	Maitz, A; Haussner, F; Braumuller, S; Hoffmann, A; Lupu, L; Wachter, U; Radermacher, P; Braun, CK; Wilke, HJ; Vogt, M; Ignatius, A; Halbgebauer, R; Bettac, L; Barth, TFE; Huber-Lang, M; Palmer, A				Maitz, Alexander; Haussner, Felix; Braumueller, Sonja; Hoffmann, Andrea; Lupu, Ludmila; Wachter, Ulrich; Radermacher, Peter; Braun, Christian K.; Wilke, Hans-Joachim; Vogt, Morten; Ignatius, Anita; Halbgebauer, Rebecca; Bettac, Lucas; Barth, Thomas F. E.; Huber-Lang, Markus; Palmer, Annette			Temporal-spatial organ response after blast-induced experimental blunt abdominal trauma	FASEB JOURNAL			English	Article						abdominal trauma; damage; organs	SERUM AMYLASE; INJURY; MANAGEMENT; DIAGNOSIS; GENDER	Abdominal trauma (AT) is of major global importance, particularly with the increased potential for civil, terroristic, and military trauma. The injury pattern and systemic consequences of blunt abdominal injuries are highly variable and frequently underestimated or even missed, and the pathomechanisms remain still poorly understood. Therefore, we investigated the temporal-spatial organ and immune response after a standardized blast-induced blunt AT. Anesthetized mice were exposed to a single blast wave centered on the epigastrium. At 2, 6, or 24 h after trauma, abdominal organ damage was assessed macroscopically, microscopically, and biochemically. A higher degree of trauma severity, determined by a reduction of the distance between the epigastrium and blast inductor, was reflected by a reduced survival rate. The hemodynamic monitoring during the first 120 min after AT revealed a decline in the mean arterial pressure within the first 80 min, whereas the heart rate remained quite stable. AT induced a systemic damage and inflammatory response, evidenced by elevated HMGB-1 and IL-6 plasma levels. The macroscopic injury pattern of the abdominal organs (while complex) was consistent, with the following frequency: liver > pancreas > spleen > left kidney > intestine > right kidney > others > lungs and was reflected by microscopic liver and pancreas damages. Plasma levels of organ dysfunction markers increased during the first 6 h after AT and subsequently declined, indicating an early, temporal impairment of the function on a multi-organ level. The established highly reproducible murine blunt AT, with time- and trauma-severity-dependent organ injury patterns, systemic inflammatory response, and impairment of various organ functions, reflects characteristics of human AT. In the future, this model may help to study the complex immuno-pathophysiological consequences and innovative therapeutic approaches after blunt AT.	[Maitz, Alexander; Haussner, Felix; Braumueller, Sonja; Lupu, Ludmila; Halbgebauer, Rebecca; Huber-Lang, Markus; Palmer, Annette] Ulm Univ Med Ctr, Inst Clin & Expt Trauma Immunol, Helmholtzstr 8-1, D-89081 Ulm, Germany; [Hoffmann, Andrea; Wachter, Ulrich; Radermacher, Peter] Ulm Univ Med Ctr, Inst Anesthesiol Pathophysiol & Proc Engn, Ulm, Germany; [Braun, Christian K.] Ulm Univ Med Ctr, Dept Pediat & Adolescent Med, Ulm, Germany; [Wilke, Hans-Joachim; Vogt, Morten; Ignatius, Anita] Ulm Univ Med Ctr, Inst Orthoped Res & Biomech, Ulm, Germany; [Bettac, Lucas] Ulm Univ Med Ctr, Dept Internal Med, Ulm, Germany; [Barth, Thomas F. E.] Ulm Univ Med Ctr, Inst Pathol, Ulm, Germany	Ulm University; Ulm University; Ulm University; Ulm University; Ulm University; Ulm University	Palmer, A (corresponding author), Ulm Univ Med Ctr, Inst Clin & Expt Trauma Immunol, Helmholtzstr 8-1, D-89081 Ulm, Germany.	annette.palmer@uniklinik-ulm.de	Wilke, Hans-Joachim/M-6440-2014; Braun, Christian K/I-5132-2018; Ignatius, Anita/M-6012-2013	Wilke, Hans-Joachim/0000-0001-6007-8844; Braun, Christian K/0000-0002-9854-3251; Ignatius, Anita/0000-0002-4782-1979; Lupu, Ludmila/0000-0002-0153-9345	German Research Foundation (DFG) [CRC1149, INST 40/479-2, INST 40/498-2]	German Research Foundation (DFG)(German Research Foundation (DFG))	German Research Foundation (DFG; CRC1149) INST 40/479-2 and INST 40/498-2	Bala M, 2008, ANN SURG, V248, P303, DOI 10.1097/SLA.0b013e318180a3f7; Barkai O, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4353-6; Beltzer C, 2020, CHIRURG, V91, P567, DOI 10.1007/s00104-020-01158-y; Bouzat P, 2020, ANAESTH CRIT CARE PA, V39, P269, DOI 10.1016/j.accpm.2019.12.001; Brenner M, 2018, EMERG MED CLIN N AM, V36, P149, DOI 10.1016/j.emc.2017.08.012; BUECHTER KJ, 1990, AM SURGEON, V56, P204; Callahan Katherine, 2018, Acad Forensic Pathol, V8, P219, DOI 10.1177/1925362118782047; Cirocchi R, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007438.pub3; Cortellini S, 2018, VET REC, V182, P228, DOI 10.1136/vr.k866; Evankovich J, 2010, J BIOL CHEM, V285, P39888, DOI 10.1074/jbc.M110.128348; Ferrah N, 2019, WORLD J SURG, V43, P1216, DOI 10.1007/s00268-018-04899-4; Gable A, 2019, RADIOLOGE, V59, P139, DOI 10.1007/s00117-018-0485-2; Halbgebauer R, 2018, J CRIT CARE, V44, P229, DOI 10.1016/j.jcrc.2017.11.025; Harmston C, 2018, EUR J TRAUMA EMERG S, V44, P369, DOI 10.1007/s00068-018-0902-2; Huber-Lang M, 2018, NAT IMMUNOL, V19, P327, DOI 10.1038/s41590-018-0064-8; Irwin RJ, 1997, J TRAUMA, V43, P650, DOI 10.1097/00005373-199710000-00015; Jurkovich GJ, 2020, J TRAUMA ACUTE CARE, V88, P19, DOI 10.1097/TA.0000000000002546; Kamo N, 2013, HEPATOLOGY, V58, P351, DOI 10.1002/hep.26320; Karamercan MA, 2011, J TRAUMA, V71, P687, DOI 10.1097/TA.0b013e31820932bf; Kuza CM, 2020, SCAND J SURG, V109, P193, DOI 10.1177/1457496919851608; Mors K, 2016, IMMUNOBIOLOGY, V221, P904, DOI 10.1016/j.imbio.2016.03.005; Odedra D, 2020, CAN ASSOC RADIOL J, V71, P344, DOI 10.1177/0846537119888383; Osaka T, 2017, CAN J PHYSIOL PHARM, V95, P652, DOI 10.1139/cjpp-2016-0195; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Prachalias AA, 2014, CURR OPIN CRIT CARE, V20, P218, DOI 10.1097/MCC.0000000000000074; Qin H, 2020, MIL MED, V185, pE742, DOI 10.1093/milmed/usz372; Sambasivan CN, 2010, J TRAUMA, V69, pS168, DOI 10.1097/TA.0b013e3181e45cef; SIEKMANN L, 1985, J CLIN CHEM CLIN BIO, V23, P137; Singh RP., 2016, J CLIN DIAGN RES, V10, pC20; Smith IM, 2015, ANN SURG, V262, P389, DOI 10.1097/SLA.0000000000001002; Smith-Palmer T, 2002, J CHROMATOGR B, V781, P93, DOI 10.1016/S1570-0232(02)00617-7; Sun KX, 2019, CLINICS, V74, DOI 10.6061/clinics/2019/e729; Takishima T, 1997, ANN SURG, V226, P70, DOI 10.1097/00000658-199707000-00010; Tornqvist E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101638; VONGIERKE HE, 1968, ANN NY ACAD SCI, V152, P172; Voth M, 2019, WORLD J EMERG SURG, V14, DOI 10.1186/s13017-019-0267-9; Yagi M, 2020, SURGERY, V167, P638, DOI 10.1016/j.surg.2019.09.024; Yu YYR, 2018, J PEDIATR SURG, V53, P1028, DOI 10.1016/j.jpedsurg.2018.02.043; Zhao C, 2014, J TRAUMA ACUTE CARE, V76, P1222, DOI 10.1097/TA.0000000000000220; Zimmermann P, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000023057	40	3	3	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22038	10.1096/fj.202100995R	http://dx.doi.org/10.1096/fj.202100995R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34748229				2022-12-28	WOS:000722321300002
J	Zegallai, HM; Abu-El-Rub, E; Cole, LK; Field, J; Mejia, EM; Gordon, JW; Marshall, AJ; Hatch, GM				Zegallai, Hana M.; Abu-El-Rub, Ejlal; Cole, Laura K.; Field, Jared; Mejia, Edgard M.; Gordon, Joseph W.; Marshall, Aaron J.; Hatch, Grant M.			Tafazzin deficiency impairs mitochondrial metabolism and function of lipopolysaccharide activated B lymphocytes in mice	FASEB JOURNAL			English	Article						B lymphocyte activation; cardiolipin; cell proliferation and survival; cytokines; immunoglobulin synthesis and secretion; immunoproteasome; lipopolysaccharide; mitochondria; proteasome; tafazzin	CELL ACTIVATION; LYMPHOBLAST MITOCHONDRIA; MEMBRANE-PROTEIN; PROTEASOME; CARDIOLIPIN; INHIBITION; COMPLEX; 26S; DYSFUNCTION; EXPRESSION	B lymphocytes are responsible for humoral immunity and play a key role in the immune response. Optimal mitochondrial function is required to support B cell activity during activation. We examined how deficiency of tafazzin, a cardiolipin remodeling enzyme required for mitochondrial function, alters the metabolic activity of B cells and their response to activation by lipopolysaccharide in mice. B cells were isolated from 3-month-old wild type or tafazzin knockdown mice and incubated for up to 72 h with lipopolysaccharide and cell proliferation, expression of cell surface markers, secretion of antibodies and chemokines, proteasome and immunoproteasome activities, and metabolic function determined. In addition, proteomic analysis was performed to identify altered levels of proteins involved in survival, immunogenic, proteasomal and mitochondrial processes. Compared to wild type lipopolysaccharide activated B cells, lipopolysaccharide activated tafazzin knockdown B cells exhibited significantly reduced proliferation, lowered expression of cluster of differentiation 86 and cluster of differentiation 69 surface markers, reduced secretion of immunoglobulin M antibody, reduced secretion of keratinocytes-derived chemokine and macrophage-inflammatory protein-2, reduced proteasome and immunoproteasome activities, and reduced mitochondrial respiration and glycolysis. Proteomic analysis revealed significant alterations in key protein targets that regulate cell survival, immunogenicity, proteasomal processing and mitochondrial function consistent with the findings of the above functional studies. The results indicate that the cardiolipin transacylase enzyme tafazzin plays a key role in regulating mouse B cell function and metabolic activity during activation through modulation of mitochondrial function.	[Zegallai, Hana M.; Cole, Laura K.; Field, Jared; Gordon, Joseph W.; Hatch, Grant M.] Childrens Hosp Res Inst Manitoba, Diabet Res Envisioned & Accomplished Manitoba DRE, Winnipeg, MB, Canada; [Zegallai, Hana M.; Cole, Laura K.; Hatch, Grant M.] Univ Manitoba, Dept Pharmacol & Therapeut, Rady Fac Hlth Sci, Winnipeg, MB, Canada; [Abu-El-Rub, Ejlal] Yarmouk Univ, Dept Physiol & Pathophysiol, Irbid, Jordan; [Abu-El-Rub, Ejlal] Yarmouk Univ, Dept Basic Med Sci, Fac Med, Irbid, Jordan; [Abu-El-Rub, Ejlal] Univ Manitoba, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada; [Abu-El-Rub, Ejlal] Univ Manitoba, Rady Fac Hlth Sci, Dept Regenerat Med, Winnipeg, MB, Canada; [Field, Jared; Gordon, Joseph W.] Univ Manitoba, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Mejia, Edgard M.; Marshall, Aaron J.] Univ Manitoba, Rady Fac Hlth Sci, Dept Immunol, Winnipeg, MB, Canada; [Gordon, Joseph W.] Univ Manitoba, Coll Nursing, Winnipeg, MB, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Yarmouk University; Yarmouk University; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Hatch, GM (corresponding author), Rady Fac Hlth Sci, Dept Pharmacol & Therapeut, 501C JBRC,715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada.	ghatch@chrim.ca			Heart and Stroke Foundation of Canada (HSF); Gouvernement du Canada, Natural Sciences and Engineering Research Council of Canada (NSERC); Children's Hospital Foundation of Manitoba, Children's Hospital Research Institute of Manitoba (CHRIM)	Heart and Stroke Foundation of Canada (HSF)(Heart & Stroke Foundation of Canada); Gouvernement du Canada, Natural Sciences and Engineering Research Council of Canada (NSERC); Children's Hospital Foundation of Manitoba, Children's Hospital Research Institute of Manitoba (CHRIM)	Heart and Stroke Foundation of Canada (HSF); Gouvernement du Canada, Natural Sciences and Engineering Research Council of Canada (NSERC); Children's Hospital Foundation of Manitoba, Children's Hospital Research Institute of Manitoba (CHRIM)	Abu-El-Rub E, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2634-6; Abu-El-Rub E, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1359-x; Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480; Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; Axelrad MD, 2013, JOVE-J VIS EXP, DOI 10.3791/50246; Azzam KM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91914; Barth Syndrome Foundation, 2018, MED US BARTH SYNDR; Berges C, 2008, IMMUNOLOGY, V124, P234, DOI 10.1111/j.1365-2567.2007.02761.x; Boothby M, 2017, IMMUNITY, V46, P743, DOI 10.1016/j.immuni.2017.04.009; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bragoszewski P, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170007; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Chen TT, 2016, J EXP MED, V213, P3025, DOI 10.1084/jem.20151620; Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; D'Amico D, 2017, TRENDS BIOCHEM SCI, V42, P712, DOI 10.1016/j.tibs.2017.05.002; Dai YM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-77; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Eissmann M, 2013, ONCOGENE, V32, P2586, DOI 10.1038/onc.2012.263; Elssner A, 2004, J IMMUNOL, V172, P7721, DOI 10.4049/jimmunol.172.12.7721; Finsterer J, 2013, CURR OPIN HEMATOL, V20, P36, DOI 10.1097/MOH.0b013e32835a01d9; Ghanem A, 2019, MOL BIOL REP, V46, P1369, DOI 10.1007/s11033-019-04587-z; Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005; Hauff KD, 2006, PROG LIPID RES, V45, P91, DOI 10.1016/j.plipres.2005.12.001; Hoffman W, 2016, CLIN J AM SOC NEPHRO, V11, P137, DOI 10.2215/CJN.09430915; Hu Lina, 2004, BMC Immunology, V5; Huang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128561; Ibanez-Vega J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00225; Ikon N, 2017, LIPIDS, V52, P99, DOI 10.1007/s11745-016-4229-7; Iosefson O, 2007, PROTEIN SCI, V16, P316, DOI 10.1110/ps.062459607; Jongstra-Bilen J, 2006, IMMUNOL RES, V35, P65, DOI 10.1385/IR:35:1:65; Krystof V, 2012, CURR PHARM DESIGN, V18, P2883, DOI 10.2174/138161212800672750; Kuhlbrandt W, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0201-x; Kuijpers TW, 2004, BLOOD, V103, P3915, DOI 10.1182/blood-2003-11-3940; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Limon JJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00228; Liu WG, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082894; Lu MF, 2016, INNATE IMMUN-LONDON, V22, P307, DOI 10.1177/1753425916644675; Ma HZ, 2019, EBIOMEDICINE, V39, P182, DOI 10.1016/j.ebiom.2018.12.022; Marshall-Clarke S, 2003, IMMUNOLOGY, V109, P102, DOI 10.1046/j.1365-2567.2003.01638.x; Martinez-Fonts K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13906-8; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Mejia EM, 2018, J BIOL CHEM, V293, P7564, DOI 10.1074/jbc.RA117.001024; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Ning ZC, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.654960; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pacheu-Grau D, 2020, J MOL BIOL, V432, P2067, DOI 10.1016/j.jmb.2020.01.036; Peng B, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0152-y; Rathmell JC, 2012, IMMUNOL REV, V249, P5, DOI 10.1111/j.1600-065X.2012.01158.x; Ren MD, 2019, AM J PHYSIOL-HEART C, V317, pH1183, DOI 10.1152/ajpheart.00504.2019; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Rouette A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34019; Schmidt C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02386; Sie L, 2009, J NEUROSCI RES, V87, P1953, DOI 10.1002/jnr.22000; Sokol AM, 2014, FEBS LETT, V588, P2484, DOI 10.1016/j.febslet.2014.05.028; Steward CG, 2019, CURR OPIN HEMATOL, V26, P6, DOI 10.1097/MOH.0000000000000472; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Tar K, 2014, J BIOL CHEM, V289, P12145, DOI 10.1074/jbc.M114.554105; Tedder TF, 2005, ADV IMMUNOL, V88, P1, DOI 10.1016/S0065-2776(05)88001-0; Urbanczyk S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082192; Waters LR, 2018, ISCIENCE, V5, P99, DOI 10.1016/j.isci.2018.07.005; Weiss RS, 2003, MOL CELL BIOL, V23, P791, DOI 10.1128/MCB.23.3.791-803.2003; Xu Y, 2005, LAB INVEST, V85, P823, DOI 10.1038/labinvest.3700274; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Zegallai HM, 2021, MOL CELL BIOCHEM, V476, P1605, DOI 10.1007/s11010-020-04021-0	66	3	3	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22023	10.1096/fj.202100811RR	http://dx.doi.org/10.1096/fj.202100811RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34767647				2022-12-28	WOS:000722321300020
J	Clarke, LE; Cook, A; Mathavarajah, S; Bera, A; Salsman, J; Habib, E; Van Iderstine, C; Bydoun, M; Lewis, SM; Dellaire, G				Clarke, Livia E.; Cook, Allyson; Mathavarajah, Sabateeshan; Bera, Amit; Salsman, Jayme; Habib, Elias; Van Iderstine, Carter; Bydoun, Moamen; Lewis, Stephen M.; Dellaire, Graham			Haploinsufficient tumor suppressor PRP4K is negatively regulated during epithelial-to-mesenchymal transition	FASEB JOURNAL			English	Article						eIF3e; epithelial-to-mesenchymal transition (EMT); haploinsufficient tumor suppression; PRP4K; PRPF4B; TGF-beta; WNT5a; YAP	KINASE; GENES; EMT; METASTASIS; EXPRESSION; SNRNP; TAZ	The pre-mRNA processing factor 4 kinase (PRP4K, also known as PRPF4B) is an essential gene. However, reduced PRP4K expression is associated with aggressive breast and ovarian cancer phenotypes including taxane therapy resistance, increased cell migration and invasion in vitro, and cancer metastasis in mice. These results are consistent with PRP4K being a haploinsufficient tumor suppressor. Increased cell migration and invasion is associated with epithelial-to-mesenchymal transition (EMT), but how reduced PRP4K levels affect normal epithelial cell migration or EMT has not been studied. Depletion of PRP4K by small hairpin RNA (shRNA) in non-transformed mammary epithelial cell lines (MCF10A, HMLE) reduced or had no effect on 2D migration in the scratch assay but resulted in greater invasive potential in 3D transwell assays. Depletion of PRP4K in mesenchymal triple-negative breast cancer cells (MDA-MB-231) resulted in both enhanced 2D migration and 3D invasion, with 3D invasion correlated with higher fibronectin levels in both MDA-MB-231 and MCF10A cells and without changes in E-cadherin. Induction of EMT in MCF10A cells, by treatment with WNT-5a and TGF-beta 1, or depletion of eukaryotic translation initiation factor 3e (eIF3e) by shRNA, resulted in significantly reduced PRP4K expression. Mechanistically, induction of EMT by WNT-5a/TGF-beta 1 reduced PRP4K transcript levels, whereas eIF3e depletion led to reduced PRP4K translation. Finally, reduced PRP4K levels after eIF3e depletion correlated with increased YAP activity and nuclear localization, both of which are reversed by overexpression of exogenous PRP4K. Thus, PRP4K is a haploinsufficient tumor suppressor negatively regulated by EMT, that when depleted in normal mammary cells can increase cell invasion without inducing full EMT.	[Clarke, Livia E.; Cook, Allyson; Mathavarajah, Sabateeshan; Salsman, Jayme; Habib, Elias; Van Iderstine, Carter; Bydoun, Moamen; Dellaire, Graham] Dalhousie Univ, Dept Pathol, POB 15000, Halifax, NS B3H 4R2, Canada; [Bera, Amit; Lewis, Stephen M.] Atlantic Canc Res Inst, Moncton, NB, Canada; [Lewis, Stephen M.] Univ Moncton, Dept Chem & Biochem, Moncton, NB, Canada; [Dellaire, Graham] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Lewis, Stephen M.; Dellaire, Graham] Beatrice Hunter Canc Res Inst, Halifax, NS, Canada	Dalhousie University; University of Moncton; Dalhousie University	Dellaire, G (corresponding author), Dalhousie Univ, Dept Pathol, POB 15000, Halifax, NS B3H 4R2, Canada.	dellaire@dal.ca		Dellaire, Graham/0000-0002-3466-6316	Breast Cancer Society of Canada (BCSC); Cancer Research Society (CRS) [24135]; Beatrice Hunter Cancer Research Institute (BHCRI); Canadian Cancer Society; Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Killam Trusts; Nova Scotia Health Research Foundation	Breast Cancer Society of Canada (BCSC); Cancer Research Society (CRS); Beatrice Hunter Cancer Research Institute (BHCRI); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Killam Trusts; Nova Scotia Health Research Foundation	Breast Cancer Society of Canada (BCSC); Cancer Research Society (CRS), Grant/Award Number: #24135; Beatrice Hunter Cancer Research Institute (BHCRI); The Canadian Cancer Society; Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Killam Trusts; Nova Scotia Health Research Foundation	Aiello NM, 2018, DEV CELL, V45, P681, DOI 10.1016/j.devcel.2018.05.027; ALAHARI SK, 1993, NUCLEIC ACIDS RES, V21, P4079, DOI 10.1093/nar/21.17.4079; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Ando K, 2019, MOL CARCINOGEN, V58, P1134, DOI 10.1002/mc.22997; Antony J, 2019, PHYS BIOL, V16, DOI 10.1088/1478-3975/ab157a; Arthur RK, 2017, NUCLEIC ACIDS RES, V45, P6350, DOI 10.1093/nar/gkx218; Bera A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21114075; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cho YS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04090-2; Corkery DP, 2018, ONCOGENE, V37, P174, DOI 10.1038/onc.2017.318; Corkery DP, 2015, NUCLEUS-PHILA, V6, P279, DOI 10.1080/19491034.2015.1062194; Corkery DP, 2015, CELL CYCLE, V14, P1059, DOI 10.1080/15384101.2015.1007775; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; Dellaire G, 2002, MOL CELL BIOL, V22, P5141, DOI 10.1128/MCB.22.14.5141-5156.2002; Diepenbruck M, 2016, CURR OPIN CELL BIOL, V43, P7, DOI 10.1016/j.ceb.2016.06.002; Diepenbruck M, 2014, J CELL SCI, V127, P1523, DOI 10.1242/jcs.139865; Fancello L, 2017, ONCOTARGET, V8, P14462, DOI 10.18632/oncotarget.14895; Gillis LD, 2013, ONCOGENE, V32, P3598, DOI 10.1038/onc.2012.371; Guo XE, 2014, CURR DRUG TARGETS, V15, P2, DOI 10.2174/1389450114666140106095151; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hossain F, 2021, CANCERS, V13, DOI 10.3390/cancers13153739; Huang BL, 2007, J IMMUNOL, V178, P7081, DOI 10.4049/jimmunol.178.11.7081; Huang Y, 2000, BIOCHEM BIOPH RES CO, V271, P456, DOI 10.1006/bbrc.2000.2651; Inoue Kazushi, 2017, Adv Med Biol, V118, P83; Kim DH, 2018, J CLIN MED, V7, DOI 10.3390/jcm7010001; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koedoot E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11020-3; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Moffitt L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061466; Montembault E, 2007, J CELL BIOL, V179, P601, DOI 10.1083/jcb.200703133; Noguchi S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113674; Padmanaban V, 2019, NATURE, V573, P439, DOI 10.1038/s41586-019-1526-3; Park J, 2014, ONCOGENE, V33, P1649, DOI 10.1038/onc.2013.118; Pradella D, 2017, MOL CANCER, V16, DOI 10.1186/s12943-016-0579-2; ROSENBERG GH, 1991, MOL GEN GENET, V226, P305, DOI 10.1007/BF00273617; Santarosa M, 2004, BBA-REV CANCER, V1654, P105, DOI 10.1016/j.bbcan.2004.01.001; Schaeffer D, 2014, MOL CELL BIOL, V34, P3486, DOI 10.1128/MCB.00694-14; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schneider M, 2010, NAT STRUCT MOL BIOL, V17, P216, DOI 10.1038/nsmb.1718; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Skovierova H, 2018, INT J MOL MED, V41, P1187, DOI 10.3892/ijmm.2017.3320; Thompson BJ, 2020, BIOESSAYS, V42, DOI 10.1002/bies.201900162; Zhang JY, 2017, CANCER DISCOV, V7, P322, DOI 10.1158/2159-8290.CD-16-1417; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	48	2	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e22001	10.1096/fj.202001063R	http://dx.doi.org/10.1096/fj.202001063R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34674320	Green Submitted, Green Published			2022-12-28	WOS:000712009200041
J	Chung, HY; Lin, BA; Lin, YX; Chang, CW; Tzou, WS; Pei, TW; Hu, CH				Chung, Hsin-Yu; Lin, Bo-An; Lin, Yi-Xuan; Chang, Chen-Wei; Tzou, Wen-Shyong; Pei, Tun-Wen; Hu, Chin-Hwa			Meis1, Hi1 alpha, and GATA1 are integrated into a hierarchical regulatory network to mediate primitive erythropoiesis	FASEB JOURNAL			English	Article						Gata1; hypoxia inducible factor 1 alpha; Meis1; primitive erythropoiesis; regulatory network; zebrafish	DEFINITIVE HEMATOPOIESIS; CELL-DEVELOPMENT; STEM-CELLS; GENE; EXPRESSION; HYPOXIA; PROTEIN; HOXA9; DIFFERENTIATION; HIF-1-ALPHA	During development, erythroid cells are generated by two waves of hematopoiesis. In zebrafish, primitive erythropoiesis takes place in the intermediate cell mass region, and definitive erythropoiesis arises from the aorta-gonad mesonephros. TALE-homeoproteins Meis1 and Pbx1 function upstream of GATA1 to specify the erythroid lineage. Embryos lacking Meis1 or Pbx1 have weak gata1 expression and fail to produce primitive erythrocytes. Nevertheless, the underlying mechanism of how Meis1 and Pbx1 mediate gata1 transcription in erythrocytes remains unclear. Here we show that Hif1 alpha acts downstream of Meis1 to mediate gata1 expression in zebrafish embryos. Inhibition of Meis1 expression resulted in suppression of hif1a expression and abrogated primitive erythropoiesis, while injection with in vitro-synthesized hif1 alpha mRNA rescued gata1 transcription in Meis1 morphants and recovered their erythropoiesis. Ablation of Hif1 alpha expression either by morpholino knockdown or Crispr-Cas9 knockout suppressed gata1 transcription and abrogated primitive erythropoiesis. Results of chromatin immunoprecipitation assays showed that Hif1 alpha associates with hypoxia-response elements located in the 3 '-flanking region of gata1 during development, suggesting that Hif1 alpha regulates gata1 expression in vivo. Together, our results indicate that Meis1, Hif1 alpha, and GATA1 indeed comprise a hierarchical regulatory network in which Hif1 alpha acts downstream of Meis1 to activate gata1 transcription through direct interactions with its cis-acting elements in primitive erythrocytes.	[Chung, Hsin-Yu; Lin, Bo-An; Lin, Yi-Xuan; Chang, Chen-Wei; Tzou, Wen-Shyong; Hu, Chin-Hwa] Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan; [Tzou, Wen-Shyong; Hu, Chin-Hwa] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan; [Pei, Tun-Wen] Natl Taipei Univ Technol, Dept Comp Sci & Informat Engn, Taipei, Taiwan	National Taiwan Ocean University; National Taiwan Ocean University; National Taipei University of Technology	Chung, HY; Hu, CH (corresponding author), Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan.	alberta.pon123@ntou.edu.tw; chhu@mail.ntou.edu.tw	Hu, Chin-Hwa/D-1178-2009	Hu, Chin-Hwa/0000-0001-9582-2303	Ministry of Science and Technology (Taiwan) [99-2627-B-019-001, 100-2627-B-019-001, 101-2627-B-019-001, 102-2627-B-019-001, 103-2627-B-019-001, 104-2627-B-019-001, 99-2313-B-019-008-MY3, 102-2313-B-019-010-MY3]; The Ministry of Science and Technology (Taiwan) [105-2311-B-019-001, 105-2313-B-019-002, 106-2313-B-019-001, 107-2313-B-019-001, 105-2811-B-019-002, 106-2811-B-019-005]	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan); The Ministry of Science and Technology (Taiwan)	Ministry of Science and Technology (Taiwan), Grant/Award Number: 99-2627-B-019-001, 100-2627-B-019-001, 101-2627-B-019-001, 102-2627-B-019-001, 103-2627-B-019-001, 104-2627-B-019-001, 99-2313-B-019-008-MY3, 102-2313-B-019-010-MY3, 105-2311-B-019-001, 105-2313-B-019-002, 106-2313-B-019-001, 107-2313-B-019-001, 105-2811-B-019-002, 106-2811-B-019-005 and 107-2313-B-019-001	Abdul-Aziz AM, 2018, ONCOGENE, V37, P2676, DOI 10.1038/s41388-018-0151-1; Adamaki M, 2015, LEUKEMIA RES, V39, P874, DOI 10.1016/j.leukres.2015.04.012; Ariki R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087646; Ayala RM, 2009, AM J HEMATOL, V84, P79, DOI 10.1002/ajh.21332; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Belele CL, 2009, BLOOD, V114, P5162, DOI 10.1182/blood-2009-05-224709; Benito Juliana, 2013, Int J Hematol Oncol, V2, P279; Bertrand JY, 2007, DEVELOPMENT, V134, P4147, DOI 10.1242/dev.012385; Cai XL, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.185116; Caldwell JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068601; Cvejic A, 2011, HAEMATOL-HEMATOL J, V96, P190, DOI 10.3324/haematol.2010.027698; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Galloway JL, 2005, DEV CELL, V8, P109, DOI 10.1016/j.devcel.2004.12.001; Gerri C, 2018, BLOOD, V131, P963, DOI 10.1182/blood-2017-07-797795; Gutierrez L, 2008, BLOOD, V111, P4375, DOI 10.1182/blood-2007-09-115121; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Imanirad P, 2014, STEM CELL RES, V12, P24, DOI 10.1016/j.scr.2013.09.006; Jin H, 2007, BLOOD, V109, P5208, DOI 10.1182/blood-2007-01-069005; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Ko CY, 2011, CELL DEATH DIFFER, V18, P1757, DOI 10.1038/cdd.2011.44; Kobayashi M, 2001, DEVELOPMENT, V128, P2341; Kobayashi M, 2007, J BIOCHEM, V142, P1, DOI 10.1093/jb/mvm122; Kocabas F, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0020-3; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Lappin TR, 2019, BLOOD REV, V37, DOI 10.1016/j.blre.2019.100590; Lawrence HJ, 1999, LEUKEMIA, V13, P1993, DOI 10.1038/sj.leu.2401578; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lyons SE, 2002, P NATL ACAD SCI USA, V99, P5454, DOI 10.1073/pnas.082695299; Miller ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151584; Munoz-Sanchez J, 2019, J APPL TOXICOL, V39, P556, DOI 10.1002/jat.3749; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Paffett-Lugassy N, 2007, BLOOD, V110, P2718, DOI 10.1182/blood-2006-04-016535; Patmasiriwat P, 1999, LEUKEMIA, V13, P891, DOI 10.1038/sj.leu.2401414; Pillay LM, 2010, DEV BIOL, V340, P306, DOI 10.1016/j.ydbio.2010.01.033; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; SHIMAMOTO T, 1995, BLOOD, V86, P3173; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Somers K, 2019, ONCOGENE, V38, P3824, DOI 10.1038/s41388-018-0666-5; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Tojo Y, 2015, MOL CELL BIOL, V35, P2658, DOI 10.1128/MCB.00161-15; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Velasco-Hernandez T, 2014, BLOOD, V124, P3597, DOI 10.1182/blood-2014-04-567065; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200; Yusuf RZ, 2012, NAT MED, V18, P865, DOI 10.1038/nm.2831; Zeddies S, 2014, HAEMATOLOGICA, V99, P1555, DOI 10.3324/haematol.2014.106567; Zeddies S, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.2330.2330; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004; Zhang FL, 2012, J CELL MOL MED, V16, P1889, DOI 10.1111/j.1582-4934.2011.01484.x	59	2	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21915	10.1096/fj.202001044RRR	http://dx.doi.org/10.1096/fj.202001044RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34496088				2022-12-28	WOS:000702238200028
J	Ko, VH; Yu, LJ; Secor, JD; Pan, A; Mitchell, PD; Kishikawa, H; Puder, M				Ko, Victoria H.; Yu, Lumeng J.; Secor, Jordan D.; Pan, Amy; Mitchell, Paul D.; Kishikawa, Hiroko; Puder, Mark			Deficiency in pigment epithelium-derived factor accelerates pulmonary growth and development in a compensatory lung growth model	FASEB JOURNAL			English	Article						compensatory lung growth; pigment epithelium-derived factor; pneumonectomy; pulmonary hypoplasia; Roxadustat; vascular endothelial growth factor	CONGENITAL DIAPHRAGMATIC-HERNIA; NF-KAPPA-B; QUANTITATIVE MICROSCOPY; PEDF; PNEUMONECTOMY; ANGIOGENESIS; EXPRESSION; VEGF; PROSTATE; RECOVERY	Children with hypoplastic lung disease associated with congenital diaphragmatic hernia (CDH) continue to suffer significant morbidity and mortality secondary to progressive pulmonary disease. Recently published work from our lab demonstrated the potential of Roxadustat (FG-4592), a prolyl hydroxylase inhibitor, as a treatment for CDH-associated pulmonary hypoplasia. Treatment with Roxadustat led to significantly accelerated compensatory lung growth (CLG) through downregulation of pigment epithelium-derived factor (PEDF), an anti-angiogenic factor, rather than upregulation of vascular endothelial growth factor (VEGF). PEDF and its role in pulmonary development is a largely unexplored field. In this study, we sought to further evaluate the role of PEDF in accelerating CLG. PEDF-deficient mice demonstrated significantly increased lung volume, total lung capacity, and alveolarization compared to wild type controls following left pneumonectomy without increased VEGF expression. Furthermore, Roxadustat administration in PEDF-deficient mice did not further accelerate CLG. Human microvascular endothelial lung cells (HMVEC-L) and human pulmonary alveolar epithelial cells (HPAEC) similarly demonstrated decreased PEDF expression with Roxadustat administration. Additionally, downregulation of PEDF in Roxadustat-treated HMVEC-L and HPAEC, a previously unreported finding, speaks to the potential translatability of Roxadustat from small animal studies. Taken together, these findings further suggest that PEDF downregulation is the primary mechanism by which Roxadustat accelerates CLG. More importantly, these data highlight the critical role PEDF may have in pulmonary growth and development, a previously unexplored field.	[Ko, Victoria H.; Yu, Lumeng J.; Secor, Jordan D.; Pan, Amy; Kishikawa, Hiroko; Puder, Mark] Harvard Med Sch, Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Ko, Victoria H.; Yu, Lumeng J.; Secor, Jordan D.; Pan, Amy; Kishikawa, Hiroko; Puder, Mark] Harvard Med Sch, Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Mitchell, Paul D.] Boston Childrens Hosp, Inst Ctr Clin & Translat Res, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital	Puder, M (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA.	mark.puder@childrens.harvard.edu			Boston Children's Hospital Surgical Foundation Vascular Biology Program at Boston Children's Hospital Corkin and Maher Family Fund	Boston Children's Hospital Surgical Foundation Vascular Biology Program at Boston Children's Hospital Corkin and Maher Family Fund	Boston Children's Hospital Surgical Foundation Vascular Biology Program at Boston Children's Hospital Corkin and Maher Family Fund	Abman SH, 2010, ADV EXP MED BIOL, V661, P323, DOI 10.1007/978-1-60761-500-2_21; Ameis D, 2017, SEMIN PEDIATR SURG, V26, P123, DOI 10.1053/j.sempedsurg.2017.04.011; Aurora AB, 2010, BLOOD, V116, P475, DOI 10.1182/blood-2009-07-232132; Barriere F, 2018, J PEDIATR-US, V193, P204, DOI 10.1016/j.jpeds.2017.09.074; BERGER LC, 1985, AM REV RESPIR DIS, V132, P777; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; BURRI PH, 1982, EXP LUNG RES, V4, P11, DOI 10.3109/01902148209039246; Cai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021164; Chandrasekharan Praveen Kumar, 2017, Matern Health Neonatol Perinatol, V3, P6, DOI 10.1186/s40748-017-0045-1; Chang R, 2004, J PEDIATR SURG, V39, P825, DOI 10.1016/j.jpedsurg.2004.02.015; Chen N, 2019, NEW ENGL J MED, V381, P1001, DOI 10.1056/NEJMoa1813599; Chen N, 2019, NEW ENGL J MED, V381, P1011, DOI 10.1056/NEJMoa1901713; Coljee VW, 2000, J CELL BIOCHEM, V79, P442, DOI 10.1002/1097-4644(20001201)79:3<442::AID-JCB90>3.0.CO;2-Z; Dao DT, 2018, PEDIATR RES, V83, P1182, DOI 10.1038/pr.2018.41; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Fan W, 2011, DIFFERENTIATION, V81, P181, DOI 10.1016/j.diff.2010.12.003; Fehrenbach H, 2008, EUR RESPIR J, V31, P515, DOI 10.1183/09031936.00109407; Gao GQ, 2001, FEBS LETT, V489, P270, DOI 10.1016/S0014-5793(01)02110-X; Gattu AK, 2013, FASEB J, V27, P4384, DOI 10.1096/fj.13-232900; Hirsch J, 2011, CYTOKINE, V55, P202, DOI 10.1016/j.cyto.2011.04.010; HSIA CCW, 1993, J CLIN INVEST, V92, P758, DOI 10.1172/JCI116647; Hsia CCW, 2004, J APPL PHYSIOL, V97, P1992, DOI 10.1152/japplphysiol.00530.2004; Huang Q, 2008, EXP EYE RES, V87, P226, DOI 10.1016/j.exer.2008.06.003; Huh J, 1998, J THORAC CARDIOV SUR, V115, P328, DOI 10.1016/S0022-5223(98)70276-4; Jakkula M, 2000, AM J PHYSIOL-LUNG C, V279, pL600, DOI 10.1152/ajplung.2000.279.3.L600; Ko VH, 2020, ANGIOGENESIS, V23, P637, DOI 10.1007/s10456-020-09735-9; LARSSON A, 1987, BRIT J ANAESTH, V59, P585, DOI 10.1093/bja/59.5.585; Lassus P, 2001, AM J RESP CRIT CARE, V164, P1981, DOI 10.1164/ajrccm.164.10.2012036; Liu H, 2004, P NATL ACAD SCI USA, V101, P6605, DOI 10.1073/pnas.0308342101; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGivern MR, 2015, ARCH DIS CHILD-FETAL, V100, pF137, DOI 10.1136/archdischild-2014-306174; Mous DS, 2018, EUR RESPIR REV, V27, DOI 10.1183/16000617.0104-2017; Muhlfeld C, 2013, AM J PHYSIOL-LUNG C, V305, P1205, DOI 10.1152/ajplung.00427.2012; Ochs M, 2013, AM J PHYSIOL-LUNG C, V305, pL15, DOI 10.1152/ajplung.00429.2012; Sakurai MK, 2007, AM J PHYSIOL-LUNG C, V292, pL742, DOI 10.1152/ajplung.00064.2006; Sakurai MK, 2005, J INVEST SURG, V18, P201, DOI 10.1080/08941930591004485; SCHERLE W, 1970, Mikroskopie, V26, P57; Shimoda LA, 2011, AM J RESP CRIT CARE, V183, P152, DOI 10.1164/rccm.201009-1393PP; Thebaud B, 2007, NEONATOLOGY, V91, P291, DOI 10.1159/000101344; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Tong HP, 2006, CLIN BIOCHEM, V39, P267, DOI 10.1016/j.clinbiochem.2005.11.013; WILCOX BR, 1979, SURGERY, V86, P294; Woik N, 2015, CELL MOL LIFE SCI, V72, P2709, DOI 10.1007/s00018-015-1907-1; Wu K, 2016, BRAIN RES, V1632, P19, DOI 10.1016/j.brainres.2015.12.017; Wynn J, 2014, SEMIN FETAL NEONAT M, V19, P324, DOI 10.1016/j.siny.2014.09.003; Yeh TL, 2017, CHEM SCI, V8, P7651, DOI 10.1039/c7sc02103h; Zhang YC, 2016, OPHTHALMIC RES, V55, P1, DOI 10.1159/000440847; Zhu Y, 2019, WOUND REPAIR REGEN, V27, P324, DOI 10.1111/wrr.12708	50	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21850	10.1096/fj.202002661RR	http://dx.doi.org/10.1096/fj.202002661RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34569654				2022-12-28	WOS:000702238200068
J	Wang, Y; Chen, XY; Fan, WL; Zhang, XJ; Zhan, SY; Zhong, T; Guo, JZ; Cao, JX; Li, L; Zhang, HP; Wang, LJ				Wang, Yan; Chen, Xingyue; Fan, Wenli; Zhang, Xujia; Zhan, Siyuan; Zhong, Tao; Guo, Jiazhong; Cao, Jiaxue; Li, Li; Zhang, Hongping; Wang, Linjie			Integrated application of metabolomics and RNA-seq reveals thermogenic regulation in goat brown adipose tissues	FASEB JOURNAL			English	Article						brown adipose tissue; goat; L-carnitine; metabolomics; RNA-seq; unsaturated fatty acid	AMBIENT-TEMPERATURE; THERMOREGULATION; AMPK; IDENTIFICATION; TRANSCRIPTOME; ADIPOCYTES; EXPRESSION; CARNITINE; OXIDATION; INSIGHTS	Brown adipose tissue (BAT) plays an important role on no shivering thermogenesis during cold exposure to maintain animal body temperature and energy homeostasis. However, knowledge of the cellular transition from white adipose tissue (WAT) to BAT is still limited. In this study, we provided a comprehensive metabolomics and transcriptional signatures of goat BAT and WAT. A total of 157 metabolites were significantly changed, including 81 upregulated and 76 downregulated metabolites. In addition, we identified the citric acid cycle, fatty acid elongation, and degradation pathways as coordinately activated in BAT. Interestingly, five unsaturated fatty acids (Eicosadienoic Acid, C20:2; gamma-Linolenic acid, C20:3; Arachidonic Acid, C20:4; Adrenic acid, C22:4; Docosahexaenoic acid, C22:6), Succinate, L-carnitine, and L-palmitoyl-carnitine were found to be abundant in BAT. Furthermore, L-carnitine, an intermediate of fatty acid degradation, is required for goat brown adipocyte differentiation and thermogenesis through activating AMPK pathway. However, L-carnitine decreased lipid accumulation through inducing lipolysis and thermogenesis in white adipocytes. These results revealed that there are the significant alterations in transcriptomic and metabolomic profiles between goat WAT and BAT, which may contribute to better understanding the roles of metabolites in BAT thermogenesis process.	[Wang, Yan; Chen, Xingyue; Fan, Wenli; Zhang, Xujia; Zhan, Siyuan; Zhong, Tao; Guo, Jiazhong; Cao, Jiaxue; Li, Li; Zhang, Hongping; Wang, Linjie] Sichuan Agr Univ, Coll Anim Sci & Technol, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Peoples R China; [Zhan, Siyuan; Zhong, Tao; Li, Li; Wang, Linjie] Sichuan Agr Univ, Inst Anim Genet & Breeding, Chengdu 611130, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Wang, LJ (corresponding author), Sichuan Agr Univ, Inst Anim Genet & Breeding, Chengdu 611130, Sichuan, Peoples R China.	wanglinjie@sicau.edu.cn		Wang, Yan/0000-0003-1412-5499	National Natural Science Foundation of China (NSFC) [32072686]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 32072686	ALjohani AM, 2017, TRENDS ENDOCRIN MET, V28, P831, DOI 10.1016/j.tem.2017.10.003; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Berg F, 2006, PLOS GENET, V2, P1178, DOI 10.1371/journal.pgen.0020129; CAMP LA, 1993, J BIOL CHEM, V268, P22566; Cao YX, 2021, ACTA BIOCH BIOPH SIN, V53, P112, DOI 10.1093/abbs/gmaa136; Carpentier AC, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00447; Carroll RG, 2018, J BIOL CHEM, V293, P5509, DOI 10.1074/jbc.RA118.001921; Clarke L, 1998, EXP PHYSIOL, V83, P651, DOI 10.1113/expphysiol.1998.sp004146; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Cui L, 2018, MASS SPECTROM REV, V37, P772, DOI 10.1002/mas.21562; Darby CJ, 1996, REPROD FERT DEVELOP, V8, P137, DOI 10.1071/RD9960137; Dasgupta B, 2018, METHODS MOL BIOL, V1732, P195, DOI 10.1007/978-1-4939-7598-3_12; Day EA, 2017, TRENDS ENDOCRIN MET, V28, P545, DOI 10.1016/j.tem.2017.05.004; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Dubikovskaya E, 2014, METHOD ENZYMOL, V538, P107, DOI 10.1016/B978-0-12-800280-3.00007-4; Flachs P, 2005, DIABETOLOGIA, V48, P2365, DOI 10.1007/s00125-005-1944-7; Fuller-Jackson JP, 2018, J ENDOCRINOL, V237, pR99, DOI 10.1530/JOE-18-0090; Gao XY, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.661773; Gonzalez-Hurtado E, 2018, MOL METAB, V7, P45, DOI 10.1016/j.molmet.2017.11.004; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Held NM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85455-4; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Ikeda K, 2018, TRENDS ENDOCRIN MET, V29, P191, DOI 10.1016/j.tem.2018.01.001; Jiang ZH, 2015, CELL MOL LIFE SCI, V72, P3425, DOI 10.1007/s00018-015-1934-y; Johnson CH, 2016, NAT REV MOL CELL BIO, V17, P451, DOI 10.1038/nrm.2016.25; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Koster KP, 2019, FRONT SYNAPTIC NEURO, V11, DOI 10.3389/fnsyn.2019.00025; Kuhl C, 2012, ANAL CHEM, V84, P283, DOI 10.1021/ac202450g; Kulterer OC, 2020, J CLIN ENDOCR METAB, V105, P2203, DOI 10.1210/clinem/dgaa183; Longo N, 2016, BBA-MOL CELL RES, V1863, P2422, DOI 10.1016/j.bbamcr.2016.01.023; Marcher AB, 2015, CELL REP, V13, P2000, DOI 10.1016/j.celrep.2015.10.069; Maurer SF, 2019, HANDB EXP PHARMACOL, V251, P183, DOI 10.1007/164_2018_150; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Olzmann JA, 2019, NAT REV MOL CELL BIO, V20, P137, DOI 10.1038/s41580-018-0085-z; Ozaki K, 2011, LAB INVEST, V91, P704, DOI 10.1038/labinvest.2011.6; Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Plush KJ, 2016, ANIM PROD SCI, V56, P736, DOI 10.1071/AN15099; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shin S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020256; Simcox J, 2017, CELL METAB, V26, P509, DOI 10.1016/j.cmet.2017.08.006; Soni N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235895; Steensels S, 2019, BBA-MOL CELL BIOL L, V1864, P79, DOI 10.1016/j.bbalip.2018.05.008; Symonds ME, 2018, J ENDOCRINOL, V238, pR53, DOI 10.1530/JOE-18-0084; Symonds ME, 2015, ANNU REV NUTR, V35, P295, DOI 10.1146/annurev-nutr-071813-105330; Symonds ME, 2012, P NUTR SOC, V71, P363, DOI 10.1017/S0029665112000584; Tabuchi C, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.595020; Takahashi T, 2008, DOMEST ANIM ENDOCRIN, V34, P432, DOI 10.1016/j.domaniend.2007.12.003; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Tung YT, 2020, MOLECULES, V25, DOI 10.3390/molecules25153329; Wang LJ, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10091626; Wang LJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080904; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu LY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00122; Xu ZY, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0693-x; Xu ZY, 2020, ADV NUTR, V11, P447, DOI 10.1093/advances/nmz070; Yang QY, 2016, CELL METAB, V24, P542, DOI 10.1016/j.cmet.2016.08.010; You M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010136; Zhang F, 2018, CELL METAB, V27, P252, DOI 10.1016/j.cmet.2017.12.004; Zhao M, 2014, BIOCHEM BIOPH RES CO, V450, P1446, DOI 10.1016/j.bbrc.2014.07.010; Zheng QT, 2017, P NATL ACAD SCI USA, V114, pE9474, DOI 10.1073/pnas.1707853114	64	1	1	3	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21868	10.1096/fj.202100493RR	http://dx.doi.org/10.1096/fj.202100493RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34449920				2022-12-28	WOS:000691122900032
J	Wang, YX; Yang, Z; Gu, JF; Zhang, YP; Wang, X; Teng, ZH; Wang, DD; Gao, L; Li, W; Yeh, SY; Han, ZW				Wang, Yaxuan; Yang, Zhan; Gu, Junfei; Zhang, Yanping; Wang, Xin; Teng, Zhihai; Wang, Dandan; Gao, Lei; Li, Wei; Yeh, Shuyuan; Han, Zhenwei			Estrogen receptor beta increases clear cell renal cell carcinoma stem cell phenotype via altering the circPHACTR4/miR-34b-5p/c-Myc signaling	FASEB JOURNAL			English	Article						circular RNA; CSCs; estrogen receptor beta; miRNA; renal cell carcinoma	CIRCULAR RNAS; ER-BETA; EXPRESSION; BRAIN; MYC; IDENTIFICATION; TRANSLATION; PROGRESSION; PROMOTES; INVASION	Early clinical studies indicated that estrogen receptor beta (ER beta) might play key roles to impact the progression of clear cell renal cell carcinoma (ccRCC). The detailed molecular mechanisms, however, remain unclear. Here, we found ER beta could increase the cancer stem cell (CSC) population via altering the circPHACTR4/miR-34b-5p/c-Myc signaling. Mechanism dissection revealed that ER beta could suppress circular RNA PHACTR4 (circPHACTR4) expression via direct binding to the estrogen response elements (EREs) on the 5 ' promoter region of its host gene, phosphatase and actin regulator 4 (PHACTR4) to decrease miR-34b-5p expression. The decreased miRNA-34b-5p could then increase c-Myc mRNA translation via targeting its 3 ' untranslated region (3 ' UTR). The in vivo mouse model with subcutaneous xenografts of ccRCC cells also validated the in vitro data. Importantly, analysis results from ccRCC TCGA database and our clinical data further confirmed the above in vitro/in vivo data. Together, these results suggest that ER beta may increase CSC population in ccRCC via altering ER beta/circPHACTR4/miR-34b-5p/c-Myc signaling and that targeting this newly identified signal pathway may help physicians to better suppress ccRCC progression.	[Wang, Yaxuan; Yang, Zhan; Gu, Junfei; Zhang, Yanping; Wang, Xin; Teng, Zhihai; Wang, Dandan; Gao, Lei; Li, Wei; Han, Zhenwei] Hebei Med Univ, Hosp 2, Dept Urol, 215 Heping W Rd, Shijiazhuang 050000, Hebei, Peoples R China; [Yang, Zhan] Hebei Med Univ, Dept Biochem & Mol Biol, Minist Educ China, Shijiazhuang, Hebei, Peoples R China; [Yeh, Shuyuan] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA	Hebei Medical University; Hebei Medical University; Ministry of Education, China; University of Rochester	Han, ZW (corresponding author), Hebei Med Univ, Hosp 2, Dept Urol, 215 Heping W Rd, Shijiazhuang 050000, Hebei, Peoples R China.	hanzhenwei@hebmu.edu.cn			National Natural Science Foundation of China [81802544, 82072842, 81970216]; Natural Science Foundation of Hebei Province [H2020206146]; Excellent Youth Science Foundation of Hebei Province [H2019206536]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Excellent Youth Science Foundation of Hebei Province	This study was supported by the National Natural Science Foundation of China (grant numbers 81802544, 82072842, 81970216); the Natural Science Foundation of Hebei Province (grant number H2020206146); and supported by the Excellent Youth Science Foundation of Hebei Province (grant number H2019206536).	Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Batistatou A, 2006, J NEURO-ONCOL, V77, P17, DOI 10.1007/s11060-005-9005-0; Bussolati B, 2008, FASEB J, V22, P3696, DOI 10.1096/fj.08-102590; Butz H, 2016, EUR UROL FOCUS, V2, P210, DOI 10.1016/j.euf.2015.11.006; Chen L, 2020, ADV SCI, V7, DOI 10.1002/advs.201900949; Comperat E, 2012, Diagn Interv Imaging, V93, P221, DOI 10.1016/j.diii.2012.01.015; D'Agostini F, 2008, INT J CANCER, V123, P2497, DOI 10.1002/ijc.23836; Dai XY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0485-1; Dong LF, 2020, AM J TRANSL RES, V12, P269; Fang PC, 2020, CURR PHARM DESIGN, V26, P1964, DOI 10.2174/1381612826666200318153106; Fujimura T, 2001, BIOCHEM BIOPH RES CO, V289, P692, DOI 10.1006/bbrc.2001.6038; Gabay M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014241; Geng HH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151753; Ghosal Suman, 2013, Frontiers in Genetics, V4, P283, DOI 10.3389/fgene.2013.00283; Gu CH, 2018, MOL THER-NUCL ACIDS, V13, P633, DOI 10.1016/j.omtn.2018.10.008; Gu JF, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2486-0; Guo XF, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01196-4; Han ZW, 2018, CANCER RES, V78, P2550, DOI 10.1158/0008-5472.CAN-17-1575; Hansen TB, 2013, CANCER RES, V73, P5609, DOI 10.1158/0008-5472.CAN-13-1568; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hartman J, 2006, CANCER RES, V66, P11207, DOI 10.1158/0008-5472.CAN-06-0017; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hsu I, 2014, CARCINOGENESIS, V35, P651, DOI 10.1093/carcin/bgt348; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Lasda E, 2014, RNA, V20, P1829, DOI 10.1261/rna.047126.114; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li M, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1077-9; Li QQ, 2017, ONCOTARGET, V8, P12067, DOI 10.18632/oncotarget.14512; Li XB, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0976-0; Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959; Liang JY, 2015, MOL CELL BIOCHEM, V401, P71, DOI 10.1007/s11010-014-2293-y; Liu YC, 2016, NUCLEIC ACIDS RES, V44, pD209, DOI 10.1093/nar/gkv940; Ma R, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw236; Majello B, 2015, BBA-GENE REGUL MECH, V1849, P467, DOI 10.1016/j.bbagrm.2014.12.006; Maroof H, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120265; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Meng SJ, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0663-2; Nan A, 2017, ARCH TOXICOL, V91, P1671, DOI 10.1007/s00204-016-1837-1; Pamudurti NR, 2017, MOL CELL, V66, P9, DOI 10.1016/j.molcel.2017.02.021; Qi W, 2015, STEM CELLS, V33, P3423, DOI 10.1002/stem.2188; Qian CS, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-1158-6; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Sattiraju A, 2017, ADV EXP MED BIOL, V1041, P119, DOI 10.1007/978-3-319-69194-7_7; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Song WB, 2015, ONCOTARGET, V6, P19290, DOI 10.18632/oncotarget.4478; Srivastava A, 2020, CANCER-AM CANCER SOC, V126, P2991, DOI 10.1002/cncr.32912; Stadler WM, 2005, CANCER-AM CANCER SOC, V104, P2323, DOI 10.1002/cncr.21453; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang KF, 2017, CANCER LETT, V394, P1, DOI 10.1016/j.canlet.2016.12.036; Wang ZS, 2019, TOXICOL SCI, V172, P252, DOI 10.1093/toxsci/kfz196; Weinstock M, 2015, THER ADV UROL, V7, P365, DOI 10.1177/1756287215597647; Wen SM, 2016, CANCER LETT, V376, P377, DOI 10.1016/j.canlet.2016.01.057; Wu G, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1048-1; Xiao T, 2018, METALLOMICS, V10, P1328, DOI 10.1039/c8mt00207j; Xiao Y, 2019, CANCER LETT, V444, P175, DOI 10.1016/j.canlet.2018.11.004; Yang CM, 2020, AM J PATHOL, V190, P674, DOI 10.1016/j.ajpath.2019.11.013; Yang Y, 2017, CELL RES, V27, P626, DOI 10.1038/cr.2017.31; Yao WX, 2018, TOXICOL SCI, V166, P465, DOI 10.1093/toxsci/kfy221; Yeh CR, 2015, ONCOTARGET, V6, P44346, DOI 10.18632/oncotarget.5884; Yoshida GJ, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0835-y; You XT, 2015, NAT NEUROSCI, V18, P603, DOI 10.1038/nn.3975; Yu SS, 2016, ONCOTARGETS THER, V9, P5825, DOI 10.2147/OTT.S97397; Yu WW, 2019, ONCOGENE, V38, P1225, DOI 10.1038/s41388-018-0463-1; Zanjani LS, 2018, CANCER BIOMARK, V21, P821, DOI 10.3233/CBM-170755; Zhang HF, 2016, STEM CELLS, V34, P2040, DOI 10.1002/stem.2395; Zhang TT, 2020, ENVIRON TOXICOL, V35, P1274, DOI 10.1002/tox.22992	70	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22163	10.1096/fj.202101645R	http://dx.doi.org/10.1096/fj.202101645R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35061326	hybrid			2022-12-28	WOS:000747987800037
J	Feng, LJ; Zhou, N; Li, ZC; Fu, DN; Guo, Y; Gao, XF; Liu, XW				Feng, Lijuan; Zhou, Nan; Li, Zichun; Fu, Dongni; Guo, Ying; Gao, Xuefeng; Liu, Xiaowei			Co-occurrence of gut microbiota dysbiosis and bile acid metabolism alteration is associated with psychological disorders in Crohn's disease	FASEB JOURNAL			English	Article						bile acids; Crohn's disease; gut microbiota; psychological disorders	INFLAMMATORY-BOWEL-DISEASE; FECAL MICROBIOTA; DEPRESSION; ANXIETY; STRESS; ACTIVATION; PHENOTYPE; SYSTEM	This study aims to elucidate the relationships between gut microbiota, bile acid metabolism, and psychological comorbidity in Crohn's disease (CD). We profiled the fecal microbiota composition and quantified the bile acid pool of 39 CD patients and 14 healthy controls using 16S rRNA gene sequencing and liquid chromatography-tandem mass spectrometry, respectively. Significant reductions in the secondary bile acids, LCA and DCA, were found in both the feces and serum samples of CD patients, while the concentration of 7-DHCA was particularly higher in the serum of CD patients with psychological disorders. The fecal levels of HDCA and 12-DHCA of the CD patients were inversely correlated with their Self-Rated Depression Scale (SDS) scores, whereas the serum level of 7-DHCA was positively correlated with the SDS scores. In addition, the fecal levels of TDCA, TLCA, and T beta MCA showed a positive correlation with the Self-Rated Anxiety Scale (SAS) scores. The fecal microbiota biodiversity was particularly declined in CD patients with psychological disorders. An enrichment of Ruminococcus gnavus in CD patients may cause psychological disorders by affecting the microbiota-gut-brain axis via its ability to degrade the gut barrier, regulate the tryptophan-kynurenine metabolism, and modulate bile acid metabolism. In addition, the overabundant Enterobacteriaceae and Lachnospiraceae in CD patients may contribute to psychological comorbidity via dysregulating their bile acids metabolism. Taken together, changes in the gut microbiota composition may cooperate with alterations in the bile acid metabolism that are involved in the development of psychological disorders in CD.	[Feng, Lijuan; Zhou, Nan; Li, Zichun; Fu, Dongni; Liu, Xiaowei] Cent South Univ, Xiangya Hosp, Dept Gastroenterol, Changsha 410008, Hunan, Peoples R China; [Feng, Lijuan; Gao, Xuefeng] Shenzhen Univ, Dept Gastroenterol & Hepatol, Gen Hosp, Shenzhen 518055, Guangdong, Peoples R China; [Guo, Ying] Cent South Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha, Peoples R China; [Gao, Xuefeng] Shenzhen Univ, Gen Hosp, Cent Lab, Shenzhen Key Lab Precis Med Hematol Malignancies, Shenzhen, Peoples R China	Central South University; Shenzhen University; Central South University; Shenzhen University	Liu, XW (corresponding author), Cent South Univ, Xiangya Hosp, Dept Gastroenterol, Changsha 410008, Hunan, Peoples R China.; Gao, XF (corresponding author), Shenzhen Univ, Dept Gastroenterol & Hepatol, Gen Hosp, Shenzhen 518055, Guangdong, Peoples R China.	xfgao@szu.edu.cn; liuxw@csu.edu.cn	FU, Dongni/GWM-6393-2022	Gao, Xuefeng/0000-0002-1904-392X	National Natural Science Foundation of China [81900474, 81770584, 81570504]; Scientific Research Plan of Health and Family Planning Commission of Hunan Province [C20180490]; Shenzhen Key Laboratory Foundation [ZDSYS20200811143757022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Plan of Health and Family Planning Commission of Hunan Province; Shenzhen Key Laboratory Foundation	This work was supported by the National Natural Science Foundation of China (81900474, 81770584, and 81570504), Scientific Research Plan of Health and Family Planning Commission of Hunan Province (C20180490), and Shenzhen Key Laboratory Foundation (ZDSYS20200811143757022)	Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Ananthakrishnan AN, 2013, CLIN GASTROENTEROL H, V11, P57, DOI 10.1016/j.cgh.2012.08.032; Bernstein CN, 2016, DIGEST DIS, V34, P58, DOI 10.1159/000442929; Biagioli M, 2017, J IMMUNOL, V199, P718, DOI 10.4049/jimmunol.1700183; Blandford LE, 2019, GUT MICROBES, V10, P569, DOI 10.1080/19490976.2018.1560755; Bonaz BL, 2013, GASTROENTEROLOGY, V144, P36, DOI 10.1053/j.gastro.2012.10.003; Chahwan B, 2019, J AFFECT DISORDERS, V253, P317, DOI 10.1016/j.jad.2019.04.097; Chen WG, 2018, PSYCHIAT RES, V264, P374, DOI 10.1016/j.psychres.2018.04.025; Chong J, 2020, NAT PROTOC, V15, P799, DOI 10.1038/s41596-019-0264-1; Cogan TA, 2007, GUT, V56, P1060, DOI 10.1136/gut.2006.114926; Crost EH, 2016, GUT MICROBES, V7, P302, DOI 10.1080/19490976.2016.1186334; Dethloff F, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00518; Duboc H, 2013, GUT, V62, P531, DOI 10.1136/gutjnl-2012-302578; Franzosa EA, 2019, NAT MICROBIOL, V4, P293, DOI 10.1038/s41564-018-0306-4; Frolkis AD, 2019, GUT, V68, P1606, DOI 10.1136/gutjnl-2018-317182; Gao K, 2020, ADV NUTR, V11, P709, DOI 10.1093/advances/nmz127; Gracie DJ, 2018, GASTROENTEROLOGY, V154, P1635, DOI 10.1053/j.gastro.2018.01.027; Grigoleit JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028330; Hang SY, 2019, NATURE, V576, P143, DOI 10.1038/s41586-019-1785-z; Hao ZK, 2019, PSYCHONEUROENDOCRINO, V104, P132, DOI 10.1016/j.psyneuen.2019.02.025; Henke MT, 2019, P NATL ACAD SCI USA, V116, P12672, DOI 10.1073/pnas.1904099116; Holzer P, 2014, ADV EXP MED BIOL, V817, P195, DOI 10.1007/978-1-4939-0897-4_9; Huang C, 2016, FEBS LETT, V590, P3233, DOI 10.1002/1873-3468.12373; Jacobs JP, 2016, CELL MOL GASTROENTER, V2, P750, DOI 10.1016/j.jcmgh.2016.06.004; Jiang HY, 2015, BRAIN BEHAV IMMUN, V48, P186, DOI 10.1016/j.bbi.2015.03.016; Kamintsky L, 2020, NEUROIMAGE-CLIN, V26, DOI 10.1016/j.nicl.2019.102049; Kochar B, 2018, AM J GASTROENTEROL, V113, P80, DOI 10.1038/ajg.2017.423; Kundu P, 2017, CELL, V171, P1481, DOI 10.1016/j.cell.2017.11.024; Lange K, 2016, DIGEST DIS, V34, P260, DOI 10.1159/000443360; Lee JY, 2013, J LIPID RES, V54, P3062, DOI 10.1194/jlr.M039834; Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9; Lu X, 2018, FUND CLIN PHARMACOL, V32, P363, DOI 10.1111/fcp.12367; McCombie AM, 2013, J CROHNS COLITIS, V7, P935, DOI 10.1016/j.crohns.2013.02.004; Mertens KL, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00617; Mittal R, 2017, J CELL PHYSIOL, V232, P2359, DOI 10.1002/jcp.25518; Miyata M, 2011, J PHARMACOL EXP THER, V336, P188, DOI 10.1124/jpet.110.171736; Moore LB, 2000, P NATL ACAD SCI USA, V97, P7500, DOI 10.1073/pnas.130155097; Nagpal S, 2020, NUCLEIC ACIDS RES, V48, pW572, DOI 10.1093/nar/gkaa254; Pang ZQ, 2021, NUCLEIC ACIDS RES, V49, pW388, DOI 10.1093/nar/gkab382; Venegas DP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00277; Quinn M, 2014, DIGEST LIVER DIS, V46, P527, DOI 10.1016/j.dld.2014.01.159; Rhee SH, 2009, NAT REV GASTRO HEPAT, V6, P306, DOI 10.1038/nrgastro.2009.35; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Seok S, 2014, NATURE, V516, P108, DOI 10.1038/nature13949; Spedding S, 2014, NUTRIENTS, V6, P1501, DOI 10.3390/nu6041501; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Tillisch K, 2017, PSYCHOSOM MED, V79, P905, DOI 10.1097/PSY.0000000000000493; Torres J, 2018, UNITED EUR GASTROENT, V6, P112, DOI 10.1177/2050640617708953; Viladomiu M, 2021, CELL HOST MICROBE, V29, P607, DOI 10.1016/j.chom.2021.01.002; Walker JR, 2008, AM J GASTROENTEROL, V103, P1989, DOI 10.1111/j.1572-0241.2008.01980.x; Walters M, 2006, INFECT IMMUN, V74, P5445, DOI 10.1128/IAI.00099-06; Wang YZ, 2021, GUT MICROBES, V13, P1, DOI 10.1080/19490976.2020.1865708; Wang YZ, 2018, J CROHNS COLITIS, V12, P337, DOI 10.1093/ecco-jcc/jjx153; Williams BB, 2014, CELL HOST MICROBE, V16, P495, DOI 10.1016/j.chom.2014.09.001; Yadav D, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0099-z; Yu M, 2017, J PHARMACEUT BIOMED, V138, P231, DOI 10.1016/j.jpba.2017.02.008; Zung W., 1980, NORMAL IS ANXIETY; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008; Zuo T, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02247	60	4	4	8	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22100	10.1096/fj.202101088RRR	http://dx.doi.org/10.1096/fj.202101088RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34939244				2022-12-28	WOS:000734992000051
J	Ke, XX; Hu, T; Jiang, MZ				Ke, Xinxin; Hu, Tao; Jiang, Mizu			cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers	FASEB JOURNAL			English	Review						cGAS; colorectal cancer; esophageal cancer; gastric cancer; gastrointestinal inflammatory disease; STING	CYCLIC GMP-AMP; DOUBLE-STRANDED DNA; COLORECTAL-CANCER; I INTERFERON; ENDOGENOUS 2ND-MESSENGER; EXPRESSION; INDUCTION; SYNTHASE; COLITIS; ADAPTER	Cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling pathway has emerged as a key DNA-sensing machinery in innate immunity. Activation of cGAS-STING signaling pathway mediates the production of interferons and proinflammatory cytokines. Although cGAS-STING signaling pathway shows critical function in the maintenance of gut homeostasis, overactive cGAS-STING signaling pathway leads to gastrointestinal (GI) inflammation. Harnessing the effect and mechanism of the cGAS-STING signaling pathway could be beneficial for the development of novel strategies for the treatment of GI diseases. This review presents recent advances regarding the role of cGAS-STING signaling pathway in GI inflammatory disease and cancers and describes perspective therapeutic strategies targeting the signaling pathway.	[Ke, Xinxin; Hu, Tao; Jiang, Mizu] Zhejiang Univ, Childrens Hosp, Natl Clin Res Ctr Child Hlth, Sch Med, 57 Zhugan Xiang, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Hu, T (corresponding author), Zhejiang Univ, Childrens Hosp, Natl Clin Res Ctr Child Hlth, Sch Med, 57 Zhugan Xiang, Hangzhou 310003, Zhejiang, Peoples R China.; Jiang, MZ (corresponding author), Zhejiang Univ, Childrens Hosp, Natl Clin Res Ctr Child Hlth, Dept Gastroenterol,Sch Med, 57 Zhugan Xiang, Hangzhou 310003, Zhejiang, Peoples R China.	hutaozd@zju.edu.cn; mizu@zju.edu.cn	hu, tao/ABB-2153-2021	hu, tao/0000-0003-3448-6515				Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Aden K, 2018, J EXP MED, V215, P2868, DOI 10.1084/jem.20171029; Ahn J, 2017, CELL REP, V21, P3873, DOI 10.1016/j.celrep.2017.11.101; An X, 2019, MOL THER-NUCL ACIDS, V14, P80, DOI 10.1016/j.omtn.2018.11.003; Andreeva L, 2017, NATURE, V549, P394, DOI 10.1038/nature23890; [Anonymous], 1994, IARC MONOGR EVAL CAR, V61, P1; Axelrad JE, 2021, THER ADV GASTROENTER, V14, DOI 10.1177/17562848211004493; Axelrad JE, 2020, ALIMENT PHARM THER, V51, P1222, DOI 10.1111/apt.15770; Babickova J, 2018, FOLIA BIOL-PRAGUE, V64, P10; Balka KR, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.056; Barnett KC, 2019, CELL, V176, P1432, DOI 10.1016/j.cell.2019.01.049; Board PDQATE, 2021, PDQ CANC INF SUMM; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Boyapati RK, 2018, INFLAMM BOWEL DIS, V24, P2113, DOI 10.1093/ibd/izy095; Canesso MCC, 2018, MUCOSAL IMMUNOL, V11, P820, DOI 10.1038/mi.2017.88; Catalano C, 2020, CANCER MED-US, V9, P1473, DOI 10.1002/cam4.2804; Chen C., 2021, SSRN, DOI [10.2139/ssrn.3756807, DOI 10.2139/SSRN.3756807]; Chen JZ, 2018, INT J RADIAT ONCOL, V101, P97, DOI 10.1016/j.ijrobp.2018.01.091; Chen SY, 2021, ANN TRANSL MED, V9, DOI 10.21037/atm-20-2430; Cheng ZL, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0198-7; ChonL HJ, 2019, J CANCER, V10, P4932, DOI 10.7150/jca.32806; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Cui KL, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.654731; de Jong PR, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1458-3; Digby-Bell JL, 2020, NAT REV GASTRO HEPAT, V17, P9, DOI 10.1038/s41575-019-0228-5; Dinallo V, 2019, J CROHNS COLITIS, V13, P772, DOI 10.1093/ecco-jcc/jjy215; DiSiena M, 2021, SOUTH MED J, V114, P161, DOI 10.14423/SMJ.0000000000001226; Dobbs N, 2015, CELL HOST MICROBE, V18, P157, DOI 10.1016/j.chom.2015.07.001; Du HS, 2021, BIOMED PHARMACOTHER, V133, DOI 10.1016/j.biopha.2020.110972; Du MJ, 2018, SCIENCE, V361, P704, DOI 10.1126/science.aat1022; Ergun SL, 2020, TRENDS CELL BIOL, V30, P399, DOI 10.1016/j.tcb.2020.01.010; Ergun SL, 2019, CELL, V178, P290, DOI 10.1016/j.cell.2019.05.036; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Fessler J, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0574-4; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Frank C, 2017, INT J CANCER, V140, P1510, DOI 10.1002/ijc.30583; Galluzzi L, 2018, CELL, V173, DOI 10.1016/j.cell.2018.03.015; Gao JH, 2020, INT IMMUNOPHARMACOL, V83, DOI 10.1016/j.intimp.2020.106426; Gao Menghui, 2020, Mol Biomed, V1, P7, DOI 10.1186/s43556-020-00006-z; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gekara NO, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aax3521; Goedegebuure RSA, 2021, J EXP CLIN CANC RES, V40, DOI 10.1186/s13046-021-01962-2; Gong WB, 2022, INFLAMM BOWEL DIS, V28, P572, DOI 10.1093/ibd/izab217; Gonugunta VK, 2017, CELL REP, V21, P3234, DOI 10.1016/j.celrep.2017.11.061; Gui X, 2019, NATURE, V567, P262, DOI 10.1038/s41586-019-1006-9; Hong S, 2020, J RADIAT RES, V61, P851, DOI 10.1093/jrr/rraa077; Hong SN, 2018, INTEST RES, V16, P327, DOI 10.5217/ir.2018.16.3.327; Howell KJ, 2018, GASTROENTEROLOGY, V154, P585, DOI 10.1053/j.gastro.2017.10.007; Hu QY, 2021, J EXP CLIN CANC RES, V40, DOI 10.1186/s13046-021-01850-9; Hu SQ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2105747118; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jiang XF, 2019, FISH SHELLFISH IMMUN, V95, P220, DOI 10.1016/j.fsi.2019.09.075; Kameyama H, 2018, WORLD J SURG ONCOL, V16, DOI 10.1186/s12957-018-1428-0; Kang LJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16191-y; Kato K, 2017, ANNU REV BIOCHEM, V86, P541, DOI 10.1146/annurev-biochem-061516-044813; Kato K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076983; Kondo T, 2013, P NATL ACAD SCI USA, V110, P2969, DOI 10.1073/pnas.1222694110; Konecna B, 2018, SCAND J IMMUNOL, V87, DOI 10.1111/sji.12651; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Kurashima Y, 2013, EUR J IMMUNOL, V43, P3108, DOI 10.1002/eji.201343782; Kwon J, 2020, CANCER DISCOV, V10, P26, DOI 10.1158/2159-8290.CD-19-0761; Laukens D, 2016, FEMS MICROBIOL REV, V40, P117, DOI 10.1093/femsre/fuv036; Lee SJ, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2020-002195; Li T, 2020, J CROHNS COLITIS, V14, P240, DOI 10.1093/ecco-jcc/jjz132; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Liu HP, 2018, NATURE, V563, P131, DOI 10.1038/s41586-018-0629-6; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Luecke S, 2017, EMBO REP, V18, P1707, DOI 10.15252/embr.201744017; Ma CM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6717; Ma RH, 2020, FASEB J, V34, P13156, DOI 10.1096/fj.202001607R; Malickova K, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/945861; Marill J, 2019, RADIOTHER ONCOL, V141, P262, DOI 10.1016/j.radonc.2019.07.029; Maronek M, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010081; Martin GR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50656-5; Miao L, 2020, THERANOSTICS, V10, P498, DOI 10.7150/thno.37745; Mukai K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11932; Ogawa E, 2018, BIOCHEM BIOPH RES CO, V503, P138, DOI 10.1016/j.bbrc.2018.05.199; Pantelidou C, 2019, CANCER DISCOV, V9, P722, DOI 10.1158/2159-8290.CD-18-1218; Plummer M, 2015, INT J CANCER, V136, P487, DOI 10.1002/ijc.28999; Reislander T, 2020, MOL CELL, V80, P21, DOI 10.1016/j.molcel.2020.07.026; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Sen T, 2019, CANCER DISCOV, V9, P646, DOI 10.1158/2159-8290.CD-18-1020; Shang GJ, 2019, NATURE, V567, P389, DOI 10.1038/s41586-019-0998-5; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shi JQ, 2021, CELL IMMUNOL, V366, DOI 10.1016/j.cellimm.2021.104384; Shi YY, 2020, J EXP MED, V217, DOI 10.1084/jem.20192282; Shmuel-Galia L, 2021, IMMUNITY, V54, P1137, DOI 10.1016/j.immuni.2021.05.008; Shu C, 2014, CYTOKINE GROWTH F R, V25, P641, DOI 10.1016/j.cytogfr.2014.06.006; Si W, 2022, GUT, V71, P521, DOI 10.1136/gutjnl-2020-323426; Soh JS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42986-1; Sokol H, 2017, GUT, V66, P1039, DOI [10.1136/gutjnl-2015-310746, 10.1136/gutjnl-20]; Song SS, 2017, SCI REP-UK, V7, DOI 10.1038/srep39858; Srikanth S, 2019, NAT IMMUNOL, V20, P152, DOI 10.1038/s41590-018-0287-8; Sun H, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108586; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Tao JL, 2016, IUBMB LIFE, V68, P858, DOI 10.1002/iub.1566; Tian JR, 2021, EMBO J, V40, DOI 10.15252/embj.2020106065; Vincent J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00833-9; Wang L, 2019, SCIENCE, V365, P656, DOI 10.1126/science.aav0758; Wang YY, 2022, ACTA PHARM SIN B, V12, P262, DOI 10.1016/j.apsb.2021.03.043; Wang ZC, 2017, INT J CLIN EXP PATHO, V10, P10066; Wei B, 2021, CANCER RES, V81, P3215, DOI 10.1158/0008-5472.CAN-20-3738; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Xie W, 2019, P NATL ACAD SCI USA, V116, P11946, DOI 10.1073/pnas.1905013116; Yang CA, 2017, ONCOLOGY-BASEL, V92, P115, DOI 10.1159/000452281; Yang H, 2019, J CLIN INVEST, V129, P4350, DOI 10.1172/JCI125413; Yang KS, 2021, BIOENGINEERED, V12, P1238, DOI 10.1080/21655979.2021.1911557; Zaidi Ali H, 2021, Oncotarget, V12, P292, DOI 10.18632/oncotarget.27886; Zhang CG, 2019, NATURE, V567, P394, DOI 10.1038/s41586-019-1000-2; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhao BY, 2019, NATURE, V569, P718, DOI 10.1038/s41586-019-1228-x; Zhao F, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04101-z; Zheng CF, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01255; Zhong GS, 2018, INT J CLIN EXP PATHO, V11, P1256; Zhou RY, 2020, INFECT GENET EVOL, V77, DOI 10.1016/j.meegid.2019.104094; Zhou W, 2018, CELL, V174, P300, DOI 10.1016/j.cell.2018.06.026; Zhu QF, 2014, J IMMUNOL, V193, P4779, DOI 10.4049/jimmunol.1402051	126	1	1	17	39	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22029	10.1096/fj.202101199R	http://dx.doi.org/10.1096/fj.202101199R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34907606	hybrid			2022-12-28	WOS:000734992000054
J	Qi, Y; Qadir, MMF; Hastreiter, AA; Fock, RA; Machi, JF; Morales, AA; Wang, Y; Meng, ZP; Rodrigues, CO				Qi, Yue; Qadir, Mirza M. F.; Hastreiter, Araceli A.; Fock, Ricardo A.; Machi, Jacqueline F.; Morales, Alejo A.; Wang, Ying; Meng, Zhipeng; Rodrigues, Claudia O.			Endothelial c-Myc knockout enhances diet-induced liver inflammation and fibrosis	FASEB JOURNAL			English	Article						c-Myc; endothelial cells; fibrosis; inflammation	ACTIVATION; CELLS; CANCER; OVEREXPRESSION; PATHWAY; GENE	Endothelial cells play an essential role in inflammation through synthesis and secretion of chemoattractant cytokines and expression of adhesion molecules required for inflammatory cell attachment and infiltration. The mechanisms by which endothelial cells control the pro-inflammatory response depend on the type of inflammatory stimuli, endothelial cell origin, and tissue involved. In the present study, we investigated the role of the transcription factor c-Myc in inflammation using a conditional knockout mouse model in which Myc is specifically deleted in the endothelium. At a systemic level, circulating monocytes, the chemokine CCL7, and the extracellular-matrix protein osteopontin were significantly increased in endothelial c-Myc knockout (EC-Myc KO) mice, whereas the cytokine TNFSF11 was downregulated. Using an experimental model of steatohepatitis, we investigated the involvement of endothelial c-Myc in diet-induced inflammation. EC-Myc KO animals displayed enhanced pro-inflammatory response, characterized by increased expression of pro-inflammatory cytokines and leukocyte infiltration, and worsened liver fibrosis. Transcriptome analysis identified enhanced expression of genes associated with inflammation, fibrosis, and hepatocellular carcinoma in EC-Myc KO mice relative to control (CT) animals after short-exposure to high-fat diet. Analysis of a single-cell RNA-sequencing dataset of human cirrhotic livers indicated downregulation of MYC in endothelial cells relative to healthy controls. In summary, our results suggest a protective role of endothelial c-Myc in diet-induced liver inflammation and fibrosis. Targeting c-Myc and its downstream pathways in the endothelium may constitute a potential strategy for the treatment of inflammatory disease.	[Qi, Yue; Machi, Jacqueline F.; Morales, Alejo A.; Wang, Ying; Meng, Zhipeng; Rodrigues, Claudia O.] Univ Miami, Dept Mol & Cellular Pharmacol, Leonard M Miller Sch Med, Miami, FL USA; [Qi, Yue; Hastreiter, Araceli A.; Fock, Ricardo A.; Machi, Jacqueline F.; Morales, Alejo A.; Rodrigues, Claudia O.] Univ Miami, Interdisciplinary Stem Cell Inst, Leonard M Miller Sch Med, Miami, FL USA; [Qadir, Mirza M. F.] Tulane Univ, Sch Med, Sect Endocrinol & Metab, Deming Dept Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Wang, Ying; Meng, Zhipeng; Rodrigues, Claudia O.] Univ Miami, Sylvester Comprehens Canc Ctr, Leonard M Miller Sch Med, Miami, FL USA; [Hastreiter, Araceli A.; Fock, Ricardo A.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil	University of Miami; University of Miami; Tulane University; University of Miami; Universidade de Sao Paulo	Rodrigues, CO (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, 777 Glades Rd,BC-71,Room 224, Boca Raton, FL 33431 USA.	crodrigues@health.fau.edu	Qadir, Fahd/B-4578-2014	Qadir, Fahd/0000-0002-6764-6151; Rodrigues, Claudia/0000-0002-8416-3602; Hastreiter, Araceli/0000-0001-6226-8772	HHS \ NTH \ National Heart, Lung, and Blood Institute (NHLBI) [1R01HL128536-01A1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2017/50022-1]; Florida Ileart Research Institute	HHS \ NTH \ National Heart, Lung, and Blood Institute (NHLBI); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Florida Ileart Research Institute	HHS | NTH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: 1R01HL128536-01A1; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Grant; Award Number: 2017/50022-1; Florida Ileart Research Institute	Balakrishnan M, 2021, CLIN GASTROENTEROL H, V19, P61, DOI 10.1016/j.cgh.2020.04.067; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Borrello MG, 2008, CANCER LETT, V267, P262, DOI 10.1016/j.canlet.2008.03.060; Cai XB, 2018, J CELL MOL MED, V22, P5050, DOI 10.1111/jcmm.13787; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen L, 2015, J HEPATOL, V62, P156, DOI 10.1016/j.jhep.2014.07.035; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Florea V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073146; Geraud C, 2017, J CLIN INVEST, V127, P1099, DOI 10.1172/JCI90086; Hammoutene A, 2019, J HEPATOL, V70, P1278, DOI 10.1016/j.jhep.2019.02.012; Jambusaria A, 2020, ELIFE, V9, DOI 10.7554/eLife.51413; Jaruga B, 2003, J IMMUNOL, V171, P3233, DOI 10.4049/jimmunol.171.6.3233; Kokai E, 2009, CIRC RES, V104, P1151, DOI 10.1161/CIRCRESAHA.108.191460; Kortlever RM, 2017, CELL, V171, P1301, DOI 10.1016/j.cell.2017.11.013; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lafdil F, 2010, CELL MOL IMMUNOL, V7, P250, DOI 10.1038/cmi.2010.5; Lasry A, 2015, TRENDS IMMUNOL, V36, P217, DOI 10.1016/j.it.2015.02.009; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Lemos DR, 2018, J AM SOC NEPHROL, V29, P1690, DOI 10.1681/ASN.2017121283; Li AY, 2019, BIOMED PHARMACOTHER, V110, P733, DOI 10.1016/j.biopha.2018.12.029; Liao WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080789; Liu T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/276850; Liu XR, 2018, CANCER SCI, V109, P3450, DOI 10.1111/cas.13794; Liu XR, 2014, CANCER RES, V74, P6623, DOI 10.1158/0008-5472.CAN-14-1279; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Miller DM, 2012, CLIN CANCER RES, V18, P5546, DOI 10.1158/1078-0432.CCR-12-0977; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nevzorova YA, 2013, BBA-MOL BASIS DIS, V1832, P1765, DOI 10.1016/j.bbadis.2013.06.001; Osterreicher CH, 2011, P NATL ACAD SCI USA, V108, P308, DOI 10.1073/pnas.1017547108; Paquissi FC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01195; Pate M, 2010, ADV CLIN CHEM, V52, P109, DOI 10.1016/S0065-2423(10)52004-3; Pelengaris S, 2003, ARCH BIOCHEM BIOPHYS, V416, P129, DOI 10.1016/S0003-9861(03)00294-7; Pham BN, 2001, J HEPATOL, V34, P537, DOI 10.1016/S0168-8278(00)00057-X; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Qadir MMF, 2020, P NATL ACAD SCI USA, V117, P10876, DOI 10.1073/pnas.1918314117; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Rau M, 2016, J IMMUNOL, V196, P97, DOI 10.4049/jimmunol.1501175; Rodrigues CO, 2008, DEVELOPMENT, V135, P1903, DOI 10.1242/dev.011296; Rodrigues SF, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.978720; Sipos F, 2016, WORLD J GASTROENTERO, V22, P7938, DOI 10.3748/wjg.v22.i35.7938; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Torre D, 2018, CELL SYST, V7, P556, DOI 10.1016/j.cels.2018.10.007; Tsou AP, 2003, ONCOGENE, V22, P298, DOI 10.1038/sj.onc.1206129; van Hinsbergh VWM, 2012, SEMIN IMMUNOPATHOL, V34, P93, DOI 10.1007/s00281-011-0285-5; Winkler M, 2021, J HEPATOL, V74, DOI 10.1016/j.jhep.2020.08.033; Wohlfeil SA, 2019, CANCER RES, V79, P598, DOI 10.1158/0008-5472.CAN-18-1752; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xiao L, 2014, AM J PHYSIOL-HEART C, V306, pH317, DOI 10.1152/ajpheart.00182.2013; Yu LX, 2018, NPJ PRECIS ONCOL, V2, DOI 10.1038/s41698-018-0048-z; Zhang HW, 2020, CIRC RES, V127, P610, DOI 10.1161/CIRCRESAHA.119.316428; Zhang JY, 2019, INT J BIOCHEM CELL B, V114, DOI 10.1016/j.biocel.2019.105574	58	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22077	10.1096/fj.202101086R	http://dx.doi.org/10.1096/fj.202101086R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34878671				2022-12-28	WOS:000734992000045
J	Tu, XK; Zhang, HB; Chen, S; Ding, YH; Wu, XY; Liang, RS; Shi, SS				Tu, Xiankun; Zhang, Huabin; Chen, Song; Ding, Yi-Hang; Wu, Xiyao; Liang, Risheng; Shi, Song-Sheng			LncRNA CEBPA-AS1 alleviates cerebral ischemia-reperfusion injury by sponging miR-340-5p regulating APPL1/LKB1/AMPK pathway	FASEB JOURNAL			English	Article						APPL1; LKB1; AMPK pathway; CEBPA-AS1; cerebral ischemia-reperfusion injury; MCAO; IR rat model; miR-340-5p	RAT MODEL; BETA-CATENIN; AMINO-ACIDS; STEM-CELLS; PROMOTES; BRAIN; APPL1; EXPRESSION; PROTECTS	Long non-coding RNAs (lncRNAs) regulate neurological damage in cerebral ischemia-reperfusion injury (CIRI). This study aimed to investigate the biological roles of lncRNA CEBPA-AS1 in CIRI. Middle cerebral artery occlusion and ischemia-reperfusion injury (MCAO/IR) rat model and oxygen-glucose deprivation and reoxygenation (OGD/R) cell lines were generated; the expression of CEBPA-AS1 was evaluated by qRT-PCR. The effects of CEBPA-AS1 on cell apoptosis and nerve damage were examined. The downstream microRNA (miRNA) and mRNA of CEBPA-AS1 were predicted and verified. We found that overexpression of CEBPA-AS1 could attenuate MCAO/IR-induced nerve damage and neuronal apoptosis in the rat model. Knockdown of CEBPA-AS1 aggravated cell apoptosis and enhanced the production of LDH and MDA in the OGD/R cells. Upon examining the molecular mechanisms, we found that CEBPA-AS1 stimulated APPL1 expression by combining with miR-340-5p, thereby regulating the APPL1/LKB1/AMPK pathway. In the rescue experiments, CEBPA-AS1 overexpression was found to attenuate OGD/R-induced cell apoptosis and MCAO/IR induced nerve damage, while miR-340-5p reversed these effects of CEBPA-AS1. In conclusion, CEBPA-AS1 could decrease CIRI by sponging miR-340-5, regulating the APPL1/LKB1/AMPK pathway.	[Tu, Xiankun; Zhang, Huabin; Chen, Song; Ding, Yi-Hang; Wu, Xiyao; Liang, Risheng; Shi, Song-Sheng] Fujian Med Univ, Neurosurg Inst Fujian Prov, Dept Neurosurg, Union Hosp, Fuzhou, Peoples R China	Fujian Medical University	Tu, XK; Liang, RS (corresponding author), Fujian Med Univ, Union Hosp, Dept Neurosurg, 29 Xinquan Rd, Fuzhou 350001, Fujian, Peoples R China.	unionnstu@hotmail.com; doctorlr@163.com			Joint Funds for the Innovation of Science and Technology of Fujian province of China, [2018Y9004]; Qihang Foundation Project of Fujian Medical University of China [2019Q111055]	Joint Funds for the Innovation of Science and Technology of Fujian province of China,; Qihang Foundation Project of Fujian Medical University of China	The Joint Funds for the Innovation of Science and Technology of Fujian province of China, Grant/Award Number: 2018Y9004: Qihang Foundation Project of Fujian Medical University of China, Grant/Award Number: 2019Q111055	Bie XD, 2007, ASIA PAC J CLIN NUTR, V16, P305; Chiang T, 2011, JOVE-J VIS EXP, DOI 10.3791/2761; Cho J, 2004, BIOL PHARM BULL, V27, P1561, DOI 10.1248/bpb.27.1561; Di GF, 2021, MOL CELL BIOL, V41, DOI 10.1128/MCB.00065-21; Du KW, 2017, EUR J CELL BIOL, V96, P496, DOI 10.1016/j.ejcb.2017.07.002; Guo SL, 2018, NEUROREPORT, V29, P1193, DOI 10.1097/WNR.0000000000001095; Guo Y, 2018, CANCER BIOL THER, V19, P205, DOI 10.1080/15384047.2017.1416276; He WZ, 2018, HUM GENE THER, V29, P719, DOI 10.1089/hum.2017.064; HOSSMANN KA, 1973, Z NEUROL, V204, P281, DOI 10.1007/BF00316009; [黄学平 Huang Xueping], 2017, [中华行为医学与脑科学杂志, Chinese Journal of Behavioral Medicine and Brain Science], V26, P395; Ke D, 2017, ONCOTARGET, V8, P21516, DOI 10.18632/oncotarget.15628; Kovalska M, 2012, NEUROCHEM RES, V37, P1568, DOI 10.1007/s11064-012-0752-y; Li J, 2007, STRUCTURE, V15, P525, DOI 10.1016/j.str.2007.03.011; Liu YR, 2014, NEUROL SCI, V35, P1229, DOI 10.1007/s10072-014-1687-7; [梅和珊 MEI Heshan], 2005, [中国药学杂志, Chinese Pharmaceutical Journal], V40, P1713; Mohammed MA, 2019, STEROIDS, V144, P1, DOI 10.1016/j.steroids.2019.01.004; Onwuekwe IO, 2012, ANN MED HEALTH SCI R, V2, P186, DOI 10.4103/2141-9248.105669; Rice AP, 2015, WIRES RNA, V6, P661, DOI 10.1002/wrna.1308; Richard JLC, 2018, SLAS TECHNOL, V23, P493, DOI 10.1177/2472630318780639; Subuddhi A, 2020, TUBERCULOSIS, V120, DOI 10.1016/j.tube.2019.101897; Tang YH, 2014, J CEREBR BLOOD F MET, V34, P1138, DOI 10.1038/jcbfm.2014.61; Wang YB, 2012, J NEUROSCI, V32, P11919, DOI 10.1523/JNEUROSCI.3852-11.2012; Wei Yuan-yuan, 2008, Zhen Ci Yan Jiu, V33, P287; Wozniak M, 2015, EXP MOL PATHOL, V99, P707, DOI 10.1016/j.yexmp.2015.11.014; Xin X, 2011, AM J PHYSIOL-ENDOC M, V300, pE103, DOI 10.1152/ajpendo.00427.2010; Xing XS, 2015, MOL MED REP, V11, P3122, DOI 10.3892/mmr.2014.3000; Xu NB, 2018, NEUROPHARMACOLOGY, V133, P415, DOI 10.1016/j.neuropharm.2018.02.024; Yang BB, 2015, CURR NEUROVASC RES, V12, P63, DOI 10.2174/1567202612666150102152350; Zhang J, 2015, J STROKE CEREBROVASC, V24, P1471, DOI 10.1016/j.jstrokecerebrovasdis.2015.02.008; Zhang M, 2019, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01527; Zheng PD, 2018, NEURAL REGEN RES, V13, P1204, DOI 10.4103/1673-5374.232476; Zheng YK, 2020, NEUROCHEM INT, V134, DOI 10.1016/j.neuint.2019.104650	32	1	1	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22075	10.1096/fj.202100826RR	http://dx.doi.org/10.1096/fj.202100826RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34919285				2022-12-28	WOS:000734992000048
J	Yang, CY; Chang, PY; Wu, BS; Tarng, DC; Lee, OKS				Yang, Chih-Yu; Chang, Pu-Yuan; Wu, Bo-Sheng; Tarng, Der-Cherng; Lee, Oscar Kuang-Sheng			Mechanical and chemical cues synergistically promote human venous smooth muscle cell osteogenesis through integrin beta 1-ERK1/2 signaling: A cell model of hemodialysis fistula calcification	FASEB JOURNAL			English	Article						arteriovenous fistula; hyperphosphatemia; osteogenesis; shear stress; venous smooth muscle cell	WALL SHEAR-STRESS; VASCULAR ACCESS CALCIFICATION; OSTEOBLASTIC DIFFERENTIATION; ARTERIAL ENLARGEMENT; DOWN-REGULATION; PROLIFERATION; EXPRESSION; ACTIVATION; SCLEROSTIN; INHIBITOR	Arteriovenous fistula (AVF) is the vascular access of choice for renal replacement therapy. However, AVF is susceptible to calcification with a high prevalence of 40%-65% in chronic hemodialysis patients. Repeated needle puncture for hemodialysis cannulation results in intimal denudation of AVF. We hypothesized that exposure to blood shear stress in the medial layer promotes venous smooth muscle cell (SMC) osteogenesis. While previous studies of shear stress focused on arterial-type SMCs, SMCs isolated from the vein had not been investigated. This study established a venous cell model of AVF using the fluid shear device, combined with a high phosphate medium to mimic the uremic milieu. Osteogenic gene expression of venous SMCs upon mechanical and chemical cues was analyzed in addition to the activated cell signaling pathways. Our findings indicated that upon shear stress and high phosphate environment, mechanical stimulation (shear stress) had an additive effect in up-regulation of an early osteogenic marker, Runx2. We further identified that the integrin beta 1-ERK1/2 signaling pathway was responsible for the molecular basis of venous SMC osteogenesis upon shear stress exposure. Mitochondrial biogenesis also took part in the early stage of this venopathy pathogenesis, evident by the up-regulated mitochondrial transcription factor A and mitochondrial DNA polymerase gamma in venous SMCs. In conclusion, synergistic effects of fluid shear stress and high phosphate induce venous SMC osteogenesis via the ERK1/2 pathway through activating the mechanosensing integrin beta 1 signaling. The present study identified a promising druggable target for reducing AVF calcification, which deserves further in vivo investigations.	[Yang, Chih-Yu; Chang, Pu-Yuan; Wu, Bo-Sheng; Tarng, Der-Cherng; Lee, Oscar Kuang-Sheng] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Sch Med, 2F,Shou Ren Bldg 155,Sec 2,Li Nong St, Taipei 11221, Taiwan; [Yang, Chih-Yu; Wu, Bo-Sheng; Tarng, Der-Cherng; Lee, Oscar Kuang-Sheng] Natl Yang Ming Chiao Tung Univ, Sch Med, Fac Med, Taipei, Taiwan; [Yang, Chih-Yu; Tarng, Der-Cherng] Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan; [Yang, Chih-Yu; Tarng, Der-Cherng] Ctr Intelligent Drug Syst & Smart Bio Devices IDS, Minist Educ, Taipei, Taiwan; [Yang, Chih-Yu; Lee, Oscar Kuang-Sheng] Natl Yang Ming Chiao Tung Univ, Stem Cell Res Ctr, Taipei, Taiwan; [Lee, Oscar Kuang-Sheng] China Med Univ Hosp, Dept Orthoped, Taichung, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Yang, CY (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Sch Med, 2F,Shou Ren Bldg 155,Sec 2,Li Nong St, Taipei 11221, Taiwan.; Yang, CY (corresponding author), Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan.	cyyang3@vghtpe.gov.tw		Yang, Chih-Yu/0000-0001-9899-3159	School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan [107F-M01-0504, 107F-M01-0510]; Ministry of Science and Technology, Taiwan [MOST 105-2628-B-075-008-MY3, MOST 108-2923-B-010-002-MY3, MOST 108-2813-C-010-034-B, MOST 109-2314-B-010-053-MY3, MOST 109-2926-I-010-502, MOST 109-2823-8-010-003-CV, MOST 109-2811-B]	School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The authors acknowledge the financial support for research purposes by the "Yin Yen--Liang Foundation Development and Construction Plan" of the School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan (107F-M01-0504 and 107F-M01-0510), the Ministry of Science and Technology, Taiwan (MOST 105-2628-B-075-008-MY3, MOST 108-2923-B-010-002-MY3, MOST 108-2813-C-010-034-B, MOST 109-2314-B-010-053-MY3, MOST 109-2926-I-010-502, MOST 109-2823-8-010-003-CV, MOST 109-2811-B-	Adragao T, 2008, KIDNEY INT, V74, P1505, DOI 10.1038/ki.2008.503; Alesutan I, 2020, J MOL MED, V98, P985, DOI 10.1007/s00109-020-01925-8; Asada H, 2005, J VASC SURG, V42, P772, DOI 10.1016/j.jvs.2005.05.046; Balci M, 2015, HERZ, V40, P289, DOI 10.1007/s00059-013-3992-y; Becker A, 2004, J INORG BIOCHEM, V98, P2032, DOI 10.1016/j.jinorgbio.2004.09.006; Bing HT, 2006, J CELL BIOCHEM, V99, P1343, DOI 10.1002/jcb.20999; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Chen NX, 2018, KIDNEY INT, V93, P343, DOI 10.1016/j.kint.2017.07.019; Delany AM, 2003, ENDOCRINOLOGY, V144, P2588, DOI 10.1210/en.2002-221044; Durham AL, 2018, CARDIOVASC RES, V114, P590, DOI 10.1093/cvr/cvy010; Feng H, 2019, ANTIOXID REDOX SIGN, V31, P75, DOI 10.1089/ars.2018.7620; Fitzgerald TN, 2008, J CELL PHYSIOL, V216, P389, DOI 10.1002/jcp.21404; Garanich JS, 2005, AM J PHYSIOL-HEART C, V288, pH2244, DOI 10.1152/ajpheart.00428.2003; Goldsmith D, 2004, KIDNEY INT, V66, P1315, DOI 10.1111/j.1523-1755.2004.00895.x; Guzman RJ, 1997, SURGERY, V122, P273, DOI 10.1016/S0039-6060(97)90018-0; Guzman RJ, 2002, J SURG RES, V108, P112, DOI 10.1006/jsre.2002.6530; Haga M, 2003, J VASC SURG, V37, P1277, DOI 10.1016/S0741-5214(03)00329-X; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; HOLLAND PWH, 1987, J CELL BIOL, V105, P473, DOI 10.1083/jcb.105.1.473; Huang J, 2013, INT J MOL MED, V32, P423, DOI 10.3892/ijmm.2013.1398; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jankovic A, 2017, INT UROL NEPHROL, V49, P881, DOI 10.1007/s11255-017-1515-0; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Kang HY, 2017, SCI REP-UK, V7, DOI 10.1038/srep42092; Kang HY, 2011, AM J PHYSIOL-HEART C, V300, pH76, DOI 10.1152/ajpheart.00905.2010; Kim SM, 2019, ANN VASC SURG, V58, P331, DOI 10.1016/j.avsg.2018.10.057; Kim SA, 2017, BIOCHEM BIOPH RES CO, V490, P1369, DOI 10.1016/j.bbrc.2017.07.033; Kirkpantur A, 2016, NEFROLOGIA, V36, P24, DOI 10.1016/j.nefro.2015.07.006; Koga N, 1989, ASAIO Trans, V35, P193, DOI 10.1097/00002480-198907000-00005; Kreke MR, 2008, TISSUE ENG PT A, V14, P529, DOI 10.1089/tea.2007.0068; Kreke MR, 2005, BONE, V36, P1047, DOI 10.1016/j.bone.2005.03.008; Krishnamoorthy MK, 2008, KIDNEY INT, V74, P1410, DOI 10.1038/ki.2008.379; Lam CF, 2006, AM J PHYSIOL-HEART C, V290, pH786, DOI 10.1152/ajpheart.00759.2005; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lee AR, 2019, ARCH PHARM RES, V42, P1052, DOI 10.1007/s12272-019-01198-x; Liang QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033126; Liao XB, 2008, AMINO ACIDS, V34, P525, DOI 10.1007/s00726-007-0003-8; Lin MC, 2009, KIDNEY INT, V75, P1117, DOI 10.1038/ki.2009.34; Lu X, 2001, AM J PHYSIOL-HEART C, V280, pH1547, DOI 10.1152/ajpheart.2001.280.4.H1547; Lu ZF, 2008, BIOCHEM BIOPH RES CO, V372, P547, DOI 10.1016/j.bbrc.2008.05.063; Ma WQ, 2019, MOL CELL ENDOCRINOL, V479, P39, DOI 10.1016/j.mce.2018.08.012; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Moon DK, 2020, J ORTHOP SURG RES, V15, DOI 10.1186/s13018-020-01684-9; Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7; Nanjo H, 2006, EXP MOL PATHOL, V80, P38, DOI 10.1016/j.yexmp.2005.04.005; Olsson LF, 2001, AM J KIDNEY DIS, V38, P377, DOI 10.1053/ajkd.2001.26104; Palumbo R, 2000, CIRCULATION, V102, P225, DOI 10.1161/01.CIR.102.2.225; Papadaki M, 1996, BIOTECHNOL BIOENG, V50, P555, DOI 10.1002/(SICI)1097-0290(19960605)50:5<555::AID-BIT10>3.0.CO;2-I; Qiu JH, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0852; Rajabi-Jagahrgh E, 2013, SEMIN DIALYSIS, V26, P511, DOI 10.1111/sdi.12045; REIDY MA, 1985, AM J PATHOL, V118, P173; Roca-Tey R, 2009, NEFROLOGIA, V29, P214, DOI 10.3265/Nefrologia.2009.29.3.5103.en.full; Schlieper G, 2008, KIDNEY INT, V74, P1582, DOI 10.1038/ki.2008.458; Shi ZD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012196; Sho E, 2004, J VASC SURG, V39, P601, DOI 10.1016/j.jvs.2003.10.058; Sho M, 2002, EXP MOL PATHOL, V72, P150, DOI 10.1006/exmp.2002.2426; Singh TM, 1998, J SURG RES, V77, P165, DOI 10.1006/jsre.1998.5376; Sugiyama T, 1997, ARTERIOSCL THROM VAS, V17, P3083, DOI 10.1161/01.ATV.17.11.3083; Sullivan RJ, 2018, CANCER DISCOV, V8, P184, DOI 10.1158/2159-8290.CD-17-1119; Toth A, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100963; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Ueba H, 1997, ARTERIOSCL THROM VAS, V17, P1512, DOI 10.1161/01.ATV.17.8.1512; Wang HQ, 2007, EUR J CELL BIOL, V86, P51, DOI 10.1016/j.ejcb.2006.09.001; Wu W, 2011, CIRCULATION, V124, P633, DOI 10.1161/CIRCULATIONAHA.110.005108; Zhang LL, 2016, EUR J PHARMACOL, V792, P15, DOI 10.1016/j.ejphar.2016.10.023; Zhang ZQ, 2016, CELL PHYSIOL BIOCHEM, V39, P423, DOI 10.1159/000445636; Zhu DX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019595; Zhu Y, 2019, CELL SIGNAL, V58, P53, DOI 10.1016/j.cellsig.2019.03.006; Zoch ML, 2016, BONE, V82, P42, DOI 10.1016/j.bone.2015.05.046	69	0	0	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22042	10.1096/fj.202101064RR	http://dx.doi.org/10.1096/fj.202101064RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34758125				2022-12-28	WOS:000722321300050
J	Charalambakis, NE; Ambulos, NP; Hockberger, P; Meyn, SM; Bowen, SK; Constable, S; Fisher, NC; Fletcher, L; Kigenyi, J; Mundoma, C; Ramirez-Aguilar, KA; Vinard, A; Winn, ME; Mische, SM				Charalambakis, Naomi E.; Ambulos, Nicholas P., Jr.; Hockberger, Philip; Meyn, Susan M.; Bowen, Sara K.; Constable, Susan; Fisher, Nancy C.; Fletcher, Luellen; Kigenyi, Justine; Mundoma, Claudius; Ramirez-Aguilar, Kathryn A.; Vinard, Andrew; Winn, Mary E.; Mische, Sheenah M.			Establishing a national strategy for shared research resources in biomedical sciences	FASEB JOURNAL			English	Article								Contemporary science has become increasingly multi-disciplinary and team-based, resulting in unprecedented growth in biomedical innovation and technology over the last several decades. Collaborative research efforts have enabled investigators to respond to the demands of an increasingly complex 21st century landscape, including pressing scientific challenges such as the COVID-19 pandemic. A major contributing factor to the success of team science is the mobilization of core facilities and shared research resources (SRRs), the scientific instrumentation and expertise that exist within research organizations that enable widespread access to advanced technologies for trainees, faculty, and staff. For over 40 years, SRRs have played a key role in accelerating biomedical research discoveries, yet a national strategy that addresses how to leverage these resources to enhance team science and achieve shared scientific goals is noticeably absent. We believe a national strategy for biomedical SRRs-led by the National Institutes of Health-is crucial to advance key national initiatives, enable long-term research efficiency, and provide a solid foundation for the next generation of scientists.	[Charalambakis, Naomi E.] Federat Amer Soc Expt Biol, Rockville, MD 20847 USA; [Ambulos, Nicholas P., Jr.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Ctr Innovat Biomed Resources, Baltimore, MD 21201 USA; [Hockberger, Philip] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Meyn, Susan M.] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Bowen, Sara K.] Barrow Neurol Inst, Flow Cytometry Core, Phoenix, AZ 85013 USA; [Constable, Susan] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Fisher, Nancy C.] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA; [Fletcher, Luellen] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kigenyi, Justine] Univ Kansas, Med Ctr, Hoglund Biomed Imaging Ctr, Kansas City, KS 66103 USA; [Mundoma, Claudius] Univ Colorado, Res & Innovat Off, Boulder, CO 80309 USA; [Ramirez-Aguilar, Kathryn A.] Univ Colorado, Environm Ctr, Boulder, CO 80309 USA; [Vinard, Andrew] Univ Massachusetts, Inst Appl Life Sci, Amherst, MA 01003 USA; [Winn, Mary E.] Van Andel Inst, Grand Rapids, MI USA; [Mische, Sheenah M.] NYU, Langone Med Ctr, New York, NY USA	University System of Maryland; University of Maryland Baltimore; Northwestern University; Feinberg School of Medicine; Vanderbilt University; Barrow Neurological Institute; H Lee Moffitt Cancer Center & Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; Pennsylvania Medicine; University of Kansas; University of Kansas Medical Center; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Massachusetts System; University of Massachusetts Amherst; Van Andel Institute; New York University; NYU Langone Medical Center	Charalambakis, NE (corresponding author), Federat Amer Soc Expt Biol, Rockville, MD 20847 USA.	ncharalambakis@faseb.org		Mische, Sheenah/0000-0002-6055-5564				Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; [Anonymous], 2021, CU GREEN LABS PROGR; Centers for Disease Control and Prevention, 2021, COVID 19 GEN EP TOOL; Daniels RJ, 2015, P NATL ACAD SCI USA, V112, P313, DOI 10.1073/pnas.1418761112; Farber GK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002421; Federation of American Societies for Experimental Biology, 2021, FASEB SHAR RES RES R; Federation of American Societies for Experimental Biology, 2021, MAX SHAR RES RES 3; Fletcher L., 2021, INNOVATE BIO NAT BIO; Greever C, 2020, FEBS LETT, V594, P3079, DOI 10.1002/1873-3468.13932; Meder D, 2016, EMBO REP, V17, P1088, DOI 10.15252/embr.201642857; Mische Sheenah M, 2020, J Biomol Tech, V31, P11, DOI 10.7171/jbt.20-3101-003; National Academies of Sciences Engineering and Medicine, 2021, LEARN RAP RESP INN A, DOI [10.17226/26131, DOI 10.17226/26131]; National Academies of Sciences Engineering and Medicine, 2019, REPRODUCIBILITY REPL, DOI [10.17226/25303, DOI 10.17226/25303]; National Institutes of Health, 2011, NOTOD12026 NIH NAT C; The Nobel Prize Organization, 2021, ALL NOB PRIZ; Tilghman S, 2021, SCIENCE, V372, P133, DOI 10.1126/science.abf9679	16	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21973	10.1096/fj.202101393	http://dx.doi.org/10.1096/fj.202101393			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34624149				2022-12-28	WOS:000712009200018
J	Kim, HY; Ahn, SB; Hong, JM; Oh, JH; Saeed, WK; Kim, GS; Kim, H; Kang, JK; Kang, S; Jun, DW				Kim, Hye Young; Ahn, Sang Bong; Hong, Jeong-Min; Oh, Ju Hee; Saeed, Waqar Khalid; Kim, Gyu Sik; Kim, Hyun; Kang, Jong Koo; Kang, Sukmo; Jun, Dae Won			BTT-105 ameliorates hepatic fibrosis in non-alcoholic fatty liver animal model	FASEB JOURNAL			English	Article						BTT-105; fibrosis; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; Nrf2	NRF2; MECHANISMS; 1-O-HEXYL-2,3,5-TRIMETHYLHYDROQUINONE; PROGRESSION; ACTIVATION; HX-1171	BTT-105 (1-O-hexyl-2,3,5-trimethylhydroquinone), a hydroquinone derivative, is a potent anti-oxidant that was safe and tolerable in phase I clinical trial. This study examined the anti-fibrotic effect of BTT-105 in a mouse model of non-alcoholic fatty liver disease (NAFLD) along with the underlying mechanisms. In vivo, efficacy of BTT-105 evaluated from three kinds of NAFLD models (methionine/choline deficient diet (MCD), high fat diet (HF) and western diet (WD)). Metabolomics and transcriptomics profiling analysis in liver tissues were conducted. In vitro, anti-fibrotic effect of BTT-105 assessed in human hepatic stellated cells (HSCs) and primary mouse HSCs. BTT-105 improved NAFLD activity score in three kinds of NAFLD animal models (MCD, HF, and WD). BTT-105 also decreased levels of hepatic pro-collagen and collagen fibers deposition in liver tissue. Metabolome and transcriptome analysis revealed that BTT-105 decreased lipid metabolites and increased antioxidants in NAFLD mice. In HepG2 cells, BTT-105 enhanced Nrf2-ARE reporter activity in a dose-dependent manner and increased the levels of antioxidant gene expression. BTT-105 showed inhibition of HSCs activation and migration. Gene expression profiling and protein expression showed that BTT-105 increased Nrf2 activation as well as decreased PI3K-Akt pathway in activated HSCs. BTT-105 attenuated ameliorates steatohepatitis and hepatic fibrosis.	[Kim, Hye Young; Oh, Ju Hee; Jun, Dae Won] Hanyang Univ, Grad Sch Biomed Sci & Engn, Dept Translat Med, Seoul, South Korea; [Ahn, Sang Bong] Eulji Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Hong, Jeong-Min; Kim, Gyu Sik; Kim, Hyun; Kang, Jong Koo; Kang, Sukmo] Biotoxtech Co Ltd, Cheongju, South Korea; [Saeed, Waqar Khalid; Jun, Dae Won] Hanyang Univ, Sch Med, Dept Internal Med, 17 Haengdang Dong, Seoul 133792, South Korea	Hanyang University; Eulji University; Hanyang University	Jun, DW (corresponding author), Hanyang Univ, Sch Med, Dept Internal Med, 17 Haengdang Dong, Seoul 133792, South Korea.; Kang, S (corresponding author), Biotoxtech Co Ltd, Res Planning Off, 53 Yeongudanji Ro, Cheongju, Chungcheongbuk, South Korea.	smkang@biotoxtech.com; noshin@hanyang.ac.kr	Jun, Dae Won/O-4529-2017	Jun, Dae Won/0000-0002-2875-6139; Oh, Ju Hee/0000-0003-2864-7677	National Research Foundation of Korea [2020R1A2C2009227, 2017R1C1B5074215]; Biotoxtech	National Research Foundation of Korea(National Research Foundation of Korea); Biotoxtech	This research was supported by grants from National Research Foundation of Korea (2020R1A2C2009227, 2017R1C1B5074215), and Biotoxtech.	Akazawa Y, 2018, J GASTROENTEROL, V53, P893, DOI 10.1007/s00535-018-1451-5; An J, 2010, HEPATOL RES, V40, P613, DOI 10.1111/j.1872-034X.2010.00638.x; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Chae YJ, 2019, J KOREAN MED SCI, V34, DOI 10.3346/jkms.2019.34.e14; Chambel SS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/597134; DULLAART RPF, 1993, KIDNEY INT, V44, P91, DOI 10.1038/ki.1993.217; Gan LT, 2014, J HEPATOL, V61, P1376, DOI 10.1016/j.jhep.2014.07.024; Guan YD, 2018, DIGEST DIS SCI, V63, P366, DOI 10.1007/s10620-017-4710-z; Hino T, 1998, BBA-GEN SUBJECTS, V1425, P47, DOI 10.1016/S0304-4165(98)00050-6; Hollie NI, 2014, BBA-MOL CELL BIOL L, V1841, P888, DOI 10.1016/j.bbalip.2013.11.013; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Jung YR, 2010, TOX RESEARCH, V26, P193, DOI 10.5487/TR.2010.26.3.193; Kakisaka K, 2012, AM J PHYSIOL-GASTR L, V302, pG77, DOI 10.1152/ajpgi.00301.2011; Kim Jimin, 2018, Oncotarget, V9, P24260, DOI 10.18632/oncotarget.24916; Kim J, 2017, J CELL BIOCHEM, V118, P3372, DOI 10.1002/jcb.25993; Kim YH, 2015, DRUG DES DEV THER, V9, P1735, DOI 10.2147/DDDT.S79724; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Law SH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051149; Li XF, 2017, ONCOTARGET, V8, P21015, DOI 10.18632/oncotarget.15472; Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004; Ni HM, 2014, J HEPATOL, V61, P617, DOI 10.1016/j.jhep.2014.04.043; Oh H, 2016, CLIN MOL HEPATOL, V22, P327, DOI 10.3350/cmh.2016.0049; Sharma RS, 2018, CELL MOL GASTROENTER, V5, P367, DOI 10.1016/j.jcmgh.2017.11.016; Son G, 2009, HEPATOLOGY, V50, P1512, DOI 10.1002/hep.23186; Son MK, 2013, SCI REP-UK, V3, DOI 10.1038/srep03470; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Uchida D, 2018, NUTRIENTS, V10, DOI 10.3390/nu10080977; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Xu DW, 2019, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01428; Zhong F, 2020, DIGESTION, V101, P522, DOI 10.1159/000501851	30	1	1	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21979	10.1096/fj.202002656RRR	http://dx.doi.org/10.1096/fj.202002656RRR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34694029				2022-12-28	WOS:000712009200008
J	Castro-Sepulveda, M; Morio, B; Tunon-Suarez, M; Jannas-Vela, S; Diaz-Castro, F; Rieusset, J; Zbinden-Foncea, H				Castro-Sepulveda, Mauricio; Morio, Beatrice; Tunon-Suarez, Mauro; Jannas-Vela, Sebastian; Diaz-Castro, Francisco; Rieusset, Jennifer; Zbinden-Foncea, Hermann			The fasting-feeding metabolic transition regulates mitochondrial dynamics	FASEB JOURNAL			English	Article						fasting; mitochondria-ER interaction; mitochondrial cristae; mitochondrial fusion; mitochondrial morphology; obesity	MEMBRANE MAM INTEGRITY; NUTRIENT AVAILABILITY; GENE-EXPRESSION; CRISTAE; LYMPHOCYTES; ADAPTATION; CLEAVAGE; FUSION	In humans, insulin resistance has been linked to an impaired metabolic transition from fasting to feeding (metabolic flexibility; MetFlex). Previous studies suggest that mitochondrial dynamics response is a putative determinant of MetFlex; however, this has not been studied in humans. Thus, the aim of this study was to investigate the mitochondrial dynamics response in the metabolic transition from fasting to feeding in human peripheral blood mononuclear cells (PBMCs). Six male subjects fasted for 16 h (fasting), immediately after which they consumed a 75-g oral glucose load (glucose). In both fasting and glucose conditions, blood samples were taken to obtain PBMCs. Mitochondrial dynamics were assessed by electron microscopy images. We exposed in vitro acetoacetate-treated PBMCs to the specific IP3R inhibitor Xestospongin B (XeB) to reduce IP3R-mediated mitochondrial Ca2+ accumulation. This allowed us to evaluate the role of ER-mitochondria Ca2+ exchange in the mitochondrial dynamic response to substrate availability. To determine whether PBMCs could be used in obesity context (low MetFlex), we measured mitochondrial dynamics in mouse spleen-derived lymphocytes from WT and ob/ob mice. We demonstrated that the transition from fasting to feeding reduces mitochondria-ER interactions, induces mitochondrial fission and reduces mitochondrial cristae density in human PBMCs. In addition, we demonstrated that IP3R activity is key in the mitochondrial dynamics response when PBMCs are treated with a fasting-substrate in vitro. In murine mononuclear-cells, we confirmed that mitochondria-ER interactions are regulated in the fasted-fed transition and we further highlight mitochondria-ER miscommunication in PBMCs of diabetic mice. In conclusion, our results demonstrate that the fasting/feeding transition reduces mitochondria-ER interactions, induces mitochondrial fission and reduces mitochondrial cristae density in human PBMCs, and that IP3R activity may potentially play a central role.	[Castro-Sepulveda, Mauricio; Tunon-Suarez, Mauro; Jannas-Vela, Sebastian; Zbinden-Foncea, Hermann] Univ Finis Terrae, Fac Med, Lab Ciencias Ejercicio, Escuela Kinesiol, Santiago, Chile; [Castro-Sepulveda, Mauricio] Pontificia Univ Catolica Chile, Fac Med, Santiago, Chile; [Morio, Beatrice; Rieusset, Jennifer] Univ Claude Bernard Lyon 1, CarMeN Lab, UMR INSERM U1060 INRA U13397, Pierre Benite, France; [Diaz-Castro, Francisco] Univ Chile, Inst Nutr & Tecnol Alimentos, Lab Invest Nutr & Actividad Fis LABINAF, Santiago, Chile; [Diaz-Castro, Francisco] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Lab Autofagia & Metabolismo, Santiago, Chile; [Zbinden-Foncea, Hermann] Clin Santa Maria, Ctr Salud Deport, Santiago, Chile	Universidad Finis Terrae; Pontificia Universidad Catolica de Chile; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universidad de Chile; Pontificia Universidad Catolica de Chile	Castro-Sepulveda, M; Zbinden-Foncea, H (corresponding author), Univ Finis Terrae, Fac Med, Lab Ciencias Ejercicio, Av Pedro de Valdivia 1509, Santiago, Chile.; Castro-Sepulveda, M; Zbinden-Foncea, H (corresponding author), Univ Finis Terrae, Fac Med, Lab Ciencias Ejercicio, Av Pedro de Valdivia 1509, Providencia, Chile.	mcastro@uft.cl; hzbinden@uft.cl	Carmen, Team2/Y-7383-2019; Rieusset, Jennifer/F-1595-2018; Morio, Beatrice/G-3571-2018	Carmen, Team2/0000-0001-9867-5724; Zbinden-Foncea, Hermann/0000-0002-9643-1037; Rieusset, Jennifer/0000-0002-1587-2253; Tunon Suarez, Mauro/0000-0002-3085-9057; Diaz-Castro, Francisco/0000-0003-1644-8742; Lab, Carmen/0000-0002-5935-3236; Morio, Beatrice/0000-0002-2418-1438	Universidad Finis Terrae [CAI 2019]; Universidad Finis Terrae	Universidad Finis Terrae; Universidad Finis Terrae	This study was funded by Research Grant awarded to MCS by Universidad Finis Terrae (Grant no. CAI 2019). The work was further supported by Universidad Finis Terrae through projects grants awarded to HZF	Ahumada-Castro U, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.629522; Begaye B, 2020, DIABETES, V69, P181, DOI 10.2337/db19-0719; Bouwens M, 2007, AM J CLIN NUTR, V86, P1515, DOI 10.1093/ajcn/86.5.1515; BOYUM A, 1976, SCAND J IMMUNOL, P9, DOI 10.1111/j.1365-3083.1976.tb03851.x; Briet F, 2003, CLIN NUTR, V22, P247, DOI 10.1016/S0261-5614(02)00233-9; Castro-Sepulveda M, 2021, FASEB J, V35, DOI 10.1096/fj.202002615RR; Castro-Sepulveda M, 2020, AM J PHYSIOL-ENDOC M, V318, pE848, DOI 10.1152/ajpendo.00025.2020; Castillo DD, 2011, J BIOL CHEM, V286, P23911, DOI 10.1074/jbc.M111.252056; de Mello VDF, 2012, MOL NUTR FOOD RES, V56, P1160, DOI 10.1002/mnfr.201100685; del Campo A, 2018, AGING-US, V10, P34, DOI 10.18632/aging.101358; Dlaskova A, 2018, BBA-BIOENERGETICS, V1859, P829, DOI 10.1016/j.bbabio.2018.04.013; Echeverria F, 2021, BRIT J NUTR, V126, P825, DOI 10.1017/S000711452000481X; Eisner V, 2018, NAT CELL BIOL, V20, P755, DOI 10.1038/s41556-018-0133-0; Fernandez-Verdejo R, 2020, OBESITY, V28, P1110, DOI 10.1002/oby.22783; Fernandez-Verdejo R, 2018, AM J PHYSIOL-ENDOC M, V315, pE715, DOI 10.1152/ajpendo.00126.2018; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Gambardella J, 2021, EXPERT OPIN DRUG DIS, V16, P709, DOI 10.1080/17460441.2021.1858792; Gao AW, 2014, EMBO MOL MED, V6, P580, DOI 10.1002/emmm.201303782; Gottschalk B, 2018, PFLUG ARCH EUR J PHY, V470, P1193, DOI 10.1007/s00424-018-2133-0; Ivanova H, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a035089; Khan H, 2019, CELL REP, V29, P3009, DOI 10.1016/j.celrep.2019.11.007; Kondadi AK, 2020, TRENDS CELL BIOL, V30, P923, DOI 10.1016/j.tcb.2020.08.008; Lee JY, 2014, J CELL SCI, V127, P4954, DOI 10.1242/jcs.157321; Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; Morabito C, 2011, ACTA PHYSIOL, V202, P69, DOI 10.1111/j.1748-1716.2010.02247.x; Picard M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7259; Picard M, 2013, J APPL PHYSIOL, V115, P1562, DOI 10.1152/japplphysiol.00819.2013; Plecita-Hlavata L, 2016, FASEB J, V30, P1941, DOI 10.1096/fj.201500176; Roest G, 2017, ADV EXP MED BIOL, V981, P149, DOI 10.1007/978-3-319-55858-5_7; Rose S, 2019, AM J PHYSIOL-ENDOC M, V317, pE503, DOI 10.1152/ajpendo.00084.2019; Salewskij K, 2020, BBA-BIOENERGETICS, V1861, DOI 10.1016/j.bbabio.2019.148091; Senyilmaz-Tiebe D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05614-6; Sood A, 2014, P NATL ACAD SCI USA, V111, P16017, DOI 10.1073/pnas.1408061111; Theurey P, 2017, TRENDS ENDOCRIN MET, V28, P32, DOI 10.1016/j.tem.2016.09.002; Theurey P, 2016, J MOL CELL BIOL, V8, P129, DOI 10.1093/jmcb/mjw004; Tubbs E, 2018, DIABETES, V67, P636, DOI 10.2337/db17-0316; Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751; Zeng YC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111816	39	4	4	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21891	10.1096/fj.202100929R	http://dx.doi.org/10.1096/fj.202100929R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34569666				2022-12-28	WOS:000702238200066
J	Chen, QC; Fang, W; Cui, K; Chen, Q; Xiang, XJ; Zhang, JZ; Zhang, YQ; Mai, KS; Ai, QH				Chen, Qiuchi; Fang, Wei; Cui, Kun; Chen, Qiang; Xiang, Xiaojun; Zhang, Junzhi; Zhang, Yunqiang; Mai, Kangsen; Ai, Qinghui			Endoplasmic reticulum stress induces hepatic steatosis by transcriptional upregulating lipid droplet protein perilipin2	FASEB JOURNAL			English	Article						ER stress; hepatic steatosis; lipid droplet; lipoprotein; perilipin2	DIFFERENTIATION-RELATED PROTEIN; ER STRESS; FATTY LIVER; PPAR-ALPHA; EXPRESSION; SECRETION; ACCUMULATION; LIPOGENESIS; ROLES; ACTIVATION	Previous studies have shown that endoplasmic reticulum (ER) stress contributes to hepatic steatosis in several manners. However, how lipid droplet (LD) proteins participate in this process has rarely been reported. In the present study, ER stress was induced at both in vitro and in vivo levels with tunicamycin in large yellow croaker (Larimichthys crocea). Effects of LD protein perilipin2 (PLIN2) on hepatic lipid accumulation and lipoprotein transport under normal physiological condition and ER stress were then explored using dsRNA mediated knockdown. Subsequently, the transcriptional regulation of plin2 expression by transcription factors generated in the unfolded protein response (UPR) was determined by dual-luciferase reporter assays, chromatin immunoprecipitation and electrophoretic mobility-shift assay. We demonstrated that ER stress could promote LDs accumulation and inhibit lipoprotein transport by transcriptionally upregulating PLIN2 in liver. Among the transcription factors generated by UPR, spliced X-box binding protein1 can directly upregulated the expression of plin2, whereas C/EBP homologous protein can upregulate the expression of plin2 through peroxisome proliferator activated-receptor alpha. These results revealed that the LD protein PLIN2 played an important role in ER stress-induced hepatic steatosis, which might be a novel mechanism explaining hepatic steatosis triggered by ER stress.	[Chen, Qiuchi; Fang, Wei; Cui, Kun; Chen, Qiang; Xiang, Xiaojun; Zhang, Junzhi; Zhang, Yunqiang; Mai, Kangsen; Ai, Qinghui] Ocean Univ China, Key Lab Aquaculture Nutr & Feed, Minist Agr & Rural Affairs, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China; [Chen, Qiuchi; Fang, Wei; Cui, Kun; Chen, Qiang; Xiang, Xiaojun; Zhang, Junzhi; Zhang, Yunqiang; Mai, Kangsen; Ai, Qinghui] Ocean Univ China, Key Lab Mariculture, Minist Educ, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China; [Mai, Kangsen; Ai, Qinghui] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China	Ministry of Agriculture & Rural Affairs; Ocean University of China; Ocean University of China; Qingdao National Laboratory for Marine Science & Technology	Ai, QH (corresponding author), Ocean Univ China, Key Lab Aquaculture Nutr & Feed, Minist Agr & Rural Affairs, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China.; Ai, QH (corresponding author), Ocean Univ China, Key Lab Mariculture, Minist Educ, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China.	qhai@ouc.edu.cn			National Science Fund for Distinguished Young Scholars of China [31525024]; Key Program of National Natural Science Foundation of China [31830103]; Scientific and Technological Innovation of Blue Granary [2018YFD0900402]	National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Innovation of Blue Granary	The National Science Fund for Distinguished Young Scholars of China, Grant/Award Number: 31525024; Key Program of National Natural Science Foundation of China, Grant/Award Number: 31830103; The Scientific and Technological Innovation of Blue Granary, Grant/Award Number: 2018YFD0900402	Almanza A, 2019, FEBS J, V286, P241, DOI 10.1111/febs.14608; Basseri S, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/841362; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; Caviglia JM, 2011, J LIPID RES, V52, P1636, DOI 10.1194/jlr.M016931; Chandrahas VK., 2018, COORDINATING ORGANIS; Chang BHJ, 2010, J LIPID RES, V51, P2132, DOI 10.1194/jlr.M004515; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Dalen KT, 2006, J LIPID RES, V47, P931, DOI 10.1194/jlr.M500459-JLR200; DeZwaan-McCabe D, 2017, CELL REP, V19, P1794, DOI 10.1016/j.celrep.2017.05.020; Fei WH, 2009, BIOCHEM J, V424, P61, DOI 10.1042/BJ20090785; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Itabe H, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0473-y; Jacquier N, 2013, J CELL SCI, V126, P5198, DOI 10.1242/jcs.131896; Jo H, 2013, HEPATOLOGY, V57, P1366, DOI 10.1002/hep.26126; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kaplowitz N, 2007, SEMIN LIVER DIS, V27, P367, DOI 10.1055/s-2007-991513; Kersten S, 2017, BIOCHIMIE, V136, P75, DOI 10.1016/j.biochi.2016.12.019; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee JS, 2012, AM J TRANSL RES, V4, P102; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Li XH, 2012, J LIPID RES, V53, P1877, DOI 10.1194/jlr.M026591; Liao K, 2017, COMP BIOCHEM PHYS B, V203, P53, DOI 10.1016/j.cbpb.2016.09.005; Libby AE, 2016, J BIOL CHEM, V291, P24231, DOI 10.1074/jbc.M116.759795; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnusson B, 2006, ARTERIOSCL THROM VAS, V26, P1566, DOI 10.1161/01.ATV.0000223345.11820.da; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Moncan M, 2021, J CELL MOL MED, V25, P1359, DOI 10.1111/jcmm.16255; Najt CP, 2016, AM J PHYSIOL-GASTR L, V310, pG726, DOI 10.1152/ajpgi.00436.2015; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Rahman K, 2016, LAB INVEST, V96, P895, DOI 10.1038/labinvest.2016.61; Schubert M, 2020, MOL PHARMACOL, V97, P212, DOI 10.1124/mol.119.117887; Seo YS, 2008, J GASTROEN HEPATOL, V23, P102, DOI 10.1111/j.1440-1746.2006.04819.x; Sztalryd C, 2014, BIOCHIMIE, V96, P96, DOI 10.1016/j.biochi.2013.08.026; Velazquez AR, 2016, J CELL BIOL, V212, P621, DOI 10.1083/jcb.201508102; Wang SY, 2015, MOL BIOL CELL, V26, P594, DOI 10.1091/mbc.E14-08-1274; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu K, 2015, J CELL BIOCHEM, V116, P192, DOI 10.1002/jcb.24958; Zhang CY, 2017, PROTEIN CELL, V8, P796, DOI 10.1007/s13238-017-0467-6; Zhang JZ, 2020, FISH SHELLFISH IMMUN, V98, P112, DOI 10.1016/j.fsi.2019.12.089; Zhou HP, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00112	43	6	6	15	32	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21900	10.1096/fj.202100739RR	http://dx.doi.org/10.1096/fj.202100739RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34547130				2022-12-28	WOS:000702238200060
J	Dai, C; Reyes-Ordonez, A; You, JS; Chen, J				Dai, Chong; Reyes-Ordonez, Adriana; You, Jae-Sung; Chen, Jie			A non-translational role of threonyl-tRNA synthetase in regulating JNK signaling during myogenic differentiation	FASEB JOURNAL			English	Article						JNK signaling; myoblast; myogenesis; skeletal muscle regeneration; threonyl-tRNA synthetase	SKELETAL MYOGENESIS; PROTEIN-KINASE; COMPLEX; DISTINCT; MEKK1; EXPRESSION; NETWORKS; REVEALS; BINDING	Aminoacyl-tRNA synthetases (aaRSs) are house-keeping enzymes that are essential for protein synthesis. However, it has become increasingly evident that some aaRSs also have non-translational functions. Here we report the identification of a non-translational function of threonyl-tRNA synthetase (ThrRS) in myogenic differentiation. We find that ThrRS negatively regulates myoblast differentiation in vitro and injury-induced skeletal muscle regeneration in vivo. This function is independent of amino acid binding or aminoacylation activity of ThrRS, and knockdown of ThrRS leads to enhanced differentiation without affecting the global protein synthesis rate. Furthermore, we show that the non-catalytic new domains (UNE-T and TGS) of ThrRS are both necessary and sufficient for the myogenic function. In searching for a molecular mechanism of this new function, we find the kinase JNK to be a downstream target of ThrRS. Our data further reveal MEKK4 and MKK4 as upstream regulators of JNK in myogenesis and the MEKK4-MKK4-JNK pathway to be a mediator of the myogenic function of ThrRS. Finally, we show that ThrRS physically interacts with Axin1, disrupts Axin1-MEKK4 interaction and consequently inhibits JNK signaling. In conclusion, we uncover a non-translational function for ThrRS in the maintenance of homeostasis of skeletal myogenesis and identify the Axin1-MEKK4-MKK4-JNK signaling axis to be an immediate target of ThrRS action.	[Dai, Chong; Reyes-Ordonez, Adriana; You, Jae-Sung; Chen, Jie] Univ Illinois, Dept Cell & Dev Biol, 601 S Goodwin Ave,B107, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Chen, J (corresponding author), Univ Illinois, Dept Cell & Dev Biol, 601 S Goodwin Ave,B107, Urbana, IL 61801 USA.	jiechen@illinois.edu	You, Jae-Sung/ABF-6763-2020	You, Jae-Sung/0000-0001-7791-8563; Chen, Jie/0000-0002-7887-3747	National Institutes of Health [R01AR048914]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: R01AR048914	Andreucci JJ, 2002, J BIOL CHEM, V277, P16426, DOI 10.1074/jbc.M110891200; Arif A, 2017, NATURE, V542, P357, DOI 10.1038/nature21380; Arif A, 2011, P NATL ACAD SCI USA, V108, P1415, DOI 10.1073/pnas.1011275108; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; BREVET A, 1982, J BIOL CHEM, V257, P4613; Casciola-Rosen L, 2005, J EXP MED, V201, P591, DOI 10.1084/jem.20041367; CERINI C, 1991, EMBO J, V10, P4267, DOI 10.1002/j.1460-2075.1991.tb05005.x; Chal J, 2017, DEVELOPMENT, V144, P2104, DOI 10.1242/dev.151035; Chen Y, 2018, NUCLEIC ACIDS RES, V46, P3643, DOI 10.1093/nar/gky211; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Figeac N, 2015, CELL SIGNAL, V27, P1652, DOI 10.1016/j.cellsig.2015.03.025; Ge YJ, 2012, J BIOL CHEM, V287, P43928, DOI 10.1074/jbc.R112.406942; Ge YJ, 2011, J BIOL CHEM, V286, P35675, DOI 10.1074/jbc.M111.262881; Ge YJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1434, DOI 10.1152/ajpcell.00248.2009; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; He WW, 2015, NATURE, V526, P710, DOI 10.1038/nature15510; Hotamisligil GS, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a006072; Jang You-Na, 2013, JAKSTAT, V2, pe23282, DOI 10.4161/jkst.23282; Jeong SJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09086-0; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; Karalaki M, 2009, IN VIVO, V23, P779; Lessard SJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05439-3; Lo WS, 2014, SCIENCE, V345, P328, DOI 10.1126/science.1252943; Luo W, 2003, J BIOL CHEM, V278, P37451, DOI 10.1074/jbc.M305277200; Mahler M, 2014, AUTOIMMUN REV, V13, P367, DOI 10.1016/j.autrev.2014.01.022; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Page JL, 2004, J BIOL CHEM, V279, P30966, DOI 10.1074/jbc.M402224200; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Son K, 2019, J CLIN INVEST, V129, P2088, DOI 10.1172/JCI122560; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Wellman TL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-620; Williams TF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01317; Wolf YI, 1999, GENOME RES, V9, P689; Yoon MS, 2013, MOL BIOL CELL, V24, P3754, DOI 10.1091/mbc.E13-06-0353; Zhang Y, 1999, J BIOL CHEM, V274, P35247, DOI 10.1074/jbc.274.49.35247; Zhou XL, 2013, NUCLEIC ACIDS RES, V41, P302, DOI 10.1093/nar/gks982	44	1	1	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21948	10.1096/fj.202101094R	http://dx.doi.org/10.1096/fj.202101094R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34569098				2022-12-28	WOS:000702238200047
J	Zafar, A; Ng, HP; Kim, GD; Chan, ER; Mahabeleshwar, GH				Zafar, Atif; Ng, Hang Pong; Kim, Gun-Dong; Chan, E. Ricky; Mahabeleshwar, Ganapati H.			BHLHE40 promotes macrophage pro-inflammatory gene expression and functions	FASEB JOURNAL			English	Article						BHLHE40; glycolysis; HIF1 alpha; hypoxia; inflammation; macrophages	TRANSCRIPTIONAL REGULATION; INNATE; IMMUNITY; STRA13; CELLS	Macrophages are the principal innate immune cells that populate all major organs and provide the first line of cellular defense against infections and/or injuries. The immediate and early-responding macrophages must mount a robust pro-inflammatory response to protect the host by eliminating deleterious agents. The effective pro-inflammatory macrophage response requires the activation of complex transcriptional programs that modulate the dynamic regulation of inflammatory and metabolic gene expression. Therefore, transcription factors that govern pro-inflammatory and metabolic gene expression play an essential role in shaping the macrophage inflammatory response. Herein, we identify the basic helix-loop-helix family member e40 (BHLHE40), as a critical transcription factor that promotes broad pro-inflammatory and glycolytic gene expression by elevating HIF1 alpha levels in macrophages. Our in vivo studies revealed that myeloid-BHLHE40 deficiency significantly attenuates macrophage and neutrophil recruitment to the site of inflammation. Our integrated transcriptomics and gene set enrichment analysis (GSEA) studies show that BHLHE40 deficiency broadly curtails inflammatory signaling pathways, hypoxia response, and glycolytic gene expression in macrophages. Utilizing complementary gain- and loss-of-function studies, our analyses uncovered that BHLHE40 promotes LPS-induced HIF1 alpha mRNA and protein expression in macrophages. More importantly, forced overexpression of oxygen stable form of HIF1 alpha completely reversed attenuated pro-inflammatory and glycolytic gene expression in BHLHE40-deficient macrophages. Collectively, these results demonstrate that BHLHE40 promotes macrophage pro-inflammatory gene expression and functions by elevating expression in macrophages.	[Zafar, Atif; Ng, Hang Pong; Kim, Gun-Dong; Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Dept Pathol, Sch Med, 2103 Cornell Rd,Room WRB5527, Cleveland, OH 44106 USA; [Chan, E. Ricky] Case Western Reserve Univ, Cleveland Inst Computat Biol, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Mahabeleshwar, GH (corresponding author), Case Western Reserve Univ, Dept Pathol, Sch Med, 2103 Cornell Rd,Room WRB5527, Cleveland, OH 44106 USA.	ghm4@case.edu			Crohn's and Colitis Foundation of America (CCFA) [421904]; National Institutes of Health [HL126626, HL141423]	Crohn's and Colitis Foundation of America (CCFA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Crohn's and Colitis Foundation of America (CCFA), Grant/Award Number: 421904; National Institutes of Health, Grant/Award Number: HL126626 and HL141423	Backer V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190074; Choudhry H, 2018, CELL METAB, V27, P281, DOI 10.1016/j.cmet.2017.10.005; Cook ME, 2020, TRENDS IMMUNOL, V41, P1023, DOI 10.1016/j.it.2020.09.002; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Date D, 2014, J BIOL CHEM, V289, P10318, DOI 10.1074/jbc.M113.526749; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Hamidzadeh K, 2017, ANNU REV PHYSIOL, V79, P567, DOI 10.1146/annurev-physiol-022516-034348; Huynh JP, 2018, J EXP MED, V215, P1823, DOI 10.1084/jem.20171704; Ivanova AV, 2004, J MOL BIOL, V340, P641, DOI 10.1016/J.Jmb.2004.05.025; Jarjour NN, 2020, J IMMUNOL, V204, P923, DOI 10.4049/jimmunol.1900978; Jarjour NN, 2019, NAT IMMUNOL, V20, P687, DOI 10.1038/s41590-019-0382-5; Kanda M, 2016, P NATL ACAD SCI USA, V113, pE3394, DOI 10.1073/pnas.1604178113; Kim GD, 2021, AM J PATHOL, V191, P1118, DOI 10.1016/j.ajpath.2021.03.008; Kim GD, 2020, FASEB J, V34, P3209, DOI 10.1096/fj.201902221R; Kim GD, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00452-17; Kiss Zsofia, 2020, Genes Cancer, V11, P1, DOI 10.18632/genesandcancer.201; Lin CC, 2016, J EXP MED, V213, P251, DOI 10.1084/jem.20150568; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Lin N, 2016, J CLIN INVEST, V126, P3661, DOI 10.1172/JCI84426; Locati M, 2020, ANNU REV PATHOL-MECH, V15, P123, DOI 10.1146/annurev-pathmechdis-012418-012718; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Monticelli S, 2017, NAT REV IMMUNOL, V17, P595, DOI 10.1038/nri.2017.51; Newson J, 2014, BLOOD, V124, P1748, DOI 10.1182/blood-2014-03-562710; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Ow JR, 2014, CURR TOP DEV BIOL, V110, P317, DOI 10.1016/B978-0-12-405943-6.00009-9; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Piper C, 2020, BLOOD, V135, P568, DOI 10.1182/blood.2019001696; Rauschmeier R, 2019, EMBO J, V38, DOI 10.15252/embj.2018101233; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Sadiku P, 2019, EMBO REP, V20, DOI 10.15252/embr.201847388; Segal BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009631; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Van den Bossche J, 2017, TRENDS IMMUNOL, V38, P395, DOI 10.1016/j.it.2017.03.001; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Yu F, 2018, J EXP MED, V215, P1813, DOI 10.1084/jem.20170155; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zhang F, 2018, J PERIODONTAL RES, V53, P883, DOI 10.1111/jre.12578; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x	40	3	3	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21940	10.1096/fj.202100944R	http://dx.doi.org/10.1096/fj.202100944R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34551158	Green Accepted			2022-12-28	WOS:000702238200053
J	Zapateria, B; Sevillano, J; Sanchez-Alonso, MG; Limones, M; Pizarro-Delgado, J; Zuccaro, A; Herradon, G; Medina-Gomez, G; Ramos-Alvarez, MP				Zapateria, Begona; Sevillano, Julio; Gracia Sanchez-Alonso, Maria; Limones, Maria; Pizarro-Delgado, Javier; Zuccaro, Agata; Herradon, Gonzalo; Medina-Gomez, Gema; Pilar Ramos-Alvarez, Maria			Deletion of pleiotrophin impairs glucose tolerance and liver metabolism in pregnant mice: Moonlighting role of glycerol kinase	FASEB JOURNAL			English	Article						glycerol kinase; liver; metabolism; pleiotrophin; pregnancy	LIPID-METABOLISM; INSULIN-RESISTANCE; FAT; RAT; EXPRESSION; RECEPTORS; MITOGEN; MIDKINE	Pleiotrophin is a pleiotropic cytokine that has been demonstrated to have a critical role in regulating energy metabolism, lipid turnover and plasticity of adipose tissue. Here, we hypothesize that this cytokine can be involved in regulatory processes of glucose and lipid homeostasis in the liver during pregnancy. Using 18-days pregnant Ptn-deficient mice, we evaluated the biochemical profile (circulating variables), tissue mRNA expression (qPCR) and protein levels of key enzymes and transcription factors involved in main metabolic pathways. Ptn deletion was associated with a reduction in body weight gain, hyperglycemia and glucose intolerance. Moreover, we observed an impairment in glucose synthesis and degradation during late pregnancy in Ptn(-/-) mice. Hepatic lipid content was significantly lower (73.6%) in Ptn(-/-) mice and was associated with a clear reduction in fatty acid, triacylglycerides and cholesterol synthesis. Ptn deletion was accompanying with a diabetogenic state in the mother and a decreased expression of key proteins involved in glucose and lipid uptake and metabolism. Moreover, Ptn(-/-) pregnant mice have a decreased expression of transcription factors, such as PPAR-alpha, regulating lipid uptake and glucose and lipid utilization. Furthermore, the augmented expression and nuclear translocation of glycerol kinase, and the decrease in NUR77 protein levels in the knock-out animals can further explain the alterations observed in hepatic glucose metabolism. Our results point out for the first time that pleiotrophin is an important player in maintaining hepatic metabolic homeostasis during late gestation, and further highlighted the moonlighting role of glycerol kinase in the regulation of maternal glucose homeostasis during pregnancy.	[Zapateria, Begona; Sevillano, Julio; Gracia Sanchez-Alonso, Maria; Limones, Maria; Pizarro-Delgado, Javier; Zuccaro, Agata; Pilar Ramos-Alvarez, Maria] Univ San Pablo CEU, CEU Univ, Fac Farm, Dept Chem & Biochem, Alcorcon, Spain; [Herradon, Gonzalo] Univ San Pablo CEU, CEU Univ, Fac Farm, Dept Pharmaceut & Hlth Sci, Alcorcon, Spain; [Medina-Gomez, Gema] Univ Rey Juan Carlos, Fac Ciencias Salud, Dept Basic Sci Hlth, Alcorcon, Spain	San Pablo CEU University; San Pablo CEU University; Universidad Rey Juan Carlos	Ramos-Alvarez, MP (corresponding author), Univ San Pablo CEU, CEU Univ, Fac Farm, Dept Chem & Biochem, Madrid 28925, Spain.	pramos@ceu.es	PIZARRO-DELGADO, JAVIER/E-7268-2012; Medina-Gomez, Gema/CAF-4668-2022; Medina-Gomez, Gema/CAI-1063-2022; Zuccaro, Agata/ABE-7801-2021; Herradon, Gonzalo/C-8305-2012; Ramos-Alvarez, Maria P./B-6359-2011; Sevillano, Julio/K-6387-2014; Sanchez, Maria Gracia/K-6404-2014	Medina-Gomez, Gema/0000-0001-8169-681X; Medina-Gomez, Gema/0000-0001-8169-681X; Herradon, Gonzalo/0000-0002-1578-3744; Ramos-Alvarez, Maria P./0000-0002-7727-7783; Sevillano, Julio/0000-0001-7726-6673; Zuccaro, Agata/0000-0003-2298-6379; Sanchez, Maria Gracia/0000-0001-7788-8923; PIZARRO-DELGADO, JAVIER/0000-0002-3735-844X	Comunidad de Madrid [S2017/BMD-3684]; Ministerio de Ciencia e Innovacion (MICINN) [RTI2018-095615-B-I00]	Comunidad de Madrid(Comunidad de Madrid); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Comunidad de Madrid, Grant/Award Number: S2017/BMD-3684; Ministerio de Ciencia e Innovacion (MICINN), Grant/Award Number: RTI2018-095615-B-I00	Ambuhl P, 1998, J CLIN INVEST, V101, P170, DOI 10.1172/JCI62; Amet LEA, 2001, MOL CELL NEUROSCI, V17, P1014, DOI 10.1006/mcne.2001.0998; Asahina K, 2002, AM J PATHOL, V160, P2191, DOI 10.1016/S0002-9440(10)61167-4; Ball M, 2009, PLACENTA, V30, P649, DOI 10.1016/j.placenta.2009.05.001; Carrara MA, 2012, LIFE SCI, V90, P831, DOI 10.1016/j.lfs.2012.03.037; Catalano PM, 2010, REPRODUCTION, V140, P365, DOI 10.1530/REP-10-0088; DARMADY JM, 1982, BRIT J OBSTET GYNAEC, V89, P211, DOI 10.1111/j.1471-0528.1982.tb03616.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gu DY, 2007, FEBS LETT, V581, P382, DOI 10.1016/j.febslet.2006.12.043; Haggarty P, 2010, ANNU REV NUTR, V30, P237, DOI 10.1146/annurev.nutr.012809.104742; Herradon G, 2004, BIOCHEM BIOPH RES CO, V324, P1041, DOI 10.1016/j.bbrc.2004.09.161; Herrera E, 2002, ENDOCRINE, V19, P43, DOI 10.1385/ENDO:19:1:43; HERRERA E, 1994, BRAZ J MED BIOL RES, V27, P2499; HERRERA E, 1988, AM J OBSTET GYNECOL, V158, P1575, DOI 10.1016/0002-9378(88)90193-7; Herrera E, 2000, EUR J CLIN NUTR, V54, pS47, DOI 10.1038/sj.ejcn.1600984; Herrera E, 2010, J PHYSIOL BIOCHEM, V66, P245, DOI 10.1007/s13105-010-0031-9; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Kalra S, 2016, DIABETES THER, V7, P1, DOI 10.1007/s13300-016-0160-4; Krellman JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100597; LOPEZLUNA P, 1991, BIOL NEONATE, V60, P29, DOI 10.1159/000243385; LOPEZLUNA P, 1986, LIFE SCI, V39, P1389, DOI 10.1016/0024-3205(86)90338-3; MacLennan NK, 2006, HUM MOL GENET, V15, P405, DOI 10.1093/hmg/ddi457; Miao LL, 2019, FASEB J, V33, P6736, DOI 10.1096/fj.201800945RR; Michelotti GA, 2016, GUT, V65, P683, DOI 10.1136/gutjnl-2014-308176; Ochiai K, 2004, LIVER INT, V24, P484, DOI 10.1111/j.1478-3231.2004.0990.x; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Ramos MP, 2003, AM J PHYSIOL-ENDOC M, V285, pE318, DOI 10.1152/ajpendo.00456.2002; Ruiz JI, 1997, J LIPID RES, V38, P1482; Sarkar M, 2020, J HEPATOL, V73, P516, DOI 10.1016/j.jhep.2020.03.049; Sato H, 1999, EXP CELL RES, V246, P152, DOI 10.1006/excr.1998.4304; Sevillano J, 2019, DIABETOLOGIA, V62, P123, DOI 10.1007/s00125-018-4746-4; Sriram G, 2010, METAB ENG, V12, P332, DOI 10.1016/j.ymben.2010.04.001; Sweeney TR, 2006, AM J PHYSIOL-ENDOC M, V290, pE1313, DOI 10.1152/ajpendo.00071.2005; Torres N, 2010, AM J PHYSIOL-ENDOC M, V298, pE270, DOI 10.1152/ajpendo.00437.2009; VILLAR J, 1992, AM J OBSTET GYNECOL, V167, P1344, DOI 10.1016/S0002-9378(11)91714-1; Wang YP, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062061; Wolska A, 2017, ATHEROSCLEROSIS, V267, P49, DOI 10.1016/j.atherosclerosis.2017.10.025; Xu CY, 2014, BIOL PHARM BULL, V37, P511, DOI 10.1248/bpb.b13-00845; Zarraga-Granados G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0222072; Zhang L, 2017, CELL DEATH DIFFER, V24, P1530, DOI 10.1038/cdd.2017.29	41	2	2	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21911	10.1096/fj.202101181R	http://dx.doi.org/10.1096/fj.202101181R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34551152	Green Published			2022-12-28	WOS:000702238200041
J	Roy, D; Ehtesham, NZ; Hasnain, SE				Roy, Deodutta; Ehtesham, Nasreen Z.; Hasnain, Seyed Ehtesham			Is Mycobacterium tuberculosis carcinogenic to humans?	FASEB JOURNAL			English	Article						malignant transformation; Mycobacterium tuberculosis; pulmonary carcinogen; TB lesion and tumor mass	MESENCHYMAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; LUNG-CANCER PATIENTS; PULMONARY TUBERCULOSIS; ACTIVE TUBERCULOSIS; LATENT TUBERCULOSIS; HEMATOPOIETIC STEM; EPITHELIAL-CELLS; PROGENITOR CELLS; INCREASED RISK	We highlight the ability of the tuberculosis (TB) causing bacterial pathogen, Mycobacterium tuberculosis (Mtb), to induce key characteristics that are associated with established IARC classified Group 1 and Group 2A carcinogenic agents. There is sufficient evidence from epidemiological case-control, cohort and meta-analysis studies of increased lung cancer (LC) risk in pre-existing/active/old TB cases. Similar to carcinogens and other pathogenic infectious agents, exposure to aerosol-containing Mtb sprays in mice produce malignant transformation of cells that result in squamous cell carcinoma. Convincing, mechanistic data show several characteristics shared between TB and LC which include chronic inflammation, genomic instability and replicative immortality, just to name a few cancer hallmarks. These hallmarks of cancer may serve as precursors to malignant transformation. Together, these findings form the basis of our postulate that Mtb is a complete human pulmonary carcinogen. We also discuss how Mtb may act as both an initiating agent and promoter of tumor growth. Forthcoming experimental studies will not only serve as proof-of-concept but will also pivot our understanding of how to manage/treat TB cases as well as offer solutions to clinical conundrums of TB lesions masquerading as tumors. Clinical validation of our concept may also help pave the way for next generation personalized medicine for the management of pulmonary TB/cancer particularly for cases that are not responding well to conventional chemotherapy or TB drugs.	[Roy, Deodutta] Florida Int Univ, Dept Environm Hlth Sci, Miami, FL USA; [Ehtesham, Nasreen Z.] ICMR Natl Inst Pathol, Safdarjung Hosp Campus, New Delhi, India; [Hasnain, Seyed Ehtesham] Sharda Univ, Sch Basic Sci & Res, Dept Life Sci, Greater Noida, India; [Hasnain, Seyed Ehtesham] Indian Inst Technol, Dept Biochem Engn & Biotechnol, Delhi IIT D, New Delhi, India	State University System of Florida; Florida International University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Pathology (IOP); Sharda University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Hasnain, SE (corresponding author), Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi 110016, India.	seyedhasnain@gmail.com			Department of Biotechnology, Ministry of Science and Technology (DBT) [BT/PR12817/COE/34/23/2015, BT/PR23135/NER/95/634/2017, BT/PR23099/NER/95/632/2017]	Department of Biotechnology, Ministry of Science and Technology (DBT)	Department of Biotechnology, Ministry of Science and Technology (DBT), Grant/Award Number: BT/PR12817/COE/34/23/2015, BT/PR23135/NER/95/634/2017 and BT/PR23099/NER/95/632/2017	Abudureheman M, 2019, EUR REV MED PHARMACO, V23, P113, DOI 10.26355/eurrev_201901_16755; Albrengues J, 2018, SCIENCE, V361, P1353, DOI 10.1126/science.aao4227; Algahtani HA, 2014, J TAIBAH UNIV MED SC, V9, P143, DOI 10.1016/j.jtumed.2013.11.002; Alto NM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006114; Amaral EP, 2017, CLIN MED INSIGHT-CAS, V9, P1; American Cancer Society, 2018, EARL HIST CANC; Anastasopoulou A, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0717-7; Arrieta O, 2015, J THORAC ONCOL, V10, P838, DOI 10.1097/JTO.0000000000000481; Arulanantham A, 2020, CASE REP SURG, V2020, DOI 10.1155/2020/8570212; Barber DL, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat2702; Barete S, 2000, ARCH DERMATOL, V136, P1452, DOI 10.1001/archderm.136.12.1452; Barh D, 2018, BIOINFORMATION, V14, P337, DOI 10.6026/97320630014337; Barrios-Payan J, 2012, J INFECT DIS, V206, P1194, DOI 10.1093/infdis/jis381; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Baslaim MM., 2013, J MYCOBAC DIS, V3, P135, DOI [10.4172/2161-1068.100, DOI 10.4172/2161-1068.100]; Baxt LA, 2013, SCIENCE, V340, P697, DOI 10.1126/science.1235771; Bayle GL., RECHERCHES PHTHISIE, P1; Beamer G, 2014, AM J PATHOL, V184, P3170, DOI 10.1016/j.ajpath.2014.08.024; Bermudez LE, 2002, INFECT IMMUN, V70, P140, DOI 10.1128/IAI.70.1.140-146.2002; Bhartiya D, 2017, STEM CELL REV REP, V13, P713, DOI 10.1007/s12015-017-9756-y; Bhawe K, 2018, CELL ONCOL, V41, P465, DOI 10.1007/s13402-018-0395-3; Bierne H, 2012, CELL MICROBIOL, V14, P622, DOI 10.1111/j.1462-5822.2012.01758.x; Brenner DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017479; Burberry A, 2014, CELL HOST MICROBE, V15, P779, DOI 10.1016/j.chom.2014.05.004; Cakar B, 2018, RESPIR MED CASE REP, V23, P33, DOI 10.1016/j.rmcr.2017.11.004; Campos-Parra AD, 2015, AM J CLIN ONCOL-CANC, V38, P33, DOI 10.1097/COC.0b013e318287bb23; Chai QY, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01318-0; Chandra S, 2009, ASIAN PAC J CANCER P, V10, P453; Chang AH, 2010, CLIN MICROBIOL REV, V23, P837, DOI 10.1128/CMR.00012-10; Chang CH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000444; Chang TS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171176; Chao WC, 2020, J MICROBIOL IMMUNOL, V53, P209, DOI 10.1016/j.jmii.2019.10.008; Chen YM, 1996, JPN J CLIN ONCOL, V26, P322, DOI 10.1093/oxfordjournals.jjco.a023240; Cheng MP, 2017, CLIN INFECT DIS, V64, P635, DOI 10.1093/cid/ciw838; Christopoulos A, 2014, CLIN RESPIR J, V8, P375, DOI 10.1111/crj.12094; Cicenas Saulius, 2007, World J Surg Oncol, V5, P22, DOI 10.1186/1477-7819-5-22; Coyne JD, 2005, J CLIN PATHOL, V58, P1290, DOI 10.1136/jcp.2004.023259; Dacosta N A, 1991, J Postgrad Med, V37, P185; Das B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004912; Das JK, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120234; Dasgupta P, 2018, CLIN CANCER INVESTIG, V7, P199, DOI 10.4103/ccij.ccij_35_18; Dasgupta Partha, 2012, J Indian Med Assoc, V110, P898; de Monerri NCS, 2014, AM J PATHOL, V184, P897, DOI 10.1016/j.ajpath.2013.12.022; Denholm R, 2014, AM J RESP CRIT CARE, V190, P549, DOI 10.1164/rccm.201402-0338OC; Denisenko E, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5450-6; Deoraj A., 2016, GENE ENV INTERACTION, P160; Dhandapani S, 2015, RESPIR MED CASE REP, V16, P35, DOI 10.1016/j.rmcr.2015.06.005; Dheda K, 2005, J INFECT DIS, V192, P1201, DOI 10.1086/444545; DiFazio RM, 2016, FIBROGENESIS TISSUE, V9, DOI 10.1186/s13069-016-0043-3; Dobler CC, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00157-2017; Domingo-Gonzalez R, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TBTB2-0018-2016; Ehlers S, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00411; Engels EA, 2009, INT J CANCER, V124, P1183, DOI 10.1002/ijc.24042; Everatt R, 2016, INT J TUBERC LUNG D, V20, P757, DOI 10.5588/ijtld.15.0783; Eyvazi S, 2020, MICROB PATHOGENESIS, V141, DOI 10.1016/j.micpath.2020.104019; Falagas ME, 2010, QJM-INT J MED, V103, P461, DOI 10.1093/qjmed/hcq068; FARWELL DJ, 1978, SOUTHERN MED J, V71, P377, DOI 10.1097/00007611-197804000-00010; Fontenelle L J, 1970, Ann Thorac Surg, V9, P431; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Fujii Y, 2012, P NATL ACAD SCI USA, V109, P20584, DOI 10.1073/pnas.1208651109; Gabel S, 2016, MOL NEUROBIOL, V53, P5041, DOI 10.1007/s12035-015-9428-3; Garnham R, 2019, ONCOL LETT, V18, P983, DOI 10.3892/ol.2019.10458; da Silva ALG, 2015, MULTIDISCIP RESP MED, V10, DOI 10.1186/s40248-015-0034-z; Gonzalez H, 2018, GENE DEV, V32, P1267, DOI 10.1101/gad.314617.118; GOPALAKRISHNAN P, 1975, AM SURGEON, V41, P405; Gottschlich A, 2018, TRANSL LUNG CANCER R, V7, pS160, DOI 10.21037/tlcr.2018.03.15; Gupta PK, 2016, CELL IMMUNOL, V300, P33, DOI 10.1016/j.cellimm.2015.11.007; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hannemann S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003668; Harikrishna J., 2012, J INDIAN ACAD CLIN M, V13, P142; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; Hess S, 2015, CURR OPIN MICROBIOL, V23, P179, DOI 10.1016/j.mib.2014.11.021; Heuvers ME, 2012, LUNG CANCER, V76, P452, DOI 10.1016/j.lungcan.2011.12.008; Holla S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-210; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Houston AM., 2014, MEDICINE, V42, P18; Hu S, 2015, EXP THER MED, V9, P2299, DOI 10.3892/etm.2015.2425; Hunter RL, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9100813; Hunter RL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02108; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V90, P1; International Agency for Research on Cancer, 2019, IARC MON ID CARC HAZ; Ito N, 2015, DEV GROWTH DIFFER, V57, P305, DOI 10.1111/dgd.12209; Jain AK, 2018, BREATHE, V14, pE94, DOI 10.1183/20734735.014617; Keikha Masoud, 2018, Adv Biomed Res, V7, P58, DOI 10.4103/abr.abr_182_17; Kennedy MP, 2008, J CARDIOTHORAC SURG, V3, DOI 10.1186/1749-8090-3-8; Koehler JE, 1997, NEW ENGL J MED, V337, P1876, DOI 10.1056/NEJM199712253372603; Kohli S, 2015, INT J MED MICROBIOL, V305, P322, DOI 10.1016/j.ijmm.2015.01.001; Kumar A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00466; Lavalett L, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00163; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Liang HY, 2009, INT J CANCER, V125, P2936, DOI 10.1002/ijc.24636; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Littman AJ, 2004, CANCER CAUSE CONTROL, V15, P819, DOI 10.1023/B:CACO.0000043432.71626.45; Liu HY, 2018, ONCOTARGET, V9, P2887, DOI 10.18632/oncotarget.20812; Luo YH, 2012, J THORAC ONCOL, V7, P299, DOI 10.1097/JTO.0b013e31823c588d; Ma JL, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10020120; Maneechotesuwan Kittipong, 2006, J Med Assoc Thai, V89 Suppl 5, pS46; Manicone AM, 2009, EXPERT REV CLIN IMMU, V5, P63, DOI 10.1586/1744666X.5.1.63; Mantovani A, 2018, IMMUNOL REV, V281, P57, DOI 10.1111/imr.12614; Masaki T, 2014, CELL REPROGRAM, V16, P9, DOI 10.1089/cell.2013.0064; Masaki T, 2013, CELL, V152, P51, DOI 10.1016/j.cell.2012.12.014; Masrour-Roudsari J, 2017, CASP J INTERN MED, V8, P153, DOI 10.22088/cjim.8.3.153; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Molina-Romero C, 2019, SALUD PUBLICA MEXICO, V61, P286, DOI 10.21149/10090; Moule MG, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00065; Muefong CN, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00962; Nakatsuka S, 2002, J CLIN ONCOL, V20, P4255, DOI 10.1200/JCO.2002.09.021; Nalbandian A, 2009, ONCOGENE, V28, P1928, DOI 10.1038/onc.2009.32; National Institute for Health and Care Excellence, 2016, TUB NICE GUID 33; Ndzi EN, 2019, INT J MYCOBACT, V8, P70, DOI 10.4103/ijmy.ijmy_9_19; Ndzi EN., 2018, J APPL BIOINFORMA CO, V7, P2; Nigro G, 2014, CELL HOST MICROBE, V15, P792, DOI 10.1016/j.chom.2014.05.003; Oh CM, 2020, J CANCER, V11, P1899, DOI 10.7150/jca.37022; Ohta K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051866; Pathak S., 2019, MODELS MOL MECH BIOG, P395; Philley JV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29471-x; Pizarro-Cerda J, 2015, BBA-MOL CELL BIOL L, V1851, P911, DOI 10.1016/j.bbalip.2014.09.011; PRYTZ S, 1976, SCAND J RESPIR DIS, V57, P239; Purohit S, 2019, BIOMED BIOTECH RES J, V3, P61, DOI 10.4103/bbrj.bbrj_143_18; Raghuvanshi S, 2010, P NATL ACAD SCI USA, V107, P21653, DOI 10.1073/pnas.1007967107; Ravimohan S, 2018, EUR RESPIR REV, V27, DOI 10.1183/16000617.0077-2017; Reece ST, 2018, J INFECT DIS, V217, P1667, DOI 10.1093/infdis/jiy041; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Riley DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003107; Ryndak MB, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00299; Ryndak MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123745; Saito A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082460; Sakuraba Motoki, 2006, Ann Thorac Cardiovasc Surg, V12, P53; Sakurada A, 2006, CLIN LUNG CANCER, V7, pS138, DOI 10.3816/CLC.2006.s.005; SAKURAI R, 1989, JPN J MED, V28, P471; Salinas-Alvarez Vanessa, 2020, Radiol Case Rep, V15, P2471, DOI 10.1016/j.radcr.2020.08.059; Sanchez VC, 2009, WIRES NANOMED NANOBI, V1, P511, DOI 10.1002/wnan.41; Sandhu GK, 2011, J GLOB INFECT DIS, V3, P143, DOI 10.4103/0974-777X.81691; Schroder G, 2011, P NATL ACAD SCI USA, V108, P14643, DOI 10.1073/pnas.1019074108; Shebl FM, 2010, JAIDS-J ACQ IMM DEF, V55, P375, DOI 10.1097/QAI.0b013e3181eef4f7; Shi LB, 2015, SCI REP-UK, V5, DOI 10.1038/srep18176; Shiels MS, 2011, CANCER EPIDEM BIOMAR, V20, P672, DOI 10.1158/1055-9965.EPI-10-1166; Simonsen DF, 2014, INT J TUBERC LUNG D, V18, P1211, DOI 10.5588/ijtld.14.0161; Simonsen DF, 2017, J INFECTION, V74, P590, DOI 10.1016/j.jinf.2017.03.012; Sinclair SH, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00274; Singh V, 2017, J INFECT DIS, V216, P477, DOI 10.1093/infdis/jix322; Singh VK, 2009, ASIAN PAC J CANCER P, V10, P335; Skrahin A, 2014, LANCET RESP MED, V2, P108, DOI 10.1016/S2213-2600(13)70234-0; Srivatsa A, 1999, NEUROL INDIA, V47, P247; STEINITZ R, 1965, AM REV RESPIR DIS, V92, P758; Sterling Timothy R, 2020, MMWR Recomm Rep, V69, P1, DOI 10.15585/mmwr.rr6901a1; Stutz MD, 2018, J LEUKOCYTE BIOL, V103, P259, DOI 10.1002/JLB.4MR0717-277R; Tahoun A, 2012, CELL HOST MICROBE, V12, P645, DOI 10.1016/j.chom.2012.10.009; Tamburini J, 2007, AIDS, V21, P1980, DOI 10.1097/QAD.0b013e3282efa62c; Tamura A, 1999, JPN J CLIN ONCOL, V29, P541, DOI 10.1093/jjco/29.11.541; Tamura A, 1999, Kekkaku, V74, P797; Tandon PN, 2018, NATL MED J INDIA, V31, P151, DOI 10.4103/0970-258X.255758; Tian YS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/827829; TING YM, 1976, RADIOLOGY, V119, P307, DOI 10.1148/119.2.307; Tocque K, 2005, INT J TUBERC LUNG D, V9, P797; Tornack J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169119; Ufimtseva EG, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073452; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; van der Meer-Janssen YPM, 2010, PROG LIPID RES, V49, P1, DOI 10.1016/j.plipres.2009.07.003; van Leeuwen LM, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12858; Vento S, 2011, LANCET ONCOL, V12, P520, DOI 10.1016/S1470-2045(11)70105-X; Villena-Suarez Juliana R, 2018, Rev. perú. med. exp. salud publica, V35, P77, DOI 10.17843/rpmesp.2018.351.3602; Vromman F, 2014, CURR OPIN MICROBIOL, V17, P38, DOI 10.1016/j.mib.2013.11.003; World Health Organization (WHO), 2019, TUBERCULOSIS; Wu CY, 2011, CANCER-AM CANCER SOC, V117, P618, DOI 10.1002/cncr.25616; Xiao L, 2017, REPROD BIOL ENDOCRIN, V15, P1, DOI 10.1186/s12958-017-0234-9; Yang CT, 1999, LIFE SCI, V64, P1383, DOI 10.1016/S0024-3205(99)00072-7; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644; Yu YH, 2011, J THORAC ONCOL, V6, P32, DOI 10.1097/JTO.0b013e3181fb4fcc; Zaharoff DA, 2009, CANCER RES, V69, P6192, DOI 10.1158/0008-5472.CAN-09-1114; Zhang H, 2015, MOL IMMUNOL, V66, P147, DOI 10.1016/j.molimm.2015.02.020; Zhang M, 2020, MATH BIOSCI ENG, V17, P1959, DOI 10.3934/mbe.2020104; ZHENG W, 1987, BRIT J CANCER, V56, P501, DOI 10.1038/bjc.1987.233; Zhou Y, 2017, ONCOL REP, V38, P685, DOI 10.3892/or.2017.5733; Zink AR, 2003, J CLIN MICROBIOL, V41, P359, DOI 10.1128/JCM.41.1.359-367.2003; Zumla A, 2015, J INTERN MED, V277, P373, DOI 10.1111/joim.12256; Zysk KG., 1998, MED VEDA RELIG HEALI	178	3	3	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21853	10.1096/fj.202001581RR	http://dx.doi.org/10.1096/fj.202001581RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34416038				2022-12-28	WOS:000691122900023
J	Ru, ZY; Yu, MK; Zhu, YJ; Chen, ZQ; Zhang, FB; Zhang, ZQ; Ding, JB				Ru, Zhenyu; Yu, Mingkai; Zhu, Yuejie; Chen, Zhiqiang; Zhang, Fengbo; Zhang, Zhiqiang; Ding, Jianbing			Immmunoinformatics-based design of a multi-epitope vaccine with CTLA-4 extracellular domain to combat Helicobacter pylori	FASEB JOURNAL			English	Article						CTLA-4 extracellular domain; Helicobacter pylori; immunoinformatics approaches; multi-epitope vaccine	ANTIGENICITY; MUTANTS; BINDING; GENOME; MODEL	In view of the high infection rate of Helicobacter pylori, a safe and effective vaccine is urgently needed. Recent trends in vaccine design have shifted toward safe and specific epitope-based vaccines. In this study, by using different immunoinformatics approaches, a total of eight linear B cell epitopes, four HTL and three CTL epitopes of FlaA and UreB proteins of H. pylori G27 strain were screened out, we also predicted the conformational epitopes of the two proteins. Then, the dominant epitopes were sequentially linked by appropriate linkers, and the cytotoxic T lymphocyte-associated antigen 4 extracellular domain was attached to the N-terminal of the epitope sequence. Meanwhile, molecular docking, molecular dynamics simulations and principal component analysis were performed to show that the multi-epitope vaccine structure had strong interactions with B7 (B7-1, B7-2) and Toll-like receptors (TLR-2, -4). Eventually, the effectiveness of the vaccine was validated using in silico cloning. These analyses suggested that the designed vaccine could target antigen-presenting cells and had high potency against H. pylori, which could provide a reference for the future development of efficient H. pylori vaccines.	[Ru, Zhenyu; Zhang, Zhiqiang] Xinjiang Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Urumqi 830054, Peoples R China; [Yu, Mingkai; Chen, Zhiqiang; Ding, Jianbing] Xinjiang Med Univ, Sch Basic Med Sci, Dept Immunol, Urumqi 830011, Peoples R China; [Zhu, Yuejie] Xinjiang Med Univ, Ctr Reprod Med, Affiliated Hosp 1, Urumqi, Peoples R China; [Zhang, Fengbo] Xinjiang Med Univ, Dept Clin Lab, Affiliated Hosp 1, Urumqi, Peoples R China; [Zhang, Fengbo; Zhang, Zhiqiang] Xinjiang Med Univ, Affiliated Hosp 1, State Key Lab Pathogenesis Prevent Treatment Cent, Urumqi, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Zhang, ZQ (corresponding author), Xinjiang Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Urumqi 830054, Peoples R China.; Ding, JB (corresponding author), Xinjiang Med Univ, Sch Basic Med Sci, Dept Immunol, Urumqi 830011, Peoples R China.	drzhiqiang@163.com; 1601379937@qq.com	Yu, Mingkai/GZL-8085-2022	Yu, Mingkai/0000-0001-6046-2846; Ding, Jianbing/0000-0001-5506-7665	Fund of State Key Laboratory of Pathogenesis, Prevention, Treatment of High Incidence Diseases in Central Asian (SKL-HIDCA-2018-); National Natural Science Foundation of China [81860352]	Fund of State Key Laboratory of Pathogenesis, Prevention, Treatment of High Incidence Diseases in Central Asian (SKL-HIDCA-2018-); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Fund of State Key Laboratory of Pathogenesis, Prevention, Treatment of High Incidence Diseases in Central Asian (SKL-HIDCA-2018-) and the National Natural Science Foundation of China (NO. 81860352)	Abduljaleel Z, 2021, BIO-DES MANUF, V4, P490, DOI 10.1007/s42242-020-00114-3; Ali A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37070-z; Ali M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09199-w; Ansari S, 2019, TOXINS, V11, DOI 10.3390/toxins11110677; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Baltrus DA, 2009, J BACTERIOL, V191, P447, DOI 10.1128/JB.01416-08; Barh D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052773; Bin Sayed S, 2020, INT J PEPT RES THER, V26, P2089, DOI 10.1007/s10989-019-10003-8; Blanchard TG, 2017, PEDIATR RES, V81, P170, DOI 10.1038/pr.2016.199; Boyle JS, 1998, NATURE, V392, P408, DOI 10.1038/32932; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; Christoffer C, 2021, NUCLEIC ACIDS RES, V49, pW359, DOI 10.1093/nar/gkab336; Clyne M, 2000, INFECT IMMUN, V68, P4335, DOI 10.1128/IAI.68.7.4335-4339.2000; Dong D, 2020, INFECT GENET EVOL, V81, DOI 10.1016/j.meegid.2020.104266; Doytchinova IA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-131; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; Farzi N, 2019, J CLIN MED, V8, DOI 10.3390/jcm8112004; Fischbach W, 2018, DTSCH ARZTEBL INT, V115, P429, DOI 10.3238/arztebl.2018.0429; GEOURJON C, 1994, PROTEIN ENG, V7, P157, DOI 10.1093/protein/7.2.157; Ghosh P, 2021, INT J PEPT RES THER, V27, P1149, DOI 10.1007/s10989-020-10157-w; Gu HY, 2017, CURR MICROBIOL, V74, P863, DOI 10.1007/s00284-017-1256-4; Hathroubi S, 2020, NPJ BIOFILMS MICROBI, V6, DOI 10.1038/s41522-020-00167-3; Hosseinzadeh F, 2017, REP BIOCHEM MOL BIOL, V6, P8; Ishihara S, 2004, J IMMUNOL, V173, P1406, DOI 10.4049/jimmunol.173.2.1406; Junaid M, 2019, J BIOMOL STRUCT DYN, V37, P4035, DOI 10.1080/07391102.2018.1537895; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee GR, 2016, PROTEINS, V84, P293, DOI 10.1002/prot.24858; Morton PA, 1996, J IMMUNOL, V156, P1047; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Olczak AA, 2002, J BACTERIOL, V184, P3186, DOI 10.1128/JB.184.12.3186-3193.2002; Pan X, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01003; Park H, 2016, J CHEM THEORY COMPUT, V12, P6201, DOI 10.1021/acs.jctc.6b00819; PEACH RJ, 1994, J EXP MED, V180, P2049, DOI 10.1084/jem.180.6.2049; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Raghavan SS, 2022, J BIOMOL STRUCT DYN, V40, P5577, DOI 10.1080/07391102.2021.1871955; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Lopez-Blanco JR, 2014, NUCLEIC ACIDS RES, V42, pW271, DOI 10.1093/nar/gku339; Rangel-Sosa Martha Montserrat, 2017, Colomb. Med., V48, P138, DOI 10.25100/cm.v48i3.2997; Reynisson B, 2020, J PROTEOME RES, V19, P2304, DOI 10.1021/acs.jproteome.9b00874; Sanami S, 2020, INT J BIOL MACROMOL, V164, P871, DOI 10.1016/j.ijbiomac.2020.07.117; Sarkar B, 2020, IMMUNOBIOLOGY, V225, DOI 10.1016/j.imbio.2020.151955; Shen CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013458; Stranzl T, 2010, IMMUNOGENETICS, V62, P357, DOI 10.1007/s00251-010-0441-4; Sukri A, 2020, APMIS, V128, P150, DOI 10.1111/apm.13034; Torok AM, 2005, INFECT IMMUN, V73, P1523, DOI 10.1128/IAI.73.3.1523-1531.2005; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Hooren L, 2017, EUR J IMMUNOL, V47, P385, DOI 10.1002/eji.201646583; Wang BN, 2014, INT J CLIN EXP PATHO, V7, P6559; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wilkins MR, 1999, METH MOL B, V112, P531; Yan L, 2003, WORLD J GASTROENTERO, V9, P2240; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045152; Yu M., 2021, FRONT IMMUNOL, V12; Zhao YH, 2018, CELL PHYSIOL BIOCHEM, V47, P721, DOI 10.1159/000490025	56	1	1	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22252	10.1096/fj.202101538RR	http://dx.doi.org/10.1096/fj.202101538RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CS	35294065	hybrid			2022-12-28	WOS:000772945600001
J	Yao, JY; Hua, XF; Shi, JW; Hu, XY; Lui, KY; He, KT; Mai, JL; Lan, T; Lu, MQ				Yao, Jiyou; Hua, Xuefeng; Shi, Jiewei; Hu, Xiaoyuan; Lui, Kayin; He, Kaitao; Mai, Jialuo; Lan, Tian; Lu, Minqiang			LncRNA THEMIS2-211, a tumor-originated circulating exosomal biomarker, promotes the growth and metastasis of hepatocellular carcinoma by functioning as a competing endogenous RNA	FASEB JOURNAL			English	Article						exosomes; HCC; lncRNA; miR-940; SPOCK1	EXPRESSION; MIR-940; BREAST; SPOCK1; PROTEOGLYCAN; TESTICAN-1; MANAGEMENT; RESISTANCE; PROGNOSIS; DIAGNOSIS	Hepatocellular carcinoma (HCC) is a major challenge for human health. Finding reliable diagnostic biomarkers and therapeutic targets for HCC is highly desired in the clinic. Currently, circulating exosomal lncRNA is a promising biomarker for the diagnosis of cancer and lncRNA is also a potential target in cancer therapy. Here, the diagnostic value of a panel based on exosomal lncRNA THEMIS2-211 and PRKACA-202, superior to that of AFP, was identified for diagnosing human HCC. Besides, the performance of exosomal lncRNA THEMIS2-211 alone exceeds that of AFP in diagnosing early-stage HCC patients (stage I). Furthermore, lncRNA THEMIS2-211 is highly expressed in HCC tissues and correlated with the poor prognosis of HCC patients. LncRNA THEMIS2-211 is upregulated and localized in the cytoplasm of HCC cells. LncRNA THEMIS2-211 exerts its biological function as an oncogene that promotes the proliferation, migration, invasion, EMT of HCC cells by physically interacting with miR-940 and therefore promoting SPOCK1 expressions. Rescue assays show the regulation of SPOCK1 by lncRNA THEMIS2-211 dependents on miR-940. The discovery of lncRNA THEMIS2-211 further illuminates the molecular pathogenesis of HCC and the THEMIS2-211/miR-940/SPOCK1 axis may act as a potential therapeutic target for HCC.	[Yao, Jiyou; Hua, Xuefeng; Shi, Jiewei; Hu, Xiaoyuan; He, Kaitao; Mai, Jialuo; Lu, Minqiang] South China Univ Technol, Affiliated Hosp 2, Sch Med, Dept HBP SURG 2, 1 Panfu Rd, Guangzhou 510180, Guangdong, Peoples R China; [Lui, Kayin] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China; [Lan, Tian] Guangdong Pharmaceut Univ, Guangdong Metab Dis Res Ctr Integrated Chinese &, 280 Waihuan East Rd, Guangzhou 510006, Guangdong, Peoples R China	South China University of Technology; Sun Yat Sen University; Guangdong Pharmaceutical University	Lu, MQ (corresponding author), South China Univ Technol, Affiliated Hosp 2, Sch Med, Dept HBP SURG 2, 1 Panfu Rd, Guangzhou 510180, Guangdong, Peoples R China.; Lan, T (corresponding author), Guangdong Pharmaceut Univ, Guangdong Metab Dis Res Ctr Integrated Chinese &, 280 Waihuan East Rd, Guangzhou 510006, Guangdong, Peoples R China.	lantian012345@163.com; larrylmq@outlook.com		Lui, Ka Yin/0000-0002-7183-6951	Guangzhou Municipal Science and Technology Project [201704020153, 202002030387]; Guangzhou Basic Research Program [202102010034]; Science Foundation of Guangzhou First People's Hospital [Q2019010]	Guangzhou Municipal Science and Technology Project; Guangzhou Basic Research Program; Science Foundation of Guangzhou First People's Hospital	Guangzhou Municipal Science and Technology Project, Grant/Award Number: 201704020153 and 202002030387; Guangzhou Basic Research Program, Grant/Award Number: 202102010034; Science Foundation of Guangzhou First People's Hospital, Grant/Award Number: Q2019010	BaSalamah MAM, 2001, BIOCHEM BIOPH RES CO, V283, P1083, DOI 10.1006/bbrc.2001.4900; Bollmann J, 2008, J STEROID BIOCHEM, V109, P16, DOI 10.1016/j.jsbmb.2007.12.007; Cheerathodi M, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13040675; Cho HJ, 2020, CANCER MED-US, V9, P5459, DOI 10.1002/cam4.3230; Choi J, 2019, HEPATOLOGY, V69, P1983, DOI 10.1002/hep.30233; Ding D, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7618342; Durazo FA, 2008, J GASTROEN HEPATOL, V23, P1541, DOI 10.1111/j.1440-1746.2008.05395.x; Edgell CJS, 2004, INT REV CYTOL, V236, P101, DOI 10.1016/S0074-7696(04)36003-1; Enright AJ, 2004, GENOME BIOL, V5; Essandoh K, 2019, FASEB J, V33, P7451, DOI 10.1096/fj.201802338RR; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo X, 2020, JAMA SURG, V155, P572, DOI 10.1001/jamasurg.2020.1133; Hausser HJ, 2004, OSTEOARTHR CARTILAGE, V12, P870, DOI 10.1016/j.joca.2004.07.008; Honeyman JN, 2014, SCIENCE, V343, P1010, DOI 10.1126/science.1249484; Hu YP, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1097-9; Huang WC, 2022, ONCOGENE, V41, P997, DOI 10.1038/s41388-021-02136-2; Jiang PQ, 2020, CANCER MANAG RES, V12, P9087, DOI 10.2147/CMAR.S259243; Kahlert C, 2014, J BIOL CHEM, V289, P3869, DOI 10.1074/jbc.C113.532267; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kamarajah SK, 2018, J SURG ONCOL, V117, P644, DOI 10.1002/jso.24908; Li HX, 2021, MOL THER-NUCL ACIDS, V25, P53, DOI 10.1016/j.omtn.2021.05.003; Li P, 2019, J CELL MOL MED, V23, P2475, DOI 10.1111/jcmm.14121; Li XY, 2020, J CELL PHYSIOL, V235, P3402, DOI 10.1002/jcp.29230; Li Y, 2013, GASTROENTEROLOGY, V144, P179, DOI 10.1053/j.gastro.2012.09.042; Li YC, 2019, CLIN CHEM, V65, P798, DOI 10.1373/clinchem.2018.301291; Li ZH, 2018, ONCOGENE, V37, P3822, DOI 10.1038/s41388-018-0237-9; Liang ZX, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2077-0; Lin LY, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0834-9; Liu XL, 2019, PHYTOMEDICINE, V62, DOI 10.1016/j.phymed.2019.152930; Marr HS, 1997, ENDOTHELIUM-NEW YORK, V5, P209, DOI 10.3109/10623329709053399; Moody SE, 2015, ONCOGENE, V34, P2061, DOI 10.1038/onc.2014.153; Okato A, 2017, INT J ONCOL, V51, P245, DOI 10.3892/ijo.2017.4008; Omata M, 2017, HEPATOL INT, V11, P317, DOI 10.1007/s12072-017-9799-9; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Peirce MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011465; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sarveazad A, 2019, J RES MED SCI, V24, DOI 10.4103/jrms.JRMS_1017_18; Song ZG, 2020, MOLECULES, V25, DOI 10.3390/molecules25235585; Strickland M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01426-2; Sun J, 2020, J CELL BIOCHEM, V121, P443, DOI 10.1002/jcb.29206; Tao Y, 2020, INT J BIOL SCI, V16, P471, DOI 10.7150/ijbs.39123; Treeck O, 2005, CYTOKINE, V32, P137, DOI 10.1016/j.cyto.2005.08.008; Turnham RE, 2016, GENE, V577, P101, DOI 10.1016/j.gene.2015.11.052; Tzartzeva K, 2018, GASTROENTEROLOGY, V154, P1706, DOI 10.1053/j.gastro.2018.01.064; von Felden J, 2020, GUT, V69, P2025, DOI 10.1136/gutjnl-2019-320282; Wang CR, 2020, MOL GENET GENOMICS, V295, P251, DOI 10.1007/s00438-019-01620-5; Wang HH, 2020, ONCOL LETT, V20, DOI 10.3892/ol.2020.11956; Wang XY, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.641526; Witjes CDM, 2013, HEPATOL INT, V7, P59, DOI 10.1007/s12072-012-9374-3; Xu RH, 2017, NAT MATER, V16, P1155, DOI [10.1038/NMAT4997, 10.1038/nmat4997]; Yang GS, 2019, CELL CYCLE, V18, P976, DOI 10.1080/15384101.2019.1601477; Ye ZQ, 2020, AM J CANCER RES, V10, P3127; Yu FB, 2016, CELL PROLIFERAT, V49, P195, DOI 10.1111/cpr.12241; Yuan B, 2015, CANCER SCI, V106, P819, DOI 10.1111/cas.12688; Zhan Y, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0893-y; Zhang SJ, 2019, J CELL MOL MED, V23, P1396, DOI 10.1111/jcmm.14042; Zhang W, 2020, CANCER LETT, V478, P22, DOI 10.1016/j.canlet.2020.02.014; Zhou C, 2020, CANCER MANAG RES, V12, P3771, DOI 10.2147/CMAR.S246311; Zhu XH, 2021, BIOENGINEERED, V12, P578, DOI 10.1080/21655979.2021.1882133; Zou HB, 2019, CELL CYCLE, V18, P2398, DOI 10.1080/15384101.2019.1618120	62	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22238	10.1096/fj.202101564R	http://dx.doi.org/10.1096/fj.202101564R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0DA	35224785				2022-12-28	WOS:000772946400001
J	Wu, RF; Cao, ST; Li, F; Feng, SC; Shu, G; Wang, LN; Gao, P; Zhu, XT; Zhu, CJ; Wang, SB; Jiang, QY				Wu, Ruifan; Cao, Shuting; Li, Fan; Feng, Shengchun; Shu, Gang; Wang, Lina; Gao, Ping; Zhu, Xiaotong; Zhu, Canjun; Wang, Songbo; Jiang, Qingyan			RNA-binding protein YBX1 promotes brown adipogenesis and thermogenesis via PINK1/PRKN-mediated mitophagy	FASEB JOURNAL			English	Article						adipogenesis; mitophagy; PINK1; PRKN; thermogenesis; YBX1	MESSENGER-RNA; ADIPOSE-TISSUE; YB-1; TRANSLATION; AUTOPHAGY	Promoting the thermogenic function of brown adipose tissue (BAT) is a promising strategy to combat obesity and metabolic disorders. While much is known about the transcriptional regulation of BAT activation, however, the underlying mechanism of post-transcriptional control by RNA binding proteins remains largely unknown. Here, we found that RNA binding protein Y-box binding protein 1 (YBX1) expression was abundant in BAT and induced by cold exposure and a beta-adrenergic agonist in mice. Loss-of-function experiments showed that YBX1 deficiency inhibited mouse primary brown adipocyte differentiation and thermogenic function. Further study showed that YBX1 positively regulates thermogenesis through enhancing mitophagy. Mechanistically, RNA immunoprecipitation identified that YBX1 directly targeted the transcripts of PTEN-induced kinase 1 (Pink1) and parkin RBR E3 ubiquitin-protein ligase (Prkn), two key regulators of mitophagy. RNA decay assay proved that loss of YBX1 decreased mRNA stability of Pink1 and Prkn, leading to reduced protein expression, thereby alleviating mitophagy and inhibiting thermogenic program. Importantly, in vivo experiments demonstrated that YBX1 overexpression in BAT promoted thermogenesis and mitophagy in mice. Collectively, our results reveal novel insight into the molecular mechanism of YBX1 in post-transcriptional regulation of PINK1/PRKN-mediated mitophagy and highlight the critical role of YBX1 in brown adipogenesis and thermogenesis.	[Wu, Ruifan; Li, Fan; Feng, Shengchun; Shu, Gang; Wang, Lina; Gao, Ping; Zhu, Xiaotong; Zhu, Canjun; Wang, Songbo; Jiang, Qingyan] South China Agr Univ, Coll Anim Sci, Guangdong Lab Lingnan Modern Agr, Guangdong Prov Key Lab Anim Nutr Regulat, Guangzhou 510642, Peoples R China; [Wu, Ruifan; Li, Fan; Feng, Shengchun; Shu, Gang; Wang, Lina; Gao, Ping; Zhu, Xiaotong; Zhu, Canjun; Wang, Songbo; Jiang, Qingyan] South China Agr Univ, Coll Anim Sci, Natl Engn Res Ctr Breeding Swine Ind, Guangzhou 510642, Peoples R China; [Cao, Shuting] Guangdong Acad Agr Sci, Guangdong Key Lab Anim Breeding & Nutr, Key Lab Anim Nutr & Feed Sci South China,Guangdon, Maoming Branch,Minist Agr,Inst Anim Sci,State Key, Guangzhou, Peoples R China	South China Agricultural University; South China Agricultural University; Guangdong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Jiang, QY (corresponding author), South China Agr Univ, Coll Anim Sci, Guangdong Lab Lingnan Modern Agr, Guangdong Prov Key Lab Anim Nutr Regulat, Guangzhou 510642, Peoples R China.; Jiang, QY (corresponding author), South China Agr Univ, Coll Anim Sci, Natl Engn Res Ctr Breeding Swine Ind, Guangzhou 510642, Peoples R China.	qyjiang@scau.edu.cn	Wu, Ruifan/AHH-6097-2022	Wu, Ruifan/0000-0003-4917-5197	National Natural Science Foundation of China [31790411, 31972636]; China Postdoctoral Science Foundation [2021M691073]; GuangDong Basic and Applied Basic Research Foundation [2021A1515111085]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); GuangDong Basic and Applied Basic Research Foundation	National Natural Science Foundation of China, Grant/Award Number: 31790411 and 31972636; China Postdoctoral Science Foundation, Grant/Award Number: 2021M691073; GuangDong Basic and Applied Basic Research Foundation, Grant/Award Number: 2021A1515111085	Altshuler-Keylin S, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai9248; Chen KH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0127-z; Cheng H, 2019, BBA-MOL BASIS DIS, V1865, P1451, DOI 10.1016/j.bbadis.2019.02.017; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021; Drew BG, 2014, DIABETES, V63, P1488, DOI 10.2337/db13-0665; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Ferhat M, 2019, ANTIOXID REDOX SIGN, V31, P487, DOI 10.1089/ars.2018.7626; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; Harms MJ, 2014, CELL METAB, V19, P593, DOI 10.1016/j.cmet.2014.03.007; Hentze MW, 2018, NAT REV MOL CELL BIO, V19, P327, DOI 10.1038/nrm.2017.130; Inagaki T, 2017, NAT REV MOL CELL BIO, V18, DOI 10.1038/nrm.2017.72; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kim D, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143520; Ko MS, 2021, AUTOPHAGY, V17, P1205, DOI 10.1080/15548627.2020.1753002; Kwon E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04092-0; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Lindquist JA, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0274-6; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lu Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26394-5; Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200; Martinez-Lopez N, 2016, CELL METAB, V23, P113, DOI 10.1016/j.cmet.2015.10.008; Matsumoto S, 2012, BIOCHEM J, V443, P573, DOI 10.1042/BJ20111728; Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985; Mordovkina D, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040591; Pi HF, 2013, AUTOPHAGY, V9, P1780, DOI 10.4161/auto.25665; Rabiee A, 2021, MOL METAB, V44, DOI 10.1016/j.molmet.2020.101137; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Seillier M, 2015, EMBO MOL MED, V7, P802, DOI 10.15252/emmm.201404318; Skabkina OV, 2005, MOL CELL BIOL, V25, P3317, DOI 10.1128/MCB.25.8.3317-3323.2005; Skabkina OV, 2003, J BIOL CHEM, V278, P18191, DOI 10.1074/jbc.M209073200; Wang T, 2019, EMBO REP, V20, DOI 10.15252/embr.201947892; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wu H, 2019, AUTOPHAGY, V15, P1882, DOI 10.1080/15548627.2019.1596482; Wu SL, 2015, NUCLEIC ACIDS RES, V43, P8516, DOI 10.1093/nar/gkv779; Xu D, 2017, DIABETES, V66, P2987, DOI 10.2337/db17-0655; Yau WW, 2019, AUTOPHAGY, V15, P131, DOI 10.1080/15548627.2018.1511263	38	1	1	6	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22219	10.1096/fj.202101810RR	http://dx.doi.org/10.1096/fj.202101810RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35195911				2022-12-28	WOS:000761250800030
J	Han, NR; Moon, PD; Nam, SY; Ko, SG; Park, HJ; Kim, HM; Jeong, HJ				Han, Na-Ra; Moon, Phil-Dong; Nam, Sun-Young; Ko, Seong-Gyu; Park, Hi-Joon; Kim, Hyung-Min; Jeong, Hyun-Ja			TSLP up-regulates inflammatory responses through induction of autophagy in T cells	FASEB JOURNAL			English	Article						autophagy; EL4 cells; inflammatory responses; thymic stromal lymphopoietin	THYMIC STROMAL LYMPHOPOIETIN; LIVER-INJURY; CYTOKINE PRODUCTION; PROTECTS MICE; MTOR; PHOSPHORYLATION; INTERLEUKIN-4; ACTIVATION; SEPSIS; STAT5	Thymic stromal lymphopoietin (TSLP), a type I cytokine belonging to the IL-2 cytokine family, promotes Th2-mediated inflammatory responses. The aim of this study is to investigate whether TSLP increases inflammatory responses via induction of autophagy using a murine T cell lymphoma cell line, EL4 cells, and lipopolysaccharide (LPS)-injected mice. TSLP increased expression levels of autophagy-related factors, such as Beclin-1, LC3-II, p62, Atg5, and lysosome associated membrane protein 1/2, whereas these factors increased by TSLP disappeared by neutralization of TSLP in EL4 cells. TSLP activated JAK1/JAK2/STAT5/JNK/PI3K, while the blockade of JAK1/JAK2/STAT5/JNK/PI3K signaling pathways reduced the expression levels of Beclin-1, LC3-II, and p62 in TSLP-stimulated EL4 cells. In addition, TSLP simultaneously increased levels of inflammatory cytokines via induction of autophagy by activation of JAK1/JAK2/STAT5/JNK/PI3K signaling pathways. In an LPS-induced acute liver injury (ALI) mouse model, exogenous TSLP increased expression levels of Beclin-1 and LC3-II, whereas functional deficiency of TSLP by TSLP siRNA resulted in lower expression of Beclin-1, LC3-II, and inflammatory cytokines, impairing their ability to form autophagosomes in ALI mice. Thus, our findings show a new role of TSLP between autophagy and inflammatory responses. In conclusion, regulating TSLP-induced autophagy may be a potential therapeutic strategy for inflammatory responses.	[Han, Na-Ra] Kyung Hee Univ, Coll Korean Med, Seoul, South Korea; [Han, Na-Ra; Ko, Seong-Gyu] Kyung Hee Univ, Coll Korean Med, Korean Med Based Drug Repositioning Canc Res Ctr, Seoul, South Korea; [Moon, Phil-Dong] Kyung Hee Univ, Ctr Converging Humanities, Seoul, South Korea; [Nam, Sun-Young; Kim, Hyung-Min] Kyung Hee Univ, Coll Korean Med, Dept Pharmacol, Seoul, South Korea; [Ko, Seong-Gyu] Kyung Hee Univ, Coll Korean Med, Dept Prevent Med, Seoul, South Korea; [Park, Hi-Joon] Kyung Hee Univ, Coll Korean Med, Dept Anat & Informat Sci, Seoul, South Korea; [Jeong, Hyun-Ja] Hoseo Univ, Dept Food Sci & Technol, Asan, Chungnam, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University; Hoseo University	Kim, HM (corresponding author), Kyung Hee Univ, Coll Korean Med, Dept Pharmacol, Seoul, South Korea.; Jeong, HJ (corresponding author), Hoseo Univ, Dept Food Sci & Technol, Asan, Chungnam, South Korea.	hmkim@khu.ac.kr; hjjeong@hoseo.edu			National Research Foundation of Korea (NRF) - Ministry of Education [2016R1D1A1B03931625]; National Research Foundation of Korea (NRF) - Korea government (MSIT) [2020R1A5A2019413]	National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of Korea); National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Grant/Award Number: 2016R1D1A1B03931625; National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT), Grant/Award Number: 2020R1A5A2019413	Abdelaziz DHA, 2015, IMMUNOL REV, V265, P194, DOI 10.1111/imr.12288; Allan S, 2008, NAT REV IMMUNOL, V8, P904, DOI 10.1038/nri2457; Alqahtani SA, 2020, UNITED EUR GASTROENT, V8, P509, DOI 10.1177/2050640620924157; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Botbol Y, 2016, EUR J IMMUNOL, V46, P1326, DOI 10.1002/eji.201545955; Botbol Y, 2015, AUTOPHAGY, V11, P1864, DOI 10.1080/15548627.2015.1089374; Caterino M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82426-7; Chapin CA, 2018, HEPATOLOGY, V68, P1087, DOI 10.1002/hep.29901; Cristofani R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0866-5; Desvaux E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254374; Dickinson JD, 2018, REDOX BIOL, V14, P272, DOI 10.1016/j.redox.2017.09.013; Dickinson JD, 2016, AUTOPHAGY, V12, P397, DOI 10.1080/15548627.2015.1056967; Dowaidar M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12747-z; Dreschers S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09359-8; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Galluzzi L, 2017, NAT REV DRUG DISCOV, V16, P487, DOI 10.1038/nrd.2017.22; Gotthardt D, 2016, CANCER DISCOV, V6, P414, DOI 10.1158/2159-8290.CD-15-0732; Han H, 2012, MUCOSAL IMMUNOL, V5, P342, DOI 10.1038/mi.2012.14; Han NR, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091350; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Hewitt G, 2016, AUTOPHAGY, V12, P1917, DOI 10.1080/15548627.2016.1210368; Hsieh HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05639-x; Hubbard VM, 2010, J IMMUNOL, V185, P7349, DOI 10.4049/jimmunol.1000576; Jacquin E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01023; Jang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056433; Jesus TT, 2017, CRIT REV BIOCHEM MOL, V52, P235, DOI 10.1080/10409238.2017.1279120; Kadandale P, 2010, P NATL ACAD SCI USA, V107, P10502, DOI 10.1073/pnas.0914168107; Kitajima M, 2011, EUR J IMMUNOL, V41, P1862, DOI 10.1002/eji.201041195; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kuethe JW, 2014, J SURG RES, V191, P19, DOI 10.1016/j.jss.2014.05.024; Kuperman DA, 2008, CURR MOL MED, V8, P384, DOI 10.2174/156652408785161032; Lee HC, 2013, HEPATOLOGY, V57, P1314, DOI 10.1002/hep.26128; Lee S, 2014, ANTIOXID REDOX SIGN, V20, P432, DOI 10.1089/ars.2013.5368; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Li H, 2021, BMC COMPLEMENT MED, V21, DOI 10.1186/s12906-020-03187-w; Li QR, 2018, INNATE IMMUN-LONDON, V24, P231, DOI 10.1177/1753425918771170; Li SL, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129013; Lin CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102066; Lin SC, 2019, PEDIATR RES, V86, P181, DOI 10.1038/s41390-018-0239-x; Liu JN, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.38; Liu WJ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2002-6; Lu LH, 2019, J INFECTION, V78, P178, DOI 10.1016/j.jinf.2018.12.003; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Matsumoto K, 2020, J ALLERGY CLIN IMMUN, V146, P55, DOI 10.1016/j.jaci.2020.05.017; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Miller K, 2020, AUTOPHAGY, V16, P2131, DOI 10.1080/15548627.2020.1817280; Molejon MI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01055; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Parekh VV, 2013, J IMMUNOL, V190, P5086, DOI 10.4049/jimmunol.1202071; Polte T, 2006, J CLIN INVEST, V116, P1025, DOI 10.1172/JCI23792; Poon AH, 2012, J ALLERGY CLIN IMMUN, V129, P569, DOI 10.1016/j.jaci.2011.09.035; Proctor WR, 2014, HEPATOLOGY, V60, P1741, DOI 10.1002/hep.27169; Redmond WL, 2009, CRIT REV IMMUNOL, V29, P187, DOI 10.1615/CritRevImmunol.v29.i3.10; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Rochman Y, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aam8858; Rochman Y, 2010, P NATL ACAD SCI USA, V107, P19455, DOI 10.1073/pnas.1008271107; Shan LY, 2010, J IMMUNOL, V184, P7134, DOI 10.4049/jimmunol.0902515; Shen CC, 2011, INT J NANOMED, V6, P1229, DOI 10.2147/IJN.S21019; Shipkova M, 2012, CLIN CHIM ACTA, V413, P1338, DOI 10.1016/j.cca.2011.11.006; Takahashi N, 2016, CANCER RES, V76, P6241, DOI 10.1158/0008-5472.CAN-16-0992; Tvorogov D, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat3834; Vasilevskaya IA, 2016, MOL CANCER RES, V14, P753, DOI 10.1158/1541-7786.MCR-16-0035; Vomero M, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.569849; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Weichhart T, 2011, BLOOD, V117, P4273, DOI 10.1182/blood-2010-09-310888; Wesche-Soldato DE, 2007, AM J PATHOL, V171, P87, DOI 10.2353/ajpath.2007.061099; Wu YJ, 2018, MOL MED REP, V17, P8003, DOI 10.3892/mmr.2018.8831; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yang MH, 2013, BIOCHEM PHARMACOL, V86, P410, DOI 10.1016/j.bcp.2013.05.013; Yang R, 2019, J IMMUNOL, V203, P2020, DOI 10.4049/jimmunol.1900859; Yu J, 2018, RSC ADV, V8, P33338, DOI 10.1039/c8ra03720e; Yu XZ, 2012, CELL IMMUNOL, V279, P174, DOI 10.1016/j.cellimm.2012.10.005; Zhong J, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau007; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854; Zhou YY, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140141	77	1	1	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22148	10.1096/fj.202101447R	http://dx.doi.org/10.1096/fj.202101447R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34997949				2022-12-28	WOS:000747987800003
J	Miyata, K; Horikami, D; Tachibana, Y; Yamamoto, T; Nakamura, T; Kobayashi, K; Murata, T				Miyata, Kana; Horikami, Daiki; Tachibana, Yuri; Yamamoto, Teruko; Nakamura, Tatsuro; Kobayashi, Koji; Murata, Takahisa			15-hydroxy eicosadienoic acid is an exacerbating factor for nasal congestion in mice	FASEB JOURNAL			English	Article						animal models; fatty acid; inflammation; oxidized lipids; vascular biology	ALLERGIC RHINITIS; POTASSIUM CHANNELS; PROSTAGLANDIN D-2; THROMBOXANE A(2); ARACHIDONIC-ACID; LINOLEIC-ACID; MAST-CELLS; RAT AORTA; HISTAMINE; INFILTRATION	Allergic rhinitis (AR) is one of the most common allergic inflammatory diseases worldwide. In AR, increased blood flow and vascular permeability in nasal mucosa cause rhinorrhea and nasal congestion. We investigated the role of an 11Z,14Z-eicosadienoic acid-derived metabolite, 15-hydroxy-11Z,13Z-eicosadienoic acid (15-HEDE), in functional changes in vasculature and nasal congestion in AR. Repeated intranasal administration of Ovalbumin (OVA) caused AR symptoms, such as sneezing and nasal congestion, in mice. OVA administration increased the level of 15-HEDE in nasal lavage fluid, which reached approximately 0.6 ng/ml after ten OVA treatments. Upon measuring vascular contraction, treatment with 0.1-3 mu M 15-HEDE did not cause contraction in mouse aortae, while it dilated aortae that were pre-contracted by thromboxane receptor stimulation. Pretreatment with the voltage-gated K+ (K-V) channel inhibitor 4-aminopyridine significantly inhibited the 15-HEDE-induced vascular relaxation. Intravital imaging showed that administration of 1 mu g 15-HEDE dilated blood vessels, and Mile's assay demonstrated that this administration also caused dye leakage, indicating vascular hyperpermeability in mouse ears. Computed tomography scanning and morphological study revealed that administration of 3 mu g 15-HEDE narrowed nasal passages and thickened nasal mucosa in mice. Finally, we confirmed that treating mice with 3 mu g 15-HEDE caused rhinitis symptoms, such as abdominal breathing, and reduced respiratory frequency, suggesting nasal congestion. 15-HEDE caused vasodilation by activating K-V channels and increased vascular permeability, which may lead to nasal congestion. Furthermore, 15-HEDE might be a new lipid mediator that exacerbates nasal congestion in AR.	[Miyata, Kana; Horikami, Daiki; Tachibana, Yuri; Yamamoto, Teruko; Nakamura, Tatsuro; Kobayashi, Koji; Murata, Takahisa] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Tokyo, Japan	University of Tokyo	Murata, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amurata@mail.ecc.u-tokyo.ac.jp		Murata, Takahisa/0000-0002-3328-0796	MEXT I Japan Society for the Promotion of Science (BPS) [20H05678, 17H06252, 18K14603, 19K15975]; Shimadzu Science Foundation; Kobayashi Foundation; Takeda Science Foundation; Medical Corporation Kihokai	MEXT I Japan Society for the Promotion of Science (BPS); Shimadzu Science Foundation; Kobayashi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Medical Corporation Kihokai	MEXT I Japan Society for the Promotion of Science (BPS), Grant/Award Number: 20H05678, 17H06252, 18K14603 and 19K15975; Shimadzu Science Foundation; Kobayashi Foundation; Takeda Science Foundation; Medical Corporation Kihokai	ADAMS DR, 1983, ZBL VET MED C, V12, P109, DOI 10.1111/j.1439-0264.1983.tb01008.x; Arebro J, 2017, SCI REP-UK, V7, DOI 10.1038/srep43568; Ashina K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132367; Baldwin SN, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.598779; Bauchau V, 2004, EUR RESPIR J, V24, P758, DOI 10.1183/09031936.04.00013904; Bousquet J, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-00227-0; Boyce JA, 2007, IMMUNOL REV, V217, P168, DOI 10.1111/j.1600-065X.2007.00512.x; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Evans SJ, 2014, J PSYCHIATR RES, V57, P58, DOI 10.1016/j.jpsychires.2014.06.001; Ichimura K., 2010, Clinical and Experimental Allergy Reviews, V10, P20; Kefaloyianni E, 2011, J VASC RES, V48, P357, DOI 10.1159/000323475; Kobayashi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep32109; Kolmert J, 2018, PROSTAG OTH LIPID M, V137, P20, DOI 10.1016/j.prostaglandins.2018.05.005; Lambrou P, 2007, ANN ALLERG ASTHMA IM, V98, P567, DOI 10.1016/S1081-1206(10)60737-5; Lavinskiene S, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0065-4; Lavinskiene S, 2012, INFLAMMATION, V35, P1600, DOI 10.1007/s10753-012-9475-0; Liou YA, 2009, PROSTAG LEUKOTR ESS, V80, P201, DOI 10.1016/j.plefa.2009.02.003; Liu YJ, 2016, NEURON, V90, P521, DOI 10.1016/j.neuron.2016.04.005; Meltzer EO, 2016, ANN ALLERG ASTHMA IM, V116, P66, DOI 10.1016/j.anai.2015.10.022; Meltzer EO, 2001, J ALLERGY CLIN IMMUN, V108, pS45, DOI 10.1067/mai.2001.115566; Mita H, 1999, PROSTAG LEUKOTR ESS, V60, P175, DOI 10.1054/plef.1999.0022; Miyahara S, 2005, J ALLERGY CLIN IMMUN, V116, P1020, DOI 10.1016/j.jaci.2005.08.020; Moody CM, 2014, LAB ANIM-UK, V48, P298, DOI 10.1177/0023677214546509; Nakamura T, 2021, FASEB J, V35, DOI 10.1096/fj.202100827R; Nakamura T, 2017, J ALLERGY CLIN IMMUN, V140, P630, DOI 10.1016/j.jaci.2017.02.030; Nathan RA, 2008, ALLERGY ASTHMA PROC, V29, P600, DOI 10.2500/aap.2008.29.3179; Omori K, 2014, BRIT J PHARMACOL, V171, P4879, DOI 10.1111/bph.12815; ROTHSCHILD AM, 1970, BRIT J PHARMACOL, V38, P253, DOI 10.1111/j.1476-5381.1970.tb10354.x; Sato K, 2014, BIOL PHARM BULL, V37, P394, DOI 10.1248/bpb.b13-00746; Shieh CC, 2000, PHARMACOL REV, V52, P557; Storms William, 2008, Prim Care Respir J, V17, P7, DOI 10.3132/pcrj.2008.00001; Takahashi G, 2012, INT ARCH ALLERGY IMM, V158, P359, DOI 10.1159/000334555; Tanaka Y, 2006, PROSTAG OTH LIPID M, V80, P144, DOI 10.1016/j.prostaglandins.2006.06.003; TAYLOR SG, 1988, BRIT J PHARMACOL, V94, P853, DOI 10.1111/j.1476-5381.1988.tb11597.x; Varga EM, 1999, ALLERGY, V54, P338, DOI 10.1034/j.1398-9995.1999.00957.x; WoodBaker R, 1996, CLIN OTOLARYNGOL, V21, P348, DOI 10.1111/j.1365-2273.1996.tb01085.x; Yamasaki M, 1997, J PHARMACOL EXP THER, V280, P1471; Zhou W, 2005, AM J PHYSIOL-HEART C, V288, pH2210, DOI 10.1152/ajpheart.00704.2004	38	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22085	10.1096/fj.202101305R	http://dx.doi.org/10.1096/fj.202101305R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34888952				2022-12-28	WOS:000734992000032
J	Ghosh-Choudhary, SK; Liu, J; Finkel, T				Ghosh-Choudhary, Shohini K.; Liu, Jie; Finkel, Toren			The role of mitochondria in cellular senescence	FASEB JOURNAL			English	Review						aging; metabolism; mitophagy; reactive oxygen species; senolytic	LIFE-SPAN; DNA-DAMAGE; OXIDATIVE STRESS; MITOPHAGY; DRP1; PROTEOSTASIS; CONTRIBUTES; METABOLISM; INCREASES; UROLITHIN	Mitochondria are intimately connected to cell fate and function. Here, we review how these intracellular organelles participate in the induction and maintenance of the senescent state. In particular, we discuss how alterations in mitochondrial metabolism, quality control and dynamics are all involved in various aspects of cellular senescence. Together, these observations suggest that mitochondria are active participants and are mechanistically linked to the unique biology of senescence. We further describe how these insights can be potentially exploited for therapeutic benefit.	[Ghosh-Choudhary, Shohini K.; Liu, Jie; Finkel, Toren] Univ Pittsburgh, Aging Inst, Sch Med, UPMC, 555 Bridgeside Point 1,100 Technol Dr, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Finkel, T (corresponding author), Univ Pittsburgh, Aging Inst, Sch Med, UPMC, 555 Bridgeside Point 1,100 Technol Dr, Pittsburgh, PA 15219 USA.	finkelt@pitt.edu			HHS \ NIH \ National Institute on Aging (NIA) [P30 AG024827, U54AG075931]; HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [5T32AG021885-18]; National Heart, Lung, and Blood Institute [1R01 HL14266, 1R01HL142589]	HHS \ NIH \ National Institute on Aging (NIA); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	HHS | NIH | National Institute on Aging (NIA), Grant/Award Number: P30 AG024827 and U54AG075931; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: 5T32AG021885--18; National Heart, Lung, and Blood Institute, Grant/Award Number: 1R01 HL14266 and 1R01HL142589	Ahmad T, 2015, FASEB J, V29, P2912, DOI 10.1096/fj.14-268276; Andreux PA, 2019, NAT METAB, V1, P595, DOI 10.1038/s42255-019-0073-4; Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031; Araya J, 2019, AUTOPHAGY, V15, P510, DOI 10.1080/15548627.2018.1532259; Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862; Covarrubias AJ, 2021, NAT REV MOL CELL BIO, V22, P119, DOI 10.1038/s41580-020-00313-x; Covarrubias AJ, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00305-3; Csordas G, 2018, TRENDS CELL BIOL, V28, P523, DOI 10.1016/j.tcb.2018.02.009; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Dollerup OL, 2018, AM J CLIN NUTR, V108, P343, DOI 10.1093/ajcn/nqy132; Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222; Fang EF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13172-8; Fang EF, 2016, CELL METAB, V24, P566, DOI 10.1016/j.cmet.2016.09.004; Fang EF, 2016, NAT REV MOL CELL BIO, V17, P308, DOI 10.1038/nrm.2016.14; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Garcia-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Grosse L, 2020, CELL METAB, V32, P87, DOI 10.1016/j.cmet.2020.05.002; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015; Jang JY, 2018, J CLIN INVEST, V128, P3662, DOI 10.1172/JCI120842; Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001; Kim YY, 2020, FASEB J, V34, P2451, DOI 10.1096/fj.201901747RR; Kim YM, 2018, CELL REP, V23, P3565, DOI 10.1016/j.celrep.2018.05.054; Kondoh H, 2005, CANCER RES, V65, P177; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; Martens CR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03421-7; Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08; Nacarelli T, 2019, NAT CELL BIOL, V21, P397, DOI 10.1038/s41556-019-0287-4; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691; PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Paul BD, 2021, TRENDS NEUROSCI, V44, P83, DOI 10.1016/j.tins.2020.10.008; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Pinti M, 2014, EUR J IMMUNOL, V44, P1552, DOI 10.1002/eji.201343921; Quijano C, 2012, CELL CYCLE, V11, P1383, DOI 10.4161/cc.19800; Rajman L, 2018, CELL METAB, V27, P529, DOI 10.1016/j.cmet.2018.02.011; Rizza S, 2018, P NATL ACAD SCI USA, V115, pE3388, DOI 10.1073/pnas.1722452115; Ruan LH, 2017, NATURE, V543, P443, DOI 10.1038/nature21695; Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132; Schafer MJ, 2016, DIABETES, V65, P1606, DOI 10.2337/db15-0291; Seluanov A, 2001, MOL CELL BIOL, V21, P1552, DOI 10.1128/MCB.21.5.1552-1564.2001; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9; Steinhauser ML, 2013, SEMIN CELL DEV BIOL, V24, P661, DOI 10.1016/j.semcdb.2013.05.001; Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041; Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009; Wakabayashi T, 2002, J CELL MOL MED, V6, P497, DOI 10.1111/j.1582-4934.2002.tb00452.x; Wang CX, 2009, ANNU REV GENET, V43, P95, DOI 10.1146/annurev-genet-102108-134850; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Wiel C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4792; Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011; Yang S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0089-1; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Yoshino J, 2018, CELL METAB, V27, P513, DOI 10.1016/j.cmet.2017.11.002; Yu B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16312-7; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693; Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445; Ziegler DV, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-20993-z	66	11	11	4	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e21991	10.1096/fj.202101462R	http://dx.doi.org/10.1096/fj.202101462R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34758157	Green Accepted			2022-12-28	WOS:000722321300045
J	Li, TY; Oasa, S; Ciruela, F; Terenius, L; Vukojevic, V; Svenningsson, P				Li, Tianyi; Oasa, Sho; Ciruela, Francisco; Terenius, Lars; Vukojevic, Vladana; Svenningsson, Per			Cytosolic GPR37, but not GPR37L1, multimerization and its reversal by Parkin: A live cell imaging study	FASEB JOURNAL			English	Article						aggregation; dimerization; G protein-coupled receptors; Pael-R; Parkinson disease	ENDOPLASMIC-RETICULUM STRESS; PAEL-R; ORGANIZATION; TRAFFICKING; SUBSTRATE; TOXICITY; PROMOTES	Biochemical data have shown aggregated G protein-coupled receptor 37 (GPR37) in the cytoplasm and Lewy bodies in Parkinson's disease (PD). Properly folded GPR37 at the plasma membrane appears to be neuroprotective. GPR37, and its homologue GPR37L1, are orphan G protein-coupled receptors and their homo- and hetero-dimers have not been established. We therefore examined GPR37 and GPR37L1 dimerization and extended studies of multimerization of GPR37 to live cells. In this study, we investigated GPR37 and GPR37L1 dimerization and multimerization in live cells using three quantitative imaging methods: Fluorescence Cross-Correlation Spectroscopy, Forster Resonance Energy Transfer, and Fluorescence Lifetime Imaging Microscopy. Our data show that GPR37 and GPR37L1 form homo- and heterodimers in live N2a cells. Importantly, aggregation of GPR37, but not GPR37L1, was identified in the cytoplasm, which could be counteracted by Parkin overexpression. These data provide further evidence that GPR37 participate in cytosolic aggregation processes implicated in PD pathology.	[Li, Tianyi; Oasa, Sho; Terenius, Lars; Vukojevic, Vladana; Svenningsson, Per] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Ciruela, Francisco] Univ Barcelona, Inst Neurosci, Sch Med & Hlth Sci, Dept Pathol & Expt Therapeut,IDIBELL,Pharmacol Un, Lhospitalet De Llobregat, Spain	Karolinska Institutet; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Li, TY (corresponding author), Karolinska Inst, Dept Clin Neurosci, NKS, Bioclinicum, J5-20 Neuro Svenningsson, S-17177 Stockholm, Sweden.	tianyi.li@ki.se; per.svenningsson@ki.se		Oasa, Sho/0000-0003-3800-590X; Terenius, Lars/0000-0003-2880-9576; Vukojevic, Vladana/0000-0003-0873-5653; Svenningsson, Per/0000-0001-6727-3802	Swedish Foundation for Strategic Research; European Research Council [649116]; Strategic Research Program in Neuroscience	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); European Research Council(European Research Council (ERC)European Commission); Strategic Research Program in Neuroscience	Swedish Foundation for Strategic Research; European Research Council, Grant/Award Number: 649116; Strategic Research Program in Neuroscience	AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; AbdAlla S, 2009, J BIOL CHEM, V284, P6566, DOI 10.1074/jbc.M808277200; Broussard JA, 2013, NAT PROTOC, V8, P265, DOI 10.1038/nprot.2012.147; Bu WY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012153; Coleman JLJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76384-9; Dunham JH, 2009, BIOCHEMISTRY-US, V48, P10286, DOI 10.1021/bi9013775; Dusonchet J, 2009, NEUROBIOL DIS, V35, P32, DOI 10.1016/j.nbd.2009.03.013; Ghukasyan V, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3290821; Giddens MM, 2017, NEUROBIOL DIS, V106, P181, DOI 10.1016/j.nbd.2017.07.006; Hertz E, 2019, NEUROPHARMACOLOGY, V152, P51, DOI 10.1016/j.neuropharm.2018.11.009; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jacobson K, 2019, CELL, V177, P806, DOI 10.1016/j.cell.2019.04.018; Kitao Y, 2007, HUM MOL GENET, V16, P50, DOI 10.1093/hmg/ddl439; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Krmpot AJ, 2019, ANAL CHEM, V91, P11129, DOI 10.1021/acs.analchem.9b01813; Leinartaite L, 2017, TRENDS PHARMACOL SCI, V38, P749, DOI 10.1016/j.tips.2017.05.006; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Lohse MJ, 2010, CURR OPIN PHARMACOL, V10, P53, DOI 10.1016/j.coph.2009.10.007; Loman A., 2008, 14 INT WORKSH SINGL; Lundius EG, 2014, J BIOL CHEM, V289, P4660, DOI 10.1074/jbc.M113.510883; Lundius EG, 2013, J NEUROCHEM, V124, P410, DOI 10.1111/jnc.12081; Marazziti D, 2013, P NATL ACAD SCI USA, V110, P16486, DOI 10.1073/pnas.1314819110; Mattila SO, 2016, J CELL SCI, V129, P1366, DOI 10.1242/jcs.176115; Morato X, 2021, TRANSL NEURODEGENER, V10, DOI 10.1186/s40035-021-00232-7; Morato X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10147-x; Muller CB, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46001; Murakami T, 2004, ANN NEUROL, V55, P439, DOI 10.1002/ana.20064; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Park PSH, 2019, J MEMBRANE BIOL, V252, P413, DOI 10.1007/s00232-019-00078-1; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Quitterer U, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00009; Shcherbakova DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12405; Smith NJ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00275; Vitali M, 2014, IEEE J SEL TOP QUANT, V20, DOI 10.1109/JSTQE.2014.2333238; Vogel SS, 2014, METHODS, V66, P131, DOI 10.1016/j.ymeth.2013.06.021; Vukojevic V, 2008, P NATL ACAD SCI USA, V105, P18176, DOI 10.1073/pnas.0809250105; Wang HQ, 2008, J NEUROCHEM, V107, P171, DOI 10.1111/j.1471-4159.2008.05607.x; Wang WJ, 2018, TRENDS PHARMACOL SCI, V39, P367, DOI 10.1016/j.tips.2018.01.001; Wouters E, 2018, NEUROMETHODS, V140, P239, DOI 10.1007/978-1-4939-8576-0_15	39	2	2	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22055	10.1096/fj.202101213R	http://dx.doi.org/10.1096/fj.202101213R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34822195	hybrid, Green Published			2022-12-28	WOS:000722321300029
J	Zhang, L; Koller, J; Ip, CK; Gopalasingam, G; Bajaj, N; Lee, NJ; Enriquez, RF; Herzog, H				Zhang, Lei; Koller, Julia; Ip, Chi Kin; Gopalasingam, Gopana; Bajaj, Nikita; Lee, Nicola J.; Enriquez, Ronaldo F.; Herzog, Herbert			Lack of neuropeptide FF signalling in mice leads to reduced repetitive behavior, altered drinking behavior, and fuel type selection	FASEB JOURNAL			English	Article						anxiety; drinking behaviors; neuropeptide FF; neuropeptide FF receptors; oxidative fuel selection; repetitive behavior	ELEVATED PLUS-MAZE; FOOD-INTAKE; PHARMACOLOGICAL CHARACTERIZATION; INDIRECT CALORIMETRY; VASOPRESSIN RELEASE; RECEPTOR; IDENTIFICATION; ACTIVATION; PEPTIDES; MODULATE	Although best known for their involvement in modulating nociception, Neuropeptide FF (NPFF) group peptides have been suggested to fulfil a variety of biological functions such as feeding, anxiety behaviors and thermogenesis. However, evidence supporting these functions of NPFF is mostly pharmacological, leaving the physiological relevance unaddressed. Here we examined the physiological impact of lack of NPFF signalling in both genders using a Npff(-/-) mouse model. NPFF expression in the mouse is restricted to the spinal cord and brainstem while its cognate receptor NPFFR2 has wider distribution throughout the brain. Both male and female Npff(-/-) mice showed reduced repetitive behaviors evidenced in the marble burying test and self-grooming test. A decrease in anxiety-related behaviors in the Npff(-/-) mice was also observe in the open field test and to a lesser degree in an elevated plus maze test. Moreover, both male and female Npff(-/-) mice exhibited increased water intake resulting from increases in drinking size, rather than number of drinking events. During a fasting-refeeding challenge, Npff(-/-) mice of both genders displayed alterations in reparatory exchange ratio that reflect a greater fuel type flexibility. Npff(-/-) mice were otherwise wild-type-like regarding body weight, body composition, feeding behaviors, locomotion or energy expenditure. Together, these findings reveal the important physiological roles of NPFF signalling in the regulation of anxiety-related and repetitive behaviors, fluid homeostasis and oxidative fuel selection, highlighting the therapeutical potential of the NPFF system in a number of behavioral and metabolic disorders.	[Zhang, Lei; Koller, Julia; Ip, Chi Kin; Gopalasingam, Gopana; Bajaj, Nikita; Lee, Nicola J.; Enriquez, Ronaldo F.; Herzog, Herbert] St Vincents Hosp, Garvan Inst Med Res, Neurosci Div, Darlinghurst, NSW, Australia; [Zhang, Lei; Koller, Julia; Ip, Chi Kin; Lee, Nicola J.] Univ NSW, St Vincents Clin Sch, Sydney, NSW, Australia; [Herzog, Herbert] Univ NSW, Sch Med Sci, Sydney, NSW, Australia; [Herzog, Herbert] Univ NSW, Fac Med, Sydney, NSW, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Zhang, L (corresponding author), Garvan Inst Med Res, Neurosci Div, 384 Victoria St, Sydney, NSW 2010, Australia.	l.zhang@garvan.org.au	; Lee, Nicola/B-2038-2013	IP, CHI KIN/0000-0002-0464-4706; , Herbert/0000-0002-1713-1029; Zhang, Lei/0000-0002-3927-8881; Lee, Nicola/0000-0001-7766-6095	National Health and Medical Research Council of Australia [1102012, 1051111, 1118775]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	National Health and Medical Research Council of Australia, Grant/Award Number: #1102012, #1051111 and #1118775	Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Arima H, 1996, ENDOCRINOLOGY, V137, P1523, DOI 10.1210/en.137.5.1523; Ayachi S, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00158; Bonini JA, 2000, J BIOL CHEM, V275, P39324, DOI 10.1074/jbc.M004385200; Chartrel N, 2003, P NATL ACAD SCI USA, V100, P15247, DOI 10.1073/pnas.2434676100; Desprat C, 1997, PHARMACOL BIOCHEM BE, V58, P559, DOI 10.1016/S0091-3057(97)00249-9; Dodd GT, 2014, CELL METAB, V20, P639, DOI 10.1016/j.cmet.2014.07.022; Elshourbagy NA, 2000, J BIOL CHEM, V275, P25965, DOI 10.1074/jbc.M004515200; Fang Q, 2008, REGUL PEPTIDES, V147, P45, DOI 10.1016/j.regpep.2007.12.007; Fang Q, 2007, NEUROPEPTIDES, V41, P339, DOI 10.1016/j.npep.2007.04.001; Fang Q, 2006, PEPTIDES, V27, P2207, DOI 10.1016/j.peptides.2006.04.002; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; FILE SE, 1993, BEHAV BRAIN RES, V58, P199, DOI 10.1016/0166-4328(93)90103-W; Findeisen M, 2011, PHARMACEUTICALS, V4, P1248, DOI 10.3390/ph4091248; Frances B, 2001, REGUL PEPTIDES, V98, P13, DOI 10.1016/S0167-0115(00)00188-9; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Gouarderes C, 1996, BRIT J PHARMACOL, V117, P493, DOI 10.1111/j.1476-5381.1996.tb15217.x; Gutierrez-Mecinas M, 2019, NEUROSCIENCE, V416, P281, DOI 10.1016/j.neuroscience.2019.08.013; Hinuma S, 2000, NAT CELL BIOL, V2, P703, DOI 10.1038/35036326; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Ip CK, 2014, DEVELOPMENT, V141, P3859, DOI 10.1242/dev.114900; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; Lee NJ, 2015, MOL METAB, V4, P164, DOI 10.1016/j.molmet.2014.12.010; Leon S, 2018, METABOLISM, V87, P87, DOI 10.1016/j.metabol.2018.07.003; Lin YT, 2016, EUR J PAIN, V20, P895, DOI 10.1002/ejp.814; Lin YT, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9112479; Lin YT, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081810; Lin YT, 2017, EXP NEUROL, V291, P62, DOI 10.1016/j.expneurol.2017.02.003; Lin YT, 2016, PSYCHONEUROENDOCRINO, V71, P73, DOI 10.1016/j.psyneuen.2016.05.014; Liu QY, 2001, J BIOL CHEM, V276, P36961, DOI 10.1074/jbc.M105308200; Ma L, 2009, EUR J NEUROSCI, V30, P1585, DOI 10.1111/j.1460-9568.2009.06956.x; McLean J., 1987, ANIMAL HUMAN CALORIM; Miklos J, 2009, HORM BEHAV, V56, P24, DOI 10.1016/j.yhbeh.2009.02.006; Mollereau C, 2002, EUR J PHARMACOL, V451, P245, DOI 10.1016/S0014-2999(02)02224-0; MONTGOMERY KC, 1955, J COMP PHYSIOL PSYCH, V48, P132, DOI 10.1037/h0048596; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Murase T, 1996, PEPTIDES, V17, P353, DOI 10.1016/0196-9781(95)02137-X; Newmyer BA, 2011, BEHAV BRAIN RES, V219, P351, DOI 10.1016/j.bbr.2010.12.001; Nicklous DM, 2003, AM J PHYSIOL-REG I, V285, pR1046, DOI 10.1152/ajpregu.00107.2003; Palotai M, 2014, BEHAV BRAIN RES, V274, P264, DOI 10.1016/j.bbr.2014.08.007; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Perry SJ, 1997, FEBS LETT, V409, P426, DOI 10.1016/S0014-5793(97)00557-7; Poling MC, 2013, J NEUROENDOCRINOL, V25, P876, DOI 10.1111/jne.12084; Selman C, 2001, J EXP BIOL, V204, P777; Silverman JL, 2010, NEUROPSYCHOPHARMACOL, V35, P976, DOI 10.1038/npp.2009.201; SUNDBLOM DM, 1995, PEPTIDES, V16, P347, DOI 10.1016/0196-9781(94)00163-4; Sunter D, 2001, NEUROSCI LETT, V313, P145, DOI 10.1016/S0304-3940(01)02267-4; Takayasu S, 2006, P NATL ACAD SCI USA, V103, P7438, DOI 10.1073/pnas.0602371103; Vilim FS, 1999, MOL PHARMACOL, V55, P804; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Waqas SFH, 2017, J CLIN INVEST, V127, P2842, DOI 10.1172/JCI90152; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; YANG HYT, 1985, P NATL ACAD SCI USA, V82, P7757, DOI 10.1073/pnas.82.22.7757; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Yokoi H, 1998, PEPTIDES, V19, P393, DOI 10.1016/S0196-9781(97)00375-6; Zhang L, 2020, J NEUROENDOCRINOL, V32, DOI 10.1111/jne.12898; Zhang L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06462-0; Zhang L, 2014, MOL METAB, V3, P581, DOI 10.1016/j.molmet.2014.05.001	59	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21980	10.1096/fj.202100703R	http://dx.doi.org/10.1096/fj.202100703R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34694651				2022-12-28	WOS:000712009200025
J	Abou Saleh, L; Boyd, A; Aragon, IV; Koloteva, A; Spadafora, D; Mneimneh, W; Barrington, RA; Richter, W				Abou Saleh, Lina; Boyd, Abigail; Aragon, Ileana, V; Koloteva, Anna; Spadafora, Domenico; Mneimneh, Wadad; Barrington, Robert A.; Richter, Wito			Ablation of PDE4B protects from Pseudomonas aeruginosa-induced acute lung injury in mice by ameliorating the cytostorm and associated hypothermia	FASEB JOURNAL			English	Article						acute lung injury; cytostorm; hypothermia; interleukin 6; PDE4B; Pseudomonas aeruginosa	SYSTEMIC INFLAMMATION; PHOSPHODIESTERASE 4D; MOUSE; INFECTION; LIPOPOLYSACCHARIDE; INHIBITION; FEVER; 4B	Pseudomonas aeruginosa is a frequent cause of hospital-acquired lung infections characterized by hyperinflammation, antibiotic resistance, and high morbidity/mortality. Here, we show that the genetic ablation of one cAMP-phosphodiesterase 4 subtype, PDE4B, is sufficient to protect mice from acute lung injury induced by P aeruginosa infection as it reduces pulmonary and systemic levels of pro-inflammatory cytokines, as well as pulmonary vascular leakage and mortality. Surprisingly, despite dampening immune responses, bacterial clearance in the lungs of PDE4B-KO mice is significantly improved compared to WT controls. In wildtypes, P aeruginosa-infection produces high systemic levels of several cytokines, including TNF-alpha, IL-1 beta, and IL-6, that act as cryogens and render the animals hypothermic. This, in turn, diminishes their ability to clear the bacteria. Ablation of PDE4B curbs both the initial production of acute response cytokines, including TNF-alpha and IL-1 beta, as well as their downstream signaling, specifically the induction of the secondary-response cytokine IL-6. This synergistic action protects PDE4B-KO mice from the deleterious effects of the P aeruginosa-induced cytostorm, while concurrently improving bacterial clearance, rather than being immunosuppressive. These benefits of PDE4B ablation are in contrast to the effects resulting from treatment with PAN-PDE4 inhibitors, which have been shown to increase bacterial burden and dissemination. Thus, PDE4B represents a promising therapeutic target in settings of P aeruginosa lung infections.	[Abou Saleh, Lina; Boyd, Abigail; Aragon, Ileana, V; Koloteva, Anna; Richter, Wito] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, 5851 USA Dr North,MSB2310, Mobile, AL 36688 USA; [Abou Saleh, Lina; Boyd, Abigail; Aragon, Ileana, V; Koloteva, Anna; Richter, Wito] Univ S Alabama, Coll Med, Ctr Lung Biol, Mobile, AL 36688 USA; [Spadafora, Domenico; Barrington, Robert A.] Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mobile, AL 36688 USA; [Mneimneh, Wadad] Univ S Alabama, Coll Med, Dept Pathol, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama	Richter, W (corresponding author), Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, 5851 USA Dr North,MSB2310, Mobile, AL 36688 USA.	richter@southalabama.edu		Richter, Wito/0000-0001-5588-9060	Cystic Fibrosis Foundation [SALEH18H0, SALEH19HO, RICHTE16GO]; National Institutes of Health [HL076125, HL141473, HL066299]; USA College of Medicine Dean's Predoctoral Fellowship Program	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USA College of Medicine Dean's Predoctoral Fellowship Program	Cystic Fibrosis Foundation, Grant/Award Number: SALEH18H0, SALEH19HO and RICHTE16GO; National Institutes of Health, Grant/Award Number: HL076125, HL141473 and HL066299; USA College of Medicine Dean's Predoctoral Fellowship Program	Aragon IV, 2021, BIOCHEM PHARMACOL, V186, DOI 10.1016/j.bcp.2021.114477; Ariga M, 2004, J IMMUNOL, V173, P7531, DOI 10.4049/jimmunol.173.12.7531; Baillie GS, 2019, NAT REV DRUG DISCOV, V18, P770, DOI 10.1038/s41573-019-0033-4; Barbier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089941; Blackman BE, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203604; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1038/s41591-020-1051-9, 10.1101/2020.05.28.20115758]; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Fitzgerald M, 2014, EXPERT OPIN EMERG DR, V19, P323, DOI 10.1517/14728214.2014.953052; Garami A, 2018, HAND CLINIC, V157, P565, DOI 10.1016/B978-0-444-64074-1.00034-3; Gazmuri RJ, 2003, CRIT CARE MED, V31, P2811, DOI 10.1097/01.CCM.0000099344.57796.F3; Geurts M, 2014, CRIT CARE MED, V42, P231, DOI 10.1097/CCM.0b013e3182a276e8; Goligher EC, 2021, NEW ENGL J MED, V385, P777, DOI [10.1056/NEJMoa2103417, 10.1056/NEJMoa2100433]; Gordon CJ, 2017, PHYSIOL BEHAV, V179, P55, DOI 10.1016/j.physbeh.2017.05.026; GORRILL RH, 1956, J PATHOL BACTERIOL, V71, P353, DOI 10.1002/path.1700710209; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Huston E, 2008, P NATL ACAD SCI USA, V105, P12791, DOI 10.1073/pnas.0805167105; Jin SLC, 2010, J ALLERGY CLIN IMMUN, V126, P1252, DOI 10.1016/j.jaci.2010.08.014; Jin SLC, 2005, J IMMUNOL, V175, P1523, DOI 10.4049/jimmunol.175.3.1523; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Kasetty G, 2016, J PHARMACOL EXP THER, V357, P66, DOI 10.1124/jpet.115.229641; Leon LR, 2004, FRONT BIOSCI, V9, P1877, DOI 10.2741/1381; Li H, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01048; Lima KM, 2017, J BIOL CHEM, V292, P13758, DOI 10.1074/jbc.M117.800391; Ma HY, 2014, BIOCHEM BIOPH RES CO, V450, P1560, DOI 10.1016/j.bbrc.2014.07.024; McDonough W, 2020, BIOCHEM PHARMACOL, V180, DOI 10.1016/j.bcp.2020.114158; McDonough W, 2020, FASEB J, V34, P12533, DOI 10.1096/fj.202001016RR; Micek ST, 2015, INFECT CONT HOSP EP, V36, P1190, DOI 10.1017/ice.2015.167; Mika D, 2014, J CELL SCI, V127, P1033, DOI 10.1242/jcs.140251; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Park T, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0751-z; Richter W, 2013, EXPERT OPIN THER TAR, V17, P1011, DOI 10.1517/14728222.2013.818656; Robichaud A, 2002, J CLIN INVEST, V110, P1045, DOI 10.1172/JCI200215506; Romanovsky AA, 2005, FRONT BIOSCI-LANDMRK, V10, P2193, DOI 10.2741/1690; Romanovsky AA, 2018, HAND CLINIC, V156, P3, DOI 10.1016/B978-0-444-63912-7.00001-1; Rudaya AY, 2005, AM J PHYSIOL-REG I, V289, pR1244, DOI 10.1152/ajpregu.00370.2005; Sawa T, 2014, J INTENSIVE CARE, V2, DOI 10.1186/2052-0492-2-10; Skelly DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069123; Soares AC, 2003, BRIT J PHARMACOL, V140, P855, DOI 10.1038/sj.bjp.0705517; Soares A, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.02057; Suzuki O, 2013, J PHARMACOL SCI, V123, P219, DOI 10.1254/jphs.13103FP; Tavares LP, 2020, PHARMACOL RES, V159, DOI 10.1016/j.phrs.2020.105030; Tavares LP, 2016, AM J RESP CELL MOL, V55, P24, DOI 10.1165/rcmb.2015-0083OC; TSUJI A, 1982, MICROBIOL IMMUNOL, V26, P15, DOI 10.1111/j.1348-0421.1982.tb00149.x; Van Linthout S, 2014, CARDIOVASC RES, V102, P258, DOI 10.1093/cvr/cvu062; Grosso-Becerraa MV, 2014, P NATL ACAD SCI USA, V111, P15562, DOI 10.1073/pnas.1402536111; Xie M, 2014, BIOCHEM J, V459, P539, DOI 10.1042/BJ20131681; Yu YRA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150606; Zhang KYJ, 2005, EXPERT OPIN THER TAR, V9, P1283, DOI 10.1517/14728222.9.6.1283	50	3	3	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21797	10.1096/fj.202100495R	http://dx.doi.org/10.1096/fj.202100495R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34383981	Green Accepted			2022-12-28	WOS:000691122900053
J	Fujikura, Y; Sugihara, H; Hatakeyama, M; Oishi, K; Yamanouchi, K				Fujikura, Yuri; Sugihara, Hidetoshi; Hatakeyama, Masaki; Oishi, Katsutaka; Yamanouchi, Keitaro			Ketogenic diet with medium-chain triglycerides restores skeletal muscle function and pathology in a rat model of Duchenne muscular dystrophy	FASEB JOURNAL			English	Article						Duchenne muscular dystrophy; ketogenic diet; ketone bodies; nutrition therapy; skeletal muscle	FAT; PROLIFERATION; MECHANISMS; RESISTANCE; THERAPY	Duchenne muscular dystrophy (DMD) is an intractable genetic disease associated with progressive skeletal muscle weakness and degeneration. Recently, it was reported that intraperitoneal injections of ketone bodies partially ameliorated muscular dystrophy by increasing satellite cell (SC) proliferation. Here, we evaluated whether a ketogenic diet (KD) with medium-chain triglycerides (MCT-KD) could alter genetically mutated DMD in model rats. We found that the MCT-KD significantly increased muscle strength and fiber diameter in these rats. The MCT-KD significantly suppressed the key features of DMD, namely, muscle necrosis, inflammation, and subsequent fibrosis. Immunocytochemical analysis revealed that the MCT-KD promoted the proliferation of muscle SCs, suggesting enhanced muscle regeneration. The muscle strength of DMD model rats fed with MCT-KD was significantly improved even at the age of 9 months. Our findings suggested that the MCT-KD ameliorates muscular dystrophy by inhibiting myonecrosis and promoting the proliferation of muscle SCs. As far as we can ascertain, this is the first study to apply a functional diet as therapy for DMD in experimental animals. Further studies are needed to elucidate the underlying mechanisms of the MCT-KD-induced improvement of DMD.	[Fujikura, Yuri; Oishi, Katsutaka] Natl Inst Adv Ind Sci & Technol, Cellular & Mol Biotechnol Res Inst, Hlth Food Sci Res Grp, Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan; [Sugihara, Hidetoshi; Yamanouchi, Keitaro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Physiol, Bunkyo Ku, Tokyo, Japan; [Hatakeyama, Masaki] Miyagi Hlth Innovat, Sendai, Miyagi, Japan; [Oishi, Katsutaka] Tokyo Univ Sci, Grad Sch Sci & Technol, Dept Appl Biol Sci, Noda, Chiba, Japan; [Oishi, Katsutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Kashiwa, Chiba, Japan; [Oishi, Katsutaka] Univ Tsukuba, Sch Integrat & Global Majors SIGMA, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; Tokyo University of Science; University of Tokyo; University of Tsukuba	Oishi, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Cellular & Mol Biotechnol Res Inst, Hlth Food Sci Res Grp, Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.; Yamanouchi, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Vet Physiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	k-ooishi@aist.go.jp; akeita@g.ecc.u-tokyo.ac.jp	Oishi, Katsutaka/L-6906-2018; Fujikura, Yuri/H-1612-2019	Oishi, Katsutaka/0000-0002-4870-0837; Fujikura, Yuri/0000-0002-3257-5146	Biosignal Research Center, Kobe University [202004]; Japan Health Foundation	Biosignal Research Center, Kobe University; Japan Health Foundation(Japan Health Foundation)	Biosignal Research Center, Kobe University, Grant/Award Number: 202004; Japan Health Foundation	Augustin K, 2018, LANCET NEUROL, V17, P84, DOI 10.1016/S1474-4422(17)30408-8; Bencze M., 2019, J VIS EXP, V5, P154; Campbell WW, 2002, J PHYSIOL-LONDON, V542, P631, DOI 10.1113/jphysiol.2002.020685; Deemer SE, 2020, NUTR RES, V77, P1, DOI 10.1016/j.nutres.2020.02.010; Fairclough RJ, 2013, NAT REV GENET, V14, P373, DOI 10.1038/nrg3460; Fujiwara D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218329; Geng SS, 2016, EUR J NUTR, V55, P931, DOI 10.1007/s00394-015-0907-0; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Grounds MD, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.043638; Harvey CJDC, 2018, J NUTR METAB, V2018, DOI 10.1155/2018/2630565; HUTTENLOCHER PR, 1971, NEUROLOGY, V21, P1097, DOI 10.1212/WNL.21.11.1097; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; Klement RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155050; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kuswanto W, 2016, IMMUNITY, V44, P355, DOI 10.1016/j.immuni.2016.01.009; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; Mercuri E, 2013, LANCET, V381, P845, DOI 10.1016/S0140-6736(12)61897-2; Motohashi N, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091066; Nakamura K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05635; NAKANO K, 1972, J NUTR, V102, P283, DOI 10.1093/jn/102.2.283; Nakao R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56166-8; Ni FF, 2016, SEIZURE-EUR J EPILEP, V38, P17, DOI 10.1016/j.seizure.2016.03.006; Noakes M, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-7; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; Okeke EB, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00680; Ribeiro AF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48156-7; Riuzzi F, 2012, J CELL SCI, V125, P1440, DOI 10.1242/jcs.092163; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; Sugihara H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73315-6; Tinsley GM, 2016, INT J SPORT NUTR EXE, V26, P78, DOI 10.1123/ijsnem.2015-0070; Usas A, 2011, MEDICINA-LITHUANIA, V47, P469, DOI 10.3390/medicina47090068; Verhaart IEC, 2019, NAT REV NEUROL, V15, P373, DOI 10.1038/s41582-019-0203-3; Villalta SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009925; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Xin LJ, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00062; Yasuda S, 2005, NATURE, V436, P1025, DOI 10.1038/nature03844; Zeng L, 2010, J BIOL CHEM, V285, P36060, DOI 10.1074/jbc.M110.160879; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693; Zou XT, 2016, J BIOL CHEM, V291, P2181, DOI 10.1074/jbc.M115.676510	39	5	5	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21861	10.1096/fj.202100629R	http://dx.doi.org/10.1096/fj.202100629R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34416029				2022-12-28	WOS:000691122900046
J	Gagnon, J; Caron, V; Gyenizse, L; Tremblay, A				Gagnon, Jonathan; Caron, Veronique; Gyenizse, Laurent; Tremblay, Andre			Atypic SUMOylation of Nor1/NR4A3 regulates neural cell viability and redox sensitivity	FASEB JOURNAL			English	Article						neuroprotection; Nor1; nuclear receptor; peroxide; SUMO-2	ORPHAN NUCLEAR RECEPTORS; NGFI-B; PROTEIN; ACTIVATION; PATHWAY; NURR1; PHOSPHORYLATION; NUR77; MOTIF; DEGRADATION	Neuron-derived orphan receptor 1, NR4A3 (Nor1)/NR4A3 is an orphan nuclear receptor involved in the transcriptional control of developmental and neurological functions. Oxidative stress-induced conditions are primarily associated with neurological defects in humans, yet the impact on Nor1-mediated transcription of neuronal genes remains with unknown mechanism. Here, we demonstrate that Nor1 is a non-conventional target of SUMO2/3 conjugation at Lys-137 contained in an atypic psi KxSP motif referred to as the pSuM. Nor1 pSuM SUMOylation differs from the canonical process with the obligate phosphorylation of Ser-139 by Ras signaling to create the required negatively charged interface for SUMOylation. Additional phosphorylation at sites flanking the pSuM is also mediated by the coordinated action of protein kinase casein kinase 2 to function as a small ubiquitin-like modifier enhancer, regulating Nor1-mediated transcription and proteasomal degradation. Nor1 responsive genes involved in cell proliferation and metabolism, such as activating transcription factor 3, cyclin D1, CASP8 and FADD-like apoptosis regulator, and enolase 3 were upregulated in response to pSuM disruption in mouse HT-22 hippocampal neuronal cells and human neuroblastoma SH-SY5Y cells. We also identified critical antioxidant genes, such as catalase, superoxide dismutase 1, and microsomal glutathione S-transferase 2, as responsive targets of Nor1 under pSuM regulation. Nor1 SUMOylation impaired gene transcription through less effective Nor1 chromatin binding and reduced enrichment of histone H3K27ac marks to gene promoters. These effects resulted in decreased neuronal cell growth, increased apoptosis, and reduced survival to oxidative stress damage, underlying the role of pSuM-modified Nor1 in redox homeostasis. Our findings uncover a hierarchical post-translational mechanism that dictates Nor1 non-canonical SUMOylation, disrupting Nor1 transcriptional competence, and neuroprotective redox sensitivity.	[Gagnon, Jonathan; Caron, Veronique; Gyenizse, Laurent; Tremblay, Andre] CHU St Justine, Res Ctr, Montreal, PQ, Canada; [Gagnon, Jonathan; Gyenizse, Laurent; Tremblay, Andre] Univ Montreal, Fac Med, Dept Biochem & Mol Med, Montreal, PQ, Canada; [Tremblay, Andre] Univ Montreal, Ctr Rech Reprod & Fertilite, St Hyacinthe, PQ, Canada; [Tremblay, Andre] Univ Montreal, Fac Med, Dept Obstet & Gynecol, Montreal, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal; Universite de Montreal	Tremblay, A (corresponding author), Ste Justine Hosp, Res Ctr, 3175 Cote Ste Catherine, Montreal, PQ H3T 1C5, Canada.	andre.tremblay.1@umontreal.ca		Tremblay, Andre/0000-0003-1547-9846	Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-05580]; Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR) [MOP152870]	Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC); Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Gouvernement du Canada vertical bar Natural Sciences and Engineering Research Council of Canada (NSERC), Grant/Award Number: RGPIN-05580; Gouvernement du Canada vertical bar Canadian Institutes of Health Research (CIHR), Grant/Award Number: MOP152870	Agarwal N, 2020, NEURON, V107, P1141, DOI 10.1016/j.neuron.2020.06.037; Arkenbout EK, 2003, ARTERIOSCL THROM VAS, V23, P1535, DOI 10.1161/01.ATV.0000084639.16462.7A; Arredondo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055035; Avallone R, 2006, MOL ENDOCRINOL, V20, P3165, DOI 10.1210/me.2006-0146; Bilodeau S, 2017, J MOL CELL BIOL, V9, P195, DOI 10.1093/jmcb/mjx009; Blanquet PR, 2000, PROG NEUROBIOL, V60, P211, DOI 10.1016/S0301-0082(99)00026-X; Campos-Melo D, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00044; Cobley JN, 2018, REDOX BIOL, V15, P490, DOI 10.1016/j.redox.2018.01.008; De Miranda BR, 2015, MOL PHARMACOL, V87, P1021, DOI 10.1124/mol.114.095398; de Villavicencio-Diaz TN, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10010027; Deutsch AJA, 2017, CANCER RES, V77, P2375, DOI 10.1158/0008-5472.CAN-16-2320; Duren RP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150450; Edjekouane L, 2016, ONCOTARGET, V7, P77276, DOI 10.18632/oncotarget.12630; Elfawy HA, 2019, LIFE SCI, V218, P165, DOI 10.1016/j.lfs.2018.12.029; Flaig R, 2005, J BIOL CHEM, V280, P19250, DOI 10.1074/jbc.M413175200; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Franchin C, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10010011; Galleguillos D, 2004, J BIOL CHEM, V279, P2005, DOI 10.1074/jbc.M308113200; Gizard F, 2011, J BIOL CHEM, V286, P35485, DOI 10.1074/jbc.M111.295840; Hammond SL, 2018, J PHARMACOL EXP THER, V365, P636, DOI 10.1124/jpet.117.246389; Hendriks IA, 2017, NAT STRUCT MOL BIOL, V24, P325, DOI 10.1038/nsmb.3366; Herring JA, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111373; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Huang B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32391-5; Jakaria M, 2019, MOL NEUROBIOL, V56, P5799, DOI 10.1007/s12035-019-1487-4; Jeon SG, 2020, AGING DIS, V11, P705, DOI 10.14336/AD.2019.0718; Jo AY, 2009, STEM CELLS, V27, P2238, DOI 10.1002/stem.146; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; Kagaya S, 2005, BIOL PHARM BULL, V28, P1603, DOI 10.1248/bpb.28.1603; Katafuchi T, 2018, P NATL ACAD SCI USA, V115, P12102, DOI 10.1073/pnas.1814522115; Katagiri Y, 2000, NAT CELL BIOL, V2, P435, DOI 10.1038/35017072; Kurakula K, 2014, BBA-MOL CELL RES, V1843, P2543, DOI 10.1016/j.bbamcr.2014.06.010; Maheux J, 2005, J PHARMACOL EXP THER, V313, P460, DOI 10.1124/jpet.104.080184; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Maira M, 1999, MOL CELL BIOL, V19, P7549; Marrero MC, 2017, PROTEINS, V85, P1593, DOI 10.1002/prot.25323; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mohan HM, 2012, CLIN CANCER RES, V18, P3223, DOI 10.1158/1078-0432.CCR-11-2953; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Nakagomi S, 2003, J NEUROSCI, V23, P5187; Niedzielska E, 2016, MOL NEUROBIOL, V53, P4094, DOI 10.1007/s12035-015-9337-5; Nomiyama T, 2009, CIRCULATION, V119, P577, DOI 10.1161/CIRCULATIONAHA.108.822056; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pearen MA, 2012, PHYSIOLOGY, V27, P156, DOI 10.1152/physiol.00007.2012; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pekarsky Y, 2001, P NATL ACAD SCI USA, V98, P3690, DOI 10.1073/pnas.051003198; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Picard N, 2008, MOL ENDOCRINOL, V22, P317, DOI 10.1210/me.2007-0281; Picard N, 2012, MOL CELL BIOL, V32, P2709, DOI 10.1128/MCB.06624-11; Ponnio T, 2004, MOL CELL BIOL, V24, P9070, DOI 10.1128/MCB.24.20.9070-9078.2004; Popichak KA, 2018, MOL PHARMACOL, V94, P1174, DOI 10.1124/mol.118.112631; Rambaud J, 2009, J BIOL CHEM, V284, P14147, DOI 10.1074/jbc.M809023200; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rodrigue-Way A, 2014, FASEB J, V28, P1910, DOI 10.1096/fj.13-240168; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Safe S, 2021, MOL CANCER RES, V19, P180, DOI 10.1158/1541-7786.MCR-20-0707; Safe S, 2014, MOL ENDOCRINOL, V28, P157, DOI 10.1210/me.2013-1291; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Sanchez M, 2013, ONCOGENE, V32, P117, DOI 10.1038/onc.2012.19; Sanchez M, 2010, TRENDS ENDOCRIN MET, V21, P104, DOI 10.1016/j.tem.2009.09.007; Sauve K, 2009, CANCER RES, V69, P5793, DOI 10.1158/0008-5472.CAN-08-4924; Smith AG, 2011, PIGM CELL MELANOMA R, V24, P551, DOI 10.1111/j.1755-148X.2011.00843.x; St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2; St-Denis N, 2015, J PROTEOMICS, V118, P49, DOI 10.1016/j.jprot.2014.10.020; Thompson J, 2010, EUR J IMMUNOL, V40, P2041, DOI 10.1002/eji.200940231; Treuter E, 2011, BBA-MOL BASIS DIS, V1812, P909, DOI 10.1016/j.bbadis.2010.12.008; van Tiel CM, 2012, BBA-MOL CELL RES, V1823, P1894, DOI 10.1016/j.bbamcr.2012.06.030; Vinayavekhin N, 2011, J AM CHEM SOC, V133, P17168, DOI 10.1021/ja208199h; Volakakis N, 2010, P NATL ACAD SCI USA, V107, P12317, DOI 10.1073/pnas.1007088107; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Wansa KDSA, 2003, J BIOL CHEM, V278, P24776, DOI 10.1074/jbc.M300088200; Ward RD, 2009, BIOFACTORS, V35, P528, DOI 10.1002/biof.66; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Yau TY, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.175703; Zarraga-Granados G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0222072; Zhang L, 2017, CELL DEATH DIFFER, V24, P1530, DOI 10.1038/cdd.2017.29	82	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21827	10.1096/fj.202100395R	http://dx.doi.org/10.1096/fj.202100395R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34383980				2022-12-28	WOS:000691122900030
J	He, JZ; Yamamoto, M; Sumiyama, K; Konagaya, Y; Terai, K; Matsuda, M; Sato, S				He, Jiazhou; Yamamoto, Masamichi; Sumiyama, Kenta; Konagaya, Yumi; Terai, Kenta; Matsuda, Michiyuki; Sato, Shinya			Two-photon AMPK and ATP imaging reveals the bias between rods and cones in glycolysis utility	FASEB JOURNAL			English	Article						AMP-activated protein kinases; ATP; FRET biosensor; photoreceptor cells; two-photon microscopy	PHOTORECEPTOR INNER; GLUCOSE-METABOLISM; OUTER SEGMENTS; MOUSE ROD; LIGHT; PHOTOTRANSDUCTION; PHOSPHORYLATION; ARCHITECTURE; RETINA; CELLS	In vertebrates, retinal rod and cone photoreceptor cells rely significantly on glycolysis. Lactate released from photoreceptor cells fuels neighboring retinal pigment epithelium cells and Muller glial cells through oxidative phosphorylation. To understand this highly heterogeneous metabolic environment around photoreceptor cells, single-cell analysis is needed. Here, we visualized cellular AMP-activated protein kinase (AMPK) activity and ATP levels in the retina by two-photon microscopy. Transgenic mice expressing a hyBRET-AMPK biosensor were used for measuring the AMPK activity. GO-ATeam2 transgenic mice were used for measuring the ATP level. Temporal metabolic responses were successfully detected in the live retinal explants upon drug perfusion. A glycolysis inhibitor, 2-deoxy-d-glucose (2-DG), activated AMPK and reduced ATP. These effects were clearly stronger in rods than in cones. Notably, rod AMPK and ATP started to recover at 30 min from the onset of 2-DG perfusion. Consistent with these findings, ex vivo electroretinogram recordings showed a transient slowdown in rod dim flash responses during a 60-min 2-DG perfusion, whereas cone responses were not affected. Based on these results, we propose that cones surrounded by highly glycolytic rods become less dependent on glycolysis, and rods also become less dependent on glycolysis within 60 min upon the glycolysis inhibition.	[He, Jiazhou; Konagaya, Yumi; Terai, Kenta; Matsuda, Michiyuki; Sato, Shinya] Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Kyoto, Japan; [Yamamoto, Masamichi] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Res Promot & Management, Osaka, Japan; [Sumiyama, Kenta] RIKEN, Lab Mouse Genet Engn, Ctr Biosyst Dynam Res, Osaka, Japan; [Matsuda, Michiyuki] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto, Japan; [Matsuda, Michiyuki] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto, Japan; [Sato, Shinya] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Adv Med Technol, 6-1 Kishibe Shinmachi, Suita, Osaka 5648565, Japan; [Konagaya, Yumi] Weill Cornell Med, Dept Cell & Dev Biol, 1300 York Ave, New York, NY 10065 USA	Kyoto University; National Cerebral & Cardiovascular Center - Japan; RIKEN; Kyoto University; Kyoto University; National Cerebral & Cardiovascular Center - Japan; Cornell University	Sato, S (corresponding author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Adv Med Technol, 6-1 Kishibe Shinmachi, Suita, Osaka 5648565, Japan.	sato.shinya@ncvc.go.jp	寺井, 健太/AFQ-7663-2022	寺井, 健太/0000-0001-7638-3720; Konagaya, Yumi/0000-0002-6631-2002; Yamamoto, Masamichi/0000-0002-9088-8044; Sato, Shinya/0000-0002-5978-0975	MEXT \ JST \ Core Research for Evolutional Science and Technology (CREST) [JPMJCR1654]; JSPS [16H06280, 20H05898, 19H00993, 19K16087]; JST [JPMJCR1654, JPMJPS2022]; AMED [19gm5010003h0003]; Shimizu Foundation for Immunology and Neuroscience; Chubei Itoh Foundation; Uehara Memorial Foundation; Takeda Science Foundation	MEXT \ JST \ Core Research for Evolutional Science and Technology (CREST); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); AMED; Shimizu Foundation for Immunology and Neuroscience; Chubei Itoh Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	MEXT vertical bar JST vertical bar Core Research for Evolutional Science and Technology (CREST), Grant/Award Number: JPMJCR1654; JSPS, Grant/Award Number: 16H06280, 20H05898, 19H00993 and 19K16087; JST, Grant/Award Number: JPMJCR1654 and JPMJPS2022; AMED, Grant/Award Number: 19gm5010003h0003; Shimizu Foundation for Immunology and Neuroscience; Chubei Itoh Foundation; Uehara Memorial Foundation; Takeda Science Foundation	Andrzejewski S, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-12; BAYLOR DA, 1973, J PHYSIOL-LONDON, V234, P163, DOI 10.1113/jphysiol.1973.sp010340; Becker S, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001571; BIERNBAUM MS, 1985, J GEN PHYSIOL, V85, P83, DOI 10.1085/jgp.85.1.83; BIERNBAUM MS, 1979, J GEN PHYSIOL, V74, P649, DOI 10.1085/jgp.74.6.649; Birol G, 2007, AM J PHYSIOL-HEART C, V293, pH1696, DOI 10.1152/ajpheart.00221.2007; Bisbach CM, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107606; Bost F, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.46; Bressan C, 2020, ELIFE, V9, DOI 10.7554/eLife.56006; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Chertov AO, 2011, J BIOL CHEM, V286, P34700, DOI 10.1074/jbc.M111.279752; Chinchore Y, 2017, ELIFE, V6, DOI 10.7554/eLife.25946; Euler T, 2019, NEUROMETHODS, V148, P225, DOI 10.1007/978-1-4939-9702-2_10; Han JYS, 2020, FASEB J, V34, P5401, DOI 10.1096/fj.201902961R; Hoang QV, 2002, VISUAL NEUROSCI, V19, P395, DOI 10.1017/S0952523802194028; Horner TJ, 2005, J BIOL CHEM, V280, P28241, DOI 10.1074/jbc.M505117200; Hurley JB, 2015, J NEUROSCI RES, V93, P1079, DOI 10.1002/jnr.23583; Ingram NT, 2020, P NATL ACAD SCI USA, V117, P19599, DOI 10.1073/pnas.2001776117; JOHNSON LV, 1986, INVEST OPHTH VIS SCI, V27, P129; Kanow MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28899; Kawashima H, 2020, FASEB J, V34, P5016, DOI 10.1096/fj.201902387RR; Komatsu N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27174-x; Konagaya Y, 2017, CELL REP, V21, P2628, DOI 10.1016/j.celrep.2017.10.113; Konishi Y, 2018, ISCIENCE, V10, P98, DOI 10.1016/j.isci.2018.11.025; Li B, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101672; Li WJ, 2019, AGING DIS, V10, P949, DOI 10.14336/AD.2019.0120; Marinangeli C, 2018, ISCIENCE, V9, P1, DOI 10.1016/j.isci.2018.10.006; Masuda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22360; May AI, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18805-x; Mazzolini M, 2015, P NATL ACAD SCI USA, V112, pE2715, DOI 10.1073/pnas.1423162112; Morshedian A, 2019, NEURON, V102, P1172, DOI 10.1016/j.neuron.2019.04.004; Nakano M, 2011, ACS CHEM BIOL, V6, P709, DOI 10.1021/cb100313n; Narayan DS, 2017, CLIN EXP OPHTHALMOL, V45, P730, DOI 10.1111/ceo.12952; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Okubo A, 1998, ANN ANAT, V180, P307, DOI 10.1016/S0940-9602(98)80031-9; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pan WW, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01765-3; Parslow AC, 2014, JOVE-J VIS EXP, DOI 10.3791/51086; Perkins GA, 2003, MOL VIS, V9, P60; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Petit L, 2018, CELL REP, V23, P2629, DOI 10.1016/j.celrep.2018.04.111; Reyes-Reveles J, 2017, J BIOL CHEM, V292, P8038, DOI 10.1074/jbc.M116.770784; Rueda EM, 2016, MOL VIS, V22, P847; SALCEDA R, 1982, VISION RES, V22, P1469, DOI 10.1016/0042-6989(82)90211-5; Sato S, 2020, P NATL ACAD SCI USA, V117, P26996, DOI 10.1073/pnas.2009164117; Sumiyama K, 2010, GENOMICS, V95, P306, DOI 10.1016/j.ygeno.2010.02.006; Terai K, 2019, CELL STRUCT FUNCT, V44, P153, DOI 10.1247/csf.18035; Viegas FO, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.656000; Vinberg F, 2015, JOVE-J VIS EXP, DOI 10.3791/52855; Vinberg F, 2014, VISION RES, V101, P108, DOI 10.1016/j.visres.2014.06.003; Wang L, 1997, INVEST OPHTH VIS SCI, V38, P48; Watabe T, 2020, ACS SENSORS, V5, P719, DOI 10.1021/acssensors.9b01941; Winkler BS, 2008, INVEST OPHTH VIS SCI, V49, P4613, DOI 10.1167/iovs.08-2004; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667; Xu L, 2018, P NATL ACAD SCI USA, V115, P10475, DOI 10.1073/pnas.1802724115; Xu L, 2016, ADV EXP MED BIOL, V854, P425, DOI 10.1007/978-3-319-17121-0_56; Yam M, 2019, J BIOL CHEM, V294, P10278, DOI 10.1074/jbc.RA119.007983; Yamamoto M, 2019, CELL REP, V28, P2923, DOI 10.1016/j.celrep.2019.07.078; Zhou ZQ, 2015, AUTOPHAGY, V11, P1821, DOI 10.1080/15548627.2015.1084456	61	2	2	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21880	10.1096/fj.202101121R	http://dx.doi.org/10.1096/fj.202101121R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34449091	Green Submitted			2022-12-28	WOS:000691122900068
J	Hsia, HE; Tushaus, J; Feng, X; Hofmann, LI; Wefers, B; Marciano, DK; Wurst, W; Lichtenthaler, SF				Hsia, Hung-En; Tueshaus, Johanna; Feng, Xiao; Hofmann, Laura, I; Wefers, Benedikt; Marciano, Denise K.; Wurst, Wolfgang; Lichtenthaler, Stefan F.			Endoglycan (PODXL2) is proteolytically processed by ADAM10 (a disintegrin and metalloprotease 10) and controls neurite branching in primary neurons	FASEB JOURNAL			English	Article						ADAM10; ADAM17; neurite branching; PODXL2; seizure protein 6	AMYLOID PRECURSOR PROTEIN; ALPHA-SECRETASE; CD34 FAMILY; DISINTEGRIN/METALLOPROTEINASE ADAM10; BETA; CLEAVAGE; LIGAND; MEMBER; BACE1; MYELINATION	Cell adhesion is tightly controlled in multicellular organisms, for example, through proteolytic ectodomain shedding of the adhesion-mediating cell surface transmembrane proteins. In the brain, shedding of cell adhesion proteins is required for nervous system development and function, but the shedding of only a few adhesion proteins has been studied in detail in the mammalian brain. One such adhesion protein is the transmembrane protein endoglycan (PODXL2), which belongs to the CD34-family of highly glycosylated sialomucins. Here, we demonstrate that endoglycan is broadly expressed in the developing mouse brains and is proteolytically shed in vitro in mouse neurons and in vivo in mouse brains. Endoglycan shedding in primary neurons was mediated by the transmembrane protease a disintegrin and metalloprotease 10 (ADAM10), but not by its homolog ADAM17. Functionally, endoglycan deficiency reduced the branching of neurites extending from primary neurons in vitro, whereas deletion of ADAM10 had the opposite effect and increased neurite branching. Taken together, our study discovers a function for endoglycan in neurite branching, establishes endoglycan as an ADAM10 substrate and suggests that ADAM10 cleavage of endoglycan may contribute to neurite branching.	[Hsia, Hung-En; Tueshaus, Johanna; Feng, Xiao; Hofmann, Laura, I; Wefers, Benedikt; Wurst, Wolfgang; Lichtenthaler, Stefan F.] German Ctr Neurodegenerat Dis DZNE, Feodor Lynen St 17, D-81377 Munich, Germany; [Hsia, Hung-En; Tueshaus, Johanna; Feng, Xiao; Hofmann, Laura, I; Lichtenthaler, Stefan F.] Tech Univ Munich, Sch Med, Klinikum Rechts Isar, Neuroprote, Munich, Germany; [Wefers, Benedikt; Wurst, Wolfgang] Helmholtz Ctr Munich, Inst Dev Genet, Neuherberg, Germany; [Marciano, Denise K.] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX USA; [Marciano, Denise K.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA; [Wurst, Wolfgang; Lichtenthaler, Stefan F.] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Wurst, Wolfgang] Tech Univ Munich Weihenstephan, Neuherberg, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Munich; Technical University of Munich	Lichtenthaler, SF (corresponding author), German Ctr Neurodegenerat Dis DZNE, Feodor Lynen St 17, D-81377 Munich, Germany.	Stefan.Lichtenthaler@dzne.de		Wurst, Wolfgang/0000-0003-4422-7410	Deutsche Forschungsgemeinschaft (DFG) [FOR2290]; Bundesministerium fur Bildung und Forschung (BMBF); Foundation for the National Institutes of Health (FNIH) [R01DK099478]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Foundation for the National Institutes of Health (FNIH)	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: EXC 2145 SyNergy-ID 390857198; Bundesministerium fur Bildung und Forschung (BMBF), Grant/Award Number: JPND PMG-AD; Foundation for the National Institutes of Health (FNIH), Grant/Award Number: R01DK099478; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: FOR2290	Altmeppen HC, 2015, ELIFE, V4, DOI 10.7554/eLife.04260; Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Baeriswyl T, 2021, ELIFE, V10, DOI 10.7554/eLife.64767; Barsegov V, 2006, J PHYS CHEM B, V110, P26403, DOI 10.1021/jp0653306; Bell KFS, 2008, NEUROBIOL AGING, V29, P554, DOI 10.1016/j.neurobiolaging.2006.11.004; Brennaman LH, 2014, J NEUROCHEM, V128, P267, DOI 10.1111/jnc.12468; Brummer T, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809695; Colombo A, 2018, EMBO J, V37, DOI 10.15252/embj.201797390; Dreymueller D, 2015, AM J PHYSIOL-LUNG C, V308, pL325, DOI 10.1152/ajplung.00294.2014; Endres K, 2014, NEUROLOGY, V83, P1930, DOI 10.1212/WNL.0000000000001017; Fernandez D, 2011, BBA-MOL CELL RES, V1813, P1504, DOI 10.1016/j.bbamcr.2011.05.009; Fieger CB, 2003, J BIOL CHEM, V278, P27390, DOI 10.1074/jbc.M304204200; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Hsia HE, 2019, CELL MOL LIFE SCI, V76, P3055, DOI 10.1007/s00018-019-03173-7; Hsia HE, 2014, P NATL ACAD SCI USA, V111, P13205, DOI 10.1073/pnas.1400737111; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Jones JC, 2016, ANNU REV PHYSIOL, V78, P243, DOI 10.1146/annurev-physiol-021014-071720; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Kerr SC, 2008, J IMMUNOL, V181, P1480, DOI 10.4049/jimmunol.181.2.1480; Kim M, 2009, HUM MOL GENET, V18, P3987, DOI 10.1093/hmg/ddp323; Kuhn PH, 2016, ELIFE, V5, DOI 10.7554/eLife.12748; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Kunkle BW, 2019, NAT GENET, V51, P414, DOI 10.1038/s41588-019-0358-2; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Laurent SA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8333; Leppanen A, 2010, GLYCOBIOLOGY, V20, P1170, DOI 10.1093/glycob/cwq083; Li X, 2015, P NATL ACAD SCI USA, V112, P6080, DOI 10.1073/pnas.1505649112; Lichtenthaler SF, 2018, EMBO J, V37, DOI 10.15252/embj.201899456; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lorenzen I, 2016, SCI REP-UK, V6, DOI 10.1038/srep35067; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Lundgren JL, 2020, BMC NEUROSCI, V21, DOI 10.1186/s12868-020-0554-0; Lundgren JL, 2015, J NEUROCHEM, V135, P606, DOI 10.1111/jnc.13287; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; Marcello E, 2017, EXPERT OPIN THER TAR, V21, P1017, DOI 10.1080/14728222.2017.1386176; Marcello E, 2013, J CLIN INVEST, V123, P2523, DOI 10.1172/JCI65401; Marcos S, 2015, J NEUROSCI, V35, P4729, DOI 10.1523/JNEUROSCI.3304-13.2015; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Meijering E, 2010, CYTOM PART A, V77A, P693, DOI 10.1002/cyto.a.20895; Muller SA, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00096; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Nowakowski A, 2010, MOL CELL NEUROSCI, V43, P90, DOI 10.1016/j.mcn.2009.09.011; Pigoni M, 2020, EMBO J, V39, DOI 10.15252/embj.2019103457; Pigoni M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0134-z; Pliassova A, 2016, MOL NEUROBIOL, V53, P5710, DOI 10.1007/s12035-015-9491-9; Prox J, 2013, J NEUROSCI, V33, P12915, DOI 10.1523/JNEUROSCI.5910-12.2013; Prox J, 2012, EXP BRAIN RES, V217, P331, DOI 10.1007/s00221-011-2952-0; Njavro JR, 2020, FASEB J, V34, P2465, DOI 10.1096/fj.201902347R; Saftig P, 2015, PROG NEUROBIOL, V135, P1, DOI 10.1016/j.pneurobio.2015.10.003; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Sarangapani KK, 2011, J BIOL CHEM, V286, P9567, DOI 10.1074/jbc.M110.196485; Sassetti C, 2000, J BIOL CHEM, V275, P9001, DOI 10.1074/jbc.275.12.9001; Schlepckow K, 2017, EMBO MOL MED, V9, P1356, DOI 10.15252/emmm.201707672; Sharma K, 2015, NAT NEUROSCI, V18, P1819, DOI 10.1038/nn.4160; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Suh J, 2013, NEURON, V80, P385, DOI 10.1016/j.neuron.2013.08.035; Tan PC, 2006, STEM CELLS, V24, P1150, DOI 10.1634/stemcells.2005-0426; Thornton P, 2017, EMBO MOL MED, V9, P1366, DOI 10.15252/emmm.201707673; Tushaus J, 2020, EMBO J, V39, DOI 10.15252/embj.2020105693; Vezzoli E, 2019, J CLIN INVEST, V129, P2390, DOI 10.1172/JCI120616; Vitureira N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012003; Wefers B, 2017, METHODS, V121, P55, DOI 10.1016/j.ymeth.2017.02.008; Wetzel S, 2017, BBA-MOL CELL RES, V1864, P2071, DOI 10.1016/j.bbamcr.2017.06.005; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Yang ZF, 2016, DEV BIOL, V418, P66, DOI 10.1016/j.ydbio.2016.08.009	68	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21813	10.1096/fj.202100475R	http://dx.doi.org/10.1096/fj.202100475R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34390512	hybrid			2022-12-28	WOS:000691122900020
J	Luo, XY; Chang, HM; Yi, YY; Leung, PCK; Sun, YP				Luo, Xiaoyan; Chang, Hsun-Ming; Yi, Yuyin; Leung, Peter C. K.; Sun, Yingpu			Bone morphogenetic protein 2 upregulates SERPINE2 expression through noncanonical SMAD2/3 and p38 MAPK signaling pathways in human granulosa-lutein cells	FASEB JOURNAL			English	Article						ALK3; BMP2; human granulosa cells; SERPINE2; SMAD2; 3	PLASMINOGEN-ACTIVATOR; CONNEXIN43 EXPRESSION; GENE-EXPRESSION; RECEPTOR; GROWTH; FERTILIZATION; COMMUNICATION; INDUCTION; OVULATION; FOLLICLE	Serine protease inhibitor-E2 (SERPINE2) is highly expressed in the granulosa cells of growing follicles and the dynamic changes in SERPINE2 expression are correlated with follicular development and ovulation in several mammals, including mice, cattle, sheep, and humans. Bone morphogenetic proteins (BMPs) and their functional receptors are extensively expressed in the ovary and play critical roles in the regulation of ovarian folliculogenesis and luteal function. To date, whether BMPs regulate the expression of SERPINE2 during human follicular development remains to be elucidated. The aim of this study was to investigate the effects of BMPs on the regulation of SERPINE2 expression (a major regulator of plasminogen activators [PA]) and the underlying mechanisms using primary and immortalized human granulosa-lutein (hGL) cells. Our results demonstrated that these BMPs (BMP2, BMP4, BMP6, BMP7, and BMP15) induced differential upregulation of SERPINE2 expression. In this regard, BMP2 is the major modulator that has the best cellular activity, which further decreased the production of urokinase PA and tissue PA in hGL cells. In addition to canonical SMAD1/5/8 signaling, BMP2 also activates noncanonical SMAD2/3 and p38 mitogen-activated protein kinase (MAPK) signaling. Using two inhibition approaches (kinase receptor inhibitors and siRNA-mediated knockdown), we found that SMAD2/3-SMAD4 and p38 MAPK, but not SMAD1/5/8 signaling, was involved in the BMP2-induced upregulation of SERPINE2 expression via activin receptor-like kinase 3. These findings deepen our understanding of the differential effect of BMPs in regulating follicular function and provide new insights of the molecular mechanisms by which BMP2 regulates the expression of SERPINE2 in human granulosa cells.	[Luo, Xiaoyan; Sun, Yingpu] Zhengzhou Univ, Ctr Reprod Med, Affiliated Hosp 1, 40 Daxue Rd, Zhengzhou 450052, Henan, Peoples R China; [Luo, Xiaoyan; Chang, Hsun-Ming; Yi, Yuyin; Leung, Peter C. K.] Univ British Columbia, BC Childrens Hosp, Dept Obstet & Gynaecol, Res Inst, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada; [Luo, Xiaoyan; Sun, Yingpu] Zhengzhou Univ, Henan Key Lab Reprod & Genet, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Luo, Xiaoyan; Sun, Yingpu] Zhengzhou Univ, Henan Prov Obstet & Gynecol Dis Reprod Med, Affiliated Hosp 1, Clin Res Ctr, Zhengzhou, Peoples R China	Zhengzhou University; BC Childrens Hospital; University of British Columbia; Zhengzhou University; Zhengzhou University	Sun, YP (corresponding author), Zhengzhou Univ, Ctr Reprod Med, Affiliated Hosp 1, 40 Daxue Rd, Zhengzhou 450052, Henan, Peoples R China.; Leung, PCK (corresponding author), Univ British Columbia, BC Childrens Hosp, Dept Obstet & Gynaecol, Res Inst, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.	peter.leung@ubc.ca; syp2008@vip.sina.com		Leung, Peter/0000-0003-3152-3800	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) [143317]; International (Regional) Cooperation and Exchange Projects from the National Natural Science Foundation of China [81820108016]; National Key R&D Program of China [2019YFA0110900]; China Scholarship Council	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); International (Regional) Cooperation and Exchange Projects from the National Natural Science Foundation of China; National Key R&D Program of China; China Scholarship Council(China Scholarship Council)	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: 143317; International (Regional) Cooperation and Exchange Projects from the National Natural Science Foundation of China, Grant/Award Number: 81820108016; National Key R&D Program of China, Grant/Award Number: 2019YFA0110900; China Scholarship Council	Bai L, 2017, ENDOCRINOLOGY, V158, P3501, DOI 10.1210/en.2017-00436; Bedard J, 2003, MOL REPROD DEV, V64, P152, DOI 10.1002/mrd.10239; BLASI F, 1987, J CELL BIOL, V104, P801, DOI 10.1083/jcb.104.4.801; Cao MJ, 2004, BIOL REPROD, V71, P887, DOI 10.1095/biolreprod.104.029702; Chang HM, 2019, HUM REPROD UPDATE, V25, P224, DOI 10.1093/humupd/dmy047; Chang HM, 2017, HUM REPROD UPDATE, V23, P1, DOI 10.1093/humupd/dmw039; Chang HM, 2014, MOL HUM REPROD, V20, P373, DOI 10.1093/molehr/gau001; CHEN L, 1993, MOL REPROD DEV, V34, P87, DOI 10.1002/mrd.1080340114; D'Alessandris C, 2001, ENDOCRINOLOGY, V142, P3033, DOI 10.1210/en.142.7.3033; Dow MPD, 2002, REPRODUCTION, V123, P711, DOI 10.1530/reprod/123.5.711; Fayad T, 2004, BIOL REPROD, V70, P523, DOI 10.1095/biolreprod.103.021709; Feng XH, 1997, EMBO J, V16, P3912, DOI 10.1093/emboj/16.13.3912; FUKUI Y, 1990, MOL REPROD DEV, V26, P40, DOI 10.1002/mrd.1080260107; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Holtzhausen A, 2014, FASEB J, V28, P1248, DOI 10.1096/fj.13-239178; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Khalaf M, 2013, EUR J ENDOCRINOL, V168, P437, DOI 10.1530/EJE-12-0891; Lee RKK, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-38; Leonardsson G, 1995, P NATL ACAD SCI USA, V92, P12446, DOI 10.1073/pnas.92.26.12446; Lie BL, 1996, MOL CELL ENDOCRINOL, V120, P169, DOI 10.1016/0303-7207(96)03835-X; LIU YX, 1987, MOL CELL ENDOCRINOL, V54, P221, DOI 10.1016/0303-7207(87)90160-2; Lu CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074602; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Murakami M, 2009, GENES CELLS, V14, P469, DOI 10.1111/j.1365-2443.2009.01283.x; Nio-Kobayashi J, 2015, ENDOCRINOLOGY, V156, P1494, DOI 10.1210/en.2014-1704; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Shi J, 2011, AM J REPROD IMMUNOL, V65, P421, DOI 10.1111/j.1600-0897.2010.00917.x; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sugiyama R, 2010, HUM CELL, V23, P83, DOI 10.1111/j.1749-0774.2010.00088.x; van der Horst E, 2009, NEOPLASIA, V11, P355, DOI 10.1593/neo.81536; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Wang Y, 2014, ENDOCRINOLOGY, V155, P1970, DOI 10.1210/en.2013-1741; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wu YT, 2017, MOL HUM REPROD, V23, P155, DOI 10.1093/molehr/gaw078; Yang GB, 2014, J CELL PHYSIOL, V229, P943, DOI 10.1002/jcp.24525; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang H, 2016, MOL CELL ENDOCRINOL, V428, P17, DOI 10.1016/j.mce.2016.03.016; Zhang XY, 2018, ENDOCRINOLOGY, V159, P2926, DOI 10.1210/en.2018-00189; Zhao HJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0230-1	40	4	4	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21845	10.1096/fj.202100670RR	http://dx.doi.org/10.1096/fj.202100670RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34369625				2022-12-28	WOS:000691122900005
J	Petrocelli, JJ; Mahmassani, ZS; Fix, DK; Montgomery, JA; Reidy, PT; McKenzie, AI; de Hart, NM; Ferrara, PJ; Kelley, JJ; Eshima, H; Funai, K; Drummond, MJ				Petrocelli, Jonathan J.; Mahmassani, Ziad S.; Fix, Dennis K.; Montgomery, Jessie A.; Reidy, Paul T.; McKenzie, Alec, I; de Hart, Naomi M.; Ferrara, Patrick J.; Kelley, Joshua J.; Eshima, Hiroaki; Funai, Katsuhiko; Drummond, Micah J.			Metformin and leucine increase satellite cells and collagen remodeling during disuse and recovery in aged muscle	FASEB JOURNAL			English	Article						aging; extracellular matrix; fibrosis; hindlimb unloading; inflammation; reloading	BED REST; PROTEIN; FIBROBLASTS; REGROWTH; EXERCISE; MASS; AMPK	Loss of muscle mass and strength after disuse followed by impaired muscle recovery commonly occurs with aging. Metformin (MET) and leucine (LEU) individually have shown positive effects in skeletal muscle during atrophy conditions but have not been evaluated in combination nor tested as a remedy to enhance muscle recovery following disuse atrophy in aging. The purpose of this study was to determine if a dual treatment of metformin and leucine (MET + LEU) would prevent disuse-induced atrophy and/or promote muscle recovery in aged mice and if these muscle responses correspond to changes in satellite cells and collagen remodeling. Aged mice (22-24 months) underwent 14 days of hindlimb unloading (HU) followed by 7 or 14 days of reloading (7 or 14 days RL). MET, LEU, or MET + LEU was administered via drinking water and were compared to Vehicle (standard drinking water) and ambulatory baseline. We observed that during HU, MET + LEU resolved whole body grip strength and soleus muscle specific force decrements caused by HU. Gastrocnemius satellite cell abundance was increased with MET + LEU treatment but did not alter muscle size during disuse or recovery conditions. Moreover, MET + LEU treatment alleviated gastrocnemius collagen accumulation caused by HU and increased collagen turnover during 7 and 14 days RL driven by a decrease in collagen IV content. Transcriptional pathway analysis revealed that MET + LEU altered muscle hallmark pathways related to inflammation and myogenesis during HU. Together, the dual treatment of MET and LEU was able to increase muscle function, satellite cell content, and reduce collagen accumulation, thus improving muscle quality during disuse and recovery in aging.	[Petrocelli, Jonathan J.; Mahmassani, Ziad S.; Fix, Dennis K.; Kelley, Joshua J.; Funai, Katsuhiko; Drummond, Micah J.] Univ Utah, Dept Phys Therapy & Athlet Training, 520 Wakara Way, Salt Lake City, UT 84108 USA; [Montgomery, Jessie A.] Univ Utah, Dept Chem, Salt Lake City, UT 84108 USA; [Reidy, Paul T.] Miami Univ, Dept Kinesiol Nutr & Hlth, Oxford, OH 45056 USA; [McKenzie, Alec, I] Univ Utah, Dept Internal Med, Salt Lake City, UT 84108 USA; [de Hart, Naomi M.; Eshima, Hiroaki; Funai, Katsuhiko] Univ Utah, Dept Nutr & Integrat Physiol, Salt Lake City, UT 84108 USA; [Ferrara, Patrick J.; Funai, Katsuhiko; Drummond, Micah J.] Univ Utah, Mol Med Program, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University System of Ohio; Miami University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Drummond, MJ (corresponding author), Univ Utah, Dept Phys Therapy & Athlet Training, 520 Wakara Way, Salt Lake City, UT 84108 USA.	micah.drummond@hsc.utah.edu		Montgomery, Jessie/0000-0002-9723-3892	NIA [R03AG064216]; NIH [1T32HL139451]; University of Utah	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Utah	NIA, Grant/Award Number: R03AG064216; NIH, Grant/Award Number: 1T32HL139451; University of Utah	Alameddine Hala S, 2016, J Neuromuscul Dis, V3, P455; Amin SN, 2018, J CELL PHYSIOL, V233, P5768, DOI 10.1002/jcp.26300; Backx EMP, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050635; Baehr LM, 2016, AGING-US, V8, P127, DOI 10.18632/aging.100879; Bosi PL, 2008, REV BRAS MED ESPORTE, V14, P436, DOI 10.1590/S1517-86922008000500007; Brown CJ, 2006, J REHABIL RES DEV, V43, P939, DOI 10.1682/JRRD.2006.04.0034; Combaret L, 2005, J PHYSIOL-LONDON, V569, P489, DOI 10.1113/jphysiol.2005.098004; Csapo R, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00253; Dai JM, 2015, NUTRIENTS, V7, P3387, DOI 10.3390/nu7053387; Dinulovic I, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0110-x; Drummond MJ, 2008, CURR OPIN CLIN NUTR, V11, P222, DOI 10.1097/MCO.0b013e3282fa17fb; English KL, 2016, AM J CLIN NUTR, V103, P465, DOI 10.3945/ajcn.115.112359; Ferrara PJ, 2018, MED SCI SPORT EXER, V50, P2015, DOI 10.1249/MSS.0000000000001673; Ferreira JA, 2011, JOVE-J VIS EXP, DOI 10.3791/2467; Fry CS, 2017, CELL STEM CELL, V20, P56, DOI 10.1016/j.stem.2016.09.010; Fu LZ, 2015, METABOLISM, V64, P845, DOI 10.1016/j.metabol.2015.03.007; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Hasan MM, 2019, J CELL BIOCHEM, V120, P5677, DOI 10.1002/jcb.27852; Jackson JR, 2012, AM J PHYSIOL-CELL PH, V303, pC854, DOI 10.1152/ajpcell.00207.2012; Kwon OS, 2015, AM J PHYSIOL-ENDOC M, V309, pE11, DOI 10.1152/ajpendo.00124.2015; Langone F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114018; Miller BF, 2019, J CACHEXIA SARCOPENI, V10, P1195, DOI 10.1002/jcsm.12470; Mobley CB, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090972; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Perandini LA, 2018, FEBS J, V285, P1973, DOI 10.1111/febs.14417; Pereira MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085283; Petrocelli JJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228650; Pisot R, 2016, J APPL PHYSIOL, V120, P922, DOI 10.1152/japplphysiol.00858.2015; Reidy PT, 2020, APPL PHYSIOL NUTR ME, V45, P1261, DOI 10.1139/apnm-2020-0064; Reidy PT, 2019, AM J PHYSIOL-ENDOC M, V317, pE85, DOI 10.1152/ajpendo.00422.2018; Rivera ME, 2020, J CELL BIOCHEM, V121, P816, DOI 10.1002/jcb.29327; Savary-Auzeloux I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081495; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Smith LR, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-21; Suetta C, 2013, J PHYSIOL-LONDON, V591, P3789, DOI 10.1113/jphysiol.2013.257121; Suwa M, 2006, J APPL PHYSIOL, V101, P1685, DOI 10.1152/japplphysiol.00255.2006; Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265; Trevino MB, 2019, AM J PHYSIOL-ENDOC M, V317, pE899, DOI 10.1152/ajpendo.00161.2019; Turban S, 2012, J BIOL CHEM, V287, P20088, DOI 10.1074/jbc.M111.330746; Tuttle CSL, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101185; Walton RG, 2019, AGING CELL, V18, DOI 10.1111/acel.13039; Welc SS, 2020, J IMMUNOL, V205, P1664, DOI 10.4049/jimmunol.2000247; Yoshimura A, 2017, CONNECT TISSUE RES, V58, P487, DOI 10.1080/03008207.2016.1257004; Yousuf Y, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-019-1480-x	45	5	5	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21862	10.1096/fj.202100883R	http://dx.doi.org/10.1096/fj.202100883R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34416035	Green Accepted			2022-12-28	WOS:000691122900047
J	Alata, W; Yogi, A; Brunette, E; Delaney, CE; van Faassen, H; Hussack, G; Iqbal, U; Kemmerich, K; Haqqani, AS; Moreno, MJ; Stanimirovic, DB				Alata, Wael; Yogi, Alvaro; Brunette, Eric; Delaney, Christie E.; van Faassen, Henk; Hussack, Greg; Iqbal, Umar; Kemmerich, Kristin; Haqqani, Arsalan S.; Moreno, Maria J.; Stanimirovic, Danica B.			Targeting insulin-like growth factor-1 receptor (IGF1R) for brain delivery of biologics	FASEB JOURNAL			English	Article						blood-brain barrier; galanin; inflammatory pain; in situ brain perfusion; insulin growth factor 1 receptor; receptor-mediated transcytosis	TRANSFERRIN RECEPTOR; BISPECIFIC ANTIBODY; ALZHEIMERS-DISEASE; HIGH-AFFINITY; BARRIER; TRANSCYTOSIS; TRANSPORT; PENETRATION; RECRUITMENT; FRAGMENTS	The blood-brain barrier (BBB) prevents the majority of drugs from crossing into the brain and reaching neurons. To overcome this challenge, safe and non-invasive technologies targeting receptor-mediated pathways have been developed. In this study, three single-domain antibodies (sdAbs; IGF1R3, IGF1R4, and IGF1R5) targeting the extracellular domain of the human insulin-like growth factor-1 receptor (IGF1R), generated by llama immunization, showed enhanced transmigration across the rat BBB model (SV-ARBEC) in vitro. The rate of brain uptake of these sdAbs fused to mouse Fc (sdAb-mFc) in vivo was estimated using the fluorescent in situ brain perfusion (ISBP) technique followed by optical brain imaging and distribution volume evaluation. Compared to the brains perfused with the negative control A20.1-mFc, the brains perfused with anti-IGF1R sdAbs showed a significant increase of the total fluorescence intensity (similar to 2-fold, p < .01) and the distribution volume (similar to 4-fold, p < .01). The concentration curve for IGF1R4-mFc demonstrated a linear accumulation plateauing at approximately 400 mu g (similar to 1 mu M), suggesting a saturable mechanism of transport. Capillary depletion and mass spectrometry analyses of brain parenchyma post-ISBP confirmed the IGF1R4-mFc brain uptake with similar to 25% of the total amount being accumulated in the parenchymal fraction in contrast to undetectable levels of A20.1-mFc after a 5-min perfusion protocol. Systemic administration of IGF1R4-mFc fused with the non-BBB crossing analgesic peptide galanin (2 and 5 mg/kg) induced a dose-dependent suppression of thermal hyperalgesia in the Hargreaves pain model. In conclusion, novel anti-IGF1R sdAbs showed receptor-mediated brain uptake with pharmacologically effective parenchymal delivery of non-permeable neuroactive peptides.	[Alata, Wael; Yogi, Alvaro; Brunette, Eric; Delaney, Christie E.; van Faassen, Henk; Hussack, Greg; Iqbal, Umar; Kemmerich, Kristin; Haqqani, Arsalan S.; Moreno, Maria J.; Stanimirovic, Danica B.] Natl Res Council Canada, Human Hlth Therapeut Res Ctr, 1200 Montreal Rd,M54, Ottawa, ON K1A 0R6, Canada	National Research Council Canada	Alata, W; Stanimirovic, DB (corresponding author), Natl Res Council Canada, Human Hlth Therapeut Res Ctr, 1200 Montreal Rd,M54, Ottawa, ON K1A 0R6, Canada.	waelalata@yahoo.com; Danica.Stanimirovic@nrc-cnrc.gc.ca		ALATA, WAEL/0000-0003-4443-9173	Gouvernement du Canada \ National Research Council Canada (NRC)	Gouvernement du Canada \ National Research Council Canada (NRC)	Gouvernement du Canada vertical bar National Research Council Canada (NRC)	Abulrob A, 2011, METHODS MOL BIOL, V763, P423, DOI 10.1007/978-1-61779-191-8_29; Alata W, 2014, MOL PHARMACEUT, V11, P243, DOI 10.1021/mp400421a; Aleksic T, 2018, CANCER RES, V78, P3497, DOI 10.1158/0008-5472.CAN-17-3498; Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; Alwatban M, 2019, J NEUROIMAGING, V29, P493, DOI 10.1111/jon.12606; Arbabi-Ghahroudi M, 2009, PROTEIN ENG DES SEL, V22, P59, DOI 10.1093/protein/gzn071; Arbabi-Ghahroudi Mehdi, 2009, V502, P341, DOI 10.1007/978-1-60327-565-1_20; ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U; Bickel Ulrich, 2005, NeuroRx, V2, P15, DOI 10.1007/BF03206639; Bourassa P, 2019, MOL PHARMACEUT, V16, P583, DOI 10.1021/acs.molpharmaceut.8b00870; Bulaj G, 2008, J MED CHEM, V51, P8038, DOI 10.1021/jm801088x; Cai WK, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-00417-7, 10.1038/ncomms14892]; Couch JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005338; Dagenais C, 2000, J CEREBR BLOOD F MET, V20, P381, DOI 10.1097/00004647-200002000-00020; Do TM, 2014, NEUROPHARMACOLOGY, V81, P311, DOI 10.1016/j.neuropharm.2014.02.010; Duarte Ana I, 2012, J Aging Res, V2012, P384017, DOI 10.1155/2012/384017; Farrington GK, 2014, FASEB J, V28, P4764, DOI 10.1096/fj.14-253369; Friden PM, 1996, J PHARMACOL EXP THER, V278, P1491; Gabathuler R, 2010, NEUROBIOL DIS, V37, P48, DOI 10.1016/j.nbd.2009.07.028; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Gosk T, 2004, J CEREBR BLOOD F MET, V24, P1193, DOI 10.1097/01.WCB.0000135592.28823.47; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Haqqani Arsalan S., 2008, V439, P241, DOI 10.1007/978-1-59745-188-8_17; Haqqani AS, 2018, J NEUROCHEM, V146, P735, DOI 10.1111/jnc.14482; Haqqani AS, 2013, MOL PHARMACEUT, V10, P1542, DOI 10.1021/mp3004995; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Iqbal U, 2011, METHODS MOL BIOL, V686, P465, DOI 10.1007/978-1-60761-938-3_24; Lee HJ, 2000, J PHARMACOL EXP THER, V292, P1048; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Manich G, 2013, EUR J PHARM SCI, V49, P556, DOI 10.1016/j.ejps.2013.05.027; Metcalf CS, 2017, EPILEPSIA, V58, P239, DOI 10.1111/epi.13647; Moreno MJ, 2020, EXPERT OPIN DRUG DIS, V15, P903, DOI 10.1080/17460441.2020.1759549; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nga BL, 2014, J EXP MED, V211, P233, DOI 10.1084/jem.20131660; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Nishijima T, 2010, NEURON, V67, P834, DOI 10.1016/j.neuron.2010.08.007; Ouellet M, 2009, NEUROCHEM INT, V55, P476, DOI 10.1016/j.neuint.2009.04.018; Pardridge William M, 2005, NeuroRx, V2, P3; Pardridge WM, 2016, EXPERT OPIN BIOL TH, V16, P1455, DOI 10.1080/14712598.2016.1230195; PARDRIDGE WM, 1995, PHARMACEUT RES, V12, P807, DOI 10.1023/A:1016244500596; Pothin E, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12100937; Robertson CR, 2011, NAT PROD REP, V28, P741, DOI 10.1039/c0np00048e; Rossotti MA, 2019, BIOCHEM J, V476, P39, DOI 10.1042/BCJ20180795; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Selles MC, 2020, MOL NEUROBIOL, V57, P1473, DOI 10.1007/s12035-019-01827-y; Sheff J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83198-w; Martins AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019846; Stanimirovic D., 2015, INSULIN LIKE GROWTH; Stanimirovic DB, 2018, BIODRUGS, V32, P547, DOI 10.1007/s40259-018-0309-y; Stocki P, 2021, FASEB J, V35, DOI 10.1096/fj.202001787R; Sumbria RK, 2013, MOL PHARMACEUT, V10, P3507, DOI 10.1021/mp400348n; Tanha Jamshid, 2003, Methods Mol Med, V89, P435; Thom G, 2018, MOL PHARMACEUT, V15, P1420, DOI 10.1021/acs.molpharmaceut.7b00937; Do TM, 2016, J ALZHEIMERS DIS, V49, P287, DOI 10.3233/JAD-150350; Wang D, 2000, NEUROSCIENCE, V96, P767, DOI 10.1016/S0306-4522(00)00005-1; Wang YY, 2009, IMMUNOTHERAPY-UK, V1, P983, DOI 10.2217/IMT.09.75; Webster CI, 2016, FASEB J, V30, P1927, DOI 10.1096/fj.201500078; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Werner H, 2014, EUR NEUROPSYCHOPHARM, V24, P1947, DOI 10.1016/j.euroneuro.2014.01.020; Wu XL, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.136855; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230; Zhang WD, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-020-00209-0; Zhang Y, 2019, NEUROSCI LETT, V706, P93, DOI 10.1016/j.neulet.2019.05.016; Zheng HY, 2012, P NATL ACAD SCI USA, V109, P7055, DOI 10.1073/pnas.1118359109; Zhou QH, 2011, J PHARMACOL EXP THER, V339, P618, DOI 10.1124/jpet.111.185876; Zuchero YJY, 2016, NEURON, V89, P70, DOI 10.1016/j.neuron.2015.11.024	67	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22208	10.1096/fj.202101644R	http://dx.doi.org/10.1096/fj.202101644R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35192204	hybrid			2022-12-28	WOS:000761250800049
J	Ghosh, A; Coffin, M; West, R; Fowler, VM				Ghosh, Arit; Coffin, Megan; West, Richard; Fowler, Velia M.			Erythroid differentiation in mouse erythroleukemia cells depends on Tmod3-mediated regulation of actin filament assembly into the erythroblast membrane skeleton	FASEB JOURNAL			English	Article						actin; cell survival; erythrocyte membrane skeleton; tropomodulin; tropomyosin	RED-BLOOD-CELLS; MECHANICAL-BEHAVIOR; F-ACTIN; TROPOMYOSIN; DISRUPTION; SPECTRIN; POLYMERIZATION; ELLIPTOCYTOSIS; CYTOSKELETON; MORPHOLOGY	Erythroid differentiation (ED) is a complex cellular process entailing morphologically distinct maturation stages of erythroblasts during terminal differentiation. Studies of actin filament (F-actin) assembly and organization during terminal ED have revealed essential roles for the F-actin pointed-end capping proteins, tropomodulins (Tmod1 and Tmod3). Tmods bind tropomyosins (Tpms), which enhance Tmod capping and F-actin stabilization. Tmods can also nucleate F-actin assembly, independent of Tpms. Tmod1 is present in the red blood cell (RBC) membrane skeleton, and deletion of Tmod1 in mice leads to a mild compensated anemia due to mis-regulated F-actin lengths and membrane instability. Tmod3 is not present in RBCs, and global deletion of Tmod3 leads to embryonic lethality in mice with impaired ED. To further decipher Tmod3's function during ED, we generated a Tmod3 knockout in a mouse erythroleukemia cell line (Mel ds19). Tmod3 knockout cells appeared normal prior to ED, but showed defects during progression of ED, characterized by a marked failure to reduce cell and nuclear size, reduced viability, and increased apoptosis. Tmod3 does not assemble with Tmod1 and Tpms into the Triton X-100 insoluble membrane skeleton during ED, and loss of Tmod3 had no effect on alpha 1,beta 1-spectrin and protein 4.1R assembly into the membrane skeleton. However, F-actin, Tmod1 and Tpms failed to assemble into the membrane skeleton during ED in absence of Tmod3. We propose that Tmod3 nucleation of F-actin assembly promotes incorporation of Tmod1 and Tpms into membrane skeleton F-actin, and that this is integral to morphological maturation and cell survival during erythroid terminal differentiation.	[Ghosh, Arit; Coffin, Megan; Fowler, Velia M.] Univ Delaware, Dept Biol Sci, 105 Green,118 Wolf Hall, Newark, DE 19716 USA; [West, Richard] Delaware Biotechnol Inst, Newark, DE USA	University of Delaware	Fowler, VM (corresponding author), Univ Delaware, Dept Biol Sci, 105 Green,118 Wolf Hall, Newark, DE 19716 USA.	vfowler@udel.edu		Ghosh, Arit/0000-0002-6582-8146	National Institute of Heart Lung and Blood at the National Institutes of Health [HL083464]	National Institute of Heart Lung and Blood at the National Institutes of Health	This research was supported by a grant from the National Institute of Heart Lung and Blood at the National Institutes of Health (HL083464) to V.M.F.	Andolfo I, 2016, HAEMATOLOGICA, V101, P1284, DOI 10.3324/haematol.2016.142463; Basu A, 2015, J PROTEOMICS, V128, P298, DOI 10.1016/j.jprot.2015.08.004; BIEKER JJ, 1995, MOL CELL BIOL, V15, P852; Bryce NS, 2003, MOL BIOL CELL, V14, P1002, DOI 10.1091/mbc.E02-04-0244; Chan MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054902; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Chhabra D, 2005, PROTEOMICS, V5, P3131, DOI 10.1002/pmic.200401127; Ciana A, 2017, CELL PHYSIOL BIOCHEM, V42, P1139, DOI 10.1159/000478769; Da Costa L, 2013, BLOOD REV, V27, P167, DOI 10.1016/j.blre.2013.04.003; Desouza Melissa, 2012, Bioarchitecture, V2, P75; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Fowler VM, 2013, CURR TOP MEMBR, V72, P39, DOI 10.1016/B978-0-12-417027-8.00002-7; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Ghosh A, 2021, CURR BIOL, V31, pR501, DOI 10.1016/j.cub.2021.01.055; Gokhin DS, 2016, CURR OPIN HEMATOL, V23, P206, DOI 10.1097/MOH.0000000000000227; Gokhin DS, 2015, MOL BIOL CELL, V26, P1699, DOI 10.1091/mbc.E14-12-1583; Gokhin DS, 2011, J CELL BIOL, V194, P105, DOI 10.1083/jcb.201011128; Hsieh FF, 2000, BLOOD, V96, P2746, DOI 10.1182/blood.V96.8.2746.h8002746_2746_2754; Kalfa TA, 2006, BLOOD, V108, P3637, DOI 10.1182/blood-2006-03-005942; Konstantinidis DG, 2010, TRANSFUS CLIN BIOL, V17, P126, DOI 10.1016/j.tracli.2010.05.002; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kulms D, 2002, CELL DEATH DIFFER, V9, P598, DOI 10.1038/sj.cdd.4401002; Kumari R, 2020, CURR BIOL, V30, P767, DOI 10.1016/j.cub.2019.12.049; LAZARIDES E, 1989, ANNU REV CELL BIOL, V5, P427; Liu J, 2010, BLOOD, V115, P2021, DOI 10.1182/blood-2009-08-241182; Lu YZ, 2016, BLOOD, V128, P93, DOI 10.1182/blood-2016-01-692251; MOHANDAS N, 1994, ANNU REV BIOPH BIOM, V23, P787, DOI 10.1146/annurev.bb.23.060194.004035; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Morley SC, 2003, J CELL BIOCHEM, V88, P1066, DOI 10.1002/jcb.10449; Moyer JD, 2010, BLOOD, V116, P2590, DOI 10.1182/blood-2010-02-268458; Nowak RB, 2017, BLOOD, V130, P1144, DOI 10.1182/blood-2017-05-787051; Pal K, 2020, BLOOD, V135, P1887, DOI 10.1182/blood.2019003064; Palis J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00003; Parreno Justin, 2018, Biophys Rev, V10, P1605, DOI 10.1007/s12551-018-0481-9; PFEFFER SR, 1986, J CELL BIOL, V103, P103, DOI 10.1083/jcb.103.1.103; RABINOVITCH PS, 1994, METHOD CELL BIOL, V41, P263; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Schevzov Galina, 2011, Bioarchitecture, V1, P135; Smith AS, 2019, AM J HEMATOL, V94, P667, DOI 10.1002/ajh.25472; Sui ZH, 2017, MOL BIOL CELL, V28, P2531, DOI 10.1091/mbc.E16-10-0699; Sui ZH, 2014, BLOOD, V123, P758, DOI 10.1182/blood-2013-03-492710; VINDELOV LL, 1977, VIRCHOWS ARCH B, V24, P227; Weber KL, 2007, J CELL SCI, V120, P3625, DOI 10.1242/jcs.011445; WICKREMA A, 1994, J CELL PHYSIOL, V160, P417, DOI 10.1002/jcp.1041600304; WOODS CM, 1985, CELL, V40, P959, DOI 10.1016/0092-8674(85)90356-3; Yamashiro S, 2014, J BIOL CHEM, V289, P11616, DOI 10.1074/jbc.M114.555128; Yamashiro S, 2012, CYTOSKELETON, V69, P337, DOI 10.1002/cm.21031; Yamashiro S, 2010, J BIOL CHEM, V285, P33265, DOI 10.1074/jbc.M110.144873; Yien YY, 2017, P NATL ACAD SCI USA, V114, pE8045, DOI 10.1073/pnas.1700632114; Yik JJ, 2018, METHODS MOL BIOL, V1698, P245, DOI 10.1007/978-1-4939-7428-3_15; Zhao BB, 2016, DEV CELL, V36, P498, DOI 10.1016/j.devcel.2016.02.001	52	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22220	10.1096/fj.202101011R	http://dx.doi.org/10.1096/fj.202101011R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35195928				2022-12-28	WOS:000761250800025
J	Kim, A; Koo, JH; Lee, JM; Joo, MS; Kim, TH; Kim, H; Jun, DW; Kim, SG				Kim, Ayoung; Koo, Ja Hyun; Lee, Jung Min; Joo, Min Sung; Kim, Tae Hyun; Kim, Hyunsung; Jun, Dae Won; Kim, Sang Geon			NRF2-mediated SIRT3 induction protects hepatocytes from ER stress-induced liver injury	FASEB JOURNAL			English	Article						CHOP; ER stress; liver disease; NRF2; SIRT3	ENDOPLASMIC-RETICULUM; MITOCHONDRIAL DYSFUNCTION; FATTY LIVER; NRF2; APOPTOSIS; ACTIVATION	Chronic endoplasmic reticulum (ER) stress in hepatocytes plays a role in the pathogenesis of nonalcoholic fatty liver disease. Therefore, given the association between oxidative stress, mitochondrial dysfunction, and ER stress, our study investigated the role of NRF2-mediated SIRT3 activation in ER stress. SIRT3, a sirtuin, was predicted as the target of NRF2 based on bioinformatic analyses and animal experiments. Nrf2 abrogation diminished mitochondrial DNA content in hepatocytes with Ppargc1 alpha and Cpt1a inhibition, whereas its overexpression enhanced oxygen consumption. Further, chromatin immunoprecipitation and luciferase reporter assays indicated that NRF2 induced SIRT3 through the antioxidant responsive element (ARE) sites comprising the -641 to -631 bp and -419 to -409 bp regions. In tunicamycin-induced ER stress conditions and liver injury animal models following ER stress, NRF2 levels were highly correlated with SIRT3. Nrf2 deficiency enhanced the tunicamycin-mediated induction of CHOP, which was attenuated by Sirt3 overexpression. Further, Sirt3 delivery to hepatocytes in Nrf2 knockout mice prevented tunicamycin from increasing mortality by decreasing ER stress. SIRT3 was upregulated in livers of patients with nonalcoholic liver diseases, whereas lower SIRT3 expression coincided with more severe disease conditions. Taken together, our findings indicated that NRF2-mediated SIRT3 induction protects hepatocytes from ER stress-induced injury, which may contribute to the inhibition of liver disease progression.	[Kim, Ayoung; Kim, Sang Geon] Dongguk Univ Seoul, Coll Pharm, Ilsandong Gu Dongguk Ro 32, Goyang Si 10326, Gyeonggi Do, South Korea; [Kim, Ayoung; Kim, Sang Geon] Dongguk Univ Seoul, Integrated Res Inst Drug Dev, Goyang Si, South Korea; [Kim, Ayoung; Koo, Ja Hyun; Lee, Jung Min; Joo, Min Sung; Kim, Tae Hyun] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Kim, Ayoung; Koo, Ja Hyun; Lee, Jung Min; Joo, Min Sung; Kim, Tae Hyun] Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul, South Korea; [Kim, Tae Hyun] Sookmyung Womens Univ, Coll Pharm, Res Inst Pharmaceut Sci, Seoul, South Korea; [Kim, Hyunsung] Hanyang Univ, Dept Pathol, Sch Med, Seoul, South Korea; [Jun, Dae Won] Hanyang Univ, Internal Med, Sch Med, Seoul, South Korea	Dongguk University; Dongguk University; Seoul National University (SNU); Seoul National University (SNU); Sookmyung Women's University; Hanyang University; Hanyang University	Kim, SG (corresponding author), Dongguk Univ Seoul, Coll Pharm, Ilsandong Gu Dongguk Ro 32, Goyang Si 10326, Gyeonggi Do, South Korea.	sgkim@dongguk.edu	Koo, Ja Hyun/GQP-5440-2022; Jun, Dae Won/O-4529-2017	Koo, Ja Hyun/0000-0001-5738-1105; Joo, Min Sung/0000-0001-7857-8302; Kim, Ayoung/0000-0003-2754-0536; Jun, Dae Won/0000-0002-2875-6139	National Research Foundation of Korea (NRF) [2021R1A2B5B03086265, 2021R1A6A3A01087745, 2021R1C1C1013323, 2021R1A4A5033289]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 2021R1A2B5B03086265, 2021R1A6A3A01087745, 2021R1C1C1013323 and 2021R1A4A5033289	Ahn SB, 2014, DIGEST DIS SCI, V59, P2975, DOI 10.1007/s10620-014-3289-x; Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735; Baiceanu A, 2016, NAT REV ENDOCRINOL, V12, P710, DOI 10.1038/nrendo.2016.124; Banales JM, 2019, NAT REV GASTRO HEPAT, V16, P269, DOI 10.1038/s41575-019-0125-y; Booth DM, 2016, MOL CELL, V63, P240, DOI 10.1016/j.molcel.2016.05.040; Borkham-Kamphorst E, 2018, CELL SIGNAL, V51, P72, DOI 10.1016/j.cellsig.2018.07.005; Chen X, 2014, AM J PATHOL, V184, P912, DOI 10.1016/j.ajpath.2013.12.002; Clementino M, 2019, TOXICOL SCI, V169, P224, DOI 10.1093/toxsci/kfz032; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Egnatchik RA, 2014, MOL METAB, V3, P544, DOI 10.1016/j.molmet.2014.05.004; Han CY, 2018, CELL REP, V24, P2985, DOI 10.1016/j.celrep.2018.07.068; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Kilanczyk E, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165895; Kim TH, 2018, J CLIN INVEST, V128, P5587, DOI [10.1172/JCI97831, 10.1172/jci97831]; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Liu JX, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.564; Mohs A, 2021, J HEPATOL, V74, P638, DOI 10.1016/j.jhep.2020.09.037; Niture SK, 2012, J BIOL CHEM, V287, P9873, DOI 10.1074/jbc.M111.312694; Satterstrom FK, 2015, AGING CELL, V14, P818, DOI 10.1111/acel.12360; Schuster S, 2018, NAT REV GASTRO HEPAT, V15, P349, DOI 10.1038/s41575-018-0009-6; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wang TS, 2019, MOL CELL, V75, P823, DOI 10.1016/j.molcel.2019.06.008; Wu TD, 2014, GENE DEV, V28, P708, DOI 10.1101/gad.238246.114; Yan WJ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00116; Yang W, 2016, CELL, V167, P985, DOI 10.1016/j.cell.2016.10.016; Younossi Z, 2019, HEPATOLOGY, V69, P2672, DOI 10.1002/hep.30251; Zhang HH, 2016, MOL CELL BIOCHEM, V420, P95, DOI 10.1007/s11010-016-2771-5; Zhang J, 2020, THERANOSTICS, V10, P8315, DOI 10.7150/thno.45922; Zhang Z, 2018, CHEM-BIOL INTERACT, V296, P76, DOI 10.1016/j.cbi.2018.09.007	35	2	2	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22170	10.1096/fj.202101470R	http://dx.doi.org/10.1096/fj.202101470R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35104011				2022-12-28	WOS:000761250800034
J	Yang, CR; Ding, HJ; Yu, M; Zhou, FH; Han, CY; Liang, R; Zhang, XY; Zhang, XL; Meng, FJ; Wang, S; Li, DD; Sun, WZ; Meng, B; Zhou, XF				Yang, Chun-Rui; Ding, Hong-Jun; Yu, Miao; Zhou, Fiona-H; Han, Chen-Yang; Liang, Rui; Zhang, Xiao-Yang; Zhang, Xiang-Lian; Meng, Fan-Jie; Wang, Shuo; Li, De-Dong; Sun, Wei-Zong; Meng, Bin; Zhou, Xin-Fu			proBDNF/p75NTR promotes rheumatoid arthritis and inflammatory response by activating proinflammatory cytokines	FASEB JOURNAL			English	Article						inflammation; p75NTR; pain; proBDNF; rheumatoid arthritis	P75 NEUROTROPHIN RECEPTOR; NERVE GROWTH-FACTOR; T-CELLS; PAIN; THERAPY; SYSTEM; LOCALIZATION; PATHOGENESIS; CONTRIBUTES; DISSECTION	P75 pan-neurotrophin receptor (p75NTR) is an important receptor for the role of neurotrophins in survival and death of neurons during development and after nerve injury. Our previous research found that the precursor of brain-derived neurotrophic factor (proBDNF) regulates pain as an inflammatory mediator. The current understanding of the role of proBDNF/p75NTR signaling pathway in inflammatory arthritis pain and rheumatoid arthritis (RA) is unclear. We recruited 20 RA patients, 20 healthy donors (HDs), and 10 osteoarthritis (OA) patients. Hematoxylin and eosin (H&E) staining and immunohistochemistry (IHC) of proBDNF and p75NTR in synovial membrane were performed and evaluated. We next examined the mRNA and protein expression of proBDNF/p75NTR signaling pathway in peripheral blood mononuclear cells (PBMCs) and synovial tissue. ELISA and flow cytometry were assessed between the blood of RA patients and HD. To induce RA, collagen-induced arthritis (CIA) were induced in mice. We found over-synovitis of RA synovial membrane compared to OA controls in histologic sections. P75NTR and sortilin mRNA, and proBDNF protein level were significantly increased in PBMCs of RA patients compared with the HD. Consistently, ELISA showed that p75NTR, sortilin, tumor necrosis factor alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and interleukin-10 (IL-10) levels in the serum of RA patients were increased compared with HD and p75NTR, sortilin were positively correlated with Disease Activity Score in 28 joints (DAS28). In addition, using flow cytometry we showed that the increased levels of proBDNF and p75NTR characterized in CD4(+) and CD8(+) T cells of RA patients were subsequently reversed with methotrexate (MTX) treatment. Furthermore, we found pathological changes, inflammatory pain, upregulation of the mRNA and protein expression of proBDNF/p75NTR signaling pathway, and upregulation of inflammatory cytokines in spinal cord using a well-established CIA mouse model. We showed intravenous treatment of recombinant p75ECD-Fc that biologically blocked all inflammatory responses and relieved inflammatory pain of animals with CIA. Our findings showed the involvement of proBDNF/p75NTR pathway in the RA inflammatory response and how blocking it with p75ECD-Fc may be a promising therapeutic treatment for RA.	[Yang, Chun-Rui; Ding, Hong-Jun] Tianjin Univ, Acad Med Engn & Translat Med, Tianjin, Peoples R China; [Yang, Chun-Rui; Liang, Rui; Zhang, Xiao-Yang; Zhang, Xiang-Lian] Tianjin Med Univ, Dept Pathol, Hosp 2, Tianjin, Peoples R China; [Ding, Hong-Jun] Tianjin Publ Secur Profess Coll, Tianjin, Peoples R China; [Yu, Miao; Meng, Bin] Tianjin Med Univ, Dept Pathol, Canc Inst & Hosp, Tianjin, Peoples R China; [Zhou, Fiona-H] Univ Adelaide, Fac Hlth Sci, Sch Med, Adelaide, SA, Australia; [Han, Chen-Yang] Tianjin Med Univ, Pain Treatment Ctr, Hosp 2, Tianjin, Peoples R China; [Meng, Fan-Jie; Wang, Shuo] Tianjin Med Univ, Dept Thorac Surg, Hosp 2, Tianjin, Peoples R China; [Li, De-Dong] Tianjin Med Univ, Dept Anesthesiol, Hosp 2, Tianjin, Peoples R China; [Sun, Wei-Zong] Tianjin Med Univ, Dept Orthoped, Hosp 2, Tianjin, Peoples R China; [Zhou, Xin-Fu] Univ South Australia, Clin & Hlth Sci, Hlth & Biomed Innovat, Adelaide, SA 5000, Australia	Tianjin University; Tianjin Medical University; Tianjin Medical University; University of Adelaide; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; University of South Australia	Meng, B (corresponding author), Tianjin Med Univ, Dept Pathol, Canc Inst & Hosp, Tianjin, Peoples R China.; Zhou, XF (corresponding author), Univ South Australia, Clin & Hlth Sci, Hlth & Biomed Innovat, Adelaide, SA 5000, Australia.	mengbin@tjmu.com; xin-fu.zhou@unisa.edu.au	Zhou, Xin-Fu/F-4119-2013	Zhou, Xin-Fu/0000-0002-8687-0175	Science & Technology Development Fund of Tianjin Education Commission for Higher Education [2018KJ086]; Youth Fund of the Second Hospital of Tianjin Medical University [2020ydey06]; National Natural Science Foundation of China [81660302]	Science & Technology Development Fund of Tianjin Education Commission for Higher Education; Youth Fund of the Second Hospital of Tianjin Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grant from the Science & Technology Development Fund of Tianjin Education Commission for Higher Education (2018KJ086), by the Youth Fund of the Second Hospital of Tianjin Medical University (2020ydey06) to CRY and by the National Natural Science Foundation of China (81660302) to RL	Ashraf S, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0996-z; Bai YY, 2016, NEUROPSYCHOPHARMACOL, V41, P2882, DOI 10.1038/npp.2016.100; Barthel C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2716; Charalampopoulos I, 2012, CELL REP, V2, P1563, DOI 10.1016/j.celrep.2012.11.009; Deinhardt K, 2014, NEUROPHARMACOLOGY, V76, P603, DOI 10.1016/j.neuropharm.2013.04.054; Ducreux J, 2014, ARTHRITIS RHEUMATOL, V66, P15, DOI 10.1002/art.38202; Dusedau HP, 2019, GLIA, V67, P193, DOI 10.1002/glia.23553; Firestein GS, 2017, IMMUNITY, V46, P183, DOI 10.1016/j.immuni.2017.02.006; Fleitas C, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0411-6; Friedman B, 2019, JOINT BONE SPINE, V86, P301, DOI 10.1016/j.jbspin.2018.07.004; Ho IHT, 2019, THERANOSTICS, V9, P1651, DOI 10.7150/thno.29703; Hu ZL, 2021, THERANOSTICS, V11, P715, DOI 10.7150/thno.51390; Huang CC, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12560; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; Kelliny S, 2021, EUR J DRUG METAB PH, V46, P235, DOI 10.1007/s13318-020-00662-0; Kelliny S, 2020, CURR DRUG METAB, V21, P235, DOI 10.2174/1389200221666200502015203; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Khan N, 2015, MOLECULES, V20, P10657, DOI 10.3390/molecules200610657; Lai NS, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041841; Lee S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0544-4; Li CQ, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-27; Linker RA, 2015, EUR J IMMUNOL, V45, P1326, DOI 10.1002/eji.201444985; Lu B, 2014, Handb Exp Pharmacol, V220, P223, DOI 10.1007/978-3-642-45106-5_9; Luo C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27171; Luo RY, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01850-0; MacDonald IJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082877; MALLETT S, 1991, IMMUNOL TODAY, V12, P220, DOI 10.1016/0167-5699(91)90033-P; Meeker R, 2014, J NEUROIMMUNE PHARM, V9, P615, DOI 10.1007/s11481-014-9566-9; Minnone G, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2017-000441; Nataraj NB, 2013, CLIN EXP IMMUNOL, V171, P155, DOI 10.1111/cei.12009; Nygaard G, 2020, NAT REV RHEUMATOL, V16, P316, DOI 10.1038/s41584-020-0413-5; Orange DE, 2018, ARTHRITIS RHEUMATOL, V70, P690, DOI 10.1002/art.40428; Patel MK, 2018, J ANAESTH CLIN PHARM, V34, P111, DOI 10.4103/joacp.JOACP_389_15; Peres RS, 2015, P NATL ACAD SCI USA, V112, P2509, DOI 10.1073/pnas.1424792112; Raychaudhuri SP, 2011, ARTHRITIS RHEUM-US, V63, P3243, DOI 10.1002/art.30564; Reparon-Schuijt CC, 2001, ARTHRITIS RHEUM, V44, P41, DOI 10.1002/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0; Rogers ML, 2010, J NEUROIMMUNOL, V226, P93, DOI 10.1016/j.jneuroim.2010.05.040; Saadipour K, 2018, J NEUROCHEM, V144, P302, DOI 10.1111/jnc.14206; Sajanti A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72061-z; Schett G, 2021, NAT REV RHEUMATOL, V17, P135, DOI 10.1038/s41584-020-00543-5; Schnitzer TJ, 2019, JAMA-J AM MED ASSOC, V322, P37, DOI 10.1001/jama.2019.8044; Schuhmann B, 2005, J NEUROIMMUNOL, V163, P15, DOI 10.1016/j.jneuroim.2005.01.023; Shen LL, 2018, MOL PSYCHIATR, V23, P1813, DOI 10.1038/s41380-018-0071-z; Shen WY, 2020, FASEB J, V34, P2541, DOI 10.1096/fj.201901905RR; Shu Y, 2017, CLIN REV ALLERG IMMU, V52, P260, DOI 10.1007/s12016-016-8590-3; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035883; Triaille C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.593083; Wang Z, 2019, NEUROTOX RES, V36, P540, DOI 10.1007/s12640-019-00081-3; Weyand CM, 2021, NAT IMMUNOL, V22, P10, DOI 10.1038/s41590-020-00816-x; Yang SJ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb0606; Zhang CH, 2021, BIOMED REP, V14, DOI 10.3892/br.2020.1392; Zhao GQ, 2017, MOL NEUROBIOL, V54, P5573, DOI 10.1007/s12035-016-0098-6; Zhou XF, 2004, J NEUROCHEM, V91, P704, DOI 10.1111/j.1471-4159.2004.02775.x	54	0	0	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22180	10.1096/fj.202101558R	http://dx.doi.org/10.1096/fj.202101558R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35129860	Green Accepted, hybrid			2022-12-28	WOS:000761250800021
J	Zhou, Y; Liu, XY; Ma, SQ; Zhang, N; Yang, DC; Wang, L; Ye, SM; Zhang, QY; Ruan, J; Ma, J; Wang, SY; Jiang, N; Zhao, ZY; Zhao, SJ; Zheng, CF; Fan, XF; Gong, YS; Razak, MYA; Hu, WT; Pan, JY; Wang, XC; Fan, JM; Li, JM; Liu, R; Shentu, YP				Zhou, Ying; Liu, Xiaoyuan; Ma, Shuqing; Zhang, Nan; Yang, Dichen; Wang, Ling; Ye, Simin; Zhang, Qiongying; Ruan, Jing; Ma, Jun; Wang, Shiyi; Jiang, Nan; Zhao, Zongyuan; Zhao, Shujue; Zheng, Chenfei; Fan, Xiaofang; Gong, Yongsheng; Razak, Mahaman Yacoubou Abdoul; Hu, Wenting; Pan, Jingye; Wang, Xiaochuan; Fan, Junming; Li, Jianmin; Liu, Rong; Shentu, Yangping			ChK1 activation induces reactive astrogliosis through CIP2A/PP2A/STAT3 pathway in Alzheimer's disease	FASEB JOURNAL			English	Article						Alzheimer's disease; astrogliosis; ChK1; CIP2A; STAT3	NEUROINFLAMMATION; PHOSPHORYLATION; CELLS; STAT3; PP2A; TAU	Cancerous Inhibitor of PP2A (CIP2A), an endogenous PP2A inhibitor, is upregulated and causes reactive astrogliosis, synaptic degeneration, and cognitive deficits in Alzheimer's disease (AD). However, the mechanism underlying the increased CIP2A expression in AD brains remains unclear. We here demonstrated that the DNA damage-related Checkpoint kinase 1 (ChK1) is activated in AD human brains and 3xTg-AD mice. ChK1-mediated CIP2A overexpression drives inhibition of PP2A and activates STAT3, then leads to reactive astrogliosis and neurodegeneration in vitro. Infection of mouse brain with GFAP-ChK1-AAV induced AD-like cognitive deficits and exacerbated AD pathologies in vivo. In conclusion, we showed that ChK1 activation induces reactive astrogliosis, degeneration of neurons, and exacerbation of AD through the CIP2A-PP2A-STAT3 pathway, and inhibiting ChK1 may be a potential therapeutic approach for AD treatment.	[Zhou, Ying; Zheng, Chenfei] Wenzhou Med Univ, Dept Nephrol, Affiliated Hosp 1, Wenzhou, Peoples R China; [Liu, Xiaoyuan; Ma, Shuqing; Zhang, Nan; Yang, Dichen; Ye, Simin; Wang, Shiyi; Jiang, Nan; Zhao, Zongyuan; Zhao, Shujue] Wenzhou Med Univ, Wenzhou, Peoples R China; [Wang, Ling] Wenzhou Med Univ, Dept Nucl Med, Affiliated Hosp 1, Wenzhou, Peoples R China; [Zhang, Qiongying; Ruan, Jing; Ma, Jun; Li, Jianmin; Shentu, Yangping] Wenzhou Med Univ, Dept Pathol, Affiliated Hosp 1, Fanhai West Rd 1, Wenzhou 325035, Peoples R China; [Fan, Xiaofang; Gong, Yongsheng; Fan, Junming] Wenzhou Med Univ, Sch Basic Med Sci, Inst Hypoxia Med, Wenzhou, Peoples R China; [Razak, Mahaman Yacoubou Abdoul] Shenzhen Univ, Affiliated Hosp 3, Cognit Impairment Ward Neurol Dept, Shenzhen, Peoples R China; [Razak, Mahaman Yacoubou Abdoul; Hu, Wenting; Wang, Xiaochuan; Liu, Rong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Pathophysiol,Key Lab,Minist Educ Neurol Diso, Hongkong Rd 13, Wuhan 430030, Peoples R China; [Pan, Jingye; Shentu, Yangping] Key Lab Crit Emergency & Artificial Intelligence, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Shenzhen University; Huazhong University of Science & Technology	Shentu, YP (corresponding author), Wenzhou Med Univ, Dept Pathol, Affiliated Hosp 1, Fanhai West Rd 1, Wenzhou 325035, Peoples R China.; Liu, R (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Pathophysiol,Key Lab,Minist Educ Neurol Diso, Hongkong Rd 13, Wuhan 430030, Peoples R China.	rong.liu@hust.edu.cn; styp@wmu.edu.cn	Yacoubou Abdoul Razak, Mahaman/GWZ-6737-2022; LI, JIAN/GRY-2197-2022; Li, Jing/GYU-5036-2022; li, jian/GSE-0245-2022	Yacoubou Abdoul Razak, Mahaman/0000-0002-9278-4185; Liu, Rong/0000-0001-7477-6520	Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) [LQ19H050002]; Zhejiang Province Public Welfare Technology Application Research Project (Public Welfare Technology Application Research Project of Zhejiang Province) [LGF19h180012]; National Natural Science Foundation of China (NSFC) [31900685, 31771189, 31970964]; Wenzhou Municipal Science and Technology Bureau (WMSTB) [Y20210079, ZS2017008, Y20180159]	Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation); Zhejiang Province Public Welfare Technology Application Research Project (Public Welfare Technology Application Research Project of Zhejiang Province); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Wenzhou Municipal Science and Technology Bureau (WMSTB)	Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation), Grant/Award Number: LQ19H050002; Zhejiang Province Public Welfare Technology Application Research Project (Public Welfare Technology Application Research Project of Zhejiang Province), Grant/Award Number: LGF19h180012; National Natural Science Foundation of China (NSFC), Grant/Award Numbers: 31900685, 31771189 and 31970964; Wenzhou Municipal Science and Technology Bureau (WMSTB), Grant/Award Numbers: Y20210079, ZS2017008 and Y20180159	Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Beurel E, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-9; Bilbo SD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.014.2009; Carter SF, 2012, J NUCL MED, V53, P37, DOI 10.2967/jnumed.110.087031; Chen ZQ, 2018, J BIOMED NANOTECHNOL, V14, P2172, DOI 10.1166/jbn.2018.2645; Frost GR, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170228; Fujiki H, 2018, J CANCER RES CLIN, V144, P2339, DOI 10.1007/s00432-018-2765-7; Furman JL, 2012, J NEUROSCI, V32, P16129, DOI 10.1523/JNEUROSCI.2323-12.2012; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; Gruol DL, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6020019; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hung CC, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1508-2; Johnson ECB, 2020, NAT MED, V26, P769, DOI 10.1038/s41591-020-0815-6; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Khanna A, 2013, CANCER RES, V73, P6757, DOI 10.1158/0008-5472.CAN-13-1002; Liu CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11798; Michalska P, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080740; Minter MR, 2016, J NEUROCHEM, V136, P457, DOI 10.1111/jnc.13411; Munger EL, 2019, J COMP NEUROL, V527, P1179, DOI 10.1002/cne.24610; O'Callaghan JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102003; O'Connor CM, 2018, INT J BIOCHEM CELL B, V96, P182, DOI 10.1016/j.biocel.2017.10.008; Patil M, 2013, CELL MOL LIFE SCI, V70, P4009, DOI 10.1007/s00018-013-1307-3; Pooler AM, 2014, NEUROPHARMACOLOGY, V76, P1, DOI 10.1016/j.neuropharm.2013.09.018; Qiu M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182150; Reichenbach N, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809665; Shentu YP, 2019, NEUROBIOL AGING, V75, P198, DOI 10.1016/j.neurobiolaging.2018.11.023; Shentu YP, 2018, CELL REP, V24, P713, DOI 10.1016/j.celrep.2018.06.009; Song I, 2018, BRAIN RES BULL, V136, P101, DOI 10.1016/j.brainresbull.2017.03.003; Sosna J, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0244-x; Tam JHK, 2012, CAN J NEUROL SCI, V39, P286, DOI 10.1017/S0317167100013408; Tamma R, 2019, TRANSL ONCOL, V12, P545, DOI 10.1016/j.tranon.2018.12.008; Togi S, 2009, BIOCHEM BIOPH RES CO, V379, P616, DOI 10.1016/j.bbrc.2008.12.132; Toral-Rios D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207458; Valles SL, 2019, INT J MED SCI, V16, P1473, DOI 10.7150/ijms.37769; Zhou SL, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4937689	37	0	0	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22209	10.1096/fj.202101625R	http://dx.doi.org/10.1096/fj.202101625R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35195302	Green Submitted			2022-12-28	WOS:000761250800045
J	Azad, A; Farhan, MA; Murray, CR; Suzuki, K; Eitzen, G; Touret, N; Moore, RB; Murray, AG				Azad, Abul K.; Farhan, Maikel A.; Murray, Cameron R.; Suzuki, Kunimasa; Eitzen, Gary; Touret, Nicolas; Moore, Ronald B.; Murray, Allan G.			FGD5 regulates endothelial cell PI3 kinase-beta to promote neo-angiogenesis	FASEB JOURNAL			English	Article						CXCL12; endothelial cell; neovascularization; phosphatidylinositide 3-kinase; Rac1 GTP-binding protein; signal transduction	P110-ALPHA ISOFORM; INHIBITION; GENES; AXIS; RAS	Angiogenesis is required in embryonic development and tissue repair in the adult. Vascular endothelial growth factor (VEGF) initiates angiogenesis, and VEGF or its receptor is targeted therapeutically to block pathological angiogenesis. Additional pro-angiogenic cues, such as CXCL12 acting via the CXCR4 receptor, co-operate with VEGF/VEGFR2 to cue vascular patterning. We studied the role of FGD5, an endothelial Rho GTP/GDP exchange factor (RhoGEF), to regulate CXCR4-dependent signals in the endothelial cell (EC). Patient-derived renal cell carcinomas produce a complex milieu of growth factors that stimulated sprouting angiogenesis and endothelial tip cell differentiation ex vivo that was blocked by EC FGD5 loss. In a simplified model, CXCL12 augmented sprouting and tip gene expression under conditions where VEGF was limiting. CXCL12-stimulated tip cell differentiation was dependent on PI3 kinase (PI3K)-beta activity. Knockdown of EC FGD5 abolished CXCR4 signaling to PI3K-beta and Akt. Further, inhibition of Rac1, a Rho GTPase required for PI3K-beta activity, recapitulated the signaling defects of FGD5 deficiency, suggesting that FGD5 may regulate PI3K-beta activity through Rac1. Overexpression of a RhoGEF deficient, Dbl domain-deleted FGD5 mutant reduced CXCL12-stimulated Akt phosphorylation and failed to rescue PI3K signaling in native FGD5-deficient EC, indicating that FGD5 RhoGEF activity is required for FDG5 function. Endothelial expression of mutant PI3K-beta with an inactivated Rho binding domain confirmed that CXCL12-stimulated PI3K activity in EC requires Rac1-GTP co-regulation. Together, this data identify the role of FGD5 to generate Rac1-GTP to regulate pro-angiogenic CXCR4-dependent PI3K-beta signaling in EC. Inhibition of FGD5 activity may complement current angiogenesis inhibitor drugs.	[Azad, Abul K.; Farhan, Maikel A.; Murray, Allan G.] Univ Alberta, Dept Med, Rm 275 HMRC, Edmonton, AB T6G 2S2, Canada; [Murray, Cameron R.; Touret, Nicolas] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Suzuki, Kunimasa] Univ Alberta, Alberta Diabet Inst, Edmonton, AB, Canada; [Eitzen, Gary] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada; [Moore, Ronald B.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Murray, AG (corresponding author), Univ Alberta, Dept Med, Rm 275 HMRC, Edmonton, AB T6G 2S2, Canada.	allan.murray@ualberta.ca	Moore, Ronald Brian/AET-3015-2022		Departmental Translational Research Scholarship; Canadian Cancer Society [CCSRI IG 703774]	Departmental Translational Research Scholarship; Canadian Cancer Society(Canadian Cancer Society (CCS))	AKA was supported in part by a Departmental Translational Research Scholarship. Operating funding fur this project was granted to AGM from the Canadian Cancer Society CCSRI IG 703774	Azad AK, 2020, ONCOGENE, V39, P6480, DOI 10.1038/s41388-020-01444-3; Bergerot P, 2019, MOL CANCER THER, V18, P2185, DOI 10.1158/1535-7163.MCT-18-1399; Bresnick AR, 2019, ENDOCRINOLOGY, V160, P536, DOI 10.1210/en.2018-00843; Cavallero S, 2015, DEV CELL, V33, P469, DOI 10.1016/j.devcel.2015.03.018; Chen XY, 2019, CARDIOVASC RES, V115, P1343, DOI 10.1093/cvr/cvy298; Cheng C, 2012, CIRCULATION, V125, P3142, DOI 10.1161/CIRCULATIONAHA.111.064030; Das S, 2019, CELL, V176, P1128, DOI 10.1016/j.cell.2018.12.023; de Palma M, 2017, NAT REV CANCER, V17, P457, DOI 10.1038/nrc.2017.51; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Eitzen G, 2019, BIOCHEM CELL BIOL, V97, P257, DOI 10.1139/bcb-2018-0185; Farhan MA, 2017, ARTERIOSCL THROM VAS, V37, P2301, DOI 10.1161/ATVBAHA.117.309978; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Gazit R, 2014, J EXP MED, V211, P1314, DOI 10.1084/jem.20130428; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Haddad G, 2014, BLOOD, V124, P2142, DOI 10.1182/blood-2014-02-557975; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; He LJ, 2017, J CLIN INVEST, V127, P2968, DOI 10.1172/JCI93868; Ho M, 2003, PHYSIOL GENOMICS, V13, P249, DOI 10.1152/physiolgenomics.00186.2002; Houslay DM, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aae0453; Hultgren NW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18633-z; Ivins S, 2015, DEV CELL, V33, P455, DOI 10.1016/j.devcel.2015.03.026; Kim BG, 2017, CARDIOVASC RES, V113, P1677, DOI 10.1093/cvr/cvx188; Kurogane Y, 2012, ARTERIOSCL THROM VAS, V32, P988, DOI 10.1161/ATVBAHA.111.244004; Lee MY, 2014, P NATL ACAD SCI USA, V111, P12865, DOI 10.1073/pnas.1408472111; Liu SL, 2018, MOL CELL, V71, P1092, DOI 10.1016/j.molcel.2018.07.035; Ma Shaolin, 2018, F1000Res, V7, P326, DOI 10.12688/f1000research.11771.1; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Marin-Juez R, 2019, DEV CELL, V51, P503, DOI 10.1016/j.devcel.2019.10.019; Motzer RJ, 2020, NAT MED, V26, P1733, DOI 10.1038/s41591-020-1044-8; Mullaly SC, 2002, EUR J IMMUNOL, V32, P1493, DOI 10.1002/1521-4141(200205)32:5<1493::AID-IMMU1493>3.0.CO;2-G; Murillo MM, 2014, J CLIN INVEST, V124, P3601, DOI 10.1172/JCI74134; Nakhaei-Nejad M, 2012, ARTERIOSCL THROM VAS, V32, P2694, DOI 10.1161/ATVBAHA.112.300074; Park Sally, 2021, Small GTPases, V12, P147, DOI 10.1080/21541248.2019.1674765; Schwartz S, 2015, CANCER CELL, V27, P109, DOI 10.1016/j.ccell.2014.11.008; Soler A, 2013, J EXP MED, V210, P1937, DOI 10.1084/jem.20121571; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Takabatake Y, 2009, J AM SOC NEPHROL, V20, P1714, DOI 10.1681/ASN.2008060640; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498; Ziegler ME, 2016, ANGIOGENESIS, V19, P359, DOI 10.1007/s10456-016-9509-6	40	0	0	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22080	10.1096/fj.202100554R	http://dx.doi.org/10.1096/fj.202100554R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34882832				2022-12-28	WOS:000734992000016
J	Stuard, WL; Titone, R; Robertson, DM				Stuard, Whitney L.; Titone, Rossella; Robertson, Danielle M.			IGFBP-3 functions as a molecular switch that mediates mitochondrial and metabolic homeostasis	FASEB JOURNAL			English	Article						autophagy; insulin-like growth factor type 1 receptor; metabolism; mitochondria; mTOR	FACTOR BINDING PROTEIN-3; CANCER-CELL RESPONSE; GROWTH; AUTOPHAGY; MITOPHAGY; DIFFERENTIATION; EXPRESSION; SURVIVAL; MECHANISMS; RECEPTORS	Mitochondrial dysfunction or loss of homeostasis is a central hallmark of many human diseases. Mitochondrial homeostasis is mediated by multiple quality control mechanisms including mitophagy, a form of selective autophagy that recycles terminally ill or dysfunctional mitochondria in order to preserve mitochondrial integrity. Our prior studies have shown that members of the insulin-like growth factor (IGF) family localize to the mitochondria and may play important roles in mediating mitochondrial health in the corneal epithelium, an integral tissue that is required for the maintenance of optical transparency and vision. Importantly, the IGF-binding protein-3, IGFBP-3, is secreted by corneal epithelial cells in response to stress and functions to mediate intracellular receptor trafficking in this cell type. In this study, we demonstrate a novel role for IGFBP-3 in mitochondrial homeostasis through regulation of the short isoform (s)BNIP3L/NIX mitophagy receptor in corneal epithelial cells and extend this finding to non-ocular epithelial cells. We further show that IGFBP-3-mediated control of mitochondrial homeostasis is associated with alterations in lamellar cristae morphology and mitochondrial dynamics. Interestingly, both loss and gain of function of IGFBP-3 drive an increase in mitochondrial respiration. This increase in respiration is associated with nuclear accumulation of IGFBP-3. Taken together, these findings support a novel role for IGFBP-3 as a key mediator of mitochondrial health in mucosal epithelia through the regulation of mitophagy and mitochondrial morphology.	[Stuard, Whitney L.; Titone, Rossella; Robertson, Danielle M.] Univ Texas Southwestern Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Robertson, DM (corresponding author), UT Southwestern Med Ctr, Dept Ophthalmol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Danielle.Robertson@UTSouthwestern.edu			NEI [R0I EY029258, R0I EY024546, F30 EY031559, P30 EY030413]; Lions Foundation for Sight; Eye Bank Association of America; Research to Prevent Blindness, New York, NY; NHL [151000021685]	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Lions Foundation for Sight; Eye Bank Association of America; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); NHL	This study was funded by NEI grants R0I EY029258 (DMR), R0I EY024546 (DMR), F30 EY031559 (WLS), P30 EY030413, NHL grant 151000021685, Lions Foundation for Sight (WLS/DMR), Eye Bank Association of America (WLS/DMR), and an unrestricted grant front Research to Prevent Blindness, New York, NY	Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Benischke AS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06523-2; Bogdan ED, 2021, INVEST OPHTH VIS SCI, V62, DOI 10.1167/iovs.62.7.11; Chen Y, 2013, J BIOL CHEM, V288, P15455, DOI 10.1074/jbc.M113.452342; Choi JW, 2016, DIABETOLOGIA, V59, P571, DOI 10.1007/s00125-015-3836-9; Chua MWY, 2015, J CELL COMMUN SIGNAL, V9, P167, DOI 10.1007/s12079-015-0262-1; Delgado O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022023; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Fei PW, 2004, CANCER CELL, V6, P597, DOI 10.1016/j.ccr.2004.10.012; Furstenberger G, 2002, LANCET ONCOL, V3, P298, DOI 10.1016/S1470-2045(02)00731-3; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Granata R, 2007, J THROMB HAEMOST, V5, P835, DOI 10.1111/j.1538-7836.2007.02431.x; Grkovic S, 2013, ONCOGENE, V32, P2412, DOI 10.1038/onc.2012.264; Hori Y, 2004, INVEST OPHTH VIS SCI, V45, P114, DOI 10.1167/iovs.03-0903; Huang R, 2015, MOL CELL, V57, P456, DOI 10.1016/j.molcel.2014.12.013; Huo HR, 2003, J BIOL CHEM, V278, P11561, DOI 10.1074/jbc.M211785200; JANSSEN PT, 1983, INVEST OPHTH VIS SCI, V24, P623; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/BSE0470053, 10.1042/bse0470053]; Jin MY, 2013, CELL, V152, P368, DOI 10.1016/j.cell.2013.01.004; Kim JH, 2011, BLOOD, V118, P2622, DOI 10.1182/blood-2010-08-299784; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; King ER, 2012, RECENT PAT ANTI-CANC, V7, P14; Kondadi AK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174311; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Lin MZ, 2014, ONCOGENE, V33, P85, DOI 10.1038/onc.2012.538; Liu L, 2014, CELL RES, V24, P787, DOI 10.1038/cr.2014.75; Lyons A, 2017, J BIOL CHEM, V292, P16983, DOI 10.1074/jbc.M117.792838; Munson MJ, 2015, AUTOPHAGY, V11, P2375, DOI 10.1080/15548627.2015.1106668; Ning Y, 2006, MOL ENDOCRINOL, V20, P2173, DOI 10.1210/me.2005-0196; O'Connor R, 2000, BIOCHEM SOC T, V28, P47, DOI 10.1042/bst0280047; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Palikaras K, 2015, AUTOPHAGY, V11, P1428, DOI 10.1080/15548627.2015.1061172; Papinski D, 2016, J MOL BIOL, V428, P1725, DOI 10.1016/j.jmb.2016.03.030; Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004; Rajah R, 1997, J BIOL CHEM, V272, P12181, DOI 10.1074/jbc.272.18.12181; Ranke MB, 2015, BEST PRACT RES CL EN, V29, P701, DOI 10.1016/j.beem.2015.06.003; Redfern RL, 2015, EXP EYE RES, V134, P80, DOI 10.1016/j.exer.2015.03.018; Robertson DM, 2007, EXP EYE RES, V85, P492, DOI 10.1016/j.exer.2007.06.015; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Salani B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014157; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Stuard WL, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00024; Stuard WL, 2017, INVEST OPHTH VIS SCI, V58, P6105, DOI 10.1167/iovs.17-22425; Titone R, 2020, FASEB J, V34, P754, DOI 10.1096/fj.201901316RR; Titone R, 2019, J CELL PHYSIOL, V234, P1426, DOI 10.1002/jcp.26948; Titone R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21031-7; Valentinis B, 2001, J CLIN PATHOL-MOL PA, V54, P133, DOI 10.1136/mp.54.3.133; Shrivastav SV, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00286; Vaughan MB, 2006, DIFFERENTIATION, V74, P141, DOI 10.1111/j.1432-0436.2006.00069.x; Vincent AM, 2002, GROWTH HORM IGF RES, V12, P193, DOI 10.1016/S1096-6374(02)00017-5; Warsito D, 2012, EMBO REP, V13, P244, DOI 10.1038/embor.2011.251; Wei HF, 2015, BBA-MOL CELL RES, V1853, P2784, DOI 10.1016/j.bbamcr.2015.03.013; Werner H, 1996, ADV CANCER RES, V68, P183, DOI 10.1016/S0065-230X(08)60354-1; Wu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042483; Wu YC, 2012, OCUL SURF, V10, P100, DOI 10.1016/j.jtos.2012.01.004; Xiong WJ, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00411; Yamada PM, 2010, ENDOCRINOLOGY, V151, P5741, DOI 10.1210/en.2010-0672; Yin HM, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.357; Yoo SM, 2018, MOL CELLS, V41, P18, DOI 10.14348/molcells.2018.2277; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16	63	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22062	10.1096/fj.202100710RR	http://dx.doi.org/10.1096/fj.202100710RR			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34918377				2022-12-28	WOS:000734992000059
J	Wang, ZX; Martellucci, S; Van Enoo, A; Austin, D; Gelber, C; Campana, WM				Wang, Zixuan; Martellucci, Stefano; Van Enoo, Alicia; Austin, Dana; Gelber, Cohava; Campana, Wendy M.			alpha 1-Antitrypsin derived SP16 peptide demonstrates efficacy in rodent models of acute and neuropathic pain	FASEB JOURNAL			English	Article						LRP1; neuroinflammation; neuropathic pain; nociception; peripheral nerve injury; SP16	RECEPTOR-RELATED PROTEIN; PLASMINOGEN-ACTIVATOR; SCHWANN-CELLS; FORMALIN TEST; BINDING; COMPLEXES; THROMBIN; INTERNALIZATION; INFLAMMATION; NOCICEPTION	SP16 is an innovative peptide derived from the carboxyl-terminus of alpha 1-Antitrypsin (AAT), corresponding to residues 364-380, and contains recognition sequences for the low-density lipoprotein receptor-related protein-1 (LRP1). LRP1 is an endocytic and cell-signaling receptor that regulates inflammation. Deletion of Lrp1 in Schwann cells increases neuropathic pain; however, the role of LRP1 activation in nociceptive and neuropathic pain regulation remains unknown. Herein, we show that SP16 is bioactive in sensory neurons in vitro. Neurite length and regenerative gene expression were increased by SP16. In PC12 cells, SP16 activated Akt and ERK1/2 cell-signaling in an LRP1-dependent manner. When formalin was injected into mouse hind paws, to model inflammatory pain, SP16 dose-dependently attenuated nociceptive pain behaviors in the early and late phases. In a second model of acute pain using capsaicin, SP16 significantly reduced paw licking in both male and female mice (p < .01) similarly to enzymatically inactive tissue plasminogen activator, a known LRP1 interactor. SP16 also prevented development of tactile allodynia after partial nerve ligation and this response was sustained for nine days (p < .01). Immunoblot analysis of the injured nerve revealed decreased CD11b (p < .01) and Toll-like receptor-4 (p < .005). In injured dorsal root ganglia SP16 reduced CD11b(+) cells (p < .05) and GFAP (p < .005), indicating that inflammatory cell recruitment and satellite cell activation were inhibited. In conclusion, administration of SP16 blocked pain-related responses in three distinct pain models, suggesting efficacy against acute nociceptive, inflammatory, and neuropathic pain. SP16 also attenuated innate immunity in the PNS. These studies identify SP16 as a potentially effective treatment for pain.	[Wang, Zixuan; Martellucci, Stefano; Van Enoo, Alicia; Campana, Wendy M.] Univ Calif San Diego, Sch Med, Dept Anesthesiol, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Van Enoo, Alicia; Campana, Wendy M.] Univ Calif San Diego, Program Neurosci, La Jolla, CA 92093 USA; [Austin, Dana; Gelber, Cohava] Serpin Pharma, Manassas, VA USA; [Campana, Wendy M.] San Diego Vet Adm Hlth Care Syst, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Campana, WM (corresponding author), Univ Calif San Diego, Sch Med, Dept Anesthesiol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	wcampana@health.ucsd.edu	Martellucci, Stefano/O-8129-2019	Martellucci, Stefano/0000-0002-3952-3162	NIH/NINDS [R01 NS097590]; Veterans Administration [1I01RX002484]	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Administration(US Department of Veterans Affairs)	This work was supported by a NIH/NINDS grant R01 NS097590 (to W.M.C) and by the Veterans Administration 1I01RX002484 (to W.M.C).	Abdo H, 2019, SCIENCE, V365, P695, DOI 10.1126/science.aax6452; Albers GW, 2000, JAMA-J AM MED ASSOC, V283, P1145, DOI 10.1001/jama.283.9.1145; Arandjelovic S, 2005, ARCH BIOCHEM BIOPHYS, V438, P29, DOI 10.1016/j.abb.2005.03.019; Attal N, 2019, REV NEUROL-FRANCE, V175, P46, DOI 10.1016/j.neurol.2018.08.005; Avraham O, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18642-y; Benchenane K, 2005, CIRCULATION, V111, P2241, DOI 10.1161/01.CIR.0000163542.48611.A2; Bravo-Caparros I, 2020, FASEB J, V34, P5951, DOI 10.1096/fj.201901921R; Brifault C, 2019, GLIA, V67, P1210, DOI 10.1002/glia.23599; Bruno K, 2018, PAIN, V159, P1908, DOI 10.1097/j.pain.0000000000001306; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chuang TY, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0343-2; CODERRE TJ, 1992, J NEUROSCI, V12, P3665; Das L, 2021, AM J PATHOL, V191, P590, DOI 10.1016/j.ajpath.2021.01.001; Das L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224738; Demeule M, 2008, J NEUROCHEM, V106, P1534, DOI 10.1111/j.1471-4159.2008.05492.x; Donnelly S, 2006, ARTHRITIS RHEUM-US, V54, P1543, DOI 10.1002/art.21783; Flutsch A, 2016, NEUROREPORT, V27, P1305, DOI 10.1097/WNR.0000000000000691; Garcia-Fernandez P, 2021, PAIN REP, V6, DOI 10.1097/PR9.0000000000000898; Gonias SL, 2014, AM J PATHOL, V184, P18, DOI 10.1016/j.ajpath.2013.08.029; Gorovoy M, 2010, J LEUKOCYTE BIOL, V88, P769, DOI 10.1189/jlb.0410220; Hanani M, 2020, NAT REV NEUROSCI, V21, P485, DOI 10.1038/s41583-020-0333-z; Hao HN, 2009, J NEUROIMMUNOL, V212, P26, DOI 10.1016/j.jneuroim.2009.04.020; HERZ J, 1991, J BIOL CHEM, V266, P21232; HOLZER P, 1991, PHARMACOL REV, V43, P143; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; JOSLIN G, 1991, J BIOL CHEM, V266, P11282; Kalinski AL, 2020, ELIFE, V9, DOI 10.7554/eLife.60223; Kohro Y, 2020, NAT NEUROSCI, V23, P1376, DOI 10.1038/s41593-020-00713-4; Kounnas MZ, 1996, J BIOL CHEM, V271, P6523, DOI 10.1074/jbc.271.11.6523; Li Y, 2015, J NEUROSCI, V35, P13487, DOI 10.1523/JNEUROSCI.1956-15.2015; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Long GL, 2003, EUR J BIOCHEM, V270, P4059, DOI 10.1046/j.1432-1033.2003.03793.x; Luo X, 2019, J NEUROSCI, V39, P6848, DOI 10.1523/JNEUROSCI.3257-18.2019; Maekawa H, 1996, J BIOL CHEM, V271, P18604, DOI 10.1074/jbc.271.31.18604; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Mantuano E, 2017, BLOOD, V130, P1364, DOI 10.1182/blood-2017-04-780205; Mantuano E, 2013, J BIOL CHEM, V288, P34009, DOI 10.1074/jbc.M113.509133; Mattei V, 2020, J NEUROCHEM, V152, P468, DOI 10.1111/jnc.14891; Migliorini M, 2020, J BIOL CHEM, V295, P212, DOI 10.1074/jbc.RA119.010449; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; Old EA, 2014, J CLIN INVEST, V124, P2023, DOI 10.1172/JCI71389; Orita S, 2013, J NEUROSCI, V33, P5590, DOI 10.1523/JNEUROSCI.3342-12.2013; Patel S, 2001, J GENE MED, V3, P271, DOI 10.1002/jgm.180; Poplawski G, 2018, GLIA, V66, P1577, DOI 10.1002/glia.23325; Potere N, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00051; Quinn KA, 1999, EXP CELL RES, V251, P433, DOI 10.1006/excr.1999.4590; Raoof R, 2018, RHEUMATOLOGY, V57, P429, DOI 10.1093/rheumatology/kex308; Sadri M, 2022, GLIA, V70, P256, DOI 10.1002/glia.24098; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Strickland DK, 2011, METHOD ENZYMOL, V499, P17, DOI 10.1016/B978-0-12-386471-0.00002-X; Toldo Stefano, 2017, JACC Basic Transl Sci, V2, P561, DOI 10.1016/j.jacbts.2017.05.007; van den Biggelaar M, 2015, J BIOL CHEM, V290, P16463, DOI 10.1074/jbc.M115.650911; Volkow N, 2018, ANNU REV MED, V69, P451, DOI 10.1146/annurev-med-011817-044739; Wen XJ, 2017, ONCOTARGET, V8, P69370, DOI 10.18632/oncotarget.20628; Wohlford GF, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247357; YAMAMOTO T, 1992, ANESTHESIOLOGY, V77, P757, DOI 10.1097/00000542-199210000-00021; Yoon C, 2013, J BIOL CHEM, V288, P26557, DOI 10.1074/jbc.M113.478552; Yu XB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13839-2; Zhang HJ, 2009, GLIA, V57, P1588, DOI 10.1002/glia.20872	63	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22093	10.1096/fj.202101031RR	http://dx.doi.org/10.1096/fj.202101031RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34888951				2022-12-28	WOS:000734992000009
J	Zhang, Z; Fan, YX; Deng, KP; Liang, YX; Zhang, GM; Gao, XX; El-Samahy, MA; Zhang, YL; Deng, MT; Wang, F				Zhang, Zhen; Fan, Yixuan; Deng, Kaiping; Liang, Yaxu; Zhang, Guomin; Gao, Xiaoxiao; El-Samahy, M. A.; Zhang, Yanli; Deng, Mingtian; Wang, Feng			Circular RNA circUSP13 sponges miR-29c to promote differentiation and inhibit apoptosis of goat myoblasts by targeting IGF1	FASEB JOURNAL			English	Article						circUSP13; differentiation; goat primary myoblast; IGF1; miR-29c	SKELETAL-MUSCLE; CELL-DIFFERENTIATION; EXPRESSION; TRANSCRIPTION; MICRORNAS	Circular RNAs (circRNAs) are an indispensable element of post-transcriptional gene regulation, influencing a variety of biological processes including myogenic differentiation; however, little is known about the function of circRNA in goat myogenic differentiation. Using RNA-sequencing data from our laboratory, we explored the influences of circUSP13, as a candidate circRNA, on myoblast differentiation since its expression is higher in myoblasts of lamb (first day of age) than that of the fetus (75th day of pregnancy). In in vitro experiments, circUSP13 significantly promoted differentiation and inhibited apoptosis in goat primary myoblasts. Mechanistically, circUSP13 localized with miR-29c in the cytoplasm of goat myoblasts to regulate IGF1 expression. We further demonstrated that circUSP13 sponges miR-29c, promoting IGF1 expression that upregulated the expression of MyoG and MyHC. Thus, our results identified circUSP13 as a molecular marker for breeding programs of mutton production, as well as the circUSP13-miR-29c-IGF1 axis as a potential therapeutic target for combating muscle wasting.	[Zhang, Zhen; Fan, Yixuan; Deng, Kaiping; Liang, Yaxu; Zhang, Guomin; Gao, Xiaoxiao; El-Samahy, M. A.; Zhang, Yanli; Deng, Mingtian; Wang, Feng] Nanjing Agr Univ, Inst Sheep & Goat Sci, Nanjing 210095, Peoples R China	Nanjing Agricultural University	Fan, YX; Wang, F (corresponding author), Nanjing Agr Univ, Inst Sheep & Goat Sci, Nanjing 210095, Peoples R China.	fanyixuan@njau.edu.cn; caeet@njau.edu.cn		Zhang, Zhen/0000-0002-4186-9744; El-Samahy, M.A./0000-0002-8876-7841	National Natural Science Foundation of China [32102520]; Natural Science Foundation of Jiangsu Province [BK20210403]; National Key R&D program of China [2018YED0501900, 901]; Key Project for JiangSu Agricultural New Variety Innovation [PZCZ201740]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Key R&D program of China; Key Project for JiangSu Agricultural New Variety Innovation	This research was supported by the National Natural Science Foundation of China (No.32102520), Natural Science Foundation of Jiangsu Province (No. BK20210403), the National Key R&D program of China (2018YED0501900, 901), and the Key Project for JiangSu Agricultural New Variety Innovation (PZCZ201740)	Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Cao LL, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2336-0; Chen B, 2016, MOL MED REP, V13, P2527, DOI 10.3892/mmr.2016.4832; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen MJ, 2021, MOL THER-NUCL ACIDS, V24, P352, DOI 10.1016/j.omtn.2021.03.004; Coenen-Stass AML, 2018, MOL THER-NUCL ACIDS, V13, P1, DOI 10.1016/j.omtn.2018.08.005; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Deng KP, 2021, EXP CELL RES, V401, DOI 10.1016/j.yexcr.2021.112524; Dixon RJ, 2005, NUCLEIC ACIDS RES, V33, P5904, DOI 10.1093/nar/gki893; Elnour IE, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010176; Guller I, 2010, J PHYSIOL-LONDON, V588, P4075, DOI 10.1113/jphysiol.2010.194175; Habibi P, 2016, ACTA ENDOCRINOL-BUCH, V12, P130, DOI 10.4183/aeb.2016.130; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hentze MW, 2013, EMBO J, V32, P923, DOI 10.1038/emboj.2013.53; Huang KW, 2021, J AGR FOOD CHEM, V69, P592, DOI 10.1021/acs.jafc.0c06400; Jiang TL, 2021, MOL CANCER, V20, DOI 10.1186/s12943-021-01358-y; Kurokawa M, 2009, MOL CELL BIOCHEM, V331, P193, DOI 10.1007/s11010-009-0158-6; Legnini I, 2017, MOL CELL, V66, P22, DOI 10.1016/j.molcel.2017.02.017; Li H, 2018, MOL THER-NUCL ACIDS, V11, P272, DOI 10.1016/j.omtn.2018.02.012; Li J, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03495-0; Li J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15201; Li XH, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.29; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lin JR, 2021, J CELL MOL MED, V25, P4420, DOI 10.1111/jcmm.16508; Ling YH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22262-4; Liu HL, 2021, THERANOSTICS, V11, P1396, DOI 10.7150/thno.53227; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Noguchi S, 2005, Acta Myol, V24, P115; Peng SJ, 2019, MOL THER-NUCL ACIDS, V16, P481, DOI 10.1016/j.omtn.2019.03.009; Qu SB, 2015, CANCER LETT, V365, P141, DOI 10.1016/j.canlet.2015.06.003; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; RUDNICKI MA, 1995, BIOESSAYS, V17, P203, DOI 10.1002/bies.950170306; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Shen SY, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01269-4; Shen XX, 2019, INT J BIOL SCI, V15, P2265, DOI 10.7150/ijbs.36412; Song CC, 2019, J CELL PHYSIOL, V234, P9839, DOI 10.1002/jcp.27672; Sui MH, 2020, ANIM BIOTECHNOL, V31, P455, DOI 10.1080/10495398.2019.1622555; Suzuki H, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl151; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Tao H, 2018, GENOMICS, V110, P257, DOI 10.1016/j.ygeno.2017.10.005; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wei XF, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.541; Xia J, 2021, MOL MED REP, V23, DOI 10.3892/mmr.2021.12071; Yang ZG, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.619329; Yue BL, 2020, MOL THER-NUCL ACIDS, V19, P1086, DOI 10.1016/j.omtn.2019.12.039; Zheng YY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57404-9; Zhou L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033766	48	7	7	6	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22097	10.1096/fj.202101317R	http://dx.doi.org/10.1096/fj.202101317R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34935184				2022-12-28	WOS:000734992000014
J	Ma, X; Takahashi, Y; Wu, WJ; Chen, JL; Dehdarani, M; Liang, WT; Shin, YH; Benyajati, S; Ma, JX				Ma, Xiang; Takahashi, Yusuke; Wu, Wenjing; Chen, Jianglei; Dehdarani, Marcus; Liang, Wentao; Shin, Young-Hwa; Benyajati, Siribhinya; Ma, Jian-xing			Soluble very low-density lipoprotein receptor (sVLDLR) inhibits fibrosis in neovascular age-related macular degeneration	FASEB JOURNAL			English	Article						fibrosis; macular degeneration; TGF-beta signaling pathway; very low-density lipoprotein receptor; Wnt signaling pathway	WNT SIGNALING PATHWAY; PATHOGENIC ROLE; TGF-BETA; PROTEIN; ISOMEROHYDROLASE; MECHANISMS; EXPRESSION; REGULATOR; RPE65; LRP6	Subretinal fibrosis is a key pathological feature in neovascular age-related macular degeneration (nAMD). Previously, we identified soluble very low-density lipoprotein receptor (sVLDLR) as an endogenous Wnt signaling inhibitor. This study investigates whether svLDLR plays an anti-fibrogenic role in nAMD models, including Vldlr(-/-) mice and laser-induced choroidal neovascularization (CNV). We found that fibrosis factors including P-Smad 2/3. alpha-SMA, and CTGF were upregulated in the subretinal area of Vldlr(-/-) mice and the laser-induced CNV model. The antibody blocking Wnt co-receptor LRP6 significantly attenuated the overexpression of fibrotic factors in these two models. Moreover, there was a significant reduction of sVLDLR in the interphotoreceptor matrix (IPM) in the laser-induced CNV model. A transgenic strain (sVLDLR-Tg) with sVLDLR overexpression in the IPM was generated. Overexpression of sVLDLR ameliorated the profibrotic changes in the subretinal area of the laser-induced CNV model. In addition, Wnt and TG F-beta signaling synergistically promoted fibrogenesis in human primary retinal pigment epithelium (RPE) cells. CRISPR/Cas9-mediated LRP6 gene knockout (KO) attenuated this synergistic effect. The disruption of VLDLR expression promoted, while the overexpression of sVLDLR inhibited TGF-beta-induced fibrosis. These findings suggest that overactivated Wnt signaling enhances the TGF-beta pathway in subretinal fibrosis. sVLDLR confers an antifibrotic effect, at least partially, through the inhibition of Wnt signaling and thus, has therapeutic potential for fibrosis.	[Ma, Xiang; Takahashi, Yusuke; Wu, Wenjing; Chen, Jianglei; Dehdarani, Marcus; Liang, Wentao; Shin, Young-Hwa; Benyajati, Siribhinya; Ma, Jian-xing] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, BSEB 328B,941 Stanton L Young Blvd, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Ma, JX (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, BSEB 328B,941 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	jian-xing-ma@ouhsc.edu		Liang, Wentao/0000-0002-0609-6280	National Institutes of Health (NIH) [EY019309, EY012231, EY028949, EY032930, EY032931]; Diabetic Animal Core and Histology and Image Core of diabetic COBRE [GM122744]; NEI P30 [EY021725]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetic Animal Core and Histology and Image Core of diabetic COBRE; NEI P30	National Institutes of Health (NIH), Grant/Award Number: EY019309, EY012231, EY028949, EY032930 and EY032931; Diabetic Animal Core and Histology and Image Core of diabetic COBRE, Grant/Award Number: GM122744; NEI P30, Grant/Award Number: EY021725	Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Argraves WS, 2001, FRONT BIOSCI, V6, pD406, DOI 10.2741/Argraves; Burgy O, 2018, MATRIX BIOL, V68-69, P67, DOI 10.1016/j.matbio.2018.03.017; Chen Q, 2016, MOL CELL BIOL, V36, P2645, DOI 10.1128/MCB.00235-16; Chen Y, 2007, J BIOL CHEM, V282, P34420, DOI 10.1074/jbc.M611289200; Chen Y, 2009, MICROVASC RES, V78, P119, DOI 10.1016/j.mvr.2009.02.005; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Daniel E, 2014, OPHTHALMOLOGY, V121, P656, DOI 10.1016/j.ophtha.2013.10.019; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Gong Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132643; Haines JL, 2006, INVEST OPHTH VIS SCI, V47, P329, DOI 10.1167/iovs.05-0116; Han JW, 2015, INVEST OPHTH VIS SCI, V56, P8314, DOI 10.1167/iovs.15-18359; Hu Y, 2013, INVEST OPHTH VIS SCI, V54, P141, DOI 10.1167/iovs.12-10281; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Hwang JC, 2011, OPHTHAL SURG LAS IM, V42, DOI 10.3928/15428877-20100924-01; Ishikawa K, 2016, EXP EYE RES, V142, P19, DOI 10.1016/j.exer.2015.03.009; Ishikawa M, 2015, EXP EYE RES, V133, P3, DOI 10.1016/j.exer.2015.02.017; Klapholz-Brown Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000945; Krebs I, 2013, BRIT J OPHTHALMOL, V97, P1443, DOI 10.1136/bjophthalmol-2013-303513; Lee K, 2014, J CELL SCI, V127, P4857, DOI 10.1242/jcs.149302; Lee K, 2012, DIABETES, V61, P2948, DOI 10.2337/db11-0300; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Liu Y, 2019, MOL THER-NUCL ACIDS, V17, P113, DOI 10.1016/j.omtn.2019.05.012; Luo K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022137; Luo XT, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.032060; Ma B, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00378; Ma WX, 2019, ELIFE, V8, DOI 10.7554/eLife.42049; Ma X, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101185; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Masckauchan T. Nestor H., 2005, Angiogenesis, V8, P43, DOI 10.1007/s10456-005-5612-9; Masuzaki H, 1996, CIRC RES, V78, P8, DOI 10.1161/01.RES.78.1.8; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Meyers EA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022244; Mitchell P, 2018, LANCET, V392, P1147, DOI 10.1016/S0140-6736(18)31550-2; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; NAN W, 1993, INVEST OPHTH VIS SCI, V34, P101; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Qiu FF, 2020, CLIN SCI, V134, P1613, DOI 10.1042/CS20200085; Qiu FF, 2019, MOL PHARMACEUT, V16, P1958, DOI 10.1021/acs.molpharmaceut.8b01319; Reddy SS, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-30; Ren Q, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.670960; Ren SY, 2013, P NATL ACAD SCI USA, V110, P1440, DOI 10.1073/pnas.1211179110; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Singh HD, 2021, BIOCHEM BIOPH RES CO, V545, P8, DOI 10.1016/j.bbrc.2021.01.068; Sun Y, 2017, J EXP MED, V214, P1753, DOI 10.1084/jem.20161645; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; Takahashi Sadao, 2004, J Atheroscler Thromb, V11, P200; Takahashi Y, 2005, FEBS LETT, V579, P5414, DOI 10.1016/j.febslet.2005.09.002; Tuo JS, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0683-x; Wang ZX, 2015, ARTERIOSCL THROM VAS, V35, P855, DOI 10.1161/ATVBAHA.114.304627; Wu D, 2019, FASEB J, V33, P2498, DOI 10.1096/fj.201801227R; Xia CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075186; Yang X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191279; Yang YH, 2020, FASEB J, V34, P8428, DOI 10.1096/fj.201903149R	55	1	1	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22058	10.1096/fj.202101334R	http://dx.doi.org/10.1096/fj.202101334R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34820908	Green Published			2022-12-28	WOS:000722321300032
J	Munetsuna, E; Yamada, H; Yamazaki, M; Ando, Y; Mizuno, G; Hattori, Y; Kageyama, I; Teshigawara, A; Nouchi, Y; Ishikawa, H; Fujii, R; Ohta, Y; Suzuki, K; Shimono, Y; Ohashi, K; Hashimoto, S				Munetsuna, Eiji; Yamada, Hiroya; Yamazaki, Mirai; Ando, Yoshitaka; Mizuno, Genki; Hattori, Yuji; Kageyama, Itsuki; Teshigawara, Atsushi; Nouchi, Yuki; Ishikawa, Hiroaki; Fujii, Ryosuke; Ohta, Yoshiji; Suzuki, Koji; Shimono, Yohei; Ohashi, Koji; Hashimoto, Shuji			Maternal fructose intake predisposes rat offspring to metabolic disorders via abnormal hepatic programming	FASEB JOURNAL			English	Article						DOHaD; hepatic microRNA expression; insulin-like growth factor-1; maternal nutrition; offspring	HIGH-FAT-DIET; INSULIN-RESISTANCE; DNA METHYLATION; LIVER-DISEASE; IGF-I; EXPRESSION; CONSUMPTION; HEALTH; RISK; EPIGENETICS	Given that fructose consumption has increased by more than 10-fold in recent decades, it is possible that excess maternal fructose consumption causes harmful effects in the next generation. This study attempted to elucidate the mechanism of the harmful effects of excessive maternal fructose intake from the perspective of offspring liver function. Female rats during gestation and lactation were fed water containing fructose, and their offspring were fed normal water. We attempted to elucidate the mechanism of fructose-induced transgenerational toxicity by conducting a longitudinal study focusing on hepatic programming prior to disease onset. Impaired Insulin resistance and decreased high-density lipoprotein-cholesterol levels were observed at 160 days of age. However, metabolic disorders were not observed in 60-day-old offspring. Microarray analysis of 60-day-old offspring livers showed the reduction of hepatic insulin-like growth factor-1 (Igf1) mRNA expression. This reduction continued until the rats were aged 160 days and attenuated Igf1 signaling. Hepatic microRNA-29 (miR-29a) and miR-130a, which target Igf1 mRNA, were also found to be upregulated. Interestingly, these miRNAs were upregulated in the absence of metabolic disorder. In this study, we found that maternal fructose intake resulted in dysregulated expression of Igf1 and its target miRNAs in the offspring liver, and that these offspring were more likely to develop metabolic disorders. Abnormal hepatic programming induced by an imbalanced maternal nutritional environment is maintained throughout life, implying that it may contribute to metabolic disorders.	[Munetsuna, Eiji; Shimono, Yohei] Fujita Hlth Univ, Dept Biochem, Sch Med, Toyoake, Aichi, Japan; [Yamada, Hiroya; Hashimoto, Shuji] Fujita Hlth Univ, Dept Hyg, Sch Med, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan; [Yamazaki, Mirai] Kagawa Prefectural Univ Hlth Sci, Dept Med Technol, Takamatsu, Kagawa, Japan; [Ando, Yoshitaka; Kageyama, Itsuki; Teshigawara, Atsushi; Nouchi, Yuki; Ishikawa, Hiroaki; Ohashi, Koji] Fujita Hlth Univ, Dept Clin Biochem, Sch Med Sci, Toyoake, Aichi, Japan; [Mizuno, Genki; Teshigawara, Atsushi] Fujita Hlth Univ Hosp, Deparment Joint Res Lab Clin Med, Toyoake, Aichi, Japan; [Mizuno, Genki; Hattori, Yuji; Fujii, Ryosuke; Suzuki, Koji] Fujita Hlth Univ, Dept Prevent Med Sci, Sch Med Sci, Toyoake, Aichi, Japan; [Ohta, Yoshiji] Fujita Hlth Univ, Dept Chem, Sch Med, Toyoake, Aichi, Japan	Fujita Health University; Fujita Health University; Fujita Health University; Fujita Health University; Fujita Health University; Fujita Health University	Yamada, H (corresponding author), Fujita Hlth Univ, Dept Hyg, Sch Med, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	hyamada@fujita-hu.ac.jp		Mizuno, Genki/0000-0001-8052-5146	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20H04134, 17K07805, 18K05493]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant/Award Number: 20H04134, 17K07805 and 18K05493	Ashino NG, 2012, J NUTR BIOCHEM, V23, P341, DOI 10.1016/j.jnutbio.2010.12.011; Bray GA, 2013, ADV NUTR, V4, P220, DOI 10.3945/an.112.002816; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Chao YM, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00660-z; Clayton ZE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141962; Friedrich N, 2012, DIABETES CARE, V35, P768, DOI 10.2337/dc11-1833; Fu Q, 2015, FASEB J, V29, P1176, DOI 10.1096/fj.14-258442; Fu Q, 2009, FASEB J, V23, P2438, DOI 10.1096/fj.08-124768; Fukunaga K, 2018, AM J PHYSIOL-ENDOC M, V315, pE1232, DOI 10.1152/ajpendo.00134.2018; Gillman MW, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0031; Hiratsuka I, 2016, THYROID, V26, P1431, DOI 10.1089/thy.2016.0062; Hiratsuka I, 2015, ENDOCR J, V62, P1059, DOI 10.1507/endocrj.EJ15-0448; Hong H, 2017, NUTR DIABETES, V7, DOI 10.1038/s41387-017-0002-0; Hsu CN, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900073; Hsu CN, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091229; Hung YH, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01367; Keleher MR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192606; Koo S, 2021, NUTR RES PRACT, V15, P160, DOI 10.4162/nrp.2021.15.2.160; Lara-Diaz VJ, 2017, J PHYSIOL BIOCHEM, V73, P245, DOI 10.1007/s13105-016-0545-x; Liang S, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0275-7; Lu L, 2015, BIOCHEM BIOPH RES CO, V465, P387, DOI 10.1016/j.bbrc.2015.08.012; Ma JT, 2015, J HEPATOL, V63, P462, DOI 10.1016/j.jhep.2015.03.032; Mizuno G, 2021, NUTR RES, V92, P40, DOI 10.1016/j.nutres.2021.06.002; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Mouralidarane A, 2015, INT J OBESITY, V39, P1339, DOI 10.1038/ijo.2015.85; Munetsuna E, 2019, J NUTR BIOCHEM, V67, P44, DOI 10.1016/j.jnutbio.2019.01.016; Munetsuna E, 2018, LIFE SCI, V202, P117, DOI 10.1016/j.lfs.2018.04.006; Ogden C. L., 2011, NCHS Data Briefs; Ohashi K, 2015, BIOCHEM BIOPH RES CO, V468, P185, DOI 10.1016/j.bbrc.2015.10.134; Ohashi K, 2015, NUTR RES, V35, P259, DOI 10.1016/j.nutres.2014.11.001; Ouni M, 2016, PHARMACOGENOMICS J, V16, P102, DOI 10.1038/tpj.2015.26; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; Painter RC, 2006, AM J CLIN NUTR, V84, P322; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Saad AF, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.03.038; Sesti G, 2005, DIABETES CARE, V28, P120, DOI 10.2337/diacare.28.1.120; Siddeek B, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0153-y; Sohi G, 2015, ENDOCRINOLOGY, V156, P3069, DOI [10.1210/en.2015-1058, 10.1210/EN.2015-1058]; Stanhope KL, 2013, CURR OPIN LIPIDOL, V24, P198, DOI 10.1097/MOL.0b013e3283613bca; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi Y, 2012, ENDOCR J, V59, P955, DOI 10.1507/endocrj.EJ12-0322; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Yamada H, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84707-7; Yamada H, 2019, FASEB J, V33, P11431, DOI 10.1096/fj.201901072R; Yamazaki M, 2020, J NUTR BIOCHEM, V82, DOI 10.1016/j.jnutbio.2020.108386; Yamazaki M, 2018, FASEB J, V32, P2549, DOI 10.1096/fj.201700783RR; Zadjali F, 2012, FASEB J, V26, P3282, DOI 10.1096/fj.12-205583; Zhang Q, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00871; Zheng J, 2016, ENDOCRINE, V54, P70, DOI 10.1007/s12020-016-0959-9	49	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22030	10.1096/fj.202101276R	http://dx.doi.org/10.1096/fj.202101276R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34748238				2022-12-28	WOS:000722321300008
J	Zhang, Y; Kishi, H; Morita, T; Kobayashi, S				Zhang, Ying; Kishi, Hiroko; Morita, Tomoka; Kobayashi, Sei			Paxillin controls actin stress fiber formation and migration of vascular smooth muscle cells by directly binding to the active Fyn	FASEB JOURNAL			English	Article						actin stress fiber; Fyn; migration; paxillin; Rho-kinase	PROTEIN-TYROSINE KINASES; RHO-ASSOCIATED KINASE; NEOINTIMA FORMATION; CA2+ SENSITIZATION; SPHINGOSYLPHOSPHORYLCHOLINE; ACTIVATION; PHYSARUM; FAK; PHOSPHORYLATION; CONTRACTION	Rho-kinase (ROK)-mediated migration of vascular smooth muscle cells plays a crucial role in cardiovascular diseases. Previously we demonstrated Fyn tyrosine kinase as an upstream molecule of ROK to mediate actin stress fiber formation that plays an important role in cell migration, but the molecular mechanism between the two kinases was unclear. To discover a novel signaling molecule that exists between Fyn and ROK, we identified paxillin acting downstream of the active Fyn by combined use of pulldown assay and mass spectrometry. Immunofluorescence staining confirmed co-localization of Fyn and paxillin at the ends of actin stress fibers in human coronary artery smooth muscle cells (CASMCs). Surface plasmon resonance assay demonstrated direct binding between constitutively active Fyn (CA-Fyn) and N-terminus of paxillin (N-pax). The sphingosylphosphorylcholine (SPC)-induced ROK activation, actin stress fiber formation and cell migration were inhibited by paxillin knockdown, which were rescued by full-length paxillin (FL-pax) but not N-pax. N-pax co-localized with CA-Fyn at the cytosol and overexpression of N-pax inhibited the SPC-induced actin stress fiber formation and cell migration, indicating that the direct binding of FL-pax and CA-Fyn at the ends of actin stress fibers is essential for the ROK-mediated actin stress fiber formation and cell migration. Paxillin, as a novel signalling molecule, mediates the SPC-induced actin stress fiber formation and migration in human CASMCs via the Fyn/paxillin/ROK signalling pathway by direct binding of active Fyn.	[Zhang, Ying; Kishi, Hiroko; Morita, Tomoka; Kobayashi, Sei] Yamaguchi Univ, Grad Sch Med, Dept Mol & Cellular Physiol, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan; [Kobayashi, Sei] Yamaguchi Univ, Sch Med, Dept Adv Prevent Med, Ube, Yamaguchi, Japan	Yamaguchi University; Yamaguchi University	Zhang, Y; Kobayashi, S (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Mol & Cellular Physiol, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	ying02@yamaguchi-u.ac.jp; seikoba@yamaguchi-u.ac.jp		Zhang, Ying/0000-0002-3778-5900	Ministry of Education, Culture, Sports, Science and Technology, Japan (JSPS KAKENHI) [JP25893150, JP15K18970, JP18K06875, JP23380077, JP23659113]	Ministry of Education, Culture, Sports, Science and Technology, Japan (JSPS KAKENHI)	This work was supported by Grants-in--Aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (JSPS KAKENHI Grant Numbers JP25893150, JP15K18970, and JP18K06875 to Y. Zhang, JP23380077 and JP23659113 to S. Kobayashi)	Boguslawski G, 2002, EXP CELL RES, V274, P264, DOI 10.1006/excr.2002.5472; Boulanger LM, 2001, CURR OPIN NEUROBIOL, V11, P568, DOI 10.1016/S0959-4388(00)00251-8; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; COOKE MP, 1991, CELL, V65, P281, DOI 10.1016/0092-8674(91)90162-R; Cortesio CL, 2011, J BIOL CHEM, V286, P9998, DOI 10.1074/jbc.M110.187294; Darnell RB, 1998, NEURON, V21, P947, DOI 10.1016/S0896-6273(00)80613-3; Deakin NO, 2014, J CELL BIOL, V206, P395, DOI 10.1083/jcb.201403039; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Du C, 2016, FEBS LETT, V590, P408, DOI 10.1002/1873-3468.12069; Shortrede JE, 2016, MOL CELL ENDOCRINOL, V430, P56, DOI 10.1016/j.mce.2016.04.007; Gadang V, 2014, ARTERIOSCL THROM VAS, V34, P1429, DOI 10.1161/ATVBAHA.114.303439; Gawlak G, 2014, FASEB J, V28, P3249, DOI 10.1096/fj.13-245142; Ginnan R, 2013, J BIOL CHEM, V288, P29703, DOI 10.1074/jbc.M113.477257; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Ishibe S, 2003, MOL CELL, V12, P1275, DOI 10.1016/S1097-2765(03)00406-4; Kaneko-Kawano T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039269; Li S, 2006, AM J PHYSIOL-HEART C, V291, pH1262, DOI 10.1152/ajpheart.00901.2005; Louis SF, 2010, EXP CLIN CARDIOL, V15, pE75; Lopez-Colome AM, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0418-y; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Matsushima S, 2016, J CLIN INVEST, V126, P3403, DOI 10.1172/JCI85624; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mukherjee A, 2020, ELIFE, V9, DOI 10.7554/eLife.50571; Nakao F, 2002, CIRC RES, V91, P953, DOI 10.1161/01.RES.0000042702.04920.BF; Nocula-Lugowska M, 2015, J MOL BIOL, V427, P2532, DOI 10.1016/j.jmb.2015.06.004; Noma K, 2008, J CLIN INVEST, V118, P1632, DOI 10.1172/JCI29226; Rawat A, 2010, BBA-BIOMEMBRANES, V1798, P1854, DOI 10.1016/j.bbamem.2010.06.009; Resh MD, 1998, INT J BIOCHEM CELL B, V30, P1159, DOI 10.1016/S1357-2725(98)00089-2; Rudijanto Achmad, 2007, Acta Med Indones, V39, P86; Saito YD, 2010, CANCER-AM CANCER SOC, V116, P1629, DOI 10.1002/cncr.24879; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Schwartz SM, 1997, J CLIN INVEST, V99, P2814, DOI 10.1172/JCI119472; Seasholtz TM, 1999, CIRC RES, V84, P1186, DOI 10.1161/01.RES.84.10.1186; Shibata R, 2001, CIRCULATION, V103, P284; Shirao S, 2002, CIRC RES, V91, P112, DOI 10.1161/01.RES.0000026057.13161.42; Teranishi S, 2009, INVEST OPHTH VIS SCI, V50, P5646, DOI 10.1167/iovs.08-2534; Tumbarello DA, 2002, FEBS LETT, V513, P114, DOI 10.1016/S0014-5793(01)03244-6; Turner CE, 2000, J CELL SCI, V113, P4139; Veith C, 2012, AM J PATHOL, V181, P1621, DOI 10.1016/j.ajpath.2012.07.026; Wilson DP, 2005, BIOCHEM J, V389, P763, DOI 10.1042/BJ20050237; Wolven A, 1997, MOL BIOL CELL, V8, P1159, DOI 10.1091/mbc.8.6.1159; Xu D, 2007, FEBS LETT, V581, P5227, DOI 10.1016/j.febslet.2007.10.010; Xu D, 2012, CELL SIGNAL, V24, P282, DOI 10.1016/j.cellsig.2011.09.013; Zhang YM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40786; Zhang Y, 2016, ACTA BIOCH BIOPH SIN, V48, P536, DOI 10.1093/abbs/gmw031; Zhang Y, 2012, J BIOCHEM, V152, P185, DOI 10.1093/jb/mvs062; Zhang Y, 2010, FEBS LETT, V584, P3486, DOI 10.1016/j.febslet.2010.07.011	50	2	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22012	10.1096/fj.202101035RR	http://dx.doi.org/10.1096/fj.202101035RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34724245				2022-12-28	WOS:000722321300030
J	Klotz, L; Enz, R				Klotz, Lisa; Enz, Ralf			MGluR7 is a presynaptic metabotropic glutamate receptor at ribbon synapses of inner hair cells	FASEB JOURNAL			English	Article						cochlea; inner hair cell; metabotropic glutamate receptor; mGlu; ribbon synapse	CENTRAL-NERVOUS-SYSTEM; MICE LACKING; LOCALIZATION; TERMINALS; SUBTYPES; RAT; SUSCEPTIBILITY; PHARMACOLOGY; EXPRESSION; PHYSIOLOGY	Glutamate is the most pivotal excitatory neurotransmitter in the central nervous system. Metabotropic glutamate receptors (mGluRs) dimerize and can couple to inhibitory intracellular signal cascades, thereby protecting glutamatergic neurons from excessive excitation and cell death. MGluR7 is correlated with age-related hearing deficits and noise-induced hearing loss; however its exact localization in the cochlea is unknown. Here, we analyzed the expression and localization of mGluR7a and mGluR7b in mouse cochlear wholemounts in detail, using confocal microscopy and 3D reconstructions. We observed a presynaptic localization of mGluR7a at inner hair cells (IHCs), close to the synaptic ribbon. To detect mGluR7b, newly generated antibodies were characterized and showed co-localization with mGluR7a at IHC ribbon synapses. Compared to the number of synaptic ribbons, the numbers of mGluR7a and mGluR7b puncta were reduced at higher frequencies (48 to 64 kHz) and in older animals (6 and 12 months). Previously, we reported a presynaptic localization of mGluR4 and mGluR8b at this synapse type. This enables the possibility for the formation of homo- and/or heterodimeric receptors composed of mGluR4, mGluR7a, mGluR7b and mGluR8b at IHC ribbon synapses. These receptor complexes might represent new molecular targets suited for pharmacological concepts to protect the cochlea against noxious stimuli and excitotoxicity.	[Klotz, Lisa; Enz, Ralf] Friedrich Alexander Univ Erlangen Nurnberg, Inst Biochem, Erlangen, Germany	University of Erlangen Nuremberg	Enz, R (corresponding author), FAU Erlangen Nurnberg, Inst Biochem, Fahrstr 17, D-91054 Erlangen, Germany.	ralf.enz@fau.de	Klotz-Weigand, Lisa Janina/AGG-1603-2022	Klotz-Weigand, Lisa Janina/0000-0001-9378-5684	Deutsche Forschungsgemeinschaft (DFG) [349/10]; Interdisciplinary Centre for Clinical Research (IZKF) at the University Hospital of the Friedrich-Alexander-Universitat Erlangen-Nurnberg [E19]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Interdisciplinary Centre for Clinical Research (IZKF) at the University Hospital of the Friedrich-Alexander-Universitat Erlangen-Nurnberg	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: 349/10; Interdisciplinary Centre for Clinical Research (IZKF) at the University Hospital of the Friedrich-Alexander-Universitat Erlangen-Nurnberg, Grant/Award Number: E19	Airas JM, 2001, FEBS LETT, V494, P60, DOI 10.1016/S0014-5793(01)02311-0; Brandstatter JH, 1996, J NEUROSCI, V16, P4749; Cai ZH, 2001, J NEUROCHEM, V78, P756, DOI 10.1046/j.1471-4159.2001.00468.x; Corti C, 2002, NEUROSCIENCE, V110, P403, DOI 10.1016/S0306-4522(01)00591-7; Cryan JF, 2003, EUR J NEUROSCI, V17, P2409, DOI 10.1046/j.1460-9568.2003.02667.x; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2006, CELL TISSUE RES, V326, P339, DOI 10.1007/s00441-006-0234-0; Doleviczenyi Z, 2005, NEUROSCI LETT, V385, P93, DOI 10.1016/j.neulet.2005.05.017; Doumazane E, 2011, FASEB J, V25, P66, DOI 10.1096/fj.10-163147; Du J, 2021, NATURE, V594, P589, DOI 10.1038/s41586-021-03641-w; Enz R, 2002, J NEUROCHEM, V81, P1130, DOI 10.1046/j.1471-4159.2002.00922.x; Enz R, 2002, FEBS LETT, V514, P184, DOI 10.1016/S0014-5793(02)02361-X; Enz R, 2007, BIOESSAYS, V29, P60, DOI 10.1002/bies.20518; Enz R, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00052; Ferre S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00243; Fettiplace R, 2017, COMPR PHYSIOL, V7, P1197, DOI 10.1002/cphy.c160049; Fisher NM, 2020, GENES BRAIN BEHAV, V19, DOI 10.1111/gbb.12654; Fisher NM, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00387; Frank MM, 2018, WIRES DEV BIOL, V7, DOI 10.1002/wdev.324; Friedman RA, 2009, HUM MOL GENET, V18, P785, DOI 10.1093/hmg/ddn402; Girotto G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085352; Habrian CH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13407-8; Haider HF, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00346; Hirbec H, 2002, J BIOL CHEM, V277, P15221, DOI 10.1074/jbc.C200112200; Kinoshita A, 1998, J COMP NEUROL, V393, P332; Klotz L., 2019, FASEB J, V33, P13734, DOI DOI 10.1096/FJ.201901543R; Kofalvi A, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-0739-0; Koulen P, 2002, INVEST OPHTH VIS SCI, V43, P1933; Koulen P, 1999, P NATL ACAD SCI USA, V96, P9909, DOI 10.1073/pnas.96.17.9909; Lee J, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107605; Liberman MC, 2017, HEARING RES, V349, P138, DOI 10.1016/j.heares.2017.01.003; Liberman MC, 2016, ADV EXP MED BIOL, V875, P1, DOI 10.1007/978-1-4939-2981-8_1; Lu Y, 2014, NEUROSCIENCE, V274, P429, DOI 10.1016/j.neuroscience.2014.05.057; Masugi M, 1999, J NEUROSCI, V19, P955; Meyer AC, 2009, NAT NEUROSCI, V12, P444, DOI 10.1038/nn.2293; Moller Thor C, 2017, Biophys Rep, V3, P57, DOI 10.1007/s41048-017-0036-9; Moser T, 2020, PHYSIOL REV, V100, P103, DOI 10.1152/physrev.00026.2018; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Navarro G, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0247-4; Newman DL, 2012, HEARING RES, V294, P125, DOI 10.1016/j.heares.2012.08.016; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Nouvian R, 2015, CELL TISSUE RES, V361, P301, DOI 10.1007/s00441-015-2158-z; Pujol R, 1999, ANN NY ACAD SCI, V884, P249, DOI 10.1111/j.1749-6632.1999.tb08646.x; Quraishi S, 2007, J COMP NEUROL, V501, P931, DOI 10.1002/cne.21274; Reiner A, 2018, NEURON, V98, P1080, DOI 10.1016/j.neuron.2018.05.018; Rose M, 2008, MOL CELL NEUROSCI, V37, P808, DOI 10.1016/j.mcn.2008.01.004; Roux I, 2016, J NEUROPHYSIOL, V116, P479, DOI 10.1152/jn.01038.2015; Ruel J, 2007, HEARING RES, V227, P19, DOI 10.1016/j.heares.2006.08.017; Sansig G, 2001, J NEUROSCI, V21, P8734, DOI 10.1523/JNEUROSCI.21-22-08734.2001; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Somogyi P, 2003, EUR J NEUROSCI, V17, P2503, DOI 10.1046/j.1460-9568.2003.02697.x; Suh YH, 2013, J BIOL CHEM, V288, P17544, DOI 10.1074/jbc.M112.439513; Tamaru Y, 2001, NEUROSCIENCE, V106, P481, DOI 10.1016/S0306-4522(01)00305-0; Van Laer L, 2010, EUR J HUM GENET, V18, P685, DOI 10.1038/ejhg.2009.234; Wada E, 1998, J COMP NEUROL, V393, P493; Wan GQ, 2015, HEARING RES, V329, P1, DOI 10.1016/j.heares.2015.04.008; Yu PP, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-017-0515-3	57	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21855	10.1096/fj.202100672R	http://dx.doi.org/10.1096/fj.202100672R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34644430				2022-12-28	WOS:000712009200013
J	Liu, F; Yu, J; Zhang, YX; Li, FZ; Liu, Q; Zhou, YY; Huang, SS; Fang, HQ; Xiao, ZP; Liao, LJ; Xu, JY; Wu, XY; Wu, F				Liu, Fan; Yu, Jing; Zhang, Yan-Xia; Li, Fangzheng; Liu, Qi; Zhou, Yueyang; Huang, Shengshuo; Fang, Houqin; Xiao, Zhuping; Liao, Lujian; Xu, Jinyi; Wu, Xin-Yan; Wu, Fang			High-throughput tandem-microwell assay for ammonia repositions FDA-Approved drugs to inhibit Helicobacter pylori urease	FASEB JOURNAL			English	Article						ammonia; antibiotic resistance; Helicobacter pylori; high-throughput screening; mechanism of action; urease	RESISTANCE	To date, little attempt has been made to develop new treatments for Helicobacter pylori (H. pylori), although the community is aware of the shortage of treatments for H. pylori. In this study, we developed a 192-tandem-microwell-based high-throughput assay for ammonia that is a known virulence factor of H. pylori and a product of urease. We could identify few drugs, that is, panobinostat, dacinostat, ebselen, captan, and disulfiram, to potently inhibit the activity of ureases from bacterial or plant species. These inhibitors suppress the activity of urease via substrate-competitive or covalent-allosteric mechanism, but all except captan prevent the antibiotic-resistant H. pylori strain from killing human gastric cells, with a more pronounced effect than acetohydroxamic acid, a well-known urease inhibitor and clinically used drug for the treatment of bacterial infection. This study offers several bases for the development of new treatments for urease-containing pathogens and to study the mechanism responsible for the regulation of urease activity.	[Liu, Fan; Li, Fangzheng; Zhou, Yueyang; Wu, Fang] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Key Lab Syst Biomed, Minist Educ, Shanghai 200240, Peoples R China; [Liu, Fan; Yu, Jing; Huang, Shengshuo] Shanghai Jiao Tong Univ, Joint Int Res Lab Metab & Dev Sci, Sheng Yushou Ctr Cell Biol & Immunol, State Key Lab Microbial Metab,Sch Life Sci & Biot, Shanghai, Peoples R China; [Zhang, Yan-Xia; Wu, Xin-Yan] East China Univ Sci & Technol, Sch Chem & Mol Engn, Shanghai, Peoples R China; [Li, Fangzheng; Xu, Jinyi] China Pharmaceut Univ, Dept Med Chem, State Key Lab Nat Med, Nanjing, Peoples R China; [Liu, Qi; Xiao, Zhuping] Jishou Univ, Hunan Engn Lab Anal & Drugs Dev Ethnomed Wuling M, Jishou, Hunan, Peoples R China; [Fang, Houqin; Liao, Lujian] East China Normal Univ, Sch Life Sci, Shanghai Key Lab Regulatory Biol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; East China University of Science & Technology; China Pharmaceutical University; Jishou University; East China Normal University	Wu, F (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Key Lab Syst Biomed, Minist Educ, Shanghai 200240, Peoples R China.	fang.wu@sjtu.edu.cn	; Wu, Fang/B-1945-2008	, jingyu/0000-0002-6646-9341; Wu, Fang/0000-0002-4194-2243	National Natural Science Foundation of China [31870763, 21834005]; Shanghai Foundation for the Development of Science and Technology [19JC1413000]; Research Fund of Medicine and Engineering of Shanghai Jiao Tong University [YG2019QNB27, YG2021QN144]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Foundation for the Development of Science and Technology; Research Fund of Medicine and Engineering of Shanghai Jiao Tong University	National Natural Science Foundation of China, Grant/Award Number: 31870763 and 21834005; Shanghai Foundation for the Development of Science and Technology, Grant/Award Number: 19JC1413000; Research Fund of Medicine and Engineering of Shanghai Jiao Tong University, Grant/Award Number: YG2019QNB27 and YG2021QN144	Armbruster CE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006434; BLOOMSTER TG, 1981, J CLIN MICROBIOL, V13, P598, DOI 10.1128/JCM.13.3.598-600.1981; Chari A, 2017, BLOOD ADV, V1, P1575, DOI 10.1182/bloodadvances.2017007427; Croppi G, 2020, CELL CHEM BIOL, V27, P1483, DOI 10.1016/j.chembiol.2020.10.012; Cunha ES, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20485-6; Debowski AW, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006464; Debraekeleer A, 2018, FUTURE MICROBIOL, V13, P671, DOI 10.2217/fmb-2017-0115; DUNN BE, 1990, J BIOL CHEM, V265, P9464; Palacios-Espinosa JF, 2014, J ETHNOPHARMACOL, V151, P990, DOI 10.1016/j.jep.2013.12.012; Diaz-Sanchez AG, 2016, MOLECULES, V21, DOI 10.3390/molecules21121628; GOLDIE J, 1991, J CLIN PATHOL, V44, P695, DOI 10.1136/jcp.44.8.695; Graham DY, 2008, NAT CLIN PRACT GASTR, V5, P321, DOI 10.1038/ncpgasthep1138; Ha NC, 2001, NAT STRUCT BIOL, V8, P505, DOI 10.1038/88563; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Irwin JJ, 2016, J MED CHEM, V59, P4103, DOI 10.1021/acs.jmedchem.5b02008; Krippendorff B, 2009, J BIOMOL SCREEN, V14, P913, DOI 10.1177/1087057109336751; Lieberman OJ, 2014, ACS CHEM BIOL, V9, P183, DOI 10.1021/cb400485k; Lucchetti N, 2016, ANGEW CHEM INT EDIT, V55, P13335, DOI 10.1002/anie.201606599; Luo CH, 2021, FREE RADICAL BIO MED, V164, P20, DOI 10.1016/j.freeradbiomed.2020.12.440; Macegoniuk K, 2016, J MED CHEM, V59, P8125, DOI 10.1021/acs.jmedchem.6b00986; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Malfertheiner P, 2017, GUT, V66, P6, DOI 10.1136/gutjnl-2016-312288; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Maroney MJ, 2014, CHEM REV, V114, P4206, DOI 10.1021/cr4004488; MARSHALL BJ, 1990, GASTROENTEROLOGY, V99, P697, DOI 10.1016/0016-5085(90)90957-3; Mazzei L, 2019, ANGEW CHEM INT EDIT, V58, P7415, DOI 10.1002/anie.201903565; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Mora D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004472; NARANG U, 1994, CHEM MATER, V6, P1596, DOI 10.1021/cm00046a004; Ngo HX, 2016, BIOORGAN MED CHEM, V24, P6298, DOI 10.1016/j.bmc.2016.03.060; NGO TT, 1982, ANAL CHEM, V54, P46, DOI 10.1021/ac00238a015; Norsworthy AN, 2017, TRENDS MICROBIOL, V25, P304, DOI 10.1016/j.tim.2016.11.015; Nussinov R, 2015, ANNU REV PHARMACOL, V55, P249, DOI 10.1146/annurev-pharmtox-010814-124401; Pacula AJ, 2018, ARKIVOC, P153, DOI 10.24820/ark.5550190.p010.311; Pierce WC., 1958, QUANTITATIVE ANAL; Sanders L, 2013, MICROBIOL-SGM, V159, P46, DOI 10.1099/mic.0.062877-0; Schweinitzer T, 2008, J BACTERIOL, V190, P3244, DOI 10.1128/JB.01940-07; Singh N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2320; Skrott Z, 2017, NATURE, V552, P194, DOI 10.1038/nature25016; Tarsia C, 2018, BBA-GEN SUBJECTS, V1862, P2245, DOI 10.1016/j.bbagen.2018.07.020; Wei W, 2017, J PROTEOME RES, V16, P1743, DOI 10.1021/acs.jproteome.7b00012; Xiao ZP, 2013, EUR J MED CHEM, V68, P212, DOI 10.1016/j.ejmech.2013.07.047; Yang XM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003887; Yu XD, 2015, J ETHNOPHARMACOL, V162, P69, DOI 10.1016/j.jep.2014.12.041; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Q, 2013, ANAL BIOCHEM, V441, P51, DOI 10.1016/j.ab.2013.06.003; Zhou YY, 2013, CHEM COMMUN, V49, P11782, DOI 10.1039/c3cc46719h	47	0	0	3	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21967	10.1096/fj.202100465RR	http://dx.doi.org/10.1096/fj.202100465RR			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34613630				2022-12-28	WOS:000712009200060
J	Panebianco, CJ; Dave, A; Charytonowicz, D; Sebra, R; Iatridis, JC				Panebianco, Christopher J.; Dave, Arpit; Charytonowicz, Daniel; Sebra, Robert; Iatridis, James C.			Single-cell RNA-sequencing atlas of bovine caudal intervertebral discs: Discovery of heterogeneous cell populations with distinct roles in homeostasis	FASEB JOURNAL			English	Article						annulus fibrosus; bovine; intervertebral disc; nucleus pulposus; single-cell RNA-sequencing analysis; tissue-specific progenitor cells	NOTOCHORDAL NUCLEUS PULPOSUS; AGE-RELATED-CHANGES; LOW-BACK-PAIN; EXTRACELLULAR-MATRIX; ANNULUS FIBROSUS; SMOOTH-MUSCLE; CATHEPSIN-K; EXPRESSION; PROTEINS; CARTILAGE	Back and neck pain are significant healthcare burdens that are commonly associated with pathologies of the intervertebral disc (IVD). The poor understanding of the cellular heterogeneity within the IVD makes it difficult to develop regenerative IVD therapies. To address this gap, we developed an atlas of bovine (Bos taurus) caudal IVDs using single-cell RNA-sequencing (scRNA-seq). Unsupervised clustering resolved 15 unique clusters, which we grouped into the following annotated partitions: nucleus pulposus (NP), outer annulus fibrosus (oAF), inner AF (iAF), notochord, muscle, endothelial, and immune cells. Analyzing the pooled gene expression profiles of the NP, oAF, and iAF partitions allowed us to identify novel markers for NP (CP, S100B, H2AC18, SNORC, CRELD2, PDIA4, DNAJC3, CHCHD7, and RCN2), oAF (IGFBP6, CTSK, LGALS1, and CCN3), and iAF (MGP, COMP, SPP1, GSN, SOD2, DCN, FN1, TIMP3, WDR73, and GAL) cells. Network analysis on subpopulations of NP and oAF cells determined that clusters NP1, NP2, NP4, and oAF1 displayed gene expression profiles consistent with cell survival, suggesting these clusters may uniquely support viability under the physiological stresses of the IVD. Clusters NP3, NP5, oAF2, and oAF3 expressed various extracellular matrix (ECM)-associated genes, suggesting their role in maintaining IVD structure. Lastly, transcriptional entropy and pseudotime analyses found that clusters NP3 and NP1 had the most stem-like gene expression signatures of the NP partition, implying these clusters may contain IVD progenitor cells. Overall, results highlight cell type diversity within the IVD, and these novel cell phenotypes may enhance our understanding of IVD development, homeostasis, degeneration, and regeneration.	[Panebianco, Christopher J.; Iatridis, James C.] Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, One Gustave L Levy Pl,Box 1188, New York, NY 10029 USA; [Dave, Arpit; Charytonowicz, Daniel; Sebra, Robert] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, 1425 Madison Ave Icahn East Bldg,Floor 14, New York, NY 10029 USA; [Sebra, Robert] Icahn Sch Med Mt Sinai, Icahn Inst Data Sci & Genom Technol, New York, NY 10029 USA; [Sebra, Robert] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Sebra, Robert] Sema4, Mt Sinai Venture, Stamford, CT USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Iatridis, JC (corresponding author), Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, One Gustave L Levy Pl,Box 1188, New York, NY 10029 USA.; Sebra, R (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, 1425 Madison Ave Icahn East Bldg,Floor 14, New York, NY 10029 USA.	robert.sebra@mssm.edu; james.iatridis@mssm.edu		Panebianco, Christopher/0000-0001-8683-5743; Dave, Arpit/0000-0002-1937-7882; Iatridis, James/0000-0002-2186-0590	National Institute of Arthritis and Musculoskeletal and Skin Diseases [NIH R01 AR057397, NIH F31 AR077385]	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	National Institute of Arthritis and Musculoskeletal and Skin Diseases, Grant/Award Number: NIH R01 AR057397 and NIH F31 AR077385	Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Andueza A, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108491; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Ariga K, 2001, SPINE, V26, P2666, DOI 10.1097/00007632-200112150-00007; Bach LA, 2016, GROWTH HORM IGF RES, V30-31, P81, DOI 10.1016/j.ghir.2016.09.004; Bedore J, 2014, MATRIX BIOL, V37, P124, DOI 10.1016/j.matbio.2014.05.005; Bezci SE, 2019, JOR SPINE, V2, DOI 10.1002/jsp2.1065; Bott AJ, 2019, CANCERS, V11, DOI 10.3390/cancers11060770; Brun J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145153; Calio M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094917; Chang HZ, 2017, BIOMED PHARMACOTHER, V89, P529, DOI 10.1016/j.biopha.2017.02.074; Chen J, 2006, EUR SPINE J, V15, pS303, DOI 10.1007/s00586-006-0088-x; Colin E, 2014, AM J HUM GENET, V95, P637, DOI 10.1016/j.ajhg.2014.10.011; Corallo D, 2015, CELL MOL LIFE SCI, V72, P2989, DOI 10.1007/s00018-015-1897-z; Coronel MF, 2017, PEPTIDES, V88, P189, DOI 10.1016/j.peptides.2017.01.001; Demers CN, 2004, SPINE, V29, P2793, DOI 10.1097/01.brs.0000147744.74215.b0; Diaz-Romero J, 2017, J CELL PHYSIOL, V232, P1979, DOI 10.1002/jcp.25720; Dieleman JL, 2020, JAMA-J AM MED ASSOC, V323, P863, DOI 10.1001/jama.2020.0734; Do Carmo S, 2007, BBA-MOL CELL RES, V1773, P954, DOI 10.1016/j.bbamcr.2007.03.007; EYRE DR, 1976, BIOCHEM J, V157, P267, DOI 10.1042/bj1570267; Fang PH, 2020, FRONT NEUROENDOCRIN, V56, DOI 10.1016/j.yfrne.2019.100801; Feldt J, 2019, EXPERT REV MOL MED, V20, DOI 10.1017/erm.2018.7; Fernandes LM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72261-7; Fujii T, 2018, J ORTHOP RES, V36, P1334, DOI 10.1002/jor.23787; Galli LM, 2006, DEV DYNAM, V235, P681, DOI 10.1002/dvdy.20681; Glowacka WK, 2012, J BIOL CHEM, V287, P27691, DOI 10.1074/jbc.M112.355917; Goncharov NV, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9759735; Gopalakrishnan R, 2005, CELLS TISSUES ORGANS, V181, P166, DOI 10.1159/000091378; Gotz W, 1997, CELL TISSUE RES, V289, P185, DOI 10.1007/s004410050864; Gurdziel K, 2016, DEV DYNAM, V245, P614, DOI [10.1002/DVDY.24399, 10.1002/dvdy.24399]; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; Hadjiargyrou M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010206; Hartvigsen J, 2018, LANCET, V391, P2356, DOI 10.1016/S0140-6736(18)30480-X; Hayes AJ, 2011, EUR CELLS MATER, V22, P226, DOI 10.22203/eCM.v022a18; He JL, 2006, METHOD ENZYMOL, V417, P247, DOI 10.1016/S0076-6879(06)17017-2; Heinonen J, 2011, OSTEOARTHR CARTILAGE, V19, P1026, DOI 10.1016/j.joca.2011.04.016; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Herring BP, 2006, AM J PHYSIOL-CELL PH, V291, pC817, DOI 10.1152/ajpcell.00198.2006; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Ishii Y, 2006, SPINE, V31, P1539, DOI 10.1097/01.brs.0000221994.61882.4a; Jha R, 2017, STEM CELL REP, V9, P513, DOI 10.1016/j.stemcr.2017.07.006; Jing LF, 2012, J ORTHOP RES, V30, P1923, DOI 10.1002/jor.22158; Joo A, 2016, BONE, V88, P170, DOI 10.1016/j.bone.2016.04.023; Kahane N, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.183996; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Katsube K, 2009, DEV GROWTH DIFFER, V51, P55, DOI 10.1111/j.1440-169X.2009.01077.x; Korpetinou A, 2014, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00327; KUHN K, 1995, MATRIX BIOL, V14, P439, DOI 10.1016/0945-053X(95)90001-2; Lee CR, 2007, EUR SPINE J, V16, P2174, DOI 10.1007/s00586-007-0475-y; Li H, 2019, BONE JOINT RES, V8, P290, DOI 10.1302/2046-3758.87.BJR-2018-0297.R1; Li KN, 2019, J ANAT, V234, P16, DOI 10.1111/joa.12904; Ling F, 2014, CURR TOP DEV BIOL, V110, P189, DOI 10.1016/B978-0-12-405943-6.00005-1; Ling XB, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091483; Ludvigsen M, 2009, PROTEOMICS, V9, P5267, DOI 10.1002/pmic.200900321; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Masuda Koichi, 2004, Spine J, V4, p330S, DOI 10.1016/j.spinee.2004.07.028; Mayanagi T, 2011, CELL ADHES MIGR, V5, P150, DOI 10.4161/cam.5.2.14398; McCann MR, 2012, DIS MODEL MECH, V5, P73, DOI 10.1242/dmm.008128; Melrose J, 2007, EUR SPINE J, V16, P2193, DOI 10.1007/s00586-007-0497-5; Minogue BM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2929; Molino M, 2000, BBA-MOL BASIS DIS, V1500, P227, DOI 10.1016/S0925-4439(99)00110-6; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ohtori S, 2015, SPINE J, V15, P1347, DOI 10.1016/j.spinee.2013.07.490; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Panebianco CJ, 2020, EUR CELLS MATER, V40, P239, DOI 10.22203/eCM.v040a15; Pattappa G, 2012, J ANAT, V221, P480, DOI 10.1111/j.1469-7580.2012.01521.x; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Pulugulla SH, 2018, CYTOKINE, V111, P373, DOI 10.1016/j.cyto.2018.10.001; Rai MF, 2021, CURR OSTEOPOROS REP, V19, P131, DOI 10.1007/s11914-021-00662-2; Rajpurohit R, 2002, CELL TISSUE RES, V308, P401, DOI 10.1007/s00441-002-0563-6; Risbud MV, 2015, J ORTHOP RES, V33, P283, DOI 10.1002/jor.22789; Risbud MV, 2010, DEV DYNAM, V239, P2141, DOI 10.1002/dvdy.22350; Sakai D, 2009, SPINE, V34, P1448, DOI 10.1097/BRS.0b013e3181a55705; Salminen-Mankonen HJ, 2007, CURR DRUG TARGETS, V8, P315, DOI 10.2174/138945007779940188; Salvador JM, 2013, ADV EXP MED BIOL, V793, P1, DOI 10.1007/978-1-4614-8289-5_1; Seguin CA, 2018, JOR SPINE, V1, DOI 10.1002/jsp2.1030; Shapiro IM., 2014, INTERVERTEBRAL DISC, DOI [10.1007/978-3-7091-1535-0, DOI 10.1007/978-3-7091-1535-0_9]; Singh K, 2009, SPINE, V34, P10, DOI 10.1097/BRS.0b013e31818e5ddd; Smith LJ, 2018, JOR SPINE, V1, DOI 10.1002/jsp2.1036; Stahl PL, 2016, SCIENCE, V353, P78, DOI 10.1126/science.aaf2403; Sterling H, 1998, J CELL BIOL, V143, P837, DOI 10.1083/jcb.143.3.837; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sun F, 2017, GENET TEST MOL BIOMA, V21, P580, DOI 10.1089/gtmb.2017.0007; Takao T, 2000, HISTOCHEM J, V32, P545, DOI 10.1023/A:1004150211097; Tam V, 2020, ELIFE, V9, DOI 10.7554/eLife.64940; Teschendorff AE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15599; Thomas PA, 2018, ADV EXP MED BIOL, V1106, P85, DOI 10.1007/978-3-030-00737-9_6; Torre OM, 2019, ANN NY ACAD SCI, V1442, P61, DOI 10.1111/nyas.13964; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Tsuji T, 2007, SPINE, V32, P849, DOI 10.1097/01.brs.0000259804.39881.62; Turanov AA, 2011, ADV NUTR, V2, P122, DOI 10.3945/an.110.000265; van den Akker GGH, 2017, EUR SPINE J, V26, P2053, DOI 10.1007/s00586-017-5150-3; van den Akker GGH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144497; van den Akker GGH, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4597; Wang J, 2021, OSTEOARTHR CARTILAGE, V29, P389, DOI 10.1016/j.joca.2020.12.005; Wang J, 2017, GENE, V618, P14, DOI 10.1016/j.gene.2017.03.005; Wang L, 2018, CANCER MANAG RES, V10, P6409, DOI 10.2147/CMAR.S183293; Wang RZ, 2020, FASEB J, V34, P3554, DOI 10.1096/fj.201902096R; Wang Y, 2019, GENET TEST MOL BIOMA, V23, P610, DOI 10.1089/gtmb.2019.0043; Wang ZY, 2020, BIOMED PHARMACOTHER, V122, DOI 10.1016/j.biopha.2019.109688; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wilson R, 2016, J PROTEOME RES, V15, P1033, DOI 10.1021/acs.jproteome.5b01115; Yammani RR, 2012, BBA-MOL BASIS DIS, V1822, P600, DOI 10.1016/j.bbadis.2012.01.006; Yang F, 2009, J PATHOL, V218, P113, DOI 10.1002/path.2519; Yi WW, 2020, J CELL PHYSIOL, V235, P8402, DOI 10.1002/jcp.29684; Yokoyama K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073210; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu SS, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0585-8; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zhou TY, 2019, EUR REV MED PHARMACO, V23, P9180, DOI 10.26355/eurrev_201911_19408; Zhu SP, 2021, J CELL PHYSIOL, V236, P41, DOI 10.1002/jcp.29893; Zhu SP, 2019, CELL MOL LIFE SCI, V76, P4493, DOI 10.1007/s00018-019-03225-y	115	6	6	8	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21919	10.1096/fj.202101149R	http://dx.doi.org/10.1096/fj.202101149R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34591994	Green Accepted			2022-12-28	WOS:000712009200035
J	Yokoo, K; Yamamoto, Y; Suzuki, T				Yokoo, Kana; Yamamoto, Yoshinari; Suzuki, Takuya			Ammonia impairs tight junction barriers by inducing mitochondrial dysfunction in Caco-2 cells	FASEB JOURNAL			English	Article						ammonia; intestine; mitochondria; oxidative stress; tight junction	INTESTINAL BARRIER; MUCOSAL BARRIER; GUT MICROBIOTA; METABOLISM; OCCLUDIN; PHOSPHORYLATION; PERMEABILITY; INFLAMMATION; DISRUPTION; DISEASE	Ammonia is one of the major metabolites produced by intestinal microorganisms; however, its role in intestinal homeostasis is poorly understood. The present study investigated the regulation of intestinal tight junction (TJ) proteins by ammonia and the underlying mechanisms in human intestinal Caco-2 cells. Ammonia (15, 30, and 60 mM) increased the permeability of the cells in a dose-dependent manner, as indicated by reduced transepithelial electrical resistance and increased dextran flux. Immunoblot and immunofluorescence analyses revealed that the ammonia-induced increase in TJ permeability reduced the membrane localization of TJ proteins such as zonula occludens (ZO)1, ZO2, occludin, claudin-1, and claudin-3. DNA microarray analysis identified a biological pathway "response to reactive oxygen species" enriched by ammonia treatment, indicating the induction of oxidative stress in the cells. Ammonia treatment also increased the malondialdehyde content and decreased the ratio of reduced to oxidized glutathione. Meanwhile, ammonia treatment-induced mitochondrial dysfunction, as indicated by the downregulation of genes associated with the electron transport chain, reduction of the cellular ATP, NADH, and tricarboxylic acid cycle intermediate content, and suppression of the mitochondrial membrane potential. In contrast, N-acetyl cysteine reversed the ammonia-induced impairment of TJ permeability and structure without affecting the mitochondrial parameters. Collectively, ammonia impaired the TJ barrier by increasing oxidative stress in Caco-2 cells. A mitochondrial dysfunction is possibly an event preceding ammonia-induced oxidative stress. The findings of this study could potentially improve our understanding of the interplay between intestinal microorganisms and their hosts.	[Yokoo, Kana; Yamamoto, Yoshinari; Suzuki, Takuya] Hiroshima Univ, Grad Sch Integrated Sci Life, 1-4-4 Kagamiyama, Higashihiroshima 7398528, Japan; [Suzuki, Takuya] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Japan	Hiroshima University; Hiroshima University	Suzuki, T (corresponding author), Hiroshima Univ, Grad Sch Integrated Sci Life, 1-4-4 Kagamiyama, Higashihiroshima 7398528, Japan.	takuya@hiroshima-u.ac.jp			JSPS Kakenhi [19H04052]	JSPS Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	JSPS Kakenhi, Grant/Award Number: 19H04052	Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Bolisetty S, 2013, INT J MOL SCI, V14, P6306, DOI 10.3390/ijms14036306; Choi WS, 2017, EXP CELL RES, V358, P71, DOI 10.1016/j.yexcr.2017.03.036; Cremin JD, 2003, AM J PHYSIOL-GASTR L, V285, pG105, DOI 10.1152/ajpgi.00437.2002; Davila AM, 2013, PHARMACOL RES, V68, P95, DOI 10.1016/j.phrs.2012.11.005; France MM, 2017, J CELL SCI, V130, P307, DOI 10.1242/jcs.193482; Gilda JE, 2013, ANAL BIOCHEM, V440, P186, DOI 10.1016/j.ab.2013.05.027; Han J, 2013, ELECTROPHORESIS, V34, P2891, DOI 10.1002/elps.201200601; Heidari R, 2019, LIFE SCI, V218, P65, DOI 10.1016/j.lfs.2018.12.030; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hughes R, 2008, NUTR CANCER, V60, P259, DOI 10.1080/01635580701649644; JanssenDuijghwjseni LM, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00794; Jing HY, 2020, SCI TOTAL ENVIRON, V726, DOI 10.1016/j.scitotenv.2020.138686; Kurose Y, 2019, BENEF MICROBES, V10, P89, DOI 10.3920/BM2018.0062; Llewellyn SR, 2018, GASTROENTEROLOGY, V154, P1037, DOI 10.1053/j.gastro.2017.11.030; MAGNUSSON M, 1991, GUT, V32, P754, DOI 10.1136/gut.32.7.754; Mayangsari Y, 2018, J AGR FOOD CHEM, V66, P12666, DOI 10.1021/acs.jafc.8b04138; McIntyre CW, 2011, CLIN J AM SOC NEPHRO, V6, P133, DOI 10.2215/CJN.04610510; Miyoshi Y, 2016, AM J PHYSIOL-GASTR L, V311, pG105, DOI 10.1152/ajpgi.00405.2015; Mouille B, 2004, AM J PHYSIOL-GASTR L, V287, pG344, DOI 10.1152/ajpgi.00445.2003; Noda S, 2013, MOL NUTR FOOD RES, V57, P2019, DOI 10.1002/mnfr.201300045; Ogata M, 2017, BRIT J NUTR, V118, P661, DOI 10.1017/S0007114517002586; Qi QQ, 2016, J DIGEST DIS, V17, P448, DOI 10.1111/1751-2980.12374; Rai R, 2015, J CLIN EXP HEPATOL, V5, pS29, DOI 10.1016/j.jceh.2014.12.003; Raleigh DR, 2011, J CELL BIOL, V193, P565, DOI 10.1083/jcb.201010065; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; Samak G, 2010, AM J PHYSIOL-GASTR L, V299, pG572, DOI 10.1152/ajpgi.00265.2010; Souza ACP, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12558; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Suzuki T, 2009, P NATL ACAD SCI USA, V106, P61, DOI 10.1073/pnas.0802741106; Hung TV, 2019, J FUNCT FOODS, V52, P276, DOI 10.1016/j.jff.2018.11.005; Van Hung T, 2018, J NUTR, V148, P552, DOI 10.1093/jn/nxy008; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ungewiss H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06713-y; Wang SC, 2019, SCI TOTAL ENVIRON, V696, DOI 10.1016/j.scitotenv.2019.134035; WILSON DR, 1968, CLIN SCI, V34, P211; Wong J, 2014, AM J NEPHROL, V39, P230, DOI 10.1159/000360010; Zoccali C, 2017, NAT REV NEPHROL, V13, DOI 10.1038/nrneph.2017.52	38	4	4	3	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21854	10.1096/fj.202100758R	http://dx.doi.org/10.1096/fj.202100758R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34597422				2022-12-28	WOS:000712009200016
J	Ormsby, TJR; Owens, SE; Horlock, AD; Davies, D; Griffiths, WJ; Wang, YQ; Cronin, JG; Bromfield, JJ; Sheldon, IM				Ormsby, Thomas J. R.; Owens, Sian E.; Horlock, Anthony D.; Davies, Daphne; Griffiths, William J.; Wang, Yuqin; Cronin, James G.; Bromfield, John J.; Sheldon, Iain M.			Oxysterols protect bovine endometrial cells against pore-forming toxins from pathogenic bacteria	FASEB JOURNAL			English	Article						cattle; cholesterol; cytoprotection; liver X receptor; uterus	LIVER-X-RECEPTOR; CHOLESTEROL-METABOLISM; ALPHA-HEMOLYSIN; IN-VITRO; ACTIVATION; 25-HYDROXYCHOLESTEROL; STEROL; 27-HYDROXYCHOLESTEROL; INFLAMMATION; MEMBRANES	Many species of pathogenic bacteria secrete toxins that form pores in mammalian cell membranes. These membrane pores enable the delivery of virulence factors into cells. result in the leakage of molecules that bacteria can use as nutrients, and facilitate pathogen invasion. Inflammatory responses to bacteria are regulated by the side-chain-hydroxycholesterols 27-hydroxycholesterol and 25-hydroxycholesterol, but their effect on the intrinsic protection of cells against pore-forming toxins is unclear. Here, we tested the hypothesis that 27-hydroxycholesterol and 25-hydroxycholesterol help protect cells against pore-forming toxins. We treated bovine endometrial epithelial and stromal cells with 27-hydroxycholesterol or 25-hydroxycholesterol, and then challenged the cells with pyolysin, which is a cholesterol-dependent cytolysin from Trueperella pyogenes that targets these endometrial cells. We found that treatment with 27-hydroxycholesterol or 25-hydroxycholesterol protected both epithelial and stomal cells against pore formation and the damage caused by pyolysin. The oxysterols limited pyolysin-induced leakage of potassium and lactate dehydrogenase from cells, and reduced cytoskeletal changes and cytolysis. This oxysterol cytoprotection against pyolysin was partially dependent on reducing cytolysin-accessible cholesterol in the cell membrane and on activating liver X receptors. Treatment with 27-hydroxycholesterol also protected the endometrial cells against Staphylococcus aureus alpha-hemolysin. Using mass spectrometry, we found 27-hydroxycholesterol and 25-hydroxycholesterol in uterine and follicular fluid. Furthermore, epithelial cells released additional 25-hydroxycholesterol in response to pyolysin. In conclusion, both 27-hydroxycholesterol and 25-hydroxycholesterol increased the intrinsic protection of bovine endometrial cells against pore-forming toxins. Our findings imply that side-chain-hydroxycholesterols may help defend the endometrium against pathogenic bacteria.	[Ormsby, Thomas J. R.; Owens, Sian E.; Horlock, Anthony D.; Davies, Daphne; Griffiths, William J.; Wang, Yuqin; Cronin, James G.; Sheldon, Iain M.] Swansea Univ, Med Sch, Swansea SA2 8PP, W Glam, Wales; [Bromfield, John J.] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA	Swansea University; State University System of Florida; University of Florida	Sheldon, IM (corresponding author), Swansea Univ, Med Sch, Swansea SA2 8PP, W Glam, Wales.	i.m.sheldon@swansea.ac.uk	Sheldon, I Martin/E-1567-2013; griffiths, william/N-4641-2016; Bromfield, John/A-8830-2014	Sheldon, I Martin/0000-0001-7902-5558; Horlock, Anthony/0000-0001-9580-552X; wang, yuqin/0000-0002-3063-3066; Ormsby, Thomas/0000-0003-4371-5316; Cronin, James/0000-0002-0590-9462; griffiths, william/0000-0002-4129-6616; Owens, Sian-Eleri/0000-0003-1806-5235; Bromfield, John/0000-0001-5438-2137	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [R01HD084316]; Biotechnology and Biological Sciences Research Council [BB/I001735/1, BB/L001942/1]; European Union via European Structural Funds as part of the Welsh Government [HE09161003]	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union via European Structural Funds as part of the Welsh Government	We thank E Yutuc for advice, and H Jost for supplying the pyolysin plasmid and anti-pyolysin antibody. This study was supported by Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number R01HD084316. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Instrumentation for oxysterol analysis was funded by Biotechnology and Biological Sciences Research Council grants BB/I001735/1 and BB/L001942/1, and the European Union via European Structural Funds as part of the Welsh Government funded Academic Expertise for Business project HE09161003.	Abdel-Khalik J, 2017, J LIPID RES, V58, P267, DOI 10.1194/jlr.P071639; Abrams ME, 2020, NAT MICROBIOL, V5, P929, DOI 10.1038/s41564-020-0701-5; Amos MR, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115972; Andrews NW, 2018, CURR BIOL, V28, pR392, DOI 10.1016/j.cub.2017.12.034; Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Mestre MB, 2010, AUTOPHAGY, V6, P110, DOI 10.4161/auto.6.1.10698; Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; Bielska AA, 2014, BIOCHEMISTRY-US, V53, P3042, DOI 10.1021/bi5000096; Billington SJ, 1997, J BACTERIOL, V179, P6100, DOI 10.1128/jb.179.19.6100-6106.1997; BONNETT BN, 1991, CAN J VET RES, V55, P168; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Crick PJ, 2015, CLIN CHEM, V61, P400, DOI 10.1373/clinchem.2014.231332; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; Das A, 2014, ELIFE, V3, DOI 10.7554/eLife.02882; Das A, 2013, P NATL ACAD SCI USA, V110, P10580, DOI 10.1073/pnas.1309273110; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Du XM, 2004, J BIOL CHEM, V279, P47010, DOI 10.1074/jbc.M408690200; DuSell CD, 2008, MOL ENDOCRINOL, V22, P65, DOI 10.1210/me.2007-0383; DZELETOVIC S, 1995, ANAL BIOCHEM, V225, P73, DOI 10.1006/abio.1995.1110; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Galvao KN, 2010, J DAIRY SCI, V93, P2926, DOI 10.3168/jds.2009-2551; Gonzalez MR, 2011, CELL MICROBIOL, V13, P1026, DOI 10.1111/j.1462-5822.2011.01600.x; Griffin S, 2018, BIOL REPROD, V99, P749, DOI 10.1093/biolre/ioy099; Griffin S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17138-y; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Ito A, 2015, ELIFE, V4, DOI 10.7554/eLife.08009; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Larpin Y, 2020, FASEB J, V34, P1665, DOI 10.1096/fj.201901737RR; Mackrill JJ, 2011, CHEM PHYS LIPIDS, V164, P488, DOI 10.1016/j.chemphyslip.2011.04.001; Maxfield FR, 2012, METHOD CELL BIOL, V108, P367, DOI 10.1016/B978-0-12-386487-1.00017-1; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mouzat K, 2013, MOL CELL ENDOCRINOL, V368, P47, DOI 10.1016/j.mce.2012.06.009; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Pospiech M, 2021, FASEB J, V35, DOI 10.1096/fj.202100164R; Preta G, 2016, BBA-BIOMEMBRANES, V1858, P2070, DOI 10.1016/j.bbamem.2016.05.016; Preta G, 2015, FASEB J, V29, P1516, DOI 10.1096/fj.14-265207; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Ribeiro ES, 2016, J DAIRY SCI, V99, P2201, DOI 10.3168/jds.2015-10337; ROSS AC, 1984, J BIOL CHEM, V259, P815; Sato H, 2004, BIOSCI BIOTECH BIOCH, V68, P1790, DOI 10.1271/bbb.68.1790; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Sheldon IM, 2019, ANNU REV ANIM BIOSCI, V7, P361, DOI 10.1146/annurev-animal-020518-115227; Sheldon IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009192; Sheldon IM, 2002, REPRODUCTION, V123, P837, DOI 10.1530/rep.0.1230837; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Spann NJ, 2013, NAT IMMUNOL, V14, P893, DOI 10.1038/ni.2681; Statt S, 2015, AM J RESP CELL MOL, V53, P689, DOI 10.1165/rcmb.2014-0391OC; Thomas MG, 2015, TOXICOL IN VITRO, V30, P300, DOI 10.1016/j.tiv.2015.10.007; Turner ML, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0219275; Turner ML, 2014, ENDOCRINOLOGY, V155, P1453, DOI 10.1210/en.2013-1822; Wang B, 2018, NAT REV ENDOCRINOL, V14, P452, DOI 10.1038/s41574-018-0037-x; Wira CR, 2015, NAT REV IMMUNOL, V15, P217, DOI 10.1038/nri3819; Zhou QD, 2020, NAT IMMUNOL, V21, P746, DOI 10.1038/s41590-020-0695-4	59	3	3	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21889	10.1096/fj.202100036R	http://dx.doi.org/10.1096/fj.202100036R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34569656	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000702238200023
J	Maung, MT; Carlson, A; Olea-Flores, M; Elkhadragy, L; Schachtschneider, KM; Navarro-Tito, N; Padilla-Benavides, T				Maung, May T.; Carlson, Alyssa; Olea-Flores, Monserrat; Elkhadragy, Lobna; Schachtschneider, Kyle M.; Navarro-Tito, Napoleon; Padilla-Benavides, Teresita			The molecular and cellular basis of copper dysregulation and its relationship with human pathologies	FASEB JOURNAL			English	Review						cancer; copper; copper-dependent diseases; cuproproteins; Menkes disease; mitochondrial myopathies; Wilson disease	CYTOCHROME-C-OXIDASE; AMYOTROPHIC-LATERAL-SCLEROSIS; MITOCHONDRIAL PHOSPHATE-CARRIER; RESPONSIVE TRANSCRIPTION FACTOR; AMYLOID PRECURSOR PROTEIN; ENDOGENOUS-RETROVIRUS-K; SPINAL MUSCULAR-ATROPHY; INDIAN CHILDHOOD CIRRHOSIS; ANTICANCER DRUG CISPLATIN; WILSONS-DISEASE PROTEIN	Copper (Cu) is an essential micronutrient required for the activity of redox-active enzymes involved in critical metabolic reactions, signaling pathways, and biological functions. Transporters and chaperones control Cu ion levels and bioavailability to ensure proper subcellular and systemic Cu distribution. Intensive research has focused on understanding how mammalian cells maintain Cu homeostasis, and how molecular signals coordinate Cu acquisition and storage within organs. In humans, mutations of genes that regulate Cu homeostasis or facilitate interactions with Cu ions lead to numerous pathologic conditions. Malfunctions of the Cu+-transporting ATPases ATP7A and ATP7B cause Menkes disease and Wilson disease, respectively. Additionally, defects in the mitochondrial and cellular distributions and homeostasis of Cu lead to severe neurodegenerative conditions, mitochondrial myopathies, and metabolic diseases. Cu has a dual nature in carcinogenesis as a promotor of tumor growth and an inducer of redox stress in cancer cells. Cu also plays role in cancer treatment as a component of drugs and a regulator of drug sensitivity and uptake. In this review, we provide an overview of the current knowledge of Cu metabolism and transport and its relation to various human pathologies.	[Maung, May T.; Carlson, Alyssa; Olea-Flores, Monserrat; Padilla-Benavides, Teresita] Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06457 USA; [Olea-Flores, Monserrat; Navarro-Tito, Napoleon] Univ Autonoma Guerrero, Fac Ciencias Quim Biol, Guerrero, Mexico; [Elkhadragy, Lobna; Schachtschneider, Kyle M.] Univ Illinois, Dept Radiol, Chicago, IL USA; [Schachtschneider, Kyle M.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA; [Schachtschneider, Kyle M.] Univ Illinois, Natl Ctr Supercomp Applicat, Urbana, IL USA; [Olea-Flores, Monserrat] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA	Wesleyan University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Urbana-Champaign; University of Massachusetts System; University of Massachusetts Worcester	Padilla-Benavides, T (corresponding author), Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06457 USA.		Padilla-Benavides, Teresita/K-1968-2012	Padilla-Benavides, Teresita/0000-0002-4624-0822; OLEA FLORES, MONSERRAT/0000-0003-1813-9062; Schachtschneider, Kyle/0000-0002-7293-8642; Carlson, Alyssa/0000-0002-4347-0278; Navarro Tito, Napoleon/0000-0003-4911-0545; Elkhadragy, Lobna/0000-0001-8956-298X	Wesleyan University	Wesleyan University	Wesleyan University	Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Abriata LA, 2008, NAT CHEM BIOL, V4, P599, DOI 10.1038/nchembio.110; Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Anderson LA, 1998, ANN PHARMACOTHER, V32, P78, DOI 10.1345/aph.17075; Andrews GK, 2001, EMBO J, V20, P1114, DOI 10.1093/emboj/20.5.1114; ANDREWS PA, 1987, CANCER CHEMOTH PHARM, V19, P149; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Arguello JM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00073; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x; Atwood CS, 1999, MET IONS BIOL SYST, V36, P309; Ayton S, 2013, ANN NEUROL, V73, P554, DOI 10.1002/ana.23817; Balamurugan K, 2004, BIOL CHEM, V385, P597, DOI 10.1515/BC.2004.074; Banci L, 2004, J BIOL CHEM, V279, P34833, DOI 10.1074/jbc.M403655200; Banci L, 2008, P NATL ACAD SCI USA, V105, P6803, DOI 10.1073/pnas.0800019105; Banci L, 2008, J BIOL CHEM, V283, P7912, DOI 10.1074/jbc.M708016200; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2010, CELL MOL LIFE SCI, V67, P2563, DOI 10.1007/s00018-010-0330-x; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Barnes N, 2005, J BIOL CHEM, V280, P9640, DOI 10.1074/jbc.M413840200; Barnes N, 2009, TRAFFIC, V10, P767, DOI 10.1111/j.1600-0854.2009.00901.x; Barnham KJ, 2014, CHEM SOC REV, V43, P6727, DOI 10.1039/c4cs00138a; Barros MH, 2004, J BIOL CHEM, V279, P31943, DOI 10.1074/jbc.M405014200; Barry AN, 2011, J BIOL CHEM, V286, P26585, DOI 10.1074/jbc.M111.229039; Barry AN, 2010, J BIOL INORG CHEM, V15, P47, DOI 10.1007/s00775-009-0595-4; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beckman JS, 2001, TRENDS NEUROSCI, V24, pS15, DOI 10.1016/S0166-2236(00)01981-0; Bertinato J, 2008, BIOCHEM J, V409, P731, DOI 10.1042/BJ20071025; Beyens A, 2019, GENES-BASEL, V10, DOI 10.3390/genes10070528; Bharathi, 2007, BIOCHEM BIOPH RES CO, V359, P115, DOI 10.1016/j.bbrc.2007.05.060; Bharucha KJ, 2008, J NEUROL, V255, P1957, DOI 10.1007/s00415-009-0063-7; Bhattacharjee A, 2016, J BIOL CHEM, V291, P16644, DOI 10.1074/jbc.M116.727248; BIAGGIONI I, 1990, NEUROLOGY, V40, P370, DOI 10.1212/WNL.40.2.370; Binolfi A, 2006, J AM CHEM SOC, V128, P9893, DOI 10.1021/ja0618649; Binolfi A, 2011, J AM CHEM SOC, V133, P194, DOI 10.1021/ja107842f; Bisaglia M, 2009, FASEB J, V23, P329, DOI 10.1096/fj.08-119784; Bjorklund G, 2018, CURR MED CHEM, V25, P2198, DOI 10.2174/0929867325666171129124616; Blair BG, 2009, CLIN CANCER RES, V15, P4312, DOI 10.1158/1078-0432.CCR-09-0311; Blockhuys S, 2020, P NATL ACAD SCI USA, V117, P2014, DOI 10.1073/pnas.1910722117; Blockhuys S, 2020, BREAST CANCER-TOKYO, V27, P505, DOI 10.1007/s12282-019-01044-4; Borm B, 2004, J PEDIATR-US, V145, P119, DOI 10.1016/j.jpeds.2004.04.033; Bortolus M, 2010, J AM CHEM SOC, V132, P18057, DOI 10.1021/ja103338n; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bost M, 2012, J TRACE ELEM MED BIO, V26, P97, DOI 10.1016/j.jtemb.2012.04.024; Boulet A, 2018, J BIOL CHEM, V293, P1887, DOI 10.1074/jbc.RA117.000265; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Boyd SD, 2020, MOLECULES, V25, DOI 10.3390/molecules25051086; Brady ST, 2017, NEUROBIOL DIS, V105, P273, DOI 10.1016/j.nbd.2017.04.010; Braiterman L, 2011, AM J PHYSIOL-GASTR L, V301, pG69, DOI 10.1152/ajpgi.00038.2011; Braiterman L, 2009, AM J PHYSIOL-GASTR L, V296, pG433, DOI 10.1152/ajpgi.90489.2008; Bredesen DE, 1997, ANN NEUROL, V42, P135, DOI 10.1002/ana.410420202; Britton RS, 1996, SEMIN LIVER DIS, V16, P3, DOI 10.1055/s-2007-1007214; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bucossi S, 2013, J ALZHEIMERS DIS, V37, P453, DOI 10.3233/JAD-130431; Bucossi S, 2012, J ALZHEIMERS DIS, V29, P913, DOI 10.3233/JAD-2012-111997; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; BULL PC, 1993, GENOMICS, V16, P593, DOI 10.1006/geno.1993.1235; Burkitt MJ, 2001, ARCH BIOCHEM BIOPHYS, V394, P117, DOI 10.1006/abbi.2001.2509; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Burton GJ, 2011, BEST PRACT RES CL OB, V25, P287, DOI 10.1016/j.bpobgyn.2010.10.016; BUSH AI, 1994, J BIOL CHEM, V269, P12152; Bush AI, 2000, CURR OPIN CHEM BIOL, V4, P184, DOI 10.1016/S1367-5931(99)00073-3; BUSH AI, 1993, J BIOL CHEM, V268, P16109; Bustos RI, 2013, BIOCHEM BIOPH RES CO, V437, P426, DOI 10.1016/j.bbrc.2013.06.095; BYERS PH, 1980, NEW ENGL J MED, V303, P61, DOI 10.1056/NEJM198007103030201; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; Camponeschi F, 2013, INORG CHEM, V52, P1358, DOI 10.1021/ic302050m; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; Cater MA, 2006, GASTROENTEROLOGY, V130, P493, DOI 10.1053/j.gastro.2005.10.054; Chalmers RM, 1997, NEUROLOGY, V49, P589, DOI 10.1212/WNL.49.2.589; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; Chen XH, 2008, NUCLEIC ACIDS RES, V36, P3128, DOI 10.1093/nar/gkn103; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; Choi BS, 2009, BRAIN RES, V1248, P14, DOI 10.1016/j.brainres.2008.10.056; CIRIOLO MR, 1990, J BIOL CHEM, V265, P11030; Cobbold C, 2002, HUM MOL GENET, V11, P2855, DOI 10.1093/hmg/11.23.2855; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; Cox DW, 2005, HUM MUTAT, V26, DOI 10.1002/humu.9358; Crider SE, 2010, METALLOMICS, V2, P74, DOI 10.1039/b916899k; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; Czlonkowska A, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0018-3; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Dagenais SL, 2001, AM J HUM GENET, V69, P420, DOI 10.1086/321290; Dahl H.-H. M., 1992, Human Mutation, V1, P97, DOI 10.1002/humu.1380010203; Davies KM, 2014, NEUROBIOL AGING, V35, P858, DOI 10.1016/j.neurobiolaging.2013.09.034; Davies KM, 2013, METALLOMICS, V5, P43, DOI 10.1039/c2mt20151h; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; De Bie P, 2005, J HERED, V96, P803, DOI 10.1093/jhered/esi110; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; Deas E, 2016, ANTIOXID REDOX SIGN, V24, P376, DOI 10.1089/ars.2015.6343; DENING TR, 1988, BRAIN, V111, P1139, DOI 10.1093/brain/111.5.1139; Desai V, 2011, CLIN GENET, V79, P176, DOI 10.1111/j.1399-0004.2010.01451.x; Desai V, 2008, AM J CLIN NUTR, V88, p855S, DOI 10.1093/ajcn/88.3.855S; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; Dhar SS, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120176; Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230; Dierick HA, 1997, HUM MOL GENET, V6, P409, DOI 10.1093/hmg/6.3.409; DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409; Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058; Dodani SC, 2011, P NATL ACAD SCI USA, V108, P5980, DOI 10.1073/pnas.1009932108; DOLCE V, 1994, J BIOL CHEM, V269, P10451; Dolce V, 1996, FEBS LETT, V399, P95, DOI 10.1016/S0014-5793(96)01294-X; Drevillon L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018334; Dudzik CG, 2011, BIOCHEMISTRY-US, V50, P1771, DOI 10.1021/bi101912q; Dupont CL, 2011, METALLOMICS, V3, P1109, DOI 10.1039/c1mt00107h; Durazo A, 2009, J BIOL CHEM, V284, P34382, DOI 10.1074/jbc.M109.052076; Dziezyc K, 2014, EUR J NEUROL, V21, P332, DOI 10.1111/ene.12320; Dziezyc K, 2017, HAND CLINIC, V142, P157, DOI 10.1016/B978-0-444-63625-6.00013-6; Eisses JF, 2000, BIOCHEMISTRY-US, V39, P7337, DOI 10.1021/bi000690j; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; Eisses JF, 2002, J BIOL CHEM, V277, P29162, DOI 10.1074/jbc.M203652200; El Meskini R, 2007, MOL CELL NEUROSCI, V34, P409, DOI 10.1016/j.mcn.2006.11.018; Elia M, 1996, BRAIN DEV-JPN, V18, P207, DOI 10.1016/0387-7604(95)00126-3; Elkiran O, 2013, ACTA CARDIOL, V68, P181, DOI 10.1080/AC.68.2.2967276; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Fedoseienko A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165385; Ferenci P, 2004, ALIMENT PHARM THER, V19, P157, DOI 10.1046/j.1365-2036.2003.01813.x; Ferenci P, 2006, HUM GENET, V120, P151, DOI 10.1007/s00439-006-0202-5; Ferenci P, 2014, ANN NY ACAD SCI, V1315, P1, DOI 10.1111/nyas.12340; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; Festa RA, 2011, CURR BIOL, V21, pR877, DOI 10.1016/j.cub.2011.09.040; Feugray G, 2020, ANN BIOL CLIN-PARIS, V78, P425, DOI 10.1684/abc.2020.1574; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013; Fodero-Tavoletti MT, 2010, J ALZHEIMERS DIS, V20, P49, DOI 10.3233/JAD-2010-1359; Forsberg K, 2011, ACTA NEUROPATHOL, V121, P623, DOI 10.1007/s00401-011-0805-3; FREEDMAN JH, 1989, J BIOL CHEM, V264, P5598; FREEDMAN JH, 1986, J BIOL CHEM, V261, P1840; Fu X, 2014, TOXICOL SCI, V139, P432, DOI 10.1093/toxsci/kfu048; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; FUKINO H, 1986, J TOXICOL ENV HEALTH, V19, P75, DOI 10.1080/15287398609530908; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587, DOI 10.1128/JB.176.18.5587-5600.1994; Gasch AT, 2002, OPHTHALMOLOGY, V109, P1477, DOI 10.1016/S0161-6420(02)01095-3; George DH, 2001, PEDIATR DEVEL PATHOL, V4, P281, DOI 10.1007/s100240010142; Gerard-Blanluet M, 2004, AM J MED GENET A, V130A, P211, DOI 10.1002/ajmg.a.30155; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Giasson BI, 2001, NEURON, V31, P885, DOI 10.1016/S0896-6273(01)00439-1; Giedroc DP, 2001, ANTIOXID REDOX SIGN, V3, P577, DOI 10.1089/15230860152542943; Gil-Bea FJ, 2017, EXPERT REV MOL MED, V19, DOI 10.1017/erm.2017.9; Gitlin JD, 2003, GASTROENTEROLOGY, V125, P1868, DOI 10.1053/j.gastro.2003.05.010; GLERUM DM, 1988, FEBS LETT, V236, P100, DOI 10.1016/0014-5793(88)80293-X; Godwin SC, 2006, J PEDIATR-US, V149, P412, DOI 10.1016/j.jpeds.2006.05.041; GOLDSTEIN S, 1986, Journal of Free Radicals in Biology and Medicine, V2, P3, DOI 10.1016/0748-5514(86)90117-0; Gonzalez MA, 2014, BRAIN, V137, P2897, DOI 10.1093/brain/awu224; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Gonzalez-Guerrero M, 2009, J BIOL CHEM, V284, P20804, DOI 10.1074/jbc.M109.016329; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Grange DK, 2005, AM J MED GENET A, V139A, P151, DOI 10.1002/ajmg.a.31001; Greenough M, 2004, AM J PHYSIOL-CELL PH, V287, pC1463, DOI 10.1152/ajpcell.00179.2004; GROBE H, 1975, ACTA PAEDIATR SCAND, V64, P755, DOI 10.1111/j.1651-2227.1975.tb03916.x; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; Gu M, 2000, LANCET, V356, P469, DOI 10.1016/S0140-6736(00)02556-3; Gunther V, 2012, BBA-MOL CELL RES, V1823, P1416, DOI 10.1016/j.bbamcr.2012.01.005; Gunes C, 1998, EMBO J, V17, P2846, DOI 10.1093/emboj/17.10.2846; GUNTHER MR, 1995, ARCH BIOCHEM BIOPHYS, V316, P515, DOI 10.1006/abbi.1995.1068; Guo Y, 2004, J BIOL CHEM, V279, P46393, DOI 10.1074/jbc.M407777200; Gupta A, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-33; Gupta A, 2009, FUTURE MED CHEM, V1, P1125, DOI 10.4155/FMC.09.84; Guthrie LM, 2020, SCIENCE, V368, P620, DOI 10.1126/science.aaz8899; Haddad MR, 2018, MOL THER-METH CLIN D, V10, P165, DOI 10.1016/j.omtm.2018.07.002; Hallas T, 2018, J CELL MOL MED, V22, P913, DOI 10.1111/jcmm.13392; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; HALLIWELL B, 1992, ANN NEUROL, V32, pS10, DOI 10.1002/ana.410320704; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hamza I, 2001, P NATL ACAD SCI USA, V98, P6848, DOI 10.1073/pnas.111058498; Harada M, 2000, BIOCHEM BIOPH RES CO, V275, P871, DOI 10.1006/bbrc.2000.3403; Hatori Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10640; Hatori Y, 2012, J BIOL CHEM, V287, P26678, DOI 10.1074/jbc.M112.381178; Hayashi H, 2013, MED MOL MORPHOL, V46, P133, DOI 10.1007/s00795-013-0015-2; Heaton DN, 2001, BIOCHEMISTRY-US, V40, P743, DOI 10.1021/bi002315x; Hedley D, 2016, LEUKEMIA LYMPHOMA, V57, P2437, DOI 10.3109/10428194.2016.1138293; Hernandez S, 2008, GASTROENTEROLOGY, V134, P1215, DOI 10.1053/j.gastro.2008.01.043; HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Hicks JD, 2012, CLIN DYSMORPHOL, V21, P59, DOI 10.1097/MCD.0b013e32834ea52b; HOAGLAND HC, 1978, MAYO CLIN PROC, V53, P498; Hodgkinson VL, 2015, AM J PHYSIOL-CELL PH, V309, pC660, DOI 10.1152/ajpcell.00130.2015; Hodgkinson VL, 2015, J PATHOL, V236, P241, DOI 10.1002/path.4511; HORN N, 1980, J MED GENET, V17, P262, DOI 10.1136/jmg.17.4.262; HORN N, 1981, PRENATAL DIAG, V1, P107, DOI 10.1002/pd.1970010205; Horng YC, 2004, J BIOL CHEM, V279, P35334, DOI 10.1074/jbc.M404747200; Horvath I, 2019, ACS CHEM NEUROSCI, V10, P4659, DOI 10.1021/acschemneuro.9b00476; Hozumi I, 2011, J NEUROL SCI, V303, P95, DOI 10.1016/j.jns.2011.01.003; Hsi G, 2004, HUM GENET, V114, P165, DOI 10.1007/s00439-003-1045-y; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Hung LW, 2012, J EXP MED, V209, P837, DOI 10.1084/jem.20112285; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; Huster D, 2014, ANN NY ACAD SCI, V1315, P37, DOI 10.1111/nyas.12337; Ilyechova EY, 2018, NEUROSCI RES, V135, P54, DOI 10.1016/j.neures.2017.11.011; Irobi-Devolder J, 2008, Verh K Acad Geneeskd Belg, V70, P25; Rodriguez-Castro KI, 2015, WORLD J HEPATOL, V7, P2859, DOI 10.4254/wjh.v7.i29.2859; Itoh S, 2008, J BIOL CHEM, V283, P9157, DOI 10.1074/jbc.M709463200; Itoh S, 2009, FREE RADICAL BIO MED, V46, P95, DOI 10.1016/j.freeradbiomed.2008.09.039; Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795; Jaksch M, 2001, HUM MOL GENET, V10, P3025, DOI 10.1093/hmg/10.26.3025; Jellinger KA, 1999, DRUG AGING, V14, P115, DOI 10.2165/00002512-199914020-00004; Jeney V, 2005, CIRC RES, V96, P723, DOI 10.1161/01.RES.0000162001.57896.66; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Jung KH, 2005, ARCH NEUROL-CHICAGO, V62, P1628, DOI 10.1001/archneur.62.10.1628; Kabashi E, 2007, ANN NEUROL, V62, P553, DOI 10.1002/ana.21319; Kahra D, 2015, PROTEIN PEPTIDE LETT, V22, P532, DOI 10.2174/0929866522666150506094546; Kaler S G, 1998, Adv Pharmacol, V42, P66; KALER SG, 1993, ANN NEUROL, V33, P171, DOI 10.1002/ana.410330206; KALER SG, 1993, J PEDIATR-US, V122, P93, DOI 10.1016/S0022-3476(05)83496-1; KALER SG, 1993, J INHERIT METAB DIS, V16, P907, DOI 10.1007/BF00714295; Kaler SG, 1998, AM J CLIN NUTR, V67, p1029S, DOI 10.1093/ajcn/67.5.1029S; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; Kaler SG, 2008, NEW ENGL J MED, V358, P605, DOI 10.1056/NEJMoa070613; Kaler SG, 2014, J TRACE ELEM MED BIO, V28, P427, DOI 10.1016/j.jtemb.2014.08.008; Kaler SG, 2014, ANN NY ACAD SCI, V1314, P64, DOI 10.1111/nyas.12422; Kaler SG, 2011, NAT REV NEUROL, V7, P15, DOI 10.1038/nrneurol.2010.180; Kaler SG, 2010, J INHERIT METAB DIS, V33, P583, DOI 10.1007/s10545-010-9118-2; Kaler SG, 2009, ANN NEUROL, V65, P108, DOI 10.1002/ana.21576; KALIMO H, 1979, ANN NEUROL, V6, P200, DOI 10.1002/ana.410060304; KANG YJ, 1988, TOXICOLOGY, V48, P93; KAPUR S, 1987, AM J MED GENET, V26, P503, DOI 10.1002/ajmg.1320260230; Kawahara M, 2017, METALLOMICS, V9, P619, DOI 10.1039/c7mt00046d; Kennerson M, 2009, NEUROLOGY, V72, P246, DOI 10.1212/01.wnl.0000339483.86094.a5; Kennerson ML, 2010, AM J HUM GENET, V86, P343, DOI 10.1016/j.ajhg.2010.01.027; Khalimonchuk E, 2005, MITOCHONDRION, V5, P363, DOI 10.1016/j.mito.2005.08.002; Kim BE, 2002, J BIOL CHEM, V277, P44079, DOI 10.1074/jbc.M208737200; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Kim H, 2009, AM J PHYSIOL-GASTR L, V296, pG356, DOI 10.1152/ajpgi.90632.2008; Kim JH, 2015, METAB BRAIN DIS, V30, P75, DOI 10.1007/s11011-014-9569-5; Kim MJ, 2018, PARKINSONISM RELAT D, V55, P117, DOI 10.1016/j.parkreldis.2018.05.022; Kim YJ, 2019, METALLOMICS, V11, P1430, DOI 10.1039/c9mt00042a; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; Kodama H, 2012, CURR DRUG METAB, V13, P237, DOI 10.2174/138920012799320455; Kodama K, 1999, PEDIATR INT, V41, P430, DOI 10.1046/j.1442-200x.1999.01091.x; Kong JM, 1998, J NEUROSCI, V18, P3241; Krebs N, 2014, J TRACE ELEM MED BIO, V28, P1, DOI 10.1016/j.jtemb.2013.09.006; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; La Fontaine S, 2007, ARCH BIOCHEM BIOPHYS, V463, P149, DOI 10.1016/j.abb.2007.04.021; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lamb AL, 1999, NAT STRUCT BIOL, V6, P724; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; Larson CA, 2010, MOL PHARMACOL, V78, P333, DOI 10.1124/mol.110.064766; Leary SC, 2004, HUM MOL GENET, V13, P1839, DOI 10.1093/hmg/ddh197; Leary SC, 2007, CELL METAB, V5, P9, DOI 10.1016/j.cmet.2006.12.001; Leary SC, 2013, HUM MUTAT, V34, P1366, DOI 10.1002/humu.22385; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Lee JY, 1999, J NEUROSCI, V19, DOI 10.1523/jneurosci.19-11-j0002.1999; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; Lenartowicz M, 2010, BIOL TRACE ELEM RES, V136, P204, DOI 10.1007/s12011-009-8533-4; Lepori MB, 2007, GENET TEST, V11, P328, DOI 10.1089/gte.2007.0015; Liang ZD, 2012, MOL PHARMACOL, V81, P455, DOI 10.1124/mol.111.076422; Linder MC, 1996, AM J CLIN NUTR, V63, P797; Linz R, 2007, J BIOENERG BIOMEMBR, V39, P403, DOI 10.1007/s10863-007-9101-2; Liu NM, 2007, J NUTR BIOCHEM, V18, P597, DOI 10.1016/j.jnutbio.2006.11.005; Loeffler DA, 1996, BRAIN RES, V738, P265, DOI 10.1016/S0006-8993(96)00782-2; LOMBES A, 1991, NEUROLOGY, V41, P491, DOI 10.1212/WNL.41.4.491; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Loudianos G, 2002, HUM MUTAT, V20, P260, DOI 10.1002/humu.10121; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Lutsenko S, 2003, ANN NY ACAD SCI, V986, P204, DOI 10.1111/j.1749-6632.2003.tb07161.x; Lutsenko S, 2003, J MEMBRANE BIOL, V191, P1, DOI 10.1007/s00232-002-1040-6; Lutsenko S, 2007, ARCH BIOCHEM BIOPHYS, V463, P134, DOI 10.1016/j.abb.2007.04.013; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Lutsenko S, 2016, METALLOMICS, V8, P840, DOI [10.1039/c6mt00176a, 10.1039/C6MT00176A]; Lutsenko S, 2010, METALLOMICS, V2, P596, DOI 10.1039/c0mt00006j; Lutsenko S, 2010, CURR OPIN CHEM BIOL, V14, P211, DOI 10.1016/j.cbpa.2010.01.003; Lynes MA, 2007, ANN NY ACAD SCI, V1113, P159, DOI 10.1196/annals.1391.010; Lyons TJ, 1996, P NATL ACAD SCI USA, V93, P12240, DOI 10.1073/pnas.93.22.12240; Lyons TJ, 1999, MET IONS BIOL SYST, V36, P125; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; Mayr JA, 2011, NEUROMUSCULAR DISORD, V21, P803, DOI 10.1016/j.nmd.2011.06.005; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; McDowall JS, 2016, METALLOMICS, V8, P385, DOI 10.1039/c6mt00026f; MENKES JH, 1962, PEDIATRICS, V29, P764; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; Miles AT, 2000, CRIT REV BIOCHEM MOL, V35, P35, DOI 10.1080/10409230091169168; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Mizuguchi M, 2007, NEUROPATHOLOGY, V27, P145, DOI 10.1111/j.1440-1789.2007.00773.x; Moir RD, 1999, BIOCHEMISTRY-US, V38, P4595, DOI 10.1021/bi982437d; Moller LB, 2000, AM J HUM GENET, V66, P1211, DOI 10.1086/302857; Moller LB., 2011, CURR PROTOC HUM GENE, V70; Moller LB, 2015, J TRACE ELEM MED BIO, V31, P173, DOI 10.1016/j.jtemb.2014.07.022; Moller LB, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-6; Moller LB, 2009, BIOCHIMIE, V91, P1273, DOI 10.1016/j.biochi.2009.05.011; Mondesert E, 2020, ANN BIOL CLIN-PARIS, V78, P441, DOI 10.1684/abc.2020.1566; Montes S, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/147251; Monzani E, 2019, ANGEW CHEM INT EDIT, V58, P6512, DOI 10.1002/anie.201811122; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Morgada MN, 2015, P NATL ACAD SCI USA, V112, P11771, DOI 10.1073/pnas.1505056112; Moriya M, 2008, AM J PHYSIOL-CELL PH, V295, pC708, DOI 10.1152/ajpcell.00029.2008; Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107; MORRIS SA, 1993, J PAEDIATR CHILD H, V29, P363, DOI 10.1111/j.1440-1754.1993.tb00536.x; Muller PAJ, 2009, INT J BIOCHEM CELL B, V41, P1233, DOI 10.1016/j.biocel.2008.08.001; Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406; MULTHAUP G, 1994, FEBS LETT, V355, P151, DOI 10.1016/0014-5793(94)01176-1; Multhaup G, 1998, BIOCHEMISTRY-US, V37, P7224, DOI 10.1021/bi980022m; MULTHAUP G, 1995, J MOL RECOGNIT, V8, P247; Munakata M, 2005, BRAIN DEV-JPN, V27, P297, DOI 10.1016/j.braindev.2004.08.002; Nagano S, 2001, EUR J NEUROSCI, V13, P1363, DOI 10.1046/j.0953-816x.2001.01512.x; NISHIYAMA K, 1995, ACTA NEUROPATHOL, V89, P471; Nose Y, 2006, TRENDS BIOCHEM SCI, V31, P604, DOI 10.1016/j.tibs.2006.09.003; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Nose Y, 2010, J BIOL CHEM, V285, P32385, DOI 10.1074/jbc.M110.143826; Nyasae L, 2007, AM J PHYSIOL-GASTR L, V292, pG1181, DOI 10.1152/ajpgi.00472.2006; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Ohrvik H, 2014, ANN NY ACAD SCI, V1314, P32, DOI 10.1111/nyas.12371; Ohrvika H, 2013, P NATL ACAD SCI USA, V110, pE4279, DOI 10.1073/pnas.1311749110; Ohrvik H, 2015, J IMMUNOL, V195, P3654, DOI 10.4049/jimmunol.1500283; ORENA SJ, 1986, BIOCHEM BIOPH RES CO, V139, P822, DOI 10.1016/S0006-291X(86)80064-X; Osman D, 2008, ADV APPL MICROBIOL, V65, P217, DOI 10.1016/S0065-2164(08)00608-4; Oswald C, 2009, J MOL BIOL, V389, P470, DOI 10.1016/j.jmb.2009.04.034; Otoikhian A, 2012, J AM CHEM SOC, V134, P10458, DOI 10.1021/ja301221s; Padilla-Benavides T, 2014, J BIOL CHEM, V289, P20492, DOI 10.1074/jbc.M114.577668; Padilla-Benavides T, 2013, J BIOL CHEM, V288, P69, DOI 10.1074/jbc.M112.420810; Paik SR, 1999, BIOCHEM J, V340, P821, DOI 10.1042/0264-6021:3400821; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; PALUMBO A, 1987, BIOCHIM BIOPHYS ACTA, V925, P203, DOI 10.1016/0304-4165(87)90110-3; PAPA S, 1994, CELL BIOL INT, V18, P345, DOI 10.1006/cbir.1994.1084; Papadopoulou LC, 1999, NAT GENET, V23, P333; Park JD, 2001, TOXICOLOGY, V163, P93, DOI 10.1016/S0300-483X(01)00375-4; Park S, 2007, HUM MUTAT, V28, P1108, DOI 10.1002/humu.20574; Parkinson J, 2002, J NEUROPSYCH CLIN N, V14, P223, DOI 10.1176/appi.neuropsych.14.2.223; Parton MJ, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9081; Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763; Paulsen M, 2006, AM J HUM GENET, V79, P214, DOI 10.1086/505407; Payne AS, 1998, P NATL ACAD SCI USA, V95, P10854, DOI 10.1073/pnas.95.18.10854; Pecina P, 2003, BBA-MOL BASIS DIS, V1639, P53, DOI 10.1016/S0925-4439(03)00127-3; Pequignot MO, 2001, HUM MUTAT, V17, P374, DOI 10.1002/humu.1112.abs; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Petris MJ, 1998, HUM MOL GENET, V7, P2063, DOI 10.1093/hmg/7.13.2063; Petris MJ, 2004, PFLUG ARCH EUR J PHY, V447, P752, DOI 10.1007/s00424-003-1092-1; Petris MJ, 1999, ADV EXP MED BIOL, V448, P53; Petris MJ, 2000, HUM MOL GENET, V9, P2845, DOI 10.1093/hmg/9.19.2845; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; Petzoldt S, 2015, BIOMETALS, V28, P577, DOI 10.1007/s10534-015-9832-1; Pfeiffer Ronald F, 2016, Continuum (Minneap Minn), V22, P1246, DOI 10.1212/CON.0000000000000350; Pham AN, 2014, J INORG BIOCHEM, V137, P74, DOI 10.1016/j.jinorgbio.2014.03.018; PHILLIPS M, 1991, BIOL TRACE ELEM RES, V29, P11, DOI 10.1007/BF03032670; Pierson H, 2018, GASTROENTEROLOGY, V154, P168, DOI 10.1053/j.gastro.2017.09.019; Polishchuk R, 2013, HISTOCHEM CELL BIOL, V140, P285, DOI 10.1007/s00418-013-1123-8; Polychronopoulos P, 2006, EPILEPSY BEHAV, V8, P438, DOI 10.1016/j.yebeh.2005.12.008; Possekel S, 1996, BBA-MOL BASIS DIS, V1316, P153, DOI 10.1016/0925-4439(96)00005-1; POST RL, 1972, J BIOL CHEM, V247, P6530; Potter BM, 2005, J BIOL CHEM, V280, P28529, DOI 10.1074/jbc.M505217200; Przybylkowski A, 2014, FUNCT NEUROL, V29, P23, DOI 10.11138/FNeur/2014.29.1.023; Puls I, 2005, ANN NEUROL, V57, P687, DOI 10.1002/ana.20468; Qi M, 1998, HUM MOL GENET, V7, P465, DOI 10.1093/hmg/7.3.465; Qin ZY, 2006, FASEB J, V20, P334, DOI 10.1096/fj.05-4564fje; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; Raimunda D, 2011, BIOMETALS, V24, P467, DOI 10.1007/s10534-010-9404-3; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Ramos D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149516; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Ren F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09376-7; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Ridge PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001378; Rigby K, 2008, J BIOL CHEM, V283, P15015, DOI 10.1074/jbc.M710072200; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; ROBERTSON D, 1986, NEW ENGL J MED, V314, P1494, DOI 10.1056/NEJM198606053142307; ROBINSON BH, 1987, J PEDIATR-US, V110, P216, DOI 10.1016/S0022-3476(87)80157-9; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; ROESER HP, 1970, J CLIN INVEST, V49, P2408, DOI 10.1172/JCI106460; Roos PM, 2013, BIOL TRACE ELEM RES, V151, P159, DOI 10.1007/s12011-012-9547-x; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Rossi L, 2004, NEUROCHEM RES, V29, P493, DOI 10.1023/B:NERE.0000014820.99232.8a; Rothstein JD, 1999, J NEUROCHEM, V72, P422, DOI 10.1046/j.1471-4159.1999.0720422.x; Rotunno MS, 2014, J BIOL CHEM, V289, P28527, DOI 10.1074/jbc.M114.581801; ROYCE PM, 1980, BIOCHEM J, V192, P579, DOI 10.1042/bj1920579; Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176; RUNSWICK MJ, 1987, EMBO J, V6, P1367, DOI 10.1002/j.1460-2075.1987.tb02377.x; Safadi SS, 2011, BIOCHEMISTRY-US, V50, P2603, DOI 10.1021/bi200065g; Saini N, 2011, MOL CELL BIOL, V31, P2151, DOI 10.1128/MCB.05207-11; Saito T, 1996, NEUROSCI LETT, V216, P195, DOI 10.1016/S0304-3940(96)13041-X; Saito T, 1999, NEUROSCI LETT, V266, P13, DOI 10.1016/S0304-3940(99)00258-X; Sala FA, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000141; Sambuughin N, 1998, J NEUROL SCI, V161, P23, DOI 10.1016/S0022-510X(98)00264-0; SAMUNI A, 1981, J BIOL CHEM, V256, P2632; SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612; SARKAR B, 1993, J PEDIATR-US, V123, P828, DOI 10.1016/S0022-3476(05)80870-4; Sauzeat L, 2018, ISCIENCE, V6, P264, DOI 10.1016/j.isci.2018.07.023; Scheiber IF, 2012, NEUROCHEM INT, V60, P292, DOI 10.1016/j.neuint.2011.12.012; Scheiber IF, 2017, HAND CLINIC, V142, P43, DOI 10.1016/B978-0-444-63625-6.00005-7; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; Schmidt K, 2018, J BIOL CHEM, V293, P20085, DOI 10.1074/jbc.RA118.004889; Schmidt PJ, 1999, J BIOL CHEM, V274, P23719, DOI 10.1074/jbc.274.34.23719; Seifert EL, 2015, BIOCHEM BIOPH RES CO, V464, P369, DOI 10.1016/j.bbrc.2015.06.031; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Selvaraj A, 2005, GENE DEV, V19, P891, DOI 10.1101/gad.1301805; Sendzik M, 2017, INORG CHEM, V56, P15057, DOI 10.1021/acs.inorgchem.7b02397; Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748; Sheng YW, 2012, CURR TOP MED CHEM, V12, P2560; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Siebert X, 2005, BIOPHYS J, V89, P3312, DOI 10.1529/biophysj.105.066100; Siegel R C, 1979, Int Rev Connect Tissue Res, V8, P73; Simon I, 2008, WORLD J GASTROENTERO, V14, P2383, DOI 10.3748/wjg.14.2383; Sims HI, 2012, P NATL ACAD SCI USA, V109, P16516, DOI 10.1073/pnas.1207737109; Sirleto P, 2009, PEDIATR RES, V65, P347, DOI 10.1203/PDR.0b013e3181973b4e; Skjorringe T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00618-6; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; SOLIOZ M, 1995, J BIOL CHEM, V270, P9217, DOI 10.1074/jbc.270.16.9217; Solioz M, 2010, J BIOL INORG CHEM, V15, P3, DOI 10.1007/s00775-009-0588-3; Soma S, 2018, P NATL ACAD SCI USA, V115, P8161, DOI 10.1073/pnas.1806296115; Son M, 2008, J BIOL CHEM, V283, P12267, DOI 10.1074/jbc.M708523200; Son M, 2007, P NATL ACAD SCI USA, V104, P6072, DOI 10.1073/pnas.0610923104; Son M, 2014, J NEUROL SCI, V336, P1, DOI 10.1016/j.jns.2013.11.004; Song IS, 2008, MOL PHARMACOL, V74, P705, DOI 10.1124/mol.108.046771; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Stendel C, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000393; Stenson PD, 2017, HUM GENET, V136, P665, DOI 10.1007/s00439-017-1779-6; STRICKLAND GT, 1975, MEDICINE, V54, P113; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; Suh SW, 2000, BRAIN RES, V852, P274, DOI 10.1016/S0006-8993(99)02096-X; Sung YH, 2006, BBA-PROTEINS PROTEOM, V1764, P5, DOI 10.1016/j.bbapap.2005.11.003; Suzuki Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3430; Swinnen B, 2014, NAT REV NEUROL, V10, P661, DOI 10.1038/nrneurol.2014.184; Symoens S, 2011, BIOCHEM J, V433, P371, DOI 10.1042/BJ20101061; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Szauter KM, 2005, PATHOL BIOL, V53, P448, DOI 10.1016/j.patbio.2004.12.033; Takata RI, 2004, J MED GENET, V41, P224, DOI 10.1136/jmg.2003.013201; Takayama SJ, 2009, J BIOL INORG CHEM, V14, P821, DOI 10.1007/s00775-009-0494-8; TANAKA K, 1990, RES COMMUN CHEM PATH, V69, P217; Tang JR, 2008, MOL GENET METAB, V95, P174, DOI 10.1016/j.ymgme.2008.06.015; Tang JR, 2006, GENET MED, V8, P711, DOI 10.1097/01.gim.0000245578.94312.1e; TATUCH Y, 1992, AM J HUM GENET, V50, P852; Tavera-Montanez C, 2019, FASEB J, V33, P14556, DOI 10.1096/fj.201901606R; Tchaparian EH, 2000, ARCH BIOCHEM BIOPHYS, V379, P71, DOI 10.1006/abbi.2000.1842; Tokuda E, 2009, J NEUROCHEM, V111, P181, DOI 10.1111/j.1471-4159.2009.06310.x; Torsdottir G, 1999, PHARMACOL TOXICOL, V85, P239, DOI 10.1111/j.1600-0773.1999.tb02015.x; Trist BG, 2017, ACTA NEUROPATHOL, V134, P113, DOI 10.1007/s00401-017-1726-6; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Tumer Z, 1997, J MED GENET, V34, P265, DOI 10.1136/jmg.34.4.265; Tumer Z, 2013, HUM MUTAT, V34, P417, DOI 10.1002/humu.22266; Tumer Z, 2010, EUR J HUM GENET, V18, P511, DOI 10.1038/ejhg.2009.187; Turski ML, 2012, MOL CELL BIOL, V32, P1284, DOI 10.1128/MCB.05722-11; UITTI RJ, 1989, CAN J NEUROL SCI, V16, P310, DOI 10.1017/S0317167100029140; Uitto J, 2013, EXP DERMATOL, V22, P88, DOI 10.1111/exd.12025; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; Valnot I, 2000, AM J HUM GENET, V67, P1104; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; van de Sluis B, 2010, J CLIN INVEST, V120, P2119, DOI 10.1172/JCI40583; van de Sluis B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007332; Van den Berghe PVE, 2007, BIOCHEM J, V407, P49, DOI 10.1042/BJ20070705; VANCOSTER R, 1991, J NEUROL SCI, V104, P97, DOI 10.1016/0022-510X(91)90222-S; VANDENBERG GJ, 1990, J INHERIT METAB DIS, V13, P207, DOI 10.1007/BF01799687; Vanisova M, 2019, FOLIA BIOL-PRAGUE, V65, P181; VANWASSENAERVANHALL HN, 1995, AM J NEURORADIOL, V16, P2021; vanWassenaervanHall HN, 1996, RADIOLOGY, V198, P531, DOI 10.1148/radiology.198.2.8596862; Vendelboe TV, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500980; Vest KE, 2018, METALLOMICS, V10, P309, DOI 10.1039/c7mt00324b; Vest KE, 2013, J BIOL CHEM, V288, P23884, DOI 10.1074/jbc.M113.470674; Violi F, 2020, METALLOMICS, V12, P668, DOI 10.1039/d0mt00051e; VOGEL A, 1979, LAB INVEST, V40, P201; Vonk WIM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092408; Vonk WIM, 2012, CELL MOL LIFE SCI, V69, P149, DOI 10.1007/s00018-011-0743-1; Vonk WIM, 2010, J BIOL CHEM, V285, P28991, DOI 10.1074/jbc.M110.101477; Vrabelova S, 2005, MOL GENET METAB, V86, P277, DOI 10.1016/j.ymgme.2005.05.004; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Walker JM, 2002, J BIOL CHEM, V277, P27953, DOI 10.1074/jbc.M203845200; WALSHE JM, 1987, LANCET, V2, P1030; Wang Y, 2004, FASEB J, V18, P1071, DOI 10.1096/fj.03-1282com; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Weihl CC, 2006, MUSCLE NERVE, V34, P789, DOI 10.1002/mus.20631; White AR, 1999, BRAIN RES, V842, P439, DOI 10.1016/S0006-8993(99)01861-2; White C, 2009, J CELL SCI, V122, P1315, DOI 10.1242/jcs.043216; WHITE SR, 1993, ELECTROEN CLIN NEURO, V87, P57, DOI 10.1016/0013-4694(93)90175-U; Wittung-Stafshede P, 2015, Q REV BIOPHYS, V48, P471, DOI 10.1017/S0033583515000128; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074; YAMAGUCHI Y, 1993, BIOCHEM BIOPH RES CO, V197, P271, DOI 10.1006/bbrc.1993.2471; Yasmeen S, 2014, EUR J HUM GENET, V22, P517, DOI 10.1038/ejhg.2013.191; Yi L, 2018, J BIOL CHEM, V293, P7606, DOI 10.1074/jbc.RA117.000686; Yi L, 2014, ANN NY ACAD SCI, V1314, P49, DOI 10.1111/nyas.12427; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Yu WH, 2001, BRAIN RES, V894, P37, DOI 10.1016/S0006-8993(00)03196-6; Yu XE, 2019, AM J NEURORADIOL, V40, P178, DOI 10.3174/ajnr.A5936; Yu ZW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009956; Yuan SM, 2017, METALLOMICS, V9, P1169, DOI 10.1039/c7mt00184c; Zhang B, 2001, MOL CELL BIOL, V21, P4505, DOI 10.1128/MCB.21.14.4505-4514.2001; Zhao YS, 2018, ANTIOXID REDOX SIGN, V28, P1323, DOI 10.1089/ars.2016.6883; Zheng ZQ, 2010, J NEUROCHEM, V114, P1630, DOI 10.1111/j.1471-4159.2010.06888.x; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804; Zischka H, 2014, ANN NY ACAD SCI, V1315, P6, DOI 10.1111/nyas.12347; Armstrong RA, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/908306; Arrasate M, 2012, EXP NEUROL, V238, P1, DOI 10.1016/j.expneurol.2011.12.013; Aschemeyer S, 2018, BLOOD, V131, P899, DOI 10.1182/blood-2017-05-786590; Aubert L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17549-y; Baker AM, 2013, ONCOGENE, V32, P1863, DOI 10.1038/onc.2012.202; Baker AM, 2011, JNCI-J NATL CANCER I, V103, P407, DOI 10.1093/jnci/djq569; Bakkar N, 2021, NEUROBIOL DIS, V149, DOI 10.1016/j.nbd.2020.105228; Bannert N, 2006, ANNU REV GENOM HUM G, V7, P149, DOI 10.1146/annurev.genom.7.080505.115700; Beshgetoor D, 1998, AM J CLIN NUTR, V67, p1017S, DOI 10.1093/ajcn/67.5.1017S; Bhatt BS, 2021, J BIOMOL STRUCT DYN, V39, P4555, DOI 10.1080/07391102.2020.1776641; BHAVE SA, 1987, J PEDIATR GASTR NUTR, V6, P562, DOI 10.1097/00005176-198707000-00013; BHAVE SA, 1982, ARCH DIS CHILD, V57, P922, DOI 10.1136/adc.57.12.922; Blackman RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029798; Blockhuys S, 2017, METALLOMICS, V9, P112, DOI 10.1039/c6mt00202a; Blockhuys S, 2017, BIOCHEM BIOPH RES CO, V483, P301, DOI 10.1016/j.bbrc.2016.12.148; Boal AK, 2009, J AM CHEM SOC, V131, P14196, DOI 10.1021/ja906363t; Bocharova OV, 2005, BIOCHEMISTRY-US, V44, P6776, DOI 10.1021/bi050251q; Boller K, 2008, J GEN VIROL, V89, P567, DOI 10.1099/vir.0.83534-0; Bompiani KM, 2016, METALLOMICS, V8, P951, DOI 10.1039/c6mt00076b; Boufraqech M, 2019, THYROID, V29, P79, DOI 10.1089/thy.2018.0424; Brady DC, 2017, CANCER RES, V77, P6240, DOI 10.1158/0008-5472.CAN-16-1190; Brady DC, 2014, NATURE, V509, P492, DOI 10.1038/nature13180; Brewer GJ, 2014, J TRACE ELEM MED BIO, V28, P372, DOI 10.1016/j.jtemb.2014.07.015; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 2001, J NEUROCHEM, V76, P69, DOI 10.1046/j.1471-4159.2001.00009.x; Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; Buscher K, 2006, MELANOMA RES, V16, P223; Buron MD, 2020, NEUROLOGY, V95, pE1041, DOI 10.1212/WNL.0000000000010135; Buscher K, 2005, CANCER RES, V65, P4172, DOI 10.1158/0008-5472.CAN-04-2983; Byun SS, 2005, BJU INT, V95, P1086, DOI 10.1111/j.1464-410X.2005.05472.x; Cabelguenne A, 2001, INT J CANCER, V93, P725, DOI 10.1002/ijc.1392; Caglayan A, 2019, J TRACE ELEM MED BIO, V52, P254, DOI 10.1016/j.jtemb.2019.01.010; Capo CR, 2017, J TRACE ELEM MED BIO, V44, P225, DOI 10.1016/j.jtemb.2017.08.002; Carver PL, 2019, METAL IONS LIFE SCI, V19, P1, DOI 10.1515/9783110527872; Cekic O, 1998, BRIT J OPHTHALMOL, V82, P186, DOI 10.1136/bjo.82.2.186; Chan N, 2017, CLIN CANCER RES, V23, P666, DOI 10.1158/1078-0432.CCR-16-1326; Chen D, 2009, CURR PHARM DESIGN, V15, P777, DOI 10.2174/138161209787582183; Chen HHW, 2008, MOL PHARMACOL, V74, P697, DOI 10.1124/mol.108.047969; Chen HHW, 2012, LUNG CANCER, V75, P228, DOI 10.1016/j.lungcan.2011.06.011; Chen J, 2020, NANOTOXICOLOGY, V14, P774, DOI 10.1080/17435390.2020.1759727; CHERIAN MG, 1994, TOXICOL APPL PHARM, V126, P1, DOI 10.1006/taap.1994.1083; Chiplunkar S, 2016, METAB BRAIN DIS, V31, P1195, DOI 10.1007/s11011-016-9854-6; Colotti G, 2013, MINI-REV MED CHEM, V13, P211; Contreras-Galindo R, 2008, J VIROL, V82, P9329, DOI 10.1128/JVI.00646-08; Corbee RJ, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11030601; Cox C, 2001, LARYNGOSCOPE, V111, P696, DOI 10.1097/00005537-200104000-00024; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; Crow JP, 1997, J NEUROCHEM, V69, P1936; Crowe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073684; Cuevas EP, 2017, SCI REP-UK, V7, DOI 10.1038/srep44988; Cullen KJ, 2003, CANCER RES, V63, P8097; Daubeuf S, 2003, BIOCHEM PHARMACOL, V66, P595, DOI 10.1016/S0006-2952(03)00343-5; Dearling JLJ, 2011, NUCL MED BIOL, V38, P29, DOI 10.1016/j.nucmedbio.2010.07.003; Denoyer D, 2015, METALLOMICS, V7, P1459, DOI 10.1039/c5mt00149h; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DLOUHY SR, 1992, NAT GENET, V1, P64, DOI 10.1038/ng0492-64; Dolgova NV, 2013, BIOCHEM J, V454, P147, DOI 10.1042/BJ20121656; Donnelly PS, 2012, P NATL ACAD SCI USA, V109, P47, DOI 10.1073/pnas.1116227108; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; Endo T, 2004, J GASTROENTEROL, V39, P1196, DOI 10.1007/s00535-004-1471-1; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fasano A, 2008, MOVEMENT DISORD, V23, P751, DOI 10.1002/mds.21938; Feng WJN, 2007, INT J CANCER, V120, P81, DOI 10.1002/ijc.22256; Fernandes C, 2015, J INORG BIOCHEM, V153, P68, DOI 10.1016/j.jinorgbio.2015.09.014; Fieten H, 2016, DIS MODEL MECH, V9, P25, DOI 10.1242/dmm.020263; Florl AR, 1999, BRIT J CANCER, V80, P1312, DOI 10.1038/sj.bjc.6690524; Fokkema E, 2002, BIOCHEM PHARMACOL, V63, P1989, DOI 10.1016/S0006-2952(02)00983-8; Fox JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000334; Frezza M, 2010, CURR PHARM DESIGN, V16, P1813, DOI 10.2174/138161210791209009; GABIZON R, 1993, AM J HUM GENET, V53, P828; Gao LN, 2020, J MATER CHEM B, V8, P4841, DOI 10.1039/d0tb00097c; Geschwind Michael D, 2015, Continuum (Minneap Minn), V21, P1612, DOI 10.1212/CON.0000000000000251; Goldstein LE, 2000, BIOCHEMISTRY-US, V39, P7266, DOI 10.1021/bi992997s; Goodman BP, 2009, J NEUROL NEUROSUR PS, V80, P524, DOI 10.1136/jnnp.2008.144683; Greenberg SA, 2004, J NEUROL, V251, P111, DOI 10.1007/s00415-004-0263-0; Gregg XT, 2002, BLOOD, V100, P1493, DOI 10.1182/blood-2002-01-0256; Gu Y, 2005, J INHERIT METAB DIS, V28, P473, DOI 10.1007/s10545-005-0473-3; Guo ZJ, 1999, ANGEW CHEM INT EDIT, V38, P1513; Gurusamy K, 2007, BIOL TRACE ELEM RES, V118, P191, DOI 10.1007/s12011-007-0008-x; Harms L, 1997, J NEUROL NEUROSUR PS, V62, P27, DOI 10.1136/jnnp.62.1.27; Harris ZL, 1998, AM J CLIN NUTR, V67, p972S, DOI 10.1093/ajcn/67.5.972S; Hasinoff BB, 2015, BIOCHEM PHARMACOL, V93, P266, DOI 10.1016/j.bcp.2014.12.008; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Henry NL, 2006, ONCOLOGY-BASEL, V71, P168, DOI 10.1159/000106066; Heron P, 2001, LIFE SCI, V68, P1575, DOI 10.1016/S0024-3205(01)00948-1; Hijazi N, 2003, BRAIN RES, V993, P192, DOI 10.1016/j.brainres.2003.09.014; Hofmann WP, 2007, SCAND J GASTROENTERO, V42, P1088, DOI 10.1080/00365520701278810; Holzer AK, 2006, CANCER RES, V66, P10944, DOI 10.1158/0008-5472.CAN-06-1710; Hood BD, 1999, J BIOL CHEM, V274, P32547, DOI 10.1074/jbc.274.46.32547; Huang Pei-Yu, 2004, Ai Zheng, V23, P845; Huppke P, 2012, AM J HUM GENET, V90, P61, DOI 10.1016/j.ajhg.2011.11.030; Ishida S, 2002, P NATL ACAD SCI USA, V99, P14298, DOI 10.1073/pnas.162491399; Ishida S, 2013, P NATL ACAD SCI USA, V110, P19507, DOI 10.1073/pnas.1318431110; Ishida S, 2010, CANCER CELL, V17, P574, DOI 10.1016/j.ccr.2010.04.011; Jaiser SR, 2010, J NEUROL, V257, P869, DOI 10.1007/s00415-010-5511-x; Jeong SY, 2006, J NEUROSCI, V26, P9810, DOI 10.1523/JNEUROSCI.2922-06.2006; Ji B, 2020, ACTA BIOMATER, V111, P363, DOI 10.1016/j.actbio.2020.04.046; Josefsen K, 2010, NEUROBIOL DIS, V40, P656, DOI 10.1016/j.nbd.2010.08.009; Juloski JT, 2020, J TRACE ELEM MED BIO, V59, DOI 10.1016/j.jtemb.2020.126451; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Kakuda M, 2020, AM J OBSTET GYNECOL, V222, DOI 10.1016/j.ajog.2019.07.030; Kaler SG, 2020, MOL GENET METAB REP, V24, DOI 10.1016/j.ymgmr.2020.100602; Kaluderovic GN, 2012, BIOINORG CHEM APPL, V2012, DOI 10.1155/2012/705907; Karimi A, 2019, BIOL TRACE ELEM RES, V191, P70, DOI 10.1007/s12011-018-1605-6; Karimi A, 2015, BIOL TRACE ELEM RES, V165, P131, DOI 10.1007/s12011-015-0256-0; Kasashima H, 2018, DIGESTION, V98, P238, DOI 10.1159/000489558; Kase H, 1998, ACTA CYTOL, V42, P1397, DOI 10.1159/000332174; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Katzourakis A, 2005, TRENDS MICROBIOL, V13, P463, DOI 10.1016/j.tim.2005.08.004; Kelkar Praful, 2008, J Clin Neuromuscul Dis, V10, P1, DOI 10.1097/CND.0b013e3181828cf7; Khan MK, 2002, NEOPLASIA, V4, P164, DOI 10.1038/sj.neo.7900218; Kim BH, 2004, MOL BRAIN RES, V124, P40, DOI 10.1016/j.molbrainres.2004.02.005; Kimura S, 2004, INT J MOL MED, V14, P185; Kirschmann DA, 2002, CANCER RES, V62, P4478; Kirshner JR, 2008, MOL CANCER THER, V7, P2319, DOI 10.1158/1535-7163.MCT-08-0298; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Komatsu M, 2000, CANCER RES, V60, P1312; Kono S, 2006, BIOL RES, V39, P15, DOI 10.4067/S0716-97602006000100003; Kono S, 2010, BBA-MOL BASIS DIS, V1802, P968, DOI 10.1016/j.bbadis.2010.07.011; Kumar N, 2006, NEURORADIOLOGY, V48, P78, DOI 10.1007/s00234-005-0016-5; Kumar N, 2004, NEUROLOGY, V63, P33, DOI 10.1212/01.WNL.0000132644.52613.FA; Kumar N, 2004, J NEUROL, V251, P747, DOI 10.1007/s00415-004-0428-x; Kumar P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-206; Kuo MTH, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104495; Lebwohl D, 1998, EUR J CANCER, V34, P1522, DOI 10.1016/S0959-8049(98)00224-X; Lehmann S, 2002, CURR OPIN CHEM BIOL, V6, P187, DOI 10.1016/S1367-5931(02)00295-8; Li Y, 2018, J CELL MOL MED, V22, P439, DOI 10.1111/jcmm.13334; Li YQ, 2020, CANCERS, V12, DOI 10.3390/cancers12010138; Liao Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14698-y; Lin JQ, 2013, UROL ONCOL-SEMIN ORI, V31, P581, DOI 10.1016/j.urolonc.2011.04.009; Liu Y, 2019, MOL PHARMACEUT, V16, P3322, DOI 10.1021/acs.molpharmaceut.9b00273; Longinetti E, 2019, CURR OPIN NEUROL, V32, P771, DOI 10.1097/WCO.0000000000000730; Lopez Jay, 2019, Met Ions Life Sci, V19, DOI 10.1515/9783110527872-018; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; Lu JJ, 2012, MOL CELL BIOCHEM, V360, P253, DOI 10.1007/s11010-011-1064-2; Lun XQ, 2016, CLIN CANCER RES, V22, P3860, DOI 10.1158/1078-0432.CCR-15-1798; MacDonald G, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004870; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Malacards, 2011, HUM DIS DAT; Marchi G, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00325; Masters JRW, 1996, EUR J CANCER, V32A, P1248, DOI 10.1016/0959-8049(96)00033-0; Mayeux R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006239; McAllum EJ, 2013, AMYOTROPH LAT SCL FR, V14, P586, DOI 10.3109/21678421.2013.824000; McColgan P, 2018, EUR J NEUROL, V25, P24, DOI 10.1111/ene.13413; Medeiros Rui, 2003, Int J Clin Oncol, V8, P156, DOI 10.1007/s10147-003-0318-8; MIYAJIMA H, 1987, NEUROLOGY, V37, P761, DOI 10.1212/WNL.37.5.761; Miyashita H, 2003, ORAL ONCOL, V39, P157, DOI 10.1016/S1368-8375(02)00038-6; Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034; Muller PAJ, 2009, TRAFFIC, V10, P514, DOI 10.1111/j.1600-0854.2009.00892.x; Muller T, 1999, J PEDIATR-US, V135, P189, DOI 10.1016/S0022-3476(99)70021-1; Muller T, 2004, HEPATOLOGY, V39, P963, DOI 10.1002/hep.20108; Muller T, 1998, AM J CLIN NUTR, V67, p1082S, DOI 10.1093/ajcn/67.5.1082S; Nagai M, 2012, FREE RADICAL BIO MED, V52, P2142, DOI 10.1016/j.freeradbiomed.2012.03.017; Nagano S, 1999, NEUROSCI LETT, V265, P159, DOI 10.1016/S0304-3940(99)00227-X; Nakayama K, 2004, CLIN CANCER RES, V10, P2804, DOI 10.1158/1078-0432.CCR-03-0454; Nash RA, 2005, ALTERN THER HEALTH M, V11, P18; Nations SP, 2008, NEUROLOGY, V71, P639, DOI 10.1212/01.wnl.0000312375.79881.94; Nayak NC, 2013, INDIAN J MED RES, V137, P1029; Ndagi U, 2017, DRUG DES DEV THER, V11, P599, DOI 10.2147/DDDT.S119488; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nguyen T, 2005, P NATL ACAD SCI USA, V102, P11840, DOI 10.1073/pnas.0502177102; Nilsson M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19608; ONEILL NC, 1989, J PEDIATR GASTR NUTR, V9, P167, DOI 10.1097/00005176-198908000-00006; Orphanet, 2011, ORPH; Osawa T, 2013, BRIT J CANCER, V109, P2237, DOI 10.1038/bjc.2013.535; Palm ME, 2011, P NATL ACAD SCI USA, V108, P6951, DOI 10.1073/pnas.1012899108; Palm-Espling ME, 2014, PROTEIN PEPTIDE LETT, V21, P63; Pamp K, 2005, FREE RADICAL RES, V39, P31, DOI 10.1080/10715760400023671; Pan Q, 2002, CANCER RES, V62, P4854; Pan QT, 2009, CLIN CANCER RES, V15, P7441, DOI 10.1158/1078-0432.CCR-09-1361; Pan XT, 2020, SMALL, V16, DOI 10.1002/smll.202000809; Pandit A, 1996, AM J CLIN NUTR, V63, P830, DOI 10.1093/ajcn/63.5.830; Pass HI, 2008, ANN THORAC SURG, V86, P383, DOI 10.1016/j.athoracsur.2008.03.016; Patel BN, 2000, J BIOL CHEM, V275, P4305, DOI 10.1074/jbc.275.6.4305; Patel BN, 1997, J BIOL CHEM, V272, P20185, DOI 10.1074/jbc.272.32.20185; Patra S, 2013, INDIAN J PEDIATR, V80, P651, DOI 10.1007/s12098-012-0935-1; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Payne SL, 2006, J CELL BIOCHEM, V98, P827, DOI 10.1002/jcb.20792; Pendyala L, 1997, CANCER CHEMOTH PHARM, V40, P38, DOI 10.1007/s002800050622; Peng YJ, 2014, J NEUROSCI, V34, P6772, DOI 10.1523/JNEUROSCI.0077-14.2014; Perego P, 1998, ANN ONCOL, V9, P423, DOI 10.1023/A:1008265012435; PETERSEN RB, 1992, NEUROLOGY, V42, P1859, DOI 10.1212/WNL.42.10.1859; PRESTAYKO AW, 1979, CANCER TREAT REV, V6, P17, DOI 10.1016/S0305-7372(79)80057-2; Pringsheim T, 2012, MOVEMENT DISORD, V27, P1083, DOI 10.1002/mds.25075; Prodan CI, 2002, NEUROLOGY, V59, P1453, DOI 10.1001/archneur.59.9.1453; Quintanar L, 2016, ACS CHEM BIOL, V11, P263, DOI 10.1021/acschembio.5b00919; Rana A, 2009, CHEM-BIOL INTERACT, V181, P282, DOI 10.1016/j.cbi.2009.07.021; Rigiracciolo DC, 2015, ONCOTARGET, V6, P34158, DOI 10.18632/oncotarget.5779; Roberti Maria do Rosário Ferraz, 2011, Rev. Bras. Hematol. Hemoter., V33, P389, DOI 10.5581/1516-8484.20110104; Roberts BR, 2014, J NEUROSCI, V34, P8021, DOI 10.1523/JNEUROSCI.4196-13.2014; Roche J, 2018, CANCERS, V10, DOI 10.3390/cancers10020052; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Roskamp KW, 2020, BIOCHEMISTRY-US, V59, P2371, DOI 10.1021/acs.biochem.0c00293; Rowe D, 2020, NEUROLOGY, V94; Safaei R, 2008, MOL PHARMACOL, V73, P461, DOI 10.1124/mol.107.040980; Safaei R, 2013, METALLOMICS, V5, P964, DOI 10.1039/c3mt00131h; Safaei R, 2009, J INORG BIOCHEM, V103, P333, DOI 10.1016/j.jinorgbio.2008.11.012; Sandahl TD, 2020, HEPATOLOGY, V71, P722, DOI 10.1002/hep.30911; Schachtschneider KM, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00190; Scheinberg IH, 1996, AM J CLIN NUTR, V63, P842; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schleper B, 2001, J NEUROL, V248, P705, DOI 10.1007/s004150170118; Schook LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128864; Sciegienka SJ, 2017, FREE RADICAL BIO MED, V108, P354, DOI 10.1016/j.freeradbiomed.2017.04.001; Seong IS, 2005, HUM MOL GENET, V14, P2871, DOI 10.1093/hmg/ddi319; Shanbhag V, 2019, P NATL ACAD SCI USA, V116, P6836, DOI 10.1073/pnas.1817473116; Shanbhag VC, 2021, BBA-MOL CELL RES, V1868, DOI 10.1016/j.bbamcr.2020.118893; Sheline CT, 2004, ANN NEUROL, V55, P645, DOI 10.1002/ana.20047; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sigurdsson EM, 2003, J BIOL CHEM, V278, P46199, DOI 10.1074/jbc.C300303200; Sinani D, 2007, J BIOL CHEM, V282, P26775, DOI 10.1074/jbc.M703973200; Skrajnowska D, 2013, BIOL TRACE ELEM RES, V156, P271, DOI 10.1007/s12011-013-9854-x; Song IS, 2004, MOL CANCER THER, V3, P1543; Soon CPW, 2011, J BIOL CHEM, V286, P44035, DOI 10.1074/jbc.M111.274407; Sorenson JRJ, 2007, CURR MED CHEM, V14, P1499; Sorokin AV, 2013, ONCOGENE, V32, P3130, DOI 10.1038/onc.2012.327; Spencer J, 2018, FUTURE MED CHEM, V10, P607, DOI 10.4155/fmc-2018-9999; Spinazzi M, 2007, J NEUROL, V254, P1012, DOI 10.1007/s00415-006-0479-2; Stewart DJ, 2007, CRIT REV ONCOL HEMAT, V63, P12, DOI 10.1016/j.critrevonc.2007.02.001; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Surowiak P, 2005, VIRCHOWS ARCH, V447, P626, DOI 10.1007/s00428-005-1228-0; Tadini-Buoninsegni F, 2014, ANGEW CHEM INT EDIT, V53, P1297, DOI 10.1002/anie.201307718; Tan JC, 2006, JPEN-PARENTER ENTER, V30, P446, DOI 10.1177/0148607106030005446; Tanimoto K, 1998, ONCOL REP, V5, P805; TANNER MS, 1979, LANCET, V1, P1203; TANNER MS, 1987, ARCH DIS CHILD, V62, P1118, DOI 10.1136/adc.62.11.1118; Tanner MS, 1998, AM J CLIN NUTR, V67, p1074S, DOI 10.1093/ajcn/67.5.1074S; Teknos TN, 2005, ARCH OTOLARYNGOL, V131, P204, DOI 10.1001/archotol.131.3.204; Thackray AM, 2002, BIOCHEM J, V362, P253, DOI 10.1042/0264-6021:3620253; Thompson KH, 2006, DALTON T, P761, DOI 10.1039/b513476e; Tsang T, 2020, NAT CELL BIOL, V22, DOI 10.1038/s41556-020-0481-4; Unrine JM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212340; van Golen KL, 2002, NEOPLASIA, V4, P373, DOI 10.1038/sj.neo.7900258; Vieira FG, 2017, IBRO REP, V2, P47, DOI 10.1016/j.ibror.2017.03.001; Voli F, 2020, CANCER RES, V80, P4129, DOI 10.1158/0008-5472.CAN-20-0471; Waggoner DJ, 1999, NEUROBIOL DIS, V6, P221, DOI 10.1006/nbdi.1999.0250; Wang DD, 2018, ACS NANO, V12, P5241, DOI 10.1021/acsnano.7b08355; Wang J, 2015, NAT CHEM, V7, P968, DOI [10.1038/NCHEM.2381, 10.1038/nchem.2381]; Wang-Johanning F, 2003, CANCER-AM CANCER SOC, V98, P187, DOI 10.1002/cncr.11451; Wang-Johanning F, 2001, CLIN CANCER RES, V7, P1553; Watts JC, 2007, BBA-MOL BASIS DIS, V1772, P654, DOI 10.1016/j.bbadis.2007.05.001; Watts JC, 2006, PLOS PATHOG, V2, P152, DOI 10.1371/journal.ppat.0020026; Weng YZW, 2020, SMALL, V16, DOI 10.1002/smll.201905184; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Wijmenga C, 1998, EUR J HUM GENET, V6, P624, DOI 10.1038/sj.ejhg.5200235; Williams JR, 2016, NEUROBIOL DIS, V89, P1, DOI 10.1016/j.nbd.2016.01.020; Willis MS, 2005, AM J CLIN PATHOL, V123, P125, DOI 10.1309/V6GVYW2QTYD5C5PJ; Wong BS, 2001, J NEUROCHEM, V78, P1400, DOI 10.1046/j.1471-4159.2001.00522.x; Wong BS, 2001, PANMINERVA MED, V43, P283; Wong CCL, 2014, HEPATOLOGY, V60, P1645, DOI 10.1002/hep.27320; Xu HD, 2005, BIOCHEM BIOPH RES CO, V328, P618, DOI 10.1016/j.bbrc.2005.01.015; Xu MM, 2018, CLIN CANCER RES, V24, P4271, DOI 10.1158/1078-0432.CCR-17-3705; Xu XY, 2004, ANN NY ACAD SCI, V1012, P299, DOI 10.1196/annals.1306.024; Yoshida H, 2013, ANTICANCER RES, V33, P1409; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Yoshii Y, 2012, NUCL MED BIOL, V39, P177, DOI 10.1016/j.nucmedbio.2011.08.008; Younan ND, 2011, J MOL BIOL, V410, P369, DOI 10.1016/j.jmb.2011.05.013; Yu Z, 2020, CLIN TRANSL MED, V10, P57, DOI 10.1002/ctm2.19; Yun Y, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0755-1; Zablocka-Slowinska K, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010060; Zablocka-Slowinska K, 2018, J TRACE ELEM MED BIO, V45, P78, DOI 10.1016/j.jtemb.2017.09.024; Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024; Zhang M, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180161; Zhang XP, 2018, J INT MED RES, V46, P4863, DOI 10.1177/0300060518798507; Zhang YA, 2019, FUTURE MED CHEM, V11, P1035, DOI 10.4155/fmc-2018-0190; Zou QL, 2017, J AM CHEM SOC, V139, P1921, DOI 10.1021/jacs.6b11382	767	16	16	21	45	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21810	10.1096/fj.202100273RR	http://dx.doi.org/10.1096/fj.202100273RR			50	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34390520	Bronze			2022-12-28	WOS:000691122900024
J	Zhang, SQ; Cao, YZ; Du, JW; Liu, H; Chen, XJ; Li, MD; Xiang, MQ; Wang, CY; Wu, XM; Liu, LJ; Wang, CL; Wu, YS; Li, ZX; Fang, SH; Shi, JL; Wang, LH				Zhang, Shuoqi; Cao, Yuze; Du, Jingwen; Liu, Huan; Chen, Xiaojing; Li, Mengdi; Xiang, Mengqi; Wang, Chengyue; Wu, Xiaoming; Liu, Langjiao; Wang, Chunli; Wu, Yinsong; Li, Zhuxin; Fang, Shaohong; Shi, Jialan; Wang, Lihua			Neutrophil extracellular traps contribute to tissue plasminogen activator resistance in acute ischemic stroke	FASEB JOURNAL			English	Article						endothelial cells; hypercoagulable state; neutrophil extracellular traps; platelets; stroke; thrombolysis resistance	VON-WILLEBRAND-FACTOR; PROCOAGULANT ACTIVITY; EARLY MANAGEMENT; IN-VITRO; THROMBOLYSIS; PLATELETS; CELLS; TPA; DNA; FIBRINOLYSIS	Circulating neutrophil extracellular traps (NETs) resistant to t-PA have not been studied completely although NETs in thrombi may contribute to tissue plasminogen activator (t-PA) resistance. This research intended to elucidate whether circulating NETs are associated with t-PA resistance and the underlying mechanism. The levels of NETs were detected in the circulating neutrophils, ischemic brain tissue of acute ischemic stroke (AIS) patients, and transient middle cerebral artery occlusion (tMCAO) models. NET formation in blood, thrombi, and ischemic brain tissue of mice were analyzed by immunofluorescence. Exposed phosphatidylserine (PS) was assessed using flow cytometry and confocal microscopy. Procoagulant activity (PCA) was evaluated using fibrin formation assays, thrombin, and purified coagulation complex. The plasma levels of NETs in AIS patients were significantly higher than those in healthy individuals. After thrombolysis, a significant increase was noted in NET markers in no-improvement patients, while the changes in improvement patients were not significant. Importantly, NETs were decorated with von Willebrand factor (vWF) and plasminogen activator inhibitor-1 (PAI-1) in the blood and thrombi, which could reverse the fibrinolytic effects. In addition, NETs activated platelets (PLTs) and endothelial cells (ECs), stimulating a procoagulant phenotype and facilitating vWF and PAI-1 release. DNase I, activated protein C (APC), and sivelestat markedly inhibited these effects. Furthermore, targeting NETs protected mice from tMCAO-induced cerebral ischemia, possibly by regulating vWF and PAI-1. In summary, NETs may contribute to t-PA resistance in AIS through activation of PLTs and ECs. Strategies against NETs may present a promising therapeutic approach to improve the thrombolysis efficiency of t-PA in AIS patients.	[Zhang, Shuoqi; Wang, Lihua] Harbin Med Univ, Affiliated Hosp 2, Dept Neurol, Harbin, Peoples R China; [Zhang, Shuoqi; Fang, Shaohong] Minist Educ, Key Lab Myocardial Ischem, Harbin, Peoples R China; [Cao, Yuze] Chinese Acad Med Sci, Dept Neurol, Peking Union Med Coll Hosp, Beijing, Peoples R China; [Du, Jingwen; Liu, Huan; Chen, Xiaojing; Li, Mengdi; Xiang, Mengqi; Wang, Chengyue; Wu, Xiaoming; Liu, Langjiao; Wang, Chunli; Wu, Yinsong; Shi, Jialan] Harbin Med Univ, Affiliated Hosp 1, Dept Hematol, Harbin, Peoples R China; [Li, Zhuxin] Heilongjiang Univ Chinese Med, Coll Acupuncture & Moxibust, Dept Acupuncture & Moxibust, Harbin, Peoples R China; [Shi, Jialan] Harvard Med Sch, Dept Med, Brigham & Womens Hosp, VA Boston Healthcare Syst, Boston, MA USA	Harbin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Harbin Medical University; Heilongjiang University of Chinese Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System	Wang, LH (corresponding author), Harbin Med Univ, Hosp 2, Dept Neurol, 246 Xuefu Rd, Harbin 150001, Peoples R China.; Shi, JL (corresponding author), Harbin Med Univ, Hosp 1, Dept Hematol, 23 Youzheng St, Harbin 150001, Peoples R China.	jialan_shi@hms.harvard.edu; wanglh211@163.com		Wu, Xiaoming/0000-0002-4271-8534; Shi, Jialan/0000-0001-5642-5436; Wang, Chengyue/0000-0002-8886-2523	National Natural Science Foundation of China [81820108014, 81771361, 81801190, 81901277, 82071407]; National Key Research and Development Project [2018YFE0114400]; Graduate Innovation Fund of Harbin Medical University [YJSSJCX2019-07HYD]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Project; Graduate Innovation Fund of Harbin Medical University	National Natural Science Foundation of China, Grant/Award Number: 81820108014, 81771361, 81801190, 81901277 and 82071407; National Key Research and Development Project, Grant/Award Number: 2018YFE0114400; Graduate Innovation Fund of Harbin Medical University, Grant/Award Number: YJSSJCX2019-07HYD	Abu-Fanne R, 2019, BLOOD, V133, P481, DOI 10.1182/blood-2018-07-861237; Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Boulaftali Y, 2011, CIRCULATION, V123, P1326, DOI 10.1161/CIRCULATIONAHA.110.000885; Bustamante Alejandro, 2016, J Circ Biomark, V5, p1849454416668791, DOI 10.1177/1849454416668791; Cai W, 2020, TRANSL STROKE RES, V11, P108, DOI 10.1007/s12975-019-00694-y; Campbell RA, 2009, BLOOD, V114, P4886, DOI 10.1182/blood-2009-06-228940; Carbone F, 2015, VASC PHARMACOL, V64, P16, DOI 10.1016/j.vph.2014.11.007; Carestia A, 2013, THROMB HAEMOSTASIS, V110, P1035, DOI 10.1160/TH13-02-0174; Chen SH, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.607287; De Meyer SF, 2012, ARTERIOSCL THROM VAS, V32, P1884, DOI 10.1161/ATVBAHA.112.250993; Denorme F, 2016, BLOOD, V127, P2337, DOI 10.1182/blood-2015-08-662650; Ducroux C, 2018, STROKE, V49, P754, DOI 10.1161/STROKEAHA.117.019896; Fassbender K, 1999, STROKE, V30, P2101, DOI 10.1161/01.STR.30.10.2101; Fernandez-Cadenas I, 2009, THROMB HAEMOSTASIS, V102, P759, DOI 10.1160/TH08-06-0398; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Gaitzsch E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01148-x; Ge L, 2015, AM J PHYSIOL-HEART C, V308, pH500, DOI 10.1152/ajpheart.00381.2014; Genchi A, 2021, J NEUROL SCI, V423, DOI 10.1016/j.jns.2021.117355; Grassle S, 2014, ARTERIOSCL THROM VAS, V34, P1382, DOI 10.1161/ATVBAHA.113.303016; Griemert EV, 2019, ANN NEUROL, V85, P667, DOI 10.1002/ana.25458; Gupta AK, 2010, FEBS LETT, V584, P3193, DOI 10.1016/j.febslet.2010.06.006; Hantgan RR, 1998, THROMB HAEMOSTASIS, V79, P602; Heo JH, 2003, STROKE, V34, pE48, DOI 10.1161/01.STR.0000073788.81170.1C; Herbig BA, 2015, J THROMB HAEMOST, V13, P1699, DOI 10.1111/jth.13044; Higashida RT, 2003, STROKE, V34, pE109, DOI 10.1161/01.STR.0000082721.62796.09; JANG IK, 1989, CIRCULATION, V79, P920, DOI 10.1161/01.CIR.79.4.920; Kim SW, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0747-x; Laridan E, 2017, ANN NEUROL, V82, P223, DOI 10.1002/ana.24993; Li BR, 2019, J CANCER RES CLIN, V145, P1695, DOI 10.1007/s00432-019-02922-2; Li T, 2020, J CROHNS COLITIS, V14, P240, DOI 10.1093/ecco-jcc/jjz132; Longstaff C, 2013, J BIOL CHEM, V288, P6946, DOI 10.1074/jbc.M112.404301; Mangold A, 2015, CIRC RES, V116, P1182, DOI 10.1161/CIRCRESAHA.116.304944; Martinod K, 2014, BLOOD, V123, P2768, DOI 10.1182/blood-2013-10-463646; Mitchell JL, 2014, BLOOD, V124, P3982, DOI 10.1182/blood-2014-06-583070; Mutch NJ, 2010, BLOOD, V115, P3980, DOI 10.1182/blood-2009-11-254029; Novotny J, 2020, NEUROLOGY, V94, pE2346, DOI 10.1212/WNL.0000000000009532; Otxoa-de-Amezaga A, 2019, STROKE, V50, P1548, DOI 10.1161/STROKEAHA.118.023837; Pena-Martinez C, 2019, STROKE, V50, P3228, DOI 10.1161/STROKEAHA.119.026848; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Praetner M, 2018, ARTERIOSCL THROM VAS, V38, P829, DOI 10.1161/ATVBAHA.117.309760; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; Ribo M, 2004, THROMB HAEMOSTASIS, V91, P1146, DOI 10.1160/TH04-02-0097; Ruggeri ZM, 2003, J THROMB HAEMOST, V1, P1335, DOI 10.1046/j.1538-7836.2003.00260.x; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Sambola A, 2016, THROMB HAEMOSTASIS, V115, P1129, DOI 10.1160/TH15-12-0985; Seners P, 2016, STROKE, V47, P2409, DOI 10.1161/STROKEAHA.116.014181; Shi KB, 2021, CIRC RES, V128, P62, DOI 10.1161/CIRCRESAHA.120.317596; Stakos DA, 2015, EUR HEART J, V36, P1405, DOI 10.1093/eurheartj/ehv007; Tanka-Salamon A, 2010, THROMB HAEMOSTASIS, V103, P291, DOI 10.1160/TH09-07-0420; Valles J, 2017, THROMB HAEMOSTASIS, V117, P1919, DOI 10.1160/TH17-02-0130; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; Yao ZP, 2017, TRANSL STROKE RES, V8, P83, DOI 10.1007/s12975-016-0501-7; Yoo DG, 2014, IMMUNOL LETT, V160, P186, DOI 10.1016/j.imlet.2014.03.003; Zhang Y, 2019, THROMB RES, V180, P87, DOI 10.1016/j.thromres.2019.06.005; Zhao LL, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0328-9; Zhou P, 2020, EBIOMEDICINE, V53, DOI 10.1016/j.ebiom.2020.102671; ZLOKOVIC BV, 1995, NEUROSURGERY, V37, P955, DOI 10.1227/00006123-199511000-00015	59	5	5	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21835	10.1096/fj.202100471RR	http://dx.doi.org/10.1096/fj.202100471RR			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34449927	hybrid			2022-12-28	WOS:000691122900050
J	Dusadeemeelap, C; Rojasawasthien, T; Matsubara, T; Kokabu, S; Addison, WN				Dusadeemeelap, Chirada; Rojasawasthien, Thira; Matsubara, Takuma; Kokabu, Shoichiro; Addison, William N.			Inhibition of TET-mediated DNA demethylation suppresses osteoblast differentiation	FASEB JOURNAL			English	Article						DNA demethylation; DNA methylation; epigenetics; osteoblast; SP7; TET; TET inhibitors	OSTERIX OSX; METHYLATION; 5-HYDROXYMETHYLCYTOSINE; EXPRESSION; TRANSCRIPTION; PROTEINS; SP7; 5-METHYLCYTOSINE; MINERALIZATION; HOMEOSTASIS	DNA methylation is an epigenetic modification critical for the regulation of chromatin structure and gene expression during development and disease. The ten-eleven translocation (TET) enzyme family catalyzes the hydroxymethylation and subsequent demethylation of DNA by oxidizing 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC). Little is known about TET protein function due to a lack of pharmacological tools to manipulate DNA hydroxymethylation levels. In this study, we examined the role of TET-mediated DNA hydroxymethylation during BMP-induced C2C12 osteoblast differentiation using a novel cytosine-based selective TET enzyme inhibitor, Bobcat339 (BC339). Treatment of C2C12 cells with BC339 increased global 5mC and decreased global 5hmC without adversely affecting cell viability, proliferation, or apoptosis. Furthermore, BC339 treatment inhibited osteoblast marker gene expression and decreased alkaline phosphatase activity during differentiation. Methylated DNA immunoprecipitation and bisulfite sequencing showed that inhibition of TET with BC339 led to increased 5mC at specific CpG-rich regions at the promoter of Sp7, a key osteoblast transcription factor. Consistent with promoter 5mC marks being associated with transcriptional repression, luciferase activity of an Sp7-promoter-reporter construct was repressed by in vitro DNA methylation or BC339. Chromatin immunoprecipitation analysis confirmed that TET2 does indeed occupy the promoter region of Sp7. Accordingly, forced overexpression of SP7 rescued the inhibition of osteogenic differentiation by BC339. In conclusion, our data suggest that TET-mediated DNA demethylation of genomic regions, including the Sp7 promoter, plays a role in the initiation of osteoblast differentiation. Furthermore, BC339 is a novel pharmacological tool for the modulation of DNA methylation dynamics for research and therapeutic applications.	[Dusadeemeelap, Chirada; Rojasawasthien, Thira; Matsubara, Takuma; Kokabu, Shoichiro; Addison, William N.] Kyushu Dent Univ, Div Mol Signaling & Biochem, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan; [Dusadeemeelap, Chirada] Kyushu Dent Univ, Div Special Needs & Geriatr Dent, Kitakyushu, Fukuoka, Japan	Kyushu Dental University; Kyushu Dental University	Addison, WN (corresponding author), Kyushu Dent Univ, Div Mol Signaling & Biochem, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	r19addison@fa.kyu-dent.ac.jp		Addison, William/0000-0002-8587-8028	NOVARTIS Foundation (Japan) for the Promotion of Science (NOVARTIS Foundation (Japan)) [20--018]; MEXT \ Japan Society for the Promotion of Science (JSPS) [19K24152]; Fukuoka Foundation for Sound Health	NOVARTIS Foundation (Japan) for the Promotion of Science (NOVARTIS Foundation (Japan)); MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fukuoka Foundation for Sound Health(Fukuoka Foundation for Sound Health)	NOVARTIS Foundation (Japan) for the Promotion of Science (NOVARTIS Foundation (Japan)), Grant/Award Number: 20--018; MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 19K24152; Fukuoka Foundation for Sound Health	Addison WN, 2015, BONE, V71, P244, DOI 10.1016/j.bone.2014.11.003; Baek WY, 2009, J BONE MINER RES, V24, P1055, DOI [10.1359/JBMR.081248, 10.1359/jbmr.081248]; Barbuto R, 2013, J MOL ENDOCRINOL, V51, P99, DOI 10.1530/JME-12-0251; Cakouros D, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-018-0247-4; Carrio E, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00019; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Chua GNL, 2019, ACS MED CHEM LETT, V10, P180, DOI 10.1021/acsmedchemlett.8b00474; Dawlaty MM, 2014, DEV CELL, V29, P102, DOI 10.1016/j.devcel.2014.03.003; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Delgado-Calle J, 2012, J BONE MINER RES, V27, P926, DOI 10.1002/jbmr.1491; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fux C, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh001; Gao J, 2016, PROTEIN CELL, V7, P351, DOI 10.1007/s13238-016-0267-4; Gao YG, 2004, GENE, V341, P101, DOI 10.1016/j.gene.2004.05.026; Hariri H, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87608-x; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hojo H, 2016, DEV CELL, V37, P238, DOI 10.1016/j.devcel.2016.04.002; Hong SHH, 2009, J MOL ENDOCRINOL, V43, P197, DOI 10.1677/JME-09-0012; Hupkes M, 2011, BBA-MOL CELL RES, V1813, P839, DOI 10.1016/j.bbamcr.2011.01.022; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Lee JY, 2006, MOL CELLS, V22, P182; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li X, 2016, P NATL ACAD SCI USA, V113, pE8267, DOI 10.1073/pnas.1617802113; Li XK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15903; Liu RJ, 2013, CIRCULATION, V128, P2047, DOI 10.1161/CIRCULATIONAHA.113.002887; Lopez-Moyado IF, 2019, P NATL ACAD SCI USA, V116, P16933, DOI 10.1073/pnas.1903059116; Montagner S, 2016, CELL REP, V15, P1566, DOI 10.1016/j.celrep.2016.04.044; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Neri F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r91; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Pleyer L, 2015, DRUG METAB REV, V47, P252, DOI 10.3109/03602532.2014.995379; Rao LJ, 2016, INT J ORAL SCI, V8, P110, DOI 10.1038/ijos.2016.4; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Reppe S, 2015, CURR GENOMICS, V16, P384, DOI 10.2174/1389202916666150817202913; Sepulveda H, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00177-17; Singh AK, 2020, P NATL ACAD SCI USA, V117, P3621, DOI 10.1073/pnas.1910702117; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Taylor SEB, 2016, J BONE MINER RES, V31, P524, DOI 10.1002/jbmr.2711; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Thaler R, 2016, J BIOL CHEM, V291, P6754, DOI 10.1074/jbc.M115.678235; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; van Wijnen AJ, 2019, J ORTHOP RES, V37, P1465, DOI 10.1002/jor.24305; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu XJ, 2017, NAT REV GENET, V18, P517, DOI 10.1038/nrg.2017.33; Yang RL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04464-6; Yasuda K, 2021, BONE REP, V15, DOI 10.1016/j.bonr.2021.101114; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yu Fangtang, 2017, Bone Rep, V6, P109, DOI 10.1016/j.bonr.2017.04.001; Zhong JN, 2017, NUCLEIC ACIDS RES, V45, P672, DOI 10.1093/nar/gkw919; Zhong X, 2017, SCI REP-UK, V7, DOI 10.1038/srep43539; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	61	3	3	6	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22153	10.1096/fj.202101402R	http://dx.doi.org/10.1096/fj.202101402R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34997955				2022-12-28	WOS:000747987800023
J	Zhang, LJ; Li, YQ; Hu, YQ; Chen, M; Cen, CH; Lin, LM; Zhou, JJ; Wang, MY; Cui, XH; Tang, FC; Gao, F				Zhang, Lianjun; Li, Yaqiong; Hu, Yuqiong; Chen, Min; Cen, Changhuo; Lin, Limei; Zhou, Jingjing; Wang, Mengyue; Cui, Xiuhong; Tang, Fuchou; Gao, Fei			Somatic cell-derived BMPs induce premature meiosis in male germ cells during the embryonic stage by upregulating Dazl expression	FASEB JOURNAL			English	Article						BMP signaling pathway; Dazl; DNA methylation; meiosis initiation; beta-catenin activation	BETA-CATENIN; SUPPRESSES MEIOSIS; MEIOTIC INITIATION; DNA METHYLATION; MOUSE; FATE; SEX; PROTEIN; NANOS2; MICE	Although germ cell fate is believed to be determined by signaling factors from differentiated somatic cells, the molecular mechanism behind this process remains obscure. In this study, premature meiosis in male germ cells was observed during the embryonic stage by conditional activation of beta-catenin in Sertoli cells. Somatic and germ cell transcriptome results indicated that the BMP signaling pathway was enriched after beta-catenin activation. In addition, we observed a decreased DNA methylation within a reduction of DNMT3A in germ cells of beta-catenin activated testes and reversed increase after inhibiting BMP signaling pathway with LDN-193189. We also found that Dazl expression was increased in beta-catenin activated testes and decreased after LDN treatment. Taken together, this study demonstrates that male germ cells entered meiosis prematurely during the embryonic stage after beta-catenin activated in Sertoli cells. BMP signaling pathway involved in germ cell meiosis initiation by mediating DNA methylation to induce meiotic genes expression.	[Zhang, Lianjun; Li, Yaqiong; Chen, Min; Cen, Changhuo; Lin, Limei; Zhou, Jingjing; Wang, Mengyue; Cui, Xiuhong; Gao, Fei] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Zhang, Lianjun; Li, Yaqiong; Chen, Min; Cen, Changhuo; Lin, Limei; Zhou, Jingjing; Wang, Mengyue; Gao, Fei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Hu, Yuqiong; Tang, Fuchou] Peking Univ, Coll Life Sci, Beijing Adv Innovat Ctr Genom, Biomed Inst Pioneering Invest Via Convergence, Beijing 100871, Peoples R China; [Hu, Yuqiong; Tang, Fuchou] Biomed Pioneering Innovat Ctr, Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing, Peoples R China; [Cen, Changhuo; Zhou, Jingjing; Wang, Mengyue; Cui, Xiuhong; Gao, Fei] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Chinese Academy of Sciences	Gao, F (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Tang, FC (corresponding author), Peking Univ, Coll Life Sci, Beijing Adv Innovat Ctr Genom, Biomed Inst Pioneering Invest Via Convergence, Beijing 100871, Peoples R China.	tangfuchou@pku.edu.cn; gaof@ioz.ac.cn			National Key R&D Program of China [2018YFA0107702]; National Science Fund for Distinguished Young Scholars [81525011]; National Natural Science Foundation of China [31970785, 32170855, 32060171]	National Key R&D Program of China; National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Key R&D Program of China, Grant/Award Number: 2018YFA0107702; National Science Fund for Distinguished Young Scholars, Grant/Award Number: 81525011; National Natural Science Foundation of China, Grant/Award Number: 31970785, 32170855 and 32060171	Adams IR, 2002, DEVELOPMENT, V129, P1155; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; BORUM K, 1961, EXP CELL RES, V24, P495, DOI 10.1016/0014-4827(61)90449-9; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Brockschnieder D, 2004, MOL CELL BIOL, V24, P7636, DOI 10.1128/MCB.24.17.7636-7642.2004; Chang H, 2008, DEVELOPMENT, V135, P1875, DOI 10.1242/dev.018572; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Coscioni AC, 2001, ANIM REPROD SCI, V67, P59, DOI 10.1016/S0378-4320(01)00116-6; Dong J, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1416-2; Fan XY, 2018, CELL RES, V28, P730, DOI 10.1038/s41422-018-0053-3; Fukuda K, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007436; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; Gill ME, 2011, P NATL ACAD SCI USA, V108, P7443, DOI 10.1073/pnas.1104501108; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hill PWS, 2018, NATURE, V555, P392, DOI 10.1038/nature25964; Kato Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11272; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Koubova J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004541; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007501; Li L, 2021, CELL RES, V31, P463, DOI 10.1038/s41422-020-00401-9; Li YQ, 2017, J BIOL CHEM, V292, P17577, DOI 10.1074/jbc.M117.811349; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Lin YF, 2005, DEV BIOL, V288, P309, DOI 10.1016/j.ydbio.2005.06.032; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; MacLean G, 2001, MECH DEVELOP, V107, P195, DOI 10.1016/S0925-4773(01)00463-4; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; MCLAREN A, 1991, BIOESSAYS, V13, P151, DOI 10.1002/bies.950130402; McLaren A, 1984, Symp Soc Exp Biol, V38, P7; McLaren A, 2001, CELL STRUCT FUNCT, V26, P119, DOI 10.1247/csf.26.119; Miyauchi H, 2017, EMBO J, V36, P3100, DOI 10.15252/embj.201796875; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagaoka SI, 2020, SCIENCE, V367, P1089, DOI 10.1126/science.aaw4115; Navarro-Costa P, 2010, HUM REPROD, V25, P2647, DOI 10.1093/humrep/deq200; Saga Y, 2010, CELL MOL LIFE SCI, V67, P3815, DOI 10.1007/s00018-010-0456-x; Smallwood SA, 2012, TRENDS GENET, V28, P33, DOI 10.1016/j.tig.2011.09.004; Souquet B, 2012, ENDOCRINOLOGY, V153, P2466, DOI 10.1210/en.2011-2056; Spiller C, 2017, STEM CELL RES, V24, P174, DOI 10.1016/j.scr.2017.07.016; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Suzuki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033558; Suzuki A, 2010, P NATL ACAD SCI USA, V107, P3594, DOI 10.1073/pnas.0908664107; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; Wu Q, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002553; Wu Q, 2013, DEVELOPMENT, V140, P291, DOI 10.1242/dev.087882; Xu HL, 2005, DEV CELL, V8, P949, DOI 10.1016/j.devcel.2005.03.018; Yu C, 2016, CELL RES, V26, P275, DOI 10.1038/cr.2016.20; Zhang LJ, 2015, REPROD FERT DEVELOP, V27, P294, DOI 10.1071/RD13281	53	1	1	3	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22131	10.1096/fj.202101585R	http://dx.doi.org/10.1096/fj.202101585R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34985827				2022-12-28	WOS:000747987800051
J	Sheikh, MH; Errede, M; D'Amati, A; Khan, NQ; Fanti, S; Loiola, RA; McArthur, S; Purvis, GSD; O'Riordan, CE; Ferorelli, D; Dell'Erba, A; Kieswich, J; Reutelingsperger, C; Maiorano, E; Yaqoob, M; Thiemermann, C; Baragetti, A; Catapano, AL; Norata, GD; Marelli-Berg, F; Virgintino, D; Solito, E				Sheikh, Madeeha H.; Errede, Mariella; D'Amati, Antonio; Khan, Noorafza Q.; Fanti, Silvia; Loiola, Rodrigo A.; McArthur, Simon; Purvis, Gareth S. D.; O'Riordan, Caroline E.; Ferorelli, Davide; Dell'Erba, Alessandro; Kieswich, Julius; Reutelingsperger, Chis; Maiorano, Eugenio; Yaqoob, Magdi; Thiemermann, Christoph; Baragetti, Andrea; Catapano, Alberico Luigi; Norata, Giuseppe Danilo; Marelli-Berg, Federica; Virgintino, Daniela; Solito, Egle			Impact of metabolic disorders on the structural, functional, and immunological integrity of the blood-brain barrier: Therapeutic avenues	FASEB JOURNAL			English	Article						basal lamina; blood-brain barrier; leukocytes migration; metabolic imbalance; MMPs; neuroinflammation	TYPE-2 DIABETES-MELLITUS; GLYCATION END-PRODUCTS; MATRIX METALLOPROTEINASES; OXIDATIVE STRESS; TISSUE INHIBITOR; MEDITERRANEAN DIET; ENDOTHELIAL-CELLS; ALZHEIMER-DISEASE; LAMININ ISOFORMS; LOW-CARBOHYDRATE	Mounting evidence has linked the metabolic disease to neurovascular disorders and cognitive decline. Using a murine model of a high-fat high-sugar diet mimicking obesity-induced type 2 diabetes mellitus (T2DM) in humans, we show that pro-inflammatory mediators and altered immune responses damage the blood-brain barrier (BBB) structure, triggering a proinflammatory metabolic phenotype. We find that disruption to tight junctions and basal lamina due to loss of control in the production of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) causes BBB impairment. Together the disruption to the structural and functional integrity of the BBB results in enhanced transmigration of leukocytes across the BBB that could contribute to an initiation of a neuroinflammatory response through activation of microglia. Using a humanized in vitro model of the BBB and T2DM patient post-mortem brains, we show the translatable applicability of our results. We find a leaky BBB phenotype in T2DM patients can be attributed to a loss of junctional proteins through changes in inflammatory mediators and MMP/TIMP levels, resulting in increased leukocyte extravasation into the brain parenchyma. We further investigated therapeutic avenues to reduce and restore the BBB damage caused by HFHS-feeding. Pharmacological treatment with recombinant annexin A1 (hrANXA1) or reversion from a high-fat high-sugar diet to a control chow diet (dietary intervention), attenuated T2DM development, reduced inflammation, and restored BBB integrity in the animals. Given the rising incidence of diabetes worldwide, understanding metabolic-disease-associated brain microvessel damage is vital and the proposed therapeutic avenues could help alleviate the burden of these diseases.	[Sheikh, Madeeha H.; Khan, Noorafza Q.; Fanti, Silvia; Loiola, Rodrigo A.; Purvis, Gareth S. D.; O'Riordan, Caroline E.; Kieswich, Julius; Yaqoob, Magdi; Thiemermann, Christoph; Marelli-Berg, Federica; Solito, Egle] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Errede, Mariella; D'Amati, Antonio; Virgintino, Daniela] Univ Bari, Dept Basic Med Sci Neurosci & Sensory Organs, Sch Med, Bari, Italy; [D'Amati, Antonio; Maiorano, Eugenio] Univ Bari, Dept Emergency & Organ Transplantat, Sect Anat Pathol, Bari, Italy; [Loiola, Rodrigo A.] Univ Artois, Fac Jean Perrin, Lab Barriere Hematoencephal, EA 2465, Arras, France; [McArthur, Simon] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, London, England; [Purvis, Gareth S. D.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; [Ferorelli, Davide; Dell'Erba, Alessandro] Univ Bari, Dept Interdisciplinary Med, Sect Legal Med, Bari, Italy; [Reutelingsperger, Chis] Maastricht Univ, Cardiovasc Res Inst, Maastricht, Netherlands; [Baragetti, Andrea; Catapano, Alberico Luigi; Norata, Giuseppe Danilo] Milan Univ, Dept Pharmacol & Biomol Sci, Milan, Italy; [Baragetti, Andrea; Catapano, Alberico Luigi; Norata, Giuseppe Danilo] IRCCS Multimed, Sesto San Giovanni, Italy; [Norata, Giuseppe Danilo] Bassini Hosp, SISA Ctr Study Atherosclerosis, Cinisello Balsamo, Italy; [Solito, Egle] Univ Naples Federico II, Dept Med Mol & Biotecnol Med, Naples, Italy	University of London; Queen Mary University London; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universite d'Artois; University of London; Queen Mary University London; University of Oxford; Universita degli Studi di Bari Aldo Moro; Maastricht University; University of Milan; IRCCS Multimedica; University of Naples Federico II	Solito, E (corresponding author), Queen Mary Univ London, Ctr Translat Med & Therapeut, Barts & London Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	e.solito@qmul.ac.uk	Loiola, Rodrigo Azevedo/C-8520-2012; dAmati, Antonio/AAT-7253-2021; Maiorano, Eugenio/F-1382-2015	Loiola, Rodrigo Azevedo/0000-0002-9820-4495; dAmati, Antonio/0000-0002-4810-1201; Norata, Giuseppe Danilo/0000-0002-6081-1257; Maiorano, Eugenio/0000-0002-0472-5338; McArthur, Simon/0000-0001-8521-1808; Thiemermann, Christoph/0000-0003-4228-9722	British Heart Foundation [FS 16/60/32739]; Ministry of Education-CAPES, Brazil [7326/201409]; Vini di Batasiolo S.p.A [AL-R1C19ABARA_01]; Fondazione Umberto Veronesi [2020-3318]; Fond a zione Cariplo [2016-0852, 2015-0524, 2015-0564]; Fondazione Telethon [GGP19146]; PRIN [2017K.55TILC, 2017H5F943]; H2020 REPROGRAM [PHC-03-2015/667837-2]; Ministero della Salute [GR-2011-02346974]; ERA NET [ER-2017-2364981]; FISM Fundazione Italianana Selerusi Multipla [2014/R/21]	British Heart Foundation(British Heart Foundation); Ministry of Education-CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Vini di Batasiolo S.p.A; Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); Fond a zione Cariplo(Fondazione Cariplo); Fondazione Telethon(Fondazione TelethonEuropean Commission); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); H2020 REPROGRAM; Ministero della Salute(Ministry of Health, Italy); ERA NET; FISM Fundazione Italianana Selerusi Multipla	British Heart Foundation, Grant; Award Number: FS 16/60/32739; Ministry of Education-CAPES, Brazil, Grant/Award Number: 7326/201409; Vini di Batasiolo S.p.A, Grant/Award Number: AL-R1C19ABARA_01; Fondazione Umberto Veronesi, Grant/Award Number: 2020-3318; Fond a zione Cariplo, Grant/Award Number: 2016-0852, 2015-0524 and 2015-0564; Fondazione Telethon, Grant/Award Number: GGP19146; PRIN, Grant/Award Number: 2017K.55TILC and 2017H5F943; H2020 REPROGRAM, Grant/Award Number: PHC-03-2015/667837-2; Ministero della Salute, Grant/Award Number: GR-2011-02346974; ERA NET, Grant/Award Number: ER-2017-2364981; FISM Fundazione Italianana Selerusi Multipla, Grant/Award Number: 2014/R/21	Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Al-Goblan AS, 2014, DIABETES METAB SYNDR, V7, P587, DOI 10.2147/DMSO.S67400; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Bowman GL, 2007, NEUROLOGY, V68, P1809, DOI 10.1212/01.wnl.0000262031.18018.1a; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Bugno M, 1999, FEBS LETT, V448, P9, DOI 10.1016/S0014-5793(99)00323-3; Caputo T, 2017, FEBS LETT, V591, P3061, DOI 10.1002/1873-3468.12742; Carvalho C, 2013, J ALZHEIMERS DIS, V35, P623, DOI 10.3233/JAD-130005; Carvalho C, 2012, DIABETES, V61, P1234, DOI 10.2337/db11-1186; Cho A, 2000, ARTERIOSCL THROM VAS, V20, P2527, DOI 10.1161/01.ATV.20.12.2527; Cristante E, 2013, P NATL ACAD SCI USA, V110, P832, DOI 10.1073/pnas.1209362110; CROSS AH, 1993, NEUROLOGY, V43, P1028, DOI 10.1212/WNL.43.5.1028; da Rosa CVD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199479; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; de Coupade C, 2003, BRIT J PHARMACOL, V140, P133, DOI 10.1038/sj.bjp.0705413; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; DEHOUCK MP, 1992, J NEUROCHEM, V58, P1790, DOI 10.1111/j.1471-4159.1992.tb10055.x; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; Dias IHK, 2014, ANN CLIN BIOCHEM, V51, P125, DOI 10.1177/0004563213508747; Dutra FF, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00115; Elhayany A, 2010, DIABETES OBES METAB, V12, P204, DOI 10.1111/j.1463-1326.2009.01151.x; Engelhardt B, 1997, BLOOD, V90, P4459, DOI 10.1182/blood.V90.11.4459.4459_4459_4472; Fracanzani AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162473; Fredman G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1065; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Frisardi V, 2010, J ALZHEIMERS DIS, V21, P57, DOI 10.3233/JAD-2010-100015; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gardner J, 2003, J NEUROSCI RES, V74, P801, DOI 10.1002/jnr.10835; Ghorpade A, 2001, J VIROL, V75, P6572, DOI 10.1128/JVI.75.14.6572-6583.2001; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Hayden M.R., 2018, NEUROGLIA, V1, P220, DOI [10.3390/neuroglia1010015, DOI 10.3390/NEUROGLIA1010015]; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Hofmann SM, 2002, DIABETES, V51, P2082, DOI 10.2337/diabetes.51.7.2082; Janelidze S, 2017, NEUROBIOL AGING, V51, P104, DOI 10.1016/j.neurobiolaging.2016.11.017; Jurado-Ruiz E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47904-z; Kanoski SE, 2010, J EXP PSYCHOL-ANIM B, V36, P313, DOI 10.1037/a0017228; Lee CH, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1607-0; Lewandowski KC, 2011, ARCH MED SCI, V7, P294, DOI 10.5114/aoms.2011.22081; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P570, DOI 10.1001/archneur.64.4.570; McArthur S, 2010, J IMMUNOL, V185, P6317, DOI 10.4049/jimmunol.1001095; McGrattan AM, 2019, CURR NUTR REP, V8, P53, DOI 10.1007/s13668-019-0271-4; Menezes MJ, 2014, J NEUROSCI, V34, P15260, DOI 10.1523/JNEUROSCI.3678-13.2014; Monteiro R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/289645; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Moran C, 2013, DIABETES CARE, V36, P4036, DOI 10.2337/dc13-0143; Murray AJ, 2009, FASEB J, V23, P4353, DOI 10.1096/fj.09-139691; Nagase Hideaki, 2008, P787, DOI 10.1007/978-0-387-69057-5_37; Norata GD, 2006, STROKE, V37, P1558, DOI 10.1161/01.STR.0000221803.16897.22; Ousman SS, 2012, NAT NEUROSCI, V15, P1096, DOI 10.1038/nn.3161; Pagenstecher A, 1998, AM J PATHOL, V152, P729; Pannacciulli N, 2006, NEUROIMAGE, V31, P1419, DOI 10.1016/j.neuroimage.2006.01.047; Panza F, 2010, J ALZHEIMERS DIS, V21, P691, DOI 10.3233/JAD-2010-091669; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Profaci CP, 2020, J EXP MED, V217, DOI 10.1084/jem.20190062; Purvis GSD, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00571; Ramage FJ., 2020, BMJ OPEN SCI, V4; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rempe RG, 2016, J CEREBR BLOOD F MET, V36, P1481, DOI 10.1177/0271678X16655551; Rezai-Zadeh K, 2009, J NEUROIMMUNE PHARM, V4, P462, DOI 10.1007/s11481-009-9166-2; Rochlani Y, 2017, THER ADV CARDIO DIS, V11, P215, DOI 10.1177/1753944717711379; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Rosenberg GA, 2016, J CEREBR BLOOD F MET, V36, P6, DOI 10.1038/jcbfm.2015.172; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Rudich A, 2007, TRENDS ENDOCRIN MET, V18, P291, DOI 10.1016/j.tem.2007.08.006; Rudziak P, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/4123605; Ryu JK, 2009, J CELL MOL MED, V13, P2911, DOI 10.1111/j.1582-4934.2008.00434.x; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Sheikh MH, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01810-8; Shi FY, 2013, DIGEST DIS SCI, V58, P3326, DOI 10.1007/s10620-013-2774-y; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; Solito E, 2000, J IMMUNOL, V165, P1573, DOI 10.4049/jimmunol.165.3.1573; Song SH, 2009, QJM-INT J MED, V102, P799, DOI 10.1093/qjmed/hcp121; Spielman LJ, 2014, J NEUROIMMUNOL, V273, P8, DOI 10.1016/j.jneuroim.2014.06.004; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Suryadevara R, 2003, GLIA, V44, P47, DOI 10.1002/glia.10266; Szmitko PE, 2003, CIRCULATION, V108, P1917, DOI 10.1161/01.CIR.0000089190.95415.9F; Szymocha R, 2000, AIDS RES HUM RETROV, V16, P1723, DOI 10.1089/08892220050193218; Takechi R, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00399; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Thibault L, 2013, ANIMAL MODELS FOR THE STUDY OF HUMAN DISEASE, P277, DOI 10.1016/B978-0-12-415894-8.00013-0; van Bloemendaal L, 2016, METAB BRAIN DIS, V31, P621, DOI 10.1007/s11011-016-9792-3; van den Brink AC, 2019, ADV NUTR, V10, P1040, DOI 10.1093/advances/nmz054; Wang FX, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00376; Wang T, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00218; Wei SY, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0388-x; Wei SY, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0318-3; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Winters WD, 2003, PHYTOTHER RES, V17, P591, DOI 10.1002/ptr.1079; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu AG, 2006, EUR J NEUROSCI, V23, P2573, DOI 10.1111/j.1460-9568.2006.04807.x; Wu YJ, 2015, INT J MOL SCI, V16, P16469, DOI 10.3390/ijms160716469; Yamagishi S, 2012, BBA-GEN SUBJECTS, V1820, P663, DOI 10.1016/j.bbagen.2011.03.014; Yousif LF, 2013, CELL ADHES MIGR, V7, P101, DOI 10.4161/cam.22680; Zhang Q, 2018, PPAR RES, V2018, DOI 10.1155/2018/4827643	100	3	3	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22107	10.1096/fj.202101297R	http://dx.doi.org/10.1096/fj.202101297R			27	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34939700	Green Published			2022-12-28	WOS:000734992000056
J	Zhang, YL; Quraishi, IH; McClure, H; Williams, LA; Cheng, Y; Kale, S; Dempsey, GT; Agrawal, S; Gerber, DJ; McManus, OB; Kaczmarek, LK				Zhang, Yalan; Quraishi, Imran H.; McClure, Heather; Williams, Luis A.; Cheng, YungChih; Kale, Siddharth; Dempsey, Graham T.; Agrawal, Sudhir; Gerber, David J.; McManus, Owen B.; Kaczmarek, Leonard K.			Suppression of Kv3.3 channels by antisense oligonucleotides reverses biochemical effects and motor impairment in spinocerebellar ataxia type 13 mice	FASEB JOURNAL			English	Article						antisense oligonucleotides; ASO; ataxia; CD63; Hax-1; KCNC3; multivesicular body; potassium channel; TBK1	POTASSIUM CHANNELS; SHAM CONTROL; ONSET; MUTATIONS; NUSINERSEN; NEURONS	Mutations in KCNC3, the gene that encodes the Kv3.3 voltage dependent potassium channel, cause Spinocerebellar Ataxia type 13 (SCA13), a disease associated with disrupted motor behaviors, progressive cerebellar degeneration, and abnormal auditory processing. The Kv3.3 channel directly binds Hax-1, a cell survival protein. A disease-causing mutation, Kv3.3-G592R, causes overstimulation of Tank Binding Kinase 1 (Tbk1) in the cerebellum, resulting in the degradation of Hax-1 by promoting its trafficking into multivesicular bodies and then to lysosomes. We have now tested the effects of antisense oligonucleotides (ASOs) directed against the Kv3.3 channel on both wild type mice and those bearing the Kv3.3-G592R-encoding mutation. Intracerebroventricular infusion of the Kcnc3-specific ASO suppressed both mRNA and protein levels of the Kv3.3 channel. In wild-type animals, this produced no change in levels of activated Tbk1, Hax-1 or Cd63, a tetraspanin marker for late endosomes/multivesicular bodies. In contrast, in mice homozygous for the Kv3.3-G592R-encoding mutation, the same ASO reduced Tbk1 activation and levels of Cd63, while restoring the expression of Hax-1 in the cerebellum. The motor behavior of the mice was tested using a rotarod assay. Surprisingly, the active ASO had no effects on the motor behavior of wild type mice but restored the behavior of the mutant mice to those of age-matched wild type animals. Our findings indicate that, in mature intact animals, suppression of Kv3.3 expression can reverse the deleterious effects of a SCA13 mutation while having little effect on wild type animals. Thus, targeting Kv3.3 expression may prove a viable therapeutic approach for SCA13.	[Zhang, Yalan; McClure, Heather; Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St,POB 208066, New Haven, CT 06520 USA; [Quraishi, Imran H.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Williams, Luis A.; Cheng, YungChih; Kale, Siddharth; Dempsey, Graham T.; Gerber, David J.; McManus, Owen B.] Q State Biosci, Cambridge, MA USA; [Agrawal, Sudhir] ARNAY Sci, Shrewsbury, MA USA; [Kaczmarek, Leonard K.] Yale Sch Med, Dept Cellular & Mol Physiol, New Haven, CT USA	Yale University; Yale University; Yale University	Kaczmarek, LK (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St,POB 208066, New Haven, CT 06520 USA.	leonard.kaczmarek@yale.edu	Quraishi, Imran/AAW-5269-2021	Quraishi, Imran/0000-0003-2859-7446; Agrawal, Sudhir/0000-0003-4275-2510; McClure, Heather/0000-0002-4441-5609	NIH [DC01919, NS111242]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by NIH grants DC01919 and NS111242 (to L.K.K). We also gratefully acknowledge the support of Lisa and Mark Shufro.	Agrawal S, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9050503; Akemann W, 2006, J NEUROSCI, V26, P4602, DOI 10.1523/JNEUROSCI.5204-05.2006; Bushart DD, 2019, NEUROSCI LETT, V688, P41, DOI 10.1016/j.neulet.2018.02.005; Bushart DD, 2018, ANN CLIN TRANSL NEUR, V5, P297, DOI 10.1002/acn3.527; Choudhury N, 2020, J PHYSIOL-LONDON, V598, P2199, DOI 10.1113/JP279668; De Vivo DC, 2019, NEUROMUSCULAR DISORD, V29, P842, DOI 10.1016/j.nmd.2019.09.007; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Figueroa KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017811; Figueroa KP, 2010, HUM MUTAT, V31, P191, DOI 10.1002/humu.21165; Finkel RS, 2017, NEW ENGL J MED, V377, P1723, DOI 10.1056/NEJMoa1702752; Friedrich J, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123193; Irie T, 2014, J PHYSIOL-LONDON, V592, P229, DOI 10.1113/jphysiol.2013.264309; Issa FA, 2012, DIS MODEL MECH, V5, P921, DOI 10.1242/dmm.010157; Issa FA, 2011, J NEUROSCI, V31, P6831, DOI 10.1523/JNEUROSCI.6572-10.2011; Joho RH, 2006, GENES BRAIN BEHAV, V5, P472, DOI 10.1111/j.1601-183X.2005.00184.x; Kaczmarek LK, 2017, PHYSIOL REV, V97, P1431, DOI 10.1152/physrev.00002.2017; Kulkarni JA, 2021, NAT NANOTECHNOL, V16, P630, DOI 10.1038/s41565-021-00898-0; Martina M, 2007, J NEUROPHYSIOL, V97, P563, DOI 10.1152/jn.00269.2006; McLoughlin HS, 2018, ANN NEUROL, V84, P64, DOI 10.1002/ana.25264; Mercuri E, 2018, NEW ENGL J MED, V378, P625, DOI 10.1056/NEJMoa1710504; Middlebrooks JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076749; Minassian NA, 2012, J PHYSIOL-LONDON, V590, P1599, DOI 10.1113/jphysiol.2012.228205; Moore LR, 2019, STEM CELL RES, V39, DOI 10.1016/j.scr.2019.101504; Moore LR, 2017, MOL THER-NUCL ACIDS, V7, P200, DOI 10.1016/j.omtn.2017.04.005; Namikawa K, 2019, J NEUROSCI, V39, P3948, DOI 10.1523/JNEUROSCI.1862-18.2019; Nemeth AH, 2013, BRAIN, V136, P3106, DOI 10.1093/brain/awt236; Niu CC, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap8677; O'Callaghan B, 2020, MOL THER-NUCL ACIDS, V21, P1006, DOI 10.1016/j.omtn.2020.07.030; Prestori F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010216; Roberts TC, 2020, NAT REV DRUG DISCOV, V19, P673, DOI 10.1038/s41573-020-0075-7; Schnekenberg RP, 2015, BRAIN, V138, P1817, DOI 10.1093/brain/awv117; Schoch KM, 2017, NEURON, V94, P1056, DOI 10.1016/j.neuron.2017.04.010; Scoles DR, 2017, NATURE, V544, P362, DOI 10.1038/nature22044; Waters MF, 2006, NAT GENET, V38, P447, DOI 10.1038/ng1758; Wu XS, 2021, NEURON, V109, DOI 10.1016/j.neuron.2021.01.006; Zhang YL, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22003-8; Zhang YL, 2016, J PHYSIOL-LONDON, V594, P4677, DOI 10.1113/JP271343; Zhang Y, 2016, CELL, V165, P434, DOI 10.1016/j.cell.2016.02.009	38	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22053	10.1096/fj.202101356R	http://dx.doi.org/10.1096/fj.202101356R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34820911	Green Accepted			2022-12-28	WOS:000722321300033
J	Dhakal, P; Fitzgerald, HC; Kelleher, AM; Liu, HY; Spencer, TE				Dhakal, Pramod; Fitzgerald, Harriet C.; Kelleher, Andrew M.; Liu, Hongyu; Spencer, Thomas E.			Uterine glands impact embryo survival and stromal cell decidualization in mice	FASEB JOURNAL			English	Article						decidualization; endometrium; FOXA2; gland; pregnancy	PLACENTAL DEVELOPMENT; HUMAN ENDOMETRIUM; MOUSE; FOXA2; IMPLANTATION; EXPRESSION; PREGNANCY; CONCEPTUS; TROPHOBLAST; MECHANISMS	Uterine glands are essential for the establishment of pregnancy and have critical roles in endometrial receptivity to blastocyst implantation, stromal cell decidualization, and placentation. Uterine gland dysfunction is considered a major contributing factor to pregnancy loss, however our understanding of how glands impact embryo survival and stromal cell decidualization is incomplete. Forkhead box A2 (FOXA2) is expressed only in the glandular epithelium and regulates its development and function. Mice with a conditional deletion of FOXA2 in the uterus are infertile due to defective embryo implantation arising from a lack of leukemia inhibitory factor (LIF), a critical factor of uterine gland origin. Here, a glandless FOXA2-deficient mouse model, coupled with LIF repletion to rescue the implantation defect, was used to investigate the roles of uterine glands in embryo survival and decidualization. Studies found that embryo survival and decidualization were compromised in glandless FOXA2-deficient mice on gestational day 6.5, resulting in abrupt pregnancy loss by day 7.5. These findings strongly support the hypothesis that uterine glands secrete factors other than LIF that impact embryo survival and stromal cell decidualization for pregnancy success.	[Dhakal, Pramod; Fitzgerald, Harriet C.; Kelleher, Andrew M.; Liu, Hongyu; Spencer, Thomas E.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Kelleher, Andrew M.; Spencer, Thomas E.] Univ Missouri, Div Obstet Gynecol & Womens Hlth, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Spencer, TE (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.	spencerte@missouri.edu		Spencer, Thomas/0000-0003-2815-766X	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01 HD096266]	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: R01 HD096266	Allen MP, 1998, J IMMUNOL, V161, P2772; Arora R, 2016, DEVELOPMENT, V143, P4749, DOI 10.1242/dev.144386; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Bu HJ, 2011, PROSTATE, V71, P575, DOI 10.1002/pros.21273; Burton GJ, 2007, PLACENTA, V28, pS64, DOI 10.1016/j.placenta.2007.01.007; Burton GJ, 2002, J CLIN ENDOCR METAB, V87, P2954, DOI 10.1210/jc.87.6.2954; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Cheng JG, 2017, ENDOCRINOLOGY, V158, P1916, DOI 10.1210/en.2017-00103; Conrad KP, 2020, OBSTET GYN CLIN N AM, V47, P163, DOI 10.1016/j.ogc.2019.10.011; Cooke PS, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097188; Dalton CF, 1998, HUM REPROD, V13, P3197, DOI 10.1093/humrep/13.11.3197; Das SK, 2010, MOL REPROD DEV, V77, P387, DOI 10.1002/mrd.21133; Das SK, 2009, REPRODUCTION, V137, P889, DOI 10.1530/REP-08-0539; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Dhakal P, 2021, MOL REPROD DEV, V88, P482, DOI 10.1002/mrd.23473; Dhakal P, 2020, P NATL ACAD SCI USA, V117, P23952, DOI 10.1073/pnas.2014272117; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; ENDERS AC, 1969, AM J ANAT, V125, P1, DOI 10.1002/aja.1001250102; Filant J, 2014, FASEB J, V28, P230, DOI 10.1096/fj.13-237446; Filant J, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107631; Garrido-Gomez T, 2017, P NATL ACAD SCI USA, V114, pE8468, DOI 10.1073/pnas.1706546114; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Goolam M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16603-z; Gray CA, 2002, REPRODUCTION, V124, P289, DOI 10.1530/rep.0.1240289; Gray CA, 2001, BIOL REPROD, V64, P1608, DOI 10.1095/biolreprod64.6.1608; Haller M, 2019, P NATL ACAD SCI USA, V116, P19541, DOI 10.1073/pnas.1907652116; Hemberger M, 2020, NAT REV GENET, V21, P27, DOI 10.1038/s41576-019-0169-4; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Hrstka R, 2017, CANCER INVEST, V35, P313, DOI 10.1080/07357907.2017.1309546; Huhn O, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14123-z; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; Kelleher AM, 2019, ENDOCR REV, V40, P1424, DOI 10.1210/er.2018-00281; Kelleher AM, 2019, FASEB J, V33, P8543, DOI 10.1096/fj.201900013R; Kelleher AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04848-8; Kelleher AM, 2017, P NATL ACAD SCI USA, V114, pE1018, DOI 10.1073/pnas.1618433114; Kelleher AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep38078; Kipp A, 2007, BIOL CHEM, V388, P1027, DOI 10.1515/BC.2007.137; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lucas ES, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0763-1; McConaha ME, 2011, REPRODUCTION, V141, P511, DOI 10.1530/REP-10-0358; Moser G, 2015, HUM REPROD, V30, P2747, DOI 10.1093/humrep/dev266; Moser G, 2010, HUM REPROD, V25, P1127, DOI 10.1093/humrep/deq035; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Qi QR, 2015, CELL CYCLE, V14, P1842, DOI 10.1080/15384101.2015.1033593; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Renaud SJ, 2017, BIOL REPROD, V96, P145, DOI 10.1095/biolreprod.116.142752; Sebastian-Leon P, 2018, HUM REPROD, V33, P626, DOI 10.1093/humrep/dey023; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Spencer TE, 2019, ANNU REV ANIM BIOSCI, V7, P125, DOI 10.1146/annurev-animal-020518-115321; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; STEWART CL, 1994, ANN NY ACAD SCI, V734, P157, DOI 10.1111/j.1749-6632.1994.tb21743.x; Sund NJ, 2000, MOL CELL BIOL, V20, P5175, DOI 10.1128/MCB.20.14.5175-5183.2000; Tan J, 2002, MECH DEVELOP, V111, P99, DOI 10.1016/S0925-4773(01)00614-1; Vanderlaag KE, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2586; Villacorte M, 2013, ONCOGENE, V32, P3477, DOI 10.1038/onc.2012.376; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Woods L, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00570; Woods L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00308-x; Yuan JB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03092-4; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011; Zhao M, 2017, REPRODUCTION, V153, P645, DOI 10.1530/REP-16-0486	62	2	2	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21938	10.1096/fj.202101170RR	http://dx.doi.org/10.1096/fj.202101170RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34547143				2022-12-28	WOS:000702238200064
J	Lee, SY; Choi, SH; Lee, MS; Kurmashev, A; Lee, HN; Ko, YG; Lee, K; Jeong, S; Seong, J; Kang, JH; Kim, H				Lee, Seon Yong; Choi, Sang-Hun; Lee, Min Seok; Kurmashev, Amanzhol; Lee, Hae Nim; Ko, Young-Gyu; Lee, Kanghun; Jeong, Sohee; Seong, Jihye; Kang, Joo H.; Kim, Hyunggee			Retraction fibers produced by fibronectin-integrin alpha 5 beta 1 interaction promote motility of brain tumor cells	FASEB JOURNAL			English	Article						cell migration; lihronectin; integrin alpha 5 beta 1; perivascular niche; retraction fiber	MIGRASOME; COMMUNICATION	Glioblastoma (GBM) is a refractory disease that has a highly infiltrative characteristic. Over the past decade, GBM perivascular niche (PVN) has been described as a route of dissemination. Here. we investigated that trailed membrane structures, namely retraction fibers (RFs). are formed by perivascular extracellular matrix (ECM) proteins. By using the anatomical GBM database, we validated that the ECM-related genes were highly expressed in the cells within the PVN where fibronectin (FN) induced RF formation. By disrupting candidates of FN-binding integrins, integrin alpha 5 beta 1 was identified as the main regulator of RF formation. De novo RFs were produced at the trailing edge, and focal adhesions were actively localized in RFs, indicating that adhesive force makes RFs remain at the bottom surface. Furthermore, we observed that GBM cells more frequently migrated along the residual RFs formed by preceding cells in microfluidic channels in comparison to those in the channels without RFs, suggesting that the infiltrative characteristics GBM could be attributed to RFs formed by the preceding cells in concert with chemoattractant cues. Altogether, we demonstrated that shedding membrane structures of GBM cells are maintained by FN-integrin alpha 5 beta 1 interaction and promoted their motility.	[Lee, Seon Yong; Choi, Sang-Hun; Lee, Kanghun; Jeong, Sohee; Kim, Hyunggee] Korea Univ, Dept Biotechnol, Seoul 02841, South Korea; [Lee, Seon Yong; Choi, Sang-Hun; Kim, Hyunggee] Korea Univ, Inst Anim Mol Biotechnol, Seoul, South Korea; [Lee, Min Seok; Kurmashev, Amanzhol; Kang, Joo H.] Ulsan Natl Inst Sci & Technol UNIST, Dept Biomed Engn, UNIST Gil 50, Ulsan 44919, South Korea; [Lee, Hae Nim; Seong, Jihye] Korea Inst Sci & Technol KIST, Brain Sci Inst, Seoul, South Korea; [Lee, Hae Nim; Seong, Jihye] Kyung Hee Univ, Dept Converging Sci & Technol, Seoul, South Korea; [Ko, Young-Gyu] Korea Univ, Dept Life Sci, Seoul, South Korea	Korea University; Korea University; Ulsan National Institute of Science & Technology (UNIST); Korea Institute of Science & Technology (KIST); Kyung Hee University; Korea University	Kim, H (corresponding author), Korea Univ, Dept Biotechnol, Seoul 02841, South Korea.; Kang, JH (corresponding author), Ulsan Natl Inst Sci & Technol UNIST, Dept Biomed Engn, UNIST Gil 50, Ulsan 44919, South Korea.	jookang@unist.ac.kr; hg-kim@korea.ac.kr	Kang, Joo H./D-5436-2017	Kang, Joo H./0000-0001-9636-3209; Lee, Min Seok/0000-0003-4372-8408; Lee, Seon Yong/0000-0003-3297-008X	National Research Foundation of Korea (NRF) [2015R1A5A1009024, 2019R1C1C1006124]; Korea Institute of Science and Technology (KIST) [2E30963]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea Institute of Science and Technology (KIST)(Korea Institute of Science & Technology (KIST))	National Research Foundation of Korea (NRF), Grant/Award Number: 2015R1A5A1009024 and 2019R1C1C1006124; Korea Institute of Science and Technology (KIST), Grant/Award Number: 2E30963	Ariazi J, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00333; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot5623; Chen LL, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-018-0078-2; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Franovic A, 2015, CANCER RES, V75, P4466, DOI 10.1158/0008-5472.CAN-15-0988; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Huang YW, 2019, NAT CELL BIOL, V21, P991, DOI 10.1038/s41556-019-0367-5; Ishii M, 2006, J BONE MINER RES, V21, P965, DOI 10.1359/JBMR.060308; Jeppesen DK, 2019, CELL, V177, P428, DOI 10.1016/j.cell.2019.02.029; Kim HW, 2019, MICROSC RES TECHNIQ, V82, P25, DOI 10.1002/jemt.23054; Kim J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00984; Knowles LM, 2013, CANCER RES, V73, P6175, DOI 10.1158/0008-5472.CAN-13-0602; Lathia JD, 2012, ANN NEUROL, V72, P766, DOI 10.1002/ana.23674; Ma L, 2015, CELL RES, V25, P24, DOI 10.1038/cr.2014.135; Naba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014647; Osswald M, 2015, NATURE, V528, P93, DOI 10.1038/nature16071; Pandya P, 2017, CURR OPIN CELL BIOL, V48, P87, DOI 10.1016/j.ceb.2017.06.006; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; PORTER KR, 1945, J EXP MED, V81, P233, DOI 10.1084/jem.81.3.233; Puchalski RB, 2018, SCIENCE, V360, P660, DOI 10.1126/science.aaf2666; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Seong JY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1414; Sherer NM, 2008, TRENDS CELL BIOL, V18, P414, DOI 10.1016/j.tcb.2008.07.003; TAYLOR AC, 1963, DEV BIOL, V7, P660, DOI 10.1016/0012-1606(63)90150-7; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wiese S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00120; Wu DN, 2017, CELL RES, V27, P1397, DOI 10.1038/cr.2017.108; Yu Q, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00130	29	3	3	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21906	10.1096/fj.202100452RR	http://dx.doi.org/10.1096/fj.202100452RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34490940				2022-12-28	WOS:000702238200044
J	Alippe, Y; Kress, D; Ricci, B; Sun, K; Yang, T; Wang, C; Xiao, JQ; Abu-Amer, Y; Mbalaviele, G				Alippe, Yael; Kress, Dustin; Ricci, Biancamaria; Sun, Kai; Yang, Tong; Wang, Chun; Xiao, Jianqiu; Abu-Amer, Yousef; Mbalaviele, Gabriel			Actions of the NLRP3 and NLRC4 inflammasomes overlap in bone resorption	FASEB JOURNAL			English	Article						bone; IL-1 beta; inflammasome; inflammation; NLRC4; NLRP3; osteoclast	GASDERMIN-D; OSTEOCLAST DIFFERENTIATION; INFLAMMATORY OSTEOLYSIS; CAUSES AUTOINFLAMMATION; MOLECULAR-MECHANISMS; IMMUNE-RESPONSES; ACTIVATION; PYROPTOSIS; CASPASE-8; LIPOPOLYSACCHARIDE	Overwhelming evidence indicates that excessive stimulation of innate immune receptors of the NOD-like receptor (NLR) family causes significant damage to multiple tissues, yet the role of these proteins in bone metabolism is not well known. Here, we studied the interaction between the NLRP3 and NLRC4 inflammasomes in bone homeostasis and disease. We found that loss of NLRP3 or NLRC4 inflammasome attenuated osteoclast differentiation in vitro. At the tissue level, lack of NLRP3, or NLRC4 to a lesser extent, resulted in higher baseline bone mass compared to wild-type (WT) mice, and conferred protection against LPS-induced inflammatory osteolysis. Bone mass accrual in mutant mice correlated with lower serum IL-1 beta levels in vivo. Unexpectedly, the phenotype of Nlrp3-deficient mice was reversed upon loss of NLRC4 as bone mass was comparable between WT mice and Nlrp3;Nlrc4 knockout mice. Thus, although bone homeostasis is perturbed to various degrees by the lack of NLRP3 or NLRC4, this tissue appears to function normally upon compound loss of the inflammasomes assembled by these receptors.	[Alippe, Yael; Kress, Dustin; Sun, Kai; Yang, Tong; Wang, Chun; Xiao, Jianqiu; Mbalaviele, Gabriel] Washington Univ, Div Bone & Mineral Dis, Sch Med, 660 South Euclid Ave,Campus Box 8301, St Louis, MO 63110 USA; [Ricci, Biancamaria; Abu-Amer, Yousef] Washington Univ, Dept Orthopaed Surg, Sch Med, St Louis, MO 63110 USA; [Sun, Kai; Yang, Tong] Xi An Jiao Tong Univ, Honghui Hosp, Dept Spine Surg, Xian, Peoples R China; [Abu-Amer, Yousef] Shriners Hosp Children, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Xi'an Jiaotong University	Mbalaviele, G (corresponding author), Washington Univ, Div Bone & Mineral Dis, Sch Med, 660 South Euclid Ave,Campus Box 8301, St Louis, MO 63110 USA.	gmbalaviele@wustl.edu		Ricci, Biancamaria/0000-0003-1574-6043	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR068972, AR076758, AR049192, AR074992, AR072623]; Shriners Hospitals for Children [85160]	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Shriners Hospitals for Children	HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR068972, AR076758, AR049192, AR074992 and AR072623; Shriners Hospitals for Children, Grant/Award Number: 85160	Aglietti RA, 2017, TRENDS IMMUNOL, V38, P261, DOI 10.1016/j.it.2017.01.003; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Alippe Y, 2019, SEMIN IMMUNOPATHOL, V41, P607, DOI 10.1007/s00281-019-00753-4; Alippe Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07014-0; Baum R, 2015, J IMMUNOL, V194, P873, DOI 10.4049/jimmunol.1402573; Bernard NJ, 2014, NAT REV RHEUMATOL, V10, DOI [10.1038/nrrheum.2014.170, 10.1038/nrrheum.2014.60, 10.1038/nrrheum.2014.166, 10.1038/nrrheum.2014.72, 10.1038/nrrheum.2014.180, 10.1038/nrrheum.2014.141, 10.1038/nrrheum.2014.25, 10.1038/nrrheum.2014.88, 10.1038/nrrheum.2013.187, 10.1038/nrrheum.2013.207, 10.1038/nrrheum.2014.96]; Bonar SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035979; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Burton L, 2013, J ORTHOP RES, V31, P73, DOI 10.1002/jor.22190; Canna SW, 2014, NAT GENET, V46, P1140, DOI 10.1038/ng.3089; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen YY, 2021, CELL PROLIFERAT, V54, DOI 10.1111/cpr.12973; Chovatiya R, 2014, MOL CELL, V54, P281, DOI 10.1016/j.molcel.2014.03.030; Detzen L, 2021, J CELL PHYSIOL, V236, P4455, DOI 10.1002/jcp.30162; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Freeman L, 2017, J EXP MED, V214, P1351, DOI 10.1084/jem.20150237; Fritsch M, 2019, NATURE, V575, P683, DOI 10.1038/s41586-019-1770-6; Furman D, 2017, NAT MED, V23, P174, DOI 10.1038/nm.4267; Halloran BP, 2002, J BONE MINER RES, V17, P1044, DOI 10.1359/jbmr.2002.17.6.1044; Haneklaus M, 2015, IMMUNOL REV, V265, P53, DOI 10.1111/imr.12285; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Heilig R, 2018, EUR J IMMUNOL, V48, P584, DOI 10.1002/eji.201747404; Hill SC, 2007, PEDIATR RADIOL, V37, P145, DOI 10.1007/s00247-006-0358-0; Jakobs C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131702; Kikuchi T, 2001, J IMMUNOL, V166, P3574, DOI 10.4049/jimmunol.166.5.3574; Kitamura A, 2014, J EXP MED, V211, P2385, DOI 10.1084/jem.20141091; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Lechtenberg BC, 2014, CURR OPIN STRUC BIOL, V29, P17, DOI 10.1016/j.sbi.2014.08.011; Lee BL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21998-3; Li Y, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.691013; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Malireddi RKS, 2020, J EXP MED, V217, DOI 10.1084/jem.20191644; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Man SM, 2013, J IMMUNOL, V191, P5239, DOI 10.4049/jimmunol.1301581; Mascarenhas DPA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006502; Mbalaviele G, 2017, J CLIN INVEST, V127, P2030, DOI 10.1172/JCI93356; McCall SH, 2008, J BONE MINER RES, V23, P30, DOI 10.1359/JBMR.071002; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mian AH, 2008, J BONE MINER METAB, V26, P469, DOI 10.1007/s00774-007-0834-0; Newton K, 2019, NATURE, V574, P428, DOI 10.1038/s41586-019-1548-x; Novack DV, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0011-2015; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Place DE, 2018, CURR OPIN IMMUNOL, V50, P32, DOI 10.1016/j.coi.2017.10.011; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Qu C, 2015, FASEB J, V29, P1269, DOI 10.1096/fj.14-264804; Qu Y, 2016, J EXP MED, V213, P877, DOI 10.1084/jem.20132234; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Rocha FRG, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64685-y; Rocha FRG, 2020, IMMUNOBIOLOGY, V225, DOI 10.1016/j.imbio.2019.10.004; Rubartelli A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00398; Sato N, 2004, J EXP MED, V200, P601, DOI 10.1084/jem.20040689; Sims NA, 2008, SEMIN CELL DEV BIOL, V19, P444, DOI 10.1016/j.semcdb.2008.07.016; Snouwaert JN, 2016, CELL REP, V17, P3077, DOI 10.1016/j.celrep.2016.11.052; So AK, 2017, NAT REV RHEUMATOL, V13, P639, DOI 10.1038/nrrheum.2017.155; Taabazuing CY, 2017, CELL CHEM BIOL, V24, P507, DOI 10.1016/j.chembiol.2017.03.009; Takami M, 2002, J IMMUNOL, V168, P4559, DOI 10.4049/jimmunol.168.9.4559; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wang C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05033-5; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Xiao JQ, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000807; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010; Zang Y, 2020, J DENT RES, V99, P1287, DOI 10.1177/0022034520933533; Zhang YF, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9656270; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	67	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21837	10.1096/fj.202100767RR	http://dx.doi.org/10.1096/fj.202100767RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34383985				2022-12-28	WOS:000691122900052
J	Asad, M; Sabur, A; Kamran, M; Shadab, M; Das, S; Ali, N				Asad, Mohammad; Sabur, Abdus; Kamran, Mohd; Shadab, Md; Das, Sonali; Ali, Nahid			Effector functions of Th17 cells are regulated by IL-35 and TGF-beta in visceral leishmaniasis	FASEB JOURNAL			English	Article						IL-35; immune suppression; immune therapy; leishmania; regulatory T cells; TGF-beta; Th17	DELTA T-CELLS; PROTECTIVE IMMUNITY; TRYPANOSOMA-CRUZI; IL-10; IL-27; GAMMA; INFECTION; MILIEU	Visceral leishmaniasis (VL) is a debilitating human pathogenesis in which the body's immune functions are severely compromised. Various subsets of T cells, including Th17 cells are important regulators of immune responses observed in various pathologies. The role of Th17 cells and its correlation with immuno-regulatory cytokines are however not well understood in human VL. Herein we studied how IL-17 is associated with the progression of Leishmania donovani infection using murine model of VL. We found induction of a strong IL-17 response at the early phase of infection which progressively reduced to basal level during chronic VL. The mechanistic study of this behavior was found to be linked with the role of regulatory T cells (CD4(+)CD25(+) T cells) that suppresses the proliferation of the Th17 cell population. Moreover, TGF-beta and IL-35 derived from CD4(+)CD25(+) T cells are the key mediators for the downregulation of IL-17 during chronic VL. Thus, this study points to an antagonistic effect of Tregs and Th17 cells that can be used for designing better therapeutic and preventive strategies against leishmaniasis.	[Asad, Mohammad; Sabur, Abdus; Kamran, Mohd; Shadab, Md; Das, Sonali; Ali, Nahid] Indian Inst Chem Biol, Infect Dis & Immunol Div, 4,Raja SC Mullick Rd, Kolkata 700032, W Bengal, India; [Asad, Mohammad] Albert Einstein Coll Med, Dept Med, Montefiore Med Ctr, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Sabur, Abdus] Univ Gour Banga, Raiganj Surendranath Mahavidyalaya, Raiganj 733134, W Bengal, India; [Shadab, Md] Univ Rochester, Dept Pediat, Med Ctr, 601 Elmwood Ave, Rochester, NY 14642 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Gour Banga; University of Rochester	Ali, N (corresponding author), Indian Inst Chem Biol, Infect Dis & Immunol Div, 4,Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	nali@iicb.res.in	KAMRAN, MOHD/ABF-8235-2021	KAMRAN, MOHD/0000-0001-9007-6735; Asad, Mohammad/0000-0003-3078-200X; Shadab, Mohammad/0000-0003-4148-0365	Council of Scientific and Industrial Research [BSC 0114]; Indian Council of Medical Research; University Grant Commission; JC Bose National Fellowship, DST, Government of India	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); University Grant Commission(University Grants Commission, India); JC Bose National Fellowship, DST, Government of India	This work has been supported by Council of Scientific and Industrial Research-BSC 0114, Indian Council of Medical Research and University Grant Commission and JC Bose National Fellowship, DST, Government of India	Afrin F, 1997, INFECT IMMUN, V65, P2371, DOI 10.1128/IAI.65.6.2371-2377.1997; Akhavanpoor M, 2014, DRUG DES DEV THER, V8, P2359, DOI [10.2147/DDDT.SD2394, 10.2147/DDDT.S72394]; Asad M. D., 2014, Proceedings of the Indian National Science Academy, V80, P247; Asad M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00616; Asad M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0928-6; Bacellar O, 2009, J INFECT DIS, V200, P75, DOI 10.1086/599380; Banerjee A, 2008, J IMMUNOL, V181, P1386, DOI 10.4049/jimmunol.181.2.1386; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Boaventura VS, 2010, EUR J IMMUNOL, V40, P2830, DOI 10.1002/eji.200940115; Chiyo M, 2005, INT J CANCER, V115, P437, DOI 10.1002/ijc.20848; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; Das Shibali, 2017, F1000Res, V6, P741, DOI 10.12688/f1000research.10862.1; Erdmann H, 2013, IMMUNOBIOLOGY, V218, P910, DOI 10.1016/j.imbio.2012.10.005; Freches D, 2013, IMMUNOLOGY, V140, P220, DOI 10.1111/imm.12130; Gautam S, 2011, J INFECT DIS, V204, P1134, DOI 10.1093/infdis/jir461; Jerschow E, 2017, J ALLER CL IMM-PRACT, V5, P998, DOI 10.1016/j.jaip.2016.11.021; Katara GK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001703; Kugyelka R, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6145810; Kumar Prabin, 2019, Trop Parasitol, V9, P30, DOI 10.4103/tp.TP_32_18; Nascimento MSL, 2015, J INFECT DIS, V211, P1015, DOI 10.1093/infdis/jiu531; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Miyazaki Y, 2010, J IMMUNOL, V185, P1150, DOI 10.4049/jimmunol.0900047; Murphy AG, 2014, J IMMUNOL, V192, P3697, DOI 10.4049/jimmunol.1303420; Novoa R, 2011, PARASITE IMMUNOL, V33, P132, DOI 10.1111/j.1365-3024.2010.01256.x; Okada K, 2017, PEERJ, V5, DOI 10.7717/peerj.2999; Pandiyan P, 2011, IMMUNITY, V34, P422, DOI 10.1016/j.immuni.2011.03.002; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pitta MGR, 2009, J CLIN INVEST, V119, P2379, DOI 10.1172/JCI38813; Quirino GFS, 2016, INFECT IMMUN, V84, P2289, DOI 10.1128/IAI.00283-16; Sabur A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00018; Sheel M, 2015, J IMMUNOL, V195, P5707, DOI 10.4049/jimmunol.1501046; Sherlock JP, 2015, CURR OPIN RHEUMATOL, V27, P71, DOI 10.1097/BOR.0000000000000132; Soong L, 2012, SEMIN IMMUNOPATHOL, V34, P735, DOI 10.1007/s00281-012-0350-8; Stanley AC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000028; Terrazas C, 2016, FASEB J, V30, P1135, DOI 10.1096/fj.15-277202; Trautwein-Weidner K, 2015, MUCOSAL IMMUNOL, V8, P221, DOI 10.1038/mi.2014.57; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Whitehead GS, 2012, J ALLERGY CLIN IMMUN, V129, P207, DOI 10.1016/j.jaci.2011.08.009; Yoshida H, 2015, ANNU REV IMMUNOL, V33, P417, DOI 10.1146/annurev-immunol-032414-112134	39	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21755	10.1096/fj.202002356RR	http://dx.doi.org/10.1096/fj.202002356RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34383962				2022-12-28	WOS:000691122900057
J	Dadwal, UC; Bhatti, FUR; Awosanya, OD; Nagaraj, RU; Perugini, AJ; Sun, S; Valuch, CR; Staut, CD; Mendenhall, SK; Tewari, NP; Mostardo, SL; Nazzal, MK; Battina, HL; Zhou, DH; Kanagasabapathy, D; Blosser, RJ; Mulcrone, PL; Li, JL; Kacena, MA				Dadwal, Ushashi C.; Bhatti, Fazal Ur Rehman; Awosanya, Olatundun D.; Nagaraj, Rohit U.; Perugini, Anthony J.; Sun, Seungyup; Valuch, Conner R.; Staut, Caio de Andrade; Mendenhall, Stephen K.; Tewari, Nikhil P.; Mostardo, Sarah L.; Nazzal, Murad K.; Battina, Hanisha L.; Zhou, Donghui; Kanagasabapathy, Deepa; Blosser, Rachel J.; Mulcrone, Patrick L.; Li, Jiliang; Kacena, Melissa A.			The effects of bone morphogenetic protein 2 and thrombopoietin treatment on angiogenic properties of endothelial cells derived from the lung and bone marrow of young and aged, male and female mice	FASEB JOURNAL			English	Article						aging; bone morphogenetic protein; endothelial cells; sex-based differences; thrombopoietin	FRACTURE; EXPRESSION; VASCULARIZATION; ANGIOPOIETIN-1; SENESCENCE; MORTALITY; STEM	With an aging world population, there is an increased risk of fracture and impaired healing. One contributing factor may be aging-associated decreases in vascular function; thus, enhancing angiogenesis could improve fracture healing. Both bone morphogenetic protein 2 (BMP-2) and thrombopoietin (TPO) have pro-angiogenic effects. The aim of this study was to investigate the effects of treatment with BMP-2 or TPO on the in vitro angiogenic and proliferative potential of endothelial cells (ECs) isolated from lungs (LECs) or bone marrow (BMECs) of young (3-4 months) and old (22-24 months), male and female, C57BL/6J mice. Cell proliferation, vessel-like structure formation, migration, and gene expression were used to evaluate angiogenic properties. In vitro characterization of ECs generally showed impaired vessel-like structure formation and proliferation in old ECs compared to young ECs, but improved migration characteristics in old BMECs. Differential sex-based angiogenic responses were observed, especially with respect to drug treatments and gene expression. Importantly, these studies suggest that NTN1, ROBO2, and SLIT3, along with angiogenic markers (CD31, FLT-1, ANGPT1, and ANGP2) differentially regulate EC proliferation and functional outcomes based on treatment, sex, and age. Furthermore, treatment of old ECs with TPO typically improved vessel-like structure parameters, but impaired migration. Thus, TPO may serve as an alternative treatment to BMP-2 for fracture healing in aging owing to improved angiogenesis and fracture healing, and the lack of side effects associated with BMP-2.	[Dadwal, Ushashi C.; Bhatti, Fazal Ur Rehman; Awosanya, Olatundun D.; Nagaraj, Rohit U.; Perugini, Anthony J.; Sun, Seungyup; Staut, Caio de Andrade; Mendenhall, Stephen K.; Tewari, Nikhil P.; Mostardo, Sarah L.; Nazzal, Murad K.; Battina, Hanisha L.; Zhou, Donghui; Kanagasabapathy, Deepa; Blosser, Rachel J.; Kacena, Melissa A.] Indiana Univ Sch Med, Dept Orthopaed Surg, 1130 W Michigan St,FH 115, Indianapolis, IN 46202 USA; [Dadwal, Ushashi C.; Bhatti, Fazal Ur Rehman; Blosser, Rachel J.; Kacena, Melissa A.] Richard L Roudebush VA Med Ctr, Indianapolis, IN USA; [Valuch, Conner R.; Li, Jiliang] Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46205 USA; [Mulcrone, Patrick L.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington	Kacena, MA (corresponding author), Indiana Univ Sch Med, Dept Orthopaed Surg, 1130 W Michigan St,FH 115, Indianapolis, IN 46202 USA.	mkacena@iupui.edu	BHATTI, FAZAL UR REHMAN/AAP-5509-2020	Sun, Seungyup/0000-0003-2990-3185	Cooperative Center of Excellence in Hematology (CCEH) Award; NIH [1U54DK106846, T32 DK007519, T32 AR065971, T32 HL007910, R01 AG060621]; National Science Foundation Grant [1618--408]; Indiana University Collaborative Research Grant	Cooperative Center of Excellence in Hematology (CCEH) Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Grant(National Science Foundation (NSF)); Indiana University Collaborative Research Grant	The authors thank the Indiana University Angiogenesis Core for assisting with wound migration studies. This project was supported, in part, by the Cooperative Center of Excellence in Hematology (CCEH) Award, funded in part by NIH 1U54DK106846 (MAK, SS), NIH T32 DK007519 (UCD), NIH T32 AR065971 (UCD), NIH T32 HL007910 (ODA) NIH R01 AG060621 (MAK, JL, ODA), and National Science Foundation Grant No. 1618--408 (ODA). In addition, the results of this work were supported with resources and the use of facilities at the Richard L. Roudebush VA Medical Center, Indianapolis, IN: VA Merit #BX003751 (MAK). This work was also supported by an Indiana University Collaborative Research Grant (MAK, JL).	Bahney CS, 2019, J ORTHOP RES, V37, P35, DOI 10.1002/jor.24170; Bardin N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/354359; Bethel M, 2015, J CELL PHYSIOL, V230, P2142, DOI 10.1002/jcp.24943; Blyth FM, 2007, EUR J PAIN, V11, P564, DOI 10.1016/j.ejpain.2006.08.001; Bochenek ML, 2016, THROMB RES, V147, P36, DOI 10.1016/j.thromres.2016.09.019; Brizzi MF, 1999, CIRC RES, V84, P785; Cao LY, 2014, BIOMATERIALS, V35, P684, DOI 10.1016/j.biomaterials.2013.10.005; Cardus A, 2013, CARDIOVASC RES, V97, P571, DOI 10.1093/cvr/cvs352; Carulli Christian, 2013, Front Endocrinol (Lausanne), V4, P106, DOI 10.3389/fendo.2013.00106; Chandrasekhar KS, 2011, CALCIFIED TISSUE INT, V89, P347, DOI 10.1007/s00223-011-9524-y; Chen WC, 2018, BIOCHEM PHARMACOL, V150, P254, DOI 10.1016/j.bcp.2018.02.021; de Vinuesa AG, 2016, CYTOKINE GROWTH F R, V27, P65, DOI 10.1016/j.cytogfr.2015.12.005; Dyer LA, 2014, TRENDS ENDOCRIN MET, V25, P472, DOI 10.1016/j.tem.2014.05.003; Fagiani E, 2013, CANCER LETT, V328, P18, DOI 10.1016/j.canlet.2012.08.018; Finkenzeller G, 2012, MICROVASC RES, V84, P81, DOI 10.1016/j.mvr.2012.03.010; Foulke BA, 2016, MATURITAS, V92, P49, DOI 10.1016/j.maturitas.2016.07.014; Grosso A, 2017, FRONT BIOENG BIOTECH, V5, DOI 10.3389/fbioe.2017.00068; Gruber R, 2006, EXP GERONTOL, V41, P1080, DOI 10.1016/j.exger.2006.09.008; Hankenson KD, 2011, INJURY, V42, P556, DOI 10.1016/j.injury.2011.03.035; Hebb JH, 2018, J ORTHOP RES, V36, P149, DOI 10.1002/jor.23652; Hegen A, 2004, ARTERIOSCL THROM VAS, V24, P1803, DOI 10.1161/01.ATV.0000140819.81839.0e; Ho Vivienne C, 2015, Methods Mol Biol, V1332, P161, DOI 10.1007/978-1-4939-2917-7_12; Hodges NA, 2018, J APPL PHYSIOL, V125, P1843, DOI 10.1152/japplphysiol.00112.2018; Hohensinner PJ, 2016, BIOCHEM BIOPH RES CO, V474, P447, DOI 10.1016/j.bbrc.2016.04.143; Huntjens KMB, 2010, OSTEOPOROSIS INT, V21, P2075, DOI 10.1007/s00198-010-1178-5; Huxley VH, 2018, J PHYSIOL-LONDON, V596, P3929, DOI 10.1113/JP276048; James AW, 2016, TISSUE ENG PART B-RE, V22, P284, DOI [10.1089/ten.teb.2015.0357, 10.1089/ten.TEB.2015.0357]; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Kacena MAZ IN US Chu T-mGC IN US  Inventors; Osteofuse Inc. (Zionsville IN US), 2019, USE COMPOUNDS THROMB; Kim David H, 2006, Spine J, V6, P479, DOI 10.1016/j.spinee.2006.04.013; Kirito K, 2005, BLOOD, V105, P4258, DOI 10.1182/blood-2004-07-2712; Koblizek TI, 1998, CURR BIOL, V8, P529, DOI 10.1016/S0960-9822(98)70205-2; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Lau E, 2008, J BONE JOINT SURG AM, V90A, P1479, DOI 10.2106/JBJS.G.00675; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Lu CY, 2008, J ORTHOP RES, V26, P1384, DOI 10.1002/jor.20667; Meijome TE, 2016, J CELL BIOCHEM, V117, P959, DOI 10.1002/jcb.25380; Moriya J, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00065; Mulcrone PL, 2017, J BONE MINER RES, V32, P1442, DOI 10.1002/jbmr.3133; Nesmith JE, 2017, DEVELOPMENT, V144, P889, DOI 10.1242/dev.145672; Pearson HB, 2019, TISSUE ENG PT A, V25, P1623, DOI [10.1089/ten.tea.2018.0326, 10.1089/ten.TEA.2018.0326]; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shibuya Masaubmi, 2006, Angiogenesis, V9, P225, DOI 10.1007/s10456-006-9055-8; Sieveking DP, 2010, J EXP MED, V207, P345, DOI 10.1084/jem.20091924; Souma T, 2018, P NATL ACAD SCI USA, V115, P1298, DOI 10.1073/pnas.1714446115; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Szymborska A, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029223; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Tian XL, 2014, J GENET GENOMICS, V41, P485, DOI 10.1016/j.jgg.2014.08.001; Ugarte F, 2013, EMBO J, V32, P2535, DOI 10.1038/emboj.2013.201; Wagner DR, 2019, WORLD J STEM CELLS, V11, P281, DOI 10.4252/wjsc.v11.i6.281; Wang JP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37130-4; Wu MF, 2017, TISSUE BARRIERS, V5, DOI 10.1080/21688370.2017.1331155; Yao YC, 2009, CIRC RES, V105, P575, DOI 10.1161/CIRCRESAHA.109.202333; Zhang YH, 2018, AM J PHYSIOL-HEART C, V315, pH1287, DOI 10.1152/ajpheart.00416.2018	57	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21840	10.1096/fj.202001616RR	http://dx.doi.org/10.1096/fj.202001616RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34423881	Green Accepted			2022-12-28	WOS:000691122900015
J	Deguchi, A; Yamamoto, T; Shibata, N; Maru, Y				Deguchi, Atsuko; Yamamoto, Tomoko; Shibata, Noriyuki; Maru, Yoshiro			S100A8 may govern hyper-inflammation in severe COVID-19	FASEB JOURNAL			English	Article						acute respiratory distress syndrome; Coronavirus disease 2019; myeloid-derived suppressor cells; Toll-like receptor	HOMEOSTATIC INFLAMMATION; PROTEINS; CELLS; NEUTROPHILS; ACTIVATION; MIGRATION; RELEASE; MRP14	The coronavirus disease 2019 (COVID-19) pandemic threatens human species with mortality rate of roughly 2%. We can hardly predict the time of herd immunity against and end of COVID-19 with or without success of vaccine. One way to overcome the situation is to define what delineates disease severity and serves as a molecular target. The most successful analogy is found in BCR-ABL in chronic myeloid leukemia, which is the golden biomarker, and simultaneously, the most effective molecular target. We hypothesize that S100 calcium-binding protein A8 (S100A8) is one such molecule. The underlying evidence includes accumulating clinical information that S100A8 is upregulated in severe forms of COVID-19, pathological similarities of the affected lungs between COVID-19 and S100A8-induced acute respiratory distress syndrome (ARDS) model, homeostatic inflammation theory in which S100A8 is an endogenous ligand for endotoxin sensor Toll-like receptor 4/Myeloid differentiation protein-2 (TLR4/MD-2) and mediates hyper-inflammation even after elimination of endotoxin-producing extrinsic pathogens, analogous findings between COVID-19-associated ARDS and pre-metastatic lungs such as S100A8 upregulation, pulmonary recruitment of myeloid cells, increased vascular permeability, and activation coagulation cascade. A successful treatment in an animal COVID-19 model is given with a reagent capable of abrogating interaction between S100A8/S100A9 and TLR4. In this paper, we try to verify our hypothesis that S100A8 governs COVID-19-associated ARDS.	[Deguchi, Atsuko; Maru, Yoshiro] Tokyo Womens Med Univ, Dept Pharmacol, Tokyo, Japan; [Yamamoto, Tomoko; Shibata, Noriyuki] Tokyo Womens Med Univ, Dept Pathol, Div Pathol Neurosci, Tokyo, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University	Maru, Y (corresponding author), Tokyo Womens Med Univ, Dept Pharmacol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	maru.yoshiro@twmu.ac.jp		Deguchi, Atsuko/0000-0001-9647-3539	Japan Society for the Promotion of Science [18K07245, 21K07157, 19K03506]; Smoking Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Smoking Research Foundation	Japan Society for the Promotion of Science, Grant/Award Number: 18K07245, 21K07157 and 19K03506; Smoking Research Foundation	ANDERSSON KB, 1988, SCAND J IMMUNOL, V28, P241, DOI 10.1111/j.1365-3083.1988.tb02437.x; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Bruger AM, 2019, CANCER IMMUNOL IMMUN, V68, P631, DOI 10.1007/s00262-018-2170-8; Cappy P, 2020, BLOOD, V136, P1888, DOI 10.1182/blood.2020008230; Chandrashekar D.S., 2020, COMP TRANSCRIPTOME A, DOI [10.1101/2020.06.24.169268, DOI 10.1101/2020.06.24.169268]; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Dash P, 2021, INT J INFECT DIS, V104, P491, DOI 10.1016/j.ijid.2021.01.020; Deguchi, UNPUBLISHED RESULTS; Deguchi A, 2016, ONCOGENE, V35, P1445, DOI 10.1038/onc.2015.211; Dinnon KH, 2020, NATURE, V586, P560, DOI 10.1038/s41586-020-2708-8; Doeing Diana C, 2003, BMC Clin Pathol, V3, P3; EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706; Elrashdy F, 2021, J BIOMOL STRUCT DYN, V39, P5831, DOI 10.1080/07391102.2020.1790426; FAGERHOL MK, 1980, SCAND J HAEMATOL, V24, P393; FRIEND C, 1978, CANCER RES, V38, P2581; Guo QR, 2021, CELL HOST MICROBE, V29, P222, DOI 10.1016/j.chom.2020.12.016; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hiratsuka S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2856; Hodgson SH, 2021, LANCET INFECT DIS, V21, pE26, DOI 10.1016/S1473-3099(20)30773-8; Hong WQ, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-020-00451-w; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Jiang RD, 2020, CELL, V182, P50, DOI 10.1016/j.cell.2020.05.027; Jreige M, 2020, J NUCL MED, V61, P26, DOI 10.2967/jnumed.119.229575; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; Lee PY, 2013, J LEUKOCYTE BIOL, V94, P585, DOI 10.1189/jlb.0113014; Li YJ, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI148635; Maru Y., 2021, INFLAMMATION METASTA, V2nd; Maru Y., 2016, INFLAMMATION METASTA, V1st ed; Maru Y, 2020, CSH PERSPECT MED, V10, DOI 10.1101/cshperspect.a036897; Maru Yoshiro, 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P337; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134; Miyake K, 2014, CURR OPIN IMMUNOL, V30, P85, DOI 10.1016/j.coi.2014.08.003; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; Ortiz-Munoz G, 2020, J CLIN INVEST, V130, P2041, DOI 10.1172/JCI129635; Pan SG, 2020, INT J ONCOL, V56, P101, DOI 10.3892/ijo.2019.4907; Price TH, 1996, BLOOD, V88, P335; Raquil MA, 2008, J IMMUNOL, V180, P3366, DOI 10.4049/jimmunol.180.5.3366; Ravindra NG, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001143; Rawal Gautam, 2018, J Transl Int Med, V6, P74, DOI 10.1515/jtim-2016-0012; Reizine F, 2021, J CLIN IMMUNOL, V41, P515, DOI 10.1007/s10875-020-00920-5; Rodriguez RA, 2009, APPL ENVIRON MICROB, V75, P297, DOI 10.1128/AEM.01150-08; Rosas IO, 2021, NEW ENGL J MED, V384, P1503, DOI 10.1056/NEJMoa2028700; Ruan SY, 2014, CRIT CARE, V18, DOI 10.1186/cc13819; Scott NR, 2020, J CLIN INVEST, V130, P3098, DOI 10.1172/JCI130546; Shah S, 2016, NEURON, V92, P342, DOI 10.1016/j.neuron.2016.10.001; Tian JB, 2020, LANCET ONCOL, V21, P893, DOI 10.1016/S1470-2045(20)30309-0; Tirkos S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-51; Tomita T, 2011, ONCOGENE, V30, P3429, DOI 10.1038/onc.2011.53; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Veras FP, 2020, J EXP MED, V217, DOI 10.1084/jem.20201129; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Whiteside Theresa L, 2018, Contemp Oncol (Pozn), V22, P38, DOI 10.5114/wo.2018.73882; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Yap GLR, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2625-7; Yipp BG, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam8929; Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017	64	5	5	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21798	10.1096/fj.202101013	http://dx.doi.org/10.1096/fj.202101013			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34339064	Green Published			2022-12-28	WOS:000691122900056
J	Garrido-Jimenez, S; Barrera-Lopez, JF; Diaz-Chamorro, S; Mateos-Quiros, CM; Rodriguez-Blanco, I; Marquez-Perez, FL; Lorenzo, MJ; Centeno, F; Roman, AC; Carvajal-Gonzalez, JM				Garrido-Jimenez, Sergio; Francisco Barrera-Lopez, Juan; Diaz-Chamorro, Selene; Maria Mateos-Quiros, Clara; Rodriguez-Blanco, Ignacio; Lourdes Marquez-Perez, Francisca; Jesus Lorenzo, Maria; Centeno, Francisco; Carlos Roman, Angel; Maria Carvajal-Gonzalez, Jose			p53 regulation by MDM2 contributes to self-renewal and differentiation of basal stem cells in mouse and human airway epithelium	FASEB JOURNAL			English	Article						airway epithelial cells; MDM2; p53	TUMOR-SUPPRESSOR; LUNG; REPAIR; MUTATIONS; COMPLEXITY; INHIBITOR; AP-1A; P63	Proper physiological function of mammalian airways requires the differentiation of basal stem cells into secretory or multiciliated cells, among others. In addition, the self-renewal ability of these basal stem cells is crucial for developing a quick response to toxic agents in order to re-establish the epithelial barrier function of the airways. Although these epithelial missions are vital, little is known about those mechanism controlling airway epithelial regeneration in health and disease. p53 has been recently proposed as the guardian of homeostasis, promoting differentiation programs, and antagonizing a de-differentiation program. Here, we exploit mouse and human tracheal epithelial cell culture models to study the role of MDM2-p53 signaling in self-renewal and differentiation in the airway epithelium. We show that p53 protein regulation by MDM2 is crucial for basal stem cell differentiation and to keep proper cell proliferation. Therefore, we suggest that MDM2/p53 interaction modulation is a potential target to control regeneration of the mammalian airway epithelia without massively affecting the epithelium integrity and differentiation potential.	[Garrido-Jimenez, Sergio; Francisco Barrera-Lopez, Juan; Diaz-Chamorro, Selene; Maria Mateos-Quiros, Clara; Jesus Lorenzo, Maria; Centeno, Francisco; Carlos Roman, Angel; Maria Carvajal-Gonzalez, Jose] Univ Extremadura, Fac Ciencias, Dept Bioquim Biol Mol & Genet, Badajoz 06071, Spain; [Rodriguez-Blanco, Ignacio; Lourdes Marquez-Perez, Francisca] Hosp Univ Badajoz, Dept Neumol, Badajoz, Spain	Universidad de Extremadura	Carvajal-Gonzalez, JM (corresponding author), Univ Extremadura, Fac Ciencias, Dept Bioquim Biol Mol & Genet, Badajoz 06071, Spain.	jmcarvaj@unex.es	Centeno, Francisco/F-7287-2016	Centeno, Francisco/0000-0001-6154-5424; Carvajal-Gonzalez, Jose Maria/0000-0001-6576-830X	Ministry of Economy [RYC-2015-17867, BFU2014-54699-P, BFU2017-85547-P]; Junta de Extremadura [IB18014, GR15164]; European Union FEDER program	Ministry of Economy; Junta de Extremadura; European Union FEDER program(European Commission)	Ministry of Economy, Grant/Award Number: RYC-2015-17867, BFU2014-54699-P and BFU2017-85547-P; Junta de Extremadura, Grant/Award Number: IB18014 and GR15164; European Union FEDER program	Barkauskas CE, 2017, DEVELOPMENT, V144, P986, DOI 10.1242/dev.140103; Beers MF, 2011, J CLIN INVEST, V121, P2065, DOI 10.1172/JCI45961; Bustamante-Marin XM, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028241; Cardoso WV, 2001, ANNU REV PHYSIOL, V63, P471, DOI 10.1146/annurev.physiol.63.1.471; Carvajal-Gonzalez JM, 2012, P NATL ACAD SCI USA, V109, P3820, DOI 10.1073/pnas.1117949109; CHEN JD, 1995, MOL MED, V1, P142, DOI 10.1007/BF03401562; Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Daniely Y, 2004, AM J PHYSIOL-CELL PH, V287, pC171, DOI 10.1152/ajpcell.00226.2003; Fischer M, 2017, ONCOGENE, V36, P3943, DOI 10.1038/onc.2016.502; Gravotta D, 2012, DEV CELL, V22, P811, DOI 10.1016/j.devcel.2012.02.004; Hallenborg P, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.188; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Her NG, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0825-1; Hogan B., 2019, NAT CELL BIOL, P1; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jain AK, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.158360; Jeong Y, 2017, CANCER DISCOV, V7, P86, DOI 10.1158/2159-8290.CD-16-0127; Junk DJ, 2008, NEOPLASIA, V10, P450, DOI 10.1593/neo.08120; Juven-Gershon T, 1998, MOL CELL BIOL, V18, P3974, DOI 10.1128/MCB.18.7.3974; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lee DF, 2012, CELL STEM CELL, V11, P179, DOI 10.1016/j.stem.2012.05.020; Li L, 2020, PHYS CHEM CHEM PHYS, V22, P9225, DOI 10.1039/c9cp06671c; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Marshall CB, 2016, CELL REP, V14, P2289, DOI 10.1016/j.celrep.2016.02.035; McConnell AM, 2016, CELL REP, V17, P2173, DOI 10.1016/j.celrep.2016.11.007; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Nemajerova A, 2016, GENE DEV, V30, P1300, DOI 10.1101/gad.279836.116; Pardo-Saganta A, 2015, NATURE, V523, P597, DOI 10.1038/nature14553; Plasschaert LW, 2018, NATURE, V560, P377, DOI 10.1038/s41586-018-0394-6; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; ROGEL A, 1985, MOL CELL BIOL, V5, P2851, DOI 10.1128/MCB.5.10.2851; Sabapathy K, 1997, EMBO J, V16, P6217, DOI 10.1093/emboj/16.20.6217; Sui P., 2019, DEVELOPMENT, V146, P1; Sun DQ, 2014, J MED CHEM, V57, P1454, DOI 10.1021/jm401753e; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Vaidyanathan S, 2020, CELL STEM CELL, V26, P161, DOI 10.1016/j.stem.2019.11.002; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Warburton David, 2008, Proc Am Thorac Soc, V5, P703, DOI 10.1513/pats.200801-012AW; Wienken M, 2016, MOL CELL, V61, P68, DOI 10.1016/j.molcel.2015.12.008; Woo AJ, 2019, BLOOD ADV, V3, P2499, DOI 10.1182/bloodadvances.2018030551; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang Y, 2018, DEV CELL, V44, P752, DOI 10.1016/j.devcel.2018.03.001; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002	52	3	3	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21816	10.1096/fj.202100638R	http://dx.doi.org/10.1096/fj.202100638R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34396583	Green Published			2022-12-28	WOS:000691122900016
J	Ruple, BA; Godwin, JS; Mesquita, PHC; Osburn, SC; Vann, CG; Lamb, DA; Sexton, CL; Candow, DG; Forbes, SC; Fruge, AD; Kavazis, AN; Young, KC; Seaborne, RA; Sharples, AP; Roberts, MD				Ruple, Bradley A.; Godwin, Joshua S.; Mesquita, Paulo H. C.; Osburn, Shelby C.; Vann, Christopher G.; Lamb, Donald A.; Sexton, Casey L.; Candow, Darren G.; Forbes, Scott C.; Fruge, Andrew D.; Kavazis, Andreas N.; Young, Kaelin C.; Seaborne, Robert A.; Sharples, Adam P.; Roberts, Michael D.			Resistance training rejuvenates the mitochondrial methylome in aged human skeletal muscle	FASEB JOURNAL			English	Article						aging; methylation; mitochondrial DNA; resistance training	DNA METHYLATION; EXERCISE; PROTEIN; TRANSCRIPTION; TRANSLATION; EPIGENETICS; ADAPTATIONS; EXPRESSION; DISEASE; GENOME	Resistance training (RT) dynamically alters the skeletal muscle nuclear DNA methylome. However, no study has examined if RT affects the mitochondrial DNA (mtDNA) methylome. Herein, ten older, Caucasian untrained males (65 +/- 7 y.o.) performed six weeks of full-body RT (twice weekly). Body composition and knee extensor torque were assessed prior to and 72 h following the last RT session. Vastus lateralis (VL) biopsies were also obtained. VL DNA was subjected to reduced representation bisulfite sequencing providing excellent coverage across the similar to 16-kilobase mtDNA methylome (254 CpG sites). Biochemical assays were also performed, and older male data were compared to younger trained males (22 +/- 2 y.o., n = 7, n = 6 Caucasian & n = 1 African American). RT increased whole-body lean tissue mass (p = .017), VL thickness (p = .012), and knee extensor torque (p = .029) in older males. RT also affected the mtDNA methylome, as 63% (159/254) of the CpG sites demonstrated reduced methylation (p < .05). Several mtDNA sites presented a more "youthful" signature in older males after RT in comparison to younger males. The 1.12 kilobase mtDNA D-loop/control region, which regulates replication and transcription, possessed enriched hypomethylation in older males following RT. Enhanced expression of mitochondrial H- and L-strand genes and complex III/IV protein levels were also observed (p < .05). While limited to a shorter-term intervention, this is the first evidence showing that RT alters the mtDNA methylome in skeletal muscle. Observed methylome alterations may enhance mitochondrial transcription, and RT evokes mitochondrial methylome profiles to mimic younger men. The significance of these findings relative to broader RT-induced epigenetic changes needs to be elucidated.	[Ruple, Bradley A.; Godwin, Joshua S.; Mesquita, Paulo H. C.; Osburn, Shelby C.; Vann, Christopher G.; Sexton, Casey L.; Kavazis, Andreas N.; Young, Kaelin C.; Roberts, Michael D.] Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA; [Lamb, Donald A.; Fruge, Andrew D.] Auburn Univ, Dept Nutr Dietet & Hospitality Management, Auburn, AL 36849 USA; [Candow, Darren G.] Univ Regina, Fac Kinesiol & Hlth Studies, Regina, SK, Canada; [Forbes, Scott C.] Brandon Univ, Fac Educ, Dept Phys Educ Studies, Brandon, MB, Canada; [Young, Kaelin C.; Roberts, Michael D.] Edward Via Coll Osteopath Med, Auburn, AL USA; [Seaborne, Robert A.] Queen Mary Univ London, Ctr Genom & Child Hlth, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Sharples, Adam P.] Norwegian Sch Sport Sci, Inst Phys Performance, Oslo, Norway	Auburn University System; Auburn University; Auburn University System; Auburn University; University of Regina; Brandon University; University of London; Queen Mary University London; Norwegian School of Sport Sciences	Roberts, MD (corresponding author), Auburn Univ, Sch Kinesiol, Mol & Appl Sci Lab, 301 Wire Rd,Off 286, Auburn, AL 36849 USA.; Seaborne, RA (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Genom & Child Hlth, 4 Newark St, London E1 2AT, England.	robseaborne@googlemail.com; mdr0024@auburn.edu	Seaborne, Robert/K-7916-2019; Candow, Darren/AAE-9931-2022; Candow, Darren/AFF-7575-2022; Mesquita, Paulo H. C./G-4912-2017	Seaborne, Robert/0000-0003-2491-3747; Mesquita, Paulo H. C./0000-0003-1112-5493; Sharples, Adam/0000-0003-1526-9400	Peanut Institute; Research Council of Norway [314157]	Peanut Institute; Research Council of Norway(Research Council of Norway)	The Peanut Institute; The Research Council of Norway, Grant/Award Number: 314157	Bagley JR, 2020, J STRENGTH COND RES, V34, P1574, DOI 10.1519/JSC.0000000000003185; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Blocquiaux S., 2020, RECURRENT TRAINING R; Brown WM, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094073; D'Aquila P, 2015, EPIGENOMICS-UK, V7, P707, DOI 10.2217/epi.15.30; Day K, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r102; EDEN S, 1994, CURR OPIN GENET DEV, V4, P255, DOI 10.1016/S0959-437X(05)80052-8; Goldsmith C, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87457-8; Groennebaek T, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00713; Haun CT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215267; Holloway GP, 2018, CELL REP, V22, P2837, DOI 10.1016/j.celrep.2018.02.069; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kephart WC, 2016, AMINO ACIDS, V48, P779, DOI 10.1007/s00726-015-2125-8; Kephart WC, 2015, EXP PHYSIOL, V100, P852, DOI 10.1113/EP085160; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lamb DA, 2020, J INT SOC SPORT NUTR, V17, DOI 10.1186/s12970-020-00397-y; Lamb DA, 2020, AGING-US, V12, P9447, DOI 10.18632/aging.103218; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Ling C, 2007, J CLIN INVEST, V117, P3427, DOI 10.1172/JCI30938; Maasar MF, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.619447; Manev Hari, 2012, Biomol Concepts, V3, P107; Mawlood SK, 2016, AGING-US, V8, P636, DOI 10.18632/aging.100892; Mechta M, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00166; Mesquita PHC, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14526; NASS MMK, 1973, J MOL BIOL, V80, P155, DOI 10.1016/0022-2836(73)90239-8; Nitert MD, 2012, DIABETES, V61, P3322, DOI 10.2337/db11-1653; Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002; Parry HA, 2020, INT J SPORTS MED, V41, P349, DOI 10.1055/a-1121-7851; Patil V, 2019, NUCLEIC ACIDS RES, V47, P10072, DOI 10.1093/nar/gkz762; Pillon NJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13869-w; Roberts MD, 2018, PEERJ, V6, DOI 10.7717/peerj.5338; Robinson MM, 2017, CELL METAB, V25, P581, DOI 10.1016/j.cmet.2017.02.009; Ronn T, 2008, DIABETOLOGIA, V51, P1159, DOI 10.1007/s00125-008-1018-8; Sawka MN, 2007, MED SCI SPORT EXER, V39, P377, DOI 10.1249/mss.0b013e31802ca597; Seaborne RA, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.213; Seaborne RA, 2020, EXERC SPORT SCI REV, V48, P188, DOI 10.1249/JES.0000000000000227; Seaborne RA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20287-3; Sharples AP, 2016, AGING CELL, V15, P603, DOI 10.1111/acel.12486; Shokolenko IN, 2017, FRONT BIOSCI-LANDMRK, V22, P835, DOI 10.2741/4520; Sun X, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0590-0; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Turner DC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72730-z; Voisin S., 2020, 315838 BIORXIV; Voisin S, 2020, J CACHEXIA SARCOPENI, V11, P887, DOI 10.1002/jcsm.12556; Wang HQ, 2011, BIOINFORMATICS, V27, P225, DOI 10.1093/bioinformatics/btq650; Wong M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00279; Wu XJ, 2017, NAT REV GENET, V18, P517, DOI 10.1038/nrg.2017.33; Zykovich A, 2014, AGING CELL, V13, P360, DOI 10.1111/acel.12180	49	10	10	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21864	10.1096/fj.202100873RR	http://dx.doi.org/10.1096/fj.202100873RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34423880	Green Submitted			2022-12-28	WOS:000691122900039
J	Suarez-Calvet, X; Fernandez-Simon, E; Pinol-Jurado, P; Alonso-Perez, J; Carrasco-Rozas, A; Lleixa, C; Lopez-Fernandez, S; Pons, G; Soria, L; Bigot, A; Mouly, V; Illa, I; Gallardo, E; Jaiswal, JK; Diaz-Manera, J				Suarez-Calvet, Xavier; Fernandez-Simon, Esther; Pinol-Jurado, Patricia; Alonso-Perez, Jorge; Carrasco-Rozas, Ana; Lleixa, Cinta; Lopez-Fernandez, Susana; Pons, Gemma; Soria, Laura; Bigot, Anne; Mouly, Vincent; Illa, Isabel; Gallardo, Eduard; Jaiswal, Jyoti K.; Diaz-Manera, Jordi			Isolation of human fibroadipogenic progenitors and satellite cells from frozen muscle biopsies	FASEB JOURNAL			English	Article						Duchenne muscular dystrophy; fibroadipogenic progenitors cells; muscle explant muscle biopsies; satellite cells	MESENCHYMAL STEM-CELLS; REGENERATION; MOUSE; INHIBITORS; EXPRESSION; FIBROSIS	Skeletal muscle contains multiple cell types that work together to maintain tissue homeostasis. Among these, satellite cells (SC) and fibroadipogenic progenitors cells (FAPs) are the two main stem cell pools. Studies of these cells using animal models have shown the importance of interactions between these cells in repair of healthy muscle, and degeneration of dystrophic muscle. Due to the unavailability of fresh patient muscle biopsies, similar analysis of interactions between human FAPs and SCs is limited especially among the muscular dystrophy patients. To address this issue here we describe a method that allows the use of frozen human skeletal muscle biopsies to simultaneously isolate and grow SCs and FAPs from healthy or dystrophic patients. We show that while the purified SCs differentiate into mature myotubes, purified FAPs can differentiate into adipocytes or fibroblasts demonstrating their multipotency. We find that these FAPs can be immortalized and the immortalized FAPs (iFAPs) retain their multipotency. These approaches open the door for carrying out personalized analysis of patient FAPs and interactions with the SCs that lead to muscle loss.	[Suarez-Calvet, Xavier; Fernandez-Simon, Esther; Pinol-Jurado, Patricia; Alonso-Perez, Jorge; Carrasco-Rozas, Ana; Lleixa, Cinta; Illa, Isabel; Gallardo, Eduard; Diaz-Manera, Jordi] Hosp Santa Creu & Sant Pau, Neuromuscular Dis Unit, Neurol Dept, C St Quinti 77, Barcelona 08041, Spain; [Suarez-Calvet, Xavier; Fernandez-Simon, Esther; Pinol-Jurado, Patricia; Alonso-Perez, Jorge; Carrasco-Rozas, Ana; Lleixa, Cinta; Illa, Isabel; Gallardo, Eduard; Diaz-Manera, Jordi] Biomed Res Inst St Pau IIB St Pau, C St Quinti 77, Barcelona 08041, Spain; [Suarez-Calvet, Xavier; Illa, Isabel; Gallardo, Eduard; Diaz-Manera, Jordi] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [Fernandez-Simon, Esther; Pinol-Jurado, Patricia; Diaz-Manera, Jordi] Univ Newcastle, John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Lopez-Fernandez, Susana; Pons, Gemma] Autonomous Univ Barcelona, Plast Surg Dept, Hosp Santa Creu & St Pau, Barcelona, Spain; [Soria, Laura] Autonomous Univ Barcelona, Orthopaed & Traumatol Dept, Hosp Santa Creu & St Pau, Barcelona, Spain; [Bigot, Anne; Mouly, Vincent] Sorbonne Univ, Ctr Res Myol, Inst Myol, Inserm,U974, Paris, France; [Jaiswal, Jyoti K.] George Washington Univ, Sch Med & Hlth Sci, Dept Genom & Precis Med, Washington, DC 20052 USA; [Jaiswal, Jyoti K.] Childrens Natl Hosp, Ctr Genet Med Res, Washington, DC USA	Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Newcastle University - UK; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; George Washington University; Children's National Health System	Suarez-Calvet, X (corresponding author), Hosp Santa Creu & Sant Pau, Neuromuscular Dis Unit, Neurol Dept, C St Quinti 77, Barcelona 08041, Spain.; Suarez-Calvet, X (corresponding author), Biomed Res Inst St Pau IIB St Pau, C St Quinti 77, Barcelona 08041, Spain.; Diaz-Manera, J (corresponding author), Newcastle Univ, John Walton Muscular Dystrophy Res Ctr, Ctr Life, Translat & Clin Res Inst, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.	xsuarez@santpau.cat; jordi.diaz-manera@newcastle.ac.uk	; Suarez-Calvet, Xavier/AAF-8273-2021; Jaiswal, Jyoti/M-5891-2013	Bigot, anne/0000-0003-0337-5425; Fernandez Simon, Esther/0000-0003-4804-6553; Suarez-Calvet, Xavier/0000-0002-5314-6607; Alonso-Perez, Jorge/0000-0001-8866-5186; Jaiswal, Jyoti/0000-0002-5992-5185	AFM-Telethon (French Muscular Dystrophy Association) [22525]; Instituto de Salud Carlos III [CD18/00195, CM19/00178, PI18/01525]; CIBERER [2019/29]	AFM-Telethon (French Muscular Dystrophy Association); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); CIBERER	AFM-Telethon (French Muscular Dystrophy Association), Grant/Award Number: 22525; Instituto de Salud Carlos III, Grant/Award Number: CD18/00195, CM19/00178 and PI18/01525; CIBERER, Grant/Award Number: 2019/29	Aure K, 2007, NEUROMUSCULAR DISORD, V17, P368, DOI 10.1016/j.nmd.2007.01.019; CARTER LS, 1981, MUSCLE NERVE, V4, P367, DOI 10.1002/mus.880040503; Chazaud B, 2020, TRENDS IMMUNOL, V41, P481, DOI 10.1016/j.it.2020.04.006; Consalvi S, 2014, EPIGENOMICS-UK, V6, P547, DOI [10.2217/EPI.14.36, 10.2217/epi.14.36]; De Micheli AJ, 2020, SKELET MUSCLE, V10, DOI 10.1186/s13395-020-00236-3; Farup J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.198; Giordani L, 2019, MOL CELL, V74, P609, DOI 10.1016/j.molcel.2019.02.026; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Hogarth MW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10438-z; Ito T, 2013, NEUROMUSCULAR DISORD, V23, P349, DOI 10.1016/j.nmd.2012.10.025; Kasai T, 2017, AM J PATHOL, V187, P2627, DOI 10.1016/j.ajpath.2017.08.008; Korner A, 2005, BIOCHEM BIOPH RES CO, V337, P540, DOI 10.1016/j.bbrc.2005.09.064; Latroche C, 2018, METHODS, V134, P50, DOI 10.1016/j.ymeth.2017.12.013; Mamchaoui K, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-34; Massenet J, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081780; Mazala DAG, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.135703; Mozzetta C, 2013, EMBO MOL MED, V5, P626, DOI 10.1002/emmm.201202096; Munoz-Canoves P, 2015, TRENDS ENDOCRIN MET, V26, P449, DOI 10.1016/j.tem.2015.07.005; Oprescu SN, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100993; Perdiguero E, 2019, METHODS MOL BIOL, V2045, P13, DOI 10.1007/7651_2019_210; Petrilli LL, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071723; Rubenstein AB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57110-6; Sandona M, 2020, EMBO REP, V21, DOI 10.15252/embr.202050863; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sibov TT, 2012, CYTOTECHNOLOGY, V64, P511, DOI 10.1007/s10616-012-9428-3; Thorley M, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0115-5; Tucciarone L, 2018, METHODS MOL BIOL, V1687, P231, DOI 10.1007/978-1-4939-7374-3_17; Uezumi A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.161; Uezumi A, 2016, METHODS MOL BIOL, V1460, P241, DOI 10.1007/978-1-4939-3810-0_17; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014	31	1	1	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21819	10.1096/fj.202100588R	http://dx.doi.org/10.1096/fj.202100588R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34405910	Green Published, hybrid			2022-12-28	WOS:000691122900017
J	Khan, S; Mentrup, HL; Novak, EA; Siow, VS; Wang, Q; Crawford, EC; Schneider, C; Comerford, TE; Firek, B; Rogers, MB; Loughran, P; Morowitz, MJ; Mollen, KP				Khan, Sidrah; Mentrup, Heather L.; Novak, Elizabeth A.; Siow, Vei Shaun; Wang, Qian; Crawford, Erin C.; Schneider, Corinne; Comerford, Thomas E.; Firek, Brian; Rogers, Matt B.; Loughran, Patricia; Morowitz, Michael J.; Mollen, Kevin P.			Cyclic GMP-AMP synthase contributes to epithelial homeostasis in intestinal inflammation via Beclin-1-mediated autophagy	FASEB JOURNAL			English	Article						cGAS; colitis; DSS; intestinal epithelium	SIROLIMUS RAPAMYCIN; CROHNS-DISEASE; BOWEL-DISEASE; COLITIS; APOPTOSIS; CGAS; PROTECTS; STIMULATION; INDUCTION; RELEVANCE	Inflammatory bowel disease (IBD) represents a set of idiopathic and chronic inflammatory diseases of the gastrointestinal tract. Central to the pathogenesis of IBD is a dysregulation of normal intestinal epithelial homeostasis. cGAS is a DNA-sensing receptor demonstrated to promote autophagy, a mechanism that removes dysfunctional cellular components. Beclin-1 is a crucial protein involved in the initiation of autophagy. We hypothesized that cGAS plays a key role in intestinal homeostasis by upregulating Beclin-1-mediated autophagy. We evaluated intestinal cGAS levels in humans with IBD and in murine colonic tissue after performing a 2% dextran sulfate sodium (DSS) colitis model. Autophagy and cell death mechanisms were studied in cGAS KO and WT mice via qPCR, WB analysis, H&E, IF, and TUNEL staining. Autophagy was measured in stimulated intestinal epithelial cells (IECs) via WB analysis. Our data demonstrates cGAS to be upregulated during human and murine colitis. Furthermore, cGAS deficiency leads to worsened colitis and decreased levels of autophagy proteins including Beclin-1 and LC3-II. Co-IP demonstrates a direct binding between cGAS and Beclin-1 in IECs. Transfection of cGAS in stimulated HCT-116 cells leads to increased autophagy. IECs isolated from cGAS KO have diminished autophagic flux. cGAS KO mice subjected to DSS have increased cell death and cleaved caspase-3. Lastly, treatment of cGAS KO mice with rapamycin decreased the severity of colitis. Our data suggest that cGAS maintains intestinal epithelial homeostasis during human IBD and murine colitis by upregulating Beclin-1-mediated autophagy and preventing IEC death. Rescue of autophagy can attenuate the severity of colitis associated with cGAS deficiency.	[Khan, Sidrah; Mentrup, Heather L.; Novak, Elizabeth A.; Siow, Vei Shaun; Firek, Brian; Rogers, Matt B.; Loughran, Patricia; Morowitz, Michael J.; Mollen, Kevin P.] Univ Pittsburgh, Dept Surg, Sch Med, 200 Lothrop St, Pittsburgh, PA 15203 USA; [Mentrup, Heather L.; Novak, Elizabeth A.; Schneider, Corinne; Firek, Brian; Rogers, Matt B.; Morowitz, Michael J.; Mollen, Kevin P.] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Div Pediat Surg, Med Ctr, Pittsburgh, PA 15203 USA; [Wang, Qian] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Dept Pathol, Med Ctr, Pittsburgh, PA 15203 USA; [Crawford, Erin C.] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Div Gastroenterol, Med Ctr, Pittsburgh, PA 15203 USA; [Comerford, Thomas E.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA; [Loughran, Patricia] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA 15203 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Khan, S (corresponding author), Univ Pittsburgh, Dept Surg, Sch Med, 200 Lothrop St, Pittsburgh, PA 15203 USA.	Khans8@upmc.edu	Loughran, Patricia/AAB-1184-2021	Khan, Sidrah/0000-0002-9545-1247	U.S. National Institutes of Health (NIH) [R01 DK120986]; Burroughs Wellcome Fund	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was supported by U.S. National Institutes of Health (NIH) Grant R01 DK120986 (to K.P.M) and the Burroughs Wellcome Fund (to S.K.). The University of Pittsburgh holds a Physician--Scientist Institutional Award from the Burroughs Wellcome Fund	Ahn J, 2017, CELL REP, V21, P3873, DOI 10.1016/j.celrep.2017.11.101; Araki Y, 2010, ONCOL REP, V24, P869, DOI 10.3892/or_00000932; Benjamin JL, 2013, CELL HOST MICROBE, V13, P723, DOI 10.1016/j.chom.2013.05.004; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cavlar T, 2012, IMMUNOL CELL BIOL, V90, P474, DOI 10.1038/icb.2012.11; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Coskun M, 2014, FRONT MED, V1, DOI 10.3389/fmed.2014.00024; Cunningham KE, 2016, J BIOL CHEM, V291, P10184, DOI 10.1074/jbc.M115.688812; de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2016.186, 10.1038/nrgastro.2015.186]; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Gatica D, 2018, NAT CELL BIOL, V20, P233, DOI 10.1038/s41556-018-0037-z; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Guan YT, 2015, J IMMUNOL, V195, P339, DOI 10.4049/jimmunol.1303356; Gui X, 2019, NATURE, V567, P262, DOI 10.1038/s41586-019-1006-9; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Han YL, 2020, J IMMUNOL, V204, P1437, DOI 10.4049/jimmunol.1900869; Haq S, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0512-2; Hotte NSC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037932; Hu SQ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2105747118; Hu SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154564; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Kato K, 2017, ANNU REV BIOCHEM, V86, P541, DOI 10.1146/annurev-biochem-061516-044813; Kelly-Scumpia KM, 2010, J EXP MED, V207, P319, DOI 10.1084/jem.20091959; Lauzier A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47659-7; Lei Z, 2018, AM J PHYSIOL-GASTR L, V314, pG655, DOI 10.1152/ajpgi.00326.2017; Li KL, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317706213; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Liang QM, 2014, CELL HOST MICROBE, V15, P228, DOI 10.1016/j.chom.2014.01.009; Lin XK, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20181822; Macias-Ceja DC, 2017, BRIT J PHARMACOL, V174, P2501, DOI 10.1111/bph.13860; Massey DCO, 2008, GUT, V57, P1294, DOI 10.1136/gut.2008.157297; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mutalib M, 2014, J CROHNS COLITIS, V8, P1730, DOI 10.1016/j.crohns.2014.08.014; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Perng YC, 2018, NAT REV MICROBIOL, V16, P423, DOI 10.1038/s41579-018-0020-5; Ramachandran A, 2000, J GASTROEN HEPATOL, V15, P109, DOI 10.1046/j.1440-1746.2000.02059.x; Rampton DS., 2016, FAST FACTS INFLAMMAT; Ratsimandresy RA, 2017, CELL MOL IMMUNOL, V14, P127, DOI 10.1038/cmi.2016.35; Renehan AG, 2001, CAN J GASTROENTEROL, V15, P166, DOI 10.1155/2001/164727; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Tsuboi K, 2015, J BIOL CHEM, V290, P20511, DOI 10.1074/jbc.M114.632257; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Valcifahmetoglu-Norberg H, 2015, J CLIN INVEST, V125, P5, DOI 10.1172/JCI73937; Vincent G, 2020, ANTIOXID REDOX SIGN, V33, P1, DOI 10.1089/ars.2018.7702; Walters W, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00009-15; Wang Y, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/192329; Wang Y, 2007, CELL RES, V17, P858, DOI 10.1038/cr.2007.81; Wang ZH, 2021, THERANOSTICS, V11, P7491, DOI 10.7150/thno.59196; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yonekawa T, 2013, ESSAYS BIOCHEM, V55, P105, DOI [10.1042/BSE0550105, 10.1042/bse0550105]; Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865; Zhong M., 2020, FRONT PHARMACOL, V11	60	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22282	10.1096/fj.202200138R	http://dx.doi.org/10.1096/fj.202200138R			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0A0AX	35344224				2022-12-28	WOS:000773625500001
J	Olate-Briones, A; Escalona, E; Salazar, C; Herrada, MJ; Liu, CH; Herrada, AA; Escobedo, N				Olate-Briones, Alexandra; Escalona, Emilia; Salazar, Celia; Jose Herrada, Maria; Liu, Chaohong; Herrada, Andres A.; Escobedo, Noelia			The meningeal lymphatic vasculature in neuroinflammation	FASEB JOURNAL			English	Review						central nervous system; meningeal lymphatic vasculature; neuroinflammation; neurological disorders; T cells	DISEASE-LIKE PATHOLOGY; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; DENDRITIC CELLS; LIVER-FAILURE; CORTICAL DEMYELINATION; CHOROID-PLEXUS; TH17 CELLS; BRAIN; SYSTEM	The lymphatic vasculature is a unidirectional network of lymphatic endothelial cells, whose main role is to maintain fluid homeostasis along with the absorption of dietary fat in the gastrointestinal organs and management and coordination of immune cell trafficking into lymph nodes during homeostasis and under inflammatory conditions. In homeostatic conditions, immune cells, such as dendritic cells, macrophages, or T cells can enter into the lymphatic vasculature and move easily through the lymph reaching secondary lymph nodes where immune cell activation or peripheral tolerance can be modulated. However, under inflammatory conditions such as pathogen infection, increased permeabilization of lymphatic vessels allows faster immune cell migration into inflamed tissues following a chemokine gradient, facilitating pathogen clearance and the resolution of inflammation. Interestingly, since the re-discovery of lymphatic vasculature in the central nervous system, known as the meningeal lymphatic vasculature, the role of these lymphatics as a key player in several neurological disorders has been described, with emphasis on the neurodegenerative process. Alternatively, less has been discussed about meningeal lymphatics and its role in neuroinflammation. In this review, we discuss current knowledge about the anatomy and function of the meningeal lymphatic vasculature and specifically analyze its contribution to different neuroinflammatory processes, highlighting the potential therapeutic target of meningeal lymphatic vasculature in these pathological conditions.	[Olate-Briones, Alexandra; Escalona, Emilia; Salazar, Celia; Herrada, Andres A.; Escobedo, Noelia] Univ Autonoma Chile, Fac Ciencias Salud, Inst Ciencias Biomed, Lymphat Vasculature & Inflammat Res Lab, Talca 3460000, Chile; [Jose Herrada, Maria] Duoc UC, Escuela Diseno, Vina Del Mar, Chile; [Liu, Chaohong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Microbiol, Wuhan, Peoples R China	Universidad Autonoma de Chile; Huazhong University of Science & Technology	Herrada, AA; Escobedo, N (corresponding author), Univ Autonoma Chile, Fac Ciencias Salud, Inst Ciencias Biomed, Lymphat Vasculature & Inflammat Res Lab, Talca 3460000, Chile.	andres.herrada@uautonoma.cl; noelia.escobedo@uautonoma.cl		Escobedo, Noelia/0000-0002-0743-2258	FONDECYT [11190253, 1201562]; Pew Charitable Trusts	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Pew Charitable Trusts	This work was funded by the following grants: FONDECYT de inicio N degrees 11190253 (A.H) and FONDECYT Regular N degrees 1201562 (N.E). AH is a Latin American Fellow in the Biomedical Sciences, supported by The Pew Charitable Trusts.	Absinta M, 2017, ELIFE, V6, DOI 10.7554/eLife.29738; Ahn JH, 2019, NATURE, V572, P62, DOI 10.1038/s41586-019-1419-5; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Anandasabapathy N, 2011, J EXP MED, V208, P1695, DOI 10.1084/jem.20102657; Antila S, 2017, J EXP MED, V214, P3645, DOI 10.1084/jem.20170391; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Aspelund A, 2014, J CLIN INVEST, V124, P3975, DOI 10.1172/JCI75395; Bardina SV, 2015, J IMMUNOL, V195, P4306, DOI 10.4049/jimmunol.1500352; Baruch K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8967; Belikan P, 2018, J IMMUNOL, V200, P2554, DOI 10.4049/jimmunol.1701419; Bolte AC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18113-4; Breuer J, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1276-4; Brigas HC, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109574; Brioschi S, 2021, SCIENCE, V373, P408, DOI 10.1126/science.abf9277; Brynskikh A, 2008, BRAIN BEHAV IMMUN, V22, P861, DOI 10.1016/j.bbi.2007.12.008; Butterworth RF, 2013, NAT REV GASTRO HEPAT, V10, P522, DOI 10.1038/nrgastro.2013.99; Caraci F, 2015, SCI REP-UK, V5, DOI 10.1038/srep11252; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Cauli O, 2006, J HEPATOL, V45, P654, DOI 10.1016/j.jhep.2006.06.019; Cekanaviciute E, 2014, GLIA, V62, P1227, DOI 10.1002/glia.22675; Chen JM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16851-z; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Chou A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061616; Clarkson BD, 2014, J NEUROIMMUNOL, V277, P39, DOI 10.1016/j.jneuroim.2014.09.016; Clemmesen JO, 1999, HEPATOLOGY, V29, P648, DOI 10.1002/hep.510290309; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Cruciani C, 2021, NEUROL-NEUROIMMUNOL, V8, DOI 10.1212/NXI.0000000000001075; D'Alessio S, 2014, J CLIN INVEST, V124, P3863, DOI 10.1172/JCI72189; Da Mesquita S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe4601; Da Mesquita S, 2021, NATURE, V593, P255, DOI 10.1038/s41586-021-03489-0; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; de Leon MJ, 2017, J NUCL MED, V58, P1471, DOI 10.2967/jnumed.116.187211; de Lima KA, 2020, ANNU REV IMMUNOL, V38, P597, DOI 10.1146/annurev-immunol-102319-103410; Del Tredici K, 2016, NEUROPATH APPL NEURO, V42, P33, DOI 10.1111/nan.12298; DeLuca GC, 2013, BRAIN, V136, P1025, DOI 10.1093/brain/awt031; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Ding XB, 2021, NAT MED, V27, P411, DOI 10.1038/s41591-020-01198-1; Dionne KR, 2011, EXP NEUROL, V228, P222, DOI 10.1016/j.expneurol.2011.01.006; DiSabato DJ, 2016, J NEUROCHEM, V139, P136, DOI 10.1111/jnc.13607; Donahue EK, 2021, MOVEMENT DISORD, V36, P1126, DOI 10.1002/mds.28473; Dugger BN, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028035; Eimer WA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-2; Escobedo N, 2017, CELL METAB, V26, P598, DOI 10.1016/j.cmet.2017.07.020; Escobedo N, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85096; Escobedo N, 2016, ANNU REV CELL DEV BI, V32, P677, DOI 10.1146/annurev-cellbio-111315-124944; Ferenci P, 2017, GASTROENTEROL REP, V5, P138, DOI 10.1093/gastro/gox013; Fernandez-Arjona MD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00235; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Fransen MF, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124507; Fujii M, 2013, TRANSL STROKE RES, V4, P432, DOI 10.1007/s12975-013-0257-2; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Gonzalez-Loyola A, 2021, ADV DRUG DELIVER REV, V169, P63, DOI 10.1016/j.addr.2020.12.005; Greenhalgh AD, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005264; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hadjihambi A, 2017, HEPATOLOGY, V65, P1306, DOI 10.1002/hep.29031; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; Henri O, 2016, CIRCULATION, V133, P1484, DOI 10.1161/CIRCULATIONAHA.115.020143; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Howell OW, 2011, BRAIN, V134, P2755, DOI 10.1093/brain/awr182; Hsu M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08163-0; Hsu SJ, 2021, GASTROENTEROLOGY, V160, P1315, DOI 10.1053/j.gastro.2020.11.036; Hu XT, 2020, CELL RES, V30, P229, DOI 10.1038/s41422-020-0287-8; Huang SC, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.585034; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Jovcevska I, 2013, MOL CLIN ONCOL, V1, P935, DOI 10.3892/mco.2013.172; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P8180, DOI 10.1073/pnas.0402268101; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Korin B, 2017, NAT NEUROSCI, V20, P1300, DOI 10.1038/nn.4610; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Kumar A, 2015, PHARMACOL REP, V67, P195, DOI 10.1016/j.pharep.2014.09.004; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Kwon MJ, 2015, J NEUROSCI, V35, P15934, DOI 10.1523/JNEUROSCI.1924-15.2015; Li PY, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006387; Liu XH, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-0888-y; Lodygin D, 2013, NAT MED, V19, P784, DOI 10.1038/nm.3182; Del Rey NLG, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00113; Louveau A, 2018, NAT NEUROSCI, V21, P1380, DOI 10.1038/s41593-018-0227-9; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lovato L, 2011, BRAIN, V134, P534, DOI 10.1093/brain/awq350; Lubetzki C, 2014, HAND CLINIC, V122, P89, DOI 10.1016/B978-0-444-52001-2.00004-2; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Lyu JX, 2021, CNS NEUROSCI THER, V27, P515, DOI 10.1111/cns.13620; Ma QL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01484-6; Ma YY, 2017, PROG NEUROBIOL, V157, P247, DOI 10.1016/j.pneurobio.2016.01.005; Machado-Santos J, 2018, BRAIN, V141, P2066, DOI 10.1093/brain/awy151; Magliozzi R, 2010, ANN NEUROL, V68, P477, DOI 10.1002/ana.22230; Marin I, 2013, LEARN MEMORY, V20, P601, DOI 10.1101/lm.028357.112; Medeiros R, 2011, CNS NEUROSCI THER, V17, P514, DOI 10.1111/j.1755-5949.2010.00177.x; Zeron HM, 2011, J TRACE ELEM MED BIO, V25, P225, DOI 10.1016/j.jtemb.2011.07.003; Merson TD, 2010, NEUROMOL MED, V12, P99, DOI 10.1007/s12017-010-8112-z; Mills JH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-193; Mishra PK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004787; Morimoto K, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00916; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; Nayak Debasis, 2012, Intravital, V1, P95, DOI 10.4161/intv.22823; Nicholson LB, 2016, ESSAYS BIOCHEM, V60, P275, DOI 10.1042/EBC20160017; Obermeier B, 2008, NAT MED, V14, P688, DOI 10.1038/nm1714; Oliver G, 2020, CELL, V182, P270, DOI 10.1016/j.cell.2020.06.039; Ortega SB, 2020, P NATL ACAD SCI USA, V117, P4983, DOI 10.1073/pnas.1913292117; Patel TK, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0312-x; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Posel C, 2016, JOVE-J VIS EXP, DOI 10.3791/53658; Polfliet MMJ, 2001, J IMMUNOL, V167, P4644, DOI 10.4049/jimmunol.167.8.4644; Quintana E, 2015, GLIA, V63, P2231, DOI 10.1002/glia.22889; Rasmussen JC, 2014, OBESITY, V22, P2186, DOI 10.1002/oby.20836; Remuzgo-Martinez S, 2013, GLIA, V61, P611, DOI 10.1002/glia.22459; Ribeiro M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aay5199; Ribes S, 2010, NEUROSCI LETT, V482, P17, DOI 10.1016/j.neulet.2010.06.078; Ringstad G, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14195-x; Rodrigo R, 2010, GASTROENTEROLOGY, V139, P675, DOI 10.1053/j.gastro.2010.03.040; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Russo MV, 2018, NAT IMMUNOL, V19, P442, DOI 10.1038/s41590-018-0086-2; Ryu Keun-Young, 2012, Exp Neurobiol, V21, P151, DOI 10.5607/en.2012.21.4.151; Santoro A, 2021, AGEING RES REV, V71, DOI 10.1016/j.arr.2021.101422; Sasaki Y, 2001, BIOCHEM BIOPH RES CO, V286, P292, DOI 10.1006/bbrc.2001.5388; Schafflick D, 2021, NAT NEUROSCI, V24, P1225, DOI 10.1038/s41593-021-00880-y; Schlager C, 2016, NATURE, V530, P349, DOI 10.1038/nature16939; Schubert JJ, 2019, J NUCL MED, V60, P1452, DOI 10.2967/jnumed.118.223834; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Simon AK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3085; Smolders J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07053-9; Song E, 2020, NATURE, V577, P689, DOI 10.1038/s41586-019-1912-x; Sowers JL, 2014, ADV EXP MED BIOL, V816, P75, DOI 10.1007/978-3-0348-0837-8_4; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Tranah TH, 2013, METAB BRAIN DIS, V28, P1, DOI 10.1007/s11011-012-9370-2; Troncoso-Escudero P, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00860; van Hooren L, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24347-7; Voet S, 2019, TRENDS MOL MED, V25, P112, DOI 10.1016/j.molmed.2018.11.005; vom Berg J, 2012, NAT MED, V18, P1812, DOI 10.1038/nm.2965; Wang QQ, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0042-0; Wang T, 2021, FOOD CHEM TOXICOL, V157, DOI 10.1016/j.fct.2021.112550; Weiss N, 2016, J HEPATOL, V65, P1120, DOI 10.1016/j.jhep.2016.07.046; Wen YR, 2018, NEURAL REGEN RES, V13, P709, DOI 10.4103/1673-5374.230299; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Winters L, 2013, NEUROSCIENCE, V238, P87, DOI 10.1016/j.neuroscience.2013.02.001; Wojciechowski S, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.559810; Wolf SA, 2009, J IMMUNOL, V182, P3979, DOI 10.4049/jimmunol.0801218; Yu LP, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0939-6; Zemtsova I, 2011, HEPATOLOGY, V54, P204, DOI 10.1002/hep.24326; Zenaro E, 2015, NAT MED, V21, P880, DOI 10.1038/nm.3913; Zhang DF, 2021, INT IMMUNOPHARMACOL, V97, DOI 10.1016/j.intimp.2021.107656; Zhang Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03692-0; Zhang Y, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-020-03385-x; Zhang ZG, 1998, BRAIN RES, V784, P210, DOI 10.1016/S0006-8993(97)01317-6; Zhou Y, 2020, ANN NEUROL, V87, P357, DOI 10.1002/ana.25670; Zhou ZM, 2020, DOSE-RESPONSE, V18, DOI 10.1177/1559325820964991; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; Zou WY, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0147-y	154	1	1	7	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22276	10.1096/fj.202101574RR	http://dx.doi.org/10.1096/fj.202101574RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0N8KF	35344212				2022-12-28	WOS:000783080000001
J	Qi, XQ; Wu, F; Kim, SH; Kaifi, JT; Kimchi, ET; Snyder, H; Illendula, A; Fox, T; Kester, M; Staveley-O'Carroll, KF; Li, GF				Qi, Xiaoqiang; Wu, Feng; Kim, Sung Hoon; Kaifi, Jussuf T.; Kimchi, Eric T.; Snyder, Helena; Illendula, Anuradha; Fox, Todd; Kester, Mark; Staveley-O'Carroll, Kevin F.; Li, Guangfu			Nanoliposome C6-Ceramide in combination with anti-CTLA4 antibody improves anti-tumor immunity in hepatocellular cancer	FASEB JOURNAL			English	Article						hepatocellular cancer (HCC); immune checkpoint blockade (ICB); Kruppel-like Factor 2 (KLF2); nanoliposome C6-ceramide (LipC6)	T-CELL QUIESCENCE; TRANSCRIPTION-FACTOR; LIVER-TRANSPLANTATION; CARCINOMA; CHECKPOINT; THERAPY; KLF2; CHEMOIMMUNOTHERAPY; EXPRESSION; GROWTH	Combination therapy represents an effective therapeutic approach to overcome hepatocellular cancer (HCC) resistance to immune checkpoint blockade (ICB). Based upon previous work demonstrating that nanoliposome C6-ceramide (LipC6) not only induces HCC apoptosis but also prevents HCC-induced immune tolerance, we now investigate the potential of LipC6 in combination with ICB in HCC treatment. We generated orthotopic HCC-bearing mice, which have typical features in common with human patients, and then treated them with LipC6 in combination with the antibodies (Abs) for programmed cell death protein 1 (PD-1) or cytotoxic T-lymphocyte antigen 4 (CTLA4). The tumor growth was monitored by magnetic resonance imaging (MRI) and the intrahepatic immune profiles were checked by flow cytometry in response to the treatments. Realtime PCR (qPCR) was used to detect the expression of target genes. The results show that LipC6 in combination with anti-CTLA4 Ab, but not anti-PD-1 Ab, significantly slowed tumor growth, enhanced tumor-infiltrating CD8(+) T cells, and suppressed tumor-resident CD4(+)CD25(+)FoxP3(+) Tregs. Further molecular investigation indicates that the combinational treatment suppressed transcriptional factor Kruppel-like Factor 2 (KLF2), forkhead box protein P3 (FoxP3), and CTLA4. Our studies suggest that LipC6 in combination with anti-CTLA4 Ab represents a novel therapeutic approach with significant potential in activating anti-HCC immune response and suppressing HCC growth.	[Qi, Xiaoqiang; Wu, Feng; Kim, Sung Hoon; Kaifi, Jussuf T.; Kimchi, Eric T.; Staveley-O'Carroll, Kevin F.; Li, Guangfu] Univ Missouri, Dept Surg, Columbia, MO 65212 USA; [Kaifi, Jussuf T.; Kimchi, Eric T.; Staveley-O'Carroll, Kevin F.; Li, Guangfu] Univ Missouri, Ellis Fischel Canc Ctr, Columbia, MO 65212 USA; [Snyder, Helena; Illendula, Anuradha; Fox, Todd; Kester, Mark] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Li, Guangfu] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Virginia; University of Missouri System; University of Missouri Columbia	Staveley-O'Carroll, KF (corresponding author), Univ Missouri, Dept Surg, Sch Med, One Hosp Dr, Columbia, MO 65212 USA.; Li, GF (corresponding author), Univ Missouri, Dept Surg, Mol Microbiol & Immunol, Ellis Fische Canc Ctr, Roy Blunt NextGen Precis Hlth Bldg,Room 2002, Columbia, MO 65212 USA.	ocarrollk@health.missouri.edu; liguan@health.missouri.edu			 [R01CA208396];  [R01 CA250536];  [I01 BX004065]	; ; 	R01CA208396 (Guangfu Li, Mark Kester, Kevin F. Staveley--O'Carroll), R01 CA250536 (Guangfu Li, Kevin F.Staveley-O'Carroll), I01 BX004065 (Eric Kimchi, Kevin Staveley-O'Carroll), and Ellis Fischel Cancer Center Pilot Project Grant (Guangfu Li)	Andrews MC, 2017, CELL, V171, P740, DOI 10.1016/j.cell.2017.10.027; Arthur B., 2017, GASTROESOPHAGEAL LIV; Avella DM, 2012, HEPATOLOGY, V55, P141, DOI 10.1002/hep.24652; Benkhoucha M, 2010, P NATL ACAD SCI USA, V107, P6424, DOI 10.1073/pnas.0912437107; Bu DX, 2010, J CLIN INVEST, V120, P1961, DOI 10.1172/JCI41384; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Chen SQ, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.635173; Clavien PA, 2012, LANCET ONCOL, V13, pE11, DOI 10.1016/S1470-2045(11)70175-9; Colombo M, 2017, J HEPATOL, V67, P216, DOI 10.1016/j.jhep.2017.05.004; Costa-Pinheiro P, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101855; El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2; Gao JJ, 2017, NAT MED, V23, P551, DOI 10.1038/nm.4308; Hage C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219517; Hahn AW, 2017, IMMUNOTHERAPY-UK, V9, P681, DOI 10.2217/imt-2017-0024; Havel JJ, 2019, NAT REV CANCER, V19, P133, DOI 10.1038/s41568-019-0116-x; HELD WA, 1989, EMBO J, V8, P183, DOI 10.1002/j.1460-2075.1989.tb03363.x; Kamada T, 2019, P NATL ACAD SCI USA, V116, P9999, DOI 10.1073/pnas.1822001116; Kester M, 2015, BIOL CHEM, V396, P737, DOI 10.1515/hsz-2015-0129; Kim HD, 2015, J HEPATOL, V62, P1076, DOI 10.1016/j.jhep.2014.12.013; Kumagai S, 2020, NAT IMMUNOL, V21, P1346, DOI 10.1038/s41590-020-0769-3; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Li GF, 2018, GASTROENTEROLOGY, V154, P1024, DOI 10.1053/j.gastro.2017.10.050; Li GF, 2017, J HEPATOL, V66, P75, DOI 10.1016/j.jhep.2016.07.044; Liu JW, 2013, FUTURE MED CHEM, V5, P1405, DOI 10.4155/fmc.13.107; Liu X, 2010, BLOOD, V116, P4192, DOI 10.1182/blood-2010-02-271080; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Llovet JM, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-020-00240-3; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Mancuso A, 2014, ALIMENT PHARM THER, V40, P1368, DOI 10.1111/apt.12989; Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Nurieva R, 2013, IMMUNOTHERAPY-UK, V5, P513, DOI [10.2217/imt.13.33, 10.2217/IMT.13.33]; O'Connor S., 2010, Morbidity and Mortality Weekly Report, V59, P517; Pabbisetty SK, 2014, P NATL ACAD SCI USA, V111, P9579, DOI 10.1073/pnas.1323493111; Petrick JL, 2016, J CLIN ONCOL, V34, P1787, DOI 10.1200/JCO.2015.64.7412; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Preston GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077537; Qi XQ, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001038; Qi Xiaoqiang, 2016, J Clin Cell Immunol, V7, DOI 10.4172/2155-9899.1000438; Qi XQ, 2015, CANCER BIOL THER, V16, P1812, DOI 10.1080/15384047.2015.1095412; Remon J, 2017, CURR OPIN ONCOL, V29, P97, DOI 10.1097/CCO.0000000000000351; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Tagaram HRS, 2011, GUT, V60, P695, DOI 10.1136/gut.2010.216671; Vitale A, 2014, J HEPATOL, V60, P1165, DOI 10.1016/j.jhep.2014.01.022; Vitale A, 2017, J HEPATOL, V66, P412, DOI 10.1016/j.jhep.2016.09.012; Walker LSK, 2013, J AUTOIMMUN, V45, P49, DOI 10.1016/j.jaut.2013.06.006; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Yang T, 2015, HEPATOLOGY, V62, P976, DOI 10.1002/hep.27702; Yau T, 2020, JAMA ONCOL, V6, DOI 10.1001/jamaoncol.2020.4564	50	4	4	6	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22250	10.1096/fj.202101707R	http://dx.doi.org/10.1096/fj.202101707R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0DB	35294071	Green Published			2022-12-28	WOS:000772946500001
J	Zalesak-Kravec, S; Huang, WL; Jones, JW; Yu, JS; Alloush, J; Defnet, AE; Moise, AR; Kane, MA				Zalesak-Kravec, Stephanie; Huang, Weiliang; Jones, Jace W.; Yu, Jianshi; Alloush, Jenna; Defnet, Amy E.; Moise, Alexander R.; Kane, Maureen A.			Role of cellular retinol-binding protein, type 1 and retinoid homeostasis in the adult mouse heart: A multi-omic approach	FASEB JOURNAL			English	Article						cellular retinol-binding protein; type 1; heart; mice; retinoic acid; retinoid metabolism	PARTIAL-BODY RADIATION; VITAMIN-A; GENE-EXPRESSION; ANGIOTENSIN-II; L-CARNITINE; IN-VITRO; ACID SUPPLEMENTATION; CELLS; DISEASE; QUANTIFICATION	The main active metabolite of Vitamin A, all-trans retinoic acid (RA), is required for proper cellular function and tissue organization. Heart development has a well-defined requirement for RA, but there is limited research on the role of RA in the adult heart. Homeostasis of RA includes regulation of membrane receptors, chaperones, enzymes, and nuclear receptors. Cellular retinol-binding protein, type 1 (CRBP1), encoded by retinol-binding protein, type 1 (Rbp1), regulates RA homeostasis by delivering vitamin A to enzymes for RA synthesis and protecting it from non-specific oxidation. In this work, a multi-omics approach was used to characterize the effect of CRBP1 loss using the Rbp1(-/-) mouse. Retinoid homeostasis was disrupted in Rbp1(-/-) mouse heart tissue, as seen by a 33% and 24% decrease in RA levels in the left and right ventricles, respectively, compared to wild-type mice (WT). To further inform on the effect of disrupted RA homeostasis, we conducted high-throughput targeted metabolomics. A total of 222 metabolite and metabolite combinations were analyzed, with 33 having differential abundance between Rbp1(-/-) and WT hearts. Additionally, we performed global proteome profiling to further characterize the impact of CRBP1 loss in adult mouse hearts. More than 2606 unique proteins were identified, with 340 proteins having differential expression between Rbp1(-/-) and WT hearts. Pathway analysis performed on metabolomic and proteomic data revealed pathways related to cellular metabolism and cardiac metabolism were the most disrupted in Rbp1(-/-) mice. Together, these studies characterize the effect of CRBP1 loss and reduced RA in the adult heart.	[Zalesak-Kravec, Stephanie; Huang, Weiliang; Jones, Jace W.; Yu, Jianshi; Alloush, Jenna; Defnet, Amy E.; Kane, Maureen A.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 N Pine St,Rm N731, Baltimore, MD 21201 USA; [Moise, Alexander R.] Northern Ontario Sch Med, Div Med Sci, Sudbury, ON, Canada	University System of Maryland; University of Maryland Baltimore; Northern Ontario School of Medicine	Kane, MA (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 N Pine St,Rm N731, Baltimore, MD 21201 USA.	mkane@rx.umaryland.edu	Moise, Alexander R/C-9498-2009	Moise, Alexander R/0000-0003-2307-6035	HHS \ NIH \ Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01HD077260]; HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [T32 GM066706]; University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center [SOP1841-IQB2014]	HHS \ NIH \ Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center	HHS vertical bar NIH vertical bar Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: R01HD077260; HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: T32 GM066706; University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center, Grant/Award Number: SOP1841-IQB2014	Adeva-Andany MM, 2017, IUBMB LIFE, V69, P578, DOI 10.1002/iub.1646; Aldehlawi H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61640-9; Amengual J, 2012, INT J BIOCHEM CELL B, V44, P2019, DOI 10.1016/j.biocel.2012.07.026; Asson-Batres MA, 2016, AM J PHYSIOL-HEART C, V310, pH1773, DOI 10.1152/ajpheart.00887.2015; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Biocrates, 2017, ANN POT IS IS LIP SP, V2; Boerman MHEM, 1996, J BIOL CHEM, V271, P5610, DOI 10.1074/jbc.271.10.5610; Cannon MV, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-015-0520-7; Chen J, 1996, J NEUROSCI, V16, P5704; Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Choudhary R, 2008, J CELL PHYSIOL, V215, P172, DOI 10.1002/jcp.21297; Choudhary R, 2008, AM J PHYSIOL-HEART C, V294, pH633, DOI 10.1152/ajpheart.01301.2007; Cifre M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082269; Clagett-Dame M, 2002, ANNU REV NUTR, V22, P347, DOI 10.1146/annurev.nutr.22.010402.102745E; CREMONA O, 1995, EXP CELL RES, V217, P280, DOI 10.1006/excr.1995.1088; de Paiva SAR, 2003, AM J PHYSIOL-HEART C, V284, pH2242, DOI 10.1152/ajpheart.00646.2002; DeLeon-Pennell KY, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-018-0699-5; Diaz-Rua R, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.33554; Distel E, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600920; Dorfer V, 2014, J PROTEOME RES, V13, P3679, DOI 10.1021/pr500202e; Drake KJ, 2012, EXP BIOL MED, V237, P1369, DOI 10.1258/ebm.2012.012025; Eng JK, 2008, J PROTEOME RES, V7, P4598, DOI 10.1021/pr800420s; Ferrari R, 2004, ANN NY ACAD SCI, V1033, P79, DOI 10.1196/annals.1320.007; Freire CMM, 2011, NUTRITION, V27, P824, DOI 10.1016/j.nut.2010.08.011; Garcia-Mariscal A., 2016, SMALL GTPASES, V9, P433; Gavrilova R, 2009, AM J MED GENET A, V149A, P2241, DOI 10.1002/ajmg.a.32998; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Gianni M, 1997, BLOOD, V89, P1001, DOI 10.1182/blood.V89.3.1001; Goodman AB, 2006, J CELL PHYSIOL, V209, P598, DOI 10.1002/jcp.20784; Halade GV, 2019, METABOLISM, V96, P22, DOI 10.1016/j.metabol.2019.04.011; Hochgreb T, 2003, DEVELOPMENT, V130, P5363, DOI 10.1242/dev.00750; Huang WL, 2020, HEALTH PHYS, V119, P621, DOI 10.1097/HP.0000000000001350; Huang WL, 2020, HEALTH PHYS, V119, P604, DOI 10.1097/HP.0000000000001351; Huang Y, 2011, CARDIOVASC RES, V90, P220, DOI 10.1093/cvr/cvr070; Irvin MR, 2014, CLIN LIPIDOL, V9, P9, DOI 10.2217/CLP.13.75; Jones JW, 2015, ANAL CHEM, V87, P3222, DOI 10.1021/ac504597q; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kane MA, 2011, MOL CELL BIOL, V31, P3277, DOI 10.1128/MCB.05516-11; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; Kane MA, 2010, FASEB J, V24, P823, DOI 10.1096/fj.09-141572; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Kitsis RN, 2018, CIRCULATION, V138, P692, DOI 10.1161/CIRCULATIONAHA.118.033907; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lin YS, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.009146; Liu Y, 2016, CIRC RES, V119, P557, DOI 10.1161/CIRCRESAHA.116.308781; Mahley RW, 2016, J MOL MED, V94, P739, DOI 10.1007/s00109-016-1427-y; Malik M, 2008, CLIN ENDOCRINOL, V69, P462, DOI 10.1111/j.1365-2265.2008.03207.x; Mao K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04805-5; McDonough CW, 2013, HYPERTENSION, V62, P48, DOI 10.1161/HYPERTENSIONAHA.111.00823; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Miano JM, 1996, CIRCULATION, V93, P1886, DOI 10.1161/01.CIR.93.10.1886; Minicucci MF, 2010, CELL PHYSIOL BIOCHEM, V26, P523, DOI 10.1159/000322320; Nagpal I, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153610; Napoli JL, 1996, FASEB J, V10, P993, DOI 10.1096/fasebj.10.9.8801182; Napoli JL, 2000, PROG NUCLEIC ACID RE, V63, P139, DOI 10.1016/S0079-6603(08)60722-9; Napoli JL, 2017, PHARMACOL THERAPEUT, V173, P19, DOI 10.1016/j.pharmthera.2017.01.004; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Neuville P, 1997, AM J PATHOL, V150, P509; Neuville P, 1999, ARTERIOSCL THROM VAS, V19, P1430, DOI 10.1161/01.ATV.19.6.1430; Paiva SAR, 2005, J NUTR, V135, P2326, DOI 10.1093/jn/135.10.2326; Pan J, 1997, CIRC RES, V81, P611, DOI 10.1161/01.RES.81.4.611; Pan J, 2007, VITAM HORM, V75, P257, DOI 10.1016/S0083-6729(06)75010-5; Park SW, 2019, EUR J PHARMACOL, V858, DOI 10.1016/j.ejphar.2019.172485; Park SW, 2018, J ENDOCRINOL, V236, P151, DOI 10.1530/JOE-17-0613; Paschaki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062274; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pierzchalski K, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119677; Pierzchalski K, 2013, FASEB J, V27, P1904, DOI 10.1096/fj.12-219410; POSCH KC, 1992, J BIOL CHEM, V267, P19676; Samouillan V, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10111471; Sanchez J, 2012, J CLIN ENDOCR METAB, V97, pE648, DOI 10.1210/jc.2011-2209; SANCHEZ M, 1993, BIOCHEM J, V295, P115, DOI 10.1042/bj2950115; Schnackenberg LK, 2016, J APPL TOXICOL, V36, P1486, DOI 10.1002/jat.3307; Stefanovic S, 2017, MECH DEVELOP, V143, P9, DOI 10.1016/j.mod.2016.12.002; Sun HD, 2019, ANAL BIOANAL CHEM, V411, P2273, DOI 10.1007/s00216-019-01668-7; Torma H, 2011, DERM-ENDOCRINOL, V3, P136, DOI 10.4161/derm.3.3.15026; Wang HJ, 2002, J APPL PHYSIOL, V92, P2162, DOI 10.1152/japplphysiol.01192.2001; Wang J, 1999, BIOCHEM J, V338, P23, DOI 10.1042/0264-6021:3380023; Wang S, 2020, PHARMACOL THERAPEUT, V205, DOI 10.1016/j.pharmthera.2019.107415; Wang SY, 2018, DEV DYNAM, V247, P976, DOI [10.1002/dvdy.24639, 10.1002/DVDY.24639]; Wang SY, 2018, FASEB J, V32, P3765, DOI 10.1096/fj.201701038R; Wang ZY, 2018, LIFE SCI, V194, P88, DOI 10.1016/j.lfs.2017.12.015; Wollert KC, 1999, CARDIOVASC RES, V43, P838, DOI 10.1016/S0008-6363(99)00145-5; Wong YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045725; Xavier-Neto J, 2015, BBA-GENE REGUL MECH, V1849, P94, DOI 10.1016/j.bbagrm.2014.08.003; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xiao Y, 2018, DEV CELL, V45, P153, DOI 10.1016/j.devcel.2018.03.019; Xu GX, 1997, AM J PATHOL, V151, P1741; Yang N., 2020, JCI; Yang N, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.137593; Yu MY, 2012, PATHOL INT, V62, P246, DOI 10.1111/j.1440-1827.2012.02802.x; Zaffran S, 2004, CIRC RES, V95, P261, DOI 10.1161/01.RES.0000136815.73623.BE; Zalesak-Kravec S, 2021, HEALTH PHYS, V121, P352, DOI 10.1097/HP.0000000000001478; Zhang H, 2015, J TRANSL MED, V13, DOI [10.3969/j.issn.1674-862X.2015.01.012, 10.1186/s12967-015-0432-1]; Zhu S, 2016, J MOL CELL CARDIOL, V99, P100, DOI 10.1016/j.yjmcc.2016.08.009; Zirn B, 2005, ONCOGENE, V24, P5246, DOI 10.1038/sj.onc.1208725; Zizola CF, 2010, MOL CELL BIOL, V30, P3412, DOI 10.1128/MCB.00014-10	102	1	1	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22242	10.1096/fj.202100901RRR	http://dx.doi.org/10.1096/fj.202100901RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CN	35253263	Green Accepted			2022-12-28	WOS:000772945100001
J	Abdelsaid, K; Sudhahar, V; Harris, RA; Das, A; Youn, SW; Liu, YT; McMenamin, M; Hou, YL; Fulton, D; Hamrick, MW; Tang, YL; Fukai, T; Ushio-Fukai, M				Abdelsaid, Kareem; Sudhahar, Varadarajan; Harris, Ryan A.; Das, Archita; Youn, Seock-Won; Liu, Yutao; McMenamin, Maggie; Hou, Yali; Fulton, David; Hamrick, Mark W.; Tang, Yaoliang; Fukai, Tohru; Ushio-Fukai, Masuko			Exercise improves angiogenic function of circulating exosomes in type 2 diabetes: Role of exosomal SOD3	FASEB JOURNAL			English	Article						exercise; exosome; SOD3; type 2 diabetes	EXTRACELLULAR-SUPEROXIDE DISMUTASE; VASCULAR SMOOTH-MUSCLE; COPPER TRANSPORTER ATP7A; SKELETAL-MUSCLE; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; EXPRESSION; VESICLES; COMMUNICATION; PROTECTION	Exosomes, key mediators of cell-cell communication, derived from type 2 diabetes mellitus (T2DM) exhibit detrimental effects. Exercise improves endothelial function in part via the secretion of exosomes into circulation. Extracellular superoxide dismutase (SOD3) is a major secretory copper (Cu) antioxidant enzyme that catalyzes the dismutation of O-2(center dot-) to H2O2 whose activity requires the Cu transporter ATP7A. However, the role of SOD3 in exercise-induced angiogenic effects of circulating plasma exosomes on endothelial cells (ECs) in T2DM remains unknown. Here, we show that both SOD3 and ATP7A proteins were present in plasma exosomes in mice, which was significantly increased after two weeks of volunteer wheel exercise. A single bout of exercise in humans also showed a significant increase in SOD3 and ATP7A protein expression in plasma exosomes. Plasma exosomes from T2DM mice significantly reduced angiogenic responses in human ECs or mouse skin wound healing models, which was associated with a decrease in ATP7A, but not SOD3 expression in exosomes. Exercise training in T2DM mice restored the angiogenic effects of T2DM exosomes in ECs by increasing ATP7A in exosomes, which was not observed in exercised T2DM/SOD3(-/-) mice. Furthermore, exosomes overexpressing SOD3 significantly enhanced angiogenesis in ECs by increasing local H2O2 levels in a heparin-binding domain-dependent manner as well as restored defective wound healing and angiogenesis in T2DM or SOD3(-/-) mice. In conclusion, exercise improves the angiogenic potential of circulating exosomes in T2DM in a SOD3-dependent manner. Exosomal SOD3 may provide an exercise mimetic therapy that supports neovascularization and wound repair in cardiometabolic disease.	[Abdelsaid, Kareem; Sudhahar, Varadarajan; Das, Archita; Youn, Seock-Won; McMenamin, Maggie; Hou, Yali; Fulton, David; Tang, Yaoliang; Fukai, Tohru; Ushio-Fukai, Masuko] Augusta Univ, Med Coll Georgia, Vasc Biol Ctr, 1460 Laney Walker Blvd, Augusta, GA 30912 USA; [Abdelsaid, Kareem; Sudhahar, Varadarajan; Fukai, Tohru] Charlie Norwood Vet Affairs Med Ctr, Augusta, GA USA; [Sudhahar, Varadarajan; Das, Archita; Fulton, David; Fukai, Tohru] Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Harris, Ryan A.] Georgia Prevent Inst, Augusta, GA USA; [Youn, Seock-Won] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA; [Liu, Yutao; Hamrick, Mark W.] Augusta Univ, Med Coll Georgia, Dept Cell Biol, Augusta, GA 30912 USA; [Tang, Yaoliang; Ushio-Fukai, Masuko] Augusta Univ, Med Coll Georgia, Dept Med Cardiol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Fukai, T; Ushio-Fukai, M (corresponding author), Augusta Univ, Med Coll Georgia, Vasc Biol Ctr, 1460 Laney Walker Blvd, Augusta, GA 30912 USA.	tfukai@augusta.edu; mfukai@augusta.edu		Abdelsaid, Kareem/0000-0002-5759-4714; Varadarajan, Sudhahar/0000-0002-9675-0097; Youn, Seock-Won/0000-0003-3275-2170	National Institute of Health [R01HL135584, R01HL147550, R01HL133613, R01HL116976, R01HL070187, R01HL134354]; Veterans Administration Merit [2I01BX001232]; Augusta University	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Merit(US Department of Veterans Affairs); Augusta University	National Institute of Health, Grant/Award Number: R01HL135584, R01HL147550, R01HL133613, R01HL116976, R01HL070187 and R01HL134354; Veterans Administration Merit, Grant/Award Number: 2I01BX001232; Augusta University	Ashino T, 2010, CIRC RES, V107, P787, DOI 10.1161/CIRCRESAHA.110.225334; Bouviere J, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10040537; Call JA, 2015, CIRC-HEART FAIL, V8, P188, DOI 10.1161/CIRCHEARTFAILURE.114.001540; Carlsson LM, 1996, P NATL ACAD SCI USA, V93, P5219, DOI 10.1073/pnas.93.11.5219; Cheng ZJ, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.019755; Cho YE, 2013, AM J PHYSIOL-CELL PH, V305, pC1033, DOI 10.1152/ajpcell.00234.2013; Chu Y, 2003, CIRC RES, V92, P461, DOI 10.1161/01.RES.0000057755.02845.F9; Chu Y, 2006, ARTERIOSCL THROM VAS, V26, P1985, DOI 10.1161/01.ATV.0000234921.88489.5c; Cianciaruso C, 2017, DIABETES, V66, P460, DOI 10.2337/db16-0671; Cypryk W, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02188; Das A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33783; Fattman CL, 2003, FREE RADICAL BIO MED, V35, P236, DOI 10.1016/S0891-5849(03)00275-2; Fattman CL, 2001, FREE RADICAL BIO MED, V31, P1198, DOI 10.1016/S0891-5849(01)00699-2; Fiuza-Luces C, 2018, NAT REV CARDIOL, V15, P731, DOI 10.1038/s41569-018-0065-1; Fortunato RS, 2020, ANTIOXID REDOX SIGN, V33, P539, DOI 10.1089/ars.2020.8095; Fricovsky ES, 2012, AM J PHYSIOL-REG I, V303, pR689, DOI 10.1152/ajpregu.00548.2011; Fruhbeis C, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.28239; Fukai T, 2000, J CLIN INVEST, V105, P1631, DOI 10.1172/JCI9551; Fukai T, 1998, J CLIN INVEST, V101, P2101, DOI 10.1172/JCI2105; Fukai T, 2018, AM J PHYSIOL-CELL PH, V315, pC186, DOI 10.1152/ajpcell.00132.2018; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Gao F, 2008, ANTIOXID REDOX SIGN, V10, P343, DOI 10.1089/ars.2007.1908; Gongora MC, 2006, HYPERTENSION, V48, P473, DOI 10.1161/01.HYP.0000235682.47673.ab; GRIENDLING KK, 1991, J BIOL CHEM, V266, P15498; Harris RA, 2008, OBESITY, V16, P578, DOI 10.1038/oby.2007.87; Helwa I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170628; Hessvik NP, 2018, CELL MOL LIFE SCI, V75, P193, DOI 10.1007/s00018-017-2595-9; Hitomi Y, 2008, REDOX REP, V13, P213, DOI 10.1179/135100008X308894; Hou ZX, 2019, CIRC RES, V124, P1386, DOI 10.1161/CIRCRESAHA.118.314635; Huang-Doran I, 2017, TRENDS ENDOCRIN MET, V28, P3, DOI 10.1016/j.tem.2016.10.003; Itoh S, 2008, J BIOL CHEM, V283, P9157, DOI 10.1074/jbc.M709463200; Ji LL, 2015, ADV PHYSIOL EDUC, V39, P352, DOI 10.1152/advan.00106.2014; Juul K, 2004, CIRCULATION, V109, P59, DOI 10.1161/01.CIR.0000105720.28086.6C; Kander MC, 2017, J CELL MOL MED, V21, P1024, DOI 10.1111/jcmm.13038; Kim HW, 2007, CIRC RES, V101, P409, DOI 10.1161/CIRCRESAHA.107.153791; Kim YM, 2018, CELL REP, V23, P3565, DOI 10.1016/j.celrep.2018.05.054; Kim YM, 2017, AM J PHYSIOL-CELL PH, V312, pC749, DOI 10.1152/ajpcell.00346.2016; Kobylecki CJ, 2015, EBIOMEDICINE, V2, P2010, DOI 10.1016/j.ebiom.2015.11.026; Kranendonk MEG, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-37; Kusuyama J, 2021, CELL METAB, V33, P939, DOI 10.1016/j.cmet.2021.03.004; Lawson C, 2016, J ENDOCRINOL, V228, pR57, DOI 10.1530/JOE-15-0201; Li GH, 2019, J CELL PHYSIOL, V234, P14896, DOI 10.1002/jcp.28319; Lund DD, 2007, J PHYSIOL-LONDON, V584, P583, DOI 10.1113/jphysiol.2007.140830; Okutsu M, 2014, CIRC-HEART FAIL, V7, P519, DOI 10.1161/CIRCHEARTFAILURE.113.000841; Oshikawa J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010189; Qin ZY, 2006, FASEB J, V20, P334, DOI 10.1096/fj.05-4564fje; Safdar A, 2016, NAT REV ENDOCRINOL, V12, P504, DOI 10.1038/nrendo.2016.76; Sudhahar V, 2018, ARTERIOSCL THROM VAS, V38, P529, DOI 10.1161/ATVBAHA.117.309819; Sudhahar V, 2013, DIABETES, V62, P3839, DOI 10.2337/db12-1228; Tan RJ, 2004, J APPL PHYSIOL, V97, P2006, DOI 10.1152/japplphysiol.00480.2004; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; Vicencio JM, 2015, J AM COLL CARDIOL, V65, P1525, DOI 10.1016/j.jacc.2015.02.026; Wadley AJ, 2019, J APPL PHYSIOL, V127, P858, DOI 10.1152/japplphysiol.00340.2019; Wedgwood S, 2011, ANTIOXID REDOX SIGN, V15, P1497, DOI 10.1089/ars.2010.3630; Whitham M, 2018, CELL METAB, V27, P237, DOI 10.1016/j.cmet.2017.12.001; Yan Z, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101508; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Youn SW, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8010018; Yuan Y, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00547; Zelko IN, 2011, AM J RESP CELL MOL, V45, P953, DOI 10.1165/rcmb.2011-0012OC; Zhang HN, 2018, P NATL ACAD SCI USA, V115, pE6927, DOI 10.1073/pnas.1721521115; Zhang TR, 2021, J CARDIOVASC TRANSL, V14, P824, DOI 10.1007/s12265-020-10082-9	64	1	1	5	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22177	10.1096/fj.202101323R	http://dx.doi.org/10.1096/fj.202101323R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35142393				2022-12-28	WOS:000761250800041
J	McKee, CM; Chapski, DJ; Wehling-Henricks, M; Rosa-Garrido, M; Kuro-O, M; Vondriska, TM; Tidball, JG				McKee, Cynthia M.; Chapski, Douglas J.; Wehling-Henricks, Michelle; Rosa-Garrido, Manuel; Kuro-O, Makoto; Vondriska, Thomas M.; Tidball, James G.			The anti-aging protein Klotho affects early postnatal myogenesis by downregulating Jmjd3 and the canonical Wnt pathway	FASEB JOURNAL			English	Article						development; myogenesis; skeletal muscle	SATELLITE CELLS; BETA-CATENIN; STEM-CELLS; READ ALIGNMENT; SELF-RENEWAL; MUSCLE; GENE; DIFFERENTIATION; ADULT; UTX	Modulating the number of muscle stems cells, called satellite cells, during early postnatal development produces long-term effects on muscle growth. We tested the hypothesis that high expression levels of the anti-aging protein Klotho in early postnatal myogenesis increase satellite cell numbers by influencing the epigenetic regulation of genes that regulate myogenesis. Our findings show that elevated klotho expression caused a transient increase in satellite cell numbers and slowed muscle fiber growth, followed by a period of accelerated muscle growth that leads to larger fibers. Klotho also transcriptionally downregulated the H3K27 demethylase Jmjd3, leading to increased H3K27 methylation and decreased expression of genes in the canonical Wnt pathway, which was associated with a delay in muscle differentiation. In addition, Klotho stimulation and Jmjd3 downregulation produced similar but not additive reductions in the expression of Wnt4, Wnt9a, and Wnt10a in myogenic cells, indicating that inhibition occurred through a common pathway. Together, our results identify a novel pathway through which Klotho influences myogenesis by reducing the expression of Jmjd3, leading to reductions in the expression of Wnt genes and inhibition of canonical Wnt signaling.	[McKee, Cynthia M.; Tidball, James G.] Univ Calif Los Angeles, Mol Cellular & Integrat Physiol Program, Los Angeles, CA 90095 USA; [Chapski, Douglas J.; Vondriska, Thomas M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol & Perioperat Med, Los Angeles, CA 90095 USA; [Wehling-Henricks, Michelle; Tidball, James G.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Rosa-Garrido, Manuel] Univ Alabama Birmingham, Dept Biomed Engn, Sch Med, Birmingham, AL 35294 USA; [Rosa-Garrido, Manuel] Univ Alabama Birmingham, Sch Engn, Birmingham, AL USA; [Kuro-O, Makoto] Jichi Med Univ, Ctr Mol Med, Div Antiaging Med, Shimotsuke, Tochigi, Japan; [Vondriska, Thomas M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Vondriska, Thomas M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Tidball, James G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Jichi Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Tidball, JG (corresponding author), Univ Calif Los Angeles, Mol Cellular & Integrat Physiol Program, Los Angeles, CA 90095 USA.	jtidball@physci.ucla.edu	Rosa-Garrido, Manuel/AAE-4188-2019	Rosa-Garrido, Manuel/0000-0002-2169-3972; Tidball, James/0000-0003-1202-8038; Chapski, Douglas/0000-0002-6730-7627	National Institutes of Health [F31AR071782, RO1HL105699, RO1AR075768, RO1AR062579, RO1AR066036, T32GM065823]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health to C.M.M. [F31AR071782]; T.M.V. [RO1HL105699] and J.G.T. [RO1AR075768, RO1AR062579, RO1AR066036, and T32GM065823]	Adhikari A, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0217-x; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Ahrens HE, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0166-x; Akiyama T, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/7215010; Akiyama T, 2016, DEVELOPMENT, V143, P3674, DOI 10.1242/dev.139360; Bachman JF, 2022, FEBS J, V289, P2710, DOI 10.1111/febs.15856; Bachman JF, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101760; Bachman JF, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.167197; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Bernardi H, 2011, AM J PHYSIOL-CELL PH, V300, pC1122, DOI 10.1152/ajpcell.00214.2010; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Carron C, 2003, J CELL SCI, V116, P2541, DOI 10.1242/jcs.00451; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Cornelison DDW, 2018, CURR TOP DEV BIOL, V126, P205, DOI 10.1016/bs.ctdb.2017.08.006; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Dilworth FJ, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt59; Dumon NA, 2015, DEVELOPMENT, V142, P1572, DOI 10.1242/dev.114223; Faralli H, 2016, J CLIN INVEST, V126, P1555, DOI 10.1172/JCI83239; Fry CS, 2015, NAT MED, V21, P76, DOI 10.1038/nm.3710; Gattazzo F, 2020, STEM CELL REP, V15, P597, DOI 10.1016/j.stemcr.2020.07.011; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Heinemann B, 2014, NATURE, V514, pE1, DOI 10.1038/nature13688; Hildyard JCW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211384; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Karasawa T, 2002, J BIOL CHEM, V277, P37479, DOI 10.1074/jbc.M205658200; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kurosaka M, 2009, J SPORT SCI MED, V8, P51; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; Narita T, 2005, DEV DYNAM, V233, P282, DOI 10.1002/dvdy.20321; Ohtani K, 2013, CIRC RES, V113, P856, DOI 10.1161/CIRCRESAHA.113.302035; ONTELL M, 1984, ANAT REC, V208, P159, DOI 10.1002/ar.1092080203; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rawls A, 1998, DEVELOPMENT, V125, P2349; Ring L, 2014, CELL SIGNAL, V26, P260, DOI 10.1016/j.cellsig.2013.11.021; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sahu A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07253-3; Sakanaka C, 2002, J BIOCHEM, V132, P697, DOI 10.1093/oxfordjournals.jbchem.a003276; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097; Seenundun S, 2010, EMBO J, V29, P1401, DOI 10.1038/emboj.2010.37; Sherr CJ, 2000, CANCER RES, V60, P3689; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Spater D, 2006, DEVELOPMENT, V133, P3039, DOI 10.1242/dev.02471; Tanaka Shingo, 2011, J Mol Signal, V6, P12, DOI 10.1186/1750-2187-6-12; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Team BC., 2016, TXDB MMUSCULUS UCSC; Thomas KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088653; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; van der Velden JLJ, 2008, J BIOL CHEM, V283, P358, DOI 10.1074/jbc.M707812200; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Villalta SA, 2011, HUM MOL GENET, V20, P790, DOI 10.1093/hmg/ddq523; Vivian JL, 2000, DEV BIOL, V224, P29, DOI 10.1006/dbio.2000.9788; Wehling-Henricks M, 2016, HUM MOL GENET, V25, P2465, DOI 10.1093/hmg/ddw111; Welc SS, 2020, EXP PHYSIOL, V105, P132, DOI 10.1113/EP088142; White JP, 2009, J APPL PHYSIOL, V107, P1420, DOI 10.1152/japplphysiol.00668.2009; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Winn RA, 2005, J BIOL CHEM, V280, P19625, DOI 10.1074/jbc.M409392200; Yablonka-Reuveni Z, 1999, DEV BIOL, V210, P440, DOI 10.1006/dbio.1999.9284; Zhang B, 2015, STEM CELL TRANSL MED, V4, P513, DOI 10.5966/sctm.2014-0267; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865	78	1	1	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22192	10.1096/fj.202101298R	http://dx.doi.org/10.1096/fj.202101298R			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35174906	hybrid, Green Published			2022-12-28	WOS:000761250800007
J	Ding, KX; Li, XZ; Ren, XM; Ding, N; Tao, L; Dong, X; Chen, Z				Ding, Kaixin; Li, Xinzhi; Ren, Xiaomeng; Ding, Na; Tao, Li; Dong, Xue; Chen, Zheng			GBP5 promotes liver injury and inflammation by inducing hepatocyte apoptosis	FASEB JOURNAL			English	Article						apoptosis; caspase 3; GBP5; liver injury; NF-kappa B-inducing kinase	REGULATES GLUCOSE-METABOLISM; LONG NONCODING RNA; KINASE; ACTIVATION; FIBROSIS; TNF; ACETAMINOPHEN; EXPRESSION; INHIBITOR; FAILURE	Liver injury is the first step in causing fibrosis, cirrhosis, and liver cancer, leading to mortality. However, the drivers of progressive liver injury are still incompletely defined. Here, we identify GBP5 as a major factor causing liver injury and inflammation. We show that the expression of GBP5 is abnormally elevated in the damaged liver, and its expression depends at least partially on the NF-kappa B-inducing kinase (NIK)/NF-kappa B2 signaling pathway. Knockout of Gbp5 ameliorates D-galactosamine/lipopolysaccharide (GalN/LPS)-induced liver injury and inflammation. Conversely, liver-specific overexpression of GBP5 induces liver injury and inflammation. Mechanistically, GBP5 induces hepatocyte apoptosis through the activation of both calpain/caspase 12/caspase 3 and TNF alpha/caspase 8/caspase 3 signaling pathways. Inhibition of either calpain activity or caspase 3 prevents GBP5-induced cell death. Our data demonstrate that GBP5 expression is induced by toxins or the NIK signaling pathway, which promotes both extrinsic and intrinsic apoptosis signaling pathways and further induces liver injury, providing a novel drug target for the treatment of liver injury and inflammation.	[Ding, Kaixin; Li, Xinzhi; Ding, Na; Chen, Zheng] Harbin Inst Technol, Sch Life Sci & Technol, HIT Ctr Life Sci, Harbin, Peoples R China; [Ren, Xiaomeng; Dong, Xue] Northeast Normal Univ, Sch Life Sci, Key Lab Mol Epigenet, Minist Educ MOE, Changchun, Peoples R China; [Ren, Xiaomeng] Shenyang Univ Chem Technol, Shenyang, Peoples R China; [Tao, Li] 305 Hosp Peoples Liberat Army, Beijing, Peoples R China	Harbin Institute of Technology; Northeast Normal University - China; Shenyang University of Chemical Technology	Chen, Z (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, HIT Ctr Life Sci, Harbin, Peoples R China.	chenzheng@hit.edu.cn	TAO, Li/HIR-4254-2022		National Natural Science Foundation of China [92057110, 31971083]; Natural Science Foundation of Heilongjiang Province [YQ2019C011]; Chinese Postdoctoral Science Foundation [AUGA4130900619]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	National Natural Science Foundation of China, Grant/Award Number: 92057110 and 31971083; Natural Science Foundation of Heilongjiang Province, Grant/Award Number: YQ2019C011; Chinese Postdoctoral Science Foundation, Grant/Award Number: AUGA4130900619	Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051; Chen Z, 2014, DIABETES, V63, P585, DOI 10.2337/db13-0666; Chen Z, 2012, DIABETES, V61, P566, DOI 10.2337/db11-0474; Chmielewski S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113318; Cubero FJ, 2016, GASTROENTEROLOGY, V150, P968, DOI 10.1053/j.gastro.2015.12.019; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Fujiwara Y, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.59; Guicciardi ME, 2010, SEMIN LIVER DIS, V30, P402, DOI 10.1055/s-0030-1267540; Jia LN, 2020, MOL METAB, V31, P85, DOI 10.1016/j.molmet.2019.11.008; Krapp C, 2016, CELL HOST MICROBE, V19, P504, DOI 10.1016/j.chom.2016.02.019; Li XZ, 2021, METABOLISM, V116, DOI 10.1016/j.metabol.2021.154702; Li XZ, 2020, MOL THER, V28, P2430, DOI 10.1016/j.ymthe.2020.07.016; Li XZ, 2018, THERANOSTICS, V8, P5960, DOI 10.7150/thno.28960; Liu RP, 2018, HEPATOLOGY, V67, P1441, DOI 10.1002/hep.29540; Liu Y, 2015, J HEPATOL, V62, P590, DOI 10.1016/j.jhep.2014.10.022; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Meunier E, 2015, NAT IMMUNOL, V16, P476, DOI 10.1038/ni.3119; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Nakama T, 2001, HEPATOLOGY, V33, P1441, DOI 10.1053/jhep.2001.24561; Nissim O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049611; Nowak M, 2000, AM J PHYSIOL-REG I, V278, pR1202, DOI 10.1152/ajpregu.2000.278.5.R1202; Pilla-Moffett D, 2016, J MOL BIOL, V428, P3495, DOI 10.1016/j.jmb.2016.04.032; Qin WS, 2016, NUCLEIC ACIDS RES, V44, P6423, DOI 10.1093/nar/gkw341; Ren XM, 2017, FASEB J, V31, P711, DOI 10.1096/fj.201600840R; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Santos JC, 2018, J LEUKOCYTE BIOL, V104, P729, DOI 10.1002/JLB.4MR0118-038R; Shen H, 2017, J HEPATOL, V67, P100, DOI 10.1016/j.jhep.2017.02.025; Shen H, 2014, HEPATOLOGY, V60, P2065, DOI 10.1002/hep.27348; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tung EKK, 2011, LIVER INT, V31, P1494, DOI 10.1111/j.1478-3231.2011.02597.x; Wang YQ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15488-2; Win S, 2011, J BIOL CHEM, V286, P35071, DOI 10.1074/jbc.M111.276089; Woolbright BL, 2017, J HEPATOL, V66, P836, DOI 10.1016/j.jhep.2016.11.017; Wree A, 2018, HEPATOLOGY, V67, P736, DOI 10.1002/hep.29523; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Xiong Y, 2018, ELIFE, V7, DOI 10.7554/eLife.34152; Zhan SS, 2006, HEPATOLOGY, V43, P435, DOI 10.1002/hep.21093; Zhang DY, 2018, THERANOSTICS, V8, P3751, DOI 10.7150/thno.22493	41	5	5	6	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22119	10.1096/fj.202101448R	http://dx.doi.org/10.1096/fj.202101448R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34958688				2022-12-28	WOS:000734992000017
J	Han, X; Zhang, YW; Lee, A; Li, ZS; Gao, J; Wu, XY; Zhao, JL; Wang, H; Chen, D; Zou, DW; Owyang, C				Han, Xu; Zhang, Yawen; Lee, Allen; Li, Zhaoshen; Gao, Jun; Wu, Xiaoyin; Zhao, Jiulong; Wang, Hui; Chen, Di; Zou, Duowu; Owyang, Chung			Upregulation of acid sensing ion channels is associated with esophageal hypersensitivity in GERD	FASEB JOURNAL			English	Article						acid sensing ion channel 1 and 3 (ASIC1 and 3); gastroesophageal reflux disease (GERD); neuronal hyperexcitability; visceral hypersensitivity	GASTROESOPHAGEAL-REFLUX DISEASE; PAIN; NEURONS; PERCEPTION; MECHANISMS; EXPRESSION; HEARTBURN; DIAGNOSIS; THERAPY; ASIC1A	Proton pump inhibitors (PPIs) are the mainstay of therapy for gastroesophageal reflux disease (GERD) but up to 60% of patients have inadequate response to therapy. Acid sensing ion channels (ASICs) play important roles in nociception. This study aimed to investigate whether the increased expression of ASICs results in neuronal hyperexcitability in GERD. Esophageal biopsies were taken from GERD patients and healthy subjects to compare expression of ASIC1 and 3. Next, gene and protein expression of ASIC1 and 3 from esophageal mucosa and dorsal root ganglia (DRG) neurons were measured by qPCR, Western-blot and immunofluorescence in rodent models of reflux esophagitis (RE), non-erosive reflux disease (NERD), and sham operated groups. Excitability of DRG neurons in the GERD and sham groups were also tested by whole-cell patch-clamp recordings. We demonstrated that ASIC1 and 3 expression were significantly increased in patients with RE compared with healthy controls. This correlated positively with symptom severity of heartburn and regurgitation (p < .001). Next, ASIC1 and 3 gene and protein expression in rodent models of RE and NERD were similarly increased in esophageal mucosa as well as T3-T5 DRG neurons compared with sham operation. DRG neurons from RE animals showed hyperexcitability compared with sham group. However, intrathecal injection of ASIC specific inhibitors, PcTx1 and APTEx-2, as well as silencing ASIC1 and 3 genes with specific siRNAs prevented visceral hypersensitivity. Overall, upregulation of ASIC1 and 3 may lead to visceral hypersensitivity in RE and NERD and may be a potential therapeutic target for PPI non-responsive patients.	[Han, Xu] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Gastroenterol, Sch Med, Shanghai, Peoples R China; [Zhang, Yawen; Lee, Allen; Wu, Xiaoyin; Owyang, Chung] Univ Michigan, Dept Internal Med, Div Gastroenterol & Hepatol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [Li, Zhaoshen; Gao, Jun; Zhao, Jiulong; Wang, Hui; Chen, Di] Second Mil Med Univ, Changhai Hosp, Div Gastroenterol, Shanghai, Peoples R China; [Zou, Duowu] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Gastroenterol, Sch Med, 197 Ruijin Second Rd, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; University of Michigan System; University of Michigan; Naval Medical University; Shanghai Jiao Tong University	Owyang, C (corresponding author), Univ Michigan, Dept Internal Med, Div Gastroenterol & Hepatol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.; Zou, DW (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Gastroenterol, Sch Med, 197 Ruijin Second Rd, Shanghai 200025, Peoples R China.	zdw_pi@163.com; cowyang@med.umich.edu			National Natural Science Foundation of China [81370493, 81670485]; National Institutes of Health (NIH) [1 K23 DK124567]; NTH [2R01 DK058913, P30 DK 34933]; Shanghai Pujiang Program [20PJ1409700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NTH; Shanghai Pujiang Program(Shanghai Pujiang Program)	The studies were supported by grants from the National Natural Science Foundation of China (Grant nos. 81370493 and 81670485) (D7.), the National Institutes of Health (NIH) 1 K23 DK124567 (AL) as well as NTH 2R01 DK058913 (CO), P30 DK 34933 (CO) and Shanghai Pujiang Program (Grant nos.20PJ1409700)	Akiba Y, 2008, GUT, V57, P1654, DOI 10.1136/gut.2007.144378; [Anonymous], 2006, GI MOTIL ONLINE, DOI DOI 10.1038/GIMO3; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; Cicala M, 2013, WORLD J GASTROENTERO, V19, P6529, DOI 10.3748/wjg.v19.i39.6529; Dean BB, 2004, CLIN GASTROENTEROL H, V2, P656, DOI 10.1016/S1542-3565(04)00288-5; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; El-Serag H, 2010, ALIMENT PHARM THER, V32, P720, DOI 10.1111/j.1365-2036.2010.04406.x; El-Serag HB, 2014, GUT, V63, P871, DOI 10.1136/gutjnl-2012-304269; Emerenziani S, 2008, GUT, V57, P443, DOI 10.1136/gut.2007.130104; Fass R, 2002, GUT, V51, P885, DOI 10.1136/gut.51.6.885; Goyal RK, 1996, NEW ENGL J MED, V334, P1106, DOI 10.1056/NEJM199604253341707; Hobson AR, 2008, NEUROGASTROENT MOTIL, V20, P877, DOI 10.1111/j.1365-2982.2008.01122.x; Holzer P, 2007, AM J PHYSIOL-GASTR L, V292, pG699, DOI 10.1152/ajpgi.00517.2006; Hu WHC, 2000, AM J GASTROENTEROL, V95, P2189; Hussain ZH, 2015, CLIN TRANSL GASTROEN, V6, DOI 10.1038/ctg.2015.32; Jones R, 2009, ALIMENT PHARM THER, V30, P1030, DOI 10.1111/j.1365-2036.2009.04142.x; Khan M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003244.pub2; Knowles CH, 2008, GUT, V57, P674, DOI 10.1136/gut.2007.127886; Lind T, 1997, SCAND J GASTROENTERO, V32, P974, DOI 10.3109/00365529709011212; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Mamet J, 2002, J NEUROSCI, V22, P10662; Matricon J, 2013, NEUROGASTROENT MOTIL, V25, pE740, DOI 10.1111/nmo.12199; Matricon J, 2011, EUR J PAIN, V15, P335, DOI 10.1016/j.ejpain.2010.08.005; MAYER EA, 1994, GASTROENTEROLOGY, V107, P271, DOI 10.1016/0016-5085(94)90086-8; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Omura N, 1999, SCAND J GASTROENTERO, V34, P948; Page AJ, 2005, GUT, V54, P1408, DOI 10.1136/gut.2005.071084; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Qin C, 2008, AM J PHYSIOL-GASTR L, V294, pG708, DOI 10.1152/ajpgi.00477.2007; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; RICHTER JE, 1986, GASTROENTEROLOGY, V91, P845, DOI 10.1016/0016-5085(86)90685-2; Rodriguez-Stanley S, 1999, AM J GASTROENTEROL, V94, P628, DOI 10.1111/j.1572-0241.1999.00925.x; Sarkar S, 2000, LANCET, V356, P1154, DOI 10.1016/S0140-6736(00)02758-6; Sarkar S, 2001, AM J PHYSIOL-GASTR L, V281, pG1196, DOI 10.1152/ajpgi.2001.281.5.G1196; Savarino E, 2017, NAT REV GASTRO HEPAT, V14, P665, DOI 10.1038/nrgastro.2017.130; Sugiura T, 2005, J NEUROSCI, V25, P2617, DOI 10.1523/JNEUROSCI.2894-04.2005; Triantos C, 2015, WORLD J GASTROENTERO, V21, P5762, DOI 10.3748/wjg.v21.i19.5762; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Wang Y, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/1505693; Wei S, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02151-w; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Wu LJ, 2004, J BIOL CHEM, V279, P43716, DOI 10.1074/jbc.M403557200; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Yerian L, 2011, DIGEST DIS SCI, V56, P2656, DOI 10.1007/s10620-011-1624-z; Yiangou YG, 2001, EUR J GASTROEN HEPAT, V13, P891, DOI 10.1097/00042737-200108000-00003; Zayachkivska O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110688	49	5	5	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22083	10.1096/fj.202100606R	http://dx.doi.org/10.1096/fj.202100606R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34918385	Green Published			2022-12-28	WOS:000734992000024
J	Liu, H; Huang, YP; Yang, YH; Han, YN; Jia, LF; Li, WR				Liu, Hao; Huang, Yiping; Yang, Yuhui; Han, Yineng; Jia, Lingfei; Li, Weiran			Compressive force-induced LincRNA-p21 inhibits mineralization of cementoblasts by impeding autophagy	FASEB JOURNAL			English	Article						autophagy; biomechanical phenomena; cementogenesis; RNA; long noncoding; root resorption	CELL; DIFFERENTIATION; ACTIVATION	The mineralization capability of cementoblasts is the foundation for repairing orthodontic treatment-induced root resorption. It is essential to investigate the regulatory mechanism of mineralization in cementoblasts under mechanical compression to improve orthodontic therapy. Autophagy has a protective role in maintaining cell homeostasis under environmental stress and was reported to be involved in the mineralization process. Long noncoding RNAs are important regulators of biological processes, but their functions in compressed cementoblasts during orthodontic tooth movement remain unclear. In this study, we showed that compressive force downregulated the expression of mineralization-related markers. LincRNA-p21 was strongly enhanced by compressive force. Overexpression of lincRNA-p21 downregulated the expression of mineralization-related markers, while knockdown of lincRNA-p21 reversed the compressive force-induced decrease in mineralization. Furthermore, we found that autophagy was impeded in compressed cementoblasts. Then, overexpression of lincRNA-p21 decreased autophagic activity, while knockdown of lincRNA-p21 reversed the autophagic process decreased by mechanical compression. However, the autophagy inhibitor 3-methyladenine abolished the lincRNA-p21 knockdown-promoted mineralization, and the autophagy activator rapamycin rescued the mineralization inhibited by lincRNA-p21 overexpression. Mechanistically, the direct binding between lincRNA-p21 and FoxO3 blocked the expression of autophagy-related genes. In a mouse orthodontic tooth movement model, knockdown of lincRNA-p21 rescued the impeded autophagic process in cementoblasts, enhanced cementogenesis, and alleviated orthodontic force-induced root resorption. Overall, compressive force-induced lincRNA-p21 inhibits the mineralization capability of cementoblasts by impeding the autophagic process.	[Liu, Hao; Huang, Yiping; Yang, Yuhui; Han, Yineng; Li, Weiran] Peking Univ Sch & Hosp Stomatol, Dept Orthodont, 22 Zhongguancun South Ave, Beijing 100081, Peoples R China; [Jia, Lingfei] Peking Univ Sch & Hosp Stomatol, Cent Lab, Beijing, Peoples R China; [Jia, Lingfei] Peking Univ Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Cent Lab, 22 Zhongguancun Ave South, Beijing 100081, Peoples R China; [Li, Weiran] Beijing Key Lab Digital Stomatol, Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China	Peking University; Peking University	Li, WR (corresponding author), Peking Univ Sch & Hosp Stomatol, Dept Orthodont, 22 Zhongguancun South Ave, Beijing 100081, Peoples R China.; Jia, LF (corresponding author), Peking Univ Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Cent Lab, 22 Zhongguancun Ave South, Beijing 100081, Peoples R China.	jialingfei1984@sina.com; weiranli@bjmu.edu.cn			National Natural Science Foundation of China [81801010, 82071142]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81801010, No. 82071142). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Castro IO, 2013, ANGLE ORTHOD, V83, P196, DOI 10.2319/032112-240.1; Chen LY, 2019, J PERIODONTOL, V90, P1170, DOI 10.1002/JPER.19-0049; Cheng ZY, 2019, TRENDS ENDOCRIN MET, V30, P658, DOI 10.1016/j.tem.2019.07.009; Feller L, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4864195; Gomez-Puerto MC, 2016, AUTOPHAGY, V12, P1804, DOI 10.1080/15548627.2016.1203484; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Huang L, 2009, MOL BIOL REP, V36, P1741, DOI 10.1007/s11033-008-9376-3; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Iglesias-Linares A, 2017, J DENT RES, V96, P145, DOI 10.1177/0022034516677539; Jia R, 2020, BMC ORAL HEALTH, V20, DOI 10.1186/s12903-019-0987-y; Jin A, 2022, J DENT RES, V101, P196, DOI 10.1177/00220345211021534; Jin SF, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0993-3; Killiany D M, 1999, Semin Orthod, V5, P128, DOI 10.1016/S1073-8746(99)80032-2; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lee JW, 2004, EXP MOL MED, V36, P1, DOI 10.1038/emm.2004.1; Li Y, 2021, AM J ORTHOD DENTOFAC, V159, P582, DOI 10.1016/j.ajodo.2020.01.027; Li ZL, 2021, CONNECT TISSUE RES, V62, P337, DOI 10.1080/03008207.2020.1736578; Lin ZY, 2020, EMBO J, V39, DOI 10.15252/embj.2019103181; Liu H, 2019, ANGLE ORTHOD, V89, P455, DOI 10.2319/061118-438.1; Lu Q, 2020, J PERIODONTOL, V91, P1532, DOI 10.1002/JPER.19-0648; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Meng SS, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1031-x; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Muppirala UK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-489; Niklas A, 2013, INT J DENT, V2013, DOI 10.1155/2013/841840; Nollet M, 2014, AUTOPHAGY, V10, P1965, DOI 10.4161/auto.36182; Peng WX, 2017, ONCOGENE, V36, P5661, DOI 10.1038/onc.2017.184; Royce-Tolland ME, 2010, NAT STRUCT MOL BIOL, V17, P948, DOI 10.1038/nsmb.1877; Schaffner I, 2018, NEURON, V99, P1188, DOI 10.1016/j.neuron.2018.08.017; Sil P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01376; Teng BT, 2011, ACTA PHYSIOL, V201, P239, DOI 10.1111/j.1748-1716.2010.02173.x; Wang DW, 2017, J CELL BIOCHEM, V118, P1606, DOI 10.1002/jcb.25823; Wang Z, 2020, BMC DEV BIOL, V20, DOI 10.1186/s12861-019-0206-8; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Xiao MY, 2019, J CANCER, V10, P3608, DOI 10.7150/jca.31832; Yang F, 2014, MOL CELL, V53, P88, DOI 10.1016/j.molcel.2013.11.004; Zhang WW, 2019, THERANOSTICS, V9, P2198, DOI 10.7150/thno.30798; Zhang YQ, 2021, EXP BIOL MED, V246, P1650, DOI 10.1177/15353702211002136; Zhao BK, 2021, FRONT BIOENG BIOTECH, V9, DOI 10.3389/fbioe.2021.615191	42	4	4	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22120	10.1096/fj.202101589R	http://dx.doi.org/10.1096/fj.202101589R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34958157				2022-12-28	WOS:000734992000028
J	Liu, L; Liu, TT; Xie, GG; Zhu, XQ; Wang, Y				Liu, Lei; Liu, Ting-Ting; Xie, Guo-Guang; Zhu, Xiao-Qi; Wang, Yun			Ubiquitin ligase TRIM32 promotes dendrite arborization by mediating degradation of the epigenetic factor CDYL	FASEB JOURNAL			English	Article						CDYL; degradation; dendrite arborization; TRIM32; ubiquitylation	GIRDLE MUSCULAR-DYSTROPHY; NEURODEVELOPMENTAL DISORDERS; MOLECULAR-MECHANISMS; PROTEIN; PLASTICITY; MIGRATION	Proper dendritic morphology is fundamental to nerve signal transmission; thus, revealing the mechanism by which dendrite arborization is regulated is of great significance. Our previous studies have found that the epigenetic molecule chromodomain Y-like (CDYL) negatively regulates dendritic branching. Current research mostly focuses on the processes downstream of CDYL, whereas the upstream regulatory process has not been investigated to date. In this study, we identified an upstream regulator of CDYL, the E3 ubiquitin ligase tripartite motif-containing protein 32 (TRIM32), which promotes dendrite arborization by mediating the ubiquitylation and degradation of CDYL. By using mass spectrometry and biochemistry strategies, we proved that TRIM32 interacted with CDYL and mediated CDYL ubiquitylation modification in vivo and in vitro. Overexpressing TRIM32 decreased the protein level of CDYL, leading to an increase in the dendritic complexity of primary cultured rat neurons. In contrast, knocking down TRIM32 increased the protein level of CDYL and decreased the dendritic complexity. The truncated form of TRIM32 without E3 ligase activity (Delta RING) lost its ability to regulate dendritic complexity. Most importantly, knockdown of CDYL abolished the reduced complexity of dendrites caused by TRIM32 knockdown, indicating that the TRIM32-mediated regulation of dendritic development depends on its regulation of downstream CDYL. Hence, our findings reveal that TRIM32 could promote dendrite arborization by mediating CDYL degradation. This work initially defines a novel biological role of TRIM32 in regulating mechanisms upstream of CDYL and further presents a potential therapeutic target for the treatment of CDYL-related neurodevelopmental disorders.	[Liu, Lei; Liu, Ting-Ting; Xie, Guo-Guang; Zhu, Xiao-Qi; Wang, Yun] Peking Univ, Sch Basic Med Sci, Dept Neurobiol, Beijing, Peoples R China; [Liu, Lei; Liu, Ting-Ting; Xie, Guo-Guang; Zhu, Xiao-Qi; Wang, Yun] Peking Univ, Neurosci Res Inst, Key Lab Neurosci, Minist Educ China, Beijing, Peoples R China; [Liu, Lei; Liu, Ting-Ting; Xie, Guo-Guang; Zhu, Xiao-Qi; Wang, Yun] Peking Univ, Natl Hlth Commiss, Beijing, Peoples R China; [Liu, Lei; Liu, Ting-Ting; Xie, Guo-Guang; Zhu, Xiao-Qi; Wang, Yun] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China; [Wang, Yun] Peking Univ, PKU IDG McGovern Inst Brain Res, Beijing, Peoples R China	Peking University; Ministry of Education, China; Peking University; Peking University; Peking University; Peking University	Wang, Y (corresponding author), Peking Univ, Sch Basic Med Sci, Neurosci Res Inst, Dept Neurobiol, Beijing 100191, Peoples R China.	wangy66@bjmu.edu.cn	liu, ting/GZM-3326-2022		National Natural Science Foundation of China (NSFC) [31530028, 31720103908, 32030052, 81821092]; Ministry of Science and Technology of the People's Republic of China (MOST) [20171'LA0701302]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China (MOST)(Ministry of Science and Technology, China)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31530028, 31720103908, 32030052 and 81821092; Ministry of Science and Technology of the People's Republic of China (MOST), Grant/Award Number: 20171' LA0701302	Caron C, 2003, EMBO REP, V4, P877, DOI 10.1038/sj.embor.embor917; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Cochran JN, 2014, BRAIN RES BULL, V103, P18, DOI 10.1016/j.brainresbull.2013.12.004; Copf T, 2016, NEUROSCI BIOBEHAV R, V68, P946, DOI 10.1016/j.neubiorev.2016.04.008; Escamilla-Del-Arenal M, 2013, MOL CELL BIOL, V33, P5005, DOI 10.1128/MCB.00866-13; Forrest MP, 2018, NAT REV NEUROSCI, V19, P215, DOI 10.1038/nrn.2018.16; Franz H, 2009, J BIOL CHEM, V284, P35049, DOI 10.1074/jbc.M109.052332; FRIDELL RA, 1995, VIROLOGY, V209, P347, DOI 10.1006/viro.1995.1266; Frosk P, 2005, EUR J HUM GENET, V13, P978, DOI 10.1038/sj.ejhg.5201436; Gulyaeva NV, 2017, BIOCHEMISTRY-MOSCOW+, V82, P237, DOI 10.1134/S0006297917030014; Hillje AL, 2011, STEM CELLS, V29, P1437, DOI 10.1002/stem.687; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Kano S, 2008, CANCER RES, V68, P5572, DOI 10.1158/0008-5472.CAN-07-6231; Koleske AJ, 2013, NAT REV NEUROSCI, V14, P536, DOI 10.1038/nrn3486; Kudryashova E, 2012, J CLIN INVEST, V122, P1764, DOI 10.1172/JCI59581; Lahn BT, 1999, NAT GENET, V21, P429, DOI 10.1038/7771; Lanoue V, 2019, DEV BIOL, V451, P16, DOI 10.1016/j.ydbio.2018.12.005; Liu J, 2014, CELL DEATH DIFFER, V21, P1792, DOI 10.1038/cdd.2014.121; Liu SM, 2017, MOL CELL, V67, P853, DOI 10.1016/j.molcel.2017.07.011; Liu YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00368-z; Liu YG, 2010, J INVEST DERMATOL, V130, P1384, DOI 10.1038/jid.2009.416; Martinez-Cerdeno V, 2017, DEV NEUROBIOL, V77, P393, DOI 10.1002/dneu.22417; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Mokhonova EI, 2015, HUM MOL GENET, V24, P2873, DOI 10.1093/hmg/ddv049; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Neri M, 2013, NEUROMUSCULAR DISORD, V23, P478, DOI 10.1016/j.nmd.2013.02.003; Nicklas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030445; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Qi C, 2014, J NEUROSCI, V34, P4494, DOI 10.1523/JNEUROSCI.3647-13.2014; Qin R, 2017, CELL REP, V18, P380, DOI 10.1016/j.celrep.2016.12.043; Saccone V, 2008, HUM MUTAT, V29, P240, DOI 10.1002/humu.20633; Sato T, 2011, J CELL SCI, V124, P3492, DOI 10.1242/jcs.088799; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; SHOLL DA, 1953, J ANAT, V87, P387; Tocchini C, 2015, SEMIN CELL DEV BIOL, V47-48, P52, DOI 10.1016/j.semcdb.2015.10.017; Wu H, 2009, PROTEINS, V76, P1054, DOI 10.1002/prot.22472; Yokota T, 2006, EUR J CLIN INVEST, V36, P820, DOI 10.1111/j.1365-2362.2006.01722.x; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608; Zhang Y, 2011, J BIOL CHEM, V286, P42414, DOI 10.1074/jbc.M111.271064	42	0	0	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22087	10.1096/fj.202100031RR	http://dx.doi.org/10.1096/fj.202100031RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34888944				2022-12-28	WOS:000734992000029
J	Yu, WQ				Yu, Weiqun			Reviving Cav1.2 as an attractive drug target to treat bladder dysfunction	FASEB JOURNAL			English	Editorial Material						calcium channel blockers; overactive bladder; smooth muscle	SPONTANEOUS PHASIC ACTIVITY; RAT URINARY-BLADDER; SMOOTH-MUSCLE; CALCIUM-CHANNEL; IN-VITRO; NIFEDIPINE; DETRUSOR; CONTRACTIONS; BAY-K-8644; VERAPAMIL	Inhibition of bladder contraction with antimuscarinics is a common approach to treat bladder hyperactivity, and the L-type voltage-gated calcium channel alpha(1C) (Cav1.2) is crucial for bladder contractility. Therefore, strategies aimed at inhibiting Cav1.2 appear warranted. However, multiple clinical trials that attempted to treat bladder overactivity with calcium channel blockers (CCBs) have been unsuccessful, creating an unsolved mystery. In contrast, cardiologists and epidemiologists have reported strong associations between CCB use and bladder hyperactivity, opposing expectations of urologists. Recent findings from our lab offer a potential explanation. We have demonstrated that ketamine which can cause cystitis, functions, like nifedipine, as a Cav1.2 antagonist. We also show that a Cav1.2 agonist which potentiates muscle contraction, rather than antagonizing it, can increase the volume of voids and reduce voiding frequency. This perspective will discuss in detail the unsuccessful urological trials of CCBs and the promise of Cav1.2 agonists as potential novel therapies for bladder dysfunctions.	[Yu, Weiqun] Beth Israel Deaconess Med Ctr, Dept Med, RN380B,99 Brookline Ave, Boston, MA 02215 USA; [Yu, Weiqun] Harvard Med Sch, RN380B,99 Brookline Ave, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Yu, WQ (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, RN380B,99 Brookline Ave, Boston, MA 02215 USA.; Yu, WQ (corresponding author), Harvard Med Sch, RN380B,99 Brookline Ave, Boston, MA 02215 USA.	wyu2@bidmc.harvard.edu			NIDA [U18DA052346]	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	The Cav1.2 work on ketamine cystitis is funded by NIDA to W.Y (U18DA052346). I thank Drs. Mark Zeidel, Seth Alper, Warren Hill, and Aria Olumi (Beth Israel Deaconess Medical Center, Boston) for useful discussions.	ABRAHAM S, 1987, BRIT J PHARMACOL, V92, P603, DOI 10.1111/j.1476-5381.1987.tb11362.x; Andersson KE, 1999, BJU INT, V84, P923; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; BO X, 1990, BRIT J PHARMACOL, V101, P494, DOI 10.1111/j.1476-5381.1990.tb12736.x; BODEN WE, 1985, JAMA-J AM MED ASSOC, V253, P1131, DOI 10.1001/jama.253.8.1131; Buckner SA, 2002, BRIT J PHARMACOL, V135, P639, DOI 10.1038/sj.bjp.0704499; Cainazzo MM, 2005, DRUG EXP CLIN RES, V31, P115; Chen H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18167-4; Chi JT, 2007, PLOS GENET, V3, P1770, DOI 10.1371/journal.pgen.0030164; Coyne KS, 2009, BJU INT, V104, P352, DOI 10.1111/j.1464-410X.2009.08427.x; Elhebir ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066708; ELLIOTT RA, 1992, EUR J CLIN PHARMACOL, V43, P149, DOI 10.1007/BF01740662; Eroglu TE, 2020, EUR HEART J-CARD PHA, V6, P347, DOI 10.1093/ehjcvp/pvz038; FAUSTINI S, 1989, ARZNEIMITTEL-FORSCH, V39-2, P899; FLECKENSTEIN A, 1975, N-S ARCH PHARMACOL, V287, pR38; Fogari R, 2005, AM J HYPERTENS, V18, P577, DOI 10.1016/j.amjhyper.2004.11.020; FORMAN A, 1978, ACTA PHARMACOL TOX, V43, P111; FOVAEUS M, 1988, ACTA PHYSIOL SCAND, V132, P233, DOI 10.1111/j.1748-1716.1988.tb08322.x; FOVAEUS M, 1987, J UROLOGY, V137, P798, DOI 10.1016/S0022-5347(17)44214-5; Godfraind T, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00286; Griffin CS, 2018, BJU INT, V121, P959, DOI 10.1111/bju.14090; Hall SA, 2012, BJU INT, V109, P1676, DOI 10.1111/j.1464-410X.2011.10593.x; Hao Y, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122112; HENRY PD, 1980, AM J CARDIOL, V46, P1047, DOI 10.1016/0002-9149(80)90366-5; Heppner TJ, 2009, J PHYSIOL-LONDON, V587, P5275, DOI 10.1113/jphysiol.2009.178806; Hofmann F, 2014, PHYSIOL REV, V94, P303, DOI 10.1152/physrev.00016.2013; Hoggatt AM, 2002, CIRC RES, V91, P1151, DOI 10.1161/01.RES.0000047508.30800.4F; Hughes Jeffery D, 2011, Qual Prim Care, V19, P223; Huster M, 2010, FASEB J, V24, P2651, DOI 10.1096/fj.09-149856; Irwin DE, 2011, BJU INT, V108, P1132, DOI 10.1111/j.1464-410X.2010.09993.x; Ito H, 2013, NEUROUROL URODYNAM, V32, P70, DOI 10.1002/nau.22267; IVES N, 1986, EUR J PHARMACOL, V130, P169, DOI 10.1016/0014-2999(86)90265-7; Jinnah HA, 1999, P NATL ACAD SCI USA, V96, P15228, DOI 10.1073/pnas.96.26.15228; KARLINER JS, 1982, J CARDIOVASC PHARM, V4, P515, DOI 10.1097/00005344-198205000-00025; KATSURAGI T, 1990, BRIT J PHARMACOL, V100, P370, DOI 10.1111/j.1476-5381.1990.tb15811.x; LAVAL KU, 1980, UROL INT, V35, P182, DOI 10.1159/000280321; Liao P, 2007, J BIOL CHEM, V282, P35133, DOI 10.1074/jbc.M705478200; Liao P, 2010, PFLUG ARCH EUR J PHY, V460, P353, DOI 10.1007/s00424-009-0753-0; LIPE S, 1983, PHARMACOL THERAPEUT, V22, P299, DOI 10.1016/0163-7258(83)90007-4; MAGGI CA, 1988, GEN PHARMACOL, V19, P73, DOI 10.1016/0306-3623(88)90008-0; Matsui M, 2002, J NEUROSCI, V22, P10627; MATTIASSON A, 1989, J UROLOGY, V141, P174, DOI 10.1016/S0022-5347(17)40635-5; MIGNOT G, 1988, LANCET, V2, P857; MOGILNICKA E, 1988, EUR J PHARMACOL, V151, P307, DOI 10.1016/0014-2999(88)90813-8; Naglie G, 2002, J UROLOGY, V167, P586, DOI 10.1016/S0022-5347(01)69090-6; Novara G, 2008, EUR UROL, V54, P740, DOI 10.1016/j.eururo.2008.06.080; RAHWAN RG, 1979, CAN J PHYSIOL PHARM, V57, P443, DOI 10.1139/y79-069; Schneider T, 2004, J PHARMACOL EXP THER, V309, P1148, DOI 10.1124/jpet.103.063735; SCHWEIZER MWF, 1993, BRIT HEART J, V70, P252; Snider ME, 2008, VASC HEALTH RISK MAN, V4, P1249; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Striessnig J, 2015, CURR MOL PHARMACOL, V8, P110, DOI 10.2174/1874467208666150507105845; Tang ZZ, 2007, CELL CALCIUM, V41, P417, DOI 10.1016/j.ceca.2006.08.002; UCHIDA W, 1994, N-S ARCH PHARMACOL, V350, P398; Uvin P, 2013, EUR UROL, V64, P502, DOI 10.1016/j.eururo.2013.05.031; Vial C, 2000, BRIT J PHARMACOL, V131, P1489, DOI 10.1038/sj.bjp.0703720; Wegener JW, 2004, FASEB J, V18, P1159, DOI 10.1096/fj.04-1516fje; WILLIAMS G, 1986, LANCET, V1, P738; Wuest M, 2007, EUR J PHARMACOL, V565, P180, DOI 10.1016/j.ejphar.2007.02.046; Yeaw J, 2009, J MANAGE CARE PHARM, V15, P728, DOI 10.18553/jmcp.2009.15.9.728; ZDERIC SA, 1994, J UROLOGY, V152, P679, DOI 10.1016/S0022-5347(17)32679-4	61	1	1	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22118	10.1096/fj.202101475R	http://dx.doi.org/10.1096/fj.202101475R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34939692				2022-12-28	WOS:000734992000039
J	Defnet, AE; Shah, SD; Huang, WL; Shapiro, P; Deshpande, DA; Kane, MA				Defnet, Amy E.; Shah, Sushrut D.; Huang, Weiliang; Shapiro, Paul; Deshpande, Deepak A.; Kane, Maureen A.			Dysregulated retinoic acid signaling in airway smooth muscle cells in asthma	FASEB JOURNAL			English	Article						airway inflammation; airway smooth muscle; asthma; retinoic acid; retinoids; vitamin A	VITAMIN-A; BODY IRRADIATION; GENE; QUANTIFICATION; AP-1; PROLIFERATION; MODEL; TRANSACTIVATION; IDENTIFICATION; MECHANISMS	Vitamin A deficiency has been shown to exacerbate allergic asthma. Previous studies have postulated that retinoic acid (RA), an active metabolite of vitamin A and high-affinity ligand for RA receptor (RAR), is reduced in airway inflammatory condition and contributes to multiple features of asthma including airway hyperresponsiveness and excessive accumulation of airway smooth muscle (ASM) cells. In this study, we directly quantified RA and examined the molecular basis for reduced RA levels and RA-mediated signaling in lungs and ASM cells obtained from asthmatic donors and in lungs from allergen-challenged mice. Levels of RA and retinol were significantly lower in lung tissues from asthmatic donors and house dust mite (HDM)-challenged mice compared to non-asthmatic human lungs and PBS-challenged mice, respectively. Quantification of mRNA and protein expression revealed dysregulation in the first step of RA biosynthesis consistent with reduced RA including decreased protein expression of retinol dehydrogenase (RDH)-10 and increased protein expression of RDH11 and dehydrogenase/reductase (DHRS)-4 in asthmatic lung. Proteomic profiling of non-asthmatic and asthmatic lungs also showed significant changes in the protein expression of AP-1 targets consistent with increased AP-1 activity. Further, basal RA levels and RA biosynthetic capabilities were decreased in asthmatic human ASM cells. Treatment of human ASM cells with all-trans RA (ATRA) or the RAR gamma-specific agonist (CD1530) resulted in the inhibition of mitogen-induced cell proliferation and AP-1-dependent transcription. These data suggest that RA metabolism is decreased in asthmatic lung and that enhancing RAR signaling using ATRA or RAR gamma agonists may mitigate airway remodeling associated with asthma.	[Defnet, Amy E.; Huang, Weiliang; Shapiro, Paul; Kane, Maureen A.] Univ Maryland, Dept Pharmaceut Sci, 20 N Pine St,Rm N731, Baltimore, MD 21201 USA; [Shah, Sushrut D.; Deshpande, Deepak A.] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, 1020 Locust St,Rm 543B, Philadelphia, PA 19107 USA	University System of Maryland; University of Maryland Baltimore; Jefferson University	Kane, MA (corresponding author), Univ Maryland, Dept Pharmaceut Sci, 20 N Pine St,Rm N731, Baltimore, MD 21201 USA.; Deshpande, DA (corresponding author), Thomas Jefferson Univ, Dept Med, Ctr Translat Med, 1020 Locust St,Rm 543B, Philadelphia, PA 19107 USA.	deepak.deshpande@jefferson.edu; mkane@rx.umaryland.edu		Deshpande, Deepak/0000-0002-6187-5332; Shah, Sushrut/0000-0002-4201-6532	HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID) [AI26492]; HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [T32 GM066706]	HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS)	HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: AI26492; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: T32 GM066706	Agache I, 2021, ALLERGY, V76, P14, DOI 10.1111/all.14425; Amrani Y, 2003, INT J BIOCHEM CELL B, V35, P272, DOI 10.1016/S1357-2725(02)00259-5; Arora P, 2002, PEDIATR ALLERGY IMMU, V13, P223, DOI 10.1034/j.1399-3038.2002.00010.x; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Bentley J Kelley, 2008, Proc Am Thorac Soc, V5, P89, DOI 10.1513/pats.200705-063VS; Biesalski HK, 1999, AM J CLIN NUTR, V69, P931; Black JL, 2001, AM J RESP CRIT CARE, V164, pS63, DOI 10.1164/ajrccm.164.supplement_2.2106059; Bourke JE, 2011, EUR RESPIR J, V37, P173, DOI 10.1183/09031936.00008109; Burgess JK, 2008, J CELL PHYSIOL, V216, P673, DOI 10.1002/jcp.21450; Checkley W, 2011, EUR RESPIR J, V38, P1310, DOI 10.1183/09031936.00006911; Chen F, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120398; Chen F, 2014, J CLIN INVEST, V124, P801, DOI 10.1172/JCI70291; CHEN JY, 1995, EMBO J, V14, P1187, DOI 10.1002/j.1460-2075.1995.tb07102.x; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Cunningham TJ, 2015, NAT REV MOL CELL BIO, V16, P110, DOI 10.1038/nrm3932; Day RM, 2006, AM J RESP CELL MOL, V34, P695, DOI 10.1165/rcmb.2005-0306OC; Defnet AE, 2019, FASEB J, V33, P10833, DOI 10.1096/fj.201900680R; Dorfer V, 2014, J PROTEOME RES, V13, P3679, DOI 10.1021/pr500202e; Dutta A, 2010, CELL ADHES MIGR, V4, P409, DOI 10.4161/cam.4.3.11682; Eng JK, 2008, J PROTEOME RES, V7, P4598, DOI 10.1021/pr800420s; EPISKOPOU V, 1993, P NATL ACAD SCI USA, V90, P2375, DOI 10.1073/pnas.90.6.2375; Fernandes D, 1999, AM J RESP CELL MOL, V21, P77, DOI 10.1165/ajrcmb.21.1.3396; Ghyselinck NB, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.167502; Huang WL, 2020, HEALTH PHYS, V119, P604, DOI 10.1097/HP.0000000000001351; Huang WL, 2019, HEALTH PHYS, V116, P503, DOI 10.1097/HP.0000000000000956; Huang WL, 2019, HEALTH PHYS, V116, P516, DOI 10.1097/HP.0000000000000951; Hufnagl K, 2018, ALLERGO J, V27, P21, DOI 10.1007/s40629-018-0054-2; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Jones JW, 2015, HEALTH PHYS, V109, P452, DOI 10.1097/HP.0000000000000346; Jones JW, 2015, ANAL CHEM, V87, P3222, DOI 10.1021/ac504597q; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kaminska B, 2000, ACTA NEUROBIOL EXP, V60, P395; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; Marquez Hector A, 2016, Mol Cell Pediatr, V3, P28, DOI 10.1186/s40348-016-0054-6; McGowan SE, 2002, AM J PHYSIOL-LUNG C, V282, pL1031, DOI 10.1152/ajplung.00319.2001; McKeever TM, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-67; MORABIA A, 1989, AM REV RESPIR DIS, V140, P1312, DOI 10.1164/ajrccm/140.5.1312; Napoli JL, 2020, METHOD ENZYMOL, V637, P27, DOI 10.1016/bs.mie.2020.02.003; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Panettieri Reynold A. Jr., 2002, Journal of Allergy and Clinical Immunology, V110, pS269, DOI 10.1067/mai.2002.129429; POSCH KC, 1992, J BIOL CHEM, V267, P19676; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Ross AC, 2012, AM J CLIN NUTR, V96, p1166S, DOI 10.3945/ajcn.112.034637; Schuster GU, 2008, J IMMUNOL, V180, P1834, DOI 10.4049/jimmunol.180.3.1834; Shannon SR, 2020, METHOD ENZYMOL, V637, P367, DOI 10.1016/bs.mie.2020.03.011; Sharma P, 2017, SCI REP-UK, V7, DOI 10.1038/srep46166; Shimono K, 2011, NAT MED, V17, P454, DOI 10.1038/nm.2334; Smolinska MJ, 2011, J IMMUNOL, V187, P6043, DOI 10.4049/jimmunol.1100967; Tang XH, 2014, P NATL ACAD SCI USA, V111, P8907, DOI 10.1073/pnas.1404828111; Thatcher JE, 2011, MOL PHARMACOL, V80, P228, DOI 10.1124/mol.111.072413; Theodosiou M, 2010, CELL MOL LIFE SCI, V67, P1423, DOI 10.1007/s00018-010-0268-z; Tian X, 2018, EXP LUNG RES, V44, P217, DOI 10.1080/01902148.2018.1493551; Tong L, 2004, CELL SIGNAL, V16, P1123, DOI 10.1016/j.cellsig.2004.03.003; Wagner EF, 2001, ONCOGENE, V20, P2334, DOI 10.1038/sj.onc.1204416; Wang S, 2020, PHARMACOL THERAPEUT, V205, DOI 10.1016/j.pharmthera.2019.107415; Zhou XF, 1999, MOL ENDOCRINOL, V13, P276, DOI 10.1210/me.13.2.276; Zou DD, 2012, LEUKEMIA RES, V36, P219, DOI 10.1016/j.leukres.2011.09.012	62	2	2	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22016	10.1096/fj.202100835R	http://dx.doi.org/10.1096/fj.202100835R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34784434	Green Accepted			2022-12-28	WOS:000722321300027
J	Long, J; Liu, N; Tang, WL; Xie, LF; Qin, FM; Zhou, LF; Tao, R; Wang, YH; Hu, Y; Jiao, YG; Li, L; Jiang, LR; Qu, JN; Chen, Q; Yao, SH				Long, Jie; Liu, Nan; Tang, Wenling; Xie, Lifang; Qin, Fengming; Zhou, Lifang; Tao, Rui; Wang, Yanhong; Hu, Yun; Jiao, Yaoge; Li, Li; Jiang, Lurong; Qu, Junyan; Chen, Qiang; Yao, Shaohua			A split cytosine deaminase architecture enables robust inducible base editing	FASEB JOURNAL			English	Article						base editing; CRISPR; Cas9; cytosine deaminase; FRB; FKBP; protein split	LONG-TERM SAFETY; GENOMIC DNA; MUTAGENESIS; EXPRESSION; DYSPLASIA; EFFICACY	Directed base substitution with base editing technology enables efficient and programmable conversion of C:G or A:T base pairs to T:A or G:C in the genome. Although this technology has shown great potentials in a variety of basic research, off-target editing is among one of the biggest challenges toward its way to clinical application. Base editing tools, especially the tools converting C to T, caused unpredictable off-target editing throughout the genome, which raise the concern that long-term application of these tools would induce genomic instability or even tumorigenesis. To overcome this challenge, we designed an inducible base editing tool that was active only in the presence of a clinically safe chemical, rapamycin. In the guidance of structural information, we designed four split-human APOBEC3A (A3A) -BE3 base editors in which these A3A deaminase enzymes were split at sites that were opposite to the protein-nucleotide interface. We showed that by inducible deaminase reconstruction with a rapamycin responsible interaction system (FRB and FKBP); three out of four split-A3A-derived base editors showed robust inducible base editing. However, in the absence of rapamycin, their editing ability was dramatically inhibited. Among these split editors, splicing at Aa85 of A3A generated the most efficient inducible editing. In addition, compared to the full-length base editor, the splitting did not obviously alter the editing window and motif preference, but slightly increased the product purity. We also expanded this strategy to another frequently used cytosine deaminase, rat APOBEC1 (rA1), and observed a similar induction response. In summary, these results demonstrated the concept that splitting deaminases is a practicable method for timely controlling of base editing tools.	[Long, Jie; Liu, Nan; Tang, Wenling; Qin, Fengming; Zhou, Lifang; Tao, Rui; Wang, Yanhong; Hu, Yun; Jiao, Yaoge; Li, Li; Jiang, Lurong; Chen, Qiang; Yao, Shaohua] Sichuan Univ, West China Hosp, Canc Ctr, Lab Biotherapy,Natl Key Lab Biotherapy, Renmin Nanlu 17, Chengdu 610041, Peoples R China; [Zhou, Lifang] Sichuan Univ, Coll Life Sci, Chengdu, Peoples R China; [Qu, Junyan] Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Yao, SH (corresponding author), Sichuan Univ, West China Hosp, Canc Ctr, Lab Biotherapy,Natl Key Lab Biotherapy, Renmin Nanlu 17, Chengdu 610041, Peoples R China.	shaohuayao@scu.edu.cn			Hi-Tech Research & Development (863) Program of China [2015AA020309]; National Natural Science Foundation of China [U19A2002, 81771220, 81974238]; Salubris Academician Workstation for Innovative Biopharmaceuticals [2017B090904017]	Hi-Tech Research & Development (863) Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Salubris Academician Workstation for Innovative Biopharmaceuticals	This work was supported by the Hi-Tech Research & Development (863) Program of China (No. 2015AA020309), National Natural Science Foundation of China (Nos. U19A2002, 81771220 and 81974238), and Salubris Academician Workstation for Innovative Biopharmaceuticals (No. 2017B090904017). We thank the reviewers and the editor for their time and valuable feedback.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Carreras A, 2019, BMC BIOL, V17, DOI 10.1186/s12915-018-0624-2; Chadwick AC, 2017, ARTERIOSCL THROM VAS, V37, P1741, DOI 10.1161/ATVBAHA.117.309881; Chen YY, 2017, SCI CHINA LIFE SCI, V60, P520, DOI 10.1007/s11427-017-9021-5; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Doman JL, 2020, NAT BIOTECHNOL, V38, P620, DOI 10.1038/s41587-020-0414-6; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Gehrke JM, 2018, NAT BIOTECHNOL, V36, P977, DOI 10.1038/nbt.4199; Grunewald J, 2019, NATURE, V569, P433, DOI 10.1038/s41586-019-1161-z; Huang TP, 2019, NAT BIOTECHNOL, V37, P626, DOI 10.1038/s41587-019-0134-y; Jin S, 2020, MOL CELL, V79, P728, DOI 10.1016/j.molcel.2020.07.005; Jin S, 2019, SCIENCE, V364, P292, DOI 10.1126/science.aaw7166; Kim D, 2019, NAT BIOTECHNOL, V37, P430, DOI 10.1038/s41587-019-0050-1; Kim D, 2017, NAT BIOTECHNOL, V35, P475, DOI 10.1038/nbt.3852; Kluesner MG, 2018, CRISPR J, V1, P239, DOI 10.1089/crispr.2018.0014; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kouno T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15024; Kurt IC, 2021, NAT BIOTECHNOL, V39, P41, DOI 10.1038/s41587-020-0609-x; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Nathwani AC, 2011, MOL THER, V19, P876, DOI 10.1038/mt.2010.274; Niemeyer GP, 2009, BLOOD, V113, P797, DOI 10.1182/blood-2008-10-181479; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Qian XB, 1998, ARTERIOSCL THROM VAS, V18, P1013, DOI 10.1161/01.ATV.18.6.1013; Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Ryu SM, 2018, NAT BIOTECHNOL, V36, P536, DOI 10.1038/nbt.4148; Salter JD, 2016, TRENDS BIOCHEM SCI, V41, P578, DOI 10.1016/j.tibs.2016.05.001; Shaban NM, 2016, J MOL BIOL, V428, P2307, DOI 10.1016/j.jmb.2016.04.026; Shinohara M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00806; Smith HC, 2017, RNA BIOL, V14, P1153, DOI 10.1080/15476286.2016.1259783; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Vasudevan AAJ, 2013, BIOL CHEM, V394, P1357, DOI 10.1515/hsz-2013-0165; Villiger L, 2018, NAT MED, V24, P1519, DOI 10.1038/s41591-018-0209-1; Wang X, 2018, NAT BIOTECHNOL, V36, P946, DOI 10.1038/nbt.4198; Wang YH, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02137-6; Wang YH, 2019, SIGNAL TRANSDUCT TAR, V4, DOI 10.1038/s41392-019-0072-7; Wolfe Aaron D, 2020, NAR Cancer, V2, pzcaa027, DOI 10.1093/narcan/zcaa027; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang YH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00175-6; Zhao DD, 2020, NAT BIOTECHNOL, DOI 10.1038/s41587-020-0592-2; Zhou CY, 2019, NATURE, V571, P275, DOI 10.1038/s41586-019-1314-0; Zuo EW, 2019, SCIENCE, V364, P289, DOI 10.1126/science.aav9973	46	1	1	7	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22045	10.1096/fj.202100123R	http://dx.doi.org/10.1096/fj.202100123R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34797942				2022-12-28	WOS:000722321300043
J	Rabaglino, MB; Secher, JBM; Sirard, MA; Hyttel, P; Kadarmideen, HN				Rabaglino, Maria B.; Secher, Jan Bojsen-Moller; Sirard, Marc-Andre; Hyttel, Poul; Kadarmideen, Haja N.			Epigenomic and transcriptomic analyses reveal early activation of the HPG axis in in vitro-produced male dairy calves	FASEB JOURNAL			English	Article						computational biology; machine learning; reproductive techniques; system biology	IN-VITRO; DNA METHYLATION; DEVELOPMENTAL ORIGINS; OFFSPRING SYNDROME; GENE-EXPRESSION; HORMONE NEURONS; EARLY-PREGNANCY; EMBRYO CULTURE; FETAL-GROWTH; BOVINE	In cattle, several calves born after IVP ("in vitro" embryo production) present similar birthweight to those generated after MOET (multiple ovulation and embryo transfer). However, the underlying molecular patterns in organs involved in the developmental process are unknown and could indicate physiological programming. The objectives of this study were: (1) to compare epigenomic and transcriptomic modifications in the hypothalamus, pituitary, gonadal and adrenal organs between 3 months old ovum pick-up-IVP and MOET male calves (n = 4 per group) and (2) to use blood epigenomic data to proxy methylation of the inner organs. Extracted gDNA and RNA were sequenced through whole-genome bisulfite sequencing and RNA sequencing, respectively. Next, bioinformatic analyses determined differentially methylated cytosines (DMC) and differentially expressed genes (DEG) (FDR < 0.05) in IVP versus MOET samples and the KEGG pathways that were overrepresented by genes associated with DMC or DEG (FDR < 0.1). Pathways related to hypothalamus, pituitary, gonadal (HPG) axis activation (GnRH secretion in the hypothalamus, GnRH signaling in the pituitary, and steroidogenesis in the testicle) were enriched in IVP calves. Modeling the effect of the methylation levels and the group on the expression of all the genes involved in these pathways confirmed their upregulation in HPG organs in IVP calves. The application of the DIABLO method allowed the identification of 15 epigenetic and five transcriptomic biomarkers, which were able to predict the embryo origin using the epigenomic data from the blood. In conclusion, the use of an integrated epigenomic-transcriptomic approach suggested an early activation of the HPG axis in male IVP calves compared to MOET counterparts, and the identification of potential biomarkers allowed the use of blood samples to proxy methylation levels of the relevant internal organs.	[Rabaglino, Maria B.; Kadarmideen, Haja N.] Tech Univ Denmark, Dept Appl Math & Comp Sci, Quantitat Genet Bioinformat & Computat Biol Grp, Lyngby, Denmark; [Secher, Jan Bojsen-Moller; Hyttel, Poul] Univ Copenhagen, Dept Vet Clin Sci, Frederiksberg, Denmark; [Sirard, Marc-Andre] Univ Laval, Ctr Rech Reprod Dev & Sante Intergenerat CRDSI, Dept Sci Anim, Laval, PQ, Canada	Technical University of Denmark; University of Copenhagen; Laval University	Kadarmideen, HN (corresponding author), Tech Univ Denmark, Dept Appl Math & Comp Sci, Quantitat Genet Bioinformat & Computat Biol Grp, DTU Compute, Bldg 324, DK-2800 Lyngby, Denmark.	hajak@dtu.dk		Secher, Jan Ole Bertelsen/0000-0002-7399-7142; Sirard, Marc Andre/0000-0001-8667-6682; Kadarmideen, Haja/0000-0001-6294-382X	Innovationsfonden (Innovation Fund Denmark) [7045-00013B]	Innovationsfonden (Innovation Fund Denmark)	Innovationsfonden (Innovation Fund Denmark), Grant/Award Number: 7045-00013B	Abreu AP, 2013, NEW ENGL J MED, V368, P2467, DOI 10.1056/NEJMoa1302160; Akalin A, 2015, BIOINFORMATICS, V31, P1127, DOI 10.1093/bioinformatics/btu775; Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R87, 10.1186/gb-2012-13-10-r87]; Anastasiadi D, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0205-1; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bertolini M, 2002, THERIOGENOLOGY, V58, P973, DOI 10.1016/S0093-691X(02)00935-4; Betsha S, 2013, MOL REPROD DEV, V80, P315, DOI 10.1002/mrd.22165; Bonilla L, 2014, J DAIRY SCI, V97, P229, DOI 10.3168/jds.2013-6943; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Causeret F, 2007, MOL BIOL CELL, V18, P4327, DOI 10.1091/mbc.E07-04-0372; Chang EI, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01858; Chen ZY, 2016, EPIGENETICS-US, V11, P501, DOI 10.1080/15592294.2016.1184805; Chen ZY, 2015, P NATL ACAD SCI USA, V112, P4618, DOI 10.1073/pnas.1422088112; Chen ZY, 2013, EPIGENETICS-US, V8, P591, DOI 10.4161/epi.24655; Corcoran D, 2006, REPRODUCTION, V131, P651, DOI 10.1530/rep.1.01015; De Boo HA, 2006, AUST NZ J OBSTET GYN, V46, P4, DOI 10.1111/j.1479-828X.2006.00506.x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drapkin Paola T, 2002, BMC Developmental Biology, V2, P1; Driver AM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-118; Ehrlich M, 2013, EPIGENOMICS-UK, V5, P553, DOI 10.2217/epi.13.43; Farin CE, 2010, REPROD FERT DEVELOP, V22, P75, DOI 10.1071/RD09217; Farin PW, 2006, THERIOGENOLOGY, V65, P178, DOI 10.1016/j.theriogenology.2005.09.022; FARIN PW, 1995, BIOL REPROD, V52, P676, DOI 10.1095/biolreprod52.3.676; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Feuer SK, 2014, ENDOCRINOLOGY, V155, P1956, DOI 10.1210/en.2013-2081; Fleming TP, 2018, LANCET, V391, P1842, DOI [10.1016/S0140-6736(18)30312-X, 10.1016/s0140-6736(18)30312-x]; Fortes MRS, 2011, J ANIM SCI, V89, P1669, DOI 10.2527/jas.2010-3681; Gad A, 2011, HUM REPROD, V26, P1693, DOI 10.1093/humrep/der110; Grazul-Bilska AT, 2014, REPRODUCTION, V147, P639, DOI 10.1530/REP-13-0663; Gui J, 2020, PLACENTA, V89, P50, DOI 10.1016/j.placenta.2019.09.011; Hammer CJ, 2001, THERIOGENOLOGY, V55, P1447, DOI 10.1016/S0093-691X(01)00493-9; Hansen PJ, 2016, CELL TISSUE RES, V363, P237, DOI 10.1007/s00441-015-2287-4; Hasler JF, 2014, THERIOGENOLOGY, V81, P152, DOI 10.1016/j.theriogenology.2013.09.010; Heras S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2393-z; Hiraizumi Y, 2008, J PHYSIOL SCI, V58, P21, DOI 10.2170/physiolsci.RP013207; Hornung R, 2017, BIOINFORMATICS, V33, P397, DOI 10.1093/bioinformatics/btw650; Howard SR, 2018, J CLIN ENDOCR METAB, V103, P3420, DOI 10.1210/jc.2018-00646; Huber W., 2003, STAT APPL GENET MOL, V2, pARTICL, DOI [10.2202/1544-6115.1008, DOI 10.2202/1544-6115.1008]; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kadarmideen HN, 2015, ANIM REPROD, V12, P389; Kotzot D, 2004, ANN GENET-PARIS, V47, P251, DOI 10.1016/j.anngen.2004.03.006; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kues WA, 2008, P NATL ACAD SCI USA, V105, P19768, DOI 10.1073/pnas.0805616105; Lazzari G, 2002, BIOL REPROD, V67, P767, DOI 10.1095/biolreprod.102.004481; Le Cao KA, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1390; Li YH, 2019, VET CLIN N AM-FOOD A, V35, P265, DOI 10.1016/j.cvfa.2019.02.007; Li Y, 2012, PROG NEUROBIOL, V98, P145, DOI 10.1016/j.pneurobio.2012.05.010; Liu XH, 2008, ENDOCRINOLOGY, V149, P4605, DOI 10.1210/en.2008-0321; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madan ML, 2005, REV SCI TECH OIE, V24, P127, DOI 10.20506/rst.24.1.1555; McEvoy TG, 1998, REPROD FERT DEVELOP, V10, P459, DOI 10.1071/RD98126; Miles JR, 2005, BIOL REPROD, V73, P663, DOI 10.1095/biolreprod.105.040808; Miller NLG, 2009, HUM MOL GENET, V18, P248, DOI 10.1093/hmg/ddn344; Najafzadeh V, 2021, THERIOGENOLOGY, V171, P44, DOI 10.1016/j.theriogenology.2021.04.020; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; Nishimura I, 2008, ENDOCRINOLOGY, V149, P774, DOI 10.1210/en.2007-0759; O'Doherty AM, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4818-3; Rabaglino MB, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252096; Rabaglino MB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1001; Rodriguez-Martinez H, 2012, REPROD DOMEST ANIM, V47, P21, DOI 10.1111/j.1439-0531.2011.01961.x; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Semaan SJ, 2013, INT J DEV NEUROSCI, V31, P452, DOI 10.1016/j.ijdevneu.2013.03.006; Sinclair K D, 2007, Soc Reprod Fertil Suppl, V64, P425; Sinclair KD, 1999, J REPROD FERTIL, V116, P177, DOI 10.1530/jrf.0.1160177; Singh A, 2019, BIOINFORMATICS, V35, P3055, DOI 10.1093/bioinformatics/bty1054; Siqueira LGB, 2017, J DAIRY SCI, V100, P5899, DOI 10.3168/jds.2016-12539; Sirard MA, 2017, J DEV ORIG HLTH DIS, V8, P411, DOI 10.1017/S2040174417000125; Sirard MA, 2018, REPRODUCTION, V156, pR1, DOI 10.1530/REP-18-0008; Smith J, 2020, TRENDS CANCER, V6, P392, DOI 10.1016/j.trecan.2020.02.007; Tenenhaus A, 2014, BIOSTATISTICS, V15, P569, DOI 10.1093/biostatistics/kxu001; Teng CS, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6722-x; Thomasen JR, 2016, J DAIRY SCI, V99, P1331, DOI 10.3168/jds.2015-9437; Tornberg J, 2011, P NATL ACAD SCI USA, V108, P11524, DOI 10.1073/pnas.1102284108; Tury A, 2012, DEV NEUROBIOL, V72, P821, DOI 10.1002/dneu.20999; Urrego R, 2014, EPIGENETICS-US, V9, P803, DOI 10.4161/epi.28711; van Wagtendonk-de Leeuw AM, 1998, THERIOGENOLOGY, V49, P883, DOI 10.1016/S0093-691X(98)00038-7; Venables WN., 2002, MODERN APPL STAT S; Volodarsky-Perel A, 2020, REPROD BIOMED ONLINE, V41, P907, DOI 10.1016/j.rbmo.2020.08.002; Walton E, 2016, SCHIZOPHRENIA BULL, V42, P406, DOI 10.1093/schbul/sbv074; Wang HQ, 2011, BIOINFORMATICS, V27, P225, DOI 10.1093/bioinformatics/btq650; Wang X, 2019, ANIM GENET, V50, P644, DOI 10.1111/age.12842; Wang X, 2020, VET SCI, V7, DOI 10.3390/vetsci7020077; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Wood CE, 2013, PHYSIOL GENOMICS, V45, P521, DOI 10.1152/physiolgenomics.00005.2013; Yeo SH, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00188; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	89	2	2	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21882	10.1096/fj.202101067R	http://dx.doi.org/10.1096/fj.202101067R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34460963	Green Published, hybrid			2022-12-28	WOS:000702238200009
J	Sun, L; Li, FH; Han, C; Wang, ZZ; Gao, KK; Qiao, YB; Ma, S; Xie, T; Wang, J				Sun, Lei; Li, Fang-Hui; Han, Chong; Wang, Zhuang-Zhi; Gao, Ke-Ke; Qiao, Yi-Bo; Ma, Song; Xie, Tian; Wang, Jing			Alterations in mitochondrial biogenesis and respiratory activity, inflammation of the senescence-associated secretory phenotype, and lipolysis in the perirenal fat and liver of rats following lifelong exercise and detraining	FASEB JOURNAL			English	Article						detraining; lifelong exercise; lipolysis; mitochondrial function; SASP	GROWTH-FACTOR-BETA; PHYSICAL PERFORMANCE; INSULIN-RESISTANCE; BODY-COMPOSITION; ADIPOSE-TISSUE; CALORIC RESTRICTION; OXIDATIVE STRESS; PROTEIN; SERUM; LONG	The primary aims of this study were to determine the effects of lifelong exercise and detraining on age-related alterations in mitochondrial function, inflammation associated with senescence-associated secretory phenotype (SASP), and lipolysis in the perirenal fat and liver of rats. Female Sprague-Dawley rats were randomly assigned to four groups: young control (n = 12), old control (n = 12), detraining (n = 12), and lifelong exercise (n = 12). We then investigated mitochondrial function, SASP-associated inflammation, and lipolysis in the perirenal fat and liver using qRT-PCR and western blotting to assess the expression of AKT, hypoxia-inducible factor 1 alpha (HIF-1 alpha), nuclear factor-kappa B (NF-kappa B), c-jun kinase (JNK), and p38 mitogen-activated protein kinase (p38MAPK). In the tissues of both the perirenal fat and liver, lifelong exercise significantly improved mitochondrial function, SASP-associated inflammation, and lipolysis. Meanwhile, pathways associated with inflammatory regulation were inhibited, predominantly via the activation of phosphorylated-AKT (p-AKT) and suppression of HIF-1 alpha in both tissues, and via JNK in the perirenal fat and p38MAPK in the liver. Furthermore, detraining activated NF-kappa B expression in both tissues and induced the upregulation of serum high-sensitivity C-reactive protein (hsCRP) levels. Collectively, lifelong exercise was found to exert beneficial effects by ameliorating age-related alterations in mitochondrial function, SASP-associated inflammation, and lipolysis in perirenal fat and liver tissues, potentially inhibiting inflammation via the JNK and p38 MAPK pathways, respectively, as well as the HIF-1 alpha and AKT pathways in both tissues. In contrast, detraining induced high levels of circulating hsCRP by activating the NF-kappa B signaling pathway in both tissues.	[Sun, Lei; Li, Fang-Hui; Han, Chong; Wang, Zhuang-Zhi; Gao, Ke-Ke; Qiao, Yi-Bo; Ma, Song; Xie, Tian; Wang, Jing] Nanjing Normal Univ, Sch Sport Sci, Nanjing, Peoples R China	Nanjing Normal University	Li, FH (corresponding author), Nanjing Normal Univ, Coll Sports Sci, 1 Wenyuan Rd Qixia Dist, Nanjing 210023, Peoples R China.	12356@njnu.edu.cn		Sun, Lei/0000-0002-3444-3251	National Natural Science Foundation of China [31971099]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX21_1313]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postgraduate Research & Practice Innovation Program of Jiangsu Province	This work was supported by the National Natural Science Foundation of China [grant no. 31971099] and the Postgraduate Research & Practice Innovation Program of Jiangsu Province [grant no. KYCX21_1313]	Aguiar SS, 2020, EXP GERONTOL, V130, DOI 10.1016/j.exger.2019.110806; Austad SN, 2016, CELL METAB, V23, P1022, DOI 10.1016/j.cmet.2016.05.019; Briken S, 2016, J NEUROIMMUNOL, V299, P53, DOI 10.1016/j.jneuroim.2016.08.007; Camell CD, 2017, NATURE, V550, P119, DOI 10.1038/nature24022; Chapman J, 2019, FEBS LETT, V593, P1566, DOI 10.1002/1873-3468.13498; Chen HT, 2018, EXP GERONTOL, V112, P112, DOI 10.1016/j.exger.2018.09.015; Chen SY, 2006, INT J OBESITY, V30, P40, DOI 10.1038/sj.ijo.0803073; Cunha TF, 2017, J APPL PHYSIOL, V122, P817, DOI 10.1152/japplphysiol.00182.2016; Teixeira AAD, 2020, LIFE SCI, V261, DOI 10.1016/j.lfs.2020.118453; Demine S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080795; Dong M, 2013, CELL METAB, V18, P118, DOI 10.1016/j.cmet.2013.06.003; Finelli C, 2013, AGEING RES REV, V12, P996, DOI 10.1016/j.arr.2013.05.007; Ghosh AK, 2019, J GERONTOL A-BIOL, V74, P1709, DOI 10.1093/gerona/gly290; Gonzalez-Rodriguez A, 2012, AGING CELL, V11, P284, DOI 10.1111/j.1474-9726.2011.00786.x; Guan RJ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00263; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Huda N, 2019, WORLD J GASTROENTERO, V25, P5069, DOI 10.3748/wjg.v25.i34.5069; Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021; Johnson ML, 2010, J APPL PHYSIOL, V109, P1573, DOI 10.1152/japplphysiol.00116.2010; Kang EB, 2013, APOPTOSIS, V18, P1332, DOI 10.1007/s10495-013-0884-9; Koelman L, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123636; Lana A, 2016, AGE AGEING, V45, P819, DOI 10.1093/ageing/afw142; Lavin KM, 2020, J APPL PHYSIOL, V128, P87, DOI 10.1152/japplphysiol.00495.2019; Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012; Li FH, 2018, EXP GERONTOL, V113, P150, DOI 10.1016/j.exger.2018.10.006; Lin JY, 2020, AGING-US, V12, P6852, DOI 10.18632/aging.103046; Mennes E, 2014, J GERONTOL A-BIOL, V69, P1060, DOI 10.1093/gerona/glt156; Mujika I, 2000, SPORTS MED, V30, P79, DOI 10.2165/00007256-200030020-00002; Nilsson MI, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210863; Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691; Pereira DS, 2013, AGE, V35, P2455, DOI 10.1007/s11357-013-9515-1; PETERSON PK, 1994, CLIN INFECT DIS, V19, P1158, DOI 10.1093/clinids/19.6.1158; Ponti F, 2020, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00861; Ranallo RF, 1998, SPORTS MED, V26, P29, DOI 10.2165/00007256-199826010-00003; Rius-Perez S, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/1452696; Rosety-Rodriguez M, 2014, J INTELL DISABIL RES, V58, P874, DOI 10.1111/jir.12096; Schafer MJ, 2016, DIABETES, V65, P1606, DOI 10.2337/db15-0291; Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y; Schulze-Osthoff K, 2017, FEBS J, V284, P4196, DOI 10.1111/febs.14330; Seco J, 2013, REHABIL NURS, V38, P37, DOI 10.1002/rnj.64; Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128; Rojas JXS, 2016, J GERONTOL A-BIOL, V71, P310, DOI 10.1093/gerona/glv117; Snodgrass RG, 2016, J BIOL CHEM, V291, P413, DOI 10.1074/jbc.M115.686709; Soro-Arnaiz I, 2016, CELL REP, V16, P2991, DOI 10.1016/j.celrep.2016.08.041; Sternfeld B, 2002, AM J EPIDEMIOL, V156, P110, DOI 10.1093/aje/kwf023; Tang Y, 2017, CLIN EXP PHARMACOL P, V44, P9, DOI 10.1111/1440-1681.12758; Teich T, 2017, J APPL PHYSIOL, V123, P1625, DOI 10.1152/japplphysiol.01115.2016; Thompson D, 2010, J APPL PHYSIOL, V108, P769, DOI 10.1152/japplphysiol.00822.2009; Vina J, 2016, J PHYSIOL-LONDON, V594, P1989, DOI 10.1113/JP270536; Wang GX, 2017, SCI REP-UK, V7, DOI 10.1038/srep45006; Wang T, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9029327; Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011; You TJ, 2007, J GERONTOL A-BIOL, V62, P1082, DOI 10.1093/gerona/62.10.1082; Young DG, 1999, CLIN EXP IMMUNOL, V117, P476; Yu ZP, 2020, MOL MED REP, V22, P1351, DOI 10.3892/mmr.2020.11207; Zhao Y, 2020, LIFE SCI, V251, DOI 10.1016/j.lfs.2020.117603	56	1	1	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21890	10.1096/fj.202100868R	http://dx.doi.org/10.1096/fj.202100868R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34460990				2022-12-28	WOS:000702238200065
J	Koekkoek, LL; Slomp, M; Castel, J; Mutersbaugh, M; Linville, I; Serlie, MJ; Luquet, SH; la Fleur, SE				Koekkoek, Laura L.; Slomp, Margo; Castel, Julien; Mutersbaugh, Michael; Linville, Ian; Serlie, Mireille J.; Luquet, Serge H.; la Fleur, Susanne E.			Disruption of lateral hypothalamic calorie detection by a free choice high fat diet	FASEB JOURNAL			English	Article						calorie detection; glutamate; hypothalamus; low-calorie sweetener; two-photon microscopy	GLUCOSE TRANSPORTERS; FLAVOR PREFERENCES; OREXIN NEURONS; INDUCED OBESE; TASTE; DOPAMINE; RESPONSES; REWARD	During the last few decades, the consumption of low-calorie sweeteners, as a substitute for caloric sweeteners, has sharply increased. Although research shows that caloric versus low-calorie sweeteners can have differential effects on the brain, it is unknown which neuronal populations are responsible for detecting the difference between the two types of sweeteners. Using in vivo two-photon calcium imaging, we investigated how drinking sucrose or sucralose (a low-calorie sweetener) affects the activity of glutamatergic neurons in the lateral hypothalamus. Furthermore, we explored the consequences of consuming a free-choice high fat diet on the calorie detection abilities of these glutamatergic neurons. We found that glutamatergic neurons indeed can discriminate sucrose from water and sucralose, and that consumption of a free-choice high fat diet shifts the glutamatergic neuronal response from sucrose-specific to sucralose-specific, thereby disrupting calorie detection. These results highlight the disruptive effects of a diet high in saturated fat on calorie detection in the lateral hypothalamus.	[Koekkoek, Laura L.; Slomp, Margo; la Fleur, Susanne E.] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Clin Chem,Locat AMC, Lab Endocrinol,Amsterdam Neurosci,Amsterdam Gastr, Amsterdam, Netherlands; [Koekkoek, Laura L.; Slomp, Margo; Serlie, Mireille J.; la Fleur, Susanne E.] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Endocrinol & Metab,Locat AMC, Amsterdam Neurosci,Amsterdam Gastroenterol Endocr, Amsterdam, Netherlands; [Koekkoek, Laura L.; Slomp, Margo; la Fleur, Susanne E.] Netherlands Inst Neurosci, Metab & Reward Grp, Amsterdam, Netherlands; [Castel, Julien; Luquet, Serge H.] Univ Paris, CNRS, BFA, UMR 8251, Paris, France; [Mutersbaugh, Michael; Linville, Ian] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University of Virginia	la Fleur, SE (corresponding author), Univ Amsterdam, Dept Endocrinol & Metab, Amsterdam UMC, Meibergdreef 9,K2-283, NL-1105 AZ Amsterdam, Netherlands.	s.e.lafleur@amsterdamumc.nl		luquet, serge/0000-0001-8668-6645; CASTEL, JULIEN/0000-0003-4309-701X	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) [016.160.617]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO))	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), Grant/Award Number: 016.160.617	Berland C, 2020, CELL METAB, V31, P773, DOI 10.1016/j.cmet.2020.02.010; BIRCH LL, 1990, PHYSIOL BEHAV, V47, P501, DOI 10.1016/0031-9384(90)90116-L; Bonacchi KB, 2008, PHYSIOL BEHAV, V95, P235, DOI 10.1016/j.physbeh.2008.06.006; Burdakov D, 2005, J NEUROSCI, V25, P2429, DOI 10.1523/JNEUROSCI.4925-04.2005; Domingos AI, 2013, ELIFE, V2, DOI 10.7554/eLife.01462; Domingos AI, 2011, NAT NEUROSCI, V14, P1562, DOI 10.1038/nn.2977; Fowler SPG, 2016, PHYSIOL BEHAV, V164, P517, DOI 10.1016/j.physbeh.2016.04.047; Frank GKW, 2008, NEUROIMAGE, V39, P1559, DOI 10.1016/j.neuroimage.2007.10.061; Fu O, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12478-x; Gonzalez JA, 2016, CURR BIOL, V26, P2486, DOI 10.1016/j.cub.2016.07.013; Gonzalez JA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11395; Kadohisa M, 2005, CHEM SENSES, V30, P401, DOI 10.1093/chemse/bji036; Li JX, 2013, J NEUROSCI, V33, P9462, DOI 10.1523/JNEUROSCI.3935-12.2013; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Mediavilla C, 2011, PHARMACOL BIOCHEM BE, V98, P385, DOI 10.1016/j.pbb.2011.01.021; Merigo F, 2011, J ANAT, V219, P243, DOI 10.1111/j.1469-7580.2011.01385.x; Mickelsen LE, 2019, NAT NEUROSCI, V22, P642, DOI 10.1038/s41593-019-0349-8; Miller PE, 2014, AM J CLIN NUTR, V100, P765, DOI 10.3945/ajcn.113.082826; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Nieh EH, 2016, NEURON, V90, P1286, DOI 10.1016/j.neuron.2016.04.035; NORGREN R, 1970, BRAIN RES, V21, P63, DOI 10.1016/0006-8993(70)90021-1; OOMURA Y, 1975, PHYSIOL BEHAV, V14, P483, DOI 10.1016/0031-9384(75)90015-3; Pnevmatikakis EA, 2017, J NEUROSCI METH, V291, P83, DOI 10.1016/j.jneumeth.2017.07.031; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Rossi MA, 2019, SCIENCE, V364, P1271, DOI 10.1126/science.aax1184; Sanchez-Tapia M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040880; Sclafani A, 2015, CHEM SENSES, V40, P245, DOI 10.1093/chemse/bjv002; Sclafani A, 2011, PHYSIOL BEHAV, V104, P64, DOI 10.1016/j.physbeh.2011.04.039; Toyono T, 2011, CELL TISSUE RES, V345, P243, DOI 10.1007/s00441-011-1210-x; van Opstal AM, 2019, NUTRITION, V60, P80, DOI 10.1016/j.nut.2018.09.004; Van Opstal AM, 2021, NUTR NEUROSCI, V24, P395, DOI 10.1080/1028415X.2019.1639306; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Xin XG, 2000, BRAIN RES BULL, V52, P235, DOI 10.1016/S0361-9230(00)00228-8; YAMAMOTO T, 1989, BRAIN RES, V481, P286, DOI 10.1016/0006-8993(89)90805-6; Yee KK, 2011, P NATL ACAD SCI USA, V108, P5431, DOI 10.1073/pnas.1100495108; Zhang XJ, 2013, PEPTIDES, V47, P115, DOI 10.1016/j.peptides.2013.07.015	36	0	0	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21804	10.1096/fj.202100762R	http://dx.doi.org/10.1096/fj.202100762R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34383974	Green Published			2022-12-28	WOS:000691122900011
J	Li, GD; Lv, DY; Yao, YJ; Wu, H; Wang, J; Deng, SL; Song, YK; Guan, SY; Wang, LK; Ma, WK; Yang, H; Yan, LQ; Zhang, JL; Ji, PY; Zhang, L; Lian, ZX; Liu, GS				Li, Guangdong; Lv, Dongying; Yao, Yujun; Wu, Hao; Wang, Jing; Deng, Shoulong; Song, Yukun; Guan, Shengyu; Wang, Likai; Ma, Wenkui; Yang, Hai; Yan, Laiqing; Zhang, Jinlong; Ji, Pengyun; Zhang, Lu; Lian, Zhengxing; Liu, Guoshi			Overexpression of ASMT likely enhances the resistance of transgenic sheep to brucellosis by influencing immune-related signaling pathways and gut microbiota	FASEB JOURNAL			English	Article						ASMT; brucellosis; immunity; melatonin; sheep	MELATONIN; SYSTEM; HEALTH	Melatonin is a pleiotropic molecule with a variety of biological functions, which include its immunoregulatory action in mammals. Brucellosis is a worldwide endemic zoonotic disease caused by the Brucella, which not only causes huge economic losses for the livestock industry but also impacts human health. To target this problem, in current study, two marker-free transgenic sheep overexpressing melatonin synthetic enzyme ASMT (acetylserotonin O-methyltransferase) gene were generated and these melatonin enrich transgenic sheep were challenged by Brucella infection. The results showed that the serum melatonin concentration was significantly higher in transgenic sheep than that of wild type (726.92 +/- 70.6074 vs 263.10 +/- 34.60 pg/mL, P < .05). Brucella challenge test showed that two thirds (4/6) of the wild-type sheep had brucellosis, while none of the transgenic sheep were infected. Whole-blood RNA-seq results showed that differential expression genes (DEGs) were significantly enriched in natural killer cell-mediated cytotoxicity, phagosome, antigen processing, and presentation signaling pathways in overexpression sheep. The DEGs of toll-like receptors (TLRs) and NOD-like receptors (NLRs) families were verified by qPCR and it showed that TLR1, TLR2, TLR7, CD14, NAIP, and CXCL8 expression levels in overexpression sheep were significantly higher and NLRP1, NLRP3, and TNF expression levels were significantly lower than those of wild type. The rectal feces were subjected to 16S rDNA amplicon sequencing, and the microbial functional analysis showed that the transgenic sheep had significantly lower abundance of microbial genes related to infectious diseases compared to the wild type, indicating overexpression animals are likely more resistant to infectious diseases than wild type. Furthermore, exogenous melatonin treatment relieved brucellosis inflammation by upregulating anti-inflammatory cytokines IL-4 and downregulating pro-inflammatory IL-2, IL-6, and IFN-gamma. Our preliminary results provide an informative reference for the study of the relationship between melatonin and brucellosis.	[Li, Guangdong; Lv, Dongying; Yao, Yujun; Wu, Hao; Wang, Jing; Song, Yukun; Guan, Shengyu; Wang, Likai; Ma, Wenkui; Yang, Hai; Yan, Laiqing; Ji, Pengyun; Zhang, Lu; Lian, Zhengxing; Liu, Guoshi] China Agr Univ, Coll Anim Sci & Technol, Beijing Key Lab Anim Genet Improvement, Natl Engn Lab Anim Breeding,Key Lab Anim Genet &, Beijing 100193, Peoples R China; [Deng, Shoulong] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Deng, Shoulong] Peking Union Med Coll, Chinese Acad Med Sci & Comparat Med Ctr, Inst Lab Anim Sci, Beijing, Peoples R China; [Zhang, Jinlong] Tianjin Acad Agr Sci, Tianjin Inst Anim Sci, Tianjin, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, GS (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Beijing Key Lab Anim Genet Improvement, Natl Engn Lab Anim Breeding,Key Lab Anim Genet &, Beijing 100193, Peoples R China.	gshliu@cau.edu.cn	Deng, Shou-Long/GWV-0452-2022; Song, Yukun/GZK-5353-2022; deng, shoulong/GWV-0293-2022	Li, Guangdong/0000-0003-3102-3929	National Science and Technology Major Project of China [2016ZX08008003, 2018ZX08008001B]; National Natural Science Foundation of China [31830091]	National Science and Technology Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by funds from the National Science and Technology Major Project of China (2016ZX08008003, 2018ZX08008001B), National Natural Science Foundation of China (31830091)	Akbulut H, 2007, Indian J Med Microbiol, V25, P387; ARENDT J, 1988, CLIN ENDOCRINOL, V29, P205, DOI 10.1111/j.1365-2265.1988.tb00263.x; Arendt J, 2006, CHRONOBIOL INT, V23, P21, DOI 10.1080/07420520500464361; Arioz BI, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01511; Baldi Pablo C, 2013, Recent Pat Antiinfect Drug Discov, V8, P18; Frungieri MB, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061170; Butler TD, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01783; Campos PC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00028; Clavel T, 2017, IMMUNOL REV, V279, P8, DOI 10.1111/imr.12578; Cruz-Chamorro I, 2019, MOL METAB, V28, P83, DOI 10.1016/j.molmet.2019.07.007; Culbertson MS, 2017, ANIM PROD SCI, V57, P2366, DOI 10.1071/AN17317; do Amaral FG, 2018, ARCH ENDOCRIN METAB, V62, P472, DOI 10.20945/2359-3997000000066; Dolasia K, 2018, INT REV IMMUNOL, V37, P3, DOI 10.1080/08830185.2017.1397656; El-Sayed A, 2018, INT J VET SCI MED, V6, pS31, DOI 10.1016/j.ijvsm.2018.01.008; Favero G, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/1835195; Franc KA, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-5016-y; Gao J, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00013; Gomes MTR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00130; Guo X., 2020, J BIOL RES THESSALON, V27, P1; Hardeland R, 2006, INT J BIOCHEM CELL B, V38, P313, DOI 10.1016/j.biocel.2005.08.020; Hardeland R, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12525; Hou HH, 2019, VACCINE, V37, P3981, DOI 10.1016/j.vaccine.2019.05.084; Hull Noah C., 2018, Infection Ecology & Epidemiology, V8, P1500846, DOI 10.1080/20008686.2018.1500846; Kennaway David J., 2002, Current Topics in Medicinal Chemistry, V2, P199, DOI 10.2174/1568026023394380; Kuklina EM, 2014, MED HYPOTHESES, V83, P404, DOI 10.1016/j.mehy.2014.07.006; Lapaque N, 2009, MICROB PATHOGENESIS, V47, P299, DOI 10.1016/j.micpath.2009.09.005; Li Yan, 2016, Journal of Animal Science and Biotechnology, V7; Liu QJ, 2020, REDOX BIOL, V34, DOI 10.1016/j.redox.2020.101560; Ma N, 2020, MED RES REV, V40, P606, DOI 10.1002/med.21628; Makki K, 2018, CELL HOST MICROBE, V23, P705, DOI 10.1016/j.chom.2018.05.012; Marim FM, 2017, SEMIN IMMUNOPATHOL, V39, P215, DOI 10.1007/s00281-016-0581-1; Maslowski KM, 2019, CLIN EXP IMMUNOL, V197, P193, DOI 10.1111/cei.13329; Mauriz JL, 2013, J PINEAL RES, V54, P1, DOI 10.1111/j.1600-079X.2012.01014.x; Mbah D. A., 2020, Journal of the Cameroon Academy of Sciences, V15, P163; Moradkhani F, 2020, J CELL PHYSIOL, V235, P745, DOI 10.1002/jcp.29036; Mortezaee K, 2019, LIFE SCI, V238, DOI 10.1016/j.lfs.2019.116960; Nabavi SM, 2019, CRIT REV FOOD SCI, V59, pS4, DOI 10.1080/10408398.2018.1487927; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Pal P.K., 2019, MELATONIN RES, V2, P158, DOI [10.32794/mr11250027, DOI 10.32794/MR11250027]; Priyanka, 2021, BIOL RHYTHM RES, V52, P1031, DOI 10.1080/09291016.2019.1613794; Rahdar HA, 2018, MICROB PATHOGENESIS, V118, P247, DOI 10.1016/j.micpath.2018.03.034; Rastelli M, 2018, OBESITY, V26, P792, DOI 10.1002/oby.22175; Reiter RJ, 2000, ANN NY ACAD SCI, V917, P376; Rong B., 2020, MELATONIN RES, V3, P58, DOI [10.32794/mr11250048, DOI 10.32794/MR11250048]; Shi L, 2013, CURR MED CHEM, V20, P2017, DOI 10.2174/09298673113209990114; Silveira TN, 2017, EUR J IMMUNOL, V47, P51, DOI 10.1002/eji.201646502; Slominski AT, 2017, EXP DERMATOL, V26, P563, DOI 10.1111/exd.13208; Srinivasan V, 2009, GYNECOL ENDOCRINOL, V25, P779, DOI 10.3109/09513590903159649; Tamtaji OR, 2019, J CELL PHYSIOL, V234, P7788, DOI 10.1002/jcp.27698; Tamura H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031135; Tuon FF, 2017, TROP MED INT HEALTH, V22, P539, DOI 10.1111/tmi.12856; Van Eenennaam AL, 2017, CURR OPIN BIOTECH, V44, P27, DOI 10.1016/j.copbio.2016.10.007; Wang B, 2019, J CELL PHYSIOL, V234, P1008, DOI 10.1002/jcp.27090; Yahaya SM., 2016, MALAYS J VET RES, V7, P59; Yin J, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12524; Yoo YM, 2016, J BIOMED RES, V30, P314, DOI 10.7555/JBR.30.2016K0010	57	3	3	3	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21783	10.1096/fj.202100651R	http://dx.doi.org/10.1096/fj.202100651R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34403510				2022-12-28	WOS:000691122900045
J	Liu, B; Zhou, YB				Liu, Bin; Zhou, Yingbi			Endothelium-dependent contraction: The non-classical action of endothelial prostacyclin, its underlying mechanisms, and implications	FASEB JOURNAL			English	Article						EDCF; endothelial COX; EP3; IP; PGI(2); TP	SPONTANEOUSLY HYPERTENSIVE-RATS; HIGH-FAT DIET; ARACHIDONIC-ACID; THROMBOXANE A(2); PROSTANOID RECEPTORS; VASOCONSTRICTOR RESPONSES; CYCLOOXYGENASE PATHWAY; VASCULAR DYSFUNCTION; RESISTANCE ARTERIES; TYROSINE NITRATION	Although commonly thought to produce prostacyclin (prostaglandin I-2; PGI(2)) that evokes vasodilatation and protects vessels from the development of diseases, the endothelial cyclooxygenase (COX)-mediated metabolism has also been found to release substance(s) called endothelium-derived contracting factor(s) (EDCF) that causes endothelium-dependent contraction and implicates in endothelial dysfunction of disease conditions. Various mechanisms have been proposed for the process; however, the major endothelial COX metabolite PGI(2), which has been classically considered to activate the I prostanoid receptor (IP) that mediates vasodilatation and opposes the effects of thromboxane (Tx) A(2) produced by COX in platelets, emerges as a major EDCF in health and disease conditions. Our recent studies from genetically altered mice further suggest that vasomotor reactions to PGI(2) are collectively modulated by IP, the vasoconstrictor Tx-prostanoid receptor (TP; the prototype receptor of TxA(2)) and E prostanoid receptor-3 (EP3; a vasoconstrictor receptor of PGE(2)) although with differences in potency and efficacy; a contraction to PGI(2) reflects activities of TP and/or EP3 outweighing that of the concurrently activated IP. Here, we discuss the history of endothelium-dependent contraction, evidences that support the above hypothesis, proposed mechanisms for the varied reactions to endothelial PGI(2) synthesis as well as the relation of its dilator activity to the effect of another NO-independent vasodilator mechanism, the endothelium-derived hyperpolarizing factor. Also, we address the possible pathological and therapeutic implications as well as questions remaining to be resolved or limitations of our above findings obtained from genetically altered mouse models.	[Liu, Bin; Zhou, Yingbi] Shantou Univ, Cardiovasc Res Ctr, Med Coll, 22 Xin Ling Rd, Shantou 515041, Peoples R China	Shantou University	Zhou, YB (corresponding author), Shantou Univ, Cardiovasc Res Ctr, Med Coll, 22 Xin Ling Rd, Shantou 515041, Peoples R China.	yz_sumc@163.com			National Natural Science Foundation of China (NSFC) [31771272, 81970433, 81770678, 82070506]; Natural Science Foundation of Guangdong Province [2019A1515011650]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31771272, 81970433, 81770678 and 82070506; Natural Science Foundation of Guangdong Province, Grant/Award Number: 2019A1515011650	Ahmetaj-Shala B, 2015, CIRCULATION, V131, P633, DOI 10.1161/CIRCULATIONAHA.114.011591; Asirvatham-Jeyaraj N, 2013, AM J PHYSIOL-HEART C, V305, pH1462, DOI 10.1152/ajpheart.00245.2013; AUCHSCHWELK W, 1989, HYPERTENSION, V13, P859, DOI 10.1161/01.HYP.13.6.859; Babaev VR, 2006, CIRCULATION, V113, P108, DOI 10.1161/CIRCULATIONAHA.105.591537; Baretella O, 2016, ADV PHARMACOL, V77, P177, DOI 10.1016/bs.apha.2016.04.006; BAXTER GS, 1995, BRIT J PHARMACOL, V116, P1692, DOI 10.1111/j.1476-5381.1995.tb16393.x; Behm DJ, 2009, J PHARMACOL EXP THER, V328, P231, DOI 10.1124/jpet.108.145102; Benyahia C, 2013, PROSTAG OTH LIPID M, V107, P48, DOI 10.1016/j.prostaglandins.2013.07.001; Blanco-Rivero J, 2005, HYPERTENSION, V46, P107, DOI 10.1161/01.HYP.0000171479.36880.17; BORDA ES, 1983, ARCH INT PHARMACOD T, V261, P79; BUNTING S, 1976, PROSTAG OTH LIPID M, V12, P897, DOI 10.1016/0090-6980(76)90125-8; Cai JY, 2020, EUR J PHARMACOL, V882, DOI 10.1016/j.ejphar.2020.173254; Chen LH, 2012, ARTERIOSCL THROM VAS, V32, P3024, DOI 10.1161/ATVBAHA.112.254052; Chenevard R, 2003, CIRCULATION, V107, P405, DOI 10.1161/01.CIR.0000051361.69808.3A; Cosentino F, 2003, CIRCULATION, V107, P1017, DOI 10.1161/01.CIR.0000051367.92927.07; Crescente M, 2019, BRIT J PHARMACOL, V176, P988, DOI 10.1111/bph.14196; Cyrus T, 2007, BLOOD, V109, P3291, DOI 10.1182/blood-2006-08-044990; DAI FX, 1992, HYPERTENSION, V19, P795, DOI 10.1161/01.HYP.19.6.795; Davidge ST, 2001, CIRC RES, V89, P650, DOI 10.1161/hh2001.098351; DEMEY JG, 1982, J PHARMACOL EXP THER, V222, P166; DEMEY JG, 1982, CIRC RES, V51, P439, DOI 10.1161/01.RES.51.4.439; DUSTING GJ, 1977, EUR J PHARMACOL, V45, P301, DOI 10.1016/0014-2999(77)90014-0; Ellis E, 2003, BRIT J PHARMACOL, V140, P1193, DOI 10.1038/sj.bjp.0705549; Elmhurst JL, 1997, J PHARMACOL EXP THER, V282, P1198; Eskildsen MP, 2014, HYPERTENSION, V64, P551, DOI 10.1161/HYPERTENSIONAHA.113.03051; Fairbrother SE, 2011, NEUROGASTROENT MOTIL, V23, P782, DOI 10.1111/j.1365-2982.2011.01727.x; Farb MG, 2014, OBESITY, V22, P349, DOI 10.1002/oby.20505; Feletou M, 2009, CLIN SCI, V117, P139, DOI 10.1042/CS20090096; Feletou M, 2009, BRIT J PHARMACOL, V156, P563, DOI 10.1111/j.1476-5381.2008.00060.x; Feng XQ, 2020, BIOL REPROD, V103, P1229, DOI 10.1093/biolre/ioaa156; FITZGERALD GA, 1984, NEW ENGL J MED, V310, P1065, DOI 10.1056/NEJM198404263101701; Francois H, 2004, HYPERTENSION, V43, P364, DOI 10.1161/01.HYP.0000112225.27560.24; Fransen P, 2008, PFLUG ARCH EUR J PHY, V455, P811, DOI 10.1007/s00424-007-0337-9; Gao YJ, 2005, BRIT J PHARMACOL, V146, P1061, DOI 10.1038/sj.bjp.0706423; Gauthier KM, 2011, AM J PHYSIOL-HEART C, V300, pH725, DOI 10.1152/ajpheart.00696.2009; Gendron ME, 2007, AM J PHYSIOL-HEART C, V293, pH2508, DOI 10.1152/ajpheart.00352.2007; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; Gross S, 2007, J EXP MED, V204, P311, DOI 10.1084/jem.20061617; Hassouneh R, 2016, DIABETOLOGIA, V59, P1318, DOI 10.1007/s00125-016-3916-5; HECKER M, 1989, J BIOL CHEM, V264, P141; Hellsten Y, 2012, J PHYSIOL-LONDON, V590, P6297, DOI 10.1113/jphysiol.2012.240762; Hoenicka M, 2011, ANN THORAC SURG, V92, P1299, DOI 10.1016/j.athoracsur.2011.05.114; Hu CJ, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01247; Hu CJ, 2018, EUR J PHARMACOL, V836, P11, DOI 10.1016/j.ejphar.2018.08.012; Ihara E, 2000, BRIT J PHARMACOL, V129, P943, DOI 10.1038/sj.bjp.0703141; Ihara E, 1999, BRIT J PHARMACOL, V128, P689, DOI 10.1038/sj.bjp.0702821; JAMESON M, 1993, HYPERTENSION, V21, P280, DOI 10.1161/01.HYP.21.3.280; Janssen LJ, 2002, J PHARMACOL EXP THER, V301, P1060, DOI 10.1124/jpet.301.3.1060; Kashiwagi H, 2019, THROMB HAEMOSTASIS, V119, P1311, DOI 10.1055/s-0039-1688906; KATUSIC ZS, 1988, STROKE, V19, P476, DOI 10.1161/01.STR.19.4.476; KATUSIC ZS, 1991, HYPERTENSION, V18, pS86; KATUSIC ZS, 1989, AM J PHYSIOL, V257, pH33, DOI 10.1152/ajpheart.1989.257.1.H33; Kawano H, 2005, INTERNAL MED, V44, P91, DOI 10.2169/internalmedicine.44.91; Kirkby NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069524; Kirkby NS, 2012, P NATL ACAD SCI USA, V109, P17597, DOI 10.1073/pnas.1209192109; Kobayashi T, 2004, J CLIN INVEST, V114, P784, DOI 10.1172/JCI200421446; KOGA T, 1989, HYPERTENSION, V14, P542, DOI 10.1161/01.HYP.14.5.542; LEVY JV, 1980, PROSTAG OTH LIPID M, V19, P517, DOI 10.1016/S0090-6980(80)80002-5; LEVY JV, 1978, PROSTAG OTH LIPID M, V16, P93, DOI 10.1016/0090-6980(78)90205-8; Li SS, 2016, CLIN EXP PHARMACOL P, V43, P67, DOI 10.1111/1440-1681.12501; Li ZH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42167; Liu B, 2020, FASEB J, V34, P16105, DOI 10.1096/fj.202000845RR; Liu B, 2020, FASEB J, V34, P2568, DOI 10.1096/fj.201901611R; Liu B, 2019, FASEB J, V33, P2451, DOI 10.1096/fj.201801064RR; Liu B, 2017, EUR J PHARMACOL, V813, P140, DOI 10.1016/j.ejphar.2017.08.015; Liu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09288-w; Liu B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136738; Liu B, 2014, EXP PHYSIOL, V99, P1, DOI 10.1113/expphysiol.2013.076653; Liu B, 2013, AM J PHYSIOL-RENAL, V305, pF1315, DOI 10.1152/ajprenal.00332.2013; Liu B, 2012, EXP PHYSIOL, V97, P895, DOI 10.1113/expphysiol.2011.063784; Liu B, 2012, AM J PHYSIOL-RENAL, V302, pF1133, DOI 10.1152/ajprenal.00604.2011; Liu B, 2012, EXP PHYSIOL, V97, P277, DOI 10.1113/expphysiol.2011.062034; Liu DL, 2015, AM J PHYSIOL-HEART C, V309, pH804, DOI 10.1152/ajpheart.00150.2015; Longrois D, 2012, EUR J PHARMACOL, V681, P55, DOI 10.1016/j.ejphar.2012.01.041; LUDMER PL, 1986, NEW ENGL J MED, V315, P1046, DOI 10.1056/NEJM198610233151702; Luo WH, 2016, EUR J PHARMACOL, V780, P148, DOI 10.1016/j.ejphar.2016.03.043; LUSCHER TF, 1986, HYPERTENSION, V8, P344, DOI 10.1161/01.HYP.8.4.344; Martinez-Revelles S, 2013, ANTIOXID REDOX SIGN, V18, P51, DOI 10.1089/ars.2011.4335; Matoba T, 2000, J CLIN INVEST, V106, P1521, DOI 10.1172/JCI10506; Mawhin MA, 2015, PROSTAG OTH LIPID M, V121, P4, DOI 10.1016/j.prostaglandins.2015.10.001; McClelland S, 2009, ATHEROSCLEROSIS, V202, P84, DOI 10.1016/j.atherosclerosis.2008.04.016; MILLER VM, 1985, AM J PHYSIOL, V248, pH432, DOI 10.1152/ajpheart.1985.248.4.H432; Mitchell JA, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf6054; Mitchell JA, 2019, CIRC RES, V125, P847, DOI 10.1161/CIRCRESAHA.119.314927; Morrison K, 2018, J PHARMACOL EXP THER, V365, P727, DOI 10.1124/jpet.117.246058; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; NEEDLEMAN P, 1976, NATURE, V261, P558, DOI 10.1038/261558a0; Noon JP, 1998, CARDIOVASC RES, V38, P480, DOI 10.1016/S0008-6363(98)00013-3; Norel X, 2004, PROSTAG OTH LIPID M, V74, P101, DOI 10.1016/j.prostaglandins.2004.07.003; OKUMURA K, 1988, J AM COLL CARDIOL, V12, P883, DOI 10.1016/0735-1097(88)90449-4; POMERANTZ K, 1978, PROSTAGLANDINS, V15, P1035, DOI 10.1016/0090-6980(78)90046-1; Pratico D, 2001, P NATL ACAD SCI USA, V98, P3358, DOI 10.1073/pnas.061607398; QIAN YM, 1994, BRIT J PHARMACOL, V113, P369, DOI 10.1111/j.1476-5381.1994.tb16997.x; Quilley J, 2003, HYPERTENSION, V42, P837, DOI 10.1161/01.HYP.0000085650.29823.F2; Raees A, 2019, LIFE SCI, V239, DOI 10.1016/j.lfs.2019.117039; Ramos-Alves FE, 2012, BRIT J PHARMACOL, V166, P2198, DOI 10.1111/j.1476-5381.2012.01945.x; Ramos-Alves FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050593; Rapoport RM, 1996, HYPERTENSION, V28, P64, DOI 10.1161/01.HYP.28.1.64; RUBANYI GM, 1985, J PHYSIOL-LONDON, V364, P45, DOI 10.1113/jphysiol.1985.sp015728; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; SCHOR N, 1981, HYPERTENSION, V3, P81, DOI 10.1161/01.HYP.3.6_Pt_2.II-81; Schuurman MJ, 2010, COMP BIOCHEM PHYS A, V157, P28, DOI 10.1016/j.cbpa.2010.05.009; Shi Y, 2007, BRIT J PHARMACOL, V150, P624, DOI 10.1038/sj.bjp.0706999; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; STERINBORDA L, 1982, DIABETOLOGIA, V22, P56, DOI 10.1007/BF00253871; Sueda S, 2015, CLIN CARDIOL, V38, P430, DOI 10.1002/clc.22403; Taddei S, 2003, CURR PHARM DESIGN, V9, P2385, DOI 10.2174/1381612033453866; Tang EHC, 2007, BRIT J PHARMACOL, V151, P15, DOI 10.1038/sj.bjp.0707190; Tazzeo T, 2003, BRIT J PHARMACOL, V140, P759, DOI 10.1038/sj.bjp.0705482; Tian XY, 2012, ANTIOXID REDOX SIGN, V16, P363, DOI 10.1089/ars.2010.3874; Vachiery JL, 2011, ADV THER, V28, P251, DOI 10.1007/s12325-011-0005-5; Vanhoutte PM, 2011, HYPERTENSION, V57, P526, DOI 10.1161/HYPERTENSIONAHA.110.165100; Vanhoutte PM, 2009, CIRC J, V73, P595, DOI 10.1253/circj.CJ-08-1169; Vanhoutte PM, 2005, BRIT J PHARMACOL, V144, P449, DOI 10.1038/sj.bjp.0706042; Versari D, 2009, BRIT J PHARMACOL, V157, P527, DOI 10.1111/j.1476-5381.2009.00240.x; Vessieres E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068217; Waldron GJ, 1999, BRIT J PHARMACOL, V128, P653, DOI 10.1038/sj.bjp.0702858; WILLARD JE, 1992, NEW ENGL J MED, V327, P175; WILLIAMS SP, 1994, AM J PHYSIOL, V267, pH796, DOI 10.1152/ajpheart.1994.267.2.H796; Wong SL, 2009, CIRC RES, V104, P228, DOI 10.1161/CIRCRESAHA.108.179770; Wong WT, 2013, J CARDIOVASC PHARM, V61, P204, DOI 10.1097/FJC.0b013e31827fe46e; Wong WT, 2010, CIRC RES, V107, P984, DOI 10.1161/CIRCRESAHA.110.222794; Xavier FE, 2008, BRIT J PHARMACOL, V154, P1225, DOI 10.1038/bjp.2008.200; Yang D, 2003, HYPERTENSION, V41, P136, DOI 10.1161/01.HYP.0000047669.93078.A7; Yang D, 2002, BRIT J PHARMACOL, V136, P104, DOI 10.1038/sj.bjp.0704669; YANG Z, 1991, CIRC RES, V68, P52, DOI 10.1161/01.RES.68.1.52; YASUE H, 1986, CIRCULATION, V74, P955, DOI 10.1161/01.CIR.74.5.955; Zhang Y., 2020, EUR J PHARMACOL, V893; Zhao YJ, 1996, J APPL PHYSIOL, V81, P2595, DOI 10.1152/jappl.1996.81.6.2595; Zhou YB, 2005, AM J PHYSIOL-HEART C, V289, pH1027, DOI 10.1152/ajpheart.00226.2005; Zhou YB, 2013, EXP PHYSIOL, V98, P1225, DOI 10.1113/expphysiol.2013.072017; Zhu NX, 2014, AM J PHYSIOL-HEART C, V307, pH319, DOI 10.1152/ajpheart.00022.2014; Zhuge X, 2006, BIOCHEM BIOPH RES CO, V351, P865, DOI 10.1016/j.bbrc.2006.10.121; Zou MH, 2002, DIABETES, V51, P198, DOI 10.2337/diabetes.51.1.198; Zou MH, 2007, PROSTAG OTH LIPID M, V82, P119, DOI 10.1016/j.prostaglandins.2006.05.005	135	1	1	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21877	10.1096/fj.202101077R	http://dx.doi.org/10.1096/fj.202101077R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34449098	hybrid			2022-12-28	WOS:000691122900062
J	Mondal, P; Gadad, SS; Adhikari, S; Ramos, EI; Sen, S; Prasad, P; Das, C				Mondal, Payel; Gadad, Shrikanth S.; Adhikari, Swagata; Ramos, Enrique, I; Sen, Sabyasachi; Prasad, Parash; Das, Chandrima			TCF19 and p53 regulate transcription of TIGAR and SCO2 in HCC for mitochondrial energy metabolism and stress adaptation	FASEB JOURNAL			English	Article						epigenetics; glucose-mediated stress; metabolism; mitochondrial energy homeostasis; transcription	PENTOSE-PHOSPHATE PATHWAY; TUMOR-SUPPRESSOR; OXIDATIVE STRESS; PROTECTS GLIOMA; CANCER-CELLS; IN-VIVO; GLYCOLYSIS; GENE; HEXOKINASE; APOPTOSIS	Alteration in glucose homeostasis during cancer metabolism is an important phenomenon. Though several important transcription factors have been well studied in the context of the regulation of metabolic gene expression, the role of epigenetic readers in this regard remains still elusive. Epigenetic reader protein transcription factor 19 (TCF19) has been recently identified as a novel glucose and insulin-responsive factor that modulates histone posttranslational modifications to regulate glucose homeostasis in hepatocytes. Here we report that TCF19 interacts with a non-histone, well-known tumor suppressor protein 53 (p53) and co-regulates a wide array of metabolic genes. Among these, the p53-responsive carbohydrate metabolic genes Tp53-induced glycolysis and apoptosis regulator (TIGAR) and Cytochrome C Oxidase assembly protein 2 (SCO2), which are the key regulators of glycolysis and oxidative phosphorylation respectively, are under direct regulation of TCF19. Remarkably, TCF19 can form different transcription activation/repression complexes which show substantial overlap with that of p53, depending on glucose-mediated variant stress situations as obtained from IP/MS studies. Interestingly, we observed that TCF19/p53 complexes either have CBP or HDAC1 to epigenetically program the expression of TIGAR and SCO2 genes depending on short-term high glucose or prolonged high glucose conditions. TCF19 or p53 knockdown significantly altered the cellular lactate production and led to increased extracellular acidification rate. Similarly, OCR and cellular ATP production were reduced and mitochondrial membrane potential was compromised upon depletion of TCF19 or p53. Subsequently, through RNA-Seq analysis from patients with hepatocellular carcinoma, we observed that TCF19/p53-mediated metabolic regulation is fundamental for sustenance of cancer cells. Together the study proposes that TCF19/p53 complexes can regulate metabolic gene expression programs responsible for mitochondrial energy homeostasis and stress adaptation.	[Mondal, Payel; Adhikari, Swagata; Sen, Sabyasachi; Das, Chandrima] Saha Inst Nucl Phys, Biophys & Struct Genom Div, 1-AF Bidhannagar, Kolkata 700064, India; [Mondal, Payel; Adhikari, Swagata; Das, Chandrima] Homi Bhaba Natl Inst, Dept Life Sci, Mumbai, Maharashtra, India; [Gadad, Shrikanth S.; Ramos, Enrique, I] Texas Tech Univ, Hlth Sci Ctr El Paso, Ctr Emphasis Canc, Dept Mol & Translat Med, El Paso, TX USA; [Prasad, Parash] CSIR Indian Inst Chem Biol, Cell Biol & Physiol Div, Kolkata, India; [Sen, Sabyasachi] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	Saha Institute of Nuclear Physics; Homi Bhabha National Institute; Texas Tech University System; Texas Tech University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of Pennsylvania; Pennsylvania Medicine	Das, C (corresponding author), Saha Inst Nucl Phys, Biophys & Struct Genom Div, 1-AF Bidhannagar, Kolkata 700064, India.	chandrima.das@saha.ac.in		Mondal, Payel/0000-0003-2271-0583; Das, Chandrima/0000-0002-8117-2810; PRASAD, PARASH/0000-0001-6825-3213; Ramos, Enrique/0000-0001-9921-7944	Department of Atomic Energy, Government of India (DAE) [RSI 4002]; DST \ Science and Engineering Research Board (SERB) [CRG/2018/000985]; Department of Science and Technology, Ministry of Science and Technology (DST) [DST/SJF/LSA-02/2017-18]; Department of Biotechnology, Ministry of Science and Technology (DBT) [BT/HRD-NBA-NWB/38/2019-20]; Cancer Prevention and Research Institute of Texas (CPRIT) [RR170020]	Department of Atomic Energy, Government of India (DAE); DST \ Science and Engineering Research Board (SERB); Department of Science and Technology, Ministry of Science and Technology (DST)(Department of Science & Technology (DOST), Philippines); Department of Biotechnology, Ministry of Science and Technology (DBT); Cancer Prevention and Research Institute of Texas (CPRIT)	Department of Atomic Energy, Government of India (DAE), Grant/Award Number: RSI 4002; DST vertical bar Science and Engineering Research Board (SERB), Grant/Award Number: CRG/2018/000985; Department of Science and Technology, Ministry of Science and Technology (DST), Grant/Award Number: DST/SJF/LSA-02/2017-18; Department of Biotechnology, Ministry of Science and Technology (DBT), Grant/Award Number: BT/HRD-NBA-NWB/38/2019-20; Cancer Prevention and Research Institute of Texas (CPRIT), Grant/Award Number: RR170020	Adhikary S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08986-5; Adhikary S, 2016, J BIOL CHEM, V291, P2664, DOI 10.1074/jbc.M115.679985; Baylin SB, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019505; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bhatnagar S, 2014, NATURE, V516, P116, DOI 10.1038/nature13955; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; Cheung EC, 2010, CURR OPIN CELL BIOL, V22, P186, DOI 10.1016/j.ceb.2009.12.006; Chittka A, 1999, P NATL ACAD SCI USA, V96, P10705, DOI 10.1073/pnas.96.19.10705; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Du WB, 2020, EUR REV MED PHARMACO, V24, P655, DOI 10.26355/eurrev_202001_20042; Fack F, 2017, EMBO MOL MED, V9, P1681, DOI 10.15252/emmm.201707729; Fan J, 2015, ACS CHEM BIOL, V10, P95, DOI 10.1021/cb500846u; Floter J, 2017, METABOLITES, V7, DOI 10.3390/metabo7020021; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Green DR, 2006, CELL, V126, P30, DOI 10.1016/j.cell.2006.06.032; Gupte R, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24225-2; Hochachka PW, 1999, P NATL ACAD SCI USA, V96, P12233, DOI 10.1073/pnas.96.22.12233; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iwao C, 2015, BIOMED RES-TOKYO, V36, P371, DOI 10.2220/biomedres.36.371; Jiang P, 2014, PROTEIN CELL, V5, P592, DOI 10.1007/s13238-014-0082-8; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Kalinina EA, 2013, COMPUT METH PROG BIO, V111, P471, DOI 10.1016/j.cmpb.2013.04.001; Kalwat MA, 2018, J GEN PHYSIOL, V150, P1747, DOI 10.1085/jgp.201812177; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kim SH, 2016, PATHOL RES PRACT, V212, P904, DOI 10.1016/j.prp.2016.07.014; Kimata M, 2010, AM J PHYSIOL-HEART C, V299, pH1908, DOI 10.1152/ajpheart.00250.2010; Ko YH, 2016, J BIOL CHEM, V291, P26291, DOI 10.1074/jbc.M116.740209; Krautkramer KA, 2013, AM J PHYSIOL-ENDOC M, V305, pE600, DOI 10.1152/ajpendo.00147.2013; KU DH, 1991, CELL GROWTH DIFFER, V2, P179; Kung CP, 2016, J ENDOCRINOL, V231, pR61, DOI 10.1530/JOE-16-0324; Lee P, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-1; Lee SH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051736; Levine AJ, 2017, GENE DEV, V31, P1195, DOI 10.1101/gad.298984.117; Liu J, 2019, J MOL CELL BIOL, V11, P284, DOI 10.1093/jmcb/mjy070; Ma WZ, 2007, J BIOENERG BIOMEMBR, V39, P243, DOI 10.1007/s10863-007-9083-0; Madan E, 2012, BRIT J CANCER, V107, P516, DOI 10.1038/bjc.2012.260; Madan E, 2013, MOL CELL BIOL, V33, P1285, DOI 10.1128/MCB.06798-11; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mathupala SP, 1997, J BIOL CHEM, V272, P22776, DOI 10.1074/jbc.272.36.22776; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mayers JR, 2014, NAT MED, V20, P1193, DOI 10.1038/nm.3686; Mendoza EE, 2012, TRANSL ONCOL, V5, P208, DOI 10.1593/tlo.11319; Metallo CM, 2013, MOL CELL, V49, P388, DOI 10.1016/j.molcel.2013.01.018; Mondal P, 2020, BIOCHEMISTRY-US, V59, P389, DOI 10.1021/acs.biochem.9b00771; Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868; Ohnishi T, 2020, BIOCHEM J, V477, P1795, DOI 10.1042/BCJ20190888; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Pelletier M, 2014, METHOD ENZYMOL, V542, P125, DOI 10.1016/B978-0-12-416618-9.00007-8; Puzio-Kuter Anna M, 2011, Genes Cancer, V2, P385, DOI 10.1177/1947601911409738; Rivadeneira DB, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1624; Ruiz-Lozano P, 1999, CELL GROWTH DIFFER, V10, P295; Salamanca-Cardona L, 2017, CELL METAB, V26, P830, DOI 10.1016/j.cmet.2017.10.001; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Sen S, 2017, J BIOL CHEM, V292, P20362, DOI 10.1074/jbc.M117.786863; Simmons SO, 2009, TOXICOL SCI, V111, P202, DOI 10.1093/toxsci/kfp140; Smith RL, 2018, ENDOCR REV, V39, P489, DOI 10.1210/er.2017-00211; Stambolsky P, 2006, CELL DEATH DIFFER, V13, P2140, DOI 10.1038/sj.cdd.4401965; Sullivan KD, 2018, CELL DEATH DIFFER, V25, P133, DOI 10.1038/cdd.2017.174; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Wang L, 2014, CELL REP, V8, P1461, DOI 10.1016/j.celrep.2014.07.053; Wang S, 2018, CELL RES, V28, P572, DOI 10.1038/s41422-018-0008-8; Wanka C, 2012, ONCOGENE, V31, P3764, DOI 10.1038/onc.2011.530; Wanka C, 2012, J BIOL CHEM, V287, P33436, DOI 10.1074/jbc.M112.384578; Wawryk-Gawda E, 2014, PROTOPLASMA, V251, P525, DOI 10.1007/s00709-013-0548-1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiersma M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101202; Won KY, 2012, HUM PATHOL, V43, P221, DOI 10.1016/j.humpath.2011.04.021; Zawacka-Pankau J, 2011, J BIOL CHEM, V286, P41600, DOI 10.1074/jbc.M111.240812; Zeng CX, 2019, NEOPLASMA, V66, P46, DOI 10.4149/neo_2018_171227N845; Zhang C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3935; Zhang K, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20160622; Zhou ZH, 2019, CELL BIOL INT, V43, P1416, DOI 10.1002/cbin.11189	75	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21814	10.1096/fj.202002486RR	http://dx.doi.org/10.1096/fj.202002486RR			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34369624				2022-12-28	WOS:000691122900021
J	Belanger, C; Cardinal, T; Leduc, E; Viger, RS; Pilon, N				Belanger, Catherine; Cardinal, Tatiana; Leduc, Elizabeth; Viger, Robert S.; Pilon, Nicolas			CHARGE syndrome-associated proteins FAM172A and CHD7 influence male sex determination and differentiation through transcriptional and alternative splicing mechanisms	FASEB JOURNAL			English	Article						alternative splicing; CHARGE syndrome; CHD7; FAM172A; Sex reversal; transcription	EPIGENETIC REGULATION; GENE-EXPRESSION; SERTOLI-CELLS; MOUSE; MUTATIONS; GATA4; PROLIFERATION; PROMOTER; BINDING; TARGET	To gain further insight into chromatin-mediated regulation of mammalian sex determination, we analyzed the role of the CHARGE syndrome-associated proteins FAM172A and CHD7. This study is based on our prior discoveries that a subset of corresponding mutant mice display complete male-to-female sex reversal, and that both of these proteins regulate co-transcriptional alternative splicing in neural crest cells. Here, we report that FAM172A and CHD7 are present in the developing gonads when sex determination normally occurs in mice. The interactome of FAM172A in pre-Sertoli cells again suggests a role at the chromatin-spliceosome interface, like in neural crest cells. Accordingly, analysis of Fam172a-mutant pre-Sertoli cells revealed transcriptional and splicing dysregulation of hundreds of genes. Many of these genes are similarly affected in Chd7-mutant pre-Sertoli cells, including several known key regulators of sex determination and subsequent formation of testis cords. Among them, we notably identified Sry as a direct transcriptional target and WNT pathway-associated Lef1 and Tcf7l2 as direct splicing targets. The identified molecular defects are also associated with the abnormal morphology of seminiferous tubules in mutant postnatal testes. Altogether, our results thus identify FAM172A and CHD7 as new players in the regulation of male sex determination and differentiation in mice, and further highlight the importance of chromatin-mediated regulatory mechanisms in these processes.	[Belanger, Catherine; Cardinal, Tatiana; Leduc, Elizabeth; Pilon, Nicolas] Univ Quebec Montreal UQAM, Dept Sci Biol, Mol Genet Dev Lab, Montreal, PQ, Canada; [Belanger, Catherine; Cardinal, Tatiana; Leduc, Elizabeth; Pilon, Nicolas] Univ Quebec Montreal, Fdn Courtois CERMO FC, Ctr Excellence Rech Sur Malad Orphelines, Montreal, PQ, Canada; [Viger, Robert S.] Univ Laval, CHU Quebec, Ctr Rech, Ctr Rech Reprod Dev & Sante Intergenerat CRDSI,Re, Quebec City, PQ, Canada; [Viger, Robert S.] Univ Laval, Fac Med, Dept Obstet Gynecol & Reprod, Quebec City, PQ, Canada; [Pilon, Nicolas] Univ Montreal, Dept Pediat, Montreal, PQ, Canada	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal; Laval University; Laval University; Universite de Montreal	Pilon, N (corresponding author), Univ Quebec Montreal, Dept Sci Biol, Fdn Courtois, 141 Ave President Kennedy, Montreal, PQ H2X 3Y7, Canada.; Pilon, N (corresponding author), Univ Quebec Montreal, Ctr Excellence Rech Malad Orphelines, Fdn Courtois, 141 Ave President Kennedy, Montreal, PQ H2X 3Y7, Canada.	pilon.nicolas@uqam.ca			Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) [PJT-152933]	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: PJT-152933	Anderzen-Carlsson A, 2015, J PEDIATR NURS, V30, P6, DOI 10.1016/j.pedn.2014.09.008; Bagheri-Fam S, 2017, ENDOCRINOLOGY, V158, P3832, DOI 10.1210/en.2017-00674; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Balasubramanian R, 2017, AM J MED GENET C, V175, P507, DOI 10.1002/ajmg.c.31585; Bao LS, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0627-7; Batsukh T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052640; Batsukh T, 2010, HUM MOL GENET, V19, P2858, DOI 10.1093/hmg/ddq189; Belanger C, 2018, P NATL ACAD SCI USA, V115, pE620, DOI 10.1073/pnas.1715378115; Bergman JEH, 2008, EUR J MED GENET, V51, P417, DOI 10.1016/j.ejmg.2008.03.003; Bergman JEH, 2010, EUR J HUM GENET, V18, P171, DOI 10.1038/ejhg.2009.158; Berube-Simard FA, 2019, TRANSCR-AUSTIN, V10, P21, DOI 10.1080/21541264.2018.1521213; Capel B, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.60; Cardinal T, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009008; CARLSSON P, 1993, GENE DEV, V7, P2418, DOI 10.1101/gad.7.12a.2418; Chen SR, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.137117; Chen SR, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105379; Chen YS, 2013, P NATL ACAD SCI USA, V110, pE3567, DOI 10.1073/pnas.1300828110; Cool J, 2012, WIRES DEV BIOL, V1, P847, DOI 10.1002/wdev.62; Deveson IW, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700731; Domingos JA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204182; Feng WJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14758; Garcia-Moreno SA, 2018, MOL CELL ENDOCRINOL, V468, P19, DOI 10.1016/j.mce.2018.01.009; Guittot SM, 2007, BIOL REPROD, V76, P85, DOI 10.1095/biolreprod.106.055137; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; Hurd EA, 2007, MAMM GENOME, V18, P94, DOI 10.1007/s00335-006-0107-6; Husu E, 2013, CLIN GENET, V83, P125, DOI 10.1111/j.1399-0004.2012.01884.x; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Jeays-Ward K, 2004, DEV BIOL, V276, P431, DOI 10.1016/j.ydbio.2004.08.049; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; Kalantari R, 2016, NUCLEIC ACIDS RES, V44, P524, DOI 10.1093/nar/gkv1305; Kasah S, 2018, J ANAT, V233, P755, DOI 10.1111/joa.12889; Kim Y, 2007, P NATL ACAD SCI USA, V104, P16558, DOI 10.1073/pnas.0702581104; Kuroki S, 2018, MOL CELL ENDOCRINOL, V468, P31, DOI 10.1016/j.mce.2017.12.006; Kuroki S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007034; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Miyamoto Y, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-44; Miyawaki S, 2020, SCIENCE, V370, P121, DOI 10.1126/science.abb6430; Pierucci-Alves F, 2001, BIOL REPROD, V65, P1392, DOI 10.1095/biolreprod65.5.1392; Pilon N, 2003, BIOL REPROD, V68, P1098, DOI 10.1095/biolreprod.102.010884; Pilon N, 2008, DEV DYNAM, V237, P1133, DOI 10.1002/dvdy.21496; Planells B, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5572-x; Qiu C, 2019, J MOL CELL BIOL, V11, P170, DOI 10.1093/jmcb/mjy029; Ragan DC, 1999, J UROLOGY, V161, P622, DOI 10.1016/S0022-5347(01)61984-0; Rahmoun M, 2017, NUCLEIC ACIDS RES, V45, P7191, DOI 10.1093/nar/gkx328; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Sab AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029038; Sanchez-Ferras O, 2014, BBA-GENE REGUL MECH, V1839, P546, DOI 10.1016/j.bbagrm.2014.04.023; Schmahl J, 2000, DEVELOPMENT, V127, P65; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Shoji Yasuko, 2014, Clin Pediatr Endocrinol, V23, P45, DOI 10.1297/cpe.23.45; Soret R, 2015, J CLIN INVEST, V125, P4483, DOI 10.1172/JCI83178; Stevant I, 2019, TRENDS GENET, V35, P346, DOI 10.1016/j.tig.2019.02.004; Stromland K, 2005, AM J MED GENET A, V133A, P331, DOI 10.1002/ajmg.a.30563; Tanwar PS, 2010, BIOL REPROD, V82, P422, DOI 10.1095/biolreprod.109.079335; Tellier AL, 1998, AM J MED GENET, V76, P402, DOI 10.1002/(SICI)1096-8628(19980413)76:5<402::AID-AJMG7>3.0.CO;2-O; Tevosian SG, 2002, DEVELOPMENT, V129, P4627; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Viger RS, 1998, DEVELOPMENT, V125, P2665; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356; Young RM, 2019, ELIFE, V8, DOI 10.7554/eLife.51447; Zentner GE, 2010, HUM MOL GENET, V19, P3491, DOI 10.1093/hmg/ddq265; Zhao L, 2018, MOL CELL ENDOCRINOL, V478, P84, DOI 10.1016/j.mce.2018.07.010; Zheng ZZ, 2019, RNA BIOL, V16, P809, DOI 10.1080/15476286.2019.1590177	64	0	0	5	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22176	10.1096/fj.202100837RR	http://dx.doi.org/10.1096/fj.202100837RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35129866	hybrid, Green Published			2022-12-28	WOS:000761250800039
J	Jin, M; Zhang, HM; Wu, MX; Wang, Z; Chen, XF; Guo, MY; Zhou, RN; Yang, H; Qian, JM				Jin, Meng; Zhang, Huimin; Wu, Meixu; Wang, Zheng; Chen, Xuanfu; Guo, Mingyue; Zhou, Runing; Yang, Hong; Qian, Jiaming			Colonic interleukin-22 protects intestinal mucosal barrier and microbiota abundance in severe acute pancreatitis	FASEB JOURNAL			English	Article						acute pancreatitis; CD177; colonic injury; interleukin-22; intestinal barrier dysfunction; microbiota	DEFINITIONS; INNATE; MICE	Intestinal barrier dysfunction plays a critical role in the pathophysiology of many diseases including severe acute pancreatitis (SAP). Interleukin-22 (IL-22) is a critical regulator of intestinal epithelial homeostasis. However, the mechanism, origin site, and characteristics of IL-22 in the intestinal barrier dysfunction remains elusive. Studies were conducted in patients with SAP and SAP mice model. SAP mice model was induced by intraductal infusion of 5% taurocholic acid. The level and source of IL-22 were analyzed by flow cytometry. The effect of IL-22 in SAP-associated intestinal injury were examined through knockout of IL-22 (IL-22(-/-)) or administration of recombinant IL-22 (rIL-22). IL-22 increased in the early phase of SAP but declined more quickly than that of proinflammatory cytokines, such as IL-6 and TNF-alpha. CD177(+) neutrophils contributed to IL-22 expression in SAP. IL-22 was activated in the colon rather than the small intestine during SAP. Deletion of IL-22 worse the severity of colonic injury, whereas administration of rIL-22 reduced colonic injury. Mechanistically, IL-22 ameliorates the intestinal barrier dysfunction in SAP through decreasing colonic mucosal permeability, upregulation of E-cadherin and ZO-1 expression, activation of pSTAT3/Reg3 pathway and restoration of fecal microbiota abundance. This study revealing that early decreased colonic IL-22 aggravates intestinal mucosal barrier dysfunction and microbiota dysbiosis in SAP. Colonic IL-22 is likely a promising treating target in the early phase of SAP management. Research in context Evidence before this study Intestinal barrier dysfunction plays a critical role in the pathophysiology of severe acute pancreatitis (SAP). Interleukin-22 (IL-22) is a critical regulator of intestinal epithelial homeostasis. However, the mechanism, origin site and characteristics of IL-22 in the intestinal barrier dysfunction remains elusive. Added value of this study Firstly, we determined the dynamic expression profile of IL-22 in SAP and found that IL-22 was mostly activated in the pancreas and colon and decreased earlier than proinflammatory cytokines. CD177(+) neutrophils contributed to IL-22 expression in SAP. Furthermore, we found that IL-22 ameliorates intestinal barrier dysfunction in SAP through decreasing colonic mucosal permeability, upregulation of E-cadherin and ZO-1 expression, activation of pSTAT3/Reg3 pathway and restoration of fecal microbiota abundance. Implications of all the available evidence This study highlights the role of colonic injury and colonic IL-22 in SAP. IL-22 is likely a promising treating target in the early phase of SAP management.	[Jin, Meng; Zhang, Huimin; Wu, Meixu; Wang, Zheng; Chen, Xuanfu; Guo, Mingyue; Zhou, Runing; Yang, Hong; Qian, Jiaming] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Gastroenterol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Yang, H; Qian, JM (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Gastroenterol, Beijing 100730, Peoples R China.	YangH@pumch.cn; qianjiaming1957@126.com	Zhang, Hui/HHN-8494-2022		Health Research and Special Projects Grant of China [201002020, 201502005]; National Natural Science Funding [81570505]; Beijing Natural Science Funding [7202161]; 2010 National Clinical Specialty Projects; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-12M-3-001]; Zhejiang Provincial Natural Science Foundation [LQ21H030008]	Health Research and Special Projects Grant of China; National Natural Science Funding(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Funding; 2010 National Clinical Specialty Projects; CAMS Innovation Fund for Medical Sciences (CIFMS); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This study was supported by the Health Research and Special Projects Grant of China (Nos. 201002020, No.201502005), the National Natural Science Funding (No. 81570505), the Beijing Natural Science Funding (No. 7202161), the 2010 National Clinical Specialty Projects and the CAMS Innovation Fund for Medical Sciences (CIFMS, 2016--12M--3--001), and the Zhejiang Provincial Natural Science Foundation (LQ21H030008).	Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Blaser AR, 2012, INTENS CARE MED, V38, P384, DOI 10.1007/s00134-011-2459-y; Cen ME, 2018, APOPTOSIS, V23, P377, DOI 10.1007/s10495-018-1464-9; Dudakov JA, 2015, ANNU REV IMMUNOL, V33, P747, DOI 10.1146/annurev-immunol-032414-112123; Eken A, 2014, MUCOSAL IMMUNOL, V7, P143, DOI 10.1038/mi.2013.33; Garg PK, 2019, GASTROENTEROLOGY, V156, P2008, DOI 10.1053/j.gastro.2018.12.041; Geng H, 2018, GASTROENTEROLOGY, V155, P144, DOI 10.1053/j.gastro.2018.03.058; Gronke K, 2019, NATURE, V566, P249, DOI 10.1038/s41586-019-0899-7; Habtezion A, 2019, GASTROENTEROLOGY, V156, P1941, DOI 10.1053/j.gastro.2018.11.082; Hwang S, 2020, HEPATOLOGY, V72, P412, DOI 10.1002/hep.31031; Ji YF, 2017, QUANT IMAG MED SURG, V7, P641, DOI 10.21037/qims.2017.12.03; Lanfranca MP, 2020, GASTROENTEROLOGY, V158, P1417, DOI 10.1053/j.gastro.2019.12.010; Li XY, 2020, WORLD J GASTROENTERO, V26, P2187, DOI 10.3748/wjg.v26.i18.2187; Merilainen S, 2013, ULTRASTRUCT PATHOL, V37, P127, DOI 10.3109/01913123.2012.745638; Miranda-Aquino T, 2016, REV GASTROENTEROL ME, V81, P230, DOI 10.1016/j.rgmx.2015.09.003; Mizoguchi A, 2018, J GASTROENTEROL, V53, P465, DOI 10.1007/s00535-017-1401-7; Perides G, 2010, NAT PROTOC, V5, P335, DOI 10.1038/nprot.2009.243; Powell N, 2020, GUT, V69, P578, DOI 10.1136/gutjnl-2019-318483; Sun JK, 2013, SURG TODAY, V43, P506, DOI 10.1007/s00595-013-0496-6; van Baal MC, 2014, PANCREATOLOGY, V14, P470, DOI 10.1016/j.pan.2014.10.002; Xuan XY, 2018, PANCREATOLOGY, V18, P231, DOI 10.1016/j.pan.2018.02.014; Xue J, 2012, GASTROENTEROLOGY, V143, P1670, DOI 10.1053/j.gastro.2012.08.051; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zhou GX, 2018, GUT, V67, P1052, DOI 10.1136/gutjnl-2016-313535	24	1	1	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22174	10.1096/fj.202101371R	http://dx.doi.org/10.1096/fj.202101371R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35137988				2022-12-28	WOS:000761250800033
J	Mikroulis, A; Ledri, M; Ruffolo, G; Palma, E; Sperk, G; Dalli, J; Vezzani, A; Kokaia, M				Mikroulis, Apostolos; Ledri, Marco; Ruffolo, Gabriele; Palma, Eleonora; Sperk, Guenther; Dalli, Jesmond; Vezzani, Annamaria; Kokaia, Merab			Lipid mediator n-3 docosapentaenoic acid-derived protectin D1 enhances synaptic inhibition of hippocampal principal neurons by interaction with a G-protein-coupled receptor	FASEB JOURNAL			English	Article						antiepileptic mechanism; GABA(A) receptors; mouse hippocampus; PD1(n-3DPA); perisomatic inhibition	BLOOD-BRAIN-BARRIER; IMMUNOCYTOCHEMICAL DISTRIBUTION; EXCITABILITY; DIVERSITY; SUBUNITS	Epilepsy is a severe neurological disease manifested by spontaneous recurrent seizures due to abnormal hyper-synchronization of neuronal activity. Epilepsy affects about 1% of the population and up to 40% of patients experience seizures that are resistant to currently available drugs, thus highlighting an urgent need for novel treatments. In this regard, anti-inflammatory drugs emerged as potential therapeutic candidates. In particular, specific molecules apt to resolve the neuroinflammatory response occurring in acquired epilepsies have been proven to counteract seizures in experimental models, and humans. One candidate investigational molecule has been recently identified as the lipid mediator n-3 docosapentaenoic acid-derived protectin D1 (PD1(n-3DPA)) which significantly reduced seizures, cell loss, and cognitive deficit in a mouse model of acquired epilepsy. However, the mechanisms that mediate the PD1(n-3DPA) effect remain elusive. We here addressed whether PD1(n-3DPA) has direct effects on neuronal activity independent of its anti-inflammatory action. We incubated, therefore, hippocampal slices with PD1(n-3DPA) and investigated its effect on excitatory and inhibitory synaptic inputs to the CA1 pyramidal neurons. We demonstrate that inhibitory drive onto the perisomatic region of the pyramidal neurons is increased by PD1(n-3DPA), and this effect is mediated by pertussis toxin-sensitive G-protein coupled receptors. Our data indicate that PD1(n-3DPA) acts directly on inhibitory transmission, most likely at the presynaptic site of inhibitory synapses as also supported by Xenopus oocytes and immunohistochemical experiments. Thus, in addition to its anti-inflammatory effects, PD1(n-3DPA) anti-seizure and neuroprotective effects may be mediated by its direct action on neuronal excitability by modulating their synaptic inputs.	[Mikroulis, Apostolos; Ledri, Marco; Kokaia, Merab] Lund Univ, Fac Med, Epilepsy Ctr, Dept Clin Sci, Lund, Sweden; [Ruffolo, Gabriele; Palma, Eleonora] Univ Rome Sapienza, Ist Pasteur Fdn Cenci Bolognetti, Dept Physiol & Pharmacol, Rome, Italy; [Ruffolo, Gabriele] IRCCS San Raffaele Pisana, Rome, Italy; [Sperk, Guenther] Med Univ Innsbruck, Dept Pharmacol, Innsbruck, Austria; [Dalli, Jesmond] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Dalli, Jesmond] Queen Mary Univ London, Ctr Inflammat & Therapeut Innovat, London, England; [Vezzani, Annamaria] Mario Negri Inst Pharmacol Res IRCCS, Milan, Italy	Lund University; Fondazione Cenci Bolognetti; Sapienza University Rome; IRCCS San Raffaele Pisana; Medical University of Innsbruck; University of London; Queen Mary University London; University of London; Queen Mary University London; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Ledri, M (corresponding author), Lund Univ, Wallenberg Neurosci Ctr, Solvegatan 17,BMC A11, Lund, Sweden.	Marco.Ledri@med.lu.se	; Palma, Eleonora/A-2775-2010; RUFFOLO, GABRIELE/A-9273-2019	Dalli, Jesmond/0000-0001-6328-3640; Palma, Eleonora/0000-0001-6026-927X; Ledri, Marco/0000-0001-8317-7976; RUFFOLO, GABRIELE/0000-0002-6554-5496; Sperk, Guenther/0000-0001-6561-8360	Vetenskapsradet (VR) [2017-00921]; Austrian Science Fund (FWF) [P 19464]; Sapienza Universita di Roma (Sapienza University of Rome); Ministero della Salute (Ministry of Health, Italy); Wellcome Trust (Wellcome) [107613/Z/15/Z]; Royal Society [107613/Z/15/Z]; Stiftelsen Olle Engkvist Byggmastare	Vetenskapsradet (VR)(Swedish Research Council); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Sapienza Universita di Roma (Sapienza University of Rome); Ministero della Salute (Ministry of Health, Italy)(Ministry of Health, Italy); Wellcome Trust (Wellcome); Royal Society(Royal Society of London); Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council)	Vetenskapsradet (VR), Grant/Award Number: 2017-00921; Austrian Science Fund (FWF), Grant/Award Number: P 19464; Sapienza Universita di Roma (Sapienza University of Rome); Ministero della Salute (Ministry of Health, Italy), Grant/Award Number: Ricerca corrente; Wellcome Trust (Wellcome), Grant/Award Number: 107613/Z/15/Z; Royal Society, Grant/Award Number: 107613/Z/15/Z; Stiftelsen Olle Engkvist Byggmastare	Cascino GD, 2021, NEUROL CLIN, V39, P181, DOI 10.1016/j.ncl.2020.09.010; Conti L, 2011, EPILEPSIA, V52, P1635, DOI 10.1111/j.1528-1167.2011.03111.x; Dalli J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01940; Dawit S, 2020, CURR NEUROL NEUROSCI, V20, DOI 10.1007/s11910-020-01061-3; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Drexel M, 2017, J NEUROSCI, V37, P8166, DOI 10.1523/JNEUROSCI.3456-16.2017; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Ferdinandusse S, 2001, J LIPID RES, V42, P1987; Frigerio F, 2018, BRAIN, V141, P3130, DOI 10.1093/brain/awy247; Gobbetti T, 2017, P NATL ACAD SCI USA, V114, P3963, DOI 10.1073/pnas.1617290114; Jinno S, 2007, J NEUROSCI, V27, P8790, DOI 10.1523/JNEUROSCI.1847-07.2007; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Khayenko V, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00162; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Mikroulis A., XPSC DETECTION TEMPL; Palma E, 2002, P NATL ACAD SCI USA, V99, P15078, DOI 10.1073/pnas.232574499; Pardridge WM, 2016, EXPERT OPIN DRUG DEL, V13, P963, DOI 10.1517/17425247.2016.1171315; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Roseti C, 2015, NEUROBIOL DIS, V82, P311, DOI 10.1016/j.nbd.2015.07.003; Ruffolo G, 2018, EPILEPSIA, V59, P2106, DOI 10.1111/epi.14574; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Serhan CN, 2018, MOL ASPECTS MED, V64, P1, DOI 10.1016/j.mam.2017.08.002; Sperk G, 1997, NEUROSCIENCE, V80, P987, DOI 10.1016/S0306-4522(97)00146-2; Taha AY, 2013, BRAIN RES, V1537, P9, DOI 10.1016/j.brainres.2013.09.004; van Vliet EA, 2018, NEUROPATH APPL NEURO, V44, P91, DOI 10.1111/nan.12444; Vezzani A, 2019, NAT REV NEUROL, V15, P459, DOI 10.1038/s41582-019-0217-x; Vezzani A, 2015, NEUROPHARMACOLOGY, V96, P70, DOI 10.1016/j.neuropharm.2014.10.027; Weissberg I, 2015, NEUROBIOL DIS, V78, P115, DOI 10.1016/j.nbd.2015.02.029; Xiao YF, 1999, BRAIN RES, V846, P112, DOI 10.1016/S0006-8993(99)01997-6	30	3	3	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22203	10.1096/fj.202101815R	http://dx.doi.org/10.1096/fj.202101815R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35188290	Green Published			2022-12-28	WOS:000761250800053
J	Xia, YJ; Wu, QY; Mak, SH; Liu, EYL; Zheng, BZY; Dong, TTX; Pi, RB; Tsim, KWK				Xia, Yingjie; Wu, Qiyun; Mak, Shinghung; Liu, Etta Y. L.; Zheng, Brody Z. Y.; Dong, Tina T. X.; Pi, Rongbiao; Tsim, Karl W. K.			Regulation of acetylcholinesterase during the lipopolysaccharide-induced inflammatory responses in microglial cells	FASEB JOURNAL			English	Article						acetylcholinesterase; Alzheimer disease; CAP; microglia; neuroinflammation	RICH-MEMBRANE-ANCHOR; NF-KAPPA-B; ALZHEIMERS-DISEASE; NICOTINIC RECEPTOR; INDUCED NEUROINFLAMMATION; CHOLINERGIC SYSTEM; GENE-EXPRESSION; TNF-ALPHA; PROTEIN; ACTIVATION	The non-classical function of acetylcholine (ACh) has been reported in neuroinflammation that represents the modulating factor in immune responses via activation of alpha 7 nicotinic acetylcholine receptor (alpha 7 nAChR), i.e., a cholinergic anti-inflammatory pathway (CAP). Acetylcholinesterase (AChE), an enzyme for ACh hydrolysis, has been proposed to have a non-classical function in immune cells. However, the involvement of AChE in neuroinflammation is unclear. Here, cultured BV2 cell, a microglial cell line, and primary microglia from rats were treated with lipopolysaccharide (LPS) to induce inflammation and to explore the regulation of AChE during this process. The expression profiles of AChE, alpha 7 nAChR, and choline acetyltransferase (ChAT) were revealed in BV2 cells. The expression of AChE (G4 form) was induced significantly in LPS-treated BV2 cells: the induction was triggered by NF-kappa B and cAMP signaling. Moreover, ACh or alpha 7 nAChR agonist suppressed the LPS-induced production of pro-inflammatory cytokines, as well as the phagocytosis of microglia, by activating alpha 7 nAChR and followed by the regulation of NF-kappa B and CREB signaling. The ACh-induced suppression of inflammation was abolished in AChE overexpressed cells, but did not show a significant change in AChE mutant (enzymatic activity knockout) transfected cells. These results indicate that the neuroinflammation-regulated function of AChE may be mediated by controlling the ACh level in the brain system.	[Xia, Yingjie; Wu, Qiyun; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Shenzhen Key Lab Edible & Med Bioresources, SRI, Shenzhen, Peoples R China; [Xia, Yingjie; Wu, Qiyun; Mak, Shinghung; Liu, Etta Y. L.; Zheng, Brody Z. Y.; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Div Life Sci, Hong Kong, Peoples R China; [Pi, Rongbiao] Sun Yat Sen Univ, Sch Med, Guangzhou, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Sun Yat Sen University	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Shenzhen Key Lab Edible & Med Bioresources, SRI, Shenzhen, Peoples R China.	botsim@ust.hk			Shenzhen Science and Technology Committee Research Grant [JCYJ20170413173747440, ZDSYS201707281432317, JCYJ20180306174903174, CKFW20160829 16015476]; China Post-doctoral Science Foundation [2019M653087]; Zhongshan Municipal Bureau of Science and Technology [ZSST20SC03]; Guangzhou Science and Technology Committee Research Grant [GZSTI16SC02, GZSTI17SC02]; Hong Kong RGC [T13-607/12R, 16100921]; Hong Kong Innovation Technology Fund [UIM/340, UIM/385, ITS/500/18FP, TCPD/17e9]; Health and Medical Research Fund of Hong Kong [HMRF18SC06, COVID190213]	Shenzhen Science and Technology Committee Research Grant; China Post-doctoral Science Foundation(China Postdoctoral Science Foundation); Zhongshan Municipal Bureau of Science and Technology; Guangzhou Science and Technology Committee Research Grant; Hong Kong RGC(Hong Kong Research Grants Council); Hong Kong Innovation Technology Fund; Health and Medical Research Fund of Hong Kong	Shenzhen Science and Technology Committee Research Grant, Grant/Award Number: JCYJ20170413173747440, ZDSYS201707281432317, JCYJ20180306174903174 and CKFW20160829 16015476; China Post--doctoral Science Foundation, Grant/Award Number: 2019M653087; Zhongshan Municipal Bureau of Science and Technology, Grant/Award Number: ZSST20SC03; Guangzhou Science and Technology Committee Research Grant, Grant/Award Number: GZSTI16SC02 and GZSTI17SC02; Hong Kong RGC, Grant/Award Number: T13--607/12R and 16100921; Hong Kong Innovation Technology Fund, Grant/Award Number: UIM/340, UIM/385, ITS/500/18FP and TCPD/17e9; Health and Medical Research Fund of Hong Kong, Grant/Award Number: HMRF18SC06 and COVID190213	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Avni D, 2010, MOL IMMUNOL, V47, P1396, DOI 10.1016/j.molimm.2010.02.015; BENAZIZALOYA R, 1993, P NATL ACAD SCI USA, V90, P2471, DOI 10.1073/pnas.90.6.2471; Bond CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004846; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broide RS, 1996, J NEUROSCI, V16, P2956; Burghaus L, 2000, MOL BRAIN RES, V76, P385; Calsolaro V, 2016, ALZHEIMERS DEMENT, V12, P719, DOI 10.1016/j.jalz.2016.02.010; Chaubourt E., 1998, Journal of Physiology Paris, V92, P420, DOI 10.1016/S0928-4257(99)80032-1; Chen VP, 2011, J BIOL CHEM, V286, P32948, DOI 10.1074/jbc.M111.261248; Choi RCY, 2000, NEUROREPORT, V11, P801, DOI 10.1097/00001756-200003200-00029; Choi RCY, 2001, MOL CELL NEUROSCI, V17, P732, DOI 10.1006/mcne.2001.0968; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Dale HH, 1929, J PHYSIOL-LONDON, V68, P97, DOI 10.1113/jphysiol.1929.sp002598; Das UN, 2007, MED SCI MONITOR, V13, pRA214; De Miranda BR, 2015, MOL PHARMACOL, V87, P1021, DOI 10.1124/mol.114.095398; DELAPORTE S, 1993, J NEUROL SCI, V117, P92, DOI 10.1016/0022-510X(93)90160-Z; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FILLIT H, 1991, NEUROSCI LETT, V129, P318, DOI 10.1016/0304-3940(91)90490-K; Fujii T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01085; Gnatek Y, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00066; Greenfield S, 2002, NEUROSCIENCE, V113, P485, DOI 10.1016/S0306-4522(02)00194-X; Greenfield SA, 2004, J NEUROCHEM, V90, P325, DOI 10.1111/j.1471-4159.2004.02494.x; Hows MEP, 2002, J NEUROSCI METH, V121, P33, DOI 10.1016/S0165-0270(02)00228-5; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Hwang J, 2010, NEUROPHARMACOLOGY, V58, P1122, DOI 10.1016/j.neuropharm.2010.02.003; Jatana M, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-12; Kawashima K, 2000, PHARMACOL THERAPEUT, V86, P29, DOI 10.1016/S0163-7258(99)00071-6; Kawashima K, 2003, LIFE SCI, V72, P2101, DOI 10.1016/S0024-3205(03)00068-7; Kawashima K, 2007, LIFE SCI, V80, P2314, DOI 10.1016/j.lfs.2007.02.036; King JR, 2017, FEBS OPEN BIO, V7, P1350, DOI 10.1002/2211-5463.12270; Li JM, 2020, EXP EYE RES, V195, DOI 10.1016/j.exer.2020.108003; Li M, 2016, INFLAMMATION, V39, P1681, DOI 10.1007/s10753-016-0402-7; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Lian H, 2016, BIOPROTOC, V6, P21; Licastro F, 2000, J NEUROIMMUNOL, V103, P97, DOI 10.1016/S0165-5728(99)00226-X; Liu EYL, 2020, ACTA PHARMACOL SIN B, V10, P1926, DOI 10.1016/j.apsb.2020.05.005; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2; Noureddine H, 2007, J BIOL CHEM, V282, P3487, DOI 10.1074/jbc.M607221200; Oshikawa J, 2003, AM J PHYSIOL-CELL PH, V285, pC567, DOI 10.1152/ajpcell.00422.2002; Parada E, 2013, ANTIOXID REDOX SIGN, V19, P1135, DOI 10.1089/ars.2012.4671; Pavlov VA, 2005, BRAIN BEHAV IMMUN, V19, P493, DOI 10.1016/j.bbi.2005.03.015; PERLMUTTER LS, 1992, J NEUROSCI RES, V33, P549, DOI 10.1002/jnr.490330407; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Reale M, 2004, J NEUROIMMUNOL, V148, P162, DOI 10.1016/j.jneuroim.2003.11.003; Samochocki M, 2003, J PHARMACOL EXP THER, V305, P1024, DOI 10.1124/jpet.102.045773; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Shytle RD, 2004, J NEUROCHEM, V89, P337, DOI 10.1046/j.1471-4159.2004.02347.x; Slevin M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02124; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tyagi E, 2008, J NEUROIMMUNOL, V205, P51, DOI 10.1016/j.jneuroim.2008.08.015; Uutela P, 2005, RAPID COMMUN MASS SP, V19, P2950, DOI 10.1002/rcm.2160; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; von Bernhardi R, 2003, NEUROBIOL DIS, V14, P447, DOI 10.1016/j.nbd.2003.08.014; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Wessler I, 1998, PHARMACOL THERAPEUT, V77, P59, DOI 10.1016/S0163-7258(97)00085-5; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wu QY, 2020, FASEB J, V34, P8941, DOI 10.1096/fj.202000708R; Wu YJ, 2021, INFLAMMATION, V44, P821, DOI 10.1007/s10753-020-01396-6; Xie HDQ, 2010, J BIOL CHEM, V285, P11537, DOI 10.1074/jbc.M109.038711; Xie HQ, 2009, BRAIN RES, V1265, P13, DOI 10.1016/j.brainres.2009.01.065; Xue XD, 2017, ADV SCI, V4, DOI 10.1002/advs.201700229; Yamada M, 2018, CURR OPIN PHARMACOL, V40, P18, DOI 10.1016/j.coph.2017.12.003; Yao NW, 2017, EXP THER MED, V13, P2193, DOI 10.3892/etm.2017.4271; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x; Zhang QC, 2017, AM J TRANSL RES, V9, P971	73	5	5	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22189	10.1096/fj.202101302RR	http://dx.doi.org/10.1096/fj.202101302RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35129858				2022-12-28	WOS:000761250800028
J	Song, WL; Isaji, T; Nakano, M; Liang, CX; Fukuda, T; Gu, JG				Song, Wanli; Isaji, Tomoya; Nakano, Miyako; Liang, Caixia; Fukuda, Tomohiko; Gu, Jianguo			O-GlcNAcylation regulates beta 1,4-GlcNAc-branched N-glycan biosynthesis via the OGT/SLC35A3/GnT-IV axis	FASEB JOURNAL			English	Article						cell adhesion; GlcNAc branching; N-glycan biosynthesis; O-GlcNAcylation	ACETYLGLUCOSAMINYLTRANSFERASE-IVA; LINKED OLIGOSACCHARIDES; INSULIN-SECRETION; CELL-MIGRATION; POOR-PROGNOSIS; GLYCOSYLATION; ROLES; MECHANISMS; EXPRESSION; GLCNAC	N-Linked glycosylation and O-linked N-acetylglucosamine (O-GlcNAc) are important protein post-translational modifications that are orchestrated by a diverse set of gene products. Thus far, the relationship between these two types of glycosylation has remained elusive, and it is unclear whether one influences the other via UDP-GlcNAc, which is a common donor substrate. Theoretically, a decrease in O-GlcNAcylation may increase the products of GlcNAc-branched N-glycans. In this study, via examination by lectin blotting, HPLC, and mass spectrometry analysis, however, we found that the amounts of GlcNAc-branched tri-antennary N-glycans catalyzed by N-acetylglucosaminyltransferase IV (GnT-IV) and tetra-antennary N-glycans were significantly decreased in O-GlcNAc transferase knockdown cells (OGT-KD) compared with those in wild type cells. We examined this specific alteration by focusing on SLC35A3, which is the main UDP-GlcNAc transporter in mammals that is believed to modulate GnT-IV activation. It is interesting that a deficiency of SLC35A3 specifically leads to a decrease in the amounts of GlcNAc-branched tri- and tetra-antennary N-glycans. Furthermore, co-immunoprecipitation experiments have shown that SLC35A3 interacts with GnT-IV, but not with N-acetylglucosaminyltransferase V. Western blot and chemoenzymatic labeling assay have confirmed that OGT modifies SLC35A3 and that O-GlcNAcylation contributes to its stability. Furthermore, we found that SLC35A3-KO enhances cell spreading and suppresses both cell migration and cell proliferation, which is similar to the phenomena observed in the OGT-KD cells. Taken together, these data are the first to demonstrate that O-GlcNAcylation specifically governs the biosynthesis of tri- and tetra-antennary N-glycans via the OGT-SLC35A3-GnT-IV axis.	[Song, Wanli; Isaji, Tomoya; Liang, Caixia; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Sendai, Miyagi, Japan; [Nakano, Miyako] Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Japan	Tohoku Medical & Pharmaceutical University; Hiroshima University	Gu, JG (corresponding author), Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-mpu.ac.jp			Japan Society for the Promotion of Science [19H03184, 19K07049]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [20H04909]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Japan Society for the Promotion of Science, Grant/Award Number: 19H03184 and 19K07049; Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant/Award Number: 20H04909	Toscanini MA, 2019, J BIOL CHEM, V294, P10042, DOI 10.1074/jbc.RA119.008827; Akimoto Y, 2007, GLYCOBIOLOGY, V17, P127, DOI 10.1093/glycob/cwl067; Biwi J, 2018, MOLECULES, V23, DOI 10.3390/molecules23112858; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Copeland RJ, 2013, PROTEOM CLIN APPL, V7, P597, DOI 10.1002/prca.201300001; Edvardson S, 2013, J MED GENET, V50, P733, DOI 10.1136/jmedgenet-2013-101753; Fan JH, 2012, GLYCOCONJUGATE J, V29, P323, DOI 10.1007/s10719-012-9414-1; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Franz CM, 2002, DEV CELL, V2, P153, DOI 10.1016/S1534-5807(02)00120-X; Gabius HJ, 2018, BIOSYSTEMS, V164, P102, DOI 10.1016/j.biosystems.2017.07.003; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Ghosh SK, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00197; Gu YC, 2014, MOL MED REP, V10, P897, DOI 10.3892/mmr.2014.2269; Gu YC, 2010, CANCER RES, V70, P6344, DOI 10.1158/0008-5472.CAN-09-1887; Guillard M, 2011, J PEDIATR-US, V159, P1041, DOI 10.1016/j.jpeds.2011.08.007; Guo S, 2001, GLYCOBIOLOGY, V11, P813, DOI 10.1093/glycob/11.10.813; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; Ide Y, 2006, BIOCHEM BIOPH RES CO, V341, P478, DOI 10.1016/j.bbrc.2005.12.208; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Kamigaito T, 2014, PROSTATE CANCER P D, V17, P18, DOI 10.1038/pcan.2013.56; Kao Shih-Han, 2015, Bio Protoc, V5, DOI 10.21769/BioProtoc.1374; Khoder-Agha F, 2019, CELL MOL LIFE SCI, V76, P1821, DOI 10.1007/s00018-019-03032-5; Kitada T, 2001, J BIOL CHEM, V276, P475, DOI 10.1074/jbc.M006689200; Kizuka Y, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020025; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Liu CF, 2020, J BIOL CHEM, V295, P7341, DOI 10.1074/jbc.RA119.012401; Ma ZY, 2013, J BIOL CHEM, V288, P15121, DOI 10.1074/jbc.M113.470047; Maszczak-Seneczko D, 2015, J BIOL CHEM, V290, P15475, DOI 10.1074/jbc.M115.636670; Maszczak-Seneczko D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.460543; Maszczak-Seneczko D, 2012, FEBS LETT, V586, P4082, DOI 10.1016/j.febslet.2012.10.016; Niimi K, 2012, BRIT J CANCER, V107, P1969, DOI 10.1038/bjc.2012.496; Oguri S, 2006, GLYCOCONJUGATE J, V23, P473, DOI 10.1007/s10719-006-6216-3; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Peterson SB, 2016, CRIT REV BIOCHEM MOL, V51, P150, DOI 10.3109/10409238.2015.1135102; Reily C, 2019, NAT REV NEPHROL, V15, P346, DOI 10.1038/s41581-019-0129-4; Rudman N, 2019, FEBS LETT, V593, P1598, DOI 10.1002/1873-3468.13495; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sato Y, 2009, J BIOL CHEM, V284, P11873, DOI 10.1074/jbc.M807660200; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi Y, 2010, LEUKEMIA, V24, P1588, DOI 10.1038/leu.2010.152; Simanek EE, 1998, J AM CHEM SOC, V120, P11567, DOI 10.1021/ja982312w; Soesanto Y, 2011, J BIOL CHEM, V286, P26118, DOI 10.1074/jbc.M111.249508; Sun SS, 2019, CLIN PROTEOM, V16, DOI 10.1186/s12014-019-9254-0; Szulc B, 2020, J BIOL CHEM, V295, P16445, DOI 10.1074/jbc.RA119.012362; Takamatsu Shinji, 2013, Methods Mol Biol, V1022, P283, DOI 10.1007/978-1-62703-465-4_21; Takamatsu S, 2010, GLYCOBIOLOGY, V20, P485, DOI 10.1093/glycob/cwp200; Tanabe K, 2006, ANAL BIOCHEM, V348, P324, DOI 10.1016/j.ab.2005.10.035; TOMIYA N, 1991, ANAL BIOCHEM, V193, P90, DOI 10.1016/0003-2697(91)90047-W; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; Varki A, 2015, ESSENTIALS GLYCOBIOL, DOI DOI 10.1101/GLYCOBIOLOGY.3E.047; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Wiertelak W, 2020, ANAL BIOCHEM, V593, DOI 10.1016/j.ab.2020.113599; Xu DG, 2019, INT J CLIN EXP PATHO, V12, P1305; Xu ZW, 2019, J BIOL CHEM, V294, P3117, DOI 10.1074/jbc.RA118.005923; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Yoshida Y, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00104; Yoshida Y, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201700215; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; Zhao LH, 2018, MOLECULES, V23, DOI 10.3390/molecules23081967; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x; Zhu QQ, 2012, MED ONCOL, V29, P985, DOI 10.1007/s12032-011-9912-1	70	3	3	8	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22149	10.1096/fj.202101520R	http://dx.doi.org/10.1096/fj.202101520R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34981577	hybrid			2022-12-28	WOS:000747987800002
J	Bassett, JJ; Robitaille, M; Peters, AA; Bong, AHL; Taing, MW; Wood, IA; Sadras, F; Roberts-Thomson, SJ; Monteith, GR				Bassett, John J.; Robitaille, Melanie; Peters, Amelia A.; Bong, Alice H. L.; Taing, Meng-Wong; Wood, Ian A.; Sadras, Francisco; Roberts-Thomson, Sarah J.; Monteith, Gregory R.			ORAI1 regulates sustained cytosolic free calcium fluctuations during breast cancer cell apoptosis and apoptotic resistance via a STIM1 independent pathway	FASEB JOURNAL			English	Article						breast cancer; calcium signaling; cell death; GCaMP6; ORAI1	INTRACELLULAR CA2+ OSCILLATIONS; MIGRATION; CHANNELS; ACTIVATION; ENTRY; SOCE; CRAC	Excessive rapid increases in cytosolic free Ca2+ have a clear association with the induction of cancer cell death. Whereas, characterizing the Ca2+ signaling events that occur during the progression of the apoptotic cascade over a period of hours or days, has not yet been possible. Now using genetically encoded Ca2+ indicators complemented with automated epifluorescence microscopy we have shown that staurosporine-induced apoptosis in MDA-MB-231 breast cancer cells was associated with delayed development of cytosolic free Ca2+ fluctuations, which were then maintained for 24 h. These cytosolic free Ca2+ fluctuations were dependent on the Ca2+ channel ORAI1. Silencing of ORAI1, but not its canonical activators STIM1 and STIM2, promoted apoptosis in this model. The pathway for this regulation implicates a mechanism previously associated with the migration of cancer cells involving ORAI1, the chaperone protein SigmaR1, and Ca2+-activated K+ channels.	[Bassett, John J.; Robitaille, Melanie; Peters, Amelia A.; Bong, Alice H. L.; Taing, Meng-Wong; Sadras, Francisco; Roberts-Thomson, Sarah J.; Monteith, Gregory R.] Univ Queensland, Sch Pharm, 20 Cornwall St, Brisbane, Qld 4102, Australia; [Wood, Ian A.] Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Monteith, GR (corresponding author), Univ Queensland, Sch Pharm, 20 Cornwall St, Brisbane, Qld 4102, Australia.	gregm@uq.edu.au	Bassett, John/AAT-2197-2021; Peters, Amelia A/E-4254-2010; Peters, Amelia/AAP-3886-2021; Taing, Dr Meng-Wong/B-9885-2014; Monteith, Gregory/B-1626-2008	Bassett, John/0000-0002-9509-0752; Peters, Amelia/0000-0002-0700-7817; Robitaille, Melanie/0000-0001-9354-5162; Taing, Dr Meng-Wong/0000-0003-0686-2632; Sadras, Francisco/0000-0001-7882-7487; Monteith, Gregory/0000-0002-4345-530X; Roberts-Thomson, Sarah/0000-0001-8202-5786	Cancer Council Queensland [1159854, 1139320]	Cancer Council Queensland(Cancer Council Queensland)	We would like to acknowledge the support of Cancer Council Queensland (1159854 and 1139320).	Aung CS, 2009, CARCINOGENESIS, V30, P1962, DOI 10.1093/carcin/bgp223; Azimi I, 2019, CANCERS, V11, DOI 10.3390/cancers11020208; Bassett JJ, 2018, CELL CALCIUM, V72, P39, DOI 10.1016/j.ceca.2018.02.003; Cantonero C, 2019, CELL CALCIUM, V80, P1, DOI 10.1016/j.ceca.2019.02.012; Chalmers SB, 2018, CELL CALCIUM, V74, P160, DOI 10.1016/j.ceca.2018.07.011; Chantome A, 2013, CANCER RES, V73, P4852, DOI 10.1158/0008-5472.CAN-12-4572; Chen J, 2017, J PHYSIOL-LONDON, V595, P3203, DOI 10.1113/JP272694; Davis FM, 2015, P NATL ACAD SCI USA, V112, P5827, DOI 10.1073/pnas.1502264112; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Flourakis M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.52; Garcia MI, 2017, CELL CALCIUM, V61, P44, DOI 10.1016/j.ceca.2016.12.010; Gueguinou M, 2017, ONCOGENE, V36, P3640, DOI 10.1038/onc.2016.501; Hammadi M, 2012, J CELL PHYSIOL, V227, P3837, DOI 10.1002/jcp.24095; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; Hougaard C, 2007, BRIT J PHARMACOL, V151, P655, DOI 10.1038/sj.bjp.0707281; Kar P, 2015, MOL CELL, V58, P232, DOI 10.1016/j.molcel.2015.02.027; Kerkhofs M, 2017, ADV EXP MED BIOL, V997, P225, DOI 10.1007/978-981-10-4567-7_17; Kondratska K, 2014, BBA-MOL CELL RES, V1843, P2263, DOI 10.1016/j.bbamcr.2014.02.012; La Rovere RML, 2016, CELL CALCIUM, V60, P74, DOI 10.1016/j.ceca.2016.04.005; Malleter M, 2013, CANCER RES, V73, P6711, DOI 10.1158/0008-5472.CAN-13-1794; McAndrew D, 2011, MOL CANCER THER, V10, P448, DOI 10.1158/1535-7163.MCT-10-0923; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Notte A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.167; Peretti M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37602-7; Peters AA, 2017, ONCOGENE, V36, P6490, DOI 10.1038/onc.2017.234; Rad SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145216; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Saul S, 2014, EUR J PHARMACOL, V739, P49, DOI 10.1016/j.ejphar.2013.10.071; Serrano-Negron JE, 2018, GLYCOBIOLOGY, V28, P61, DOI 10.1093/glycob/cwx098; Sun JW, 2014, J CELL BIOL, V207, P535, DOI 10.1083/jcb.201407082; Tanwar J, 2018, CELL CALCIUM, V69, P19, DOI 10.1016/j.ceca.2017.06.002; Trebak M, 2017, PHYSIOLOGY, V32, P332, DOI 10.1152/physiol.00011.2017; Vacher P, 2015, J IMMUNOL, V195, P2207, DOI 10.4049/jimmunol.1402942; Wang LW, 2017, J BIOL CHEM, V292, P11714, DOI 10.1074/jbc.M117.789917; Wang LW, 2016, J PHYSIOL-LONDON, V594, P2867, DOI 10.1113/JP271140; Wang W, 2018, CELL PHYSIOL BIOCHEM, V48, P2273, DOI 10.1159/000492645; Wang Y, 2019, CANCERS, V11, DOI 10.3390/cancers11040558; Wheeler DG, 2012, CELL, V149, P1112, DOI 10.1016/j.cell.2012.03.041; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Zhang L, 2018, BIOL REPROD, V98, P510, DOI 10.1093/biolre/ioy016; Zhu H, 2014, ONCOTARGET, V5, P3455, DOI 10.18632/oncotarget.1903; Zuccolo E, 2017, CELL CALCIUM, V66, P33, DOI 10.1016/j.ceca.2017.06.003	47	4	4	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22108	10.1096/fj.202002031RR	http://dx.doi.org/10.1096/fj.202002031RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34939697				2022-12-28	WOS:000734992000033
J	Hu, XH; Li, ZH; Muyayalo, KP; Wang, LL; Liu, CY; Mor, G; Liao, AH				Hu, Xiao-Hui; Li, Zhi-Hui; Muyayalo, Kahindo P.; Wang, Li-Ling; Liu, Chun-Yan; Mor, Gil; Liao, Ai-Hua			A newly intervention strategy in preeclampsia: Targeting PD-1/Tim-3 signaling pathways to modulate the polarization of decidual macrophages	FASEB JOURNAL			English	Article						decidual macrophage; Gal-9; PD-1; PD-L1; preeclampsia; rat; Tim-3	CANCER-THERAPY; CELLS; BETA; PHENOTYPE; BLOCKADE; INHIBITION; TIM-3	Programmed cell death-1 (PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) are important immune checkpoint receptors that prevent an overreacted maternal immune response to fetal antigens during pregnancy. Disruption of complex immune regulation mechanisms is associated with adverse pregnancy outcomes, including preeclampsia (PE). Our recent study showed that the Tim-3 pathway was involved in the regulation of decidual macrophage polarization. Decidual macrophages polarized to the M1 phenotype may impair uterine vessel remodeling during placentation, accounting for the occurrence of PE. Co-blockade of the PD-1/Tim-3 pathway was shown to successfully control tumor growth in preclinical cancer models. However, the effects of activating both PD-1 and Tim-3 pathways as a combined intervention strategy in PE are never reported. Herein, we observed the skew of decidual macrophage polarization toward the M1 phenotype in patients with PE and lipopolysaccharide (LPS)-induced PE-like rat model. Moreover, we found that the activation of PD-1/Tim-3 pathway by using PD-L1 and Gal-9 fusion proteins could alleviate the manifestation of the LPS-induced PE-like rats and protect their offspring. Compared with the single intervention, the combination of PD-L1and Gal-9 fusion proteins exhibited obvious advantages in the relief of PE-like symptoms, trophoblast invasion, and fetal vascular development, indicating a synergistic effect of the activated PD-1/Tim-3 pathway. The in vitro study also revealed that the combined intervention using PD-L1 and Gal-9 fusion proteins inhibited the LPS-induced M1 macrophage polarization via the synergic activation of the ERK/GSK3 beta/beta-catenin signaling pathway. Together, our findings provide the first evidence that simultaneous activation of PD-1/Tim-3 signaling pathways may have an optimal protective effect and serve as a new potential target for PE intervention.	[Hu, Xiao-Hui; Li, Zhi-Hui; Muyayalo, Kahindo P.; Wang, Li-Ling; Liu, Chun-Yan; Mor, Gil; Liao, Ai-Hua] Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Reprod Med, Inst Reprod Hlth, 13 Hangkong Rd, Wuhan 430030, Peoples R China; [Mor, Gil] Wayne State Univ, Dept Obstet & Gynecol, CS Mott Ctr Human Growth & Dev, Detroit, MI USA	Huazhong University of Science & Technology; Wayne State University	Liao, AH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Reprod Med, Inst Reprod Hlth, 13 Hangkong Rd, Wuhan 430030, Peoples R China.	aihua_liao@sina.com	Muyayalo, Kahinho Patrick/ABG-5966-2020	Muyayalo, Kahinho Patrick/0000-0001-7055-4138; Liao, Aihua/0000-0001-8533-8315; Mor, Gil/0000-0002-5499-3912	National Natural Science Foundation of China (NSFC) [81671490]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81671490	Anderson AC, 2014, CANCER IMMUNOL RES, V2, P393, DOI 10.1158/2326-6066.CIR-14-0039; Aneman I, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01864; Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160; Brown MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00606; Chabtini L, 2013, J IMMUNOL, V190, P88, DOI 10.4049/jimmunol.1202176; Chen LP, 2015, J CLIN INVEST, V125, P3384, DOI 10.1172/JCI80011; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Colomb F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00267; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Gokyavuz B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39553-z; Habicht A, 2007, J IMMUNOL, V179, P5211, DOI 10.4049/jimmunol.179.8.5211; Jena MK, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10060953; Kikushige Y, 2015, CELL STEM CELL, V17, P341, DOI 10.1016/j.stem.2015.07.011; Li M, 2016, AM J PATHOL, V186, P1258, DOI 10.1016/j.ajpath.2015.12.021; Li ZH, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03142; Lively S, 2016, J NEUROPATH EXP NEUR, V75, P1058, DOI 10.1093/jnen/nlw081; Ma Y, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015080; Okada K, 2016, J LEUKOCYTE BIOL, V100, P1093, DOI 10.1189/jlb.2A0415-170RRR; Palmer JA, 2014, CELLS TISSUES ORGANS, V199, P169, DOI 10.1159/000363693; Paluch C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02306; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; PrabhuDas M, 2015, NAT IMMUNOL, V16, P328, DOI 10.1038/ni.3131; Raedler Lisa A, 2015, Am Health Drug Benefits, V8, P180; Romero D, 2016, NAT REV CLIN ONCOL, V13, DOI 10.1038/nrclinonc.2016.40; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Shin DS, 2015, CURR OPIN IMMUNOL, V33, P23, DOI 10.1016/j.coi.2015.01.006; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Svensson-Arvelund J, 2015, AM J REPROD IMMUNOL, V74, P100, DOI 10.1111/aji.12357; Tang ZH, 2013, AM J REPROD IMMUNOL, V70, P104, DOI 10.1111/aji.12112; Timmerman I, 2012, MOL BIOL CELL, V23, P4212, DOI 10.1091/mbc.E12-01-0038; Tripathi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123439; Wang M, 2017, J IMMUNOL, V198, P4327, DOI 10.4049/jimmunol.1700162; Xiang DM, 2017, HEPATOLOGY, V65, P1566, DOI 10.1002/hep.28919; Yamaguchi H, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00015; Yao AH, 2014, NEUROTHERAPEUTICS, V11, P636, DOI 10.1007/s13311-013-0254-x; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Zhang YH, 2019, HUM REPROD, V34, P25, DOI 10.1093/humrep/dey347; Zhao SJ, 2020, THERANOSTICS, V10, P17, DOI 10.7150/thno.36930; Zhao Z, 2014, CLIN EXP IMMUNOL, V178, P279, DOI 10.1111/cei.12401	40	6	6	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22073	10.1096/fj.202101306R	http://dx.doi.org/10.1096/fj.202101306R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34847253				2022-12-28	WOS:000734992000042
J	Jin, DH; Lin, LH; Xie, YX; Jia, M; Qiu, H; Xun, K				Jin, Donghua; Lin, Lihua; Xie, Yuxian; Jia, Miao; Qiu, Hong; Xun, Kang			NRF2-suppressed vascular calcification by regulating the antioxidant pathway in chronic kidney disease	FASEB JOURNAL			English	Article						antioxidant pathway; chronic kidney disease; NRF2; vascular calcification	OXIDATIVE STRESS; RENAL-DISEASE; IN-VITRO; NRF2; APOPTOSIS; SENESCENCE; CATENIN	Vascular calcification (VC), in which vascular smooth muscle cells (VSMCs) undergo differentiation and osteogenic transition, is a common complication of chronic kidney disease (CKD). Recent findings show that nuclear factor-erythroid-2-related factor 2 (NRF2) is an evolutionarily conserved antioxidant and beneficial in preventing vascular senescence and calcification. The roles of NRF2 in the initiation and progression of VC in CKD still need further investigation. CKD-associated VC model rats exhibited significant upregulation of NRF2, NAD(P)H: quinone oxidoreductase-1 (NQO1), osteogenic markers such as alkaline phosphatase (ALP), runt-related transcription factor-2 (RUNX2) and osteopontin (OPN), and beta-catenin compared to CKD rats. Immunohistochemistry further verified these results. In addition, rat aortic VSMCs were isolated and subjected to four treatments: normal control, phosphorus-induced (Pi), Pi + NRF2 activator DMF, and Pi + NRF2 inhibitor ML385. The reactive oxygen species (ROS) generation, malondialdehyde (MDA) content, and calcium deposition of the four treatments were determined. The mRNA and protein expression levels of NRF2, NQO1, and haem oxygenase 1 (HO1) and the osteogenic markers ALP, Runx1, OPN, bone morphogenetic protein 2 (BMP2), and beta-catenin were quantified by RT-PCR and western blotting. VSMC apoptosis was calculated by flow cytometry. The in vitro results suggested that intracellular oxidative stress and calcification were closely associated with NRF2 activity and that the activation of NRF2 could significantly suppress osteogenic transition and apoptosis in VSMCs. Thus, this study indicated that the NRF2-related antioxidant pathway can positively respond to and protect against the initiation and progression of VC in CKD by reducing oxidative stress. This study may contribute insights facilitating the application of the NRF2 antioxidative system as a therapeutic treatment for vascular diseases such as CKD.	[Jin, Donghua; Lin, Lihua; Xie, Yuxian; Jia, Miao; Qiu, Hong; Xun, Kang] Peoples Hosp Suzhou New Dist, Dept Nephrol, 95 Huashan Rd, Suzhou 215129, Jiangsu, Peoples R China		Jin, DH; Xun, K (corresponding author), Peoples Hosp Suzhou New Dist, Dept Nephrol, 95 Huashan Rd, Suzhou 215129, Jiangsu, Peoples R China.	nephrologyofsnd@sina.com; kfyyxk@163.com			Key Project of Medical and Health Science and Technology Plan of Suzhou New District [2019Z005]; Science and Technology Development Project of Suzhou [SYSD2020087]	Key Project of Medical and Health Science and Technology Plan of Suzhou New District; Science and Technology Development Project of Suzhou	This study was supported by the funds from the Key Project of Medical and Health Science and Technology Plan of Suzhou New District (2019Z005) and the Science and Technology Development Project of Suzhou (SYSD2020087).	Agharazii M, 2015, AM J HYPERTENS, V28, P746, DOI 10.1093/ajh/hpu225; Arefin S, 2020, CLIN CHIM ACTA, V505, P108, DOI 10.1016/j.cca.2020.02.026; Bellezza I, 2018, BBA-MOL CELL RES, V1865, P721, DOI 10.1016/j.bbamcr.2018.02.010; Bruck K, 2016, J AM SOC NEPHROL, V27, P2135, DOI 10.1681/ASN.2015050542; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Cui L, 2020, FREE RADICAL BIO MED, V161, P23, DOI 10.1016/j.freeradbiomed.2020.09.028; Cui L, 2017, VASC PHARMACOL, V88, P21, DOI 10.1016/j.vph.2016.11.006; Durham AL, 2018, CARDIOVASC RES, V114, P590, DOI 10.1093/cvr/cvy010; Fouzder C, 2021, ARCH BIOCHEM BIOPHYS, V697, DOI 10.1016/j.abb.2020.108700; Guo ZL, 2020, J CLIN INVEST, V130, P5893, DOI 10.1172/JCI136466; Ha CM, 2014, VASC PHARMACOL, V63, P29, DOI 10.1016/j.vph.2014.06.007; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Huang M, 2020, J MOL CELL CARDIOL, V138, P256, DOI 10.1016/j.yjmcc.2019.12.006; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; Iyemere VP, 2006, J INTERN MED, V260, P192, DOI 10.1111/j.1365-2796.2006.01692.x; Jaminon A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225694; Kakani E, 2019, SEMIN DIALYSIS, V32, P553, DOI 10.1111/sdi.12840; Keum YS, 2014, MOLECULES, V19, P10074, DOI 10.3390/molecules190710074; Kovac S, 2015, BBA-GEN SUBJECTS, V1850, P794, DOI 10.1016/j.bbagen.2014.11.021; Lee SJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082685; Li PF, 1999, CIRCULATION, V100, P967, DOI 10.1161/01.CIR.100.9.967; Liou SF, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100956; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Lv JC, 2019, ADV EXP MED BIOL, V1165, P3, DOI 10.1007/978-981-13-8871-2_1; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Marchev AS, 2017, ANN NY ACAD SCI, V1401, P114, DOI 10.1111/nyas.13407; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Rong S, 2014, CELL PHYSIOL BIOCHEM, V34, P2049, DOI 10.1159/000366400; Ruiz S, 2013, KIDNEY INT, V83, P1029, DOI 10.1038/ki.2012.439; Russo D, 2011, KIDNEY INT, V80, P112, DOI 10.1038/ki.2011.69; Sajadimajd S, 2018, CURR CANCER DRUG TAR, V18, P538, DOI 10.2174/1568009617666171002144228; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Tang ZH, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1701-3; Voelkl J, 2019, CELL MOL LIFE SCI, V76, P2077, DOI 10.1007/s00018-019-03054-z; Wei R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46824-2; Yamada S, 2017, BONE, V100, P87, DOI 10.1016/j.bone.2016.11.012; Yao L, 2017, J CELL BIOCHEM, V118, P4708, DOI 10.1002/jcb.26137; Yao L, 2015, AM J NEPHROL, V41, P28, DOI 10.1159/000370250; Zhao MM, 2011, KIDNEY INT, V79, P1071, DOI 10.1038/ki.2011.18; Zhou P, 2019, J CELL MOL MED, V23, P7088, DOI 10.1111/jcmm.14611; Zhu XT, 2019, CHROMOSOME RES, V27, P167, DOI 10.1007/s10577-019-09608-y	43	6	6	6	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22098	10.1096/fj.202100625RR	http://dx.doi.org/10.1096/fj.202100625RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34918390				2022-12-28	WOS:000734992000010
J	Ke, QQ; Shi, CF; Lv, YH; Wang, LL; Luo, J; Jiang, L; Yang, JW; Zhou, Y				Ke, Qingqing; Shi, Caifeng; Lv, Yunhui; Wang, Lulu; Luo, Jing; Jiang, Lei; Yang, Junwei; Zhou, Yang			SGLT2 inhibitor counteracts NLRP3 inflammasome via tubular metabolite itaconate in fibrosis kidney	FASEB JOURNAL			English	Article						fibrosis; inflammasome; metabolism; metabolite; SGLT2	GLUCOSE COTRANSPORTER-2 INHIBITORS; FATTY-ACID OXIDATION; ADVERSE OUTCOMES; ACTIVATION; DISEASE; EMPAGLIFLOZIN; DAPAGLIFLOZIN; MECHANISMS; PREVENTION; INJURY	Large clinical trials and real-world studies have demonstrated that the beneficial effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on renal outcomes regardless of the presence of diabetes. However, the mechanism remains obscure. Here, we analyze the anti-fibrotic and anti-inflammatory effects of dapagliflozin, a SGLT2 inhibitor, on renal alternations using the ischemia/reperfusion-induced fibrosis model. Transcriptome and metabolome analysis showed that the accumulation of tricarboxylic acid (TCA) cycle metabolites and upregulation of inflammation in fibrosis renal cortical tissue were mitigated by dapagliflozin treatment. Moreover, dapagliflozin markedly relieved the activation of mammalian target of rapamycin and hypoxia inducible factor-1 alpha signaling and restored tubular cell-preferred fatty acid oxidation. Notably, NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) inflammasome activation was strikingly blocked by dapagliflozin. We further demonstrated that the immunomodulatory metabolite itaconate derived from the TCA cycle was significantly boosted as a result of decreased isocitrate dehydrogenase 2 and increased immune-responsive gene 1 and mitochondrial citrate carrier in dapagliflozin-treated mice, which contributed to the inhibitory effect of dapagliflozin on NLRP3 inflammasome activation. Furthermore, administration of cell-permeable itaconate surrogate prevented activation of NLRP3 inflammasome and protected kidney against fibrosis development. Our results identify a novel mechanism coupling metabolism and inflammation for kidney benefits of SGLT2 inhibition in progressive chronic kidney disease.	[Ke, Qingqing; Shi, Caifeng; Lv, Yunhui; Wang, Lulu; Luo, Jing; Jiang, Lei; Yang, Junwei; Zhou, Yang] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, 262 N Zhongshan Rd, Nanjing 210003, Jiangsu, Peoples R China	Nanjing Medical University	Yang, JW; Zhou, Y (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, 262 N Zhongshan Rd, Nanjing 210003, Jiangsu, Peoples R China.	jwyang@njmu.edu.cn; zhouyang@njmu.edu.cn	yang, jun/GQH-0635-2022	Jiang, Lei/0000-0002-7322-4502; Zhou, Yang/0000-0003-0453-4598	Natural Science Foundation of Jiangsu province [BK20201497]; National Natural Science Foundation of China [81873618]	Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Natural Science Foundation of Jiangsu province: General program BK20201497 Yang Zhou, and National Natural Science Foundation of China: General program 81873618 to Junwei Yang	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Cahn A, 2019, DIABETES OBES METAB, V21, P340, DOI 10.1111/dom.13532; Cherney DZI, 2018, KIDNEY INT, V93, P231, DOI 10.1016/j.kint.2017.06.017; Dekkers CCJ, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-0992-6; Dekkers CCJ, 2018, NEPHROL DIAL TRANSPL, V33, P2005, DOI 10.1093/ndt/gfx350; Donnan JR, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022577; Gross CJ, 2016, IMMUNITY, V45, P761, DOI 10.1016/j.immuni.2016.08.010; Heerspink HJL, 2020, NEW ENGL J MED, V383, P1436, DOI 10.1056/NEJMoa2024816; Heerspink HJL, 2020, NEPHROL DIAL TRANSPL, V35, P274, DOI 10.1093/ndt/gfz290; Heerspink HJL, 2020, LANCET DIABETES ENDO, V8, P27, DOI 10.1016/S2213-8587(19)30384-5; Heerspink HJL, 2019, DIABETOLOGIA, V62, P1154, DOI 10.1007/s00125-019-4859-4; Heerspink HJL, 2016, CIRCULATION, V134, P752, DOI 10.1161/CIRCULATIONAHA.116.021887; Hesp AC, 2020, KIDNEY INT, V98, P579, DOI 10.1016/j.kint.2020.02.041; Hooftman A, 2020, CELL METAB, V32, P468, DOI 10.1016/j.cmet.2020.07.016; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Iskander C, 2020, CAN MED ASSOC J, V192, pE351, DOI 10.1503/cmaj.191283; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Jiang L, 2013, J AM SOC NEPHROL, V24, P1114, DOI 10.1681/ASN.2012050476; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; Kovacs CS, 2014, DIABETES OBES METAB, V16, P147, DOI 10.1111/dom.12188; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Lauritsen KM, 2021, DIABETES, V70, P800, DOI 10.2337/db20-0921; Liao ST, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13078-5; Liu HJ, 2021, J DIABETES INVEST, V12, P697, DOI 10.1111/jdi.13478; Martin-Sanchez D, 2018, P NATL ACAD SCI USA, V115, P4182, DOI 10.1073/pnas.1716578115; Martin-Sanchez D, 2017, J AM SOC NEPHROL, V28, P218, DOI 10.1681/ASN.2015121376; Menne J, 2019, PLOS MED, V16, DOI [10.1371/journal.pmed.1002983, 10.1371/journal.pmed.1002983.r001, 10.1371/journal.pmed.1002983.r002, 10.1371/journal.pmed.1002983.r003, 10.1371/journal.pmed.1002983.r004, 10.1371/journal.pmed.1002983.r005]; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704; Moon JS, 2015, J CLIN INVEST, V125, P665, DOI 10.1172/JCI78253; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Neuen BL, 2019, LANCET DIABETES ENDO, V7, P845, DOI 10.1016/S2213-8587(19)30256-6; Packer M, 2020, NEW ENGL J MED, V383, P1413, DOI 10.1056/NEJMoa2022190; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Pasternak B, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1186; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; Qin N, 2019, J PATHOL, V247, P392, DOI 10.1002/path.5198; Qin W, 2020, J AM CHEM SOC, V142, P10894, DOI 10.1021/jacs.9b11962; Qin W, 2019, NAT CHEM BIOL, V15, P983, DOI 10.1038/s41589-019-0323-5; Rajasekeran H, 2017, CURR OPIN NEPHROL HY, V26, P358, DOI 10.1097/MNH.0000000000000343; Rampersad C, 2020, AM J KIDNEY DIS, V76, P471, DOI 10.1053/j.ajkd.2020.03.019; Ruiz-Ortega M, 2020, NAT REV NEPHROL, V16, P269, DOI 10.1038/s41581-019-0248-y; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Tanaka S, 2018, KIDNEY INT, V94, P912, DOI 10.1016/j.kint.2018.04.025; Terryn S, 2007, AM J PHYSIOL-RENAL, V293, pF476, DOI 10.1152/ajprenal.00363.2006; Tomita I, 2020, CELL METAB, V32, P404, DOI 10.1016/j.cmet.2020.06.020; Vielhauer V, 2004, KIDNEY INT, V66, P2264, DOI 10.1111/j.1523-1755.2004.66038.x; Wheeler DC, 2020, NEPHROL DIAL TRANSPL, V35, P1700, DOI 10.1093/ndt/gfaa234; Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI 10.1056/NEJMoa1812389; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Zhang YF, 2018, KIDNEY INT, V94, P524, DOI 10.1016/j.kint.2018.05.002; Zinman B, 2016, NEW ENGL J MED, V374, P1094, DOI 10.1056/NEJMc1600827	54	8	8	6	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22078	10.1096/fj.202100909RR	http://dx.doi.org/10.1096/fj.202100909RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34918381				2022-12-28	WOS:000734992000037
J	Saeidi, S; Kim, SJ; Guillen-Quispe, YN; Jagadeesh, ASV; Han, HJ; Kim, SH; Zhong, XC; Piao, JY; Kim, SJ; Jeong, J; Shin, YJ; Cha, YJ; Lee, HB; Han, W; Min, SH; Tian, W; Kitamura, H; Surh, YJ				Saeidi, Soma; Kim, Su-Jung; Guillen-Quispe, Yanymee N.; Jagadeesh, Achanta Sri Venkata; Han, Hyeong-Jun; Kim, Seung Hyeon; Zhong, Xiancai; Piao, Juan-Yu; Kim, Seong-Jin; Jeong, Joon; Shin, Yun Jin; Cha, Yoon Jin; Lee, Han-Byoel; Han, Wonshik; Min, Sang-Hyun; Tian, Wang; Kitamura, Hiroshi; Surh, Young-Joon			Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancer	FASEB JOURNAL			English	Article						breast cancer; Keap1; Nrf2; Pin1; protein-protein interaction	TRANSCRIPTIONAL ACTIVITY; NUCLEAR TRANSLOCATION; SIGNALING PATHWAY; PIN1; PHOSPHORYLATION; ACTIVATION; TRANSFORMATION; PHOSPHOSERINE; DEGRADATION; PROMOTES	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1) has been frequently overexpressed in many types of malignancy, suggesting its oncogenic function. It recognizes phosphorylated serine or threonine (pSer/Thr) of a target protein and isomerizes the adjacent proline (Pro) residue, thereby altering folding, subcellular localization, stability, and function of target proteins. The oncogenic transcription factor, Nrf2 harbors the pSer/Thr-Pro motif. This prompted us to investigate whether Pin1 could bind to Nrf2 and influence its stability and function in the context of implications for breast cancer development and progression. The correlation between Pin1 and Nrf2 in the triple-negative breast cancer cells was validated by RNASeq analysis as well as immunofluorescence staining. Interaction between Pin1 and Nrf2 was assessed by co-immunoprecipitation and an in situ proximity ligation assay. We found that mRNA and protein levels of Pin1 were highly increased in the tumor tissues of triple-negative breast cancer patients and the human breast cancer cell line. Genetic or pharmacologic inhibition of Pin1 enhanced the ubiquitination and degradation of Nrf2. In contrast, the overexpression of Pin1 resulted in the accumulation of Nrf2 in the nucleus, without affecting its transcription. Notably, the phosphorylation of Nrf2 at serine 215, 408, and 577 is essential for its interaction with Pin1. We also identified phosphorylated Ser104 and Thr277 residues in Keap1, a negative regulator of Nrf2, for Pin1 binding. Pin1 plays a role in breast cancer progression through stabilization and constitutive activation of Nrf2 by competing with Keap1 for Nrf2 binding.	[Saeidi, Soma; Kim, Su-Jung; Guillen-Quispe, Yanymee N.; Han, Hyeong-Jun; Kim, Seung Hyeon; Zhong, Xiancai; Piao, Juan-Yu; Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Seoul, South Korea; [Saeidi, Soma; Guillen-Quispe, Yanymee N.; Surh, Young-Joon] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Jagadeesh, Achanta Sri Venkata; Kim, Seung Hyeon; Lee, Han-Byoel; Han, Wonshik; Surh, Young-Joon] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Kim, Seong-Jin] GILO Inst, Seoul, South Korea; [Jeong, Joon; Shin, Yun Jin] Yonsei Univ, Gangnam Severance Hosp, Dept Surg, Coll Med, Seoul, South Korea; [Cha, Yoon Jin] Yonsei Univ, Gangnam Severance Hosp, Dept Pathol, Coll Med, Seoul, South Korea; [Lee, Han-Byoel; Han, Wonshik] Seoul Natl Univ Hosp, Dept Surg, Seoul, South Korea; [Min, Sang-Hyun] New Drug Dev Ctr DGMIF, Daegu, South Korea; [Min, Sang-Hyun] Kyungpook Natl Univ, Sch Life Sci, Daegu, South Korea; [Tian, Wang] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Kitamura, Hiroshi] Tohoku Univ, Inst Dev Aging & Canc IDAC, Dept Gene Express Regulat, Div Aging Sci, Sendai, Miyagi, Japan	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University Hospital; Kyungpook National University; University of Arizona; Tohoku University	Surh, YJ (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul 08826, South Korea.	surh@snu.ac.kr	Zhong, Xiancai/AAV-2761-2020; Zhong, Xiancai/AAM-3069-2020	Zhong, Xiancai/0000-0001-8312-4057; Zhong, Xiancai/0000-0001-8312-4057; Kim, Seung Hyeon/0000-0001-9197-5978; Jeong, Joon/0000-0003-0397-0005; Cha, Yoon Jin/0000-0002-5967-4064	National Research Foundation of Korea (NRE) [2021R1A2C2014186, 5120200513755, 2021R1I1A1A01046540]	National Research Foundation of Korea (NRE)(National Research Foundation of Korea)	National Research Foundation of Korea (NRE), Grant/Award Number: 2021R1A2C2014186, 5120200513755 and 2021R1I1A1A01046540	Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Cheng KC, 2019, EBIOMEDICINE, V45, P25, DOI 10.1016/j.ebiom.2019.06.022; Cloer EW, 2019, CANCER RES, V79, P889, DOI 10.1158/0008-5472.CAN-18-2723; de la Vega MR, 2018, CANCER CELL, V34, P21, DOI 10.1016/j.ccell.2018.03.022; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Guo P, 2019, P NATL ACAD SCI USA, V116, P18295, DOI 10.1073/pnas.1904697116; Han HJ, 2017, CURR PHARM DESIGN, V23, P4422, DOI 10.2174/1381612823666170703164711; Han HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147038; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hu X, 2017, ONCOGENE, V36, P5177, DOI 10.1038/onc.2017.137; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lee YM, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00469; Liang C, 2019, CANCER RES, V79, P133, DOI 10.1158/0008-5472.CAN-18-1968; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Lu K, 2017, CANCER RES, V77, P2881, DOI 10.1158/0008-5472.CAN-16-2204; Lu KP, 2004, TRENDS BIOCHEM SCI, V29, P200, DOI 10.1016/j.tibs.2004.02.002; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Lu ZM, 2014, CELL RES, V24, P1033, DOI 10.1038/cr.2014.109; Mizukami Y, 1997, J BIOL CHEM, V272, P16657, DOI 10.1074/jbc.272.26.16657; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Pani E, 2008, BBA-MOL CELL RES, V1783, P1121, DOI 10.1016/j.bbamcr.2008.02.020; Reineke EL, 2008, MOL CELL BIOL, V28, P997, DOI 10.1128/MCB.01848-07; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Saeidi S, 2020, TOXICOL APPL PHARM, V402, DOI 10.1016/j.taap.2020.115121; Sun Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006588; Taguchi K, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00085; Takahashi K, 2007, ONCOGENE, V26, P3835, DOI 10.1038/sj.onc.1210153; Tsang YHN, 2013, ONCOGENE, V32, P1488, DOI 10.1038/onc.2012.178; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Wulf G, 2004, EMBO J, V23, P3397, DOI 10.1038/sj.emboj.7600323; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Xu M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156833; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yu R, 2000, J BIOL CHEM, V275, P39907, DOI 10.1074/jbc.M004037200; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	47	2	2	4	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22068	10.1096/fj.202100776RR	http://dx.doi.org/10.1096/fj.202100776RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34918396				2022-12-28	WOS:000734992000053
J	Wen, X; Xi, YX; Zhang, YZ; Jiao, LJ; Shi, S; Bai, SZ; Sun, FQ; Chang, GQ; Wu, R; Hao, JH; Li, HZ				Wen, Xin; Xi, Yuxin; Zhang, Yuanzhou; Jiao, Lijie; Shi, Sa; Bai, Shuzhi; Sun, Fengqi; Chang, Guiquan; Wu, Ren; Hao, Jinghui; Li, Hongzhu			DR1 activation promotes vascular smooth muscle cell apoptosis via up-regulation of CSE/H2S pathway in diabetic mice	FASEB JOURNAL			English	Article						apoptosis; diabetic mice; dopamine D1 receptors; hydrogen sulfide; VSMCs	HYDROGEN-SULFIDE; HIGH-GLUCOSE; GROWTH-FACTOR; DOPAMINE-RECEPTORS; PROLIFERATION; EXPRESSION; CALCIUM; INHIBITION; RAT; H2S	The important role of hydrogen sulfide (H2S) as a novel gasotransmitter in inhibiting proliferation and promoting apoptosis of vascular smooth muscle cells (VSMCs) has been widely recognized. The dopamine D1 receptor (DR1), a G protein coupled receptor, inhibits atherosclerosis by suppressing VSMC proliferation. However, whether DR1 contributes to VSMC apoptosis via the induction of endogenous H2S in diabetic mice is unclear. Here, we found that hyperglycemia decreased the expressions of DR1 and cystathionine-gamma-lyase (CSE, a key enzyme for endogenous H2S production) and reduced endogenous H2S generation in mouse arteries and cultured VSMCs. DR1 agonist SKF38393 increased DR1 and CSE expressions and stimulated endogenous H2S generation. Sodium hydrosulfide (NaHS, a H2S donor) increased CSE expressions and H2S generation but had no effect on DR1 expression. In addition, high glucose (HG) increased VSMC apoptosis, up-regulated IGF-1-IGF-1R and HB-EGF-EGFR, and stimulated ERK1/2 and PI3K-Akt pathways. Overexpression of DR1, the addition of SKF38393 or supply of NaHS further promoted VSMC apoptosis and down-regulated the above pathways. Knock out of CSE or the addition of the CSE inhibitor poly propylene glycol diminished the effect of SKF38393. Moreover, calmodulin (CaM) interacted with CSE in VSMCs; HG increased intracellular Ca2+ concentration and induced CaM expression, further strengthened the interaction of CaM with CSE in VSMCs, which were further enhanced by SKF38393. CaM inhibitor W-7, inositol 1,4,5-trisphosphate (IP3) inhibitor 2-APB, or ryanodine receptor inhibitor tetracaine abolished the stimulatory effect of SKF38393 on CaM expression and intracellular Ca2+ concentration. Taken together, these results suggest that DR1 up-regulates CSE/H2S signaling by inducing the Ca2+-CaM pathway followed by down-regulations of IGF-1-IGF-1R and HB-EGF-EGFR and their downstream ERK1/2 and PI3K-Akt, finally promoting the apoptosis of VSMCs in diabetic mice.	[Wen, Xin; Xi, Yuxin; Shi, Sa; Bai, Shuzhi; Sun, Fengqi; Chang, Guiquan; Wu, Ren; Hao, Jinghui; Li, Hongzhu] Harbin Med Univ, Dept Pathophysiol, Harbin, Peoples R China; [Zhang, Yuanzhou] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai, Peoples R China; [Jiao, Lijie; Li, Hongzhu] Xiamen Univ, Sch Med, Xiamen 361100, Fujian, Peoples R China	Harbin Medical University; Shanghai Jiao Tong University; Xiamen University	Li, HZ (corresponding author), Xiamen Univ, Sch Med, Xiamen 361100, Fujian, Peoples R China.	lhz2020@xmu.edu.cn	Xi, Yuxin/GWZ-8648-2022		National Natural Science Foundation of China [81770486, 81200160]; Heilongjiang Province Natural Science Foundation of China [H2018005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Province Natural Science Foundation of China(Natural Science Foundation of Heilongjiang Province)	This study was supported by the National Natural Science Foundation of China (No. 81770486, No. 81200160) and the Heilongjiang Province Natural Science Foundation of China (No. H2018005)	ABRAHAM JA, 1993, BIOCHEM BIOPH RES CO, V190, P125, DOI 10.1006/bbrc.1993.1020; Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Bakker AD, 2016, J CELL PHYSIOL, V231, P1283, DOI 10.1002/jcp.25228; Berke JD, 2018, NAT NEUROSCI, V21, P787, DOI 10.1038/s41593-018-0152-y; Chen JT, 2016, INT J CARDIOL, V220, P681, DOI 10.1016/j.ijcard.2016.06.200; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Flamant M, 2012, NEPHROL DIAL TRANSPL, V27, P1297, DOI 10.1093/ndt/gfs030; Goldenberg JZ, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4743; Hong F, 2001, LIFE SCI, V68, P1095, DOI 10.1016/S0024-3205(00)01012-2; Huang YL, 2009, CELL SIGNAL, V21, P954, DOI 10.1016/j.cellsig.2009.02.005; Jafari M, 2019, J CELL PHYSIOL, V234, P2373, DOI 10.1002/jcp.27262; Jeong IK, 2011, EXP MOL MED, V43, P684, DOI 10.3858/emm.2011.43.12.079; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Le Coz V, 2016, ONCOTARGET, V7, P82511, DOI 10.18632/oncotarget.12733; Li HZ, 2008, BASIC CLIN PHARMACOL, V102, P329, DOI 10.1111/j.1742-7843.2007.00177.x; Li HZ, 2017, AM J PHYSIOL-HEART C, V312, pH406, DOI 10.1152/ajpheart.00245.2016; Li HZ, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0035-9; Li HZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041614; Li SS, 2015, ANTIOXID REDOX SIGN, V23, P630, DOI 10.1089/ars.2014.6186; Liu N, 2017, J CELL MOL MED, V21, P3190, DOI 10.1111/jcmm.13223; LOKHANDWALA MF, 1982, J AUTON PHARMACOL, V2, P189, DOI 10.1111/j.1474-8673.1982.tb00489.x; Makam AN, 2017, CIRCULATION, V135, P180, DOI 10.1161/CIRCULATIONAHA.116.022622; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; O'Neill BT, 2019, DIABETES, V68, P556, DOI 10.2337/db18-0416; Orrenius S, 2015, BIOCHEM BIOPH RES CO, V460, P72, DOI 10.1016/j.bbrc.2015.01.137; Raab G, 1997, BBA-REV CANCER, V1333, pF179, DOI 10.1016/S0304-419X(97)00024-3; RAJFER SI, 1990, CIRCULATION, V82, P97; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Sahinturk V, 2020, LIFE SCI, V246, DOI 10.1016/j.lfs.2020.117416; Shi LL, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0177-4; Shuang T, 2018, BIOCHEM PHARMACOL, V149, P143, DOI 10.1016/j.bcp.2017.12.009; Sun WM, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0196-9; Sun YT, 2018, J CELL PHYSIOL, V233, P3066, DOI 10.1002/jcp.26087; Tang BL, 2006, NEUROBIOL AGING, V27, P501, DOI 10.1016/j.neurobiolaging.2005.02.001; TENNANT M, 1990, AUST NZ J SURG, V60, P747, DOI 10.1111/j.1445-2197.1990.tb07468.x; Wallace JL, 2015, ANTIOXID REDOX SIGN, V22, P398, DOI 10.1089/ars.2014.5901; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wang YW, 2016, EXP CELL RES, V347, P184, DOI 10.1016/j.yexcr.2016.08.004; Wu YT, 2019, EUR J PHARMACOL, V853, P93, DOI 10.1016/j.ejphar.2019.03.021; Wu YS, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4196482; Yang BY, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12590; Yang GD, 2004, FASEB J, V18, P1782, DOI 10.1096/fj.04-2279fje; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang GD, 2010, CARDIOVASC RES, V86, P487, DOI 10.1093/cvr/cvp420; Yang J, 2011, J AGR FOOD CHEM, V59, P11483, DOI 10.1021/jf2024819; Yao WD, 2008, BIOCHEM PHARMACOL, V75, P2055, DOI 10.1016/j.bcp.2008.01.018; Zeng CY, 2009, J HYPERTENS, V27, P1033, DOI 10.1097/HJH.0b013e3283293c7b; Zhang LX, 2021, J CELL MOL MED, V25, P8201, DOI 10.1111/jcmm.16688; Zhang M, 2012, STRUCTURE, V20, P911, DOI 10.1016/j.str.2012.03.019; Zhang YZ, 2019, AGING-US, V11, P1745, DOI 10.18632/aging.101866; Zhou DM, 2020, AGING-US, V12, P5352, DOI 10.18632/aging.102955; Zhu Q, 2015, J VASC RES, V52, P291, DOI 10.1159/000442980	60	6	6	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22070	10.1096/fj.202101455R	http://dx.doi.org/10.1096/fj.202101455R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34859931	hybrid			2022-12-28	WOS:000734992000043
J	Shen, JH; Rossato, FA; Cano, I; Ng, YSE				Shen, Junhui; Rossato, Franco Aparecido; Cano, Issahy; Ng, Yin Shan Eric			Novel engineered, membrane-tethered VEGF-A variants promote formation of filopodia, proliferation, survival, and cord or tube formation by endothelial cells via persistent VEGFR2/ERK signaling and activation of CDC42/ROCK pathways	FASEB JOURNAL			English	Article						filopodia; isoform; membrane-tethered; therapeutic angiogenesis; VEGF-A	GENE-TRANSFER; RHO GTPASES; COLLATERAL DEVELOPMENT; ANGIOGENESIS; ISOFORMS; BINDING; DISEASE; TRANSDUCTION; RECEPTOR; KINASES	Therapeutic angiogenesis would be clinically valuable in situations such as peripheral vascular disease in diabetic patients and tissue reperfusion following ischemia or injury, but approaches using traditional isoforms of vascular endothelial growth factor-A (VEGF) have had little success. The isoform VEGF165 is both soluble and matrix-associated, but can cause pathologic vascular changes. Freely diffusible VEGF121 is not associated with pathologic angiogenesis, but its failure to remain in the vicinity of the targeted area presents therapeutic challenges. In this study, we evaluate the cellular effects of engineered VEGF variants that tether extracellular VEGF121 to the cell membrane with the goal of activating VEGF receptor 2 (VEGFR2) in a sustained, autologous fashion in endothelial cells. When expressed by primary human retinal endothelial cells (hRECs), the engineered, membrane-tethered variants eVEGF-38 and eVEGF-53 provide a lasting VEGF signal that induces cell proliferation and survival, increases endothelial permeability, promotes the formation of a cord/tube network, and stimulates the formation of elongated filopodia on the endothelial cells. The engineered VEGF variants activate VEGFR2, MAPK/ERK, and the Rho GTPase mediators CDC42 and ROCK, activities that are required for the formation of the elongated filopodia. The sustained, pro-angiogenic activities induced by eVEGF-38 and eVEGF-53 support the potential of engineered VEGF variants-overexpressing endothelial cells as a novel combination of gene and cell-based therapeutic strategy for stimulating endothelial cell-autologous therapeutic angiogenesis.	[Shen, Junhui; Rossato, Franco Aparecido; Cano, Issahy; Ng, Yin Shan Eric] Schepens Eye Res Inst Massachusetts Eye & Ear, Harvard Ophthalmol, 20 Staniford St, Boston, MA 02114 USA; [Shen, Junhui] Zhejiang Univ, Sch Med, Eye Ctr, Affiliated Hosp 2, Hangzhou, Peoples R China	Zhejiang University	Ng, YSE (corresponding author), Schepens Eye Res Inst Massachusetts Eye & Ear, Harvard Ophthalmol, 20 Staniford St, Boston, MA 02114 USA.	eric_ng@meei.harvard.edu	Ng, Wing Yin/HHN-1743-2022		Research to Prevent Blindness; China Scholarship Council [201606260221]; National Natural Science Foundation of China [82000886]; National Institute of Health National Eye Institute Core grant [P30EY003790]	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Health National Eye Institute Core grant	Supported by an unrestricted grant from Research to Prevent Blindness (YSN, PI: Joan Miller), the China Scholarship Council (JS, Grant No. 201606260221), National Natural Science Foundation of China (JS, Grant No. 82000886) and the National Institute of Health National Eye Institute Core grant P30EY003790	Abraham S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8286; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; El Baba N, 2020, ANAL CELL PATHOL, V2020, DOI 10.1155/2020/2097214; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Esser S, 1998, J CELL SCI, V111, P1853; Fan LF, 2012, BIOCHEM SOC T, V40, P268, DOI 10.1042/BST20110625; Fantin A, 2015, CELL REP, V11, P1577, DOI 10.1016/j.celrep.2015.05.018; Fearnley GW, 2016, BIOL OPEN, V5, P571, DOI 10.1242/bio.017434; Fearnley GW, 2015, BIOL OPEN, V4, P731, DOI 10.1242/bio.201410884; Galambos C, 2002, AM J RESP CELL MOL, V27, P194, DOI 10.1165/ajrcmb.27.2.4703; Hanna S, 2013, CELL SIGNAL, V25, P1955, DOI 10.1016/j.cellsig.2013.04.009; Hellstrom M, 2007, CELL ADHES MIGR, V1, P133, DOI 10.4161/cam.1.3.4978; Huang XG, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-20537; Huang Yaqing, 2020, Matrix Biol Plus, V6-7, P100037, DOI 10.1016/j.mbplus.2020.100037; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Isner JM, 1996, LANCET, V348, P370, DOI 10.1016/S0140-6736(96)03361-2; Iyer Sunil R, 2017, JACC Basic Transl Sci, V2, P503, DOI 10.1016/j.jacbts.2017.07.012; Jacquemet G, 2019, CURR BIOL, V29, P202, DOI 10.1016/j.cub.2018.11.053; Jacquemet G, 2015, CURR OPIN CELL BIOL, V36, P23, DOI 10.1016/j.ceb.2015.06.007; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Krilleke D, 2009, BIOCHEM SOC T, V37, P1201, DOI 10.1042/BST0371201; LeBlanc ME, 2017, J EXP MED, V214, P1029, DOI 10.1084/jem.20161802; Loirand G, 2015, PHARMACOL REV, V67, P1074, DOI 10.1124/pr.115.010595; Mamer SB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71484-y; Mammadzada P, 2016, ACTA OPHTHALMOL, V94, P805, DOI [10.1111/aos.13119, 10.1111/j.1755-3768.2016.0399]; Martins-Green M, 2008, METHOD ENZYMOL, V443, P137, DOI 10.1016/S0076-6879(08)02008-9; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Ng YS, 2006, EXP CELL RES, V312, P527, DOI 10.1016/j.yexcr.2005.11.008; Ng YS, 2001, CURR CONTR TRIALS C, V2, P278, DOI 10.1186/CVM-2-6-278; Ng YS, 2001, DEV DYNAM, V220, P112, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1093>3.0.CO;2-D; Okonkwo UA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231962; Ruch C, 2007, NAT STRUCT MOL BIOL, V14, P249, DOI 10.1038/nsmb1202; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sarabipour S, 2018, CELL ADHES MIGR, V12, P204, DOI 10.1080/19336918.2017.1372878; Sarwar S, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011346.pub2; Shen JH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1049-0; Sit ST, 2011, J CELL SCI, V124, P679, DOI 10.1242/jcs.064964; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Srinivasan B, 2019, BLOOD BRAIN BARRIER, P99, DOI [DOI 10.1007/978-1-4939-8946-1_6, 10.1007/978-1-4939-8946-1_6]; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Su HLC, 2020, J CLIN IMMUNOL, V40, P551, DOI 10.1007/s10875-020-00785-8; Su Q, 2017, J CELL BIOCHEM, V118, P4568, DOI 10.1002/jcb.26120; Takeshita S, 1996, LAB INVEST, V75, P487; Tsurumi Y, 1996, CIRCULATION, V94, P3281, DOI 10.1161/01.CIR.94.12.3281; Uccelli A, 2019, SWISS MED WKLY, V149, DOI 10.4414/smw.2019.20011; Usui T, 2004, INVEST OPHTH VIS SCI, V45, P368, DOI 10.1167/iovs.03-0106; Wang YN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130341	49	3	4	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22036	10.1096/fj.202100448RR	http://dx.doi.org/10.1096/fj.202100448RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34793603	Green Accepted			2022-12-28	WOS:000722321300007
J	Wei, ZT; Cui, YQ; Tian, L; Liu, Y; Yu, Y; Jin, X; Li, H; Wang, KJ; Sun, Q				Wei, Zhitao; Cui, Yaqian; Tian, Lei; Liu, Yu; Yu, Yang; Jin, Xi; Li, Hong; Wang, Kunjie; Sun, Qun			Probiotic Lactiplantibacillus plantarum N-1 could prevent ethylene glycol-induced kidney stones by regulating gut microbiota and enhancing intestinal barrier function	FASEB JOURNAL			English	Article						gut microbiota; hyperoxaluria; intestinal barrier; intestinal inflammation; kidney stones; Lactiplantibacillus plantarum N-1	OXALATE-DEGRADING BACTERIA; CHAIN FATTY-ACIDS; OXALOBACTER-FORMIGENES; EPITHELIAL-CELLS; CALCIUM; HYPEROXALURIA; COLONIZATION; UROLITHIASIS; EXCRETION; PROTEINS	Defective permeability barrier is considered to be an incentive of hyperuricemia, however, the link between them has not been proven. Here, we evaluated the potential preventive effects of Lactiplantibacillus plantarum N-1 (LPN1) on gut microbiota and intestinal barrier function in rats with hyperoxaluria-induced kidney stones. Male rats were supplied with 1% ethylene glycol (EG) dissolved in drinking water for 4 weeks to develop hyperoxaluria, and some of them were administered with LPN1 for 4 weeks before EG treatment as a preventive intervention. We found that EG not only resulted hyperoxaluria and kidney stone formation, but also promoted the intestinal inflammation, elevated intestinal permeability, and gut microbiota disorders. Supplementation of LPN1 inhibited the renal crystalline deposits through reducing urinary oxalic acid and renal osteopontin and CD44 expression and improved EG-induced intestinal inflammation and barrier function by decreasing the serum LPS and TLR4/NF-kappa B signaling and up-regulating tight junction Claudin-2 in the colon, as well as increasing the production of short-chain fatty acid (SCFAs) and the abundance of beneficial SCFAs-producing bacteria, mainly from the families of Lachnospiraceae and Ruminococcaceae. Probiotic LPN1 could prevent EG-induced hyperoxaluria by regulating gut microbiota and enhancing intestinal barrier function.	[Wei, Zhitao; Liu, Yu; Jin, Xi; Li, Hong; Wang, Kunjie] Sichuan Univ, West China Hosp, Dept Urol, Inst Urol,Lab Reconstruct Urol, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China; [Cui, Yaqian; Tian, Lei; Sun, Qun] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, 24 South Sect 1,Yihuan Rd, Chengdu 610065, Sichuan, Peoples R China; [Yu, Yang] Sichuan Acad Agr Sci, Soil & Fertilizer Inst, Natl Local Joint Engn Lab Breeding & Cultivat Edi, Chengdu, Peoples R China	Sichuan University; Sichuan University; Sichuan Academy of Agricultural Sciences (SAAS)	Wang, KJ (corresponding author), Sichuan Univ, West China Hosp, Dept Urol, Inst Urol,Lab Reconstruct Urol, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China.; Sun, Q (corresponding author), Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, 24 South Sect 1,Yihuan Rd, Chengdu 610065, Sichuan, Peoples R China.	wangkj@scu.edu.cn; qunsun@scu.edu.cn		Wei, Zhitao/0000-0002-1285-9328	National Natural Science Foundation of China (NSFC) [81770703, 81970602]; National Key Research and Development Projects of China [2019YFE0103800]; International Research and Development Program of Sichuan [2019YFH0113, 2021YFH0060]; 1.3.5 Project for Disciplines of Excellence by the West China Hospital of Sichuan University [ZYGD18011, ZYJC18015]; West China Hospital, Sichuan University [2019HXBH049]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Research and Development Projects of China; International Research and Development Program of Sichuan; 1.3.5 Project for Disciplines of Excellence by the West China Hospital of Sichuan University; West China Hospital, Sichuan University(Sichuan University)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81770703 and 81970602; National Key Research and Development Projects of China, Grant/Award Number: 2019YFE0103800; International Research and Development Program of Sichuan, Grant/Award Number: 2019YFH0113 and 2021YFH0060; 1.3.5 Project for Disciplines of Excellence by the West China Hospital of Sichuan University, Grant/Award Number: ZYGD18011 and ZYJC18015; Post-Doctor Research Project by West China Hospital, Sichuan University, Grant/Award Number: 2019HXBH049	Abratt VR, 2010, ADV APPL MICROBIOL, V72, P63, DOI 10.1016/S0065-2164(10)72003-7; Al-Wahsh I, 2012, UROL RES, V40, P191, DOI 10.1007/s00240-011-0421-7; Antonelli JA, 2014, EUR UROL, V66, P724, DOI 10.1016/j.eururo.2014.06.036; Ashida H, 2012, NAT CHEM BIOL, V8, P36, DOI 10.1038/nchembio.741; Aslani MR, 2011, TROP ANIM HEALTH PRO, V43, P1065, DOI 10.1007/s11250-011-9818-0; Bhandari A, 2002, J UROLOGY, V168, P253, DOI 10.1016/S0022-5347(05)64903-8; Blanchard C, 2017, OBES SURG, V27, P2590, DOI 10.1007/s11695-017-2670-1; Campieri C, 2001, KIDNEY INT, V60, P1097, DOI 10.1046/j.1523-1755.2001.0600031097.x; Chen ZQ, 2003, CHINESE MED J-PEKING, V116, P1749; COE FL, 1982, AM J MED, V72, P25, DOI 10.1016/0002-9343(82)90567-8; Gaspar SRD, 2016, UROL ANNALS, V8, P297, DOI 10.4103/0974-7796.184879; De Baere S, 2013, J PHARMACEUT BIOMED, V80, P107, DOI 10.1016/j.jpba.2013.02.032; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Falony G, 2018, NAT MICROBIOL, V3, P526, DOI 10.1038/s41564-018-0143-5; Fujimoto T, 2013, J GASTROEN HEPATOL, V28, P613, DOI 10.1111/jgh.12073; Fujita H, 2008, MOL BIOL CELL, V19, P1912, DOI 10.1091/mbc.E07-09-0973; Gnanandarajah JS, 2012, J APPL MICROBIOL, V113, P745, DOI 10.1111/j.1365-2672.2012.05390.x; Gomez-Hurtado I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023037; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Hatch M, 2005, UROL RES, V33, P1, DOI 10.1007/s00240-004-0445-3; Hatch M, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2016.12.70; Holleran G, 2017, MINERVA GASTROENTERO, V63, P373, DOI 10.23736/S1121-421X.17.02386-8; Holmes RP, 2016, UROLITHIASIS, V44, P27, DOI 10.1007/s00240-015-0839-4; Ilyin VK, 2014, ACTA NATURAE, V6, P10, DOI 10.32607/20758251-2014-6-2-10-18; Joshi S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185009; Kullin BR., 2016, ROLE BACTERIA UROLOG, P63; Li J, 2016, CIRCULATION, V133, P2434, DOI 10.1161/CIRCULATIONAHA.115.019645; Liebman M, 2011, ADV NUTR, V2, P254, DOI 10.3945/an.111.000414; Liu J., 2018, PHARM J CHIN PLA, V34, P66; Liu RM., 2018, THESIS SICHUAN U; Liu RM., 2017, CHINA MEASUREMENT TE, V43, P58, DOI DOI 10.11857/J.ISSN.1674-5124.2017.12.011; Liu Y, 2020, FASEB J, V34, P11200, DOI 10.1096/fj.202000786R; Machiels K, 2014, GUT, V63, P1275, DOI 10.1136/gutjnl-2013-304833; Miller AW, 2013, PATHOGENS, V2, P636, DOI 10.3390/pathogens2040636; Miller C, 2000, TOXICOL APPL PHARM, V162, P132, DOI 10.1006/taap.1999.8835; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Plociennikowska A, 2015, CELL MOL LIFE SCI, V72, P557, DOI 10.1007/s00018-014-1762-5; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sadaf H, 2017, MICROB PATHOGENESIS, V109, P287, DOI 10.1016/j.micpath.2017.06.009; Sanderson IR, 2004, J NUTR, V134, p2450S, DOI 10.1093/jn/134.9.2450S; Scott KP, 2013, PHARMACOL RES, V69, P52, DOI 10.1016/j.phrs.2012.10.020; Sharma R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/305879; Siener R, 2003, KIDNEY INT, V63, P1037, DOI 10.1046/j.1523-1755.2003.00807.x; Siener R, 2013, KIDNEY INT, V83, P1144, DOI 10.1038/ki.2013.104; Stapenhorst L, 2008, PEDIATR NEPHROL, V23, P2277, DOI 10.1007/s00467-008-0917-8; Stewart CS, 2004, FEMS MICROBIOL LETT, V230, P1, DOI 10.1016/S0378-1097(03)00864-4; Theka T, 2013, UROLITHIASIS, V41, P111, DOI 10.1007/s00240-013-0543-1; Thurgood LA, 2012, BJU INT, V109, P1100, DOI 10.1111/j.1464-410X.2011.10530.x; Turroni S, 2010, APPL ENVIRON MICROB, V76, P5609, DOI 10.1128/AEM.00844-10; Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009; Worcester EM, 2010, NEW ENGL J MED, V363, P954, DOI 10.1056/NEJMcp1001011	53	7	8	6	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21937	10.1096/fj.202100887RR	http://dx.doi.org/10.1096/fj.202100887RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34606628	hybrid			2022-12-28	WOS:000712009200001
J	Ballasy, NN; Jadli, AS; Edalat, P; Kang, SA; Hassanabad, AF; Gomes, KP; Fedak, PWM; Patel, VB				Ballasy, Noura N.; Jadli, Anshul S.; Edalat, Pariya; Kang, Sean; Hassanabad, Ali Fatehi; Gomes, Karina P.; Fedak, Paul W. M.; Patel, Vaibhav B.			Potential role of epicardial adipose tissue in coronary artery endothelial cell dysfunction in type 2 diabetes	FASEB JOURNAL			English	Article						cardiovascular disease; endothelial cell dysfunction; epicardial adipose tissue; inflammation; type 2 diabetes	VASCULAR COMPLICATIONS; MELLITUS; DISEASE; EXPRESSION; OBESITY; RISK; INFLAMMATION; ADIPONECTIN; HEALTH; LPS	Cardiovascular disease is the most prevalent cause of morbidity and mortality in diabetes. Epicardial adipose tissue (EAT) lies in direct contact with the myocardium and coronary arteries and can influence cardiac (patho) physiology through paracrine signaling pathways. This study hypothesized that the proteins released from EAT represent a critical molecular link between the diabetic state and coronary artery endothelial cell dysfunction. To simulate type 2 diabetes-associated metabolic and inflammatory status in an ex vivo tissue culture model, human EAT samples were treated with a cocktail composed of high glucose, high palmitate, and lipopolysaccharide (gplEAT) and were compared with control EAT (conEAT). Compared to conEAT, gplEAT showed a markedly increased gene expression profile of proinflammatory cytokines, corroborating EAT inflammation, a hallmark feature observed in patients with type 2 diabetes. Luminex assay of EAT-secretome identified increased release of various proinflammatory cytokines, including tumor necrosis factor-alpha (TNF-alpha), interferon-alpha 2 (IFNA2), interleukin 1 beta (IL1B), interleukin 5 (IL5), interleukin 13 (IL13), and CCL5, among others, in response to high glucose, high palmitate, and lipopolysaccharide. Conditioned culture media was used to collect the concentrated proteins (CPs). In response to gplEAT-CPs, human coronary artery endothelial cells (HCAECs) exhibited an inflammatory endothelial cell phenotype, featuring a significantly increased gene expression of proinflammatory cytokines and cell surface expression of VCAM-1. Moreover, gplEAT-CPs severely decreased Akt-eNOS signaling, nitric oxide production, and angiogenic potential of HCAECs, when compared with conEAT-CPs. These findings indicate that EAT inflammation may play a key role in coronary artery endothelial cell dysfunction in type 2 diabetes.	[Ballasy, Noura N.; Jadli, Anshul S.; Edalat, Pariya; Gomes, Karina P.; Patel, Vaibhav B.] Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Ballasy, Noura N.; Jadli, Anshul S.; Edalat, Pariya; Kang, Sean; Hassanabad, Ali Fatehi; Gomes, Karina P.; Fedak, Paul W. M.; Patel, Vaibhav B.] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB, Canada; [Kang, Sean; Hassanabad, Ali Fatehi; Fedak, Paul W. M.] Univ Calgary, Cumming Sch Med, Dept Cardiac Sci, Sect Cardiac Surg, Calgary, AB, Canada	University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary	Patel, VB (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Cumming Sch Med, Libin Cardiovasc Inst, 3330 Hosp Dr NW,HMRB-G71, Calgary, AB T2N 4N1, Canada.	vaibhav@ucalgary.ca	Jadli, Anshul/HCI-3785-2022; Patel, Vaibhav/B-4163-2016	Patel, Vaibhav/0000-0001-5917-5962	Libin Cardiovascular Institute, Cumming School of Medicine; Alberta Diabetes Institute	Libin Cardiovascular Institute, Cumming School of Medicine; Alberta Diabetes Institute	This work received support from Libin Cardiovascular Institute, Cumming School of Medicine (Start-up operating funds to VBP) and Alberta Diabetes Institute (Operating funds to VBP).	Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; Ahmad R, 2018, J IMMUNOL, V200, P3599, DOI 10.4049/jimmunol.1701552; ANDREWS HE, 1987, NATURE, V327, P237, DOI 10.1038/327237a0; Angulo-Urarte A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07172-3; Antonopoulos AS, 2018, CIRC-CARDIOVASC IMAG, V11, DOI 10.1161/CIRCIMAGING.118.008083; Antonopoulos AS, 2016, CIRC RES, V118, P842, DOI 10.1161/CIRCRESAHA.115.307856; Baker AR, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-1; Bale LK, 2018, GROWTH HORM IGF RES, V42-43, P1, DOI 10.1016/j.ghir.2018.07.002; Bambace C, 2014, HEART VESSELS, V29, P42, DOI 10.1007/s00380-012-0315-9; Bitar MS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030673; Boshuizen MCS, 2015, ARTERIOSCL THROM VAS, V35, P1579, DOI 10.1161/ATVBAHA.115.305464; Cao WN, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00647; Cao Y, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112794; Carantoni M, 1997, DIABETES CARE, V20, P1462, DOI 10.2337/diacare.20.9.1462; Cefalu WT, 2019, DIABETES CARE, V42, pS103, DOI 10.2337/dc19S010; Cheng XF, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/3765173; Cho Yoon Mi, 2018, Exp Mol Med, V50, P1, DOI 10.1038/s12276-018-0131-0; COHEN RA, 1988, CIRC RES, V63, P903, DOI 10.1161/01.RES.63.5.903; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Deng XR, 2019, MOL THER-NUCL ACIDS, V18, P903, DOI 10.1016/j.omtn.2019.10.014; Ding H, 2005, VASC HEALTH RISK MAN, V1, P55, DOI 10.2147/vhrm.1.1.55.58939; Dong JS, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1360-0; Fadini GP, 2006, DIABETOLOGIA, V49, P3075, DOI 10.1007/s00125-006-0401-6; Fuster JJ, 2016, CIRC RES, V118, P1786, DOI 10.1161/CIRCRESAHA.115.306885; Gaborit B, 2017, COMPR PHYSIOL, V7, P1051, DOI 10.1002/cphy.c160034; Gonzalez-Castro TB, 2019, AM J MED GENET B, V180, P320, DOI 10.1002/ajmg.b.32731; Greulich S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059697; Greulich S, 2012, CIRCULATION, V126, P2324, DOI 10.1161/CIRCULATIONAHA.111.039586; Greulich S, 2011, J CELL MOL MED, V15, P2399, DOI 10.1111/j.1582-4934.2010.01232.x; Gu K, 1998, DIABETES CARE, V21, P1138, DOI 10.2337/diacare.21.7.1138; Ha EE, 2018, ARTERIOSCL THROM VAS, V38, pE137, DOI 10.1161/ATVBAHA.118.311421; Hassan M, 2012, NAT REV CARDIOL, V9, P689, DOI 10.1038/nrcardio.2012.148; Tong HV, 2017, J DIABETES INVEST, V8, P295, DOI 10.1111/jdi.12579; Iacobellis G, 2005, CYTOKINE, V29, P251, DOI 10.1016/j.cyto.2004.11.002; Iacobellis G., 2020, EPICARDIAL ADIPOSE T, P9; Iacobellis G, 2011, TRENDS ENDOCRIN MET, V22, P450, DOI 10.1016/j.tem.2011.07.003; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jayashree B, 2014, MOL CELL BIOCHEM, V388, P203, DOI 10.1007/s11010-013-1911-4; Karastergiou K, 2010, ARTERIOSCL THROM VAS, V30, P1340, DOI 10.1161/ATVBAHA.110.204719; Kimber-Trojnar Z, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120505; Le Brocq M, 2008, ANTIOXID REDOX SIGN, V10, P1631, DOI 10.1089/ars.2007.2013; Lee MW, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060854; Li YJ, 2007, DIABETES, V56, P656, DOI 10.2337/db06-0999; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Lin YC, 2017, ONCOTARGET, V8, P17518, DOI 10.18632/oncotarget.15418; Liu XF, 2018, MOL MED REP, V17, P5484, DOI 10.3892/mmr.2018.8542; Mikolajczyk TP, 2016, FASEB J, V30, P1987, DOI 10.1096/fj.201500088R; Nishimura Y, 2008, CIRC J, V72, P469, DOI 10.1253/circj.72.469; Nteeba J, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001243; Oikonomou EK, 2019, NAT REV CARDIOL, V16, P83, DOI 10.1038/s41569-018-0097-6; Pate VB, 2016, DIABETES, V65, P85, DOI 10.2337/db15-0399; Patel VB, 2012, CIRC RES, V110, P1322, DOI 10.1161/CIRCRESAHA.112.268029; Pilz S, 2008, CLIN CHEM LAB MED, V46, P429, DOI 10.1515/CCLM.2008.118; Raghavan S, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011295; Sacks HS, 2011, DIABETES CARE, V34, P730, DOI 10.2337/dc10-2083; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Scheithauer TPM, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.571731; Sena CM, 2013, BBA-MOL BASIS DIS, V1832, P2216, DOI 10.1016/j.bbadis.2013.08.006; Shih CH, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060887; Shimabukuro M, 2013, ARTERIOSCL THROM VAS, V33, P1077, DOI 10.1161/ATVBAHA.112.300829; Stefan N, 2010, DIABETES CARE, V33, P405, DOI [10.2337/dc10-0002, 10.2337/dc09-0544]; Sun HJ, 2020, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01568; Vallejo S, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0158-z; Fricke ACV, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235989; Vural B, 2008, CARDIOVASC PATHOL, V17, P392, DOI 10.1016/j.carpath.2008.02.006; Wang R, 2016, SCI REP-UK, V6, DOI 10.1038/srep36790; Zhang WX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02683-3; Zobel EH, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-020-0995-x	69	5	5	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21878	10.1096/fj.202100684RR	http://dx.doi.org/10.1096/fj.202100684RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34469050				2022-12-28	WOS:000702238200040
J	Bonda, WLM; Lavergne, M; Vasseur, V; Brisson, L; Roger, S; Legras, A; Guillon, A; Guyetant, S; Hiemstra, PS; Si-Tahar, M; Iochmann, S; Reverdiau, P				Bonda, Woodys Lenga Ma; Lavergne, Marion; Vasseur, Virginie; Brisson, Lucie; Roger, Sebastien; Legras, Antoine; Guillon, Antoine; Guyetant, Serge; Hiemstra, Pieter S.; Si-Tahar, Mustapha; Iochmann, Sophie; Reverdiau, Pascale			Kallikrein-related peptidase 5 contributes to the remodeling and repair of bronchial epithelium	FASEB JOURNAL			English	Article						airway repair; bronchial remodeling; COPD; epithelial-mesenchymal transition; kallikrein-related peptidase 5	OBSTRUCTIVE PULMONARY-DISEASE; MESSENGER-RNA EXPRESSION; CIGARETTE-SMOKE DISRUPTS; HUMAN TISSUE; PROTEOLYTIC CASCADE; TUMOR PROGRESSION; SERINE PROTEASES; KLK5; CANCER; FAMILY	Inflammation, oxidative stress, and protease/protease inhibitor imbalance with excessive production of proteases are factors associated with pathogenesis of the chronic obstructive pulmonary disease (COPD). In this study, we report that kallikrein-related peptidase 5 (KLK5) is a crucial protease involved in extracellular matrix (ECM) remodeling and bronchial epithelial repair after injury. First, we showed that KLK5 degrades the basal layer formed by culture of primary bronchial epithelial cells from COPD or non-COPD patients. Also, exogenous KLK5 acted differently on BEAS-2B cells already engaged in epithelial-to-mesenchymal transition (EMT) or on 16HBE 14o- cells harboring epithelial characteristics. Indeed, by inducing EMT, KLK5 reduced BEAS-2B cell adherence to the ECM. This effect, neutralized by tissue factor pathway inhibitor 2, a kunitz-type serine protease inhibitor, was due to a direct proteolytic activity of KLK5 on E-cadherin, beta-catenin, fibronectin, and alpha 5 beta 1 integrin. Thus, KLK5 may strengthen EMT mechanisms and promote the migration of cells by activating the mitogen-activated protein kinase signaling pathway required for this function. In contrast, knockdown of endogenous KLK5 in 16HBE14o- cells, accelerated wound healing repair after injury, and exogenous KLK5 addition delayed the closure repair. These data suggest that among proteases, KLK5 could play a critical role in airway remodeling events associated with COPD during exposure of the pulmonary epithelium to inhaled irritants or smoking and the inflammation process.	[Bonda, Woodys Lenga Ma; Lavergne, Marion; Vasseur, Virginie; Brisson, Lucie; Roger, Sebastien; Legras, Antoine; Guillon, Antoine; Guyetant, Serge; Si-Tahar, Mustapha; Iochmann, Sophie; Reverdiau, Pascale] Univ Tours, Tours, France; [Bonda, Woodys Lenga Ma; Lavergne, Marion; Vasseur, Virginie; Guillon, Antoine; Si-Tahar, Mustapha; Iochmann, Sophie; Reverdiau, Pascale] INSERM, Ctr Etud Pathol Resp CEPR, UMR 1100, Tours, France; [Brisson, Lucie] INSERM, Nutr Croissance & Canc N2C, UMR 1069, Tours, France; [Roger, Sebastien] Transplantat Immunol Inflammat, EA 4245, Tours, France; [Roger, Sebastien] Inst Univ France, Paris, France; [Legras, Antoine] CHRU Tours, Dept Chirurg Thorac, Tours, France; [Guillon, Antoine] CHRU Tours, Serv Med Intens & Reanimat, Tours, France; [Guyetant, Serge] CHRU Tours, Dept Danat & Cytol Pathol, Tours, France; [Hiemstra, Pieter S.] Leiden Univ, Dept Pulmonol, Med Ctr, Leiden, Netherlands; [Iochmann, Sophie; Reverdiau, Pascale] Inst Univ Technol, Tours, France	Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Universitaire de France; CHU Tours; CHU Tours; CHU Tours; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Reverdiau, P (corresponding author), INSERM, Ctr Etud Pathol Resp, Fac Med, UMR 1100, Bat 47C,10 Blvd, F-37032 Tours, France.	reverdiau@med.univ-tours.fr	SI-TAHAR, Mustapha/L-4149-2014	SI-TAHAR, Mustapha/0000-0002-5792-7742; REVERDIAU, Pascale/0000-0002-7530-6237; IOCHMANN, Sophie/0000-0002-4877-895X	Ligue Contre le Cancer; University of Tours	Ligue Contre le Cancer(Ligue nationale contre le cancer); University of Tours	We thank Yves Courty for introducing us to the fascinating world of KLKs. We are grateful to Sonia Georgeault and Julien Burlaud-Gaillard from the IBiSA Electron Microscopy platform of Tours University for scanning and transmission electron microscopy analysis and technical assistance for confocal microscopy. We particularly thank Laura Smales for editing the English text. Studies were supported by the "Ligue Contre le Cancer" and we especially thank the departmental committees of Indre et Loire and Charente Maritime. W. Lenga Ma Bonda was supported by a doctoral fellowship from the University of Tours.	Amatngalim GD, 2015, J IMMUNOL, V194, P3340, DOI 10.4049/jimmunol.1402169; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Avgeris Margaritis, 2011, Clin Proteomics, V8, P5, DOI 10.1186/1559-0275-8-5; Bagdonas E, 2015, INT J CHRONIC OBSTR, V10, P995, DOI 10.2147/COPD.S82518; BIETH JG, 1984, BIOCHEM MED METAB B, V32, P387, DOI 10.1016/0006-2944(84)90046-2; Bon E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13648; Bonda WLM, 2018, BIOL CHEM, V399, P959, DOI 10.1515/hsz-2018-0114; Boxio R, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0449-x; Brannstrom K, 2012, BIOL CHEM, V393, P369, DOI 10.1515/hsz-2011-0238; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Chand HS, 2005, THROMB HAEMOSTASIS, V94, P1122, DOI 10.1160/TH05-07-0509; Charbonnier JP, 2019, RESP MED, V146, P36, DOI 10.1016/j.rmed.2018.11.014; de Souza LR, 2013, BIOCHEM BIOPH RES CO, V433, P333, DOI 10.1016/j.bbrc.2013.03.001; Debela M, 2008, BIOL CHEM, V389, P623, DOI 10.1515/BC.2008.075; Descargues P, 2006, J INVEST DERMATOL, V126, P1622, DOI 10.1038/sj.jid.5700284; Dorn J, 2016, AM J CANCER RES, V6, P61; Emami N, 2010, BIOL CHEM, V391, P85, DOI 10.1515/BC.2010.007; Gao W, 2015, RESPIROLOGY, V20, P722, DOI 10.1111/resp.12542; Gaud G, 2011, J CELL MOL MED, V15, P196, DOI 10.1111/j.1582-4934.2009.00989.x; Goettig P, 2010, BIOCHIMIE, V92, P1546, DOI 10.1016/j.biochi.2010.06.022; Gong WW, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5901-0; Guillon-Munos A, 2011, J BIOL CHEM, V286, P25505, DOI 10.1074/jbc.M110.213231; Haddada M, 2018, BIOL CHEM, V399, P1099, DOI 10.1515/hsz-2017-0339; Hiemstra PS, 2018, TOXICOL IN VITRO, V47, P137, DOI 10.1016/j.tiv.2017.11.005; Higham A, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1017-y; Hou W, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/2025636; Iochmann S, 2009, CLIN EXP METASTAS, V26, P457, DOI 10.1007/s10585-009-9245-z; Ito JT, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040342; Jiang YY, 2012, RESP MED, V106, P1680, DOI 10.1016/j.rmed.2012.08.018; Jonsson M, 2005, BIOCHEM J, V387, P447, DOI 10.1042/BJ20041424; Kishibe M, 2019, J DERMATOL SCI, V95, P50, DOI 10.1016/j.jdermsci.2019.06.007; Kraen M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211987; Kryza T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24576-9; Lavergne M, 2013, FEBS OPEN BIO, V3, P291, DOI 10.1016/j.fob.2013.06.004; Lizama AJ, 2015, INNATE IMMUN-LONDON, V21, P575, DOI 10.1177/1753425914566083; Loessner D, 2012, GYNECOL ONCOL, V127, P569, DOI 10.1016/j.ygyno.2012.09.001; Ma H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38362-0; Magnen M, 2017, J VIROL, V91, DOI 10.1128/JVI.00421-17; Masurier N, 2018, MED RES REV, V38, P655, DOI 10.1002/med.21451; Meyer-Hoffert U, 2010, J BIOL CHEM, V285, P32174, DOI 10.1074/jbc.M109.091850; Meyer-Hoffert U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004372; Michael IP, 2006, J BIOL CHEM, V281, P12743, DOI 10.1074/jbc.M600326200; Navratilova Z, 2016, ARCH IMMUNOL THER EX, V64, P177, DOI 10.1007/s00005-015-0375-5; Nishida K, 2017, AM J PHYSIOL-LUNG C, V313, pL581, DOI 10.1152/ajplung.00074.2017; Nishioka M, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0232-4; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Papachristopoulou G, 2019, CLIN CHEM LAB MED, V57, P1251, DOI 10.1515/cclm-2018-1010; Pawar NR, 2019, CANCER RES, V79, P301, DOI 10.1158/0008-5472.CAN-18-1745; Petersen LC, 1996, BIOCHEMISTRY-US, V35, P266, DOI 10.1021/bi951501d; Planque C, 2005, BIOCHEM BIOPH RES CO, V329, P1260, DOI 10.1016/j.bbrc.2005.02.100; Prezas P, 2006, BIOL CHEM, V387, P807, DOI 10.1515/BC.2006.102; Rooney C, 2011, RESPIRATION, V81, P89, DOI 10.1159/000323946; Wang ZY, 2018, MOL MED REP, V18, P3143, DOI 10.3892/mmr.2018.9320; Yamasaki K, 2007, NAT MED, V13, P975, DOI 10.1038/nm1616; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com; Yousef GM, 2002, PROSTATE, V51, P126, DOI 10.1002/pros.10067; Yousef GM, 2002, CLIN CHEM, V48, P1241; Zhang LL, 2013, J PATHOL, V229, P74, DOI 10.1002/path.4070	60	3	3	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21838	10.1096/fj.202002649R	http://dx.doi.org/10.1096/fj.202002649R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34582061				2022-12-28	WOS:000702238200027
J	Ochiai, T; Sasaki, Y; Yokoyama, C; Kuwata, H; Hara, S				Ochiai, Tsubasa; Sasaki, Yuka; Yokoyama, Chieko; Kuwata, Hiroshi; Hara, Shuntaro			Absence of prostacyclin greatly relieves cyclophosphamide-induced cystitis and bladder pain in mice	FASEB JOURNAL			English	Article						bladder; cyclophosphamide; cystitis; inflammation; prostaglandins	INDUCED HEMORRHAGIC CYSTITIS; INFLAMMATORY RESPONSE; VASCULAR-PERMEABILITY; INTERNATIONAL UNION; NITRIC-OXIDE; RECEPTOR; MODEL; EXPRESSION; SYNTHASES; ROLES	Cyclophosphamide (CP) has been widely used in the treatment of various malignancies and autoimmune diseases. but acrolein, a byproduct of CP, causes severe hemorrhagic cystitis as the major side effect of CP. On the other hand, a large amount of prostacyclin (PGI(2)) is produced in bladder tissues, and PGI(2) has been shown to play a critical role in bladder homeostasis. PGI(2) is biosynthesized from prostaglandin (PG) H-2, the common precursor of PGs, by PGI(2) synthase (PTGIS) and is known to also be involved in inflammatory responses. However, little is known about the roles of PTGIS-derived PGI(2) in bladder inflammation including CP-induced hemorrhagic cystitis. Using both genetic and pharmacological approaches, we here revealed that PTGIS-derived PGI(2)-IP (PGI(2) receptor) signaling exacerbated CP-induced bladder inflammatory reactions. Ptgis deficiency attenuated CP-induced vascular permeability and chemokine-mediated neutrophil migration into bladder tissues and then suppressed hemorrhagic cystitis. Treatment with RO1138452, an IP selective antagonist, also suppressed CP-induced cystitis. We further found that cystitis-related nociceptive behavior was also relieved in both Ptgis(-/-) mice and RO1138452-treated mice. Our findings may provide new drug targets for bladder inflammation and inflammatory pain in CP-induced hemorrhagic cystitis.	[Ochiai, Tsubasa; Sasaki, Yuka; Kuwata, Hiroshi; Hara, Shuntaro] Showa Univ, Sch Pharm, Dept Healthcare & Regulatory Sci, Div Hlth Chem, Tokyo, Japan; [Yokoyama, Chieko] Kanagawa Inst Technol, Dept Nutr & Life Sci, Atsugi, Kanagawa, Japan	Showa University; Kanagawa Institute Technology	Hara, S (corresponding author), Showa Univ, Div Hlth Chem, Dept Healthcare & Regulatory Sci, Sch Pharm,Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	haras@pharm.showa-u.ac.jp			MEXT | Japan Society for the Promotion of Science (JSPS) [25293033, 21K06549, 16H05108, 19H03375, 23116515]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 25293033, 21K06549, 16H05108, 19H03375, 23116515 and 25293033	Anders HJ, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-019-0141-9; ANDERSON KE, 1993, PHARMACOL REV, V45, P253; Auge C, 2013, EUR J PHARMACOL, V707, P32, DOI 10.1016/j.ejphar.2013.03.008; Bao XQ, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/8424872; Bassiouni W, 2019, N-S ARCH PHARMACOL, V392, P437, DOI 10.1007/s00210-018-01599-7; Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105; Berry SH, 2011, J UROLOGY, V186, P540, DOI 10.1016/j.juro.2011.03.132; Boddy AV, 2000, CLIN PHARMACOKINET, V38, P291, DOI 10.2165/00003088-200038040-00001; Bradbury CA, 2020, BLOOD, V136, P1091, DOI 10.1182/blood.2020005125; Macedo FYB, 2008, EXP TOXICOL PATHOL, V59, P425, DOI 10.1016/j.etp.2007.10.010; Macedo FYB, 2012, INFLAMMATION, V35, P297, DOI 10.1007/s10753-011-9319-3; Cetinel S, 2011, BJU INT, V107, P1320, DOI 10.1111/j.1464-410X.2010.09532.x; Cheung KCP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17329-8; Chuang YC, 2009, EUR UROL, V56, P159, DOI 10.1016/j.eururo.2008.05.007; COLEMAN RA, 1994, PHARMACOL REV, V46, P205; DeBerry JJ, 2014, PAIN, V155, P1280, DOI 10.1016/j.pain.2014.03.023; Dornelas AF, 2018, INT IMMUNOPHARMACOL, V62, P96, DOI 10.1016/j.intimp.2018.06.031; Emadi A, 2009, NAT REV CLIN ONCOL, V6, P638, DOI 10.1038/nrclinonc.2009.146; ERLANSSON M, 1989, INFLAMMATION, V13, P693, DOI 10.1007/BF00914313; Fall M, 2010, EUR UROL, V57, P35, DOI 10.1016/j.eururo.2009.08.020; Fatobene G, 2020, J CLIN ONCOL, V38, P1518, DOI 10.1200/JCO.19.02408; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; HALL AG, 1992, BLOOD REV, V6, P163, DOI 10.1016/0268-960X(92)90028-O; Hara S, 2017, P JPN ACAD B-PHYS, V93, P703, DOI 10.2183/pjab.93.044; Hara S, 2010, BIOCHIMIE, V92, P651, DOI 10.1016/j.biochi.2010.02.007; Ipseiz N, 2020, EMBO J, V39, DOI 10.15252/embj.2019103454; Joshi SK, 2008, J PAIN, V9, P146, DOI 10.1016/j.jpain.2007.09.004; Kamei D, 2004, J BIOL CHEM, V279, P33684, DOI 10.1074/jbc.M400199200; Klinger MB, 2007, AM J PHYSIOL-REG I, V293, pR677, DOI 10.1152/ajpregu.00305.2007; Kloos RQH, 2013, BIOL BLOOD MARROW TR, V19, P1263, DOI 10.1016/j.bbmt.2013.05.014; KOMORIYA K, 1978, PROSTAGLANDINS, V15, P557, DOI 10.1016/0090-6980(78)90052-7; Korkmaz A, 2007, CELL BIOL TOXICOL, V23, P303, DOI 10.1007/s10565-006-0078-0; Kuwamoto S, 1997, FEBS LETT, V409, P242, DOI 10.1016/S0014-5793(97)00516-4; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Le Guenno G, 2011, ARTHRITIS RHEUM-US, V63, P1435, DOI 10.1002/art.30296; LEVINE LA, 1993, J UROLOGY, V149, P719, DOI 10.1016/S0022-5347(17)36192-X; Liang Liuqin, 2017, Drugs Real World Outcomes, V4, P175, DOI 10.1007/s40801-017-0112-y; LIEDBERG C-F, 1970, Scandinavian Journal of Urology and Nephrology, V4, P183, DOI 10.3109/00365597009137596; Linares-Fernandez BE, 2007, J UROLOGY, V177, P1531, DOI 10.1016/j.juro.2006.11.072; Martins JP, 2012, BRIT J PHARMACOL, V165, P183, DOI 10.1111/j.1476-5381.2011.01535.x; Miki T, 2011, PAIN, V152, P1373, DOI 10.1016/j.pain.2011.02.019; MOHIUDDIN J, 1984, ANN INTERN MED, V101, P142, DOI 10.7326/0003-4819-101-1-142_1; Moller AD, 1999, CRIT CARE MED, V27, P130, DOI 10.1097/00003246-199901000-00040; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Murohara T, 1998, CIRCULATION, V97, P99, DOI 10.1161/01.CIR.97.1.99; Nakae K, 2005, NEUROSCI LETT, V388, P132, DOI 10.1016/j.neulet.2005.06.058; Nakajima S, 2010, J IMMUNOL, V184, P5595, DOI 10.4049/jimmunol.0903260; Newman PJ, 1997, J CLIN INVEST, V99, P3, DOI 10.1172/JCI119129; Nickel JC, 2020, EUR UROL, V78, P122, DOI 10.1016/j.eururo.2020.04.067; Norel X, 2020, PHARMACOL REV, V72, P910, DOI 10.1124/pr.120.019331; Ochiai T, 2021, BIOCHEM BIOPH RES CO, V546, P124, DOI 10.1016/j.bbrc.2021.02.004; Offiah I, 2016, EUR UROL, V70, P283, DOI 10.1016/j.eururo.2016.02.058; OKIJI T, 1989, ARCH ORAL BIOL, V34, P523, DOI 10.1016/0003-9969(89)90090-3; Omori K, 2014, BRIT J PHARMACOL, V171, P4879, DOI 10.1111/bph.12815; PITCHFORD S, 1991, NEUROSCI LETT, V132, P105, DOI 10.1016/0304-3940(91)90444-X; Pulli B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067976; Sasaki Y, 2021, PROSTAG OTH LIPID M, V153, DOI [10.1016/j.prostaglins.2020.106523, 10.1016/j.prostaglandins.2020.106523]; Sasaki Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17376; Smith JAM, 1998, BRIT J PHARMACOL, V124, P513, DOI 10.1038/sj.bjp.0701853; STILLWELL TJ, 1988, CANCER, V61, P451, DOI 10.1002/1097-0142(19880201)61:3<451::AID-CNCR2820610308>3.0.CO;2-G; Stucchi AF, 2000, AM J PHYSIOL-GASTR L, V279, pG1298, DOI 10.1152/ajpgi.2000.279.6.G1298; TAIWO YO, 1989, NEUROSCIENCE, V32, P577, DOI 10.1016/0306-4522(89)90280-7; Takagi-Matsumoto H, 2004, J PHARMACOL SCI, V95, P458, DOI 10.1254/jphs.FP0040098; Takahashi Y, 2002, BRIT J PHARMACOL, V137, P315, DOI 10.1038/sj.bjp.0704872; TalarWilliams C, 1996, ANN INTERN MED, V124, P477, DOI 10.7326/0003-4819-124-5-199603010-00003; Vaz-Luis I, 2020, J CLIN ONCOL, V38, P2390, DOI 10.1200/JCO.19.02484; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Walsh M, 2020, NEW ENGL J MED, V382, P622, DOI 10.1056/NEJMoa1803537; WATSON N A, 1973, British Journal of Urology, V45, P606, DOI 10.1111/j.1464-410X.1973.tb12230.x; WILLIAMS TJ, 1979, BRIT J PHARMACOL, V65, P517, DOI 10.1111/j.1476-5381.1979.tb07860.x; Yilmaz N, 2015, J RHEUMATOL, V42, P1661, DOI 10.3899/jrheum.150065	71	1	1	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21952	10.1096/fj.202101025R	http://dx.doi.org/10.1096/fj.202101025R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34555210				2022-12-28	WOS:000702238200036
J	Abellan-Alvaro, M; Ayala, G; Barneo-Munoz, M; Martinez-Garcia, F; Agustin-Pavon, C; Lanuza, E				Abellan-Alvaro, Maria; Ayala, Guillermo; Barneo-Munoz, Manuela; Martinez-Garcia, Fernando; Agustin-Pavon, Carmen; Lanuza, Enrique			Motherhood-induced gene expression in the mouse medial amygdala: Changes induced by pregnancy and lactation but not by pup stimuli	FASEB JOURNAL			English	Article						aggression; prolactin; RNA-Seq; transcriptome; vomeronasal amygdala	GONADOTROPIN-RELEASING-HORMONE; MESSENGER-RNA LEVELS; PROLACTIN-LIKE; AGGRESSIVE-BEHAVIOR; ESTROUS-CYCLE; PREOPTIC AREA; IMMUNOREACTIVE NEURONS; GLYCOPROTEIN HORMONES; MATERNAL AGGRESSION; STRIA TERMINALIS	During lactation, adult female mice display aggressive responses toward male intruders, triggered by male-derived chemosensory signals. This aggressive behavior is not shown by pup-sensitized virgin females sharing pup care with dams. The genetic mechanisms underlying the switch from attraction to aggression are unknown. In this work, we investigate the differential gene expression in lactating females expressing maternal aggression compared to pup-sensitized virgin females in the medial amygdala (Me), a key neural structure integrating chemosensory and hormonal information. The results showed 197 genes upregulated in dams, including genes encoding hormones such as prolactin, growth hormone, or follicle-stimulating hormone, neuropeptides such as galanin, oxytocin, and pro-opiomelanocortin, and genes related to catecholaminergic and cholinergic neurotransmission. In contrast, 99 genes were downregulated in dams, among which we find those encoding for inhibins and transcription factors of the Fos and early growth response families. The gene set analysis revealed numerous Gene Ontology functional groups with higher expression in dams than in pup-sensitized virgin females, including those related with the regulation of the Jak/Stat cascade. Of note, a number of olfactory and vomeronasal receptor genes was expressed in the Me, although without differences between dams and virgins. For prolactin and growth hormone, a qPCR experiment comparing dams, pup-sensitized, and pup-naive virgin females showed that dams expressed higher levels of both hormones than pup-naive virgins, with pup-sensitized virgins showing intermediate levels. Altogether, the results show important gene expression changes in the Me, which may underlie some of the behavioral responses characterizing maternal behavior.	[Abellan-Alvaro, Maria; Agustin-Pavon, Carmen; Lanuza, Enrique] Univ Valencia, Fac Ciencies Biol, Dept Biol Cellular Biol Func & Antropol Fis, Unitat Mixta UV UJI Neuroanat Func Comparada, Valencia, Spain; [Ayala, Guillermo] Univ Valencia, Fac Matemat, Dept Estadist & Invest Operat, Valencia, Spain; [Barneo-Munoz, Manuela; Martinez-Garcia, Fernando] Univ Jaume 1, Fac Ciencies Salut, Unitat Predepartamental Med, Unitat Mixta UV UJI Neuroanat Func Comparada, Castellon de La Plana, Spain	University of Valencia; University of Valencia; Universitat Jaume I	Lanuza, E (corresponding author), Univ Valencia, Dept Biol Cellular Biol Func & Antropol Fis, Fac Ciencies Biol, C Dr Moliner 50, ES-46100 Valencia, Spain.	Enrique.Lanuza@uv.es	Lanuza, Enrique/C-4068-2009; Abellán-Álvaro, María/AAT-6759-2021; Ayala, Guillermo/A-8077-2008; Martinez-Garcia, Fernando/K-7159-2013; Agustin-Pavon, Carmen/A-5638-2013	Lanuza, Enrique/0000-0001-9498-7966; Abellán-Álvaro, María/0000-0001-8974-330X; Ayala, Guillermo/0000-0002-6231-2865; Martinez-Garcia, Fernando/0000-0003-3181-4579; Agustin-Pavon, Carmen/0000-0002-6725-6954	Spanish Ministry of Economy and Competitiveness-FEDER [BFU2016-77691-C2-2-P, BFU2016-77691-C2-1-P]; Spanish Ministry of Science, Innovation and Universities [DPI2017-87333-R]; Generalitat Valenciana [PROMETEO/2016/076]; Universitat Jaume I de Castello [UJI-B2016-45]; Programa de Empleo Joven of the Spanish Government [PEJ-2014-A-63220]	Spanish Ministry of Economy and Competitiveness-FEDER(Spanish Government); Spanish Ministry of Science, Innovation and Universities(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Universitat Jaume I de Castello; Programa de Empleo Joven of the Spanish Government	This study was funded by the Spanish Ministry of Economy and Competitiveness-FEDER (BFU2016-77691-C2-2-P and C2-1-P), the Spanish Ministry of Science, Innovation and Universities (DPI2017-87333-R), the Generalitat Valenciana (PROMETEO/2016/076), and the Universitat Jaume I de Castello (UJI-B2016-45). M.A-A. was a fellow of the "Programa de Empleo Joven" PEJ-2014-A-63220 of the Spanish Government	Albertson AJ, 2008, J CHEM NEUROANAT, V35, P326, DOI 10.1016/j.jchemneu.2008.03.004; Anderson AK, 2006, P NATL ACAD SCI USA, V103, P1599, DOI 10.1073/pnas.0506308103; Anderson ST, 2006, ENDOCRINOLOGY, V147, P1195, DOI 10.1210/en.2005-0905; Arakawa H, 2010, NEUROSCIENCE, V171, P1141, DOI 10.1016/j.neuroscience.2010.10.013; Arbeitman MN, 2019, G3-GENES GENOM GENET, V9, P2623, DOI 10.1534/g3.119.400249; ARBOGAST LA, 1991, ENDOCRINOLOGY, V128, P997, DOI 10.1210/endo-128-2-997; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; ASMUS SE, 1992, BRAIN RES, V575, P199, DOI 10.1016/0006-8993(92)90080-S; Augustine RA, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12569; Augustine RA, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12350; Bancalari RE, 2012, ENDOCR DEV, V23, P1, DOI 10.1159/000341733; Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOCKERS TM, 1994, EUR J ENDOCRINOL, V131, P540, DOI 10.1530/eje.0.1310540; Bridges RS, 2019, J NEUROENDOCRINOL, V31, DOI 10.1111/jne.12669; BROAD KD, 1993, J NEUROENDOCRINOL, V5, P711, DOI 10.1111/j.1365-2826.1993.tb00544.x; Brown RSE, 2011, BIOL REPROD, V84, P826, DOI 10.1095/biolreprod.110.089185; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cadiz-Moretti B, 2013, CHEM SIGNAL, V12, P3, DOI 10.1007/978-1-4614-5927-9_1; CLAPP C, 1994, P NATL ACAD SCI USA, V91, P10384, DOI 10.1073/pnas.91.22.10384; Daude N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149410; DiCarlo LM, 2017, J COMP NEUROL, V525, P3360, DOI 10.1002/cne.24282; EMANUELE NV, 1992, MOL ENDOCRINOL, V6, P35, DOI 10.1210/me.6.1.35; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Foissac S., 2009, INTEGROMICS WHITE PA, V1, P1; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Furigo IC, 2017, BRAIN STRUCT FUNCT, V222, P341, DOI 10.1007/s00429-016-1221-1; GHOSH R, 1995, BRAIN RES, V672, P24, DOI 10.1016/0006-8993(94)01340-N; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Gore AC., 2002, GNRH MASTER MOL REPR, P9; HARLAN RE, 1989, NEUROENDOCRINOLOGY, V49, P7, DOI 10.1159/000125085; Hasen NS, 2006, BRAIN RES, V1108, P147, DOI 10.1016/j.brainres.2006.06.007; Hayden N., RSAMTOOLS BINARY ALI; HOJVAT S, 1982, BRAIN RES, V239, P543, DOI 10.1016/0006-8993(82)90529-7; Insel TR., 2003, HORM BR BEHAV, P418, DOI 10.1007/b97533; JENNES L, 1987, BRAIN RES, V404, P339, DOI 10.1016/0006-8993(87)91391-6; JENNES L, 1988, BRAIN RES, V452, P156, DOI 10.1016/0006-8993(88)90020-0; Jozefczuk J, 2011, METHOD ENZYMOL, V500, P99, DOI 10.1016/B978-0-12-385118-5.00006-2; Kang N, 2009, EUR J NEUROSCI, V29, P624, DOI 10.1111/j.1460-9568.2009.06638.x; KENDALL SK, 1994, MOL ENDOCRINOL, V8, P1420, DOI 10.1210/me.8.10.1420; KENDRICK KM, 1992, SCIENCE, V256, P833, DOI 10.1126/science.1589766; Kennett JE, 2012, J NEUROENDOCRINOL, V24, P403, DOI 10.1111/j.1365-2826.2011.02263.x; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KOOLHAAS JM, 1990, AGGRESSIVE BEHAV, V16, P223; Krebs DL, 2000, J CELL SCI, V113, P2813; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li Y, 2017, CELL, V171, P1176, DOI 10.1016/j.cell.2017.10.015; Lim MM, 2006, HORM BEHAV, V50, P506, DOI 10.1016/j.yhbeh.2006.06.028; Liu JX, 2001, P NATL ACAD SCI USA, V98, P8674, DOI 10.1073/pnas.141234898; Lonstein JS, 2002, NEUROSCI BIOBEHAV R, V26, P869, DOI 10.1016/S0149-7634(02)00087-8; Ma FY, 2005, ENDOCRINOLOGY, V146, P93, DOI 10.1210/en.2004-0800; Ma S, 2005, J NEUROENDOCRINOL, V17, P22, DOI 10.1111/j.1365-2826.2005.01279.x; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martin-Sanchez A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00197; Martin-Sanchez A, 2015, HORM BEHAV, V68, P65, DOI 10.1016/j.yhbeh.2014.08.007; Medina L., 2017, AMYGDALA EVOLUTION N, P427, DOI [10.1016/B978-0-12-804042-3.00019-1, DOI 10.1016/B978-0-12-804042-3.00019-1, 10.1016/b978-0-12-804042-3.00019-1]; MELANDER T, 1986, J COMP NEUROL, V248, P475, DOI 10.1002/cne.902480404; MEUNIER H, 1988, MOL ENDOCRINOL, V2, P1352, DOI 10.1210/mend-2-12-1352; Mineur YS, 2018, NEUROPSYCHOPHARMACOL, V43, P2118, DOI 10.1038/s41386-018-0024-x; Miranda LA, 2007, J FISH BIOL, V71, P1571, DOI 10.1111/j.1095-8649.2007.01621.x; Montgomery DW, 2001, LUPUS, V10, P665, DOI 10.1191/096120301717164895; Murphy M., 2005, GENE HELP INTEGRATED; MUSKE LE, 1993, BRAIN BEHAV EVOLUT, V42, P215, DOI 10.1159/000114156; Nahi F, 2003, ENDOCRINE, V20, P115, DOI 10.1385/ENDO:20:1-2:115; Navarro S, 2016, J MOL ENDOCRINOL, V56, pT113, DOI 10.1530/JME-15-0288; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; Niikura K, 2013, NEUROSCIENCE, V236, P220, DOI 10.1016/j.neuroscience.2012.12.071; Northcutt KV, 2007, J COMP NEUROL, V500, P103, DOI 10.1002/cne.21148; NOWAKOWSKI BE, 1994, MOL ENDOCRINOL, V8, P1742, DOI 10.1210/me.8.12.1742; Numan M, 1998, BRAIN RES, V792, P348, DOI 10.1016/S0006-8993(98)00257-1; Numan M., 2003, NEUROBIOLOGY PARENTA, P8, DOI [10.1007/0-387-21799-1_2, DOI 10.1007/0-387-21799-1_2]; Oh S. June, 2018, Genomics & Informatics, V16, P2, DOI 10.5808/GI.2018.16.1.2; Ons S, 2010, EUR J NEUROSCI, V31, P2043, DOI 10.1111/j.1460-9568.2010.07242.x; Palle A, 2019, FASEB J, V33, P6995, DOI 10.1096/fj.201801600R; Patil MJ, 2013, AM J PHYSIOL-ENDOC M, V305, pE1154, DOI 10.1152/ajpendo.00187.2013; PAUTPAGANO L, 1993, NEUROENDOCRINOLOGY, V58, P682, DOI 10.1159/000126609; Pavlidis P, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-10-research0042; Paxinos G., 2001, MOUSE BRAIN STEREOTA, DOI [10.1016/S0306-4530(03)00088-X, DOI 10.1016/S0306-4530(03)00088-X]; Perez SE, 2001, J COMP NEUROL, V434, P158, DOI 10.1002/cne.1171; Petrulis A, 2013, FRONT NEUROENDOCRIN, V34, P255, DOI 10.1016/j.yfrne.2013.07.007; Pezet A, 1999, J BIOL CHEM, V274, P24497, DOI 10.1074/jbc.274.35.24497; PFAFFLE RW, 1992, SCIENCE, V257, P1118, DOI 10.1126/science.257.5073.1118; PLANAS B, 1994, NEUROSCIENCE, V63, P851, DOI 10.1016/0306-4522(94)90529-0; Quentien MH, 2002, J BIOL CHEM, V277, P44408, DOI 10.1074/jbc.M207824200; Ray S, 2016, G3-GENES GENOM GENET, V6, P221, DOI [10.1534/g3.115.020982/-/DC1, 10.1534/g3.115.020982]; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salais-Lopez H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208960; Salais-Lopez H, 2017, BRAIN STRUCT FUNCT, V222, P895, DOI 10.1007/s00429-016-1254-5; SANCHEZ MA, 1995, BRAIN RES BULL, V38, P313, DOI 10.1016/0361-9230(95)00094-U; Sano K, 2013, EUR J NEUROSCI, V37, P1308, DOI 10.1111/ejn.12131; SCALIA F, 1975, J COMP NEUROL, V161, P31, DOI 10.1002/cne.901610105; SCHACHTER BS, 1984, ENDOCRINOLOGY, V114, P1947, DOI 10.1210/endo-114-5-1947; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; SIAUD P, 1989, CELL TISSUE RES, V255, P107; SIMERLY RB, 1990, J COMP NEUROL, V294, P76, DOI 10.1002/cne.902940107; Slattery DA, 2008, J PHYSIOL-LONDON, V586, P377, DOI 10.1113/jphysiol.2007.145896; STOECKEL ME, 1994, CELL TISSUE RES, V278, P617; Todd RM, 2011, NEUROPSYCHOLOGIA, V49, P734, DOI 10.1016/j.neuropsychologia.2010.11.010; Torner L, 1999, J ENDOCRINOL, V161, P423, DOI 10.1677/joe.0.1610423; Torner L, 2002, EUR J NEUROSCI, V15, P1381, DOI 10.1046/j.1460-9568.2002.01965.x; Torner L, 2002, STRESS, V5, P249, DOI 10.1080/1025389021000048638; TOUBEAU G, 1979, NEUROENDOCRINOLOGY, V29, P374, DOI 10.1159/000122948; TOUBEAU G, 1979, J ENDOCRINOL, V83, P261, DOI 10.1677/joe.0.0830261; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tremblay JJ, 1998, MOL ENDOCRINOL, V12, P428, DOI 10.1210/me.12.3.428; Tsuneoka Y, 2013, J COMP NEUROL, V521, P1633, DOI 10.1002/cne.23251; Unger EK, 2015, CELL REP, V10, P453, DOI 10.1016/j.celrep.2014.12.040; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; VOSS JW, 1992, CELL, V70, P527, DOI 10.1016/0092-8674(92)90422-9; Wang Y, 2013, BEHAV BRAIN RES, V245, P42, DOI 10.1016/j.bbr.2013.02.002; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wen SP, 2011, ENDOCRINOLOGY, V152, P1515, DOI 10.1210/en.2010-1208; WILSON DM, 1992, ENDOCRINOLOGY, V131, P2488, DOI 10.1210/en.131.5.2488; Wood RI, 1997, NEUROSCIENCE, V78, P1027, DOI 10.1016/S0306-4522(96)00629-X; Woodruff TK, 1996, ENDOCRINOLOGY, V137, P5463, DOI 10.1210/en.137.12.5463; Wu Z, 2014, NATURE, V509, P325, DOI 10.1038/nature13307; Wyatt TD, 2003, PHEROMONES ANIMAL BE, V2, P405, DOI [10.1016/0018-506X(73)90032-9, DOI 10.1016/0018-506X(73)90032-9]; Yip SH, 2012, J NEUROENDOCRINOL, V24, P1484, DOI 10.1111/j.1365-2826.2012.02357.x	123	2	2	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21806	10.1096/fj.202100163RR	http://dx.doi.org/10.1096/fj.202100163RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34369605	hybrid, Green Published			2022-12-28	WOS:000691122900002
J	Balczon, R; Lin, MT; Lee, JY; Abbasi, A; Renema, P; Voth, SB; Zhou, C; Koloteva, A; Francis, CM; Sodha, NR; Pittet, JF; Wagener, BM; Bell, J; Choi, CS; Ventetuolo, CE; Stevens, T				Balczon, Ron; Lin, Mike T.; Lee, Ji Young; Abbasi, Adeel; Renema, Phoibe; Voth, Sarah B.; Zhou, Chun; Koloteva, Anna; Francis, C. Michael; Sodha, Neel R.; Pittet, Jean-Francois; Wagener, Brant M.; Bell, Jessica; Choi, Chung-Sik; Ventetuolo, Corey E.; Stevens, Troy			Pneumonia initiates a tauopathy	FASEB JOURNAL			English	Article						dementia; extracorporeal membrane oxygenation; long-term potentiation; lung; prion disease	TERM COGNITIVE IMPAIRMENT; FUNCTIONAL DISABILITY; CARDIOVASCULAR EVENTS; CRITICAL ILLNESS; SURVIVORS; DELIRIUM; OUTCOMES; PHOSPHORYLATION; HOSPITALIZATION; MORTALITY	Pneumonia causes short- and long-term cognitive dysfunction in a high proportion of patients, although the mechanism(s) responsible for this effect are unknown. Here, we tested the hypothesis that pneumonia-elicited cytotoxic amyloid and tau variants: (1) are present in the circulation during infection; (2) lead to impairment of long-term potentiation; and, (3) inhibit long-term potentiation dependent upon tau. Cytotoxic amyloid and tau species were recovered from the blood and the hippocampus following pneumonia, and they were present in the extracorporeal membrane oxygenation oxygenators of patients with pneumonia, especially in those who died. Introduction of immunopurified blood-borne amyloid and tau into either the airways or the blood of uninfected animals acutely and chronically impaired hippocampal information processing. In contrast, the infection did not impair long-term potentiation in tau knockout mice and the amyloid- and tau-dependent disruption in hippocampal signaling was less severe in tau knockout mice. Moreover, the infection did not elicit cytotoxic amyloid and tau variants in tau knockout mice. Therefore, pneumonia initiates a tauopathy that contributes to cognitive dysfunction.	[Balczon, Ron] Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA; [Balczon, Ron; Lin, Mike T.; Lee, Ji Young; Renema, Phoibe; Voth, Sarah B.; Zhou, Chun; Koloteva, Anna; Francis, C. Michael; Bell, Jessica; Choi, Chung-Sik; Stevens, Troy] Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA; [Lin, Mike T.; Lee, Ji Young; Renema, Phoibe; Voth, Sarah B.; Zhou, Chun; Koloteva, Anna; Francis, C. Michael; Bell, Jessica; Choi, Chung-Sik; Stevens, Troy] Univ S Alabama, Coll Med, Ctr Lung Biol, Dept Physiol & Cell Biol, Mobile, AL 36688 USA; [Lee, Ji Young; Stevens, Troy] Univ S Alabama, Internal Med, Mobile, AL 36688 USA; [Abbasi, Adeel; Ventetuolo, Corey E.] Brown Univ, Dept Med, Pulm Crit Care & Sleep Med, Alpert Med Sch, Providence, RI 02912 USA; [Sodha, Neel R.] Brown Univ, Dept Surg, Providence, RI 02912 USA; [Pittet, Jean-Francois; Wagener, Brant M.] Univ Alabama Birmingham, Sch Med, Dept Anesthesiol & Perioperat Med, Birmingham, AL USA; [Ventetuolo, Corey E.] Brown Univ, Hlth Serv, Policy & Practice, Sch Publ Hlth, Providence, RI 02912 USA	University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama; Brown University; Brown University; University of Alabama System; University of Alabama Birmingham; Brown University	Stevens, T (corresponding author), Univ S Alabama, Coll Med, Ctr Lung Biol, Dept Physiol & Cell Biol, Mobile, AL 36688 USA.; Ventetuolo, CE (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Med, Pulm Crit Care & Sleep Med,Alpert Med Sch, Providence, RI 02912 USA.	corey_ventetuolo@brown.edu	Voth, Sarah B./AGJ-8666-2022	Voth, Sarah B./0000-0003-3796-7154; Renema, Phoibe/0000-0003-0230-7068; Lin, Mike/0000-0002-9806-8198; Lee, Ji Young/0000-0002-8005-2446; Francis, Christopher/0000-0001-6001-2618	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [HL60024, HL66299, HL1480 69, HL140182, HL147512, HL136869, H L143017, HL134625, HL141268]; HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [GM127584]; American Heart Association (AHA) [18CDA34080151]	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); American Heart Association (AHA)(American Heart Association)	HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL60024,HL66299,HL1480 69,HL140182,HL147512,HL136869,H L143017,HL134625,HL141268; HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM127584; American Heart Association (AHA), Grant/Award Number: 18CDA34080151	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Alexeyev M, 2020, AM J PHYSIOL-HEART C, V319, pH349, DOI 10.1152/ajpheart.00276.2020; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Balczon R, 2019, FASEB J, V33, P10300, DOI 10.1096/fj.201900322R; Balczon R, 2017, FASEB J, V31, P2785, DOI 10.1096/fj.201601042RR; Balczon R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074343; Bell BJ, 2020, ACS CHEM NEUROSCI, V11, P3499, DOI 10.1021/acschemneuro.0c00531; Brummel NE, 2017, AM J RESP CRIT CARE, V196, P64, DOI 10.1164/rccm.201605-0939OC; Brummel NE, 2014, CRIT CARE MED, V42, P369, DOI 10.1097/CCM.0b013e3182a645bd; Chen N, 2020, LANCET, V395; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Combes A, 2018, NEW ENGL J MED, V378, P1965, DOI 10.1056/NEJMoa1800385; Corrales-Medina VF, 2015, JAMA-J AM MED ASSOC, V313, P264, DOI 10.1001/jama.2014.18229; Corrales-Medina VF, 2013, LANCET, V381, P496, DOI 10.1016/S0140-6736(12)61266-5; Dujardin S, 2020, NAT MED, V26, P1256, DOI 10.1038/s41591-020-0938-9; Ehlenbach WJ, 2010, JAMA-J AM MED ASSOC, V303, P763, DOI 10.1001/jama.2010.167; Ely EW, 2007, CRIT CARE MED, V35, P112, DOI 10.1097/01.CCM.0000251925.18961.CA; Fan E, 2014, CRIT CARE MED, V42, P849, DOI 10.1097/CCM.0000000000000040; Feigin V.L., 2019, LANCET NEUROL, V18, P459, DOI [DOI 10.1136/BMJ.L94, DOI 10.1136/bmj.l94]; Ferrante LE, 2019, AM J RESP CRIT CARE, V200, P107, DOI 10.1164/rccm.201806-1144LE; Ferrante LE, 2015, JAMA INTERN MED, V175, P523, DOI 10.1001/jamainternmed.2014.7889; Gerson JE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00093; Girard TD, 2018, J GEN INTERN MED, V33, P929, DOI 10.1007/s11606-017-4301-x; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Goligher EC, 2018, JAMA-J AM MED ASSOC, V320, P2251, DOI 10.1001/jama.2018.14276; He ZH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13787-x; Hermans G, 2019, THORAX, V74, P1037, DOI 10.1136/thoraxjnl-2018-213020; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Hippensteel JA, 2019, J CLIN INVEST, V129, P1779, DOI 10.1172/JCI124485; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Horwitz R, 2021, AM J MED, V134, P418, DOI 10.1016/j.amjmed.2020.12.007; Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jackson JC, 2014, LANCET RESP MED, V2, P369, DOI 10.1016/S2213-2600(14)70051-7; Kanaan NM, 2016, J NEUROPATH EXP NEUR, V75, P19, DOI 10.1093/jnen/nlv001; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lee JY, 2020, PULM CIRC, V10, DOI 10.1177/2045894020908787; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lin MT, 2018, AM J RESP CRIT CARE, V198, P1575, DOI 10.1164/rccm.201801-0060LE; Mikkelsen ME, 2012, AM J RESP CRIT CARE, V185, P1307, DOI 10.1164/rccm.201111-2025OC; Morrow KA, 2016, AM J PHYSIOL-LUNG C, V310, P1337, DOI 10.1152/ajplung.00103.2015; Munshi L, 2019, LANCET RESP MED, V7, P163, DOI 10.1016/S2213-2600(18)30452-1; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Ochoa CD, 2012, J BIOL CHEM, V287, P25407, DOI 10.1074/jbc.M111.301440; Ou SM, 2016, AM J RESP CRIT CARE, V194, P209, DOI 10.1164/rccm.201510-2023OC; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Rauch JN, 2020, NATURE, V580, P381, DOI 10.1038/s41586-020-2156-5; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Sayner SL, 2004, CIRC RES, V95, P196, DOI 10.1161/01.RES.0000134922.25721.d9; Scheckel C, 2018, NAT REV GENET, V19, P405, DOI 10.1038/s41576-018-0011-4; Scott AM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66321-1; Shah FA, 2013, AM J RESP CRIT CARE, V188, P586, DOI 10.1164/rccm.201212-2154OC; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Siegelman JN, 2020, JAMA-J AM MED ASSOC, V324, P2031, DOI 10.1001/jama.2020.22130; Stanford PM, 2004, J NEUROL, V251, P1098, DOI 10.1007/s00415-004-0489-x; Takeda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9490; Voth S, 2020, FASEB J, V34, P9156, DOI 10.1096/fj.202000051RRR; Yende S, 2014, AM J RESP CRIT CARE, V189, P1065, DOI 10.1164/rccm.201307-1321OC; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	64	6	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21807	10.1096/fj.202100718R	http://dx.doi.org/10.1096/fj.202100718R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34384141	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000691122900003
J	Floy, ME; Givens, SE; Matthys, OB; Mateyka, TD; Kerr, CM; Steinberg, AB; Silva, AC; Zhang, JH; Mei, Y; Ogle, BM; McDevitt, TC; Kamp, TJ; Palecek, SP				Floy, Martha E.; Givens, Sophie E.; Matthys, Oriane B.; Mateyka, Taylor D.; Kerr, Charles M.; Steinberg, Alexandra B.; Silva, Ana C.; Zhang, Jianhua; Mei, Ying; Ogle, Brenda M.; McDevitt, Todd C.; Kamp, Timothy J.; Palecek, Sean P.			Developmental lineage of human pluripotent stem cell-derived cardiac fibroblasts affects their functional phenotype	FASEB JOURNAL			English	Article						cardiac; fibroblast; pluripotent stem cell	FACTOR BINDING PROTEIN-1; 2ND HEART; OUTFLOW TRACT; COLLAGEN; DIFFERENTIATION; CONTRIBUTE; PERLECAN; WNT5A; CARDIOMYOCYTES; HETEROGENEITY	Cardiac fibroblasts (CFBs) support heart function by secreting extracellular matrix (ECM) and paracrine factors, respond to stress associated with injury and disease, and therefore are an increasingly important therapeutic target. We describe how developmental lineage of human pluripotent stem cell-derived CFBs, epicardial (EpiC-FB), and second heart field (SHF-FB) impacts transcriptional and functional properties. Both EpiC-FBs and SHF-FBs exhibited CFB transcriptional programs and improved calcium handling in human pluripotent stem cell-derived cardiac tissues. We identified differences including in composition of ECM synthesized, secretion of growth and differentiation factors, and myofibroblast activation potential, with EpiC-FBs exhibiting higher stress-induced activation potential akin to myofibroblasts and SHF-FBs demonstrating higher calcification and mineralization potential. These phenotypic differences suggest that EpiC-FBs have utility in modeling fibrotic diseases while SHF-FBs are a promising source of cells for regenerative therapies. This work directly contrasts regional and developmental specificity of CFBs and informs CFB in vitro model selection.	[Floy, Martha E.; Mateyka, Taylor D.; Steinberg, Alexandra B.; Palecek, Sean P.] Univ Wisconsin, Dept Chem & Biol Engn, 1415 Engn Hall, Madison, WI 53706 USA; [Givens, Sophie E.; Ogle, Brenda M.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN USA; [Matthys, Oriane B.] Univ Calif Berkeley, UC San Francisco, Grad Program Bioengn, Berkeley, CA USA; [Matthys, Oriane B.; Silva, Ana C.; McDevitt, Todd C.] Gladstone Inst Cardiovasc Dis, Gladstone Inst, San Francisco, CA USA; [Kerr, Charles M.] Med Univ South Carolina, Mol Cell Biol & Pathobiol Program, Charleston, SC 29425 USA; [Zhang, Jianhua; Kamp, Timothy J.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; [Mei, Ying] Clemson Univ, Dept Bioengn, Clemson, SC USA; [Ogle, Brenda M.] Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA	University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; University of California System; University of California San Francisco; The J David Gladstone Institutes; Medical University of South Carolina; University of Wisconsin System; University of Wisconsin Madison; Clemson University; University of Minnesota System; University of Minnesota Twin Cities	Palecek, SP (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, 1415 Engn Hall, Madison, WI 53706 USA.	sppalecek@wisc.edu		Floy, Martha/0000-0003-1992-5911; Kerr, Charles/0000-0001-8736-4795; Matthys, Oriane/0000-0002-5530-7945; Mei, Ying/0000-0002-8508-4076	NSF Engineering Research Center for Cell Manufacturing Technologies [NSF EEC-1648035, CBET-1066311, R01 EB007534]; National Science Foundation [1650113, 2019272038]; California Institute for Regenerative Medicine [LA1-08015]; NIH [T32 HL007260, F31 HL154665, R01 HL133308, R01 HL137204]	NSF Engineering Research Center for Cell Manufacturing Technologies(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NSF Engineering Research Center for Cell Manufacturing Technologies, Grant/Award Number: NSF EEC-1648035, CBET-1066311 and R01 EB007534; National Science Foundation, Grant/Award Number: 1650113 and 2019272038; California Institute for Regenerative Medicine, Grant/Award Number: LA1-08015; NIH, Grant/Award Number: T32 HL007260, F31 HL154665, R01 HL133308 and R01 HL137204	Acharya A, 2012, DEVELOPMENT, V139, P2139, DOI 10.1242/dev.079970; Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Ahmed T., 2020, STATPEARLS; Alfieri CM, 2010, DEV BIOL, V338, P127, DOI 10.1016/j.ydbio.2009.11.030; Ali SR, 2014, CIRC RES, V115, P625, DOI 10.1161/CIRCRESAHA.115.303794; [Anonymous], 2019, PHEN VAR STROM CELLS; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asp M, 2019, CELL, V179, P1647, DOI 10.1016/j.cell.2019.11.025; Bakker ML, 2008, CIRC RES, V102, P1340, DOI 10.1161/CIRCRESAHA.107.169565; Bao XP, 2017, NAT PROTOC, V12, P1890, DOI 10.1038/nprot.2017.080; Bao XP, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0003; Bargehr J, 2019, NAT BIOTECHNOL, V37, P895, DOI 10.1038/s41587-019-0197-9; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cao JL, 2018, NAT REV CARDIOL, V15, P631, DOI 10.1038/s41569-018-0046-4; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; CHEN LB, 1978, CELL, V14, P377, DOI 10.1016/0092-8674(78)90123-X; Chen L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002571; Costell M, 2002, CIRC RES, V91, P158, DOI 10.1161/01.RES.0000026056.81424.DA; Cui YL, 2019, CELL REP, V26, P1934, DOI 10.1016/j.celrep.2019.01.079; Floy ME, 2020, STEM CELL RES, V45, DOI 10.1016/j.scr.2020.101831; George RM, 2019, ANAT REC, V302, P101, DOI 10.1002/ar.23910; Giacomelli E, 2020, CELL STEM CELL, V26, P862, DOI 10.1016/j.stem.2020.05.004; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Greulich F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156787; Greulich F, 2011, CARDIOVASC RES, V91, P212, DOI 10.1093/cvr/cvr112; Hanson KP, 2013, TISSUE ENG PT A, V19, P1132, DOI [10.1089/ten.tea.2012.0316, 10.1089/ten.TEA.2012.0316]; Harrela M, 2002, HORM METAB RES, V34, P144, DOI 10.1055/s-2002-23198; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; Harris GM, 2018, METHOD CELL BIOL, V143, P97, DOI 10.1016/bs.mcb.2017.08.007; Hookway TA, 2016, METHODS, V101, P11, DOI 10.1016/j.ymeth.2015.11.027; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Iwabu A, 2002, BASIC RES CARDIOL, V97, P214, DOI 10.1007/s003950200014; Iyer D, 2015, DEVELOPMENT, V142, P1528, DOI 10.1242/dev.119271; Jin G, 2020, ENGINEERING STRATEGIES FOR REGENERATIVE MEDICINE, P177, DOI 10.1016/B978-0-12-816221-7.00006-9; Jonsson Malin K B, 2016, JACC Basic Transl Sci, V1, P590, DOI 10.1016/j.jacbts.2016.07.007; Kostina A, 2018, J MOL CELL CARDIOL, V114, P211, DOI 10.1016/j.yjmcc.2017.11.009; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Li D, 2016, DEV BIOL, V412, P18, DOI 10.1016/j.ydbio.2016.02.017; Li YZ, 2017, ACTA BIOMATER, V55, P120, DOI 10.1016/j.actbio.2017.04.027; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Liau B, 2017, SCI REP-UK, V7, DOI 10.1038/srep42290; Litvinukova M, 2020, NATURE, V588, P466, DOI 10.1038/s41586-020-2797-4; MacGrogan D, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a013912; Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2; Mandegar MA, 2016, CELL STEM CELL, V18, P541, DOI 10.1016/j.stem.2016.01.022; MARIJIANOWSKI MMH, 1994, J AM COLL CARDIOL, V23, P1204, DOI 10.1016/0735-1097(94)90612-2; Masjedi S, 2016, CARDIOVASC PATHOL, V25, P185, DOI 10.1016/j.carpath.2015.12.002; Mayourian J, 2018, CIRC RES, V122, P167, DOI 10.1161/CIRCRESAHA.117.311589; McArthur L, 2015, BIOCHEM SOC T, V43, P513, DOI 10.1042/BST20150035; McNally EM, 2009, CIRC RES, V104, P285, DOI 10.1161/CIRCRESAHA.109.193680; Meilhac SM, 2018, NAT REV CARDIOL, V15, P705, DOI 10.1038/s41569-018-0086-9; Mienaltowski MJ, 2014, ADV EXP MED BIOL, V802, P5, DOI 10.1007/978-94-007-7893-1_2; Mittal A, 2013, DEV BIOL, V381, P73, DOI 10.1016/j.ydbio.2013.06.010; Moore-Morris T, 2014, J CLIN INVEST, V124, P2921, DOI 10.1172/JCI74783; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morita Y, 2016, J MOL CELL CARDIOL, V92, P158, DOI 10.1016/j.yjmcc.2016.02.008; Mueller KAL, 2013, J CARD FAIL, V19, P678, DOI 10.1016/j.cardfail.2013.09.001; Muhl L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17740-1; Naugle JE, 2006, AM J PHYSIOL-HEART C, V290, pH323, DOI 10.1152/ajpheart.00321.2005; Norris RA, 2009, J CELL COMMUN SIGNAL, V3, P275, DOI 10.1007/s12079-009-0063-5; Park S, 2018, CIRCULATION, V138, P1224, DOI 10.1161/CIRCULATIONAHA.118.035420; Pillai ICL, 2017, CELL STEM CELL, V20, P218, DOI 10.1016/j.stem.2016.10.005; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; PNAS, GENE SET ENRICHMENT; Rana MS, 2014, CIRC RES, V115, P790, DOI 10.1161/CIRCRESAHA.115.305020; Ridge LA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007068; Rodriguez KJ, 2011, MATRIX BIOL, V30, P70, DOI 10.1016/j.matbio.2010.09.001; Rudat C, 2012, CIRC RES, V111, P165, DOI 10.1161/CIRCRESAHA.112.273946; Sasse P, 2008, CARDIOVASC RES, V80, P435, DOI 10.1093/cvr/cvn225; Schleiffarth JR, 2007, PEDIATR RES, V61, P386, DOI 10.1203/pdr.0b013e3180323810; Schmuck EG, 2014, CARDIOVASC ENG TECHN, V5, P119, DOI 10.1007/s13239-013-0167-1; Schwach V, 2019, BIOMATER SCI-UK, V7, P3566, DOI 10.1039/c8bm01348a; Silva A., 2020, DEVELOPMENTAL COEMER; Sinha T, 2015, HUM MOL GENET, V24, P1704, DOI 10.1093/hmg/ddu584; Skelly DA, 2018, CELL REP, V22, P600, DOI 10.1016/j.celrep.2017.12.072; Snarr BS, 2007, DEV DYNAM, V236, P1287, DOI 10.1002/dvdy.21074; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Theocharidis G, 2016, J INVEST DERMATOL, V136, P74, DOI 10.1038/JID.2015.352; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Tucker NR, 2020, CIRCULATION, V142, P466, DOI 10.1161/CIRCULATIONAHA.119.045401; Unden AL, 2005, CLIN ENDOCRINOL, V63, P94, DOI 10.1111/j.1365-2265.2005.02306.x; Vidal R, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131092; Wang Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16204-w; Watanabe S, 2010, EUR J HEART FAIL, V12, P1214, DOI 10.1093/eurjhf/hfq166; Wessels A, 2012, DEV BIOL, V366, P111, DOI 10.1016/j.ydbio.2012.04.020; Williams C, 2014, ACTA BIOMATER, V10, P194, DOI 10.1016/j.actbio.2013.08.037; Witty AD, 2014, NAT BIOTECHNOL, V32, P1026, DOI 10.1038/nbt.3002; Wu CC, 2020, CIRC RES, V127, P896, DOI 10.1161/CIRCRESAHA.119.316303; Zhang H, 2019, CIRC RES, V125, P552, DOI 10.1161/CIRCRESAHA.119.315491; Zhang JH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09831-5; Zhao JM, 2017, STEM CELLS DEV, V26, P528, DOI 10.1089/scd.2016.0208; Zheng DP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03148-3; Zhou PZ, 2016, CIRC RES, V118, P368, DOI 10.1161/CIRCRESAHA.116.308139; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022	96	1	1	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21799	10.1096/fj.202100523R	http://dx.doi.org/10.1096/fj.202100523R			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34339055	Green Accepted			2022-12-28	WOS:000691122900059
J	Huang, WX; Dai, MY; Qiu, TT; Liang, TT; Xie, JY; Mi, CY; Zhao, JS; Chen, WN; Tian, P; Zhang, SM; Zhang, HD				Huang, Wenxin; Dai, Mengyuan; Qiu, Taotao; Liang, Tingting; Xie, Jiayu; Mi, Chenyang; Zhao, Jingsong; Chen, Weina; Tian, Peng; Zhang, Shuming; Zhang, Huidong			Novel lncRNA-HZ04 promotes BPDE-induced human trophoblast cell apoptosis and miscarriage by upregulating IP3R1/CaMKII/SGCB pathway by competitively binding with miR-hz04	FASEB JOURNAL			English	Article						competing endogenous RNAs (ceRNAs); environmental BaP or BPDE; female trophoblast cell apoptosis; IP3R1; Ca2+; CaMKII; SGCB; miscarriage or spontaneous abortion; noncoding lncRNA-HZ04 and miR-hz04	LONG NONCODING RNA; RECURRENT SPONTANEOUS-ABORTION; TRISPHOSPHATE RECEPTOR; MISSED ABORTION; EXPOSURE; SURVIVAL; DIFFERENTIATION; IMPLANTATION; DYSFUNCTION; COMPLEXITY	Normal pregnancy is essential for human reproduction. However, BaP (benzo(a)pyrene) and its metabolite BPDE (benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide) could cause dysfunctions of human trophoblast cells and might further induce miscarriage. Yet, the underlying mechanisms remain largely unknown. Herein, we identified a novel upregulated lnc-HZ04 and a novel downregulated miR-hz04 in villous tissues of unexplained recurrent miscarriage (RM) relative to those in healthy control tissues and also in BPDE-treated human trophoblast cells. Lnc-HZ04 directly and specifically bound with miR-hz04, diminished the reduction effects of miR-hz04 on IP3R1 mRNA expression level and on IP3R1 mRNA stability, and then activated the Ca2+-mediated IP3R1/p-CaMKII/SGCB pathway, which further promoted trophoblast cell apoptosis. The miR-hz04 target site on lnc-HZ04 played crucial roles in these regulations. In normal trophoblast, relatively less lnc-HZ04 and more miR-hz04 suppressed this apoptosis pathway and gave normal pregnancy. After exposure to BPDE or in RM tissues, p53 was upregulated, which might promote p53-mediated lnc-HZ04 transcription. Relatively more lnc-HZ04 and less miR-hz04 activated this apoptosis pathway and might further induce miscarriage. BaP could also induce mice miscarriage by upregulating its corresponding murine apoptosis pathway. Therefore, BPDE-induced apoptosis of human trophoblast cells was associated with the occurrence of miscarriage. This work discovered the regulation roles of lnc-HZ04 and miR-hz04 and provided scientific and clinical understanding of the occurrence of unexplained miscarriage.	[Huang, Wenxin; Dai, Mengyuan; Zhang, Huidong] Sun Yat Sen Univ, Affiliated Hosp 8, Res Ctr Environm & Female Reprod Hlth, Shenzhen 518033, Peoples R China; [Huang, Wenxin; Dai, Mengyuan] Fujian Med Univ, Sch Publ Hlth, Dept Toxicol, Fuzhou, Peoples R China; [Qiu, Taotao; Liang, Tingting; Xie, Jiayu; Mi, Chenyang; Zhao, Jingsong; Chen, Weina; Tian, Peng; Zhang, Shuming; Zhang, Huidong] Sichuan Univ, West China Sch Publ Hlth, Key Lab Environm & Female Reprod Hlth, Chengdu, Peoples R China; [Qiu, Taotao; Liang, Tingting; Xie, Jiayu; Mi, Chenyang; Zhao, Jingsong; Chen, Weina; Tian, Peng; Zhang, Shuming; Zhang, Huidong] Sichuan Univ, West China Hosp 4, Chengdu, Peoples R China	Sun Yat Sen University; Fujian Medical University; Sichuan University; Sichuan University	Zhang, HD (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 8, Res Ctr Environm & Female Reprod Hlth, Shenzhen 518033, Peoples R China.	zhanghd29@mail.sysu.edu.cn		peng, Tian/0000-0001-8380-9646	National Natural Science Foundation of China (NSFC) [82073589]; China Key Research and Dvelopment Program [2017YFC1002002]; Fundamental Funds for the Central Universities; Sun Yat-sen University; Sichuan University	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Key Research and Dvelopment Program; Fundamental Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Sun Yat-sen University; Sichuan University(Sichuan University)	National Natural Science Foundation of China (NSFC), Grant/Award Number: NSFC No. 82073589; China Key Research and Dvelopment Program, Grant/Award Number: 2017YFC1002002; Fundamental Funds for the Central Universities; Sun Yat-sen University; Sichuan University	Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P1103, DOI 10.1016/j.fertnstert.2012.06.048; Anderson KJ, 2019, WORLD J GASTROENTERO, V25, P5732, DOI 10.3748/wjg.v25.i38.5732; Antigny F, 2014, CELL CALCIUM, V56, P513, DOI 10.1016/j.ceca.2014.10.014; Archibong AE, 2002, REPROD TOXICOL, V16, P801, DOI 10.1016/S0890-6238(02)00058-8; Banu SK, 2017, REPROD TOXICOL, V68, P171, DOI 10.1016/j.reprotox.2016.07.006; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen GD, 2008, AM J PHYSIOL-REG I, V294, pR487, DOI 10.1152/ajpregu.00600.2007; Choi JY, 2004, AM J PHYSIOL-CELL PH, V287, pC971, DOI 10.1152/ajpcell.00571.2003; Fazio S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020354; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Garrido-Gimenez C, 2015, POSTGRAD MED J, V91, P151, DOI 10.1136/postgradmedj-2014-132672; Gawronski AR, 2018, BIOINFORMATICS, V34, P3101, DOI 10.1093/bioinformatics/bty208; Green RS, 2009, ENVIRON HEALTH PERSP, V117, P1939, DOI 10.1289/ehp.0900943; Guo L, 2019, J FOOD DRUG ANAL, V27, P518, DOI 10.1016/j.jfda.2019.03.001; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Hu YL, 2020, J ETHNOPHARMACOL, V251, DOI 10.1016/j.jep.2019.112535; Hu YP, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1097-9; Huang Y, 2018, J CELL MOL MED, V22, P5768, DOI 10.1111/jcmm.13866; Huang ZY, 2018, EBIOMEDICINE, V38, P162, DOI 10.1016/j.ebiom.2018.11.015; Hudecova S, 2016, ONCOTARGET, V7, P61403, DOI 10.18632/oncotarget.8968; La Rovere RML, 2016, CELL CALCIUM, V60, P74, DOI 10.1016/j.ceca.2016.04.005; Lamont K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3080; Lee BM, 2007, J TOXICOL ENV HEAL A, V70, P1391, DOI 10.1080/15287390701434182; Liang T., 2021, CELL BIOL TOXICOL, DOI [10.1007/s10565-10021-09583-10563, DOI 10.1007/S10565-10021-09583-10563]; Liu HN, 2020, REPROD SCI, V27, P152, DOI 10.1007/s43032-019-00003-w; Liu LP, 2018, EUR REV MED PHARMACO, V22, P7105, DOI 10.26355/eurrev_201811_16242; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marzioni M, 2006, GASTROENTEROLOGY, V130, P1831, DOI 10.1053/j.gastro.2006.02.021; Nacson J, 2020, MOL CELL, V78, P951, DOI 10.1016/j.molcel.2020.04.006; Neal MS, 2007, HUM REPROD, V22, P961, DOI 10.1093/humrep/del487; Nik-Zainal S, 2015, MUTAGENESIS, V30, P763, DOI 10.1093/mutage/gev073; Pesarico AP, 2016, EUR J PHARMACOL, V782, P6, DOI 10.1016/j.ejphar.2016.04.046; Premkumar KV, 2014, IN VITRO CELL DEV-AN, V50, P640, DOI 10.1007/s11626-014-9749-y; Ptashekas Julius, 1996, Journal of Environmental Pathology Toxicology and Oncology, V15, P135; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Rajab KE, 2000, INT J GYNECOL OBSTET, V68, P139, DOI 10.1016/S0020-7292(99)00195-2; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Royce-Tolland ME, 2010, NAT STRUCT MOL BIOL, V17, P948, DOI 10.1038/nsmb.1877; Rull Kristiina, 2012, Frontiers in Genetics, V3, P34, DOI 10.3389/fgene.2012.00034; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sheng F, 2019, J CELL BIOCHEM, V120, P17378, DOI 10.1002/jcb.29002; Shimobayashi E, 2018, CURR NEUROPHARMACOL, V16, P151, DOI 10.2174/1570159X15666170529104000; Slack FJ, 2019, CELL, V179, P1033, DOI 10.1016/j.cell.2019.10.017; Straszewski-Chavez SL, 2009, PLACENTA, V30, P939, DOI 10.1016/j.placenta.2009.08.007; Sun Q, 2017, EUR REV MED PHARMACO, V21, P12; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Tian Z, 2018, TOXICOL SCI, V166, P25, DOI 10.1093/toxsci/kfy182; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wang WP, 2018, ENVIRON POLLUT, V233, P820, DOI 10.1016/j.envpol.2017.11.022; Wu J, 2010, SCI TOTAL ENVIRON, V408, P2312, DOI 10.1016/j.scitotenv.2010.02.028; Wu XS, 2017, EMBO REP, V18, P1837, DOI 10.15252/embr.201744147; Xie J., 2021, CELL BIOL TOXICOL, DOI [10.1007/s10565-10021-09606-z, DOI 10.1007/S10565-10021-09606-Z]; Xu D, 2017, EUR REV MED PHARMACO, V21, P5717, DOI 10.26355/eurrev_201712_14018; Xu ZY, 2021, SCI TOTAL ENVIRON, V776, DOI 10.1016/j.scitotenv.2021.145950; Yan BA, 2015, CIRC RES, V116, P1143, DOI 10.1161/CIRCRESAHA.116.305510; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zenclussen AC, 2002, SCAND J IMMUNOL, V55, P560, DOI 10.1046/j.1365-3083.2002.01091.x; Zhang BY, 2010, INT J GYNECOL OBSTET, V108, P135, DOI 10.1016/j.ijgo.2009.09.019; Zhang Y, 2017, MOL THER, V25, P2394, DOI 10.1016/j.ymthe.2017.06.028; Zhang Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1443-2; Zheng Q, 2017, CELL DEATH DIFFER, V24, P2161, DOI 10.1038/cdd.2017.136; Zhu HL, 2019, ENVIRON POLLUT, V254, DOI 10.1016/j.envpol.2019.112991; Zhu Q, 2020, REPRODUCTION, V159, P525, DOI 10.1530/REP-19-0282	65	6	6	3	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21789	10.1096/fj.202100376RR	http://dx.doi.org/10.1096/fj.202100376RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34383983	Green Submitted			2022-12-28	WOS:000691122900043
J	Bloch, JS; Sequeira, JM; Ramirez, AS; Quadros, EV; Locher, KP				Bloch, Joel S.; Sequeira, Jeffrey M.; Ramirez, Ana S.; Quadros, Edward, V; Locher, Kaspar P.			Generation of nanobodies targeting the human, transcobalamin-mediated vitamin B-12 uptake route	FASEB JOURNAL			English	Article						crystal structure; drug-delivery; nanobody; TCblR; transcobalamin	CELLULAR UPTAKE; RECEPTOR; TCBLR/CD320; PROTEIN; TRANSPORT; COBALAMIN; DOMAINS; CELLS; GENE; TOOL	Cellular uptake of vitamin B-12 in humans is mediated by the endocytosis of the B-12 carrier protein transcobalamin (TC) via its cognate cell surface receptor TCblR, encoded by the CD320 gene. Because CD320 expression is associated with the cell cycle and upregulated in highly proliferating cells including cancer cells, this uptake route is a potential target for cancer therapy. We developed and characterized four camelid nanobodies that bind holo-TC (TC in complex with B-12) or the interface of the human holo-TC:TCblR complex with nanomolar affinities. We determined X-ray crystal structures of these nanobodies bound to holo-TC:TCblR, which enabled us to map their binding epitopes. When conjugated to the model toxin saporin, three of our nanobodies caused growth inhibition of HEK293T cells and therefore have the potential to inhibit the growth of human cancer cells. We visualized the cellular binding and endocytic uptake of the most potent nanobody (TC-Nb4) using fluorescent light microscopy. The co-crystal structure of holo-TC:TCblR with another nanobody (TC-Nb34) revealed novel features of the interface of TC and the LDLR-A1 domain of TCblR, rationalizing the decrease in the affinity of TC-B-12 binding caused by the Delta 88 mutation in CD320.	[Bloch, Joel S.; Ramirez, Ana S.; Locher, Kaspar P.] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Otto Stern Weg 5, CH-8093 Zurich, Switzerland; [Sequeira, Jeffrey M.; Quadros, Edward, V] SUNY Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Locher, KP (corresponding author), Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Otto Stern Weg 5, CH-8093 Zurich, Switzerland.	locher@mol.biol.ethz.ch		Quadros, Edward/0000-0002-7663-8014; Ramirez, Ana S./0000-0002-1619-0721; Bloch, Joel/0000-0002-5786-0488	Swiss National Science Foundation [310030B_166672]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Swiss National Science Foundation, Grant/Award Number: 310030B_166672	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alam A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12100; AMAGASAKI T, 1990, BLOOD, V76, P1380; Bloch JS, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2115435118; Bloch JS, 2020, NATURE, V579, P443, DOI 10.1038/s41586-020-2044-z; BRINKLEY M, 1992, BIOCONJUGATE CHEM, V3, P2, DOI 10.1021/bc00013a001; Chapman-Smith A, 1999, BIOMOL ENG, V16, P119, DOI 10.1016/S1050-3862(99)00046-7; Clardy SM, 2011, EXPERT OPIN DRUG DEL, V8, P127, DOI 10.1517/17425247.2011.539200; De Meyer T, 2014, TRENDS BIOTECHNOL, V32, P263, DOI 10.1016/j.tibtech.2014.03.001; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10368-w; Gick GG, 2020, EXP CELL RES, V396, DOI 10.1016/j.yexcr.2020.112256; HALL CA, 1987, J CELL PHYSIOL, V133, P187, DOI 10.1002/jcp.1041330125; Jiang WX, 2013, FASEB J, V27, P2988, DOI 10.1096/fj.13-230185; Jiang WX, 2011, DRUG DELIV, V18, P74, DOI 10.3109/10717544.2010.509745; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kishan KVR, 2001, PROTEIN SCI, V10, P1046, DOI 10.1110/ps.50401; LINDEMANS J, 1989, EXP CELL RES, V184, P449, DOI 10.1016/0014-4827(89)90343-1; Liu YX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09836-0; Martinez-Jothar L, 2019, MOL PHARMACEUT, V16, P1633, DOI 10.1021/acs.molpharmaceut.8b01318; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mireku SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14512-8; Mohanty R, 2019, ONCOL REP, V42, P2183, DOI 10.3892/or.2019.7335; Morrison C, 2019, NAT REV DRUG DISCOV, V18, P485, DOI 10.1038/d41573-019-00104-w; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nielsen MJ, 2012, NAT REV GASTRO HEPAT, V9, P345, DOI 10.1038/nrgastro.2012.76; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Polito L, 2013, TOXINS, V5, P1698, DOI 10.3390/toxins5101698; Punjani A, 2021, J STRUCT BIOL, V213, DOI 10.1016/j.jsb.2021.107702; Quadros Edward V, 2013, J Cancer Ther, V4, P1074; Quadros EV, 2010, MOL CANCER THER, V9, P3033, DOI 10.1158/1535-7163.MCT-10-0513; Quadros EV, 2010, HUM MUTAT, V31, P924, DOI 10.1002/humu.21297; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Scully M, 2019, NEW ENGL J MED, V380, P335, DOI 10.1056/NEJMoa1806311; Vaneycken I, 2011, FASEB J, V25, P2433, DOI 10.1096/fj.10-180331; Waibel R, 2008, CANCER RES, V68, P2904, DOI 10.1158/0008-5472.CAN-07-6771; Wang YZ, 2016, INT J NANOMED, V11, P3287, DOI 10.2147/IJN.S107194; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wuerges J, 2006, P NATL ACAD SCI USA, V103, P4386, DOI 10.1073/pnas.0509099103	41	0	0	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22222	10.1096/fj.202101376RR	http://dx.doi.org/10.1096/fj.202101376RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0DE	35218573	Green Published, Green Submitted			2022-12-28	WOS:000772946800001
J	Jiang, NH; Huang, R; Zhang, JH; Xu, DX; Li, TL; Sun, ZY; Su, LJ; Peng, ZY				Jiang, Nanhui; Huang, Rong; Zhang, Jiahao; Xu, Dongxue; Li, Tianlong; Sun, Zhongyi; Su, Lianjiu; Peng, Zhiyong			TIMP2 mediates endoplasmic reticulum stress contributing to sepsis-induced acute kidney injury	FASEB JOURNAL			English	Article						acute kidney injury (AKI); apoptosis; endoplasmic reticulum stress (ER stress); sepsis; tissue inhibitor of metalloproteinase 2 (TIMP2)	UNFOLDED PROTEIN RESPONSE; CRITICALLY-ILL PATIENTS; BCL-2 FAMILY-MEMBERS; TISSUE INHIBITOR; KAPPA-B; ER; METALLOPROTEINASE-2; VALIDATION; INDUCTION; SECRETION	Tissue inhibitor of metalloproteinase 2 (TIMP2) has been recognized as an important biomarker for predicting acute kidney injury (AKI) because of its involvement in the process of inflammation and apoptosis in septic AKI. Endoplasmic reticulum (ER) stress, a condition of disrupted ER homeostasis, is implicated in multiple pathophysiological processes, including kidney disease. Herein, we investigated the correlation between ER stress and septic AKI and further explored how TIMP2 regulated ER stress-mediated apoptosis. To assess the role of TIMP2 in sepsis-induced AKI, we used a cecal ligation and puncture (CLP) model in mice with tubule-specific deficiency of TIMP2 (Ksp-Cre/TIMP2(flox)(/)(flox)) and their wild-type counterparts. Compared to the wild-type mice, TIMP2-deficient mice demonstrated lower serum creatinine levels and decreased ER stress-mediated apoptosis when subjected to CLP. Interestingly, in human kidney (HK-2) cells, overexpression of TIMP2 caused ER stress, whereas TIMP2 knockdown attenuated lipopolysaccharide-induced ER stress and apoptosis. TIMP2 interacted with the binding immunoglobulin protein, an ER chaperone, and facilitates its extracellular secretion, thereby triggering ER stress. This study identified that the deletion of TIMP2 in mouse tubules mitigated sepsis-induced AKI by inhibiting ER stress-mediated apoptosis, which might be a potential therapeutic strategy to alleviate renal injury.	[Jiang, Nanhui; Huang, Rong; Zhang, Jiahao; Xu, Dongxue; Li, Tianlong; Sun, Zhongyi; Su, Lianjiu; Peng, Zhiyong] Wuhan Univ, Dept Crit Care Med, Zhongnan Hosp, 169 Donghu Rd, Wuhan 430071, Hubei, Peoples R China; [Peng, Zhiyong] Univ Pittsburgh, Ctr Crit Nephrol, Dept Crit Care Med, Med Ctr, Pittsburgh, PA USA	Wuhan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Su, LJ; Peng, ZY (corresponding author), Wuhan Univ, Dept Crit Care Med, Zhongnan Hosp, 169 Donghu Rd, Wuhan 430071, Hubei, Peoples R China.	sulianjiu@whu.edu.cn; pengzy5@hotmail.com			National Natural Science Foundation of China (NSFC) [81772046, 81971816, 82102298]; Major National Science and Technology Projects of China [2020ZX09201007]; Innovation Cultivation Foundation of Wuhan University/Zhongnan Hospital [413000345/CXPY2020017]; Research Project Foundation of Zhongnan Hospital [ZNYB2020013]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major National Science and Technology Projects of China; Innovation Cultivation Foundation of Wuhan University/Zhongnan Hospital; Research Project Foundation of Zhongnan Hospital	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81772046, 81971816 and 82102298; Major National Science and Technology Projects of China, Grant/Award Number: 2020ZX09201007; Innovation Cultivation Foundation of Wuhan University/Zhongnan Hospital, Grant/Award Number: 413000345/CXPY2020017; Research Project Foundation of Zhongnan Hospital, Grant/Award Number: ZNYB2020013	Axten JM, 2013, ACS MED CHEM LETT, V4, P964, DOI 10.1021/ml400228e; Bellomo R, 2017, INTENS CARE MED, V43, P816, DOI 10.1007/s00134-017-4755-7; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Bihorac A, 2014, AM J RESP CRIT CARE, V189, P932, DOI 10.1164/rccm.201401-0077OC; Borkan SC, 2016, SEMIN NEPHROL, V36, P237, DOI 10.1016/j.semnephrol.2016.04.001; Carrara M, 2015, ELIFE, V4, DOI 10.7554/eLife.03522; Chen HG, 2020, INT IMMUNOPHARMACOL, V78, DOI 10.1016/j.intimp.2019.106049; Cybulsky AV, 2017, NAT REV NEPHROL, V13, P681, DOI 10.1038/nrneph.2017.129; DORNER AJ, 1992, EMBO J, V11, P1563, DOI 10.1002/j.1460-2075.1992.tb05201.x; Frakes AE, 2017, MOL CELL, V66, P761, DOI 10.1016/j.molcel.2017.05.031; Grootjans J, 2016, NAT REV IMMUNOL, V16, P469, DOI 10.1038/nri.2016.62; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7; Jin H, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00222; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kimura K, 2008, BIOCHEM BIOPH RES CO, V366, P1048, DOI 10.1016/j.bbrc.2007.12.098; Kopp MC, 2019, NAT STRUCT MOL BIOL, V26, P1053, DOI 10.1038/s41594-019-0324-9; Koyner JL, 2015, J AM SOC NEPHROL, V26, P1747, DOI 10.1681/ASN.2014060556; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Levey AS, 2017, ANN INTERN MED, V167, pITC65, DOI 10.7326/AITC201711070; Li YM, 2019, BBA-MOL BASIS DIS, V1865, P558, DOI 10.1016/j.bbadis.2018.10.041; Liew HK, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111326; Liu ZW, 2020, THERANOSTICS, V10, P11963, DOI 10.7150/thno.50093; Luo CJ, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0157-1; Mami L, 2016, J AM SOC NEPHROL, V27, P863, DOI 10.1681/ASN.2015020196; Mehta RL, 2011, INTENS CARE MED, V37, P241, DOI 10.1007/s00134-010-2089-9; Miyaji T, 2003, KIDNEY INT, V64, P1620, DOI 10.1046/j.1523-1755.2003.00268.x; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Oakes SA, 2015, ANNU REV PATHOL-MECH, V10, P173, DOI 10.1146/annurev-pathol-012513-104649; Peerapornratana S, 2019, KIDNEY INT, V96, P1083, DOI 10.1016/j.kint.2019.05.026; Pike F, 2015, CLIN J AM SOC NEPHRO, V10, P1332, DOI 10.2215/CJN.09911014; Seo DW, 2006, J BIOL CHEM, V281, P3711, DOI 10.1074/jbc.M509932200; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Stasi A, 2017, NEPHROL DIAL TRANSPL, V32, P24, DOI 10.1093/ndt/gfw250; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Sunami Y, 2016, HEPATOLOGY, V63, P1592, DOI 10.1002/hep.28435; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Vitale M, 2019, ELIFE, V8, DOI 10.7554/eLife.41168; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Xu XH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11417-4; Yamamoto K, 2003, J BIOL CHEM, V278, P34525, DOI 10.1074/jbc.M304188200; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	45	3	3	4	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22228	10.1096/fj.202101555RR	http://dx.doi.org/10.1096/fj.202101555RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CQ	35218571				2022-12-28	WOS:000772945400001
J	Kalyanaraman, B				Kalyanaraman, Balaraman			Exploiting the tumor immune microenvironment and immunometabolism using mitochondria-targeted drugs: Challenges and opportunities in racial disparity and cancer outcome research	FASEB JOURNAL			English	Review						mitochondrial drugs; OXPHOS inhibitors; racial disparity; tumor microenvironment	SUPPRESSOR-CELLS; IMMUNOSUPPRESSIVE FUNCTIONS; LUNG-CANCER; COMPLEX I; METFORMIN; METABOLISM; EXPRESSION; HEALTH; DETERMINANTS; INHIBITION	Black and Hispanic cancer patients have a higher incidence of cancer mortality. Many factors (e.g., socioeconomic differences, insufficient access to healthcare) contribute to racial disparity. Emerging research implicates biological disparity in cancer outcomes. Studies show distinct differences in the tumor immune microenvironment (TIME) in Black cancer patients. Studies also have linked altered mitochondrial metabolism to changes in immune cell activation in TIME. Recent publications revealed a novel immunomodulatory role for triphenylphosphonium-based mitochondrial-targeted drugs (MTDs). These are synthetically modified, naturally occurring molecules (e.g., honokiol, magnolol, metformin) or FDA-approved small molecule drugs (e.g., atovaquone, hydroxyurea). Modifications involve conjugating the parent molecule via an alkyl linker chain to a triphenylphosphonium moiety. These modified molecules (e.g., Mito-honokiol, Mito-magnolol, Mito-metformin, Mito-atovaquone, Mito-hydroxyurea) accumulate in tumor cell mitochondria more effectively than in normal cells and inhibit mitochondrial respiration, induce reactive oxygen species, activate AMPK and redox transcription factors, and inhibit cancer cell proliferation. Besides these intrinsic effects of MTDs in redox signaling and proliferation in tumors, MTDs induced extrinsic effects in the TIME of mouse xenografts. MTD treatment inhibited tumor-suppressive immune cells, myeloid-derived suppressor cells, and regulatory T cells, and activated T cells and antitumor immune effects. One key biological disparity in Black cancer patients was related to altered mitochondrial oxidative metabolism; MTDs targeting vulnerabilities in tumor cells and the TIME may help us understand this biological disparity. Clinical trials should include an appropriate number of Black and Hispanic cancer patients and should validate the intratumoral, antihypoxic effects of MTDs with imaging.	[Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Kalyanaraman, Balaraman] Med Coll Wisconsin, Ctr Dis Prevent Res, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Kalyanaraman, B (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	balarama@mcw.edu			HHS | NIH | National Cancer Institute (NCI) [R01CA208648, R01CA232433]	HHS | NIH | National Cancer Institute (NCI)	HHS | NIH | National Cancer Institute (NCI), Grant/Award Number: R01CA208648 and R01CA232433	AbuEid M, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102653; Adashek JJ, 2020, J CLIN ONCOL, V38; Ahmad A, 2017, BBA-REV CANCER, V1868, P16, DOI 10.1016/j.bbcan.2017.01.001; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Ankley LM, 2021, J IMMUNOL, V206; Ashton TM, 2018, CLIN CANCER RES, V24, P2482, DOI 10.1158/1078-0432.CCR-17-3070; Bader JE, 2020, MOL CELL, V78, P1019, DOI 10.1016/j.molcel.2020.05.034; Beebe-Dimmer JL, 2019, J CLIN INVEST, V129, P2187, DOI 10.1172/JCI128707; Bonifaz LC, 2015, IMMUNOLOGY, V144, P461, DOI 10.1111/imm.12392; Boreel DF, 2021, CLIN CANCER RES, V27, P2970, DOI 10.1158/1078-0432.CCR-20-3913; Boyle KA, 2018, J BIOL CHEM, V293, P14891, DOI 10.1074/jbc.RA117.001469; Brown JM, 1998, CANCER RES, V58, P1408; Bu LL, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1130206; Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005; Cha JH, 2019, MOL CELL, V76, P359, DOI 10.1016/j.molcel.2019.09.030; Chen DW, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000289; Chen Q, 2018, TRENDS PHARMACOL SCI, V39, P59, DOI 10.1016/j.tips.2017.10.009; Cheng G, 2014, BRIT J CANCER, V111, P85, DOI 10.1038/bjc.2014.272; Cheng G, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102673; Cheng G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74808-0; Cheng Gang, 2020, Cancer Treat Res Commun, V25, P100210, DOI 10.1016/j.ctarc.2020.100210; Cheng Gang, 2019, Oncotarget, V10, P3518, DOI 10.18632/oncotarget.26943; Cheng G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10042-1; Cheng G, 2018, J BIOL CHEM, V293, P10363, DOI 10.1074/jbc.RA118.003044; Cheng G, 2016, CANCER RES, V76, P3904, DOI 10.1158/0008-5472.CAN-15-2534; Cheng G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-285; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Choudhury AR, 2017, SEMIN CANCER BIOL, V47, P125, DOI 10.1016/j.semcancer.2017.05.001; Clever D, 2016, CELL, V166, P1117, DOI 10.1016/j.cell.2016.07.032; Colombani T, 2021, ADV FUNCT MATER, V31, DOI 10.1002/adfm.202102234; Deshmukh SK, 2017, CARCINOGENESIS, V38, P757, DOI 10.1093/carcin/bgx037; Devall M, 2021, JNCI-J NATL CANCER I, V113, P1779, DOI 10.1093/jnci/djaa206; Dhanasekaran A, 2005, FREE RADICAL BIO MED, V39, P567, DOI 10.1016/j.freeradbiomed.2005.04.016; Dhatchinamoorthy K, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.636568; Faubert B, 2020, SCIENCE, V368, P152, DOI 10.1126/science.aaw5473; Feng T, 2015, CANCER PREV RES, V8, P1055, DOI 10.1158/1940-6207.CAPR-15-0141; Fischer GM, 2019, CANCER DISCOV, V9, P628, DOI 10.1158/2159-8290.CD-18-1489; Gammon ST, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121487; Giedt RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32985; Gouirand V, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00117; Han YY, 2020, AM J CANCER RES, V10, P727; Harada Y, 2012, CANCER LETT, V319, P83, DOI 10.1016/j.canlet.2011.12.034; Hardie DG, 2014, PHYSIOLOGY, V29, P99, DOI 10.1152/physiol.00050.2013; Hatfield SM, 2020, J CLIN INVEST, V130, P5629, DOI 10.1172/JCI137554; Hossain F, 2015, CANCER IMMUNOL RES, V3, P1236, DOI 10.1158/2326-6066.CIR-15-0036; Huang CY, 2020, CANCERS, V12, DOI 10.3390/cancers12010181; Kalyanaraman B, 2019, CELL BIOCHEM BIOPHYS, V77, P89, DOI 10.1007/s12013-018-0858-1; Kawano Y, 2015, IMMUNOL REV, V263, P160, DOI 10.1111/imr.12233; Kim G, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01022; Kim SH, 2017, J INVEST DERMATOL, V137, P1740, DOI 10.1016/j.jid.2017.03.033; Kiritsy MC, 2021, ELIFE, V10, DOI [10.7554/eLife.65109, 10.7554/eLife.65109.sa0, 10.7554/eLife.65109.sa1, 10.7554/eLife.65109.sa2]; Klein K, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.573326; Kloepping KC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244540; Law AMK, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030561; Li YL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01591; Marlein CR, 2017, BLOOD, V130, P1649, DOI 10.1182/blood-2017-03-772939; Matheoud D, 2016, CELL, V166, P314, DOI 10.1016/j.cell.2016.05.039; Miranda-Goncalves V, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00427; Mistry JJ, 2019, P NATL ACAD SCI USA, V116, P24610, DOI 10.1073/pnas.1913278116; Mohammed Sulma I, 2012, Methods Mol Biol, V863, P395, DOI 10.1007/978-1-61779-612-8_25; Molina JR, 2018, NAT MED, V24, P1036, DOI 10.1038/s41591-018-0052-4; Morrison AJ, 2022, FEBS J, V289, P1302, DOI 10.1111/febs.16032; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Musetti S, 2018, ACS NANO, V12, P11740, DOI 10.1021/acsnano.8b05893; Nagaraj S, 2013, J IMMUNOL, V191, P17, DOI 10.4049/jimmunol.1300654; Najjar YG, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124989; Okugawa Y, 2015, GASTROENTEROLOGY, V149, P1204, DOI 10.1053/j.gastro.2015.07.011; Ostrand-Rosenberg S, 2021, ANNU REV CANC BIOL, V5, P17, DOI 10.1146/annurev-cancerbio-042120-105240; Pan J, 2018, ISCIENCE, V3, P192, DOI 10.1016/j.isci.2018.04.013; Piyarathna DWB, 2019, J CLIN INVEST, V129, P2351, DOI 10.1172/JCI127579; Rai R, 2019, CANCER REP-US, V2, DOI 10.1002/cnr2.1153; Reddy CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089351; Rohlenova K, 2017, ANTIOXID REDOX SIGN, V26, P84, DOI 10.1089/ars.2016.6677; Saha T, 2022, NAT NANOTECHNOL, V17, P98, DOI 10.1038/s41565-021-01000-4; Salminen A, 2018, INT IMMUNOPHARMACOL, V61, P231, DOI 10.1016/j.intimp.2018.06.005; Sawant A, 2013, CANCER RES, V73, P6609, DOI 10.1158/0008-5472.CAN-13-0987; Scharping NE, 2017, CANCER IMMUNOL RES, V5, P9, DOI 10.1158/2326-6066.CIR-16-0103; Shukla P, 2021, TRENDS CANCER, V7, P93, DOI 10.1016/j.trecan.2020.10.014; Skwarski M, 2021, CLIN CANCER RES, V27, P2459, DOI 10.1158/1078-0432.CCR-20-4128; Smalley KSM, 2005, AM J PATHOL, V166, P1541, DOI 10.1016/S0002-9440(10)62370-X; Sotgia F, 2017, ONCOTARGET, V8, P67117, DOI 10.18632/oncotarget.19962; Steinberg G, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14949-y; Sugiura A, 2018, J IMMUNOL, V200, P400, DOI 10.4049/jimmunol.1701041; Tang TY, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-020-00449-4; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Trillo-Tinoco J, 2019, CANCER RES, V79, P5034, DOI 10.1158/0008-5472.CAN-19-0880; Trovato R, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0734-6; Wang B, 2021, J EXP CLIN CANC RES, V40, DOI 10.1186/s13046-020-01820-7; Weinberg SE, 2019, NATURE, V565, P495, DOI 10.1038/s41586-018-0846-z; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Williams LK, 2014, J CLIN ENDOCR METAB, V99, P3160, DOI 10.1210/jc.2014-1539; Xu YB, 2020, J MED CHEM, V63, P14276, DOI 10.1021/acs.jmedchem.0c01013; Yao S, 2021, JNCI-J NATL CANCER I, V113, P1036, DOI 10.1093/jnci/djaa215; Zeng D, 2020, TRANSL CANCER RES, V9, P5787, DOI 10.21037/tcr.2020.01.52; Zhang JJ, 2019, AM J TRANSL RES, V11, P6965; Zheng ZN, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000207; Zielonka J, 2017, CHEM REV, V117, P10043, DOI 10.1021/acs.chemrev.7b00042	97	0	0	4	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22226	10.1096/fj.202101862R	http://dx.doi.org/10.1096/fj.202101862R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CC	35233843	Green Published			2022-12-28	WOS:000772944000001
J	Nakladal, D; Lambooy, SPH; Misuth, S; Jepcova, D; Joschko, CP; van Buiten, A; Goris, M; Hoogstra-Berends, F; Kloosterhuis, NJ; Huijkman, N; van de Sluis, B; Diercks, GF; Buikema, JH; Henning, RH; Deelman, LE				Nakladal, D.; Lambooy, S. P. H.; Misuth, S.; Jepcova, D.; Joschko, C. P.; van Buiten, A.; Goris, M.; Hoogstra-Berends, F.; Kloosterhuis, N. J.; Huijkman, N.; van de Sluis, B.; Diercks, G. F.; Buikema, J. H.; Henning, R. H.; Deelman, L. E.			Homozygous whole body Cbs knockout in adult mice features minimal pathology during ageing despite severe homocysteinemia	FASEB JOURNAL			English	Article						cystathionine beta synthase deficiency; hydrogen sulfide; hyperhomocysteinemia; inducible mouse model; vascular dysfunction	CYSTATHIONINE-BETA-SYNTHASE; DEFICIENT MICE; RISK-FACTOR; HYDROGEN-SULFIDE; ANIMAL-MODEL; MOUSE MODEL; STEATOSIS; PHENOTYPE; FIBROSIS; DISEASE	Deficiencies in Cystathionine-beta-synthase (CBS) lead to hyperhomocysteinemia (HHCy), which is considered a risk factor for cardiovascular, bone and neurological disease. Moreover, CBS is important for the production of cysteine, hydrogen sulfide (H2S) and glutathione. Studying the biological role of CBS in adult mice has been severely hampered by embryological disturbances and perinatal mortality. To overcome these issues and assess the effects of whole-body CBS deficiency in adult mice, we engineered and characterized a Cre-inducible Cbs knockout model during ageing. No perinatal mortality occurred before Cbs(-/-) induction at 10 weeks of age. Mice were followed until 90 weeks of age and ablation of Cbs was confirmed in liver and kidney but not in brain. Severe HHCy was observed in Cbs(-/-) (289 +/- 58 mu M) but not in Cbs(+/-) or control mice (<10 mu M). Cbs(-/-) showed impaired growth, facial alopecia, endothelial dysfunction in absence of increased mortality, and signs of liver or kidney damage. CBS expression in skin localized to sebaceous glands and epidermis, suggesting local effects of Cbs(-/-) on alopecia. Cbs(-/-) showed increased markers of oxidative stress and senescence but expression of other H2S producing enzymes (CSE and 3-MST) was not affected. CBS deficiency severely impaired H2S production capacity in liver, but not in brain or kidney. In summary, Cbs(-/-) mice presented a mild phenotype without mortality despite severe HHCy. The findings demonstrate that HHCy is not directly linked to development of end organ damage.	[Nakladal, D.; Lambooy, S. P. H.; Misuth, S.; Jepcova, D.; Joschko, C. P.; van Buiten, A.; Goris, M.; Hoogstra-Berends, F.; Buikema, J. H.; Henning, R. H.; Deelman, L. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Misuth, S.; Jepcova, D.] Comenius Univ, Fac Pharm, Dept Pharmacol & Toxicol, Bratislava, Slovakia; [Kloosterhuis, N. J.; van de Sluis, B.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands; [Huijkman, N.; van de Sluis, B.] Univ Groningen, Univ Med Ctr Groningen, iPSC CRISPR Ctr Groningen, Groningen, Netherlands; [Diercks, G. F.] Univ Groningen, Univ Med Ctr Groningen, Ctr Blistering Dis, Dept Dermatol, Groningen, Netherlands	University of Groningen; Comenius University Bratislava; University of Groningen; University of Groningen; University of Groningen	Nakladal, D; Deelman, LE (corresponding author), Univ Med Ctr Groningen UMCG, Dept Clin Pharm & Pharmacol, AP50,Hanzepl 1,POB 30001, NL-9700 RB Groningen, Netherlands.	d.nakladal@umcg.nl; l.e.deelman@umcg.nl		Joschko, Christian Paul/0000-0003-2267-5108; Nakladal, Dalibor/0000-0003-0900-0130; Diercks, Gilles/0000-0001-8053-216X; van de Sluis, Bart (A.J.A.)/0000-0003-3039-4365	Graduate School of Medical Sciences, University of Groningen, University Medical Center Groningen; Life Sciences and Health-Topconsortium voor Kennis en Innovatie (Stichting LSH-TKI) [2019-017]	Graduate School of Medical Sciences, University of Groningen, University Medical Center Groningen; Life Sciences and Health-Topconsortium voor Kennis en Innovatie (Stichting LSH-TKI)	DN was financially supported by an Abel Tasman PhD scholarship by the Graduate School of Medical Sciences, University of Groningen, University Medical Center Groningen and by Life Sciences and Health-Topconsortium voor Kennis en Innovatie (Stichting LSH-TKI): PPP project-2019-017	Akahoshi N, 2008, HUM MOL GENET, V17, P1994, DOI 10.1093/hmg/ddn097; Arndt S, 2017, J BIOL CHEM, V292, P7761, DOI 10.1074/jbc.M117.784678; Beyer K, 2004, CURR ALZHEIMER RES, V1, P127, DOI 10.2174/1567205043332243; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; BRENTON D P, 1972, Journal of Bone and Joint Surgery British Volume, V54, P277; Chen XB, 2017, REDOX BIOL, V12, P987, DOI 10.1016/j.redox.2017.04.031; Cheng ZJ, 2011, BLOOD, V118, P1998, DOI 10.1182/blood-2011-01-333310; Dai YN, 2016, J CLIN BIOCHEM NUTR, V58, P76, DOI 10.3164/jcbn.15-54; Dayal S, 2012, BLOOD, V119, P3176, DOI 10.1182/blood-2011-09-380568; FOSMIRE GJ, 1990, AM J CLIN NUTR, V51, P225, DOI 10.1093/ajcn/51.2.225; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Ganguly P, 2015, NUTR J, V14, DOI 10.1186/1475-2891-14-6; Gupta S, 2021, FASEB J, V35, DOI 10.1096/fj.202100302R; Gupta S, 2014, FASEB J, V28, P781, DOI 10.1096/fj.13-240770; Gupta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027598; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Hanada K, 1998, J INVEST DERMATOL, V110, P259, DOI 10.1046/j.1523-1747.1998.00125.x; Hine C, 2018, ANTIOXID REDOX SIGN, V28, P1483, DOI 10.1089/ars.2017.7434; Jiang JY, 2016, CLIN EXP HYPERTENS, V38, P393, DOI 10.3109/10641963.2016.1148155; Jiang XH, 2005, ARTERIOSCL THROM VAS, V25, P2515, DOI 10.1161/01.ATV.0000189559.87328.e4; Kanagy NL, 2017, AM J PHYSIOL-CELL PH, V312, pC537, DOI 10.1152/ajpcell.00329.2016; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; Karmin O, 2018, CURR MED CHEM, V25, P367, DOI 10.2174/0929867324666170509145240; Kim CS, 2011, CARDIOVASC RES, V92, P466, DOI 10.1093/cvr/cvr250; Lee HO, 2021, J INHERIT METAB DIS, V44, P1382, DOI 10.1002/jimd.12437; Leustek Thomas, 2002, Arabidopsis Book, V1, pe0017, DOI 10.1199/tab.0017; Li N, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6492469; Maclean KN, 2010, MOL GENET METAB, V101, P153, DOI 10.1016/j.ymgme.2010.06.010; Majtan T, 2018, MOL THER, V26, P834, DOI 10.1016/j.ymthe.2017.12.014; Park I, 2020, HUM MUTAT, V41, P1662, DOI 10.1002/humu.24072; Polhemus DJ, 2015, CARDIOVASC THER, V33, P216, DOI 10.1111/1755-5922.12128; QUENTIN R, 1990, EUR J CLIN MICROBIOL, V9, P138, DOI 10.1007/BF01963641; Rittie L, 2016, J INVEST DERMATOL, V136, P1792, DOI 10.1016/j.jid.2016.05.113; Robert K, 2005, GASTROENTEROLOGY, V128, P1405, DOI 10.1053/j.gastro.2005.02.034; Robert K, 2004, ANAT REC PART A, V280A, P1072, DOI 10.1002/ar.a.20082; Son P., 2021, HYPERHOMOCYSTEINEMIA; Speir RW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126622; Sundberg JP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205775; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang LQ, 2004, CIRC RES, V94, P1318, DOI 10.1161/01.RES.0000129182.46440.4a; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Hoss GRW, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1214; Whiting DA, 2001, CLIN DERMATOL, V19, P211, DOI 10.1016/S0738-081X(00)00132-2; Wu DD, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2715718; Yan WJ, 2021, CLIN EXP PHARMACOL P, V48, P524, DOI 10.1111/1440-1681.13442; Zaric BL, 2019, CURR MED CHEM, V26, P2948, DOI 10.2174/0929867325666180313105949; Zou CG, 2005, ANTIOXID REDOX SIGN, V7, P547, DOI 10.1089/ars.2005.7.547	49	0	0	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22260	10.1096/fj.202101550R	http://dx.doi.org/10.1096/fj.202101550R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35315960	Green Published, hybrid			2022-12-28	WOS:000772957100006
J	Li, D; Li, JY; Liu, HN; Zhai, LN; Hu, WL; Xia, N; Tang, TT; Jiao, J; Lv, BJ; Nie, SF; Hu, DS; Liao, YH; Yang, XP; Shi, GP; Cheng, X				Li, Dan; Li, Jingyong; Liu, Henan; Zhai, Luna; Hu, Wangling; Xia, Ni; Tang, Tingting; Jiao, Jiao; Lv, Bingjie; Nie, Shaofang; Hu, Desheng; Liao, Yuhua; Yang, Xiangping; Shi, Guo-Ping; Cheng, Xiang			Pathogenic Tconvs promote inflammatory macrophage polarization through GM-CSF and exacerbate abdominal aortic aneurysm formation	FASEB JOURNAL			English	Article						abdominal aortic aneurysm; CXCR6; GM-CSF; Tconvs	CHEMOKINE RECEPTOR CXCR6; REGULATORY T-CELLS; IFN-GAMMA; ACCUMULATION; LYMPHOCYTES; HOMEOSTASIS; EXPRESSION; PHENOTYPES; LEUKOCYTES; RESPONSES	Abdominal aortic aneurysms (AAAs) elicit massive inflammatory leukocyte recruitment to the aorta. CD4(+) T cells, which include regulatory T cells (Tregs) and conventional T cells (Tconvs), are involved in the progression of AAA. Tregs have been reported to limit AAA formation. However, the function and phenotype of the Tconvs found in AAAs remain poorly understood. We characterized aortic Tconvs by bulk RNA sequencing and discovered that Tconvs in aortic aneurysm highly expressed Cxcr6 and Csf2. Herein, we determined that the CXCR6/CXCL16 signaling axis controlled the recruitment of Tconvs to aortic aneurysms. Deficiency of granulocyte-macrophage colony-stimulating factor (GM-CSF), encoded by Csf2, markedly inhibited AAA formation and led to a decrease of inflammatory monocytes, due to a reduction of CCL2 expression. Conversely, the exogenous administration of GM-CSF exacerbated inflammatory monocyte infiltration by upregulating CCL2 expression, resulting in worsened AAA formation. Mechanistically, GM-CSF upregulated the expression of interferon regulatory factor 5 to promote M1-like macrophage differentiation in aortic aneurysms. Importantly, we also demonstrated that the GM-CSF produced by Tconvs enhanced the polarization of M1-like macrophages and exacerbated AAA formation. Our findings revealed that GM-CSF, which was predominantly derived from Tconvs in aortic aneurysms, played a pathogenic role in the progression of AAAs and may represent a potential target for AAA treatment.	[Li, Dan; Li, Jingyong; Liu, Henan; Zhai, Luna; Hu, Wangling; Xia, Ni; Tang, Tingting; Jiao, Jiao; Lv, Bingjie; Nie, Shaofang; Liao, Yuhua; Cheng, Xiang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiol, 1277 Jiefang Ave, Wuhan 430022, Peoples R China; [Li, Dan; Li, Jingyong; Liu, Henan; Zhai, Luna; Hu, Wangling; Xia, Ni; Tang, Tingting; Jiao, Jiao; Lv, Bingjie; Nie, Shaofang; Liao, Yuhua; Cheng, Xiang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Key Lab Biol Targeted Therapy,Educ Minist & Hubei, Wuhan, Peoples R China; [Hu, Desheng] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Integrated Tradit Chinese & Western Med, Wuhan, Peoples R China; [Hu, Desheng] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China; [Yang, Xiangping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Wuhan, Peoples R China; [Shi, Guo-Ping] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Shi, Guo-Ping] Harvard Med Sch, Boston, MA 02115 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Cheng, X (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiol, 1277 Jiefang Ave, Wuhan 430022, Peoples R China.	nathancx@hust.edu.cn			National Natural Science Foundation of China (NSFC) [82030016, 81720108005, 81770503, 81400364, 81974037, 82000443]; National Heart, Lung, and Blood Institute [HL151627, HL157073]; National Institute of Neurological Disorders and Stroke [AG063839]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 82030016; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81720108005; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81770503; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81400364; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81974037; National Natural Science Foundation of China (NSFC), Grant/Award Number: 82000443; National Heart, Lung, and Blood Institute, Grant/Award Number: HL151627; National Heart, Lung, and Blood Institute, Grant/Award Number: HL157073; National Institute of Neurological Disorders and Stroke, Grant/Award Number: AG063839	Alkhatib G, 1997, NATURE, V388, P238, DOI 10.1038/40789; Anzai A, 2017, J EXP MED, V214, P3293, DOI 10.1084/jem.20170689; Becher B, 2016, IMMUNITY, V45, P963, DOI 10.1016/j.immuni.2016.10.026; BURGESS AW, 1980, BLOOD, V56, P947; Butcher MJ, 2016, INT IMMUNOL, V28, P255, DOI 10.1093/intimm/dxv068; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Collado A, 2018, CARDIOVASC RES, V114, P1764, DOI 10.1093/cvr/cvy135; Izquierdo MC, 2014, CYTOKINE GROWTH F R, V25, P317, DOI 10.1016/j.cytogfr.2014.04.002; Corbin AL, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aax6085; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Dale MA, 2015, ARTERIOSCL THROM VAS, V35, P1746, DOI 10.1161/ATVBAHA.115.305269; Eberl G, 2018, TRENDS IMMUNOL, V39, P261, DOI 10.1016/j.it.2017.11.004; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Galkina E, 2007, CIRCULATION, V116, P1801, DOI 10.1161/CIRCULATIONAHA.106.678474; Germanov E, 2008, J IMMUNOL, V181, P81, DOI 10.4049/jimmunol.181.1.81; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Griseri T, 2015, IMMUNITY, V43, P187, DOI 10.1016/j.immuni.2015.07.008; Hamilton JA, 2020, J EXP MED, V217, DOI 10.1084/jem.20190945; Kim CH, 2001, J CLIN INVEST, V107, P595, DOI 10.1172/JCI11902; Komuczki J, 2019, IMMUNITY, V50, P1289, DOI 10.1016/j.immuni.2019.04.006; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Latta M, 2007, IMMUNOLOGY, V121, P555, DOI 10.1111/j.1365-2567.2007.02603.x; Li JY, 2022, ADV SCI, V9, DOI 10.1002/advs.202104338; Li JY, 2019, ARTERIOSCL THROM VAS, V39, P446, DOI 10.1161/ATVBAHA.118.312023; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; MacRitchie N, 2020, CARDIOVASC RES, V116, P306, DOI 10.1093/cvr/cvz102; Mandai Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065488; Mossanen JC, 2019, GASTROENTEROLOGY, V156, P1877, DOI 10.1053/j.gastro.2019.01.247; Muller WA, 2013, VET PATHOL, V50, P7, DOI 10.1177/0300985812469883; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nores GDG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04418-y; Ocana E, 2008, ATHEROSCLEROSIS, V200, P264, DOI 10.1016/j.atherosclerosis.2007.12.043; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Piper C, 2020, BLOOD, V135, P568, DOI 10.1182/blood.2019001696; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Robinet P, 2018, ARTERIOSCL THROM VAS, V38, P292, DOI 10.1161/ATVBAHA.117.309524; Romain M, 2013, ARTERIOSCL THROM VAS, V33, P581, DOI 10.1161/ATVBAHA.112.300516; Sakalihasani N, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0030-7; Sampson UKA, 2014, GLOB HEART, V9, P159, DOI 10.1016/j.gheart.2013.12.009; Sharma AK, 2012, CIRCULATION, V126, pS38, DOI 10.1161/CIRCULATIONAHA.111.083451; Sheng W, 2014, CELL RES, V24, P1387, DOI 10.1038/cr.2014.154; Shimizu K, 2004, J CLIN INVEST, V114, P300, DOI 10.1172/JCI200419855; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Sho E, 2004, EXP MOL PATHOL, V76, P108, DOI 10.1016/j.yexmp.2003.11.003; Son BK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7994; Stock AT, 2016, J EXP MED, V213, P1983, DOI 10.1084/jem.20151853; Tao H, 2019, GASTROENTEROLOGY, V157, P1169, DOI 10.1053/j.gastro.2019.05.075; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Xiong WF, 2004, J IMMUNOL, V172, P2607, DOI 10.4049/jimmunol.172.4.2607; Yamanouchi D, 2012, J VASC SURG, V56, P455, DOI 10.1016/j.jvs.2012.01.038; Ye P, 2013, J CLIN INVEST, V123, P2317, DOI 10.1172/JCI67356; Yodoi K, 2015, HYPERTENSION, V65, P889, DOI 10.1161/HYPERTENSIONAHA.114.04934; Zhan YF, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02679; Zhao GZ, 2021, CARDIOVASC RES, V117, P1402, DOI 10.1093/cvr/cvaa214; Zhou Y, 2015, CARDIOVASC RES, V107, P98, DOI 10.1093/cvr/cvv119	57	1	1	4	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22172	10.1096/fj.202101576R	http://dx.doi.org/10.1096/fj.202101576R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35133017	Green Published			2022-12-28	WOS:000761250800031
J	Ming, X; Bo, ZY; Miao, YR; Chen, H; Bao, CY; Sun, LM; Xi, R; Zhong, QP; Zhao, P; Jung, YS; Qian, YJ				Ming, Xin; Bo, Zongyi; Miao, Yurun; Chen, Huan; Bao, Chenyi; Sun, Liumei; Xi, Rui; Zhong, Qiuping; Zhao, Pu; Jung, Yong-Sam; Qian, Yingjuan			Pseudorabies virus kinase UL13 phosphorylates H2AX to foster viral replication	FASEB JOURNAL			English	Article						ATM; DNA damage response; pseudorabies virus; UL13; gamma H2AX	DNA-DAMAGE RESPONSE; HISTONE H2AX; ATR; PK; PATHOGENESIS; ACTIVATION; PATHWAY; MODES	The DNA damage response (DDR) pathway is critical for maintaining genomic integrity and sustaining organismal development. Viruses can either utilize or circumvent the DDR to facilitate their replication. Pseudorabies virus (PRV) infection was shown to induce apoptosis via stimulating DDR. However, the underlying mechanisms have not been fully explored to date. This study showed that PRV infection robustly activates the ATM and DNA-PK signaling pathways shortly after infection. However, inhibition of ATM, but not DNA-PK, could dampen PRV replication in cells. Importantly, we found that PRV-encoded serine/threonine kinase UL13 interacts with and subsequently phosphorylates H2AX. Furthermore, we found that UL13 deletion largely attenuates PRV neuroinvasiveness and virulence in vivo. In addtion, we showed that UL13 contributes to H2AX phosphorylation upon PRV infection both in vitro and in vivo, but does not affect ATM phosphorylation. Finally, we showed that knockdown of H2AX reduces PRV replication, while this reduction can be further enhanced by deletion of UL13. Taken together, we conclude that PRV-encoded kinase UL13 regulates DNA damage marker gamma H2AX and UL13-mediated H2AX phosphorylation plays a pivotal role in efficient PRV replication and progeny production.	[Ming, Xin; Bo, Zongyi; Miao, Yurun; Chen, Huan; Bao, Chenyi; Sun, Liumei; Xi, Rui; Zhong, Qiuping; Zhao, Pu; Jung, Yong-Sam; Qian, Yingjuan] Nanjing Agr Univ, Coll Vet Med, MOA Key Lab Anim Bacteriol, MOE Joint Int Res Lab Anim Hlth & Food Safety, Nanjing, Peoples R China; [Bo, Zongyi] Yangzhou Univ, Joint Int Res Lab Agr & Agriprod Safety, Minist Educ China, Yangzhou, Jiangsu, Peoples R China; [Qian, Yingjuan] Jiangsu Agrianim Husb Vocat Coll, Jiangsu Key Lab High Tech Res & Dev Vet Biopharma, Taizhou, Peoples R China; [Sun, Liumei] Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang, Jiangsu, Peoples R China	Nanjing Agricultural University; Ministry of Education, China; Yangzhou University; Jiangsu Agri-animal Husbandry Vocational College; Jiangsu University of Science & Technology	Qian, YJ (corresponding author), Nanjing Agr Univ, Coll Vet Med, 1 Weigang, Nanjing 210095, Jiangsu, Peoples R China.	yqian@njau.edu.cn			National Natural Science Foundation of China (NSFC) [31472218]; Fundamental Research Funds for the Central Universities [Y0201700559]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31472218; Fundamental Research Funds for the Central Universities, Grant/Award Number: Y0201700559; Priority Academic Program Development of Jiangsu Higher Education Institutions	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bo ZY, 2020, VET RES, V51, DOI 10.1186/s13567-020-00843-4; Bo ZY, 2021, TRANSBOUND EMERG DIS, V68, P1454, DOI 10.1111/tbed.13813; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Brittle EE, 2004, J VIROL, V78, P12951, DOI 10.1128/JVI.78.23.12951-12963.2004; Burdak-Rothkamm S, 2007, ONCOGENE, V26, P993, DOI 10.1038/sj.onc.1209863; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cramer SD, 2011, J VET DIAGN INVEST, V23, P915, DOI 10.1177/1040638711416628; de Heer EC, 2020, J CLIN INVEST, V130, P5074, DOI 10.1172/JCI137552; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; FIELD HJ, 1974, J GEN VIROL, V23, P145, DOI 10.1099/0022-1317-23-2-145; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hollingworth R, 2017, J VIROL, V91, DOI 10.1128/JVI.00930-17; Jacob T, 2011, J VIROL, V85, P1158, DOI 10.1128/JVI.01369-10; Kawaguchi Y, 2003, REV MED VIROL, V13, P331, DOI 10.1002/rmv.402; Klupp BG, 2004, J VIROL, V78, P424, DOI 10.1128/JVI.78.1.424-440.2004; Lai IH, 2019, INTERVIROLOGY, V62, P116, DOI 10.1159/000502047; Laval K, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008087; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lehman IR, 1999, J BIOL CHEM, V274, P28059, DOI 10.1074/jbc.274.40.28059; Li RF, 2011, CELL HOST MICROBE, V10, P390, DOI 10.1016/j.chom.2011.08.013; Lian X, 2019, J VIROL, V93, DOI 10.1128/JVI.02290-18; Lilley CE, 2007, TRENDS MICROBIOL, V15, P119, DOI 10.1016/j.tim.2007.01.003; Lilley CE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002084; Luftig MA, 2014, ANNU REV VIROL, V1, P605, DOI 10.1146/annurev-virology-031413-085548; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Mettenleiter TC, 2000, VET RES, V31, P99, DOI 10.1051/vetres:2000059; Park EJ, 2003, NUCLEIC ACIDS RES, V31, P6819, DOI 10.1093/nar/gkg921; Pomeranz LE, 2005, MICROBIOL MOL BIOL R, V69, P462, DOI 10.1128/MMBR.69.3.462-500.2005; Rawlinson SM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05354-7; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Ryan EL, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010002; Smith S, 2015, FUTURE VIROL, V10, P383, DOI 10.2217/FVL.15.18; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Sun LM, 2021, J VIROL, V95, DOI 10.1128/JVI.02344-20; Tarakanova VL, 2007, CELL HOST MICROBE, V1, P275, DOI 10.1016/j.chom.2007.05.008; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Weitzman MD, 2018, ANNU REV VIROL, V5, P141, DOI 10.1146/annurev-virology-092917-043534; Weller SK, 2012, FASEB J, V26; Weyemi U, 2019, P NATL ACAD SCI USA, V116, P7471, DOI 10.1073/pnas.1820245116; Weyemi U, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03948-9; Yedjou CG, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010056; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	48	1	1	4	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22221	10.1096/fj.202101360RR	http://dx.doi.org/10.1096/fj.202101360RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35199383				2022-12-28	WOS:000761250800027
J	Gao, YH; Zhang, Q; Sun, JB; Liang, Y; Zhang, ML; Zhao, MX; Zhang, KL; Dong, CA; Ma, Q; Liu, W; Li, WP; Chen, YW; Han, LY; Jin, FG				Gao, Yongheng; Zhang, Qian; Sun, Jinbo; Liang, Yuan; Zhang, Minlong; Zhao, Mingxuan; Zhang, Kailiang; Dong, Chuan; Ma, Qiong; Liu, Wei; Li, Wangping; Chen, Yanwei; Han, Luyao; Jin, Faguang			Extracellular vesicles derived from PM2.5-exposed alveolar epithelial cells mediate endothelial adhesion and atherosclerosis in ApoE(-/-) mice	FASEB JOURNAL			English	Article						endothelium adhesion; miR-326-3p; p65; particle matters	PARTICULATE AIR-POLLUTION; MYOCARDIAL-INFARCTION; VASCULAR FUNCTION; TERM EXPOSURE; IN-VITRO; INFLAMMATION; PM2.5; EXPRESSION; INJURY; ALPHA	Epidemiological studies suggested that PM2.5 (particle matters with an aerodynamic diameter <= 2.5 mu m) exposure is associated with atherosclerosis. Extracellular vesicles (EVs) are messengers between intracellular communications which are important in diseases procession. At present, whether EVs derived from PM2.5-exposed alveolar epithelial cells (P-EVs) involve in atherosclerosis has not been clearly understood. This study is performed to investigate the effects of P-EVs on the development of endothelium adhesion and atherosclerosis. Here, ApoE(-/-) mice were randomized into different groups receiving one of the following treatments, filtered air (FA), PM2.5, PBS, PBS-treated alveolar epithelial cells-derived EVs (EVs), or P-EVs. Then the atherosclerosis level in aortas or aorta sections was evaluated by oil red O staining. The results indicated that ApoE(-/-) mice treated with P-EVs or PM2.5 showed more obvious atherosclerosis plaques in aortas and aortic arches than those treated with EVs or PBS. Endothelial cells (ECs) were treated with PBS, EVs, P-EVs, or PM2.5. The adhesion property, miRNAs level and expressions of I kappa B alpha, phosphorylated I kappa B alpha, NF-kappa B p65, phosphorylated NF-kappa B p65, and VCAM1 in ECs were determined. It was found that P-EVs activated I kappa B alpha-NF-kappa B-VCAM1 signaling and increased adhesion of ECs, and such effects could be reversed by adalimumab (the TNF-alpha inhibitor) or miR-326-3p inhibitor. Further study suggested that P-EVs induced upregulation of TNF-alpha and miR-326-3p in recipient ECs and contributed to the phosphorylation of NF-kappa B p65. Collectively, EVs derived from PM2.5-exposed alveolar epithelial cells played an important role in the development of atherosclerosis via activating I kappa B alpha-NF-kappa B-VCAM1 signaling.	[Gao, Yongheng; Zhang, Qian; Liu, Wei; Li, Wangping; Chen, Yanwei; Han, Luyao; Jin, Faguang] Fourth Mil Med Univ, Tangdu Hosp, Dept Respirat, Xinsi Rd 569, Xian 710038, Shaanxi, Peoples R China; [Sun, Jinbo] Gen Hosp Cent Theater Command, Dept Urol, Wuhan, Peoples R China; [Liang, Yuan] 920th Hosp Joint Logist Support Force, Dept Geriatr, Kunming, Yunnan, Peoples R China; [Zhang, Minlong] 309th Hosp Chinese Peoples Liberat Army, Dept Respirat, Beijing, Peoples R China; [Zhao, Mingxuan] Yunnan Univ Chinese Med, Affiliated Hosp 1, Res Ctr Clin Pharmacol, Kunming, Yunnan, Peoples R China; [Zhang, Kailiang; Dong, Chuan; Ma, Qiong] Fourth Mil Med Univ, Tangdu Hosp, Dept Orthoped, Xian, Peoples R China	Air Force Military Medical University; Yunnan University of Chinese Medicine; Air Force Military Medical University	Jin, FG (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Respirat, Xinsi Rd 569, Xian 710038, Shaanxi, Peoples R China.	jinfag@fmmu.edu.cn			Shaanxi Key RD Program [2018ZDCXL-SF-02-03-02]; National Natural Science Foundation of China [82070096]	Shaanxi Key RD Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Shaanxi Key R&D Program, Grant/Award Number: 2018ZDCXL-SF-02-03-02; National Natural Science Foundation of China, Grant/Award Number: 82070096	Bai YT, 2016, BBA-GEN SUBJECTS, V1860, P2863, DOI 10.1016/j.bbagen.2016.04.030; Benagiano M, 2012, P NATL ACAD SCI USA, V109, P1222, DOI 10.1073/pnas.1111833109; Chen T, 2013, TOXICOL LETT, V223, P146, DOI 10.1016/j.toxlet.2013.09.004; Cheng HS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00422; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; D'Ippoliti D, 2003, EPIDEMIOLOGY, V14, P528, DOI 10.1097/01.ede.0000082046.22919.72; Dai JW, 2017, INT J BIOL SCI, V13, P868, DOI 10.7150/ijbs.19868; Deng WY, 2019, CLIN CHIM ACTA, V495, P109, DOI 10.1016/j.cca.2019.04.051; Elliott RO, 2021, PHARMACEUTICS, V13, DOI 10.3390/pharmaceutics13010122; Endter S, 2009, J PHARM PHARMACOL, V61, P583, DOI 10.1211/jpp/61.05.0006; Fonseka P, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1597614; Gao W, 2016, J CELL MOL MED, V20, P2318, DOI 10.1111/jcmm.12923; Gao YH, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.922782; Gaudet AD, 2018, NEUROSCIENTIST, V24, P221, DOI 10.1177/1073858417721150; Ge CX, 2018, REDOX BIOL, V19, P147, DOI 10.1016/j.redox.2018.08.009; Gomzikova MO, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67563-9; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; He S, 2018, SCAND J IMMUNOL, V87, DOI 10.1111/sji.12648; Hwang SJ, 1997, CIRCULATION, V96, P4219; Kanj RS, 2005, J TOXICOL ENV HEAL A, V68, P185, DOI 10.1080/15287390590890509; Kaufman JD, 2016, LANCET, V388, P696, DOI 10.1016/S0140-6736(16)00378-0; Kletting S, 2018, ALTEX-ALTERN ANIM EX, V35, P211, DOI 10.14573/altex.1607191; Li W, 2019, INT J BIOL MACROMOL, V129, P904, DOI 10.1016/j.ijbiomac.2019.02.088; Liang S, 2020, PART FIBRE TOXICOL, V17, DOI 10.1186/s12989-020-00391-x; LIBBY P, 1991, LAB INVEST, V64, P5; Long YM, 2020, J HAZARD MATER, V386, DOI 10.1016/j.jhazmat.2019.121659; Loyer X, 2014, CIRC RES, V114, P345, DOI 10.1161/CIRCRESAHA.113.300858; Macias S, 2015, MOL CELL, V60, P873, DOI 10.1016/j.molcel.2015.11.011; Mastrandrea LD, 2010, VASC HEALTH RISK MAN, V6, P47; Montiel-Davalos A, 2007, INHAL TOXICOL, V19, P91, DOI 10.1080/08958370701495212; Montoya LD, 2019, SCI TOTAL ENVIRON, V690, P209, DOI 10.1016/j.scitotenv.2019.06.535; Nanes MS, 2003, GENE, V321, P1, DOI 10.1016/S0378-1119(03)00841-2; Oberoi R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160145; Osornio-Vargas AR, 2003, ENVIRON HEALTH PERSP, V111, P1289, DOI 10.1289/ehp.5913; Pan YJ, 2019, CANCER MANAG RES, V11, P10411, DOI 10.2147/CMAR.S223875; Peters A, 2001, CIRCULATION, V103, P2810; Pope CA, 2006, CIRCULATION, V114, P2443, DOI 10.1161/CIRCULATIONAHA.106.636977; Pope CA, 2016, CIRC RES, V119, P1204, DOI 10.1161/CIRCRESAHA.116.309279; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Pope CA., 2006, J AIR WASTE MANAG AS, V56, p709; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; Recht PA, 2004, ATHEROSCLEROSIS, V173, P321, DOI 10.1016/j.atherosclerosis.2003.11.023; Rodosthenous RS, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0121-0; Schneider A, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-14; Shan K, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.145; Sheng L, 2018, BIOMED PHARMACOTHER, V103, P851, DOI 10.1016/j.biopha.2018.03.173; Song KY, 2018, EXP THER MED, V15, P4557, DOI 10.3892/etm.2018.5947; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Tao F, 2002, AM J RESP CELL MOL, V26, P499, DOI 10.1165/ajrcmb.26.4.4749; Tornqvist H, 2007, AM J RESP CRIT CARE, V176, P395, DOI 10.1164/rccm.200606-872OC; von Klot S, 2005, CIRCULATION, V112, P3073, DOI 10.1161/CIRCULATIONAHA.105.548743; Wang HY, 2018, FREE RADICAL BIO MED, V121, P202, DOI 10.1016/j.freeradbiomed.2018.05.008; Wang Y, 2019, ECOTOX ENVIRON SAFE, V169, P863, DOI 10.1016/j.ecoenv.2018.11.114; Wu CT, 2018, INT J BIOCHEM CELL B, V101, P1, DOI 10.1016/j.biocel.2018.04.019; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Yang G, 2014, NEURO-ONCOLOGY, V16, P652, DOI 10.1093/neuonc/not307; Yang SJ, 2018, J CELL MOL MED, V22, P2739, DOI 10.1111/jcmm.13567; Yin YQ, 2016, CELL PHYSIOL BIOCHEM, V40, P486, DOI 10.1159/000452563; Ying ZK, 2009, TOXICOL SCI, V111, P80, DOI 10.1093/toxsci/kfp004; Zanobetti A, 2005, ENVIRON HEALTH PERSP, V113, P978, DOI 10.1289/ehp.7550; Zhang LW, 2014, CARDIOVASC DRUG THER, V28, P303, DOI 10.1007/s10557-014-6533-x; Zheng B, 2017, MOL THER, V25, P1279, DOI 10.1016/j.ymthe.2017.03.031; Zhong L, 2018, FASEB J, V32, P4070, DOI 10.1096/fj.201701536R	64	3	3	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22161	10.1096/fj.202100927RR	http://dx.doi.org/10.1096/fj.202100927RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35061300	hybrid			2022-12-28	WOS:000747987800040
J	Kljakic, O; Janickova, H; Skirzewski, M; Reichelt, A; Memar, S; El Mestikawy, S; Li, YL; Saksida, LM; Bussey, TJ; Prado, VF; Prado, MAM				Kljakic, Ornela; Janickova, Helena; Skirzewski, Miguel; Reichelt, Amy; Memar, Sara; El Mestikawy, Salah; Li, Yulong; Saksida, Lisa M.; Bussey, Timothy J.; Prado, Vania F.; Prado, Marco A. M.			Functional dissociation of behavioral effects from acetylcholine and glutamate released from cholinergic striatal interneurons	FASEB JOURNAL			English	Article						acetylcholine; dopamine; glutamate; striatum	BASAL GANGLIA; TRANSPORTER VGLUT3; DOPAMINE RELEASE; MICE DEFICIENT; ATTENTION; NEURONS; REWARD; MODEL; ABNORMALITIES; ACTIVATION	In the striatum, cholinergic interneurons (CINs) have the ability to release both acetylcholine and glutamate, due to the expression of the vesicular acetylcholine transporter (VAChT) and the vesicular glutamate transporter 3 (VGLUT3). However, the relationship these neurotransmitters have in the regulation of behavior is not fully understood. Here we used reward-based touchscreen tests in mice to assess the individual and combined contributions of acetylcholine/glutamate co-transmission in behavior. We found that reduced levels of the VAChT from CINs negatively impacted dopamine signalling in response to reward, and disrupted complex responses in a sequential chain of events. In contrast, diminished VGLUT3 levels had somewhat opposite effects. When mutant mice were treated with haloperidol in a cue-based task, the drug did not affect the performance of VAChT mutant mice, whereas VGLUT3 mutant mice were highly sensitive to haloperidol. In mice where both vesicular transporters were deleted from CINs, we observed altered reward-evoked dopaminergic signalling and behavioral deficits that resemble, but were worse, than those in mice with specific loss of VAChT alone. These results demonstrate that the ability to secrete two different neurotransmitters allows CINs to exert complex modulation of a wide range of behaviors.	[Kljakic, Ornela; Janickova, Helena; Skirzewski, Miguel; Reichelt, Amy; Memar, Sara; Saksida, Lisa M.; Bussey, Timothy J.; Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, Translat Neurosci Grp, 1151 Richmond St North, London, ON N6A 5B7, Canada; [Kljakic, Ornela; Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON, Canada; [Skirzewski, Miguel; Memar, Sara; Saksida, Lisa M.; Bussey, Timothy J.; Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Reichelt, Amy; Saksida, Lisa M.; Bussey, Timothy J.; Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada; [El Mestikawy, Salah] McGill Univ, Douglas Mental Hlth Univ Inst, Dept Psychiat, Montreal, PQ, Canada; [El Mestikawy, Salah] Sorbonne Univ, Neurosci Paris Seine Inst Biol Paris Seine NPS IB, CNRS, INSERM, Paris, France; [Li, Yulong] Peking Univ, Sch Life Sci, State Key Lab Membrane Biol, Beijing, Peoples R China	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); McGill University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Peking University	Prado, VF; Prado, MAM (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, Translat Neurosci Grp, 1151 Richmond St North, London, ON N6A 5B7, Canada.	vprado@robarts.ca; mprado@robarts.ca	Janickova, Helena/Q-7211-2017	Janickova, Helena/0000-0003-0310-7893; Skirzewski, Miguel/0000-0002-0980-0878	Ontario Graduate Scholarship; Jonathan and Joshua Graduate Scholarship; Fondation Brain Canada (Brain Canada); Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR) [MOP 126000, MOP 136930, MOP 89919, PJT 162431, PJT 159781]; Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC) [402524-2013 RGPIN, 03592-2021 RGPIN]; Weston Brain Institute; Canada First Research Excellence Fund (CFREF)	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Jonathan and Joshua Graduate Scholarship; Fondation Brain Canada (Brain Canada); Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC); Weston Brain Institute; Canada First Research Excellence Fund (CFREF)	Ontario Graduate Scholarship; Jonathan and Joshua Graduate Scholarship; Fondation Brain Canada (Brain Canada); Gouvernement du Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: MOP 126000, MOP 136930, MOP 89919, PJT 162431 and PJT 159781; Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC), Grant/Award Number: 402524-2013 RGPIN and 03592-2021 RGPIN; Weston Brain Institute; Canada First Research Excellence Fund CFREF)	Abudukeyoumu N, 2019, EUR J NEUROSCI, V49, P604, DOI 10.1111/ejn.13949; Aguilar JI, 2017, NEURON, V95, P1074, DOI 10.1016/j.neuron.2017.07.038; Al-Onaizi MA, 2017, CEREB CORTEX, V27, P1615, DOI 10.1093/cercor/bhv349; Aoki S, 2015, J NEUROSCI, V35, P9424, DOI 10.1523/JNEUROSCI.0490-15.2015; AYLWARD EH, 1994, AM J PSYCHIAT, V151, P687; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Beraldo FH, 2015, DIS MODEL MECH, V8, P1457, DOI 10.1242/dmm.022525; BERNARD V, 1992, J NEUROSCI, V12, P3591; Brunelin J, 2013, CURR MED CHEM, V20, P397; Cachope R, 2012, CELL REP, V2, P33, DOI 10.1016/j.celrep.2012.05.011; Dautan D, 2014, J NEUROSCI, V34, P4509, DOI 10.1523/JNEUROSCI.5071-13.2014; de Rover M, 2002, EUR J NEUROSCI, V16, P2279, DOI 10.1046/j.1460-9568.2002.02289.x; Divito CB, 2015, J NEUROSCI, V35, P14983, DOI 10.1523/JNEUROSCI.2124-15.2015; El Mestikawy S, 2011, NAT REV NEUROSCI, V12, P204, DOI 10.1038/nrn2969; Fasano C, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00140; Favier M, 2020, J CLIN INVEST, V130, P6616, DOI 10.1172/JCI138532; Fladung AK, 2010, AM J PSYCHIAT, V167, P206, DOI 10.1176/appi.ajp.2009.09010071; Gangarossa G, 2016, NEUROBIOL DIS, V87, P69, DOI 10.1016/j.nbd.2015.12.010; GERFEN CR, 1988, J ELECTRON MICR TECH, V10, P265, DOI 10.1002/jemt.1060100305; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gonzales KK, 2015, ANN NY ACAD SCI, V1349, P1, DOI 10.1111/nyas.12762; Gras C, 2008, NAT NEUROSCI, V11, P292, DOI 10.1038/nn2052; Guzman MS, 2013, J NEUROCHEM, V124, P658, DOI 10.1111/jnc.12128; Guzman MS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001194; Heath Christopher J, 2016, Curr Protoc Neurosci, V74, DOI 10.1002/0471142301.ns0834s74; Helseth AR, 2021, SCIENCE, V372, P361, DOI 10.1126/science.abe1931; Higley MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019155; Janickova Helena, 2021, Curr Protoc, V1, pe268, DOI 10.1002/cpz1.268; Jin X, 2014, NAT NEUROSCI, V17, P423, DOI 10.1038/nn.3632; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Joviano-Santos JV, 2021, FEBS J, V288, P5331, DOI 10.1111/febs.15825; Karcher NR, 2019, BIOL PSYCHIAT-COGN N, V4, P956, DOI 10.1016/j.bpsc.2019.05.017; Keeler JF, 2014, NEUROSCIENCE, V282, P156, DOI 10.1016/j.neuroscience.2014.07.021; Kegeles LS, 2010, ARCH GEN PSYCHIAT, V67, P231, DOI 10.1001/archgenpsychiatry.2010.10; Kharkwal G, 2016, NEURON, V91, P67, DOI 10.1016/j.neuron.2016.06.014; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033612; Kljakic O, 2017, J NEUROCHEM, V142, P90, DOI 10.1111/jnc.14003; Kolisnyk B, 2015, BRIT J PHARMACOL, V172, P4919, DOI 10.1111/bph.13260; Kolisnyk B, 2013, J NEUROSCI, V33, P14908, DOI 10.1523/JNEUROSCI.1933-13.2013; Kolisnyk B, 2013, J NEUROSCI, V33, P10427, DOI 10.1523/JNEUROSCI.0395-13.2013; KOOB GF, 1992, ANN NY ACAD SCI, V654, P171, DOI 10.1111/j.1749-6632.1992.tb25966.x; Lebouc M, 2020, NEUROBIOL DIS, V145, DOI 10.1016/j.nbd.2020.105076; Lim Sean Austin O, 2014, Front Synaptic Neurosci, V6, P22, DOI 10.3389/fnsyn.2014.00022; Lobo MK, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00041; Martins-Silva C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017611; Martos YV, 2017, J NEUROSCI, V37, P2849, DOI 10.1523/JNEUROSCI.3460-16.2017; Nelson AB, 2014, J NEUROSCI, V34, P8772, DOI 10.1523/JNEUROSCI.0901-14.2014; Nithianantharajah J, 2013, NEUROBIOL LEARN MEM, V105, P13, DOI 10.1016/j.nlm.2013.06.006; Palmer D, 2016, BEHAV BRAIN RES, V311, P267, DOI 10.1016/j.bbr.2016.05.050; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pisani A, 2007, TRENDS NEUROSCI, V30, P545, DOI 10.1016/j.tins.2007.07.008; Prado VF, 2017, NEUROSCIENCE, V345, P130, DOI 10.1016/j.neuroscience.2016.09.013; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Pujol J, 2004, ARCH GEN PSYCHIAT, V61, P720, DOI 10.1001/archpsyc.61.7.720; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Romberg C, 2013, NEUROBIOL AGING, V34, P731, DOI 10.1016/j.neurobiolaging.2012.08.006; Sakae DY, 2015, MOL PSYCHIATR, V20, P1448, DOI 10.1038/mp.2015.104; SALAMONE JD, 1994, BEHAV BRAIN RES, V65, P221, DOI 10.1016/0166-4328(94)90108-2; Saxena S, 1998, BRIT J PSYCHIAT, V173, P26; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Sherer LM, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008609; Silm K, 2019, NEURON, V102, P786, DOI 10.1016/j.neuron.2019.03.031; Smith-Roe SL, 2000, J NEUROSCI, V20, P7737; Sullivan MA, 2008, J NEUROSCI, V28, P8682, DOI 10.1523/JNEUROSCI.2411-08.2008; Sun FM, 2020, NAT METHODS, V17, P1156, DOI 10.1038/s41592-020-00981-9; Tecuapetla F, 2016, CELL, V166, P703, DOI 10.1016/j.cell.2016.06.032; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Trudeau LE, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00113; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wassum KM, 2012, BIOL PSYCHIAT, V71, P846, DOI 10.1016/j.biopsych.2011.12.019; Yan Z, 2001, NEUROSCIENCE, V103, P1017, DOI 10.1016/S0306-4522(01)00039-2; Zhai SY, 2018, CURR OPIN NEUROBIOL, V48, P9, DOI 10.1016/j.conb.2017.08.004	76	1	1	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22135	10.1096/fj.202101425R	http://dx.doi.org/10.1096/fj.202101425R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35032355	hybrid, Green Published			2022-12-28	WOS:000747987800046
J	DeDreu, J; Pal-Ghosh, S; Mattapallil, MJ; Caspi, RR; Stepp, MA; Menko, AS				DeDreu, JodiRae; Pal-Ghosh, Sonali; Mattapallil, Mary J.; Caspi, Rachel R.; Stepp, Mary Ann; Menko, A. Sue			Uveitis-mediated immune cell invasion through the extracellular matrix of the lens capsule	FASEB JOURNAL			English	Article						basement membrane; immune cell attachment; immune cell infiltration; immune cell migration; immune privilege; inflammation; lens; matrix; uveitic	BLOOD-RETINAL BARRIER; TRABECULAR MESHWORK; CATARACT; ANGIOGENESIS; HUMOR; EYE; COMPLICATIONS; UVEORETINITIS; RESPONSES; PROTEINS	While the eye is considered an immune privileged site, its privilege is abrogated when immune cells are recruited from the surrounding vasculature in response to trauma, infection, aging, and autoimmune diseases like uveitis. Here, we investigate whether in uveitis immune cells become associated with the lens capsule and compromise its privilege in studies of C57BL/6J mice with experimental autoimmune uveitis. These studies show that at D14, the peak of uveitis in these mice, T cells, macrophages, and Ly6G/Ly6C+ immune cells associate with the lens basement membrane capsule, burrow into the capsule matrix, and remain integrated with the capsule as immune resolution is occurring at D26. 3D surface rendering image analytics of confocal z-stacks and scanning electron microscopy imaging of the lens surface show the degradation of the lens capsule as these lens-associated immune cells integrate with and invade the lens capsule, with a subset infiltrating both epithelial and fiber cell regions of lens tissue, abrogating its immune privilege. Those immune cells that remain on the surface often become entwined with a fibrillar net-like structure. Immune cell invasion of the lens capsule in uveitis has not been described previously and may play a role in induction of lens and other eye pathologies associated with autoimmunity.	[DeDreu, JodiRae; Menko, A. Sue] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Pal-Ghosh, Sonali; Stepp, Mary Ann] George Washington Univ, Sch Med & Hlth Sci, Dept Anat & Cell Biol, Washington, DC 20052 USA; [Mattapallil, Mary J.; Caspi, Rachel R.] NEI, Lab Immunol, NIH, Bethesda, MD 20892 USA; [Stepp, Mary Ann] George Washington Univ, Sch Med & Hlth Sci, Dept Ophthalmol, Washington, DC 20052 USA; [Menko, A. Sue] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Ophthalmol, Philadelphia, PA 19107 USA	Jefferson University; George Washington University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); George Washington University; Jefferson University	Menko, AS (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 564 Jefferson Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA.; Menko, AS (corresponding author), Thomas Jefferson Univ, Wills Vis Res Ctr Jefferson, 564 Jefferson Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA.	sue.menko@jefferson.edu		Mattapallil, Mary/0000-0003-0615-7343; Menko, A. Sue/0000-0002-7514-4696; Stepp, Mary Ann/0000-0001-5623-2538	National Institute of Health, National Eye Institute [EY021784]	National Institute of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a grant from the National Institute of I lealth, National Eye Institute, EY021784 to ASM and MAS. Scanning Electron Microscopy was done at the GWU Nanofabrication and Imaging Center directed by Anastas Popratiloff.	Agarwal RK, 2004, METH MOLEC MED, V102, P395; Bajwa A, 2015, CLIN OPHTHALMOL, V9, P889, DOI 10.2147/OPTH.S80972; Bednarczyk M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041402; Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6; Blum-Hareuveni T, 2017, AM J OPHTHALMOL, V177, P139, DOI 10.1016/j.ajo.2017.02.023; Bos KJ, 2001, J MOL BIOL, V306, P1011, DOI 10.1006/jmbi.2000.4429; Burkholder BM, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4979; Carreon T, 2017, PROG RETIN EYE RES, V57, P108, DOI 10.1016/j.preteyeres.2016.12.004; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; Caspi Rachel R, 2003, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1506s53; CHAN CC, 1990, J AUTOIMMUN, V3, P247, DOI 10.1016/0896-8411(90)90144-H; Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072161; Chen L, 2008, INVEST OPHTH VIS SCI, V49, P4476, DOI 10.1167/iovs.08-1971; Chen M, 2018, AM J PATHOL, V188, P1007, DOI 10.1016/j.ajpath.2017.12.021; Chong WP, 2020, IMMUNITY, V53, P384, DOI 10.1016/j.immuni.2020.06.022; Crabtree E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56462-3; DeDreu J, 2021, MATRIX BIOL, V96, P18, DOI 10.1016/j.matbio.2020.12.005; DeDreu J, 2020, FASEB J, V34, P9316, DOI 10.1096/fj.202000289R; Demir I., 2015, VISION MODELING VISU, P65; Diacovo TG, 1996, BLOOD, V88, P146; Dick AD, 2016, OPHTHALMOLOGY, V123, P655, DOI 10.1016/j.ophtha.2015.10.028; Dustin ML, 2019, CELL, V177, P499, DOI 10.1016/j.cell.2019.03.038; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Gery I, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02304; GHOSH S, 1991, J CELL PHYSIOL, V149, P184, DOI 10.1002/jcp.1041490203; Guo TT, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01769; Harkness LM, 2017, J CELL MOL MED, V21, P3288, DOI 10.1111/jcmm.13232; Heissig B, 2010, HISTOL HISTOPATHOL, V25, P765, DOI 10.14670/HH-25.765; Jakos T, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02037; Ji YH, 2015, CLIN BIOCHEM, V48, P1304, DOI 10.1016/j.clinbiochem.2015.08.006; Jones W, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.037283; Kezic JM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3697; Klaassen I, 2013, PROG RETIN EYE RES, V34, P19, DOI 10.1016/j.preteyeres.2013.02.001; Lee EJ, 2016, J IMMUNOL, V196, P3148, DOI 10.4049/jimmunol.1502355; Llop SM, 2018, SEMIN OPHTHALMOL, V33, P64, DOI 10.1080/08820538.2017.1353815; Logan CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16456-5; Mattapallil MJ, 2015, INVEST OPHTH VIS SCI, V56, P5439, DOI 10.1167/iovs.15-17280; Mecham RP, 2015, MATRIX BIOL, V47, P13, DOI 10.1016/j.matbio.2015.05.003; Molzer C, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.608377; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Napier RJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18961-0; Neill T, 2021, MATRIX BIOL, V100, P118, DOI 10.1016/j.matbio.2021.04.001; Ohlmann AV, 2005, CURR EYE RES, V30, P27, DOI 10.1080/02713680490894333; Ozates S, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-020-01373-5; Palsson S, 2017, CLIN OPHTHALMOL, V11, P1549, DOI 10.2147/OPTH.S143886; Pepple KL, 2018, INVEST OPHTH VIS SCI, V59, P2504, DOI 10.1167/iovs.18-24192; Perez VL, 2015, TRENDS IMMUNOL, V36, P354, DOI 10.1016/j.it.2015.04.003; Prieto-del-Cura M, 2020, EUR J OPHTHALMOL, V30, P1381, DOI 10.1177/1120672119899379; Richardson RB, 2020, INT J RADIAT BIOL, V96, P1339, DOI 10.1080/09553002.2020.1812759; Rosenbaum JT, 2008, OPHTHAL RES, V40, P165, DOI 10.1159/000119870; Rosenzweig HL, 2009, J LEUKOCYTE BIOL, V85, P711, DOI 10.1189/jlb.0808478; Runkle EA, 2011, METHODS MOL BIOL, V686, P133, DOI 10.1007/978-1-60761-938-3_5; Saunders AE, 2010, CELL SIGNAL, V22, P339, DOI 10.1016/j.cellsig.2009.10.003; Sharma SM, 2017, BEST PRACT RES CL RH, V31, P846, DOI 10.1016/j.berh.2018.08.002; Smigiel KS, 2017, PROG MOL BIOL TRANSL, V147, P167, DOI 10.1016/bs.pmbts.2017.01.003; Stepp MA, 2021, TRANSL RES, V236, P52, DOI 10.1016/j.trsl.2021.05.005; Streilein JW, 2003, J LEUKOCYTE BIOL, V74, P179, DOI 10.1189/jlb.1102574; Sun Y, 2020, SURV OPHTHALMOL, V65, P133, DOI 10.1016/j.survophthal.2019.10.003; Tamm ER, 2009, EXP EYE RES, V88, P648, DOI 10.1016/j.exer.2009.02.007; Tsirouki T, 2018, OCUL IMMUNOL INFLAMM, V26, P2, DOI 10.1080/09273948.2016.1196713; Tu ZD, 2012, INVEST OPHTH VIS SCI, V53, P959, DOI 10.1167/iovs.11-8377; Vafadari B, 2016, J NEUROCHEM, V139, P91, DOI 10.1111/jnc.13415; van der Wijk AE, 2019, FASEB J, V33, P5320, DOI 10.1096/fj.201801499RRR; Walia A, 2015, BBA-GEN SUBJECTS, V1850, P2422, DOI 10.1016/j.bbagen.2015.09.007; Wight TN, 2017, CELL IMMUNOL, V312, P1, DOI 10.1016/j.cellimm.2016.12.003; Wormstone IM, 2021, PROG RETIN EYE RES, V82, DOI 10.1016/j.preteyeres.2020.100905; Zhang YB, 2012, IMMUNOLOGY, V135, P268, DOI 10.1111/j.1365-2567.2011.03549.x	67	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e21995	10.1096/fj.202101098R	http://dx.doi.org/10.1096/fj.202101098R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34874579	Green Published			2022-12-28	WOS:000734992000023
J	Li, HY; Long, DL; Lv, GH; Cheng, X; Wang, G; Yang, XS				Li, Haiyang; Long, Denglu; Lv, Guohua; Cheng, Xin; Wang, Guang; Yang, Xuesong			The double-edged sword role of TGF-beta signaling pathway between intrauterine inflammation and cranial neural crest development	FASEB JOURNAL			English	Article						double-edged sword role; inflammation; intrauterine infection; neural crest development; TGF-beta signaling	CONGENITAL-ABNORMALITIES; OROFACIAL CLEFTS; CELLS; INFECTION; PREGNANCY; FETAL; RISK; BIRTH; ASSOCIATION; EXPRESSION	Intrauterine infection would harm a developing embryo/fetus, thereby increasing the risk of developmental malformation. But, whether or not the infection-induced inflammation affects neural crest development still remains obscure. In this study, we employed meta-analysis to demonstrate the potential correlation between infection-induced inflammation and craniofacial anomalies, which was usually derived from the problems in neural crest cell development. The correlation was further verified by inflammatory cytokine release and the activation of nuclear factor kappa-light-chain enhancer of activated B cells signaling in lipopolysaccharide-treated HH10 chicken embryos. In such an inflammatory condition, AP-2 alpha- and Pax7-labeled pre-migratory and migratory neural crest cells in HH10 chicken embryos were significantly less than the ones in control. The bioinformatics analysis of RNA-seq data demonstrated that the principal differential gene expression occurred in transforming growth factor-beta (TGF-beta) signaling pathway, which was confirmed by the subsequent experimental results of quantitative PCR and immunofluorescent staining. Under this inflammatory circumstance, whole-mount in situ hybridization, immunofluorescence, and quantitative PCR showed the gene expression changes of key EMT-related transcription factors including upregulated Msx1, downregulated Slug, and FoxD3, as well as adhesion molecules and extracellular matrix protein including upregulated Cadherrin6B, E-cadherin, N-cadherin, and Laminin at the dorsal portion of neural tube of HH10 chicken embryos. Meanwhile, the bioinformatics analysis of RNA-seq data also manifested the differential gene expressions relevant to cell proliferation, which was confirmed by proliferating cell nuclear antigen Western blot data and co-immunofluorescence staining of human natural killer-1 and phosphorylated histone H3. In brief, this study revealed for the first time that the double-edged sword role of TGF-beta signaling pathway between intrauterine inflammation (protective role) and cranial neural crest development (harmful role).	[Li, Haiyang; Long, Denglu; Lv, Guohua; Cheng, Xin; Wang, Guang; Yang, Xuesong] Jinan Univ, Med Coll, Div Histol & Embryol, Int Joint Lab Embryon Dev & Prenatal Med, Guangzhou 510632, Peoples R China; [Long, Denglu] Jinan Univ, Med Records Dept, Qual & Safety Management Off, Affiliated Hosp 1, Guangzhou, Peoples R China; [Yang, Xuesong] Jinan Univ, Key Lab Regenerat Med, Minist Educ, Guangzhou, Peoples R China	Jinan University; Jinan University; Jinan University	Wang, G; Yang, XS (corresponding author), Jinan Univ, Med Coll, Div Histol & Embryol, Int Joint Lab Embryon Dev & Prenatal Med, Guangzhou 510632, Peoples R China.	wangguang7453@126.com; yang_xuesong@126.com	Wang, Guang/AAC-4624-2019	Yang, Xuesong/0000-0002-2537-5752	National Natural Science Foundation of China (NSFC) [31771331, 31971108]; Special Funds for the Cultivation of Guangdong College Students' Scientific and Technological Innovation [pdth202160064]; National Innovation and Entrepreneurship Training Program for Undergraduate [202010559076]; Fundamental Research Funds for the Central Universities [21621106]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Special Funds for the Cultivation of Guangdong College Students' Scientific and Technological Innovation; National Innovation and Entrepreneurship Training Program for Undergraduate; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	National Natural Science Foundation of China (NSFC), Grant Award Number: 31771331 and 31971108; Special Funds for the Cultivation of Guangdong College Students' Scientific and Technological Innovation, Grant/Award Number: pdth202160064; National Innovation and Entrepreneurship Training Program for Undergraduate, Grant/Award Number: 202010559076; Fundamental Research Funds for the Central Universities, Grant/Award Number 21621106	Acs L, 2020, ORTHOD CRANIOFAC RES, V23, P174, DOI 10.1111/ocr.12361; Acs N, 2006, EUR J EPIDEMIOL, V21, P65, DOI 10.1007/s10654-005-5364-2; Acs N, 2005, BIRTH DEFECTS RES A, V73, P989, DOI 10.1002/bdra.20195; Acs Nandor, 2006, Congenital Anomalies, V46, P86, DOI 10.1111/j.1741-4520.2006.00108.x; AKITAYA T, 1992, DEV DYNAM, V194, P12, DOI 10.1002/aja.1001940103; Bangor A, 2009, J USABILITY STUD, V4, P114; Banhidy F, 2010, BIRTH DEFECTS RES A, V88, P466, DOI 10.1002/bdra.20664; Brecchia G, 2010, ANIM REPROD SCI, V118, P310, DOI 10.1016/j.anireprosci.2009.06.016; Chi CC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007346.pub3; Clemente NS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69235-0; Conway SJ, 2011, CELL ADHES MIGR, V5, P232, DOI 10.4161/cam.5.3.15498; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Dombrowski JG, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.3300; El-Ghali N, 2010, MICROSC RES TECHNIQ, V73, P58, DOI 10.1002/jemt.20753; ERICKSON CA, 1989, DEV BIOL, V134, P112, DOI 10.1016/0012-1606(89)90082-1; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gorlin RJ, 1990, PLAST RECONSTR SURG; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; Hao Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112767; Hao YR, 2015, NUTRIENTS, V7, P7172, DOI 10.3390/nu7095328; He J, 2017, KIDNEY BLOOD PRESS R, V42, P232, DOI 10.1159/000477221; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hosokawa R, 2010, DEV BIOL, V341, P186, DOI 10.1016/j.ydbio.2010.02.030; Kahata K, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a022194; Kizil C, 2015, EMBO REP, V16, P416, DOI 10.15252/embr.201439702; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Kurlansky P, 2015, J THORAC CARDIOV SUR, V149, P866, DOI 10.1016/j.jtcvs.2014.11.070; Le Douarin NM, 1999, NEURAL CREST, V2; Leviton A, 1999, PEDIATR RES, V46, P566, DOI 10.1203/00006450-199911000-00013; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Liu HY, 2018, ONCOTARGET, V9, P2887, DOI 10.18632/oncotarget.20812; Long DL, 2021, PHARMACOL RES, V167, DOI 10.1016/j.phrs.2021.105543; Menard JP, 2010, OBSTET GYNECOL, V115, P134, DOI 10.1097/AOG.0b013e3181c391d7; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nieto MA, 2001, MECH DEVELOP, V105, P27, DOI 10.1016/S0925-4773(01)00394-X; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Park CW, 2014, J MATERN-FETAL NEO M, V27, P98, DOI 10.3109/14767058.2013.806898; Romero R, 2003, J NUTR, V133, p1668S, DOI 10.1093/jn/133.5.1668S; Seemann S, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0370-8; Siismets EM, 2020, J DEV BIOL, V8, DOI 10.3390/jdb8030018; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; Takeichi M, 2000, PHILOS T ROY SOC B, V355, P885, DOI 10.1098/rstb.2000.0624; Trainor PA, 2000, NAT REV NEUROSCI, V1, P116, DOI 10.1038/35039056; Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232; Wang CJ, 2016, J AGR FOOD CHEM, V64, P4705, DOI 10.1021/acs.jafc.6b01478; Wang W, 2009, PAEDIATR PERINAT EP, V23, P310, DOI 10.1111/j.1365-3016.2009.01025.x; Wang XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep18321; Williams RM, 2019, DEV CELL, V51, P255, DOI 10.1016/j.devcel.2019.10.003; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yan Y, 2019, INFECT GENET EVOL, V69, P176, DOI 10.1016/j.meegid.2019.01.023; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Zhang Jun, 1993, Pediatrics, V92, P559; Zhang P, 2017, TOXICOL LETT, V281, P53, DOI 10.1016/j.toxlet.2017.09.010; Zhou Y, 2016, KIDNEY BLOOD PRESS R, V41, P901, DOI 10.1159/000452591	58	1	1	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22113	10.1096/fj.202101343R	http://dx.doi.org/10.1096/fj.202101343R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34939699				2022-12-28	WOS:000734992000035
J	Hamdi, M; Canon-Beltran, K; Mazzarella, R; Cajas, YN; Leal, CLV; Gutierrez-Adan, A; Gonzalez, EM; Da Silveira, JC; Rizos, D				Hamdi, Meriem; Canon-Beltran, Karina; Mazzarella, Rosane; Cajas, Yulia N.; Leal, Claudia L. V.; Gutierrez-Adan, Alfonso; Gonzalez, Encina M.; Da Silveira, Juliano C.; Rizos, Dimitrios			Characterization and profiling analysis of bovine oviduct and uterine extracellular vesicles and their miRNA cargo through the estrous cycle	FASEB JOURNAL			English	Article						estrous cycle; extracellular vesicles; microRNA; oviduct; uterus	OOCYTE MATURATION; BLOOD-PLASMA; AMINO-ACIDS; MICRORNA; EMBRYO; EXOSOMES; FLUID; IDENTIFICATION	Extracellular vesicles (EVs) found in various biological fluids and particularly in reproductive fluids, have gained considerable attention for their possible role in cell- to- cell communication. Among, the different bioactive molecules cargos of EVs, MicroRNAs (miRNAs) are emerging as promising diagnostic biomarkers with high clinical potential. Aiming to understand the roles of EVs in bovine reproductive tract, we intended to characterize and profile the EVs of oviduct and uterine fluids (OF-EVs, UF-EVs) and their miRNA across the estrous cycle. Nanoparticle tracking analysis and transmission electron microscopy confirmed the existence of small EV population in OF and UF at all stages, (size between 30 and 200 nm; concentration: 3.4 x 10(10) EVs/ml and 6.0 x 10(10) EVs/ml for OF and UF, respectively, regardless of stage). The identification of EV markers (CD9, HSP70, and ALIX proteins) was confirmed by western blot. The miRNA analysis revealed the abundance of 310 and 351 miRNAs in OF-EVs and UF-EVs, respectively. Nine miRNAs were differentially abundant in OF-EVs between stages of the cycle, eight of them displayed a progressive increase from S1 to S4 (p < .05). In UF-EVs, a total of 14 miRNAs were differentially abundant between stages. Greater differences were observed between stage 1 (S1) and stage 3 (S3), with 11 miRNAs enriched in S3 compared to S1. Functional enrichment analysis revealed the involvement of these miRNAs in relevant pathways such as cell signaling, intercellular junctions, and reproductive functions that may be implicated in oviduct and uterus modulation across the cycle, but also in their preparation for embryo/conceptus presence and development.	[Hamdi, Meriem; Canon-Beltran, Karina; Cajas, Yulia N.; Gutierrez-Adan, Alfonso; Rizos, Dimitrios] INIA CSIC, Dept Anim Reprod, Madrid, Spain; [Hamdi, Meriem] Univ Zurich, Vetsuisse Fac, Dept Farm Anim, Genet & Funct Genom,Clin Reprod Med, Zurich, Switzerland; [Canon-Beltran, Karina] Fdn Univ Juan Castellanos, Programa Med Vet, Fac Ciencias Agr & Ambientales, Tunja, Colombia; [Mazzarella, Rosane; Leal, Claudia L. V.; Da Silveira, Juliano C.] Univ Sao Paulo, Fac Anim Sci & Food Engn, Dept Vet Med, Pirassununga, Brazil; [Cajas, Yulia N.] Univ Cuenca UC, Fac Ciencias Agr, Lab Biotecnol Reprod Anim, Cuenca, Ecuador; [Gonzalez, Encina M.] Complutense Univ Madrid UCM, Fac Vet, Dept Anat & Embryol, Madrid, Spain	University of Zurich; Universidade de Sao Paulo; Complutense University of Madrid	Hamdi, M (corresponding author), Univ Zurich, Vetsuisse Fac, Dept Farm Anim, Genet & Funct Genom,Clin Reprod Med, Zurich, Switzerland.	meriem.hamdi@uzh.ch	Gutierrez-Adan, Alfonso/A-1485-2014; Rizos, Dimitrios/E-7058-2012; Hamdi, Meriem/AAT-3131-2020; Gonzalez Martinez, Maria Encina/AAB-3915-2019	Gutierrez-Adan, Alfonso/0000-0001-9893-9179; Rizos, Dimitrios/0000-0001-6813-3940; Hamdi, Meriem/0000-0002-5210-4915; Gonzalez Martinez, Maria Encina/0000-0002-6217-866X; Cajas, Yulia N./0000-0001-9791-6733	Spanish Ministry of Science and Innovation [PID2019-111641RB-I00, RTI2018-093548-B-I00]; Minciencias-Colombia [848-2019]; Secretaria de Educacion Superior, Ciencia y Tecnologia e Innovacion (SENESCYT-Ecuador); Sao Paulo Research Foundation, Brazil (FAPESP) [2017/20339-3]; CNPq-Brazil [304276/2018-9, 2019/04981-2, 2014/22887-0, 2015/21829-9]; COST Action [CA16119]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Minciencias-Colombia; Secretaria de Educacion Superior, Ciencia y Tecnologia e Innovacion (SENESCYT-Ecuador); Sao Paulo Research Foundation, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); COST Action(European Cooperation in Science and Technology (COST))	This work was supported by the Spanish Ministry of Science and Innovation (PID2019--111641RB--I00 to DR, and RTI2018--093548--B-I00 to AGA); Minciencias--Colombia (848--2019) Postdoctoral Fellowship contract to KC--B; Secretaria de Educacion Superior, Ciencia y Tecnologia e Innovacion (SENESCYT--Ecuador) to YNC; Sao Paulo Research Foundation, Brazil (FAPESP; #2017/20339--3 and CNPq--Brazil 304276/2018--9 to CLVL; #2019/04981--2 to RM; 2014/22887--0 and 2015/21829--9 to JCDS). The Authors are members of the COST Action CA16119 in vitro 3--D total cell guidance and fitness (CellFit)	Al-Dossary AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080181; Alminana C, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4982-5; Alminana C, 2020, THERIOGENOLOGY, V150, P59, DOI 10.1016/j.theriogenology.2020.01.077; Alminana C, 2019, BIOENGINEERING-BASEL, V6, DOI 10.3390/bioengineering6020032; Alminana C, 2017, REPRODUCTION, V154, P253, DOI 10.1530/REP-17-0054; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Binelli M, 2018, BIOLOGY-BASEL, V7, DOI 10.3390/biology7010015; Boing AN, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23430; Burns DA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086855, 10.1371/journal.pone.0090913]; Burns GW, 2018, BIOL REPROD, V98, P612, DOI 10.1093/biolre/ioy011; Canon-Beltran K, 2021, METHODS MOL BIOL, V2273, P219, DOI 10.1007/978-1-0716-1246-0_16; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Chen L, 2019, BRIEF BIOINFORM, V20, P1836, DOI 10.1093/bib/bby054; Chen S, 2017, SCI REP-UK, V7, DOI 10.1038/srep42298; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Colas AR, 2012, GENE DEV, V26, P2567, DOI 10.1101/gad.200758.112; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Da Silveira J, 2018, METHODS MOL BIOL, V1733, P53, DOI 10.1007/978-1-4939-7601-0_4; da Silveira JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179451; da Silveira JC, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093252; de Avila ACFCM, 2020, REPROD FERT DEVELOP, V32, P56, DOI 10.1071/RD19278; Eulalio A, 2015, J BIOMOL SCREEN, V20, P1003, DOI 10.1177/1087057115578837; Fleming TP, 2000, SEMIN REPROD MED, V18, P185, DOI 10.1055/s-2000-12557; Gatien J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246339; Gonella-Diaza AM, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22020953; Greening DW, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.134890; Griffiths GS, 2008, MOL REPROD DEV, V75, P1627, DOI 10.1002/mrd.20907; Hugentobler SA, 2008, MOL REPROD DEV, V75, P496, DOI 10.1002/mrd.20760; Hugentobler SA, 2010, REPROD FERT DEVELOP, V22, P684, DOI 10.1071/RD09129; Hugentobler SA, 2007, MOL REPROD DEV, V74, P445, DOI 10.1002/mrd.20607; Ioannidis J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158160; Ioannidis J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2529-1; IRELAND JJ, 1980, J DAIRY SCI, V63, P155, DOI 10.3168/jds.S0022-0302(80)82901-8; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kurian NK, 2019, J ASSIST REPROD GEN, V36, P189, DOI 10.1007/s10815-018-1343-x; Kusama K, 2018, BIOCHEM BIOPH RES CO, V495, P1370, DOI 10.1016/j.bbrc.2017.11.176; Lasser C, 2012, JOVE-J VIS EXP, DOI 10.3791/3037; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lopera-Vasquez R, 2017, REPRODUCTION, V153, P461, DOI 10.1530/REP-16-0384; Lopera-Vasquez R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148083; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Markkandan K, 2018, GENES GENOM, V40, P1111, DOI 10.1007/s13258-018-0668-2; Mazzarella R, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.639752; Mol EA, 2017, NANOMED-NANOTECHNOL, V13, P2061, DOI 10.1016/j.nano.2017.03.011; Mondou E, 2012, MOL HUM REPROD, V18, P425, DOI 10.1093/molehr/gas015; Monguio-Tortajada Marta, 2019, Curr Protoc Stem Cell Biol, V49, pe82, DOI 10.1002/cpsc.82; Nakamura K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158278; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Otsuka M, 2008, J CLIN INVEST, V118, P1944, DOI 10.1172/JCI33680; Pohler KG, 2017, MOL REPROD DEV, V84, P731, DOI 10.1002/mrd.22856; Portela VM, 2010, FERTIL STERIL, V93, P2050, DOI 10.1016/j.fertnstert.2009.01.151; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Qiao F, 2018, THERIOGENOLOGY, V114, P199, DOI 10.1016/j.theriogenology.2018.03.027; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Tannetta D, 2014, CELL MOL IMMUNOL, V11, P548, DOI 10.1038/cmi.2014.42; Tesfaye D, 2009, MOL REPROD DEV, V76, P665, DOI 10.1002/mrd.21005; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Vilella F, 2015, DEVELOPMENT, V142, P3210, DOI 10.1242/dev.124289; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; Xie GH, 2013, HEPATOLOGY, V58, P1801, DOI 10.1002/hep.26511; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066	63	3	3	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22000	10.1096/fj.202101023R	http://dx.doi.org/10.1096/fj.202101023R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34731497	Green Submitted			2022-12-28	WOS:000722321300042
J	Sirbulescu, RF; Mamidi, A; Chan, SYC; Jin, G; Boukhali, M; Sobell, D; Ilies, I; Chung, JY; Haas, W; Whalen, MJ; Sluder, AE; Poznansky, MC				Sirbulescu, Ruxandra F.; Mamidi, Akshay; Chan, Shu-Yi Claire; Jin, Gina; Boukhali, Myriam; Sobell, Don; Ilies, Iulian; Chung, Joon Yong; Haas, Wilhelm; Whalen, Michael J.; Sluder, Ann E.; Poznansky, Mark C.			B cells support the repair of injured tissues by adopting MyD88-dependent regulatory functions and phenotype	FASEB JOURNAL			English	Article						B cells; immunomodulation; injury; MyD88; regulatory mechanisms; TLR	TOLL-LIKE RECEPTORS; CNS INFLAMMATION; PROTEIN; AUTOIMMUNE; PROTEOMICS; IMMUNITY; ALPHA; LINE	Exogenously applied mature naive B220(+)/CD19(+)/IgM(+)/IgD(+) B cells are strongly protective in the context of tissue injury. However, the mechanisms by which B cells detect tissue injury and aid repair remain elusive. Here, we show in distinct models of skin and brain injury that MyD88-dependent toll-like receptor (TLR) signaling through TLR2/6 and TLR4 is essential for the protective benefit of B cells in vivo, while B cell-specific deletion of MyD88 abrogated this effect. The B cell response to injury was multi-modal with simultaneous production of both regulatory cytokines, such as IL-10, IL-35, and transforming growth factor beta (TGF beta), and inflammatory cytokines, such as tumor necrosis factor alpha (TNF alpha), IL-6, and interferon gamma. Cytometry analysis showed that this response was time and environment-dependent in vivo, with 20%-30% of applied B cells adopting an immune modulatory phenotype with high co-expression of anti- and pro-inflammatory cytokines after 18-48 h at the injury site. B cell treatment reduced the expression of TNF alpha and increased IL-10 and TGF beta in infiltrating immune cells and fibroblasts at the injury site. Proteomic analysis further showed that B cells have a complex time-dependent homeostatic effect on the injured microenvironment, reducing the expression of inflammation-associated proteins, and increasing proteins associated with proliferation, tissue remodeling, and protection from oxidative stress. These findings chart and validate a first mechanistic understanding of the effects of B cells as an immunomodulatory cell therapy in the context of tissue injury.	[Sirbulescu, Ruxandra F.; Mamidi, Akshay; Chan, Shu-Yi Claire; Jin, Gina; Sobell, Don; Sluder, Ann E.; Poznansky, Mark C.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Vaccine & Immunotherapy Ctr, Boston, MA USA; [Mamidi, Akshay] Nanyang Technol Univ, Sch Chem & Biochem Engn, Singapore, Singapore; [Jin, Gina; Chung, Joon Yong; Whalen, Michael J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Neurosci Ctr, Boston, MA USA; [Haas, Wilhelm] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Ctr Canc Res, Boston, MA USA; [Ilies, Iulian] Northeastern Univ, Healthcare Syst Engn Inst, Dept Mech & Ind Engn, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Northeastern University	Sirbulescu, RF (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Vaccine & Immunotherapy Ctr, Boston, MA USA.; Sirbulescu, RF (corresponding author), Vaccine & Immunotherapy Ctr, 149,13th St, Charlestown, MA 02129 USA.	rsirbulescu@mgh.harvard.edu; mpoznansky@mgh.harvard.edu		Ilies, Iulian/0000-0002-2727-324X; Chung, Joon Yong/0000-0002-3980-2065	HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) [R01NS117598]; Vaccine and Immunotherapy Center Innovation Fund; Holy Cross Hospital, Ft. Lauderdale, FL	HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS); Vaccine and Immunotherapy Center Innovation Fund; Holy Cross Hospital, Ft. Lauderdale, FL	HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: R01NS117598; Vaccine and Immunotherapy Center Innovation Fund; Holy Cross Hospital, Ft. Lauderdale, FL	Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Bao WDN, 2016, SCI REP-UK, V6, DOI 10.1038/srep22579; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bodhankar S, 2014, METAB BRAIN DIS, V29, P59, DOI 10.1007/s11011-013-9474-3; Bodhankar S, 2013, METAB BRAIN DIS, V28, P375, DOI 10.1007/s11011-013-9413-3; Cambi A, 2009, CURR BIOL, V19, pR375, DOI 10.1016/j.cub.2009.03.032; Edwards A, 2016, METHODS MOL BIOL, V1394, P1, DOI 10.1007/978-1-4939-3341-9_1; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Ellis TN, 2004, IMMUNOLOGY, V112, P2, DOI 10.1111/j.1365-2567.2004.01849.x; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Evans JG, 2007, J IMMUNOL, V178, P7868, DOI 10.4049/jimmunol.178.12.7868; Fellner L, 2013, GLIA, V61, P349, DOI 10.1002/glia.22437; Fillatreau S, 2015, CURR OPIN PHARMACOL, V23, P1, DOI 10.1016/j.coph.2015.04.006; Goodchild TT, 2009, JACC-CARDIOVASC INTE, V2, P1005, DOI 10.1016/j.jcin.2009.08.010; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Iwata Y, 2009, AM J PATHOL, V175, P649, DOI 10.2353/ajpath.2009.080355; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; KATZ SI, 1974, NATURE, V251, P550, DOI 10.1038/251550a0; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kreuzer J, 2019, METHOD ENZYMOL, V626, P41, DOI 10.1016/bs.mie.2019.07.027; Kumar V, 2019, J NEUROIMMUNOL, V332, P16, DOI 10.1016/j.jneuroim.2019.03.012; Lapek JD, 2017, NAT BIOTECHNOL, V35, P983, DOI 10.1038/nbt.3955; Li L, 2021, BRAIN BEHAV IMMUN, V91, P740, DOI 10.1016/j.bbi.2020.10.007; Liu SR, 2012, J IMMUNOL, V188, P1098, DOI 10.4049/jimmunol.1101121; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Parsa R, 2016, J EXP MED, V213, P1537, DOI 10.1084/jem.20150577; Ritsu M, 2017, J DERMATOL DERMATOL, V21, P14, DOI 10.1016/j.jdds.2016.09.001; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Sirbulescu RF, 2019, J NEUROTRAUM, V36, P2579, DOI 10.1089/neu.2018.6368; Sirbulescu RF, 2017, WOUND REPAIR REGEN, V25, P774, DOI 10.1111/wrr.12584; Sun L, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1008-1; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; van de Veen W, 2016, J ALLERGY CLIN IMMUN, V138, P654, DOI 10.1016/j.jaci.2016.07.006	37	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22019	10.1096/fj.202101095RR	http://dx.doi.org/10.1096/fj.202101095RR			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34792819	Green Accepted			2022-12-28	WOS:000722321300026
J	Cimmino, I; Prisco, F; Orso, S; Agognon, AL; Liguoro, P; De Biase, D; Doti, N; Ruvo, M; Paciello, O; Beguinot, F; Formisano, P; Oriente, F				Cimmino, Ilaria; Prisco, Francesco; Orso, Sonia; Agognon, Ayewa L.; Liguoro, Pasquale; De Biase, Davide; Doti, Nunzianna; Ruvo, Menotti; Paciello, Orlando; Beguinot, Francesco; Formisano, Pietro; Oriente, Francesco			Interleukin 6 reduces vascular smooth muscle cell apoptosis via Prep1 and is associated with aging	FASEB JOURNAL			English	Article						aging; apoptosis; interleukin 6; Prep1; vascular smooth muscle cells	UP-REGULATION; GENE; IL-6; AGE; PROTEINS; SUSCEPTIBILITY; TRANSCRIPTION; SENSITIVITY; ACTIVATION; SENESCENCE	Aging exacerbates neointimal formation by reducing apoptosis of vascular smooth muscle cells (VSMCs) and induces inflammation within vascular wall. Prep1 is a homeodomain transcription factor which stimulates the expression of proinflammatory cytokines in aortic endothelial cell models and plays a primary role in the regulation of apoptosis. In this study, we have investigated the role of Prep1 in aorta of Prep1 hypomorphic heterozygous mice (Prep1(i/+)) and in VSMCs, and its correlation with aging. Histological analysis from Prep1(i/+) aortas revealed a 25% reduction in medial smooth muscle cell density compared to WT animals. This result paralleled higher apoptosis, caspase 3, caspase 9 and p53 levels in Prep1(i/+) mice and lower Bcl-xL. Prep1 overexpression in VSMCs decreased apoptosis by 25% and caspase 3 and caspase 9 expression by 40% and 37%. In parallel, Bcl-xL inhibition by BH3I-1 and p53 induction by etoposide reverted the antiapoptotic effect of Prep1. Experiments performed in aorta from 18 months old WT mice showed a significant increase in Prep1, p16(INK4), p21(Waf1) and interleukin 6 (IL-6) compared to youngest animals. Similar results have been observed in H2O2-induced senescent VSMCs. Interestingly, the synthetic Prep1 inhibitory peptide Prep1 (54-72) reduced the antiapoptotic effects mediated by IL-6, particularly in senescent VSMCs. These results indicate that IL-6-Prep1 signaling reduces apoptosis, by modulating Bcl-xL and p53 both in murine aorta and in VSMCs. In addition, age-dependent increase in IL-6 and Prep1 in senescent VSMCs and in old mice may be involved in the aging-related vascular dysfunction.	[Cimmino, Ilaria; Orso, Sonia; Agognon, Ayewa L.; Liguoro, Pasquale; Beguinot, Francesco; Formisano, Pietro; Oriente, Francesco] Federico II Univ Naples, Dept Translat Med, Via Pansini 5, I-80131 Naples, Italy; [Cimmino, Ilaria; Orso, Sonia; Agognon, Ayewa L.; Liguoro, Pasquale; Beguinot, Francesco; Formisano, Pietro; Oriente, Francesco] Natl Council Res CNR, URT Genom Diabet Inst Expt Endocrinol & Oncol, Via Pansini 5, I-80131 Naples, Italy; [Prisco, Francesco; De Biase, Davide; Paciello, Orlando] Federico II Univ Naples, Dept Vet Med & Anim Prod, Naples, Italy; [Doti, Nunzianna; Ruvo, Menotti] CNR, Inst Biostruct & Bioimaging, Naples, Italy; [Doti, Nunzianna; Ruvo, Menotti] Interuniv Res Ctr Bioact Peptides Naples, Naples, Italy	University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)	Formisano, P (corresponding author), Federico II Univ Naples, Dept Translat Med, Via Pansini 5, I-80131 Naples, Italy.; Formisano, P (corresponding author), Natl Council Res CNR, URT Genom Diabet Inst Expt Endocrinol & Oncol, Via Pansini 5, I-80131 Naples, Italy.	fpietro@unina.it	Prisco, Francesco/AGZ-9000-2022; Doti, Nunzianna/ABC-9948-2020; ORIENTE, Francesco/J-6652-2018	Prisco, Francesco/0000-0002-0399-1239; ORIENTE, Francesco/0000-0003-4375-4526	Regione Campania [COEPICA,SATIN,RARE-PLAT NET]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG19001]	Regione Campania(Regione Campania); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	Regione Campania, Grant/Award Number: COEPICA,SATIN,RARE-PLAT NET; Associazione Italiana per la Ricerca sul Cancro (AIRC), Grant/Award Number: IG19001	Bailey JS, 2004, MOL ENDOCRINOL, V18, P1158, DOI 10.1210/me.2003-0442; Berthelsen J, 1998, EMBO J, V17, P1423, DOI 10.1093/emboj/17.5.1423; Caporale A, 2018, PEPTIDES, V102, P38, DOI 10.1016/j.peptides.2018.02.006; Chen RH, 1999, J BIOL CHEM, V274, P23013, DOI 10.1074/jbc.274.33.23013; Chen WK, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01884-4; Cimmino I, 2019, FASEB J, V33, P13893, DOI 10.1096/fj.201901230RR; Cimmino I, 2019, J MOL ENDOCRINOL, V63, P273, DOI 10.1530/JME-18-0265; Cimmino I, 2017, ONCOTARGET, V8, P71845, DOI 10.18632/oncotarget.18286; Cohen HJ, 1997, J GERONTOL A-BIOL, V52, pM201, DOI 10.1093/gerona/52A.4.M201; De Biase D, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073609; De Biase D, 2020, J CELL PHYSIOL, V235, P5394, DOI 10.1002/jcp.29426; Diaz VM, 2007, MOL CELL BIOL, V27, P7981, DOI 10.1128/MCB.01290-07; ERSHLER WB, 1993, LYMPHOKINE CYTOK RES, V12, P225; Favaloro B, 2012, AGING-US, V4, P330, DOI 10.18632/aging.100459; Fernandez-Diaz LC, 2010, DEVELOPMENT, V137, P3393, DOI 10.1242/dev.050567; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; Ferrucci L, 2005, BLOOD, V105, P2294, DOI 10.1182/blood-2004-07-2599; HAGER K, 1994, NEUROBIOL AGING, V15, P771, DOI 10.1016/0197-4580(94)90066-3; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Herzig S, 2000, J BIOL CHEM, V275, P27989; IKEDA U, 1991, AM J PHYSIOL, V260, pH1713, DOI 10.1152/ajpheart.1991.260.5.H1713; KANIA DM, 1995, J AM GERIATR SOC, V43, P236, DOI 10.1111/j.1532-5415.1995.tb07328.x; Klouche M, 1999, J IMMUNOL, V163, P4583; Lavrik IN, 2010, CURR OPIN BIOTECH, V21, P551, DOI 10.1016/j.copbio.2010.07.001; Lin MT, 2001, CARCINOGENESIS, V22, P1947, DOI 10.1093/carcin/22.12.1947; Liotti A, 2018, BBA-MOL CELL BIOL L, V1863, P515, DOI 10.1016/j.bbalip.2018.02.005; Longobardi E, 2010, MOL ONCOL, V4, P126, DOI 10.1016/j.molonc.2010.01.001; Lorenzo V, 2016, MOL BIOTECHNOL, V58, P328, DOI 10.1007/s12033-016-9932-3; McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092; Micali N, 2010, NUCLEIC ACIDS RES, V38, P3595, DOI 10.1093/nar/gkq019; Micali N, 2009, MOL CELL BIOL, V29, P1143, DOI 10.1128/MCB.01273-08; Monk BA, 2015, GERONTOLOGY, V61, P416, DOI 10.1159/000368576; OHKAWA F, 1994, AM J PHYSIOL, V266, pH898, DOI 10.1152/ajpheart.1994.266.3.H898; Oriente F, 2008, MOL CELL BIOL, V28, P5634, DOI 10.1128/MCB.00117-08; Oriente F, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00346; Oriente F, 2013, DIABETOLOGIA, V56, P2713, DOI 10.1007/s00125-013-3053-3; Pagano TB, 2020, VET PATHOL, V57, P272, DOI 10.1177/0300985819891257; Prisco F, 2021, POULTRY SCI, V100, DOI 10.1016/j.psj.2021.101150; Puzianowska-Kuznicka M, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0076-x; Qian DH, 2011, INT J MOL MED, V28, P207, DOI 10.3892/ijmm.2011.671; Rapa SF, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031135; Ricci S, 2018, MOL NEUROBIOL, V55, P6801, DOI 10.1007/s12035-018-0873-7; Rodriguez-Menocal L, 2014, AM J PHYSIOL-HEART C, V306, pH641, DOI 10.1152/ajpheart.00641.2013; Rudin CM, 1997, ANNU REV MED, V48, P267; Tower J, 2015, AGEING RES REV, V23, P90, DOI 10.1016/j.arr.2015.04.002; Uryga AK, 2016, J PHYSIOL-LONDON, V594, P2115, DOI 10.1113/JP270923; Van Eycke YR, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep42964; Vazquez-Padron RI, 2004, J VASC SURG, V40, P1199, DOI 10.1016/j.jvs.2004.08.034; Wang E, 1999, J CELL BIOCHEM, P95; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388; Wang ZB, 2003, J SURG RES, V111, P261, DOI 10.1016/S0022-4804(03)00087-8; Wang Z, 2013, METHODS MOL BIOL, V1048, P135, DOI 10.1007/978-1-62703-556-9_11; Watanabe S, 2004, AM J NEPHROL, V24, P387, DOI 10.1159/000079706; WEI J, 1992, LIFE SCI, V51, P1953, DOI 10.1016/0024-3205(92)90112-3	54	0	0	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21989	10.1096/fj.202100943R	http://dx.doi.org/10.1096/fj.202100943R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34679197	hybrid			2022-12-28	WOS:000712009200027
J	D'Addio, M; Frey, J; Tacconi, C; Commerford, CD; Halin, C; Detmar, M; Cummings, RD; Otto, VI				D'Addio, Marco; Frey, Jasmin; Tacconi, Carlotta; Commerford, Catharina D.; Halin, Cornelia; Detmar, Michael; Cummings, Richard D.; Otto, Vivianne, I			Sialoglycans on lymphatic endothelial cells augment interactions with Siglec-1 (CD169) of lymph node macrophages	FASEB JOURNAL			English	Article						endothelial cells; glycocalyx; lymph nodes; macrophages; sialic acid-binding Ig-like lectin 1; sialic acids	SUBCAPSULAR SINUS MACROPHAGES; MYELIN-ASSOCIATED GLYCOPROTEIN; ACID-BINDING-RECEPTOR; CYSTEINE-RICH DOMAIN; SIALIC-ACID; MASS-SPECTROMETRY; L-SELECTIN; B-CELL; SIALOADHESIN; IDENTIFICATION	Cellular interactions between endothelial cells and macrophages regulate macrophage localization and phenotype, but the mechanisms underlying these interactions are poorly understood. Here we explored the role of sialoglycans on lymphatic endothelial cells (LEC) in interactions with macrophage-expressed Siglec-1 (CD169). Lectin-binding assays and mass spectrometric analyses revealed that LEC from human skin express more sialylated glycans than the corresponding blood endothelial cells. Higher amounts of sialylated and/or sulfated glycans on LEC than BEC were consistently observed in murine skin, lung and lymph nodes. The floor LEC of the subcapsular sinus (SCS) in murine lymph nodes (LN) displayed sialylated glycans at particularly high densities. The sialoglycans of LN LEC were strongly bound by Siglec-1. Such binding plays an important role in the localization of Siglec-1(+) LN-SCS macrophages, as their numbers are strongly reduced in mice expressing a Siglec-1 mutant that is defective in sialoglycan binding. The residual Siglec-1(+) macrophages are less proliferative and have a more anti-inflammatory phenotype. We propose that the densely clustered, sialylated glycans on the SCS floor LEC are a key component of the macrophage niche, providing anchorage for the Siglec-1(+) LN-SCS macrophages.	[D'Addio, Marco; Frey, Jasmin; Tacconi, Carlotta; Commerford, Catharina D.; Halin, Cornelia; Detmar, Michael; Otto, Vivianne, I] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland; [Cummings, Richard D.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02115 USA; [Tacconi, Carlotta] Univ Milan, Dept Biosci, Via Celoria 26 Corpo B, I-20133 Milan, Italy	Swiss Federal Institutes of Technology Domain; ETH Zurich; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Milan	Otto, VI (corresponding author), Swiss Fed Inst Technol, Inst Pharmaceut Sci, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland.	vivianne.otto@pharma.ethz.ch		Tacconi, Carlotta/0000-0002-6431-7555; Otto, Vivianne/0000-0002-1157-0186	ETH Zurich foundation [2015-48]; OPO foundation Zurich	ETH Zurich foundation(ETH Zurich); OPO foundation Zurich	ETH Zurich foundation, Grant/Award Number: 2015-48(2); OPO foundation Zurich	Abeln M, 2017, CHEMBIOCHEM, V18, P1305, DOI 10.1002/cbic.201700083; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bellomo A, 2018, CELL IMMUNOL, V330, P168, DOI 10.1016/j.cellimm.2018.01.010; Blixt O, 2003, J BIOL CHEM, V278, P31007, DOI 10.1074/jbc.M304331200; BORN GVR, 1985, BRIT J EXP PATHOL, V66, P543; Bovay E, 2018, J EXP MED, V215, P2760, DOI 10.1084/jem.20180217; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Camara A, 2019, IMMUNITY, V50, P1467, DOI 10.1016/j.immuni.2019.05.008; Commerford CD, 2018, CELL REP, V25, P3554, DOI 10.1016/j.celrep.2018.12.002; CROCKER PR, 1991, EMBO J, V10, P1661, DOI 10.1002/j.1460-2075.1991.tb07689.x; Crocker PR, 1999, BIOCHEM J, V341, P355, DOI 10.1042/0264-6021:3410355; CROCKER PR, 1994, EMBO J, V13, P4490, DOI 10.1002/j.1460-2075.1994.tb06771.x; D'Addio M, 2020, GLYCOBIOLOGY, V30, P490, DOI 10.1093/glycob/cwaa008; DELL A, 1994, METHOD ENZYMOL, V230, P108; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Fujimoto N, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000704; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Gray EE, 2012, J INNATE IMMUN, V4, P424, DOI 10.1159/000337007; Gray EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038258; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Heinzel K, 2007, P NATL ACAD SCI USA, V104, P8421, DOI 10.1073/pnas.0608274104; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kalucka J, 2020, CELL, V180, P764, DOI 10.1016/j.cell.2020.01.015; Kawasaki N, 2013, P NATL ACAD SCI USA, V110, P7826, DOI 10.1073/pnas.1219888110; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; Klaas M, 2012, J IMMUNOL, V189, P2414, DOI 10.4049/jimmunol.1200776; Kruger-Genge A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184411; Kudelka MR, 2016, NAT METHODS, V13, P81, DOI [10.1038/NMETH.3675, 10.1038/nmeth.3675]; Lawrenson JG, 2000, J ANAT, V196, P55, DOI 10.1046/j.1469-7580.2000.19610055.x; Louie DAP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00347; Martinez-Pomares L, 1999, J BIOL CHEM, V274, P35211, DOI 10.1074/jbc.274.49.35211; MartinezPomares L, 1996, J EXP MED, V184, P1927, DOI 10.1084/jem.184.5.1927; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; Mondor I, 2019, IMMUNITY, V50, P1453, DOI 10.1016/j.immuni.2019.04.002; Moseman EA, 2012, IMMUNITY, V36, P415, DOI 10.1016/j.immuni.2012.01.013; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Oetke C, 2006, MOL CELL BIOL, V26, P1549, DOI 10.1128/MCB.26.4.1549-1557.2006; Park C, 2016, METHODS MOL BIOL, V1407, P195, DOI 10.1007/978-1-4939-3480-5_15; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Rapoport EM, 2006, BIOCHEMISTRY-MOSCOW+, V71, P496, DOI 10.1134/S0006297906050051; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Russo E, 2016, CELL REP, V14, P1723, DOI 10.1016/j.celrep.2016.01.048; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Saunderson SC, 2014, BLOOD, V123, P208, DOI 10.1182/blood-2013-03-489732; SIMIONESCU M, 1985, J CELL BIOL, V100, P1396, DOI 10.1083/jcb.100.5.1396; Strenge K, 1998, EUR J BIOCHEM, V258, P677, DOI 10.1046/j.1432-1327.1998.2580677.x; T'Jonck W, 2018, CELL IMMUNOL, V330, P43, DOI 10.1016/j.cellimm.2018.02.005; Travaglini KJ, 2020, NATURE, V587, DOI 10.1038/s41586-020-2922-4; Ulvmar MH, 2016, CARDIOVASC RES, V111, P310, DOI 10.1093/cvr/cvw175; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; Varki A., 2022, ESSENTIALS GLYCOBIOL, V4; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Vinson M, 1996, J BIOL CHEM, V271, P9267, DOI 10.1074/jbc.271.16.9267; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Xiang M, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00052; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4	68	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e22017	10.1096/fj.202100300R	http://dx.doi.org/10.1096/fj.202100300R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34699642	hybrid, Green Published			2022-12-28	WOS:000712009200065
J	Yamada, T; Kimura, I; Ashida, Y; Tamai, K; Fusagawa, H; Tohse, N; Westerblad, H; Andersson, DC; Sato, T				Yamada, Takashi; Kimura, Iori; Ashida, Yuki; Tamai, Katsuyuki; Fusagawa, Hiroyori; Tohse, Noritsugu; Westerblad, Hakan; Andersson, Daniel C.; Sato, Tatsuya			Larger improvements in fatigue resistance and mitochondrial function with high- than with low-intensity contractions during interval training of mouse skeletal muscle	FASEB JOURNAL			English	Article						contraction intensity; fatigue resistance; interval training; mitochondria; skeletal muscle; supercomplex	5'-AMP-ACTIVATED PROTEIN-KINASE; EXERCISE INTENSITY; SPRINT INTERVAL; ADAPTATIONS; EXPRESSION; PERFORMANCE; ACTIVATION; ABUNDANCE; CAPACITY; INCREASE	Interval training (IT) results in improved fatigue resistance in skeletal muscle mainly due to an increased aerobic capacity, which involves increased muscle mitochondrial content and/or improved mitochondrial function. We hypothesized that IT with high-intensity contractions is more effective in increasing mitochondrial function, and hence fatigue resistance, than low-intensity contractions. To study this hypothesis without interference from differences in muscle fiber recruitment obliged to occur during voluntary contractions, IT was performed with in situ supramaximal electrical stimulation where all muscle fibers are recruited. We compared the effect of IT with repeated low-intensity (20 Hz stimulation, IT20) and high-intensity (100 Hz stimulation, IT100) contractions on fatigue resistance and mitochondrial content and function in mouse plantar flexor muscles. Muscles were stimulated every other day for 4 weeks. The averaged peak torque during IT bouts was 4.2-fold higher with IT100 than with IT20. Both stimulation protocols markedly improved in situ fatigue resistance, although the improvement was larger with IT100. The citrate synthase activity, a biomarker of mitochondrial content, was similarly increased with IT20 and IT100. Conversely, increased expression of mitochondrial respiratory chain (MRC) complexes I, III, and IV was only observed with IT100 and this was accompanied by increases in MRC supercomplex formation and pyruvate-malate-driven state 3 respiration in isolated mitochondria. In conclusion, the IT-induced increase in fatigue resistance is larger with high-intensity than with low-intensity contractions and this is linked to improved mitochondrial function due to increased expression of MRC complexes and assembly of MRC supercomplexes.	[Yamada, Takashi; Kimura, Iori; Ashida, Yuki; Tamai, Katsuyuki] Sapporo Med Univ, Grad Sch & Iealth Sci, Sapporo, Hokkaido 0608556, Japan; [Ashida, Yuki] Japan Soc Promot Sci, Tokyo, Japan; [Fusagawa, Hiroyori; Tohse, Noritsugu; Sato, Tatsuya] Sapporo Med Univ, Dept Cellular Physiol & Signal Transduct, Sch Med, Sapporo, Hokkaido, Japan; [Fusagawa, Hiroyori] Sapporo Med Univ, Dept Orthoped Surg, Sch Med, Sapporo, Hokkaido, Japan; [Westerblad, Hakan; Andersson, Daniel C.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Andersson, Daniel C.] Karolinska Univ Hosp, Cardiol Unit, Heart Vasc & Neurol Theme, Stockholm, Sweden; [Sato, Tatsuya] Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan	Sapporo Medical University; Japan Society for the Promotion of Science; Sapporo Medical University; Sapporo Medical University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Sapporo Medical University	Yamada, T (corresponding author), Sapporo Med Univ, Grad Sch & Iealth Sci, Sapporo, Hokkaido 0608556, Japan.	takashi.yamada1976@sapmed.ac.jp	Andersson, Daniel/AAE-9968-2019; Yamada, Takashi/U-8443-2019	Andersson, Daniel/0000-0003-4548-702X; Yamada, Takashi/0000-0003-1797-3880; Sato, Tatsuya/0000-0001-7876-1772; Westerblad, Hakan/0000-0002-8180-3029	MEXT \ Japan Society for the Promotion of Science (JSPS) [JP21H03292]; Svenska Forskningsradet Formas (Swedish Research Council Formas) [2018-02576, P2019-060]; Hjart-Lungfonden (Swedish Heart-Lung Foundation) [20180637]; Swedish Society for Medical Research [S16-0159]	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Svenska Forskningsradet Formas (Swedish Research Council Formas)(Swedish Research Council Formas); Hjart-Lungfonden (Swedish Heart-Lung Foundation)(Swedish Heart-Lung Foundation); Swedish Society for Medical Research	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP21H03292; Svenska Forskningsradet Formas (Swedish Research Council Formas), Grant/Award Number: 2018-02576 and P2019-060; Hjart-Lungfonden (Swedish Heart-Lung Foundation), Grant/Award Number: 20180637; Swedish Society for Medical Research, Grant/Award Number: S16-0159	Antoun G, 2015, DIABETOLOGIA, V58, P2861, DOI 10.1007/s00125-015-3772-8; Bacon AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073182; Ballmann C, 2016, AM J PHYSIOL-ENDOC M, V311, pE928, DOI 10.1152/ajpendo.00209.2016; Bishop DJ, 2014, BBA-GEN SUBJECTS, V1840, P1266, DOI 10.1016/j.bbagen.2013.10.012; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Crossland H, 2019, J PHYSIOL-LONDON, V597, P1259, DOI 10.1113/JP275444; Daussin FN, 2008, AM J PHYSIOL-REG I, V295, pR264, DOI 10.1152/ajpregu.00875.2007; DUDLEY GA, 1982, J APPL PHYSIOL, V53, P844, DOI 10.1152/jappl.1982.53.4.844; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; Fiorenza M, 2018, J PHYSIOL-LONDON, V596, P2823, DOI 10.1113/JP275972; FITTS RH, 1977, AM J PHYSIOL, V233, pC86, DOI 10.1152/ajpcell.1977.233.3.C86; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Goo CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045806; Granata C, 2018, SPORTS MED, V48, P1809, DOI 10.1007/s40279-018-0936-y; Granata C, 2016, FASEB J, V30, P959, DOI 10.1096/fj.15-276907; Granata C, 2016, FASEB J, V30, P3413, DOI 10.1096/fj.201500100R; Greggio C, 2017, CELL METAB, V25, P301, DOI 10.1016/j.cmet.2016.11.004; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; Ismail H, 2013, JACC-HEART FAIL, V1, P514, DOI 10.1016/j.jchf.2013.08.006; Iuso A, 2017, METHODS MOL BIOL, V1567, P217, DOI 10.1007/978-1-4939-6824-4_13; Jacobs RA, 2013, J APPL PHYSIOL, V114, P344, DOI 10.1152/japplphysiol.01081.2012; Jacobs RA, 2013, J APPL PHYSIOL, V115, P785, DOI 10.1152/japplphysiol.00445.2013; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Lundby AKM, 2018, ACTA PHYSIOL, V222, DOI 10.1111/apha.12905; MacDougall KB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68392-6; MacInnis MJ, 2017, J PHYSIOL-LONDON, V595, P2955, DOI 10.1113/JP272570; MacInnis MJ, 2017, J PHYSIOL-LONDON, V595, P2915, DOI 10.1113/JP273196; Nielsen JN, 2003, J APPL PHYSIOL, V94, P631, DOI 10.1152/japplphysiol.00642.2002; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; Place N, 2015, P NATL ACAD SCI USA, V112, P15492, DOI 10.1073/pnas.1507176112; Raleigh JP, 2018, APPL PHYSIOL NUTR ME, V43, P1059, DOI 10.1139/apnm-2017-0864; Reisch AS, 2007, METHOD CELL BIOL, V80, P199, DOI 10.1016/S0091-679X(06)80010-5; Rose AJ, 2006, J PHYSIOL-LONDON, V574, P889, DOI 10.1113/jphysiol.2006.111757; Rowe GC, 2013, CELL REP, V3, P1449, DOI 10.1016/j.celrep.2013.04.023; Rowe GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041817; Sato T, 2018, P NATL ACAD SCI USA, V115, pE6291, DOI 10.1073/pnas.1804701115; SMITH L, 1955, Methods Biochem Anal, V2, P427, DOI 10.1002/9780470110188.ch13; Spina RJ, 1996, J APPL PHYSIOL, V80, P2250, DOI 10.1152/jappl.1996.80.6.2250; Taylor EB, 2005, AM J PHYSIOL-ENDOC M, V289, pE960, DOI 10.1152/ajpendo.00237.2005; TROUP JP, 1986, J APPL PHYSIOL, V60, P1743, DOI 10.1152/jappl.1986.60.5.1743; Wada M, 1996, AM J PHYSIOL-CELL PH, V271, pC1250, DOI 10.1152/ajpcell.1996.271.4.C1250; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x	46	1	1	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2021	35	11							e21988	10.1096/fj.202101204R	http://dx.doi.org/10.1096/fj.202101204R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	WN8IK	34665879				2022-12-28	WOS:000712009200028
J	Ben Zemzem, A; Genevaux, A; Wahart, A; Bodey, AJ; Blaise, S; Romier-Crouzet, B; Jonquet, J; Bour, C; Cogranne, R; Beauseroy, P; Dauchez, M; Sherratt, MJ; Debelle, L; Almagro, S				Ben Zemzem, Aicha; Genevaux, Aline; Wahart, Amandine; Bodey, Andrew J.; Blaise, Sebastien; Romier-Crouzet, Beatrice; Jonquet, Jessica; Bour, Camille; Cogranne, Remi; Beauseroy, Pierre; Dauchez, Manuel; Sherratt, Michael J.; Debelle, Laurent; Almagro, Sebastien			X-ray microtomography reveals a lattice-like network within aortic elastic lamellae	FASEB JOURNAL			English	Article						aorta; elastic lamellae; elastin; synchrotron X-ray micro-computed tomography		The arterial wall consists of three concentric layers: intima, media, and adventitia. Beyond their resident cells, these layers are characterized by an extracellular matrix (ECM), which provides both biochemical and mechanical support. Elastin, the major component of arterial ECM, is present in the medial layer and organized in concentric elastic lamellae that confer resilience to the wall. We explored the arterial wall structures from C57Bl6 (control), db/db (diabetic), and ApoE(-/-) (atherogenic) mice aged 3 months using synchrotron X-ray computed microtomography on fixed and unstained tissues with a large image field (8 mm(3)). This approach combined a good resolution (0.83 mu m/voxel), large 3D imaging field. and an excellent signal to noise ratio conferred by phase-contrast imaging. We determined from 2D virtual slices that the thickness of intramural ECM structures was comparable between strains but automated image analysis of the 3D arterial volumes revealed a lattice-like network within concentric elastic lamellae. We hypothesize that this network could play a role in arterial mechanics. This work demonstrates that phase-contrast synchrotron X-ray computed microtomography is a powerful technique which to characterize unstained soft tissues.	[Ben Zemzem, Aicha; Genevaux, Aline; Wahart, Amandine; Blaise, Sebastien; Romier-Crouzet, Beatrice; Jonquet, Jessica; Bour, Camille; Dauchez, Manuel; Debelle, Laurent; Almagro, Sebastien] Univ Reims, CNRS UMR7369 MEDyC, F-51100 Reims, France; [Bodey, Andrew J.] Diamond Light Source, Didcot, Oxon, England; [Cogranne, Remi; Beauseroy, Pierre] Univ Technol Troyes, UMR CNRS 6281 ICD ROSAS LM2S, Troyes, France; [Sherratt, Michael J.; Debelle, Laurent] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England	Universite de Reims Champagne-Ardenne; Diamond Light Source; Universite de Technologie de Troyes; University of Manchester	Almagro, S (corresponding author), Univ Reims, CNRS UMR7369 MEDyC, F-51100 Reims, France.	sebastien.almagro@univ-reims.fr			DLS [MT12776]; University of Reims Champagne-Ardenne; DRRT of Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS)	DLS; University of Reims Champagne-Ardenne; DRRT of Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	DLS, Grant/Award Number: MT12776; University of Reims Champagne-Ardenne; DRRT of Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS)	Fhayll W, 2019, MATRIX BIOL, V84, P41, DOI 10.1016/j.matbio.2019.08.005; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Graham HK, 2010, MATRIX BIOL, V29, P254, DOI 10.1016/j.matbio.2010.01.008; Kozel BA, 2019, MATRIX BIOL, V84, P31, DOI 10.1016/j.matbio.2019.10.002; Lopez-Guimet J, 2018, THERANOSTICS, V8, P6038, DOI 10.7150/thno.26598; Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9; O'Connell MK, 2008, MATRIX BIOL, V27, P171, DOI 10.1016/j.matbio.2007.10.008; O'Rourke MF, 2010, VASC MED, V15, P461, DOI 10.1177/1358863X10382946; Pesic ZD, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/18/182003; Rau C, 2011, PHYS STATUS SOLIDI A, V208, P2522, DOI 10.1002/pssa.201184272; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204; Shearer T, 2016, J CELL SCI, V129, P2483, DOI 10.1242/jcs.179077; Titarenko V, 2016, J SYNCHROTRON RADIAT, V23, P1447, DOI 10.1107/S160057751601479X; Walton LA., 2014, MOL TISSUES CHARACTE; Walton LA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10074; Wheeler JB, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001744	17	2	2	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21844	10.1096/fj.202100323RR	http://dx.doi.org/10.1096/fj.202100323RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34473371	Green Published, hybrid			2022-12-28	WOS:000702238200012
J	Fischer, J; Gresnigt, MS; Werz, O; Hube, B; Garscha, U				Fischer, Jana; Gresnigt, Mark S.; Werz, Oliver; Hube, Bernhard; Garscha, Ulrike			Candida albicans-induced leukotriene biosynthesis in neutrophils is restricted to the hyphal morphology	FASEB JOURNAL			English	Article						5-lipoxygenase; fungi; immune response; inflammation; lipid mediator; oxylipins	ASPARTYL PROTEINASES; IMMUNE RECOGNITION; ARACHIDONIC-ACID; BETA-GLUCAN; HUMAN BLOOD; B-4; 5-LIPOXYGENASE; GENE; TRIGGERS; RELEASE	Neutrophils are the most abundant leukocytes in circulation playing a key role in acute inflammation during microbial infections. Phagocytosis, one of the crucial defence mechanisms of neutrophils against pathogens, is amplified by chemotactic leukotriene (LT)B-4, which is biosynthesized via 5-lipoxygenase (5-LOX). However, extensive liberation of LTB4 can be destructive by over-intensifying the inflammatory process. While enzymatic biosynthesis of LTB4 is well characterized, less is known about molecular mechanisms that activate 5-LOX and lead to LTB4 formation during host-pathogen interactions. Here, we investigated the ability of the common opportunistic fungal pathogen Candida albicans to induce LTB4 formation in neutrophils, and elucidated pathogen-mediated drivers and cellular processes that activate this pathway. We revealed that C. albicans-induced LTB4 biosynthesis requires both the morphological transition from yeast cells to hyphae and the expression of hyphae-associated genes, as exclusively viable hyphae or yeast-locked mutant cells expressing hyphae-associated genes stimulated 5-LOX by [Ca2+](i) mobilization and p38 MAPK activation. LTB4 biosynthesis was orchestrated by synergistic activation of dectin-1 and Toll-like receptor 2, and corresponding signaling via SYK and MYD88, respectively. Conclusively, we report hyphae-specific induction of LTB4 biosynthesis in human neutrophils. This highlights an expanding role of neutrophils during inflammatory processes in the response to C. albicans infections.	[Fischer, Jana; Garscha, Ulrike] Greifswald Univ, Inst Pharm, Dept Pharmaceut Med Chem, Friedrich Ludwig Jahn Str 17, D-17489 Greifswald, Germany; [Fischer, Jana; Werz, Oliver; Garscha, Ulrike] Friedrich Schiller Univ Jena, Inst Pharm, Dept Pharmaceut Med Chem, Jena, Germany; [Gresnigt, Mark S.] Leibniz Inst Nat Prod Res & Infect Biol, Jr Res Grp Adapt Pathogenic Strategies, Hans Knoell Inst, Jena, Germany; [Hube, Bernhard] Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogenic Mech, Hans Knoell Inst, Jena, Germany; [Hube, Bernhard] Friedrich Schiller Univ Jena, Inst Microbiol, Jena, Germany	Friedrich Schiller University of Jena; Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Garscha, U (corresponding author), Greifswald Univ, Inst Pharm, Dept Pharmaceut Med Chem, Friedrich Ludwig Jahn Str 17, D-17489 Greifswald, Germany.	ulrike.garscha@uni-greifswald.de	Gresnigt, Mark/H-3530-2015	Gresnigt, Mark/0000-0002-9514-4634; Werz, Oliver/0000-0002-5064-4379	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [UG GA-2101/2-1]; Collaborative Research Centre (CRC)/Transregio TRR124 FungiNet "Pathogenic fungi and their human host: Networks of Interaction" [210879364]; Balance of the Microverse Cluster (Germany's Excellence Strategy-EXC 2051) [390713860]; Emmy Noether Program [434385622/GR 5617/1-1]; Jena University	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Collaborative Research Centre (CRC)/Transregio TRR124 FungiNet "Pathogenic fungi and their human host: Networks of Interaction"; Balance of the Microverse Cluster (Germany's Excellence Strategy-EXC 2051); Emmy Noether Program(German Research Foundation (DFG)); Jena University	The project was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation): UG GA-2101/2-1; BH within the Collaborative Research Centre (CRC)/Transregio TRR124 FungiNet "Pathogenic fungi and their human host: Networks of Interaction," project number 210879364 (project C1) and the Balance of the Microverse Cluster (Germany's Excellence Strategy-EXC 2051-Project-ID 390713860); MSG by the Emmy Noether Program (project no. 434385622/GR 5617/1-1), JF by Jena University Grant for completing a doctorate	AHARONY D, 1986, J BIOL CHEM, V261, P1512; Alex H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15834-4; Becker KL, 2016, MBIO, V7, DOI 10.1128/mBio.01823-15; Bougnoux ME, 2006, J CLIN MICROBIOL, V44, P1810, DOI 10.1128/JCM.44.5.1810-1820.2006; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; CLAESSON HE, 1985, BIOCHIM BIOPHYS ACTA, V836, P361, DOI 10.1016/0005-2760(85)90140-7; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Desai JV, 2018, CURR CLIN MICROBIOL, V5, P181, DOI 10.1007/s40588-018-0098-6; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; DOERFLER ME, 1989, J CLIN INVEST, V83, P970, DOI 10.1172/JCI113983; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Flamand L, 2007, J IMMUNOL, V178, P8036, DOI 10.4049/jimmunol.178.12.8036; FONZI WA, 1993, GENETICS, V134, P717; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Gerstmeier J, 2016, FASEB J, V30, P276, DOI 10.1096/fj.15-278010; GILLARD J, 1989, CAN J PHYSIOL PHARM, V67, P456, DOI 10.1139/y89-073; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; HUBE B, 1994, MOL MICROBIOL, V14, P87, DOI 10.1111/j.1365-2958.1994.tb01269.x; Jacobsen ID, 2012, EXPERT REV ANTI-INFE, V10, P85, DOI [10.1586/eri.11.152, 10.1586/ERI.11.152]; Jayaraja S, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0165-9; Jordan PM, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108247; Jouault T, 2003, J INFECT DIS, V188, P165, DOI 10.1086/375784; Koeberle SC, 2012, NAT CHEM BIOL, V8, P141, DOI 10.1038/nchembio.761; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Kullberg BJ, 2015, NEW ENGL J MED, V373, P1445, DOI 10.1056/NEJMra1315399; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lavigne LM, 2006, J IMMUNOL, V177, P8667, DOI 10.4049/jimmunol.177.12.8667; Lee EKS, 2018, CELL HOST MICROBE, V23, P121, DOI 10.1016/j.chom.2017.11.009; Lee SP, 2009, J IMMUNOL, V182, P530, DOI 10.4049/jimmunol.182.1.530; Liu YP, 2011, EUKARYOT CELL, V10, P168, DOI 10.1128/EC.00279-10; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lowman DW, 2014, J BIOL CHEM, V289, P3432, DOI 10.1074/jbc.M113.529131; Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913; Mayer FL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002592; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Mejia-Chew C, 2019, LANCET INFECT DIS, V19, P1336, DOI 10.1016/S1473-3099(19)30405-0; Morgan J, 2005, INFECT CONT HOSP EP, V26, P540, DOI 10.1086/502581; Moyes DL, 2016, NATURE, V532, P64, DOI 10.1038/nature17625; Mukaremera L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00629; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Niemiec MJ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4097-4; Nikou SA, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8020053; Okamoto F, 2010, J BIOL CHEM, V285, P41113, DOI 10.1074/jbc.M110.175497; Okusawa T, 2004, INFECT IMMUN, V72, P1657, DOI 10.1128/IAI.72.3.1657-1665.2004; PALMER RMJ, 1983, IMMUNOLOGY, V50, P65; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; Parti RP, 2010, AM J RESP CELL MOL, V42, P415, DOI 10.1165/rcmb.2009-0110OC; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Romp E, 2020, CELL MOL LIFE SCI, V77, P3841, DOI 10.1007/s00018-019-03393-x; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; STEINHILBER D, 1989, J CHROMATOGR-BIOMED, V493, P361, DOI 10.1016/S0378-4347(00)82742-5; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Suram S, 2010, J BIOL CHEM, V285, P30676, DOI 10.1074/jbc.M110.143800; SURETTE ME, 1993, J EXP MED, V178, P1347, DOI 10.1084/jem.178.4.1347; Tada H, 2002, MICROBIOL IMMUNOL, V46, P503, DOI 10.1111/j.1348-0421.2002.tb02727.x; Tan SY, 2017, CURR OPIN IMMUNOL, V44, P34, DOI 10.1016/j.coi.2016.11.002; Tsuchimori N, 2000, INFECT IMMUN, V68, P1997, DOI 10.1128/IAI.68.4.1997-2002.2000; Wan M, 2007, FASEB J, V21, P2897, DOI 10.1096/fj.06-7974com; Werner M, 2019, FASEB J, V33, P6140, DOI 10.1096/fj.201802509R; Werz O, 2000, P NATL ACAD SCI USA, V97, P5261, DOI 10.1073/pnas.050588997; Werz O, 2002, FASEB J, V16, P1441, DOI 10.1096/fj.01-0909fje; Werz O, 2002, BLOOD, V99, P1044, DOI 10.1182/blood.V99.3.1044; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Wozniok I, 2008, CELL MICROBIOL, V10, P807, DOI 10.1111/j.1462-5822.2007.01086.x; Yapar N, 2014, THER CLIN RISK MANAG, V10, P95, DOI 10.2147/TCRM.S40160; Yun B, 2016, J BIOL CHEM, V291, P7070, DOI 10.1074/jbc.M116.714873; Zheng XD, 2004, EMBO J, V23, P1845, DOI 10.1038/sj.emboj.7600195	76	3	3	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21820	10.1096/fj.202100516RR	http://dx.doi.org/10.1096/fj.202100516RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34569657	hybrid			2022-12-28	WOS:000702238200055
J	Yang, AT; Yan, XZ; Xu, HF; Fan, X; Zhang, MY; Huang, T; Li, WY; Chen, W; Jia, JD; You, H				Yang, Aiting; Yan, Xuzhen; Xu, Hufeng; Fan, Xu; Zhang, Mengyang; Huang, Tao; Li, Weiyu; Chen, Wei; Jia, Jidong; You, Hong			Selective depletion of hepatic stellate cells-specific LOXL1 alleviates liver fibrosis	FASEB JOURNAL			English	Article						extracellular matrix; hepatic stellate cells; ITGA8; liver fibrosis; LOXL1	LYSYL OXIDASE; EXPRESSION; COLLAGEN; PROGRESSION; INHIBITION; ELASTIN; ALPHA-8-BETA-1; REGENERATION; PULMONARY; INTEGRIN	The role of LOXL1 in fibrosis via mediating ECM crosslinking and stabilization is well established; however, the role of hepatic stellate cells (HSCs)-specific LOXL1 in the development of fibrosis remains unknown. We generated HSCs-specific Loxl1-depleted mice (Loxl1(Gfap-cre) mice) to investigate the HSCs-specific contribution of LOXL1 in the pathogenesis of fibrosis. Loxl1(fl/fl) mice were used as the control. Furthermore, we used RNA sequencing to explore the underlying changes in the transcriptome. Results of the sirius red staining, type I collagen immunolabeling, and hydroxyproline content analysis, coupled with the reduced expression of profibrogenic genes revealed that Loxl1(Gfap-cre) mice with CCl4-induced fibrosis exhibited decreased hepatic fibrosis. In addition, Loxl1(Gfap-cre) mice exhibited reduced macrophage tissue infiltration by CD68-positive cells and decreased expression of inflammatory genes compared with the controls. RNA sequencing identified integrin alpha 8 (ITGA8) as a key modulator of LOXL1-mediated liver fibrosis. Functional analyses showed that siRNA silencing of Itga8 in cultured fibroblasts led to a decline in the LOXL1 expression and inhibition of fibroblast activation. Mechanistic analyses indicated that LOXL1 activated the FAK/PI3K/AKT/HIF1a signaling pathway, and the addition of inhibitors of FAK or PI3K reversed these results via downregulation of LOXL1. Furthermore, HIF1a directly interacted with LOXL1 and upregulated its expression, indicating that LOXL1 can positively self-regulate by forming a positive feedback loop with the FAK/PI3K/AKT/HIF1a pathway. We demonstrated that HSCs-specific Loxl1 deficiency prevented fibrosis, inflammation and that ITGA8/FAK/PI3K/AKT/HIF1a was essential for the function and expression of LOXL1. Knowledge of this approach can provide novel mechanisms and targets to treat fibrosis in the future.	[Yang, Aiting; Xu, Hufeng; Huang, Tao; Chen, Wei] Capital Med Univ, Beijing Friendship Hosp, Expt & Translat Res Ctr, Beijing, Peoples R China; [Yang, Aiting; Xu, Hufeng; Huang, Tao; Chen, Wei; Jia, Jidong; You, Hong] Beijing Clin Med Inst, Beijing, Peoples R China; [Yang, Aiting; Yan, Xuzhen; Xu, Hufeng; Fan, Xu; Zhang, Mengyang; Huang, Tao; Li, Weiyu; Chen, Wei; Jia, Jidong; You, Hong] Natl Clin Res Ctr Digest Dis, Beijing, Peoples R China; [Yan, Xuzhen; Fan, Xu; Zhang, Mengyang; Li, Weiyu; Jia, Jidong; You, Hong] Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing Key Lab Translat Med Liver Cirrhosis, Beijing 100050, Peoples R China	Capital Medical University; Capital Medical University	You, H (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing Key Lab Translat Med Liver Cirrhosis, Beijing 100050, Peoples R China.	youhongliver@ccmu.edu.cn	Fan, Xu/GSE-2196-2022		National Natural Science Foundation of China [81970524, 81500456]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81970524 and 81500456).	Alperin M, 2008, INT UROGYNECOL J, V19, P977, DOI 10.1007/s00192-008-0561-7; Amendola PG, 2019, CANCERS, V11, DOI 10.3390/cancers11050729; Anderson Michael G, 2018, J Glaucoma, V27 Suppl 1, pS78, DOI 10.1097/IJG.0000000000000911; Barnett R, 2018, LANCET, V392, P275, DOI 10.1016/S0140-6736(18)31659-3; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Behmoaras J, 2008, REJUV RES, V11, P883, DOI 10.1089/rej.2008.0760; Bellaye PS, 2018, AM J RESP CELL MOL, V58, P461, DOI 10.1165/rcmb.2017-0252OC; Bouzeghrane F, 2004, J MOL CELL CARDIOL, V36, P343, DOI 10.1016/j.yjmcc.2003.11.007; Cai QX, 2020, METABOLISM, V104, DOI 10.1016/j.metabol.2020.154140; Chen W, 2020, HEPATOLOGY, V72, P729, DOI 10.1002/hep.31236; Chen W, 2019, J CELL PHYSIOL, V234, P22613, DOI 10.1002/jcp.28827; Conroy KP, 2016, CELL TISSUE RES, V365, P511, DOI 10.1007/s00441-016-2407-9; Cordero-Espinoza L, 2018, J CLIN INVEST, V128, P85, DOI 10.1172/JCI93562; Fan X, 2013, CELL BIOL INT, V37, P284, DOI 10.1002/cbin.10035; Frangogiannis NG, 2019, J AM COLL CARDIOL, V73, P2283, DOI 10.1016/j.jacc.2018.10.094; Greene AG, 2020, EXP EYE RES, V193, DOI 10.1016/j.exer.2020.107975; Gustilo-Ashby Arlan Marcus, 2010, Female Pelvic Med Reconstr Surg, V16, P21, DOI 10.1097/SPV.0b013e3181d00035; Hartner A, 2008, AM J NEPHROL, V28, P168, DOI 10.1159/000110022; Hung CF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197937; Ikenaga N, 2017, GUT, V66, P1697, DOI 10.1136/gutjnl-2016-312473; Kisseleva T, 2021, NAT REV GASTRO HEPAT, V18, P151, DOI 10.1038/s41575-020-00372-7; Lambrecht J, 2020, EXPERT OPIN PHARMACO, V21, P1637, DOI 10.1080/14656566.2020.1774553; Lampi MC, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao0475; Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1; Levine D, 2000, AM J PATHOL, V156, P1927, DOI 10.1016/S0002-9440(10)65066-3; Liu GM, 2007, BJU INT, V100, P414, DOI 10.1111/j.1464-410X.2007.06929.x; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Liu SB, 2016, FASEB J, V30, P1599, DOI 10.1096/fj.14-268425; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Ma L, 2018, BIOMED PHARMACOTHER, V107, P1728, DOI 10.1016/j.biopha.2018.08.156; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Matsuo A, 2021, EUR J PHARMACOL, V892, DOI 10.1016/j.ejphar.2020.173754; Matsushima S, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-1054-9; Molnar J, 2003, BBA-PROTEINS PROTEOM, V1647, P220, DOI 10.1016/S1570-9639(03)00053-0; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P533, DOI 10.1196/annals.1333.061; Nishimichi N, 2021, J PATHOL, V253, P366, DOI 10.1002/path.5618; Niu YY, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2404-5; Parsons CJ, 2007, J GASTROEN HEPATOL, V22, pS79, DOI 10.1111/j.1440-1746.2006.04659.x; Pellicoro A, 2012, HEPATOLOGY, V55, P1965, DOI 10.1002/hep.25567; Perepelyuk M, 2013, AM J PHYSIOL-GASTR L, V304, pG605, DOI 10.1152/ajpgi.00222.2012; Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025; Popov Y, 2008, J HEPATOL, V48, P453, DOI 10.1016/j.jhep.2007.11.021; Puente A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071634; Schlotzer-Schrehardt U, 2019, EXP EYE RES, V189, DOI 10.1016/j.exer.2019.107818; Schuppan D, 2018, MATRIX BIOL, V68-69, P435, DOI 10.1016/j.matbio.2018.04.006; Shochet GE, 2020, THER ADV CHRONIC DIS, V11, DOI 10.1177/2040622320936023; Staiculescu MC, 2017, AM J PHYSIOL-HEART C, V313, pH446, DOI 10.1152/ajpheart.00712.2016; Thibault G, 2001, AM J PHYSIOL-CELL PH, V281, pC1457, DOI 10.1152/ajpcell.2001.281.5.C1457; Tjin G, 2017, DIS MODEL MECH, V10, P1301, DOI 10.1242/dmm.030114; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; Vallet SD, 2019, ESSAYS BIOCHEM, V63, P349, DOI 10.1042/EBC20180050; Wei J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0623-9; Yang AT, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1492694; Yang AT, 2021, HEPATOL INT, V15, P1122, DOI 10.1007/s12072-021-10210-w; Zhao WS, 2018, BBA-MOL BASIS DIS, V1864, P1129, DOI 10.1016/j.bbadis.2018.01.019	55	3	3	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21918	10.1096/fj.202100374R	http://dx.doi.org/10.1096/fj.202100374R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34569648				2022-12-28	WOS:000702238200026
J	Yao, ZL; Chen, PY; Fan, LY; Chen, PS; Zhang, XR; Yu, B				Yao, Zilong; Chen, Pengyu; Fan, Liuyi; Chen, Peisheng; Zhang, Xianrong; Yu, Bin			CCL2 is a critical mechano-responsive mediator in crosstalk between osteoblasts and bone mesenchymal stromal cells	FASEB JOURNAL			English	Article						bone remodeling; chemokine; mechanical loading; progenitor; recruitment	MONOCYTE CHEMOATTRACTANT PROTEIN-1; STEM-CELLS; PROGENITOR CELLS; GENE-EXPRESSION; PRIMARY CILIA; ACTIVATION; MECHANOTRANSDUCTION; EXERCISE; SIGNALS; KINASE	It has been known that moderate mechanical loading, like that caused by exercise, promotes bone formation. However, its underlying mechanisms remain elusive. Here we showed that moderate running dramatically improved trabecular bone in mice tibias with an increase in bone volume fraction and trabecular number and a decrease in trabecular pattern factor. Results of immunohistochemical and histochemical staining revealed that moderate running mainly increased the number of osteoblasts but had no effect on osteoclasts. In addition, we observed a dramatic increase in the number of colony forming unit-fibroblast in endosteal bone marrow and the percentage of CD45(-)Leptin receptor(+) (CD45(-)LepR(+)) endosteal mesenchymal progenitors. Bioinformatics analysis of the transcriptional data from gene expression omnibus (GEO) database identified chemokine c-c-motif ligands (CCL2) as a critical candidate induced by mechanical loading. Interestingly, we found that CCL2 was up-regulated mainly in osteoblastic cells in the tibia of mice after moderate running. Further, we found that mechanical loading up-regulated the expression of CCL2 by activating ERK1/2 pathway, thereby stimulating migration of endosteal progenitors. Finally, neutralizing CCL2 abolished the recruitment of endosteal progenitors and the increased bone formation in mice after 4 weeks running. These results therefore uncover an unknown connection between osteoblasts and endosteal progenitors recruited in the increased bone formation induced by mechanical loading.	[Yao, Zilong; Chen, Pengyu; Fan, Liuyi; Zhang, Xianrong; Yu, Bin] Southern Med Univ, Nanfang Hosp, Dept Orthopaed, Div Orthopaed & Traumatol, Guangzhou, Peoples R China; [Yao, Zilong; Chen, Pengyu; Fan, Liuyi; Chen, Peisheng; Zhang, Xianrong; Yu, Bin] Southern Med Univ, Nanfang Hosp, Guangdong Prov Key Lab Bone & Cartilage Regenerat, Guangzhou, Peoples R China; [Chen, Peisheng] Xiamen Univ, Fuzhou Hosp Affiliated 2, Dept Orthoped, Fuzhou, Peoples R China	Southern Medical University - China; Southern Medical University - China; Xiamen University	Zhang, XR; Yu, B (corresponding author), Nanfang Hosp, Dept Orthopaed, Div Orthopaed & Traumatol, 1838 Guangzhou Ave North, Guangzhou 510515, Peoples R China.	xianrongzh@smu.edu.cn; yubin@smu.edu.cn	Chen, Peisheng/AAL-5382-2021	Chen, Peisheng/0000-0002-2472-2898; , xianrong/0000-0002-0992-5013	National Natural Science Foundation of China (NSFC) [81830079]; Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province) [2019B020201013, 2019A1515110818]; Nanfang Hospital [2019Z012]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province); Nanfang Hospital	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81830079; Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province), Grant/Award Number: 2019B020201013 and 2019A1515110818; Nanfang Hospital, Grant/Award Number: 2019Z012	Albiol L, 2020, CALCIFIED TISSUE INT, V106, P415, DOI 10.1007/s00223-019-00648-4; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bohm AM, 2019, DEV CELL, V51, P236, DOI 10.1016/j.devcel.2019.08.013; Brylka LJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02182; Cambre I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06933-4; Cao W, 2020, CURR OSTEOPOROS REP, V18, P541, DOI 10.1007/s11914-020-00610-6; Chen JC, 2016, FASEB J, V30, P1504, DOI 10.1096/fj.15-276402; Chen PS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01093; Crane JL, 2014, J CLIN INVEST, V124, P466, DOI 10.1172/JCI70050; Curtis KJ, 2018, BONE, V107, P78, DOI 10.1016/j.bone.2017.11.007; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dirckx N, 2013, BIRTH DEFECTS RES C, V99, P170, DOI 10.1002/bdrc.21047; Eichholz KF, 2020, STEM CELL TRANSL MED, V9, P1431, DOI 10.1002/sctm.19-0405; Fantuzzi L, 2019, CELL MOL LIFE SCI, V76, P4869, DOI 10.1007/s00018-019-03255-6; Fu XR, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080784; Galea GL, 2017, BONE, V96, P38, DOI 10.1016/j.bone.2016.10.008; Grayson WL, 2015, NAT REV ENDOCRINOL, V11, P140, DOI 10.1038/nrendo.2014.234; He J, 2015, AM J CHINESE MED, V43, P305, DOI 10.1142/S0192415X15500202; He Z, 2016, OSTEOARTHR CARTILAGE, V24, P892, DOI 10.1016/j.joca.2015.11.015; Hou YL, 2019, CLIN SCI, V133, P1297, DOI 10.1042/CS20181001; Huang J, 2018, THERANOSTICS, V8, P2435, DOI 10.7150/thno.22144; Josephson AM, 2019, P NATL ACAD SCI USA, V116, P6995, DOI 10.1073/pnas.1810692116; Kechagia JZ, 2019, NAT REV MOL CELL BIO, V20, P457, DOI 10.1038/s41580-019-0134-2; Kim J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19155-4; Lassen NE, 2017, J BONE MINER RES, V32, P1395, DOI 10.1002/jbmr.3091; Liu C, 2016, INTEGR BIOL-UK, V8, P785, DOI 10.1039/c6ib00070c; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Lu N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153792; Metzger CE, 2017, BONE, V105, P26, DOI 10.1016/j.bone.2017.08.002; Moore ER, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/3094154; Morse A, 2018, J BONE MINER RES, V33, P486, DOI 10.1002/jbmr.3330; Ono N, 2019, CURR TOP DEV BIOL, V133, P1, DOI 10.1016/bs.ctdb.2019.01.006; Osman AM, 2019, NEUROSCIENCE, V405, P92, DOI 10.1016/j.neuroscience.2017.10.034; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; Park JES, 2014, THORAX, V69, P1120, DOI 10.1136/thoraxjnl-2013-204190; Qin L, 2020, BONE RES, V8, DOI 10.1038/s41413-020-0099-y; Reijnders CMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079672; Roosa SMM, 2011, BONE, V48, P543, DOI 10.1016/j.bone.2010.11.006; Roosa SMM, 2011, J BONE MINER RES, V26, P100, DOI 10.1002/jbmr.193; Rubin J, 2002, J BONE MINER RES, V17, P1452, DOI 10.1359/jbmr.2002.17.8.1452; Sato T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17099-3; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tamasi JA, 2013, J BONE MINER RES, V28, P1975, DOI 10.1002/jbmr.1933; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; Vico L, 2018, NAT REV RHEUMATOL, V14, P229, DOI 10.1038/nrrheum.2018.37; Wang ML, 2018, J MATER CHEM B, V6, P4765, DOI 10.1039/c8tb01201f; Wang XE, 2019, STEM CELLS, V37, P150, DOI 10.1002/stem.2924; Wong SP, 2015, PHARMACOL THERAPEUT, V151, P107, DOI 10.1016/j.pharmthera.2015.03.006; Wong VW, 2012, NAT MED, V18, P148, DOI 10.1038/nm.2574; Wu J, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/1540148; Yan YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035709; Yao ZL, 2019, J CELL PHYSIOL, V234, P17946, DOI 10.1002/jcp.28427; Ye DP, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/9405738; Yuan Y, 2016, PROG BIOPHYS MOL BIO, V122, P122, DOI 10.1016/j.pbiomolbio.2015.11.005; Zannit HM, 2020, FASEB J, V34, P12739, DOI 10.1096/fj.202000614R; Zhang LL, 2017, J BONE MINER METAB, V35, P265, DOI 10.1007/s00774-016-0764-9	58	4	4	2	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21851	10.1096/fj.202002808RR	http://dx.doi.org/10.1096/fj.202002808RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34547121				2022-12-28	WOS:000702238200071
J	Kakadia, J; Biggar, K; Jain, B; Chen, AW; Nygard, K; Li, C; Nathanielsz, PW; Jansson, T; Gupta, MB				Kakadia, Jenica; Biggar, Kyle; Jain, Bhawani; Chen, Allan W.; Nygard, Karen; Li, Cun; Nathanielsz, Peter W.; Jansson, Thomas; Gupta, Madhulika B.			Mechanisms linking hypoxia to phosphorylation of insulin-like growth factor binding protein-1 in baboon fetuses with intrauterine growth restriction and in cell culture	FASEB JOURNAL			English	Article						fetal growth; fetal hypoxia; hypoxia-inducible factor 1; mechanistic target of rapamycin complex 1; non-human primate; regulated in development and DNA damage responses 1	MATERNAL NUTRIENT RESTRICTION; FOR-GESTATIONAL-AGE; KINASE-C; LEUCINE DEPRIVATION; OXIDATIVE STRESS; IGFBP-1 PHOSPHORYLATION; DOWN-REGULATION; HIGH-ALTITUDE; MTOR; LEADS	Hypoxia increases fetal hepatic insulin-like growth factor binding protein-1 (IGFBP-1) phosphorylation mediated by mechanistic target of rapamycin (mTOR) inhibition. Whether maternal nutrient restriction (MNR) causes fetal hypoxia remains unclear. We used fetal liver from a baboon (Papio sp.) model of intrauterine growth restriction due to MNR (70% global diet of Control) and liver hepatocellular carcinoma (HepG2) cells as a model for human fetal hepatocytes and tested the hypothesis that mTOR-mediated IGFBP-1 hyperphosphorylation in response to hypoxia requires hypoxia-inducible factor-1 alpha (HIF-1 alpha) and regulated in development and DNA-damage responses-1 (REDD-1) signaling. Western blotting (n = 6) and immunohistochemistry (n = 3) using fetal liver indicated greater expression of HIF-1 alpha, REDD-1 as well as erythropoietin and its receptor, and vascular endothelial growth factor at GD120 (GD185 term) in MNR versus Control. Moreover, treatment of HepG2 cells with hypoxia (1% pO(2)) (n = 3) induced REDD-1, inhibited mTOR complex-1 (mTORC1) activity and increased IGFBP-1 secretion/phosphorylation (Ser101/Ser119/Ser169). HIF-1 alpha inhibition by echinomycin or small interfering RNA silencing prevented the hypoxia-mediated inhibition of mTORC1 and induction of IGFBP-1 secretion/phosphorylation. dimethyloxaloylglycine (DMOG) induced HIF-1 alpha and also REDD-1 expression, inhibited mTORC1 and increased IGFBP-1 secretion/phosphorylation. Induction of HIF-1 alpha (DMOG) and REDD-1 by Compound 3 inhibited mTORC1, increased IGFBP-1 secretion/ phosphorylation and protein kinase PKC alpha expression. Together, our data demonstrate that HIF-1 alpha induction, increased REDD-1 expression and mTORC1 inhibition represent the mechanistic link between hypoxia and increased IGFBP-1 secretion/phosphorylation. We propose that maternal undernutrition limits fetal oxygen delivery, as demonstrated by increased fetal liver expression of hypoxia-responsive proteins in baboon MNR. These findings have important implications for our understanding of the pathophysiology of restricted fetal growth.	[Kakadia, Jenica; Jain, Bhawani; Chen, Allan W.; Gupta, Madhulika B.] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Biggar, Kyle] Carleton Univ, Inst Biochem, Ottawa, ON, Canada; [Nygard, Karen] Univ Western Ontario, Biotron Integrated Microscopy Facil, London, ON, Canada; [Li, Cun; Nathanielsz, Peter W.] Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA; [Li, Cun; Nathanielsz, Peter W.] Southwest Natl Primate Res Ctr, San Antonio, TX USA; [Jansson, Thomas] Univ Colorado, Div Reprod Sci, Dept Obstet & Gynecol, Anschutz Med Campus, Aurora, CO USA; [Gupta, Madhulika B.] Childrens Hlth Res Inst, London, ON, Canada; [Gupta, Madhulika B.] Univ Western Ontario, Dept Pediat, VRL Room A5-136 WC,800 Commissioners Rd E, London, ON N6C 2V5, Canada	Western University (University of Western Ontario); Carleton University; Western University (University of Western Ontario); University of Wyoming; Texas Biomedical Research Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; Western University (University of Western Ontario)	Gupta, MB (corresponding author), Univ Western Ontario, Dept Pediat, VRL Room A5-136 WC,800 Commissioners Rd E, London, ON N6C 2V5, Canada.	mbgupta@uwo.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (RGPIN); National Institute of Health [R03HD078313]; Lawson Research Grant [F0609]; Department of Pediatrics (UWO) Graduate Studentship; Department of Pediatrics Graduate Studentship award (UWO);  [P01HD021350];  [R03HD093950]	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (RGPIN); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lawson Research Grant; Department of Pediatrics (UWO) Graduate Studentship; Department of Pediatrics Graduate Studentship award (UWO); ; 	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (RGPIN to MBG), National Institute of Health (R03HD078313 to MBG and TJ), Program Project grant (P01HD021350 and R03HD093950 to PWN) and in part by Lawson Research Grant (F0609 to MBG). JK received Department of Pediatrics (UWO) Graduate Studentship and AWC received Children's Health Research Institute and Department of Pediatrics Graduate Studentship award (UWO).	Abu Shehab M, 2020, MOL CELL ENDOCRINOL, V512, DOI 10.1016/j.mce.2020.110865; Abu Shehab M, 2014, ENDOCRINOLOGY, V155, P1327, DOI 10.1210/en.2013-1759; Abu Shehab M, 2013, ENDOCRINOLOGY, V154, P1130, DOI 10.1210/en.2012-1962; Ahmed A, 2000, PLACENTA, V21, pS16, DOI 10.1053/plac.1999.0524; Alexander BT, 2003, HYPERTENSION, V41, P457, DOI 10.1161/01.HYP.0000053448.95913.3D; Aljunaidy MM, 2016, AM J PHYSIOL-REG I, V311, pR1068, DOI 10.1152/ajpregu.00119.2016; Ankrapp DP, 1996, J CELL BIOCHEM, V60, P387, DOI 10.1002/(SICI)1097-4644(19960301)60:3<387::AID-JCB10>3.0.CO;2-I; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Ben Lagha N, 2006, ENDOCRINOLOGY, V147, P4730, DOI 10.1210/en.2006-0171; Bornancin F, 1997, J BIOL CHEM, V272, P3544, DOI 10.1074/jbc.272.6.3544; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; CAZAUBON S, 1994, BIOCHEM J, V301, P443, DOI 10.1042/bj3010443; CHARD T, 1994, GROWTH REGULAT, V4, P91; Cheng K M, 1988, Nihon Sanka Fujinka Gakkai Zasshi, V40, P781; Cox LA, 2006, J PHYSIOL-LONDON, V572, P67, DOI 10.1113/jphysiol.2006.106872; Dall'Asta Andrea, 2017, Matern Health Neonatol Perinatol, V3, P2, DOI 10.1186/s40748-016-0041-x; Damerill I, 2016, MOL ENDOCRINOL, V30, P201, DOI 10.1210/me.2015-1194; Donella-Deana A, 2001, BIOCHEM J, V357, P563, DOI 10.1042/0264-6021:3570563; ECONOMIDES DL, 1989, AM J OBSTET GYNECOL, V160, P385, DOI 10.1016/0002-9378(89)90453-5; Elias AA, 2017, PEDIATR RES, V82, P141, DOI 10.1038/pr.2017.92; Elorza A, 2012, MOL CELL, V48, P681, DOI 10.1016/j.molcel.2012.09.017; Faust M, 2000, CELL TISSUE RES, V301, P329, DOI 10.1007/s004410000256; FROST RA, 1991, J BIOL CHEM, V266, P18082; Giussani DA, 2007, J PHYSIOL-LONDON, V585, P911, DOI 10.1113/jphysiol.2007.141572; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gould CM, 2008, CURR DRUG TARGETS, V9, P614, DOI 10.2174/138945008785132411; Guven ESG, 2013, J MATERN-FETAL NEO M, V26, P576, DOI 10.3109/14767058.2012.745497; Gysin S, 1996, EUR J BIOCHEM, V240, P747, DOI 10.1111/j.1432-1033.1996.0747h.x; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Hashimoto T, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00033; Hellstrom A, 2016, AM J PERINAT, V33, P1067, DOI 10.1055/s-0036-1586109; Horak P, 2010, P NATL ACAD SCI USA, V107, P4675, DOI 10.1073/pnas.0907705107; Jagannathan-Bogdan M, 2013, DEVELOPMENT, V140, P2463, DOI 10.1242/dev.083147; Jansson T, 2012, PLACENTA, V33, pE23, DOI 10.1016/j.placenta.2012.05.010; Jensen GM, 1997, AM J PUBLIC HEALTH, V87, P1003, DOI 10.2105/AJPH.87.6.1003; Kakadia JH, 2020, AM J PHYSIOL-ENDOC M, V319, pE614, DOI 10.1152/ajpendo.00220.2020; Kavitha JV, 2014, FASEB J, V28, P1294, DOI 10.1096/fj.13-242271; KELLY JH, 1989, IN VITRO CELL DEV B, V25, P217; LEE PDK, 1992, J CLIN ENDOCR METAB, V75, P459, DOI 10.1210/jc.75.2.459; Li C, 2009, ENDOCRINOLOGY, V150, P4634, DOI 10.1210/en.2008-1648; Luria A, 2000, BIOL REPROD, V62, P1564, DOI 10.1095/biolreprod62.6.1564; Maiese K, 2008, CURR NEUROVASC RES, V5, P125, DOI 10.2174/156720208784310231; Malamitsi-Puchner A, 2005, MEDIAT INFLAMM, P293, DOI 10.1155/MI.2005.293; Malkani N, 2016, MOL CELL ENDOCRINOL, V425, P48, DOI 10.1016/j.mce.2015.12.006; Moore LG, 2011, RESP PHYSIOL NEUROBI, V178, P181, DOI 10.1016/j.resp.2011.04.017; NICOLAIDES KH, 1989, AM J OBSTET GYNECOL, V161, P996, DOI 10.1016/0002-9378(89)90770-9; Ostlund E, 2000, ACTA OBSTET GYN SCAN, V79, P276, DOI 10.1034/j.1600-0412.2000.079004276.x; Pallotto EK, 2006, CLIN OBSTET GYNECOL, V49, P257, DOI 10.1097/00003081-200606000-00008; Parraguez VH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140902; Potdar N, 2009, BJOG-INT J OBSTET GY, V116, P637, DOI 10.1111/j.1471-0528.2008.02096.x; Rashid CS, 2018, PHYSIOLOGY, V33, P348, DOI 10.1152/physiol.00023.2018; Ratcliffe PJ, 2007, J CLIN INVEST, V117, P862, DOI 10.1172/JCI31750; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Romo Agustin, 2009, Pediatr Endocrinol Rev, V6 Suppl 3, P332; Schlabritz-Loutsevitch NE, 2007, BRIT J NUTR, V98, P276, DOI 10.1017/S0007114507700727; Seferovic MD, 2011, J PROTEOME RES, V10, P1495, DOI 10.1021/pr100879z; Seferovic MD, 2009, ENDOCRINOLOGY, V150, P220, DOI 10.1210/en.2008-0657; Singal SS, 2018, AM J PATHOL, V188, P111, DOI 10.1016/j.ajpath.2017.09.009; TAPANAINEN PJ, 1994, PEDIATR RES, V36, P152, DOI 10.1203/00006450-199408000-00004; Tazuke SI, 1998, P NATL ACAD SCI USA, V95, P10188, DOI 10.1073/pnas.95.17.10188; Teramo KA, 2009, NEONATOLOGY, V95, P105, DOI 10.1159/000153094; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; Wilkening S, 2003, DRUG METAB DISPOS, V31, P1035, DOI 10.1124/dmd.31.8.1035; Zhang CC, 2014, ANTIOXID REDOX SIGN, V20, P1891, DOI 10.1089/ars.2012.5019	65	2	2	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21788	10.1096/fj.202100397R	http://dx.doi.org/10.1096/fj.202100397R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34425031	Green Accepted			2022-12-28	WOS:000691122900040
J	Yu, HY; Wang, ZL; Li, ZN; An, Y; Yan, MS; Ji, ST; Xu, MH; Wang, LQ; Dong, WJ; Shi, JL; Gao, CY				Yu, Hongyin; Wang, Zelong; Li, Zhanni; An, Yao; Yan, Meishan; Ji, Shuting; Xu, Minghui; Wang, Liqiu; Dong, Weijun; Shi, Jialan; Gao, Chunyan			Hyperuricemia enhances procoagulant activity of vascular endothelial cells through TMEM16F regulated phosphatidylserine exposure and microparticle release	FASEB JOURNAL			English	Article						hyperuricemia; phosphatidylserine; TMEM16F; vascular endothelial cell; venous thromboembolism	RED-BLOOD-CELLS; URIC-ACID; VENOUS THROMBOEMBOLISM; OXIDATIVE STRESS; ACTIVATION; THROMBOSIS; CA2+; HYPERTENSION; INHIBITION; RISK	The link between serum uric acid (SUA) and the risk of venous thromboembolism (VTE) is well established. Recent data suggested a causative role of UA in endothelial cells (ECs) dysfunction. However, the molecular mechanism of high UA on thrombogenesis is unknown. We investigate whether high UA induce phosphatidylserine (PS) externalization and microparticle (MP) shedding in cultured EC, and contribute to UA-induced hypercoagulable state. In the present study, we demonstrate that UA induces PS exposure and EMP release of EC in a concentration- and time-dependent manner, which enhances the procoagulant activity (PCA) of EC and inhibited over 90% by lactadherin in vitro. Furthermore, hyperuricemic rat model was used to evaluate the development of thrombi following by flow stasis in the inferior vena cava (IVC). Hyperuricemia group is more likely to form large and hard thrombi compared with control. Importantly, we found that TMEM16F expression is significantly upregulated in UA-treated EC, which is crucial for UA-induced PS exposure and MP formation. Additionally, UA increases the generation of reactive oxygen species (ROS), lipid peroxidation, and cytosolic Ca2+ concentration in EC, which might contribute to increased TMEM16F expression. Using confocal microscopy, we also observed disruption of the actin cytoskeleton, suggesting that depolymerization of actin filaments might be required for TMEM16F activation and followed by PS exposure and membrane blebbing in UA-treated EC. Our results demonstrate a thrombotic role of EC in hyperuricemia through TMEM16F-mediated PS exposure and MPs release.	[Yu, Hongyin; Wang, Zelong; Li, Zhanni; An, Yao; Yan, Meishan; Ji, Shuting; Xu, Minghui; Gao, Chunyan] Harbin Med Univ Daqing, Dept Med Lab Sci & Technol, Daqing 163000, Peoples R China; [Wang, Liqiu] Harbin Med Univ, Hosp 5, Dept Clin Lab, Daqing, Peoples R China; [Dong, Weijun] Harbin Med Univ, Hosp 5, Dept Gen Surg, Daqing, Peoples R China; [Shi, Jialan] Harbin Med Univ, Hosp 1, Dept Hematol, Harbin, Peoples R China; [Shi, Jialan] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Gao, CY (corresponding author), Harbin Med Univ Daqing, Dept Med Lab Sci & Technol, Daqing 163000, Peoples R China.	gaochunyan1234@163.com	yan, mei/AAA-1379-2022	Shi, Jialan/0000-0001-5642-5436	National Natural Science Foundation of China [82070140]; Natural Science Foundation of Heilongjiang Province [LH2020H029]; Heilongjiang Postdoctoral Science Foundation [LBHQ19127]; PhD Fund of Harbin Medical University-Daqing [XQBSQDJ201902]; Weihan Foundation of Harbin Medical University [31021180167, DQYWH201801]; Fundamental Research Funds for the Provincial Universities [2018XN-09, 2018XN-16, 2019-KYYWF-0375]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Heilongjiang Postdoctoral Science Foundation; PhD Fund of Harbin Medical University-Daqing; Weihan Foundation of Harbin Medical University; Fundamental Research Funds for the Provincial Universities	National Natural Science Foundation of China, Grant/Award Number: 82070140; Natural Science Foundation of Heilongjiang Province, Grant/Award Number: LH2020H029; Heilongjiang Postdoctoral Science Foundation, Grant/Award Number: LBHQ19127; PhD Fund of Harbin Medical University-Daqing, Grant/Award Number: XQBSQDJ201902; Yu Weihan Foundation of Harbin Medical University, Grant/Award Number: 31021180167 and DQYWH201801; The Fundamental Research Funds for the Provincial Universities, Grant/Award Number: 2018XN-09, 2018XN-16 and 2019-KYYWF-0375	Alvadia C, 2019, ELIFE, V8, DOI 10.7554/eLife.44365; Bannow BTS, 2018, THROMB RES, V163, P138, DOI 10.1016/j.thromres.2018.01.037; Bardin T, 2014, CURR OPIN RHEUMATOL, V26, P186, DOI 10.1097/BOR.0000000000000028; BEVERS EM, 1992, BLOOD, V79, P380, DOI 10.1182/blood.V79.2.380.380; Brill A, 2011, BLOOD, V117, P1400, DOI 10.1182/blood-2010-05-287623; Cai W, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4391920; Crisan TO, 2016, ANN RHEUM DIS, V75, P755, DOI 10.1136/annrheumdis-2014-206564; De Lucchi L, 2021, J THROMB HAEMOST, V19, P194, DOI 10.1111/jth.15139; Falsetti Lorenzo, 2017, Neurol Int, V9, P6920, DOI 10.4081/ni.2017.6920; Gao CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142835; Gao CY, 2015, TOXINS, V7, P4390, DOI 10.3390/toxins7114390; Han TW, 2019, P NATL ACAD SCI USA, V116, P1309, DOI 10.1073/pnas.1817498116; Hsu WL, 2017, TOXINS, V9, DOI 10.3390/toxins9010020; Ji ST, 2020, J THROMB HAEMOST, V18, P222, DOI 10.1111/jth.14617; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kimura AK, 2021, FASEB J, V35, DOI 10.1096/fj.202001802R; Ko J, 2019, FASEB J, V33, P13334, DOI 10.1096/fj.201901148R; Kubota Y, 2016, THROMB RES, V144, P144, DOI 10.1016/j.thromres.2016.06.020; Lin H, 2018, BIOCHEM BIOPH RES CO, V503, P2348, DOI 10.1016/j.bbrc.2018.06.160; Liu GX, 2015, CELL PHYSIOL BIOCHEM, V37, P1934, DOI 10.1159/000438554; Liu XX, 2019, BIOFACTORS, V45, P326, DOI 10.1002/biof.1491; Mackman N, 2012, J CLIN INVEST, V122, P2331, DOI 10.1172/JCI60229; Martillo MA, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-013-0400-9; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Maruhashi T, 2018, ATHEROSCLEROSIS, V278, P226, DOI 10.1016/j.atherosclerosis.2018.10.007; Mazza A, 2017, BIOMED PHARMACOTHER, V86, P590, DOI 10.1016/j.biopha.2016.11.104; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Naess IA, 2007, J THROMB HAEMOST, V5, P692, DOI 10.1111/j.1538-7836.2007.02450.x; Nakagawa T, 2006, BLOOD PURIFICAT, V24, P67, DOI 10.1159/000089440; Ousingsawat J, 2019, CANCERS, V11, DOI 10.3390/cancers11050625; Ousingsawat J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0373-8; Ousingsawat J, 2017, CELL MOL LIFE SCI, V74, P173, DOI 10.1007/s00018-016-2338-3; Ozsu S, 2017, RESP CARE, V62, P1091, DOI 10.4187/respcare.05433; Sanchez-Lozada LG, 2008, AM J PHYSIOL-RENAL, V295, pF1134, DOI 10.1152/ajprenal.00104.2008; Sanchez-Lozada LG, 2012, NEPHRON EXP NEPHROL, V121, pE71, DOI 10.1159/000345509; Schenk LK, 2016, CELL PHYSIOL BIOCHEM, V38, P2452, DOI 10.1159/000445596; Schmitz B, 2016, J HYPERTENS, V34, P2138, DOI 10.1097/HJH.0000000000001109; Schreiber R, 2018, J PHYSIOL-LONDON, V596, P217, DOI 10.1113/JP275175; Simoes F, 2018, PFLUG ARCH EUR J PHY, V470, P305, DOI 10.1007/s00424-017-2065-0; Sommer A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11523; Sultan AA, 2019, CAN MED ASSOC J, V191, pE597, DOI 10.1503/cmaj.180717; Sun XL, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.602419; Toti F, 1996, BLOOD, V87, P1409, DOI 10.1182/blood.V87.4.1409.bloodjournal8741409; VanLangevelde LA, 2005, COMPARATIVE MED, V55, P55; Zhang YN, 2013, MOL CELL ENDOCRINOL, V375, P89, DOI 10.1016/j.mce.2013.04.027	45	3	3	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21808	10.1096/fj.202100426R	http://dx.doi.org/10.1096/fj.202100426R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34390515				2022-12-28	WOS:000691122900004
J	Parveen, A; Bohnert, KR; da Silva, MT; Wen, YF; Bhat, R; Roy, A; Kumar, A				Parveen, Arshiya; Bohnert, Kyle R.; Tomaz da Silva, Meiricris; Wen, Yefei; Bhat, Raksha; Roy, Anirban; Kumar, Ashok			MyD88-mediated signaling intercedes in neurogenic muscle atrophy through multiple mechanisms	FASEB JOURNAL			English	Article						denervation; ER stress; inflammation; NF-kappa B; skeletal muscle; XBP1	PATTERN-RECOGNITION RECEPTORS; PROTEIN RESPONSE PATHWAYS; SKELETAL-MUSCLE; ER STRESS; AUTOPHAGY-LYSOSOME; TARGETED ABLATION; AMPK ACTIVATION; TOLL; MASS	Skeletal muscle atrophy is a debilitating complication of many chronic disease states and disuse conditions including denervation. However, molecular and signaling mechanisms of muscle wasting remain less understood. Here, we demonstrate that the levels of several toll-like receptors (TLRs) and their downstream signaling adaptor, myeloid differentiation primary response 88 (MyD88), are induced in skeletal muscle of mice in response to sciatic nerve denervation. Muscle-specific ablation of MyD88 mitigates denervation-induced skeletal muscle atrophy in mice. Targeted ablation of MyD88 suppresses the components of ubiquitin-proteasome system, autophagy, and FOXO transcription factors in skeletal muscle during denervation. We also found that specific inhibition of MyD88 reduces the activation of canonical nuclear factor-kappa (NF-kappa B) pathway and expression of receptors for inflammatory cytokines in denervated muscle. In contrast, inhibition of MyD88 stimulates the activation of non-canonical NF-kappa B signaling in denervated skeletal muscle. Ablation of MyD88 also inhibits the denervation-induced increase in phosphorylation of AMPK without having any effect on the phosphorylation of mTOR. Moreover, targeted ablation of MyD88 inhibits the activation of a few components of the unfolded protein response (UPR) pathways, especially X-box protein 1 (XBP1). Importantly, myofiber-specific ablation of XBP1 mitigates denervation-induced skeletal muscle atrophy in mice. Collectively, our experiments suggest that TLR-MyD88 signaling mediates skeletal muscle wasting during denervation potentially through the activation of canonical NF-kappa B signaling, AMPK and UPR pathways.	[Parveen, Arshiya; Tomaz da Silva, Meiricris; Wen, Yefei; Bhat, Raksha; Roy, Anirban; Kumar, Ashok] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Hlth Bldg 2,Room 5012,4849 Calhoun Rd, Houston, TX 77204 USA; [Bohnert, Kyle R.] St Ambrose Univ, Dept Kinesiol, Davenport, IA USA	University of Houston System; University of Houston	Kumar, A (corresponding author), Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Hlth Bldg 2,Room 5012,4849 Calhoun Rd, Houston, TX 77204 USA.	akumar43@Central.UH.EDU	Bhat, Raksha/GNW-3971-2022; Roy, Anirban/AAZ-4361-2021	Bhat, Raksha/0000-0002-0026-1118; Roy, Anirban/0000-0002-5625-5403; Tomaz da Silva, Meiricris/0000-0002-7479-2595; Kumar, Ashok/0000-0001-8571-2848	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR059810, AR068313]	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR059810 and AR068313	Afroze D, 2019, FEBS J, V286, P379, DOI 10.1111/febs.14358; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Bakkar N, 2012, J CELL BIOL, V196, P497, DOI 10.1083/jcb.201108118; Bohnert KR, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00184-19; Bohnert KR, 2018, J CELL PHYSIOL, V233, P67, DOI 10.1002/jcp.25852; Bohnert KR, 2016, FASEB J, V30, P3053, DOI 10.1096/fj.201600250RR; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Bujak AL, 2015, CELL METAB, V21, P883, DOI 10.1016/j.cmet.2015.05.016; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Egawa T, 2015, AM J PHYSIOL-ENDOC M, V309, pE651, DOI 10.1152/ajpendo.00165.2015; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; Enwere EK, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003086; Flamment M, 2012, TRENDS ENDOCRIN MET, V23, P381, DOI 10.1016/j.tem.2012.06.003; Gallot YS, 2019, FASEB J, V33, P1946, DOI 10.1096/fj.201800683RR; Guo YT, 2016, ARCH BIOCHEM BIOPHYS, V600, P56, DOI 10.1016/j.abb.2016.04.015; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Henriques-Pons A, 2014, HUM MOL GENET, V23, P2604, DOI 10.1093/hmg/ddt656; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hindi SM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98441; Hindi SM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01866-w; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Jackman RW, 2013, EXP PHYSIOL, V98, P19, DOI 10.1113/expphysiol.2011.063321; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kjobsted R, 2018, FASEB J, V32, P1741, DOI 10.1096/fj.201700442R; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Larsson L, 2019, PHYSIOL REV, V99, P427, DOI 10.1152/physrev.00061.2017; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Madaro L, 2018, NAT CELL BIOL, V20, P917, DOI 10.1038/s41556-018-0151-y; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Nakashima K, 2007, BIOSCI BIOTECH BIOCH, V71, P1650, DOI 10.1271/bbb.70057; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Razani B, 2011, IMMUNOL REV, V244, P44, DOI 10.1111/j.1600-065X.2011.01059.x; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Salcedo R, 2013, TRENDS IMMUNOL, V34, P379, DOI 10.1016/j.it.2013.03.008; Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Sartori R, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20123-1; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Van Gammeren D, 2009, FASEB J, V23, P362, DOI 10.1096/fj.08-114249; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yu ZG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002321; Yuasa K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26632-w; Zhang GH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00726-x; Zhu XX, 2019, J CACHEXIA SARCOPENI, V10, P378, DOI 10.1002/jcsm.12377	53	5	5	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21821	10.1096/fj.202100777RR	http://dx.doi.org/10.1096/fj.202100777RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34325487	Green Accepted			2022-12-28	WOS:000678975300020
